Altmetric Attention Score,Title,Journal/Collection Title,Authors at my Institution,Departments,Output Type,Publication Date,DOI,ISBN,National Clinical Trial ID,URI,PubMed ID,PubMedCentral ID,Handle.net ID,ADS Bibcode,arXiv ID,RePEc ID,SSRN,Number of news stories,Number of blog posts,Number of policy documents,Number of tweets,Number of peer reviews,Number of weibo posts,Number of Facebook posts,Number of Wikipedia pages,Number of Google+ posts,Number of LinkedIn posts,Number of Reddit posts,Number of pins,Number of Research highlight platforms,Number of Q&A threads,Number of videos,Number of Mendeley readers,Details Page URL,Badge URL 2447,"10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer",New England Journal of Medicine,,,Article,2016-09-14,10.1056/nejmoa1606220,,,,27626136,,,,,,,289,17,0,637,0,0,17,0,7,0,2,0,2,0,0,304,https://www.altmetric.com/details/12003554,https://api.altmetric.com/v1/donut/12003554_240.png 1171,Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer,New England Journal of Medicine,,,Article,2016-07-06,10.1056/nejmoa1603144,,,,27433846,,,,,,,129,4,0,444,0,0,9,0,1,0,1,0,0,0,0,59,https://www.altmetric.com/details/9282970,https://api.altmetric.com/v1/donut/9282970_240.png 738,Sexual factors and prostate cancer,British Journal of Urology,,,Article,2003-07-23,10.1046/j.1464-410x.2003.04319.x,,,,12887469,,,,,,,1,5,0,767,0,0,80,4,12,0,9,0,0,1,3,79,https://www.altmetric.com/details/425010,https://api.altmetric.com/v1/donut/425010_240.png 649,Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study,Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70366-8,,,,24051140,,,,,,,69,6,0,132,0,0,87,1,12,0,2,0,0,0,0,177,https://www.altmetric.com/details/1753675,https://api.altmetric.com/v1/donut/1753675_240.png 633,Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer,JAMA Oncology,,,Article,2016-06-04,10.1001/jamaoncol.2016.1828,,,,27262168,,,,,,,138,1,0,62,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/8478110,https://api.altmetric.com/v1/donut/8478110_240.png 622,Increasing incidence of metastatic prostate cancer in the United States (2004–2013),Prostate Cancer & Prostatic Diseases,,,Article,2016-07-19,10.1038/pcan.2016.30,,,,27431496,,,,,,,91,4,0,12,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/9850895,https://api.altmetric.com/v1/donut/9850895_240.png 604,Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.,New England Journal of Medicine,,,Article,2015-10-29,10.1056/nejmp1510443,,,,26510017,,,,,,,24,11,0,597,1,0,22,1,5,0,3,0,0,0,0,5,https://www.altmetric.com/details/4700036,https://api.altmetric.com/v1/donut/4700036_240.png 566,Nut consumption and prostate cancer risk and mortality,British Journal of Cancer,,,Article,2016-06-09,10.1038/bjc.2016.181,,,,27280637,,,,,,,71,0,0,14,0,0,12,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8761160,https://api.altmetric.com/v1/donut/8761160_240.png 533,Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT),JAMA: Journal of the American Medical Association,,,Article,2011-10-12,10.1001/jama.2011.1437,,,,21990298,,,,,,,35,32,0,188,0,0,25,1,5,0,0,0,1,2,1,53,https://www.altmetric.com/details/399609,https://api.altmetric.com/v1/donut/399609_240.png 523,Recommendations on screening for prostate cancer with the prostate-specific antigen test,Canadian Medical Association Journal,,,Article,2014-11-04,10.1503/cmaj.140703,,,,25349003,,,,,,,35,1,0,379,0,0,15,0,3,0,0,0,0,0,0,14,https://www.altmetric.com/details/2812284,https://api.altmetric.com/v1/donut/2812284_240.png 500,Current Status of Prostate Cancer Diagnosis and Management in the United States,JAMA Oncology,,,Article,2016-06-23,10.1001/jamaoncol.2016.1785,,,,27356204,,,,,,,61,0,0,40,0,0,2,0,2,0,0,0,0,0,0,1,https://www.altmetric.com/details/8999914,https://api.altmetric.com/v1/donut/8999914_240.png 469,Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up,European Urology,,,Article,2016-03-29,10.1016/j.eururo.2016.03.027,,,,27033442,,,,,,,25,2,0,368,0,0,30,0,5,0,0,0,0,0,0,28,https://www.altmetric.com/details/6368624,https://api.altmetric.com/v1/donut/6368624_240.png 467,"Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis",Lancet Oncology,,,Article,2016-10-01,10.1016/s1470-2045(16)30491-0,,,,27743920,,,,,,,60,1,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12618486,https://api.altmetric.com/v1/donut/12618486_240.png 451,"Clinicopathological, functional, and immediate oncologic outcome assessment in men aged?50 years with prostate cancer after robotic prostatectomy",Urologic Oncology,,,Article,2016-08-24,10.1016/j.urolonc.2016.07.016,,,,27567690,,,,,,,57,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11676914,https://api.altmetric.com/v1/donut/11676914_240.png 450,Radical prostatectomy versus observation for localized prostate cancer.,New England Journal of Medicine,,,Article,2012-07-19,10.1056/nejmoa1113162,,,,22808955,,,,,,,11,20,6,366,0,0,11,1,3,0,1,0,3,0,0,127,https://www.altmetric.com/details/846235,https://api.altmetric.com/v1/donut/846235_240.png 443,"Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies.",American Journal of Clinical Nutrition,,,Article,2015-01-15,10.3945/ajcn.113.067157,,,,25527754,,,,,,,6,3,0,120,0,0,48,0,422,0,0,0,0,0,0,1,https://www.altmetric.com/details/2907287,https://api.altmetric.com/v1/donut/2907287_240.png 441,"Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer",New England Journal of Medicine,,,Article,2016-09-14,10.1056/nejmoa1606221,,,,27626365,,,,,,,49,5,0,160,0,0,5,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/12003565,https://api.altmetric.com/v1/donut/12003565_240.png 433,Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt174,,,,23843441,,,,,,,36,6,2,172,0,0,70,1,5,0,1,0,0,1,2,116,https://www.altmetric.com/details/1615930,https://api.altmetric.com/v1/donut/1615930_240.png 425,DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.,New England Journal of Medicine,,,Article,2015-10-29,10.1056/nejmoa1506859,,,,26510020,,,,,,,36,7,0,262,0,0,15,0,3,0,2,0,1,0,0,234,https://www.altmetric.com/details/4700077,https://api.altmetric.com/v1/donut/4700077_240.png 411,Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2015-01-27,10.1001/jama.2014.17942,,,,25626035,,,,,,,43,6,0,197,0,0,10,0,0,0,0,0,2,0,1,161,https://www.altmetric.com/details/3108917,https://api.altmetric.com/v1/donut/3108917_240.png 399,"Sexual partners, sexually transmitted infections, and prostate cancer risk",Cancer Epidemiology,,,Article,2014-12-01,10.1016/j.canep.2014.09.005,,,,25277695,,,,,,,44,6,0,62,0,2,5,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2820648,https://api.altmetric.com/v1/donut/2820648_240.png 380,Vasectomy and Risk of Aggressive Prostate Cancer: A 24-Year Follow-Up Study,Journal of Clinical Oncology,,,Article,2014-07-06,10.1200/jco.2013.54.8446,,,,25002716,,,,,,,49,1,0,47,0,2,4,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2493264,https://api.altmetric.com/v1/donut/2493264_240.png 374,Ejaculation frequency and subsequent risk of prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,2004-04-07,10.1001/jama.291.13.1578,,,,15069045,,,,,,,33,9,0,151,0,0,7,2,1,0,1,0,0,0,2,49,https://www.altmetric.com/details/273460,https://api.altmetric.com/v1/donut/273460_240.png 353,Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up ,The Lancet,,,Article,2014-08-05,10.1016/s0140-6736(14)60525-0,,,,25108889,,,,,,,24,11,0,219,0,1,10,0,0,0,0,0,0,0,0,117,https://www.altmetric.com/details/2577281,https://api.altmetric.com/v1/donut/2577281_240.png 352,Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk,JNCI: Journal of the National Cancer Institute,,,Article,2014-02-22,10.1093/jnci/djt456,,,,24563519,,,,,,,35,4,1,137,0,0,7,1,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/2139986,https://api.altmetric.com/v1/donut/2139986_240.png 329,Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies,JNCI: Journal of the National Cancer Institute,,,Article,2016-11-01,10.1093/jnci/djw153,,,,27385803,,,,,,,50,0,0,12,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9285931,https://api.altmetric.com/v1/donut/9285931_240.png 314,Long-term survival of participants in the prostate cancer prevention trial.,New England Journal of Medicine,,,Article,2013-08-15,10.1056/nejmoa1215932,,,,23944298,,,,,,,30,6,0,67,0,0,6,0,0,0,0,0,2,0,0,29,https://www.altmetric.com/details/1689776,https://api.altmetric.com/v1/donut/1689776_240.png 308,Integrative Clinical Genomics of Advanced Prostate Cancer.,Cell,,,Article,2015-05-23,10.1016/j.cell.2015.05.001,,,,26000489,,,,,,,25,7,0,110,8,0,4,0,2,0,0,0,1,0,0,342,https://www.altmetric.com/details/4036975,https://api.altmetric.com/v1/donut/4036975_240.png 304,Vasectomy and Prostate Cancer Incidence and Mortality in a Large US Cohort,Journal of Clinical Oncology,,,Article,2016-09-21,10.1200/jco.2015.66.2361,,,,27646949,,,,,,,35,2,0,57,0,0,2,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/12090725,https://api.altmetric.com/v1/donut/12090725_240.png 291,Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening,JAMA Oncology,,,Article,2016-08-18,10.1001/jamaoncol.2016.2667,,,,27541955,,,,,,,39,0,0,191,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10683413,https://api.altmetric.com/v1/donut/10683413_240.png 284,mtDNA mutations increase tumorigenicity in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2005-01-18,10.1073/pnas.0408894102,,,,15647368,,,,,,,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,142,https://www.altmetric.com/details/6120668,https://api.altmetric.com/v1/donut/6120668_240.png 273,"Prostate metastatic bone cancer in an Egyptian Ptolemaic mummy, a proposed radiological diagnosis ",International Journal of Paleopathology,,,Article,2011-10-02,10.1016/j.ijpp.2011.09.002,,,,,,,,,,,35,1,0,8,0,0,4,0,1,0,0,0,0,0,0,33,https://www.altmetric.com/details/433365,https://api.altmetric.com/v1/donut/433365_240.png 262,"Vegetarianism, low meat consumption and the risk of lung, postmenopausal breast and prostate cancer in a population-based cohort study",European Journal of Clinical Nutrition,,,Article,2016-03-02,10.1038/ejcn.2016.25,,,,26931668,,,,,,,1,0,0,341,0,0,11,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6039505,https://api.altmetric.com/v1/donut/6039505_240.png 257,Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden,JAMA Oncology,,,Article,2016-10-20,10.1001/jamaoncol.2016.3600,,,,27768168,,,,,,,38,1,0,58,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12859304,https://api.altmetric.com/v1/donut/12859304_240.png 255,"Snus use, smoking and survival among prostate cancer patients",International Journal of Cancer,,,Article,2016-10-12,10.1002/ijc.30411,,,,27582277,,,,,,,41,1,0,17,2,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12584521,https://api.altmetric.com/v1/donut/12584521_240.png 248,Final Results of a Phase I/II Multicenter Trial of WST11 (TOOKAD® Soluble) Vascular-Targeted Photodynamic Therapy (VTP) for Hemiablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Conducted in the United States,The Journal of Urology,,,Article,2016-06-09,10.1016/j.juro.2016.05.113,,,,27291652,,,,,,,37,0,0,10,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8621749,https://api.altmetric.com/v1/donut/8621749_240.png 246,Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.,New England Journal of Medicine,,,Article,2015-08-06,10.1056/nejmoa1503747,,,,26244877,,,,,,,16,2,0,243,0,0,13,0,0,0,0,0,1,0,0,212,https://www.altmetric.com/details/4368820,https://api.altmetric.com/v1/donut/4368820_240.png 242,"Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study",JNCI: Journal of the National Cancer Institute,,,Article,2016-10-01,10.1093/jnci/djw110,,,,27400876,,,,,,,34,0,0,14,0,0,1,0,1,0,2,0,0,0,0,1,https://www.altmetric.com/details/9577877,https://api.altmetric.com/v1/donut/9577877_240.png 241,Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study,Lancet Oncology,,,Article,2015-07-22,10.1016/s1470-2045(13)70606-5,,,,24440474,,,,,,,15,3,0,169,0,0,6,0,1,0,0,0,0,0,0,58,https://www.altmetric.com/details/2049691,https://api.altmetric.com/v1/donut/2049691_240.png 240,"Annual Report to the Nation on the status of cancer, 1975?2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer",Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28509,,,,24343171,,,,,,,28,5,0,81,0,0,16,0,1,0,0,0,0,0,0,195,https://www.altmetric.com/details/1983605,https://api.altmetric.com/v1/donut/1983605_240.png 239,Implementation of a Machine Learning–Based Automatic Contour Quality Assurance Tool for Online Adaptive Radiation Therapy of Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-10-01,10.1016/j.ijrobp.2016.06.2300,,,,27675310,,,,,,,33,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12577712,https://api.altmetric.com/v1/donut/12577712_240.png 233,Serial MRI in Active Surveillance of Prostate Cancer: Incremental Value ,The Journal of Urology,,,Article,2015-12-18,10.1016/j.juro.2015.11.055,,,,26674305,,,,,,,35,0,0,9,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4849878,https://api.altmetric.com/v1/donut/4849878_240.png 232,The relationship between intolerance of uncertainty and anxiety in men on active surveillance for prostate cancer,The Journal of Urology,,,Article,2016-02-09,10.1016/j.juro.2016.01.108,,,,26872841,,,,,,,35,0,0,8,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5172754,https://api.altmetric.com/v1/donut/5172754_240.png 232,Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians,Annals of Internal Medicine,,,Article,2013-01-01,10.7326/0003-4819-158-10-201305210-00633,,,,23567643,,,,,,,14,5,0,166,0,0,5,1,0,0,0,0,0,0,0,76,https://www.altmetric.com/details/1353241,https://api.altmetric.com/v1/donut/1353241_240.png 230,Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-06-13,10.1200/jco.2016.66.7527,,,,27298404,,,,,,,21,2,0,129,0,0,4,0,0,0,0,0,1,0,0,17,https://www.altmetric.com/details/8713973,https://api.altmetric.com/v1/donut/8713973_240.png 229,"A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer|[mdash]|the UK NCRN Pomi-T study",Prostate Cancer & Prostatic Diseases,,,Article,2014-03-11,10.1038/pcan.2014.6,,,,24614693,,,,,,,3,0,0,292,0,0,13,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/2186096,https://api.altmetric.com/v1/donut/2186096_240.png 228,Urologists' use of intensity-modulated radiation therapy for prostate cancer.,New England Journal of Medicine,,,Article,2013-10-24,10.1056/nejmsa1201141,,,,24152262,,,,,,,29,6,0,75,0,0,1,0,1,0,0,0,1,0,0,30,https://www.altmetric.com/details/1854451,https://api.altmetric.com/v1/donut/1854451_240.png 228,The evolutionary history of lethal metastatic prostate cancer,Nature,,,Article,2015-04-01,10.1038/nature14347,,,,25830880,,,,,,,11,8,0,176,0,0,9,0,2,0,0,0,1,0,0,403,https://www.altmetric.com/details/3860330,https://api.altmetric.com/v1/donut/3860330_240.png 226,Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer,New England Journal of Medicine,,,Article,2013-01-31,10.1056/nejmoa1209978,,,,23363497,,,,,,,14,4,0,113,0,0,8,1,2,0,0,0,1,0,0,116,https://www.altmetric.com/details/1208871,https://api.altmetric.com/v1/donut/1208871_240.png 225,Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis,JAMA Oncology,,,Article,2016-01-21,10.1001/jamaoncol.2015.5871,,,,26794060,,,,,,,24,0,0,164,0,0,8,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5022664,https://api.altmetric.com/v1/donut/5022664_240.png 221,"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial ",Lancet Oncology,,,Article,2016-06-20,10.1016/s1470-2045(16)30102-4,,,,27339115,PMC4961874,,,,,,21,1,0,164,0,0,2,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/8941057,https://api.altmetric.com/v1/donut/8941057_240.png 219,"Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",Journal of Clinical Oncology,,,Article,2014-09-14,10.1200/jco.2014.55.4279,,,,25225425,,,,,,,16,1,0,116,0,0,7,0,3,0,2,0,0,0,1,27,https://www.altmetric.com/details/2686085,https://api.altmetric.com/v1/donut/2686085_240.png 219,A role for finasteride in the prevention of prostate cancer?,New England Journal of Medicine,,,Article,2013-08-15,10.1056/nejme1307059,,,,23944306,,,,,,,24,2,0,13,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1689909,https://api.altmetric.com/v1/donut/1689909_240.png 218,Benefits of whole ginger extract in prostate cancer.,British Journal of Nutrition,,,Article,1970-01-01,10.1017/s0007114511003308,,,,21849094,,,,,,,2,6,0,98,0,0,70,0,107,0,0,0,0,0,0,59,https://www.altmetric.com/details/240586,https://api.altmetric.com/v1/donut/240586_240.png 216,Effect of Acute Exercise on Prostate Cancer Cell Growth,PLoS ONE,,,Article,2013-07-05,10.1371/journal.pone.0067579,,,,23861774,,,,,,,0,1,0,274,0,0,35,0,10,0,5,0,0,0,0,47,https://www.altmetric.com/details/1610037,https://api.altmetric.com/v1/donut/1610037_240.png 208,Radical prostatectomy or watchful waiting in early prostate cancer.,New England Journal of Medicine,,,Article,2014-03-06,10.1056/nejmoa1311593,,,,24597866,,,,,,,19,6,0,93,0,0,4,0,8,0,0,0,2,0,0,22,https://www.altmetric.com/details/2170875,https://api.altmetric.com/v1/donut/2170875_240.png 200,Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B,Nature Medicine,,,Article,2012-08-05,10.1038/nm.2890,,,,22863786,,,,,,,1,7,0,146,0,0,148,1,1,0,0,1,4,1,0,257,https://www.altmetric.com/details/873851,https://api.altmetric.com/v1/donut/873851_240.png 198,Vitamin d deficiency predicts prostate biopsy outcomes.,Clinical Cancer Research,,,Article,2014-05-01,10.1158/1078-0432.ccr-13-3085,,,,24789033,,,,,,,23,5,0,28,0,0,8,0,0,0,0,0,0,0,1,23,https://www.altmetric.com/details/2318433,https://api.altmetric.com/v1/donut/2318433_240.png 198,"An Observational Study of Erectile Dysfunction, Infertility, and Prostate Cancer in Regular Cyclists: Cycling for Health UK Study",Journal of Men's Health,,,Article,2014-06-01,10.1089/jomh.2014.0012,,,,,,,,,,,21,1,0,52,0,4,5,1,0,0,2,0,0,0,1,12,https://www.altmetric.com/details/2440494,https://api.altmetric.com/v1/donut/2440494_240.png 197,Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-03-24,10.1097/coc.0000000000000285,,,http://journals.lww.com/amjclinicaloncology/Fulltext/publishahead/Impact_of_Radiation_Therapy_Dose_Escalation_on.99059.aspx,27014930,,,,,,,29,2,0,15,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6346893,https://api.altmetric.com/v1/donut/6346893_240.png 194,Active Surveillance for Low-Risk Prostate Cancer—An Evolving International Standard of Care,JAMA Oncology,,,Article,2016-10-20,10.1001/jamaoncol.2016.3179,,,,27768167,,,,,,,31,1,0,33,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12859305,https://api.altmetric.com/v1/donut/12859305_240.png 193,Prostate-cancer mortality at 11 years of follow-up.,New England Journal of Medicine,,,Article,2012-03-15,10.1056/nejmoa1113135,,,,22417251,,,,,,,10,12,1,118,0,0,11,0,3,0,0,0,0,0,0,235,https://www.altmetric.com/details/649295,https://api.altmetric.com/v1/donut/649295_240.png 191,Enzalutamide in Metastatic Prostate Cancer before Chemotherapy.,New England Journal of Medicine,,,Article,2014-06-01,10.1056/nejmoa1405095,,,,24881730,,,,,,,19,2,0,98,0,1,8,2,0,0,0,0,1,0,0,182,https://www.altmetric.com/details/2398809,https://api.altmetric.com/v1/donut/2398809_240.png 190,Coffee Consumption and Prostate Cancer Risk and Progression in the Health Professionals Follow-up Study,JNCI: Journal of the National Cancer Institute,,,Article,2011-05-17,10.1093/jnci/djr151,,,,21586702,PMC3110172,,,,,,10,6,0,122,0,0,21,0,1,0,0,0,0,0,0,55,https://www.altmetric.com/details/101710,https://api.altmetric.com/v1/donut/101710_240.png 185,Combining radiotherapy and immunotherapy for prostate cancer: two decades of research from preclinical to clinical trials,Journal of Radiation Oncology,,,Article,2015-12-09,10.1007/s13566-015-0240-5,,,,,,,,,,,32,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4870367,https://api.altmetric.com/v1/donut/4870367_240.png 182,Population-based assessment of determining predictors for quality of prostate cancer surveillance.,Cancer (0008543X),,,Article,2015-12-01,10.1002/cncr.29574,,,,26307939,,,,,,,24,1,0,10,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4459500,https://api.altmetric.com/v1/donut/4459500_240.png 181,Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer,The Journal of Urology,,,Article,2016-03-11,10.1016/j.juro.2016.02.2972,,,,26976206,,,,,,,43,1,0,17,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6174219,https://api.altmetric.com/v1/donut/6174219_240.png 180,Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations,JAMA: Journal of the American Medical Association,,,Article,2015-11-17,10.1001/jama.2015.14905,,,,26575061,,,,,,,8,4,0,166,0,0,4,0,0,0,0,0,1,0,0,61,https://www.altmetric.com/details/4773469,https://api.altmetric.com/v1/donut/4773469_240.png 178,Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells,Cancer Research,,,Article,2016-05-01,10.1158/0008-5472.can-15-2186,,,,27197266,PMC4874658,,,,,,24,1,0,6,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/7130783,https://api.altmetric.com/v1/donut/7130783_240.png 176,Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial,The Journal of Urology,,,Article,2016-01-10,10.1016/j.juro.2015.12.083,,,,26748164,,,,,,,27,0,0,7,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4942470,https://api.altmetric.com/v1/donut/4942470_240.png 175,"Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial",The Lancet,,,Article,2015-12-01,10.1016/s0140-6736(15)01037-5,,,,26719232,,,,,,,4,2,0,230,0,0,7,0,1,0,0,0,0,0,0,147,https://www.altmetric.com/details/4908127,https://api.altmetric.com/v1/donut/4908127_240.png 172,Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-04-17,10.1158/1055-9965.epi-13-1126,,,,24748218,,,,,,,28,1,0,12,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2290987,https://api.altmetric.com/v1/donut/2290987_240.png 172,Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.,EBioMedicine,,,Article,2015-07-01,10.1016/j.ebiom.2015.07.017,,,,26501111,,,,,,,15,5,0,75,0,0,4,0,0,0,0,0,0,0,0,86,https://www.altmetric.com/details/4342127,https://api.altmetric.com/v1/donut/4342127_240.png 172,Screening and prostate-cancer mortality in a randomized European study.,New England Journal of Medicine,,,Article,2009-03-26,10.1056/nejmoa0810084,,,,19297566,,,,,,,9,18,0,15,0,0,0,1,0,0,0,0,5,0,0,799,https://www.altmetric.com/details/408292,https://api.altmetric.com/v1/donut/408292_240.png 169,Mortality results from a randomized prostate-cancer screening trial.,New England Journal of Medicine,,,Article,2009-03-26,10.1056/nejmoa0810696,,,,19297565,,,,,,,11,19,0,10,0,0,0,2,0,0,0,0,4,0,0,344,https://www.altmetric.com/details/408291,https://api.altmetric.com/v1/donut/408291_240.png 168,"A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer",Nature Genetics,,,Article,2014-09-14,10.1038/ng.3094,,,,25217961,,,,,,,16,2,0,87,0,5,1,0,1,0,0,0,0,0,0,129,https://www.altmetric.com/details/2682608,https://api.altmetric.com/v1/donut/2682608_240.png 168,Adherence to dietary and lifestyle recommendations and prostate cancer risk in the Prostate Testing for Cancer and Treatment (ProtecT) trial,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-07-12,10.1158/1055-9965.epi-14-0322,,,,25017249,,,,,,,15,8,0,20,0,1,10,0,0,0,1,0,0,1,1,54,https://www.altmetric.com/details/2526652,https://api.altmetric.com/v1/donut/2526652_240.png 166,The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications,Indian Journal of Urology,,,Article,2012-01-01,10.4103/0970-1591.94942,,,,22557710,,,,,,,1,0,0,88,0,0,436,0,30,0,0,0,0,1,12,11,https://www.altmetric.com/details/693733,https://api.altmetric.com/v1/donut/693733_240.png 165,Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer,JAMA Oncology,,,Article,2015-10-22,10.1001/jamaoncol.2015.3384,,,,26502115,,,,,,,23,2,0,43,0,0,6,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4661873,https://api.altmetric.com/v1/donut/4661873_240.png 163,Alpha emitter radium-223 and survival in metastatic prostate cancer.,New England Journal of Medicine,,,Article,2013-07-18,10.1056/nejmoa1213755,,,,23863050,,,,,,,6,4,5,144,2,0,6,0,2,0,0,0,1,0,0,372,https://www.altmetric.com/details/1631816,https://api.altmetric.com/v1/donut/1631816_240.png 162,Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.,Lancet Oncology,,,Article,2015-11-14,10.1016/s1470-2045(15)00361-7,,,,26563502,,,,,,,16,0,0,99,0,0,3,1,1,0,0,0,0,0,0,73,https://www.altmetric.com/details/4742986,https://api.altmetric.com/v1/donut/4742986_240.png 161,Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer,Journal of Clinical Oncology,,,Article,2014-12-15,10.1200/jco.2014.55.1192,,,,25512465,,,,,,,16,3,0,73,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2987226,https://api.altmetric.com/v1/donut/2987226_240.png 160,Effectiveness of Androgen-Deprivation Therapy and Radiotherapy for Older Men With Locally Advanced Prostate Cancer.,Journal of Clinical Oncology,,,Article,2015-03-01,10.1200/jco.2014.57.2743,,,,25559808,,,,,,,22,0,0,29,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3039103,https://api.altmetric.com/v1/donut/3039103_240.png 159,"Trends in Management for Patients With Localized Prostate Cancer, 1990-2013",JAMA: Journal of the American Medical Association,,,Article,2015-07-07,10.1001/jama.2015.6036,,,,26151271,,,,,,,14,4,0,101,0,0,12,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4252081,https://api.altmetric.com/v1/donut/4252081_240.png 159,Screening for prostate cancer,Cochrane database of systematic reviews,,,Article,2013-01-01,10.1002/14651858.cd004720.pub3,,,,23440794,,,,,,,19,4,6,80,0,0,8,0,1,0,1,0,1,0,0,85,https://www.altmetric.com/details/1211321,https://api.altmetric.com/v1/donut/1211321_240.png 157,Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2015-09-22,10.1001/jama.2015.8577,,,,26393854,,,,,,,17,5,0,42,0,0,5,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4541324,https://api.altmetric.com/v1/donut/4541324_240.png 153,Treatment or Monitoring for Early Prostate Cancer,New England Journal of Medicine,,,Article,2016-09-14,10.1056/nejme1610395,,,,27627134,,,,,,,12,1,0,116,0,0,4,0,1,0,1,0,0,0,0,0,https://www.altmetric.com/details/12003714,https://api.altmetric.com/v1/donut/12003714_240.png 153,Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis,British Medical Journal,,,Article,2016-03-02,10.1136/bmj.i851,,,,26936410,PMC4775870,,,,,,6,3,0,162,0,0,6,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6043125,https://api.altmetric.com/v1/donut/6043125_240.png 153,Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate CancerAdvanced Treatment Among Men With Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2013-01-01,10.1001/jama.2013.6882,,,,23800935,,,,,,,11,3,0,64,0,0,4,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1582598,https://api.altmetric.com/v1/donut/1582598_240.png 152,Autonomic Nerve Development Contributes to Prostate Cancer Progression,Science,,,Article,2013-07-12,10.1126/science.1236361,,,,23846904,,,,,,,14,3,0,40,0,0,13,0,0,0,0,0,2,0,0,8,https://www.altmetric.com/details/1619256,https://api.altmetric.com/v1/donut/1619256_240.png 150,"Roles of diet, lifetime physical activity and oxidative DNA damage in the occurrence of prostate cancer among men in Klang Valley, Malaysia.",Asian Pacific Journal of Cancer Prevention,,,Article,2011-06-02,,,,,21627352,,,,,,,1,0,0,5,0,0,75,0,124,0,0,0,0,0,0,27,https://www.altmetric.com/details/2376616,https://api.altmetric.com/v1/donut/2376616_240.png 149,Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients,PLoS ONE,,,Article,2016-02-10,10.1371/journal.pone.0147739,,,,26863016,,,,,,,20,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5322612,https://api.altmetric.com/v1/donut/5322612_240.png 148,Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array,Nature Genetics,,,Article,2013-03-27,10.1038/ng.2560,,,,23535732,,,,,,,23,1,0,10,0,0,3,0,0,0,0,0,0,0,0,180,https://www.altmetric.com/details/1325131,https://api.altmetric.com/v1/donut/1325131_240.png 145,Olfactory System of Highly Trained Dogs Detects Prostate Cancer in Urine Samples,The Journal of Urology,,,Article,2014-09-24,10.1016/j.juro.2014.09.099,,,,25264338,,,,,,,12,3,0,33,0,0,15,0,1,0,0,0,0,1,0,40,https://www.altmetric.com/details/2717902,https://api.altmetric.com/v1/donut/2717902_240.png 144,Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening,Cancer (0008543X),,,Article,2016-09-22,10.1002/cncr.30330,,,,27658175,,,,,,,24,0,0,14,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12155459,https://api.altmetric.com/v1/donut/12155459_240.png 142,Dietary Patterns after Prostate Cancer Diagnosis in Relation to Disease-Specific and Total Mortality,Cancer Prevention Research,,,Article,2015-06-01,10.1158/1940-6207.capr-14-0442,,,,26031631,,,,,,,13,2,0,43,0,0,15,0,3,0,0,0,0,0,0,13,https://www.altmetric.com/details/4077147,https://api.altmetric.com/v1/donut/4077147_240.png 142,Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial,European Journal of Cancer (1965),,,Article,2016-05-01,10.1016/j.ejca.2016.02.014,,,,27035363,,,,,,,14,2,0,37,0,0,1,0,1,0,1,0,0,0,0,7,https://www.altmetric.com/details/6391322,https://api.altmetric.com/v1/donut/6391322_240.png 137,Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers,Endocrine-Related Cancer,,,Article,2014-08-01,10.1530/erc-14-0234,,,,24859988,,,,,,,13,6,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2410118,https://api.altmetric.com/v1/donut/2410118_240.png 137,Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality,JAMA Internal Medicine,,,Article,2013-01-01,10.1001/jamainternmed.2013.6536,,,,23752662,,,,,,,13,1,0,47,0,0,12,0,1,0,0,0,0,0,0,38,https://www.altmetric.com/details/1547057,https://api.altmetric.com/v1/donut/1547057_240.png 136,Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy.,New England Journal of Medicine,,,Article,2012-12-10,10.1056/nejmoa1209096,,,,23228172,,,,,,,2,7,6,122,0,0,4,1,0,0,0,0,2,0,0,388,https://www.altmetric.com/details/1116937,https://api.altmetric.com/v1/donut/1116937_240.png 133,Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement.,Annals of Internal Medicine,,,Article,2012-01-01,10.1059/0003-4819-157-2-201207170-00459,,,,22615453,,,,,,,0,7,0,114,0,0,8,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/754448,https://api.altmetric.com/v1/donut/754448_240.png 131,AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer.,New England Journal of Medicine,,,Article,2014-09-03,10.1056/nejmoa1315815,,,,25184630,,,,,,,15,2,0,24,0,0,1,3,1,0,0,0,2,0,0,299,https://www.altmetric.com/details/2653421,https://api.altmetric.com/v1/donut/2653421_240.png 131,Are strict vegetarians protected against prostate cancer?,American Journal of Clinical Nutrition,,,Article,2015-11-13,10.3945/ajcn.114.106450,,,,26561618,,,,,,,2,0,0,152,0,0,15,0,0,0,5,0,0,0,0,27,https://www.altmetric.com/details/4752275,https://api.altmetric.com/v1/donut/4752275_240.png 130,High-Intensity Focused Ultrasound for Prostate Cancer: Novelty or Innovation?,JAMA: Journal of the American Medical Association,,,Article,2016-06-28,10.1001/jama.2016.5002,,,,27367874,,,,,,,14,1,0,41,0,0,0,0,2,0,0,0,0,0,0,1,https://www.altmetric.com/details/9102034,https://api.altmetric.com/v1/donut/9102034_240.png 129,Prevalence of Prostate Cancer on Autopsy: Cross-Sectional Study on Unscreened Caucasian and Asian Men,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt151,,,,23847245,,,,,,,14,0,0,29,0,0,9,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1619400,https://api.altmetric.com/v1/donut/1619400_240.png 127,Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States,The Journal of Urology,,,Article,2015-06-19,10.1016/j.juro.2015.06.075,,,,26087383,,,,,,,7,3,0,88,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/4164671,https://api.altmetric.com/v1/donut/4164671_240.png 127,A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.,New England Journal of Medicine,,,Article,2002-09-12,10.1056/nejmoa012794,,,,,,,,,,,0,0,0,162,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1577069,https://api.altmetric.com/v1/donut/1577069_240.png 127,Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy.,New England Journal of Medicine,,,Article,2012-08-15,10.1056/nejmoa1207506,,,,22894553,,,,,,,2,4,6,130,0,0,13,1,0,1,0,0,3,0,0,232,https://www.altmetric.com/details/889555,https://api.altmetric.com/v1/donut/889555_240.png 126,"Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.",Cancer Research,,,Article,2006-01-01,10.1158/0008-5472.can-05-0087,,,,16540674,,,,,,,1,5,0,70,0,0,138,0,1,0,0,0,0,0,0,56,https://www.altmetric.com/details/572701,https://api.altmetric.com/v1/donut/572701_240.png 126,Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study,Science Translational Medicine,,,Article,2015-01-07,10.1126/scitranslmed.3010563,,,,25568070,,,,,,,13,3,0,16,0,0,5,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3044756,https://api.altmetric.com/v1/donut/3044756_240.png 124,Integrating Molecular Profiling of Liquid Biopsy Samples with a Calculator Algorithm To Detect High-risk Prostate Cancer,European Urology,,,Article,2016-05-25,10.1016/j.eururo.2016.05.012,,,,27234996,,,,,,,35,0,0,16,0,0,1,0,3,0,0,0,0,0,0,3,https://www.altmetric.com/details/8207544,https://api.altmetric.com/v1/donut/8207544_240.png 123,A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score ,European Urology,,,Article,2015-07-15,10.1016/j.eururo.2015.06.046,,,,26166626,,,,,,,1,1,0,260,0,0,7,0,1,0,0,0,0,0,0,109,https://www.altmetric.com/details/4267725,https://api.altmetric.com/v1/donut/4267725_240.png 122,Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth In Vitro,PLoS ONE,"SOLO, Ben",School of Medicine & Medical Science; Department of Life Sciences,Article,2014-03-03,10.1371/journal.pone.0090332,,,,24594937,,,,,,,13,2,0,24,0,0,0,0,0,0,2,0,0,0,0,18,https://www.altmetric.com/details/2159473,https://api.altmetric.com/v1/donut/2159473_240.png 122,Consumption of deep?fried foods and risk of prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22643,,,,23335051,,,,,,,9,4,0,51,0,0,19,0,2,0,0,0,0,0,0,28,https://www.altmetric.com/details/1190250,https://api.altmetric.com/v1/donut/1190250_240.png 120,Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2016-03-01,10.1093/jnci/djv329,,,,26577654,,,,,,,11,2,0,42,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4777254,https://api.altmetric.com/v1/donut/4777254_240.png 120,A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease,Human Molecular Genetics,,,Article,2013-01-01,10.1093/hmg/dds425,,,,23065704,,,,,,,18,0,0,1,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1134262,https://api.altmetric.com/v1/donut/1134262_240.png 120,Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity.,British Journal of Urology,,,Article,2015-02-27,10.1111/bju.12969,,,,25345838,,,,,,,10,5,0,53,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3270940,https://api.altmetric.com/v1/donut/3270940_240.png 119,A Walnut-Enriched Diet Reduces the Growth of LNCaP Human Prostate Cancer Xenografts in Nude Mice,Cancer Investigation,,,Article,2013-06-15,10.3109/07357907.2013.800095,,,,23758186,,,,,,,14,1,0,7,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1628720,https://api.altmetric.com/v1/donut/1628720_240.png 118,Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-10-09,10.1158/1055-9965.epi-14-0458,,,,25304929,,,,,,,12,3,0,21,0,0,7,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2759044,https://api.altmetric.com/v1/donut/2759044_240.png 118,Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT),JAMA: Journal of the American Medical Association,,,Article,2009-01-07,10.1001/jama.2008.864,,,,19066370,,,,,,,8,7,2,8,0,0,2,2,1,0,0,0,1,0,0,71,https://www.altmetric.com/details/184926,https://api.altmetric.com/v1/donut/184926_240.png 117,The cost implications of prostate cancer screening in the Medicare population,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28373,,,,24122801,,,,,,,15,0,0,24,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1804075,https://api.altmetric.com/v1/donut/1804075_240.png 117,Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement,Annals of Internal Medicine,,,Article,2012-01-01,10.7326/0003-4819-157-2-201207170-00459,,,,22801674,,,,,,,11,6,0,31,0,0,19,0,2,0,0,0,0,0,0,50,https://www.altmetric.com/details/843906,https://api.altmetric.com/v1/donut/843906_240.png 116,Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy in the treatment of prostate cancer,Journal of Radiation Oncology,,,Article,2015-12-12,10.1007/s13566-015-0239-y,,,,,,,,,,,14,2,0,10,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4870385,https://api.altmetric.com/v1/donut/4870385_240.png 116,"Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial",JAMA: Journal of the American Medical Association,,,Article,2011-06-08,10.1001/jama.2011.766,,,,21642681,,,,,,,3,19,1,36,0,0,3,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/113181,https://api.altmetric.com/v1/donut/113181_240.png 115,Agent Orange as a risk factor for high-grade prostate cancer.,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27941,,,,23670242,,,,,,,14,0,0,29,0,0,9,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1470074,https://api.altmetric.com/v1/donut/1470074_240.png 114,"Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies",The Prostate,,,Article,2016-04-28,10.1002/pros.23191,,,,27121847,,,,,,,15,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7068807,https://api.altmetric.com/v1/donut/7068807_240.png 113,Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer,Circulation,,,Article,2016-02-02,10.1161/circulationaha.115.012519,,,,26831435,,,,,,,12,1,0,23,0,0,6,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5072979,https://api.altmetric.com/v1/donut/5072979_240.png 113,Fifteen-Year Survival Outcomes Following Primary Androgen-Deprivation Therapy for Localized Prostate Cancer.,JAMA Internal Medicine,,,Article,2014-07-13,10.1001/jamainternmed.2014.3028,,,,25023796,,,,,,,10,1,0,61,0,0,2,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2508287,https://api.altmetric.com/v1/donut/2508287_240.png 113,Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice,Scientific Reports,,,Article,2016-08-31,10.1038/srep32062,,,,27576789,,,,,,,14,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10962481,https://api.altmetric.com/v1/donut/10962481_240.png 113,"Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression",Human Molecular Genetics,,,Article,2013-01-01,10.1093/hmg/ddt086,,,,23535824,,,,,,,17,0,0,1,0,0,1,0,0,0,0,0,0,0,0,77,https://www.altmetric.com/details/1324864,https://api.altmetric.com/v1/donut/1324864_240.png 113,The Pendulum of Prostate Cancer Screening,JAMA: Journal of the American Medical Association,,,Article,2015-11-17,10.1001/jama.2015.13775,,,,26575059,,,,,,,12,6,0,13,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4773471,https://api.altmetric.com/v1/donut/4773471_240.png 112,Light Reflectance Spectroscopy to Detect Positive Surgical Margins on Prostate Cancer Specimens,The Journal of Urology,,,Article,2015-09-28,10.1016/j.juro.2015.05.115,,,,26410735,,,,,,,15,1,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4550858,https://api.altmetric.com/v1/donut/4550858_240.png 112,Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer,JAMA Oncology,,,Article,2015-07-16,10.1001/jamaoncol.2015.2316,,,,26181727,,,,,,,9,2,0,79,0,0,7,0,1,0,0,0,0,0,0,21,https://www.altmetric.com/details/4285184,https://api.altmetric.com/v1/donut/4285184_240.png 112,Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-09-02,10.1200/jco.2015.62.5764,,,,26324359,,,,,,,7,3,0,72,0,0,1,0,1,0,0,0,0,0,0,40,https://www.altmetric.com/details/4457474,https://api.altmetric.com/v1/donut/4457474_240.png 111,Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-04-11,10.1200/jco.2015.64.1969,,,,27069075,,,,,,,12,1,0,39,0,0,4,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/6616244,https://api.altmetric.com/v1/donut/6616244_240.png 111,Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).,JAMA Oncology,,,Article,2015-04-16,10.1001/jamaoncol.2015.0513,,,,26181184,,,,,,,5,0,0,125,0,0,10,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3914338,https://api.altmetric.com/v1/donut/3914338_240.png 110,Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70121-3,,,,22512844,,,,,,,11,0,0,24,0,0,3,1,0,0,0,0,2,0,0,156,https://www.altmetric.com/details/699945,https://api.altmetric.com/v1/donut/699945_240.png 108,Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1,Journal of Clinical Oncology,,,Article,2016-07-11,10.1200/jco.2015.65.5597,,,,27400947,,,,,,,13,1,0,28,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9623172,https://api.altmetric.com/v1/donut/9623172_240.png 108,Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer,Nature Communications,,,Article,2016-02-29,10.1038/ncomms10798,,,,26924072,,,,,,,14,3,0,15,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6019014,https://api.altmetric.com/v1/donut/6019014_240.png 107,The Association Between Phosphodiesterase Type-5 Inhibitors and Prostate Cancer: Results from the REDUCE Study,The Journal of Urology,,,Article,2016-04-05,10.1016/j.juro.2016.03.172,,,,27060053,,,,,,,14,1,0,10,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6488634,https://api.altmetric.com/v1/donut/6488634_240.png 107,Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.,The Prostate,,,Article,2003-06-15,10.1002/pros.10190,,,,12746841,,,,,,,0,0,0,55,0,0,331,0,35,0,0,0,0,0,9,23,https://www.altmetric.com/details/1136630,https://api.altmetric.com/v1/donut/1136630_240.png 107,Randomized Trial to Assess the Impact of Venlafaxine and Soy Protein on Hot Flashes and Quality of Life in Men With Prostate Cancer.,Journal of Clinical Oncology,,,Article,2013-09-30,10.1200/jco.2012.48.1432,,,,24081940,,,,,,,14,0,0,7,0,0,0,0,2,0,0,0,1,0,0,9,https://www.altmetric.com/details/1796056,https://api.altmetric.com/v1/donut/1796056_240.png 107,Vegetable and fruit intake after diagnosis and risk of prostate cancer progression.,International Journal of Cancer,,,Article,2011-08-05,10.1002/ijc.26348,,,,21823116,,,,,,,0,2,0,13,0,0,355,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/481597,https://api.altmetric.com/v1/donut/481597_240.png 105,Individualized Estimates of Overdiagnosis in Screen-Detected Prostate Cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2014-01-07,10.1093/jnci/djt367,,,,24399850,,,,,,,19,1,0,11,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2028415,https://api.altmetric.com/v1/donut/2028415_240.png 105,Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.,Oncogene,,,Article,2014-11-10,10.1038/onc.2014.360,,,,25381816,,,,,,,9,4,0,4,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2870525,https://api.altmetric.com/v1/donut/2870525_240.png 104,Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis,European Urology,,,Article,2015-12-15,10.1016/j.eururo.2015.11.010,,,,26700655,,,,,,,11,0,0,49,0,0,5,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/4877388,https://api.altmetric.com/v1/donut/4877388_240.png 104,Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement,Journal of Clinical Oncology,,,Article,2016-02-16,10.1200/jco.2015.65.7759,,,,26884580,,,,,,,13,0,0,68,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5622831,https://api.altmetric.com/v1/donut/5622831_240.png 104,"Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial",Cancer (0008543X),,,Article,2014-12-22,10.1002/cncr.28952,,,,25533883,,,,,,,13,1,0,11,0,0,4,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/3006725,https://api.altmetric.com/v1/donut/3006725_240.png 103,Plasma AR and abiraterone-resistant prostate cancer,Science Translational Medicine,,,Article,2015-11-04,10.1126/scitranslmed.aac9511,,,,26537258,,,,,,,9,3,0,27,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/4724685,https://api.altmetric.com/v1/donut/4724685_240.png 102,Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.,Archives of Pathology & Laboratory Medicine,,,Article,2016-01-14,10.5858/arpa.2015-0487-sa,,,,26756649,,,,,,,0,3,0,249,0,0,3,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4989386,https://api.altmetric.com/v1/donut/4989386_240.png 102,Physician Variation in Management of Low-Risk Prostate Cancer: A Population-Based Cohort Study.,JAMA Internal Medicine,,,Article,2014-09-01,10.1001/jamainternmed.2014.3021,,,,25023650,,,,,,,11,0,0,46,0,0,1,1,1,0,0,0,0,0,0,33,https://www.altmetric.com/details/2508286,https://api.altmetric.com/v1/donut/2508286_240.png 102,Circumcision and the risk of prostate cancer,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.26653,,,,22411189,,,,,,,4,6,0,54,0,0,4,0,1,0,0,0,0,0,0,20,https://www.altmetric.com/details/645162,https://api.altmetric.com/v1/donut/645162_240.png 101,Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djs463,,,,23243199,,,,,,,6,6,0,29,0,0,1,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1125346,https://api.altmetric.com/v1/donut/1125346_240.png 99,Milk stimulates growth of prostate cancer cells in culture.,Nutrition and Cancer,,,Article,2011-11-01,10.1080/01635581.2011.609306,,,,22043817,,,,,,,3,2,0,75,0,0,3,0,1,0,0,0,0,1,3,10,https://www.altmetric.com/details/472284,https://api.altmetric.com/v1/donut/472284_240.png 99,Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study,European Urology,,,Article,2015-02-11,10.1016/j.eururo.2015.01.030,,,,25682339,,,,,,,12,0,0,35,0,0,2,0,1,0,0,0,0,0,0,45,https://www.altmetric.com/details/3542505,https://api.altmetric.com/v1/donut/3542505_240.png 99,Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue,Nature Genetics,,,Article,2015-03-02,10.1038/ng.3221,,,,25730763,,,,,,,7,5,0,18,0,0,1,0,1,0,0,0,1,0,0,175,https://www.altmetric.com/details/3747014,https://api.altmetric.com/v1/donut/3747014_240.png 99,"Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7",European Urology,,,Article,2016-03-29,10.1016/j.eururo.2016.03.021,,,,27025586,,,,,,,11,1,0,18,0,0,2,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/6370182,https://api.altmetric.com/v1/donut/6370182_240.png 98,A Molecular Signature Predictive of Indolent Prostate Cancer,Science Translational Medicine,,,Article,2013-09-11,10.1126/scitranslmed.3006408,,,,24027026,,,,,,,10,0,0,33,0,0,1,0,0,0,0,0,1,0,0,103,https://www.altmetric.com/details/1743910,https://api.altmetric.com/v1/donut/1743910_240.png 98,Population-Based Assessment of Determining Treatments for Prostate Cancer,JAMA Oncology,,,Article,2015-07-17,10.1001/jamaoncol.2014.192,,,,26182305,,,,,,,12,0,0,48,0,0,3,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3714948,https://api.altmetric.com/v1/donut/3714948_240.png 98,The Molecular Taxonomy of Primary Prostate Cancer.,Cell,,,Article,2015-05-11,10.1016/j.cell.2015.10.025,,,,26544944,,,,,,,5,1,0,82,0,0,1,0,0,0,0,0,0,0,0,97,https://www.altmetric.com/details/4729022,https://api.altmetric.com/v1/donut/4729022_240.png 98,Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer,Nature Communications,,,Article,2016-06-28,10.1038/ncomms11906,,,,27350604,PMC4931234,,,,,,15,0,0,26,0,0,4,0,0,0,0,0,1,0,0,22,https://www.altmetric.com/details/9103211,https://api.altmetric.com/v1/donut/9103211_240.png 98,Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.,Journal of Clinical Investigation,,,Article,2011-04-01,10.1172/jci43414,,,,21436587,PMC3069764,,,,,,0,1,0,86,0,0,0,1,0,0,0,0,2,0,0,2,https://www.altmetric.com/details/211854,https://api.altmetric.com/v1/donut/211854_240.png 97,Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer,JAMA Oncology,,,Article,2015-05-07,10.1001/jamaoncol.2015.0829,,,,26181260,,,,,,,3,2,0,102,0,0,6,0,2,0,0,0,1,0,0,13,https://www.altmetric.com/details/3975912,https://api.altmetric.com/v1/donut/3975912_240.png 97,A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy,JAMA Oncology,,,Article,2016-03-31,10.1001/jamaoncol.2016.0097,,,,27032035,,,,,,,8,1,0,55,0,0,5,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6409676,https://api.altmetric.com/v1/donut/6409676_240.png 96,Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial,Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70424-8,,,,24075621,,,,,,,9,1,0,44,0,0,1,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/1780153,https://api.altmetric.com/v1/donut/1780153_240.png 96,African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.47.0302,,,,23775960,,,,,,,10,0,0,28,0,0,3,0,0,0,0,0,1,0,0,37,https://www.altmetric.com/details/1582481,https://api.altmetric.com/v1/donut/1582481_240.png 96,"RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a driver of Pten-mutant metastasis.",Cancer Discovery,,,Article,2014-01-20,10.1158/2159-8290.cd-13-0346,,,,24444712,,,,,,,16,1,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/2071338,https://api.altmetric.com/v1/donut/2071338_240.png 96,"A milk protein, casein, as a proliferation promoting factor in prostate cancer cells.",The world journal of men's health,,,Article,2014-08-01,10.5534/wjmh.2014.32.2.76,,,,25237656,PMC4166373,,,,,,0,0,0,322,0,0,12,0,1,0,0,0,0,0,1,9,https://www.altmetric.com/details/2706519,https://api.altmetric.com/v1/donut/2706519_240.png 96,"Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study.",European Urology,,,Article,2016-08-05,10.1016/j.eururo.2016.07.023,,,,27481175,,,,,,,11,0,0,33,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/10288621,https://api.altmetric.com/v1/donut/10288621_240.png 95,Superporous Poly(ethylene glycol) Diacrylate Cryogel with a Defined Elastic Modulus for Prostate Cancer Cell Research,Small,,,Article,2016-05-30,10.1002/smll.201600683,,,,27240250,,,,,,,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8828837,https://api.altmetric.com/v1/donut/8828837_240.png 95,Levels of Fatigue and Distress in Senior Prostate Cancer Survivors Enrolled in a 12-Week Randomized Controlled Trial of Qigong,Journal of Cancer Survivorship,,,Article,2013-10-30,10.1007/s11764-013-0315-5,,,,24170679,,,,,,,12,1,0,4,0,0,2,0,4,0,0,0,0,0,0,34,https://www.altmetric.com/details/1870614,https://api.altmetric.com/v1/donut/1870614_240.png 95,Prostate cancer screening: going beyond the clinical evidence.,Canadian Medical Association. Journal,,,Article,2014-10-27,10.1503/cmaj.141252,,,,25349002,,,,,,,10,0,0,43,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/2823300,https://api.altmetric.com/v1/donut/2823300_240.png 94,Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-06-20,10.1200/jco.2016.67.4788,,,,27325855,,,,,,,4,2,0,71,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/8930472,https://api.altmetric.com/v1/donut/8930472_240.png 94,In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer,PLoS ONE,,,Article,2012-09-18,10.1371/journal.pone.0044954,,,,23028701,PMC3445615,,,,,,12,4,1,17,0,0,2,1,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/952884,https://api.altmetric.com/v1/donut/952884_240.png 94,Olfactory Detection of Prostate Cancer by Dogs Sniffing Urine: A Step Forward in Early Diagnosis,European Urology,,,Article,2010-10-15,10.1016/j.eururo.2010.10.006,,,,20970246,,,,,,,8,3,0,15,0,0,2,0,0,0,0,0,1,1,0,100,https://www.altmetric.com/details/241216,https://api.altmetric.com/v1/donut/241216_240.png 94,"Meat consumption, Cooking Practices, Meat Mutagens and Risk of Prostate Cancer",Nutrition and Cancer,"SKYHOPPER, Leia",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-04-29,10.1080/01635581.2011.539311,,,,21526454,,,,,,,11,2,0,4,0,0,5,1,1,0,0,0,0,0,0,43,https://www.altmetric.com/details/1582405,https://api.altmetric.com/v1/donut/1582405_240.png 94,"Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study",Journal of Cancer Survivorship,,,Article,2015-04-16,10.1007/s11764-015-0426-2,,,,25876555,,,,,,,8,2,0,26,0,0,5,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3913749,https://api.altmetric.com/v1/donut/3913749_240.png 93,Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.,JAMA Oncology,,,Article,2015-03-12,10.1001/jamaoncol.2015.37,,,,26181021,,,,,,,7,2,0,57,0,0,5,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3780952,https://api.altmetric.com/v1/donut/3780952_240.png 93,"Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States",JNCI: Journal of the National Cancer Institute,,,Article,2016-05-01,10.1093/jnci/djv382,,,,26705361,,,,,,,8,1,0,48,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4922168,https://api.altmetric.com/v1/donut/4922168_240.png 93,CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene-Transformed Metastatic Prostate Cancer Cell Lines.,Cancer Research,,,Article,2014-12-01,10.1158/0008-5472.can-14-0612,,,,25452256,,,,,,,11,1,0,5,0,0,3,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2938179,https://api.altmetric.com/v1/donut/2938179_240.png 93,Single- vs Multiple-Fraction Radiotherapy for Bone Metastases From Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2013-10-09,10.1001/jama.2013.277081,,,,24104375,,,,,,,12,0,0,38,0,0,0,0,2,0,0,0,0,0,0,10,https://www.altmetric.com/details/1813176,https://api.altmetric.com/v1/donut/1813176_240.png 93,"Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up",JNCI: Journal of the National Cancer Institute,,,Article,2012-01-11,10.1093/jnci/djr500,,,,22228146,,,,,,,2,6,5,52,0,0,2,0,1,0,0,0,1,0,0,1,https://www.altmetric.com/details/550437,https://api.altmetric.com/v1/donut/550437_240.png 93,Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-04-04,10.1200/jco.2016.67.0448,,,,27044935,,,,,,,10,1,0,26,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6475103,https://api.altmetric.com/v1/donut/6475103_240.png 92,Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.,British Medical Journal,,,Article,2014-03-28,10.1136/bmj.g2296,,,,24682399,,,,,,,5,1,0,79,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2222968,https://api.altmetric.com/v1/donut/2222968_240.png 92,Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer,Science as Culture,,,Article,2015-09-03,10.1080/09505431.2015.1063597,,,,27335534,PMC4894087,1893/22787,,,,,6,2,0,139,0,0,14,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4471481,https://api.altmetric.com/v1/donut/4471481_240.png 91,Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study,PLoS Medicine,,,Article,2016-08-02,10.1371/journal.pmed.1002063,,,,27483464,,,,,,,14,1,0,16,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10223770,https://api.altmetric.com/v1/donut/10223770_240.png 91,Coffee and tea consumption in relation to prostate cancer prognosis,Cancer Causes and Control,,,Article,2013-08-02,10.1007/s10552-013-0270-5,,,,23907772,,,,,,,8,1,0,28,0,0,2,0,2,0,0,0,0,0,0,17,https://www.altmetric.com/details/1673248,https://api.altmetric.com/v1/donut/1673248_240.png 91,Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.,Nature,,,Article,2014-04-23,10.1038/nature13229,,,,24759320,,,,,,,9,0,0,32,1,2,1,0,0,0,0,0,1,0,0,200,https://www.altmetric.com/details/2299516,https://api.altmetric.com/v1/donut/2299516_240.png 91,Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer,Cell,,,Article,2016-08-04,10.1016/j.cell.2016.07.007,,,,27499020,,,,,,,8,1,0,76,0,0,0,0,1,0,0,0,0,0,0,71,https://www.altmetric.com/details/10267078,https://api.altmetric.com/v1/donut/10267078_240.png 91,Prostate?specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.27503,,,,22847578,,,,,,,5,1,1,55,0,0,8,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/863907,https://api.altmetric.com/v1/donut/863907_240.png 91,DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis,Cancer Cell,,,Article,2015-07-16,10.1016/j.ccell.2015.06.004,,,,26175416,,,,,,,9,0,0,28,0,0,1,0,0,0,0,0,1,0,0,65,https://www.altmetric.com/details/4270047,https://api.altmetric.com/v1/donut/4270047_240.png 91,Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate,Science Translational Medicine,,,Article,2013-08-14,10.1126/scitranslmed.3006070,,,,23946197,,,,,,,11,0,0,17,0,1,1,1,1,0,0,0,0,0,0,73,https://www.altmetric.com/details/1690157,https://api.altmetric.com/v1/donut/1690157_240.png 91,Androgen Deprivation Therapy and Risk of Acute Kidney Injury in Patients With Prostate CancerAndrogen Deprivation for Prostate Cancer and Kidney InjuryAndrogen Deprivation for Prostate Cancer and Kidney Injury,JAMA: Journal of the American Medical Association,,,Article,2013-01-01,10.1001/jama.2013.8638,,,,23860987,,,,,,,6,1,0,49,0,0,3,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1628947,https://api.altmetric.com/v1/donut/1628947_240.png 91,Vitamin D3 Supplementation at 4000 International Units Per Day for One Year Results in a Decrease of Positive Cores at Repeat Biopsy in Subjects with Low-Risk Prostate Cancer under Active Surveillance,The Journal of Clinical Endocrinology & Metabolism,,,Article,2012-01-01,10.1210/jc.2012-1451,,,,22508710,,,,,,,10,1,0,31,0,0,10,0,0,0,0,0,1,0,0,41,https://www.altmetric.com/details/699762,https://api.altmetric.com/v1/donut/699762_240.png 90,Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity.,Journal of Clinical Oncology,,,Article,2014-04-20,10.1200/jco.2013.53.8652,,,,24616315,,,,,,,11,0,0,27,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2177359,https://api.altmetric.com/v1/donut/2177359_240.png 90,An Interaction with Ewing’s Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer,Cell Reports,,,Article,2016-10-01,10.1016/j.celrep.2016.10.001,,,,27783944,,,,,,,14,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/13030769,https://api.altmetric.com/v1/donut/13030769_240.png 90,Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28349,,,,24323568,,,,,,,10,1,0,7,0,0,2,0,1,0,0,0,0,0,0,30,https://www.altmetric.com/details/1966638,https://api.altmetric.com/v1/donut/1966638_240.png 89,Prostate Cancer Imaging Trends After a Nationwide Effort to Discourage Inappropriate Prostate Cancer Imaging,JNCI: Journal of the National Cancer Institute,,,Article,2013-07-17,10.1093/jnci/djt175,,,,23853055,,,,,,,11,0,0,23,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1643181,https://api.altmetric.com/v1/donut/1643181_240.png 89,Hand pattern indicates prostate cancer risk,British Journal of Cancer,,,Article,2010-11-30,10.1038/sj.bjc.6605986,,,,21119657,PMC3039824,,,,,,9,1,0,9,0,0,1,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/128860,https://api.altmetric.com/v1/donut/128860_240.png 88,Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.,New England Journal of Medicine,,,Article,2011-10-26,10.1056/nejmp1112191,,,,22029759,,,,,,,1,1,1,80,0,0,3,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/430518,https://api.altmetric.com/v1/donut/430518_240.png 88,Prostate cancer screening and the management of clinically localized disease.,British Medical Journal,,,Article,2013-01-29,10.1136/bmj.f325,,,,23360718,,,,,,,0,1,0,116,0,0,0,0,0,0,0,0,0,1,0,35,https://www.altmetric.com/details/1206468,https://api.altmetric.com/v1/donut/1206468_240.png 88,Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.,Cancer (0008543X),,,Article,2015-03-09,10.1002/cncr.29075,,,,25754547,,,,,,,9,1,0,27,0,0,6,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/3768138,https://api.altmetric.com/v1/donut/3768138_240.png 88,ROR-? drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer,Nature Medicine,,,Article,2016-03-28,10.1038/nm.4070,,,,27019329,,,,,,,9,2,0,14,0,0,2,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/6363652,https://api.altmetric.com/v1/donut/6363652_240.png 87,Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort,European Urology,,,Article,2016-03-05,10.1016/j.eururo.2016.02.054,,,,26951947,,,,,,,12,0,0,9,0,0,2,0,1,0,0,0,0,0,0,13,https://www.altmetric.com/details/6120192,https://api.altmetric.com/v1/donut/6120192_240.png 87,Physical Activity and Survival among Men Diagnosed with Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-01-01,10.1158/1055-9965.epi-14-0707,,,,25527697,,,,,,,8,1,0,35,0,0,19,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3000798,https://api.altmetric.com/v1/donut/3000798_240.png 87,Intensive lifestyle changes may affect the progression of prostate cancer.,The Journal of Urology,,,Article,2005-08-13,10.1097/01.ju.0000169487.49018.73,,,,16094059,,,,,,,7,3,0,28,0,0,25,1,1,0,0,0,0,0,8,69,https://www.altmetric.com/details/805991,https://api.altmetric.com/v1/donut/805991_240.png 86,Whole Milk Intake Is Associated with Prostate Cancer-Specific Mortality among U.S. Male Physicians.,Journal of Nutrition,,,Article,2013-01-01,10.3945/jn.112.168484,,,,23256145,,,,,,,3,0,0,56,0,0,48,0,2,0,0,0,0,0,4,22,https://www.altmetric.com/details/1135685,https://api.altmetric.com/v1/donut/1135685_240.png 85,A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.,Biomaterials,,,Article,2016-01-01,10.1016/j.biomaterials.2015.10.059,,,,26599623,,,,,,,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4894906,https://api.altmetric.com/v1/donut/4894906_240.png 85,Utility of Prostate Cancer Screening in Kidney Transplant Candidates,Journal of the American Society of Nephrology,,,Article,2015-12-23,10.1681/asn.2014121182,,,,26701982,,,,,,,10,1,0,10,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4916546,https://api.altmetric.com/v1/donut/4916546_240.png 85,"EPI-001, a compound active against castration-resistant prostate cancer, targets transactivation unit 5 of the androgen receptor",ACS Chemical Biology,,,Article,2016-06-29,10.1021/acschembio.6b00182,,,,27356095,,,,,,,12,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/9270631,https://api.altmetric.com/v1/donut/9270631_240.png 85,Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease,British Journal of Cancer,,,Article,2014-02-20,10.1038/bjc.2014.30,,,,24556621,,,,,,,8,1,0,13,0,0,0,0,5,0,0,0,0,0,0,35,https://www.altmetric.com/details/2135438,https://api.altmetric.com/v1/donut/2135438_240.png 85,Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer,Nature Biotechnology,,,Article,2014-04-20,10.1038/nbt.2892,,,,24752078,,,,,,,0,0,0,142,0,1,0,1,0,0,0,0,0,0,0,189,https://www.altmetric.com/details/2292287,https://api.altmetric.com/v1/donut/2292287_240.png 85,"Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.",Lancet Oncology,,,Article,2015-01-15,10.1016/s1470-2045(14)71205-7,,,,25601341,,,,,,,10,1,0,29,0,0,5,0,0,0,0,0,0,0,0,101,https://www.altmetric.com/details/3070299,https://api.altmetric.com/v1/donut/3070299_240.png 84,Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer,Cancer (0008543X),,,Article,2016-08-04,10.1002/cncr.30224,,,,27490845,,,,,,,11,0,0,14,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10272808,https://api.altmetric.com/v1/donut/10272808_240.png 84,Ethnic differences in patients' preferences for prostate cancer investigation: a vignette-based survey in primary care.,British Journal of General Practice,,,Article,2015-03-15,10.3399/bjgp15x683965,,,,25733437,PMC4337304,,,,,,11,0,0,1,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3745355,https://api.altmetric.com/v1/donut/3745355_240.png 84,Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy,European Urology,,,Article,2015-06-08,10.1016/j.eururo.2015.05.038,,,,26050111,,,,,,,7,1,0,41,0,0,8,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4090505,https://api.altmetric.com/v1/donut/4090505_240.png 84,BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence,Nature Genetics,,,Article,2014-12-08,10.1038/ng.3165,,,,25485837,,,,,,,9,0,0,29,0,0,6,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/2963518,https://api.altmetric.com/v1/donut/2963518_240.png 83,The Prostate Cancer Susceptibility Variant rs2735839 Near KLK3 Gene Is Associated with Aggressive Prostate Cancer and Can Stratify Gleason Score 7 Patients,Clinical Cancer Research,,,Article,2014-09-30,10.1158/1078-0432.ccr-14-0661,,,,25274378,,,,,,,10,1,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2730660,https://api.altmetric.com/v1/donut/2730660_240.png 83,Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer,Journal of Nuclear Medicine,,,Article,2015-04-19,10.2967/jnumed.114.147413,,,,25883127,,,,,,,10,1,0,3,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3921163,https://api.altmetric.com/v1/donut/3921163_240.png 83,American Cancer Society prostate cancer survivorship care guidelines,CA: A Cancer Journal for Clinicians ,,,Article,2014-06-10,10.3322/caac.21234,,,,24916760,,,,,,,5,2,0,59,0,0,1,0,2,0,0,0,0,0,0,35,https://www.altmetric.com/details/2424197,https://api.altmetric.com/v1/donut/2424197_240.png 82,Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer,Nature Medicine,,,Article,2016-02-29,10.1038/nm.4053,,,,26928463,,,,,,,1,0,0,135,0,0,3,0,0,0,0,0,0,0,0,106,https://www.altmetric.com/details/6020563,https://api.altmetric.com/v1/donut/6020563_240.png 82,Prediction of Prostate Cancer Recurrence Using Quantitative Phase Imaging,Scientific Reports,,,Article,2015-05-15,10.1038/srep09976,,,,25975368,,,,,,,7,5,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4001090,https://api.altmetric.com/v1/donut/4001090_240.png 82,"Egg, Red Meat, and Poultry Intake and Risk of Lethal Prostate Cancer in the Prostate-Specific Antigen-Era: Incidence and Survival.",Cancer Prevention Research,,,Article,2011-09-19,10.1158/1940-6207.capr-11-0354,,,,21930800,,,,,,,0,0,0,89,0,0,15,0,1,0,1,0,0,0,4,36,https://www.altmetric.com/details/387617,https://api.altmetric.com/v1/donut/387617_240.png 82,miR-34 Cooperates with p53 in Suppression of Prostate Cancer by Joint Regulation of Stem Cell Compartment,Cell Reports,,,Article,2014-03-13,10.1016/j.celrep.2014.02.023,,,,24630988,,,,,,,9,1,0,15,10,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2185217,https://api.altmetric.com/v1/donut/2185217_240.png 82,Sleep Disruption Among Older Men and Risk of Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-01-01,10.1158/1055-9965.epi-12-1227-t,,,,23652374,,,,,,,9,1,0,21,0,0,14,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/1452189,https://api.altmetric.com/v1/donut/1452189_240.png 82,"Dietary Lycopene, Angiogenesis, and Prostate Cancer: A Prospective Study in the Prostate-Specific Antigen Era",JNCI: Journal of the National Cancer Institute,,,Article,2014-02-01,10.1093/jnci/djt430,,,,24463248,,,,,,,1,4,0,6,0,0,2,0,53,0,0,0,0,0,0,90,https://www.altmetric.com/details/2070472,https://api.altmetric.com/v1/donut/2070472_240.png 81,Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer,World Journal of Urology,,,Article,2015-08-13,10.1007/s00345-015-1655-8,,,,26267808,,,,,,,11,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4389390,https://api.altmetric.com/v1/donut/4389390_240.png 81,Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer,JAMA Oncology,,,Article,2015-06-04,10.1001/jamaoncol.2015.1341,,,,26181238,,,,,,,7,1,0,51,0,0,6,0,1,0,0,0,0,0,0,48,https://www.altmetric.com/details/4093954,https://api.altmetric.com/v1/donut/4093954_240.png 81,Circulating microRNAs predict biochemical recurrence in prostate cancer patients.,British Journal of Cancer,,,Article,2013-07-11,10.1038/bjc.2013.369,,,,23846169,,,,,,,7,5,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2410182,https://api.altmetric.com/v1/donut/2410182_240.png 81,Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness,EMBO Reports,,,Article,2016-09-05,10.15252/embr.201642352,,,,27596623,,,,,,,10,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11763404,https://api.altmetric.com/v1/donut/11763404_240.png 80,Prostate cancer risk prediction based on complete prostate cancer family history,The Prostate,,,Article,2014-11-18,10.1002/pros.22925,,,,25408531,,,,,,,11,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2923852,https://api.altmetric.com/v1/donut/2923852_240.png 80,National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.,Journal of Clinical Oncology,,,Article,2015-06-10,10.1200/jco.2015.61.6532,,,,26056181,,,,,,,5,4,0,42,0,0,3,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/4120155,https://api.altmetric.com/v1/donut/4120155_240.png 80,A prospective study of meat and meat mutagens and prostate cancer risk.,Cancer Research,,,Article,2005-12-17,10.1158/0008-5472.can-05-2191,,,,16357191,,,,,,,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3341822,https://api.altmetric.com/v1/donut/3341822_240.png 79,Prostate cancer screening comes of age,The Lancet (British Edition),,,Article,,10.1016/s0140-6736(14)61008-4,,,,,,,,,,,10,0,0,6,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2580631,https://api.altmetric.com/v1/donut/2580631_240.png 79,Oral contraceptive use is associated with prostate cancer: an ecological study,BMJ Open,,,Article,2011-01-01,10.1136/bmjopen-2011-000311,,,,22102643,PMC3221291,,,,,,2,4,0,64,0,0,8,0,8,0,0,0,0,0,0,11,https://www.altmetric.com/details/454897,https://api.altmetric.com/v1/donut/454897_240.png 79,Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: A Bayesian network analysis of data from a tissue microarray,The Prostate,,,Article,2014-06-01,10.1002/pros.22827,,,,24913716,,,,,,,0,0,0,7,0,0,338,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2428234,https://api.altmetric.com/v1/donut/2428234_240.png 79,Functional Outcomes after Treatment for Prostate Cancer,New England Journal of Medicine,,,Article,2013-04-25,10.1056/nejmc1302509,,,,23614595,,,,,,,8,0,0,5,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1411690,https://api.altmetric.com/v1/donut/1411690_240.png 79,Progress in Understanding What Is Being Statin(ed) in Prostate Cancer,JAMA Oncology,,,Article,2015-05-07,10.1001/jamaoncol.2015.0833,,,,26181247,,,,,,,4,1,0,71,0,0,6,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/3977060,https://api.altmetric.com/v1/donut/3977060_240.png 78,Restriction spectrum imaging improves MRI-based prostate cancer detection,Abdominal Radiology,,,Article,2016-02-24,10.1007/s00261-016-0659-1,,,,26910114,,,,,,,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8421642,https://api.altmetric.com/v1/donut/8421642_240.png 78,Prostate Cancer Takes Nerve,Science,,,Article,2013-07-11,10.1126/science.1241776,,,,23846894,,,,,,,8,0,0,16,0,0,5,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/1619460,https://api.altmetric.com/v1/donut/1619460_240.png 78,"Effect of Soy Protein Isolate Supplementation on Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Randomized Trial",JAMA: Journal of the American Medical Association,,,Article,2013-01-01,10.1001/jama.2013.7842,,,,23839751,,,,,,,5,2,0,65,0,0,9,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1613722,https://api.altmetric.com/v1/donut/1613722_240.png 78,TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.,Journal of Controlled Release,,,Article,2016-01-07,10.1016/j.jconrel.2015.12.048,,,,26732555,PMC4724502,,,,,,9,1,0,9,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4944909,https://api.altmetric.com/v1/donut/4944909_240.png 77,Prostate Cancer Screening.,JAMA: Journal of the American Medical Association,,,Article,2015-11-17,10.1001/jama.2015.15295,,,,26575077,,,,,,,0,1,0,103,0,0,23,0,6,0,0,0,0,0,0,1,https://www.altmetric.com/details/4774462,https://api.altmetric.com/v1/donut/4774462_240.png 76,African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance,The Journal of Urology,,,Article,2015-09-06,10.1016/j.juro.2015.08.089,,,,26341575,,,,,,,20,0,0,8,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4463151,https://api.altmetric.com/v1/donut/4463151_240.png 76,Gene regulatory mechanisms underpinning prostate cancer susceptibility,Nature Genetics,,,Article,2016-03-07,10.1038/ng.3523,,,,26950096,,,,,,,7,0,0,35,0,0,4,0,1,0,0,0,0,0,0,25,https://www.altmetric.com/details/6133414,https://api.altmetric.com/v1/donut/6133414_240.png 76,"Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate Cancer",Annals of Internal Medicine,,,Article,2013-01-01,10.7326/0003-4819-158-10-201305210-00005,,,,23689764,,,,,,,4,2,1,29,0,0,4,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1494279,https://api.altmetric.com/v1/donut/1494279_240.png 75,Molecular profiling of ETS and non?ETS aberrations in prostate cancer patients from northern India,The Prostate,,,Article,2015-03-27,10.1002/pros.22989,,,,25809148,,,,,,,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3849020,https://api.altmetric.com/v1/donut/3849020_240.png 75,Prostate Cancer Screening,JAMA: Journal of the American Medical Association,,,Article,2015-08-25,10.1001/jama.2015.8033,,,,26305653,,,,,,,0,0,0,128,0,0,2,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/4432747,https://api.altmetric.com/v1/donut/4432747_240.png 75,Active surveillance in Canadian men with low-grade prostate cancer,Canadian Medical Association Journal,,,Article,2016-02-29,10.1503/cmaj.150832,,,,26927971,,,,,,,9,0,0,23,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6021972,https://api.altmetric.com/v1/donut/6021972_240.png 75,Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer,European Urology,,,Article,2014-11-06,10.1016/j.eururo.2014.10.022,,,,25454609,,,,,,,8,0,0,32,0,0,2,0,1,0,0,0,0,0,0,33,https://www.altmetric.com/details/2855777,https://api.altmetric.com/v1/donut/2855777_240.png 74,Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness.,Cell Metabolism (Science Direct),,,Article,2014-03-04,10.1016/j.cmet.2014.01.019,,,,24606897,,,,,,,9,0,0,8,0,0,0,0,0,0,0,0,1,0,0,103,https://www.altmetric.com/details/2161785,https://api.altmetric.com/v1/donut/2161785_240.png 74,Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer,Clinical Chemistry,,,Article,2014-10-27,10.1373/clinchem.2014.226571,,,,25348670,,,,,,,9,2,0,29,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2822933,https://api.altmetric.com/v1/donut/2822933_240.png 74,Association of androgen?deprivation therapy with excess cardiac?specific mortality in men with prostate cancer,British Journal of Urology,,,Article,2014-08-14,10.1111/bju.12905,,,,25124891,,,,,,,6,4,0,9,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2604200,https://api.altmetric.com/v1/donut/2604200_240.png 74,“Screening” for Prostate Cancer in New York’s Skid Row: History and Implications,American Journal of Public Health,,,Article,2013-10-17,10.2105/ajph.2013.301446,,,,24134358,,,,,,,8,0,0,6,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1838291,https://api.altmetric.com/v1/donut/1838291_240.png 74,"Cigarette Smoking and Prostate Cancer Mortality in Four US States, 1999–2010","Preventing Chronic Disease: Public Health Research, Practice and Policy",,,Article,2016-04-14,10.5888/pcd13.150454,,,,27079649,,,,,,,4,0,0,69,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6713785,https://api.altmetric.com/v1/donut/6713785_240.png 74,The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer,Nutrition & Metabolism,,,Article,2012-01-01,10.1186/1743-7075-9-74,,,,22891897,,,,,,,1,2,0,79,0,0,31,0,3,0,0,0,0,0,1,48,https://www.altmetric.com/details/887186,https://api.altmetric.com/v1/donut/887186_240.png 73,"Unemployment and prostate cancer mortality in the OECD, 1990–2009",ecancer.org,,,Article,,,,,http://ecancer.org/journal/9/538-unemployment-and-prostate-cancer-mortality-in-the-oecd-1990-2009.php,,,,,,,,7,2,0,10,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3996384,https://api.altmetric.com/v1/donut/3996384_240.png 73,Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial,Journal of Clinical Oncology,,,Article,2016-09-06,10.1200/jco.2016.68.4530,,,,27601545,,,,,,,8,1,0,11,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/11887624,https://api.altmetric.com/v1/donut/11887624_240.png 73,Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis,Cancer (0008543X),,,Article,2014-05-01,10.1002/cncr.28757,,,,24824511,,,,,,,10,0,0,15,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2358935,https://api.altmetric.com/v1/donut/2358935_240.png 72,Focusing PSA Testing on Detection of High-Risk Prostate Cancers by Incorporating Patient Preferences Into Decision Making,JAMA: Journal of the American Medical Association,,,Article,2014-08-03,10.1001/jama.2014.9680,,,,25090603,,,,,,,7,0,0,30,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2569369,https://api.altmetric.com/v1/donut/2569369_240.png 72,Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.,JAMA: Journal of the American Medical Association,,,Article,2014-03-19,10.1001/jama.2014.2085,,,,24643604,,,,,,,0,1,0,100,0,0,1,1,2,0,0,0,0,0,0,8,https://www.altmetric.com/details/2195400,https://api.altmetric.com/v1/donut/2195400_240.png 72,The Proteome of Primary Prostate Cancer,European Urology,,,Article,2015-12-02,10.1016/j.eururo.2015.10.053,,,,26651926,,,,,,,10,0,0,5,0,0,2,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/4830292,https://api.altmetric.com/v1/donut/4830292_240.png 72,MR/Ultrasound Fusion–Guided Biopsy in Prostate Cancer: What Is the Evidentiary Standard?,JAMA: Journal of the American Medical Association,,,Article,2015-01-27,10.1001/jama.2014.17943,,,,25626034,,,,,,,9,0,0,12,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3109456,https://api.altmetric.com/v1/donut/3109456_240.png 72,Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1581,,,,24255071,,,,,,,9,1,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1919392,https://api.altmetric.com/v1/donut/1919392_240.png 72,Cancer–Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer,Microarrays,,,Article,2015-10-29,10.3390/microarrays4040503,,,,,,,,,,,9,1,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4700966,https://api.altmetric.com/v1/donut/4700966_240.png 72,Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-07-22,10.1200/jco.2014.59.8912,,,,26195723,,,,,,,8,0,0,43,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4297220,https://api.altmetric.com/v1/donut/4297220_240.png 71,Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.,British Medical Journal,,,Article,2014-02-26,10.1136/bmj.g1502,,,,24574496,,,,,,,9,1,0,91,0,0,1,0,0,0,0,0,0,0,1,52,https://www.altmetric.com/details/2151877,https://api.altmetric.com/v1/donut/2151877_240.png 71,On Risk Estimation versus Risk Stratification in Early Prostate Cancer,PLoS Medicine,,,Article,2016-08-02,10.1371/journal.pmed.1002100,,,,27482892,,,,,,,8,1,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10224524,https://api.altmetric.com/v1/donut/10224524_240.png 71,Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.,Journal of Clinical Oncology,,,Article,2015-07-01,10.1200/jco.2014.57.7510,,,,25691677,,,,,,,1,1,0,92,0,0,2,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3708112,https://api.altmetric.com/v1/donut/3708112_240.png 71,Mummy diagnosed with prostate cancer,Nature Middle East,,,Article,2012-02-12,10.1038/nmiddleeast.2012.15,,,,,,,,,,,0,0,0,88,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/600472,https://api.altmetric.com/v1/donut/600472_240.png 71,It Is Time to Stop Screening for Prostate Cancer,JAMA Internal Medicine,,,Article,2014-08-31,10.1001/jamainternmed.2014.3078,,,,25178980,,,,,,,0,4,0,85,1,0,2,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/2646021,https://api.altmetric.com/v1/donut/2646021_240.png 71,A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.,Nature Genetics,,,Article,2014-01-05,10.1038/ng.2862,,,,24390282,,,,,,,8,0,0,15,0,0,0,0,1,0,0,0,1,0,0,99,https://www.altmetric.com/details/2023127,https://api.altmetric.com/v1/donut/2023127_240.png 71,Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG.,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt332,,,,24292212,,,,,,,9,0,0,9,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1946695,https://api.altmetric.com/v1/donut/1946695_240.png 71,Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial,American Journal of Epidemiology,,,Article,2011-04-24,10.1093/aje/kwr027,,,,21518693,PMC3145396,,,,,,4,4,2,16,0,0,10,2,0,0,0,0,0,1,0,57,https://www.altmetric.com/details/100885,https://api.altmetric.com/v1/donut/100885_240.png 70,STAT3 regulated ARF expression suppresses prostate cancer metastasis,Nature Communications,,,Article,2015-07-22,10.1038/ncomms8736,,,,26198641,,,,,,,10,0,0,3,0,0,1,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/4303707,https://api.altmetric.com/v1/donut/4303707_240.png 70,Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment,European Urology,,,Article,2015-05-01,10.1016/j.eururo.2015.04.039,,,,25985884,,,,,,,6,3,0,27,0,0,2,0,1,0,0,0,0,0,0,33,https://www.altmetric.com/details/4001237,https://api.altmetric.com/v1/donut/4001237_240.png 70,Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).,American Journal of Clinical Nutrition,,,Article,2008-04-12,,,,,18400723,,,,,,,2,8,0,31,0,0,7,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1487362,https://api.altmetric.com/v1/donut/1487362_240.png 69,Long Noncoding RNAs as Putative Biomarkers for Prostate Cancer Detection,The Journal of Molecular Diagnostics,,,Article,2014-01-11,10.1016/j.jmoldx.2014.06.009,,,,25307116,,,,,,,8,2,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2764320,https://api.altmetric.com/v1/donut/2764320_240.png 69,"Multi-site experience of the safety, detection rate and diagnostic performance of fluciclovine (18F) PET/CT imaging in the staging of biochemically recurrent prostate cancer",The Journal of Urology,,,Article,2016-10-18,10.1016/j.juro.2016.09.117,,,,27746282,,,,,,,11,0,0,6,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12606030,https://api.altmetric.com/v1/donut/12606030_240.png 69,Dairy intake after prostate cancer diagnosis in relation to disease?specific and total mortality,International Journal of Cancer,,,Article,2015-06-03,10.1002/ijc.29608,,,,25989745,,,,,,,1,0,0,62,0,0,13,0,5,0,0,0,0,0,1,20,https://www.altmetric.com/details/4055041,https://api.altmetric.com/v1/donut/4055041_240.png 69,“All boys and men can play football”: A qualitative investigation of recreational football in prostate cancer patients,Scandinavian Journal of Medicine & Science in Sports,,,Article,2014-06-19,10.1111/sms.12193,,,,24944135,,,,,,,9,0,0,2,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2453448,https://api.altmetric.com/v1/donut/2453448_240.png 69,Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate,Cancer Cell International,,,Article,2014-04-03,10.1186/1475-2867-14-30,,,,24685270,,,,,,,0,0,0,1,0,0,545,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2785890,https://api.altmetric.com/v1/donut/2785890_240.png 68,Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer,Nature Chemical Biology,,,Article,2016-08-08,10.1038/nchembio.2131,,,,27501397,,,,,,,10,0,0,3,0,0,1,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/10335426,https://api.altmetric.com/v1/donut/10335426_240.png 68,Meat and Meat-related Compounds and Risk of Prostate Cancer in a Large Prospective Cohort Study in the United States,American Journal of Epidemiology,,,Article,2009-01-01,10.1093/aje/kwp280,,,,19808637,PMC2781742,,,,,,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1548676,https://api.altmetric.com/v1/donut/1548676_240.png 68,Asthma and risk of lethal prostate cancer in the Health Professionals Follow?Up Study,International Journal of Cancer,,,Article,2015-02-03,10.1002/ijc.29463,,,,25648070,,,,,,,8,1,0,7,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3352120,https://api.altmetric.com/v1/donut/3352120_240.png 68,Voxel Level Radiologic–Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer,Clinical Cancer Research,,,Article,2016-06-01,10.1158/1078-0432.ccr-15-2429,,,,27250935,PMC4896066,,,,,,9,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8408442,https://api.altmetric.com/v1/donut/8408442_240.png 68,Assessing Cancer Risk in Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the PRI-MUS (prostate risk identification using micro-ultrasound) protocol,The Journal of Urology,,,Article,2016-01-23,10.1016/j.juro.2015.12.093,,,,26791931,,,,,,,9,0,0,7,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4980947,https://api.altmetric.com/v1/donut/4980947_240.png 68,Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries,The Journal of Urology,,,Article,2015-01-01,10.1016/j.juro.2014.06.071,,,,24980615,,,,,,,7,1,0,17,0,0,3,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2481180,https://api.altmetric.com/v1/donut/2481180_240.png 68,Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression,Nature,"LANE, Louis P",Department of Life Sciences; School of Natural Sciences,Article,2009-02-12,10.1038/nature07762,,,,19212411,,,2009Natur.457..910S,,,,5,5,0,1,0,0,0,1,0,0,0,0,2,0,0,624,https://www.altmetric.com/details/182958,https://api.altmetric.com/v1/donut/182958_240.png 68,Coffee Consumption and Prostate Cancer Risk: A Meta-Analysis of Cohort Studies.,Nutrition and Cancer,,,Article,2015-02-23,10.1080/01635581.2015.1004727,,,,25706900,,,,,,,7,1,0,19,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3727490,https://api.altmetric.com/v1/donut/3727490_240.png 68,Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence,JNCI: Journal of the National Cancer Institute,,,Article,2014-03-07,10.1093/jnci/dju007,,,,24610909,,,,,,,9,0,0,5,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2173478,https://api.altmetric.com/v1/donut/2173478_240.png 68,Improving Detection of Clinically Significant Prostate Cancer: MRI/TRUS Fusion-Guided Prostate Biopsy.,The Journal of Urology,,,Article,2013-12-13,10.1016/j.juro.2013.12.007,,,,24333515,,,,,,,6,0,0,26,0,0,1,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/1977992,https://api.altmetric.com/v1/donut/1977992_240.png 67,Vasectomy and risk of prostate cancer: population based matched cohort study,British Medical Journal,,,Article,2016-11-03,10.1136/bmj.i5546,,,,27811008,,,,,,,0,0,0,111,0,0,6,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13309022,https://api.altmetric.com/v1/donut/13309022_240.png 67,Inhibition of prostate cancer cell growth by an avocado extract: role of lipid-soluble bioactive substances,Journal of Nutritional Biochemistry,,,Article,2005-01-01,10.1016/j.jnutbio.2004.08.003,,,,15629237,,,,,,,21,2,0,39,0,0,14,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/817720,https://api.altmetric.com/v1/donut/817720_240.png 67,Sipuleucel-T immunotherapy for castration-resistant prostate cancer.,New England Journal of Medicine,,,Article,2010-07-29,10.1056/nejmoa1001294,,,,20818862,,,,,,,4,3,7,10,0,0,1,2,0,0,0,0,6,0,0,495,https://www.altmetric.com/details/235599,https://api.altmetric.com/v1/donut/235599_240.png 67,Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.,British Journal of Cancer,,,Article,2009-09-15,10.1038/sj.bjc.6605248,,,,19690545,PMC2743360,,,,,,0,1,0,35,0,0,248,1,12,0,0,0,0,0,6,47,https://www.altmetric.com/details/241576,https://api.altmetric.com/v1/donut/241576_240.png 67,Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer,JAMA Oncology,,,Article,2015-02-19,10.1001/jamaoncol.2014.284,,,,26181182,,,,,,,3,0,0,75,0,0,8,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3723733,https://api.altmetric.com/v1/donut/3723733_240.png 67,Early Human Prostate Adenocarcinomas Harbor Androgen-Independent Cancer Cells,PLoS ONE,,,Article,2013-09-25,10.1371/journal.pone.0074438,,,,24086346,,,,,,,9,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1784948,https://api.altmetric.com/v1/donut/1784948_240.png 67,Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison,Journal of Clinical Oncology,,,Article,2015-05-13,10.1200/jco.2014.60.1963,,,,25964245,,,,,,,9,1,0,17,0,0,4,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3992223,https://api.altmetric.com/v1/donut/3992223_240.png 67,Prostate cancer and the PCP: the screening dilemma,International journal of clinical practice,,,Article,2015-09-01,10.1111/ijcp.12745,,,,26459772,,,,,,,8,0,0,7,0,0,2,0,3,0,0,0,0,0,0,10,https://www.altmetric.com/details/4617978,https://api.altmetric.com/v1/donut/4617978_240.png 67,Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse,Science Translational Medicine,,,Article,2016-04-06,10.1126/scitranslmed.aad5659,,,,27053771,,,,,,,8,0,0,15,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6504301,https://api.altmetric.com/v1/donut/6504301_240.png 67,Financial toxicity: a potential side effect of prostate cancer treatment among Australian men,European Journal of Cancer Care,,,Article,2015-09-01,10.1111/ecc.12392,,,,26423576,,,,,,,7,0,0,12,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4588872,https://api.altmetric.com/v1/donut/4588872_240.png 67,Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis.,Medicine,,,Article,2015-08-01,10.1097/md.0000000000001260,,,,26287411,,,,,,,1,0,0,6,0,0,2,0,52,0,0,0,0,0,0,32,https://www.altmetric.com/details/4454000,https://api.altmetric.com/v1/donut/4454000_240.png 67,Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy,Scandinavian Journal of Medicine & Science in Sports,,,Article,2014-08-01,10.1111/sms.12260,,,,24944134,,,,,,,10,0,0,2,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2451679,https://api.altmetric.com/v1/donut/2451679_240.png 67,Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer,EBioMedicine,,,Article,2016-07-01,10.1016/j.ebiom.2016.07.022,,,,27515689,,,,,,,7,0,0,28,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9929094,https://api.altmetric.com/v1/donut/9929094_240.png 66,Prognostic value of changes in quality of life scores in prostate cancer,BMC Urology,,,Article,2013-07-10,10.1186/1471-2490-13-32,,,,23837903,PMC3708783,,,,,,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9207384,https://api.altmetric.com/v1/donut/9207384_240.png 66,Effectiveness of Primary Androgen-Deprivation Therapy for Clinically Localized Prostate Cancer,Journal of Clinical Oncology,,,Article,2014-03-17,10.1200/jco.2013.52.5782,,,,24638009,,,,,,,7,1,0,11,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2193457,https://api.altmetric.com/v1/donut/2193457_240.png 66,Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity,Nature Communications,,,Article,2016-01-12,10.1038/ncomms10230,,,,26756352,,,,,,,7,0,0,29,0,0,3,0,0,0,1,0,0,0,0,47,https://www.altmetric.com/details/4984424,https://api.altmetric.com/v1/donut/4984424_240.png 66,Rethinking Screening for Breast Cancer and Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2009-10-21,10.1001/jama.2009.1498,,,,19843904,,,,,,,3,4,0,10,0,0,0,1,0,0,0,0,1,0,0,14,https://www.altmetric.com/details/520351,https://api.altmetric.com/v1/donut/520351_240.png 66,"Nutrition, dietary interventions and prostate cancer: the latest evidence",BMC Medicine,,,Article,2015-01-08,10.1186/s12916-014-0234-y,,,,25573005,PMC4286914,,,,,,1,1,0,84,0,0,4,1,1,0,0,0,0,0,0,74,https://www.altmetric.com/details/3046923,https://api.altmetric.com/v1/donut/3046923_240.png 66,Clinical practice. Screening for prostate cancer.,New England Journal of Medicine,,,Article,2011-10-26,10.1056/nejmcp1103642,,,,22029754,,,,,,,0,0,1,70,0,0,3,0,0,0,0,0,1,0,0,6,https://www.altmetric.com/details/430973,https://api.altmetric.com/v1/donut/430973_240.png 66,The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation,Oncogene,,,Article,2015-12-08,10.1038/onc.2015.445,,,,26640143,,,,,,,8,0,0,6,0,0,5,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4853680,https://api.altmetric.com/v1/donut/4853680_240.png 66,Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations.,European Journal of Applied Physiology and Occupational Physiology,,,Article,2015-11-30,10.1007/s00421-015-3301-y,,,,26620651,,,,,,,8,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4830491,https://api.altmetric.com/v1/donut/4830491_240.png 65,An Integrated Computational Model of the Bone Microenvironment in Bone-Metastatic Prostate Cancer,Cancer Research,,,Article,2014-04-30,10.1158/0008-5472.can-13-2652,,,,24788098,,,,,,,6,2,0,23,0,0,0,0,1,0,0,0,0,0,1,23,https://www.altmetric.com/details/2317896,https://api.altmetric.com/v1/donut/2317896_240.png 65,CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer,Clinical Cancer Research,,,Article,2015-11-15,10.1158/1078-0432.ccr-14-3129,,,,26567358,,,,,,,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4817644,https://api.altmetric.com/v1/donut/4817644_240.png 65,Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.46.7043,,,,23918942,,,,,,,5,0,0,31,0,0,6,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1670591,https://api.altmetric.com/v1/donut/1670591_240.png 65,RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.,Endocrine-Related Cancer,,,Article,2014-01-29,10.1530/erc-13-0548,,,,24478054,,,,,,,11,1,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2089362,https://api.altmetric.com/v1/donut/2089362_240.png 64,The DNA Structure-Specific Endonuclease MUS81 Mediates DNA Sensor STING-Dependent Host Rejection of Prostate Cancer Cells,Immunity,,,Article,2016-05-10,10.1016/j.immuni.2016.04.010,,,,27178469,,,,,,,5,1,0,42,0,0,2,0,1,0,0,0,0,0,0,31,https://www.altmetric.com/details/7323798,https://api.altmetric.com/v1/donut/7323798_240.png 64,Researchers Look to MRI and Biomarkers to Help Improve Detection of Aggressive Prostate Cancers,JAMA: Journal of the American Medical Association,,,Article,2015-01-28,10.1001/jama.2015.169,,,,25629168,,,,,,,0,0,0,93,0,0,9,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3116209,https://api.altmetric.com/v1/donut/3116209_240.png 64,Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate cancer: A Prospective Multicentric Hemiablation Study of 111 Patients,European Urology,,,Article,2016-10-01,10.1016/j.eururo.2016.09.039,,,,27720531,,,,,,,9,0,0,18,0,0,1,0,2,0,0,0,0,0,0,9,https://www.altmetric.com/details/12557031,https://api.altmetric.com/v1/donut/12557031_240.png 64,Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70040-3,,,,24581940,,,,,,,5,1,0,34,1,0,0,0,0,0,0,0,0,0,0,91,https://www.altmetric.com/details/2145861,https://api.altmetric.com/v1/donut/2145861_240.png 63,"The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists and the Prostate Cancer Foundation.",Archives of Pathology & Laboratory Medicine,,,Article,2014-08-05,10.5858/arpa.2014-0219-sa,,,,25092589,,,,,,,6,2,0,31,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2573754,https://api.altmetric.com/v1/donut/2573754_240.png 63,Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-08-01,10.1200/jco.2016.68.3425,,,,27480153,,,,,,,5,0,0,38,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/10192296,https://api.altmetric.com/v1/donut/10192296_240.png 63,Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt248,,,,24092918,,,,,,,8,0,0,9,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1807646,https://api.altmetric.com/v1/donut/1807646_240.png 63,Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability ,EBioMedicine,,,Article,2016-04-19,10.1016/j.ebiom.2016.04.018,,,,27428423,PMC4919605,11287/607243,,,,,6,1,0,16,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6953387,https://api.altmetric.com/v1/donut/6953387_240.png 63,Do dietary lycopene and other carotenoids protect against prostate cancer?,International Journal of Cancer,,,Article,2005-01-03,10.1002/ijc.20667,,,,15514967,,,,,,,1,0,0,1,0,0,0,0,52,0,0,0,0,0,0,36,https://www.altmetric.com/details/2722505,https://api.altmetric.com/v1/donut/2722505_240.png 63,A basal stem cell signature identifies aggressive prostate cancer phenotypes,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-10-12,10.1073/pnas.1518007112,,,,26460041,,,,,,,6,3,0,21,0,0,2,0,0,0,2,0,0,0,0,45,https://www.altmetric.com/details/4614875,https://api.altmetric.com/v1/donut/4614875_240.png 63,The Meaning of Race in Prostate Cancer Treatment,JAMA Oncology,,,Article,2015-10-22,10.1001/jamaoncol.2015.3615,,,,26502032,,,,,,,9,1,0,19,0,0,3,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4661970,https://api.altmetric.com/v1/donut/4661970_240.png 63,TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.49.8386,,,,24297949,,,,,,,9,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1953050,https://api.altmetric.com/v1/donut/1953050_240.png 63,"A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer.",Experimental Biology and Medicine,,,Article,2002-11-01,,,,,12424325,,,,,,,2,0,0,0,0,0,1,0,48,0,0,0,0,0,0,73,https://www.altmetric.com/details/4367143,https://api.altmetric.com/v1/donut/4367143_240.png 63,Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy,Cancer Cell,,,Article,2014-12-05,10.1016/j.ccr.2014.03.017,,,,24823640,,,,,,,7,0,0,15,0,0,0,0,1,0,0,0,0,0,0,111,https://www.altmetric.com/details/2347595,https://api.altmetric.com/v1/donut/2347595_240.png 62,Hypnotic relaxation therapy for treatment of hot flashes following prostate cancer surgery: a case study.,International Journal of Clinical and Experimental Hypnosis,,,Article,2014-05-21,10.1080/00207144.2014.901051,,,,24837059,,,,,,,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2499297,https://api.altmetric.com/v1/donut/2499297_240.png 62,Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.,Science,,,Article,2014-08-01,10.1126/science.1251343,,,,25082706,,,,,,,2,0,0,68,0,0,1,0,1,0,0,0,0,0,0,211,https://www.altmetric.com/details/2558582,https://api.altmetric.com/v1/donut/2558582_240.png 62,99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer.,Journal of Nuclear Medicine,,,Article,,10.2967/jnumed.114.140426,,,,25342385,,,,,,,8,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2860609,https://api.altmetric.com/v1/donut/2860609_240.png 62,Measuring the Effectiveness of Androgen-Deprivation Therapy for Prostate Cancer in the Medicare Population: Adequate Data Are Neither the Same as Nor the Enemy of Perfect Data,JAMA Internal Medicine,,,Article,2014-09-01,10.1001/jamainternmed.2014.1107,,,,25023522,,,,,,,6,0,0,22,0,0,0,1,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/2508288,https://api.altmetric.com/v1/donut/2508288_240.png 62,Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013,Prostate Cancer & Prostatic Diseases,,,Article,2016-08-23,10.1038/pcan.2016.34,,,,27549566,,,,,,,8,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10778840,https://api.altmetric.com/v1/donut/10778840_240.png 62,Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens,The Journal of Molecular Diagnostics,,,Article,2016-03-06,10.1016/j.jmoldx.2015.12.006,,,,26945428,,,,,,,13,0,0,8,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6128529,https://api.altmetric.com/v1/donut/6128529_240.png 61,Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial,Journal of Clinical Oncology,,,Article,2016-01-25,10.1200/jco.2015.64.9285,,,,26811535,,,,,,,3,0,0,64,0,0,1,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/5040988,https://api.altmetric.com/v1/donut/5040988_240.png 61,Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy,Nature,,,Article,2016-05-25,10.1038/nature17954,,,,27225130,,,,,,,2,2,0,48,0,0,0,1,0,0,0,0,2,0,0,33,https://www.altmetric.com/details/8248756,https://api.altmetric.com/v1/donut/8248756_240.png 60,Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations,The Journal of Urology,,,Article,2016-04-13,10.1016/j.juro.2016.04.031,,,,27321505,,,,,,,8,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6661751,https://api.altmetric.com/v1/donut/6661751_240.png 60,"Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants",Cell Reports,,,Article,2014-02-06,10.1016/j.celrep.2014.01.013,,,,24508459,,,,,,,8,0,0,4,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2103601,https://api.altmetric.com/v1/donut/2103601_240.png 60,Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort,BMC Medicine,,,Article,2016-04-04,10.1186/s12916-016-0602-x,,,,27044414,,,,,,,4,2,0,26,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6478234,https://api.altmetric.com/v1/donut/6478234_240.png 60,Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study,Lancet Oncology,,,Article,2014-11-13,10.1016/s1470-2045(14)71021-6,,,,25456371,,,,,,,3,2,0,26,0,5,1,0,1,0,0,0,0,0,0,125,https://www.altmetric.com/details/2882323,https://api.altmetric.com/v1/donut/2882323_240.png 60,Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer,Cancer Research,,,Article,2005-01-01,10.1158/0008-5472.can-04-3410,,,,15753356,,,,,,,0,0,0,23,0,0,273,0,12,0,0,0,0,0,5,32,https://www.altmetric.com/details/442881,https://api.altmetric.com/v1/donut/442881_240.png 60,Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.,Prostate Cancer & Prostatic Diseases,,,Article,2015-01-06,10.1038/pcan.2014.50,,,,25559097,,,,,,,6,2,0,5,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3041044,https://api.altmetric.com/v1/donut/3041044_240.png 59,A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer,Biomaterials,,,Article,2016-06-01,10.1016/j.biomaterials.2016.03.023,,,,27019026,,,,,,,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6763449,https://api.altmetric.com/v1/donut/6763449_240.png 59,A Simple Schema for Informed Decision Making About Prostate Cancer Screening,Annals of Internal Medicine,,,Article,2014-09-15,10.7326/m14-0151,,,,25222389,,,,,,,1,0,0,72,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2685430,https://api.altmetric.com/v1/donut/2685430_240.png 59,Prostate cancer in young men: an important clinical entity,Nature Reviews Urology,,,Article,2014-05-13,10.1038/nrurol.2014.91,,,,24818853,,,,,,,6,2,0,7,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2362268,https://api.altmetric.com/v1/donut/2362268_240.png 59,Decipher correlation patterns post prostatectomy: initial experience from 2?342 prospective patients,Prostate Cancer & Prostatic Diseases,,,Article,2016-08-30,10.1038/pcan.2016.38,,,,27574020,,,,,,,13,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10910355,https://api.altmetric.com/v1/donut/10910355_240.png 59,Clinical decisions. Screening for prostate cancer.,New England Journal of Medicine,,,Article,2012-08-16,10.1056/nejmclde1209426,,,,22894598,,,,,,,0,0,1,84,0,0,6,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/889554,https://api.altmetric.com/v1/donut/889554_240.png 59,"Inactivation of ATP citrate lyase by Cucurbitacin B, a bioactive compound from cucumber, inhibits prostate cancer growth.",Cancer Letters,,,Article,2014-04-04,10.1016/j.canlet.2014.03.015,,,,24690568,,,,,,,0,0,0,1,0,0,77,0,52,0,0,0,0,0,0,13,https://www.altmetric.com/details/2774832,https://api.altmetric.com/v1/donut/2774832_240.png 59,Noninvasive prostate cancer screening based on serum surface-enhanced Raman spectroscopy and support vector machine,Applied Physics Letters,,,Article,2014-09-02,10.1063/1.4892667,,,,,,,,,,,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2647966,https://api.altmetric.com/v1/donut/2647966_240.png 59,Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015,Annals of Oncology,,,Article,2015-06-05,10.1093/annonc/mdv257,,,,26041764,,,,,,,1,0,0,100,0,0,4,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/4091757,https://api.altmetric.com/v1/donut/4091757_240.png 59,Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy.,JNCI: Journal of the National Cancer Institute,,,Article,2013-10-17,10.1093/jnci/djt280,,,,24136890,,,,,,,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1842887,https://api.altmetric.com/v1/donut/1842887_240.png 58,Punctuated Evolution of Prostate Cancer Genomes,Cell,,,Article,2013-01-01,10.1016/j.cell.2013.03.021,,,,23622249,,,,,,,2,2,0,38,0,0,0,0,0,0,0,0,1,0,0,458,https://www.altmetric.com/details/1412789,https://api.altmetric.com/v1/donut/1412789_240.png 58,Dietary carrot consumption and the risk of prostate cancer,European Journal of Nutrition,,,Article,2014-02-12,10.1007/s00394-014-0667-2,,,,24519559,,,,,,,3,1,0,18,0,0,20,0,10,0,0,0,0,0,0,4,https://www.altmetric.com/details/2126002,https://api.altmetric.com/v1/donut/2126002_240.png 58,Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer: The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial,JAMA: Journal of the American Medical Association,,,Article,2014-04-01,10.1001/jama.2014.2626,,,,24691606,,,,,,,6,0,0,31,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2229346,https://api.altmetric.com/v1/donut/2229346_240.png 58,Tracking the clonal origin of lethal prostate cancer.,Journal of Clinical Investigation,,,Article,2013-01-01,10.1172/jci70354,,,,24135135,,,,,,,5,0,0,38,0,0,1,1,0,0,0,0,0,0,0,142,https://www.altmetric.com/details/1859589,https://api.altmetric.com/v1/donut/1859589_240.png 58,SUV39H1|[sol]|H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells,Oncogenesis,,,Article,2014-01-01,10.1038/oncsis.2014.47,,,,25486523,,,,,,,4,3,0,11,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2966280,https://api.altmetric.com/v1/donut/2966280_240.png 58,Abiraterone and increased survival in metastatic prostate cancer.,New England Journal of Medicine,,,Article,2011-05-26,10.1056/nejmoa1014618,,,,21612468,,,,,,,1,8,6,2,0,0,0,1,0,0,0,0,4,0,0,229,https://www.altmetric.com/details/173633,https://api.altmetric.com/v1/donut/173633_240.png 58,"Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study",American Journal of Clinical Nutrition,,,Article,2001-10-01,,,,,11566656,,,,,,,2,5,0,11,0,0,24,0,0,0,0,0,0,0,2,9,https://www.altmetric.com/details/176207,https://api.altmetric.com/v1/donut/176207_240.png 58,Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth,Cancer Research,,,Article,2015-11-18,10.1158/0008-5472.can-15-0224,,,,26573794,,,,,,,8,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4779917,https://api.altmetric.com/v1/donut/4779917_240.png 58,Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening Strategies: Model Estimates of Potential Benefits and Harms,Annals of Internal Medicine,,,Article,2013-01-01,10.7326/0003-4819-158-3-201302050-00003,,,,23381039,,,,,,,0,2,1,51,0,0,1,1,1,0,0,0,0,0,0,29,https://www.altmetric.com/details/1217787,https://api.altmetric.com/v1/donut/1217787_240.png 58,Prostate cancer--uncertainty and a way forward.,New England Journal of Medicine,,,Article,2012-07-19,10.1056/nejme1205012,,,,22808963,,,,,,,2,5,0,14,0,0,2,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/846349,https://api.altmetric.com/v1/donut/846349_240.png 57,"Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer",Journal of Clinical Oncology,,,Article,2013-04-08,10.1200/jco.2012.43.1882,,,,23569316,,,,,,,3,3,0,20,0,0,2,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/1359675,https://api.altmetric.com/v1/donut/1359675_240.png 57,Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer,British Journal of Cancer,,,Article,2014-01-30,10.1038/bjc.2014.13,,,,24481405,,,,,,,7,0,0,5,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2116362,https://api.altmetric.com/v1/donut/2116362_240.png 57,"Asthma, allergy and the risk of prostate cancer: Results from the Montreal PROtEuS study",Cancer Epidemiology,,,Article,,10.1016/j.canep.2014.10.003,,,,25453783,,,,,,,7,0,0,8,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2880733,https://api.altmetric.com/v1/donut/2880733_240.png 56,Organoid Cultures Derived from Patients with Advanced Prostate Cancer,Cell,,,Article,2014-09-02,10.1016/j.cell.2014.08.016,,,,25201530,,,,,,,4,1,0,22,0,1,3,0,0,0,0,0,1,0,0,232,https://www.altmetric.com/details/2654061,https://api.altmetric.com/v1/donut/2654061_240.png 56,Expected population impacts of discontinued prostate?specific antigen screening,Cancer (0008543X),,,Article,2014-11-15,10.1002/cncr.28932,,,,25065910,,,,,,,2,0,0,85,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2541904,https://api.altmetric.com/v1/donut/2541904_240.png 56,Effects of Exercise on Treatment-Related Adverse Effects for Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Systematic Review.,Journal of Clinical Oncology,,,Article,2013-12-16,10.1200/jco.2013.49.5523,,,,24344218,,,,,,,4,0,0,46,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1987939,https://api.altmetric.com/v1/donut/1987939_240.png 56,Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis,Journal of Clinical Investigation,,,Article,2014-05-26,10.1172/jci70982,,,,24865426,,,,,,,7,3,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2383533,https://api.altmetric.com/v1/donut/2383533_240.png 56,Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells.,British Journal of Cancer,,,Article,2015-04-02,10.1038/bjc.2015.113,,,,25839988,,,,,,,8,1,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3872272,https://api.altmetric.com/v1/donut/3872272_240.png 56,Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer.,Nature Communications,,,Article,2013-05-28,10.1038/ncomms2912,,,,23715282,,,,,,,6,0,0,4,0,0,1,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1517389,https://api.altmetric.com/v1/donut/1517389_240.png 56,Association between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men with High Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-03-15,10.1016/j.ijrobp.2015.12.008,,,,26972640,,,,,,,6,1,0,18,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4877427,https://api.altmetric.com/v1/donut/4877427_240.png 55,MNX1 is oncogenically upregulated in African-American prostate cancer,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-0087,,,,27578002,PMC5093064,,,,,,9,0,0,11,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10919154,https://api.altmetric.com/v1/donut/10919154_240.png 55,"Risk of dying from early prostate cancer is low regardless of treatment, study finds",British Medical Journal,,,Article,2016-09-15,10.1136/bmj.i4984,,,,27633860,,,,,,,6,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12009110,https://api.altmetric.com/v1/donut/12009110_240.png 54,Guideline of guidelines: prostate cancer screening,British Journal of Urology,,,Article,2014-06-30,10.1111/bju.12854,,,,24981126,,,,,,,0,7,0,69,0,0,1,0,1,0,0,0,0,0,0,33,https://www.altmetric.com/details/2478859,https://api.altmetric.com/v1/donut/2478859_240.png 54,Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome,Cancer Research,,,Article,2016-06-16,10.1158/0008-5472.can-16-0902,,,,27302169,,,,,,,6,0,0,9,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8752267,https://api.altmetric.com/v1/donut/8752267_240.png 54,"Circumcision and prostate cancer: a population?based case?control study in Montreal, Canada",British Journal of Urology,,,Article,2014-03-01,10.1111/bju.12741,,,,24655933,,,,,,,5,1,0,33,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2209307,https://api.altmetric.com/v1/donut/2209307_240.png 54,Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions,Medical Decision Making,,,Article,2016-08-10,10.1177/0272989x16662841,,,,27510740,,,,,,,3,4,0,9,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10393834,https://api.altmetric.com/v1/donut/10393834_240.png 54,Testosterone Therapy In Patients With Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes,The Journal of Urology,,,Article,2016-04-28,10.1016/j.juro.2016.04.069,,,,27131465,,,,,,,4,3,0,15,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7050795,https://api.altmetric.com/v1/donut/7050795_240.png 54,Men’s Health Supplement Use and Outcomes Among Men Receiving Definitive IMRT for Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-11,10.1016/j.ijrobp.2015.07.1044,,,,,,,,,,,9,2,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4647958,https://api.altmetric.com/v1/donut/4647958_240.png 54,AEG-1 Promoter–Mediated Imaging of Prostate Cancer,Cancer Research,,,Article,2014-08-20,10.1158/0008-5472.can-14-0018,,,,25145668,,,,,,,7,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2626145,https://api.altmetric.com/v1/donut/2626145_240.png 54,The impact of robotic surgery on the surgical management of prostate cancer in the USA,British Journal of Urology,,,Article,2014-06-26,10.1111/bju.12850,,,,24958338,,,,,,,6,0,0,12,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/2548946,https://api.altmetric.com/v1/donut/2548946_240.png 54,Behavioral stress accelerates prostate cancer development in mice,Journal of Clinical Investigation,,,Article,2013-01-01,10.1172/jci63324,,,,23348742,,,,,,,6,1,0,24,0,0,16,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1197881,https://api.altmetric.com/v1/donut/1197881_240.png 54,Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer,Cell Reports,,,Article,2014-07-24,10.1016/j.celrep.2014.06.053,,,,25066126,,,,,,,5,1,0,13,0,1,0,0,0,0,0,0,1,0,0,120,https://www.altmetric.com/details/2536358,https://api.altmetric.com/v1/donut/2536358_240.png 54,N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells,Cancer Cell,,,Article,2016-03-31,10.1016/j.ccell.2016.03.001,,,,27050099,,,,,,,3,1,0,37,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6408897,https://api.altmetric.com/v1/donut/6408897_240.png 53,Metastatic Prostate Cancer in Men Initially Managed with Active Surveillance,The Journal of Urology,,,Article,2015-12-29,10.1016/j.juro.2015.11.075,,,,26707510,,,,,,,4,1,0,23,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4891575,https://api.altmetric.com/v1/donut/4891575_240.png 53,Exercise for Men with Prostate Cancer: A Systematic Review and Meta-analysis,European Urology,,,Article,2015-11-27,10.1016/j.eururo.2015.10.047,,,,26632144,,,,,,,0,0,0,122,0,0,7,0,4,0,0,0,0,0,0,21,https://www.altmetric.com/details/4812948,https://api.altmetric.com/v1/donut/4812948_240.png 53,Prediction of erectile function following treatment for prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,2011-09-21,10.1001/jama.2011.1333,,,,21934053,,,,,,,1,4,0,26,0,0,3,0,0,0,0,0,2,0,0,4,https://www.altmetric.com/details/377203,https://api.altmetric.com/v1/donut/377203_240.png 53,Comparative Effectiveness of Intensity-Modulated Radiotherapy and Conventional Conformal Radiotherapy in the Treatment of Prostate Cancer After Radical ProstatectomyComparative Effectiveness in Prostate Cancer,JAMA Internal Medicine,,,Article,2013-06-24,10.1001/jamainternmed.2013.1020,,,,23689844,,,,,,,4,1,0,21,0,0,3,0,2,0,0,0,0,0,0,20,https://www.altmetric.com/details/1495689,https://api.altmetric.com/v1/donut/1495689_240.png 53,Milk Intake in Early Life and Risk of Advanced Prostate Cancer.,American Journal of Epidemiology,,,Article,2011-12-24,10.1093/aje/kwr289,,,,22190107,,,,,,,2,2,0,26,0,0,4,0,1,0,0,0,0,0,5,22,https://www.altmetric.com/details/503180,https://api.altmetric.com/v1/donut/503180_240.png 53,Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study,The Journal of Urology,,,Article,2014-02-26,10.1016/j.juro.2014.01.113,,,,24582536,,,,,,,5,2,0,9,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2147249,https://api.altmetric.com/v1/donut/2147249_240.png 52,A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer,Cell,,,Article,2013-01-01,10.1016/j.cell.2013.07.029,,,,23993097,,,,,,,6,0,0,9,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/1718493,https://api.altmetric.com/v1/donut/1718493_240.png 52,Adherence to world cancer research fund/american institute for cancer research lifestyle recommendations reduces prostate cancer aggressiveness among african and caucasian americans.,Nutrition and Cancer,,,Article,2013-07-01,10.1080/01635581.2013.789540,,,,23859030,,,,,,,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1636695,https://api.altmetric.com/v1/donut/1636695_240.png 52,"A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling.",European Urology,,,Article,2014-05-15,10.1016/j.eururo.2014.05.004,,,,24836057,,,,,,,3,0,0,57,0,0,0,0,0,0,0,0,0,0,0,84,https://www.altmetric.com/details/2355345,https://api.altmetric.com/v1/donut/2355345_240.png 52,"Effect of Depression on Diagnosis, Treatment, and Mortality of Men With Clinically Localized Prostate Cancer.",Journal of Clinical Oncology,,,Article,2014-07-06,10.1200/jco.2013.51.1048,,,,25002728,,,,,,,4,3,0,19,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2493076,https://api.altmetric.com/v1/donut/2493076_240.png 52,Radiation Protection of the Gastrointestinal Tract and Growth Inhibition of Prostate Cancer Xenografts by a Single Compound.,Molecular Cancer Therapeutics,,,Article,2014-12-01,10.1158/1535-7163.mct-14-0354,,,,25398830,,,,,,,6,1,0,12,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2890171,https://api.altmetric.com/v1/donut/2890171_240.png 52,"Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial ",Lancet Oncology,,,Article,2016-05-04,10.1016/s1470-2045(16)00107-8,,,,27155740,,,,,,,2,0,0,58,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/7150806,https://api.altmetric.com/v1/donut/7150806_240.png 52,Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial,JAMA Oncology,,,Article,2015-08-20,10.1001/jamaoncol.2015.2993,,,,26291583,,,,,,,0,0,0,97,0,0,6,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4418465,https://api.altmetric.com/v1/donut/4418465_240.png 52,Gleason 6 Prostate Cancer: Translating Biology into Population Health,The Journal of Urology,,,Article,2015-04-08,10.1016/j.juro.2015.01.126,,,,25849602,,,,,,,5,0,0,28,0,0,1,1,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3878318,https://api.altmetric.com/v1/donut/3878318_240.png 52,Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.,Genome Biology (Online Edition),,,Article,2014-08-26,10.1186/preaccept-1882913817126479,,,,25155515,,,,,,,3,2,0,22,0,1,0,0,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/2625934,https://api.altmetric.com/v1/donut/2625934_240.png 52,"Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer",Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2011.39.2381,,,,22508819,,,,,,,0,2,0,50,0,0,6,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/699927,https://api.altmetric.com/v1/donut/699927_240.png 51,Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer,Nature Medicine,,,Article,2016-02-08,10.1038/nm.4045,,,,26855148,,,,,,,1,0,0,63,0,0,6,0,1,0,0,0,0,0,0,104,https://www.altmetric.com/details/5108079,https://api.altmetric.com/v1/donut/5108079_240.png 51,Patients Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer,Annals of Family Medicine,,,Article,2016-05-01,10.1370/afm.1926,,,,27184990,,,,,,,4,2,0,19,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7556962,https://api.altmetric.com/v1/donut/7556962_240.png 51,Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance.,British Journal of Urology,,,Article,2014-05-01,10.1111/bju.12682,,,,24898919,,,,,,,4,4,0,6,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2137434,https://api.altmetric.com/v1/donut/2137434_240.png 51,Use of Statins and the Risk of Death in Patients With Prostate Cancer.,Journal of Clinical Oncology,,,Article,2014-01-01,10.1200/jco.2013.49.4757,,,,24190110,,,,,,,4,1,0,42,0,0,6,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/1883643,https://api.altmetric.com/v1/donut/1883643_240.png 51,Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-03-07,10.1200/jco.2015.65.7270,,,,26951312,,,,,,,6,0,0,25,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6135557,https://api.altmetric.com/v1/donut/6135557_240.png 51,The Influence of Finasteride on the Development of Prostate Cancer,New England Journal of Medicine,,,Article,2003-07-17,10.1056/nejmoa030660,,,,12824459,,,,,,,3,5,0,2,0,0,0,0,0,0,0,0,2,0,0,49,https://www.altmetric.com/details/860112,https://api.altmetric.com/v1/donut/860112_240.png 51,Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies.,Nutrition and Cancer,,,Article,2009-01-01,10.1080/01635580902825639,,,,19838933,,,,,,,0,3,0,2,0,0,1,1,27,0,0,0,0,0,0,36,https://www.altmetric.com/details/181202,https://api.altmetric.com/v1/donut/181202_240.png 51,HDAC inhibitor confers radiosensitivity to prostate stem-like cells,British Journal of Cancer,,,Article,2013-11-12,10.1038/bjc.2013.691,,,,24220693,,,,,,,5,3,0,2,0,0,0,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/1903935,https://api.altmetric.com/v1/donut/1903935_240.png 50,Threshold-based parametric analysis of diffusion-weighted magnetic resonance imaging at 3.0 Tesla to identify men with prostate cancer,Advances in Modern Oncology Research,,,Article,2015-12-04,10.18282/amor.v1.i2.37,,,,,,,,,,,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4904597,https://api.altmetric.com/v1/donut/4904597_240.png 50,Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer,European Urology,,,Article,2016-07-23,10.1016/j.eururo.2016.07.012,,,,27460352,,,,,,,5,1,0,13,0,0,2,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/9977293,https://api.altmetric.com/v1/donut/9977293_240.png 50,Radical prostatectomy versus watchful waiting in early prostate cancer.,New England Journal of Medicine,,,Article,2011-05-05,10.1056/nejmoa1011967,,,,21542742,,,,,,,1,5,7,10,0,0,1,1,0,0,0,0,3,0,0,22,https://www.altmetric.com/details/173655,https://api.altmetric.com/v1/donut/173655_240.png 50,"Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study",Lancet Oncology,,,Article,2016-01-18,10.1016/s1470-2045(15)00518-5,,,,26774508,,,,,,,6,0,0,24,0,0,1,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/4990268,https://api.altmetric.com/v1/donut/4990268_240.png 50,Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial,Cancer (0008543X),,,Article,2016-09-20,10.1002/cncr.30336,,,,27648814,,,,,,,6,0,0,8,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12226975,https://api.altmetric.com/v1/donut/12226975_240.png 50,"Procyanidin B2 3,3?-di-O-gallate, a Biologically Active Constituent of Grape Seed Extract, Induces Apoptosis in Human Prostate Cancer Cells Via Targeting NF-?B, Stat3, and AP1 Transcription Factors.",Nutrition and Cancer,,,Article,2013-11-05,10.1080/01635581.2013.783602,,,,24191894,,,,,,,5,1,0,8,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1955773,https://api.altmetric.com/v1/donut/1955773_240.png 50,Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.,Nature,,,Article,2015-06-01,10.1038/nature14406,,,,26030522,,,,,,,1,3,0,37,0,0,0,1,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/4078120,https://api.altmetric.com/v1/donut/4078120_240.png 50,Obesity and Future Prostate Cancer Risk among Men after an Initial Benign Biopsy of the Prostate,"Cancer Epidemiology, Biomarkers & Prevention","MESSI, Linus",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-01-01,10.1158/1055-9965.epi-12-0965,,,,23613026,,,,,,,6,1,0,24,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1407367,https://api.altmetric.com/v1/donut/1407367_240.png 50,Prospective Study Evaluating Na18F-Positron Emission Tomography/Computed Tomography (NaF-PET/CT) in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.,Journal of Nuclear Medicine,,,Article,2016-01-23,10.2967/jnumed.115.166512,,,,26795292,,,,,,,5,0,0,43,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5030767,https://api.altmetric.com/v1/donut/5030767_240.png 50,Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study,Journal of Cancer Education,,,Article,2016-07-15,10.1007/s13187-016-1073-7,,,,27418065,,,,,,,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9831756,https://api.altmetric.com/v1/donut/9831756_240.png 49,Novel Fusion Transcripts Associate with Progressive Prostate Cancer,American Journal of Pathology,,,Article,2014-08-31,10.1016/j.ajpath.2014.06.025,,,,25238935,,,,,,,6,0,0,4,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2686800,https://api.altmetric.com/v1/donut/2686800_240.png 49,Toward a common therapeutic framework in castration-resistant prostate cancer: A model for urologic oncology and medical oncology interaction.,Urologic Oncology,,,Article,2013-12-05,10.1016/j.urolonc.2013.09.010,,,,24316022,,,,,,,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1973335,https://api.altmetric.com/v1/donut/1973335_240.png 49,Small Molecule-Induced Mitochondrial Disruption Directs Prostate Cancer Inhibition via UPR Signaling.,Oncotarget,,,Article,2013-08-03,10.18632/oncotarget.1130,,,,23902736,PMC3787152,,,,,,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1688155,https://api.altmetric.com/v1/donut/1688155_240.png 49,"Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF ",Translational Oncology,,,Article,2008-01-07,10.1593/tlo.08106,,,,18633461,PMC2510818,,,,,,0,2,0,49,0,0,9,1,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/1386043,https://api.altmetric.com/v1/donut/1386043_240.png 49,Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study,British Medical Journal,,,Article,2013-04-16,10.1136/bmj.f2023,,,,23596126,,,,,,,2,2,0,33,0,0,3,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/1408537,https://api.altmetric.com/v1/donut/1408537_240.png 49,Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer,European Urology,,,Article,2015-11-10,10.1016/j.eururo.2015.10.040,,,,26563871,,,,,,,0,0,0,129,0,0,7,0,5,0,0,0,0,0,0,26,https://www.altmetric.com/details/4743405,https://api.altmetric.com/v1/donut/4743405_240.png 49,Discussing Uncertainty and Risk in Primary Care: Recommendations of a Multi-Disciplinary Panel Regarding Communication Around Prostate Cancer Screening.,JGIM: Journal of General Internal Medicine,,,Article,2013-05-07,10.1007/s11606-013-2419-z,,,,23649782,PMC3797347,,,,,,0,0,0,50,0,0,14,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/1457306,https://api.altmetric.com/v1/donut/1457306_240.png 49,Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malmö Diet and Cancer cohort,American Journal of Clinical Nutrition,,,Article,2012-01-01,10.3945/ajcn.112.039438,,,,23134882,,,,,,,2,2,0,22,0,0,15,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1060745,https://api.altmetric.com/v1/donut/1060745_240.png 49,Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Anti-neoplastic Activity of Metformin in Prostate Cancer.,Journal of Biological Chemistry,,,Article,2014-12-10,10.1074/jbc.m114.596817,,,,25505174,,,,,,,5,1,0,2,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2991699,https://api.altmetric.com/v1/donut/2991699_240.png 48,Expression and Functional Role of Orphan Receptor GPR158 in Prostate Cancer Growth and Progression,PLoS ONE,,,Article,2015-08-30,10.1371/journal.pone.0117758,,,,25693195,,,,,,,6,0,0,8,0,0,1,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3715254,https://api.altmetric.com/v1/donut/3715254_240.png 48,The Prostate Health Index: a new test for the detection of prostate cancer,Therapeutic Advances in Urology,,,Article,2014-04-01,10.1177/1756287213513488,,,,24688603,PMC3943368,,,,,,2,3,0,6,0,0,0,0,2,0,0,0,0,0,0,37,https://www.altmetric.com/details/2163536,https://api.altmetric.com/v1/donut/2163536_240.png 48,Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.,British Journal of Cancer,,,Article,2014-04-10,10.1038/bjc.2014.192,,,,24722183,,,,,,,6,0,0,5,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/2272204,https://api.altmetric.com/v1/donut/2272204_240.png 48,Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2,Carcinogenesis,,,Article,2012-04-27,10.1093/carcin/bgs156,,,,22532249,,,,,,,0,0,0,3,0,0,46,0,38,0,0,0,0,0,0,4,https://www.altmetric.com/details/2523325,https://api.altmetric.com/v1/donut/2523325_240.png 48,Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2,Carcinogenesis,,,Article,2012-01-01,10.1093/carcin/bgs312,,,,23042094,,,,,,,2,1,0,24,0,0,11,0,1,0,1,0,0,0,0,62,https://www.altmetric.com/details/999556,https://api.altmetric.com/v1/donut/999556_240.png 48,Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421,JNCI: Journal of the National Cancer Institute,,,Article,2014-02-27,10.1093/jnci/dju013,,,,24565955,,,,,,,5,1,0,9,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2174329,https://api.altmetric.com/v1/donut/2174329_240.png 48,The Female Prostate,JNCI: Journal of the National Cancer Institute,,,Article,1998-01-01,10.1093/jnci/90.9.713,,,,9586671,,,,,,,5,0,0,35,0,0,2,1,1,0,2,0,0,0,0,1,https://www.altmetric.com/details/1021179,https://api.altmetric.com/v1/donut/1021179_240.png 48,"Spatial genomic heterogeneity within localized, multifocal prostate cancer",Nature Genetics,,,Article,2015-05-25,10.1038/ng.3315,,,,26005866,,,,,,,2,0,0,51,0,0,1,0,1,0,0,0,0,0,0,185,https://www.altmetric.com/details/4056244,https://api.altmetric.com/v1/donut/4056244_240.png 47,Impact of Prostate Cancer Diagnosis on Noncancer Hospitalizations Among Elderly Medicare Beneficiaries With Incident Prostate Cancer.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2016-02-01,,,,,26850489,,,,,,,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6252143,https://api.altmetric.com/v1/donut/6252143_240.png 47,Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-01-01,10.1158/1055-9965.epi-12-0944,,,,23532004,,,,,,,7,0,0,6,0,0,2,0,0,0,1,0,0,0,0,7,https://www.altmetric.com/details/1324365,https://api.altmetric.com/v1/donut/1324365_240.png 47,A Transgenic Mouse Model for Early Prostate Metastasis to Lymph Nodes,Cancer Research,,,Article,2014-02-01,10.1158/0008-5472.can-13-1157,,,,24492704,,,,,,,6,1,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2092451,https://api.altmetric.com/v1/donut/2092451_240.png 47,Targeting hypoxic prostate tumours using the novel hypoxia-activated prodrug OCT1002 inhibits expression of genes associated with malignant progression,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-1361,,,,27697998,,,,,,,5,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12411405,https://api.altmetric.com/v1/donut/12411405_240.png 47,Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial,JAMA Oncology,,,Article,2015-11-25,10.1001/jamaoncol.2015.4350,,,,26606329,,,,,,,0,1,0,74,0,0,4,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4811407,https://api.altmetric.com/v1/donut/4811407_240.png 47,"Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2016-10-10,10.1200/jco.2016.69.1584,,,,,,,,,,,1,1,0,51,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12571981,https://api.altmetric.com/v1/donut/12571981_240.png 47,Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.,European Urology,,,Article,2015-05-25,10.1016/j.eururo.2015.04.036,,,,26003223,,,,,,,0,0,0,75,0,0,7,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4035724,https://api.altmetric.com/v1/donut/4035724_240.png 47,Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer,British Journal of Cancer,,,Article,2015-02-17,10.1038/bjc.2015.54,,,,25688739,,,,,,,2,1,0,38,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3710395,https://api.altmetric.com/v1/donut/3710395_240.png 47,A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population,The Journal of Urology,,,Article,2016-02-12,10.1016/j.juro.2016.01.114,,,,26880413,,,,,,,16,0,0,31,0,0,3,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5527964,https://api.altmetric.com/v1/donut/5527964_240.png 47,Decision Making in Prostate Cancer Screening Using Decision Aids vs Usual Care: A Randomized Clinical Trial.,JAMA Internal Medicine,,,Article,2013-07-29,10.1001/jamainternmed.2013.9253,,,,23896732,,,,,,,4,1,0,12,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1657907,https://api.altmetric.com/v1/donut/1657907_240.png 47,Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis.,American Journal of Clinical Nutrition,,,Article,2009-01-01,10.3945/ajcn.2008.27029,,,,19211820,,,,,,,4,1,0,5,0,0,0,1,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/1628612,https://api.altmetric.com/v1/donut/1628612_240.png 47,Statin Use in Relation to Prostate Cancer Outcomes in a Population-based Patient Cohort Study.,The Prostate,,,Article,2013-01-01,10.1002/pros.22671,,,,23633265,,,,,,,5,0,0,6,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1427141,https://api.altmetric.com/v1/donut/1427141_240.png 47,Bibliography. Current world literature. Prostate cancer.,Current Opinion in Urology,,,Article,2006-05-10,doi,,,,16679858,,,,,,,11,1,0,8,0,0,3,0,1,0,0,0,0,1,0,184,https://www.altmetric.com/details/1593294,https://api.altmetric.com/v1/donut/1593294_240.png 46,Racial Disparities in Prostate Cancer Mortality in the 50 Largest US Cities,Cancer Epidemiology,,,Article,2016-10-01,10.1016/j.canep.2016.07.019,,,,27566470,,,,,,,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10905627,https://api.altmetric.com/v1/donut/10905627_240.png 46,Possible Confusion in Names of New Treatments for Prostate Cancer,New England Journal of Medicine,,,Article,2013-01-10,10.1056/nejmc1213236,,,,23301754,,,,,,,0,0,0,63,0,0,5,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1166855,https://api.altmetric.com/v1/donut/1166855_240.png 46,Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof-of-Principle Study,Cancer Research,,,Article,2006-01-01,10.1158/0008-5472.can-05-1145,,,,16424063,,,,,,,3,1,0,23,0,2,0,0,0,0,0,0,0,0,0,104,https://www.altmetric.com/details/1900661,https://api.altmetric.com/v1/donut/1900661_240.png 46,"XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors",Proceedings of the National Academy of Sciences of the United States of America,"DENT, Harris",Department of Life Sciences; School of Natural Sciences,Article,2009-09-08,10.1073/pnas.0906922106,,,,19805305,PMC2739868,,2009PNAS..10616351S,,,,0,11,0,0,0,0,0,2,2,0,0,0,0,0,6,108,https://www.altmetric.com/details/108824,https://api.altmetric.com/v1/donut/108824_240.png 46,Advances in the Treatment of Metastatic Prostate Cancer,Mayo Clinic Proceedings,,,Article,2015-01-12,10.1016/j.mayocp.2015.10.010,,,,26653301,,,,,,,0,0,0,79,0,0,9,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4862863,https://api.altmetric.com/v1/donut/4862863_240.png 46,Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists,Medical care,,,Article,2014-07-01,10.1097/mlr.0000000000000155,,,,24926704,,,,,,,4,0,0,22,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2440486,https://api.altmetric.com/v1/donut/2440486_240.png 45,MP79-06 CLINICAL IMPACT OF 68GA-PSMA PET/CT IN PROSTATE CANCER PATIENTS WITH RISING PSA AFTER TREATMENT WITH CURATIVE INTENT: PRELIMINARY ANALYSIS OF 42 CONSECUTIVE PATIENTS,The Journal of Urology,,,Article,2016-04-01,10.1016/j.juro.2016.02.2004,,,,,,,,,,,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6972337,https://api.altmetric.com/v1/donut/6972337_240.png 45,Inhibition of Gli/hedgehog signaling in prostate cancer cells by “cancer bush” Sutherlandia frutescens extract,Cell Biology International,,,Article,2015-09-01,10.1002/cbin.10544,,,,26377232,,,,,,,4,1,0,14,0,0,3,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4536776,https://api.altmetric.com/v1/donut/4536776_240.png 45,Effects of Screening on Radical Prostatectomy Efficacy: The Prostate Cancer Intervention Versus Observation Trial,JNCI: Journal of the National Cancer Institute,,,Article,2013-02-14,10.1093/jnci/djt017,,,,23411592,,,,,,,6,0,0,16,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1241531,https://api.altmetric.com/v1/donut/1241531_240.png 45,Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991,Journal of Clinical Oncology,,,Article,2016-03-14,10.1200/jco.2015.64.8055,,,,26976418,,,,,,,2,1,0,36,0,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6190349,https://api.altmetric.com/v1/donut/6190349_240.png 45,Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer,EMBO Journal,,,Article,2014-12-22,10.15252/embj.201490306,,,,25535248,,,,,,,5,1,0,4,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3012779,https://api.altmetric.com/v1/donut/3012779_240.png 45,Screening for prostate cancer: time to put all the data on the table:,British Medical Journal,,,Article,2016-05-25,10.1136/bmj.i2574,,,,27226459,,,,,,,0,0,0,74,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8227261,https://api.altmetric.com/v1/donut/8227261_240.png 45,"Occupation, industry, and the risk of prostate cancer: a case-control study in Montréal, Canada",Environmental Health: A Global Access Science Source,,,Article,2016-10-21,10.1186/s12940-016-0185-1,,,,27769264,,,,,,,5,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12858597,https://api.altmetric.com/v1/donut/12858597_240.png 45,Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings,European Urology Focus ,,,Article,2016-06-17,10.1016/j.euf.2016.05.009,,,,,,,,,,,6,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8813890,https://api.altmetric.com/v1/donut/8813890_240.png 45,Risk of second primary tumors in men diagnosed with prostate cancer: A population?based cohort study,Cancer (0008543X),,,Article,2014-05-22,10.1002/cncr.28769,,,,24842808,,,,,,,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2378063,https://api.altmetric.com/v1/donut/2378063_240.png 45,"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial",The Lancet (British Edition),,,Article,2011-01-01,10.1016/s0140-6736(11)61095-7,,,,22056152,,,,,,,14,1,0,21,0,0,1,1,0,0,0,0,1,0,0,35,https://www.altmetric.com/details/438878,https://api.altmetric.com/v1/donut/438878_240.png 45,Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer.,PLoS Genetics,,,Article,2014-02-15,10.1371/journal.pgen.1004129,,,,24550738,PMC3923678,,,,,,2,2,0,32,0,0,0,0,0,0,0,0,0,0,0,87,https://www.altmetric.com/details/2119210,https://api.altmetric.com/v1/donut/2119210_240.png 45,Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.,Clinical Cancer Research,,,Article,2006-07-01,10.1158/1078-0432.ccr-05-2290,,,,16818701,,,,,,,1,4,0,3,0,0,5,1,0,0,0,0,0,0,1,114,https://www.altmetric.com/details/175083,https://api.altmetric.com/v1/donut/175083_240.png 45,How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review.,European Urology,,,Article,2014-10-31,10.1016/j.eururo.2014.10.028,,,,25454617,,,,,,,2,0,0,40,0,0,0,0,2,0,0,0,1,0,0,41,https://www.altmetric.com/details/2829884,https://api.altmetric.com/v1/donut/2829884_240.png 45,Early Detection of Prostate Cancer: AUA Guideline,The Journal of Urology,,,Article,2013-05-07,10.1016/j.juro.2013.04.119,,,,23659877,,,,,,,5,0,3,8,0,0,1,1,0,0,0,0,0,0,0,113,https://www.altmetric.com/details/1453258,https://api.altmetric.com/v1/donut/1453258_240.png 45,Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline,Journal of Clinical Oncology,,,Article,2014-09-07,10.1200/jco.2013.54.8404,,,,25199761,,,,,,,0,1,0,61,0,0,6,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/2665800,https://api.altmetric.com/v1/donut/2665800_240.png 45," Germline Mutations in and Prostate-Cancer Risk ",New England Journal of Medicine,,,Article,2012-01-12,10.1056/nejmoa1110000,,,,22236224,,,,,,,0,3,0,37,0,0,0,1,1,0,0,0,1,0,0,76,https://www.altmetric.com/details/556318,https://api.altmetric.com/v1/donut/556318_240.png 44,Patient-physician-communication and health related quality of life of localized prostate cancer patients undergoing radical prostatectomy - a longitudinal multilevel analysis,British Journal of Urology,,,Article,2016-04-01,10.1111/bju.13495,,,,27037732,,,,,,,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7142141,https://api.altmetric.com/v1/donut/7142141_240.png 44,"A prospective study of tomato products, lycopene, and prostate cancer risk.",JNCI: Journal of the National Cancer Institute,,,Article,2002-03-06,10.1093/jnci/94.5.391,,,,11880478,,,,,,,5,0,0,2,0,0,4,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/2113358,https://api.altmetric.com/v1/donut/2113358_240.png 44,Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer,European Urology,,,Article,2015-03-20,10.1016/j.eururo.2015.03.021,,,,25800944,,,,,,,4,0,0,58,0,0,3,0,1,0,0,0,0,0,0,21,https://www.altmetric.com/details/3817494,https://api.altmetric.com/v1/donut/3817494_240.png 44,Pairing Physician Education With Patient Activation to Improve Shared Decisions in Prostate Cancer Screening: A Cluster Randomized Controlled Trial,Annals of Family Medicine,,,Article,2013-01-01,10.1370/afm.1550,,,,23835818,PMC3704492,,,,,,3,1,0,4,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/1612497,https://api.altmetric.com/v1/donut/1612497_240.png 44,Mitochondrial dysfunction-mediated apoptosis resistance associates with defective heat shock protein response in African|[ndash]|American men with prostate cancer,British Journal of Cancer,,,Article,2016-04-26,10.1038/bjc.2016.88,,,,27115471,,,,,,,6,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6974876,https://api.altmetric.com/v1/donut/6974876_240.png 44,Variation in prostate cancer treatment associated with population density of the county of residence,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-19,10.1038/pcan.2015.65,,,,26782713,,,,,,,5,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5013164,https://api.altmetric.com/v1/donut/5013164_240.png 44,Radiotherapy and short-term androgen deprivation for localized prostate cancer.,New England Journal of Medicine,,,Article,2011-07-14,10.1056/nejmoa1012348,,,,21751904,,,,,,,5,1,0,22,0,0,0,0,0,0,0,0,1,0,0,102,https://www.altmetric.com/details/187668,https://api.altmetric.com/v1/donut/187668_240.png 44,Psychological Research and the Prostate-Cancer Screening Controversy,Psychological Science (Sage Publications Inc.),,,Article,2012-01-01,10.1177/0956797612437428,,,,22555966,,,,,,,2,1,1,22,0,0,0,0,1,0,0,0,0,0,0,84,https://www.altmetric.com/details/728021,https://api.altmetric.com/v1/donut/728021_240.png 44,Prospective Study of Trichomonas vaginalis Infection and Prostate Cancer Incidence and Mortality: Physicians' Health Study,JNCI: Journal of the National Cancer Institute,,,Article,2009-09-09,10.1093/jnci/djp306,,,,19741211,,,,,,,3,1,0,8,0,0,1,0,0,0,0,0,0,0,1,28,https://www.altmetric.com/details/413673,https://api.altmetric.com/v1/donut/413673_240.png 44,Tumor associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.,Genome Medicine,,,Article,2013-04-05,10.1186/gm434,,,,23561577,,,,,,,2,2,0,36,0,0,0,0,0,0,0,0,0,0,0,130,https://www.altmetric.com/details/1363516,https://api.altmetric.com/v1/donut/1363516_240.png 44,Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer,Nature Communications,,,Article,2015-04-01,10.1038/ncomms7605,,,,25827447,,11343/55097,,,,,0,3,0,32,0,0,4,0,0,0,0,0,0,0,0,133,https://www.altmetric.com/details/3859517,https://api.altmetric.com/v1/donut/3859517_240.png 44,Decision aids for localized prostate cancer treatment choice: Systematic review and meta?analysis,CA: A Cancer Journal for Clinicians ,,,Article,2015-03-12,10.3322/caac.21272,,,,25772796,,,,,,,3,0,0,44,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3790399,https://api.altmetric.com/v1/donut/3790399_240.png 43,"â??The Older, the Wiserâ?? in Prostate Cancer Treatment Choices?",Annals of Internal Medicine,,,Article,2013-01-01,10.7326/0003-4819-158-10-201305210-00013,,,,23689767,,,,,,,4,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1494389,https://api.altmetric.com/v1/donut/1494389_240.png 43,How Active is Active Surveillance? Intensity of Follow-Up During Active Surveillance for Prostate Cancer in the United States,The Journal of Urology,,,Article,2016-03-02,10.1016/j.juro.2016.02.2963,,,,26946161,,,,,,,2,0,0,46,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6043000,https://api.altmetric.com/v1/donut/6043000_240.png 43,Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis,JAMA Oncology,,,Article,2015-09-17,10.1001/jamaoncol.2015.2895,,,,26378418,,,,,,,1,0,0,79,0,0,3,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4524551,https://api.altmetric.com/v1/donut/4524551_240.png 43,Green Tea Consumption and Prostate Cancer Risk in Japanese Men: A Prospective Study,American Journal of Epidemiology,,,Article,2008-01-01,10.1093/aje/kwm249,,,,17906295,,,,,,,1,9,0,2,0,0,8,0,0,0,0,0,0,0,1,40,https://www.altmetric.com/details/387997,https://api.altmetric.com/v1/donut/387997_240.png 43,Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.,New England Journal of Medicine,,,Article,2011-10-26,10.1056/nejmp1112140,,,,22029756,,,,,,,0,2,1,29,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/430532,https://api.altmetric.com/v1/donut/430532_240.png 43,PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-06-06,10.1073/pnas.1521738113,,,,27274052,,,,,,,5,1,0,3,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/8519859,https://api.altmetric.com/v1/donut/8519859_240.png 43,Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy.,Journal of Clinical Oncology,,,Article,2012-08-27,10.1200/jco.2011.41.0308,,,,22927523,,,,,,,0,2,0,37,0,2,3,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/916882,https://api.altmetric.com/v1/donut/916882_240.png 43,Whole genomic copy number alterations in circulating tumor cells from men with abiraterone or enzalutamide resistant metastatic castration-resistant prostate cancer,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-1211,,,,27601596,,,,,,,6,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11870561,https://api.altmetric.com/v1/donut/11870561_240.png 43,Contemporary Nationwide Patterns of Active Surveillance Use for Prostate Cancer,JAMA Internal Medicine,,,Article,2015-06-29,10.1001/jamainternmed.2015.2835,,,,26121305,,,,,,,2,1,0,39,0,0,5,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/4225201,https://api.altmetric.com/v1/donut/4225201_240.png 43,Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study.,Journal of Clinical Oncology,,,Article,2011-02-20,10.1200/jco.2010.31.5226,,,,21205749,,,,,,,0,1,0,43,0,0,3,1,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/252287,https://api.altmetric.com/v1/donut/252287_240.png 43,Metastatic Castration-Resistant Prostate Cancer Hungers for Leucine.,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt252,,,,24052625,,,,,,,7,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1770170,https://api.altmetric.com/v1/donut/1770170_240.png 43,Intermittent versus continuous androgen deprivation in prostate cancer.,New England Journal of Medicine,,,Article,2013-04-04,10.1056/nejmoa1212299,,,,23550669,,,,,,,6,0,0,19,0,0,3,0,0,0,0,0,2,0,0,105,https://www.altmetric.com/details/1337520,https://api.altmetric.com/v1/donut/1337520_240.png 43,Prostate Cancer Screening In Men Ages 75 And Older Fell By 8 Percentage Points After Task Force Recommendation,Health Affairs,,,Article,2013-01-01,10.1377/hlthaff.2012.0555,,,,23459740,,,,,,,0,1,0,49,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1280125,https://api.altmetric.com/v1/donut/1280125_240.png 43,Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study.,PLoS ONE,,,Article,2015-02-23,10.1371/journal.pone.0115999,,,,25706755,,,,,,,5,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3795601,https://api.altmetric.com/v1/donut/3795601_240.png 43,Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement,Annals of Internal Medicine,,,Article,2012-01-01,10.7326/0003-4819-157-2-201207170-00464,,,,22801691,,,,,,,4,2,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/865545,https://api.altmetric.com/v1/donut/865545_240.png 42,Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening,Journal of Clinical Oncology,,,Article,2016-06-22,10.1200/jco.2016.68.2138,,,,27325846,,,,,,,1,0,0,54,0,0,6,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8949248,https://api.altmetric.com/v1/donut/8949248_240.png 42,Physical Activity and Survival After Prostate Cancer.,European Urology,,,Article,2016-01-08,10.1016/j.eururo.2015.12.032,,,,26774959,,,,,,,2,1,0,34,0,0,10,0,1,0,0,0,0,0,0,24,https://www.altmetric.com/details/4968488,https://api.altmetric.com/v1/donut/4968488_240.png 42,Daily Aspirin Use and Prostate Cancer–Specific Mortality in a Large Cohort of Men with Nonmetastatic Prostate Cancer,Journal of Clinical Oncology,,,Article,2014-10-19,10.1200/jco.2013.54.8875,,,,25332245,,,,,,,1,0,0,47,0,0,7,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2797671,https://api.altmetric.com/v1/donut/2797671_240.png 42,Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study.,JNCI: Journal of the National Cancer Institute,,,Article,2007-01-01,10.1093/jnci/djk177,,,,17505071,,,,,,,1,5,0,4,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/583906,https://api.altmetric.com/v1/donut/583906_240.png 42,Polar biophenolics in sweet potato greens extract synergize to inhibit prostate cancer cell proliferation and in vivo tumor growth,Carcinogenesis,,,Article,2013-05-01,10.1093/carcin/bgt141,,,,23629419,,,,,,,0,0,0,15,0,0,113,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1430095,https://api.altmetric.com/v1/donut/1430095_240.png 42,Lineage Relationship of Gleason Patterns in Gleason Score 7 Prostate Cancer,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-2803,,,,23695551,,,,,,,6,0,0,3,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1507443,https://api.altmetric.com/v1/donut/1507443_240.png 42,Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome.,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.44.1238,,,,23530095,,,,,,,3,0,0,23,0,0,3,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1322302,https://api.altmetric.com/v1/donut/1322302_240.png 42,Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.,eLife,,,Article,2015-04-08,10.7554/elife.02935,,,,25271376,,,,,,,1,1,0,46,0,0,0,0,0,0,0,0,0,0,0,98,https://www.altmetric.com/details/2732938,https://api.altmetric.com/v1/donut/2732938_240.png 41,Recommendations for Prostate Cancer Survivorship Care: An Update to the 2009 Michigan Cancer Consortium Guidelines for the Primary Care Management of Prostate Cancer Post-Treatment Sequelae,Journal of Men's Health,,,Article,2014-09-01,10.1089/jomh.2014.0026,,,,,,,,,,,4,0,0,16,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2526630,https://api.altmetric.com/v1/donut/2526630_240.png 41,Vaccination with tumor cells expressing IL-15 and IL-15R|[alpha]| inhibits murine breast and prostate cancer,Gene Therapy,,,Article,2014-02-27,10.1038/gt.2014.10,,,,24572789,,,,,,,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2151014,https://api.altmetric.com/v1/donut/2151014_240.png 41,"Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development.",JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt241,,,,24052624,,,,,,,5,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1770169,https://api.altmetric.com/v1/donut/1770169_240.png 41,Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-03-11,10.1073/pnas.1202653110,,,,23479624,PMC3612646,,,,,,4,0,0,7,0,0,1,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1307032,https://api.altmetric.com/v1/donut/1307032_240.png 41,Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing,Mayo Clinic Proceedings,,,Article,2015-12-22,10.1016/j.mayocp.2015.07.030,,,,26688045,,,,,,,5,0,0,6,0,0,0,0,2,0,0,0,0,0,0,14,https://www.altmetric.com/details/4864686,https://api.altmetric.com/v1/donut/4864686_240.png 41,National trends in prostate cancer screening among older American men with limited 9-year life expectancies: Evidence of an increased need for shared decision making.,Cancer (0008543X),,,Article,2014-02-12,10.1002/cncr.28600,,,,24523016,,,,,,,1,2,0,33,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2116910,https://api.altmetric.com/v1/donut/2116910_240.png 41,Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-11-26,10.1073/pnas.1320565110,,,,24282295,,,,,,,5,0,0,7,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1939482,https://api.altmetric.com/v1/donut/1939482_240.png 41,A Preclinical Xenograft Model Identifies Castration-Tolerant Cancer-Repopulating Cells in Localized Prostate Tumors,Science Translational Medicine,,,Article,2013-05-29,10.1126/scitranslmed.3005688,,,,23720582,,,,,,,3,0,0,21,0,0,2,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1518704,https://api.altmetric.com/v1/donut/1518704_240.png 40,"Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial",The Lancet,,,Article,2012-01-28,10.1016/s0140-6736(11)61619-x,,,,22277570,,,,,,,1,1,0,38,0,0,1,0,0,0,0,0,6,0,0,15,https://www.altmetric.com/details/571540,https://api.altmetric.com/v1/donut/571540_240.png 40,A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer,PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0101411,,,,24983969,,,,,,,5,0,0,10,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2480997,https://api.altmetric.com/v1/donut/2480997_240.png 40,"Sensitivity, Specificity, and Predictors of Positive 68Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis",European Urology,,,Article,2016-06-28,10.1016/j.eururo.2016.06.021,,,,27363387,,,,,,,0,0,0,71,0,0,2,0,2,0,0,0,0,0,0,8,https://www.altmetric.com/details/9087186,https://api.altmetric.com/v1/donut/9087186_240.png 40,Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2014-04-10,10.1200/jco.2013.51.7417,,,,24616308,,,,,,,3,0,0,25,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/2176762,https://api.altmetric.com/v1/donut/2176762_240.png 40,Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer.,Journal of Clinical Oncology,,,Article,2015-03-02,10.1200/jco.2014.59.1792,,,,25732167,,,,,,,3,0,0,29,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3754840,https://api.altmetric.com/v1/donut/3754840_240.png 40,"Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial",European Urology,,,Article,2016-04-16,10.1016/j.eururo.2016.03.048,,,,27090975,,,,,,,0,0,0,68,0,0,6,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/6749934,https://api.altmetric.com/v1/donut/6749934_240.png 40,Fighting Prostate Cancer with Radium-223 — Not Your Madame's Isotope,New England Journal of Medicine,,,Article,2013-07-18,10.1056/nejme1304041,,,,23863055,,,,,,,4,0,0,15,0,0,3,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/1632009,https://api.altmetric.com/v1/donut/1632009_240.png 40,Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate,Clinical Cancer Research,,,Article,2015-01-15,10.1158/1078-0432.ccr-14-1961,,,,25593303,,,,,,,4,1,0,5,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3074329,https://api.altmetric.com/v1/donut/3074329_240.png 39,The TGF-? Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone,Cancer Cell,,,Article,2015-05-20,10.1016/j.ccell.2015.04.009,,,,25982816,,,,,,,4,0,0,17,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3996388,https://api.altmetric.com/v1/donut/3996388_240.png 39,"Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)",Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70025-1,,,,23465742,,,,,,,3,0,0,13,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1276805,https://api.altmetric.com/v1/donut/1276805_240.png 39,Androgen deprivation therapy use and risk of death in men treated with high-dose radiation for intermediate-risk prostate cancer,Cancer (0008543X),,,Article,2016-05-01,10.1002/cncr.30048,,,,27191800,,,,,,,5,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8168159,https://api.altmetric.com/v1/donut/8168159_240.png 39,"Modulation of Blood Flow, Hypoxia, and Vascular Function in Orthotopic Prostate Tumors During Exercise",JNCI: Journal of the National Cancer Institute,,,Article,2014-03-13,10.1093/jnci/dju036,,,,24627275,,,,,,,4,0,0,14,0,0,4,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2194150,https://api.altmetric.com/v1/donut/2194150_240.png 39,The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model.,Cancer Prevention Research,,,Article,2013-01-01,10.1158/1940-6207.capr-12-0443,,,,23592738,,,,,,,4,0,0,6,0,0,3,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1457632,https://api.altmetric.com/v1/donut/1457632_240.png 39,Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type 2 Diabetes,Cancer Prevention Research,,,Article,2016-03-29,10.1158/1940-6207.capr-15-0425,,,,27026681,,,,,,,5,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6463086,https://api.altmetric.com/v1/donut/6463086_240.png 39,"Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial",Osteoporosis International,,,Article,2015-11-16,10.1007/s00198-015-3399-0,,,,26572756,,,,,,,4,0,0,10,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4769492,https://api.altmetric.com/v1/donut/4769492_240.png 39,Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910,Journal of Clinical Oncology,,,Article,2015-02-01,10.1200/jco.2014.58.0662,,,,25534388,,,,,,,1,1,0,36,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3008795,https://api.altmetric.com/v1/donut/3008795_240.png 39,African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men,Urologic Oncology,,,Article,2014-10-07,10.1016/j.urolonc.2014.07.005,,,,25304288,,,,,,,5,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2766479,https://api.altmetric.com/v1/donut/2766479_240.png 39,Association between exercise and primary incidence of prostate cancer: Does race matter?,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27791,,,,23401030,,,,,,,3,0,0,28,0,0,7,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1232133,https://api.altmetric.com/v1/donut/1232133_240.png 39,New Data on Prostate-Cancer Mortality after PSA Screening,New England Journal of Medicine,,,Article,2012-03-15,10.1056/nejme1200185,,,,22417259,,,,,,,5,1,0,6,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/649348,https://api.altmetric.com/v1/donut/649348_240.png 39,Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials,Supportive Care in Cancer,,,Article,2011-10-12,10.1007/s00520-011-1271-0,,,,21989678,,,,,,,3,1,0,5,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/443247,https://api.altmetric.com/v1/donut/443247_240.png 39,"Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention",Cancer Prevention Research,,,Article,2015-10-01,10.1158/1940-6207.capr-14-0324,,,,25873370,,,,,,,4,0,0,8,0,0,2,0,0,0,1,0,0,0,0,1,https://www.altmetric.com/details/4027427,https://api.altmetric.com/v1/donut/4027427_240.png 39,"Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case–control study",Carcinogenesis,"JONES, India",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-07-25,10.1093/carcin/bgs242,,,,22822096,,,,,,,0,0,0,47,0,0,5,1,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/891553,https://api.altmetric.com/v1/donut/891553_240.png 38,Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging,PLoS ONE,,,Article,2015-10-07,10.1371/journal.pone.0139696,,,,26444548,,,,,,,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4818527,https://api.altmetric.com/v1/donut/4818527_240.png 38,Long noncoding RNAs as putative biomarkers for prostate cancer detection.,The Journal of Molecular Diagnostics,,,Article,2014-12-18,,,,,25513185,,,,,,,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3074283,https://api.altmetric.com/v1/donut/3074283_240.png 38,Predictive Value of Sp1/Sp3/FLIP Signature for Prostate Cancer Recurrence,PLoS ONE,,,Article,2012-09-13,10.1371/journal.pone.0044917,,,,23028678,PMC3441693,,,,,,3,1,1,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/944729,https://api.altmetric.com/v1/donut/944729_240.png 38,Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study,Nature Genetics,,,Article,2011-07-10,10.1038/ng.882,,,,21743467,,,,,,,0,3,0,20,0,0,1,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/183933,https://api.altmetric.com/v1/donut/183933_240.png 38,DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases,Science Translational Medicine,,,Article,2013-01-23,10.1126/scitranslmed.3005211,,,,23345608,,,,,,,1,2,0,25,0,0,0,0,0,0,0,0,0,0,0,124,https://www.altmetric.com/details/1193690,https://api.altmetric.com/v1/donut/1193690_240.png 38,"Testosterone Therapy after Radiation Therapy for Low, Intermediate, and High Risk Prostate Cancer.",The Journal of Urology,,,Article,2015-05-31,10.1016/j.juro.2015.05.084,,,,26025500,,,,,,,1,3,0,17,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4061352,https://api.altmetric.com/v1/donut/4061352_240.png 38,Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force,European Urology,,,Article,2016-06-25,10.1016/j.eururo.2016.06.011,,,,27349615,,,,,,,0,0,0,69,0,0,3,0,2,0,0,0,0,0,0,11,https://www.altmetric.com/details/9028822,https://api.altmetric.com/v1/donut/9028822_240.png 38,Local Treatment of the Prostate in Metastatic Prostate Cancer: Need to Change the Concept?,European Urology,,,Article,2016-06-21,10.1016/j.eururo.2016.06.008,,,,27339835,,,,,,,0,0,0,85,0,0,2,0,3,0,0,0,0,0,0,2,https://www.altmetric.com/details/8939912,https://api.altmetric.com/v1/donut/8939912_240.png 38,Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy,European Urology,,,Article,2015-06-29,10.1016/j.eururo.2015.06.010,,,,26116958,,,,,,,0,0,0,65,0,0,8,0,3,0,0,0,0,0,0,35,https://www.altmetric.com/details/4207843,https://api.altmetric.com/v1/donut/4207843_240.png 38,Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project,Prostate Cancer & Prostatic Diseases,,,Article,2016-09-06,10.1038/pcan.2016.39,,,,27595916,,,,,,,3,1,0,14,0,0,4,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11852067,https://api.altmetric.com/v1/donut/11852067_240.png 38,The genomic complexity of primary human prostate cancer,Nature,"KENT, Clarkson S",Department of Life Sciences; School of Natural Sciences,Article,2011-02-09,10.1038/nature09744,,,,21307934,PMC3075885,,2011Natur.470..214B,,,,0,4,0,5,0,0,1,1,1,0,0,0,0,0,0,423,https://www.altmetric.com/details/215617,https://api.altmetric.com/v1/donut/215617_240.png 38,"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.",Lancet Oncology,,,Article,2014-05-11,10.1016/s1470-2045(14)70189-5,,,,24831977,,,,,,,2,2,0,16,0,1,2,0,0,0,0,0,1,0,0,98,https://www.altmetric.com/details/2346345,https://api.altmetric.com/v1/donut/2346345_240.png 38,Effect of Caffeine on Exercise Capacity and Function in Prostate Cancer Survivors.,Medicine & Science in Sports & Exercise,,,Article,2014-06-30,10.1249/mss.0000000000000429,,,,24977700,,,,,,,3,1,0,17,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2479652,https://api.altmetric.com/v1/donut/2479652_240.png 38,Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series,European Urology,,,Article,2016-07-01,10.1016/j.eururo.2016.07.028,,,,27484843,,,,,,,0,0,0,55,0,0,0,0,2,0,0,0,0,0,0,15,https://www.altmetric.com/details/10266750,https://api.altmetric.com/v1/donut/10266750_240.png 38,"Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial ",Lancet Oncology,,,Article,2016-07-01,10.1016/s1470-2045(16)30173-5,,,,27473888,,,,,,,1,0,0,51,0,0,2,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/10067479,https://api.altmetric.com/v1/donut/10067479_240.png 37,Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer ,The Journal of Urology,,,Article,2015-06-13,10.1016/j.juro.2015.05.099,,,,26066403,,,,,,,3,0,0,13,0,0,7,0,1,0,2,0,0,0,0,9,https://www.altmetric.com/details/4118968,https://api.altmetric.com/v1/donut/4118968_240.png 37,Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost?utility analysis,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11597.x,,,,23279038,,,,,,,3,1,0,15,0,0,1,0,0,0,0,0,0,0,1,67,https://www.altmetric.com/details/1146708,https://api.altmetric.com/v1/donut/1146708_240.png 37,Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.08.024,,,,25159890,,,,,,,2,1,0,45,0,0,1,0,1,0,0,0,0,0,0,33,https://www.altmetric.com/details/2621679,https://api.altmetric.com/v1/donut/2621679_240.png 37,Consideration of comorbidity in risk stratification prior to prostate biopsy,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28044,,,,23619920,,,,,,,4,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1415041,https://api.altmetric.com/v1/donut/1415041_240.png 37,Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer: A Randomized Trial,JAMA: Journal of the American Medical Association,,,Article,2008-01-23,10.1001/jama.299.3.289,,,,18212313,,,,,,,3,2,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2774296,https://api.altmetric.com/v1/donut/2774296_240.png 37,Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study,American Journal of Epidemiology,,,Article,2016-01-15,10.1093/aje/kwv190,,,,26764224,PMC4724092,,,,,,4,0,0,11,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4998156,https://api.altmetric.com/v1/donut/4998156_240.png 37,Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4.,Cancer Research,,,Article,2006-06-03,10.1158/0008-5472.can-06-0516,,,,16740699,PMC2276876,,,,,,3,2,2,0,0,0,0,0,0,0,0,0,0,0,0,105,https://www.altmetric.com/details/1084349,https://api.altmetric.com/v1/donut/1084349_240.png 37,Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature,European Urology,,,Article,2015-02-02,10.1016/j.eururo.2015.01.013,,,,25656808,,1854/LU-6843465,,,,,0,1,0,41,0,0,7,0,1,0,0,0,0,0,0,90,https://www.altmetric.com/details/3256492,https://api.altmetric.com/v1/donut/3256492_240.png 37,Primary Care Physicians’ Use of an Informed Decision-Making Process for Prostate Cancer Screening,Annals of Family Medicine,,,Article,2013-01-01,10.1370/afm.1445,,,,23319508,,,,,,,1,3,0,13,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1176953,https://api.altmetric.com/v1/donut/1176953_240.png 37,An imaging agent to detect androgen receptor and its active splice variants in prostate cancer,Journal of Clinical Investigation,,,Article,2016-07-21,10.1172/jci.insight.87850,,,,27525313,,,,,,,4,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9926987,https://api.altmetric.com/v1/donut/9926987_240.png 37,Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians,Annals of Internal Medicine,,,Article,2013-01-01,10.7326/0003-4819-158-10-201305210-00634,,,,23567761,,,,,,,3,0,0,12,0,0,3,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1357480,https://api.altmetric.com/v1/donut/1357480_240.png 37,Readability of Websites Containing Information About Prostate Cancer Treatment Options.,The Journal of Urology,,,Article,2012-10-18,10.1016/j.juro.2012.07.105,,,,23083852,,,,,,,3,0,0,20,0,0,2,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1008980,https://api.altmetric.com/v1/donut/1008980_240.png 37,"Hybrids of a Genetically Engineered Antibody and a Carbon Nanotube Transistor for Detection of Prostate Cancer Biomarkers",ACS Nano,,,Article,2012-01-01,10.1021/nn300819s,,,,22575126,,,,1302.2958,,,1,5,0,5,0,0,1,0,1,0,0,0,0,0,0,71,https://www.altmetric.com/details/1238397,https://api.altmetric.com/v1/donut/1238397_240.png 36,Targeted Reduction in Body Mass Index Is a Worthwhile Risk Reduction Strategy for Prostate Cancer,JAMA Oncology,,,Article,2015-04-16,10.1001/jamaoncol.2015.0514,,,,26181185,,,,,,,2,0,0,33,0,0,7,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3914543,https://api.altmetric.com/v1/donut/3914543_240.png 36,Recent Trends in PSA Testing and Prostate Cancer Incidence: A Look at Context,JAMA Oncology,,,Article,2016-03-24,10.1001/jamaoncol.2015.6310,,,,27010657,,,,,,,3,0,0,25,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6314423,https://api.altmetric.com/v1/donut/6314423_240.png 36,"Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression",American Journal of Clinical Nutrition,,,Article,2010-01-01,10.3945/ajcn.2009.28474,,,,20042525,PMC3132069,,,,,,0,3,0,14,0,0,5,0,1,0,0,0,0,0,2,36,https://www.altmetric.com/details/570124,https://api.altmetric.com/v1/donut/570124_240.png 36,The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-03-20,10.1016/j.eururo.2016.03.017,,,,27006332,,,,,,,0,0,0,59,0,0,2,0,1,0,0,0,0,0,0,21,https://www.altmetric.com/details/6245016,https://api.altmetric.com/v1/donut/6245016_240.png 36,What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation,Annals of Internal Medicine,,,Article,2010-01-01,10.1059/0003-4819-157-2-201207170-00463,,,,22615455,,,,,,,0,3,0,15,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/754656,https://api.altmetric.com/v1/donut/754656_240.png 36,Prostate Cancer Screening: Biases and the Need for Consensus,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt266,,,,24092919,,,,,,,4,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1807651,https://api.altmetric.com/v1/donut/1807651_240.png 36,Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA,Science Translational Medicine,,,Article,2011-08-03,10.1126/scitranslmed.3001970,,,,21813756,,,,,,,1,1,0,24,0,0,1,0,0,0,0,0,0,0,0,99,https://www.altmetric.com/details/203805,https://api.altmetric.com/v1/donut/203805_240.png 35,Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter,Urology,,,Article,2016-09-01,10.1016/j.urology.2016.07.045,,,,27667157,,,,,,,6,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12145477,https://api.altmetric.com/v1/donut/12145477_240.png 35,Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).,The Lancet,,,Article,2012-01-01,10.1016/s0140-6736(12)61253-7,,,,23084481,,1854/LU-3161949,,,,,0,1,0,51,1,0,2,0,0,0,0,0,0,0,0,91,https://www.altmetric.com/details/1009804,https://api.altmetric.com/v1/donut/1009804_240.png 35,"The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature",British Journal of Cancer,,,Article,1970-01-01,10.1038/bjc.2011.423,,,,22048034,,,,,,,3,0,0,11,0,0,0,0,0,0,0,0,0,0,0,109,https://www.altmetric.com/details/763542,https://api.altmetric.com/v1/donut/763542_240.png 35,Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force,Annals of Internal Medicine,,,Article,2011-01-01,10.7326/0003-4819-155-11-201112060-00375,,,,,,,,,,,4,1,0,0,0,0,0,0,2,0,0,0,0,0,0,6,https://www.altmetric.com/details/1652275,https://api.altmetric.com/v1/donut/1652275_240.png 35,Choline intake and risk of lethal prostate cancer: incidence and survival.,American Journal of Clinical Nutrition,,,Article,2012-09-05,10.3945/ajcn.112.039784,,,,22952174,,,,,,,1,2,0,9,0,0,6,0,1,0,2,0,0,0,4,15,https://www.altmetric.com/details/935100,https://api.altmetric.com/v1/donut/935100_240.png 35,Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force.,Annals of Internal Medicine,,,Article,2011-10-07,10.1059/0003-4819-155-11-201112060-00375,,,,21984740,,,,,,,1,2,0,9,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/398717,https://api.altmetric.com/v1/donut/398717_240.png 35,Who and when should we screen for prostate cancer? Interviews with key opinion leaders,BMC Medicine,,,Article,2015-11-27,10.1186/s12916-015-0526-x,,,,26612204,,,,,,,0,2,0,43,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/4813951,https://api.altmetric.com/v1/donut/4813951_240.png 35,ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment,Cancer Research,,,Article,2012-01-20,10.1158/0008-5472.can-11-3948,,,,22266222,,,,,,,0,4,1,18,0,0,1,2,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/650600,https://api.altmetric.com/v1/donut/650600_240.png 35,Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer,Scientific Reports,,,Article,2016-07-26,10.1038/srep30346,,,,27456457,PMC4960556,,,,,,6,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10108437,https://api.altmetric.com/v1/donut/10108437_240.png 35,Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-07-01,10.1073/pnas.1510077112,,,,26124144,,,,,,,1,3,0,25,0,0,0,2,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/4225117,https://api.altmetric.com/v1/donut/4225117_240.png 35,Androgen Deprivation Therapy for Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2005-01-01,10.1001/jama.294.2.238,,,,16014598,,,,,,,1,1,0,22,0,0,2,1,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/2553971,https://api.altmetric.com/v1/donut/2553971_240.png 35,A patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials,Scientific Data,,,Article,2016-05-10,10.1038/sdata.2016.27,,,,27163794,,,,,,,0,2,0,41,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7322534,https://api.altmetric.com/v1/donut/7322534_240.png 35,No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28485,,,,24258693,,,,,,,3,0,0,20,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1920481,https://api.altmetric.com/v1/donut/1920481_240.png 35,Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials,British Medical Journal,,,Article,2010-01-01,10.1136/bmj.c4543,,,,20843937,PMC2939952,,,,,,0,6,0,8,0,0,1,1,0,0,0,0,0,1,0,145,https://www.altmetric.com/details/1205817,https://api.altmetric.com/v1/donut/1205817_240.png 35,A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ?3 ng/ml: A Plea for Individualized Prostate Cancer Screening,European Urology,,,Article,2015-10-01,10.1016/j.eururo.2014.04.005,,,,24794075,,,,,,,0,0,0,50,0,0,3,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2292352,https://api.altmetric.com/v1/donut/2292352_240.png 35,"High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.",Lancet Oncology,,,Article,2015-02-18,10.1016/s1470-2045(15)70045-8,,,,25702876,,,,,,,2,1,0,20,0,0,6,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/3712738,https://api.altmetric.com/v1/donut/3712738_240.png 35,Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer,Journal of Clinical Oncology,,,Article,2014-12-10,10.1200/jco.2013.54.7893,,,,25245445,,,,,,,0,0,0,56,0,0,0,0,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/2704230,https://api.altmetric.com/v1/donut/2704230_240.png 35,Public knowledge of benefits of breast and prostate cancer screening in Europe.,JNCI: Journal of the National Cancer Institute,,,Article,2009-01-01,10.1093/jnci/djp237,,,,19671770,,,,,,,1,2,0,28,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/1408447,https://api.altmetric.com/v1/donut/1408447_240.png 34,Weighing the Benefits of Fish Oil for Patients With Prostate Cancer: A Subcohort Review From the SELECT Trial.,Journal of the Advanced Practitioner in Oncology,,,Article,2015-07-01,,,,,26705498,PMC4677810,,,,,,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12568858,https://api.altmetric.com/v1/donut/12568858_240.png 34,Active surveillance for prostate cancer: current evidence and contemporary state of practice,Nature Reviews Urology,,,Article,2016-03-08,10.1038/nrurol.2016.45,,,,26954332,,,,,,,1,0,0,49,0,0,3,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6137974,https://api.altmetric.com/v1/donut/6137974_240.png 34,"Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: A nationwide family study",European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.05.018,,,,24953336,,,,,,,4,0,0,15,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2463002,https://api.altmetric.com/v1/donut/2463002_240.png 34,"Novel Biomarkers for Prostate Cancer Revealed by (?,?)-k-Feature Sets",,,,Article,2016-01-29,10.1007/978-3-642-01536-6_7,,,,,,,,,,,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1664746,https://api.altmetric.com/v1/donut/1664746_240.png 34,Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression,The Journal of Urology,,,Article,2016-07-01,10.1016/j.juro.2016.07.075,,,,27449261,,,,,,,4,0,0,11,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9987658,https://api.altmetric.com/v1/donut/9987658_240.png 34,Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer,JAMA Oncology,,,Article,2015-12-23,10.1001/jamaoncol.2015.4655,,,,26720308,,,,,,,2,0,0,26,0,0,3,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/4917310,https://api.altmetric.com/v1/donut/4917310_240.png 34,Prostate Cancer in Elderly Men,Reviews in Urology,,,Article,,,,,,18660852,PMC2483315,,,,,,1,0,0,25,0,0,0,0,0,0,1,0,0,0,0,38,https://www.altmetric.com/details/3076072,https://api.altmetric.com/v1/donut/3076072_240.png 34,Effect of 5?-Reductase Inhibitor Use on Mortality From Prostate Cancer,JAMA Oncology,,,Article,2015-04-02,10.1001/jamaoncol.2015.0408,,,,26181178,,,,,,,1,0,0,42,0,0,4,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3866409,https://api.altmetric.com/v1/donut/3866409_240.png 34,Cost implications of the rapid adoption of newer technologies for treating prostate cancer.,Journal of Clinical Oncology,,,Article,2011-04-20,10.1200/jco.2010.31.1217,,,,21402604,,,,,,,2,2,0,4,0,0,0,0,0,0,0,0,1,0,0,78,https://www.altmetric.com/details/383861,https://api.altmetric.com/v1/donut/383861_240.png 34,Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer,Cancer Cell,,,Article,2013-01-01,10.1016/j.ccr.2013.01.002,,,,23410972,,,,,,,2,1,0,20,0,0,1,0,0,0,0,0,0,0,0,145,https://www.altmetric.com/details/1233173,https://api.altmetric.com/v1/donut/1233173_240.png 34,Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation,Endocrinology,,,Article,2000-01-01,10.1210/en.141.1.118,,,,10614630,,,,,,,2,0,0,21,0,0,53,1,2,0,0,0,0,0,1,42,https://www.altmetric.com/details/911522,https://api.altmetric.com/v1/donut/911522_240.png 34,Liquid biopsy: Clues on prostate cancer drug resistance,Science Translational Medicine,,,Article,2015-11-04,10.1126/scitranslmed.aad4008,,,,26537254,,,,,,,2,0,0,30,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/4724650,https://api.altmetric.com/v1/donut/4724650_240.png 34,Long-Term Results of Optimized Focal Therapy for Prostate Cancer: Average 10-Year Follow-Up in 70 Patients,Journal of Men's Health,,,Article,2014-06-01,10.1089/jomh.2014.0017,,,,,,,,,,,3,1,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2458260,https://api.altmetric.com/v1/donut/2458260_240.png 34,The impact of supportive nursing care on the needs of men with prostate cancer: a study across seven European countries,British Journal of Cancer,,,Article,2013-09-24,10.1038/bjc.2013.568,,,,24064968,,2445/67519,,,,,4,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1781705,https://api.altmetric.com/v1/donut/1781705_240.png 34,"Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial",Lancet Oncology,,,Article,2016-03-08,10.1016/s1470-2045(15)00567-7,,,,26968359,,,,,,,4,0,0,20,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6186051,https://api.altmetric.com/v1/donut/6186051_240.png 34,Personal History of Prostate Cancer and Increased Risk of Incident Melanoma in the United States,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.51.1915,,,,24190118,,,,,,,3,0,0,23,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1884423,https://api.altmetric.com/v1/donut/1884423_240.png 34,Sexual activity and prostate cancer risk in men diagnosed at a younger age.,British Journal of Urology,,,Article,2009-01-01,10.1111/j.1464-410x.2008.08030.x,,,,19016689,,,,,,,0,4,0,4,0,0,2,3,0,0,1,0,0,0,0,23,https://www.altmetric.com/details/126255,https://api.altmetric.com/v1/donut/126255_240.png 34,Vitamins E and C in the Prevention of Prostate and Total Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial,JAMA: Journal of the American Medical Association,,,Article,2009-01-07,10.1001/jama.2008.862,,,,19066368,PMC2774210,,,,,,0,4,2,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/107478,https://api.altmetric.com/v1/donut/107478_240.png 34,Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison,The Journal of Urology,,,Article,2015-03-16,10.1016/j.juro.2015.03.026,,,,25791402,,,,,,,4,0,0,9,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3799325,https://api.altmetric.com/v1/donut/3799325_240.png 34,The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer—The Problem Is How to Avoid Finding These Cancers,European Urology,,,Article,2016-02-23,10.1016/j.eururo.2016.02.032,,,,26916048,,,,,,,0,0,0,54,0,0,5,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/5972867,https://api.altmetric.com/v1/donut/5972867_240.png 33,Remembering Charles B. Huggins’ Nobel Prize for Hormonal Treatment of Prostatic Cancer at its 50th Anniversary ,European Urology,,,Article,2016-01-31,10.1016/j.eururo.2016.01.030,,,,26838478,,,,,,,0,0,0,59,0,0,4,0,2,0,0,0,0,0,0,2,https://www.altmetric.com/details/5066656,https://api.altmetric.com/v1/donut/5066656_240.png 33,Consumption of Fish Products across the Lifespan and Prostate Cancer Risk,PLoS ONE,,,Article,2013-04-17,10.1371/journal.pone.0059799,,,,23613715,PMC3629172,,,,,,1,0,0,12,0,0,42,0,2,0,0,0,0,0,0,21,https://www.altmetric.com/details/1396327,https://api.altmetric.com/v1/donut/1396327_240.png 33,Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery.,British Journal of Urology,,,Article,2014-04-29,10.1111/bju.12789,,,,24784420,,,,,,,4,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2315742,https://api.altmetric.com/v1/donut/2315742_240.png 33,"Impact of Meat Consumption, Preparation, and Mutagens on Aggressive Prostate Cancer",PLoS ONE,,,Article,2011-11-23,10.1371/journal.pone.0027711,,,,22132129,,,,,,,12,0,0,17,0,0,2,0,0,0,0,0,0,0,1,25,https://www.altmetric.com/details/466999,https://api.altmetric.com/v1/donut/466999_240.png 33,"Hair, Hormones, and High-Risk Prostate Cancer",Journal of Clinical Oncology,,,Article,2014-12-29,10.1200/jco.2014.58.5588,,,,25547509,,,,,,,1,0,0,29,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3023068,https://api.altmetric.com/v1/donut/3023068_240.png 33,Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.,JAMA: Journal of the American Medical Association,,,Article,2011-12-08,10.1001/jama.2011.1745,,,,22147380,,,,,,,0,3,0,11,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/482733,https://api.altmetric.com/v1/donut/482733_240.png 33,Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells,Genome Research,,,Article,2015-05-13,10.1101/gr.190470.115,,,,25963125,,,,,,,0,1,0,49,0,0,6,0,1,0,0,0,0,0,0,101,https://www.altmetric.com/details/3985289,https://api.altmetric.com/v1/donut/3985289_240.png 33,Risk of colorectal cancer after the diagnosis of prostate cancer: A population?based study,Cancer (0008543X),,,Article,2016-02-01,10.1002/cncr.29919,,,,26919270,,,,,,,4,0,0,12,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6004059,https://api.altmetric.com/v1/donut/6004059_240.png 33,A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.,European Urology,,,Article,2014-11-29,10.1016/j.eururo.2014.11.030,,,,25465337,,,,,,,4,0,0,25,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2936110,https://api.altmetric.com/v1/donut/2936110_240.png 33,Active Surveillance is An Appropriate Management Strategy for A Proportion of Men Diagnosed With Prostate Cancer by PSA Testing.,The Journal of Urology,,,Article,2015-01-09,10.1016/j.juro.2015.01.089,,,,25636657,,,,,,,2,0,0,24,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3109973,https://api.altmetric.com/v1/donut/3109973_240.png 33,Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies,European Urology,,,Article,2014-03-14,10.1016/j.eururo.2014.03.002,,,,24666839,,,,,,,1,0,0,36,0,0,0,1,0,0,0,0,0,0,0,108,https://www.altmetric.com/details/2207711,https://api.altmetric.com/v1/donut/2207711_240.png 33,A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy,Journal of Clinical Oncology,,,Article,2016-04-04,10.1200/jco.2015.65.3154,,,,27044933,,,,,,,3,1,0,16,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6473798,https://api.altmetric.com/v1/donut/6473798_240.png 33,Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced pro-inflammatory cytokines and immunosuppressive cells.,Cancer Prevention Research,,,Article,2015-08-16,10.1158/1940-6207.capr-14-0464,,,,26276751,,,,,,,3,0,0,9,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4402020,https://api.altmetric.com/v1/donut/4402020_240.png 33,The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening ,Urology,,,Article,2016-02-01,10.1016/j.urology.2015.12.054,,,,26850815,,,,,,,0,0,0,46,0,0,2,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/5080573,https://api.altmetric.com/v1/donut/5080573_240.png 33,Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.,Lancet Oncology,,,Article,2010-08-01,10.1016/s1470-2045(10)70146-7,,,,20598634,,,,,,,2,1,0,8,0,0,1,0,0,0,0,0,3,0,0,199,https://www.altmetric.com/details/211922,https://api.altmetric.com/v1/donut/211922_240.png 33,"Acupuncture relieves symptoms in chronic prostatitis|[sol]|chronic pelvic pain syndrome: a randomized, sham-controlled trial",Prostate Cancer & Prostatic Diseases,,,Article,2015-05-05,10.1038/pcan.2015.13,,,,25939517,,,,,,,1,0,0,28,0,0,18,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3973827,https://api.altmetric.com/v1/donut/3973827_240.png 33,An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection,JNCI: Journal of the National Cancer Institute,,,Article,2011-02-24,10.1093/jnci/djr028,,,,21350221,PMC3057983,,,,,,2,1,0,1,0,0,0,1,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/184281,https://api.altmetric.com/v1/donut/184281_240.png 33,Prospective Study of Fruit and Vegetable Intake and Risk of Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2007-07-24,10.1093/jnci/djm065,,,,17652276,,,,,,,1,3,0,2,0,0,2,0,5,0,1,0,0,0,0,37,https://www.altmetric.com/details/401278,https://api.altmetric.com/v1/donut/401278_240.png 32,"Vegetarianism and breast, colorectal and prostate cancer risk: an overview and meta-analysis of cohort studies.",Journal of Human Nutrition & Dietetics,,,Article,2016-10-06,10.1111/jhn.12426,,,,27709695,,,,,,,0,0,0,45,0,0,5,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/12534261,https://api.altmetric.com/v1/donut/12534261_240.png 32,Changing attitudes towards management of men with locally advanced prostate cancer following radical prostatectomy: A follow-up survey of Australia-based urologists,Journal of Medical Imaging & Radiation Oncology,,,Article,2016-06-27,10.1111/1754-9485.12483,,,,27346844,,,,,,,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9522163,https://api.altmetric.com/v1/donut/9522163_240.png 32,Sociodemographic and clinical predictors of switching to active treatment among a large ethnically diverse cohort of men with low-risk prostate cancer on observational management,The Journal of Urology,,,Article,2016-04-14,10.1016/j.juro.2016.04.045,,,,27091570,,,,,,,17,0,0,10,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6723732,https://api.altmetric.com/v1/donut/6723732_240.png 32,5?-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer,JAMA Internal Medicine,,,Article,2014-06-01,10.1001/jamainternmed.2014.1600,,,,24887392,,,,,,,0,1,0,31,0,0,4,0,3,0,0,0,0,0,0,16,https://www.altmetric.com/details/2399776,https://api.altmetric.com/v1/donut/2399776_240.png 32,The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis,European Urology,,,Article,2016-05-10,10.1016/j.eururo.2016.04.031,,,,27174537,,,,,,,0,0,0,53,0,0,4,0,1,0,0,0,1,0,0,12,https://www.altmetric.com/details/7314121,https://api.altmetric.com/v1/donut/7314121_240.png 32,Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial,European Urology,,,Article,2016-10-01,10.1016/j.eururo.2016.09.040,,,,27720537,,,,,,,0,0,0,51,0,0,2,0,2,0,0,0,0,0,0,9,https://www.altmetric.com/details/12522490,https://api.altmetric.com/v1/donut/12522490_240.png 32,Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion,Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2012.43.3441,,,,22802323,,,,,,,0,0,1,38,0,0,5,3,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/842531,https://api.altmetric.com/v1/donut/842531_240.png 32,Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis,European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.07.004,,,,26189689,,,,,,,0,0,0,126,0,0,2,0,1,0,0,0,0,0,0,27,https://www.altmetric.com/details/4790844,https://api.altmetric.com/v1/donut/4790844_240.png 32,"HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study",Lancet Oncology,,,Article,2016-08-26,10.1016/s1470-2045(16)30227-3,,,,27575027,,,,,,,3,0,0,24,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/10851408,https://api.altmetric.com/v1/donut/10851408_240.png 32,Chickpea (Cicer arietinum) and Other Plant-Derived Protease Inhibitor Concentrates Inhibit Breast and Prostate Cancer Cell Proliferation In Vitro.,Nutrition and Cancer,,,Article,2012-06-04,10.1080/01635581.2012.688914,,,,22662866,,,,,,,0,0,0,4,0,0,23,0,29,0,0,0,0,0,0,2,https://www.altmetric.com/details/783119,https://api.altmetric.com/v1/donut/783119_240.png 32,Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer,Nature Genetics,,,Article,2016-08-15,10.1038/ng.3637,,,,27526323,,,,,,,1,0,0,41,0,0,1,0,0,0,0,0,1,0,0,35,https://www.altmetric.com/details/10523683,https://api.altmetric.com/v1/donut/10523683_240.png 32,The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer,The Journal of Urology,,,Article,2014-11-15,10.1016/j.juro.2014.10.121,,,,25463993,,,,,,,2,1,0,10,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2890580,https://api.altmetric.com/v1/donut/2890580_240.png 32,Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data,British Journal of Cancer,,,Article,2015-07-23,10.1038/bjc.2015.262,,,,26203762,,,,,,,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4313342,https://api.altmetric.com/v1/donut/4313342_240.png 32,Cell cycle progression score and treatment decisions in prostate cancer: Results from an ongoing registry.,Current Medical Research & Opinion,,,Article,2014-03-01,10.1185/03007995.2014.899208,,,,24576172,,,,,,,2,0,0,17,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2157670,https://api.altmetric.com/v1/donut/2157670_240.png 32,Proton therapy for prostate cancer: time for evidence ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70304-3,,,,,,,,,,,0,0,0,48,0,1,5,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2474455,https://api.altmetric.com/v1/donut/2474455_240.png 32,Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer,JAMA Surgery,,,Article,2016-09-21,10.1001/jamasurg.2016.2907,,,,27653425,,,,,,,0,0,0,52,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12122281,https://api.altmetric.com/v1/donut/12122281_240.png 32,ERK and AKT Signaling Drive MED1 Overexpression in Prostate Cancer in Association with Elevated Proliferation and Tumorigenicity,Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-12-0618,,,,23538858,,,,,,,4,0,0,7,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1633735,https://api.altmetric.com/v1/donut/1633735_240.png 32,Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986–2005,JNCI: Journal of the National Cancer Institute,,,Article,2009-01-01,10.1093/jnci/djp278,,,,19720969,PMC2758309,,,,,,4,4,0,2,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/1444884,https://api.altmetric.com/v1/donut/1444884_240.png 32,Folic acid and risk of prostate cancer: results from a randomized clinical trial.,JNCI: Journal of the National Cancer Institute,,,Article,2009-01-01,10.1093/jnci/djp019,,,,19276452,PMC2657096,,,,,,1,2,0,6,0,0,2,2,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/940776,https://api.altmetric.com/v1/donut/940776_240.png 32,"Utilizing time?driven activity?based costing to understand the short? and long?term costs of treating localized, low?risk prostate cancer",Cancer (0008543X),,,Article,2015-10-01,10.1002/cncr.29743,,,,26524087,,,,,,,3,0,0,15,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/4713873,https://api.altmetric.com/v1/donut/4713873_240.png 31,Reasons for Abandonment of Active Surveillance in Men with Prostate Cancer,The Journal of Urology,,,Article,2016-06-14,10.1016/j.juro.2016.06.078,,,,27316451,,,,,,,15,0,0,6,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8744985,https://api.altmetric.com/v1/donut/8744985_240.png 31,Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer,JGIM: Journal of General Internal Medicine,,,Article,2013-05-14,10.1007/s11606-013-2477-2,,,,23670565,,,,,,,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1478160,https://api.altmetric.com/v1/donut/1478160_240.png 31,Towards the use of non?psychoactive cannabinoids for prostate cancer,British Journal of Pharmacology,,,Article,2012-07-31,10.1111/j.1476-5381.2012.02121.x,,,,22849856,,,,,,,2,0,0,12,0,0,14,0,1,0,0,0,0,0,3,42,https://www.altmetric.com/details/871637,https://api.altmetric.com/v1/donut/871637_240.png 31,"Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome",PLoS ONE,,,Article,2010-04-01,10.1371/journal.pone.0009948,,,,20376347,PMC2848589,,,,,,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/182188,https://api.altmetric.com/v1/donut/182188_240.png 31,Increase in Prostate Cancer Metastases at Radical Prostatectomy in the United States,European Urology,,,Article,2016-07-09,10.1016/j.eururo.2016.06.036,,,,27402061,,,,,,,1,1,0,21,0,0,2,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/9527660,https://api.altmetric.com/v1/donut/9527660_240.png 31,"Prostate Cancer Screening: What We Know, Don't Know, and Believe",Annals of Internal Medicine,,,Article,2012-01-01,10.7326/0003-4819-157-2-201207170-00460,,,,22801675,,,,,,,0,2,1,15,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/850753,https://api.altmetric.com/v1/donut/850753_240.png 31,Active surveillance for prostate cancer: the role of the pathologist,Pathology,,,Article,2015-01-01,10.1097/pat.0000000000000186,,,,25474525,,,,,,,4,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2987579,https://api.altmetric.com/v1/donut/2987579_240.png 31,Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients,OncoTargets and therapy,,,Article,2013-07-11,10.2147/ott.s44144,,,,23836984,PMC3699299,,,,,,2,1,0,3,0,0,0,0,3,0,0,0,0,0,0,3,https://www.altmetric.com/details/1635644,https://api.altmetric.com/v1/donut/1635644_240.png 31,Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial ,Lancet Oncology,,,Article,2015-01-03,10.1016/s1470-2045(14)70482-6,,,,25656287,,,,,,,2,1,0,13,0,0,2,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/3262061,https://api.altmetric.com/v1/donut/3262061_240.png 31,PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients,British Journal of Cancer,,,Article,2015-09-17,10.1038/bjc.2015.332,,,,26379078,,,,,,,3,0,0,6,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/4585051,https://api.altmetric.com/v1/donut/4585051_240.png 31,The effect of bicycling on PSA levels: a systematic review and meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2015-05-05,10.1038/pcan.2015.16,,,,25939515,,,,,,,2,0,0,23,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3972079,https://api.altmetric.com/v1/donut/3972079_240.png 31,"Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?",Journal of Cancer Survivorship,,,Article,2013-02-16,10.1007/s11764-013-0267-9,,,,23417882,,,,,,,2,0,0,17,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1265431,https://api.altmetric.com/v1/donut/1265431_240.png 31,"Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial",The Lancet,,,Article,2011-01-01,10.1016/s0140-6736(11)61226-9,,,,22093187,,,,,,,0,1,1,30,0,0,0,0,0,0,0,0,2,0,0,48,https://www.altmetric.com/details/456800,https://api.altmetric.com/v1/donut/456800_240.png 31,Targeting the Androgen Receptor in Prostate Cancer - A Resilient Foe.,New England Journal of Medicine,,,Article,2014-09-03,10.1056/nejme1409306,,,,25184629,,,,,,,2,0,0,25,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2657781,https://api.altmetric.com/v1/donut/2657781_240.png 31,Variation in treatment associated with life expectancy in a population?based cohort of men with early?stage prostate cancer,Cancer (0008543X),,,Article,2014-07-16,10.1002/cncr.28926,,,,25042117,,,,,,,4,1,0,7,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2915013,https://api.altmetric.com/v1/donut/2915013_240.png 31,"Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.",Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70372-8,,,,23059046,,,,,,,3,1,0,10,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/990561,https://api.altmetric.com/v1/donut/990561_240.png 31,Temporal Trends in Cause of Death Among Swedish and US Men with Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djs299,,,,22835388,,,,,,,1,1,0,16,0,0,5,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/858047,https://api.altmetric.com/v1/donut/858047_240.png 31,Multiparametric magnetic resonance imaging findings in men with low?risk prostate cancer followed using active surveillance,British Journal of Urology,,,Article,2013-03-09,10.1111/j.1464-410x.2012.11641.x,,,,23464904,,,,,,,1,3,1,5,0,0,1,0,0,0,0,0,1,0,0,22,https://www.altmetric.com/details/1328243,https://api.altmetric.com/v1/donut/1328243_240.png 31,Prostate Specific Antigen Retargeted Recombinant Newcastle Disease Virus for Prostate Cancer Virotherapy,Journal of Virology,,,Article,2013-01-01,10.1128/jvi.02394-12,,,,23345509,,,,,,,4,0,0,4,0,0,5,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1269449,https://api.altmetric.com/v1/donut/1269449_240.png 31,Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.51.1972,,,,24101042,,,,,,,2,0,0,24,0,0,0,0,1,0,0,0,0,0,0,81,https://www.altmetric.com/details/1810433,https://api.altmetric.com/v1/donut/1810433_240.png 31,Prostate Cancer Cell Telomere Length Variability and Stromal Cell Telomere Length as Prognostic Markers for Metastasis and Death,Cancer Discovery,,,Article,2013-01-01,10.1158/2159-8290.cd-13-0135,,,,23779129,,,,,,,2,1,0,10,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1568389,https://api.altmetric.com/v1/donut/1568389_240.png 31,Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review ,European Urology,,,Article,2014-11-15,10.1016/j.eururo.2014.10.050,,,,25511988,,,,,,,0,0,0,55,0,0,0,0,3,0,0,0,0,0,0,44,https://www.altmetric.com/details/2890591,https://api.altmetric.com/v1/donut/2890591_240.png 30,"Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer",JAMA: Journal of the American Medical Association,,,Article,2012-04-18,10.1001/jama.2012.460,,,,22511689,,,,,,,0,2,0,15,0,0,2,1,1,0,0,0,1,0,0,15,https://www.altmetric.com/details/701392,https://api.altmetric.com/v1/donut/701392_240.png 30,Consensus guidelines for reporting prostate cancer Gleason Grade,British Journal of Urology,,,Article,2016-06-13,10.1111/bju.13470,,,,27173992,,,,,,,3,0,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8284791,https://api.altmetric.com/v1/donut/8284791_240.png 30,Shared Decision Making and Use of Decision Aids for Localized Prostate Cancer : Perceptions From Radiation Oncologists and Urologists,JAMA Internal Medicine,,,Article,2015-03-09,10.1001/jamainternmed.2015.63,,,,25751604,,,,,,,1,0,0,35,0,0,4,0,2,0,0,0,0,0,0,12,https://www.altmetric.com/details/3769004,https://api.altmetric.com/v1/donut/3769004_240.png 30,"Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial ",Lancet Oncology,,,Article,2016-06-25,10.1016/s1470-2045(16)30070-5,,,,27339116,,,,,,,4,1,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8944090,https://api.altmetric.com/v1/donut/8944090_240.png 30,Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Updated Systematic Review,Annals of Internal Medicine,,,Article,,10.7326/0003-4819-155-3-201108020-00347,,,,,,,,,,,0,1,0,27,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1696851,https://api.altmetric.com/v1/donut/1696851_240.png 30,Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells.,International Journal of Oncology,,,Article,2008-04-22,,,,,18425335,,,,,,,0,3,0,11,0,0,3,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/676030,https://api.altmetric.com/v1/donut/676030_240.png 30,"EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer",European Urology,,,Article,2013-11-12,10.1016/j.eururo.2013.11.002,,,,24321502,,,,,,,1,3,0,8,0,0,0,0,1,0,0,0,0,0,0,20,https://www.altmetric.com/details/2124882,https://api.altmetric.com/v1/donut/2124882_240.png 30,Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment,European Urology,,,Article,2015-12-30,10.1016/j.eururo.2015.12.013,,,,26743040,,,,,,,1,0,0,39,0,0,3,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/4936055,https://api.altmetric.com/v1/donut/4936055_240.png 30,Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-09-26,10.1073/pnas.1108745108,,,,21949389,PMC3193229,,2011PNAS..10817087K,,,,1,1,0,12,0,0,1,0,1,0,0,0,1,0,0,196,https://www.altmetric.com/details/384403,https://api.altmetric.com/v1/donut/384403_240.png 30,Let's Not Throw the Baby out With the Bathwater in Prostate Cancer Screening,Journal of Clinical Oncology,,,Article,2016-07-18,10.1200/jco.2016.68.7194,,,,27432920,,,,,,,2,1,0,12,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9914150,https://api.altmetric.com/v1/donut/9914150_240.png 30,The Oncologist’s Perspective: A Patient With Prostate Cancer,JAMA Oncology,,,Article,2015-07-02,10.1001/jamaoncol.2015.1844,,,,26182169,,,,,,,0,0,0,48,0,0,3,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4239835,https://api.altmetric.com/v1/donut/4239835_240.png 30,Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries,European Urology,,,Article,2016-06-09,10.1016/j.eururo.2016.05.043,,,,27289567,,,,,,,0,0,0,56,0,0,2,0,1,0,0,0,0,0,0,27,https://www.altmetric.com/details/8599279,https://api.altmetric.com/v1/donut/8599279_240.png 30,"Adding chemotherapy to hormonal therapy prolongs survival in metastatic prostate cancer, study finds",British Medical Journal,,,Article,2015-08-06,10.1136/bmj.h4253,,,,26251343,,,,,,,1,0,0,35,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4367791,https://api.altmetric.com/v1/donut/4367791_240.png 30,Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-01-01,10.1158/1055-9965.epi-13-0345,,,,23833122,,,,,,,4,0,0,5,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1721685,https://api.altmetric.com/v1/donut/1721685_240.png 30,Ginger Phytochemicals Exhibit Synergy to Inhibit Prostate Cancer Cell Proliferation,Nutrition and Cancer,,,Article,2013-03-01,10.1080/01635581.2013.749925,,,,23441614,,,,,,,0,0,0,4,0,0,8,0,27,0,0,0,0,0,0,25,https://www.altmetric.com/details/1320692,https://api.altmetric.com/v1/donut/1320692_240.png 30,TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-03-01,10.1016/j.eururo.2016.02.034,,,,26948395,,,,,,,1,0,0,41,0,0,3,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/6025885,https://api.altmetric.com/v1/donut/6025885_240.png 30,Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer,JAMA Oncology,,,Article,2016-05-05,10.1001/jamaoncol.2016.0494,,,,27148695,,,,,,,1,0,0,40,0,0,3,0,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/7207570,https://api.altmetric.com/v1/donut/7207570_240.png 30,"ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells",PeerJ,,,Article,2013-01-01,10.7717/peerj.144,,,,24058878,PMC3775631,,,,,,2,2,0,3,5,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1748076,https://api.altmetric.com/v1/donut/1748076_240.png 30,The Anticancer Effect of Fucoidan in PC-3 Prostate Cancer Cells.,Marine Drugs,,,Article,2013-08-24,10.3390/md11082982,,,,23966032,,,,,,,0,0,0,30,0,0,14,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1711309,https://api.altmetric.com/v1/donut/1711309_240.png 29,"Physical activity communication between oncology providers and patients with early?stage breast, colon, or prostate cancer",Cancer (0008543X),,,Article,2015-11-01,10.1002/cncr.29786,,,,26566177,,,,,,,1,0,0,36,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4759264,https://api.altmetric.com/v1/donut/4759264_240.png 29,Fear of recurrence: the importance of self-efficacy and satisfaction with care in gay men with prostate cancer.,Psycho-Oncology,,,Article,2014-07-23,10.1002/pon.3630,,,,25060033,,,,,,,3,0,0,16,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2545532,https://api.altmetric.com/v1/donut/2545532_240.png 29,Loss of caveolin?1 in prostate cancer stroma correlates with reduced relapse?free survival and is functionally relevant to tumour progression,The Journal of Pathology,,,Article,2013-06-06,10.1002/path.4217,,,,23729330,,,,,,,4,0,0,0,0,0,0,0,1,0,0,0,0,0,0,24,https://www.altmetric.com/details/1582392,https://api.altmetric.com/v1/donut/1582392_240.png 29,"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial ",The Lancet (British Edition),,,Article,2009-01-24,10.1016/s0140-6736(08)61815-2,,,,19091394,,,,,,,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,141,https://www.altmetric.com/details/211944,https://api.altmetric.com/v1/donut/211944_240.png 29,Racial differences in time from prostate cancer diagnosis to treatment initiation,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27975,,,,23716470,,,,,,,3,0,0,4,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1515152,https://api.altmetric.com/v1/donut/1515152_240.png 29,An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.,Genome Research,,,Article,2010-07-13,10.1101/gr.105361.110,,,,20627891,PMC2928497,,,,,,0,4,0,0,0,0,0,0,0,0,0,0,1,1,0,70,https://www.altmetric.com/details/223329,https://api.altmetric.com/v1/donut/223329_240.png 29,Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk,Therapeutic Advances in Urology,,,Article,2015-12-01,10.1177/1756287215597633,,,,26622322,,,,,,,2,0,0,13,0,0,0,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/4402305,https://api.altmetric.com/v1/donut/4402305_240.png 29,Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols,British Journal of Urology,,,Article,2014-06-01,10.1111/bju.12828,,,,24904995,,,,,,,1,5,0,13,0,0,1,0,0,0,0,0,0,0,1,14,https://www.altmetric.com/details/2409879,https://api.altmetric.com/v1/donut/2409879_240.png 29,MicroRNA Expression Profile of Primary Prostate Cancer Stem Cells as a Source of Biomarkers and Therapeutic Targets.,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.09.005,,,,25234358,,,,,,,4,0,0,10,0,0,0,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/2686292,https://api.altmetric.com/v1/donut/2686292_240.png 29,Coffee consumption and risk of prostate cancer: A meta-analysis of prospective cohort studies.,Carcinogenesis,,,Article,2013-01-01,10.1093/carcin/bgt482,,,,24343360,,,,,,,1,2,0,21,0,0,3,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1988314,https://api.altmetric.com/v1/donut/1988314_240.png 29,Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis,Journal of Cancer Research & Clinical Oncology,,,Article,2014-05-17,10.1007/s00432-014-1706-3,,,,24838848,,,,,,,2,1,0,9,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2364170,https://api.altmetric.com/v1/donut/2364170_240.png 29,N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer,Cancer Cell,,,Article,2016-10-01,10.1016/j.ccell.2016.09.005,,,,27728805,,,,,,,2,0,0,19,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/12546233,https://api.altmetric.com/v1/donut/12546233_240.png 29,Prevalence of incidental prostate cancer: A systematic review of autopsy studies,International Journal of Cancer,,,Article,2015-04-22,10.1002/ijc.29538,,,,25821151,,,,,,,2,0,0,24,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3930053,https://api.altmetric.com/v1/donut/3930053_240.png 29,Fish consumption and prostate cancer risk: a review and meta-analysis.,American Journal of Clinical Nutrition,,,Article,2010-01-01,10.3945/ajcn.2010.29530,,,,20844069,,,,,,,2,1,0,2,0,0,2,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/581282,https://api.altmetric.com/v1/donut/581282_240.png 29,Prostate Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement,Journal of Clinical Oncology,,,Article,2015-02-09,10.1200/jco.2014.60.2557,,,,25667275,,,,,,,1,1,0,24,0,0,3,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3446822,https://api.altmetric.com/v1/donut/3446822_240.png 29,MR Imaging-guided Focal Laser Ablation for Prostate Cancer: Phase I Trial.,Radiology,,,Article,2013-01-01,10.1148/radiol.13121652,,,,23440319,,,,,,,2,1,0,4,0,0,1,0,0,0,0,0,1,0,0,25,https://www.altmetric.com/details/1264459,https://api.altmetric.com/v1/donut/1264459_240.png 29,Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.,Oncogene,,,Article,2015-04-13,10.1038/onc.2015.91,,,,25867060,,,,,,,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3908144,https://api.altmetric.com/v1/donut/3908144_240.png 29,Vasectomy and prostate cancer risk: a meta-analysis of cohort studies,Scientific Reports,,,Article,2015-04-30,10.1038/srep09920,,,,25927401,,,,,,,2,2,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3964469,https://api.altmetric.com/v1/donut/3964469_240.png 28,Comparison of pathologic outcomes for men with low-risk prostate cancer from diverse practice settings—similar results from immediate prostatectomy or initial surveillance with delayed prostatectomy,The Journal of Urology,,,Article,2016-05-31,10.1016/j.juro.2016.05.095,,,,27256204,,,,,,,14,0,0,14,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8400309,https://api.altmetric.com/v1/donut/8400309_240.png 28,Plasma genistein and risk of prostate cancer in Chinese population,International Urology and Nephrology,,,Article,2015-05-14,10.1007/s11255-015-0981-5,,,,25971353,,,,,,,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4004471,https://api.altmetric.com/v1/donut/4004471_240.png 28,Expectant management for men with early stage prostate cancer.,CA: A Cancer Journal for Clinicians ,,,Article,2015-05-08,10.3322/caac.21278,,,,25958817,,,,,,,2,0,0,21,0,0,4,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3983956,https://api.altmetric.com/v1/donut/3983956_240.png 28,Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-07-16,10.1073/pnas.1121174109,,,,22802668,,,2012PNAS..10912426S,,,,1,2,0,1,0,0,2,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/842566,https://api.altmetric.com/v1/donut/842566_240.png 28,Using routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme,British Journal of Cancer,,,Article,2015-03-19,10.1038/bjc.2014.650,,,,25791873,,,,,,,1,0,0,32,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3812546,https://api.altmetric.com/v1/donut/3812546_240.png 28,Regional Variation in Quality of Prostate Cancer Care.,The Journal of Urology,,,Article,2013-10-21,10.1016/j.juro.2013.10.066,,,,24144685,,,,,,,1,1,0,15,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1846746,https://api.altmetric.com/v1/donut/1846746_240.png 28,"Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.",PLoS ONE,,,Article,2013-07-24,10.1371/journal.pone.0068331,,,,23874588,PMC3710024,,,,,,1,2,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1652007,https://api.altmetric.com/v1/donut/1652007_240.png 28,Adding radiotherapy to hormone treatment improves survival in older men with prostate cancer,British Medical Journal,,,Article,2015-01-08,10.1136/bmj.h84,,,,25569548,,,,,,,1,0,0,28,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3046296,https://api.altmetric.com/v1/donut/3046296_240.png 28,The mutational landscape of lethal castration-resistant prostate cancer,Nature,,,Article,2012-05-20,10.1038/nature11125,,,,22722839,,,2012Natur.487..239G,,,,0,1,0,25,0,0,2,1,0,0,0,0,1,0,0,469,https://www.altmetric.com/details/753034,https://api.altmetric.com/v1/donut/753034_240.png 28,Effect of dutasteride on the risk of prostate cancer.,New England Journal of Medicine,,,Article,2010-04-01,10.1056/nejmoa0908127,,,,20357281,,,,,,,1,2,0,3,0,0,1,0,0,0,0,0,6,0,0,10,https://www.altmetric.com/details/131819,https://api.altmetric.com/v1/donut/131819_240.png 28,"Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer",Journal of Clinical Oncology,,,Article,2010-01-01,10.1200/jco.2009.24.2180,,,,19917860,,,,,,,2,3,0,1,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/774327,https://api.altmetric.com/v1/donut/774327_240.png 28,Non?steroidal Anti?inflammatory Drug use Not Associated with Erectile Dysfunction Risk: Results from the Prostate Cancer Prevention Trial,British Journal of Urology,,,Article,2015-08-26,10.1111/bju.13264,,,,26305866,,,,,,,1,3,0,14,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4436619,https://api.altmetric.com/v1/donut/4436619_240.png 28,A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2015-02-01,10.1093/jnci/djv346,,,,26615022,,,,,,,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4818866,https://api.altmetric.com/v1/donut/4818866_240.png 28,Population-Based Assessment of Determining Treatments for Prostate Cancer,JAMA Oncology,,,Article,2015-07-17,10.1001/jamaoncol.2014.183,,,,26182306,,,,,,,2,0,0,17,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3721507,https://api.altmetric.com/v1/donut/3721507_240.png 28,Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators,European Urology,,,Article,2016-07-21,10.1016/j.eururo.2016.07.008,,,,27451135,,,,,,,0,0,0,60,0,0,2,0,3,0,0,0,0,0,0,17,https://www.altmetric.com/details/9916878,https://api.altmetric.com/v1/donut/9916878_240.png 28,A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening—a qualitative analysis,BMJ Open,,,Article,2014-04-01,10.1136/bmjopen-2013-004682,,,,24785399,,,,,,,0,1,0,39,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2317715,https://api.altmetric.com/v1/donut/2317715_240.png 28,"Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.",Lancet Oncology,,,Article,2014-08-05,10.1016/s1470-2045(14)70303-1,,,,,,,,,,,1,2,0,14,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2573803,https://api.altmetric.com/v1/donut/2573803_240.png 28,The E3 Ubiquitin Ligase Siah2 Contributes to Castration-Resistant Prostate Cancer by Regulation of Androgen Receptor Transcriptional Activity,Cancer Cell,,,Article,2013-01-01,10.1016/j.ccr.2013.02.016,,,,23518348,,,,,,,2,1,0,6,0,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1307929,https://api.altmetric.com/v1/donut/1307929_240.png 28,Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary–Early Detection Research Network Active Surveillance Biopsy Risk Calculator,European Urology,,,Article,2015-03-31,10.1016/j.eururo.2015.03.023,,,,25819722,,,,,,,0,0,0,95,0,0,5,0,1,0,0,0,0,0,0,21,https://www.altmetric.com/details/3840057,https://api.altmetric.com/v1/donut/3840057_240.png 28,An Approach Using PSA Levels of 1.5 ng/ml as the Cutoff for Prostate Cancer Screening in Primary Care,Urology,,,Article,2016-07-01,10.1016/j.urology.2016.07.001,,,,27450937,,,,,,,1,0,0,39,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9934533,https://api.altmetric.com/v1/donut/9934533_240.png 27,Screening for Prostate Cancer Starting at Age 50–54 Years. A Population-based Cohort Study,European Urology,,,Article,2016-04-13,10.1016/j.eururo.2016.03.026,,,,27084245,,,,,,,0,0,0,57,0,0,2,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/6637085,https://api.altmetric.com/v1/donut/6637085_240.png 27,Case-control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority.,British Medical Journal,,,Article,1993-11-27,,,,,8274891,PMC1679658,,,,,,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4866475,https://api.altmetric.com/v1/donut/4866475_240.png 27,Developmental exposure to bisphenol A increases prostate cancer susceptibility in adult rats: epigenetic mode of action is implicated,Fertility & Sterility,,,Article,2008-02-01,10.1016/j.fertnstert.2007.12.023,,,,18308059,PMC2531072,,,,,,2,3,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3275254,https://api.altmetric.com/v1/donut/3275254_240.png 27,5?-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer,JAMA Oncology,,,Article,2015-04-02,10.1001/jamaoncol.2015.0387,,,,26181177,,,,,,,0,0,0,45,0,0,6,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3863870,https://api.altmetric.com/v1/donut/3863870_240.png 27,Metformin Use and Prostate Cancer Risk,European Urology,,,Article,,10.1016/j.eururo.2014.04.027,,,,24857538,,,,,,,2,0,0,33,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2370226,https://api.altmetric.com/v1/donut/2370226_240.png 27,PREFEREnce-based Randomized Evaluation of Treatment Modalities in Low or Early Intermediate-risk Prostate Cancer.,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.09.016,,,,25269383,,,,,,,0,0,0,39,0,0,0,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/2721374,https://api.altmetric.com/v1/donut/2721374_240.png 27,The Time Is Ripe for a Randomized Trial of Metformin in Clinically Localized Prostate Cancer,Journal of Clinical Oncology,,,Article,2013-08-05,10.1200/jco.2013.50.7715,,,,23918948,,,,,,,3,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1673941,https://api.altmetric.com/v1/donut/1673941_240.png 27,"Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial",JAMA Oncology,,,Article,2016-01-21,10.1001/jamaoncol.2015.5570,,,,26794729,,,,,,,1,0,0,37,0,0,5,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5025173,https://api.altmetric.com/v1/donut/5025173_240.png 27,"Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate",CA: A Cancer Journal for Clinicians ,,,Article,2008-12-30,10.3322/canjclin.22.4.232,,,,,,,,,,,2,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3220691,https://api.altmetric.com/v1/donut/3220691_240.png 27,Calcium and Fructose Intake in Relation to Risk of Prostate Cancer,Cancer Research,,,Article,1998-01-01,,,,,9458087,,,,,,,1,1,0,4,0,0,6,1,0,0,0,0,0,0,2,3,https://www.altmetric.com/details/862509,https://api.altmetric.com/v1/donut/862509_240.png 27,Prostate cancer: send away the PSA?,The Lancet (British Edition),,,Article,2012-07-28,10.1016/s0140-6736(12)61232-x,,,,22841322,,,,,,,0,0,0,39,0,0,3,0,1,0,0,0,0,0,0,13,https://www.altmetric.com/details/858530,https://api.altmetric.com/v1/donut/858530_240.png 27,"Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",American Journal of Clinical Nutrition,,,Article,2006-04-09,,,,,16600944,,,,,,,0,3,0,7,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/627259,https://api.altmetric.com/v1/donut/627259_240.png 27,A phase 2 clinical trial of everolimus plus bicalutamide for castration?resistant prostate cancer,Cancer (0008543X),,,Article,2016-03-01,10.1002/cncr.29927,,,,27019001,,,,,,,3,0,0,8,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6364963,https://api.altmetric.com/v1/donut/6364963_240.png 27,Prostate cancer,World Cancer Research Fund International,,,Article,,,,,http://www.wcrf.org/int/research-we-fund/continuous-update-project-findings-reports/prostate-cancer,,,,,,,,1,0,0,22,0,0,5,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4336368,https://api.altmetric.com/v1/donut/4336368_240.png 27,Immediate Versus Delayed Radical Prostatectomy: Updated Outcomes Following Active Surveillance of Prostate Cancer.,European Urology,,,Article,2015-09-01,10.1016/j.eururo.2015.06.011,,,,26138041,,,,,,,2,0,0,30,0,0,2,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/4280564,https://api.altmetric.com/v1/donut/4280564_240.png 27,Drug discovery in advanced prostate cancer: translating biology into therapy,Nature Reviews Drug Discovery,,,Article,2016-07-22,10.1038/nrd.2016.120,,,,27444228,,,,,,,1,1,0,15,0,0,3,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/9953751,https://api.altmetric.com/v1/donut/9953751_240.png 27,Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer,European Urology,,,Article,2016-06-09,10.1016/j.eururo.2016.05.023,,,,27289566,,,,,,,1,1,0,15,0,0,1,0,1,0,0,0,0,0,0,22,https://www.altmetric.com/details/8599278,https://api.altmetric.com/v1/donut/8599278_240.png 27,The transcription factor SPDEF is required for E-Cadherin expression in prostate cancer cells,Journal of Biological Chemistry,,,Article,2013-01-01,10.1074/jbc.m112.434225,,,,23449978,,,,,,,2,1,0,2,20,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1273091,https://api.altmetric.com/v1/donut/1273091_240.png 27,Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.45.0494,,,,23169517,,,,,,,1,0,0,29,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1078193,https://api.altmetric.com/v1/donut/1078193_240.png 27,"Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research.",,,,Article,2004-12-15,,,,,15570047,,,,,,,0,3,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4314197,https://api.altmetric.com/v1/donut/4314197_240.png 27,The Impact of Recent Screening Recommendations on Prostate Cancer Screening in a Large Health Care System.,The Journal of Urology,,,Article,2013-12-16,10.1016/j.juro.2013.12.010,,,,24342148,,,,,,,3,0,0,9,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1982807,https://api.altmetric.com/v1/donut/1982807_240.png 26,The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients,European Urology,,,Article,2016-03-23,10.1016/j.eururo.2016.03.010,,,,27016464,,,,,,,0,0,0,47,0,0,5,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/6268205,https://api.altmetric.com/v1/donut/6268205_240.png 26,"Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial",Lancet Oncology,,,Article,2015-11-03,10.1016/s1470-2045(15)00280-6,,,,26522334,,,,,,,2,0,0,12,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/4683054,https://api.altmetric.com/v1/donut/4683054_240.png 26,"Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2013-12-09,10.1200/jco.2012.48.5268,,,,24323035,,,,,,,1,1,0,23,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1968204,https://api.altmetric.com/v1/donut/1968204_240.png 26,"Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial",Lancet Oncology,,,Article,2015-04-19,10.1016/s1470-2045(15)70113-0,,,,25888263,,,,,,,1,1,0,24,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/3913797,https://api.altmetric.com/v1/donut/3913797_240.png 26,Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions.,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2014-04-05,10.1089/cbr.2013.1578,,,,24693958,,,,,,,3,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2284119,https://api.altmetric.com/v1/donut/2284119_240.png 26,Coffee consumption and risk of prostate cancer: a meta?analysis of epidemiological studies,British Journal of Urology,,,Article,2010-01-01,10.1111/j.1464-410x.2010.09493.x,,,,20590551,,,,,,,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2678599,https://api.altmetric.com/v1/donut/2678599_240.png 26,Selenium Supplementation and Prostate Cancer Mortality,JNCI: Journal of the National Cancer Institute,,,Article,2015-01-01,10.1093/jnci/dju360,,,,25505227,,,,,,,1,0,0,23,0,1,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2981848,https://api.altmetric.com/v1/donut/2981848_240.png 26,Variations in the Open Market Costs for Prostate Cancer Surgery: A Survey of US Hospitals,Urology,,,Article,2014-01-15,10.1016/j.urology.2013.09.066,,,,24439795,,,,,,,2,1,0,4,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2059591,https://api.altmetric.com/v1/donut/2059591_240.png 26,An androgen receptor N-terminal domain antagonist for treating prostate cancer,Journal of Clinical Investigation,,,Article,2013-01-01,10.1172/jci66398,,,,23722902,PMC3696543,,,,,,2,0,0,4,0,0,2,1,0,0,0,0,1,0,0,53,https://www.altmetric.com/details/1528597,https://api.altmetric.com/v1/donut/1528597_240.png 26,Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.,British Medical Journal,,,Article,2012-01-01,10.1136/bmj.d7894,,,,22232535,,,,,,,2,2,1,9,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/552486,https://api.altmetric.com/v1/donut/552486_240.png 26,A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer,European Urology,,,Article,2016-01-16,10.1016/j.eururo.2015.12.050,,,,26782346,,,,,,,0,0,0,36,0,0,4,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/5000427,https://api.altmetric.com/v1/donut/5000427_240.png 26,"Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer—a dose–response meta-analysis",Annals of Oncology,,,Article,2013-11-24,10.1093/annonc/mdt420,,,,24276028,,,,,,,1,1,0,13,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1939549,https://api.altmetric.com/v1/donut/1939549_240.png 26,Cumulative Association of Five Genetic Variants with Prostate Cancer,New England Journal of Medicine,,,Article,2008-02-28,10.1056/nejmoa075819,,,,18199855,,,,,,,2,3,0,0,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/173602,https://api.altmetric.com/v1/donut/173602_240.png 26,Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial,European Urology,,,Article,2015-12-25,10.1016/j.eururo.2015.12.006,,,,26724840,,,,,,,0,0,0,36,0,0,3,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4922231,https://api.altmetric.com/v1/donut/4922231_240.png 26,"Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses",PLoS Medicine,,,Article,2016-09-06,10.1371/journal.pmed.1002118,,,,27598322,,,,,,,2,0,0,21,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11863624,https://api.altmetric.com/v1/donut/11863624_240.png 26,Enhancing active surveillance of prostate cancer: the potential of exercise medicine,Nature Reviews Urology,,,Article,2016-03-08,10.1038/nrurol.2016.46,,,,26954333,,,,,,,2,0,0,13,0,0,8,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6137972,https://api.altmetric.com/v1/donut/6137972_240.png 26,Prostate cancer detection with magnetic resonance?ultrasound fusion biopsy: The role of systematic and targeted biopsies,Cancer (0008543X),,,Article,2016-01-01,10.1002/cncr.29874,,,,26749141,,,,,,,1,1,0,18,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/4966745,https://api.altmetric.com/v1/donut/4966745_240.png 26,Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach,European Urology,,,Article,2015-07-02,10.1016/j.eururo.2015.06.007,,,,26129856,,,,,,,0,0,0,43,0,0,6,0,3,0,0,0,0,0,0,41,https://www.altmetric.com/details/4220680,https://api.altmetric.com/v1/donut/4220680_240.png 26,Two major studies strengthen case for prostate cancer drug before chemo,ecancer.org,,,Article,,,,,http://ecancer.org/news/6953-two-major-studies-strengthen-case-for-prostate-cancer-drug-before-chemo.php,,,,,,,,2,0,0,13,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3353008,https://api.altmetric.com/v1/donut/3353008_240.png 26,"Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2000-08-01,,,,,10952096,,,,,,,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1072084,https://api.altmetric.com/v1/donut/1072084_240.png 26,Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study,European Journal of Cancer (1965),,,Article,2016-11-01,10.1016/j.ejca.2016.07.021,,,,27620947,,,,,,,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/12467160,https://api.altmetric.com/v1/donut/12467160_240.png 25,"Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2016-06-13,10.1200/jco.2016.66.9697,,,,27298414,,,,,,,2,0,0,19,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8715858,https://api.altmetric.com/v1/donut/8715858_240.png 25,Ageism in the Undertreatment of High-Risk Prostate Cancer: How Long Will Clinical Practice Patterns Resist the Weight of Evidence?,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.59.4093,,,,25559801,,,,,,,1,0,0,23,0,0,4,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3041536,https://api.altmetric.com/v1/donut/3041536_240.png 25,Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion,The Prostate,,,Article,2013-10-01,10.1002/pros.22740,,,,24154958,,,,,,,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1864767,https://api.altmetric.com/v1/donut/1864767_240.png 25,Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer,European Urology,,,Article,2015-09-01,10.1016/j.eururo.2015.04.034,,,,25957851,,,,,,,2,0,0,14,0,0,4,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3994847,https://api.altmetric.com/v1/donut/3994847_240.png 25,Population Based Study of Use and Determinants of Active Surveillance and Watchful Waiting for Low and Intermediate Risk Prostate Cancer,The Journal of Urology,,,Article,2013-05-31,10.1016/j.juro.2013.05.054,,,,23727309,,,,,,,1,2,0,7,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1523315,https://api.altmetric.com/v1/donut/1523315_240.png 25,Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial ,The Lancet,,,Article,2010-10-02,10.1016/s0140-6736(10)61389-x,,,,20888992,,,,,,,0,4,0,1,0,0,0,1,0,0,0,0,3,0,0,324,https://www.altmetric.com/details/210391,https://api.altmetric.com/v1/donut/210391_240.png 25,The Association between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-Risk Prostate Cancer,Urology,,,Article,2016-07-01,10.1016/j.urology.2016.06.042,,,,27392652,,,,,,,2,1,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9662291,https://api.altmetric.com/v1/donut/9662291_240.png 25,Prostate cancer: 4 big questions.,Nature,,,Article,2015-12-15,10.1038/528s137a,,,,26672789,,,,,,,2,0,0,41,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/4885232,https://api.altmetric.com/v1/donut/4885232_240.png 25,"Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",American Journal of Clinical Nutrition,,,Article,2015-08-15,10.3945/ajcn.115.113282,,,,26269366,,,,,,,0,1,0,30,0,0,2,0,0,0,0,0,0,0,2,6,https://www.altmetric.com/details/4400686,https://api.altmetric.com/v1/donut/4400686_240.png 25,A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update,European Urology,,,Article,2016-02-03,10.1016/j.eururo.2016.01.026,,,,26850969,,,,,,,0,0,0,42,0,0,6,0,1,0,0,0,0,0,0,19,https://www.altmetric.com/details/5081522,https://api.altmetric.com/v1/donut/5081522_240.png 25,"Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer",European Urology,,,Article,2015-12-01,10.1016/j.eururo.2015.04.029,,,,25979568,,,,,,,3,0,0,2,0,0,2,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4126300,https://api.altmetric.com/v1/donut/4126300_240.png 25,"Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial",Clinical Trials,,,Article,2010-01-08,10.1177/1740774510374091,,,,20571134,,,,,,,2,1,0,2,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/634231,https://api.altmetric.com/v1/donut/634231_240.png 25,Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.,Science Translational Medicine,,,Article,2012-06-27,10.1126/scitranslmed.3003886,,,,22745436,,,,,,,1,0,0,19,0,0,1,1,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/812174,https://api.altmetric.com/v1/donut/812174_240.png 25,To screen or not to screen for prostate cancer?,The Lancet,,,Article,2012-06-02,10.1016/s0140-6736(12)60878-2,,,,22656872,,,,,,,0,0,0,38,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/771632,https://api.altmetric.com/v1/donut/771632_240.png 25,The role of focal therapy in the management of localised prostate cancer: a systematic review.,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.05.048,,,,23769825,PMC4179888,,,,,,1,1,0,11,0,0,0,0,1,0,0,0,0,0,0,65,https://www.altmetric.com/details/2387372,https://api.altmetric.com/v1/donut/2387372_240.png 25,Quantifying the role of PSA screening in the US prostate cancer mortality decline,Cancer Causes and Control,,,Article,2007-11-20,10.1007/s10552-007-9083-8,,,,18027095,PMC3064270,,,,,,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/2022511,https://api.altmetric.com/v1/donut/2022511_240.png 25,"Clinical performance of Prostate Health Index (PHI) for prediction of prostate cancer in obese men: data from a multicenter European prospective study, PROMEtheuS project",British Journal of Urology,,,Article,2015-03-25,10.1111/bju.12907,,,,25130593,,,,,,,1,4,0,9,0,0,1,0,0,0,0,0,0,0,1,4,https://www.altmetric.com/details/2594453,https://api.altmetric.com/v1/donut/2594453_240.png 25,ProstaCaid™ inhibits tumor growth in a xenograft model of human prostate cancer.,International Journal of Oncology,,,Article,2012-01-24,10.3892/ijo.2012.1344,,,,22293856,,,,,,,1,2,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/587252,https://api.altmetric.com/v1/donut/587252_240.png 25,Survival in men older than 75 years with low- and intermediate-grade prostate cancer managed with watchful waiting with active surveillance,Family Medicine and Community Health,,,Article,2015-09-01,10.15212/fmch.2015.0129,,,,,,,,,,,2,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4659399,https://api.altmetric.com/v1/donut/4659399_240.png 25,Primary care providers' perspectives on discontinuing prostate cancer screening,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.27577,,,,22517310,,,,,,,3,0,1,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/761925,https://api.altmetric.com/v1/donut/761925_240.png 25,Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2008-12-01,10.1158/1055-9965.epi-08-0008,,,,19064574,PMC2703189,,,,,,1,1,0,5,0,0,2,0,0,0,0,0,0,0,2,64,https://www.altmetric.com/details/111983,https://api.altmetric.com/v1/donut/111983_240.png 25,RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1,Lancet Oncology,,,Article,2014-11-17,10.1016/s1470-2045(14)71113-1,,,,25456366,,,,,,,1,0,0,24,0,0,1,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2897041,https://api.altmetric.com/v1/donut/2897041_240.png 25,Will Changes to Prostate Cancer Screening Guidelines Preserve Benefits and Reduce Harm?,European Urology,,,Article,2016-04-16,10.1016/j.eururo.2016.04.002,,,,27090973,,,,,,,0,0,0,56,0,0,3,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/6749935,https://api.altmetric.com/v1/donut/6749935_240.png 25,Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaid™: mechanism of activity.,International Journal of Oncology,,,Article,2011-04-07,10.3892/ijo.2011.996,,,,21468543,,,,,,,1,2,0,3,0,0,2,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1262380,https://api.altmetric.com/v1/donut/1262380_240.png 25,Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.,European Urology,,,Article,,10.1016/j.eururo.2015.06.012,,,,26138043,,,,,,,0,0,0,33,0,0,2,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4259823,https://api.altmetric.com/v1/donut/4259823_240.png 25,"Unemployment and prostate cancer mortality in the OECD, 1990–2009",Ecancermedicalscience,,,Article,2015-05-14,10.3332/ecancer.2015.538,,,http://www.ecancer.org/journal/9/full/538-unemployment-and-prostate-cancer-mortality-in-the-oecd-1990-2009.php,26045715,,,,,,,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4001426,https://api.altmetric.com/v1/donut/4001426_240.png 25,A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment.,Cancer (0008543X),,,Article,2011-09-30,10.1002/cncr.26308,,,,21953578,,,,,,,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/631246,https://api.altmetric.com/v1/donut/631246_240.png 25,A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences,Cancer Discovery,,,Article,2015-06-03,10.1158/2159-8290.cd-15-0315,,,,26034056,,,,,,,3,0,0,6,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4082459,https://api.altmetric.com/v1/donut/4082459_240.png 25,Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer,European Urology,,,Article,2016-09-04,10.1016/j.eururo.2016.08.051,,,,27600589,,,,,,,0,0,0,45,0,0,1,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/11716992,https://api.altmetric.com/v1/donut/11716992_240.png 25,Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials,Annals of Oncology,,,Article,2015-11-27,10.1093/annonc/mdv545,,,,26609008,,,,,,,1,1,0,23,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4815318,https://api.altmetric.com/v1/donut/4815318_240.png 25,"Knowledge, attitudes and practices of clinicians in promoting physical activity to prostate cancer survivors",Health Education Journal,,,Article,2013-01-01,10.1177/0017896913508395,,,,,,,,,,,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1907766,https://api.altmetric.com/v1/donut/1907766_240.png 25,Black men less willing than white men to be investigated for prostate cancer,British Medical Journal,,,Article,2015-03-02,10.1136/bmj.h1132,,,,25733595,,,,,,,1,0,0,21,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3747077,https://api.altmetric.com/v1/donut/3747077_240.png 25,Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.,European Urology,,,Article,2014-11-06,10.1016/j.eururo.2014.10.033,,,,25466942,,,,,,,0,0,0,45,0,0,4,0,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/2857300,https://api.altmetric.com/v1/donut/2857300_240.png 25,Carotenoids affect proliferation of human prostate cancer cells.,Journal of Nutrition,,,Article,2001-12-01,,,,,11739884,,,,,,,0,0,0,8,0,0,6,0,18,0,0,0,0,0,0,7,https://www.altmetric.com/details/2167885,https://api.altmetric.com/v1/donut/2167885_240.png 25,Prostate Cancer Mortality in the Finnish Randomized Screening Trial,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt038,,,,23479454,,,,,,,1,0,1,11,0,0,2,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1301964,https://api.altmetric.com/v1/donut/1301964_240.png 25,A Systematic Review and Meta-analysis of Tobacco Use and Prostate Cancer Mortality and Incidence in Prospective Cohort Studies,European Urology,,,Article,2014-09-17,10.1016/j.eururo.2014.08.059,,,,25242554,,,,,,,0,0,0,37,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2696636,https://api.altmetric.com/v1/donut/2696636_240.png 25,"Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: Results from the SEARCH database.",Cancer (0008543X),,,Article,2013-10-10,10.1002/cncr.28423,,,,24127391,,,,,,,1,0,0,21,0,0,1,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/1820364,https://api.altmetric.com/v1/donut/1820364_240.png 25,The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).,JNCI: Journal of the National Cancer Institute,,,Article,2015-12-01,10.1093/jnci/djv261,,,,26409187,,,,,,,1,1,0,11,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4557793,https://api.altmetric.com/v1/donut/4557793_240.png 25,Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer,ads,,,Article,1970-01-01,10.1126/science.1168175,,,,19359544,PMC2981508,,2009Sci...324..787T,,,,1,2,0,0,0,0,0,3,0,0,0,0,1,0,0,243,https://www.altmetric.com/details/439560,https://api.altmetric.com/v1/donut/439560_240.png 25,Trends in Metastatic Breast and Prostate Cancer.,New England Journal of Medicine,,,Article,2016-02-11,10.1056/nejmc1515983,,,,26863368,,,,,,,1,1,0,13,1,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5309793,https://api.altmetric.com/v1/donut/5309793_240.png 24,Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer,European Urology,,,Article,2016-05-19,10.1016/j.eururo.2016.05.008,,,,27209538,,,,,,,0,0,0,34,0,0,3,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/7608098,https://api.altmetric.com/v1/donut/7608098_240.png 24,Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer,Science,,,Article,2014-10-03,10.1126/science.1250255,,,,25278611,,,,,,,0,0,0,28,0,6,0,0,0,0,0,0,1,0,0,54,https://www.altmetric.com/details/2738670,https://api.altmetric.com/v1/donut/2738670_240.png 24,DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation,Cell Death & Differentiation,,,Article,2014-01-24,10.1038/cdd.2013.202,,,,24464224,,,,,,,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2073632,https://api.altmetric.com/v1/donut/2073632_240.png 24,Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer,JAMA Oncology,,,Article,2016-07-14,10.1001/jamaoncol.2016.1368,,,,27415446,,,,,,,0,0,0,42,0,0,0,0,3,0,0,0,0,0,0,1,https://www.altmetric.com/details/9734915,https://api.altmetric.com/v1/donut/9734915_240.png 24,Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions,JNCI: Journal of the National Cancer Institute,,,Article,2016-04-29,10.1093/jnci/djw039,,,,27130933,,,,,,,0,1,0,26,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7106162,https://api.altmetric.com/v1/donut/7106162_240.png 24,Dietary intake of n?3 and n?6 fatty acids and the risk of prostate cancer,American Journal of Clinical Nutrition,,,Article,2004-06-24,,,,,15213050,,,,,,,0,2,1,2,0,0,3,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/992260,https://api.altmetric.com/v1/donut/992260_240.png 24,Screening for prostate cancer--the controversy that refuses to die.,New England Journal of Medicine,,,Article,2009-03-26,10.1056/nejme0901166,,,,19297564,,,,,,,0,3,0,2,0,0,1,0,0,0,0,0,0,0,0,124,https://www.altmetric.com/details/399598,https://api.altmetric.com/v1/donut/399598_240.png 24,The metabolic co-regulator PGC1? suppresses prostate cancer metastasis,Nature Cell Biology,,,Article,2016-05-23,10.1038/ncb3357,,,,27214280,PMC4884178,,,,,,2,0,0,8,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8198032,https://api.altmetric.com/v1/donut/8198032_240.png 24,Brassica Vegetables and Prostate Cancer Risk: A Review of the Epidemiological Evidence,Nutrition and Cancer,,,Article,2002-01-01,10.1207/s15327914nc421_1,,,,12235639,,,,,,,0,0,0,1,0,0,1,0,25,0,0,0,0,0,0,27,https://www.altmetric.com/details/4094999,https://api.altmetric.com/v1/donut/4094999_240.png 24,Satisfaction with Information Used to Choose Prostate Cancer Treatment,The Journal of Urology,,,Article,2013-12-13,10.1016/j.juro.2013.12.008,,,,24333514,,,,,,,4,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1977991,https://api.altmetric.com/v1/donut/1977991_240.png 24,Impact of Androgen Deprivation Therapy on Mental and Emotional Well-Being in Men with Prostate Cancer: Analysis from the CaPSURE™ Registry,The Journal of Urology,,,Article,2013-10-30,10.1016/j.juro.2013.10.098,,,,24184370,,,,,,,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1870344,https://api.altmetric.com/v1/donut/1870344_240.png 24,Male pattern baldness and prostate cancer risk in a population-based case–control study,Cancer Epidemiology,,,Article,2010-04-01,10.1016/j.canep.2010.02.003,,,,20206591,PMC2911123,,,,,,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/758733,https://api.altmetric.com/v1/donut/758733_240.png 24,Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial,European Urology,,,Article,2015-06-03,10.1016/j.eururo.2015.05.024,,,,26033153,,,,,,,0,0,0,35,0,0,6,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/4073000,https://api.altmetric.com/v1/donut/4073000_240.png 24,"Dietary ?-Linolenic Acid Is Associated with Reduced Risk of Fatal Coronary Heart Disease, but Increased Prostate Cancer Risk: A Meta-Analysis",Journal of Nutrition,,,Article,2004-01-01,,,,,15051847,,,,,,,0,2,1,2,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2074325,https://api.altmetric.com/v1/donut/2074325_240.png 24,"Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma",Journal of Clinical Oncology,,,Article,2011-01-01,10.1200/jco.2010.31.3304,,,,21343556,,,,,,,1,2,1,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1583824,https://api.altmetric.com/v1/donut/1583824_240.png 24,Urologists’ Self-Referral For Pathology Of Biopsy Specimens Linked To Increased Use And Lower Prostate Cancer Detection,Health Affairs,,,Article,2012-01-01,10.1377/hlthaff.2011.1372,,,,22492891,,,,,,,1,0,0,19,0,0,0,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/690540,https://api.altmetric.com/v1/donut/690540_240.png 24,Raising the Bar for Therapeutic Trials in Advanced Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-07-11,10.1200/jco.2016.68.0439,,,,27400946,,,,,,,1,1,0,14,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9630005,https://api.altmetric.com/v1/donut/9630005_240.png 24,Trends in the Incidence of Fatal Prostate Cancer in the United States by Race,European Urology,,,Article,2016-07-28,10.1016/j.eururo.2016.05.011,,,,27476048,,,,,,,0,0,0,45,0,0,2,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/10083410,https://api.altmetric.com/v1/donut/10083410_240.png 24,Selenium status and risk of prostate cancer in a Danish population,British Journal of Nutrition,,,Article,2016-03-14,10.1017/s0007114516000726,,,,26971676,,,,,,,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6320483,https://api.altmetric.com/v1/donut/6320483_240.png 24,Prostate cancer.,Nature,,,Article,2015-12-16,10.1038/528s117a,,,,26672779,,,,,,,0,0,0,41,0,0,2,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4885268,https://api.altmetric.com/v1/donut/4885268_240.png 24,A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer,Nature Genetics,,,Article,2013-06-02,10.1038/ng.2650,,,,23727860,,,,,,,2,0,0,8,4,0,2,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/1528938,https://api.altmetric.com/v1/donut/1528938_240.png 24,Five-Year Outcomes from 3 Prospective Trials of Image-Guided Proton Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-03-01,10.1016/j.ijrobp.2013.11.007,,,,24521677,,,,,,,1,0,0,25,0,0,1,0,3,0,0,0,0,0,0,31,https://www.altmetric.com/details/2118214,https://api.altmetric.com/v1/donut/2118214_240.png 24,Prospective Cohort Study of the Risk of Prostate Cancer among Rotating-Shift Workers: Findings from the Japan Collaborative Cohort Study,American Journal of Epidemiology,,,Article,2006-01-01,10.1093/aje/kwj232,,,,16829554,,,,,,,1,1,0,5,0,0,0,0,0,0,0,0,0,0,0,92,https://www.altmetric.com/details/1038468,https://api.altmetric.com/v1/donut/1038468_240.png 24,Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors,Science Signaling,,,Article,2015-11-17,10.1126/scisignal.aad5111,,,,26577921,,,,,,,0,0,0,34,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4777869,https://api.altmetric.com/v1/donut/4777869_240.png 24,Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-07-22,10.1158/1055-9965.epi-11-0403,,,,21784952,PMC3188814,,,,,,0,3,0,15,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/720687,https://api.altmetric.com/v1/donut/720687_240.png 24,"Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer",Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mds526,,,,23149571,,,,,,,1,0,0,19,0,0,0,0,0,1,0,0,0,0,0,51,https://www.altmetric.com/details/1066362,https://api.altmetric.com/v1/donut/1066362_240.png 24,A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid?derived suppressor cells for Agaricus bisporus–induced prostate?specific antigen responses,Cancer (0008543X),,,Article,2015-05-18,10.1002/cncr.29421,,,,25989179,,,,,,,3,0,0,4,0,0,5,0,0,0,1,0,0,0,0,16,https://www.altmetric.com/details/4112774,https://api.altmetric.com/v1/donut/4112774_240.png 24,Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide,The Prostate,,,Article,2014-12-01,10.1002/pros.22890,,,,25262981,,,,,,,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2791773,https://api.altmetric.com/v1/donut/2791773_240.png 24,Tumor clone dynamics in lethal prostate cancer.,Science Translational Medicine,,,Article,2014-09-17,10.1126/scitranslmed.3009448,,,,25232177,,,,,,,2,0,0,12,0,0,0,0,0,0,0,0,1,0,0,135,https://www.altmetric.com/details/2692459,https://api.altmetric.com/v1/donut/2692459_240.png 24,Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy,European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.09.007,,,,27639533,,,,,,,1,0,0,36,0,0,1,0,2,0,0,0,0,0,0,3,https://www.altmetric.com/details/12007424,https://api.altmetric.com/v1/donut/12007424_240.png 24,"miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src",Cancer Research,,,Article,2015-11-18,10.1158/0008-5472.can-14-0795,,,,26573802,,,,,,,3,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4772033,https://api.altmetric.com/v1/donut/4772033_240.png 24,"Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer",Cancer Research,,,Article,2009-04-01,10.1158/0008-5472.can-08-3667,,,,19339269,,,,,,,0,2,1,0,0,0,0,1,0,0,0,0,0,0,0,148,https://www.altmetric.com/details/408169,https://api.altmetric.com/v1/donut/408169_240.png 24,Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study.,JNCI: Journal of the National Cancer Institute,,,Article,1998-11-04,,,,,9811313,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4910827,https://api.altmetric.com/v1/donut/4910827_240.png 24,Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial,Prostate Cancer & Prostatic Diseases,,,Article,2013-01-15,10.1038/pcan.2012.52,,,,23318529,,,,,,,0,2,0,26,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1179938,https://api.altmetric.com/v1/donut/1179938_240.png 24,Acne in Adolescence and Cause-specific Mortality: Lower Coronary Heart Disease but Higher Prostate Cancer Mortality The Glasgow Alumni Cohort Study,American Journal of Epidemiology,,,Article,2005-01-01,10.1093/aje/kwi147,,,,15937017,,,,,,,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1436631,https://api.altmetric.com/v1/donut/1436631_240.png 23,Randomised prostate cancer screening trial: 20 year follow-up.,British Medical Journal,,,Article,2011-01-01,10.1136/bmj.d1539,,,,21454449,PMC3069219,,,,,,0,2,3,5,0,0,2,0,0,0,0,0,1,1,0,78,https://www.altmetric.com/details/221900,https://api.altmetric.com/v1/donut/221900_240.png 23,Prostate cancer: Increased dementia risk following androgen deprivation therapy?,Nature Reviews Urology,,,Article,2016-02-23,10.1038/nrurol.2016.34,,,,26902342,,,,,,,1,0,0,21,0,0,3,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/5975314,https://api.altmetric.com/v1/donut/5975314_240.png 23,Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes,European Urology,,,Article,2015-05-15,10.1016/j.eururo.2015.04.033,,,,25964175,,,,,,,2,0,0,39,0,0,2,0,1,0,0,0,0,0,0,44,https://www.altmetric.com/details/3998080,https://api.altmetric.com/v1/donut/3998080_240.png 23,"Boiled coffee consumption and the risk of prostate cancer: follow-up of 224,234 Norwegian men 20|[ndash]|69 years",British Journal of Cancer,,,Article,2014-12-23,10.1038/bjc.2014.645,,,,25535729,,,,,,,2,0,0,6,0,0,1,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/3013489,https://api.altmetric.com/v1/donut/3013489_240.png 23,"Finasteride for prostate cancer prevention has no effect on survival, study finds.",British Medical Journal,,,Article,2013-08-20,10.1136/bmj.f5203,,,,23963667,,,,,,,0,0,0,34,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1699756,https://api.altmetric.com/v1/donut/1699756_240.png 23,Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial,European Urology,,,Article,2014-12-31,10.1016/j.eururo.2014.12.006,,,,25556937,,,,,,,0,0,0,38,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3028757,https://api.altmetric.com/v1/donut/3028757_240.png 23,Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation1,Endocrinology,,,Article,2000-01-01,10.1210/endo.141.1.7239,,,,10614630,,,,,,,0,0,0,2,0,0,150,1,11,0,0,0,0,0,2,42,https://www.altmetric.com/details/2675807,https://api.altmetric.com/v1/donut/2675807_240.png 23,Quality of Life in Men Undergoing Active Surveillance for Localized Prostate Cancer,Journal of the National Cancer Institute. Monographs,,,Article,2012-01-01,10.1093/jncimonographs/lgs026,,,,23271780,,,,,,,0,2,0,9,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1196609,https://api.altmetric.com/v1/donut/1196609_240.png 23,Developing a nanoparticle test for prostate cancer scoring,Journal of Translational Medicine,,,Article,2012-03-09,10.1186/1479-5876-10-44,,,,22404986,,,,,,,1,1,0,3,0,0,1,0,0,1,0,0,0,0,0,24,https://www.altmetric.com/details/670607,https://api.altmetric.com/v1/donut/670607_240.png 23,Prostate cancer: Lessons from PIVOT lost in media hype,Nature Reviews Urology,,,Article,2012-08-07,10.1038/nrurol.2012.166,,,,22868995,,,,,,,0,2,0,31,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/876442,https://api.altmetric.com/v1/donut/876442_240.png 23,American Cancer Society guideline for the early detection of prostate cancer: update 2010.,CA: A Cancer Journal for Clinicians ,,,Article,2010-03-01,10.3322/caac.20066,,,,20200110,,,,,,,0,1,2,21,0,0,0,2,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/487976,https://api.altmetric.com/v1/donut/487976_240.png 23,Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-03-23,10.1200/jco.2014.55.3487,,,,25800753,,,,,,,1,1,0,15,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3831232,https://api.altmetric.com/v1/donut/3831232_240.png 23,Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen?deprivation therapy: a randomised controlled trial,British Journal of Urology,,,Article,2014-07-27,10.1111/bju.12646,,,,24467669,,,,,,,0,0,0,41,0,0,1,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2075831,https://api.altmetric.com/v1/donut/2075831_240.png 23,Green tea polyphenols for prostate cancer chemoprevention: A translational perspective,Phytomedicine,,,Article,2010-01-01,10.1016/j.phymed.2009.09.011,,,,19959000,PMC2789276,,,,,,2,0,0,2,0,0,3,0,0,1,0,0,0,0,0,38,https://www.altmetric.com/details/995052,https://api.altmetric.com/v1/donut/995052_240.png 23,"A Whole of Population, Multiuser Series of High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: Outcomes and Implications",Journal of Endourology,,,Article,2015-01-28,10.1089/end.2014.0696,,,,25621993,,,,,,,0,0,0,31,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3786392,https://api.altmetric.com/v1/donut/3786392_240.png 23,Prostate Cancer Mortality following Active Surveillance versus Immediate Radical Prostatectomy,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-1502,,,,23008476,,,,,,,0,2,1,20,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/964198,https://api.altmetric.com/v1/donut/964198_240.png 23,Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score,European Urology,,,Article,2016-04-21,10.1016/j.eururo.2016.04.012,,,,27108162,,,,,,,1,0,0,25,0,0,4,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/6849389,https://api.altmetric.com/v1/donut/6849389_240.png 23,Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer,Modern Pathology,,,Article,2015-11-27,10.1038/modpathol.2015.136,,,,26612463,,,,,,,2,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4814267,https://api.altmetric.com/v1/donut/4814267_240.png 23,Dietary Fat and Reduced Prostate Cancer Mortality: Does the Type of Fat Matter?,JAMA Internal Medicine,,,Article,2013-01-01,10.1001/jamainternmed.2013.7744,,,,23752858,,,,,,,2,0,0,8,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1547734,https://api.altmetric.com/v1/donut/1547734_240.png 23,Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial,Journal of Clinical Oncology,,,Article,2009-12-03,10.1200/jco.2009.23.2488,,,,19949016,,,,,,,1,0,0,13,0,0,1,0,0,0,0,0,3,0,0,119,https://www.altmetric.com/details/522645,https://api.altmetric.com/v1/donut/522645_240.png 23,Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-06,10.1016/j.ijrobp.2014.02.034,,,,24837889,PMC4026796,,,,,,3,0,0,9,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2337204,https://api.altmetric.com/v1/donut/2337204_240.png 23,The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis,Canadian Urological Association Journal,,,Article,2013-06-15,10.5489/cuaj.1056,,,,23766835,,,,,,,0,1,2,11,0,0,3,1,1,0,0,0,0,0,0,20,https://www.altmetric.com/details/1617122,https://api.altmetric.com/v1/donut/1617122_240.png 23,Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2011-11-01,,,,,22110202,,,,,,,0,0,0,18,0,0,53,0,0,0,0,0,0,0,6,19,https://www.altmetric.com/details/482610,https://api.altmetric.com/v1/donut/482610_240.png 23,Survival following primary androgen deprivation therapy among men with localized prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,2008-07-09,10.1001/jama.300.2.173,,,,18612114,PMC2645653,,,,,,1,2,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/211960,https://api.altmetric.com/v1/donut/211960_240.png 23,The Master Neural Transcription Factor BRN2 is an Androgen Receptor Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer,Cancer Discovery,,,Article,2016-01-01,10.1158/2159-8290.cd-15-1263,,,,27784708,,,,,,,0,0,0,45,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13060577,https://api.altmetric.com/v1/donut/13060577_240.png 23,"Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death",European Urology,,,Article,2015-03-17,10.1016/j.eururo.2015.03.017,,,,25794458,,,,,,,0,0,0,115,0,0,4,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/3801499,https://api.altmetric.com/v1/donut/3801499_240.png 23,The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer,Nature Communications,,,Article,2014-01-01,10.1038/ncomms6383,,,,25415230,,,,,,,0,1,0,22,0,3,0,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/2915695,https://api.altmetric.com/v1/donut/2915695_240.png 23,The use of aspirin and the risk of mortality in patients with prostate cancer.,The Journal of Urology,,,Article,2014-11-14,10.1016/j.juro.2014.11.018,,,,25463991,,,,,,,2,0,0,10,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2887184,https://api.altmetric.com/v1/donut/2887184_240.png 23,"Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada.",Nutrition and Cancer,,,Article,1999-01-01,10.1207/s15327914nc3402_8,,,,10578485,,,,,,,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3711115,https://api.altmetric.com/v1/donut/3711115_240.png 23,Impact of the U.S. Preventive Services Task Force Recommendations against Prostate Specific Antigen Screening on Prostate Biopsy and Cancer Detection Rates,The Journal of Urology,,,Article,2014-12-03,10.1016/j.juro.2014.11.096,,,,25481037,,,,,,,1,1,0,13,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2947968,https://api.altmetric.com/v1/donut/2947968_240.png 22,Quality of care achievements of the Prostate Cancer Outcomes Registry–Victoria,Medical Journal of Australia,,,Article,2016-05-02,10.5694/mja15.01041,,,,27125808,,,,,,,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7103911,https://api.altmetric.com/v1/donut/7103911_240.png 22,Active Surveillance in Prostate Cancer: How Far Should We Go?,JAMA Oncology,,,Article,2015-07-17,10.1001/jamaoncol.2015.103,,,,26181183,,,,,,,1,0,0,21,0,0,2,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/3717233,https://api.altmetric.com/v1/donut/3717233_240.png 22,Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Less Cost at the Expense of More Genitourinary Toxicity Is a Concerning But Testable Hypothesis.,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.55.2380,,,,24616317,,,,,,,2,0,0,9,0,1,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2182177,https://api.altmetric.com/v1/donut/2182177_240.png 22,A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells.,Environmental Health Perspectives,,,Article,2002-02-01,,,,,11836146,PMC1240732,,,,,,2,0,0,12,0,0,2,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/687220,https://api.altmetric.com/v1/donut/687220_240.png 22,Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml.,Archives of Internal Medicine,,,Article,2010-07-26,10.1001/archinternmed.2010.221,,,,20660846,,,,,,,1,2,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/448180,https://api.altmetric.com/v1/donut/448180_240.png 22,"Researcher, Two Universities Sued Over Validity of Prostate Cancer Test",Science,,,Article,2009-09-18,10.1126/science.325_1484,,,,19762612,,,,,,,0,5,0,1,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/547490,https://api.altmetric.com/v1/donut/547490_240.png 22,Dose-Escalated Radiotherapy for Prostate Cancer: Is the Sky the Limit?,JAMA Oncology,,,Article,2015-07-16,10.1001/jamaoncol.2015.2419,,,,26181340,,,,,,,1,1,0,20,0,0,4,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4289637,https://api.altmetric.com/v1/donut/4289637_240.png 22,Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection,Retrovirology: Research & Treatment,,,Article,2011-01-01,10.1186/1742-4690-8-13,,,,21352548,PMC3050814,,,,,,0,2,0,3,0,0,2,2,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/108311,https://api.altmetric.com/v1/donut/108311_240.png 22,Survivorship and Improving Quality of Life in Men with Prostate Cancer.,European Urology,,,Article,2015-05-06,10.1016/j.eururo.2015.04.023,,,,25941049,,,,,,,0,1,0,22,0,0,5,0,1,0,0,0,0,0,0,36,https://www.altmetric.com/details/3962422,https://api.altmetric.com/v1/donut/3962422_240.png 22,Omega-3 Fatty Acids and Other FFA4 Agonists Inhibit Growth Factor Signaling in Human Prostate Cancer Cells,The Journal of Pharmacology and Experimental Therapeutics,,,Article,2014-12-09,10.1124/jpet.114.218974,,,,25491146,,,,,,,1,1,0,11,0,0,10,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2980282,https://api.altmetric.com/v1/donut/2980282_240.png 22,Testosterone Therapy in Men With Prostate Cancer,European Urology,,,Article,2015-12-22,10.1016/j.eururo.2015.12.005,,,,26719015,,,,,,,0,0,0,38,0,0,7,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/4907771,https://api.altmetric.com/v1/donut/4907771_240.png 22,Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-05-03,10.1016/j.eururo.2016.03.049,,,,27117751,,,,,,,1,1,0,8,0,0,0,0,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/7298590,https://api.altmetric.com/v1/donut/7298590_240.png 22,Smoking and prostate cancer survival and recurrence.,JAMA: Journal of the American Medical Association,,,Article,2011-06-22,10.1001/jama.2011.879,,,,21693743,,,,,,,1,0,0,12,0,0,6,0,0,0,0,0,2,0,0,46,https://www.altmetric.com/details/175056,https://api.altmetric.com/v1/donut/175056_240.png 22,Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study,JNCI: Journal of the National Cancer Institute,,,Article,2004-01-01,10.1093/jnci/djh259,,,,15367568,,,,,,,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/1789955,https://api.altmetric.com/v1/donut/1789955_240.png 22,"EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013.",European Urology,,,Article,2013-10-06,10.1016/j.eururo.2013.09.046,,,,24207135,,,,,,,1,1,0,9,0,0,0,0,1,0,0,0,0,0,0,59,https://www.altmetric.com/details/1899435,https://api.altmetric.com/v1/donut/1899435_240.png 22,Decline in prostate cancer screening by primary care physicians: an analysis of trends in the use of digital rectal examination and prostate specific antigen testing,The Journal of Urology,,,Article,2016-04-05,10.1016/j.juro.2016.03.171,,,,27060052,,,,,,,2,0,0,13,0,0,1,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/6488635,https://api.altmetric.com/v1/donut/6488635_240.png 22,"A review and meta-analysis of prospective studies of red and processed meat, meat cooking methods, heme iron, heterocyclic amines and prostate cancer",Nutrition Journal,,,Article,2015-12-21,10.1186/s12937-015-0111-3,,,,26689289,PMC4687294,,,,,,0,1,0,19,0,0,1,0,0,0,0,0,0,0,1,13,https://www.altmetric.com/details/4906332,https://api.altmetric.com/v1/donut/4906332_240.png 22,Baseline Selenium and Prostate Cancer Risk: Comments and Open Questions.,JNCI: Journal of the National Cancer Institute,,,Article,2014-03-01,10.1093/jnci/dju005,,,,24563520,,,,,,,2,0,0,4,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2139987,https://api.altmetric.com/v1/donut/2139987_240.png 22,Prostate cancer overdiagnosis and overtreatment.,"Current Opinion in Endocrinology, Diabetes and Obesity",,,Article,2013-06-01,10.1097/med.0b013e328360332a,,,,23609043,,,,,,,2,0,0,6,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/1416053,https://api.altmetric.com/v1/donut/1416053_240.png 22,Frequency of Ejaculation and Risk of Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2004-07-21,10.1001/jama.292.3.329-a,,,,15265846,,,,,,,2,0,0,1,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1012586,https://api.altmetric.com/v1/donut/1012586_240.png 22,Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement,Annals of Internal Medicine,,,Article,,10.1059/0003-4819-157-2-201207170-00464,,,,22615452,,,,,,,0,2,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/754544,https://api.altmetric.com/v1/donut/754544_240.png 22,What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation,Annals of Internal Medicine,,,Article,2012-01-01,10.7326/0003-4819-157-2-201207170-00463,,,,22801676,,,,,,,1,1,0,6,0,0,4,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/849482,https://api.altmetric.com/v1/donut/849482_240.png 22,Association of body mass index and prostate cancer mortality,Obesity Research & Clinical Practice,,,Article,2013-08-01,10.1016/j.orcp.2013.06.002,,,,25091359,,,,,,,2,0,0,6,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1868941,https://api.altmetric.com/v1/donut/1868941_240.png 22,Active surveillance for early-stage prostate cancer,The Lancet (British Edition),,,Article,2014-01-18,10.1016/s0140-6736(14)60058-1,,,,24439724,,,,,,,0,0,0,38,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2049611,https://api.altmetric.com/v1/donut/2049611_240.png 22,Exercise therapy for sexual dysfunction after prostate cancer,Nature Reviews Urology,,,Article,2013-10-08,10.1038/nrurol.2013.206,,,,24100515,,,,,,,2,0,0,12,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1812916,https://api.altmetric.com/v1/donut/1812916_240.png 22,Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer,British Journal of Cancer,,,Article,2009-12-11,10.1038/sj.bjc.6605481,,,,19997104,PMC2816655,,,,,,0,3,0,1,0,0,6,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/958183,https://api.altmetric.com/v1/donut/958183_240.png 22,"Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.",Lancet Oncology,,,Article,2015-12-01,10.1016/s1470-2045(15)00489-1,,,,26718929,,,,,,,1,0,0,24,0,0,2,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/4906302,https://api.altmetric.com/v1/donut/4906302_240.png 22,Genomic Predictors of Outcome in Prostate Cancer ,European Urology,,,Article,2015-04-29,10.1016/j.eururo.2015.04.008,,,,25913390,,,,,,,0,0,0,36,0,0,2,0,1,0,0,0,0,0,0,82,https://www.altmetric.com/details/3940310,https://api.altmetric.com/v1/donut/3940310_240.png 22,"Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer",The Journal of Urology,,,Article,2015-01-08,10.1016/j.juro.2015.02.015,,,,25681290,,,,,,,2,0,0,8,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3528650,https://api.altmetric.com/v1/donut/3528650_240.png 22,Influence of a genomic classifier on postoperative treatment decisions in high-risk prostate cancer patients: Results from the PRO-ACT study.,Current Medical Research & Opinion,,,Article,2014-05-09,10.1185/03007995.2014.919908,,,,24803160,,,,,,,3,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2350904,https://api.altmetric.com/v1/donut/2350904_240.png 22,Impact of Prostate Cancer on Sexual Relationships: A Longitudinal Perspective on Intimate Partners' Experiences,Journal of Sexual Medicine,,,Article,2013-01-01,10.1111/jsm.12295,,,,24118980,,,,,,,0,1,0,18,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1798084,https://api.altmetric.com/v1/donut/1798084_240.png 22,Variation in prostate cancer care.,JAMA: Journal of the American Medical Association,,,Article,2015-05-27,10.1001/jama.2015.0607,,,,26010635,,,,,,,0,0,0,33,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4060054,https://api.altmetric.com/v1/donut/4060054_240.png 22,Management of Prostate Cancer in Older Patients. Educational resources for oncology professionals,ecancer.org,,,Article,,,,,http://ecancer.org/education/module/167-management-of-prostate-cancer-in-older-patients.php,,,,,,,,0,0,0,63,0,0,2,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/3972524,https://api.altmetric.com/v1/donut/3972524_240.png 22,"Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway)",Cancer Causes and Control,,,Article,2004-03-15,10.1023/b:caco.0000019494.34403.09,,,,15017127,,,,,,,1,2,0,0,0,0,0,0,1,0,0,0,0,0,0,35,https://www.altmetric.com/details/5524097,https://api.altmetric.com/v1/donut/5524097_240.png 22,NICE guidance on radium–223 dichloride for hormone–relapsed prostate cancer with bone metastases,Lancet Oncology,,,Article,2016-01-01,10.1016/s1470-2045(16)00060-7,,,,26827242,,,,,,,3,0,0,23,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5049738,https://api.altmetric.com/v1/donut/5049738_240.png 22,"Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer",Journal of Nuclear Medicine,,,Article,2015-09-26,10.2967/jnumed.115.162610,,,,26405167,,,,,,,2,0,0,5,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4555973,https://api.altmetric.com/v1/donut/4555973_240.png 22,Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djr514,,,,22232132,,,,,,,2,0,0,10,0,0,2,1,0,0,0,0,1,0,0,62,https://www.altmetric.com/details/646371,https://api.altmetric.com/v1/donut/646371_240.png 22,A population-based study of progression to metastatic prostate cancer in Australia.,Cancer Epidemiology,,,Article,2015-05-20,10.1016/j.canep.2015.04.013,,,,25983117,,,,,,,2,0,0,9,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3997888,https://api.altmetric.com/v1/donut/3997888_240.png 22,Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer,Frontiers in Pharmacology,,,Article,2013-01-01,10.3389/fphar.2013.00080,,,,23805102,,,,,,,0,0,0,17,0,0,26,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/1538225,https://api.altmetric.com/v1/donut/1538225_240.png 21,Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone,Endocrine-Related Cancer,,,Article,2014-06-01,10.1530/erc-14-0071,,,,24741024,,,,,,,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5377249,https://api.altmetric.com/v1/donut/5377249_240.png 21,Degarelix: A gonadotropin-releasing hormone antagonist for the management of prostate cancer,Clinical Therapeutics,,,Article,2009-01-01,10.1016/j.clinthera.2009.11.009,,,,20110043,,,,,,,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2839520,https://api.altmetric.com/v1/donut/2839520_240.png 21,Shared common variants in prostate cancer and blood lipids.,International Journal of Epidemiology,,,Article,2014-04-30,10.1093/ije/dyu090,,,,24786909,,,,,,,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2322933,https://api.altmetric.com/v1/donut/2322933_240.png 21,Lack of association between COX-2 staining level and biochemical recurrence following salvage radiation therapy for recurrent prostate cancer,Journal of Radiation Oncology,,,Article,2013-04-03,10.1007/s13566-013-0099-2,,,,24073305,PMC3780452,,,,,,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1781071,https://api.altmetric.com/v1/donut/1781071_240.png 21,"Diet Dairy Products, Calcium, and Vitamin D and Risk of Prostate Cancer",Epidemiologic Reviews,,,Article,2001-01-01,,,,,11588859,,,,,,,2,0,0,3,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1577508,https://api.altmetric.com/v1/donut/1577508_240.png 21,The Role of Radical Prostatectomy and Lymph Node Dissection in Lymph Node–Positive Prostate Cancer: A Systematic Review of the Literature,European Urology,,,Article,2013-06-07,10.1016/j.eururo.2013.05.033,,,,23735200,,,,,,,0,0,0,32,0,0,4,0,1,0,0,0,0,0,0,32,https://www.altmetric.com/details/1560697,https://api.altmetric.com/v1/donut/1560697_240.png 21,Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients,Retrovirology: Research & Treatment,,,Article,2009-01-01,10.1186/1742-4690-6-92,,,,19835577,,,,,,,0,3,0,0,0,0,0,2,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/413966,https://api.altmetric.com/v1/donut/413966_240.png 21,SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.,Journal of Clinical Oncology,,,Article,2015-04-08,10.1200/jco.2014.59.4127,,,,25847934,,,,,,,1,0,0,22,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3884018,https://api.altmetric.com/v1/donut/3884018_240.png 21,"Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.",Lancet Oncology,,,Article,2014-08-13,10.1016/s1470-2045(14)70328-6,,,,25130995,,,,,,,2,0,0,10,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2600284,https://api.altmetric.com/v1/donut/2600284_240.png 21,A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2012-06-12,10.1038/pcan.2012.20,,,,22689129,,,,,,,0,3,0,5,0,0,8,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/787794,https://api.altmetric.com/v1/donut/787794_240.png 21,Detailed Quantification of High-grade Cancer Allows Precise Prediction of Prostate Cancer Prognosis.,European Urology,,,Article,2015-10-04,10.1016/j.eururo.2015.09.016,,,,26443431,,,,,,,1,0,0,25,0,0,1,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/4590830,https://api.altmetric.com/v1/donut/4590830_240.png 21,Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies,Nucleic Acids Research,,,Article,2015-04-25,10.1093/nar/gkv262,,,,25908785,,,,,,,2,0,0,10,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3937531,https://api.altmetric.com/v1/donut/3937531_240.png 21,"The REDUCE Follow-Up Study: Low Rate of New Prostate Cancer Diagnoses Observed During a 2-Year, Observational, Followup Study of Men Who Participated in the REDUCE Trial",The Journal of Urology,,,Article,2012-09-26,10.1016/j.juro.2012.09.099,,,,23021996,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1202545,https://api.altmetric.com/v1/donut/1202545_240.png 21,Survival after Conservative Management Versus External Beam Radiotherapy in Elderly Patients with Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-05-01,10.1016/j.ijrobp.2016.05.004,,,,27478167,,,,,,,1,0,0,17,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7352810,https://api.altmetric.com/v1/donut/7352810_240.png 21,The effect of meeting physical activity guidelines for cancer survivors on quality of life following radical prostatectomy for prostate cancer,Journal of Cancer Survivorship,,,Article,2013-12-11,10.1007/s11764-013-0329-z,,,,24317972,,,,,,,1,0,0,11,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2051518,https://api.altmetric.com/v1/donut/2051518_240.png 21,Predicting the future of advanced prostate cancer,Lancet Oncology,,,Article,2012-11-01,10.1016/s1470-2045(12)70398-4,,,,23059048,,,,,,,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1032286,https://api.altmetric.com/v1/donut/1032286_240.png 21,More US men with low risk prostate cancer opt for watchful waiting,British Medical Journal,,,Article,2015-07-10,10.1136/bmj.h3777,,,,26163150,,,,,,,1,0,0,20,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4261518,https://api.altmetric.com/v1/donut/4261518_240.png 21,"Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial",Lancet Oncology,,,Article,2015-03-02,10.1016/s1470-2045(15)70025-2,,,,25743937,,,,,,,1,0,0,18,0,0,3,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3748869,https://api.altmetric.com/v1/donut/3748869_240.png 21,Video?based educational tool improves patient comprehension of common prostate health terminology,Cancer (0008543X),,,Article,2014-11-12,10.1002/cncr.29101,,,,25393416,,,,,,,2,0,0,6,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2883669,https://api.altmetric.com/v1/donut/2883669_240.png 21,Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location,European Urology,,,Article,2015-10-04,10.1016/j.eururo.2015.09.031,,,,26443432,,,,,,,0,0,0,44,0,0,6,0,2,0,0,0,0,0,0,10,https://www.altmetric.com/details/4598310,https://api.altmetric.com/v1/donut/4598310_240.png 21,Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-07-20,10.1016/j.ijrobp.2014.04.052,,,,25035207,,,,,,,2,0,0,6,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2611807,https://api.altmetric.com/v1/donut/2611807_240.png 21,Prostate Cancer and the Therapeutic Benefits of Structured Exercise.,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.53.4289,,,,24344219,,,,,,,2,0,0,7,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1986871,https://api.altmetric.com/v1/donut/1986871_240.png 21,"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.",The Lancet,,,Article,2011-03-05,10.1016/s0140-6736(10)62344-6,,,,21353695,PMC3090685,,,,,,1,1,1,3,0,0,0,0,0,0,0,0,3,0,0,80,https://www.altmetric.com/details/236300,https://api.altmetric.com/v1/donut/236300_240.png 21,"Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop",Urology,,,Article,2015-12-02,10.1016/j.urology.2015.11.018,,,,26621480,,,,,,,0,0,0,41,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4804586,https://api.altmetric.com/v1/donut/4804586_240.png 21,Prostate Cancer: A New Twist on Active Surveillance,JNCI: Journal of the National Cancer Institute,,,Article,2016-05-01,10.1093/jnci/djw136,,,,27130917,,,,,,,0,0,0,38,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7069696,https://api.altmetric.com/v1/donut/7069696_240.png 21,A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy,European Urology,,,Article,2014-11-12,10.1016/j.eururo.2014.10.036,,,,25466945,,,,,,,1,0,0,30,0,0,3,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/2882817,https://api.altmetric.com/v1/donut/2882817_240.png 21,"Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.",Nature Genetics,,,Article,2007-07-01,10.1038/ng2062,,,,17603485,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,148,https://www.altmetric.com/details/124547,https://api.altmetric.com/v1/donut/124547_240.png 21,Reaction-based fluorescent sensor for investigating mobile Zn2+ in mitochondria of healthy versus cancerous prostate cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-12-12,10.1073/pnas.1310583110,,,,24335702,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,1,0,0,63,https://www.altmetric.com/details/1977501,https://api.altmetric.com/v1/donut/1977501_240.png 21,"A Systems Genetics Approach Identifies CXCL14, ITGAX, and LPCAT2 as Novel Aggressive Prostate Cancer Susceptibility Genes.",PLoS Genetics,,,Article,2014-11-20,10.1371/journal.pgen.1004809,,,,25411967,,,,,,,1,1,0,6,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2920140,https://api.altmetric.com/v1/donut/2920140_240.png 21,Prospective study on metabolic factors and risk of prostate cancer,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.27677,,,,23090855,,,,,,,0,1,1,16,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1015384,https://api.altmetric.com/v1/donut/1015384_240.png 21,"Key considerations for the experimental training and evaluation of cancer odour detection dogs: lessons learnt from a double-blind, controlled trial of prostate cancer detection.",BMC Urology,,,Article,2014-02-27,10.1186/1471-2490-14-22,,,,24575737,,,,,,,2,0,0,6,0,0,2,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2152539,https://api.altmetric.com/v1/donut/2152539_240.png 21,Ericifolin: a novel antitumor compound from allspice that silences androgen receptor in prostate cancer,Carcinogenesis,,,Article,2013-08-14,10.1093/carcin/bgt123,,,,23568956,,,,,,,2,0,0,7,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1418996,https://api.altmetric.com/v1/donut/1418996_240.png 21,First-in-Man Evaluation of Two High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer.,Journal of Nuclear Medicine,,,Article,2013-01-09,10.2967/jnumed.112.111203,,,,23303962,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1169948,https://api.altmetric.com/v1/donut/1169948_240.png 21,A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer,Nutrition Journal,,,Article,2011-12-13,10.1186/1475-2891-9-50,,,,21044319,PMC2987772,,,,,,1,0,0,3,0,0,2,1,0,0,0,0,0,1,0,57,https://www.altmetric.com/details/491547,https://api.altmetric.com/v1/donut/491547_240.png 21,Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial,Lancet Oncology,,,Article,2011-08-09,10.1016/s1470-2045(11)70162-0,,,,21821474,,,,,,,0,0,1,18,0,0,0,1,0,0,0,0,2,0,0,78,https://www.altmetric.com/details/206843,https://api.altmetric.com/v1/donut/206843_240.png 21,Medium-term Outcomes of Active Surveillance for Localised Prostate Cancer.,European Urology,,,Article,2013-03-12,10.1016/j.eururo.2013.02.020,,,,23473579,,,,,,,0,2,1,6,0,0,0,0,0,0,0,0,1,0,0,34,https://www.altmetric.com/details/1328184,https://api.altmetric.com/v1/donut/1328184_240.png 21,Screening for prostate cancer: an updated Cochrane systematic review,British Journal of Urology,,,Article,2011-03-01,10.1111/j.1464-410x.2010.10032.x,,,,21392207,,,,,,,0,3,1,4,0,0,1,0,0,0,0,0,0,0,0,80,https://www.altmetric.com/details/215847,https://api.altmetric.com/v1/donut/215847_240.png 21,"Effect of Age, Tumor Risk, and Comorbidity on Prostate Cancer Survival",Annals of Internal Medicine,,,Article,,10.7326/0003-4819-158-10-201305210-00001,,,,,,,,,,,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1495692,https://api.altmetric.com/v1/donut/1495692_240.png 21,Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.,European Urology,,,Article,2014-01-15,10.1016/j.eururo.2014.01.003,,,,24484606,,,,,,,0,1,0,20,0,0,0,0,0,0,0,0,1,0,0,80,https://www.altmetric.com/details/2047695,https://api.altmetric.com/v1/donut/2047695_240.png 21,Increased risk of high?grade prostate cancer among infertile men,Cancer (0008543X),,,Article,2010-01-05,10.1002/cncr.25075,,,,20309846,,,,,,,1,1,0,2,0,0,1,0,0,0,0,0,1,0,0,18,https://www.altmetric.com/details/542299,https://api.altmetric.com/v1/donut/542299_240.png 20,Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer,Nature Communications,,,Article,2016-05-19,10.1038/ncomms11612,,,,27194471,,,,,,,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8075622,https://api.altmetric.com/v1/donut/8075622_240.png 20,"Radiation Therapy after Radical Prostatectomy for Prostate Cancer: Evaluation of Complications and Influence of Radiation Timing on Outcomes in a Large, Population-Based Cohort",PLoS ONE,,,Article,2015-02-23,10.1371/journal.pone.0118430,,,,25706657,,,,,,,2,0,0,5,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3721066,https://api.altmetric.com/v1/donut/3721066_240.png 20,The E-cadherin (CDH1) |[minus]|160 C|[sol]|A polymorphism and prostate cancer risk: a meta-analysis,European Journal of Human Genetics,,,Article,2008-09-10,10.1038/ejhg.2008.157,,,,18781193,PMC2986056,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2994608,https://api.altmetric.com/v1/donut/2994608_240.png 20,Vasectomy and Prostate Cancer,Reviews in Urology,,,Article,,,,,,16985574,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2513675,https://api.altmetric.com/v1/donut/2513675_240.png 20,Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization,Endocrine-Related Cancer,,,Article,2012-09-22,10.1530/erc-12-0171,,,,22993077,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,8,https://www.altmetric.com/details/1255792,https://api.altmetric.com/v1/donut/1255792_240.png 20,Type 10 Soluble Adenylyl Cyclase Is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2012-12-19,10.1074/jbc.m112.403279,,,,23255611,,,,,,,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1222427,https://api.altmetric.com/v1/donut/1222427_240.png 20,Enzalutamide--a major advance in the treatment of metastatic prostate cancer.,New England Journal of Medicine,,,Article,2012-09-27,10.1056/nejme1209041,,,,23013078,,,,,,,0,1,0,9,0,0,2,2,0,1,0,0,0,0,0,39,https://www.altmetric.com/details/967641,https://api.altmetric.com/v1/donut/967641_240.png 20,Active Surveillance for Prostate Cancer: A Systematic Review of the Literature.,European Urology,,,Article,2012-06-17,10.1016/j.eururo.2012.05.072,,,,22698574,,,,,,,1,0,3,1,0,0,0,1,0,0,0,0,1,0,0,52,https://www.altmetric.com/details/897897,https://api.altmetric.com/v1/donut/897897_240.png 20,Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer,Cancer Research,,,Article,2015-03-15,10.1158/0008-5472.can-14-1596,,,,25770290,,,,,,,2,1,0,4,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3790328,https://api.altmetric.com/v1/donut/3790328_240.png 20,Preliminary Results of a Randomised Controlled Trial of an Online Psychological Intervention to Reduce Distress in Men Treated for Localised Prostate Cancer.,European Urology,,,Article,2014-10-28,10.1016/j.eururo.2014.10.024,,,,25454611,,,,,,,0,0,0,44,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2815052,https://api.altmetric.com/v1/donut/2815052_240.png 20,Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial,Lancet Oncology,,,Article,2015-06-02,10.1016/s1470-2045(15)00011-x,,,,26028518,,,,,,,1,0,0,18,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/4071619,https://api.altmetric.com/v1/donut/4071619_240.png 20,Physical activity and its mechanistic effects on prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-03-24,10.1038/pcan.2015.9,,,,25800589,,,,,,,1,0,0,21,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3831179,https://api.altmetric.com/v1/donut/3831179_240.png 20,Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.,Urology,,,Article,2006-01-02,10.1016/j.urology.2005.08.040,,,,16442597,,,,,,,1,0,0,21,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1467959,https://api.altmetric.com/v1/donut/1467959_240.png 20,Active Surveillance for Patients with Low-Risk Localized Prostate Cancer,Journal Watch,,,Article,2016-07-07,10.1056/nejm-jw.na41711,,,,,,,,,,,0,0,0,34,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9353550,https://api.altmetric.com/v1/donut/9353550_240.png 20,"Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system",Prostate Cancer & Prostatic Diseases,,,Article,2015-01-13,10.1038/pcan.2014.51,,,,25582624,,,,,,,1,0,0,20,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3062022,https://api.altmetric.com/v1/donut/3062022_240.png 20,National Trends in the Management of Low and Intermediate Risk Prostate Cancer in the United States,The Journal of Urology,,,Article,2014-08-04,10.1016/j.juro.2014.07.111,,,,25106900,,,,,,,1,1,0,9,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2580866,https://api.altmetric.com/v1/donut/2580866_240.png 20,American Cancer Society questions study claiming increase in metastatic prostate cancer,British Medical Journal,,,Article,2016-07-25,10.1136/bmj.i4125,,,,27455848,,,,,,,1,0,0,23,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10024971,https://api.altmetric.com/v1/donut/10024971_240.png 20,The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer,European Urology,,,Article,2015-11-11,10.1016/j.eururo.2015.10.042,,,,26572708,,,,,,,0,0,0,58,0,0,5,0,4,0,0,0,0,0,0,12,https://www.altmetric.com/details/4748137,https://api.altmetric.com/v1/donut/4748137_240.png 20,The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer,European Urology,,,Article,2015-07-08,10.1016/j.eururo.2015.06.016,,,,26144873,,,,,,,2,0,0,8,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4256440,https://api.altmetric.com/v1/donut/4256440_240.png 20,The Melbourne Consensus Statement on the early detection of prostate cancer,British Journal of Urology,,,Article,2014-02-01,10.1111/bju.12556,,,,24206066,,,,,,,1,5,0,7,0,0,0,0,1,0,0,0,0,0,1,17,https://www.altmetric.com/details/2040077,https://api.altmetric.com/v1/donut/2040077_240.png 20,Barriers to Prostate Cancer Care: Affordable Care is Not Enough,Qualitative Health Research,,,Article,2012-11-30,10.1177/1049732312467852,,,,23202482,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1102287,https://api.altmetric.com/v1/donut/1102287_240.png 20,Decision-Making Process Reported by Medicare Patients Who Had Coronary Artery Stenting or Surgery for Prostate Cancer,JGIM: Journal of General Internal Medicine,,,Article,2012-02-28,10.1007/s11606-012-2009-5,,,,22370767,,,,,,,0,1,0,13,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/631461,https://api.altmetric.com/v1/donut/631461_240.png 20,Multiple newly identified loci associated with prostate cancer susceptibility.,Nature Genetics,,,Article,2008-02-10,10.1038/ng.90,,,,18264097,,,,,,,0,3,0,1,0,0,0,2,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/114986,https://api.altmetric.com/v1/donut/114986_240.png 20,Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis.,European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.07.029,,,,26215604,,,,,,,1,0,0,16,0,0,1,0,1,0,0,0,1,0,0,33,https://www.altmetric.com/details/4579308,https://api.altmetric.com/v1/donut/4579308_240.png 20,Androgen deprivation treatment in prostate cancer.,British Medical Journal,,,Article,2013-01-09,10.1136/bmj.e8555,,,,23303885,,,,,,,0,1,0,18,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1167150,https://api.altmetric.com/v1/donut/1167150_240.png 20,Caffeic Acid Phenethyl Ester Suppresses the Proliferation of Human Prostate Cancer Cells through Inhibition of p70S6K and Akt Signaling Networks,Cancer Prevention Research,,,Article,2012-01-01,10.1158/1940-6207.capr-12-0004-t,,,,22562408,,,,,,,0,1,0,12,0,0,5,0,1,0,0,0,0,0,0,13,https://www.altmetric.com/details/728487,https://api.altmetric.com/v1/donut/728487_240.png 20,Activation of an olfactory receptor inhibits proliferation of prostate cancer cells.,Journal of Biological Chemistry,,,Article,2009-04-25,10.1074/jbc.m109.012096,,,,19389702,PMC2713531,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2771211,https://api.altmetric.com/v1/donut/2771211_240.png 20,STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression,American Journal of Pathology,,,Article,2013-05-09,10.1016/j.ajpath.2013.02.044,,,,23660011,,,,,,,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1461040,https://api.altmetric.com/v1/donut/1461040_240.png 20,B4 androgen ablation: attacking the prostate cancer stem cell.,Journal of Clinical Investigation,,,Article,2013-01-01,10.1172/jci67460,,,,23348735,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1200946,https://api.altmetric.com/v1/donut/1200946_240.png 20,"Silibinin inhibits prostate cancer cellsâ?? and RANKLâ??induced osteoclastogenesis by targeting NFATc1, NFâ??B, and APâ??1 Activation in RAW264.7 cells",Molecular Carcinogenesis,,,Article,2012-10-31,10.1002/mc.21959,,,,23115104,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1036379,https://api.altmetric.com/v1/donut/1036379_240.png 20,25 year disease free survival rate after irradiation of prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy,The Journal of Urology,,,Article,2012-10-25,10.1016/j.juro.2012.10.061,,,,23103235,,,,,,,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1022745,https://api.altmetric.com/v1/donut/1022745_240.png 20,Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification,European Urology,,,Article,2014-10-31,10.1016/j.eururo.2014.10.010,,,,25457014,,,,,,,0,0,0,32,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/2829881,https://api.altmetric.com/v1/donut/2829881_240.png 20,A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men,EBioMedicine,,,Article,2016-02-05,10.1016/j.ebiom.2015.10.028,,,,26844274,PMC4703707,,,,,,1,1,0,22,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4708179,https://api.altmetric.com/v1/donut/4708179_240.png 20,Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis,BMJ Open,,,Article,2014-05-01,10.1136/bmjopen-2013-004285,,,,24833678,,,,,,,1,1,0,4,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2406127,https://api.altmetric.com/v1/donut/2406127_240.png 20,Allium Vegetables and Risk of Prostate Cancer: A Population-Based Study,JNCI: Journal of the National Cancer Institute,,,Article,2002-01-01,10.1093/jnci/94.21.1648,,,,12419792,,,,,,,1,2,0,0,0,0,1,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/2288988,https://api.altmetric.com/v1/donut/2288988_240.png 20,Limitations of Basing Screening Policies on Screening Trials: The US Preventive Services Task Force and Prostate Cancer Screening.,Medical care,,,Article,2012-12-23,10.1097/mlr.0b013e31827da979,,,,23269114,,,,,,,0,1,1,16,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1145931,https://api.altmetric.com/v1/donut/1145931_240.png 20,Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis,European Urology,,,Article,2015-09-26,10.1016/j.eururo.2015.09.013,,,,26422676,,,,,,,0,0,0,33,0,0,3,0,1,0,0,0,0,0,0,25,https://www.altmetric.com/details/4555252,https://api.altmetric.com/v1/donut/4555252_240.png 20,Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition,American Journal of Clinical Nutrition,,,Article,2012-01-01,10.3945/ajcn.112.034157,,,,23134890,,,,,,,1,0,0,10,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1104866,https://api.altmetric.com/v1/donut/1104866_240.png 20,Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer,Oncotarget,,,Article,2016-07-12,10.18632/oncotarget.10547,,,,27429197,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9668889,https://api.altmetric.com/v1/donut/9668889_240.png 20,Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer,JAMA Oncology,,,Article,2016-01-07,10.1001/jamaoncol.2015.4955,,,,26746117,,,,,,,1,0,0,29,0,0,5,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4966655,https://api.altmetric.com/v1/donut/4966655_240.png 20,Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-04-04,10.1073/pnas.1304502110,,,,23559371,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1339715,https://api.altmetric.com/v1/donut/1339715_240.png 20,Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302),European Urology,,,Article,2014-03-27,10.1016/j.eururo.2014.02.056,,,,24647231,,,,,,,0,3,0,12,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/2165727,https://api.altmetric.com/v1/donut/2165727_240.png 20,DNA Repair in Prostate Cancer: Biology and Clinical Implications,European Urology,,,Article,2016-08-31,10.1016/j.eururo.2016.08.037,,,,27590317,,,,,,,1,0,0,14,0,0,3,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/10919064,https://api.altmetric.com/v1/donut/10919064_240.png 20,Current use of PSMA-PET in prostate cancer management,Nature Reviews Urology,,,Article,2016-02-23,10.1038/nrurol.2016.26,,,,26902337,,,,,,,1,0,0,20,0,0,8,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5981229,https://api.altmetric.com/v1/donut/5981229_240.png 20,"Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",Annals of Oncology,,,Article,2015-07-25,10.1093/annonc/mdv222,,,,26205393,,,,,,,1,0,0,18,0,0,1,0,0,0,0,0,0,0,0,76,https://www.altmetric.com/details/4309901,https://api.altmetric.com/v1/donut/4309901_240.png 20,"Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial",Lancet Oncology,,,Article,2014-05-12,10.1016/s1470-2045(14)70183-4,,,,24836273,,,,,,,1,0,0,16,0,0,1,0,0,0,0,0,0,0,0,75,https://www.altmetric.com/details/2348886,https://api.altmetric.com/v1/donut/2348886_240.png 20,Physical Activity after Diagnosis and Risk of Prostate Cancer Progression: Data from the Cancer of the Prostate Strategic Urologic Research Endeavor,Cancer Research,,,Article,2011-05-24,10.1158/0008-5472.can-10-3932,,,,21610110,PMC3107352,,,,,,1,0,0,9,0,0,2,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/186416,https://api.altmetric.com/v1/donut/186416_240.png 20,Evolution of androgen receptor targeted therapy for advanced prostate cancer.,Nature Reviews Clinical Oncology,,,Article,2014-05-20,10.1038/nrclinonc.2014.72,,,,24840076,,,,,,,0,3,0,4,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/2374126,https://api.altmetric.com/v1/donut/2374126_240.png 20,Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates,Journal of Clinical Epidemiology,,,Article,2011-10-30,10.1016/j.jclinepi.2011.06.011,,,,22032753,,,,,,,1,1,0,3,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/764390,https://api.altmetric.com/v1/donut/764390_240.png 20,GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.,The Journal of Urology,,,Article,2014-04-21,10.1016/j.juro.2014.04.082,,,,24769028,,,,,,,2,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2313697,https://api.altmetric.com/v1/donut/2313697_240.png 19,Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011.,Medical Journal of Australia,,,Article,2013-06-05,10.5694/mja12.11241,,,,23725268,,,,,,,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1558307,https://api.altmetric.com/v1/donut/1558307_240.png 19,Chemopreventive potential of curcumin in prostate cancer.,Genes & Nutrition,,,Article,2010-03-01,10.1007/s12263-009-0152-3,,,,19806380,PMC2820199,,,,,,0,0,0,24,0,0,1,0,0,0,0,0,0,0,0,78,https://www.altmetric.com/details/676283,https://api.altmetric.com/v1/donut/676283_240.png 19,Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer,Nature Communications,,,Article,2016-06-22,10.1038/ncomms12008,,,,27328849,PMC4917969,,,,,,0,0,0,36,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/8969581,https://api.altmetric.com/v1/donut/8969581_240.png 19,Fat Intake Is Not Linked to Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis,PLoS ONE,,,Article,2015-07-17,10.1371/journal.pone.0131747,,,,26186528,,,,,,,0,0,0,32,0,0,2,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/4289087,https://api.altmetric.com/v1/donut/4289087_240.png 19,"Unemployment and prostate cancer mortality in the OECD, 1990–2009",ecancer.org,,,Article,,,,,http://ecancer.org/journal/9/full/538-unemployment-and-prostate-cancer-mortality-in-the-oecd-1990-2009.php,,,,,,,,1,1,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3996803,https://api.altmetric.com/v1/donut/3996803_240.png 19,Metformin and prostate cancer stem cells: a novel therapeutic target,Prostate Cancer & Prostatic Diseases,,,Article,2015-07-28,10.1038/pcan.2015.35,,,,26215782,,,,,,,1,0,0,15,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4338574,https://api.altmetric.com/v1/donut/4338574_240.png 19,Oncologic and functional outcomes one year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial,British Journal of Urology,,,Article,2016-02-01,10.1111/bju.13444,,,,26867018,,,,,,,1,5,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5627849,https://api.altmetric.com/v1/donut/5627849_240.png 19,Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer.,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.12.019,,,,24411988,,,,,,,0,2,0,2,1,0,0,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/2124830,https://api.altmetric.com/v1/donut/2124830_240.png 19,PARP inhibitor recognised as FDA breakthrough therapy in castration resistant prostate cancer: beyond germline BRCA mutations,Annals of Oncology,,,Article,2016-02-13,10.1093/annonc/mdw048,,,,26865580,,,,,,,0,0,0,39,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5530219,https://api.altmetric.com/v1/donut/5530219_240.png 19,The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in Perspective,Journal of Clinical Medicine Research,,,Article,2013-08-01,10.4021/jocmr1395w,,,,23864914,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4724200,https://api.altmetric.com/v1/donut/4724200_240.png 19,Coffee consumption and prostate cancer risk: further evidence for inverse relationship,Nutrition Journal,,,Article,2012-06-13,10.1186/1475-2891-11-42,,,,22695052,,,,,,,0,0,0,21,0,0,3,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/791487,https://api.altmetric.com/v1/donut/791487_240.png 19,Role of diet in prostate cancer: the epigenetic link,Oncogene,,,Article,2014-12-22,10.1038/onc.2014.422,,,,25531313,,,,,,,0,0,0,33,0,0,22,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3009322,https://api.altmetric.com/v1/donut/3009322_240.png 19,Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11232.x,,,,22584031,,,,,,,0,1,0,14,0,0,1,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/746422,https://api.altmetric.com/v1/donut/746422_240.png 19,Beyond PSA: The Next Generation of Prostate Cancer Biomarkers,Science Translational Medicine,,,Article,2012-03-28,10.1126/scitranslmed.3003180,,,,22461644,,,,,,,0,1,0,12,0,0,0,0,0,0,0,0,0,0,0,203,https://www.altmetric.com/details/671756,https://api.altmetric.com/v1/donut/671756_240.png 19,Endocrine disruptors and prostate cancer risk.,Endocrine-Related Cancer,,,Article,2008-01-01,10.1677/erc-08-0043,,,,18524946,PMC2822396,,,,,,0,2,0,3,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/773680,https://api.altmetric.com/v1/donut/773680_240.png 19,Hypofractionation for prostate cancer: tested and proven,Lancet Oncology,,,Article,2016-06-20,10.1016/s1470-2045(16)30150-4,,,,27339117,,,,,,,0,0,0,29,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8947153,https://api.altmetric.com/v1/donut/8947153_240.png 19,EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent,Science,,,Article,2012-12-13,10.1126/science.1227604,,,,23239736,,,,,,,0,1,0,13,0,0,1,0,0,0,0,0,2,0,0,159,https://www.altmetric.com/details/1123560,https://api.altmetric.com/v1/donut/1123560_240.png 19,How Often is Biopsy Necessary in Patients with Prostate Cancer on Active Surveillance?,The Journal of Urology,,,Article,2015-10-18,10.1016/j.juro.2015.10.061,,,,26475660,,,,,,,10,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4620342,https://api.altmetric.com/v1/donut/4620342_240.png 19,Personalizing the Use of Active Surveillance As an Initial Approach for Men With Newly Diagnosed Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-09-02,10.1200/jco.2015.63.6118,,,,26324374,,,,,,,2,0,0,8,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4457812,https://api.altmetric.com/v1/donut/4457812_240.png 19,Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?,The Journal of Urology,,,Article,2015-07-21,10.1016/j.juro.2015.07.078,,,,26192258,,,,,,,10,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4289878,https://api.altmetric.com/v1/donut/4289878_240.png 19,Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?,Journal of Clinical Oncology,,,Article,2014-11-10,10.1200/jco.2013.52.8505,,,,25385735,,,,,,,1,0,0,13,0,0,2,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2873964,https://api.altmetric.com/v1/donut/2873964_240.png 19,"Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden)",Cancer Causes and Control,,,Article,1998-01-01,10.1023/a:1008823601897,,,,,,,,,,,1,2,0,0,0,0,0,0,0,0,0,0,0,0,1,12,https://www.altmetric.com/details/2313865,https://api.altmetric.com/v1/donut/2313865_240.png 19,Magnetic Resonance Imaging-targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis.,European Urology,,,Article,2014-12-02,10.1016/j.eururo.2014.11.037,,,,25480312,,,,,,,0,1,0,20,0,0,0,0,0,0,0,0,0,0,0,88,https://www.altmetric.com/details/2944747,https://api.altmetric.com/v1/donut/2944747_240.png 19,Somatic Alterations Contributing to Metastasis of a Castration Resistant Prostate Cancer,Human Mutation,,,Article,2013-01-01,10.1002/humu.22346,,,,23636849,,,,,,,0,0,0,25,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1451686,https://api.altmetric.com/v1/donut/1451686_240.png 19,Strength Training Induces Muscle Hypertrophy and Functional Gains in Black Prostate Cancer Patients Despite Androgen Deprivation Therapy,Journals of Gerontology Series A: Biological Sciences & Medical Sciences,,,Article,2012-01-01,10.1093/gerona/gls206,,,,23089339,,,,,,,0,0,0,33,0,0,2,0,0,0,0,0,0,0,1,36,https://www.altmetric.com/details/1028304,https://api.altmetric.com/v1/donut/1028304_240.png 19,PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges,Prostate Cancer & Prostatic Diseases,,,Article,2016-05-03,10.1038/pcan.2016.13,,,,27136743,,,,,,,1,0,0,17,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7147596,https://api.altmetric.com/v1/donut/7147596_240.png 19,Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen,BMC Medicine,,,Article,2014-02-11,10.1186/1741-7015-12-26,,,,24512643,PMC3922189,,,,,,1,1,0,16,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2112624,https://api.altmetric.com/v1/donut/2112624_240.png 19,Let's talk about gay sex: gay and bisexual men's sexual communication with healthcare professionals after prostate cancer,European Journal of Cancer Care,,,Article,2016-02-01,10.1111/ecc.12469,,,,26918877,,,,,,,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6056446,https://api.altmetric.com/v1/donut/6056446_240.png 19,A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer,European Urology,,,Article,2015-04-01,10.1016/j.eururo.2014.10.004,,,,25457497,,,,,,,0,0,0,78,0,0,1,0,1,0,0,0,0,0,0,24,https://www.altmetric.com/details/2780119,https://api.altmetric.com/v1/donut/2780119_240.png 19,Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2011-03-26,,,,,21434853,,,,,,,0,2,0,0,0,0,7,0,0,0,0,0,0,1,0,16,https://www.altmetric.com/details/1490525,https://api.altmetric.com/v1/donut/1490525_240.png 19,Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy,Journal of Nuclear Medicine,,,Article,2016-06-03,10.2967/jnumed.116.173492,,,,27261524,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8489003,https://api.altmetric.com/v1/donut/8489003_240.png 19,Prostate cancer: On the right path[mdash]Stat3 signalling controls the ARF-Mdm2-p53 tumour-suppressor pathway,Nature Reviews Urology,,,Article,2015-08-11,10.1038/nrurol.2015.205,,,,26260883,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4383572,https://api.altmetric.com/v1/donut/4383572_240.png 19,The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer.,Journal of Clinical Oncology,,,Article,2014-03-10,10.1200/jco.2013.54.7307,,,,24616311,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2174690,https://api.altmetric.com/v1/donut/2174690_240.png 19,"Use of 5?-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study",British Medical Journal,,,Article,2013-06-18,10.1136/bmj.f3406,,,,23778271,,,,,,,0,0,0,35,0,0,3,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1564834,https://api.altmetric.com/v1/donut/1564834_240.png 19,Nomogram Predicting Prostate Cancer–specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy,European Urology,,,Article,2014-10-05,10.1016/j.eururo.2014.09.019,,,,25301759,,,,,,,1,0,0,26,0,0,3,0,1,0,0,0,0,0,0,34,https://www.altmetric.com/details/2748071,https://api.altmetric.com/v1/donut/2748071_240.png 19,Medical Oncology Consultation and Minimization of Overtreatment in Men With Low-Risk Prostate Cancer,Journal of Oncology Practice,,,Article,,10.1200/jop.2013.000902,,,,24399853,,,,,,,1,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2028931,https://api.altmetric.com/v1/donut/2028931_240.png 19,Psychosocial interventions for men with prostate cancer,Cochrane database of systematic reviews,,,Article,2013-12-24,10.1002/14651858.cd008529.pub3,,,,24368598,,,,,,,0,0,0,40,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2010585,https://api.altmetric.com/v1/donut/2010585_240.png 19,Prevention and early detection of prostate cancer.,Lancet Oncology,,,Article,2014-10-14,10.1016/s1470-2045(14)70211-6,,,,25281467,,,,,,,1,0,0,15,0,0,1,0,0,0,0,0,0,0,0,131,https://www.altmetric.com/details/2729679,https://api.altmetric.com/v1/donut/2729679_240.png 19,The Ongoing Need for Improved Risk Stratification and Monitoring for Those on Active Surveillance for Early Stage Prostate Cancer,European Urology,,,Article,,10.1016/j.eururo.2014.02.044,,,,24636678,,,,,,,1,0,0,17,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2146960,https://api.altmetric.com/v1/donut/2146960_240.png 19,Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects.,Oncogene,,,Article,2014-05-19,10.1038/onc.2014.115,,,,24837363,,,,,,,0,3,0,2,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/2365371,https://api.altmetric.com/v1/donut/2365371_240.png 19,Prostate Cancer in the Elderly Patient.,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.55.1531,,,,25071137,,,,,,,0,1,0,19,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2550494,https://api.altmetric.com/v1/donut/2550494_240.png 19,Immunotherapy for prostate cancer: False promises or true hope?,Cancer (0008543X),,,Article,2016-09-20,10.1002/cncr.30250,,,,27649312,,,,,,,1,0,0,13,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12118969,https://api.altmetric.com/v1/donut/12118969_240.png 18,PSMA-theranostics using PET and subsequent radioguided surgery in recurrent prostate cancer,Clinical Genitourinary Cancer,,,Article,2016-05-01,10.1016/j.clgc.2016.05.020,,,,27318956,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8939822,https://api.altmetric.com/v1/donut/8939822_240.png 18,Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer,JAMA Oncology,,,Article,2015-12-23,10.1001/jamaoncol.2015.4682,,,,26720183,,,,,,,1,0,0,16,0,0,3,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4917366,https://api.altmetric.com/v1/donut/4917366_240.png 18,Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death,European Urology,,,Article,2015-09-18,10.1016/j.eururo.2015.08.054,,,,26388503,,,,,,,0,0,0,24,0,0,3,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/4526943,https://api.altmetric.com/v1/donut/4526943_240.png 18,Prostate Cancer Registries: Current Status and Future Directions,European Urology,,,Article,2015-06-10,10.1016/j.eururo.2015.05.046,,,,26056070,,,,,,,0,0,0,29,0,0,8,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/4103228,https://api.altmetric.com/v1/donut/4103228_240.png 18,Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2004-01-01,,,,,15466982,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2313867,https://api.altmetric.com/v1/donut/2313867_240.png 18,Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2008-01-01,10.1158/1055-9965.epi-08-0342,,,,18768501,PMC2566735,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/1652614,https://api.altmetric.com/v1/donut/1652614_240.png 18,Screening for prostate cancer among men 75 years of age or older.,New England Journal of Medicine,,,Article,2008-12-11,10.1056/nejmp0807209,,,,19073973,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/173870,https://api.altmetric.com/v1/donut/173870_240.png 18,Prostate cancer: Is prostatectomy for Gleason score 6 a treatment failure?,Nature Reviews Urology,,,Article,2014-12-09,10.1038/nrurol.2014.335,,,,25487050,,,,,,,1,1,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2965514,https://api.altmetric.com/v1/donut/2965514_240.png 18,Active Surveillance for Low-risk Prostate Cancer: Developments to Date,European Urology,,,Article,2015-04-01,10.1016/j.eururo.2014.11.004,,,,25435266,,,,,,,1,0,0,13,0,0,1,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/2931923,https://api.altmetric.com/v1/donut/2931923_240.png 18,"Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.",Lancet Oncology,,,Article,2014-10-17,10.1016/s1470-2045(14)70474-7,,,,,,,,,,,1,0,0,17,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2787530,https://api.altmetric.com/v1/donut/2787530_240.png 18,Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement,Annals of Internal Medicine,,,Article,2008-01-01,10.7326/0003-4819-149-3-200808050-00008,,,,,,,,,,,0,2,0,2,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1445002,https://api.altmetric.com/v1/donut/1445002_240.png 18,Prostate cancer: Changing standard of care in hormone-sensitive disease,Nature Reviews Urology,,,Article,2016-01-20,10.1038/nrurol.2016.4,,,,26787390,,,,,,,2,0,0,18,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5016868,https://api.altmetric.com/v1/donut/5016868_240.png 18,"Compliance to exercise?oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life",Psycho-Oncology,,,Article,2015-06-19,10.1002/pon.3882,,,,26087455,,,,,,,0,0,0,31,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4189200,https://api.altmetric.com/v1/donut/4189200_240.png 18,Predicting Life Expectancy in Men Diagnosed with Prostate Cancer,European Urology,,,Article,2015-03-31,10.1016/j.eururo.2015.03.020,,,,25819724,,,,,,,0,0,0,32,0,0,3,0,1,0,0,0,0,0,0,26,https://www.altmetric.com/details/3840066,https://api.altmetric.com/v1/donut/3840066_240.png 18,Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer,European Urology,,,Article,2015-03-16,10.1016/j.eururo.2015.02.042,,,,25791513,,,,,,,0,0,0,27,0,0,5,0,1,0,0,0,0,0,0,22,https://www.altmetric.com/details/3796980,https://api.altmetric.com/v1/donut/3796980_240.png 18,Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices.,International Journal of Cancer,,,Article,2002-03-10,,,,,11857417,,,,,,,0,1,0,9,0,0,11,0,0,0,0,0,0,0,1,29,https://www.altmetric.com/details/1021223,https://api.altmetric.com/v1/donut/1021223_240.png 18,"Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010",BMC Medicine,,,Article,2015-07-30,10.1186/s12916-015-0405-5,,,,26224061,,,,,,,1,1,0,7,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4350215,https://api.altmetric.com/v1/donut/4350215_240.png 18,"Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition",British Journal of Cancer,,,Article,2008-04-01,10.1038/sj.bjc.6604331,,,,18382426,,,,,,,0,1,0,10,0,0,14,0,0,0,0,0,0,0,1,56,https://www.altmetric.com/details/1223173,https://api.altmetric.com/v1/donut/1223173_240.png 18,Investigating prostate cancer tumour|[ndash]|stroma interactions: clinical and biological insights from an evolutionary game,British Journal of Cancer,,,Article,2011-12-01,10.1038/bjc.2011.517,,,,22134510,,,,,,,0,4,0,25,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/701391,https://api.altmetric.com/v1/donut/701391_240.png 18,Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin,European Urology,,,Article,2015-03-26,10.1016/j.eururo.2015.03.026,,,,25819720,,,,,,,0,0,0,123,0,0,3,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/3881815,https://api.altmetric.com/v1/donut/3881815_240.png 18,Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis,Cancer Epidemiology,,,Article,2014-07-07,10.1016/j.canep.2014.06.002,,,,24986642,,,,,,,0,1,0,10,0,0,0,9,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2498943,https://api.altmetric.com/v1/donut/2498943_240.png 18,"Diet, Supplement Use, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial",American Journal of Epidemiology,,,Article,2010-01-01,10.1093/aje/kwq148,,,,20693267,PMC2950820,,,,,,1,1,0,0,0,0,1,1,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/1205552,https://api.altmetric.com/v1/donut/1205552_240.png 18,Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer,Gene Therapy,,,Article,2016-01-27,10.1038/gt.2016.5,,,,26814609,,,,,,,1,1,0,8,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5077410,https://api.altmetric.com/v1/donut/5077410_240.png 18,Screening for prostate cancer.,New England Journal of Medicine,,,Article,1970-01-01,10.1056/nejmp0901825,,,,19297563,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1379369,https://api.altmetric.com/v1/donut/1379369_240.png 18,Cancer-Related Axonogenesis and Neurogenesis in Prostate Cancer,Clinical Cancer Research,,,Article,2008-01-01,10.1158/1078-0432.ccr-08-1164,,,,19047084,,,,,,,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2618893,https://api.altmetric.com/v1/donut/2618893_240.png 18,"Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995?2011",Cancer (0008543X),,,Article,2015-07-01,10.1002/cncr.29535,,,,26149752,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4296548,https://api.altmetric.com/v1/donut/4296548_240.png 18,Single-Cell Copy Number Analysis of Prostate Cancer Cells Captured with GEDI Microdevices.,Analytical Chemistry,,,Article,2014-11-04,10.1021/ac503453v,,,,25363873,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2850430,https://api.altmetric.com/v1/donut/2850430_240.png 18,What Couples Say about Their Recovery of Sexual Intimacy after Prostatectomy: Toward the Development of a Conceptual Model of Couples' Sexual Recovery after Surgery for Prostate Cancer,Journal of Sexual Medicine,,,Article,2014-10-31,10.1111/jsm.12732,,,,25358901,,,,,,,0,0,0,28,0,0,2,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2835250,https://api.altmetric.com/v1/donut/2835250_240.png 18,Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer,British Journal of Cancer,,,Article,2014-03-04,10.1038/bjc.2014.99,,,,24595005,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2283190,https://api.altmetric.com/v1/donut/2283190_240.png 18,Association Between Metformin Use and Risk of Prostate Cancer and Its Grade,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt170,,,,23853056,,,,,,,2,0,0,2,0,0,2,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1629095,https://api.altmetric.com/v1/donut/1629095_240.png 18,Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells,Nature Communications,,,Article,2013-03-27,10.1038/ncomms2627,,,,23535644,,,,,,,1,0,0,7,0,0,14,0,2,0,0,0,0,0,0,19,https://www.altmetric.com/details/1328425,https://api.altmetric.com/v1/donut/1328425_240.png 18,Phase 1b Study of Abiraterone Acetate Plus Prednisone and Docetaxel in Patients with Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-02-04,10.1016/j.eururo.2016.01.028,,,,26852075,,,,,,,0,0,0,38,0,0,4,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/5088676,https://api.altmetric.com/v1/donut/5088676_240.png 18,Coffee consumption linked to a reduction in prostate cancer recurrence,Cancer (0008543X),,,Article,2014-01-15,10.1002/cncr.28542,,,,24399415,,,,,,,0,0,0,27,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2026696,https://api.altmetric.com/v1/donut/2026696_240.png 18,A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: A randomized controlled trial,The Prostate,,,Article,2013-06-15,10.1002/pros.22682,,,,23775525,PMC3767289,,,,,,1,1,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1602534,https://api.altmetric.com/v1/donut/1602534_240.png 18,Perspectives of Prostate Cancer Patients on Gleason Scores and the New Grade Groups: Initial Qualitative Study,European Urology,,,Article,2016-06-07,10.1016/j.eururo.2016.05.039,,,,27283215,,,,,,,0,0,0,37,0,0,3,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/8522844,https://api.altmetric.com/v1/donut/8522844_240.png 18,PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy,Modern Pathology,,,Article,2014-07-04,10.1038/modpathol.2014.85,,,,24993522,,,,,,,1,0,0,12,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2487651,https://api.altmetric.com/v1/donut/2487651_240.png 18,Case–control and prospective studies of dietary ?-linolenic acid intake and prostate cancer risk: a meta-analysis,BMJ Open,,,Article,2013-01-01,10.1136/bmjopen-2012-002280,,,,23674441,,,,,,,1,0,0,9,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1480451,https://api.altmetric.com/v1/donut/1480451_240.png 18,Corrigendum re: “Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer” [Eur Urol 2014;66:145–55],European Urology,,,Article,2016-04-01,10.1016/j.eururo.2016.03.014,,,,27302299,,,,,,,0,2,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6417358,https://api.altmetric.com/v1/donut/6417358_240.png 18,Magnetic resonance/transrectal ultrasound fusion biopsy of the prostate compared to systematic 12-core biopsy for the diagnosis and characterization of prostate cancer: multi-institutional retrospective analysis of 389 patients,Urologic Oncology,,,Article,2016-05-16,10.1016/j.urolonc.2016.04.008,,,,27197921,,,,,,,2,0,0,6,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7537035,https://api.altmetric.com/v1/donut/7537035_240.png 18,Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2015-07-01,10.1093/jnci/djv119,,,,25957435,,,,,,,1,0,0,15,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3995447,https://api.altmetric.com/v1/donut/3995447_240.png 18,Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results.,European Urology,,,Article,2015-02-13,10.1016/j.eururo.2015.01.027,,,,25687533,,,,,,,0,0,0,27,0,0,4,2,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3613820,https://api.altmetric.com/v1/donut/3613820_240.png 18,Weighing the Addition of Androgen Suppression Therapy to Radiotherapy Dose Escalation for Intermediate-Risk Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-03-14,10.1200/jco.2015.66.2320,,,,26976421,,,,,,,1,1,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6190345,https://api.altmetric.com/v1/donut/6190345_240.png 18,"Evolving information needs among colon, breast, and prostate cancer survivors: Results from a longitudinal mixed-effects analysis.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-05-21,10.1158/1055-9965.epi-15-0041,,,,25979968,,,,,,,1,1,0,4,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4007822,https://api.altmetric.com/v1/donut/4007822_240.png 18,Impact of Family History on Prostate Cancer Mortality in White Men Undergoing Prostate Specific Antigen Based Screening,The Journal of Urology,,,Article,2014-07-23,10.1016/j.juro.2014.07.085,,,,25066872,,,,,,,1,1,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2546594,https://api.altmetric.com/v1/donut/2546594_240.png 18,Limitations of Assessing Value in Robotic Surgery for Prostate Cancer: What Data Should Patients and Physicians Use to Make the Best Decision?,Journal of Clinical Oncology,,,Article,,10.1200/jco.2013.54.9741,,,,,,,,,,,1,0,0,12,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2280241,https://api.altmetric.com/v1/donut/2280241_240.png 18,Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).,European Urology,,,Article,2009-08-09,10.1016/j.eururo.2009.07.018,,,,19660851,,,,,,,1,0,0,4,0,0,0,1,0,0,0,0,1,0,0,56,https://www.altmetric.com/details/541671,https://api.altmetric.com/v1/donut/541671_240.png 18,Selenium and prostate cancer prevention.,Seminars in Urologic Oncology,,,Article,1999-05-01,,,,,10332922,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1714947,https://api.altmetric.com/v1/donut/1714947_240.png 18,How Common Is Incidental Prostate Cancer?,NEJM Journal Watch,,,Article,,10.1056/jw200803110000005,,,,,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1789953,https://api.altmetric.com/v1/donut/1789953_240.png 18,"Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-05-19,10.1158/1055-9965.epi-06-0861,,,,17507623,,,,,,,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1181963,https://api.altmetric.com/v1/donut/1181963_240.png 18,Long-Term Active Surveillance for Prostate Cancer: Answers and Questions.,Journal of Clinical Oncology,,,Article,2014-12-15,10.1200/jco.2014.59.2329,,,,25512464,,,,,,,0,0,0,24,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2986971,https://api.altmetric.com/v1/donut/2986971_240.png 18,"Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.",Lancet Oncology,,,Article,2014-08-20,10.1016/s1470-2045(14)70361-4,,,,25163905,,,,,,,0,0,0,30,0,0,1,0,0,0,0,0,0,0,0,115,https://www.altmetric.com/details/2620332,https://api.altmetric.com/v1/donut/2620332_240.png 18,"Prostate Cancer Screening: What We Know, Don't Know, and Believe",Annals of Internal Medicine,,,Article,,10.1059/0003-4819-157-2-201207170-00460,,,,22615454,,,,,,,0,1,0,14,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/754523,https://api.altmetric.com/v1/donut/754523_240.png 18,Dietary glucosinolate intake and risk of prostate cancer in the EPIC-Heidelberg cohort study.,International Journal of Cancer,,,Article,2009-11-01,10.1002/ijc.24555,,,,19585501,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/481596,https://api.altmetric.com/v1/donut/481596_240.png 18,Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2009-08-10,10.1200/jco.2008.20.0642,,,,19470933,,,,,,,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,92,https://www.altmetric.com/details/377526,https://api.altmetric.com/v1/donut/377526_240.png 18,Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells,PLoS ONE,,,Article,2015-07-31,10.1371/journal.pone.0134137,,,,26230090,,,,,,,0,2,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4412957,https://api.altmetric.com/v1/donut/4412957_240.png 18,"Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitro",Cancer Prevention Research,,,Article,2009-07-01,10.1158/1940-6207.capr-08-0167,,,,19542190,,,,,,,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4276391,https://api.altmetric.com/v1/donut/4276391_240.png 18,Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.04.015,,,,26059076,,,,,,,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4207933,https://api.altmetric.com/v1/donut/4207933_240.png 17,Targeting the MLL complex in castration-resistant prostate cancer,Nature Medicine,,,Article,2015-03-30,10.1038/nm.3830,,,,25822367,,,,,,,2,0,0,2,0,0,1,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/3855746,https://api.altmetric.com/v1/donut/3855746_240.png 17,"Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer",The Prostate,,,Article,2011-06-15,10.1002/pros.21314,,,,21541975,PMC3083484,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3028387,https://api.altmetric.com/v1/donut/3028387_240.png 17,Prostate cancer vaccines.,Expert Review of Vaccines,,,Article,2013-03-20,10.1586/erv.13.27,,,,23496665,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2659302,https://api.altmetric.com/v1/donut/2659302_240.png 17,Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes.,BMC Cancer,,,Article,2013-01-19,10.1186/1471-2407-13-23,,,,23324165,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1504288,https://api.altmetric.com/v1/donut/1504288_240.png 17,The influence of PSA-RNA yield on the analysis of expressed prostatic secretions (EPS) for prostate cancer diagnosis.,Canadian Journal of Urology,,,Article,2013-02-27,,,,,23433128,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1338092,https://api.altmetric.com/v1/donut/1338092_240.png 17,"Evaluation of the association of prostate cancerâ??specific anxiety with sexual function, depression and cancer aggressiveness in men 1â??year following surgical treatment for localized prostate cancer",Psycho-Oncology,,,Article,2013-01-01,10.1002/pon.3138,,,,22855322,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/964250,https://api.altmetric.com/v1/donut/964250_240.png 17,Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.,New England Journal of Medicine,,,Article,1970-01-01,10.1056/nejmoa031918,,,,15163773,,,,,,,1,0,1,2,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/884139,https://api.altmetric.com/v1/donut/884139_240.png 17,BRCA1 mutations increase risk of prostate cancer,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70182-1,,,,,,,,,,,0,0,0,24,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/719591,https://api.altmetric.com/v1/donut/719591_240.png 17,Systematic review and meta-analysis on management of acute urinary retention,Prostate Cancer & Prostatic Diseases,,,Article,2015-07-21,10.1038/pcan.2015.15,,,,26195469,,,,,,,1,0,0,15,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/4301720,https://api.altmetric.com/v1/donut/4301720_240.png 17,"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer",Nature Genetics,,,Article,2012-05-20,10.1038/ng.2279,,,,22610119,,,,,,,0,1,0,9,0,0,0,2,0,0,0,0,0,0,0,338,https://www.altmetric.com/details/753086,https://api.altmetric.com/v1/donut/753086_240.png 17,Higher BPA Levels Associated with Prostate Cancer,NEJM Journal Watch,,,Article,,10.1056/nejm-jw.fw108551,,,,,,,,,,,0,1,0,15,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2159829,https://api.altmetric.com/v1/donut/2159829_240.png 17,Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer,Nature Reviews Cancer,,,Article,2015-11-13,10.1038/nrc4016,,,,26563462,,,,,,,0,0,0,27,0,0,4,0,0,0,0,0,0,0,0,111,https://www.altmetric.com/details/4756787,https://api.altmetric.com/v1/donut/4756787_240.png 17,Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs,British Journal of Cancer,,,Article,2006-03-07,10.1038/sj.bjc.6603030,,,,16523199,PMC2361380,,,,,,1,1,0,1,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/498392,https://api.altmetric.com/v1/donut/498392_240.png 17,Prostate Cancer and the Hypofractionation Hypothesis,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.52.4942,,,,24101055,,,,,,,1,0,0,12,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1811773,https://api.altmetric.com/v1/donut/1811773_240.png 17,Dietary zinc and prostate cancer survival in a Swedish cohort,American Journal of Clinical Nutrition,,,Article,2011-03-01,10.3945/ajcn.110.004804,,,,21228268,PMC3041600,,,,,,0,2,0,1,0,0,2,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/214074,https://api.altmetric.com/v1/donut/214074_240.png 17,Prostate cancer: CYP17A1 inhibitor failure-lessons for future drug development.,Nature Reviews Urology,,,Article,2015-03-31,10.1038/nrurol.2015.66,,,,25823374,,,,,,,1,1,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3854718,https://api.altmetric.com/v1/donut/3854718_240.png 17,"Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage and Improve?",Urology,,,Article,2016-02-11,10.1016/j.urology.2015.11.053,,,,26876460,,,,,,,2,0,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5517345,https://api.altmetric.com/v1/donut/5517345_240.png 17,SNP-SNP Interaction Network in Angiogenesis Genes Associated with Prostate Cancer Aggressiveness,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0059688,,,,23593148,PMC3618555,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1371125,https://api.altmetric.com/v1/donut/1371125_240.png 17,Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.,New England Journal of Medicine,,,Article,2004-10-08,10.1056/nejmoa040720,,,,15470213,,,,,,,1,0,1,2,0,0,0,2,0,0,0,0,1,0,0,480,https://www.altmetric.com/details/840247,https://api.altmetric.com/v1/donut/840247_240.png 17,The endocannabinoid system in prostate cancer.,Nature Reviews Urology,,,Article,2011-09-13,10.1038/nrurol.2011.130,,,,21912423,,,,,,,0,0,0,11,0,0,11,0,7,0,0,0,0,0,3,15,https://www.altmetric.com/details/374486,https://api.altmetric.com/v1/donut/374486_240.png 17,Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer,Cancer (0008543X),,,Article,2016-08-09,10.1002/cncr.30221,,,,27505036,,,,,,,1,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10360088,https://api.altmetric.com/v1/donut/10360088_240.png 17,Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.,European Urology,,,Article,2015-02-11,10.1016/j.eururo.2015.01.009,,,,25682340,,,,,,,1,0,0,16,0,0,3,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3542506,https://api.altmetric.com/v1/donut/3542506_240.png 17,Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy|[quest]|,Prostate Cancer & Prostatic Diseases,,,Article,2016-10-11,10.1038/pcan.2016.41,,,,27725729,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12560296,https://api.altmetric.com/v1/donut/12560296_240.png 17,Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy,Journal of Clinical Oncology,,,Article,2016-08-29,10.1200/jco.2016.69.2509,,,,27573664,,,,,,,1,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10903454,https://api.altmetric.com/v1/donut/10903454_240.png 17,"Hormonal impact of the 17?-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer",British Journal of Cancer,,,Article,2004-06-14,10.1038/sj.bjc.6601879,,,,15150570,PMC2409523,,,,,,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/109731,https://api.altmetric.com/v1/donut/109731_240.png 17,Lycopene/Tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies.,Journal of Nutritional Science & Vitaminology,,,Article,2013-01-01,,,,,23883692,,,,,,,0,1,0,8,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2028054,https://api.altmetric.com/v1/donut/2028054_240.png 17,"Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.",International Journal of Cancer,,,Article,2011-03-15,10.1002/ijc.25439,,,,20473927,,,,,,,0,1,0,7,0,0,1,0,2,0,0,0,1,0,0,35,https://www.altmetric.com/details/425258,https://api.altmetric.com/v1/donut/425258_240.png 17,Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC).,International Journal of Cancer,,,Article,2004-03-01,10.1002/ijc.11671,,,,14735477,,,,,,,1,5,0,0,0,0,6,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/394797,https://api.altmetric.com/v1/donut/394797_240.png 17,"Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies",American Journal of Clinical Nutrition,,,Article,2013-01-01,10.3945/ajcn.112.039222,,,,23193007,,,,,,,1,1,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1109881,https://api.altmetric.com/v1/donut/1109881_240.png 17,Late side effects after image-guided intensity modulated radiotherapy compared to 3D-conformal radiotherapy for prostate cancer: results from two prospective cohorts,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-01,10.1016/j.ijrobp.2016.01.031,,,,27055398,,,,,,,0,0,0,28,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5029386,https://api.altmetric.com/v1/donut/5029386_240.png 17,"Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort",The Journal of Urology,,,Article,2015-09-04,10.1016/j.juro.2015.08.087,,,,26327354,,,,,,,1,0,0,11,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4448092,https://api.altmetric.com/v1/donut/4448092_240.png 17,"Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study",Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70379-0,,,,22995653,,,,,,,0,0,5,16,0,0,3,1,0,0,0,0,0,0,0,172,https://www.altmetric.com/details/950828,https://api.altmetric.com/v1/donut/950828_240.png 17,"Commentary: Prostate cancer is omnipresent, but should we screen for it?",International Journal of Epidemiology,,,Article,2007-01-01,10.1093/ije/dym049,,,,17567642,,,,,,,0,1,0,11,0,0,8,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1480110,https://api.altmetric.com/v1/donut/1480110_240.png 17,Calcium and Vitamin D Supplementation During Androgen Deprivation Therapy for Prostate Cancer: A Critical Review,Oncologist,,,Article,2012-01-01,10.1634/theoncologist.2012-0051,,,,22836449,,,,,,,0,1,0,8,0,0,2,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/876651,https://api.altmetric.com/v1/donut/876651_240.png 17,Defining the Incremental Utility of Prostate Multiparametric Magnetic Resonance Imaging at Standard and Specialized Read in Predicting Extracapsular Extension of Prostate Cancer,European Urology,,,Article,2015-11-07,10.1016/j.eururo.2015.10.041,,,,26553331,,,,,,,0,0,0,39,0,0,7,0,2,0,0,0,0,0,0,9,https://www.altmetric.com/details/4734794,https://api.altmetric.com/v1/donut/4734794_240.png 17,Comorbidity and the risk of venous thromboembolism in prostate cancer,Cancer (0008543X),,,Article,2015-07-06,10.1002/cncr.29536,,,,26149890,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4265476,https://api.altmetric.com/v1/donut/4265476_240.png 17,Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study.,Journal of Clinical Oncology,,,Article,2014-11-20,10.1200/jco.2013.53.4578,,,,25311217,,,,,,,1,0,0,13,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2771905,https://api.altmetric.com/v1/donut/2771905_240.png 17,Shiftwork and Prostate-Specific Antigen in the National Health and Nutrition Examination Survey,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt169,,,,23943864,,,,,,,1,0,0,5,0,0,3,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1686583,https://api.altmetric.com/v1/donut/1686583_240.png 17,Changes in serum prostate?specific antigen levels and the identification of prostate cancer in a large managed care population,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11651.x,,,,23320750,,,,,,,1,0,1,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1187559,https://api.altmetric.com/v1/donut/1187559_240.png 17,Cruciferous vegetables intake and risk of prostate cancer: A metaâ??analysis,International Journal of Urology,,,Article,2011-11-30,10.1111/j.1442-2042.2011.02906.x,,,,22121852,,,,,,,1,0,0,8,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/474212,https://api.altmetric.com/v1/donut/474212_240.png 17,Acute toxicity and quality of life in patients with prostate cancer treated with protons or carbon ions in a prospective randomized phase II study – the IPI trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-12,10.1016/j.ijrobp.2016.02.025,,,,27084659,,,,,,,1,0,0,10,0,0,2,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/5528624,https://api.altmetric.com/v1/donut/5528624_240.png 17,Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.,Journal of Clinical Oncology,,,Article,2015-05-28,10.1200/jco.2014.57.8724,,,,26014295,,,,,,,1,0,0,15,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4061697,https://api.altmetric.com/v1/donut/4061697_240.png 17,Prostate cancer survivorship guidelines.,CA: A Cancer Journal for Clinicians ,,,Article,2014-07-01,10.3322/caac.21236,,,,24916846,,,,,,,1,0,0,15,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2425306,https://api.altmetric.com/v1/donut/2425306_240.png 17,Prostate Cancer Incidence and Prostate-Specific Antigen Testing Among HIV-Positive and HIV-Negative Men.,JAIDS: Journal of Acquired Immune Deficiency Syndromes,,,Article,2014-05-15,10.1097/qai.0000000000000202,,,,24820107,,,,,,,1,0,0,9,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2361708,https://api.altmetric.com/v1/donut/2361708_240.png 17,Pathological Outcome Following Radical Prostatectomy in Men with PSA Greater than 10 and Histologically Favorable-Risk Prostate Cancer,The Journal of Urology,,,Article,2015-11-27,10.1016/j.juro.2015.11.031,,,,26608903,,,,,,,0,2,0,5,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4786460,https://api.altmetric.com/v1/donut/4786460_240.png 17,High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers,Annals of Oncology,,,Article,2015-09-09,10.1093/annonc/mdv356,,,,26347108,,,,,,,1,1,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4489401,https://api.altmetric.com/v1/donut/4489401_240.png 17,Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer,European Urology,,,Article,2014-10-29,10.1016/j.eururo.2014.10.001,,,,25449207,,,,,,,0,0,0,87,0,0,2,0,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/2825658,https://api.altmetric.com/v1/donut/2825658_240.png 17,Coffee consumption and the risk of prostate cancer: the Ohsaki Cohort Study.,British Journal of Cancer,,,Article,2013-05-14,10.1038/bjc.2013.238,,,,23674088,,,,,,,0,0,0,23,0,0,6,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1480401,https://api.altmetric.com/v1/donut/1480401_240.png 17,The PSA?/lo prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration,Cell Stem Cell,"BALE, Gary",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-01-01,10.1016/j.stem.2012.03.009,,,,22560078,PMC3348510,,,,,,0,1,0,9,0,0,2,1,0,0,0,0,1,0,0,60,https://www.altmetric.com/details/726613,https://api.altmetric.com/v1/donut/726613_240.png 17,Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients,Biometrics,,,Article,2016-05-01,10.1111/biom.12537,,,,27148956,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7166916,https://api.altmetric.com/v1/donut/7166916_240.png 17,Effect of Carotene and Lycopene on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Observational Studies,PLoS ONE,,,Article,2015-09-15,10.1371/journal.pone.0137427,,,,26372549,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4514009,https://api.altmetric.com/v1/donut/4514009_240.png 17,Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.,European Urology,,,Article,2014-11-01,10.1016/j.eururo.2014.10.026,,,,25454618,,,,,,,0,0,0,24,0,0,0,0,1,0,0,0,0,0,0,70,https://www.altmetric.com/details/2836644,https://api.altmetric.com/v1/donut/2836644_240.png 17,The association between race and treatment regret among men with recurrent prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-10-28,10.1038/pcan.2014.42,,,,25348256,,,,,,,2,0,0,10,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2817798,https://api.altmetric.com/v1/donut/2817798_240.png 17,Survival after radical prostatectomy for clinically localised prostate cancer: a population?based study,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12065,,,,23495721,,,,,,,1,3,0,1,0,0,0,0,0,0,0,0,0,0,1,10,https://www.altmetric.com/details/2267594,https://api.altmetric.com/v1/donut/2267594_240.png 17,A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy,European Urology,,,Article,2013-04-03,10.1016/j.eururo.2013.03.033,,,,23541457,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1419282,https://api.altmetric.com/v1/donut/1419282_240.png 17,Low-Carbohydrate Diets and Prostate Cancer: How Low Is “Low Enough”?,Cancer Prevention Research,,,Article,2010-01-01,10.1158/1940-6207.capr-10-0071,,,,20716631,,,,,,,0,1,0,7,0,0,3,0,1,0,0,0,0,0,0,36,https://www.altmetric.com/details/1400936,https://api.altmetric.com/v1/donut/1400936_240.png 17,Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer,British Journal of Cancer,,,Article,2009-05-01,10.1038/sj.bjc.6605058,,,,19401683,PMC2696767,,,,,,2,0,0,1,0,0,0,2,0,0,0,0,2,0,0,223,https://www.altmetric.com/details/520417,https://api.altmetric.com/v1/donut/520417_240.png 17,The accuracy of prostate cancer localization diagnosed on transrectal ultrasound-guided biopsy compared to 3-dimensional transperineal approach.,Advances in Urology,,,Article,2014-01-30,10.1155/2013/249080,,,,24470798,PMC3891607,,,,,,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2098471,https://api.altmetric.com/v1/donut/2098471_240.png 17,Prostate cancer: Towards effective combination of ADT and immunotherapy,Nature Reviews Urology,,,Article,2016-04-26,10.1038/nrurol.2016.80,,,,27112389,,,,,,,1,0,0,10,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6967213,https://api.altmetric.com/v1/donut/6967213_240.png 17,"Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial",Lancet Oncology,,,Article,2015-02-17,10.1016/s1470-2045(15)70027-6,,,,25701170,,,,,,,1,0,0,11,0,0,2,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3708270,https://api.altmetric.com/v1/donut/3708270_240.png 17,BRCA-targeting drugs could treat prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6546-brca-targeting-drugs-could-treat-prostate-cancer.php,,,,,,,,1,0,0,11,0,0,4,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2850733,https://api.altmetric.com/v1/donut/2850733_240.png 17,Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial,JNCI: Journal of the National Cancer Institute,,,Article,2016-10-17,10.1093/jnci/djw225,,,,27754927,,,,,,,0,0,0,25,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12947740,https://api.altmetric.com/v1/donut/12947740_240.png 17,Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-03-08,10.1016/j.eururo.2016.02.035,,,,26965562,,,,,,,1,0,0,12,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6136681,https://api.altmetric.com/v1/donut/6136681_240.png 17,"Mindfulness?Based Stress Reduction in Relation to Quality of Life, Mood, Symptoms of Stress, and Immune Parameters in Breast and Prostate Cancer Outpatients",Psychosomatic Medicine (Highwire),,,Article,2003-01-01,10.1097/01.psy.0000074003.35911.41,,,,12883107,,,,,,,2,0,0,4,0,0,3,0,0,0,0,0,0,0,0,145,https://www.altmetric.com/details/1316445,https://api.altmetric.com/v1/donut/1316445_240.png 17,Control of Prostate Cancer by Transrectal HIFU in 227 Patients,European Urology,,,Article,2007-02-01,10.1016/j.eururo.2006.04.012,,,,16857310,,,,,,,0,2,5,0,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/110372,https://api.altmetric.com/v1/donut/110372_240.png 17,Vasectomy and risk of prostate cancer: a systematic review and meta?analysis of cohort studies,Andrology,,,Article,2015-06-03,10.1111/andr.12040,,,,26041315,,,,,,,1,1,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4110557,https://api.altmetric.com/v1/donut/4110557_240.png 17,Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.,European Urology,,,Article,2014-10-25,10.1016/j.eururo.2014.10.014,,,,25457020,,,,,,,0,1,0,24,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2815486,https://api.altmetric.com/v1/donut/2815486_240.png 16,"Reply to being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff point",Cancer (0008543X),,,Article,2016-06-01,10.1002/cncr.30097,,,,27286520,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8728057,https://api.altmetric.com/v1/donut/8728057_240.png 16,Current management of castrate-resistant prostate cancer.,Current Oncology,,,Article,2010-09-01,,,,,20882137,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6496878,https://api.altmetric.com/v1/donut/6496878_240.png 16,An exploratory study of the factors that influence physical activity for prostate cancer survivors,Supportive Care in Cancer,,,Article,2010-07-10,10.1007/s00520-010-0929-3,,,,20623146,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3911698,https://api.altmetric.com/v1/donut/3911698_240.png 16,Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure,Prostate Cancer & Prostatic Diseases,,,Article,2009-06-02,10.1038/pcan.2009.12,,,,19488067,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3911696,https://api.altmetric.com/v1/donut/3911696_240.png 16,Coffee consumption and prostate cancer risk: an updated meta-analysis.,Cancer Causes and Control,,,Article,2014-03-02,10.1007/s10552-014-0364-8,,,,24584929,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2164044,https://api.altmetric.com/v1/donut/2164044_240.png 16,Androgenetic Alopecia and Prostate Cancer: Findings from an Australian Case-Control Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2002-01-01,,,,,12050096,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1986915,https://api.altmetric.com/v1/donut/1986915_240.png 16,"IMAGEâ??DIRECTED, TISSUEâ??PRESERVING FOCAL THERAPY OF PROSTATE CANCER: A FEASIBILITY STUDY OF A NOVEL DEFORMABLE MRâ??US REGISTRATION SYSTEM",British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12223,,,,23819525,,,,,,,1,1,0,1,0,0,0,0,1,0,0,0,0,0,0,39,https://www.altmetric.com/details/1478501,https://api.altmetric.com/v1/donut/1478501_240.png 16,Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.,The Journal of Urology,,,Article,2009-01-28,10.1016/j.juro.2008.11.032,,,,19167731,,,,,,,1,2,0,0,0,0,0,1,0,0,0,0,1,0,0,162,https://www.altmetric.com/details/537104,https://api.altmetric.com/v1/donut/537104_240.png 16,A luminal epithelial stem cell that is a cell of origin for prostate cancer,Nature,,,Article,2009-09-24,10.1038/nature08361,,,,19741607,,,2009Natur.461..495W,,,,1,1,0,1,0,0,0,0,0,0,0,0,3,0,0,116,https://www.altmetric.com/details/234289,https://api.altmetric.com/v1/donut/234289_240.png 16,"A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer",Prostate Cancer & Prostatic Diseases,,,Article,2015-07-14,10.1038/pcan.2015.32,,,,26169045,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4273681,https://api.altmetric.com/v1/donut/4273681_240.png 16,Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer,European Urology,,,Article,2015-03-31,10.1016/j.eururo.2014.12.026,,,,25813688,,,,,,,0,0,0,21,0,0,3,0,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/3826162,https://api.altmetric.com/v1/donut/3826162_240.png 16,The specialist nursing workforce caring for men with prostate cancer in the UK,International Journal of Urological Nursing,,,Article,2015-11-01,10.1111/ijun.12104,,,,,,,,,,,0,0,0,23,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4784955,https://api.altmetric.com/v1/donut/4784955_240.png 16,Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer,European Urology,,,Article,2014-06-29,10.1016/j.eururo.2014.06.010,,,,24993868,,,,,,,0,0,0,26,0,0,2,0,1,0,0,0,0,0,0,30,https://www.altmetric.com/details/2475632,https://api.altmetric.com/v1/donut/2475632_240.png 16,Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable?,European Urology,,,Article,2016-03-01,10.1016/j.eururo.2016.02.037,,,,26948397,,,,,,,0,0,0,36,0,0,4,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/6025884,https://api.altmetric.com/v1/donut/6025884_240.png 16,Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer,Molecular Imaging & Biology,,,Article,2015-04-21,10.1007/s11307-015-0850-8,,,,25896814,,,,,,,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3956727,https://api.altmetric.com/v1/donut/3956727_240.png 16,Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening,The Journal of Urology,,,Article,2015-02-13,10.1016/j.juro.2015.02.043,,,,25686543,,,,,,,1,0,0,9,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3613662,https://api.altmetric.com/v1/donut/3613662_240.png 16,Vitamin D Status: Ready for Guiding Prostate Cancer Diagnosis and Treatment?,Clinical Cancer Research,,,Article,2014-05-01,10.1158/1078-0432.ccr-14-0369,,,,24789031,,,,,,,1,0,0,9,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2317903,https://api.altmetric.com/v1/donut/2317903_240.png 16,Intake of carotenoids and retinol in relation to risk of prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,1995-12-06,10.1093/jnci/87.23.1767,,,,7473833,,,,,,,1,0,0,5,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/862778,https://api.altmetric.com/v1/donut/862778_240.png 16,Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program,Journal of Clinical Oncology,,,Article,2010-10-06,10.1200/jco.2009.25.7311,,,,20439642,,,,,,,0,1,1,4,0,0,0,1,0,0,0,0,3,0,0,56,https://www.altmetric.com/details/531640,https://api.altmetric.com/v1/donut/531640_240.png 16,Prostate Cancer: Evolution or Revolution?,Journal of Clinical Oncology,,,Article,2011-01-01,10.1200/jco.2011.37.8653,,,,21859996,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/406024,https://api.altmetric.com/v1/donut/406024_240.png 16,Hypofractionated radiotherapy in prostate cancer ,Lancet Oncology,,,Article,2015-02-02,10.1016/s1470-2045(15)70021-5,,,,25656288,,,,,,,1,1,0,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3254742,https://api.altmetric.com/v1/donut/3254742_240.png 16,Effect of mammalian lignans on the growth of prostate cancer cell lines.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2001-01-01,,,,,11911282,,,,,,,1,2,0,1,0,0,0,0,0,0,0,0,0,0,1,12,https://www.altmetric.com/details/2315394,https://api.altmetric.com/v1/donut/2315394_240.png 16,"Meat, fish, poultry, and egg intake at diagnosis and risk of prostate cancer progression",Cancer Prevention Research,,,Article,2016-01-01,10.1158/1940-6207.capr-16-0070,,,,27651069,,,,,,,0,1,0,15,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12141376,https://api.altmetric.com/v1/donut/12141376_240.png 16,TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer,Cancer Cell,,,Article,2016-05-26,10.1016/j.ccell.2016.04.012,,,,27238081,,,,,,,0,0,0,29,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/8288125,https://api.altmetric.com/v1/donut/8288125_240.png 16,"Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort",Prostate Cancer & Prostatic Diseases,,,Article,2015-03-31,10.1038/pcan.2015.12,,,,25823651,,,,,,,2,0,0,5,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3855602,https://api.altmetric.com/v1/donut/3855602_240.png 16,Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak.,Molecular Cancer Therapeutics,,,Article,2007-05-23,10.1158/1535-7163.mct-06-0754,,,,17513609,PMC2805823,,,,,,0,0,0,4,0,0,11,0,9,0,0,0,0,0,0,10,https://www.altmetric.com/details/2108218,https://api.altmetric.com/v1/donut/2108218_240.png 16,Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomised controlled trials.,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12435,,,,24053483,,,,,,,0,1,0,5,0,0,5,0,1,0,0,0,0,0,0,28,https://www.altmetric.com/details/1754255,https://api.altmetric.com/v1/donut/1754255_240.png 16,"Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Risk of Advanced Prostate Cancer",Cancer Research,,,Article,2005-01-01,10.1158/0008-5472.can-04-3134,,,,15958597,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/461989,https://api.altmetric.com/v1/donut/461989_240.png 16,Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3,Journal of Clinical Oncology,,,Article,2016-02-24,10.1200/jco.2015.64.2702,,,,26903579,,,,,,,0,0,0,27,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/5985652,https://api.altmetric.com/v1/donut/5985652_240.png 16,Family History of Prostate Cancer Associated with Increased Risk for Breast Cancer,Journal Watch,,,Article,,10.1056/nejm-jw.fw109951,,,,,,,,,,,0,0,0,23,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3767311,https://api.altmetric.com/v1/donut/3767311_240.png 16,Circumcision reduces prostate cancer risk,Asian Journal of Andrology,,,Article,2012-05-28,10.1038/aja.2012.47,,,,22635160,,,,,,,0,0,0,250,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/771171,https://api.altmetric.com/v1/donut/771171_240.png 16,Prostate cancer: Moderate hypofractionated radiotherapy [mdash] not yet a standard of care,Nature Reviews Clinical Oncology,,,Article,2016-09-20,10.1038/nrclinonc.2016.147,,,,27644320,,,,,,,1,0,0,13,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12107503,https://api.altmetric.com/v1/donut/12107503_240.png 16,"Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.",American Journal of Clinical Nutrition,,,Article,2015-10-09,10.3945/ajcn.115.114306,,,,26447150,,,,,,,0,1,0,9,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4599510,https://api.altmetric.com/v1/donut/4599510_240.png 16,Proapoptotic effect of endocannabinoids in prostate cancer cells.,Oncology Reports,,,Article,2015-01-21,10.3892/or.2015.3746,,,,25606819,,,,,,,0,0,0,10,0,0,22,0,3,0,0,0,0,0,0,31,https://www.altmetric.com/details/3092175,https://api.altmetric.com/v1/donut/3092175_240.png 16,A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications,European Urology,,,Article,2013-08-01,10.1016/j.eururo.2013.08.015,,,,24011426,,,,,,,0,1,0,11,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1696979,https://api.altmetric.com/v1/donut/1696979_240.png 16,T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-09-10,10.1073/pnas.1209042109,,,,23019373,,,2012PNAS..10915877H,,,,1,0,0,7,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/945789,https://api.altmetric.com/v1/donut/945789_240.png 16,"Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-07-01,,,,,12869397,,,,,,,0,1,0,6,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/399634,https://api.altmetric.com/v1/donut/399634_240.png 16,Improved Clinical Outcomes with High-Dose Image Guided Radiotherapy Compared with Non-IGRT for the Treatment of Clinically Localized Prostate Cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.11.047,,,,22330997,,,,,,,0,1,0,9,0,0,2,0,1,0,0,0,0,0,0,98,https://www.altmetric.com/details/915316,https://api.altmetric.com/v1/donut/915316_240.png 16,Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post hoc Analysis of the Mainsail Study,JAMA Oncology,,,Article,2016-08-25,10.1001/jamaoncol.2016.3000,,,,27560549,,,,,,,1,0,0,18,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10823008,https://api.altmetric.com/v1/donut/10823008_240.png 16,The role of glycans in the development and progression of prostate cancer,Nature Reviews Urology,,,Article,2016-04-19,10.1038/nrurol.2016.65,,,,27091662,,,,,,,1,0,0,10,0,0,5,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6821038,https://api.altmetric.com/v1/donut/6821038_240.png 16,Prostate cancer: Predicting prostate biopsy results[mdash]PCA3 versus phi,Nature Reviews Urology,,,Article,2015-02-03,10.1038/nrurol.2015.1,,,,25644161,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3434411,https://api.altmetric.com/v1/donut/3434411_240.png 16,Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2015-12-24,10.1016/j.eururo.2015.11.022,,,,26724258,,,,,,,0,1,0,19,0,0,5,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4919025,https://api.altmetric.com/v1/donut/4919025_240.png 16,Urinary Quality of Life Outcomes in Men Treated with Image-Guided Intensity-Modulated Radiation Therapy for Prostate Cancer,Advances in Radiation Oncology ,,,Article,2016-10-01,10.1016/j.adro.2016.10.005,,,,,,,,,,,0,0,0,19,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13164247,https://api.altmetric.com/v1/donut/13164247_240.png 16,A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel,Annals of Oncology,,,Article,2015-12-20,10.1093/annonc/mdv594,,,,26685010,,,,,,,0,0,0,30,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4893912,https://api.altmetric.com/v1/donut/4893912_240.png 16,Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217).,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-07-15,10.1158/1055-9965.epi-14-0202,,,,25028457,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2517048,https://api.altmetric.com/v1/donut/2517048_240.png 16,Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer: Challenges for Sexual Health Providers,Journal of Sexual Medicine,,,Article,2014-05-30,10.1111/jsm.12598,,,,24888965,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2400582,https://api.altmetric.com/v1/donut/2400582_240.png 16,Primary Care Providers' Response to the US Preventive Services Task Force Draft Recommendations on Screening for Prostate Cancer,Archives of Internal Medicine,,,Article,2012-01-01,10.1001/archinternmed.2012.135,,,,22529237,,,,,,,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/714358,https://api.altmetric.com/v1/donut/714358_240.png 16,Prostate Cancer Screening—Time to Abandon One-Size-Fits-All Approach?,JAMA: Journal of the American Medical Association,,,Article,2011-01-01,10.1001/jama.2011.1881,,,,22203541,,,,,,,1,0,1,6,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/509089,https://api.altmetric.com/v1/donut/509089_240.png 16,Radical prostatectomy versus watchful waiting in early prostate cancer.,New England Journal of Medicine,,,Article,2005-05-12,10.1056/nejmoa043739,,,,15888698,,,,,,,0,1,1,2,0,0,0,1,0,0,0,0,1,0,0,5,https://www.altmetric.com/details/211946,https://api.altmetric.com/v1/donut/211946_240.png 16,"Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.",Journal of Biological Chemistry,,,Article,2003-03-27,10.1074/jbc.m300588200,,,,12665522,,,,,,,0,2,0,6,0,0,0,3,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/178212,https://api.altmetric.com/v1/donut/178212_240.png 16,A common variant associated with prostate cancer in European and African populations.,Nature Genetics,,,Article,2006-05-07,10.1038/ng1808,,,,16682969,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,2,0,0,97,https://www.altmetric.com/details/116559,https://api.altmetric.com/v1/donut/116559_240.png 16,Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up,European Urology,,,Article,2016-08-27,10.1016/j.eururo.2016.08.040,,,,27574820,,,,,,,0,0,0,23,0,0,5,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/10857752,https://api.altmetric.com/v1/donut/10857752_240.png 16,Intensity?modulated radiotherapy reduces toxicity with similar biochemical control compared with 3?dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial,Cancer (0008543X),,,Article,2016-03-01,10.1002/cncr.29983,,,,27028170,,,,,,,1,0,0,12,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6378024,https://api.altmetric.com/v1/donut/6378024_240.png 16,Is birthweight associated with total and aggressive|[sol]|lethal prostate cancer risks|[quest]| A systematic review and meta-analysis,British Journal of Cancer,,,Article,2016-03-01,10.1038/bjc.2016.38,,,,26930450,,,,,,,2,0,0,11,1,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6031959,https://api.altmetric.com/v1/donut/6031959_240.png 16,Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly,European Urology,,,Article,,10.1016/j.eururo.2014.06.005,,,,24954793,,,,,,,0,0,0,23,0,0,0,0,3,0,0,0,0,0,0,15,https://www.altmetric.com/details/2449824,https://api.altmetric.com/v1/donut/2449824_240.png 16,"Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer",Cancer (0008543X),,,Article,2016-05-25,10.1002/cncr.30101,,,,27224858,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8462378,https://api.altmetric.com/v1/donut/8462378_240.png 16,In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in Endometrial and Prostate Cancer Cell Lines,Journal of Cancer Science & Therapy,,,Article,2015-08-27,10.4172/1948-5956.1000358,,,,,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6198043,https://api.altmetric.com/v1/donut/6198043_240.png 16,Increasing body mass index linked with worse localised prostate cancer outcomes,ecancer.org,,,Article,,,,,http://ecancer.org/news/7366-increasing-body-mass-index-linked-with-worse-localised-prostate-cancer-outcomes.php,,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4069506,https://api.altmetric.com/v1/donut/4069506_240.png 16,Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra,Annals of Oncology,,,Article,2015-05-24,10.1093/annonc/mdv245,,,,26002607,,,,,,,0,0,0,33,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4041858,https://api.altmetric.com/v1/donut/4041858_240.png 16,Guideline Addresses Care for Prostate Cancer Survivors,JAMA: Journal of the American Medical Association,,,Article,,10.1001/jama.2014.8006,,,,25027123,,,,,,,0,0,0,22,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2511739,https://api.altmetric.com/v1/donut/2511739_240.png 16,Proton Beam Therapy for Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2011-01-01,10.1001/jama.2014.1016,,,,24715088,,,,,,,0,0,0,22,0,0,3,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/2265756,https://api.altmetric.com/v1/donut/2265756_240.png 16,Scanometric MicroRNA Array Profiling of Prostate Cancer Markers Using Spherical Nucleic Acid–Gold Nanoparticle Conjugates,Analytical Chemistry,,,Article,2012-04-10,10.1021/ac3004055,,,,22489825,,,,,,,0,1,0,6,0,0,1,0,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/692644,https://api.altmetric.com/v1/donut/692644_240.png 16,Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis,BMC Medicine,,,Article,2014-03-28,10.1186/1741-7015-12-55,,,,24678716,,,,,,,0,1,0,15,0,0,0,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/2216845,https://api.altmetric.com/v1/donut/2216845_240.png 16,Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation,British Journal of Urology,,,Article,2013-06-20,10.1111/bju.12321,,,,23937636,,,,,,,0,1,0,10,0,0,1,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/1688444,https://api.altmetric.com/v1/donut/1688444_240.png 16,The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer,The Journal of Urology,,,Article,2015-11-04,10.1016/j.juro.2015.10.140,,,,26529298,,,,,,,1,0,0,3,0,0,1,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4710108,https://api.altmetric.com/v1/donut/4710108_240.png 16,18F-DCFBC PET/CT for PSMA-based Detection and Characterization of Primary Prostate Cancer,Journal of Nuclear Medicine,,,Article,2015-06-13,10.2967/jnumed.115.154336,,,,26069305,,,,,,,3,0,0,6,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4147661,https://api.altmetric.com/v1/donut/4147661_240.png 16,"Assessing Adverse Events of Postprostatectomy Radiation Therapy for Prostate Cancer: Evaluation of Outcomes in the Regione Emilia-Romagna, Italy","International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-03-15,10.1016/j.ijrobp.2014.11.038,,,,25752388,,,,,,,1,1,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3747006,https://api.altmetric.com/v1/donut/3747006_240.png 16,"Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells",Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-1308,,,,23072969,,,,,,,1,0,0,6,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1005856,https://api.altmetric.com/v1/donut/1005856_240.png 16,Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model.,Cancer Research,,,Article,2008-04-15,10.1158/0008-5472.can-07-5616,,,,18413778,PMC2902987,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1367828,https://api.altmetric.com/v1/donut/1367828_240.png 16,The need for a personalized approach for prostate cancer management,BMC Medicine,,,Article,2015-05-09,10.1186/s12916-015-0344-1,,,,25956920,,,,,,,1,0,0,10,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3979453,https://api.altmetric.com/v1/donut/3979453_240.png 16,Lifestyle Changes for Improving Disease-specific Quality of Life in Sedentary Men on Long-term Androgen-Deprivation Therapy for Advanced Prostate Cancer: A Randomised Controlled Trial,European Urology,,,Article,2013-10-04,10.1016/j.eururo.2013.09.040,,,,24119318,,,,,,,1,0,0,18,0,0,1,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/1826683,https://api.altmetric.com/v1/donut/1826683_240.png 16,Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-19,10.1038/pcan.2015.58,,,,26782711,,,,,,,1,0,0,11,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5013165,https://api.altmetric.com/v1/donut/5013165_240.png 16,ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis,Circulation,,,Article,2015-11-03,10.1161/circulationaha.115.012521,,,,26527696,,,,,,,0,0,0,29,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4715274,https://api.altmetric.com/v1/donut/4715274_240.png 16,Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer,Journal of Clinical Oncology,,,Article,2006-09-20,10.1200/jco.2006.06.2497,,,,16983113,,,,,,,0,2,0,0,0,0,1,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/230436,https://api.altmetric.com/v1/donut/230436_240.png 16,Circulating Tumor Cells in Advanced Prostate Cancer: Time to Move from Prognostic to Predictive Ability,European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.08.053,,,,27591932,,,,,,,0,0,0,25,0,0,1,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/10957746,https://api.altmetric.com/v1/donut/10957746_240.png 16,Association of male circumcision with risk of prostate cancer: a meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2015-07-28,10.1038/pcan.2015.34,,,,26215783,,,,,,,1,0,0,8,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4338575,https://api.altmetric.com/v1/donut/4338575_240.png 16,Factors associated with emotional distress in newly diagnosed prostate cancer patients,Psycho-Oncology,,,Article,2015-01-31,10.1002/pon.3751,,,,25631163,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3237468,https://api.altmetric.com/v1/donut/3237468_240.png 16,Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2016-07-20,10.1093/jnci/90.23.1817,,,,9839522,,,,,,,2,1,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3244468,https://api.altmetric.com/v1/donut/3244468_240.png 16,"Which, when and why|[quest]| Rational use of tissue-based molecular testing in localized prostate cancer",Prostate Cancer & Prostatic Diseases,,,Article,2015-06-30,10.1038/pcan.2015.31,,,,26123120,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4228365,https://api.altmetric.com/v1/donut/4228365_240.png 16,The citrus flavonoid naringenin stimulates DNA repair in prostate cancer cells.,Journal of Nutritional Biochemistry,,,Article,2005-08-24,10.1016/j.jnutbio.2005.05.009,,,,16111881,,,,,,,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2517022,https://api.altmetric.com/v1/donut/2517022_240.png 16,External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-resistant Prostate Cancer Patients Treated with Abiraterone ,European Urology,,,Article,2014-03-26,10.1016/j.eururo.2014.03.020,,,,24685433,,,,,,,0,3,0,6,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2213424,https://api.altmetric.com/v1/donut/2213424_240.png 15,Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer,Urology,,,Article,2002-09-01,10.1016/s0090-4295(02)01560-1,,,,12231037,,,,,,,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12598050,https://api.altmetric.com/v1/donut/12598050_240.png 15,Improving quality in prostate cancer,Medical Journal of Australia,,,Article,2016-05-02,10.5694/mja16.00161,,,,,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7103912,https://api.altmetric.com/v1/donut/7103912_240.png 15,Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-04-01,10.1016/j.ijrobp.2016.02.003,,,,27026303,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6245278,https://api.altmetric.com/v1/donut/6245278_240.png 15,High-Dose-Rate Monotherapy for Localized Prostate Cancer—What More Will It Take to Make This a Standard Therapy?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-03-15,10.1016/j.ijrobp.2015.12.375,,,,26972639,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6204310,https://api.altmetric.com/v1/donut/6204310_240.png 15,A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer,Cancer Discovery,,,Article,2015-02-17,10.1158/2159-8290.cd-14-1057,,,,25691096,,,,,,,2,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3714067,https://api.altmetric.com/v1/donut/3714067_240.png 15,Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2015-02-10,10.1038/pcan.2014.52,,,,25667109,,,,,,,2,0,0,5,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3544900,https://api.altmetric.com/v1/donut/3544900_240.png 15,The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study ,European Urology,,,Article,2008-01-15,10.1016/j.eururo.2007.02.047,,,,17368710,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3064690,https://api.altmetric.com/v1/donut/3064690_240.png 15,What Do Prostate Cancer Patients Die Of?,Oncologist,,,Article,2011-02-01,10.1634/theoncologist.2010-0338,,,,21257717,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2956010,https://api.altmetric.com/v1/donut/2956010_240.png 15,The role of prevalence in the diagnosis of prostate cancer.,Cancer Control: Journal of the Moffitt Cancer Center,,,Article,2006-08-04,,,,,16885911,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2956009,https://api.altmetric.com/v1/donut/2956009_240.png 15,Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes,Prostate Cancer & Prostatic Diseases,,,Article,2014-11-18,10.1038/pcan.2014.47,,,,25403419,,,,,,,2,0,0,18,0,0,2,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2912242,https://api.altmetric.com/v1/donut/2912242_240.png 15,Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies,JNCI: Journal of the National Cancer Institute,,,Article,2014-09-12,10.1093/jnci/dju240,,,,25210201,,,,,,,1,0,0,5,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2891257,https://api.altmetric.com/v1/donut/2891257_240.png 15,Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.,JNCI: Journal of the National Cancer Institute,,,Article,2006-01-01,10.1093/jnci/djj131,,,,16622122,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/2574407,https://api.altmetric.com/v1/donut/2574407_240.png 15,"Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.50.1684,,,,24002508,,,,,,,1,0,0,7,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1729571,https://api.altmetric.com/v1/donut/1729571_240.png 15,Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate?specific antigen (PSA) testing by Dutch general practitioners,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12029,,,,23465178,,,,,,,1,2,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1648437,https://api.altmetric.com/v1/donut/1648437_240.png 15,Early Detection of Prostate Cancer: European Association of Urology Recommendation,European Urology,,,Article,2013-07-09,10.1016/j.eururo.2013.06.051,,,,23856038,,,,,,,0,1,0,13,0,0,1,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/1630731,https://api.altmetric.com/v1/donut/1630731_240.png 15,"Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study.",American Journal of Epidemiology,,,Article,2007-01-01,10.1093/aje/kwm269,,,,17925283,,,,,,,1,0,0,2,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1172459,https://api.altmetric.com/v1/donut/1172459_240.png 15,Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer,British Journal of Urology,,,Article,2012-05-01,10.1111/j.1464-410x.2011.10612.x,,,,21933336,,,,,,,0,1,2,2,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/694331,https://api.altmetric.com/v1/donut/694331_240.png 15,RETRACTED: EPCA-2: A Highly Specific Serum Marker for Prostate Cancer ,Urology,,,Article,2007-04-17,10.1016/j.urology.2007.01.097,,,,17445657,,,,,,,0,1,0,2,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/550351,https://api.altmetric.com/v1/donut/550351_240.png 15,Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort,European Urology,,,Article,2015-10-17,10.1016/j.eururo.2015.10.010,,,,26482887,,,,,,,0,1,0,11,0,0,2,0,1,0,0,0,0,0,0,20,https://www.altmetric.com/details/4643251,https://api.altmetric.com/v1/donut/4643251_240.png 15,Prostate cancer: Treatment with ADT impairs cognitive performance,Nature Reviews Urology,,,Article,2015-05-26,10.1038/nrurol.2015.126,,,,26032541,,,,,,,1,0,0,7,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4058729,https://api.altmetric.com/v1/donut/4058729_240.png 15,Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective Trials,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-10-10,10.1016/j.ijrobp.2013.08.019,,,,24119836,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1819326,https://api.altmetric.com/v1/donut/1819326_240.png 15,Examining a Therapeutic Yoga Program for Prostate Cancer Survivors.,Integrative Cancer Therapies,,,Article,2012-06-27,10.1177/1534735412446862,,,,22740082,,,,,,,1,0,0,8,0,0,2,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/817225,https://api.altmetric.com/v1/donut/817225_240.png 15,MP4-09 ENDOGENOUS AND EXOGENOUS TESTOSTERONE AND THE RISK OF PROSTATE CANCER AND PROSTATE SPECIFIC ANTIGEN,The Journal of Urology,,,Article,2015-06-14,10.1016/j.juro.2014.07.102,,,,25072182,,,,,,,0,1,0,14,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2546587,https://api.altmetric.com/v1/donut/2546587_240.png 15,Multitargeted Tyrosine Kinase Inhibition Produces Discordant Changes Between 99mTc-MDP Bone Scans and Other Disease Biomarkers: Analysis of a Phase II Study of Sunitinib for Metastatic Castration-Resistant Prostate Cancer.,Journal of Nuclear Medicine,,,Article,2012-09-19,10.2967/jnumed.112.105007,,,,22984218,,,,,,,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1178501,https://api.altmetric.com/v1/donut/1178501_240.png 15,Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.,Modern Pathology,,,Article,2014-09-05,10.1038/modpathol.2014.116,,,,25189638,,,,,,,0,0,0,28,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2658431,https://api.altmetric.com/v1/donut/2658431_240.png 15,Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-11-18,10.1073/pnas.1319948110,,,,24248375,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,1,0,0,32,https://www.altmetric.com/details/1915539,https://api.altmetric.com/v1/donut/1915539_240.png 15,Role of diet in prostate cancer development and progression.,Journal of Clinical Oncology,,,Article,2005-11-10,10.1200/jco.2005.03.1492,,,,16278466,,,,,,,1,0,1,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/738019,https://api.altmetric.com/v1/donut/738019_240.png 15,Risk factors for prostate cancer incidence and progression in the health professionals follow?up study,International Journal of Cancer,,,Article,2007-01-10,10.1002/ijc.22788,,,,17450530,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/663263,https://api.altmetric.com/v1/donut/663263_240.png 15,Prostate Cancer Early Detection,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2010-02-01,,,,,20141680,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6005099,https://api.altmetric.com/v1/donut/6005099_240.png 15,Prostate MRI and MRI-Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement of the American Urological Association and the Society of Abdominal Radiology’s Prostate Cancer Disease-Focused Panel,The Journal of Urology,,,Article,2016-06-16,10.1016/j.juro.2016.06.079,,,,27320841,,,,,,,0,0,0,29,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8804416,https://api.altmetric.com/v1/donut/8804416_240.png 15,"METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer",European Urology,,,Article,2016-06-15,10.1016/j.eururo.2016.05.033,,,,27317091,,,,,,,0,0,0,25,0,0,2,0,1,0,0,0,0,0,0,13,https://www.altmetric.com/details/8751612,https://api.altmetric.com/v1/donut/8751612_240.png 15,MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells,Scientific Reports,,,Article,2016-06-02,10.1038/srep27346,,,,27250340,PMC4890029,,,,,,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8468558,https://api.altmetric.com/v1/donut/8468558_240.png 15,Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate,Prostate Cancer & Prostatic Diseases,,,Article,2015-07-21,10.1038/pcan.2015.33,,,,26195470,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4301719,https://api.altmetric.com/v1/donut/4301719_240.png 15,Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-02-09,10.1073/pnas.1500097112,,,,25675522,,,,,,,0,0,0,25,0,0,3,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3443842,https://api.altmetric.com/v1/donut/3443842_240.png 15,Denosumab in bone-metastatic prostate cancer: known effects on skeletal-related events but unknown effects on quality of life,Asian Journal of Andrology,,,Article,2011-04-18,10.1038/aja.2011.33,,,,21499282,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/590335,https://api.altmetric.com/v1/donut/590335_240.png 15,Does Degree of Androgen Suppression Matter in Hormone-Sensitive Prostate Cancer?,Journal of Clinical Oncology,,,Article,2015-03-02,10.1200/jco.2014.60.1419,,,,25732171,,,,,,,1,0,0,12,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3747216,https://api.altmetric.com/v1/donut/3747216_240.png 15,"Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer.",Clinical Cancer Research,,,Article,2014-10-01,10.1158/1078-0432.ccr-14-0489,,,,25278449,,,,,,,1,0,0,5,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2739354,https://api.altmetric.com/v1/donut/2739354_240.png 15,The Impact of Repeat Biopsies on Infectious Complications in Men with Prostate Cancer on Active Surveillance.,The Journal of Urology,,,Article,2013-09-06,10.1016/j.juro.2013.08.088,,,,24018237,,,,,,,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1799997,https://api.altmetric.com/v1/donut/1799997_240.png 15,Testosterone Replacement Therapy in Patients with Prostate Cancer After Radical Prostatectomy.,The Journal of Urology,,,Article,2013-02-11,10.1016/j.juro.2013.02.002,,,,23395803,,,,,,,0,1,0,5,0,0,1,2,1,0,0,0,1,0,0,30,https://www.altmetric.com/details/1234030,https://api.altmetric.com/v1/donut/1234030_240.png 15,National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study,Cancer (0008543X),,,Article,2016-03-01,10.1002/cncr.29960,,,,26970022,,,,,,,1,0,0,10,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6169346,https://api.altmetric.com/v1/donut/6169346_240.png 15,Pretreatment Tables Predicting Pathologic Stage of Locally Advanced Prostate Cancer,European Urology,,,Article,2014-03-21,10.1016/j.eururo.2014.03.013,,,,24684960,,,,,,,0,0,0,73,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2204597,https://api.altmetric.com/v1/donut/2204597_240.png 15,Patient-reported outcomes in metastatic castration-resistant prostate cancer,Nature Reviews Clinical Oncology,,,Article,2016-06-28,10.1038/nrclinonc.2016.100,,,,27349193,,,,,,,1,0,0,10,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9101759,https://api.altmetric.com/v1/donut/9101759_240.png 15,Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?,JAMA Oncology,,,Article,2015-06-04,10.1001/jamaoncol.2015.1457,,,,26181796,,,,,,,0,0,0,31,0,0,6,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/4095479,https://api.altmetric.com/v1/donut/4095479_240.png 15,Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study,Journal for Immunotherapy of Cancer,,,Article,2015-01-01,10.1186/s40425-015-0068-y,,,,26082837,,,,,,,1,0,0,5,0,0,1,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4184300,https://api.altmetric.com/v1/donut/4184300_240.png 15,Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?,European Urology,,,Article,2015-03-10,10.1016/j.eururo.2015.02.038,,,,25769986,,,,,,,0,0,0,26,0,0,4,0,1,0,0,0,0,0,0,12,https://www.altmetric.com/details/3774053,https://api.altmetric.com/v1/donut/3774053_240.png 15,Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2014.12.012,,,,25624093,,,,,,,0,1,0,10,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3105701,https://api.altmetric.com/v1/donut/3105701_240.png 15,Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer,Cancer (0008543X),,,Article,2016-05-18,10.1002/cncr.30049,,,,27191936,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8186397,https://api.altmetric.com/v1/donut/8186397_240.png 15,Prostate cancer: Novel xenografts in mice[mdash]a new wave of preclinical models,Nature Reviews Urology,,,Article,2015-08-18,10.1038/nrurol.2015.198,,,,26282212,,,,,,,1,0,0,8,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4407945,https://api.altmetric.com/v1/donut/4407945_240.png 15,"Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)",European Urology,,,Article,2014-10-05,10.1016/j.eururo.2014.09.032,,,,25301760,,,,,,,0,0,0,25,0,0,1,0,0,0,0,0,1,0,0,77,https://www.altmetric.com/details/2748072,https://api.altmetric.com/v1/donut/2748072_240.png 15,"Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future",European Urology,,,Article,2016-05-03,10.1016/j.eururo.2016.04.024,,,,27156443,,,,,,,0,0,0,30,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7126292,https://api.altmetric.com/v1/donut/7126292_240.png 15,Ultrasound-enhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles.,Journal of Controlled Release,,,Article,,10.1016/j.jconrel.2014.05.020,,,,24852099,,,,,,,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2380039,https://api.altmetric.com/v1/donut/2380039_240.png 15,Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group,Journal of Clinical Oncology,,,Article,2008-01-01,10.1200/jco.2007.12.4487,,,,18309951,,,,,,,1,0,2,3,0,0,0,0,0,0,0,0,0,0,0,185,https://www.altmetric.com/details/1786339,https://api.altmetric.com/v1/donut/1786339_240.png 15,Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression.,Prostate Cancer & Prostatic Diseases,,,Article,2013-07-23,10.1038/pcan.2013.19,,,,23877027,,,,,,,1,0,0,3,0,0,3,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1647160,https://api.altmetric.com/v1/donut/1647160_240.png 15,"Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers",Physical Biology,,,Article,2012-02-01,10.1088/1478-3975/9/1/016003,,,,22306768,,,2012PhBio...9a6003M,,,,1,0,0,3,0,0,0,1,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/593628,https://api.altmetric.com/v1/donut/593628_240.png 15,Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review.,International Journal of Food Sciences & Nutrition,,,Article,2011-07-15,10.3109/09637486.2011.598849,,,,21762028,,,,,,,0,1,0,1,0,0,0,3,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/189958,https://api.altmetric.com/v1/donut/189958_240.png 15,Radical prostatectomy and observation did not differ for mortality in localized prostate cancer.,Annals of Internal Medicine,,,Article,2012-10-16,10.7326/0003-4819-157-8-201210160-02005,,,,23070507,,,,,,,0,1,0,9,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1006096,https://api.altmetric.com/v1/donut/1006096_240.png 15,In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2001-12-01,,,,,11916349,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1368879,https://api.altmetric.com/v1/donut/1368879_240.png 15,Whole-gland Ablation of Localized Prostate Cancer with High-intensity Focused Ultrasound: Oncologic Outcomes and Morbidity in 1002 Patients.,European Urology,,,Article,2013-05-16,10.1016/j.eururo.2013.04.039,,,,23669165,,,,,,,1,0,0,8,0,0,0,0,1,0,0,0,0,0,0,41,https://www.altmetric.com/details/2252872,https://api.altmetric.com/v1/donut/2252872_240.png 15,Risk stratification in prostate cancer screening,Nature Reviews Urology,,,Article,2012-12-18,10.1038/nrurol.2012.225,,,,23247693,,,,,,,0,1,1,9,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/1132858,https://api.altmetric.com/v1/donut/1132858_240.png 15,"Diet, Nutrition and Physical Activity and Prostate Cancer. 2014",World Cancer Research Fund International,,,Article,,,,,http://www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf,,,,,,,,0,1,0,5,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4095460,https://api.altmetric.com/v1/donut/4095460_240.png 15,Diagnosing ‘male’ depression in men diagnosed with prostate cancer: the next step in effective translational psycho?oncology interventions?,Psycho-Oncology,,,Article,2014-04-06,10.1002/pon.3530,,,,24700681,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2281121,https://api.altmetric.com/v1/donut/2281121_240.png 15,Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-03-08,10.1016/j.eururo.2016.02.055,,,,26965561,,,,,,,0,1,0,13,0,0,3,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/6136585,https://api.altmetric.com/v1/donut/6136585_240.png 15,Prostate Cancer and Testosterone Replacement Therapy—What is the Risk?,The Journal of Urology,,,Article,2015-09-20,10.1016/j.juro.2015.09.059,,,,26386278,,,,,,,1,0,0,11,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4525489,https://api.altmetric.com/v1/donut/4525489_240.png 15,Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy,Canadian Urological Association Journal,,,Article,2013-07-14,10.5489/cuaj.175,,,,24032068,PMC3758950,,,,,,0,0,0,14,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4093894,https://api.altmetric.com/v1/donut/4093894_240.png 15,Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b|[sol]|4 PCa: a multi-institutional outcome study of 266 patients,Prostate Cancer & Prostatic Diseases,,,Article,2014-12-23,10.1038/pcan.2014.41,,,,25535100,,,,,,,1,0,0,6,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3010293,https://api.altmetric.com/v1/donut/3010293_240.png 15,"Urinary Melatonin Levels, Sleep Disruption, and Risk of Prostate Cancer in Elderly Men",European Urology,,,Article,2015-02-01,10.1016/j.eururo.2014.07.008,,,,25107635,,,,,,,1,0,0,15,0,0,4,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/2574063,https://api.altmetric.com/v1/donut/2574063_240.png 15,Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Prostate Cancer Cell Migration and Invasion Induced by Tumor-Associated Macrophages,PLoS ONE,,,Article,2014-06-12,10.1371/journal.pone.0099630,,,,24925287,,,,,,,1,0,0,2,1,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2434612,https://api.altmetric.com/v1/donut/2434612_240.png 15,"Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study",Lancet Oncology,,,Article,2014-04-14,10.1016/s1470-2045(14)70129-9,,,,24739897,,,,,,,0,0,0,16,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2276834,https://api.altmetric.com/v1/donut/2276834_240.png 15,Acne and risk of prostate cancer.,International Journal of Cancer,,,Article,2007-12-15,10.1002/ijc.23032,,,,17724724,PMC3076591,,,,,,1,1,0,0,0,0,0,0,1,0,0,0,0,0,1,2,https://www.altmetric.com/details/3035832,https://api.altmetric.com/v1/donut/3035832_240.png 15,Downregulation of signalling molecules involved in angiogenesis of prostate cancer cell line (PC-3) by kombucha (lyophilized),Biomedicine & Preventive Nutrition,,,Article,2013-01-01,10.1016/j.bionut.2012.08.001,,,,,,,,,,,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1545915,https://api.altmetric.com/v1/donut/1545915_240.png 15,Prostate Cancer Focal Therapy: Just Because You Can Does Not Mean You Should,European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.09.025,,,,27665321,,,,,,,0,0,0,29,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/12129872,https://api.altmetric.com/v1/donut/12129872_240.png 15,The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer,European Urology,,,Article,2016-03-06,10.1016/j.eururo.2016.02.047,,,,26961255,,,,,,,0,0,0,33,0,0,6,0,2,0,0,0,0,0,0,3,https://www.altmetric.com/details/6126852,https://api.altmetric.com/v1/donut/6126852_240.png 15,Morbidity Associated with Primary High Intensity Focused Ultrasound and Redo High Intensity Focused Ultrasound for Localized Prostate Cancer,The Journal of Urology,,,Article,2013-12-26,10.1016/j.juro.2013.12.036,,,,24373800,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2005547,https://api.altmetric.com/v1/donut/2005547_240.png 15,"Dietary Flavonoid Intake, Black Tea Consumption, and Risk of Overall and Advanced Stage Prostate Cancer",American Journal of Epidemiology,,,Article,2013-05-30,10.1093/aje/kws419,,,,23722011,,,,,,,0,1,0,10,0,0,4,0,1,0,0,0,0,0,0,19,https://www.altmetric.com/details/1525552,https://api.altmetric.com/v1/donut/1525552_240.png 15,Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer.,PLoS ONE,,,Article,2013-05-10,10.1371/journal.pone.0063723,,,,23675504,PMC3651196,,,,,,0,1,0,8,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1464495,https://api.altmetric.com/v1/donut/1464495_240.png 15,"An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?",World Journal of Urology,,,Article,2015-02-20,10.1007/s00345-015-1514-7,,,,25698456,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3773146,https://api.altmetric.com/v1/donut/3773146_240.png 15,"Circulating vitamin D, vitamin D–related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium",Cancer (0008543X),,,Article,2015-03-02,10.1002/cncr.29320,,,,25731953,,,,,,,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3752544,https://api.altmetric.com/v1/donut/3752544_240.png 15,Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy,British Journal of Urology,,,Article,2012-05-28,10.1111/j.1464-410x.2012.11268.x,,,,22639942,,,,,,,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/767930,https://api.altmetric.com/v1/donut/767930_240.png 15,No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients,PLoS ONE,,,Article,2012-05-16,10.1371/journal.pone.0036073,,,,22615749,,,2012PLoSO...7E6073M,,,,0,1,0,5,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/750281,https://api.altmetric.com/v1/donut/750281_240.png 15,Absence of XMRV and Closely Related Viruses in Primary Prostate Cancer Tissues Used to Derive the XMRV-Infected Cell Line 22Rv1,PLoS ONE,,,Article,2012-05-16,10.1371/journal.pone.0036072,,,,22615748,,,2012PLoSO...7E6072D,,,,0,1,0,5,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/748461,https://api.altmetric.com/v1/donut/748461_240.png 15,Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest,Journal of Biological Chemistry,,,Article,2006-12-22,10.1074/jbc.m603495200,,,,17068343,,,,,,,0,0,0,5,0,0,46,0,0,0,0,0,0,0,3,34,https://www.altmetric.com/details/478968,https://api.altmetric.com/v1/donut/478968_240.png 15,A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.,Nature Genetics,,,Article,2012-10-28,10.1038/ng.2437,,,,23104005,,,,,,,0,2,0,9,0,0,2,0,0,0,0,0,0,0,0,96,https://www.altmetric.com/details/1039164,https://api.altmetric.com/v1/donut/1039164_240.png 15,Age dependent associations between androgenetic alopecia and prostate cancer risk.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-10-16,10.1158/1055-9965.epi-12-0860,,,,23074289,,11343/44041,,,,,1,0,0,7,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1008262,https://api.altmetric.com/v1/donut/1008262_240.png 15,Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer,Oncologist,,,Article,2013-01-01,10.1634/theoncologist.2012-314,,,,23340005,,,,,,,0,1,0,5,0,0,1,1,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/1616104,https://api.altmetric.com/v1/donut/1616104_240.png 15,"2013 AUA Guideline on Early Detection of Prostate Cancer Continues to Support Rational, Limited Screening.",The Journal of Urology,,,Article,2013-05-22,10.1016/j.juro.2013.05.030,,,,23688640,,,,,,,0,1,0,9,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1506082,https://api.altmetric.com/v1/donut/1506082_240.png 15,Therapeutic Targeting of SPINK1-Positive Prostate Cancer,Science Translational Medicine,,,Article,2011-03-05,10.1126/scitranslmed.3001498,,,,21368222,PMC3211047,,,,,,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1357286,https://api.altmetric.com/v1/donut/1357286_240.png 15,"Improved Overall Survival Trends of Men with Newly Diagnosed M1 Prostate Cancer: A SWOG Phase III Trial Experience (S8494, S8894 and S9346)",The Journal of Urology,,,Article,2012-08-23,10.1016/j.juro.2012.06.046,,,,22921015,,,,,,,0,1,0,10,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/910076,https://api.altmetric.com/v1/donut/910076_240.png 15,"Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations",Nature Reviews Urology,,,Article,2016-10-11,10.1038/nrurol.2016.175,,,,27725639,,,,,,,1,0,0,8,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12555965,https://api.altmetric.com/v1/donut/12555965_240.png 15,Intermittent Androgen Deprivation Therapy—An Important Treatment Option for Prostate Cancer,JAMA Oncology,,,Article,2016-08-25,10.1001/jamaoncol.2016.3138,,,,27560985,,,,,,,0,0,0,29,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/10820109,https://api.altmetric.com/v1/donut/10820109_240.png 15,Intake of dietary antioxidants is inversely associated with biomarkers of oxidative stress among men with prostate cancer,British Journal of Nutrition,,,Article,2015-11-03,10.1017/s0007114515004249,,,,26521663,,,,,,,1,0,0,7,0,0,5,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4716522,https://api.altmetric.com/v1/donut/4716522_240.png 15,"Prostate cancer: Cabazitaxel[mdash]a key therapeutic option in prostate cancer",Nature Reviews Urology,,,Article,2015-05-26,10.1038/nrurol.2015.98,,,,26032550,,,,,,,1,0,0,6,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4058428,https://api.altmetric.com/v1/donut/4058428_240.png 15,Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer,European Urology,,,Article,2015-08-01,10.1016/j.eururo.2014.07.020,,,,25108577,,,,,,,0,0,0,21,0,0,1,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/2577737,https://api.altmetric.com/v1/donut/2577737_240.png 15,"Follow-Up Care Experiences and Perceived Quality of Care Among Long-Term Survivors of Breast, Prostate, Colorectal, and Gynecologic Cancers",Journal of Oncology Practice,,,Article,,10.1200/jop.2013.001175,,,,,,,,,,,0,0,0,23,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2231105,https://api.altmetric.com/v1/donut/2231105_240.png 15,Will Focal Therapy Remain Only an Attractive Illusion for the Primary Treatment of Prostate Cancer?,Journal of Clinical Oncology,,,Article,,10.1200/jco.2013.54.8214,,,,24687824,,,,,,,0,0,0,24,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2229232,https://api.altmetric.com/v1/donut/2229232_240.png 15,Watchful Waiting–Active Surveillance in Low-Risk Prostate Cancer,JAMA Oncology,,,Article,2015-06-04,10.1001/jamaoncol.2015.1214,,,,26182350,,,,,,,0,0,0,24,0,0,2,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4118758,https://api.altmetric.com/v1/donut/4118758_240.png 15,"ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer",ecancer.org,,,Article,,,,,http://ecancer.org/news/7350-asco-2015--first-effective-adjuvant-chemotherapy-for-high-risk--localised-prostate-cancer.php,,,,,,,,1,0,0,10,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4074201,https://api.altmetric.com/v1/donut/4074201_240.png 15,Radiotherapy for high-risk prostate cancer,Nature Reviews Urology,,,Article,2015-02-24,10.1038/nrurol.2015.25,,,,25708578,,,,,,,1,0,0,8,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3729960,https://api.altmetric.com/v1/donut/3729960_240.png 15,FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer,Journal of Clinical Investigation,,,Article,2011-03-26,10.1172/jci44325,,,,21436588,PMC3069771,,,,,,1,1,0,0,1,0,0,0,0,0,0,0,1,0,0,61,https://www.altmetric.com/details/535532,https://api.altmetric.com/v1/donut/535532_240.png 14,Lysophosphatidic acid receptor isoforms expression in prostate cancer cells is differentially regulated by the CYP17A1 inhibitor abiraterone and depends on the androgen receptor,Advances in Modern Oncology Research,,,Article,2016-02-19,10.18282/amor.v2.i1.83,,,,,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6019392,https://api.altmetric.com/v1/donut/6019392_240.png 14,Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).,American Journal of Clinical Nutrition,,,Article,2008-12-15,10.3945/ajcn.2008.26205,,,,19064517,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/5471297,https://api.altmetric.com/v1/donut/5471297_240.png 14,Survival in men older than 75 years with low- and intermediate-grade prostate cancer managed with watchful waiting with active surveillance,,,,Article,,10.15212/fmch.2015.0129.,,,,,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4820166,https://api.altmetric.com/v1/donut/4820166_240.png 14,Cytoplasmic PML promotes TGF-|[beta]|-associated epithelial|[ndash]|mesenchymal transition and invasion in prostate cancer,Oncogene,,,Article,2015-11-09,10.1038/onc.2015.409,,,,26549027,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4788049,https://api.altmetric.com/v1/donut/4788049_240.png 14,"Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions",Human Molecular Genetics,,,Article,2015-10-21,10.1093/hmg/ddv440,,,,26483192,,,,,,,1,0,0,15,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4653423,https://api.altmetric.com/v1/donut/4653423_240.png 14,Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-02-10,10.1038/pcan.2015.1,,,,25667108,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3549207,https://api.altmetric.com/v1/donut/3549207_240.png 14,A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer,Cancer Cell,,,Article,2015-09-02,10.1016/j.ccell.2014.11.013,,,,25670080,,,,,,,1,0,0,2,0,1,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/3446399,https://api.altmetric.com/v1/donut/3446399_240.png 14,"Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5.",Journal of Clinical Oncology,,,Article,2015-01-26,10.1200/jco.2014.56.5119,,,,25624429,,,,,,,0,0,0,21,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3105703,https://api.altmetric.com/v1/donut/3105703_240.png 14,Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody,Lab on a Chip - Miniaturisation for Chemistry & Biology,,,Article,2009-11-16,10.1039/b917959c,,,,20024046,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,160,https://www.altmetric.com/details/2900937,https://api.altmetric.com/v1/donut/2900937_240.png 14,Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer,Genome Biology (Online Edition),,,Article,2014-08-26,10.1186/s13059-014-0426-y,,,,,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/2628213,https://api.altmetric.com/v1/donut/2628213_240.png 14,Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the REDUCE Study,Clinical Cancer Research,,,Article,2014-08-18,10.1158/1078-0432.ccr-13-2394,,,,25139338,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2611863,https://api.altmetric.com/v1/donut/2611863_240.png 14,Thromboelastography Identifies Hypercoagulablilty and Predicts Thromboembolic Complications in Patients with Prostate Cancer,Thrombosis Research,,,Article,2013-11-21,10.1016/j.thromres.2013.10.007,,,,24246296,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2080462,https://api.altmetric.com/v1/donut/2080462_240.png 14,Proteomic Analysis of Formalin-fixed Prostate Cancer Tissue,Molecular and Cellular Proteomics (MCP Online),,,Article,2005-08-19,10.1074/mcp.m500102-mcp200,,,,16091476,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1815440,https://api.altmetric.com/v1/donut/1815440_240.png 14,Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-09-01,,,,,14504196,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1418362,https://api.altmetric.com/v1/donut/1418362_240.png 14,"Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cellâ??line specific manner, through paradoxical effects on oncogenic pathways",The Prostate,,,Article,2013-01-01,10.1002/pros.22619,,,,23192356,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1094016,https://api.altmetric.com/v1/donut/1094016_240.png 14,Variation in selenoenzyme genes and prostate cancer risk and survival.,The Prostate,,,Article,2012-01-01,10.1002/pros.22617,,,,23143801,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1058591,https://api.altmetric.com/v1/donut/1058591_240.png 14,Potential for prostate cancer prevention through physical activity,World Journal of Urology,,,Article,2011-12-28,10.1007/s00345-011-0812-y,,,,22198724,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/520478,https://api.altmetric.com/v1/donut/520478_240.png 14,Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies.,Nutrition and Cancer,,,Article,2011-06-10,10.1080/01635581.2011.570895,,,,21667398,,,,,,,0,1,0,2,0,0,1,2,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/171997,https://api.altmetric.com/v1/donut/171997_240.png 14,Immediate Risk of Suicide and Cardiovascular Death After a Prostate Cancer Diagnosis: Cohort Study in the United States,JNCI: Journal of the National Cancer Institute,,,Article,2010-01-01,10.1093/jnci/djp537,,,,20124521,,,,,,,0,2,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/683349,https://api.altmetric.com/v1/donut/683349_240.png 14,Re: Endogenous and Exogenous Testosterone and the Risk of Prostate Cancer and Increased Prostate Specific Antigen (PSA): A Meta-Analysis,The Journal of Urology,,,Article,2016-06-15,10.1016/j.juro.2016.06.061,,,,27597096,,,,,,,0,0,0,30,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8775454,https://api.altmetric.com/v1/donut/8775454_240.png 14,Effects of exercise training on tumor hypoxia and vascular function in the rodent pre-clinical orthotopic prostate cancer model.,Journal of Applied Physiology,,,Article,2013-10-31,10.1152/japplphysiol.00949.2013,,,,24177690,,,,,,,1,0,0,7,0,0,4,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1877932,https://api.altmetric.com/v1/donut/1877932_240.png 14,Dietary antioxidants and prostate cancer: a review.,Nutrition and Cancer,,,Article,2013-08-01,10.1080/01635581.2013.806672,,,,23909722,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1671722,https://api.altmetric.com/v1/donut/1671722_240.png 14,Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer,Nature Communications,,,Article,2016-03-15,10.1038/ncomms10982,,,,26975529,,,,,,,0,0,0,31,0,0,3,0,2,0,0,0,0,0,0,63,https://www.altmetric.com/details/6197487,https://api.altmetric.com/v1/donut/6197487_240.png 14,Potent induction of phase 2 enzymes in human prostate cells by sulforaphane.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2001-09-01,,,,,11535546,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1148837,https://api.altmetric.com/v1/donut/1148837_240.png 14,A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.,The Journal of Urology,,,Article,2011-01-01,10.1016/j.juro.2010.12.032,,,,21419439,PMC3140702,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/1458983,https://api.altmetric.com/v1/donut/1458983_240.png 14,Prostate cancer: Antiandrogens reverse docetaxel resistance via ABCB1 inhibition,Nature Reviews Urology,,,Article,2015-06-09,10.1038/nrurol.2015.135,,,,26057062,,,,,,,1,0,0,3,0,0,1,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4124115,https://api.altmetric.com/v1/donut/4124115_240.png 14,Fat intake after prostate cancer diagnosis and mortality in the Physicians’ Health Study,Cancer Causes and Control,,,Article,2015-06-06,10.1007/s10552-015-0606-4,,,,26047644,,,,,,,1,0,0,8,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4103208,https://api.altmetric.com/v1/donut/4103208_240.png 14,Guideline of Guidelines: Imaging of Localized Prostate Cancer,British Journal of Urology,,,Article,2015-06-01,10.1111/bju.13104,,,,25715887,,,,,,,0,3,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3740903,https://api.altmetric.com/v1/donut/3740903_240.png 14,"A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model",PLoS ONE,,,Article,,10.1371/journal.pone.0114260,,,,25479232,,,,,,,1,0,0,7,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2957487,https://api.altmetric.com/v1/donut/2957487_240.png 14,Trends in Prostate Cancer Screening Following Changes Made by the US Preventive Services Task Force,JAMA Surgery,,,Article,2016-11-02,10.1001/jamasurg.2016.3999,,,,27806148,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13286033,https://api.altmetric.com/v1/donut/13286033_240.png 14,Prostate cancer: No need to rush for men with low-risk disease,Nature Reviews Urology,,,Article,2015-02-10,10.1038/nrurol.2015.23,,,,25666895,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3447148,https://api.altmetric.com/v1/donut/3447148_240.png 14,Retraction: Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells,Cancer Research,,,Article,2016-03-24,10.1158/0008-5472.can-16-0505,,,,27013202,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6324858,https://api.altmetric.com/v1/donut/6324858_240.png 14,Body mass index and mortality in prostate cancer patients: a dose|[ndash]|response meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-12,10.1038/pcan.2015.64,,,,26754262,,,,,,,1,0,0,6,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4982955,https://api.altmetric.com/v1/donut/4982955_240.png 14,Emerging mechanisms of enzalutamide resistance in prostate cancer,Nature Reviews Urology,,,Article,2014-09-16,10.1038/nrurol.2014.243,,,,25224448,,,,,,,1,0,0,7,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2689671,https://api.altmetric.com/v1/donut/2689671_240.png 14,"Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies.",Nutrition and Cancer,,,Article,2007-12-31,10.1080/01635580801911779,,,,18584476,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1474916,https://api.altmetric.com/v1/donut/1474916_240.png 14,Genome-wide DNA methylation events in TMPRSS2:ERG fusion negative prostate cancers implicate an EZH2 dependent mechanism with miRNA-26a hypermethylation.,Cancer Discovery,,,Article,2012-08-28,10.1158/2159-8290.cd-12-0041,,,,22930729,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/920880,https://api.altmetric.com/v1/donut/920880_240.png 14,White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice.,Nutrition and Cancer,,,Article,2008-01-01,10.1080/01635580802192866,,,,19005974,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/466823,https://api.altmetric.com/v1/donut/466823_240.png 14,Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.,Nature Genetics,,,Article,2008-02-10,10.1038/ng.89,,,,18264098,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,90,https://www.altmetric.com/details/114981,https://api.altmetric.com/v1/donut/114981_240.png 14,"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.",JAMA: Journal of the American Medical Association,,,Article,1998-09-16,,,,,9749478,,,,,,,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1596229,https://api.altmetric.com/v1/donut/1596229_240.png 14,Association between travel distance and choice of treatment for prostate cancer: does geography reduce patient choice?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-05-01,10.1016/j.ijrobp.2016.05.022,,,,27496390,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8325238,https://api.altmetric.com/v1/donut/8325238_240.png 14,Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target,JNCI: Journal of the National Cancer Institute,,,Article,2016-05-01,10.1093/jnci/djv371,,,,26657335,,,,,,,1,0,0,7,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4869191,https://api.altmetric.com/v1/donut/4869191_240.png 14,Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort,British Journal of Cancer,,,Article,2015-06-23,10.1038/bjc.2015.223,,,,26103570,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4204132,https://api.altmetric.com/v1/donut/4204132_240.png 14,Patients with prostate cancer and BRCA2 mutations need urgent treatment,British Medical Journal,,,Article,2013-04-09,10.1136/bmj.f2223,,,,23571745,,,,,,,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1359330,https://api.altmetric.com/v1/donut/1359330_240.png 14,Active Surveillance of Very-low-risk Prostate Cancer in the Setting of Active Treatment of Benign Prostatic Hyperplasia With 5?-reductase Inhibitors.,Urology,,,Article,2013-03-20,10.1016/j.urology.2012.10.089,,,,23523297,,,,,,,2,0,0,8,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1332153,https://api.altmetric.com/v1/donut/1332153_240.png 14,Adding age and genetic risk to PSA test could improve screening for prostate cancer,British Medical Journal,,,Article,2012-11-06,10.1136/bmj.e7467,,,,23131672,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1045353,https://api.altmetric.com/v1/donut/1045353_240.png 14,Active Surveillance in Men With Localized Prostate Cancer: A Systematic Review.,Annals of Internal Medicine,,,Article,2012-02-20,10.1059/0003-4819-156-8-201204170-00397,,,,22351515,,,,,,,0,0,0,23,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/617023,https://api.altmetric.com/v1/donut/617023_240.png 14,Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue,BMC Medicine,,,Article,2012-09-25,10.1186/1741-7015-10-108,,,,23009291,,,,,,,0,1,0,9,0,0,3,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/964022,https://api.altmetric.com/v1/donut/964022_240.png 14,Male pattern baldness and the risk of prostate cancer,Annals of Oncology,,,Article,2011-01-01,10.1093/annonc/mdq695,,,,21324955,,,,,,,0,1,0,6,0,0,1,0,0,0,0,0,1,0,0,22,https://www.altmetric.com/details/504622,https://api.altmetric.com/v1/donut/504622_240.png 14,Case-control studies of prostate cancer in blacks and whites in southern California.,JNCI: Journal of the National Cancer Institute,,,Article,1987-05-01,,,,,3471995,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1374809,https://api.altmetric.com/v1/donut/1374809_240.png 14,Dietary Total and Insoluble Fiber Intakes Are Inversely Associated with Prostate Cancer Risk.,Journal of Nutrition,,,Article,,10.3945/jn.113.189670,,,,24553693,,,,,,,0,0,0,23,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2132754,https://api.altmetric.com/v1/donut/2132754_240.png 14,The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer,FASEB Journal,,,Article,2010-06-03,10.1096/fj.10-160838,,,,20522783,,,,,,,0,1,0,11,0,0,3,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/222140,https://api.altmetric.com/v1/donut/222140_240.png 14,Natural History of Clinical Recurrence Patterns of Lymph Node–Positive Prostate Cancer After Radical Prostatectomy,European Urology,,,Article,2015-04-14,10.1016/j.eururo.2015.03.036,,,,25865061,,,,,,,1,0,0,7,0,0,4,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/3894914,https://api.altmetric.com/v1/donut/3894914_240.png 14,Male pattern baldness in relation to prostate cancer risks: An analysis in the VITamins and lifestyle (VITAL) cohort study.,The Prostate,,,Article,2014-12-09,10.1002/pros.22927,,,,25492530,,,,,,,1,0,0,7,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2968334,https://api.altmetric.com/v1/donut/2968334_240.png 14,An evaluation of the ‘weekend effect’ in patients admitted with metastatic prostate cancer,British Journal of Urology,,,Article,2015-04-01,10.1111/bju.12891,,,,25099032,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2578812,https://api.altmetric.com/v1/donut/2578812_240.png 14,Very-high-risk localized prostate cancer: definition and outcomes.,Prostate Cancer & Prostatic Diseases,,,Article,2013-11-07,10.1038/pcan.2013.46,,,,24189998,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2182520,https://api.altmetric.com/v1/donut/2182520_240.png 14,American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12318,,,,23924423,,,,,,,0,3,0,10,0,0,1,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/1673969,https://api.altmetric.com/v1/donut/1673969_240.png 14,"Association between race and follow?up diagnostic care after a positive prostate cancer screening test in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial",Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28042,,,,23559420,,,,,,,1,0,1,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1343674,https://api.altmetric.com/v1/donut/1343674_240.png 14,National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer,Annals of Internal Medicine,,,Article,2012-01-01,10.1059/0003-4819-156-8-201204170-00401,,,,22351514,,,,,,,0,0,0,17,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/624845,https://api.altmetric.com/v1/donut/624845_240.png 14,Rectal swab testing before prostate biopsy: experience in a VA Medical Center urology practice,Prostate Cancer & Prostatic Diseases,,,Article,2015-08-11,10.1038/pcan.2015.38,,,,26260997,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4386109,https://api.altmetric.com/v1/donut/4386109_240.png 14,Sexual Factors and the Risk of Prostate Cancer,American Journal of Epidemiology,,,Article,2001-01-01,10.1093/aje/153.12.1152,,,,11415949,,,,,,,0,1,0,3,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1365512,https://api.altmetric.com/v1/donut/1365512_240.png 14,Spotlight on prostate cancer: the latest evidence and current controversies,BMC Medicine,,,Article,2015-03-24,10.1186/s12916-015-0311-x,,,,25857774,,,,,,,0,1,0,14,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3826146,https://api.altmetric.com/v1/donut/3826146_240.png 14,Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.,American Journal of Clinical Nutrition,,,Article,2008-01-01,,,,,18469265,,,,,,,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1367826,https://api.altmetric.com/v1/donut/1367826_240.png 14,Prostate cancer: The applicability of textural analysis of MRI for grading,Nature Reviews Urology,,,Article,2016-02-16,10.1038/nrurol.2016.33,,,,26878802,,,,,,,1,0,0,8,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5616501,https://api.altmetric.com/v1/donut/5616501_240.png 14,NICE guidance on sipuleucel-T for asymptomatic or minimally symptomatic metastatic hormone-relapsed prostate cancer,Lancet Oncology,,,Article,2015-02-24,10.1016/s1470-2045(14)70485-1,,,,25732545,,,,,,,1,0,0,8,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3731242,https://api.altmetric.com/v1/donut/3731242_240.png 14,Disparities in Access to Hospitals with Robotic Surgery for Patients with Prostate Cancer Undergoing Radical Prostatectomy,The Journal of Urology,,,Article,2012-12-18,10.1016/j.juro.2012.09.033,,,,23253307,,,,,,,2,0,0,3,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1133698,https://api.altmetric.com/v1/donut/1133698_240.png 14,Adoption of a plant-based diet by patients with recurrent prostate cancer.,Integrative Cancer Therapies,,,Article,2006-08-03,10.1177/1534735406292053,,,,16880426,,,,,,,0,1,0,2,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/802492,https://api.altmetric.com/v1/donut/802492_240.png 14,"Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.",The Prostate,,,Article,2008-01-01,10.1002/pros.20683,,,,17999389,PMC3959866,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/192751,https://api.altmetric.com/v1/donut/192751_240.png 14,Probing the invasiveness of prostate cancer cells in a 3D microfabricated landscape,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-04-07,10.1073/pnas.1102808108,,,,21474778,PMC3084062,,2011PNAS..108.6853L,,,,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,85,https://www.altmetric.com/details/423078,https://api.altmetric.com/v1/donut/423078_240.png 14,Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array,British Journal of Cancer,,,Article,2016-03-10,10.1038/bjc.2016.50,,,,26964030,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6159975,https://api.altmetric.com/v1/donut/6159975_240.png 14,Reconciling Primary Care and Specialist Perspectives on Prostate Cancer Screening,Annals of Family Medicine,,,Article,2012-11-12,10.1370/afm.1399,,,,23149535,,,,,,,0,0,0,21,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1063639,https://api.altmetric.com/v1/donut/1063639_240.png 14,A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.,Cancer (0008543X),,,Article,2014-11-25,10.1002/cncr.29148,,,,25423899,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2975685,https://api.altmetric.com/v1/donut/2975685_240.png 14,Quality of care received and patient-reported regret in prostate cancer: Analysis of a population-based prospective cohort,Cancer (0008543X),,,Article,2016-09-13,10.1002/cncr.30315,,,,27622730,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11998476,https://api.altmetric.com/v1/donut/11998476_240.png 14,Low?grade prostate cancer diverges early from high grade and metastatic disease,Cancer Science,,,Article,2014-08-01,10.1111/cas.12460,,,,24890684,,,,,,,0,1,0,6,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/2413497,https://api.altmetric.com/v1/donut/2413497_240.png 14,Effects of resistance training frequency on physical functioning and quality of life in prostate cancer survivors: a pilot randomized controlled trial,Prostate Cancer & Prostatic Diseases,,,Article,2015-06-16,10.1038/pcan.2015.28,,,,26078203,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4176329,https://api.altmetric.com/v1/donut/4176329_240.png 14,Induction of apoptosis by thiosulfinates in primary human prostate cancer cells.,International Journal of Oncology,,,Article,2008-03-25,,,,,18360714,,,,,,,0,0,0,3,0,0,28,0,4,0,0,0,0,0,0,1,https://www.altmetric.com/details/2691784,https://api.altmetric.com/v1/donut/2691784_240.png 14,Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside?,Oncologist,,,Article,2012-01-01,10.1634/theoncologist.2012-0094,,,,22618569,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/898086,https://api.altmetric.com/v1/donut/898086_240.png 14,Identification of a new prostate cancer susceptibility locus on chromosome 8q24,Nature Genetics,,,Article,2009-09-20,10.1038/ng.444,,,,19767755,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/413744,https://api.altmetric.com/v1/donut/413744_240.png 14,Prostate cancer: No evidence for adjuvant chemotherapy in high-risk disease,Nature Reviews Urology,,,Article,2015-09-01,10.1038/nrurol.2015.219,,,,26334083,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4459163,https://api.altmetric.com/v1/donut/4459163_240.png 14,Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone,British Journal of Cancer,,,Article,2015-04-21,10.1038/bjc.2015.128,,,,25897673,,,,,,,1,0,0,14,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3928861,https://api.altmetric.com/v1/donut/3928861_240.png 14,Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology,European Urology,,,Article,2014-09-21,10.1016/j.eururo.2014.08.079,,,,25257029,,,,,,,0,1,0,9,0,0,2,0,1,0,0,0,0,0,0,56,https://www.altmetric.com/details/2705179,https://api.altmetric.com/v1/donut/2705179_240.png 14,Loss of SLCO1B3 drives taxane resistance in prostate cancer,British Journal of Cancer,,,Article,2016-08-18,10.1038/bjc.2016.251,,,,27537383,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10916501,https://api.altmetric.com/v1/donut/10916501_240.png 14,PET imaging of recurrent and metastatic prostate cancer with novel tracers,Future Oncology,,,Article,2016-08-17,10.2217/fon-2016-0270,,,,27527923,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10530118,https://api.altmetric.com/v1/donut/10530118_240.png 14,International Society of Urological Pathology (ISUP) Grading of Prostate Cancer,The American Journal of Surgical Pathology,,,Article,2016-03-28,10.1097/pas.0000000000000642,,,http://journals.lww.com/ajsp/Fulltext/publishahead/International_Society_of_Urological_Pathology.98264.aspx,27023325,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6380310,https://api.altmetric.com/v1/donut/6380310_240.png 14," Atg7 cooperates with Pten loss to drive prostate cancer tumor growth ",Genes & Development,,,Article,2016-02-16,10.1101/gad.274134.115,,,,26883359,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5607494,https://api.altmetric.com/v1/donut/5607494_240.png 14,Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and Therapies,European Urology,,,Article,2015-06-14,10.1016/j.eururo.2015.05.041,,,,26070514,,,,,,,0,0,0,23,0,0,4,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/4127565,https://api.altmetric.com/v1/donut/4127565_240.png 14,Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study,The Prostate,,,Article,2015-03-01,10.1002/pros.22975,,,,25728717,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3756576,https://api.altmetric.com/v1/donut/3756576_240.png 14,"Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies.",BMC Public Health,,,Article,2014-12-29,10.1186/1471-2458-14-1326,,,,25543518,,,,,,,1,0,0,2,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3037712,https://api.altmetric.com/v1/donut/3037712_240.png 14,Can Targeting the Androgen Receptor in Localized Prostate Cancer Provide Insights Into Why Men With Metastatic Castration-Resistant Prostate Cancer Die?,Journal of Clinical Oncology,,,Article,2014-10-13,10.1200/jco.2014.57.8534,,,,25311216,,,,,,,1,0,0,2,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2780827,https://api.altmetric.com/v1/donut/2780827_240.png 14,High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients,BMC Cancer,,,Article,2014-09-02,10.1186/1471-2407-14-649,,,,25182503,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2648808,https://api.altmetric.com/v1/donut/2648808_240.png 14,Why Do African- American Men Suffer More Prostate Cancer?,JNCI: Journal of the National Cancer Institute,,,Article,1997-01-01,10.1093/jnci/89.3.188,,,,9016996,,,,,,,0,0,0,17,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2511178,https://api.altmetric.com/v1/donut/2511178_240.png 14,Role of multiparametric 3.0?Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12423,,,,24053308,,,,,,,1,5,0,0,0,0,0,0,0,0,0,0,0,0,1,9,https://www.altmetric.com/details/2350490,https://api.altmetric.com/v1/donut/2350490_240.png 14,Population-Based Study of Predictors for Adverse Pathology Among Candidates for Active Surveillance With Gleason 6 Prostate Cancer,The Journal of Urology,,,Article,2013-09-25,10.1016/j.juro.2013.09.034,,,,24071481,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1781714,https://api.altmetric.com/v1/donut/1781714_240.png 14,Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.,"Prostaglandins, Leukotrienes and Essential Fatty Acids",,,Article,2011-10-11,10.1016/j.plefa.2011.09.007,,,,21995886,,,,,,,2,0,0,2,0,0,0,0,1,0,0,0,0,0,5,9,https://www.altmetric.com/details/428581,https://api.altmetric.com/v1/donut/428581_240.png 14,Androgen deprivation followed by acute androgen stimulation selectively sensitizes AR-positive prostate cancer cells to ionizing radiation,Clinical Cancer Research,,,Article,2016-02-03,10.1158/1078-0432.ccr-15-1147,,,,26831716,,,,,,,0,1,0,12,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5073358,https://api.altmetric.com/v1/donut/5073358_240.png 14,"The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells",Prostate Cancer & Prostatic Diseases,,,Article,2016-06-21,10.1038/pcan.2016.19,,,,27324222,,,,,,,1,0,0,8,0,0,3,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8954244,https://api.altmetric.com/v1/donut/8954244_240.png 14,Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate Cancer,European Urology,,,Article,2015-01-20,10.1016/j.eururo.2015.01.004,,,,25616709,,,,,,,0,1,0,14,0,0,2,0,1,0,0,0,0,0,0,43,https://www.altmetric.com/details/3084605,https://api.altmetric.com/v1/donut/3084605_240.png 14,The Expanding Role of Body Mass in Active Surveillance for Prostate Cancer,European Urology,,,Article,2014-11-01,10.1016/j.eururo.2014.06.043,,,,25037639,,,,,,,0,0,0,19,0,0,3,0,2,0,0,0,0,0,0,2,https://www.altmetric.com/details/2585004,https://api.altmetric.com/v1/donut/2585004_240.png 14,Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need,Urology,,,Article,2016-01-17,10.1016/j.urology.2015.10.048,,,,26772643,,,,,,,0,0,0,22,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4963631,https://api.altmetric.com/v1/donut/4963631_240.png 14,"Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review",Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2011.40.4327,,,,22711853,,,,,,,0,0,0,21,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/799626,https://api.altmetric.com/v1/donut/799626_240.png 14,Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2014-01-21,10.1200/jco.2013.52.3696,,,,24449231,,,,,,,0,1,0,12,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2063661,https://api.altmetric.com/v1/donut/2063661_240.png 14,Racial disparities in active surveillance for prostate cancer,The Journal of Urology,,,Article,2016-09-07,10.1016/j.juro.2016.08.104,,,,27596691,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11469814,https://api.altmetric.com/v1/donut/11469814_240.png 14,Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials,BMC Medicine,,,Article,2015-12-22,10.1186/s12916-015-0543-9,,,,26695172,PMC4687286,,,,,,0,0,0,29,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4910159,https://api.altmetric.com/v1/donut/4910159_240.png 14,Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis.,European Journal of Clinical Nutrition,,,Article,2013-12-04,10.1038/ejcn.2013.256,,,,24300907,,,,,,,0,0,0,19,0,0,1,0,0,0,1,0,0,0,0,9,https://www.altmetric.com/details/1957457,https://api.altmetric.com/v1/donut/1957457_240.png 14,Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase,Biochemical & Biophysical Research Communications,,,Article,2004-03-01,10.1016/j.bbrc.2004.01.100,,,,14975747,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1763114,https://api.altmetric.com/v1/donut/1763114_240.png 14,Comparative Cost-Effectiveness of Stereotactic Body Radiation Therapy Versus Intensity-Modulated and Proton Radiation Therapy for Localized Prostate Cancer,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00081,,,,22934286,,,,,,,0,0,0,13,0,0,4,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/907188,https://api.altmetric.com/v1/donut/907188_240.png 14,"Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.",Journal of Clinical Oncology,,,Article,2008-10-01,10.1200/jco.2007.15.9749,,,,18645193,,,,,,,0,3,0,0,0,0,0,2,0,0,0,0,2,0,0,145,https://www.altmetric.com/details/210507,https://api.altmetric.com/v1/donut/210507_240.png 14,Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets,Cancer Discovery,,,Article,2011-11-16,10.1158/2159-8290.cd-11-0130,,,,22389870,PMC3290518,,,,,,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/472087,https://api.altmetric.com/v1/donut/472087_240.png 14,Phase II Evaluation of MRI-Guided Focal Laser Ablation of Prostate Cancer,The Journal of Urology,,,Article,2016-07-01,10.1016/j.juro.2016.07.074,,,,27449263,,,,,,,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10116134,https://api.altmetric.com/v1/donut/10116134_240.png 14,Prostate cancer: A step to identifying men at high risk of metastatic disease,Nature Reviews Urology,,,Article,2016-07-26,10.1038/nrurol.2016.140,,,,27455893,,,,,,,1,0,0,7,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10050618,https://api.altmetric.com/v1/donut/10050618_240.png 14,Two susceptibility loci identified for prostate cancer aggressiveness.,Nature Communications,,,Article,2015-05-05,10.1038/ncomms7889,,,,25939597,,,,,,,0,0,0,27,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3972342,https://api.altmetric.com/v1/donut/3972342_240.png 14,Prostate cancer: Towards mechanical distinction of tissues during MIRP,Nature Reviews Urology,,,Article,2014-11-25,10.1038/nrurol.2014.329,,,,25420438,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2923224,https://api.altmetric.com/v1/donut/2923224_240.png 14,Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer,European Urology,,,Article,2014-09-14,10.1016/j.eururo.2014.08.075,,,,25234359,,,,,,,0,0,0,20,0,0,1,0,1,0,0,0,0,0,0,51,https://www.altmetric.com/details/2686293,https://api.altmetric.com/v1/donut/2686293_240.png 14,A prospective study of lifetime physical activity and prostate cancer incidence and mortality,British Journal of Cancer,,,Article,2009-10-27,10.1038/sj.bjc.6605404,,,,19861965,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1870618,https://api.altmetric.com/v1/donut/1870618_240.png 13,Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition,British Journal of Cancer,,,Article,2016-09-06,10.1038/bjc.2016.278,,,,27599042,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11878444,https://api.altmetric.com/v1/donut/11878444_240.png 13,Circulating microRNA signature for the diagnosis of very high-risk prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-09-06,10.1073/pnas.1611596113,,,,27601638,,,,,,,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11862066,https://api.altmetric.com/v1/donut/11862066_240.png 13,Are MRI-TRUS-guided targeted biopsies non-inferior to TRUS-guided systematic biopsies for the detection of prostate cancer in patients with a single suspicious focus on multiparametric prostate MRI? Results of a multicentric controlled trial,The Journal of Urology,,,Article,2016-04-11,10.1016/j.juro.2016.04.003,,,,27079582,,,,,,,0,1,0,11,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6617304,https://api.altmetric.com/v1/donut/6617304_240.png 13,Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls,European Urology,,,Article,2016-04-07,10.1016/j.eururo.2016.03.029,,,,27061263,,,,,,,0,0,0,20,0,0,4,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/6517493,https://api.altmetric.com/v1/donut/6517493_240.png 13,Serial Percent-Free PSA in Combination with PSA for Population-Based Early Detection of Prostate Cancer,The Journal of Urology,,,Article,2016-03-12,10.1016/j.juro.2016.03.011,,,,26979652,,,,,,,1,0,0,8,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6178568,https://api.altmetric.com/v1/donut/6178568_240.png 13,Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort,British Journal of Urology,,,Article,2016-03-01,10.1111/bju.13314,,,,26332503,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5986138,https://api.altmetric.com/v1/donut/5986138_240.png 13,68Ga?PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment,British Journal of Urology,,,Article,2015-12-01,10.1111/bju.13397,,,,26683282,,,,,,,0,3,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4895297,https://api.altmetric.com/v1/donut/4895297_240.png 13,Towards “next-generation” prostate cancer screening ,Lancet Oncology,,,Article,2015-11-14,10.1016/s1470-2045(15)00395-2,,,,26563501,,,,,,,2,0,0,8,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4742404,https://api.altmetric.com/v1/donut/4742404_240.png 13,Focal Therapy for Prostate Cancer: Don’t Believe the Hype,The Journal of Urology,,,Article,2015-07-18,10.1016/j.juro.2015.07.050,,,,26184066,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4270870,https://api.altmetric.com/v1/donut/4270870_240.png 13,Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard.,Prostate Cancer & Prostatic Diseases,,,Article,2013-10-14,10.1038/pcan.2013.43,,,,24126797,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3878189,https://api.altmetric.com/v1/donut/3878189_240.png 13,A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.,Prostate Cancer & Prostatic Diseases,,,Article,2015-02-17,10.1038/pcan.2015.4,,,,25687401,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3710604,https://api.altmetric.com/v1/donut/3710604_240.png 13,Detection of Prostate Cancer in Urine by Dogs,The Journal of Urology,,,Article,2015-01-04,10.1016/j.juro.2015.01.065,,,,25596359,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3066383,https://api.altmetric.com/v1/donut/3066383_240.png 13,"Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression",Journal of Clinical Investigation,,,Article,2013-01-01,10.1172/jci63672,,,,23434594,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1259813,https://api.altmetric.com/v1/donut/1259813_240.png 13,Novel Oncogene Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-2133,,,,23204233,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1112103,https://api.altmetric.com/v1/donut/1112103_240.png 13,Certificate of Need Legislation and the Dissemination of Robotic Surgery for Prostate Cancer,The Journal of Urology,,,Article,2012-11-19,10.1016/j.juro.2012.08.185,,,,23164388,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1087285,https://api.altmetric.com/v1/donut/1087285_240.png 13,Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer,Journal of Clinical Oncology,,,Article,2012-09-10,10.1200/jco.2011.40.7783,,,,22965953,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/953902,https://api.altmetric.com/v1/donut/953902_240.png 13,"Positive Surgical Margin and Perioperative Complication Rates of Primary Surgical Treatments for Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Retropubic, Laparoscopic, and Robotic Prostatectomy.",European Urology,,,Article,2012-03-14,10.1016/j.eururo.2012.02.029,,,,22405509,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,83,https://www.altmetric.com/details/815861,https://api.altmetric.com/v1/donut/815861_240.png 13,Screening Men for Prostate and Colorectal Cancer in the United States: Does Practice Reflect the Evidence?,JAMA: Journal of the American Medical Association,,,Article,2003-01-01,10.1001/jama.289.11.1414,,,,12636464,,,,,,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/435907,https://api.altmetric.com/v1/donut/435907_240.png 13,Imaging and evaluation of patients with high-risk prostate cancer,Nature Reviews Urology,,,Article,2015-10-20,10.1038/nrurol.2015.242,,,,26481576,,,,,,,1,0,0,6,0,0,3,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4648899,https://api.altmetric.com/v1/donut/4648899_240.png 13,Advances in prostate cancer - Expert discussion. Advances in prostate cancer - Expert discussion,ecancer.org,,,Article,,,,,http://ecancer.org/video/3479/advances-in-prostate-cancer---expert-discussion.php,,,,,,,,1,0,0,9,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3098065,https://api.altmetric.com/v1/donut/3098065_240.png 13,Prostate Cancer and Occupational Whole-Body Vibration Exposure,Annals of Occupational Hygiene,,,Article,2012-01-01,10.1093/annhyg/mes010,,,,22539558,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1002783,https://api.altmetric.com/v1/donut/1002783_240.png 13,Radiation for Prostate Cancer: Intensity Modulated Radiation Therapy versus Proton Beam ,The Journal of Urology,,,Article,2015-01-15,10.1016/j.juro.2015.01.069,,,,25598137,,,,,,,0,1,0,4,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3072600,https://api.altmetric.com/v1/donut/3072600_240.png 13,Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required,European Urology,,,Article,2016-03-22,10.1016/j.eururo.2016.03.007,,,,27012550,,,,,,,0,0,0,22,0,0,3,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/6256529,https://api.altmetric.com/v1/donut/6256529_240.png 13,A circulating miRNA assay as a first-line test for prostate cancer screening,British Journal of Cancer,,,Article,2016-05-26,10.1038/bjc.2016.151,,,,27228285,,,,,,,2,0,0,9,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8311732,https://api.altmetric.com/v1/donut/8311732_240.png 13,Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients.,Prostate Cancer & Prostatic Diseases,,,Article,2015-02-10,10.1038/pcan.2015.2,,,,25667107,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3540862,https://api.altmetric.com/v1/donut/3540862_240.png 13,Nuclear iASPP may facilitate prostate cancer progression,Annals of Occupational and Environmental Medicine,,,Article,2014-10-01,10.1038/cddis.2014.442,,,,25341046,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2808125,https://api.altmetric.com/v1/donut/2808125_240.png 13,Depression and androgen deprivation therapy for prostate cancer: A prospective controlled study.,Health Psychology,,,Article,2013-01-01,10.1037/a0031639,,,,23477572,,,,,,,1,0,0,3,1,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1652718,https://api.altmetric.com/v1/donut/1652718_240.png 13,Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen,Cancer Discovery,,,Article,2012-01-01,10.1158/2159-8290.cd-11-0316,,,,22576209,PMC3351274,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/692449,https://api.altmetric.com/v1/donut/692449_240.png 13,Improving the Quality of Decision-Making Processes for Prostate Cancer Screening: Progress and Challenges.,JAMA Internal Medicine,,,Article,2013-07-29,10.1001/jamainternmed.2013.6561,,,,23897402,,,,,,,0,1,0,9,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1658530,https://api.altmetric.com/v1/donut/1658530_240.png 13,Prostate cancer: Fat attracts cancer cells,Nature Reviews Urology,,,Article,2016-02-02,10.1038/nrurol.2016.28,,,,26832162,,,,,,,0,0,0,21,0,0,5,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5077535,https://api.altmetric.com/v1/donut/5077535_240.png 13,"Effective adjuvant chemotherapy for high-risk, localised prostate cancer. Effective adjuvant chemotherapy for high-risk, localised prostate cancer",ecancer.org,,,Article,,,,,http://ecancer.org/video/3722/effective-adjuvant-chemotherapy-for-high-risk--localised-prostate-cancer.php,,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4074844,https://api.altmetric.com/v1/donut/4074844_240.png 13,A prospective study of cruciferous vegetables and prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-12-01,,,,,14693729,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/411027,https://api.altmetric.com/v1/donut/411027_240.png 13," Prostate cancer imaging: a special focus issue from Future Oncology ",Future Oncology,,,Article,2016-11-01,10.2217/fon-2016-0396,,,,27734724,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12621211,https://api.altmetric.com/v1/donut/12621211_240.png 13,"EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer",European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.08.002,,,,27591931,,,,,,,0,0,0,30,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/10957757,https://api.altmetric.com/v1/donut/10957757_240.png 13,Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation,Nature Communications,,,Article,2016-04-07,10.1038/ncomms10979,,,,27052111,,,,,,,0,0,0,21,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6557082,https://api.altmetric.com/v1/donut/6557082_240.png 13,The contribution of rare variation to prostate cancer heritability,Nature Genetics,,,Article,2015-11-16,10.1038/ng.3446,,,,26569126,,,,,,,0,0,0,26,0,0,1,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/4767579,https://api.altmetric.com/v1/donut/4767579_240.png 13,Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer.,Journal of Oncology Pharmacy Practice,,,Article,2015-10-24,10.1177/1078155215612541,,,,26493871,,,,,,,0,0,0,22,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4667561,https://api.altmetric.com/v1/donut/4667561_240.png 13,The diffusion of docetaxel in patients with metastatic prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2015-02-15,10.1093/jnci/dju412,,,,25540245,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3015194,https://api.altmetric.com/v1/donut/3015194_240.png 13,"Retraction for Schlaberg et al., XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2014-08-11,10.1073/pnas.1409186111,,,,25114258,,,,,,,0,1,0,2,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2590941,https://api.altmetric.com/v1/donut/2590941_240.png 13,Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort,British Journal of Cancer,,,Article,2012-02-23,10.1038/bjc.2012.39,,,,22361632,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/1496902,https://api.altmetric.com/v1/donut/1496902_240.png 13,Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial.,Nutrition and Cancer,,,Article,2006-12-31,10.1080/01635580701308034,,,,17571965,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,39,https://www.altmetric.com/details/1344421,https://api.altmetric.com/v1/donut/1344421_240.png 13,The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man,Cancer Cell,,,Article,2012-12-20,10.1016/j.ccr.2012.11.010,,,,23260764,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,2,0,0,101,https://www.altmetric.com/details/1135921,https://api.altmetric.com/v1/donut/1135921_240.png 13,Population Based Study of Long-Term Rates of Surgery for Urinary Incontinence After Radical Prostatectomy for Prostate Cancer,The Journal of Urology,,,Article,2012-06-15,10.1016/j.juro.2012.04.005,,,,22704098,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/817142,https://api.altmetric.com/v1/donut/817142_240.png 13,Statin use and fatal prostate cancer,Cancer (0008543X),,,Article,2011-01-01,10.1002/cncr.26720,,,,22180145,,,,,,,0,1,0,8,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/499242,https://api.altmetric.com/v1/donut/499242_240.png 13,Can nomograms improve our ability to select candidates for active surveillance for prostate cancer?,Prostate Cancer & Prostatic Diseases,,,Article,2016-07-19,10.1038/pcan.2016.27,,,,27431497,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9869750,https://api.altmetric.com/v1/donut/9869750_240.png 13,Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells,OncoTargets and therapy,,,Article,2016-05-30,10.2147/ott.s105725,,,,27313468,PMC4892832,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8423987,https://api.altmetric.com/v1/donut/8423987_240.png 13,Risk of prostate cancer in low?dose aspirin users: A retrospective cohort study,International Journal of Cancer,,,Article,2016-02-01,10.1002/ijc.30061,,,,26915905,,,,,,,0,0,0,20,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5995659,https://api.altmetric.com/v1/donut/5995659_240.png 13,Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer.,CA: A Cancer Journal for Clinicians ,,,Article,2015-11-01,10.3322/caac.21333,,,,26594835,,,,,,,0,0,0,27,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4798233,https://api.altmetric.com/v1/donut/4798233_240.png 13,Prostate cancer: High-dose-rate brachytherapy as monotherapy in prostate cancer,Nature Reviews Urology,,,Article,2015-06-23,10.1038/nrurol.2015.151,,,,26101110,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4199921,https://api.altmetric.com/v1/donut/4199921_240.png 13,Prostate cancer: Can image-guided biopsy findings evaluate risk of ECE?,Nature Reviews Urology,,,Article,2015-05-05,10.1038/nrurol.2015.86,,,,25941788,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3969595,https://api.altmetric.com/v1/donut/3969595_240.png 13,Prostate cancer: Can imaging accurately diagnose lymph node involvement?,Nature Reviews Urology,,,Article,2015-05-05,10.1038/nrurol.2015.91,,,,25941790,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3969589,https://api.altmetric.com/v1/donut/3969589_240.png 13,Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina Health Access and Prostate Cancer Treatment Project (HCaP-NC).,Cancer (0008543X),,,Article,2015-03-03,10.1002/cncr.29309,,,,25740564,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3765192,https://api.altmetric.com/v1/donut/3765192_240.png 13,Androgen Deprivation Causes Epithelial–Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-11-3004,,,,22108827,,,,,,,1,0,0,9,0,0,0,0,0,0,0,0,0,0,0,145,https://www.altmetric.com/details/563171,https://api.altmetric.com/v1/donut/563171_240.png 13,Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells,PLoS ONE,,,Article,2013-06-28,10.1371/journal.pone.0068003,,,,23840802,,,,,,,0,1,0,2,0,0,0,2,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/1593861,https://api.altmetric.com/v1/donut/1593861_240.png 13,Supplements Meant to Prevent Prostate Cancer Can Actually Increase Risk,NEJM Journal Watch,,,Article,,10.1056/nejm-jw.fw108508,,,,,,,,,,,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2140367,https://api.altmetric.com/v1/donut/2140367_240.png 13,Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique.,Radiotherapy & Oncology,,,Article,2014-02-03,10.1016/j.radonc.2013.12.012,,,,24485765,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/2095106,https://api.altmetric.com/v1/donut/2095106_240.png 13,"Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study",Lancet Oncology,,,Article,2007-07-01,10.1016/s1470-2045(07)70147-x,,,,17544845,,,,,,,0,1,0,2,0,0,0,1,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/1356987,https://api.altmetric.com/v1/donut/1356987_240.png 13,Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer,Science,,,Article,2005-10-28,10.1126/science.1117679,,,,16254181,,,2005Sci...310..644T,,,,0,2,0,1,0,0,0,2,0,0,0,0,3,0,0,523,https://www.altmetric.com/details/144335,https://api.altmetric.com/v1/donut/144335_240.png 13,Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy,The American Journal of Surgical Pathology,,,Article,2016-07-01,10.1097/pas.0000000000000691,,,http://journals.lww.com/ajsp/Fulltext/publishahead/Prognostic_Significance_of_Percentage_and.98223.aspx,27379821,,,,,,,0,0,0,21,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9267121,https://api.altmetric.com/v1/donut/9267121_240.png 13,Prostate cancer: Interfering with abiraterone metabolism to optimize therapy,Nature Reviews Urology,,,Article,2016-06-01,10.1038/nrurol.2016.101,,,,27245501,,,,,,,2,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8419303,https://api.altmetric.com/v1/donut/8419303_240.png 13,The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review.,Supportive Care in Cancer,,,Article,2015-05-25,10.1007/s00520-015-2782-x,,,,26003426,,,,,,,0,0,0,20,0,0,0,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/4055617,https://api.altmetric.com/v1/donut/4055617_240.png 13,Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates,BMJ Open,,,Article,2014-03-01,10.1136/bmjopen-2013-003901,,,,24625637,,,,,,,0,0,0,24,3,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2190053,https://api.altmetric.com/v1/donut/2190053_240.png 13,The utility of urine-circulating miRNAs for detection of prostate cancer,British Journal of Cancer,,,Article,2016-08-04,10.1038/bjc.2016.233,,,,27490805,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10276595,https://api.altmetric.com/v1/donut/10276595_240.png 13,Complications after prostate biopsies in men on active surveillance and its effect on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study,British Journal of Urology,,,Article,2016-01-01,10.1111/bju.13410,,,,26765682,,,,,,,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5018556,https://api.altmetric.com/v1/donut/5018556_240.png 13,Comparison of Prostate-Specific Membrane Antigen–Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer,Journal of Nuclear Medicine,,,Article,2015-10-24,10.2967/jnumed.115.163782,,,,26493203,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4669722,https://api.altmetric.com/v1/donut/4669722_240.png 13,MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer,PLoS ONE,,,Article,2015-04-29,10.1371/journal.pone.0124410,,,,25922934,,,,,,,0,1,0,2,1,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3965340,https://api.altmetric.com/v1/donut/3965340_240.png 13,CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.,International Journal of Cancer,,,Article,2014-10-03,10.1002/ijc.29231,,,,25242736,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2700671,https://api.altmetric.com/v1/donut/2700671_240.png 13,Prostate Cancer and Supplementation With ?-Tocopherol and ?-Carotene: Incidence and Mortality in a Controlled Trial,JNCI: Journal of the National Cancer Institute,,,Article,1998-01-01,10.1093/jnci/90.6.440,,,,9521168,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1973611,https://api.altmetric.com/v1/donut/1973611_240.png 13,Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse,Journal of Clinical Investigation,,,Article,2013-01-01,10.1172/jci64791,,,,24091326,PMC3784522,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1754292,https://api.altmetric.com/v1/donut/1754292_240.png 13,Retracted: Many young men with prostate?specific antigen (PSA) screen?detected prostate cancers may be candidates for active surveillance,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11768.x,,,,23350937,,,,,,,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1198224,https://api.altmetric.com/v1/donut/1198224_240.png 13,"HOXB13 mutations in a population-based, case-control study of prostate cancer.",The Prostate,,,Article,2012-01-01,10.1002/pros.22604,,,,23129385,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1042553,https://api.altmetric.com/v1/donut/1042553_240.png 13,Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent.,The Prostate,,,Article,2013-01-01,10.1002/pros.22612,,,,23129512,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1042551,https://api.altmetric.com/v1/donut/1042551_240.png 13,Gynecomastia Induced by Prostate-Cancer Treatment,New England Journal of Medicine,,,Article,2012-10-11,10.1056/nejmicm1209166,,,,23050528,,,,,,,0,0,0,11,0,0,3,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/996831,https://api.altmetric.com/v1/donut/996831_240.png 13,A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70263-2,,,,23059047,,,,,,,2,0,0,5,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/990889,https://api.altmetric.com/v1/donut/990889_240.png 13,Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device,PLoS ONE,,,Article,2012-04-27,10.1371/journal.pone.0035976,,,,22558290,,,2012PLoSO...7E5976K,,,,0,1,0,3,0,0,1,0,0,0,0,0,0,0,0,106,https://www.altmetric.com/details/718295,https://api.altmetric.com/v1/donut/718295_240.png 13,Prostate cancer and inositol hexaphosphate: efficacy and mechanisms.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2004-12-07,,,,,16080543,,,,,,,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,16,https://www.altmetric.com/details/709350,https://api.altmetric.com/v1/donut/709350_240.png 13,Radiation therapy for prostate cancer increases the risk of subsequent rectal cancer.,Annals of Surgery,,,Article,2011-12-01,10.1097/sla.0b013e3182382fd5,,,,22107741,,,,,,,1,0,1,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/488324,https://api.altmetric.com/v1/donut/488324_240.png 13,Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies.,Asia Pacific Journal of Clinical Nutrition,,,Article,2007-01-01,,,,,17704029,,,,,,,0,1,0,4,0,0,4,0,0,0,0,0,0,0,4,24,https://www.altmetric.com/details/1964359,https://api.altmetric.com/v1/donut/1964359_240.png 13,Aspirin Use in Relation to Risk of Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2002-01-01,,,,,12376516,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1439344,https://api.altmetric.com/v1/donut/1439344_240.png 13,Re-irradiation of prostate cancer local failures after previous curative radiotherapy: long-term outcome and tolerance,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-05-01,10.1016/j.ijrobp.2016.05.024,,,,27475672,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8344286,https://api.altmetric.com/v1/donut/8344286_240.png 13,Prostate cancer: Exosome RNA expression predicts high-grade disease,Nature Reviews Urology,,,Article,2016-04-19,10.1038/nrurol.2016.78,,,,27091664,,,,,,,1,0,0,6,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6813964,https://api.altmetric.com/v1/donut/6813964_240.png 13,Systematic Review of Decision Aids for Newly Diagnosed Prostate Cancer Patients Making Treatment Decisions.,The Journal of Urology,,,Article,2015-06-10,10.1016/j.juro.2015.05.093,,,,26055824,,,,,,,0,1,0,10,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4103424,https://api.altmetric.com/v1/donut/4103424_240.png 13,Accuracy of Multiparametric MRI for Prostate Cancer Detection: A Meta-Analysis,American Journal of Roentgenology,,,Article,2014-02-01,10.2214/ajr.13.11046,,,,24450675,,,,,,,0,1,0,8,0,0,0,0,0,0,0,0,0,0,0,80,https://www.altmetric.com/details/2071505,https://api.altmetric.com/v1/donut/2071505_240.png 13,"Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort",American Journal of Clinical Nutrition,,,Article,2005-05-11,,,,,15883441,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,1,21,https://www.altmetric.com/details/1385777,https://api.altmetric.com/v1/donut/1385777_240.png 13,A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).,Nutrition and Cancer,,,Article,2009-12-31,10.1080/01635581.2010.509833,,,,20924966,,,,,,,0,1,0,4,0,0,1,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1485817,https://api.altmetric.com/v1/donut/1485817_240.png 13,Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy.,Clinical Genitourinary Cancer,,,Article,2012-09-28,10.1016/j.clgc.2012.08.003,,,,23010414,,1854/LU-3222274,,,,,0,1,0,8,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2663177,https://api.altmetric.com/v1/donut/2663177_240.png 13,Measuring the effects of fractionated radiation therapy in a 3D prostate cancer model system using SERS nanosensors,Analyst,,,Article,2016-06-16,10.1039/c6an01032f,,,,27310732,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8794916,https://api.altmetric.com/v1/donut/8794916_240.png 13,Translational and clinical implications of the genetic landscape of prostate cancer,Nature Reviews Clinical Oncology,,,Article,2016-06-01,10.1038/nrclinonc.2016.76,,,,27245282,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/8418956,https://api.altmetric.com/v1/donut/8418956_240.png 13,Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH,Modern Pathology,,,Article,2016-05-13,10.1038/modpathol.2016.88,,,,27174589,,,,,,,2,0,0,6,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7387087,https://api.altmetric.com/v1/donut/7387087_240.png 13,Prostate Cancer Diagnosis Using MR/Ultrasound–Fusion Guided Biopsy: Ending the “Needle in a Haystack” Conundrum?,JAMA Oncology,,,Article,2015-06-04,10.1001/jamaoncol.2015.1063,,,,26181913,,,,,,,0,0,0,25,0,0,3,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/4118214,https://api.altmetric.com/v1/donut/4118214_240.png 13,ASCO 2015: Latest developments in prostate cancer treatment. ASCO 2015: Latest developments in prostate cancer treatment,ecancer.org,,,Article,,,,,http://ecancer.org/video/3738/asco-2015--latest-developments-in-prostate-cancer-treatment.php,,,,,,,,1,0,0,6,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4076408,https://api.altmetric.com/v1/donut/4076408_240.png 13,Cyclodextrin mediated delivery of NF-|[kappa]|B and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro,Gene Therapy,,,Article,2015-05-26,10.1038/gt.2015.50,,,,26005860,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4058174,https://api.altmetric.com/v1/donut/4058174_240.png 13,Radiation dosimetry and first therapy results with a 124I/ 131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2014-02-28,10.1007/s00259-014-2713-y,,,,24577951,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2177071,https://api.altmetric.com/v1/donut/2177071_240.png 13,Prospective Studies of Dairy Product and Calcium Intakes and Prostate Cancer Risk: A Meta-Analysis,JNCI: Journal of the National Cancer Institute,,,Article,2005-12-07,10.1093/jnci/dji402,,,,16333032,,,,,,,2,0,0,3,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1964371,https://api.altmetric.com/v1/donut/1964371_240.png 13,Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance,The Journal of Urology,,,Article,2013-05-01,10.1016/j.juro.2013.04.071,,,,23643603,,,,,,,1,0,0,3,0,0,2,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1428479,https://api.altmetric.com/v1/donut/1428479_240.png 13,Fourteenâ??year oncological and functional outcomes of highâ??intensity focused ultrasound in localized prostate cancer,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11715.x,,,,23356910,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1202898,https://api.altmetric.com/v1/donut/1202898_240.png 13,Genome Abnormalities Precede Prostate Cancer and Predict Clinical Relapse,American Journal of Pathology,,,Article,2012-05-01,10.1016/j.ajpath.2012.03.008,,,,22569189,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/732716,https://api.altmetric.com/v1/donut/732716_240.png 13,A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.,The Journal of Urology,,,Article,2011-07-28,10.1016/j.juro.2011.04.083,,,,21788033,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,1,0,0,30,https://www.altmetric.com/details/571223,https://api.altmetric.com/v1/donut/571223_240.png 13,Photoacoustic imaging with an acoustic lens detects prostate cancer cells labeled with PSMA-targeting near-infrared dye-conjugates,Journal of Biomedical Optics,,,Article,2016-06-01,10.1117/1.jbo.21.6.066019,,,,27367255,,,,,,,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9173530,https://api.altmetric.com/v1/donut/9173530_240.png 13,[Vasectomy does not increase the risk of prostate cancer in Chinese men: A meta-analysis].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-08-01,,,,,26442305,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12091368,https://api.altmetric.com/v1/donut/12091368_240.png 13,Vasectomy and the risk of prostate cancer: a meta-analysis of cohort studies.,International Journal of Clinical and Experimental Medicine,,,Article,2015-01-01,,,,,26770392,PMC4694292,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12091367,https://api.altmetric.com/v1/donut/12091367_240.png 13,Vasectomy and prostate cancer risk: a historical synopsis of undulating false causality,Research and Reports in Urology,,,Article,2016-09-19,10.2147/rru.s71325,,,,27486569,PMC4958361,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12091366,https://api.altmetric.com/v1/donut/12091366_240.png 13,Getting Personal with Prostate Cancer: DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer,British Journal of Urology,,,Article,2016-05-01,10.1111/bju.13522,,,,27154575,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9390864,https://api.altmetric.com/v1/donut/9390864_240.png 13,Nigerian foodstuffs with prostate cancer chemopreventive polyphenols,Infectious Agents and Cancer,,,Article,2011-11-02,10.1186/1750-9378-6-s2-s9,,,,21992488,PMC3194188,,,,,,0,1,0,12,0,0,11,0,1,0,0,0,0,0,0,31,https://www.altmetric.com/details/438233,https://api.altmetric.com/v1/donut/438233_240.png 13,Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer,European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.08.048,,,,27638094,,,,,,,0,0,0,24,0,0,1,0,3,0,0,0,0,0,0,2,https://www.altmetric.com/details/11986483,https://api.altmetric.com/v1/donut/11986483_240.png 13,Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.,Cancer Research,,,Article,2009-07-31,10.1158/0008-5472.can-08-4516,,,,19622771,,,,,,,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6063354,https://api.altmetric.com/v1/donut/6063354_240.png 13,A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-11-24,10.1038/pcan.2015.55,,,,26597660,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4804463,https://api.altmetric.com/v1/donut/4804463_240.png 13,Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression,British Journal of Cancer,,,Article,2015-11-17,10.1038/bjc.2015.335,,,,26575822,,,,,,,1,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4776684,https://api.altmetric.com/v1/donut/4776684_240.png 13,Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LC?-3PUFA) and Prostate Cancer.,Nutrition and Cancer,,,Article,2015-03-31,10.1080/01635581.2015.1015745,,,,25826711,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3962876,https://api.altmetric.com/v1/donut/3962876_240.png 13,Personalizing the Duration of Androgen-Deprivation Therapy Use in the Management of Intermediate-Risk Prostate Cancer,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.59.0968,,,,,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3008796,https://api.altmetric.com/v1/donut/3008796_240.png 13,"Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia",British Journal of Urology,,,Article,2015-04-01,10.1111/bju.12899,,,,25124107,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2607353,https://api.altmetric.com/v1/donut/2607353_240.png 13,Steroid receptors aplenty in prostate cancer.,New England Journal of Medicine,,,Article,2014-03-06,10.1056/nejmcibr1315706,,,,24597872,,,,,,,2,0,0,5,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2170386,https://api.altmetric.com/v1/donut/2170386_240.png 13,Survival in the Prostate Cancer Prevention Trial,New England Journal of Medicine,,,Article,2013-11-14,10.1056/nejmc1311498,,,,24224632,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1905021,https://api.altmetric.com/v1/donut/1905021_240.png 13,"Current Status of Xenotropic Murine Leukemia Virus-Related Retrovirus in Chronic Fatigue Syndrome and Prostate Cancer: Reach for a Scorecard, Not a Prescription Pad",Journal of Infectious Diseases,,,Article,1970-01-01,10.1086/657169,,,,20936981,,,,,,,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1386689,https://api.altmetric.com/v1/donut/1386689_240.png 13,Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies,JNCI: Journal of the National Cancer Institute,,,Article,2008-01-01,10.1093/jnci/djm323,,,,18230794,,,,,,,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,89,https://www.altmetric.com/details/930271,https://api.altmetric.com/v1/donut/930271_240.png 13,Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001,Nature,,,Article,2012-01-22,10.1038/nature10743,,,,22266943,,,2012Natur.482..116D,,,,1,0,0,4,0,0,2,0,0,0,0,0,2,0,0,119,https://www.altmetric.com/details/569985,https://api.altmetric.com/v1/donut/569985_240.png 13,A Chemically Induced Vaccine Strategy for Prostate Cancer,ACS Chemical Biology,,,Article,2011-09-21,10.1021/cb200222s,,,,21936526,,,,,,,2,0,1,1,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/399882,https://api.altmetric.com/v1/donut/399882_240.png 13,Screening for prostate cancer,Cochrane database of systematic reviews,,,Article,2006-07-22,10.1002/14651858.cd004720.pub2,,,,16856057,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,17,https://www.altmetric.com/details/2202711,https://api.altmetric.com/v1/donut/2202711_240.png 13,Germline Variants of Prostate Cancer in Japanese Families,PLoS ONE,,,Article,2016-10-04,10.1371/journal.pone.0164233,,,,27701467,,,,,,,0,1,0,7,0,0,0,0,0,0,1,0,0,0,0,0,https://www.altmetric.com/details/12425325,https://api.altmetric.com/v1/donut/12425325_240.png 13,Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.,The Journal of Urology,,,Article,2007-02-15,10.1016/j.juro.2006.10.097,,,,17222629,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/5584719,https://api.altmetric.com/v1/donut/5584719_240.png 13,Disrupting the Status Quo in Prostate Cancer Diagnosis,European Urology,,,Article,2016-08-21,10.1016/j.eururo.2016.08.018,,,,27554242,,,,,,,0,0,0,21,0,0,2,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/10731545,https://api.altmetric.com/v1/donut/10731545_240.png 13,"Active Surveillance for Prostate Cancer: Debate over the Application, Not the Concept",European Urology,,,Article,2015-01-24,10.1016/j.eururo.2015.01.007,,,,25630451,,,,,,,0,0,0,23,0,0,3,0,2,0,0,0,0,0,0,7,https://www.altmetric.com/details/3101520,https://api.altmetric.com/v1/donut/3101520_240.png 13,New agents for prostate cancer.,Annals of Oncology,,,Article,2014-03-20,10.1093/annonc/mdu038,,,,24658665,,,,,,,0,0,0,20,0,0,0,3,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2203713,https://api.altmetric.com/v1/donut/2203713_240.png 13,"A Double-Blind, Randomized, Neoadjuvant Study of the Tissue Effects of POMx Pills in Men with Prostate Cancer Before Radical Prostatectomy",Cancer Prevention Research,,,Article,2013-01-01,10.1158/1940-6207.capr-12-0423,,,,23985577,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2000588,https://api.altmetric.com/v1/donut/2000588_240.png 13,"Reduced Penile Size and Treatment Regret in Men With Recurrent Prostate Cancer After Surgery, Radiotherapy Plus Androgen Deprivation, or Radiotherapy Alone",Urology,,,Article,2013-01-02,10.1016/j.urology.2012.08.068,,,,23273077,,,,,,,0,1,0,9,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1159067,https://api.altmetric.com/v1/donut/1159067_240.png 13,Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy,Research and Reports in Urology,,,Article,2016-08-16,10.2147/rru.s107852,,,,27574584,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10866413,https://api.altmetric.com/v1/donut/10866413_240.png 13,Re: Postoperative Radiotherapy After Radical Prostatectomy for High-risk Prostate Cancer: Long-term Results of a Randomised Controlled Trial (EORTC Trial 22911) ,European Urology,,,Article,2013-06-14,10.1016/j.eururo.2013.03.021,,,,23608082,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3763057,https://api.altmetric.com/v1/donut/3763057_240.png 13,Toward a Smarter Prostate Cancer Screening Program,European Urology,,,Article,2015-10-01,10.1016/j.eururo.2014.05.002,,,,24836056,,,,,,,0,0,0,23,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2355346,https://api.altmetric.com/v1/donut/2355346_240.png 13,Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies.,Nutrition and Cancer,,,Article,2004-06-19,10.1207/s15327914nc4801_4,,,,15203374,,,,,,,0,1,0,5,0,0,0,0,0,0,1,0,0,0,5,24,https://www.altmetric.com/details/687813,https://api.altmetric.com/v1/donut/687813_240.png 13,Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone,Annals of Oncology,,,Article,2016-10-18,10.1093/annonc/mdw441,,,,,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12757781,https://api.altmetric.com/v1/donut/12757781_240.png 13,Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study,Prostate Cancer & Prostatic Diseases,,,Article,2016-09-13,10.1038/pcan.2016.43,,,,27618951,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11980879,https://api.altmetric.com/v1/donut/11980879_240.png 13,Prostate cancer: Caveat Emptor — long-term outcomes in the Göteborg active surveillance cohort,Nature Reviews Urology,,,Article,2016-05-10,10.1038/nrurol.2016.85,,,,27162050,,,,,,,1,0,0,6,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7319186,https://api.altmetric.com/v1/donut/7319186_240.png 13,A novel model used to detect differential splice junctions as biomarkers in prostate cancer from RNA-Seq data,Journal of Biomedical Informatics,,,Article,2016-04-01,10.1016/j.jbi.2016.03.010,,,,26992567,,,,,,,0,1,0,11,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6245659,https://api.altmetric.com/v1/donut/6245659_240.png 13,ADT in prostate cancer and risk of Alzheimer's disease.,Lancet Oncology,,,Article,2015-12-22,10.1016/s1470-2045(15)00578-1,,,,26687595,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4867543,https://api.altmetric.com/v1/donut/4867543_240.png 13,Prostate cancer: Molecular stratification and repair defects: revealing hidden treasures,Nature Reviews Clinical Oncology,,,Article,2015-11-17,10.1038/nrclinonc.2015.205,,,,26573421,,,,,,,3,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4776746,https://api.altmetric.com/v1/donut/4776746_240.png 13,Prostate cancer: Platelet-to-lymphocyte ratio predicts prostate cancer prognosis,Nature Reviews Urology,,,Article,2015-03-31,10.1038/nrurol.2015.69,,,,25823375,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3854659,https://api.altmetric.com/v1/donut/3854659_240.png 13,Prostate cancer: ASCO endorses adjuvant and salvage radiotherapy guideline,Nature Reviews Urology,,,Article,2014-11-25,10.1038/nrurol.2014.325,,,,25420441,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2921710,https://api.altmetric.com/v1/donut/2921710_240.png 13,Mechanisms of Omega-3 Polyunsaturated Fatty Acids in Prostate Cancer Prevention,BioMed Research International,,,Article,2013-01-01,10.1155/2013/824563,,,,23762859,,,,,,,0,0,0,18,0,0,2,0,0,0,0,0,0,0,0,277,https://www.altmetric.com/details/1556186,https://api.altmetric.com/v1/donut/1556186_240.png 13,Zinc supplement use and risk of prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2003-01-01,10.1093/jnci/95.13.1004,,,,12837837,,,,,,,0,1,0,3,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/596870,https://api.altmetric.com/v1/donut/596870_240.png 13,Adenovirus-Mediated Overexpression of REIC/Dkk-3 Selectively Induces Apoptosis in Human Prostate Cancer Cells through Activation of c-Jun-NH2-Kinase,Cancer Research,,,Article,2005-11-04,10.1158/0008-5472.can-05-0829,,,,16266978,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2727557,https://api.altmetric.com/v1/donut/2727557_240.png 13,Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms.,European Urology,,,Article,2013-01-16,10.1016/j.eururo.2012.12.029,,,,23313031,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1668239,https://api.altmetric.com/v1/donut/1668239_240.png 13,Functional screen identifies kinases driving prostate cancer visceral and bone metastasis,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-11-30,10.1073/pnas.1521674112,,,,26621741,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4830450,https://api.altmetric.com/v1/donut/4830450_240.png 13,Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients,Cancer Causes and Control,,,Article,2015-11-16,10.1007/s10552-015-0694-1,,,,26573844,,,,,,,1,0,0,8,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4774229,https://api.altmetric.com/v1/donut/4774229_240.png 13,"Dietary Fat, Fatty Acids, and Risk of Prostate Cancer in the NIH-AARP Diet and Health Study.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-04-05,10.1158/1055-9965.epi-12-1196-t,,,,23549401,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1616893,https://api.altmetric.com/v1/donut/1616893_240.png 13,Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles,Biomaterials,,,Article,2013-05-14,10.1016/j.biomaterials.2013.01.062,,,,23419645,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/12125439,https://api.altmetric.com/v1/donut/12125439_240.png 13,"Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology",Circulation,,,Article,2010-01-01,10.1161/circulationaha.109.192695,,,,20124128,PMC3023973,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1487916,https://api.altmetric.com/v1/donut/1487916_240.png 13,Multiple loci identified in a genome-wide association study of prostate cancer.,Nature Genetics,,,Article,2008-02-10,10.1038/ng.91,,,,18264096,,,,,,,0,1,0,2,0,0,0,1,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/114983,https://api.altmetric.com/v1/donut/114983_240.png 12,Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment,The Journal of Urology,,,Article,2016-09-01,10.1016/j.juro.2016.08.101,,,,27593476,,,,,,,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10993624,https://api.altmetric.com/v1/donut/10993624_240.png 12,Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population,Cancer (0008543X),,,Article,2016-07-01,10.1002/cncr.30184,,,,27379732,,,,,,,2,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9307283,https://api.altmetric.com/v1/donut/9307283_240.png 12,SOST Inhibits Prostate Cancer Invasion,PLoS ONE,,,Article,2015-11-06,10.1371/journal.pone.0142058,,,,26545120,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4777647,https://api.altmetric.com/v1/donut/4777647_240.png 12,Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control,Prostate Cancer & Prostatic Diseases,,,Article,2015-10-13,10.1038/pcan.2015.47,,,,26458959,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4747042,https://api.altmetric.com/v1/donut/4747042_240.png 12,Utilization Trends at a Multidisciplinary Prostate Cancer Clinic: Initial 5-Year Experience From the Duke Prostate Center,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2011.09.040,,,,22088334,,,,,,,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4464007,https://api.altmetric.com/v1/donut/4464007_240.png 12,Initial prostate cancer diagnosis and disease staging[mdash]the role of choline-PET-CT,Nature Reviews Urology,,,Article,2015-08-11,10.1038/nrurol.2015.191,,,,26260884,,,,,,,1,0,0,3,0,0,5,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4385369,https://api.altmetric.com/v1/donut/4385369_240.png 12,Prognostic role of genetic biomarkers in clinical progression of prostate cancer,Experimental and Molecular Medicine,,,Article,2015-08-01,10.1038/emm.2015.43,,,,26251261,,,,,,,0,0,0,17,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4372560,https://api.altmetric.com/v1/donut/4372560_240.png 12,The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy,Prostate Cancer & Prostatic Diseases,,,Article,2015-08-04,10.1038/pcan.2015.36,,,,26238233,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4362851,https://api.altmetric.com/v1/donut/4362851_240.png 12,Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound?fusion biopsy for the diagnosis of prostate cancer,British Journal of Urology,,,Article,2015-04-27,10.1111/bju.13023,,,,25523210,,,,,,,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4139302,https://api.altmetric.com/v1/donut/4139302_240.png 12,Uncovering the Metabolic Complications of Androgen Deprivation Therapy in Patients with Prostate Cancer—Where Do We Take it Next?,The Journal of Urology,,,Article,2015-01-06,10.1016/j.juro.2015.03.070,,,,25794833,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3806298,https://api.altmetric.com/v1/donut/3806298_240.png 12,Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer,Clinical Cancer Research,,,Article,2015-02-15,10.1158/1078-0432.ccr-14-1358,,,,25691773,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3706978,https://api.altmetric.com/v1/donut/3706978_240.png 12,Risk of prostate cancer in a randomized clinical trial of calcium supplementation.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2005-03-15,10.1158/1055-9965.epi-04-0319,,,,15767334,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3342361,https://api.altmetric.com/v1/donut/3342361_240.png 12,Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study.,Journal of Clinical Oncology,,,Article,2014-12-18,,,,,25513466,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3001583,https://api.altmetric.com/v1/donut/3001583_240.png 12,The contemporary concept of significant versus insignificant prostate cancer.,European Urology,,,Article,2011-05-24,10.1016/j.eururo.2011.05.006,,,,21601982,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,78,https://www.altmetric.com/details/2571742,https://api.altmetric.com/v1/donut/2571742_240.png 12,Prostate-Specific Antigen Screening in Prostate Cancer: Perspectives on the Evidence,JNCI: Journal of the National Cancer Institute,,,Article,2014-03-04,10.1093/jnci/dju010,,,,24594482,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2161895,https://api.altmetric.com/v1/donut/2161895_240.png 12,Prediction of Gene Function by Genome-Scale Expression Analysis: Prostate Cancer-Associated Genes,Genome Research,,,Article,1999-12-01,,,,,10613842,,,,,,,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2054712,https://api.altmetric.com/v1/donut/2054712_240.png 12,"An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression",Cancer Cell,,,Article,2010-01-01,10.1016/j.ccr.2010.03.018,,,,20478527,,,,,,,0,1,0,0,0,0,0,3,0,0,0,0,0,0,0,248,https://www.altmetric.com/details/2019302,https://api.altmetric.com/v1/donut/2019302_240.png 12,"Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections with XMRV (Xenotropic Murine Leukemia Virus-Related Virus), a Human Retrovirus Associated with Prostate Cancer",Journal of Virology,,,Article,2009-04-29,10.1128/jvi.00268-09,,,,19403677,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1834435,https://api.altmetric.com/v1/donut/1834435_240.png 12,Soy and Isoflavone Consumption in Relation to Prostate Cancer Risk in China,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-01-01,,,,,12869409,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1790290,https://api.altmetric.com/v1/donut/1790290_240.png 12,RETRACTED: Horizon scanning for novel therapeutics for the treatment of prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2010-09-28,10.1517/13543784.2010.514261,,,,20868208,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1447743,https://api.altmetric.com/v1/donut/1447743_240.png 12,Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610,Radiation Oncology,,,Article,2013-04-25,10.1186/1748-717x-8-100,,,,23618468,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1412859,https://api.altmetric.com/v1/donut/1412859_240.png 12,XMRV: A New Virus in Prostate Cancer?,Cancer Research,,,Article,2010-10-24,10.1158/0008-5472.can-10-2837,,,,20966126,PMC3005136,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1386687,https://api.altmetric.com/v1/donut/1386687_240.png 12,Active Surveillance for Prostate Cancer: For Whom?,Journal of Clinical Oncology,,,Article,2005-11-11,10.1200/jco.2005.03.3134,,,,16278468,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1259822,https://api.altmetric.com/v1/donut/1259822_240.png 12,PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy.,ACS Nano,,,Article,2012-08-09,10.1021/nn301725w,,,,22866897,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/884948,https://api.altmetric.com/v1/donut/884948_240.png 12,Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer,Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2012.42.8466,,,,22851571,,,,,,,0,0,0,14,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/864489,https://api.altmetric.com/v1/donut/864489_240.png 12,The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.,Nature Reviews Urology,,,Article,2010-06-01,10.1038/nrurol.2010.77,,,,20517289,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/751244,https://api.altmetric.com/v1/donut/751244_240.png 12,Prostate cancer risk and vitamin E.,JAMA: Journal of the American Medical Association,,,Article,2012-01-31,10.1001/jama.2012.55,,,,22298668,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/584051,https://api.altmetric.com/v1/donut/584051_240.png 12,Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.,Journal of Clinical Virology,,,Article,2008-11-01,10.1016/j.jcv.2008.04.016,,,,18823818,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/414894,https://api.altmetric.com/v1/donut/414894_240.png 12,Implications for RNase L in prostate cancer biology.,Biochemistry (00062979),,,Article,2003-02-01,10.1021/bi027147i,,,,,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/414893,https://api.altmetric.com/v1/donut/414893_240.png 12,Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.,Journal of Clinical Oncology,,,Article,2010-05-20,10.1200/jco.2009.24.1968,,,,20421547,PMC2881727,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,44,https://www.altmetric.com/details/210452,https://api.altmetric.com/v1/donut/210452_240.png 12,Doctors' and Patients' Preferences for Participation and Treatment in Curative Prostate Cancer Radiotherapy,Journal of Clinical Oncology,,,Article,2007-07-20,10.1200/jco.2006.07.4955,,,,17634489,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/175047,https://api.altmetric.com/v1/donut/175047_240.png 12,Debate Continues on Use of PSA Testing for Early Detection of Prostate Cancer,JAMA : the journal of the American Medical Association,,,Article,2011-06-08,10.1001/jama.2011.777,,,,21642668,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/129761,https://api.altmetric.com/v1/donut/129761_240.png 12,Isolation of a human prostate carcinoma cell line (DU 145),International Journal of Cancer,,,Article,1978-03-15,10.1002/ijc.2910210305,,,,631930,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/108312,https://api.altmetric.com/v1/donut/108312_240.png 12,Structure?Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC),Journal of Medicinal Chemistry,,,Article,1970-01-01,10.1021/jm901488g,,,,20218717,PMC3180999,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,46,https://www.altmetric.com/details/439562,https://api.altmetric.com/v1/donut/439562_240.png 12,Pelvis Plus Prostate Radiation Therapy and the Risk of Death in Men With Newly Diagnosed Node-Positive Prostate Cancer,JAMA Oncology,,,Article,2015-11-25,10.1001/jamaoncol.2015.4342,,,,26605852,,,,,,,0,0,0,24,0,0,4,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4811857,https://api.altmetric.com/v1/donut/4811857_240.png 12,Impact of Age on Quality-of-life Outcomes After Treatment for Localized Prostate Cancer.,European Urology,,,Article,2015-02-02,10.1016/j.eururo.2015.01.008,,,,25656807,,,,,,,0,0,0,20,0,0,2,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3256479,https://api.altmetric.com/v1/donut/3256479_240.png 12,Metabolic Syndrome and its Components in Prostate Cancer Patients under Androgen Deprivation Therapy.,The Journal of Urology,,,Article,2015-01-06,10.1016/j.juro.2014.12.086,,,,25541340,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3008320,https://api.altmetric.com/v1/donut/3008320_240.png 12,"The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium",Cancer Causes and Control,,,Article,2015-09-21,10.1007/s10552-015-0654-9,,,,26387087,,,,,,,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/4535872,https://api.altmetric.com/v1/donut/4535872_240.png 12,Characteristics and Experiences of Patients with Localized Prostate Cancer Who Left an Active Surveillance Program,The Patient,,,Article,2014-06-12,10.1007/s40271-014-0066-z,,,,24920082,,,,,,,0,1,0,14,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2447326,https://api.altmetric.com/v1/donut/2447326_240.png 12,Prostate cancer: Co-targeting mTOR and AR-Vs is efficacious for CRPC,Nature Reviews Urology,,,Article,2016-01-20,10.1038/nrurol.2016.12,,,,26787397,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5017198,https://api.altmetric.com/v1/donut/5017198_240.png 12,Yoga Intervention for Patients With Prostate Cancer Undergoing External Beam Radiation Therapy A Pilot Feasibility Study,Integrative Cancer Therapies,,,Article,2015-11-22,10.1177/1534735415617022,,,,26590125,,,,,,,1,0,0,6,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4790473,https://api.altmetric.com/v1/donut/4790473_240.png 12,Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence,Prostate Cancer & Prostatic Diseases,,,Article,2015-08-04,10.1038/pcan.2015.27,,,,26238235,,10161/10664,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4360506,https://api.altmetric.com/v1/donut/4360506_240.png 12,Prostate cancer: Charting a course in metastatic castration-sensitive prostate cancer,Nature Reviews Urology,,,Article,2015-06-16,10.1038/nrurol.2015.144,,,,26077994,,,,,,,1,0,0,5,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4168943,https://api.altmetric.com/v1/donut/4168943_240.png 12,"Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.",British Journal of Urology,,,Article,2012-08-16,10.1111/j.1464-410x.2012.11385.x,,,,22889401,,,,,,,2,0,0,7,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2256228,https://api.altmetric.com/v1/donut/2256228_240.png 12,RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.,Nature Genetics,,,Article,2002-12-01,10.1038/ng1021,,,,12415269,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/413672,https://api.altmetric.com/v1/donut/413672_240.png 12,"Symptoms, unmet needs, psychological well-being and health status in prostate cancer survivors: implications for redesigning follow-up.",British Journal of Urology,,,Article,2015-04-01,10.1111/bju.13122,,,,25818406,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3859660,https://api.altmetric.com/v1/donut/3859660_240.png 12,Prostate cancer: NCCN guidelines for prostate cancer updated,Nature Reviews Urology,,,Article,2014-12-23,10.1038/nrurol.2014.350,,,,25534996,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3009035,https://api.altmetric.com/v1/donut/3009035_240.png 12,Correlation of gleason scores with magnetic resonance diffusion tensor imaging in peripheral zone prostate cancer,Journal of Magnetic Resonance Imaging,,,Article,2014-12-03,10.1002/jmri.24813,,,,25469909,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2954823,https://api.altmetric.com/v1/donut/2954823_240.png 12,"Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis.",Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2013-01-01,10.1155/2013/247504,,,,23710216,PMC3655614,,,,,,0,1,0,0,0,0,15,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1928606,https://api.altmetric.com/v1/donut/1928606_240.png 12,"Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study-II Nutrition Cohort.",International Journal of Cancer,,,Article,2016-02-01,10.1002/ijc.30027,,,,26830232,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/5075651,https://api.altmetric.com/v1/donut/5075651_240.png 12,Prostate cancer: Targetable YAP1-AR interaction key to disease progression,Nature Reviews Urology,,,Article,2015-09-22,10.1038/nrurol.2015.240,,,,26390969,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4539345,https://api.altmetric.com/v1/donut/4539345_240.png 12,Impact of 18F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry.,Journal of Nuclear Medicine,,,Article,,10.2967/jnumed.113.130005,,,,24578240,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2195105,https://api.altmetric.com/v1/donut/2195105_240.png 12,Statin use and risk of prostate cancer: a meta-analysis of observational studies.,PLoS ONE,,,Article,2012-10-01,10.1371/journal.pone.0046691,,,,23049713,,,2012PLoSO...7E6691B,,,,0,1,0,2,0,0,1,1,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/975711,https://api.altmetric.com/v1/donut/975711_240.png 12,Meta-analysis of measures of sexual activity and prostate cancer.,Epidemiology,,,Article,2002-01-01,,,,,11805589,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1435451,https://api.altmetric.com/v1/donut/1435451_240.png 12,Comparative effectiveness research in localized prostate cancer treatment.,Journal of Comparative Effectiveness Research,,,Article,2013-11-01,10.2217/cer.13.66,,,,24236797,,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1909151,https://api.altmetric.com/v1/donut/1909151_240.png 12,Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base,Brachytherapy,,,Article,2016-01-26,10.1016/j.brachy.2015.11.006,,,,26825856,,,,,,,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5079879,https://api.altmetric.com/v1/donut/5079879_240.png 12,Improving Prostate Cancer Screening and Diagnosis,JAMA Oncology,,,Article,2016-03-31,10.1001/jamaoncol.2016.0170,,,,27031887,,,,,,,0,0,0,19,0,0,3,0,2,0,0,0,0,0,0,1,https://www.altmetric.com/details/6428184,https://api.altmetric.com/v1/donut/6428184_240.png 12,Survival Outcomes in Men Undergoing Radical Prostatectomy After Primary Radiation Treatment for Adenocarcinoma of the Prostate,Clinical Genitourinary Cancer,,,Article,2015-12-16,10.1016/j.clgc.2015.12.010,,,,26774347,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6162424,https://api.altmetric.com/v1/donut/6162424_240.png 12,Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy.,Annals of Oncology,,,Article,2015-12-15,10.1093/annonc/mdv600,,,,26659397,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4880034,https://api.altmetric.com/v1/donut/4880034_240.png 12,Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years,ecancer.org,,,Article,,,,,http://ecancer.org/news/7239-prostate-cancer-patients-who-receive-permanent-radiotherapy-implants-twice-as-likely-to-be-free-of-cancer-after-five-years.php,,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3944717,https://api.altmetric.com/v1/donut/3944717_240.png 12,Conditional Probability of Reclassification within an Active Surveillance Program for Prostate Cancer.,The Journal of Urology,,,Article,2015-01-05,10.1016/j.juro.2014.12.091,,,,25572035,,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3038681,https://api.altmetric.com/v1/donut/3038681_240.png 12,Expression of the cancer?testis antigen BORIS correlates with prostate cancer,The Prostate,,,Article,2013-10-16,10.1002/pros.22738,,,,24123052,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2147058,https://api.altmetric.com/v1/donut/2147058_240.png 12,Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer,Archives of Internal Medicine,,,Article,2010-01-01,10.1001/archinternmed.2010.1,,,,20212180,,,,,,,0,1,1,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1444909,https://api.altmetric.com/v1/donut/1444909_240.png 12,"Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate Cancer",Cancer Research,,,Article,2005-03-15,10.1158/0008-5472.can-04-3535,,,,15781667,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/184925,https://api.altmetric.com/v1/donut/184925_240.png 12,New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men,European Urology,,,Article,2015-11-11,10.1016/j.eururo.2015.10.043,,,,26572707,,,,,,,0,0,0,40,0,0,5,0,2,0,0,0,0,0,0,4,https://www.altmetric.com/details/4748136,https://api.altmetric.com/v1/donut/4748136_240.png 12,Prostate cancer: Estimated life expectancy: integration of age and comorbidities,Nature Reviews Urology,,,Article,2016-10-18,10.1038/nrurol.2016.203,,,,27754470,,,,,,,1,0,0,6,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12717696,https://api.altmetric.com/v1/donut/12717696_240.png 12,National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?,Cancer (0008543X),,,Article,2016-07-19,10.1002/cncr.30205,,,,27434225,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9896626,https://api.altmetric.com/v1/donut/9896626_240.png 12,Prostate cancer: Novel subtyping could aid stratification and therapy,Nature Reviews Urology,,,Article,2016-07-05,10.1038/nrurol.2016.130,,,,27377159,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9241885,https://api.altmetric.com/v1/donut/9241885_240.png 12,Genetics: Known prostate cancer risk loci-guilty by association?,Nature Reviews Urology,,,Article,2015-06-30,10.1038/nrurol.2015.157,,,,26123040,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4227563,https://api.altmetric.com/v1/donut/4227563_240.png 12,Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer,British Journal of Cancer,,,Article,2015-01-06,10.1038/bjc.2014.640,,,,25562437,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3046560,https://api.altmetric.com/v1/donut/3046560_240.png 12,AGE modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.,The Journal of Pathology,,,Article,2014-12-24,10.1002/path.4485,,,,25408555,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2903556,https://api.altmetric.com/v1/donut/2903556_240.png 12,Educational benefits of Internet and computer-based programmes for prostate cancer patients: A systematic review.,Patient Education & Counseling,,,Article,2013-08-30,10.1016/j.pec.2013.08.022,,,,24021418,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1783747,https://api.altmetric.com/v1/donut/1783747_240.png 12,Symptom burden and information needs in prostate cancer survivors: A case for tailored long?term survivorship care,British Journal of Urology,,,Article,2015-09-01,10.1111/bju.13329,,,,26389529,,,,,,,0,2,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4544832,https://api.altmetric.com/v1/donut/4544832_240.png 12,Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2010-01-27,10.1200/jco.2009.25.0597,,,,20100959,PMC2834462,,,,,,0,0,0,14,0,0,0,2,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/2812138,https://api.altmetric.com/v1/donut/2812138_240.png 12,"Multi-parametric magnetic resonance imaging guiding diagnostic biopsy detects significant prostate cancer, and could reduce unnecessary biopsies and over-detection: a prospective study.",The Journal of Urology,,,Article,2014-02-08,10.1016/j.juro.2014.01.014,,,,24518762,,,,,,,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/2265464,https://api.altmetric.com/v1/donut/2265464_240.png 12,A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial.,British Journal of Urology,,,Article,2014-03-15,10.1111/bju.12623,,,,24894850,,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2170640,https://api.altmetric.com/v1/donut/2170640_240.png 12,An Expressed Retrogene of the Master Embryonic Stem Cell Gene POU5F1 Is Associated with Prostate Cancer Susceptibility,American Journal of Human Genetics,,,Article,2014-02-27,10.1016/j.ajhg.2014.01.019,,,,24581739,,,,,,,0,1,0,12,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2150363,https://api.altmetric.com/v1/donut/2150363_240.png 12,Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with C-11 Choline PET and Multiparametric MRI,The Journal of Urology,,,Article,2016-07-20,10.1016/j.juro.2016.07.073,,,,27449262,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10122847,https://api.altmetric.com/v1/donut/10122847_240.png 12,A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer,Oncogene,,,Article,2016-06-06,10.1038/onc.2016.185,,,,27270433,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8513598,https://api.altmetric.com/v1/donut/8513598_240.png 12,Active surveillance for the management of localized prostate cancer: Guideline recommendations,Canadian Urological Association Journal,,,Article,2015-05-01,10.5489/cuaj.2806,,,,26225165,,,,,,,2,0,0,2,0,0,0,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/6043851,https://api.altmetric.com/v1/donut/6043851_240.png 12,Isoflavones and Prostate Cancer: A Review of Some Critical Issues.,Chinese Medical Journal,,,Article,2016-02-07,10.4103/0366-6999.174488,,,,26831238,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5103715,https://api.altmetric.com/v1/donut/5103715_240.png 12,Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?,PLoS ONE,,,Article,2016-01-25,10.1371/journal.pone.0147191,,,,26807740,PMC4726731,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5059145,https://api.altmetric.com/v1/donut/5059145_240.png 12,Prostate cancer: Docetaxel plus ADT significantly improves patient outcomes,Nature Reviews Clinical Oncology,,,Article,2015-08-25,10.1038/nrclinonc.2015.145,,,,26305034,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4432740,https://api.altmetric.com/v1/donut/4432740_240.png 12,Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain,BMC Cancer,,,Article,2015-07-21,10.1186/1471-2407-14-874,,,,25421124,,,,,,,0,0,0,20,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4298899,https://api.altmetric.com/v1/donut/4298899_240.png 12,Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes,European Urology,,,Article,2015-07-13,10.1016/j.eururo.2015.06.018,,,,26164416,,,,,,,0,0,0,20,0,0,4,0,2,0,0,0,0,0,0,21,https://www.altmetric.com/details/4291397,https://api.altmetric.com/v1/donut/4291397_240.png 12,Prostate cancer: Radiotherapy is effective in old men with high-risk cancer,Nature Reviews Urology,,,Article,2015-07-07,10.1038/nrurol.2015.165,,,,26150239,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4254335,https://api.altmetric.com/v1/donut/4254335_240.png 12,Primary radiotherapy vs conservative management for localized prostate cancer|[mdash]|a population-based study,Prostate Cancer & Prostatic Diseases,,,Article,2015-06-23,10.1038/pcan.2015.30,,,,26101187,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4201112,https://api.altmetric.com/v1/donut/4201112_240.png 12,What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer?,The Journal of Urology,,,Article,2015-06-17,10.1016/j.juro.2015.06.069,,,,26079332,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4148890,https://api.altmetric.com/v1/donut/4148890_240.png 12,Prostate cancer: PSA kinetics predict survival in patients treated with abiraterone,Nature Reviews Urology,,,Article,2015-04-21,10.1038/nrurol.2015.87,,,,25896180,,,,,,,1,0,0,5,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3927095,https://api.altmetric.com/v1/donut/3927095_240.png 12,A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation,Nucleic Acids Research,,,Article,2015-04-08,10.1093/nar/gkv273,,,,25845598,,,,,,,0,1,0,3,0,0,1,3,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3882602,https://api.altmetric.com/v1/donut/3882602_240.png 12,"An Age Adjusted Comorbidity Index to Predict Long-Term, Other Cause Mortality in Men with Prostate Cancer",The Journal of Urology,,,Article,2015-01-07,10.1016/j.juro.2015.01.081,,,,25623745,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3099038,https://api.altmetric.com/v1/donut/3099038_240.png 12,[Ga-68-PSMA PET/CT for Prostate Cancer.],Aktuelle Urologie,,,Article,2014-11-01,10.1055/s-0034-1395529,,,,25518963,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2999328,https://api.altmetric.com/v1/donut/2999328_240.png 12,The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer,British Journal of Cancer,,,Article,2014-12-02,10.1038/bjc.2014.604,,,,25461803,,,,,,,1,0,0,3,0,0,2,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2945449,https://api.altmetric.com/v1/donut/2945449_240.png 12,A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer,European Urology,,,Article,2014-10-27,10.1016/j.eururo.2014.10.021,,,,25454615,,,,,,,0,0,0,29,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2855283,https://api.altmetric.com/v1/donut/2855283_240.png 12,Copper Signaling Axis as a Target for Prostate Cancer Therapeutics,Cancer Research,,,Article,2014-10-14,10.1158/0008-5472.can-13-3527,,,,25320179,,10161/9192,,,,,1,0,0,1,0,0,6,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2776377,https://api.altmetric.com/v1/donut/2776377_240.png 12,"Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer",Cancer (0008543X),,,Article,2008-01-01,10.1002/cncr.23695,,,,18666213,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2313863,https://api.altmetric.com/v1/donut/2313863_240.png 12,"Pancreatic cancer risk: Associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.",Molecular Carcinogenesis,,,Article,2011-12-15,10.1002/mc.20794,,,,22162237,,,,,,,11,0,0,1,0,0,2,0,0,0,0,0,0,0,1,21,https://www.altmetric.com/details/2255971,https://api.altmetric.com/v1/donut/2255971_240.png 12,Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study,British Medical Journal,,,Article,2002-10-05,10.1136/bmj.325.7367.766,,,,12364308,PMC1124277,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,110,https://www.altmetric.com/details/2248241,https://api.altmetric.com/v1/donut/2248241_240.png 12,Risk of Developing Myelodysplastic Syndromes in Prostate Cancer Patients Definitively Treated With Radiation.,JNCI: Journal of the National Cancer Institute,,,Article,2014-02-27,10.1093/jnci/djt462,,,,24577815,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2154656,https://api.altmetric.com/v1/donut/2154656_240.png 12,"Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial",Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70184-0,,,,23742877,,,,,,,0,0,0,20,0,0,2,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/1529275,https://api.altmetric.com/v1/donut/1529275_240.png 12,Castration-resistant prostate cancer: systemic therapy in 2012,Clinics,,,Article,2012-01-01,10.6061/clinics/2012(04)13,,,,,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/707272,https://api.altmetric.com/v1/donut/707272_240.png 12,Obesity and Mortality in Men With Locally Advanced Prostate Cancer: Analysis of RTOG 85-31,Cancer (0008543X),,,Article,2007-12-15,10.1002/cncr.23093,,,,17999404,PMC3047389,2027.42/57506,,,,,1,0,0,3,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/232556,https://api.altmetric.com/v1/donut/232556_240.png 12,Early Prostate Cancer — Treat or Watch?,New England Journal of Medicine,,,Article,2011-08-11,10.1056/nejmc1106325,,,,21830974,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/221522,https://api.altmetric.com/v1/donut/221522_240.png 12,Identification of Replication Competent Murine Gammaretroviruses in Commonly Used Prostate Cancer Cell Lines,PLoS ONE,,,Article,2011-06-17,10.1371/journal.pone.0020874,,,,21698104,PMC3117837,,,,,,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/171981,https://api.altmetric.com/v1/donut/171981_240.png 12,Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: A systematic review.,BMC Medicine,,,Article,2012-08-28,10.1186/1741-7015-10-96,,,,22925442,,,,,,,0,1,0,12,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/916534,https://api.altmetric.com/v1/donut/916534_240.png 12,"A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer",PLoS Medicine,,,Article,2007-03-20,10.1371/journal.pmed.0040103,,,,17388667,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/1367589,https://api.altmetric.com/v1/donut/1367589_240.png 12,The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial,Prostate Cancer & Prostatic Diseases,,,Article,2016-07-12,10.1038/pcan.2016.7,,,,27401032,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10561675,https://api.altmetric.com/v1/donut/10561675_240.png 12,The combination of DNA ploidy status and PTEN/6q15 deletions provides strong and independent prognostic information in prostate cancer,Clinical Cancer Research,,,Article,2016-01-26,10.1158/1078-0432.ccr-15-0635,,,,26813356,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5049271,https://api.altmetric.com/v1/donut/5049271_240.png 12,Intermittent Versus Continuous Androgen Deprivation Therapy in Patients with Relapsing or Locally Advanced Prostate Cancer: A Phase 3b Randomised Study (ICELAND),European Urology,,,Article,2015-10-29,10.1016/j.eururo.2015.10.007,,,,26520703,,,,,,,0,0,0,21,1,0,3,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/4699575,https://api.altmetric.com/v1/donut/4699575_240.png 12,Prostate cancer: Breaking AKR1C3-mediated enzalutamide resistance by inhibiting androgen synthesis,Nature Reviews Urology,,,Article,2015-02-24,10.1038/nrurol.2015.31,,,,,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3722564,https://api.altmetric.com/v1/donut/3722564_240.png 12,Prostate cancer: Active surveillance comes of age,Nature Reviews Urology,,,Article,2015-01-06,10.1038/nrurol.2014.363,,,,25558835,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3039456,https://api.altmetric.com/v1/donut/3039456_240.png 12,Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance).,Journal of Clinical Oncology,,,Article,2014-03-03,10.1200/jco.2013.51.6500,,,,24590644,,,,,,,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2160769,https://api.altmetric.com/v1/donut/2160769_240.png 12,"Clinical features of prostate cancer before diagnosis: a population-based, case-control study.",British Journal of General Practice,,,Article,2006-01-10,,,,,17007705,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1386094,https://api.altmetric.com/v1/donut/1386094_240.png 12,Disparities in Castration-Resistant Prostate Cancer Trials,Journal of Clinical Oncology,,,Article,2015-02-17,10.1200/jco.2014.58.1751,,,,25691679,,,,,,,0,0,0,17,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3708111,https://api.altmetric.com/v1/donut/3708111_240.png 12,Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events,Annals of Oncology,,,Article,2014-11-25,10.1093/annonc/mdu519,,,,25425475,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2929861,https://api.altmetric.com/v1/donut/2929861_240.png 12,Mediterranean Diet and Prostate Cancer Risk and Mortality in the Health Professionals Follow-up Study,European Urology,,,Article,2013-08-23,10.1016/j.eururo.2013.08.009,,,,23962747,,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1710983,https://api.altmetric.com/v1/donut/1710983_240.png 12,Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08|[sol]|09),Prostate Cancer & Prostatic Diseases,,,Article,2015-03-10,10.1038/pcan.2015.8,,,,25753371,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3840428,https://api.altmetric.com/v1/donut/3840428_240.png 12,Pomegranate and Its Components as Alternative Treatment for Prostate Cancer,International Journal of Molecular Sciences,,,Article,2014-01-01,10.3390/ijms150914949,,,,25158234,,,,,,,1,0,0,4,0,0,2,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2632849,https://api.altmetric.com/v1/donut/2632849_240.png 12,High diagnostic ability of multi-parametric magnetic resonance imaging in detecting anterior prostate cancer missed by transrectal 12-core biopsy.,The Journal of Urology,,,Article,2013-04-03,10.1016/j.juro.2013.03.078,,,,23542406,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1403692,https://api.altmetric.com/v1/donut/1403692_240.png 12,Early Detection of Prostate Cancer: Serendipity Strikes Again,JAMA: Journal of the American Medical Association,,,Article,1997-01-01,10.1001/jama.1997.03550180066039,,,,,,,,,,,0,1,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2743815,https://api.altmetric.com/v1/donut/2743815_240.png 12,"Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.",Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(12)70560-0,,,,23306100,,,,,,,0,1,0,7,0,0,2,0,0,0,0,0,0,0,0,108,https://www.altmetric.com/details/1160263,https://api.altmetric.com/v1/donut/1160263_240.png 12,Osteoclast Inhibitors in Advanced Prostate Cancer: Does the Benefit Extend Beyond Skeletal-Related Events?,European Urology,,,Article,2015-06-28,10.1016/j.eururo.2015.06.009,,,,26116295,,,,,,,0,0,0,19,0,0,5,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/4203644,https://api.altmetric.com/v1/donut/4203644_240.png 12,Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells,Cancer Cell,,,Article,2012-01-01,10.1016/j.ccr.2012.07.016,,,,22975379,,,,,,,0,0,0,16,10,0,2,0,1,0,0,0,0,0,0,104,https://www.altmetric.com/details/938310,https://api.altmetric.com/v1/donut/938310_240.png 12,No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan,Retrovirology: Research & Treatment,,,Article,2011-01-01,10.1186/1742-4690-8-20,,,,21414229,,,,,,,0,1,0,1,0,0,0,2,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/108807,https://api.altmetric.com/v1/donut/108807_240.png 12,The current evidence on statin use and prostate cancer prevention: are we there yet?,Nature Reviews Urology,,,Article,2016-10-25,10.1038/nrurol.2016.199,,,,27779230,,,,,,,1,0,0,2,0,0,6,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13039359,https://api.altmetric.com/v1/donut/13039359_240.png 12,The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy,European Urology,,,Article,2016-08-28,10.1016/j.eururo.2016.08.015,,,,27576750,,,,,,,0,0,0,19,0,0,2,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/10870711,https://api.altmetric.com/v1/donut/10870711_240.png 12,Prostate cancer: Validating early PSA response to enable improved treatment decisions,Nature Reviews Urology,,,Article,2016-03-22,10.1038/nrurol.2016.59,,,,27001015,,,,,,,2,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6259094,https://api.altmetric.com/v1/donut/6259094_240.png 12,"Retraction: Suppression of N-Methyl-N-nitrosourea/Testosterone-Induced Rat Prostate Cancer Growth by Celecoxib: Effects on Cyclooxygenase-2, Cell Cycle Regulation, and Apoptosis Mechanism(s)",Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-15-2811,,,,26728412,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4956898,https://api.altmetric.com/v1/donut/4956898_240.png 12,Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-12-16,10.1200/jco.2015.62.5988,,,,26668348,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4876058,https://api.altmetric.com/v1/donut/4876058_240.png 12,Prostate cancer: miRNA-mRNA pairs are differently expressed in African American men.,Nature Reviews Urology,,,Article,2015-07-07,10.1038/nrurol.2015.161,,,,26150241,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4251435,https://api.altmetric.com/v1/donut/4251435_240.png 12,"Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocopherol, beta-carotene cancer prevention study.",International Journal of Cancer,,,Article,2015-05-09,10.1002/ijc.29576,,,,25904191,,,,,,,1,0,0,4,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3965875,https://api.altmetric.com/v1/donut/3965875_240.png 12,Prostate cancer: Post-treatment imaging[mdash]a desperate need for solid evidence,Nature Reviews Urology,,,Article,2015-04-28,10.1038/nrurol.2015.84,,,,25917889,,,,,,,1,0,0,3,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3948825,https://api.altmetric.com/v1/donut/3948825_240.png 12,Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project,Prostate Cancer & Prostatic Diseases,,,Article,2015-02-10,10.1038/pcan.2015.3,,,,25667110,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3544899,https://api.altmetric.com/v1/donut/3544899_240.png 12,Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer: A Decision Analysis,JAMA: Journal of the American Medical Association,,,Article,2010-12-01,10.1001/jama.2010.1720,,,,21119084,PMC3055173,,,,,,0,0,1,10,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2096499,https://api.altmetric.com/v1/donut/2096499_240.png 12,Diet and prostate cancer risk with specific focus on dairy products and dietary calcium: a case-control study.,The Prostate,,,Article,2010-03-18,10.1002/pros.21139,,,,20232354,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1681203,https://api.altmetric.com/v1/donut/1681203_240.png 12,Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-01,10.1158/1055-9965.epi-11-1004,,,,22315365,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/612845,https://api.altmetric.com/v1/donut/612845_240.png 12,Quantitative ratiometric discrimination between noncancerous and cancerous prostate cells based on neuropilin-1 overexpression,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-09-19,10.1073/pnas.1109490108,,,,21930955,,,2011PNAS..10816559P,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/377663,https://api.altmetric.com/v1/donut/377663_240.png 12,Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21,Nature Genetics,"BOND, Jim C",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-05-22,10.1038/ng.839,,,,21602798,PMC3102788,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/175293,https://api.altmetric.com/v1/donut/175293_240.png 12,Prostate cancer perspectives after chaarted: Optimizing treatment sequence,Critical Reviews in Oncology/Hematology,,,Article,2016-08-21,10.1016/j.critrevonc.2016.08.007,,,,,,,,,,,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10864878,https://api.altmetric.com/v1/donut/10864878_240.png 12,Prostate cancer: Why the prostate arm of the PLCO trial failed and what it has taught us,Nature Reviews Urology,,,Article,2016-07-12,10.1038/nrurol.2016.116,,,,27400667,,,,,,,0,0,0,22,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9728661,https://api.altmetric.com/v1/donut/9728661_240.png 12,Utility of Reporting the Percentage of High-grade Prostate Cancer,European Urology,,,Article,2015-11-20,10.1016/j.eururo.2015.11.008,,,,26607687,,,,,,,0,0,0,23,0,0,3,0,3,0,0,0,0,0,0,0,https://www.altmetric.com/details/4829348,https://api.altmetric.com/v1/donut/4829348_240.png 12,Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas,Clinical Cancer Research,,,Article,2015-08-08,10.1158/1078-0432.ccr-15-0744,,,,26246306,,,,,,,0,0,0,23,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4369617,https://api.altmetric.com/v1/donut/4369617_240.png 12,The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base,Cancer (0008543X),,,Article,2014-04-15,10.1002/cncr.28697,,,,24737481,,,,,,,2,0,0,8,0,0,0,0,1,0,0,0,0,0,0,21,https://www.altmetric.com/details/2287173,https://api.altmetric.com/v1/donut/2287173_240.png 12,Folate Nutrition and Prostate Cancer Incidence in a Large Cohort of US Men,American Journal of Epidemiology,,,Article,2006-01-01,10.1093/aje/kwj126,,,,16554345,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1379426,https://api.altmetric.com/v1/donut/1379426_240.png 12,"Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study",Occupational and environmental medicine,,,Article,2002-04-01,10.1136/oem.59.4.257,,,,11934953,PMC1740270,,,,,,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,43,https://www.altmetric.com/details/5524096,https://api.altmetric.com/v1/donut/5524096_240.png 12,Men's help?seeking in the first year after diagnosis of localised prostate cancer,European Journal of Cancer Care,,,Article,2016-04-01,10.1111/ecc.12497,,,,27111695,,,,,,,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6944929,https://api.altmetric.com/v1/donut/6944929_240.png 12,Evaluation of Diffusion-Weighted MR Imaging at Inclusion in an Active Surveillance Protocol for Low-Risk Prostate Cancer.,Investigative Radiology,,,Article,2013-01-16,10.1097/rli.0b013e31827b711e,,,,23328910,,,,,,,0,0,1,15,0,0,3,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1183812,https://api.altmetric.com/v1/donut/1183812_240.png 12,Prostate cancer: Hypofractionated radiotherapy confirmed effective and safe,Nature Reviews Urology,,,Article,2016-07-05,10.1038/nrurol.2016.129,,,,27377157,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9241870,https://api.altmetric.com/v1/donut/9241870_240.png 12,The Role of Magnetic Resonance Imaging in Prostate Cancer: Focusing on What Really Matters,European Urology,,,Article,2016-02-07,10.1016/j.eururo.2016.01.039,,,,26861475,,,,,,,0,0,0,21,0,0,3,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/5104274,https://api.altmetric.com/v1/donut/5104274_240.png 12,Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP|[quest]| A multi-institutional review,Prostate Cancer & Prostatic Diseases,,,Article,2015-11-17,10.1038/pcan.2015.52,,,,26857145,,,,,,,2,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4777100,https://api.altmetric.com/v1/donut/4777100_240.png 12,Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database,,,,Article,2015-09-28,10.1016/j.euf.2015.05.003,,,,,,,,,,,0,0,0,22,0,0,2,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4669447,https://api.altmetric.com/v1/donut/4669447_240.png 12,Prostate cancer: ERG fusion and AKR1C3 form AR signalling feed-forward loop,Nature Reviews Urology,,,Article,2015-03-24,10.1038/nrurol.2015.61,,,,,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3826793,https://api.altmetric.com/v1/donut/3826793_240.png 12,Prostate cancer: Effect of enzalutamide on health-related quality of life,Nature Reviews Urology,,,Article,2014-11-25,10.1038/nrurol.2014.322,,,,25420439,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2921708,https://api.altmetric.com/v1/donut/2921708_240.png 12,Re-Examining Racial Disparities in Prostate Cancer Outcomes,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.50.7723,,,,23878300,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1648165,https://api.altmetric.com/v1/donut/1648165_240.png 12,"Evidence of a Healthy Volunteer Effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",American Journal of Epidemiology,,,Article,2007-01-01,10.1093/aje/kwk075,,,,17244633,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1006062,https://api.altmetric.com/v1/donut/1006062_240.png 12,Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.,Cancer Research,,,Article,2009-03-01,10.1158/0008-5472.can-08-3502,,,,19223537,PMC2683380,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/394795,https://api.altmetric.com/v1/donut/394795_240.png 12,Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2011-01-01,10.1002/jcb.22770,,,,20658545,,,,,,,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2344146,https://api.altmetric.com/v1/donut/2344146_240.png 12,"Down?regulation of Notch?1 and Jagged?1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF??B signaling pathways",Journal of Cellular Biochemistry,,,Article,2010-01-07,10.1002/jcb.22451,,,,20052673,,,,,,,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/2199780,https://api.altmetric.com/v1/donut/2199780_240.png 12,The relationship between obesity and prostate cancer: from genetics to disease treatment and prevention,BMC Medicine,,,Article,2012-09-25,10.1186/1741-7015-10-109,,,,23009325,,,,,,,0,1,0,6,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/964112,https://api.altmetric.com/v1/donut/964112_240.png 12,NICE recommends abiraterone for prostate cancer after manufacturer reduces price,British Medical Journal,,,Article,2012-05-18,10.1136/bmj.e3520,,,,22611169,,,,,,,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/750348,https://api.altmetric.com/v1/donut/750348_240.png 12,Current status of immunological therapies for prostate cancer.,Current Opinion in Urology,,,Article,2010-02-25,10.1097/mou.0b013e3283381793,,,,20179598,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1429250,https://api.altmetric.com/v1/donut/1429250_240.png 11,Salvage Radiotherapy Dose Response for Biochemical Failure of Prostate Cancer after Prostatectomy - A Multi-Institutional Observational Study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-09-01,10.1016/j.ijrobp.2016.08.043,,,,27745980,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12225478,https://api.altmetric.com/v1/donut/12225478_240.png 11,Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting,Prostate Cancer & Prostatic Diseases,,,Article,2016-05-17,10.1038/pcan.2016.17,,,,27184811,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7563536,https://api.altmetric.com/v1/donut/7563536_240.png 11,TINT Tumor Indicating Normal Tissue : new field of diagnostic biomarkers for prostate cancer,,,,Article,2016-04-28,,,,,,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7548781,https://api.altmetric.com/v1/donut/7548781_240.png 11,Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk,Prostate Cancer & Prostatic Diseases,,,Article,2016-05-03,10.1038/pcan.2016.15,,,,27136742,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7147600,https://api.altmetric.com/v1/donut/7147600_240.png 11,The implications of ageing and life expectancy in prostate cancer treatment,Nature Reviews Urology,,,Article,2016-03-22,10.1038/nrurol.2016.52,,,,27001016,,,,,,,2,0,0,4,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6259095,https://api.altmetric.com/v1/donut/6259095_240.png 11,An update on enzalutamide in the treatment of prostate cancer,Therapeutic Advances in Urology,,,Article,2015-02-01,10.1177/1756287214555336,,,,25642291,PMC4294802,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6052445,https://api.altmetric.com/v1/donut/6052445_240.png 11,Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry,Journal of Medical Imaging & Radiation Oncology,,,Article,2015-12-01,10.1111/1754-9485.12407,,,,26548940,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4765641,https://api.altmetric.com/v1/donut/4765641_240.png 11,Prostate cancer: Intrapatient heterogeneity in prostate cancer,Nature Reviews Urology,,,Article,2015-07-28,10.1038/nrurol.2015.182,,,,26215693,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4336738,https://api.altmetric.com/v1/donut/4336738_240.png 11,Prostate cancer: Optimizing prostate cancer survivorship care,Nature Reviews Urology,,,Article,2015-06-02,10.1038/nrurol.2015.123,,,,26032549,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4080889,https://api.altmetric.com/v1/donut/4080889_240.png 11,Targeting bone metastases in prostate cancer: improving clinical outcome,Nature Reviews Urology,,,Article,2015-05-05,10.1038/nrurol.2015.90,,,,25850797,,,,,,,1,0,0,3,0,0,3,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3969591,https://api.altmetric.com/v1/donut/3969591_240.png 11,Prostate cancer: How good are guidelines for localized prostate cancer?,Nature Reviews Urology,,,Article,2015-02-03,10.1038/nrurol.2015.3,,,,25644156,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3434410,https://api.altmetric.com/v1/donut/3434410_240.png 11,Re-purposing cryoablation: a combinatorial |[lsquo]|therapy|[rsquo]| for the destruction of tissue,Prostate Cancer & Prostatic Diseases,,,Article,2015-01-27,10.1038/pcan.2014.54,,,,25622539,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3245665,https://api.altmetric.com/v1/donut/3245665_240.png 11,Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and|[sol]|or docetaxel,Prostate Cancer & Prostatic Diseases,,,Article,2015-01-20,10.1038/pcan.2014.53,,,,25600186,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3083369,https://api.altmetric.com/v1/donut/3083369_240.png 11,CHEMOPREVENTION OF PROSTATE CANCER WITH LYCOPENE IN THE TRAMP MODEL,The Prostate,,,Article,2010-10-01,10.1002/pros.21190,,,,20687227,PMC2930120,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2788702,https://api.altmetric.com/v1/donut/2788702_240.png 11,"International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption.",Cancer (0008543X),,,Article,1986-12-01,,,,,3768832,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/2455568,https://api.altmetric.com/v1/donut/2455568_240.png 11,Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases,Cancer Cell International,,,Article,2014-03-20,10.1186/1475-2867-14-26,,,,24645697,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2198661,https://api.altmetric.com/v1/donut/2198661_240.png 11,"Akt/CREB/Cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate (TRAMP) model mediated by Nexrutine®, a Phellodendron amurense bark extract",Clinical Cancer Research,,,Article,2007-01-01,10.1158/1078-0432.ccr-06-2974,,,,17473212,,,,,,,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2159049,https://api.altmetric.com/v1/donut/2159049_240.png 11,High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique.,Journal of Magnetic Resonance Imaging,,,Article,2011-10-01,10.1002/jmri.22745,,,,21928309,,,,,,,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,26,https://www.altmetric.com/details/1914211,https://api.altmetric.com/v1/donut/1914211_240.png 11,Use of Testosterone Replacement Therapy in the United States and Its Effect on Subsequent Prostate Cancer Outcomes,Urology,,,Article,2013-05-28,10.1016/j.urology.2013.03.049,,,,23706552,,,,,,,1,0,0,2,0,0,3,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1515280,https://api.altmetric.com/v1/donut/1515280_240.png 11,A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.11.023,,,,23234624,,,,,,,0,1,3,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1150949,https://api.altmetric.com/v1/donut/1150949_240.png 11,Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer,British Journal of Urology,,,Article,2012-07-06,10.1111/j.1464-410x.2012.11272.x,,,,22757686,,,,,,,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/881157,https://api.altmetric.com/v1/donut/881157_240.png 11,Can homeopathic treatment slow prostate cancer growth?,Integrative Cancer Therapies,,,Article,2006-01-01,10.1177/1534735406294225,,,,17101763,,,,,,,0,0,0,18,0,0,4,0,0,0,0,0,0,0,2,15,https://www.altmetric.com/details/574863,https://api.altmetric.com/v1/donut/574863_240.png 11,Calcium intake and prostate cancer among African Americans: Effect modification by vitamin D receptor calcium absorption genotype.,Journal of Bone & Mineral Research,"LEE, Bruce Q",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-09-01,10.1002/jbmr.505,,,,21887707,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/253063,https://api.altmetric.com/v1/donut/253063_240.png 11,Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men,JAMA: Journal of the American Medical Association,,,Article,2006-12-13,10.1001/jama.296.22.2683,,,,17164454,,,,,,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/226540,https://api.altmetric.com/v1/donut/226540_240.png 11,No evidence of XMRV in prostate cancer cohorts in the Midwestern United States,Retrovirology,,,Article,2011-01-01,10.1186/1742-4690-8-23,,,,21447170,PMC3077333,,,,,,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/186449,https://api.altmetric.com/v1/donut/186449_240.png 11,"Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy",Prostate Cancer & Prostatic Diseases,,,Article,2012-08-21,10.1038/pcan.2012.32,,,,22907512,,,,,,,0,2,0,5,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/896664,https://api.altmetric.com/v1/donut/896664_240.png 11,Advances in the management of castration resistant prostate cancer,British Medical Journal,,,Article,2016-10-17,10.1136/bmj.i4405,,,,,,,,,,,0,0,0,25,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12686308,https://api.altmetric.com/v1/donut/12686308_240.png 11,Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer,Cancer Treatment Reviews,,,Article,2016-06-17,10.1016/j.ctrv.2016.06.006,,,,27347670,,,,,,,0,0,0,28,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8993559,https://api.altmetric.com/v1/donut/8993559_240.png 11,Prostate cancer: A prognostic pathway signature for personalizing therapy,Nature Reviews Urology,,,Article,2016-01-27,10.1038/nrurol.2016.21,,,,26813956,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5048991,https://api.altmetric.com/v1/donut/5048991_240.png 11,TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression,Nature Communications,,,Article,2015-09-26,10.1038/ncomms9219,,,,26404510,,,,,,,0,1,0,9,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4556598,https://api.altmetric.com/v1/donut/4556598_240.png 11,"Abstracts of the 2nd Prostate Cancer World Congress, Australia, 17-21 August 2015.",British Journal of Urology,,,Article,2015-08-01,10.1111/bju.13196,,,,26250590,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4403747,https://api.altmetric.com/v1/donut/4403747_240.png 11,Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in a German Chemical Company.,Deutsches Aerzteblatt International,,,Article,2015-07-29,10.3238/arztebl.2015.0463,,,,26214232,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4338598,https://api.altmetric.com/v1/donut/4338598_240.png 11,Prostate cancer: TGF-[beta] signalling regulator PMEPA1 halts metastases to bone,Nature Reviews Urology,,,Article,2015-06-09,10.1038/nrurol.2015.136,,,,26057060,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4126453,https://api.altmetric.com/v1/donut/4126453_240.png 11,Prostate cancer: The complex relationships of malignant cells in lethal metastatic castration-resistant disease,Nature Reviews Urology,,,Article,2015-04-14,10.1038/nrurol.2015.75,,,,25868559,,,,,,,1,0,0,3,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3909819,https://api.altmetric.com/v1/donut/3909819_240.png 11,Targeting heat shock proteins in metastatic castration-resistant prostate cancer,Nature Reviews Urology,,,Article,2014-12-16,10.1038/nrurol.2014.320,,,,25512207,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2987776,https://api.altmetric.com/v1/donut/2987776_240.png 11,The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer,Gene Therapy,,,Article,2014-12-11,10.1038/gt.2014.110,,,,25503693,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2977656,https://api.altmetric.com/v1/donut/2977656_240.png 11,Complications of prostate cancer treatment,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70092-0,,,,,,,,,,,0,0,0,21,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/2226161,https://api.altmetric.com/v1/donut/2226161_240.png 11,Multispectral Photoacoustic Imaging of Prostate Cancer: Preliminary Ex-vivo Results,Journal of Clinical Imaging Science,,,Article,2013-01-01,10.4103/2156-7514.119139,,,,24228210,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2199734,https://api.altmetric.com/v1/donut/2199734_240.png 11,Sedentary Behavior and Prostate Cancer Risk in the NIH–AARP Diet and Health Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-05-01,10.1158/1055-9965.epi-13-0808,,,,24526287,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2120529,https://api.altmetric.com/v1/donut/2120529_240.png 11,Long?acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer,British Journal of Urology,,,Article,2014-05-02,10.1111/bju.12668,,,,,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2115265,https://api.altmetric.com/v1/donut/2115265_240.png 11,Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.,Cancer Research,,,Article,2013-11-12,10.1158/0008-5472.can-13-0275,,,,24220242,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1908044,https://api.altmetric.com/v1/donut/1908044_240.png 11,The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex,Nature Genetics,,,Article,2013-09-29,10.1038/ng.2771,,,,24076601,,,,,,,0,0,0,19,0,0,0,0,1,0,0,0,0,0,0,184,https://www.altmetric.com/details/1791438,https://api.altmetric.com/v1/donut/1791438_240.png 11,Daily life and life quality 3 years following prostate cancer treatment,BMC Nursing,,,Article,2013-04-10,10.1186/1472-6955-12-11,,,,23574878,,,,,,,0,2,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1355125,https://api.altmetric.com/v1/donut/1355125_240.png 11,Rye bread consumption in early life and reduced risk of advanced prostate cancer.,Cancer Causes and Control,,,Article,2012-04-26,10.1007/s10552-012-9965-2,,,,22527172,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1079835,https://api.altmetric.com/v1/donut/1079835_240.png 11,Cancer incidence after localized therapy for prostate cancer,Cancer (0008543X),,,Article,2006-09-01,10.1002/cncr.22083,,,,16878323,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/468979,https://api.altmetric.com/v1/donut/468979_240.png 11,Prevalence of prostate cancer across the globe: what can autopsy stuies teach us about this peculiar disease?,Archivos Españoles de Urología,,,Article,2014-06-12,,,,,24914839,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2447487,https://api.altmetric.com/v1/donut/2447487_240.png 11,"Palliative Radical (Cysto-)prostatectomy for Locally Advanced, Symptomatic Castration-resistant Prostate Cancer",European Urology Focus ,,,Article,2016-10-01,10.1016/j.euf.2016.08.009,,,,,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12554997,https://api.altmetric.com/v1/donut/12554997_240.png 11,Striving Toward a Cure for Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-03-28,10.1200/jco.2015.66.3146,,,,27022121,,,,,,,0,0,0,20,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6370757,https://api.altmetric.com/v1/donut/6370757_240.png 11,Prostate MRI based on PI-RADS version 2: how we review and report,Cancer Imaging,,,Article,2016-04-11,10.1186/s40644-016-0068-2,,,,27067275,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6626351,https://api.altmetric.com/v1/donut/6626351_240.png 11,The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients,European Urology,,,Article,2016-10-14,10.1016/j.eururo.2016.08.012,,,,27733296,,,,,,,0,0,0,19,0,0,1,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/12525914,https://api.altmetric.com/v1/donut/12525914_240.png 11,Prostate cancer: Focal laser ablation improves short-term outcomes,Nature Reviews Urology,,,Article,2016-08-09,10.1038/nrurol.2016.151,,,,27502550,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10350295,https://api.altmetric.com/v1/donut/10350295_240.png 11,Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy,British Journal of Urology,,,Article,2016-08-01,10.1111/bju.13461,,,,26935133,,,,,,,0,2,0,5,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10065707,https://api.altmetric.com/v1/donut/10065707_240.png 11, v 6 Integrin Promotes Castrate-Resistant Prostate Cancer Through JNK1-Mediated Activation of Androgen Receptor,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-0543,,,,27450452,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9979504,https://api.altmetric.com/v1/donut/9979504_240.png 11,Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity,British Journal of Cancer,,,Article,2016-04-12,10.1038/bjc.2016.94,,,,27070714,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6634532,https://api.altmetric.com/v1/donut/6634532_240.png 11,"Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition",British Journal of Cancer,,,Article,2016-03-08,10.1038/bjc.2016.29,,,,26954717,,,,,,,1,0,0,3,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6142957,https://api.altmetric.com/v1/donut/6142957_240.png 11,Prostate cancer: Multilayered mutation analysis indicates divergent clonal evolution,Nature Reviews Urology,,,Article,2016-02-23,10.1038/nrurol.2016.38,,,,26902334,,,,,,,2,0,0,5,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5973391,https://api.altmetric.com/v1/donut/5973391_240.png 11,Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-resistant Prostate Cancer,Clinical Cancer Research,,,Article,2016-02-04,10.1158/1078-0432.ccr-15-2512,,,,26839144,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5081319,https://api.altmetric.com/v1/donut/5081319_240.png 11,Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer,Laboratory Investigation,,,Article,2015-12-07,10.1038/labinvest.2015.136,,,,26641067,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4852271,https://api.altmetric.com/v1/donut/4852271_240.png 11,Prostate cancer: Molecular stratification and repair defects: revealing hidden treasures,Nature Reviews Urology,,,Article,2015-11-24,10.1038/nrurol.2015.284,,,,26597617,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4800443,https://api.altmetric.com/v1/donut/4800443_240.png 11,Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance,Prostate Cancer & Prostatic Diseases,,,Article,2015-08-11,10.1038/pcan.2015.39,,,,26260996,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4386113,https://api.altmetric.com/v1/donut/4386113_240.png 11,Western diet after prostate cancer diagnosis associated with increased risk of death,ecancer.org,,,Article,,,,,http://ecancer.org/news/7372-western-diet-after-prostate-cancer-diagnosis-associated-with-increased-risk-of-death.php,,,,,,,,1,0,0,5,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4076910,https://api.altmetric.com/v1/donut/4076910_240.png 11,What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation ,Radiotherapy & Oncology,,,Article,2015-06-02,10.1016/j.radonc.2015.05.011,,,,26028229,,,,,,,0,0,0,21,0,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/4069815,https://api.altmetric.com/v1/donut/4069815_240.png 11,miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.,Carcinogenesis,,,Article,2015-05-16,10.1093/carcin/bgv063,,,,25969144,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4002007,https://api.altmetric.com/v1/donut/4002007_240.png 11,Long-term Efficacy and Safety Results: Can Enzalutamide Challenge the Dogma of Androgen Deprivation Therapy in Hormone-naïve Prostate Cancer?,European Urology,,,Article,2015-04-30,10.1016/j.eururo.2015.04.019,,,,25922192,,,,,,,0,0,0,23,0,0,9,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/3940609,https://api.altmetric.com/v1/donut/3940609_240.png 11,Effect of Individual Omega-3 Fatty Acids on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.,Journal of Epidemiology,,,Article,2015-03-20,10.2188/jea.je20140120,,,,25787237,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3820619,https://api.altmetric.com/v1/donut/3820619_240.png 11,Prostate cancer: Abiraterone treatment improves overall survival in patients with mCRPC,Nature Reviews Urology,,,Article,2015-02-03,10.1038/nrurol.2015.14,,,,25644162,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3261197,https://api.altmetric.com/v1/donut/3261197_240.png 11,Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer.,The Journal of Urology,,,Article,2015-01-06,10.1016/j.juro.2014.12.027,,,,25524243,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2986273,https://api.altmetric.com/v1/donut/2986273_240.png 11,Prostate cancer: Urinary glycoprofile identifies presence and grade of cancer,Nature Reviews Urology,,,Article,2014-11-18,10.1038/nrurol.2014.317,,,,25403242,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2898643,https://api.altmetric.com/v1/donut/2898643_240.png 11,Prostate cancer services vary in England and Wales ,Lancet Oncology,,,Article,2014-11-14,10.1016/s1470-2045(14)71119-2,,,,,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2888728,https://api.altmetric.com/v1/donut/2888728_240.png 11,Prostate cancer: immunoPET for imaging disease progression in prostate cancer,Nature Reviews Urology,,,Article,2014-11-04,10.1038/nrurol.2014.304,,,,25366295,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2848529,https://api.altmetric.com/v1/donut/2848529_240.png 11,"The Dark Side of 5?-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression",Korean Journal of Urology,,,Article,2014-06-01,10.4111/kju.2014.55.6.367,,,,24955220,PMC4064044,,,,,,0,0,0,18,0,0,3,4,0,0,1,0,0,0,0,31,https://www.altmetric.com/details/2458342,https://api.altmetric.com/v1/donut/2458342_240.png 11,An Orthotopic Murine Model of Human Prostate Cancer Metastasis,Journal of Visualized Experiments,,,Article,2013-01-01,10.3791/50873,,,,24084571,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,17,https://www.altmetric.com/details/1759673,https://api.altmetric.com/v1/donut/1759673_240.png 11,MR Imaging-guided Focal Cryoablation in Patients with Recurrent Prostate Cancer.,Radiology,,,Article,2013-03-22,10.1148/radiol.13121291,,,,23525206,,,,,,,1,0,0,3,0,0,2,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1321576,https://api.altmetric.com/v1/donut/1321576_240.png 11,Evolution and outcomes of 3 MHz High intensity focused ultrasound therapy for localized prostate cancer over 15 years,The Journal of Urology,,,Article,2013-02-13,10.1016/j.juro.2013.02.010,,,,23415962,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1237388,https://api.altmetric.com/v1/donut/1237388_240.png 11,Targeting Poly(ADP-Ribose) Polymerase and the c-Myb-Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer,Science Signaling,,,Article,2014-05-20,10.1126/scisignal.2005070,,,,24847116,,,,,,,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2367664,https://api.altmetric.com/v1/donut/2367664_240.png 11,Androgen receptor signaling regulates DNA repair in prostate cancers,Cancer Discovery,,,Article,2013-01-01,10.1158/2159-8290.cd-13-0172,,,,24027196,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/1752598,https://api.altmetric.com/v1/donut/1752598_240.png 11,Imaging Prostate Cancer: A Multidisciplinary Perspective,Radiology,,,Article,2007-04-14,10.1148/radiol.2431030580,,,,17392247,,,,,,,0,0,0,19,0,0,2,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/12033829,https://api.altmetric.com/v1/donut/12033829_240.png 11,The Impact of an Outpatient Palliative Care Consultation on Symptom Burden in Advanced Prostate Cancer Patients.,Journal of Palliative Medicine,,,Article,2011-12-08,10.1089/jpm.2011.0219,,,,22141432,,,,,,,0,1,0,5,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/547162,https://api.altmetric.com/v1/donut/547162_240.png 11,Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach,Cancer Prevention Research,,,Article,2008-01-01,10.1158/1940-6207.capr-08-0092,,,,19138953,PMC2844801,,,,,,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1444982,https://api.altmetric.com/v1/donut/1444982_240.png 11,Prostate cancer: Kinases and CHIPS sign-off personalization of therapy,Nature Reviews Urology,,,Article,2016-10-11,10.1038/nrurol.2016.194,,,,27725640,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12555962,https://api.altmetric.com/v1/donut/12555962_240.png 11,Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis,EMBO Molecular Medicine,,,Article,2016-05-19,10.15252/emmm.201506059,,,,27198502,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8081275,https://api.altmetric.com/v1/donut/8081275_240.png 11,Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression,British Journal of Cancer,,,Article,2016-03-17,10.1038/bjc.2016.61,,,,26986253,,,,,,,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6226969,https://api.altmetric.com/v1/donut/6226969_240.png 11,MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221|[sol]|222 cluster functions as a tumour suppressor and disease progression marker,British Journal of Cancer,,,Article,2015-09-01,10.1038/bjc.2015.300,,,,26325107,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4463271,https://api.altmetric.com/v1/donut/4463271_240.png 11,Applying precision medicine to the active surveillance of prostate cancer,Cancer (0008543X),,,Article,2015-07-01,10.1002/cncr.29496,,,,26149066,,,,,,,0,0,0,15,0,0,1,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/4251367,https://api.altmetric.com/v1/donut/4251367_240.png 11,Prostate cancer: Fetuin-A[mdash]a marker for metastatic disease?,Nature Reviews Urology,,,Article,2015-02-24,10.1038/nrurol.2015.34,,,,,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3722560,https://api.altmetric.com/v1/donut/3722560_240.png 11,Prostate cancer: Improving early detection[mdash]can PCA3 do more?,Nature Reviews Urology,,,Article,2014-11-25,10.1038/nrurol.2014.326,,,,25420437,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2921711,https://api.altmetric.com/v1/donut/2921711_240.png 11,Prostate cancer: LHRH-receptor-targeted doxorubicin shows promise,Nature Reviews Urology,,,Article,2014-10-21,10.1038/nrurol.2014.295,,,,25330791,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2796874,https://api.altmetric.com/v1/donut/2796874_240.png 11,"Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era",Journal of Oncology,,,Article,2012-06-14,10.1155/2012/271063,,,,22690215,PMC3368367,,,,,,0,1,1,0,0,0,2,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1159438,https://api.altmetric.com/v1/donut/1159438_240.png 11,"Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial",International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.27909,,,,23065684,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1003182,https://api.altmetric.com/v1/donut/1003182_240.png 11,Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.,Cancer Cell,,,Article,2011-05-17,10.1016/j.ccr.2011.04.008,,,,21575859,PMC3142785,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,1,0,0,203,https://www.altmetric.com/details/222822,https://api.altmetric.com/v1/donut/222822_240.png 11,Mechanisms of Vitamin D-mediated Growth Inhibition in Prostate Cancer Cells: Inhibition of the Prostaglandin Pathway,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2006-07-01,,,,,16886660,,,,,,,0,0,0,13,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3128028,https://api.altmetric.com/v1/donut/3128028_240.png 11,"Multifocal prostate cancer: biologic, prognostic, and therapeutic implications.",Human Pathology,,,Article,2010-05-15,10.1016/j.humpath.2010.02.011,,,,20466122,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/3754574,https://api.altmetric.com/v1/donut/3754574_240.png 11,Should Chemotherapy Be Used in Nonmetastatic Prostate Cancer?,JAMA Oncology,,,Article,2016-11-03,10.1001/jamaoncol.2016.3623,,,,27812686,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13313015,https://api.altmetric.com/v1/donut/13313015_240.png 11,Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?,Nature Reviews Urology,,,Article,2016-06-14,10.1038/nrurol.2016.106,,,,27296648,,,,,,,1,0,0,4,0,0,3,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8727109,https://api.altmetric.com/v1/donut/8727109_240.png 11,68Ga-PSMA-HBED-CC PET/CT detects location and extent of primary prostate cancer,Journal of Nuclear Medicine,,,Article,2016-06-03,10.2967/jnumed.116.172627,,,,27261520,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8489015,https://api.altmetric.com/v1/donut/8489015_240.png 11,Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment,Prostate Cancer & Prostatic Diseases,,,Article,2016-03-01,10.1038/pcan.2016.4,,,,26926928,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6033297,https://api.altmetric.com/v1/donut/6033297_240.png 11,"Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer",Prostate Cancer & Prostatic Diseases,,,Article,2015-12-01,10.1038/pcan.2015.54,,,,26620738,,,,,,,0,1,0,6,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4842079,https://api.altmetric.com/v1/donut/4842079_240.png 11,Replication of a genetic variant for prostate cancer-specific mortality,Prostate Cancer & Prostatic Diseases,,,Article,2015-05-05,10.1038/pcan.2015.18,,,,25939514,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3973497,https://api.altmetric.com/v1/donut/3973497_240.png 11,The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer,Oncologist,,,Article,2015-03-16,10.1634/theoncologist.2015-0054,,,,25777346,,,,,,,1,0,0,5,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3795558,https://api.altmetric.com/v1/donut/3795558_240.png 11,Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents,British Journal of Cancer,,,Article,2015-02-26,10.1038/bjc.2015.63,,,,25719830,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3740976,https://api.altmetric.com/v1/donut/3740976_240.png 11,A urine-based methylation signature for risk stratification within low-risk prostate cancer,British Journal of Cancer,,,Article,2015-02-19,10.1038/bjc.2015.7,,,,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3716582,https://api.altmetric.com/v1/donut/3716582_240.png 11,Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images,Prostate Cancer & Prostatic Diseases,,,Article,2015-02-03,10.1038/pcan.2014.55,,,,25644248,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3435172,https://api.altmetric.com/v1/donut/3435172_240.png 11,The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices,Prostate Cancer & Prostatic Diseases,,,Article,2014-12-16,10.1038/pcan.2014.49,,,,25512262,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2987232,https://api.altmetric.com/v1/donut/2987232_240.png 11,BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability,British Journal of Cancer,,,Article,2014-12-02,10.1038/bjc.2014.603,,,,25461807,,,,,,,1,0,0,1,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2945447,https://api.altmetric.com/v1/donut/2945447_240.png 11,Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience,Journal of Clinical Oncology,,,Article,2011-04-07,10.1200/jco.2010.32.8112,,,,21464416,,,,,,,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2447341,https://api.altmetric.com/v1/donut/2447341_240.png 11,Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy,Scandinavian Journal of Urology & Nephrology,,,Article,2012-11-27,10.3109/00365599.2012.747562,,,,23181478,,,,,,,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1092944,https://api.altmetric.com/v1/donut/1092944_240.png 11,Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.,Lancet Oncology,,,Article,2006-06-01,10.1016/s1470-2045(06)70700-8,,,,16750497,,,,,,,0,2,0,2,0,0,0,0,0,0,0,0,1,0,0,136,https://www.altmetric.com/details/226581,https://api.altmetric.com/v1/donut/226581_240.png 11,Risk-based management of prostate cancer.,New England Journal of Medicine,,,Article,2011-07-14,10.1056/nejme1103829,,,,21751910,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/188486,https://api.altmetric.com/v1/donut/188486_240.png 11,Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate Cancer,Chemistry & Biology,,,Article,2011-08-03,10.1016/j.chembiol.2011.05.009,,,,21802006,PMC3149849,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/403799,https://api.altmetric.com/v1/donut/403799_240.png 11,Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study,PLoS Medicine,,,Article,2009-12-15,10.1371/journal.pmed.1000197,,,,20016838,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1372355,https://api.altmetric.com/v1/donut/1372355_240.png 11,Potential Genetic Biomarker Found for Treatment-Resistant Prostate Cancer,Oncology times,,,Article,2016-10-25,10.1097/01.cot.0000505524.94609.71,,,http://journals.lww.com/oncology-times/Fulltext/2016/10250/Potential_Genetic_Biomarker_Found_for.7.aspx,,,,,,,,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12629133,https://api.altmetric.com/v1/donut/12629133_240.png 11,Making Radiation Therapy for Prostate Cancer More Economical and More Convenient,Journal of Clinical Oncology,,,Article,2016-04-18,10.1200/jco.2016.67.3764,,,,27091711,,,,,,,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6788001,https://api.altmetric.com/v1/donut/6788001_240.png 11,Defining new standards of care for men with prostate cancer,The Lancet,,,Article,2016-03-19,10.1016/s0140-6736(15)01235-0,,,,27025318,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6226256,https://api.altmetric.com/v1/donut/6226256_240.png 11,Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome?,European Urology,,,Article,2015-09-20,10.1016/j.eururo.2015.09.006,,,,26395652,,,,,,,0,0,0,18,0,0,3,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/4534354,https://api.altmetric.com/v1/donut/4534354_240.png 11,Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells,European Urology,,,Article,2015-08-06,10.1016/j.eururo.2015.07.007,,,,26188394,,,,,,,0,0,0,17,0,0,2,0,1,0,0,0,0,0,0,38,https://www.altmetric.com/details/4368463,https://api.altmetric.com/v1/donut/4368463_240.png 11,New Guidelines on Follow-Up Care for Prostate Cancer Survivors,Journal Watch,,,Article,2014-06-12,10.1056/nejm-jw.fw108933,,,,,,,,,,,0,0,0,19,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2428417,https://api.altmetric.com/v1/donut/2428417_240.png 11,Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.,Carcinogenesis,,,Article,2005-01-01,10.1093/carcin/bgi077,,,,15817614,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/499678,https://api.altmetric.com/v1/donut/499678_240.png 11,Prostate cancer: Exosomal AR-V7 is a marker of hormonal therapy resistance,Nature Reviews Urology,,,Article,2016-10-25,10.1038/nrurol.2016.220,,,,27779227,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13044856,https://api.altmetric.com/v1/donut/13044856_240.png 11,Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer,European Urology,,,Article,2016-07-26,10.1016/j.eururo.2016.07.021,,,,27471164,,,,,,,0,0,0,15,0,0,2,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/10044507,https://api.altmetric.com/v1/donut/10044507_240.png 11,"Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort",European Urology,,,Article,2016-05-09,10.1016/j.eururo.2016.04.023,,,,27160947,,,,,,,0,0,0,15,0,0,2,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/7297958,https://api.altmetric.com/v1/donut/7297958_240.png 11,Lethal Prostate Cancer in the PLCO Cancer Screening Trial,European Urology,,,Article,2016-05-09,10.1016/j.eururo.2016.01.009,,,,27166670,,,,,,,0,0,0,17,0,0,2,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/7297655,https://api.altmetric.com/v1/donut/7297655_240.png 11,Prostate cancer: Little intraindividual heterogeneity in metastases,Nature Reviews Clinical Oncology,,,Article,2016-03-15,10.1038/nrclinonc.2016.44,,,,26977784,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6193200,https://api.altmetric.com/v1/donut/6193200_240.png 11,"Complications After Radical Prostatectomy or Radiotherapy for Prostate Cancer: Results of a Population-based, Propensity Score-matched Analysis.",Urology,,,Article,2015-03-15,10.1016/j.urology.2014.11.037,,,,25733275,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4250256,https://api.altmetric.com/v1/donut/4250256_240.png 11,Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302,European Urology,,,Article,2015-05-20,10.1016/j.eururo.2015.04.032,,,,25985882,,,,,,,0,0,0,35,0,0,4,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4001238,https://api.altmetric.com/v1/donut/4001238_240.png 11,Certain classes of genes in patients that could lead to prostate cancer. Certain classes of genes in patients that could lead to prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3636/certain-classes-of-genes-in-patients-that-could-lead-to-prostate-cancer.php,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3961410,https://api.altmetric.com/v1/donut/3961410_240.png 11,Recent advances in current treatment practices in prostate cancer. Recent advances in current treatment practices in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/2845/recent-advances-in-current-treatment-practices-in-prostate-cancer.php,,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2355781,https://api.altmetric.com/v1/donut/2355781_240.png 11,Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.50.3201,,,,24101043,,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1818388,https://api.altmetric.com/v1/donut/1818388_240.png 11,The melanoma epidemic: lessons from prostate cancer,Journal of Cutaneous Pathology,,,Article,2012-01-01,10.1111/j.1600-0560.2011.01848.x,,,,22211331,,,,,,,0,2,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/510251,https://api.altmetric.com/v1/donut/510251_240.png 11,Highlights in Genitourinary (Prostate) Cancer,JAMA Oncology,,,Article,2016-08-18,10.1001/jamaoncol.2016.3325,,,,27541619,,,,,,,0,0,0,25,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10683175,https://api.altmetric.com/v1/donut/10683175_240.png 11,Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate Cancer,European Urology,,,Article,2016-06-23,10.1016/j.eururo.2016.06.014,,,,27344293,,,,,,,0,0,0,24,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8983248,https://api.altmetric.com/v1/donut/8983248_240.png 11,Zinc intake from supplements and diet and prostate cancer.,Nutrition and Cancer,,,Article,2016-09-29,10.1080/01635580802419749,,,,19235036,PMC2664741,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4862939,https://api.altmetric.com/v1/donut/4862939_240.png 11,Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer,Cancer Discovery,,,Article,2012-01-01,10.1158/2159-8290.cd-12-0222,,,,23093251,,,,,,,0,0,0,17,0,0,1,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/1022757,https://api.altmetric.com/v1/donut/1022757_240.png 11,The Relationship Between Clinical Benefit and Receipt of Curative Therapy for Prostate Cancer,Archives of Internal Medicine,,,Article,2012-01-01,10.1001/archinternmed.2011.1494,,,,22371925,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/635039,https://api.altmetric.com/v1/donut/635039_240.png 11,Fruit and Vegetable Intakes and Prostate Cancer Risk,JNCI: Journal of the National Cancer Institute,,,Article,2000-01-05,10.1093/jnci/92.1.61,,,,,,,,,,,0,1,0,2,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/411026,https://api.altmetric.com/v1/donut/411026_240.png 11,Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo.,Carcinogenesis,,,Article,2011-12-01,10.1093/carcin/bgr215,,,,21948980,PMC3220609,,,,,,0,1,0,2,0,0,5,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1237598,https://api.altmetric.com/v1/donut/1237598_240.png 11,"SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma",Prostate Cancer & Prostatic Diseases,,,Article,2016-10-25,10.1038/pcan.2016.50,,,,27779203,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12994474,https://api.altmetric.com/v1/donut/12994474_240.png 11,Role of OATP transporters in steroid uptake by prostate cancer cells in vivo,Prostate Cancer & Prostatic Diseases,,,Article,2016-09-20,10.1038/pcan.2016.42,,,,27645128,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12099166,https://api.altmetric.com/v1/donut/12099166_240.png 11,Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Con,The Journal of Urology,,,Article,2016-08-09,10.1016/j.juro.2016.08.010,,,,27520085,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10362730,https://api.altmetric.com/v1/donut/10362730_240.png 11,A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment,Prostate Cancer & Prostatic Diseases,,,Article,2016-07-19,10.1038/pcan.2016.28,,,,27431498,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9869752,https://api.altmetric.com/v1/donut/9869752_240.png 11,Prostate cancer: Inhibiting initiation — targeting BMI1 is effective,Nature Reviews Urology,,,Article,2016-07-05,10.1038/nrurol.2016.131,,,,27377156,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9241879,https://api.altmetric.com/v1/donut/9241879_240.png 11,Systemic radioligand therapy with 177Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer,The Journal of Urology,,,Article,2016-03-07,10.1016/j.juro.2016.02.2969,,,,26964917,,,,,,,1,0,0,8,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6135292,https://api.altmetric.com/v1/donut/6135292_240.png 11,Prostate cancer: SLCO2B1 variants correlate with castration resistance,Nature Reviews Urology,,,Article,2015-12-31,10.1038/nrurol.2015.306,,,,26718456,,,,,,,2,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4940878,https://api.altmetric.com/v1/donut/4940878_240.png 11,Prostate cancer: A walk on the wild side [mdash] wild-type kinases promote metastasis,Nature Reviews Urology,,,Article,2015-12-22,10.1038/nrurol.2015.300,,,,26689840,,,,,,,1,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4910584,https://api.altmetric.com/v1/donut/4910584_240.png 11,Patient–Provider Communication About Prostate Cancer Screening and Treatment New Evidence From the Health Information National Trends Survey,American Journal of Men's Health,,,Article,2015-11-26,10.1177/1557988315614082,,,,26614441,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4829255,https://api.altmetric.com/v1/donut/4829255_240.png 11,Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk,Human Molecular Genetics,,,Article,2015-11-26,10.1093/hmg/ddv462,,,,26604137,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4810401,https://api.altmetric.com/v1/donut/4810401_240.png 11,Metabolic and molecular regulation of dietary polyunsaturated fatty acids on prostate cancer,PROTEOMICS - Clinical Applications,,,Article,2015-11-01,10.1002/prca.201500066,,,,26929070,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4783033,https://api.altmetric.com/v1/donut/4783033_240.png 11,Prostate cancer: Dysregulated stress-related signalling pathways associated with lethality of prostate cancer,Nature Reviews Urology,,,Article,2015-11-10,10.1038/nrurol.2015.273,,,,26553626,,,,,,,1,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4757926,https://api.altmetric.com/v1/donut/4757926_240.png 11,Prostate cancer: Of margins and men[mdash]do surgical margins matter?,Nature Reviews Urology,,,Article,2015-08-25,10.1038/nrurol.2015.211,,,,26304006,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4430430,https://api.altmetric.com/v1/donut/4430430_240.png 11,"Black men in England are twice as likely to get prostate cancer as white men, study shows",British Medical Journal,,,Article,2015-07-30,10.1136/bmj.h4138,,,,26228590,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4344308,https://api.altmetric.com/v1/donut/4344308_240.png 11,Prostate cancer: USPSTF recommendations reduce diagnosis of new cases,Nature Reviews Urology,,,Article,2015-07-07,10.1038/nrurol.2015.163,,,,26150238,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4251434,https://api.altmetric.com/v1/donut/4251434_240.png 11,Prostate cancer: PTEN loss and PSGR overexpression promote cancer progression,Nature Reviews Urology,,,Article,2015-06-16,10.1038/nrurol.2015.147,,,,26077992,,,,,,,1,0,0,4,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4168949,https://api.altmetric.com/v1/donut/4168949_240.png 11,ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors,Cancer Cell,,,Article,2015-08-06,10.1016/j.ccell.2015.05.005,,,,26058078,,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/4123640,https://api.altmetric.com/v1/donut/4123640_240.png 11,Discovery and Longitudinal Evaluation of Candidate Protein Biomarkers for Disease Recurrence in Prostate Cancer,Journal of Proteome Research,,,Article,2015-07-02,10.1021/acs.jproteome.5b00041,,,,26011319,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4102319,https://api.altmetric.com/v1/donut/4102319_240.png 11,Obesity Associated with Higher Risk for Prostate Cancer in Black Men,Journal Watch,,,Article,,10.1056/nejm-jw.fw110105,,,,,,,,,,,0,0,0,16,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3915360,https://api.altmetric.com/v1/donut/3915360_240.png 11,Two trials show efficacy for enzalutamide in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/7106-two-trials-show-efficacy-for-enzalutamide-in-prostate-cancer.php,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3841293,https://api.altmetric.com/v1/donut/3841293_240.png 11,Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-03-17,10.1038/pcan.2015.7,,,,25777155,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3803002,https://api.altmetric.com/v1/donut/3803002_240.png 11,Prostate cancer: Multifocal disease[mdash]independent clonal lineages in malignant nodules and even in normal tissue,Nature Reviews Urology,,,Article,2015-03-17,10.1038/nrurol.2015.52,,,,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3799206,https://api.altmetric.com/v1/donut/3799206_240.png 11,Prostate cancer: 2-year ADT improves survival in patients receiving high-dose radiotherapy,Nature Reviews Urology,,,Article,2015-03-10,10.1038/nrurol.2015.43,,,,25753100,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3770967,https://api.altmetric.com/v1/donut/3770967_240.png 11,ASCO GU: Men who have had testicular cancer are more likely to develop prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/7012-asco-gu--men-who-have-had-testicular-cancer-are-more-likely-to-develop-prostate-cancer.php,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3727098,https://api.altmetric.com/v1/donut/3727098_240.png 11,Prostate cancer: AR targeting[mdash]it all makes sense,Nature Reviews Urology,,,Article,2015-02-17,10.1038/nrurol.2015.26,,,,25687267,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3705556,https://api.altmetric.com/v1/donut/3705556_240.png 11,Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men,The Journal of Urology,,,Article,2015-01-07,10.1016/j.juro.2015.01.091,,,,25636659,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3109971,https://api.altmetric.com/v1/donut/3109971_240.png 11,Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin,New England Journal of Medicine,,,Article,1997-07-31,10.1056/nejm199707313370502,,,,9233866,,,,,,,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2928137,https://api.altmetric.com/v1/donut/2928137_240.png 11,Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials,Prostate Cancer & Prostatic Diseases,,,Article,2014-11-11,10.1038/pcan.2014.44,,,,25384338,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2878464,https://api.altmetric.com/v1/donut/2878464_240.png 11,Prostate cancer: Copper unlocks therapeutic potential of disulfiram,Nature Reviews Urology,,,Article,2014-11-04,10.1038/nrurol.2014.303,,,,25366297,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2848593,https://api.altmetric.com/v1/donut/2848593_240.png 11,Prognostic Impact of Synchronous Second Primary Malignancies on the Overall Survival of Patients with Metastatic Prostate Cancer,The Journal of Urology,,,Article,2015-01-04,10.1016/j.juro.2014.10.088,,,,25444987,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2808621,https://api.altmetric.com/v1/donut/2808621_240.png 11,"Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8",Journal of Antibiotics,,,Article,2014-10-01,10.1038/ja.2014.135,,,,25269460,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2733332,https://api.altmetric.com/v1/donut/2733332_240.png 11,Fatty fish consumption and risk of prostate cancer.,The Lancet,,,Article,2001-06-02,10.1016/s0140-6736(00)04889-3,,,,11403817,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2677141,https://api.altmetric.com/v1/donut/2677141_240.png 11,"Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations.",Epidemiology,,,Article,2014-09-09,10.1097/ede.0000000000000174,,,,25207955,,,,,,,1,0,0,11,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2674670,https://api.altmetric.com/v1/donut/2674670_240.png 11,Complications of prostate cancer treatment – Author's reply,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70127-5,,,,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2231856,https://api.altmetric.com/v1/donut/2231856_240.png 11,"Broccoli, PTEN deletion and prostate cancer: where is the link?",Molecular Cancer,,,Article,2010-12-01,10.1186/1476-4598-9-308,,,,21122140,,,,,,,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1959163,https://api.altmetric.com/v1/donut/1959163_240.png 11,Development and validation of a 32-gene prognostic index for prostate cancer progression.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-03-26,10.1073/pnas.1215870110,,,,23533275,,,,,,,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1324702,https://api.altmetric.com/v1/donut/1324702_240.png 11,ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer,Journal of Clinical Investigation,,,Article,2013-01-01,10.1172/jci66666,,,,23426182,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1245210,https://api.altmetric.com/v1/donut/1245210_240.png 11,Postoperative radiation for prostate cancer,The Lancet (British Edition),,,Article,2012-01-01,10.1016/s0140-6736(12)61608-0,,,,23084480,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1009824,https://api.altmetric.com/v1/donut/1009824_240.png 11,M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer,Nature Nanotechnology,,,Article,2012-09-16,10.1038/nnano.2012.146,,,,22983492,,,2012NatNa...7..677G,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,92,https://www.altmetric.com/details/950140,https://api.altmetric.com/v1/donut/950140_240.png 11,Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44,Nature Medicine,"GREY, Jane W",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-02-01,10.1038/nm.2284,,,,21240262,PMC3076220,,,,,,0,2,0,0,0,0,1,1,0,0,0,0,3,0,0,27,https://www.altmetric.com/details/210139,https://api.altmetric.com/v1/donut/210139_240.png 11,Reimbursement policy and androgen-deprivation therapy for prostate cancer.,New England Journal of Medicine,,,Article,2010-04-11,10.1056/nejmsa0910784,,,,21047226,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/542750,https://api.altmetric.com/v1/donut/542750_240.png 11,Serum retinol and risk of prostate cancer.,American Journal of Epidemiology,,,Article,2011-04-01,10.1093/aje/kwq429,,,,21389041,PMC3105279,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/509991,https://api.altmetric.com/v1/donut/509991_240.png 11,"Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.",BJU international,,,Article,2003-05-01,,,,,12699469,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/419255,https://api.altmetric.com/v1/donut/419255_240.png 11,"Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men.",International Journal of Cancer,,,Article,1997-11-27,,,,,9398038,,,,,,,0,0,0,11,0,0,10,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1620515,https://api.altmetric.com/v1/donut/1620515_240.png 11,Tea Consumption and the Risk of Overall and Grade Specific Prostate Cancer: A Large Prospective Cohort Study of Scottish Men,Nutrition and Cancer,,,Article,2012-06-16,10.1080/01635581.2012.690063,,,,22697604,,,,,,,0,0,0,11,0,0,2,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/799261,https://api.altmetric.com/v1/donut/799261_240.png 11,"XMRV Induces Cell Migration, Cytokine Expression and Tumor Angiogenesis: Are 22Rv1 Cells a Suitable Prostate Cancer Model?",PLoS ONE,,,Article,2012-07-27,10.1371/journal.pone.0042321,,,,22848758,,,,,,,0,1,0,6,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/860275,https://api.altmetric.com/v1/donut/860275_240.png 11,"Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)",Cancer Causes and Control,,,Article,1995-05-01,10.1007/bf00051795,,,,,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5524095,https://api.altmetric.com/v1/donut/5524095_240.png 11,Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis,International Journal of Cancer,,,Article,2016-10-01,10.1002/ijc.30462,,,,27741566,,,,,,,0,0,0,18,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12660632,https://api.altmetric.com/v1/donut/12660632_240.png 11,A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation,European Urology,,,Article,2015-06-04,10.1016/j.eururo.2015.05.023,,,,26038098,,,,,,,0,0,0,20,0,0,3,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4075054,https://api.altmetric.com/v1/donut/4075054_240.png 11,Seeing and Not Believing: Oligometastases and the Future of Metastatic Prostate Cancer,European Urology,,,Article,2015-05-01,10.1016/j.eururo.2014.09.035,,,,25311954,,,,,,,0,0,0,19,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/2763180,https://api.altmetric.com/v1/donut/2763180_240.png 11,Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer,Supportive Care in Cancer,,,Article,2014-07-10,10.1007/s00520-014-2327-8,,,,25005233,,,,,,,0,0,0,25,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2498993,https://api.altmetric.com/v1/donut/2498993_240.png 11,Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials,Annals of Oncology,,,Article,2013-10-14,10.1093/annonc/mdt397,,,,24126362,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1829521,https://api.altmetric.com/v1/donut/1829521_240.png 11,Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial,The Prostate,,,Article,2016-05-16,10.1002/pros.23200,,,,27197965,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8080279,https://api.altmetric.com/v1/donut/8080279_240.png 11,Focal Therapy for Prostate Cancer: An “À la Carte” Approach,European Urology,,,Article,2016-01-06,10.1016/j.eururo.2015.12.015,,,,26778462,,,,,,,0,0,0,18,0,0,3,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4958848,https://api.altmetric.com/v1/donut/4958848_240.png 11,Prostate cancer: cT2c prostate cancer is intermediate-risk disease,Nature Reviews Urology,,,Article,2015-01-06,10.1038/nrurol.2014.365,,,,25558842,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3039460,https://api.altmetric.com/v1/donut/3039460_240.png 11,Prostate cancer: Predicting outcomes of recurrence after escalated-dose radiotherapy,Nature Reviews Urology,,,Article,2014-10-28,10.1038/nrurol.2014.299,,,,25348170,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2817909,https://api.altmetric.com/v1/donut/2817909_240.png 11,Prostate cancer: Predicting resistance[mdash]AR-V7 is a potential biomarker,Nature Reviews Urology,,,Article,2014-09-30,10.1038/nrurol.2014.272,,,,25266571,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2726957,https://api.altmetric.com/v1/donut/2726957_240.png 11,Prostate cancer: Genetic risk analysis goes global,Nature Reviews Urology,,,Article,2014-09-30,10.1038/nrurol.2014.277,,,,25266569,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2726952,https://api.altmetric.com/v1/donut/2726952_240.png 11,Prostate Cancer Screening — Polling Results,New England Journal of Medicine,,,Article,2012-10-25,10.1056/nejmclde1212034,,,,23094752,,,,,,,0,0,0,14,0,0,1,0,0,0,0,0,1,0,0,2,https://www.altmetric.com/details/1021258,https://api.altmetric.com/v1/donut/1021258_240.png 11,High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study.,Journal of Endourology,,,Article,2003-10-01,10.1089/089277903322518699,,,,14622488,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/110371,https://api.altmetric.com/v1/donut/110371_240.png 11,Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer.,International Journal of Urology,,,Article,2006-03-01,10.1111/j.1442-2042.2006.01272.x,,,,16643614,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/110367,https://api.altmetric.com/v1/donut/110367_240.png 11,Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.,Nature,"PARKER, Pita X",Department of Life Sciences; School of Natural Sciences,Article,2007-03-24,10.1038/nature05656,,,,17377533,,,2007Natur.446..690L,,,,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1357282,https://api.altmetric.com/v1/donut/1357282_240.png 11,A Two-Step Toward Personalized Therapies for Prostate Cancer,Science Translational Medicine,,,Article,2011-03-02,10.1126/scitranslmed.3002169,,,,21368221,PMC3089975,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/129736,https://api.altmetric.com/v1/donut/129736_240.png 11,RETRACTED ARTICLE: The Risk of Prostate Cancer in Pilots: A Meta-Analysis,Aerospace medicine and human performance,,,Article,2015-02-01,10.3357/amhp.4075.2015,,,,25946735,,,,,,,0,1,0,3,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4106642,https://api.altmetric.com/v1/donut/4106642_240.png 11,Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study,The Lancet,,,Article,2010-04-24,10.1016/s0140-6736(10)60172-9,,,,20398925,PMC2948179,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,1,0,0,49,https://www.altmetric.com/details/211937,https://api.altmetric.com/v1/donut/211937_240.png 10,"Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis",Prostate Cancer & Prostatic Diseases,,,Article,2016-11-01,10.1038/pcan.2016.49,,,,27801901,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13230615,https://api.altmetric.com/v1/donut/13230615_240.png 10,Detection of Aggressive Prostate Cancer?Associated Glycoproteins in Urine using Glycoproteomics and Mass Spectrometry,PROTEOMICS,,,Article,2016-10-01,10.1002/pmic.201500506,,,,27749016,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12681401,https://api.altmetric.com/v1/donut/12681401_240.png 10,An update on focal therapy for prostate cancer,Nature Reviews Urology,,,Article,2016-09-27,10.1038/nrurol.2016.177,,,,27670618,,,,,,,1,0,0,1,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12246969,https://api.altmetric.com/v1/donut/12246969_240.png 10,Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight,Cancer Letters,,,Article,2003-03-31,10.1016/s0304-3835(02)00710-3,,,,12668278,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12129835,https://api.altmetric.com/v1/donut/12129835_240.png 10,[Vasectomy not associated with prostate cancer: a meta-analysis].,Zhonghua nan ke xue National journal of andrology,,,Article,2009-06-14,,,,,19593998,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12090726,https://api.altmetric.com/v1/donut/12090726_240.png 10,Screening digital rectal examination and prostate cancer mortality: a case-control study,Journal of Medical Screening,,,Article,1998-06-01,10.1136/jms.5.2.99,,,,9718529,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11964462,https://api.altmetric.com/v1/donut/11964462_240.png 10,Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer,Oncogene,,,Article,2016-06-27,10.1038/onc.2016.232,,,,27345403,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9085717,https://api.altmetric.com/v1/donut/9085717_240.png 10,Dendritic cells serve as a “Trojan horse” for oncolytic adenovirus delivery in the treatment of mouse prostate cancer,Acta Pharmacologica Sinica,,,Article,2016-06-27,10.1038/aps.2016.59,,,,27345628,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9083925,https://api.altmetric.com/v1/donut/9083925_240.png 10,MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer,Oncogene,,,Article,2016-06-06,10.1038/onc.2016.164,,,,27270442,,,,,,,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8513605,https://api.altmetric.com/v1/donut/8513605_240.png 10,Prostate cancer: Combining endocrine treatment and radiotherapy: a bright future,Nature Reviews Urology,,,Article,2016-06-01,10.1038/nrurol.2016.100,,,,27245503,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8419302,https://api.altmetric.com/v1/donut/8419302_240.png 10,Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.,Medicine,,,Article,2016-05-06,10.1097/md.0000000000003493,,,http://journals.lww.com/md-journal/Fulltext/2016/05030/Benign_Prostatic_Hyperplasia_and_the_Risk_of.12.aspx,27149447,,,,,,,0,1,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7221315,https://api.altmetric.com/v1/donut/7221315_240.png 10,CYP17 inhibitors for prostate cancer therapy,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2011-05-01,10.1016/j.jsbmb.2010.11.005,,,,21092758,PMC3047603,,,,,,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/6502501,https://api.altmetric.com/v1/donut/6502501_240.png 10,Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy,Prostate Cancer & Prostatic Diseases,,,Article,2016-03-08,10.1038/pcan.2016.6,,,,26951714,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6145280,https://api.altmetric.com/v1/donut/6145280_240.png 10,The characteristics of bladder cancer after radiotherapy for prostate cancer,Urologic Oncology,,,Article,2012-05-07,10.1016/j.urolonc.2012.04.006,,,,22575239,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6135083,https://api.altmetric.com/v1/donut/6135083_240.png 10,Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening,CMAJ Open,,,Article,2016-03-01,10.9778/cmajo.20140079,,,,27280117,PMC4866930,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6044513,https://api.altmetric.com/v1/donut/6044513_240.png 10,The microRNA-23b|[sol]|-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related,Oncogene,,,Article,2016-02-22,10.1038/onc.2016.6,,,,26898757,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5959263,https://api.altmetric.com/v1/donut/5959263_240.png 10,The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone,Oncologist,,,Article,2016-02-13,10.1634/theoncologist.2015-0327,,,,26865591,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5524315,https://api.altmetric.com/v1/donut/5524315_240.png 10,Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers,Radiology,,,Article,2016-02-02,10.1148/radiol.16151133,,,,26836049,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/5087019,https://api.altmetric.com/v1/donut/5087019_240.png 10,Prostate cancer: Effectiveness of abiraterone is unaffected by prior ADT,Nature Reviews Urology,,,Article,2015-11-10,10.1038/nrurol.2015.274,,,,26553628,,,,,,,2,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4767389,https://api.altmetric.com/v1/donut/4767389_240.png 10,Radiation Dose to the Penile Structures and Patient?Reported Sexual Dysfunction in Long?Term Prostate Cancer Survivors,Journal of Sexual Medicine,,,Article,2015-12-01,10.1111/jsm.13031,,,,26564611,,,,,,,1,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4757931,https://api.altmetric.com/v1/donut/4757931_240.png 10,Androgen receptor antagonists for prostate cancer therapy,Endocrine-Related Cancer,,,Article,2014-08-01,10.1530/erc-13-0545,,,,24639562,,,,,,,1,0,0,0,0,0,0,3,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4499505,https://api.altmetric.com/v1/donut/4499505_240.png 10,PSA Velocity in Risk Stratification of Prostate Cancer,Reviews in Urology,,,Article,2015-09-01,,,,,24659919,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4461271,https://api.altmetric.com/v1/donut/4461271_240.png 10,Prostate cancer: A simplified prostate cancer grading system,Nature Reviews Urology,,,Article,2015-08-25,10.1038/nrurol.2015.212,,,,26304009,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4432044,https://api.altmetric.com/v1/donut/4432044_240.png 10,Patient?reported ‘ever had’ and ‘current’ long?term physical symptoms after prostate cancer treatments,British Journal of Urology,,,Article,2015-09-01,10.1111/bju.13036,,,,25597493,,,,,,,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4407837,https://api.altmetric.com/v1/donut/4407837_240.png 10,Body concentrations of persistent organic pollutants and prostate cancer: a meta-analysis.,Environmental Science & Pollution Research,,,Article,2015-03-24,10.1007/s11356-015-4315-z,,,,25797015,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4404606,https://api.altmetric.com/v1/donut/4404606_240.png 10,Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts,Prostate Cancer & Prostatic Diseases,,,Article,2015-08-04,10.1038/pcan.2015.37,,,,26238234,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4362852,https://api.altmetric.com/v1/donut/4362852_240.png 10,Urological cancer: Management of patients with prostate cancer: evolution towards a risk-stratified approach,Nature Reviews Clinical Oncology,,,Article,2015-07-28,10.1038/nrclinonc.2015.135,,,,26215045,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4337515,https://api.altmetric.com/v1/donut/4337515_240.png 10,The Prostate Cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and Baseline Results of a Randomized Controlled Trial Comparing Radical Prostatectomy With Watchful Waiting for Men With Clinically Localized Prostate Cancer,Journal of the National Cancer Institute. Monographs,,,Article,2012-12-01,10.1093/jncimonographs/lgs041,,,,23271771,,,,,,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/4323076,https://api.altmetric.com/v1/donut/4323076_240.png 10,Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease,British Journal of Cancer,,,Article,2015-07-14,10.1038/bjc.2015.240,,,,26171936,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4281159,https://api.altmetric.com/v1/donut/4281159_240.png 10,Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer,British Journal of Cancer,,,Article,2015-06-23,10.1038/bjc.2015.228,,,,26103574,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4205767,https://api.altmetric.com/v1/donut/4205767_240.png 10,Pre-diagnostic obesity and physical inactivity are associated with shorter telomere length in prostate stromal cells,Cancer Prevention Research,,,Article,,10.1158/1940-6207.capr-15-0097,,,,25990087,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4078885,https://api.altmetric.com/v1/donut/4078885_240.png 10,The index lesion and the origin of prostate cancer.,,,,Article,2009-10-21,10.1056/nejmcibr0905562,,,,19846858,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/4038847,https://api.altmetric.com/v1/donut/4038847_240.png 10,Prostate Cancer,New England Journal of Medicine,,,Article,2003-07-24,10.1056/nejmra021562,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4003988,https://api.altmetric.com/v1/donut/4003988_240.png 10,Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment,Molecular Pharmacology,,,Article,2007-01-01,10.1124/mol.106.031153,,,,17050804,,,,,,,0,2,0,0,21,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4003729,https://api.altmetric.com/v1/donut/4003729_240.png 10,"Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy",Acta Oncologica,,,Article,,10.3109/0284186x.2015.1037008,,,,25927504,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3964813,https://api.altmetric.com/v1/donut/3964813_240.png 10,Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation.,Prostate Cancer & Prostatic Diseases,,,Article,2015-04-21,10.1038/pcan.2015.14,,,,25896264,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3928752,https://api.altmetric.com/v1/donut/3928752_240.png 10,First use of low temperature plasmas for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/7155-first-use-of-low-temperature-plasmas-for-prostate-cancer.php,,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3896871,https://api.altmetric.com/v1/donut/3896871_240.png 10,Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-03-03,10.1038/pcan.2015.5,,,,25732928,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3788984,https://api.altmetric.com/v1/donut/3788984_240.png 10,Do healthy-looking prostate cancer cells mask deadly cancer-causing mutations?,ecancer.org,,,Article,,,,,http://ecancer.org/news/7042-do-healthy-looking-prostate-cancer-cells-mask-deadly-cancer-causing-mutations.php,,,,,,,,1,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3765928,https://api.altmetric.com/v1/donut/3765928_240.png 10,Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells,Biochemistry and Cell Biology,,,Article,2005-10-20,10.1139/o05-063,,,,16234852,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3443014,https://api.altmetric.com/v1/donut/3443014_240.png 10,High-dose testosterone therapy helps some men with advanced prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6864-high-dose-testosterone-therapy-helps-some-men-with-advanced-prostate-cancer.php,,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3080479,https://api.altmetric.com/v1/donut/3080479_240.png 10,Treatment decision?making for localized prostate cancer: What younger men choose and why,The Prostate,,,Article,2011-04-25,10.1002/pros.21406,,,,21520163,,,,,,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3078338,https://api.altmetric.com/v1/donut/3078338_240.png 10,Prostate cancer: Better use of bone scans in prostate cancer,Nature Reviews Urology,,,Article,2014-11-11,10.1038/nrurol.2014.305,,,,25385459,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2876337,https://api.altmetric.com/v1/donut/2876337_240.png 10,Factors That Influence Patient Enrollment in Active Surveillance for Low-risk Prostate Cancer,Urology,,,Article,2011-01-07,10.1016/j.urology.2010.10.039,,,,21215429,,,,,,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2839566,https://api.altmetric.com/v1/donut/2839566_240.png 10,Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.,Cancer Investigation,,,Article,2009-02-25,10.1080/07357900802208608,,,,19235596,PMC2648132,,,,,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2839538,https://api.altmetric.com/v1/donut/2839538_240.png 10,Suicidal ideation in prostate cancer survivors: Understanding the role of physical and psychological health outcomes,Cancer (0008543X),,,Article,2014-06-23,10.1002/cncr.28880,,,,24962506,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2802168,https://api.altmetric.com/v1/donut/2802168_240.png 10,Ultrasound Improves the Uptake and Distribution of Liposomal Doxorubicin in Prostate Cancer Xenografts.,Ultrasound in Medicine & Biology,,,Article,2013-05-08,10.1016/j.ultrasmedbio.2013.02.010,,,,23643054,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2689864,https://api.altmetric.com/v1/donut/2689864_240.png 10,Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.,Radiology,,,Article,2006-01-11,10.1148/radiol.2412051866,,,,16966484,,,,,,,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2475730,https://api.altmetric.com/v1/donut/2475730_240.png 10,RE: Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dju079,,,,24771874,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2362349,https://api.altmetric.com/v1/donut/2362349_240.png 10,SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design.,Prostate Cancer & Prostatic Diseases,,,Article,2000-11-01,10.1038/sj.pcan.4500412,,,,12497090,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2313320,https://api.altmetric.com/v1/donut/2313320_240.png 10,Statin Drug Use is Not Associated with Prostate Cancer Risk in Men Who are Regularly Screened ,The Journal of Urology,,,Article,2014-02-14,10.1016/j.juro.2014.01.095,,,,24518774,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2254317,https://api.altmetric.com/v1/donut/2254317_240.png 10,Androgens regulate prostate cancer cell growth via an AMPK-PGC-1|[alpha]|-mediated metabolic switch,Oncogene,,,Article,2013-11-04,10.1038/onc.2013.463,,,,24186207,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/1896801,https://api.altmetric.com/v1/donut/1896801_240.png 10,Use of ?-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy,The Prostate,,,Article,2013-02-15,10.1002/pros.22564,,,,22821802,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1811097,https://api.altmetric.com/v1/donut/1811097_240.png 10,A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder,European Journal of Medical Research,,,Article,2013-10-03,10.1186/2047-783x-18-36,,,,,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1800254,https://api.altmetric.com/v1/donut/1800254_240.png 10,Differential Patterns of Large Tumor Antigen-Specific Immune Responsiveness in Patients with BK Polyomavirus-Positive Prostate Cancer or Benign Prostatic Hyperplasia,Journal of Virology,,,Article,2012-05-30,10.1128/jvi.00005-12,,,,22647697,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1749532,https://api.altmetric.com/v1/donut/1749532_240.png 10,Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer.,Journal of the American College of Radiology,,,Article,2013-02-01,10.1016/j.jacr.2012.06.014,,,,23245437,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1749494,https://api.altmetric.com/v1/donut/1749494_240.png 10,Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy,British Journal of Urology,,,Article,2013-08-04,10.1111/bju.12151,,,,23826840,,,,,,,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1715843,https://api.altmetric.com/v1/donut/1715843_240.png 10,Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis,Urology,,,Article,2013-01-01,10.1016/j.urology.2013.01.078,,,,23896094,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1710402,https://api.altmetric.com/v1/donut/1710402_240.png 10,Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo,The Prostate,,,Article,2004-09-25,10.1002/pros.20126,,,,15389801,,,,,,,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1652074,https://api.altmetric.com/v1/donut/1652074_240.png 10,Can MR-US Fusion Biopsy Improve Cancer Detection in Enlarged Prostates?,The Journal of Urology,,,Article,2013-06-19,10.1016/j.juro.2013.05.118,,,,23792130,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1567807,https://api.altmetric.com/v1/donut/1567807_240.png 10,Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo,Proceedings of the National Academy of Sciences of the United States of America,"BANNER, Britney S",Department of Life Sciences; School of Natural Sciences,Article,2011-02-01,10.1073/pnas.1011379108,,,,21233423,PMC3033286,,2011PNAS..108.1850D,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,170,https://www.altmetric.com/details/1504325,https://api.altmetric.com/v1/donut/1504325_240.png 10,Association of variants in estrogen-related pathway genes with prostate cancer risk.,The Prostate,,,Article,2012-05-04,10.1002/pros.22534,,,,22549291,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1497349,https://api.altmetric.com/v1/donut/1497349_240.png 10,Usefulness of prebiopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer,The Journal of Urology,,,Article,2013-03-08,10.1016/j.juro.2013.02.3197,,,,23473904,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1319563,https://api.altmetric.com/v1/donut/1319563_240.png 10,Chronic Fatigue and Prostate Cancer: A Retroviral Connection?,Science,,,Article,2009-10-09,10.1126/science.326_215a,,,,19815745,,,2009Sci...326..215K,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1161108,https://api.altmetric.com/v1/donut/1161108_240.png 10,"Certificate of Need Programs, Intensity Modulated Radiation Therapy Use and the Cost of Prostate Cancer Care",The Journal of Urology,,,Article,2012-11-19,10.1016/j.juro.2012.08.181,,,,23164382,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1087284,https://api.altmetric.com/v1/donut/1087284_240.png 10,"First Synthesis of (+)-Myrrhanol C, an anti- prostate cancer lead",Organic and Biomolecular Chemistry,,,Article,2012-01-01,10.1039/c2ob26947c,,,,23147747,,,,,,,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1038403,https://api.altmetric.com/v1/donut/1038403_240.png 10,"Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case–control study",Cancer Causes and Control,,,Article,2012-06-20,10.1007/s10552-012-9948-3,,,,22706676,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/884061,https://api.altmetric.com/v1/donut/884061_240.png 10,Global Methylation Profiling for Risk Prediction of Prostate Cancer,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-11-2090,,,,22589488,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/754647,https://api.altmetric.com/v1/donut/754647_240.png 10,Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.,European Urology,,,Article,2010-03-03,10.1016/j.eururo.2010.02.003,,,,20189711,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,35,https://www.altmetric.com/details/537918,https://api.altmetric.com/v1/donut/537918_240.png 10,The effect of breast cancer awareness month on internet search activity - a comparison with awareness campaigns for lung and prostate cancer.,BMC Cancer,,,Article,2011-10-12,10.1186/1471-2407-11-442,,,,21993136,PMC3210140,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/401156,https://api.altmetric.com/v1/donut/401156_240.png 10,Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling,PLoS ONE,,,Article,2012-04-13,10.1371/journal.pone.0034630,,,,22514647,PMC3326063,,2012PLoSO...7E4630D,,,,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/696950,https://api.altmetric.com/v1/donut/696950_240.png 10,Quo vadis: Advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies.,Cancer (0008543X),,,Article,2014-09-18,10.1002/cncr.28929,,,,25236176,,,,,,,0,0,0,9,0,0,1,1,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/2765634,https://api.altmetric.com/v1/donut/2765634_240.png 10,Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis,European Urology,,,Article,2014-08-20,10.1016/j.eururo.2014.08.007,,,,25154392,,,,,,,0,0,0,23,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2620222,https://api.altmetric.com/v1/donut/2620222_240.png 10,"Cohort Study of Insulin Glargine and Risk of Breast, Prostate, and Colorectal Cancer Among Patients With Diabetes.",Diabetes Care,,,Article,2013-12-01,10.2337/dc13-0140,,,,24170756,,,,,,,0,0,0,22,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1937218,https://api.altmetric.com/v1/donut/1937218_240.png 10,The transcriptional program of the androgen receptor (AR) in prostate cancer.,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12415,,,,24053777,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1694592,https://api.altmetric.com/v1/donut/1694592_240.png 10,"Small study finds that 3?years after prostate cancer treatment, men may report high quality of life and functioning",Evidence Based Nursing,,,Article,2013-07-13,10.1136/eb-2013-101420,,,,23852889,,,,,,,0,2,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1622755,https://api.altmetric.com/v1/donut/1622755_240.png 10,Prediction of the Pathologic Gleason Score to Inform a Personalized Management Program for Prostate Cancer,European Urology,,,Article,2016-08-12,10.1016/j.eururo.2016.08.005,,,,27523594,,,,,,,0,0,0,23,0,0,2,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/10428339,https://api.altmetric.com/v1/donut/10428339_240.png 10,"The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers",Hereditary Cancer in Clinical Practice,,,Article,2015-08-01,10.1186/s13053-015-0038-x,,,,26236408,,,,,,,0,0,0,20,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/4350890,https://api.altmetric.com/v1/donut/4350890_240.png 10,Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality,JNCI: Journal of the National Cancer Institute,,,Article,2007-01-01,10.1093/jnci/djm168,,,,17925537,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,31,https://www.altmetric.com/details/490198,https://api.altmetric.com/v1/donut/490198_240.png 10,Salvage Surgery for Nodal Recurrence of Prostate Cancer: Might the Robotic Approach Render an Experimental Procedure More Acceptable?,European Urology,,,Article,2016-11-01,10.1016/j.eururo.2016.10.033,,,,,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13264645,https://api.altmetric.com/v1/donut/13264645_240.png 10,Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.,Carcinogenesis,,,Article,2011-11-23,10.1093/carcin/bgr277,,,,22114073,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/469510,https://api.altmetric.com/v1/donut/469510_240.png 10,"Effectiveness of community-based football compared to usual care in men with prostate cancer: Protocol for a randomised, controlled, parallel group, multicenter superiority trial (The FC Prostate Community Trial)",BMC Cancer,,,Article,2016-10-03,10.1186/s12885-016-2805-0,,,,27716218,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12419980,https://api.altmetric.com/v1/donut/12419980_240.png 10,Regulation of miR-200c and miR-141 by methylation in prostate cancer,The Prostate,,,Article,2016-05-16,10.1002/pros.23201,,,,27198154,,,,,,,0,0,0,14,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8088103,https://api.altmetric.com/v1/donut/8088103_240.png 10,Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival,European Urology,,,Article,2015-05-16,10.1016/j.eururo.2015.04.035,,,,25959166,,,,,,,0,0,0,32,0,0,3,0,2,0,0,0,0,0,0,20,https://www.altmetric.com/details/4001199,https://api.altmetric.com/v1/donut/4001199_240.png 10,Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer,Frontiers in oncology,,,Article,2014-11-24,10.3389/fonc.2014.00351,,,,25566495,,,,,,,0,0,0,16,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2978770,https://api.altmetric.com/v1/donut/2978770_240.png 10,Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-06-21,10.1158/1055-9965.epi-12-0495,,,,22714738,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/806620,https://api.altmetric.com/v1/donut/806620_240.png 10,Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide,Nature Reviews Urology,,,Article,2016-11-02,10.1038/nrurol.2016.212,,,,27804988,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13276761,https://api.altmetric.com/v1/donut/13276761_240.png 10,Assessing Metastatic Disease in Advanced Prostate Cancer: It's Time to Change Imaging,European Urology,,,Article,2016-08-30,10.1016/j.eururo.2016.08.045,,,,27595376,,,,,,,0,0,0,17,0,0,1,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/10899803,https://api.altmetric.com/v1/donut/10899803_240.png 10,PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure,Prostate Cancer & Prostatic Diseases,,,Article,2016-07-19,10.1038/pcan.2016.23,,,,27431499,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10002510,https://api.altmetric.com/v1/donut/10002510_240.png 10,Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform,European Urology,,,Article,2016-07-20,10.1016/j.eururo.2016.07.015,,,,27450106,,,,,,,0,0,0,18,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9870431,https://api.altmetric.com/v1/donut/9870431_240.png 10," Truncating and Missense PPM1D Mutations in Early-Onset and/or Familial/Hereditary Prostate Cancer Patients ","Genes, Chromosomes, and Cancer",,,Article,2016-07-01,10.1002/gcc.22393,,,,27401275,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9652562,https://api.altmetric.com/v1/donut/9652562_240.png 10,Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review,Integrative Cancer Therapies,,,Article,2016-06-29,10.1177/1534735416656052,,,,27365385,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,1,6,https://www.altmetric.com/details/9223346,https://api.altmetric.com/v1/donut/9223346_240.png 10,Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth,Oncogene,,,Article,2016-06-06,10.1038/onc.2016.171,,,,27270436,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8513602,https://api.altmetric.com/v1/donut/8513602_240.png 10,Prostate cancer: Independent validation of the five-tier grade group system,Nature Reviews Urology,,,Article,2016-05-04,10.1038/nrurol.2016.83,,,,27142124,,,,,,,2,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7142393,https://api.altmetric.com/v1/donut/7142393_240.png 10,"Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-02-01,10.1158/1055-9965.epi-15-0723,,,,26646364,,,,,,,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5715976,https://api.altmetric.com/v1/donut/5715976_240.png 10,Prostate cancer: Enzalutamide is superior to bicalutamide for mCRPC,Nature Reviews Urology,,,Article,2016-02-02,10.1038/nrurol.2016.24,,,,26832166,,,,,,,2,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5077548,https://api.altmetric.com/v1/donut/5077548_240.png 10,Association of diet and lifestyle with chronic prostatitis|[sol]|chronic pelvic pain syndrome and pain severity: a case|[ndash]|control study,Prostate Cancer & Prostatic Diseases,,,Article,2015-12-15,10.1038/pcan.2015.57,,,,26666410,,,,,,,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4883071,https://api.altmetric.com/v1/donut/4883071_240.png 10,Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-12-15,10.1038/pcan.2015.56,,,,26666409,,,,,,,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4878390,https://api.altmetric.com/v1/donut/4878390_240.png 10,Prostate cancer: PD-L1 expression is common and indicates poor prognosis,Nature Reviews Urology,,,Article,2015-12-01,10.1038/nrurol.2015.287,,,,26620611,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4825570,https://api.altmetric.com/v1/donut/4825570_240.png 10,Active surveillance preferred for low-risk prostate cancer,Lancet Oncology,,,Article,2015-07-21,10.1016/s1470-2045(15)00155-2,,,,26190749,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4288050,https://api.altmetric.com/v1/donut/4288050_240.png 10,High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2015-05-19,10.1038/pcan.2015.22,,,,25986914,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4010949,https://api.altmetric.com/v1/donut/4010949_240.png 10,Prostate cancer: Promising combination treatment for prostate cancer,Nature Reviews Urology,,,Article,2015-05-19,10.1038/nrurol.2015.118,,,,25986761,,,,,,,1,0,0,1,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4010168,https://api.altmetric.com/v1/donut/4010168_240.png 10,"Intraprostatic inflammation is positively associated with serum PSA in men with PSA |[minus]|1, normal DRE and negative for prostate cancer",Prostate Cancer & Prostatic Diseases,,,Article,2015-05-05,10.1038/pcan.2015.19,,,,25939516,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3985692,https://api.altmetric.com/v1/donut/3985692_240.png 10,Interventions that may reduce depressive symptoms among prostate cancer patients: a systematic review and meta-analysis.,Psycho-Oncology,,,Article,2015-03-05,10.1002/pon.3781,,,,25753507,,,,,,,1,0,0,10,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3901337,https://api.altmetric.com/v1/donut/3901337_240.png 10,Prostate cancer: Orphan receptor GPR158 finds a home in prostate cancer growth and progression,Nature Reviews Urology,,,Article,2015-03-10,10.1038/nrurol.2015.44,,,,25753095,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3770969,https://api.altmetric.com/v1/donut/3770969_240.png 10,Prostate cancer: MRI/TRUS fusion outperforms standard and combined biopsy approaches,Nature Reviews Urology,,,Article,2015-02-17,10.1038/nrurol.2015.28,,,,25687268,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3705558,https://api.altmetric.com/v1/donut/3705558_240.png 10,Prostate cancer: Hypofractionation not associated with reduced toxicity,Nature Reviews Urology,,,Article,2015-02-17,10.1038/nrurol.2015.27,,,,25687269,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3705554,https://api.altmetric.com/v1/donut/3705554_240.png 10,Prostate cancer: Integrated test predicts outcome,Nature Reviews Urology,,,Article,2014-12-02,10.1038/nrurol.2014.331,,,,25447834,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2941747,https://api.altmetric.com/v1/donut/2941747_240.png 10,Prostate cancer: IADT combined with 5[alpha]-reductase inhibition,Nature Reviews Urology,,,Article,2014-11-25,10.1038/nrurol.2014.323,,,,25420442,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2921706,https://api.altmetric.com/v1/donut/2921706_240.png 10,Prostate cancer: Clinical implications of therapeutic sequence in mCRPC,Nature Reviews Urology,,,Article,2014-11-18,10.1038/nrurol.2014.308,,,,25403243,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2898645,https://api.altmetric.com/v1/donut/2898645_240.png 10,Chromoplexy and hypoxic microenvironment drives prostate cancer ,Lancet Oncology,,,Article,2014-11-13,10.1016/s1470-2045(14)71114-3,,,,,,,,,,,1,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2886372,https://api.altmetric.com/v1/donut/2886372_240.png 10,"Prostate cancer: Treatment-specific nomograms, biochemical recurrence, and prostate cancer-specific mortality",Nature Reviews Urology,,,Article,2014-10-21,10.1038/nrurol.2014.294,,,,25330792,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2796878,https://api.altmetric.com/v1/donut/2796878_240.png 10,An increase in PSA after prostate cancer surgery may not lead to metastasis in their lifetime,ecancer.org,,,Article,,,,,http://ecancer.org/news/6481-an-increase-in-psa-after-prostate-cancer-surgery-may-not-lead-to-metastasis-in-their-lifetime.php,,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2795166,https://api.altmetric.com/v1/donut/2795166_240.png 10,Prostate cancer: PLK-1 inhibition improves abiraterone efficacy,Nature Reviews Urology,,,Article,2014-10-14,10.1038/nrurol.2014.287,,,,25311682,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2777215,https://api.altmetric.com/v1/donut/2777215_240.png 10,A Phase II Trial of a Combination Herbal Supplement for Men with Biochemically Recurrent Prostate Cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-09-23,10.1038/pcan.2014.37,,,,25245366,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2707730,https://api.altmetric.com/v1/donut/2707730_240.png 10,Reducing Prostate Cancer Racial Disparity: Evidence for Aggressive Early Prostate Cancer PSA Testing of African American Men.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-13-1328,,,,24802741,,,,,,,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2560392,https://api.altmetric.com/v1/donut/2560392_240.png 10,Proteins that Deliver Leucine to Prostate Cancer Cells Are Therapeutic Targets,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djt288,,,,,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1770171,https://api.altmetric.com/v1/donut/1770171_240.png 10,Circulating microRNAs as potential new biomarkers for prostate cancer,British Journal of Cancer,,,Article,2013-04-30,10.1038/bjc.2013.192,,,,23632485,,,,,,,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,88,https://www.altmetric.com/details/1666162,https://api.altmetric.com/v1/donut/1666162_240.png 10,Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized Trials,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.46.5492,,,,23630216,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,1,0,0,38,https://www.altmetric.com/details/1421345,https://api.altmetric.com/v1/donut/1421345_240.png 10,"Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2008-04-01,10.1158/1055-9965.epi-07-2681,,,,18398033,,,,,,,0,0,0,2,0,0,1,1,4,0,0,0,0,0,2,19,https://www.altmetric.com/details/393805,https://api.altmetric.com/v1/donut/393805_240.png 10,Adjuvant radiation therapy is associated with better oncological outcome compared to salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy,British Journal of Urology,,,Article,2016-10-01,10.1111/bju.13679,,,,27743493,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12637072,https://api.altmetric.com/v1/donut/12637072_240.png 10,SPOP mutation leads to genomic instability in prostate cancer,eLife,,,Article,2015-09-16,10.7554/elife.09207,,,,26374986,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,1,0,0,30,https://www.altmetric.com/details/4520411,https://api.altmetric.com/v1/donut/4520411_240.png 10,Blood Level Omega-3 Fatty Acids as Risk Determinant Molecular Biomarker for Prostate Cancer,Prostate Cancer,,,Article,2013-01-01,10.1155/2013/875615,,,,23589776,PMC3621295,,,,,,0,0,1,8,0,0,1,0,1,0,0,0,0,0,1,12,https://www.altmetric.com/details/1622860,https://api.altmetric.com/v1/donut/1622860_240.png 10,Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer.,Cell Reports,,,Article,2015-12-03,10.1016/j.celrep.2015.10.078,,,,26628371,PMC4684962,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4836156,https://api.altmetric.com/v1/donut/4836156_240.png 10,Prostate cancer: PSA testing in older men|[mdash]|are we following the guidelines?,Nature Reviews Urology,,,Article,2012-05-29,10.1038/nrurol.2012.115,,,,22641163,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/766616,https://api.altmetric.com/v1/donut/766616_240.png 10,Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort,The Journal of Urology,,,Article,2015-01-07,10.1016/j.juro.2015.01.102,,,,25660208,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3333959,https://api.altmetric.com/v1/donut/3333959_240.png 10,Comparison of high?dose IMRT (86.4 Gy) to combined brachytherapy plus IMRT for intermediate?risk prostate cancer,British Journal of Urology,,,Article,2014-01-22,10.1111/bju.12514,,,,24447404,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1829052,https://api.altmetric.com/v1/donut/1829052_240.png 10,"Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants.",International journal of clinical practice,,,Article,2014-12-11,10.1111/ijcp.12514,,,,25495842,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3006397,https://api.altmetric.com/v1/donut/3006397_240.png 10,Chemotherapy for metastatic castrate-sensitive prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2016-03-15,10.1038/pcan.2016.10,,,,26976365,,,,,,,0,0,0,16,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6244683,https://api.altmetric.com/v1/donut/6244683_240.png 10,Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer.,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2012.11.014,,,,23201468,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,78,https://www.altmetric.com/details/2227837,https://api.altmetric.com/v1/donut/2227837_240.png 10,Skeletal Response to Resistance and Impact Training in Prostate Cancer Survivors,Medicine & Science in Sports & Exercise,,,Article,2014-02-04,10.1249/mss.0000000000000265,,,,24500540,,,,,,,0,0,0,15,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2103169,https://api.altmetric.com/v1/donut/2103169_240.png 10,Effect of Repeated Prostate Biopsies on Erectile Function in Men under Active Surveillance for Prostate Cancer.,The Journal of Urology,,,Article,2013-09-06,10.1016/j.juro.2013.08.054,,,,24012535,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,1,0,0,14,https://www.altmetric.com/details/1734366,https://api.altmetric.com/v1/donut/1734366_240.png 10,Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor,Proceedings of the National Academy of Sciences of the United States of America,"WAYNE, Britney M",Department of Life Sciences; School of Natural Sciences,Article,1970-01-01,10.1073/pnas.1012443107,,,,20823238,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,128,https://www.altmetric.com/details/890313,https://api.altmetric.com/v1/donut/890313_240.png 10,Tracking the Origin of Metastatic Prostate Cancer,European Urology,,,Article,2014-09-18,10.1016/j.eururo.2014.09.006,,,,25246081,,,,,,,0,0,0,17,0,0,3,0,1,0,0,0,0,0,0,35,https://www.altmetric.com/details/2699762,https://api.altmetric.com/v1/donut/2699762_240.png 10,Prostate cancer incidence in males with Lynch syndrome,Genetics in Medicine,,,Article,1970-01-01,10.1038/gim.2013.193,,,,24434690,,,,,,,0,0,0,16,0,0,4,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2049135,https://api.altmetric.com/v1/donut/2049135_240.png 10,Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study,European Urology,,,Article,2013-11-01,10.1016/j.eururo.2013.11.012,,,,24290503,,,,,,,0,1,0,2,0,0,1,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/1946523,https://api.altmetric.com/v1/donut/1946523_240.png 10,Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy,Cancer Gene Therapy,,,Article,2016-10-21,10.1038/cgt.2016.53,,,,27767086,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13044649,https://api.altmetric.com/v1/donut/13044649_240.png 10,Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer,British Journal of Cancer,,,Article,2016-10-18,10.1038/bjc.2016.328,,,,27755533,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12752031,https://api.altmetric.com/v1/donut/12752031_240.png 10,Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer,Cancer (0008543X),,,Article,2016-09-01,10.1002/cncr.30320,,,,27583806,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11186446,https://api.altmetric.com/v1/donut/11186446_240.png 10,Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth,Oncogene,,,Article,2016-08-22,10.1038/onc.2016.287,,,,27546619,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10746595,https://api.altmetric.com/v1/donut/10746595_240.png 10,Tumor features and survival after radical prostatectomy among antidiabetic drug users,Prostate Cancer & Prostatic Diseases,,,Article,2016-08-09,10.1038/pcan.2016.32,,,,27502739,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10370394,https://api.altmetric.com/v1/donut/10370394_240.png 10,Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2016-08-09,10.1038/pcan.2016.31,,,,27502737,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/10370304,https://api.altmetric.com/v1/donut/10370304_240.png 10,Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis,Prostate Cancer & Prostatic Diseases,,,Article,2016-07-19,10.1038/pcan.2016.29,,,,27431500,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9869751,https://api.altmetric.com/v1/donut/9869751_240.png 10,p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer,Oncogene,,,Article,2016-05-16,10.1038/onc.2016.175,,,,27181203,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7548573,https://api.altmetric.com/v1/donut/7548573_240.png 10,CONTINUOUS VERSUS INTERMITTENT DOCETAXEL FOR METASTATIC CASTRATION RESISTANT PROSTATE CANCER,Critical Reviews in Oncology/Hematology,,,Article,2016-04-28,10.1016/j.critrevonc.2016.04.014,,,,27157868,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7090456,https://api.altmetric.com/v1/donut/7090456_240.png 10,Castration-Resistant Prostate Cancer: Will Earlier Intervention Improve Outcomes?,Journal Watch,,,Article,2016-04-06,10.1056/nejm-jw.na40993,,,,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6504719,https://api.altmetric.com/v1/donut/6504719_240.png 10,Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy,International Journal of Cancer,,,Article,2016-04-01,10.1002/ijc.30123,,,,27038059,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6447064,https://api.altmetric.com/v1/donut/6447064_240.png 10,Reply to the letter to the editor ‘Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy’ by Tannock et al.,Annals of Oncology,,,Article,2016-04-01,10.1093/annonc/mdw023,,,,26802159,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6255894,https://api.altmetric.com/v1/donut/6255894_240.png 10,p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells,Cell Death & Disease,,,Article,2016-02-01,10.1038/cddis.2016.32,,,,26913608,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6006590,https://api.altmetric.com/v1/donut/6006590_240.png 10,Targeting fatty acid synthase with ASC?J9 suppresses proliferation and invasion of prostate cancer cells,Molecular Carcinogenesis,,,Article,2016-02-19,10.1002/mc.22468,,,,26894509,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5971030,https://api.altmetric.com/v1/donut/5971030_240.png 10,Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer.,New England Journal of Medicine,,,Article,2016-01-21,10.1056/nejmc1511800,,,,26789883,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5020689,https://api.altmetric.com/v1/donut/5020689_240.png 10,Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer,Cancer Research,,,Article,2016-01-15,10.1158/0008-5472.can-14-3280,,,,26554830,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4997505,https://api.altmetric.com/v1/donut/4997505_240.png 10,Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients,PLoS ONE,,,Article,2016-01-08,10.1371/journal.pone.0146264,,,,26745889,PMC4706411,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4973912,https://api.altmetric.com/v1/donut/4973912_240.png 10,Prostate cancer: Staying grounded [mdash] flightless-1 is a tumour supressor,Nature Reviews Urology,,,Article,2015-11-17,10.1038/nrurol.2015.278,,,,26572083,,,,,,,3,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4770569,https://api.altmetric.com/v1/donut/4770569_240.png 10,Prostate cancer: High-risk disease common in low-risk prostate cancer,Nature Reviews Urology,,,Article,2015-10-13,10.1038/nrurol.2015.248,,,,26458754,,,,,,,2,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4616852,https://api.altmetric.com/v1/donut/4616852_240.png 10,HAROW: the first comprehensive prospective observational study comparing treatment options in localized prostate cancer,World Journal of Urology,,,Article,2015-09-15,10.1007/s00345-015-1675-4,,,,26373955,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4565014,https://api.altmetric.com/v1/donut/4565014_240.png 10,A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet,PeerJ,,,Article,2015-07-02,10.7717/peerj.1080,,,,26157638,PMC4493678,,,,,,0,0,0,12,4,0,9,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4234656,https://api.altmetric.com/v1/donut/4234656_240.png 10,Predicting response to chemotherapy for prostate cancer and other stories . . .,British Medical Journal,,,Article,2015-07-01,10.1136/bmj.h3452,,,,,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4232806,https://api.altmetric.com/v1/donut/4232806_240.png 10,"Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition.",International Journal of Cancer,,,Article,2013-04-14,10.1002/ijc.27836,,,,22965418,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4058986,https://api.altmetric.com/v1/donut/4058986_240.png 10,Prostate cancer: Absorbable spacers in men undergoing prostate IG-IMRT,Nature Reviews Urology,,,Article,2015-05-12,10.1038/nrurol.2015.108,,,,25963960,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3988531,https://api.altmetric.com/v1/donut/3988531_240.png 10,Prostate cancer: Under pressure[mdash]physical force promotes tumour growth,Nature Reviews Urology,,,Article,2015-04-28,10.1038/nrurol.2015.95,,,,25917891,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3948829,https://api.altmetric.com/v1/donut/3948829_240.png 10,Prostate cancer: PREVAILing wind blows more good news for enzalutamide,Nature Reviews Urology,,,Article,2015-04-28,10.1038/nrurol.2015.94,,,,25917887,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3948828,https://api.altmetric.com/v1/donut/3948828_240.png 10,Dutch and US cancer researchers reiterate benefits of exercise for prostate cancer survivors,ecancer.org,,,Article,,,,,http://ecancer.org/news/7232-dutch-and-us-cancer-researchers-reiterate-benefits-of-exercise-for-prostate-cancer-survivors.php,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3935853,https://api.altmetric.com/v1/donut/3935853_240.png 10,High-throughput image analysis solutions for prostate cancer can improve accuracy and speed of diagnosis,ecancer.org,,,Article,,,,,http://ecancer.org/news/7172-high-throughput-image-analysis-solutions-for-prostate-cancer-can-improve-accuracy-and-speed-of-diagnosis.php,,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3907908,https://api.altmetric.com/v1/donut/3907908_240.png 10,Prostate cancer: Sequencing AR-targeted agents might be ineffective in mCRPC,Nature Reviews Urology,,,Article,2015-04-14,10.1038/nrurol.2015.81,,,,25868561,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3906366,https://api.altmetric.com/v1/donut/3906366_240.png 10,ASCO GU: Early evidence of increase in higher-risk prostate cancers from 2011-2013,ecancer.org,,,Article,,,,,http://ecancer.org/news/7027-asco-gu--early-evidence-of-increase-in-higher-risk-prostate-cancers-from-2011-2013.php,,,,,,,,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3745081,https://api.altmetric.com/v1/donut/3745081_240.png 10,Adjuvant Versus Neoadjuvant Androgen Deprivation With Radiotherapy for Prostate Cancer: Does Sequencing Matter?,Clinical Genitourinary Cancer,,,Article,,10.1016/j.clgc.2014.12.009,,,,25660127,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3266307,https://api.altmetric.com/v1/donut/3266307_240.png 10,Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer,British Journal of Cancer,,,Article,2015-01-29,10.1038/bjc.2014.622,,,,25633035,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3213914,https://api.altmetric.com/v1/donut/3213914_240.png 10,Prostate cancer: Nerve-sparing surgery and risk of positive surgical margins,Nature Reviews Urology,,,Article,2015-01-06,10.1038/nrurol.2014.359,,,,25558840,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3042474,https://api.altmetric.com/v1/donut/3042474_240.png 10,Urological cancer: Epigenetics in prostate cancer aggression and recurrence.,Nature Reviews Clinical Oncology,,,Article,2014-12-23,10.1038/nrclinonc.2014.230,,,,25533944,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3010904,https://api.altmetric.com/v1/donut/3010904_240.png 10,Evaluation of PSF1 as a prognostic biomarker for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-11-18,10.1038/pcan.2014.46,,,,25403418,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2912243,https://api.altmetric.com/v1/donut/2912243_240.png 10,Global DNA hypomethylation in prostate cancer development and progression: a systematic review,Prostate Cancer & Prostatic Diseases,,,Article,2014-11-11,10.1038/pcan.2014.45,,,,25384337,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2878465,https://api.altmetric.com/v1/donut/2878465_240.png 10,Comparison of patients undergoing laser vaporization of the prostate versus TURP using the ACS-NSQIP database,Prostate Cancer & Prostatic Diseases,,,Article,2014-10-14,10.1038/pcan.2014.39,,,,25311768,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2775405,https://api.altmetric.com/v1/donut/2775405_240.png 10,New horizons in prostate cancer: The final results of the COU-302 abiraterone study. New horizons in prostate cancer: The final results of the COU-302 abiraterone study,ecancer.org,,,Article,,,,,http://ecancer.org/video/3134/new-horizons-in-prostate-cancer--the-final-results-of-the-cou-302-abiraterone-study.php,,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2723422,https://api.altmetric.com/v1/donut/2723422_240.png 10,Enzalutamide may offer chemotherapy alternative in metastatic castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6337-enzalutamide-may-offer-chemotherapy-alternative-in-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2694745,https://api.altmetric.com/v1/donut/2694745_240.png 10,Prostate cancer: Irreversible electroporation is a safe and feasible option for focal therapy,Nature Reviews Urology,,,Article,2014-09-16,10.1038/nrurol.2014.260,,,,25224444,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2689670,https://api.altmetric.com/v1/donut/2689670_240.png 10,Influence of polyphenol extract from evening primrose (Oenothera paradoxa) seeds on human prostate and breast cancer cell lines.,Post?py higieny i medycyny do?wiadczalnej,,,Article,2014-02-06,10.5604/17322693.1088036,,,,24491902,,,,,,,0,0,0,2,0,0,18,0,3,0,0,0,0,0,0,3,https://www.altmetric.com/details/2438105,https://api.altmetric.com/v1/donut/2438105_240.png 10,Antitumor activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signaling.,Journal of Pineal Research,,,Article,2014-05-04,10.1111/jpi.12142,,,,24786921,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2333041,https://api.altmetric.com/v1/donut/2333041_240.png 10,Carbohydrate Sequence of the Prostate Cancer-associated Antigen F77 Assigned by a Mucin O-Glycome Designer Array,Journal of Biological Chemistry,,,Article,2014-04-20,10.1074/jbc.m114.558932,,,,24753245,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2294300,https://api.altmetric.com/v1/donut/2294300_240.png 10,"Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men",Frontiers in oncology,,,Article,2013-12-09,10.3389/fonc.2013.00312,,,,24392353,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2000112,https://api.altmetric.com/v1/donut/2000112_240.png 10,"Chemoprevention of Prostate Cancer by D,L-Sulforaphane Is Augmented by Pharmacological Inhibition of Autophagy",Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-13-0755,,,,23921360,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1674053,https://api.altmetric.com/v1/donut/1674053_240.png 10,Development of a label?free LC?MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy,PROTEOMICS - Clinical Applications,,,Article,2013-01-01,10.1002/prca.201300004,,,,23670859,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1594219,https://api.altmetric.com/v1/donut/1594219_240.png 10,Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-06-24,10.1073/pnas.1304318110,,,,23798432,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1588340,https://api.altmetric.com/v1/donut/1588340_240.png 10,Receipt of National Comprehensive Cancer Network guidelineâ??concordant prostate cancer care among African American and Caucasian American men in North Carolina,Cancer (0008543X),"BOND, Jim C",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-01-01,10.1002/cncr.28004,,,,23575751,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1533259,https://api.altmetric.com/v1/donut/1533259_240.png 10,Current Status of Biomarkers for Prostate Cancer,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140611034,,,,23708103,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,114,https://www.altmetric.com/details/1511929,https://api.altmetric.com/v1/donut/1511929_240.png 10,Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer,European Urology,,,Article,2013-03-06,10.1016/j.eururo.2013.02.023,,,,23453420,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1504836,https://api.altmetric.com/v1/donut/1504836_240.png 10,Intensityâ??modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: A study of adverse effects and their relation to quality of life,The Prostate,,,Article,2013-01-01,10.1002/pros.22651,,,,23532709,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1340821,https://api.altmetric.com/v1/donut/1340821_240.png 10,Latest UK figures show increase in prostate cancer diagnoses and falling death rate,British Medical Journal,,,Article,2012-05-08,10.1136/bmj.e3252,,,,22569872,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/732190,https://api.altmetric.com/v1/donut/732190_240.png 10,Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer,"Cancer Immunology, Immunotherapy",,,Article,2009-11-07,10.1007/s00262-009-0782-8,,,,19890632,PMC2832083,,,,,,0,0,1,7,0,0,0,1,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2812155,https://api.altmetric.com/v1/donut/2812155_240.png 10,Prevalence of the HOXB13?G84E prostate cancer risk allele in men treated with radical prostatectomy,British Journal of Urology,,,Article,2013-10-20,10.1111/bju.12522,,,,24148311,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2164270,https://api.altmetric.com/v1/donut/2164270_240.png 10,The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model.,The Prostate,,,Article,2012-10-04,10.1002/pros.22586,,,,23038057,,,,,,,0,0,0,10,0,0,4,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/986181,https://api.altmetric.com/v1/donut/986181_240.png 10,Androgen-Independent Molecular Imaging Vectors to Detect Castration-Resistant and Metastatic Prostate Cancer,Cancer Research,,,Article,2011-09-20,10.1158/0008-5472.can-11-1520,,,,21933883,PMC3185197,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/377488,https://api.altmetric.com/v1/donut/377488_240.png 10,Racial differences in the androgen/androgen receptor pathway in prostate cancer.,Journal of the National Medical Association,,,Article,1999-12-01,,,,,10628124,PMC2608588,,,,,,0,1,0,3,0,0,0,0,0,0,5,0,0,0,0,9,https://www.altmetric.com/details/1113900,https://api.altmetric.com/v1/donut/1113900_240.png 10,Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-11-02,10.1073/pnas.1505935112,,,,26578786,,,,,,,0,1,0,4,0,0,1,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/4717349,https://api.altmetric.com/v1/donut/4717349_240.png 10,Young-age prostate cancer,Journal of Clinical Pathology,,,Article,2015-04-02,10.1136/jclinpath-2015-202993,,,,25837493,,,,,,,0,0,0,18,0,0,3,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3865633,https://api.altmetric.com/v1/donut/3865633_240.png 10,Unorganized Prostate-specific Antigen–based Screening for Prostate Cancer: More Harm than Benefit. When Will We Finally Start to Implement Guidelines and Risk Assessment Tools in Clinical Practice?,European Urology,,,Article,2015-03-10,10.1016/j.eururo.2015.02.036,,,,25769985,,,,,,,0,0,0,14,0,0,3,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/3774054,https://api.altmetric.com/v1/donut/3774054_240.png 10,Green tea and prostate cancer: from bench to clinic,Frontiers in bioscience Elite edition,,,Article,2009-01-01,,,,,19482620,PMC2728057,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1337834,https://api.altmetric.com/v1/donut/1337834_240.png 10,Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response,European Urology,,,Article,2016-08-11,10.1016/j.eururo.2016.07.033,,,,27497761,,,,,,,0,0,0,15,0,0,1,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/10406301,https://api.altmetric.com/v1/donut/10406301_240.png 10,Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions,JNCI: Journal of the National Cancer Institute,,,Article,2016-12-01,10.1093/jnci/djw165,,,,27418620,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9719124,https://api.altmetric.com/v1/donut/9719124_240.png 10,Prostate cancer: is it time to expand the research focus to early-life exposures?,Nature Reviews Cancer,,,Article,2013-01-31,10.1038/nrc3434,,,,23363989,,,,,,,0,0,0,13,0,0,2,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/1210023,https://api.altmetric.com/v1/donut/1210023_240.png 10,Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2011.10633.x,,,,22077593,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/455247,https://api.altmetric.com/v1/donut/455247_240.png 10,"Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: Toxicity, biochemical, and patient-reported health-related quality-of-life outcomes",Practical Radiation Oncology,,,Article,2015-04-24,10.1016/j.prro.2015.02.015,,,,25899220,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3939354,https://api.altmetric.com/v1/donut/3939354_240.png 10,NICE prostate cancer quality standards,Journal of Clinical Urology,,,Article,2016-04-11,10.1177/2051415816642694,,,,,,,,,,,0,0,0,19,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6624249,https://api.altmetric.com/v1/donut/6624249_240.png 10,Immunotherapy for prostate cancer,Current Opinion in Urology,,,Article,2016-09-09,10.1097/mou.0000000000000334,,,http://journals.lww.com/co-urology/Fulltext/publishahead/Immunotherapy_for_prostate_cancer___is_prostate_an.99349.aspx,27533500,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11999596,https://api.altmetric.com/v1/donut/11999596_240.png 10,The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies,Urology,,,Article,2016-09-07,10.1016/j.urology.2016.08.032,,,,27591810,,,,,,,0,0,0,19,0,0,2,0,2,0,0,0,0,0,0,1,https://www.altmetric.com/details/10955341,https://api.altmetric.com/v1/donut/10955341_240.png 10,Preselection of A- and B- modified d-homo lactone and d-seco androstane derivatives as potent compounds with antiproliferative activity against breast and prostate cancer cells – QSAR approach and molecular docking analysis,European Journal of Pharmaceutical Sciences,,,Article,2016-08-01,10.1016/j.ejps.2016.08.009,,,,27503457,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10371297,https://api.altmetric.com/v1/donut/10371297_240.png 10,Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium,British Journal of Cancer,,,Article,2016-08-04,10.1038/bjc.2016.228,,,,27490808,,,,,,,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10276597,https://api.altmetric.com/v1/donut/10276597_240.png 10,Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302,European Urology,,,Article,2016-07-09,10.1016/j.eururo.2016.06.033,,,,27402060,,,,,,,0,0,0,12,0,0,1,0,3,0,0,0,0,0,0,9,https://www.altmetric.com/details/9527663,https://api.altmetric.com/v1/donut/9527663_240.png 10,Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition,Oncogene,,,Article,2016-07-04,10.1038/onc.2016.240,,,,27375020,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9233452,https://api.altmetric.com/v1/donut/9233452_240.png 10,Expression of two WFDC1|[sol]|ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2|[sol]|COX-2,British Journal of Cancer,,,Article,2016-04-26,10.1038/bjc.2016.91,,,,27115470,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6974873,https://api.altmetric.com/v1/donut/6974873_240.png 10,Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer,British Journal of Cancer,,,Article,2016-04-12,10.1038/bjc.2016.95,,,,27070713,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6634531,https://api.altmetric.com/v1/donut/6634531_240.png 10,Formulation of acid-sensitive micelles for delivery of cabazitaxel into prostate cancer cells,Molecular Pharmaceutics,,,Article,2016-03-15,10.1021/acs.molpharmaceut.6b00147,,,,26977718,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6197762,https://api.altmetric.com/v1/donut/6197762_240.png 10,NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer,"Genes, Chromosomes, and Cancer",,,Article,2016-01-23,10.1002/gcc.22340,,,,26799514,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5030978,https://api.altmetric.com/v1/donut/5030978_240.png 10,LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer,PLoS ONE,,,Article,2016-01-16,10.1371/journal.pone.0146549,,,,26771192,PMC4714844,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5001591,https://api.altmetric.com/v1/donut/5001591_240.png 10,Insertion of an SVA-E retrotransposon into the CASP8 gene is associated with protection against prostate cancer.,Human Molecular Genetics,,,Article,2016-01-08,10.1093/hmg/ddv622,,,,26740556,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4969389,https://api.altmetric.com/v1/donut/4969389_240.png 10,The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro,Bioscience Reports,,,Article,2015-11-28,10.1042/bsr20150003,,,,26612002,,,,,,,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4816968,https://api.altmetric.com/v1/donut/4816968_240.png 10,[68Ga]PSMA-HBED PET for differential diagnosis of suspicious lung lesions in patients with prostate cancer.,Journal of Nuclear Medicine,,,Article,2015-11-22,10.2967/jnumed.115.164442,,,,26585062,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4793184,https://api.altmetric.com/v1/donut/4793184_240.png 10,The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo,Molecular Cancer Therapeutics,,,Article,2015-10-24,10.1158/1535-7163.mct-15-0279,,,,26494858,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4669690,https://api.altmetric.com/v1/donut/4669690_240.png 10,"Focused Decision Support: a Data Mining Tool to Query the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset and Guide Screening Management for the Individual Patient",Journal of Digital Imaging,,,Article,2015-09-20,10.1007/s10278-015-9826-0,,,,26385814,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4533407,https://api.altmetric.com/v1/donut/4533407_240.png 10,Genetics: Integrated analyses for prostate cancer risk stratification,Nature Reviews Urology,,,Article,2015-08-25,10.1038/nrurol.2015.216,,,,26304007,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4430432,https://api.altmetric.com/v1/donut/4430432_240.png 10,Prostate cancer: Loss of cyclin D1 indicates prostatic adenocarcinoma,Nature Reviews Urology,,,Article,2015-08-25,10.1038/nrurol.2015.214,,,,26304004,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4430431,https://api.altmetric.com/v1/donut/4430431_240.png 10,Factor structure of a combined measure of major depressive disorder and male depression in prostate cancer patients,Psycho-Oncology,,,Article,2015-07-01,10.1002/pon.3928,,,,26228568,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4349180,https://api.altmetric.com/v1/donut/4349180_240.png 10,Visceral adipose tissue measured by computed tomography and high-grade prostate cancer after radical prostatectomy,International Journal of Obesity,,,Article,2015-06-23,10.1038/ijo.2015.111,,,,26100296,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4272645,https://api.altmetric.com/v1/donut/4272645_240.png 10,Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases,Cancer (0008543X),,,Article,2015-05-14,10.1002/cncr.29455,,,,25975562,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3996781,https://api.altmetric.com/v1/donut/3996781_240.png 10,Men’s strategies for preserving emotional well-being in advanced prostate cancer: An interpretative phenomenological analysis,Psychology & Health,,,Article,2015-04-15,10.1080/08870446.2015.1040016,,,,25871263,,,,,,,0,0,0,29,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3910354,https://api.altmetric.com/v1/donut/3910354_240.png 10,Prostate cancer: MR-TRUS fusion biopsy[mdash]defining a new standard,Nature Reviews Clinical Oncology,,,Article,2015-04-14,10.1038/nrclinonc.2015.70,,,,25869459,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3908189,https://api.altmetric.com/v1/donut/3908189_240.png 10,TGF|[beta]|-induced phosphorylation of Par6 promotes migration and invasion in prostate cancer cells,British Journal of Cancer,,,Article,2015-03-10,10.1038/bjc.2015.71,,,,25756394,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3799831,https://api.altmetric.com/v1/donut/3799831_240.png 10,Prostate cancer: ASCO endorses ACS Survivorship Care Guidelines,Nature Reviews Urology,,,Article,2015-03-03,10.1038/nrurol.2015.38,,,,25732854,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3788423,https://api.altmetric.com/v1/donut/3788423_240.png 10,Prostate cancer: BCR risk decreases with time after radical prostatectomy,Nature Reviews Urology,,,Article,2015-03-03,10.1038/nrurol.2015.36,,,,25732856,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3788422,https://api.altmetric.com/v1/donut/3788422_240.png 10,Prostate cancer: A urine-based methylation signature for risk stratification,Nature Reviews Urology,,,Article,2015-03-10,10.1038/nrurol.2015.45,,,,25753098,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3770970,https://api.altmetric.com/v1/donut/3770970_240.png 10,Prostate cancer: Enzalutamide has durable antitumour activity,Nature Reviews Urology,,,Article,2015-03-10,10.1038/nrurol.2015.46,,,,25753097,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3770964,https://api.altmetric.com/v1/donut/3770964_240.png 10,Prostate cancer: The end of the road for orteronel,Nature Reviews Urology,,,Article,2015-03-10,10.1038/nrurol.2015.47,,,,25753096,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3770963,https://api.altmetric.com/v1/donut/3770963_240.png 10,Abiraterone declined by Scottish Medicines Consortium for use before chemo in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6968-abiraterone-declined-by-scottish-medicines-consortium-for-use-before-chemo-in-prostate-cancer.php,,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3536023,https://api.altmetric.com/v1/donut/3536023_240.png 10,Loss of JUNB/AP-1 promotes invasive prostate cancer.,Cell Death & Differentiation,,,Article,2014-12-19,10.1038/cdd.2014.213,,,,25526087,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3001018,https://api.altmetric.com/v1/donut/3001018_240.png 10,Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data,JNCI: Journal of the National Cancer Institute,,,Article,2015-01-01,10.1093/jnci/dju366,,,,25505238,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2981151,https://api.altmetric.com/v1/donut/2981151_240.png 10,Prostate cancer: Bicalutamide dose increase in castration-resistant disease,Nature Reviews Urology,,,Article,2014-12-09,10.1038/nrurol.2014.334,,,,25487048,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2965513,https://api.altmetric.com/v1/donut/2965513_240.png 10,Prostate cancer: Phase I study shows potential of TRC105 in mCRPC,Nature Reviews Urology,,,Article,2014-12-09,10.1038/nrurol.2014.336,,,,25487051,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2965511,https://api.altmetric.com/v1/donut/2965511_240.png 10,Prostate cancer: Identifying sites of recurrence with choline-PET-CT imaging,Nature Reviews Urology,,,Article,2014-12-02,10.1038/nrurol.2014.321,,,,25447835,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2941753,https://api.altmetric.com/v1/donut/2941753_240.png 10,Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.,Animal Biotelemetry,,,Article,2014-11-01,10.1038/cddis.2014.500,,,,25412314,,,,,,,1,0,0,13,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2911285,https://api.altmetric.com/v1/donut/2911285_240.png 10,Hip fracture complications of prostate cancer treatment. Hip fracture complications of prostate cancer treatment,ecancer.org,,,Article,,,,,http://ecancer.org/video/3219/hip-fracture-complications-of-prostate-cancer-treatment.php,,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2862723,https://api.altmetric.com/v1/donut/2862723_240.png 10,Enzalutamide in metastatic prostate cancer before chemotherapy.,New England Journal of Medicine,,,Article,2014-10-30,10.1056/nejmc1410239,,,,25354111,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2829350,https://api.altmetric.com/v1/donut/2829350_240.png 10,Prostate cancer: Early PSA measurement can predict recurrence,Nature Reviews Urology,,,Article,2014-10-21,10.1038/nrurol.2014.297,,,,25330793,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2796879,https://api.altmetric.com/v1/donut/2796879_240.png 10,Prostate cancer: mpMRI and MRI/TRUS fusion in men with negative biopsy,Nature Reviews Urology,,,Article,2014-10-14,10.1038/nrurol.2014.290,,,,25311672,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2777221,https://api.altmetric.com/v1/donut/2777221_240.png 10,Prostate cancer: Rare snp predisposes men to aggressive disease,Nature Reviews Urology,,,Article,2014-10-14,10.1038/nrurol.2014.291,,,,25311671,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2777217,https://api.altmetric.com/v1/donut/2777217_240.png 10,Prostate cancer: Analysis of circulating tumour DNA could guide therapy,Nature Reviews Urology,,,Article,2014-10-07,10.1038/nrurol.2014.282,,,,25287784,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2762128,https://api.altmetric.com/v1/donut/2762128_240.png 10,"PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.",Cell Death & Disease,,,Article,2014-10-01,10.1038/cddis.2014.415,,,,25275598,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2737438,https://api.altmetric.com/v1/donut/2737438_240.png 10,Association of variants in genes related to the immune response and obesity with BPH in CLUE II.,Prostate Cancer & Prostatic Diseases,,,Article,2014-09-16,10.1038/pcan.2014.36,,,,25224558,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2687744,https://api.altmetric.com/v1/donut/2687744_240.png 10,Prostate cancer: NANOG implicated in proliferation,Nature Reviews Urology,,,Article,2014-09-16,10.1038/nrurol.2014.254,,,,25224441,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2686701,https://api.altmetric.com/v1/donut/2686701_240.png 10,"Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer. Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer",ecancer.org,,,Article,,,,,http://ecancer.org/video/2903/addition-of-docetaxel-to-initial-hormone-therapy-substantially-improves-survival-in-metastatic--hormone-sensitive-prostate-cancer.php,,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2396855,https://api.altmetric.com/v1/donut/2396855_240.png 10,Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials.,Radiotherapy & Oncology,,,Article,2013-09-20,10.1016/j.radonc.2013.08.030,,,,24060175,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1900210,https://api.altmetric.com/v1/donut/1900210_240.png 10,"Circulating 25?hydroxyvitamin D, vitamin D?binding protein and risk of prostate cancer",International Journal of Cancer,,,Article,2012-11-29,10.1002/ijc.27969,,,,23180681,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1553370,https://api.altmetric.com/v1/donut/1553370_240.png 10,MR Imaging of Prostate Cancer in Radiation Oncology: What Radiologists Need to Know,RadioGraphics,,,Article,2013-05-17,10.1148/rg.333125041,,,,23674772,,,,,,,0,0,0,10,0,0,6,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/1517324,https://api.altmetric.com/v1/donut/1517324_240.png 10,Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice,Cancer Research,,,Article,2008-01-01,10.1158/0008-5472.can-07-1246,,,,18339885,,,,,,,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1377424,https://api.altmetric.com/v1/donut/1377424_240.png 10,"Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.",British Journal of Cancer,,,Article,2010-08-10,10.1038/sj.bjc.6605810,,,,20648015,PMC2939793,,,,,,0,2,0,1,0,0,1,0,0,0,0,0,1,0,0,253,https://www.altmetric.com/details/106878,https://api.altmetric.com/v1/donut/106878_240.png 10,Complications from treatment of localised prostate cancer,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70015-4,,,,24440475,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2050018,https://api.altmetric.com/v1/donut/2050018_240.png 10,"Effect of a Dementia Diagnosis on Survival of Older Patients After a Diagnosis of Breast, Colon, or Prostate Cancer: Implications for Cancer Care",Archives of Internal Medicine,,,Article,2008-10-13,10.1001/archinte.168.18.2033,,,,,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1428785,https://api.altmetric.com/v1/donut/1428785_240.png 10,Comparative Effectiveness of Prostate Cancer Treatments: Evaluating Statistical Adjustments for Confounding in Observational Data,JNCI: Journal of the National Cancer Institute,,,Article,2010-01-01,10.1093/jnci/djq393,,,,20944078,PMC2994860,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/1393427,https://api.altmetric.com/v1/donut/1393427_240.png 10,Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer,Scientific Reports,,,Article,2016-07-14,10.1038/srep29384,,,,27411810,PMC4944130,,,,,,0,0,0,21,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9729023,https://api.altmetric.com/v1/donut/9729023_240.png 10,Prostate cancer awareness survey to proud postcards,Sexual and Relationship Therapy,,,Article,2016-07-15,10.1080/14681994.2016.1200026,,,,,,,,,,,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9727042,https://api.altmetric.com/v1/donut/9727042_240.png 10,The Role of Pelvic Lymph Node Dissection during Radical Prostatectomy in Patients with Gleason Grade 6 Intermediate-Risk Prostate Cancer,Urology,,,Article,2016-03-08,10.1016/j.urology.2016.02.046,,,,26968487,,,,,,,0,0,0,16,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6143205,https://api.altmetric.com/v1/donut/6143205_240.png 10,Current challenges in prostate cancer: an interview with Prostate Cancer UK,BMC Medicine,,,Article,2015-07-24,10.1186/s12916-015-0411-7,,,,26205142,,,,,,,0,0,0,20,0,0,1,0,0,0,0,0,0,0,1,1,https://www.altmetric.com/details/4311599,https://api.altmetric.com/v1/donut/4311599_240.png 10,‘Healthy on Hormones’: improving the experience of men with advanced prostate cancer,International Journal of Urological Nursing,,,Article,2014-07-07,10.1111/ijun.12046,,,,,,,,,,,0,0,0,18,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2493509,https://api.altmetric.com/v1/donut/2493509_240.png 10,Niclosamide inhibits androgen receptor variants expression and overcomes Enzalutamide resistance in castration resistant prostate cancer.,Clinical Cancer Research,,,Article,2014-06-15,10.1158/1078-0432.ccr-13-3296,,,,24740322,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2286561,https://api.altmetric.com/v1/donut/2286561_240.png 10,Prostate cancer: ESMO Consensus Conference Guidelines 2012,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mds624,,,,23303340,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/1167118,https://api.altmetric.com/v1/donut/1167118_240.png 10,"Proton Beam Therapy and Treatment for Localized Prostate Cancer: If You Build It, They Will Come",Archives of Internal Medicine,,,Article,2012-02-13,10.1001/archinternmed.2011.711,,,,22332166,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/613208,https://api.altmetric.com/v1/donut/613208_240.png 10,A network biology approach to prostate cancer,Robotics and Biomimetics,,,Article,2007-02-13,10.1038/msb4100125,,,,17299418,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/116299,https://api.altmetric.com/v1/donut/116299_240.png 10,"Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer",International Journal of Epidemiology,,,Article,2016-07-17,10.1093/ije/dyw129,,,,27427428,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9847217,https://api.altmetric.com/v1/donut/9847217_240.png 10,"Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men With Heterosexual Men ",Journal of Sexual Medicine,,,Article,2016-02-01,10.1016/j.jsxm.2015.12.026,,,,26853048,,,,,,,0,0,0,15,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5108977,https://api.altmetric.com/v1/donut/5108977_240.png 10,Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?,British Journal of Urology,,,Article,2015-07-01,10.1111/bju.13239,,,,26207642,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4313827,https://api.altmetric.com/v1/donut/4313827_240.png 10,Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results,Journal of Clinical Oncology,,,Article,2015-01-26,10.1200/jco.2014.55.3875,,,,25624432,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3105644,https://api.altmetric.com/v1/donut/3105644_240.png 10,"Causes of death in men with localised prostate cancer: a nationwide, population?based study",British Journal of Urology,,,Article,2015-01-22,10.1111/bju.13059,,,,25604807,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3100040,https://api.altmetric.com/v1/donut/3100040_240.png 10,Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis,Genetics in Medicine,,,Article,2015-01-08,10.1038/gim.2014.192,,,,25569441,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3047517,https://api.altmetric.com/v1/donut/3047517_240.png 10,Using Patient-Reported Outcomes to Assess and Improve Prostate Cancer Brachytherapy.,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12464,,,,24112602,,,,,,,0,3,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2370697,https://api.altmetric.com/v1/donut/2370697_240.png 10,The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate?risk disease,Cancer (0008543X),,,Article,2014-03-06,10.1002/cncr.28609,,,,24604289,,,,,,,0,1,0,2,0,0,0,0,1,0,0,0,0,0,0,20,https://www.altmetric.com/details/2195163,https://api.altmetric.com/v1/donut/2195163_240.png 10,Green Tea Polyphenols Induce p53-Dependent and p53-Independent Apoptosis in Prostate Cancer Cells through Two Distinct Mechanisms.,PLoS ONE,,,Article,2013-01-05,10.1371/journal.pone.0052572,,,,23285096,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1175123,https://api.altmetric.com/v1/donut/1175123_240.png 10,"Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001–2007",Prostate Cancer,,,Article,2012-01-01,10.1155/2012/691380,,,,23251806,PMC3515924,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1091878,https://api.altmetric.com/v1/donut/1091878_240.png 10,Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.,Lancet Oncology,,,Article,2011-03-01,10.1016/s1470-2045(10)70295-3,,,,21310658,PMC3091030,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,106,https://www.altmetric.com/details/210409,https://api.altmetric.com/v1/donut/210409_240.png 10,"Inflammation, Microbiota, and Prostate Cancer",European Urology Focus ,,,Article,2016-08-28,10.1016/j.euf.2016.08.010,,,,,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10870721,https://api.altmetric.com/v1/donut/10870721_240.png 10,Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.,Radiology,,,Article,2016-02-01,10.1148/radiol.2015150799,,,,26807894,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/5072910,https://api.altmetric.com/v1/donut/5072910_240.png 10,Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.,Nature Genetics,,,Article,2007-04-01,10.1038/ng2022,,,,17401363,,,,,,,0,1,0,2,0,0,1,0,0,0,0,0,0,0,0,184,https://www.altmetric.com/details/125446,https://api.altmetric.com/v1/donut/125446_240.png 10,Randomized Phase 2 Trial of Custirsen (OGX-011) with Docetaxel or Mitoxantrone in Patients with Metastatic Castrate-Resistant Prostate Cancer: CUOG Trial P06c,Clinical Cancer Research,,,Article,2011-07-25,10.1158/1078-0432.ccr-11-0859,,,,21788353,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/212088,https://api.altmetric.com/v1/donut/212088_240.png 10,"General Practitioners’ Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative Study",PLoS ONE,,,Article,2016-04-21,10.1371/journal.pone.0153299,,,,27100402,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6871186,https://api.altmetric.com/v1/donut/6871186_240.png 10,RETRACTED: Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer,Cancer Letters,,,Article,2006-01-01,10.1016/j.canlet.2005.11.002,,,,16458425,,,,,,,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2426576,https://api.altmetric.com/v1/donut/2426576_240.png 10,Hydroxytyrosol promotes superoxide production and defects in autophagy leading to anti-proliferation and apoptosis on human prostate cancer cells.,Current Cancer Drug Targets,,,Article,2013-07-01,,,,,23597197,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2016730,https://api.altmetric.com/v1/donut/2016730_240.png 10,IMO-HIP 2015 Report: An Evolutionary Game Theory Approach to evolutionary-enlightened application of chemotherapy in bone metastatic prostate cancer,bioRxiv,,,Article,2015-10-30,10.1101/030262,,,,,,,,,,,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4707191,https://api.altmetric.com/v1/donut/4707191_240.png 10,Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer,The Prostate,,,Article,2015-04-28,10.1002/pros.22998,,,,25919471,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3951089,https://api.altmetric.com/v1/donut/3951089_240.png 9,"Associations of energy, fat, calcium, and vitamin D with prostate cancer risk.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2002-01-01,,,,,12163324,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12889570,https://api.altmetric.com/v1/donut/12889570_240.png 9,Role of Mammalian Lignans in the Prevention and Treatment of Prostate Cancer,Nutrition and Cancer,,,Article,2005-05-01,10.1207/s15327914nc5201_1,,,,16090998,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6938719,https://api.altmetric.com/v1/donut/6938719_240.png 9,Circulating 25-hydroxyvitamin D and prostate cancer survival,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-01-25,10.1158/1055-9965.epi-15-0991,,,,26809275,,,,,,,0,2,0,4,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5629106,https://api.altmetric.com/v1/donut/5629106_240.png 9,Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.,Neoplasia,,,Article,2006-10-14,10.1593/neo.06328,,,,17032503,PMC1715921,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5105623,https://api.altmetric.com/v1/donut/5105623_240.png 9,Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.,Oncogene,,,Article,2008-12-04,10.1038/onc.2008.327,,,,18794802,PMC2676849,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/5105622,https://api.altmetric.com/v1/donut/5105622_240.png 9,The arachidonic acid pathway and its role in prostate cancer development and progression.,The Journal of Urology,,,Article,2008-05-01,10.1016/j.juro.2007.12.037,,,,18343442,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/5086429,https://api.altmetric.com/v1/donut/5086429_240.png 9,Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.,The Prostate,,,Article,2010-02-15,10.1002/pros.21057,,,,19790237,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5086428,https://api.altmetric.com/v1/donut/5086428_240.png 9,The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer,Biologics: Targets & Therapy,,,Article,2008-12-01,,,,,19707453,PMC2727910,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5086427,https://api.altmetric.com/v1/donut/5086427_240.png 9,"Suppression of N-Methyl-N-nitrosourea/Testosterone-induced Rat Prostate Cancer Growth by Celecoxib Effects on Cyclooxygenase-2, Cell Cycle Regulation, and Apoptosis Mechanism(s)",Clinical Cancer Research,,,Article,2003-08-15,,,,,12960143,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4966830,https://api.altmetric.com/v1/donut/4966830_240.png 9,Final quality of life and safety data for patients with metastatic castration?resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279),British Journal of Urology,,,Article,2015-12-01,10.1111/bju.13069,,,,25639506,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4820136,https://api.altmetric.com/v1/donut/4820136_240.png 9,"A positive family history as a risk factor for prostate cancer in a population?based study with organised prostate?specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)",British Journal of Urology,,,Article,2015-09-01,10.1111/bju.13310,,,,26332304,,,,,,,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4818915,https://api.altmetric.com/v1/donut/4818915_240.png 9,The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.,,,,Article,2012-04-14,10.1016/j.pcd.2011.10.004,,,,22056422,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4573966,https://api.altmetric.com/v1/donut/4573966_240.png 9,Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.,Cancer Causes and Control,,,Article,2007-11-15,10.1007/s10552-007-9031-7,,,,17641982,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4325975,https://api.altmetric.com/v1/donut/4325975_240.png 9,"Prostate carcinoma screening in the county of Tyrol, Austria",Cancer (0008543X),,,Article,1997-11-01,10.1002/(sici)1097-0142(19971101)80:9<1818::aid-cncr21>3.0.co;2-7,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4325974,https://api.altmetric.com/v1/donut/4325974_240.png 9,"Prostate Cancer Screening in Tyrol, Austria: Experience and Results",European Urology,,,Article,2012-04-16,10.1159/000019893,,,,10325519,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4325973,https://api.altmetric.com/v1/donut/4325973_240.png 9,Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate ,Cancer Letters,,,Article,2016-06-09,10.1016/0304-3835(95)03948-v,,,,7585463,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3772691,https://api.altmetric.com/v1/donut/3772691_240.png 9,[A critical assessment of phytotherapy for prostate cancer].,Der Urologe A,,,Article,2009-01-03,10.1007/s00120-008-1929-5,,,,19153707,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3107761,https://api.altmetric.com/v1/donut/3107761_240.png 9,Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data.,IN VIVO,,,Article,2007-04-17,,,,,17436567,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3107760,https://api.altmetric.com/v1/donut/3107760_240.png 9,Predicting pathological outcomes in patients undergoing robot?assisted radical prostatectomy for high?risk prostate cancer: a preoperative nomogram,British Journal of Urology,,,Article,2014-11-23,10.1111/bju.12998,,,,25413443,,,,,,,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2963576,https://api.altmetric.com/v1/donut/2963576_240.png 9,Patient Opinions on Prostate Cancer Screening Are Swayed by the United States Preventative Services Task Force Recommendations ,Urology,,,Article,,10.1016/j.urology.2014.04.026,,,,24929945,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2629033,https://api.altmetric.com/v1/donut/2629033_240.png 9,The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act,Prostate Cancer & Prostatic Diseases,,,Article,2014-07-02,10.1038/pcan.2014.23,,,,24980272,,,,,,,1,0,0,7,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2487087,https://api.altmetric.com/v1/donut/2487087_240.png 9,Conventional Treatments of Localized Prostate Cancer,Urology,,,Article,2008-01-01,10.1016/j.urology.2008.10.005,,,,19095125,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2262232,https://api.altmetric.com/v1/donut/2262232_240.png 9,"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.",The Journal of Urology,,,Article,1994-05-01,,,,,7512659,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1619865,https://api.altmetric.com/v1/donut/1619865_240.png 9,Association between antibiotic use and risk of prostate cancer.,International Journal of Cancer,,,Article,2009-12-30,10.1002/ijc.25139,,,,20039321,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1542147,https://api.altmetric.com/v1/donut/1542147_240.png 9,BIOLOGICAL MEDIATORS OF EFFECT OF DIET AND STRESS REDUCTION ON PROSTATE CANCER,Integrative Cancer Therapies,,,Article,2008-09-01,10.1177/1534735408322849,,,,18815144,PMC2733349,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1542142,https://api.altmetric.com/v1/donut/1542142_240.png 9,Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer?,The Journal of Urology,,,Article,2001-12-01,,,,,11696736,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/1542141,https://api.altmetric.com/v1/donut/1542141_240.png 9,Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence.,Cancer Research,,,Article,2004-02-21,10.1158/0008-5472.can-03-3830,,,,14973081,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1487496,https://api.altmetric.com/v1/donut/1487496_240.png 9,Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.,Clinical Cancer Research,,,Article,2003-07-01,,,,,12855654,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1487494,https://api.altmetric.com/v1/donut/1487494_240.png 9,Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model.,The Journal of Urology,,,Article,2010-02-24,10.1016/j.juro.2009.12.003,,,,20172549,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1487490,https://api.altmetric.com/v1/donut/1487490_240.png 9,Retraction – Horizon scanning for novel therapeutics for the treatment of prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2012-09-22,10.1517/13543784.2012.728383,,,,22992004,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1447742,https://api.altmetric.com/v1/donut/1447742_240.png 9,"Retraction: psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated akt signaling in androgen-independent prostate cancer cells.",Cancer Prevention Research,,,Article,,10.1158/1940-6207.capr-11-0467,,,,22025547,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1447109,https://api.altmetric.com/v1/donut/1447109_240.png 9,"Psoralidin, an Herbal Molecule, Inhibits Phosphatidylinositol 3-Kinase–Mediated Akt Signaling in Androgen-Independent Prostate Cancer Cells",Cancer Prevention Research,,,Article,2009-01-01,10.1158/1940-6207.capr-08-0129,,,,19223576,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1447107,https://api.altmetric.com/v1/donut/1447107_240.png 9,Replication of Prostate Cancer Risk Loci in a Japanese Case–Control Association Study,JNCI: Journal of the National Cancer Institute,,,Article,2009-01-01,10.1093/jnci/djp287,,,,19726753,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1430312,https://api.altmetric.com/v1/donut/1430312_240.png 9,"Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma",PLoS ONE,,,Article,2009-03-11,10.1371/journal.pone.0004812,,,,19277124,,,2009PLoSO...4.4812M,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1430267,https://api.altmetric.com/v1/donut/1430267_240.png 9,"Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer",Journal of Virology,,,Article,2008-01-01,10.1128/jvi.01299-08,,,,18684813,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/1386685,https://api.altmetric.com/v1/donut/1386685_240.png 9,"Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.",The Journal of Urology,,,Article,2010-03-20,10.1016/j.juro.2010.01.015,,,,20299055,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1384114,https://api.altmetric.com/v1/donut/1384114_240.png 9,Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.,Integrative Cancer Therapies,,,Article,2003-12-12,10.1177/1534735402238186,,,,14664728,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1355533,https://api.altmetric.com/v1/donut/1355533_240.png 9,Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis,Annals of Oncology,,,Article,2013-03-18,10.1093/annonc/mdt077,,,,23508824,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1312243,https://api.altmetric.com/v1/donut/1312243_240.png 9,Association of [-2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer.,The Journal of Urology,,,Article,2012-08-16,10.1016/j.juro.2012.06.009,,,,22901577,,,,,,,0,2,0,6,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/890841,https://api.altmetric.com/v1/donut/890841_240.png 9,Selenium and prostate cancer: systematic review and meta-analysis,American Journal of Clinical Nutrition,,,Article,2011-01-01,10.3945/ajcn.111.033373,,,,22648711,,,,,,,0,0,0,11,0,0,2,1,0,0,0,1,0,0,0,53,https://www.altmetric.com/details/770556,https://api.altmetric.com/v1/donut/770556_240.png 9,Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer,Nano Letters,,,Article,2012-01-11,10.1021/nl2035354,,,,22165988,,,2012NanoL..12..287H,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/566944,https://api.altmetric.com/v1/donut/566944_240.png 9,Physician Social Networks and Variation in Prostate Cancer Treatment in Three Cities,Health Services Research,,,Article,2011-01-01,10.1111/j.1475-6773.2011.01331.x,,,,22092259,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/430661,https://api.altmetric.com/v1/donut/430661_240.png 9,NO EVIDENCE OF XMRV IN IRISH PROSTATE CANCER PATIENTS WITH THE R462Q MUTATION,European Urology Supplements,,,Article,2008-03-01,10.1016/s1569-9056%2808%2960798-8,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/414895,https://api.altmetric.com/v1/donut/414895_240.png 9,ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice,European Urology,,,Article,2009-08-01,10.1016/j.eururo.2009.04.036,,,,19409690,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,96,https://www.altmetric.com/details/408170,https://api.altmetric.com/v1/donut/408170_240.png 9,Testosterone Therapy in Men With Untreated Prostate Cancer,The Journal of Urology,,,Article,2011-04-01,10.1016/j.juro.2010.11.084,,,,21334649,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,2,0,0,14,https://www.altmetric.com/details/236262,https://api.altmetric.com/v1/donut/236262_240.png 9,Leptin increases motility and integrin up-regulation in human prostate cancer cells.,Journal of cellular physiology,,,Article,2011-05-01,10.1002/jcp.22455,,,,20945385,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/199442,https://api.altmetric.com/v1/donut/199442_240.png 9,Leptin induces cell migration and the expression of growth factors in human prostate cancer cells.,American journal of surgery,,,Article,2004-11-01,10.1016/j.amjsurg.2004.07.031,,,,15546570,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/199441,https://api.altmetric.com/v1/donut/199441_240.png 9,Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans,PLoS Genetics,SKYRUNNER Luke,School of Medicine & Medical Science; Department of Life Sciences,Article,2011-05-26,10.1371/journal.pgen.1001387,,,,21637779,PMC3102736,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/175292,https://api.altmetric.com/v1/donut/175292_240.png 9,Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.,New England Journal of Medicine,,,Article,1991-04-25,10.1056/nejm199104253241702,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/173693,https://api.altmetric.com/v1/donut/173693_240.png 9,Aspirin and Hormone Therapy for Prostate Cancer,New England Journal of Medicine,,,Article,2007-12-27,10.1056/nejmc0706698,,,,18160699,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/173585,https://api.altmetric.com/v1/donut/173585_240.png 9,Integrative Clinical Genomics of Advanced Prostate Cancer,Cell,,,Article,,10.1016/j.cell.2015.06.053,,,,,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4284740,https://api.altmetric.com/v1/donut/4284740_240.png 9,"Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-02-23,10.1158/1055-9965.epi-14-1363,,,,25713025,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3735193,https://api.altmetric.com/v1/donut/3735193_240.png 9,68Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging: The New Kid on the Block—Early or Too Early to Draw Conclusions?,European Urology,,,Article,2016-08-11,10.1016/j.eururo.2016.07.045,,,,27481174,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10654744,https://api.altmetric.com/v1/donut/10654744_240.png 9,Prostate-Cancer Mortality after PSA Screening,New England Journal of Medicine,,,Article,2012-06-07,10.1056/nejmc1204298,,,,,,,,,,,0,0,0,13,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/781372,https://api.altmetric.com/v1/donut/781372_240.png 9,Biomarkers for prostate cancer: present challenges and future opportunities,Future Science OA,,,Article,2015-12-17,10.4155/fso.15.72,,,,,,,,,,,0,1,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4903839,https://api.altmetric.com/v1/donut/4903839_240.png 9,The epidemiology of prostate cancer in Jamaica.,The Journal of Urology,,,Article,1998-06-01,10.1016/s0022-5347(01)63220-8,,,,9598503,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/803346,https://api.altmetric.com/v1/donut/803346_240.png 9,Long-term Cancer Control Outcomes in Patients with Clinically High-risk Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Results from a Multi-institutional Study of 1100 Patients,European Urology,,,Article,2015-06-30,10.1016/j.eururo.2015.06.020,,,,26119559,,,,,,,0,0,0,17,0,0,7,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4213417,https://api.altmetric.com/v1/donut/4213417_240.png 9,Low serum testosterone levels are predictive of prostate cancer,World Journal of Urology,,,Article,2011-11-09,10.1007/s00345-011-0793-x,,,,22068548,,,,,,,0,0,1,7,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/449925,https://api.altmetric.com/v1/donut/449925_240.png 9,Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer,Clinical Cancer Research,,,Article,2009-01-01,10.1158/1078-0432.ccr-08-2660,,,,19638458,PMC2842118,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2590113,https://api.altmetric.com/v1/donut/2590113_240.png 9,"Hair dye use, regular exercise, and the risk and prognosis of prostate cancer: multicenter case–control and case-only studies",BMC Cancer,,,Article,2016-03-21,10.1186/s12885-016-2280-7,,,,26996776,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6252107,https://api.altmetric.com/v1/donut/6252107_240.png 9,The Efficacy of Multiparametric Magnetic Resonance Imaging and MRI-Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance,The Journal of Urology,,,Article,2016-02-23,10.1016/j.juro.2016.02.084,,,,26920465,,,,,,,0,0,0,15,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5982183,https://api.altmetric.com/v1/donut/5982183_240.png 9,Estrogen action and prostate cancer,Expert Review of Endocrinology & Metabolism,,,Article,2011-05-01,10.1586/eem.11.20,,,,21765856,PMC3134227,,,,,,0,2,0,2,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/5089356,https://api.altmetric.com/v1/donut/5089356_240.png 9,Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer,European Urology,,,Article,2016-01-19,10.1016/j.eururo.2015.12.053,,,,26795686,,,,,,,0,0,0,16,0,0,3,0,1,0,0,0,0,0,0,30,https://www.altmetric.com/details/5009703,https://api.altmetric.com/v1/donut/5009703_240.png 9,Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer,British Journal of Cancer,,,Article,2016-01-14,10.1038/bjc.2015.479,,,,26766737,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4997698,https://api.altmetric.com/v1/donut/4997698_240.png 9,Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to Prostate Cancer.,European Urology,,,Article,2015-11-03,10.1016/j.eururo.2015.10.031,,,,26542946,,,,,,,0,0,0,16,0,0,3,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/4716551,https://api.altmetric.com/v1/donut/4716551_240.png 9,Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes.,Patient related outcome measures,,,Article,2015-01-01,10.2147/prom.s49588,,,,25834471,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3918150,https://api.altmetric.com/v1/donut/3918150_240.png 9,Maximal Exercise Testing of Men with Prostate Cancer being Treated with ADT.,Medicine & Science in Sports & Exercise,,,Article,2014-04-01,10.1249/mss.0000000000000353,,,,24694745,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2247823,https://api.altmetric.com/v1/donut/2247823_240.png 9,Alcohol Intake Increases High-grade Prostate Cancer Risk Among Men Taking Dutasteride in the REDUCE Trial ,European Urology,,,Article,2014-02-09,10.1016/j.eururo.2014.01.037,,,,24568894,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2124898,https://api.altmetric.com/v1/donut/2124898_240.png 9,Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades.,European Urology,,,Article,2012-02-19,10.1016/j.eururo.2012.01.050,,,,22336380,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/921905,https://api.altmetric.com/v1/donut/921905_240.png 9,Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10207,,,,27340920,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9034016,https://api.altmetric.com/v1/donut/9034016_240.png 9,Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries,Journal of Clinical Oncology,,,Article,2016-07-25,10.1200/jco.2016.68.9216,,,,27458297,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10073958,https://api.altmetric.com/v1/donut/10073958_240.png 9,Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial,Cancer (0008543X),,,Article,2016-05-10,10.1002/cncr.30071,,,,27164191,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7323585,https://api.altmetric.com/v1/donut/7323585_240.png 9,Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015,Annals of Oncology,,,Article,2016-05-02,10.1093/annonc/mdw180,,,,27141017,,,,,,,0,0,0,15,0,0,0,0,1,0,2,0,0,0,0,2,https://www.altmetric.com/details/7115290,https://api.altmetric.com/v1/donut/7115290_240.png 9,Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the Exercising Together project.,Journal of Cancer Survivorship,,,Article,2015-12-29,10.1007/s11764-015-0509-0,,,,26715587,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4937752,https://api.altmetric.com/v1/donut/4937752_240.png 9,Validation of an Age-adjusted Prostate Cancer–Specific Comorbidity Index,European Urology,,,Article,2015-11-09,10.1016/j.eururo.2015.10.045,,,,26558839,,,,,,,0,0,0,32,0,0,5,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4739477,https://api.altmetric.com/v1/donut/4739477_240.png 9,PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-06-17,10.1073/pnas.1507882112,,,,26080435,,,,,,,0,0,0,11,0,0,3,0,1,0,0,0,0,0,0,34,https://www.altmetric.com/details/4168629,https://api.altmetric.com/v1/donut/4168629_240.png 9,Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.,Science Translational Medicine,,,Article,2010-03-31,10.1126/scitranslmed.3000403,,,,20424012,,,,,,,0,1,0,2,0,0,1,0,0,0,0,0,1,0,0,173,https://www.altmetric.com/details/171948,https://api.altmetric.com/v1/donut/171948_240.png 9,"Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.",American Journal of Pathology,,,Article,2011-08-17,10.1016/j.ajpath.2011.06.005,,,,21854754,PMC3181394,,,,,,0,2,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/243944,https://api.altmetric.com/v1/donut/243944_240.png 9,Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment.,Oncology Reports,,,Article,2014-01-21,10.3892/or.2014.2988,,,,24452514,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2073389,https://api.altmetric.com/v1/donut/2073389_240.png 9,High frequency of gene mutations in metastatic prostate cancer ,Lancet Oncology,,,Article,2016-07-01,10.1016/s1470-2045(16)30316-3,,,,27425814,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9732294,https://api.altmetric.com/v1/donut/9732294_240.png 9,Silibinin Inhibits Wnt/?-catenin Signaling by Suppressing Wnt Co-receptor LRP6 Expression in Human Prostate and Breast Cancer Cells.,Cellular Signalling,,,Article,2012-07-19,10.1016/j.cellsig.2012.07.009,,,,22820499,,,,,,,0,1,0,1,0,0,6,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/855634,https://api.altmetric.com/v1/donut/855634_240.png 9,Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer.,Clinical Cancer Research,,,Article,2011-01-01,10.1158/1078-0432.ccr-10-2410,,,,21364037,,,,,,,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/1356995,https://api.altmetric.com/v1/donut/1356995_240.png 9,Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort.,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2011.08.042,,,,21924545,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,86,https://www.altmetric.com/details/640340,https://api.altmetric.com/v1/donut/640340_240.png 9,"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types",Cancer Discovery,,,Article,2016-07-20,10.1158/2159-8290.cd-15-1227,,,,27432226,,,,,,,0,0,0,15,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/9805907,https://api.altmetric.com/v1/donut/9805907_240.png 9,Researchers Link Early Hair Loss and Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt246,,,,23956452,,,,,,,0,0,0,15,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1695761,https://api.altmetric.com/v1/donut/1695761_240.png 9,The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine,PLoS ONE,,,Article,2010-10-13,10.1371/journal.pone.0013363,,,,20967219,PMC2954177,,,,,,0,1,0,0,0,0,0,2,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/1434707,https://api.altmetric.com/v1/donut/1434707_240.png 9,"Re: 10-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer",European Urology,,,Article,2016-11-01,10.1016/j.eururo.2016.10.037,,,,,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13320538,https://api.altmetric.com/v1/donut/13320538_240.png 9,The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer,British Journal of Cancer,,,Article,2014-08-07,10.1038/bjc.2014.428,,,,25101567,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2581876,https://api.altmetric.com/v1/donut/2581876_240.png 9,Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening,Annals of Internal Medicine,,,Article,2013-01-01,10.7326/0003-4819-158-11-201306040-00008,,,,23732716,,,,,,,0,0,0,17,0,0,1,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1529247,https://api.altmetric.com/v1/donut/1529247_240.png 9,The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer,Oncologist,,,Article,2016-05-05,10.1634/theoncologist.2015-0336,,,,27151655,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7539853,https://api.altmetric.com/v1/donut/7539853_240.png 9,YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer,Nature Communications,,,Article,2015-09-01,10.1038/ncomms9126,,,,,,,,,,,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,12,https://www.altmetric.com/details/4476347,https://api.altmetric.com/v1/donut/4476347_240.png 9,A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer,Implementation Science,,,Article,2016-09-02,10.1186/s13012-016-0484-5,,,,27590603,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11196123,https://api.altmetric.com/v1/donut/11196123_240.png 9,Docetaxel Activity in the Era of Life-prolonging Hormonal Therapies for Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-05-14,10.1016/j.eururo.2016.05.002,,,,27184379,,,,,,,0,0,0,14,0,0,3,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/7463995,https://api.altmetric.com/v1/donut/7463995_240.png 9,Re: Benign Prostatic Hyperplasia is a Significant Risk Factor for Bladder Cancer in Diabetic Patients: A Population-Based Cohort Study Using the National Health Insurance in Taiwan,The Journal of Urology,,,Article,,10.1016/j.juro.2013.10.010,,,,24331477,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2104110,https://api.altmetric.com/v1/donut/2104110_240.png 9,Physical activity as a risk factor for prostate cancer diagnosis: a prospective biopsy cohort analysis.,British Journal of Urology,,,Article,2015-06-06,10.1111/bju.13157,,,,25908534,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3949240,https://api.altmetric.com/v1/donut/3949240_240.png 9,"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.",CA: A Cancer Journal for Clinicians ,,,Article,2016-02-13,,,,,4625049,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3108793,https://api.altmetric.com/v1/donut/3108793_240.png 9,Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database,Journal of Medical Genetics,,,Article,2012-05-01,10.1136/jmedgenet-2011-100290,,,,22581973,,,,,,,0,1,0,3,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/739338,https://api.altmetric.com/v1/donut/739338_240.png 9,Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review,European Urology,,,Article,2015-12-13,10.1016/j.eururo.2015.11.023,,,,26691493,,,,,,,0,0,0,13,0,0,2,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/4871605,https://api.altmetric.com/v1/donut/4871605_240.png 9,Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-12-01,,,,,26637918,,,,,,,1,0,0,5,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4852320,https://api.altmetric.com/v1/donut/4852320_240.png 9,Men with a negative real?time MRI/ultrasound?fusion guided targeted biopsy but prostate cancer detection on TRUS?guided random biopsy – what are the reasons for targeted biopsy failure?,British Journal of Urology,,,Article,2015-09-01,10.1111/bju.13327,,,,26384851,,,,,,,0,4,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4534380,https://api.altmetric.com/v1/donut/4534380_240.png 9,Prostate Cancer Death of Men Treated With Initial Active Surveillance: Clinical and Biochemical Characteristics,The Journal of Urology,,,Article,2010-01-07,10.1016/j.juro.2010.03.041,,,,20478589,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2386716,https://api.altmetric.com/v1/donut/2386716_240.png 9,Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance,European Urology,,,Article,,10.1016/j.eururo.2014.02.051,,,,24630416,,,,,,,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2162770,https://api.altmetric.com/v1/donut/2162770_240.png 9,Commentary: On the incidence of histological prostate cancer and the probable diagnosis of cases with tumours too small to produce symptoms or to attract attention on physical examination—the findings of Dr Arnold Rice Rich,International Journal of Epidemiology,,,Article,2007-01-01,10.1093/ije/dym053,,,,17440029,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2019041,https://api.altmetric.com/v1/donut/2019041_240.png 9,Genetic factors regulating inflammation and DNA methylation associated with prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2012-07-31,10.1038/pcan.2012.30,,,,22850906,,,,,,,0,1,0,3,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/869289,https://api.altmetric.com/v1/donut/869289_240.png 9,Lack of Association between Y-Chromosomal Haplogroups and Prostate Cancer in the Korean Population,PLoS ONE,,,Article,2007-01-24,10.1371/journal.pone.0000172,,,,17245448,PMC1766463,,2007PLoSO...2..172K,,,,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/122937,https://api.altmetric.com/v1/donut/122937_240.png 9,Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-10-2349,,,,21233334,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,77,https://www.altmetric.com/details/1483736,https://api.altmetric.com/v1/donut/1483736_240.png 9,Second to fourth digit ratio: a predictor of prostate?specific antigen level and the presence of prostate cancer,British Journal of Urology,,,Article,2011-02-01,10.1111/j.1464-410x.2010.09490.x,,,,20633006,,,,,,,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/215864,https://api.altmetric.com/v1/donut/215864_240.png 9,The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.,European Urology,,,Article,2015-11-02,10.1016/j.eururo.2015.10.030,,,,26525837,,,,,,,0,0,0,15,0,0,4,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4866025,https://api.altmetric.com/v1/donut/4866025_240.png 9,Expectant management of veterans with early-stage prostate cancer.,Cancer (0008543X),,,Article,2015-11-01,10.1002/cncr.29785,,,,26540451,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4728842,https://api.altmetric.com/v1/donut/4728842_240.png 9,Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2.,Acta Oncologica,,,Article,2015-09-12,10.3109/0284186x.2015.1067714,,,,26360800,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4499757,https://api.altmetric.com/v1/donut/4499757_240.png 9,Relationship of Dietary Intake of Omega-3 and Omega-6 Fatty Acids with Risk of Prostate Cancer Development: A Meta-Analysis of Prospective Studies and Review of Literature,Prostate Cancer,,,Article,2013-01-13,10.1155/2012/826254,,,,23193480,,,,,,,0,0,1,6,0,0,3,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1173327,https://api.altmetric.com/v1/donut/1173327_240.png 9,XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH.,Urology,,,Article,2010-01-04,10.1016/j.urology.2010.01.038,,,,20371060,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1485554,https://api.altmetric.com/v1/donut/1485554_240.png 9,Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy,Clinical Epigenetics,,,Article,2016-09-15,10.1186/s13148-016-0260-z,,,,27651837,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12017509,https://api.altmetric.com/v1/donut/12017509_240.png 9,Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease,European Urology,,,Article,2016-09-03,10.1016/j.eururo.2016.08.055,,,,27597240,,,,,,,0,0,0,20,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11672144,https://api.altmetric.com/v1/donut/11672144_240.png 9,Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment?,European Urology,,,Article,2015-02-27,10.1016/j.eururo.2015.02.020,,,,25736732,,,,,,,0,0,0,14,0,0,5,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/3740403,https://api.altmetric.com/v1/donut/3740403_240.png 9,Identifying Optimal Candidates for Local Treatment of the Primary Tumor Among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-based Study.,European Urology,,,Article,,10.1016/j.eururo.2014.08.056,,,,25217422,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2670470,https://api.altmetric.com/v1/donut/2670470_240.png 9,The Role of Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection in the Management of High-risk Prostate Cancer: A Systematic Review,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.05.026,,,,,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2274833,https://api.altmetric.com/v1/donut/2274833_240.png 9,"Phase II Trial of Docetaxel, Bevacizumab, Lenalidomide, and Prednisone in Patients With Metastatic Castration?Resistant Prostate Cancer",British Journal of Urology,,,Article,2016-01-01,10.1111/bju.13412,,,,26780387,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5084890,https://api.altmetric.com/v1/donut/5084890_240.png 9,"The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions.",Journal of Nuclear Medicine,,,Article,2015-08-22,10.2967/jnumed.115.161299,,,,26294298,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/4424236,https://api.altmetric.com/v1/donut/4424236_240.png 9,Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Detected by 11C-Choline Positron Emission Tomography/Computed Tomography.,The Journal of Urology,,,Article,2014-08-27,10.1016/j.juro.2014.08.082,,,,25150640,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2652738,https://api.altmetric.com/v1/donut/2652738_240.png 9,Primary Gleason Grade 4 at the Positive Margin Is Associated with Metastasis and Death Among Patients with Gleason 7 Prostate Cancer Undergoing Radical Prostatectomy,European Urology,,,Article,2014-07-19,10.1016/j.eururo.2014.07.004,,,,25052213,,,,,,,0,0,0,12,0,0,0,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/2539956,https://api.altmetric.com/v1/donut/2539956_240.png 9,No association of germline alteration of MSR1 with prostate cancer risk.,Nature Genetics,,,Article,2003-09-07,10.1038/ng1239,,,,,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1376479,https://api.altmetric.com/v1/donut/1376479_240.png 9,A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells,Genome Research,,,Article,2013-01-01,10.1101/gr.144774.112,,,,23403032,,,,,,,0,1,0,7,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1236150,https://api.altmetric.com/v1/donut/1236150_240.png 9,Multiple regions within 8q24 independently affect risk for prostate cancer,Nature Genetics,,,Article,2007-04-01,10.1038/ng2015,,,,17401364,PMC2638766,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,115,https://www.altmetric.com/details/125443,https://api.altmetric.com/v1/donut/125443_240.png 9,"New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature",European Urology,,,Article,2016-02-03,10.1016/j.eururo.2016.01.029,,,,26850970,,,,,,,0,0,0,12,0,0,2,1,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/5081461,https://api.altmetric.com/v1/donut/5081461_240.png 9,Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1? signaling.,International Journal of Oncology,,,Article,2015-10-27,10.3892/ijo.2015.3202,,,,26499200,,,,,,,0,0,0,10,0,0,7,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4679409,https://api.altmetric.com/v1/donut/4679409_240.png 9,Targeting the Mechanisms of Progression in Castration-resistant Prostate Cancer,European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.11.024,,,,25465967,,,,,,,0,0,0,15,0,0,0,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/2914265,https://api.altmetric.com/v1/donut/2914265_240.png 9,PSA screening for prostate cancer,British Medical Journal,,,Article,2014-04-15,10.1136/bmj.g2559,,,,24736396,,,,,,,0,0,0,11,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/2285158,https://api.altmetric.com/v1/donut/2285158_240.png 9,Repurposing to Fight Cancer: The Metformin–Prostate Cancer Connection,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dju030,,,,24511112,,,,,,,0,0,0,14,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2107285,https://api.altmetric.com/v1/donut/2107285_240.png 9,Study changes how physicians treat metastatic prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28314,,,,24037668,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1699712,https://api.altmetric.com/v1/donut/1699712_240.png 9,Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate lyase signaling.,Oncotarget,,,Article,2014-07-02,10.18632/oncotarget.2138,,,,24980815,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3224683,https://api.altmetric.com/v1/donut/3224683_240.png 9,"Blood Magnesium, and the Interaction with Calcium, on the Risk of High-Grade Prostate Cancer",PLoS ONE,,,Article,2011-04-25,10.1371/journal.pone.0018237,,,,21541018,,,2011PLoSO...6E8237D,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1449846,https://api.altmetric.com/v1/donut/1449846_240.png 9,Loss of TGF-? Responsiveness in Prostate Stromal Cells Alters Chemokine Levels and Facilitates the Development of Mixed Osteoblastic/Osteolytic Bone Lesions,Molecular Cancer Research,,,Article,2012-02-02,10.1158/1541-7786.mcr-11-0506,,,,22290877,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/858449,https://api.altmetric.com/v1/donut/858449_240.png 9,Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA,Clinical Nutrition,,,Article,2016-06-01,10.1016/j.clnu.2016.06.014,,,,27406859,,,,,,,0,0,0,10,0,0,6,0,0,0,1,0,0,0,0,24,https://www.altmetric.com/details/9720463,https://api.altmetric.com/v1/donut/9720463_240.png 9,VPAC1 Targeted (64)Cu-TP3805 PET Imaging of Prostate Cancer: Preliminary Evaluation in Man.,Urology,,,Article,2015-11-01,10.1016/j.urology.2015.10.012,,,,26519886,,,,,,,1,0,0,6,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4699093,https://api.altmetric.com/v1/donut/4699093_240.png 9,Laparoscopic extended pelvic lymph node dissection as validation of the performance of [(11) C]-acetate-PET/CT in detection of lymph node metastasis in intermediate and high-risk prostate cancer.,British Journal of Urology,,,Article,2015-06-16,10.1111/bju.13202,,,,26074275,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4167438,https://api.altmetric.com/v1/donut/4167438_240.png 9,Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model.,Journal for Immunotherapy of Cancer,,,Article,2015-01-01,10.1186/s40425-015-0056-2,,,,25901284,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4024603,https://api.altmetric.com/v1/donut/4024603_240.png 9,Long-term Safety and Antitumor Activity in the Phase 1–2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer,European Urology,,,Article,2015-02-16,10.1016/j.eururo.2015.01.026,,,,25698064,,,,,,,0,0,0,17,0,0,3,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/3705208,https://api.altmetric.com/v1/donut/3705208_240.png 9,Endostatin: A novel inhibitor of androgen receptor function in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-02-03,10.1073/pnas.1417660112,,,,25605930,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/3388742,https://api.altmetric.com/v1/donut/3388742_240.png 9,Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends,JNCI: Journal of the National Cancer Institute,,,Article,2015-10-09,10.1093/jnci/94.13.981,,,,12096083,,,,,,,0,2,0,2,0,0,1,0,0,0,0,0,0,0,0,76,https://www.altmetric.com/details/3051393,https://api.altmetric.com/v1/donut/3051393_240.png 9,Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic,Cancer (0008543X),,,Article,2014-12-23,10.1002/cncr.29215,,,,25538017,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3022683,https://api.altmetric.com/v1/donut/3022683_240.png 9,The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam Radiotherapy,European Urology,,,Article,2014-10-08,10.1016/j.eururo.2014.09.028,,,,25308970,,,,,,,0,0,0,23,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2756609,https://api.altmetric.com/v1/donut/2756609_240.png 9,"Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor–Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and Xenografts",Cancer Research,,,Article,2007-02-15,10.1158/0008-5472.can-06-3546,,,,17308104,,,,,,,1,0,0,0,0,0,5,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2351582,https://api.altmetric.com/v1/donut/2351582_240.png 9,Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,1996-08-21,,,,,8757191,,,,,,,0,1,0,0,0,0,1,2,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1647763,https://api.altmetric.com/v1/donut/1647763_240.png 9,Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2011-05-28,,,,,21617228,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1611315,https://api.altmetric.com/v1/donut/1611315_240.png 9,Zinc as an anti-tumor agent in prostate cancer and in other cancers ,Archives of Biochemistry & Biophysics,,,Article,2007-04-04,10.1016/j.abb.2007.02.033,,,,17400177,PMC1991338,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/1118508,https://api.altmetric.com/v1/donut/1118508_240.png 9,The Impact of Serial Prostate Biopsies on Sexual Function in Men on Active Surveillance for Prostate Cancer.,The Journal of Urology,,,Article,2012-08-17,10.1016/j.juro.2012.06.013,,,,22902015,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/892545,https://api.altmetric.com/v1/donut/892545_240.png 9,Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials ,Radiotherapy & Oncology,,,Article,2016-01-01,10.1016/j.radonc.2015.12.020,,,,26796591,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4988194,https://api.altmetric.com/v1/donut/4988194_240.png 9,Resistance Training Reduces Disability in Prostate Cancer Survivors on Androgen Deprivation Therapy: Evidence From a Randomized Controlled Trial,Archives of Physical Medicine & Rehabilitation,,,Article,2015-01-01,10.1016/j.apmr.2014.08.010,,,,25194450,,,,,,,0,0,0,9,0,0,6,0,2,0,0,0,0,0,0,27,https://www.altmetric.com/details/2670132,https://api.altmetric.com/v1/donut/2670132_240.png 9,Predictors of Pathologic Progression on Biopsy Among Men on Active Surveillance for Localized Prostate Cancer: The Value of the Pattern of Surveillance Biopsies,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.060,,,,24035632,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2367981,https://api.altmetric.com/v1/donut/2367981_240.png 9,"Allium vegetables and risk of prostate cancer: evidence from 132,192 subjects.",Asian Pacific Journal of Cancer Prevention,,,Article,2013-09-03,,,,,23991965,,,,,,,0,0,0,8,0,0,5,0,0,0,1,0,0,0,0,0,https://www.altmetric.com/details/1732021,https://api.altmetric.com/v1/donut/1732021_240.png 9,Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-08-20,10.1073/pnas.1300013110,,,,23918357,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1701458,https://api.altmetric.com/v1/donut/1701458_240.png 9,Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70473-4,,,,23142059,,,,,,,0,0,3,8,0,0,2,0,0,0,0,0,0,0,0,86,https://www.altmetric.com/details/1056911,https://api.altmetric.com/v1/donut/1056911_240.png 9,Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70006-2,,,,22326924,,,,,,,0,0,0,7,0,0,0,1,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/607315,https://api.altmetric.com/v1/donut/607315_240.png 9,No Association of Xenotropic Murine Leukemia Virus-Related Viruses with Prostate Cancer,PLoS ONE,,,Article,2011-01-01,10.1371/journal.pone.0019065,,,,21573232,PMC3087753,,2011PLoSO...6E9065S,,,,0,1,0,1,0,0,0,0,0,0,1,0,0,0,0,9,https://www.altmetric.com/details/186055,https://api.altmetric.com/v1/donut/186055_240.png 9,The psychological impact of undergoing genetic?risk profiling in men with a family history of prostate cancer,Psycho-Oncology,,,Article,2015-04-14,10.1002/pon.3814,,,,25872100,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3928058,https://api.altmetric.com/v1/donut/3928058_240.png 9,Prostate specific antigen for early detection of prostate cancer: longitudinal study,British Medical Journal,,,Article,2009-09-24,10.1136/bmj.b3537,,,,,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/1371206,https://api.altmetric.com/v1/donut/1371206_240.png 9,"Cancer-specific mortality in men diagnosed with prostate cancer before age 50 years, a nationwide population-based study",The Journal of Urology,,,Article,2016-06-17,10.1016/j.juro.2016.06.080,,,,27328367,,,,,,,0,0,0,19,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8848536,https://api.altmetric.com/v1/donut/8848536_240.png 9,A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk,Cancer Research,,,Article,2016-02-26,10.1158/0008-5472.can-15-1551,,,,26921328,,,,,,,0,0,0,14,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6012342,https://api.altmetric.com/v1/donut/6012342_240.png 9,Re: Long-Term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate Cancer,The Journal of Urology,,,Article,2015-10-20,10.1016/j.juro.2015.08.058,,,,26478031,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4398734,https://api.altmetric.com/v1/donut/4398734_240.png 9,Prostate Cancer Survivorship Care Guidelines: American Society of Clinical Oncology Practice Guideline Endorsement.,Journal of Oncology Practice,,,Article,2015-04-02,10.1200/jop.2015.004606,,,,25829527,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3859255,https://api.altmetric.com/v1/donut/3859255_240.png 9,Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer.,Brachytherapy,,,Article,2012-01-18,10.1016/j.brachy.2011.12.003,,,,22244438,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3612978,https://api.altmetric.com/v1/donut/3612978_240.png 9,MRl of Prostate Cancer Antigen Expression for Diagnosis and lmmunotherapy,PLoS ONE,,,Article,2012-06-27,10.1371/journal.pone.0038350,,,,22761679,PMC3384648,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/829952,https://api.altmetric.com/v1/donut/829952_240.png 9,Erectile function status is highly associated with prostate?specific antigen bounce in localized prostate cancer patients treated with permanent prostate brachytherapy,International Journal of Urology,,,Article,2015-12-01,10.1111/iju.13029,,,,26663514,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4889240,https://api.altmetric.com/v1/donut/4889240_240.png 9,Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis,Annals of Oncology,,,Article,2014-11-17,10.1093/annonc/mdu525,,,,25403590,,,,,,,0,0,0,17,0,0,0,0,0,0,2,0,0,0,0,6,https://www.altmetric.com/details/2905057,https://api.altmetric.com/v1/donut/2905057_240.png 9,"The impact of bone mineral density testing, fracture assessment, and osteoporosis education in men treated by androgen deprivation for prostate cancer: a pilot study",Supportive Care in Cancer,,,Article,2014-04-05,10.1007/s00520-014-2183-6,,,,24696083,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2746834,https://api.altmetric.com/v1/donut/2746834_240.png 9,A systematic review: Effectiveness of rectal emptying preparation in prostate cancer patients,Practical Radiation Oncology,,,Article,2014-11-01,10.1016/j.prro.2014.06.005,,,,25407867,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2633561,https://api.altmetric.com/v1/donut/2633561_240.png 9,Cost-effectiveness of Magnetic Resonance (MR) Imaging and MR-guided Targeted Biopsy Versus Systematic Transrectal Ultrasound–Guided Biopsy in Diagnosing Prostate Cancer: A Modelling Study from a Health Care Perspective,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.12.012,,,,24377803,,,,,,,0,0,0,10,0,0,0,1,0,0,0,0,0,0,0,89,https://www.altmetric.com/details/2124832,https://api.altmetric.com/v1/donut/2124832_240.png 9,A review of physical activity and prostate cancer risk.,Cancer Causes and Control,,,Article,2001-06-01,,,,,11545461,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11990784,https://api.altmetric.com/v1/donut/11990784_240.png 9,Nested case–control study of occupational physical activity and prostate cancer among workers using a job exposure matrix,Cancer Causes and Control,,,Article,2008-02-01,10.1007/s10552-007-9076-7,,,,18064535,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11990782,https://api.altmetric.com/v1/donut/11990782_240.png 9,Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression,Current Drug Targets,,,Article,2013-04-01,,,,,23410127,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2659476,https://api.altmetric.com/v1/donut/2659476_240.png 9,False-positive screening results in the Finnish prostate cancer screening trial,British Journal of Cancer,,,Article,2010-01-05,10.1038/sj.bjc.6605512,,,,20051951,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1386107,https://api.altmetric.com/v1/donut/1386107_240.png 9,"Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.",British Journal of Urology,,,Article,2002-07-01,,,,,12081758,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/1386091,https://api.altmetric.com/v1/donut/1386091_240.png 9,"Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.",American Journal of Clinical Nutrition,,,Article,2007-01-09,,,,,17823432,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1386074,https://api.altmetric.com/v1/donut/1386074_240.png 9,Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.,European Journal of Cancer (1965),,,Article,2008-04-01,10.1016/j.ejca.2008.02.020,,,,18343654,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1386006,https://api.altmetric.com/v1/donut/1386006_240.png 9,Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2008-01-01,10.1093/jnci/djn150,,,,18505969,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,77,https://www.altmetric.com/details/1385997,https://api.altmetric.com/v1/donut/1385997_240.png 9,TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer,Cancer Research,,,Article,2006-01-01,10.1158/0008-5472.can-06-1482,,,,16951139,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,91,https://www.altmetric.com/details/463400,https://api.altmetric.com/v1/donut/463400_240.png 9,Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.,Nature Genetics,,,Article,2009-09-20,10.1038/ng.448,,,,19767754,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/413743,https://api.altmetric.com/v1/donut/413743_240.png 9,Multiple loci on 8q24 associated with prostate cancer susceptibility.,Nature Genetics,,,Article,2009-09-20,10.1038/ng.452,,,,19767752,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/413742,https://api.altmetric.com/v1/donut/413742_240.png 9,Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.,Nature Genetics,,,Article,2009-09-20,10.1038/ng.450,,,,19767753,PMC2846760,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,84,https://www.altmetric.com/details/413741,https://api.altmetric.com/v1/donut/413741_240.png 9,Hypoxia in prostate cancer: a powerful shield against tumour destruction?,Cancer treatment reviews,,,Article,2008-06-01,10.1016/j.ctrv.2008.01.006,,,,18334284,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/412986,https://api.altmetric.com/v1/donut/412986_240.png 9,Body Size and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2008-11-01,10.1158/1055-9965.epi-08-0609,,,,18990768,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/412740,https://api.altmetric.com/v1/donut/412740_240.png 9,Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer.,"International journal of radiation oncology, biology, physics",,,Article,2004-09-01,10.1016/j.ijrobp.2004.02.022,,,,15337535,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/408824,https://api.altmetric.com/v1/donut/408824_240.png 9,Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial,Lancet Oncology,,,Article,2011-05-01,10.1016/s1470-2045(11)70063-8,,,,21440505,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,94,https://www.altmetric.com/details/408823,https://api.altmetric.com/v1/donut/408823_240.png 9,Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome,Oncogene,,,Article,2004-06-07,10.1038/sj.onc.1207800,,,,15184867,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/408340,https://api.altmetric.com/v1/donut/408340_240.png 9,Trials of prostate-cancer screening are not worthwhile,The Lancet Oncology,,,Article,2009-03-01,10.1016/s1470-2045(09)70066-x,,,,19261258,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/408293,https://api.altmetric.com/v1/donut/408293_240.png 9,"Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer.",Journal of medicinal chemistry,,,Article,1995-06-23,,,,,7608911,,,,,,,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/109729,https://api.altmetric.com/v1/donut/109729_240.png 9,Prostate Cancer in Nigerians: Facts and Nonfacts,The Journal of Urology,,,Article,1997-01-04,10.1016/s0022-5347(01)64966-8,,,,9120935,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3174034,https://api.altmetric.com/v1/donut/3174034_240.png 9,Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance,British Journal of Radiology,,,Article,2011-01-01,10.1259/bjr/14556365,,,,21172965,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1022394,https://api.altmetric.com/v1/donut/1022394_240.png 9,Mouse Models of Prostate Cancer,Prostate Cancer,,,Article,2011-01-01,10.1155/2011/895238,,,,22111002,PMC3221286,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,101,https://www.altmetric.com/details/575451,https://api.altmetric.com/v1/donut/575451_240.png 9,Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition,American Journal of Clinical Nutrition,,,Article,2008-01-01,10.3945/ajcn.2008.26369,,,,18996872,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1392627,https://api.altmetric.com/v1/donut/1392627_240.png 9,Increased Fall Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer,Urology,,,Article,2016-06-15,10.1016/j.urology.2016.05.058,,,,27318262,,,,,,,0,0,0,16,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8775008,https://api.altmetric.com/v1/donut/8775008_240.png 9,Hypofractionated radiation therapy versus conventional radiation therapy in prostate cancer: A systematic review of its safety and efficacy.,Actas Urológicas Españolas,,,Article,2015-02-05,10.1016/j.acuro.2014.12.005,,,,25660427,,,,,,,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4536183,https://api.altmetric.com/v1/donut/4536183_240.png 9,Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer.,Cancer (0008543X),,,Article,2011-01-01,10.1002/cncr.25291,,,,20803609,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/4194869,https://api.altmetric.com/v1/donut/4194869_240.png 9,A Genome-wide Pleiotropy Scan for Prostate Cancer Risk,European Urology,,,Article,2014-09-28,10.1016/j.eururo.2014.09.020,,,,25277271,,,,,,,0,0,0,23,0,0,0,0,1,0,0,0,0,0,0,20,https://www.altmetric.com/details/2725954,https://api.altmetric.com/v1/donut/2725954_240.png 9,Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer,European Urology,,,Article,2015-07-01,10.1016/j.eururo.2014.08.010,,,,25151013,,,,,,,0,0,0,11,0,0,1,0,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/2614050,https://api.altmetric.com/v1/donut/2614050_240.png 9,Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression,Oncogene,,,Article,2013-06-03,10.1038/onc.2013.191,,,,23728338,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,104,https://www.altmetric.com/details/2194337,https://api.altmetric.com/v1/donut/2194337_240.png 9,Prostate cancer stem cells,The Journal of Pathology,,,Article,2009-01-01,10.1002/path.2478,,,,19040209,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1937321,https://api.altmetric.com/v1/donut/1937321_240.png 9,Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis,PLoS ONE,,,Article,2013-06-18,10.1371/journal.pone.0065651,,,,23824286,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10056759,https://api.altmetric.com/v1/donut/10056759_240.png 9,Dietary tomato and lycopene impact androgen signaling- and carcinogenesis-related gene expression during early TRAMP prostate carcinogenesis.,Cancer Prevention Research,,,Article,2014-10-13,10.1158/1940-6207.capr-14-0182,,,,25315431,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2942757,https://api.altmetric.com/v1/donut/2942757_240.png 9,"Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers.",Carcinogenesis,,,Article,2004-01-01,10.1093/carcin/bgh116,,,,14976130,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2006539,https://api.altmetric.com/v1/donut/2006539_240.png 9,Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery.,Molecular Cancer Therapeutics,,,Article,2004-08-11,,,,,15299076,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1662165,https://api.altmetric.com/v1/donut/1662165_240.png 9,Phase transitions in tumor growth: II prostate cancer cell lines,bioRxiv,,,Article,2014-11-06,10.1101/011189,,,,,,,,,,,0,1,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2860808,https://api.altmetric.com/v1/donut/2860808_240.png 9,Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born,Therapeutic Advances in Urology,,,Article,2012-08-01,10.1177/1756287212452196,,,,22852027,PMC3398601,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1911524,https://api.altmetric.com/v1/donut/1911524_240.png 9,Castration-refractory prostate cancer: New drugs in the pipeline,Advances in Therapy,,,Article,2010-06-04,10.1007/s12325-010-0038-1,,,,,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/106704,https://api.altmetric.com/v1/donut/106704_240.png 9,"Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry",British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12509,,,,24128010,,11343/44059,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1829057,https://api.altmetric.com/v1/donut/1829057_240.png 8,"Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells.",Journal of Medicinal Chemistry,,,Article,2001-12-20,,,,,11741487,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/10744154,https://api.altmetric.com/v1/donut/10744154_240.png 8,Enzymatic activation of prodrugs by prostate-specific antigen: targeted therapy for metastatic prostate cancer.,Cancer Journal from Scientific American,,,Article,1998-05-01,,,,,9619266,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10744153,https://api.altmetric.com/v1/donut/10744153_240.png 8,Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,,,,,,12837835,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/10744152,https://api.altmetric.com/v1/donut/10744152_240.png 8,Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis,Cancer (0008543X),,,Article,2016-07-26,10.1002/cncr.30192,,,,27459245,,,,,,,1,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10103081,https://api.altmetric.com/v1/donut/10103081_240.png 8,Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage,World Journal of Urology,,,Article,2016-05-04,10.1007/s00345-016-1838-y,,,,27147512,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9149599,https://api.altmetric.com/v1/donut/9149599_240.png 8,Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model,PLoS ONE,,,Article,2016-06-03,10.1371/journal.pone.0155856,,,,27258119,PMC4892614,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8511764,https://api.altmetric.com/v1/donut/8511764_240.png 8,Improving multivariable prostate cancer risk assessment using the Prostate Health Index,British Journal of Urology,,,Article,2016-03-01,10.1111/bju.13143,,,,25847734,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5942759,https://api.altmetric.com/v1/donut/5942759_240.png 8,The implementation of screening for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2010-08-03,10.1038/pcan.2010.14,,,,20680029,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5055746,https://api.altmetric.com/v1/donut/5055746_240.png 8,Enzalutamide: targeting the androgen signalling pathway in metastatic castration?resistant prostate cancer,British Journal of Urology,,,Article,2015-06-06,10.1111/bju.13123,,,,25818596,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/5052979,https://api.altmetric.com/v1/donut/5052979_240.png 8,International trends and patterns of prostate cancer incidence and mortality,International Journal of Cancer,,,Article,2000-01-01,10.1002/(sici)1097-0215(20000101)85:1<60::aid-ijc11>3.0.co;2-b,,,,,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4795126,https://api.altmetric.com/v1/donut/4795126_240.png 8,Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer.,Magnetic resonance imaging clinics of North America,,,Article,2015-10-28,10.1016/j.mric.2015.05.014,,,,26499278,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4694753,https://api.altmetric.com/v1/donut/4694753_240.png 8,Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.,Molecular Imaging & Biology,,,Article,2015-05-27,10.1007/s11307-015-0866-0,,,,26013479,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4534273,https://api.altmetric.com/v1/donut/4534273_240.png 8,"HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.",Oncology Reports,,,Article,,10.3892/or.2015.4085,,,,26135141,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4469240,https://api.altmetric.com/v1/donut/4469240_240.png 8,Depression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot Study,Psycho-Oncology,,,Article,2002-12-10,10.1002/pon.592,,,,,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4048135,https://api.altmetric.com/v1/donut/4048135_240.png 8,The Relationship Between Prostate Specific Antigen Change and Biopsy Progression in Patients on Active Surveillance for Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2010.12.042,,,,21419438,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3674819,https://api.altmetric.com/v1/donut/3674819_240.png 8,The influence of family history on prostate cancer risk: implications for clinical management,British Journal of Urology,,,Article,2010-12-16,10.1111/j.1464-410x.2010.10024.x,,,,21166744,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078564,https://api.altmetric.com/v1/donut/3078564_240.png 8,Anxiety and distress during active surveillance for early prostate cancer,Cancer (0008543X),,,Article,2009-07-27,10.1002/cncr.24446,,,,19637245,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/3077679,https://api.altmetric.com/v1/donut/3077679_240.png 8,Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2008-05-09,10.1007/s00259-008-0788-z,,,,18465129,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/3012719,https://api.altmetric.com/v1/donut/3012719_240.png 8,Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer|[mdash]|what has gone wrong|[quest]| A blueprint for the way forward in biomarker studies,British Journal of Cancer,,,Article,2014-11-25,10.1038/bjc.2014.588,,,,25422912,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/2929097,https://api.altmetric.com/v1/donut/2929097_240.png 8,Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population,Prostate Cancer & Prostatic Diseases,,,Article,2014-10-14,10.1038/pcan.2014.38,,,,25311766,,,,,,,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2775411,https://api.altmetric.com/v1/donut/2775411_240.png 8,Clinical utility of 18 F-fluorocholine PET-CT in biochemical relapse of prostate cancer after radical treatment. Results of a multicentre study.,British Journal of Urology,,,Article,2015-01-21,10.1111/bju.12953,,,,25307619,,,,,,,0,3,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2768240,https://api.altmetric.com/v1/donut/2768240_240.png 8,Hospital admissions after transrectal ultrasound?guided biopsy of the prostate in men diagnosed with prostate cancer: A database analysis in England,International Journal of Urology,,,Article,2014-09-28,10.1111/iju.12634,,,,25257575,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2732287,https://api.altmetric.com/v1/donut/2732287_240.png 8,"The impact of prostate?specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate",Cancer (0008543X),,,Article,2008-01-01,10.1002/cncr.23235,,,,18098207,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2590722,https://api.altmetric.com/v1/donut/2590722_240.png 8,Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis,European Urology,,,Article,2014-08-07,10.1016/j.eururo.2014.07.028,,,,25108579,,,,,,,0,0,0,10,0,0,1,0,1,0,0,0,0,0,0,34,https://www.altmetric.com/details/2577739,https://api.altmetric.com/v1/donut/2577739_240.png 8,Fatherhood and incident prostate cancer in a prospective US cohort,International Journal of Epidemiology,,,Article,2011-01-04,10.1093/ije/dyq163,,,,20959354,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2438181,https://api.altmetric.com/v1/donut/2438181_240.png 8,Reduced risk of prostate cancer in men who are childless as compared to those who have fathered a child: A population based case?control study,International Journal of Cancer,,,Article,2005-01-01,10.1002/ijc.20963,,,,15729731,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2438180,https://api.altmetric.com/v1/donut/2438180_240.png 8,Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells.,Biofactors,,,Article,2005-09-24,,,,,16179751,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2340439,https://api.altmetric.com/v1/donut/2340439_240.png 8,Malignant Transformation of Cells Derived from Mouse Prostate by Epoxides and Other Derivatives of Polycyclic Hydrocarbons,Cancer Research,,,Article,1972-01-01,,,,,5014782,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2313866,https://api.altmetric.com/v1/donut/2313866_240.png 8,Body Size and Prostate Cancer: A 20-Year Follow-up Study Among 135006 Swedish Construction Workers,JNCI: Journal of the National Cancer Institute,,,Article,1997-01-01,10.1093/jnci/89.5.385,,,,9060961,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2313864,https://api.altmetric.com/v1/donut/2313864_240.png 8,2061 THE IMPACT OF RECENT SCREENING RECOMMENDATIONS ON PROSTATE CANCER SCREENING IN A LARGE HEALTH SYSTEM,The Journal of Urology,,,Article,,10.1016/j.juro.2013.02.2480,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2200440,https://api.altmetric.com/v1/donut/2200440_240.png 8,Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer,Oncotarget,,,Article,2013-11-23,10.18632/oncotarget.1586,,,,24353195,PMC3926840,,,,,,0,0,0,8,0,0,3,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1998017,https://api.altmetric.com/v1/donut/1998017_240.png 8,Anti-Oxidants from Green Tea and Pomegranate for Chemoprevention of Prostate Cancer,Molecular Biotechnology,,,Article,2007-08-04,10.1007/s12033-007-0047-8,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1930845,https://api.altmetric.com/v1/donut/1930845_240.png 8,|[lsqb]|-2|[rsqb]|proPSA is an early marker for prostate cancer aggressiveness,Prostate Cancer & Prostatic Diseases,,,Article,2013-10-29,10.1038/pcan.2013.50,,,,24165692,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1873945,https://api.altmetric.com/v1/donut/1873945_240.png 8,Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment,European Urology,,,Article,2013-09-27,10.1016/j.eururo.2013.09.025,,,,24094576,,,,,,,0,0,0,13,0,0,0,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/1866233,https://api.altmetric.com/v1/donut/1866233_240.png 8,"Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer",JAMA: Journal of the American Medical Association,,,Article,1998-01-01,10.1001/jama.280.11.969,,,,,,,,,,,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1732507,https://api.altmetric.com/v1/donut/1732507_240.png 8,Can one blood draw replace transrectal ultrasonography?estimated prostate volume to predict prostate cancer risk?,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11690.x,,,,23448270,,,,,,,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1730617,https://api.altmetric.com/v1/donut/1730617_240.png 8,Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study,European Urology,,,Article,2012-11-21,10.1016/j.eururo.2012.11.005,,,,23159452,,,,,,,0,1,0,5,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/1723216,https://api.altmetric.com/v1/donut/1723216_240.png 8,Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.,Journal of Clinical Oncology,,,Article,2010-02-19,10.1200/jco.2009.22.2265,,,,20159826,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/1715845,https://api.altmetric.com/v1/donut/1715845_240.png 8,Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators,Journal of Clinical Oncology,,,Article,2011-01-01,10.1200/jco.2010.32.6371,,,,21690464,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1536335,https://api.altmetric.com/v1/donut/1536335_240.png 8,Endothelial cells enhance prostate cancer metastasis via IL6->androgen receptor->TGF?->MMP9 signals.,Molecular Cancer Therapeutics,,,Article,2013-03-30,10.1158/1535-7163.mct-12-0895,,,,23536722,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1384595,https://api.altmetric.com/v1/donut/1384595_240.png 8,Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?,Lancet Oncology,,,Article,2012-11-01,10.1016/s1470-2045(12)70388-1,,,,23117005,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1035482,https://api.altmetric.com/v1/donut/1035482_240.png 8,Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study,The Journal of Urology,,,Article,2008-09-20,10.1016/j.juro.2008.07.038,,,,18801517,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,40,https://www.altmetric.com/details/540764,https://api.altmetric.com/v1/donut/540764_240.png 8,Denosumab in men receiving androgen-deprivation therapy for prostate cancer.,New England Journal of Medicine,,,Article,2009-08-20,10.1056/nejmoa0809003,,,,19671656,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,44,https://www.altmetric.com/details/516694,https://api.altmetric.com/v1/donut/516694_240.png 8,High-risk prostate cancer: treat the prostate ,The Lancet (British Edition),,,Article,2011-11-08,10.1016/s0140-6736(11)61254-3,,,,22056154,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/438880,https://api.altmetric.com/v1/donut/438880_240.png 8,Associations between Serum Testosterone Fall and Cognitive Function in Prostate Cancer Patients,Clinical Cancer Research,,,Article,2004-11-15,10.1158/1078-0432.ccr-04-0750,,,,15569988,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/185295,https://api.altmetric.com/v1/donut/185295_240.png 8,Global histone modification patterns predict risk of prostate cancer recurrence.,Nature,,,Article,2005-06-30,10.1038/nature03672,,,,15988529,,,2005Natur.435.1262S,,,,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,211,https://www.altmetric.com/details/146386,https://api.altmetric.com/v1/donut/146386_240.png 8,Accumulating Evidence for Physical Activity and Prostate Cancer Survival: Time for a Definitive Trial of Exercise Medicine?,European Urology,,,Article,2016-05-03,10.1016/j.eururo.2016.04.018,,,,27118414,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7285956,https://api.altmetric.com/v1/donut/7285956_240.png 8,PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance,Modern Pathology,,,Article,2016-04-15,10.1038/modpathol.2016.63,,,,27080984,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6739524,https://api.altmetric.com/v1/donut/6739524_240.png 8,"Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer",JNCI: Journal of the National Cancer Institute,,,Article,2015-08-31,10.1093/jnci/djv246,,,,26319099,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4451426,https://api.altmetric.com/v1/donut/4451426_240.png 8,Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study.,Psycho-Oncology,,,Article,2015-07-01,10.1002/pon.3909,,,,26249170,,,,,,,0,0,0,16,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4371740,https://api.altmetric.com/v1/donut/4371740_240.png 8,US Food and Drug Administration Approval of Drugs for the Treatment of Prostate Cancer: A New Era Has Begun,Journal of Clinical Oncology,,,Article,2013-12-16,10.1200/jco.2013.53.9528,,,,24344221,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1986416,https://api.altmetric.com/v1/donut/1986416_240.png 8,"Associations of lower urinary tract symptoms with prostateâ??specific antigen levels, and screenâ??detected localized and advanced prostate cancer: a caseâ??control study nested within the UK populationâ??based ProtecT (Prostate testing for cancer and Treatment) study",British Journal of Urology,,,Article,2008-01-01,10.1111/j.1464-410x.2008.07817.x,,,,18540932,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1294161,https://api.altmetric.com/v1/donut/1294161_240.png 8,Recent trends in prostate cancer testing and incidence among men under age of 50.,Cancer Epidemiology,,,Article,2011-11-21,10.1016/j.canep.2011.10.014,,,,22112545,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/473473,https://api.altmetric.com/v1/donut/473473_240.png 8,Positive Pelvic Lymph Nodes in Prostate Cancer Harbor Immune Suppressor Cells To Impair Tumor-reactive T Cells,European Urology Focus ,,,Article,2016-09-01,10.1016/j.euf.2016.09.003,,,,,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12130026,https://api.altmetric.com/v1/donut/12130026_240.png 8,Rectourethral Fistulas Secondary to Prostate Cancer Treatment: Management and Outcomes from a Multi-Institutional Combined Experience,The Journal of Urology,,,Article,2016-08-18,10.1016/j.juro.2016.08.080,,,,27544625,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10672443,https://api.altmetric.com/v1/donut/10672443_240.png 8,"Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools",American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2016-01-01,10.14694/edbk_159244,,,,27249729,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8437565,https://api.altmetric.com/v1/donut/8437565_240.png 8,The Aging Prostate Is Never “Normal”: Implications from the Genomic Characterization of Multifocal Prostate Cancers,European Urology,,,Article,2015-04-29,10.1016/j.eururo.2015.04.012,,,,25913065,,,,,,,0,0,0,12,0,0,4,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/3933540,https://api.altmetric.com/v1/donut/3933540_240.png 8,Psychosocial interventions for men with prostate cancer: a Cochrane systematic review,British Journal of Urology,,,Article,2015-03-17,10.1111/bju.12989,,,,25429987,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2935059,https://api.altmetric.com/v1/donut/2935059_240.png 8,A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease,Cancer Research,,,Article,2012-10-31,10.1158/0008-5472.can-12-1260,,,,23108139,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/1037887,https://api.altmetric.com/v1/donut/1037887_240.png 8,Vasectomy Doesn't Seem to Increase Risk for Prostate Cancer,Journal Watch,,,Article,2016-09-20,10.1056/nejm-jw.fw112049,,,,,,,,,,,0,0,0,13,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12091917,https://api.altmetric.com/v1/donut/12091917_240.png 8,"The impact of socio-economic deprivation on incidence, treatment and mortality from prostate cancer in England, 1990–2010",Journal of Clinical Urology,,,Article,2015-07-21,10.1177/2051415815594976,,,,,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4304279,https://api.altmetric.com/v1/donut/4304279_240.png 8,Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer: A Systematic Review and Meta-analysis.,Clinical Nuclear Medicine,,,Article,2013-03-11,10.1097/rlu.0b013e3182867f3c,,,,23486334,,,,,,,0,0,0,13,0,0,2,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1305336,https://api.altmetric.com/v1/donut/1305336_240.png 8,Germline genetic profiling in prostate cancer: latest developments and potential clinical applications,Future Science OA,,,Article,2015-12-18,10.4155/fso.15.87,,,,,,,,,,,0,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4903846,https://api.altmetric.com/v1/donut/4903846_240.png 8,SOX9 drives WNT pathway activation in prostate cancer,Journal of Clinical Investigation,,,Article,2016-04-04,10.1172/jci78815,,,,27043282,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6478251,https://api.altmetric.com/v1/donut/6478251_240.png 8,Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology,Lancet Oncology,,,Article,2014-08-14,10.1016/s1470-2045(14)70018-x,,,,25079103,,,,,,,0,0,0,18,0,0,2,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2547626,https://api.altmetric.com/v1/donut/2547626_240.png 8,A New RNA-Seq Method to Detect the Transcription and Non-coding RNA in Prostate Cancer.,Pathology & Oncology Research,,,Article,2013-09-17,10.1007/s12253-013-9618-0,,,,24043589,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1760274,https://api.altmetric.com/v1/donut/1760274_240.png 8,DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer,Genome Research,,,Article,2011-04-26,10.1101/gr.119487.110,,,,21521786,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/179061,https://api.altmetric.com/v1/donut/179061_240.png 8,Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223,The Prostate,,,Article,2016-11-01,10.1002/pros.23272,,,,27800631,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13262952,https://api.altmetric.com/v1/donut/13262952_240.png 8,Effect of dietary omega-3 fatty acids on tumor-associated macrophages and prostate cancer progression,The Prostate,,,Article,2016-06-01,10.1002/pros.23218,,,,27338236,,,,,,,0,2,0,2,0,0,1,0,0,0,0,0,0,0,1,2,https://www.altmetric.com/details/9050382,https://api.altmetric.com/v1/donut/9050382_240.png 8,Regulation of prostate cancer progression by the tumor microenvironment.,Cancer Letters,,,Article,2016-01-28,10.1016/j.canlet.2015.12.022,,,,26828013,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5058738,https://api.altmetric.com/v1/donut/5058738_240.png 8,
Predicting discontinuation of docetaxel treatment for metastatic castration-resistant prostate cancer (mCRPC) with hill-climbing and random forest
,F1000Research,,,Article,2015-11-30,10.7490/f1000research.1111091.1,,,,,,,,,,,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4847834,https://api.altmetric.com/v1/donut/4847834_240.png 8,Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening,The Journal of Urology,,,Article,2015-11-04,10.1016/j.juro.2015.10.166,,,,26852972,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4725757,https://api.altmetric.com/v1/donut/4725757_240.png 8,Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair,Science Translational Medicine,,,Article,2015-11-04,10.1126/scitranslmed.aac5671,,,,26537259,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4725754,https://api.altmetric.com/v1/donut/4725754_240.png 8,Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies,European Urology,,,Article,2015-10-25,10.1016/j.eururo.2015.10.021,,,,26508309,,,,,,,0,0,0,11,0,0,1,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/4671364,https://api.altmetric.com/v1/donut/4671364_240.png 8,Suicide and accidental deaths among patients with non?metastatic prostate cancer,British Journal of Urology,,,Article,2015-08-27,10.1111/bju.13257,,,,26305451,,,,,,,1,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4440853,https://api.altmetric.com/v1/donut/4440853_240.png 8,The contribution of rare variation to prostate cancer heritability,bioRxiv,,,Article,2015-07-31,10.1101/023440,,,,,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4350737,https://api.altmetric.com/v1/donut/4350737_240.png 8,Is clinical stage T2c prostate cancer an intermediate? or high?risk disease?,Cancer (0008543X),,,Article,2014-12-09,10.1002/cncr.29147,,,,25492369,,,,,,,2,0,0,3,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2968448,https://api.altmetric.com/v1/donut/2968448_240.png 8,Is It Time To Change the Treatment Paradigm for Lymph Node–Positive Prostate Cancer?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.06.040,,,,23849997,,,,,,,0,0,0,10,0,0,0,0,2,0,0,0,0,0,0,3,https://www.altmetric.com/details/2542906,https://api.altmetric.com/v1/donut/2542906_240.png 8,Gleason Score 3?+?4=7 Prostate Cancer With Minimal Quantity of Gleason Pattern 4 on Needle Biopsy Is Associated With Low-risk Tumor in Radical Prostatectomy Specimen.,The American Journal of Surgical Pathology,,,Article,2014-05-14,10.1097/pas.0000000000000235,,,,24832163,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2358187,https://api.altmetric.com/v1/donut/2358187_240.png 8,"Phytochemicals from Cruciferous Vegetables, Epigenetics, and Prostate Cancer Prevention",The AAPS Journal,"CROFT, Laura B",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-06-26,10.1208/s12248-013-9504-4,,,,23800833,,,,,,,0,0,0,18,0,0,8,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1589082,https://api.altmetric.com/v1/donut/1589082_240.png 8,Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer,Journal of Clinical Oncology,,,Article,2010-02-05,10.1200/jco.2009.26.0133,,,,20124165,PMC2834465,,,,,,0,0,1,3,0,0,0,1,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1332451,https://api.altmetric.com/v1/donut/1332451_240.png 8,Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.12.081,,,,22444999,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/965287,https://api.altmetric.com/v1/donut/965287_240.png 8,Clinical Events in Prostate Cancer Lifestyle Trial: Results From Two Years of Follow-Up,Urology,,,Article,2008-07-09,10.1016/j.urology.2008.04.050,,,,18602144,,,,,,,0,0,1,2,0,0,1,1,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/805990,https://api.altmetric.com/v1/donut/805990_240.png 8,"Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts",Medical care,,,Article,2013-04-29,10.1097/mlr.0b013e318277eb6f,,,,23222531,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1485341,https://api.altmetric.com/v1/donut/1485341_240.png 8,"Re: Cigarette Smoking is Associated with an Increased Risk of Biochemical Disease Recurrence, Metastasis, Castration-Resistant Prostate Cancer, and Mortality after Radical Prostatectomy: Results from the SEARCH Database",The Journal of Urology,,,Article,2014-01-06,10.1016/j.juro.2014.03.065,,,,25280282,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2425496,https://api.altmetric.com/v1/donut/2425496_240.png 8,Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-01-14,10.1158/1055-9965.epi-13-1165,,,,24425144,,,,,,,0,0,0,18,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2048473,https://api.altmetric.com/v1/donut/2048473_240.png 8,Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917,Cancer Prevention Research,,,Article,2011-09-08,10.1158/1940-6207.capr-10-0343,,,,21896650,PMC3208719,,,,,,0,0,2,4,0,0,0,0,0,0,0,0,1,0,0,28,https://www.altmetric.com/details/549026,https://api.altmetric.com/v1/donut/549026_240.png 8,In touch with your feminine side: how oestrogen metabolism impacts prostate cancer,Endocrine-Related Cancer,,,Article,2016-05-18,10.1530/erc-16-0118,,,,27194038,,,,,,,0,0,0,6,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8125720,https://api.altmetric.com/v1/donut/8125720_240.png 8,Re: Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer,The Journal of Urology,,,Article,2016-05-18,10.1016/j.juro.2016.05.068,,,,27479379,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7600600,https://api.altmetric.com/v1/donut/7600600_240.png 8,SOX4 is essential for prostate tumorigenesis initiated by PTEN ablation.,Cancer Research,,,Article,2016-01-04,10.1158/0008-5472.can-15-1868,,,,26701805,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4951665,https://api.altmetric.com/v1/donut/4951665_240.png 8,Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer,European Urology,,,Article,2015-07-01,10.1016/j.eururo.2014.10.018,,,,25457017,,,,,,,0,0,0,25,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2825660,https://api.altmetric.com/v1/donut/2825660_240.png 8,Prostate Cancer Support Groups Canada-Based Specialists’ Perspectives,American Journal of Men's Health,,,Article,2014-07-23,10.1177/1557988314543510,,,,25061087,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2685450,https://api.altmetric.com/v1/donut/2685450_240.png 8,Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).,European Urology,,,Article,2012-06-20,10.1016/j.eururo.2012.05.068,,,,22704366,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/803637,https://api.altmetric.com/v1/donut/803637_240.png 8,Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation project.,BMJ Open,,,Article,2016-10-01,10.1136/bmjopen-2016-011773,,,,27697869,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12446551,https://api.altmetric.com/v1/donut/12446551_240.png 8,Is It Time to Revisit the Role of Prostate-Specific Antigen Kinetics in Active Surveillance for Prostate Cancer?,Urology,,,Article,2016-04-26,10.1016/j.urology.2016.04.016,,,,27130265,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6976732,https://api.altmetric.com/v1/donut/6976732_240.png 8,Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin – A multicenter study,Radiotherapy & Oncology,,,Article,2015-01-07,10.1016/j.radonc.2015.06.021,,,,26138059,,,,,,,1,0,0,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4313229,https://api.altmetric.com/v1/donut/4313229_240.png 8,A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-07-26,10.1016/j.ijrobp.2015.05.024,,,,26209502,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4057584,https://api.altmetric.com/v1/donut/4057584_240.png 8,Randomized Clinical Trial of Vitamin D3 Doses on Prostatic Vitamin D Metabolite Levels and Ki67 Labeling in Prostate Cancer Patients,The Journal of Clinical Endocrinology & Metabolism,,,Article,2013-01-01,10.1210/jc.2012-4019,,,,23463655,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1302129,https://api.altmetric.com/v1/donut/1302129_240.png 8,Metabolomic Imaging for Human Prostate Cancer Detection,Science Translational Medicine,,,Article,1970-01-01,10.1126/scitranslmed.3000513,,,,20371475,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1358017,https://api.altmetric.com/v1/donut/1358017_240.png 8,Detection of DNA viruses in prostate cancer,Scientific Reports,,,Article,2016-04-28,10.1038/srep25235,,,,27121729,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7069399,https://api.altmetric.com/v1/donut/7069399_240.png 8,The expanding role of chemotherapy in prostate cancer.,Future Oncology,,,Article,2015-09-06,10.2217/fon.15.197,,,,26338513,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4477670,https://api.altmetric.com/v1/donut/4477670_240.png 8,Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?,Cancer Medicine,,,Article,2013-01-01,10.1002/cam4.64,,,,23634292,PMC3639663,,,,,,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1357158,https://api.altmetric.com/v1/donut/1357158_240.png 8,Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy,Journal of Nuclear Medicine,,,Article,2016-01-24,10.2967/jnumed.115.168443,,,,26795286,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5033910,https://api.altmetric.com/v1/donut/5033910_240.png 8,Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models ,Cell Reports,,,Article,2015-09-22,10.1016/j.celrep.2015.08.051,,,,26387954,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4529197,https://api.altmetric.com/v1/donut/4529197_240.png 8,Psychosocial perspectives on sexual recovery after prostate cancer treatment,Nature Reviews Urology,,,Article,2015-03-10,10.1038/nrurol.2015.29,,,,25753250,,,,,,,0,0,0,15,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3770817,https://api.altmetric.com/v1/donut/3770817_240.png 8,Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer.,Psycho-Oncology,,,Article,2015-03-01,10.1002/pon.3776,,,,25728586,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3753031,https://api.altmetric.com/v1/donut/3753031_240.png 8,Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS).,Journal of Comparative Effectiveness Research,,,Article,2015-01-09,10.2217/cer.14.67,,,,25565065,,,,,,,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3059471,https://api.altmetric.com/v1/donut/3059471_240.png 8,Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience,Radiation Oncology,,,Article,2014-10-20,10.3389/fonc.2014.00313,,,,25452934,PMC4231839,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2888916,https://api.altmetric.com/v1/donut/2888916_240.png 8,Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE Registry.,European Urology,,,Article,2014-09-17,10.1016/j.eururo.2014.08.074,,,,25242555,,,,,,,0,0,0,23,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2696637,https://api.altmetric.com/v1/donut/2696637_240.png 8,"Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer",Journal of Clinical Oncology,,,Article,2006-05-08,10.1200/jco.2005.04.5252,,,,,,,,,,,0,0,0,5,0,0,0,1,0,0,0,0,1,0,0,86,https://www.altmetric.com/details/2302362,https://api.altmetric.com/v1/donut/2302362_240.png 8,Estrogen-Related Receptors in Breast Cancer and Prostate Cancer.,Frontiers in endocrinology,,,Article,2015-05-15,10.3389/fendo.2015.00083,,,,26074877,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3997985,https://api.altmetric.com/v1/donut/3997985_240.png 8,Prostate cancer: Developing novel approaches to castration-sensitive disease,Cancer (0008543X),,,Article,2016-11-01,10.1002/cncr.30329,,,,27802360,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13316475,https://api.altmetric.com/v1/donut/13316475_240.png 8,Risk of Hospitalization Following Primary Treatment for Prostate Cancer,British Journal of Urology,,,Article,2016-08-01,10.1111/bju.13647,,,,27561186,,,,,,,1,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10842687,https://api.altmetric.com/v1/donut/10842687_240.png 8,Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome,British Journal of Cancer,,,Article,2016-04-21,10.1038/bjc.2016.86,,,,27100731,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6869349,https://api.altmetric.com/v1/donut/6869349_240.png 8,Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer,Medicine,,,Article,2016-01-01,10.1097/md.0000000000002299,,,http://journals.lww.com/md-journal/Fulltext/2016/01120/Lack_of_Cumulative_Toxicity_Associated_With.13.aspx,26765406,PMC4718232,,,,,,0,1,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5060861,https://api.altmetric.com/v1/donut/5060861_240.png 8,"The Challenge for Urologists Is to Screen, Detect, and Treat Prostate Cancer “Smarter”: Will Ablative Technology Result in Smarter Treatment?",European Urology,,,Article,2016-01-21,10.1016/j.eururo.2016.01.024,,,,26803477,,,,,,,0,0,0,22,0,0,8,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5020718,https://api.altmetric.com/v1/donut/5020718_240.png 8,The Movember campaign: Impact on referral patterns and diagnosis of prostate cancer.,Scandinavian Journal of Public Health,,,Article,2015-10-30,10.1177/1403494815613184,,,,26511591,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4701567,https://api.altmetric.com/v1/donut/4701567_240.png 8,More nomograms or better lymph node dissection - what do we need in prostate cancer?,British Journal of Urology,,,Article,2015-10-09,10.1111/bju.13045,,,,26449167,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4644609,https://api.altmetric.com/v1/donut/4644609_240.png 8,Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer.,,,,Article,2006-04-14,10.1016/j.jpsychores.2005.08.001,,,,16581368,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4505535,https://api.altmetric.com/v1/donut/4505535_240.png 8,Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy,Scandinavian Journal of Medicine & Science in Sports,,,Article,2015-09-01,10.1111/sms.12543,,,,26282343,,,,,,,0,0,0,12,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4406832,https://api.altmetric.com/v1/donut/4406832_240.png 8,Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up,The Journal of Urology,,,Article,2015-01-08,10.1016/j.juro.2015.05.064,,,,26195362,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4007854,https://api.altmetric.com/v1/donut/4007854_240.png 8,The experience and perceptions of men with prostate cancer and their partners of the CONNECT psychosocial intervention: a qualitative exploration,Journal of Advanced Nursing,,,Article,2015-03-26,10.1111/jan.12648,,,,25818026,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3859634,https://api.altmetric.com/v1/donut/3859634_240.png 8,Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria,British Journal of Urology,,,Article,2015-05-11,10.1111/bju.13103,,,,25711672,,,,,,,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3729717,https://api.altmetric.com/v1/donut/3729717_240.png 8,FOXO3a modulates WNT/?-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.,Cellular Signalling,,,Article,2015-01-08,10.1016/j.cellsig.2015.01.001,,,,25578861,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3063991,https://api.altmetric.com/v1/donut/3063991_240.png 8,Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study,European Journal of Cancer (1965),,,Article,2014-04-12,10.1016/j.ejca.2014.03.279,,,,24736041,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2278548,https://api.altmetric.com/v1/donut/2278548_240.png 8,The role of magnetic resonance imaging in the diagnosis and management of prostate cancer,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12381,,,,24127671,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/1941604,https://api.altmetric.com/v1/donut/1941604_240.png 8,Evaluating Baculovirus as a Vector for Human Prostate Cancer Gene Therapy,PLoS ONE,,,Article,2013-06-06,10.1371/journal.pone.0065557,,,,23755250,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1537999,https://api.altmetric.com/v1/donut/1537999_240.png 8,"Indole-3-carbinol and 3', 3'-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells",Cancer Prevention Research,,,Article,2013-01-01,10.1158/1940-6207.capr-12-0419,,,,23585426,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1390390,https://api.altmetric.com/v1/donut/1390390_240.png 8,One thousand genomes imputation in the national cancer institute breast and prostate cancer cohort consortium aggressive prostate cancer genomeâ??wide association study,The Prostate,,,Article,2012-01-01,10.1002/pros.22608,,,,23255287,,,,,,,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1134689,https://api.altmetric.com/v1/donut/1134689_240.png 8,Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies.,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.08.025,,,,23083875,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/1089077,https://api.altmetric.com/v1/donut/1089077_240.png 8,Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis.,Clinical Chemistry & Laboratory Medicine,,,Article,2012-11-15,10.1515/cclm-2012-0410,,,,23154423,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1074183,https://api.altmetric.com/v1/donut/1074183_240.png 8,The differential effects of statins on the metastatic behaviour of prostate cancer,British Journal of Cancer,,,Article,2012-04-24,10.1038/bjc.2012.138,,,,22531631,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/736894,https://api.altmetric.com/v1/donut/736894_240.png 8,2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates,JAMA: Journal of the American Medical Association,,,Article,2012-01-01,10.1001/jama.2012.534,,,,22535850,,,,,,,0,0,1,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/713782,https://api.altmetric.com/v1/donut/713782_240.png 8,Combined 18F?fluorocholine and 18F?fluoride positron emission tomography/computed tomography imaging for staging of high?risk prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11123.x,,,,22502982,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/696014,https://api.altmetric.com/v1/donut/696014_240.png 8,Pros and Cons of Focal Therapy for Localised Prostate Cancer,Prostate Cancer,,,Article,2011-12-02,10.1155/2011/584784,,,,22110990,PMC3200263,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/477670,https://api.altmetric.com/v1/donut/477670_240.png 8,Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2013-10-01,10.1038/pcan.2013.41,,,,24080993,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1816869,https://api.altmetric.com/v1/donut/1816869_240.png 8,Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial,European Urology,,,Article,2016-08-11,10.1016/j.eururo.2016.07.027,,,,27497762,,,,,,,0,0,0,13,0,0,0,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/10526246,https://api.altmetric.com/v1/donut/10526246_240.png 8,Multigene panels in prostate cancer risk assessment: a systematic review,Genetics in Medicine,,,Article,2015-10-02,10.1038/gim.2015.125,,,,26426883,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4578845,https://api.altmetric.com/v1/donut/4578845_240.png 8,Prostate cancer: summary of updated NICE guidance,British Medical Journal,,,Article,2014-01-08,10.1136/bmj.f7524,,,,24401467,,,,,,,0,0,0,11,0,0,0,0,0,0,1,0,0,0,0,41,https://www.altmetric.com/details/2029450,https://api.altmetric.com/v1/donut/2029450_240.png 8,A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-01-01,10.1158/1055-9965.epi-06-1033,,,,17585059,,,,,,,0,0,1,5,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1669310,https://api.altmetric.com/v1/donut/1669310_240.png 8,Expanded Criteria to Identify Men Eligible for Active Surveillance of Low-Risk Prostate Cancer at Johns Hopkins: A Preliminary Analysis.,The Journal of Urology,,,Article,2013-05-14,10.1016/j.juro.2013.05.015,,,,23680308,,,,,,,0,0,2,8,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1476240,https://api.altmetric.com/v1/donut/1476240_240.png 8,Dietary Supplement Use and Prostate Cancer Risk in the Carotene and Retinol Efficacy Trial,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-08-01,10.1158/1055-9965.epi-09-0013,,,,19661078,PMC2733330,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/590069,https://api.altmetric.com/v1/donut/590069_240.png 8,Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force,European Urology,,,Article,2016-10-11,10.1016/j.eururo.2016.09.041,,,,27720532,,,,,,,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/12481045,https://api.altmetric.com/v1/donut/12481045_240.png 8,"Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy",Urology,,,Article,2016-03-22,10.1016/j.urology.2016.01.041,,,,27015944,,,,,,,0,0,0,13,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6267092,https://api.altmetric.com/v1/donut/6267092_240.png 8,The Potential of MicroRNAs as Prostate Cancer Biomarkers,European Urology,,,Article,2016-01-22,10.1016/j.eururo.2015.12.054,,,,26806656,,,,,,,0,0,0,11,0,0,4,0,1,0,0,0,0,0,0,43,https://www.altmetric.com/details/5025017,https://api.altmetric.com/v1/donut/5025017_240.png 8,Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer,Radiation Oncology,,,Article,2015-10-24,10.1186/s13014-015-0522-5,,,,26499318,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4669303,https://api.altmetric.com/v1/donut/4669303_240.png 8,Monitoring of Early Prostate Cancer Tied to Higher Risk for Metastases,Journal Watch,,,Article,2016-09-15,10.1056/nejm-jw.fw112034,,,,,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12004893,https://api.altmetric.com/v1/donut/12004893_240.png 8,Metastatic Prostate Cancer on the Rise in the U.S.,Journal Watch,,,Article,2016-07-20,10.1056/nejm-jw.fw111821,,,,,,,,,,,0,0,0,11,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9866750,https://api.altmetric.com/v1/donut/9866750_240.png 8,"Patient?reported outcomes in the ProtecT randomised trial of clinically localised prostate cancer treatments: design and baseline urinary, bowel and sexual function and quality of life",British Journal of Urology,,,Article,2016-07-01,10.1111/bju.13582,,,,27415448,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9695753,https://api.altmetric.com/v1/donut/9695753_240.png 8,Indocyanine Green guided pelvic lymph node dissection. An efficient technique to classify the lymph node status of patients with prostate cancer who underwent radical prostatectomy,The Journal of Urology,,,Article,2016-05-25,10.1016/j.juro.2016.05.087,,,,27235788,,,,,,,0,0,0,11,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8271785,https://api.altmetric.com/v1/donut/8271785_240.png 8,"A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality",Cancer Causes and Control,,,Article,2015-09-09,10.1007/s10552-015-0659-4,,,,26354897,,,,,,,0,0,0,8,0,0,0,1,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/4504954,https://api.altmetric.com/v1/donut/4504954_240.png 8,Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison,Clinical Medicine Insights: Oncology,,,Article,2014-03-01,10.4137/cmo.s13671,,,,24678245,PMC3964205,,,,,,0,0,0,7,0,0,1,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2195359,https://api.altmetric.com/v1/donut/2195359_240.png 8,"Androgen deprivation for prostate cancer: when and how, the good and the bad.",American Society of Clinical Oncology Educational Book,,,Article,2013-01-01,10.1200/edbook_am.2013.33.e176,,,,23714494,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1522020,https://api.altmetric.com/v1/donut/1522020_240.png 8,Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2008-04-01,10.1097/cej.0b013e3280145b4c,,,http://journals.lww.com/eurjcancerprev/Fulltext/2008/04000/Pesticides_and_prostate_cancer__a_review_of.5.aspx,18287866,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1205555,https://api.altmetric.com/v1/donut/1205555_240.png 8,Epidemiology of prostate cancer,CA: A Cancer Journal for Clinicians ,,,Article,1997-09-01,10.3322/canjclin.47.5.273,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1205554,https://api.altmetric.com/v1/donut/1205554_240.png 8,Vitamin and mineral use and risk of prostate cancer: the case–control surveillance study,Cancer Causes and Control,,,Article,2008-12-19,10.1007/s10552-008-9282-y,,,,19093214,PMC2755205,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1205553,https://api.altmetric.com/v1/donut/1205553_240.png 8,An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011,British Journal of Urology,,,Article,2012-07-29,10.1111/j.1464-410x.2012.11324.x,,,,22834909,,,,,,,0,0,0,6,0,0,1,1,0,0,0,0,0,0,1,69,https://www.altmetric.com/details/877828,https://api.altmetric.com/v1/donut/877828_240.png 8,Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles ,International Journal of Pharmaceutics,,,Article,2015-09-01,10.1016/j.ijpharm.2015.07.042,,,,26200751,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4337889,https://api.altmetric.com/v1/donut/4337889_240.png 8,"What Do Myeloma, Breast Cancer, and Prostate Cancer Have in Common?",European Urology,,,Article,2016-09-04,10.1016/j.eururo.2016.08.058,,,,27600588,,,,,,,0,0,0,20,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11716994,https://api.altmetric.com/v1/donut/11716994_240.png 8,Definition of Insignificant Tumor Volume of Gleason Score 3+3=6 (Grade Group 1) Prostate Cancer at Radical Prostatectomy – Is it Time to Increase the Threshold?,The Journal of Urology,,,Article,2016-06-14,10.1016/j.juro.2016.06.013,,,,27291653,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8621748,https://api.altmetric.com/v1/donut/8621748_240.png 8,Differences in cancer dynamics may explain why prostate screening has cut metastatic disease while breast screening has not,British Medical Journal,,,Article,2015-10-29,10.1136/bmj.h5741,,,,,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4699529,https://api.altmetric.com/v1/donut/4699529_240.png 8,Androgen receptor profiling predicts prostate cancer outcome.,EMBO Molecular Medicine,,,Article,2015-09-27,10.15252/emmm.201505424,,,,26412853,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4558383,https://api.altmetric.com/v1/donut/4558383_240.png 8,Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study,Colorectal Disease,,,Article,2015-08-01,10.1111/codi.12933,,,,25735444,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3754514,https://api.altmetric.com/v1/donut/3754514_240.png 8,"Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.",PLoS ONE,,,Article,2011-06-02,10.1371/journal.pone.0020164,,,,21629786,PMC3100339,,2011PLoSO...6E0164C,,,,0,0,0,6,0,0,13,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2356901,https://api.altmetric.com/v1/donut/2356901_240.png 8,Stem cells in prostate cancer: treating the root of the problem,Endocrine-Related Cancer,,,Article,2010-01-01,10.1677/erc-10-0145,,,,20660571,,,,,,,0,1,0,2,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1937322,https://api.altmetric.com/v1/donut/1937322_240.png 8,"Coffee consumption and risk of localized, advanced and fatal prostate cancer: a population-based prospective study.",Annals of Oncology,,,Article,2013-03-18,10.1093/annonc/mdt105,,,,23508823,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1311627,https://api.altmetric.com/v1/donut/1311627_240.png 8,Cyclooxygenase?2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice,British Journal of Urology,,,Article,,10.1111/bju.12503,,,,24127882,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1829058,https://api.altmetric.com/v1/donut/1829058_240.png 8,Fate of the human Y chromosome linked genes and loci in prostate cancer cell lines DU145 and LNCaP,BMC Genomics,,,Article,2013-05-11,10.1186/1471-2164-14-323,,,,23663454,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1470209,https://api.altmetric.com/v1/donut/1470209_240.png 8,Cost-savings analysis of AR-V7 testing in patients with metastatic castration-resistant prostate cancer eligible for treatment with abiraterone or enzalutamide,The Prostate,,,Article,2016-07-12,10.1002/pros.23232,,,,27404039,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9660321,https://api.altmetric.com/v1/donut/9660321_240.png 8,Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells.,Amino Acids,,,Article,2015-12-24,10.1007/s00726-015-2143-6,,,,26704566,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4926711,https://api.altmetric.com/v1/donut/4926711_240.png 8,Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells.,Oncotarget,,,Article,2015-12-20,10.18632/oncotarget.6606,,,,26683224,PMC4826221,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4901680,https://api.altmetric.com/v1/donut/4901680_240.png 8,The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer,BMC Urology,,,Article,2015-09-11,10.1186/s12894-015-0079-5,,,,26269129,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4496546,https://api.altmetric.com/v1/donut/4496546_240.png 8,The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model,PLoS ONE,,,Article,2015-09-01,10.1371/journal.pone.0136981,,,,26325195,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4464265,https://api.altmetric.com/v1/donut/4464265_240.png 8,"Arum Palaestinum with isovanillin, linolenic acid and ?-sitosterol inhibits prostate cancer spheroids and reduces the growth rate of prostate tumors in mice.",BMC Complementary and Alternative Medicine,,,Article,2015-08-05,10.1186/s12906-015-0774-5,,,,26243305,,,,,,,1,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4365183,https://api.altmetric.com/v1/donut/4365183_240.png 8,"Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.",Carcinogenesis,,,Article,2003-10-01,10.1093/carcin/bgg123,,,,12896904,,,,,,,0,0,0,0,0,0,29,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4018935,https://api.altmetric.com/v1/donut/4018935_240.png 8,"Improving the Prediction of Pathologic Outcomes in Patients Undergoing Radical Prostatectomy: The Value of Prostate Cancer Antigen 3 (PCA3), Prostate Health Index (Phi) and Sarcosine.",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-02-15,,,,,25667489,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3896374,https://api.altmetric.com/v1/donut/3896374_240.png 8,Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408 ,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-06-25,10.1016/j.ijrobp.2015.03.017,,,,26104939,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3841714,https://api.altmetric.com/v1/donut/3841714_240.png 8,Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound?guided biopsy: the Victorian Transperineal Biopsy Collaboration experience,British Journal of Urology,,,Article,2015-10-01,10.1111/bju.13031,,,,25560926,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3045705,https://api.altmetric.com/v1/donut/3045705_240.png 8,A phase I study of TRC105 anti?endoglin (CD105) antibody in metastatic castration?resistant prostate cancer,British Journal of Urology,,,Article,2015-06-08,10.1111/bju.12986,,,,25407442,,,,,,,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2919296,https://api.altmetric.com/v1/donut/2919296_240.png 8,Prostate Cancer Debate: Round table expert discussion. Prostate Cancer Debate: Round table expert discussion,ecancer.org,,,Article,,,,,http://ecancer.org/video/3201/prostate-cancer-debate--round-table-expert-discussion.php,,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2833945,https://api.altmetric.com/v1/donut/2833945_240.png 8,The safety of testosterone supplementation therapy in prostate cancer,Nature Reviews Urology,,,Article,2014-07-31,10.1038/nrurol.2014.163,,,,25069737,,,,,,,0,0,0,15,0,0,0,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/2715529,https://api.altmetric.com/v1/donut/2715529_240.png 8,Progress and controversies: Radiation therapy for prostate cancer.,CA: A Cancer Journal for Clinicians ,,,Article,2014-09-17,10.3322/caac.21250,,,,25234700,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2698197,https://api.altmetric.com/v1/donut/2698197_240.png 8,Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer ,Radiotherapy & Oncology,,,Article,2014-08-06,10.1016/j.radonc.2014.04.017,,,,25086852,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2592546,https://api.altmetric.com/v1/donut/2592546_240.png 8,Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?,British Journal of Urology,,,Article,2015-08-01,10.1111/bju.12880,,,,25060664,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2538272,https://api.altmetric.com/v1/donut/2538272_240.png 8,Influence of ellagic acid on prostate cancer cell proliferation: a caspase-dependent pathway.,Asian Pacific Journal of Tropical Medicine,,,Article,2011-08-03,10.1016/s1995-7645(11)60144-2,,,,21803307,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2483878,https://api.altmetric.com/v1/donut/2483878_240.png 8,"In situ sequencing identifies TMPRSS2-ERG fusion transcripts, somatic point mutations and gene expression levels in prostate cancers.",The Journal of Pathology,,,Article,2014-06-14,10.1002/path.4392,,,http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-109002,24931216,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2442535,https://api.altmetric.com/v1/donut/2442535_240.png 8,"Spine Metastases in Prostate Cancer: Comparison of [99m Tc]MDP Wholebody Bone Scintigraphy, [18 F]Choline PET/CT, and [18 F]NaF PET/CT.",British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12599,,,,24314065,,,,,,,0,5,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2370827,https://api.altmetric.com/v1/donut/2370827_240.png 8,"Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer",PLoS ONE,,,Article,2014-05-16,10.1371/journal.pone.0098037,,,,24837491,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2360887,https://api.altmetric.com/v1/donut/2360887_240.png 8,"Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2004-02-21,,,,,14973107,,,,,,,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2139216,https://api.altmetric.com/v1/donut/2139216_240.png 8,Making Individualized Decisions in the Midst of Uncertainties: The Case of Prostate Cancer and Biochemical Recurrence,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.07.001,,,,23871403,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2125065,https://api.altmetric.com/v1/donut/2125065_240.png 8,Tea consumption and prostate cancer: an updated meta-analysis,World Journal of Surgical Oncology,,,Article,2014-02-14,10.1186/1477-7819-12-38,,,,24528523,,,,,,,0,0,0,8,0,0,0,3,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2121631,https://api.altmetric.com/v1/donut/2121631_240.png 8,Detection of the Index Tumor and Tumor Volume in Prostate Cancer using T2w and DW MRI alone,British Journal of Urology,,,Article,2014-12-01,10.1111/bju.12637,,,,24447606,,,,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2060266,https://api.altmetric.com/v1/donut/2060266_240.png 8,Prognostic significance of patterns of seminal vesicle invasion in prostate cancer,Histopathology,,,Article,2013-01-01,10.1111/his.12104,,,,23570376,,,,,,,0,0,1,9,0,0,3,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1199051,https://api.altmetric.com/v1/donut/1199051_240.png 8,Treatment Patterns for Prostate Cancer: Comparison of Medicare Claims Data to Medical Record Review,Medical care,,,Article,2012-12-06,10.1097/mlr.0b013e318277eba5,,,,23222532,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1119722,https://api.altmetric.com/v1/donut/1119722_240.png 8,Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines.,Prostate Cancer & Prostatic Diseases,,,Article,2005-12-31,10.1038/sj.pcan.4500845,,,,16314891,,,,,,,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1074895,https://api.altmetric.com/v1/donut/1074895_240.png 8,Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models,PLoS ONE,,,Article,2012-01-27,10.1371/journal.pone.0030815,,,,22303460,PMC3267747,,2012PLoSO...7E0815S,,,,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/577206,https://api.altmetric.com/v1/donut/577206_240.png 8,Acceptability and Preliminary Feasibility of an Internet/CD-ROM-Based Education and Decision Program for Early-Stage Prostate Cancer Patients: Randomized Pilot Study,Journal of Medical Internet Research,,,Article,2012-01-18,10.2196/jmir.1891,,,,22246148,,,,,,,0,0,0,13,0,0,0,1,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/558834,https://api.altmetric.com/v1/donut/558834_240.png 8,Consensus Guidelines for Reporting Prostate Cancer Gleason Grade,Urology,,,Article,2016-03-22,10.1016/j.urology.2016.03.002,,,,27015942,,,,,,,0,0,0,16,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6267091,https://api.altmetric.com/v1/donut/6267091_240.png 8,Metastatic prostate cancer in 2015: The new and the old that is new again,Nature Reviews Clinical Oncology,,,Article,2015-12-31,10.1038/nrclinonc.2015.226,,,,26718107,,,,,,,0,0,0,15,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4941508,https://api.altmetric.com/v1/donut/4941508_240.png 8,"Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis.",Cancer Causes and Control,,,Article,1998-12-01,,,,,10189042,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4403764,https://api.altmetric.com/v1/donut/4403764_240.png 8,Prediction of individual genetic risk to prostate cancer using a polygenic score,The Prostate,,,Article,2015-06-01,10.1002/pros.23037,,,,26177737,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/4304264,https://api.altmetric.com/v1/donut/4304264_240.png 8,Cytoreductive Radical Prostatectomy in Patients with prostate cancer and low volume skeletal metastases - results of a feasibility and case-control study.,The Journal of Urology,,,Article,2014-09-20,10.1016/j.juro.2014.09.089,,,,25254935,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2736131,https://api.altmetric.com/v1/donut/2736131_240.png 8,"Overtreatment of low risk prostate cancer: incidence in USA, cost, complications and implications. Overtreatment of low risk prostate cancer: incidence in USA, cost, complications and implications",ecancer.org,,,Article,,,,,http://ecancer.org/video/1873/overtreatment-of-low-risk-prostate-cancer--incidence-in-usa--cost--complications-and-implications.php,,,,,,,,0,0,0,11,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1277937,https://api.altmetric.com/v1/donut/1277937_240.png 8,Prostate cancer: Postoperative RT response prediction,Nature Reviews Urology,,,Article,2016-11-02,10.1038/nrurol.2016.223,,,,27804989,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13276765,https://api.altmetric.com/v1/donut/13276765_240.png 8,The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer,Diagnostics,,,Article,2016-07-18,10.3390/diagnostics6030027,,,,27438858,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9921326,https://api.altmetric.com/v1/donut/9921326_240.png 8,Re: Enzalutamide versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial,The Journal of Urology,,,Article,2016-06-16,10.1016/j.juro.2016.06.066,,,,27597064,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8807584,https://api.altmetric.com/v1/donut/8807584_240.png 8,Re: Adverse Health Events following Intermittent and Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer,The Journal of Urology,,,Article,2016-05-18,10.1016/j.juro.2016.05.067,,,,27479380,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7600626,https://api.altmetric.com/v1/donut/7600626_240.png 8,Fortifying the Treatment of Prostate Cancer with Physical Activity,Prostate Cancer,,,Article,2016-02-10,10.1155/2016/9462975,,,,26977321,,,,,,,0,0,0,9,0,0,4,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5306571,https://api.altmetric.com/v1/donut/5306571_240.png 8,Super bone scan: bone metastases of prostate cancer,BMJ Case Reports,,,Article,2014-09-16,10.1136/bcr-2014-206886,,,,25228679,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2713580,https://api.altmetric.com/v1/donut/2713580_240.png 8,"Professor was harassed by his university after criticising routine prostate cancer screening, inquiry finds",British Medical Journal,,,Article,2012-06-14,10.1136/bmj.e4150,,,,22700817,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/792401,https://api.altmetric.com/v1/donut/792401_240.png 8,Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015,The Journal of Urology,,,Article,2015-10-27,10.1016/j.juro.2015.10.086,,,,26498056,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/4657867,https://api.altmetric.com/v1/donut/4657867_240.png 8,Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study,JNCI: Journal of the National Cancer Institute,,,Article,2015-04-13,10.1093/jnci/djv095,,,,25863334,,,,,,,0,0,0,9,0,0,4,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3901444,https://api.altmetric.com/v1/donut/3901444_240.png 8,Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years,Radiation Oncology,,,Article,2013-05-13,10.1186/1748-717x-8-118,,,,23668632,,,,,,,0,0,0,9,0,0,3,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1471107,https://api.altmetric.com/v1/donut/1471107_240.png 8,Cannabis chemicals stop prostate cancer growth,ecancer.org,,,Article,,,,,http://ecancer.org/news/680-cannabis-chemicals-stop-prostate-cancer-growth.php,,,,,,,,0,0,0,5,0,0,10,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1319581,https://api.altmetric.com/v1/donut/1319581_240.png 8,Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity.,European Urology,,,Article,2012-09-05,10.1016/j.eururo.2012.08.053,,,,22981675,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,1,0,0,186,https://www.altmetric.com/details/951495,https://api.altmetric.com/v1/donut/951495_240.png 8,SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.,Nature,"KENT, Clarkson S",Department of Life Sciences; School of Natural Sciences,Article,2011-02-10,10.1038/nature09677,,,,21289624,,,2011Natur.470..269D,,,,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,206,https://www.altmetric.com/details/210137,https://api.altmetric.com/v1/donut/210137_240.png 8,Approach to Oligometastatic Prostate Cancer,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2016-06-03,10.14694/edbk_159241,,,,27249693,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8467205,https://api.altmetric.com/v1/donut/8467205_240.png 8,A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer,American Journal of Epidemiology,,,Article,2015-12-28,10.1093/aje/kwv262,,,,26702631,PMC4724096,,,,,,0,0,0,11,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4929835,https://api.altmetric.com/v1/donut/4929835_240.png 8,Screening for Prostate Cancer: Current Status and Future Directions,,,,Article,2015-09-28,10.1016/j.euf.2015.02.003,,,,,,,,,,,0,0,0,11,0,0,2,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/4563776,https://api.altmetric.com/v1/donut/4563776_240.png 8,"Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies",Scientific Reports,,,Article,2015-07-03,10.1038/srep12007,,,,26137992,,,,,,,0,0,0,6,0,0,0,3,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4239670,https://api.altmetric.com/v1/donut/4239670_240.png 8,A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1-3 ng/ml.,European Urology,,,Article,2013-07-19,10.1016/j.eururo.2013.07.005,,,,23891454,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,1,0,0,23,https://www.altmetric.com/details/1662627,https://api.altmetric.com/v1/donut/1662627_240.png 8,Ejaculation Frequency and Subsequent Risk of Prostate Cancer,The Journal of Urology,,,Article,2004-10-01,10.1016/s0022-5347(05)61232-3,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13033755,https://api.altmetric.com/v1/donut/13033755_240.png 7,Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2003-01-01,10.1097/01.cej.0000090180.08740.05,,,,14512806,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13285251,https://api.altmetric.com/v1/donut/13285251_240.png 7,Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population,Scientific Reports,,,Article,2016-09-23,10.1038/srep33818,,,,27658807,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13091191,https://api.altmetric.com/v1/donut/13091191_240.png 7,Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’,British Journal of Cancer,,,Article,2016-10-25,10.1038/bjc.2016.347,,,,27780194,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/13044936,https://api.altmetric.com/v1/donut/13044936_240.png 7,Comment on ‘Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome’,British Journal of Cancer,,,Article,2016-10-25,10.1038/bjc.2016.346,,,,27780195,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13044935,https://api.altmetric.com/v1/donut/13044935_240.png 7,Identification and Validation of Intrinsic Subtypes of Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-10-01,10.1016/j.ijrobp.2016.06.025,,,,27675894,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/13032027,https://api.altmetric.com/v1/donut/13032027_240.png 7,The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population,Scientific Reports,,,Article,2016-10-17,10.1038/srep35364,,,,27748407,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12923012,https://api.altmetric.com/v1/donut/12923012_240.png 7,"NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results","International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-10-01,10.1016/j.ijrobp.2016.06.023,,,,27675773,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12555573,https://api.altmetric.com/v1/donut/12555573_240.png 7,Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer.,P & T,,,Article,2011-04-01,,,,,21572775,PMC3086121,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12511323,https://api.altmetric.com/v1/donut/12511323_240.png 7,Molecular Imaging and Targeted Radionuclide Therapy of Prostate Cancer.,Journal of Nuclear Medicine,,,Article,,10.2967/jnumed.116.175497,,,,27694170,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12508733,https://api.altmetric.com/v1/donut/12508733_240.png 7,Associations of post-diagnosis physical activity and change from pre-diagnosis physical activity with quality of life in prostate cancer survivors,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-01-01,10.1158/1055-9965.epi-16-0465,,,,27677728,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12403288,https://api.altmetric.com/v1/donut/12403288_240.png 7,Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study,British Journal of Cancer,,,Article,2016-09-29,10.1038/bjc.2016.291,,,,27685442,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12346886,https://api.altmetric.com/v1/donut/12346886_240.png 7,"Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial",British Journal of Cancer,,,Article,2016-09-27,10.1038/bjc.2016.305,,,,27673363,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12247634,https://api.altmetric.com/v1/donut/12247634_240.png 7,The management of metastatic prostate cancer,International Journal of Urological Nursing,,,Article,2010-01-08,10.1111/j.1749-771x.2009.01078.x,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12131328,https://api.altmetric.com/v1/donut/12131328_240.png 7,Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-11-01,10.1016/j.ijrobp.2010.07.170,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12009578,https://api.altmetric.com/v1/donut/12009578_240.png 7,A Prospective Phase III Randomized Trial of Hypofractionation Versus Conventional Fractionation in Patients With High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-08-31,10.1016/j.ijrobp.2009.07.1691,,,,20047800,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/12009577,https://api.altmetric.com/v1/donut/12009577_240.png 7,Abstract 1502: Three intrinsic subtypes of prostate cancer with distinct pathway activation profiles differ in prognosis and treatment response,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1502,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11870969,https://api.altmetric.com/v1/donut/11870969_240.png 7,Optimal Number of Docetaxel Cycles in Castration-Resistant Metastatic Prostate Cancer,Journal Watch,,,Article,2016-09-01,10.1056/nejm-jw.na42213,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11011866,https://api.altmetric.com/v1/donut/11011866_240.png 7,Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists,American Journal of Roentgenology,,,Article,2015-07-01,10.2214/ajr.14.13600,,,,26102421,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11010742,https://api.altmetric.com/v1/donut/11010742_240.png 7,Radiation Therapy for Metastatic Prostate Cancer,Journal Watch,,,Article,2016-08-26,10.1056/nejm-jw.na42117,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10864610,https://api.altmetric.com/v1/donut/10864610_240.png 7,Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,1999-10-01,,,,,10548318,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10729084,https://api.altmetric.com/v1/donut/10729084_240.png 7,"Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis",Prostate Cancer & Prostatic Diseases,,,Article,2016-08-16,10.1038/pcan.2016.36,,,,27526964,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10570413,https://api.altmetric.com/v1/donut/10570413_240.png 7,The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial,Prostate Cancer & Prostatic Diseases,,,Article,2016-08-09,10.1038/pcan.2016.37,,,,27502740,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10561674,https://api.altmetric.com/v1/donut/10561674_240.png 7,Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate Cancer,Oncology Nursing Forum,,,Article,2009-01-09,10.1188/09.onf.89-96,,,,19136342,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/10321865,https://api.altmetric.com/v1/donut/10321865_240.png 7,Role of Active Surveillance in the Management of Localized Prostate Cancer,Journal of the National Cancer Institute. Monographs,,,Article,2012-12-01,10.1093/jncimonographs/lgs032,,,,23271774,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10321863,https://api.altmetric.com/v1/donut/10321863_240.png 7,Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey,Urology,,,Article,2003-02-01,10.1016/s0090-4295(02)02162-3,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10321862,https://api.altmetric.com/v1/donut/10321862_240.png 7,Treatment decision-making strategies and influences in patients with localized prostate carcinoma,Cancer (0008543X),,,Article,2005-09-30,10.1002/cncr.21330,,,,16080181,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/10321859,https://api.altmetric.com/v1/donut/10321859_240.png 7,Cancer Treatment: Superporous Poly(ethylene glycol) Diacrylate Cryogel with a Defined Elastic Modulus for Prostate Cancer Cell Research (Small 29/2016),Small,,,Article,2016-08-01,10.1002/smll.201670146,,,,27477259,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10278220,https://api.altmetric.com/v1/donut/10278220_240.png 7,"Self-management for men surviving prostate cancer: a review of behavioural and psychosocial interventions to understand what strategies can work, for whom and in what circumstances",Psycho-Oncology,,,Article,2010-09-01,10.1002/pon.1657,,,,20119934,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/9949499,https://api.altmetric.com/v1/donut/9949499_240.png 7,Expectant management of prostate cancer.,Reviews in Urology,,,Article,,,,,,16985847,PMC1508370,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9727246,https://api.altmetric.com/v1/donut/9727246_240.png 7,Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003,Cancer Radiotherapie,,,Article,2016-06-01,10.1016/j.canrad.2016.02.009,,,,27318554,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9519289,https://api.altmetric.com/v1/donut/9519289_240.png 7,Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer,Oncogene,,,Article,2016-07-04,10.1038/onc.2016.223,,,,27375016,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9233448,https://api.altmetric.com/v1/donut/9233448_240.png 7,A randomised trial of robotic and open prostatectomy in men with localised prostate cancer,BMC Cancer,,,Article,2012-05-24,10.1186/1471-2407-12-189,,,,22632109,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/9067051,https://api.altmetric.com/v1/donut/9067051_240.png 7,Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer,Pharmaceutical Research,,,Article,2016-06-24,10.1007/s11095-016-1971-8,,,,27343000,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9045532,https://api.altmetric.com/v1/donut/9045532_240.png 7,No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.,Asian Journal of Andrology,,,Article,2016-06-04,,,,,27232853,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8467744,https://api.altmetric.com/v1/donut/8467744_240.png 7,Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation,Cell Death & Disease,,,Article,2016-06-01,10.1038/cddis.2016.123,,,,27253416,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8461790,https://api.altmetric.com/v1/donut/8461790_240.png 7,Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment,Carcinogenesis,,,Article,2016-06-01,10.1093/carcin/bgw039,,,,27207648,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8383904,https://api.altmetric.com/v1/donut/8383904_240.png 7,Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration,OncoTargets and therapy,,,Article,2016-05-12,10.2147/ott.s101794,,,,27274278,PMC4869668,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7564087,https://api.altmetric.com/v1/donut/7564087_240.png 7,"The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments",Nature Reviews Clinical Oncology,,,Article,2016-05-10,10.1038/nrclinonc.2016.80,,,,27161939,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7330637,https://api.altmetric.com/v1/donut/7330637_240.png 7,Real-time cancer diagnosis during prostate biopsy: ex vivo evaluation of full-field optical coherence tomography (FFOCT) imaging on biopsy cores,World Journal of Urology,,,Article,2015-06-23,10.1007/s00345-015-1620-6,,,,26100944,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7328773,https://api.altmetric.com/v1/donut/7328773_240.png 7,Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance,European Urology,,,Article,2016-05-01,10.1016/j.eururo.2016.04.021,,,,27157998,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7326608,https://api.altmetric.com/v1/donut/7326608_240.png 7,Toward prostate cancer contouring guidelines on MRI: dominant lesion gross and clinical target volume coverage via accurate histology fusion,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-04-01,10.1016/j.ijrobp.2016.04.018,,,,27375167,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7217377,https://api.altmetric.com/v1/donut/7217377_240.png 7,Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro,Acta Pharmacologica Sinica,,,Article,2016-05-02,10.1038/aps.2016.26,,,,27133304,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7137784,https://api.altmetric.com/v1/donut/7137784_240.png 7,The possible role of the tumour necrosis factor polymorphisms and human leucocyte antigens in the development of prostate cancer,International Journal of Immunogenetics,,,Article,2016-04-01,10.1111/iji.12262,,,,27102235,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6976221,https://api.altmetric.com/v1/donut/6976221_240.png 7,Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer,Andrology,,,Article,2016-04-07,10.1111/andr.12187,,,,27062333,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6748132,https://api.altmetric.com/v1/donut/6748132_240.png 7,Ten-year outcomes using low dose rate brachytherapy for localised prostate cancer: An update to the first Australian experience,Journal of Medical Imaging & Radiation Oncology,,,Article,2016-03-01,10.1111/1754-9485.12453,,,,27020620,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6632908,https://api.altmetric.com/v1/donut/6632908_240.png 7,Quality of Life in Prostate Cancer Patients Taking Androgen Deprivation Therapy,Journal of the American Geriatrics Society,,,Article,2006-01-15,10.1111/j.1532-5415.2005.00567.x,,,,16420202,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6631124,https://api.altmetric.com/v1/donut/6631124_240.png 7,Hypofractionation for prostate cancer: a word of caution,Lancet Oncology,,,Article,2016-03-08,10.1016/s1470-2045(15)00626-9,,,,26968358,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6335609,https://api.altmetric.com/v1/donut/6335609_240.png 7,Prostate Brachytherapy and Second Primary Cancer Risk: A Competitive Risk Analysis,Journal of Clinical Oncology,,,Article,2011-12-01,10.1200/jco.2011.35.0991,,,,22025166,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6324480,https://api.altmetric.com/v1/donut/6324480_240.png 7,Radiation-Induced Secondary Malignancy in Prostate Cancer: A Systematic Review and Meta-Analysis,Urologia Internationalis,,,Article,2014-08-16,10.1159/000356115,,,,25139441,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6324477,https://api.altmetric.com/v1/donut/6324477_240.png 7,WHAT ARE THE RISKS OF SECOND CANCER FORMATION AFTER RADIOTHERAPY TO THE PROSTATE?,British Journal of Urology,,,Article,2006-09-01,10.1111/j.1464-410x.2006.06288.x,,,,16925740,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6324474,https://api.altmetric.com/v1/donut/6324474_240.png 7,Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model,Physics in Medicine & Biology,,,Article,2009-02-07,10.1088/0031-9155/54/3/009,,,,19124952,,11541.2/116529,2009PMB....54..611T,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6324472,https://api.altmetric.com/v1/donut/6324472_240.png 7,Increased risk of rectal cancer after prostate radiation: A population-based study,Gastroenterology,,,Article,2014-03-05,10.1053/j.gastro.2004.12.038,,,,15825064,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6324466,https://api.altmetric.com/v1/donut/6324466_240.png 7,Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer,Radiotherapy & Oncology,,,Article,2010-10-18,10.1016/j.radonc.2010.09.012,,,,20951450,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6324464,https://api.altmetric.com/v1/donut/6324464_240.png 7,Higher Than Expected Association of Clinical Prostate and Bladder Cancers,The Journal of Urology,,,Article,2008-05-01,10.1016/j.juro.2008.03.130,,,,18405742,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6324461,https://api.altmetric.com/v1/donut/6324461_240.png 7,Bladder Cancer Incidence and Risk Factors in Men With Prostate Cancer: Results From Cancer of the Prostate Strategic Urologic Research Endeavor,The Journal of Urology,,,Article,2007-03-01,10.1016/j.juro.2006.10.071,,,,17296367,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6324459,https://api.altmetric.com/v1/donut/6324459_240.png 7,Increasing Age and Treatment Modality Are Predictors for Subsequent Diagnosis of Bladder Cancer Following Prostate Cancer Diagnosis,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-03-29,10.1016/j.ijrobp.2009.09.055,,,,20350797,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6324458,https://api.altmetric.com/v1/donut/6324458_240.png 7,"The Rate of Secondary Malignancies After Radical Prostatectomy Versus External Beam Radiation Therapy for Localized Prostate Cancer: A Population-Based Study on 17,845 Patients","International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-02-01,10.1016/j.ijrobp.2009.02.011,,,,20117287,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6324456,https://api.altmetric.com/v1/donut/6324456_240.png 7,Second Primary Cancer After Radiotherapy for Prostate Cancer—A SEER Analysis of Brachytherapy Versus External Beam Radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2008-03-27,10.1016/j.ijrobp.2007.12.043,,,,18374503,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6324455,https://api.altmetric.com/v1/donut/6324455_240.png 7,Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2006-03-16,10.1016/j.ijrobp.2005.11.013,,,,16545920,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6324454,https://api.altmetric.com/v1/donut/6324454_240.png 7,Secondary Cancer After Radiotherapy for Prostate Cancer: Should We Be More Aware of the Risk?,European Urology,,,Article,2007-10-14,10.1016/j.eururo.2007.07.002,,,,17644245,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6324451,https://api.altmetric.com/v1/donut/6324451_240.png 7,"946: Incidence of second malignancies for prostate cancer in the canton of Zurich, 1980-2010",European Journal of Cancer (1965),,,Article,2014-07-01,10.1016/s0959-8049(14)50838-6,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6324448,https://api.altmetric.com/v1/donut/6324448_240.png 7,"The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984–2000",Radiotherapy & Oncology,,,Article,2002-12-01,10.1016/s0167-8140(02)00307-9,,,,12464442,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6324446,https://api.altmetric.com/v1/donut/6324446_240.png 7,Increased risk of colon cancer after external radiation therapy for prostate cancer,International Journal of Cancer,,,Article,2008-09-01,10.1002/ijc.23601,,,,18546265,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6324444,https://api.altmetric.com/v1/donut/6324444_240.png 7,Frequent mismatch-repair defects link prostate cancer to Lynch syndrome,BMC Urology,,,Article,2016-03-24,10.1186/s12894-016-0130-1,,,,27013479,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6309198,https://api.altmetric.com/v1/donut/6309198_240.png 7,Relaxin Promotes Prostate Cancer Progression,Clinical Cancer Research,,,Article,2007-03-15,10.1158/1078-0432.ccr-06-2492,,,,17363522,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6288014,https://api.altmetric.com/v1/donut/6288014_240.png 7,Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.,JNCI: Journal of the National Cancer Institute,,,Article,2009-03-18,10.1093/jnci/djp001,,,,19276453,PMC2720697,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107,https://www.altmetric.com/details/6090943,https://api.altmetric.com/v1/donut/6090943_240.png 7,"Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.",British Journal of Cancer,,,Article,2009-08-03,10.1038/sj.bjc.6605159,,,,19568244,PMC2720230,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6064588,https://api.altmetric.com/v1/donut/6064588_240.png 7,Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.,Journal of Proteome Research,,,Article,2009-06-14,10.1021/pr8009337,,,,19275204,PMC2790378,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6063530,https://api.altmetric.com/v1/donut/6063530_240.png 7,Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort,Carcinogenesis,,,Article,2016-03-01,10.1093/carcin/bgw001,,,,26775038,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6025915,https://api.altmetric.com/v1/donut/6025915_240.png 7,Prostate cancer: Integrin inhibitors active against bone metastases,Nature Reviews Urology,,,Article,2016-02-23,10.1038/nrurol.2016.42,,,,26902336,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5977939,https://api.altmetric.com/v1/donut/5977939_240.png 7,"Watching, waiting and uncertainty in prostate cancer.",Journal of Clinical Nursing,,,Article,2007-04-14,10.1111/j.1365-2702.2005.01545.x,,,,17402955,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/5802334,https://api.altmetric.com/v1/donut/5802334_240.png 7,Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate,British Journal of Urology,,,Article,2015-05-01,10.1111/bju.13108,,,,25726856,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5307893,https://api.altmetric.com/v1/donut/5307893_240.png 7,Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer,Practical Radiation Oncology,,,Article,2015-06-06,10.1016/j.prro.2015.04.006,,,,26059510,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5307892,https://api.altmetric.com/v1/donut/5307892_240.png 7,Androgenetic Alopecia at Various Ages and Prostate Cancer Risk in an Equal Access Multiethnic Case Control Series of Veterans,Cancer Causes and Control,,,Article,2013-05-01,10.1007/s10552-013-0182-4,,,,23529469,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5302149,https://api.altmetric.com/v1/donut/5302149_240.png 7,FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer,Journal of Clinical Investigation,,,Article,2015-05-01,10.1172/jci81878,,,,25932678,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5104075,https://api.altmetric.com/v1/donut/5104075_240.png 7,Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.,Oncotarget,,,Article,2013-11-23,10.18632/oncotarget.1572,,,,24293458,PMC3926837,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/5055507,https://api.altmetric.com/v1/donut/5055507_240.png 7,Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results.,Biomarkers in Medicine,,,Article,2016-01-19,10.2217/bmm.15.114,,,,26764285,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5009456,https://api.altmetric.com/v1/donut/5009456_240.png 7,Replication study of 34 common SNPs associated with prostate cancer in the Romanian population,Journal of Cellular and Molecular Medicine,,,Article,2016-01-01,10.1111/jcmm.12729,,,,26773531,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5009431,https://api.altmetric.com/v1/donut/5009431_240.png 7,"Quality of Life, Morbidity, and Mortality Results of a Prospective Phase II Study of Intermittent Androgen Suppression for Men with Evidence of Prostate-Specific Antigen Relapse After Radiation Therapy for Locally Advanced Prostate Cancer",Clinical Genitourinary Cancer,,,Article,2008-01-03,10.3816/cgc.2008.n.008,,,,18501083,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4961173,https://api.altmetric.com/v1/donut/4961173_240.png 7,Impact of aspirin on clinical outcomes for African American men with prostate cancer undergoing radiation.,Tumori,,,Article,,10.5301/tj.5000424,,,,26429642,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4960739,https://api.altmetric.com/v1/donut/4960739_240.png 7,Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer,Journal of Nuclear Medicine,,,Article,2015-12-16,10.2967/jnumed.115.168393,,,,26659347,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4881250,https://api.altmetric.com/v1/donut/4881250_240.png 7,Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion,Medical Oncology,,,Article,2013-08-08,10.1007/s12032-013-0674-9,,,,23925662,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4820355,https://api.altmetric.com/v1/donut/4820355_240.png 7,Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-10-01,10.1158/1055-9965.epi-10-0555,,,,20841388,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/4818376,https://api.altmetric.com/v1/donut/4818376_240.png 7,Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-10-13,10.1038/pcan.2015.46,,,,26458958,,10161/10917,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4817986,https://api.altmetric.com/v1/donut/4817986_240.png 7,Evaluation of Posttreatment Follow-Up of Patients With Prostate Cancer Relative to the American College of Radiology's Appropriateness Criteria,American Journal of Roentgenology,,,Article,,10.2214/ajr.14.13766,,,,26496548,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4768304,https://api.altmetric.com/v1/donut/4768304_240.png 7,DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis,Cell Death & Disease,,,Article,2015-10-01,10.1038/cddis.2015.289,,,,26512963,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4704180,https://api.altmetric.com/v1/donut/4704180_240.png 7,Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status,Prostate Cancer & Prostatic Diseases,,,Article,2015-10-27,10.1038/pcan.2015.49,,,,26503111,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4681868,https://api.altmetric.com/v1/donut/4681868_240.png 7,Update of the results of the Spanish branch of the European randomized study on screening for prostate cancer (ERSPC),Actas Urologicas Espanolas - English Edition,,,Article,2015-09-01,10.1016/j.acuroe.2015.06.004,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4579115,https://api.altmetric.com/v1/donut/4579115_240.png 7,Abstract B48: Anticancer effect of guava leaves (Psidium guajava L.) in prostate cancer cells,Cancer Prevention Research,,,Article,2012-11-01,10.1158/1940-6207.prev-12-b48,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4541294,https://api.altmetric.com/v1/donut/4541294_240.png 7,Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma,Cancer (0008543X),,,Article,2002-07-15,10.1002/cncr.10647,,,,12124837,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/4368653,https://api.altmetric.com/v1/donut/4368653_240.png 7,Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors,British Journal of Cancer,,,Article,2015-08-04,10.1038/bjc.2015.275,,,,26241816,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4362796,https://api.altmetric.com/v1/donut/4362796_240.png 7,TH-AB-304-01: Dose-Volume Relations for Late Rectal Bleeding in 1001 Patients From Five Prostate Cancer Cohorts,Medical Physics,,,Article,2015-06-01,10.1118/1.4926116,,,,26129417,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4347965,https://api.altmetric.com/v1/donut/4347965_240.png 7,"Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England.",British Journal of Urology,,,Article,,10.1111/j.1464-410x.2009.08940.x,,,,19878505,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4343295,https://api.altmetric.com/v1/donut/4343295_240.png 7,Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging,Radiology,,,Article,,10.1148/radiol.15141412,,,,25848900,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4330649,https://api.altmetric.com/v1/donut/4330649_240.png 7,Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer,The Prostate,,,Article,2015-06-12,10.1002/pros.23034,,,,26074449,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4223321,https://api.altmetric.com/v1/donut/4223321_240.png 7,Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance,Prostate Cancer & Prostatic Diseases,,,Article,2015-06-16,10.1038/pcan.2015.29,,,,26078202,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4176707,https://api.altmetric.com/v1/donut/4176707_240.png 7,"An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality",British Journal of Cancer,,,Article,2015-06-11,10.1038/bjc.2015.199,,,,26068399,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4153722,https://api.altmetric.com/v1/donut/4153722_240.png 7,The biopsy Gleason score 3|[plus]|4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3|[plus]|3: looking for larger selection criteria for active surveillance candidates,Prostate Cancer & Prostatic Diseases,,,Article,2015-06-09,10.1038/pcan.2015.21,,,,26055663,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4140219,https://api.altmetric.com/v1/donut/4140219_240.png 7,Clinical characteristics and quality?of?life in patients surviving a decade of prostate cancer with bone metastases,British Journal of Urology,,,Article,2015-07-14,10.1111/bju.13190,,,,26033416,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4130008,https://api.altmetric.com/v1/donut/4130008_240.png 7,Performance of biopsy factors in predicting unfavorable disease in patients eligible for active surveillance according to the PRIAS criteria,Prostate Cancer & Prostatic Diseases,,,Article,2015-06-02,10.1038/pcan.2015.26,,,,26032650,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4085258,https://api.altmetric.com/v1/donut/4085258_240.png 7,"Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.",,,,Article,2015-05-20,10.1186/1471-2407-9-84,,,,19292893,PMC2670317,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/4034570,https://api.altmetric.com/v1/donut/4034570_240.png 7,Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2015-05-19,10.1038/pcan.2015.20,,,,25986915,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4012816,https://api.altmetric.com/v1/donut/4012816_240.png 7,Prostate cancer: Two novel loci associated with Gleason score identified,Nature Reviews Urology,,,Article,2015-05-19,10.1038/nrurol.2015.120,,,,25986765,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4011428,https://api.altmetric.com/v1/donut/4011428_240.png 7,Prostate cancer: Assay for PTEN deletion developed for clinical use,Nature Reviews Urology,,,Article,2015-05-19,10.1038/nrurol.2015.121,,,,25986763,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4011426,https://api.altmetric.com/v1/donut/4011426_240.png 7,"Prostate cancer: Selenium, lycopene and GTC[mdash]a case of 'chemopromotion'",Nature Reviews Urology,,,Article,2015-05-12,10.1038/nrurol.2015.97,,,,25963959,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4004128,https://api.altmetric.com/v1/donut/4004128_240.png 7,Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-05-12,10.1038/pcan.2015.17,,,,25964141,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4003820,https://api.altmetric.com/v1/donut/4003820_240.png 7,AACR 2015: Subgroup of men with metastatic prostate cancer responded to olaparib treatment,ecancer.org,,,Article,,,,,http://ecancer.org/news/7192-aacr-2015--subgroup-of-men-with-metastatic-prostate-cancer-responded-to-olaparib-treatment.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3928023,https://api.altmetric.com/v1/donut/3928023_240.png 7,Re: Comparison of MR/Ultrasound Fusion-Guided Biopsy with Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer,The Journal of Urology,,,Article,2015-01-07,10.1016/j.juro.2015.04.062,,,,26088222,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,161,https://www.altmetric.com/details/3920024,https://api.altmetric.com/v1/donut/3920024_240.png 7,Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2015-04-14,10.1038/pcan.2015.11,,,,25868764,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3907909,https://api.altmetric.com/v1/donut/3907909_240.png 7,Gonadotropin-releasing hormone agonist overuse: urologists|[rsquo]| response to reimbursement and characteristics associated with persistent overuse,Prostate Cancer & Prostatic Diseases,,,Article,2015-04-07,10.1038/pcan.2015.10,,,,25849354,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3885286,https://api.altmetric.com/v1/donut/3885286_240.png 7,Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer,British Journal of Cancer,,,Article,2015-03-31,10.1038/bjc.2015.74,,,,25867259,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3860228,https://api.altmetric.com/v1/donut/3860228_240.png 7,Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.,,,,Article,2007-07-03,10.1093/jnci/djm023,,,,17596576,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3860220,https://api.altmetric.com/v1/donut/3860220_240.png 7,Validation of the omega-3 fatty acid intake measured by a web-based food frequency questionnaire against omega-3 fatty acids in red blood cells in men with prostate cancer,European Journal of Clinical Nutrition,,,Article,2015-03-11,10.1038/ejcn.2015.7,,,,25758837,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3839988,https://api.altmetric.com/v1/donut/3839988_240.png 7,Urological cancer: Urinary methylation signature predicts prostate cancer risk,Nature Reviews Clinical Oncology,,,Article,2015-03-10,10.1038/nrclinonc.2015.49,,,,25754954,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3839984,https://api.altmetric.com/v1/donut/3839984_240.png 7,Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.,The Prostate,,,Article,2014-12-31,10.1002/pros.22943,,,,25545744,,,,,,,0,0,0,3,0,0,2,0,4,0,0,0,0,0,0,25,https://www.altmetric.com/details/3809393,https://api.altmetric.com/v1/donut/3809393_240.png 7,Taxane response in prostate cancer may not be influenced by androgen receptor variations. Taxane response in prostate cancer may not be influenced by androgen receptor variations,ecancer.org,,,Article,,,,,http://ecancer.org/video/3511/taxane-response-in-prostate-cancer-may-not-be-influenced-by-androgen-receptor-variations.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3783190,https://api.altmetric.com/v1/donut/3783190_240.png 7,ASCO GU: Active surveillance of intermediate-risk prostate cancer associated with decreased survival,ecancer.org,,,Article,,,,,http://ecancer.org/news/7013-asco-gu--active-surveillance-of-intermediate-risk-prostate-cancer-associated-with-decreased-survival.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3769816,https://api.altmetric.com/v1/donut/3769816_240.png 7,Prostate cancer screening in Primary Health Care: the current state of affairs,SpringerPlus,,,Article,2015-02-13,10.1186/s40064-015-0819-8,,,,25713765,PMC4332913,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3742441,https://api.altmetric.com/v1/donut/3742441_240.png 7,Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,1998-08-01,,,,,9718219,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3711109,https://api.altmetric.com/v1/donut/3711109_240.png 7,Utility of Multiparametric Magnetic Resonance Imaging Suspicion Levels for Detecting Prostate Cancer,The Journal of Urology,,,Article,2013-11-15,10.1016/j.juro.2013.05.052,,,,23727310,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/3443438,https://api.altmetric.com/v1/donut/3443438_240.png 7,Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2010-04-27,10.1038/pcan.2010.12,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3436416,https://api.altmetric.com/v1/donut/3436416_240.png 7,Local insulin-like growth factor-I of ventral prostate was upregulated during long-term castration and may function through the autocrine system,Prostate Cancer & Prostatic Diseases,,,Article,2011-04-05,10.1038/pcan.2011.19,,,,21468026,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3436415,https://api.altmetric.com/v1/donut/3436415_240.png 7,Prostate cancer: DTCs are not associated with clinical outcome,Nature Reviews Urology,,,Article,2015-02-03,10.1038/nrurol.2015.19,,,,25644159,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3434418,https://api.altmetric.com/v1/donut/3434418_240.png 7,Prostate cancer: Predictors of high-grade tumours at radical prostatectomy,Nature Reviews Urology,,,Article,2015-02-03,10.1038/nrurol.2015.18,,,,25644155,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3434417,https://api.altmetric.com/v1/donut/3434417_240.png 7,Prostate cancer: Reducing hospital admissions following prostate biopsy,Nature Reviews Urology,,,Article,2015-02-03,10.1038/nrurol.2015.21,,,,25644158,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3434414,https://api.altmetric.com/v1/donut/3434414_240.png 7,Prostate cancer: Metformin not associated with prostate cancer diagnosis,Nature Reviews Urology,,,Article,2015-02-03,10.1038/nrurol.2015.9,,,,25644157,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3434412,https://api.altmetric.com/v1/donut/3434412_240.png 7,Androgen Receptors in Hormone-Dependent and Castration-Resistant Prostate Cancer.,Pharmacology & Therapeutics,,,Article,2013-07-19,10.1016/j.pharmthera.2013.07.003,,,,23859952,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/3388739,https://api.altmetric.com/v1/donut/3388739_240.png 7,Prostate cancer: TXNDC5 is important in castration-resistant prostate cancer,Nature Reviews Urology,,,Article,2015-01-06,10.1038/nrurol.2014.368,,,,25558844,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3042472,https://api.altmetric.com/v1/donut/3042472_240.png 7,Prostate cancer: Enzalutamide[mdash]differential cross resistance with taxanes,Nature Reviews Urology,,,Article,2014-12-23,10.1038/nrurol.2014.353,,,,25534993,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3011876,https://api.altmetric.com/v1/donut/3011876_240.png 7,Active surveillance for clinically localized prostate cancer––A systematic review,Journal of Surgical Oncology,,,Article,2014-03-07,10.1002/jso.23584,,,,24610744,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3003219,https://api.altmetric.com/v1/donut/3003219_240.png 7,Genetic Variation in the Vitamin D Pathway in Relation to Risk of Prostate Cancer - Results from Breast and Prostate Cancer Cohort Consortium (BPC3).,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-02-06,10.1158/1055-9965.epi-13-0007-t,,,,23377224,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3000242,https://api.altmetric.com/v1/donut/3000242_240.png 7,Enzalutamide now approved in Europe for the treatment of chemotherapy-naïve men with metastatic castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6761-enzalutamide-now-approved-in-europe-for-the-treatment-of-chemotherapy-na--ve-men-with-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2974991,https://api.altmetric.com/v1/donut/2974991_240.png 7,Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-12-09,10.1038/pcan.2014.48,,,,25487136,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2971538,https://api.altmetric.com/v1/donut/2971538_240.png 7,Galeterone activity in castration-resistant prostate cancer ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)71165-9,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2931838,https://api.altmetric.com/v1/donut/2931838_240.png 7,Urological cancer: PCA3 scoring could improve prostate cancer risk estimation,Nature Reviews Clinical Oncology,,,Article,2014-11-25,10.1038/nrclinonc.2014.209,,,,25421277,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2926715,https://api.altmetric.com/v1/donut/2926715_240.png 7,"Development, feasibility and usability of an online psychological intervention for men with prostate cancer: My Road Ahead ",Internet Interventions - The application of information technology in mental and behavioural,,,Article,2014-10-01,10.1016/j.invent.2014.10.001,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2920327,https://api.altmetric.com/v1/donut/2920327_240.png 7,Prostate Cancer: Diagnostic Performance of Real-time Shear-Wave Elastography,Radiology,,,Article,2014-11-19,10.1148/radiol.14140567,,,,25599156,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2914640,https://api.altmetric.com/v1/donut/2914640_240.png 7,Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy,Prostate Cancer & Prostatic Diseases,,,Article,2014-11-04,10.1038/pcan.2014.43,,,,25348255,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2851664,https://api.altmetric.com/v1/donut/2851664_240.png 7,Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin,Prostate Cancer & Prostatic Diseases,,,Article,2014-10-21,10.1038/pcan.2014.40,,,,25330857,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2799309,https://api.altmetric.com/v1/donut/2799309_240.png 7,Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone,British Journal of Cancer,,,Article,2014-10-14,10.1038/bjc.2014.531,,,,25314055,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2779533,https://api.altmetric.com/v1/donut/2779533_240.png 7,Decade in review[mdash]prostate cancer: A decade of progress in detection and treatment,Nature Reviews Urology,,,Article,2014-10-14,10.1038/nrurol.2014.284,,,,25311674,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2777223,https://api.altmetric.com/v1/donut/2777223_240.png 7,Prostate cancer: Final analysis of early-access protocol trial to enable worldwide preapproval access to abiraterone,Nature Reviews Urology,,,Article,2014-10-14,10.1038/nrurol.2014.293,,,,25311681,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2777214,https://api.altmetric.com/v1/donut/2777214_240.png 7,Does Exposure to Agricultural Chemicals Increase the Risk of Prostate Cancer among Farmers?,McGill Journal of Medicine,,,Article,2009-01-01,,,,,19753293,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2742858,https://api.altmetric.com/v1/donut/2742858_240.png 7,Radiorecurrent Prostate Cancer: An Emerging and Largely Mismanaged Epidemic,European Urology,,,Article,2011-01-01,10.1016/j.eururo.2011.01.007,,,,21247684,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2712415,https://api.altmetric.com/v1/donut/2712415_240.png 7,ASTRO: Prostate cancer patients who receive hypofractionated RT report consistent QoL,ecancer.org,,,Article,,,,,http://ecancer.org/news/6323-astro--prostate-cancer-patients-who-receive-hypofractionated-rt-report-consistent-qol.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2692356,https://api.altmetric.com/v1/donut/2692356_240.png 7,ASTRO: Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function,ecancer.org,,,Article,,,,,http://ecancer.org/news/6322-astro--prostate-cancer-patients-surveyed-5-years-after-vessel-sparing-rt-report-preserved-sexual-function.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2692351,https://api.altmetric.com/v1/donut/2692351_240.png 7,Interactions of a Non?Thermal Atmospheric Pressure Plasma Effluent with PC?3 Prostate Cancer Cells,Plasma Processes and Polymers,,,Article,2014-09-12,10.1002/ppap.201400111,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2690344,https://api.altmetric.com/v1/donut/2690344_240.png 7,Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population,Prostate Cancer & Prostatic Diseases,,,Article,2014-09-16,10.1038/pcan.2014.34,,,,25224557,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2687745,https://api.altmetric.com/v1/donut/2687745_240.png 7,Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid.,BMC Urology,,,Article,2014-08-03,10.1186/1471-2490-14-59,,,,25086448,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2568254,https://api.altmetric.com/v1/donut/2568254_240.png 7,The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2014-07-08,10.1016/j.clgc.2014.04.008,,,,24999166,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2499602,https://api.altmetric.com/v1/donut/2499602_240.png 7,Should all colorectal cancer patients over age 60 be screened for prostate cancer?,Oncology (Williston Park),,,Article,2013-12-26,,,,,24367864,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2419892,https://api.altmetric.com/v1/donut/2419892_240.png 7,Prostate Cancer Screening and Risk of Litigation: Caught between Scylla and Charybdis,The Journal of Urology,,,Article,,10.1016/j.juro.2014.03.085,,,,24656674,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2400133,https://api.altmetric.com/v1/donut/2400133_240.png 7,"Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer. Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer",ecancer.org,,,Article,,,,,http://ecancer.org/video/2856/addition-of-docetaxel-to-initial-hormone-therapy-substantially-improves-survival-in-metastatic--hormone-sensitive-prostate-cancer.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2397469,https://api.altmetric.com/v1/donut/2397469_240.png 7,Identification of specific Y chromosomes associated with increased prostate cancer risk.,The Prostate,,,Article,2014-05-06,10.1002/pros.22821,,,,24796687,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2336536,https://api.altmetric.com/v1/donut/2336536_240.png 7,Reduction in Patient-reported Acute Morbidity in Prostate Cancer Patients Treated With 81-Gy Intensity-modulated Radiotherapy Using Reduced Planning Target Volume Margins and Electromagnetic Tracking: Assessing the Impact of Margin Reduction Study,Urology,,,Article,2010-01-05,10.1016/j.urology.2009.10.072,,,,20153881,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2335997,https://api.altmetric.com/v1/donut/2335997_240.png 7,"Determinants of NCI Cancer Center Attendance in Medicare Patients with Lung, Breast, Colorectal, or Prostate Cancer",JGIM: Journal of General Internal Medicine,,,Article,2009-02-01,10.1007/s11606-008-0863-y,,,,19067086,PMC2628988,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2315378,https://api.altmetric.com/v1/donut/2315378_240.png 7,Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparison,CMAJ Open,,,Article,2014-04-24,10.9778/cmajo.20130037,,,,25077131,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2315215,https://api.altmetric.com/v1/donut/2315215_240.png 7,Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling.,Stem Cell Research & Therapy,,,Article,2014-04-19,10.1186/scrt443,,,,24739733,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2292658,https://api.altmetric.com/v1/donut/2292658_240.png 7,"The More, The Merrier: Including a Medical Oncologist in Treatment Planning for Localized Prostate Cancer",Journal of Oncology Practice,,,Article,2014-01-07,10.1200/jop.2013.001247,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2274179,https://api.altmetric.com/v1/donut/2274179_240.png 7,The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-specific Antigen Levels: A Meta-analysis.,Academic Radiology,,,Article,2014-05-01,10.1016/j.acra.2014.01.004,,,,24703470,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2268134,https://api.altmetric.com/v1/donut/2268134_240.png 7,Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer,Journal of Oncology,,,Article,2010-01-01,10.1155/2010/617421,,,,20016752,PMC2793426,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,180,https://www.altmetric.com/details/2227216,https://api.altmetric.com/v1/donut/2227216_240.png 7, Prostate cancer testing: a snapshot of the attitudes and practice of Australian general practitioners,Australian Journal of Primary Health,,,Article,2013-11-01,10.1071/py13078,,,,24176263,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2211172,https://api.altmetric.com/v1/donut/2211172_240.png 7,"Is Robot-Assisted Radical Prostatectomy Safe in Men with High-Risk Prostate Cancer? Assessment of Perioperative Outcomes, Positive Surgical Margins, and Use of Additional Cancer Treatments.",Journal of Endourology,,,Article,2014-02-08,10.1089/end.2013.0774,,,,24499306,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2118510,https://api.altmetric.com/v1/donut/2118510_240.png 7,Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb?conjugated SPIONs for specific detection of prostate cancer,Contrast Media and Molecular Imaging,,,Article,2013-01-04,10.1002/cmmi.1514,,,,23281290,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2057581,https://api.altmetric.com/v1/donut/2057581_240.png 7,Efficacy of c-Met inhibitor for advanced prostate cancer,BMC Cancer,,,Article,2010-10-14,10.1186/1471-2407-10-556,,,,20946682,PMC2964640,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1983829,https://api.altmetric.com/v1/donut/1983829_240.png 7,How does initial treatment choice affect short?term and long?term costs for clinically localized prostate cancer?,Cancer (0008543X),,,Article,2010-01-01,10.1002/cncr.25517,,,,20734396,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1983803,https://api.altmetric.com/v1/donut/1983803_240.png 7,Preliminary Analysis of 3D-CRT vs. IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Toxicity Report,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2011.06.004,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1983800,https://api.altmetric.com/v1/donut/1983800_240.png 7,Five Year Results of a Randomized External Beam Radiotherapy Hypofractionation Trial for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.06.003,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1983799,https://api.altmetric.com/v1/donut/1983799_240.png 7,Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer,Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2011.36.5791,,,,22231045,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/1983732,https://api.altmetric.com/v1/donut/1983732_240.png 7,MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells,BMC Complementary and Alternative Medicine,,,Article,2013-11-23,10.1186/1472-6882-13-325,,,,24267199,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1931840,https://api.altmetric.com/v1/donut/1931840_240.png 7,The Prognostic Value of Pathologic Prostate-specific Antigen Mass Ratio in Patients With Localized Prostate Cancer With Negative Surgical Resection Margins,Urology,,,Article,2013-10-01,10.1016/j.urology.2013.04.040,,,,23830078,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1807410,https://api.altmetric.com/v1/donut/1807410_240.png 7,Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12280,,,,24006951,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1791793,https://api.altmetric.com/v1/donut/1791793_240.png 7,Prostate cancer drug development update. Prostate cancer drug development update,ecancer.org,,,Article,,,,,http://ecancer.org/video/1148/prostate-cancer-drug-development-update.php,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1731761,https://api.altmetric.com/v1/donut/1731761_240.png 7,Variation in Treatment Recommendations of Adjuvant Radiation Therapy for High-risk Prostate Cancer by Physician Specialty.,Urology,,,Article,2013-08-01,10.1016/j.urology.2013.04.060,,,,23910088,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1675749,https://api.altmetric.com/v1/donut/1675749_240.png 7,Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.,Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70294-8,,,,23871417,,,,,,,0,0,0,10,0,0,1,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1629118,https://api.altmetric.com/v1/donut/1629118_240.png 7,Prediagnostic Circulating Sex Hormones Are Not Associated with Mortality for Men with Prostate Cancer.,European Urology,,,Article,2013-01-25,10.1016/j.eururo.2013.01.003,,,,23340241,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1504859,https://api.altmetric.com/v1/donut/1504859_240.png 7,Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor mediated signaling in prostate cancer.,Endocrine-Related Cancer,,,Article,2013-04-26,10.1530/erc-13-0133,,,,23612613,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1497225,https://api.altmetric.com/v1/donut/1497225_240.png 7,Impact of preâ??treatment prostate tissue androgen content on the prediction of future castrationâ??resistant prostate cancer development in patients treated with primary androgen deprivation therapy,Andrology,,,Article,2013-05-14,10.1111/j.2047-2927.2013.00068.x,,,,23444052,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1283557,https://api.altmetric.com/v1/donut/1283557_240.png 7,Cabozantinib in Prostate Cancer: The Beginning of a Precision Paradigm?,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.46.6185,,,,23248244,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1130239,https://api.altmetric.com/v1/donut/1130239_240.png 7,Endogenous immune response to gangliosides in patients with confined prostate cancer,International Journal of Cancer,,,Article,2005-01-01,10.1002/ijc.21023,,,,15818621,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/876525,https://api.altmetric.com/v1/donut/876525_240.png 7,Chemoprevention of prostate cancer with nutrients and supplements,Cancer Management and Research,,,Article,2012-07-28,10.2147/cmr.s18503,,,,21629831,PMC3097798,,,,,,0,0,1,11,0,0,4,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/861154,https://api.altmetric.com/v1/donut/861154_240.png 7,Pre-treatment risk stratification of prostate cancer patients: A critical review.,Canadian Urological Association Journal,,,Article,2012-04-20,10.5489/cuaj.11085,,,,22511420,,,,,,,0,0,2,1,0,0,0,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/712602,https://api.altmetric.com/v1/donut/712602_240.png 7,The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers,Cancer Cell,,,Article,2008-01-06,10.1016/j.ccr.2008.04.016,,,,18538735,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,2,0,0,74,https://www.altmetric.com/details/528633,https://api.altmetric.com/v1/donut/528633_240.png 7,Dasatinib combined with docetaxel for castration?resistant prostate cancer,Cancer (0008543X),,,Article,2011-01-01,10.1002/cncr.26204,,,,21381005,,,,,,,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/477134,https://api.altmetric.com/v1/donut/477134_240.png 7,Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand,Molecular Pharmaceutics,,,Article,2009-06-01,10.1021/mp900069d,,,,19361233,,,,,,,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/399881,https://api.altmetric.com/v1/donut/399881_240.png 7,US expert panel recommends against prostate cancer screening,British Medical Journal,,,Article,2011-10-10,10.1136/bmj.d6479,,,,21987717,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,1,0,1,https://www.altmetric.com/details/397980,https://api.altmetric.com/v1/donut/397980_240.png 7,A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.,Journal of Clinical Oncology,,,Article,2007-08-20,10.1200/jco.2006.10.3820,,,,17704404,,,,,,,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/211999,https://api.altmetric.com/v1/donut/211999_240.png 7,External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study,Lancet Oncology,,,Article,2010-11-01,10.1016/s1470-2045(10)70223-0,,,,20933466,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,147,https://www.altmetric.com/details/211888,https://api.altmetric.com/v1/donut/211888_240.png 7,Targeted biopsy to detect Gleason score upgrading during active surveillance for men with low- vs. intermediate-risk prostate cancer,The Journal of Urology,,,Article,2016-09-19,10.1016/j.juro.2016.09.070,,,,27639713,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12004567,https://api.altmetric.com/v1/donut/12004567_240.png 7,Is It Time to Re-Examine the Prostate Cancer Treatment Paradigm by Targeting the Interaction Between the Prostate and Metastases?,Journal of Clinical Oncology,,,Article,2016-07-18,10.1200/jco.2016.68.4738,,,,27432923,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9872151,https://api.altmetric.com/v1/donut/9872151_240.png 7,Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial ,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-11-19,10.1016/j.ijrobp.2015.09.020,,,,26576711,,,,,,,0,0,0,8,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4538881,https://api.altmetric.com/v1/donut/4538881_240.png 7,The changes in prostate cancer and its management in the North West of England over a 10-year period,Journal of Clinical Urology,,,Article,2015-03-04,10.1177/2051415815575218,,,,,,,,,,,0,0,0,21,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3756984,https://api.altmetric.com/v1/donut/3756984_240.png 7,Vitamin d in blood and risk of prostate cancer: lessons from the selenium and vitamin e cancer prevention trial and the prostate cancer prevention trial.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-08-14,10.1158/1055-9965.epi-14-0520,,,,25085835,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2560397,https://api.altmetric.com/v1/donut/2560397_240.png 7,Prostate cancer and the influence of dietary factors and supplements: a systematic review,Nutrition & Metabolism,,,Article,2014-07-10,10.1186/1743-7075-11-30,,,,24976856,,,,,,,0,0,0,10,0,0,3,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/2498306,https://api.altmetric.com/v1/donut/2498306_240.png 7,Prostatic Artery Embolization to Treat Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia and Bleeding in Patients with Prostate Cancer: Proceedings from a Multidisciplinary Research Consensus Panel,Journal of Vascular and Interventional Radiology,,,Article,2014-02-21,10.1016/j.jvir.2013.11.003,,,,24560898,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2136243,https://api.altmetric.com/v1/donut/2136243_240.png 7,Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.,Nat Med,,,Article,2008-07-17,10.1038/nm.1727,,,,18622403,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/527384,https://api.altmetric.com/v1/donut/527384_240.png 7,Periprostatic Fat: A Risk Factor for Prostate Cancer?,Urology,,,Article,2016-09-01,10.1016/j.urology.2016.07.042,,,,27592523,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11532523,https://api.altmetric.com/v1/donut/11532523_240.png 7,Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer ,European Urology Focus ,,,Article,2015-12-02,10.1016/j.euf.2015.11.004,,,,27766313,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4830301,https://api.altmetric.com/v1/donut/4830301_240.png 7,A Randomized Controlled Trial for the Effectiveness of Progressive Muscle Relaxation and Guided Imagery as Anxiety Reducing Interventions in Breast and Prostate Cancer Patients Undergoing Chemotherapy,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2015-08-06,10.1155/2015/270876,,,,26347018,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4370237,https://api.altmetric.com/v1/donut/4370237_240.png 7,Latest developments in prostate cancer. Latest developments in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3692/latest-developments-in-prostate-cancer.php,,,,,,,,0,0,0,17,0,0,4,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4015861,https://api.altmetric.com/v1/donut/4015861_240.png 7,"The effect, moderators, and mediators of resistance and aerobic exercise on health?related quality of life in older long?term survivors of prostate cancer",Cancer (0008543X),,,Article,2015-04-17,10.1002/cncr.29406,,,,25891302,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3952957,https://api.altmetric.com/v1/donut/3952957_240.png 7,A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer,Journal of Cancer Survivorship,,,Article,2015-04-28,10.1007/s11764-014-0417-8,,,,25916660,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3951054,https://api.altmetric.com/v1/donut/3951054_240.png 7,Clinical Implications of a Multiparametric Magnetic Resonance Imaging Based Nomogram Applied to Prostate Cancer Active Surveillance,The Journal of Urology,,,Article,2015-01-26,10.1016/j.juro.2015.01.088,,,,25633923,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3105596,https://api.altmetric.com/v1/donut/3105596_240.png 7,Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias?,European Urology,,,Article,2015-08-01,10.1016/j.eururo.2014.10.035,,,,25466944,,,,,,,0,0,0,12,0,0,2,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/2848066,https://api.altmetric.com/v1/donut/2848066_240.png 7,ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.,Cancer Research,,,Article,2013-08-07,10.1158/0008-5472.can-13-0882,,,,23913826,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2057152,https://api.altmetric.com/v1/donut/2057152_240.png 7,Prevalence of Pain and Analgesic Use in Men With Metastatic Prostate Cancer Using a Patient-Reported Outcome Measure,Journal of Oncology Practice,,,Article,2013-01-01,10.1200/jop.2013.000876,,,,23943897,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1584047,https://api.altmetric.com/v1/donut/1584047_240.png 7,Clinical Uncertainty of Prostate Cancer Genetic Risk Panels,Science Translational Medicine,,,Article,2013-04-24,10.1126/scitranslmed.3004696,,,,23616119,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1411577,https://api.altmetric.com/v1/donut/1411577_240.png 7,Prostate cancer screening practices of African-American and non-African-American US primary care physicians: a cross-sectional survey,International Journal of General Medicine,,,Article,2012-10-11,10.2147/ijgm.s36028,,,,23049271,,,,,,,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1001943,https://api.altmetric.com/v1/donut/1001943_240.png 7,"Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker",Journal of the American Chemical Society,,,Article,2016-03-23,10.1021/jacs.6b00986,,,,26967262,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6720437,https://api.altmetric.com/v1/donut/6720437_240.png 7,Combined Biparametric Prostate MRI and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy Naïve Patient Population,Urology,,,Article,2015-12-19,10.1016/j.urology.2015.09.035,,,,26680244,,,,,,,0,0,0,12,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4854867,https://api.altmetric.com/v1/donut/4854867_240.png 7,Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue,European Urology,,,Article,2015-10-19,10.1016/j.eururo.2015.09.019,,,,26489476,,,,,,,0,0,0,13,0,0,2,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/4643885,https://api.altmetric.com/v1/donut/4643885_240.png 7,Mortality After Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt059,,,,23615689,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1415086,https://api.altmetric.com/v1/donut/1415086_240.png 7,Molecular classification of prostate cancer using curated expression signatures,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-11-28,10.1073/pnas.1117029108,,,,22123976,,,2011PNAS..10821276M,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,48,https://www.altmetric.com/details/476204,https://api.altmetric.com/v1/donut/476204_240.png 7,"Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial",Cancer (0008543X),,,Article,2016-05-03,10.1002/cncr.30004,,,,27149646,,,,,,,0,0,0,12,0,0,4,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7131380,https://api.altmetric.com/v1/donut/7131380_240.png 7,Occupational exposure to pesticides and prostate cancer: a systematic review and meta-analysis,Occupational and environmental medicine,,,Article,2015-12-07,10.1136/oemed-2014-102692,,,,26644457,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4848959,https://api.altmetric.com/v1/donut/4848959_240.png 7,Long?term exposure to leptin enhances the growth of prostate cancer cells.,International Journal of Oncology,,,Article,2015-01-23,10.3892/ijo.2015.2845,,,,25625287,,,,,,,0,0,0,12,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3112154,https://api.altmetric.com/v1/donut/3112154_240.png 7,"Prostate cancer: AS[mdash]contemplation, not intervention",Nature Reviews Urology,,,Article,2015-09-15,10.1038/nrurol.2015.224,,,,26369726,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4509289,https://api.altmetric.com/v1/donut/4509289_240.png 7,Palliative pelvic radiotherapy of symptomatic incurable prostate cancer - A systematic review.,Radiotherapy & Oncology,,,Article,2013-09-17,10.1016/j.radonc.2013.08.008,,,,24044801,,,,,,,0,0,2,10,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1757756,https://api.altmetric.com/v1/donut/1757756_240.png 7,Aspirin Use is Associated with Lower Prostate Cancer Risk in Male Carriers of BRCA Mutations.,Journal of Genetic Counseling,,,Article,2013-07-26,10.1007/s10897-013-9629-8,,,,23881471,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1657731,https://api.altmetric.com/v1/donut/1657731_240.png 7,BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells,British Journal of Cancer,,,Article,2006-01-24,10.1038/sj.bjc.6602935,,,,16434996,,,,,,,0,0,0,1,1,0,12,1,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/545697,https://api.altmetric.com/v1/donut/545697_240.png 7,Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo,International Journal of Cancer,,,Article,2011-11-16,10.1002/ijc.27361,,,,22095615,,,,,,,0,0,1,1,0,0,1,1,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/463508,https://api.altmetric.com/v1/donut/463508_240.png 7,Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-07-27,10.1073/pnas.1107898108,,,,21795608,,,2011PNAS..10813728C,,,,0,0,0,3,0,0,2,1,0,0,0,0,2,0,0,61,https://www.altmetric.com/details/208005,https://api.altmetric.com/v1/donut/208005_240.png 7,Quality of prostate cancer care among rural men in the Veterans Health Administration.,Cancer (0008543X),,,Article,2013-10-15,10.1002/cncr.28275,,,,23913676,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1893190,https://api.altmetric.com/v1/donut/1893190_240.png 7,Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2006-08-16,10.1016/j.ijrobp.2006.04.048,,,,16904843,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1411502,https://api.altmetric.com/v1/donut/1411502_240.png 7,Inherited variants in SULT1E1 and response to abiraterone acetate in men with metastatic castration refractory prostate cancer (mCRPC),The Journal of Urology,,,Article,2016-05-02,10.1016/j.juro.2016.04.079,,,,27150425,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7119830,https://api.altmetric.com/v1/donut/7119830_240.png 7,Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study,Journal of Cancer Survivorship,,,Article,2016-04-20,10.1007/s11764-016-0543-6,,,,27098346,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6843875,https://api.altmetric.com/v1/donut/6843875_240.png 7,Re: Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients with Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408,The Journal of Urology,,,Article,2016-02-10,10.1016/j.juro.2015.10.167,,,,26852974,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4725759,https://api.altmetric.com/v1/donut/4725759_240.png 7,Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation,PLoS ONE,,,Article,2013-12-30,10.1371/journal.pone.0084757,,,,24386413,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2013762,https://api.altmetric.com/v1/donut/2013762_240.png 7,Management of prostate cancer patients with lymph node involvement: A rapidly evolving paradigm,Cancer Treatment Reviews,,,Article,2012-01-01,10.1016/j.ctrv.2012.05.005,,,,22703831,,,,,,,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/1115561,https://api.altmetric.com/v1/donut/1115561_240.png 7,"(8R)-3?,8-Dihydroxypolypoda-13E,17E,21-triene Induces Cell Cycle Arrest and Apoptosis in Treatment-Resistant Prostate Cancer Cells",Journal of Natural Products,,,Article,2011-08-03,10.1021/np200161a,,,,21800858,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1440402,https://api.altmetric.com/v1/donut/1440402_240.png 7,The Clinical Impact of Genetic Susceptibility to Prostate Cancer,European Urology,,,Article,2014-09-01,10.1016/j.eururo.2014.03.021,,,,24702982,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2213505,https://api.altmetric.com/v1/donut/2213505_240.png 7,Intake of Grains and Dietary Fiber and Prostate Cancer Aggressiveness by Race,Prostate Cancer,"CROFT, Laura B",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-01-01,10.1155/2012/323296,,,,23213538,,,,,,,0,0,0,10,0,0,1,0,0,0,1,0,0,0,0,16,https://www.altmetric.com/details/1064108,https://api.altmetric.com/v1/donut/1064108_240.png 7,Highâ??intensity focused ultrasound for localized prostate cancer: initial experience with a 2â??year followâ??up,British Journal of Urology,,,Article,2009-07-01,10.1111/j.1464-410x.2009.08355.x,,,,19220245,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/616511,https://api.altmetric.com/v1/donut/616511_240.png 7,Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death,The Prostate,,,Article,2016-08-16,10.1002/pros.23247,,,,27527734,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10707937,https://api.altmetric.com/v1/donut/10707937_240.png 7,Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95?577 cases from a nationwide German health insurance database,Prostate Cancer & Prostatic Diseases,,,Article,2016-08-09,10.1038/pcan.2016.33,,,,27502738,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10486885,https://api.altmetric.com/v1/donut/10486885_240.png 7,Pathologic and Biochemical Outcomes among African-American and Caucasian Men with Low-Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy,The Journal of Urology,,,Article,2016-06-25,10.1016/j.juro.2016.06.086,,,,27352635,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/9040115,https://api.altmetric.com/v1/donut/9040115_240.png 7,Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer.,Critical Reviews in Oncology/Hematology,,,Article,2015-06-24,10.1016/j.critrevonc.2015.05.019,,,,26100652,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4156496,https://api.altmetric.com/v1/donut/4156496_240.png 7,Achieving Quality Assurance of Prostate Cancer Surgery During Reorganisation of Cancer Services,European Urology,,,Article,2015-03-11,10.1016/j.eururo.2015.02.028,,,,25770482,,,,,,,0,0,0,14,0,0,4,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3793758,https://api.altmetric.com/v1/donut/3793758_240.png 7,Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level,European Urology,,,Article,2014-10-07,10.1016/j.eururo.2014.09.049,,,,25306226,,,,,,,0,0,0,33,0,0,0,0,1,0,0,0,0,0,0,67,https://www.altmetric.com/details/2755038,https://api.altmetric.com/v1/donut/2755038_240.png 7,Re: Long-Term Survival of Participants in the Prostate Cancer Prevention Trial,The Journal of Urology,,,Article,,10.1016/j.juro.2013.11.012,,,,24411851,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2186522,https://api.altmetric.com/v1/donut/2186522_240.png 7,Longitudinal analysis of pain in patients with metastatic prostate cancer using natural language processing of medical record text.,Journal of the American Medical Informatics Association,,,Article,2012-11-09,10.1136/amiajnl-2012-001076,,,,23144336,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,1,0,0,1,https://www.altmetric.com/details/1057385,https://api.altmetric.com/v1/donut/1057385_240.png 7,Avoiding Undertreatment of Aggressive Prostate Cancer by Early Use of Chemotherapy,JAMA Oncology,,,Article,2016-11-03,10.1001/jamaoncol.2016.3634,,,,27812683,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13313013,https://api.altmetric.com/v1/donut/13313013_240.png 7,Molecular analysis of low grade prostate cancer utilizing a genomic classifier of metastatic potential,The Journal of Urology,,,Article,2016-08-30,10.1016/j.juro.2016.08.091,,,,27569435,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10836295,https://api.altmetric.com/v1/donut/10836295_240.png 7,Prostate cancer: Urology journals recommend new prostate cancer grade groups,Nature Reviews Urology,,,Article,2016-06-07,10.1038/nrurol.2016.96,,,,27273379,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8530740,https://api.altmetric.com/v1/donut/8530740_240.png 7,Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer,European Urology,,,Article,2016-05-01,10.1016/j.eururo.2016.04.019,,,,27160946,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7339497,https://api.altmetric.com/v1/donut/7339497_240.png 7,Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials,Endocrine-Related Cancer,,,Article,2015-11-21,10.1530/erc-15-0456,,,,26584972,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4791644,https://api.altmetric.com/v1/donut/4791644_240.png 7,Are We Targeting the Right Outcome for Sexual Health After Prostate Cancer Treatment?,European Urology,,,Article,2015-06-11,10.1016/j.eururo.2015.05.044,,,,26058958,,,,,,,0,0,0,12,0,0,6,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/4107549,https://api.altmetric.com/v1/donut/4107549_240.png 7,PD6-07 EJACULATION FREQUENCY AND RISK OF PROSTATE CANCER: UPDATED RESULTS FROM THE HEALTH PROFESSIONALS FOLLOW-UP STUDY,The Journal of Urology,,,Article,2015-01-04,10.1016/j.juro.2015.02.802,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4065599,https://api.altmetric.com/v1/donut/4065599_240.png 7,Prioritizing precision medicine for prostate cancer,Annals of Oncology,,,Article,2015-06-01,10.1093/annonc/mdv179,,,,25862438,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3976248,https://api.altmetric.com/v1/donut/3976248_240.png 7,A trial of devices for urinary incontinence following treatment for prostate cancer.,British Journal of Urology,,,Article,2014-12-18,10.1111/bju.13016,,,,25496354,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3007167,https://api.altmetric.com/v1/donut/3007167_240.png 7,Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer,Modern Pathology,,,Article,2014-06-13,10.1038/modpathol.2014.77,,,,24925052,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2434551,https://api.altmetric.com/v1/donut/2434551_240.png 7,Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study.,Cancer Causes and Control,,,Article,2013-05-26,10.1007/s10552-013-0234-9,,,,23702886,,,,,,,0,0,0,8,0,0,3,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1526965,https://api.altmetric.com/v1/donut/1526965_240.png 7,Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2003-06-18,,,,,12813170,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/2072729,https://api.altmetric.com/v1/donut/2072729_240.png 7,"ACR Appropriateness Criteria® External beam Radiation Therapy treatment planning for Clinically localized Prostate Cancer, Part I of II",Advances in Radiation Oncology ,,,Article,2016-10-01,10.1016/j.adro.2016.10.002,,,,,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12884961,https://api.altmetric.com/v1/donut/12884961_240.png 7,Clinical and translational assessment of VEGFR1 as a mediator of the pre-metastatic niche in high-risk localized prostate cancer,Molecular Cancer Therapeutics,,,Article,2015-10-10,10.1158/1535-7163.mct-15-0367,,,,26450920,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4603468,https://api.altmetric.com/v1/donut/4603468_240.png 7,"Effects of physical and mental health on relationship satisfaction: a dyadic, longitudinal examination of couples facing prostate cancer",Psycho-Oncology,,,Article,2015-01-01,10.1002/pon.3931,,,,26257321,,,,,,,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4404244,https://api.altmetric.com/v1/donut/4404244_240.png 7,Association between very small tumour size and increased cancer?specific mortality after radical prostatectomy in lymph node?positive prostate cancer,British Journal of Urology,,,Article,2015-08-01,10.1111/bju.13248,,,,26235660,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4402398,https://api.altmetric.com/v1/donut/4402398_240.png 7,Tweeting About Prostate and Testicular Cancers: Do Twitter Conversations and the 2013 Movember Canada Campaign Objectives Align?,Journal of Cancer Education,,,Article,2015-02-04,10.1007/s13187-015-0796-1,,,,25649663,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3348119,https://api.altmetric.com/v1/donut/3348119_240.png 7,"A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma",JNCI: Journal of the National Cancer Institute,,,Article,2002-10-02,10.1093/jnci/94.19.1458,,,,12359855,,,,,,,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/3174022,https://api.altmetric.com/v1/donut/3174022_240.png 7,Bisphosphonates for advanced prostate cancer,Cochrane database of systematic reviews,,,Article,2006-10-22,10.1002/14651858.cd006250,,,,17054286,,,,,,,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2423003,https://api.altmetric.com/v1/donut/2423003_240.png 7,6-Shogaol from Dried Ginger Inhibits Growth of Prostate Cancer Cells Both In Vitro and In Vivo through Inhibition of STAT3 and NF-?B Signaling.,Cancer Prevention Research,,,Article,2014-04-04,10.1158/1940-6207.capr-13-0420,,,,24691500,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2284587,https://api.altmetric.com/v1/donut/2284587_240.png 7,Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone.,European Urology,,,Article,2013-07-17,10.1016/j.eururo.2013.06.042,,,,23849416,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,1,0,0,69,https://www.altmetric.com/details/1697902,https://api.altmetric.com/v1/donut/1697902_240.png 7,Advanced Prostate Cancer Risk in Relation to Toenail Selenium Levels,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt186,,,,23878355,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1644364,https://api.altmetric.com/v1/donut/1644364_240.png 7,Use of Advanced Technologies in Low-Risk Prostate Cancer on the Rise,Journal Watch,,,Article,2013-06-27,10.1056/nejm-jw.fw107656,,,,,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1587024,https://api.altmetric.com/v1/donut/1587024_240.png 7,"ACR Appropriateness Criteria Prostate Cancer—Pretreatment Detection, Staging, and Surveillance",Journal of the American College of Radiology,,,Article,2013-01-01,10.1016/j.jacr.2012.10.021,,,,23374687,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1538100,https://api.altmetric.com/v1/donut/1538100_240.png 7,Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival,PLoS ONE,,,Article,2011-01-01,10.1371/journal.pone.0019059,,,,21552559,,,2011PLoSO...6E9059H,,,,0,0,1,2,0,0,0,1,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/890304,https://api.altmetric.com/v1/donut/890304_240.png 7,Management of low (favourable)?risk prostate cancer,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2010.10489.x,,,,22077546,,,,,,,0,0,1,1,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/454547,https://api.altmetric.com/v1/donut/454547_240.png 7,"Robotic Image-Guided Stereotactic Radiotherapy, for Isolated Recurrent Primary, Lymph Node or Metastatic Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-27,10.1016/j.ijrobp.2010.11.031,,,,21277113,,,,,,,0,0,1,4,0,0,2,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/176432,https://api.altmetric.com/v1/donut/176432_240.png 7,Review: evidence from 2 low quality screening studies does not show a reduction in death from prostate cancer,Evidence Based Medicine,,,Article,2007-04-01,10.1136/ebm.12.2.40,,,,17400632,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1379368,https://api.altmetric.com/v1/donut/1379368_240.png 7,"Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk",Carcinogenesis,,,Article,2008-01-01,10.1093/carcin/bgn212,,,,18784358,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1379366,https://api.altmetric.com/v1/donut/1379366_240.png 7,Combined Lycopene and Vitamin E Treatment Suppresses the Growth of PC-346C Human Prostate Cancer Cells in Nude Mice,Journal of Nutrition,,,Article,2006-01-01,,,,,16614418,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1379356,https://api.altmetric.com/v1/donut/1379356_240.png 7,Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate Cancer,Journal of the American Chemical Society,,,Article,2009-11-07,10.1021/ja906844e,,,,19888723,PMC2794306,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,87,https://www.altmetric.com/details/520870,https://api.altmetric.com/v1/donut/520870_240.png 7,Androgen Deprivation Therapy for Prostate Cancer Tied to Dementia Risk,Journal Watch,,,Article,2016-10-14,10.1056/nejm-jw.fw112142,,,,,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12604574,https://api.altmetric.com/v1/donut/12604574_240.png 7,Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study,Journal of Geriatric Oncology,,,Article,2016-02-27,10.1016/j.jgo.2016.02.002,,,,26916611,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6012789,https://api.altmetric.com/v1/donut/6012789_240.png 7,Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without Incentives for Overutilization,Health Services Research,,,Article,2015-09-01,10.1111/1475-6773.12395,,,,26423687,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4575442,https://api.altmetric.com/v1/donut/4575442_240.png 7,Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms,Endocrine-Related Cancer,,,Article,2015-07-19,10.1530/erc-14-0541,,,,26187127,,,,,,,0,0,0,21,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4293575,https://api.altmetric.com/v1/donut/4293575_240.png 7,SYK is a candidate kinase target for the treatment of advanced prostate cancer.,Cancer Research,,,Article,2014-11-11,10.1158/0008-5472.can-14-0629,,,,25388286,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2878503,https://api.altmetric.com/v1/donut/2878503_240.png 7,Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer,European Urology,,,Article,2014-08-12,10.1016/j.eururo.2014.07.035,,,,25129854,,,,,,,0,0,0,12,0,0,0,0,1,0,0,0,0,0,0,50,https://www.altmetric.com/details/2596794,https://api.altmetric.com/v1/donut/2596794_240.png 7,Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy.,Radiation Oncology,,,Article,2012-06-09,10.1186/1748-717x-7-82,,,,22681643,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/789120,https://api.altmetric.com/v1/donut/789120_240.png 7,"Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707–708",European Urology,,,Article,2016-10-11,10.1016/j.eururo.2016.09.036,,,,27720530,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12480974,https://api.altmetric.com/v1/donut/12480974_240.png 7,The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting,British Journal of Urology,,,Article,2016-08-01,10.1111/bju.13619,,,,27488931,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10321798,https://api.altmetric.com/v1/donut/10321798_240.png 7,Abstract LB-253: Control of tumor growth in vivo by a synthetic multi-antigen DNA immune therapy for prostate cancer,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-lb-253,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10074928,https://api.altmetric.com/v1/donut/10074928_240.png 7,Variation in Testosterone Levels and Health Related Quality of Life in Men Diagnosed with Prostate Cancer on Active Surveillance,Urology,,,Article,2016-05-11,10.1016/j.urology.2016.03.056,,,,27179775,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7350717,https://api.altmetric.com/v1/donut/7350717_240.png 7,Positron Emission Tomography–computed Tomography with Prostate-specific Membrane Antigen Ligands as a Promising Tool for Imaging of Prostate Cancer,European Urology,,,Article,2015-09-15,10.1016/j.eururo.2015.08.059,,,,26382086,,,,,,,0,0,0,9,0,0,2,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/4508770,https://api.altmetric.com/v1/donut/4508770_240.png 7,Intensity-Modulated Radiation Therapy Leads to Survival Benefit Only in Patients with High-Risk Prostate Cancer: a Population-Based Study.,Annals of Oncology,,,Article,,10.1093/annonc/mdu087,,,,24562445,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2135704,https://api.altmetric.com/v1/donut/2135704_240.png 7,Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies,Prostate Cancer & Prostatic Diseases,,,Article,2012-10-02,10.1038/pcan.2012.40,,,,23032360,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/979189,https://api.altmetric.com/v1/donut/979189_240.png 7,Localized Prostate Cancer—No Mortality Gain From Early Active Treatment,Oncology times,,,Article,2016-10-10,10.1097/01.cot.0000503432.09745.46,,,http://journals.lww.com/oncology-times/Fulltext/2016/10100/Localized_Prostate_Cancer_No_Mortality_Gain_From.7.aspx,,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12583315,https://api.altmetric.com/v1/donut/12583315_240.png 7,Advances in genetics: widening our understanding of prostate cancer,F1000 Research,,,Article,2016-01-01,10.12688/f1000research.8019.1,,,,27408704,PMC4926757,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9713423,https://api.altmetric.com/v1/donut/9713423_240.png 7,Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL,Annals of Oncology,,,Article,2015-11-18,10.1093/annonc/mdv542,,,,26578735,,,,,,,0,0,0,14,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4778143,https://api.altmetric.com/v1/donut/4778143_240.png 7,Patients Present with More Advanced Prostate Cancer since the USPSTF Screening Recommendations,The Journal of Urology,,,Article,2015-09-20,10.1016/j.juro.2015.09.033,,,,26384450,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4513994,https://api.altmetric.com/v1/donut/4513994_240.png 7,Responses to a Decision Aid on Prostate Cancer Screening in Primary Care Practices,American Journal of Preventive Medicine,,,Article,2015-05-12,10.1016/j.amepre.2015.03.002,,,,25960395,,,,,,,0,0,0,8,0,0,3,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3979540,https://api.altmetric.com/v1/donut/3979540_240.png 7,Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease,Frontiers in Genetics,,,Article,2015-05-06,10.3389/fgene.2015.00168,,,,25999983,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3972567,https://api.altmetric.com/v1/donut/3972567_240.png 7,Progress in Management of Low-risk Prostate Cancer: How Registries May Change the World,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.09.008,,,,25242556,,,,,,,0,0,0,10,0,0,0,0,2,0,0,0,0,0,0,3,https://www.altmetric.com/details/2696633,https://api.altmetric.com/v1/donut/2696633_240.png 7,Prostate Cancer Tumour Features on Template Prostate-mapping Biopsies: Implications for Focal Therapy,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.09.045,,,,24207133,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2389505,https://api.altmetric.com/v1/donut/2389505_240.png 7,Testosterone Replacement Therapy Following the Diagnosis of Prostate Cancer: Outcomes and Utilization Trends,Journal of Sexual Medicine,,,Article,2014-04-01,10.1111/jsm.12429,,,,24443943,,,,,,,0,0,0,7,0,0,3,0,1,0,0,0,0,0,0,13,https://www.altmetric.com/details/2060397,https://api.altmetric.com/v1/donut/2060397_240.png 7,Cancer Talk on Twitter: Community Structure and Information Sources in Breast and Prostate Cancer Social Networks,Journal of Health Communication,,,Article,2013-01-01,10.1080/10810730.2013.811321,,,,24111482,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1819761,https://api.altmetric.com/v1/donut/1819761_240.png 7,Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4,Cancer Research,,,Article,2012-12-05,10.1158/0008-5472.can-12-2799,,,,23204237,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1212097,https://api.altmetric.com/v1/donut/1212097_240.png 7,Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.,International Journal of Cancer,,,Article,2011-08-30,10.1002/ijc.26405,,,,22052531,,,,,,,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/444982,https://api.altmetric.com/v1/donut/444982_240.png 7,Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer.,Journal of Sexual Medicine,,,Article,2010-01-13,10.1111/j.1743-6109.2009.01644.x,,,,20059662,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1575290,https://api.altmetric.com/v1/donut/1575290_240.png 7,Prostate cancer: AR-V7 status in CTCs is a treatment-specific biomarker,Nature Reviews Urology,,,Article,2016-06-28,10.1038/nrurol.2016.113,,,,27349368,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9143384,https://api.altmetric.com/v1/donut/9143384_240.png 7,Blood lipids and prostate cancer: a Mendelian randomization analysis,Cancer Medicine,,,Article,2016-03-01,10.1002/cam4.695,,,,26992435,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6235525,https://api.altmetric.com/v1/donut/6235525_240.png 7,Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone with Reduced Side Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer,European Urology,,,Article,2015-02-01,10.1016/j.eururo.2014.06.011,,,,24968970,,,,,,,0,0,0,6,0,0,0,2,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2478849,https://api.altmetric.com/v1/donut/2478849_240.png 7,Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics ,European Urology,,,Article,,10.1016/j.eururo.2014.03.026,,,,24746973,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2257404,https://api.altmetric.com/v1/donut/2257404_240.png 7,Prostate cancer in Asian men,Nature Reviews Urology,,,Article,2014-03-04,10.1038/nrurol.2014.42,,,,24595118,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/2164912,https://api.altmetric.com/v1/donut/2164912_240.png 7,An expression signature at diagnosis to estimate prostate cancer patients|[rsquo]| overall survival,Prostate Cancer & Prostatic Diseases,,,Article,2014-01-07,10.1038/pcan.2013.57,,,,24394557,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2029047,https://api.altmetric.com/v1/donut/2029047_240.png 7,Cancer: Prostate cancer under attack,Nature,,,Article,2016-04-06,10.1038/532009c,,,,,,,,,,,0,0,0,16,0,0,3,0,0,0,1,0,0,0,0,1,https://www.altmetric.com/details/6503065,https://api.altmetric.com/v1/donut/6503065_240.png 7,Is computed tomography a necessary part of a metastatic evaluation for castration?resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database,Cancer (0008543X),,,Article,2015-10-01,10.1002/cncr.29748,,,,26484853,,,,,,,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4656928,https://api.altmetric.com/v1/donut/4656928_240.png 7,Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies,The Journal of Urology,,,Article,2015-07-22,10.1016/j.juro.2015.06.106,,,,26196735,,,,,,,0,0,0,6,0,0,3,0,0,0,0,0,1,0,0,43,https://www.altmetric.com/details/4292741,https://api.altmetric.com/v1/donut/4292741_240.png 7,Fat and meat intake and prostate cancer risk: The multiethnic cohort study,International Journal of Cancer,,,Article,2007-05-10,10.1002/ijc.22805,,,,17487838,,,,,,,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3842776,https://api.altmetric.com/v1/donut/3842776_240.png 7,Cryotherapy in prostate cancer,Journal of Clinical Urology,,,Article,2014-02-03,10.1177/2051415814521806,,,,,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/2719842,https://api.altmetric.com/v1/donut/2719842_240.png 7,Long-Term Outcomes from a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-02-01,10.1016/j.ijrobp.2010.11.054,,,,21300474,,,,,,,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/1766029,https://api.altmetric.com/v1/donut/1766029_240.png 7,Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective,Supportive Care in Cancer,,,Article,2013-08-17,10.1007/s00520-013-1931-3,,,,23955026,PMC4535430,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1700072,https://api.altmetric.com/v1/donut/1700072_240.png 7,Associations of tea and coffee consumption with prostate cancer risk,Cancer Causes and Control,,,Article,2013-02-15,10.1007/s10552-013-0170-8,,,,23412806,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1257390,https://api.altmetric.com/v1/donut/1257390_240.png 7,The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression,Oncogene,,,Article,2012-02-13,10.1038/onc.2011.641,,,,22330138,,,,,,,0,0,0,6,2,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1181236,https://api.altmetric.com/v1/donut/1181236_240.png 7,"2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial",Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(12)70537-5,,,,23294853,,,,,,,0,0,1,5,0,0,1,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/1155410,https://api.altmetric.com/v1/donut/1155410_240.png 7,Willingness to Pay for Prostate Cancer Treatment among Patients and Their Family Members at 1 Year After Diagnosis.,Value in Health (Elsevier Science),,,Article,2012-07-01,10.1016/j.jval.2012.03.003,,,,22867781,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/878403,https://api.altmetric.com/v1/donut/878403_240.png 7,"Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.",Molecular Cancer,,,Article,2010-06-15,10.1186/1476-4598-9-148,,,,20550708,,,,,,,0,1,0,0,4,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1485248,https://api.altmetric.com/v1/donut/1485248_240.png 7,Prostate cancer: Targeting apoptosis Resistance in CRPC,Nature Reviews Urology,,,Article,2016-10-11,10.1038/nrurol.2016.200,,,,27725637,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12555964,https://api.altmetric.com/v1/donut/12555964_240.png 7,Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference,European Radiology,,,Article,2015-09-22,10.1007/s00330-015-4015-6,,,,26396111,,,,,,,0,0,0,3,0,0,2,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/5099214,https://api.altmetric.com/v1/donut/5099214_240.png 7,"Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer—going beyond PSA and imaging, a systematic literature review",Annals of Oncology,,,Article,2015-07-29,10.1093/annonc/mdv326,,,,26216388,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4340630,https://api.altmetric.com/v1/donut/4340630_240.png 7,Watchful Waiting–Active Surveillance in Low-Risk Prostate Cancer—Reply,JAMA Oncology,,,Article,2015-06-04,10.1001/jamaoncol.2015.1199,,,,26181144,,,,,,,0,0,0,12,0,0,2,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4104939,https://api.altmetric.com/v1/donut/4104939_240.png 7,A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer,European Urology,,,Article,2015-10-01,10.1016/j.eururo.2014.08.009,,,,25171903,,,,,,,0,0,0,11,0,0,0,0,1,0,0,0,0,0,0,57,https://www.altmetric.com/details/2629803,https://api.altmetric.com/v1/donut/2629803_240.png 7,Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-02-25,10.1038/pcan.2014.3,,,,24566445,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2144774,https://api.altmetric.com/v1/donut/2144774_240.png 7,Physical activity and prostate gene expression in men with low-risk prostate cancer,Cancer Causes and Control,,,Article,2014-02-07,10.1007/s10552-014-0354-x,,,,24504435,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2107962,https://api.altmetric.com/v1/donut/2107962_240.png 7,Posterior urethral complications of the treatment of prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10864.x,,,,22340079,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/610628,https://api.altmetric.com/v1/donut/610628_240.png 7,SIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer,Cancer Research,,,Article,2007-07-15,10.1158/0008-5472.can-07-0085,,,,17638871,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/123237,https://api.altmetric.com/v1/donut/123237_240.png 7,Effects of androgen deprivation on cerebral morphometry in prostate cancer patients - an exploratory study.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0072032,,,,23977199,PMC3747074,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1716572,https://api.altmetric.com/v1/donut/1716572_240.png 7,Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men,Cancer (0008543X),,,Article,2016-07-19,10.1002/cncr.30162,,,,27433786,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9911012,https://api.altmetric.com/v1/donut/9911012_240.png 7,Re: Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: A Prospective Development Study,The Journal of Urology,,,Article,2016-05-18,10.1016/j.juro.2016.05.070,,,,27479382,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7600593,https://api.altmetric.com/v1/donut/7600593_240.png 7,Prostate cancer screening: what we have learned from the PLCO and ERSPC trials.,Current Urology Reports,,,Article,2010-01-05,10.1007/s11934-010-0109-5,,,,20425627,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1385133,https://api.altmetric.com/v1/donut/1385133_240.png 7,A systematic review and meta-analysis of familial prostate cancer risk.,BJU international,,,Article,2003-06-01,,,,,12780833,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/118457,https://api.altmetric.com/v1/donut/118457_240.png 7,"Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations",Cancer Research,,,Article,2016-04-20,10.1158/0008-5472.can-15-2980,,,,27197191,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6848708,https://api.altmetric.com/v1/donut/6848708_240.png 7,"Long-Term Efficacy and Toxicity of Low-Dose-Rate 125I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-05-13,10.1016/j.ijrobp.2015.02.047,,,,25962627,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3765076,https://api.altmetric.com/v1/donut/3765076_240.png 7,Smoking Is Associated with Acute and Chronic Prostatic Inflammation: Results from the REDUCE Study,Cancer Prevention Research,,,Article,2015-02-02,10.1158/1940-6207.capr-14-0260,,,,25644151,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3333155,https://api.altmetric.com/v1/donut/3333155_240.png 7,A randomized controlled trial of a selfâ??management psychosocial intervention for men with prostate cancer and their partners: a study protocol,Journal of Advanced Nursing,,,Article,2013-01-01,10.1111/jan.12132,,,,23528148,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1322371,https://api.altmetric.com/v1/donut/1322371_240.png 7,"Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase (MTAP), an Exploitable Tumor Target",Molecular Cancer Therapeutics,,,Article,2012-01-01,10.1158/1535-7163.mct-11-0826,,,,22252602,,,,,,,0,0,0,6,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/638300,https://api.altmetric.com/v1/donut/638300_240.png 7,"Obesity, body composition, and prostate cancer.",BMC Cancer,,,Article,2012-01-18,10.1186/1471-2407-12-23,,,,22257467,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/564111,https://api.altmetric.com/v1/donut/564111_240.png 7,Nuclear Magnetic Resonance–Based Metabolomics Enable Detection of the Effects of a Whole Grain Rye and Rye Bran Diet on the Metabolic Profile of Plasma in Prostate Cancer Patients,Journal of Nutrition,,,Article,2011-01-01,10.3945/jn.111.148239,,,,22013201,,,,,,,0,0,1,6,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/461334,https://api.altmetric.com/v1/donut/461334_240.png 7,Docosahexaenoic acid in combination with celecoxib modulates HSP70 and p53 proteins in prostate cancer cells.,International Journal of Cancer,,,Article,2006-04-29,10.1002/ijc.22031,,,,16646082,,,,,,,0,1,0,0,5,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2516676,https://api.altmetric.com/v1/donut/2516676_240.png 7,"A phase II study of mifepristone (RU?486) in castration?resistant prostate cancer, with a correlative assessment of androgen?related hormones",British Journal of Urology,,,Article,2008-04-11,10.1111/j.1464-410x.2008.07509.x,,,,18399827,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/522741,https://api.altmetric.com/v1/donut/522741_240.png 7,"Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer",BMC Medical Genomics,,,Article,2008-01-31,10.1186/1755-8794-1-1,,,,18237448,PMC2227949,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/185148,https://api.altmetric.com/v1/donut/185148_240.png 7,Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.,Cancer research,,,Article,2000-01-01,,,,,10646870,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/621769,https://api.altmetric.com/v1/donut/621769_240.png 7,"Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis",Journal of Clinical Oncology,,,Article,2005-11-10,10.1200/jco.2005.03.4777,,,,16278481,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,100,https://www.altmetric.com/details/587406,https://api.altmetric.com/v1/donut/587406_240.png 7,"Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping",European Urology,,,Article,2016-10-01,10.1016/j.eururo.2016.10.011,,,,27771128,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13129933,https://api.altmetric.com/v1/donut/13129933_240.png 7,Integrating MRI for the diagnosis of prostate cancer,Current Opinion in Urology,,,Article,2016-06-01,10.1097/mou.0000000000000323,,,http://journals.lww.com/co-urology/Fulltext/2016/09000/Integrating_MRI_for_the_diagnosis_of_prostate.13.aspx,27367259,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9228794,https://api.altmetric.com/v1/donut/9228794_240.png 7,Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume,The Journal of Urology,,,Article,2015-04-29,10.1016/j.juro.2015.04.075,,,,25912496,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3933685,https://api.altmetric.com/v1/donut/3933685_240.png 7,Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits,Clinical Oncology,,,Article,2015-03-06,10.1016/j.clon.2015.02.008,,,,25752244,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3898927,https://api.altmetric.com/v1/donut/3898927_240.png 7,"Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening.",Colorectal Cancer,,,Article,2014-08-23,10.2217/crc.14.18,,,,25143785,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2700855,https://api.altmetric.com/v1/donut/2700855_240.png 7,External Beam Radiation Therapy Plus High-Dose-Rate Brachytherapy in the Treatment of Locally Advanced Prostate Cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-09,10.1016/j.ijrobp.2014.05.1368,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2690318,https://api.altmetric.com/v1/donut/2690318_240.png 7,Suppression of Androgen Receptor Expression by Dibenzoylmethane as a Therapeutic Objective in Advanced Prostate Cancer,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2007-01-01,,,,,17595765,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1370738,https://api.altmetric.com/v1/donut/1370738_240.png 6,Hypofractionated Radiotherapy for Prostate Cancer,Oncology times,,,Article,2016-09-10,10.1097/01.cot.0000499606.90328.d8,,,http://journals.lww.com/oncology-times/Fulltext/2016/09100/Hypofractionated_Radiotherapy_for_Prostate_Cancer.5.aspx,,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11940805,https://api.altmetric.com/v1/donut/11940805_240.png 6,A Specific Mapping Study Using Fluorescence Sentinel Lymph Node Detection in Patients with Intermediate- and High-risk Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection,European Urology,,,Article,2016-02-06,10.1016/j.eururo.2016.01.034,,,,26856960,,,,,,,0,0,0,12,0,0,3,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/5100837,https://api.altmetric.com/v1/donut/5100837_240.png 6,Magnetic Resonance Imaging–Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial ,European Urology,,,Article,2016-01-07,10.1016/j.eururo.2015.12.029,,,,26777228,,,,,,,0,0,0,14,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4963923,https://api.altmetric.com/v1/donut/4963923_240.png 6,Adjuvant Radiotherapy in Prostate Cancer Patients Treated with Surgery: The Impact of Age and Tumor Characteristics,,,,Article,2015-09-28,10.1016/j.euf.2015.06.008,,,,,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4732424,https://api.altmetric.com/v1/donut/4732424_240.png 6,Cadmium and prostate cancer: a critical epidemiologic analysis.,,,,Article,,,,,,15945511,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4314590,https://api.altmetric.com/v1/donut/4314590_240.png 6,Case-control study of toenail cadmium and prostate cancer risk in Italy.,,,,Article,2007-02-01,10.1016/j.scitotenv.2006.11.005,,,,17175009,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4314513,https://api.altmetric.com/v1/donut/4314513_240.png 6,Prostate cancer,The Lancet,,,Article,2008-05-16,10.1016/s0140-6736(08)60729-1,,,,18486743,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,101,https://www.altmetric.com/details/4243802,https://api.altmetric.com/v1/donut/4243802_240.png 6,Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer. Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3493/dose-escalated-brachytherapy-best-treatment-for-unfavourable-risk-localised-prostate-cancer.php,,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3749588,https://api.altmetric.com/v1/donut/3749588_240.png 6,Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy,Medical Oncology,,,Article,2009-04-14,10.1007/s12032-009-9218-8,,,,19365737,,,,,,,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078561,https://api.altmetric.com/v1/donut/3078561_240.png 6,Treatment options for localized prostate cancer.,American Family Physician,,,Article,2011-08-17,,,,,21842788,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078435,https://api.altmetric.com/v1/donut/3078435_240.png 6,"Spondin-2 (SPON2), a More Prostate-Cancer-Specific Diagnostic Biomarker",PLoS ONE,,,Article,2012-05-23,10.1371/journal.pone.0037225,,,,22615945,,,2012PLoSO...7E7225Q,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078376,https://api.altmetric.com/v1/donut/3078376_240.png 6,Screening for prostate cancer: the current evidence and guidelines controversy.,Canadian Journal of Urology,,,Article,2011-10-24,,,,,22018148,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078373,https://api.altmetric.com/v1/donut/3078373_240.png 6, MDV3100 for the treatment of prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2012-01-12,10.1517/13543784.2012.651125,,,,22229405,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078314,https://api.altmetric.com/v1/donut/3078314_240.png 6,"Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues",Prostate Cancer & Prostatic Diseases,,,Article,2003-09-01,10.1038/sj.pcan.4500674,,,,,,,,,,,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078225,https://api.altmetric.com/v1/donut/3078225_240.png 6,Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness,International Journal of Cancer,,,Article,2005-08-17,10.1002/ijc.21442,,,,16108038,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078219,https://api.altmetric.com/v1/donut/3078219_240.png 6,Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues,The Prostate,,,Article,2003-06-30,10.1002/pros.10263,,,,,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078201,https://api.altmetric.com/v1/donut/3078201_240.png 6,Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma,International Journal of Cancer,,,Article,2009-08-12,10.1002/ijc.24827,,,,19676045,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078176,https://api.altmetric.com/v1/donut/3078176_240.png 6,A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone?refractory prostate cancer who are refractory to docetaxel,Cancer (0008543X),,,Article,2007-12-17,10.1002/cncr.23195,,,,,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078085,https://api.altmetric.com/v1/donut/3078085_240.png 6,Predictive value of PCA3 in urinary sediments in determining clinico?pathological characteristics of prostate cancer,The Prostate,,,Article,2009-08-25,10.1002/pros.21032,,,,19708043,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3078038,https://api.altmetric.com/v1/donut/3078038_240.png 6,Internet Patient Decision Support: A Randomized Controlled Trial Comparing Alternative Approaches for Men Considering Prostate Cancer Screening,Archives of Internal Medicine,,,Article,2008-02-25,10.1001/archinternmed.2007.111,,,,18299490,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3078010,https://api.altmetric.com/v1/donut/3078010_240.png 6,Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer,World Journal of Urology,,,Article,2011-08-11,10.1007/s00345-011-0745-5,,,,21833557,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077962,https://api.altmetric.com/v1/donut/3077962_240.png 6,Chemotherapy for hormone?refractory prostate cancer,Cochrane database of systematic reviews,,,Article,2006-10-18,10.1002/14651858.cd005247.pub2,,,,17054249,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077961,https://api.altmetric.com/v1/donut/3077961_240.png 6,Ribosomal Protein L19 Is a Prognostic Marker for Human Prostate Cancer,Clinical Cancer Research,,,Article,2006-04-01,10.1158/1078-0432.ccr-05-2445,,,,16609016,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077919,https://api.altmetric.com/v1/donut/3077919_240.png 6,Increased expression of elongation factor-1? is significantly correlated with poor prognosis of human prostate cancer,Scandinavian Journal of Urology & Nephrology,,,Article,2010-01-11,10.3109/00365599.2010.492787,,,,20545466,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077916,https://api.altmetric.com/v1/donut/3077916_240.png 6,Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration?resistant prostate cancer,The Prostate,,,Article,2011-01-26,10.1002/pros.21342,,,,21271613,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077891,https://api.altmetric.com/v1/donut/3077891_240.png 6,Assessment of prognosis with the total illness burden index for prostate cancer,Cancer (0008543X),,,Article,2007-03-12,10.1002/cncr.22615,,,,17354226,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3077852,https://api.altmetric.com/v1/donut/3077852_240.png 6,Use and assessment of PSA in prostate cancer.,Medical clinics of North America,,,Article,2010-11-27,10.1016/j.mcna.2010.08.024,,,,21095422,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3077841,https://api.altmetric.com/v1/donut/3077841_240.png 6,EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer,International Journal of Cancer,,,Article,2003-05-16,10.1002/ijc.11205,,,,,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077839,https://api.altmetric.com/v1/donut/3077839_240.png 6,Prognostic value of promoter hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer,Chinese Journal of Cancer Research,,,Article,2011-12-22,10.1007/s11670-011-0306-x,,,,23358881,PMC3551302,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077758,https://api.altmetric.com/v1/donut/3077758_240.png 6,Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy,Cancer (0008543X),,,Article,2006-10-12,10.1002/cncr.22262,,,,17039503,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3077724,https://api.altmetric.com/v1/donut/3077724_240.png 6,Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2010-03-26,,,,,20332487,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077717,https://api.altmetric.com/v1/donut/3077717_240.png 6,Elevated plasma tissue inhibitor of metalloproteinase?1 levels predict decreased survival in castration?resistant prostate cancer patients,Cancer (0008543X),,,Article,2010-09-22,10.1002/cncr.25394,,,,20862742,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077665,https://api.altmetric.com/v1/donut/3077665_240.png 6,The multi-disciplinary management of high-risk prostate cancer,Urologic Oncology,,,Article,2012-01-01,10.1016/j.urolonc.2009.09.002,,,,19945310,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077624,https://api.altmetric.com/v1/donut/3077624_240.png 6,Lycopene for the prevention of prostate cancer,Cochrane database of systematic reviews,,,Article,2011-11-09,10.1002/14651858.cd008007.pub2,,,,22071840,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/3077565,https://api.altmetric.com/v1/donut/3077565_240.png 6,Guideline for the management of clinically localized prostate cancer: 2007 update.,The Journal of Urology,,,Article,2007-06-01,10.1016/j.juro.2007.03.003,,,,17509297,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2839613,https://api.altmetric.com/v1/donut/2839613_240.png 6,PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging.,European Urology,,,Article,2008-01-11,10.1016/j.eururo.2008.06.076,,,,18614274,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2839608,https://api.altmetric.com/v1/donut/2839608_240.png 6,Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study,Quality of Life Research,,,Article,2010-12-04,10.1007/s11136-010-9805-3,,,,21132389,PMC3066264,,,,,,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2839552,https://api.altmetric.com/v1/donut/2839552_240.png 6,Bicalutamide 150?mg plus standard care vs standard care alone for early prostate cancer,British Journal of Urology,,,Article,2006-02-01,10.1111/j.1464-410x.2005.06051.x,,,,16430622,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2549839,https://api.altmetric.com/v1/donut/2549839_240.png 6,Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells,Journal of Inflammation Research,,,Article,2014-06-29,10.2147/jir.s61365,,,,24971028,PMC4070858,,,,,,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/2490772,https://api.altmetric.com/v1/donut/2490772_240.png 6,"A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival",British Journal of Cancer,,,Article,2006-04-29,10.1038/sj.bjc.6603105,,,,16641912,PMC2361275,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2475800,https://api.altmetric.com/v1/donut/2475800_240.png 6,"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.",European Urology,,,Article,2010-11-10,10.1016/j.eururo.2010.10.039,,,,21056534,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,338,https://www.altmetric.com/details/2475780,https://api.altmetric.com/v1/donut/2475780_240.png 6,Impact of PSA Screening on the Incidence of Advanced Stage Prostate Cancer in the United States: A Surveillance Modeling Approach,Medical Decision Making,,,Article,2008-02-12,10.1177/0272989x07312719,,,,18319508,,,,,,,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2475771,https://api.altmetric.com/v1/donut/2475771_240.png 6,Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy,European Radiology,,,Article,2008-10-17,10.1007/s00330-008-1190-8,,,,,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2475759,https://api.altmetric.com/v1/donut/2475759_240.png 6,Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature.,European Urology,,,Article,2007-08-29,10.1016/j.eururo.2007.08.006,,,,17720304,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/2475741,https://api.altmetric.com/v1/donut/2475741_240.png 6,Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.,Lancet Oncology,,,Article,2014-01-08,10.1016/s1470-2045(14)70240-2,,,,24974051,,,,,,,0,0,0,5,0,0,1,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2467920,https://api.altmetric.com/v1/donut/2467920_240.png 6,Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?,World Journal of Urology,,,Article,2012-11-29,10.1007/s00345-012-0989-8,,,,23184141,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2414948,https://api.altmetric.com/v1/donut/2414948_240.png 6,"Disease Progression Increases the Risk of Skeletal-Related Events in Patients With Bone Metastases From Castration-Resistant Prostate Cancer, Lung Cancer, or Other Solid Tumors",Cancer Investigation,,,Article,2010-07-02,10.3109/07357907.2010.483508,,,,20590447,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2412839,https://api.altmetric.com/v1/donut/2412839_240.png 6,Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer,Drugs,,,Article,2013-11-23,10.1007/s40265-013-0150-z,,,,24271422,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1942820,https://api.altmetric.com/v1/donut/1942820_240.png 6,Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion Device.,The Journal of Urology,,,Article,2012-11-15,10.1016/j.juro.2012.08.095,,,,23158413,,,,,,,0,0,0,5,0,0,2,1,0,0,0,0,0,0,0,85,https://www.altmetric.com/details/1069008,https://api.altmetric.com/v1/donut/1069008_240.png 6,Specialty Supplements and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort,Nutrition and Cancer,,,Article,2011-05-01,10.1080/01635581.2011.553022,,,,21598177,PMC3100666,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/783613,https://api.altmetric.com/v1/donut/783613_240.png 6,The Use of the Finasteride-Adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican Referral Population: A Validation Study.,Urologia Internationalis,,,Article,2012-05-27,10.1159/000338270,,,,22626812,,,,,,,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/768640,https://api.altmetric.com/v1/donut/768640_240.png 6,"Non?steroidal anti?inflammatory drug use and the risk of benign prostatic hyperplasia?related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10867.x,,,,22429766,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/657063,https://api.altmetric.com/v1/donut/657063_240.png 6,Prostate cancer: Resveratrol and apoptotic proteins enhance radiosensitivity.,Nature Reviews Urology,,,Article,2012-01-17,10.1038/nrurol.2011.228,,,,22249189,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/563659,https://api.altmetric.com/v1/donut/563659_240.png 6,Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor.,Cancer Cell,,,Article,2010-06-15,10.1016/j.ccr.2010.04.027,,,,20541699,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,2,0,0,89,https://www.altmetric.com/details/210176,https://api.altmetric.com/v1/donut/210176_240.png 6,Identification of a cell-of-origin for human prostate cancer,Science,"PENNYWORTH, Andrea",Department of Life Sciences; School of Natural Sciences,Article,2010-07-30,10.1126/science.1189992,,,,20671189,PMC2917982,,2010Sci...329..568G,,,,0,0,0,0,0,0,0,2,0,0,0,0,2,0,0,66,https://www.altmetric.com/details/131437,https://api.altmetric.com/v1/donut/131437_240.png 6,"A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer.",JNCI: Journal of the National Cancer Institute,,,Article,2005-09-09,10.1093/jnci/dji252,,,,16145049,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2181960,https://api.altmetric.com/v1/donut/2181960_240.png 6,Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.,Journal of Clinical Oncology,,,Article,2010-08-25,10.1200/jco.2009.26.8771,,,,20733135,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2181959,https://api.altmetric.com/v1/donut/2181959_240.png 6,Silencing prostate cancer,Nature Biotechnology,,,Article,2009-09-01,10.1038/nbt0909-821,,,,19741638,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1486607,https://api.altmetric.com/v1/donut/1486607_240.png 6,A Matched Cohort Analysis of Prostate Cancer Screening in Younger Men in Sweden,European Urology,,,Article,2016-04-16,10.1016/j.eururo.2016.04.006,,,,27090976,,,,,,,0,0,0,13,0,0,4,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6749936,https://api.altmetric.com/v1/donut/6749936_240.png 6,Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2016-02-09,10.1038/pcan.2016.1,,,,26857023,,,,,,,0,0,0,13,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5229746,https://api.altmetric.com/v1/donut/5229746_240.png 6,Re: Duration of Androgen Suppression before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910,The Journal of Urology,,,Article,2015-12-25,10.1016/j.juro.2015.10.057,,,,26699964,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4632006,https://api.altmetric.com/v1/donut/4632006_240.png 6,Physical activity and body mass index as predictors of prostate cancer risk,World Journal of Urology,,,Article,2015-01-04,10.1007/s00345-014-1464-5,,,,25557943,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077409,https://api.altmetric.com/v1/donut/3077409_240.png 6,In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines,Pharmacology & Pharmacy,,,Article,2014-07-03,10.4236/pp.2014.58091,,,,,,,,,,,0,0,0,6,0,0,6,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/2500384,https://api.altmetric.com/v1/donut/2500384_240.png 6,The Politics of Prostate Cancer Screening ,Urologic Clinics of North America,,,Article,2014-05-01,10.1016/j.ucl.2014.01.004,,,,24725487,,,,,,,0,0,0,10,1,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2281059,https://api.altmetric.com/v1/donut/2281059_240.png 6,Individualized image-based lymph node irradiation for prostate cancer,Nature Reviews Urology,,,Article,2013-05-28,10.1038/nrurol.2013.111,,,,23712209,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1520831,https://api.altmetric.com/v1/donut/1520831_240.png 6,Quality of life after prostate cancer treatments in patients comparable at baseline,British Journal of Cancer,,,Article,2013-04-23,10.1038/bjc.2013.181,,,,23612450,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1413554,https://api.altmetric.com/v1/donut/1413554_240.png 6,Sexuality in men after prostate cancer surgery: a qualitative interview study,Scandinavian Journal of Caring Sciences,,,Article,2016-04-14,10.1111/scs.12328,,,,27074959,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6736739,https://api.altmetric.com/v1/donut/6736739_240.png 6,Targeting prostate cancer cells en route to dissemination ,Journal of Controlled Release,,,Article,2016-02-01,10.1016/j.jconrel.2016.01.025,,,,26802318,,,,,,,0,0,0,14,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5021937,https://api.altmetric.com/v1/donut/5021937_240.png 6,Radiotherapy for isolated lymph node metastases in patients with locally advanced prostate cancer after primary therapy,World Journal of Urology,,,Article,2015-11-27,10.1007/s00345-015-1733-y,,,,26612676,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,1,0,0,2,https://www.altmetric.com/details/4839994,https://api.altmetric.com/v1/donut/4839994_240.png 6,Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?,European Urology,,,Article,2015-09-11,10.1016/j.eururo.2015.08.057,,,,26364550,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4496376,https://api.altmetric.com/v1/donut/4496376_240.png 6,Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy ?for Prostate Cancer.,Oncology Nursing Forum,,,Article,2015-07-07,10.1188/15.onf.348-356,,,,26148314,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4252127,https://api.altmetric.com/v1/donut/4252127_240.png 6,Vasectomy-associated prostate cancer risk 'small',ecancer.org,,,Article,,,,,http://ecancer.org/news/5958-vasectomy-associated-prostate-cancer-risk--small.php,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2507939,https://api.altmetric.com/v1/donut/2507939_240.png 6,More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer,European Urology,,,Article,2015-02-01,10.1016/j.eururo.2014.05.011,,,,24882672,,,,,,,0,0,0,8,0,0,0,0,1,0,0,0,0,0,0,25,https://www.altmetric.com/details/2390393,https://api.altmetric.com/v1/donut/2390393_240.png 6,Rationale for Stereotactic Body Radiation Therapy in Treating Patients with Oligometastatic Hormone-Naïve Prostate Cancer.,Frontiers in oncology,,,Article,2013-11-18,10.3389/fonc.2013.00293,,,,24350058,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1951500,https://api.altmetric.com/v1/donut/1951500_240.png 6,Re: Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djn287,,,,18812556,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,https://www.altmetric.com/details/3784757,https://api.altmetric.com/v1/donut/3784757_240.png 6,"Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Arm",The Journal of Urology,,,Article,2016-08-30,10.1016/j.juro.2016.08.092,,,,27569432,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10836293,https://api.altmetric.com/v1/donut/10836293_240.png 6,Antitumour activity of platinum compounds in advanced prostate cancer – a systematic literature review,Annals of Oncology,,,Article,2016-04-06,10.1093/annonc/mdw156,,,,27052650,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6496646,https://api.altmetric.com/v1/donut/6496646_240.png 6,"Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life Following Delivery of Dose-Escalated Image-Guided Proton Therapy for Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-16,10.1016/j.ijrobp.2016.02.038,,,,27084658,,,,,,,0,0,0,11,0,0,3,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/5622860,https://api.altmetric.com/v1/donut/5622860_240.png 6,DNA Damage and Repair Pathway Profiles as Biomarkers in High-Risk Prostate Cancer,JAMA Oncology,,,Article,2016-01-07,10.1001/jamaoncol.2015.4952,,,,26747678,,,,,,,0,0,0,14,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4968634,https://api.altmetric.com/v1/donut/4968634_240.png 6,National economic conditions and patient insurance status predict prostate cancer diagnosis rates and management decisions,The Journal of Urology,,,Article,2015-12-29,10.1016/j.juro.2015.12.071,,,,26707507,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4891577,https://api.altmetric.com/v1/donut/4891577_240.png 6,Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study.,American Journal of Clinical Nutrition,,,Article,2015-01-15,10.3945/ajcn.114.088716,,,,25527761,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2908168,https://api.altmetric.com/v1/donut/2908168_240.png 6,The Thoc1 Ribonucleoprotein and Prostate Cancer Progression,JNCI: Journal of the National Cancer Institute,,,Article,2014-11-15,10.1093/jnci/dju306,,,,25296641,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2754390,https://api.altmetric.com/v1/donut/2754390_240.png 6,Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study,Journal of Clinical Oncology,,,Article,2014-09-14,10.1200/jco.2013.54.5954,,,,25225437,,,,,,,0,0,0,8,0,2,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2687301,https://api.altmetric.com/v1/donut/2687301_240.png 6,Effects of Calorie Restriction and IGF-1 Receptor Blockade on the Progression of 22Rv1 Prostate Cancer Xenografts,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140713782,,,,23823800,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1766329,https://api.altmetric.com/v1/donut/1766329_240.png 6,Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy,The Journal of Urology,,,Article,2011-01-01,10.1016/j.juro.2010.10.057,,,,21239008,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,106,https://www.altmetric.com/details/1539639,https://api.altmetric.com/v1/donut/1539639_240.png 6,Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines.,Andrology,,,Article,2013-05-20,10.1111/j.2047-2927.2013.00093.x,,,,23686896,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1496933,https://api.altmetric.com/v1/donut/1496933_240.png 6,Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases.,Acta Oncologica,,,Article,2013-04-02,10.3109/0284186x.2013.764010,,,,23544357,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1336897,https://api.altmetric.com/v1/donut/1336897_240.png 6,Magnetic Resonance Imaging for Predicting Prostate Biopsy Findings in Patients Considered for Active Surveillance of Clinically Low Risk Prostate Cancer,The Journal of Urology,,,Article,2012-09-26,10.1016/j.juro.2012.07.024,,,,23017866,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/967497,https://api.altmetric.com/v1/donut/967497_240.png 6,Active surveillance for prostate cancer: a narrative review of clinical guidelines,Nature Reviews Urology,,,Article,2016-01-27,10.1038/nrurol.2015.313,,,,26813955,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/5056156,https://api.altmetric.com/v1/donut/5056156_240.png 6,Re: Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?,The Journal of Urology,,,Article,2015-06-20,10.1016/j.juro.2015.04.066,,,,26088225,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3920026,https://api.altmetric.com/v1/donut/3920026_240.png 6,Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer.,European Urology,,,Article,2014-05-28,10.1016/j.eururo.2014.05.005,,,,24882673,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2390340,https://api.altmetric.com/v1/donut/2390340_240.png 6,Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-2240,,,,24277453,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1934508,https://api.altmetric.com/v1/donut/1934508_240.png 6,The androgen receptor and prostate cancer: A role for sexual selection and sexual conflict?,Medical Hypotheses,,,Article,2007-07-28,10.1016/j.mehy.2007.04.044,,,,17656031,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1383143,https://api.altmetric.com/v1/donut/1383143_240.png 6," Implications of high rates of metastatic prostate cancer in BRCA2 mutation carriers ",The Prostate,,,Article,2016-05-01,10.1002/pros.23204,,,,27225637,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8304913,https://api.altmetric.com/v1/donut/8304913_240.png 6,Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation.,Advances in Urology,,,Article,2015-10-26,10.1155/2015/976235,,,,26587019,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4679603,https://api.altmetric.com/v1/donut/4679603_240.png 6,Sequencing of agents in castration-resistant prostate cancer,Lancet Oncology,,,Article,2015-01-06,10.1016/s1470-2045(15)70033-1,,,,26065613,,,,,,,0,0,0,9,0,0,4,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/4064982,https://api.altmetric.com/v1/donut/4064982_240.png 6,Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer,The AAPS Journal,,,Article,2013-07-01,10.1208/s12248-013-9486-2,,,,23588585,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2631927,https://api.altmetric.com/v1/donut/2631927_240.png 6,NICE rejects use of abiraterone for advanced prostate cancer before chemo,ecancer.org,,,Article,,,,,http://ecancer.org/news/5651-nice-rejects-use-of-abiraterone-for-advanced-prostate-cancer-before-chemo.php,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2349574,https://api.altmetric.com/v1/donut/2349574_240.png 6,Selenium and Vitamin E Supplementation Above Recommended Dietary Intake May Increase Prostate Cancer Risk,JNCI: Journal of the National Cancer Institute,,,Article,2014-02-22,10.1093/jnci/dju060,,,,,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2154542,https://api.altmetric.com/v1/donut/2154542_240.png 6,Testosterone and Prostate Cancer: An Historical Perspective on a Modern Myth,European Urology,,,Article,2006-11-01,10.1016/j.eururo.2006.06.034,,,,16875775,,,,,,,0,0,0,3,0,0,1,1,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/1893455,https://api.altmetric.com/v1/donut/1893455_240.png 6,Severe lack of comprehension of common prostate health terms among low-income inner-city men.,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28186,,,,23733135,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1528949,https://api.altmetric.com/v1/donut/1528949_240.png 6,"XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27Kip1",The Prostate,,,Article,2011-01-01,10.1002/pros.21491,,,,21932423,,,,,,,0,0,0,13,1,0,4,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/376213,https://api.altmetric.com/v1/donut/376213_240.png 6,Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression,Cancer Cell,,,Article,2011-08-15,10.1016/j.ccr.2011.07.013,,,,21840483,PMC3176728,,,,,,0,0,0,4,0,0,1,1,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/237230,https://api.altmetric.com/v1/donut/237230_240.png 6,Editorial,Prostate Cancer & Prostatic Diseases,,,Article,2004-06-01,10.1038/sj.pcan.4500731,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/632404,https://api.altmetric.com/v1/donut/632404_240.png 6,Re: Axel Heidenreich. Consensus Criteria for the Use of Magnetic Resonance Imaging in the Diagnosis and Staging of Prostate Cancer: Not Ready for Routine Use. Eur Urol 2011;59:495–7,European Urology,,,Article,2011-07-01,10.1016/j.eururo.2011.03.013,,,,21429656,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/640339,https://api.altmetric.com/v1/donut/640339_240.png 6,"Three-Tesla Magnetic Resonance–Guided Prostate Biopsy in Men With Increased Prostate-Specific Antigen and Repeated, Negative, Random, Systematic, Transrectal Ultrasound Biopsies: Detection of Clinically Significant Prostate Cancers",European Urology,,,Article,2012-02-01,10.1016/j.eururo.2012.01.047,,,,22325447,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,86,https://www.altmetric.com/details/640338,https://api.altmetric.com/v1/donut/640338_240.png 6,Relationship between Apparent Diffusion Coefficients at 3.0-T MR Imaging and Gleason Grade in Peripheral Zone Prostate Cancer,Radiology,,,Article,2011-04-18,10.1148/radiol.11091409,,,,21502392,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,88,https://www.altmetric.com/details/640337,https://api.altmetric.com/v1/donut/640337_240.png 6,Prostate Cancer Disparities throughout the Cancer Control Continuum,Social Sciences,,,Article,2013-11-08,10.3390/socsci2040247,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4768234,https://api.altmetric.com/v1/donut/4768234_240.png 6,Limitations in predicting organ-confined prostate cancer in patients with Gleason pattern 4 on biopsy: Implications for active surveillance,The Journal of Urology,,,Article,2016-07-22,10.1016/j.juro.2016.07.076,,,,27457260,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10121348,https://api.altmetric.com/v1/donut/10121348_240.png 6,Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis,European Urology,,,Article,2016-01-15,10.1016/j.eururo.2015.12.045,,,,26776937,,,,,,,0,0,0,12,0,0,5,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4996203,https://api.altmetric.com/v1/donut/4996203_240.png 6,Focal Therapy Gains Ground in Low-Risk Prostate Cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2015-09-06,10.1093/jnci/djv269,,,,26341001,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4475099,https://api.altmetric.com/v1/donut/4475099_240.png 6,Assessment of Prospectively Assigned Likert Scores for Targeted MR Imaging-Transrectal US Fusion Biopsies in Patients with Suspected Prostate Cancer.,The Journal of Urology,,,Article,2015-07-21,10.1016/j.juro.2015.07.080,,,,26192254,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/4289869,https://api.altmetric.com/v1/donut/4289869_240.png 6,Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism ,European Urology,,,Article,2015-07-04,10.1016/j.eururo.2015.06.022,,,,26138040,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4242335,https://api.altmetric.com/v1/donut/4242335_240.png 6,MLC Tracking Improves Dose Delivery for Prostate Cancer Radiotherapy: Results of the First Clinical Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-07-22,10.1016/j.ijrobp.2015.04.024,,,,26194684,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3920531,https://api.altmetric.com/v1/donut/3920531_240.png 6,Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force,Annals of Internal Medicine,,,Article,2008-08-05,10.7326/0003-4819-149-3-200808050-00009,,,,,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3756543,https://api.altmetric.com/v1/donut/3756543_240.png 6,Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis,Journal of Clinical Investigation,,,Article,2015-02-09,10.1172/jci76029,,,,25664849,,,,,,,0,0,0,11,0,0,3,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3444117,https://api.altmetric.com/v1/donut/3444117_240.png 6,miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen,European Urology,,,Article,,10.1016/j.eururo.2014.12.025,,,,25556023,,,,,,,0,0,0,16,0,0,3,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3026499,https://api.altmetric.com/v1/donut/3026499_240.png 6,Testosterone Replacement Therapy in Men with Prostate Cancer: A Time?Varying Analysis,Journal of Sexual Medicine,,,Article,2014-12-11,10.1111/jsm.12768,,,,25496237,,,,,,,0,0,0,8,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2978234,https://api.altmetric.com/v1/donut/2978234_240.png 6,Biomarker predicts treatment resistance in prostate cancer,Lancet Oncology,,,Article,2014-09-19,10.1016/s1470-2045(14)70468-1,,,,24731400,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2697242,https://api.altmetric.com/v1/donut/2697242_240.png 6,Implications of the New AUA Guidelines on Prostate Cancer Detection in the U.S.,Current Urology Reports,,,Article,2014-07-01,10.1007/s11934-014-0420-7,,,,24844775,,,,,,,0,0,0,9,1,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2374337,https://api.altmetric.com/v1/donut/2374337_240.png 6,Focal Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial Design,European Urology,,,Article,2014-06-01,10.1016/j.eururo.2014.01.001,,,,24444476,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2124855,https://api.altmetric.com/v1/donut/2124855_240.png 6,Comparative effectiveness study of patient?reported outcomes after proton therapy or intensity?modulated radiotherapy for prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28536,,,,24382757,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2030043,https://api.altmetric.com/v1/donut/2030043_240.png 6,Declines in Prostate Cancer Incidence After Changes in Screening Recommendations,Archives of Internal Medicine,,,Article,2012-01-01,10.1001/archinternmed.2012.2768,,,,22826149,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1790334,https://api.altmetric.com/v1/donut/1790334_240.png 6,Taking omega-3 fish oil supplements may increase the risk of aggressive prostate cancer by 70%,ecancer.org,,,Article,,,,,http://ecancer.org/news/4228-taking-omega-3-fish-oil-supplements-may-increase-the-risk-of-aggressive-prostate-cancer-by-70.php,,,,,,,,0,0,0,10,0,0,2,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1618383,https://api.altmetric.com/v1/donut/1618383_240.png 6,Is the ?/? ratio for prostate tumours really low and does it vary with the level of risk at diagnosis?,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2013-03-01,,,,,23482774,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1493553,https://api.altmetric.com/v1/donut/1493553_240.png 6,Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.,American Journal of Medicine,,,Article,2002-12-01,,,,,12505117,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1444899,https://api.altmetric.com/v1/donut/1444899_240.png 6,Overdiagnosis Since Introduction of Prostate Cancer Screening,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djp330,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1444898,https://api.altmetric.com/v1/donut/1444898_240.png 6,Populationâ??based 10â??year oncologic outcomes after lowâ??doseâ??rate brachytherapy for lowâ??risk and intermediateâ??risk prostate cancer,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.27911,,,,23280183,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1144191,https://api.altmetric.com/v1/donut/1144191_240.png 6,“True” Antiandrogens—Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor–Coactivator Interactions: Novel Tools for Prostate Cancer,Journal of Medicinal Chemistry,,,Article,2012-02-10,10.1021/jm201438f,,,,22280402,,1959.8/151737,,,,,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/606451,https://api.altmetric.com/v1/donut/606451_240.png 6,The RNA-binding protein HuR opposes the repression of ERBB-2 expression by miR-331-3p in prostate cancer cells.,Journal of Biological Chemistry,,,Article,2011-01-01,10.1074/jbc.m111.301481,,,,21971048,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/406326,https://api.altmetric.com/v1/donut/406326_240.png 6,The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy,Cancer (0008543X),,,Article,2010-04-01,10.1002/cncr.24890,,,,20143436,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4325890,https://api.altmetric.com/v1/donut/4325890_240.png 6,External Beam Radiotherapy for Prostate Cancer Patients on Anticoagulation Therapy: How Significant is the Bleeding Toxicity?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-03-01,10.1016/j.ijrobp.2009.02.026,,,,19464123,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4325888,https://api.altmetric.com/v1/donut/4325888_240.png 6,"Association Study of Prostate Cancer Susceptibility Variants with Risks of Invasive Ovarian, Breast, and Colorectal Cancer",Cancer Research,,,Article,1970-01-01,10.1158/0008-5472.can-08-2363,,,,18974127,PMC2666188,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1374870,https://api.altmetric.com/v1/donut/1374870_240.png 6,CASE NUMBER AND THE FINANCIAL IMPACT OF CIRCUMCISION IN REDUCING PROSTATE CANCER,British Journal of Urology,,,Article,2007-07-01,10.1111/j.1464-410x.2007.06875.x,,,,17419695,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1374819,https://api.altmetric.com/v1/donut/1374819_240.png 6,Circumcision and Prostatic Cancer,Journal of Internal Medicine,,,Article,2009-04-24,10.1111/j.0954-6820.1965.tb04294.x,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1374816,https://api.altmetric.com/v1/donut/1374816_240.png 6,A case-control study of cancer of the prostate in Somerset and east Devon.,British Journal of Cancer,,,Article,1996-08-01,,,,,8761387,PMC2074670,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1374813,https://api.altmetric.com/v1/donut/1374813_240.png 6,Prostate cancer in systemic lupus erythematosus.,International Journal of Cancer,,,Article,2011-03-31,10.1002/ijc.25956,,,,21448902,PMC3203250,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1374388,https://api.altmetric.com/v1/donut/1374388_240.png 6,Implementation of the AUA Castration Resistant Prostate Cancer Guidelines into Practice: Establishing a Multidisciplinary Clinic,Urology Practice,,,Article,2016-02-12,10.1016/j.urpr.2015.07.001,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8164340,https://api.altmetric.com/v1/donut/8164340_240.png 6,Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening,The Journal of Urology,,,Article,2016-01-21,10.1016/j.juro.2016.01.034,,,,27302784,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5024150,https://api.altmetric.com/v1/donut/5024150_240.png 6,Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing,Bulletin of Experimental Biology & Medicine,,,Article,2016-10-04,10.1007/s10517-016-3490-3,,,,27704352,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13077312,https://api.altmetric.com/v1/donut/13077312_240.png 6,A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2004-10-01,,,,,15486186,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/8795413,https://api.altmetric.com/v1/donut/8795413_240.png 6,Generalizability of associations from prostate cancer genome-wide association studies in multiple populations,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-04-14,10.1158/1055-9965.epi-08-1142,,,,19318432,PMC2917607,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5630612,https://api.altmetric.com/v1/donut/5630612_240.png 6,Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer,Clinical Cancer Research,,,Article,2009-03-01,10.1158/1078-0432.ccr-08-1593,,,,19223501,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5630606,https://api.altmetric.com/v1/donut/5630606_240.png 6,Association Studies of Serum Prostate-specific Antigen Levels and the Genetic Polymorphisms at the Androgen Receptor and Prostate-specific Antigen Genes,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2002-07-01,,,,,12101115,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4870125,https://api.altmetric.com/v1/donut/4870125_240.png 6,Susceptibility to Prostate Cancer: Interaction between Genotypes at the Androgen Receptor and Prostate-specific Antigen Loci,Cancer Research,,,Article,2000-02-15,,,,,10706090,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4870124,https://api.altmetric.com/v1/donut/4870124_240.png 6,Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans,Frontiers in immunology,,,Article,2016-02-22,10.3389/fimmu.2016.00053,,,,26941739,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5910452,https://api.altmetric.com/v1/donut/5910452_240.png 6,Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base ,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-12-01,10.1016/j.ijrobp.2015.09.006,,,,26581142,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4526928,https://api.altmetric.com/v1/donut/4526928_240.png 6,"Re: Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) plus Prednisone with Placebo plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer that has Progressed during or after Docetaxel-Based Therapy: ELM-PC 5",The Journal of Urology,,,Article,2015-09-19,10.1016/j.juro.2015.07.010,,,,26382777,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4258214,https://api.altmetric.com/v1/donut/4258214_240.png 6,"Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment",Urologic Oncology,,,Article,2015-03-16,10.1016/j.urolonc.2015.02.009,,,,25791755,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3816327,https://api.altmetric.com/v1/donut/3816327_240.png 6,Are Biochemical Recurrence Outcomes Similar After Radical Prostatectomy and Radiation Therapy? Analysis of Prostate Cancer–Specific Mortality by Nomogram-predicted Risks of Biochemical Recurrence,European Urology,,,Article,2014-10-03,10.1016/j.eururo.2014.09.017,,,,25294696,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2746131,https://api.altmetric.com/v1/donut/2746131_240.png 6,High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models,European Urology,,,Article,2015-06-01,10.1016/j.eururo.2014.08.053,,,,25220373,,,,,,,0,0,0,17,0,0,0,0,1,0,0,0,0,0,0,32,https://www.altmetric.com/details/2682001,https://api.altmetric.com/v1/donut/2682001_240.png 6,Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models,European Urology,,,Article,2014-08-19,10.1016/j.eururo.2014.08.006,,,,25151012,,,,,,,0,0,0,10,0,0,1,0,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/2620677,https://api.altmetric.com/v1/donut/2620677_240.png 6,Anterior Gradient Protein-2 Is a Regulator of Cellular Adhesion in Prostate Cancer,PLoS ONE,,,Article,2014-02-27,10.1371/journal.pone.0089940,,,,24587138,PMC3937391,,,,,,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2190562,https://api.altmetric.com/v1/donut/2190562_240.png 6,‘Race’ and Prostate Cancer Mortality in Equal-access Healthcare Systems,American Journal of Medicine,,,Article,2013-12-01,10.1016/j.amjmed.2013.08.012,,,,24262722,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1925377,https://api.altmetric.com/v1/donut/1925377_240.png 6,Pharmacologic Inhibition of Jak2–Stat5 Signaling By Jak2 Inhibitor AZD1480 Potently Suppresses Growth of Both Primary and Castrate-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-0422,,,,23942095,,,,,,,0,0,0,6,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1688269,https://api.altmetric.com/v1/donut/1688269_240.png 6,"Associations between Testosterone Levels and Incident Prostate, Lung, and Colorectal Cancer. A Population-Based Study","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-01,10.1158/1055-9965.epi-12-0129,,,,22828207,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/855097,https://api.altmetric.com/v1/donut/855097_240.png 6,CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.,British Journal of Cancer,,,Article,2008-02-13,10.1038/sj.bjc.6604242,,,,18268494,PMC2259168,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/1449741,https://api.altmetric.com/v1/donut/1449741_240.png 6,Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study,Science,,,Article,1998-01-23,10.1126/science.279.5350.563,,,,9438850,,,1998Sci...279..563C,,,,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1790486,https://api.altmetric.com/v1/donut/1790486_240.png 6,Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial,JNCI: Journal of the National Cancer Institute,,,Article,2016-12-01,10.1093/jnci/djw168,,,,27565902,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10854725,https://api.altmetric.com/v1/donut/10854725_240.png 6,Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers,Cancer Nanotechnology,,,Article,2016-07-04,10.1186/s12645-016-0018-5,,,,27441041,PMC4932125,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9242787,https://api.altmetric.com/v1/donut/9242787_240.png 6,"Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic Review",Frontiers in Pharmacology,,,Article,2015-11-12,10.3389/fphar.2015.00273,,,,26834632,PMC4714608,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4753712,https://api.altmetric.com/v1/donut/4753712_240.png 6,Prostate cancer is five different diseases,ecancer.org,,,Article,,,,,http://ecancer.org/news/7561-prostate-cancer-is-five-different-diseases.php,,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4344585,https://api.altmetric.com/v1/donut/4344585_240.png 6,"Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review",Family Practise,,,Article,2015-07-05,10.1093/fampra/cmv053,,,,26142418,,,,,,,0,0,0,16,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4244061,https://api.altmetric.com/v1/donut/4244061_240.png 6,An Investigation into the Association between DNA Damage and Dietary Fatty Acid in Men with Prostate Cancer,Nutrients,,,Article,2015-01-01,10.3390/nu7010405,,,,25580814,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3064955,https://api.altmetric.com/v1/donut/3064955_240.png 6,Outcomes for depressed patients with prostate cancer ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70339-0,,,,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2519617,https://api.altmetric.com/v1/donut/2519617_240.png 6,"New Zealand prostate cancer awareness programme is likely to increase unnecessary PSA testing, critics say",British Medical Journal,,,Article,2013-12-16,10.1136/bmj.f7537,,,,24342970,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/1983249,https://api.altmetric.com/v1/donut/1983249_240.png 6,Comparison of prostate cancer diagnosis in patients receiving unrelated urological and nonâ??urological cancer care,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12220,,,,23795784,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1582490,https://api.altmetric.com/v1/donut/1582490_240.png 6,"Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada.",American Journal of Epidemiology,,,Article,1995-04-15,,,,,7535977,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2743818,https://api.altmetric.com/v1/donut/2743818_240.png 6,Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result.,American Journal of Medicine,,,Article,2004-11-15,10.1016/j.amjmed.2004.06.036,,,,15541320,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2743817,https://api.altmetric.com/v1/donut/2743817_240.png 6,Prostate cancer: to screen or not to screen?,Nature Reviews Urology,,,Article,2009-01-06,10.1038/nrurol.2009.92,,,,19498405,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2743816,https://api.altmetric.com/v1/donut/2743816_240.png 6,The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis,Family Practise,,,Article,1999-01-01,10.1093/fampra/16.6.621,,,,10625141,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2743814,https://api.altmetric.com/v1/donut/2743814_240.png 6,Prostate cancer screening: role of the digital rectal examination and prostate-specific antigen.,Annals of Surgical Oncology,,,Article,1994-03-01,,,,,7530587,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2743813,https://api.altmetric.com/v1/donut/2743813_240.png 6,"Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study",Lancet Oncology,,,Article,2007-07-01,10.1016/s1470-2045%2807%2970147-x,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1429066,https://api.altmetric.com/v1/donut/1429066_240.png 6,Pain Predicts Overall Survival in Men With Metastatic Castration-Refractory Prostate Cancer,Journal of Clinical Oncology,,,Article,2008-01-01,10.1200/jco.2007.15.0367,,,,18487572,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1428869,https://api.altmetric.com/v1/donut/1428869_240.png 6,The androgen axis in recurrent prostate cancer.,,,,Article,2004-01-15,,,,,14760063,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/4536969,https://api.altmetric.com/v1/donut/4536969_240.png 6,Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.,Surgery gynecology obstetrics,,,Article,1967-05-01,,,,,6022476,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3108794,https://api.altmetric.com/v1/donut/3108794_240.png 6,"Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer ",Journal of Steroid Biochemistry & Molecular Biology,,,Article,2016-06-23,10.1016/j.jsbmb.2016.06.007,,,,27329245,,,,,,,0,0,0,2,0,0,2,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8991737,https://api.altmetric.com/v1/donut/8991737_240.png 6,Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer Study,European Urology,,,Article,2016-05-20,10.1016/j.eururo.2016.05.009,,,,27210461,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7857391,https://api.altmetric.com/v1/donut/7857391_240.png 6,A new human retrovirus associated with prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2007-01-30,10.1073/pnas.0610912104,,,,17244700,PMC1785241,,2007PNAS..104.1449F,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5631285,https://api.altmetric.com/v1/donut/5631285_240.png 6,Radical Prostatectomy versus Radiation Therapy: Can Pretreatment Nomograms Be Used to Select the Appropriate Prostate Cancer Treatment?,European Urology,,,Article,2015-02-01,10.1016/j.eururo.2014.10.009,,,,25457494,,,,,,,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/2815051,https://api.altmetric.com/v1/donut/2815051_240.png 6,Indole-3-Carbinol and Prostate Cancer,Journal of Nutrition,,,Article,2004-01-12,,,,,15570059,,,,,,,0,1,0,0,0,0,2,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2766195,https://api.altmetric.com/v1/donut/2766195_240.png 6,Dietary n – 6 and n – 3 Polyunsaturated Fatty Acids and Prostate Cancer Risk: A Review of Epidemiological and Experimental Evidence,Cancer Causes and Control,,,Article,2004-05-01,10.1023/b:caco.0000027498.94238.a3,,,,15141138,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,18,https://www.altmetric.com/details/2564808,https://api.altmetric.com/v1/donut/2564808_240.png 6,Re: First Round of Targeted Biopsies with Magnetic Resonance Imaging/Ultrasound-Fusion Images Compared to Conventional Ultrasound-Guided Trans-Rectal Biopsies for the Diagnosis of Localised Prostate Cancer,The Journal of Urology,,,Article,2014-01-07,10.1016/j.juro.2014.04.075,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2521271,https://api.altmetric.com/v1/donut/2521271_240.png 6,Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.,New England Journal of Medicine,,,Article,2003-06-19,10.1056/nejmoa022749,,,,,,,,,,,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2115945,https://api.altmetric.com/v1/donut/2115945_240.png 6,Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment,Radiation Oncology,,,Article,2013-04-21,10.1186/1748-717x-8-94,,,,23601254,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1401845,https://api.altmetric.com/v1/donut/1401845_240.png 6,Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models.,Integrative Cancer Therapies,,,Article,2006-01-12,10.1177/1534735406295350,,,,17101766,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,2,17,https://www.altmetric.com/details/1340934,https://api.altmetric.com/v1/donut/1340934_240.png 6,Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis.,Cancer Research,,,Article,2012-05-15,10.1158/0008-5472.can-11-2928,,,,22589273,,,,,,,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/748290,https://api.altmetric.com/v1/donut/748290_240.png 6,"Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.",JNCI: Journal of the National Cancer Institute,,,Article,2006-01-01,10.1093/jnci/djj050,,,,16478743,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/714033,https://api.altmetric.com/v1/donut/714033_240.png 6,Duration of androgen suppression in the treatment of prostate cancer.,New England Journal of Medicine,,,Article,2009-11-06,10.1056/nejmoa0810095,,,,19516032,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,2,0,0,8,https://www.altmetric.com/details/525636,https://api.altmetric.com/v1/donut/525636_240.png 6,Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.,Clinical Cancer Research,,,Article,2008-10-01,10.1158/1078-0432.ccr-08-0872,,,,18829513,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,1,0,0,90,https://www.altmetric.com/details/517033,https://api.altmetric.com/v1/donut/517033_240.png 6,Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial,Lancet Oncology,,,Article,2011-12-17,10.1016/s1470-2045(11)70293-5,,,,22169269,,,,,,,0,0,0,5,0,0,0,1,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/490425,https://api.altmetric.com/v1/donut/490425_240.png 6,Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers,Cancer Research,,,Article,2011-09-06,10.1158/0008-5472.can-11-1637,,,,21896641,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/261412,https://api.altmetric.com/v1/donut/261412_240.png 6,Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Randomized Clinical Trial,JAMA: Journal of the American Medical Association,,,Article,2006-11-15,10.1001/jama.296.19.2329,,,,17105795,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/226543,https://api.altmetric.com/v1/donut/226543_240.png 6,Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy,BMC Urology,,,Article,2013-01-29,10.1186/1471-2490-13-6,,,,23356551,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2112648,https://api.altmetric.com/v1/donut/2112648_240.png 6,Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer,Basic and Clinical Andrology,,,Article,2013-08-29,10.1186/2051-4190-23-2,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1718121,https://api.altmetric.com/v1/donut/1718121_240.png 6,Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years.,The Journal of Urology,,,Article,2004-11-01,,,,,15540740,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1370785,https://api.altmetric.com/v1/donut/1370785_240.png 6,A Prospective Study of Total and Ionized Serum Calcium and Fatal Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-01-01,10.1158/1055-9965.epi-08-0915,,,,19190170,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1439370,https://api.altmetric.com/v1/donut/1439370_240.png 6,Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-01-01,10.1158/1055-9965.epi-07-0197,,,,17971519,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1439346,https://api.altmetric.com/v1/donut/1439346_240.png 6,Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: Prostate health outcomes in the Registry of Hypogonadism in Men (RHYME),British Journal of Urology,,,Article,2016-07-01,10.1111/bju.13578,,,,27409523,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9712053,https://api.altmetric.com/v1/donut/9712053_240.png 6,Local anesthetic bupivacaine induced ovarian and prostate cancer apoptotic cell death and underlying mechanisms in vitro.,Scientific Reports,,,Article,2016-05-20,10.1038/srep26277,,,,27195613,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,1,0,0,2,https://www.altmetric.com/details/7869117,https://api.altmetric.com/v1/donut/7869117_240.png 6,P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer,Cell Reports,,,Article,2016-02-01,10.1016/j.celrep.2016.02.016,,,,26923603,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6015037,https://api.altmetric.com/v1/donut/6015037_240.png 6,Prostate cancer in men of African origin,Nature Reviews Urology,,,Article,2015-12-31,10.1038/nrurol.2015.298,,,,26718455,,,,,,,0,0,0,11,0,0,1,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/4942117,https://api.altmetric.com/v1/donut/4942117_240.png 6,"Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies",International Journal of Cancer,,,Article,2015-12-01,10.1002/ijc.29973,,,,26685908,,,,,,,0,0,0,6,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4898681,https://api.altmetric.com/v1/donut/4898681_240.png 6,Life Expectancy and Treatment Choice for Men with High-risk Prostate Cancer,European Urology,,,Article,2015-03-31,10.1016/j.eururo.2015.01.006,,,,25813689,,,,,,,0,0,0,9,0,0,3,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/3826149,https://api.altmetric.com/v1/donut/3826149_240.png 6,The Era of Prostate-specific Antigen-based Personalized Prostate Cancer Screening Has Only Just Begun,European Urology,,,Article,2015-02-10,10.1016/j.eururo.2015.01.031,,,,25680240,,,,,,,0,0,0,11,0,0,3,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3529408,https://api.altmetric.com/v1/donut/3529408_240.png 6,Heterosexual couples and prostate cancer support groups: a gender relations analysis,Supportive Care in Cancer,,,Article,2014-12-21,10.1007/s00520-014-2562-z,,,,25527241,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3013840,https://api.altmetric.com/v1/donut/3013840_240.png 6,miRNA-128 Suppresses Prostate Cancer by Inhibiting BMI-1 to Inhibit Tumor-Initiating Cells,Cancer Research,,,Article,2014-06-04,10.1158/0008-5472.can-14-0404,,,,24903149,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2441149,https://api.altmetric.com/v1/donut/2441149_240.png 6,High-risk prostate cancer[mdash]classification and therapy,Nature Reviews Clinical Oncology,,,Article,2014-05-20,10.1038/nrclinonc.2014.68,,,,24840073,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,88,https://www.altmetric.com/details/2365020,https://api.altmetric.com/v1/donut/2365020_240.png 6,"Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk",European Journal of Epidemiology,,,Article,2014-02-13,10.1007/s10654-014-9884-5,,,,24519551,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2175618,https://api.altmetric.com/v1/donut/2175618_240.png 6,A Multicentre Year-long Randomised Controlled Trial of Exercise Training Targeting Physical Functioning in Men with Prostate Cancer Previously Treated with Androgen Suppression and Radiation from TROG 03.04 RADAR.,European Urology,,,Article,2013-10-03,10.1016/j.eururo.2013.09.041,,,,24113319,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/1821496,https://api.altmetric.com/v1/donut/1821496_240.png 6,Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?,Nuclear Medicine Communications,,,Article,2013-05-15,10.1097/mnm.0b013e3283620d5e,,,,23680652,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1483571,https://api.altmetric.com/v1/donut/1483571_240.png 6,Aspirin may help men with prostate cancer live longer,ecancer.org,,,Article,,,,,http://ecancer.org/news/3335-aspirin-may-help-men-with-prostate-cancer-live-longer.php,,,,,,,,0,0,0,8,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250706,https://api.altmetric.com/v1/donut/1250706_240.png 6,Health-Related Quality-of-Life Findings for the Prostate Cancer Prevention Trial,JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djs359,,,,22972968,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/943921,https://api.altmetric.com/v1/donut/943921_240.png 6,Germline BRCA1 mutations increase prostate cancer risk,British Journal of Cancer,,,Article,2012-04-19,10.1038/bjc.2012.146,,,,22516946,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/711202,https://api.altmetric.com/v1/donut/711202_240.png 6,Competing-risks Mortality After Radiotherapy vs. Observation for Localized Prostate Cancer: A Population-based Study.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-02-16,10.1016/j.ijrobp.2011.11.034,,,,22330991,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/639836,https://api.altmetric.com/v1/donut/639836_240.png 6,Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.,JNCI: Journal of the National Cancer Institute,,,Article,2007-09-19,10.1093/jnci/djm117,,,,17848673,,,,,,,0,0,0,8,0,0,3,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/211998,https://api.altmetric.com/v1/donut/211998_240.png 6,Arachidonic Acid Activates Phosphatidylinositol 3-Kinase Signaling and Induces Gene Expression in Prostate Cancer,Cancer Research,,,Article,2006-01-01,10.1158/0008-5472.can-05-0914,,,,16452198,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1485789,https://api.altmetric.com/v1/donut/1485789_240.png 6,Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.,Cancer Research,,,Article,2011-09-10,10.1158/0008-5472.can-11-1646,,,,21903767,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1485354,https://api.altmetric.com/v1/donut/1485354_240.png 6,Comparison of MR/Ultrasound Fusion-Guided Biopsy with Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer,Urology,,,Article,2015-11-10,10.1016/j.urology.2015.10.010,,,,26548951,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4731027,https://api.altmetric.com/v1/donut/4731027_240.png 6,Controversies in management of high?risk prostate and bladder cancer,British Journal of Urology,,,Article,2015-11-01,10.1111/bju.13340,,,,26449166,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4608559,https://api.altmetric.com/v1/donut/4608559_240.png 6,"Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men",Cancer Causes and Control,,,Article,,10.1007/bf01831383,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4453797,https://api.altmetric.com/v1/donut/4453797_240.png 6,Factors Driving Inequality in Prostate Cancer Survival: A Population Based Study,PLoS ONE,,,Article,2014-09-11,10.1371/journal.pone.0106456,,,,25203444,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2751826,https://api.altmetric.com/v1/donut/2751826_240.png 6,Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years,European Urology,,,Article,2015-02-01,10.1016/j.eururo.2014.02.011,,,,24571959,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/2127127,https://api.altmetric.com/v1/donut/2127127_240.png 6,Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2016-10-04,10.1001/jama.2016.9778,,,,27701653,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12446287,https://api.altmetric.com/v1/donut/12446287_240.png 6,Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement Summary,Journal of Oncology Practice,,,Article,2016-02-18,10.1200/jop.2015.010017,,,,26883405,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5624502,https://api.altmetric.com/v1/donut/5624502_240.png 6,Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.,Strahlentherapie und Onkologie,,,Article,2015-07-09,10.1007/s00066-015-0866-7,,,,26156249,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4258053,https://api.altmetric.com/v1/donut/4258053_240.png 6,Potential Role for Androgen-Deprivation Therapy and Pelvic Radiation Therapy in Node-Positive Postprostatectomy Prostate Cancer.,Journal of Clinical Oncology,,,Article,2014-10-20,10.1200/jco.2014.57.8302,,,,25332250,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2805183,https://api.altmetric.com/v1/donut/2805183_240.png 6,"Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both.",European Urology,,,Article,2014-09-08,10.1016/j.eururo.2014.08.061,,,,25217421,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2670469,https://api.altmetric.com/v1/donut/2670469_240.png 6,Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series,Radiation Oncology,,,Article,2014-09-09,10.1186/1748-717x-9-200,,,,25205146,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2668846,https://api.altmetric.com/v1/donut/2668846_240.png 6,Prostate Cancer That Is Within 0.1 mm of the Surgical Margin of a Radical Prostatectomy Predicts Greater Likelihood of Recurrence,The American Journal of Surgical Pathology,,,Article,2014-03-01,10.1097/pas.0000000000000162,,,,24525503,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2121163,https://api.altmetric.com/v1/donut/2121163_240.png 6,Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci,PLoS Genetics,,,Article,2014-01-30,10.1371/journal.pgen.1004102,,,,24497837,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/2086413,https://api.altmetric.com/v1/donut/2086413_240.png 6,Risk of suicide in men with low-risk prostate cancer,European Journal of Cancer (1965),,,Article,2013-01-21,10.1016/j.ejca.2012.12.018,,,,23337463,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1189040,https://api.altmetric.com/v1/donut/1189040_240.png 6,Clinical development of novel therapeutics for castration?resistant prostate cancer,CA: A Cancer Journal for Clinicians ,,,Article,2012-01-01,10.3322/caac.21141,,,,22535487,,,,,,,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/711860,https://api.altmetric.com/v1/donut/711860_240.png 6,Active Surveillance Versus Surgery for Low Risk Prostate Cancer: A Clinical Decision Analysis,The Journal of Urology,,,Article,2012-02-15,10.1016/j.juro.2011.12.015,,,,22335873,,,,,,,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/610564,https://api.altmetric.com/v1/donut/610564_240.png 6,Lifetime economic burden of prostate cancer,BMC Health Services Research,,,Article,2011-12-28,10.1186/1472-6963-11-349,,,,22204308,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/510091,https://api.altmetric.com/v1/donut/510091_240.png 6,Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation,Molecular Cancer,,,Article,2014-01-18,10.1186/1476-4598-13-10,,,,24438191,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2116317,https://api.altmetric.com/v1/donut/2116317_240.png 6,Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.,Nature Genetics,,,Article,2007-04-01,10.1038/ng1999,,,,17401366,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,110,https://www.altmetric.com/details/125442,https://api.altmetric.com/v1/donut/125442_240.png 6,Multiple prostate cancer risk variants on 8q24,Nature Genetics,,,Article,2007-05-01,10.1038/ng0507-579,,,,17460686,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/125393,https://api.altmetric.com/v1/donut/125393_240.png 6,"Diet, microRNAs and prostate cancer.",Pharmaceutical Research,,,Article,2010-03-12,10.1007/s11095-010-0086-x,,,,20221895,PMC2872011,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/2136479,https://api.altmetric.com/v1/donut/2136479_240.png 6,Lymph node parameters and complications following laparoscopic extended pelvic lymphadenectomy for prostate cancer in 1000 consecutive patients,Journal of Clinical Urology,,,Article,2016-03-24,10.1177/2051415816639775,,,,,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11672861,https://api.altmetric.com/v1/donut/11672861_240.png 6,Racial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States,"Preventing Chronic Disease: Public Health Research, Practice and Policy",,,Article,2016-07-21,10.5888/pcd13.160148,,,,27442995,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9926839,https://api.altmetric.com/v1/donut/9926839_240.png 6,Re: Expectant Management of Veterans with Early-Stage Prostate Cancer,The Journal of Urology,,,Article,2016-06-16,10.1016/j.juro.2016.06.069,,,,27597067,,,,,,,0,0,0,18,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8807585,https://api.altmetric.com/v1/donut/8807585_240.png 6,Salvage Radiotherapy for Postoperative Biochemical Failure of Prostate Cancer: The Path Toward Personalized Medicine,European Urology,,,Article,2016-01-30,10.1016/j.eururo.2016.01.033,,,,26831623,,,,,,,0,0,0,11,0,0,4,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5063845,https://api.altmetric.com/v1/donut/5063845_240.png 6,Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer,European Urology,,,Article,2015-12-24,10.1016/j.eururo.2015.12.003,,,,26724257,,,,,,,0,0,0,12,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4919026,https://api.altmetric.com/v1/donut/4919026_240.png 6,Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.6141,,,,26485765,PMC4747356,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4796806,https://api.altmetric.com/v1/donut/4796806_240.png 6,Re: Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-Cause Mortality in Elderly Men with Prostate Cancer,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.03.045,,,,25986793,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3789461,https://api.altmetric.com/v1/donut/3789461_240.png 6,Cholesterol unlocks clues to prostate cancer spread,ecancer.org,,,Article,,,,,http://ecancer.org/news/5564-cholesterol-unlocks-clues-to-prostate-cancer-spread.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2283567,https://api.altmetric.com/v1/donut/2283567_240.png 6,Is a Treatment Delay in Radical Prostatectomy Safe in Individuals with Lowâ??Risk Prostate Cancer?,Journal of Sexual Medicine,,,Article,2012-01-01,10.1111/j.1743-6109.2012.02806.x,,,,22672479,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/786369,https://api.altmetric.com/v1/donut/786369_240.png 6,Caveolin-1 Upregulation Contributes to c-Myc-Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer.,Molecular Cancer Research,,,Article,2011-12-05,10.1158/1541-7786.mcr-11-0451,,,,22144662,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/486238,https://api.altmetric.com/v1/donut/486238_240.png 6,"Calcium, Dairy Foods, and Risk of Incident and Fatal Prostate Cancer The NIH-AARP Diet and Health Study",American Journal of Epidemiology,,,Article,2007-08-28,10.1093/aje/kwm268,,,,18000020,,,,,,,0,2,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4295769,https://api.altmetric.com/v1/donut/4295769_240.png 6,Serum vitamin D concentration and prostate cancer risk: a nested case-control study.,JNCI: Journal of the National Cancer Institute,,,Article,2008-01-01,10.1093/jnci/djn152,,,,18505967,,,,,,,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2080762,https://api.altmetric.com/v1/donut/2080762_240.png 6,Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression,Oncogene,,,Article,2014-09-15,10.1038/onc.2014.302,,,,25220414,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2821485,https://api.altmetric.com/v1/donut/2821485_240.png 6,Emission guided radiation therapy for lung and prostate cancers: A feasibility study on a digital patient,Medical Physics,,,Article,2012-11-01,10.1118/1.4761951,,,,23127105,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2257163,https://api.altmetric.com/v1/donut/2257163_240.png 6,Alcohol Consumption and Prostate Cancer Incidence and Progression: A Mendelian Randomization Study.,International Journal of Cancer,,,Article,2016-09-01,10.1002/ijc.30436,,,,27643404,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12099403,https://api.altmetric.com/v1/donut/12099403_240.png 6,Tumour microenvironment: Obesity promotes prostate cancer invasion,Nature Reviews Cancer,,,Article,2016-02-02,10.1038/nrc.2016.12,,,,26822573,,,,,,,0,0,0,9,0,0,10,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/5075913,https://api.altmetric.com/v1/donut/5075913_240.png 6,"Cycloartan-24-ene-1?,2?,3?-triol, a cycloartane-type triterpenoid from the resinous exudates of Commiphora myrrha, induces apoptosis in human prostatic cancer PC-3 cells.",Oncology Reports,,,Article,2015-01-15,10.3892/or.2015.3725,,,,25591732,,,,,,,0,0,0,0,0,0,22,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4888543,https://api.altmetric.com/v1/donut/4888543_240.png 6,Prostate Cancer,Annals of Internal Medicine,,,Article,2015-12-01,10.7326/aitc201512010,,,,26618297,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4826689,https://api.altmetric.com/v1/donut/4826689_240.png 6,Absolute Effect of Prostate Cancer Screening: Balance of benefits and harms by center within the European Randomized Study of Prostate Cancer Screening.,Clinical Cancer Research,,,Article,2015-08-21,10.1158/1078-0432.ccr-15-0941,,,,26289069,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4416988,https://api.altmetric.com/v1/donut/4416988_240.png 6,"Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future.",Indian Journal of Urology,,,Article,,10.4103/0970-1591.60436,,,,20535278,PMC2878418,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4325190,https://api.altmetric.com/v1/donut/4325190_240.png 6,Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans,Human Molecular Genetics,,,Article,2015-05-31,10.1093/hmg/ddv203,,,,26025378,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4075299,https://api.altmetric.com/v1/donut/4075299_240.png 6,Gamma-tocotrienol metabolism and antiproliferative effect in prostate cancer cells.,Annals of the New York Academy of Sciences,,,Article,2006-01-12,10.1196/annals.1331.054,,,,15753178,,,2004NYASA1031..391C,,,,0,0,0,0,0,0,1,1,2,0,0,0,0,0,0,14,https://www.altmetric.com/details/3339355,https://api.altmetric.com/v1/donut/3339355_240.png 6,Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes,The Journal of Urology,,,Article,2015-01-07,10.1016/j.juro.2015.01.077,,,,25623742,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3099058,https://api.altmetric.com/v1/donut/3099058_240.png 6,Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer,Strahlentherapie und Onkologie,,,Article,2015-01-15,10.1007/s00066-014-0806-y,,,,25589224,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3065162,https://api.altmetric.com/v1/donut/3065162_240.png 6,Advances in prostate cancer chemoprevention: a translational perspective.,Nutrition and Cancer,,,Article,2013-05-26,10.1080/01635581.2013.785006,,,,23682779,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2516020,https://api.altmetric.com/v1/donut/2516020_240.png 6,Functional and oncological outcomeS of patients younger than 50 years treated with radical prostatectomy for localized prostate cancer in A European population.,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12407,,,,24053677,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,1,4,https://www.altmetric.com/details/2460674,https://api.altmetric.com/v1/donut/2460674_240.png 6,"Selenoprotein Gene Variants, Toenail Selenium Levels, and Risk for Advanced Prostate Cancer",JNCI: Journal of the National Cancer Institute,,,Article,2014-03-01,10.1093/jnci/dju003,,,,24563517,,,,,,,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/2220400,https://api.altmetric.com/v1/donut/2220400_240.png 6,Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group,European Urology,,,Article,2013-04-17,10.1016/j.eururo.2013.03.055,,,,23582949,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/1646614,https://api.altmetric.com/v1/donut/1646614_240.png 6,Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids,Journal of Clinical Investigation,,,Article,2007-01-07,10.1172/jci31494,,,,17607361,,,,,,,0,0,0,2,0,0,3,3,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/1617522,https://api.altmetric.com/v1/donut/1617522_240.png 6,Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study ,Lancet Oncology,,,Article,2008-04-22,10.1016/s1470-2045(08)70104-9,,,,18424233,PMC2760747,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,75,https://www.altmetric.com/details/1450274,https://api.altmetric.com/v1/donut/1450274_240.png 6,Prostate cancer: Why is PSA velocity such a sticky concept?,Nature Reviews Urology,,,Article,2013-03-12,10.1038/nrurol.2013.47,,,,23478537,,,,,,,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1296783,https://api.altmetric.com/v1/donut/1296783_240.png 6,Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis,Journal of the American Academy of Dermatology,,,Article,2013-02-01,10.1016/j.jaad.2012.11.034,,,,23395589,,,,,,,0,0,0,7,0,0,3,0,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/1235164,https://api.altmetric.com/v1/donut/1235164_240.png 6,Cause-specific mortality following radical prostatectomy.,Prostate Cancer & Prostatic Diseases,,,Article,2011-11-17,10.1038/pcan.2011.55,,,,22083265,,,,,,,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1184467,https://api.altmetric.com/v1/donut/1184467_240.png 6,Enzalutamide in Prostate Cancer after Chemotherapy,New England Journal of Medicine,,,Article,2012-12-20,10.1056/nejmc1212940,,,,,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1135074,https://api.altmetric.com/v1/donut/1135074_240.png 6,"Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways",Radiation Oncology,,,Article,2011-10-28,10.1186/1748-717x-6-144,,,,22029423,PMC3217881,,,,,,0,0,0,5,0,0,1,0,2,0,0,0,0,0,0,33,https://www.altmetric.com/details/572869,https://api.altmetric.com/v1/donut/572869_240.png 6,Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.,Journal of Nuclear Medicine,,,Article,2011-08-24,10.2967/jnumed.110.086520,,,,21865288,,,,,,,0,0,0,6,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/246053,https://api.altmetric.com/v1/donut/246053_240.png 6,"Digital Quantification of Five High-Grade Prostate Cancer Patterns, Including the Cribriform Pattern, and Their Association With Adverse Outcome",American Journal of Clinical Pathology,,,Article,2011-01-01,10.1309/ajcpz7wbu9yxsjpe,,,,21685037,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1485251,https://api.altmetric.com/v1/donut/1485251_240.png 6,Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer,European Urology,,,Article,2016-10-04,10.1016/j.eururo.2016.09.020,,,,27692705,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12302790,https://api.altmetric.com/v1/donut/12302790_240.png 6,Healthcare integration and quality among men with prostate cancer,The Journal of Urology,,,Article,2016-07-14,10.1016/j.juro.2016.07.040,,,,27423758,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10128467,https://api.altmetric.com/v1/donut/10128467_240.png 6,External evaluation of a novel prostate cancer risk calculator (ProstateCheck) based on data of the Swiss arm of the ERSPC,The Journal of Urology,,,Article,2016-05-14,10.1016/j.juro.2016.05.081,,,,27188476,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7477392,https://api.altmetric.com/v1/donut/7477392_240.png 6,An immune-inflammation gene expression signature in prostate tumors of smokers.,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-14-3630,,,,26719530,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4943659,https://api.altmetric.com/v1/donut/4943659_240.png 6,Re: Difference in Association of Obesity with Prostate Cancer Risk between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT),The Journal of Urology,,,Article,2016-02-19,10.1016/j.juro.2015.12.017,,,,26887708,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4865468,https://api.altmetric.com/v1/donut/4865468_240.png 6,"A “Chicken or Egg” Conundrum: Race, Molecular Subtype, and Tumor Location in Prostate Cancer",European Urology,,,Article,2015-11-26,10.1016/j.eururo.2015.11.012,,,,,,,,,,,0,0,0,12,0,0,4,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4809165,https://api.altmetric.com/v1/donut/4809165_240.png 6,Re: A Genomic Classifier Improves Prediction of Metastatic Disease within 5 Years after Surgery in Node-Negative High-Risk Prostate Cancer Patients Managed by Radical Prostatectomy without Adjuvant Therapy,The Journal of Urology,,,Article,2015-12-25,10.1016/j.juro.2015.10.056,,,,26699962,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4632011,https://api.altmetric.com/v1/donut/4632011_240.png 6,Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer,The Journal of Urology,,,Article,2016-01-01,10.1016/j.juro.2015.10.055,,,,26699961,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4632007,https://api.altmetric.com/v1/donut/4632007_240.png 6,Perceived influences on post?diagnostic dietary change among a group of men with prostate cancer,European Journal of Cancer Care,,,Article,2015-07-01,10.1111/ecc.12357,,,,26202726,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4308788,https://api.altmetric.com/v1/donut/4308788_240.png 6,Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-13,10.1016/j.ijrobp.2014.11.018,,,,25596107,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3063643,https://api.altmetric.com/v1/donut/3063643_240.png 6,Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.,Nuclear Medicine & Biology,,,Article,2014-12-04,10.1016/j.nucmedbio.2014.10.002,,,,25459113,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2957384,https://api.altmetric.com/v1/donut/2957384_240.png 6,Focal Therapy Will Become a Standard Option for Selected Men With Localized Prostate Cancer.,Journal of Clinical Oncology,,,Article,2014-08-20,10.1200/jco.2014.56.7792,,,,25135989,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2617617,https://api.altmetric.com/v1/donut/2617617_240.png 6,Efficacy of Enzalutamide Following Abiraterone Acetate in Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer Patients,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.06.045,,,,25018038,,,,,,,0,0,0,9,0,0,0,0,1,0,0,0,0,0,0,40,https://www.altmetric.com/details/2501022,https://api.altmetric.com/v1/donut/2501022_240.png 6,When is Prostate Cancer Really Cancer?,Urologic Clinics of North America,,,Article,2014-05-01,10.1016/j.ucl.2014.01.006,,,,24725494,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2280748,https://api.altmetric.com/v1/donut/2280748_240.png 6,The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer,BMC Health Services Research,,,Article,2014-04-10,10.1186/1472-6963-14-163,,,,24721557,,,,,,,0,0,0,6,1,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2275441,https://api.altmetric.com/v1/donut/2275441_240.png 6,Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer,Nucleic Acids Research,,,Article,2014-04-01,10.1093/nar/gkt1382,,,,24423874,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2041892,https://api.altmetric.com/v1/donut/2041892_240.png 6,Prostate cancer genetic-susceptibility locus on chromosome 20q13 is androgen receptor-regulated and amplified in metastatic tumors,Molecular Cancer Research,,,Article,2013-12-30,10.1158/1541-7786.mcr-13-0477,,,,24379448,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2015656,https://api.altmetric.com/v1/donut/2015656_240.png 6,Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases.,Prostate Cancer & Prostatic Diseases,,,Article,2013-08-06,10.1038/pcan.2013.22,,,,23917308,,,,,,,0,0,0,7,0,0,3,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1683365,https://api.altmetric.com/v1/donut/1683365_240.png 6,"A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.",British Journal of Urology,,,Article,2013-07-01,10.1111/bju.12209,,,,23795800,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1585462,https://api.altmetric.com/v1/donut/1585462_240.png 6,Prostate cancer: Does uptake of technology promote diagnostic testing?,Nature Reviews Urology,,,Article,2013-05-28,10.1038/nrurol.2013.123,,,,23712206,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1521169,https://api.altmetric.com/v1/donut/1521169_240.png 6,"A Large Prospective Study of SEP15 Genetic Variation, Interaction with Plasma Selenium Levels, and Prostate Cancer Risk and Survival",Cancer Prevention Research,,,Article,2010-01-01,10.1158/1940-6207.capr-09-0216,,,,20424130,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1137694,https://api.altmetric.com/v1/donut/1137694_240.png 6,Is Prostate Cancer Prevention with Selenium All in the Genes?,Cancer Prevention Research,,,Article,2010-01-01,10.1158/1940-6207.capr-10-0072,,,,20424133,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1137693,https://api.altmetric.com/v1/donut/1137693_240.png 6,"Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial",British Journal of Urology,,,Article,2003-01-01,10.1046/j.1464-410x.2003.04167.x,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1137691,https://api.altmetric.com/v1/donut/1137691_240.png 6,PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer,Cancer (0008543X),,,Article,2016-05-24,10.1002/cncr.30093,,,,27219522,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8399499,https://api.altmetric.com/v1/donut/8399499_240.png 6,"Re: Fascelli M, Et Al. Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy-Naive Patient Population",Urology,,,Article,2016-04-22,10.1016/j.urology.2016.04.011,,,,27112511,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6907021,https://api.altmetric.com/v1/donut/6907021_240.png 6,"Known Knowns, Known Unknowns, and Unknown Unknowns of High-intensity Focused Ultrasound for Prostate Cancer",European Urology Focus ,,,Article,2015-09-28,10.1016/j.euf.2015.07.003,,,,,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4336543,https://api.altmetric.com/v1/donut/4336543_240.png 6,Breast cancer risk may be increased in women who have first-degree relatives with a history of prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/7039-breast-cancer-risk-may-be-increased-in-women-who-have-first-degree-relatives-with-a-history-of-prostate-cancer.php,,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3768154,https://api.altmetric.com/v1/donut/3768154_240.png 6,"The Relationship Between Illness Uncertainty, Anxiety, Fear of Progression, and Quality of Life in Men With Favorable Risk Prostate Cancer Undergoing Active Surveillance.",British Journal of Urology,,,Article,2015-02-24,10.1111/bju.13099,,,,25714186,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3729964,https://api.altmetric.com/v1/donut/3729964_240.png 6,Androgen-deprivation Therapy and Risk for Biliary Disease in Men with Prostate Cancer,European Urology,,,Article,2014-03-01,10.1016/j.eururo.2013.02.003,,,,23428068,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2323394,https://api.altmetric.com/v1/donut/2323394_240.png 6,Perceptions of Radiation Oncologists and Urologists on Sources and Type of Evidence to Inform Prostate Cancer Treatment Decisions,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-03-28,10.1016/j.ijrobp.2014.02.001,,,,24685153,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2221939,https://api.altmetric.com/v1/donut/2221939_240.png 6,Genetic variation 'predicts behaviour of prostate cancer',ecancer.org,,,Article,,,,,http://ecancer.org/news/2805-genetic-variation--predicts-behaviour-of-prostate-cancer.php,,,,,,,,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250756,https://api.altmetric.com/v1/donut/1250756_240.png 6,Cyclooxygenase-2 Selective Inhibitors and Prostate Cancer: What Is the Clinical Benefit?,Journal of Clinical Oncology,,,Article,2006-01-01,10.1200/jco.2006.05.9709,,,,16782907,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/423091,https://api.altmetric.com/v1/donut/423091_240.png 6,"Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-01-01,10.1158/1055-9965.epi-10-0299,,,,20705937,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1444699,https://api.altmetric.com/v1/donut/1444699_240.png 6,Missing the Mark: Prostate Cancer Upgrading By Systematic Biopsy over MRI/TRUS Fusion Biopsy,The Journal of Urology,,,Article,2016-08-28,10.1016/j.juro.2016.08.097,,,,27582434,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10879746,https://api.altmetric.com/v1/donut/10879746_240.png 6,Serum Vitamin D is not Helpful in Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health Index,The Journal of Urology,,,Article,2016-03-11,10.1016/j.juro.2016.03.009,,,,26976204,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6174218,https://api.altmetric.com/v1/donut/6174218_240.png 6,The Patient Burden of Bladder Outlet Obstruction After Prostate Cancer Treatment,The Journal of Urology,,,Article,2015-12-20,10.1016/j.juro.2015.11.072,,,,26682759,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4859348,https://api.altmetric.com/v1/donut/4859348_240.png 6,"Specific Myosins Control Actin Organization, Cell Morphology, and Migration in Prostate Cancer Cells",Cell Reports,,,Article,2015-12-17,10.1016/j.celrep.2015.11.012,,,,26670045,PMC4688110,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4853560,https://api.altmetric.com/v1/donut/4853560_240.png 6,Responses and relationship dynamics of men and their spouses during active surveillance for prostate cancer: health literacy as an inquiry framework,BMC Public Health,,,Article,2015-08-01,10.1186/s12889-015-2068-8,,,,26231177,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4354734,https://api.altmetric.com/v1/donut/4354734_240.png 6,Toward ethically responsible choice architecture in prostate cancer treatment decision?making,CA: A Cancer Journal for Clinicians ,,,Article,2015-05-21,10.3322/caac.21283,,,,25998159,,,,,,,0,0,0,14,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4043207,https://api.altmetric.com/v1/donut/4043207_240.png 6,Higher-Intensity Exercise Results in More Sustainable Improvements for VO2peak for Breast and Prostate Cancer Survivors.,Oncology Nursing Forum,,,Article,2015-04-24,10.1188/15.onf.42-03ap,,,,25901376,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3936695,https://api.altmetric.com/v1/donut/3936695_240.png 6,Re: Cost-Effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data,The Journal of Urology,,,Article,2015-06-20,10.1016/j.juro.2015.04.064,,,,26088223,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/3920023,https://api.altmetric.com/v1/donut/3920023_240.png 6,SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations,Molecular Cancer,,,Article,2014-10-21,10.1186/1476-4598-13-237,,,,25331979,,2445/65227,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2796082,https://api.altmetric.com/v1/donut/2796082_240.png 6,Identifying the self-management behaviours performed by prostate cancer survivors: a systematic review of the evidence,Journal of Research in Nursing,,,Article,2014-03-26,10.1177/1744987114523976,,,,,,,,,,,0,0,0,18,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2217495,https://api.altmetric.com/v1/donut/2217495_240.png 6,"Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.",Brachytherapy,,,Article,2013-07-24,10.1016/j.brachy.2013.05.004,,,,23871661,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1656490,https://api.altmetric.com/v1/donut/1656490_240.png 6,IGF-I and Prostate Cancer,Science,,,Article,1998-10-09,10.1126/science.282.5387.199a,,,,,,,1998Sci...282..199S,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1618231,https://api.altmetric.com/v1/donut/1618231_240.png 6,Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.01.036,,,,22704706,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/914713,https://api.altmetric.com/v1/donut/914713_240.png 6,Prostate cancer screening has no effect on prostate cancer specific mortality over 20 years of follow-up of Swedish men,Evidence Based Medicine,,,Article,2012-02-01,10.1136/ebm-2011-100070,,,,21733924,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/571418,https://api.altmetric.com/v1/donut/571418_240.png 6," mda-7 /IL-24 Differentially Regulates Soluble and Nuclear Clusterin in Prostate Cancer ",Journal of Cellular Physiology,,,Article,2014-04-01,10.1002/jcp.24451,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9699125,https://api.altmetric.com/v1/donut/9699125_240.png 6," Addendum to Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005; 78: S103–S111 ",British Journal of Radiology,,,Article,2014-02-15,10.1259/bjr.20139007,,,,24407774,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6609924,https://api.altmetric.com/v1/donut/6609924_240.png 6," Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and 1 H MR Spectroscopy1 ",RadioGraphics,,,Article,2004-10-14,10.1148/24si045516,,,,15486239,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/6609918,https://api.altmetric.com/v1/donut/6609918_240.png 6,MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer,British Journal of Radiology,,,Article,2005-10-01,10.1259/bjr/11253478,,,,16306632,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6609916,https://api.altmetric.com/v1/donut/6609916_240.png 6,"Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities.",Cancer Prevention Research,,,Article,2012-02-15,10.1158/1940-6207.capr-11-0306,,,,22044694,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6067358,https://api.altmetric.com/v1/donut/6067358_240.png 6,Preliminary results from the monitoring programme of the active surveillance for prostate cancer in Spain of the Society Spanish of Urology.,Actas Urológicas Españolas,,,Article,,10.1016/j.acuro.2015.05.006,,,,26115777,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5311798,https://api.altmetric.com/v1/donut/5311798_240.png 6,"Cohort study of diet, lifestyle, and prostate cancer in Adventist men.",Cancer (0008543X),,,Article,1989-08-01,,,,,2743254,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/5008032,https://api.altmetric.com/v1/donut/5008032_240.png 6,Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.,,,,Article,2008-07-14,10.1016/j.crad.2008.02.001,,,,18555035,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/5007179,https://api.altmetric.com/v1/donut/5007179_240.png 6,"Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-01-01,10.1158/1055-9965.epi-06-0754,,,,17179486,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4780753,https://api.altmetric.com/v1/donut/4780753_240.png 6,Biomarqueurs urinaires du cancer de prostate ,Progrès en Urologie,,,Article,2010-12-15,10.1016/j.purol.2010.07.017,,,,21130396,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4755256,https://api.altmetric.com/v1/donut/4755256_240.png 6,Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States),Cancer Causes and Control,,,Article,2006-12-15,10.1007/s10552-006-0052-4,,,,17111254,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4709580,https://api.altmetric.com/v1/donut/4709580_240.png 6,Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk,Human Genetics,,,Article,2001-08-04,10.1007/s004390100576,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4709577,https://api.altmetric.com/v1/donut/4709577_240.png 6,5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males ,The Lancet,,,Article,1992-10-01,10.1016/0140-6736(92)90927-u,,,,1435107,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4709576,https://api.altmetric.com/v1/donut/4709576_240.png 6,The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk,British Journal of Cancer,,,Article,2006-01-24,10.1038/sj.bjc.6602925,,,,16434997,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4351089,https://api.altmetric.com/v1/donut/4351089_240.png 6,Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials,Lancet Oncology,,,Article,2009-01-09,10.1016/s1470-2045(09)70201-3,,,,19674936,PMC2748902,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4351088,https://api.altmetric.com/v1/donut/4351088_240.png 6,Initial management of low?risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry,British Journal of Urology,,,Article,2010-10-14,10.1111/j.1464-410x.2010.09288.x,,,,20456339,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4351083,https://api.altmetric.com/v1/donut/4351083_240.png 6,"Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters",European Radiology,,,Article,2015-03-07,10.1007/s00330-014-3479-0,,,,25749786,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/4351042,https://api.altmetric.com/v1/donut/4351042_240.png 6,"Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention",Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2011-03-15,10.1093/ecam/nep031,,,,19376839,PMC3135793,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5083350,https://api.altmetric.com/v1/donut/5083350_240.png 6,"Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen.",Nutrition and Cancer,,,Article,1998-01-01,10.1080/01635589809514691,,,,9770724,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5083349,https://api.altmetric.com/v1/donut/5083349_240.png 6,Effect of diet and exercise intervention on the growth of prostate epithelial cells,Prostate Cancer & Prostatic Diseases,,,Article,2008-02-19,10.1038/pcan.2008.6,,,,18283296,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5083348,https://api.altmetric.com/v1/donut/5083348_240.png 6,Fatty acid composition of plasma phospholipids and risk of prostate cancer,American Journal of Clinical Nutrition,,,Article,2009-01-01,10.3945/ajcn.2009.27682,,,,19369373,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1392623,https://api.altmetric.com/v1/donut/1392623_240.png 6,?-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor,PLoS ONE,,,Article,2010-02-05,10.1371/journal.pone.0009060,,,,20140206,,,2010PLoSO...5.9060G,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1381261,https://api.altmetric.com/v1/donut/1381261_240.png 6,Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3),Human Molecular Genetics,,,Article,2009-07-02,10.1093/hmg/ddp302,,,,19574343,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/407294,https://api.altmetric.com/v1/donut/407294_240.png 6,Does the racialâ??ethnic variation in prostate cancer risk have a hormonal basis?,Cancer,,,Article,1995-04-01,10.1002/1097-0142(19950401)75:7+<1778::aid-cncr2820751605>3.0.co;2-j,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/407289,https://api.altmetric.com/v1/donut/407289_240.png 6,Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer,Urology,,,Article,1999-01-29,10.1016/s0090-4295(98)00481-6,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/407275,https://api.altmetric.com/v1/donut/407275_240.png 6,The Role of Transforming Growth Factor- -Mediated Tumor-Stroma Interactions in Prostate Cancer Progression: An Integrative Approach,Cancer Research,,,Article,2009-08-25,10.1158/0008-5472.can-08-3957,,,,19706777,PMC2748342,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/408001,https://api.altmetric.com/v1/donut/408001_240.png 6,Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection,Prostate Cancer & Prostatic Diseases,,,Article,2015-11-10,10.1038/pcan.2015.51,,,,26553644,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4747536,https://api.altmetric.com/v1/donut/4747536_240.png 6,Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes.,International Journal of Urology,,,Article,2015-08-01,10.1111/iju.12876,,,,26251127,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4403065,https://api.altmetric.com/v1/donut/4403065_240.png 6,Testosterone therapy and prostate cancer[mdash]safety concerns are well founded,Nature Reviews Urology,,,Article,2015-01-07,10.1038/nrurol.2014.338,,,,25563848,,,,,,,0,0,0,16,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3043044,https://api.altmetric.com/v1/donut/3043044_240.png 6,Metformin to Prevent Prostate Cancer: A Call to Unite,European Urology,,,Article,,10.1016/j.eururo.2014.05.012,,,,24908475,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2405542,https://api.altmetric.com/v1/donut/2405542_240.png 6,Vitamin D deficiency may be linked to aggressive prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5609-vitamin-d-deficiency-may-be-linked-to-aggressive-prostate-cancer.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2318158,https://api.altmetric.com/v1/donut/2318158_240.png 6,Hierarchical Organization of Prostate Cancer Cells in Xenograft Tumors: The CD44+?2?1+ Cell Population Is Enriched in Tumor-Initiating Cells,Cancer Research,,,Article,2007-01-01,10.1158/0008-5472.can-07-0490,,,,17638891,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1937323,https://api.altmetric.com/v1/donut/1937323_240.png 6,A preclinical xenograft model of prostate cancer using human tumors,Nature Protocols,,,Article,2013-04-04,10.1038/nprot.2013.043,,,,23558784,,,,,,,0,0,0,11,0,0,2,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1350742,https://api.altmetric.com/v1/donut/1350742_240.png 6,Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis,Prostate Cancer & Prostatic Diseases,,,Article,2013-02-12,10.1038/pcan.2013.3,,,,23399779,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1253618,https://api.altmetric.com/v1/donut/1253618_240.png 6,Long-term Survival and Toxicity in Patients Treated With High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.05.023,,,,22795805,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1236388,https://api.altmetric.com/v1/donut/1236388_240.png 6,PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.,Clinical Cancer Research,,,Article,2011-01-06,10.1158/1078-0432.ccr-10-3126,,,,21471425,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,107,https://www.altmetric.com/details/1131959,https://api.altmetric.com/v1/donut/1131959_240.png 6,Correction: Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population.,PloS one,,,Article,2011-01-01,10.1371/annotation/b0312c4c-e06a-47ef-9e9c-b044dbfa3d6a,,,,21674070,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/168384,https://api.altmetric.com/v1/donut/168384_240.png 6,Correction: Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis,PLoS ONE,,,Article,2013-08-26,10.1371/annotation/9e4eacfb-5de5-44f5-b027-b694f35e370e,,,,24098616,PMC3782371,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10414568,https://api.altmetric.com/v1/donut/10414568_240.png 6,Retraction: “Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells” by Wang et al.,Journal of Cellular Biochemistry,,,Article,2016-06-15,10.1002/jcb.25587,,,,27301889,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8844254,https://api.altmetric.com/v1/donut/8844254_240.png 6,"Retraction: “Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-?B signaling pathways” by Wang et al.",Journal of Cellular Biochemistry,,,Article,2016-08-15,10.1002/jcb.25585,,,,27301887,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8844253,https://api.altmetric.com/v1/donut/8844253_240.png 6,"RETRACTED: SELECT Trial Results Examined: Why Fish Oil, DHA and “Oily Fish” Are Inflammatory, Leading to Increases in Prostate Cancer, Epithelial Cancers and CVD",Food and Nutrition Sciences,,,Article,2013-10-07,10.4236/fns.2013.411147,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4507167,https://api.altmetric.com/v1/donut/4507167_240.png 6,Effect of lycopene isolated from Chlorella marina on proliferation and apoptosis in human prostate cancer cell line PC-3.,Tumor Biology,,,Article,2014-07-31,10.1007/s13277-014-2339-5,,,,25073513,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3050154,https://api.altmetric.com/v1/donut/3050154_240.png 6,Molecular effects of bioactive fraction of Curcuma mangga (DLBS4847) as a downregulator of 5?-reductase activity pathways in prostatic epithelial cells.,Cancer Management and Research,,,Article,2014-06-20,10.2147/cmar.s61111,,,,24944518,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2932263,https://api.altmetric.com/v1/donut/2932263_240.png 6,Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment,American Journal of Translational Research,,,Article,2014-09-23,,,,,24349627,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2704490,https://api.altmetric.com/v1/donut/2704490_240.png 6,Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.,British Journal of Urology,,,Article,1998-05-01,,,,,9634050,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/2667315,https://api.altmetric.com/v1/donut/2667315_240.png 6,Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.,Biological and Pharmaceutical Bulletin,,,Article,2010-01-01,,,,,21048307,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1766378,https://api.altmetric.com/v1/donut/1766378_240.png 6,Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas.,Cancer Research,,,Article,2007-01-01,10.1158/0008-5472.can-06-3462,,,,17213256,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1508337,https://api.altmetric.com/v1/donut/1508337_240.png 6,PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK,BMC Family Practice,,,Article,2005-06-09,10.1186/1471-2296-6-24,,,,15946386,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/109499,https://api.altmetric.com/v1/donut/109499_240.png 6,"A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.",Urology,,,Article,2007-02-01,10.1016/j.urology.2006.10.019,,,,17320666,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/453056,https://api.altmetric.com/v1/donut/453056_240.png 6,Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis.,Oncogene,,,Article,2009-04-23,10.1038/onc.2009.30,,,,19305425,PMC2672965,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/107726,https://api.altmetric.com/v1/donut/107726_240.png 6,HE3235 Inhibits Growth of Castration-Resistant Prostate Cancer,"Neoplasia (New York, N.Y.)",,,Article,2009-11-01,,,,,19881957,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/106703,https://api.altmetric.com/v1/donut/106703_240.png 6,Efficacy of transferrin?conjugated paclitaxel?loaded nanoparticles in a murine model of prostate cancer,International Journal of Cancer,,,Article,2004-06-16,10.1002/ijc.20405,,,,15352049,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/3823259,https://api.altmetric.com/v1/donut/3823259_240.png 6,Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells.,Journal of Physiological Sciences,,,Article,2012-03-08,10.1007/s12576-012-0204-0,,,,22392350,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2597367,https://api.altmetric.com/v1/donut/2597367_240.png 6,Endocrine prevention and treatment of prostate cancer,Molecular & Cellular Endocrinology,,,Article,2012-01-01,10.1016/j.mce.2012.03.002,,,,22465099,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2345987,https://api.altmetric.com/v1/donut/2345987_240.png 6,Calcitriol in the treatment of prostate cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,16886675,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2080759,https://api.altmetric.com/v1/donut/2080759_240.png 6,Primary Cryosurgery for Clinically Localized Prostate Cancer – Do Perioperative Tumor Characteristics Correlate With Post-treatment Biopsy Results?,Urology,,,Article,2013-12-01,10.1016/j.urology.2013.10.018,,,,24315311,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1964692,https://api.altmetric.com/v1/donut/1964692_240.png 6,"Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NF?B Signaling",Integrative Cancer Therapies,,,Article,2013-01-01,10.1177/1534735413510557,,,,24287876,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1942778,https://api.altmetric.com/v1/donut/1942778_240.png 6,Evolution of the Treatment Paradigm for Patients with Metastatic Castration-Resistant Prostate Cancer,Advances in Therapy,,,Article,2013-11-26,10.1007/s12325-013-0070-z,,,,24276853,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1932573,https://api.altmetric.com/v1/donut/1932573_240.png 6,"Statin use and risk of prostate cancer: A Danish population-based case-control study, 1997–2010",Cancer Epidemiology,,,Article,2013-11-01,10.1016/j.canep.2013.10.010,,,,24275259,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1929876,https://api.altmetric.com/v1/donut/1929876_240.png 6,Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study,Journal of Cancer Survivorship,,,Article,2013-11-10,10.1007/s11764-013-0312-8,,,,24214413,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1895836,https://api.altmetric.com/v1/donut/1895836_240.png 6,Evaluation of reported prostate cancer riskâ??associated SNPs from genomeâ??wide association studies of various racial populations in Chinese men,The Prostate,,,Article,2013-01-01,10.1002/pros.22629,,,,24038036,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1739019,https://api.altmetric.com/v1/donut/1739019_240.png 6,UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis,ISRN Oncology,,,Article,2013-09-09,10.1155/2013/465916,,,,24106614,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1738223,https://api.altmetric.com/v1/donut/1738223_240.png 6,Age-Related DNA Methylation Changes in Normal Human Prostate Tissues,Clinical Cancer Research,,,Article,2007-01-01,10.1158/1078-0432.ccr-07-0085,,,,17606710,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/624688,https://api.altmetric.com/v1/donut/624688_240.png 6,Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.,Cancer Research,,,Article,2002-04-15,,,,,11956072,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/184794,https://api.altmetric.com/v1/donut/184794_240.png 6,Effective Testosterone Suppression for Prostate Cancer: Is There a Best Castration Therapy?,Reviews in Urology,,,Article,1970-01-01,,,,,19680526,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/2140323,https://api.altmetric.com/v1/donut/2140323_240.png 5,5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia,Mayo Clinic Proceedings,,,Article,2016-10-01,10.1016/j.mayocp.2016.07.023,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13292780,https://api.altmetric.com/v1/donut/13292780_240.png 5,"Meat Consumption, Related Nutrients, Obesity and Risk of Prostate Cancer: a Case-Control Study in Uruguay.",Asian Pacific Journal of Cancer Prevention,,,Article,,,,,,27221879,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13027686,https://api.altmetric.com/v1/donut/13027686_240.png 5,Comparison of perspectives on prostate cancer: analyses of survey data.,Urology,,,Article,1997-01-01,,,,,9301699,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12943152,https://api.altmetric.com/v1/donut/12943152_240.png 5,A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer,Cancer (0008543X),,,Article,2009-11-24,10.1002/cncr.24779,,,,19937954,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/12644548,https://api.altmetric.com/v1/donut/12644548_240.png 5,The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-09-01,10.1158/1055-9965.epi-15-0247,,,,26108461,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12576945,https://api.altmetric.com/v1/donut/12576945_240.png 5,The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial,Carcinogenesis,,,Article,2013-06-01,10.1093/carcin/bgt055,,,,23393222,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12576943,https://api.altmetric.com/v1/donut/12576943_240.png 5," Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness ",British Journal of Urology,,,Article,2016-02-12,10.1111/bju.13416,,,,26779768,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12576942,https://api.altmetric.com/v1/donut/12576942_240.png 5,Some prostate cancers are invisible to magnetic resonance imaging!,British Journal of Urology,,,Article,2016-09-14,10.1111/bju.13440,,,,27625328,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12447548,https://api.altmetric.com/v1/donut/12447548_240.png 5,Evidence for Masturbation and Prostate Cancer Risk: Do We Have a Verdict?,Sexual Medicine Reviews,,,Article,2016-03-23,10.1016/j.sxmr.2016.02.006,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9877403,https://api.altmetric.com/v1/donut/9877403_240.png 5,Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis ,Biochemical & Biophysical Research Communications,,,Article,2016-07-11,10.1016/j.bbrc.2016.07.019,,,,27395338,,,,,,,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/9278856,https://api.altmetric.com/v1/donut/9278856_240.png 5,Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study,British Journal of Urology,,,Article,2016-06-01,10.1111/bju.13307,,,,26332130,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9115763,https://api.altmetric.com/v1/donut/9115763_240.png 5,New evidence from the Prostate Cancer Prevention Trial may exculpate cyclooxygenase (COX) blockers in erectile dysfunction,British Journal of Urology,,,Article,2016-03-01,10.1111/bju.13343,,,,26876900,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8820431,https://api.altmetric.com/v1/donut/8820431_240.png 5,Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome.,Journal of Clinical Oncology,,,Article,1997-04-01,,,,,9193343,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8767721,https://api.altmetric.com/v1/donut/8767721_240.png 5,Half of Men With Early-Stage Prostate Cancer Choose Active Surveillance,Journal Watch,,,Article,2016-05-26,10.1056/nejm-jw.fw111613,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8270917,https://api.altmetric.com/v1/donut/8270917_240.png 5,PSMA-targeted imaging of prostate cancer: the best is yet to come,British Journal of Urology,,,Article,2016-05-01,10.1111/bju.13435,,,,27079480,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7581717,https://api.altmetric.com/v1/donut/7581717_240.png 5,Accuracy of Endorectal Magnetic Resonance/Transrectal Ultrasound Fusion for Detection of Prostate Cancer During Brachytherapy,Urology,,,Article,2013-06-14,10.1016/j.urology.2012.12.051,,,,23490527,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/7301986,https://api.altmetric.com/v1/donut/7301986_240.png 5,Brachytherapy: state-of-the-art radiotherapy in prostate cancer,British Journal of Urology,,,Article,2015-08-11,10.1111/bju.13252,,,,26260701,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7301971,https://api.altmetric.com/v1/donut/7301971_240.png 5,CpG oligonucleotide as an adjuvant for the treatment of prostate cancer,Advanced Drug Delivery Reviews,,,Article,2009-03-28,10.1016/j.addr.2008.12.005,,,,19166887,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/7107358,https://api.altmetric.com/v1/donut/7107358_240.png 5,Family History of Prostate Cancer in Men Being Followed by Active Surveillance Does Not Increase Risk of Being Diagnosed With High-grade Disease,Urology,,,Article,2015-02-21,10.1016/j.urology.2014.10.060,,,,25709045,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6647128,https://api.altmetric.com/v1/donut/6647128_240.png 5,An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis,PLoS ONE,,,Article,2011-10-31,10.1371/journal.pone.0027130,,,,22073129,PMC3205054,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6647125,https://api.altmetric.com/v1/donut/6647125_240.png 5," 1?,25-Dihydroxyvitamin D 3 Inhibits Growth of VCaP Prostate Cancer Cells Despite Inducing the Growth-Promoting TMPRSS2:ERG Gene Fusion ",Endocrinology,,,Article,2010-04-14,10.1210/en.2009-0991,,,,20147525,PMC2850246,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6386534,https://api.altmetric.com/v1/donut/6386534_240.png 5,Immunocytochemical detection of ERG expression in exfoliated urinary cells identifies with high specificity patients with prostate cancer,British Journal of Urology,,,Article,2015-07-29,10.1111/bju.13184,,,,26471473,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6386518,https://api.altmetric.com/v1/donut/6386518_240.png 5,"Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer.",American journal of clinical and experimental urology,,,Article,,,,,,25606581,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6271270,https://api.altmetric.com/v1/donut/6271270_240.png 5,Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy,Prostate Cancer & Prostatic Diseases,,,Article,2016-03-08,10.1038/pcan.2016.8,,,,26951713,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6146599,https://api.altmetric.com/v1/donut/6146599_240.png 5,Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.,International Journal of Cancer,,,Article,2010-05-31,10.1002/ijc.24988,,,,19856314,PMC2874465,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6103549,https://api.altmetric.com/v1/donut/6103549_240.png 5,Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study.,Molecular Carcinogenesis,,,Article,2012-12-15,10.1002/mc.20866,,,,22006862,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6082453,https://api.altmetric.com/v1/donut/6082453_240.png 5,Prostate cancer survivorship: Lessons from caring for the uninsured.,Urologic Oncology,,,Article,2012-01-01,10.1016/j.urolonc.2011.09.001,,,,22127017,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6053261,https://api.altmetric.com/v1/donut/6053261_240.png 5,Doubling our precision of risk stratification in early prostate cancer: too good to be true?,British Journal of Urology,,,Article,2016-01-01,10.1111/bju.13119,,,,26676679,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5986137,https://api.altmetric.com/v1/donut/5986137_240.png 5,Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients,Urology,,,Article,2005-12-01,10.1016/j.urology.2005.06.108,,,,16360451,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/5986131,https://api.altmetric.com/v1/donut/5986131_240.png 5,Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2009-06-15,10.1093/jnci/djp114,,,http://www.rand.org/pubs/external_publications/EP20090629.html,19509365,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/5536203,https://api.altmetric.com/v1/donut/5536203_240.png 5,Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators ,European Urology,,,Article,2012-03-15,10.1016/j.eururo.2011.11.012,,,,22104592,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/5105611,https://api.altmetric.com/v1/donut/5105611_240.png 5,Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort,European Journal of Cancer (1965),,,Article,2012-03-09,10.1016/j.ejca.2012.02.002,,,,22406050,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5105610,https://api.altmetric.com/v1/donut/5105610_240.png 5,Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.,Clinical Cancer Research,,,Article,2001-10-01,,,,,11595700,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5089357,https://api.altmetric.com/v1/donut/5089357_240.png 5,Humoral mechanisms in prostate cancer:,Urologic Oncology,,,Article,2001-07-01,10.1016/s1078-1439(00)00124-1,,,,11418318,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5085602,https://api.altmetric.com/v1/donut/5085602_240.png 5,Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer,Clinical Cancer Research,,,Article,2009-12-01,10.1158/1078-0432.ccr-09-1263,,,,19934305,PMC2787812,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/5047800,https://api.altmetric.com/v1/donut/5047800_240.png 5,"A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [?2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-05-01,10.1158/1055-9965.epi-10-0007,,,,20447916,PMC2867076,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/5047799,https://api.altmetric.com/v1/donut/5047799_240.png 5,Prostate Specific Antigen Kinetics in the Management of Prostate Cancer,The Journal of Urology,,,Article,2008-01-03,10.1016/j.juro.2007.10.023,,,,18221963,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5047798,https://api.altmetric.com/v1/donut/5047798_240.png 5,From prostate?specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer,British Journal of Urology,,,Article,2013-10-01,10.1111/j.1464-410x.2012.11329.x,,,,22759214,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5047797,https://api.altmetric.com/v1/donut/5047797_240.png 5,The percentage of prostate?specific antigen (PSA) isoform [–2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ?65 years,British Journal of Urology,,,Article,2015-05-24,10.1111/bju.13139,,,,25818705,,,,,,,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5047796,https://api.altmetric.com/v1/donut/5047796_240.png 5,Risk stratification of pN+ prostate cancer after radical prostatectomy from a large single institutional series with long-term follow-up,The Journal of Urology,,,Article,2016-01-03,10.1016/j.juro.2015.12.074,,,,26723866,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4918263,https://api.altmetric.com/v1/donut/4918263_240.png 5,"The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.",,,,Article,2011-06-14,,,,,21703046,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4888083,https://api.altmetric.com/v1/donut/4888083_240.png 5,Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study,Urologic Oncology,,,Article,2015-01-01,10.1016/j.urolonc.2014.09.013,,,,25443268,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/4857103,https://api.altmetric.com/v1/donut/4857103_240.png 5,Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices,Clinical Genitourinary Cancer,,,Article,2015-01-08,10.1016/j.clgc.2014.12.019,,,,25743206,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4830892,https://api.altmetric.com/v1/donut/4830892_240.png 5,Is a Limited Lymph Node Dissection An Adequate Staging Procedure for Prostate Cancer?,The Journal of Urology,,,Article,2002-01-08,10.1016/s0022-5347(05)64670-8,,,,12131300,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4805192,https://api.altmetric.com/v1/donut/4805192_240.png 5,Anatomical Basis for Pelvic Lymphadenectomy in Prostate Cancer: Results of an Autopsy Study and Implications for the Clinic,The Journal of Urology,,,Article,1996-01-12,10.1016/s0022-5347(01)65406-5,,,,8911367,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4805190,https://api.altmetric.com/v1/donut/4805190_240.png 5,Do All High- and Intermediate-Risk Patients With Metastatic Castration-Resistant Prostate Cancer Really Benefit From Abiraterone?,Journal of Clinical Oncology,,,Article,2015-11-25,10.1200/jco.2015.62.8537,,,,26598758,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4800295,https://api.altmetric.com/v1/donut/4800295_240.png 5,Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95,Journal of Clinical Oncology,,,Article,2009-06-20,10.1200/jco.2008.18.9563,,,,19433689,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,131,https://www.altmetric.com/details/4778213,https://api.altmetric.com/v1/donut/4778213_240.png 5,Observational studies and the natural history of screen-detected prostate cancer.,Current Opinion in Urology,,,Article,2015-02-16,10.1097/mou.0000000000000157,,,,25692723,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4680168,https://api.altmetric.com/v1/donut/4680168_240.png 5,"Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.",Cancer Epidemiology,,,Article,2012-12-01,10.1016/j.canep.2012.08.008,,,,23000116,PMC3582194,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4680167,https://api.altmetric.com/v1/donut/4680167_240.png 5,"Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2010-04-20,10.1200/jco.2009.25.4524,,,,20308663,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4655699,https://api.altmetric.com/v1/donut/4655699_240.png 5,Perioperative changes in pro and anticoagulant factors in prostate cancer patients undergoing laparoscopic and robotic radical prostatectomy with different anaesthetic techniques,Journal of Experimental & Clinical Cancer Research,,,Article,2014-08-17,10.1186/s13046-014-0063-z,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4648223,https://api.altmetric.com/v1/donut/4648223_240.png 5,Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer,International Journal of Cancer,,,Article,1998-09-25,10.1002/(sici)1097-0215(19980925)78:1<1::aid-ijc1>3.0.co;2-u,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4612645,https://api.altmetric.com/v1/donut/4612645_240.png 5,No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters,British Journal of Cancer,,,Article,1997-10-01,10.1038/bjc.1997.498,,,,9376279,PMC2228090,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4612644,https://api.altmetric.com/v1/donut/4612644_240.png 5,"Predisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43",American Journal of Human Genetics,,,Article,1998-06-01,10.1086/301879,,,,9585607,PMC1377158,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4612641,https://api.altmetric.com/v1/donut/4612641_240.png 5,Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene,American Journal of Human Genetics,,,Article,2003-01-01,10.1086/345310,,,,12474142,PMC420008,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/4612640,https://api.altmetric.com/v1/donut/4612640_240.png 5,Contemporary Grading for Prostate Cancer: Implications for Patient Care ,European Urology,,,Article,2013-05-01,10.1016/j.eururo.2012.10.015,,,,23092544,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/4605968,https://api.altmetric.com/v1/donut/4605968_240.png 5,"Wang, R. et al. Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone. Semin. Cancer Biol. 15, 353-364",Seminars in Cancer Biology,,,Article,2005-11-01,10.1016/j.semcancer.2005.05.005,,,,15982899,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,128,https://www.altmetric.com/details/4586786,https://api.altmetric.com/v1/donut/4586786_240.png 5,Response of the Insulin-Like Growth Factor (IGF) System to IGF-IR inhibition and Androgen Deprivation in a Neoadjuvant Prostate Cancer Trial: Effects of Obesity and Androgen Deprivation.,The Journal of Clinical Endocrinology & Metabolism,,,Article,2013-05-14,10.1210/jc.2012-3856,,,,23533230,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4491335,https://api.altmetric.com/v1/donut/4491335_240.png 5,IGFBP-3 Nuclear Localization Predicts Human Prostate Cancer Recurrence.,Hormones and Cancer,,,Article,2013-02-15,10.1007/s12672-012-0124-8,,,,23011725,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4491334,https://api.altmetric.com/v1/donut/4491334_240.png 5,"Prediagnostic plasma IGFBP?1, IGF?1 and risk of prostate cancer",International Journal of Cancer,,,Article,2014-10-27,10.1002/ijc.29295,,,,25348852,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4474028,https://api.altmetric.com/v1/donut/4474028_240.png 5,"MicroRNA in prostate, bladder, and kidney cancer: a systematic review.",European Urology,,,Article,2011-05-14,10.1016/j.eururo.2011.01.044,,,,21296484,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,161,https://www.altmetric.com/details/4320359,https://api.altmetric.com/v1/donut/4320359_240.png 5,microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.,Biochemical & Biophysical Research Communications,,,Article,2014-12-13,10.1016/j.bbrc.2014.12.026,,,,25511701,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4320344,https://api.altmetric.com/v1/donut/4320344_240.png 5,Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen),Clinical Cancer Research,,,Article,2004-05-01,10.1158/1078-0432.ccr-03-0287,,,,15131061,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4275051,https://api.altmetric.com/v1/donut/4275051_240.png 5,Peripheral T-Cell Tolerance Associated with Prostate Cancer Is Independent from CD4+CD25+ Regulatory T Cells,Cancer Research,,,Article,2008-01-01,10.1158/0008-5472.can-07-2429,,,,18172322,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4274329,https://api.altmetric.com/v1/donut/4274329_240.png 5,"Re: Relationship between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",The Journal of Urology,,,Article,2015-01-10,10.1016/j.juro.2015.07.029,,,,26382778,,,,,,,0,0,0,9,0,0,1,0,2,0,0,0,0,0,0,1,https://www.altmetric.com/details/4270172,https://api.altmetric.com/v1/donut/4270172_240.png 5,"Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.",European Urology,,,Article,2010-03-15,10.1016/j.eururo.2009.02.041,,,,19303197,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4086443,https://api.altmetric.com/v1/donut/4086443_240.png 5,Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis,BMJ Open,,,Article,2014-06-14,10.1136/bmjopen-2014-004895,,,,24934207,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3910024,https://api.altmetric.com/v1/donut/3910024_240.png 5,The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal—Implications for targeted therapies,Urologic Oncology,,,Article,2014-06-30,10.1016/j.urolonc.2014.06.001,,,,24996772,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3899850,https://api.altmetric.com/v1/donut/3899850_240.png 5,Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells.,,,,Article,2013-08-19,10.1080/14786419.2013.824440,,,,23962092,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3899844,https://api.altmetric.com/v1/donut/3899844_240.png 5,The impact of baseline [?2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort,Journal of Cancer Research & Clinical Oncology,,,Article,2013-12-19,10.1007/s00432-013-1566-2,,,,24352745,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3858858,https://api.altmetric.com/v1/donut/3858858_240.png 5,Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database,Prostate Cancer & Prostatic Diseases,,,Article,2009-07-07,10.1038/pcan.2009.11,,,,19581922,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3858857,https://api.altmetric.com/v1/donut/3858857_240.png 5,"Clinical performance of serum prostate?specific antigen isoform [?2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project",British Journal of Urology,,,Article,2013-07-04,10.1111/bju.12217,,,,23826841,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3858856,https://api.altmetric.com/v1/donut/3858856_240.png 5,LC-MS/MS Quantification of Zn-?2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer,Clinical Chemistry,,,Article,,10.1373/clinchem.2006.079681,,,,17317883,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3838022,https://api.altmetric.com/v1/donut/3838022_240.png 5,Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.,Journal of Clinical Oncology,,,Article,2008-05-20,10.1200/jco.2007.14.9021,,,,18413638,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3826219,https://api.altmetric.com/v1/donut/3826219_240.png 5,Prostate-Specific Antigen Levels as a Predictor of Lethal Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djk110,,,,17405997,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3708540,https://api.altmetric.com/v1/donut/3708540_240.png 5,Combined blockade of testicular and locally made androgens in prostate cancer: A highly significant medical progress based upon intracrinology.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2014-06-14,10.1016/j.jsbmb.2014.05.012,,,,24925260,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3434748,https://api.altmetric.com/v1/donut/3434748_240.png 5,Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer,Pharmacogenomics and Personalized Medicine,,,Article,2014-08-01,10.2147/pgpm.s38117,,,,25206306,PMC4157396,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3222280,https://api.altmetric.com/v1/donut/3222280_240.png 5,Circulating insulin-like growth factor (IGF) peptides and prostate cancer risk: a systematic review and meta-analysis,International Journal of Cancer,,,Article,2009-05-14,10.1002/ijc.24202,,,,19142965,,,,,,,0,0,0,0,0,0,7,2,0,0,0,0,0,0,1,37,https://www.altmetric.com/details/3218366,https://api.altmetric.com/v1/donut/3218366_240.png 5,"Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent's University Hospital, Dublin (2009-2011).",Irish Journal of Medical Science,,,Article,2013-02-20,10.1007/s11845-013-0920-3,,,,23417241,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3097822,https://api.altmetric.com/v1/donut/3097822_240.png 5,Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2011-07-09,,,,,21738117,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3012718,https://api.altmetric.com/v1/donut/3012718_240.png 5,"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.",Journal of Nuclear Medicine,,,Article,2006-01-02,,,,,16455635,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/3012717,https://api.altmetric.com/v1/donut/3012717_240.png 5,"Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer.",Urologic Nursing,,,Article,2006-01-08,,,,,16939047,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2903417,https://api.altmetric.com/v1/donut/2903417_240.png 5,Prostate cancer and adiponectin.,Urology,,,Article,2005-01-06,10.1016/j.urology.2004.12.053,,,,15922427,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2884214,https://api.altmetric.com/v1/donut/2884214_240.png 5,New therapies for castration-resistant prostate cancer: efficacy and safety.,European Urology,,,Article,,10.1016/j.eururo.2011.04.038,,,,21592649,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/2849164,https://api.altmetric.com/v1/donut/2849164_240.png 5,Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.,European Urology,,,Article,2009-01-05,10.1016/j.eururo.2009.01.046,,,,19211184,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/2802969,https://api.altmetric.com/v1/donut/2802969_240.png 5,Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.,Urologic Oncology,,,Article,2013-03-17,10.1016/j.urolonc.2012.10.009,,,,23490908,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2802968,https://api.altmetric.com/v1/donut/2802968_240.png 5,"Fast Facts: Prostate Cancer, seventh edition",British Journal of Urology,,,Article,,10.1111/j.1464-410x.2012.10615.x,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2692027,https://api.altmetric.com/v1/donut/2692027_240.png 5,Pathologic Prostate Cancer Characteristics in Patients Eligible for Active Surveillance: A Head-to-Head Comparison of Contemporary Protocols,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2012.03.011,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2664694,https://api.altmetric.com/v1/donut/2664694_240.png 5,Inflammation and Its Role in Prostate Cancer,Journal of Cancer Therapy,,,Article,2014-08-07,10.4236/jct.2014.59092,,,,,,,,,,,0,0,0,3,0,1,1,0,3,0,0,0,0,0,0,0,https://www.altmetric.com/details/2641386,https://api.altmetric.com/v1/donut/2641386_240.png 5,The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis,British Journal of Urology,,,Article,2002-01-01,10.1046/j.1464-410x.2002.02733.x,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2631377,https://api.altmetric.com/v1/donut/2631377_240.png 5,Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy,The Journal of Urology,,,Article,2003-01-01,10.1097/01.ju.0000062674.43964.d0,,,,12686805,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2631376,https://api.altmetric.com/v1/donut/2631376_240.png 5,Prostate cancer screening: The clinical value of diffusion?weighted imaging and dynamic MR imaging in combination with T2?weighted imaging,Journal of Magnetic Resonance Imaging,,,Article,2007-01-01,10.1002/jmri.20793,,,,17139633,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/2590725,https://api.altmetric.com/v1/donut/2590725_240.png 5,Assessing longitudinal quality of life in prostate cancer patients and their spouses: a multilevel modeling approach.,Quality of Life Research,,,Article,2010-10-12,10.1007/s11136-010-9753-y,,,,20927648,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2590723,https://api.altmetric.com/v1/donut/2590723_240.png 5,Evolution of health-related quality of life two to seven years after retropubic radical prostatectomy: evaluation by UCLA prostate cancer index,World Journal of Urology,,,Article,2005-09-01,10.1007/s00345-005-0004-8,,,,16136358,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2590720,https://api.altmetric.com/v1/donut/2590720_240.png 5,Randomized clinical trial of a family intervention for prostate cancer patients and their spouses,Cancer (0008543X),,,Article,2007-01-01,10.1002/cncr.23114,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/2590719,https://api.altmetric.com/v1/donut/2590719_240.png 5,Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.,European Urology,,,Article,2006-09-09,10.1016/j.eururo.2006.08.015,,,,16959399,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2589020,https://api.altmetric.com/v1/donut/2589020_240.png 5,"Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.",European Urology,,,Article,2008-10-09,10.1016/j.eururo.2008.09.043,,,,18838212,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2589019,https://api.altmetric.com/v1/donut/2589019_240.png 5,Mapping of Pelvic Lymph Node Metastases in Prostate Cancer.,European Urology,,,Article,2012-07-18,10.1016/j.eururo.2012.06.057,,,,22795517,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/2589015,https://api.altmetric.com/v1/donut/2589015_240.png 5,Does age influence the behaviour of localized prostate cancer?,British Journal of Urology,,,Article,2001-01-01,10.1046/j.1464-410x.2001.02141.x,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2532670,https://api.altmetric.com/v1/donut/2532670_240.png 5,Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28216,,,,23821585,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/2403192,https://api.altmetric.com/v1/donut/2403192_240.png 5,Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo?On?Line Database (COLD) Registry,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12476,,,,24112776,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2332593,https://api.altmetric.com/v1/donut/2332593_240.png 5,"Segmental dosimetry, toxicity and long?term outcome in patients with prostate cancer treated with permanent seed implants",British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11558.x,,,,23305079,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2183806,https://api.altmetric.com/v1/donut/2183806_240.png 5,Incremental detection rate of prostate cancer by real?time elastography targeted biopsies in combination with a conventional 10?core biopsy in 1024 consecutive patients,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12517,,,,24128330,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2120924,https://api.altmetric.com/v1/donut/2120924_240.png 5,Elevated levels of mitochondrion?associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer,Cancer (0008543X),,,Article,2014-01-03,10.1002/cncr.28551,,,,24390809,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2111966,https://api.altmetric.com/v1/donut/2111966_240.png 5,To treat or not to treat: is the way forward clearer in lowâ??risk prostate cancer?,British Journal of Urology,,,Article,2013-08-14,10.1111/j.1464-410x.2012.11723.x,,,,23469893,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1732506,https://api.altmetric.com/v1/donut/1732506_240.png 5,Standardized comparison of robotâ??assisted limited and extended pelvic lymphadenectomy for prostate cancer,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11788.x,,,,23351148,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1720478,https://api.altmetric.com/v1/donut/1720478_240.png 5,"Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-institutional Pooled Analysis",JAMA: Journal of the American Medical Association,,,Article,1999-01-01,10.1001/jama.281.17.1598,,,,,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1715844,https://api.altmetric.com/v1/donut/1715844_240.png 5,Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imagingâ??targeted and systematic biopsy for significant prostate cancer detection,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2011.10112.x,,,,21426475,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1551046,https://api.altmetric.com/v1/donut/1551046_240.png 5,Cumulative cost pattern comparison of prostate cancer treatments,Cancer (0008543X),,,Article,2007-01-01,10.1002/cncr.22433,,,,17186528,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1551045,https://api.altmetric.com/v1/donut/1551045_240.png 5,Impact of the 2008 US Preventive Services Task Force Recommendation to Discontinue Prostate Cancer Screening Among Male Medicare Beneficiaries,Archives of Internal Medicine,,,Article,2012-01-01,10.1001/archinternmed.2012.3726,,,,22987029,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1489425,https://api.altmetric.com/v1/donut/1489425_240.png 5,The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.,EMBO Journal,,,Article,2011-05-24,10.1038/emboj.2011.158,,,,21602788,PMC3155295,,,,,,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,118,https://www.altmetric.com/details/1469397,https://api.altmetric.com/v1/donut/1469397_240.png 5,"Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up.",European Urology,,,Article,2012-10-24,10.1016/j.eururo.2012.10.002,,,,23084329,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,36,https://www.altmetric.com/details/1255974,https://api.altmetric.com/v1/donut/1255974_240.png 5,Human castration resistant prostate cancer rather prefer to decreased 5[agr]-reductase activity,Scientific Reports,,,Article,2013-02-14,10.1038/srep01268,,,,23429215,,,,,,,0,0,0,11,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1242585,https://api.altmetric.com/v1/donut/1242585_240.png 5,"Prostate specific membrane antigen (PSMA): A novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells",The Prostate,,,Article,2013-01-01,10.1002/pros.22627,,,,23255296,,,,,,,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1134674,https://api.altmetric.com/v1/donut/1134674_240.png 5,Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice,International Journal of Cancer,,,Article,2009-01-01,10.1002/ijc.24336,,,,19326431,,,,,,,0,0,0,4,1,0,4,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/1079479,https://api.altmetric.com/v1/donut/1079479_240.png 5,Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009,Clinical and Translational Oncology,,,Article,2012-08-04,10.1007/s12094-012-0913-0,,,,22855195,,,,,,,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1018309,https://api.altmetric.com/v1/donut/1018309_240.png 5,Sexuality and Intimacy After Definitive Treatment and Subsequent Androgen Deprivation Therapy for Prostate Cancer,Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2012.41.8509,,,,23008326,,,,,,,0,0,0,3,0,0,0,1,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/1009783,https://api.altmetric.com/v1/donut/1009783_240.png 5,Long?term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11367.x,,,,,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/959233,https://api.altmetric.com/v1/donut/959233_240.png 5,Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11504.x,,,,22989066,,,,,,,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/955328,https://api.altmetric.com/v1/donut/955328_240.png 5,Management of bone metastases in refractory prostate cancer – role of denosumab,Clinical Interventions in Aging,,,Article,2012-09-01,10.2147/cia.s27930,,,,23049248,,,,,,,0,0,1,2,0,0,1,0,1,0,0,0,0,0,0,33,https://www.altmetric.com/details/950826,https://api.altmetric.com/v1/donut/950826_240.png 5,Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-01-01,10.1158/1055-9965.epi-06-0973,,,,17416774,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/858546,https://api.altmetric.com/v1/donut/858546_240.png 5,The absence of voiding symptoms in men with a prostate?specific antigen (PSA) concentration of ?3.0?ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial,British Journal of Urology,,,Article,2012-05-02,10.1111/j.1464-410x.2012.10962.x,,,,22540895,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,8,https://www.altmetric.com/details/831325,https://api.altmetric.com/v1/donut/831325_240.png 5,Distinct microRNA Expression Profiles in Prostate Cancer Stem/Progenitor Cells and Tumor-Suppressive Functions of let-7.,Cancer Research,"CROFT, Laura B",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-01-01,10.1158/0008-5472.can-11-3864,,,,22719071,,,,,,,0,0,0,4,0,0,0,2,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/805112,https://api.altmetric.com/v1/donut/805112_240.png 5,The quantitative Gleason score improves prostate cancer risk assessment,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.27670,,,,22674220,,,,,,,0,0,1,10,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/782285,https://api.altmetric.com/v1/donut/782285_240.png 5,Disparities in prostate cancer in African American men: What primary care physicians can do.,Cleveland Clinic Journal of Medicine,,,Article,2012-01-01,10.3949/ccjm.79a.11001,,,,22550073,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/729589,https://api.altmetric.com/v1/donut/729589_240.png 5,"Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature.",Journal of Nutrition,,,Article,2005-01-01,,,,,16046732,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/631259,https://api.altmetric.com/v1/donut/631259_240.png 5,Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate?specific antigen at or before age 50,Cancer (0008543X),,,Article,2011-03-15,10.1002/cncr.25568,,,,20960520,,,,,,,0,0,6,1,0,0,0,0,0,0,0,0,1,0,0,36,https://www.altmetric.com/details/514205,https://api.altmetric.com/v1/donut/514205_240.png 5,Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer,British Journal of Urology,,,Article,2011-11-17,10.1111/j.1464-410x.2011.10709.x,,,,22085233,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/486166,https://api.altmetric.com/v1/donut/486166_240.png 5,"Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men.",Chronobiology International: The Journal of Biological & Medical Rhythm Research,,,Article,2009-01-01,10.1080/07420520802694020,,,,19142761,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/456521,https://api.altmetric.com/v1/donut/456521_240.png 5,Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-11-1821,,,,22007000,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/411924,https://api.altmetric.com/v1/donut/411924_240.png 5,Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.,Oncogene,,,Article,2011-05-02,10.1038/onc.2011.144,,,,21532617,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/392533,https://api.altmetric.com/v1/donut/392533_240.png 5,"Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis",BMC Cancer,,,Article,2011-08-25,10.1186/1471-2407-11-375,,,,21867506,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/248048,https://api.altmetric.com/v1/donut/248048_240.png 5,The role of the cell adhesion molecules (integrins / cadherins) in prostate cancer,International Brazilian Journal of Urology,,,Article,2011-06-01,10.1590/s1677-55382011000300002,,,,,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/220261,https://api.altmetric.com/v1/donut/220261_240.png 5,PSA Failure Following Definitive Treatment of Prostate Cancer Having Biopsy Gleason Score 7 With Tertiary Grade 5,JAMA: Journal of the American Medical Association,,,Article,2007-10-03,10.1001/jama.298.13.1533,,,,17911498,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/211988,https://api.altmetric.com/v1/donut/211988_240.png 5,Changes in Body Composition during Androgen Deprivation Therapy for Prostate Cancer,Journal of Clinical Endocrinology & Metabolism,,,Article,2002-02-01,10.1210/jc.87.2.599,,,,,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/185291,https://api.altmetric.com/v1/donut/185291_240.png 5,Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer,Journal of Clinical Endocrinology & Metabolism,,,Article,2005-12-01,10.1210/jc.2005-0183,,,,16189261,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/185283,https://api.altmetric.com/v1/donut/185283_240.png 5,Bone Loss in Men with Prostate Cancer Treated with Gonadotropin-Releasing Hormone Agonists,Journal of Clinical Endocrinology & Metabolism,,,Article,2001-06-01,10.1210/jc.86.6.2787,,,,,,,,,,,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/185282,https://api.altmetric.com/v1/donut/185282_240.png 5,Focal Adhesion Kinase Controls Prostate Cancer Progression via Intrinsic Kinase and Scaffolding Functions.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2011-03-01,,,,,21355844,,,,,,,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/175177,https://api.altmetric.com/v1/donut/175177_240.png 5,Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States,JAMA Oncology,,,Article,2016-06-30,10.1001/jamaoncol.2016.1143,,,,27367418,,,,,,,0,0,0,10,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/9151308,https://api.altmetric.com/v1/donut/9151308_240.png 5,Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2016-03-08,10.1038/pcan.2016.9,,,,26951715,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6152749,https://api.altmetric.com/v1/donut/6152749_240.png 5,Inadvisable breast and prostate cancer screenings in the USA ,Lancet Oncology,,,Article,2016-01-28,10.1016/s1470-2045(16)00069-3,,,,26831288,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5057875,https://api.altmetric.com/v1/donut/5057875_240.png 5,Two-drug combination boosts survival in metastatic prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/7590-two-drug-combination-boosts-survival-in-metastatic-prostate-cancer.php,,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4373215,https://api.altmetric.com/v1/donut/4373215_240.png 5,The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer,Cell Reports,,,Article,2015-08-04,10.1016/j.celrep.2015.07.012,,,,26235627,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4348116,https://api.altmetric.com/v1/donut/4348116_240.png 5,Re: Salvage High-Intensity Focused Ultrasound for Patients with Recurrent Prostate Cancer after Brachytherapy,The Journal of Urology,,,Article,2015-06-20,10.1016/j.juro.2015.04.065,,,,26088224,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3920027,https://api.altmetric.com/v1/donut/3920027_240.png 5,Genitourinary Cancers Other than Prostate Cancer in a BRCA-tested Cohort from a Single Institution,European Urology,,,Article,2015-06-01,10.1016/j.eururo.2015.01.001,,,,25597019,,,,,,,0,0,0,7,0,0,1,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/3066558,https://api.altmetric.com/v1/donut/3066558_240.png 5,Fiber intake and risk of subsequent prostate cancer in Japanese men.,American Journal of Clinical Nutrition,,,Article,2015-01-01,10.3945/ajcn.114.089581,,,,25527755,,,,,,,0,0,0,5,0,1,1,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2910357,https://api.altmetric.com/v1/donut/2910357_240.png 5,Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified?,European Urology,,,Article,,10.1016/j.eururo.2014.10.046,,,,25465975,,,,,,,0,0,0,9,0,0,1,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/2882815,https://api.altmetric.com/v1/donut/2882815_240.png 5,Experts condemn “flawed” NICE process over its rejection of prostate cancer drug,British Medical Journal,,,Article,2014-08-19,10.1136/bmj.g5224,,,,25139515,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2603745,https://api.altmetric.com/v1/donut/2603745_240.png 5,Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer,Cochrane database of systematic reviews,,,Article,2014-06-30,10.1002/14651858.cd009266.pub2,,,,24979481,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2476243,https://api.altmetric.com/v1/donut/2476243_240.png 5,Preferences in management of high-risk prostate cancer among urologists in Europe: results of a web-based survey,British Journal of Urology,,,Article,2014-05-01,10.1111/bju.12796,,,,24802335,,1854/LU-4419676,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2340226,https://api.altmetric.com/v1/donut/2340226_240.png 5,Focused Screening Strategy for Prostate Cancer,Journal Watch,,,Article,2014-05-01,10.1056/nejm-jw.na34512,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2322268,https://api.altmetric.com/v1/donut/2322268_240.png 5,Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12568,,,,24224648,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2201273,https://api.altmetric.com/v1/donut/2201273_240.png 5,What should we tell prostate cancer patients about (secondary) prevention?,Current Opinion in Urology,,,Article,2014-03-15,10.1097/mou.0000000000000049,,,,24625429,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2190859,https://api.altmetric.com/v1/donut/2190859_240.png 5,Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors,Therapeutic Advances in Medical Oncology,,,Article,2016-07-05,10.1177/1758834016656493,,,,27583024,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9286497,https://api.altmetric.com/v1/donut/9286497_240.png 5,Incidental prostate cancer diagnosed following a transurethral resection of the prostate: A national database analysis in England,Journal of Clinical Urology,,,Article,2015-11-24,10.1177/2051415815603275,,,,,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8484740,https://api.altmetric.com/v1/donut/8484740_240.png 5,Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate Cancer,Journal of Sexual Medicine,,,Article,2015-04-01,10.1111/jsm.12867,,,,25847707,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3858727,https://api.altmetric.com/v1/donut/3858727_240.png 5,Radiation plus hormone therapy prolongs survival for older men with prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6824-radiation-plus-hormone-therapy-prolongs-survival-for-older-men-with-prostate-cancer.php,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3047448,https://api.altmetric.com/v1/donut/3047448_240.png 5,Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-Guided Biopsy of the Prostate to Detect High-Grade Cancer,"Journal of Endourology Part B, Videourology",,,Article,2014-10-01,10.1089/vid.2013.0098,,,,,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2821772,https://api.altmetric.com/v1/donut/2821772_240.png 5,Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.007,,,,23957945,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2234354,https://api.altmetric.com/v1/donut/2234354_240.png 5,Occupational exposure to solar ultraviolet radiation and the risk of prostate cancer,Occupational and environmental medicine,,,Article,2016-07-27,10.1136/oemed-2016-103567,,,,27466617,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10241333,https://api.altmetric.com/v1/donut/10241333_240.png 5," Commentary: On Gao C et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer ",International Journal of Epidemiology,,,Article,2016-07-17,10.1093/ije/dyw127,,,,27427429,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9866295,https://api.altmetric.com/v1/donut/9866295_240.png 5,PSMA PET May Improve the Diagnostic Accuracy of mpMRI in Localised Prostate Cancer as Confirmed by Whole-Mount Histopathology,The Journal of Urology,,,Article,2016-05-21,10.1016/j.juro.2016.02.3000,,,,27220897,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8101191,https://api.altmetric.com/v1/donut/8101191_240.png 5,Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy,Brachytherapy,,,Article,2016-05-01,10.1016/j.brachy.2016.03.012,,,,27180125,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7373953,https://api.altmetric.com/v1/donut/7373953_240.png 5,Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project,World Journal of Urology,,,Article,2016-02-18,10.1007/s00345-016-1782-x,,,,26892160,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/5892812,https://api.altmetric.com/v1/donut/5892812_240.png 5,Re: Long-Term Follow-up of a Randomized Trial of Radiation with or without Androgen Deprivation Therapy for Localized Prostate Cancer,The Journal of Urology,,,Article,2016-02-10,10.1016/j.juro.2016.02.022,,,,27186728,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5306487,https://api.altmetric.com/v1/donut/5306487_240.png 5,RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice,The Prostate,,,Article,2015-10-01,10.1002/pros.23110,,,,26477693,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4649787,https://api.altmetric.com/v1/donut/4649787_240.png 5,Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer,Urology,,,Article,2015-09-12,10.1016/j.urology.2015.08.024,,,,26358397,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4482394,https://api.altmetric.com/v1/donut/4482394_240.png 5,Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma,European Urology,,,Article,2015-08-06,10.1016/j.eururo.2015.07.023,,,,26238432,,,,,,,0,0,0,12,0,0,2,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/4368497,https://api.altmetric.com/v1/donut/4368497_240.png 5,Finding the Wolf in Sheep’s Clothing: The 4Kscore Is a Novel Blood Test That Can Accurately Identify the Risk of Aggressive Prostate Cancer,Reviews in Urology,,,Article,2015-07-09,,,,,26028995,,,,,,,0,0,0,8,0,0,0,0,1,0,0,0,0,0,0,19,https://www.altmetric.com/details/4258011,https://api.altmetric.com/v1/donut/4258011_240.png 5,Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia.,Clinical Biochemistry,,,Article,1999-08-01,,,,,10667474,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4064766,https://api.altmetric.com/v1/donut/4064766_240.png 5,Image Guided Focal Therapy Of MRI-Visible Prostate Cancer: Defining a 3D Treatment Margin based on MRI-Histology Co-registration Analysis,The Journal of Urology,,,Article,2015-02-21,10.1016/j.juro.2015.02.080,,,,25711199,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3724536,https://api.altmetric.com/v1/donut/3724536_240.png 5,Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis.,Prostate Cancer & Prostatic Diseases,,,Article,1999-08-31,10.1038/sj.pcan.4500308,,,,12496826,,,,,,,0,0,0,2,0,0,0,2,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3177663,https://api.altmetric.com/v1/donut/3177663_240.png 5,"Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer",PLoS ONE,,,Article,2012-10-24,10.1371/journal.pone.0046737,,,,23091600,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,70,https://www.altmetric.com/details/3077775,https://api.altmetric.com/v1/donut/3077775_240.png 5,Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe,European Urology,,,Article,2014-09-09,10.1016/j.eururo.2014.08.076,,,,25218582,,,,,,,0,0,0,12,0,0,0,0,1,0,0,0,0,0,0,22,https://www.altmetric.com/details/2677570,https://api.altmetric.com/v1/donut/2677570_240.png 5,"DNA damage response and prostate cancer: defects, regulation and therapeutic implications.",Oncogene,,,Article,2014-08-18,10.1038/onc.2014.238,,,,25132269,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2603893,https://api.altmetric.com/v1/donut/2603893_240.png 5,A Role for WDR5 in Integrating Threonine 11 Phosphorylation to Lysine 4 Methylation on Histone H3 during Androgen Signaling and in Prostate Cancer.,Molecular Cell,,,Article,2014-04-29,10.1016/j.molcel.2014.03.043,,,,24793694,,,,,,,0,0,0,7,17,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/2319513,https://api.altmetric.com/v1/donut/2319513_240.png 5,A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer,Human Gene Therapy,,,Article,2014-04-02,10.1089/hum.2013.209,,,,24694017,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2242191,https://api.altmetric.com/v1/donut/2242191_240.png 5,"Diet and Exercise Intervention Adherence and Health-Related Outcomes among Older Long-Term Breast, Prostate, and Colorectal Cancer Survivors.",Annals of Behavioral Medicine,,,Article,2014-03-20,10.1007/s12160-014-9598-7,,,,24648018,,,,,,,0,0,0,7,1,0,2,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2205621,https://api.altmetric.com/v1/donut/2205621_240.png 5,Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up,European Urology,,,Article,2013-07-01,10.1016/j.eururo.2013.07.024,,,,23932338,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,1,0,0,37,https://www.altmetric.com/details/1784576,https://api.altmetric.com/v1/donut/1784576_240.png 5,How User Characteristics Affect Use Patterns in Web-Based Illness Management Support for Patients with Breast and Prostate Cancer,Journal of Medical Internet Research,,,Article,2013-01-01,10.2196/jmir.2285,,,,23454601,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1273188,https://api.altmetric.com/v1/donut/1273188_240.png 5,"Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008",International Journal of Public Health,,,Article,1970-01-01,10.1007/s00038-011-0266-4,,,,21681451,,,,,,,0,0,1,4,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1225095,https://api.altmetric.com/v1/donut/1225095_240.png 5,"Resisting the screening imperative: patienthood, populations and politics in prostate cancer detection technologies for the UK",Sociology of Health & Illness,,,Article,2012-01-01,10.1111/j.1467-9566.2011.01385.x,,,,21812794,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1192199,https://api.altmetric.com/v1/donut/1192199_240.png 5,Dual Tracer 11C-Choline and FDG-PET in the Diagnosis of Biochemical Prostate Cancer Relapse After Radical Treatment,Molecular Imaging & Biology,,,Article,2010-01-04,10.1007/s11307-009-0243-y,,,,19543774,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/835249,https://api.altmetric.com/v1/donut/835249_240.png 5,Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States,Cancer (0008543X),,,Article,2012-03-01,10.1002/cncr.26416,,,,21823112,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/610486,https://api.altmetric.com/v1/donut/610486_240.png 5,Androgen deprivation and thromboembolic events in men with prostate cancer,Cancer (0008543X),,,Article,2011-01-01,10.1002/cncr.26623,,,,22072494,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/477480,https://api.altmetric.com/v1/donut/477480_240.png 5,"One year pre–post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients ","Brain, Behavior & Immunity",,,Article,2007-11-01,10.1016/j.bbi.2007.04.002,,,,17521871,,,,,,,0,0,0,54,0,0,0,0,0,0,0,0,0,0,0,390,https://www.altmetric.com/details/426765,https://api.altmetric.com/v1/donut/426765_240.png 5,No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe,PLoS ONE,,,Article,2011-10-12,10.1371/journal.pone.0025592,,,,22022417,,,,,,,0,0,0,4,0,0,5,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/401251,https://api.altmetric.com/v1/donut/401251_240.png 5,Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey,European Urology Focus ,,,Article,2016-10-01,10.1016/j.euf.2016.09.005,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12554996,https://api.altmetric.com/v1/donut/12554996_240.png 5,Advances in Prostate Cancer MRI and PET/CT for Staging and Radiotherapy Treatment Planning ,Seminars in Radiation Oncology,,,Article,,10.1016/j.semradonc.2016.08.008,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10959511,https://api.altmetric.com/v1/donut/10959511_240.png 5,Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-08-11,10.1016/j.eururo.2016.07.051,,,,27522164,,,,,,,0,0,0,12,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10396905,https://api.altmetric.com/v1/donut/10396905_240.png 5,STAT3 in Prostate Cancer: Whom Should We Treat and When?,European Urology,,,Article,2016-07-09,10.1016/j.eururo.2016.06.034,,,,27402062,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9527662,https://api.altmetric.com/v1/donut/9527662_240.png 5,Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?,OncoTargets and therapy,,,Article,2016-03-17,10.2147/ott.s102327,,,,27073327,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8875517,https://api.altmetric.com/v1/donut/8875517_240.png 5,Re: Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men with Castration-Resistant Prostate Cancer,The Journal of Urology,,,Article,2016-06-16,10.1016/j.juro.2016.06.067,,,,27597066,,,,,,,0,0,0,17,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8807579,https://api.altmetric.com/v1/donut/8807579_240.png 5,Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study,European Urology Focus ,,,Article,2016-06-14,10.1016/j.euf.2016.06.001,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8719390,https://api.altmetric.com/v1/donut/8719390_240.png 5,miR-24 regulates CDKN1B/p27 expression in prostate cancer.,The Prostate,,,Article,2016-02-07,10.1002/pros.23156,,,,26847530,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5103750,https://api.altmetric.com/v1/donut/5103750_240.png 5,Transurethral (TURP) biopsy of suspected anterior prostate cancers identified by multi-parametric MRI: a pilot study of a novel technique,Urology,,,Article,2016-02-01,10.1016/j.urology.2015.12.063,,,,26845054,,,,,,,0,0,0,13,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5074325,https://api.altmetric.com/v1/donut/5074325_240.png 5,Relationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer.,International Journal of Urology,,,Article,2016-01-01,10.1111/iju.13043,,,,26763083,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4990975,https://api.altmetric.com/v1/donut/4990975_240.png 5,Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery,European Urology,,,Article,2015-10-06,10.1016/j.eururo.2015.09.032,,,,26456680,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4590835,https://api.altmetric.com/v1/donut/4590835_240.png 5,A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group,Journal of Clinical Medicine,,,Article,2015-07-07,10.3390/jcm4071369,,,,26239681,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4251441,https://api.altmetric.com/v1/donut/4251441_240.png 5,Low testosterone level is an independent risk factor for high?grade prostate cancer detection via biopsy,British Journal of Urology,,,Article,2015-06-19,10.1111/bju.13206,,,,26086732,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4188899,https://api.altmetric.com/v1/donut/4188899_240.png 5,Re: Randomized Clinical Trial of Brewed Green and Black Tea in Men with Prostate Cancer Prior to Prostatectomy,The Journal of Urology,,,Article,2015-08-22,10.1016/j.juro.2015.06.050,,,,26292860,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4174045,https://api.altmetric.com/v1/donut/4174045_240.png 5,Effects of a 15-Month Supervised Exercise Program on Physical and Psychological Outcomes in Prostate Cancer Patients Following Prostatectomy The ProRehab Study,Integrative Cancer Therapies,,,Article,2015-04-30,10.1177/1534735415583552,,,,25917814,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3956101,https://api.altmetric.com/v1/donut/3956101_240.png 5,Prostate MRI Can Reduce Overdiagnosis and Overtreatment of Prostate Cancer,Academic Radiology,,,Article,2015-03-17,10.1016/j.acra.2015.02.006,,,,25791578,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3818625,https://api.altmetric.com/v1/donut/3818625_240.png 5,Prostate Cancer Immunotherapy: Beyond Immunity to Curability,Cancer immunology research,,,Article,2014-11-01,10.1158/2326-6066.cir-14-0174,,,,25367978,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2858661,https://api.altmetric.com/v1/donut/2858661_240.png 5,Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer,IUBMB Life,,,Article,2014-06-30,10.1002/iub.1281,,,,24979663,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2488116,https://api.altmetric.com/v1/donut/2488116_240.png 5,Prostate cancer surgery vs radiation: has the fat lady sung?,British Journal of Urology,,,Article,2014-02-15,10.1111/bju.12393,,,,24712697,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2052616,https://api.altmetric.com/v1/donut/2052616_240.png 5,Distribution of metastatic sites in patients with prostate cancer: A population?based analysis,The Prostate,,,Article,2013-01-01,10.1002/pros.22742,,,,24132735,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1846411,https://api.altmetric.com/v1/donut/1846411_240.png 5,Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-3283,,,,23515404,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1313910,https://api.altmetric.com/v1/donut/1313910_240.png 5,Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study.,Journal of registry management,,,Article,2011-01-01,,,,,22096878,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/493068,https://api.altmetric.com/v1/donut/493068_240.png 5,Prospective Evaluation of the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) for Prostate Cancer Detection,The Journal of Urology,,,Article,2016-04-18,10.1016/j.juro.2016.04.057,,,,27101772,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6789302,https://api.altmetric.com/v1/donut/6789302_240.png 5,Expression profile analysis of microRNAs in prostate cancer by next?generation sequencing,The Prostate,,,Article,2015-01-16,10.1002/pros.22936,,,,25597612,,,,,,,0,0,0,9,0,0,1,0,1,0,0,0,0,0,0,24,https://www.altmetric.com/details/3080865,https://api.altmetric.com/v1/donut/3080865_240.png 5,Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention,Frontiers in oncology,,,Article,2014-12-04,10.3389/fonc.2014.00370,,,,25566507,,,,,,,0,0,0,3,0,0,0,2,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3050338,https://api.altmetric.com/v1/donut/3050338_240.png 5,Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells,BMC Complementary and Alternative Medicine,,,Article,2014-03-12,10.1186/1472-6882-14-97,,,,24617993,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2182250,https://api.altmetric.com/v1/donut/2182250_240.png 5,Comparative efficacy of bisphosphonates in metastatic breast and prostate cancer and multiple myeloma: a mixed-treatment meta-analysis,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-2275,,,,24166910,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1870015,https://api.altmetric.com/v1/donut/1870015_240.png 5,Impact of 18F-Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence: Influence of Androgen Deprivation Therapy and Correlation with PSA Kinetics,Journal of Nuclear Medicine,,,Article,2013-04-04,10.2967/jnumed.112.110148,,,,23559588,,,,,,,0,0,1,4,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1346899,https://api.altmetric.com/v1/donut/1346899_240.png 5,The Relationship Between Nutrition and Prostate Cancer: Is More Always Better? ,European Urology,,,Article,2012-11-15,10.1016/j.eururo.2012.11.012,,,,23219353,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,76,https://www.altmetric.com/details/1120045,https://api.altmetric.com/v1/donut/1120045_240.png 5,"How reliable are ""reputable sources"" for medical information on the Internet? The case of hormonal therapy to treat prostate cancer.",Urologic Oncology,,,Article,2012-11-14,10.1016/j.urolonc.2012.08.003,,,,23141782,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1107227,https://api.altmetric.com/v1/donut/1107227_240.png 5,Direct 2-Arm Comparison Shows Benefit of High-Dose-Rate Brachytherapy Boost vs External Beam Radiation Therapy Alone for Prostate Cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-09-08,10.1016/j.ijrobp.2012.07.006,,,,22954770,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1019598,https://api.altmetric.com/v1/donut/1019598_240.png 5,Landmarks in prostate cancer diagnosis: the biomarkers,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.011429.x,,,,23046035,,,,,,,0,0,1,2,0,0,1,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/1007849,https://api.altmetric.com/v1/donut/1007849_240.png 5,Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22562,,,,22851253,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/866318,https://api.altmetric.com/v1/donut/866318_240.png 5,The prostate cancer conundrum revisited,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.27594,,,,22605665,,,,,,,0,0,1,4,0,0,2,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/764793,https://api.altmetric.com/v1/donut/764793_240.png 5,Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study,British Medical Journal,,,Article,2010-01-01,10.1136/bmj.c4521,,,,20843935,PMC2939950,,,,,,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/211889,https://api.altmetric.com/v1/donut/211889_240.png 5,Caregiving and social support for gay and bisexual men with prostate cancer,Psycho-Oncology,,,Article,2016-09-15,10.1002/pon.4249,,,,27530377,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12740042,https://api.altmetric.com/v1/donut/12740042_240.png 5,Methodological exemplar of integrating quantitative and qualitative evidence- Supportive care for men with prostate cancer: what are the most important components?,Journal of Advanced Nursing,,,Article,2016-07-01,10.1111/jan.13082,,,,27461976,,,,,,,0,0,0,19,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10174487,https://api.altmetric.com/v1/donut/10174487_240.png 5,Disparities in Staging Prostate Magnetic Resonance Imaging Utilization for Non-Metastatic Prostate Cancer Patients Undergoing Definitive Radiotherapy,Advances in Radiation Oncology ,,,Article,2016-07-22,10.1016/j.adro.2016.07.003,,,,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10118836,https://api.altmetric.com/v1/donut/10118836_240.png 5,Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer,Virchows Archiv,,,Article,2016-07-10,10.1007/s00428-016-1981-2,,,,27394432,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9798556,https://api.altmetric.com/v1/donut/9798556_240.png 5,Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?,Prostate Cancer & Prostatic Diseases,,,Article,2016-07-05,10.1038/pcan.2016.26,,,,27377207,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9244501,https://api.altmetric.com/v1/donut/9244501_240.png 5,Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747),British Journal of Urology,,,Article,2016-06-01,10.1111/bju.13549,,,,27256016,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8664103,https://api.altmetric.com/v1/donut/8664103_240.png 5,Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older Men,Urology,,,Article,2016-06-08,10.1016/j.urology.2016.05.054,,,,27289026,,,,,,,0,0,0,15,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8594774,https://api.altmetric.com/v1/donut/8594774_240.png 5,"Metformin Inhibits Prostate Cancer Cell Proliferation, Migration, and Tumor Growth through Upregulation of PEDF Expression",Cancer Biology and Therapy,,,Article,2016-03-17,10.1080/15384047.2016.1156273,,,,26987032,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6271113,https://api.altmetric.com/v1/donut/6271113_240.png 5,Characteristics of anteriorly located prostate cancer and the usefulness of multiparametric magnetic resonance imaging for its diagnosis,The Journal of Urology,,,Article,2016-03-17,10.1016/j.juro.2016.03.075,,,,26997311,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6226279,https://api.altmetric.com/v1/donut/6226279_240.png 5,Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.,Modern Pathology,,,Article,2016-01-08,10.1038/modpathol.2015.148,,,,26743468,PMC4732921,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4970325,https://api.altmetric.com/v1/donut/4970325_240.png 5,Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study,Supportive Care in Cancer,,,Article,2015-11-23,10.1007/s00520-015-3033-x,,,,26594035,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4864764,https://api.altmetric.com/v1/donut/4864764_240.png 5,Diagnostic Efficacy of 68Gallium-PSMA-PET compared to Conventional Imaging in Lymph Node Staging of of 130 consecutive Patients with Intermediate to High-Risk Prostate Cancer,The Journal of Urology,,,Article,2015-12-20,10.1016/j.juro.2015.12.025,,,,26682756,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/4859349,https://api.altmetric.com/v1/donut/4859349_240.png 5,A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2015-08-14,10.1016/j.eururo.2015.07.053,,,,26278804,,,,,,,0,0,0,9,0,0,3,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4395045,https://api.altmetric.com/v1/donut/4395045_240.png 5,Unemployment linked to rise in prostate cancer deaths,ecancer.org,,,Article,,,,,http://ecancer.org/news/7305-unemployment-linked-to-rise-in-prostate-cancer-deaths.php,,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3999158,https://api.altmetric.com/v1/donut/3999158_240.png 5,"Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-07-01,10.1158/1055-9965.epi-14-0317,,,,25837820,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3906851,https://api.altmetric.com/v1/donut/3906851_240.png 5,Identification of a candidate gene panel for the early diagnosis of prostate cancer.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-14-3334,,,,25788493,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3808419,https://api.altmetric.com/v1/donut/3808419_240.png 5,Quality of Life After Primary Treatment for Localized Prostate Cancer: Long-term Considerations,European Urology,,,Article,2015-10-01,10.1016/j.eururo.2014.12.003,,,,25533419,,,,,,,0,0,0,10,0,0,0,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/2998213,https://api.altmetric.com/v1/donut/2998213_240.png 5,"Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer",European Urology,,,Article,2014-12-04,10.1016/j.eururo.2014.11.033,,,,25484141,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,26,https://www.altmetric.com/details/2953165,https://api.altmetric.com/v1/donut/2953165_240.png 5,PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models.,PLoS ONE,,,Article,2014-10-03,10.1371/journal.pone.0109427,,,,25279468,,,,,,,0,0,0,5,0,1,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2770032,https://api.altmetric.com/v1/donut/2770032_240.png 5,Androgen Deprivation Therapy in Prostate Cancer: Looking Beyond Prostate-specific Antigen and Testosterone Levels,European Urology,,,Article,2014-08-24,10.1016/j.eururo.2014.08.033,,,,25168615,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/2627442,https://api.altmetric.com/v1/donut/2627442_240.png 5,Evolution of advanced technologies in prostate cancer radiotherapy.,Nature Reviews Urology,,,Article,2013-09-12,10.1038/nrurol.2013.185,,,,24018567,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2465929,https://api.altmetric.com/v1/donut/2465929_240.png 5,The costs of identifying undiagnosed prostate cancer in asymptomatic men in New Zealand general practice.,Family Practise,,,Article,2013-01-01,10.1093/fampra/cmt049,,,,24055993,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1774075,https://api.altmetric.com/v1/donut/1774075_240.png 5,Hormonal therapy with external radiation therapy for metastatic spinal cord compression from newly diagnosed prostate cancer,Journal of Orthopaedic Science,,,Article,2013-05-28,10.1007/s00776-013-0409-y,,,,23712788,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1520782,https://api.altmetric.com/v1/donut/1520782_240.png 5,Selenium and Prostate Cancer Prevention: Insights from the Selenium and Vitamin E Cancer Prevention Trial (SELECT).,Nutrients,,,Article,2013-01-01,10.3390/nu5041122,,,,23552052,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1381451,https://api.altmetric.com/v1/donut/1381451_240.png 5,PRSS3/mesotrypsin in prostate cancer progression: implications for translational medicine,Asian Journal of Andrology,,,Article,2013-03-18,10.1038/aja.2013.14,,,,23503422,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1318274,https://api.altmetric.com/v1/donut/1318274_240.png 5,A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer,BMC Cancer,,,Article,2013-02-26,10.1186/1471-2407-13-89,,,,23442556,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,80,https://www.altmetric.com/details/1263754,https://api.altmetric.com/v1/donut/1263754_240.png 5,Interactions Between Genetic Variants and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium,JNCI: Journal of the National Cancer Institute,,,Article,2011-07-26,10.1093/jnci/djr265,,,,21791674,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/198911,https://api.altmetric.com/v1/donut/198911_240.png 5,The 22nd annual prostate cancer foundation scientific retreat report,The Prostate,,,Article,2016-05-01,10.1002/pros.23193,,,,27272144,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/8593658,https://api.altmetric.com/v1/donut/8593658_240.png 5,Gene-specific hypermethylation (GSTP1) and global hypomethylation (LINE-1) on initial negative prostate biopsy as markers of prostate cancer on a rebiopsy,Clinical Cancer Research,,,Article,2015-10-18,10.1158/1078-0432.ccr-15-0606,,,,26475336,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4641952,https://api.altmetric.com/v1/donut/4641952_240.png 5,New Formula Reduces Distressing Radiation Complication in Prostate Cancer,Oncology times,,,Article,2015-09-10,10.1097/01.cot.0000471647.25812.c3,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4460813,https://api.altmetric.com/v1/donut/4460813_240.png 5,High-intensity Focused Ultrasound for Prostate Cancer: Tempering Our Enthusiasm,European Urology,,,Article,2014-05-01,10.1016/j.eururo.2013.06.016,,,,23827736,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2307119,https://api.altmetric.com/v1/donut/2307119_240.png 5,Metformin Targets c-MYC Oncogene to Prevent Prostate Cancer,Carcinogenesis,,,Article,2013-01-01,10.1093/carcin/bgt307,,,,24130167,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1840114,https://api.altmetric.com/v1/donut/1840114_240.png 5,"Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer",American Journal of Clinical Nutrition,,,Article,2008-01-01,,,,,18469268,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/796917,https://api.altmetric.com/v1/donut/796917_240.png 5,MRI-TRUS Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer,The Journal of Urology,,,Article,2016-09-11,10.1016/j.juro.2016.08.109,,,,27613356,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/11870014,https://api.altmetric.com/v1/donut/11870014_240.png 5,"Feasibility, acceptability and preliminary psychological benefits of mindfulness meditation training in a sample of men diagnosed with prostate cancer on active surveillance: results from a randomized controlled pilot trial",Psycho-Oncology,,,Article,2016-01-01,10.1002/pon.4135,,,,27145355,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7141426,https://api.altmetric.com/v1/donut/7141426_240.png 5,Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy,Diagnostic Pathology,,,Article,2015-06-13,10.1186/s13000-015-0294-0,,,,26070608,PMC4465166,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4145865,https://api.altmetric.com/v1/donut/4145865_240.png 5,Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis,The Journal of Urology,,,Article,2015-02-21,10.1016/j.juro.2015.02.084,,,,25711194,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3722958,https://api.altmetric.com/v1/donut/3722958_240.png 5,HES5 silencing is an early and recurrent change in prostate tumourigenesis,Endocrine-Related Cancer,,,Article,2015-01-05,10.1530/erc-14-0454,,,,25560400,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3041273,https://api.altmetric.com/v1/donut/3041273_240.png 5,Fibre Diffraction Analysis of Skin Offers a Very Early and Extremely Accurate Diagnostic Test for Prostate Cancer,Journal of Cancer Research,,,Article,,10.1155/2014/179608,,,,,,,,,,,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2697787,https://api.altmetric.com/v1/donut/2697787_240.png 5,Sentinel Node Biopsy for Prostate Cancer: A Useless Surgical Exercise?,European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.052,,,,25199716,,,,,,,0,0,0,10,0,0,1,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2661092,https://api.altmetric.com/v1/donut/2661092_240.png 5,"Prostate Capsule Sparing versus Nerve Sparing Radical Cystectomy for Bladder Cancer: Results of a Randomized, Controlled Trial",The Journal of Urology,,,Article,2014-07-23,10.1016/j.juro.2014.07.090,,,,25066875,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2546578,https://api.altmetric.com/v1/donut/2546578_240.png 5,Prostate cancer: an occupational hazard?,Future Oncology,,,Article,2014-06-21,10.2217/fon.14.33,,,,24941975,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2463343,https://api.altmetric.com/v1/donut/2463343_240.png 5,"The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionals",BMC Family Practice,,,Article,2014-05-03,10.1186/1471-2296-15-81,,,,24886169,PMC4020306,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/2322554,https://api.altmetric.com/v1/donut/2322554_240.png 5,Optimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus Panel,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.03.010,,,,24703899,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/2247657,https://api.altmetric.com/v1/donut/2247657_240.png 5,The New Promise of FACBC Position Emission Tomography/Computed Tomography in the Localization of Disease Relapse After Radical Treatment for Prostate Cancer: Are We Turning to the Right Radiotracer?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.053,,,,24094575,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2125110,https://api.altmetric.com/v1/donut/2125110_240.png 5,Prostate cancer incidence in orchidectomised male?to?female transsexual persons treated with oestrogens,International Journal of Clinical Oncology,,,Article,2013-01-01,10.1111/and.12208,,,,24329588,,,,,,,0,0,0,5,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1979024,https://api.altmetric.com/v1/donut/1979024_240.png 5,Targeted Androgen Pathway Suppression in Localized Prostate Cancer: A Pilot Study.,Journal of Clinical Oncology,"SKYHOPPER, Leia",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-12-09,10.1200/jco.2012.48.6431,,,,24323034,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1973238,https://api.altmetric.com/v1/donut/1973238_240.png 5,A longitudinal study of coping strategies in men receiving radiotherapy and neoâ??adjuvant androgen deprivation for prostate cancer: a quantitative and qualitative study,Journal of Advanced Nursing,,,Article,2014-03-01,10.1111/jan.12224,,,,23919321,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1673644,https://api.altmetric.com/v1/donut/1673644_240.png 5,Prostate cancer mortality among Catholic priests.,Journal of Surgical Oncology,,,Article,1981-01-01,,,,,7242091,,,,,,,0,0,0,4,0,0,1,0,0,0,1,0,0,0,1,1,https://www.altmetric.com/details/1280550,https://api.altmetric.com/v1/donut/1280550_240.png 5,Researchers reveal underlying mechanism of powerfulchemotherapy for prostate cancer treatment. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3385-researchers-reveal-underlying-mechanism-of-powerful-chemotherapy-for-prostate-cancer-treatment.php,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250699,https://api.altmetric.com/v1/donut/1250699_240.png 5,Incorporating genomics into breast and prostate cancer screening: assessing the implications,Genetics in Medicine,,,Article,1970-01-01,10.1038/gim.2012.167,,,,23412607,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1241621,https://api.altmetric.com/v1/donut/1241621_240.png 5,Association Between Use of ?-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease.,European Urology,,,Article,2013-01-30,10.1016/j.eururo.2013.01.007,,,,23351721,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1216672,https://api.altmetric.com/v1/donut/1216672_240.png 5,Selective detection of histologically aggressive prostate cancer,Cancer (0008543X),,,Article,2011-10-19,10.1002/cncr.26396,,,,22006057,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/804076,https://api.altmetric.com/v1/donut/804076_240.png 5,Evolution of the clinical presentation of men undergoing radical prostatectomy for high?risk prostate cancer,British Journal of Urology,,,Article,2010-01-01,10.1111/j.1464-410x.2011.10514.x,,,,21880104,,,,,,,0,0,1,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/597761,https://api.altmetric.com/v1/donut/597761_240.png 5,Clinical management and research priorities for high-risk prostate cancer in the UK: Meeting report of a multidisciplinary panel in conjunction with the NCRI Prostate Cancer Clinical Studies Localised Subgroup,Journal of Clinical Urology,,,Article,2016-09-02,10.1177/2051415816651362,,,,,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12190789,https://api.altmetric.com/v1/donut/12190789_240.png 5,"Novel Improved Synthesis of HSP70 Inhibitor, Pifithrin-? in Vitro Synergy Quantification of Pifithrin-? Combined with Pt Drugs in Prostate and Colorectal Cancer Cells",Molecules,,,Article,2016-07-21,10.3390/molecules21070949,,,,27455212,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9918991,https://api.altmetric.com/v1/donut/9918991_240.png 5,The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness,Brachytherapy,,,Article,2016-06-01,10.1016/j.brachy.2016.05.001,,,,27317191,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8860549,https://api.altmetric.com/v1/donut/8860549_240.png 5,Leveraging Outcomes Research to Optimize Prostate Cancer Care,Urology Practice,,,Article,2016-01-01,10.1016/j.urpr.2015.04.001,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5037989,https://api.altmetric.com/v1/donut/5037989_240.png 5,Re: Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study,The Journal of Urology,,,Article,2015-11-20,10.1016/j.juro.2015.09.014,,,,26582666,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/4487577,https://api.altmetric.com/v1/donut/4487577_240.png 5,Systemic therapy in men with metastatic castration-resistant prostate cancer: american society of clinical oncology and cancer care ontario clinical practice guideline summary.,Journal of Oncology Practice,,,Article,,10.1200/jop.2014.001701,,,,25398964,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2892014,https://api.altmetric.com/v1/donut/2892014_240.png 5,Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men.,Clinical Cancer Research,,,Article,2014-07-26,10.1158/1078-0432.ccr-13-2265,,,,25056375,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2751836,https://api.altmetric.com/v1/donut/2751836_240.png 5,A three?protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease,Cancer Medicine,,,Article,2014-06-06,10.1002/cam4.281,,,,24909936,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2425588,https://api.altmetric.com/v1/donut/2425588_240.png 5,A near miss for prostate cancer immunotherapy.,Lancet Oncology,,,Article,2014-05-11,10.1016/s1470-2045(14)70220-7,,,,24831980,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2346127,https://api.altmetric.com/v1/donut/2346127_240.png 5,"Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.",Cancer (0008543X),,,Article,2009-06-20,10.1002/cncr.24429,,,,19536890,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,1,0,0,124,https://www.altmetric.com/details/2302395,https://api.altmetric.com/v1/donut/2302395_240.png 5,Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer,BMJ Open,,,Article,2014-03-01,10.1136/bmjopen-2014-004972,,,,24604487,,11343/51008,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2220757,https://api.altmetric.com/v1/donut/2220757_240.png 5,Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.,Journal of Clinical Oncology,,,Article,2003-05-01,10.1200/jco.2003.09.534,,,,12721238,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1898017,https://api.altmetric.com/v1/donut/1898017_240.png 5,Characteristics of prostate cancer detected by digital rectal examination only.,Urology,,,Article,2007-12-01,10.1016/j.urology.2007.07.019,,,,18158030,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1784098,https://api.altmetric.com/v1/donut/1784098_240.png 5,Prostate-Specific Antigen Velocity Risk Count Predicts Biopsy Reclassification for Men with Very-Low-Risk Prostate Cancer.,The Journal of Urology,,,Article,2013-09-23,10.1016/j.juro.2013.09.029,,,,24060641,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1775591,https://api.altmetric.com/v1/donut/1775591_240.png 5,What are the outcomes of radical prostatectomy for high-risk prostate cancer?,Urology,,,Article,2009-11-27,10.1016/j.urology.2009.09.014,,,,19931898,PMC2889156,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1386743,https://api.altmetric.com/v1/donut/1386743_240.png 5,Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer.,Journal of Medicinal Food,,,Article,2013-04-01,10.1089/jmf.2012.0159,,,,23566060,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1359040,https://api.altmetric.com/v1/donut/1359040_240.png 5,It Takes Two to Talk about Prostate Cancer: A Qualitative Assessment of African-American Men’s and Women’s Cancer Communication Practices and Recommendations,American Journal of Men's Health,,,Article,2012-01-01,10.1177/1557988312453478,,,,22806569,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/984399,https://api.altmetric.com/v1/donut/984399_240.png 5,Prostate cancer incidence in Australia correlates inversely with solar radiation,British Journal of Urology,,,Article,2011-11-01,10.1111/j.1464-410x.2011.10736.x,,,,22085133,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/491900,https://api.altmetric.com/v1/donut/491900_240.png 5,"SPINK1 defines a molecular subtype of prostate cancer in men with more rapid progression in an at-risk, natural history radical prostatectomy cohort",The Journal of Urology,,,Article,2016-05-27,10.1016/j.juro.2016.05.092,,,,27238617,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8323129,https://api.altmetric.com/v1/donut/8323129_240.png 5,Serial Anatomic Prostate Ultrasound Imaging During Prostate Cancer Active Surveillance,The Journal of Urology,,,Article,2016-04-23,10.1016/j.juro.2016.03.179,,,,27117443,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6926623,https://api.altmetric.com/v1/donut/6926623_240.png 5,DIAGNOSTIC GLEASON SCORE AND CASTRATION-RESISTANT PROSTATE CANCER,Annals of Oncology,,,Article,2016-04-18,10.1093/annonc/mdw179,,,,27091809,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6789929,https://api.altmetric.com/v1/donut/6789929_240.png 5,Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer,Trends in Pharmacological Sciences,,,Article,2016-04-07,10.1016/j.tips.2016.03.003,,,,27068431,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6557053,https://api.altmetric.com/v1/donut/6557053_240.png 5,Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10,Journal of Clinical Oncology,,,Article,2015-11-04,10.1200/jco.2015.63.3529,,,,26527774,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4715849,https://api.altmetric.com/v1/donut/4715849_240.png 5,Review of the different treatments and management for prostate cancer and fertility,Urology,,,Article,2015-09-15,10.1016/j.urology.2015.07.010,,,,26368508,,,,,,,0,0,0,4,0,0,2,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4499028,https://api.altmetric.com/v1/donut/4499028_240.png 5,Gynecomastia in Patients with Prostate Cancer: A Systematic Review.,PLoS ONE,,,Article,2015-08-26,10.1371/journal.pone.0136094,,,,26308532,,,,,,,0,0,0,1,0,0,0,1,1,0,1,0,0,0,0,5,https://www.altmetric.com/details/4439452,https://api.altmetric.com/v1/donut/4439452_240.png 5,Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer ,The Journal of Urology,,,Article,2015-06-10,10.1016/j.juro.2015.05.091,,,,26055823,,,,,,,0,0,0,8,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4103442,https://api.altmetric.com/v1/donut/4103442_240.png 5,Pathologic Lymph Node–positive Prostate Cancer: Some Answers … with Many More Questions,European Urology,,,Article,2015-05-25,10.1016/j.eururo.2015.05.002,,,,26003222,,,,,,,0,0,0,10,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4035757,https://api.altmetric.com/v1/donut/4035757_240.png 5,Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study.,European Journal of Cancer (1965),,,Article,2015-03-23,10.1016/j.ejca.2015.03.003,,,,25794605,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,21,https://www.altmetric.com/details/3842686,https://api.altmetric.com/v1/donut/3842686_240.png 5,Sanguinarine Suppresses Prostate Tumor Growth and Inhibits Survivin Expression,Genes & Cancer,,,Article,2011-02-16,10.1177/1947601910368849,,,,21318089,PMC3036540,,,,,,0,0,0,3,0,0,2,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3315273,https://api.altmetric.com/v1/donut/3315273_240.png 5,Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.0908908106,,,,19805354,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3128255,https://api.altmetric.com/v1/donut/3128255_240.png 5,Multiparametric Magnetic Resonance Imaging Enhances Detection of Significant Tumor in Patients on Active Surveillance for Prostate Cancer ,Urology,,,Article,2015-02-01,10.1016/j.urology.2014.09.060,,,,25623709,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3119694,https://api.altmetric.com/v1/donut/3119694_240.png 5,Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading,British Journal of Urology,,,Article,2007-10-29,10.1111/j.1464-410x.2007.07199.x,,,,17979924,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078228,https://api.altmetric.com/v1/donut/3078228_240.png 5,Markers for the Early Detection of Prostate Cancer: Some Principles for Statistical Reporting and Interpretation,Journal of Clinical Oncology,,,Article,2014-11-06,10.1200/jco.2014.58.5547,,,,25366689,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2865383,https://api.altmetric.com/v1/donut/2865383_240.png 5,The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2014-01-21,10.1038/pcan.2013.60,,,,24445948,,,,,,,0,0,0,6,0,0,2,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/2063602,https://api.altmetric.com/v1/donut/2063602_240.png 5,Inflammatory biomarkers and emotional approach coping in men with prostate cancer ,"Brain, Behavior & Immunity",,,Article,2013-05-01,10.1016/j.bbi.2013.04.008,,,,23624266,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1450915,https://api.altmetric.com/v1/donut/1450915_240.png 5,Low-Dose Chemotherapy with Insulin (Insulin Potentiation Therapy) in Combination with Hormone Therapy for Treatment of Castration-Resistant Prostate Cancer,ISRN Urology,,,Article,2012-11-14,10.5402/2012/140182,,,,22649741,,,,,,,0,0,0,2,0,0,4,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1065788,https://api.altmetric.com/v1/donut/1065788_240.png 5,Dual-Phase PET-CT to Differentiate [ 18 F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer,PLoS ONE,,,Article,2012-10-31,10.1371/journal.pone.0048430,,,,23119014,PMC3485217,,,,,,0,0,1,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1034669,https://api.altmetric.com/v1/donut/1034669_240.png 5,Blood-Based Biomarkers of Aggressive Prostate Cancer,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0045802,,,,23071848,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/1006577,https://api.altmetric.com/v1/donut/1006577_240.png 5,"Effect of Naturopathic and Nutritional Supplement Treatment on Tumor Response, Control, and Recurrence in Patients with Prostate Cancer Treated with Radiation Therapy",Journal of Alternative & Complementary Medicine,,,Article,2012-10-04,10.1089/acm.2011.0657,,,,23036139,,,,,,,0,0,0,9,0,0,4,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/983140,https://api.altmetric.com/v1/donut/983140_240.png 5,Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo.,The Prostate,,,Article,2013-01-01,10.1002/pros.22571,,,,22911222,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/898038,https://api.altmetric.com/v1/donut/898038_240.png 5,Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27774,,,,22893105,,,,,,,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/887339,https://api.altmetric.com/v1/donut/887339_240.png 5,"Dietary Fatty Acid Intake and Prostate Cancer Survival in Orebro County, Sweden.",American Journal of Epidemiology,,,Article,2012-01-01,10.1093/aje/kwr520,,,,22781428,,,,,,,0,0,0,6,0,0,3,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/859885,https://api.altmetric.com/v1/donut/859885_240.png 5,Prostate cancer active surveillance and health?related quality of life: results of the Finnish arm of the prospective trial,British Journal of Urology,,,Article,2012-06-01,10.1111/j.1464-410x.2011.10677.x,,,,22044485,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/745824,https://api.altmetric.com/v1/donut/745824_240.png 5,An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer,British Journal of Urology,,,Article,2011-10-01,10.1111/j.1464-410x.2010.09983.x,,,,21446935,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/652010,https://api.altmetric.com/v1/donut/652010_240.png 5,Computer-aided quantitative bone scan assessment of prostate cancer treatment response.,Nuclear Medicine Communications,,,Article,2012-04-01,10.1097/mnm.0b013e3283503ebf,,,,22367858,,,,,,,0,0,1,5,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/629585,https://api.altmetric.com/v1/donut/629585_240.png 5,Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer,Journal of Clinical Oncology,,,Article,2010-12-02,10.1200/jco.2010.31.4252,,,,21115873,PMC3058278,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,68,https://www.altmetric.com/details/542904,https://api.altmetric.com/v1/donut/542904_240.png 5,A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy.,Anti-Cancer Drugs,,,Article,2010-04-01,10.1097/cad.0b013e3283355211,,,,20016365,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,6,https://www.altmetric.com/details/516266,https://api.altmetric.com/v1/donut/516266_240.png 5,Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy,The Prostate,,,Article,2011-12-15,10.1002/pros.22467,,,,22161896,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/484693,https://api.altmetric.com/v1/donut/484693_240.png 5,Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.,JNCI: Journal of the National Cancer Institute,,,Article,2007-09-19,10.1093/jnci/djm119,,,,17848671,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/211989,https://api.altmetric.com/v1/donut/211989_240.png 5,MRI Underestimation of Prostate Cancer Geometry: Use of Patient-Specific Molds to Correlate Images with Whole-Mount Pathology,The Journal of Urology,,,Article,2016-07-30,10.1016/j.juro.2016.07.084,,,,27484386,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/10139482,https://api.altmetric.com/v1/donut/10139482_240.png 5,Re: Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker with Outcomes and Survival in Castration-Resistant Prostate Cancer,The Journal of Urology,,,Article,2016-07-18,10.1016/j.juro.2016.07.066,,,,27628794,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10128073,https://api.altmetric.com/v1/donut/10128073_240.png 5,Implementation of a patient decision aid for men with localized prostate cancer: evaluation of patient outcomes and practice variation,Implementation Science,,,Article,2016-07-02,10.1186/s13012-016-0451-1,,,,27368830,PMC4930601,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9205803,https://api.altmetric.com/v1/donut/9205803_240.png 5,Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells,Heliyon,,,Article,2016-04-05,10.1016/j.heliyon.2016.e00104,,,,27441277,PMC4946174,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7158663,https://api.altmetric.com/v1/donut/7158663_240.png 5,Re: Nine-Year Follow-up for a Study of Diffusion-Weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort,The Journal of Urology,,,Article,2016-03-16,10.1016/j.juro.2016.03.059,,,,27191070,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6202348,https://api.altmetric.com/v1/donut/6202348_240.png 5,Re: DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer,The Journal of Urology,,,Article,2016-01-01,10.1016/j.juro.2016.01.052,,,,27302781,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5029090,https://api.altmetric.com/v1/donut/5029090_240.png 5,Impact of Prostate Cancer Treatment on the Sexual Quality of Life for Men-Who-Have-Sex-with-Men.,Journal of Sexual Medicine,,,Article,2015-11-01,10.1111/jsm.13030,,,,26537853,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4726595,https://api.altmetric.com/v1/donut/4726595_240.png 5,"Re: High-Dose Radiotherapy with Short-Term or Long-Term Androgen Deprivation in Localised Prostate Cancer (DART01/05 GICOR): A Randomised, Controlled, Phase 3 Trial",The Journal of Urology,,,Article,2015-09-19,10.1016/j.juro.2015.07.009,,,,26382776,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/4258219,https://api.altmetric.com/v1/donut/4258219_240.png 5,Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events,Annals of Oncology,,,Article,2015-06-01,10.1093/annonc/mdv155,,,,26003617,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4054105,https://api.altmetric.com/v1/donut/4054105_240.png 5,Re: Intense Androgen-Deprivation Therapy with Abiraterone Acetate plus Leuprolide Acetate in Patients with Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study,The Journal of Urology,,,Article,2015-01-06,10.1016/j.juro.2015.03.046,,,,25986794,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3789462,https://api.altmetric.com/v1/donut/3789462_240.png 5,Guideline-Discordant Use of Imaging During Work-Up of Newly Diagnosed Prostate Cancer.,Journal of Oncology Practice,,,Article,2015-02-10,10.1200/jop.2014.001818,,,,25670199,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3552980,https://api.altmetric.com/v1/donut/3552980_240.png 5,Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs,European Journal of Cancer Care,,,Article,2015-01-29,10.1111/ecc.12286,,,,25630851,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3217214,https://api.altmetric.com/v1/donut/3217214_240.png 5,Re: Overdiagnosis and Overtreatment of Prostate Cancer,The Journal of Urology,,,Article,2014-01-10,10.1016/j.juro.2014.07.069,,,,25304554,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2685409,https://api.altmetric.com/v1/donut/2685409_240.png 5,Analysis of regional Bone Scan Index measurements for the survival of patients with prostate cancer,BMC Medical Imaging,,,Article,2014-07-10,10.1186/1471-2342-14-24,,,,25012268,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2512526,https://api.altmetric.com/v1/donut/2512526_240.png 5,Degarelix as an Intermittent Androgen Deprivation Therapy for One or More Treatment Cycles in Patients with Prostate Cancer,European Urology,,,Article,,10.1016/j.eururo.2014.05.037,,,,24954791,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2448716,https://api.altmetric.com/v1/donut/2448716_240.png 5,Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing?risks analysis,British Journal of Urology,,,Article,2014-07-15,10.1111/bju.12645,,,,24467651,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2075829,https://api.altmetric.com/v1/donut/2075829_240.png 5,"Use of Bone Scan During Initial Prostate Cancer Workup, Downstream Procedures, and Associated Medicare Costs","International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-12-09,10.1016/j.ijrobp.2013.10.023,,,,24321784,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1968627,https://api.altmetric.com/v1/donut/1968627_240.png 5,Stereotactic Body Radiotherapy in Prostate Cancer: Is Rapidarc a Better Solution than Cyberknife?,Clinical Oncology,,,Article,2013-09-01,10.1016/j.clon.2013.08.008,,,,24071450,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1778557,https://api.altmetric.com/v1/donut/1778557_240.png 5,Prostate Cancer Localization Using Multiparametric MR Imaging: Comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert Scales,Radiology,,,Article,2013-01-01,10.1148/radiol.13122233,,,,23788719,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/1625722,https://api.altmetric.com/v1/donut/1625722_240.png 5,Genetic abnormalities in benign or malignant tissues predictrelapse of prostate cancer. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/2821-genetic-abnormalities-in-benign-or-malignant-tissues-predict-relapse-of-prostate-cancer.php,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251356,https://api.altmetric.com/v1/donut/1251356_240.png 5,"Fewer complications, better outcomes with robot-assisted prostate cancer surgery",ecancer.org,,,Article,,,,,http://ecancer.org/news/2755-fewer-complications--better-outcomes-with-robot-assisted-prostate-cancer-surgery.php,,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251258,https://api.altmetric.com/v1/donut/1251258_240.png 5,CYP17 inhibitors in prostate cancer: latest evidence and clinical potential,Therapeutic Advances in Medical Oncology,,,Article,2016-07-01,10.1177/1758834016642370,,,,27482286,PMC4952018,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10266495,https://api.altmetric.com/v1/donut/10266495_240.png 5,Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer,Medical Oncology,,,Article,2016-06-14,10.1007/s12032-016-0793-1,,,,27300548,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8819790,https://api.altmetric.com/v1/donut/8819790_240.png 5,Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer,Urology Annals,,,Article,2016-04-01,10.4103/0974-7796.176872,,,,27141178,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7171304,https://api.altmetric.com/v1/donut/7171304_240.png 5,Determinants of participation in prostate cancer screening: A simple analytical framework to account for healthy?user bias,Cancer Science,,,Article,2014-12-03,10.1111/cas.12561,,,,25456306,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2947518,https://api.altmetric.com/v1/donut/2947518_240.png 5,Silibinin Up-Regulates Insulin-like Growth Factor-Binding Protein 3 Expression and Inhibits Proliferation of Androgen-independent Prostate Cancer Cells,Cancer Research,,,Article,2000-01-01,,,,,11059749,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2342835,https://api.altmetric.com/v1/donut/2342835_240.png 5,Costs of Radical Prostatectomy for Prostate Cancer: A Systematic Review,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2012.08.059,,,,22981673,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2124892,https://api.altmetric.com/v1/donut/2124892_240.png 5,"Re: Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer",The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.08.075,,,,23141230,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1062929,https://api.altmetric.com/v1/donut/1062929_240.png 5,Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancer.,Cancer Biology and Therapy,,,Article,2004-09-01,,,,,15254411,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/446417,https://api.altmetric.com/v1/donut/446417_240.png 5,Making decisions for treating prostate cancer . . . and other stories,British Medical Journal,,,Article,2016-09-08,10.1136/bmj.i4750,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11905208,https://api.altmetric.com/v1/donut/11905208_240.png 5,"Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer",European Urology,,,Article,2016-09-03,10.1016/j.eururo.2016.08.047,,,,27597241,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11672138,https://api.altmetric.com/v1/donut/11672138_240.png 5,Prostate-specific antigen and prostate cancer in Chinese men undergoing initial prostate biopsies in comparison with Western cohorts: data from the PBCG and CPCC,The Journal of Urology,,,Article,2016-09-07,10.1016/j.juro.2016.08.103,,,,27593477,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10993623,https://api.altmetric.com/v1/donut/10993623_240.png 5,A Whole Blood Assay for AR-V7 and ARv567es in Prostate Cancer Patients,The Journal of Urology,,,Article,2016-07-20,10.1016/j.juro.2016.06.095,,,,27449259,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10121920,https://api.altmetric.com/v1/donut/10121920_240.png 5,Expression of STAT3 in Prostate Cancer Metastases,European Urology,,,Article,2016-06-23,10.1016/j.eururo.2016.06.018,,,,27344294,,,,,,,0,0,0,14,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8983151,https://api.altmetric.com/v1/donut/8983151_240.png 5,Outcomes of Scheduled Versus For-Cause Biopsy Regimens for Prostate Cancer Active Surveillance,The Journal of Urology,,,Article,2016-05-05,10.1016/j.juro.2016.05.003,,,,27157375,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7219445,https://api.altmetric.com/v1/donut/7219445_240.png 5,Re: Prostate Cancer Detection with Magnetic Resonance-Ultrasound Fusion Biopsy: The Role of Systematic and Targeted Biopsies,The Journal of Urology,,,Article,2016-04-14,10.1016/j.juro.2016.04.039,,,,27321501,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6726980,https://api.altmetric.com/v1/donut/6726980_240.png 5,"As Smoking Declined, So Too Did Prostate Cancer Mortality",Journal Watch,,,Article,2016-04-15,10.1056/nejm-jw.fw111447,,,,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6724038,https://api.altmetric.com/v1/donut/6724038_240.png 5,Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer,European Urology Focus ,,,Article,2016-03-19,10.1016/j.euf.2016.02.018,,,,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6233573,https://api.altmetric.com/v1/donut/6233573_240.png 5,Prostate cancer: Personalized risk [mdash] stratified screening or abandoning it altogether?,Nature Reviews Clinical Oncology,,,Article,2016-02-02,10.1038/nrclinonc.2016.11,,,,26831183,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5076958,https://api.altmetric.com/v1/donut/5076958_240.png 5,Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating,PLoS ONE,,,Article,2015-12-15,10.1371/journal.pone.0145016,,,,26671576,PMC4679176,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4885975,https://api.altmetric.com/v1/donut/4885975_240.png 5,Network analysis of an in vitro model of androgen-resistance in prostate cancer,BMC Cancer,,,Article,2015-11-10,10.1186/s12885-015-1884-7,,,,26553226,,11343/57412,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4743712,https://api.altmetric.com/v1/donut/4743712_240.png 5,Presence of Magnetic Resonance Imaging Suspicious Lesion Predicts Gleason 7 or Greater Prostate Cancer in Biopsy-Naive Patients,Urology,,,Article,2015-11-08,10.1016/j.urology.2015.10.023,,,,26545849,,,,,,,0,0,0,7,0,0,3,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4725308,https://api.altmetric.com/v1/donut/4725308_240.png 5,Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2015-10-27,10.1038/pcan.2015.48,,,,26503110,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4680354,https://api.altmetric.com/v1/donut/4680354_240.png 5,Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis,OncoTargets and therapy,,,Article,2015-10-05,10.2147/ott.s89769,,,,26491356,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4598315,https://api.altmetric.com/v1/donut/4598315_240.png 5,Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review,European Urology,,,Article,2015-09-20,10.1016/j.eururo.2015.09.005,,,,26391636,,,,,,,0,0,0,9,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4534360,https://api.altmetric.com/v1/donut/4534360_240.png 5,Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance,Reports of Practical Oncology & Radiotherapy,,,Article,2015-06-26,10.1016/j.rpor.2015.04.003,,,,26109913,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4080972,https://api.altmetric.com/v1/donut/4080972_240.png 5,Dietary Carbohydrate and Prostate Cancer Risk: A Meta-Analysis.,Nutrition and Cancer,,,Article,,10.1080/01635581.2015.1019639,,,,25875159,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3943715,https://api.altmetric.com/v1/donut/3943715_240.png 5,Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.,Cancer (0008543X),,,Article,2015-04-02,10.1002/cncr.29362,,,,25847819,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3889433,https://api.altmetric.com/v1/donut/3889433_240.png 5,Making Progress on Progression in Metastatic Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-02-09,10.1200/jco.2014.59.4283,,,,25667271,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3526560,https://api.altmetric.com/v1/donut/3526560_240.png 5,Quantifying Observational Evidence for Risk of Fatal and Nonfatal Cardiovascular Disease Following Androgen Deprivation Therapy for Prostate Cancer: A Meta-analysis,European Urology,,,Article,2014-12-05,10.1016/j.eururo.2014.11.039,,,,25484142,,,,,,,0,0,0,8,0,0,2,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/2953130,https://api.altmetric.com/v1/donut/2953130_240.png 5,Combining Immunotherapy and Radiation for Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2015-01-02,10.1016/j.clgc.2014.09.001,,,,25450032,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2949082,https://api.altmetric.com/v1/donut/2949082_240.png 5,Clinical Management of Prostate Cancer in Men with BRCA Mutations,European Urology,,,Article,2015-08-01,10.1016/j.eururo.2014.11.005,,,,25465969,,,,,,,0,0,0,9,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2892637,https://api.altmetric.com/v1/donut/2892637_240.png 5,Bone Turnover Markers and Prostate Cancer: Not Just a Measure of Bone Disease?,European Urology,,,Article,2014-11-11,10.1016/j.eururo.2014.10.041,,,,25466938,,,,,,,0,0,0,8,0,0,2,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2878494,https://api.altmetric.com/v1/donut/2878494_240.png 5,Regarding Relative Toxicities of Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.56.5572,,,,25185083,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2787501,https://api.altmetric.com/v1/donut/2787501_240.png 5,Weighted Versus Unweighted Charlson Score to Predict Long-term Other-cause Mortality in Men with Early-stage Prostate Cancer.,European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.05.029,,,,24924554,,,,,,,0,0,0,11,0,0,0,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/2465842,https://api.altmetric.com/v1/donut/2465842_240.png 5,Omega-3 and Prostate Cancer: Examining the Pertinent Evidence.,Mayo Clinic Proceedings,,,Article,,10.1016/j.mayocp.2013.10.029,,,,24613035,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2174715,https://api.altmetric.com/v1/donut/2174715_240.png 5,Maintaining and reprogramming genomic androgen receptor activity in prostate cancer,Nature Reviews Cancer,,,Article,2014-02-24,10.1038/nrc3678,,,,24561445,,,,,,,0,0,0,8,0,0,0,0,1,0,0,0,0,0,0,93,https://www.altmetric.com/details/2141131,https://api.altmetric.com/v1/donut/2141131_240.png 5,Nomogram to determine individualized estimates of screen-detected prostate cancer overdiagnosis,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dju001,,,,,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2034904,https://api.altmetric.com/v1/donut/2034904_240.png 5,Risk of Gleason Grade Inaccuracies in Prostate Cancer Patients Eligible for Active Surveillance,Urology,,,Article,2012-08-30,10.1016/j.urology.2012.06.022,,,,22925240,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1658302,https://api.altmetric.com/v1/donut/1658302_240.png 5,Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy,PLoS ONE,,,Article,2013-06-24,10.1371/journal.pone.0066855,,,,23826159,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,82,https://www.altmetric.com/details/1586471,https://api.altmetric.com/v1/donut/1586471_240.png 5,"Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer",PLoS ONE,,,Article,2012-10-13,10.1371/journal.pone.0045539,,,,23056207,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1335749,https://api.altmetric.com/v1/donut/1335749_240.png 5,The Impact of PSA Screening on Prostate Cancer Mortality and Overdiagnosis of Prostate Cancer in the United States,Journals of Gerontology Series A: Biological Sciences & Medical Sciences,,,Article,2012-01-01,10.1093/gerona/gls135,,,,22562961,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/1153593,https://api.altmetric.com/v1/donut/1153593_240.png 5,Functional p53 determines docetaxel sensitivity in prostate cancer cells,The Prostate,,,Article,2013-01-01,10.1002/pros.22583,,,,22996738,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/971804,https://api.altmetric.com/v1/donut/971804_240.png 5,Using age?referenced prostate?specific antigen percentile to predict survival outcomes in screened Taiwanese men,International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.27842,,,,22987331,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/947010,https://api.altmetric.com/v1/donut/947010_240.png 5,Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract,International Journal of Cancer,,,Article,2011-05-07,10.1002/ijc.26168,,,,21544815,,,,,,,0,0,0,2,0,0,0,0,4,0,0,0,0,0,0,27,https://www.altmetric.com/details/912903,https://api.altmetric.com/v1/donut/912903_240.png 5,Prostate cancer screening.,Pathology,,,Article,2012-02-01,10.1097/pat.0b013e32834fbb2c,,,,22198258,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/588685,https://api.altmetric.com/v1/donut/588685_240.png 5,Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-06-17,10.1007/s00259-016-3439-9,,,,27317482,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8881295,https://api.altmetric.com/v1/donut/8881295_240.png 5,Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts,JNCI: Journal of the National Cancer Institute,,,Article,2016-07-10,10.1093/jnci/djm231,,,,18042933,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3206169,https://api.altmetric.com/v1/donut/3206169_240.png 5,Re: Are Elderly Patients with Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.01.058,,,,25890513,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3083763,https://api.altmetric.com/v1/donut/3083763_240.png 5,"Re: Effect of Radium-223 Dichloride on Symptomatic Skeletal Events in Patients with Castration-Resistant Prostate Cancer and Bone Metastases: Results from a Phase 3, Double-Blind, Randomised Trial",The Journal of Urology,,,Article,,10.1016/j.juro.2014.12.077,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2997558,https://api.altmetric.com/v1/donut/2997558_240.png 5,Rb Loss is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1982,,,,24323898,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1968987,https://api.altmetric.com/v1/donut/1968987_240.png 5,Early Docetaxel Plus Androgen-Deprivation Therapy Improves Survival in Metastatic Prostate Cancer,Journal Watch,,,Article,2013-12-09,10.1056/nejm-jw.fw108234,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1965207,https://api.altmetric.com/v1/donut/1965207_240.png 5,Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity,Cancer (0008543X),,,Article,2013-05-03,10.1002/cncr.28128,,,,23633434,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1451581,https://api.altmetric.com/v1/donut/1451581_240.png 5,Feasibility of Presurgical Exercise in Men With Prostate Cancer Undergoing Prostatectomy,Integrative Cancer Therapies,,,Article,2016-09-01,10.1177/1534735416666373,,,,27585629,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11678998,https://api.altmetric.com/v1/donut/11678998_240.png 5,DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities,Oncologist,,,Article,2016-06-17,10.1634/theoncologist.2016-0135,,,,27317574,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8881422,https://api.altmetric.com/v1/donut/8881422_240.png 5,Outcome of Gleason 3+5=8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4+4=8,The Journal of Urology,,,Article,2016-06-02,10.1016/j.juro.2016.05.105,,,,27265220,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8448900,https://api.altmetric.com/v1/donut/8448900_240.png 5,Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancer,British Journal of Urology,,,Article,2016-04-01,10.1111/bju.13482,,,,26991743,,,,,,,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6917556,https://api.altmetric.com/v1/donut/6917556_240.png 5,Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-04-18,10.1007/s00259-016-3383-8,,,,27091135,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6833550,https://api.altmetric.com/v1/donut/6833550_240.png 5,Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment,Radiation Oncology,,,Article,2016-03-11,10.1186/s13014-016-0615-9,,,,26968955,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6168456,https://api.altmetric.com/v1/donut/6168456_240.png 5,Low other cause mortality rates reflect good patient selection in prostate cancer patients treated with radical prostatectomy,The Journal of Urology,,,Article,2016-02-26,10.1016/j.juro.2016.01.122,,,,26925872,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6011389,https://api.altmetric.com/v1/donut/6011389_240.png 5,When to Start Prostate Cancer Screening and When to Stop: Insights from Göteborg,The Journal of Urology,,,Article,2016-02-18,10.1016/j.juro.2016.02.079,,,,26901508,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5635352,https://api.altmetric.com/v1/donut/5635352_240.png 5,The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients,European Urology,,,Article,2016-01-01,10.1016/j.eururo.2015.12.010,,,,26749093,,,,,,,0,0,0,10,0,0,4,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4942895,https://api.altmetric.com/v1/donut/4942895_240.png 5,"Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)",The Journal of Urology,,,Article,2015-11-04,10.1016/j.juro.2015.10.165,,,,26852973,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4725758,https://api.altmetric.com/v1/donut/4725758_240.png 5,Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies,American journal of clinical and experimental urology,,,Article,2015-01-01,,,,,26309896,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/4465486,https://api.altmetric.com/v1/donut/4465486_240.png 5,Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer,Clinical Cancer Research,,,Article,2015-05-23,10.1158/1078-0432.ccr-15-0269,,,,25995342,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4037332,https://api.altmetric.com/v1/donut/4037332_240.png 5,Role of (64)CuCl 2 PET/CT in staging of prostate cancer.,Annals of Nuclear Medicine,,,Article,2015-04-04,10.1007/s12149-015-0968-4,,,,25833290,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3876859,https://api.altmetric.com/v1/donut/3876859_240.png 5,Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer.,Cancer Research,,,Article,2015-02-03,10.1158/0008-5472.can-14-3080,,,,25649766,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3359888,https://api.altmetric.com/v1/donut/3359888_240.png 5,Physiology and Endocrinology of Hot Flashes in Prostate Cancer,American Journal of Men's Health,,,Article,2007-03-15,10.1177/1557988306294162,,,,19482779,,,,,,,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3229479,https://api.altmetric.com/v1/donut/3229479_240.png 5,The Next Generation of Clinical Decision-Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape.,The Journal of Urology,,,Article,2015-01-27,10.1016/j.juro.2015.01.092,,,,25636656,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3109969,https://api.altmetric.com/v1/donut/3109969_240.png 5,CYP17A1 inhibitors in castration-resistant prostate cancer.,Steroids,,,Article,2015-01-03,10.1016/j.steroids.2014.12.021,,,,25560485,,,,,,,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3045594,https://api.altmetric.com/v1/donut/3045594_240.png 5,Home - PA Prostate Cancer Coalition,paprostatecancer.org,,,Article,,,,,http://paprostatecancer.org/,,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2757308,https://api.altmetric.com/v1/donut/2757308_240.png 5,Stereotactic body radiotherapy for primary prostate cancer: A systematic review.,Journal of Medical Imaging & Radiation Oncology,,,Article,2014-08-25,10.1111/1754-9485.12213,,,,25155286,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2626990,https://api.altmetric.com/v1/donut/2626990_240.png 5,Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.,British Journal of Urology,,,Article,2015-03-07,10.1111/bju.12874,,,,25053197,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2531733,https://api.altmetric.com/v1/donut/2531733_240.png 5,PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation.,Tumor Biology,,,Article,2014-03-16,10.1007/s13277-014-1818-z,,,,24627133,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2238680,https://api.altmetric.com/v1/donut/2238680_240.png 5,"Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial",Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70479-0,,,,24211163,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/1891069,https://api.altmetric.com/v1/donut/1891069_240.png 5,Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies.,Prostate Cancer & Prostatic Diseases,,,Article,2013-08-20,10.1038/pcan.2013.27,,,,23958895,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1722366,https://api.altmetric.com/v1/donut/1722366_240.png 5,mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer,PLoS ONE,,,Article,2012-11-07,10.1371/journal.pone.0049144,,,,23145101,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/1055566,https://api.altmetric.com/v1/donut/1055566_240.png 5,Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.,Translational Oncology,,,Article,2012-10-01,,,,,23066443,,,,,,,0,0,0,6,0,0,4,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1005404,https://api.altmetric.com/v1/donut/1005404_240.png 5,Accuracy of Primary Systematic Template Guided Transperineal Biopsy of the Prostate for Locating Prostate Cancer: A Comparison With Radical Prostatectomy Specimens,The Journal of Urology,,,Article,2012-04-12,10.1016/j.juro.2012.01.066,,,,22498226,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/694210,https://api.altmetric.com/v1/donut/694210_240.png 5,Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer.,Journal of Nutrition,,,Article,2007-10-01,,,,,17885008,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,1,14,https://www.altmetric.com/details/629346,https://api.altmetric.com/v1/donut/629346_240.png 5,A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance.,European Urology,,,Article,2009-12-01,10.1016/j.eururo.2008.11.051,,,,19095345,,,,,,,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,33,https://www.altmetric.com/details/527814,https://api.altmetric.com/v1/donut/527814_240.png 5,Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer.,Clinical Nuclear Medicine,,,Article,2011-10-01,10.1097/rlu.0b013e318219ae29,,,,21892036,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/443908,https://api.altmetric.com/v1/donut/443908_240.png 5,Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery,British Journal of Urology,,,Article,2011-11-01,10.1111/j.1464-410x.2011.10169.x,,,,21443651,PMC3163799,,,,,,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/432655,https://api.altmetric.com/v1/donut/432655_240.png 5,Prediction of pathological outcomes for a single microfocal (?3?mm) Gleason 6 prostate cancer detected via contemporary multicore (?12) biopsy in men with prostate?specific antigen ?10?ng/mL,British Journal of Urology,,,Article,2011-10-01,10.1111/j.1464-410x.2010.09996.x,,,,21199287,,,,,,,0,0,2,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/406901,https://api.altmetric.com/v1/donut/406901_240.png 5,Optimal prostate-specific antigen screening interval for prostate cancer,Annals of Oncology,,,Article,2011-09-23,10.1093/annonc/mdr413,,,,21948815,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/387515,https://api.altmetric.com/v1/donut/387515_240.png 5,The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls,BMC Cancer,,,Article,2011-09-13,10.1186/1471-2407-11-391,,,,21914193,,,,,,,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/261490,https://api.altmetric.com/v1/donut/261490_240.png 5,The use of PCA3 in the diagnosis of prostate cancer.,Nature reviews. Urology,,,Article,2009-05-01,10.1038/nrurol.2009.40,,,,19424173,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,64,https://www.altmetric.com/details/233844,https://api.altmetric.com/v1/donut/233844_240.png 5,PET and PET/CT in radiation treatment planning for prostate cancer,Expert Review of Anticancer Therapy,,,Article,2011-07-01,10.1586/era.11.51,,,,21806327,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/204270,https://api.altmetric.com/v1/donut/204270_240.png 5,Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer,BMC Cancer,,,Article,2011-07-27,10.1186/1471-2407-11-317,,,,21791109,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/202429,https://api.altmetric.com/v1/donut/202429_240.png 5,Re: Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk,The Journal of Urology,,,Article,2016-07-14,10.1016/j.juro.2016.07.026,,,,27628796,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10128897,https://api.altmetric.com/v1/donut/10128897_240.png 5,Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging–DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score,American Journal of Roentgenology,,,Article,2016-06-28,10.2214/ajr.15.15626,,,,27352026,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9120446,https://api.altmetric.com/v1/donut/9120446_240.png 5,The role of mindfulness in distress and quality of life for men with advanced prostate cancer,Quality of Life Research,,,Article,2016-06-17,10.1007/s11136-016-1341-3,,,,27315118,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8889955,https://api.altmetric.com/v1/donut/8889955_240.png 5,Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer,Nature Communications,,,Article,2016-04-25,10.1038/ncomms11418,,,,27108958,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6965186,https://api.altmetric.com/v1/donut/6965186_240.png 5,Re: Medium-Term Outcomes after Whole-Gland High-Intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort,The Journal of Urology,,,Article,2016-04-14,10.1016/j.juro.2016.04.041,,,,27321502,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6726978,https://api.altmetric.com/v1/donut/6726978_240.png 5,Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study,Annals of Oncology,,,Article,2016-03-01,10.1093/annonc/mdv607,,,,26681677,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6019179,https://api.altmetric.com/v1/donut/6019179_240.png 5,PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases ,Advances in Medical Sciences,,,Article,2016-09-01,10.1016/j.advms.2016.01.003,,,,26895459,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5628426,https://api.altmetric.com/v1/donut/5628426_240.png 5,Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate specific antigen (PSA): a meta?analysis,British Journal of Urology,,,Article,2016-01-01,10.1111/bju.13417,,,,26779889,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/5011406,https://api.altmetric.com/v1/donut/5011406_240.png 5,The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.,Clinical Cancer Research,,,Article,2015-12-17,10.1158/1078-0432.ccr-15-0137,,,,26671992,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4884126,https://api.altmetric.com/v1/donut/4884126_240.png 5,Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy,Nature Reviews Urology,,,Article,2015-12-08,10.1038/nrurol.2015.254,,,,26643568,,,,,,,0,0,0,9,0,0,6,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4852707,https://api.altmetric.com/v1/donut/4852707_240.png 5,Perception and satisfaction with the information received during the medical care process in patients with prostate cancer.,Actas Urológicas Españolas,,,Article,2016-03-01,10.1016/j.acuro.2015.08.008,,,,26548516,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4752528,https://api.altmetric.com/v1/donut/4752528_240.png 5,Personalising the treatment of prostate cancer ,Lancet Oncology,,,Article,2015-11-10,10.1016/s1470-2045(15)00474-x,,,,26549591,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4732914,https://api.altmetric.com/v1/donut/4732914_240.png 5,Health-Related Quality of Life and Efficacy Outcomes of Cs-131 Brachytherapy in Combination With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-11,10.1016/j.ijrobp.2015.07.1130,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4680061,https://api.altmetric.com/v1/donut/4680061_240.png 5,"Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.",The Prostate,,,Article,2015-10-01,10.1002/pros.23107,,,,26477609,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4648053,https://api.altmetric.com/v1/donut/4648053_240.png 5,Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.,Nature Communications,,,Article,2015-10-07,10.1038/ncomms9469,,,,26443449,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4600988,https://api.altmetric.com/v1/donut/4600988_240.png 5,Re: Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy,The Journal of Urology,,,Article,2015-10-20,10.1016/j.juro.2015.08.057,,,,26478030,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4398733,https://api.altmetric.com/v1/donut/4398733_240.png 5,Risk of prostate cancer in African?American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status,The Prostate,,,Article,2015-06-05,10.1002/pros.23018,,,,26047130,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4130225,https://api.altmetric.com/v1/donut/4130225_240.png 5,PROSTATIC CANCER TREATED BY ORCHIECTOMY: THE FIVE YEAR RESULTS,Journal of the American Medical Association,,,Article,,10.1001/jama.1946.02870240008003,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3102829,https://api.altmetric.com/v1/donut/3102829_240.png 5,Criteria used for the active surveillance of localised prostate cancer in the UK,Journal of Clinical Urology,,,Article,2014-05-22,10.1177/2051415814534233,,,,,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3101747,https://api.altmetric.com/v1/donut/3101747_240.png 5,PSA testing beneficial for prostate cancer,Lancet Oncology,,,Article,2014-08-15,10.1016/s1470-2045(14)70385-7,,,,24602760,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,76,https://www.altmetric.com/details/2603442,https://api.altmetric.com/v1/donut/2603442_240.png 5,Identification of threshold prostate-specific antigen levels to optimize the detection of clinically-significant prostate cancer by MRI/US fusion guided biopsy.,The Journal of Urology,,,Article,2014-08-16,10.1016/j.juro.2014.08.002,,,,25117476,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2599088,https://api.altmetric.com/v1/donut/2599088_240.png 5,Risk of fracture after androgen deprivation for prostate cancer.,New England Journal of Medicine,,,Article,1970-01-01,10.1056/nejmoa041943,,,,15647578,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/2451258,https://api.altmetric.com/v1/donut/2451258_240.png 5,Multiparametric magnetic resonance imaging (MRI) and active surveillance for prostate cancer: future directions,British Journal of Urology,,,Article,2014-06-06,10.1111/bju.12473,,,,24905655,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2431676,https://api.altmetric.com/v1/donut/2431676_240.png 5,Prostate MRI: Evaluating Tumor Volume and Apparent Diffusion Coefficient as Surrogate Biomarkers for Predicting Tumor Gleason Score,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-14-0044,,,,24850842,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2371382,https://api.altmetric.com/v1/donut/2371382_240.png 5,The impact of prostate cancer on partners: a qualitative exploration,Psycho-Oncology,,,Article,2014-04-24,10.1002/pon.3552,,,,24764291,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2317891,https://api.altmetric.com/v1/donut/2317891_240.png 5,HIFU for prostate cancer – a nursing perspective,International Journal of Urological Nursing,,,Article,2014-04-22,10.1111/ijun.12039,,,,,,,,,,,0,0,0,7,0,0,3,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2297013,https://api.altmetric.com/v1/donut/2297013_240.png 5,Dietary Patterns and Prostate Cancer Risk: Report from the Population Based ULSAM Cohort Study of Swedish Men.,Nutrition and Cancer,,,Article,2013-12-10,10.1080/01635581.2014.851712,,,,24325263,,,,,,,0,0,0,4,0,0,5,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1978841,https://api.altmetric.com/v1/donut/1978841_240.png 5,T2?weighted prostate MRI at 7 tesla using a simplified external transmit?receive coil array: Correlation with radical prostatectomy findings in two prostate cancer patients,Journal of Magnetic Resonance Imaging,,,Article,2013-01-01,10.1002/jmri.24511,,,,24259458,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1953008,https://api.altmetric.com/v1/donut/1953008_240.png 5,NCRI 2013: Prostate cancer test can spot the difference between aggressive and slow-growing tumours,ecancer.org,,,Article,,,,,http://ecancer.org/news/4711-ncri-2013--prostate-cancer-test-can-spot-the-difference-between-aggressive-and-slow-growing-tumours.php,,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1884202,https://api.altmetric.com/v1/donut/1884202_240.png 5,"Finasteride Lowers Risk for Prostate Cancer, But Offers No Mortality Advantage",NEJM Journal Watch,,,Article,,10.1056/nejm-jw.fw107791,,,,,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1689328,https://api.altmetric.com/v1/donut/1689328_240.png 5,Delivering highâ??quality care to prostate cancer survivors,Cancer (0008543X),,,Article,2006-01-01,10.1002/cncr.28236,,,,23893779,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1645367,https://api.altmetric.com/v1/donut/1645367_240.png 5,Randomized Controlled Trial of a Behavior Change Intervention to Increase Physical Activity and Quality of Life in Prostate Cancer Survivors,Annals of Behavioral Medicine,,,Article,2013-06-20,10.1007/s12160-013-9519-1,,,,23783829,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1598920,https://api.altmetric.com/v1/donut/1598920_240.png 5,A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer ,Biomaterials,,,Article,2013-04-10,10.1016/j.biomaterials.2013.03.005,,,,23562048,,,,,,,0,0,0,6,0,0,3,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1500556,https://api.altmetric.com/v1/donut/1500556_240.png 5,Molecular Archeology: Unearthing Androgen-Induced Structural Rearrangements in Prostate Cancer Genomes,Cancer Cell,,,Article,2013-01-01,10.1016/j.ccr.2013.01.019,,,,23410968,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1233174,https://api.altmetric.com/v1/donut/1233174_240.png 5,New Agents for the Management of Castration-Resistant Prostate Cancer (November),Annals of Pharmacotherapy,,,Article,2012-01-01,10.1345/aph.1r169,,,,23136351,,,,,,,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/1055227,https://api.altmetric.com/v1/donut/1055227_240.png 5,"Identification and characterization of MEL-3, a novel androgen receptor antagonist that suppresses prostate cancer cell growth",Molecular Cancer Therapeutics,,,Article,2012-01-01,10.1158/1535-7163.mct-11-0763,,,,22496481,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/691567,https://api.altmetric.com/v1/donut/691567_240.png 5,Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy.,Anti-Cancer Drugs,,,Article,2011-12-31,10.1097/cad.0b013e32834fd01f,,,,22205155,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/571436,https://api.altmetric.com/v1/donut/571436_240.png 5,Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2010-06-01,10.1200/jco.2009.27.3003,,,,20421534,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/211931,https://api.altmetric.com/v1/donut/211931_240.png 5,Management of Localized Prostate Cancer: Data at Last,Journal Watch,,,Article,2016-09-19,10.1056/nejm-jw.na42342,,,,,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12099570,https://api.altmetric.com/v1/donut/12099570_240.png 5,Treatment options in castration-resistant prostate cancer: Expert discussion. ESMO 2014,ecancer.org,,,Article,,,,,http://ecancer.org/conference/500-esmo-2014/video/3104/treatment-options-in-castration-resistant-prostate-cancer--expert-discussion.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2728366,https://api.altmetric.com/v1/donut/2728366_240.png 5,Plasma Antibodies against Trichomonas vaginalis and Subsequent Risk of Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2006-01-01,10.1158/1055-9965.epi-05-0781,,,,16702374,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2369409,https://api.altmetric.com/v1/donut/2369409_240.png 5,Communicating Value in Health Care Using Radar Charts: A Case Study of Prostate Cancer,Journal of Oncology Practice,,,Article,2016-08-30,10.1200/jop.2016.011320,,,,27577622,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10923946,https://api.altmetric.com/v1/donut/10923946_240.png 5,Docetaxel for Metastatic Hormone-sensitive Prostate Cancer: Urgent Need to Minimize the Risk of Neutropenic Fever,European Urology,,,Article,2016-07-12,10.1016/j.eururo.2016.06.041,,,,27417033,,,,,,,0,0,0,11,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9619554,https://api.altmetric.com/v1/donut/9619554_240.png 5,Re: Dietary Flavonoid Fisetin Binds to ?-Tubulin and Disrupts Microtubule Dynamics in Prostate Cancer Cells,The Journal of Urology,,,Article,2016-05-10,10.1016/j.juro.2016.05.011,,,,27479440,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7331112,https://api.altmetric.com/v1/donut/7331112_240.png 5,Experts call for younger men to be offered PSA test for prostate cancer,British Medical Journal,,,Article,2016-03-30,10.1136/bmj.i1802,,,,27030505,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6383779,https://api.altmetric.com/v1/donut/6383779_240.png 5,68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT,Clinical Nuclear Medicine,,,Article,2016-03-01,10.1097/rlu.0000000000001197,,,http://journals.lww.com/nuclearmed/Fulltext/2016/07000/68Ga_PSMA_PET_CT_in_Patients_With_Biochemical.1.aspx,26975008,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6194363,https://api.altmetric.com/v1/donut/6194363_240.png 5,Retained Basal cells in Metastatic Prostate Cancer,Histopathology,,,Article,2016-01-01,10.1111/his.12928,,,,26749042,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4968837,https://api.altmetric.com/v1/donut/4968837_240.png 5,PSA Mass Density – A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity,Urology,,,Article,2016-01-17,10.1016/j.urology.2015.11.042,,,,26773349,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4968194,https://api.altmetric.com/v1/donut/4968194_240.png 5,"Long-term Incidence of Hematuria, Urethral Stricture and Bladder Cancer after Radiation Therapy for Prostate Cancer",Urology Practice,,,Article,2015-01-11,10.1016/j.urpr.2015.01.001,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4764752,https://api.altmetric.com/v1/donut/4764752_240.png 5,Prostate cancer: Analysing prostate cancer biomarkers in voided urine,Nature Reviews Urology,,,Article,2015-09-15,10.1038/nrurol.2015.233,,,,26369724,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4509290,https://api.altmetric.com/v1/donut/4509290_240.png 5,Prostate cancer: Urinary PCA3 and TMPRSS2:ERG reduce the need for repeat biopsy,Nature Reviews Urology,,,Article,2015-09-08,10.1038/nrurol.2015.221,,,,26345208,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4483627,https://api.altmetric.com/v1/donut/4483627_240.png 5,Mortality in Older Men With Low-Risk Prostate Cancer and High Comorbidity,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.58.2536,,,,25646191,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3261251,https://api.altmetric.com/v1/donut/3261251_240.png 5,Re: Organoid Cultures Derived from Patients with Advanced Prostate Cancer,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.01.059,,,,25890569,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3083715,https://api.altmetric.com/v1/donut/3083715_240.png 5,Anti-CD27 Antibody Potentiates Antitumor Effect of Dendritic Cell–Based Vaccine in Prostate Cancer–Bearing Mice,International surgery,,,Article,,10.9738/intsurg-d-14-00147.1,,,,25594656,,,,,,,0,0,0,9,0,0,3,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3075417,https://api.altmetric.com/v1/donut/3075417_240.png 5,Effect of Topical Vaginal Androgens in a Woman on the Testosterone Levels of Her Sexual Partner With Prostate Cancer,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.59.7773,,,,,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3040192,https://api.altmetric.com/v1/donut/3040192_240.png 5,Pleiotropy in Aggressive Prostate Cancer?,European Urology,,,Article,2015-04-01,10.1016/j.eururo.2014.11.029,,,,25468285,,,,,,,0,0,0,9,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2921287,https://api.altmetric.com/v1/donut/2921287_240.png 5,THE EFFECT OF SMOKING ON OUTCOME FOLLOWING EXTERNAL RADIATION FOR LOCALIZED PROSTATE CANCER,The Journal of Urology,,,Article,2004-03-17,10.1097/01.ju.0000118292.25214.a4,,,,15017216,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2916901,https://api.altmetric.com/v1/donut/2916901_240.png 5,Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model,European Urology,,,Article,2014-09-28,10.1016/j.eururo.2014.09.022,,,,25277272,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2725955,https://api.altmetric.com/v1/donut/2725955_240.png 5,Obesity Increases the Risk for High-Grade Prostate Cancer: Results from the REDUCE Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-09-26,10.1158/1055-9965.epi-14-0795,,,,25261967,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2721801,https://api.altmetric.com/v1/donut/2721801_240.png 5,Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2014-11-01,10.1093/jnci/dju268,,,,25255802,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/2713414,https://api.altmetric.com/v1/donut/2713414_240.png 5,Repeated biopsies in patients with prostate cancer on active surveillance: clinical implications of interobserver variation in histopathological assessment,British Journal of Urology,,,Article,2014-08-16,10.1111/bju.12820,,,,24903618,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2409443,https://api.altmetric.com/v1/donut/2409443_240.png 5,Diagnostic Challenges of Clonal Heterogeneity in Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-03-01,10.1200/jco.2013.50.3540,,,,24638011,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2195469,https://api.altmetric.com/v1/donut/2195469_240.png 5,"Enzalutamide (Xtandi) for Patients With Metastatic, Resistant Prostate Cancer.",Annals of Pharmacotherapy,,,Article,2014-01-23,10.1177/1060028013518899,,,,24458946,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2068926,https://api.altmetric.com/v1/donut/2068926_240.png 5,Comprehensive Assessment and Network Analysis of the Emerging Genetic Susceptibility Landscape of Prostate Cancer,Cancer Informatics,,,Article,2013-08-01,10.4137/cin.s12128,,,,24031161,,,,,,,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/1841828,https://api.altmetric.com/v1/donut/1841828_240.png 5,Potent anti-cancer effects of citrus peel flavonoids in human prostate xenograft tumors,Food & Function,,,Article,2013-01-01,10.1039/c3fo60037h,,,,23673480,,,,,,,0,0,0,4,0,0,8,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1505880,https://api.altmetric.com/v1/donut/1505880_240.png 5,Prostate-Specific Antigen Testing in Men Aged 40-64 Years: Impact of Publication of Clinical Trials.,JNCI: Journal of the National Cancer Institute,,,Article,2013-03-04,10.1093/jnci/djt039,,,,23459245,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1283559,https://api.altmetric.com/v1/donut/1283559_240.png 5,Prostate Cancer Survival Rates Improved Since Introduction of PSA Testing,ecancer.org,,,Article,,,,,http://ecancer.org/news/3316-prostate-cancer-survival-rates-improved-since-introduction-of-psa-testing.php,,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251677,https://api.altmetric.com/v1/donut/1251677_240.png 5,Aberrant PSA glycosylation|[mdash]|a sweet predictor of prostate cancer,Nature Reviews Urology,,,Article,2013-01-15,10.1038/nrurol.2012.258,,,,23318363,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1179650,https://api.altmetric.com/v1/donut/1179650_240.png 5,"Does the ‘Scottish effect’ apply to all ethnic groups? All-cancer, lung, colorectal, breast and prostate cancer in the Scottish Health and Ethnicity Linkage Cohort Study",BMJ Open,,,Article,2012-01-01,10.1136/bmjopen-2012-001957,,,,23012329,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/966375,https://api.altmetric.com/v1/donut/966375_240.png 5,"First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients",Journal of Translational Medicine,,,Article,2012-08-03,10.1186/1479-5876-10-156,,,,22862954,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/872394,https://api.altmetric.com/v1/donut/872394_240.png 5,Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal,ISRN Oncology,,,Article,2011-11-28,10.5402/2011/943704,,,,22091437,PMC3196002,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/471847,https://api.altmetric.com/v1/donut/471847_240.png 5,"Higher BMI, waist circumference associated with increased risk of prostate cancer",Cancer (0008543X),,,Article,2016-09-20,10.1002/cncr.30335,,,,,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12115983,https://api.altmetric.com/v1/donut/12115983_240.png 5,An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol,BMC Cancer,,,Article,2016-08-02,10.1186/s12885-016-2605-6,,,,27484002,PMC4971725,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10238592,https://api.altmetric.com/v1/donut/10238592_240.png 5,Surgical Management of Ureteral Strictures Arising From Radiotherapy for Prostate Cancer,Urology Case Reports,,,Article,2016-03-28,10.1016/j.eucr.2016.03.003,,,,27175344,PMC4856339,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6368125,https://api.altmetric.com/v1/donut/6368125_240.png 5,Is There Another Bite of the Cherry? The Case for Radical Local Therapy for Oligometastatic Disease in Prostate Cancer,European Urology,,,Article,2015-08-15,10.1016/j.eururo.2015.07.073,,,,26283009,,,,,,,0,0,0,7,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4399006,https://api.altmetric.com/v1/donut/4399006_240.png 5,A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy,Scandinavian Journal of Urology,,,Article,2015-06-26,10.3109/21681805.2015.1042038,,,,26116048,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4348898,https://api.altmetric.com/v1/donut/4348898_240.png 5,A Qualitative Study Exploring the Perceptions ?of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy.,Oncology Nursing Forum,,,Article,,10.1188/15.onf.398-406,,,,26148319,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4261968,https://api.altmetric.com/v1/donut/4261968_240.png 5,"Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.",Oncotarget,,,Article,2015-06-03,10.18632/oncotarget.4328,,,,26035357,PMC4673295,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4085888,https://api.altmetric.com/v1/donut/4085888_240.png 5,RE: Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data,JNCI: Journal of the National Cancer Institute,,,Article,2015-04-19,10.1093/jnci/djv110,,,,25888716,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3919729,https://api.altmetric.com/v1/donut/3919729_240.png 5,Enzalutamide: A new prostate cancer targeted therapy against the androgen receptor.,Cancer Treatment Reviews,,,Article,,10.1016/j.ctrv.2014.12.006,,,,25638257,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3046057,https://api.altmetric.com/v1/donut/3046057_240.png 5,A Phase II Trial Evaluating the Efficacy and Safety of Efavirenz in Metastatic Castration-Resistant Prostate Cancer,Oncologist,,,Article,,10.1634/theoncologist.2014-0345,,,,25355844,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2955838,https://api.altmetric.com/v1/donut/2955838_240.png 5,Prostate Cancer: Hypofractionated IMRT Shown as Safe Option for Localized Disease,Oncology times,,,Article,2014-05-25,10.1097/01.cot.0000450366.00293.75,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2356750,https://api.altmetric.com/v1/donut/2356750_240.png 5,Robotic Prostatectomy for High-risk Prostate Cancer: Translating the Evidence into Lessons for Clinical Practice,European Urology,,,Article,,10.1016/j.eururo.2013.05.056,,,,,,,,,,,0,0,0,5,0,0,1,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2306452,https://api.altmetric.com/v1/donut/2306452_240.png 5,Is There a Role for Body Mass Index in the Assessment of Prostate Cancer Risk on Biopsy?,The Journal of Urology,,,Article,2014-04-17,10.1016/j.juro.2014.04.015,,,,24747090,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2296207,https://api.altmetric.com/v1/donut/2296207_240.png 5,Impact of Folate Intake on Prostate Cancer Recurrence Following Definitive Therapy: Data from CaPSURE,The Journal of Urology,,,Article,2013-10-07,10.1016/j.juro.2013.09.065,,,,24095905,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1808452,https://api.altmetric.com/v1/donut/1808452_240.png 5,"Tumor suppressor miRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.",Cancer Prevention Research,,,Article,2013-03-20,10.1158/1940-6207.capr-12-0253,,,,23503652,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1511243,https://api.altmetric.com/v1/donut/1511243_240.png 4,The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study,PLoS ONE,,,Article,2016-08-01,10.1371/journal.pone.0158354,,,,27479125,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12892597,https://api.altmetric.com/v1/donut/12892597_240.png 4,Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors,Scientific Reports,,,Article,2016-07-12,10.1038/srep29468,,,,27406023,PMC4942611,,,,,,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10179650,https://api.altmetric.com/v1/donut/10179650_240.png 4,DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk,Epigenetics,,,Article,2016-07-14,10.1080/15592294.2016.1208891,,,,27415467,,,,,,,0,0,0,6,0,0,1,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/9731470,https://api.altmetric.com/v1/donut/9731470_240.png 4,MP84-04 GENOMIC SCREEN IDENTIFIES ACTIONABLE KINASES FOR OBESITY DRIVEN PROSTATE CANCER,The Journal of Urology,,,Article,2016-04-01,10.1016/j.juro.2016.02.2228,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6621036,https://api.altmetric.com/v1/donut/6621036_240.png 4,MP90-02 CARBOHYDRATE RESTRICTION OPPOSES TUMOR-PROMOTING EFFECTS OF OBESITY IN THE HI-MYC TRANSGENIC MOUSE MODEL OF PROSTATE CANCER.,The Journal of Urology,,,Article,2016-04-01,10.1016/j.juro.2016.02.2546,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6391624,https://api.altmetric.com/v1/donut/6391624_240.png 4,MP04-12 COMORBIDITY STATUS AS A PREDICTOR OF HIGH-GRADE DISEASE IN MEN WITH PROSTATE CANCER,The Journal of Urology,,,Article,2016-04-01,10.1016/j.juro.2016.02.1947,,,,,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6391623,https://api.altmetric.com/v1/donut/6391623_240.png 4,Prostate cancer: 'Stem-like' prostate basal cells,Nature Reviews Urology,,,Article,2016-03-15,10.1038/nrurol.2016.55,,,,26976245,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6191754,https://api.altmetric.com/v1/donut/6191754_240.png 4,Determining optimal prostate-specific antigen thresholds to identify an increased 4-year risk of prostate cancer development: an analysis within the Veterans Affairs Health Care System,World Journal of Urology,,,Article,2016-01-11,10.1007/s00345-015-1754-6,,,,26753559,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5022849,https://api.altmetric.com/v1/donut/5022849_240.png 4,Re: Detection of Local Recurrence of Prostate Cancer after Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI,The Journal of Urology,,,Article,2016-01-19,10.1016/j.juro.2016.01.018,,,,27302786,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5014673,https://api.altmetric.com/v1/donut/5014673_240.png 4,Comparison of digit ratio (2D:4D) between Brazilian men with and without prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-12,10.1038/pcan.2015.62,,,,26754259,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4983321,https://api.altmetric.com/v1/donut/4983321_240.png 4,Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer ,Radiotherapy & Oncology,,,Article,2015-12-26,10.1016/j.radonc.2015.11.022,,,,26702991,,,,,,,0,0,0,3,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4884042,https://api.altmetric.com/v1/donut/4884042_240.png 4,Re: Dose-Escalated Irradiation and Overall Survival in Men with Nonmetastatic Prostate Cancer,The Journal of Urology,,,Article,2016-02-19,10.1016/j.juro.2015.12.018,,,,26887709,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4865469,https://api.altmetric.com/v1/donut/4865469_240.png 4,Trade-Off Between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era ,The Journal of Urology,,,Article,2015-12-15,10.1016/j.juro.2015.11.056,,,,26656266,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4834722,https://api.altmetric.com/v1/donut/4834722_240.png 4,The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells.,Oncotarget,,,Article,2015-12-02,10.18632/oncotarget.6415,,,,26625315,PMC4811481,,,,,,0,0,0,1,0,0,11,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/4831481,https://api.altmetric.com/v1/donut/4831481_240.png 4,Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial,Cancer Causes and Control,,,Article,2015-11-16,10.1007/s10552-015-0693-2,,,,26573846,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4774233,https://api.altmetric.com/v1/donut/4774233_240.png 4,Development of castration-resistant prostate cancer can be predicted by a DNA hypermethylation profile.,The Journal of Urology,,,Article,2015-11-10,10.1016/j.juro.2015.10.172,,,,26551297,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4734602,https://api.altmetric.com/v1/donut/4734602_240.png 4,The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment,Korean Journal of Urology,,,Article,2015-10-24,10.4111/kju.2015.56.10.689,,,,26495069,PMC4610895,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4669687,https://api.altmetric.com/v1/donut/4669687_240.png 4,Impact of the CCP test on physician and patient treatment selection for localized prostate cancer,The Journal of Urology,,,Article,2015-09-26,10.1016/j.juro.2015.09.072,,,,26403586,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4538204,https://api.altmetric.com/v1/donut/4538204_240.png 4,Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.05.032,,,,26162485,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4337112,https://api.altmetric.com/v1/donut/4337112_240.png 4,18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT,Clinical Nuclear Medicine,,,Article,2015-08-01,10.1097/rlu.0000000000000849,,,,26053708,,,,,,,0,0,0,4,0,0,1,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4144351,https://api.altmetric.com/v1/donut/4144351_240.png 4,The Importance of Accurate Life Expectancy Prediction in Men with Prostate Cancer,European Urology,,,Article,2015-04-29,10.1016/j.eururo.2015.03.040,,,,25913392,,,,,,,0,0,0,6,0,0,4,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/3937588,https://api.altmetric.com/v1/donut/3937588_240.png 4,Spontaneous Metastasis of Prostate Cancer Is Promoted by Excess Hyaluronan Synthesis and Processing,American Journal of Pathology,,,Article,2009-03-01,10.2353/ajpath.2009.080501,,,,19218337,PMC2665762,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3795041,https://api.altmetric.com/v1/donut/3795041_240.png 4,Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.,Molecular Therapy,,,Article,2009-09-22,10.1038/mt.2009.218,,,,19773744,PMC2810133,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3699544,https://api.altmetric.com/v1/donut/3699544_240.png 4,High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance.,PLoS ONE,,,Article,2015-02-08,10.1371/journal.pone.0115537,,,,25658878,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3608499,https://api.altmetric.com/v1/donut/3608499_240.png 4,"Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost?effectiveness",Cancer Science,,,Article,2010-11-22,10.1111/j.1349-7006.2010.01774.x,,,,21091846,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3209183,https://api.altmetric.com/v1/donut/3209183_240.png 4,6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.,JAMA: Journal of the American Medical Association,,,Article,,10.1001/jama.292.7.821,,,,15315996,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,11,https://www.altmetric.com/details/3205347,https://api.altmetric.com/v1/donut/3205347_240.png 4,The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis.,American Journal of Clinical Nutrition,,,Article,2009-05-14,10.3945/ajcn.2009.26736e,,,,19321563,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3181007,https://api.altmetric.com/v1/donut/3181007_240.png 4,The UCSF Cancer of the Prostate Risk Assessment (CAPRA) Score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy,The Journal of Urology,,,Article,2005-06-14,10.1097/01.ju.0000158155.33890.e7,,,http://www.rand.org/pubs/external_publications/EP20050621.html,15879786,PMC2948569,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,61,https://www.altmetric.com/details/3174127,https://api.altmetric.com/v1/donut/3174127_240.png 4,"Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France",International Journal of Cancer,,,Article,2006-07-17,10.1002/ijc.2910200506,,,,,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3174086,https://api.altmetric.com/v1/donut/3174086_240.png 4,Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy,Endocrine,,,Article,2015-01-31,10.1007/s12020-015-0536-7,,,,25636442,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3168193,https://api.altmetric.com/v1/donut/3168193_240.png 4,"Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States)",Cancer Causes and Control,,,Article,,10.1007/bf00052432,,,,,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3151870,https://api.altmetric.com/v1/donut/3151870_240.png 4,Tumour Cannabinoid CB 1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer,PLoS ONE,,,Article,2011-01-05,10.1371/journal.pone.0015205,,,,21203460,PMC3009725,,2010PLoSO...515205F,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078533,https://api.altmetric.com/v1/donut/3078533_240.png 4,Treatment and survival outcomes in young men diagnosed with prostate cancer,Cancer (0008543X),,,Article,2009-05-22,10.1002/cncr.24324,,,,19466697,PMC2948666,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078125,https://api.altmetric.com/v1/donut/3078125_240.png 4,Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer,"Drug Design, Development and Therapy",,,Article,2011-03-01,10.2147/dddt.s13029,,,,21448449,PMC3063116,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3077929,https://api.altmetric.com/v1/donut/3077929_240.png 4,Explaining racial differences in prostate cancer mortality,Cancer (0008543X),,,Article,2012-01-13,10.1002/cncr.27379,,,,22246942,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3077772,https://api.altmetric.com/v1/donut/3077772_240.png 4,Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation,Cancer (0008543X),,,Article,2006-06-02,10.1002/cncr.21978,,,,16752412,,,,,,,0,0,1,0,17,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3077744,https://api.altmetric.com/v1/donut/3077744_240.png 4,Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing,Journal of Clinical Pathology,,,Article,2015-01-13,10.1136/jclinpath-2014-202754,,,,25586381,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,1,0,0,14,https://www.altmetric.com/details/3061772,https://api.altmetric.com/v1/donut/3061772_240.png 4,Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy,New England Journal of Medicine,,,Article,2004-07-08,10.1056/nejmoa032975,,,,,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2980443,https://api.altmetric.com/v1/donut/2980443_240.png 4,The prognostic significance of perineural invasion in prostatic cancer biopsies,Cancer (0008543X),,,Article,2006-11-22,10.1002/cncr.22388,,,,17123267,,,,,,,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2839606,https://api.altmetric.com/v1/donut/2839606_240.png 4,Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment,The Journal of Urology,,,Article,2007-01-09,10.1016/j.juro.2007.03.135,,,,17644125,PMC2987559,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,1,0,0,64,https://www.altmetric.com/details/2839546,https://api.altmetric.com/v1/donut/2839546_240.png 4,"Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study.",PLoS ONE,,,Article,2014-10-24,10.1371/journal.pone.0110506,,,,25337702,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2829296,https://api.altmetric.com/v1/donut/2829296_240.png 4,IS IT TIME TO MISS THE TARGET FOR PROSTATE CANCER?,British Journal of Urology,,,Article,2012-02-01,10.1111/j.1464-410x.2011.10857.x,,,,22313501,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2790633,https://api.altmetric.com/v1/donut/2790633_240.png 4,Safety of antiandrogen therapy for treating prostate cancer,Expert Opinion on Drug Safety,,,Article,2014-10-03,10.1517/14740338.2014.966686,,,,25270521,,,,,,,0,0,0,3,0,0,0,2,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2742901,https://api.altmetric.com/v1/donut/2742901_240.png 4,Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.,Clinical Cancer Research,,,Article,2010-11-27,10.1158/1078-0432.ccr-10-1762,,,,21106727,,,,,,,0,0,0,4,0,0,0,1,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/2710888,https://api.altmetric.com/v1/donut/2710888_240.png 4,Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria.,International Journal of Urology,,,Article,2014-08-23,10.1111/iju.12605,,,,25141965,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2699649,https://api.altmetric.com/v1/donut/2699649_240.png 4,The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis,BMC Cancer,,,Article,2006-07-26,10.1186/1471-2407-6-195,,,,16859559,PMC1557671,,,,,,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2599484,https://api.altmetric.com/v1/donut/2599484_240.png 4,The “Artificial” Docetaxel Space: The Evolving Treatment Paradigm of Metastatic Castration-Resistant Prostate Cancer,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.07.030,,,,25108578,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2577653,https://api.altmetric.com/v1/donut/2577653_240.png 4,"Dietary patterns and risk of prostate cancer in Ontario, Canada",International Journal of Cancer,,,Article,2005-04-14,10.1002/ijc.21112,,,,15825170,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2564931,https://api.altmetric.com/v1/donut/2564931_240.png 4,Docetaxel-Carboxymethylcellulose Nanoparticles Display Enhanced Anti-tumor Activity in Murine Models of Castration-Resistant Prostate Cancer.,International Journal of Pharmaceutics,,,Article,2014-05-25,10.1016/j.ijpharm.2014.05.021,,,,24853460,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2555836,https://api.altmetric.com/v1/donut/2555836_240.png 4,Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.,Canadian Journal of Urology,,,Article,2014-07-02,,,,,24978358,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2555759,https://api.altmetric.com/v1/donut/2555759_240.png 4,Substance use disorder and its effects on outcomes in men with advanced?stage prostate cancer,Cancer (0008543X),,,Article,2014-07-09,10.1002/cncr.28861,,,,25042396,,,,,,,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2529628,https://api.altmetric.com/v1/donut/2529628_240.png 4,Understanding regional variation in medicare expenditures for initial episodes of prostate cancer care.,Medical care,,,Article,2014-08-01,10.1097/mlr.0000000000000158,,,,25023913,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2515489,https://api.altmetric.com/v1/donut/2515489_240.png 4,Impact of Baseline Corticosteroids on Survival and Steroid Androgens in Metastatic Castration-resistant Prostate Cancer: Exploratory Analysis from COU-AA-301.,European Urology,,,Article,2014-07-09,10.1016/j.eururo.2014.06.042,,,,25018037,,,,,,,0,0,0,11,0,0,1,0,1,0,0,0,0,0,0,31,https://www.altmetric.com/details/2500940,https://api.altmetric.com/v1/donut/2500940_240.png 4,Emerging Therapies to Prevent Skeletal Morbidity in Men With Prostate Cancer,Journal of Clinical Oncology,,,Article,2011-08-22,10.1200/jco.2010.34.4994,,,,21860001,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,40,https://www.altmetric.com/details/2414782,https://api.altmetric.com/v1/donut/2414782_240.png 4,Long?term survival after radical prostatectomy versus external?beam radiotherapy for patients with high?risk prostate cancer,Cancer (0008543X),,,Article,2011-06-22,10.1002/cncr.25900,,,,21692049,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/2358746,https://api.altmetric.com/v1/donut/2358746_240.png 4,Cancer: High cholesterol in prostate tumours,Nature,,,Article,2014-03-12,10.1038/507143c,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2179728,https://api.altmetric.com/v1/donut/2179728_240.png 4,"Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases",Clinical Genitourinary Cancer,,,Article,2012-10-03,10.1016/j.clgc.2012.07.002,,,,23021204,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,14,https://www.altmetric.com/details/2158597,https://api.altmetric.com/v1/donut/2158597_240.png 4,Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.,Cancer Research,,,Article,2005-03-01,10.1158/0008-5472.can-04-1837,,,,15753383,,,,,,,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2093342,https://api.altmetric.com/v1/donut/2093342_240.png 4,Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.,Cancer Research,,,Article,1999-07-01,,,,,10397265,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,89,https://www.altmetric.com/details/2079713,https://api.altmetric.com/v1/donut/2079713_240.png 4,Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer.,Urology,,,Article,2013-09-01,10.1016/j.urology.2013.04.022,,,,23768520,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2061413,https://api.altmetric.com/v1/donut/2061413_240.png 4,Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells,The Prostate,,,Article,2013-01-01,10.1002/pros.22741,,,,24307657,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1843082,https://api.altmetric.com/v1/donut/1843082_240.png 4,"Lactase Persistence, Dietary Intake of Milk, and the Risk for Prostate Cancer in Sweden and Finland","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-01-01,10.1158/1055-9965.epi-06-0985,,,,17507622,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1782004,https://api.altmetric.com/v1/donut/1782004_240.png 4,PSA Velocity and Doubling Time in Diagnosis and Prognosis of Prostate Cancer?,Journal of Clinical Urology,,,Article,2012-07-01,10.1016/j.bjmsu.2011.08.006,,,,22712027,PMC3375697,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1750787,https://api.altmetric.com/v1/donut/1750787_240.png 4,"Vitamin K2, a Naturally Occurring Menaquinone, Exerts Therapeutic Effects on Both Hormone-Dependent and Hormone-Independent Prostate Cancer Cells",Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2013-01-01,10.1155/2013/287358,,,,24062781,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1709535,https://api.altmetric.com/v1/donut/1709535_240.png 4,"Prostate-Specific Antigen, Prostate Cancer Screening, and the Pathologist: What Should Be Our Role?",Archives of Pathology & Laboratory Medicine,,,Article,2012-07-19,10.5858/arpa.2012-0241-ed,,,,22799565,,,,,,,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/1707691,https://api.altmetric.com/v1/donut/1707691_240.png 4,"HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy.",Cancer Gene Therapy,,,Article,2013-07-19,10.1038/cgt.2013.43,,,,23868101,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/1642784,https://api.altmetric.com/v1/donut/1642784_240.png 4,The Association of Plasma Fatty Acids with Prostate Cancer Risk in African Americans and Africans,Journal of health care for the poor and underserved (Online),,,Article,2010-02-24,10.1353/hpu.0.0242,,,,20173289,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1616917,https://api.altmetric.com/v1/donut/1616917_240.png 4,Serum Androgens As Prognostic Biomarkers in Castration-Resistant Prostate Cancer: Results From an Analysis of a Randomized Phase III Trial,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.45.4595,,,,23816964,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1597953,https://api.altmetric.com/v1/donut/1597953_240.png 4,Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mdt138,,,,23585511,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1596273,https://api.altmetric.com/v1/donut/1596273_240.png 4,Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance.,European Urology,,,Article,2013-01-31,10.1016/j.eururo.2013.01.009,,,,23357351,,,,,,,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,30,https://www.altmetric.com/details/1536551,https://api.altmetric.com/v1/donut/1536551_240.png 4,"Smarter screening for prostate cancer: for the few, not the many? A stratified approach based on baseline risk.",Expert Review of Anticancer Therapy,,,Article,2011-02-24,10.1586/era.10.233,,,,21342035,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1476046,https://api.altmetric.com/v1/donut/1476046_240.png 4,Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study,Prostate Cancer & Prostatic Diseases,,,Article,2013-04-09,10.1038/pcan.2013.10,,,,23567655,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1432159,https://api.altmetric.com/v1/donut/1432159_240.png 4,"Nutrition, social factors and prostatic cancer in a Northern Italian population.",British Journal of Cancer,,,Article,1986-06-01,,,,,3718835,,,,,,,0,0,0,0,0,0,4,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1427754,https://api.altmetric.com/v1/donut/1427754_240.png 4,"A populationâ??based study comparing HRQoL among breast, prostate, and colorectal cancer survivors to propensity score matched controls, by cancer type, and gender",Psycho-Oncology,,,Article,2013-01-01,10.1002/pon.3288,,,,23606210,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1407778,https://api.altmetric.com/v1/donut/1407778_240.png 4,Delayed radical prostatectomy for intermediate?risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database,The Prostate,,,Article,2012-09-22,10.1002/pros.22582,,,,22996686,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/1376015,https://api.altmetric.com/v1/donut/1376015_240.png 4,Effect of treatment with 5?? reductase inhibitors on progression in monitored men with favourable?risk prostate cancer,British Journal of Urology,,,Article,2012-02-02,10.1111/j.1464-410x.2011.10875.x,,,,22289613,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1335510,https://api.altmetric.com/v1/donut/1335510_240.png 4,Role of MRI in prostate cancer detection,NMR in Biomedicine,,,Article,2013-01-01,10.1002/nbm.2934,,,,23495081,,,,,,,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,29,https://www.altmetric.com/details/1305887,https://api.altmetric.com/v1/donut/1305887_240.png 4,Prostate cancer: 1HMRS-DCEMR at 3?T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP),European Journal of Radiology,,,Article,2011-02-19,10.1016/j.ejrad.2011.01.095,,,,21330082,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,41,https://www.altmetric.com/details/1297234,https://api.altmetric.com/v1/donut/1297234_240.png 4,Uncertainty and Quality of Life Among Men Undergoing Active Surveillance for Prostate Cancer in the United States and Ireland,American Journal of Men's Health,,,Article,2008-01-01,10.1177/1557988307300467,,,,19477777,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1276747,https://api.altmetric.com/v1/donut/1276747_240.png 4,Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer,Expert Review of Pharmacoeconomics and Outcomes Research,,,Article,2012-05-02,10.1586/erp.12.31,,,,22540167,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1261082,https://api.altmetric.com/v1/donut/1261082_240.png 4,Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e318282635a,,,,23337756,,,,,,,0,0,0,2,0,0,0,3,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1201287,https://api.altmetric.com/v1/donut/1201287_240.png 4,Associations of Serum Concentrations of Organochlorine Pesticides with Breast Cancer and Prostate Cancer in U.S. Adults,Environmental Health Perspectives,,,Article,2010-01-01,10.1289/ehp.0900919,,,,20056587,PMC2831969,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1171520,https://api.altmetric.com/v1/donut/1171520_240.png 4,Hyaluronan (HA) Interacting Proteins RHAMM and Hyaluronidase Impact Prostate Cancer Cell Behavior and Invadopodia Formation in 3D HA-Based Hydrogels,PLoS ONE,,,Article,2012-11-16,10.1371/journal.pone.0050075,,,,23166824,,,,,,,0,0,0,4,0,0,1,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1073547,https://api.altmetric.com/v1/donut/1073547_240.png 4,?-Linolenic Acid and Risk of Prostate Cancer: A Case-Control Study in Uruguay,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2000-03-01,,,,,10750674,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1065166,https://api.altmetric.com/v1/donut/1065166_240.png 4,Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules,Oncology (08909091),,,Article,2013-01-01,10.1159/000343821,,,,23128186,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1053851,https://api.altmetric.com/v1/donut/1053851_240.png 4,Midkine is associated with neuroendocrine differentiation in castration?resistant prostate cancer,The Prostate,,,Article,2012-01-01,10.1002/pros.22607,,,,23129424,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1042552,https://api.altmetric.com/v1/donut/1042552_240.png 4,The Lobund-Wistar rat model of prostate cancer.,Journal of cellular biochemistry Supplement,,,Article,1992-01-01,,,,,1289678,,,,,,,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,1,https://www.altmetric.com/details/973887,https://api.altmetric.com/v1/donut/973887_240.png 4,General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10730.x,,,,22077729,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/932378,https://api.altmetric.com/v1/donut/932378_240.png 4,Staging of prostate cancer,Histopathology,,,Article,2012-01-01,10.1111/j.1365-2559.2011.04025.x,,,,22212080,,,,,,,0,0,1,1,0,0,3,0,0,0,0,0,0,0,0,101,https://www.altmetric.com/details/893605,https://api.altmetric.com/v1/donut/893605_240.png 4,A Case of Multimodality Multiparametric 11C-Choline PET/MR for Biopsy Targeting in Prior Biopsy-Negative Primary Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2012-09-01,10.1097/rlu.0b013e31825b23a6,,,,22889793,,,,,,,0,0,1,2,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/889299,https://api.altmetric.com/v1/donut/889299_240.png 4,Survival Benefit of Radical Prostatectomy in Patients with Localized Prostate Cancer: Estimations of the Number Needed to Treat According to Tumor and Patient Characteristics,The Journal of Urology,,,Article,2012-05-16,10.1016/j.juro.2012.03.005,,,,22578732,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/874862,https://api.altmetric.com/v1/donut/874862_240.png 4,Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer ,Vaccine,,,Article,2011-11-30,10.1016/j.vaccine.2011.11.058,,,,22122856,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/861027,https://api.altmetric.com/v1/donut/861027_240.png 4,Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly,European Urology,,,Article,2009-01-01,10.1016/j.eururo.2008.09.007,,,,18805628,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,55,https://www.altmetric.com/details/860089,https://api.altmetric.com/v1/donut/860089_240.png 4,The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy,British Journal of Urology,,,Article,2012-01-11,10.1111/j.1464-410x.2011.10682.x,,,,22221521,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/831343,https://api.altmetric.com/v1/donut/831343_240.png 4,Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway.,PLoS ONE,,,Article,2012-06-29,10.1371/journal.pone.0040021,,,,22768203,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/819513,https://api.altmetric.com/v1/donut/819513_240.png 4,"Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer",EMBO Journal,,,Article,2011-09-16,10.1038/emboj.2011.328,,,,21915096,PMC3209787,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,76,https://www.altmetric.com/details/788927,https://api.altmetric.com/v1/donut/788927_240.png 4,MicroRNAs as putative mediators of treatment response in prostate cancer,Nature Reviews Urology,,,Article,2012-05-22,10.1038/nrurol.2012.104,,,,22613932,,,,,,,0,0,0,6,0,0,3,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/775913,https://api.altmetric.com/v1/donut/775913_240.png 4,Traversing the genomic landscape of prostate cancer from diagnosis to death,Nature Genetics,,,Article,2012-05-29,10.1038/ng.2301,,,,22641202,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/769635,https://api.altmetric.com/v1/donut/769635_240.png 4,Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer.,European Urology,,,Article,2012-01-04,10.1016/j.eururo.2011.12.028,,,,22209376,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,29,https://www.altmetric.com/details/739492,https://api.altmetric.com/v1/donut/739492_240.png 4,"Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.",Journal of Clinical Oncology,,,Article,1970-01-01,10.1200/jco.2011.35.6295,,,,21931019,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,35,https://www.altmetric.com/details/739443,https://api.altmetric.com/v1/donut/739443_240.png 4,"From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer",The Journal of Pathology,,,Article,2012-01-01,10.1002/path.4047,,,,22553170,,,,,,,0,0,1,2,0,0,1,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/726769,https://api.altmetric.com/v1/donut/726769_240.png 4,Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging,Annals of Nuclear Medicine,,,Article,2012-05-02,10.1007/s12149-012-0601-8,,,,22549847,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/725944,https://api.altmetric.com/v1/donut/725944_240.png 4,Prostate?specific antigen vs prostate?specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11182.x,,,,22540236,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/724674,https://api.altmetric.com/v1/donut/724674_240.png 4,Usefulness of prostate?specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study,British Journal of Urology,,,Article,1970-01-01,10.1111/j.1464-410x.2011.10373.x,,,,21699645,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,28,https://www.altmetric.com/details/719199,https://api.altmetric.com/v1/donut/719199_240.png 4,Dutasteride and active surveillance of low-risk prostate cancer,The Lancet (British Edition),,,Article,2012-04-28,10.1016/s0140-6736(12)60678-3,,,,22541581,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/717893,https://api.altmetric.com/v1/donut/717893_240.png 4,Overcoming castration resistance in prostate cancer.,Current Opinion in Urology,,,Article,2012-05-01,10.1097/mou.0b013e3283523b8b,,,,22472508,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/706337,https://api.altmetric.com/v1/donut/706337_240.png 4,Low testosterone level predicts prostate cancer in re?biopsy in patients with high grade prostatic intraepithelial neoplasia,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10876.x,,,,22257176,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/694359,https://api.altmetric.com/v1/donut/694359_240.png 4,Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0?ng/ml,The Prostate,,,Article,2012-01-01,10.1002/pros.22514,,,,22430630,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/653158,https://api.altmetric.com/v1/donut/653158_240.png 4,Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines,Carcinogenesis,,,Article,2010-01-09,10.1093/carcin/bgq151,,,,20660502,,,,,,,0,0,0,2,0,0,1,1,0,0,0,0,0,0,3,28,https://www.altmetric.com/details/647818,https://api.altmetric.com/v1/donut/647818_240.png 4,The prostate cancer bone marrow niche: more than just 'fertile soil',Asian Journal of Andrology,,,Article,2012-02-27,10.1038/aja.2011.164,,,,22367179,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/638599,https://api.altmetric.com/v1/donut/638599_240.png 4,Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study.,European Urology,,,Article,2012-02-22,10.1016/j.eururo.2012.02.002,,,,22342775,,,,,,,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/621098,https://api.altmetric.com/v1/donut/621098_240.png 4,Gamma?tocotrienol as an effective agent in targeting prostate cancer stem cell?like population,International Journal of Cancer,,,Article,2011-01-05,10.1002/ijc.25546,,,,20617516,,,,,,,0,0,0,4,0,0,2,0,2,0,0,0,0,0,0,39,https://www.altmetric.com/details/597557,https://api.altmetric.com/v1/donut/597557_240.png 4,Cell-to-Cell Signaling Influences the Fate of Prostate Cancer Stem Cells and Their Potential to Generate More Aggressive Tumors,PLoS ONE,,,Article,2012-02-06,10.1371/journal.pone.0031467,,,,22328933,,,2012PLoSO...7E1467S,,,,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/592132,https://api.altmetric.com/v1/donut/592132_240.png 4,Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer,The Prostate,"EVERDEEN, Katie",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-02-03,10.1002/pros.22499,,,,22298119,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/589458,https://api.altmetric.com/v1/donut/589458_240.png 4,Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high?risk localized prostate cancer,Cancer (0008543X),,,Article,2012-01-29,10.1002/cncr.27416,,,,22282219,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/576617,https://api.altmetric.com/v1/donut/576617_240.png 4,Practical aspects of metastatic castration?resistant prostate cancer management: patient case studies,British Journal of Urology,,,Article,2012-03-01,10.1111/j.1464-410x.2011.10872.x,,,,22257100,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/569625,https://api.altmetric.com/v1/donut/569625_240.png 4,"Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity",Journal of Medicinal Chemistry,,,Article,2011-12-15,10.1021/jm2014056,,,,22148427,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/569372,https://api.altmetric.com/v1/donut/569372_240.png 4,Loss of HOXC6 expression induces apoptosis in prostate cancer cells,Oncogene,,,Article,2005-01-08,10.1038/sj.onc.1207906,,,,15637592,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/564203,https://api.altmetric.com/v1/donut/564203_240.png 4,Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis,Strahlentherapie und Onkologie,,,Article,2008-12-25,10.1007/s00066-008-1896-1,,,,19107351,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/540827,https://api.altmetric.com/v1/donut/540827_240.png 4,Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated With the Development of Erectile Dysfunction in African-American Men After Radiotherapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-10-12,10.1016/j.ijrobp.2010.07.036,,,,20932654,PMC2991431,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/538364,https://api.altmetric.com/v1/donut/538364_240.png 4,Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer.,J Clin Oncol,,,Article,2008-02-20,10.1200/jco.2007.13.6804,,,,18281655,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/536313,https://api.altmetric.com/v1/donut/536313_240.png 4,Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer.,British Journal of Urology,,,Article,2008-02-01,10.1111/j.1464-410x.2007.07232.x,,,,17922870,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,45,https://www.altmetric.com/details/536299,https://api.altmetric.com/v1/donut/536299_240.png 4,A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer,Cancer Research,,,Article,2008-01-02,10.1158/0008-5472.can-07-3224,,,,18245462,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,1,0,0,80,https://www.altmetric.com/details/536294,https://api.altmetric.com/v1/donut/536294_240.png 4,Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results,European Radiology,,,Article,2010-11-04,10.1007/s00330-010-1999-9,,,,21046403,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,23,https://www.altmetric.com/details/535740,https://api.altmetric.com/v1/donut/535740_240.png 4,Inducible FGFR-1 Activation Leads to Irreversible Prostate Adenocarcinoma and an Epithelial-to-Mesenchymal Transition,Cancer Cell,,,Article,2007-12-01,10.1016/j.ccr.2007.11.004,,,,18068632,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,75,https://www.altmetric.com/details/532238,https://api.altmetric.com/v1/donut/532238_240.png 4,Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer,Nature Medicine,,,Article,2009-01-05,10.1038/nm.1944,,,,19363497,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,169,https://www.altmetric.com/details/529140,https://api.altmetric.com/v1/donut/529140_240.png 4,Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2008-01-02,10.1016/j.ijrobp.2007.10.004,,,,18164858,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,64,https://www.altmetric.com/details/525454,https://api.altmetric.com/v1/donut/525454_240.png 4,Serum miRNA?21: Elevated levels in patients with metastatic hormone?refractory prostate cancer and potential predictive factor for the efficacy of docetaxel?based chemotherapy,The Prostate,,,Article,2010-09-17,10.1002/pros.21246,,,,20842666,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,54,https://www.altmetric.com/details/523687,https://api.altmetric.com/v1/donut/523687_240.png 4,Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-?B signalling,Nature Communications,,,Article,2011-01-18,10.1038/ncomms1159,,,,21245843,,,2011NatCo...2E.162R,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,74,https://www.altmetric.com/details/516101,https://api.altmetric.com/v1/donut/516101_240.png 4,Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in Caucasian patients with androgen-independent prostatic cancer,Clinical Cancer Research,,,Article,2008-06-01,10.1158/1078-0432.ccr-07-4118,,,,18519758,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,2,0,0,22,https://www.altmetric.com/details/512100,https://api.altmetric.com/v1/donut/512100_240.png 4,"?-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth.",Carcinogenesis,"JONES, India",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-12-09,10.1093/carcin/bgr291,,,,22159229,,,,,,,0,0,0,2,0,0,13,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/494424,https://api.altmetric.com/v1/donut/494424_240.png 4,Outcomes in patients with Gleason score 8–10 prostate cancer: relation to preoperative PSA level,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2011.10628.x,,,,22017732,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/433765,https://api.altmetric.com/v1/donut/433765_240.png 4,Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy,Radiation Oncology,,,Article,2011-10-28,10.1186/1748-717x-6-145,,,,22035354,PMC3217047,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/432924,https://api.altmetric.com/v1/donut/432924_240.png 4,Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer,The Korean Journal of Laboratory Medicine,,,Article,2011-10-01,10.3343/kjlm.2011.31.4.285,,,,22016684,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/429645,https://api.altmetric.com/v1/donut/429645_240.png 4,Vaccination of prostate cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax): a phase 2 trial.,Journal of Immunotherapy,,,Article,2008-06-06,10.1097/cji.0b013e31817deafd,,,,18528296,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/416021,https://api.altmetric.com/v1/donut/416021_240.png 4,Characterising the castration?resistant prostate cancer population: a systematic review,International journal of clinical practice,,,Article,2011-11-01,10.1111/j.1742-1241.2011.02799.x,,,,21995694,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/406418,https://api.altmetric.com/v1/donut/406418_240.png 4,BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients,British Journal of Cancer,,,Article,2011-09-27,10.1038/bjc.2011.383,,,,21952622,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/399746,https://api.altmetric.com/v1/donut/399746_240.png 4,Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.,Cancer Research,,,Article,2005-02-01,,,,,15705868,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,188,https://www.altmetric.com/details/396804,https://api.altmetric.com/v1/donut/396804_240.png 4,Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer.,Clinical Cancer Research,,,Article,2005-06-01,10.1158/1078-0432.ccr-04-2690,,,,15930336,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/396686,https://api.altmetric.com/v1/donut/396686_240.png 4,The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study.,The Prostate,,,Article,2011-09-15,10.1002/pros.21362,,,,21321981,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/395168,https://api.altmetric.com/v1/donut/395168_240.png 4,Tumour markers in prostate cancer III: Biomarkers in urine,Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.524935,,,,21604945,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/260130,https://api.altmetric.com/v1/donut/260130_240.png 4,"Meat, Meat Cooking Methods and Preservation, and Risk for Colorectal Adenoma",Cancer Research,,,Article,2005-09-01,10.1158/0008-5472.can-04-3429,,,,16140978,,,,,,,0,0,2,3,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/260013,https://api.altmetric.com/v1/donut/260013_240.png 4,Gene Expression and Biological Pathways in Tissue of Men with Prostate Cancer in a Randomized Clinical Trial of Lycopene and Fish Oil Supplementation,PLoS ONE,,,Article,2011-09-01,10.1371/journal.pone.0024004,,,,21912659,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/256614,https://api.altmetric.com/v1/donut/256614_240.png 4,Emerging treatment options for patients with castration?resistant prostate cancer,The Prostate,,,Article,2011-11-07,10.1002/pros.21435,,,,21748753,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/244324,https://api.altmetric.com/v1/donut/244324_240.png 4,A Cullin3-KLHL20 Ubiquitin Ligase-Dependent Pathway Targets PML to Potentiate HIF-1 Signaling and Prostate Cancer Progression,"",,,Article,2011-08-15,10.1016/j.ccr.2011.07.008,,,,21840486,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,2,0,0,56,https://www.altmetric.com/details/237406,https://api.altmetric.com/v1/donut/237406_240.png 4,18F-fluorocholine for prostate cancer imaging: a systematic review of the literature,Prostate Cancer & Prostatic Diseases,,,Article,2011-08-16,10.1038/pcan.2011.35,,,,21844889,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/237077,https://api.altmetric.com/v1/donut/237077_240.png 4,A pilot study of the vulnerable elders survey?13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation,Cancer (0008543X),,,Article,2007-02-15,10.1002/cncr.22495,,,,17219443,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,2,0,0,44,https://www.altmetric.com/details/231165,https://api.altmetric.com/v1/donut/231165_240.png 4,Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2011-07-16,10.1007/s00259-011-1876-z,,,,21833840,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/224227,https://api.altmetric.com/v1/donut/224227_240.png 4,Active surveillance for prostate cancer: progress and promise.,Journal of Clinical Oncology,,,Article,2011-08-08,10.1200/jco.2011.34.9738,,,,21825257,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/223900,https://api.altmetric.com/v1/donut/223900_240.png 4,Penile length changes in men treated with androgen suppression plus radiation therapy for local or locally advanced prostate cancer.,The Journal of Urology,,,Article,2007-01-01,10.1016/j.juro.2006.08.113,,,,17162022,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/212031,https://api.altmetric.com/v1/donut/212031_240.png 4,Short? vs long?term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node?negative high?risk adenocarcinoma of the prostate,Cancer (0008543X),,,Article,2007-05-15,10.1002/cncr.22628,,,,17397033,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/212025,https://api.altmetric.com/v1/donut/212025_240.png 4,"Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.",Urology,,,Article,2007-06-01,10.1016/j.urology.2007.03.042,,,,17572194,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,85,https://www.altmetric.com/details/212019,https://api.altmetric.com/v1/donut/212019_240.png 4,Effect of obesity on prostate?specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group?American Society for Therapeutic Radiation and Oncology (RTOG?ASTRO) Phoenix consensus definition,Cancer (0008543X),,,Article,2007-09-01,10.1002/cncr.22873,,,,17614338,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/212007,https://api.altmetric.com/v1/donut/212007_240.png 4,Nomogram incorporating PSA level to predict cancer?specific survival for men with clinically localized prostate cancer managed without curative intent,Cancer (0008543X),,,Article,2008-01-01,10.1002/cncr.23106,,,,18000803,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/211978,https://api.altmetric.com/v1/donut/211978_240.png 4,Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.,Journal of Clinical Investigation,,,Article,2010-08-02,10.1172/jci41824,,,,20644256,PMC2912187,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,91,https://www.altmetric.com/details/211899,https://api.altmetric.com/v1/donut/211899_240.png 4,Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surveillance,The Journal of Urology,,,Article,2011-02-01,10.1016/j.juro.2010.09.115,,,,21167525,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/211873,https://api.altmetric.com/v1/donut/211873_240.png 4,Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.,Cancer Cell,,,Article,2011-05-17,10.1016/j.ccr.2011.04.010,,,,21575865,PMC3113473,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,134,https://www.altmetric.com/details/208463,https://api.altmetric.com/v1/donut/208463_240.png 4,"Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.",Nature Biotechnology,,,Article,2011-07-31,10.1038/nbt.1914,,,,21804560,PMC3152676,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,369,https://www.altmetric.com/details/201565,https://api.altmetric.com/v1/donut/201565_240.png 4,"Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells",Molecular Nutrition & Food Research,"SOLO, Ben",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-07-01,10.1002/mnfr.201000547,,,,21374800,PMC3129466,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/192229,https://api.altmetric.com/v1/donut/192229_240.png 4,Overcoming Chemotherapy Resistance in Prostate Cancer,Clinical Cancer Research,,,Article,2011-06-15,10.1158/1078-0432.ccr-10-2654,,,,21680545,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/174133,https://api.altmetric.com/v1/donut/174133_240.png 4,Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2004-01-13,10.1073/pnas.0307161101,,,,14695896,,,2004PNAS..101..464C,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/155157,https://api.altmetric.com/v1/donut/155157_240.png 4,"RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo",Journal of Biological Chemistry,,,Article,2005-10-28,10.1074/jbc.m503111200,,,,16127174,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,1,0,0,63,https://www.altmetric.com/details/145416,https://api.altmetric.com/v1/donut/145416_240.png 4,Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2006-02-28,10.1073/pnas.0510842103,,,,16492776,,,2006PNAS..103.3100B,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/142312,https://api.altmetric.com/v1/donut/142312_240.png 4,Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist.,Cancer Research,,,Article,2006-07-01,10.1158/0008-5472.can-06-0632,,,,16818617,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/139912,https://api.altmetric.com/v1/donut/139912_240.png 4,A Mouse Stromal Response to Tumor Invasion Predicts Prostate and Breast Cancer Patient Survival,PLoS ONE,,,Article,2006-01-01,10.1371/journal.pone.0000032,,,,17183660,PMC1762322,,2006PLoSO...1...32B,,,,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/137032,https://api.altmetric.com/v1/donut/137032_240.png 4,Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.,The Prostate,,,Article,2008-11-01,10.1002/pros.20830,,,,18668525,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/133204,https://api.altmetric.com/v1/donut/133204_240.png 4,Overtreatment of men with low?risk prostate cancer and significant comorbidity,Cancer (0008543X),,,Article,2011-05-15,10.1002/cncr.25751,,,,21523717,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/129753,https://api.altmetric.com/v1/donut/129753_240.png 4,Fruit and vegetables consumption is directly associated to survival after prostate cancer.,Molecular Nutrition & Food Research,,,Article,2016-11-04,10.1002/mnfr.201600816,,,,27805317,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13337663,https://api.altmetric.com/v1/donut/13337663_240.png 4,Predictors of Time to Metastasis in Castration-Resistant Prostate Cancer,Urology,,,Article,2016-06-15,10.1016/j.urology.2016.06.011,,,,27318265,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8775010,https://api.altmetric.com/v1/donut/8775010_240.png 4,Improving Survival for Metastatic Castrate-resistant Prostate Cancer: Will Combination Therapy Help Us To Move Forward?,European Urology,,,Article,2016-05-31,10.1016/j.eururo.2016.05.030,,,,27255585,,,,,,,0,0,0,8,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8384542,https://api.altmetric.com/v1/donut/8384542_240.png 4,Expanding the Armamentarium for Castrate-resistant Prostate Cancer,European Urology,,,Article,2016-05-25,10.1016/j.eururo.2016.05.022,,,,27234999,,,,,,,0,0,0,10,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8207543,https://api.altmetric.com/v1/donut/8207543_240.png 4,MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection,Medical Physics,,,Article,2016-04-06,10.1118/1.4944871,,,,27147334,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6499683,https://api.altmetric.com/v1/donut/6499683_240.png 4,"The Effects of Exercise on Fatigue, Quality of Life, and Psychological Function for Men with Prostate Cancer: Systematic Review and Meta-analyses",European Urology Focus ,,,Article,2016-03-10,10.1016/j.euf.2016.02.011,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6152933,https://api.altmetric.com/v1/donut/6152933_240.png 4,"Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men: A Review",LGBT Health,,,Article,,10.1089/lgbt.2015.0092,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5092514,https://api.altmetric.com/v1/donut/5092514_240.png 4,The ERSPC Risk Calculators Significantly Outperform The PCPT 2.0 In The Prediction Of Prostate Cancer; A Multi?Institutional Study,British Journal of Urology,,,Article,2016-02-01,10.1111/bju.13437,,,,26833820,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5077631,https://api.altmetric.com/v1/donut/5077631_240.png 4,Prostate cancer: Immunotherapy with PPV effective,Nature Reviews Urology,,,Article,2016-02-02,10.1038/nrurol.2016.27,,,,26832167,,,,,,,0,0,0,11,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5077536,https://api.altmetric.com/v1/donut/5077536_240.png 4,Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.,Oncogene,,,Article,2016-01-25,10.1038/onc.2015.498,,,,26804168,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5036399,https://api.altmetric.com/v1/donut/5036399_240.png 4,Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel,European Urology,,,Article,2015-10-21,10.1016/j.eururo.2015.10.008,,,,26497922,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4676247,https://api.altmetric.com/v1/donut/4676247_240.png 4,Psychological effects of androgen?deprivation therapy on men with prostate cancer and their partners,Cancer (0008543X),,,Article,2015-09-16,10.1002/cncr.29672,,,,26372364,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4511686,https://api.altmetric.com/v1/donut/4511686_240.png 4,"Feasibility, acceptability, and preliminary efficacy of a technology?assisted psychosocial intervention for racially diverse men with advanced prostate cancer",Cancer (0008543X),,,Article,2015-09-10,10.1002/cncr.29658,,,,26348661,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4494917,https://api.altmetric.com/v1/donut/4494917_240.png 4,Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08,European Urology,,,Article,2015-09-09,10.1016/j.eururo.2015.08.027,,,,26362090,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4487262,https://api.altmetric.com/v1/donut/4487262_240.png 4,The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer,European Journal of Cancer (1965),,,Article,2015-01-09,10.1016/j.ejca.2015.06.106,,,,26169016,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4426146,https://api.altmetric.com/v1/donut/4426146_240.png 4,Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies,World Journal of Surgical Oncology,,,Article,2015-07-31,10.1186/s12957-015-0648-9,,,,26228387,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4349964,https://api.altmetric.com/v1/donut/4349964_240.png 4,ABLATION OF B7-H3 BUT NOT B7-H4 RESULTS IN HIGHLY INCREASED TUMOR BURDEN IN A MURINE MODEL OF SPONTANEOUS PROSTATE CANCER.,Cancer Immunology Research,,,Article,,10.1158/2326-6066.cir-15-0100,,,,26122284,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4235435,https://api.altmetric.com/v1/donut/4235435_240.png 4,"Grasping the ‘teachable moment’: time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors",Psycho-Oncology,,,Article,2015-06-08,10.1002/pon.3857,,,,26060053,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4130474,https://api.altmetric.com/v1/donut/4130474_240.png 4,"Relationship Between Aerobic Fitness, the Serum IGF-1 Profiles of Healthy Young Adult African American Males, and Growth of Prostate Cancer Cells",American Journal of Men's Health,,,Article,2015-05-21,10.1177/1557988315587740,,,,25990510,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4021656,https://api.altmetric.com/v1/donut/4021656_240.png 4,Re: Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-Specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study,The Journal of Urology,,,Article,2015-07-22,10.1016/j.juro.2015.05.066,,,,26195364,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4007853,https://api.altmetric.com/v1/donut/4007853_240.png 4,"Re: Effect of Enzalutamide on Time to First Skeletal-Related Event, Pain, and Quality of Life in Men with Castration-Resistant Prostate Cancer: Results from the Randomised, Phase 3 AFFIRM Trial",The Journal of Urology,,,Article,2015-07-22,10.1016/j.juro.2015.05.065,,,,26195363,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4007847,https://api.altmetric.com/v1/donut/4007847_240.png 4,A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.,BMC Cancer,,,Article,2015-04-25,10.1186/s12885-015-1316-8,,,,25908311,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3940339,https://api.altmetric.com/v1/donut/3940339_240.png 4,Re: Five-Year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.03.043,,,,25986791,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3789460,https://api.altmetric.com/v1/donut/3789460_240.png 4,A Qualitative Exploration of the Experience of Men With Prostate Cancer Involved in Supervised Exercise Programs,Oncology Nursing Forum,,,Article,2015-01-01,10.1188/15.onf.24-32,,,,25542318,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3026913,https://api.altmetric.com/v1/donut/3026913_240.png 4,Rectal Toxicity After Proton Therapy For Prostate Cancer: An Analysis of Outcomes of Prospective Studies Conducted at the University of Florida Proton Therapy Institute.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2014.08.353,,,,25442338,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2868156,https://api.altmetric.com/v1/donut/2868156_240.png 4,Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature,European Urology,,,Article,2014-09-16,10.1016/j.eururo.2014.09.004,,,,25240974,,1854/LU-5834602,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2693713,https://api.altmetric.com/v1/donut/2693713_240.png 4,The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008.,Hematology oncology and stem cell therapy,,,Article,2013-11-20,10.1016/j.hemonc.2013.10.001,,,,24239850,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2253297,https://api.altmetric.com/v1/donut/2253297_240.png 4,A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.,Future Oncology,,,Article,2014-02-26,10.2217/fon.13.196,,,,24559451,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2252311,https://api.altmetric.com/v1/donut/2252311_240.png 4,A Commentary on PSA Velocity and Doubling Time for Clinical Decisions in Prostate Cancer,Urology,,,Article,2014-03-15,10.1016/j.urology.2013.09.075,,,,24581521,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2152833,https://api.altmetric.com/v1/donut/2152833_240.png 4,Circulating Tumor Cells from Prostate Cancer Patients Interact with E-Selectin under Physiologic Blood Flow,PLoS ONE,,,Article,2013-12-27,10.1371/journal.pone.0085143,,,,24386459,PMC3874033,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2115617,https://api.altmetric.com/v1/donut/2115617_240.png 4,Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents,Cancer Treatment Reviews,,,Article,2013-08-19,10.1016/j.ctrv.2013.06.008,,,,23958310,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/1775459,https://api.altmetric.com/v1/donut/1775459_240.png 4,Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time,Journal of Clinical Oncology,,,Article,2013-09-16,10.1200/jco.2012.44.6716,,,,24043751,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1758064,https://api.altmetric.com/v1/donut/1758064_240.png 4,PSA-based screening for prostate cancer. Too many adverse effects.,Prescrire international,,,Article,2012-09-30,,,,,23016259,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1208780,https://api.altmetric.com/v1/donut/1208780_240.png 4,Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica,Cancer Causes and Control,,,Article,2011-10-12,10.1007/s10552-011-9850-4,,,,21984307,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,1,10,https://www.altmetric.com/details/548078,https://api.altmetric.com/v1/donut/548078_240.png 4,Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice,The Prostate,,,Article,2010-07-01,10.1002/pros.21136,,,,20166128,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4550229,https://api.altmetric.com/v1/donut/4550229_240.png 4,Predictors of dyadic planning: Perspectives of prostate cancer survivors and their partners,British Journal of Health Psychology,,,Article,2016-10-15,10.1111/bjhp.12216,,,,27743412,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12637658,https://api.altmetric.com/v1/donut/12637658_240.png 4,Castration-resistant Prostate Cancer: Preservation of Quality of Life and Well-being,European Urology Focus ,,,Article,2016-09-01,10.1016/j.euf.2016.08.011,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12007423,https://api.altmetric.com/v1/donut/12007423_240.png 4,Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions,European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.08.038,,,,27591934,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10957748,https://api.altmetric.com/v1/donut/10957748_240.png 4,Contemporary National Trends of Prostate Cancer Screening among Privately Insured Men in the United States,Urology,,,Article,2016-08-12,10.1016/j.urology.2016.06.067,,,,27527411,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10525434,https://api.altmetric.com/v1/donut/10525434_240.png 4,Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials,European Journal of Cancer (1965),,,Article,2016-05-07,10.1016/j.ejca.2016.04.002,,,,27162152,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8386422,https://api.altmetric.com/v1/donut/8386422_240.png 4,Chromatin interactions and candidate genes at ten prostate cancer risk loci,Scientific Reports,,,Article,2016-03-16,10.1038/srep23202,,,,26979803,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6204624,https://api.altmetric.com/v1/donut/6204624_240.png 4,Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration,Journal of Translational Medicine,,,Article,2016-03-15,10.1186/s12967-016-0830-z,,,,26975394,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6194661,https://api.altmetric.com/v1/donut/6194661_240.png 4,The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study.,Journal of Nutrition,,,Article,2016-03-11,10.3945/jn.115.225623,,,,26962176,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6162633,https://api.altmetric.com/v1/donut/6162633_240.png 4," Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset ",The Prostate,,,Article,2016-03-01,10.1002/pros.23176,,,,26959281,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6152457,https://api.altmetric.com/v1/donut/6152457_240.png 4,Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics,The Prostate,,,Article,2016-03-01,10.1002/pros.23175,,,,27159573,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6140253,https://api.altmetric.com/v1/donut/6140253_240.png 4,Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or HIFU,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-18,10.1016/j.ijrobp.2015.12.351,,,,26883560,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4896811,https://api.altmetric.com/v1/donut/4896811_240.png 4,Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.,Nuclear Medicine Communications,,,Article,2015-12-04,10.1097/mnm.0000000000000457,,,http://journals.lww.com/nuclearmedicinecomm/Fulltext/2016/04000/Pairwise_comparison_of_18F_FDG_and_18F_FCH_PET_CT.3.aspx,26642435,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4851451,https://api.altmetric.com/v1/donut/4851451_240.png 4,Intermittent Androgen Deprivation in Prostate Cancer: Are We Ready to Quit?,Journal of Clinical Oncology,,,Article,2015-12-03,10.1200/jco.2015.64.1019,,,,26628474,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4834053,https://api.altmetric.com/v1/donut/4834053_240.png 4,Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set,Nature Communications,,,Article,2015-11-28,10.1038/ncomms9653,,,,26611117,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/4817132,https://api.altmetric.com/v1/donut/4817132_240.png 4,Prostate cancer: STHLM3 model for prostate cancer screening,Nature Reviews Urology,,,Article,2015-11-24,10.1038/nrurol.2015.286,,,,26597612,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4800440,https://api.altmetric.com/v1/donut/4800440_240.png 4,The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer,Nuclear Medicine Communications,,,Article,2015-11-21,10.1097/mnm.0000000000000444,,,,26588068,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4791130,https://api.altmetric.com/v1/donut/4791130_240.png 4,Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT,Diagnostics,,,Article,2015-10-13,10.3390/diagnostics5040413,,,,26854163,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4643981,https://api.altmetric.com/v1/donut/4643981_240.png 4,The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer,Abdominal Imaging,,,Article,2015-10-03,10.1007/s00261-015-0547-0,,,,26428685,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4583445,https://api.altmetric.com/v1/donut/4583445_240.png 4,Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy,BMC Cancer,,,Article,2015-09-13,10.1186/s12885-015-1623-0,,,,26362197,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4502613,https://api.altmetric.com/v1/donut/4502613_240.png 4,Socioeconomic inequalities in prostate cancer survival: A review of the evidence and explanatory factors ,Social Science & Medicine,,,Article,2015-08-19,10.1016/j.socscimed.2015.07.006,,,,26281022,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4329674,https://api.altmetric.com/v1/donut/4329674_240.png 4,Serial blood-based analysis of AR-V7 in men with advanced prostate cancer,Annals of Oncology,,,Article,2015-06-29,10.1093/annonc/mdv282,,,,26117829,,,,,,,0,0,0,7,1,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4223780,https://api.altmetric.com/v1/donut/4223780_240.png 4,Age is associated with upgrading at confirmatory biopsy among men with prostate cancer treated with active surveillance,The Journal of Urology,,,Article,2015-06-30,10.1016/j.juro.2015.06.084,,,,26119671,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4212885,https://api.altmetric.com/v1/donut/4212885_240.png 4,Re: The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-Specific Antigen Levels: A Meta-Analysis,The Journal of Urology,,,Article,2015-01-08,10.1016/j.juro.2015.05.013,,,,26195367,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3986228,https://api.altmetric.com/v1/donut/3986228_240.png 4,A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: A role for Monocarboxylate Transporters as metabolic targets for therapy.,The Journal of Pathology,,,Article,2015-04-16,10.1002/path.4547,,,,25875424,,,,,,,0,0,0,9,0,0,2,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3910018,https://api.altmetric.com/v1/donut/3910018_240.png 4,Seminal fluid: a useful source of prostate cancer biomarkers?,Biomarkers in Medicine,,,Article,2015-02-15,10.2217/bmm.14.110,,,,25689895,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3714838,https://api.altmetric.com/v1/donut/3714838_240.png 4,Digital Solutions for Informed Decision Making: An Academic-Community Partnership for the Development of a Prostate Cancer Decision Aid for African American Men.,American Journal of Men's Health,,,Article,2015-01-09,10.1177/1557988314564178,,,,25563381,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3055252,https://api.altmetric.com/v1/donut/3055252_240.png 4,The Role of miRNAs in Prostate Cancer,European Urology,,,Article,2015-10-01,10.1016/j.eururo.2014.12.037,,,,25577717,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3045738,https://api.altmetric.com/v1/donut/3045738_240.png 4,PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.,Nanomedicine,,,Article,2014-11-19,10.2217/nnm.14.122,,,,25407827,,1959.8/162633,,,,,0,0,0,16,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2906659,https://api.altmetric.com/v1/donut/2906659_240.png 4,Influence of Age on Incident Diabetes and Cardiovascular Disease in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy,The Journal of Urology,,,Article,2014-11-11,10.1016/j.juro.2014.11.006,,,,25451829,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2872223,https://api.altmetric.com/v1/donut/2872223_240.png 4,Epigenetic test could eliminate repeat biopsies for prostate cancer,Cancer (0008543X),,,Article,2014-11-15,10.1002/cncr.29109,,,,25368970,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2853299,https://api.altmetric.com/v1/donut/2853299_240.png 4,Are HIV-Infected Men Vulnerable to Prostate Cancer Treatment Disparities?,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-14-0614,,,,25063519,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2730712,https://api.altmetric.com/v1/donut/2730712_240.png 4,Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth,Cell Reports,,,Article,2014-08-26,10.1016/j.celrep.2014.07.053,,,,25176644,,,,,,,0,0,0,7,0,1,1,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/2638193,https://api.altmetric.com/v1/donut/2638193_240.png 4,Improved Outcomes with Advancements in High Intensity Focused Ultrasound Devices for the Treatment of Localized Prostate Cancer,The Journal of Urology,,,Article,2014-07-28,10.1016/j.juro.2014.07.096,,,,25079940,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2546589,https://api.altmetric.com/v1/donut/2546589_240.png 4,Observation for Clinically Localized Prostate Cancer.,Journal of Clinical Oncology,,,Article,2014-03-20,10.1200/jco.2013.54.2043,,,,24637994,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2305797,https://api.altmetric.com/v1/donut/2305797_240.png 4,Aggressive Variants of Castration Resistant Prostate Cancer.,Clinical Cancer Research,,,Article,2014-04-10,10.1158/1078-0432.ccr-13-3309,,,,24727321,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2275223,https://api.altmetric.com/v1/donut/2275223_240.png 4,Focal Therapy in the Treatment of Localised Prostate Cancer: Primum Non Nocere,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2012.12.027,,,,23290301,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,12,https://www.altmetric.com/details/2174597,https://api.altmetric.com/v1/donut/2174597_240.png 4,Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.008,,,,23957948,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/2124896,https://api.altmetric.com/v1/donut/2124896_240.png 4,"HOXB13, RFX6 and prostate cancer risk",Nature Genetics,,,Article,2014-01-29,10.1038/ng.2881,,,,24473320,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2083027,https://api.altmetric.com/v1/donut/2083027_240.png 4,Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-0839,,,,24097861,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1805465,https://api.altmetric.com/v1/donut/1805465_240.png 4,Semaphorin 4F as a Critical Regulator of Neuro-Epithelial Interactions and a Biomarker of Aggressive Prostate Cancer,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-3669,,,,24097862,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1805450,https://api.altmetric.com/v1/donut/1805450_240.png 4,Epigenetic susceptibility factors for prostate cancer with aging,The Prostate,,,Article,2013-01-01,10.1002/pros.22716,,,,23999928,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1728495,https://api.altmetric.com/v1/donut/1728495_240.png 4,"Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines.",Journal of Complementary and Integrative Medicine,,,Article,2013-07-07,10.1515/jcim-2013-0007,,,,23828331,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1641649,https://api.altmetric.com/v1/donut/1641649_240.png 4,An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis,PLoS ONE,,,Article,2013-05-30,10.1371/journal.pone.0063941,,,,23737958,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1521653,https://api.altmetric.com/v1/donut/1521653_240.png 4,Intratumoral inflammation is associated with more aggressive prostate cancer,World Journal of Urology,,,Article,2013-04-02,10.1007/s00345-013-1065-8,,,,23546767,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1336950,https://api.altmetric.com/v1/donut/1336950_240.png 4,Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study.,The Journal of Urology,,,Article,2012-09-18,10.1016/j.juro.2012.08.219,,,,22999998,,1854/LU-3168737,,,,,0,0,0,6,0,0,1,0,0,0,0,0,1,0,0,38,https://www.altmetric.com/details/981943,https://api.altmetric.com/v1/donut/981943_240.png 4,Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram,Prostate Cancer & Prostatic Diseases,,,Article,2012-06-19,10.1038/pcan.2012.21,,,,22710832,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/799092,https://api.altmetric.com/v1/donut/799092_240.png 4,Changes in circulating microRNA levels associated with prostate cancer,British Journal of Cancer,,,Article,2012-01-14,10.1038/bjc.2011.595,,,,22240788,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,1,0,0,144,https://www.altmetric.com/details/561933,https://api.altmetric.com/v1/donut/561933_240.png 4,Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy.,Canadian Journal of Urology,,,Article,2012-04-14,,,,,22512958,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12662515,https://api.altmetric.com/v1/donut/12662515_240.png 4,The role of medical physics in prostate cancer radiation therapy,Physica Medica,,,Article,2016-03-01,10.1016/j.ejmp.2016.03.020,,,,27095755,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10052653,https://api.altmetric.com/v1/donut/10052653_240.png 4,Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012,Cancer (0008543X),,,Article,2016-05-01,10.1002/cncr.30034,,,,27171855,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7560054,https://api.altmetric.com/v1/donut/7560054_240.png 4,Fear of cancer recurrence in prostate cancer survivors,Acta Oncologica,,,Article,2016-03-05,10.3109/0284186x.2016.1150607,,,,26935517,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6125522,https://api.altmetric.com/v1/donut/6125522_240.png 4,Predictive Parameters of Symptomatic Haematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-12-01,10.1016/j.ijrobp.2015.12.010,,,,27026311,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4919069,https://api.altmetric.com/v1/donut/4919069_240.png 4,Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives,Frontiers in oncology,,,Article,2015-01-09,10.3389/fonc.2015.00006,,,,25699233,PMC4313607,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3258965,https://api.altmetric.com/v1/donut/3258965_240.png 4,PSA testing for prostate cancer screening,Lancet Oncology,,,Article,2015-01-01,10.1016/s1470-2045(14)71108-8,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3024012,https://api.altmetric.com/v1/donut/3024012_240.png 4,Retrospective Studies on Active Surveillance for Low-risk Prostate Cancer: Beware of a Narrow View of the Matter,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.09.006,,,,24055433,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2377977,https://api.altmetric.com/v1/donut/2377977_240.png 4,Determining the Optimal Treatment for Metastatic Castration-resistant Prostate Cancer: Age Should Not Be a Factor,European Urology,,,Article,2013-10-15,10.1016/j.eururo.2013.10.002,,,,24157242,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/2308190,https://api.altmetric.com/v1/donut/2308190_240.png 4,A quarter of men drop out of prostate cancer monitoring,ecancer.org,,,Article,,,,,http://ecancer.org/news/5544-a-quarter-of-men-drop-out-of-prostate-cancer-monitoring.php,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2276056,https://api.altmetric.com/v1/donut/2276056_240.png 4,"Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 Norwegian men",International Journal of Cancer,,,Article,1997-01-01,10.1002/(sici)1097-0215(19971127)73:5<634::aid-ijc4>3.0.co;2-y,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1347026,https://api.altmetric.com/v1/donut/1347026_240.png 4,Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) Survey,Practical Radiation Oncology,,,Article,2012-03-14,10.1016/j.prro.2012.01.006,,,,23471563,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/657817,https://api.altmetric.com/v1/donut/657817_240.png 4,High Intensity Focused Ultrasound is a Good Treatment Option for Localized Prostate Cancer: Con,The Journal of Urology,,,Article,2016-09-18,10.1016/j.juro.2016.09.007,,,,27638336,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11983158,https://api.altmetric.com/v1/donut/11983158_240.png 4,"Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-Line Long-Term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial",The Journal of Urology,,,Article,2016-07-18,10.1016/j.juro.2016.07.067,,,,27628795,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10128072,https://api.altmetric.com/v1/donut/10128072_240.png 4,Appropriateness Criteria for Active Surveillance of Prostate Cancer,The Journal of Urology,,,Article,2016-07-13,10.1016/j.juro.2016.07.005,,,,27422298,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10127631,https://api.altmetric.com/v1/donut/10127631_240.png 4,The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer,Urologic Oncology,,,Article,2016-07-13,10.1016/j.urolonc.2016.05.023,,,,27423822,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10121482,https://api.altmetric.com/v1/donut/10121482_240.png 4,Stricter active surveillance criteria for prostate cancer do not result in significantly better outcomes: A comparison of contemporary protocols,The Journal of Urology,,,Article,2016-06-24,10.1016/j.juro.2016.06.083,,,,27350077,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9024901,https://api.altmetric.com/v1/donut/9024901_240.png 4,Integrating patient preferences into treatment decisions for men with prostate cancer at the point of care,The Journal of Urology,,,Article,2016-06-23,10.1016/j.juro.2016.06.082,,,,27346032,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9000978,https://api.altmetric.com/v1/donut/9000978_240.png 4,Do Black Non-Hispanic Men Produce Less Prostate Specific Antigen in Benign Prostate Tissue or Cancer Compared to White Non-Hispanic Men with Gleason Score 6 (Grade Group 1) Prostate Cancer?,The Journal of Urology,,,Article,2016-06-22,10.1016/j.juro.2016.06.081,,,,27343801,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8979955,https://api.altmetric.com/v1/donut/8979955_240.png 4,Silencing of CD24 enhances the PRIMA-1-induced restoration of mutant p53 in prostate cancer cells,Clinical Cancer Research,,,Article,2015-12-30,10.1158/1078-0432.ccr-15-1927,,,,26712693,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4933751,https://api.altmetric.com/v1/donut/4933751_240.png 4,Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry,BMC Urology,,,Article,2015-12-16,10.1186/s12894-015-0116-4,,,,26674089,PMC4681133,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4901673,https://api.altmetric.com/v1/donut/4901673_240.png 4,Molecular Imaging of Prostate Cancer,RadioGraphics,,,Article,,10.1148/rg.2016150059,,,,26587888,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4797688,https://api.altmetric.com/v1/donut/4797688_240.png 4,The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-11-17,10.1038/pcan.2015.53,,,,26857146,,,,,,,0,0,0,22,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4771868,https://api.altmetric.com/v1/donut/4771868_240.png 4,The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer.,PLoS ONE,,,Article,2015-11-11,10.1371/journal.pone.0142662,,,,26559958,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4754386,https://api.altmetric.com/v1/donut/4754386_240.png 4,"MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells",Journal of Translational Medicine,,,Article,2015-09-04,10.1186/s12967-015-0650-6,,,,26337460,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/4470018,https://api.altmetric.com/v1/donut/4470018_240.png 4,Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer,The Journal of Urology,,,Article,2015-07-08,10.1016/j.juro.2015.07.004,,,,26151676,,,,,,,0,0,0,7,0,0,4,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4243457,https://api.altmetric.com/v1/donut/4243457_240.png 4,Factors that influence patient preferences for prostate cancer management options: A systematic review,Patient preference and adherence,,,Article,2015-07-15,10.2147/ppa.s83333,,,,26170640,,,,,,,0,0,0,6,0,0,1,0,1,0,0,0,0,0,0,16,https://www.altmetric.com/details/4237559,https://api.altmetric.com/v1/donut/4237559_240.png 4,Enzalutamide for the treatment of metastatic castration-resistant prostate cancer,"Drug Design, Development and Therapy",,,Article,2015-07-15,10.2147/dddt.s69433,,,,26170619,,,,,,,0,0,0,2,0,0,0,2,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4230206,https://api.altmetric.com/v1/donut/4230206_240.png 4,High PSA anxiety and Low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?,Annals of Oncology,,,Article,,10.1093/annonc/mdv185,,,,25926039,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3970855,https://api.altmetric.com/v1/donut/3970855_240.png 4,Defining the “Hostile Pelvis” for Intensity Modulated Radiation Therapy: The Impact of Anatomic Variations in Pelvic Dimensions on Dose Delivered to Target Volumes and Organs at Risk in Patients With High-Risk Prostate Cancer Treated With Whole Pelvic Radiation Therapy ,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-06-25,10.1016/j.ijrobp.2015.03.014,,,,26104941,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3838251,https://api.altmetric.com/v1/donut/3838251_240.png 4,Prostate-specific Antigen Pox Virus Vaccination for Recurrent Prostate Cancer,European Urology,,,Article,2015-03-10,10.1016/j.eururo.2015.02.025,,,,25766723,,,,,,,0,0,0,7,0,0,3,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/3770328,https://api.altmetric.com/v1/donut/3770328_240.png 4,Do treatment differences between arms affect the main outcome of the European Randomized study of Screening for Prostate Cancer (ERSPC) Rotterdam?,The Journal of Urology,,,Article,2015-01-08,10.1016/j.juro.2015.02.045,,,,25698407,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3704799,https://api.altmetric.com/v1/donut/3704799_240.png 4,Who Bears the Greatest Burden of Aggressive Treatment of Indolent Prostate Cancer?,American Journal of Medicine,,,Article,2015-01-30,10.1016/j.amjmed.2014.12.030,,,,25644324,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3315409,https://api.altmetric.com/v1/donut/3315409_240.png 4,"Gleason score at diagnosis predicts the detection rate of 18F-choline PET/CT performed at biochemical recurrence of prostate cancer: experience with 1,000 patients.",Journal of Nuclear Medicine,,,Article,,10.2967/jnumed.114.141887,,,,25552670,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3028958,https://api.altmetric.com/v1/donut/3028958_240.png 4,"Aspirin, NSAID and risk of prostate cancer: Results from the REDUCE study.",Clinical Cancer Research,,,Article,2015-02-15,10.1158/1078-0432.ccr-14-2235,,,,25520389,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2995917,https://api.altmetric.com/v1/donut/2995917_240.png 4,A systematic literature review of life expectancy prediction tools for localized prostate cancer patients.,The Journal of Urology,,,Article,2014-11-15,10.1016/j.juro.2014.11.082,,,,25463998,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2892796,https://api.altmetric.com/v1/donut/2892796_240.png 4,First prostate cancer audit calls for wider use of modern imaging techniques,British Medical Journal,,,Article,2014-11-10,10.1136/bmj.g6723,,,,25385433,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2874158,https://api.altmetric.com/v1/donut/2874158_240.png 4,The Relationship between Total Testosterone Levels and Prostate Cancer: A Review of the Continuing Controversy,The Journal of Urology,,,Article,,10.1016/j.juro.2014.07.123,,,,25260832,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2721858,https://api.altmetric.com/v1/donut/2721858_240.png 4,Enzalutamide in castration-resistant prostate cancer ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70251-7,,,,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2408829,https://api.altmetric.com/v1/donut/2408829_240.png 4,Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation.,The American Journal of Surgical Pathology,,,Article,2014-04-03,10.1097/pas.0000000000000208,,,,24705311,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2263176,https://api.altmetric.com/v1/donut/2263176_240.png 4,The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy,Critical Reviews in Oncology/Hematology,,,Article,2013-01-01,10.1016/j.critrevonc.2013.01.006,,,,23484454,,,,,,,0,0,0,1,0,0,2,2,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2171309,https://api.altmetric.com/v1/donut/2171309_240.png 4,"Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells.",BMC Complementary and Alternative Medicine,,,Article,2014-02-21,10.1186/1472-6882-14-68,,,,24555771,,,,,,,0,0,0,7,0,0,0,0,0,0,1,0,0,0,0,3,https://www.altmetric.com/details/2136078,https://api.altmetric.com/v1/donut/2136078_240.png 4,The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature.,Neuroendocrinology Letters,,,Article,2013-12-01,,,,,24378460,,,,,,,0,0,0,2,0,0,10,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2014640,https://api.altmetric.com/v1/donut/2014640_240.png 4,The Expanding Role of MRI in Prostate Cancer,American Journal of Roentgenology,,,Article,2013-12-01,10.2214/ajr.12.10178,,,,24261361,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1975333,https://api.altmetric.com/v1/donut/1975333_240.png 4,Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and Focal Adhesion Kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells.,Biochemical & Biophysical Research Communications,,,Article,2013-10-01,10.1016/j.bbrc.2013.10.112,,,,24177008,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1900783,https://api.altmetric.com/v1/donut/1900783_240.png 4,Effectiveness of epidural versus alternate analgesia for pain relief after radical prostatectomy and correlation with biochemical recurrence in men with prostate cancer.,Research and Reports in Urology,,,Article,2013-10-01,10.2147/rru.s49219,,,,24400245,PMC3826925,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1856397,https://api.altmetric.com/v1/donut/1856397_240.png 4,11C-Choline PET/CT Scan in Patients With Prostate Cancer Treated With Intermittent ADT: A Sequential PET/CT Study.,Clinical Nuclear Medicine,,,Article,2013-05-21,10.1097/rlu.0b013e3182952c4c,,,,23698461,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1506190,https://api.altmetric.com/v1/donut/1506190_240.png 4,Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-3606,,,,23704282,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1502285,https://api.altmetric.com/v1/donut/1502285_240.png 4,Model-based patterns in prostate cancer mortality worldwide,British Journal of Cancer,,,Article,2013-05-09,10.1038/bjc.2013.217,,,,23660943,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1476168,https://api.altmetric.com/v1/donut/1476168_240.png 4,Castration-Resistant Prostate Cancer: AUA Guideline,The Journal of Urology,,,Article,2013-05-10,10.1016/j.juro.2013.05.005,,,,23665272,,,,,,,0,0,6,1,0,0,1,0,0,0,0,0,0,0,0,87,https://www.altmetric.com/details/1463672,https://api.altmetric.com/v1/donut/1463672_240.png 4,Critical evaluation of MRI-targeted TRUS-guided transperineal fusion biopsy for detection of prostate cancer.,The Journal of Urology,,,Article,2013-04-22,10.1016/j.juro.2013.04.043,,,,23608676,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1404095,https://api.altmetric.com/v1/donut/1404095_240.png 4,Identification of somatic mutations in human prostate cancer by RNA-Seq.,Gene,,,Article,2013-02-19,10.1016/j.gene.2013.01.046,,,,23434521,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/1264925,https://api.altmetric.com/v1/donut/1264925_240.png 4,HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-2888,,,,23340301,,,,,,,0,0,1,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1192555,https://api.altmetric.com/v1/donut/1192555_240.png 4,"Role of 18F-Choline PET/CT in Biochemically Relapsed Prostate Cancer After Radical Prostatectomy: Correlation With Trigger PSA, PSA Velocity, PSA Doubling Time, and Metastatic Distribution.",Clinical Nuclear Medicine,,,Article,2013-01-01,10.1097/rlu.0b013e318266cc38,,,,23242060,,,,,,,0,0,1,2,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1185597,https://api.altmetric.com/v1/donut/1185597_240.png 4,"Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions",OncoTargets and therapy,,,Article,2013-01-01,10.2147/ott.s24941,,,,23319868,PMC3540953,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1157342,https://api.altmetric.com/v1/donut/1157342_240.png 4,Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011,PLoS ONE,,,Article,2012-11-26,10.1371/journal.pone.0049914,,,,23189170,PMC3506536,,,,,,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1092219,https://api.altmetric.com/v1/donut/1092219_240.png 4,Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2012-07-01,10.1097/rlu.0b013e318252d829,,,,22691503,PMC3375600,,,,,,0,0,1,2,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/789124,https://api.altmetric.com/v1/donut/789124_240.png 4,Prostate-Cancer Mortality at 11 Years of Follow-up,New England Journal of Medicine,,,Article,2012-05-31,10.1056/nejmx120029,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/770561,https://api.altmetric.com/v1/donut/770561_240.png 4,Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.,PLoS ONE,,,Article,2011-11-17,10.1371/journal.pone.0027970,,,,22114732,PMC3219707,,2011PLoSO...6E7970Z,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/728039,https://api.altmetric.com/v1/donut/728039_240.png 4,"Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-04-10,10.1073/pnas.1117405109,,,,22496589,,,2012PNAS..109.6686D,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/690680,https://api.altmetric.com/v1/donut/690680_240.png 4,Statin Use As a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients,Diabetes Care,,,Article,2012-01-01,10.2337/dc11-1829,,,,22456867,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/671906,https://api.altmetric.com/v1/donut/671906_240.png 4,Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer,Journal of Nuclear Medicine,,,Article,2012-03-16,10.2967/jnumed.111.091421,,,,22419751,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/653979,https://api.altmetric.com/v1/donut/653979_240.png 4,Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy.,Clinical Nuclear Medicine,,,Article,2012-04-01,10.1097/rlu.0b013e31823363b0,,,,22391699,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/640787,https://api.altmetric.com/v1/donut/640787_240.png 4,Prostateâ??specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer,British Journal of Urology,,,Article,2012-02-03,10.1111/j.1464-410x.2011.10900.x,,,,22296334,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/587811,https://api.altmetric.com/v1/donut/587811_240.png 4,Patient acceptance of active surveillance as a treatment option for low?risk prostate cancer,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2011.10200.x,,,,21507187,,,,,,,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/474113,https://api.altmetric.com/v1/donut/474113_240.png 4,S-allylcysteine induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells.,Molecular Medicine Reports,,,Article,2011-11-02,10.3892/mmr.2011.658,,,,22052207,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,3,https://www.altmetric.com/details/444870,https://api.altmetric.com/v1/donut/444870_240.png 4,Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era,Journal of Neuro-Oncology,,,Article,2011-10-12,10.1007/s11060-011-0734-y,,,,21989810,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/403478,https://api.altmetric.com/v1/donut/403478_240.png 4,"Understanding the pathological features of focality, grade and tumour volume of early?stage prostate cancer as a foundation for parenchyma?sparing prostate cancer therapies: active surveillance and focal targeted therapy",British Journal of Urology,,,Article,2011-10-01,10.1111/j.1464-410x.2010.10039.x,,,,21489116,,,,,,,0,0,1,1,0,0,2,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/390289,https://api.altmetric.com/v1/donut/390289_240.png 4,Epstein criteria for insignificant prostate cancer,British Journal of Urology,,,Article,2011-08-01,10.1111/j.1464-410x.2011.09979.x,,,,21320276,,,,,,,0,0,1,2,0,0,2,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/204085,https://api.altmetric.com/v1/donut/204085_240.png 4,Prostate?specific antigen velocity based risk?adapted discontinuation of prostate cancer screening in elderly men,British Journal of Urology,,,Article,2011-07-01,10.1111/j.1464-410x.2010.09812.x,,,,21050357,,,,,,,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/175644,https://api.altmetric.com/v1/donut/175644_240.png 4,Infiltration of tumour?associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer,British Journal of Urology,,,Article,2011-06-01,10.1111/j.1464-410x.2010.09804.x,,,,21044246,,,,,,,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/100777,https://api.altmetric.com/v1/donut/100777_240.png 4,"A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial",International Journal of Clinical Oncology,,,Article,2016-09-10,10.1007/s10147-016-1037-2,,,,27614621,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11959068,https://api.altmetric.com/v1/donut/11959068_240.png 4,Re: Pattern of Progression After Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences,European Urology,,,Article,2016-08-25,10.1016/j.eururo.2016.08.032,,,,27568063,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10806148,https://api.altmetric.com/v1/donut/10806148_240.png 4,H&E-stained Whole Slide Deep Learning Predicts SPOP Mutation State in Prostate Cancer,bioRxiv,,,Article,2016-07-17,10.1101/064279,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9796478,https://api.altmetric.com/v1/donut/9796478_240.png 4,"Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications",Medical care,,,Article,2016-08-01,10.1097/mlr.0000000000000562,,,http://journals.lww.com/lww-medicalcare/Fulltext/2016/08000/Impact_of_Adherence_to_Quality_Measures_for.2.aspx,27219634,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9746412,https://api.altmetric.com/v1/donut/9746412_240.png 4,Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.,Supportive Care in Cancer,,,Article,2015-11-13,10.1007/s00520-015-3016-y,,,,26563183,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4773531,https://api.altmetric.com/v1/donut/4773531_240.png 4,Docetaxel for Castration-sensitive Prostate Cancer: Wrapping up Unfinished Business?,European Urology,,,Article,2015-10-21,10.1016/j.eururo.2015.10.022,,,,26497920,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4655331,https://api.altmetric.com/v1/donut/4655331_240.png 4,Impact of Early Diagnosis of Prostate Cancer on Survival Outcomes,,,,Article,2015-09-28,10.1016/j.euf.2015.01.002,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4591234,https://api.altmetric.com/v1/donut/4591234_240.png 4,Marital rehabilitation after prostate cancer – a matter of intimacy,International Journal of Urological Nursing,,,Article,2015-08-18,10.1111/ijun.12091,,,,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4433860,https://api.altmetric.com/v1/donut/4433860_240.png 4,18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-08-09,10.1097/rlu.0000000000000932,,,,26252326,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4377281,https://api.altmetric.com/v1/donut/4377281_240.png 4,Building Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer,JMIR Medical Informatics,,,Article,2015-07-10,10.2196/medinform.4221,,,,26162314,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4262141,https://api.altmetric.com/v1/donut/4262141_240.png 4,Population-based study of long-term functional outcomes after prostate cancer treatment,British Journal of Urology,,,Article,2015-05-13,10.1111/bju.13179,,,,25959859,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3992808,https://api.altmetric.com/v1/donut/3992808_240.png 4,Development and preliminary testing of PROGRESS: a Web-based education program for prostate cancer survivors transitioning from active treatment.,Journal of Cancer Survivorship,,,Article,2015-02-20,10.1007/s11764-015-0431-5,,,,25697335,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3715059,https://api.altmetric.com/v1/donut/3715059_240.png 4,"Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study",Tumor Biology,,,Article,2014-11-25,10.1007/s13277-014-2854-4,,,,25420908,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/2928870,https://api.altmetric.com/v1/donut/2928870_240.png 4,National Prostate Cancer Registries: Contemporary Trends of Prostate Cancer in the United States,Urology Practice,,,Article,,10.1016/j.urpr.2014.07.005,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2656495,https://api.altmetric.com/v1/donut/2656495_240.png 4,SnapShot: Prostate Cancer,Cancer Cell,,,Article,2013-09-09,10.1016/j.ccr.2013.08.033,,,,24029235,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/2371000,https://api.altmetric.com/v1/donut/2371000_240.png 4,Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC),Prostate Cancer & Prostatic Diseases,,,Article,2014-03-11,10.1038/pcan.2014.7,,,,24614694,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2348940,https://api.altmetric.com/v1/donut/2348940_240.png 4,Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer,Annals of Oncology,,,Article,2014-01-23,10.1093/annonc/mdt581,,,,24458472,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2069627,https://api.altmetric.com/v1/donut/2069627_240.png 4,Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate-resistance and novel therapeutic approaches,Oncogene,,,Article,2013-06-10,10.1038/onc.2013.206,,,,23752182,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,141,https://www.altmetric.com/details/1966652,https://api.altmetric.com/v1/donut/1966652_240.png 4,Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?,Genetics in Medicine,,,Article,1970-01-01,10.1038/gim.2013.141,,,,24071797,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1784850,https://api.altmetric.com/v1/donut/1784850_240.png 4,Men with incurable prostate cancer living for twice as long as decade ago,ecancer.org,,,Article,,,,,http://ecancer.org/news/4275-men-with-incurable-prostate-cancer-living-for-twice-as-long-as-decade-ago.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1658620,https://api.altmetric.com/v1/donut/1658620_240.png 4,ASTRO 2012: Annual prostate cancer screening improvesquality-adjusted life expectancy for high-risk patients compared tounscreened patients. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3523-astro-2012--annual-prostate-cancer-screening-improves-quality-adjusted-life-expectancy-for--high-risk-patients-compared-to-unscreened-patients.php,,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251784,https://api.altmetric.com/v1/donut/1251784_240.png 4,Antioxidant beta-carotene use safe during radiationtreatment for prostate cancer. ecancer - News,ecancer,,,Article,,,,,http://ecancer.org/news/2878-antioxidant-beta-carotene-use-safe-during-radiation-treatment-for-prostate-cancer.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250746,https://api.altmetric.com/v1/donut/1250746_240.png 4,MRI-Guided Interventions for the Treatment of Prostate Cancer,American Journal of Roentgenology,,,Article,2012-01-01,10.2214/ajr.12.8725,,,,22997360,,,,,,,0,0,0,6,0,0,3,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/959310,https://api.altmetric.com/v1/donut/959310_240.png 4,Inverse Relationship Between Biochemical Outcome and Acute Toxicity After Image-Guided Radiotherapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.07.019,,,,22099034,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/745633,https://api.altmetric.com/v1/donut/745633_240.png 4,Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies,Annals of Oncology,,,Article,2012-01-11,10.1093/annonc/mdr603,,,,22228452,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,1,0,0,32,https://www.altmetric.com/details/657856,https://api.altmetric.com/v1/donut/657856_240.png 4,A population study of neutering status as a risk factor for canine prostate cancer.,The Prostate,,,Article,2007-05-23,10.1002/pros.20590,,,,17516571,,,,,,,0,0,0,3,0,0,4,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/631526,https://api.altmetric.com/v1/donut/631526_240.png 4,Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway.,Molecular and Cellular Biochemistry,,,Article,,10.1007/s11010-015-2429-8,,,,25957503,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4060387,https://api.altmetric.com/v1/donut/4060387_240.png 4,Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research,Future Oncology,,,Article,2016-08-16,10.2217/fon-2016-0298,,,,27528114,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10535004,https://api.altmetric.com/v1/donut/10535004_240.png 4,Re: Bone Metastasis in Prostate Cancer: Recurring Mitochondrial DNA Mutation Reveals Selective Pressure Exerted by the Bone Microenvironment,The Journal of Urology,,,Article,2016-06-14,10.1016/j.juro.2016.06.026,,,,27597110,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8746435,https://api.altmetric.com/v1/donut/8746435_240.png 4,Personalized medicine approaches in prostate cancer employing patient derived 3D organoids and humanized mice,Frontiers in Cell and Developmental Biology,,,Article,2016-06-09,10.3389/fcell.2016.00064,,,,27446916,PMC4917534,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8612428,https://api.altmetric.com/v1/donut/8612428_240.png 4,A Novel Selective Androgen Receptor Modulator (SARM) MK-4541 Exerts Anti-Androgenic Activity in the Prostate Cancer Xenograft R-3327G and Anabolic Activity on Skeletal Muscle Mass & Function in Castrated Mice.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2016-04-24,10.1016/j.jsbmb.2016.04.007,,,,27106747,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,1,1,https://www.altmetric.com/details/6931973,https://api.altmetric.com/v1/donut/6931973_240.png 4,Quantitative Network Measures as Biomarkers for Classifying Prostate Cancer Disease States: A Systems Approach to Diagnostic Biomarkers,PLoS ONE,,,Article,2013-11-13,10.1371/journal.pone.0077602,,,,24236006,PMC3827206,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6293262,https://api.altmetric.com/v1/donut/6293262_240.png 4,Re: Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients with Hormone-Sensitive Prostate Cancer,The Journal of Urology,,,Article,2016-03-16,10.1016/j.juro.2016.03.058,,,,27191069,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6202357,https://api.altmetric.com/v1/donut/6202357_240.png 4,Personalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancer,Radiation Oncology,,,Article,2016-03-11,10.1186/s13014-016-0609-7,,,,26968687,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6168453,https://api.altmetric.com/v1/donut/6168453_240.png 4,"Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.010",European Urology,,,Article,2016-03-01,10.1016/j.eururo.2016.02.044,,,,26948396,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6025886,https://api.altmetric.com/v1/donut/6025886_240.png 4,Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials,British Journal of Urology,,,Article,2016-02-01,10.1111/bju.13361,,,,26898239,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6017974,https://api.altmetric.com/v1/donut/6017974_240.png 4,Organoid culture systems for prostate epithelial and cancer tissue,Nature Protocols,,,Article,2016-01-21,10.1038/nprot.2016.006,,,,26797458,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/5028576,https://api.altmetric.com/v1/donut/5028576_240.png 4,A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result,Prostate Cancer & Prostatic Diseases,,,Article,2015-09-08,10.1038/pcan.2015.40,,,,26345389,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4484461,https://api.altmetric.com/v1/donut/4484461_240.png 4,Docetaxel for hormone-sensitive metastatic prostate cancer,Lancet Oncology,,,Article,2015-08-19,10.1016/s1470-2045(15)00227-2,,,,26278160,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4396667,https://api.altmetric.com/v1/donut/4396667_240.png 4,Re: Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Verification of EAU Guideline Criteria,The Journal of Urology,,,Article,2015-07-22,10.1016/j.juro.2015.05.067,,,,26195365,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4007866,https://api.altmetric.com/v1/donut/4007866_240.png 4,Tweeting About Prostate and Testicular Cancers: What Are Individuals Saying in Their Discussions About the 2013 Movember Canada Campaign?,Journal of Cancer Education,,,Article,2015-04-24,10.1007/s13187-015-0838-8,,,,25903054,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3947928,https://api.altmetric.com/v1/donut/3947928_240.png 4,CE: Early Localized Prostate Cancer,American Journal of Nursing,,,Article,2015-03-01,10.1097/01.naj.0000461809.26978.cd,,,,25674683,,,,,,,0,0,0,4,0,0,7,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3758016,https://api.altmetric.com/v1/donut/3758016_240.png 4,Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM,BMC Immunology,,,Article,2015-01-31,10.1186/s12865-014-0064-x,,,,25636521,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3225016,https://api.altmetric.com/v1/donut/3225016_240.png 4,Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence,CA: A Cancer Journal for Clinicians ,,,Article,2015-01-30,10.3322/caac.21263,,,,25640813,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3168619,https://api.altmetric.com/v1/donut/3168619_240.png 4,The Current Utilization of Imaging After Primary Treatment for Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2015.01.097,,,,25640648,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3163313,https://api.altmetric.com/v1/donut/3163313_240.png 4,"Prostate Cancer Early Detection, Version 1.2014",Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2014-09-07,,,,,25190691,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2728168,https://api.altmetric.com/v1/donut/2728168_240.png 4,[Antiproliferative effect of cycloartane-type triterpenoid from myrrh against human prostate cancer cells].,Zhong yao cai Zhongyaocai Journal of Chinese medicinal materials,,,Article,2014-04-27,,,,,24761675,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2583020,https://api.altmetric.com/v1/donut/2583020_240.png 4,"Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: a randomized double blinded, placebo controlled pilot study.",Supportive Care in Cancer,,,Article,2014-07-07,10.1007/s00520-014-2335-8,,,,24993395,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2577910,https://api.altmetric.com/v1/donut/2577910_240.png 4,No Increased MDS Risk in Men with Prostate Cancer Receiving Radiation,Oncology times,,,Article,2014-04-25,10.1097/01.cot.0000446653.12833.9d,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2291334,https://api.altmetric.com/v1/donut/2291334_240.png 4,Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study ,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2014.01.020,,,,24486307,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/2124863,https://api.altmetric.com/v1/donut/2124863_240.png 4,Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium,European Urology,,,Article,2014-06-01,10.1016/j.eururo.2013.12.058,,,,24411283,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2124860,https://api.altmetric.com/v1/donut/2124860_240.png 4,The role of IL-6 in the radiation response of prostate cancer,Radiation Oncology,,,Article,2013-06-27,10.1186/1748-717x-8-159,,,,23806095,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1595288,https://api.altmetric.com/v1/donut/1595288_240.png 4,CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-1342,,,,23492366,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1302346,https://api.altmetric.com/v1/donut/1302346_240.png 4,"The impact of prostate volume, number of biopsy cores, and AUA symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial Risk Calculator",The Journal of Urology,,,Article,2013-01-10,10.1016/j.juro.2012.12.108,,,,23313212,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1168110,https://api.altmetric.com/v1/donut/1168110_240.png 4,Cabazitaxel: More Than a New Taxane for Metastatic Castrate-resistant Prostate Cancer?,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-1584,,,,23091116,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1017127,https://api.altmetric.com/v1/donut/1017127_240.png 4,Transperineal magnetic resonance image-targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer,The Journal of Urology,,,Article,2012-10-11,10.1016/j.juro.2012.10.009,,,,23063807,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,50,https://www.altmetric.com/details/996275,https://api.altmetric.com/v1/donut/996275_240.png 4,Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?,Journal of Oncology,,,Article,2012-01-01,10.1155/2012/645146,,,,22848218,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/836828,https://api.altmetric.com/v1/donut/836828_240.png 4,The Impact of Brachytherapy on Prostate Cancer–Specific Mortality for Definitive Radiation Therapy of High-Grade Prostate Cancer: A Population-Based Analysis,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2008-01-01,10.1016/j.ijrobp.2011.09.055,,,,22270175,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/576986,https://api.altmetric.com/v1/donut/576986_240.png 4,"The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study",BMC Medical Genomics,,,Article,2015-10-15,10.1186/s12920-015-0140-y,,,,26468061,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4628874,https://api.altmetric.com/v1/donut/4628874_240.png 4,Development and evaluation of radiographer led telephone follow up following radical radiotherapy to the prostate. A report of a Macmillan Cancer Support Sponsored Pilot project at Mount Vernon Hospital,Radiography (00338281),,,Article,2015-01-02,10.1016/j.radi.2014.05.003,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4568907,https://api.altmetric.com/v1/donut/4568907_240.png 4,Understanding Long-term Urinary Adverse Events After Treatment of Localized Prostate Cancer: A Key Tool in Informed Decision-making,European Urology,,,Article,,10.1016/j.eururo.2014.09.029,,,,25282365,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2752128,https://api.altmetric.com/v1/donut/2752128_240.png 4,Development and assessment of an evidence-based prostate cancer intervention programme for black men: the W.O.R.D. on prostate cancer video,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/460-development-and-assessment-of-an-evidence-based-prostate-cancer-intervention-programme-for-black-men-the-w-o-r-d-on-prostate-cancer-video.php,,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2637114,https://api.altmetric.com/v1/donut/2637114_240.png 4,Estimated phytanic acid intake and prostate cancer risk: A prospective cohort study.,International Journal of Cancer,,,Article,2011-11-30,10.1002/ijc.27372,,,,22120496,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2325246,https://api.altmetric.com/v1/donut/2325246_240.png 4,New model can predict therapy outcomes in prostate cancer with bone metastasis,ecancer.org,,,Article,,,,,http://ecancer.org/news/5610-new-model-can-predict-therapy-outcomes-in-prostate-cancer-with-bone-metastasis.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2318603,https://api.altmetric.com/v1/donut/2318603_240.png 4,Characteristics of patients with familial versus sporadic prostate cancer.,The Journal of Urology,,,Article,2006-11-07,10.1016/j.juro.2006.07.159,,,,17085123,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2249566,https://api.altmetric.com/v1/donut/2249566_240.png 4,"The association of ultraviolet radiation-B (305Â nm), season of diagnosis, and latitude on the survival outcome of prostate cancer in the high UV environment of Australia",Cancer Causes and Control,,,Article,2013-08-24,10.1007/s10552-013-0277-y,,,,23974842,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1725310,https://api.altmetric.com/v1/donut/1725310_240.png 4,TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer,PLoS ONE,,,Article,2013-07-22,10.1371/journal.pone.0069398,,,,23894469,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1642078,https://api.altmetric.com/v1/donut/1642078_240.png 4,Disproportionate Presentation of High Risk Prostate Cancer in a Safety Net Health System,The Journal of Urology,,,Article,2010-01-11,10.1016/j.juro.2010.06.116,,,,20846693,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1222599,https://api.altmetric.com/v1/donut/1222599_240.png 4,Reply to prostateâ??specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27875,,,,23097014,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1018785,https://api.altmetric.com/v1/donut/1018785_240.png 4,Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer,Radiation Oncology,,,Article,2012-10-12,10.1186/1748-717x-7-168,,,,23062178,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1000681,https://api.altmetric.com/v1/donut/1000681_240.png 4,"The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPAR?-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.",PPAR Research,,,Article,2012-01-01,10.1155/2012/929052,,,,22448169,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/669391,https://api.altmetric.com/v1/donut/669391_240.png 4,Acute and Late Toxicity After Dose Escalation to 82 GyE Using Conformal Proton Radiation for Localized Prostate Cancer: Initial Report of American College of Radiology Phase II Study 03-12.,"International journal of radiation oncology, biology, physics",,,Article,2011-11-15,10.1016/j.ijrobp.2010.06.047,,,,20932675,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/446207,https://api.altmetric.com/v1/donut/446207_240.png 4,Nanoknife Electroporation Ablation Trial (NEAT): a prospective development study investigating focal irreversible electroporation for localised prostate cancer,The Journal of Urology,,,Article,2016-10-05,10.1016/j.juro.2016.09.091,,,,27697580,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12346792,https://api.altmetric.com/v1/donut/12346792_240.png 4,Blood Based Detection of Androgen Receptor Splice Variants in Patients with Advanced Prostate Cancer,The Journal of Urology,,,Article,2016-09-14,10.1016/j.juro.2016.09.001,,,,27620214,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11921186,https://api.altmetric.com/v1/donut/11921186_240.png 4,AR-V7 transcripts in whole blood RNA of patients with metastatic castration resistant prostate cancer correlate with response to Abiraterone acetate,The Journal of Urology,,,Article,2016-07-01,10.1016/j.juro.2016.06.094,,,,27436429,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9948163,https://api.altmetric.com/v1/donut/9948163_240.png 4,Hedgehog Proteins Consume Steroidal CYP17A1 Antagonists: Potential Therapeutic Significance in Advanced Prostate Cancer,ChemMedChem,,,Article,2016-07-01,10.1002/cmdc.201600238,,,,27435344,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9879214,https://api.altmetric.com/v1/donut/9879214_240.png 4,Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review,PLoS ONE,,,Article,2016-04-12,10.1371/journal.pone.0153417,,,,27070904,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6636588,https://api.altmetric.com/v1/donut/6636588_240.png 4,Lack of impact of robotic-assisted laparoscopic radical prostatectomy on intraoperative levels of prostate cancer circulating tumor cells,The Journal of Urology,,,Article,2015-11-20,10.1016/j.juro.2015.11.013,,,,26581128,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4756539,https://api.altmetric.com/v1/donut/4756539_240.png 4,Survival Outcomes of Dose-Escalated External Beam Radiotherapy (DE-EBRT) Versus Combined Brachytherapy for Intermediate- and High-Risk Prostate Cancer Using the National Cancer Data Base,The Journal of Urology,,,Article,2015-11-19,10.1016/j.juro.2015.11.005,,,,26576709,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4751254,https://api.altmetric.com/v1/donut/4751254_240.png 4,ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer.,Expert Review of Anticancer Therapy,,,Article,,10.1586/14737140.2015.1081566,,,,26313416,,,,,,,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4485079,https://api.altmetric.com/v1/donut/4485079_240.png 4,Definition and Validation of “Favorable High-Risk Prostate Cancer”: Implications for Personalizing Treatment of Radiation-Managed Patients ,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-11-05,10.1016/j.ijrobp.2015.07.2281,,,,26530751,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4337485,https://api.altmetric.com/v1/donut/4337485_240.png 4,Baseline Perineural Invasion is Associated with Shorter Time to Progression in Men with Prostate Cancer Undergoing Active Surveillance: Results from the REDEEM Study,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.04.113,,,,25988518,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4003036,https://api.altmetric.com/v1/donut/4003036_240.png 4,Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases.,Cancer Research,,,Article,2015-06-01,10.1158/0008-5472.can-14-2493,,,,25855383,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3932240,https://api.altmetric.com/v1/donut/3932240_240.png 4,CCAAT|[sol]|Enhancer binding protein |[beta]| controls androgen-deprivation-induced senescence in prostate cancer cells,Oncogene,,,Article,2015-03-16,10.1038/onc.2015.41,,,,25772238,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3799437,https://api.altmetric.com/v1/donut/3799437_240.png 4,"Celastrol, a triterpene extracted from the Chinese ""Thunder of God Vine,"" is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.",Cancer Research,,,Article,2006-05-01,10.1158/0008-5472.can-05-4529,,,,16651429,,,,,,,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3673838,https://api.altmetric.com/v1/donut/3673838_240.png 4,EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer,Oncotarget,,,Article,2015-01-12,10.18632/oncotarget.2924,,,,25669987,PMC4414155,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3613020,https://api.altmetric.com/v1/donut/3613020_240.png 4,"Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients",Radiation Oncology,,,Article,2015-02-11,10.1186/s13014-014-0309-0,,,,25889107,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3544414,https://api.altmetric.com/v1/donut/3544414_240.png 4,A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer,Journal of Immunotherapy,,,Article,,10.1097/cji.0000000000000063,,,,25658616,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3433542,https://api.altmetric.com/v1/donut/3433542_240.png 4,"Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.",The Journal of Urology,,,Article,2002-02-01,,,,,11905923,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3296114,https://api.altmetric.com/v1/donut/3296114_240.png 4,"External Validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score",Urology,,,Article,2008-01-08,10.1016/j.urology.2007.11.165,,,,18372031,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3205352,https://api.altmetric.com/v1/donut/3205352_240.png 4,Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth,Clinical Cancer Research,,,Article,2015-04-01,10.1158/1078-0432.ccr-14-1108,,,,25634993,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,1,0,0,11,https://www.altmetric.com/details/3179236,https://api.altmetric.com/v1/donut/3179236_240.png 4,CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR,The Prostate,,,Article,2015-01-13,10.1002/pros.22940,,,,25586052,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3083710,https://api.altmetric.com/v1/donut/3083710_240.png 4,Prostate-Specific Antigen Screening for Prostate Cancer in Older Men in the United States of America.,Gerontology,,,Article,2012-02-16,10.1159/000334242,,,,22343605,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078237,https://api.altmetric.com/v1/donut/3078237_240.png 4,SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.,Nucleic Acids Research,,,Article,,10.1093/nar/gku1375,,,,25552417,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3028825,https://api.altmetric.com/v1/donut/3028825_240.png 4,The Genomic Diversity of Prostate Cancer: Our Achilles Heel Explored,European Urology,,,Article,2014-11-26,10.1016/j.eururo.2014.11.026,,,,25433913,,,,,,,0,0,0,9,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2928929,https://api.altmetric.com/v1/donut/2928929_240.png 4,"Pelvic node dissection in prostate cancer: extended, limited, or not at all?",Current Opinion in Urology,,,Article,2010-05-01,10.1097/mou.0b013e328338405d,,,,20224412,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2847047,https://api.altmetric.com/v1/donut/2847047_240.png 4,Radiobiological Modeling and the Study of Hypofractionated Radiotherapy for Prostate Cancer,European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.07.036,,,,25130566,,,,,,,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/2593760,https://api.altmetric.com/v1/donut/2593760_240.png 4,A Drug-Loaded Aptamer?Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer,ACS Nano,,,Article,2010-06-17,10.1021/nn901877h,,,,20550178,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2524453,https://api.altmetric.com/v1/donut/2524453_240.png 4,Copy number alteration burden predicts prostate cancer relapse.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2014-07-14,10.1073/pnas.1411446111,,,,25024180,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/2508579,https://api.altmetric.com/v1/donut/2508579_240.png 4,"Diminished expression of h2-calponin in prostate cancer cells promotes cell proliferation, migration and the dependence of cell adhesion on substrate stiffness ",FEBS Open Bio,,,Article,2014-06-24,10.1016/j.fob.2014.06.003,,,,25161871,PMC4141211,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2490215,https://api.altmetric.com/v1/donut/2490215_240.png 4,Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases,Drugs,,,Article,2014-03-08,10.1007/s40265-014-0198-4,,,,24610703,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2395498,https://api.altmetric.com/v1/donut/2395498_240.png 4,The social network of PELP1 and its implications in breast and prostate cancers,Endocrine-Related Cancer,,,Article,2014-05-23,10.1530/erc-13-0502,,,,24859989,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2381436,https://api.altmetric.com/v1/donut/2381436_240.png 4,Statins and prostate cancer risk: a case-control study.,American Journal of Epidemiology,,,Article,2005-01-01,10.1093/aje/kwi203,,,,16014776,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2358617,https://api.altmetric.com/v1/donut/2358617_240.png 4,MicroRNAs and Drug Resistance in Prostate Cancer.,Molecular Pharmaceutics,,,Article,2014-04-20,10.1021/mp500099g,,,,24742219,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2297722,https://api.altmetric.com/v1/donut/2297722_240.png 4,Recurrent Prostate Cancer Genomic Alterations Predict Response to Brachytherapy Treatment.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-02-13,10.1158/1055-9965.epi-13-1180,,,,24515272,,,,,,,0,0,0,8,2,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2253559,https://api.altmetric.com/v1/donut/2253559_240.png 4,Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model,Oncogene,,,Article,2014-03-24,10.1038/onc.2014.25,,,,24662833,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2225690,https://api.altmetric.com/v1/donut/2225690_240.png 4,"Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3",Cancer Research,,,Article,,10.1158/0008-5472.can-13-1606,,,,24607843,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2170850,https://api.altmetric.com/v1/donut/2170850_240.png 4,A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.,"Cancer Immunology, Immunotherapy",,,Article,2014-02-11,10.1007/s00262-014-1524-0,,,,24514956,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2122778,https://api.altmetric.com/v1/donut/2122778_240.png 4,Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression.,The Prostate,,,Article,2013-01-01,10.1002/pros.22758,,,,24311408,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1962410,https://api.altmetric.com/v1/donut/1962410_240.png 4,Re-irradiation for salvage of prostate cancer failures after primary radiotherapy,World Journal of Urology,,,Article,2012-09-28,10.1007/s00345-012-0953-7,,,,23053208,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1922059,https://api.altmetric.com/v1/donut/1922059_240.png 4,Role of hormonal and other factors in human prostate cancer.,"Journal of Toxicology and Environmental Health, Part B",,,Article,2008-03-01,10.1080/10937400701873548,,,,18368555,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1921526,https://api.altmetric.com/v1/donut/1921526_240.png 4,Complete clinical and biological response to zoledronic acid in castrate-resistant prostate cancer metastatic to bone.,Anti-Cancer Drugs,,,Article,2012-01-01,10.1097/cad.0b013e32834bede5,,,,21934600,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1910111,https://api.altmetric.com/v1/donut/1910111_240.png 4,Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes,International Journal of Cancer,,,Article,2014-01-01,10.1002/ijc.28326,,,,23754304,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1882187,https://api.altmetric.com/v1/donut/1882187_240.png 4,Src?dependent Tks5 phosphorylation regulates invadopodia?associated invasion in prostate cancer cells,The Prostate,,,Article,2013-01-01,10.1002/pros.22735,,,,24174371,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1877559,https://api.altmetric.com/v1/donut/1877559_240.png 4,Linking the SWI/SNF complex to prostate cancer,Nature Genetics,,,Article,2013-10-29,10.1038/ng.2805,,,,24165726,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1866963,https://api.altmetric.com/v1/donut/1866963_240.png 4,"Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer",World Journal of Urology,,,Article,2013-04-01,10.1007/s00345-012-0908-z,,,,22814886,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1854634,https://api.altmetric.com/v1/donut/1854634_240.png 4,Is there a link between BPH and prostate cancer?,Practitioner,,,Article,2012-04-01,,,,,22792684,,,,,,,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1803918,https://api.altmetric.com/v1/donut/1803918_240.png 4,Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors,New England Journal of Medicine,,,Article,2008-03-21,10.1056/nejmoa074311,,,,18354103,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,226,https://www.altmetric.com/details/1747322,https://api.altmetric.com/v1/donut/1747322_240.png 4,"Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France.",International Journal of Cancer,,,Article,1977-11-15,,,,,924691,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1668330,https://api.altmetric.com/v1/donut/1668330_240.png 4,Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits.,Annals of Family Medicine,,,Article,2013-01-01,10.1370/afm.1509,,,,23835817,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1618877,https://api.altmetric.com/v1/donut/1618877_240.png 4,The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?,The Journal of Urology,,,Article,2004-09-17,,,,,15371827,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,55,https://www.altmetric.com/details/1574771,https://api.altmetric.com/v1/donut/1574771_240.png 4,Prognostic Significance of Lymphovascular Invasion in Clinically Localized Prostate Cancer after Radical Prostatectomy,Robotics and Biomimetics,,,Article,2008-01-01,10.1100/tsw.2008.49,,,,18379707,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1542232,https://api.altmetric.com/v1/donut/1542232_240.png 4,Incidental cancer of the prostate in patients with bladder urothelial carcinoma: comprehensive analysis of 1476 radical cystoprostatectomy specimens,The Journal of Urology,,,Article,2013-05-24,10.1016/j.juro.2013.05.034,,,,23707451,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1506182,https://api.altmetric.com/v1/donut/1506182_240.png 4,Risk-Based Prostate Cancer Screening ,European Urology,,,Article,2011-12-04,10.1016/j.eururo.2011.11.029,,,,22134009,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1502658,https://api.altmetric.com/v1/donut/1502658_240.png 4,Radical prostatectomy in high?risk prostate cancer,International Journal of Urology,,,Article,2013-01-01,10.1111/iju.12069,,,,23305529,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/1465021,https://api.altmetric.com/v1/donut/1465021_240.png 4,DNA Mismatch Repair in Prostate Cancer.,Journal of Clinical Oncology,,,Article,2013-03-28,10.1200/jco.2012.48.4667,,,,23530097,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1454929,https://api.altmetric.com/v1/donut/1454929_240.png 4,Curation-free biomodules mechanisms in prostate cancer predict recurrent disease,BMC Medical Genomics,,,Article,2013-05-07,10.1186/1755-8794-6-s2-s4,,,,23819917,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1453394,https://api.altmetric.com/v1/donut/1453394_240.png 4,Estrogen-Dependent Dynamic Profile of eNOS-DNA Associations in Prostate Cancer,PLoS ONE,,,Article,2013-05-03,10.1371/journal.pone.0062522,,,,23658738,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1438302,https://api.altmetric.com/v1/donut/1438302_240.png 4,Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100),Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mdt136,,,,23576708,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,48,https://www.altmetric.com/details/1358505,https://api.altmetric.com/v1/donut/1358505_240.png 4,Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.,European Journal of Cancer (1965),,,Article,2013-04-01,10.1016/j.ejca.2013.02.026,,,,23541563,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1341179,https://api.altmetric.com/v1/donut/1341179_240.png 4,Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer,PLoS ONE,,,Article,2011-04-06,10.1371/journal.pone.0018625,,,,21494639,,,2011PLoSO...6E8625F,,,,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1315576,https://api.altmetric.com/v1/donut/1315576_240.png 4,Markers of field cancerization: proposed clinical applications in prostate biopsies.,Prostate Cancer,,,Article,2012-06-07,10.1155/2012/302894,,,,22666601,PMC3361299,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1301327,https://api.altmetric.com/v1/donut/1301327_240.png 4,The economics of active surveillance for prostate cancer.,Current Opinion in Urology,,,Article,2013-02-27,10.1097/mou.0b013e32835f4b6b,,,,23449496,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1275502,https://api.altmetric.com/v1/donut/1275502_240.png 4,CCR new strategies: Targeting the androgen receptor signaling pathway in metastatic prostate cancer,Clinical Cancer Research,,,Article,2011-01-01,10.1158/1078-0432.ccr-10-0567,,,,21372223,,,,,,,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1273389,https://api.altmetric.com/v1/donut/1273389_240.png 4,Prostate cancer stem cells: a new target for therapy.,Journal of Clinical Oncology,,,Article,2008-01-01,10.1200/jco.2007.15.1472,,,,18539965,,,,,,,0,0,0,0,0,0,2,3,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1273388,https://api.altmetric.com/v1/donut/1273388_240.png 4,Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret.,Current Oncology,,,Article,2012-12-01,10.3747/co.19.1287,,,,23355792,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1255890,https://api.altmetric.com/v1/donut/1255890_240.png 4,Betulinic Acid Selectively Increases Protein Degradation and Enhances Prostate Cancer-Specific Apoptosis: Possible Role for Inhibition of Deubiquitinase Activity,PLoS ONE,,,Article,2013-02-12,10.1371/journal.pone.0056234,,,,23424652,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1235865,https://api.altmetric.com/v1/donut/1235865_240.png 4,Expression and role of the angiotensin II AT2 receptor in human prostate tissue: In search of a new therapeutic option for prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22653,,,,23389987,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1223605,https://api.altmetric.com/v1/donut/1223605_240.png 4,New developments in castrate?resistant prostate cancer,British Journal of Urology,,,Article,2012-06-16,10.1111/j.1464-410x.2012.11217.x,,,,22672122,,,,,,,0,0,1,0,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1215117,https://api.altmetric.com/v1/donut/1215117_240.png 4,"Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates",Clinical Epidemiology,,,Article,2013-01-30,10.2147/clep.s16747,,,,22291478,PMC3266864,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,82,https://www.altmetric.com/details/1207692,https://api.altmetric.com/v1/donut/1207692_240.png 4,Validation of the prognostic grouping of the seventh edition of the tumor?nodes?metastasis classification using a large?scale prospective cohort study database of prostate cancer treated with primary androgen deprivation therapy,International Journal of Urology,,,Article,2013-01-01,10.1111/iju.12064,,,,23347189,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1195771,https://api.altmetric.com/v1/donut/1195771_240.png 4,Use of radionuclides in metastatic prostate cancer: pain relief and beyond.,Current Opinion in Supportive and Palliative Care,,,Article,2012-06-21,10.1097/spc.0b013e328355e082,,,,22710580,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1161132,https://api.altmetric.com/v1/donut/1161132_240.png 4,Patterns of Care for Elderly Men Diagnosed With Favorable-risk Prostate Cancer From 2004 to 2008: A Population-based Analysis.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-12-27,10.1097/coc.0b013e318261056c,,,,22892435,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1151628,https://api.altmetric.com/v1/donut/1151628_240.png 4,¹?F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.,Nuclear Medicine Communications,,,Article,2011-03-01,10.1097/mnm.0b013e3283412ef5,,,,21076343,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1144624,https://api.altmetric.com/v1/donut/1144624_240.png 4,"A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over?detection",Biometrical Journal,,,Article,2012-01-01,10.1002/bimj.201000107,,,,22213054,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1085198,https://api.altmetric.com/v1/donut/1085198_240.png 4,"Predictors of Adverse Smoking Outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial",JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djs398,,,,23104210,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1031827,https://api.altmetric.com/v1/donut/1031827_240.png 4,Radiofluorinated Derivatives of 2-(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer,Journal of Medicinal Chemistry,,,Article,2012-10-04,10.1021/jm300710j,,,,23025786,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1021571,https://api.altmetric.com/v1/donut/1021571_240.png 4,The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study,The Journal of Urology,,,Article,2011-01-08,10.1016/j.juro.2011.03.115,,,,21679996,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1019582,https://api.altmetric.com/v1/donut/1019582_240.png 4,Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.,Oncogene,,,Article,2012-01-23,10.1038/onc.2011.624,,,,22266859,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1000813,https://api.altmetric.com/v1/donut/1000813_240.png 4,Radical Prostatectomy versus Observation for Prostate Cancer,New England Journal of Medicine,,,Article,2012-10-11,10.1056/nejmc1209800,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/995961,https://api.altmetric.com/v1/donut/995961_240.png 4,Alcohol consumption and PSA-detected prostate cancer risk—A case-control nested in the ProtecT study,International Journal of Cancer,,,Article,2012-01-01,10.1002/ijc.27877,,,,23024014,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/975915,https://api.altmetric.com/v1/donut/975915_240.png 4,"‘A matter of faith, not science’: analysis of media coverage of prostate cancer screening in Australian news media 2003-2006",Journal of the Royal Society of Medicine,,,Article,2007-01-01,10.1258/jrsm.100.11.513,,,,18048709,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/959381,https://api.altmetric.com/v1/donut/959381_240.png 4,Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11513.x,,,,22984785,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/953000,https://api.altmetric.com/v1/donut/953000_240.png 4,Anterior gradient 2 (AGR2): Blood?based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype,The Prostate,,,Article,2012-08-24,10.1002/pros.22569,,,,22911164,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/943638,https://api.altmetric.com/v1/donut/943638_240.png 4,Serum Lycopene Concentration and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-02-23,10.1158/1055-9965.epi-10-1221,,,,21335507,PMC3070045,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,30,https://www.altmetric.com/details/919086,https://api.altmetric.com/v1/donut/919086_240.png 4,Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer.,OMICS: A Journal of Integrative Biology,,,Article,2011-02-27,10.1089/omi.2010.0090,,,,21348634,PMC3125548,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/915958,https://api.altmetric.com/v1/donut/915958_240.png 4,Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00048,,,,22655274,PMC3358653,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/906800,https://api.altmetric.com/v1/donut/906800_240.png 4,Screening for Prostate Cancer: Early Detection or Overdetection?,Annual Review of Medicine,,,Article,2011-11-08,10.1146/annurev-med-050710-134421,,,,22053739,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/881060,https://api.altmetric.com/v1/donut/881060_240.png 4,"Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer",PLoS ONE,,,Article,2012-08-03,10.1371/journal.pone.0042516,,,,22880013,PMC3411755,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/872635,https://api.altmetric.com/v1/donut/872635_240.png 4,A Summary of the Prostate Cancer Prevention Trials With a Focus on the Role of Vitamin E,Home Health Care Management & Practice,,,Article,2012-01-01,10.1177/1084822312453048,,,,,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/870886,https://api.altmetric.com/v1/donut/870886_240.png 4,Review of evidence concerning PSA screening for prostate cancer has limitations as basis for policy development,Evidence Based Medicine,,,Article,2012-07-07,10.1136/eb-2012-100803,,,,22773765,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/863858,https://api.altmetric.com/v1/donut/863858_240.png 4,Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer,"Drug Design, Development and Therapy",,,Article,2012-02-02,10.2147/dddt.s15850,,,,22291466,PMC3267518,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/861374,https://api.altmetric.com/v1/donut/861374_240.png 4,Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,2012-07-03,10.1007/s00280-012-1916-9,,,,,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/828727,https://api.altmetric.com/v1/donut/828727_240.png 4,Preoperative Clinical Factors for Diagnosis of Incidental Prostate Cancer in the Era of Tissue-Ablative Surgery for Benign Prostatic Hyperplasia: A Korean Multi-Center Review,Korean Journal of Urology,,,Article,2012-06-30,10.4111/kju.2012.53.6.391,,,,22741046,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/821864,https://api.altmetric.com/v1/donut/821864_240.png 4,Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers,The Prostate,,,Article,2012-01-01,10.1002/pros.22550,,,,22753310,PMC3878994,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/820350,https://api.altmetric.com/v1/donut/820350_240.png 4,DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time,"Cancer Immunology, Immunotherapy",,,Article,2012-05-22,10.1007/s00262-012-1270-0,,,,22729556,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/809381,https://api.altmetric.com/v1/donut/809381_240.png 4,Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study,British Journal of Cancer,,,Article,2012-06-21,10.1038/bjc.2012.227,,,,22722313,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/807805,https://api.altmetric.com/v1/donut/807805_240.png 4,Image guidance in the focal treatment of prostate cancer.,Current Opinion in Urology,,,Article,2012-07-01,10.1097/mou.0b013e32835482cc,,,,22647649,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/786081,https://api.altmetric.com/v1/donut/786081_240.png 4,"Long-Term Dynamics of Bone Mineral Density During Intermittent Androgen Deprivation for Men With Nonmetastatic, Hormone-Sensitive Prostate Cancer",Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2011.38.3745,,,,22493411,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/751247,https://api.altmetric.com/v1/donut/751247_240.png 4,The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific Antigen.,European Urology,,,Article,2012-01-25,10.1016/j.eururo.2012.01.008,,,,22264679,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/744779,https://api.altmetric.com/v1/donut/744779_240.png 4,L?dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11152.x,,,,22571720,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/736603,https://api.altmetric.com/v1/donut/736603_240.png 4,miRNA-708 control of CD44+ prostate cancer initiating cells.,Cancer Research,,,Article,2012-05-02,10.1158/0008-5472.can-12-0540,,,,22552290,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/728825,https://api.altmetric.com/v1/donut/728825_240.png 4,Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening,International Journal of Cancer,,,Article,2011-01-01,10.1002/ijc.27340,,,,22052356,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/717335,https://api.altmetric.com/v1/donut/717335_240.png 4,Active surveillance for prostate cancer,Current opinion in oncology,,,Article,2012-05-01,10.1097/cco.0b013e3283527f99,,,,22450149,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/715910,https://api.altmetric.com/v1/donut/715910_240.png 4,The Prostate cancer Research International,Current Opinion in Urology,,,Article,2012-05-01,10.1097/mou.0b013e328351dcc7,,,,22453333,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/715739,https://api.altmetric.com/v1/donut/715739_240.png 4,Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT.,Clinical Nuclear Medicine,,,Article,2010-02-01,10.1097/rlu.0b013e3181c7c019,,,,20090467,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/713754,https://api.altmetric.com/v1/donut/713754_240.png 4,Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients,British Journal of Urology,,,Article,2008-01-01,10.1111/j.1464-410x.2012.11147.x,,,,22520619,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/710415,https://api.altmetric.com/v1/donut/710415_240.png 4,Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines: The William Beaumont Hospital Experience.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-04-06,10.1097/coc.0b013e318243708f,,,,22307214,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/701660,https://api.altmetric.com/v1/donut/701660_240.png 4,Patient?reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11117.x,,,,22502770,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/696018,https://api.altmetric.com/v1/donut/696018_240.png 4,Abiraterone in Prostate Cancer: A New Angle to an Old Problem,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-11-1805,,,,22451619,PMC3761800,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/679218,https://api.altmetric.com/v1/donut/679218_240.png 4,High dose rate and external beam radiotherapy in locally advanced prostate cancer.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2009-04-01,10.1097/coc.0b013e3181841f78,,,,19307949,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/674353,https://api.altmetric.com/v1/donut/674353_240.png 4,"Functional Metabolic Screen Identifies 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4 as an Important Regulator of Prostate Cancer Cell Survival",Cancer Discovery,,,Article,2012-01-01,10.1158/2159-8290.cd-11-0234,,,,22576210,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/671069,https://api.altmetric.com/v1/donut/671069_240.png 4,"Prostate cancers detected during 5?-reductase inhibitor use are smaller, de-differentiated, but confined when compared to controls.",Journal of Cancer,,,Article,2012-03-14,10.7150/jca.4123,,,,22408685,PMC3297839,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/664295,https://api.altmetric.com/v1/donut/664295_240.png 4,Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge™ era.,Expert Review of Vaccines,,,Article,2012-03-03,10.1586/erv.11.183,,,,22380822,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/661277,https://api.altmetric.com/v1/donut/661277_240.png 4,IL?4 induces proliferation in prostate cancer PC3 cells under nutrient?depletion stress through the activation of the JNK?pathway and survivin up?regulation,Journal of Cellular Biochemistry,,,Article,2012-05-01,10.1002/jcb.24025,,,,22174091,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/652601,https://api.altmetric.com/v1/donut/652601_240.png 4,The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance,British Journal of Urology,,,Article,2011-08-23,10.1111/j.1464-410x.2011.10480.x,,,,21854535,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/650558,https://api.altmetric.com/v1/donut/650558_240.png 4,Does baseline total testosterone improve the yielding of prostate cancer screening?,European Journal of Cancer (1965),,,Article,2012-02-20,10.1016/j.ejca.2012.01.025,,,,22342552,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/627050,https://api.altmetric.com/v1/donut/627050_240.png 4,Disseminated Prostate Cancer Cells Can Instruct Hematopoietic Stem and Progenitor Cells To Regulate Bone Phenotype.,Molecular Cancer Research,,,Article,2012-01-01,10.1158/1541-7786.mcr-11-0404,,,,22241219,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/618360,https://api.altmetric.com/v1/donut/618360_240.png 4,Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.,Clinical Nuclear Medicine,,,Article,2010-01-01,10.1097/rlu.0b013e3181c361d6,,,,20026972,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/617297,https://api.altmetric.com/v1/donut/617297_240.png 4,"Relationship Between Prostate-specific Antigen, Age, and Body Mass Index in a Prostate Cancer Screening Population.",American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-02-05,10.1097/coc.0b013e31821a83be,,,,21577087,PMC3162083,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/601876,https://api.altmetric.com/v1/donut/601876_240.png 4,"Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer",PLoS Computational Biology,,,Article,2012-02-09,10.1371/journal.pcbi.1002347,,,,22346740,PMC3276504,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/597908,https://api.altmetric.com/v1/donut/597908_240.png 4,Initial Experience With Identifying High-Grade Prostate Cancer Using Diffusion-Weighted MR Imaging (DWI) in Patients With a Gleason Score ?3 + 3 = 6 Upon Schematic TRUS-Guided Biopsy: A Radical Prostatectomy Correlated Series.,Investigative Radiology,,,Article,2012-01-30,10.1097/rli.0b013e31823ea1f0,,,,22293513,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/590814,https://api.altmetric.com/v1/donut/590814_240.png 4,Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy,Aging Male,,,Article,2012-03-01,10.3109/13685538.2011.580398,,,,21615239,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/590374,https://api.altmetric.com/v1/donut/590374_240.png 4,Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer,Critical Reviews in Oncology/Hematology,,,Article,2012-02-01,10.1016/j.critrevonc.2012.01.002,,,,22285697,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/587781,https://api.altmetric.com/v1/donut/587781_240.png 4,A Genome-Wide Search for Loci Interacting with Known Prostate Cancer Risk-Associated Genetic Variants.,Carcinogenesis,,,Article,2012-01-07,10.1093/carcin/bgr316,,,,22219177,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/574588,https://api.altmetric.com/v1/donut/574588_240.png 4,Novel approaches to improve prostate cancer diagnosis and management in early?stage disease,British Journal of Urology,,,Article,2012-03-01,10.1111/j.1464-410x.2011.10870.x,,,,22257098,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/569626,https://api.altmetric.com/v1/donut/569626_240.png 4,Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer.,Journal of Nutrition,,,Article,2007-06-23,,,,,17585029,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,26,https://www.altmetric.com/details/551274,https://api.altmetric.com/v1/donut/551274_240.png 4,SHOULD WE REALLY CONSIDER GLEASON 6 PROSTATE CANCER?,British Journal of Urology,,,Article,2011-12-24,10.1111/j.1464-410x.2011.10854.x,,,,22193242,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/505105,https://api.altmetric.com/v1/donut/505105_240.png 4,Diet and prostate cancer: mechanisms of action and implications for chemoprevention.,Nature Reviews Urology,,,Article,2010-07-20,10.1038/nrurol.2010.102,,,,20647991,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/472100,https://api.altmetric.com/v1/donut/472100_240.png 4,Predicting prostate cancer many years before diagnosis: how and why?,World Journal of Urology,,,Article,2011-11-20,10.1007/s00345-011-0795-8,,,,22101902,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/468807,https://api.altmetric.com/v1/donut/468807_240.png 4,Circulating insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) in PSA-detected prostate cancer: the large case control study ProtecT.,Cancer Research,,,Article,2011-11-21,10.1158/0008-5472.can-11-1601,,,,22106399,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/467634,https://api.altmetric.com/v1/donut/467634_240.png 4,Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.,Urology,,,Article,2004-09-01,10.1016/j.urology.2004.04.009,,,,15351581,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,34,https://www.altmetric.com/details/452056,https://api.altmetric.com/v1/donut/452056_240.png 4,A Prostate Cancer Chemoprevention Study: An Investigative Randomized Control Study Using Purified Isoflavones in Men with Rising PSA,Cancer Science,,,Article,2011-01-01,10.1111/j.1349-7006.2011.02120.x,,,,21988617,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/420162,https://api.altmetric.com/v1/donut/420162_240.png 4,Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.,Anticancer research,,,Article,2011-10-01,,,,,21965742,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/403063,https://api.altmetric.com/v1/donut/403063_240.png 4,Targeted treatment of prostate cancer.,Journal of Cellular Biochemistry,,,Article,2007-10-15,10.1002/jcb.21491,,,,17685433,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/395702,https://api.altmetric.com/v1/donut/395702_240.png 4,Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide).,Molecular Urology,,,Article,2000-01-01,,,,,10851301,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/386643,https://api.altmetric.com/v1/donut/386643_240.png 4,The Prostate Cancer Risk Calculator From the Prostate Cancer Prevention Trial Underestimates the Risk of High Grade Cancer in Contemporary Referral Patients,The Journal of Urology,,,Article,2011-02-01,10.1016/j.juro.2010.09.101,,,,21167519,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/382066,https://api.altmetric.com/v1/donut/382066_240.png 4,Changes in PSA kinetics predict metastasis?free survival in men with PSA?recurrent prostate cancer treated with nonhormonal agents,Cancer (0008543X),,,Article,2011-10-01,10.1002/cncr.26437,,,,21960118,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/256067,https://api.altmetric.com/v1/donut/256067_240.png 4,MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis.,Urologic Oncology,,,Article,2011-08-29,10.1016/j.urolonc.2011.07.002,,,,21880514,,,,,,,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/252516,https://api.altmetric.com/v1/donut/252516_240.png 4,Abiraterone and Increased Survival in Metastatic Prostate Cancer,New England Journal of Medicine,,,Article,2011-08-25,10.1056/nejmc1107198,,,,21864182,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/245939,https://api.altmetric.com/v1/donut/245939_240.png 4,No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.,Molecular & Cellular Probes,,,Article,2011-01-01,10.1016/j.mcp.2011.01.005,,,,21281710,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/186838,https://api.altmetric.com/v1/donut/186838_240.png 4,Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome,Reviews in Medical Virology,,,Article,2011-01-01,10.1002/rmv.673,,,,21294212,,,,,,,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/186774,https://api.altmetric.com/v1/donut/186774_240.png 4,Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer,Scientific Reports,,,Article,2016-10-17,10.1038/srep35354,,,,27748439,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13007815,https://api.altmetric.com/v1/donut/13007815_240.png 4,MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells,Journal of Cancer Research & Clinical Oncology,,,Article,2016-08-25,10.1007/s00432-016-2222-4,,,,27562865,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10862603,https://api.altmetric.com/v1/donut/10862603_240.png 4,Salvage Therapies for Radiorecurrent Prostate Cancer,Urology Practice,,,Article,2015-01-05,10.1016/j.urpr.2014.10.004,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9882738,https://api.altmetric.com/v1/donut/9882738_240.png 4,Prostate cancer: Tumour genomes are highly plastic,Nature Reviews Urology,,,Article,2016-07-12,10.1038/nrurol.2016.132,,,,27400668,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9728768,https://api.altmetric.com/v1/donut/9728768_240.png 4,Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy,British Journal of Cancer,,,Article,2016-07-12,10.1038/bjc.2016.171,,,,27404586,PMC4947697,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9654439,https://api.altmetric.com/v1/donut/9654439_240.png 4,Prostate cancer: Midlife PSA levels predict lethal disease,Nature Reviews Urology,,,Article,2016-06-28,10.1038/nrurol.2016.119,,,,27349374,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9153926,https://api.altmetric.com/v1/donut/9153926_240.png 4,"Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories",Cancer Medicine,,,Article,2016-02-01,10.1002/cam4.665,,,,26923095,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6018851,https://api.altmetric.com/v1/donut/6018851_240.png 4,Deletion of interstitial genes between TMPRSS2 and ERG promotes prostate cancer progression,Cancer Research,,,Article,2016-02-15,10.1158/0008-5472.can-15-1911,,,,26880803,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5615416,https://api.altmetric.com/v1/donut/5615416_240.png 4,Diet-induced alteration of fatty acid synthase in prostate cancer progression,Oncogenesis,,,Article,2016-02-01,10.1038/oncsis.2015.42,,,,26878389,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5614335,https://api.altmetric.com/v1/donut/5614335_240.png 4,Urological cancer: CHAARTED/GETUG 12[mdash]docetaxel in non-castrate prostate cancers,Nature Reviews Clinical Oncology,,,Article,2015-11-10,10.1038/nrclinonc.2015.192,,,,26552950,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4758332,https://api.altmetric.com/v1/donut/4758332_240.png 4,Local Coverage Determination Policy and the Use of Stereotactic Body Radiation Therapy for Prostate Cancer,Urology Practice,,,Article,2015-01-11,10.1016/j.urpr.2015.05.006,,,,27493987,PMC4968880,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4733702,https://api.altmetric.com/v1/donut/4733702_240.png 4,"Impact of a printed decision aid on patients’ intention to undergo prostate cancer screening: a multicentre, pragmatic randomised controlled trial in primary care",British Journal of General Practice,,,Article,2015-05-01,10.3399/bjgp15x684817,,,,25918334,,,,,,,0,0,0,4,1,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4523330,https://api.altmetric.com/v1/donut/4523330_240.png 4,Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options,European Urology,,,Article,2015-07-13,10.1016/j.eururo.2015.06.039,,,,26153564,,,,,,,0,0,0,6,0,0,4,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4284633,https://api.altmetric.com/v1/donut/4284633_240.png 4,DNA vaccination for prostate cancer: key concepts and considerations,Cancer Nanotechnology,,,Article,2015-07-15,10.1186/s12645-015-0010-5,,,,26161151,PMC4488504,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4277864,https://api.altmetric.com/v1/donut/4277864_240.png 4,Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective,PharmacoEconomics,,,Article,2015-05-29,10.1007/s40273-015-0296-5,,,,26017401,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4070097,https://api.altmetric.com/v1/donut/4070097_240.png 4,Word on the Street Engaging Local Leaders in a Dialogue About Prostate Cancer Among African Americans,American Journal of Men's Health,,,Article,2015-01-15,10.1177/1557988314566503,,,,25595017,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3083142,https://api.altmetric.com/v1/donut/3083142_240.png 4,Prostate cancer: New imaging method to improve prostate cancer detection,Nature Reviews Urology,,,Article,2015-01-20,10.1038/nrurol.2015.2,,,,25600093,,,,,,,0,0,0,9,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3080723,https://api.altmetric.com/v1/donut/3080723_240.png 4,"Variability in date of prostate cancer diagnosis: a comparison of cancer registry, pathology report, and electronic health data sources",Annals of Epidemiology,,,Article,2014-09-17,10.1016/j.annepidem.2014.09.004,,,,25282324,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2745996,https://api.altmetric.com/v1/donut/2745996_240.png 4,"Can We Eat Our Way to a Lower Prostate Cancer Risk, and If So, How?",European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.09.017,,,,24075579,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2284940,https://api.altmetric.com/v1/donut/2284940_240.png 4,The impact of androgen?deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non?metastatic prostate cancer: a population?based study,British Journal of Urology,,,Article,2014-07-27,10.1111/bju.12732,,,,24612110,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2173207,https://api.altmetric.com/v1/donut/2173207_240.png 4,Effects of Nonlinear Aerobic Training on Erectile Dysfunction and Cardiovascular Function Following Radical Prostatectomy for Clinically Localized Prostate Cancer,European Urology,,,Article,2013-12-11,10.1016/j.eururo.2013.11.009,,,,24315706,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2056576,https://api.altmetric.com/v1/donut/2056576_240.png 4,Prevention and Detection of Prostate Cancer: A Pilot Intervention in a Resource-Poor South African Community,Cancer nursing (Online),,,Article,2013-05-01,10.1097/ncc.0b013e31829194d2,,,,23632472,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1444946,https://api.altmetric.com/v1/donut/1444946_240.png 4,NCRI 2012: Personalised prostate cancer screening may savethousands from unnecessary treatment. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3528-ncri-2012--personalised-prostate-cancer-screening-may-save-thousands-from-unnecessary-treatment.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251782,https://api.altmetric.com/v1/donut/1251782_240.png 4,Circumcision may help protect against prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2566-circumcision-may-help-protect-against-prostate-cancer.php,,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251028,https://api.altmetric.com/v1/donut/1251028_240.png 4,Socio-Economic Inequalities in Survival of Patients with Prostate Cancer: Role of Age and Gleason Grade at Diagnosis,PLoS ONE,,,Article,2013-02-13,10.1371/journal.pone.0056184,,,,23418534,PMC3571964,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1238683,https://api.altmetric.com/v1/donut/1238683_240.png 4,New Strategies in Prostate Cancer: Translating Genomics into the Clinic,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-1452,,,,23248095,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1130715,https://api.altmetric.com/v1/donut/1130715_240.png 4,Statins increase the risk of prostate cancer: A population?based case–control study,The Prostate,,,Article,2011-04-13,10.1002/pros.21401,,,,21480313,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/254124,https://api.altmetric.com/v1/donut/254124_240.png 4,Does Enzalutamide Really Reduce the Risk of Progression Compared With Bicalutamide in Patients With Castration-Resistant Prostate Cancer?,Journal of Clinical Oncology,,,Article,2016-10-10,10.1200/jco.2016.68.0389,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12578912,https://api.altmetric.com/v1/donut/12578912_240.png 4,Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling,Biomedicine & Pharmacotherapy,,,Article,2016-12-01,10.1016/j.biopha.2016.09.037,,,,27657825,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12139673,https://api.altmetric.com/v1/donut/12139673_240.png 4,Prostate cancer: Birth of a standard: MET-RADS-P for metastatic prostate cancer,Nature Reviews Urology,,,Article,2016-08-31,10.1038/nrurol.2016.163,,,,27578044,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11730934,https://api.altmetric.com/v1/donut/11730934_240.png 4,Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol,BMJ Open,,,Article,2016-06-29,10.1136/bmjopen-2016-011460,,,,27357198,PMC4932293,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9160906,https://api.altmetric.com/v1/donut/9160906_240.png 4,The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-06-01,10.1097/coc.0000000000000313,,,http://journals.lww.com/amjclinicaloncology/Fulltext/publishahead/The_Missing_Pieces_in_Reporting_of_Randomized.99030.aspx,27322694,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9002506,https://api.altmetric.com/v1/donut/9002506_240.png 4,Re: Racial Differences in the Surgical Care of Medicare Beneficiaries with Localized Prostate Cancer,The Journal of Urology,,,Article,2016-06-16,10.1016/j.juro.2016.06.068,,,,27597065,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8807581,https://api.altmetric.com/v1/donut/8807581_240.png 4,Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-06-12,10.1007/s00259-016-3435-0,,,,27290607,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8707860,https://api.altmetric.com/v1/donut/8707860_240.png 4,Re: A Review of Detrusor Overactivity and the Overactive Bladder after Radical Prostate Cancer Treatment,The Journal of Urology,,,Article,2016-05-18,10.1016/j.juro.2016.05.076,,,,27479404,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7600601,https://api.altmetric.com/v1/donut/7600601_240.png 4,Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer,Clinical Cancer Research,,,Article,2016-05-10,10.1158/1078-0432.ccr-16-0205,,,,27166397,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7487272,https://api.altmetric.com/v1/donut/7487272_240.png 4,Surgery Provides Better Oncologic Outcomes than Radiation for the Treatment of Prostate Cancer,The Journal of Urology,,,Article,2016-05-06,10.1016/j.juro.2016.05.007,,,,27164515,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7274323,https://api.altmetric.com/v1/donut/7274323_240.png 4,Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease,Prostate Cancer & Prostatic Diseases,,,Article,2016-04-26,10.1038/pcan.2016.14,,,,27112529,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7100068,https://api.altmetric.com/v1/donut/7100068_240.png 4,Medical Help-Seeking for Sexual Concerns in Prostate Cancer Survivors,Sexual Medicine,,,Article,2016-03-01,10.1016/j.esxm.2015.12.004,,,,26796856,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6927711,https://api.altmetric.com/v1/donut/6927711_240.png 4,Re: Prostate-Specific Antigen Decline after 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer,The Journal of Urology,,,Article,2016-04-14,10.1016/j.juro.2016.04.040,,,,27321503,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6726982,https://api.altmetric.com/v1/donut/6726982_240.png 4,No Let Down: Viagra Does Not Increase Prostate Cancer Recurrences,Oncology times,,,Article,2016-02-25,10.1097/01.cot.0000481197.70486.46,,,,,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5532485,https://api.altmetric.com/v1/donut/5532485_240.png 4,"The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.",Oncology (08909091),,,Article,2016-01-16,10.1159/000441148,,,,26771576,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5001915,https://api.altmetric.com/v1/donut/5001915_240.png 4,Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men,The Prostate,,,Article,2015-12-01,10.1002/pros.23126,,,,26660354,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4864021,https://api.altmetric.com/v1/donut/4864021_240.png 4,Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies,PLoS ONE,,,Article,2015-11-25,10.1371/journal.pone.0143404,,,,26605548,,,,,,,0,0,0,3,1,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4815394,https://api.altmetric.com/v1/donut/4815394_240.png 4,Germline copy number variation analysis in Finnish families with hereditary prostate cancer.,The Prostate,,,Article,2015-11-01,10.1002/pros.23123,,,,26552734,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4748287,https://api.altmetric.com/v1/donut/4748287_240.png 4,Re: PLC? Knockdown Inhibits Prostate Cancer Cell Proliferation via Suppression of Notch Signalling and Nuclear Translocation of the Androgen Receptor,The Journal of Urology,,,Article,2016-02-10,10.1016/j.juro.2015.10.122,,,,26853036,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4707536,https://api.altmetric.com/v1/donut/4707536_240.png 4,Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2015-10-23,10.1158/1078-0432.ccr-15-0190,,,,26490309,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4661486,https://api.altmetric.com/v1/donut/4661486_240.png 4,Prostate Single Nucleotide Polymorphism Provides a Crucial Clue to Cancer Aggression in Active Surveillance Patients,European Urology,,,Article,2015-10-09,10.1016/j.eururo.2015.09.038,,,,26455355,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4603627,https://api.altmetric.com/v1/donut/4603627_240.png 4,"In parallel comparative evaluation between multiparametric mri, pca3 and phi in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance.",British Journal of Urology,,,Article,2015-09-01,10.1111/bju.13318,,,,26350955,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4500712,https://api.altmetric.com/v1/donut/4500712_240.png 4,Targetable mutations found in metastatic prostate cancer,Lancet Oncology,,,Article,2015-06-05,10.1016/s1470-2045(15)00010-8,,,,26040853,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4077646,https://api.altmetric.com/v1/donut/4077646_240.png 4,Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer.,PLoS ONE,,,Article,,10.1371/journal.pone.0122143,,,,25933431,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3979561,https://api.altmetric.com/v1/donut/3979561_240.png 4,Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2015-04-16,10.1093/jnci/djv085,,,,25868577,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3912143,https://api.altmetric.com/v1/donut/3912143_240.png 4,Clinicians' Perceptions of the Benefits and Harms of Prostate and Colorectal Cancer Screening.,Medical Decision Making,,,Article,2015-01-30,10.1177/0272989x15569780,,,,25637592,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3211094,https://api.altmetric.com/v1/donut/3211094_240.png 4,Smoking may increase risks for patients being treated for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6891-smoking-may-increase-risks-for-patients-being-treated-for-prostate-cancer.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3107114,https://api.altmetric.com/v1/donut/3107114_240.png 4,The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate?specific Antigen?era,International Journal of Cancer,,,Article,2014-12-29,10.1002/ijc.29408,,,,25557753,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3037721,https://api.altmetric.com/v1/donut/3037721_240.png 4,Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis,European Urology,,,Article,2015-10-15,10.1016/j.eururo.2014.11.038,,,,25481455,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2948234,https://api.altmetric.com/v1/donut/2948234_240.png 4,A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity,Frontiers in oncology,,,Article,2014-11-05,10.3389/fonc.2014.00336,,,,25505734,PMC4244529,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2925753,https://api.altmetric.com/v1/donut/2925753_240.png 4,Risk Stratification in Hormone-sensitive Metastatic Prostate Cancer: More Questions than Answers,European Urology,,,Article,2015-08-01,10.1016/j.eururo.2014.10.007,,,,25457495,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2775983,https://api.altmetric.com/v1/donut/2775983_240.png 4,"Bioactivity of Greek honey extracts on breast cancer (MCF-7), prostate cancer (PC-3) and endometrial cancer (Ishikawa) cells: Profile analysis of extracts ",Food Chemistry,,,Article,2009-01-01,10.1016/j.foodchem.2009.03.024,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2685387,https://api.altmetric.com/v1/donut/2685387_240.png 4,Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.,BMC Biotechnology,,,Article,2014-09-03,10.1186/1472-6750-14-81,,,,25186190,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2653257,https://api.altmetric.com/v1/donut/2653257_240.png 4,"The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men",European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.011,,,,25168616,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,30,https://www.altmetric.com/details/2627438,https://api.altmetric.com/v1/donut/2627438_240.png 4,Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.,British Journal of Urology,,,Article,2014-08-08,,,,,25101359,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2584807,https://api.altmetric.com/v1/donut/2584807_240.png 4,"Sunlight exposure during leisure activities and risk of prostate cancer in Montréal, Canada, 2005–2009",BMC Public Health,,,Article,2014-07-28,10.1186/1471-2458-14-756,,,,25065376,,,,,,,0,0,0,7,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2568245,https://api.altmetric.com/v1/donut/2568245_240.png 4,The struggle towards ‘the New Normal’: a qualitative insight into psychosexual adjustment to prostate cancer,BMC Urology,,,Article,2014-07-30,10.1186/1471-2490-14-56,,,,25073798,,,,,,,0,0,0,12,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2551886,https://api.altmetric.com/v1/donut/2551886_240.png 4,Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1? stabilization.,The Journal of Pathology,,,Article,2014-09-15,10.1002/path.4413,,,,25065497,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2544629,https://api.altmetric.com/v1/donut/2544629_240.png 4,"Proton Beam Therapy for Localized Prostate Cancer 101: Basics, Controversies, and Facts",Reviews in Urology,,,Article,2014-07-17,,,,,25009446,PMC4080851,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2516268,https://api.altmetric.com/v1/donut/2516268_240.png 4,Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort,European Urology,,,Article,2015-02-01,10.1016/j.eururo.2014.05.039,,,,24998118,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,52,https://www.altmetric.com/details/2482739,https://api.altmetric.com/v1/donut/2482739_240.png 4,Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy,JAMA: Journal of the American Medical Association,,,Article,2005-01-01,10.1001/jama.294.4.433,,,,16046649,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2457826,https://api.altmetric.com/v1/donut/2457826_240.png 4,Prostate cancer: Metformin[mdash]the new wonder drug?,Nature Reviews Urology,,,Article,2014-06-10,10.1038/nrurol.2014.136,,,,24914783,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2427202,https://api.altmetric.com/v1/donut/2427202_240.png 4,Role of Radical Prostatectomy in Metastatic Prostate Cancer: Data from the Munich Cancer Registry,European Urology,,,Article,2014-09-01,10.1016/j.eururo.2014.04.009,,,,24821581,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2340733,https://api.altmetric.com/v1/donut/2340733_240.png 4,"Testing the feasibility, acceptability and effectiveness of a decision navigation intervention for early stage prostate cancer patients in Scotland a randomised controlled trial",Psycho-Oncology,,,Article,2013-01-01,10.1002/pon.3093,,,,22570252,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2223487,https://api.altmetric.com/v1/donut/2223487_240.png 4,Prostate cancer: Radiotherapy[mdash]treating patients in a fast-moving field,Nature Reviews Urology,,,Article,2014-03-25,10.1038/nrurol.2014.72,,,,24662729,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2210896,https://api.altmetric.com/v1/donut/2210896_240.png 4,Relationship Between Radiation-Induced Apoptosis of T Lymphocytes and Chronic Toxicity in Patients With Prostate Cancer Treated by Radiation Therapy: A Prospective Study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2014.01.002,,,,24661659,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2207653,https://api.altmetric.com/v1/donut/2207653_240.png 4,Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate Cancer.,European Urology,,,Article,,10.1016/j.eururo.2014.01.026,,,,24495466,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2125104,https://api.altmetric.com/v1/donut/2125104_240.png 4,Prostate-specific membrane antigen expression in normal and malignant human tissues.,Clinical Cancer Research,,,Article,1997-01-01,,,,,9815541,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1920943,https://api.altmetric.com/v1/donut/1920943_240.png 4,Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary.,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-2134,,,,24150234,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1853072,https://api.altmetric.com/v1/donut/1853072_240.png 4,Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-10-01,10.1016/j.ijrobp.2013.08.032,,,,24139077,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1829644,https://api.altmetric.com/v1/donut/1829644_240.png 4,Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines,Investigational New Drugs,,,Article,2013-09-13,10.1007/s10637-013-0006-0,,,,24026433,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/1769602,https://api.altmetric.com/v1/donut/1769602_240.png 4,Probiotics for Rectal Volume Variation During Radiation Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-09-19,10.1016/j.ijrobp.2013.07.038,,,,24054874,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1768232,https://api.altmetric.com/v1/donut/1768232_240.png 4,Gene Expression Profiling of Localized Prostate Cancer: Getting Answers to the Questions That Really Matter,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.51.0420,,,,23940217,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1691809,https://api.altmetric.com/v1/donut/1691809_240.png 4,Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers,Radiation Oncology,,,Article,2013-07-25,10.1186/1748-717x-8-188,,,,23885662,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1649660,https://api.altmetric.com/v1/donut/1649660_240.png 4,More Evidence for Link Between Omega-3 Fatty Acids and Prostate Cancer,Journal Watch,,,Article,2013-07-11,10.1056/nejm-jw.fw107685,,,,,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1617117,https://api.altmetric.com/v1/donut/1617117_240.png 4,Transrectal Saturation Technique May Improve Cancer Detection as an Initial Prostate Biopsy Strategy in Men with Prostate-specific Antigen <10 ng/ml.,European Urology,,,Article,2013-06-04,10.1016/j.eururo.2013.05.047,,,,23768632,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1567237,https://api.altmetric.com/v1/donut/1567237_240.png 4,Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors,Medical Dosimetry,,,Article,2013-06-01,10.1016/j.meddos.2013.03.007,,,,23747223,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1537549,https://api.altmetric.com/v1/donut/1537549_240.png 4,Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis.,European Urology,,,Article,2012-11-07,10.1016/j.eururo.2012.10.036,,,,23122664,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1313890,https://api.altmetric.com/v1/donut/1313890_240.png 4,"Prostate Cancer and Prostatic Intraepithelial Neoplasia: True, True, and Unrelated?",Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.46.6151,,,,23295801,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1159931,https://api.altmetric.com/v1/donut/1159931_240.png 4,Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation,Journal of Clinical Investigation,,,Article,2012-06-13,10.1172/jci62044,,,,22684108,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,33,https://www.altmetric.com/details/866279,https://api.altmetric.com/v1/donut/866279_240.png 4,New Insights Into the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate Cancer.,Nutrition and Cancer,,,Article,2011-11-23,10.1080/01635581.2012.630158,,,,22098273,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/829309,https://api.altmetric.com/v1/donut/829309_240.png 4,Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-11-3795,,,,22461511,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/746763,https://api.altmetric.com/v1/donut/746763_240.png 4,Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.,Journal of Clinical Oncology,,,Article,2007-01-01,10.1200/jco.2006.06.9351,,,,17264339,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/719964,https://api.altmetric.com/v1/donut/719964_240.png 4,"Caffeic Acid Phenethyl Ester Causes p21Cip1 Induction, Akt Signaling Reduction, and Growth Inhibition in PC-3 Human Prostate Cancer Cells",PLoS ONE,,,Article,2012-02-07,10.1371/journal.pone.0031286,,,,22347457,,,2012PLoSO...7E1286L,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/595907,https://api.altmetric.com/v1/donut/595907_240.png 4,Is prostate cancer screening responsible for the negative results of prostate cancer treatment trials?,Medical Hypotheses,,,Article,2016-08-01,10.1016/j.mehy.2016.05.019,,,,27372859,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9218921,https://api.altmetric.com/v1/donut/9218921_240.png 4,Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.,European Urology,,,Article,2008-04-01,10.1016/j.eururo.2007.11.064,,,,18079051,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/5501454,https://api.altmetric.com/v1/donut/5501454_240.png 4,"Re: A 17-Gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling",The Journal of Urology,,,Article,2014-01-10,10.1016/j.juro.2014.07.068,,,,25304553,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2717786,https://api.altmetric.com/v1/donut/2717786_240.png 4,Prostate cancer: Preventing metastasis to bone: is this the end of the story?,Nature Reviews Urology,,,Article,2014-04-15,10.1038/nrurol.2014.88,,,,24731994,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2280783,https://api.altmetric.com/v1/donut/2280783_240.png 4,PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy,Clinical Epigenetics,,,Article,2016-09-26,10.1186/s13148-016-0270-x,,,,27708722,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12243767,https://api.altmetric.com/v1/donut/12243767_240.png 4,Re: Identification of Bone Metastasis with Routine Prostate MRI: A Study of Patients with Newly Diagnosed Prostate Cancer,The Journal of Urology,,,Article,2016-10-19,10.1016/j.juro.2016.08.066,,,,27751455,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10772087,https://api.altmetric.com/v1/donut/10772087_240.png 4,Emotional distress increases the likelihood of receiving surgery among men with localized prostate cancer,The Journal of Urology,,,Article,2016-08-06,10.1016/j.juro.2016.08.007,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10307859,https://api.altmetric.com/v1/donut/10307859_240.png 4,225Ac-PSMA-617 for PSMA targeting alpha-radiation therapy of patients with metastatic castration-resistant prostate cancer,Journal of Nuclear Medicine,,,Article,2016-07-07,10.2967/jnumed.116.178673,,,,27390158,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9534712,https://api.altmetric.com/v1/donut/9534712_240.png 4,Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients,EBioMedicine,,,Article,2016-04-01,10.1016/j.ebiom.2016.03.041,,,,27322461,PMC4909641,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6775418,https://api.altmetric.com/v1/donut/6775418_240.png 4,New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2015-07-29,,,,,26222274,,,,,,,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6403821,https://api.altmetric.com/v1/donut/6403821_240.png 4,Statins May Prevent Rectal Radiation Injury in Prostate Cancer Patients,Oncology times,,,Article,2016-03-10,10.1097/01.cot.0000481875.84617.aa,,,http://journals.lww.com/oncology-times/Fulltext/2016/03100/Statins_May_Prevent_Rectal_Radiation_Injury_in.13.aspx,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6041658,https://api.altmetric.com/v1/donut/6041658_240.png 4,Artificial neural networks and prostate cancer--tools for diagnosis and management,Nature Reviews Urology,,,Article,2013-03-15,10.1038/nrurol.2013.9,,,,23399728,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/5911393,https://api.altmetric.com/v1/donut/5911393_240.png 4,Re: PSA Mass Density - a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution,Urology,,,Article,2016-01-01,10.1016/j.urology.2016.01.013,,,,26809070,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5029021,https://api.altmetric.com/v1/donut/5029021_240.png 4,Prostate cancer: Proteomics provides a prognostic marker,Nature Reviews Urology,,,Article,2015-12-22,10.1038/nrurol.2015.305,,,,26689842,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4910583,https://api.altmetric.com/v1/donut/4910583_240.png 4,Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis,JNCI: Journal of the National Cancer Institute,,,Article,2016-05-01,10.1093/jnci/djv380,,,,26683407,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4896572,https://api.altmetric.com/v1/donut/4896572_240.png 4,PAX2 promoted prostate cancer cell invasion through transcriptional regulation of HGF in an in vitro model ,Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,,,Article,2015-08-19,10.1016/j.bbadis.2015.08.008,,,,26296757,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4451672,https://api.altmetric.com/v1/donut/4451672_240.png 4,Genome-Wide Association Study of Prostate Cancer–Specific Survival,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-08-27,10.1158/1055-9965.epi-15-0543,,,,26307654,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4441501,https://api.altmetric.com/v1/donut/4441501_240.png 4,A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2015-10-01,10.1093/jnci/djv197,,,,26242893,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4362937,https://api.altmetric.com/v1/donut/4362937_240.png 4,Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study,BMC Urology,,,Article,2015-07-02,10.1186/s12894-015-0058-x,,,,26134117,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4247923,https://api.altmetric.com/v1/donut/4247923_240.png 4,"Prospective Comparison of the detection rate of18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy",Journal of Nuclear Medicine,,,Article,2015-06-27,10.2967/jnumed.115.160382,,,,26112024,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,36,https://www.altmetric.com/details/4219262,https://api.altmetric.com/v1/donut/4219262_240.png 4,Prostate cancer ,The Lancet,,,Article,2015-06-16,10.1016/s0140-6736(14)61947-4,,,,26074382,,,,,,,0,0,0,8,0,0,6,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4137161,https://api.altmetric.com/v1/donut/4137161_240.png 4,ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer,Journal of Clinical Pathology,,,Article,2015-06-09,10.1136/jclinpath-2015-202894,,,,26060265,,,,,,,0,0,0,10,0,0,3,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4125120,https://api.altmetric.com/v1/donut/4125120_240.png 4,Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.,Oncotarget,,,Article,2015-06-04,10.18632/oncotarget.3854,,,,26036629,PMC4599273,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4093307,https://api.altmetric.com/v1/donut/4093307_240.png 4,Cisobitan® in Treatment of Prostatic Cancer,Scandinavian Journal of Urology & Nephrology,,,Article,1983-01-01,10.3109/00365598309179778,,,,6346476,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4030848,https://api.altmetric.com/v1/donut/4030848_240.png 4,Prostate cancer: Intermediate risk: RT or ADT?,Nature Reviews Urology,,,Article,2015-05-19,10.1038/nrurol.2015.117,,,,25986764,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4010094,https://api.altmetric.com/v1/donut/4010094_240.png 4,Enzalutamide: A Review of Its Use in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer,Drugs & Aging,,,Article,2015-02-25,10.1007/s40266-015-0248-y,,,,25711765,,,,,,,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3743285,https://api.altmetric.com/v1/donut/3743285_240.png 4,Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer,Oncogene,,,Article,2004-06-28,10.1038/sj.onc.1207880,,,,15221013,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/3557272,https://api.altmetric.com/v1/donut/3557272_240.png 4,Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells.,Molecular and Cellular Proteomics (MCP Online),,,Article,2007-04-01,10.1074/mcp.m600249-mcp200,,,,17220478,,,,,,,0,0,0,0,0,0,1,14,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3492173,https://api.altmetric.com/v1/donut/3492173_240.png 4,Inhibitory mechanisms of Agaricus blazei Murill on the growth of prostate cancer in vitro and in vivo.,Journal of Nutritional Biochemistry,,,Article,2015-05-22,10.1016/j.jnutbio.2008.07.004,,,,18926679,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3325176,https://api.altmetric.com/v1/donut/3325176_240.png 4,International epidemiology of prostate cancer: geographical distribution and secular trends.,Molecular Nutrition & Food Research,,,Article,2008-12-19,10.1002/mnfr.200700511,,,,19101947,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,88,https://www.altmetric.com/details/3218155,https://api.altmetric.com/v1/donut/3218155_240.png 4,Prostate cancer epidemiology.,Frontiers in Bioscience,,,Article,2005-12-22,,,,,16368524,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3174028,https://api.altmetric.com/v1/donut/3174028_240.png 4,The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis.,Family Practise,,,Article,,10.1093/fampra/cmq115,,,,21273283,,,,,,,0,0,0,1,0,0,0,2,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3165044,https://api.altmetric.com/v1/donut/3165044_240.png 4,Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.,European Urology,,,Article,,10.1016/j.eururo.2008.09.024,,,,18838208,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/3147931,https://api.altmetric.com/v1/donut/3147931_240.png 4,Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review).,International Journal of Oncology,,,Article,2010-07-29,,,,,20664922,,,,,,,0,0,0,1,0,0,0,3,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3120148,https://api.altmetric.com/v1/donut/3120148_240.png 4,Prostate cancer: a practical guide,Lancet Oncology,,,Article,2015-01-02,10.1016/s1470-2045(15)70042-2,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3118260,https://api.altmetric.com/v1/donut/3118260_240.png 4,Focal therapy in prostate cancer: the current situation.,Ecancermedicalscience,,,Article,2014-12-07,10.3332/ecancer.2014.435,,,,24944577,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2960458,https://api.altmetric.com/v1/donut/2960458_240.png 4,PD-L1 is highly expressed in Enzalutamide resistant prostate cancer.,Oncotarget,,,Article,2014-11-06,10.18632/oncotarget.2703,,,,25428917,PMC4381591,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2932830,https://api.altmetric.com/v1/donut/2932830_240.png 4,The Effect of Dietary and Exercise Interventions on Body Weight in Prostate Cancer Patients: A Systematic Review.,Nutrition and Cancer,,,Article,2014-11-25,10.1080/01635581.2015.976313,,,,25425328,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2929653,https://api.altmetric.com/v1/donut/2929653_240.png 4,Association between dietary inflammatory index and prostate cancer among Italian men,British Journal of Nutrition,,,Article,2014-11-17,10.1017/s0007114514003572,,,,25400225,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2902423,https://api.altmetric.com/v1/donut/2902423_240.png 4,[Dietary fatty acids and colorectal and prostate cancers: epidemiological studies].,Bulletin du Cancer,,,Article,2005-08-28,,,,,16123006,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2837995,https://api.altmetric.com/v1/donut/2837995_240.png 4,Decreased expression of EFS is correlated with the advanced prostate cancer.,Tumor Biology,,,Article,2014-10-09,10.1007/s13277-014-2703-5,,,,25296736,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2804764,https://api.altmetric.com/v1/donut/2804764_240.png 4,Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis,Cancer Letters,,,Article,2009-02-18,10.1016/j.canlet.2008.09.023,,,,19006645,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2727520,https://api.altmetric.com/v1/donut/2727520_240.png 4,Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis,Journal of Clinical Oncology,,,Article,,10.1200/jco.2013.54.3553,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/2686613,https://api.altmetric.com/v1/donut/2686613_240.png 4,Luminal Cells Are Favored as the Cell of Origin for Prostate Cancer,Cell Reports,,,Article,2014-08-26,10.1016/j.celrep.2014.08.002,,,,25176651,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/2635492,https://api.altmetric.com/v1/donut/2635492_240.png 4,Perspective on prostate cancer screening,International journal of clinical practice,,,Article,2011-01-01,10.1111/j.1742-1241.2010.02456.x,,,,21155942,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,https://www.altmetric.com/details/2487016,https://api.altmetric.com/v1/donut/2487016_240.png 4,Testosterone serum levels and prostate cancer prognosis: the double face of Janus.,Future Oncology,,,Article,2014-06-21,10.2217/fon.14.1,,,,24947249,,,,,,,0,0,0,5,0,0,2,0,1,0,1,0,0,0,0,5,https://www.altmetric.com/details/2457823,https://api.altmetric.com/v1/donut/2457823_240.png 4,Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer,Cancer (0008543X),,,Article,2014-06-10,10.1002/cncr.28790,,,,24917122,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2429801,https://api.altmetric.com/v1/donut/2429801_240.png 4,Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis,Supportive Care in Cancer,,,Article,2014-05-25,10.1007/s00520-014-2285-1,,,,24859915,,,,,,,0,0,0,2,0,0,2,0,2,0,0,0,0,0,0,12,https://www.altmetric.com/details/2381171,https://api.altmetric.com/v1/donut/2381171_240.png 4,Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance.,Cancer Prevention Research,,,Article,,10.1158/1940-6207.capr-13-0349,,,,24824038,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2350814,https://api.altmetric.com/v1/donut/2350814_240.png 4,Prostate cancer: Enzalutamide impresses in European studies,Nature Reviews Urology,,,Article,2014-04-29,10.1038/nrurol.2014.98,,,,24776976,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2312102,https://api.altmetric.com/v1/donut/2312102_240.png 4,"To Treat or Not to Treat, That Is the Question: The Role of Bone-Targeted Therapy in Metastatic Prostate Cancer",Journal of Clinical Oncology,,,Article,,10.1200/jco.2013.53.8900,,,,24590651,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2257528,https://api.altmetric.com/v1/donut/2257528_240.png 4,Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.,JNCI: Journal of the National Cancer Institute,,,Article,1970-01-01,10.1093/jnci/djj190,,,,16705126,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/2254137,https://api.altmetric.com/v1/donut/2254137_240.png 4,Extracts from Epilobium sp. herbs induce apoptosis in human hormone-dependent prostate cancer cells by activating the mitochondrial pathway.,Journal of Pharmacy & Pharmacology,,,Article,2013-06-08,10.1111/jphp.12063,,,,23738732,,,,,,,0,0,0,2,0,0,1,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2251995,https://api.altmetric.com/v1/donut/2251995_240.png 4,Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression,Molecular Cancer,,,Article,2014-03-31,10.1186/1476-4598-13-74,,,,24684754,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2233043,https://api.altmetric.com/v1/donut/2233043_240.png 4,"Is ""pelvic radiation disease"" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy?",Radiotherapy & Oncology,,,Article,2014-01-02,10.1016/j.radonc.2013.11.012,,,,24412017,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2203944,https://api.altmetric.com/v1/donut/2203944_240.png 4,Diffusion-Weighted Magnetic Resonance Imaging Detects Significant Prostate Cancer with High Probability,The Journal of Urology,,,Article,2014-03-17,10.1016/j.juro.2014.03.039,,,,24641913,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2191759,https://api.altmetric.com/v1/donut/2191759_240.png 4,Prevention of Bone Metastases in Patients with High-risk Nonmetastatic Prostate Cancer Treated with Zoledronic Acid: Efficacy and Safety Results of the Zometa European Study (ZEUS),European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.02.014,,,,24630685,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2166379,https://api.altmetric.com/v1/donut/2166379_240.png 4,Prospective Evaluation of an Extended 21-Core Biopsy Scheme as Initial Prostate Cancer Diagnostic Strategy.,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2012.05.049,,,,22698576,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2125086,https://api.altmetric.com/v1/donut/2125086_240.png 4,Serum levels of arachidonic acid metabolites change during prostate cancer progression.,The Prostate,,,Article,2013-01-01,10.1002/pros.22779,,,,24435810,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2079732,https://api.altmetric.com/v1/donut/2079732_240.png 4,The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2013-10-01,10.1016/j.eururo.2013.09.024,,,,24120464,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,31,https://www.altmetric.com/details/1835638,https://api.altmetric.com/v1/donut/1835638_240.png 4,American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,1999-07-01,,,,,10386635,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,85,https://www.altmetric.com/details/1805282,https://api.altmetric.com/v1/donut/1805282_240.png 4,"Activation of the Wnt pathway through use of AR79, a glycogen synthase kinase 3beta inhibitor, promotes prostate cancer growth in soft tissue and bone.",Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-13-0332-t,,,,24088787,,,,,,,0,0,0,4,2,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1800613,https://api.altmetric.com/v1/donut/1800613_240.png 4,Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro.,Integrative Cancer Therapies,,,Article,2006-12-01,10.1177/1534735406294224,,,,17101765,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1798794,https://api.altmetric.com/v1/donut/1798794_240.png 4,Prostate-specific Antigen–Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer,European Urology,,,Article,2013-08-01,10.1016/j.eururo.2013.08.005,,,,23954085,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1690425,https://api.altmetric.com/v1/donut/1690425_240.png 4,Circulating Steroid Hormones and the Risk of Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2006-01-26,10.1158/1055-9965.epi-05-0633,,,,16434592,,1959.8/122008,,,,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1647762,https://api.altmetric.com/v1/donut/1647762_240.png 4,Prostate cancer invasion and metastasis: insights from mining genomic data.,Briefings in Functional Genomics,,,Article,2013-07-22,10.1093/bfgp/elt021,,,,23878130,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,23,https://www.altmetric.com/details/1645478,https://api.altmetric.com/v1/donut/1645478_240.png 4,Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells.,International Journal of Oncology,,,Article,2001-01-01,,,,,11115542,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1612544,https://api.altmetric.com/v1/donut/1612544_240.png 4,Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.,Cancer Research,,,Article,2007-01-01,10.1158/0008-5472.can-06-4069,,,,17804756,,,,,,,0,0,0,0,0,0,2,2,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1514104,https://api.altmetric.com/v1/donut/1514104_240.png 4,"Serum Prostate-Specific Antigen for the Early Detection of Prostate Cancer: Always, Never, or Only Sometimes?",Journal of Clinical Oncology,,,Article,2011-01-01,10.1200/jco.2010.32.5308,,,,21189396,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1483300,https://api.altmetric.com/v1/donut/1483300_240.png 4,Effect of capsaicin on prostate cancer cells.,Future Oncology,,,Article,2010-11-11,10.2217/fon.10.117,,,,21062154,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1475906,https://api.altmetric.com/v1/donut/1475906_240.png 4,The Role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.,European Urology,,,Article,2013-04-19,10.1016/j.eururo.2013.04.019,,,,23628493,,,,,,,0,0,3,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1424794,https://api.altmetric.com/v1/donut/1424794_240.png 4,Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study,Radiation Oncology,,,Article,2013-04-23,10.1186/1748-717x-8-96,,,,23618548,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1406652,https://api.altmetric.com/v1/donut/1406652_240.png 4,"Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study.",American Journal of Epidemiology,,,Article,2004-01-01,10.1093/aje/kwh062,,,,14977640,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1367136,https://api.altmetric.com/v1/donut/1367136_240.png 4,"Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB 1 Receptor Expression and Regulation by IL-4",PLoS ONE,,,Article,2010-08-19,10.1371/journal.pone.0012275,,,,20808855,,,2010PLoSO...512275T,,,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1353238,https://api.altmetric.com/v1/donut/1353238_240.png 4,Analysis of intraprostatic therapeutic effects in prostate cancer patients using [(11)C]-choline pet/ct after external-beam radiation therapy.,Current Oncology,,,Article,2013-04-01,10.3747/co.20.1217,,,,23559873,PMC3615852,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1348646,https://api.altmetric.com/v1/donut/1348646_240.png 4,"Genetic Susceptibility Loci, Pesticide Exposure and Prostate Cancer Risk",PLoS ONE,"DARWIN, Chuckie G",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-04-04,10.1371/journal.pone.0058195,,,,23593118,PMC3617165,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1339737,https://api.altmetric.com/v1/donut/1339737_240.png 4,MicroRNAs and prostate cancer.,Acta Biochimica et Biophysica Sinica,,,Article,2010-06-13,,,,,20539944,,,,,,,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1335417,https://api.altmetric.com/v1/donut/1335417_240.png 4,Robotic-assisted prostate cancer surgery drives up costs,ecancer.org,,,Article,,,,,http://ecancer.org/news/2855-robotic-assisted-prostate-cancer-surgery-drives-up-costs.php,,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251405,https://api.altmetric.com/v1/donut/1251405_240.png 4,Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.,Cancer Research,,,Article,2005-01-01,10.1158/0008-5472.can-04-4662,,,,15899838,,,,,,,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1244882,https://api.altmetric.com/v1/donut/1244882_240.png 4,Bitter Melon Extract Impairs Prostate Cancer Cell-Cycle Progression and Delays Prostatic Intraepithelial Neoplasia in TRAMP Model,Cancer Prevention Research,,,Article,2011-09-14,10.1158/1940-6207.capr-11-0376,,,,21911444,,,,,,,0,0,0,3,0,0,4,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1233463,https://api.altmetric.com/v1/donut/1233463_240.png 4,False-negative bone scan and choline pet/ct study in a case of prostate cancer: the pitfall of the small cell prostate carcinoma variant.,World Journal of Nuclear Medicine,,,Article,2013-02-02,10.4103/1450-1147.103422,,,,23372441,PMC3555398,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1215503,https://api.altmetric.com/v1/donut/1215503_240.png 4,15-Lipoxygenase Metabolites of Docosahexaenoic Acid Inhibit Prostate Cancer Cell Proliferation and Survival,PLoS ONE,,,Article,2013-01-12,10.1371/journal.pone.0045480,,,,23029040,PMC3447860,,,,,,0,0,0,0,0,0,1,3,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1171848,https://api.altmetric.com/v1/donut/1171848_240.png 4,Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial,Prostate Cancer,,,Article,2012-01-01,10.1155/2012/814724,,,,23320177,PMC3540903,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1141144,https://api.altmetric.com/v1/donut/1141144_240.png 4,"Vitamin D3 supplementation, low-risk prostate cancer, and health disparities",Journal of Steroid Biochemistry & Molecular Biology,,,Article,2012-12-01,10.1016/j.jsbmb.2012.11.012,,,,23220550,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1121444,https://api.altmetric.com/v1/donut/1121444_240.png 4,Immunotherapy for the treatment of prostate cancer.,Nature Reviews Clinical Oncology,,,Article,2011-05-24,10.1038/nrclinonc.2011.72,,,,21606971,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1100716,https://api.altmetric.com/v1/donut/1100716_240.png 4,Androgen receptor molecular biology and potential targets in prostate cancer,Therapeutic Advances in Urology,,,Article,2010-01-01,10.1177/1756287210372380,,,,21789088,PMC3126091,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1087379,https://api.altmetric.com/v1/donut/1087379_240.png 4,11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2012-11-14,10.1007/s00259-012-2272-z,,,,23151910,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1072902,https://api.altmetric.com/v1/donut/1072902_240.png 4,DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.02.014,,,,22494583,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1071373,https://api.altmetric.com/v1/donut/1071373_240.png 4,High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-08-27,10.1016/j.ijrobp.2012.07.004,,,,22929859,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1020534,https://api.altmetric.com/v1/donut/1020534_240.png 4,A Multiplex Assay to Measure RNA Transcripts of Prostate Cancer in Urine,PLoS ONE,,,Article,2012-09-20,10.1371/journal.pone.0045656,,,,23029164,PMC3447789,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/957194,https://api.altmetric.com/v1/donut/957194_240.png 4,Emerging and second line therapies for the management of metastatic castration?resistant prostate cancer: The Australian perspective,Asia Pacific Journal of Clinical Oncology,,,Article,2012-01-01,10.1111/j.1743-7563.2011.01506.x,,,,22369442,,,,,,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/947968,https://api.altmetric.com/v1/donut/947968_240.png 4,Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2012-03-16,10.1007/s00259-012-2083-2,,,,22415598,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/932940,https://api.altmetric.com/v1/donut/932940_240.png 4,Contemporary role of androgen deprivation therapy for prostate cancer.,European Urology,,,Article,2011-08-30,10.1016/j.eururo.2011.08.026,,,,21871711,,,,,,,0,0,0,2,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/840296,https://api.altmetric.com/v1/donut/840296_240.png 4,Immunotherapy for Prostate Cancer Enters Its Golden Age,Clinical Medicine Insights: Oncology,,,Article,2012-07-01,10.4137/cmo.s7475,,,,22844202,PMC3403579,,,,,,0,0,0,2,0,0,1,0,1,0,0,0,0,0,0,13,https://www.altmetric.com/details/832059,https://api.altmetric.com/v1/donut/832059_240.png 4,Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djs288,,,,22781434,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/830737,https://api.altmetric.com/v1/donut/830737_240.png 4,Cost?effectiveness of Prostate Health Index for prostate cancer detection,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2011.10751.x,,,,22077934,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/811651,https://api.altmetric.com/v1/donut/811651_240.png 4,Predicting Survival for Surgery of Metastatic Spinal Cord Compression in Prostate Cancer: A New Score.,Spine,,,Article,2012-06-05,10.1097/brs.0b013e31826011bc,,,,22648028,,,,,,,0,0,1,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/785582,https://api.altmetric.com/v1/donut/785582_240.png 4,Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy,Advances in Urology,,,Article,2012-01-01,10.1155/2012/862639,,,,22649447,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/772615,https://api.altmetric.com/v1/donut/772615_240.png 4,Prostate cancer treatment unblinded,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70136-5,,,,22512845,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/700769,https://api.altmetric.com/v1/donut/700769_240.png 4,"Prostate cancer genomics, biology, and risk assessment through genome?wide association studies",Cancer Science,,,Article,2012-04-01,10.1111/j.1349-7006.2011.02193.x,,,,22181854,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/669908,https://api.altmetric.com/v1/donut/669908_240.png 4,Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer,Molecular Endocrinology,,,Article,2012-01-01,10.1210/me.2011-1101,,,,22403175,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/647199,https://api.altmetric.com/v1/donut/647199_240.png 4,Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer,Radiation Oncology,,,Article,2012-03-07,10.1186/1748-717x-7-31,,,,22397528,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/640128,https://api.altmetric.com/v1/donut/640128_240.png 4,Unusual f-18 choline uptake in penile metastasis from prostate cancer.,Clinical Nuclear Medicine,,,Article,2012-04-01,10.1097/rlu.0b013e3182485311,,,,22391732,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/638490,https://api.altmetric.com/v1/donut/638490_240.png 4,Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer,Histopathology,,,Article,2012-01-01,10.1111/j.1365-2559.2011.04004.x,,,,22212083,,,,,,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/602238,https://api.altmetric.com/v1/donut/602238_240.png 4,Study on the distribution features of bone metastases in prostate cancer.,Nuclear Medicine Communications,,,Article,2012-01-29,10.1097/mnm.0b013e3283504528,,,,22293499,,,,,,,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/586526,https://api.altmetric.com/v1/donut/586526_240.png 4,Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050).,The Prostate,,,Article,2011-10-05,10.1002/pros.21495,,,,22287276,,,,,,,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/581935,https://api.altmetric.com/v1/donut/581935_240.png 4,"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group",British Journal of Urology,,,Article,2012-02-01,10.1111/j.1464-410x.2011.10827.x,,,,22239226,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/576935,https://api.altmetric.com/v1/donut/576935_240.png 4,Abiraterone acetate: redefining hormone treatment for advanced prostate cancer.,Drug Discovery Today,,,Article,2011-12-19,10.1016/j.drudis.2011.12.012,,,,22198164,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/509822,https://api.altmetric.com/v1/donut/509822_240.png 4,Sipuleucel?T (Provenge®) for castration?resistant prostate cancer,British Journal of Urology,,,Article,2011-12-16,10.1111/j.1464-410x.2011.10790.x,,,,22177289,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/501258,https://api.altmetric.com/v1/donut/501258_240.png 4,Hepatic Splenosis Diagnosed After Inappropriate Metastatic Evaluation in Patient With Low-risk Prostate Cancer,Urology,,,Article,2011-11-30,10.1016/j.urology.2011.09.041,,,,22119260,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/471183,https://api.altmetric.com/v1/donut/471183_240.png 4,"Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: a case report",Journal of Medical Case Reports,,,Article,2011-08-25,10.1186/1752-1947-5-413,,,,21867542,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/420013,https://api.altmetric.com/v1/donut/420013_240.png 4,Superscan pattern of F-18 sodium fluoride PET/CT study in a case of prostate cancer.,Clinical Nuclear Medicine,,,Article,2011-11-01,10.1097/rlu.0b013e3182291c3d,,,,21975402,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/396702,https://api.altmetric.com/v1/donut/396702_240.png 4,In vivo visualization of somatostatin receptor expression with Ga-68-DOTA-TATE PET/CT in advanced metastatic prostate cancer.,Clinical Nuclear Medicine,,,Article,2011-11-01,10.1097/rlu.0b013e31822920c9,,,,21975409,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/396550,https://api.altmetric.com/v1/donut/396550_240.png 4,Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population,PLoS ONE,,,Article,2011-05-16,10.1371/journal.pone.0019804,,,,21603625,PMC3095629,,2011PLoSO...6E9804L,,,,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/375691,https://api.altmetric.com/v1/donut/375691_240.png 4,Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells,Integrative Biology,,,Article,2011-01-01,10.1039/c0ib00122h,,,,21594291,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/375274,https://api.altmetric.com/v1/donut/375274_240.png 4,Combination of IG-IMRT and permanent source prostate brachytherapy in patients with organ-confined prostate cancer: GU and GI toxicity and effect on erectile function,Brachytherapy,,,Article,2011-01-01,10.1016/j.brachy.2010.09.004,,,,21030319,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/257677,https://api.altmetric.com/v1/donut/257677_240.png 4,Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic.,Cancer Research,,,Article,2010-03-09,10.1158/0008-5472.can-09-2408,,,,20215509,,,,,,,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/242430,https://api.altmetric.com/v1/donut/242430_240.png 4,Surgical management after active surveillance for low?risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment,British Journal of Urology,,,Article,2011-04-01,10.1111/j.1464-410x.2010.09589.x,,,,20804478,,,,,,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/215839,https://api.altmetric.com/v1/donut/215839_240.png 4,Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis,International Journal of Cancer,,,Article,2011-03-28,10.1002/ijc.26097,,,,21445975,,,,,,,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/214087,https://api.altmetric.com/v1/donut/214087_240.png 4,Heterogeneous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2011-08-01,10.1002/jcb.23291,,,,21809373,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/203168,https://api.altmetric.com/v1/donut/203168_240.png 4,Recent advances in second-line treatment of castration-resistant prostate cancer.,Current Opinion in Supportive and Palliative Care,,,Article,2011-07-02,10.1097/spc.0b013e32834903aa,,,,21734586,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/182466,https://api.altmetric.com/v1/donut/182466_240.png 4,Elderly and prostate cancer screening.,Urology Journal,,,Article,2011-01-01,,,,,21656465,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/150047,https://api.altmetric.com/v1/donut/150047_240.png 4,Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients,Expert Opinion on Pharmacotherapy,,,Article,2011-06-15,10.1517/14656566.2011.590132,,,,21671835,,,,,,,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/129872,https://api.altmetric.com/v1/donut/129872_240.png 4,The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients,Prostate Cancer & Prostatic Diseases,,,Article,2016-10-25,10.1038/pcan.2016.52,,,,27779202,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13044925,https://api.altmetric.com/v1/donut/13044925_240.png 4,Prostate cancer screening: Do guidelines matter?,Cancer (0008543X),,,Article,2016-09-22,10.1002/cncr.30331,,,,27656862,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12239477,https://api.altmetric.com/v1/donut/12239477_240.png 4,Anti-CD24 Nano-targeted Delivery of Docetaxel for the Treatment of Prostate Cancer,"Nanomedicine: Nanotechnology, Biology and Medicine",,,Article,2016-08-23,10.1016/j.nano.2016.08.017,,,,27565690,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10809166,https://api.altmetric.com/v1/donut/10809166_240.png 4,Prostate cancer: Fitting to overcome enzalutamide resistance,Nature Reviews Urology,,,Article,2016-08-23,10.1038/nrurol.2016.160,,,,27549359,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10775115,https://api.altmetric.com/v1/donut/10775115_240.png 4,Radium-223 in prostate cancer: emitting the right signals ,Lancet Oncology,,,Article,2016-07-31,10.1016/s1470-2045(16)30248-0,,,,27473889,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10067482,https://api.altmetric.com/v1/donut/10067482_240.png 4,miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis,PLoS ONE,,,Article,2016-07-22,10.1371/journal.pone.0159601,,,,27447934,PMC4957825,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10009930,https://api.altmetric.com/v1/donut/10009930_240.png 4,"A urologist’s perspective on prostate cancer imaging: past, present, and future",Abdominal radiology (New York),,,Article,2016-05-02,10.1007/s00261-016-0751-6,,,,27138438,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8207382,https://api.altmetric.com/v1/donut/8207382_240.png 4,Cancer Related Fatigue and Quality of Life in Patients with Advanced Prostate Cancer Undergoing Chemotherapy,BioMed Research International,,,Article,2016-02-14,10.1155/2016/3989286,,,,26981530,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5634107,https://api.altmetric.com/v1/donut/5634107_240.png 4,Aminomethylphosphonic acid inhibits growth and metastasis of human prostate cancer in an orthotopic xenograft mouse model.,Oncotarget,,,Article,2016-02-05,10.18632/oncotarget.7055,,,,26840261,PMC4891145,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5094809,https://api.altmetric.com/v1/donut/5094809_240.png 4,Prostate Cancer Grading: A Contemporary Photomontage,The American Journal of Surgical Pathology,,,Article,2016-01-01,10.1097/pas.0000000000000563,,,,26658665,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4867109,https://api.altmetric.com/v1/donut/4867109_240.png 4,What is the Need for Prostatic Biomarkers in Prostate Cancer Management?,Current Urology Reports,,,Article,2015-10-02,10.1007/s11934-015-0545-3,,,,26267226,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4580421,https://api.altmetric.com/v1/donut/4580421_240.png 4,Proton therapy for prostate cancer: why and what orthopaedic surgeons need to know about it.,Journal of surgical orthopaedic advances,,,Article,2015-01-01,,,,,25988689,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4097252,https://api.altmetric.com/v1/donut/4097252_240.png 4,Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure.,World Journal of Urology,,,Article,2015-03-19,10.1007/s00345-015-1535-2,,,,25786708,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3806457,https://api.altmetric.com/v1/donut/3806457_240.png 4,Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer,Oncologist,,,Article,,10.1634/theoncologist.2014-0167,,,,25361624,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2955837,https://api.altmetric.com/v1/donut/2955837_240.png 4,"Men, culture and hegemonic masculinity: understanding the experience of prostate cancer",Nursing Inquiry,,,Article,2005-05-12,10.1111/j.1440-1800.2005.00258.x,,,,15892724,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2944567,https://api.altmetric.com/v1/donut/2944567_240.png 4,Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer,International journal of clinical practice,,,Article,2014-10-06,10.1111/ijcp.12512,,,,25283500,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,1,19,https://www.altmetric.com/details/2918126,https://api.altmetric.com/v1/donut/2918126_240.png 4,Elevated cholesterol and triglycerides may increase the risk for prostate cancer recurrence,ecancer.org,,,Article,,,,,http://ecancer.org/news/6446-elevated-cholesterol-and-triglycerides-may-increase-the-risk-for-prostate-cancer-recurrence.php,,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2757774,https://api.altmetric.com/v1/donut/2757774_240.png 4,"TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.",The Prostate,,,Article,2014-06-27,10.1002/pros.22832,,,,24961829,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2749170,https://api.altmetric.com/v1/donut/2749170_240.png 4,Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials,JNCI: Journal of the National Cancer Institute,,,Article,2014-07-11,10.1093/jnci/dju132,,,,25006192,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2546185,https://api.altmetric.com/v1/donut/2546185_240.png 4,Aspirin and Prostate Cancer Prevention,Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer,,,Article,2014-02-19,10.1007/978-3-642-45195-9_11,,,,24531782,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2356493,https://api.altmetric.com/v1/donut/2356493_240.png 4,Beyond Approval: What Is the Most Appropriate Way to Use the Expanding Armamentarium in Metastatic Castration-resistant Prostate Cancer and How Do We Move Forward?,European Urology,,,Article,2014-11-01,10.1016/j.eururo.2014.03.046,,,,24751214,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2266475,https://api.altmetric.com/v1/donut/2266475_240.png 4,Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion. Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion,ecancer.org,,,Article,,,,,http://ecancer.org/video/2621/maximizing-survival-in-metastatic-castration-resistant-prostate-cancer--panel-discussion.php,,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2034263,https://api.altmetric.com/v1/donut/2034263_240.png 4,Changing presentation of prostate cancer in a UK population |[ndash]| 10 year trends in prostate cancer risk profiles in the East of England,British Journal of Cancer,,,Article,2013-09-26,10.1038/bjc.2013.589,,,,24071596,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1786406,https://api.altmetric.com/v1/donut/1786406_240.png 4,Urological cancer: Reduction in the risk of prostate cancer with finasteride,Nature Reviews Clinical Oncology,,,Article,2013-09-03,10.1038/nrclinonc.2013.163,,,,23999217,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1726591,https://api.altmetric.com/v1/donut/1726591_240.png 4,Life expectancy estimates as a key factor in over-treatment: The case of prostate cancer ,Cancer Epidemiology,,,Article,2013-05-01,10.1016/j.canep.2013.03.014,,,,23623489,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1485092,https://api.altmetric.com/v1/donut/1485092_240.png 4,A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer,European Journal of Cancer (1965),,,Article,2013-02-22,10.1016/j.ejca.2013.01.024,,,,23433847,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1257830,https://api.altmetric.com/v1/donut/1257830_240.png 4,Prostate cancer: New types of radiotherapy improve cancer outcome but at what cost?,Nature Reviews Urology,,,Article,2012-07-03,10.1038/nrurol.2012.137,,,,22750953,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/820513,https://api.altmetric.com/v1/donut/820513_240.png 4,Active surveillance for low-risk prostate cancer: an update,Nature Reviews Urology,,,Article,2011-04-28,10.1038/nrurol.2011.50,,,,21519351,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/746218,https://api.altmetric.com/v1/donut/746218_240.png 4,"VM -- The Debate Over Prostate Cancer Screening Guidelines, Jan 11 ... Virtual Mentor",virtual mentor VM,,,Article,2011-01-01,10.1001/virtualmentor.2011.13.1.ccas2-1101,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/579787,https://api.altmetric.com/v1/donut/579787_240.png 4,What Early ProtecT Results Have Confirmed About Risk-stratified Prostate Cancer Management,European Urology,,,Article,2016-11-01,10.1016/j.eururo.2016.10.017,,,,,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13321315,https://api.altmetric.com/v1/donut/13321315_240.png 4,Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database,Prostate Cancer & Prostatic Diseases,,,Article,2016-10-04,10.1038/pcan.2016.47,,,,27698439,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12968369,https://api.altmetric.com/v1/donut/12968369_240.png 4,Prostate cancer: HSD3B1 variant confers inferior ADT outcomes,Nature Reviews Urology,,,Article,2016-09-20,10.1038/nrurol.2016.183,,,,27644933,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12098440,https://api.altmetric.com/v1/donut/12098440_240.png 4,Risk of Pathological Upgrading and Upstaging among Men with Low-Risk Prostate Cancer Varies By Race: Results from the National Cancer Data Base,The Journal of Urology,,,Article,2016-09-02,10.1016/j.juro.2016.08.095,,,,27582435,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10879856,https://api.altmetric.com/v1/donut/10879856_240.png 4,"Mastery, Isolation, or Acceptance: Gay and Bisexual Men’s Construction of Aging in the Context of Sexual Embodiment After Prostate Cancer",Journal of Sex Research,,,Article,2016-08-12,10.1080/00224499.2016.1211600,,,,27712111,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10523950,https://api.altmetric.com/v1/donut/10523950_240.png 4,Dosimetric impact of different bladder and rectum filling during prostate cancer radiotherapy,Radiation Oncology,,,Article,2016-08-02,10.1186/s13014-016-0681-z,,,,27485637,PMC4969718,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10212108,https://api.altmetric.com/v1/donut/10212108_240.png 4,Prostate cancer: Biomarkers from liquid biopsy,Nature Reviews Urology,,,Article,2016-07-19,10.1038/nrurol.2016.133,,,,27431337,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9845808,https://api.altmetric.com/v1/donut/9845808_240.png 4,New drugs in prostate cancer,Prostate International,,,Article,2016-06-01,10.1016/j.prnil.2016.05.001,,,,27358841,PMC4916061,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9552509,https://api.altmetric.com/v1/donut/9552509_240.png 4,Treatment Preferences for Active Surveillance vs. Active Treatment Among Men with Low-Risk Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-06-02,10.1158/1055-9965.epi-15-1079,,,,27257092,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8506937,https://api.altmetric.com/v1/donut/8506937_240.png 4,"Selenium- or vitamin E-related gene variants, interaction with supplementation, and risk of high-grade prostate cancer in SELECT","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-05-06,10.1158/1055-9965.epi-16-0104,,,,27197287,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8133139,https://api.altmetric.com/v1/donut/8133139_240.png 4,Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer,PLoS ONE,,,Article,2016-05-09,10.1371/journal.pone.0154918,,,,27159369,PMC4861293,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7318436,https://api.altmetric.com/v1/donut/7318436_240.png 4,Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of Literature.,Medicine,,,Article,2016-04-01,10.1097/md.0000000000002754,,,http://journals.lww.com/md-journal/Fulltext/2016/04050/Docetaxel_Rechallenge_in_a_Heavily_Pretreated.2.aspx,27057826,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6661375,https://api.altmetric.com/v1/donut/6661375_240.png 4,Mutational landscape of aggressive prostate tumors in African American men,Cancer Research,,,Article,2016-02-28,10.1158/0008-5472.can-15-1787,,,,26921337,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6015727,https://api.altmetric.com/v1/donut/6015727_240.png 4,Admissions to hospital due to fracture in England in prostate cancer patients treated with Androgen Deprivation Therapy (ADT) – do we have to worry about the hormones?,British Journal of Urology,,,Article,2016-02-01,10.1111/bju.13441,,,,26857695,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5910116,https://api.altmetric.com/v1/donut/5910116_240.png 4,Prostate cancer: Adverse events associated with intermittent ADT,Nature Reviews Urology,,,Article,2016-01-20,10.1038/nrurol.2016.8,,,,26787393,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5091058,https://api.altmetric.com/v1/donut/5091058_240.png 4,"Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain",Radiation Oncology,,,Article,2015-12-30,10.1186/s13014-015-0572-8,,,,26715201,PMC4696097,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4937206,https://api.altmetric.com/v1/donut/4937206_240.png 4,Quality of preventive care before and after prostate cancer diagnosis,Journal of Men's Health,,,Article,2015-05-01,,,,,26430473,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4606786,https://api.altmetric.com/v1/donut/4606786_240.png 4,Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer,Cancer Treatment Reviews,,,Article,2015-12-01,10.1016/j.ctrv.2015.08.002,,,,26342718,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4586334,https://api.altmetric.com/v1/donut/4586334_240.png 4,Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis,BMC Systems Biology,,,Article,2015-09-06,10.1186/s12918-015-0201-z,,,,26341082,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4478497,https://api.altmetric.com/v1/donut/4478497_240.png 4,"Re: Urinary Melatonin Levels, Sleep Disruption, and Risk of Prostate Cancer in Elderly Men",The Journal of Urology,,,Article,2015-10-20,10.1016/j.juro.2015.08.034,,,,26478033,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4398735,https://api.altmetric.com/v1/donut/4398735_240.png 4,Re: Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer,The Journal of Urology,,,Article,2015-01-09,10.1016/j.juro.2015.06.049,,,,26292859,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4174044,https://api.altmetric.com/v1/donut/4174044_240.png 4,Re: Complications following Surgery with or without Radiotherapy or Radiotherapy Alone for Prostate Cancer,The Journal of Urology,,,Article,2015-01-09,10.1016/j.juro.2015.06.048,,,,26292858,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4163888,https://api.altmetric.com/v1/donut/4163888_240.png 4,Prostate Cancer: what we know and what we would like to know,Frontiers in oncology,,,Article,2015-05-15,10.3389/fonc.2015.00114,,,,26052506,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3998117,https://api.altmetric.com/v1/donut/3998117_240.png 4,Significance of Change in Gleason Grade in Patients on Active Surveillance for Prostate Cancer,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.04.069,,,,25892137,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3916057,https://api.altmetric.com/v1/donut/3916057_240.png 4,Re: Transition Zone Prostate Cancer: Revisiting the Role of Multiparametric MRI at 3 T,The Journal of Urology,,,Article,2015-01-07,10.1016/j.juro.2015.04.008,,,,26088226,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3889918,https://api.altmetric.com/v1/donut/3889918_240.png 4,Reducing PSA-Based Prostate Cancer Screening in Men Aged?75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support,JGIM: Journal of General Internal Medicine,,,Article,2015-03-05,10.1007/s11606-015-3249-y,,,,25740462,,,,,,,0,0,0,5,0,0,2,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/3756259,https://api.altmetric.com/v1/donut/3756259_240.png 4,Prostate Cancer and Vasectomy: Déjà Vu!,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.59.1669,,,,25605850,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3482844,https://api.altmetric.com/v1/donut/3482844_240.png 4,A Pilot Study of Potential Pre-Operative Barriers to Couples’ Sexual Recovery After Radical Prostatectomy for Prostate Cancer,Journal of Sex & Marital Therapy,,,Article,2014-01-12,10.1080/0092623x.2013.842194,,,,24405053,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2944016,https://api.altmetric.com/v1/donut/2944016_240.png 4,Key regulators in prostate cancer identified by co-expression module analysis,BMC Genomics,,,Article,2014-11-24,10.1186/1471-2164-15-1015,,,,25418933,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2918361,https://api.altmetric.com/v1/donut/2918361_240.png 4,Additive Interactions Between Susceptibility Single-Nucleotide Polymorphisms Identified in Genome-Wide Association Studies and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium,American Journal of Epidemiology,,,Article,2014-09-24,10.1093/aje/kwu214,,,,25255808,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2901393,https://api.altmetric.com/v1/donut/2901393_240.png 4,Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.11.066,,,,25617272,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2890468,https://api.altmetric.com/v1/donut/2890468_240.png 4,Biologic differences between peripheral and transition zone prostate cancer,The Prostate,,,Article,2014-10-18,10.1002/pros.22903,,,,25327466,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2795451,https://api.altmetric.com/v1/donut/2795451_240.png 4,"Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study",European Urology,,,Article,2015-07-01,10.1016/j.eururo.2014.07.034,,,,25139197,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2597885,https://api.altmetric.com/v1/donut/2597885_240.png 4,Primary ADT Provides No Survival Benefit in Localized Prostate Cancer,Journal Watch,,,Article,2014-07-15,10.1056/nejm-jw.fw109054,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2508550,https://api.altmetric.com/v1/donut/2508550_240.png 4,Selenium and Prostate Cancer Prevention: What next - if anything?,Cancer Prevention Research,,,Article,2014-07-02,10.1158/1940-6207.capr-14-0197,,,,24994662,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2493695,https://api.altmetric.com/v1/donut/2493695_240.png 4,Phase II Study of Single-Agent Orteronel (TAK-700) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer and Rising Prostate-Specific Antigen,Clinical Cancer Research,,,Article,2014-06-24,10.1158/1078-0432.ccr-14-0356,,,,24965748,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2465776,https://api.altmetric.com/v1/donut/2465776_240.png 4,Nutrient-based dietary patterns and prostate cancer risk: a case-control study from Italy.,Cancer Causes and Control,,,Article,2014-02-11,10.1007/s10552-014-0356-8,,,,24515125,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2175608,https://api.altmetric.com/v1/donut/2175608_240.png 4,Quality of Life in Patients with Low-Risk Prostate Cancer. A Comparative Retrospective Study: Brachytherapy Versus Robot-Assisted Laparoscopic Prostatectomy Versus Active Surveillance,Journal of Endourology,,,Article,2013-08-29,10.1089/end.2013.0349,,,,23978277,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2103495,https://api.altmetric.com/v1/donut/2103495_240.png 4,Estrogen receptor beta in prostate cancer: friend or foe?,Endocrine-Related Cancer,,,Article,2014-01-08,10.1530/erc-13-0508,,,,24402043,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,27,https://www.altmetric.com/details/2037227,https://api.altmetric.com/v1/donut/2037227_240.png 4,Evaluation of Stem Cell Marker Gene Expression in Canine Prostate Carcinoma- and Prostate Cyst-derived Cell Lines,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2013-01-01,,,,,24324078,,,,,,,0,0,0,6,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/1979114,https://api.altmetric.com/v1/donut/1979114_240.png 4,The NCRN Pomi-T study: polyphenol rich whole food supplementslows PSA progression in prostate cancer. The NCRN Pomi-T study:polyphenol rich whole food supplement slows PSA progression inprostate cancer. ecancer.tv - Essential viewing foroncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2404/the-ncrn-pomi-t-study--polyphenol-rich-whole-food-supplement-slows-psa-progression-in-prostate-cancer.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1908826,https://api.altmetric.com/v1/donut/1908826_240.png 4,Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1184,,,,24150235,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1853067,https://api.altmetric.com/v1/donut/1853067_240.png 4,A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate cancer,Frontiers in Genetics,,,Article,2013-01-01,10.3389/fgene.2013.00152,,,,23970893,PMC3747326,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1698839,https://api.altmetric.com/v1/donut/1698839_240.png 4,JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-13-0874,,,,23824741,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/1671781,https://api.altmetric.com/v1/donut/1671781_240.png 4,Functional Activation of ATM by the Prostate Cancer Suppressor NKX3.1,Cell Reports,,,Article,2013-07-25,10.1016/j.celrep.2013.06.039,,,,23890999,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1656312,https://api.altmetric.com/v1/donut/1656312_240.png 4,A Tailored Prostate Cancer Education Intervention for Low-income African Americans: Impact on Knowledge and Screening.,Journal of health care for the poor and underserved (Online),,,Article,2013-02-06,10.1353/hpu.2013.0033,,,,23377736,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1237786,https://api.altmetric.com/v1/donut/1237786_240.png 4,A Randomized Trial of Aerobic versus Resistance Exercise in Prostate Cancer Survivors.,Journal of Aging & Physical Activity,,,Article,2012-12-10,,,,,23238110,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/1126263,https://api.altmetric.com/v1/donut/1126263_240.png 4,Molecular and Systems Pathology in Prostate Cancer,AACR Education Book,,,Article,2012-01-01,10.1158/aacr.edb-12-8965,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/831435,https://api.altmetric.com/v1/donut/831435_240.png 4,Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus,Genome Research,,,Article,2012-01-01,10.1101/gr.135665.111,,,,22665440,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/776608,https://api.altmetric.com/v1/donut/776608_240.png 4,Changes in Biomarkers of Inflammation and Angiogenesis During Androgen Deprivation Therapy for Prostate Cancer,Oncologist,,,Article,2012-02-02,10.1634/theoncologist.2011-0321,,,,22302227,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/589599,https://api.altmetric.com/v1/donut/589599_240.png 4,Influence of obesity on tumour volume in patients with prostate cancer,British Journal of Urology,,,Article,2011-07-24,10.1111/j.1464-410x.2011.10453.x,,,,21777363,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/241073,https://api.altmetric.com/v1/donut/241073_240.png 4,Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study.,Journal of Clinical Oncology,,,Article,2009-03-31,10.1200/jco.2008.18.5850,,,,19255325,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3038406,https://api.altmetric.com/v1/donut/3038406_240.png 4,The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-05-12,10.1016/j.ijrobp.2009.11.023,,,,20452135,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2337363,https://api.altmetric.com/v1/donut/2337363_240.png 4,Gallium-68 DOTATOC PET/CT In Vivo Characterization of Somatostatin Receptor Expression in the Prostate.,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2014-01-22,10.1089/cbr.2013.1570,,,,24450327,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2072657,https://api.altmetric.com/v1/donut/2072657_240.png 4,Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells,Frontiers in oncology,,,Article,2013-01-01,10.3389/fonc.2013.00239,,,,24066278,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1775030,https://api.altmetric.com/v1/donut/1775030_240.png 4,Chronic Chlorpyrifos Exposure Does Not Promote Prostate Cancer in Prostate Specific PTEN Mutant Mice.,"Journal of Environmental Pathology, Toxicology & Oncology",,,Article,2013-06-15,,,,,23758150,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1642972,https://api.altmetric.com/v1/donut/1642972_240.png 4,3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models,BMC Pharmacology and Toxicology,,,Article,2013-02-11,10.1186/2050-6511-14-11,,,,23394161,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1234977,https://api.altmetric.com/v1/donut/1234977_240.png 4,Multicenter Evaluation of [?2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer,Clinical Chemistry,,,Article,2013-01-01,10.1373/clinchem.2012.195784,,,,23213080,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1110526,https://api.altmetric.com/v1/donut/1110526_240.png 4,Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells,European Journal of Cancer (1965),,,Article,2012-10-22,10.1016/j.ejca.2012.09.023,,,,23089465,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1015882,https://api.altmetric.com/v1/donut/1015882_240.png 3,"Haplotypes, Loss of Heterozygosity, and Expression Levels of Glycine N-Methyltransferase in Prostate Cancer",Clinical Cancer Research,,,Article,2007-03-01,10.1158/1078-0432.ccr-06-1551,,,,17332283,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13266276,https://api.altmetric.com/v1/donut/13266276_240.png 3,Prostate cancer: Analysis of progression through time and space,Nature Reviews Urology,,,Article,2016-10-25,10.1038/nrurol.2016.219,,,,27779231,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13197256,https://api.altmetric.com/v1/donut/13197256_240.png 3,Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.,Molecular & Cellular Biology,,,Article,2003-12-15,,,,,14612401,PMC262657,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13140969,https://api.altmetric.com/v1/donut/13140969_240.png 3,Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells,Oncogene,,,Article,2006-03-29,10.1038/sj.onc.1209231,,,,16434977,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/13138677,https://api.altmetric.com/v1/donut/13138677_240.png 3,Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer.,Urology,,,Article,1999-01-01,,,,,9933058,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13083296,https://api.altmetric.com/v1/donut/13083296_240.png 3,Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations.,The Journal of Urology,,,Article,,,,,,4987666,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12983133,https://api.altmetric.com/v1/donut/12983133_240.png 3,Single drug polyestradiol phosphate therapy in prostatic cancer.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,1988-01-01,,,,,3242384,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12957083,https://api.altmetric.com/v1/donut/12957083_240.png 3,Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients,The Prostate,,,Article,1998-12-07,10.1002/(sici)1097-0045(199605)28:5<307::aid-pros6>3.0.co;2-8,,,,8610057,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12862535,https://api.altmetric.com/v1/donut/12862535_240.png 3,"Bicalutamide 80?mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients",Prostate Cancer & Prostatic Diseases,,,Article,2007-01-02,10.1038/sj.pcan.4500934,,,,17199134,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/12850656,https://api.altmetric.com/v1/donut/12850656_240.png 3,Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years,Scandinavian Journal of Urology & Nephrology,,,Article,2009-07-09,10.1080/00365590601017329,,,,17130095,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12850611,https://api.altmetric.com/v1/donut/12850611_240.png 3,Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth,Oncotarget,,,Article,2014-09-16,10.18632/oncotarget.2478,,,,25294816,PMC4259447,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12615330,https://api.altmetric.com/v1/donut/12615330_240.png 3,IGFBP3 and MAPK/ERK signaling mediates melatonin?induced anti?tumor activity in prostate cancer,Journal of Pineal Research,,,Article,2016-10-01,10.1111/jpi.12373,,,,27736013,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12598033,https://api.altmetric.com/v1/donut/12598033_240.png 3,Up-regulating of RASD1 and Apoptosis of DU-145 Human Prostate Cancer Cells Induced by Formononetin in Vitro.,Asian Pacific Journal of Cancer Prevention,,,Article,,,,,,24761910,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12546467,https://api.altmetric.com/v1/donut/12546467_240.png 3,CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients,Oncotarget,,,Article,2016-07-22,10.18632/oncotarget.10786,,,,27462860,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12543647,https://api.altmetric.com/v1/donut/12543647_240.png 3,Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.,Clinical Cancer Research,,,Article,1997-08-01,,,,,9815823,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12454492,https://api.altmetric.com/v1/donut/12454492_240.png 3,Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.,Oncogene,,,Article,1995-03-02,,,,,7534899,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/12454491,https://api.altmetric.com/v1/donut/12454491_240.png 3,Paracrine Sonic Hedgehog Signaling Contributes Significantly to Acquired Steroidogenesis in the Prostate Tumor Microenvironment,International Journal of Cancer,,,Article,2016-09-01,10.1002/ijc.30450,,,,27672740,,,,,,,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12429593,https://api.altmetric.com/v1/donut/12429593_240.png 3,Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial.,British Journal of Urology,,,Article,1980-06-01,,,,,7000222,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12363540,https://api.altmetric.com/v1/donut/12363540_240.png 3,Prediction of Survival of Metastatic Prostate Cancer Based on Early Serial Measurements of Prostate Specific Antigen and Alkaline Phosphatase,The Journal of Urology,,,Article,2008-01-01,10.1016/j.juro.2007.08.132,,,,17997442,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/12121975,https://api.altmetric.com/v1/donut/12121975_240.png 3,Preclinical Characterization of a Novel Diphenyl Benzamide Selective ER? Agonist for Hormone Therapy in Prostate Cancer,Endocrinology,,,Article,2012-03-15,10.1210/en.2011-1608,,,,22294742,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12067451,https://api.altmetric.com/v1/donut/12067451_240.png 3,Epigenetic modulators as therapeutic targets in prostate cancer,Clinical Epigenetics,,,Article,2016-09-15,10.1186/s13148-016-0264-8,,,,27651838,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12025961,https://api.altmetric.com/v1/donut/12025961_240.png 3,Hormone Therapy in Breast and Prostate Cancer,,,,Article,2016-09-15,10.1007/978-1-59259-152-7_15,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12022947,https://api.altmetric.com/v1/donut/12022947_240.png 3,Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup.,The Journal of Urology,,,Article,2000-11-01,,,,,11025708,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/12021990,https://api.altmetric.com/v1/donut/12021990_240.png 3,Adjuvant bicalutamide for early prostate cancer: an update,Nature Clinical Practice Urology,,,Article,2006-08-14,10.1038/ncpuro0518,,,,16902511,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11950553,https://api.altmetric.com/v1/donut/11950553_240.png 3,Androgen Receptor Antagonists in the Treatment of Prostate Cancer,"Clinical Immunology, Endocrine & Metabolic Drugs",,,Article,2014-07-30,10.2174/22127070114019990002,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11915414,https://api.altmetric.com/v1/donut/11915414_240.png 3,"Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment",Journal of Cancer,,,Article,2014-01-01,10.7150/jca.7773,,,,24494031,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11915413,https://api.altmetric.com/v1/donut/11915413_240.png 3,Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients,Cancer Detection & Prevention,,,Article,2007-01-01,10.1016/j.cdp.2007.10.005,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11914297,https://api.altmetric.com/v1/donut/11914297_240.png 3,A novel algorithm for the prediction of prostate cancer in clinically suspected patients.,Cancer Biomarkers,,,Article,2013-01-01,10.3233/cbm-130357,,,,24240583,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11914295,https://api.altmetric.com/v1/donut/11914295_240.png 3,THE OCCURRENCE OF PROSTATE-SPECIFIC ANTIGEN - IGM IMMUNE COMPLEXES (IC) AS NOVEL SERUM BIOMARKER FOR PROSTATE CANCER,European Urology Supplements,,,Article,2006-04-01,10.1016/s1569-9056(06)60568-x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11914284,https://api.altmetric.com/v1/donut/11914284_240.png 3,The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review.,Oncology Reports,,,Article,2004-06-14,,,,,15138573,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11909298,https://api.altmetric.com/v1/donut/11909298_240.png 3,"A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer",European Journal of Cancer (1965),,,Article,2015-08-01,10.1016/j.ejca.2015.04.028,,,,26048455,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11909294,https://api.altmetric.com/v1/donut/11909294_240.png 3,Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design.,Canadian Journal of Urology,,,Article,2009-10-14,,,,,19796455,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11909292,https://api.altmetric.com/v1/donut/11909292_240.png 3,Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,2005-10-14,10.1007/s00280-005-1016-1,,,,15838655,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11900930,https://api.altmetric.com/v1/donut/11900930_240.png 3,Bicalutamide (Casodex®) in the treatment of prostate cancer: History of clinical development,The Prostate,,,Article,1998-12-07,10.1002/(sici)1097-0045(19980101)34:1<61::aid-pros8>3.0.co;2-n,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11898846,https://api.altmetric.com/v1/donut/11898846_240.png 3,Anemia Related to Hormonal Ablation Therapy for Prostate Cancer,Prostate Journal,,,Article,2001-12-21,10.1046/j.1525-1411.2001.003001014.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11897352,https://api.altmetric.com/v1/donut/11897352_240.png 3,Which is the optimal antiandrogen for use in combined androgen blockade of advanced prostate cancer? The transition from a first- to second-generation antiandrogen.,Anti-Cancer Drugs,,,Article,1999-10-01,,,,,10587288,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11738584,https://api.altmetric.com/v1/donut/11738584_240.png 3,"[A new anti-androgen, bicalutamide (Casodex), for the treatment of prostate cancer--basic clinical aspects].",Gan to kagaku ryoho Cancer chemotherapy,,,Article,1999-07-01,,,,,10431591,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11737431,https://api.altmetric.com/v1/donut/11737431_240.png 3,Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer,Clinical Pharmacokinetics,,,Article,2012-09-13,10.2165/00003088-199834050-00005,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10995334,https://api.altmetric.com/v1/donut/10995334_240.png 3,Non-steroidal anti-androgens in prostate cancer - current treatment practice,Expert Opinion on Pharmacotherapy,,,Article,2005-02-24,10.1517/14656566.1.3.443,,,,11249529,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10957089,https://api.altmetric.com/v1/donut/10957089_240.png 3,Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens,Urology,,,Article,1997-01-01,10.1016/s0090-4295(96)00325-1,,,,9000189,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10956914,https://api.altmetric.com/v1/donut/10956914_240.png 3,"Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.",Drugs & Aging,,,Article,1993-01-01,,,,,8453188,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10942675,https://api.altmetric.com/v1/donut/10942675_240.png 3,Androgen deprivation therapy for prostate cancer: Current status and future prospects,The Prostate,,,Article,2004-04-26,10.1002/pros.20115,,,,15389811,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/10922914,https://api.altmetric.com/v1/donut/10922914_240.png 3,Androgen receptors beyond prostate cancer: an old marker as a new target,Oncotarget,,,Article,2014-12-02,10.18632/oncotarget.2831,,,,25595907,PMC4359241,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/10919759,https://api.altmetric.com/v1/donut/10919759_240.png 3,Management of gynaecomastia in patients with prostate cancer: a systematic review.,Lancet Oncology,,,Article,2005-12-15,10.1016/s1470-2045(05)70464-2,,,,16321765,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/10919078,https://api.altmetric.com/v1/donut/10919078_240.png 3,Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer.,Journal of Clinical Oncology,,,Article,2006-06-20,10.1200/jco.2005.03.8505,,,,16782932,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10919073,https://api.altmetric.com/v1/donut/10919073_240.png 3,"Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.",,,,Article,2007-07-14,10.1016/j.eururo.2007.01.031,,,,17270340,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/10918832,https://api.altmetric.com/v1/donut/10918832_240.png 3,The role of antiandrogen monotherapy in the treatment of prostate cancer,British Journal of Urology,,,Article,2003-02-26,10.1046/j.1464-410x.2003.04026.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10918241,https://api.altmetric.com/v1/donut/10918241_240.png 3,"EAU–ESTRO–SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent",European Urology,,,Article,2016-08-26,10.1016/j.eururo.2016.08.003,,,,27568654,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/10837435,https://api.altmetric.com/v1/donut/10837435_240.png 3,[Celioscopic lymphatic excision and perineal radical prostatectomy: a strategy for the treatment of prostatic cancer].,Progrès en Urologie,,,Article,1993-04-01,,,,,8508202,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10820489,https://api.altmetric.com/v1/donut/10820489_240.png 3,Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer,Pharmaceutical Patent Analyst,,,Article,2015-09-01,10.4155/ppa.15.20,,,,26389532,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10795464,https://api.altmetric.com/v1/donut/10795464_240.png 3,Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2007-03-01,10.1016/j.ijrobp.2006.10.011,,,,17293235,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/10729034,https://api.altmetric.com/v1/donut/10729034_240.png 3,Review article Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options,Journal of Contemporary Brachytherapy,,,Article,2013-03-15,10.5114/jcb.2013.34342,,,,23634153,PMC3635047,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/10729033,https://api.altmetric.com/v1/donut/10729033_240.png 3,Flutamide: an antiandrogen for advanced prostate cancer.,DICP: The Annals of Pharmacotherapy,,,Article,1990-06-01,,,,,2193461,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10574629,https://api.altmetric.com/v1/donut/10574629_240.png 3,Current topics and perspectives relating to hormone therapy for prostate cancer,International Journal of Clinical Oncology,,,Article,2008-10-23,10.1007/s10147-008-0830-y,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10480334,https://api.altmetric.com/v1/donut/10480334_240.png 3,Overview of Current Treatment Strategies in Prostate Cancer,European Urology Supplements,,,Article,2004-02-01,10.1016/j.eursup.2003.12.002,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10480002,https://api.altmetric.com/v1/donut/10480002_240.png 3,Pharmacotherapy for prostate cancer: the role of hormonal treatment.,Discovery Medicine,,,Article,2007-08-14,,,,,18093474,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10480000,https://api.altmetric.com/v1/donut/10480000_240.png 3,"Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer",Powder Technology,,,Article,2015-10-01,10.1016/j.powtec.2015.04.053,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/10473589,https://api.altmetric.com/v1/donut/10473589_240.png 3,Identification and characterization of circulating prostate carcinoma cells.,Cancer (0008543X),,,Article,2000-06-15,,,,,10870062,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/10473165,https://api.altmetric.com/v1/donut/10473165_240.png 3,Association of Mycoplasma hominis infection with prostate cancer,Oncotarget,,,Article,2011-04-04,10.18632/oncotarget.256,,,,21471611,PMC3248169,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/10449873,https://api.altmetric.com/v1/donut/10449873_240.png 3,"The pure antiandrogen ru 23908 (anandron®), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review",The Prostate,,,Article,1984-01-01,10.1002/pros.2990050307,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10442799,https://api.altmetric.com/v1/donut/10442799_240.png 3,Advancements in Non-steroidal Antiandrogens as Potential Therapeutic Agents for the Treatment of Prostate Cancer.,Mini Reviews in Medicinal Chemistry,,,Article,,,,,,26776222,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10424142,https://api.altmetric.com/v1/donut/10424142_240.png 3,Enzalutamide: a new agent for the prostate cancer treatment armamentarium.,Journal of the Advanced Practitioner in Oncology,,,Article,2013-05-14,,,,,25031999,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10397650,https://api.altmetric.com/v1/donut/10397650_240.png 3,Antiandrogens in Prostate Cancer,,,,Article,1996-08-10,10.1007/978-3-642-45745-6_10,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10373108,https://api.altmetric.com/v1/donut/10373108_240.png 3,Castrate-resistant prostate cancer: the future of antiandrogens,Trends in Urology and Men's Health,,,Article,2014-01-30,10.1002/tre.371,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10364541,https://api.altmetric.com/v1/donut/10364541_240.png 3,Overall information needs of early-stage prostate cancer patients over a decade: highly variable and remarkably stable,Supportive Care in Cancer,,,Article,2008-10-02,10.1007/s00520-008-0514-1,,,,18830718,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/10299434,https://api.altmetric.com/v1/donut/10299434_240.png 3,Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African-Americans,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-08-02,10.1158/1055-9965.epi-16-0373,,,,27486019,PMC5093030,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10261712,https://api.altmetric.com/v1/donut/10261712_240.png 3,Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort,Cancer Causes and Control,,,Article,2010-11-20,10.1007/s10552-010-9680-9,,,,21103922,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10063506,https://api.altmetric.com/v1/donut/10063506_240.png 3,Management of advanced prostate cancer,Revista da Associação Médica Brasileira,,,Article,2008-04-01,10.1590/s0104-42302008000200025,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9900417,https://api.altmetric.com/v1/donut/9900417_240.png 3,"SUPPRESSION OF PLASMA ANDROGENS BY THE ANTIANDROGEN FLUTAMIDE IN PROSTATIC CANCER PATIENTS TREATED WITH ZOLADEX, A GnRH ANALOGUE",Clinical Endocrinology,,,Article,2008-06-28,10.1111/j.1365-2265.1990.tb00874.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9529405,https://api.altmetric.com/v1/donut/9529405_240.png 3,"Comments on: ""A comprehensive repertoire of tRNA-derived fragments in prostate cancer""",bioRxiv,,,Article,2016-07-07,10.1101/061572,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9320332,https://api.altmetric.com/v1/donut/9320332_240.png 3,Novel immunotherapeutic approaches to prostate cancer.,,,,Article,2005-02-15,,,,,15732527,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9240723,https://api.altmetric.com/v1/donut/9240723_240.png 3,"Alcohol intake, drinking patterns, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins",Cancer Causes and Control,,,Article,2016-06-28,10.1007/s10552-016-0778-6,,,,27351919,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9217460,https://api.altmetric.com/v1/donut/9217460_240.png 3,The response of advanced prostatic cancer to a new non-steroidal antiandrogen: results of a multicenter open phase II study of Casodex. European/Australian Co-operative Group.,European Urology,,,Article,1990-01-01,,,,,2094607,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9214259,https://api.altmetric.com/v1/donut/9214259_240.png 3,Exciting Therapies Ahead in Prostate Cancer.,P & T,,,Article,2015-08-01,,,,,26236143,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9214258,https://api.altmetric.com/v1/donut/9214258_240.png 3,"Hormonal therapy for prostate cancer: past, present and future",Expert Review of Anticancer Therapy,,,Article,2014-01-10,10.1586/14737140.2.1.37,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9182823,https://api.altmetric.com/v1/donut/9182823_240.png 3,Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data,bioRxiv,,,Article,2016-06-29,10.1101/061085,,,,,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9115056,https://api.altmetric.com/v1/donut/9115056_240.png 3,Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial,Lancet Oncology,,,Article,2005-04-19,10.1016/s1470-2045(05)70103-0,,,,15863377,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/8876260,https://api.altmetric.com/v1/donut/8876260_240.png 3,Antiandrogens in the Treatment of Prostate Cancer,European Urology,,,Article,2007-02-15,10.1016/j.eururo.2006.08.043,,,,17007995,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/8876090,https://api.altmetric.com/v1/donut/8876090_240.png 3,Phase II Trial of Copper Depletion with Tetrathiomolybdate as an Antiangiogenesis Strategy in Patients with Hormone-Refractory Prostate Cancer,Oncology (08909091),,,Article,2007-07-18,10.1159/000106066,,,,17641535,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8859104,https://api.altmetric.com/v1/donut/8859104_240.png 3,Predictors of patient preferences and treatment choices for localized prostate cancer,Cancer (0008543X),,,Article,2008-10-15,10.1002/cncr.23807,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/8812120,https://api.altmetric.com/v1/donut/8812120_240.png 3,[Conservative therapy of prostate cancer using Turisteron].,Zeitschrift für Urologie und Nephrologie,,,Article,1987-03-01,,,,,3111122,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8690357,https://api.altmetric.com/v1/donut/8690357_240.png 3," Suppression of Plasma Androgen Levels with a Combination Therapy of Depot-Estrogen (Turisteron R ) and Dexamethasone R in Patients with Prostatic Cancer ",Experimental & Clinical Endocrinology & Diabetes,,,Article,2009-07-16,10.1055/s-0029-1210905,,,,2630306,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8690356,https://api.altmetric.com/v1/donut/8690356_240.png 3," Successful Treatment of Prostatic Cancer with the Orally Active Depot Estrogen Ethinylestradiol Sulfonate (Turisteron ® ) ",Experimental & Clinical Endocrinology & Diabetes,,,Article,2009-07-16,10.1055/s-0029-1210486,,,,3912197,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8690354,https://api.altmetric.com/v1/donut/8690354_240.png 3,System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer,Journal of Biomedical Optics,,,Article,2010-09-01,10.1117/1.3495720,,,,21054129,,,2010JBO....15e8003S,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/8591582,https://api.altmetric.com/v1/donut/8591582_240.png 3,Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells.,Cancer treatment reports,,,Article,1977-03-01,,,,,68820,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8508423,https://api.altmetric.com/v1/donut/8508423_240.png 3,An Evaluation of Bicalutamide in the Treatment of Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2004-03-01,10.3816/cgc.2004.n.002,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8446719,https://api.altmetric.com/v1/donut/8446719_240.png 3,Epidemiology of prostate cancer.,Urology,,,Article,2003-12-22,,,,,14706503,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8441965,https://api.altmetric.com/v1/donut/8441965_240.png 3,"Androgen receptor: structure, role in prostate cancer and drug discovery",Acta Pharmacologica Sinica,,,Article,2014-06-09,10.1038/aps.2014.18,,,,24909511,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,109,https://www.altmetric.com/details/8422142,https://api.altmetric.com/v1/donut/8422142_240.png 3,15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.,Cancer Research,,,Article,2001-01-15,,,,,11212240,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8418572,https://api.altmetric.com/v1/donut/8418572_240.png 3,Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer—a pilot study,Prostate Cancer & Prostatic Diseases,,,Article,2005-02-15,10.1038/sj.pcan.4500784,,,,15711607,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8395663,https://api.altmetric.com/v1/donut/8395663_240.png 3,Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program,The Journal of Urology,,,Article,2002-08-01,10.1016/s0022-5347(05)64652-6,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8394465,https://api.altmetric.com/v1/donut/8394465_240.png 3,Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.,Cancer Research,,,Article,2002-05-01,,,,,11980674,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8391850,https://api.altmetric.com/v1/donut/8391850_240.png 3,Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors,European Journal of Cancer (1965),,,Article,2016-05-02,10.1016/j.ejca.2016.03.070,,,,27151554,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8386324,https://api.altmetric.com/v1/donut/8386324_240.png 3,The Dilemma of Localizing Disease Relapse After Radical Treatment for Prostate Cancer: Which is The Value of The Actual Imaging Techniques?,Current Radiopharmaceuticals,,,Article,2013-06-05,,,,,23597246,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/8383170,https://api.altmetric.com/v1/donut/8383170_240.png 3,Different effect of sodium butyrate on cancer and normal prostate cells,Toxicology in Vitro,,,Article,2013-08-14,10.1016/j.tiv.2013.03.002,,,,23524101,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7534646,https://api.altmetric.com/v1/donut/7534646_240.png 3,Surgery Provides Better Oncologic Outcomes than Radiation for the Treatment of Prostate Cancer: Pro,The Journal of Urology,,,Article,2016-05-06,10.1016/j.juro.2016.05.008,,,,27164513,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7274315,https://api.altmetric.com/v1/donut/7274315_240.png 3,Long-Term Oncological Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer,The Journal of Urology,,,Article,2016-05-05,10.1016/j.juro.2016.04.080,,,,27157372,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7219444,https://api.altmetric.com/v1/donut/7219444_240.png 3,Antiandrogens as monotherapy for prostate cancer.,European Urology,,,Article,1998-01-01,,,,,9854190,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7135600,https://api.altmetric.com/v1/donut/7135600_240.png 3,Prostate cancer: Connecting androgen receptor and immunity,Nature Reviews Cancer,,,Article,2016-04-26,10.1038/nrc.2016.46,,,,27112203,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6966681,https://api.altmetric.com/v1/donut/6966681_240.png 3,Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells,Oncogene,,,Article,2001-01-29,10.1038/sj.onc.1204112,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6845817,https://api.altmetric.com/v1/donut/6845817_240.png 3,Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours,Endocrine-Related Cancer,,,Article,2009-12-01,10.1677/erc-09-0028,,,,19635783,PMC2782800,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6830280,https://api.altmetric.com/v1/donut/6830280_240.png 3,Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity,Cancer Research,,,Article,2016-04-05,10.1158/0008-5472.can-15-1965,,,,27197252,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6492368,https://api.altmetric.com/v1/donut/6492368_240.png 3,Histopathological outcomes after irreversible electroporation in prostate cancer; Results of an ablate-and-resect study,The Journal of Urology,,,Article,2016-03-19,10.1016/j.juro.2016.02.2977,,,,27004693,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6244252,https://api.altmetric.com/v1/donut/6244252_240.png 3,Proton therapy for prostate cancer: the initial Loma Linda University experience,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-06-01,10.1016/j.ijrobp.2003.10.011,,,,15145147,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6137833,https://api.altmetric.com/v1/donut/6137833_240.png 3,"Comparative Epidemiology of Cancers of the Colon, Rectum, Prostate and Breast in Shanghai, China versus the United States",International Journal of Epidemiology,,,Article,1991-03-01,10.1093/ije/20.1.76,,,,2066247,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6132554,https://api.altmetric.com/v1/donut/6132554_240.png 3,Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer.,Magnetic Resonance Imaging (0730725X),,,Article,2010-02-15,10.1016/j.mri.2009.07.007,,,,19695815,PMC3075841,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6102504,https://api.altmetric.com/v1/donut/6102504_240.png 3,Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-04-08,10.1158/1055-9965.epi-13-1000,,,,24718283,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6097216,https://api.altmetric.com/v1/donut/6097216_240.png 3,FYN is overexpressed in human prostate cancer.,British Journal of Urology,,,Article,2009-01-01,10.1111/j.1464-410x.2008.08009.x,,,,18990162,PMC2741693,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6089520,https://api.altmetric.com/v1/donut/6089520_240.png 3,"A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.",Urologic Oncology,,,Article,2013-07-14,10.1016/j.urolonc.2011.04.009,,,,21816640,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6075670,https://api.altmetric.com/v1/donut/6075670_240.png 3,A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention.,Cancer Research,,,Article,2009-02-15,10.1158/0008-5472.can-09-0029,,,,19208829,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6075502,https://api.altmetric.com/v1/donut/6075502_240.png 3,Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.,PLoS ONE,,,Article,2014-05-06,10.1371/journal.pone.0094683,,,,24800880,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6072559,https://api.altmetric.com/v1/donut/6072559_240.png 3,Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy,Journal of Interferon & Cytokine Research,,,Article,2009-02-01,10.1089/jir.2008.0024,,,,19014338,PMC2956618,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6066281,https://api.altmetric.com/v1/donut/6066281_240.png 3,Supervised Multi-View Canonical Correlation Analysis (sMVCCA): Integrating histologic and proteomic features for predicting recurrent prostate cancer.,IEEE Transactions on Medical Imaging,,,Article,2014-09-04,10.1109/tmi.2014.2355175,,,,25203987,,,,,,,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6056783,https://api.altmetric.com/v1/donut/6056783_240.png 3,Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients.,PLoS ONE,,,Article,2016-09-01,10.1371/journal.pone.0097954,,,,24875018,,,,,,,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6056779,https://api.altmetric.com/v1/donut/6056779_240.png 3,Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer. - PubMed - NCBI,Current Urology Reports,,,Article,2016-02-23,10.1007/s11934-016-0584-4,,,,26902623,,,,,,,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6014246,https://api.altmetric.com/v1/donut/6014246_240.png 3,Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker,BMC Cancer,,,Article,2015-02-18,10.1186/s12885-015-1073-8,,,,25777401,PMC4336758,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6005117,https://api.altmetric.com/v1/donut/6005117_240.png 3,High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer,Cancer Research,,,Article,2010-06-14,10.1158/0008-5472.can-09-3806,,,,20516116,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,75,https://www.altmetric.com/details/5904959,https://api.altmetric.com/v1/donut/5904959_240.png 3,"Early growth, adult body size and prostate cancer risk.",International Journal of Cancer,,,Article,2003-01-10,10.1002/ijc.10810,,,,12455039,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5846037,https://api.altmetric.com/v1/donut/5846037_240.png 3,The Application of the Heuristic-Systematic Processing Model to Treatment Decision Making about Prostate Cancer,Medical Decision Making,,,Article,2004-11-01,10.1177/0272989x04271044,,,,15534339,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/5840271,https://api.altmetric.com/v1/donut/5840271_240.png 3,Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells.,The Journal of Urology,,,Article,1999-09-01,10.1097/00005392-199909010-00034,,,,10458358,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5799476,https://api.altmetric.com/v1/donut/5799476_240.png 3,Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.,Pathology International,,,Article,2010-10-14,10.1111/j.1440-1827.2010.02584.x,,,,20846264,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5733586,https://api.altmetric.com/v1/donut/5733586_240.png 3,VOICES: QOL Awareness Suggested for Managing Prostate Cancer Survivors,Oncology times,,,Article,2016-02-25,10.1097/01.cot.0000481215.40885.91,,,http://journals.lww.com/oncology-times/Fulltext/2016/02250/VOICES__QOL_Awareness_Suggested_for_Managing.26.aspx,,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5711157,https://api.altmetric.com/v1/donut/5711157_240.png 3,Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.,Cancer (0008543X),,,Article,2009-07-31,10.1002/cncr.24393,,,,19484788,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5583166,https://api.altmetric.com/v1/donut/5583166_240.png 3,Re: Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer,The Journal of Urology,,,Article,2016-02-10,10.1016/j.juro.2016.02.024,,,,27186729,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5306488,https://api.altmetric.com/v1/donut/5306488_240.png 3,"Pharmacokinetics of enzalutamide, an anti-prostate cancer drug, in rats.",Archives of Pharmacal Research,,,Article,,10.1007/s12272-015-0592-9,,,,25956695,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5303836,https://api.altmetric.com/v1/donut/5303836_240.png 3,High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression,Diagnostic Pathology,,,Article,2011-09-28,10.1186/1746-1596-6-91,,,,21955582,PMC3195697,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/5104236,https://api.altmetric.com/v1/donut/5104236_240.png 3,Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells.,,,,Article,2013-08-18,10.1016/j.febslet.2013.06.029,,,,23831020,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5089534,https://api.altmetric.com/v1/donut/5089534_240.png 3,Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients,Clinical Cancer Research,,,Article,2011-06-15,10.1158/1078-0432.ccr-10-3120,,,,21555375,PMC3117947,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/5071234,https://api.altmetric.com/v1/donut/5071234_240.png 3,Activation of Urokinase Plasminogen Activator and Its Receptor Axis Is Essential for Macrophage Infiltration in a Prostate Cancer Mouse Model,Neoplasia,,,Article,2011-01-15,,,,,21245937,PMC3022425,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/5071233,https://api.altmetric.com/v1/donut/5071233_240.png 3,Hypoxia stabilizes GAS6/AXl signaling in metastatic prostate cancer.,Molecular Cancer Research,,,Article,2012-06-14,10.1158/1541-7786.mcr-11-0569,,,,22516347,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/5071228,https://api.altmetric.com/v1/donut/5071228_240.png 3,"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer",Investigational New Drugs,,,Article,2012-08-21,10.1007/s10637-012-9869-8,,,,22907596,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/5071227,https://api.altmetric.com/v1/donut/5071227_240.png 3,Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial ,European Journal of Cancer (1965),,,Article,2016-03-01,10.1016/j.ejca.2015.12.009,,,,26829012,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/5066454,https://api.altmetric.com/v1/donut/5066454_240.png 3,Epidemiologic determinants of clinically relevant prostate cancer,International Journal of Cancer,,,Article,2000-05-20,10.1002/1097-0215(20000520)89:3<259::aid-ijc8>3.0.co;2-f,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5058914,https://api.altmetric.com/v1/donut/5058914_240.png 3,"The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma",Cancer (0008543X),,,Article,2000-06-15,10.1002/1097-0142(20000615)88:12+<2989::aid-cncr14>3.3.co;2-h,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5058912,https://api.altmetric.com/v1/donut/5058912_240.png 3,Men’s and carers’ experiences of care for prostate cancer: a narrative literature review,Health Expectations,,,Article,2009-09-01,10.1111/j.1369-7625.2009.00546.x,,,,19754693,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/5004518,https://api.altmetric.com/v1/donut/5004518_240.png 3,Developmental Life Stage and Couples?? Experiences With Prostate Cancer,Cancer nursing (Online),,,Article,2005-03-01,10.1097/00002820-200503000-00002,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5004511,https://api.altmetric.com/v1/donut/5004511_240.png 3,Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature,Psycho-Oncology,,,Article,2006-11-01,10.1002/pon.1031,,,,16521081,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/5004510,https://api.altmetric.com/v1/donut/5004510_240.png 3,Married couples' perspectives on prostate cancer diagnosis and treatment decision?making,Psycho-Oncology,,,Article,2001-03-01,10.1002/pon.504,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/5004505,https://api.altmetric.com/v1/donut/5004505_240.png 3,Treatment of hot flushes in breast and prostate cancer,Expert Opinion on Pharmacotherapy,,,Article,2005-06-14,10.1517/14656566.6.7.1095,,,,15957964,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5004429,https://api.altmetric.com/v1/donut/5004429_240.png 3,BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer,International Journal of Cancer,,,Article,2011-04-15,10.1002/ijc.25522,,,,20568112,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/5000871,https://api.altmetric.com/v1/donut/5000871_240.png 3,Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells,Molecular Biology of the Cell,,,Article,2004-02-01,10.1091/mbc.e03-07-0501,,,,14617803,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4975494,https://api.altmetric.com/v1/donut/4975494_240.png 3,Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite,Carcinogenesis,,,Article,2008-05-14,10.1093/carcin/bgn007,,,,18310093,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4975492,https://api.altmetric.com/v1/donut/4975492_240.png 3,15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells,Carcinogenesis,,,Article,2013-01-01,10.1093/carcin/bgs324,,,,23066085,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4953762,https://api.altmetric.com/v1/donut/4953762_240.png 3,Activation of the Leukotriene B4 Receptor 2-Reactive Oxygen Species (BLT2-ROS) Cascade following Detachment Confers Anoikis Resistance in Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2013-10-18,10.1074/jbc.m113.481283,,,,23986446,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4953682,https://api.altmetric.com/v1/donut/4953682_240.png 3,Androgen receptor in prostate cancer.,,,,Article,2004-04-14,,,,,15082523,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,188,https://www.altmetric.com/details/4950540,https://api.altmetric.com/v1/donut/4950540_240.png 3,Androgen Receptor in Prostate Cancer,Endocrine Reviews,,,Article,,10.1210/er.2002-0032,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,188,https://www.altmetric.com/details/4950539,https://api.altmetric.com/v1/donut/4950539_240.png 3,Treatment of advanced cancer of the prostate,Seminars in Surgical Oncology,,,Article,1985-01-01,10.1002/ssu.2980010106,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4947780,https://api.altmetric.com/v1/donut/4947780_240.png 3,CARBESTROL (NSC-19962) TREATMENT OF PATIENTS WITH PROSTATIC CARCINOMA-PRELIMINARY REPORT.,Cancer chemotherapy reports Part 1,,,Article,1964-07-01,,,,,14201278,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4947706,https://api.altmetric.com/v1/donut/4947706_240.png 3,Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells.,Oncogene,,,Article,2003-09-11,10.1038/sj.onc.1206795,,,,12970744,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4947394,https://api.altmetric.com/v1/donut/4947394_240.png 3,Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.,Expert Opinion on Investigational Drugs,,,Article,2006-03-15,10.1517/13543784.15.3.293,,,,16503765,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4944569,https://api.altmetric.com/v1/donut/4944569_240.png 3,Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only,Case Reports in Urology,,,Article,2015-03-26,10.1155/2015/928787,,,,25883827,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4929002,https://api.altmetric.com/v1/donut/4929002_240.png 3,The challenging landscape of medical device approval in localized prostate cancer,Nature Reviews Urology,,,Article,2015-12-15,10.1038/nrurol.2015.289,,,,26666364,,,,,,,0,0,0,5,0,0,4,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4878066,https://api.altmetric.com/v1/donut/4878066_240.png 3,The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells,British Journal of Cancer,,,Article,2014-02-11,10.1038/bjc.2014.22,,,,24518597,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4858666,https://api.altmetric.com/v1/donut/4858666_240.png 3,Interactions of Sequence Variants in Interleukin-1 Receptor–Associated Kinase4 and the Toll-Like Receptor 6-1-10 Gene Cluster Increase Prostate Cancer Risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2006-03-15,10.1158/1055-9965.epi-05-0645,,,,16537705,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4839557,https://api.altmetric.com/v1/donut/4839557_240.png 3,Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer,Neoplasia,,,Article,2008-02-15,,,,,18283340,PMC2244693,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,142,https://www.altmetric.com/details/4792471,https://api.altmetric.com/v1/donut/4792471_240.png 3,Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate,Pharmacogenomics Journal,,,Article,2007-03-27,10.1038/sj.tpj.6500449,,,,17387331,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4748498,https://api.altmetric.com/v1/donut/4748498_240.png 3,S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.,,,,Article,2006-01-15,10.1016/j.yexcr.2005.10.013,,,,16297907,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/4736043,https://api.altmetric.com/v1/donut/4736043_240.png 3,Androgens down-regulate myosin light chain kinase in human prostate cancer cells.,,,,Article,2009-04-14,10.1016/j.jsbmb.2009.02.002,,,,19429448,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4705996,https://api.altmetric.com/v1/donut/4705996_240.png 3,Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model,BMC Cancer,,,Article,2015-10-26,10.1186/s12885-015-1833-5,,,,26502956,,,,,,,0,0,0,4,0,0,1,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/4677102,https://api.altmetric.com/v1/donut/4677102_240.png 3,Alcohol consumption and risk of prostate cancer,Nutrition and Cancer,,,Article,2009-08-04,10.1080/01635589409514301,,,,,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4633069,https://api.altmetric.com/v1/donut/4633069_240.png 3,Recent discoveries and developments of androgen receptor based therapy for prostate cancer,MedChemComm,,,Article,2015-05-13,10.1039/c4md00416g,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4613690,https://api.altmetric.com/v1/donut/4613690_240.png 3,"The association between body size, prostate volume and prostate-specific antigen",Prostate Cancer & Prostatic Diseases,,,Article,2006-12-19,10.1038/sj.pcan.4500924,,,,17179979,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4588002,https://api.altmetric.com/v1/donut/4588002_240.png 3,Variation of Serum Prostate?Specific Antigen in Men with Prostate Cancer Managed with Active Surveillance,British Journal of Urology,,,Article,2015-09-01,10.1111/bju.13328,,,,26385021,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4553062,https://api.altmetric.com/v1/donut/4553062_240.png 3,Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function.,British Journal of Urology,,,Article,2001-01-01,,,,,11121992,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4533753,https://api.altmetric.com/v1/donut/4533753_240.png 3,Hepsin and prostate cancer.,,,,Article,2007-08-31,,,,,17569629,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4532713,https://api.altmetric.com/v1/donut/4532713_240.png 3,Hepsin and prostate cancer,Frontiers in Bioscience,,,Article,2007-01-01,10.2741/2447,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4532712,https://api.altmetric.com/v1/donut/4532712_240.png 3,iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer.,PLoS ONE,,,Article,2012-02-15,10.1371/journal.pone.0030885,,,,22355332,,,2012PLoSO...7E0885R,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/4529989,https://api.altmetric.com/v1/donut/4529989_240.png 3,Autoantibody signatures in prostate cancer.,New England Journal of Medicine,,,Article,2005-09-21,10.1056/nejmoa051931,,,,16177248,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,108,https://www.altmetric.com/details/4519659,https://api.altmetric.com/v1/donut/4519659_240.png 3,The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.,Clinical Cancer Research,,,Article,2002-12-01,,,,,12473608,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4509413,https://api.altmetric.com/v1/donut/4509413_240.png 3,Resistance Emerges to Second Generation Anti-Androgens in Prostate Cancer,Cancer Discovery,,,Article,2013-09-01,10.1158/2159-8290.cd-13-0405,,,,24019330,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4507754,https://api.altmetric.com/v1/donut/4507754_240.png 3,Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer,Prostate Cancer,,,Article,2015-09-14,10.1155/2013/981684,,,,23819055,PMC3684034,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4507753,https://api.altmetric.com/v1/donut/4507753_240.png 3,"Targeting the androgen receptor in the management of castration-resistant prostate cancer: rationale, progress, and future directions",Current Oncology,,,Article,2012-12-15,10.3747/co.19.1281,,,,23355790,PMC3553559,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4507752,https://api.altmetric.com/v1/donut/4507752_240.png 3,ODM-201 Is Safe and Active in Metastatic Castration-Resistant Prostate Cancer.,Cancer Discovery,,,Article,2014-09-01,10.1158/2159-8290.cd-rw2014-150,,,,25185192,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4507693,https://api.altmetric.com/v1/donut/4507693_240.png 3,Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2.,,,,Article,,10.1371/journal.pone.0055922,,,,23431365,PMC3576345,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4501251,https://api.altmetric.com/v1/donut/4501251_240.png 3,Enzalutamide for patients with metastatic castration-resistant prostate cancer,OncoTargets and therapy,,,Article,2015-04-17,10.2147/ott.s80488,,,,25945058,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4501142,https://api.altmetric.com/v1/donut/4501142_240.png 3,Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal,British Journal of Urology,,,Article,2011-07-14,10.1111/j.1464-410x.2010.09764.x,,,,20955264,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4499504,https://api.altmetric.com/v1/donut/4499504_240.png 3,Bicalutamide (Casodex®) in the treatment of prostate cancer,Expert Review of Anticancer Therapy,,,Article,,10.1586/14737140.4.1.37,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4499503,https://api.altmetric.com/v1/donut/4499503_240.png 3,Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function,British Journal of Urology,,,Article,,10.1046/j.1464-410x.2001.00988.x,,,,,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4499500,https://api.altmetric.com/v1/donut/4499500_240.png 3,Hormone therapy of prostate cancer: is there a role for antiandrogen monotherapy?,Critical Reviews in Oncology/Hematology,,,Article,2000-01-08,10.1016/s1040-8428(00)00051-2,,,,10936469,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4499471,https://api.altmetric.com/v1/donut/4499471_240.png 3,Endocrine therapy for prostate cancer,Acta Oncologica,,,Article,,10.1080/02841860510029743,,,,16165920,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4499469,https://api.altmetric.com/v1/donut/4499469_240.png 3,"Tolerability, efficacy and pharmacokinetics of bicalutamide 300?mg, 450?mg or 600?mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration",British Journal of Urology,,,Article,2006-09-14,10.1111/j.1464-410x.2006.06275.x,,,,16771791,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4499323,https://api.altmetric.com/v1/donut/4499323_240.png 3,Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole,Prostate Cancer & Prostatic Diseases,,,Article,2005-02-01,10.1038/sj.pcan.4500782,,,,15685254,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4499320,https://api.altmetric.com/v1/donut/4499320_240.png 3,Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain.,BMC cancer,,,Article,2014-11-20,10.1186/1471-2407-14-852,,,,25409762,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4491247,https://api.altmetric.com/v1/donut/4491247_240.png 3,Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.,Journal of Clinical Investigation,,,Article,2002-08-01,10.1172/jci15529,,,,12163454,PMC151092,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4478899,https://api.altmetric.com/v1/donut/4478899_240.png 3,Novel and next-generation androgen receptor-directed therapies for prostate cancer: Beyond abiraterone and enzalutamide.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.05.025,,,,26162486,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4461801,https://api.altmetric.com/v1/donut/4461801_240.png 3,Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer,Asian Journal of Andrology,,,Article,2014-05-01,10.4103/1008-682x.129133,,,,24759590,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4461800,https://api.altmetric.com/v1/donut/4461800_240.png 3,ANTI-CANCER ACTIVITY OF A NOVEL SELECTIVE CYP17A1 INHIBITOR IN PRE-CLINICAL MODELS OF CASTRATE RESISTANT PROSTATE CANCER.,Molecular Cancer Therapeutics,,,Article,2015-01-01,10.1158/1535-7163.mct-14-0521,,,,25351916,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4461799,https://api.altmetric.com/v1/donut/4461799_240.png 3,Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer,International Journal of Molecular Sciences,,,Article,2013-07-04,10.3390/ijms140713958,,,,23880851,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/4461795,https://api.altmetric.com/v1/donut/4461795_240.png 3,Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.,Cancer Research,,,Article,1998-12-15,,,,,9865729,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4461674,https://api.altmetric.com/v1/donut/4461674_240.png 3,Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.,The Prostate,,,Article,2013-05-01,10.1002/pros.22620,,,,23192371,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4461566,https://api.altmetric.com/v1/donut/4461566_240.png 3,A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy.,PLoS ONE,,,Article,2008-05-28,10.1371/journal.pone.0002318,,,,18846227,PMC2565588,,2008PLoSO...3.2318N,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/4461565,https://api.altmetric.com/v1/donut/4461565_240.png 3,Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.,PLoS ONE,,,Article,2010-10-19,10.1371/journal.pone.0013500,,,,20976069,PMC2957443,,2010PLoSO...513500M,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4461561,https://api.altmetric.com/v1/donut/4461561_240.png 3,Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.,Cancer Investigation,,,Article,2009-06-14,10.1080/07357900802620794,,,,19229700,PMC2693083,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4461547,https://api.altmetric.com/v1/donut/4461547_240.png 3,Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer,Core Evidence,,,Article,2013-04-04,10.2147/ce.s34747,,,,23589709,PMC3622394,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4460888,https://api.altmetric.com/v1/donut/4460888_240.png 3,Posterior reversible encephalopathy syndrome induced by enzalutamide in a patient with castration-resistant prostate cancer.,Investigational New Drugs,,,Article,2014-12-03,10.1007/s10637-014-0193-3,,,,25467090,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4460887,https://api.altmetric.com/v1/donut/4460887_240.png 3,Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score.,British Journal of Urology,,,Article,2006-08-01,10.1111/j.1464-410x.2006.06224.x,,,,16879693,,,,,,,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4452669,https://api.altmetric.com/v1/donut/4452669_240.png 3,Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression.,,,,Article,2012-04-05,10.1016/j.bbrc.2012.03.012,,,,22426480,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4452530,https://api.altmetric.com/v1/donut/4452530_240.png 3,Activation of extracellular signal-regulated kinase by 12-hydroxyheptadecatrienoic acid in prostate cancer PC3 cells.,Archives of Biochemistry & Biophysics,,,Article,2007-11-01,10.1016/j.abb.2007.08.005,,,,17880908,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4452529,https://api.altmetric.com/v1/donut/4452529_240.png 3,Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation.,Cancer Biology and Therapy,,,Article,2007-02-15,,,,,17218785,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4452528,https://api.altmetric.com/v1/donut/4452528_240.png 3,Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells.,Journal of Biological Chemistry,,,Article,2006-07-07,10.1074/jbc.m601887200,,,,16638750,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4452480,https://api.altmetric.com/v1/donut/4452480_240.png 3,Dicarbonyl/L-xylulose reductase: a potential biomarker identified by laser-capture microdissection-micro serial analysis of gene expression of human prostate adenocarcinoma.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-12-01,10.1158/1055-9965.epi-07-0684,,,,18086765,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4451420,https://api.altmetric.com/v1/donut/4451420_240.png 3,NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer,Oncotarget,,,Article,2014-08-27,10.18632/oncotarget.2404,,,,25415046,PMC4294365,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4451326,https://api.altmetric.com/v1/donut/4451326_240.png 3,The emerging role of histone lysine demethylases in prostate cancer.,Molecular Cancer,,,Article,2012-08-06,10.1186/1476-4598-11-52,,,,22867098,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/4451204,https://api.altmetric.com/v1/donut/4451204_240.png 3,Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.,Cancer Research,,,Article,2006-12-01,10.1158/0008-5472.can-06-1570,,,,17145880,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,84,https://www.altmetric.com/details/4451167,https://api.altmetric.com/v1/donut/4451167_240.png 3,Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer,Science,,,Article,2009-11-27,10.1126/science.1178124,,,,19933109,PMC2935583,,2009Sci...326.1230M,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,142,https://www.altmetric.com/details/4420769,https://api.altmetric.com/v1/donut/4420769_240.png 3,Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases,PLoS ONE,,,Article,2009-09-18,10.1371/journal.pone.0007075,,,,19763266,,,2009PLoSO...4.7075V,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4420767,https://api.altmetric.com/v1/donut/4420767_240.png 3,KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis,Journal of Clinical Investigation,,,Article,2008-08-01,10.1172/jci34780,,,,18596922,PMC2441856,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/4420765,https://api.altmetric.com/v1/donut/4420765_240.png 3,Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer,Molecular and Cellular Proteomics (MCP Online),,,Article,2010-02-01,10.1074/mcp.m900159-mcp200,,,,19955085,PMC2830841,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/4420764,https://api.altmetric.com/v1/donut/4420764_240.png 3,Interstitial pneumonitis induced by bicalutamide given for prostate cancer,International Journal of Clinical Oncology,,,Article,2011-05-03,10.1007/s10147-011-0239-x,,,,21537882,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4414446,https://api.altmetric.com/v1/donut/4414446_240.png 3,Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer,Cancer Research,,,Article,2015-08-19,10.1158/0008-5472.can-15-0217,,,,26282172,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4411632,https://api.altmetric.com/v1/donut/4411632_240.png 3,Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials,The Lancet,,,Article,2000-04-29,10.1016/s0140-6736(00)02163-2,,,,10801170,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/4406933,https://api.altmetric.com/v1/donut/4406933_240.png 3,Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study,Journal of Clinical Oncology,,,Article,2011-05-20,10.1200/jco.2010.32.2776,,,,21502546,PMC3107759,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/4401674,https://api.altmetric.com/v1/donut/4401674_240.png 3,Re: Radiation for Prostate Cancer: Intensity Modulated Radiation Therapy versus Proton Beam,The Journal of Urology,,,Article,2015-08-11,10.1016/j.juro.2015.05.089,,,,26257214,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4370869,https://api.altmetric.com/v1/donut/4370869_240.png 3,The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression,European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.06.054,,,,26215610,,,,,,,0,0,0,6,0,0,2,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/4362393,https://api.altmetric.com/v1/donut/4362393_240.png 3,RE: Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial,JNCI: Journal of the National Cancer Institute,,,Article,2014-04-01,10.1093/jnci/dju020,,,,24685933,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4360128,https://api.altmetric.com/v1/donut/4360128_240.png 3,"Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment of prostate cancer (ID 3588) and “upper respiratory tract” (ID 3589) pursuant to Article 13(1) of Regulation (EC) No 1924/2006",EFSA Journal,,,Article,2011-07-28,10.2903/j.efsa.2011.2264,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4324246,https://api.altmetric.com/v1/donut/4324246_240.png 3,Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer.,Cancer Biomarkers,,,Article,2010-01-01,10.3233/cbm-2010-0152,,,,21178268,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4323226,https://api.altmetric.com/v1/donut/4323226_240.png 3,"Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer",Journal of Clinical Oncology,,,Article,2008-11-10,10.1200/jco.2008.16.9524,,,,18794543,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4323086,https://api.altmetric.com/v1/donut/4323086_240.png 3,Predicting Life Expectancy in Men With Clinically Localized Prostate Cancer,The Journal of Urology,,,Article,2006-01-01,10.1016/s0022-5347(05)00018-2,,,,16406881,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4323069,https://api.altmetric.com/v1/donut/4323069_240.png 3,Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam.,,,,Article,2011-04-14,10.1016/j.eururo.2011.01.001,,,,21334136,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4323067,https://api.altmetric.com/v1/donut/4323067_240.png 3,"Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study",Clinical Cancer Research,,,Article,2008-05-01,10.1158/1078-0432.ccr-07-0944,,,,18451243,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/4323065,https://api.altmetric.com/v1/donut/4323065_240.png 3,Radionuclide and hybrid imaging of recurrent prostate cancer,Lancet Oncology,,,Article,2011-01-02,10.1016/s1470-2045(10)70103-0,,,,20599424,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/4323059,https://api.altmetric.com/v1/donut/4323059_240.png 3,Circulating fatty acids and prostate cancer risk in a nested case–control study: the Multiethnic Cohort,Cancer Causes and Control,,,Article,2008-09-27,10.1007/s10552-008-9236-4,,,,18821021,PMC2711978,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4322882,https://api.altmetric.com/v1/donut/4322882_240.png 3,Erythrocyte fatty acids and prostate cancer risk: A comparison of methods,"Prostaglandins, Leukotrienes and Essential Fatty Acids",,,Article,2010-01-09,10.1016/j.plefa.2010.06.003,,,,20630734,PMC2939373,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4322880,https://api.altmetric.com/v1/donut/4322880_240.png 3,"Effect of Altering Dietary ?-6/?-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2",Clinical Cancer Research,,,Article,2006-08-01,10.1158/1078-0432.ccr-06-0459,,,,16899616,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/4322878,https://api.altmetric.com/v1/donut/4322878_240.png 3,The association of fatty acids with prostate cancer risk,The Prostate,,,Article,2001-06-01,10.1002/pros.1070,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4322870,https://api.altmetric.com/v1/donut/4322870_240.png 3,Prostatic origin of fucosyl transferase in human seminal plasma--a study on healthy controls and on men with infertility or with prostatic cancer.,Urological Research,,,Article,1984-01-01,,,,,6240149,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4304646,https://api.altmetric.com/v1/donut/4304646_240.png 3,"Expression of prostasome-like granules by the prostate cancer cell lines PC3, Du145 and LnCaP grown in monolayer.",Upsala Journal of Medical Sciences,,,Article,1999-01-01,,,,,10680953,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4303473,https://api.altmetric.com/v1/donut/4303473_240.png 3,Prothrombotic effects of prostasomes isolated from prostatic cancer cell lines and seminal plasma.,Seminars in Thrombosis & Hemostasis,,,Article,2007-01-29,10.1055/s-2006-958466,,,,17253194,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4303224,https://api.altmetric.com/v1/donut/4303224_240.png 3,Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-05-24,10.1073/pnas.1019330108,,,,21555566,PMC3102389,,2011PNAS..108.8809T,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/4303222,https://api.altmetric.com/v1/donut/4303222_240.png 3,MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.,Clinical Cancer Research,,,Article,2009-08-15,10.1158/1078-0432.ccr-09-0051,,,,19671871,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4292961,https://api.altmetric.com/v1/donut/4292961_240.png 3,The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics ,Biomaterials,,,Article,2015-07-22,10.1016/j.biomaterials.2015.07.019,,,,26196533,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/4290659,https://api.altmetric.com/v1/donut/4290659_240.png 3,Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial.,Radiation Oncology,,,Article,2015-07-08,10.1186/s13014-015-0442-4,,,,26152590,PMC4493985,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4255026,https://api.altmetric.com/v1/donut/4255026_240.png 3,Hormonal therapy in prostate cancer: historical approaches.,,,,Article,,,,,,16985934,PMC1472891,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4243805,https://api.altmetric.com/v1/donut/4243805_240.png 3,Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study,Anti-Cancer Drugs,,,Article,2003-09-01,10.1097/00001813-200309000-00003,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4243441,https://api.altmetric.com/v1/donut/4243441_240.png 3,"Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse",Cancer Letters,,,Article,2001-10-03,10.1016/s0304-3835(00)00705-9,,,,11166909,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4241695,https://api.altmetric.com/v1/donut/4241695_240.png 3,Toward a global characterization of the phosphoproteome in prostate cancer cells: Identification of phosphoproteins in the LNCaP cell line,Electrophoresis,,,Article,2007-05-09,10.1002/elps.200600782,,,,17487921,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4179649,https://api.altmetric.com/v1/donut/4179649_240.png 3,"microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.",,,,Article,2012-06-14,10.3892/or.2012.1711,,,,22407299,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4179311,https://api.altmetric.com/v1/donut/4179311_240.png 3,MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells.,,,,Article,,10.1371/journal.pone.0029722,,,,22235332,PMC3250472,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/4179294,https://api.altmetric.com/v1/donut/4179294_240.png 3,Arachidonic acid metabolism in human prostate cancer.,International Journal of Oncology,,,Article,2012-10-14,10.3892/ijo.2012.1588,,,,22895552,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4178844,https://api.altmetric.com/v1/donut/4178844_240.png 3,Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2010-02-02,10.1073/pnas.0914061107,,,,20080650,PMC2836698,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/4178266,https://api.altmetric.com/v1/donut/4178266_240.png 3,LHRH-Conjugated Micelles for Targeted Delivery of Antiandrogen to Treat Advanced Prostate Cancer.,Pharmaceutical Research,,,Article,2014-05-01,10.1007/s11095-014-1375-6,,,,24789451,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4173320,https://api.altmetric.com/v1/donut/4173320_240.png 3,Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer.,Pharmaceutical Research,,,Article,2012-03-27,10.1007/s11095-012-0737-1,,,,22451249,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4173310,https://api.altmetric.com/v1/donut/4173310_240.png 3,The Expression and Clinical Significance of GTP-binding RAS-like 3 (ARHI) and MicroRNA 221 and 222 in Prostate Cancer.,,,,Article,,,,,,22117988,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4172630,https://api.altmetric.com/v1/donut/4172630_240.png 3,Motexafin lutetium-photodynamic therapy of prostate cancer: Short and long term effects on PSA,Clinical Cancer Research,,,Article,2008-07-31,10.1158/1078-0432.ccr-08-0317,,,,18676760,PMC2680073,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4170540,https://api.altmetric.com/v1/donut/4170540_240.png 3,Supplemental and Dietary Vitamin E Intakes and Risk of Prostate Cancer in a Large Prospective Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-06-14,10.1158/1055-9965.epi-06-1071,,,,17548674,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4164247,https://api.altmetric.com/v1/donut/4164247_240.png 3,Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.,,,,Article,2005-09-14,10.1158/0008-5472.can-05-0399,,,,16166332,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4159045,https://api.altmetric.com/v1/donut/4159045_240.png 3,Precise microdissection of human prostate cancers reveals genotypic heterogeneity.,Cancer Research,,,Article,1998-01-01,,,,,9426051,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4159044,https://api.altmetric.com/v1/donut/4159044_240.png 3,Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer.,,,,Article,,10.1007/s10038-005-0285-1,,,,16172807,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4158934,https://api.altmetric.com/v1/donut/4158934_240.png 3,KLF6 Loss of Function in Human Prostate Cancer Progression Is Implicated in Resistance to Androgen Deprivation.,,,,Article,2012-09-14,10.1016/j.ajpath.2012.06.008,,,,22819534,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4157833,https://api.altmetric.com/v1/donut/4157833_240.png 3,"Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.",,,,Article,2010-08-10,10.1371/journal.pone.0012107,,,,20711410,PMC2920336,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4157723,https://api.altmetric.com/v1/donut/4157723_240.png 3,Diet and prostatic cancer: a case-control study in northern Italy.,Nutrition and Cancer,,,Article,1992-01-01,10.1080/01635589209514228,,,,1296201,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4157510,https://api.altmetric.com/v1/donut/4157510_240.png 3,CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer.,,,,Article,2009-03-10,10.1038/sj.bjc.6604904,,,,19223900,PMC2653756,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/4151805,https://api.altmetric.com/v1/donut/4151805_240.png 3,Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.,,,,Article,2011-03-01,10.1158/0008-5472.can-10-2421,,,,21343391,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/4150471,https://api.altmetric.com/v1/donut/4150471_240.png 3,DNA methylation silences miR-132 in prostate cancer.,Oncogene,,,Article,2013-01-03,10.1038/onc.2012.14,,,,22310291,,1854/LU-3213160,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/4150376,https://api.altmetric.com/v1/donut/4150376_240.png 3,miR 488* inhibits androgen receptor expression in prostate carcinoma cells.,International Journal of Cancer,,,Article,2011-08-14,10.1002/ijc.25753,,,,21710544,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4150252,https://api.altmetric.com/v1/donut/4150252_240.png 3,MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.,,,,Article,2009-09-23,10.1038/onc.2009.192,,,,19597470,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/4150125,https://api.altmetric.com/v1/donut/4150125_240.png 3,Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.,,,,Article,2008-07-31,10.1158/0008-5472.can-08-0144,,,,18676839,PMC2597340,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,145,https://www.altmetric.com/details/4150096,https://api.altmetric.com/v1/donut/4150096_240.png 3,miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue.,,,,Article,,10.1016/j.urolonc.2009.05.008,,,,19734068,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/4150094,https://api.altmetric.com/v1/donut/4150094_240.png 3,Circulating microRNAs (miRNA) in serum of patients with prostate cancer.,,,,Article,2011-05-14,10.1016/j.urology.2011.01.020,,,,21539977,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/4150087,https://api.altmetric.com/v1/donut/4150087_240.png 3,Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.,,,,Article,2006-04-14,10.1016/j.cancergencyto.2005.09.012,,,,16631469,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,424,https://www.altmetric.com/details/4149148,https://api.altmetric.com/v1/donut/4149148_240.png 3,Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.,,,,Article,,,,,,21628883,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4148469,https://api.altmetric.com/v1/donut/4148469_240.png 3,Evidence for field cancerization of the prostate,The Prostate,,,Article,2009-05-21,10.1002/pros.20983,,,,19462462,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/4148082,https://api.altmetric.com/v1/donut/4148082_240.png 3,Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.,Nature Genetics,,,Article,,10.1038/ng.635,,,,20676098,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/4147412,https://api.altmetric.com/v1/donut/4147412_240.png 3,Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.,Cancer Prevention Research,,,Article,2010-08-14,10.1158/1940-6207.capr-09-0261,,,,20647336,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4138000,https://api.altmetric.com/v1/donut/4138000_240.png 3,Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer.,International Journal of Biochemistry & Cell Biology,,,Article,2010-02-15,10.1016/j.biocel.2009.11.001,,,,19914392,PMC2818495,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4133895,https://api.altmetric.com/v1/donut/4133895_240.png 3,VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms.,International Journal of Cancer,,,Article,2000-03-20,,,,,10754495,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4131021,https://api.altmetric.com/v1/donut/4131021_240.png 3,Comparison of Microsatellites Versus Single-Nucleotide Polymorphisms in a Genome Linkage Screen for Prostate Cancer–Susceptibility Loci,American Journal of Human Genetics,,,Article,2004-01-12,10.1086/425870,,,,15514889,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/4128736,https://api.altmetric.com/v1/donut/4128736_240.png 3,Might early baldness protect from prostate cancer by increasing skin exposure to ultraviolet radiation?,Cancer Epidemiology,,,Article,2010-01-08,10.1016/j.canep.2010.04.014,,,,20451486,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4128427,https://api.altmetric.com/v1/donut/4128427_240.png 3,Quantitative Proteomics Reveals that Enzymes of the Ketogenic Pathway are Associated with Prostate Cancer Progression.,Molecular and Cellular Proteomics (MCP Online),,,Article,2013-06-01,10.1074/mcp.m112.023887,,,,23443136,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/4127388,https://api.altmetric.com/v1/donut/4127388_240.png 3,Indium-111 capromab pendetide in the management of recurrent prostate cancer,Expert Review of Anticancer Therapy,,,Article,2008-02-15,10.1586/14737140.8.2.175,,,,18279057,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4125459,https://api.altmetric.com/v1/donut/4125459_240.png 3,Mitochondrial DNA Haplogroup Analysis Reveals no Association between the Common Genetic Lineages and Prostate Cancer in the Korean Population,PLoS ONE,,,Article,2008-05-21,10.1371/journal.pone.0002211,,,,18493608,PMC2376063,,2008PLoSO...3.2211K,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4120658,https://api.altmetric.com/v1/donut/4120658_240.png 3,"Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients",Journal of comparative effectiveness research,,,Article,2014-09-14,10.2217/cer.14.41,,,,25350803,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4118995,https://api.altmetric.com/v1/donut/4118995_240.png 3,Identification of Pathogen Signatures in Prostate Cancer Using RNA-seq.,PLoS ONE,,,Article,2015-06-08,10.1371/journal.pone.0128955,,,,26053031,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4117959,https://api.altmetric.com/v1/donut/4117959_240.png 3,Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer.,Annals of Oncology,,,Article,2000-02-01,,,,,10761752,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4117812,https://api.altmetric.com/v1/donut/4117812_240.png 3,Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting,Prostate Cancer & Prostatic Diseases,,,Article,2009-09-29,10.1038/pcan.2009.42,,,,19786982,PMC2834351,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/4114392,https://api.altmetric.com/v1/donut/4114392_240.png 3,Optimal biopsy strategies for the diagnosis and staging of prostate cancer,Current Opinion in Urology,,,Article,2009-05-01,10.1097/mou.0b013e328329a33e,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4114388,https://api.altmetric.com/v1/donut/4114388_240.png 3,Reproducibility of plasma alkylresorcinols during a 6-week rye intervention study in men with prostate cancer.,,,,Article,2009-05-14,10.3945/jn.108.099952,,,,19321581,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4113037,https://api.altmetric.com/v1/donut/4113037_240.png 3,"Evaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer",,,,Article,2012-03-15,10.2217/fon.12.7,,,,22409460,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4112322,https://api.altmetric.com/v1/donut/4112322_240.png 3,Recombinant Semliki forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo.,International Journal of Molecular Medicine,,,Article,2000-03-01,,,,,10677563,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4111609,https://api.altmetric.com/v1/donut/4111609_240.png 3,An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer.,,,,Article,2011-06-14,10.1177/1756287211414457,,,,21904569,PMC3159401,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4108299,https://api.altmetric.com/v1/donut/4108299_240.png 3,A systematic review of brachytherapy. Is it an effective and safe treatment for localised prostate cancer?,,,,Article,2004-07-14,,,,,15301172,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4101580,https://api.altmetric.com/v1/donut/4101580_240.png 3,Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review,Radiotherapy & Oncology,,,Article,2009-11-15,10.1016/j.radonc.2009.08.033,,,,19748692,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/4101575,https://api.altmetric.com/v1/donut/4101575_240.png 3,Non-surgical treatment of localised prostate cancer,Surgical Oncology,,,Article,2009-09-14,10.1016/j.suronc.2009.03.006,,,,19442516,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4101567,https://api.altmetric.com/v1/donut/4101567_240.png 3,Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A Single-Institution Matched-Pair Analysis,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-01-01,10.1016/j.ijrobp.2009.01.081,,,,19570619,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/4101564,https://api.altmetric.com/v1/donut/4101564_240.png 3,High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial,Radiotherapy & Oncology,,,Article,2007-08-14,10.1016/j.radonc.2007.04.011,,,,17531335,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4101562,https://api.altmetric.com/v1/donut/4101562_240.png 3,Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-03-15,10.1016/j.ijrobp.2003.08.003,,,,15001244,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4101561,https://api.altmetric.com/v1/donut/4101561_240.png 3,"An Assessment of Quality of Life Following Radical Prostatectomy, High Dose External Beam Radiation Therapy and Brachytherapy Iodine Implantation as Monotherapies for Localized Prostate Cancer",The Journal of Urology,,,Article,2007-06-14,10.1016/j.juro.2007.01.134,,,,17509305,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4101556,https://api.altmetric.com/v1/donut/4101556_240.png 3,"Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT)",Radiation Oncology,,,Article,2008-07-14,10.1186/1748-717x-3-20,,,,18627617,PMC2494997,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4101553,https://api.altmetric.com/v1/donut/4101553_240.png 3,"Quality of life after surgery, external beam irradiation, or brachytherapy for early?stage prostate cancer",Cancer (0008543X),,,Article,2007-05-31,10.1002/cncr.22676,,,,17455209,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/4101552,https://api.altmetric.com/v1/donut/4101552_240.png 3,Evaluation of Dosimetric Parameters and Disease Response After 125Iodine Transperineal Brachytherapy for Low- and Intermediate-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-03-31,10.1016/j.ijrobp.2008.07.042,,,,19036530,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4101551,https://api.altmetric.com/v1/donut/4101551_240.png 3,Treatment decisions for localized prostate cancer: asking men what's important.,JGIM: Journal of General Internal Medicine,,,Article,2000-10-01,,,,,11089712,PMC1495597,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4101550,https://api.altmetric.com/v1/donut/4101550_240.png 3,"Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.",,,,Article,2009-07-14,,,,,19574206,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4101547,https://api.altmetric.com/v1/donut/4101547_240.png 3,Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade,Modern Pathology,,,Article,2007-02-02,10.1038/modpathol.3800743,,,,17277764,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4089321,https://api.altmetric.com/v1/donut/4089321_240.png 3,Docetaxel for advanced prostate cancer: how early to start?,Lancet Oncology,,,Article,2015-06-02,10.1016/s1470-2045(15)00012-1,,,,26028517,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4069595,https://api.altmetric.com/v1/donut/4069595_240.png 3,"Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis",Lancet Oncology,,,Article,2008-01-11,10.1016/s1470-2045(08)70235-3,,,,18835745,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/4064785,https://api.altmetric.com/v1/donut/4064785_240.png 3,Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.,Cancer Genetics & Cytogenetics,,,Article,2006-01-09,10.1016/j.cancergencyto.2006.03.015,,,,16938574,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4049038,https://api.altmetric.com/v1/donut/4049038_240.png 3,Psychosocial Adjustment in Newly Diagnosed Prostate Cancer,Australian & New Zealand Journal of Psychiatry,,,Article,2008-05-14,10.1080/00048670801961081,,,,18473260,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4048018,https://api.altmetric.com/v1/donut/4048018_240.png 3,Dairy product consumption and the risk of prostate cancer,International Dairy Journal,,,Article,2009-10-01,10.1016/j.idairyj.2009.05.006,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4045178,https://api.altmetric.com/v1/donut/4045178_240.png 3,trans-Fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant,Carcinogenesis,,,Article,2007-06-14,10.1093/carcin/bgm002,,,,17234723,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4045011,https://api.altmetric.com/v1/donut/4045011_240.png 3,Gene therapy approach in prostate cancer cells using an active Wnt signal.,Biomedicine & Pharmacotherapy,,,Article,2007-10-01,10.1016/j.biopha.2007.08.010,,,,17904788,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4042937,https://api.altmetric.com/v1/donut/4042937_240.png 3,The impact of increasing dose on overall survival in prostate cancer,Radiation Oncology,,,Article,2015-05-21,10.1186/s13014-015-0419-3,,,,25990489,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4036724,https://api.altmetric.com/v1/donut/4036724_240.png 3,Urolithin A causes p21 up-regulation in prostate cancer cells.,European Journal of Nutrition,,,Article,2015-05-12,10.1007/s00394-015-0924-z,,,,25962506,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4014749,https://api.altmetric.com/v1/donut/4014749_240.png 3,Management of node only recurrence after primary local treatment for prostate cancer: a systematic review of the literature,The Journal of Urology,,,Article,2015-05-13,10.1016/j.juro.2015.04.103,,,,25963190,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3980558,https://api.altmetric.com/v1/donut/3980558_240.png 3,Nadir Testosterone after Long-Term Follow-Up Predicts Prognosis of Prostate Cancer Patients Treated With Combined Androgen Blockade,The Journal of Urology,,,Article,2015-04-12,10.1016/j.juro.2015.03.120,,,,25861958,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3886078,https://api.altmetric.com/v1/donut/3886078_240.png 3,Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.,Nuclear Medicine Communications,,,Article,2015-03-03,10.1097/mnm.0000000000000290,,,http://journals.lww.com/nuclearmedicinecomm/Fulltext/2015/06000/Evaluation_of_PSMA_PET_CT_imaging_using_a.6.aspx,25738559,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3757309,https://api.altmetric.com/v1/donut/3757309_240.png 3,Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel,Radiation Oncology,,,Article,2015-02-27,10.1186/s13014-015-0348-1,,,,25886457,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3737268,https://api.altmetric.com/v1/donut/3737268_240.png 3,A dietary tomato supplement prevents prostate cancer in TRAMP mice.,Cancer Prevention Research,,,Article,,10.1158/1940-6207.capr-09-0237,,,,20716635,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3701155,https://api.altmetric.com/v1/donut/3701155_240.png 3,Phase I Dose-Escalation Study of the Novel Anti-androgen BMS-641988 in Patients with Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2011-02-15,10.1158/1078-0432.ccr-10-2955,,,,21131556,PMC3070382,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3699771,https://api.altmetric.com/v1/donut/3699771_240.png 3,SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.0710343105,,,,18087039,,,2007PNAS..10420793K,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/3698312,https://api.altmetric.com/v1/donut/3698312_240.png 3,Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.,The Prostate,,,Article,2006-09-05,10.1002/pros.20509,,,,16955399,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3697880,https://api.altmetric.com/v1/donut/3697880_240.png 3,"Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.",The Prostate,,,Article,1981-01-01,,,,,6458025,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3697111,https://api.altmetric.com/v1/donut/3697111_240.png 3,"Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer",The Prostate,,,Article,2006-07-20,10.1002/pros.2990020310,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3697108,https://api.altmetric.com/v1/donut/3697108_240.png 3,PRAC2: a new gene expressed in human prostate and prostate cancer.,The Prostate,,,Article,2003-05-07,10.1002/pros.10185,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3696364,https://api.altmetric.com/v1/donut/3696364_240.png 3,Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer.,Clinical Chemistry,,,Article,,10.1373/clinchem.2010.143297,,,,20581083,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3696268,https://api.altmetric.com/v1/donut/3696268_240.png 3,Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.,Asian Journal of Andrology,,,Article,2012-02-23,10.1038/aja.2011.141,,,,22343493,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3694460,https://api.altmetric.com/v1/donut/3694460_240.png 3,Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer,The Journal of Urology,,,Article,2009-05-01,10.1016/j.juro.2009.01.047,,,,19286225,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3694223,https://api.altmetric.com/v1/donut/3694223_240.png 3,Immunohistochemical characterization of neuroendocrine cells in prostate cancer.,The Prostate,,,Article,2006-07-24,10.1002/pros.20434,,,,16865726,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3694175,https://api.altmetric.com/v1/donut/3694175_240.png 3,Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer.,Pathobiology,,,Article,2009-02-02,10.1159/000178153,,,,19188748,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3694174,https://api.altmetric.com/v1/donut/3694174_240.png 3,Neuroendocrine differentiation in prostate cancer,American Journal of Translational Research,,,Article,2009-12-05,,,,,19956427,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3694172,https://api.altmetric.com/v1/donut/3694172_240.png 3,Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities.,European Urology,,,Article,2005-01-22,10.1016/j.eururo.2004.09.007,,,,15661408,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3694171,https://api.altmetric.com/v1/donut/3694171_240.png 3,Alternative splicing and biological heterogeneity in prostate cancer,Nature Reviews Urology,,,Article,2009-08-01,10.1038/nrurol.2009.125,,,,19657379,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3693818,https://api.altmetric.com/v1/donut/3693818_240.png 3,Toponome mapping in prostate cancer: detection of 2000 cell surface protein clusters in a single tissue section and cell type specific annotation by using a three symbol code.,Journal of Proteome Research,,,Article,2009-03-13,10.1021/pr800944f,,,,19275201,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3693624,https://api.altmetric.com/v1/donut/3693624_240.png 3,Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.,Apoptosis,,,Article,2006-05-11,10.1007/s10495-006-6796-1,,,,16699961,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3693600,https://api.altmetric.com/v1/donut/3693600_240.png 3,"Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.",Oncogene,,,Article,2004-01-15,10.1038/sj.onc.1207069,,,,14724589,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3693194,https://api.altmetric.com/v1/donut/3693194_240.png 3,Longer (TA)n repeat but not A49T and V89L polymorphisms in SRD5A2 gene may confer prostate cancer risk in South Indian men.,The Journal of Andrology,,,Article,2013-01-02,10.2164/jandrol.108.007377,,,,19443907,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3692045,https://api.altmetric.com/v1/donut/3692045_240.png 3,GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men.,Journal of Human Genetics,,,Article,2006-09-13,10.1007/s10038-006-0051-z,,,,16969583,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3692042,https://api.altmetric.com/v1/donut/3692042_240.png 3,South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.,Journal of Human Genetics,,,Article,2006-01-26,10.1007/s10038-005-0346-5,,,,16437189,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3692040,https://api.altmetric.com/v1/donut/3692040_240.png 3,Focal Therapy for Prostate Cancer: Rationale and Treatment Opportunities.,Clinical Oncology,,,Article,,10.1016/j.clon.2013.05.002,,,,23759249,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3690610,https://api.altmetric.com/v1/donut/3690610_240.png 3,Irreversible electroporation: implications for prostate ablation.,Technology in Cancer Research and Treatment,,,Article,2007-01-08,,,,,17668936,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,70,https://www.altmetric.com/details/3690605,https://api.altmetric.com/v1/donut/3690605_240.png 3,"The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts.",The Prostate,,,Article,2007-03-20,10.1002/pros.20573,,,,17373719,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3687748,https://api.altmetric.com/v1/donut/3687748_240.png 3,"Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer",British Journal of Cancer,,,Article,2009-09-15,10.1038/sj.bjc.6605322,,,,19755981,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3687746,https://api.altmetric.com/v1/donut/3687746_240.png 3,Androgen receptor and its splice variants in prostate cancer.,Cellular & Molecular Life Sciences,,,Article,2011-07-12,10.1007/s00018-011-0766-7,,,,21748469,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3687594,https://api.altmetric.com/v1/donut/3687594_240.png 3,MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2.,Cancer Research,,,Article,2011-01-15,10.1158/0008-5472.can-10-2587,,,,21224345,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3685146,https://api.altmetric.com/v1/donut/3685146_240.png 3,"Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic and Therapeutic Targets",Advances in Anatomic Pathology,,,Article,2008-11-01,10.1097/pap.0b013e31818a5c19,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3684309,https://api.altmetric.com/v1/donut/3684309_240.png 3,Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased?,Hellenic Journal of Nuclear Medicine,,,Article,2012-12-13,,,,,23227460,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3684248,https://api.altmetric.com/v1/donut/3684248_240.png 3,Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.,British Medical Journal,,,Article,1983-04-23,,,,,6404441,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3684080,https://api.altmetric.com/v1/donut/3684080_240.png 3,The functional significance of microRNA-145 in prostate cancer,British Journal of Cancer,,,Article,2010-06-29,10.1038/sj.bjc.6605742,,,,20588276,PMC2906737,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/3683857,https://api.altmetric.com/v1/donut/3683857_240.png 3,miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.,Cancer Research,,,Article,,10.1158/0008-5472.can-08-2894,,,,19244118,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,75,https://www.altmetric.com/details/3683854,https://api.altmetric.com/v1/donut/3683854_240.png 3,"PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12.",Cancer Research,,,Article,2000-02-15,,,,,10706094,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3681393,https://api.altmetric.com/v1/donut/3681393_240.png 3,Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer.,Bioorganic & Medicinal Chemistry,,,Article,2010-01-12,10.1016/j.bmc.2010.10.023,,,,21050768,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3681066,https://api.altmetric.com/v1/donut/3681066_240.png 3,Structural basis for antagonism and resistance of bicalutamide in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.0500381102,,,,15833816,,,2005PNAS..102.6201B,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3680756,https://api.altmetric.com/v1/donut/3680756_240.png 3,Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.,The Prostate,,,Article,2011-02-09,10.1002/pros.21351,,,,21308717,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3680747,https://api.altmetric.com/v1/donut/3680747_240.png 3,INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling,Cancer Cell International,,,Article,,10.1186/1475-2867-9-28,,,,19906297,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3680689,https://api.altmetric.com/v1/donut/3680689_240.png 3,Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway.,Oncotarget,,,Article,2014-10-28,10.18632/oncotarget.2429,,,,25344864,PMC4253438,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3678119,https://api.altmetric.com/v1/donut/3678119_240.png 3,"A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer.",Cancer Chemotherapy & Pharmacology,,,Article,2013-01-13,10.1007/s00280-013-2079-z,,,,23314737,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3677678,https://api.altmetric.com/v1/donut/3677678_240.png 3,Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation.,The Prostate,,,Article,2005-11-02,10.1002/pros.20345,,,,16267859,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3677230,https://api.altmetric.com/v1/donut/3677230_240.png 3,"Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status.",Annals of Oncology,,,Article,,10.1093/annonc/12.suppl_2.s141,,,,11762342,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3674044,https://api.altmetric.com/v1/donut/3674044_240.png 3,Neuroendocrine differentiation and hormone-refractory prostate cancer.,Prostate Supplement,,,Article,1996-01-01,,,,,8630226,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3674038,https://api.altmetric.com/v1/donut/3674038_240.png 3,"Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.",Cancer (0008543X),,,Article,1992-07-01,,,,,1350941,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3674037,https://api.altmetric.com/v1/donut/3674037_240.png 3,The molecular face of prostate cancer.,Journal of Proteome Research,,,Article,2009-04-24,10.1021/pr9003129,,,,19385645,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3672691,https://api.altmetric.com/v1/donut/3672691_240.png 3,"Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,1998-05-01,,,,,9610788,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3672665,https://api.altmetric.com/v1/donut/3672665_240.png 3,Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.,Annals of Oncology,,,Article,,10.1093/annonc/mdn544,,,,18695026,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/3672189,https://api.altmetric.com/v1/donut/3672189_240.png 3,Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populations,European Journal of Human Genetics,,,Article,2010-04-21,10.1038/ejhg.2010.53,,,,20407466,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3671578,https://api.altmetric.com/v1/donut/3671578_240.png 3,Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients,British Journal of Cancer,,,Article,2005-08-30,10.1038/sj.bjc.6602761,,,,16136047,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3669546,https://api.altmetric.com/v1/donut/3669546_240.png 3,Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer.,Cancer Biomarkers,,,Article,2004-12-31,,,,,17192049,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3668755,https://api.altmetric.com/v1/donut/3668755_240.png 3,Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population.,Asian Pacific Journal of Cancer Prevention,,,Article,2005-10-20,,,,,16235991,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3668748,https://api.altmetric.com/v1/donut/3668748_240.png 3,Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases.,Clinical Cancer Research,,,Article,2007-04-30,10.1158/1078-0432.ccr-06-2163,,,,17473194,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3667736,https://api.altmetric.com/v1/donut/3667736_240.png 3,"A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.",Chemico-Biological Interactions,,,Article,2010-08-10,10.1016/j.cbi.2010.07.024,,,,20692244,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3667035,https://api.altmetric.com/v1/donut/3667035_240.png 3,584 Early clinical experience of focal therapy for localised prostate cancer using irreversible electroporation,European Urology Supplements,,,Article,2013-03-01,10.1016/s1569-9056(13)61067-2,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3665092,https://api.altmetric.com/v1/donut/3665092_240.png 3,Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2,Neoplasia,,,Article,2011-06-16,,,,,21677876,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3664172,https://api.altmetric.com/v1/donut/3664172_240.png 3,Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells.,Cancer Gene Therapy,,,Article,2009-04-17,10.1038/cgt.2009.28,,,,19373278,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3661743,https://api.altmetric.com/v1/donut/3661743_240.png 3,The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer.,Expert Opinion on Investigational Drugs,,,Article,2010-09-14,10.1517/13543784.2010.514262,,,,20836618,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3658003,https://api.altmetric.com/v1/donut/3658003_240.png 3,"Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors",Molecular Cancer,,,Article,,10.1186/1476-4598-9-107,,,,20470445,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3658001,https://api.altmetric.com/v1/donut/3658001_240.png 3,A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth,Cancer Research,,,Article,2009-03-15,10.1158/0008-5472.can-08-3795,,,,19244107,PMC2672822,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,106,https://www.altmetric.com/details/3657557,https://api.altmetric.com/v1/donut/3657557_240.png 3,Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.,Cancer Research,,,Article,2009-01-01,10.1158/0008-5472.can-08-2764,,,,19117982,PMC2614301,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,118,https://www.altmetric.com/details/3657552,https://api.altmetric.com/v1/donut/3657552_240.png 3,The mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice,Cancer Cell,,,Article,2009-02-03,10.1016/j.ccr.2008.12.017,,,,19185849,PMC2701381,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,143,https://www.altmetric.com/details/3657104,https://api.altmetric.com/v1/donut/3657104_240.png 3,Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack.,The Prostate,,,Article,2004-05-06,10.1002/pros.20102,,,,15389819,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3656713,https://api.altmetric.com/v1/donut/3656713_240.png 3,Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells.,Biochimica et Biophysica Acta (BBA),,,Article,2012-09-18,10.1016/j.bbagrm.2012.08.016,,,,22982408,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,75,https://www.altmetric.com/details/3656707,https://api.altmetric.com/v1/donut/3656707_240.png 3,Activation of Stat3 through a Phosphomimetic Serine727 Promotes Prostate Tumorigenesis Independent of Tyrosine705 phosphorylation,Cancer Research,,,Article,,10.1158/0008-5472.can-08-1125,,,,18829527,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3656575,https://api.altmetric.com/v1/donut/3656575_240.png 3,"Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.",Journal of Clinical Oncology,,,Article,,10.1200/jco.2004.10.195,,,,15289492,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3656301,https://api.altmetric.com/v1/donut/3656301_240.png 3,Interaction of Tomato Lycopene and Ketosamine against Rat Prostate Tumorigenesis,Cancer Research,,,Article,,10.1158/0008-5472.can-08-0108,,,,18519700,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3656219,https://api.altmetric.com/v1/donut/3656219_240.png 3,Potent oncolytic activity of human enteroviruses against human prostate cancer.,The Prostate,,,Article,2008-02-20,10.1002/pros.20741,,,,18288643,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3656129,https://api.altmetric.com/v1/donut/3656129_240.png 3,The language of prostate cancer treatments and implications for informed decision making by patients.,European Journal of Cancer Care,,,Article,2012-05-11,10.1111/j.1365-2354.2012.01359.x,,,,22574619,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3650714,https://api.altmetric.com/v1/donut/3650714_240.png 3,N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer,Neoplasia,,,Article,2009-01-08,,,,,19649210,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3648810,https://api.altmetric.com/v1/donut/3648810_240.png 3,Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein,British Journal of Cancer,,,Article,2004-03-08,10.1038/sj.bjc.6601642,,,,14997204,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3648807,https://api.altmetric.com/v1/donut/3648807_240.png 3,The role of microRNA-221 and -222 in Androgen-independent Prostate Cancer Cell lines,Cancer Research,,,Article,2009-04-14,10.1158/0008-5472.can-08-4112,,,,19351832,PMC2703812,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3647668,https://api.altmetric.com/v1/donut/3647668_240.png 3,"miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice",PLoS ONE,,,Article,2009-10-28,10.1371/journal.pone.0007542,,,,19855844,,,2009PLoSO...4.7542C,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3646871,https://api.altmetric.com/v1/donut/3646871_240.png 3,MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.,Cancer (0008543X),,,Article,2010-08-24,10.1002/cncr.25488,,,,20737563,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3646794,https://api.altmetric.com/v1/donut/3646794_240.png 3,Quantitative Determination of Expression of the Prostate Cancer Protein ?-Methylacyl-CoA Racemase Using Automated Quantitative Analysis (AQUA) : A Novel Paradigm for Automated and Continuous Biomarker Measurements,American Journal of Pathology,,,Article,2004-02-27,,,,,14982837,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3645906,https://api.altmetric.com/v1/donut/3645906_240.png 3,Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies,Molecular Cancer,,,Article,,10.1186/1476-4598-5-24,,,,16784538,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,190,https://www.altmetric.com/details/3645554,https://api.altmetric.com/v1/donut/3645554_240.png 3,Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2008.05.059,,,,18755555,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3644487,https://api.altmetric.com/v1/donut/3644487_240.png 3,Fas ligand is constitutively secreted by prostate cancer cells in vitro.,Clinical Cancer Research,,,Article,1998-07-01,,,,,9676859,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3642727,https://api.altmetric.com/v1/donut/3642727_240.png 3,The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.,Urology,,,Article,,10.1016/j.urology.2007.11.058,,,,18336888,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3639667,https://api.altmetric.com/v1/donut/3639667_240.png 3,Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.,The Prostate,,,Article,1996-09-01,,,,,8827083,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3638571,https://api.altmetric.com/v1/donut/3638571_240.png 3,"Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells.",Organic Letters,,,Article,2008-06-10,10.1021/ol802021w,,,,18834139,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3638568,https://api.altmetric.com/v1/donut/3638568_240.png 3,The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth.,Molecular & Cellular Endocrinology,,,Article,2010-10-23,10.1016/j.mce.2010.09.013,,,,20965230,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3638549,https://api.altmetric.com/v1/donut/3638549_240.png 3,Sipuleucel-T: in metastatic castration-resistant prostate cancer.,Drugs,,,Article,2012-11-29,10.2165/11206840-000000000-00000,,,,21175243,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3638261,https://api.altmetric.com/v1/donut/3638261_240.png 3,Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2006.04.029,,,,16798415,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,121,https://www.altmetric.com/details/3638253,https://api.altmetric.com/v1/donut/3638253_240.png 3,"Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.",Drugs in R&D,,,Article,2006-06-07,,,,,16752945,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3638252,https://api.altmetric.com/v1/donut/3638252_240.png 3,"Bowel, Urinary, and Sexual Problems Among Long-Term Prostate Cancer Survivors: A Population-Based Study","International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2008.04.004,,,,18538503,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3633906,https://api.altmetric.com/v1/donut/3633906_240.png 3,Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djm153,,,,17895474,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3633905,https://api.altmetric.com/v1/donut/3633905_240.png 3,"Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer",British Journal of Cancer,,,Article,2009-11-10,10.1038/sj.bjc.6605422,,,,19904272,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3633904,https://api.altmetric.com/v1/donut/3633904_240.png 3,Active surveillance for low-risk prostate cancer,Critical Reviews in Oncology/Hematology,,,Article,,10.1016/j.critrevonc.2012.07.005,,,,22878262,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3633903,https://api.altmetric.com/v1/donut/3633903_240.png 3,Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer,JAMA: Journal of the American Medical Association,,,Article,1994-02-02,10.1001/jama.271.5.368,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,93,https://www.altmetric.com/details/3633901,https://api.altmetric.com/v1/donut/3633901_240.png 3,"PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-02-19,10.1073/pnas.97.22.12216,,,,11050243,PMC17321,,2000PNAS...9712216S,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/3632936,https://api.altmetric.com/v1/donut/3632936_240.png 3,"Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.",Cancer Detection & Prevention,,,Article,,10.1016/j.cdp.2008.12.002,,,,19186008,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3632934,https://api.altmetric.com/v1/donut/3632934_240.png 3,LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer,BMC Medical Genomics,,,Article,2010-09-23,10.1186/1755-8794-3-43,,,,20868494,PMC2956710,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/3632931,https://api.altmetric.com/v1/donut/3632931_240.png 3,Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression.,Recent Patents on DNA & Gene Sequences,,,Article,2009-11-07,,,,,19891595,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3632930,https://api.altmetric.com/v1/donut/3632930_240.png 3,Androgen Deprivation Therapy in the Treatment of Advanced Prostate Cancer,Reviews in Urology,,,Article,2007-03-28,,,,,17387371,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3632035,https://api.altmetric.com/v1/donut/3632035_240.png 3,Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.,The Journal of Urology,,,Article,2010-07-14,10.1016/j.juro.2010.03.012,,,,20478579,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3630421,https://api.altmetric.com/v1/donut/3630421_240.png 3,"Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells.",Biochemical & Biophysical Research Communications,,,Article,2004-08-18,10.1016/j.bbrc.2004.07.094,,,,15313200,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3629352,https://api.altmetric.com/v1/donut/3629352_240.png 3,Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer.,Clinical Cancer Research,,,Article,2005-07-14,10.1158/1078-0432.ccr-05-0299,,,,16033841,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3629303,https://api.altmetric.com/v1/donut/3629303_240.png 3,Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials,Annals of Oncology,,,Article,2010-02-15,10.1093/annonc/mdp308,,,,19633053,PMC2852201,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3629293,https://api.altmetric.com/v1/donut/3629293_240.png 3,Proteomics in prostate cancer biomarker discovery.,Expert Review of Proteomics,,,Article,2010-02-05,10.1586/epr.09.89,,,,20121479,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3628643,https://api.altmetric.com/v1/donut/3628643_240.png 3,Prostate cancer vaccines: current status and future potential.,BioDrugs,,,Article,2008-03-20,,,,,18345705,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3628612,https://api.altmetric.com/v1/donut/3628612_240.png 3,Prostate Cancer Vaccines,BioDrugs,,,Article,2012-08-15,10.2165/00063030-200822020-00001,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3628609,https://api.altmetric.com/v1/donut/3628609_240.png 3,The health and well-being of prostate cancer patients and male-to-female transsexuals on androgen deprivation therapy: a qualitative study with comments on expectations and estrogen.,"Psychology, Health & Medicine",,,Article,2011-01-15,10.1080/13548506.2010.516364,,,,21218363,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3627647,https://api.altmetric.com/v1/donut/3627647_240.png 3,The role of exercise in managing the adverse effects of androgen deprivation therapy in men with prostate cancer,Physical Therapy Reviews,,,Article,2011-08-01,10.1179/1743288x11y.0000000029,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3627646,https://api.altmetric.com/v1/donut/3627646_240.png 3,Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life.,Journal of Sexual Medicine,,,Article,2010-07-07,10.1111/j.1743-6109.2010.01902.x,,,,20626600,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3627644,https://api.altmetric.com/v1/donut/3627644_240.png 3,Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy.,The Journal of Urology,,,Article,,10.1016/j.juro.2010.08.094,,,,21074215,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3627638,https://api.altmetric.com/v1/donut/3627638_240.png 3,Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.,Cancer Research,,,Article,2008-01-01,10.1158/0008-5472.can-07-5352,,,,18172298,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/3627020,https://api.altmetric.com/v1/donut/3627020_240.png 3,"Identification and characterization of prostein, a novel prostate-specific protein.",Cancer Research,,,Article,2001-02-15,,,,,11245466,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3627018,https://api.altmetric.com/v1/donut/3627018_240.png 3,"Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells",Journal of Molecular Medicine,,,Article,2008-01-12,10.1007/s00109-007-0296-9,,,,18193184,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/3627015,https://api.altmetric.com/v1/donut/3627015_240.png 3,Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.,International Journal of Cancer,,,Article,2009-07-07,10.1002/ijc.24715,,,,19585579,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/3626805,https://api.altmetric.com/v1/donut/3626805_240.png 3,MicroRNAs and prostate cancer,Acta Biochimica et Biophysica Sinica,,,Article,,10.1093/abbs/gmq038,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3626785,https://api.altmetric.com/v1/donut/3626785_240.png 3,"miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.",Stem Cells,,,Article,2009-04-23,10.1002/stem.101,,,,19544444,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/3626618,https://api.altmetric.com/v1/donut/3626618_240.png 3,ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-09-2904,,,,20048076,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3625510,https://api.altmetric.com/v1/donut/3625510_240.png 3,Overexpression of hepatocyte nuclear factor-3alpha induces apoptosis through the upregulation and accumulation of cytoplasmic p53 in prostate cancer cells.,The Prostate,,,Article,2009-10-28,10.1002/pros.21069,,,,19866472,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3625121,https://api.altmetric.com/v1/donut/3625121_240.png 3,New therapies for castration-resistant prostate cancer.,New England Journal of Medicine,,,Article,2010-09-07,10.1056/nejme1006300,,,,20818868,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3623878,https://api.altmetric.com/v1/donut/3623878_240.png 3,L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer.,Pathology International,,,Article,2008-12-15,10.1111/j.1440-1827.2008.02319.x,,,,19121087,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3620822,https://api.altmetric.com/v1/donut/3620822_240.png 3,"Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer.",Clinical Cancer Research,,,Article,2009-11-15,10.1158/1078-0432.ccr-09-1722,,,,19887483,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3620393,https://api.altmetric.com/v1/donut/3620393_240.png 3,Development of an integrated prostate cancer research information system.,Clinical Genitourinary Cancer,,,Article,2006-06-14,10.3816/cgc.2006.n.019,,,,16859581,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3620391,https://api.altmetric.com/v1/donut/3620391_240.png 3,"Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.",Cancer (0008543X),,,Article,2008-01-18,10.1002/cncr.23304,,,,18293426,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3620388,https://api.altmetric.com/v1/donut/3620388_240.png 3,Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare?,Urology,,,Article,,10.1016/j.urology.2009.08.008,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3620387,https://api.altmetric.com/v1/donut/3620387_240.png 3,"A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.",Cancer (0008543X),,,Article,2003-11-10,10.1002/cncr.11829,,,,14669278,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3620386,https://api.altmetric.com/v1/donut/3620386_240.png 3,"A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer.",Clinical Cancer Research,,,Article,2005-01-01,,,,,15671557,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3620383,https://api.altmetric.com/v1/donut/3620383_240.png 3,Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.,Cancer (0008543X),,,Article,2010-11-08,10.1002/cncr.25504,,,,21381010,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3620369,https://api.altmetric.com/v1/donut/3620369_240.png 3,Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats.,The Prostate,,,Article,1998-06-01,,,,,9609545,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3618046,https://api.altmetric.com/v1/donut/3618046_240.png 3,"The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.",Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-07-4649,,,,18519790,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3617983,https://api.altmetric.com/v1/donut/3617983_240.png 3,Functional and profiling studies prove that prostate cancer upregulated neuroblastoma thymosin beta is the true human homologue of rat thymosin beta15.,Febs Letters,,,Article,,10.1016/j.febslet.2007.09.003,,,,17888914,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3617410,https://api.altmetric.com/v1/donut/3617410_240.png 3,Thymosin ?15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer,Nature Medicine,,,Article,1996-12-01,10.1038/nm1296-1322,,,,8946830,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3617409,https://api.altmetric.com/v1/donut/3617409_240.png 3,Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.,Journal of Clinical Oncology,,,Article,2000-12-01,,,,,11099318,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,75,https://www.altmetric.com/details/3615910,https://api.altmetric.com/v1/donut/3615910_240.png 3,Glycomic Characterization of Prostate Specific Antigen and Prostatic Acid Phosphatase in Prostate Cancer and Benign Disease Seminal Plasma Fluids,Journal of Proteome Research,,,Article,2009-01-09,10.1021/pr8007545,,,,19128049,PMC2651839,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3615909,https://api.altmetric.com/v1/donut/3615909_240.png 3,The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.,Cancer Research,,,Article,2003-09-15,,,,,14522935,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3615575,https://api.altmetric.com/v1/donut/3615575_240.png 3,Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines,Clinical and Experimental Metastasis,,,Article,,10.1023/a:1018499515883,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3614893,https://api.altmetric.com/v1/donut/3614893_240.png 3,"Akt- and CREB-Mediated Prostate Cancer Cell Proliferation Inhibition by Nexrutine, a Phellodendron amurense Extract",Neoplasia,,,Article,2006-06-01,10.1593/neo.05745,,,,16820098,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3612919,https://api.altmetric.com/v1/donut/3612919_240.png 3,Screening for prostate cancer. American College of Physicians.,Annals of Internal Medicine,,,Article,1997-03-15,,,,,9072936,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3611153,https://api.altmetric.com/v1/donut/3611153_240.png 3,CLINICAL GUIDELINE: PART III: Screening for Prostate Cancer,Annals of Internal Medicine,,,Article,,10.7326/0003-4819-126-6-199703150-00011,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3611151,https://api.altmetric.com/v1/donut/3611151_240.png 3,Sequential changes of urinary pyridinoline and deoxypyridinoline as markers of metastatic bone tumor in patients with prostate cancer: a preliminary study.,Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/27.1.26,,,,9070337,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3610851,https://api.altmetric.com/v1/donut/3610851_240.png 3,A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study,Journal of Medical Genetics,,,Article,,10.1136/jmg.40.11.815,,,,14627670,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3603302,https://api.altmetric.com/v1/donut/3603302_240.png 3,Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.,British Journal of Urology,,,Article,1997-02-01,,,,,9052476,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3601525,https://api.altmetric.com/v1/donut/3601525_240.png 3,Robotic Radical Prostatectomy for Patients with Locally Advanced Prostate Cancer Is Feasible: Results of a Single-Institution Study,Journal of Laparoendoscopic & Advanced Surgical Techniques,,,Article,2009-01-06,10.1089/lap.2008.0344,,,,19397390,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3601524,https://api.altmetric.com/v1/donut/3601524_240.png 3,Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial,British Journal of Urology,,,Article,2003-10-29,10.1046/j.1464-410x.1997.d01-6840.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3601523,https://api.altmetric.com/v1/donut/3601523_240.png 3,Emerging role of HIFU as a noninvasive ablative method to treat localized prostate cancer.,Oncology (08909091),,,Article,2008-02-01,,,,,18409659,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3601522,https://api.altmetric.com/v1/donut/3601522_240.png 3,"Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-11-15,10.1158/1055-9965.epi-10-0582,,,,20852008,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3600851,https://api.altmetric.com/v1/donut/3600851_240.png 3,A Randomized Phase II Study of Concurrent Docetaxel Plus Vaccine Versus Vaccine Alone in Metastatic Androgen Independent Prostate Cancer,Clinical Cancer Research,,,Article,2006-02-22,10.1158/1078-0432.ccr-05-2059,,,,16489082,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/3600807,https://api.altmetric.com/v1/donut/3600807_240.png 3,Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer,Clinical Cancer Research,,,Article,2005-05-03,10.1158/1078-0432.ccr-04-2062,,,,15867235,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3600804,https://api.altmetric.com/v1/donut/3600804_240.png 3,Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells.,International Journal of Oncology,,,Article,2001-01-01,10.3892/ijo.18.1.81,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3598877,https://api.altmetric.com/v1/donut/3598877_240.png 3,Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.,Clinical Cancer Research,,,Article,,,,,,14581350,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/3594548,https://api.altmetric.com/v1/donut/3594548_240.png 3,"ANTIANDROGEN, VACCINE AND COMBINATION THERAPY IN PATIENTS WITH NONMETASTATIC HORMONE REFRACTORY PROSTATE CANCER",The Journal of Urology,,,Article,2005-01-08,10.1097/01.ju.0000165159.33772.5b,,,,16006888,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3592062,https://api.altmetric.com/v1/donut/3592062_240.png 3,Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV?PSA) in patients with metastatic androgen?independent prostate cancer,The Prostate,,,Article,2002-10-01,10.1002/pros.10130,,,,12242725,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3592059,https://api.altmetric.com/v1/donut/3592059_240.png 3,Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.,Medical Oncology,,,Article,2008-11-12,10.1007/s12032-008-9120-9,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3585112,https://api.altmetric.com/v1/donut/3585112_240.png 3,"Isolation of the novel human guanine nucleotide exchange factor Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF) and of C-terminal SGEF, an N-terminally truncated form of SGEF, the expression of which is regulated by androgen in prostate cancer cells.",Endocrinology,,,Article,2003-05-01,10.1210/en.2002-220984,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3581650,https://api.altmetric.com/v1/donut/3581650_240.png 3,PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.,Urology,,,Article,,10.1016/j.urology.2006.12.014,,,,17382159,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/3580963,https://api.altmetric.com/v1/donut/3580963_240.png 3,Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?,The American Journal of Surgical Pathology,,,Article,2004-06-29,,,,,15223967,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3580958,https://api.altmetric.com/v1/donut/3580958_240.png 3,In vivo amplification of the androgen receptor gene and progression of human prostate cancer.,Nature Genetics,,,Article,1995-04-01,10.1038/ng0495-401,,,,7795646,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/3580954,https://api.altmetric.com/v1/donut/3580954_240.png 3,Loss of the expression and localization of inhibin alpha-subunit in high grade prostate cancer.,The Journal of Clinical Endocrinology & Metabolism,,,Article,1998-03-01,10.1210/jcem.83.3.4640,,,,9506758,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3579085,https://api.altmetric.com/v1/donut/3579085_240.png 3,Loss of the Expression and Localization of Inhibin -Subunit in High Grade Prostate Cancer,The Journal of Clinical Endocrinology & Metabolism,,,Article,1998-03-01,10.1210/jc.83.3.969,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3579084,https://api.altmetric.com/v1/donut/3579084_240.png 3,National Comprehensive Cancer Network guidelines for the management of prostate cancer.,Urology,,,Article,2003-02-01,,,,,12667883,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3578179,https://api.altmetric.com/v1/donut/3578179_240.png 3,National Comprehensive Cancer Network guidelines for the management of prostate cancer,Urology,,,Article,,10.1016/s0090-4295(02)02395-6,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3578176,https://api.altmetric.com/v1/donut/3578176_240.png 3,"Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by anvirzel and its cardiac glycoside component, oleandrin",Biochemical Pharmacology,,,Article,2001-08-01,10.1016/s0006-2952(01)00690-6,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3578086,https://api.altmetric.com/v1/donut/3578086_240.png 3,GPRC6A regulates prostate cancer progression.,The Prostate,,,Article,2011-06-16,10.1002/pros.21442,,,,21681779,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3577316,https://api.altmetric.com/v1/donut/3577316_240.png 3,Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis.,Clinical Biochemistry,,,Article,2008-07-21,10.1016/j.clinbiochem.2008.06.013,,,,18640109,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3577085,https://api.altmetric.com/v1/donut/3577085_240.png 3,PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.,The Journal of Urology,,,Article,,10.1016/j.juro.2008.01.013,,,,18353398,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3577046,https://api.altmetric.com/v1/donut/3577046_240.png 3,Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test.,European Urology,,,Article,2010-01-10,10.1016/j.eururo.2010.06.039,,,,20637539,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3577018,https://api.altmetric.com/v1/donut/3577018_240.png 3,Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.,The Prostate,,,Article,2009-09-16,10.1002/pros.21040,,,,19760627,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3577011,https://api.altmetric.com/v1/donut/3577011_240.png 3,Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled.,The Journal of Urology,,,Article,,10.1016/s0022-5347(05)00064-9,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3576675,https://api.altmetric.com/v1/donut/3576675_240.png 3,Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy.,Clinics,,,Article,2008-06-23,,,,,18568243,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3576674,https://api.altmetric.com/v1/donut/3576674_240.png 3,Prostate Cancer Detection at Rebiopsy After an Initial Benign Diagnosis: Results Using Sextant Extended Prostate Biopsy,Clinics,,,Article,,10.1590/s1807-59322008000300009,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3576671,https://api.altmetric.com/v1/donut/3576671_240.png 3,"Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin.",Biochemical Pharmacology,,,Article,2001-08-15,,,,,11448457,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3576422,https://api.altmetric.com/v1/donut/3576422_240.png 3,Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer.,Clinical Cancer Research,,,Article,2007-05-31,10.1158/1078-0432.ccr-06-2237,,,,17545517,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3575725,https://api.altmetric.com/v1/donut/3575725_240.png 3,Multifeature prostate cancer diagnosis and Gleason grading of histological images.,IEEE Transactions on Medical Imaging,,,Article,,10.1109/tmi.2007.898536,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3575658,https://api.altmetric.com/v1/donut/3575658_240.png 3,"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.",Cancer Research,,,Article,,,,,,10606244,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,172,https://www.altmetric.com/details/3575002,https://api.altmetric.com/v1/donut/3575002_240.png 3,Does PCA3 help identify clinically significant prostate cancer?,European Urology,,,Article,2008-08-07,10.1016/j.eururo.2008.07.027,,,,18684556,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3574972,https://api.altmetric.com/v1/donut/3574972_240.png 3,[Value of urinary PCA3 test for prostate cancer diagnosis].,Progrès en Urologie,,,Article,2008-01-05,10.1016/j.purol.2008.03.029,,,,18538269,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3574833,https://api.altmetric.com/v1/donut/3574833_240.png 3,Progensa PCA3 test for prostate cancer detection.,Expert Review of Molecular Diagnostics,,,Article,2007-09-26,10.1586/14737159.7.5.491,,,,17892357,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3574832,https://api.altmetric.com/v1/donut/3574832_240.png 3,"New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.",Urology,,,Article,2003-11-11,,,,,14607216,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3574828,https://api.altmetric.com/v1/donut/3574828_240.png 3,"New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene",Urology,,,Article,,10.1016/s0090-4295(03)00759-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3574827,https://api.altmetric.com/v1/donut/3574827_240.png 3,New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression,PLoS ONE,,,Article,2009-03-26,10.1371/journal.pone.0004995,,,,19319183,PMC2655648,,2009PLoSO...4.4995C,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3574826,https://api.altmetric.com/v1/donut/3574826_240.png 3,Predicting prostate cancer risk through incorporation of prostate cancer gene 3.,The Journal of Urology,,,Article,,10.1016/j.juro.2008.06.038,,,,18707724,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3574821,https://api.altmetric.com/v1/donut/3574821_240.png 3,Interpretation of the prostate cancer gene 3 in reference to the individual clinical background: implications for daily practice.,Urologia Internationalis,,,Article,2010-04-27,10.1159/000314078,,,,20424427,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3574820,https://api.altmetric.com/v1/donut/3574820_240.png 3,DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.,European Urology,,,Article,2003-07-01,,,,,12814669,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/3574819,https://api.altmetric.com/v1/donut/3574819_240.png 3,DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer,European Urology,,,Article,2003-07-01,10.1016/s0302-2838(03)00201-x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3574814,https://api.altmetric.com/v1/donut/3574814_240.png 3,Is DD3 a new prostate-specific gene?,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,12680228,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3574813,https://api.altmetric.com/v1/donut/3574813_240.png 3,The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.,Biomarkers,,,Article,2009-01-06,10.1080/13547500902807306,,,,19489685,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3574812,https://api.altmetric.com/v1/donut/3574812_240.png 3,PCA3 gene expression in prostate cancer tissue in a Chinese population: quantification by real-time FQ-RT-PCR based on exon 3 of PCA3.,Experimental & Molecular Pathology,,,Article,2010-02-02,10.1016/j.yexmp.2010.01.008,,,,20114043,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3574810,https://api.altmetric.com/v1/donut/3574810_240.png 3,Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.,Cancer (0008543X),,,Article,2008-03-10,10.1002/cncr.23353,,,,18330908,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3574741,https://api.altmetric.com/v1/donut/3574741_240.png 3,Unified theory of prostate cancer: the role of steroid 5 alpha reductase and steroid aromatase,Urology,,,Article,,10.1016/j.urology.2005.06.039,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3574738,https://api.altmetric.com/v1/donut/3574738_240.png 3,"Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancer.",The Journal of Urology,,,Article,2002-02-01,,,,,11792913,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3574729,https://api.altmetric.com/v1/donut/3574729_240.png 3,"DIETHYLSTILBESTEROL REVISITED: ANDROGEN DEPRIVATION, OSTEOPOROSIS AND PROSTATE CANCER",The Journal of Urology,,,Article,,10.1016/s0022-5347(01)69080-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3574724,https://api.altmetric.com/v1/donut/3574724_240.png 3,High expression of the Met receptor in prostate cancer metastasis to bone.,Urology,,,Article,2002-12-01,,,,,12475693,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3574723,https://api.altmetric.com/v1/donut/3574723_240.png 3,High expression of the Met receptor in prostate cancer metastasis to bone,Urology,,,Article,,10.1016/s0090-4295(02)01954-4,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3574722,https://api.altmetric.com/v1/donut/3574722_240.png 3,The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.,The Journal of Urology,,,Article,,10.1097/01.ju.0000077558.48257.3d,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3574719,https://api.altmetric.com/v1/donut/3574719_240.png 3,BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy.,The Journal of Urology,,,Article,,10.1097/00005392-199907000-00003,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3574708,https://api.altmetric.com/v1/donut/3574708_240.png 3,A population-based study of renal cell carcinoma and prostate cancer in the same patients.,British Journal of Urology,,,Article,2005-11-10,10.1111/j.1464-410x.2005.05880.x,,,,16336324,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3574705,https://api.altmetric.com/v1/donut/3574705_240.png 3,Improved prediction of prostate cancer recurrence based on an automated tissue image analysis system,,,,Article,,10.1109/isbi.2004.1398523,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3573827,https://api.altmetric.com/v1/donut/3573827_240.png 3,Biochemical recurrence and survival prediction models for the management of clinically localized prostate cancer.,Clinical Genitourinary Cancer,,,Article,2004-04-09,,,,,15072605,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3573653,https://api.altmetric.com/v1/donut/3573653_240.png 3,Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery,British Journal of Urology,,,Article,2011-03-28,10.1111/j.1464-410x.2011.10169.x.,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3573651,https://api.altmetric.com/v1/donut/3573651_240.png 3,NEW PROSTATE CANCER AGENT CLASS,Chemical & Engineering News,,,Article,2008-09-22,10.1021/cen-v086n038.p084,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3572729,https://api.altmetric.com/v1/donut/3572729_240.png 3,Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.,Cancer Research,,,Article,,,,,,10363963,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3571481,https://api.altmetric.com/v1/donut/3571481_240.png 3,Cardiovascular follow?up of patients with prostatic cancer treated with single?drug polyestradiol phosphate,The Prostate,,,Article,2006-07-20,10.1002/pros.2990130308,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3571019,https://api.altmetric.com/v1/donut/3571019_240.png 3,Characterization of TMPRSS2-ETS Gene Aberrations in Androgen Independent Metastatic Prostate Cancer,Cancer Research,,,Article,,10.1158/0008-5472.can-07-6154,,,,18483239,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3569868,https://api.altmetric.com/v1/donut/3569868_240.png 3,"New Treatments for Castration-Resistant Prostate Cancer: Highlights from the 44th Annual Meeting of the American Society of Clinical Oncology, May 30–June 3, 2008, Chicago, IL",Reviews in Urology,,,Article,2009-01-17,,,,,19145273,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3568147,https://api.altmetric.com/v1/donut/3568147_240.png 3,Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance,Molecular Medicine,,,Article,2008-12-18,10.2119/molmed.2008.00116,,,,19081770,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3567985,https://api.altmetric.com/v1/donut/3567985_240.png 3,"Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis.",Archivos Españoles de Urología,,,Article,2011-11-05,,,,,22052751,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3567510,https://api.altmetric.com/v1/donut/3567510_240.png 3,The Janus-faced nature of prostasomes: their pluripotency favours the normal reproductive process and malignant prostate growth.,Prostate Cancer & Prostatic Diseases,,,Article,2004-03-01,10.1038/sj.pcan.4500684,,,,14999234,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3566071,https://api.altmetric.com/v1/donut/3566071_240.png 3,Molecular analysis of WFDC1/ps20 gene in prostate cancer.,The Prostate,,,Article,2004-04-26,10.1002/pros.20100,,,,15305342,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3566038,https://api.altmetric.com/v1/donut/3566038_240.png 3,cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer.,Genomics,,,Article,1998-07-01,10.1006/geno.1998.5359,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3565551,https://api.altmetric.com/v1/donut/3565551_240.png 3,Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer,Journal of Biological Chemistry,,,Article,2010-04-01,10.1074/jbc.m110.122226,,,,20353938,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3564422,https://api.altmetric.com/v1/donut/3564422_240.png 3,"Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.",Oncogene,,,Article,2005-05-09,10.1038/sj.onc.1208677,,,,15897894,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3564049,https://api.altmetric.com/v1/donut/3564049_240.png 3,"PTOV-1, a Novel Protein Overexpressed in Prostate Cancer, Shuttles between the Cytoplasm and the Nucleus and Promotes Entry into the S Phase of the Cell Division Cycle",American Journal of Pathology,,,Article,,10.1016/s0002-9440(10)63885-0,,,,12598323,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3563912,https://api.altmetric.com/v1/donut/3563912_240.png 3,Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2009.09.015,,,,19959380,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3563466,https://api.altmetric.com/v1/donut/3563466_240.png 3,Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology.,American Journal of Pathology,,,Article,1997-08-01,,,,,9250159,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3563465,https://api.altmetric.com/v1/donut/3563465_240.png 3,"Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.",The Prostate,,,Article,2005-12-30,10.1002/pros.20353,,,,16388505,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3563040,https://api.altmetric.com/v1/donut/3563040_240.png 3,What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.,Geriatrics,,,Article,2009-03-06,,,,,19256581,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3563028,https://api.altmetric.com/v1/donut/3563028_240.png 3,Acceptability and Preliminary Feasibility of an Internet/CD-ROM-Based Education and Decision Program for Early-Stage Prostate Cancer Patients: Randomized Pilot Study,Journal of Medical Internet Research,,,Article,,10.2196/jmir.1891.,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3563007,https://api.altmetric.com/v1/donut/3563007_240.png 3,Unnecessary imaging for the staging of low-risk prostate cancer is common.,Urology,,,Article,,10.1016/j.urology.2010.07.491,,,,20932557,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3563006,https://api.altmetric.com/v1/donut/3563006_240.png 3,"Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.",The Prostate,,,Article,2002-04-01,,,,,11920956,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3562452,https://api.altmetric.com/v1/donut/3562452_240.png 3,"Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers",The Prostate,,,Article,2002-03-15,10.1002/pros.10076,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3562449,https://api.altmetric.com/v1/donut/3562449_240.png 3,Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.,Clinical Cancer Research,,,Article,2005-02-16,,,,,15709168,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3562164,https://api.altmetric.com/v1/donut/3562164_240.png 3,"Gene transfer of alpha1,3-fucosyltransferase increases tumor growth of the PC-3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells.",International Journal of Cancer,,,Article,2003-09-18,10.1002/ijc.11513,,,,14601054,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3562022,https://api.altmetric.com/v1/donut/3562022_240.png 3,"Correction to ""Modulation of oncogenic potential by alternative gene use in human prostate cancer""",Nature Medicine,,,Article,1999-09-01,10.1038/12530,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3561893,https://api.altmetric.com/v1/donut/3561893_240.png 3,"CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.",International Journal of Cancer,,,Article,2002-04-22,10.1002/ijc.10393,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3561794,https://api.altmetric.com/v1/donut/3561794_240.png 3,Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.,Clinical Chemistry,,,Article,,10.1373/clinchem.2003.028563,,,,14988224,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3561605,https://api.altmetric.com/v1/donut/3561605_240.png 3,Circulating tumor cells as biomarkers in prostate cancer.,Clinical Cancer Research,,,Article,2011-06-14,10.1158/1078-0432.ccr-10-2650,,,,21680546,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,82,https://www.altmetric.com/details/3561594,https://api.altmetric.com/v1/donut/3561594_240.png 3,Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.,The Prostate,,,Article,2002-07-08,10.1002/pros.10067,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3561251,https://api.altmetric.com/v1/donut/3561251_240.png 3,The Role of ?v?3 in Prostate Cancer Progression,Neoplasia,,,Article,,10.1038/sj/neo/7900224,,,,11988838,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3561238,https://api.altmetric.com/v1/donut/3561238_240.png 3,Two differentially expressed genes in normal human prostate tissue and in carcinoma.,Cancer Research,,,Article,1996-08-15,,,,,8705997,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3561171,https://api.altmetric.com/v1/donut/3561171_240.png 3,Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.,Endocrine-Related Cancer,,,Article,,10.1677/erc.1.00958,,,,16172196,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3560911,https://api.altmetric.com/v1/donut/3560911_240.png 3,Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.,Journal of Experimental Therapeutics & Oncology,,,Article,2006-12-31,,,,,17552366,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3560575,https://api.altmetric.com/v1/donut/3560575_240.png 3,Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-0768-03,,,,15041717,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3560551,https://api.altmetric.com/v1/donut/3560551_240.png 3,Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.,Pancreas,,,Article,2005-07-18,,,,,16024997,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3560444,https://api.altmetric.com/v1/donut/3560444_240.png 3,Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer,Pancreas,,,Article,2005-08-01,10.1097/01.mpa.0000173459.81193.4d,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3560442,https://api.altmetric.com/v1/donut/3560442_240.png 3,"ANX7, a candidate tumor suppressor gene for prostate cancer",Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.071055798,,,,11287641,,,2001PNAS...98.4575S,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3560367,https://api.altmetric.com/v1/donut/3560367_240.png 3,Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.,Clinica Chimica Acta,,,Article,2005-05-17,10.1016/j.cccn.2005.03.026,,,,15893744,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3559806,https://api.altmetric.com/v1/donut/3559806_240.png 3,"Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck.",Cancer Research,,,Article,1996-12-15,,,,,8971156,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3559309,https://api.altmetric.com/v1/donut/3559309_240.png 3,Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.,Cancer Research,,,Article,2003-09-15,,,,,14522910,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3558982,https://api.altmetric.com/v1/donut/3558982_240.png 3,Differential expression of anterior gradient gene AGR2 in prostate cancer,BMC Cancer,,,Article,2010-12-16,10.1186/1471-2407-10-680,,,,21144054,PMC3009682,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3558721,https://api.altmetric.com/v1/donut/3558721_240.png 3,"PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.",,,,Article,2001-03-22,10.1038/sj.onc.1204233,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3558672,https://api.altmetric.com/v1/donut/3558672_240.png 3,"MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.",Oncogene,,,Article,2003-03-06,10.1038/sj.onc.1206154,,,,12618764,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3557982,https://api.altmetric.com/v1/donut/3557982_240.png 3,Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer,British Journal of Cancer,,,Article,2000-09-01,10.1054/bjoc.2000.1365,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3557842,https://api.altmetric.com/v1/donut/3557842_240.png 3,All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.,Annals of Oncology,,,Article,,10.1093/annonc/mdq030,,,,20147742,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3557449,https://api.altmetric.com/v1/donut/3557449_240.png 3,The Drg-1 gene suppresses tumor metastasis in prostate cancer.,Cancer Research,,,Article,2003-04-15,,,,,12702552,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3556725,https://api.altmetric.com/v1/donut/3556725_240.png 3,A candidate prostate cancer susceptibility gene encodes tRNA 3? processing endoribonuclease,Nucleic Acids Research,,,Article,,10.1093/nar/gkg337,,,,12711671,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3556237,https://api.altmetric.com/v1/donut/3556237_240.png 3,Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.,International Journal of Cancer,,,Article,2003-07-16,10.1002/ijc.11347,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3556236,https://api.altmetric.com/v1/donut/3556236_240.png 3,Role of HPC2/ELAC2 in hereditary prostate cancer.,Cancer Research,,,Article,2001-09-01,,,,,11522646,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3556234,https://api.altmetric.com/v1/donut/3556234_240.png 3,Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer,Neoplasia,,,Article,2008-11-01,,,,,18953438,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3554037,https://api.altmetric.com/v1/donut/3554037_240.png 3,Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.,Nature Genetics,,,Article,2002-09-16,10.1038/ng994,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3553624,https://api.altmetric.com/v1/donut/3553624_240.png 3,Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis.,Molecular Cancer Therapeutics,,,Article,,10.1158/1535-7163.mct-06-0570,,,,17172423,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3553005,https://api.altmetric.com/v1/donut/3553005_240.png 3,Reg IV: a promising marker of hormone refractory metastatic prostate cancer.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-04-0356,,,,15788672,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3552702,https://api.altmetric.com/v1/donut/3552702_240.png 3,A novel gene on human chromosome 2p24 is differentially expressed between androgen-dependent and androgen-independent prostate cancer cells.,European Journal of Cancer (1965),,,Article,2001-11-01,,,,,11597395,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3551812,https://api.altmetric.com/v1/donut/3551812_240.png 3,A novel gene on human chromosome 2p24 is differentially expressed between androgen-dependent and androgen-independent prostate cancer cells,European Journal of Cancer (1965),,,Article,2001-11-01,10.1016/s0959-8049(01)00259-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3551811,https://api.altmetric.com/v1/donut/3551811_240.png 3,Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-06-0141,,,,16896035,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3551693,https://api.altmetric.com/v1/donut/3551693_240.png 3,"Myopodin, a Synaptopodin Homologue, Is Frequently Deleted in Invasive Prostate Cancers",American Journal of Pathology,,,Article,,10.1016/s0002-9440(10)63006-4,,,,11696420,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3551138,https://api.altmetric.com/v1/donut/3551138_240.png 3,"Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer.",Cancer Research,,,Article,2003-08-01,,,,,12907652,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3551083,https://api.altmetric.com/v1/donut/3551083_240.png 3,Short-term sexual function after prostate brachytherapy.,International Journal of Cancer,,,Article,2001-10-20,,,,,11582584,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3549824,https://api.altmetric.com/v1/donut/3549824_240.png 3,Short?term sexual function after prostate brachytherapy,International Journal of Cancer,,,Article,2001-08-20,10.1002/ijc.1028,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3549819,https://api.altmetric.com/v1/donut/3549819_240.png 3,"OXER1, a G protein-coupled oxoeicosatetraenoid receptor, mediates the survival-promoting effects of arachidonate 5-lipoxygenase in prostate cancer cells",Cancer Letters,,,Article,2013-08-08,10.1016/j.canlet.2013.04.027,,,,23643940,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3549047,https://api.altmetric.com/v1/donut/3549047_240.png 3,Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon,Biochimica et Biophysica Acta (BBA),,,Article,2011-08-10,10.1016/j.bbamcr.2011.07.015,,,,21824498,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3549044,https://api.altmetric.com/v1/donut/3549044_240.png 3,Ack1 mediated androgen receptor phosphorylation modulates radiation resistance in castration resistant prostate cancer.,Journal of Biological Chemistry,,,Article,2012-06-21,10.1074/jbc.m112.357384.,,,,22566699,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3548672,https://api.altmetric.com/v1/donut/3548672_240.png 3,Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.,The Prostate,,,Article,2004-05-04,10.1002/pros.20117,,,,15389810,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3548251,https://api.altmetric.com/v1/donut/3548251_240.png 3,Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-03-2675,,,,14744752,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3548101,https://api.altmetric.com/v1/donut/3548101_240.png 3,Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m005432200,,,,11010966,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3547824,https://api.altmetric.com/v1/donut/3547824_240.png 3,Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium.,Cancer Research,,,Article,2001-02-15,,,,,11245473,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3547787,https://api.altmetric.com/v1/donut/3547787_240.png 3,Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m208230200,,,,12446720,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3547758,https://api.altmetric.com/v1/donut/3547758_240.png 3,Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.,Molecular Cancer Research,,,Article,,10.1158/1541-7786.mcr-05-0165,,,,16547154,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3547555,https://api.altmetric.com/v1/donut/3547555_240.png 3,Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines.,The Prostate,,,Article,2001-09-15,,,,,11550212,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3547273,https://api.altmetric.com/v1/donut/3547273_240.png 3,Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines,The Prostate,,,Article,2001-08-28,10.1002/pros.1119,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3547271,https://api.altmetric.com/v1/donut/3547271_240.png 3,Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients.,Prostate Cancer & Prostatic Diseases,,,Article,2007-04-24,10.1038/sj.pcan.4500960,,,,17457305,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3547225,https://api.altmetric.com/v1/donut/3547225_240.png 3,Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m108754200,,,,11799114,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3544516,https://api.altmetric.com/v1/donut/3544516_240.png 3,ADAM15 Disintegrin Is Associated with Aggressive Prostate and Breast Cancer Disease,Neoplasia,,,Article,,10.1593/neo.05682,,,,16756724,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3544449,https://api.altmetric.com/v1/donut/3544449_240.png 3,Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.,Cancer Research,,,Article,2003-05-01,,,,,12727822,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3543258,https://api.altmetric.com/v1/donut/3543258_240.png 3,Evaluation of Linkage and Association of HPC2/ELAC2 in Patients with Familial or Sporadic Prostate Cancer,American Journal of Human Genetics,,,Article,,10.1086/319513,,,,11254448,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3542699,https://api.altmetric.com/v1/donut/3542699_240.png 3,Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.,"Genes, Chromosomes, and Cancer",,,Article,2006-03-30,10.1002/gcc.20329,,,,16575875,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3542449,https://api.altmetric.com/v1/donut/3542449_240.png 3,Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.,Oncology Reports,,,Article,2004-01-02,,,,,14719083,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3542280,https://api.altmetric.com/v1/donut/3542280_240.png 3,Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules,Oncology Reports,,,Article,2004-02-01,10.3892/or.11.2.453,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3542278,https://api.altmetric.com/v1/donut/3542278_240.png 3,The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection,The Prostate,,,Article,2010-10-14,10.1002/pros.21273,,,,20945500,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3542247,https://api.altmetric.com/v1/donut/3542247_240.png 3,Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.,Modern Pathology,,,Article,2007-07-13,10.1038/modpathol.3800903,,,,17632455,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3542214,https://api.altmetric.com/v1/donut/3542214_240.png 3,Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties.,Febs Letters,,,Article,,10.1016/0014-5793(95)00324-3,,,,7737407,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3541586,https://api.altmetric.com/v1/donut/3541586_240.png 3,Decreased expression of prostatic secretory protein PSP94 in prostate cancer.,Cancer Letters,,,Article,,10.1016/0304-3835(93)90049-f,,,,7506990,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3541508,https://api.altmetric.com/v1/donut/3541508_240.png 3,P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.,Clinical Cancer Research,,,Article,1997-11-01,,,,,9815605,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3541340,https://api.altmetric.com/v1/donut/3541340_240.png 3,Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors.,Cellular Signalling,,,Article,2001-12-01,,,,,11728828,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3540635,https://api.altmetric.com/v1/donut/3540635_240.png 3,Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors,Cellular Signalling,,,Article,2001-12-01,10.1016/s0898-6568(01)00199-1,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3540632,https://api.altmetric.com/v1/donut/3540632_240.png 3,"Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells",British Journal of Cancer,,,Article,2008-10-21,10.1038/sj.bjc.6604712,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3540316,https://api.altmetric.com/v1/donut/3540316_240.png 3,Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.,,,,Article,2000-04-13,10.1038/sj.onc.1203511,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3539577,https://api.altmetric.com/v1/donut/3539577_240.png 3,"P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells.",Biochemical & Biophysical Research Communications,,,Article,2003-03-28,,,,,12646190,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3539325,https://api.altmetric.com/v1/donut/3539325_240.png 3,"p202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells",Biochemical & Biophysical Research Communications,,,Article,2003-03-01,10.1016/s0006-291x(03)00320-6,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3539324,https://api.altmetric.com/v1/donut/3539324_240.png 3,Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27,Genome Research,,,Article,,10.1101/gr.4212705,,,,16251457,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3538776,https://api.altmetric.com/v1/donut/3538776_240.png 3,"Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.",Cancer Research,,,Article,2001-08-01,,,,,11479226,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3538712,https://api.altmetric.com/v1/donut/3538712_240.png 3,Androgen-induced proliferative quiescence in prostate cancer cells: The role of AS3 as its mediator,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.97.18.10185,,,,10963680,,,2000PNAS...9710185G,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3538156,https://api.altmetric.com/v1/donut/3538156_240.png 3,"Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus.",Journal of Steroid Biochemistry & Molecular Biology,,,Article,1999-01-01,,,,,10215036,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3538151,https://api.altmetric.com/v1/donut/3538151_240.png 3,"Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus",Journal of Steroid Biochemistry & Molecular Biology,,,Article,1999-01-01,10.1016/s0960-0760(98)00165-4,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3538149,https://api.altmetric.com/v1/donut/3538149_240.png 3,EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.,Cancer Research,,,Article,2003-05-15,,,,,12750295,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3537680,https://api.altmetric.com/v1/donut/3537680_240.png 3,Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma.,Endocrine-Related Cancer,,,Article,,10.1677/erc.1.01190,,,,16954433,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3537649,https://api.altmetric.com/v1/donut/3537649_240.png 3,TARP: A nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor ? chain locus,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.160270597,,,,10931945,,,2000PNAS...97.9437W,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3537151,https://api.altmetric.com/v1/donut/3537151_240.png 3,Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.,Oncogene,,,Article,2003-09-04,10.1038/sj.onc.1206797,,,,12955079,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3536666,https://api.altmetric.com/v1/donut/3536666_240.png 3,Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo.,The Prostate,,,Article,1993-01-01,,,,,8488155,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3535640,https://api.altmetric.com/v1/donut/3535640_240.png 3,Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo,The Prostate,,,Article,2006-07-20,10.1002/pros.2990220305,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3535637,https://api.altmetric.com/v1/donut/3535637_240.png 3,"Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.","Genes, Chromosomes, and Cancer",,,Article,2003-11-20,10.1002/gcc.10308,,,,14695991,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3535613,https://api.altmetric.com/v1/donut/3535613_240.png 3,"PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer.",International Journal of Cancer,,,Article,2005-10-04,10.1002/ijc.21527,,,,16206286,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3535336,https://api.altmetric.com/v1/donut/3535336_240.png 3,Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.,International Journal of Cancer,,,Article,2004-10-21,10.1002/ijc.20635,,,,15499628,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3535066,https://api.altmetric.com/v1/donut/3535066_240.png 3,"Evidence of a novel biomarker, alphas1-Casein, a milk protein, in benign prostate hyperplasia.",Prostate Cancer & Prostatic Diseases,,,Article,2006-05-09,10.1038/sj.pcan.4500872,,,,16683014,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3534929,https://api.altmetric.com/v1/donut/3534929_240.png 3,"WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.",The Journal of Pathology,,,Article,2003-08-18,10.1002/path.1449,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3534760,https://api.altmetric.com/v1/donut/3534760_240.png 3,Variants in the HEPSIN gene are associated with prostate cancer in men of European origin.,Human Genetics,,,Article,2006-06-17,10.1007/s00439-006-0204-3,,,,16783571,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3533932,https://api.altmetric.com/v1/donut/3533932_240.png 3,Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.,The Journal of Urology,,,Article,,10.1097/01.ju.0000050648.40164.0d,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3533931,https://api.altmetric.com/v1/donut/3533931_240.png 3,Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells.,European Journal of Histochemistry,,,Article,2003-12-07,,,,,15590418,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3533296,https://api.altmetric.com/v1/donut/3533296_240.png 3,Association of HPC2/ELAC2 Genotypes and Prostate Cancer,American Journal of Human Genetics,,,Article,,10.1086/303096,,,,10986046,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3532935,https://api.altmetric.com/v1/donut/3532935_240.png 3,HPC2/ELAC2 gene variants associated with incident prostate cancer.,Journal of Human Genetics,,,Article,2003-11-19,10.1007/s10038-003-0091-6,,,,14625808,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3532932,https://api.altmetric.com/v1/donut/3532932_240.png 3,The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex.,International Journal of Cancer,,,Article,2003-01-13,10.1002/ijc.10945,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3532931,https://api.altmetric.com/v1/donut/3532931_240.png 3,"ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.",Oncogene,,,Article,2006-04-24,10.1038/sj.onc.1209571,,,,16636667,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3532930,https://api.altmetric.com/v1/donut/3532930_240.png 3,Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement,Neoplasia,,,Article,,10.1593/neo.06283,,,,16820092,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3531852,https://api.altmetric.com/v1/donut/3531852_240.png 3,Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m501379200,,,,15817459,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/3531578,https://api.altmetric.com/v1/donut/3531578_240.png 3,Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer,Molecular & Cellular Biology,,,Article,2006-09-14,10.1128/mcb.00147-06,,,,16914734,PMC1592843,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3531315,https://api.altmetric.com/v1/donut/3531315_240.png 3,Down-regulation of Lsm1 is involved in human prostate cancer progression,British Journal of Cancer,,,Article,2002-03-18,10.1038/sj.bjc.6600163,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3531306,https://api.altmetric.com/v1/donut/3531306_240.png 3,Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.,The Prostate,,,Article,2005-12-30,10.1002/pros.20342,,,,16388501,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3531055,https://api.altmetric.com/v1/donut/3531055_240.png 3,"AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer.","Genes, Chromosomes, and Cancer",,,Article,2005-04-15,10.1002/gcc.20188,,,,15834940,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3530996,https://api.altmetric.com/v1/donut/3530996_240.png 3,Genome-wide impact of Androgen Receptor Trapped Clone-27 Loss on Androgen-regulated Transcription in Prostate Cancer Cells,Cancer Research,,,Article,2009-03-31,10.1158/0008-5472.can-08-3738,,,,19318562,PMC2702238,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3530867,https://api.altmetric.com/v1/donut/3530867_240.png 3,Com-1/p8 acts as a putative tumour suppressor in prostate cancer.,International Journal of Molecular Medicine,,,Article,2006-10-03,,,,,17016631,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3530036,https://api.altmetric.com/v1/donut/3530036_240.png 3,Com-1/p8 acts as a putative tumour suppressor in prostate cancer,International Journal of Molecular Medicine,,,Article,2006-11-01,10.3892/ijmm.18.5.981,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3530035,https://api.altmetric.com/v1/donut/3530035_240.png 3,A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer.,European Urology,,,Article,2002-09-01,,,,,12234517,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3529404,https://api.altmetric.com/v1/donut/3529404_240.png 3,A Candidate Gene Approach within the Susceptibility Region PCaP on 1q42.2–43 Excludes Deleterious Mutations of the PCTA-1 Gene to be Responsible for Hereditary Prostate Cancer,European Urology,,,Article,2002-09-01,10.1016/s0302-2838(02)00280-4,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3529402,https://api.altmetric.com/v1/donut/3529402_240.png 3,"Quantification of expression of netrins, slits and their receptors in human prostate tumors.",International Journal of Cancer,,,Article,2002-11-13,10.1002/ijc.10821,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3529397,https://api.altmetric.com/v1/donut/3529397_240.png 3,Prostate stem cell antigen: A cell surface marker overexpressed in prostate?cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-04-22,10.1073/pnas.95.4.1735,,,,9465086,PMC19171,,1998PNAS...95.1735R,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,76,https://www.altmetric.com/details/3529087,https://api.altmetric.com/v1/donut/3529087_240.png 3,Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.,Cancer Research,,,Article,2002-05-01,,,,,11980648,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3529083,https://api.altmetric.com/v1/donut/3529083_240.png 3,Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.,Molecular Cancer Research,,,Article,2002-12-01,,,,,12496358,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3529082,https://api.altmetric.com/v1/donut/3529082_240.png 3,Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-03-2025,,,,15059887,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3528694,https://api.altmetric.com/v1/donut/3528694_240.png 3,Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.,Human Molecular Genetics,,,Article,,10.1093/hmg/ddi487,,,,16434482,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3528689,https://api.altmetric.com/v1/donut/3528689_240.png 3,"Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3?-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells",Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.95.7.3644,,,,9520419,,,1998PNAS...95.3644Q,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3528130,https://api.altmetric.com/v1/donut/3528130_240.png 3,Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-04-3744,,,,15958558,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3526161,https://api.altmetric.com/v1/donut/3526161_240.png 3,Cardiovascular and all?cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population,The Prostate,,,Article,2006-07-20,10.1002/pros.2990180205,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3525516,https://api.altmetric.com/v1/donut/3525516_240.png 3,Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.,The Prostate,,,Article,1991-01-01,,,,,2006119,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3525515,https://api.altmetric.com/v1/donut/3525515_240.png 3,Cost Comparison of Parenteral Estrogen and Conventional Hormonal Treatment in Patients With Prostatic Cancer,International Journal of Technology Assessment in Health Care,,,Article,2009-03-10,10.1017/s0266462300005110,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3525510,https://api.altmetric.com/v1/donut/3525510_240.png 3,Estrogens in the Treatment of Prostate Cancer,The Journal of Urology,,,Article,,10.1016/s0022-5347(01)66670-9,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3525496,https://api.altmetric.com/v1/donut/3525496_240.png 3,A novel human G protein-coupled receptor is over-expressed in prostate cancer.,Genetics and Molecular Research,,,Article,2005-02-04,,,,,15688318,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3524549,https://api.altmetric.com/v1/donut/3524549_240.png 3,The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m707465200,,,,18057003,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/3524037,https://api.altmetric.com/v1/donut/3524037_240.png 3,"Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.",JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djm107,,,,17728215,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3523824,https://api.altmetric.com/v1/donut/3523824_240.png 3,The Matrix Protein CCN1 is Critical for Prostate Carcinoma Cell Proliferation and TRAIL-Induced Apoptosis,Molecular Cancer Research,,,Article,,10.1158/1541-7786.mcr-09-0017,,,,19584265,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3521715,https://api.altmetric.com/v1/donut/3521715_240.png 3,"Deletion, Mutation, and Loss of Expression of KLF6 in Human Prostate Cancer",American Journal of Pathology,,,Article,,10.1016/s0002-9440(10)63930-2,,,,12651626,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3519114,https://api.altmetric.com/v1/donut/3519114_240.png 3,ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.,Cancer Research,,,Article,,10.1158/0008-5472.can-07-2432,,,,18281484,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3518530,https://api.altmetric.com/v1/donut/3518530_240.png 3,Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.,International Journal of Cancer,,,Article,1999-05-05,,,,,10209959,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3518207,https://api.altmetric.com/v1/donut/3518207_240.png 3,"Down-regulation of Cdc6, a cell cycle regulatory gene, in prostate cancer.",Journal of Biological Chemistry,,,Article,,10.1074/jbc.m201199200,,,,12006585,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3517751,https://api.altmetric.com/v1/donut/3517751_240.png 3,"Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.",Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-05-1995,,,,16675569,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3516093,https://api.altmetric.com/v1/donut/3516093_240.png 3,"Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.",Cancer Research,,,Article,2002-08-01,,,,,12154022,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3515784,https://api.altmetric.com/v1/donut/3515784_240.png 3,Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.,The Prostate,,,Article,2004-12-14,10.1002/pros.20177,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3515701,https://api.altmetric.com/v1/donut/3515701_240.png 3,Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.,JNCI: Journal of the National Cancer Institute,,,Article,2002-04-03,10.1093/jnci/94.7.482,,,,11929948,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3515455,https://api.altmetric.com/v1/donut/3515455_240.png 3,Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.,Oncogene,,,Article,2003-12-22,10.1038/sj.onc.1207328,,,,14691453,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3515452,https://api.altmetric.com/v1/donut/3515452_240.png 3,CIP2A expression is increased in prostate cancer,Journal of Experimental & Clinical Cancer Research,,,Article,,10.1186/1756-9966-29-136,,,,20964854,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3515133,https://api.altmetric.com/v1/donut/3515133_240.png 3,"Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer.",Journal of Biological Chemistry,,,Article,,10.1074/jbc.m202414200,,,,12095985,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3515028,https://api.altmetric.com/v1/donut/3515028_240.png 3,Recognition of Six-Transmembrane Epithelial Antigen of the Prostate–Expressing Tumor Cells by Peptide Antigen–Induced Cytotoxic T Lymphocytes,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-04-2235,,,,15958640,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3514270,https://api.altmetric.com/v1/donut/3514270_240.png 3,"Molecular cloning, expression, localization, and gene organization of PTX1, a human nuclear protein that is downregulated in prostate cancer.",DNA & Cell Biology,,,Article,2001-06-01,10.1089/10445490152122460,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3514240,https://api.altmetric.com/v1/donut/3514240_240.png 3,PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism.,Journal of Cellular Biochemistry,,,Article,2005-07-28,10.1002/jcb.20533,,,,16052512,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3514166,https://api.altmetric.com/v1/donut/3514166_240.png 3,A novel human RasGAP-like gene that maps within the prostate cancer susceptibility locus at chromosome 1q25.,Febs Letters,,,Article,,10.1016/s0014-5793(98)01530-0,,,,9877179,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3514014,https://api.altmetric.com/v1/donut/3514014_240.png 3,PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism.,Cancer Research,,,Article,,10.1158/0008-5472.can-07-2041,,,,18006831,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3513997,https://api.altmetric.com/v1/donut/3513997_240.png 3,RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.,"Genes, Chromosomes, and Cancer",,,Article,2003-09-19,10.1002/gcc.10289,,,,14603436,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3513852,https://api.altmetric.com/v1/donut/3513852_240.png 3,"Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.",Cancer Genetics & Cytogenetics,,,Article,,10.1016/j.cancergencyto.2005.02.006,,,,16102578,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3513657,https://api.altmetric.com/v1/donut/3513657_240.png 3,Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.,Urology,,,Article,,10.1016/j.urology.2007.03.001,,,,17826523,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3513145,https://api.altmetric.com/v1/donut/3513145_240.png 3,UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m703370200,,,,17848572,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3513143,https://api.altmetric.com/v1/donut/3513143_240.png 3,PTX1(ERGIC2)-VP22 fusion protein upregulates interferon-beta in prostate cancer cell line PC-3.,DNA & Cell Biology,,,Article,2006-09-22,10.1089/dna.2006.25.523,,,,16989575,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3512920,https://api.altmetric.com/v1/donut/3512920_240.png 3,Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.,International Journal of Oncology,,,Article,2003-12-05,,,,,14654946,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3512892,https://api.altmetric.com/v1/donut/3512892_240.png 3,Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells,International Journal of Oncology,,,Article,2004-01-01,10.3892/ijo.24.1.97,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3512891,https://api.altmetric.com/v1/donut/3512891_240.png 3,Effects of PTX1 expression on growth and tumorigenicity of the prostate cancer cell line PC-3.,DNA & Cell Biology,,,Article,2003-07-01,10.1089/104454903322247343,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3512709,https://api.altmetric.com/v1/donut/3512709_240.png 3,"Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.",Cancer Research,,,Article,,10.1158/0008-5472.can-06-1636,,,,16951154,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3512669,https://api.altmetric.com/v1/donut/3512669_240.png 3,hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands,Molecular Cancer,,,Article,2016-02-20,10.1186/1476-4598-6-37,,,,17550612,PMC1892035,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3512662,https://api.altmetric.com/v1/donut/3512662_240.png 3,"Identification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cells.",Journal of Biological Chemistry,,,Article,,10.1074/jbc.m203940200,,,,12084720,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3512649,https://api.altmetric.com/v1/donut/3512649_240.png 3,Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP,Molecular Cancer Research,,,Article,2009-04-14,10.1158/1541-7786.mcr-08-0400,,,,19372581,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3512646,https://api.altmetric.com/v1/donut/3512646_240.png 3,"EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance",Molecular Cancer Therapeutics,,,Article,,10.1158/1535-7163.mct-08-0526,,,,18852121,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3512474,https://api.altmetric.com/v1/donut/3512474_240.png 3,IL-10/IL-10 receptor signaling regulates TIMP-1 expression in primary human prostate tumor lines.,Cancer Biology and Therapy,,,Article,,,,,,12496489,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3512230,https://api.altmetric.com/v1/donut/3512230_240.png 3,Interleukin-10 activation of the interleukin-10E1 pathway and tissue inhibitor of metalloproteinase-1 expression is enhanced by proteasome inhibitors in primary prostate tumor lines.,Molecular Cancer Research,,,Article,2003-07-01,,,,,12861049,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3512218,https://api.altmetric.com/v1/donut/3512218_240.png 3,The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.,Cancer Cell,,,Article,,10.1016/s1535-6108(04)00055-8,,,,15050917,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/3511278,https://api.altmetric.com/v1/donut/3511278_240.png 3,Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus.,Genomics,,,Article,2001-04-01,10.1006/geno.2001.6500,,,,,,,,,,,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3510673,https://api.altmetric.com/v1/donut/3510673_240.png 3,Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.,Cancer Research,,,Article,1999-06-15,,,,,10383164,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3510370,https://api.altmetric.com/v1/donut/3510370_240.png 3,Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.,Cancer Research,,,Article,2000-08-01,,,,,10945637,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/3510273,https://api.altmetric.com/v1/donut/3510273_240.png 3,"Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.",Molecular & Cellular Endocrinology,,,Article,2001-09-01,,,,,11514053,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3510116,https://api.altmetric.com/v1/donut/3510116_240.png 3,"Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells",Molecular & Cellular Endocrinology,,,Article,2001-09-01,10.1016/s0303-7207(01)00560-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3510114,https://api.altmetric.com/v1/donut/3510114_240.png 3,Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression.,Laboratory Investigation,,,Article,2000-08-01,,,,,10950117,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3509876,https://api.altmetric.com/v1/donut/3509876_240.png 3,Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer Progression,Laboratory Investigation,,,Article,2000-08-01,10.1038/labinvest.3780134,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3509874,https://api.altmetric.com/v1/donut/3509874_240.png 3,"RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer.",Cancer Research,,,Article,,10.1158/0008-5472.can-03-2592,,,,14871827,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3509838,https://api.altmetric.com/v1/donut/3509838_240.png 3,Expression and Function of the Human Androgen-Responsive Gene ADI1 in Prostate Cancer,Neoplasia,,,Article,,10.1593/neo.07415,,,,17786183,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3508990,https://api.altmetric.com/v1/donut/3508990_240.png 3,Bax Inhibitor-1 Is Overexpressed in Prostate Cancer and Its Specific Down-Regulation by RNA Interference Leads to Cell Death in Human Prostate Carcinoma Cells,American Journal of Pathology,,,Article,,10.1016/s0002-9440(10)63682-6,,,,12875974,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3508050,https://api.altmetric.com/v1/donut/3508050_240.png 3,Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells.,Biochemical & Biophysical Research Communications,,,Article,2006-02-06,10.1016/j.bbrc.2006.03.175,,,,16630558,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3507726,https://api.altmetric.com/v1/donut/3507726_240.png 3,Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line.,Journal of Cell Science,,,Article,,10.1242/jcs.01420,,,,15466889,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3507619,https://api.altmetric.com/v1/donut/3507619_240.png 3,Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer.,Oncogene,,,Article,2005-06-20,10.1038/sj.onc.1208824,,,,16007164,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3507403,https://api.altmetric.com/v1/donut/3507403_240.png 3,Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.,American Journal of Physiology: Cell Physiology,,,Article,,10.1152/ajpcell.00503.2006,,,,17329398,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3507178,https://api.altmetric.com/v1/donut/3507178_240.png 3,Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cells.,Molecular Medicine,,,Article,2002-02-01,,,,,12080185,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3506604,https://api.altmetric.com/v1/donut/3506604_240.png 3,Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.,Cancer Research,,,Article,2000-01-01,,,,,10646846,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3506466,https://api.altmetric.com/v1/donut/3506466_240.png 3,Protein Kinase CK2 Controls the Stability of Prostate Derived ETS Factor,Open Cancer Journal,,,Article,2010-05-30,10.2174/1874079001003010109,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3505981,https://api.altmetric.com/v1/donut/3505981_240.png 3,"Prostatic secretory protein (PSP94) expression in human female reproductive tissues, breast and in endometrial cancer cell lines.",Journal of Endocrinology,,,Article,,10.1677/joe.0.1650425,,,,10810306,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3505480,https://api.altmetric.com/v1/donut/3505480_240.png 3,The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.,The Prostate,,,Article,2009-09-29,10.1002/pros.21059,,,,19790236,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3505474,https://api.altmetric.com/v1/donut/3505474_240.png 3,Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.,Asian Journal of Andrology,,,Article,2010-08-02,10.1038/aja.2010.56,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3505470,https://api.altmetric.com/v1/donut/3505470_240.png 3,Common Sequence Variants of the Macrophage Scavenger Receptor 1 Gene Are Associated with Prostate Cancer Risk,American Journal of Human Genetics,,,Article,,10.1086/345802,,,,12471593,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3505439,https://api.altmetric.com/v1/donut/3505439_240.png 3,Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men.,Cancer Research,,,Article,2003-07-01,,,,,12839931,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3505426,https://api.altmetric.com/v1/donut/3505426_240.png 3,"Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer.",Oncogene,,,Article,2007-05-07,10.1038/sj.onc.1210472,,,,17486081,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3505277,https://api.altmetric.com/v1/donut/3505277_240.png 3,CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-04-0534,,,,15894682,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3504947,https://api.altmetric.com/v1/donut/3504947_240.png 3,The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.,The Prostate,,,Article,2006-02-20,10.1002/pros.20389,,,,16491480,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3504706,https://api.altmetric.com/v1/donut/3504706_240.png 3,D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate.,Biochemical & Biophysical Research Communications,,,Article,2004-08-18,10.1016/j.bbrc.2004.07.106,,,,15313197,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3504678,https://api.altmetric.com/v1/donut/3504678_240.png 3,Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.,Clinical Cancer Research,,,Article,,,,,,15701844,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3504629,https://api.altmetric.com/v1/donut/3504629_240.png 3,Identification of a prostate-specific G-protein coupled receptor in prostate cancer.,,,,Article,2001-09-13,10.1038/sj.onc.1204803,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3504381,https://api.altmetric.com/v1/donut/3504381_240.png 3,"PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.",Cancer Research,,,Article,2000-12-01,,,,,11118034,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3504380,https://api.altmetric.com/v1/donut/3504380_240.png 3,GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.,The Prostate,,,Article,2008-09-14,10.1002/pros.20806,,,,18543251,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3504012,https://api.altmetric.com/v1/donut/3504012_240.png 3,Quantitative expression profile of PSGR in prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2005-10-18,10.1038/sj.pcan.4500836,,,,16231015,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3503990,https://api.altmetric.com/v1/donut/3503990_240.png 3,"Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.",Molecular Endocrinology,,,Article,2005-12-31,10.1210/me.2005-0346,,,,16384856,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3503772,https://api.altmetric.com/v1/donut/3503772_240.png 3,The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots,Molecular Cancer,,,Article,,10.1186/1476-4598-5-17,,,,16700911,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,101,https://www.altmetric.com/details/3503666,https://api.altmetric.com/v1/donut/3503666_240.png 3,Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.,Molecular Endocrinology,,,Article,2006-06-10,10.1210/me.2006-0048,,,,16762975,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3503660,https://api.altmetric.com/v1/donut/3503660_240.png 3,hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer,Molecular Cancer,,,Article,,10.1186/1476-4598-4-32,,,,16153295,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3503604,https://api.altmetric.com/v1/donut/3503604_240.png 3,Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.,The Prostate,,,Article,2005-09-19,10.1002/pros.20328,,,,16173030,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3503443,https://api.altmetric.com/v1/donut/3503443_240.png 3,Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.,The Prostate,,,Article,2007-05-02,10.1002/pros.20607,,,,17476687,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3503190,https://api.altmetric.com/v1/donut/3503190_240.png 3,Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.,The Prostate,,,Article,2005-03-07,10.1002/pros.20243,,,,15754346,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3502272,https://api.altmetric.com/v1/donut/3502272_240.png 3,Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.,Cancer Research,,,Article,2001-07-01,,,,,11431361,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3501880,https://api.altmetric.com/v1/donut/3501880_240.png 3,Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.,Cancer Research,,,Article,2003-07-15,,,,,12874026,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3501035,https://api.altmetric.com/v1/donut/3501035_240.png 3,Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.,Clinical Cancer Research,,,Article,2016-09-05,10.1158/1078-0432.ccr-0707-03,,,,14760084,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3500903,https://api.altmetric.com/v1/donut/3500903_240.png 3,A Novel Role for Wnt/Ca2+ Signaling in Actin Cytoskeleton Remodeling and Cell Motility in Prostate Cancer,PLoS ONE,,,Article,2010-05-11,10.1371/journal.pone.0010456,,,,20454608,,,2010PLoSO...510456W,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,104,https://www.altmetric.com/details/3500537,https://api.altmetric.com/v1/donut/3500537_240.png 3,Expression of Clostridium Perfringens Enterotoxin Receptors Claudin-3 and Claudin-4 in Prostate Cancer Epithelium,Cancer Research,,,Article,2001-11-01,,,,,11691807,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3500163,https://api.altmetric.com/v1/donut/3500163_240.png 3,Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis.,Molecular Carcinogenesis,,,Article,2003-02-27,10.1002/mc.10108,,,,12619034,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3499814,https://api.altmetric.com/v1/donut/3499814_240.png 3,Meta-Analysis of Associations of the Ser217Leu and Ala541Thr Variants in ELAC2 (HPC2) and Prostate Cancer,American Journal of Human Genetics,,,Article,,10.1086/344516,,,,12515253,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3499723,https://api.altmetric.com/v1/donut/3499723_240.png 3,ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago.,Human Genetics,,,Article,,10.1007/s00439-002-0816-1,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3499722,https://api.altmetric.com/v1/donut/3499722_240.png 3,ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.,Cancer Research,,,Article,2001-08-15,,,,,11507049,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3499721,https://api.altmetric.com/v1/donut/3499721_240.png 3,"ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.",JNCI: Journal of the National Cancer Institute,,,Article,2016-02-21,10.1093/jnci/95.11.818,,,,12783937,,1959.8/121690,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3499719,https://api.altmetric.com/v1/donut/3499719_240.png 3,Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.,Journal of Human Genetics,,,Article,2002-12-01,10.1007/s100380200099,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3499716,https://api.altmetric.com/v1/donut/3499716_240.png 3,Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-09-01,,,,,14504198,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3499711,https://api.altmetric.com/v1/donut/3499711_240.png 3,Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m210975200,,,,12586837,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3499127,https://api.altmetric.com/v1/donut/3499127_240.png 3,The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-06-0943,,,,17178897,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3499062,https://api.altmetric.com/v1/donut/3499062_240.png 3,Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells.,International Journal of Oncology,,,Article,2007-03-29,,,,,17390026,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3498658,https://api.altmetric.com/v1/donut/3498658_240.png 3,Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells,International Journal of Oncology,,,Article,2007-05-01,10.3892/ijo.30.5.1231,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3498656,https://api.altmetric.com/v1/donut/3498656_240.png 3,ZFY gene expression and retention in human prostate adenocarcinoma.,"Genes, Chromosomes, and Cancer",,,Article,1993-02-01,,,,,7680890,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3498545,https://api.altmetric.com/v1/donut/3498545_240.png 3,ZFY gene expression and retention in human prostate adenocarcinoma,"Genes, Chromosomes, and Cancer",,,Article,2006-07-14,10.1002/gcc.2870060202,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3498544,https://api.altmetric.com/v1/donut/3498544_240.png 3,Immunohistological detection of BRAF25 in human prostate tumor and cancer specimens.,Biochemical & Biophysical Research Communications,,,Article,2002-07-05,,,,,12083780,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3498313,https://api.altmetric.com/v1/donut/3498313_240.png 3,Immunohistological detection of BRAF25 in human prostate tumor and cancer specimens,Biochemical & Biophysical Research Communications,,,Article,2002-07-01,10.1016/s0006-291x(02)00625-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3498311,https://api.altmetric.com/v1/donut/3498311_240.png 3,The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2.,Journal of Biological Chemistry,,,Article,2015-05-22,10.1074/jbc.m110568200,,,,11812785,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3498309,https://api.altmetric.com/v1/donut/3498309_240.png 3,ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.,The Prostate,,,Article,2002-12-12,10.1002/pros.10161,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3497881,https://api.altmetric.com/v1/donut/3497881_240.png 3,Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m109372200,,,,11706037,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3497834,https://api.altmetric.com/v1/donut/3497834_240.png 3,A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2002-05-01,,,,,12010866,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3497229,https://api.altmetric.com/v1/donut/3497229_240.png 3,TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-06-0168,,,,16585160,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/3496920,https://api.altmetric.com/v1/donut/3496920_240.png 3,"The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells",Biochemical Journal,,,Article,2005-06-15,10.1042/bj20041066,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3496914,https://api.altmetric.com/v1/donut/3496914_240.png 3,Expression analysis of thirty one Y chromosome genes in human prostate cancer.,Molecular Carcinogenesis,,,Article,2000-04-01,,,,,10747295,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3496867,https://api.altmetric.com/v1/donut/3496867_240.png 3,Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer.,International Journal of Cancer,,,Article,2005-08-16,10.1002/ijc.21449,,,,16106424,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3495716,https://api.altmetric.com/v1/donut/3495716_240.png 3,p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells.,Oncogene,,,Article,2003-04-17,10.1038/sj.onc.1206325,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3494894,https://api.altmetric.com/v1/donut/3494894_240.png 3,NKX-3.1 Interacts with Prostate-derived Ets Factor and Regulates the Activity of the PSA Promoter,Cancer Research,,,Article,2002-01-15,,,,,11809674,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3494892,https://api.altmetric.com/v1/donut/3494892_240.png 3,Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression,Molecular & Cellular Biology,,,Article,,10.1128/mcb.20.5.1723-1732.2000,,,,10669749,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3494592,https://api.altmetric.com/v1/donut/3494592_240.png 3,Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2002-11-01,,,,,12433721,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3494579,https://api.altmetric.com/v1/donut/3494579_240.png 3,Knockdown of AGR2 induces cellular senescence in prostate cancer cells,Carcinogenesis,,,Article,2012-04-03,10.1093/carcin/bgs141,,,,22467239,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3494392,https://api.altmetric.com/v1/donut/3494392_240.png 3,"ART-27, an androgen receptor coactivator regulated in prostate development and cancer.",Journal of Biological Chemistry,,,Article,,10.1074/jbc.m306576200,,,,14711828,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3494074,https://api.altmetric.com/v1/donut/3494074_240.png 3,Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.,Cancer Research,,,Article,1999-09-01,,,,,10485450,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3494045,https://api.altmetric.com/v1/donut/3494045_240.png 3,Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.,Oncology Reports,,,Article,2007-03-29,,,,,17390040,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3494043,https://api.altmetric.com/v1/donut/3494043_240.png 3,Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer,Oncology Reports,,,Article,2007-05-01,10.3892/or.17.5.1033,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3494041,https://api.altmetric.com/v1/donut/3494041_240.png 3,Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.,Cancer Research,,,Article,2001-02-15,,,,,11245484,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3494037,https://api.altmetric.com/v1/donut/3494037_240.png 3,Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.,Cancer Research,,,Article,1994-12-15,,,,,7987830,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3493471,https://api.altmetric.com/v1/donut/3493471_240.png 3,Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene.,Cancer Letters,,,Article,,10.1016/s0304-3835(01)00703-0,,,,11734337,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3493467,https://api.altmetric.com/v1/donut/3493467_240.png 3,Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer.,Nature Genetics,,,Article,2005-03-06,10.1038/ng1528,,,,15750593,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3493275,https://api.altmetric.com/v1/donut/3493275_240.png 3,Germline ATBF1 mutations and prostate cancer risk.,The Prostate,,,Article,2006-04-24,10.1002/pros.20430,,,,16637072,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3493273,https://api.altmetric.com/v1/donut/3493273_240.png 3,"TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence.",International Journal of Cancer,,,Article,2001-10-15,,,,,11668495,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3492894,https://api.altmetric.com/v1/donut/3492894_240.png 3,"TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence",International Journal of Cancer,,,Article,2001-08-02,10.1002/ijc.1450,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3492892,https://api.altmetric.com/v1/donut/3492892_240.png 3,HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4.,Cancer Research,,,Article,,10.1158/0008-5472.can-03-2614,,,,15126340,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3492619,https://api.altmetric.com/v1/donut/3492619_240.png 3,HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.,Cancer Research,,,Article,,10.1158/0008-5472.can-04-1330,,,,15604291,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3492617,https://api.altmetric.com/v1/donut/3492617_240.png 3,An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer.,Biochemical & Biophysical Research Communications,,,Article,2005-05-10,10.1016/j.bbrc.2005.04.022,,,,15882971,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3492398,https://api.altmetric.com/v1/donut/3492398_240.png 3,Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.,Carcinogenesis,,,Article,,10.1093/carcin/23.6.967,,,,12082018,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3492167,https://api.altmetric.com/v1/donut/3492167_240.png 3,Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.,Cancer Research,,,Article,1999-08-15,,,,,10463585,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3491956,https://api.altmetric.com/v1/donut/3491956_240.png 3,"Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression.",Glycobiology,,,Article,,10.1093/glycob/cwi086,,,,15932919,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3491714,https://api.altmetric.com/v1/donut/3491714_240.png 3,Human acid ceramidase is overexpressed but not mutated in prostate cancer.,"Genes, Chromosomes, and Cancer",,,Article,2000-10-01,,,,,10959093,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3491409,https://api.altmetric.com/v1/donut/3491409_240.png 3,Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.,Molecular Endocrinology,,,Article,2006-11-04,10.1210/me.2006-0104,,,,17082327,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3491127,https://api.altmetric.com/v1/donut/3491127_240.png 3,Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.,Cancer Research,,,Article,2002-01-01,,,,,11782391,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3490940,https://api.altmetric.com/v1/donut/3490940_240.png 3,Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues.,Urology,,,Article,2003-05-01,,,,,12736044,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3490938,https://api.altmetric.com/v1/donut/3490938_240.png 3,Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues,Urology,,,Article,,10.1016/s0090-4295(02)02443-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3490936,https://api.altmetric.com/v1/donut/3490936_240.png 3,"Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms.",The Prostate,,,Article,2003-11-25,10.1002/pros.10348,,,,14968442,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3490484,https://api.altmetric.com/v1/donut/3490484_240.png 3,Staphylococcal Nuclease Domain-Containing Protein 1 as a Potential Tissue Marker for Prostate Cancer,American Journal of Pathology,,,Article,,10.2353/ajpath.2009.080776,,,,19435788,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3489918,https://api.altmetric.com/v1/donut/3489918_240.png 3,Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.c400105200,,,,15143072,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3489856,https://api.altmetric.com/v1/donut/3489856_240.png 3,"Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.",The Prostate,,,Article,2005-08-20,10.1002/pros.20312,,,,16114059,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3489528,https://api.altmetric.com/v1/donut/3489528_240.png 3,"Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.",,,,Article,2000-03-07,10.1038/sj.onc.1203426,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3488774,https://api.altmetric.com/v1/donut/3488774_240.png 3,Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.,Annals of Surgical Oncology,,,Article,2006-09-07,10.1245/s10434-006-9029-5,,,,16957968,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3488760,https://api.altmetric.com/v1/donut/3488760_240.png 3,Prostate stem cell antigen is overexpressed in prostate cancer metastases.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-04-1842,,,,15814638,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3488756,https://api.altmetric.com/v1/donut/3488756_240.png 3,Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.,Cancer Research,,,Article,2001-06-15,,,,,11406532,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3488750,https://api.altmetric.com/v1/donut/3488750_240.png 3,Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-05-1906,,,,16533763,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3488011,https://api.altmetric.com/v1/donut/3488011_240.png 3,"Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.",Cancer Research,,,Article,1999-09-01,,,,,10485467,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3487134,https://api.altmetric.com/v1/donut/3487134_240.png 3,Regulation of FGF8 expression by the androgen receptor in human prostate cancer.,Oncogene,,,Article,2002-07-29,10.1038/sj.onc.1205663,,,,12140757,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3486647,https://api.altmetric.com/v1/donut/3486647_240.png 3,Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.0700420104,,,,17494760,,,2007PNAS..104.8438M,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3484895,https://api.altmetric.com/v1/donut/3484895_240.png 3,Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer.,The Prostate,,,Article,2000-05-01,,,,,10754528,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3484383,https://api.altmetric.com/v1/donut/3484383_240.png 3,Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer.,Biochemical & Biophysical Research Communications,,,Article,2003-10-24,,,,,14550308,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3484366,https://api.altmetric.com/v1/donut/3484366_240.png 3,Metallothionein 2A interacts with the kinase domain of PKC? in prostate cancer,Biochemical & Biophysical Research Communications,,,Article,2003-10-01,10.1016/j.bbrc.2003.09.118,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3484365,https://api.altmetric.com/v1/donut/3484365_240.png 3,"Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma.",International Journal of Cancer,,,Article,1995-07-04,,,,,7541394,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3484133,https://api.altmetric.com/v1/donut/3484133_240.png 3,"Expression of acid cysteine proteinase inhibitor (acpi) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma",International Journal of Cancer,,,Article,2006-07-17,10.1002/ijc.2910620102,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3484131,https://api.altmetric.com/v1/donut/3484131_240.png 3,Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.,Japanese journal of cancer research Gann,,,Article,2002-06-01,,,,,12079507,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3484111,https://api.altmetric.com/v1/donut/3484111_240.png 3,Promoter Methylation of TSLC1 and Tumor Suppression by Its Gene Product in Human Prostate Cancer,Cancer Science,,,Article,2005-08-22,10.1111/j.1349-7006.2002.tb01297.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3484110,https://api.altmetric.com/v1/donut/3484110_240.png 3,Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.,Cancer Research,,,Article,,10.1158/0008-5472.can-05-1127,,,,16288044,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3484102,https://api.altmetric.com/v1/donut/3484102_240.png 3,"KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.",Science,,,Article,,10.1126/science.7754374,,,,7754374,,,1995Sci...268..884D,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3481903,https://api.altmetric.com/v1/donut/3481903_240.png 3,Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11.,Cancer Research,,,Article,1992-06-15,,,,,1596907,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3481900,https://api.altmetric.com/v1/donut/3481900_240.png 3,Genetic factors and suppression of metastatic ability of prostatic cancer.,Cancer Research,,,Article,1991-07-15,,,,,2065333,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3481898,https://api.altmetric.com/v1/donut/3481898_240.png 3,Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells.,Oncogene,,,Article,2002-12-13,10.1038/sj.onc.1205992,,,,12483528,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3481170,https://api.altmetric.com/v1/donut/3481170_240.png 3,Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.,,,,Article,2001-06-29,10.1038/sj.onc.1204489,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3481023,https://api.altmetric.com/v1/donut/3481023_240.png 3,"Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers.",Biochemical & Biophysical Research Communications,,,Article,2002-08-23,,,,,12176020,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3479654,https://api.altmetric.com/v1/donut/3479654_240.png 3,"Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers ",Biochemical & Biophysical Research Communications,,,Article,2002-08-01,10.1016/s0006-291x(02)00920-8,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3479631,https://api.altmetric.com/v1/donut/3479631_240.png 3,Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.,Journal of the Chinese Medical Association,,,Article,2004-03-17,,,,,15015823,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3479497,https://api.altmetric.com/v1/donut/3479497_240.png 3,BICALUTAMIDE (150 MG) VERSUS PLACEBO AS IMMEDIATE THERAPY ALONE OR AS ADJUVANT TO THERAPY WITH CURATIVE INTENT FOR EARLY NONMETASTATIC PROSTATE CANCER: 5.3-YEAR MEDIAN FOLLOWUP FROM THE SCANDINAVIAN PROSTATE CANCER GROUP STUDY NUMBER 6,The Journal of Urology,,,Article,,10.1097/01.ju.0000139719.99825.54,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3479491,https://api.altmetric.com/v1/donut/3479491_240.png 3,Estrogens in the treatment of prostate cancer.,The Journal of Urology,,,Article,1995-12-01,,,,,7500443,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3479489,https://api.altmetric.com/v1/donut/3479489_240.png 3,Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate.,The Prostate,,,Article,1988-01-01,,,,,3211807,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3479486,https://api.altmetric.com/v1/donut/3479486_240.png 3,Cost comparison of parenteral estrogen and conventional hormonal treatment in patients with prostatic cancer.,International Journal of Technology Assessment in Health Care,,,Article,1991-01-01,,,,,1907600,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3479482,https://api.altmetric.com/v1/donut/3479482_240.png 3,Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6.,The Journal of Urology,,,Article,2004-11-01,,,,,15540741,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3479477,https://api.altmetric.com/v1/donut/3479477_240.png 3,Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study.,Urology,,,Article,2000-03-01,,,,,10699602,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3479473,https://api.altmetric.com/v1/donut/3479473_240.png 3,Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5,Scandinavian Journal of Urology & Nephrology,,,Article,2002-01-01,10.1080/003655902762467549,,,,12623503,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3479471,https://api.altmetric.com/v1/donut/3479471_240.png 3,Therapy Insight: parenteral estrogen treatment for prostate cancer|[mdash]|a new dawn for an old therapy,Nature Clinical Practice Oncology,,,Article,2006-01-10,10.1038/ncponc0602,,,,17019433,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3479470,https://api.altmetric.com/v1/donut/3479470_240.png 3,Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.,Scandinavian Journal of Urology & Nephrology,,,Article,2008-04-24,10.1080/00365590801943274,,,,18432528,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3479469,https://api.altmetric.com/v1/donut/3479469_240.png 3,Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.,Archivio italiano di urologia andrologia organo ufficiale di Società italiana di ecografia urologica e nefrologica,,,Article,1999-12-01,,,,,10673793,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3479431,https://api.altmetric.com/v1/donut/3479431_240.png 3,PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.,Oncogene,,,Article,2006-01-19,10.1038/sj.onc.1209020,,,,16421604,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/3478814,https://api.altmetric.com/v1/donut/3478814_240.png 3,RhoA as a Mediator of Clinically Relevant Androgen Action in Prostate Cancer Cells,Molecular Endocrinology,,,Article,2012-03-30,10.1210/me.2011-1130,,,,22456196,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3478732,https://api.altmetric.com/v1/donut/3478732_240.png 3,"A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.",Cancer Research,,,Article,2001-10-15,,,,,11606364,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3478535,https://api.altmetric.com/v1/donut/3478535_240.png 3,Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases,American Journal of Pathology,,,Article,2009-01-05,10.2353/ajpath.2009.080751,,,,19342366,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3476227,https://api.altmetric.com/v1/donut/3476227_240.png 3,Suppressor of Cytokine Signaling-3 Antagonizes cAMP Effects on Proliferation and Apoptosis and Is Expressed in Human Prostate Cancer,American Journal of Pathology,,,Article,2006-01-12,10.2353/ajpath.2006.060171,,,,17148681,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3476217,https://api.altmetric.com/v1/donut/3476217_240.png 3,Expression and functional role of CCR9 in prostate cancer cell migration and invasion.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-04-0266,,,,15623660,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3476097,https://api.altmetric.com/v1/donut/3476097_240.png 3,Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.,Urologic Oncology,,,Article,,10.1016/s1078-1439(01)00173-9,,,,12474541,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3475929,https://api.altmetric.com/v1/donut/3475929_240.png 3,Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.,The Journal of Urology,,,Article,,10.1016/j.juro.2007.01.010,,,,17437806,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3475504,https://api.altmetric.com/v1/donut/3475504_240.png 3,Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m104765200,,,,11509567,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3474365,https://api.altmetric.com/v1/donut/3474365_240.png 3,Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.,Cancer Research,,,Article,2000-08-15,,,,,10969806,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3473409,https://api.altmetric.com/v1/donut/3473409_240.png 3,Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.,The Journal of Urology,,,Article,,10.1016/j.juro.2010.09.077,,,,21168877,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3473104,https://api.altmetric.com/v1/donut/3473104_240.png 3,Sarcosine as a potential prostate cancer biomarker and therapeutic target,Cancer Biology and Therapy,,,Article,2010-02-13,,,,,20150759,PMC2874119,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3473073,https://api.altmetric.com/v1/donut/3473073_240.png 3,Sarcosine as a potential prostate cancer biomarker and therapeutic target,Cancer Biology and Therapy,,,Article,2014-10-27,10.4161/cbt.9.5.11310,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3473072,https://api.altmetric.com/v1/donut/3473072_240.png 3,Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development,The Journal of Urology,,,Article,2010-04-14,10.1016/j.juro.2009.12.006,,,,20172544,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3471094,https://api.altmetric.com/v1/donut/3471094_240.png 3,Somatostatin receptors in human prostate and prostate cancer.,The Journal of Clinical Endocrinology & Metabolism,,,Article,1995-09-01,10.1210/jcem.80.9.7673428,,,,7673428,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3471063,https://api.altmetric.com/v1/donut/3471063_240.png 3,Somatostatin receptors in human prostate and prostate cancer,The Journal of Clinical Endocrinology & Metabolism,,,Article,1995-09-01,10.1210/jc.80.9.2806,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3471060,https://api.altmetric.com/v1/donut/3471060_240.png 3,"Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.",Cancer Research,,,Article,,10.1158/0008-5472.can-05-1731,,,,16230377,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/3470492,https://api.altmetric.com/v1/donut/3470492_240.png 3,Upregulation of L-plastin gene by testosterone in breast and prostate cancer cells: identification of three cooperative androgen receptor-binding sequences.,DNA & Cell Biology,,,Article,2000-01-01,10.1089/104454900314654,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3470102,https://api.altmetric.com/v1/donut/3470102_240.png 3,"Gonadoblastoma, testicular and prostate cancers, and the TSPY gene.",American Journal of Human Genetics,,,Article,,10.1086/302353,,,,10090875,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3469963,https://api.altmetric.com/v1/donut/3469963_240.png 3,Membrane Microvesicles as Actors in the Establishment of a Favorable Prostatic Tumoral Niche: A Role for Activated Fibroblasts and CX3CL1-CX3CR1 Axis,Cancer Research,,,Article,,10.1158/0008-5472.can-08-1946,,,,19155311,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/3469905,https://api.altmetric.com/v1/donut/3469905_240.png 3,The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.,Clinical Cancer Research,,,Article,2003-05-01,,,,,12738739,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3469762,https://api.altmetric.com/v1/donut/3469762_240.png 3,Par-4 inducible apoptosis in prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2004-01-14,10.1002/jcb.20000,,,,14755681,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3468791,https://api.altmetric.com/v1/donut/3468791_240.png 3,"Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue.",PLoS ONE,,,Article,2014-01-06,10.1371/journal.pone.0084295,,,,24386364,PMC3874000,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3468337,https://api.altmetric.com/v1/donut/3468337_240.png 3,"AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.",Clinical Cancer Research,,,Article,2001-08-01,,,,,11489829,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3468333,https://api.altmetric.com/v1/donut/3468333_240.png 3,Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.274.31.21528,,,,10419456,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/3468297,https://api.altmetric.com/v1/donut/3468297_240.png 3,"Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.",Cancer (0008543X),,,Article,2007-02-26,10.1002/cncr.22551,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3468023,https://api.altmetric.com/v1/donut/3468023_240.png 3,Modulation of oncogenic potential by alternative gene use in human prostate cancer.,Nature Medicine,,,Article,1999-03-01,10.1038/6488,,,,,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3467749,https://api.altmetric.com/v1/donut/3467749_240.png 3,"Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.",Cancer Research,,,Article,1999-04-01,,,,,10197620,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3467320,https://api.altmetric.com/v1/donut/3467320_240.png 3,"Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.",International Journal of Cancer,,,Article,2001-11-01,,,,,11745444,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3467316,https://api.altmetric.com/v1/donut/3467316_240.png 3,"Human kallikrein 2 (hK2), but not prostate?specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI?6) released from prostate carcinoma cells ",International Journal of Cancer,,,Article,2001-08-23,10.1002/ijc.1501,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3467314,https://api.altmetric.com/v1/donut/3467314_240.png 3,Gene expression profiling predicts clinical outcome of prostate cancer,Journal of Clinical Investigation,,,Article,,10.1172/jci200420032,,,,15067324,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3466465,https://api.altmetric.com/v1/donut/3466465_240.png 3,Krüppel Cripples Prostate Cancer : KLF6 Progress and Prospects,American Journal of Pathology,,,Article,2003-04-01,10.1016/s0002-9440(10)63901-6,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3466463,https://api.altmetric.com/v1/donut/3466463_240.png 3,A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.,Endocrinology,,,Article,2002-05-01,10.1210/endo.143.5.8778,,,,11956172,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3465874,https://api.altmetric.com/v1/donut/3465874_240.png 3,A Glucocorticoid-Responsive Mutant Androgen Receptor Exhibits Unique Ligand Specificity: Therapeutic Implications for Androgen-Independent Prostate Cancer,Endocrinology,,,Article,2002-05-01,10.1210/en.143.5.1889,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3465871,https://api.altmetric.com/v1/donut/3465871_240.png 3,Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.,Journal of the Formosan Medical Association,,,Article,2000-12-01,,,,,11155740,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3465831,https://api.altmetric.com/v1/donut/3465831_240.png 3,Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate.,International Journal of Cancer,,,Article,1990-04-15,,,,,1691151,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3464448,https://api.altmetric.com/v1/donut/3464448_240.png 3,Expression of the gene coding for human prostate?specific antigen and related hGK?1 in benign and malignant tumors of the human prostate,International Journal of Cancer,,,Article,2006-07-17,10.1002/ijc.2910450414,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3464447,https://api.altmetric.com/v1/donut/3464447_240.png 3,The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells.,Oncogene,,,Article,2007-01-22,10.1038/sj.onc.1210224,,,,17237817,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3463064,https://api.altmetric.com/v1/donut/3463064_240.png 3,New prostate cancer drug: Prostate cancer's day in the sun.,British Medical Journal,,,Article,2008-08-11,10.1136/bmj.a1249,,,,18694888,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3462505,https://api.altmetric.com/v1/donut/3462505_240.png 3,MUC1 is a promising therapeutic target for prostate cancer therapy.,Current Cancer Drug Targets,,,Article,2007-01-05,10.2174/156800907780618338,,,,17504123,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3461734,https://api.altmetric.com/v1/donut/3461734_240.png 3,Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.,British Journal of Urology,,,Article,2005-09-29,10.1111/j.1464-410x.2005.05821.x,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3461391,https://api.altmetric.com/v1/donut/3461391_240.png 3,Cancer expert doubts claims about prostate cancer trial.,British Medical Journal,,,Article,,10.1136/bmj.a979,,,,18653636,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3461385,https://api.altmetric.com/v1/donut/3461385_240.png 3,Skp2: a novel potential therapeutic target for prostate cancer,Biochimica et Biophysica Acta (BBA),,,Article,2011-10-04,10.1016/j.bbcan.2011.09.002,,,,21963805,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3461265,https://api.altmetric.com/v1/donut/3461265_240.png 3,The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.,Cancer Research,,,Article,1999-06-15,,,,,10383151,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3459444,https://api.altmetric.com/v1/donut/3459444_240.png 3,Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging,Journal of Nanoparticle Research,,,Article,2011-09-30,10.1007/s11051-011-0439-3,,,,22121333,PMC3223933,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3457510,https://api.altmetric.com/v1/donut/3457510_240.png 3,"Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.",The Lancet (British Edition),,,Article,,10.1016/s0140-6736(98)11282-5,,,,10501358,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3456443,https://api.altmetric.com/v1/donut/3456443_240.png 3,CAN DIET IN CONJUNCTION WITH STRESS REDUCTION AFFECT THE RATE OF INCREASE IN PROSTATE SPECIFIC ANTIGEN AFTER BIOCHEMICAL RECURRENCE OF PROSTATE CANCER?,The Journal of Urology,,,Article,,10.1016/s0022-5347(05)65535-8,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3456406,https://api.altmetric.com/v1/donut/3456406_240.png 3,Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells.,Cancer Research,,,Article,,10.1158/0008-5472.can-04-2146,,,,15548706,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3456101,https://api.altmetric.com/v1/donut/3456101_240.png 3,Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers.,Peptides,,,Article,2002-06-01,,,,,12126741,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3451937,https://api.altmetric.com/v1/donut/3451937_240.png 3,Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers,Peptides,,,Article,2002-06-01,10.1016/s0196-9781(02)00043-8,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3451936,https://api.altmetric.com/v1/donut/3451936_240.png 3,GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells.,Regulatory Peptides,,,Article,2002-11-15,,,,,12409226,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3451869,https://api.altmetric.com/v1/donut/3451869_240.png 3,GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells,Regulatory Peptides,,,Article,2002-11-01,10.1016/s0167-0115(02)00197-0,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3451868,https://api.altmetric.com/v1/donut/3451868_240.png 3,hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.,Cancer Research,,,Article,,10.1158/0008-5472.can-05-2183,,,,16585177,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3451799,https://api.altmetric.com/v1/donut/3451799_240.png 3,"Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.",Cancer (0008543X),,,Article,2004-05-28,10.1002/cncr.20327,,,,15221992,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3449758,https://api.altmetric.com/v1/donut/3449758_240.png 3,Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.,The Prostate,,,Article,2006-05-16,10.1002/pros.20438,,,,16705743,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3448333,https://api.altmetric.com/v1/donut/3448333_240.png 3,Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-08-1980,,,,19141649,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3447730,https://api.altmetric.com/v1/donut/3447730_240.png 3,Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer.,Blood,,,Article,1998-02-01,,,,,9446667,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3444338,https://api.altmetric.com/v1/donut/3444338_240.png 3,DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation.,Febs Letters,,,Article,2006-04-03,10.1016/j.febslet.2006.03.041,,,,16580667,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,104,https://www.altmetric.com/details/3440945,https://api.altmetric.com/v1/donut/3440945_240.png 3,DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.,BONE,,,Article,2007-04-14,10.1016/j.bone.2006.11.006,,,,17196895,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3440936,https://api.altmetric.com/v1/donut/3440936_240.png 3,Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.,,,,Article,2000-04-17,10.1038/sj.pcan.4500384,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3432855,https://api.altmetric.com/v1/donut/3432855_240.png 3,Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer.,Aging Male,,,Article,2010-02-10,10.3109/13685530903536668,,,,20136572,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3432219,https://api.altmetric.com/v1/donut/3432219_240.png 3,The Prostate Cancer-Associated Human Retrovirus XMRV Lacks Direct Transforming Activity but Can Induce Low Rates of Transformation in Cultured Cells,Journal of Virology,,,Article,2010-02-15,10.1128/jvi.01941-09,,,,20007266,PMC2812358,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3431502,https://api.altmetric.com/v1/donut/3431502_240.png 3,Protein kinase C-alpha: a novel target for the therapy of androgen-independent prostate cancer? (Review-hypothesis).,Oncology Reports,,,Article,,,,,,9468546,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3430233,https://api.altmetric.com/v1/donut/3430233_240.png 3,Protein kinase C-alpha: a novel target for the therapy of androgen-independent prostate cancer? (Review-hypothesis).,Oncology Reports,,,Article,1998-03-01,10.3892/or.5.2.305,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3430232,https://api.altmetric.com/v1/donut/3430232_240.png 3,Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.,British Journal of Urology,,,Article,2005-12-16,10.1111/j.1464-410x.2005.05944.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3430065,https://api.altmetric.com/v1/donut/3430065_240.png 3,Identification of viral infections in the prostate and evaluation of their association with cancer,BMC Cancer,,,Article,,10.1186/1471-2407-10-326,,,,20576103,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3429690,https://api.altmetric.com/v1/donut/3429690_240.png 3,Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.,Human Pathology,,,Article,,10.1016/j.humpath.2006.11.012,,,,17320151,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3428779,https://api.altmetric.com/v1/donut/3428779_240.png 3,"Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy.",Pathology & Oncology Research,,,Article,2008-08-28,10.1007/s12253-008-9077-1,,,,18752058,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3428370,https://api.altmetric.com/v1/donut/3428370_240.png 3,"Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer",EMBO Journal,,,Article,,10.1038/sj.emboj.7600969,,,,16467855,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3427227,https://api.altmetric.com/v1/donut/3427227_240.png 3,Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.,Cancer Research,,,Article,1993-01-15,,,,,8417812,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3427223,https://api.altmetric.com/v1/donut/3427223_240.png 3,A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms.,The Prostate,,,Article,2007-12-28,10.1002/pros.20680,,,,18163428,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3425103,https://api.altmetric.com/v1/donut/3425103_240.png 3,Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2009-06-02,10.1002/jcb.22211,,,,19492334,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3423326,https://api.altmetric.com/v1/donut/3423326_240.png 3,Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction.,Biochemical & Biophysical Research Communications,,,Article,2008-12-10,10.1016/j.bbrc.2008.11.114,,,,19059205,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3421632,https://api.altmetric.com/v1/donut/3421632_240.png 3,Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.,Clinical Cancer Research,,,Article,1996-09-01,,,,,9816319,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3421345,https://api.altmetric.com/v1/donut/3421345_240.png 3,Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands,International Journal of Cancer,,,Article,2008-07-25,10.1002/ijc.23717,,,,18661519,PMC2778289,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3421343,https://api.altmetric.com/v1/donut/3421343_240.png 3,Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.,Clinical Cancer Research,,,Article,2003-12-26,,,,,14695135,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3421341,https://api.altmetric.com/v1/donut/3421341_240.png 3,"Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.",Molecular Cancer Research,,,Article,,10.1158/1541-7786.mcr-08-0171,,,,18922975,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3418376,https://api.altmetric.com/v1/donut/3418376_240.png 3,Signal transducer and activator of transcription 5A/B in prostate and breast cancers.,Endocrine-Related Cancer,,,Article,,10.1677/erc-08-0013,,,,18508994,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3418111,https://api.altmetric.com/v1/donut/3418111_240.png 3,"Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.",Journal of Steroid Biochemistry & Molecular Biology,,,Article,2003-05-01,,,,,12798352,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3416772,https://api.altmetric.com/v1/donut/3416772_240.png 3,"Inhibition of fatty acid synthase expression by 1?,25-dihydroxyvitamin D3 in prostate cancer cells",Journal of Steroid Biochemistry & Molecular Biology,,,Article,2003-05-01,10.1016/s0960-0760(03)00142-0,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3416771,https://api.altmetric.com/v1/donut/3416771_240.png 3,The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth.,Biochemical & Biophysical Research Communications,,,Article,,10.1016/j.bbrc.2004.05.014,,,,15178414,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3416761,https://api.altmetric.com/v1/donut/3416761_240.png 3,Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.,Febs Letters,,,Article,,10.1016/j.febslet.2004.10.044,,,,15556626,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3416757,https://api.altmetric.com/v1/donut/3416757_240.png 3,CD146 protein in prostate cancer: revisited with two different antibodies.,Pathology,,,Article,2008-07-08,10.1080/00313020802197996,,,,18604730,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3416599,https://api.altmetric.com/v1/donut/3416599_240.png 3,NO EVIDENCE OF XMRV IN IRISH PROSTATE CANCER PATIENTS WITH THE R462Q MUTATION,European Urology Supplements,,,Article,,10.1016/s1569-9056(08)60798-8,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3415123,https://api.altmetric.com/v1/donut/3415123_240.png 3,Is a retrovirus implicated in familial prostate cancer?,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djp137,,,,19436028,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3415122,https://api.altmetric.com/v1/donut/3415122_240.png 3,Xenotropic Murine Leukemia Virus-Related Virus in Chronic Fatigue Syndrome and Prostate Cancer,Current Allergy and Asthma Reports,,,Article,2010-04-07,10.1007/s11882-010-0106-2,,,,20425007,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3415119,https://api.altmetric.com/v1/donut/3415119_240.png 3,Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients.,The Prostate,,,Article,2010-09-28,10.1002/pros.21255,,,,20878949,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3415115,https://api.altmetric.com/v1/donut/3415115_240.png 3,Prostate Cancer: New Data Help Refine Risk Stratification,Oncology times,,,Article,2009-01-25,10.1097/01.cot.0000345494.12042.f8,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3415091,https://api.altmetric.com/v1/donut/3415091_240.png 3,Distress due to unwanted side-effects of prostate cancer treatment is related to impaired well-being (quality of life).,,,,Article,1998-03-05,10.1038/sj.pcan.4500226,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3414131,https://api.altmetric.com/v1/donut/3414131_240.png 3,Can urinary exosomes act as treatment response markers in prostate cancer?,Journal of Translational Medicine,,,Article,2009-01-12,10.1186/1479-5876-7-4,,,,19138409,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,108,https://www.altmetric.com/details/3414102,https://api.altmetric.com/v1/donut/3414102_240.png 3,"A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.","Genes, Chromosomes, and Cancer",,,Article,1998-05-01,,,,,9591631,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3413295,https://api.altmetric.com/v1/donut/3413295_240.png 3,Predicting Prostate Cancer Biochemical Recurrence Using a Panel of Serum Proteomic Biomarkers,The Journal of Urology,,,Article,2009-03-15,10.1016/j.juro.2008.10.142,,,,19157448,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3412197,https://api.altmetric.com/v1/donut/3412197_240.png 3,Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA,Molecular Endocrinology,,,Article,2009-08-14,10.1210/me.2008-0470,,,,19389811,PMC2718746,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3411988,https://api.altmetric.com/v1/donut/3411988_240.png 3,Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel.,Investigational New Drugs,,,Article,,10.1007/s10637-005-5856-7,,,,15744587,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3411915,https://api.altmetric.com/v1/donut/3411915_240.png 3,"A phase I study with adecatumumab, a human antibody directed against epithelial cell adhesion molecule, in hormone refractory prostate cancer patients.",European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2006.05.029,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3410947,https://api.altmetric.com/v1/donut/3410947_240.png 3,Interference with HH-GLI signaling inhibits prostate cancer.,Trends in Molecular Medicine,,,Article,2005-05-10,10.1016/j.molmed.2005.03.004,,,,15882606,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3409947,https://api.altmetric.com/v1/donut/3409947_240.png 3,Fatty acid synthase: A metabolic oncogene in prostate cancer?,Journal of Cellular Biochemistry,,,Article,2003-11-04,10.1002/jcb.10708,,,,14689581,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3409162,https://api.altmetric.com/v1/donut/3409162_240.png 3,Butanol Fraction Containing Berberine or Related Compound From Nexrutine® Inhibits NF?B Signaling and Induces Apoptosis in Prostate Cancer Cells,The Prostate,,,Article,2008-12-23,10.1002/pros.20899,,,,19107816,PMC2674392,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3408917,https://api.altmetric.com/v1/donut/3408917_240.png 3,"Identification of Leukocyte E-selectin Ligands, P-selectin Glycoprotein Ligand-1 and E-selectin Ligand-1, on Human Metastatic Prostate Tumor Cells",Cancer Research,,,Article,,10.1158/0008-5472.can-04-4653,,,,15994950,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3407979,https://api.altmetric.com/v1/donut/3407979_240.png 3,Dilemmas in the treatment of urothelial cancers of the prostate.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2007.12.010,,,,18439852,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3407250,https://api.altmetric.com/v1/donut/3407250_240.png 3,Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents.,Acta Pharmacologica Sinica,,,Article,2007-09-01,10.1111/j.1745-7254.2007.00683.x,,,,17723170,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3403618,https://api.altmetric.com/v1/donut/3403618_240.png 3,Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients.,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,,,Article,2006-02-14,10.1016/j.mrfmmm.2005.10.012,,,,16472830,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3401165,https://api.altmetric.com/v1/donut/3401165_240.png 3,Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays,PLoS ONE,,,Article,2009-03-15,10.1371/journal.pone.0004830,,,,19283074,,,2009PLoSO...4.4830K,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/3396850,https://api.altmetric.com/v1/donut/3396850_240.png 3,"Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.",International Journal of Oncology,,,Article,2011-11-15,10.3892/ijo.2011.1251,,,,22076499,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3396162,https://api.altmetric.com/v1/donut/3396162_240.png 3,Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells.,Cancer Genetics & Cytogenetics,,,Article,,10.1016/j.cancergencyto.2005.05.007,,,,16337854,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3393390,https://api.altmetric.com/v1/donut/3393390_240.png 3,"KLF6, a candidate tumor suppressor gene mutated in prostate cancer.",Science,,,Article,2016-05-30,10.1126/science.1066326,,,,11752579,,,2001Sci...294.2563N,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3392605,https://api.altmetric.com/v1/donut/3392605_240.png 3,Marital satisfaction of advanced prostate cancer survivors and their spousal caregivers: the dyadic effects of physical and mental health.,Psycho-Oncology,,,Article,2010-10-05,10.1002/pon.1855,,,,20925137,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3392545,https://api.altmetric.com/v1/donut/3392545_240.png 3,Early identification of individuals with prostate cancer in negative biopsies.,The Journal of Urology,,,Article,,10.1097/01.ju.0000116545.94813.27,,,,15017188,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3391459,https://api.altmetric.com/v1/donut/3391459_240.png 3,Detection of prostate cancer with a blood-based assay for early prostate cancer antigen.,Cancer Research,,,Article,,10.1158/0008-5472.can-04-4523,,,,15899799,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3391452,https://api.altmetric.com/v1/donut/3391452_240.png 3,Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-07-1078,,,,17908958,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3388315,https://api.altmetric.com/v1/donut/3388315_240.png 3,Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.,Cancer Research,,,Article,1997-10-01,,,,,9331107,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3388240,https://api.altmetric.com/v1/donut/3388240_240.png 3,Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.,Journal of biological regulators and homeostatic agents,,,Article,,,,,,11501969,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3380586,https://api.altmetric.com/v1/donut/3380586_240.png 3,"The interaction between beta-catenin, GSK3beta and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer.",International Journal of Oncology,,,Article,2001-04-01,,,,,11251183,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3379857,https://api.altmetric.com/v1/donut/3379857_240.png 3,"The interaction between ?-catenin, GSK3? and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer",International Journal of Oncology,,,Article,2001-04-01,10.3892/ijo.18.4.843,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3379856,https://api.altmetric.com/v1/donut/3379856_240.png 3,Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells.,Cancer Research,,,Article,,10.1158/0008-5472.can-04-2332,,,,15520170,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3375389,https://api.altmetric.com/v1/donut/3375389_240.png 3,Modulation of liver X receptor signaling as novel therapy for prostate cancer.,Journal of Biomedical Science,,,Article,2007-03-20,10.1007/s11373-007-9160-8,,,,17372849,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3375380,https://api.altmetric.com/v1/donut/3375380_240.png 3,Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.,Croatian Medical Journal,,,Article,2005-04-29,,,,,15861517,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3373016,https://api.altmetric.com/v1/donut/3373016_240.png 3,Distinct Redox Profiles of Selected Human Prostate Carcinoma Cell Lines: Implications for Rational Design of Redox Therapy,Cancers,,,Article,,10.3390/cancers3033557,,,,22163073,PMC3232682,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3371854,https://api.altmetric.com/v1/donut/3371854_240.png 3,Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein.,Biochemical Pharmacology,,,Article,2006-09-15,10.1016/j.bcp.2006.08.012,,,,16970927,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3371275,https://api.altmetric.com/v1/donut/3371275_240.png 3,Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.,Cancer Research,,,Article,2002-05-15,,,,,12019176,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3371206,https://api.altmetric.com/v1/donut/3371206_240.png 3,Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m600326200,,,,16517595,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3371178,https://api.altmetric.com/v1/donut/3371178_240.png 3,Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.,Journal of Clinical Oncology,,,Article,,10.1200/jco.2005.11.148,,,,15572727,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3370562,https://api.altmetric.com/v1/donut/3370562_240.png 3,"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.",Science,,,Article,,10.1126/science.275.5308.1943,,,,9072974,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3369636,https://api.altmetric.com/v1/donut/3369636_240.png 3,"Microscale Synthesis and Spectroscopic Analysis of Flutamide, an Antiandrogen Prostate Cancer Drug",Journal of Chemical Education,,,Article,2003-12-01,10.1021/ed080p1439,,,,,,,2003JChEd..80.1439S,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3369445,https://api.altmetric.com/v1/donut/3369445_240.png 3,Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation,Medical Hypotheses,,,Article,2008-01-01,10.1016/j.mehy.2007.07.044,,,,17910907,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3368305,https://api.altmetric.com/v1/donut/3368305_240.png 3,A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region.,Genomics,,,Article,2000-02-01,10.1006/geno.1999.6051,,,,10708513,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3367593,https://api.altmetric.com/v1/donut/3367593_240.png 3,Abstract B58: Discovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotype,Cancer Prevention Research,,,Article,,10.1158/1940-6207.prev-10-b58,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3364087,https://api.altmetric.com/v1/donut/3364087_240.png 3," A Phase II Study of [ 90 Y] Yttrium-Capromab Pendetide in the Treatment of Men with Prostate Cancer Recurrence Following Radical Prostatectomy ",Cancer Biotherapy & Radiopharmaceuticals,,,Article,1999-04-01,10.1089/cbr.1999.14.99,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3363888,https://api.altmetric.com/v1/donut/3363888_240.png 3,Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.,Lancet Oncology,,,Article,,10.1016/s1470-2045%2807%2970284-x,,,,17942366,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3361646,https://api.altmetric.com/v1/donut/3361646_240.png 3,"Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.",Drugs & Aging,,,Article,1995-07-01,,,,,7579781,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3361645,https://api.altmetric.com/v1/donut/3361645_240.png 3,Waning sexual function--the most important disease-specific distress for patients with prostate cancer.,British Journal of Cancer,,,Article,1996-06-01,,,,,8645589,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3360861,https://api.altmetric.com/v1/donut/3360861_240.png 3,Waning sexual function-the most important disease-specific distress for patients with prostate cancer,British Journal of Cancer,,,Article,1996-06-01,10.1038/bjc.1996.268,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3360858,https://api.altmetric.com/v1/donut/3360858_240.png 3,Emotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patients.,Scandinavian Journal of Urology & Nephrology,,,Article,2001-04-01,,,,,11411666,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3360857,https://api.altmetric.com/v1/donut/3360857_240.png 3,Emotional Isolation: Prevalence and the Effect on Well-being among 50-80-Year-Old Prostate Cancer Patients,Scandinavian Journal of Urology & Nephrology,,,Article,2001-03-01,10.1080/003655901750170407,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3360855,https://api.altmetric.com/v1/donut/3360855_240.png 3,Molecular pathology of prostate cancer,Journal of Clinical Pathology,,,Article,2005-07-01,10.1136/jcp.2002.003954,,,,15976331,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/3357135,https://api.altmetric.com/v1/donut/3357135_240.png 3,Prostate-cancer screening.,New England Journal of Medicine,,,Article,2009-09-06,,,,,19593852,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3356456,https://api.altmetric.com/v1/donut/3356456_240.png 3,?2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-08-0793,,,,18765525,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3354268,https://api.altmetric.com/v1/donut/3354268_240.png 3,Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.,La Radiologia Medica,,,Article,2003-12-11,,,,,15722999,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3354032,https://api.altmetric.com/v1/donut/3354032_240.png 3,Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer.,The Prostate,,,Article,2000-06-15,,,,,10861754,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3353891,https://api.altmetric.com/v1/donut/3353891_240.png 3,Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.,Urology,,,Article,1997-06-01,,,,,9187691,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3353685,https://api.altmetric.com/v1/donut/3353685_240.png 3,Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker,Urology,,,Article,,10.1016/s0090-4295(97)00108-8,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3353684,https://api.altmetric.com/v1/donut/3353684_240.png 3,"A 12 Week, Open Label, Phase I/IIa Study Using Apatone® for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy",International Journal of Medical Sciences,,,Article,2008-04-09,,,,,18392145,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3352841,https://api.altmetric.com/v1/donut/3352841_240.png 3," A 12 Week, Open Label, Phase I/IIa Study Using Apatone ® for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy ",International Journal of Medical Sciences,,,Article,2008-01-01,10.7150/ijms.5.62,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3352839,https://api.altmetric.com/v1/donut/3352839_240.png 3,Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.,American Journal of Human Genetics,,,Article,1998-03-01,10.1086/301745,,,,9497242,PMC1376940,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3352268,https://api.altmetric.com/v1/donut/3352268_240.png 3,Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.,Science,,,Article,,10.1126/science.274.5291.1371,,,,8910276,,,1996Sci...274.1371S,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3352263,https://api.altmetric.com/v1/donut/3352263_240.png 3,Involvement of the RNAse L gene in prostate cancer.,Bulletin de la Société des sciences médicales du Grand Duché de Luxembourg,,,Article,2006-07-28,,,,,16869093,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3352261,https://api.altmetric.com/v1/donut/3352261_240.png 3,?-Tocotrienol induces growth arrest through a novel pathway with TGF?2 in prostate cancer.,Free Radical Biology & Medicine,,,Article,2011-02-23,10.1016/j.freeradbiomed.2011.02.007,,,,21335085,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3349756,https://api.altmetric.com/v1/donut/3349756_240.png 3,?-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways,British Journal of Cancer,,,Article,2008-11-11,10.1038/sj.bjc.6604763,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3349527,https://api.altmetric.com/v1/donut/3349527_240.png 3,beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis.,Cancer Research,,,Article,,10.1158/0008-5472.can-06-1996,,,,16982753,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3345765,https://api.altmetric.com/v1/donut/3345765_240.png 3,Screening for Prostate Cancer: A Recommendation from the U.S. Preventive Services Task Force,Annals of Internal Medicine,,,Article,,10.7326/0003-4819-137-11-200212030-00005,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3345468,https://api.altmetric.com/v1/donut/3345468_240.png 3,Ten-year survival and cardiovascular mortality in patients with advanced prostate cancer primarily treated by intramuscular polyestradiol phosphate or orchiectomy.,The Prostate,,,Article,2007-01-11,10.1002/pros.20547,,,,17219379,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3344930,https://api.altmetric.com/v1/donut/3344930_240.png 3,Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia.,Prostate Cancer & Prostatic Diseases,,,Article,2007-10-02,10.1038/sj.pcan.4501014,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3344767,https://api.altmetric.com/v1/donut/3344767_240.png 3,Prostatic acid phosphatase is not a prostate specific target.,Cancer Research,,,Article,,10.1158/0008-5472.can-07-1651,,,,17638863,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3344431,https://api.altmetric.com/v1/donut/3344431_240.png 3,Reviving the acid phosphatase test for prostate cancer.,Oncology (Williston Park),,,Article,2007-01-07,,,,,17715699,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3344428,https://api.altmetric.com/v1/donut/3344428_240.png 3,Prostatic acid phosphatase in serum of patients with prostatic cancer is a specific phosphotyrosine acid phosphatase.,Clinical Chemistry,,,Article,1990-08-01,,,,,1696855,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3344424,https://api.altmetric.com/v1/donut/3344424_240.png 3,Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer.,The Journal of Supportive Oncology,,,Article,2010-11-23,,,,,21086876,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3342660,https://api.altmetric.com/v1/donut/3342660_240.png 3,Longitudinal Effects of Social Support and Adaptive Coping on the Emotional Well-Being of Survivors of Localized Prostate Cancer,The Journal of Supportive Oncology,,,Article,2010-09-01,10.1016/j.suponc.2010.09.004,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3342659,https://api.altmetric.com/v1/donut/3342659_240.png 3,Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer.,Journal of Nutrition,,,Article,2001-01-01,,,,,11208954,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3342444,https://api.altmetric.com/v1/donut/3342444_240.png 3,APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy.,Frontiers in Bioscience,,,Article,2005-12-22,,,,,16368536,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3341286,https://api.altmetric.com/v1/donut/3341286_240.png 3,APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy,Frontiers in Bioscience,,,Article,2006-01-01,10.2741/1903,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3341285,https://api.altmetric.com/v1/donut/3341285_240.png 3,Mendelian inheritance of familial prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.89.8.3367,,,,1565627,,,1992PNAS...89.3367C,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/3341042,https://api.altmetric.com/v1/donut/3341042_240.png 3,Two New Cases of Polysomy 13 in Canine Prostate Cancer,Cytogenetic & Genome Research,,,Article,2010-07-29,10.1159/000317077,,,,20668368,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3339348,https://api.altmetric.com/v1/donut/3339348_240.png 3,Alcohol consumption and risk of prostate cancer: The Harvard Alumni Health Study.,International Journal of Epidemiology,,,Article,,10.1093/ije/30.4.749,,,,11511598,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3338568,https://api.altmetric.com/v1/donut/3338568_240.png 3,Alcohol consumption and risk of prostate cancer in middle-aged men.,International Journal of Cancer,,,Article,2004-08-25,10.1002/ijc.20528,,,,15386436,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3338557,https://api.altmetric.com/v1/donut/3338557_240.png 3,Alcohol use and prostate cancer: a meta-analysis.,Molecular Nutrition & Food Research,,,Article,2009-01-20,10.1002/mnfr.200800122,,,,19156715,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3338508,https://api.altmetric.com/v1/donut/3338508_240.png 3,"HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells.",International Journal of Molecular Medicine,,,Article,2001-04-01,,,,,11254878,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3338168,https://api.altmetric.com/v1/donut/3338168_240.png 3,"HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells",International Journal of Molecular Medicine,,,Article,2001-04-01,10.3892/ijmm.7.4.385,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3338166,https://api.altmetric.com/v1/donut/3338166_240.png 3,Determination of tag density required for digital transcriptome analysis: Application to an androgen-sensitive prostate cancer model,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.0807121105,,,,19088194,,,2008PNAS..10520179L,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,191,https://www.altmetric.com/details/3333620,https://api.altmetric.com/v1/donut/3333620_240.png 3,LNCaP model of human prostatic carcinoma.,Cancer Research,,,Article,1983-04-01,,,,,6831420,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1162,https://www.altmetric.com/details/3333618,https://api.altmetric.com/v1/donut/3333618_240.png 3,Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m400970200,,,,14966121,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3333214,https://api.altmetric.com/v1/donut/3333214_240.png 3,TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.,Cancer Research,,,Article,,10.1158/0008-5472.can-07-6059,,,,18451177,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3333204,https://api.altmetric.com/v1/donut/3333204_240.png 3,A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m108312200,,,,11673464,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3333201,https://api.altmetric.com/v1/donut/3333201_240.png 3,Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.,Molecular Endocrinology,,,Article,,10.1210/me.2003-0436,,,,15256534,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3333193,https://api.altmetric.com/v1/donut/3333193_240.png 3,TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.,The Prostate,,,Article,2003-08-25,10.1002/pros.10282,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3333191,https://api.altmetric.com/v1/donut/3333191_240.png 3,Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.,Journal of Biological Chemistry,,,Article,1997-07-11,,,,,9211894,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3333185,https://api.altmetric.com/v1/donut/3333185_240.png 3,Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP,Journal of Biological Chemistry,,,Article,,10.1074/jbc.272.28.17485,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3333184,https://api.altmetric.com/v1/donut/3333184_240.png 3,AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR,Molecular & Cellular Biology,,,Article,,10.1128/mcb.23.1.104-118.2003,,,,12482965,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3333181,https://api.altmetric.com/v1/donut/3333181_240.png 3,The role of the cell adhesion molecules (integrins/cadherins) in prostate cancer.,International Brazilian Journal of Urology,,,Article,2010-12-05,,,,,21756376,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3333016,https://api.altmetric.com/v1/donut/3333016_240.png 3,Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.,Cancer Research,,,Article,1994-05-15,,,,,8168083,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3329887,https://api.altmetric.com/v1/donut/3329887_240.png 3,The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.0810956106,,,,19116269,,,2009PNAS..106..268D,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/3329396,https://api.altmetric.com/v1/donut/3329396_240.png 3,From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.96.10.5458,,,,10318905,,,1999PNAS...96.5458Y,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3328966,https://api.altmetric.com/v1/donut/3328966_240.png 3,The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth,Cancer Research,,,Article,2009-04-14,10.1158/0008-5472.can-08-3821,,,,19351840,PMC2669850,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3328890,https://api.altmetric.com/v1/donut/3328890_240.png 3,Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.,Molecular Endocrinology,,,Article,2004-10-14,10.1210/me.2004-0117,,,,15205473,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3328828,https://api.altmetric.com/v1/donut/3328828_240.png 3,T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin.,Cancer Research,,,Article,2001-11-15,,,,,11719440,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3327818,https://api.altmetric.com/v1/donut/3327818_240.png 3,"Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer.",European Urology,,,Article,2009-11-27,10.1016/j.eururo.2009.11.008,,,,19931979,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/3327114,https://api.altmetric.com/v1/donut/3327114_240.png 3,Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.,International Journal of Cancer,,,Article,1994-05-01,,,,,8169003,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3326604,https://api.altmetric.com/v1/donut/3326604_240.png 3,Derivation of androgen?independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells,International Journal of Cancer,,,Article,2006-07-18,10.1002/ijc.2910570319,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3326602,https://api.altmetric.com/v1/donut/3326602_240.png 3,Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.,The Prostate,,,Article,2001-05-01,10.1002/pros.1065,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3326600,https://api.altmetric.com/v1/donut/3326600_240.png 3,Human Checkpoint Protein hRad9 Functions as a Negative Coregulator To Repress Androgen Receptor Transactivation in Prostate Cancer Cells,Molecular & Cellular Biology,,,Article,,10.1128/mcb.24.5.2202-2213.2004,,,,14966297,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3326148,https://api.altmetric.com/v1/donut/3326148_240.png 3,Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.,Oncogene,,,Article,2006-01-30,10.1038/sj.onc.1209327,,,,16449977,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,163,https://www.altmetric.com/details/3325793,https://api.altmetric.com/v1/donut/3325793_240.png 3,ALDH1A1 Is a Marker for Malignant Prostate Stem Cells and Predictor of Prostate Cancer Patients’ Outcome,Laboratory Investigation,,,Article,2009-12-14,10.1038/labinvest.2009.127,,,,20010854,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/3325263,https://api.altmetric.com/v1/donut/3325263_240.png 3,Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.,Endocrine-Related Cancer,,,Article,,10.1677/erc.1.00799,,,,15613453,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3324967,https://api.altmetric.com/v1/donut/3324967_240.png 3,"Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells",Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.95.13.7379,,,,9636157,,,1998PNAS...95.7379M,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3323904,https://api.altmetric.com/v1/donut/3323904_240.png 3,"Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer",British Journal of Cancer,,,Article,2001-12-11,10.1054/bjoc.2001.2179,,,,11747336,PMC2364015,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3323885,https://api.altmetric.com/v1/donut/3323885_240.png 3,Diffusion tensor magnetic resonance imaging of prostate cancer.,Investigative Radiology,,,Article,2007-05-18,10.1097/01.rli.0000264059.46444.bf,,,,17507813,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3322895,https://api.altmetric.com/v1/donut/3322895_240.png 3,Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m203313200,,,,12163482,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3322586,https://api.altmetric.com/v1/donut/3322586_240.png 3,"Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.",Biochemical & Biophysical Research Communications,,,Article,1998-07-20,10.1006/bbrc.1998.8974,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3322571,https://api.altmetric.com/v1/donut/3322571_240.png 3,Robotic Assisted Laparoscopic Prostatectomy Versus Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer: Comparison of Short-Term Biochemical Recurrence-Free Survival,The Journal of Urology,,,Article,,10.1016/j.juro.2009.11.017,,,,20083261,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3321749,https://api.altmetric.com/v1/donut/3321749_240.png 3,Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database.,Surgery,,,Article,2002-08-01,10.1067/msy.2002.125315,,,,12219014,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3321745,https://api.altmetric.com/v1/donut/3321745_240.png 3,Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.,The Prostate,,,Article,1999-06-01,,,,,10344214,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3320705,https://api.altmetric.com/v1/donut/3320705_240.png 3,Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.,Cancer Chemotherapy & Pharmacology,,,Article,2007-02-10,10.1007/s00280-007-0429-4,,,,17294190,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3318079,https://api.altmetric.com/v1/donut/3318079_240.png 3,Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population,Indian Journal of Human Genetics,,,Article,,10.4103/0971-6866.96648,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3317742,https://api.altmetric.com/v1/donut/3317742_240.png 3,EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).,International Journal of Cancer,,,Article,2004-06-02,10.1002/ijc.20362,,,,15305378,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3314733,https://api.altmetric.com/v1/donut/3314733_240.png 3,The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells.,Steroids,,,Article,2004-08-03,10.1016/j.steroids.2004.05.011,,,,15288768,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3314714,https://api.altmetric.com/v1/donut/3314714_240.png 3,Androgen receptor and prostate cancer invasion.,International Journal of Andrology,,,Article,2003-02-01,,,,,12534934,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3314700,https://api.altmetric.com/v1/donut/3314700_240.png 3,Androgen receptor and prostate cancer invasion1,International Journal of Andrology,,,Article,2003-01-10,10.1046/j.1365-2605.2003.00375.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3314696,https://api.altmetric.com/v1/donut/3314696_240.png 3,Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer.,Cancer Control: Journal of the Moffitt Cancer Center,,,Article,2013-01-12,,,,,23302902,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3311480,https://api.altmetric.com/v1/donut/3311480_240.png 3,5?-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.,The Prostate,,,Article,2010-12-28,10.1002/pros.21318,,,,21557268,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3310772,https://api.altmetric.com/v1/donut/3310772_240.png 3,HIV?1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling,Cancer Science,,,Article,2005-01-07,10.1111/j.1349-7006.2005.00063.x,,,,16053514,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3307814,https://api.altmetric.com/v1/donut/3307814_240.png 3,A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients,Investigational New Drugs,,,Article,2006-11-01,10.1007/s10637-006-9019-2,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3307611,https://api.altmetric.com/v1/donut/3307611_240.png 3,Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.,The Journal of Urology,,,Article,,10.1097/01.ju.0000136430.37245.b9,,,,15310997,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3306030,https://api.altmetric.com/v1/donut/3306030_240.png 3,Establishment and characterization of a new human prostatic cancer cell line: DuCaP.,IN VIVO: International Journal of Experimental and Clinical Pathophysiology and Drug Research,,,Article,,,,,,11317521,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3304827,https://api.altmetric.com/v1/donut/3304827_240.png 3,"CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.",Cancer Research,,,Article,,,,,,11454691,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3300893,https://api.altmetric.com/v1/donut/3300893_240.png 3,Prostate Attenuated Replication Competent Adenovirus (ARCA) CN706: A Selective Cytotoxic for Prostate-specific Antigen-positive Prostate Cancer Cells,Cancer Research,,,Article,,,,,,9205053,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3300869,https://api.altmetric.com/v1/donut/3300869_240.png 3,Inverse-electron-demand Diels-Alder reaction as a highly efficient chemoselective ligation procedure: synthesis and function of a BioShuttle for temozolomide transport into prostate cancer cells.,Journal of Peptide Science,,,Article,2009-01-28,10.1002/psc.1108,,,,19177421,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3300069,https://api.altmetric.com/v1/donut/3300069_240.png 3,Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC).,Biomedicine & Pharmacotherapy,,,Article,2004-01-10,10.1016/j.biopha.2004.08.006,,,,15464874,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3299840,https://api.altmetric.com/v1/donut/3299840_240.png 3,Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells.,The Prostate,,,Article,2002-12-19,10.1002/pros.10172,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3299696,https://api.altmetric.com/v1/donut/3299696_240.png 3,Progress in emerging therapies for advanced prostate cancer.,Cancer Treatment Reviews,,,Article,,10.1016/j.ctrv.2012.09.005,,,,23107383,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/3299505,https://api.altmetric.com/v1/donut/3299505_240.png 3,Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer.,Human vaccines immunotherapeutics,,,Article,2012-07-27,10.4161/hv.19795,,,,22832254,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3299477,https://api.altmetric.com/v1/donut/3299477_240.png 3,Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer.,Journal of Psychosomatic Research,,,Article,,10.1016/j.jpsychores.2010.04.019,,,,21109047,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3297118,https://api.altmetric.com/v1/donut/3297118_240.png 3,Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model.,FASEB Journal,,,Article,,10.1096/fj.03-1116fje,,,,15084515,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3296294,https://api.altmetric.com/v1/donut/3296294_240.png 3,Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer.,Drugs,,,Article,2006-05-19,,,,,16706554,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3296203,https://api.altmetric.com/v1/donut/3296203_240.png 3,"Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group.",Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/29.11.562,,,,10678560,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3296186,https://api.altmetric.com/v1/donut/3296186_240.png 3,Studies on Prostatic Cancer,The Journal of Urology,,,Article,2002-07-01,10.1097/00005392-200207000-00004,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3296111,https://api.altmetric.com/v1/donut/3296111_240.png 3,Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.,Endocrine-Related Cancer,,,Article,,10.1677/erc.0.0110117,,,,15027889,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3292730,https://api.altmetric.com/v1/donut/3292730_240.png 3,Aromatase and prostate cancer.,Minerva Endocrinologica,,,Article,2006-02-25,,,,,16498360,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3287325,https://api.altmetric.com/v1/donut/3287325_240.png 3,Polymorphisms in mitochondrial genes and prostate cancer risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-08-0434,,,,19064571,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3286794,https://api.altmetric.com/v1/donut/3286794_240.png 3,Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.,Journal of Clinical Oncology,,,Article,2006-08-20,10.1200/jco.2005.04.0756,,,,16921049,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,72,https://www.altmetric.com/details/3286647,https://api.altmetric.com/v1/donut/3286647_240.png 3,The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study.,The Prostate,,,Article,2006-08-22,10.1002/pros.20499,,,,16927304,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3283341,https://api.altmetric.com/v1/donut/3283341_240.png 3,"Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer.",Cancer Science,,,Article,2007-11-06,10.1111/j.1349-7006.2007.00656.x,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3283339,https://api.altmetric.com/v1/donut/3283339_240.png 3,Chemoprevention of prostate cancer.,New England Journal of Medicine,,,Article,2010-04-01,10.1056/nejme1001045,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3283296,https://api.altmetric.com/v1/donut/3283296_240.png 3,A review of prostate motion with considerations for the treatment of prostate cancer,Medical Dosimetry,,,Article,,10.1016/j.meddos.2005.03.005,,,,16112467,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3280777,https://api.altmetric.com/v1/donut/3280777_240.png 3,SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.,Cancer Research,,,Article,2009-03-20,10.1158/0008-5472.can-08-4926,,,,19293179,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/3280114,https://api.altmetric.com/v1/donut/3280114_240.png 3,Cimetidine use and risk of prostate and breast cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,,,,,10750671,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3275915,https://api.altmetric.com/v1/donut/3275915_240.png 3,P450-dependent enzymes as targets for prostate cancer therapy.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,1996-01-01,,,,,8603034,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3268983,https://api.altmetric.com/v1/donut/3268983_240.png 3,P450-dependent enzymes as targets for prostate cancer therapy,Journal of Steroid Biochemistry & Molecular Biology,,,Article,1996-01-01,10.1016/0960-0760(95)00230-8,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3268981,https://api.altmetric.com/v1/donut/3268981_240.png 3,Trends and patterns of prostate cancer: what do they suggest?,Epidemiologic Reviews,,,Article,,,,,,11588851,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3268278,https://api.altmetric.com/v1/donut/3268278_240.png 3,Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven.,Cancer Research,,,Article,,10.1158/0008-5472.can-08-4531,,,,19509232,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3265779,https://api.altmetric.com/v1/donut/3265779_240.png 3,Angiotensin Receptor Blockers and Risk of Prostate Cancer among United States Veterans,Journal of Clinical Pharmacology,,,Article,2013-05-17,10.1002/jcph.98,,,,23686462,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3265106,https://api.altmetric.com/v1/donut/3265106_240.png 3,Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,,10.1073/pnas.190353897,,,,11016951,,,2000PNAS...9711256Y,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3263815,https://api.altmetric.com/v1/donut/3263815_240.png 3,The miR-15a|[ndash]|miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities,Nature Medicine,,,Article,2008-10-19,10.1038/nm.1880,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,173,https://www.altmetric.com/details/3261933,https://api.altmetric.com/v1/donut/3261933_240.png 3,"Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study.",Journal of Clinical Oncology,,,Article,2005-10-19,10.1200/jco.2005.05.025,,,,16002836,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3256316,https://api.altmetric.com/v1/donut/3256316_240.png 3,Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2005-03-24,10.1016/j.bbrc.2005.02.116,,,,15781230,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/3250049,https://api.altmetric.com/v1/donut/3250049_240.png 3,Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.,International Journal of Biochemistry & Cell Biology,,,Article,2012-09-12,10.1016/j.biocel.2012.08.013,,,,22964025,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/3242681,https://api.altmetric.com/v1/donut/3242681_240.png 3,Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480.,Cancer (0008543X),,,Article,2004-10-13,10.1002/cncr.20655,,,,15484217,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3233040,https://api.altmetric.com/v1/donut/3233040_240.png 3,TRANSDERMAL ESTRADIOL THERAPY FOR PROSTATE CANCER REDUCES THROMBOPHILIC ACTIVATION AND PROTECTS AGAINST THROMBOEMBOLISM,The Journal of Urology,,,Article,,10.1097/01.ju.0000165567.99142.1f,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3219791,https://api.altmetric.com/v1/donut/3219791_240.png 3,Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group.,Urology,,,Article,1989-05-01,,,,,2652864,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3219112,https://api.altmetric.com/v1/donut/3219112_240.png 3,Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer,Urology,,,Article,,10.1016/0090-4295(89)90037-x,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3219110,https://api.altmetric.com/v1/donut/3219110_240.png 3,A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States).,Cancer Causes and Control,,,Article,,10.1007/s10552-006-0014-x,,,,16783606,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3218706,https://api.altmetric.com/v1/donut/3218706_240.png 3,3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores,Canadian Urological Association Journal,,,Article,2010-10-14,,,,,20944788,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3218194,https://api.altmetric.com/v1/donut/3218194_240.png 3,Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.,Cancer (0008543X),,,Article,2003-04-01,10.1002/cncr.11262,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3218158,https://api.altmetric.com/v1/donut/3218158_240.png 3,"Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer",Journal of Clinical Oncology,,,Article,2009-07-31,10.1200/jco.2008.18.8938,,,,19528373,PMC2720077,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3218156,https://api.altmetric.com/v1/donut/3218156_240.png 3,Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.,Cancer (0008543X),,,Article,2000-01-15,,,,,10640974,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/3218153,https://api.altmetric.com/v1/donut/3218153_240.png 3,Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.,Journal of Clinical Oncology,,,Article,,10.1200/jco.2002.01.150,,,,12177097,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3218150,https://api.altmetric.com/v1/donut/3218150_240.png 3,Prostate cancer therapy with high-intensity focused ultrasound.,Clinical Genitourinary Cancer,,,Article,,10.3816/cgc.2005.n.031,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3218147,https://api.altmetric.com/v1/donut/3218147_240.png 3,Resveratrol: a candidate nutritional substance for prostate cancer prevention.,Journal of Nutrition,,,Article,,,,,,12840221,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3217711,https://api.altmetric.com/v1/donut/3217711_240.png 3,Leuprolide versus diethylstilbestrol for metastatic prostate cancer. The Leuprolide Study Group.,New England Journal of Medicine,,,Article,1984-11-15,10.1056/nejm198411153112004,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3215659,https://api.altmetric.com/v1/donut/3215659_240.png 3,Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer.,BMC Cancer,,,Article,,10.1186/1471-2407-11-233,,,,21663671,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3211563,https://api.altmetric.com/v1/donut/3211563_240.png 3,Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer.,Urology,,,Article,1999-09-01,,,,,10475347,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3211449,https://api.altmetric.com/v1/donut/3211449_240.png 3,Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer,Urology,,,Article,,10.1016/s0090-4295(99)00203-4,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3211446,https://api.altmetric.com/v1/donut/3211446_240.png 3,"Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.",DNA & Cell Biology,,,Article,2006-03-29,10.1089/dna.2006.25.135,,,,16569192,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3209930,https://api.altmetric.com/v1/donut/3209930_240.png 3,"NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.",Investigational New Drugs,,,Article,2009-09-23,10.1007/s10637-009-9304-y,,,,19771394,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3209184,https://api.altmetric.com/v1/donut/3209184_240.png 3,Association between Statin Usage and Prostate Cancer Prevention: A Refined Meta-Analysis Based on Literature from the Years 2005-2010.,Urologia Internationalis,,,Article,2012-10-09,10.1159/000341977,,,,23052323,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3209095,https://api.altmetric.com/v1/donut/3209095_240.png 3,Association of Statin Use With Pathological Tumor Characteristics and Prostate Cancer Recurrence After Surgery,The Journal of Urology,,,Article,2011-04-14,10.1016/j.juro.2010.11.089,,,,21334020,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3209087,https://api.altmetric.com/v1/donut/3209087_240.png 3,"Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer.",Urology,,,Article,2003-02-01,,,,,12597955,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3206378,https://api.altmetric.com/v1/donut/3206378_240.png 3,"Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer",Urology,,,Article,,10.1016/s0090-4295(02)02166-0,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3206376,https://api.altmetric.com/v1/donut/3206376_240.png 3,GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.,Journal of Cellular Biochemistry,,,Article,2003-12-15,10.1002/jcb.10740,,,,14755684,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/3205463,https://api.altmetric.com/v1/donut/3205463_240.png 3,"Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.",The Journal of Urology,,,Article,2006-09-14,10.1016/j.juro.2006.04.075,,,,16890703,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3205393,https://api.altmetric.com/v1/donut/3205393_240.png 3,Drug resistance in metastatic castration-resistant prostate cancer,Nature Reviews Clinical Oncology,,,Article,2011-01-01,10.1038/nrclinonc.2010.136,,,,20859283,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3205392,https://api.altmetric.com/v1/donut/3205392_240.png 3,Outcomes of Localized Prostate Cancer Following Conservative Management,JAMA: Journal of the American Medical Association,,,Article,2009-09-15,10.1001/jama.2009.1348,,,,19755699,PMC2822438,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3205390,https://api.altmetric.com/v1/donut/3205390_240.png 3,Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djp122,,,,19509351,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/3205389,https://api.altmetric.com/v1/donut/3205389_240.png 3,Meta-Analysis of Measures of Sexual Activity and Prostate Cancer,Epidemiology,,,Article,2002-01-01,10.1097/00001648-200201000-00012,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3205387,https://api.altmetric.com/v1/donut/3205387_240.png 3,Management of localized prostate cancer in senior adults: the crucial role of comorbidity.,British Journal of Urology,,,Article,2008-02-28,10.1111/j.1464-410x.2007.07487.x,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3205385,https://api.altmetric.com/v1/donut/3205385_240.png 3,Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate.,JAMA: Journal of the American Medical Association,,,Article,1996-12-25,,,,,8971068,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3205382,https://api.altmetric.com/v1/donut/3205382_240.png 3,Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate,JAMA: Journal of the American Medical Association,,,Article,1996-12-25,10.1001/jama.276.24.1976,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3205381,https://api.altmetric.com/v1/donut/3205381_240.png 3,[Characteristics of prostate cancer in men less than 50-year-old].,Progrès en Urologie,,,Article,2009-01-12,10.1016/j.purol.2009.04.010,,,,19945663,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3205378,https://api.altmetric.com/v1/donut/3205378_240.png 3,BCL-2 in prostate cancer: a minireview.,Apoptosis,,,Article,2003-01-01,,,,,12510149,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3205376,https://api.altmetric.com/v1/donut/3205376_240.png 3,Positron emission tomography imaging of prostate cancer,Amino Acids,,,Article,2009-11-28,10.1007/s00726-009-0394-9,,,,19946787,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3205375,https://api.altmetric.com/v1/donut/3205375_240.png 3,Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK–RhoA signaling pathway,Oncogene,,,Article,2009-11-30,10.1038/onc.2009.420,,,,19946339,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3205374,https://api.altmetric.com/v1/donut/3205374_240.png 3,BCL-2 in prostate cancer: A minireview,Apoptosis,,,Article,,10.1023/a:1021692801278,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3205373,https://api.altmetric.com/v1/donut/3205373_240.png 3,Prostate cancer: 3. Individual risk factors,Canadian Medical Association. Journal,,,Article,1998-10-06,,,,,9805030,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3205372,https://api.altmetric.com/v1/donut/3205372_240.png 3,[Fusion genes and prostate cancer. From discovery to prognosis and therapeutic perspectives].,Progrès en Urologie,,,Article,2009-01-12,10.1016/j.purol.2009.06.002,,,,19945666,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3205370,https://api.altmetric.com/v1/donut/3205370_240.png 3,A history of prostate cancer treatment.,Nature Reviews Cancer,,,Article,2002-05-01,10.1038/nrc801,,,,,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/3205369,https://api.altmetric.com/v1/donut/3205369_240.png 3,Blood pressure and risk of prostate cancer: Cohort Norway (CONOR).,Cancer Causes and Control,,,Article,2009-12-01,10.1007/s10552-009-9477-x,,,,19949849,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3205368,https://api.altmetric.com/v1/donut/3205368_240.png 3,Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.,Cancer Research,,,Article,,,,,,7511045,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3205366,https://api.altmetric.com/v1/donut/3205366_240.png 3,The role of increasing detection in the rising incidence of prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,1995-02-15,,,,,7530782,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3205350,https://api.altmetric.com/v1/donut/3205350_240.png 3,The role of increasing detection in the rising incidence of prostate cancer,JAMA: Journal of the American Medical Association,,,Article,1995-02-15,10.1001/jama.273.7.548,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3205349,https://api.altmetric.com/v1/donut/3205349_240.png 3,The specific role of isoflavones in reducing prostate cancer risk.,The Prostate,,,Article,2003-12-11,10.1002/pros.10362,,,,15042614,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3205348,https://api.altmetric.com/v1/donut/3205348_240.png 3,"Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.",JNCI: Journal of the National Cancer Institute,,,Article,1999-06-16,10.1093/jnci/91.12.1017,,,,10379964,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3205345,https://api.altmetric.com/v1/donut/3205345_240.png 3,"Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.",The Journal of Urology,,,Article,,10.1097/01.ju.0000162061.40533.0f,,,,15947595,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3205342,https://api.altmetric.com/v1/donut/3205342_240.png 3,"Prostate carcinoma presentation, diagnosis, and staging",Cancer (0008543X),,,Article,2003-09-15,10.1002/cncr.11635,,,,12973840,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3205341,https://api.altmetric.com/v1/donut/3205341_240.png 3,Family history and the risk of prostate cancer.,The Prostate,,,Article,1990-01-01,,,,,2251225,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3205340,https://api.altmetric.com/v1/donut/3205340_240.png 3,Epidemiologic association between prostatitis and prostate cancer.,Urology,,,Article,2002-07-01,,,,,12100928,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/3205339,https://api.altmetric.com/v1/donut/3205339_240.png 3,Family history and the risk of prostate cancer,The Prostate,,,Article,2006-07-20,10.1002/pros.2990170409,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3205336,https://api.altmetric.com/v1/donut/3205336_240.png 3,Epidemiologic association between prostatitis and prostate cancer,Urology,,,Article,,10.1016/s0090-4295(02)01637-0,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3205335,https://api.altmetric.com/v1/donut/3205335_240.png 3,A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dji173,,,,15998950,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3205334,https://api.altmetric.com/v1/donut/3205334_240.png 3,Results of radical prostatectomy in men with clinically localized prostate cancer,JAMA: Journal of the American Medical Association,,,Article,1996-08-28,10.1001/jama.276.8.615,,,,8773633,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3205333,https://api.altmetric.com/v1/donut/3205333_240.png 3,Short-term effects of population-based screening for prostate cancer on health-related quality of life.,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/90.12.925,,,,9637143,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3205326,https://api.altmetric.com/v1/donut/3205326_240.png 3,"American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.",Journal of Clinical Oncology,,,Article,2004-07-14,10.1200/jco.2004.04.579,,,,15184404,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3205324,https://api.altmetric.com/v1/donut/3205324_240.png 3,Watchful waiting and factors predictive of secondary treatment of localized prostate cancer.,The Journal of Urology,,,Article,2004-03-15,10.1097/01.ju.0000113300.74132.8b,,,,14767282,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3205323,https://api.altmetric.com/v1/donut/3205323_240.png 3,"Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.",Cancer (0008543X),,,Article,1993-12-01,,,,,7694785,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3205322,https://api.altmetric.com/v1/donut/3205322_240.png 3,[Descriptive epidemiology of prostate cancer in Japan and Western countries].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2005-02-19,,,,,15714967,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3205313,https://api.altmetric.com/v1/donut/3205313_240.png 3,"Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer.",Prostate Cancer & Prostatic Diseases,,,Article,2005-07-05,10.1038/sj.pcan.4500817,,,,15999119,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3201717,https://api.altmetric.com/v1/donut/3201717_240.png 3,Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis.,Cancer Causes and Control,,,Article,2009-11-18,10.1007/s10552-009-9465-1,,,,19921446,,,,,,,0,0,0,1,0,0,0,0,3,0,0,0,0,0,0,10,https://www.altmetric.com/details/3199859,https://api.altmetric.com/v1/donut/3199859_240.png 3,Serum selenium and risk of prostate cancer—a nested case-control study,American Journal of Clinical Nutrition,,,Article,2015-06-05,,,,,17209198,PMC1839923,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3199487,https://api.altmetric.com/v1/donut/3199487_240.png 3,Effects of False-Positive Prostate Cancer Screening Results on Subsequent Prostate Cancer Screening Behavior,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2005-01-01,,,,,15668495,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3197688,https://api.altmetric.com/v1/donut/3197688_240.png 3,Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.,Cancer (0008543X),,,Article,1999-09-15,,,,,10491529,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3197654,https://api.altmetric.com/v1/donut/3197654_240.png 3,Estradiol Inhibits Growth of Hormone-nonresponsive PC3 Human Prostate Cancer Cells,Cancer Research,,,Article,2015-06-05,,,,,8118804,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3192158,https://api.altmetric.com/v1/donut/3192158_240.png 3,Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism.,The Journal of Urology,,,Article,2005-01-08,,,,,16006886,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3192157,https://api.altmetric.com/v1/donut/3192157_240.png 3,Antiandrogen treatments in locally advanced prostate cancer: are they all the same?,Journal of Cancer Research & Clinical Oncology,,,Article,2006-07-15,10.1007/s00432-006-0133-5,,,,16845534,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3191918,https://api.altmetric.com/v1/donut/3191918_240.png 3,Phyto-oestrogens and risk of prostate cancer in Scottish men,British Journal of Nutrition,,,Article,2007-04-03,10.1017/s0007114507700703,,,,17403269,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3187421,https://api.altmetric.com/v1/donut/3187421_240.png 3,Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer.,Urology,,,Article,2001-08-01,,,,,11502439,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3185197,https://api.altmetric.com/v1/donut/3185197_240.png 3,Targeting Continued Androgen Receptor Signaling in Prostate Cancer,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-10-2815,,,,21680543,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3185188,https://api.altmetric.com/v1/donut/3185188_240.png 3,Dietary fat intake and prostate cancer risk: a case-control study in Spain.,Cancer Causes and Control,,,Article,2000-09-01,,,,,11065004,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3181003,https://api.altmetric.com/v1/donut/3181003_240.png 3,Dietary fat intake and prostate cancer risk: a case–control study in Spain,Cancer Causes and Control,,,Article,,10.1023/a:1008924116552,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3181000,https://api.altmetric.com/v1/donut/3181000_240.png 3,"Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.",American Journal of Epidemiology,,,Article,,10.1093/aje/kwm389,,,,18263602,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/3177690,https://api.altmetric.com/v1/donut/3177690_240.png 3,"3,3?-Diindolylmethane Induces a G1 Arrest in Human Prostate Cancer Cells Irrespective of Androgen Receptor and p53 Status",Biochemical Pharmacology,,,Article,,10.1016/j.bcp.2009.05.008,,,,19433067,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3177669,https://api.altmetric.com/v1/donut/3177669_240.png 3,Prostate cancer screening: clinical applications and challenges.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2004.04.014,,,,15283896,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3177485,https://api.altmetric.com/v1/donut/3177485_240.png 3,Five-alpha-reductase Inhibitors for prostate cancer prevention,Cochrane database of systematic reviews,,,Article,2008-04-23,10.1002/14651858.cd007091,,,,,,,,,,,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3177417,https://api.altmetric.com/v1/donut/3177417_240.png 3,Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay.,Prostate Cancer & Prostatic Diseases,,,Article,2010-01-19,10.1038/pcan.2009.64,,,,20084081,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3174749,https://api.altmetric.com/v1/donut/3174749_240.png 3,Autoantibodies to prostasomes as new markers for prostate cancer.,Upsala Journal of Medical Sciences,,,Article,2001-01-01,,,,,11817562,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3174299,https://api.altmetric.com/v1/donut/3174299_240.png 3,The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.,The Journal of Urology,,,Article,2012-01-15,10.1016/j.juro.2011.09.042,,,,22088337,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3174280,https://api.altmetric.com/v1/donut/3174280_240.png 3,Prostate cancer: palliative care and pain relief.,British Medical Bulletin,,,Article,,10.1093/bmb/ldm018,,,,17628024,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3174279,https://api.altmetric.com/v1/donut/3174279_240.png 3,Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,1998-10-27,,,,,9789062,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/3174276,https://api.altmetric.com/v1/donut/3174276_240.png 3,The novel prostate cancer antigen 3 (PCA3) biomarker.,International Brazilian Journal of Urology,,,Article,2009-12-11,,,,,21176272,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3174268,https://api.altmetric.com/v1/donut/3174268_240.png 3,The novel prostate cancer antigen 3 (PCA3) biomarker,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-55382010000600003,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3174267,https://api.altmetric.com/v1/donut/3174267_240.png 3,Advanced prostate cancer-a case for adjuvant differentiation therapy.,Nature Reviews Urology,,,Article,2012-08-14,10.1038/nrurol.2012.157,,,,22890299,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3174256,https://api.altmetric.com/v1/donut/3174256_240.png 3,[Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology].,Progrès en Urologie,,,Article,2009-01-12,10.1016/j.purol.2009.02.008,,,,19945664,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3174232,https://api.altmetric.com/v1/donut/3174232_240.png 3,Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer,Cell Cycle,,,Article,,,,,,19946220,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3174212,https://api.altmetric.com/v1/donut/3174212_240.png 3,Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer,Cell Cycle,,,Article,2014-10-28,10.4161/cc.8.24.10316,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3174210,https://api.altmetric.com/v1/donut/3174210_240.png 3,Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate Cancer,American Journal of Pathology,,,Article,2010-01-15,10.2353/ajpath.2010.090521,,,,19948822,PMC2797899,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3174200,https://api.altmetric.com/v1/donut/3174200_240.png 3,Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy.,Journal of Cancer Research & Clinical Oncology,,,Article,2009-11-28,10.1007/s00432-009-0718-x,,,,19946707,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3174193,https://api.altmetric.com/v1/donut/3174193_240.png 3,[TGF-beta/Smad in prostate cancer: an update].,Zhonghua nan ke xue National journal of andrology,,,Article,2009-12-03,,,,,19947572,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3174192,https://api.altmetric.com/v1/donut/3174192_240.png 3,Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.,Cancer Research,,,Article,,,,,,11325816,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3174189,https://api.altmetric.com/v1/donut/3174189_240.png 3,Androgen receptor gene amplification and protein expression in recurrent prostate cancer.,The Journal of Urology,,,Article,,10.1097/01.ju.0000091873.09677.f4,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3174184,https://api.altmetric.com/v1/donut/3174184_240.png 3,Prostate cancer: a brief history and the discovery of hormonal ablation treatment.,The Journal of Urology,,,Article,2001-06-01,,,,,11371867,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3174166,https://api.altmetric.com/v1/donut/3174166_240.png 3,PROSTATE CANCER: A BRIEF HISTORY AND THE DISCOVERY OF HORMONAL ABLATION TREATMENT,The Journal of Urology,,,Article,,10.1016/s0022-5347(05)66228-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3174163,https://api.altmetric.com/v1/donut/3174163_240.png 3,The current state of hormonal therapy for prostate cancer.,CA Magazine (Scotland),,,Article,,,,,,12018929,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3174162,https://api.altmetric.com/v1/donut/3174162_240.png 3,The Current State of Hormonal Therapy for Prostate Cancer,CA Magazine (Scotland),,,Article,2008-12-31,10.3322/canjclin.52.3.154,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3174159,https://api.altmetric.com/v1/donut/3174159_240.png 3,The development of androgen-independent prostate cancer.,Nature Reviews Cancer,,,Article,2001-10-01,10.1038/35094009,,,,,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,139,https://www.altmetric.com/details/3174146,https://api.altmetric.com/v1/donut/3174146_240.png 3,Fatty Acids and Risk of Prostate Cancer in a Nested Case-Control Study in Male Smokers,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-01-12,,,,,14693732,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3174145,https://api.altmetric.com/v1/donut/3174145_240.png 3,Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.,Annals of Internal Medicine,,,Article,2002-12-03,,,,,12458993,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3174114,https://api.altmetric.com/v1/donut/3174114_240.png 3,Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force,Annals of Internal Medicine,,,Article,2002-12-03,10.7326/0003-4819-137-11-200212030-00014,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3174111,https://api.altmetric.com/v1/donut/3174111_240.png 3,Screening for prostate cancer: recommendation and rationale.,Annals of Internal Medicine,,,Article,2002-12-03,,,,,12458992,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3174108,https://api.altmetric.com/v1/donut/3174108_240.png 3,Screening for Prostate Cancer: Recommendation and Rationale,Annals of Internal Medicine,,,Article,2002-12-03,10.7326/0003-4819-137-11-200212030-00013,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3174106,https://api.altmetric.com/v1/donut/3174106_240.png 3,Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach.,Prostate Cancer & Prostatic Diseases,,,Article,2005-11-29,10.1038/sj.pcan.4500853,,,,16314889,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3174103,https://api.altmetric.com/v1/donut/3174103_240.png 3,Protective effects of green tea against prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2006-04-15,10.1586/14737140.6.4.507,,,,16613539,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3174099,https://api.altmetric.com/v1/donut/3174099_240.png 3,Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/93.5.388,,,,11238701,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3174095,https://api.altmetric.com/v1/donut/3174095_240.png 3,No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study,British Journal of Cancer,,,Article,2006-06-27,10.1038/sj.bjc.6603230,,,,16804523,PMC2360636,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3174088,https://api.altmetric.com/v1/donut/3174088_240.png 3,Assessment of screening for prostate cancer using the digital rectal examination.,The Journal of Urology,,,Article,1989-05-01,,,,,2709500,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3174054,https://api.altmetric.com/v1/donut/3174054_240.png 3,Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer.,Urology,,,Article,2002-08-01,,,,,12206842,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3174050,https://api.altmetric.com/v1/donut/3174050_240.png 3,Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer,Urology,,,Article,,10.1016/s0090-4295(02)01678-3,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3174048,https://api.altmetric.com/v1/donut/3174048_240.png 3,How is androgen-dependent metastatic prostate cancer best treated?,Hematology/oncology clinics of North America,,,Article,1996-06-01,,,,,8773508,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3174044,https://api.altmetric.com/v1/donut/3174044_240.png 3,HOW IS ANDROGEN-DEPENDENT METASTATIC PROSTATE CANCER BEST TREATED?,Hematology/oncology clinics of North America,,,Article,1996-06-01,10.1016/s0889-8588(05)70364-6,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3174041,https://api.altmetric.com/v1/donut/3174041_240.png 3,International trends and patterns of prostate cancer incidence and mortality.,International Journal of Cancer,,,Article,2000-01-01,,,,,10585584,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3174032,https://api.altmetric.com/v1/donut/3174032_240.png 3,Prostate cancer epidemiology,Frontiers in Bioscience,,,Article,2006-01-01,10.2741/1891,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3174027,https://api.altmetric.com/v1/donut/3174027_240.png 3,Predicting clinical end points: treatment nomograms in prostate cancer.,Seminars in oncology,,,Article,2003-10-01,,,,,14571407,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3174025,https://api.altmetric.com/v1/donut/3174025_240.png 3,Predicting clinical end points: treatment nomograms in prostate cancer,Seminars in oncology,,,Article,,10.1016/s0093-7754(03)00351-8,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3174021,https://api.altmetric.com/v1/donut/3174021_240.png 3,Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland.,Journal of Agricultural & Food Chemistry,,,Article,2007-08-28,10.1021/jf071303g,,,,17722872,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/3170613,https://api.altmetric.com/v1/donut/3170613_240.png 3,"Comparisons of Percent Equol Producers between Prostate Cancer Patients and Controls: Case-controlled Studies of Isoflavones in Japanese, Korean and American Residents",Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/hyh015,,,,15067102,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3160923,https://api.altmetric.com/v1/donut/3160923_240.png 3,"Null Association between Prostate Cancer and Serum Folate, Vitamin B6, Vitamin B12, and Homocysteine","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-11-01,,,,,14652294,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3157103,https://api.altmetric.com/v1/donut/3157103_240.png 3,"Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.",JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/92.24.2018,,,,11121464,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3156962,https://api.altmetric.com/v1/donut/3156962_240.png 3,"Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States).",Cancer Causes and Control,,,Article,1993-11-01,,,,,8280834,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3151871,https://api.altmetric.com/v1/donut/3151871_240.png 3,Human prostate cancer risk factors.,Cancer (0008543X),,,Article,2004-10-19,10.1002/cncr.20408,,,,15495199,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,135,https://www.altmetric.com/details/3151816,https://api.altmetric.com/v1/donut/3151816_240.png 3,Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men.,American Journal of Human Biology,,,Article,2010-01-19,10.1002/ajhb.21016,,,,20087895,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3151801,https://api.altmetric.com/v1/donut/3151801_240.png 3,Prostate cancer in men using testosterone supplementation.,The Journal of Urology,,,Article,,10.1097/01.ju.0000165166.36280.60,,,,16006887,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3144385,https://api.altmetric.com/v1/donut/3144385_240.png 3,Androgen replacement in men undergoing treatment for prostate cancer.,Journal of Sexual Medicine,,,Article,2008-07-15,10.1111/j.1743-6109.2008.00925.x,,,,18638000,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3144344,https://api.altmetric.com/v1/donut/3144344_240.png 3,Acupuncture for treating hot flushes in men with prostate cancer: a systematic review.,Supportive Care in Cancer,,,Article,2009-02-18,10.1007/s00520-009-0589-3,,,,19224253,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3142496,https://api.altmetric.com/v1/donut/3142496_240.png 3,Adverse Events Associated with Hormonal Therapy for Prostate Cancer,Reviews in Urology,,,Article,2015-01-29,,,,,16985883,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3131909,https://api.altmetric.com/v1/donut/3131909_240.png 3,Induction of cancer-specific cytotoxicity towards human prostate and skin cells using quercetin and ultrasound,British Journal of Cancer,,,Article,2005-02-01,10.1038/sj.bjc.6602364,,,,15685239,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3130987,https://api.altmetric.com/v1/donut/3130987_240.png 3,Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha.,Biochemical & Biophysical Research Communications,,,Article,2006-09-19,10.1016/j.bbrc.2006.09.002,,,,16979586,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3130298,https://api.altmetric.com/v1/donut/3130298_240.png 3,"Update on the relationship of fish intake with prostate, breast, and colorectal cancers.",Critical Reviews in Food Science and Nutrition,,,Article,2011-09-05,10.1080/10408398.2010.483527,,,,21888535,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3129173,https://api.altmetric.com/v1/donut/3129173_240.png 3,The evolving role of estrogen therapy in prostate cancer.,Clinical Genitourinary Cancer,,,Article,2004-03-29,,,,,15046698,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3128869,https://api.altmetric.com/v1/donut/3128869_240.png 3,The Evolving Role of Estrogen Therapy in Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2002-09-01,10.3816/cgc.2002.n.009,,,,,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3128866,https://api.altmetric.com/v1/donut/3128866_240.png 3,Epigenetic changes in prostate cancer: implication for diagnosis and treatment.,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dji010,,,,15657340,,,,,,,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,109,https://www.altmetric.com/details/3120149,https://api.altmetric.com/v1/donut/3120149_240.png 3,Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (Review),International Journal of Oncology,,,Article,2010-07-21,10.3892/ijo_00000702,,,,,,,,,,,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3120147,https://api.altmetric.com/v1/donut/3120147_240.png 3,The role of anxiety in prostate carcinoma,Cancer (0008543X),,,Article,2005-06-15,10.1002/cncr.21198,,,,15959911,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3079815,https://api.altmetric.com/v1/donut/3079815_240.png 3,Men with Prostate Cancer: Making Decisions about Complementary/Alternative Medicine,Medical Decision Making,,,Article,2003-11-01,10.1177/0272989x03259815,,,,14672107,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3079814,https://api.altmetric.com/v1/donut/3079814_240.png 3,Cabazitaxel Plus Prednisone for Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel: Results from the German Compassionate-use Programme.,European Urology,,,Article,2012-11-04,10.1016/j.eururo.2012.08.058,,,,23116658,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3079813,https://api.altmetric.com/v1/donut/3079813_240.png 3,A systematic overview of radiation therapy effects in prostate cancer,Acta Oncologica,,,Article,2004-01-01,10.1080/02841860410030661,,,,,,,,,,,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3079812,https://api.altmetric.com/v1/donut/3079812_240.png 3,Diagnostic and prognostic molecular biomarkers for prostate cancer,Histopathology,,,Article,2011-12-23,10.1111/j.1365-2559.2011.04083.x,,,,22212082,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3079811,https://api.altmetric.com/v1/donut/3079811_240.png 3,Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era,Journal of Clinical Oncology,,,Article,2009-09-10,10.1200/jco.2008.18.2501,,,,19636023,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,87,https://www.altmetric.com/details/3079808,https://api.altmetric.com/v1/donut/3079808_240.png 3,Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer,Quality of Life Research,,,Article,2009-08-09,10.1007/s11136-009-9516-9,,,,19669670,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3079803,https://api.altmetric.com/v1/donut/3079803_240.png 3,Alpha?methylacyl?CoA racemase: a multi?institutional study of a new prostate cancer marker,Histopathology,,,Article,2004-08-26,10.1111/j.1365-2559.2004.01930.x,,,,15330799,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3079800,https://api.altmetric.com/v1/donut/3079800_240.png 3,International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume,Modern Pathology,,,Article,2010-09-03,10.1038/modpathol.2010.156,,,,20818340,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/3079798,https://api.altmetric.com/v1/donut/3079798_240.png 3,Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial,Clinical Trials,,,Article,2013-08-28,10.1177/1740774513498008,,,,23988464,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3079797,https://api.altmetric.com/v1/donut/3079797_240.png 3,Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer.,European Urology,,,Article,2010-01-05,10.1016/j.eururo.2009.07.027,,,,19664875,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3079796,https://api.altmetric.com/v1/donut/3079796_240.png 3,Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature,International Urology and Nephrology,,,Article,2013-05-11,10.1007/s11255-013-0462-7,,,,23666549,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3079795,https://api.altmetric.com/v1/donut/3079795_240.png 3,"Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China",Medical Oncology,,,Article,2010-01-14,10.1007/s12032-009-9409-3,,,,20077039,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078642,https://api.altmetric.com/v1/donut/3078642_240.png 3,Effects of commercially available soy products on PSA in androgen-deprivation-naïve and castration-resistant prostate cancer.,Southern Medical Journal,,,Article,2011-11-01,10.1097/smj.0b013e3182335151,,,,22024780,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078641,https://api.altmetric.com/v1/donut/3078641_240.png 3,Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study,Cancer Chemotherapy & Pharmacology,,,Article,2012-06-03,10.1007/s00280-012-1896-9,,,,22660737,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078639,https://api.altmetric.com/v1/donut/3078639_240.png 3,C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.,Clinical Nuclear Medicine,,,Article,2011-03-01,10.1097/rlu.0b013e318208f140,,,,21285676,PMC3129631,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078633,https://api.altmetric.com/v1/donut/3078633_240.png 3,Prostate Cancer Imaging,Radiologic Clinics of North America,,,Article,2012-11-07,10.1016/j.rcl.2012.08.004,,,,23122036,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/3078632,https://api.altmetric.com/v1/donut/3078632_240.png 3,Management of localized prostate cancer in men over 65 years.,Current Opinion in Urology,,,Article,2009-05-01,10.1097/mou.0b013e328329a303,,,,19357512,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078631,https://api.altmetric.com/v1/donut/3078631_240.png 3,Expression of the Ca2|[plus]|-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression,Oncogene,,,Article,2003-10-30,10.1038/sj.onc.1206895,,,,14586412,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078630,https://api.altmetric.com/v1/donut/3078630_240.png 3,Urinary engrailed?2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer,British Journal of Urology,,,Article,2012-05-15,10.1111/j.1464-410x.2012.11208.x,,,,22583908,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3078629,https://api.altmetric.com/v1/donut/3078629_240.png 3,Prognostic value of nuclear matrix protein expression in localized prostate cancer,Journal of Cancer Research & Clinical Oncology,,,Article,2012-04-10,10.1007/s00432-012-1216-0,,,,22488172,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078628,https://api.altmetric.com/v1/donut/3078628_240.png 3,Factors Influencing Men’s Decisions Regarding Prostate Cancer Screening: A Qualitative Study,Journal of Community Health,,,Article,2011-02-20,10.1007/s10900-011-9383-5,,,,21336996,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3078625,https://api.altmetric.com/v1/donut/3078625_240.png 3,"A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL",Investigational New Drugs,,,Article,2011-07-20,10.1007/s10637-011-9718-1,,,,21773733,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078623,https://api.altmetric.com/v1/donut/3078623_240.png 3,Role of PTEN gene in progression of prostate cancer.,Urology Journal,,,Article,2006-11-30,,,,,17701929,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/3078621,https://api.altmetric.com/v1/donut/3078621_240.png 3,Stage migration in localized prostate cancer has no effect on the post?radical prostatectomy Kattan nomogram,British Journal of Urology,,,Article,2009-09-14,10.1111/j.1464-410x.2009.08842.x,,,,19751263,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078618,https://api.altmetric.com/v1/donut/3078618_240.png 3,A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,2010-07-03,10.1007/s00280-010-1389-7,,,,20602233,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078617,https://api.altmetric.com/v1/donut/3078617_240.png 3,Clinical endpoints for drug development in prostate cancer.,Current Opinion in Urology,,,Article,2008-05-01,10.1097/mou.0b013e3282fb7807,,,,18382240,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078614,https://api.altmetric.com/v1/donut/3078614_240.png 3,Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer,Cancer (0008543X),,,Article,2005-12-20,10.1002/cncr.21605,,,,16369982,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078611,https://api.altmetric.com/v1/donut/3078611_240.png 3,The effect of study arm on prostate cancer treatment in the large screening trial ERSPC,International Journal of Cancer,,,Article,2009-09-08,10.1002/ijc.24870,,,,19739124,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078610,https://api.altmetric.com/v1/donut/3078610_240.png 3,Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance,British Journal of Urology,,,Article,2011-12-07,10.1111/j.1464-410x.2011.10791.x,,,,22145791,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3078609,https://api.altmetric.com/v1/donut/3078609_240.png 3,"Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography.",Current Opinion in Urology,,,Article,2009-03-01,10.1097/mou.0b013e328323f5ed,,,,19188771,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3078608,https://api.altmetric.com/v1/donut/3078608_240.png 3,Transurethral resection of the prostate immediately after high?intensity focused ultrasound treatment for prostate cancer,International Journal of Urology,,,Article,2010-10-04,10.1111/j.1442-2042.2010.02638.x,,,,20969640,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078607,https://api.altmetric.com/v1/donut/3078607_240.png 3,Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes,Integrative Biology,,,Article,2011-09-07,10.1039/c1ib00038a,,,,21901193,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078605,https://api.altmetric.com/v1/donut/3078605_240.png 3,UNINFORMED CONSENT: MASS SCREENING FOR PROSTATE CANCER,Bioethics,,,Article,2010-05-17,10.1111/j.1467-8519.2010.01826.x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078604,https://api.altmetric.com/v1/donut/3078604_240.png 3,KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.,Biological Chemistry,,,Article,2010-01-01,10.1515/bc.2010.026,,,,20128692,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078603,https://api.altmetric.com/v1/donut/3078603_240.png 3,Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration?resistant nonmetastatic prostate cancer,Cancer (0008543X),,,Article,2010-11-16,10.1002/cncr.25762,,,,21082701,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3078601,https://api.altmetric.com/v1/donut/3078601_240.png 3,MicroRNA-335 Acts as a Candidate Tumor Suppressor in Prostate Cancer,Pathology & Oncology Research,,,Article,2013-03-03,10.1007/s12253-013-9613-5,,,,23456549,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078600,https://api.altmetric.com/v1/donut/3078600_240.png 3,The effect of warfarin use on clinical stage and histological grade of prostate cancer,Pharmacoepidemiology & Drug Safety,,,Article,2010-03-31,10.1002/pds.1943,,,,20437456,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078599,https://api.altmetric.com/v1/donut/3078599_240.png 3,"Association of tissue promoter methylation levels of APC, TGF?2, HOXD3 and RASSF1A with prostate cancer progression",International Journal of Cancer,,,Article,2011-04-13,10.1002/ijc.25908,,,,21207416,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3078598,https://api.altmetric.com/v1/donut/3078598_240.png 3,Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients,The Prostate,,,Article,2009-02-02,10.1002/pros.20927,,,,19189305,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078597,https://api.altmetric.com/v1/donut/3078597_240.png 3,Cranial nerve deficit caused by skull metastasis of prostate cancer: three Japanese castration-resistant prostate cancer cases,International Journal of Clinical Oncology,,,Article,2010-06-05,10.1007/s10147-010-0098-x,,,,20526645,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078595,https://api.altmetric.com/v1/donut/3078595_240.png 3,Glycemic control and prostate cancer progression: Results from the SEARCH database,The Prostate,,,Article,2010-05-20,10.1002/pros.21189,,,,20687228,PMC2930134,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078590,https://api.altmetric.com/v1/donut/3078590_240.png 3,Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2008-12-01,10.1097/coc.0b013e318172aa92,,,,19060583,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078589,https://api.altmetric.com/v1/donut/3078589_240.png 3,Neuroendocrine differentiation in stage D2 prostate cancers,International Journal of Urology,,,Article,2008-03-13,10.1111/j.1442-2042.2008.02015.x,,,,18452460,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078588,https://api.altmetric.com/v1/donut/3078588_240.png 3,"Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies.",Tumori,,,Article,2010-12-07,10.1700/950.10401,,,,21989437,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078587,https://api.altmetric.com/v1/donut/3078587_240.png 3,Restricted Water Diffusibility as Measured by Diffusion-weighted MR Imaging and Choline Uptake in 11C-Choline PET/CT are Correlated in Pelvic Lymph Nodes in Patients with Prostate Cancer,Molecular Imaging & Biology,,,Article,2010-05-19,10.1007/s11307-010-0337-6,,,,20490932,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3078586,https://api.altmetric.com/v1/donut/3078586_240.png 3,Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.,Pathology,,,Article,2010-01-06,10.3109/00313021003767280,,,,20438405,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078584,https://api.altmetric.com/v1/donut/3078584_240.png 3,Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis,Prostate Cancer & Prostatic Diseases,,,Article,2008-09-02,10.1038/pcan.2008.46,,,,18762813,PMC2790323,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078583,https://api.altmetric.com/v1/donut/3078583_240.png 3,Combined c?Myc and caveolin?1 expression in human prostate carcinoma predicts prostate carcinoma progression,Cancer (0008543X),,,Article,2005-02-14,10.1002/cncr.20905,,,,15712208,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078582,https://api.altmetric.com/v1/donut/3078582_240.png 3,"The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer",Cancer Causes and Control,,,Article,2010-12-19,10.1007/s10552-010-9713-4,,,,21170754,PMC3042514,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3078581,https://api.altmetric.com/v1/donut/3078581_240.png 3,Survival after incidental prostate cancer diagnosis at transurethral resection of prostate: 10-year outcomes,Irish Journal of Medical Science,,,Article,2011-09-11,10.1007/s11845-011-0753-x,,,,21910023,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078579,https://api.altmetric.com/v1/donut/3078579_240.png 3,Critical appraisal of cabazitaxel in the management of advanced prostate cancer,Clinical Interventions in Aging,,,Article,2010-12-01,10.2147/cia.s14570,,,,21152241,PMC2998247,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078578,https://api.altmetric.com/v1/donut/3078578_240.png 3,Can Prostate Specific Antigen Derivatives and Pathological Parameters Predict Significant Change in Expectant Management Criteria for Prostate Cancer?,The Journal of Urology,,,Article,2003-01-12,10.1097/01.ju.0000097124.21878.6b,,,,14634395,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078576,https://api.altmetric.com/v1/donut/3078576_240.png 3,Quantitative analysis of a panel of gene expression in prostate cancer—with emphasis on NPY expression analysis,Journal of Zhejiang University - Science B,,,Article,2007-12-15,10.1631/jzus.2007.b0853,,,,18257117,PMC2100155,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078575,https://api.altmetric.com/v1/donut/3078575_240.png 3,Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients,Clinical Cancer Research,,,Article,2011-06-15,10.1158/1078-0432.ccr-11-0943,,,,21680542,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3078574,https://api.altmetric.com/v1/donut/3078574_240.png 3,Prostate cancer epidemiology in the United States,World Journal of Urology,,,Article,2012-04-05,10.1007/s00345-012-0824-2,,,,22476558,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,83,https://www.altmetric.com/details/3078573,https://api.altmetric.com/v1/donut/3078573_240.png 3,A stochastic approach to risk management for prostate cancer patients on active surveillance.,Journal of Theoretical Biology,,,Article,2011-07-05,10.1016/j.jtbi.2011.06.013,,,,21723300,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078572,https://api.altmetric.com/v1/donut/3078572_240.png 3,Treating Prostate Cancer in Elderly Men: How Does Aging Affect the Outcome?,Current Treatment Options in Oncology,,,Article,2011-06-09,10.1007/s11864-011-0160-6,,,,21656153,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3078571,https://api.altmetric.com/v1/donut/3078571_240.png 3,Prostate Cancer Knowledge in Irish Men,Journal of Cancer Education,,,Article,2011-08-02,10.1007/s13187-011-0256-5,,,,21808998,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078570,https://api.altmetric.com/v1/donut/3078570_240.png 3,Testing the evolution process of prostate?specific antigen in early stage prostate cancer: what is the proper underlying model?,Statistics in Medicine,,,Article,2011-08-08,10.1002/sim.4329,,,,21826698,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078566,https://api.altmetric.com/v1/donut/3078566_240.png 3,Use of Gold Markers for Setup in Image-Guided Fractionated High-Dose-Rate Brachytherapy as a Monotherapy for Prostate Cancer,Strahlentherapie und Onkologie,,,Article,2009-11-10,10.1007/s00066-009-2007-7,,,,19899006,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078563,https://api.altmetric.com/v1/donut/3078563_240.png 3,"Targeting prostate cancer with HTI?286, a synthetic analog of the marine sponge product hemiasterlin",International Journal of Cancer,,,Article,2008-01-31,10.1002/ijc.23406,,,,18240145,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078562,https://api.altmetric.com/v1/donut/3078562_240.png 3,XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence,World Journal of Urology,,,Article,2011-10-04,10.1007/s00345-011-0768-y,,,,21969130,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078560,https://api.altmetric.com/v1/donut/3078560_240.png 3,High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death,Virchows Archiv,,,Article,2011-05-03,10.1007/s00428-011-1084-z,,,,21538124,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078559,https://api.altmetric.com/v1/donut/3078559_240.png 3,Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis,Journal of Cancer Epidemiology,,,Article,2012-04-11,10.1155/2012/291704,,,,22570655,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078558,https://api.altmetric.com/v1/donut/3078558_240.png 3,Physiologic Reactions After Proton Beam Therapy in Patients With Prostate Cancer: Significance of Urinary Autoactivation,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-01-10,10.1016/j.ijrobp.2009.02.085,,,,19735884,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078557,https://api.altmetric.com/v1/donut/3078557_240.png 3,"Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer",The Prostate,,,Article,2012-07-20,10.1002/pros.22563,,,,22821767,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078555,https://api.altmetric.com/v1/donut/3078555_240.png 3,High-intensity focused ultrasound for prostate cancer: a practice guideline.,Canadian Urological Association Journal,,,Article,2010-08-10,,,,,20694096,PMC2910764,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078554,https://api.altmetric.com/v1/donut/3078554_240.png 3,Prostate-specific antigen testing across the spectrum of prostate cancer.,Biomarkers in Medicine,,,Article,2011-08-25,10.2217/bmm.11.53,,,,21861672,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078553,https://api.altmetric.com/v1/donut/3078553_240.png 3,The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy,World Journal of Urology,,,Article,2011-08-17,10.1007/s00345-011-0738-4,,,,21847658,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078552,https://api.altmetric.com/v1/donut/3078552_240.png 3,"Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.",European Urology,,,Article,2004-10-12,10.1016/j.eururo.2004.07.010,,,,15474265,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078550,https://api.altmetric.com/v1/donut/3078550_240.png 3,Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia,The Journal of Pathology,,,Article,2004-01-19,10.1002/path.1503,,,,14743506,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3078549,https://api.altmetric.com/v1/donut/3078549_240.png 3,Brachytherapy for prostate cancer: follow-up and management of treatment failures.,Urologic Clinics of North America,,,Article,2003-12-19,,,,,14680311,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078548,https://api.altmetric.com/v1/donut/3078548_240.png 3,Evolution from active surveillance to focal therapy in the management of prostate cancer.,Future Oncology,,,Article,2011-06-16,10.2217/fon.11.51,,,,21675840,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078547,https://api.altmetric.com/v1/donut/3078547_240.png 3,Time Trends in Clinical Risk Stratification for Prostate Cancer: Implications for Outcomes (Data From CaPSURE),The Journal of Urology,,,Article,2003-01-12,10.1097/01.ju.0000095025.03331.c6,,,,14610406,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078544,https://api.altmetric.com/v1/donut/3078544_240.png 3,Informed prostate cancer risk?adjusted testing: a new paradigm,British Journal of Urology,,,Article,2012-11-29,10.1111/j.1464-410x.2012.11621.x,,,,23194122,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078543,https://api.altmetric.com/v1/donut/3078543_240.png 3,Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers,Scandinavian Journal of Urology & Nephrology,,,Article,2012-04-24,10.3109/00365599.2012.675586,,,,22519924,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078542,https://api.altmetric.com/v1/donut/3078542_240.png 3,"Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation",Radiotherapy & Oncology,,,Article,2004-01-04,10.1016/j.radonc.2003.12.011,,,,15066293,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3078541,https://api.altmetric.com/v1/donut/3078541_240.png 3,Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients,Journal of Cancer Research & Clinical Oncology,,,Article,2011-12-02,10.1007/s00432-011-1101-2,,,,22134838,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078540,https://api.altmetric.com/v1/donut/3078540_240.png 3,High?level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB,The Journal of Pathology,,,Article,2005-05-04,10.1002/path.1760,,,,15880754,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3078539,https://api.altmetric.com/v1/donut/3078539_240.png 3,Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer,Medical Oncology,,,Article,2009-02-26,10.1007/s12032-009-9185-0,,,,19242826,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078538,https://api.altmetric.com/v1/donut/3078538_240.png 3,An evidence review of active surveillance in men with localized prostate cancer.,Evidence report technology assessment,,,Article,2012-11-08,,,,,23126653,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078537,https://api.altmetric.com/v1/donut/3078537_240.png 3,Stromal PDGFR? Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival,PLoS ONE,,,Article,2010-05-20,10.1371/journal.pone.0010747,,,,20505768,,,2010PLoSO...510747H,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3078536,https://api.altmetric.com/v1/donut/3078536_240.png 3,Targeted therapeutic approaches for hormone-refractory prostate cancer.,Cancer Treatment Reviews,,,Article,2010-01-04,10.1016/j.ctrv.2009.06.001,,,,20106600,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3078535,https://api.altmetric.com/v1/donut/3078535_240.png 3,Detection of tumor?specific DNA in blood and bone marrow plasma from patients with prostate cancer,International Journal of Cancer,,,Article,2007-01-04,10.1002/ijc.22470,,,,17205532,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078534,https://api.altmetric.com/v1/donut/3078534_240.png 3,Association between family history of prostate cancer and positive biopsies in a Brazilian screening program,World Journal of Urology,,,Article,2012-07-21,10.1007/s00345-012-0904-3,,,,22820620,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078532,https://api.altmetric.com/v1/donut/3078532_240.png 3,Docetaxel in the management of prostate cancer: current standard of care and future directions,Expert Opinion on Pharmacotherapy,,,Article,2008-07-16,10.1517/14656566.9.11.1969,,,,18627334,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078531,https://api.altmetric.com/v1/donut/3078531_240.png 3,The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2008-01-01,10.1517/13543784.17.1.23,,,,18095916,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078529,https://api.altmetric.com/v1/donut/3078529_240.png 3,"Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer.",Oncology Reports,,,Article,2011-01-04,10.3892/or.2011.1154,,,,21249322,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078527,https://api.altmetric.com/v1/donut/3078527_240.png 3,Intrinsic Religiousness as a Mediator Between Fatalism and Cancer-Specific Fear: Clarifying the Role of Fear in Prostate Cancer Screening,Journal of Religion & Health,,,Article,2012-12-22,10.1007/s10943-012-9670-1,,,,23263790,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078526,https://api.altmetric.com/v1/donut/3078526_240.png 3,Improving Outcomes With Recent Advances in Chemotherapy for Castrate-Resistant Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2010-01-12,10.3816/cgc.2010.n.004,,,,21208852,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078525,https://api.altmetric.com/v1/donut/3078525_240.png 3,High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies,"Magnetic Resonance Materials in Biology, Physics, & Medicine",,,Article,2008-11-25,10.1007/s10334-008-0156-9,,,,19031091,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078524,https://api.altmetric.com/v1/donut/3078524_240.png 3,Contemporary Therapeutic Approaches Targeting Bone Complications in Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2010-01-12,10.3816/cgc.2010.n.005,,,,21208853,PMC3090680,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078523,https://api.altmetric.com/v1/donut/3078523_240.png 3,Cyclooxygenase?2 (cox?2) expression is an independent predictor of prostate cancer recurrence,International Journal of Cancer,,,Article,2006-03-23,10.1002/ijc.21749,,,,16557596,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078521,https://api.altmetric.com/v1/donut/3078521_240.png 3,Changing Therapeutic Paradigms in Castrate-Resistant Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2010-01-12,10.3816/cgc.2010.n.003,,,,21208851,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078520,https://api.altmetric.com/v1/donut/3078520_240.png 3,Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts,World Journal of Urology,,,Article,2011-11-25,10.1007/s00345-011-0799-4,,,,22116599,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3078519,https://api.altmetric.com/v1/donut/3078519_240.png 3,Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels,International Urology and Nephrology,,,Article,2012-02-05,10.1007/s11255-011-0119-3,,,,22311386,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078518,https://api.altmetric.com/v1/donut/3078518_240.png 3,Predictors of prostate?specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy,Cancer (0008543X),,,Article,2004-03-18,10.1002/cncr.20122,,,,15073850,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078517,https://api.altmetric.com/v1/donut/3078517_240.png 3,ZD4054: a specific endothelin A receptor antagonist with promising activity in metastatic castration-resistant prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2008-07-11,10.1517/13543784.17.8.1237,,,,18616419,PMC2908530,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078516,https://api.altmetric.com/v1/donut/3078516_240.png 3,Watchful Waiting and Active Surveillance Approach in Patients with Low Risk Localized Prostatic Cancer: An Experience of Out-Patients Clinic with 12-Year Follow-Up,Pathology & Oncology Research,,,Article,2011-06-08,10.1007/s12253-011-9400-0,,,,21655925,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078515,https://api.altmetric.com/v1/donut/3078515_240.png 3,The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting,Prostate Cancer & Prostatic Diseases,,,Article,2006-06-13,10.1038/sj.pcan.4500889,,,,16770340,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3078514,https://api.altmetric.com/v1/donut/3078514_240.png 3,Pathological significance and predictive value for biochemical recurrence of c?Fes expression in prostate cancer,The Prostate,,,Article,2011-05-11,10.1002/pros.21422,,,,21563194,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078513,https://api.altmetric.com/v1/donut/3078513_240.png 3,Use of tumor dynamics to clarify the observed variability among biochemical recurrence nomograms for prostate cancer,The Prostate,,,Article,2011-05-31,10.1002/pros.21429,,,,21630294,PMC3188696,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078512,https://api.altmetric.com/v1/donut/3078512_240.png 3,Role of 11C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation,Japanese Journal of Radiology,,,Article,2011-07-24,10.1007/s11604-011-0570-1,,,,21786095,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078511,https://api.altmetric.com/v1/donut/3078511_240.png 3,Cabazitaxel: filling one of the gaps in the treatment of prostate cancer.,Cancer Biology and Therapy,,,Article,2010-11-27,,,,,21107022,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078510,https://api.altmetric.com/v1/donut/3078510_240.png 3,The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level,Annals of Nuclear Medicine,,,Article,2010-10-08,10.1007/s12149-010-0424-4,,,,20931305,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078509,https://api.altmetric.com/v1/donut/3078509_240.png 3,Impact of prostate?specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen?deprivation therapy,The Prostate,,,Article,2011-01-12,10.1002/pros.21334,,,,21656829,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078508,https://api.altmetric.com/v1/donut/3078508_240.png 3,Prostate?derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer,The Prostate,,,Article,2011-01-12,10.1002/pros.21333,,,,21229552,PMC3112264,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078507,https://api.altmetric.com/v1/donut/3078507_240.png 3,Resistance to docetaxel?induced apoptosis in prostate cancer cells by p38/p53/p21 signaling,The Prostate,,,Article,2011-01-12,10.1002/pros.21331,,,,21229560,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078506,https://api.altmetric.com/v1/donut/3078506_240.png 3,Prostate cancer antigen-1 as a potential novel marker for prostate cancer,Asian Journal of Andrology,,,Article,2007-11-01,10.1111/j.1745-7262.2007.00279.x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078505,https://api.altmetric.com/v1/donut/3078505_240.png 3,Early detection of prostate cancer with emphasis on genetic markers,Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.529824,,,,21604936,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078504,https://api.altmetric.com/v1/donut/3078504_240.png 3,Combining 153Sm-Lexidronam and Docetaxel for the Treatment of Patients with Hormone-Refractory Prostate Cancer: First Experience,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2008-10-01,10.1089/cbr.2008.0487,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078501,https://api.altmetric.com/v1/donut/3078501_240.png 3,Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer,"Cancer Immunology, Immunotherapy",,,Article,2011-12-31,10.1007/s00262-011-1193-1,,,,22210552,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3078500,https://api.altmetric.com/v1/donut/3078500_240.png 3,Contemporary outcomes of focal therapy in prostate cancer: what do we know so far…,World Journal of Urology,,,Article,2010-08-03,10.1007/s00345-010-0584-9,,,,20680294,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078498,https://api.altmetric.com/v1/donut/3078498_240.png 3,Novel strategies in the treatment of castration-resistant prostate cancer (Review).,International Journal of Oncology,,,Article,2012-02-12,10.3892/ijo.2012.1364,,,,22322981,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078497,https://api.altmetric.com/v1/donut/3078497_240.png 3,Prostate cancer: Defining biochemical failure in patients treated with HIFU,Nature Reviews Urology,,,Article,2010-04-01,10.1038/nrurol.2010.12,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078495,https://api.altmetric.com/v1/donut/3078495_240.png 3,Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance,British Journal of Urology,,,Article,2011-11-11,10.1111/j.1464-410x.2011.10750.x,,,,22077888,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078494,https://api.altmetric.com/v1/donut/3078494_240.png 3,Screening for prostate cancer: growth without control.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2011-01-01,10.1097/01.cej.0000391568.26136.bc,,,,21245678,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078492,https://api.altmetric.com/v1/donut/3078492_240.png 3,"Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: Single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.",International Journal of Oncology,,,Article,2012-11-17,10.3892/ijo.2012.1694,,,,23151842,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078490,https://api.altmetric.com/v1/donut/3078490_240.png 3,Prostate?specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration?resistant prostate cancer,British Journal of Urology,,,Article,2012-02-28,10.1111/j.1464-410x.2012.10959.x,,,,22369348,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078488,https://api.altmetric.com/v1/donut/3078488_240.png 3,From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.,,,,Article,2010-01-01,10.1007/978-1-60761-806-5_17,,,,20690063,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078487,https://api.altmetric.com/v1/donut/3078487_240.png 3,Carbidopa abrogates L?dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression,International Journal of Cancer,,,Article,2011-09-14,10.1002/ijc.26287,,,,21780103,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078486,https://api.altmetric.com/v1/donut/3078486_240.png 3,Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma,Cancer (0008543X),,,Article,2003-11-03,10.1002/cncr.11850,,,,14669274,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078485,https://api.altmetric.com/v1/donut/3078485_240.png 3,The additional value of TGF?1 and IL-7 to predict the course of prostate cancer progression,"Cancer Immunology, Immunotherapy",,,Article,2011-11-24,10.1007/s00262-011-1159-3,,,,22113713,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078484,https://api.altmetric.com/v1/donut/3078484_240.png 3,Penile Implant Utilization Following Treatment for Prostate Cancer: Analysis of the SEER-Medicare Database,Journal of Sexual Medicine,,,Article,2011-03-22,10.1111/j.1743-6109.2011.02240.x,,,,21426495,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078482,https://api.altmetric.com/v1/donut/3078482_240.png 3,The 6?year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes,British Journal of Urology,,,Article,2012-03-08,10.1111/j.1464-410x.2012.10970.x,,,,22404874,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3078478,https://api.altmetric.com/v1/donut/3078478_240.png 3,What's Wrong With Chemoprevention of Prostate Cancer?,The American Journal of Bioethics,,,Article,2011-12-08,10.1080/15265161.2011.623932,,,,22146025,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078476,https://api.altmetric.com/v1/donut/3078476_240.png 3,Delay of Surgery in Men With Low Risk Prostate Cancer,The Journal of Urology,,,Article,2011-01-06,10.1016/j.juro.2011.02.009,,,,21496847,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078475,https://api.altmetric.com/v1/donut/3078475_240.png 3,Phase III data for abiraterone in an evolving landscape for castration-resistant prostate cancer,Maturitas,,,Article,2011-01-02,10.1016/j.maturitas.2010.10.009,,,,21093995,PMC3161066,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078474,https://api.altmetric.com/v1/donut/3078474_240.png 3,Identification of Clinically Significant Prostate Cancer by Prostate-Specific Antigen Screening,Archives of Internal Medicine,,,Article,2004-06-14,10.1001/archinte.164.11.1227,,,,15197049,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078473,https://api.altmetric.com/v1/donut/3078473_240.png 3,Sexual function with localized prostate cancer: active surveillance vs radical therapy,British Journal of Urology,,,Article,2012-01-19,10.1111/j.1464-410x.2011.10846.x,,,,22260273,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3078472,https://api.altmetric.com/v1/donut/3078472_240.png 3,Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review,ISRN Oncology,,,Article,2011-12-18,10.5402/2011/219064,,,,22220283,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078470,https://api.altmetric.com/v1/donut/3078470_240.png 3,Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design.,Clinical Nuclear Medicine,,,Article,2009-05-01,10.1097/rlu.0b013e31819e51e3,,,,19387202,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078469,https://api.altmetric.com/v1/donut/3078469_240.png 3,Should Bone Scan be Performed in Chinese Prostate Cancer Patients at the Time of Diagnosis?,Urologia Internationalis,,,Article,2013-03-28,10.1159/000348330,,,,23548369,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078468,https://api.altmetric.com/v1/donut/3078468_240.png 3,Standard and saturation transrectal prostate biopsy techniques are equally accurate among prostate cancer active surveillance candidates,International Journal of Urology,,,Article,2012-12-20,10.1111/iju.12061,,,,23278942,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078467,https://api.altmetric.com/v1/donut/3078467_240.png 3,Locally advanced prostate cancer: a population?based study of treatment patterns,British Journal of Urology,,,Article,2011-11-15,10.1111/j.1464-410x.2011.10760.x,,,,22085255,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078466,https://api.altmetric.com/v1/donut/3078466_240.png 3,Minimally invasive treatment for localized prostate cancer.,Minerva Urologica E Nefrologica,,,Article,2013-01-06,,,,,23288211,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078462,https://api.altmetric.com/v1/donut/3078462_240.png 3,Early Prostate Cancer Antigen Expression in Predicting Presence of Prostate Cancer in Men With Histologically Negative Biopsies,The Journal of Urology,,,Article,2007-01-05,10.1016/j.juro.2007.01.013,,,,17437801,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078459,https://api.altmetric.com/v1/donut/3078459_240.png 3,Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients,British Journal of Urology,,,Article,2010-11-02,10.1111/j.1464-410x.2010.09811.x,,,,21050356,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078458,https://api.altmetric.com/v1/donut/3078458_240.png 3,PSA density versus risk stratification for lymphadenectomy-making decision in patients with prostate cancer undergoing radical prostatectomy,International Urology and Nephrology,,,Article,2011-03-26,10.1007/s11255-011-9942-9,,,,21437595,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078456,https://api.altmetric.com/v1/donut/3078456_240.png 3,The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer.,Experimental & Molecular Pathology,,,Article,2011-11-23,10.1016/j.yexmp.2011.11.001,,,,22101258,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078455,https://api.altmetric.com/v1/donut/3078455_240.png 3,Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.,European Urology,,,Article,2006-01-28,10.1016/j.eururo.2005.11.007,,,,16439050,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3078452,https://api.altmetric.com/v1/donut/3078452_240.png 3,MRI of localized prostate cancer: coming of age in the PSA era.,Diagnostic and Interventional Radiology,,,Article,2011-01-01,10.4261/1305-3825.dir.4478-11.1,,,,21922459,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3078450,https://api.altmetric.com/v1/donut/3078450_240.png 3,The face of high risk prostate cancer,World Journal of Urology,,,Article,2008-04-10,10.1007/s00345-008-0254-3,,,,18401585,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078449,https://api.altmetric.com/v1/donut/3078449_240.png 3,Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A cost-effectiveness analysis,Journal of Medical Economics,,,Article,2012-08-09,10.3111/13696998.2012.719054,,,,22870908,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078448,https://api.altmetric.com/v1/donut/3078448_240.png 3,The current state of brachytherapy nomograms for patients with clinically localized prostate cancer,Cancer (0008543X),,,Article,2009-06-19,10.1002/cncr.24344,,,,19544540,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078447,https://api.altmetric.com/v1/donut/3078447_240.png 3,Biomolecular markers of outcome prediction in prostate cancer,Cancer (0008543X),,,Article,2009-06-19,10.1002/cncr.24346,,,,19544547,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078446,https://api.altmetric.com/v1/donut/3078446_240.png 3,An Accurate Prostate Cancer Prognosticator Using a Seven-Gene Signature Plus Gleason Score and Taking Cell Type Heterogeneity into Account,PLoS ONE,,,Article,2012-10-03,10.1371/journal.pone.0045178,,,,23028830,PMC3460942,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078445,https://api.altmetric.com/v1/donut/3078445_240.png 3,Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years,Cancer (0008543X),,,Article,2004-01-16,10.1002/cncr.20048,,,,14983492,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078443,https://api.altmetric.com/v1/donut/3078443_240.png 3,Predictive models in external beam radiotherapy for clinically localized prostate cancer,Cancer (0008543X),,,Article,2009-06-19,10.1002/cncr.24348,,,,19544539,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078442,https://api.altmetric.com/v1/donut/3078442_240.png 3,Contemporary role of prostate cancer gene 3 in the management of prostate cancer.,Current Opinion in Urology,,,Article,2011-05-01,10.1097/mou.0b013e328344939c,,,,21301341,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078441,https://api.altmetric.com/v1/donut/3078441_240.png 3,Prognostic Value of Body Mass Index in Korean Patients with Castration-Resistant Prostate Cancer,Korean Journal of Urology,,,Article,2012-11-01,10.4111/kju.2012.53.11.761,,,,23185667,PMC3502734,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078440,https://api.altmetric.com/v1/donut/3078440_240.png 3,PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapy,World Journal of Urology,,,Article,2010-12-31,10.1007/s00345-010-0631-6,,,,21193912,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078439,https://api.altmetric.com/v1/donut/3078439_240.png 3,Predicting biopsy-proven prostate cancer recurrence following cryosurgery,Urologic Oncology,,,Article,2010-09-10,10.1016/j.urolonc.2010.04.001,,,,20826095,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078437,https://api.altmetric.com/v1/donut/3078437_240.png 3,Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high?risk” prostate cancer compared to MRI or CT,Scandinavian Journal of Urology & Nephrology,,,Article,2002-12-31,10.1080/00365590310006309,,,,14594685,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078436,https://api.altmetric.com/v1/donut/3078436_240.png 3,Prostate cancer: who should be treated?,American Family Physician,,,Article,2011-08-17,,,,,21842789,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078434,https://api.altmetric.com/v1/donut/3078434_240.png 3,Allelic Losses in Localized Prostate Cancer: Association With Prognostic Factors,The Journal of Urology,,,Article,2003-01-10,10.1097/01.ju.0000083329.89215.91,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078433,https://api.altmetric.com/v1/donut/3078433_240.png 3,Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer,Oncogene,,,Article,2007-07-16,10.1038/sj.onc.1210640,,,,17637754,PMC2646890,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/3078432,https://api.altmetric.com/v1/donut/3078432_240.png 3,Prognostic factors for and outcome of locally advanced prostate cancer after radical prostatectomy,British Journal of Urology,,,Article,2009-11-12,10.1111/j.1464-410x.2009.09054.x,,,,19912180,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078431,https://api.altmetric.com/v1/donut/3078431_240.png 3,Smarcc1 expression: A significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure ,Scandinavian Journal of Urology & Nephrology,,,Article,2010-11-23,10.3109/00365599.2010.530295,,,,21087120,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078430,https://api.altmetric.com/v1/donut/3078430_240.png 3,Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis,The Prostate,,,Article,2009-03-09,10.1002/pros.20948,,,,19274666,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078429,https://api.altmetric.com/v1/donut/3078429_240.png 3,??Methylacyl?CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow?up Study,The Prostate,,,Article,2011-06-28,10.1002/pros.21432,,,,21713964,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078427,https://api.altmetric.com/v1/donut/3078427_240.png 3,[11C]Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.09.001,,,,23164385,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078426,https://api.altmetric.com/v1/donut/3078426_240.png 3,Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2007-10-10,10.1007/s00259-007-0552-9,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/3078425,https://api.altmetric.com/v1/donut/3078425_240.png 3,Insulin-like growth factors (IGFs) and IGF-binding proteins in active monitoring of localized prostate cancer: a population-based observational study,Cancer Causes and Control,,,Article,2012-10-21,10.1007/s10552-012-0087-7,,,,23085814,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3078424,https://api.altmetric.com/v1/donut/3078424_240.png 3,Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.,The American Journal of Surgical Pathology,,,Article,2012-06-01,10.1097/pas.0b013e3182486faf,,,,22592143,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3078422,https://api.altmetric.com/v1/donut/3078422_240.png 3,Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade,Korean Journal of Urology,,,Article,2012-12-01,10.4111/kju.2012.53.12.826,,,,23301125,PMC3531634,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078420,https://api.altmetric.com/v1/donut/3078420_240.png 3,"Long?term aspirin use and the risk of total, high?grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988–2006",International Journal of Cancer,,,Article,2011-02-26,10.1002/ijc.25811,,,,21128233,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3078419,https://api.altmetric.com/v1/donut/3078419_240.png 3,The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend,Korean Journal of Urology,,,Article,2012-10-01,10.4111/kju.2012.53.10.686,,,,23136628,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078418,https://api.altmetric.com/v1/donut/3078418_240.png 3,Diabetes mellitus and health?related quality of life in prostate cancer: 5?year results from the Prostate Cancer Outcomes Study,British Journal of Urology,,,Article,2010-11-11,10.1111/j.1464-410x.2010.09861.x,,,,21070583,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078417,https://api.altmetric.com/v1/donut/3078417_240.png 3,Compliance with biopsy recommendations of a prostate cancer risk calculator,British Journal of Urology,,,Article,2011-09-20,10.1111/j.1464-410x.2011.10611.x,,,,21933335,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3078416,https://api.altmetric.com/v1/donut/3078416_240.png 3,Active surveillance for prostate cancer: an Australian experience,British Journal of Urology,,,Article,2012-03-28,10.1111/j.1464-410x.2012.11045.x,,,,22458492,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078415,https://api.altmetric.com/v1/donut/3078415_240.png 3,Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy,Cancer (0008543X),,,Article,2007-09-07,10.1002/cncr.22972,,,,17828774,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078414,https://api.altmetric.com/v1/donut/3078414_240.png 3,Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression,Cancer Biology and Therapy,,,Article,2014-10-27,10.4161/cbt.6.1.3489,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3078413,https://api.altmetric.com/v1/donut/3078413_240.png 3,Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer,The Prostate,,,Article,2005-07-13,10.1002/pros.20304,,,,16015610,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078412,https://api.altmetric.com/v1/donut/3078412_240.png 3,Low p27 expression predicts biochemical relapse after radical prostatectomy in patients with clinically localised prostate cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2004-02-27,,,,,14981973,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078411,https://api.altmetric.com/v1/donut/3078411_240.png 3,Prostate Cancer Guidelines on Web 2.0-Based Sites: The Screening Dilemma Continues Online,Journal of Cancer Education,,,Article,2010-12-12,10.1007/s13187-010-0180-0,,,,21153573,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3078410,https://api.altmetric.com/v1/donut/3078410_240.png 3,The role of PET/computed tomography scan in the management of prostate cancer.,Current Opinion in Urology,,,Article,2011-05-01,10.1097/mou.0b013e328344e556,,,,21378572,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078409,https://api.altmetric.com/v1/donut/3078409_240.png 3,PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2010-03-20,10.1007/s00259-010-1403-7,,,,20306038,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3078407,https://api.altmetric.com/v1/donut/3078407_240.png 3,Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2009-06-02,10.1038/pcan.2009.19,,,,19488066,PMC2834323,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078406,https://api.altmetric.com/v1/donut/3078406_240.png 3,"Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer",PROTEOMICS,,,Article,2006-08-03,10.1002/pmic.200600148,,,,16888723,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078404,https://api.altmetric.com/v1/donut/3078404_240.png 3,"A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer",Cancer Biotherapy & Radiopharmaceuticals,,,Article,2009-01-04,10.1089/cbr.2008.0588,,,,19409038,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078403,https://api.altmetric.com/v1/donut/3078403_240.png 3,Radiation therapy for high-risk prostate cancer--a review.,Canadian Journal of Urology,,,Article,2005-07-16,,,,,16018830,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078400,https://api.altmetric.com/v1/donut/3078400_240.png 3,Percentage of positive biopsies predicts lymph node involvement in men with low?risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy,British Journal of Urology,,,Article,2010-06-30,10.1111/j.1464-410x.2010.09485.x,,,,20590538,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078399,https://api.altmetric.com/v1/donut/3078399_240.png 3,Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer,Cancer Management and Research,,,Article,2011-04-01,10.2147/cmr.s19291,,,,21629833,PMC3097800,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078398,https://api.altmetric.com/v1/donut/3078398_240.png 3,Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands,Familial Cancer,,,Article,2011-12-11,10.1007/s10689-011-9500-8,,,,22160565,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3078397,https://api.altmetric.com/v1/donut/3078397_240.png 3,Robotic prostate biopsy and its relevance to focal therapy of prostate cancer,Nature Reviews Urology,,,Article,2011-09-20,10.1038/nrurol.2011.131,,,,21931344,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078396,https://api.altmetric.com/v1/donut/3078396_240.png 3,F-18 FDG PET/CT imaging in small cell prostate cancer.,Clinical Nuclear Medicine,,,Article,2010-06-01,10.1097/rlu.0b013e3181db4ce9,,,,20479600,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078395,https://api.altmetric.com/v1/donut/3078395_240.png 3,"Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki?67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine?treated prostate cancer",British Journal of Urology,,,Article,2011-05-18,10.1111/j.1464-410x.2011.10253.x,,,,21592298,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078392,https://api.altmetric.com/v1/donut/3078392_240.png 3,Single Agent Vinflunine in the Salvage Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Trial of the Sarah Cannon Research Consortium,Cancer Investigation,,,Article,2010-02-19,10.3109/07357900902918460,,,,20158340,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078391,https://api.altmetric.com/v1/donut/3078391_240.png 3,Impact of docetaxel?based chemotherapy on quality of life of patients with castration?resistant prostate cancer: results from a prospective phase II randomized trial,British Journal of Urology,,,Article,2011-05-26,10.1111/j.1464-410x.2011.10277.x,,,,21615854,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078390,https://api.altmetric.com/v1/donut/3078390_240.png 3,External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series.,Urologic Oncology,,,Article,2012-01-09,10.1016/j.urolonc.2010.06.007,,,,20822930,PMC3137684,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078389,https://api.altmetric.com/v1/donut/3078389_240.png 3,Isolated calcaneal metastasis from prostate cancer.,Annals of the Royal College of Surgeons of England,,,Article,2008-04-01,10.1308/147870808x257265,,,,18430327,PMC2430443,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078388,https://api.altmetric.com/v1/donut/3078388_240.png 3,The association between radiographic response and overall survival in men with metastatic castration?resistant prostate cancer receiving chemotherapy,Cancer (0008543X),,,Article,2011-03-01,10.1002/cncr.25982,,,,21365623,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078386,https://api.altmetric.com/v1/donut/3078386_240.png 3,Current Clinical Trials in Castrate-Resistant Prostate Cancer,Current Urology Reports,,,Article,2011-04-30,10.1007/s11934-011-0187-z,,,,21533748,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078385,https://api.altmetric.com/v1/donut/3078385_240.png 3,Bone Scan Overuse in Staging of Prostate Cancer: An Analysis of a Veterans Affairs Cohort,Urology,,,Article,2011-01-06,10.1016/j.urology.2010.12.083,,,,21492911,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078384,https://api.altmetric.com/v1/donut/3078384_240.png 3,Promising novel cytotoxic agents and combinations in metastatic prostate cancer.,Cancer Journal,,,Article,2008-01-01,10.1097/ppo.0b013e31816220b7,,,,18303478,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078383,https://api.altmetric.com/v1/donut/3078383_240.png 3,A gene signature identified using a mouse model of androgen receptor?dependent prostate cancer predicts biochemical relapse in human disease,International Journal of Cancer,,,Article,2012-01-24,10.1002/ijc.26414,,,,22275114,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3078381,https://api.altmetric.com/v1/donut/3078381_240.png 3,Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study,British Journal of Urology,,,Article,2010-09-14,10.1111/j.1464-410x.2010.09648.x,,,,20840664,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3078380,https://api.altmetric.com/v1/donut/3078380_240.png 3,"Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination",Molecular Biology Reports,,,Article,2009-03-14,10.1007/s11033-009-9501-y,,,,19288219,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078379,https://api.altmetric.com/v1/donut/3078379_240.png 3,Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer,New England Journal of Medicine,,,Article,2001-09-27,10.1056/nejmoa010845,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078374,https://api.altmetric.com/v1/donut/3078374_240.png 3,Treatment failure after primary and salvage therapy for prostate cancer,Cancer (0008543X),,,Article,2007-11-29,10.1002/cncr.23161,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3078370,https://api.altmetric.com/v1/donut/3078370_240.png 3,A panel of five circulating microRNAs as potential biomarkers for prostate cancer,The Prostate,,,Article,2012-02-01,10.1002/pros.22495,,,,22298030,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3078369,https://api.altmetric.com/v1/donut/3078369_240.png 3,Time to prostate?specific antigen nadir independently predicts overall survival in patients who have metastatic hormone?sensitive prostate cancer treated with androgen?deprivation therapy,Cancer (0008543X),,,Article,2009-01-17,10.1002/cncr.24064,,,,19152438,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078368,https://api.altmetric.com/v1/donut/3078368_240.png 3,SEOM clinical guidelines for treatment of prostate cancer,Clinical and Translational Oncology,,,Article,2012-07-01,10.1007/s12094-012-0835-x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078365,https://api.altmetric.com/v1/donut/3078365_240.png 3,Clinical efficacy and safety of zoledronic acid in prostate and breast cancer,Expert Review of Anticancer Therapy,,,Article,2009-01-09,10.1586/era.09.95,,,,19761424,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078364,https://api.altmetric.com/v1/donut/3078364_240.png 3,Novel secondary hormonal therapy in advanced prostate cancer: an update.,Current Opinion in Urology,,,Article,2009-05-01,10.1097/mou.0b013e328329b73a,,,,19342958,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078362,https://api.altmetric.com/v1/donut/3078362_240.png 3,Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer,Oncology Reports,,,Article,2007-07-01,10.3892/or.18.1.145,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078361,https://api.altmetric.com/v1/donut/3078361_240.png 3,"Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer",Journal of Infection & Chemotherapy,,,Article,2010-01-01,10.1007/s10156-010-0047-7,,,,20221782,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078360,https://api.altmetric.com/v1/donut/3078360_240.png 3,Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.,Cancer Genomics & Proteomics,,,Article,2009-12-03,,,,,20335524,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078359,https://api.altmetric.com/v1/donut/3078359_240.png 3,Predictive Factors of Gleason Score Upgrading in Localized and Locally Advanced Prostate Cancer Diagnosed by Prostate Biopsy,Korean Journal of Urology,,,Article,2010-10-01,10.4111/kju.2010.51.10.677,,,,21031086,PMC2963779,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078358,https://api.altmetric.com/v1/donut/3078358_240.png 3,The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2007-09-22,10.1007/s00259-007-0581-4,,,,17891394,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3078357,https://api.altmetric.com/v1/donut/3078357_240.png 3,Predictive models of toxicity with external radiotherapy for prostate cancer,Cancer (0008543X),,,Article,2009-06-19,10.1002/cncr.24356,,,,19544543,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078354,https://api.altmetric.com/v1/donut/3078354_240.png 3,Development of a prostate cancer metagram,Cancer (0008543X),,,Article,2009-06-19,10.1002/cncr.24355,,,,19544545,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3078353,https://api.altmetric.com/v1/donut/3078353_240.png 3,From two-dimensional to three-dimensional conformal radiotherapy in prostate cancer: An Indian experience,Indian Journal of Cancer,,,Article,2010-07-01,10.4103/0019-509x.64718,,,,20587913,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078351,https://api.altmetric.com/v1/donut/3078351_240.png 3,Early chemotherapy in prostate cancer,Nature Reviews Urology,,,Article,2008-09-01,10.1038/ncpuro1204,,,,18769375,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078350,https://api.altmetric.com/v1/donut/3078350_240.png 3,Adverse prognostic impact of capsular incision at radical prostatectomy for Japanese men with clinically localized prostate cancer,International Urology and Nephrology,,,Article,2008-09-11,10.1007/s11255-008-9467-z,,,,18784981,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078347,https://api.altmetric.com/v1/donut/3078347_240.png 3,Visualization of Somatostatin Receptors in Prostate Cancer and its Bone Metastases with Ga-68–DOTATOC PET/CT,Molecular Imaging & Biology,,,Article,2009-05-07,10.1007/s11307-009-0230-3,,,,19421819,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078346,https://api.altmetric.com/v1/donut/3078346_240.png 3,Vasculogenic mimicry is a marker of poor prognosis in prostate cancer,Cancer Biology and Therapy,,,Article,2014-11-05,10.4161/cbt.19602,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078345,https://api.altmetric.com/v1/donut/3078345_240.png 3,Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer,Urology,,,Article,2004-07-12,10.1016/j.urology.2004.03.006,,,,15245942,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078344,https://api.altmetric.com/v1/donut/3078344_240.png 3,Discussions About Prostate Cancer Screening Between U.S. Primary Care Physicians and Their Patients,JGIM: Journal of General Internal Medicine,,,Article,2011-03-18,10.1007/s11606-011-1682-0,,,,21416405,PMC3181308,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3078342,https://api.altmetric.com/v1/donut/3078342_240.png 3,Prostate Cancer Prevention: Do the 5-ARIs Make the Grade?,The American Journal of Bioethics,,,Article,2011-12-08,10.1080/15265161.2011.626666,,,,22146028,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078341,https://api.altmetric.com/v1/donut/3078341_240.png 3,Men with prostate cancer make positive dietary changes following diagnosis and treatment,Cancer Causes and Control,,,Article,2013-03-22,10.1007/s10552-013-0189-x,,,,23519639,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3078340,https://api.altmetric.com/v1/donut/3078340_240.png 3,Prostate cancer risk variants are not associated with disease progression,The Prostate,,,Article,2011-04-25,10.1002/pros.21403,,,,21520160,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078339,https://api.altmetric.com/v1/donut/3078339_240.png 3,Younger patients have poorer biochemical outcome after radical prostatectomy in high-risk prostate cancer.,Asian Journal of Andrology,,,Article,2011-01-09,10.1038/aja.2011.39,,,,21706038,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078337,https://api.altmetric.com/v1/donut/3078337_240.png 3,Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: A retrospective study from the view point of new 2010 anatomic stage/prognostic groups,Journal of Surgical Oncology,,,Article,2011-06-07,10.1002/jso.21988,,,,21656527,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3078335,https://api.altmetric.com/v1/donut/3078335_240.png 3,The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival,European Journal of Cancer (1965),,,Article,2010-01-02,10.1016/j.ejca.2009.11.007,,,,20005697,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078334,https://api.altmetric.com/v1/donut/3078334_240.png 3,New treatment options for patients with metastatic castration-resistant prostate cancer.,Cancer Treatment Reviews,,,Article,2012-01-08,10.1016/j.ctrv.2011.07.007,,,,21944872,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078333,https://api.altmetric.com/v1/donut/3078333_240.png 3,Docetaxel?mediated apoptosis in myeloid progenitor TF?1 cells is mitigated by zinc: Potential implication for prostate cancer therapy,The Prostate,,,Article,2011-02-09,10.1002/pros.21357,,,,21308721,PMC3106130,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078331,https://api.altmetric.com/v1/donut/3078331_240.png 3,Prognostic value of microvessel density in prostate cancer: a tissue microarray study,World Journal of Urology,,,Article,2009-08-28,10.1007/s00345-009-0471-4,,,,19714336,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078330,https://api.altmetric.com/v1/donut/3078330_240.png 3,Economic analysis of active surveillance for localized prostate cancer.,Current Opinion in Urology,,,Article,2012-05-01,10.1097/mou.0b013e328351dd32,,,,22388666,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078329,https://api.altmetric.com/v1/donut/3078329_240.png 3,[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2011-09-20,10.1007/s00259-011-1920-z,,,,21932120,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078328,https://api.altmetric.com/v1/donut/3078328_240.png 3,Active surveillance for prostate cancer compared with immediate treatment,Cancer (0008543X),,,Article,2011-12-16,10.1002/cncr.26688,,,,22180322,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/3078326,https://api.altmetric.com/v1/donut/3078326_240.png 3,The great prostate cancer debate.,Scientific American,,,Article,2012-02-04,,,,,22295676,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078323,https://api.altmetric.com/v1/donut/3078323_240.png 3,Non-surgical treatment for early prostate cancer.,journal of the Royal College of Physicians of Edinburgh,,,Article,2010-12-01,10.4997/jrcpe.2010.419,,,,21132145,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078322,https://api.altmetric.com/v1/donut/3078322_240.png 3,High accuracy of Swedish death certificates in men participating in screening for prostate cancer: A comparative study of official death certificates with a cause of death committee using a standardized algorithm,Scandinavian Journal of Urology & Nephrology,,,Article,2011-04-06,10.3109/00365599.2011.559950,,,,21463227,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078321,https://api.altmetric.com/v1/donut/3078321_240.png 3,A rapid access diagnostic clinic for prostate cancer: the experience after one year,Irish Journal of Medical Science,,,Article,2011-02-04,10.1007/s11845-011-0695-3,,,,21293947,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078320,https://api.altmetric.com/v1/donut/3078320_240.png 3,"Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer",Lancet Oncology,,,Article,2015-11-17,10.1016/s1470-2045(03)01035-0,,,,12681267,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3078319,https://api.altmetric.com/v1/donut/3078319_240.png 3,A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.,Anti-Cancer Drugs,,,Article,2009-03-01,10.1097/cad.0b013e328325a867,,,,19396016,PMC3225398,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078318,https://api.altmetric.com/v1/donut/3078318_240.png 3,"Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer",Cancer Chemotherapy & Pharmacology,,,Article,2007-03-21,10.1007/s00280-007-0445-4,,,,17375305,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078317,https://api.altmetric.com/v1/donut/3078317_240.png 3,Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,2012-07-01,10.1007/s00280-012-1914-y,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078313,https://api.altmetric.com/v1/donut/3078313_240.png 3,Simultaneous FDG PET+/Glut1+ lung and FDG PET?/Glut1? subcarinal lymph node metastases from prostate cancer,Annals of Nuclear Medicine,,,Article,2009-05-13,10.1007/s12149-009-0264-2,,,,19437096,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078312,https://api.altmetric.com/v1/donut/3078312_240.png 3,Evaluation of prediagnostic prostate?specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively,International Journal of Cancer,,,Article,2010-07-23,10.1002/ijc.25570,,,,20658531,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078308,https://api.altmetric.com/v1/donut/3078308_240.png 3,Predictors of mortality after androgen?deprivation therapy in patients with rapidly rising prostate?specific antigen levels after local therapy for prostate cancer,Cancer (0008543X),,,Article,2006-06-22,10.1002/cncr.22018,,,,16795068,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078307,https://api.altmetric.com/v1/donut/3078307_240.png 3,Docetaxel as a vital option for corticosteroid-refractory prostate cancer,International Urology and Nephrology,,,Article,2011-03-11,10.1007/s11255-011-9922-0,,,,21394439,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078306,https://api.altmetric.com/v1/donut/3078306_240.png 3,"External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes","International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-01-06,10.1016/j.ijrobp.2003.10.033,,,,15145150,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078304,https://api.altmetric.com/v1/donut/3078304_240.png 3,Prostate Cancer Screening,Current Oncology Reports,,,Article,2010-10-28,10.1007/s11912-010-0136-x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078303,https://api.altmetric.com/v1/donut/3078303_240.png 3,Older Korean American Men’s Prostate Cancer Screening Behavior: The Prime Role of Culture,Journal of Immigrant & Minority Health,,,Article,2013-03-16,10.1007/s10903-013-9804-x,,,,23504334,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3078302,https://api.altmetric.com/v1/donut/3078302_240.png 3,"Correlations between age, Charlson score and outcome in clinical unilateral T3a prostate cancer",Asian Journal of Andrology,,,Article,2008-12-15,10.1038/aja.2008.35,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078301,https://api.altmetric.com/v1/donut/3078301_240.png 3,Biomarkers for the diagnosis of new and recurrent prostate cancer,Biomarkers in Medicine,,,Article,2012-10-01,10.2217/bmm.12.72,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078299,https://api.altmetric.com/v1/donut/3078299_240.png 3,The burden of prostate cancer in Asian nations,Journal of Carcinogenesis,,,Article,2012-01-01,10.4103/1477-3163.94025,,,,22529743,PMC3327049,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078296,https://api.altmetric.com/v1/donut/3078296_240.png 3,Molecular markers of outcome after radiotherapy in patients with prostate carcinoma,Cancer (0008543X),,,Article,2003-03-18,10.1002/cncr.11230,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078294,https://api.altmetric.com/v1/donut/3078294_240.png 3,Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer,The Journal of Urology,,,Article,2011-01-09,10.1016/j.juro.2011.04.076,,,,21788044,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078293,https://api.altmetric.com/v1/donut/3078293_240.png 3,Treatment of Painful Bone Metastases in Hormone-Refractory Prostate Cancer with Zoledronic Acid and Samarium-153-Ethylenediaminetetramethylphosphonic Acid Combined,Journal of Palliative Medicine,,,Article,2009-07-15,10.1089/jpm.2009.9591,,,,19594354,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078291,https://api.altmetric.com/v1/donut/3078291_240.png 3,Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.,Current opinion in oncology,,,Article,2009-09-01,10.1097/cco.0b013e32832d56e4,,,,19535981,PMC2788311,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078289,https://api.altmetric.com/v1/donut/3078289_240.png 3,Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy,World Journal of Urology,,,Article,2011-08-11,10.1007/s00345-011-0741-9,,,,21833558,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078288,https://api.altmetric.com/v1/donut/3078288_240.png 3,Management of lymph nodes in early prostate cancer.,Minerva Urologica E Nefrologica,,,Article,2008-04-22,,,,,18427434,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078286,https://api.altmetric.com/v1/donut/3078286_240.png 3,Positive predictive value of prostate biopsy indicated by prostate?specific?antigen?based prostate cancer screening: trends over time in a European randomized trial*,British Journal of Urology,,,Article,2012-10-08,10.1111/j.1464-410x.2012.11481.x,,,,23043563,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078285,https://api.altmetric.com/v1/donut/3078285_240.png 3,Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients,International Journal of Clinical Oncology,,,Article,2009-04-24,10.1007/s10147-008-0814-y,,,,19390944,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078283,https://api.altmetric.com/v1/donut/3078283_240.png 3,"EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.",European Urology,,,Article,2011-02-16,10.1016/j.eururo.2011.01.025,,,,21315502,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,141,https://www.altmetric.com/details/3078281,https://api.altmetric.com/v1/donut/3078281_240.png 3,Time to an undetectable prostate?specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer?specific mortality,Cancer (0008543X),,,Article,2007-02-21,10.1002/cncr.22550,,,,17315162,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078280,https://api.altmetric.com/v1/donut/3078280_240.png 3,Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer,British Journal of Urology,,,Article,2010-11-02,10.1111/j.1464-410x.2010.09816.x,,,,21050360,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078279,https://api.altmetric.com/v1/donut/3078279_240.png 3,Patient Satisfaction with Health-Related Quality of Life: Implications for Prognosis in Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2008-01-09,10.3816/cgc.2008.n.014,,,,18824431,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078278,https://api.altmetric.com/v1/donut/3078278_240.png 3,Pilot Study of Rapamycin in Patients with Hormone-Refractory Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2008-01-09,10.3816/cgc.2008.n.015,,,,18824432,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078277,https://api.altmetric.com/v1/donut/3078277_240.png 3,Contemporary management of patients with T1a and T1b prostate cancer.,Current Opinion in Urology,,,Article,2011-05-01,10.1097/mou.0b013e328344e4ad,,,,21358335,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078276,https://api.altmetric.com/v1/donut/3078276_240.png 3,Prostate cancer diagnosis: The impact on patients’ mental health,European Journal of Cancer (1965),,,Article,2006-01-15,10.1016/j.ejca.2005.10.011,,,,16326098,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078273,https://api.altmetric.com/v1/donut/3078273_240.png 3,Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis.,Archives of Medical Science,,,Article,2012-11-29,10.5114/aoms.2012.31610,,,,23185184,PMC3506233,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078272,https://api.altmetric.com/v1/donut/3078272_240.png 3,Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer,Urologic Oncology,,,Article,2012-01-07,10.1016/j.urolonc.2010.08.007,,,,21163673,PMC3107360,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078271,https://api.altmetric.com/v1/donut/3078271_240.png 3,Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease,Oncology Reports,,,Article,2004-09-01,10.3892/or.12.3.631,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078267,https://api.altmetric.com/v1/donut/3078267_240.png 3,Screening for prostate cancer: an updated review,Expert Review of Anticancer Therapy,,,Article,2012-12-26,10.1586/era.12.154,,,,23259431,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078266,https://api.altmetric.com/v1/donut/3078266_240.png 3,"Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer",Urology,,,Article,2005-01-12,10.1016/j.urology.2005.06.106,,,,16360448,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078265,https://api.altmetric.com/v1/donut/3078265_240.png 3,Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsy,International Journal of Urology,,,Article,2010-03-29,10.1111/j.1442-2042.2010.02513.x,,,,20370843,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078262,https://api.altmetric.com/v1/donut/3078262_240.png 3,Significance of increased scrotal Tc-99m MDP uptake in patients with prostate cancer.,Nuclear Medicine Communications,,,Article,2011-02-01,10.1097/mnm.0b013e328341a75c,,,,21085045,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078259,https://api.altmetric.com/v1/donut/3078259_240.png 3,Much has been made of prostate cancer screening recently. What are the pros and cons of screening for this disease?,Duke Medicine Health News,,,Article,2012-03-10,,,,,22397014,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078256,https://api.altmetric.com/v1/donut/3078256_240.png 3,"ACTIVE SURVEILLANCE: A SAFE, LOW?COST PROGNOSTIC TEST FOR PROSTATE CANCER",British Journal of Urology,,,Article,2008-03-05,10.1111/j.1464-410x.2008.07553.x,,,,18325062,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078253,https://api.altmetric.com/v1/donut/3078253_240.png 3,"Active Surveillance for Favorable-risk Prostate Cancer: Background, Patient Selection, Triggers for Intervention, and Outcomes",Current Urology Reports,,,Article,2012-04-04,10.1007/s11934-012-0242-4,,,,22477615,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078252,https://api.altmetric.com/v1/donut/3078252_240.png 3,"Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future",Advances in Urology,,,Article,2012-05-16,10.1155/2012/589160,,,,22666240,PMC3362007,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3078249,https://api.altmetric.com/v1/donut/3078249_240.png 3,Landmarks in non?hormonal pharmacological therapies for castration?resistant prostate cancer,British Journal of Urology,,,Article,2012-10-10,10.1111/j.1464-410x.2012.11430.x,,,,23046036,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078248,https://api.altmetric.com/v1/donut/3078248_240.png 3,Role of histopathology and molecular markers in the active surveillance of prostate cancer,Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.522199,,,,21604942,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3078247,https://api.altmetric.com/v1/donut/3078247_240.png 3,Preoperative predictors of pathologic stage T2a and pathologic Gleason score ? 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance,Medical Oncology,,,Article,2012-12-22,10.1007/s12032-012-0326-5,,,,23263824,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078245,https://api.altmetric.com/v1/donut/3078245_240.png 3,The role of MRI in active surveillance of prostate cancer,Current Opinion in Urology,,,Article,2013-03-01,10.1097/mou.0b013e32835f899f,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078244,https://api.altmetric.com/v1/donut/3078244_240.png 3,Optimizing molecular signatures for predicting prostate cancer recurrence,The Prostate,,,Article,2009-04-02,10.1002/pros.20961,,,,19343730,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078242,https://api.altmetric.com/v1/donut/3078242_240.png 3,"Identifying and characterizing “escapes”—men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam)",International Journal of Cancer,,,Article,2011-03-29,10.1002/ijc.25947,,,,21448904,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078241,https://api.altmetric.com/v1/donut/3078241_240.png 3,Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences,The Prostate,,,Article,2011-05-02,10.1002/pros.21418,,,,21538426,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078239,https://api.altmetric.com/v1/donut/3078239_240.png 3,"Evidence of a novel docetaxel sensitizer, garlic?derived S?allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer",International Journal of Cancer,,,Article,2008-01-08,10.1002/ijc.23355,,,,18183597,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078238,https://api.altmetric.com/v1/donut/3078238_240.png 3,Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7,The Prostate,,,Article,2006-03-15,10.1002/pros.20418,,,,16541423,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078236,https://api.altmetric.com/v1/donut/3078236_240.png 3,Management of locally advanced prostate cancer,Asian Journal of Andrology,,,Article,2008-12-01,10.1038/aja.2008.9,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078234,https://api.altmetric.com/v1/donut/3078234_240.png 3,Comparison of incidentally detected prostate cancer with screen?detected prostate cancer treated by prostatectomy,The Prostate,,,Article,2011-05-02,10.1002/pros.21415,,,,21538424,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078233,https://api.altmetric.com/v1/donut/3078233_240.png 3,Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance,Scandinavian Journal of Urology & Nephrology,,,Article,2012-08-01,10.3109/00365599.2012.669791,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078232,https://api.altmetric.com/v1/donut/3078232_240.png 3,Randomized phase II study of danusertib in patients with metastatic castration?resistant prostate cancer after docetaxel failure,British Journal of Urology,,,Article,2012-08-29,10.1111/j.1464-410x.2012.11404.x,,,,22928785,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078230,https://api.altmetric.com/v1/donut/3078230_240.png 3,The Feasibility of Multiparametric Magnetic Resonance Imaging for Targeted Biopsy Using Novel Navigation Systems to Detect Early Stage Prostate Cancer: The Preliminary Experience,Journal of Endourology,,,Article,2012-09-13,10.1089/end.2012.0215,,,,22966987,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3078226,https://api.altmetric.com/v1/donut/3078226_240.png 3,MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer,PLoS ONE,,,Article,2011-07-14,10.1371/journal.pone.0021366,,,,21754986,PMC3130772,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078224,https://api.altmetric.com/v1/donut/3078224_240.png 3,Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review,Medical Oncology,,,Article,2011-02-20,10.1007/s12032-011-9855-6,,,,21336988,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,298,https://www.altmetric.com/details/3078222,https://api.altmetric.com/v1/donut/3078222_240.png 3,Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer.,Nuclear Medicine Communications,,,Article,2011-06-01,10.1097/mnm.0b013e3283455765,,,,21394046,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078221,https://api.altmetric.com/v1/donut/3078221_240.png 3,Population screening for prostate cancer: An overview of available studies and meta?analysis,International Journal of Urology,,,Article,2011-11-22,10.1111/j.1442-2042.2011.02912.x,,,,22103653,,1854/LU-2028734,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078216,https://api.altmetric.com/v1/donut/3078216_240.png 3,Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies,Expert Review of Anticancer Therapy,,,Article,2010-01-12,10.1586/era.10.191,,,,21110764,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078215,https://api.altmetric.com/v1/donut/3078215_240.png 3,"Phase II study of cytarabine in men with docetaxel?refractory, castration?resistant prostate cancer with evaluation of TMPRSS2?ERG and SPINK1 as serum biomarkers",British Journal of Urology,,,Article,2012-02-07,10.1111/j.1464-410x.2011.10922.x,,,,22313860,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078214,https://api.altmetric.com/v1/donut/3078214_240.png 3,Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.,The American Journal of Surgical Pathology,,,Article,2011-09-01,10.1097/pas.0b013e3182217b79,,,,21836493,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078213,https://api.altmetric.com/v1/donut/3078213_240.png 3,A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer,Scandinavian Journal of Urology & Nephrology,,,Article,2011-09-13,10.3109/00365599.2011.615759,,,,21905981,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078212,https://api.altmetric.com/v1/donut/3078212_240.png 3,Additive effect of zoledronic acid on serum prostate?specific antigen changes for hormone?sensitive prostate cancer patients with bone metastasis treated by combined androgen blockade,International Journal of Urology,,,Article,2011-11-29,10.1111/j.1442-2042.2011.02914.x,,,,22126137,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078210,https://api.altmetric.com/v1/donut/3078210_240.png 3,"Screening, risk assessment, and the approach to therapy in patients with prostate cancer",Cancer (0008543X),,,Article,2010-10-19,10.1002/cncr.25477,,,,20960523,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3078209,https://api.altmetric.com/v1/donut/3078209_240.png 3,'Free' prostate cancer screens can be costly.,Consumer Reports,,,Article,2011-04-26,,,,,21513002,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078207,https://api.altmetric.com/v1/donut/3078207_240.png 3,Relative 8q gain predicts disease?specific survival irrespective of the TMPRSS2?ERG fusion status in diagnostic biopsies of prostate cancer,"Genes, Chromosomes, and Cancer",,,Article,2011-05-16,10.1002/gcc.20888,,,,21584900,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078206,https://api.altmetric.com/v1/donut/3078206_240.png 3,Prospective evaluation of a 12-week walking exercise program and its effect on fatigue in prostate cancer patients undergoing radical external beam radiotherapy.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2011-08-01,10.1097/coc.0b013e3181e841ec,,,,20686404,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078204,https://api.altmetric.com/v1/donut/3078204_240.png 3,Active surveillance for low-risk prostate cancer,F1000Prime Rep,,,Article,2012-08-01,10.3410/m4-16,,,,22891078,PMC3412317,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078202,https://api.altmetric.com/v1/donut/3078202_240.png 3,APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis,European Journal of Human Genetics,,,Article,2013-01-09,10.1038/ejhg.2012.281,,,,23299921,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078200,https://api.altmetric.com/v1/donut/3078200_240.png 3,Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer,Annals of Oncology,,,Article,2009-03-15,10.1093/annonc/mdn665,,,,19087985,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078199,https://api.altmetric.com/v1/donut/3078199_240.png 3,Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study,British Journal of Urology,,,Article,2011-11-23,10.1111/j.1464-410x.2011.10679.x,,,,22112199,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3078198,https://api.altmetric.com/v1/donut/3078198_240.png 3,18F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2011-05-15,10.1007/s00259-011-1837-6,,,,21573978,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078197,https://api.altmetric.com/v1/donut/3078197_240.png 3,Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patients.,European Urology,,,Article,2005-01-08,10.1016/j.eururo.2005.03.017,,,,16005374,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078195,https://api.altmetric.com/v1/donut/3078195_240.png 3,Care of the Elderly Patient with Prostate Cancer: What's New and What's the Same,Consultant Pharmacist,,,Article,2011-06-01,10.4140/tcp.n.2011.390,,,,21628138,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078194,https://api.altmetric.com/v1/donut/3078194_240.png 3,Detection of prostate cancer relapse with PET/CT using a novel radiotracer,Acta Oncologica,,,Article,2012-03-01,10.3109/0284186x.2011.614638,,,,21936756,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078193,https://api.altmetric.com/v1/donut/3078193_240.png 3,Resolution of Thrombocytopenia Secondary to Disseminated Intravascular Coagulation With Docetaxel Chemotherapy in Prostate Cancer,American journal of therapeutics (Print),,,Article,2012-01-01,10.1097/mjt.0b013e3181e1cb8c,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078192,https://api.altmetric.com/v1/donut/3078192_240.png 3,Patterns and Correlates of Prostate Cancer Treatment in Older Men,American Journal of Medicine,,,Article,2011-01-03,10.1016/j.amjmed.2010.10.016,,,,21396507,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078191,https://api.altmetric.com/v1/donut/3078191_240.png 3,ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis,Virchows Archiv,,,Article,2006-11-08,10.1007/s00428-006-0315-1,,,,17106710,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078189,https://api.altmetric.com/v1/donut/3078189_240.png 3,Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer.,Canadian Urological Association Journal,,,Article,2010-08-10,,,,,20694103,PMC2910771,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078186,https://api.altmetric.com/v1/donut/3078186_240.png 3,Imaging Prostate Cancer: An Update on Positron Emission Tomography and Magnetic Resonance Imaging,Current Urology Reports,,,Article,2010-03-19,10.1007/s11934-010-0105-9,,,,20425625,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3078184,https://api.altmetric.com/v1/donut/3078184_240.png 3,Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2011-11-16,10.1007/s00259-011-1970-2,,,,22086143,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3078181,https://api.altmetric.com/v1/donut/3078181_240.png 3,Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates,Journal of Cellular Biochemistry,,,Article,2011-04-18,10.1002/jcb.23070,,,,21344486,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3078180,https://api.altmetric.com/v1/donut/3078180_240.png 3,Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials,Supportive Care in Cancer,,,Article,2011-07-01,10.1007/s00520-011-1219-4,,,,21720747,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078179,https://api.altmetric.com/v1/donut/3078179_240.png 3,Solitary pulmonary metastasis from prostate sarcomatoid cancer,World Journal of Surgical Oncology,,,Article,2010-11-19,10.1186/1477-7819-8-101,,,,21092117,PMC2995788,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078178,https://api.altmetric.com/v1/donut/3078178_240.png 3,Expression of matrix metalloproteinase-9 in prostate cancer. Preliminary experience.,Archivos Españoles de Urología (Ed. impresa),,,Article,2010-04-01,,,,,20354276,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078175,https://api.altmetric.com/v1/donut/3078175_240.png 3,Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma,Cancer (0008543X),,,Article,2004-04-28,10.1002/cncr.20305,,,,15197798,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078173,https://api.altmetric.com/v1/donut/3078173_240.png 3,ACP Journal Club. Review: Prostate cancer screening using PSA does not decrease mortality.,Annals of Internal Medicine,,,Article,2011-01-19,10.1059/0003-4819-154-2-201101180-02002,,,,21242356,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078172,https://api.altmetric.com/v1/donut/3078172_240.png 3,Predicting life expectancy in prostate cancer patients.,Current Opinion in Supportive and Palliative Care,,,Article,2009-09-01,10.1097/spc.0b013e32832e9c80,,,,19553817,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078171,https://api.altmetric.com/v1/donut/3078171_240.png 3,"Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent®) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer",Journal of Cancer Research & Clinical Oncology,,,Article,2007-06-26,10.1007/s00432-007-0247-4,,,,17593391,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078170,https://api.altmetric.com/v1/donut/3078170_240.png 3,High?resolution magic angle spinning 1H MRS in prostate cancer,NMR in Biomedicine,,,Article,2013-03-26,10.1002/nbm.2944,,,,23529951,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078168,https://api.altmetric.com/v1/donut/3078168_240.png 3,Zoledronic acid to prevent bone loss in Chinese men receiving androgen deprivation therapy for prostate cancer,Asia Pacific Journal of Clinical Oncology,,,Article,2011-05-18,10.1111/j.1743-7563.2011.01388.x,,,,21585697,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078167,https://api.altmetric.com/v1/donut/3078167_240.png 3,DNA Methylation Changes Correlate with Gleason Score and Tumor Stage in Prostate Cancer,DNA & Cell Biology,,,Article,2011-08-12,10.1089/dna.2011.1311,,,,21830905,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078166,https://api.altmetric.com/v1/donut/3078166_240.png 3,Recurrence?free survival rates after external?beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate?specific antigen era,Cancer (0008543X),,,Article,2004-02-13,10.1002/cncr.20093,,,,15022298,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078165,https://api.altmetric.com/v1/donut/3078165_240.png 3,Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer,La Radiologia Medica,,,Article,2008-04-14,10.1007/s11547-008-0263-8,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3078164,https://api.altmetric.com/v1/donut/3078164_240.png 3,"Clinical, Demographic and Psychosocial Correlates of Complementary and Alternative Medicine Use by Men Diagnosed With Localized Prostate Cancer",The Journal of Urology,,,Article,2003-01-07,10.1097/01.ju.0000070963.12496.cc,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078163,https://api.altmetric.com/v1/donut/3078163_240.png 3,Is there a role for chemotherapy in nonmetastatic prostate cancer?,Current Opinion in Supportive and Palliative Care,,,Article,2010-09-01,10.1097/spc.0b013e32833c6cfe,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078162,https://api.altmetric.com/v1/donut/3078162_240.png 3,Contemporary management of metastatic castration-resistant prostate cancer.,Current Opinion in Urology,,,Article,2011-05-01,10.1097/mou.0b013e3283449e19,,,,21455038,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078161,https://api.altmetric.com/v1/donut/3078161_240.png 3,12-YEAR OUTCOMES FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER,The Journal of Urology,,,Article,2005-04-12,10.1097/01.ju.0000154633.73092.8e,,,,15821486,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078159,https://api.altmetric.com/v1/donut/3078159_240.png 3,Management of metastatic prostate cancer: the crucial role of geriatric assessment,British Journal of Urology,,,Article,2008-02-28,10.1111/j.1464-410x.2007.07486.x,,,,18307689,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3078158,https://api.altmetric.com/v1/donut/3078158_240.png 3,Characterization of ZAG protein expression in prostate cancer using a semi?automated microscope system,The Prostate,,,Article,2006-04-05,10.1002/pros.20405,,,,16598739,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078157,https://api.altmetric.com/v1/donut/3078157_240.png 3,The nutritional status of older men with advanced prostate cancer and factors affecting it,Supportive Care in Cancer,,,Article,2004-08-21,10.1007/s00520-004-0635-0,,,,15322967,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078156,https://api.altmetric.com/v1/donut/3078156_240.png 3,Focal Therapy in the Management of Prostate Cancer: An Emerging Approach for Localized Prostate Cancer,Advances in Urology,,,Article,2012-04-24,10.1155/2012/391437,,,,22593764,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3078155,https://api.altmetric.com/v1/donut/3078155_240.png 3,"The effect of dyadic intervention on self?efficacy, social support, and depression for men with prostate cancer",Psycho-Oncology,,,Article,2003-06-03,10.1002/pon.718,,,,14745745,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3078153,https://api.altmetric.com/v1/donut/3078153_240.png 3,Coffee Consumption and Prostate Cancer Aggressiveness Among African and Caucasian Americans in a Population-Based Study,Nutrition and Cancer,,,Article,2012-05-09,10.1080/01635581.2012.676144,,,,22564042,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078149,https://api.altmetric.com/v1/donut/3078149_240.png 3,Assays for Prostate Cancer,Molecular Diagnosis & Therapy,,,Article,2013-01-25,10.1007/s40291-013-0014-y,,,,23355098,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078148,https://api.altmetric.com/v1/donut/3078148_240.png 3,The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen Deprivation,The Prostate,,,Article,2011-03-22,10.1002/pros.21377,,,,21432863,PMC3183345,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078146,https://api.altmetric.com/v1/donut/3078146_240.png 3,Methylation of the ASC gene promoter is associated with aggressive prostate cancer,The Prostate,,,Article,2006-01-19,10.1002/pros.20371,,,,16425203,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078145,https://api.altmetric.com/v1/donut/3078145_240.png 3,The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes,The Prostate,,,Article,2010-06-16,10.1002/pros.21204,,,,20564320,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078144,https://api.altmetric.com/v1/donut/3078144_240.png 3,Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer,Quality of Life Research,,,Article,2006-08-10,10.1007/s11136-006-0003-2,,,,16830258,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078142,https://api.altmetric.com/v1/donut/3078142_240.png 3,Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small?volume or low?grade prostate cancer,International Journal of Cancer,,,Article,2008-11-24,10.1002/ijc.24174,,,,19117060,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078141,https://api.altmetric.com/v1/donut/3078141_240.png 3,Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases,Medical Hypotheses,,,Article,2009-01-09,10.1016/j.mehy.2009.01.054,,,,19403241,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078139,https://api.altmetric.com/v1/donut/3078139_240.png 3,Improved Biochemical Disease-Free Survival of Men Younger Than 60 Years With Prostate Cancer Treated With High Dose Conformal External Beam Radiotherapy,The Journal of Urology,,,Article,2003-01-11,10.1097/01.ju.0000093720.46502.24,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078138,https://api.altmetric.com/v1/donut/3078138_240.png 3,Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer,Supportive Care in Cancer,,,Article,2007-01-30,10.1007/s00520-006-0203-x,,,,17262196,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078137,https://api.altmetric.com/v1/donut/3078137_240.png 3,Landmarks in prostate cancer screening,British Journal of Urology,,,Article,2012-10-10,10.1111/j.1464-410x.2012.011428.x,,,,23046034,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078136,https://api.altmetric.com/v1/donut/3078136_240.png 3,Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives.,Future Oncology,,,Article,2011-04-06,10.2217/fon.11.14,,,,21463143,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078135,https://api.altmetric.com/v1/donut/3078135_240.png 3,Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis,Current Medical Research & Opinion,,,Article,2011-01-01,10.1185/03007995.2010.535511,,,,21083514,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078131,https://api.altmetric.com/v1/donut/3078131_240.png 3,Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry,British Journal of Urology,,,Article,2011-04-21,10.1111/j.1464-410x.2011.10193.x,,,,21518230,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078129,https://api.altmetric.com/v1/donut/3078129_240.png 3,Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.,European Urology,,,Article,2008-01-02,10.1016/j.eururo.2007.06.020,,,,17611015,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078128,https://api.altmetric.com/v1/donut/3078128_240.png 3,The ratio of matrix metalloproteinase to E?cadherin expression: A pilot study to assess mRNA and protein expression among African American prostate cancer patients,The Prostate,,,Article,2008-07-10,10.1002/pros.20812,,,,18618693,PMC2574568,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078124,https://api.altmetric.com/v1/donut/3078124_240.png 3,Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high?risk prostate cancer,British Journal of Urology,,,Article,2012-11-06,10.1111/j.1464-410x.2012.11646.x,,,,23130821,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3078121,https://api.altmetric.com/v1/donut/3078121_240.png 3,Active surveillance for prostate cancer: a review.,Archivos Españoles de Urología (Ed. impresa),,,Article,2011-11-05,,,,,22052761,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078120,https://api.altmetric.com/v1/donut/3078120_240.png 3,A miRNA expression signature that separates between normal and malignant prostate tissues,Cancer Cell International,,,Article,2011-05-27,10.1186/1475-2867-11-14,,,,21619623,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3078119,https://api.altmetric.com/v1/donut/3078119_240.png 3,"Associations of Serum Testosterone with Microvessel Density, Androgen Receptor Density and Androgen Receptor Gene polymorphism In prostate cancer",The Journal of Urology,,,Article,2003-04-01,10.1097/01.ju.0000056900.26628.16,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078116,https://api.altmetric.com/v1/donut/3078116_240.png 3,Prostate-Specific Antigen Test for Prostate Cancer Screening: American Society of Clinical Oncology Provisional Clinical Opinion,Journal of Oncology Practice,,,Article,2012-09-01,10.1200/jop.2012.000715,,,,23277770,PMC3439233,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078115,https://api.altmetric.com/v1/donut/3078115_240.png 3,Optimal timing of chemotherapy in androgen independent prostate cancer,Urologic Oncology,,,Article,2015-07-25,10.1016/j.urolonc.2008.04.004,,,,19111808,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078113,https://api.altmetric.com/v1/donut/3078113_240.png 3,Biochemical and clinical significance of the posttreatment prostate?specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone,Cancer (0008543X),,,Article,2006-08-30,10.1002/cncr.22183,,,,16944536,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078112,https://api.altmetric.com/v1/donut/3078112_240.png 3,Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer,International Journal of Cancer,,,Article,2011-05-28,10.1002/ijc.26043,,,,21387309,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078111,https://api.altmetric.com/v1/donut/3078111_240.png 3,Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer,Virchows Archiv,,,Article,2012-07-06,10.1007/s00428-012-1259-2,,,,22767265,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078107,https://api.altmetric.com/v1/donut/3078107_240.png 3,Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy,Journal of Cancer Research & Clinical Oncology,,,Article,2003-09-26,10.1007/s00432-003-0496-9,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078106,https://api.altmetric.com/v1/donut/3078106_240.png 3,Cabazitaxel for the treatment of castration-resistant prostate cancer.,Future Oncology,,,Article,2010-12-23,10.2217/fon.10.168,,,,21174534,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078105,https://api.altmetric.com/v1/donut/3078105_240.png 3,New strategies for medical management of castration-resistant prostate cancer.,Oncology (08909091),,,Article,2011-05-16,10.1159/000323495,,,,21577012,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078102,https://api.altmetric.com/v1/donut/3078102_240.png 3,DNA content in the diagnostic biopsy for benign?adjacent and cancer?tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme,British Journal of Urology,,,Article,2009-08-12,10.1111/j.1464-410x.2009.08791.x,,,,19678815,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078101,https://api.altmetric.com/v1/donut/3078101_240.png 3,The rising incidence and mortality of prostate cancer in Belgrade population.,Collegium Antropologicum,,,Article,2011-01-06,,,,,21755724,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078100,https://api.altmetric.com/v1/donut/3078100_240.png 3,Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer,International Journal of Cancer,,,Article,2003-08-29,10.1002/ijc.11471,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078098,https://api.altmetric.com/v1/donut/3078098_240.png 3,Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2009-01-04,,,,,19414350,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078097,https://api.altmetric.com/v1/donut/3078097_240.png 3,188Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2009-03-25,10.1007/s00259-009-1119-8,,,,19319526,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078096,https://api.altmetric.com/v1/donut/3078096_240.png 3,Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores,BMC Cancer,,,Article,2010-06-30,10.1186/1471-2407-10-341,,,,20591150,PMC2909208,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078094,https://api.altmetric.com/v1/donut/3078094_240.png 3,Improved Clinical Staging System Combining Biopsy Laterality and TNM Stage for Men With T1c and T2 Prostate Cancer: Results From the SEARCH Database,The Journal of Urology,,,Article,2003-01-06,10.1097/01.ju.0000065763.21602.14,,,,12771734,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078091,https://api.altmetric.com/v1/donut/3078091_240.png 3,MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden,British Journal of Cancer,,,Article,2007-08-28,10.1038/sj.bjc.6603944,,,,17726465,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078090,https://api.altmetric.com/v1/donut/3078090_240.png 3,Management of Prostate Cancer in the Older Man,Seminars in oncology,,,Article,2008-01-12,10.1053/j.seminoncol.2008.08.003,,,,19027464,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3078089,https://api.altmetric.com/v1/donut/3078089_240.png 3,"Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer",Acta Oncologica,,,Article,2012-07-01,10.3109/0284186x.2012.682627,,,,22793038,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078087,https://api.altmetric.com/v1/donut/3078087_240.png 3,Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.,Urology,,,Article,2007-01-03,10.1016/j.urology.2006.12.015,,,,17382161,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078086,https://api.altmetric.com/v1/donut/3078086_240.png 3,Lymphovascular invasion in prostate cancer,Cancer (0008543X),,,Article,2006-03-03,10.1002/cncr.21774,,,,16518811,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078084,https://api.altmetric.com/v1/donut/3078084_240.png 3,Re?evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer,British Journal of Urology,,,Article,2012-11-29,10.1111/j.1464-410x.2012.11477.x,,,,23194127,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078083,https://api.altmetric.com/v1/donut/3078083_240.png 3,PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2011-04-22,,,,,21508392,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078082,https://api.altmetric.com/v1/donut/3078082_240.png 3,Prostate cancer staging and grading at radical prostatectomy over time.,Advances in Anatomic Pathology,,,Article,2011-03-01,10.1097/pap.0b013e31820cb506,,,,21326013,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078081,https://api.altmetric.com/v1/donut/3078081_240.png 3,Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy,Journal of Translational Medicine,,,Article,2011-09-14,10.1186/1479-5876-9-153,,,,21917134,PMC3184272,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3078079,https://api.altmetric.com/v1/donut/3078079_240.png 3,Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma,Cancer (0008543X),,,Article,2005-12-01,10.1002/cncr.21577,,,,16323173,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3078078,https://api.altmetric.com/v1/donut/3078078_240.png 3,A longitudinal study of changes in provider–patient interaction in treatment of localized prostate cancer,Supportive Care in Cancer,,,Article,2011-04-12,10.1007/s00520-011-1151-7,,,,21479989,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078077,https://api.altmetric.com/v1/donut/3078077_240.png 3,Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer,Urology,,,Article,2006-01-06,10.1016/j.urology.2005.12.009,,,,16697447,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078076,https://api.altmetric.com/v1/donut/3078076_240.png 3,Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer.,Tumori,,,Article,2013-02-09,10.1700/1217.13491,,,,23389354,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078075,https://api.altmetric.com/v1/donut/3078075_240.png 3,The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma,The Prostate,,,Article,2009-05-28,10.1002/pros.20988,,,,19479898,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078073,https://api.altmetric.com/v1/donut/3078073_240.png 3,[You have to take the prostate cancer seriously].,MMW - Fortschritte der Medizin,,,Article,2012-05-31,,,,,22642002,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078072,https://api.altmetric.com/v1/donut/3078072_240.png 3,"Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer",The Prostate,,,Article,2004-09-17,10.1002/pros.20163,,,,15378518,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078071,https://api.altmetric.com/v1/donut/3078071_240.png 3,Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging,Medical Physics,,,Article,2012-06-11,10.1118/1.4722753,,,,22830742,,,2012MedPh..39.4093S,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/3078067,https://api.altmetric.com/v1/donut/3078067_240.png 3,Active surveillance as a practical strategy to differentiate lethal and non-lethal prostate cancer subtypes.,Asian Journal of Andrology,,,Article,2012-04-17,10.1038/aja.2011.151,,,,22504873,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078066,https://api.altmetric.com/v1/donut/3078066_240.png 3,Combining 33 genetic variants with prostate?specific antigen for prediction of prostate cancer: Longitudinal study,International Journal of Cancer,,,Article,2011-04-01,10.1002/ijc.25986,,,,21328341,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3078065,https://api.altmetric.com/v1/donut/3078065_240.png 3,Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer,Journal of Biomedicine & Biotechnology,,,Article,2009-10-22,10.1155/2009/625394,,,,19859572,PMC2765690,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3078064,https://api.altmetric.com/v1/donut/3078064_240.png 3,Radical Prostatectomy for High-risk Prostate Cancer Defined by Preoperative Criteria: Oncologic Follow-up in National Multicenter Study in 813 Patients and Assessment of Easy-to-use Prognostic Substratification,Urology,,,Article,2011-01-09,10.1016/j.urology.2011.05.021,,,,21783233,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3078063,https://api.altmetric.com/v1/donut/3078063_240.png 3,A self-adaptive case-based reasoning system for dose planning in prostate cancer radiotherapy,Medical Physics,,,Article,2011-11-21,10.1118/1.3660517,,,,22149835,,,2011MedPh..38.6528M,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3078060,https://api.altmetric.com/v1/donut/3078060_240.png 3,Combination Therapy of Ethinylestradiol and Somatostatin Analogue Reintroduces Objective Clinical Responses and Decreases Chromogranin A in Patients With Androgen Ablation Refractory Prostate Cancer,The Journal of Urology,,,Article,2003-01-11,10.1097/01.ju.0000092480.71873.26,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078059,https://api.altmetric.com/v1/donut/3078059_240.png 3,Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer.,Urologia Internationalis,,,Article,2010-05-28,10.1159/000315491,,,,20516669,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078058,https://api.altmetric.com/v1/donut/3078058_240.png 3,PET/CT Imaging and Radioimmunotherapy of Prostate Cancer,Seminars in Nuclear Medicine,,,Article,2011-01-01,10.1053/j.semnuclmed.2010.08.005,,,,21111858,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/3078056,https://api.altmetric.com/v1/donut/3078056_240.png 3,"Preoperative detection of prostate cancer: A comparison with 11C?choline PET, 18F?fluorodeoxyglucose PET and MR imaging",Journal of Magnetic Resonance Imaging,,,Article,2010-04-23,10.1002/jmri.22157,,,,20432351,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3078054,https://api.altmetric.com/v1/donut/3078054_240.png 3,The prognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantly modified by androgen?deprivation therapy,The Prostate,,,Article,2010-01-19,10.1002/pros.21104,,,,20087896,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078051,https://api.altmetric.com/v1/donut/3078051_240.png 3,Advanced clinical States in prostate cancer.,Urologic Clinics of North America,,,Article,2012-10-23,10.1016/j.ucl.2012.07.011,,,,23084531,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078050,https://api.altmetric.com/v1/donut/3078050_240.png 3,The Experience with Cytotoxic Chemotherapy in Metastatic Castration-Resistant Prostate Cancer.,Urologic Clinics of North America,,,Article,2012-10-23,10.1016/j.ucl.2012.07.012,,,,23084532,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078049,https://api.altmetric.com/v1/donut/3078049_240.png 3,Prostate cancer in Denmark 1978–2009 — trends in incidence and mortality,Acta Oncologica,,,Article,2013-05-01,10.3109/0284186x.2012.702922,,,,22809166,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3078048,https://api.altmetric.com/v1/donut/3078048_240.png 3,"Gemcitabine and docetaxel in metastatic, castrate?resistant prostate cancer",Cancer (0008543X),,,Article,2010-10-04,10.1002/cncr.25457,,,,20922803,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078046,https://api.altmetric.com/v1/donut/3078046_240.png 3,Prostate Cancer With Tertiary Gleason Pattern 5 in Prostate Needle Biopsy,The American Journal of Surgical Pathology,,,Article,2009-02-01,10.1097/pas.0b013e31817fb3bd,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078045,https://api.altmetric.com/v1/donut/3078045_240.png 3,Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.,Future Oncology,,,Article,2011-12-15,10.2217/fon.11.131,,,,22149034,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078043,https://api.altmetric.com/v1/donut/3078043_240.png 3,The role of enzalutamide in the treatment of castration-resistant prostate cancer.,Future Oncology,,,Article,2012-10-04,10.2217/fon.12.99,,,,23030482,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3078042,https://api.altmetric.com/v1/donut/3078042_240.png 3,Long?term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma,Cancer (0008543X),,,Article,2003-02-03,10.1002/cncr.11154,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078040,https://api.altmetric.com/v1/donut/3078040_240.png 3,"Surgery confounds biology: The predictive value of stage?, grade? and prostate?specific antigen for recurrence after radical prostatectomy as a function of surgeon experience",International Journal of Cancer,,,Article,2010-06-09,10.1002/ijc.25502,,,,20533547,PMC2970654,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078039,https://api.altmetric.com/v1/donut/3078039_240.png 3,Global levels of histone modifications predict prostate cancer recurrence,The Prostate,,,Article,2009-09-08,10.1002/pros.21038,,,,19739128,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3078037,https://api.altmetric.com/v1/donut/3078037_240.png 3,The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer,International Urology and Nephrology,,,Article,2006-12-13,10.1007/s11255-006-0096-0,,,,17171425,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078036,https://api.altmetric.com/v1/donut/3078036_240.png 3, Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: A study from the National Prostate Cancer Register (NPCR) of Sweden ,Scandinavian Journal of Urology & Nephrology,,,Article,2012-06-01,10.3109/00365599.2012.691110,,,,22647143,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3078035,https://api.altmetric.com/v1/donut/3078035_240.png 3,Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2012-02-15,,,,,21864229,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078034,https://api.altmetric.com/v1/donut/3078034_240.png 3,Forfeited Health: Response to Open Peer Commentaries on “What's Wrong With Chemoprevention of Prostate Cancer?”,The American Journal of Bioethics,,,Article,2011-12-08,10.1080/15265161.2011.623988,,,,22146047,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3078033,https://api.altmetric.com/v1/donut/3078033_240.png 3,Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis,Urologic Oncology,,,Article,2009-01-07,10.1016/j.urolonc.2008.04.013,,,,18639473,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078032,https://api.altmetric.com/v1/donut/3078032_240.png 3,The significance of LMO2 expression in the progression of prostate cancer,The Journal of Pathology,,,Article,2006-12-14,10.1002/path.2109,,,,17167821,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078030,https://api.altmetric.com/v1/donut/3078030_240.png 3,Independent Diagnostic and Post-Treatment Prognostic Models for Prostate Cancer Demonstrate Significant Correlation with Disease Progression End Points,Journal of Endourology,,,Article,2011-09-29,10.1089/end.2011.0192,,,,21942796,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078029,https://api.altmetric.com/v1/donut/3078029_240.png 3,Prostate cancer brachytherapy: guidelines overview.,Journal of Contemporary Brachytherapy,,,Article,2013-01-27,10.5114/jcb.2012.29370,,,,23349655,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078026,https://api.altmetric.com/v1/donut/3078026_240.png 3,Clinical Significance of a Large Difference (? 2 points) between Biopsy and Post-prostatectomy Pathological Gleason Scores in Patients with Prostate Cancer,Journal of Korean Medical Science,,,Article,2011-04-01,10.3346/jkms.2011.26.4.507,,,,21468257,PMC3069569,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078024,https://api.altmetric.com/v1/donut/3078024_240.png 3,Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort,Prostate Cancer,,,Article,2011-06-26,10.1155/2011/234519,,,,22096650,PMC3195388,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3078023,https://api.altmetric.com/v1/donut/3078023_240.png 3,The Epigenetic promise for prostate cancer diagnosis,The Prostate,,,Article,2011-12-07,10.1002/pros.22459,,,,22161815,,1854/LU-3168836,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3078022,https://api.altmetric.com/v1/donut/3078022_240.png 3,Is there a role for ibandronate in the treatment of prostate cancer patients with bony metastases?,Acta Oncologica,,,Article,2009-11-22,10.1080/02841860902874748,,,,19925378,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3078021,https://api.altmetric.com/v1/donut/3078021_240.png 3,"Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer",Journal of Clinical Epidemiology,,,Article,2005-01-05,10.1016/j.jclinepi.2004.08.019,,,,15845333,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3078020,https://api.altmetric.com/v1/donut/3078020_240.png 3,Abiraterone acetate: a promising drug for the treatment of castration-resistant prostate cancer.,Future Oncology,,,Article,2010-05-15,10.2217/fon.10.48,,,,20465382,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078019,https://api.altmetric.com/v1/donut/3078019_240.png 3,Chemotherapy in hormone?refractory prostate cancer,British Journal of Urology,,,Article,2008-02-28,10.1111/j.1464-410x.2007.07485.x,,,,18307687,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078018,https://api.altmetric.com/v1/donut/3078018_240.png 3,Measurement of Circulating Cell?Free DNA in Relation to 18F?Fluorocholine PET/CT Imaging in Chemotherapy?Treated Advanced Prostate Cancer,CTS: Clinical & Translational Science,,,Article,2012-02-23,10.1111/j.1752-8062.2011.00375.x,,,,22376260,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3078017,https://api.altmetric.com/v1/donut/3078017_240.png 3,Response assessment of hormonal therapy in prostate cancer by [11C] choline PET/CT.,Clinical Nuclear Medicine,,,Article,2010-09-01,10.1097/rlu.0b013e3181e9faf5,,,,20706046,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3078016,https://api.altmetric.com/v1/donut/3078016_240.png 3,Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade,Human Pathology,,,Article,2005-01-11,10.1016/j.humpath.2005.07.023,,,,16260272,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3078015,https://api.altmetric.com/v1/donut/3078015_240.png 3,"Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study",Journal of Cancer Research & Clinical Oncology,,,Article,2008-05-20,10.1007/s00432-008-0409-z,,,,18491137,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078011,https://api.altmetric.com/v1/donut/3078011_240.png 3,Identification of AKAP?4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer,The Prostate,,,Article,2011-04-25,10.1002/pros.21400,,,,21520158,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3078009,https://api.altmetric.com/v1/donut/3078009_240.png 3,Second?line therapy for castrate?resistant prostate cancer: A literature review,Asia Pacific Journal of Clinical Oncology,,,Article,2011-08-28,10.1111/j.1743-7563.2011.01421.x,,,,21884433,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3078008,https://api.altmetric.com/v1/donut/3078008_240.png 3,Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer,International Urology and Nephrology,,,Article,2011-06-26,10.1007/s11255-011-0020-0,,,,21706297,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3078007,https://api.altmetric.com/v1/donut/3078007_240.png 3,Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer,Journal of Medicinal Chemistry,,,Article,2008-12-06,10.1021/jm801055h,,,,19053825,PMC2631656,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3078005,https://api.altmetric.com/v1/donut/3078005_240.png 3,Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer,British Journal of Urology,,,Article,2011-09-20,10.1111/j.1464-410x.2011.10583.x,,,,21933333,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3078002,https://api.altmetric.com/v1/donut/3078002_240.png 3,Variations in health-related quality of life in Japanese men who underwent iodine-125 permanent brachytherapy for localized prostate cancer,Brachytherapy,,,Article,2010-01-10,10.1016/j.brachy.2009.07.013,,,,20708440,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3078000,https://api.altmetric.com/v1/donut/3078000_240.png 3,Is 153Samarium-ethylene-diamine-tetramethyl-phosphonate (EDTMP) bone uptake influenced by bisphosphonates in patients with castration-resistant prostate cancer?,World Journal of Urology,,,Article,2011-05-11,10.1007/s00345-011-0685-0,,,,21559805,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077998,https://api.altmetric.com/v1/donut/3077998_240.png 3,"Perioperative, functional and oncological outcomes after open and minimally invasive prostate cancer surgery: experience from Australasia",British Journal of Urology,,,Article,2011-04-15,10.1111/j.1464-410x.2011.10053.x,,,,21492370,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077997,https://api.altmetric.com/v1/donut/3077997_240.png 3,Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy,International Urology and Nephrology,,,Article,2007-06-30,10.1007/s11255-007-9221-y,,,,17602304,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077996,https://api.altmetric.com/v1/donut/3077996_240.png 3,p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape,The Prostate,,,Article,2008-05-05,10.1002/pros.20772,,,,18459105,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3077994,https://api.altmetric.com/v1/donut/3077994_240.png 3,Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer,Medical Oncology,,,Article,2012-02-10,10.1007/s12032-012-0178-z,,,,22323054,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077993,https://api.altmetric.com/v1/donut/3077993_240.png 3,Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy gleason score ? 8 via contemporary multi (?12)?core prostate biopsy,British Journal of Urology,,,Article,2010-11-17,10.1111/j.1464-410x.2010.09814.x,,,,21083642,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077992,https://api.altmetric.com/v1/donut/3077992_240.png 3,A systems?based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long?term outcome in men with localized prostate cancer,British Journal of Urology,,,Article,2011-07-06,10.1111/j.1464-410x.2011.10316.x,,,,21733075,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3077990,https://api.altmetric.com/v1/donut/3077990_240.png 3,Antibodies against the cancer?testis antigen CTSP?1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical?recurrence,International Journal of Cancer,,,Article,2008-01-23,10.1002/ijc.23369,,,,18214856,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077987,https://api.altmetric.com/v1/donut/3077987_240.png 3,Prognostic significance of osteopontin expression in human prostate cancer,International Journal of Cancer,,,Article,2005-12-05,10.1002/ijc.21619,,,,16331611,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077986,https://api.altmetric.com/v1/donut/3077986_240.png 3,Initial evaluation of prostate cancer with real?time elastography based on step?section pathologic analysis after radical prostatectomy: A preliminary study,International Journal of Urology,,,Article,2007-08-02,10.1111/j.1442-2042.2007.01829.x,,,,17760747,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3077984,https://api.altmetric.com/v1/donut/3077984_240.png 3,Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?,Journal of Endourology,,,Article,2010-01-05,10.1089/end.2009.0470,,,,20367444,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077983,https://api.altmetric.com/v1/donut/3077983_240.png 3,Budget impact analysis of a new prostate cancer risk index for prostate cancer detection,Prostate Cancer & Prostatic Diseases,,,Article,2011-05-03,10.1038/pcan.2011.16,,,,21537346,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077981,https://api.altmetric.com/v1/donut/3077981_240.png 3,Ten-year survival in patients with metastatic prostate cancer.,Clinical Genitourinary Cancer,,,Article,2004-03-29,,,,,15046683,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077978,https://api.altmetric.com/v1/donut/3077978_240.png 3,"BCAR1 expression in prostate cancer: Association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining",The Prostate,,,Article,2006-12-27,10.1002/pros.20516,,,,17192874,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077977,https://api.altmetric.com/v1/donut/3077977_240.png 3,A review of expression profiling of circulating microRNAs in men with prostate cancer,British Journal of Urology,,,Article,2012-05-22,10.1111/j.1464-410x.2012.11244.x,,,,22612403,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3077976,https://api.altmetric.com/v1/donut/3077976_240.png 3,Role of Pelvic Lymph Node Dissection in Prostate Cancer Treatment,Korean Journal of Urology,,,Article,2011-07-01,10.4111/kju.2011.52.7.437,,,,21860762,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077973,https://api.altmetric.com/v1/donut/3077973_240.png 3,Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials,The Journal of Urology,,,Article,2006-01-12,10.1016/j.juro.2006.06.081,,,,17084158,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077970,https://api.altmetric.com/v1/donut/3077970_240.png 3,A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-01-06,10.1016/j.ijrobp.2003.10.059,,,,15145151,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077969,https://api.altmetric.com/v1/donut/3077969_240.png 3,Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2006-08-24,10.1007/s00259-006-0190-7,,,,16932935,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3077967,https://api.altmetric.com/v1/donut/3077967_240.png 3,Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells,The Prostate,,,Article,2010-02-17,10.1002/pros.21132,,,,20166136,PMC2877267,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077966,https://api.altmetric.com/v1/donut/3077966_240.png 3,Does Valproic Acid Induce Neuroendocrine Differentiation in Prostate Cancer?,Journal of Biomedicine & Biotechnology,,,Article,2015-07-25,10.1155/2011/607480,,,,20981253,PMC2963803,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077965,https://api.altmetric.com/v1/donut/3077965_240.png 3,Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.,European Urology,,,Article,2004-04-14,10.1016/j.eururo.2003.11.032,,,,15082200,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3077964,https://api.altmetric.com/v1/donut/3077964_240.png 3,Effect of Family History on Outcomes in Patients Treated With Definitive Brachytherapy for Clinically Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-01-01,10.1016/j.ijrobp.2008.04.031,,,,18692325,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077960,https://api.altmetric.com/v1/donut/3077960_240.png 3,Good Ethics Begins With Sound Medicine: Prostate Cancer Screening and Chemoprevention,The American Journal of Bioethics,,,Article,2011-12-08,10.1080/15265161.2011.568583,,,,22146026,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077958,https://api.altmetric.com/v1/donut/3077958_240.png 3,A Rational Basis for Chemoprevention of Prostate Cancer,The American Journal of Bioethics,,,Article,2011-12-08,10.1080/15265161.2011.568586,,,,22146027,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077957,https://api.altmetric.com/v1/donut/3077957_240.png 3,Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4),Scandinavian Journal of Urology & Nephrology,,,Article,2011-01-27,10.3109/00365599.2010.545075,,,,21265595,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077955,https://api.altmetric.com/v1/donut/3077955_240.png 3,PCA3 in the detection and management of early prostate cancer,Tumor Biology,,,Article,2013-03-16,10.1007/s13277-013-0739-6,,,,23504524,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077954,https://api.altmetric.com/v1/donut/3077954_240.png 3,Electrophoretic fingerprint metallothionein analysis as a potential prostate cancer biomarker,Electrophoresis,,,Article,2011-05-09,10.1002/elps.201000519,,,,21557258,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3077952,https://api.altmetric.com/v1/donut/3077952_240.png 3,Prediction of Perineural Invasion and Its Prognostic Value in Patients with Prostate Cancer,Korean Journal of Urology,,,Article,2010-11-01,10.4111/kju.2010.51.11.745,,,,21165193,PMC2991570,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077951,https://api.altmetric.com/v1/donut/3077951_240.png 3,Global Histone H3K27 Methylation Levels are Different in Localized and Metastatic Prostate Cancer,Cancer Investigation,,,Article,2011-12-15,10.3109/07357907.2011.636117,,,,22149091,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077950,https://api.altmetric.com/v1/donut/3077950_240.png 3,Active surveillance for the management of prostate cancer in a contemporary cohort,Cancer (0008543X),,,Article,2008-04-23,10.1002/cncr.23502,,,,18433013,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/3077949,https://api.altmetric.com/v1/donut/3077949_240.png 3,Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group,World Journal of Urology,,,Article,2011-12-28,10.1007/s00345-011-0804-y,,,,22203238,,10161/8621,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3077947,https://api.altmetric.com/v1/donut/3077947_240.png 3,Focal therapy for prostate cancer: opportunities and uncertainties.,Discovery Medicine,,,Article,2011-09-30,,,,,21955852,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077945,https://api.altmetric.com/v1/donut/3077945_240.png 3,"Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer",Cancer Chemotherapy & Pharmacology,,,Article,2009-10-31,10.1007/s00280-009-1163-x,,,,19882157,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077943,https://api.altmetric.com/v1/donut/3077943_240.png 3,Increased expression of estrogen?related receptor ? (ERR?) is a negative prognostic predictor in human prostate cancer,International Journal of Cancer,,,Article,2007-02-09,10.1002/ijc.22363,,,,17294452,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077942,https://api.altmetric.com/v1/donut/3077942_240.png 3,"Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy",Cancer (0008543X),,,Article,2005-04-08,10.1002/cncr.20991,,,,15822118,PMC1852497,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077941,https://api.altmetric.com/v1/donut/3077941_240.png 3,Active Surveillance as a Treatment Option for Prostate Cancer,Seminars in Oncology Nursing,,,Article,2011-01-11,10.1016/j.soncn.2011.07.004,,,,22018405,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077940,https://api.altmetric.com/v1/donut/3077940_240.png 3,Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer,Current Treatment Options in Oncology,,,Article,2012-04-27,10.1007/s11864-012-0188-2,,,,22539224,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077938,https://api.altmetric.com/v1/donut/3077938_240.png 3,"Should you skip your PSA test? The science is uncertain for now, so arm yourself with deep knowledge of the pros and cons of prostate cancer screening.",Harvard Men's Health Watch,,,Article,2012-11-29,,,,,23175860,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3077937,https://api.altmetric.com/v1/donut/3077937_240.png 3,Hormonal therapy for prostate cancer: toward further unraveling of androgen receptor function.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2009-09-02,,,,,19719456,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077934,https://api.altmetric.com/v1/donut/3077934_240.png 3,Angiogenesis inhibition in the treatment of prostate cancer.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2009-09-02,,,,,19719453,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077933,https://api.altmetric.com/v1/donut/3077933_240.png 3,Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men,Carcinogenesis,,,Article,2009-08-14,10.1093/carcin/bgp148,,,,19528667,PMC2718079,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077932,https://api.altmetric.com/v1/donut/3077932_240.png 3,Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy,Scand J Urol,,,Article,2013-01-20,10.3109/21681805.2013.765910,,,,23327661,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077931,https://api.altmetric.com/v1/donut/3077931_240.png 3,Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer,Urology,,,Article,2005-01-06,10.1016/j.urology.2004.12.014,,,,15922433,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077930,https://api.altmetric.com/v1/donut/3077930_240.png 3,Castration-Resistant Prostate Cancer,Drugs,,,Article,2012-09-19,10.2165/10898600-000000000-00000,,,,20481655,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3077928,https://api.altmetric.com/v1/donut/3077928_240.png 3,The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer.,Current opinion in oncology,,,Article,2012-05-01,10.1097/cco.0b013e328351059d,,,,22327837,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3077927,https://api.altmetric.com/v1/donut/3077927_240.png 3,Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer,World Journal of Urology,,,Article,2008-02-12,10.1007/s00345-008-0242-7,,,,18265988,PMC2413091,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077925,https://api.altmetric.com/v1/donut/3077925_240.png 3,A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.,European Urology,,,Article,2010-10-23,10.1016/j.eururo.2010.10.003,,,,20965646,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3077921,https://api.altmetric.com/v1/donut/3077921_240.png 3,Outcomes of initially expectantly managed patients with low or intermediate risk screen?detected localized prostate cancer,British Journal of Urology,,,Article,2012-08-29,10.1111/j.1464-410x.2012.11434.x,,,,22928973,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3077918,https://api.altmetric.com/v1/donut/3077918_240.png 3,A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer.,Anti-Cancer Drugs,,,Article,2010-11-01,10.1097/cad.0b013e32833db887,,,,20827173,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077917,https://api.altmetric.com/v1/donut/3077917_240.png 3,New Strategies Against Prostate Cancer Pt(II)-Based Chemotherapy.,Current Medicinal Chemistry,,,Article,2012-08-04,,,,,22856665,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077915,https://api.altmetric.com/v1/donut/3077915_240.png 3,Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature,Cancer Investigation,,,Article,2012-01-14,10.3109/07357907.2011.629381,,,,22236184,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077914,https://api.altmetric.com/v1/donut/3077914_240.png 3,A survival score for patients with metastatic spinal cord compression from prostate cancer,Strahlentherapie und Onkologie,,,Article,2012-04-25,10.1007/s00066-012-0106-3,,,,22526228,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077911,https://api.altmetric.com/v1/donut/3077911_240.png 3,Treatment of localized prostate cancer: when is active surveillance appropriate?,Nature Reviews Clinical Oncology,,,Article,2010-05-04,10.1038/nrclinonc.2010.63,,,,20440282,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077910,https://api.altmetric.com/v1/donut/3077910_240.png 3,"Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update",Aktuelle Urologie,,,Article,2004-09-14,10.1055/s-2004-834369,,,,15384003,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3077909,https://api.altmetric.com/v1/donut/3077909_240.png 3,Comprehensive report on prostate cancer misclassification by 16 currently used low?risk and active surveillance criteria,British Journal of Urology,,,Article,2012-02-07,10.1111/j.1464-410x.2012.10935.x,,,,22314081,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077908,https://api.altmetric.com/v1/donut/3077908_240.png 3,The possible role of chromogranin A as a prognostic factor in organ-confined prostate cancer.,International Journal of Biological Markers,,,Article,2006-12-22,,,,,17177161,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077907,https://api.altmetric.com/v1/donut/3077907_240.png 3,PSA screening and prostate cancer risk reduction,Urologic Oncology,,,Article,2012-01-11,10.1016/j.urolonc.2012.09.009,,,,23218069,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077905,https://api.altmetric.com/v1/donut/3077905_240.png 3,Treatment and prevention of bone complications from prostate cancer,BONE,,,Article,2011-01-01,10.1016/j.bone.2010.05.038,,,,20621630,PMC3010497,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077903,https://api.altmetric.com/v1/donut/3077903_240.png 3,Radionuclide based imaging of prostate cancer.,Current Topics in Medicinal Chemistry,,,Article,2009-12-31,,,,,20583988,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3077902,https://api.altmetric.com/v1/donut/3077902_240.png 3,What's new in prostate cancer disease assessment in 2006?,Current Opinion in Urology,,,Article,2006-05-09,10.1097/01.mou.0000193389.31727.9b,,,,16679850,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077898,https://api.altmetric.com/v1/donut/3077898_240.png 3,Potential Consequences of Low Biopsy Core Number in Selection of Patients With Prostate Cancer for Current Active Surveillance Protocols,Urology,,,Article,2013-01-04,10.1016/j.urology.2012.10.068,,,,23395126,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077897,https://api.altmetric.com/v1/donut/3077897_240.png 3,Primary Intermittent Androgen Deprivation As Initial Therapy for Men with Newly Diagnosed Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2011-01-12,10.1016/j.clgc.2011.07.002,,,,21993252,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077895,https://api.altmetric.com/v1/donut/3077895_240.png 3,Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients,International Journal of Cancer,,,Article,2013-01-24,10.1002/ijc.28002,,,,23280694,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077894,https://api.altmetric.com/v1/donut/3077894_240.png 3,Treatment of prostate cancer in unfit senior adult patients,Cancer Treatment Reviews,,,Article,2009-01-10,10.1016/j.ctrv.2009.04.014,,,,19487081,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3077892,https://api.altmetric.com/v1/donut/3077892_240.png 3,Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments,International braz j urol,,,Article,2007-08-01,10.1590/s1677-55382007000400004,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3077890,https://api.altmetric.com/v1/donut/3077890_240.png 3,Cytochrome P450 2B6 is a growth?inhibitory and prognostic factor for prostate cancer,The Prostate,,,Article,2007-04-23,10.1002/pros.20597,,,,17455229,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077888,https://api.altmetric.com/v1/donut/3077888_240.png 3,The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges,Prostate Cancer,,,Article,2012-12-31,10.1155/2012/587139,,,,23346405,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077887,https://api.altmetric.com/v1/donut/3077887_240.png 3,18F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2010-09-23,10.1007/s00259-010-1579-x,,,,20862471,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077884,https://api.altmetric.com/v1/donut/3077884_240.png 3,New agents and strategies for the hormonal treatment of castration-resistant prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2010-06-08,10.1517/13543784.2010.494178,,,,20524793,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077883,https://api.altmetric.com/v1/donut/3077883_240.png 3,Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment,Cancer (0008543X),,,Article,2011-10-21,10.1002/cncr.26619,,,,22020835,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077882,https://api.altmetric.com/v1/donut/3077882_240.png 3,"Castration?resistant prostate cancer: Many treatments, many options, many challenges ahead",Cancer (0008543X),,,Article,2011-10-28,10.1002/cncr.26582,,,,22038761,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077881,https://api.altmetric.com/v1/donut/3077881_240.png 3,Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer.,International journal of immunopathology and pharmacology,,,Article,2008-01-10,,,,,18179749,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077880,https://api.altmetric.com/v1/donut/3077880_240.png 3,The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review,Annals of Nuclear Medicine,,,Article,2012-05-08,10.1007/s12149-012-0602-7,,,,22566040,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3077879,https://api.altmetric.com/v1/donut/3077879_240.png 3,TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer.,Future Oncology,,,Article,2011-04-06,10.2217/fon.11.23,,,,21463139,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077878,https://api.altmetric.com/v1/donut/3077878_240.png 3,Pathological findings and prostate?specific antigen outcomes after laparoscopic radical prostatectomy for high?risk prostate cancer,British Journal of Urology,,,Article,2009-11-20,10.1111/j.1464-410x.2009.09080.x,,,,19930177,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077877,https://api.altmetric.com/v1/donut/3077877_240.png 3,Comparative analysis of three risk assessment tools in Australian patients with prostate cancer,British Journal of Urology,,,Article,2011-11-15,10.1111/j.1464-410x.2011.10687.x,,,,22085129,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077875,https://api.altmetric.com/v1/donut/3077875_240.png 3,When is active surveillance the appropriate treatment for prostate cancer?,Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.526634,,,,21604952,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077872,https://api.altmetric.com/v1/donut/3077872_240.png 3,Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer,Acta Oncologica,,,Article,2011-05-01,10.3109/0284186x.2010.541935,,,,21174520,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3077871,https://api.altmetric.com/v1/donut/3077871_240.png 3,Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data,The European Journal of Health Economics,,,Article,2010-06-13,10.1007/s10198-010-0250-6,,,,20549536,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077870,https://api.altmetric.com/v1/donut/3077870_240.png 3,Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer,Korean Journal of Urology,,,Article,2012-09-01,10.4111/kju.2012.53.9.607,,,,23060997,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077867,https://api.altmetric.com/v1/donut/3077867_240.png 3,Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype,The Journal of Pathology,,,Article,2009-10-27,10.1002/path.2657,,,,19960500,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077866,https://api.altmetric.com/v1/donut/3077866_240.png 3,Global update on defining and treating high?risk localized prostate cancer with leuprorelin: an Asian perspective,British Journal of Urology,,,Article,2006-12-08,10.1111/j.1464-410x.2007.06592.x,,,,17229160,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077865,https://api.altmetric.com/v1/donut/3077865_240.png 3,Novel options for the treatment of castration-resistant prostate cancer,World Journal of Urology,,,Article,2011-11-20,10.1007/s00345-011-0796-7,,,,22101903,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077864,https://api.altmetric.com/v1/donut/3077864_240.png 3,Clinical and pathologic features of prostate cancer detected after repeat false?negative biopsy in a screening population,The Prostate,,,Article,2003-11-04,10.1002/pros.10330,,,,14743467,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077863,https://api.altmetric.com/v1/donut/3077863_240.png 3,Prostate?specific antigen relapse?free survival and side?effects in 734 patients with up to 10?years of follow?up with localized prostate cancer treated by permanent 125iodine implants,British Journal of Urology,,,Article,2010-01-08,10.1111/j.1464-410x.2009.09096.x,,,,20067460,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077861,https://api.altmetric.com/v1/donut/3077861_240.png 3,The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo,The Prostate,,,Article,2010-05-26,10.1002/pros.21173,,,,20623636,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077860,https://api.altmetric.com/v1/donut/3077860_240.png 3,Caveolin?1 expression is a predictor of recurrence?free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients,Cancer (0008543X),,,Article,2003-02-20,10.1002/cncr.11198,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077858,https://api.altmetric.com/v1/donut/3077858_240.png 3,Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue,Cancer Causes and Control,,,Article,2012-06-19,10.1007/s10552-012-0016-9,,,,22710747,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077857,https://api.altmetric.com/v1/donut/3077857_240.png 3,Low risk prostate cancer in men ? 70 years old: To treat or not to treat,Urologic Oncology,,,Article,2013-01-08,10.1016/j.urolonc.2011.07.004,,,,21872499,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077856,https://api.altmetric.com/v1/donut/3077856_240.png 3,Modular therapy approach in metastatic castration-refractory prostate cancer,World Journal of Urology,,,Article,2010-05-19,10.1007/s00345-010-0567-x,,,,20490506,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077855,https://api.altmetric.com/v1/donut/3077855_240.png 3,Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT,Annals of Nuclear Medicine,,,Article,2011-11-09,10.1007/s12149-011-0551-6,,,,22069194,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077851,https://api.altmetric.com/v1/donut/3077851_240.png 3,Whole Blood Stem Cell Reinfusion and Escalated Dose Melphalan in Castration-Resistant Prostate Cancer: A Phase 1 Study,Clinical Cancer Research,,,Article,2012-04-15,10.1158/1078-0432.ccr-11-3293,,,,22392912,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077850,https://api.altmetric.com/v1/donut/3077850_240.png 3,Hepsin is Highly Over Expressed in and a New Candidate for a Prognostic Indicator in Prostate Cancer,The Journal of Urology,,,Article,2004-01-01,10.1097/01.ju.0000101622.74236.94,,,,14665873,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3077849,https://api.altmetric.com/v1/donut/3077849_240.png 3,Relationship between prostate?specific antigen and obesity in prostate cancer screening: Analysis of a large cohort in Japan,International Journal of Urology,,,Article,2010-11-18,10.1111/j.1442-2042.2010.02667.x,,,,21198939,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077848,https://api.altmetric.com/v1/donut/3077848_240.png 3,TP53INP1 as new therapeutic target in castration?resistant prostate cancer,The Prostate,,,Article,2011-12-27,10.1002/pros.22477,,,,22213058,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077845,https://api.altmetric.com/v1/donut/3077845_240.png 3,Hypofractionated Conformal HDR Brachytherapy in Hormone Naïve Men with Localized Prostate Cancer,Strahlentherapie und Onkologie,,,Article,2006-03-15,10.1007/s00066-006-1448-5,,,,16520907,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3077844,https://api.altmetric.com/v1/donut/3077844_240.png 3,"Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate?risk prostate cancer",The Prostate,,,Article,2011-12-27,10.1002/pros.22478,,,,22213075,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077843,https://api.altmetric.com/v1/donut/3077843_240.png 3,Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer,Medical Oncology,,,Article,2012-06-12,10.1007/s12032-012-0270-4,,,,22688447,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077840,https://api.altmetric.com/v1/donut/3077840_240.png 3,Prognostic significance of focal neuroendocrine differentiation in prostate cancer: Cases with autopsy-verified cause of death,Indian Journal of Urology,,,Article,2015-07-25,10.4103/0970-1591.60442,,,,20535283,PMC2878436,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077838,https://api.altmetric.com/v1/donut/3077838_240.png 3,Clinical Significance of Tumor Necrosis Factor Receptor Superfamily Member 11b Polymorphism in Prostate Cancer,Annals of Surgical Oncology,,,Article,2010-03-04,10.1245/s10434-010-0994-3,,,,20204532,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077836,https://api.altmetric.com/v1/donut/3077836_240.png 3,The Current Status of Active Surveillance for Prostate Cancer,Postgraduate Medicine,,,Article,2012-06-14,10.3810/pgm.2012.05.2548,,,,22691899,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077834,https://api.altmetric.com/v1/donut/3077834_240.png 3,State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer,Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.578369,,,,21604938,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077832,https://api.altmetric.com/v1/donut/3077832_240.png 3,The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.,International Journal of Oncology,,,Article,2011-09-30,10.3892/ijo.2011.1216,,,,21956230,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077829,https://api.altmetric.com/v1/donut/3077829_240.png 3,Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer.,International Journal of Oncology,,,Article,2011-12-15,10.3892/ijo.2011.1292,,,,22159900,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3077825,https://api.altmetric.com/v1/donut/3077825_240.png 3,Should we abstain from Gleason score 2–4 in the diagnosis of prostate cancer? Results of a German multicentre study,World Journal of Urology,,,Article,2010-12-30,10.1007/s00345-010-0632-5,,,,21191597,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077824,https://api.altmetric.com/v1/donut/3077824_240.png 3,Cabazitaxel in metastatic castration-resistant prostate cancer,Expert Review of Anticancer Therapy,,,Article,2012-10-26,10.1586/era.12.88,,,,23098113,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077823,https://api.altmetric.com/v1/donut/3077823_240.png 3,Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability,World Journal of Urology,,,Article,2008-04-05,10.1007/s00345-008-0257-0,,,,18392627,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077822,https://api.altmetric.com/v1/donut/3077822_240.png 3,Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers,Prostate Cancer,,,Article,2012-08-28,10.1155/2012/640968,,,,22970379,PMC3434411,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3077821,https://api.altmetric.com/v1/donut/3077821_240.png 3,Minimally Invasive Ablative Therapies for Definitive Treatment of Localized Prostate Cancer in the Primary Setting,Prostate Cancer,,,Article,2010-12-05,10.1155/2011/394182,,,,22110985,PMC3216008,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077820,https://api.altmetric.com/v1/donut/3077820_240.png 3,Beta-tubulin III expression in prostate cancer,Scandinavian Journal of Urology & Nephrology,,,Article,2010-09-14,10.3109/00365599.2010.515612,,,,20831453,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077819,https://api.altmetric.com/v1/donut/3077819_240.png 3,"Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC)",Investigational New Drugs,,,Article,2007-09-06,10.1007/s10637-007-9074-3,,,,17846704,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077818,https://api.altmetric.com/v1/donut/3077818_240.png 3,Molecular imaging of prostate cancer: a concise synopsis.,Molecular Imaging,,,Article,2008-12-03,,,,,19397851,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077817,https://api.altmetric.com/v1/donut/3077817_240.png 3,Prostate needle biopsies,Cancer (0008543X),,,Article,2004-06-18,10.1002/cncr.20415,,,,15274065,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077816,https://api.altmetric.com/v1/donut/3077816_240.png 3,Management of Metastatic Castration-Resistant Prostate Cancer,Drugs,,,Article,2012-12-10,10.2165/11633360-000000000-00000,,,,22621691,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077815,https://api.altmetric.com/v1/donut/3077815_240.png 3,Active surveillance with selective delayed intervention for favorable risk prostate cancer,Urologic Oncology,,,Article,2006-01-01,10.1016/j.urolonc.2005.07.002,,,,16414494,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3077813,https://api.altmetric.com/v1/donut/3077813_240.png 3,Prostate Risk Index (PRIX) as a New Method of Risk Classification for Clinically Localized Prostate Cancer,Strahlentherapie und Onkologie,,,Article,2007-09-14,10.1007/s00066-007-1692-3,,,,17762923,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077812,https://api.altmetric.com/v1/donut/3077812_240.png 3,Optimal treatment of intermediate?risk prostate carcinoma with radiotherapy,Cancer (0008543X),,,Article,2005-07-08,10.1002/cncr.21257,,,,16007687,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077810,https://api.altmetric.com/v1/donut/3077810_240.png 3,Modalities for Imaging of Prostate Cancer,Advances in Urology,,,Article,2010-03-17,10.1155/2009/818065,,,,20339583,PMC2841248,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3077809,https://api.altmetric.com/v1/donut/3077809_240.png 3,Phase II study of personalized peptide vaccination for castration?resistant prostate cancer patients who failed in docetaxel?based chemotherapy,The Prostate,,,Article,2011-09-19,10.1002/pros.21485,,,,21932426,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3077808,https://api.altmetric.com/v1/donut/3077808_240.png 3,Incidental detection of granulomatous prostatitis by F-18 FDG PET/CT in a patient with bladder cancer: a rare complication of BCG instillation therapy.,Clinical Nuclear Medicine,,,Article,2009-09-01,10.1097/rlu.0b013e3181b06c89,,,,19692827,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077807,https://api.altmetric.com/v1/donut/3077807_240.png 3,Therapeutic Strategies for Bone Metastases and Their Clinical Sequelae in Prostate Cancer,Current Treatment Options in Oncology,,,Article,2012-04-25,10.1007/s11864-012-0190-8,,,,22528368,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077806,https://api.altmetric.com/v1/donut/3077806_240.png 3,Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner,Cancer Chemotherapy & Pharmacology,,,Article,2008-12-23,10.1007/s00280-008-0892-6,,,,19104815,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077805,https://api.altmetric.com/v1/donut/3077805_240.png 3,Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC study,Prostate Cancer & Prostatic Diseases,,,Article,2004-06-01,10.1038/sj.pcan.4500719,,,,15175665,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077804,https://api.altmetric.com/v1/donut/3077804_240.png 3,Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients,The Prostate,,,Article,2011-05-11,10.1002/pros.21396,,,,21563191,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077803,https://api.altmetric.com/v1/donut/3077803_240.png 3,A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial),European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2011-07-27,10.1007/s00259-011-1883-0,,,,21792569,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3077802,https://api.altmetric.com/v1/donut/3077802_240.png 3,Radical Prostatectomy Versus External-Beam Radiotherapy for Localized Prostate Cancer: Long-Term Effect on Biochemical Control—In Search of the Optimal Treatment,Annals of Surgical Oncology,,,Article,2011-03-23,10.1245/s10434-011-1660-0,,,,21431406,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077801,https://api.altmetric.com/v1/donut/3077801_240.png 3,"Neuroendocrine tumor cells in prostate cancer: Evaluation of the neurosecretory products serotonin, bombesin, and gastrin – impact on angiogenesis and clinical follow?up",The Prostate,,,Article,2011-04-07,10.1002/pros.21392,,,,21480309,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077800,https://api.altmetric.com/v1/donut/3077800_240.png 3,"Four prognostic indices in advanced prostate cancer patients, under palliative androgen deprivation treatment.",Hellenic Journal of Nuclear Medicine,,,Article,2008-04-09,,,,,18392222,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077797,https://api.altmetric.com/v1/donut/3077797_240.png 3,Prostate cancer update: 2007.,Current opinion in oncology,,,Article,2008-05-01,10.1097/cco.0b013e3282f8b075,,,,18391629,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077795,https://api.altmetric.com/v1/donut/3077795_240.png 3,"Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy",European Urology,,,Article,2008-05-01,10.1016/j.eururo.2007.10.008,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3077794,https://api.altmetric.com/v1/donut/3077794_240.png 3,A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2003-05-22,10.1007/s00259-003-1197-y,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3077793,https://api.altmetric.com/v1/donut/3077793_240.png 3,MR spectroscopic imaging and diffusion?weighted imaging of prostate cancer with Gleason scores,Journal of Magnetic Resonance Imaging,,,Article,2012-05-11,10.1002/jmri.23676,,,,22581787,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077790,https://api.altmetric.com/v1/donut/3077790_240.png 3,Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence,NuclearMedicine,,,Article,2008-12-22,10.3413/nukmed-0194,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077789,https://api.altmetric.com/v1/donut/3077789_240.png 3,Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation,British Journal of Cancer,,,Article,2004-08-03,10.1038/sj.bjc.6602030,,,,15292941,PMC2409889,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077787,https://api.altmetric.com/v1/donut/3077787_240.png 3,Ultrasound of prostate cancer: recent advances,European Radiology,,,Article,2007-10-16,10.1007/s00330-007-0779-7,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/3077778,https://api.altmetric.com/v1/donut/3077778_240.png 3,Shared decision-making—Results from an interdisciplinary consulting service for prostate cancer,World Journal of Urology,,,Article,2004-09-16,10.1007/s00345-004-0447-3,,,,15378335,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077777,https://api.altmetric.com/v1/donut/3077777_240.png 3,Long?term outcome in patients with a Gleason score ?6 prostate cancer treated by radical prostatectomy,British Journal of Urology,,,Article,2011-01-12,10.1111/j.1464-410x.2010.09978.x,,,,21223479,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077776,https://api.altmetric.com/v1/donut/3077776_240.png 3,Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer.,Clinical Nuclear Medicine,,,Article,2009-12-01,10.1097/rlu.0b013e3181bed0ae,,,,20139852,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077774,https://api.altmetric.com/v1/donut/3077774_240.png 3,"Prostate cancer: PSA screening|[mdash]|more data, more debate",Nature Reviews Urology,,,Article,2012-02-09,10.1038/nrurol.2012.7,,,,22318289,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077773,https://api.altmetric.com/v1/donut/3077773_240.png 3,Secretory phospholipase A2?IIa is a target gene of the HER/HER2?elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer,The Prostate,,,Article,2011-11-29,10.1002/pros.22463,,,,22127954,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3077771,https://api.altmetric.com/v1/donut/3077771_240.png 3,Prospects in radionuclide imaging of prostate cancer,The Prostate,,,Article,2011-11-29,10.1002/pros.22462,,,,22127918,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077770,https://api.altmetric.com/v1/donut/3077770_240.png 3,Novel therapeutics for the management of castration?resistant prostate cancer (CRPC),British Journal of Urology,,,Article,2011-10-28,10.1111/j.1464-410x.2011.10643.x,,,,22035221,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3077769,https://api.altmetric.com/v1/donut/3077769_240.png 3,Biochemical control of prostate cancer with iodine-125 brachytherapy alone: experience from a single institution,Clinical and Translational Oncology,,,Article,2012-05-08,10.1007/s12094-012-0810-6,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077768,https://api.altmetric.com/v1/donut/3077768_240.png 3,The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.,Future Oncology,,,Article,2012-03-15,10.2217/fon.12.3,,,,22409467,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077767,https://api.altmetric.com/v1/donut/3077767_240.png 3,"A comparative performance analysis of total prostate?specific antigen, percentage free prostate?specific antigen, prostate?specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy",British Journal of Urology,,,Article,2011-09-21,10.1111/j.1464-410x.2011.10584.x,,,,21939492,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077766,https://api.altmetric.com/v1/donut/3077766_240.png 3,Up?regulation of Wnt?1 and ??catenin production in patients with advanced metastatic prostate carcinoma,Cancer (0008543X),,,Article,2004-08-04,10.1002/cncr.20518,,,,15316903,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3077764,https://api.altmetric.com/v1/donut/3077764_240.png 3,Correlation Analysis of JAK-STAT Pathway Components on Prognosis of Patients with Prostate Cancer,Pathology & Oncology Research,,,Article,2011-06-18,10.1007/s12253-011-9410-y,,,,21681602,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077763,https://api.altmetric.com/v1/donut/3077763_240.png 3,Immunohistochemical study of chromogranin A in Stage D2 prostate cancer,Urology,,,Article,2005-01-07,10.1016/j.urology.2005.01.026,,,,15992907,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077762,https://api.altmetric.com/v1/donut/3077762_240.png 3,Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma,Cancer Epidemiology,,,Article,2010-01-06,10.1016/j.canep.2010.04.003,,,,20427255,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077760,https://api.altmetric.com/v1/donut/3077760_240.png 3,Fibroblast growth factor 17 is over?expressed in human prostate cancer,The Journal of Pathology,,,Article,2004-11-10,10.1002/path.1668,,,,15538740,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077757,https://api.altmetric.com/v1/donut/3077757_240.png 3,Diagnosis and treatment of prostate cancer in renal-transplant recipients,International Urology and Nephrology,,,Article,2011-05-26,10.1007/s11255-011-9988-8,,,,21614508,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077753,https://api.altmetric.com/v1/donut/3077753_240.png 3,Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,2012-10-12,10.1007/s00280-012-2001-0,,,,23064959,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077752,https://api.altmetric.com/v1/donut/3077752_240.png 3,First Danish Single-Institution Experience with Radical Prostatectomy: Biochemical Outcome in 1200 Consecutive Patients,Prostate Cancer,,,Article,2010-12-22,10.1155/2011/236357,,,,22096651,PMC3215946,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077751,https://api.altmetric.com/v1/donut/3077751_240.png 3,Imaging low-risk prostate cancer.,Current Opinion in Urology,,,Article,2008-01-01,10.1097/mou.0b013e3282f13adc,,,,18090495,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077749,https://api.altmetric.com/v1/donut/3077749_240.png 3,Protein-Coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy,American Journal of Pathology,,,Article,2011-01-07,10.1016/j.ajpath.2011.03.008,,,,21703393,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3077748,https://api.altmetric.com/v1/donut/3077748_240.png 3,Appropriate use of nomograms to guide prostate cancer treatment selection.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2010-02-10,,,,,20141677,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077747,https://api.altmetric.com/v1/donut/3077747_240.png 3,Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease.,Journal of Clinical Oncology,,,Article,2004-09-15,10.1200/jco.2004.01.164,,,,15365069,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077746,https://api.altmetric.com/v1/donut/3077746_240.png 3,Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer,The Journal of Urology,,,Article,2009-01-07,10.1016/j.juro.2009.02.105,,,,19447430,PMC3869185,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077742,https://api.altmetric.com/v1/donut/3077742_240.png 3,Novel agents for the management of castration-resistant prostate cancer.,Current Opinion in Urology,,,Article,2012-05-01,10.1097/mou.0b013e3283523ba0,,,,22472509,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077741,https://api.altmetric.com/v1/donut/3077741_240.png 3,Multiparametric MRI and prostate cancer diagnosis and risk stratification.,Current Opinion in Urology,,,Article,2012-07-01,10.1097/mou.0b013e32835481c2,,,,22617060,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3077740,https://api.altmetric.com/v1/donut/3077740_240.png 3,A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,2010-03-09,10.1007/s00280-010-1289-x,,,,20217089,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077738,https://api.altmetric.com/v1/donut/3077738_240.png 3,Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer,Cancer Science,,,Article,2008-08-14,10.1111/j.1349-7006.2008.00846.x,,,,18754868,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077733,https://api.altmetric.com/v1/donut/3077733_240.png 3,Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer,Acta Oncologica,,,Article,2010-10-01,10.3109/0284186x.2010.499371,,,,20590366,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3077732,https://api.altmetric.com/v1/donut/3077732_240.png 3,Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series,British Journal of Urology,,,Article,2011-12-22,10.1111/j.1464-410x.2011.10776.x,,,,22192756,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3077731,https://api.altmetric.com/v1/donut/3077731_240.png 3,Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a “normal” prostate specific antigen and digital rectal examination,The Prostate,,,Article,2010-09-21,10.1002/pros.21253,,,,20860009,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077730,https://api.altmetric.com/v1/donut/3077730_240.png 3,Significant prognostic factor of immunohistochemical HER?2 expression using initial prostate biopsy specimens with M1b prostate cancer,The Prostate,,,Article,2010-09-01,10.1002/pros.21252,,,,20812221,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077729,https://api.altmetric.com/v1/donut/3077729_240.png 3,The evolving role of familial history for prostate cancer,Acta Oncologica,,,Article,2011-01-01,10.3109/0284186x.2010.521191,,,,20874046,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077728,https://api.altmetric.com/v1/donut/3077728_240.png 3,Clinical and histopathological characteristics of familial prostate cancer in Finland,British Journal of Urology,,,Article,2011-04-20,10.1111/j.1464-410x.2011.10198.x,,,,21507186,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077727,https://api.altmetric.com/v1/donut/3077727_240.png 3,Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: validation of the stephenson nomogram,World Journal of Urology,,,Article,2010-05-07,10.1007/s00345-010-0559-x,,,,20449749,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077726,https://api.altmetric.com/v1/donut/3077726_240.png 3,Optimal biopsy strategies for the diagnosis and staging of prostate cancer.,Current Opinion in Urology,,,Article,2009-04-16,,,,,19365892,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077725,https://api.altmetric.com/v1/donut/3077725_240.png 3,Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions,World Journal of Urology,,,Article,2010-10-20,10.1007/s00345-010-0602-y,,,,20959991,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3077722,https://api.altmetric.com/v1/donut/3077722_240.png 3,Localised prostate cancer - current treatment options.,Australian Family Physician,,,Article,2011-10-18,,,,,22003477,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077721,https://api.altmetric.com/v1/donut/3077721_240.png 3,Effect of intra?observer variation in prostate volume measurement on prostate?specific antigen density calculations among prostate cancer active surveillance participants,British Journal of Urology,,,Article,2011-07-08,10.1111/j.1464-410x.2011.10223.x,,,,21736692,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077720,https://api.altmetric.com/v1/donut/3077720_240.png 3,Prostate Cancer Radiotherapy Dose Response: An Update of the Fox Chase Experience,The Journal of Urology,,,Article,2004-01-03,10.1097/01.ju.0000111844.95024.74,,,,14767286,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077719,https://api.altmetric.com/v1/donut/3077719_240.png 3,"Role of androgen deprivation treatment in patients with castration-resistant prostate cancer, receiving docetaxel-based chemotherapy.",American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2010-08-01,10.1097/coc.0b013e3181d2ed7d,,,,20686407,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077718,https://api.altmetric.com/v1/donut/3077718_240.png 3,Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal?related events in patients with prostate cancer with bone metastasis,British Journal of Urology,,,Article,2011-05-23,10.1111/j.1464-410x.2011.10192.x,,,,21599822,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3077716,https://api.altmetric.com/v1/donut/3077716_240.png 3,Specimen Orientation by Marking the Peripheral End: (Potential) Clinical Advantages in Prostate Biopsy,Prostate Cancer,,,Article,2011-07-27,10.1155/2011/270403,,,,22096654,PMC3200280,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077715,https://api.altmetric.com/v1/donut/3077715_240.png 3,"Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoring.",European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2013-03-01,10.1097/cej.0b013e3283584954,,,,22955340,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3077714,https://api.altmetric.com/v1/donut/3077714_240.png 3,Significant addition to treatment options for bone metastasis in prostate cancer,Cancer Biology and Therapy,,,Article,2012-02-19,10.4161/cbt.13.2.18441,,,,22336908,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077713,https://api.altmetric.com/v1/donut/3077713_240.png 3,Clinical features of patients who present with metastatic prostate carcinoma and serum prostate?specific antigen (PSA) levels < 10 ng/mL,Cancer (0008543X),,,Article,2003-10-20,10.1002/cncr.11821,,,,14635070,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077710,https://api.altmetric.com/v1/donut/3077710_240.png 3,PSA?detected prostate cancer and the potential for dedifferentiation—estimating the proportion capable of progression,International Journal of Cancer,,,Article,2010-05-24,10.1002/ijc.25471,,,,20499312,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3077709,https://api.altmetric.com/v1/donut/3077709_240.png 3,Current trials using bone-targeting agents in prostate cancer.,Cancer Journal,,,Article,2008-01-01,10.1097/ppo.0b013e318161d32d,,,,18303481,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077708,https://api.altmetric.com/v1/donut/3077708_240.png 3,Intensity-Modulated Radiotherapy for Prostate Cancer Implementing Molecular Imaging with 18F-Choline PET-CT to Define a Simultaneous Integrated Boost,Strahlentherapie und Onkologie,,,Article,2010-09-30,10.1007/s00066-010-2122-5,,,,20936457,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077705,https://api.altmetric.com/v1/donut/3077705_240.png 3,Low?dose docetaxel enhances the sensitivity of S?1 in a xenograft model of human castration resistant prostate cancer,International Journal of Cancer,,,Article,2011-04-25,10.1002/ijc.26012,,,,21351099,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077703,https://api.altmetric.com/v1/donut/3077703_240.png 3,"Clinical outcomes of prostate cancer patients detected by prostate?specific antigen?based population screening in Kanazawa City, Japan",International Journal of Urology,,,Article,2011-06-16,10.1111/j.1442-2042.2011.02796.x,,,,21679256,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077702,https://api.altmetric.com/v1/donut/3077702_240.png 3,Molecular markers and death from prostate cancer.,Annals of Internal Medicine,,,Article,2009-05-04,,,,,19414838,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3077701,https://api.altmetric.com/v1/donut/3077701_240.png 3,Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease,International Journal of Urology,,,Article,2010-05-31,10.1111/j.1442-2042.2010.02569.x,,,,20529137,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077700,https://api.altmetric.com/v1/donut/3077700_240.png 3,Obesity and prostate enlargement in men with localized prostate cancer,British Journal of Urology,,,Article,2011-07-08,10.1111/j.1464-410x.2011.10227.x,,,,21736693,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077699,https://api.altmetric.com/v1/donut/3077699_240.png 3,Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow?up from a prospective trial,British Journal of Urology,,,Article,2013-03-04,10.1111/j.1464-410x.2012.11607.x,,,,23452046,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077696,https://api.altmetric.com/v1/donut/3077696_240.png 3,Abiraterone acetate for castration resistant prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2010-03-18,10.1517/13543781003639427,,,,20225998,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077695,https://api.altmetric.com/v1/donut/3077695_240.png 3,"The impact of place and time on the proportion of late-stage diagnosis: The case of prostate cancer in Florida, 1981–2007",Spatial and Spatio-temporal Epidemiology,,,Article,2012-09-01,10.1016/j.sste.2012.03.001,,,,22749210,PMC3389349,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3077694,https://api.altmetric.com/v1/donut/3077694_240.png 3,Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer,Cancer Science,,,Article,2011-11-27,10.1111/j.1349-7006.2011.02143.x,,,,22050110,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077693,https://api.altmetric.com/v1/donut/3077693_240.png 3,Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml,Korean Journal of Urology,,,Article,2011-03-01,10.4111/kju.2011.52.3.166,,,,21461279,PMC3065127,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077691,https://api.altmetric.com/v1/donut/3077691_240.png 3,Japan Cancer of the Prostate Risk Assessment for combined androgen blockade including bicalutamide: Clinical application and validation,International Journal of Urology,,,Article,2012-12-06,10.1111/iju.12037,,,,23216462,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077689,https://api.altmetric.com/v1/donut/3077689_240.png 3,Genomic analysis of prostate carcinoma specimens obtained via ultrasound?guided needle biopsy may be of use in preoperative decision?making,Cancer (0008543X),,,Article,2004-09-09,10.1002/cncr.20527,,,,15386312,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077687,https://api.altmetric.com/v1/donut/3077687_240.png 3,Tumor Length in Prostate Cancer,American Journal of Clinical Pathology,,,Article,2008-07-01,10.1309/pjnrht63tp6fvc8b,,,,18550474,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077686,https://api.altmetric.com/v1/donut/3077686_240.png 3,Natural history of disease progression in patients who fail to achieve an undetectable prostate?specific antigen level after undergoing radical prostatectomy,Cancer (0008543X),,,Article,2004-10-06,10.1002/cncr.20637,,,,15470681,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077684,https://api.altmetric.com/v1/donut/3077684_240.png 3,Beyond Castration—Defining Future Directions in the Hormonal Treatment of Prostate Cancer,Hormones and Cancer,,,Article,2011-11-29,10.1007/s12672-011-0096-0,,,,22124843,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077682,https://api.altmetric.com/v1/donut/3077682_240.png 3,Simulation optimization of PSA-threshold based prostate cancer screening policies,Health Care Management Science,,,Article,2012-02-03,10.1007/s10729-012-9195-x,,,,22302420,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3077681,https://api.altmetric.com/v1/donut/3077681_240.png 3,Rational approach to implementation of prostate cancer antigen 3 into clinical care,Cancer (0008543X),,,Article,2009-06-10,10.1002/cncr.24447,,,,19517474,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077680,https://api.altmetric.com/v1/donut/3077680_240.png 3,Ellagic Acid: Cytodifferentiating and Antiproliferative Effects In Human Prostatic Cancer Cell Lines.,Current Pharmaceutical Design,,,Article,2012-10-25,,,,,23092326,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077677,https://api.altmetric.com/v1/donut/3077677_240.png 3,Focal Therapy of Prostate Cancer: Evidence-based Analysis for Modern Selection Criteria,Current Urology Reports,,,Article,2012-02-02,10.1007/s11934-012-0241-5,,,,22298223,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077676,https://api.altmetric.com/v1/donut/3077676_240.png 3,Long?term overall survival and metastasis?free survival for men with prostate?specific antigen?recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database,British Journal of Urology,,,Article,2010-11-23,10.1111/j.1464-410x.2010.09878.x,,,,21091976,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077675,https://api.altmetric.com/v1/donut/3077675_240.png 3,Tumour markers in prostate cancer II: Diagnostic and prognostic cellular biomarkers,Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.531284,,,,21604944,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/3077673,https://api.altmetric.com/v1/donut/3077673_240.png 3,Bone imaging in prostate cancer,Nature Reviews Urology,,,Article,2008-08-01,10.1038/ncpuro1190,,,,18682719,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077672,https://api.altmetric.com/v1/donut/3077672_240.png 3,"The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The prostate cancer screening results in context",Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.531283,,,,21604935,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077671,https://api.altmetric.com/v1/donut/3077671_240.png 3,Twenty?four?month postradiation prostate biopsies are strongly predictive of 7?year disease?free survival,Cancer (0008543X),,,Article,2008-12-30,10.1002/cncr.24020,,,,19117039,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077670,https://api.altmetric.com/v1/donut/3077670_240.png 3,Prostate-specific Antigen-negative Prostate Cancer Recurrence?,Urology,,,Article,2013-01-02,10.1016/j.urology.2012.10.036,,,,23374851,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077669,https://api.altmetric.com/v1/donut/3077669_240.png 3,Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.,European Urology,,,Article,2008-05-30,10.1016/j.eururo.2008.04.091,,,,18508188,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3077668,https://api.altmetric.com/v1/donut/3077668_240.png 3,Health-related quality of life in prostate cancer,Acta Oncologica,,,Article,2013-08-01,10.3109/0284186x.2012.760848,,,,23368678,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077664,https://api.altmetric.com/v1/donut/3077664_240.png 3,Management of synchronous rectal and prostate cancer,International Journal of Colorectal Disease,,,Article,2012-03-28,10.1007/s00384-012-1465-z,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077661,https://api.altmetric.com/v1/donut/3077661_240.png 3,Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry,Urologic Oncology,,,Article,2013-01-07,10.1016/j.urolonc.2011.05.009,,,,21704537,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077660,https://api.altmetric.com/v1/donut/3077660_240.png 3,Gleason 7 prostate cancer treated with low?dose?rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure,British Journal of Urology,,,Article,2012-05-09,10.1111/j.1464-410x.2012.11057.x,,,,22571680,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077658,https://api.altmetric.com/v1/donut/3077658_240.png 3,"How much does Gleason grade of follow?up biopsy differ from that of initial biopsy in untreated, Gleason score 4–7, clinically localized prostate cancer?",The Prostate,,,Article,2007-09-06,10.1002/pros.20648,,,,17823923,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077657,https://api.altmetric.com/v1/donut/3077657_240.png 3,Uptake of prostate?specific antigen testing for early prostate cancer detection in Sweden,International Journal of Cancer,,,Article,2011-03-25,10.1002/ijc.25846,,,,21154740,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077656,https://api.altmetric.com/v1/donut/3077656_240.png 3,High-Risk Prostate Cancer With Gleason Score 8–10 and PSA Level ?15 ng/ mL Treated With Permanent Interstitial Brachytherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-11-15,10.1016/j.ijrobp.2010.07.006,,,,20932674,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077655,https://api.altmetric.com/v1/donut/3077655_240.png 3,Combination therapy: Abiraterone prolongs survival in metastatic prostate cancer,Nature Reviews Clinical Oncology,,,Article,2011-08-02,10.1038/nrclinonc.2011.111,,,,21808270,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077654,https://api.altmetric.com/v1/donut/3077654_240.png 3,"A multiplex model of combining gene?based, protein?based, and metabolite?based with positive and negative markers in urine for the early diagnosis of prostate cancer",The Prostate,,,Article,2010-10-18,10.1002/pros.21286,,,,20957673,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077652,https://api.altmetric.com/v1/donut/3077652_240.png 3,Gastrin?releasing peptide: Predictor of castration?resistant prostate cancer?,The Prostate,,,Article,2010-10-13,10.1002/pros.21280,,,,20945407,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077649,https://api.altmetric.com/v1/donut/3077649_240.png 3,Systemic nonhormonal management of advanced prostate cancer and its likely impact on patients' survival and quality of life.,Anti-Cancer Drugs,,,Article,2008-07-01,10.1097/cad.0b013e3282ff0f48,,,,18525325,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077648,https://api.altmetric.com/v1/donut/3077648_240.png 3,Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial,Quality of Life Research,,,Article,2009-01-09,10.1007/s11136-008-9433-3,,,,19130298,PMC2859212,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077647,https://api.altmetric.com/v1/donut/3077647_240.png 3,Prostate Cancer Postoperative Nomogram Scores and Obesity,PLoS ONE,,,Article,2011-03-12,10.1371/journal.pone.0017382,,,,21390220,PMC3044730,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077646,https://api.altmetric.com/v1/donut/3077646_240.png 3,Optimal cost-effective staging evaluations in prostate cancer,Current Urology Reports,,,Article,2007-05-30,10.1007/s11934-007-0005-9,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077645,https://api.altmetric.com/v1/donut/3077645_240.png 3,Possibility of using mRNA expression levels for nucleic acid-metabolizing enzymes within prostate cancer cells as indices for prognostic factors,Oncology Letters,,,Article,2010-09-01,10.3892/ol.2010.165,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077644,https://api.altmetric.com/v1/donut/3077644_240.png 3,Functional Imaging of Localized Prostate Cancer Aggressiveness Using 11C-Acetate PET/CT and 1H-MR Spectroscopy,Journal of Nuclear Medicine,,,Article,2010-11-15,10.2967/jnumed.110.078667,,,,20956477,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3077643,https://api.altmetric.com/v1/donut/3077643_240.png 3,Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial,Cancer Biology and Therapy,,,Article,2010-01-09,10.4161/cbt.10.6.12611,,,,20657175,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3077642,https://api.altmetric.com/v1/donut/3077642_240.png 3,The association between patient age and prostate cancer stage and grade at diagnosis,British Journal of Urology,,,Article,2004-08-03,10.1111/j.1464-410x.2004.04883.x,,,,15291856,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077639,https://api.altmetric.com/v1/donut/3077639_240.png 3,Recent advances in the therapy of castration-resistant prostate cancer: The price of progress,Maturitas,,,Article,2011-01-10,10.1016/j.maturitas.2011.07.018,,,,21831545,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077638,https://api.altmetric.com/v1/donut/3077638_240.png 3,Quality of Life Among Men With Prostate Cancer in Rural Georgia,Urology,,,Article,2011-01-04,10.1016/j.urology.2010.12.027,,,,21334050,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077637,https://api.altmetric.com/v1/donut/3077637_240.png 3,FDG PET/CT demonstration of pancreatic metastasis from prostate cancer.,Clinical Nuclear Medicine,,,Article,2011-10-01,10.1097/rlu.0b013e3182291d1a,,,,21892064,PMC3167095,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077634,https://api.altmetric.com/v1/donut/3077634_240.png 3,Satraplatin for the therapy of castration-resistant prostate cancer.,Future Oncology,,,Article,2009-10-02,10.2217/fon.09.84,,,,19792961,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077633,https://api.altmetric.com/v1/donut/3077633_240.png 3,Dynamic prediction of metastases after radical prostatectomy for prostate cancer,British Journal of Urology,,,Article,2011-05-26,10.1111/j.1464-410x.2011.10208.x,,,,21615849,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077632,https://api.altmetric.com/v1/donut/3077632_240.png 3,Chemotherapy in patients with castration-resistant prostate cancer,European Journal of Cancer (1965),,,Article,2009-09-14,10.1016/s0959-8049(09)70029-2,,,,19775615,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077630,https://api.altmetric.com/v1/donut/3077630_240.png 3,Combined Prostate-specific Antigen Density and Biopsy Features to Predict “Clinically Insignificant” Prostate Cancer,Urology,,,Article,2008-01-07,10.1016/j.urology.2007.11.009,,,,18436287,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077629,https://api.altmetric.com/v1/donut/3077629_240.png 3,The role of docetaxel based therapy for prostate cancer in the era of targeted medicine,International Journal of Urology,,,Article,2010-01-19,10.1111/j.1442-2042.2010.02449.x,,,,20088874,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077628,https://api.altmetric.com/v1/donut/3077628_240.png 3,Screening for prostate cancer using multivariate mixed-effects models,Journal of Applied Statistics,,,Article,2012-06-09,10.1080/02664763.2011.644523,,,,22679342,PMC3367770,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077627,https://api.altmetric.com/v1/donut/3077627_240.png 3,New options for the management of castration-resistant prostate cancer: a case perspective.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2011-05-20,,,,,21357663,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077626,https://api.altmetric.com/v1/donut/3077626_240.png 3,Association between utility and treatment among patients with prostate cancer,Quality of Life Research,,,Article,2010-03-05,10.1007/s11136-010-9622-8,,,,20204704,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077623,https://api.altmetric.com/v1/donut/3077623_240.png 3,Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-01-02,10.1016/j.ijrobp.2008.04.075,,,,18707821,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3077622,https://api.altmetric.com/v1/donut/3077622_240.png 3,Insignificant prostate cancer and active surveillance: from definition to clinical implications.,European Urology,,,Article,2009-01-06,10.1016/j.eururo.2009.02.028,,,,19286302,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/3077621,https://api.altmetric.com/v1/donut/3077621_240.png 3,A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.,European Urology,,,Article,2009-03-15,10.1016/j.eururo.2009.02.022,,,,19282098,PMC2885777,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077620,https://api.altmetric.com/v1/donut/3077620_240.png 3,[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2010-05-30,10.1007/s00259-010-1493-2,,,,20512572,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077618,https://api.altmetric.com/v1/donut/3077618_240.png 3,The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2007-12-01,10.1097/coc.0b013e318145b9ba,,,,18091053,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077617,https://api.altmetric.com/v1/donut/3077617_240.png 3,Gene expression profiling identifies clinically relevant subtypes of prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2004-01-20,10.1073/pnas.0304146101,,,,14711987,PMC321763,,2004PNAS..101..811L,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,110,https://www.altmetric.com/details/3077615,https://api.altmetric.com/v1/donut/3077615_240.png 3,"[11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy",European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2008-01-16,10.1007/s00259-008-0716-2,,,,18200444,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3077614,https://api.altmetric.com/v1/donut/3077614_240.png 3,FGF8 isoform b expression in human prostate cancer,British Journal of Cancer,,,Article,2003-05-06,10.1038/sj.bjc.6600875,,,,12778074,PMC2741033,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077613,https://api.altmetric.com/v1/donut/3077613_240.png 3,The current status of cryotherapy and high-intensity focused ultrasound in the treatment of low-grade prostate cancer.,Reviews on Recent Clinical Trials,,,Article,2011-01-19,,,,,21241237,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077611,https://api.altmetric.com/v1/donut/3077611_240.png 3,Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle?aged men,Cancer (0008543X),,,Article,2007-02-20,10.1002/cncr.22534,,,,17311344,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077610,https://api.altmetric.com/v1/donut/3077610_240.png 3,Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.,Asian Journal of Andrology,,,Article,2008-07-23,10.1111/j.1745-7262.2008.00423.x,,,,18645679,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077609,https://api.altmetric.com/v1/donut/3077609_240.png 3,Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer.,Current opinion in oncology,,,Article,2013-03-01,10.1097/cco.0b013e32835ff161,,,,23511665,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3077606,https://api.altmetric.com/v1/donut/3077606_240.png 3,Cysteine?rich secretory protein 3 and ??microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome,British Journal of Urology,,,Article,2011-03-16,10.1111/j.1464-410x.2010.10059.x,,,,21410630,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077604,https://api.altmetric.com/v1/donut/3077604_240.png 3,Current and emerging treatments in the management of castration-resistant prostate cancer,Expert Review of Anticancer Therapy,,,Article,2012-08-01,10.1586/era.12.59,,,,22845410,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077603,https://api.altmetric.com/v1/donut/3077603_240.png 3,When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?,Asian Journal of Andrology,,,Article,2008-11-01,10.1111/j.1745-7262.2008.00427.x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077602,https://api.altmetric.com/v1/donut/3077602_240.png 3,Clinical usefulness of bone markers in prostate cancer with bone metastasis,International Journal of Urology,,,Article,2012-07-17,10.1111/j.1442-2042.2012.03098.x,,,,22805007,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077601,https://api.altmetric.com/v1/donut/3077601_240.png 3,Emerging therapies in castrate-resistant prostate cancer.,Current opinion in oncology,,,Article,2009-05-01,10.1097/cco.0b013e32832a1868,,,,19363343,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077600,https://api.altmetric.com/v1/donut/3077600_240.png 3,Response to the U.S. Preventative Services Task Force Decision on Prostate Cancer Screening,Current Urology Reports,,,Article,2013-04-09,10.1007/s11934-013-0318-9,,,,23568623,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077599,https://api.altmetric.com/v1/donut/3077599_240.png 3,Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme,Public Health (Elsevier),,,Article,2012-01-12,10.1016/j.puhe.2012.01.016,,,,22381571,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077598,https://api.altmetric.com/v1/donut/3077598_240.png 3,Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implications,International Journal of Cancer,,,Article,2004-05-20,10.1002/ijc.20314,,,,15252851,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3077596,https://api.altmetric.com/v1/donut/3077596_240.png 3,Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening,Journal of Internal Medicine,,,Article,2010-12-08,10.1111/j.1365-2796.2010.02284.x,,,,21138491,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077595,https://api.altmetric.com/v1/donut/3077595_240.png 3,Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player,International Journal of Cancer,,,Article,2009-02-03,10.1002/ijc.24305,,,,19319982,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077594,https://api.altmetric.com/v1/donut/3077594_240.png 3,Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer.,European Urology,,,Article,2011-11-23,10.1016/j.eururo.2011.11.009,,,,22099611,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/3077593,https://api.altmetric.com/v1/donut/3077593_240.png 3,The significance of strong histone deacetylase 1 expression in the progression of prostate cancer,Histopathology,,,Article,2011-03-25,10.1111/j.1365-2559.2011.03797.x,,,,21438903,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077592,https://api.altmetric.com/v1/donut/3077592_240.png 3,Prostate cancer screening: Attitudes and practices of family physicians in Ontario.,Canadian Urological Association Journal,,,Article,2012-06-06,10.5489/cuaj.11290,,,,22664631,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077590,https://api.altmetric.com/v1/donut/3077590_240.png 3,Update on castrate-resistant prostate cancer: 2010.,Current opinion in oncology,,,Article,2010-05-01,10.1097/cco.0b013e3283380939,,,,20177381,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077589,https://api.altmetric.com/v1/donut/3077589_240.png 3,Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models,International Journal of Cancer,,,Article,2009-06-15,10.1002/ijc.24644,,,,19530253,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077588,https://api.altmetric.com/v1/donut/3077588_240.png 3,IgG gene expression and its possible significance in prostate cancers,The Prostate,,,Article,2011-08-30,10.1002/pros.21476,,,,22430367,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077585,https://api.altmetric.com/v1/donut/3077585_240.png 3,Targeting CYP17: established and novel approaches in prostate cancer.,Current Opinion in Pharmacology,,,Article,2008-07-16,10.1016/j.coph.2008.06.004,,,,18619560,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3077584,https://api.altmetric.com/v1/donut/3077584_240.png 3,"Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer",Cancer Causes and Control,,,Article,2010-11-20,10.1007/s10552-010-9684-5,,,,21103921,PMC3002170,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3077583,https://api.altmetric.com/v1/donut/3077583_240.png 3,No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer,British Journal of Urology,,,Article,2010-10-15,10.1111/j.1464-410x.2010.09712.x,,,,20950305,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077582,https://api.altmetric.com/v1/donut/3077582_240.png 3,The Impact of Financial Interest in Intensity-Modulated Radiation Therapy on the Utilization of Radiation Therapy for Treatment of Newly Diagnosed Prostate Cancer: A Single Center Experience,ISRN Urology,,,Article,2012-03-11,10.5402/2012/759258,,,,22567423,PMC3329792,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077580,https://api.altmetric.com/v1/donut/3077580_240.png 3,Prognostic relevance of Bcl?2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene,The Prostate,,,Article,2011-10-24,10.1002/pros.21504,,,,22024950,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077579,https://api.altmetric.com/v1/donut/3077579_240.png 3,Docetaxel–ST1481 sequence exerts a potent cytotoxic activity on hormone?resistant prostate cancer cells by reducing drug resistance?related gene expression,The Prostate,,,Article,2009-09-29,10.1002/pros.21055,,,,19790230,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077578,https://api.altmetric.com/v1/donut/3077578_240.png 3,Copy number alterations of c?MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy,Cancer (0008543X),,,Article,2012-01-26,10.1002/cncr.26729,,,,22281794,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3077577,https://api.altmetric.com/v1/donut/3077577_240.png 3,Early detection of high?grade prostate cancer using digital rectal examination (DRE) in men with a prostate?specific antigen level of <2.5?ng/mL and the risk of death,British Journal of Urology,,,Article,2012-07-03,10.1111/j.1464-410x.2012.11354.x,,,,22757982,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077575,https://api.altmetric.com/v1/donut/3077575_240.png 3,Early prostate cancer – which treatment do men prefer and why?,British Journal of Urology,,,Article,2010-11-17,10.1111/j.1464-410x.2010.09833.x,,,,21083643,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3077574,https://api.altmetric.com/v1/donut/3077574_240.png 3,Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.,European Urology,,,Article,2008-01-10,10.1016/j.eururo.2008.01.021,,,,18243498,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3077573,https://api.altmetric.com/v1/donut/3077573_240.png 3,Phase 3 clinical trial investigating the effect of selenium supplementation in men at high?risk for prostate cancer,The Prostate,,,Article,2012-08-10,10.1002/pros.22573,,,,22887343,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3077572,https://api.altmetric.com/v1/donut/3077572_240.png 3,Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence,Urologic Oncology,,,Article,2012-01-09,10.1016/j.urolonc.2012.07.008,,,,23021557,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077571,https://api.altmetric.com/v1/donut/3077571_240.png 3,Pathological and biochemical outcomes after radical prostatectomy in men with low?risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria,British Journal of Urology,,,Article,2013-01-15,10.1111/j.1464-410x.2012.11658.x,,,,23320782,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3077570,https://api.altmetric.com/v1/donut/3077570_240.png 3,Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design,Expert Opinion on Biological Therapy,,,Article,2009-10-28,10.1517/14712590903321421,,,,19857185,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077569,https://api.altmetric.com/v1/donut/3077569_240.png 3,Disease?specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three?dimensional conformal radiotherapy,Cancer (0008543X),,,Article,2003-10-14,10.1002/cncr.11805,,,,14635067,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077568,https://api.altmetric.com/v1/donut/3077568_240.png 3,Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion,World Journal of Urology,,,Article,2011-07-01,10.1007/s00345-011-0721-0,,,,21720862,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077566,https://api.altmetric.com/v1/donut/3077566_240.png 3,Active surveillance in prostate cancer: patient selection and triggers for intervention.,Current Opinion in Urology,,,Article,2012-05-01,10.1097/mou.0b013e328351dc47,,,,22388664,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077564,https://api.altmetric.com/v1/donut/3077564_240.png 3,[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2007-09-09,10.1007/s00259-007-0530-2,,,,17828534,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3077563,https://api.altmetric.com/v1/donut/3077563_240.png 3,The development of metachronous prostate cancer and chronic myeloid leukemia in a patient with metastatic rectal cancer.,Journal of B U ON official journal of the Balkan Union of Oncology,,,Article,2008-06-16,,,,,18555476,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3077562,https://api.altmetric.com/v1/donut/3077562_240.png 3,"External Validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese Patients Receiving Radical Prostatectomy",Japanese Journal of Clinical Oncology,,,Article,2011-11-01,10.1093/jjco/hyr136,,,,21940731,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077561,https://api.altmetric.com/v1/donut/3077561_240.png 3,Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2011-07-06,10.1007/s00259-011-1867-0,,,,21732105,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077560,https://api.altmetric.com/v1/donut/3077560_240.png 3,Active surveillance in prostate cancer: the need to standardize,Tumor Biology,,,Article,2011-05-28,10.1007/s13277-011-0193-2,,,,21625940,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3077557,https://api.altmetric.com/v1/donut/3077557_240.png 3,Serum Early Prostate Cancer Antigen (EPCA) Level and Its Association with Disease Progression in Prostate Cancer in a Chinese Population,PLoS ONE,,,Article,2011-03-05,10.1371/journal.pone.0019284,,,,21559289,,,2011PLoSO...6E9284Z,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077555,https://api.altmetric.com/v1/donut/3077555_240.png 3,Efficacy of brachytherapy for prostate cancer in African Americans compared with Caucasians,Brachytherapy,,,Article,2004-01-01,10.1016/j.brachy.2003.11.003,,,,15110311,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077554,https://api.altmetric.com/v1/donut/3077554_240.png 3,Mediated decision support in prostate cancer screening: A randomized controlled trial of decision counseling,Patient Education & Counseling,,,Article,2011-01-05,10.1016/j.pec.2010.06.011,,,,20619576,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/3077553,https://api.altmetric.com/v1/donut/3077553_240.png 3,Staging of prostate cancer.,Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer,,,Article,2007-04-17,,,,,17432557,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077551,https://api.altmetric.com/v1/donut/3077551_240.png 3,Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2007-12-22,10.1007/s00259-007-0659-z,,,,18157530,PMC2668561,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3077549,https://api.altmetric.com/v1/donut/3077549_240.png 3,External Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy Pathology Among Japanese Patients,Urology,,,Article,2010-01-08,10.1016/j.urology.2009.05.084,,,,19716590,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077548,https://api.altmetric.com/v1/donut/3077548_240.png 3,High-dose 3D-CRT in the radical and postoperative setting for prostate cancer. Analysis of survival and late rectal and urinary toxicity.,Tumori,,,Article,2012-07-25,10.1700/1125.12402,,,,22825510,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077545,https://api.altmetric.com/v1/donut/3077545_240.png 3,Imaging prostate cancer lymph node metastases with a multimodality contrast agent,The Prostate,,,Article,2011-05-02,10.1002/pros.21413,,,,21538422,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077543,https://api.altmetric.com/v1/donut/3077543_240.png 3,The Epothilones: New Therapeutic Agents for Castration-Resistant Prostate Cancer,Oncologist,,,Article,2011-10-01,10.1634/theoncologist.2010-0014,,,,21964003,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077542,https://api.altmetric.com/v1/donut/3077542_240.png 3,TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse,The Prostate,,,Article,2011-05-02,10.1002/pros.21412,,,,21538421,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077541,https://api.altmetric.com/v1/donut/3077541_240.png 3,Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea,British Journal of Urology,,,Article,2012-02-07,10.1111/j.1464-410x.2011.10927.x,,,,22314007,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077540,https://api.altmetric.com/v1/donut/3077540_240.png 3,States renewing attention to prostate cancer.,NCSL legisbrief,,,Article,2012-10-17,,,,,23072022,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3077539,https://api.altmetric.com/v1/donut/3077539_240.png 3,SEOM clinical guidelines for treatment of prostate cancer.,Clinical and Translational Oncology,,,Article,2012-06-23,,,,,22721797,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077538,https://api.altmetric.com/v1/donut/3077538_240.png 3,Tumor markers in prostate cancer I: Blood-based markers,Acta Oncologica,,,Article,2011-06-01,10.3109/0284186x.2010.542174,,,,21604943,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/3077536,https://api.altmetric.com/v1/donut/3077536_240.png 3,Cabazitaxel for the treatment of prostate cancer,Expert Opinion on Pharmacotherapy,,,Article,2011-01-04,10.1517/14656566.2011.567268,,,,21406025,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077535,https://api.altmetric.com/v1/donut/3077535_240.png 3,Systemic therapy after first-line docetaxel in metastatic castration-resistant prostate cancer.,Current Opinion in Supportive and Palliative Care,,,Article,2008-09-01,10.1097/spc.0b013e32830c48a3,,,,18685415,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077534,https://api.altmetric.com/v1/donut/3077534_240.png 3,MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy,World Journal of Urology,,,Article,2011-04-22,10.1007/s00345-011-0675-2,,,,21512807,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/3077533,https://api.altmetric.com/v1/donut/3077533_240.png 3,"Recombinant Human IFN-? Affects Androgen Receptor Level, Neuroendocrine Differentiation, Cell Adhesion, and Motility in Prostate Cancer Cells",Journal of Interferon & Cytokine Research,,,Article,2007-09-06,10.1089/jir.2006.0120,,,,17784816,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077530,https://api.altmetric.com/v1/donut/3077530_240.png 3,Recent advances in immunotherapy for the treatment of prostate cancer,Expert Opinion on Biological Therapy,,,Article,2011-06-16,10.1517/14712598.2011.575357,,,,21675925,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077527,https://api.altmetric.com/v1/donut/3077527_240.png 3,Factors influencing primary care physicians’ decision to order prostate-specific antigen (PSA) test for men without prostate cancer,Acta Oncologica,,,Article,2013-11-01,10.3109/0284186x.2012.762998,,,http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-96081,23421929,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3077526,https://api.altmetric.com/v1/donut/3077526_240.png 3,Characterisation and manipulation of docetaxel resistant prostate cancer cell lines,Molecular Cancer,,,Article,2011-10-07,10.1186/1476-4598-10-126,,,,21982118,PMC3203088,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/3077525,https://api.altmetric.com/v1/donut/3077525_240.png 3,Increased C-11 Choline Uptake in Pagetic Bone in a Patient With Coexisting Skeletal Metastases From Prostate Cancer,Clinical Nuclear Medicine,,,Article,2008-11-01,10.1097/rlu.0b013e318187ee35,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3077523,https://api.altmetric.com/v1/donut/3077523_240.png 3,Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid,International Journal of Cancer,,,Article,2007-10-24,10.1002/ijc.23187,,,,17960623,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077522,https://api.altmetric.com/v1/donut/3077522_240.png 3,Undetectable prostate specific antigen at 6–12 months,Cancer (0008543X),,,Article,2005-04-25,10.1002/cncr.21077,,,,15852361,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077521,https://api.altmetric.com/v1/donut/3077521_240.png 3,"Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL?1), CD44v6 and microvessel density for prostate cancer",International Journal of Cancer,,,Article,2004-06-02,10.1002/ijc.20368,,,,15305383,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3077520,https://api.altmetric.com/v1/donut/3077520_240.png 3,Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer.,Journal of nanomedicine nanotechnology,,,Article,2012-02-11,10.4172/2157-7439.1000112,,,,22319675,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077519,https://api.altmetric.com/v1/donut/3077519_240.png 3,Snail1 is over?expressed in prostate cancer,APMIS,,,Article,2009-02-25,10.1111/j.1600-0463.2008.00007.x,,,,19245592,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3077516,https://api.altmetric.com/v1/donut/3077516_240.png 3,Phase II trial of oxaliplatin and capecitabine after progression to first-line chemotherapy in androgen-independent prostate cancer patients.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2010-06-01,10.1097/coc.0b013e3181d6b453,,,,20539209,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077514,https://api.altmetric.com/v1/donut/3077514_240.png 3,Salvage radiation in men after prostate?specific antigen failure and the risk of death,Cancer (0008543X),,,Article,2011-03-22,10.1002/cncr.25993,,,,21437885,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3077513,https://api.altmetric.com/v1/donut/3077513_240.png 3,The emerging role of high-dose-rate brachytherapy for prostate cancer.,Clinical Oncology,,,Article,2005-07-07,,,,,15997914,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077512,https://api.altmetric.com/v1/donut/3077512_240.png 3,Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial,Radiotherapy & Oncology,,,Article,2010-01-07,10.1016/j.radonc.2010.02.022,,,,20227123,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077511,https://api.altmetric.com/v1/donut/3077511_240.png 3,Active surveillance criteria for prostate cancer: Can they be applied to Japanese patients?,International Journal of Urology,,,Article,2011-11-09,10.1111/j.1442-2042.2011.02900.x,,,,22070372,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077510,https://api.altmetric.com/v1/donut/3077510_240.png 3,Contemporary experience with ketoconazole in patients with metastatic castration?resistant prostate cancer: Clinical factors associated with PSA response and disease progression,The Prostate,,,Article,2011-06-17,10.1002/pros.21447,,,,21688281,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077509,https://api.altmetric.com/v1/donut/3077509_240.png 3,Chronic pulmonary disease negatively influences the prognosis of patients with advanced prostate cancer,World Journal of Urology,,,Article,2009-02-13,10.1007/s00345-009-0375-3,,,,19214529,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077508,https://api.altmetric.com/v1/donut/3077508_240.png 3,Active Surveillance for Favorable Risk Prostate Cancer,The Journal of Urology,,,Article,2009-01-12,10.1016/j.juro.2009.09.038,,,,19836767,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077507,https://api.altmetric.com/v1/donut/3077507_240.png 3,LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer,International Journal of Cancer,,,Article,2011-04-08,10.1002/ijc.25820,,,,21128282,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077506,https://api.altmetric.com/v1/donut/3077506_240.png 3,Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate?specific antigen levels,Cancer (0008543X),,,Article,2004-06-22,10.1002/cncr.20390,,,,15305405,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077503,https://api.altmetric.com/v1/donut/3077503_240.png 3,The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers.,Pathology,,,Article,2003-01-12,10.1080/00313020310001619163,,,,14660096,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077501,https://api.altmetric.com/v1/donut/3077501_240.png 3,Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer,ISRN Oncology,,,Article,2012-06-13,10.5402/2012/242850,,,,22745916,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3077500,https://api.altmetric.com/v1/donut/3077500_240.png 3,Detection of circulating tumor cells in different stages of prostate cancer,Journal of Cancer Research & Clinical Oncology,,,Article,2013-01-29,10.1007/s00432-013-1377-5,,,,23358719,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/3077499,https://api.altmetric.com/v1/donut/3077499_240.png 3,"A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer",Cancer Causes and Control,,,Article,2012-12-08,10.1007/s10552-012-0108-6,,,,23224323,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077498,https://api.altmetric.com/v1/donut/3077498_240.png 3,Zibotentan for the treatment of castrate-resistant prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2010-07-01,10.1517/13543784.2010.491822,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077497,https://api.altmetric.com/v1/donut/3077497_240.png 3,Towards an optimal interval for prostate cancer screening.,European Urology,,,Article,2011-08-15,10.1016/j.eururo.2011.08.002,,,,21840117,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3077496,https://api.altmetric.com/v1/donut/3077496_240.png 3,The role of abiraterone in the management of metastatic castration-resistant prostate cancer,Expert Review of Anticancer Therapy,,,Article,2012-04-17,10.1586/era.12.12,,,,22500680,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3077495,https://api.altmetric.com/v1/donut/3077495_240.png 3,Lymph node assessment and lymphadenectomy in prostate cancer,Journal of Surgical Oncology,,,Article,2009-01-23,10.1002/jso.21225,,,,19170044,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077493,https://api.altmetric.com/v1/donut/3077493_240.png 3,Use of Complementary and Alternative Medicine Among Men with Prostate Cancer in a Rural Setting,Journal of Community Health,,,Article,2011-04-17,10.1007/s10900-011-9402-6,,,,21499937,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077491,https://api.altmetric.com/v1/donut/3077491_240.png 3,"Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer",Current Oncology Reports,,,Article,2011-01-18,10.1007/s11912-011-0153-4,,,,21243537,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3077490,https://api.altmetric.com/v1/donut/3077490_240.png 3,Expression and prognostic role of syndecan-2 in prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2009-09-29,10.1038/pcan.2009.43,,,,19786981,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3077488,https://api.altmetric.com/v1/donut/3077488_240.png 3,"Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression",The Prostate,,,Article,2003-12-11,10.1002/pros.10361,,,,15042598,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077487,https://api.altmetric.com/v1/donut/3077487_240.png 3,An updated catalog of prostate cancer predictive tools,Cancer (0008543X),,,Article,2008-09-29,10.1002/cncr.23908,,,,18823041,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/3077486,https://api.altmetric.com/v1/donut/3077486_240.png 3,Randomized trial to assess the efficacy of intraoperative steroid use in decreasing acute urinary retention after transperineal radioactive iodine?125 implantation for prostate cancer,Cancer (0008543X),,,Article,2008-09-24,10.1002/cncr.23905,,,,18816596,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3077485,https://api.altmetric.com/v1/donut/3077485_240.png 3,Focal therapy for prostate cancer: patient selection and evaluation,Expert Review of Anticancer Therapy,,,Article,2011-12-15,10.1586/era.11.144,,,,22149434,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3077483,https://api.altmetric.com/v1/donut/3077483_240.png 3,Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials,Journal of Cancer Research & Clinical Oncology,,,Article,2011-09-14,10.1007/s00432-011-1052-7,,,,21915752,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3077482,https://api.altmetric.com/v1/donut/3077482_240.png 3,"Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.",Pathology,,,Article,2010-09-21,10.3109/00313025.2010.508788,,,,20854069,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3077480,https://api.altmetric.com/v1/donut/3077480_240.png 3,"Increased Expression of Tumor-Associated Trypsin Inhibitor, TATI, in Prostate Cancer and in Androgen-Independent 22Rv1 Cells",European Urology,,,Article,2007-12-01,10.1016/j.eururo.2007.01.096,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3077479,https://api.altmetric.com/v1/donut/3077479_240.png 3,Cell signaling modifiers in prostate cancer.,Cancer Journal,,,Article,2008-01-01,10.1097/ppo.0b013e318161d40f,,,,18303482,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3077476,https://api.altmetric.com/v1/donut/3077476_240.png 3,Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms,Urologic Oncology,,,Article,2015-01-06,10.1016/j.urolonc.2014.10.009,,,,25575714,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3063409,https://api.altmetric.com/v1/donut/3063409_240.png 3,The Role of Dietary Fat throughout the Prostate Cancer Trajectory,Nutrients,,,Article,2014-12-22,10.3390/nu6126095,,,,25533015,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3011463,https://api.altmetric.com/v1/donut/3011463_240.png 3,Gyrus|[trade]| bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1|[thinsp]|y follow-up,Prostate Cancer & Prostatic Diseases,,,Article,2003-06-01,10.1038/sj.pcan.4500631,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2907606,https://api.altmetric.com/v1/donut/2907606_240.png 3,Nutrition and prostate cancer: an overview.,Expert Review of Anticancer Therapy,,,Article,2014-11-01,10.1586/14737140.2014.972946,,,,25367323,,,,,,,0,0,0,4,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2859044,https://api.altmetric.com/v1/donut/2859044_240.png 3,International Variation in Prostate Cancer Incidence and Mortality Rates.,European Urology,,,Article,2012-03-21,10.1016/j.eururo.2012.02.054,,,,22424666,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,231,https://www.altmetric.com/details/2841917,https://api.altmetric.com/v1/donut/2841917_240.png 3,A systematic review and meta?analysis of familial prostate cancer risk,British Journal of Urology,,,Article,2003-05-23,10.1046/j.1464-410x.2003.04232.x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2841916,https://api.altmetric.com/v1/donut/2841916_240.png 3,Alcohol consumption and prostate cancer risk,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2012-07-01,10.1097/cej.0b013e32834dbc11,,,,22095143,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2841914,https://api.altmetric.com/v1/donut/2841914_240.png 3,Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses.,Future Oncology,,,Article,2010-08-31,10.2217/fon.10.95,,,,20799875,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2841912,https://api.altmetric.com/v1/donut/2841912_240.png 3,Risk Stratification of Men Choosing Surveillance for Low Risk Prostate Cancer,The Journal of Urology,,,Article,2010-03-22,10.1016/j.juro.2010.01.001,,,,20304433,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2839654,https://api.altmetric.com/v1/donut/2839654_240.png 3,Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance,Cancer (0008543X),,,Article,2008-05-16,10.1002/cncr.23575,,,,18484590,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2839653,https://api.altmetric.com/v1/donut/2839653_240.png 3,Urologic imaging for localized prostate cancer in 2007,World Journal of Urology,,,Article,2007-03-21,10.1007/s00345-007-0155-x,,,,17375307,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2839652,https://api.altmetric.com/v1/donut/2839652_240.png 3,What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?,Nature Reviews Urology,,,Article,2008-09-23,10.1038/ncpuro1217,,,,18813218,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2839651,https://api.altmetric.com/v1/donut/2839651_240.png 3,Novel targeted therapeutics for metastatic castration-resistant prostate cancer,Cancer Letters,,,Article,2009-09-01,10.1016/j.canlet.2009.08.012,,,,19717225,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/2839650,https://api.altmetric.com/v1/donut/2839650_240.png 3,[11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy,World Journal of Urology,,,Article,2009-02-21,10.1007/s00345-009-0371-7,,,,19234708,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2839649,https://api.altmetric.com/v1/donut/2839649_240.png 3,Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome,The Journal of Urology,,,Article,2006-09-01,10.1016/j.juro.2006.04.102,,,,16890675,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2839648,https://api.altmetric.com/v1/donut/2839648_240.png 3,Adjuvant medical therapy for prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2010-12-02,10.1517/14656566.2010.516252,,,,21118060,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839647,https://api.altmetric.com/v1/donut/2839647_240.png 3,[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2006-07-25,10.1007/s00259-006-0150-2,,,,16865395,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2839646,https://api.altmetric.com/v1/donut/2839646_240.png 3,"Prostate cancer: HIFU is effective, but associated morbidity still remains unclear",Nature Reviews Urology,,,Article,2010-11-10,10.1038/nrurol.2010.176,,,,21068758,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839645,https://api.altmetric.com/v1/donut/2839645_240.png 3,Do Anxiety and Distress Increase During Active Surveillance for Low Risk Prostate Cancer?,The Journal of Urology,,,Article,2010-03-17,10.1016/j.juro.2009.12.099,,,,20299064,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2839644,https://api.altmetric.com/v1/donut/2839644_240.png 3,Older Age Predicts Decreased Metastasis and Prostate Cancer-Specific Death for Men Treated With Radiation Therapy: Meta-Analysis of Radiation Therapy Oncology Group Trials,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-04-01,10.1016/j.ijrobp.2010.07.2004,,,,21458924,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2839643,https://api.altmetric.com/v1/donut/2839643_240.png 3,The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2008-06-24,10.1038/pcan.2008.36,,,,18574490,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839642,https://api.altmetric.com/v1/donut/2839642_240.png 3,Short?term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study,British Journal of Urology,,,Article,2009-10-08,10.1111/j.1464-410x.2009.08887.x,,,,19817747,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2839641,https://api.altmetric.com/v1/donut/2839641_240.png 3,Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection?,The Journal of Urology,,,Article,2010-01-01,10.1016/j.juro.2009.08.156,,,,19913814,PMC3140466,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2839640,https://api.altmetric.com/v1/donut/2839640_240.png 3,Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer.,Cancer Investigation,,,Article,2010-01-05,10.3109/07357900903287048,,,,20073578,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2839639,https://api.altmetric.com/v1/donut/2839639_240.png 3,RADIATION IN HIGH?RISK PROSTATE CANCER: HOW MUCH IS ENOUGH?,British Journal of Urology,,,Article,2008-05-12,10.1111/j.1464-410x.2008.07701.x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2839637,https://api.altmetric.com/v1/donut/2839637_240.png 3,Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer,World Journal of Urology,,,Article,2010-03-14,10.1007/s00345-010-0527-5,,,,20229232,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2839636,https://api.altmetric.com/v1/donut/2839636_240.png 3,Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance.,European Urology,,,Article,2010-12-16,10.1016/j.eururo.2010.11.044,,,,21156337,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2839635,https://api.altmetric.com/v1/donut/2839635_240.png 3,Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.,European Urology,,,Article,2007-01-30,10.1016/j.eururo.2007.01.030,,,,17257742,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839634,https://api.altmetric.com/v1/donut/2839634_240.png 3,Secondary effects and biochemical control in patients with early prostate cancer treated with (125)-I seeds.,Clinical and Translational Oncology,,,Article,2008-06-19,,,,,18558583,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839633,https://api.altmetric.com/v1/donut/2839633_240.png 3,Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.,Radiology,,,Article,2007-01-10,10.1148/radiol.2451061502,,,,17717328,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2839631,https://api.altmetric.com/v1/donut/2839631_240.png 3,Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy,Annals of Nuclear Medicine,,,Article,2010-06-11,10.1007/s12149-010-0390-x,,,,20544323,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2839630,https://api.altmetric.com/v1/donut/2839630_240.png 3,Prostatourethral?rectal fistula after prostate brachytherapy,Cancer (0008543X),,,Article,2000-11-13,10.1002/1097-0142(20001115)89:10<2085::aid-cncr8>3.0.co;2-q,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2839629,https://api.altmetric.com/v1/donut/2839629_240.png 3,Pretreatment Endorectal Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging Features of Prostate Cancer as Predictors of Response to External Beam Radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2008-08-29,10.1016/j.ijrobp.2008.04.056,,,,18760545,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2839628,https://api.altmetric.com/v1/donut/2839628_240.png 3,Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer,Expert Review of Medical Devices,,,Article,2010-01-07,10.1586/erd.10.24,,,,20583890,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2839626,https://api.altmetric.com/v1/donut/2839626_240.png 3,Critical Review: Is Watchful Waiting a Viable Management Option for Older Men With Prostate Cancer?,American Journal of Men's Health,,,Article,2007-03-15,10.1177/1557988306294161,,,,19482780,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2839625,https://api.altmetric.com/v1/donut/2839625_240.png 3,"Variations in International Prostate Symptom Scores, Uroflowmetric Parameters, and Prostate Volume After 125I Permanent Brachytherapy for Localized Prostate Cancer",Urology,,,Article,2009-04-20,10.1016/j.urology.2008.12.062,,,,19376570,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839624,https://api.altmetric.com/v1/donut/2839624_240.png 3,Technologies for localization and diagnosis of prostate cancer,Journal of Medical Engineering & Technology,,,Article,2008-12-31,10.3109/03091900903111966,,,,19848851,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2839622,https://api.altmetric.com/v1/donut/2839622_240.png 3,2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy,Clinical Cancer Research,,,Article,2005-07-01,10.1158/1078-0432.ccr-05-0249,,,,16000572,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2839621,https://api.altmetric.com/v1/donut/2839621_240.png 3,18F-choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer,Annals of Nuclear Medicine,,,Article,2009-06-16,10.1007/s12149-009-0273-1,,,,19529978,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2839620,https://api.altmetric.com/v1/donut/2839620_240.png 3,Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2009-02-07,,,,,19192649,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839619,https://api.altmetric.com/v1/donut/2839619_240.png 3,"Ten?year outcomes of high?dose, intensity?modulated radiotherapy for localized prostate cancer",Cancer (0008543X),,,Article,2010-11-08,10.1002/cncr.25467,,,,21061333,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/2839618,https://api.altmetric.com/v1/donut/2839618_240.png 3,"Five Year Biochemical Recurrence Free Survival for Intermediate Risk Prostate Cancer After Radical Prostatectomy, External Beam Radiation Therapy or Permanent Seed Implantation",Urology,,,Article,2010-01-11,10.1016/j.urology.2010.01.010,,,,20378156,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2839617,https://api.altmetric.com/v1/donut/2839617_240.png 3,Docetaxel-based combination therapy for castration-resistant prostate cancer,Annals of Oncology,,,Article,2010-11-01,10.1093/annonc/mdq050,,,,20351071,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2839616,https://api.altmetric.com/v1/donut/2839616_240.png 3,Topographical Sensitivity and Specificity of Endorectal Coil Magnetic Resonance Imaging for Prostate Cancer Detection,Urologia Internationalis,,,Article,2010-03-20,10.1159/000300572,,,,20332606,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839615,https://api.altmetric.com/v1/donut/2839615_240.png 3,"Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.",Asian Journal of Andrology,,,Article,2009-04-08,10.1038/aja.2009.10,,,,19349948,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2839612,https://api.altmetric.com/v1/donut/2839612_240.png 3,Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer,World Journal of Urology,,,Article,2008-06-26,10.1007/s00345-008-0286-8,,,,18581118,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2839611,https://api.altmetric.com/v1/donut/2839611_240.png 3,High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.,Acta bio medica Atenei Parmensis,,,Article,2009-03-06,,,,,19260381,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2839610,https://api.altmetric.com/v1/donut/2839610_240.png 3,State-of-the-art: prostate LDR brachytherapy,Prostate Cancer & Prostatic Diseases,,,Article,2008-03-25,10.1038/pcan.2008.9,,,,18364676,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2839609,https://api.altmetric.com/v1/donut/2839609_240.png 3,A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer,European Journal of Radiology,,,Article,2010-02-01,10.1016/j.ejrad.2008.10.034,,,,19084363,,1854/LU-1097855,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2839607,https://api.altmetric.com/v1/donut/2839607_240.png 3,Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?,Cancer (0008543X),,,Article,2009-05-29,10.1002/cncr.24392,,,,19484790,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2839604,https://api.altmetric.com/v1/donut/2839604_240.png 3,Long-term follow-up after triple treatment of prostate cancer stage pT3.,Scandinavian Journal of Urology & Nephrology,,,Article,2009-04-10,10.1080/00365590902833887,,,,19353383,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839603,https://api.altmetric.com/v1/donut/2839603_240.png 3,Measuring illness uncertainty in men undergoing active surveillance for prostate cancer,Applied Nursing Research,,,Article,2011-01-11,10.1016/j.apnr.2009.08.001,,,,20974073,PMC3070758,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2839602,https://api.altmetric.com/v1/donut/2839602_240.png 3,Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit,European Journal of Cancer (1965),,,Article,2009-10-05,10.1016/j.ejca.2009.09.008,,,,19804966,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2839601,https://api.altmetric.com/v1/donut/2839601_240.png 3,Pathology of prostate cancer and focal therapy ('male lumpectomy').,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2010-01-02,,,,,20044631,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2839600,https://api.altmetric.com/v1/donut/2839600_240.png 3,Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer,British Journal of Urology,,,Article,2010-06-13,10.1111/j.1464-410x.2009.09057.x,,,,19912205,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2839599,https://api.altmetric.com/v1/donut/2839599_240.png 3,Evaluation of [11C]?choline positron?emission/computed tomography in patients with increasing prostate?specific antigen levels after primary treatment for prostate cancer,British Journal of Urology,,,Article,2007-09-03,10.1111/j.1464-410x.2007.07083.x,,,,17822459,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2839597,https://api.altmetric.com/v1/donut/2839597_240.png 3,Prostate cancer detection with magnetic resonance imaging: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?,Diagnostic and Interventional Radiology,,,Article,2010-01-01,10.4261/1305-3825.dir.3605-10.1,,,,20859852,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2839596,https://api.altmetric.com/v1/donut/2839596_240.png 3,The role of biopsy core number in selecting prostate cancer patients for active surveillance.,European Urology,,,Article,2009-08-19,10.1016/j.eururo.2009.07.053,,,,19683860,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2839595,https://api.altmetric.com/v1/donut/2839595_240.png 3,Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2007-06-19,10.1038/sj.pcan.4500988,,,,17579613,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2839593,https://api.altmetric.com/v1/donut/2839593_240.png 3,Changes in Continence and Health-Related Quality of Life After Curative Treatment and Watchful Waiting of Prostate Cancer,Urology,,,Article,2007-06-01,10.1016/j.urology.2007.02.003,,,,17572206,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2839591,https://api.altmetric.com/v1/donut/2839591_240.png 3,The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis,International Journal of Clinical Oncology,,,Article,2007-08-20,10.1007/s10147-007-0669-7,,,,17701002,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2839589,https://api.altmetric.com/v1/donut/2839589_240.png 3,"Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2?weighted, dynamic contrast?enhanced and diffusion?weighted imaging",British Journal of Urology,,,Article,2010-11-02,10.1111/j.1464-410x.2010.09808.x,,,,21044250,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,78,https://www.altmetric.com/details/2839588,https://api.altmetric.com/v1/donut/2839588_240.png 3,Bladder neck involvement as pT4 disease in prostate cancer: implications for prognosis and patient surveillance.,Future Oncology,,,Article,2009-01-08,10.2217/fon.09.59,,,,19663730,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839587,https://api.altmetric.com/v1/donut/2839587_240.png 3,The role of brachytherapy in the 21st century for prostate cancer.,Minerva Urologica E Nefrologica,,,Article,2010-06-23,,,,,20562800,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839586,https://api.altmetric.com/v1/donut/2839586_240.png 3,Results of the three rounds of the Finnish Prostate Cancer Screening Trial—The incidence of advanced cancer is decreased by screening,International Journal of Cancer,,,Article,2010-04-05,10.1002/ijc.25368,,,,20473861,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2839584,https://api.altmetric.com/v1/donut/2839584_240.png 3,The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer,Urologic Oncology,,,Article,2009-04-13,10.1016/j.urolonc.2009.01.005,,,,19362864,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2839582,https://api.altmetric.com/v1/donut/2839582_240.png 3,Patient-reported outcomes after cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: A systematic review,Cancer Treatment Reviews,,,Article,2010-02-24,10.1016/j.ctrv.2010.02.001,,,,20181431,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2839581,https://api.altmetric.com/v1/donut/2839581_240.png 3,The Utility of Transrectal Real-Time Elastography in the Diagnosis of Prostate Cancer,Ultrasound in Medicine & Biology,,,Article,2008-02-13,10.1016/j.ultrasmedbio.2007.12.002,,,,18255215,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2839579,https://api.altmetric.com/v1/donut/2839579_240.png 3,Outcomes Following Iodine-125 Monotherapy for Localized Prostate Cancer: The Results of Leeds 10-Year Single-Center Brachytherapy Experience,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-01-01,10.1016/j.ijrobp.2009.01.050,,,,20005453,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2839578,https://api.altmetric.com/v1/donut/2839578_240.png 3,Radical retropubic prostatectomy for prostate cancer with microscopic bladder neck involvement: survival and prognostic implications,British Journal of Urology,,,Article,2009-10-05,10.1111/j.1464-410x.2009.08914.x,,,,19804424,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839577,https://api.altmetric.com/v1/donut/2839577_240.png 3,"High-risk prostate cancer in the United States, 1990–2007",World Journal of Urology,,,Article,2008-03-28,10.1007/s00345-008-0250-7,,,,18369637,PMC2948572,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2839576,https://api.altmetric.com/v1/donut/2839576_240.png 3,Dynamic MRI and CAD vs. Choline MRS: Where is the detection level for a lesion characterisation in prostate cancer?,International Journal of Radiation Biology,,,Article,2009-08-26,10.1080/09553000903090027,,,,19701842,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2839575,https://api.altmetric.com/v1/donut/2839575_240.png 3,The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.,European Urology,,,Article,2010-09-28,10.1016/j.eururo.2010.09.004,,,,20869161,,,,,,,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2839574,https://api.altmetric.com/v1/donut/2839574_240.png 3,The interval from the last cycle of docetaxel-based chemotherapy to progression is associated with the efficacy of subsequent docetaxel in patients with prostate cancer,European Journal of Cancer (1965),,,Article,2010-05-19,10.1016/j.ejca.2010.04.010,,,,20483588,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2839573,https://api.altmetric.com/v1/donut/2839573_240.png 3,High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer,Brachytherapy,,,Article,2009-10-21,10.1016/j.brachy.2009.04.007,,,,19846348,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2839572,https://api.altmetric.com/v1/donut/2839572_240.png 3,Docetaxel?based chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: Factors predicting response and survival,International Journal of Urology,,,Article,2009-09-14,10.1111/j.1442-2042.2009.02351.x,,,,19769656,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839571,https://api.altmetric.com/v1/donut/2839571_240.png 3,Combined Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy Imaging in the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis,European Urology,,,Article,2009-03-01,10.1016/j.eururo.2008.10.019,,,,18952365,PMC2803037,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2839569,https://api.altmetric.com/v1/donut/2839569_240.png 3,"Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone?refractory prostate cancer patients",International Journal of Urology,,,Article,2010-04-26,10.1111/j.1442-2042.2010.02544.x,,,,20438593,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2839567,https://api.altmetric.com/v1/donut/2839567_240.png 3,Outcomes of Radical Prostatectomy in Clinically Locally Advanced N0M0 Prostate Cancer,Urologia Internationalis,,,Article,2010-06-18,10.1159/000316944,,,,20558980,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2839565,https://api.altmetric.com/v1/donut/2839565_240.png 3,"Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience.",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2009-04-02,,,,,19331234,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839564,https://api.altmetric.com/v1/donut/2839564_240.png 3,Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer.,Current Opinion in Urology,,,Article,2007-01-01,10.1097/mou.0b013e328011b85c,,,,17143110,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2839563,https://api.altmetric.com/v1/donut/2839563_240.png 3,Trials of Decision Aids for Prostate Cancer Screening,American Journal of Preventive Medicine,,,Article,2007-11-01,10.1016/j.amepre.2007.07.030,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2839562,https://api.altmetric.com/v1/donut/2839562_240.png 3,Is radical prostatectomy a viable therapeutic option in clinically locally advanced (cT3) prostate cancer?,British Journal of Urology,,,Article,2010-09-14,10.1111/j.1464-410x.2010.09630.x,,,,20840545,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2839561,https://api.altmetric.com/v1/donut/2839561_240.png 3,Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single?centre experience,British Journal of Urology,,,Article,2008-11-25,10.1111/j.1464-410x.2008.08208.x,,,,19040530,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2839559,https://api.altmetric.com/v1/donut/2839559_240.png 3,"Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer",International Journal of Urology,,,Article,2008-04-15,10.1111/j.1442-2042.2008.02042.x,,,,18422574,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839558,https://api.altmetric.com/v1/donut/2839558_240.png 3,Visualization of Prostate Cancer with 11C-Choline Positron Emission Tomography,European Urology,,,Article,2002-07-01,10.1016/s0302-2838(02)00129-x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2839557,https://api.altmetric.com/v1/donut/2839557_240.png 3,High?intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure,British Journal of Urology,,,Article,2009-04-22,10.1111/j.1464-410x.2009.08518.x,,,,19388986,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2839556,https://api.altmetric.com/v1/donut/2839556_240.png 3,Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging.,Radiology,,,Article,2009-10-31,10.1148/radiol.2532081390,,,,19864529,PMC2770114,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2839555,https://api.altmetric.com/v1/donut/2839555_240.png 3,Screening for prostate cancer (PC)—an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC),Urologic Oncology,,,Article,2008-09-01,10.1016/j.urolonc.2008.03.011,,,,18774469,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2839554,https://api.altmetric.com/v1/donut/2839554_240.png 3,HIGH?INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER: INITIAL EXPERIENCE WITH A 2?YEAR FOLLOW?UP,British Journal of Urology,,,Article,2009-09-14,10.1111/j.1464-410x.2009.08892_1.x,,,,19764975,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2839553,https://api.altmetric.com/v1/donut/2839553_240.png 3,"Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials","International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-08-01,10.1016/j.ijrobp.2008.10.091,,,,19616743,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/2839551,https://api.altmetric.com/v1/donut/2839551_240.png 3,Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance,Urology,,,Article,2006-01-01,10.1016/j.urology.2005.07.056,,,,16413347,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2839550,https://api.altmetric.com/v1/donut/2839550_240.png 3,Proton beam therapy for prostate cancer.,Johns Hopkins Medical Letter: Health After 50,,,Article,2009-01-04,,,,,19489147,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839549,https://api.altmetric.com/v1/donut/2839549_240.png 3,The urologist’s guide to low dose?rate interstitial brachytherapy with permanent seed implants for localized prostate cancer,British Journal of Urology,,,Article,2006-11-07,10.1111/j.1464-410x.2006.06587.x,,,,17092283,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2839547,https://api.altmetric.com/v1/donut/2839547_240.png 3,Radiotherapy for patients with localized hormone?refractory prostate cancer: results of the Patterns of Care Study in Japan,British Journal of Urology,,,Article,2009-06-12,10.1111/j.1464-410x.2009.08616.x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2839544,https://api.altmetric.com/v1/donut/2839544_240.png 3,Controversies in the treatment of high?risk prostate cancer—what is the optimal combination of hormonal therapy and radiotherapy: a review of literature,The Prostate,,,Article,2009-12-16,10.1002/pros.21102,,,,20017166,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2839543,https://api.altmetric.com/v1/donut/2839543_240.png 3,PSA surge/flare?up in patients with castration?refractory prostate cancer during the initial phase of chemotherapy,The Prostate,,,Article,2009-08-12,10.1002/pros.21024,,,,19676083,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839541,https://api.altmetric.com/v1/donut/2839541_240.png 3,Surgical management of high risk prostate cancer: The Mayo Clinic experience,Urologic Oncology,,,Article,2008-01-09,10.1016/j.urolonc.2008.03.009,,,,18774468,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839536,https://api.altmetric.com/v1/donut/2839536_240.png 3,Ultrasound of the prostate.,Cancer Imaging,,,Article,2010-03-03,10.1102/1470-7330.2010.0004,,,,20199941,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2839535,https://api.altmetric.com/v1/donut/2839535_240.png 3,"Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10?years",Radiotherapy & Oncology,,,Article,2010-04-02,10.1016/j.radonc.2010.03.004,,,,20362348,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2839533,https://api.altmetric.com/v1/donut/2839533_240.png 3,Proton-Beam Therapy for Prostate Cancer,Cancer Journal,,,Article,2010-09-01,10.1097/ppo.0b013e3181f8c25d,,,,20890135,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2839532,https://api.altmetric.com/v1/donut/2839532_240.png 3,Long-term quality of life following primary treatment in men with clinical stage T3 prostate cancer,Quality of Life Research,,,Article,2010-07-31,10.1007/s11136-010-9721-6,,,,20680687,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2839529,https://api.altmetric.com/v1/donut/2839529_240.png 3,Advantages of second line estramustine for overall survival of hormone-refractory prostate cancer (HRPC) patients.,Asian Pacific Journal of Cancer Prevention,,,Article,2009-05-28,,,,,19469628,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2839528,https://api.altmetric.com/v1/donut/2839528_240.png 3,Carbon ion radiotherapy for treatment of prostate cancer and subsequent outcomes after biochemical failure.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2010-12-30,,,,,21187497,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839527,https://api.altmetric.com/v1/donut/2839527_240.png 3,A prospective randomized trial comparing contrast?enhanced targeted versus systematic ultrasound guided biopsies: Impact on prostate cancer detection,The Prostate,,,Article,2007-08-17,10.1002/pros.20639,,,,17705242,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2839526,https://api.altmetric.com/v1/donut/2839526_240.png 3,Safety and efficacy of active surveillance in patients with localized prostate cancer.,Indian Journal of Urology,,,Article,2008-01-01,,,,,19468382,PMC2684239,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839525,https://api.altmetric.com/v1/donut/2839525_240.png 3,Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy,Strahlentherapie und Onkologie,,,Article,2009-02-25,10.1007/s00066-009-1970-3,,,,19240995,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2839524,https://api.altmetric.com/v1/donut/2839524_240.png 3,Prostate cancer: current evidence weighs against population screening.,CA: A Cancer Journal for Clinicians ,,,Article,2009-07-02,10.3322/caac.20025,,,,19564244,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2839523,https://api.altmetric.com/v1/donut/2839523_240.png 3,The potential role of prebiopsy magnetic resonance imaging combined with prostate?specific antigen density in the detection of prostate cancer,International Journal of Urology,,,Article,2008-02-18,10.1111/j.1442-2042.2008.01991.x,,,,18380820,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2839522,https://api.altmetric.com/v1/donut/2839522_240.png 3,Gleason score 7 screen?detected prostate cancers initially managed expectantly: outcomes in 50 men,British Journal of Urology,,,Article,2009-01-19,10.1111/j.1464-410x.2008.08281.x,,,,19154509,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2839519,https://api.altmetric.com/v1/donut/2839519_240.png 3,ARE THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDELINES THAT PROMULGATE ACTIVE SURVEILLANCE FOR LOW?RISK PROSTATE CANCER JUSTIFIED BY THE AVAILABLE EVIDENCE?,British Journal of Urology,,,Article,2009-02-02,10.1111/j.1464-410x.2009.08395_3.x,,,,19187350,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839518,https://api.altmetric.com/v1/donut/2839518_240.png 3,When watchful waiting is right choice for prostate cancer.,Johns Hopkins Medical Letter: Health After 50,,,Article,2006-01-10,,,,,17146873,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839517,https://api.altmetric.com/v1/donut/2839517_240.png 3,Nomogram use for the prediction of indolent prostate cancer,Cancer (0008543X),,,Article,2007-09-24,10.1002/cncr.23029,,,,17893906,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2839516,https://api.altmetric.com/v1/donut/2839516_240.png 3,High-intensity focused ultrasound in the management of prostate cancer.,Expert Review of Medical Devices,,,Article,2010-03-11,10.1586/erd.09.66,,,,20214427,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2839515,https://api.altmetric.com/v1/donut/2839515_240.png 3,Locally advanced prostate cancer: the role of surgical management,British Journal of Urology,,,Article,2009-07-07,10.1111/j.1464-410x.2009.08741.x,,,,19664112,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2839514,https://api.altmetric.com/v1/donut/2839514_240.png 3,Health-Related Quality of Life in Patients with Hormone Refractory Prostate Cancer Receiving Gefitinib,Urologia Internationalis,,,Article,2009-03-19,10.1159/000200800,,,,19322010,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2839512,https://api.altmetric.com/v1/donut/2839512_240.png 3,Staging Saturation Biopsy in Patients with Prostate Cancer on Active Surveillance Protocol,Urology,,,Article,2008-04-01,10.1016/j.urology.2007.11.094,,,,18387385,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2839511,https://api.altmetric.com/v1/donut/2839511_240.png 3,Treatment Results of PDR Brachytherapy Combined With External Beam Radiotherapy in 106 Patients With Intermediate- to High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-06-10,10.1016/j.ijrobp.2009.12.044,,,,20510545,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2839510,https://api.altmetric.com/v1/donut/2839510_240.png 3,Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991,European Journal of Cancer (1965),,,Article,2009-08-17,10.1016/j.ejca.2009.07.009,,,,19682889,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2839509,https://api.altmetric.com/v1/donut/2839509_240.png 3,High-risk localized prostate cancer: role of radical prostatectomy,Current Opinion in Urology,,,Article,2010-05-01,10.1097/mou.0b013e3283384101,,,,20216315,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2839507,https://api.altmetric.com/v1/donut/2839507_240.png 3,Radiation dose escalation for localized prostate cancer,Cancer (0008543X),,,Article,2009-08-10,10.1002/cncr.24558,,,,19670452,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2839505,https://api.altmetric.com/v1/donut/2839505_240.png 3,ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program,Urology,,,Article,2011-01-10,10.1016/j.urology.2010.07.526,,,,21216447,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2839504,https://api.altmetric.com/v1/donut/2839504_240.png 3,Time course of late rectal toxicity after radiation therapy for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2009-12-29,10.1038/pcan.2009.56,,,,20038960,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2839500,https://api.altmetric.com/v1/donut/2839500_240.png 3,Enhanced Transrectal Ultrasound Modalities in the Diagnosis of Prostate Cancer,Urology,,,Article,2010-01-11,10.1016/j.urology.2010.05.022,,,,20719368,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2839499,https://api.altmetric.com/v1/donut/2839499_240.png 3,Pathological results and rates of treatment failure in high?risk prostate cancer patients after radical prostatectomy,British Journal of Urology,,,Article,2010-09-28,10.1111/j.1464-410x.2010.09594.x,,,,20875089,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2839498,https://api.altmetric.com/v1/donut/2839498_240.png 3,Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use,Prostate Cancer & Prostatic Diseases,,,Article,2010-01-05,10.1038/pcan.2009.57,,,,20048758,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2839497,https://api.altmetric.com/v1/donut/2839497_240.png 3,Predictive modelling in hormone-refractory prostate cancer (HRPC),Clinical and Translational Oncology,,,Article,2009-02-18,10.1007/s12094-009-0318-x,,,,,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2839496,https://api.altmetric.com/v1/donut/2839496_240.png 3,Contrast-Enhanced Harmonic Ultrasonography for the Assessment of Prostate Cancer Aggressiveness: a Preliminary Study,Korean Journal of Radiology,,,Article,2010-02-01,10.3348/kjr.2010.11.1.75,,,,20046498,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2839495,https://api.altmetric.com/v1/donut/2839495_240.png 3,"The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise",Urologic Oncology,,,Article,2004-07-01,10.1016/j.urolonc.2004.04.013,,,,15283897,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2838867,https://api.altmetric.com/v1/donut/2838867_240.png 3,"Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial",American Journal of Obstetrics & Gynecology,,,Article,2005-11-01,10.1016/j.ajog.2005.05.005,,,,16260202,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2838814,https://api.altmetric.com/v1/donut/2838814_240.png 3,Molecular Signature of Cancer at Gene Level or Pathway Level? Case Studies of Colorectal Cancer and Prostate Cancer Microarray Data,Computational & Mathematical Methods in Medicine,,,Article,2013-01-16,10.1155/2013/909525,,,,23401724,PMC3562646,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2838440,https://api.altmetric.com/v1/donut/2838440_240.png 3,Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer,New England Journal of Medicine,,,Article,2010-11-11,10.1056/nejmc1009982,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2837938,https://api.altmetric.com/v1/donut/2837938_240.png 3,"Intakes of Selected Nutrients, Foods, and Phytochemicals and Prostate Cancer Risk in Western New York ",Nutrition and Cancer,,,Article,2005-12-16,10.1207/s15327914nc5301_4,,,,16351504,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2837646,https://api.altmetric.com/v1/donut/2837646_240.png 3,Efficacy of Antioxidant Vitamins and Selenium Supplement in Prostate Cancer Prevention: A Meta-Analysis of Randomized Controlled Trials,Nutrition and Cancer,,,Article,2010-07-29,10.1080/01635581.2010.494335,,,,20661819,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2837617,https://api.altmetric.com/v1/donut/2837617_240.png 3,Serum and Dietary Vitamin E in Relation to Prostate Cancer Risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-06-01,10.1158/1055-9965.epi-06-1084,,,,17548693,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2837605,https://api.altmetric.com/v1/donut/2837605_240.png 3,Dietary vitamins E and C and prostate cancer risk,Acta Oncologica,,,Article,2008-12-31,10.1080/02841860902946546,,,,19452333,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2837599,https://api.altmetric.com/v1/donut/2837599_240.png 3,Elevated LIM Kinase 1 in Nonmetastatic Prostate Cancer Reflects Its Role in Facilitating Androgen Receptor Nuclear Translocation,Molecular Cancer Therapeutics,,,Article,2015-01-01,10.1158/1535-7163.mct-14-0447,,,,25344584,,,,,,,0,0,0,5,0,0,2,0,2,0,0,0,0,0,0,21,https://www.altmetric.com/details/2834465,https://api.altmetric.com/v1/donut/2834465_240.png 3,Prostate cancer (early).,Clinical Evidence,,,Article,2006-01-02,,,,,19454100,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2788554,https://api.altmetric.com/v1/donut/2788554_240.png 3,"Prostate cancer incidence, clinical stage and survival in relation to obesity: A prospective cohort study in Denmark",International Journal of Cancer,,,Article,2014-09-26,10.1002/ijc.29238,,,,25264293,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2721329,https://api.altmetric.com/v1/donut/2721329_240.png 3,New method for non-invasive prostate cancer screening,ecancer.org,,,Article,,,,,http://ecancer.org/news/6202-new-method-for-non-invasive-prostate-cancer-screening.php,,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2647915,https://api.altmetric.com/v1/donut/2647915_240.png 3,"The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index—Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?",The Journal of Urology,,,Article,2014-02-14,10.1016/j.juro.2014.01.030,,,,24518780,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2582458,https://api.altmetric.com/v1/donut/2582458_240.png 3,Concomitant i.v. and oral clodronate in the relief of bone pain – a double-blind placebo-controlled study in patients with prostate cancer,British Journal of Cancer,,,Article,1997-10-01,10.1038/bjc.1997.488,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2574893,https://api.altmetric.com/v1/donut/2574893_240.png 3,Efficacy of Short-Term Androgen Deprivation With High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer in Japan,Urology,,,Article,2008-01-12,10.1016/j.urology.2007.12.041,,,,18355899,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2549842,https://api.altmetric.com/v1/donut/2549842_240.png 3,A study on staging bone scans in newly diagnosed prostate cancer.,Urologia Internationalis,,,Article,2006-04-09,10.1159/000091620,,,,16601380,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2549838,https://api.altmetric.com/v1/donut/2549838_240.png 3,Early outcomes of active surveillance for localized prostate cancer,British Journal of Urology,,,Article,2005-05-01,10.1111/j.1464-410x.2005.05446.x,,,,15839912,,,,,,,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2549836,https://api.altmetric.com/v1/donut/2549836_240.png 3,Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial,Lancet Oncology,,,Article,2007-06-01,10.1016/s1470-2045(07)70143-2,,,,17482880,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,109,https://www.altmetric.com/details/2549835,https://api.altmetric.com/v1/donut/2549835_240.png 3,Active surveillance versus radical treatment for favorable-risk localized prostate cancer.,Current Treatment Options in Oncology,,,Article,2006-08-16,,,,,16904052,,,,,,,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2549834,https://api.altmetric.com/v1/donut/2549834_240.png 3,QUALITY OF LIFE OF ASYMPTOMATIC MEN WITH NONMETASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY,The Journal of Urology,,,Article,2000-06-01,10.1016/s0022-5347(05)67533-7,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2549833,https://api.altmetric.com/v1/donut/2549833_240.png 3,TESTOSTERONE REPLACEMENT THERAPY AFTER PRIMARY TREATMENT FOR PROSTATE CANCER,The Journal of Urology,,,Article,2005-01-02,10.1097/01.ju.0000143942.55896.64,,,,15643240,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2549832,https://api.altmetric.com/v1/donut/2549832_240.png 3,Insignificant Prostate Cancer in Radical Prostatectomy Specimen: Time Trends and Preoperative Prediction,European Urology,,,Article,2003-05-01,10.1016/s0302-2838(03)00139-8,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2549830,https://api.altmetric.com/v1/donut/2549830_240.png 3,Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men.,Cancer Science,,,Article,2004-01-01,,,,,14720329,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2549829,https://api.altmetric.com/v1/donut/2549829_240.png 3,Experiences with a New High-Dose-Rate Brachytherapy (HDR-BT) Boost Technique for T3b Prostate Cancer,Strahlentherapie und Onkologie,,,Article,2007-07-05,10.1007/s00066-007-1643-z,,,,17609874,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2549827,https://api.altmetric.com/v1/donut/2549827_240.png 3,Incidence and management of hot flashes in prostate cancer.,The Journal of Supportive Oncology,,,Article,2004-09-02,,,,,15334868,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2549825,https://api.altmetric.com/v1/donut/2549825_240.png 3,High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer.,European Urology,,,Article,2005-03-20,10.1016/j.eururo.2004.11.014,,,,15774239,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2549824,https://api.altmetric.com/v1/donut/2549824_240.png 3,Prostate Cancer: Value of Multiparametric MR Imaging at 3 T for Detection—Histopathologifc Correlation 1 ,Radiology,,,Article,2010-01-04,10.1148/radiol.09090475,,,,20308447,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,133,https://www.altmetric.com/details/2549823,https://api.altmetric.com/v1/donut/2549823_240.png 3,THE EFFICACY OF SILDENAFIL CITRATE FOLLOWING RADIATION THERAPY FOR PROSTATE CANCER: TEMPORAL CONSIDERATIONS,The Journal of Urology,,,Article,2005-01-07,10.1097/01.ju.0000164286.47518.1e,,,,15947650,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2549107,https://api.altmetric.com/v1/donut/2549107_240.png 3,Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning.,Radiology,,,Article,2011-01-15,10.1148/radiol.10101251,,,,21233291,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/2475802,https://api.altmetric.com/v1/donut/2475802_240.png 3,Serial Biopsy Results in Prostate Cancer Screening Study,The Journal of Urology,,,Article,2002-06-01,10.1016/s0022-5347(05)64999-3,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2475801,https://api.altmetric.com/v1/donut/2475801_240.png 3,Patient and Community Preferences for Outcomes in Prostate Cancer,Medical care,,,Article,2003-01-01,10.1097/00005650-200301000-00017,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2475799,https://api.altmetric.com/v1/donut/2475799_240.png 3,Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.,European Radiology,,,Article,2012-04-04,10.1007/s00330-012-2430-5,,,,22466514,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2475798,https://api.altmetric.com/v1/donut/2475798_240.png 3,Discriminating Cancer From Noncancer Tissue in the Prostate by 3-Dimensional Proton Magnetic Resonance Spectroscopic Imaging,Investigative Radiology,,,Article,2011-01-01,10.1097/rli.0b013e3181f54081,,,,,,1854/LU-1242126,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2475793,https://api.altmetric.com/v1/donut/2475793_240.png 3,Focal therapy in the management of localized prostate cancer,British Journal of Urology,,,Article,2011-05-11,10.1111/j.1464-410x.2010.09975.x,,,,21223478,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2475792,https://api.altmetric.com/v1/donut/2475792_240.png 3,Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer,Urology,,,Article,2001-09-01,10.1016/s0090-4295(01)01233-x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2475790,https://api.altmetric.com/v1/donut/2475790_240.png 3,Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.,Urologic Oncology,,,Article,2011-09-14,10.1016/j.urolonc.2011.07.010,,,,21906966,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2475788,https://api.altmetric.com/v1/donut/2475788_240.png 3,PROSTATE CANCER DIAGNOSIS USING A SATURATION NEEDLE BIOPSY TECHNIQUE AFTER PREVIOUS NEGATIVE SEXTANT BIOPSIES,The Journal of Urology,,,Article,2001-07-01,10.1016/s0022-5347(05)66083-1,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2475787,https://api.altmetric.com/v1/donut/2475787_240.png 3,Factors associated with variation in utility scores among patients with prostate cancer.,Value in Health (Elsevier Science),,,Article,2008-01-12,10.1111/j.1524-4733.2008.00336.x,,,,18489508,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2475786,https://api.altmetric.com/v1/donut/2475786_240.png 3,Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer,American Journal of Roentgenology,,,Article,2007-08-01,10.2214/ajr.07.2211,,,,17646457,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,143,https://www.altmetric.com/details/2475785,https://api.altmetric.com/v1/donut/2475785_240.png 3,Prostate cancer: local staging at 3-T endorectal MR imaging--early experience.,Radiology,,,Article,2005-11-25,10.1148/radiol.2381041832,,,,16304091,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2475779,https://api.altmetric.com/v1/donut/2475779_240.png 3,INCREASED POSITIVE YIELD OF CLINICALLY SIGNIFICANT PROSTATE CANCER WITH MRI PROMPTED BIOPSIES,The Journal of Urology,,,Article,2009-04-01,10.1016/s0022-5347(09)62179-0,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2475778,https://api.altmetric.com/v1/donut/2475778_240.png 3,Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer,British Journal of Urology,,,Article,2007-05-01,10.1111/j.1464-410x.2006.06690.x,,,,17437438,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2475776,https://api.altmetric.com/v1/donut/2475776_240.png 3,A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool.,Korean Journal of Radiology,,,Article,2008-10-09,10.3348/kjr.2008.9.5.432,,,,18838853,PMC2627206,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2475774,https://api.altmetric.com/v1/donut/2475774_240.png 3,Is race a positive predictor of cancer on repeat prostate biopsy?,The Journal of Urology,,,Article,2006-08-09,10.1016/j.juro.2006.04.041,,,,16890704,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2475773,https://api.altmetric.com/v1/donut/2475773_240.png 3,Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols,British Journal of Urology,,,Article,2006-09-01,10.1111/j.1464-410x.2006.06325.x,,,,16925754,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2475772,https://api.altmetric.com/v1/donut/2475772_240.png 3,Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?,Radiology,,,Article,2011-01-02,10.1148/radiol.10100667,,,,21177390,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/2475770,https://api.altmetric.com/v1/donut/2475770_240.png 3,2123 HARD TO DETECT PROSTATE CANCER DIAGNOSED BY TARGETED BIOPSY USING COMBINED T2 WEIGHTED AND DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING,The Journal of Urology,,,Article,2011-04-01,10.1016/j.juro.2011.02.2320,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2475767,https://api.altmetric.com/v1/donut/2475767_240.png 3,Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection.,European Journal of Radiology,,,Article,2011-01-11,10.1016/j.ejrad.2010.12.017,,,,21215541,,1854/LU-1109624,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2475766,https://api.altmetric.com/v1/donut/2475766_240.png 3,1852 ENDORECTAL MAGNETIC RESONANCE IMAGING OF THE PROSTATE. A USEFUL TOOL IN THE DETECTION OF ANTERIOR PROSTATE CANCER,The Journal of Urology,,,Article,2010-04-01,10.1016/j.juro.2010.02.1791,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2475765,https://api.altmetric.com/v1/donut/2475765_240.png 3,[Health-economic evaluation of magnetic resonance imaging before biopsy for diagnosis of prostate cancer].,RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren,,,Article,2011-08-26,10.1055/s-0031-1281601,,,,21863536,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2475764,https://api.altmetric.com/v1/donut/2475764_240.png 3,Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2000-01-19,10.1001/jama.283.3.354,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2475763,https://api.altmetric.com/v1/donut/2475763_240.png 3," Localized Prostate Cancer: Effect of Hormone Deprivation Therapy Measured by Using Combined Three-dimensional 1 H MR Spectroscopy and MR Imaging: Clinicopathologic Case-controlled Study1 ",Radiology,,,Article,2001-11-01,10.1148/radiol.2211001582,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2475762,https://api.altmetric.com/v1/donut/2475762_240.png 3,Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.,International Journal of Cancer,,,Article,2005-04-01,10.1002/ijc.21043,,,,15800919,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2475761,https://api.altmetric.com/v1/donut/2475761_240.png 3,Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863.,European Journal of Cancer (1965),,,Article,2004-07-16,10.1016/j.ejca.2003.12.027,,,,15251156,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2475760,https://api.altmetric.com/v1/donut/2475760_240.png 3,Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study.,European Urology,,,Article,2005-04-14,10.1016/j.eururo.2005.01.015,,,,15826747,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2475757,https://api.altmetric.com/v1/donut/2475757_240.png 3,Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.,Investigative Radiology,,,Article,2007-01-17,10.1097/01.rli.0000251541.03822.bb,,,,17220729,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2475755,https://api.altmetric.com/v1/donut/2475755_240.png 3,Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.,European Urology,,,Article,2008-07-05,10.1016/j.eururo.2008.06.043,,,,18597923,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2475753,https://api.altmetric.com/v1/donut/2475753_240.png 3,Preferences of husbands and wives for outcomes of prostate cancer screening and treatment.,JGIM: Journal of General Internal Medicine,,,Article,2004-04-07,10.1111/j.1525-1497.2004.30046.x,,,,15061743,PMC1492196,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2475752,https://api.altmetric.com/v1/donut/2475752_240.png 3,Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol.,The Journal of Urology,,,Article,2009-08-19,10.1016/j.juro.2009.06.037,,,,19683269,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2475751,https://api.altmetric.com/v1/donut/2475751_240.png 3,"Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trial",British Journal of Urology,,,Article,2007-04-01,10.1111/j.1464-410x.2007.06708.x,,,,17223921,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2475748,https://api.altmetric.com/v1/donut/2475748_240.png 3,135 Targeting prostate cancer in the central gland with endorectal MRI and spectroscopy,European Urology Supplements,,,Article,2004-02-01,10.1016/s1569-9056(04)90137-6,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2475747,https://api.altmetric.com/v1/donut/2475747_240.png 3,The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels,British Journal of Urology,,,Article,2009-03-01,10.1111/j.1464-410x.2008.08205.x,,,,19154475,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2475746,https://api.altmetric.com/v1/donut/2475746_240.png 3,13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.,The Journal of Urology,,,Article,2007-02-14,10.1016/j.juro.2006.10.051,,,,17296379,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2475745,https://api.altmetric.com/v1/donut/2475745_240.png 3,"PROSPECTIVE EVALUATION OF PROSTATE CANCER DETECTED ON BIOPSIES 1, 2, 3 AND 4: WHEN SHOULD WE STOP?",The Journal of Urology,,,Article,2001-11-01,10.1016/s0022-5347(05)65652-2,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2475743,https://api.altmetric.com/v1/donut/2475743_240.png 3,298 VALUE OF 3 TESLA MULTIMO DALITY MR GUIDED BIOPSY (MRGB) TO DETECT PROSTATE CANCER IN PATIENTS AFTER AT LEAST TWO PREVIOUS NEGATIVE BIOPSIES AND AN ELEVATED PSA,European Urology Supplements,,,Article,2009-03-01,10.1016/s1569-9056(09)60303-1,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2475742,https://api.altmetric.com/v1/donut/2475742_240.png 3,Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate.,Prostate Cancer & Prostatic Diseases,,,Article,2009-09-17,10.1038/pcan.2009.41,,,,19752886,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2475739,https://api.altmetric.com/v1/donut/2475739_240.png 3,A Markov model of the natural history of prostate cancer,Journal of Clinical Epidemiology,,,Article,1994-01-01,10.1016/0895-4356(94)90029-9,,,,8283192,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2475738,https://api.altmetric.com/v1/donut/2475738_240.png 3,Saturation biopsy for detecting and characterizing prostate cancer,British Journal of Urology,,,Article,2007-06-01,10.1111/j.1464-410x.2007.06868.x,,,,17428241,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2475737,https://api.altmetric.com/v1/donut/2475737_240.png 3,20-year outcomes following conservative management of clinically localized prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,2005-04-05,10.1001/jama.293.17.2095,,,,15870412,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2475736,https://api.altmetric.com/v1/donut/2475736_240.png 3,A review of repeat prostate biopsies and the influence of technique on cancer detection: our experience.,Irish Journal of Medical Science,,,Article,2009-01-09,10.1007/s11845-009-0362-0,,,,19495832,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2475735,https://api.altmetric.com/v1/donut/2475735_240.png 3,The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique.,International Urology and Nephrology,,,Article,2006-12-31,10.1007/s11255-006-9009-5,,,,16835725,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2475734,https://api.altmetric.com/v1/donut/2475734_240.png 3,Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.,Radiology,,,Article,2005-12-14,10.1148/radiol.2382041905,,,,16344335,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2475732,https://api.altmetric.com/v1/donut/2475732_240.png 3,Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.,The Prostate,,,Article,2004-09-25,10.1002/pros.20124,,,,15389803,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/2475731,https://api.altmetric.com/v1/donut/2475731_240.png 3,"Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006.",European Journal of Cancer (1965),,,Article,2010-01-07,10.1016/j.ejca.2010.03.040,,,,20471247,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2475728,https://api.altmetric.com/v1/donut/2475728_240.png 3,Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy,British Journal of Urology,,,Article,2009-08-01,10.1111/j.1464-410x.2009.08406.x,,,,19220263,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2475726,https://api.altmetric.com/v1/donut/2475726_240.png 3,PROSTATE CANCER DETECTION USING AN EXTENDED PROSTATE BIOPSY SCHEMA IN COMBINATION WITH ADDITIONAL TARGETED CORES FROM SUSPICIOUS IMAGES IN CONVENTIONAL AND FUNCTIONAL ENDORECTAL MAGNETIC RESONANCE IMAGING OF THE PROSTATE,The Journal of Urology,,,Article,2009-04-01,10.1016/s0022-5347(09)61988-1,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2475725,https://api.altmetric.com/v1/donut/2475725_240.png 3,Prostate cancer,Surgery,,,Article,2013-10-01,10.1016/j.mpsur.2013.08.001,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2416960,https://api.altmetric.com/v1/donut/2416960_240.png 3,An evidence-based approach to prostate cancer follow-up,Seminars in oncology,,,Article,2003-06-01,10.1016/s0093-7754(03)00099-x,,,,12870141,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2414959,https://api.altmetric.com/v1/donut/2414959_240.png 3,Rising incidence of prostate cancer in Scotland: increased risk or increased detection?,British Journal of Urology,,,Article,2000-03-01,10.1046/j.1464-410x.2000.00487.x,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2414957,https://api.altmetric.com/v1/donut/2414957_240.png 3,Risk factors for prostate cancer,Nature Clinical Practice Urology,,,Article,2009-02-11,10.1038/ncpuro1290,,,,19198622,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2414955,https://api.altmetric.com/v1/donut/2414955_240.png 3,Bone Health in Men Receiving Androgen Deprivation Therapy for Prostate Cancer,The Journal of Urology,,,Article,2006-12-13,10.1016/j.juro.2006.08.089,,,,17161994,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2414946,https://api.altmetric.com/v1/donut/2414946_240.png 3,Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer,Urology,,,Article,2011-01-05,10.1016/j.urology.2011.01.006,,,,21539969,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2414786,https://api.altmetric.com/v1/donut/2414786_240.png 3,Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment,Oncologist,,,Article,2011-02-24,10.1634/theoncologist.2010-0216,,,,21339259,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2414783,https://api.altmetric.com/v1/donut/2414783_240.png 3,SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer,Cancer Treatment Reviews,,,Article,2009-12-18,10.1016/j.ctrv.2009.11.005,,,,20015594,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2414781,https://api.altmetric.com/v1/donut/2414781_240.png 3,Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy,Urology,,,Article,1997-11-01,10.1016/s0090-4295(97)00326-9,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2412933,https://api.altmetric.com/v1/donut/2412933_240.png 3,A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer,Radiotherapy & Oncology,,,Article,1994-04-01,10.1016/0167-8140(94)90411-1,,,,7518932,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2412931,https://api.altmetric.com/v1/donut/2412931_240.png 3,Role of bisphosphonates in prostate cancer.,European Urology,,,Article,2004-01-01,,,,,14667511,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2412929,https://api.altmetric.com/v1/donut/2412929_240.png 3,Time and costs associated with preparing and administering zoledronic acid in patients with breast or prostate cancer and metastatic bone disease,Community Oncology,,,Article,2009-11-01,10.1016/s1548-5315(11)70357-6,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2412927,https://api.altmetric.com/v1/donut/2412927_240.png 3,Should patients with prostate cancer without bone metastases receive sodium clodronate?,Nature Reviews Urology,,,Article,2007-01-11,10.1038/ncpuro0911,,,,17726430,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2412925,https://api.altmetric.com/v1/donut/2412925_240.png 3,"Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)",The Journal of Urology,,,Article,2010-05-22,10.1016/j.juro.2010.03.034,,,,20483155,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/2412923,https://api.altmetric.com/v1/donut/2412923_240.png 3,47 COST EFFECTIVENESS OF ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL RELATED EVENTS IN PROSTATE CANCER PATIENTS WITH BONE METASTASES IN FRANCE AND GERMANY,European Urology Supplements,,,Article,2009-03-01,10.1016/s1569-9056(09)60055-5,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2412920,https://api.altmetric.com/v1/donut/2412920_240.png 3,The risk of renal impairment in hormone?refractory prostate cancer patients with bone metastases treated with zoledronic acid,Cancer (0008543X),,,Article,1970-01-01,10.1002/cncr.22504,,,,17311345,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2412917,https://api.altmetric.com/v1/donut/2412917_240.png 3,"Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors",JNCI: Journal of the National Cancer Institute,,,Article,2005-01-07,10.1093/jnci/dji002,,,,15632381,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2412912,https://api.altmetric.com/v1/donut/2412912_240.png 3,648 BENEFIT OF DENOSUMAB THERAPY IN PATIENTS WITH BONE METASTASES FROM CASTRATE RESISTANT PROSTATE CANCER: A NUMBER-NEEDED-TO-TREAT (NNT) ANALYSIS,The Journal of Urology,,,Article,2011-04-01,10.1016/j.juro.2011.02.1550,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2412909,https://api.altmetric.com/v1/donut/2412909_240.png 3,"Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain",Journal of Clinical Oncology,,,Article,2003-09-01,10.1200/jco.2003.03.042,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2412904,https://api.altmetric.com/v1/donut/2412904_240.png 3,Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer,Annals of Oncology,,,Article,2006-03-16,10.1093/annonc/mdl041,,,,16533874,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2412901,https://api.altmetric.com/v1/donut/2412901_240.png 3,Palliation of Bone Pain in Prostate Cancer Using Chemotherapy and Strontium-89. A Randomized Phase II Study,Journal of Pain & Symptom Management,,,Article,2005-04-30,10.1016/j.jpainsymman.2004.07.008,,,,15857738,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2412895,https://api.altmetric.com/v1/donut/2412895_240.png 3,Clinical Benefit of Zoledronic Acid for the Prevention of Skeletal Complications in Advanced Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2005-06-01,10.3816/cgc.2005.n.009,,,,,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2412891,https://api.altmetric.com/v1/donut/2412891_240.png 3,"Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999|[ndash]|2006",Prostate Cancer & Prostatic Diseases,,,Article,2011-01-06,10.1038/pcan.2011.7,,,,21403668,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2412889,https://api.altmetric.com/v1/donut/2412889_240.png 3,"A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial)",JNCI: Journal of the National Cancer Institute,,,Article,2003-09-03,10.1093/jnci/djg038,,,,12953084,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2412868,https://api.altmetric.com/v1/donut/2412868_240.png 3,COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL COMPLICATIONS IN PATIENTS WITH PROSTATE CANCER,The Journal of Urology,,,Article,2004-03-17,10.1097/01.ju.0000116777.94426.60,,,,15017215,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2412850,https://api.altmetric.com/v1/donut/2412850_240.png 3,Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,1993-04-01,10.1016/0360-3016(93)90309-j,,,,8478230,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2412843,https://api.altmetric.com/v1/donut/2412843_240.png 3,Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-13-2876,,,,24556717,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/2294774,https://api.altmetric.com/v1/donut/2294774_240.png 3,Plasma Vitamin D and Prostate Cancer Risk; Results from the Selenium and Vitamin E Cancer Prevention Trial.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-04-14,10.1158/1055-9965.epi-14-0115,,,,24732629,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2283648,https://api.altmetric.com/v1/donut/2283648_240.png 3,A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome,Breast Cancer: Basic & Clinical Research,,,Article,2014-02-01,10.4137/bcbcr.s13833,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2150908,https://api.altmetric.com/v1/donut/2150908_240.png 3,Supporting Patients Treated for Prostate Cancer: A Video Vignette Study With an Email-Based Educational Program in General Practice,Journal of Medical Internet Research,,,Article,2016-02-10,10.2196/jmir.3003,,,,24571952,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2147265,https://api.altmetric.com/v1/donut/2147265_240.png 3,CCL11 (eotaxin?1): A new diagnostic serum marker for prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22597,,,,23059958,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2053265,https://api.altmetric.com/v1/donut/2053265_240.png 3,High mitochondria content is associated with prostate cancer disease progression,Molecular Cancer,,,Article,2013-11-21,10.1186/1476-4598-12-145,,,,24261794,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1933584,https://api.altmetric.com/v1/donut/1933584_240.png 3,Do Margins Matter? The Influence of Positive Surgical Margins on Prostate Cancer-Specific Mortality.,European Urology,,,Article,2013-08-01,10.1016/j.eururo.2013.08.036,,,,24035631,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,30,https://www.altmetric.com/details/1824951,https://api.altmetric.com/v1/donut/1824951_240.png 3,The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancer,Annals of Occupational and Environmental Medicine,,,Article,2013-09-01,10.1136/bmjopen-2013-003226,,,,24038007,,,,,,,0,0,0,2,3,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1755269,https://api.altmetric.com/v1/donut/1755269_240.png 3,Cancer biology: Nerves spur prostate cancer,Nature,,,Article,2013-07-17,10.1038/499257b,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1631353,https://api.altmetric.com/v1/donut/1631353_240.png 3,"The association between overall survival of prostate cancer patients and hypertension, hyperglycemia, and overweight in Southern China: a prospective cohort study",Journal of Cancer Research & Clinical Oncology,,,Article,2013-02-27,10.1007/s00432-013-1407-3,,,,23443257,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1476230,https://api.altmetric.com/v1/donut/1476230_240.png 3,Identification of New Genes Downregulated in Prostate Cancer and Investigation of Their Effects on Prognosis,Genetic Testing,,,Article,2013-04-27,10.1089/gtmb.2012.0524,,,,23621580,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1423892,https://api.altmetric.com/v1/donut/1423892_240.png 3,"Association of Energy Intake and Energy Balance with Postmenopausal Breast Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2006-01-01,10.1158/1055-9965.epi-05-0479,,,,16492925,,,,,,,0,0,0,2,0,0,4,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1400187,https://api.altmetric.com/v1/donut/1400187_240.png 3,Who makes the decision regarding the treatment of clinically localized prostate cancer–the patient or physician?,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27738,,,,22786794,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1339675,https://api.altmetric.com/v1/donut/1339675_240.png 3,Effect of intermittent fasting on prostate cancer tumor growth in a mouse model,Prostate Cancer & Prostatic Diseases,,,Article,2010-08-25,10.1038/pcan.2010.24,,,,20733612,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1322690,https://api.altmetric.com/v1/donut/1322690_240.png 3,2-virus link to prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/3277-2-virus-link-to-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251566,https://api.altmetric.com/v1/donut/1251566_240.png 3,Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.41.7634,,,,23295793,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1196607,https://api.altmetric.com/v1/donut/1196607_240.png 3,Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.,International Journal of Oncology,,,Article,2004-04-07,,,,,15067330,,,,,,,0,0,0,1,0,0,16,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1000960,https://api.altmetric.com/v1/donut/1000960_240.png 3,Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study.,British Journal of Cancer,,,Article,2012-07-31,10.1038/bjc.2012.311,,,,22850555,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/904255,https://api.altmetric.com/v1/donut/904255_240.png 3,The use of LC?MS to identify differentially expressed proteins in docetaxel?resistant prostate cancer cell lines,PROTEOMICS,,,Article,2012-01-01,10.1002/pmic.201100489,,,,22623417,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/849951,https://api.altmetric.com/v1/donut/849951_240.png 3,Value of prostate?specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ?10?ng/mL,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2011.10764.x,,,,22093144,,,,,,,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/814300,https://api.altmetric.com/v1/donut/814300_240.png 3,"Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-06-22,10.1073/pnas.1200853109,,,,22730461,,,2012PNAS..10911252G,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/807408,https://api.altmetric.com/v1/donut/807408_240.png 3,Exercise Modulation of the Host - Tumor Interaction in an Orthotopic Model of Murine Prostate Cancer.,Journal of Applied Physiology,,,Article,2012-05-17,10.1152/japplphysiol.01575.2011,,,,22604887,,,,,,,0,0,0,4,0,0,3,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/751754,https://api.altmetric.com/v1/donut/751754_240.png 3,Nelfinavir inhibits regulated intramembrane proteolysis of SREBPâ??1 and ATF6 in castrationâ??resistant prostate cancer,FEBS Journal,,,Article,2012-01-01,10.1111/j.1742-4658.2012.08619.x,,,,22540830,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/718969,https://api.altmetric.com/v1/donut/718969_240.png 3,"Appropriate And Inappropriate Imaging Rates For Prostate Cancer Go Hand In Hand By Region, As If Set By Thermostat",Health Affairs,,,Article,2012-04-09,10.1377/hlthaff.2011.0336,,,,22492890,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/689207,https://api.altmetric.com/v1/donut/689207_240.png 3,Androgen Deprivation Therapy for Prostate Cancer and Cardiovascular Death—Reply,JAMA: Journal of the American Medical Association,,,Article,2012-03-27,10.1001/jama.2012.353,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/668944,https://api.altmetric.com/v1/donut/668944_240.png 3,The Effect of Herbal Medications on Thyroid Hormone Economy and Estrogen-Sensitive Hepatic Proteins in a Patient With Prostate Cancer,Archives of Internal Medicine,,,Article,2012-01-01,10.1001/archinternmed.2011.596,,,,22232148,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/560326,https://api.altmetric.com/v1/donut/560326_240.png 3,"Heart healthy|[equals]|prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms?",Asian Journal of Andrology,,,Article,2011-12-26,10.1038/aja.2011.174,,,,22198632,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/508747,https://api.altmetric.com/v1/donut/508747_240.png 3,RECK overexpression decreases invasive potential in prostate cancer cells,The Prostate,,,Article,2011-10-27,10.1002/pros.21498,,,,22025325,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/431922,https://api.altmetric.com/v1/donut/431922_240.png 3,Impact of 5?-reductase inhibitors on men followed by active surveillance for prostate cancer.,European Urology,,,Article,2011-04-01,10.1016/j.eururo.2010.12.018,,,,21211899,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/211866,https://api.altmetric.com/v1/donut/211866_240.png 3,Coprescription of Chinese Herbal Medicine and Western Medications among Prostate Cancer Patients: A Population-Based Study in Taiwan,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2011-08-05,10.1155/2012/147015,,,,21792368,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/205009,https://api.altmetric.com/v1/donut/205009_240.png 3,Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.,Cancer research,,,Article,2001-10-01,,,,,11585763,,,,,,,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/166568,https://api.altmetric.com/v1/donut/166568_240.png 3,"Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.",Nature Medicine,,,Article,2010-12-01,10.1038/nm.2236,,,,21057494,PMC3088104,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,117,https://www.altmetric.com/details/131114,https://api.altmetric.com/v1/donut/131114_240.png 3,Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?,Nature Reviews Urology,,,Article,2011-06-14,10.1038/nrurol.2011.80,,,,21670752,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/130472,https://api.altmetric.com/v1/donut/130472_240.png 3,Local Therapy for Gleason 9–10 Prostate Cancer: Looking to the Future,European Urology,,,Article,2016-08-11,10.1016/j.eururo.2016.07.025,,,,27481178,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10700850,https://api.altmetric.com/v1/donut/10700850_240.png 3,Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study,European Urology,,,Article,2016-07-01,10.1016/j.eururo.2016.07.032,,,,27477525,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10396357,https://api.altmetric.com/v1/donut/10396357_240.png 3,Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer,International Journal of Nanomedicine,,,Article,2016-07-26,10.2147/ijn.s105420,,,,27555767,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10061429,https://api.altmetric.com/v1/donut/10061429_240.png 3,Transrectal Saturation Biopsy Improves Risk Stratification (Reclassification) of Patients with Prostate Cancer on Active Surveillance,Urology Practice,,,Article,2015-01-05,10.1016/j.urpr.2014.10.002,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9883038,https://api.altmetric.com/v1/donut/9883038_240.png 3," Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer ",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-06-29,10.1073/pnas.1601571113,,,,27357679,PMC4961202,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9621707,https://api.altmetric.com/v1/donut/9621707_240.png 3,Prostate Cancer Characteristics and Outcome in Renal Transplant Recipients: Results from a Contemporary Monocentric Study,Clinical Transplantation,,,Article,2016-06-01,10.1111/ctr.12773,,,,27251769,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8798783,https://api.altmetric.com/v1/donut/8798783_240.png 3,Dietary inflammatory index and prostate cancer survival,International Journal of Cancer,,,Article,2016-05-01,10.1002/ijc.30208,,,,27242333,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8759164,https://api.altmetric.com/v1/donut/8759164_240.png 3,Prostate cancer: Models to detect high-grade cancer,Nature Reviews Urology,,,Article,2016-05-10,10.1038/nrurol.2016.82,,,,27162051,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7319178,https://api.altmetric.com/v1/donut/7319178_240.png 3,Prostate cancer: ROR-? drives androgen receptor expression,Nature Reviews Urology,,,Article,2016-04-13,10.1038/nrurol.2016.71,,,,27071453,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6642561,https://api.altmetric.com/v1/donut/6642561_240.png 3,Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study,JNCI: Journal of the National Cancer Institute,,,Article,2001-05-16,10.1093/jnci/93.10.783,,,,11353789,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5033346,https://api.altmetric.com/v1/donut/5033346_240.png 3,The Role PET with 68Gallium (Ga)-Labelled Prostate-Specific Membrane Antigen (PSMA) in the Management of Patient with Organ Confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and after Radical Prostatectomy,Urology,,,Article,2016-01-23,10.1016/j.urology.2015.12.048,,,,26790588,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4980966,https://api.altmetric.com/v1/donut/4980966_240.png 3,Comparison of oncological and health?related quality of life outcomes between open and robot?assisted radical prostatectomy for localised prostate cancer – findings from the population?based Victorian Prostate Cancer Registry,British Journal of Urology,,,Article,2015-11-01,10.1111/bju.13380,,,,26573954,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4823742,https://api.altmetric.com/v1/donut/4823742_240.png 3,"Dietary fiber, whole grains, carbohydrate, glycemic index, and glycemic load in relation to risk of prostate cancer.",OncoTargets and therapy,,,Article,2015-09-02,10.2147/ott.s88528,,,,26366096,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4474087,https://api.altmetric.com/v1/donut/4474087_240.png 3,The psychosocial dimensions of fatigue in men treated for prostate cancer,International Journal of Urological Nursing,,,Article,2016-03-01,10.1111/ijun.12089,,,,,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4447629,https://api.altmetric.com/v1/donut/4447629_240.png 3,The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis,Blood,,,Article,2015-07-11,10.1182/blood-2015-01-622811,,,,26153520,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4263961,https://api.altmetric.com/v1/donut/4263961_240.png 3,An Iterative Process for Developing and Evaluating a Computer-Based Prostate Cancer Decision Aid for African American Men,Health Promotion Practice,,,Article,2015-05-21,10.1177/1524839915585737,,,,25983084,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4035727,https://api.altmetric.com/v1/donut/4035727_240.png 3,Prostate cancer in 2014: The year chemotherapy finally gets some respect!,Nature Reviews Urology,,,Article,2015-01-20,10.1038/nrurol.2014.362,,,,25600097,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3092723,https://api.altmetric.com/v1/donut/3092723_240.png 3,Re: Contemporary Use of Initial Active Surveillance among Men in Michigan with Low-Risk Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.076,,,,25523659,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2808622,https://api.altmetric.com/v1/donut/2808622_240.png 3,Prostate cancer: The best fit for enzalutamide in metastatic prostate cancer,Nature Reviews Clinical Oncology,,,Article,2014-07-29,10.1038/nrclinonc.2014.128,,,,25073005,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2553943,https://api.altmetric.com/v1/donut/2553943_240.png 3,"A service evaluation describing a nurse?led prostate cancer service in NHS, Ayrshire and Arran",International Journal of Urological Nursing,,,Article,2014-07-18,10.1111/ijun.12049,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2520188,https://api.altmetric.com/v1/donut/2520188_240.png 3,"Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories.",Scand J Urol,,,Article,2014-03-14,10.3109/21681805.2014.892150,,,,24611795,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2259776,https://api.altmetric.com/v1/donut/2259776_240.png 3,Re: Validation of the European Society of Urogenital Radiology Scoring System for Prostate Cancer Diagnosis on Multiparametric Magnetic Resonance Imaging in a Cohort of Repeat Biopsy Patients,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2013.06.070,,,,24029314,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1792809,https://api.altmetric.com/v1/donut/1792809_240.png 3,A randomized trial of aerobic versus resistance exercise in prostate cancer survivors.,Journal of Aging & Physical Activity,,,Article,2013-10-01,,,,,24052601,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1772312,https://api.altmetric.com/v1/donut/1772312_240.png 3,"Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review.",Journal of Pain & Symptom Management,,,Article,2012-01-01,10.1016/j.jpainsymman.2011.03.006,,,,21640547,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/1755046,https://api.altmetric.com/v1/donut/1755046_240.png 3,Urological cancer: Life after prostate cancer treatment,Nature Reviews Clinical Oncology,,,Article,2013-02-12,10.1038/nrclinonc.2013.21,,,,23400001,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1235069,https://api.altmetric.com/v1/donut/1235069_240.png 3,Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.,Nutrition and Cancer,,,Article,2012-03-27,10.1080/01635581.2012.661514,,,,22452782,PMC3363324,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/719755,https://api.altmetric.com/v1/donut/719755_240.png 3,Mathematical modeling of prostate cancer progression in response to androgen ablation therapy,Proceedings of the National Academy of Sciences,,,Article,2011-11-21,10.1073/pnas.1115750108,,,,22106268,,,2011PNAS..10819701J,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/468895,https://api.altmetric.com/v1/donut/468895_240.png 3,Prostate cancer: Circulating miRNAs indicate high-risk disease,Nature Reviews Urology,,,Article,2016-09-27,10.1038/nrurol.2016.191,,,,27670617,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12239379,https://api.altmetric.com/v1/donut/12239379_240.png 3,Prophylactic Robotic-assisted Laparoscopic Radical Prostatectomy for Preoperative Suspicion of Prostate Cancer: Experience with 55 Cases.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,27630346,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12138343,https://api.altmetric.com/v1/donut/12138343_240.png 3,"Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial",The Journal of Urology,,,Article,2016-10-19,10.1016/j.juro.2016.08.067,,,,27751451,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10789198,https://api.altmetric.com/v1/donut/10789198_240.png 3,Hypertension and risk of prostate cancer: a systematic review and meta-analysis,Scientific Reports,,,Article,2016-08-11,10.1038/srep31358,,,,27511796,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10470639,https://api.altmetric.com/v1/donut/10470639_240.png 3,Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study,Journal of Magnetic Resonance Imaging,,,Article,2016-07-08,10.1002/jmri.25372,,,,27391860,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9516492,https://api.altmetric.com/v1/donut/9516492_240.png 3,Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone,Journal of Magnetic Resonance Imaging,,,Article,2016-07-07,10.1002/jmri.25353,,,,27383502,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9301077,https://api.altmetric.com/v1/donut/9301077_240.png 3,Primary Gleason Pattern Upgrading in contemporary D'Amico low-risk prostate cancer patients: Implications for future biomarkers and imaging modalities,British Journal of Urology,,,Article,2016-07-01,10.1111/bju.13570,,,,27367469,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9228565,https://api.altmetric.com/v1/donut/9228565_240.png 3," Haralick textural features on T 2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer ",Journal of Magnetic Resonance Imaging,,,Article,2016-06-27,10.1002/jmri.25335,,,,27345946,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/9063414,https://api.altmetric.com/v1/donut/9063414_240.png 3,Socioeconomic status and health-related quality of life among patients with prostate cancer 6?months after radical prostatectomy: a longitudinal analysis,BMJ Open,,,Article,2016-06-01,10.1136/bmjopen-2015-010968,,,,27259527,PMC4893844,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8499690,https://api.altmetric.com/v1/donut/8499690_240.png 3,Elevated Expression of Hepatoma Up-Regulated Protein Inhibits ?-Irradiation-Induced Apoptosis of Prostate Cancer Cells,Journal of Cellular Biochemistry,,,Article,2015-11-17,10.1002/jcb.25419,,,,26505164,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8384357,https://api.altmetric.com/v1/donut/8384357_240.png 3,Histone deacetylase inhibition in prostate cancer triggers miR-320-mediated suppression of the androgen receptor,Cancer Research,,,Article,2016-05-23,10.1158/0008-5472.can-15-3339,,,,27216188,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8243350,https://api.altmetric.com/v1/donut/8243350_240.png 3,Prostate cancer: Genetics of mCRPC tracked in ctDNA,Nature Reviews Urology,,,Article,2016-05-24,10.1038/nrurol.2016.98,,,,27215427,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8198140,https://api.altmetric.com/v1/donut/8198140_240.png 3,Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer,Oncotarget,,,Article,2015-11-07,10.18632/oncotarget.9027,,,,27127882,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7088857,https://api.altmetric.com/v1/donut/7088857_240.png 3," Is Prostate Cancer Incidence Worldwide Linked to Artificial Light at Night Exposures? Earlier Findings' Revisit and Current Trends ' Analysis ",Archives of Environmental & Occupational Health,,,Article,2016-03-30,10.1080/19338244.2016.1169980,,,,27029744,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6478607,https://api.altmetric.com/v1/donut/6478607_240.png 3,Imaging for Prostate Cancer Recurrence,European Urology Focus ,,,Article,2016-02-23,10.1016/j.euf.2016.02.006,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5972871,https://api.altmetric.com/v1/donut/5972871_240.png 3,Prevalence of Nonrecommended Screening for Prostate and Breast Cancer Varies Across States,Journal Watch,,,Article,2016-01-28,10.1056/nejm-jw.na40251,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5063720,https://api.altmetric.com/v1/donut/5063720_240.png 3,Osteoporosis and Fracture Risk in Men with Prostate Cancer,European Urology,,,Article,2016-01-01,10.1016/j.eururo.2015.12.036,,,,26749094,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4942894,https://api.altmetric.com/v1/donut/4942894_240.png 3,Will chemotherapy change the management of prostate cancer?,British Journal of Urology,,,Article,2015-12-01,10.1111/bju.13400,,,,26696125,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4914197,https://api.altmetric.com/v1/donut/4914197_240.png 3,Linking obesogenic dysregulation to prostate cancer progression,Endocrine Connections,,,Article,2015-12-01,10.1530/ec-15-0080,,,,26581226,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4873615,https://api.altmetric.com/v1/donut/4873615_240.png 3,Sexual activity and the risk of prostate cancer: Review article.,Archivio italiano di urologia andrologia organo ufficiale di Società italiana di ecografia urologica e nefrologica,,,Article,2015-09-01,10.4081/aiua.2015.3.214,,,,26428643,,,,,,,0,0,0,4,0,0,0,0,0,0,1,0,0,0,0,2,https://www.altmetric.com/details/4618127,https://api.altmetric.com/v1/donut/4618127_240.png 3,Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models,BMC Medical Imaging,,,Article,2015-08-05,10.1186/s12880-015-0069-9,,,,26242589,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4365688,https://api.altmetric.com/v1/donut/4365688_240.png 3,Ethnicity and prostate cancer: the way to solve the screening problem?,BMC Medicine,,,Article,2015-08-04,10.1186/s12916-015-0427-z,,,,26239718,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4364508,https://api.altmetric.com/v1/donut/4364508_240.png 3,A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate Cancer,Sexual Medicine,,,Article,2015-08-01,10.1002/sm2.78,,,,26468379,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4347747,https://api.altmetric.com/v1/donut/4347747_240.png 3,Molecular landscape of prostate cancer: Implications for current clinical trials.,Cancer Treatment Reviews,,,Article,2015-07-27,10.1016/j.ctrv.2015.07.001,,,,26210103,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/4333072,https://api.altmetric.com/v1/donut/4333072_240.png 3,"Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case–control study",World Journal of Urology,,,Article,2015-06-25,10.1007/s00345-015-1625-1,,,,26108732,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4252784,https://api.altmetric.com/v1/donut/4252784_240.png 3,"Trends in Prostate-specific Antigen Screening, Prostate Biopsies, Urology Visits, and Prostate Cancer Treatments From 2000 to 2012 ",Urology,,,Article,2015-07-01,10.1016/j.urology.2015.04.063,,,,26123517,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4218210,https://api.altmetric.com/v1/donut/4218210_240.png 3,Genome-wide detection of allelic genetic variation to predict advanced-stage prostate cancer after radical prostatectomy using an exome SNP chip.,Urologic Oncology,,,Article,2015-06-20,10.1016/j.urolonc.2015.05.016,,,,26087972,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4192008,https://api.altmetric.com/v1/donut/4192008_240.png 3,"2,4-Dichlorophenoxyacetic Acid and Non-Hodgkin's Lymphoma, Gastric Cancer, and Prostate Cancer: Meta-analyses of the Published Literature",Annals of Epidemiology,,,Article,2015-06-13,10.1016/j.annepidem.2015.04.002,,,,26066538,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4082360,https://api.altmetric.com/v1/donut/4082360_240.png 3,Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-05-26,10.1038/pcan.2015.25,,,,26171882,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4058942,https://api.altmetric.com/v1/donut/4058942_240.png 3,Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration?resistant progression and survival of prostate cancer patients,The Prostate,,,Article,2015-05-19,10.1002/pros.23011,,,,25990623,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4033226,https://api.altmetric.com/v1/donut/4033226_240.png 3,Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer,BioDrugs,,,Article,2015-09-16,10.1007/s40259-015-0122-9,,,,25859858,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/4029375,https://api.altmetric.com/v1/donut/4029375_240.png 3,Body Mass Index and mortality in men with prostate cancer,The Prostate,,,Article,2015-04-30,10.1002/pros.23001,,,,25929695,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3961415,https://api.altmetric.com/v1/donut/3961415_240.png 3,Prospective quality?of?life outcomes for low?risk prostate cancer: Active surveillance versus radical prostatectomy,Cancer (0008543X),,,Article,2015-04-06,10.1002/cncr.29370,,,,25845467,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3888645,https://api.altmetric.com/v1/donut/3888645_240.png 3,"Re: Steven Joniau, Alberto Briganti, Paolo Gontero, et al. Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study. Eur Urol 2015;67:157–64",European Urology,,,Article,2015-04-08,10.1016/j.eururo.2015.03.038,,,,25846751,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3875362,https://api.altmetric.com/v1/donut/3875362_240.png 3,Organ-Confined Prostate Cancer: Are We Moving Towards More or Less Radical Surgical Intervention?,Current Urology Reports,,,Article,2015-03-17,10.1007/s11934-015-0504-z,,,,25773349,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3814053,https://api.altmetric.com/v1/donut/3814053_240.png 3,Prostate Cancer Recurrence Manifesting as Superior Vena Cava Syndrome,Journal of Vascular and Interventional Radiology,,,Article,2015-03-06,10.1016/j.jvir.2015.01.012,,,,25754140,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3763598,https://api.altmetric.com/v1/donut/3763598_240.png 3,ASCO GU 2015: Review of the latest data in prostate cancer. ASCO GU 2015: Review of the latest data in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3506/asco-gu-2015--review-of-the-latest-data-in-prostate-cancer.php,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3740585,https://api.altmetric.com/v1/donut/3740585_240.png 3,"The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.",European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2015.02.003,,,,25727881,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3727732,https://api.altmetric.com/v1/donut/3727732_240.png 3,Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines,Biomed Res Int,,,Article,2015-02-05,10.1155/2015/762178,,,,25649906,PMC4306438,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3432784,https://api.altmetric.com/v1/donut/3432784_240.png 3,Metabolomics Derived Prostate Cancer Biomarkers: Fact or Fiction.,Journal of Proteome Research,,,Article,2015-01-24,10.1021/pr5011108,,,,25609016,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3163744,https://api.altmetric.com/v1/donut/3163744_240.png 3,Orphan nuclear receptor TLX functions as a potent suppressor of oncogene?induced senescence in prostate cancer via its transcriptional co?regulation of CDKN1A (p21WAF1/CIP1) and SIRT1 genes,The Journal of Pathology,,,Article,2015-02-02,10.1002/path.4505,,,,25557355,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3031346,https://api.altmetric.com/v1/donut/3031346_240.png 3,"[Prostate cancer screening benefit very low, even after 13 years].",Nederlands Tijdschrift voor Geneeskunde,,,Article,2014-01-01,,,,,25492737,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2976247,https://api.altmetric.com/v1/donut/2976247_240.png 3,Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.,International Journal of Urology,,,Article,2009-01-06,10.1111/j.1442-2042.2008.02172.x,,,,19120529,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2913760,https://api.altmetric.com/v1/donut/2913760_240.png 3,Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer.,Brachytherapy,,,Article,,10.1016/j.brachy.2014.08.047,,,,25255713,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2900248,https://api.altmetric.com/v1/donut/2900248_240.png 3,Who dies from prostate cancer|[quest]|,Prostate Cancer & Prostatic Diseases,,,Article,2014-10-14,10.1038/pcan.2014.35,,,,25311767,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2843686,https://api.altmetric.com/v1/donut/2843686_240.png 3,Coupling of Prostate and Thyroid Cancer Diagnoses in the United States,Annals of Surgical Oncology,,,Article,2014-09-10,10.1245/s10434-014-4066-y,,,,25205302,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2675836,https://api.altmetric.com/v1/donut/2675836_240.png 3,NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer,Nature Reviews Urology,,,Article,2014-08-19,10.1038/nrurol.2014.195,,,,25134838,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2633612,https://api.altmetric.com/v1/donut/2633612_240.png 3,Corticosteroids and Prostate Cancer: Friend or Foe?,European Urology,,,Article,2015-05-01,10.1016/j.eururo.2014.08.008,,,,25151018,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,5,https://www.altmetric.com/details/2614051,https://api.altmetric.com/v1/donut/2614051_240.png 3,Reducing Prostate Cancer Deaths: Unsupported Speculation About the Androgen Deprivation Hypothesis,European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.06.051,,,,25018035,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/2501019,https://api.altmetric.com/v1/donut/2501019_240.png 3,TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer,European Urology,,,Article,,10.1016/j.eururo.2014.06.027,,,,25015038,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,20,https://www.altmetric.com/details/2494976,https://api.altmetric.com/v1/donut/2494976_240.png 3,Localised prostate cancer: clinical and cost-effectiveness of new and emerging technologies,Journal of Clinical Urology,,,Article,2014-01-27,10.1177/2051415813519628,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2446983,https://api.altmetric.com/v1/donut/2446983_240.png 3,Metastatic Castration-resistant Prostate Cancer: Piling Up the Benefits of Chemotherapy,European Urology,,,Article,,10.1016/j.eururo.2014.05.030,,,,24908474,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2405622,https://api.altmetric.com/v1/donut/2405622_240.png 3,Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: A systematic review of randomised trials,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.04.004,,,,24825113,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2343977,https://api.altmetric.com/v1/donut/2343977_240.png 3,Zometa European Study (ZEUS): Another Failed Crusade for the Holy Grail of Prostate Cancer Bone Metastases Prevention?,European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.03.009,,,,24666840,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2197594,https://api.altmetric.com/v1/donut/2197594_240.png 3,A risk-adjusted definition of biochemical recurrence after radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2014-03-11,10.1038/pcan.2014.5,,,,24614692,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2189572,https://api.altmetric.com/v1/donut/2189572_240.png 3,Prophylactic Sildenafil Citrate For Improvement of Erectile Function in Men Treated by Radiotherapy for Prostate Cancer,The Journal of Urology,,,Article,2014-03-04,10.1016/j.juro.2014.02.097,,,,24603102,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2161120,https://api.altmetric.com/v1/donut/2161120_240.png 3,Consistency in Design and Collaboration in Delivery: Key to Successful Randomised Controlled Trials in Focal Therapy for Prostate Cancer ,European Urology,,,Article,,10.1016/j.eururo.2014.02.039,,,,24602932,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2152437,https://api.altmetric.com/v1/donut/2152437_240.png 3,Intraductal spread of prostate cancer into the seminal vesicles,Histopathology,,,Article,2014-02-12,10.1111/his.12351,,,,24517365,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2115299,https://api.altmetric.com/v1/donut/2115299_240.png 3,Vitamin d and prostate cancer survival in veterans.,Military Medicine,,,Article,2014-01-01,10.7205/milmed-d-12-00540,,,,24402990,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2035101,https://api.altmetric.com/v1/donut/2035101_240.png 3,A cohort study investigating aspirin use and survival in men with prostate cancer.,Annals of Oncology,,,Article,2014-01-01,10.1093/annonc/mdt428,,,,24356627,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2010762,https://api.altmetric.com/v1/donut/2010762_240.png 3,Re: Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer,The Journal of Urology,,,Article,2013-12-04,10.1016/j.juro.2013.11.087,,,,24522034,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1954922,https://api.altmetric.com/v1/donut/1954922_240.png 3,Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.,Endocrine,,,Article,2013-10-31,10.1007/s12020-013-0083-z,,,,24174178,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1875449,https://api.altmetric.com/v1/donut/1875449_240.png 3,"First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.",British Journal of Cancer,,,Article,2013-10-29,10.1038/bjc.2013.619,,,,24169353,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1873340,https://api.altmetric.com/v1/donut/1873340_240.png 3,Perceived barriers and facilitators to physical activity in men with prostate cancer: possible influence of androgen deprivation therapy,European Journal of Cancer Care,,,Article,2013-01-01,10.1111/ecc.12141,,,,24134506,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1845646,https://api.altmetric.com/v1/donut/1845646_240.png 3,Intermittent Versus Continuous Androgen Deprivation Treatment of Prostate Cancer,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.52.0908,,,,24062402,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1783092,https://api.altmetric.com/v1/donut/1783092_240.png 3,Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy.,Psycho-Oncology,,,Article,2013-08-01,10.1002/pon.3363,,,,23904113,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1756465,https://api.altmetric.com/v1/donut/1756465_240.png 3,"Expanding Utilization of Intensity-Modulated Radiotherapy for Prostate Cancer: Soaring Costs, Dubious Benefits: Comment on “Comparative Effectiveness of Intensity-Modulated Radiotherapy and Conventional Conformal Radiotherapy in the Treatment of Prostate Cancer After Radical Prostatectomy”",JAMA Internal Medicine,,,Article,2013-01-01,10.1001/jamainternmed.2013.6755,,,,23689487,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1496086,https://api.altmetric.com/v1/donut/1496086_240.png 3,Effect of Practice Integration between Urologists and Radiation Oncologists on Prostate Cancer Treatment Patterns,The Journal of Urology,,,Article,2013-02-11,10.1016/j.juro.2013.01.103,,,,23399652,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1232726,https://api.altmetric.com/v1/donut/1232726_240.png 3,How Surgical Innovation Reduced Death and Suffering From Prostate Cancer,Journal of Craniofacial Surgery,,,Article,2013-01-13,10.1097/scs.0b013e318270fbe0,,,,23321869,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1183073,https://api.altmetric.com/v1/donut/1183073_240.png 3,Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan,BMC Cancer,,,Article,2013-01-04,10.1186/1471-2407-13-7,,,,23286275,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1154534,https://api.altmetric.com/v1/donut/1154534_240.png 3,"Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.03.004,,,,22652106,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1127449,https://api.altmetric.com/v1/donut/1127449_240.png 3,In vivo biomarker expression patterns are preserved in 3D cultures of Prostate Cancer ,Experimental Cell Research,,,Article,2012-08-01,10.1016/j.yexcr.2012.07.013,,,,22841689,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/881401,https://api.altmetric.com/v1/donut/881401_240.png 3,Proton beam therapy for the treatment of prostate cancer,Practical Radiation Oncology,,,Article,2012-07-16,10.1016/j.prro.2012.05.010,,,,24674325,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/842960,https://api.altmetric.com/v1/donut/842960_240.png 3,Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer,Modern Pathology,"GREY, Jane W",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-03-30,10.1038/modpathol.2012.51,,,,22460812,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/826767,https://api.altmetric.com/v1/donut/826767_240.png 3,Incidentally Found Prostate Cancer and Influence on Overall Survival after Radical Cystoprostatectomy,Prostate Cancer,,,Article,2012-01-01,10.1155/2012/690210,,,,22701798,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/775014,https://api.altmetric.com/v1/donut/775014_240.png 3,"Androgens, diabetes and prostate cancer.",Endocrine-Related Cancer,,,Article,2012-04-20,10.1530/erc-12-0067,,,,22514110,,11343/41358,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/709042,https://api.altmetric.com/v1/donut/709042_240.png 3,Screening for Prostate Cancer,Annals of Internal Medicine,,,Article,2012-01-01,10.1059/0003-4819-156-7-201204030-00014,,,,22473441,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/686248,https://api.altmetric.com/v1/donut/686248_240.png 3,Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer,British Journal of Urology,,,Article,2012-02-01,10.1111/j.1464-410x.2011.10825.x,,,,22239224,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/574410,https://api.altmetric.com/v1/donut/574410_240.png 3,FOCAL THERAPY FOR LOCALISED PROSTATE CANCER: ARE WE ASKING THE CORRECT RESEARCH QUESTIONS?,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10804.x,,,,22151749,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/490285,https://api.altmetric.com/v1/donut/490285_240.png 3,"Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa",Infectious Agents and Cancer,,,Article,2011-11-12,10.1186/1750-9378-4-s1-s2,,,,19208207,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/452442,https://api.altmetric.com/v1/donut/452442_240.png 3,Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies,Cancer Gene Therapy,,,Article,2016-10-14,10.1038/cgt.2016.42,,,,27740614,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13074543,https://api.altmetric.com/v1/donut/13074543_240.png 3,Inhibition of LDHA suppresses tumor progression in prostate cancer.,Tumor Biology,,,Article,2015-05-16,10.1007/s13277-015-3540-x,,,,25983002,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4055752,https://api.altmetric.com/v1/donut/4055752_240.png 3,Surgical Management of Node-positive Prostate Cancer: Perspectives from Breast Oncology,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.09.007,,,,24094573,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2361298,https://api.altmetric.com/v1/donut/2361298_240.png 3,More judicious use of expectant management for localized prostate cancer over the past two decades,The Journal of Urology,,,Article,2016-10-01,10.1016/j.juro.2016.10.067,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13088363,https://api.altmetric.com/v1/donut/13088363_240.png 3,Circadian rhythmicity and the influence of 'clock' genes on prostate cancer,Endocrine-Related Cancer,,,Article,2016-09-22,10.1530/erc-16-0366,,,,27660402,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12192721,https://api.altmetric.com/v1/donut/12192721_240.png 3,"Vasectomy is not linked to raised risk of prostate cancer, study finds",British Medical Journal,,,Article,2016-09-20,10.1136/bmj.i5080,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12095809,https://api.altmetric.com/v1/donut/12095809_240.png 3,High Intensity Focused Ultrasound is a Good Treatment Option for Localized Prostate Cancer: Pro,The Journal of Urology,,,Article,2016-09-18,10.1016/j.juro.2016.09.006,,,,27638337,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11983159,https://api.altmetric.com/v1/donut/11983159_240.png 3,Rapidly changing landscape of PET/CT imaging in prostate cancer,Current Opinion in Urology,,,Article,2016-09-01,10.1097/mou.0000000000000309,,,http://journals.lww.com/co-urology/Fulltext/2016/09000/Rapidly_changing_landscape_of_PET_CT_imaging_in.17.aspx,27467137,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10113851,https://api.altmetric.com/v1/donut/10113851_240.png 3,Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients,Journal of Magnetic Resonance Imaging,,,Article,2016-07-21,10.1002/jmri.25391,,,,27442039,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9949496,https://api.altmetric.com/v1/donut/9949496_240.png 3,Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10520,,,,27409348,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9713251,https://api.altmetric.com/v1/donut/9713251_240.png 3,Exercise and prostate cancer: evidence and proposed mechanisms for disease modification,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-07-07,10.1158/1055-9965.epi-16-0223,,,,27389872,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9533911,https://api.altmetric.com/v1/donut/9533911_240.png 3,68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report,Cancer Imaging,,,Article,2016-06-08,10.1186/s40644-016-0072-6,,,,27277843,PMC4898465,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8634967,https://api.altmetric.com/v1/donut/8634967_240.png 3,"Re: Alison J. Price, Ruth C. Travis, Paul N. Appleby, et al. Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.03.029",European Urology,,,Article,2016-05-26,10.1016/j.eururo.2016.05.024,,,,27236495,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8287699,https://api.altmetric.com/v1/donut/8287699_240.png 3,Deciphering the function of non-coding RNAs in prostate cancer,Cancer and Metastasis Reviews,,,Article,2016-05-25,10.1007/s10555-016-9628-y,,,,27221068,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8282983,https://api.altmetric.com/v1/donut/8282983_240.png 3,Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castrationresistant prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9535,,,,27221037,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8282125,https://api.altmetric.com/v1/donut/8282125_240.png 3,The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5,Science Signaling,,,Article,2016-05-10,10.1126/scisignal.aad5582,,,,27165781,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7326068,https://api.altmetric.com/v1/donut/7326068_240.png 3,"The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements",Biomarkers in cancer,,,Article,2016-05-05,10.4137/bic.s31802,,,,27168728,PMC4859450,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/7211053,https://api.altmetric.com/v1/donut/7211053_240.png 3,Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes,Scientific Reports,,,Article,2016-04-22,10.1038/srep24922,,,,27102850,,10453/43692,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6918568,https://api.altmetric.com/v1/donut/6918568_240.png 3,Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer,The Journal of Urology,,,Article,2016-04-22,10.1016/j.juro.2016.02.2986,,,,27113966,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6905863,https://api.altmetric.com/v1/donut/6905863_240.png 3,Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2016-04-19,10.1097/rlu.0000000000001240,,,http://journals.lww.com/nuclearmed/Fulltext/2016/07000/Radioligand_Therapy_With_177Lu_PSMA_617_as_A_Novel.2.aspx,27088387,,,,,,,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6810165,https://api.altmetric.com/v1/donut/6810165_240.png 3,Equol inhibits prostate cancer growth via degradation of the androgen receptor by Skp2,Cancer Science,,,Article,2016-04-01,10.1111/cas.12948,,,,27088761,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6782810,https://api.altmetric.com/v1/donut/6782810_240.png 3,Response and tolerability of a single dose of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: a multicenter retrospective analysis,Journal of Nuclear Medicine,,,Article,2016-04-07,10.2967/jnumed.116.173757,,,,27056618,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6575897,https://api.altmetric.com/v1/donut/6575897_240.png 3,Androgen-deprivation therapy plus chemotherapy in metastatic hormone-sensitive prostate cancer. A systematic review and meta-analysis of randomized clinical trials,Urologic Oncology,,,Article,2016-04-02,10.1016/j.urolonc.2016.03.003,,,,27052629,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6447895,https://api.altmetric.com/v1/donut/6447895_240.png 3,"MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer",International Journal of Molecular Sciences,,,Article,2016-03-22,10.3390/ijms17030421,,,,27011184,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6264132,https://api.altmetric.com/v1/donut/6264132_240.png 3,Co-Targeting Hexokinase 2-Mediated Warburg Effect and ULK1-Dependent Autophagy Suppresses Tumor Growth of PTEN- and TP53-Deficiency-Driven Castration-Resistant Prostate Cancer,EBioMedicine,,,Article,2016-03-01,10.1016/j.ebiom.2016.03.022,,,,27322458,PMC4909365,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6253244,https://api.altmetric.com/v1/donut/6253244_240.png 3,Prostate cancer: Proton therapy delays progression,Nature Reviews Urology,,,Article,2016-03-08,10.1038/nrurol.2016.50,,,,26954330,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6137976,https://api.altmetric.com/v1/donut/6137976_240.png 3,"Early?stage prostate cancer, PSA screening rates decline",Cancer (0008543X),,,Article,2016-03-15,10.1002/cncr.29930,,,,26938268,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6046145,https://api.altmetric.com/v1/donut/6046145_240.png 3,Prostate Cancer Diagnosis on repeat MRI-TRUS Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling,The Journal of Urology,,,Article,2016-02-12,10.1016/j.juro.2016.02.066,,,,26880408,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5527966,https://api.altmetric.com/v1/donut/5527966_240.png 3,Prostate cancer: Testosterone-guided ADT for prostate cancer,Nature Reviews Urology,,,Article,2016-01-27,10.1038/nrurol.2016.9,,,,26813950,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5070298,https://api.altmetric.com/v1/donut/5070298_240.png 3,"EC-70124, a novel glycosylated indolocarbazole multi-kinase inhibitor, reverts tumorigenic and stem cell properties in prostate cancer by inhibiting STAT3 and NF-?B.",Molecular Cancer Therapeutics,,,Article,2016-01-31,10.1158/1535-7163.mct-15-0791,,,,26826115,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5067122,https://api.altmetric.com/v1/donut/5067122_240.png 3,Re: Sex Hormone-Dependent tRNA Halves Enhance Cell Proliferation in Breast and Prostate Cancers,The Journal of Urology,,,Article,2016-01-21,10.1016/j.juro.2016.01.019,,,,27302822,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5024149,https://api.altmetric.com/v1/donut/5024149_240.png 3,Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients.,OncoTargets and therapy,,,Article,2015-12-31,10.2147/ott.s95565,,,,26770063,PMC4706124,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/4963894,https://api.altmetric.com/v1/donut/4963894_240.png 3,More Favorable Pathological Outcomes in Men with Low-Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound-Guided Prostate Biopsy,The Journal of Urology,,,Article,2016-01-03,10.1016/j.juro.2015.12.079,,,,26724397,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4921651,https://api.altmetric.com/v1/donut/4921651_240.png 3,Upregulation of LAT1 during anti-androgen therapy contribute to progression in prostate cancer cells,The Journal of Urology,,,Article,2015-12-20,10.1016/j.juro.2015.11.071,,,,26682754,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4859347,https://api.altmetric.com/v1/donut/4859347_240.png 3,Time Trends in Histological Features of Latent Prostate Cancer in Japan ,The Journal of Urology,,,Article,2015-12-19,10.1016/j.juro.2015.11.068,,,,26678955,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4854858,https://api.altmetric.com/v1/donut/4854858_240.png 3,"HDAC inhibition impedes epithelial|[ndash]|mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer",Oncogene,,,Article,2015-12-07,10.1038/onc.2015.444,,,,26640144,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4847679,https://api.altmetric.com/v1/donut/4847679_240.png 3,A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens,European Urology,,,Article,2012-07-01,10.1016/j.eururo.2012.02.055,,,,22421083,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/4795598,https://api.altmetric.com/v1/donut/4795598_240.png 3,A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.,Oncotarget,,,Article,2015-11-18,10.18632/oncotarget.6330,,,,26575023,PMC4792591,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4779443,https://api.altmetric.com/v1/donut/4779443_240.png 3,The immune checkpoint regulator PD-L1 is highly expressed in aggressive primary prostate cancer,Clinical Cancer Research,,,Article,2015-11-18,10.1158/1078-0432.ccr-15-2042,,,,26573597,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/4773082,https://api.altmetric.com/v1/donut/4773082_240.png 3,Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.,PLoS ONE,,,Article,2015-11-06,10.1371/journal.pone.0142373,,,,26544868,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4733912,https://api.altmetric.com/v1/donut/4733912_240.png 3,Re: Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map,The Journal of Urology,,,Article,2016-02-10,10.1016/j.juro.2015.10.127,,,,26852975,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4707537,https://api.altmetric.com/v1/donut/4707537_240.png 3,Re: Regulation of the ITGA2 Gene by Epigenetic Mechanisms in Prostate Cancer,The Journal of Urology,,,Article,2016-02-09,10.1016/j.juro.2015.10.123,,,,26853039,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4707535,https://api.altmetric.com/v1/donut/4707535_240.png 3,High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer.,Clinical Epigenetics,,,Article,2015-10-15,10.1186/s13148-015-0146-5,,,,26478752,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4639705,https://api.altmetric.com/v1/donut/4639705_240.png 3,Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells.,Frontiers in Plant Science,,,Article,2015-10-02,10.3389/fpls.2015.00822,,,,26500666,,,,,,,0,0,0,5,0,0,0,0,5,0,0,0,0,0,0,7,https://www.altmetric.com/details/4579215,https://api.altmetric.com/v1/donut/4579215_240.png 3,"Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study.",European Journal of Cancer (1965),,,Article,2015-01-10,10.1016/j.ejca.2015.07.027,,,,26421823,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4556498,https://api.altmetric.com/v1/donut/4556498_240.png 3,Re: A Feedback Regulation between miR-145 and DNA Methyltransferase 3b in Prostate Cancer Cell and Their Responses to Irradiation,The Journal of Urology,,,Article,2015-11-20,10.1016/j.juro.2015.09.002,,,,26582710,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4477846,https://api.altmetric.com/v1/donut/4477846_240.png 3,Fistulation into the Pubic Symphysis following treatment of Prostate Cancer - an important and surgically correctable complication,The Journal of Urology,,,Article,2015-08-25,10.1016/j.juro.2015.08.074,,,,26301787,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4422487,https://api.altmetric.com/v1/donut/4422487_240.png 3,Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients,Molecules,,,Article,2015-08-14,10.3390/molecules200814860,,,,26287143,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4395799,https://api.altmetric.com/v1/donut/4395799_240.png 3,False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance,Insights Into Imaging,,,Article,2015-05-23,10.1007/s13244-015-0411-3,,,,26002487,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4282572,https://api.altmetric.com/v1/donut/4282572_240.png 3,A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study,PLoS ONE,,,Article,2015-06-24,10.1371/journal.pone.0127702,,,,26106884,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4222907,https://api.altmetric.com/v1/donut/4222907_240.png 3,Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts,PLoS ONE,,,Article,2015-06-16,10.1371/journal.pone.0130340,,,,26075720,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4170073,https://api.altmetric.com/v1/donut/4170073_240.png 3,A microRNA code for prostate cancer metastasis.,Oncogene,,,Article,2015-06-15,10.1038/onc.2015.176,,,,26073083,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4159664,https://api.altmetric.com/v1/donut/4159664_240.png 3,"A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination.",The Prostate,,,Article,2015-05-27,10.1002/pros.23024,,,,26012728,,,,,,,0,0,0,2,0,0,7,0,0,0,1,0,0,0,0,11,https://www.altmetric.com/details/4094168,https://api.altmetric.com/v1/donut/4094168_240.png 3,Re: Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study,The Journal of Urology,,,Article,2015-06-07,10.1016/j.juro.2015.02.2952,,,,26048857,,,,,,,0,0,0,4,0,0,3,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4085106,https://api.altmetric.com/v1/donut/4085106_240.png 3,"Androgen-induced TMPRSS2 activates matriptase and promotes extracellular matrix degradation, prostate cancer cell invasion, tumor growth and metastasis.",Cancer Research,,,Article,2015-07-15,10.1158/0008-5472.can-14-3297,,,,26018085,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4083591,https://api.altmetric.com/v1/donut/4083591_240.png 3,Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones,Journal of Clinical Pathology,,,Article,2015-06-04,10.1136/jclinpath-2015-203001,,,,26038242,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4083003,https://api.altmetric.com/v1/donut/4083003_240.png 3,"Polybrominated Diphenyl Ethers and Thyroid Cancer Risk in the Prostate, Colorectal, Lung, and Ovarian Cancer Screening Trial Cohort",American Journal of Epidemiology,,,Article,2015-06-01,10.1093/aje/kwu358,,,,25939348,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4015409,https://api.altmetric.com/v1/donut/4015409_240.png 3,MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer,PLoS ONE,,,Article,2015-05-13,10.1371/journal.pone.0125576,,,,25969992,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3994273,https://api.altmetric.com/v1/donut/3994273_240.png 3,"Re: Byron H. Lee, Adam S. Kibel, Jay P. Ciezki, et al. Are Biochemical Recurrence Outcomes Similar After Radical Prostatectomy and Radiation Therapy? Analysis of Prostate Cancer–Specific Mortality by Nomogram-predicted Risks of Biochemical Recurrence. Eur Urol 2015;67:204–9",European Urology,,,Article,2015-04-29,10.1016/j.eururo.2015.04.015,,,,25913064,,,,,,,0,0,0,6,0,0,3,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3933544,https://api.altmetric.com/v1/donut/3933544_240.png 3,Targeting the adaptive molecular landscape of castration?resistant prostate cancer,EMBO Molecular Medicine,,,Article,2015-04-22,10.15252/emmm.201303701,,,,25896606,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3924468,https://api.altmetric.com/v1/donut/3924468_240.png 3,Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells ,Toxicology,,,Article,2015-04-09,10.1016/j.tox.2015.04.002,,,,25846647,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/3889665,https://api.altmetric.com/v1/donut/3889665_240.png 3,Low Utilization of Immediate and Delayed Postoperative Radiation for Prostate Cancer with Adverse Pathologic Features,The Journal of Urology,,,Article,2015-04-11,10.1016/j.juro.2015.03.122,,,,25858420,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3882587,https://api.altmetric.com/v1/donut/3882587_240.png 3,Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2015-03-11,10.1073/pnas.1500128112,,,,25762070,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3779209,https://api.altmetric.com/v1/donut/3779209_240.png 3,Integrative molecular profiling of routine clinical prostate cancer specimens.,Annals of Oncology,,,Article,2015-03-03,10.1093/annonc/mdv134,,,,25735316,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3757194,https://api.altmetric.com/v1/donut/3757194_240.png 3,"Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?",Frontiers in oncology,,,Article,2015-02-03,10.3389/fonc.2015.00037,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3750431,https://api.altmetric.com/v1/donut/3750431_240.png 3,Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2015-05-15,10.1158/1078-0432.ccr-14-2666,,,,25712683,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3731293,https://api.altmetric.com/v1/donut/3731293_240.png 3,Re: Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.02.069,,,,25895764,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3712690,https://api.altmetric.com/v1/donut/3712690_240.png 3,MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens,Frontiers in oncology,,,Article,2015-01-29,10.3389/fonc.2015.00030,,,,25741473,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3707516,https://api.altmetric.com/v1/donut/3707516_240.png 3,Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: A comparison of Australian series,Journal of Medical Imaging & Radiation Oncology,,,Article,2015-01-15,10.1111/1754-9485.12275,,,,25588566,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3552373,https://api.altmetric.com/v1/donut/3552373_240.png 3,"Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases ",Medical Hypotheses,,,Article,2007-01-01,10.1016/j.mehy.2006.08.025,,,,17045417,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/3309305,https://api.altmetric.com/v1/donut/3309305_240.png 3,The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma.,Oncotarget,,,Article,2015-01-02,10.18632/oncotarget.2763,,,,25638161,PMC4359337,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3235223,https://api.altmetric.com/v1/donut/3235223_240.png 3,Prostate atypia: Does repeat biopsy detect clinically significant prostate cancer?,The Prostate,,,Article,2015-01-16,10.1002/pros.22950,,,,25597982,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3076967,https://api.altmetric.com/v1/donut/3076967_240.png 3,Prostate Cancer Risk Estimation Tool Usage Among Members of the American Urological Association (AUA): A Survey-Based Study,The Journal of Urology,,,Article,,10.1016/j.juro.2014.12.090,,,,25562444,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3034398,https://api.altmetric.com/v1/donut/3034398_240.png 3,Innovative and Community-Guided Evaluation and Dissemination of a Prostate Cancer Education Program for African-American Men and Women.,Journal of Cancer Education,,,Article,2014-12-16,10.1007/s13187-014-0774-z,,,,25510370,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2994263,https://api.altmetric.com/v1/donut/2994263_240.png 3,Comprehensive Study of Gene and microRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer.,PLoS ONE,,,Article,2014-11-19,10.1371/journal.pone.0113700,,,,25409297,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2905936,https://api.altmetric.com/v1/donut/2905936_240.png 3,The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer,Radiation Oncology,,,Article,2014-09-26,10.3389/fonc.2014.00278,,,,25401085,PMC4215618,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2832654,https://api.altmetric.com/v1/donut/2832654_240.png 3,Neuroendocrine (Small-Cell) Carcinomas: Why They Teach Us Essential Lessons About Prostate Cancer.,Oncology (Williston Park),,,Article,2014-10-18,,,,,25323607,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2793395,https://api.altmetric.com/v1/donut/2793395_240.png 3,Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors,Clinical Cancer Research,,,Article,2014-10-15,10.1158/1078-0432.ccr-14-1220,,,,25320358,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2786743,https://api.altmetric.com/v1/donut/2786743_240.png 3,Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial,BMC Cancer,,,Article,2014-09-15,10.1186/1471-2407-14-671,,,,25223986,,1854/LU-5834444,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2745177,https://api.altmetric.com/v1/donut/2745177_240.png 3,Hypernociceptive responses following the intratibial inoculation of RM1 prostate cancer cells in mice,The Prostate,,,Article,2014-09-27,10.1002/pros.22893,,,,25263196,,,,,,,0,0,0,7,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2721430,https://api.altmetric.com/v1/donut/2721430_240.png 3,Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer,European Journal of Cancer (1965),,,Article,2014-09-06,10.1016/j.ejca.2014.08.009,,,,25204806,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2677510,https://api.altmetric.com/v1/donut/2677510_240.png 3,AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis,Cancer Research,,,Article,2014-06-25,10.1158/0008-5472.can-13-3233,,,,24970477,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2604979,https://api.altmetric.com/v1/donut/2604979_240.png 3,Genetic Ablation of Metadherin Inhibits Autochthonous Prostate Cancer Progression and Metastasis,Cancer Research,,,Article,2014-07-28,10.1158/0008-5472.can-14-1349,,,,25074613,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2572697,https://api.altmetric.com/v1/donut/2572697_240.png 3,Serum 25-hydroxyvitamin d concentrations and risk of prostate cancer: results from the prostate cancer prevention trial.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-08-14,10.1158/1055-9965.epi-13-1340,,,,25085836,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2560394,https://api.altmetric.com/v1/donut/2560394_240.png 3,Study links vasectomy to small raised risk of aggressive prostate cancer,British Medical Journal,,,Article,2014-07-15,10.1136/bmj.g4617,,,,25027490,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2509950,https://api.altmetric.com/v1/donut/2509950_240.png 3,Pharmacologic Inhibition of Myostatin and Changes in Lean Body Mass and Lower Extremity Muscle Size in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer.,The Journal of Clinical Endocrinology & Metabolism,,,Article,2014-06-26,10.1210/jc.2014-1271,,,,24971661,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/2471071,https://api.altmetric.com/v1/donut/2471071_240.png 3,Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer,Radiation Oncology,,,Article,2014-06-26,10.1186/1748-717x-9-148,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2464865,https://api.altmetric.com/v1/donut/2464865_240.png 3,Prostate cancer cells preferentially home to osteoblast?rich areas in the early stages of bone metastasis evidence from in vivo models,Journal of Bone & Mineral Research,,,Article,2014-06-22,10.1002/jbmr.2300,,,,24956445,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2464660,https://api.altmetric.com/v1/donut/2464660_240.png 3,Prostate cancer epigenetic biomarkers: next-generation technologies.,Oncogene,,,Article,2014-05-19,10.1038/onc.2014.111,,,,24837368,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/2365370,https://api.altmetric.com/v1/donut/2365370_240.png 3,Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.,Journal of Geriatric Oncology,,,Article,2014-01-02,10.1016/j.jgo.2013.12.001,,,,24495703,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,21,https://www.altmetric.com/details/2200474,https://api.altmetric.com/v1/donut/2200474_240.png 3,The impact of pathologic staging on the long?term oncologic outcomes of patients with clinically high?risk prostate cancer,Cancer (0008543X),,,Article,2014-03-19,10.1002/cncr.28647,,,,24647966,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/2197917,https://api.altmetric.com/v1/donut/2197917_240.png 3,Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort.,European Urology,,,Article,2014-02-20,10.1016/j.eururo.2014.02.013,,,,24631409,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2164864,https://api.altmetric.com/v1/donut/2164864_240.png 3,Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.,Future Oncology,,,Article,2013-12-03,10.2217/fon.13.256,,,,24295376,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1955038,https://api.altmetric.com/v1/donut/1955038_240.png 3,Mounting Evidence for Prediagnostic Use of Statins in Reducing Risk of Lethal Prostate Cancer,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.53.2770,,,,24276780,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1935761,https://api.altmetric.com/v1/donut/1935761_240.png 3,Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-10-09,10.1016/j.ijrobp.2013.07.041,,,,24113055,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,45,https://www.altmetric.com/details/1816812,https://api.altmetric.com/v1/donut/1816812_240.png 3,Targeting the RANKL Pathway: Putting the Brakes on Prostate Cancer Progression in Bone,Journal of Clinical Oncology,,,Article,2013-09-16,10.1200/jco.2013.50.1544,,,,24043735,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1755257,https://api.altmetric.com/v1/donut/1755257_240.png 3,Prostate cancer could be dealt major blow through discovery of new 'biological markers',ecancer.org,,,Article,,,,,http://ecancer.org/news/4276-prostate-cancer-could-be-dealt-major-blow-through-discovery-of-new--biological-markers.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1658408,https://api.altmetric.com/v1/donut/1658408_240.png 3,Pesticide exposure and inherited variants in vitamin D pathway genes in relation to prostate cancer,"Cancer Epidemiology, Biomarkers & Prevention","SKYHOPPER, Leia",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-01-01,10.1158/1055-9965.epi-12-1454,,,,23833127,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1651273,https://api.altmetric.com/v1/donut/1651273_240.png 3,Influence of pH on the cytotoxic activity of inositol hexakisphosphate (IP6) in prostate cancer,Frontiers in oncology,,,Article,2011-01-01,10.3389/fonc.2011.00040,,,,22655245,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1526485,https://api.altmetric.com/v1/donut/1526485_240.png 3,Prostate cancer and physical activity: Adaptive response to oxidative stress.,Free Radical Biology & Medicine,,,Article,2013-03-08,10.1016/j.freeradbiomed.2013.02.009,,,,23462616,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1501026,https://api.altmetric.com/v1/donut/1501026_240.png 3,Phase III Trials With Docetaxel-Based Combinations for Metastatic Castration-Resistant Prostate Cancer: Time to Learn From Past Experiences,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2013.48.8825,,,,23569320,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1362547,https://api.altmetric.com/v1/donut/1362547_240.png 3,Using Genetic Proxies for Lifecourse Sun Exposure to Assess the Causal Relationship of Sun Exposure with Circulating Vitamin D and Prostate Cancer Risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-02-28,10.1158/1055-9965.epi-12-1248,,,,23441100,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,1,0,0,51,https://www.altmetric.com/details/1291761,https://api.altmetric.com/v1/donut/1291761_240.png 3,Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy,PLoS ONE,,,Article,2013-02-07,10.1371/journal.pone.0055790,,,,23409045,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1227253,https://api.altmetric.com/v1/donut/1227253_240.png 3,Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer,Frontiers in oncology,,,Article,2013-01-01,10.3389/fonc.2012.00215,,,,23346551,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1189869,https://api.altmetric.com/v1/donut/1189869_240.png 3,Does Changing Androgen Receptor Status during Prostate Cancer Development Impact upon Cholesterol Homeostasis?,PLoS ONE,,,Article,2013-01-08,10.1371/journal.pone.0054007,,,,23320115,PMC3540066,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1162059,https://api.altmetric.com/v1/donut/1162059_240.png 3,Physician Evaluation of Internet Health Information on Proton Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-12-13,10.1016/j.ijrobp.2012.10.039,,,,23245278,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1129238,https://api.altmetric.com/v1/donut/1129238_240.png 3,Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3128,,,,23233737,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,21,https://www.altmetric.com/details/1127343,https://api.altmetric.com/v1/donut/1127343_240.png 3,Risk of Total and Aggressive Prostate Cancer and Pesticide Use in the Agricultural Health Study,American Journal of Epidemiology,"GREY, Jane W",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-01-01,10.1093/aje/kws225,,,,23171882,,,,,,,0,0,0,4,0,0,3,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1094934,https://api.altmetric.com/v1/donut/1094934_240.png 3,Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70423-0,,,,23151431,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1061418,https://api.altmetric.com/v1/donut/1061418_240.png 3,The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.,Oncologist,,,Article,2012-10-05,10.1634/theoncologist.2012-s1-23,,,,23015682,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1001114,https://api.altmetric.com/v1/donut/1001114_240.png 3,Targeting the skeletal muscle-metabolism axis in prostate-cancer therapy.,New England Journal of Medicine,,,Article,2012-09-06,10.1056/nejmcibr1203160,,,,22931265,,,,,,,0,0,0,3,0,0,2,0,1,0,0,0,0,0,0,12,https://www.altmetric.com/details/924077,https://api.altmetric.com/v1/donut/924077_240.png 3,"Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-08-27,10.1073/pnas.1203525109,,,,22927397,,,2012PNAS..10914977H,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/917056,https://api.altmetric.com/v1/donut/917056_240.png 3,Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States),Cancer Causes and Control,,,Article,1998-01-01,10.1023/a:1008819500080,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/836838,https://api.altmetric.com/v1/donut/836838_240.png 3,Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion,Molecular Cancer,,,Article,2012-01-11,10.1186/1476-4598-11-3,,,,22236567,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/555850,https://api.altmetric.com/v1/donut/555850_240.png 3,"Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer",Journal of Magnetic Resonance Imaging,,,Article,2012-01-01,10.1002/jmri.22790,,,,22174000,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/497176,https://api.altmetric.com/v1/donut/497176_240.png 3,A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality,The American Journal of Clinical Nutrition,,,Article,2008-01-01,,,,,18996866,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/418224,https://api.altmetric.com/v1/donut/418224_240.png 3,"Efficacy and Safety of Short-Term Genistein Intervention in Patients with Localized Prostate Cancer Prior to Radical Prostatectomy: A Randomized, Placebo-Controlled, Double-Blind Phase 2 Clinical Trial",Nutrition and Cancer,,,Article,2011-08-01,10.1080/01635581.2011.582221,,,,21714686,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/405106,https://api.altmetric.com/v1/donut/405106_240.png 3,"Dietary Omega-3 Fatty Acids, COX-2 Genetic Variation, and Aggressive Prostate Cancer Risk",Clinical Cancer Research,,,Article,1970-01-01,10.1158/1078-0432.ccr-08-2503,,,,19318492,PMC2749066,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/213795,https://api.altmetric.com/v1/donut/213795_240.png 3,Cancer: Vaccine cure for prostate cancer?,Nature Reviews Drug Discovery,,,Article,2011-08-01,10.1038/nrd3524,,,,21804590,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/204854,https://api.altmetric.com/v1/donut/204854_240.png 3,The Risks and Benefits of 5?-Reductase Inhibitors for Prostate-Cancer Prevention,New England Journal of Medicine,,,Article,2011-07-14,10.1056/nejmp1106783,,,,21675880,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,2,0,0,8,https://www.altmetric.com/details/188769,https://api.altmetric.com/v1/donut/188769_240.png 3,"Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence",European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2016.09.026,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13337176,https://api.altmetric.com/v1/donut/13337176_240.png 3,Higher Prostate Cancer Grade Groups Are Detected in Patients Undergoing Multiparametric MRI-targeted Biopsy Compared With Standard Biopsy,The American Journal of Surgical Pathology,,,Article,2016-08-29,10.1097/pas.0000000000000723,,,http://journals.lww.com/ajsp/Fulltext/publishahead/Higher_Prostate_Cancer_Grade_Groups_Are_Detected.98193.aspx,27574875,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10920724,https://api.altmetric.com/v1/donut/10920724_240.png 3,Whole blood mRNA in prostate cancer reveals a 4-gene androgen regulated panel,Endocrine-Related Cancer,,,Article,2016-09-01,10.1530/erc-16-0287,,,,27578825,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10908174,https://api.altmetric.com/v1/donut/10908174_240.png 3,Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-?1,Stem Cells,,,Article,2016-07-01,10.1002/stem.2412,,,,27300750,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9221902,https://api.altmetric.com/v1/donut/9221902_240.png 3,Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy,PLoS ONE,,,Article,2016-06-23,10.1371/journal.pone.0157313,,,,27336392,PMC4919096,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9100537,https://api.altmetric.com/v1/donut/9100537_240.png 3,BMI-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer,Clinical Cancer Research,,,Article,2016-06-15,10.1158/1078-0432.ccr-15-3107,,,,27307599,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8791761,https://api.altmetric.com/v1/donut/8791761_240.png 3,Intimacy after prostate cancer: A brief couples' workshop is associated with improvements in relationship satisfaction,Psycho-Oncology,,,Article,2016-01-01,10.1002/pon.4147,,,,27197037,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8592208,https://api.altmetric.com/v1/donut/8592208_240.png 3,"Association between Dietary Vitamin C Intake and Risk of Prostate Cancer: A Meta-analysis Involving 103,658 Subjects",Journal of Cancer,,,Article,2016-05-24,10.7150/jca.12162,,,,26284143,PMC4532989,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8185861,https://api.altmetric.com/v1/donut/8185861_240.png 3,"Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment.",Central European Journal of Urology,,,Article,2016-05-03,10.5173/ceju.2016.734,,,,27123316,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/7133496,https://api.altmetric.com/v1/donut/7133496_240.png 3,Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer,Journal of Medical Economics,,,Article,2016-04-20,10.3111/13696998.2016.1173042,,,,27031255,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6835240,https://api.altmetric.com/v1/donut/6835240_240.png 3,Prostate cancer radiation therapy: A physician’s perspective,Physica Medica,,,Article,2016-04-01,10.1016/j.ejmp.2016.02.012,,,,27056435,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6632921,https://api.altmetric.com/v1/donut/6632921_240.png 3,Step-by-Step Technique for Irreversible Electroporation of Focal Prostate Cancer: An Instructional Video Guide,Journal of Vascular and Interventional Radiology,,,Article,2016-04-01,10.1016/j.jvir.2016.01.003,,,,27013005,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6562984,https://api.altmetric.com/v1/donut/6562984_240.png 3,Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-04-01,10.1097/coc.0000000000000043,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/04000/Treatment_Outcomes_in_Very_High_risk_Prostate.13.aspx,24517957,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6418257,https://api.altmetric.com/v1/donut/6418257_240.png 3,Smoking and Prostate Cancer: A Systematic Review,European Urology Focus ,,,Article,2015-08-01,10.1016/j.euf.2014.10.002,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5061593,https://api.altmetric.com/v1/donut/5061593_240.png 3,Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer,Neoplasia,,,Article,2016-01-01,10.1016/j.neo.2015.11.009,,,,26806347,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5028965,https://api.altmetric.com/v1/donut/5028965_240.png 3,Meeting the unmet support needs of BME men with prostate cancer,British Journal of Nursing (BJN),,,Article,2015-11-12,10.12968/bjon.2015.24.20.1010,,,,26559104,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4784354,https://api.altmetric.com/v1/donut/4784354_240.png 3,Prostate cancer: Should men with metastases undergo radical prostatectomy?,,,,Article,2013-09-14,10.1038/nrurol.2013.154,,,,23857177,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4766653,https://api.altmetric.com/v1/donut/4766653_240.png 3,Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy,British Journal of Urology,,,Article,2015-10-27,10.1111/bju.13360,,,,26497726,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4677590,https://api.altmetric.com/v1/donut/4677590_240.png 3,Epidemiology of prostate cancer in India,Meta Gene,,,Article,2014-12-01,10.1016/j.mgene.2014.07.007,,,,25606442,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4628991,https://api.altmetric.com/v1/donut/4628991_240.png 3,Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence,Human Pathology,,,Article,2015-11-29,10.1016/j.humpath.2015.09.026,,,,26614400,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4615869,https://api.altmetric.com/v1/donut/4615869_240.png 3,Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications,Endocrine-Related Cancer,,,Article,2015-08-20,10.1530/erc-15-0217,,,,26285606,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4416188,https://api.altmetric.com/v1/donut/4416188_240.png 3,Prostate Cancer on the Web-Expedient Tool for Patients' Decision-Making?,Journal of Cancer Education,,,Article,2015-08-05,10.1007/s13187-015-0891-3,,,,26234650,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4365031,https://api.altmetric.com/v1/donut/4365031_240.png 3,Multiparametric MRI Improves Accuracy of Clinical Nomograms for Predicting Extracapsular Extension of Prostate Cancer,Urology,,,Article,2015-07-22,10.1016/j.urology.2015.06.003,,,,26194289,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4148892,https://api.altmetric.com/v1/donut/4148892_240.png 3,"First effective adjuvant chemotherapy for high-risk, localised prostate cancer. First effective adjuvant chemotherapy for high-risk, localised prostate cancer",ecancer.org,,,Article,,,,,http://ecancer.org/video/3713/first-effective-adjuvant-chemotherapy-for-high-risk--localised-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4075994,https://api.altmetric.com/v1/donut/4075994_240.png 3,Robotic radical prostatectomy in high-risk prostate cancer: current perspectives.,Asian Journal of Andrology,,,Article,2015-05-23,,,,,25994643,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4052093,https://api.altmetric.com/v1/donut/4052093_240.png 3,Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer,BMC Cancer,,,Article,2015-04-18,10.1186/s12885-015-1284-z,,,,25884438,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3917177,https://api.altmetric.com/v1/donut/3917177_240.png 3,Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging,Medical Physics,,,Article,2015-04-16,10.1118/1.4918318,,,,25979032,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3914420,https://api.altmetric.com/v1/donut/3914420_240.png 3,Evidence that Vitamin D Can Slow or Reverse Low-Grade Prostate Cancer,Oncology times,,,Article,2015-04-25,10.1097/01.cot.0000465178.67466.2a,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3911653,https://api.altmetric.com/v1/donut/3911653_240.png 3,Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPAR?-independent mechanism.,Cancer Biology and Therapy,,,Article,2011-04-28,,,,,21525782,PMC3142365,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3747191,https://api.altmetric.com/v1/donut/3747191_240.png 3,A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer,European Journal of Epidemiology,,,Article,2014-07-30,10.1007/s10654-014-9931-2,,,,25064616,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3533712,https://api.altmetric.com/v1/donut/3533712_240.png 3,UK single centre experience of rare and atypical variant of castrate-resistant prostate cancer: Poorly differentiated neuroendocrine small-cell carcinoma,Journal of Clinical Urology,,,Article,2014-06-16,10.1177/2051415814534234,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3435594,https://api.altmetric.com/v1/donut/3435594_240.png 3,N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy ,Molecular Oncology,,,Article,2014-11-15,10.1016/j.molonc.2014.10.014,,,,25432105,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2927212,https://api.altmetric.com/v1/donut/2927212_240.png 3,Active Surveillance of Prostate Cancer in African American Men,Urology,,,Article,,10.1016/j.urology.2014.06.064,,,,25283702,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2740985,https://api.altmetric.com/v1/donut/2740985_240.png 3,"Some Caveats, but Prostate Cancer Study Adds to Urgency of Relieving Depression in Older Men",Oncology times,,,Article,2014-09-25,10.1097/01.cot.0000454898.73928.28,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2715555,https://api.altmetric.com/v1/donut/2715555_240.png 3,Abiraterone acetate in metastatic castration-resistant prostate cancer: A retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.06.004,,,,25042152,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2517591,https://api.altmetric.com/v1/donut/2517591_240.png 3,Inefficacy of Therapeutic Cancer Vaccines and Proposed Improvements. Casus of Prostate Cancer,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2014-06-14,,,,,24922629,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2471303,https://api.altmetric.com/v1/donut/2471303_240.png 3,Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition,International Journal of Cancer,,,Article,2014-05-29,10.1002/ijc.28989,,,,24862312,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2404219,https://api.altmetric.com/v1/donut/2404219_240.png 3,Multiparametric MRI in prostate cancer management,Nature Reviews Clinical Oncology,,,Article,2014-05-20,10.1038/nrclinonc.2014.69,,,,24840072,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2368522,https://api.altmetric.com/v1/donut/2368522_240.png 3,To Treat or Not to Treat with Testosterone Replacement Therapy: a Contemporary Review of Management of Late-Onset Hypogonadism and Critical Issues Related to Prostate Cancer,Current Urology Reports,,,Article,2014-05-16,10.1007/s11934-014-0422-5,,,,24832199,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2365575,https://api.altmetric.com/v1/donut/2365575_240.png 3,Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer,Modern Pathology,,,Article,2014-04-25,10.1038/modpathol.2014.70,,,,24762546,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2304855,https://api.altmetric.com/v1/donut/2304855_240.png 3,Combination of Diffusion-weighted Magnetic Resonance Imaging and Extended Prostate Biopsy Predicts Lobes Without Significant Cancer: Application in Patient Selection for Hemiablative Focal Therapy,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2012.10.010,,,,23084330,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2267116,https://api.altmetric.com/v1/donut/2267116_240.png 3,Metabolic Syndrome as a Marker for Prostate Cancer: Still a Work in Progress,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.03.018,,,,24685434,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2213425,https://api.altmetric.com/v1/donut/2213425_240.png 3,Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management,Case Reports in Oncology,,,Article,2014-03-22,10.1159/000361042,,,,24803898,PMC4000295,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2212812,https://api.altmetric.com/v1/donut/2212812_240.png 3,Impact of Laparoscopic Radical Prostatectomy on Clinical T3 Prostate Cancer: Experience of Single Center With Long Term Follow?Up,British Journal of Urology,,,Article,2015-03-27,10.1111/bju.12710,,,,24571244,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2149470,https://api.altmetric.com/v1/donut/2149470_240.png 3,Re: Effect of Soy Protein Isolate Supplementation on Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy: A Randomized Trial,The Journal of Urology,,,Article,,10.1016/j.juro.2013.09.076,,,,24331479,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2116748,https://api.altmetric.com/v1/donut/2116748_240.png 3,Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer,Molecular Cancer,,,Article,2013-09-30,10.1186/1476-4598-12-112,,,,24073816,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1791284,https://api.altmetric.com/v1/donut/1791284_240.png 3,Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of korean men.,Korean Journal of Urology,,,Article,2010-01-12,10.4111/kju.2010.51.12.819,,,,21221200,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1559157,https://api.altmetric.com/v1/donut/1559157_240.png 3,Unusually Large Numbers Needed to Treat for Radical Prostatectomy in Prostate Cancer Patients with PSA Velocity ?2 ng/ml/Year.,Urologia Internationalis,,,Article,2012-07-22,10.1159/000339604,,,,22814092,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1240879,https://api.altmetric.com/v1/donut/1240879_240.png 3,Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151,PLoS ONE,,,Article,2012-08-23,10.1371/journal.pone.0043812,,,,22928040,PMC3426544,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/943993,https://api.altmetric.com/v1/donut/943993_240.png 3,Enzalutamide for prostate cancer,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70384-4,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/912484,https://api.altmetric.com/v1/donut/912484_240.png 3,Prostate cancer management: (2) an update on locally advanced and metastatic disease,Postgraduate Medical Journal,,,Article,2003-11-01,10.1136/pmj.79.937.643,,,,14654575,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/569297,https://api.altmetric.com/v1/donut/569297_240.png 3,The Emerging Role of MRI in Prostate Cancer Active Surveillance and Ongoing Challenges,American Journal of Roentgenology,,,Article,2016-10-11,10.2214/ajr.16.16355,,,,27726415,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12949695,https://api.altmetric.com/v1/donut/12949695_240.png 3,Metastatic Prostate Cancer Presenting as Lower Extremity Soft Tissue Mass: a Rare Case Presentation,Urology,,,Article,2016-10-22,10.1016/j.urology.2016.10.008,,,,27765593,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12690380,https://api.altmetric.com/v1/donut/12690380_240.png 3,What do we know about the ?/? for prostate cancer?,Medical Physics,,,Article,2012-05-17,10.1118/1.4712224,,,,22755703,,,2012MedPh..39.3189O,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12658321,https://api.altmetric.com/v1/donut/12658321_240.png 3," 18 F-FECH PET/CT to Assess Clinically Significant Disease in Prostate Cancer: Correlation With Maximum and Total Cancer Core Length Obtained via MRI-Guided Template Mapping Biopsies ",American Journal of Roentgenology,,,Article,2016-09-09,10.2214/ajr.15.15679,,,,27611962,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11933352,https://api.altmetric.com/v1/donut/11933352_240.png 3,Magnetic Resonance Imaging–Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance,European Urology,,,Article,2016-08-30,10.1016/j.eururo.2016.08.023,,,,27595378,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10899805,https://api.altmetric.com/v1/donut/10899805_240.png 3,A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer,Research and Reports in Urology,,,Article,2016-08-01,10.2147/rru.s58262,,,,27574585,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10738390,https://api.altmetric.com/v1/donut/10738390_240.png 3,Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis,International Journal of Pharmaceutics,,,Article,2016-08-01,10.1016/j.ijpharm.2016.07.079,,,,27492023,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10318110,https://api.altmetric.com/v1/donut/10318110_240.png 3,"Cardiovascular and Skeletal-Related Events Following Localised Prostate Cancer Treatment: Role of Surgery, Radiotherapy and Androgen-Deprivation.",Urology,,,Article,2016-08-05,10.1016/j.urology.2016.08.002,,,,27502032,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10290020,https://api.altmetric.com/v1/donut/10290020_240.png 3,Retraction: Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis,PLoS ONE,,,Article,2016-07-26,10.1371/journal.pone.0160298,,,,27458923,PMC4961360,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10055699,https://api.altmetric.com/v1/donut/10055699_240.png 3,Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer,Targeted Oncology,,,Article,2016-07-11,10.1007/s11523-016-0450-9,,,,27402433,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9652376,https://api.altmetric.com/v1/donut/9652376_240.png 3,Can vitamin D supplementation reduce prostate cancer disparities?,Pharmacogenomics,,,Article,2016-07-06,10.2217/pgs-2016-0089,,,,27380910,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9639863,https://api.altmetric.com/v1/donut/9639863_240.png 3,Integration of 68Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study,Radiation Oncology,,,Article,2016-05-26,10.1186/s13014-016-0646-2,,,,27229485,PMC4882861,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8305507,https://api.altmetric.com/v1/donut/8305507_240.png 3,Risk of prostate cancer mortality in men with a history of prior cancer,British Journal of Urology,,,Article,2016-06-01,10.1111/bju.13144,,,,25845283,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8085562,https://api.altmetric.com/v1/donut/8085562_240.png 3,Activation of endogenous TRPV1 fails to induce overstimulation-based cytotoxicity in breast and prostate cancer cells but not in pain-sensing neurons,Biochimica et biophysica acta,,,Article,2016-05-11,10.1016/j.bbamcr.2016.05.007,,,,27180305,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7594409,https://api.altmetric.com/v1/donut/7594409_240.png 3," 18 F sodium fluoride PET/CT in patients with prostate cancer: Quantification of normal tissues, benign degenerative lesions, and malignant lesions ",World Journal of Nuclear Medicine,,,Article,2016-05-01,10.4103/1450-1147.172301,,,,27134560,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7123969,https://api.altmetric.com/v1/donut/7123969_240.png 3,Chemical vs Surgical ADT in Metastatic Prostate Cancer: A Comparison of Side Effects,Urology,,,Article,2016-04-20,10.1016/j.urology.2016.04.002,,,,27107624,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6843872,https://api.altmetric.com/v1/donut/6843872_240.png 3,Clinical Utility of Biomarkers in Localized Prostate Cancer,Current Oncology Reports,,,Article,2016-03-29,10.1007/s11912-016-0513-1,,,,27023445,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6471356,https://api.altmetric.com/v1/donut/6471356_240.png 3,Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines,Advances in Radiation Oncology ,,,Article,2016-01-01,10.1016/j.adro.2015.11.004,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6396104,https://api.altmetric.com/v1/donut/6396104_240.png 3,Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents,Drugs,,,Article,2016-02-12,10.1007/s40265-015-0530-7,,,,26873496,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6291835,https://api.altmetric.com/v1/donut/6291835_240.png 3," A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growth in vivo ",Cancer Biology and Therapy,,,Article,2016-03-08,10.1080/15384047.2016.1156266,,,,26954374,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6154949,https://api.altmetric.com/v1/donut/6154949_240.png 3,Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine,Prostate Cancer,,,Article,2016-02-16,10.1155/2016/4897515,,,,27022486,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/5944048,https://api.altmetric.com/v1/donut/5944048_240.png 3,The genetic classification of prostate cancer: what’s on the horizon?,Future Oncology,,,Article,2016-02-09,10.2217/fon.15.352,,,,26859444,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5297593,https://api.altmetric.com/v1/donut/5297593_240.png 3,Maintaining intimacy for prostate cancer patients on androgen deprivation therapy,Current Opinion in Supportive and Palliative Care,,,Article,2016-01-15,10.1097/spc.0000000000000190,,,,26761788,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5013134,https://api.altmetric.com/v1/donut/5013134_240.png 3,Integrated network model provides new insights into castration-resistant prostate cancer,Scientific Reports,,,Article,2015-11-26,10.1038/srep17280,,,,26603105,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4810229,https://api.altmetric.com/v1/donut/4810229_240.png 3,Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities ,Preventive Medicine,,,Article,,10.1016/j.ypmed.2015.11.009,,,,26582208,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4802862,https://api.altmetric.com/v1/donut/4802862_240.png 3,Prostate cancer: Elective pelvic nodal radiotherapy: is the jury still out?,Nature Reviews Urology,,,Article,2015-11-24,10.1038/nrurol.2015.283,,,,26597615,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4800441,https://api.altmetric.com/v1/donut/4800441_240.png 3,"Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study.",Scientific Reports,,,Article,2015-11-18,10.1038/srep16758,,,,26577038,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4782839,https://api.altmetric.com/v1/donut/4782839_240.png 3,Adeno-associated Virus Serotype Vectors Efficiently Transduce Normal Prostate Tissue and Prostate Cancer Cells,European Urology,,,Article,2015-10-30,10.1016/j.eururo.2015.10.019,,,,26526960,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4704170,https://api.altmetric.com/v1/donut/4704170_240.png 3,Treatment costs for advanced prostate cancer using LHRH agonists: a solid biodegradable leuprorelin implant versus other formulations.,Journal of Comparative Effectiveness Research,,,Article,2014-12-18,10.2217/cer.14.82,,,,25521079,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4665169,https://api.altmetric.com/v1/donut/4665169_240.png 3,"Love, faith and hope – a secondary analysis of prostate cancer survivors and their partners",Contemporary Nurse: A Journal for the Australian Nursing Profession,,,Article,2015-10-28,10.1080/10376178.2015.1101352,,,,26503326,,11541.2/111959,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4587699,https://api.altmetric.com/v1/donut/4587699_240.png 3,Lower urinary tract symptoms among Caucasian-European men who have sex with men: findings from a real-life survey,Prostate Cancer & Prostatic Diseases,,,Article,2015-09-29,10.1038/pcan.2015.41,,,,26415556,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4567014,https://api.altmetric.com/v1/donut/4567014_240.png 3,Prostate Cancer Screening Biomarkers: An Emerging Embarrassment of ‘Riches’?,European Urology,,,Article,2015-09-15,10.1016/j.eururo.2015.09.002,,,,26382084,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4508769,https://api.altmetric.com/v1/donut/4508769_240.png 3,Prostate Cancer Screening and the Associated Controversy,Surgical Clinics of North America,,,Article,2015-09-02,10.1016/j.suc.2015.05.001,,,,26315521,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4463595,https://api.altmetric.com/v1/donut/4463595_240.png 3,Discovery Radiomics for Multi-Parametric MRI Prostate Cancer Detection,,,,Article,,,,,,,,,,1509.00111,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4462249,https://api.altmetric.com/v1/donut/4462249_240.png 3,Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer,Cancer Epidemiology,,,Article,2015-01-10,10.1016/j.canep.2015.06.008,,,,26165176,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4428594,https://api.altmetric.com/v1/donut/4428594_240.png 3,The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.,Familial Cancer,,,Article,2015-08-22,10.1007/s10689-015-9832-x,,,,26289772,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4420107,https://api.altmetric.com/v1/donut/4420107_240.png 3,Prostate Cancer Progression: The Smoking Gun?,European Urology,,,Article,2015-08-06,10.1016/j.eururo.2015.07.046,,,,26254511,,,,,,,0,0,0,5,0,0,4,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4368807,https://api.altmetric.com/v1/donut/4368807_240.png 3,Assessment of activity and outcome from a one-stop clinic for men with suspected prostate cancer: Five years’ experience,Journal of Clinical Urology,,,Article,2015-06-26,10.1177/2051415815590527,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4216732,https://api.altmetric.com/v1/donut/4216732_240.png 3,Randomized Phase II Trial of Docetaxel with or without PSA-TRICOM Vaccine in Patients with Castrate-Resistant Metastatic Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E1809),Human vaccines immunotherapeutics,,,Article,2015-06-26,10.1080/21645515.2015.1062190,,,,26111351,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4214437,https://api.altmetric.com/v1/donut/4214437_240.png 3,Clinical Research in Metastatic Prostate Cancer: A Focus on Impact and Value,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2015-05-22,10.14694/edbook_am.2015.35.17,,,,25993136,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4042418,https://api.altmetric.com/v1/donut/4042418_240.png 3,The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells,BMC Biochemistry,,,Article,2015-05-06,10.1186/s12858-015-0042-9,,,,25943311,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3970394,https://api.altmetric.com/v1/donut/3970394_240.png 3,Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial,JMIR Research Protocols,,,Article,2015-04-29,10.2196/resprot.4462,,,,25926023,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3953510,https://api.altmetric.com/v1/donut/3953510_240.png 3,HES6 promotes prostate cancer aggressiveness independently of Notch signalling,Journal of Cellular and Molecular Medicine,,,Article,2015-04-12,10.1111/jcmm.12537,,,,25864518,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3924311,https://api.altmetric.com/v1/donut/3924311_240.png 3,"Reply to Jovo Bogdanovi? and Vuk Sekuli?’s Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212–9",European Urology,,,Article,2015-03-19,10.1016/j.eururo.2015.03.019,,,,25801052,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3812497,https://api.altmetric.com/v1/donut/3812497_240.png 3,223Ra ?-Therapy in Patients with Bone Metastases from Castration-resistant Prostate Cancer,Journal of Medical Imaging & Radiation Sciences,,,Article,2015-01-06,10.1016/j.jmir.2015.01.003,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3774934,https://api.altmetric.com/v1/donut/3774934_240.png 3,Targeting ASCT2?mediated glutamine uptake blocks prostate cancer growth and tumour development,The Journal of Pathology,,,Article,2015-07-01,10.1002/path.4518,,,,25693838,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3713318,https://api.altmetric.com/v1/donut/3713318_240.png 3,Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic.,Canadian Urological Association Journal,,,Article,2014-12-10,10.5489/cuaj.1970,,,,25485004,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3709244,https://api.altmetric.com/v1/donut/3709244_240.png 3,Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer,Oncogene,,,Article,2014-02-03,10.1038/onc.2013.591,,,,24488012,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3134885,https://api.altmetric.com/v1/donut/3134885_240.png 3,PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2015-02-15,10.1093/jnci/dju407,,,,25505253,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2981150,https://api.altmetric.com/v1/donut/2981150_240.png 3,Primary Radical Therapy Selection in High-risk Non-metastatic Prostate Cancer,Clinical Oncology,,,Article,2014-11-28,10.1016/j.clon.2014.11.004,,,,25441052,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2934468,https://api.altmetric.com/v1/donut/2934468_240.png 3,Non-coding RNAs as biomarkers for metastatic prostate cancer,Lancet Oncology,,,Article,2014-11-17,10.1016/s1470-2045(14)71124-6,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2897043,https://api.altmetric.com/v1/donut/2897043_240.png 3,Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial,Annals of Oncology,,,Article,,10.1093/annonc/mdu510,,,,25361992,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2845267,https://api.altmetric.com/v1/donut/2845267_240.png 3,"Re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound-Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies. Eur Urol 2014;66:22-9.",European Urology,,,Article,2014-09-03,10.1016/j.eururo.2014.08.065,,,,25201751,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2660406,https://api.altmetric.com/v1/donut/2660406_240.png 3,The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis.,Cancer Discovery,,,Article,2014-08-12,10.1158/2159-8290.cd-13-1010,,,,25122198,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2605897,https://api.altmetric.com/v1/donut/2605897_240.png 3,Prostate Cancer in a Man with a BRCA2 Mutation and a Personal History of Bilateral Breast Cancer.,Clinical Genetics,,,Article,2014-08-14,10.1111/cge.12478,,,,25112434,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2593832,https://api.altmetric.com/v1/donut/2593832_240.png 3,How Many Prostate Cancer–bearing Lymph Nodes Did We Miss in the Past?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.03.001,,,,23499363,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/2542352,https://api.altmetric.com/v1/donut/2542352_240.png 3,A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease,British Journal of Urology,,,Article,2014-06-19,10.1111/bju.12847,,,,24952954,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2452569,https://api.altmetric.com/v1/donut/2452569_240.png 3,Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis,Oncogene,,,Article,2013-06-10,10.1038/onc.2013.235,,,,23752196,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2391229,https://api.altmetric.com/v1/donut/2391229_240.png 3,Re: Serum Androgens as Prognostic Biomarkers in Castration-Resistant Prostate Cancer: Results from an Analysis of a Randomized Phase III Trial,The Journal of Urology,,,Article,2014-01-04,10.1016/j.juro.2014.01.076,,,,24703119,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2359769,https://api.altmetric.com/v1/donut/2359769_240.png 3,Prostate cancer: BETting on epigenetic therapy,Nature Reviews Cancer,,,Article,2014-05-15,10.1038/nrc3750,,,,24827504,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2356903,https://api.altmetric.com/v1/donut/2356903_240.png 3,"HOXB13 G84E-related Familial Prostate Cancers: A Clinical, Histologic, and Molecular Survey.",The American Journal of Surgical Pathology,,,Article,2014-05-01,10.1097/pas.0000000000000090,,,,24722062,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2275021,https://api.altmetric.com/v1/donut/2275021_240.png 3,Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study,Prostate Cancer & Prostatic Diseases,,,Article,2014-04-01,10.1038/pcan.2014.11,,,,24686772,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2228370,https://api.altmetric.com/v1/donut/2228370_240.png 3,ERG Protein Expression in Diagnostic Specimens Is Associated with Increased Risk of Progression During Active Surveillance for Prostate Cancer,European Urology,,,Article,2014-11-01,10.1016/j.eururo.2014.02.058,,,,24630684,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2168519,https://api.altmetric.com/v1/donut/2168519_240.png 3,The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer ,European Urology,,,Article,2014-01-24,10.1016/j.eururo.2014.01.018,,,,24491307,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,6,https://www.altmetric.com/details/2125117,https://api.altmetric.com/v1/donut/2125117_240.png 3,"Effects of Sulforaphane and 3,3?-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells",PLoS ONE,"POWERS, Justin K",School of Medicine & Medical Science; Department of Life Sciences,Article,2014-02-06,10.1371/journal.pone.0086787,,,,24466240,PMC3899342,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2102735,https://api.altmetric.com/v1/donut/2102735_240.png 3,Statins: protectors or pretenders in prostate cancer?,Trends in Endocrinology & Metabolism,,,Article,2014-01-23,10.1016/j.tem.2013.12.007,,,,24462080,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2067827,https://api.altmetric.com/v1/donut/2067827_240.png 3,Intraductal spread of prostate cancer into the seminal vesicles,Histopathology,,,Article,2013-12-01,10.1111/j.1365-2559.2013.12351.x,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2005091,https://api.altmetric.com/v1/donut/2005091_240.png 3,Palliative care in advanced prostate cancer. Palliative carein advanced prostate cancer. ecancer.tv - Essential viewing foroncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2479/palliative-care-in-advanced-prostate-cancer.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1940748,https://api.altmetric.com/v1/donut/1940748_240.png 3,Neither Body nor Brain: Comparing Preventive Attitudes to Prostate Cancer and Alzheimer’s Disease,Body & Society,,,Article,2013-01-01,10.1177/1357034x13477163,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1881341,https://api.altmetric.com/v1/donut/1881341_240.png 3,RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-13-0615,,,,24063893,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1787551,https://api.altmetric.com/v1/donut/1787551_240.png 3,Cell mates: paracrine and stromal targets for prostate cancer therapy,Nature Reviews Urology,,,Article,2013-07-16,10.1038/nrurol.2013.146,,,,23857181,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1627993,https://api.altmetric.com/v1/donut/1627993_240.png 3,Toxicities Following Treatment with Bisphosphonates and Receptor Activator of Nuclear Factor-?B Ligand Inhibitors in Patients with Advanced Prostate Cancer,European Urology,,,Article,2013-05-29,10.1016/j.eururo.2013.05.015,,,,23706567,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1530248,https://api.altmetric.com/v1/donut/1530248_240.png 3,High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients,Radiation Oncology,,,Article,2013-05-08,10.1186/1748-717x-8-115,,,,23656899,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1465219,https://api.altmetric.com/v1/donut/1465219_240.png 3,"Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials",Maturitas,,,Article,2013-04-05,10.1016/j.maturitas.2013.03.006,,,,23567264,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1359332,https://api.altmetric.com/v1/donut/1359332_240.png 3,Dietary patterns as predictors of prostate cancer in jamaican men.,Nutrition and Cancer,,,Article,2013-04-01,10.1080/01635581.2013.757631,,,,23530635,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1330580,https://api.altmetric.com/v1/donut/1330580_240.png 3,PSA screening to detect prostate cancer can be beneficial to younger and at-risk men,ecancer.org,,,Article,,,,,http://ecancer.org/news/2798-psa-screening-to-detect-prostate-cancer-can-be-beneficial-to-younger-and-at-risk-men.php,,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251324,https://api.altmetric.com/v1/donut/1251324_240.png 3,Milk thistle hits prostate cancer two ways,ecancer.org,,,Article,,,,,http://ecancer.org/news/2731-milk-thistle-hits-prostate-cancer-two-ways.php,,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251231,https://api.altmetric.com/v1/donut/1251231_240.png 3,Sound-wave therapy for prostate cancer may reduce side effects,ecancer.org,,,Article,,,,,http://ecancer.org/news/2730-sound-wave-therapy-for-prostate-cancer-may-reduce-side-effects.php,,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251230,https://api.altmetric.com/v1/donut/1251230_240.png 3,Current treatment practices in metastatic castrationresistant prostate cancer. Current treatment practices inmetastatic castration resistant prostate cancer. ecancer.tv -Essential viewing for oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/1426/current-treatment-practices-in-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250752,https://api.altmetric.com/v1/donut/1250752_240.png 3,Prostate cancer: Diabetes and prostate cancer|[mdash]|an open debate,Nature Reviews Urology,,,Article,2012-12-04,10.1038/nrurol.2012.239,,,,23208302,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1110981,https://api.altmetric.com/v1/donut/1110981_240.png 3,Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.02.049,,,,22537541,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/1065090,https://api.altmetric.com/v1/donut/1065090_240.png 3,Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR),Histopathology,,,Article,2013-01-01,10.1111/his.12042,,,,23240714,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/993924,https://api.altmetric.com/v1/donut/993924_240.png 3,Re: Primary Care Providers' Response to the US Preventive Services Task Force Draft Recommendations on Screening for Prostate Cancer,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.06.130,,,,22971366,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/969760,https://api.altmetric.com/v1/donut/969760_240.png 3,"High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer",PLoS ONE,,,Article,2012-06-28,10.1371/journal.pone.0039801,,,,22761906,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/814695,https://api.altmetric.com/v1/donut/814695_240.png 3,American cranberry (Vaccinium macrocarpon) extract affects human prostate cancer cell growth via cell cycle arrest by modulating expression of cell cycle regulators.,Food & Function,,,Article,2012-03-05,10.1039/c2fo10145a,,,,22388548,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,1,5,https://www.altmetric.com/details/639968,https://api.altmetric.com/v1/donut/639968_240.png 3,The effect of metformin use during docetaxel chemotherapy on prostate cancer-specific and overall survival of diabetic castration-resistant prostate cancer patients,The Journal of Urology,,,Article,2016-10-01,10.1016/j.juro.2016.10.069,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13088643,https://api.altmetric.com/v1/donut/13088643_240.png 3,Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues,Journal of Clinical Oncology,,,Article,2016-10-20,10.1200/jco.2016.68.2617,,,,27458304,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12596855,https://api.altmetric.com/v1/donut/12596855_240.png 3,Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial--There is No Significant Reduction in Death (Yet),Journal of Clinical Oncology,,,Article,2016-10-10,10.1200/jco.2016.67.4630,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12578913,https://api.altmetric.com/v1/donut/12578913_240.png 3,Re: Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2016.09.105,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12436634,https://api.altmetric.com/v1/donut/12436634_240.png 3,Re: A Comparison of Web-Based versus Print-Based Decision Aids for Prostate Cancer Screening: Participants’ Evaluation and Utilization,The Journal of Urology,,,Article,,10.1016/j.juro.2016.09.106,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12436617,https://api.altmetric.com/v1/donut/12436617_240.png 3,UGT2B17 expedites progression of castration-resistant prostate cancers by promoting ligand-independent AR signaling,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-1518,,,,27659047,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12151587,https://api.altmetric.com/v1/donut/12151587_240.png 3,Machine learning for survival analysis: a case study on recurrence of prostate cancer,Artificial Intelligence in Medicine,,,Article,2000-08-01,10.1016/s0933-3657(00)00053-1,,,,11185421,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,26,https://www.altmetric.com/details/10800733,https://api.altmetric.com/v1/donut/10800733_240.png 3,The Role of ?1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers,International Journal of Molecular Sciences,,,Article,2016-08-16,10.3390/ijms17081339,,,,27537875,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10700141,https://api.altmetric.com/v1/donut/10700141_240.png 3,Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-0385,,,,27488525,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10319469,https://api.altmetric.com/v1/donut/10319469_240.png 3,Rationale for Modernising Imaging in Advanced Prostate Cancer,European Urology Focus ,,,Article,2016-07-15,10.1016/j.euf.2016.06.018,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9719160,https://api.altmetric.com/v1/donut/9719160_240.png 3,"Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database",Cancer (0008543X),,,Article,2016-06-28,10.1002/cncr.30154,,,,27352280,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9146023,https://api.altmetric.com/v1/donut/9146023_240.png 3,The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts,Prostate Cancer & Prostatic Diseases,,,Article,2016-06-28,10.1038/pcan.2016.22,,,,27349497,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9132511,https://api.altmetric.com/v1/donut/9132511_240.png 3,Couple therapy following prostate cancer surgery: a manual to guide treatment,Journal of Family Therapy,,,Article,2016-06-01,10.1111/1467-6427.12129,,,,,,1893/23446,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9092229,https://api.altmetric.com/v1/donut/9092229_240.png 3,Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21,Human Genetics,,,Article,2016-06-04,10.1007/s00439-016-1690-6,,,,27262462,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8508374,https://api.altmetric.com/v1/donut/8508374_240.png 3,Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer,European Urology Focus ,,,Article,2016-06-03,10.1016/j.euf.2016.05.004,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8452648,https://api.altmetric.com/v1/donut/8452648_240.png 3,A comparative analysis of lncRNAs in prostate cancer exosomes and their parental cell lines,Genomics Data,,,Article,2016-05-01,10.1016/j.gdata.2016.05.010,,,,27330995,PMC4909828,10453/43930,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8399181,https://api.altmetric.com/v1/donut/8399181_240.png 3,Re: Treatment Patterns for Older Veterans with Localized Prostate Cancer,The Journal of Urology,,,Article,2016-04-14,10.1016/j.juro.2016.04.016,,,,27321508,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6726979,https://api.altmetric.com/v1/donut/6726979_240.png 3,Computational Reconstruction of NF?B Pathway Interaction Mechanisms during Prostate Cancer,PLoS Computational Biology,,,Article,2016-04-14,10.1371/journal.pcbi.1004820,,,,27078000,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6721218,https://api.altmetric.com/v1/donut/6721218_240.png 3,An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis,PLoS ONE,,,Article,2016-04-13,10.1371/journal.pone.0153496,,,,27073921,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6658623,https://api.altmetric.com/v1/donut/6658623_240.png 3,Re: Autophagy Defects Suggested by Low Levels of Autophagy Activator MAP1S and High Levels of Autophagy Inhibitor LRPPRC Predict Poor Prognosis of Prostate Cancer Patients,The Journal of Urology,,,Article,2016-03-19,10.1016/j.juro.2016.03.018,,,,27191117,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6233462,https://api.altmetric.com/v1/donut/6233462_240.png 3,Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy,Modern Pathology,,,Article,2016-03-04,10.1038/modpathol.2016.49,,,,26939875,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6052415,https://api.altmetric.com/v1/donut/6052415_240.png 3,The Treatment Challenges of Neuroendocrine Prostate Cancer,Oncology times,,,Article,2015-02-25,10.1097/01.cot.0000461860.84751.a3,,,http://journals.lww.com/oncology-times/Fulltext/2015/02250/The_Treatment_Challenges_of_Neuroendocrine.3.aspx,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6043900,https://api.altmetric.com/v1/donut/6043900_240.png 3,Prostate cancer and curcumin: Add spice to your life,Cancer Biology and Therapy,,,Article,2014-10-27,10.4161/cbt.7.9.6659,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,28,https://www.altmetric.com/details/5618860,https://api.altmetric.com/v1/donut/5618860_240.png 3,"Integrated clinical, whole genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer",Cold Spring Harbor Molecular Case Studies,,,Article,2016-05-06,10.1101/mcs.a000752,,,,27148588,PMC4853517,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5152460,https://api.altmetric.com/v1/donut/5152460_240.png 3,Biology of Bone Metastases in Prostate Cancer,Urology,,,Article,2016-01-16,10.1016/j.urology.2015.12.039,,,,26768714,,,,,,,0,0,0,7,0,0,3,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4957851,https://api.altmetric.com/v1/donut/4957851_240.png 3,Orchiectomy has fewer adverse effects than chemical castration for metastatic prostate cancer,British Medical Journal,,,Article,2015-12-24,10.1136/bmj.h6966,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4919250,https://api.altmetric.com/v1/donut/4919250_240.png 3,Re: Expression of Nuclear Matrix Proteins Binding Matrix Attachment Regions in Prostate Cancer. PARP-1: New Player in Tumor Progression,The Journal of Urology,,,Article,2016-02-19,10.1016/j.juro.2015.12.001,,,,26887755,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4865456,https://api.altmetric.com/v1/donut/4865456_240.png 3,The effect of start and stop age at screening on the risk of being diagnosed with prostate cancer ,The Journal of Urology,,,Article,2015-12-19,10.1016/j.juro.2015.11.062,,,,26678954,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4854857,https://api.altmetric.com/v1/donut/4854857_240.png 3,Combination of ?-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells.,PLoS ONE,,,Article,2015-12-02,10.1371/journal.pone.0144293,,,,26630272,PMC4668011,,,,,,0,0,0,3,0,0,1,0,0,0,1,0,0,0,0,7,https://www.altmetric.com/details/4833533,https://api.altmetric.com/v1/donut/4833533_240.png 3,Re: Should the Urologist Treat Castration Resistant Prostate Cancer? Yes,The Journal of Urology,,,Article,2015-12-08,10.1016/j.juro.2015.08.106,,,,26638024,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4816077,https://api.altmetric.com/v1/donut/4816077_240.png 3,Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial,European Urology,,,Article,2015-11-21,10.1016/j.eururo.2015.11.005,,,,26610858,,,,,,,0,0,0,4,0,0,3,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4805780,https://api.altmetric.com/v1/donut/4805780_240.png 3,Prospects for the future of prostate cancer vaccines,Expert Review of Vaccines,,,Article,2015-11-13,10.1586/14760584.2015.1118348,,,,26560494,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4759195,https://api.altmetric.com/v1/donut/4759195_240.png 3,Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-12,10.1016/j.ijrobp.2015.08.005,,,,26581143,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4756579,https://api.altmetric.com/v1/donut/4756579_240.png 3,"Re: Trends in Management for Patients with Localized Prostate Cancer, 1990–2013",The Journal of Urology,,,Article,2015-11-02,10.1016/j.juro.2015.10.150,,,,26852976,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4716324,https://api.altmetric.com/v1/donut/4716324_240.png 3,Molecular Updates in Prostate Cancer,Surgical Pathology Clinics,,,Article,2015-11-28,10.1016/j.path.2015.08.003,,,,26612215,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4628598,https://api.altmetric.com/v1/donut/4628598_240.png 3,Re: Course and Predictors of Cognitive Function in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison,The Journal of Urology,,,Article,2015-12-25,10.1016/j.juro.2015.10.038,,,,26699965,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4626112,https://api.altmetric.com/v1/donut/4626112_240.png 3,Re: Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists,The Journal of Urology,,,Article,2015-12-25,10.1016/j.juro.2015.10.021,,,,26699963,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4621152,https://api.altmetric.com/v1/donut/4621152_240.png 3,Re: Elf5 Inhibits TGF-?-Driven Epithelial-Mesenchymal Transition in Prostate Cancer by Repressing SMAD3 Activation,The Journal of Urology,,,Article,2015-12-25,10.1016/j.juro.2015.10.012,,,,26699995,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4621151,https://api.altmetric.com/v1/donut/4621151_240.png 3,Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer,European Urology,,,Article,2015-09-25,10.1016/j.eururo.2015.09.004,,,,26411806,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4551459,https://api.altmetric.com/v1/donut/4551459_240.png 3,Effect of androgen deprivation therapy on arterial stiffness and serum lipid profile changes in patients with prostate cancer: a prospective study of initial 6-month follow-up,International Journal of Clinical Oncology,,,Article,2015-08-22,10.1007/s10147-015-0891-7,,,,26296528,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4421719,https://api.altmetric.com/v1/donut/4421719_240.png 3,"Multiparametric MRI strongly predicts post-surgical pathology, but misses aggressive prostate cancers as assessed by cell cycle progression (CCP) score",The Journal of Urology,,,Article,2015-08-15,10.1016/j.juro.2015.06.107,,,,26272031,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4381847,https://api.altmetric.com/v1/donut/4381847_240.png 3,A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer ,European Journal of Cancer (1965),,,Article,2015-08-10,10.1016/j.ejca.2015.07.019,,,,26254809,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4368002,https://api.altmetric.com/v1/donut/4368002_240.png 3,Adding Early Docetaxel to ADT for Metastatic Prostate Cancer Improves Survival,Journal Watch,,,Article,2015-08-06,10.1056/nejm-jw.fw110491,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4366275,https://api.altmetric.com/v1/donut/4366275_240.png 3,The importance of patient preference in the decision to screen for prostate cancer,JGIM: Journal of General Internal Medicine,,,Article,1996-06-01,10.1007/bf02600045,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,https://www.altmetric.com/details/4267425,https://api.altmetric.com/v1/donut/4267425_240.png 3,The genomic evolution of human prostate cancer,British Journal of Cancer,,,Article,2015-06-30,10.1038/bjc.2015.234,,,,26125442,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/4231844,https://api.altmetric.com/v1/donut/4231844_240.png 3,Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example.,Clinical Chemistry,,,Article,1995-08-01,,,,,7628115,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,31,https://www.altmetric.com/details/4212285,https://api.altmetric.com/v1/donut/4212285_240.png 3,Environmental exposure to lead as a risk for prostate cancer.,Biomedical & Environmental Sciences,,,Article,2002-12-01,,,,,12642986,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,2,https://www.altmetric.com/details/4211777,https://api.altmetric.com/v1/donut/4211777_240.png 3,Dietary botanicals for chemoprevention of prostate cancer.,,,,Article,2014-04-14,10.4103/2225-4110.130371,,,,24860728,PMC4003704,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,4,https://www.altmetric.com/details/4211578,https://api.altmetric.com/v1/donut/4211578_240.png 3,Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells.,,,,Article,2010-09-14,10.1016/j.tiv.2010.06.014,,,,20600798,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,5,https://www.altmetric.com/details/4211576,https://api.altmetric.com/v1/donut/4211576_240.png 3,siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2015-06-25,10.1158/1078-0432.ccr-15-0866,,,,26106075,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4205307,https://api.altmetric.com/v1/donut/4205307_240.png 3,Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-07-01,10.1158/1055-9965.epi-14-1329,,,,25953767,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3991445,https://api.altmetric.com/v1/donut/3991445_240.png 3,"Knowledge-based radiation therapy (KBRT) treatment-planning versus planning by experts: validation of a KBRT algorithm for prostate cancer treatment-planning ",Radiation Oncology,,,Article,2015-05-10,10.1186/s13014-015-0416-6,,,,25957871,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3982154,https://api.altmetric.com/v1/donut/3982154_240.png 3,Evolving transcriptomic fingerprint based on genome?wide data as prognostic tools in prostate cancer,Biology of the Cell,,,Article,2015-04-23,10.1111/boc.201400097,,,,25900404,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3927245,https://api.altmetric.com/v1/donut/3927245_240.png 3,"FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.",The Prostate,,,Article,2015-03-23,10.1002/pros.22982,,,,25808853,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3855387,https://api.altmetric.com/v1/donut/3855387_240.png 3,Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence,British Journal of Urology,,,Article,2014-12-08,10.1111/bju.13013,,,,25762434,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3820311,https://api.altmetric.com/v1/donut/3820311_240.png 3,Survivin and PSMA loaded dendritic cell vaccine for the treatment of Prostate Cancer.,Biological and Pharmaceutical Bulletin,,,Article,2015-03-17,10.1248/bpb.b14-00518,,,,25787895,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3813189,https://api.altmetric.com/v1/donut/3813189_240.png 3,Sensitization to docetaxel in prostate cancer cells by green tea and quercetin.,Journal of Nutritional Biochemistry,,,Article,2015-02-08,10.1016/j.jnutbio.2014.11.017,,,,25655047,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3788154,https://api.altmetric.com/v1/donut/3788154_240.png 3,Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.,Urologic Oncology,,,Article,2015-03-11,10.1016/j.urolonc.2015.01.023,,,,25754621,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3787511,https://api.altmetric.com/v1/donut/3787511_240.png 3,Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic Biopsies,The Journal of Urology,,,Article,2015-01-08,10.1016/j.juro.2015.02.2938,,,,25747105,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3756565,https://api.altmetric.com/v1/donut/3756565_240.png 3,"Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention.",Asian Journal of Andrology,,,Article,2015-02-03,10.4103/1008-682x.148070,,,,25657084,,,,,,,0,0,0,2,0,1,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3434312,https://api.altmetric.com/v1/donut/3434312_240.png 3,OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.,Molecular Cancer,,,Article,2015-01-27,10.1186/s12943-014-0280-2,,,,25623341,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3111396,https://api.altmetric.com/v1/donut/3111396_240.png 3,Vitamin D-associated genetic variation and risk of breast cancer in the Breast and Prostate Cancer Cohort Consortium (BPC3).,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-12-26,10.1158/1055-9965.epi-14-1127,,,,25542828,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3025873,https://api.altmetric.com/v1/donut/3025873_240.png 3,"Antiproliferative Activity of Aqueous Leaf Extract of Annona muricata L. on the Prostate, BPH-1 Cells, and Some Target Genes",Integrative Cancer Therapies,,,Article,2014-11-22,10.1177/1534735414550198,,,,25411208,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2962222,https://api.altmetric.com/v1/donut/2962222_240.png 3,Genomic rearrangements in prostate cancer.,Current Opinion in Urology,,,Article,2014-11-12,10.1097/mou.0000000000000129,,,http://journals.lww.com/co-urology/Fulltext/2015/01000/Genomic_rearrangements_in_prostate_cancer.13.aspx,25393273,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/2893520,https://api.altmetric.com/v1/donut/2893520_240.png 3,PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate,European Urology,,,Article,2015-04-01,10.1016/j.eururo.2014.10.027,,,,25454616,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/2848067,https://api.altmetric.com/v1/donut/2848067_240.png 3,Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-10-26,10.1158/1055-9965.epi-14-0786-t,,,,25342390,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2836873,https://api.altmetric.com/v1/donut/2836873_240.png 3,Michigan Urological Surgery Improvement Collaborative: Patterns of Care in the Radiographic Staging of Men with Newly Diagnosed Low Risk Prostate Cancer.,The Journal of Urology,,,Article,2014-10-31,10.1016/j.juro.2014.10.102,,,,25444985,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2835958,https://api.altmetric.com/v1/donut/2835958_240.png 3,The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor,Frontiers in oncology,,,Article,2014-10-09,10.3389/fonc.2014.00295,,,,25386409,PMC4208414,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2811512,https://api.altmetric.com/v1/donut/2811512_240.png 3,Prostate cancer: Depression and prostate cancer[mdash]why do they show up together?,Nature Reviews Urology,,,Article,2014-08-26,10.1038/nrurol.2014.226,,,,25155784,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2626745,https://api.altmetric.com/v1/donut/2626745_240.png 3,"""It's all very well reading the letters in the genome, but it's a long way to being able to write"": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer.",Familial Cancer,,,Article,2014-07-03,10.1007/s10689-014-9734-3,,,,24980079,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2496582,https://api.altmetric.com/v1/donut/2496582_240.png 3,Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment,British Journal of Cancer,,,Article,2014-07-08,10.1038/bjc.2014.311,,,,25003663,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2495308,https://api.altmetric.com/v1/donut/2495308_240.png 3,Flexibility in Men's Sexual Practices in Response to Iatrogenic Erectile Dysfunction after Prostate Cancer Treatment.,Sexual Medicine,,,Article,2014-06-26,10.1002/sm2.32,,,,25356308,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2491852,https://api.altmetric.com/v1/donut/2491852_240.png 3,Integrative genomic analysis for the discovery of biomarkers in prostate cancer.,Biomarker Insights,,,Article,2014-06-01,10.4137/bmi.s13729,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2482145,https://api.altmetric.com/v1/donut/2482145_240.png 3,EZH2-Mediated Inactivation of IFN-?-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer,Cell Reports,,,Article,,10.1016/j.celrep.2014.05.045,,,,24953652,,,,,,,0,0,0,4,0,1,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2462664,https://api.altmetric.com/v1/donut/2462664_240.png 3,Remodeling of Channel-Forming ORAI Proteins Determines an Oncogenic Switch in Prostate Cancer,Cancer Cell,,,Article,,10.1016/j.ccr.2014.04.025,,,,24954132,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2449853,https://api.altmetric.com/v1/donut/2449853_240.png 3,Reliability of Maximal Cardiopulmonary Exercise Testing in Men with Prostate Cancer,Medicine & Science in Sports & Exercise,,,Article,2014-04-28,10.1249/mss.0000000000000370,,,,24781891,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2321469,https://api.altmetric.com/v1/donut/2321469_240.png 3,Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: A prospective diagnostic trial,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-2653,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2304456,https://api.altmetric.com/v1/donut/2304456_240.png 3,Inaccuracy of screening techniques for prostate cancer,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70166-4,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2294830,https://api.altmetric.com/v1/donut/2294830_240.png 3,Notch signaling in prostate cancer: A moving target.,The Prostate,,,Article,2014-04-16,10.1002/pros.22811,,,,24737393,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2287780,https://api.altmetric.com/v1/donut/2287780_240.png 3,Exploring the role of the partner in couples' sexual recovery after surgery for prostate cancer.,Supportive Care in Cancer,,,Article,2014-04-13,10.1007/s00520-014-2244-x,,,,24728619,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2284873,https://api.altmetric.com/v1/donut/2284873_240.png 3,Nestin regulates prostate cancer cell invasion by influencing FAK and integrin localisation and functions,Journal of Cell Science,,,Article,,10.1242/jcs.125062,,,,24610946,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2169768,https://api.altmetric.com/v1/donut/2169768_240.png 3,A Different Method of Evaluation of the ERSPC Trial Confirms That Prostate-specific Antigen Testing Has a Significant Impact on Prostate Cancer Mortality ,European Urology,,,Article,2014-01-07,10.1016/j.eururo.2013.12.055,,,,24412230,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2124852,https://api.altmetric.com/v1/donut/2124852_240.png 3,The prostate cancer risk stratification project: database construction and risk stratification outcome analysis.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2014-01-01,,,,,24453293,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2072347,https://api.altmetric.com/v1/donut/2072347_240.png 3,11C-Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy.,Journal of Nuclear Medicine,,,Article,2014-01-09,10.2967/jnumed.113.123380,,,,24408897,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2036778,https://api.altmetric.com/v1/donut/2036778_240.png 3,Future directions in the prevention of prostate cancer,Nature Reviews Clinical Oncology,,,Article,2013-11-26,10.1038/nrclinonc.2013.211,,,,24281061,,,,,,,0,0,0,10,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1943677,https://api.altmetric.com/v1/donut/1943677_240.png 3,The Osteoblastic and Osteoclastic Interactions in Spinal Metastases Secondary to Prostate Cancer,Cancer Growth & Metastasis,,,Article,2013-11-01,10.4137/cgm.s12769,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1939735,https://api.altmetric.com/v1/donut/1939735_240.png 3,Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-3580,,,,24081977,,,,,,,0,0,0,3,0,0,2,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/1794948,https://api.altmetric.com/v1/donut/1794948_240.png 3,Can the Mediterranean diet prevent prostate cancer?,Molecular Nutrition & Food Research,,,Article,2009-01-01,10.1002/mnfr.200800207,,,,19051189,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1747805,https://api.altmetric.com/v1/donut/1747805_240.png 3,Alcohol and smoking and subsequent risk of prostate cancer in Japanese men: The Japan Public Health Center?based prospective study,International Journal of Cancer,,,Article,2013-08-09,10.1002/ijc.28423,,,,23929133,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1682089,https://api.altmetric.com/v1/donut/1682089_240.png 3,Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated radiotherapy,Clinical and Translational Oncology,,,Article,2013-01-29,10.1007/s12094-012-0987-8,,,,23359176,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1626101,https://api.altmetric.com/v1/donut/1626101_240.png 3,"Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells.",PLoS ONE,,,Article,2013-06-18,10.1371/journal.pone.0065889,,,,23824300,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1568304,https://api.altmetric.com/v1/donut/1568304_240.png 3,Latest on metastatic castration resistant prostate cancer from ASCO 2013. Latest on metastatic castration resistant prostate cancer from ASCO 2013,ecancer.org,,,Article,,,,,http://ecancer.org/video/2022/latest-on-metastatic-castration-resistant-prostate-cancer-from-asco-2013.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1545870,https://api.altmetric.com/v1/donut/1545870_240.png 3,Prostate cancer: A good night's sleep might protect against prostate cancer,Nature Reviews Urology,,,Article,2013-05-28,10.1038/nrurol.2013.122,,,,23712198,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1521203,https://api.altmetric.com/v1/donut/1521203_240.png 3,A Peptide against Soluble Guanylyl Cyclase ?1: A New Approach to Treating Prostate Cancer,PLoS ONE,,,Article,2013-05-27,10.1371/journal.pone.0064189,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1513252,https://api.altmetric.com/v1/donut/1513252_240.png 3,Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis,PLoS ONE,,,Article,2013-05-22,10.1371/journal.pone.0064275,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1500306,https://api.altmetric.com/v1/donut/1500306_240.png 3,Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics,Prostate Cancer & Prostatic Diseases,,,Article,2013-05-14,10.1038/pcan.2013.13,,,,23670256,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1479496,https://api.altmetric.com/v1/donut/1479496_240.png 3,The Association of Retinoic Acid Receptor Beta2(RAR?2) Methylation Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis,PLoS ONE,,,Article,2013-05-13,10.1371/journal.pone.0062950,,,,23675444,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1476693,https://api.altmetric.com/v1/donut/1476693_240.png 3,Single-port transvesical laparoscopic radical prostatectomy for organ-confined prostate cancer: technique and outcomes.,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12225,,,,23826929,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,3,https://www.altmetric.com/details/1472711,https://api.altmetric.com/v1/donut/1472711_240.png 3,Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians,Journal of Translational Medicine,,,Article,2013-05-13,10.1186/1479-5876-11-121,,,,23668334,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1470607,https://api.altmetric.com/v1/donut/1470607_240.png 3,Comparative Effectiveness Review: Prostate Cancer Antigen 3 (PCA3) Testing For the Diagnosis and Management of Prostate Cancer.,The Journal of Urology,,,Article,2013-04-04,10.1016/j.juro.2013.02.005,,,,23545099,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1435990,https://api.altmetric.com/v1/donut/1435990_240.png 3,Abiraterone in Metastatic Prostate Cancer,New England Journal of Medicine,,,Article,2013-04-11,10.1056/nejmc1301594,,,,23574133,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1355565,https://api.altmetric.com/v1/donut/1355565_240.png 3,Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?,Trends in Molecular Medicine,,,Article,2013-03-15,10.1016/j.molmed.2013.02.002,,,,23499575,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1323224,https://api.altmetric.com/v1/donut/1323224_240.png 3,Quantitative Analysis of Multiparametric Prostate MR Images: Differentiation between Prostate Cancer and Normal Tissue and Correlation with Gleason Score—A Computer-aided Diagnosis Development Study,Radiology,,,Article,2013-02-10,10.1148/radiol.13121454,,,,23392430,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/1289614,https://api.altmetric.com/v1/donut/1289614_240.png 3,ASCO 2012: Study finds intermittent hormonal therapy less effective than continuous therapy in certain men with advanced prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2883-asco-2012--study-finds-intermittent-hormonal-therapy-less-effective-than-continuous-therapy-in-certain-men-with-advanced-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251450,https://api.altmetric.com/v1/donut/1251450_240.png 3,4 new drugs will change prostate cancer care,ecancer.org,,,Article,,,,,http://ecancer.org/news/2471-4-new-drugs-will-change-prostate-cancer-care.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250962,https://api.altmetric.com/v1/donut/1250962_240.png 3,Researchers discover mechanism leading from trichomoniasis to prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/3337-researchers-discover-mechanism-leading-from-trichomoniasis-to-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250908,https://api.altmetric.com/v1/donut/1250908_240.png 3,Tumor Cell Survival Mechanisms in Lethal Metastatic Prostate Cancer Differ Between Bone and Soft Tissue Metastases,The Journal of Pathology,,,Article,2013-01-01,10.1002/path.4180,,,,23420560,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1247161,https://api.altmetric.com/v1/donut/1247161_240.png 3,"BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells",PLoS ONE,,,Article,2013-02-08,10.1371/journal.pone.0055837,,,,23409057,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1232481,https://api.altmetric.com/v1/donut/1232481_240.png 3,A note on the catchâ??up time method for estimating lead or sojourn time in prostate cancer screening,Statistics in Medicine,,,Article,2013-01-01,10.1002/sim.5750,,,,23364954,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1214320,https://api.altmetric.com/v1/donut/1214320_240.png 3,New prostate cancer drugs hold promise,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27943,,,,23292897,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1167781,https://api.altmetric.com/v1/donut/1167781_240.png 3,"DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?",Genetic Vaccines and Therapy,,,Article,2012-10-09,10.1186/1479-0556-10-9,,,,23046944,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/998756,https://api.altmetric.com/v1/donut/998756_240.png 3,Abiraterone acetate for metastatic prostate cancer,Lancet Oncology,,,Article,2012-10-01,10.1016/s1470-2045(12)70392-3,,,,22995649,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/973024,https://api.altmetric.com/v1/donut/973024_240.png 3,Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?,BMC Cancer,,,Article,2012-09-26,10.1186/1471-2407-12-432,,,,23013489,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/970515,https://api.altmetric.com/v1/donut/970515_240.png 3,Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States),Cancer Causes and Control,,,Article,1998-12-01,,,,,10189040,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/943964,https://api.altmetric.com/v1/donut/943964_240.png 3,Cross-talk between Androgen Receptors and Cell Signaling Pathways in Prostate Cancer,AACR Education Book,,,Article,2012-01-01,10.1158/aacr.edb-12-8404,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/767269,https://api.altmetric.com/v1/donut/767269_240.png 3,The Adipocyte-Derived Hormone Leptin Has Proliferative Actions on Androgen-Resistant Prostate Cancer Cells Linking Obesity to Advanced Stages of Prostate Cancer,Journal of Oncology,,,Article,2012-01-01,10.1155/2012/280386,,,,22690216,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/765036,https://api.altmetric.com/v1/donut/765036_240.png 3,Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2012-05-22,10.1038/pcan.2012.16,,,,22614062,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/755329,https://api.altmetric.com/v1/donut/755329_240.png 3,"Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer",Carcinogenesis,"GREY, Jane W",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-05-18,10.1093/carcin/bgs175,,,,22610071,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/751529,https://api.altmetric.com/v1/donut/751529_240.png 3,"Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer",JGIM: Journal of General Internal Medicine,,,Article,2011-09-21,10.1007/s11606-011-1869-4,,,,21935751,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/746711,https://api.altmetric.com/v1/donut/746711_240.png 3,Next-generation Prostate Cancer Biobanking: Toward a Processing Protocol Amenable for the International Cancer Genome Consortium.,Diagnostic Molecular Pathology,,,Article,2012-05-06,10.1097/pdm.0b013e31823b6da6,,,,22555088,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/734020,https://api.altmetric.com/v1/donut/734020_240.png 3,"Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401",Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2011.39.4767,,,,22454414,PMC3383121,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/668203,https://api.altmetric.com/v1/donut/668203_240.png 3,"Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial",Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70088-8,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,2,0,0,0,https://www.altmetric.com/details/665315,https://api.altmetric.com/v1/donut/665315_240.png 3,"Vitamin E increases prostate cancer risk in middle-aged men relative to placebo: no significant association observed with selenium, either alone or in combination with vitamin E",Evidence Based Nursing,,,Article,2012-03-12,10.1136/ebnurs-2012-100551,,,,22411161,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/647207,https://api.altmetric.com/v1/donut/647207_240.png 3,Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer Initiation,Cancer Cell,,,Article,2012-01-01,10.1016/j.ccr.2012.01.005,,,,22340597,PMC3285423,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,64,https://www.altmetric.com/details/608996,https://api.altmetric.com/v1/donut/608996_240.png 3,Evaluation of the Efficacy and Safety of Salvia officinalis in Controlling Hot Flashes in Prostate Cancer Patients Treated with Androgen Deprivation,Phytotherapy Research,,,Article,2012-02-01,10.1002/ptr.3528,,,,21630361,,1854/LU-2028764,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/581598,https://api.altmetric.com/v1/donut/581598_240.png 3,Seven years of experience with highâ??intensity focused ultrasound for prostate cancer: Advantages and limitations,The Prostate,,,Article,2012-01-20,10.1002/pros.22491,,,,22253052,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/565496,https://api.altmetric.com/v1/donut/565496_240.png 3,Effect of dual inhibition of apoptosis and autophagy in prostate cancer,The Prostate,,,Article,2012-01-15,10.1002/pros.22487,,,,22241682,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/561014,https://api.altmetric.com/v1/donut/561014_240.png 3,Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer,The Journal of Clinical Endocrinology & Metabolism,,,Article,2011-12-17,10.1210/jc.2011-2189,,,,22170708,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,41,https://www.altmetric.com/details/560179,https://api.altmetric.com/v1/donut/560179_240.png 3,"Fish intake, cooking practices, and risk of prostate cancer: results from a multi-ethnic case–control study",Cancer Causes and Control,"ANDERSSON, Benilda",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-12-30,10.1007/s10552-011-9889-2,,,,22207320,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/547089,https://api.altmetric.com/v1/donut/547089_240.png 3,"Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer.",Nutr Cancer,,,Article,2007-12-31,10.1080/01635580701586770,,,,18444130,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,14,https://www.altmetric.com/details/543481,https://api.altmetric.com/v1/donut/543481_240.png 3,Adjuvant radiotherapy following radical prostatectomy for prostate cancer,Cochrane database of systematic reviews,,,Article,2011-01-01,10.1002/14651858.cd007234.pub2,,,,22161411,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,1,https://www.altmetric.com/details/500393,https://api.altmetric.com/v1/donut/500393_240.png 3,Physical Activity and Natural Anti-VIP Antibodies: Potential Role in Breast and Prostate Cancer Therapy,PLoS ONE,,,Article,2011-11-30,10.1371/journal.pone.0028304,,,,22140573,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/479753,https://api.altmetric.com/v1/donut/479753_240.png 3,"Oldest known case of metastasizing prostate carcinoma diagnosed in the skeleton of a 2,700?year?old Scythian king from Arzhan (Siberia, Russia)",International Journal of Cancer,,,Article,2007-12-15,10.1002/ijc.23073,,,,17918181,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/441104,https://api.altmetric.com/v1/donut/441104_240.png 3,Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.,Journal of Clinical Oncology,,,Article,2011-07-10,10.1200/jco.2010.33.0134,,,,21632511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,42,https://www.altmetric.com/details/383859,https://api.altmetric.com/v1/donut/383859_240.png 3,"The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.",European Urology,,,Article,2008-09-01,10.1016/j.eururo.2008.03.104,,,,18423977,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/211949,https://api.altmetric.com/v1/donut/211949_240.png 3,Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer,The Journal of Urology,,,Article,2011-03-01,10.1016/j.juro.2010.10.080,,,,21239003,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/211855,https://api.altmetric.com/v1/donut/211855_240.png 3,Correction: Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD,Cancer Research,,,Article,2011-06-14,10.1158/0008-5472.can-11-1747,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/190164,https://api.altmetric.com/v1/donut/190164_240.png 3,Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells,PLoS ONE,,,Article,2011-07-11,10.1371/journal.pone.0022118,,,,21779382,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/186196,https://api.altmetric.com/v1/donut/186196_240.png 3,Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-07-05,10.1073/pnas.1105160108,,,,21730179,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/181609,https://api.altmetric.com/v1/donut/181609_240.png 3,Active Monitoring Safe for Gleason Grade 6 & 7 Prostate Cancer,Oncology times,,,Article,2016-10-25,10.1097/01.cot.0000505522.09857.9e,,,http://journals.lww.com/oncology-times/Fulltext/2016/10250/Active_Monitoring_Safe_for_Gleason_Grade_6___7.5.aspx,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13039293,https://api.altmetric.com/v1/donut/13039293_240.png 3,Central Body Fat Mass Measured by Bioelectrical Impedanciometry But Not Body Mass Index Is a High-Grade Prostate Cancer Risk Factor,Urologia Internationalis,,,Article,2016-07-06,10.1159/000447249,,,,27379569,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12692339,https://api.altmetric.com/v1/donut/12692339_240.png 3,Active surveillance for prostate cancer: is it too active?,British Journal of Urology,,,Article,2016-08-14,10.1111/bju.13473,,,,27524716,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10803504,https://api.altmetric.com/v1/donut/10803504_240.png 3,Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study,BMC Cancer,,,Article,2016-07-11,10.1186/s12885-016-2486-8,,,,27400803,PMC4939657,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9714052,https://api.altmetric.com/v1/donut/9714052_240.png 3,Re: Validation of an RNA Cell Cycle Progression Score for Predicting Death from Prostate Cancer in a Conservatively Managed Needle Biopsy Cohort,The Journal of Urology,,,Article,2016-03-16,10.1016/j.juro.2016.03.057,,,,27191067,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/8316779,https://api.altmetric.com/v1/donut/8316779_240.png 3,Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).,Journal of Clinical Epidemiology,,,Article,2003-07-01,10.1016/s0895-4356(03)00083-0,,,,12921927,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/5501543,https://api.altmetric.com/v1/donut/5501543_240.png 3,Trichosporon asahii Infection in a Patient with Metastatic Prostate Cancer as an Example of an Emerging Fungal Pathogen,Laboratory Medicine,,,Article,2015-01-01,10.1309/lmdducadj31le0ml,,,,26404775,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4555965,https://api.altmetric.com/v1/donut/4555965_240.png 3,Prostate cancer: MRI-TRUS fusion biopsy versus 12-core systematic biopsy,Nature Reviews Urology,,,Article,2015-06-16,10.1038/nrurol.2015.143,,,,26077997,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4168942,https://api.altmetric.com/v1/donut/4168942_240.png 3,Re: Tadalafil for Prevention of Erectile Dysfunction after Radiotherapy for Prostate Cancer: The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial,The Journal of Urology,,,Article,2014-01-12,10.1016/j.juro.2014.09.056,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2962648,https://api.altmetric.com/v1/donut/2962648_240.png 3,Does Physical Activity Reduce the Risk of Prostate Cancer? A Systematic Review and Meta-analysis ,European Urology,,,Article,,10.1016/j.eururo.2011.07.007,,,,21802197,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/2845617,https://api.altmetric.com/v1/donut/2845617_240.png 3,Clinical Decision Making in Castration-resistant Prostate Cancer According to Baseline Prostate-specific Antigen: Are We Measuring Disease Burden or Disease Biology?,European Urology,,,Article,2014-09-10,10.1016/j.eururo.2014.08.069,,,,25220371,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2682009,https://api.altmetric.com/v1/donut/2682009_240.png 3,RNA sequence could help doctors to tailor unique prostate cancer treatment programmes,ecancer.org,,,Article,,,,,http://ecancer.org/news/6163-rna-sequence-could-help-doctors-to-tailor-unique-prostate-cancer-treatment-programmes.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2626883,https://api.altmetric.com/v1/donut/2626883_240.png 3,Optimisation of Fluorescence Guidance During Robot-assisted Laparoscopic Sentinel Node Biopsy for Prostate Cancer,European Urology,,,Article,,10.1016/j.eururo.2014.07.014,,,,25092539,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2570183,https://api.altmetric.com/v1/donut/2570183_240.png 3,Prostate cancer: Surgery versus observation for localized prostate cancer,Nature Reviews Urology,,,Article,2014-05-13,10.1038/nrurol.2014.109,,,,24818851,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2420440,https://api.altmetric.com/v1/donut/2420440_240.png 3,Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review,European Urology,,,Article,2014-01-28,10.1016/j.eururo.2014.01.027,,,,24491309,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/2135548,https://api.altmetric.com/v1/donut/2135548_240.png 3,Cabazitaxel: a guide to its use in hormone-refractory metastatic prostate cancer.,Drugs & Aging,,,Article,2013-05-01,10.1007/s40266-013-0078-8,,,,23532557,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1875709,https://api.altmetric.com/v1/donut/1875709_240.png 3,Total antioxidant intake in relation to prostate cancer incidence in the health professionals follow up study.,International Journal of Cancer,,,Article,2013-08-19,10.1002/ijc.28438,,,,23959920,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1702561,https://api.altmetric.com/v1/donut/1702561_240.png 3,Screening for Prostate Cancer: Can We Learn from the Mistakes of the Breast Screening Experience?,European Urology,,,Article,2013-06-06,10.1016/j.eururo.2013.05.053,,,,23768633,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1584503,https://api.altmetric.com/v1/donut/1584503_240.png 3,Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness,PLoS ONE,,,Article,2013-04-23,10.1371/journal.pone.0062375,,,,23626811,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1407743,https://api.altmetric.com/v1/donut/1407743_240.png 3,Sentinel Lymph Node Biopsy for Prostate Cancer: A Hybrid Approach.,Journal of Nuclear Medicine,,,Article,2013-03-14,10.2967/jnumed.112.113746,,,,23492883,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1306571,https://api.altmetric.com/v1/donut/1306571_240.png 3,Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men.,Cancer (0008543X),,,Article,2016-10-11,10.1002/cncr.30367,,,,27727462,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12684556,https://api.altmetric.com/v1/donut/12684556_240.png 3,"Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate Cancer",Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000214,,,"http://journals.lww.com/journalppo/Fulltext/2016/09000/Androgen_Receptor_and_Beyond,_Targeting_Androgen.4.aspx",27749325,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12620177,https://api.altmetric.com/v1/donut/12620177_240.png 3,Prognostic outlier genes for enhanced prostate cancer treatment,Future Oncology,,,Article,2016-10-12,10.2217/fon-2016-0223,,,,27728977,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12600655,https://api.altmetric.com/v1/donut/12600655_240.png 3,Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives,Applied Health Economics and Health Policy,,,Article,2016-10-04,10.1007/s40258-016-0282-x,,,,27704390,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12452973,https://api.altmetric.com/v1/donut/12452973_240.png 3,"Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion",Tumori,,,Article,2016-08-05,10.5301/tj.5000547,,,,27514314,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12382307,https://api.altmetric.com/v1/donut/12382307_240.png 3,The Cohesive Metastasis Phenotype in Human Prostate Cancer,Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,,,Article,2016-09-24,10.1016/j.bbcan.2016.09.005,,,,27678419,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12377964,https://api.altmetric.com/v1/donut/12377964_240.png 3,"The emerging role of obesity, diet and lipid metabolism in prostate cancer",Future Oncology,,,Article,2016-09-14,10.2217/fon-2016-0217,,,,27624840,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12016967,https://api.altmetric.com/v1/donut/12016967_240.png 3,"Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction",Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11896,,,,27626681,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12012494,https://api.altmetric.com/v1/donut/12012494_240.png 3,Does Certificate of Need Minimize Intensity Modulated Radiation Therapy Use in Patients with Low Risk Prostate Cancer?,Urology Practice,,,Article,2016-06-28,10.1016/j.urpr.2015.09.001,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11961968,https://api.altmetric.com/v1/donut/11961968_240.png 3,The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease,Current Osteoporosis Reports,,,Article,2016-08-26,10.1007/s11914-016-0323-2,,,,27566487,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10902338,https://api.altmetric.com/v1/donut/10902338_240.png 3,Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials,Frontiers in oncology,,,Article,2016-08-29,10.3389/fonc.2016.00185,,,,27622157,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10889620,https://api.altmetric.com/v1/donut/10889620_240.png 3,The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer,Quality of Life Research,,,Article,2016-02-23,10.1007/s11136-016-1254-1,,,,26908258,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10396716,https://api.altmetric.com/v1/donut/10396716_240.png 3,Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse.,Clinical Nuclear Medicine,,,Article,2016-08-01,10.1097/rlu.0000000000001328,,,,27500509,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10349918,https://api.altmetric.com/v1/donut/10349918_240.png 3,"Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)",The Prostate,,,Article,2016-07-26,10.1002/pros.23236,,,,27457964,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10227185,https://api.altmetric.com/v1/donut/10227185_240.png 3,Thoughts on Criteria for Active Surveillance of Favorable-risk Prostate Cancer,European Urology,,,Article,2016-07-12,10.1016/j.eururo.2016.06.032,,,,27417029,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9846987,https://api.altmetric.com/v1/donut/9846987_240.png 3,Imaging: PSMA PET–CT in initial prostate cancer staging,Nature Reviews Urology,,,Article,2016-07-19,10.1038/nrurol.2016.136,,,,27431335,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9845804,https://api.altmetric.com/v1/donut/9845804_240.png 3,Metformin elicits antitumor effects and downregulates the histone methyltransferase multiple myeloma SET domain (MMSET) in prostate cancer cells,The Prostate,,,Article,2016-07-12,10.1002/pros.23235,,,,27404348,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9652984,https://api.altmetric.com/v1/donut/9652984_240.png 3,Is it time for everolimus-based combination in castration-resistant prostate cancer?,Future Oncology,,,Article,2016-06-02,10.2217/fon-2016-0136,,,,27250597,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9190700,https://api.altmetric.com/v1/donut/9190700_240.png 3,Prostate cancer: SRRM4 drives NEPC progression,Nature Reviews Urology,,,Article,2016-06-01,10.1038/nrurol.2016.102,,,,27245506,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8433094,https://api.altmetric.com/v1/donut/8433094_240.png 3,Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT,Radiotherapy & Oncology,,,Article,2016-05-09,10.1016/j.radonc.2016.04.023,,,,27173457,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7317729,https://api.altmetric.com/v1/donut/7317729_240.png 3,Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology,Molecular Therapy,,,Article,2016-04-29,10.1038/mt.2016.85,,,,27125502,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7089764,https://api.altmetric.com/v1/donut/7089764_240.png 3,"Are We Eating Our Way to Prostate Cancer—A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150",Non-Coding RNA,,,Article,2016-04-21,10.3390/ncrna2020002,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6849810,https://api.altmetric.com/v1/donut/6849810_240.png 3,"What Is a ""Good"" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer",Medical Decision Making,,,Article,2016-03-08,10.1177/0272989x16635633,,,,26957566,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6155332,https://api.altmetric.com/v1/donut/6155332_240.png 3,Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial.,European Urology,,,Article,2012-08-14,10.1016/j.eururo.2012.04.024,,,,22541389,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6096973,https://api.altmetric.com/v1/donut/6096973_240.png 3,Expression and co-localization of beta-catenin and lymphoid enhancing factor-1 in prostate cancer progression,Human Pathology,,,Article,2016-04-14,10.1016/j.humpath.2015.12.024,,,,27067790,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5014749,https://api.altmetric.com/v1/donut/5014749_240.png 3,The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation,Modern Pathology,,,Article,2016-01-08,10.1038/modpathol.2015.146,,,,26743470,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4970323,https://api.altmetric.com/v1/donut/4970323_240.png 3,The 4Kscore Predicts the Grade and Stage of Prostate Cancer in the Radical Prostatectomy Specimen: Results from a Multi-institutional Prospective Trial,,,,Article,2016-01-07,10.1016/j.euf.2015.12.005,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4963922,https://api.altmetric.com/v1/donut/4963922_240.png 3,Knowledge and attitudes regarding clinical trials and willingness to participate among prostate cancer patients.,Contemporary Clinical Trials,,,Article,,10.1016/j.cct.2015.09.023,,,,26435199,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4958174,https://api.altmetric.com/v1/donut/4958174_240.png 3,Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials,Therapeutic Advances in Urology,,,Article,2015-12-16,10.1177/1756287215621471,,,,27034720,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4926768,https://api.altmetric.com/v1/donut/4926768_240.png 3,Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain,Clinical and Translational Oncology,,,Article,2015-12-02,10.1007/s12094-015-1454-0,,,,26621508,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4832296,https://api.altmetric.com/v1/donut/4832296_240.png 3,"Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.",The Prostate,,,Article,,10.1002/pros.23125,,,,26585352,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4812213,https://api.altmetric.com/v1/donut/4812213_240.png 3,Image-Guided Hypofractionated Post-prostatectomy Intensity-Modulated Radiotherapy for Prostate Cancer ,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-13,10.1016/j.ijrobp.2015.11.025,,,,26867889,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4790381,https://api.altmetric.com/v1/donut/4790381_240.png 3,"3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system.",Journal of Bioenergetics & Biomembranes,,,Article,2015-11-03,10.1007/s10863-015-9631-y,,,,26530987,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4749440,https://api.altmetric.com/v1/donut/4749440_240.png 3,The Role of Exercise Training in Men With Prostate Cancer,Topics in Geriatric Rehabilitation,,,Article,2015-01-01,10.1097/tgr.0000000000000083,,,http://journals.lww.com/topicsingeriatricrehabilitation/Fulltext/2015/10000/The_Role_of_Exercise_Training_in_Men_With_Prostate.3.aspx,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4703724,https://api.altmetric.com/v1/donut/4703724_240.png 3,MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer,Journal of Clinical Medicine,,,Article,2015-10-21,10.3390/jcm4101853,,,,26506397,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4656296,https://api.altmetric.com/v1/donut/4656296_240.png 3,Prostate cancer: How to differenti-8 Gleason scores?,Nature Reviews Urology,,,Article,2015-10-06,10.1038/nrurol.2015.245,,,,26439507,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4591701,https://api.altmetric.com/v1/donut/4591701_240.png 3,Occult High-Risk Disease in Clinically Low-Risk Prostate Cancer with ?50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low-Risk?,Urology,,,Article,2015-09-24,10.1016/j.urology.2015.08.026,,,,26391387,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4530301,https://api.altmetric.com/v1/donut/4530301_240.png 3,Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer,European Journal of Cancer (1965),,,Article,2015-01-09,10.1016/j.ejca.2015.06.128,,,,26208462,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4426141,https://api.altmetric.com/v1/donut/4426141_240.png 3,Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti–Prostate Cancer Activity,Clinical Cancer Research,,,Article,2015-08-22,10.1158/1078-0432.ccr-15-0824,,,,26289068,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4416976,https://api.altmetric.com/v1/donut/4416976_240.png 3,Cardiovascular effects of hormone therapy for prostate cancer.,"Drug, Healthcare and Patient Safety",,,Article,2015-07-23,10.2147/dhps.s50549,,,,26229507,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4352123,https://api.altmetric.com/v1/donut/4352123_240.png 3,Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice,Urology Practice,,,Article,2015-07-01,10.1016/j.urpr.2014.11.001,,,,26925454,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4320999,https://api.altmetric.com/v1/donut/4320999_240.png 3,Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method.,Tumori,,,Article,2015-07-16,10.5301/tj.5000389,,,,26166221,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4285631,https://api.altmetric.com/v1/donut/4285631_240.png 3,Prostate Cancer: Observational-Study Evidence Continues to Mount—ADT Associated with Increased Cardiovascular Risk,Oncology times,,,Article,2015-07-25,10.1097/01.cot.0000470197.17137.ae,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4279312,https://api.altmetric.com/v1/donut/4279312_240.png 3,10-year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate Specific Antigen Screening Era.,Urology,,,Article,2015-07-15,10.1016/j.urology.2015.05.034,,,,26163812,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4258129,https://api.altmetric.com/v1/donut/4258129_240.png 3,Docosahexaenoic acid inhibits the growth of hormone-dependent prostate cancer cells by promoting the degradation of the androgen receptor.,Molecular Medicine Reports,,,Article,,10.3892/mmr.2015.3813,,,,25997493,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4226720,https://api.altmetric.com/v1/donut/4226720_240.png 3,SBRT: An Opportunity to Improve Quality of Life for Oligometastatic Prostate Cancer.,Frontiers in oncology,,,Article,2015-05-05,10.3389/fonc.2015.00101,,,,26000249,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3969260,https://api.altmetric.com/v1/donut/3969260_240.png 3,The 21st Annual Prostate Cancer Foundation Scientific Retreat report.,The Prostate,,,Article,2015-04-20,10.1002/pros.22993,,,,25893521,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3953866,https://api.altmetric.com/v1/donut/3953866_240.png 3,Targeting the interleukin?11 receptor ? in metastatic prostate cancer: A first?in?man study,Cancer (0008543X),,,Article,2015-04-01,10.1002/cncr.29344,,,,25832466,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3860678,https://api.altmetric.com/v1/donut/3860678_240.png 3,PROMIS - Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.,Contemporary Clinical Trials,,,Article,2015-03-03,10.1016/j.cct.2015.02.008,,,,25749312,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3831495,https://api.altmetric.com/v1/donut/3831495_240.png 3,Dietary Polyphenols in Prevention and Treatment of Prostate Cancer,International Journal of Molecular Sciences,,,Article,2015-02-03,10.3390/ijms16023350,,,,25654230,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/3395173,https://api.altmetric.com/v1/donut/3395173_240.png 3,A single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score,Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/hyu186,,,,25381383,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3241038,https://api.altmetric.com/v1/donut/3241038_240.png 3,Targeted biopsy boosts detection of high-risk prostate cancer,Lancet Oncology,,,Article,,10.1016/s1470-2045(15)70022-7,,,,,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3167636,https://api.altmetric.com/v1/donut/3167636_240.png 3,"Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom?related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial",British Journal of Urology,,,Article,2015-01-20,10.1111/bju.13050,,,,25601300,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3082876,https://api.altmetric.com/v1/donut/3082876_240.png 3,Is robotic arm stereotactic body radiation therapy ‘virtual high-dose rate brachytherapy’ effective for prostate cancer? An analysis of comparative effectiveness using published data,Expert Review of Medical Devices,,,Article,2014-12-31,10.1586/17434440.2015.994606,,,,25540018,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3043298,https://api.altmetric.com/v1/donut/3043298_240.png 3,MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers,BMC Cancer,,,Article,2014-12-10,10.1186/1471-2407-14-930,,,,25496077,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2971908,https://api.altmetric.com/v1/donut/2971908_240.png 3,Estimating Preferences for Treatments in Patients With Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-02,10.1016/j.ijrobp.2014.09.044,,,,25491504,,,,,,,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2959811,https://api.altmetric.com/v1/donut/2959811_240.png 3,Multiparametric Magnetic Resonance Imaging and Image-Guided Biopsy to Detect Seminal Vesicle Invasion by Prostate Cancer.,Journal of Endourology,,,Article,2014-07-11,10.1089/end.2014.0250,,,,25010361,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2940341,https://api.altmetric.com/v1/donut/2940341_240.png 3,"Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer",American Journal of Pathology,,,Article,2014-11-25,10.1016/j.ajpath.2014.10.012,,,,25432062,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2924874,https://api.altmetric.com/v1/donut/2924874_240.png 3,Stereotactic body radiation therapy for prostate cancer: Rational and reasonable,Practical Radiation Oncology,,,Article,,10.1016/j.prro.2014.08.018,,,,25413392,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2793815,https://api.altmetric.com/v1/donut/2793815_240.png 3,Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2014-09-22,10.1016/j.clgc.2014.08.014,,,,25450039,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2783885,https://api.altmetric.com/v1/donut/2783885_240.png 3,Extended Followup and Risk Factors for Disease Reclassification in a Large Active Surveillance Cohort for Localized Prostate Cancer,The Journal of Urology,,,Article,2014-09-28,10.1016/j.juro.2014.09.094,,,,25261803,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2729504,https://api.altmetric.com/v1/donut/2729504_240.png 3,A Novel Method for Intraoperative Sentinel Lymph Node Detection in Prostate Cancer Patients Using Superparamagnetic Iron Oxide Nanoparticles and a Handheld Magnetometer: The Initial Clinical Experience,Annals of Surgical Oncology,,,Article,2014-09-06,10.1245/s10434-014-4024-8,,,,25190119,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2664957,https://api.altmetric.com/v1/donut/2664957_240.png 3,Preoperative 3-T Diffusion-Weighted MRI for the Qualitative and Quantitative Assessment of Extracapsular Extension in Patients With Intermediate- or High-Risk Prostate Cancer,American Journal of Roentgenology,,,Article,2014-09-01,10.2214/ajr.13.11754,,,,25148185,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2624898,https://api.altmetric.com/v1/donut/2624898_240.png 3,Tea and lycopene protect against prostate cancer.,Asia Pacific Journal of Clinical Nutrition,,,Article,2007-03-30,,,,,17392149,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2623694,https://api.altmetric.com/v1/donut/2623694_240.png 3,Wnt signaling in castration-resistant prostate cancer: implications for therapy.,American journal of clinical and experimental urology,,,Article,2014-04-15,,,,,25143959,,,,,,,0,0,0,4,0,0,0,0,2,0,0,0,0,0,0,1,https://www.altmetric.com/details/2618935,https://api.altmetric.com/v1/donut/2618935_240.png 3,Prostate cancer: Optimizing fluorescence guidance in sentinel node biopsy.,Nature Reviews Urology,,,Article,2014-08-19,10.1038/nrurol.2014.217,,,,25134831,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2614226,https://api.altmetric.com/v1/donut/2614226_240.png 3,Metastatic Prostate Cancer: Chemohormonal Therapy Extends Survival by More than a Year,Oncology times,,,Article,2014-07-25,10.1097/01.cot.0000452589.50386.c1,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2575867,https://api.altmetric.com/v1/donut/2575867_240.png 3,Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer.,Future Oncology,,,Article,2014-07-29,10.2217/fon.14.157,,,,25075962,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2556066,https://api.altmetric.com/v1/donut/2556066_240.png 3,Incidence of second malignancies for prostate cancer.,PLoS ONE,,,Article,2014-07-21,10.1371/journal.pone.0102596,,,,25047238,PMC4105414,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2530485,https://api.altmetric.com/v1/donut/2530485_240.png 3,Population-based analysis of treatment modalities and survival for clinically localized small-cell carcinoma of the prostate,Prostate Cancer & Prostatic Diseases,,,Article,2014-07-15,10.1038/pcan.2014.26,,,,25027862,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2510206,https://api.altmetric.com/v1/donut/2510206_240.png 3,The role of microRNA in castration-resistant prostate cancer,Urologic Oncology,,,Article,2014-06-18,10.1016/j.urolonc.2013.11.004,,,,24935732,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2451075,https://api.altmetric.com/v1/donut/2451075_240.png 3,Circumcision unlikely to be associated with prostate cancer risk,Cancer (0008543X),,,Article,2012-06-30,10.1002/cncr.27711,,,,22744840,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2390758,https://api.altmetric.com/v1/donut/2390758_240.png 3,'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.,Psycho-Oncology,,,Article,2014-05-15,10.1002/pon.3576,,,,24830805,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2375333,https://api.altmetric.com/v1/donut/2375333_240.png 3,Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system,Radiation Oncology,,,Article,2014-05-21,10.1186/1748-717x-9-118,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2368464,https://api.altmetric.com/v1/donut/2368464_240.png 3,The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-05-10,10.1158/1055-9965.epi-13-0568,,,,24812039,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2344074,https://api.altmetric.com/v1/donut/2344074_240.png 3,Recent advances in bone-targeted therapies of metastatic prostate cancer,Cancer Treatment Reviews,,,Article,2014-04-16,10.1016/j.ctrv.2014.04.003,,,,24767837,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2313612,https://api.altmetric.com/v1/donut/2313612_240.png 3,Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies,International Journal of Urology,,,Article,2014-04-15,10.1111/iju.12458,,,,24735055,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2283898,https://api.altmetric.com/v1/donut/2283898_240.png 3,One Size Does Not Fit All: Can We Choose the Best Sequence of Treatment in Asymptomatic Castration-resistant Prostate Cancer Patients?,European Urology,,,Article,,10.1016/j.eururo.2014.03.024,,,,24735730,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2227058,https://api.altmetric.com/v1/donut/2227058_240.png 3,Variation in use of active surveillance among men undergoing expectant management for early-stage prostate cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.01.105,,,,24518783,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2177467,https://api.altmetric.com/v1/donut/2177467_240.png 3,Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents.,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.11.044,,,,24411987,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2124839,https://api.altmetric.com/v1/donut/2124839_240.png 3,"Phase 1/2 Trial of Orteronel (TAK-700) - an Investigational 17,20-Lyase Inhibitor - in Patients with Metastatic Castration-Resistant Prostate Cancer",Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-2436,,,,24418642,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2042471,https://api.altmetric.com/v1/donut/2042471_240.png 3,Prostate Cancer: Diffusion-Weighted Imaging Versus Dynamic-Contrast Enhanced Imaging for Tumor Localization-A Meta-Analysis,Journal of Computer Assisted Tomography,,,Article,1970-01-01,10.1097/rct.0b013e3182a3f9c7,,,,24270122,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1984094,https://api.altmetric.com/v1/donut/1984094_240.png 3,Inhibition of PARP1 by small interfering RNA enhances docetaxel activity against human prostate cancer PC3 cells.,Biochemical & Biophysical Research Communications,,,Article,2013-11-15,10.1016/j.bbrc.2013.11.027,,,,24239883,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1964997,https://api.altmetric.com/v1/donut/1964997_240.png 3,Prostate cancer: Vitamin D receptor agonist reduces intracrine androgens,Nature Reviews Urology,,,Article,2013-12-03,10.1038/nrurol.2013.295,,,,24296709,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1955220,https://api.altmetric.com/v1/donut/1955220_240.png 3,Re: Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial,The Journal of Urology,,,Article,2013-12-04,10.1016/j.juro.2013.11.088,,,,24522035,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1954923,https://api.altmetric.com/v1/donut/1954923_240.png 3,Declining use of brachytherapy for the treatment of prostate cancer,Brachytherapy,,,Article,2013-09-19,10.1016/j.brachy.2013.08.005,,,,24050892,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1855946,https://api.altmetric.com/v1/donut/1855946_240.png 3,PLASMA SELENIUM LEVEL BEFORE DIAGNOSIS AND THE RISK OF PROSTATE CANCER DEVELOPMENT,The Journal of Urology,,,Article,2002-01-01,,,,,11696701,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1824324,https://api.altmetric.com/v1/donut/1824324_240.png 3,Prostate cancer: Understanding why,Nature Reviews Cancer,,,Article,2013-10-10,10.1038/nrc3615,,,,24108098,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1817302,https://api.altmetric.com/v1/donut/1817302_240.png 3,Gay Men and Prostate Cancer: Invisible Diversity,Journal of Clinical Oncology,,,Article,2005-01-01,10.1200/jco.2005.00.968,,,,15837977,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1804398,https://api.altmetric.com/v1/donut/1804398_240.png 3,"Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada",Journal of Cancer Survivorship,,,Article,2013-08-28,10.1007/s11764-013-0305-7,,,,23975612,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1734303,https://api.altmetric.com/v1/donut/1734303_240.png 3,Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy.,Journal of the American Association of Nurse Practitioners,,,Article,2013-08-26,10.1002/2327-6924.12066,,,,24170604,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1717047,https://api.altmetric.com/v1/donut/1717047_240.png 3,Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells,Clinical Epigenetics,,,Article,2011-01-01,10.1186/1868-7083-3-3,,,,22303414,PMC3257546,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1693508,https://api.altmetric.com/v1/donut/1693508_240.png 3,Tumor Lesion Diameter on Diffusion Weighted Magnetic Resonance Imaging Could Help Predict Insignificant Prostate Cancer in Patients Eligible for Active Surveillance: Preliminary Analysis,The Journal of Urology,,,Article,2013-05-30,10.1016/j.juro.2013.03.127,,,,23727188,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1520364,https://api.altmetric.com/v1/donut/1520364_240.png 3,Particular DNA changes linked with prostate cancer development and lethality,ecancer.org,,,Article,,,,,http://ecancer.org/news/4015-particular-dna-changes-linked-with-prostate-cancer-development-and-lethality.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1403808,https://api.altmetric.com/v1/donut/1403808_240.png 3,The Worldwide Epidemiology of Prostate Cancer: Perspectives from Autopsy Studies,Canadian Journal of Urology,,,Article,2008-02-01,,,,,18304396,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,121,https://www.altmetric.com/details/1262234,https://api.altmetric.com/v1/donut/1262234_240.png 3,Proposed mechanisms of action for prostate cancer vaccines,Nature Reviews Urology,,,Article,2013-02-12,10.1038/nrurol.2013.8,,,,23399727,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1234176,https://api.altmetric.com/v1/donut/1234176_240.png 3,New insights into prostate cancer stem cells.,Cell Cycle,,,Article,2013-02-02,,,,,23370446,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1216722,https://api.altmetric.com/v1/donut/1216722_240.png 3,Case-control study of lifetime alcohol intake and prostate cancer risk.,Cancer Causes and Control,,,Article,2012-12-28,10.1007/s10552-012-0131-7,,,,23271409,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1146914,https://api.altmetric.com/v1/donut/1146914_240.png 3,Clinical Implementation Of Quality Of Life Instruments And Prediction Tools For Localized Prostate Cancer: Results From A National Survey Of Radiation Oncologists And Urologists.,The Journal of Urology,,,Article,2012-12-03,10.1016/j.juro.2012.11.174,,,,23219546,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1120259,https://api.altmetric.com/v1/donut/1120259_240.png 3,Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer,Radiation Oncology,,,Article,2012-11-20,10.1186/1748-717x-7-194,,,,23164305,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1078150,https://api.altmetric.com/v1/donut/1078150_240.png 3,"Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.",Molecular Biology Reports,,,Article,2012-10-10,10.1007/s11033-012-2023-z,,,,23054000,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/999336,https://api.altmetric.com/v1/donut/999336_240.png 3,Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostateâ??specific antigen expression and secretion,International Journal of Cancer,,,Article,2012-01-01,10.1002/ijc.27811,,,,22945374,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/928268,https://api.altmetric.com/v1/donut/928268_240.png 3,KHC-4 Anti-Cancer Effects on Human PC3 Prostate Cancer Cell Line.,American Journal of Chinese Medicine,,,Article,2012-08-31,10.1142/s0192415x12500784,,,,22928835,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/927232,https://api.altmetric.com/v1/donut/927232_240.png 3,Quality-of-life effects of screening for prostate cancer,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70386-8,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/912472,https://api.altmetric.com/v1/donut/912472_240.png 3,Comparative Effectiveness of External-Beam Radiation Approaches for Prostate Cancer.,European Urology,,,Article,2012-07-06,10.1016/j.eururo.2012.06.055,,,,22790288,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/841055,https://api.altmetric.com/v1/donut/841055_240.png 3,Variants and Unusual Patterns of Prostate Cancer: Clinicopathologic and Differential Diagnostic Considerations,Advances in Anatomic Pathology,,,Article,2012-07-01,10.1097/pap.0b013e31825c6b92,,,,22692283,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/801715,https://api.altmetric.com/v1/donut/801715_240.png 3,National Comprehensive Cancer Network Practice Guidelines 2011: Need for More Accurate Recommendations for Pelvic Lymph Node Dissection in Prostate Cancer,The Journal of Urology,,,Article,2012-06-14,10.1016/j.juro.2012.03.129,,,,22698627,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/792353,https://api.altmetric.com/v1/donut/792353_240.png 3,Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse.,Health Affairs,,,Article,2012-01-01,10.1377/hlthaff.2011.1062,,,,22492892,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/692686,https://api.altmetric.com/v1/donut/692686_240.png 3,"Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.",Breast Cancer Research and Treatment,,,Article,2012-02-14,10.1007/s10549-012-1972-1,,,,22331481,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/610884,https://api.altmetric.com/v1/donut/610884_240.png 3,PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-11-2189,,,,22114138,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/606165,https://api.altmetric.com/v1/donut/606165_240.png 3,Frequency and determinants of disagreement and error in gleason scores: A population-based study of prostate cancer.,The Prostate,,,Article,2012-01-11,10.1002/pros.22484,,,,22228120,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/550528,https://api.altmetric.com/v1/donut/550528_240.png 3,A prospective study of physical activity and incident and fatal prostate cancer.,Archives of Internal Medicine,,,Article,2005-05-09,10.1001/archinte.165.9.1005,,,,15883238,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/480410,https://api.altmetric.com/v1/donut/480410_240.png 3,MNX1: a novel prostate cancer oncogene,Lancet Oncology,,,Article,2016-10-01,10.1016/s1470-2045(16)30553-8,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13091387,https://api.altmetric.com/v1/donut/13091387_240.png 3,Using a Mystery-Caller Approach to Examine Access to Prostate Cancer Care in Philadelphia,PLoS ONE,,,Article,2016-10-10,10.1371/journal.pone.0164411,,,,27723780,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12569742,https://api.altmetric.com/v1/donut/12569742_240.png 3,Paired high-content analysis of prostate cancer cells in bone marrow and blood characterizes increased androgen receptor expression in tumor cell clusters,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-1355,,,,27702818,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12445256,https://api.altmetric.com/v1/donut/12445256_240.png 3,Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review,BMC Health Services Research,,,Article,2016-10-03,10.1186/s12913-016-1781-z,,,,27716267,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12430409,https://api.altmetric.com/v1/donut/12430409_240.png 3,A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer.,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-0987,,,,27683182,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12283615,https://api.altmetric.com/v1/donut/12283615_240.png 3,68Ga-PSMA-11 PET as a gate-keeper for the treatment of metastatic prostate cancer with radium-223: proof of concept,Journal of Nuclear Medicine,,,Article,2016-09-22,10.2967/jnumed.116.178533,,,,27660148,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12185008,https://api.altmetric.com/v1/donut/12185008_240.png 3,Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.,Cancer Imaging,,,Article,2016-09-02,10.1186/s40644-016-0085-1,,,,27581366,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11002655,https://api.altmetric.com/v1/donut/11002655_240.png 3,TCNQ-Doped Cu-Metal Organic Framework as a Novel Conductometric Immunosensing Platform for the Quantification of Prostate Cancer Antigen,Sensors & Actuators B: Chemical,,,Article,2016-08-01,10.1016/j.snb.2016.08.138,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10897984,https://api.altmetric.com/v1/donut/10897984_240.png 3,Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles,International Journal of Nanomedicine,,,Article,2016-08-12,10.2147/ijn.s112951,,,,27574424,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10515547,https://api.altmetric.com/v1/donut/10515547_240.png 3,Metastatic progression of prostate cancer is mediated by autonomous binding of galectin-4-O-glycan to cancer cells,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-0641,,,,27485450,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10250703,https://api.altmetric.com/v1/donut/10250703_240.png 3,Clinical Use of EPIC for Clinical Practice (EPIC-CP) to Assess Patient-Reported Prostate Cancer Quality-of-Life Following Robot-Assisted Radical Prostatectomy,The Journal of Urology,,,Article,2016-07-27,10.1016/j.juro.2016.07.080,,,,27475967,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10120452,https://api.altmetric.com/v1/donut/10120452_240.png 3," 68 Ga-HBED-CC-PSMA PET/CT Versus Histopathology In Primary Localized Prostate Cancer: A Voxel-Wise Comparison ",Theranostics,,,Article,2016-01-01,10.7150/thno.15344,,,,27446496,PMC4955061,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10010078,https://api.altmetric.com/v1/donut/10010078_240.png 3,Thermally Reduced Graphene Oxide Nanohybrids of Chiral Functional Naphthalenediimides for Prostate Cancer Cells Bioimaging,Advanced Functional Materials,,,Article,2016-06-01,10.1002/adfm.201601123,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9503820,https://api.altmetric.com/v1/donut/9503820_240.png 3,Influence of Four Radiotracers in PET/CT on Diagnostic Accuracy for Prostate Cancer: A Bivariate Random-Effects Meta-Analysis,Cellular Physiology & Biochemistry,,,Article,2016-07-07,10.1159/000445639,,,,27383216,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9340159,https://api.altmetric.com/v1/donut/9340159_240.png 3,Oncology EDGE Task Force on Prostate Cancer Outcomes: A Systematic Review of Outcome Measures for Functional Mobility,Rehabilitation Oncology,,,Article,2016-07-01,10.1097/01.reo.0000000000000029,,,http://journals.lww.com/rehabonc/Fulltext/2016/07000/Oncology_EDGE_Task_Force_on_Prostate_Cancer.3.aspx,,,,,,,,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9156936,https://api.altmetric.com/v1/donut/9156936_240.png 3,Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2016-06-21,10.1158/1078-0432.ccr-16-1137,,,,27330057,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8990873,https://api.altmetric.com/v1/donut/8990873_240.png 3,Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk,JNCI: Journal of the National Cancer Institute,,,Article,2016-11-01,10.1093/jnci/djw141,,,,27297429,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8719980,https://api.altmetric.com/v1/donut/8719980_240.png 3,"Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases",Andrology,,,Article,2016-05-01,10.1111/andr.12196,,,,27260185,,,,,,,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8545683,https://api.altmetric.com/v1/donut/8545683_240.png 3,Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects,Cancer Research,,,Article,2016-05-25,10.1158/0008-5472.can-15-3173,,,,27216195,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8142943,https://api.altmetric.com/v1/donut/8142943_240.png 3,High-Resolution Diffusion-Weighted Imaging Increases Prostate Cancer Visibility?,EBioMedicine,,,Article,2016-04-16,10.1016/j.ebiom.2016.04.015,,,,27322448,PMC4909480,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6775416,https://api.altmetric.com/v1/donut/6775416_240.png 3,Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer,BMJ Open,,,Article,2016-04-15,10.1136/bmjopen-2015-010332,,,,27084275,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6765470,https://api.altmetric.com/v1/donut/6765470_240.png 3,Re: Clinical Outcomes of Helical Tomotherapy for Super-Elderly Patients with Localized and Locally Advanced Prostate Cancer: Comparison with Patients under 80 Years of Age,The Journal of Urology,,,Article,2016-04-14,10.1016/j.juro.2016.04.015,,,,27321509,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6726981,https://api.altmetric.com/v1/donut/6726981_240.png 3,"Re: Annual Medical Expenditure and Productivity Loss among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States",The Journal of Urology,,,Article,2016-04-13,10.1016/j.juro.2016.04.030,,,,27321506,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6661748,https://api.altmetric.com/v1/donut/6661748_240.png 3,Prostate cancer urine assay could spare biopsies ,Lancet Oncology,,,Article,2016-04-07,10.1016/s1470-2045(16)30046-8,,,,27067830,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6557588,https://api.altmetric.com/v1/donut/6557588_240.png 3,REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8433,,,,27034167,PMC5041970,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6439037,https://api.altmetric.com/v1/donut/6439037_240.png 3,Early Salvage Radiation Extends Prostate Cancer Survival,Oncology times,,,Article,2016-03-10,10.1097/01.cot.0000481876.84617.71,,,http://journals.lww.com/oncology-times/Fulltext/2016/03100/Early_Salvage_Radiation_Extends_Prostate_Cancer.14.aspx,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6413919,https://api.altmetric.com/v1/donut/6413919_240.png 3,Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer,Journal of Clinical Oncology,,,Article,2016-03-21,10.1200/jco.2015.66.3237,,,,27001587,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6370682,https://api.altmetric.com/v1/donut/6370682_240.png 3,Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer,Genomics Data,,,Article,2016-03-01,10.1016/j.gdata.2015.12.020,,,,26981385,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6204600,https://api.altmetric.com/v1/donut/6204600_240.png 3,Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study,American Journal of Roentgenology,,,Article,,10.2214/ajr.15.14967,,,,26901012,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6006714,https://api.altmetric.com/v1/donut/6006714_240.png 3,MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer,Cancer Cell International,,,Article,2016-02-19,10.1186/s12935-016-0285-6,,,,26900347,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5974797,https://api.altmetric.com/v1/donut/5974797_240.png 3,Chemotherapy at First Diagnosis of Advanced Prostate Cancer – Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer ,Clinical Oncology,,,Article,2016-02-01,10.1016/j.clon.2016.01.006,,,,26874654,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5308772,https://api.altmetric.com/v1/donut/5308772_240.png 3,Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7,JNCI: Journal of the National Cancer Institute,,,Article,2016-07-01,10.1093/jnci/djw005,,,,26857528,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5111544,https://api.altmetric.com/v1/donut/5111544_240.png 3,Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer,BMC Cancer,,,Article,2016-02-05,10.1186/s12885-016-2075-x,,,,26850040,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5100645,https://api.altmetric.com/v1/donut/5100645_240.png 3,Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients,Genome Biology (Online Edition),,,Article,2016-01-26,10.1186/s13059-015-0864-1,,,,26813233,PMC4729137,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/5050097,https://api.altmetric.com/v1/donut/5050097_240.png 3,Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations,The Journal of Urology,,,Article,2016-01-01,10.1016/j.juro.2016.01.053,,,,27302782,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5029094,https://api.altmetric.com/v1/donut/5029094_240.png 3,Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-12,10.1038/pcan.2015.63,,,,26754263,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4985609,https://api.altmetric.com/v1/donut/4985609_240.png 3,The Case for Tailored Prostate Cancer Screening: An NCCN Perspective,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2015-12-01,,,,,26656524,,,,,,,0,0,0,1,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/4885756,https://api.altmetric.com/v1/donut/4885756_240.png 3,It Is Time to Harmonize the Design and Conduct of Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer,European Urology,,,Article,2015-12-10,10.1016/j.eururo.2015.11.025,,,,26683759,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4860148,https://api.altmetric.com/v1/donut/4860148_240.png 3,The Cancer-Promoting Gene Fatty Acid-Binding Protein 5 (FABP5) is Epigenetically Regulated During Human Prostate Carcinogenesis,Biochemical Journal,,,Article,2015-11-29,10.1042/bj20150926,,,,26614767,,,,,,,0,0,0,14,0,0,6,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4819400,https://api.altmetric.com/v1/donut/4819400_240.png 3,Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial,Cancer Causes and Control,,,Article,2015-11-20,10.1007/s10552-015-0695-0,,,,26589415,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/4789665,https://api.altmetric.com/v1/donut/4789665_240.png 3,"BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.",JNCI: Journal of the National Cancer Institute,,,Article,2016-02-01,10.1093/jnci/djv315,,,,26586665,,1854/LU-7158225,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4786540,https://api.altmetric.com/v1/donut/4786540_240.png 3,The current use of Active Surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry.,British Journal of Urology,,,Article,2015-01-19,10.1111/bju.13049,,,,25601201,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4756899,https://api.altmetric.com/v1/donut/4756899_240.png 3,Re: Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis,The Journal of Urology,,,Article,2015-11-02,10.1016/j.juro.2015.10.149,,,,26852977,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4716325,https://api.altmetric.com/v1/donut/4716325_240.png 3,Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions,Expert Review of Vaccines,,,Article,2015-10-22,10.1586/14760584.2015.1099437,,,,26488270,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4660700,https://api.altmetric.com/v1/donut/4660700_240.png 3,Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.,Oncotarget,,,Article,2015-10-21,10.18632/oncotarget.5554,,,,26485759,PMC4741850,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4653767,https://api.altmetric.com/v1/donut/4653767_240.png 3,Prostate cancer: Growth of AS in the USA signals reduction in overtreatment,Nature Reviews Urology,,,Article,2015-09-22,10.1038/nrurol.2015.236,,,,26390970,,,,,,,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,8,https://www.altmetric.com/details/4539348,https://api.altmetric.com/v1/donut/4539348_240.png 3,Epigenetic Regulation of Steroid Inactivating UDP-Glucuronosyltransferases by microRNAs in Prostate Cancer.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2015-09-20,10.1016/j.jsbmb.2015.09.021,,,,26385605,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4533713,https://api.altmetric.com/v1/donut/4533713_240.png 3,Human endogenous retrovirus HERV?K(HML?2) activity in prostate cancer is dominated by a few loci,The Prostate,,,Article,2015-09-19,10.1002/pros.23095,,,,26384005,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4531324,https://api.altmetric.com/v1/donut/4531324_240.png 3,PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.,The Prostate,,,Article,2015-09-01,10.1002/pros.23096,,,,26384170,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/4530934,https://api.altmetric.com/v1/donut/4530934_240.png 3,Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.,Oncotarget,,,Article,2015-09-17,10.18632/oncotarget.5056,,,,26375444,PMC4741617,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4523217,https://api.altmetric.com/v1/donut/4523217_240.png 3,ATM Inhibition Potentiates Death of Androgen Receptor-inactivated Prostate Cancer Cells with Telomere Dysfunction,Journal of Biological Chemistry,,,Article,2015-10-16,10.1074/jbc.m115.671404,,,,26336104,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4478696,https://api.altmetric.com/v1/donut/4478696_240.png 3,Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients.,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2015-09-12,10.1155/2015/480369,,,,26357522,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4433797,https://api.altmetric.com/v1/donut/4433797_240.png 3,"Egg intake and cancers of the breast, ovary and prostate: a dose–response meta-analysis of prospective observational studies",British Journal of Nutrition,,,Article,2015-08-22,10.1017/s0007114515002135,,,,26293984,,,,,,,0,0,0,3,0,0,7,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4423453,https://api.altmetric.com/v1/donut/4423453_240.png 3,CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer,Clinical Cancer Research,,,Article,2015-08-09,10.1158/1078-0432.ccr-15-1181,,,,26253870,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4375597,https://api.altmetric.com/v1/donut/4375597_240.png 3,"Associations of Body Mass Index, Smoking, and Alcohol Consumption With Prostate Cancer Mortality in the Asia Cohort Consortium",American Journal of Epidemiology,,,Article,2015-08-04,10.1093/aje/kwv089,,,,26243736,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4370277,https://api.altmetric.com/v1/donut/4370277_240.png 3,Survivin mRNA-circulating tumor cells are associated with prostate cancer metastasis.,Tumor Biology,,,Article,2015-08-06,10.1007/s13277-015-3812-5,,,,26242261,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4365266,https://api.altmetric.com/v1/donut/4365266_240.png 3,"Effects of Patient Centered Interventions on Persistent Urinary Incontinence after Prostate Cancer Treatment: A Randomized, Controlled Trial",The Journal of Urology,,,Article,2015-08-02,10.1016/j.juro.2015.07.090,,,,26231554,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4338896,https://api.altmetric.com/v1/donut/4338896_240.png 3,The FORECAST Study - Focal Recurrent Assessment and Salvage Treatment for Radiorecurrent Prostate Cancer,Contemporary Clinical Trials,,,Article,,10.1016/j.cct.2015.07.004,,,,26184343,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4295668,https://api.altmetric.com/v1/donut/4295668_240.png 3,Re: Shear Wave Elastography for Localization of Prostate Cancer Lesions and Assessment of Elasticity Thresholds: Implications for Targeted Biopsies and Active Surveillance Protocols,The Journal of Urology,,,Article,2015-07-03,10.1016/j.juro.2015.04.084,,,,26133562,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4225568,https://api.altmetric.com/v1/donut/4225568_240.png 3,Hsp27 regulates EGF/??catenin mediated epithelial to mesenchymal transition in prostate cancer,International Journal of Cancer,,,Article,2014-12-04,10.1002/ijc.29122,,,,25130271,,,,,,,0,0,0,28,0,0,5,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/4202834,https://api.altmetric.com/v1/donut/4202834_240.png 3,Image-guided radiotherapy for prostate cancer using 3 different techniques: localization data of 186 patients.,Tumori,,,Article,,10.5301/tj.5000322,,,,25908027,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4202501,https://api.altmetric.com/v1/donut/4202501_240.png 3,Metformin induces ER stress-dependent apoptosis through miR-708-5p|[sol]|NNAT pathway in prostate cancer,Oncogenesis,,,Article,2015-01-01,10.1038/oncsis.2015.18,,,,26075749,,,,,,,0,0,0,3,0,0,4,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4167031,https://api.altmetric.com/v1/donut/4167031_240.png 3,A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer,Cancer Management and Research,,,Article,2015-06-26,10.2147/cmar.s50585,,,,26109877,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4163763,https://api.altmetric.com/v1/donut/4163763_240.png 3,"MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells.",Cellular and molecular biology,,,Article,2015-06-13,,,,,26068914,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4144997,https://api.altmetric.com/v1/donut/4144997_240.png 3,Radical Prostatectomy for Locally Advanced Prostate Cancer: Current Status,Urology,,,Article,2015-06-07,10.1016/j.urology.2015.03.012,,,,26048432,,,,,,,0,0,0,4,0,0,3,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4085244,https://api.altmetric.com/v1/donut/4085244_240.png 3,Sexual Healing in Patients with Prostate Cancer on Hormone Therapy,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2015-06-18,10.14694/edbook_am.2015.35.e562,,,,25993223,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4071618,https://api.altmetric.com/v1/donut/4071618_240.png 3,Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study,Urologic Oncology,,,Article,2015-01-07,10.1016/j.urolonc.2015.04.003,,,,25960412,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4016428,https://api.altmetric.com/v1/donut/4016428_240.png 3,68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-05-17,10.1007/s00259-015-3078-6,,,,25975367,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/4003571,https://api.altmetric.com/v1/donut/4003571_240.png 3,Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression,American Journal of Pathology,,,Article,2015-01-07,10.1016/j.ajpath.2015.03.015,,,,25956032,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3989525,https://api.altmetric.com/v1/donut/3989525_240.png 3,Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis,Biochemical Journal,,,Article,2015-05-05,10.1042/bj20150122,,,,25940306,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3968843,https://api.altmetric.com/v1/donut/3968843_240.png 3,Modulation of cell growth and apoptosis response in human prostate cancer cells supplemented with tocotrienols,European Journal of Lipid Science and Technology,,,Article,2008-01-18,10.1002/ejlt.200700068,,,,,,,,,,,0,0,0,0,0,0,1,0,2,0,0,0,0,0,0,8,https://www.altmetric.com/details/3914359,https://api.altmetric.com/v1/donut/3914359_240.png 3,Re: Ion Channel TRPM8 Promotes Hypoxic Growth of Prostate Cancer Cells via an O2-Independent and RACK1-Mediated Mechanism of HIF-1? Stabilization,The Journal of Urology,,,Article,2015-06-20,10.1016/j.juro.2015.04.027,,,,26088253,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3908518,https://api.altmetric.com/v1/donut/3908518_240.png 3,Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.,Urologic Oncology,,,Article,2015-06-01,10.1016/j.urolonc.2015.03.007,,,,25858102,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3908288,https://api.altmetric.com/v1/donut/3908288_240.png 3,Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series.,Case Reports in Oncological Medicine,,,Article,2015-01-01,10.1155/2015/471861,,,,25861496,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3902880,https://api.altmetric.com/v1/donut/3902880_240.png 3,"Re: Arun A. Azad, Bernhard J. Eigl, Raya Leibowitz-Amit, et al. Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status. Eur Urol 2015;67:441–7",European Urology,,,Article,2015-04-14,10.1016/j.eururo.2015.03.043,,,,25865060,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3894918,https://api.altmetric.com/v1/donut/3894918_240.png 3,Aldehyde Dehydrogenase Is Regulated by ?-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells,Cancer Research,,,Article,2015-02-10,10.1158/0008-5472.can-14-1924,,,,25670168,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3858309,https://api.altmetric.com/v1/donut/3858309_240.png 3,Role of 3T multiparametric magnetic resonance imaging without endorectal coil in the detection of local recurrent prostate cancer after radical prostatectomy: the radiation oncology point of view.,Scandinavian journal of urology,,,Article,2015-02-04,10.3109/21681805.2015.1004643,,,,25652562,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3856270,https://api.altmetric.com/v1/donut/3856270_240.png 3,"PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy",Cancer Research,,,Article,2015-03-25,10.1158/0008-5472.can-14-3602,,,,25808865,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3847262,https://api.altmetric.com/v1/donut/3847262_240.png 3,"Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212–9",European Urology,,,Article,2015-03-19,10.1016/j.eururo.2015.03.018,,,,25801051,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3812498,https://api.altmetric.com/v1/donut/3812498_240.png 3,Models for predicting objective function weights in prostate cancer IMRT,Medical Physics,,,Article,2015-03-17,10.1118/1.4914140,,,,25832049,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3799514,https://api.altmetric.com/v1/donut/3799514_240.png 3,Re: Testosterone Replacement Therapy in Men with Prostate Cancer: A Time-Varying Analysis,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.03.067,,,,25986797,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3789463,https://api.altmetric.com/v1/donut/3789463_240.png 3,Re: Low Incidence of New Biochemical Hypogonadism after Intensity Modulated Radiation Therapy for Prostate Cancer,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.03.066,,,,25986798,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3789458,https://api.altmetric.com/v1/donut/3789458_240.png 3,PD19-01 PROSTATE CANCER URINE DETECTION THROUGH HIGHLY-TRAINED DOGS’ OLFACTORY SYSTEM: A REAL CLINICAL OPPORTUNITY,The Journal of Urology,,,Article,2014-01-04,10.1016/j.juro.2014.02.1520,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3776282,https://api.altmetric.com/v1/donut/3776282_240.png 3,Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis,World Journal of Urology,,,Article,2014-11-12,10.1007/s00345-014-1439-6,,,,25387877,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3747344,https://api.altmetric.com/v1/donut/3747344_240.png 3,Development of Interpretable Predictive Models for BPH and Prostate Cancer,Clinical Medicine Insights: Oncology,,,Article,2015-02-01,10.4137/cmo.s19739,,,,25780348,PMC4345941,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3738955,https://api.altmetric.com/v1/donut/3738955_240.png 3,A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer,Endocrine-Related Cancer,,,Article,2015-02-10,10.1530/erc-15-0013,,,,25670033,,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3545290,https://api.altmetric.com/v1/donut/3545290_240.png 3,"Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.",International Journal of Cancer,,,Article,2004-10-21,10.1002/ijc.20646,,,,15499634,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3174179,https://api.altmetric.com/v1/donut/3174179_240.png 3,Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: Results from ACRIN 6687.,Journal of Nuclear Medicine,,,Article,2015-01-29,10.2967/jnumed.114.146936,,,,25635138,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3165773,https://api.altmetric.com/v1/donut/3165773_240.png 3,PMPA for nephroprotection in PSMA-targeted radionuclide therapy of prostate cancer.,Journal of Nuclear Medicine,,,Article,,10.2967/jnumed.114.147181,,,,25613537,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3095781,https://api.altmetric.com/v1/donut/3095781_240.png 3,Should We Perform Prostatectomy in the Face of Metastatic Prostate Cancer?,The Journal of Urology,,,Article,2014-12-17,10.1016/j.juro.2014.12.066,,,,25526996,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,12,https://www.altmetric.com/details/2989535,https://api.altmetric.com/v1/donut/2989535_240.png 3,"Reply from Authors re: Camillo Porta, Sergio Bracarda, Romano Danesi. Steroids in Prostate Cancer: The Jury Is Still Out... and Even More Confused. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.11.002: Corticosteroids in Prostate Cancer: Known Benefits Versus Potential Risks",European Urology,,,Article,2015-04-01,10.1016/j.eururo.2014.11.042,,,,25442054,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2934487,https://api.altmetric.com/v1/donut/2934487_240.png 3,Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study,Frontiers in oncology,,,Article,2014-10-25,10.3389/fonc.2014.00319,,,,25505731,PMC4245005,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2927419,https://api.altmetric.com/v1/donut/2927419_240.png 3,Re: Vasectomy and Risk of Aggressive Prostate Cancer: A 24-Year Follow-up Study,The Journal of Urology,,,Article,,10.1016/j.juro.2014.11.054,,,,25617303,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2898239,https://api.altmetric.com/v1/donut/2898239_240.png 3,Castration-Resistant Prostate Cancer: AUA Guideline Amendment,The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.104,,,,25444753,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2835907,https://api.altmetric.com/v1/donut/2835907_240.png 3,N-3 polyunsaturated fatty acids inhibit IFN-?-induced IL-18 binding protein production by prostate cancer cells.,"Cancer Immunology, Immunotherapy",,,Article,2014-10-29,10.1007/s00262-014-1630-z,,,,25351720,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2825517,https://api.altmetric.com/v1/donut/2825517_240.png 3,Sequential Use of the Androgen Synthesis Inhibitors Ketoconazole and Abiraterone Acetate in Castration-Resistant Prostate Cancer and the Predictive Value of Circulating Androgens,Clinical Cancer Research,,,Article,2014-10-20,10.1158/1078-0432.ccr-14-1595,,,,25336698,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2802349,https://api.altmetric.com/v1/donut/2802349_240.png 3,miR-154* and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer,Clinical Cancer Research,,,Article,2014-10-15,10.1158/1078-0432.ccr-14-1784,,,,25324143,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2785554,https://api.altmetric.com/v1/donut/2785554_240.png 3,The Impact of Numeracy on Verbatim Knowledge of the Longitudinal Risk for Prostate Cancer Recurrence following Radiation Therapy.,Medical Decision Making,,,Article,2014-10-02,10.1177/0272989x14551639,,,,25277673,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2741621,https://api.altmetric.com/v1/donut/2741621_240.png 3,NQO1 suppresses NF-?B-p300 interaction to regulate inflammatory mediators associated with prostate tumorigenesis.,Cancer Research,,,Article,2014-08-17,10.1158/0008-5472.can-14-0562,,,,25125658,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2655007,https://api.altmetric.com/v1/donut/2655007_240.png 3,Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.,Future Oncology,,,Article,2014-08-27,10.2217/fon.14.72,,,,25145435,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2650525,https://api.altmetric.com/v1/donut/2650525_240.png 3,Detection of infectious organisms in archival prostate cancer tissues.,BMC Cancer,,,Article,2014-08-09,10.1186/1471-2407-14-579,,,,25106851,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2582980,https://api.altmetric.com/v1/donut/2582980_240.png 3,Novel commercially available genomic tests for prostate cancer: a roadmap to understanding their clinical impact,British Journal of Urology,,,Article,2014-07-14,10.1111/bju.12695,,,,25146527,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2576162,https://api.altmetric.com/v1/donut/2576162_240.png 3,Incidence of needle?tract seeding following prostate biopsy for suspected cancer: a review of the literature,British Journal of Urology,,,Article,2014-10-22,10.1111/bju.12849,,,,24958224,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2519266,https://api.altmetric.com/v1/donut/2519266_240.png 3,"Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer.",Journal of Cancer Survivorship,,,Article,2014-07-15,10.1007/s11764-014-0379-x,,,,25023039,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2518132,https://api.altmetric.com/v1/donut/2518132_240.png 3,No cost or safety advantage to robot?assisted radical prostatectomy compared with open?procedure surgery for patients with prostate cancer,CA: A Cancer Journal for Clinicians ,,,Article,2014-07-15,10.3322/caac.21241,,,,25043742,,,,,,,0,0,0,2,0,0,2,0,2,0,0,0,0,0,0,3,https://www.altmetric.com/details/2514308,https://api.altmetric.com/v1/donut/2514308_240.png 3,T-box Transcription Factor Brachyury Is Associated with Prostate Cancer Progression and Aggressiveness,Clinical Cancer Research,,,Article,2014-07-08,10.1158/1078-0432.ccr-14-0421,,,,25009296,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2498914,https://api.altmetric.com/v1/donut/2498914_240.png 3,Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.,International Journal of Cancer,,,Article,2013-10-11,10.1002/ijc.28482,,,,24105486,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2289202,https://api.altmetric.com/v1/donut/2289202_240.png 3,Iodine Uptake and Prostate Cancer in the TRAMP Mouse Model,Molecular Medicine,,,Article,2014-04-04,10.2119/molmed.2013.00093,,,,24306422,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2255674,https://api.altmetric.com/v1/donut/2255674_240.png 3,Prostate cancer: Melbourne Consensus[mdash]noble but misguided,Nature Reviews Urology,,,Article,2014-03-25,10.1038/nrurol.2014.65,,,,24662731,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2210894,https://api.altmetric.com/v1/donut/2210894_240.png 3,"Relative value of race, family history and prostate-specific antigen as indications for early initiation of prostate cancer screening.",The Journal of Urology,,,Article,2014-03-17,10.1016/j.juro.2014.03.032,,,,24641912,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2191757,https://api.altmetric.com/v1/donut/2191757_240.png 3,Targeted Focal Therapy for the Management of Organ Confined Prostate Cancer,The Journal of Urology,,,Article,2014-03-17,10.1016/j.juro.2014.03.033,,,,24641910,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2191756,https://api.altmetric.com/v1/donut/2191756_240.png 3,"Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness|[quest]|",British Journal of Cancer,,,Article,2012-11-29,10.1038/bjc.2012.523,,,,23321508,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2191020,https://api.altmetric.com/v1/donut/2191020_240.png 3,Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort,European Urology,,,Article,,10.1016/j.eururo.2014.01.040,,,,24568896,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2124900,https://api.altmetric.com/v1/donut/2124900_240.png 3,Statin use and incident prostate cancer risk: does the statin brand matter|[quest]| A population-based cohort study,Prostate Cancer & Prostatic Diseases,,,Article,2013-09-24,10.1038/pcan.2013.34,,,,24061633,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2116073,https://api.altmetric.com/v1/donut/2116073_240.png 3,Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer,Radiation Oncology,,,Article,2014-02-05,10.1186/1748-717x-9-47,,,,24499610,PMC3940027,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2102420,https://api.altmetric.com/v1/donut/2102420_240.png 3,Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer. Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/2650/prostate-cancer-debate-2014--evolving-treatment-options-in-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,5,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/2079425,https://api.altmetric.com/v1/donut/2079425_240.png 3,"Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis",BMC Urology,,,Article,2014-01-25,10.1186/1471-2490-14-9,,,,24460605,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2073220,https://api.altmetric.com/v1/donut/2073220_240.png 3,Is Human Papillomavirus Associated with Prostate Cancer Survival?,Disease Markers,,,Article,2013-12-17,10.1155/2013/735843,,,,24288430,PMC3830784,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1986689,https://api.altmetric.com/v1/donut/1986689_240.png 3,The prostate cancer risk stratification (ProCaRS) project: Recursive partitioning risk stratification analysis.,Radiotherapy & Oncology,,,Article,2013-11-11,10.1016/j.radonc.2013.07.020,,,,24231239,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1927794,https://api.altmetric.com/v1/donut/1927794_240.png 3,Potential role of gastrointestinal microbiota composition in prostate cancer risk.,Infectious Agents and Cancer,,,Article,2013-11-04,10.1186/1750-9378-8-42,,,,24180596,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1885732,https://api.altmetric.com/v1/donut/1885732_240.png 3,"The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and Its Associated Research Resource",JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt281,,,,24115361,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1817339,https://api.altmetric.com/v1/donut/1817339_240.png 3,A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.,Radiation Oncology,,,Article,2013-09-04,10.1186/1748-717x-8-206,,,,24007322,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1730760,https://api.altmetric.com/v1/donut/1730760_240.png 3,Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era,BioMed Research International,,,Article,2013-01-01,10.1155/2013/901578,,,,23957008,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1705161,https://api.altmetric.com/v1/donut/1705161_240.png 3,Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells,PeerJ,,,Article,2013-01-01,10.7717/peerj.122,,,,23940835,PMC3740138,,,,,,0,0,0,0,3,0,1,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/1677670,https://api.altmetric.com/v1/donut/1677670_240.png 3,"How Can I Help Myself? A Critical Review of Modifiable Behaviors, Medications, and Complementary Alternative Medicine for Men Receiving Radiotherapy for Prostate Cancer",Seminars in Radiation Oncology,,,Article,2013-06-15,10.1016/j.semradonc.2013.01.003,,,,23763883,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1609661,https://api.altmetric.com/v1/donut/1609661_240.png 3,High fiber diet prevents prostate cancer progression in mice,Cancer (0008543X),,,Article,2013-07-01,10.1002/cncr.28207,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1565063,https://api.altmetric.com/v1/donut/1565063_240.png 3,Effects of lycopene on protein expression in human primary prostatic epithelial cells.,Cancer Prevention Research,,,Article,2013-05-01,10.1158/1940-6207.capr-12-0364,,,,23483004,,,,,,,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1549363,https://api.altmetric.com/v1/donut/1549363_240.png 3,Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature.,European Urology,,,Article,2013-05-16,10.1016/j.eururo.2013.05.025,,,,23721958,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/1526727,https://api.altmetric.com/v1/donut/1526727_240.png 3,The Prostate Cancer Prevention Trial risk calculator and the relationship between prostateâ??specific antigen and biopsy outcome,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28114,,,,23720006,PMC3735626,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1521086,https://api.altmetric.com/v1/donut/1521086_240.png 3,Advancing Precision Medicine for Prostate Cancer Through Genomics,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.45.3662,,,,23589550,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,87,https://www.altmetric.com/details/1485665,https://api.altmetric.com/v1/donut/1485665_240.png 3,New treatment options for castration-resistant prostate cancer,American Journal of Health-System Pharmacy,,,Article,2013-01-01,10.2146/ajhp110586,,,,23640346,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1428128,https://api.altmetric.com/v1/donut/1428128_240.png 3,The epigenetic potentials of dietary polyphenols in prostate cancer management,Biochemistry and Cell Biology,,,Article,2013-10-23,10.1139/bcb-2012-0044,,,,24219277,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1427879,https://api.altmetric.com/v1/donut/1427879_240.png 3,A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-0319,,,,23553848,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1338025,https://api.altmetric.com/v1/donut/1338025_240.png 3,Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer,Cancer Causes and Control,,,Article,2013-04-02,10.1007/s10552-012-0132-6,,,,23546609,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1336948,https://api.altmetric.com/v1/donut/1336948_240.png 3,"Traffic-related air pollution and prostate cancer risk: a case-control study in Montreal, Canada.",Occupational and environmental medicine,,,Article,2013-03-26,10.1136/oemed-2012-101211,,,,23531743,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1327877,https://api.altmetric.com/v1/donut/1327877_240.png 3,d -Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis,Journal of Carcinogenesis,,,Article,2009-05-27,10.4103/1477-3163.51368,,,,19465777,PMC2699604,,,,,,0,0,0,2,4,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1295230,https://api.altmetric.com/v1/donut/1295230_240.png 3,"Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers",Nature Reviews Urology,,,Article,2013-02-26,10.1038/nrurol.2013.24,,,,23443013,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1271215,https://api.altmetric.com/v1/donut/1271215_240.png 3,"Physangulidine A, a Withanolide from Physalis angulata, Perturbs the Cell Cycle and Induces Cell Death by Apoptosis in Prostate Cancer Cells",Journal of Natural Products,,,Article,2012-12-30,10.1021/np300457g,,,,23270478,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1260655,https://api.altmetric.com/v1/donut/1260655_240.png 3,Enzalutamide: a novel anti-androgen for patients with castrate resistant prostate cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-2910,,,,23300275,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/1164800,https://api.altmetric.com/v1/donut/1164800_240.png 3,Overdiagnosis of Prostate Cancer,Journal of the National Cancer Institute. Monographs,,,Article,2012-12-27,10.1093/jncimonographs/lgs031,,,,23271765,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,38,https://www.altmetric.com/details/1146779,https://api.altmetric.com/v1/donut/1146779_240.png 3,Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway,PLoS ONE,,,Article,2012-12-13,10.1371/journal.pone.0051655,,,,23272133,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/1129646,https://api.altmetric.com/v1/donut/1129646_240.png 3,Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer,Journal of Clinical Oncology,,,Article,2012-11-23,10.1200/jco.2011.41.5166,,,,23169519,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1129616,https://api.altmetric.com/v1/donut/1129616_240.png 3,PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.,,,,Article,2012-11-06,10.1186/1471-2407-12-507,,,,23130941,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1052533,https://api.altmetric.com/v1/donut/1052533_240.png 3,Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer.,Journal of Medicinal Food,,,Article,2009-09-09,10.1089/jmf.2008.1232,,,,19735167,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1008094,https://api.altmetric.com/v1/donut/1008094_240.png 3,Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4,Nature Genetics,,,Article,2012-09-30,10.1038/ng.2424,,,,23023329,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/973919,https://api.altmetric.com/v1/donut/973919_240.png 3,Mate Pair Sequencing of Whole-Genome-Amplified DNA Following Laser Capture Microdissection of Prostate Cancer.,DNA Research,,,Article,2012-01-01,10.1093/dnares/dss021,,,,22991452,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/957674,https://api.altmetric.com/v1/donut/957674_240.png 3,Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell.,PROTEOMICS,,,Article,2012-09-04,10.1002/pmic.201200084,,,,22945439,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/931691,https://api.altmetric.com/v1/donut/931691_240.png 3,Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.08.034,,,,22172904,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/914596,https://api.altmetric.com/v1/donut/914596_240.png 3,"Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.",Head & Neck,,,Article,2012-06-21,10.1002/hed.23052,,,,22711227,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/882437,https://api.altmetric.com/v1/donut/882437_240.png 3,Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy,BMC Cancer,,,Article,2012-07-30,10.1186/1471-2407-12-324,,,,22846379,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/863681,https://api.altmetric.com/v1/donut/863681_240.png 3,Wellâ??Defined Degradable Cationic Polylactide as Nanocarrier for the Delivery of siRNA to Silence Angiogenesis in Prostate Cancer,Advanced Healthcare Materials,,,Article,2012-01-01,10.1002/adhm.201200094,,,,23184827,,,,,,,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/857708,https://api.altmetric.com/v1/donut/857708_240.png 3,Inuit are protected against prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-09-01,,,,,14504206,,,,,,,0,0,0,2,0,0,2,0,0,0,1,0,0,0,0,6,https://www.altmetric.com/details/854445,https://api.altmetric.com/v1/donut/854445_240.png 3,Modulation of Akt/mTOR Signaling Overcomes Sunitinib Resistance in Renal and Prostate Cancer Cells,Molecular Cancer Therapeutics,,,Article,2012-01-01,10.1158/1535-7163.mct-11-0907,,,,22532600,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/825488,https://api.altmetric.com/v1/donut/825488_240.png 3,New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists,Prostate Cancer & Prostatic Diseases,,,Article,2012-07-03,10.1038/pcan.2012.25,,,,22751146,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/820590,https://api.altmetric.com/v1/donut/820590_240.png 3,Uptake and antitumoral effects of iodine and 6â??iodolactone in differentiated and undifferentiated human prostate cancer cell lines,The Prostate,,,Article,2013-01-01,10.1002/pros.22536,,,,22576883,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/738000,https://api.altmetric.com/v1/donut/738000_240.png 3,Long-term recovery of irradiated prostate cancer increases cancer stem cells.,The Prostate,,,Article,2012-01-01,10.1002/pros.22527,,,,22513891,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/702927,https://api.altmetric.com/v1/donut/702927_240.png 3,Adaptive autoâ??regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer,The Prostate,,,Article,2012-01-01,10.1002/pros.22504,,,,22396319,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/637976,https://api.altmetric.com/v1/donut/637976_240.png 3,Recent developments in treatments targeting castration-resistant prostate cancer bone metastases,Annals of Oncology,,,Article,2012-01-25,10.1093/annonc/mdr573,,,,22267211,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/570642,https://api.altmetric.com/v1/donut/570642_240.png 3,"Prostate Cancer Screening—The Evidence, the Recommendations, and the Clinical Implications",JAMA: The Journal of the American Medical Association,,,Article,2011-01-01,10.1001/jama.2011.1891,,,,22203543,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/509090,https://api.altmetric.com/v1/donut/509090_240.png 3,5?-Reductase inhibitors for prostate-cancer prevention.,The New England journal of medicine,,,Article,2011-12-15,10.1056/nejmc1112146,,,,22168662,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/497291,https://api.altmetric.com/v1/donut/497291_240.png 3,Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials,Lancet Oncology,,,Article,2011-11-26,10.1016/s1470-2045(11)70295-9,,,,22112793,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/465507,https://api.altmetric.com/v1/donut/465507_240.png 3,The shortâ??term use of erythropoetinâ??stimulating agents: impact on the biochemical recurrence of prostate cancer,British Journal of Urology,,,Article,2011-11-01,10.1111/j.1464-410x.2011.10173.x,,,,21443653,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/437845,https://api.altmetric.com/v1/donut/437845_240.png 3,Metformin in prostate cancer: two for the price of one,Annals of Oncology,,,Article,2011-01-01,10.1093/annonc/mdr037,,,,21421541,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/425696,https://api.altmetric.com/v1/donut/425696_240.png 3,Prostate cancer: Intermediate-risk patients on radiotherapy benefit from addition of short-term ADT,Nature Reviews Urology,,,Article,2011-09-08,10.1038/nrurol.2011.121,,,,21901016,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/257582,https://api.altmetric.com/v1/donut/257582_240.png 3,"Dairy products, calcium and prostate cancer risk",British Journal of Cancer,,,Article,2006-11-14,10.1038/sj.bjc.6603475,,,,17106437,PMC2360740,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/224337,https://api.altmetric.com/v1/donut/224337_240.png 3,Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.,Nature Genetics,,,Article,2010-08-01,10.1038/ng.613,,,,20601956,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,122,https://www.altmetric.com/details/211916,https://api.altmetric.com/v1/donut/211916_240.png 3,Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2010-12-01,10.1093/jnci/djq419,,,,21068432,PMC2994861,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,14,https://www.altmetric.com/details/211882,https://api.altmetric.com/v1/donut/211882_240.png 3,Re: Investigation on Lower Urinary Tract Symptoms (LUTS) in Elderly Patients with Prostate Cancer (PC) Received Endocrine Therapy,The Journal of Urology,,,Article,2016-11-01,10.1016/j.juro.2016.08.039,,,,27751476,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12953135,https://api.altmetric.com/v1/donut/12953135_240.png 3,"Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient´s metabolic status: potential value as a non-invasive biomarker",Cancer Letters,,,Article,2016-09-01,10.1016/j.canlet.2016.09.022,,,,27693462,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12344595,https://api.altmetric.com/v1/donut/12344595_240.png 3,Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors,Cancer Letters,,,Article,2016-05-17,10.1016/j.canlet.2016.05.013,,,,27224892,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8309553,https://api.altmetric.com/v1/donut/8309553_240.png 3,Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy,Brachytherapy,,,Article,2016-02-01,10.1016/j.brachy.2015.12.007,,,,26853354,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8084545,https://api.altmetric.com/v1/donut/8084545_240.png 3,Molecular Discriminators of Racial Disparities in Prostate Cancer,Trends in Cancer,,,Article,2016-02-11,10.1016/j.trecan.2016.01.005,,,,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6842037,https://api.altmetric.com/v1/donut/6842037_240.png 3,Meta-Analysis: Radiotherapy for Prostate Cancer Linked to Small Increase in Risk for Secondary Cancers,Journal Watch,,,Article,2016-03-04,10.1056/nejm-jw.fw111266,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6047989,https://api.altmetric.com/v1/donut/6047989_240.png 3,Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study,Journal of Racial and Ethnic Health Disparities,,,Article,2016-02-21,10.1007/s40615-015-0109-8,,,,26896103,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5898199,https://api.altmetric.com/v1/donut/5898199_240.png 3,"Aspirin Found to Prevent Death from Prostate Cancer, but Not to Protect from Prostate Cancer",Oncology times,,,Article,2016-02-10,10.1097/01.cot.0000480907.28388.81,,,http://journals.lww.com/oncology-times/Fulltext/2016/02100/Aspirin_Found_to_Prevent_Death_from_Prostate.7.aspx,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5079261,https://api.altmetric.com/v1/donut/5079261_240.png 3,Texas Native Plants Yield Compounds with Cytotoxic Activities against Prostate Cancer Cells,Journal of Natural Products,,,Article,2016-01-27,10.1021/acs.jnatprod.5b00908,,,,26785306,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5045748,https://api.altmetric.com/v1/donut/5045748_240.png 3,Robotic-assisted radical prostatectomy is less stressful than the open approach: results of a contemporary prospective study evaluating pathophysiology of cortisol stress-related kinetics in prostate cancer surgery,Journal of Robotic Surgery,,,Article,2015-07-24,10.1007/s11701-015-0522-3,,,,26531206,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5001642,https://api.altmetric.com/v1/donut/5001642_240.png 3,"A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy",Medical Physics,,,Article,2016-01-14,10.1118/1.4939260,,,,26843237,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4994590,https://api.altmetric.com/v1/donut/4994590_240.png 3,The Evolution of Active Surveillance for Prostate Cancer,European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.07.020,,,,26215607,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4545870,https://api.altmetric.com/v1/donut/4545870_240.png 3,Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer ,Journal of Controlled Release,,,Article,2015-04-29,10.1016/j.jconrel.2015.04.025,,,,25912409,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3949129,https://api.altmetric.com/v1/donut/3949129_240.png 3,Synchronous rectal and prostate cancer – The impact of MRI on incidence and imaging findings,European Journal of Radiology,,,Article,2015-01-04,10.1016/j.ejrad.2014.12.030,,,,25638578,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3844613,https://api.altmetric.com/v1/donut/3844613_240.png 3,Predictors of urinary continence recovery after modified radical prostatectomy for clinically high-risk prostate cancer.,Urology Journal,,,Article,2015-02-24,,,,,25703912,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3737838,https://api.altmetric.com/v1/donut/3737838_240.png 3,Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study,British Journal of Cancer,,,Article,2011-08-26,10.1038/bjc.2011.314,,,,21863028,PMC3185935,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2721080,https://api.altmetric.com/v1/donut/2721080_240.png 3,Fighting prostate cancer with a tomato-rich diet,ecancer.org,,,Article,,,,,http://ecancer.org/news/6204-fighting-prostate-cancer-with-a-tomato-rich-diet.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2632523,https://api.altmetric.com/v1/donut/2632523_240.png 3,Preventing prostate cancer through androgen deprivation mayhave harmful effects. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3663-preventing-prostate-cancer-through-androgen-deprivation-may-have-harmful-effects.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2321473,https://api.altmetric.com/v1/donut/2321473_240.png 3,Genetic screening can identify men with advanced prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5283-genetic-screening-can-identify-men-with-advanced-prostate-cancer.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2135141,https://api.altmetric.com/v1/donut/2135141_240.png 3,Red wine consumption and risk of prostate cancer: the California men's health study.,International Journal of Cancer,,,Article,2010-01-01,10.1002/ijc.24637,,,,19521962,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1894758,https://api.altmetric.com/v1/donut/1894758_240.png 3,Managing localized prostate cancer in the era of prostateâ??specific antigen screening,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28301,,,,24006273,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1729871,https://api.altmetric.com/v1/donut/1729871_240.png 3,MicroRNA Signature Helps Distinguish Early from Late Biochemical Failure in Prostate Cancer,Clinical Chemistry,,,Article,2013-01-01,10.1373/clinchem.2013.205450,,,,23958847,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1715733,https://api.altmetric.com/v1/donut/1715733_240.png 3,The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11530.x,,,,23116361,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1048815,https://api.altmetric.com/v1/donut/1048815_240.png 3,Livin expression may be regulated by miR-198 in human prostate cancer cell lines,European Journal of Cancer (1965),,,Article,2012-10-16,10.1016/j.ejca.2012.08.029,,,,23069480,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1004656,https://api.altmetric.com/v1/donut/1004656_240.png 3,Genetic variations of prostate stem cell antigen (PSCA) contribute to the risk of gastric cancer for Eastern Asians: A meta-analysis based on 16792 individuals.,Gene,,,Article,2011-12-15,10.1016/j.gene.2011.11.017,,,,22155405,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/633532,https://api.altmetric.com/v1/donut/633532_240.png 3,Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1,Cancer Letters,,,Article,2016-10-01,10.1016/j.canlet.2016.10.028,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13308235,https://api.altmetric.com/v1/donut/13308235_240.png 3,Prostate cancer: Notching up roles in advanced disease,Nature Reviews Urology,,,Article,2016-10-18,10.1038/nrurol.2016.210,,,,27754473,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12717695,https://api.altmetric.com/v1/donut/12717695_240.png 3,A brain lesion as the sole metastasis of prostate cancer,Journal of Clinical Urology,,,Article,2014-09-08,10.1177/2051415814549204,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12658575,https://api.altmetric.com/v1/donut/12658575_240.png 3,The Association of Metabolic Syndrome and Its Components with Serum Prostate-Specific Antigen Levels in a Korean-Screened Population,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-02-01,10.1158/1055-9965.epi-09-0760,,,,20086117,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12632234,https://api.altmetric.com/v1/donut/12632234_240.png 3,Outcomes After a First and/or Second Salvage Treatment in Patients With Oligometastatic Prostate Cancer Recurrence Detected by (18-F) Choline Positron Emission Tomography/Computed Tomography,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-10-01,10.1016/j.ijrobp.2016.06.1250,,,,27674175,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12546342,https://api.altmetric.com/v1/donut/12546342_240.png 3,Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment?,European Urology,,,Article,2016-09-04,10.1016/j.eururo.2016.08.052,,,,27600590,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11716993,https://api.altmetric.com/v1/donut/11716993_240.png 3,Prostate cancer: Targeting the ribosome in advanced disease,Nature Reviews Urology,,,Article,2016-08-23,10.1038/nrurol.2016.162,,,,27549356,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10775112,https://api.altmetric.com/v1/donut/10775112_240.png 3,Prostate cancer: Radium-223 safe in combination,Nature Reviews Urology,,,Article,2016-08-17,10.1038/nrurol.2016.156,,,,27530262,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10575006,https://api.altmetric.com/v1/donut/10575006_240.png 3,Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancer,Radiotherapy & Oncology,,,Article,2016-07-01,10.1016/j.radonc.2016.07.004,,,,27470308,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10056788,https://api.altmetric.com/v1/donut/10056788_240.png 3,Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer,Nature Reviews Urology,,,Article,2016-07-19,10.1038/nrurol.2016.118,,,,27431338,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9845805,https://api.altmetric.com/v1/donut/9845805_240.png 3,Tasquinimod treatment for prostate cancer,Lancet Oncology,,,Article,2016-06-23,10.1016/s1470-2045(16)30272-8,,,,27345634,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9012801,https://api.altmetric.com/v1/donut/9012801_240.png 3,Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients,PLoS ONE,,,Article,2016-06-15,10.1371/journal.pone.0157566,,,,27305142,PMC4909321,,,,,,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,12,https://www.altmetric.com/details/8768282,https://api.altmetric.com/v1/donut/8768282_240.png 3,Prostatectomy vs radiation therapy for prostate cancer: The (still) unsolved dilemma,Radiotherapy & Oncology,,,Article,2016-06-04,10.1016/j.radonc.2016.03.026,,,,27267818,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8489501,https://api.altmetric.com/v1/donut/8489501_240.png 3,Second-generation Androgen Receptor–targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?,European Urology,,,Article,2016-05-27,10.1016/j.eururo.2016.05.026,,,,27238654,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8299673,https://api.altmetric.com/v1/donut/8299673_240.png 3,Prostate cancer: ADT after radical prostatectomy — when and how?,Nature Reviews Urology,,,Article,2016-05-24,10.1038/nrurol.2016.97,,,,27215428,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8198141,https://api.altmetric.com/v1/donut/8198141_240.png 3,Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences,Clinical Oncology,,,Article,2016-04-28,10.1016/j.clon.2016.04.040,,,,27133946,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7091448,https://api.altmetric.com/v1/donut/7091448_240.png 3,Recent advances in prostate cancer pathology: Gleason grading and beyond,Pathology International,,,Article,2016-03-18,10.1111/pin.12398,,,,26991008,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6351275,https://api.altmetric.com/v1/donut/6351275_240.png 3,"Using others’ experiences. Cancer patients’ expectations and navigation of a website providing narratives on prostate, breast and colorectal cancer",Patient Education & Counseling,,,Article,2016-03-17,10.1016/j.pec.2016.03.015,,,,27067064,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6226538,https://api.altmetric.com/v1/donut/6226538_240.png 3,Acknowledging unreported problems with active surveillance for prostate cancer: a prospective single-centre observational study,BMJ Open,,,Article,2016-02-01,10.1136/bmjopen-2015-010191,,,,26888730,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6194892,https://api.altmetric.com/v1/donut/6194892_240.png 3,"Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.",Carcinogenesis,,,Article,2009-05-14,10.1093/carcin/bgp055,,,,19255064,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/6064609,https://api.altmetric.com/v1/donut/6064609_240.png 3,Functional Quality-of-Life Outcomes Reported by Men Treated for Localized Prostate Cancer: A Systematic Literature Review,Oncology Nursing Forum,,,Article,2016-02-27,10.1188/16.onf.199-218,,,,26906131,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6014568,https://api.altmetric.com/v1/donut/6014568_240.png 3,The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance ,Cellular Signalling,,,Article,2016-05-01,10.1016/j.cellsig.2016.01.013,,,,26829214,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/5303460,https://api.altmetric.com/v1/donut/5303460_240.png 3,Prostate cancer diagnosis by optical coherence tomography: First results from a needle based optical platform for tissue sampling,Journal of Biophotonics,,,Article,2016-03-01,10.1002/jbio.201500252,,,,26856796,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/5112786,https://api.altmetric.com/v1/donut/5112786_240.png 3,Dose-Escalated Stereotactic Body Radiation Therapy for Patients with Intermediate and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-06,10.1016/j.ijrobp.2016.02.009,,,,27302511,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5104289,https://api.altmetric.com/v1/donut/5104289_240.png 3,Racial difference seen in outcomes for older patients with prostate cancer,Cancer (0008543X),,,Article,2016-02-15,10.1002/cncr.29897,,,,26844939,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5091989,https://api.altmetric.com/v1/donut/5091989_240.png 3,Prostate cancer: Increased adverse event risk with GnRHa therapy,Nature Reviews Urology,,,Article,2016-01-20,10.1038/nrurol.2016.5,,,,26787398,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5015869,https://api.altmetric.com/v1/donut/5015869_240.png 3,Predicting survival of men with recurrent prostate cancer after radical prostatectomy.,European Journal of Cancer (1965),,,Article,2015-12-29,10.1016/j.ejca.2015.11.004,,,,26707594,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4897306,https://api.altmetric.com/v1/donut/4897306_240.png 3,Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2007-01-08,10.1016/j.ijrobp.2007.01.067,,,,17544601,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,87,https://www.altmetric.com/details/4736697,https://api.altmetric.com/v1/donut/4736697_240.png 3,A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers,PLoS ONE,,,Article,2015-09-30,10.1371/journal.pone.0139484,,,,26421725,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4573664,https://api.altmetric.com/v1/donut/4573664_240.png 3,Prostate cancer in East Asia: evolving trend over the last decade.,Asian Journal of Andrology,,,Article,2014-07-14,10.4103/1008-682x.132780,,,,25080928,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4525394,https://api.altmetric.com/v1/donut/4525394_240.png 3,Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer,Supportive Care in Cancer,,,Article,2015-09-03,10.1007/s00520-015-2904-5,,,,26335402,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4505921,https://api.altmetric.com/v1/donut/4505921_240.png 3,Optimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk non-metastatic prostate cancer: A systematic review and meta-analysis,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2014.0412,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4411355,https://api.altmetric.com/v1/donut/4411355_240.png 3,'Carrying on the way we are is becoming shambolic' - An interview study with prostate cancer specialists about their usual practice of follow-up,Journal of Clinical Urology,,,Article,2014-10-28,10.1177/2051415814545804,,,,,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4232596,https://api.altmetric.com/v1/donut/4232596_240.png 3,"Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom",BMC Urology,,,Article,2015-06-13,10.1186/s12894-015-0049-y,,,,26070313,PMC4465007,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4144256,https://api.altmetric.com/v1/donut/4144256_240.png 3,High-dose-rate brachytherapy as monotherapy for intermediate- and high-risk prostate cancer: Clinical results for a median eight-year follow-up,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-08-05,10.1016/j.ijrobp.2015.05.044,,,,26238951,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4095549,https://api.altmetric.com/v1/donut/4095549_240.png 3,Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer,Frontiers in oncology,,,Article,2015-05-22,10.3389/fonc.2015.00129,,,,26125012,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4040259,https://api.altmetric.com/v1/donut/4040259_240.png 3,TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients,Clinical Cancer Research,,,Article,2015-05-15,10.1158/1078-0432.ccr-14-3145,,,,25967142,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3992435,https://api.altmetric.com/v1/donut/3992435_240.png 3,Cognitive existential couple therapy (CECT) in men and partners facing localised prostate cancer: a randomised controlled trial,British Journal of Urology,,,Article,2015-04-01,10.1111/bju.12991,,,,25828172,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3885684,https://api.altmetric.com/v1/donut/3885684_240.png 3,Role of MicroRNAs in Prostate Cancer Pathogenesis,Clinical Genitourinary Cancer,,,Article,2015-01-24,10.1016/j.clgc.2015.01.003,,,,25733057,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3753918,https://api.altmetric.com/v1/donut/3753918_240.png 3,Optimizing survival in advanced prostate cancer. Educational resources for oncology professionals,ecancer.org,,,Article,,,,,http://ecancer.org/education/module/158-optimizing-survival-in-advanced-prostate-cancer.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/3235123,https://api.altmetric.com/v1/donut/3235123_240.png 3,"The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.",Cancer Causes and Control,,,Article,2014-12-23,10.1007/s10552-014-0511-2,,,,25534917,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3012792,https://api.altmetric.com/v1/donut/3012792_240.png 3,A Review of Statin Use and Prostate Cancer,Current Atherosclerosis Reports,,,Article,2014-11-30,10.1007/s11883-014-0474-5,,,,25433554,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2936238,https://api.altmetric.com/v1/donut/2936238_240.png 3,Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens.,The Prostate,,,Article,2014-11-21,10.1002/pros.22928,,,,25417762,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2915407,https://api.altmetric.com/v1/donut/2915407_240.png 3,Re: Diffusion-Weighted MR Imaging in Early Assessment of Tumor Response to Radiotherapy in High-Risk Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.11.068,,,,25617273,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2890460,https://api.altmetric.com/v1/donut/2890460_240.png 3,Re: Imaging Treated Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.11.065,,,,25617276,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2890453,https://api.altmetric.com/v1/donut/2890453_240.png 3,"Researching Depression in Prostate Cancer Patients: Factors, Timing, and Measures",Journal of Men's Health,,,Article,2014-12-01,10.1089/jomh.2014.0036,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2871133,https://api.altmetric.com/v1/donut/2871133_240.png 3,Implementation of a Novel Algorithm For Generating Synthetic CT Images From Magnetic Resonance Imaging Data Sets for Prostate Cancer Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2014.09.015,,,,25442341,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2868158,https://api.altmetric.com/v1/donut/2868158_240.png 3,Clinical Practice Guidelines on Prostate Cancer: A Critical Appraisal,The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.105,,,,25451831,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2847368,https://api.altmetric.com/v1/donut/2847368_240.png 3,Gender relations and couple negotiations of British men's food practice changes after prostate cancer.,Appetite,,,Article,2014-10-07,10.1016/j.appet.2014.09.026,,,,25305464,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2757247,https://api.altmetric.com/v1/donut/2757247_240.png 3,Re: Determination of Optimal Drug Dose and Light Dose Index to Achieve Minimally Invasive Focal Ablation of Localized Prostate Cancer Using WST11-Vascular Targeted Photodynamic (VTP) Therapy,The Journal of Urology,,,Article,2014-01-10,10.1016/j.juro.2014.07.071,,,,25304557,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2729210,https://api.altmetric.com/v1/donut/2729210_240.png 3,Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,1996-11-01,,,,,8922296,,,,,,,0,0,0,9,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2686475,https://api.altmetric.com/v1/donut/2686475_240.png 3,"Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial",Gynecologic Oncology,,,Article,2014-08-27,10.1016/j.ygyno.2014.08.025,,,,25158036,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2636575,https://api.altmetric.com/v1/donut/2636575_240.png 3,Stat Bite Percentage of New Cases of Prostate Cancer by Age in the United States (2007–2011),JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dju279,,,,25122738,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2619926,https://api.altmetric.com/v1/donut/2619926_240.png 3,An Investigation into the Anticancer Effects and Mechanism of Action of Hop ?-Acid Lupulone and Its Natural and Synthetic Derivatives in Prostate Cancer Cells.,Nutrition and Cancer,,,Article,2013-11-01,10.1080/01635581.2013.850963,,,,24168111,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2544225,https://api.altmetric.com/v1/donut/2544225_240.png 3,Radical Prostatectomy or Radiotherapy in High-Risk Prostate Cancer: A Systematic Review and Metaanalysis.,Clinical Genitourinary Cancer,,,Article,2014-02-06,10.1016/j.clgc.2014.01.010,,,,24589471,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2526969,https://api.altmetric.com/v1/donut/2526969_240.png 3,"Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life.",Radiotherapy & Oncology,,,Article,2014-07-09,10.1016/j.radonc.2014.06.013,,,,24998704,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2502094,https://api.altmetric.com/v1/donut/2502094_240.png 3,Avoiding obsolescence in advanced prostate cancer management: a guide for urologists,British Journal of Urology,,,Article,2014-06-26,10.1111/bju.12665,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2466227,https://api.altmetric.com/v1/donut/2466227_240.png 3,Prostate cancer: Optimizing active surveillance: patient and protocol,Nature Reviews Urology,,,Article,2014-06-24,10.1038/nrurol.2014.146,,,,24960595,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2464326,https://api.altmetric.com/v1/donut/2464326_240.png 3,Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers.,Carcinogenesis,,,Article,2014-05-23,10.1093/carcin/bgu114,,,,24858205,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2381072,https://api.altmetric.com/v1/donut/2381072_240.png 3,Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-05-05,10.1016/j.ijrobp.2014.03.018,,,,24803033,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2328841,https://api.altmetric.com/v1/donut/2328841_240.png 3,Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.011,,,,24054872,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2282783,https://api.altmetric.com/v1/donut/2282783_240.png 3,TMPRSS:ERG Fusion in Prostate Cancer: From Experimental Approaches to Prognostic Studies,European Urology,,,Article,,10.1016/j.eururo.2014.03.045,,,,24768276,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2266472,https://api.altmetric.com/v1/donut/2266472_240.png 3,The Ups and Downs of Gay Sex After Prostate Cancer Treatment,Journal of Gay & Lesbian Psychotherapy,,,Article,2005-02-15,10.1300/j236v09n01_04,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2217363,https://api.altmetric.com/v1/donut/2217363_240.png 3,"Is Metastatic Prostate Cancer Changing, and How Will We Know It? It's Time for Standard Nomenclature for Nonosseous Metastases in Clinical Trials of Patients with Metastatic Castration Resistant Prostate Cancer",European Urology,,,Article,2014-08-01,10.1016/j.eururo.2013.12.061,,,,24433812,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2124859,https://api.altmetric.com/v1/donut/2124859_240.png 3,Intensity-Modulated Radiation Therapy for Prostate Cancer,New England Journal of Medicine,,,Article,2014-02-13,10.1056/nejmc1314524,,,,24521125,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2117718,https://api.altmetric.com/v1/donut/2117718_240.png 3,Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer,Frontiers in oncology,,,Article,2014-01-14,10.3389/fonc.2014.00008,,,,24478988,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2079048,https://api.altmetric.com/v1/donut/2079048_240.png 3,Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate?specific antigen (PSA)?based detection of prostate cancer in men without prior biopsies,British Journal of Urology,,,Article,2014-01-21,10.1111/bju.12639,,,,24447678,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2060254,https://api.altmetric.com/v1/donut/2060254_240.png 3,Interfractional variability in intensity-modulated radiotherapy of prostate cancer with or without thermoplastic pelvic immobilization,Strahlentherapie und Onkologie,,,Article,2013-11-08,10.1007/s00066-013-0452-9,,,,24343757,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2028412,https://api.altmetric.com/v1/donut/2028412_240.png 3,New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,Journal of Oncology Pharmacy Practice,,,Article,2013-01-01,10.1177/1078155213509505,,,,24243919,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1909532,https://api.altmetric.com/v1/donut/1909532_240.png 3,Potentially Harmful Effect of a Testosterone Dietary Supplement on Prostate Cancer Growth and Metastasis,Archives of Internal Medicine,,,Article,2008-01-01,10.1001/archinternmed.2007.34,,,,18227373,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1881072,https://api.altmetric.com/v1/donut/1881072_240.png 3,Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer.,"Cancer Immunology, Immunotherapy",,,Article,2013-10-23,10.1007/s00262-013-1482-y,,,,24149465,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1863342,https://api.altmetric.com/v1/donut/1863342_240.png 3,Re: Mortality after Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2013.06.104,,,,24029312,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1799017,https://api.altmetric.com/v1/donut/1799017_240.png 3,Hedgehog signaling is active in human prostate cancer stroma and regulates proliferation and differentiation of adjacent epithelium,The Prostate,,,Article,2013-01-01,10.1002/pros.22720,,,,24105601,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1780707,https://api.altmetric.com/v1/donut/1780707_240.png 3,Conflict-of-Interest Seen in Some Prescribing Radiotherapy for Prostate Cancer,Journal Watch,,,Article,2013-08-20,10.1056/nejm-jw.fw107806,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1698117,https://api.altmetric.com/v1/donut/1698117_240.png 3,Radioactive drug prolongs survival from advanced prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/4261-radioactive-drug-prolongs-survival-from-advanced-prostate-cancer.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1642379,https://api.altmetric.com/v1/donut/1642379_240.png 3,Lipids and Prostate Cancer,Prostaglandins & Other Lipid Mediators,,,Article,2012-05-01,10.1016/j.prostaglandins.2012.03.003,,,,22503963,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/1598045,https://api.altmetric.com/v1/donut/1598045_240.png 3,Epigenomic Alterations in Localized and Advanced Prostate Cancer,Neoplasia,,,Article,2013-04-06,,,,,23555183,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1570798,https://api.altmetric.com/v1/donut/1570798_240.png 3,Fundraising Ideas | Women Against Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/donate/fundraising-ideas/,,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1424203,https://api.altmetric.com/v1/donut/1424203_240.png 3,Antiâ??Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer,Drug Development Research,,,Article,2013-03-15,10.1002/ddr.21063,,,,25152555,PMC4139012,,,,,,0,0,0,7,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1272012,https://api.altmetric.com/v1/donut/1272012_240.png 3,Prostate cancer drug turned down by SMC,ecancer.org,,,Article,,,,,http://ecancer.org/news/2572-prostate-cancer-drug-turned-down-by-smc.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251036,https://api.altmetric.com/v1/donut/1251036_240.png 3,Radiotherapy after surgery slows progress of 'high-risk'prostate cancer. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3483-radiotherapy-after-surgery-slows-progress-of--high-risk--prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250690,https://api.altmetric.com/v1/donut/1250690_240.png 3,Re: Delayed Radical Prostatectomy for Intermediate-Risk Prostate Cancer is Associated with Biochemical Recurrence: Possible Implications for Active Surveillance from the SEARCH Database,The Journal of Urology,,,Article,2013-01-23,10.1016/j.juro.2012.11.131,,,,23394637,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1193903,https://api.altmetric.com/v1/donut/1193903_240.png 3,No association between XMRV or related gammaretroviruses in Australian prostate cancer patients,Virology Journal,,,Article,2013-01-10,10.1186/1743-422x-10-20,,,,23305518,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1168074,https://api.altmetric.com/v1/donut/1168074_240.png 3,Extended Followup Oncologic Outcome of Randomized Trial Between Cryoablation and External Beam Therapy for Locally Advanced Prostate Cancer (T2c-T3b),The Journal of Urology,,,Article,2012-08-16,10.1016/j.juro.2012.06.014,,,,22901586,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/890839,https://api.altmetric.com/v1/donut/890839_240.png 3,Serum ?-Tocopherol and ?-Tocopherol Concentrations and Prostate Cancer Risk in the PLCO Screening Trial: A Nested Case-Control Study,PLoS ONE,,,Article,2012-07-05,10.1371/journal.pone.0040204,,,,22792240,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/824662,https://api.altmetric.com/v1/donut/824662_240.png 3,A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy,AIP Advances,,,Article,2011-01-01,10.1063/1.3697848,,,,,,,2012AIPA....2a1002P,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/655398,https://api.altmetric.com/v1/donut/655398_240.png 3,Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.,Oncology Reports,,,Article,2011-10-01,10.3892/or.2011.1359,,,,21725602,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/432578,https://api.altmetric.com/v1/donut/432578_240.png 3,A hypothesis on the sexual behaviour of men who are destined to develop prostate cancer,International Journal of Epidemiology,,,Article,2005-01-01,10.1093/ije/dyh248,,,,15231758,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/426022,https://api.altmetric.com/v1/donut/426022_240.png 2,How the TRAMP Model Revolutionized the Study of Prostate Cancer Progression,Cancer Research,,,Article,2016-11-01,10.1158/0008-5472.can-16-2636,,,,27803100,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13210202,https://api.altmetric.com/v1/donut/13210202_240.png 2,Preclinical Evaluation of [18F]PSMA-1007: A New PSMA-Ligand for Prostate Cancer Imaging,Journal of Nuclear Medicine,,,Article,2016-10-27,10.2967/jnumed.116.181768,,,,27789722,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13168569,https://api.altmetric.com/v1/donut/13168569_240.png 2,A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer,International Journal of Clinical Oncology,,,Article,2016-10-24,10.1007/s10147-016-1057-y,,,,27778117,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13130713,https://api.altmetric.com/v1/donut/13130713_240.png 2,PROACT: Iterative Design of a Patient-Centered Visualization for Effective Prostate Cancer Health Risk Communication,IEEE Transactions on Visualization and Computer Graphics,,,Article,2016-01-01,10.1109/tvcg.2016.2598588,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13055848,https://api.altmetric.com/v1/donut/13055848_240.png 2,"More men with low risk prostate cancer are opting for active surveillance, study finds",British Medical Journal,,,Article,2016-10-21,10.1136/bmj.i5688,,,,27769959,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13042144,https://api.altmetric.com/v1/donut/13042144_240.png 2,Do African-American men need separate prostate cancer screening guidelines?,BMC Urology,,,Article,2016-05-10,10.1186/s12894-016-0137-7,,,,27165293,PMC4862049,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12928697,https://api.altmetric.com/v1/donut/12928697_240.png 2,INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer,BMC Cancer,,,Article,2016-10-21,10.1186/s12885-016-2856-2,,,,27769214,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12914593,https://api.altmetric.com/v1/donut/12914593_240.png 2," GSTT1 Null Genotype Is Associated with an Increased Risk of Prostate Cancer in Caucasians: A Meta-Analysis ",Urologia Internationalis,,,Article,2013-01-18,10.1159/000345420,,,,23343819,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12679559,https://api.altmetric.com/v1/donut/12679559_240.png 2,Prediction of the Risk of Harboring Prostate Cancer by a Prebiopsy Nomogram Based on Extended Biopsy Protocol,Urologia Internationalis,,,Article,2013-01-05,10.1159/000345603,,,,23295308,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12679324,https://api.altmetric.com/v1/donut/12679324_240.png 2,"Genomic and Biological Markers to Select Treatment in Patients with Prostate Cancer: Choose Wisely, My Friend",The Journal of Urology,,,Article,2016-10-18,10.1016/j.juro.2016.10.048,,,,27746279,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12606029,https://api.altmetric.com/v1/donut/12606029_240.png 2,Re: Resistance to Docetaxel in Prostate Cancer is Associated with Androgen Receptor Activation and Loss of KDM5D Expression,The Journal of Urology,,,Article,,10.1016/j.juro.2016.10.010,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12515667,https://api.altmetric.com/v1/donut/12515667_240.png 2,Deciphering the Effect of Metformin on Prostate Cancer Risk by Ethnicity,Cancer Prevention Research,,,Article,2016-10-01,10.1158/1940-6207.capr-16-0173,,,,27432345,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12475400,https://api.altmetric.com/v1/donut/12475400_240.png 2,Re: Can Radiologic Staging with Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?,The Journal of Urology,,,Article,,10.1016/j.juro.2016.09.096,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12436615,https://api.altmetric.com/v1/donut/12436615_240.png 2,Fried food and prostate cancer risk: systematic review and meta-analysis,International Journal of Food Sciences & Nutrition,,,Article,2015-06-26,10.3109/09637486.2015.1056111,,,,26114920,,,,,,,0,0,0,2,0,0,4,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12426389,https://api.altmetric.com/v1/donut/12426389_240.png 2,Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer,New England Journal of Medicine,,,Article,1998-09-17,10.1056/nejm199809173391201,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12414962,https://api.altmetric.com/v1/donut/12414962_240.png 2,Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.,Scientific Reports,,,Article,2016-09-20,10.1038/srep33510,,,,27641228,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12098710,https://api.altmetric.com/v1/donut/12098710_240.png 2,Re: Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-?1,The Journal of Urology,,,Article,,10.1016/j.juro.2016.09.014,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12005341,https://api.altmetric.com/v1/donut/12005341_240.png 2,Application of an unsupervised multi-characteristic framework for intermediate-high risk prostate cancer localization using diffusion-weighted MRI,Magnetic Resonance Imaging (0730725X),,,Article,2016-11-01,10.1016/j.mri.2016.06.004,,,,27451403,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10879483,https://api.altmetric.com/v1/donut/10879483_240.png 2,Spirituality is Associated with Less Treatment Regret in Men with Localized Prostate Cancer,Psycho-Oncology,,,Article,2016-01-01,10.1002/pon.4248,,,,27530290,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10686860,https://api.altmetric.com/v1/donut/10686860_240.png 2,Association Between Depression and Hospital Admission in Older Men with Prostate Cancer,Journal of the American Geriatrics Society,,,Article,2016-08-03,10.1111/jgs.14424,,,,27487263,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10247148,https://api.altmetric.com/v1/donut/10247148_240.png 2,Re: Recovery of Baseline Erectile Function in Men following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures,The Journal of Urology,,,Article,2016-07-14,10.1016/j.juro.2016.07.019,,,,27628822,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10128902,https://api.altmetric.com/v1/donut/10128902_240.png 2,Physical and emotional health information needs and preferences of long-term prostate cancer survivors,Patient Education & Counseling,,,Article,2016-07-13,10.1016/j.pec.2016.07.017,,,,27439668,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10127642,https://api.altmetric.com/v1/donut/10127642_240.png 2,Re: More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy,The Journal of Urology,,,Article,2016-07-29,10.1016/j.juro.2016.05.112,,,,27479525,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10124432,https://api.altmetric.com/v1/donut/10124432_240.png 2,Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade,The Journal of Urology,,,Article,2016-07-20,10.1016/j.juro.2016.07.069,,,,27450464,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10122907,https://api.altmetric.com/v1/donut/10122907_240.png 2,Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images,Medical Physics,,,Article,2016-07-18,10.1118/1.4958677,,,,27487880,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9827218,https://api.altmetric.com/v1/donut/9827218_240.png 2,A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago,Advances in Urology,,,Article,2016-07-17,10.1155/2016/2075021,,,,27493662,PMC4967437,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9825218,https://api.altmetric.com/v1/donut/9825218_240.png 2,Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis,International Journal of Molecular Sciences,,,Article,2016-07-02,10.3390/ijms17071061,,,,27384557,PMC4964437,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9518488,https://api.altmetric.com/v1/donut/9518488_240.png 2,Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies,The Prostate,,,Article,2016-04-22,10.1002/pros.23141,,,,26689606,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9163907,https://api.altmetric.com/v1/donut/9163907_240.png 2,Results From the Scandinavian Prostate Cancer Group Trial Number 4: A Randomized Controlled Trial of Radical Prostatectomy Versus Watchful Waiting,Journal of the National Cancer Institute. Monographs,,,Article,2012-09-01,10.1093/jncimonographs/lgs025,,,,23271778,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/8756578,https://api.altmetric.com/v1/donut/8756578_240.png 2,Re: Anatomical Patterns of Recurrence following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer,The Journal of Urology,,,Article,2016-06-10,10.1016/j.juro.2016.03.178,,,,27294293,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8653856,https://api.altmetric.com/v1/donut/8653856_240.png 2,"Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.03.027",European Urology,,,Article,2016-06-05,10.1016/j.eururo.2016.05.044,,,,27267886,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8490531,https://api.altmetric.com/v1/donut/8490531_240.png 2,An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer,Advances in Therapy,,,Article,2016-05-31,10.1007/s12325-016-0351-4,,,,27246172,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8418794,https://api.altmetric.com/v1/donut/8418794_240.png 2,"Factors Affecting Quality of Life at Different Time Points since Treatment in a Sample of Men with Localized Prostate Cancer: The Unique Influence of Treatment Decision Making Satisfaction, Personality, and Sexual Functioning",The Journal of Urology,,,Article,2016-05-31,10.1016/j.juro.2016.05.099,,,,27259651,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8403024,https://api.altmetric.com/v1/donut/8403024_240.png 2,Cabazitaxel for metastatic hormone-relapsed prostate cancer treated with docetaxel,Lancet Oncology,,,Article,2016-05-24,10.1016/s1470-2045(16)30165-6,,,,27234583,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8229616,https://api.altmetric.com/v1/donut/8229616_240.png 2,Prostate Cancer in Pilots,Aerospace medicine and human performance,,,Article,2016-01-01,10.3357/amhp.4453.2016,,,,27208680,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8217416,https://api.altmetric.com/v1/donut/8217416_240.png 2,Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer,Abdominal Radiology,,,Article,2015-12-22,10.1007/s00261-015-0579-5,,,,27193786,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7533388,https://api.altmetric.com/v1/donut/7533388_240.png 2,Primary Care of the Prostate Cancer Survivor.,American Family Physician,,,Article,2016-05-15,,,,,27175954,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7471193,https://api.altmetric.com/v1/donut/7471193_240.png 2,Re: Molecular Imaging of Prostate Cancer,The Journal of Urology,,,Article,2016-05-10,10.1016/j.juro.2016.05.026,,,,27479383,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7331114,https://api.altmetric.com/v1/donut/7331114_240.png 2,"Reply to Herney Andrés García-Perdomo and Ramiro Manzano Nunez's Letter to the Editor Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer M. Sinnott, Rachel S. Kelly, Lorelei A. Mucci, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.03.027",European Urology,,,Article,2016-05-01,10.1016/j.eururo.2016.04.032,,,,27156131,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7300093,https://api.altmetric.com/v1/donut/7300093_240.png 2,Are Small Reimbursement Changes Enough to Change Cancer Care? Reimbursement Variation in Prostate Cancer Treatment,Journal of Oncology Practice,,,Article,2016-04-01,10.1200/jop.2015.007344,,,,26957641,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6740234,https://api.altmetric.com/v1/donut/6740234_240.png 2,Planned versus ‘delivered’ bladder dose reconstructed using solid and hollow organ models during prostate cancer IMRT,Radiotherapy & Oncology,,,Article,2016-04-09,10.1016/j.radonc.2016.03.022,,,,27072936,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6596119,https://api.altmetric.com/v1/donut/6596119_240.png 2,The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening,PLoS ONE,,,Article,2016-04-06,10.1371/journal.pone.0152999,,,,27050101,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6512902,https://api.altmetric.com/v1/donut/6512902_240.png 2,Prostate cancer: Radiotherapy induces epigenetic changes,Nature Reviews Urology,,,Article,2016-04-05,10.1038/nrurol.2016.68,,,,27041209,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6478802,https://api.altmetric.com/v1/donut/6478802_240.png 2,Stat Bite Percentage of New Cases by Age Group For Prostate Cancer (2008-2012).,JNCI: Journal of the National Cancer Institute,,,Article,2016-04-01,10.1093/jnci/djw117,,,,27038118,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6448441,https://api.altmetric.com/v1/donut/6448441_240.png 2,An epigenetic reprogramming strategy to re-sensitize radioresistant prostate cancer cells.,Cancer Research,,,Article,2016-03-16,10.1158/0008-5472.can-15-2116,,,,26984757,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/6203226,https://api.altmetric.com/v1/donut/6203226_240.png 2,Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer,Clinical Medicine Insights: Oncology,,,Article,2016-03-16,10.4137/cmo.s34534,,,,27013902,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6201761,https://api.altmetric.com/v1/donut/6201761_240.png 2,Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice,European Urology Focus ,,,Article,2016-03-10,10.1016/j.euf.2016.02.013,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6152934,https://api.altmetric.com/v1/donut/6152934_240.png 2,ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2016-03-05,10.1158/1078-0432.ccr-15-2309,,,,26936914,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6043244,https://api.altmetric.com/v1/donut/6043244_240.png 2,Assessment of PI-RADS v2 for the Detection of Prostate Cancer ,European Journal of Radiology,,,Article,2016-04-01,10.1016/j.ejrad.2016.01.011,,,,26971415,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6042114,https://api.altmetric.com/v1/donut/6042114_240.png 2,DNA methylation profiles in African American prostate cancer patients in relation to disease progression,Genomics,,,Article,2016-02-24,10.1016/j.ygeno.2016.02.004,,,,26902887,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5985791,https://api.altmetric.com/v1/donut/5985791_240.png 2,"Re: Trends in Prostate-Specific Antigen Screening, Prostate Biopsies, Urology Visits, and Prostate Cancer Treatments from 2000 to 2012",The Journal of Urology,,,Article,2016-02-15,10.1016/j.juro.2016.02.052,,,,27186731,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5614792,https://api.altmetric.com/v1/donut/5614792_240.png 2,Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer,Clinical Epigenetics,,,Article,2016-02-12,10.1186/s13148-016-0182-9,,,,26877821,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5518428,https://api.altmetric.com/v1/donut/5518428_240.png 2,Racial Differences in Age-Related Variations of Testosterone Levels Among US Males: Potential Implications for Prostate Cancer and Personalized Medication.,Journal of Racial and Ethnic Health Disparities,,,Article,2016-02-11,10.1007/s40615-014-0049-8,,,,26863244,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/5309957,https://api.altmetric.com/v1/donut/5309957_240.png 2,Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2016-02-10,10.1158/1078-0432.ccr-15-2638,,,,26858312,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5110686,https://api.altmetric.com/v1/donut/5110686_240.png 2,Detection of AR-V7 mRNA in whole blood may not predict the effectiveness of novel endocrine drugs for castration-resistant prostate cancer,Research and Reports in Urology,,,Article,2016-01-28,10.2147/rru.s98877,,,,26870716,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5058828,https://api.altmetric.com/v1/donut/5058828_240.png 2,"Protons, Photons, and the Prostate – Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?",Frontiers in oncology,,,Article,2016-01-28,10.3389/fonc.2016.00008,,,,26858936,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/5053266,https://api.altmetric.com/v1/donut/5053266_240.png 2,Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.,Molecular Oncology,,,Article,2016-01-27,10.1016/j.molonc.2015.12.010,,,,26809501,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5048959,https://api.altmetric.com/v1/donut/5048959_240.png 2,Prostate cancer: Gene expression signature in tumours of smokers,Nature Reviews Urology,,,Article,2016-01-20,10.1038/nrurol.2016.7,,,,26787391,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5037248,https://api.altmetric.com/v1/donut/5037248_240.png 2,Prostate cancer expression profiles of cytoplasmic ER?1 and nuclear ER?2 are associated with poor outcomes following radical prostatectomy,The Journal of Urology,,,Article,2016-01-26,10.1016/j.juro.2015.12.101,,,,26804755,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5024586,https://api.altmetric.com/v1/donut/5024586_240.png 2,First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry.,Urologic Oncology,,,Article,2016-01-19,10.1016/j.urolonc.2015.12.005,,,,26777260,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5013088,https://api.altmetric.com/v1/donut/5013088_240.png 2,New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy.,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-15-0820,,,,26728408,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4950451,https://api.altmetric.com/v1/donut/4950451_240.png 2,[Primary candidate rna biomarker screening by RNA-seq for prostate cancer diagnostics].,Biomeditsinskaia khimiia,,,Article,2015-11-01,,,,,26716753,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4940698,https://api.altmetric.com/v1/donut/4940698_240.png 2,"Prostate Cancer Early Detection, Version 2.2015",Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2015-12-01,,,,,26656522,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4905996,https://api.altmetric.com/v1/donut/4905996_240.png 2,Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.,PLoS ONE,,,Article,2015-12-18,10.1371/journal.pone.0145322,,,,26683658,PMC4687717,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4896468,https://api.altmetric.com/v1/donut/4896468_240.png 2,Vasomotor symptoms in prostate cancer survivors undergoing androgen deprivation therapy.,Climacteric,,,Article,2015-12-18,10.3109/13697137.2015.1125460,,,,26673756,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4893640,https://api.altmetric.com/v1/donut/4893640_240.png 2,Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.,Clinical Epigenetics,,,Article,2015-12-12,10.1186/s13148-015-0161-6,,,,26692910,PMC4676897,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4871501,https://api.altmetric.com/v1/donut/4871501_240.png 2,Re: Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison with Low- and High-Grade Prostate Cancer,The Journal of Urology,,,Article,2016-02-19,10.1016/j.juro.2015.12.007,,,,26887710,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4865461,https://api.altmetric.com/v1/donut/4865461_240.png 2,miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells,PLoS ONE,,,Article,2015-12-09,10.1371/journal.pone.0144073,,,,26650737,PMC4674136,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4863236,https://api.altmetric.com/v1/donut/4863236_240.png 2,Hypofractionated Versus Conventionally Fractionated Radiation Therapy for Prostate Cancer: Five-Year Oncologic Outcomes of the Dutch Randomized Phase 3 HYPRO Trial ,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-01,10.1016/j.ijrobp.2015.10.045,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4860161,https://api.altmetric.com/v1/donut/4860161_240.png 2,"Predicting prostate cancer treatment choices: The role of numeracy, time discounting, and risk attitudes.",Journal of Health Psychology,,,Article,2015-11-29,10.1177/1359105315615931,,,,26613709,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4819647,https://api.altmetric.com/v1/donut/4819647_240.png 2,Cytogenetics and Molecular Genetics of Prostate Cancer: A Comprehensive Update.,Journal of the Association of Genetic Technologists,,,Article,2015-01-01,,,,,26606177,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4810402,https://api.altmetric.com/v1/donut/4810402_240.png 2,The prevalence of clinically significant prostate cancer according to commonly used histological thresholds in men undergoing template prostate mapping biopsies,The Journal of Urology,,,Article,,10.1016/j.juro.2015.11.047,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4809230,https://api.altmetric.com/v1/donut/4809230_240.png 2,Pilot study on the detection of antiandrogen resistance using serial diffusion?weighted imaging of bone metastases in prostate cancer,Journal of Magnetic Resonance Imaging,,,Article,2015-11-01,10.1002/jmri.25102,,,,26587694,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4788488,https://api.altmetric.com/v1/donut/4788488_240.png 2,Prostate cancer: Galeterone ARMORs up against CRPC,Nature Reviews Urology,,,Article,2015-11-17,10.1038/nrurol.2015.279,,,,26572085,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4770568,https://api.altmetric.com/v1/donut/4770568_240.png 2,Dysregulation of microRNA-212 Promotes Castration Resistance via hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.,Clinical Cancer Research,,,Article,2015-11-11,10.1158/1078-0432.ccr-15-1606,,,,26553749,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4745637,https://api.altmetric.com/v1/donut/4745637_240.png 2,Younger British men’s understandings of prostate cancer: A qualitative study,Journal of Health Psychology,,,Article,2015-11-04,10.1177/1359105315613776,,,,26537520,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4731669,https://api.altmetric.com/v1/donut/4731669_240.png 2,Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.,,,,Article,2010-01-15,10.1258/ebm.2009.009128,,,,20404023,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4719920,https://api.altmetric.com/v1/donut/4719920_240.png 2,Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancer.,Cancer informatics,,,Article,,10.4137/cin.s19745,,,,25506196,PMC4251540,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4697888,https://api.altmetric.com/v1/donut/4697888_240.png 2,Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer ,Molecular & Cellular Endocrinology,,,Article,2015-10-28,10.1016/j.mce.2015.10.011,,,,26499396,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4692470,https://api.altmetric.com/v1/donut/4692470_240.png 2,Modelling and structural characteristics analysis of gene networks for prostate cancer.,International Journal of Data Mining and Bioinformatics,,,Article,2015-01-01,,,,,26489139,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4666922,https://api.altmetric.com/v1/donut/4666922_240.png 2,Enabling or Cultivating? The Role of Prostate Cancer Patients’ Received Partner Support and Self-Efficacy in the Maintenance of Pelvic Floor Exercise Following Tumor Surgery,Annals of Behavioral Medicine,,,Article,2015-10-21,10.1007/s12160-015-9748-6,,,,26489842,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4659114,https://api.altmetric.com/v1/donut/4659114_240.png 2,"Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells",PLoS ONE,,,Article,2015-10-20,10.1371/journal.pone.0141090,,,,26485709,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4653269,https://api.altmetric.com/v1/donut/4653269_240.png 2,Diagnosis of prostate cancer via nanotechnological approach,International Journal of Nanomedicine,,,Article,2015-10-19,10.2147/ijn.s91908,,,,26527873,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/4650433,https://api.altmetric.com/v1/donut/4650433_240.png 2,Association of very low prostate?specific antigen levels with increased cancer?specific death in men with high?grade prostate cancer,Cancer (0008543X),,,Article,2015-09-01,10.1002/cncr.29691,,,,26371600,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4544825,https://api.altmetric.com/v1/donut/4544825_240.png 2,High-Resolution Rapid Diagnostic Imaging of Whole Prostate Biopsies Using Video-Rate Fluorescence Structured Illumination Microscopy,Cancer Research,,,Article,2015-10-01,10.1158/0008-5472.can-14-3806,,,,26282168,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/4496726,https://api.altmetric.com/v1/donut/4496726_240.png 2,Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer,International Journal of Nanomedicine,,,Article,2015-09-09,10.2147/ijn.s90559,,,,26425080,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4491524,https://api.altmetric.com/v1/donut/4491524_240.png 2,Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer,The Journal of Urology,,,Article,2015-09-12,10.1016/j.juro.2015.05.096,,,,26354886,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4469942,https://api.altmetric.com/v1/donut/4469942_240.png 2,Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging.,Frontiers in oncology,,,Article,2015-09-01,10.3389/fonc.2015.00194,,,,26389077,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4460273,https://api.altmetric.com/v1/donut/4460273_240.png 2,The clinical significance of biochemical failure in the first 2 years in patients treated with neo-adjuvant androgen deprivation and radiotherapy for prostate cancer, Research Journal of Infectious Diseases,,,Article,2013-04-22,10.7243/2052-6199-1-2,,,,,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4431931,https://api.altmetric.com/v1/donut/4431931_240.png 2,Re: Interruption of KLF5 Acetylation Converts its Function from Tumor Suppressor to Tumor Promoter in Prostate Cancer Cells,The Journal of Urology,,,Article,2015-10-20,10.1016/j.juro.2015.08.009,,,,26478085,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4392208,https://api.altmetric.com/v1/donut/4392208_240.png 2,Re: Effects of Luteinizing Hormone Receptor Signaling in Prostate Cancer Cells,The Journal of Urology,,,Article,2015-10-20,10.1016/j.juro.2015.08.008,,,,26478083,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4392207,https://api.altmetric.com/v1/donut/4392207_240.png 2,Acidosis-Induced Changes in Proteome Patterns of the Prostate Cancer-Derived Tumor Cell Line AT-1,Journal of Proteome Research,,,Article,2015-07-28,10.1021/acs.jproteome.5b00503,,,,26214752,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4336350,https://api.altmetric.com/v1/donut/4336350_240.png 2,Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations,Journal of the American Board of Family Medicine (formerly Journal of the American Board of Family Practice),,,Article,2015-07-15,10.3122/jabfm.2015.04.150062,,,,26152440,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4269517,https://api.altmetric.com/v1/donut/4269517_240.png 2,Baseline prostate atrophy is associated with reduced risk of prostate cancer in men undergoing repeat prostate biopsy,The Journal of Urology,,,Article,2015-07-15,10.1016/j.juro.2015.05.103,,,,26165588,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4262693,https://api.altmetric.com/v1/donut/4262693_240.png 2,"Xanthohumol impairs human prostate cancer cell growth and invasion, and diminishes the incidence and progression of advanced tumors in TRAMP mice.",,,,Article,2012-12-06,10.2119/molmed.2012.00174,,,,22952060,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4241273,https://api.altmetric.com/v1/donut/4241273_240.png 2,TU-CD-BRB-12: Radiogenomics of MRI-Guided Prostate Cancer Biopsy Habitats.,Medical Physics,,,Article,2015-07-02,10.1118/1.4925597,,,,26128897,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4235097,https://api.altmetric.com/v1/donut/4235097_240.png 2,Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells,PLoS ONE,,,Article,2015-06-29,10.1371/journal.pone.0131811,,,,26121643,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4225426,https://api.altmetric.com/v1/donut/4225426_240.png 2,Triexponential function analysis of diffusion?weighted MRI for diagnosing prostate cancer,Journal of Magnetic Resonance Imaging,,,Article,2015-06-27,10.1002/jmri.24974,,,,26119033,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4219459,https://api.altmetric.com/v1/donut/4219459_240.png 2,A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance,BMJ Open,,,Article,2015-05-01,10.1136/bmjopen-2014-006674,,,,26002689,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4176423,https://api.altmetric.com/v1/donut/4176423_240.png 2,Prostate cancer: Docetaxel in high-risk disease,Nature Reviews Urology,,,Article,2015-06-16,10.1038/nrurol.2015.146,,,,26077993,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4168944,https://api.altmetric.com/v1/donut/4168944_240.png 2,Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients,BMC Cancer,,,Article,2015-06-09,10.1186/s12885-015-1478-4,,,,26051431,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4151949,https://api.altmetric.com/v1/donut/4151949_240.png 2,Re: A Human Prostatic Bacterial Isolate Alters the Prostatic Microenvironment and Accelerates Prostate Cancer Progression,The Journal of Urology,,,Article,2015-08-22,10.1016/j.juro.2015.06.023,,,,26292899,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4137192,https://api.altmetric.com/v1/donut/4137192_240.png 2,C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer.,Oncotarget,,,Article,2015-06-05,10.18632/oncotarget.4172,,,,26041889,PMC4627319,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4098355,https://api.altmetric.com/v1/donut/4098355_240.png 2,Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer,Marine Drugs,,,Article,2015-05-27,10.3390/md13063276,,,,26023836,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4096964,https://api.altmetric.com/v1/donut/4096964_240.png 2,Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.,American Journal of Preventive Medicine,,,Article,2015-08-01,10.1016/j.amepre.2015.02.007,,,,25997905,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4082663,https://api.altmetric.com/v1/donut/4082663_240.png 2,Circulating tumor cells in prostate cancer: Does (nuclear) size matter?,Cancer (0008543X),,,Article,2015-05-14,10.1002/cncr.29454,,,,25980931,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4038730,https://api.altmetric.com/v1/donut/4038730_240.png 2,"Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, (18)F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.",Acta Oncologica,,,Article,2015-04-02,10.3109/0284186x.2015.1027411,,,,25833330,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4032234,https://api.altmetric.com/v1/donut/4032234_240.png 2,"Similarities of prostate and breast cancer: Evolution, diet, and estrogens.",Urology,,,Article,,,,,,11295592,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/4014627,https://api.altmetric.com/v1/donut/4014627_240.png 2,Enhancing Accumulation and Penetration of HPMA Copolymer–Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer,Journal of the American Chemical Society,,,Article,2015-06-03,10.1021/jacs.5b00922,,,,25963409,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/4011766,https://api.altmetric.com/v1/donut/4011766_240.png 2,Should the urologist should treat castration resistant prostate cancer: No,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.05.037,,,,25986508,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4000992,https://api.altmetric.com/v1/donut/4000992_240.png 2,Should the urologist should treat castration resistant prostate cancer,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.05.036,,,,25986513,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4000990,https://api.altmetric.com/v1/donut/4000990_240.png 2,The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines,Cancer Genetics & Cytogenetics,,,Article,,10.1016/s0165-4608(00)00339-3,,,,11172901,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3998189,https://api.altmetric.com/v1/donut/3998189_240.png 2,Association between serum phospholipid fatty acids and intraprostatic inflammation in the placebo arm of the Prostate Cancer Prevention Trial.,Cancer Prevention Research,,,Article,2015-04-29,10.1158/1940-6207.capr-14-0398,,,,25926387,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3997604,https://api.altmetric.com/v1/donut/3997604_240.png 2,Patterns of Local Failure Following Radiation Therapy for Prostate Cancer,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.04.111,,,,25983194,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3997582,https://api.altmetric.com/v1/donut/3997582_240.png 2,Regulation of tumor cell plasticity by the androgen receptor in prostate cancer,Endocrine-Related Cancer,,,Article,2015-06-01,10.1530/erc-15-0137,,,,25934687,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3982243,https://api.altmetric.com/v1/donut/3982243_240.png 2,"Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients.",OncoTargets and therapy,,,Article,2015-05-23,10.2147/ott.s78836,,,,25995645,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/3980032,https://api.altmetric.com/v1/donut/3980032_240.png 2,Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer,The Journal of Urology,,,Article,2015-05-11,10.1016/j.juro.2014.12.104,,,,25958020,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3974360,https://api.altmetric.com/v1/donut/3974360_240.png 2,Fluorescence – guided targeted pelvic Lymph node dissection in intermediate and high risk prostate cancer,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.03.127,,,,25896557,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3920096,https://api.altmetric.com/v1/donut/3920096_240.png 2,Cell-free DNA (cfDNA) as a prognostic marker for response to taxan-based chemotherapy in prostate cancer (PCA) patients,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.04.055,,,,25896555,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3920095,https://api.altmetric.com/v1/donut/3920095_240.png 2,Re: A Randomised Controlled Trial of a Couples-Based Sexuality Intervention for Men with Localised Prostate Cancer and their Female Partners,The Journal of Urology,,,Article,2015-06-20,10.1016/j.juro.2015.04.061,,,,26088241,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3916054,https://api.altmetric.com/v1/donut/3916054_240.png 2,Re: Bone-Induced c-Kit Expression in Prostate Cancer: A Driver of Intraosseous Tumor Growth,The Journal of Urology,,,Article,2015-06-20,10.1016/j.juro.2015.04.026,,,,26088254,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3908525,https://api.altmetric.com/v1/donut/3908525_240.png 2,Associations of obesity with prostate cancer risk differ between u.s. African-american and non-Hispanic white men: results from the selenium and vitamin e cancer prevention trial.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-04-04,10.1158/1055-9965.epi-15-0117,,,,25834168,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3874386,https://api.altmetric.com/v1/donut/3874386_240.png 2,Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTA-huJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.,Current Radiopharmaceuticals,,,Article,2015-03-18,,,,,25771365,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3844793,https://api.altmetric.com/v1/donut/3844793_240.png 2,Gross tumor volume and clinical target volume in prostate cancer: How do satellites relate to the index lesion,Radiotherapy & Oncology,,,Article,2015-03-18,10.1016/j.radonc.2015.01.021,,,,25796092,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3812223,https://api.altmetric.com/v1/donut/3812223_240.png 2,Keeping an Open Mind About Novel Concepts for Management of Prostate Cancer,European Urology,,,Article,2015-03-11,10.1016/j.eururo.2015.02.024,,,,25770483,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3791597,https://api.altmetric.com/v1/donut/3791597_240.png 2,Accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinical significant prostate cancer in enlarged compared to smaller prostates,The Journal of Urology,,,Article,,10.1016/j.juro.2015.03.025,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3789413,https://api.altmetric.com/v1/donut/3789413_240.png 2,Re: Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.03.005,,,,25986841,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3789228,https://api.altmetric.com/v1/donut/3789228_240.png 2,Re: Hospital Admissions after Transrectal Ultrasound-Guided Biopsy of the Prostate in Men Diagnosed with Prostate Cancer: A Database Analysis in England,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.03.014,,,,25986796,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3789221,https://api.altmetric.com/v1/donut/3789221_240.png 2,Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.,Journal of Cancer Research & Clinical Oncology,,,Article,2015-03-13,10.1007/s00432-015-1947-9,,,,25764380,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3783727,https://api.altmetric.com/v1/donut/3783727_240.png 2,Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous 18F-fluorocholine PET/MRI for primary prostate cancer characterization,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-03-11,10.1007/s00259-015-3026-5,,,,25759164,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3779702,https://api.altmetric.com/v1/donut/3779702_240.png 2,Improving Prediction of Prostate Cancer Recurrence using Chemical Imaging,Scientific Reports,,,Article,2015-03-04,10.1038/srep08758,,,,25737022,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/3772474,https://api.altmetric.com/v1/donut/3772474_240.png 2,CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy,Cancer Research,,,Article,2015-03-15,10.1158/0008-5472.can-14-0992,,,,25736687,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3753010,https://api.altmetric.com/v1/donut/3753010_240.png 2,Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells,Naunyn-Schmiedeberg's Archives of Pharmacology,,,Article,2015-02-24,10.1007/s00210-015-1104-7,,,,25708950,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3730628,https://api.altmetric.com/v1/donut/3730628_240.png 2,Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review,Radiation Oncology,,,Article,2015-02-22,10.1186/s13014-015-0349-0,,,,25880809,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3718662,https://api.altmetric.com/v1/donut/3718662_240.png 2,Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer,Radiation Oncology,,,Article,2015-02-19,10.1186/s13014-015-0351-6,,,,25890265,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3716487,https://api.altmetric.com/v1/donut/3716487_240.png 2,Metastatic prostate cancer mimicking thrombotic thrombocytopenic purpura,Blood,,,Article,,10.1182/blood-2014-11-608828,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3715100,https://api.altmetric.com/v1/donut/3715100_240.png 2,Re: Telomere Length as a Risk Factor for Hereditary Prostate Cancer,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.02.047,,,,25895768,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3712695,https://api.altmetric.com/v1/donut/3712695_240.png 2,Re: Management of Prostate Cancer in Older Patients: Updated Recommendations of a Working Group of the International Society of Geriatric Oncology,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.02.049,,,,25895769,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3712683,https://api.altmetric.com/v1/donut/3712683_240.png 2,Re: A Biopsy-Based 17-Gene Genomic Prostate Score Predicts Recurrence after Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-Risk Prostate Cancer,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.02.070,,,,25895765,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3712682,https://api.altmetric.com/v1/donut/3712682_240.png 2,Cross?talk of alpha tocopherol?associated protein and JNK controls the oxidative stress?induced apoptosis in prostate cancer cells,International Journal of Cancer,,,Article,2012-11-28,10.1002/ijc.27927,,,,23129185,,,,,,,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3702899,https://api.altmetric.com/v1/donut/3702899_240.png 2,Ethanol extract of Remotiflori radix induces endoplasmic reticulum stress-mediated cell death through AMPK/mTOR signaling in human prostate cancer cells,Scientific Reports,,,Article,2015-02-11,10.1038/srep08394,,,,25670261,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,10,https://www.altmetric.com/details/3553826,https://api.altmetric.com/v1/donut/3553826_240.png 2,Re: Estrogen Receptor ? Upregulates FOXO3a and Causes Induction of Apoptosis through PUMA in Prostate Cancer,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.02.021,,,,25895808,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3526949,https://api.altmetric.com/v1/donut/3526949_240.png 2,Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial - lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer),BMC Medical Research Methodology,,,Article,2015-01-23,10.1186/1471-2288-15-6,,,,25613468,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3111204,https://api.altmetric.com/v1/donut/3111204_240.png 2,Systematic Review and Meta-analysis of the Survival Outcomes of First-line Treatment Options in High-risk Prostate Cancer,Scientific Reports,,,Article,2015-01-12,10.1038/srep07713,,,,25578739,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3107629,https://api.altmetric.com/v1/donut/3107629_240.png 2,Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease,The Journal of Urology,,,Article,2015-01-07,10.1016/j.juro.2015.01.078,,,,25623747,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3099040,https://api.altmetric.com/v1/donut/3099040_240.png 2,Gene expression profiling analysis of castration-resistant prostate cancer.,Medical science monitor international medical journal of experimental and clinical research,,,Article,2015-01-01,10.12659/msm.891193,,,,25592164,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3075760,https://api.altmetric.com/v1/donut/3075760_240.png 2,Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials,Annals of Oncology,,,Article,2014-12-15,10.1093/annonc/mdu569,,,,25515657,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2995861,https://api.altmetric.com/v1/donut/2995861_240.png 2,Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99],European Urology,,,Article,2015-05-07,10.1016/j.eururo.2014.12.001,,,,25944041,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2994292,https://api.altmetric.com/v1/donut/2994292_240.png 2,A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.,Investigational New Drugs,,,Article,2014-11-29,10.1007/s10637-014-0189-z,,,,25431127,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2968809,https://api.altmetric.com/v1/donut/2968809_240.png 2,Long-term testosterone therapy does not increase the risk of prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6690-long-term-testosterone-therapy-does-not-increase-the-risk-of-prostate-cancer.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2927398,https://api.altmetric.com/v1/donut/2927398_240.png 2,Epigenetics in breast and prostate cancer.,Methods in molecular biology,,,Article,2015-01-01,10.1007/978-1-4939-1804-1_23,,,,25421674,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2926042,https://api.altmetric.com/v1/donut/2926042_240.png 2,"Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort.",The Prostate,,,Article,2000-05-01,,,,,10754529,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2918942,https://api.altmetric.com/v1/donut/2918942_240.png 2,A Comprehensive Review of Contemporary Role of Local Treatment of the Primary Tumor and/or the Metastases in Metastatic Prostate Cancer.,BioMed Research International,,,Article,,10.1155/2014/501213,,,,25485280,,,,,,,0,0,0,5,0,0,0,0,0,0,1,0,0,0,0,2,https://www.altmetric.com/details/2917424,https://api.altmetric.com/v1/donut/2917424_240.png 2,Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3?+?4 prostate cancer,European Radiology,,,Article,2014-08-07,10.1007/s00330-014-3367-7,,,,25100337,,,,,,,0,0,0,2,0,0,4,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2916463,https://api.altmetric.com/v1/donut/2916463_240.png 2,"Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis",Cent European J Urol,,,Article,2014-04-24,10.5173/ceju.2013.04.art7,,,,24757532,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2879200,https://api.altmetric.com/v1/donut/2879200_240.png 2,"A Novel Subset of Human Tumors That Simultaneously Overexpress Multiple E2F-responsive Genes Found in Breast, Ovarian, and Prostate Cancers.",Cancer Informatics,,,Article,2014-11-01,10.4137/cin.s14062,,,,25392696,PMC4221091,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2856606,https://api.altmetric.com/v1/donut/2856606_240.png 2,"TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer",Biological Research,,,Article,2013-01-01,10.4067/s0716-97602013000400014,,,,24510145,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2826207,https://api.altmetric.com/v1/donut/2826207_240.png 2,"Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study",JNCI: Journal of the National Cancer Institute,,,Article,1998-06-17,10.1093/jnci/90.12.911,,,,9637140,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2815023,https://api.altmetric.com/v1/donut/2815023_240.png 2,Integrative analysis of FOXP1 function reveals a tumor suppressive effect in prostate cancer.,Molecular Endocrinology,,,Article,2014-10-20,10.1210/me.2014-1171,,,,25329375,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2797450,https://api.altmetric.com/v1/donut/2797450_240.png 2,"Oxidative Stress–Related Genetic Variants, Pro- and Antioxidant Intake and Status, and Advanced Prostate Cancer Risk","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-10-17,10.1158/1055-9965.epi-14-0968,,,,25315963,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2794348,https://api.altmetric.com/v1/donut/2794348_240.png 2,Exploiting Literature-derived Knowledge and Semantics to Identify Potential Prostate Cancer Drugs,Cancer Informatics,,,Article,2014-10-01,10.4137/cin.s13889,,,,,,,,,,,0,0,0,2,1,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2790541,https://api.altmetric.com/v1/donut/2790541_240.png 2,"Melatonin, Sleep, and Prostate Cancer in Elderly Men: Study, Hypothesis Development, and Icelandic Options",European Urology,,,Article,2014-09-30,10.1016/j.eururo.2014.09.033,,,,25282366,,,,,,,0,0,0,1,0,0,3,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/2767090,https://api.altmetric.com/v1/donut/2767090_240.png 2,"Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.",Journal of Steroid Biochemistry & Molecular Biology,,,Article,2014-10-08,10.1016/j.jsbmb.2014.10.004,,,,25305352,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2765839,https://api.altmetric.com/v1/donut/2765839_240.png 2,Obesity and Prostate Cancer: Weighing the Evidence.,European Urology,,,Article,2013-05-01,10.1016/j.eururo.2012.11.013,,,,23219374,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,101,https://www.altmetric.com/details/2737009,https://api.altmetric.com/v1/donut/2737009_240.png 2,Inhibition of CHOP accentuates the apoptotic effect of ?-mangostin from the mangosteen fruit (Garcinia mangostana) in 22Rv1 prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2014-09-24,10.1016/j.bbrc.2014.09.054,,,,25261723,,,,,,,0,0,0,2,0,0,7,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2722758,https://api.altmetric.com/v1/donut/2722758_240.png 2,"Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial ",Lancet Oncology,,,Article,2014-09-17,10.1016/s1470-2045(14)70417-6,,,,25242048,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2697119,https://api.altmetric.com/v1/donut/2697119_240.png 2,Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review,Prostate Cancer & Prostatic Diseases,,,Article,2014-05-06,10.1038/pcan.2014.17,,,,24796290,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2664625,https://api.altmetric.com/v1/donut/2664625_240.png 2,Decisional Conflict in Economically Disadvantaged Men With Newly Diagnosed Prostate Cancer: Baseline Results From a Shared Decision-Making Trial.,Cancer (0008543X),,,Article,2014-05-08,10.1002/cncr.28755,,,,24816472,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2635558,https://api.altmetric.com/v1/donut/2635558_240.png 2,Engineered M13 Bacteriophage Nanocarriers for Intracellular Delivery of Exogenous Proteins to Human Prostate Cancer Cells.,Bioconjugate Chemistry,,,Article,2014-08-20,10.1021/bc500339k,,,,25134017,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2620282,https://api.altmetric.com/v1/donut/2620282_240.png 2,Single-Cell Genetic Analysis Reveals Insights into Clonal Development of Prostate Cancers and Indicates Loss of PTEN as a Marker of Poor Prognosis,American Journal of Pathology,,,Article,2014-01-10,10.1016/j.ajpath.2014.06.030,,,,25131421,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/2598041,https://api.altmetric.com/v1/donut/2598041_240.png 2,Prostate Cancer Cells Alter the Nature of Their Calcium Influx to Promote Growth and Acquire Apoptotic Resistance,Cancer Cell,,,Article,,10.1016/j.ccr.2014.06.015,,,,25026203,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2511358,https://api.altmetric.com/v1/donut/2511358_240.png 2,"Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer.",Urologic Oncology,,,Article,2014-04-30,10.1016/j.urolonc.2013.10.020,,,,24768356,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/2506126,https://api.altmetric.com/v1/donut/2506126_240.png 2,Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study.,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2014.03.05,,,,25010298,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2504329,https://api.altmetric.com/v1/donut/2504329_240.png 2,"Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival.",JNCI: Journal of the National Cancer Institute,,,Article,2014-05-17,10.1093/jnci/dju085,,,,24824313,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2495071,https://api.altmetric.com/v1/donut/2495071_240.png 2,Mortality in Prostate Cancer and Use of Statins,Journal of Clinical Oncology,,,Article,2014-06-11,10.1200/jco.2013.54.3264,,,,24912890,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2433473,https://api.altmetric.com/v1/donut/2433473_240.png 2,Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence,Radiation Oncology,,,Article,2014-06-12,10.1186/1748-717x-9-135,,,,24920079,,1854/LU-4424637,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2431246,https://api.altmetric.com/v1/donut/2431246_240.png 2,New tool helps predict risk of prostate cancer overdiagnosis,Cancer (0008543X),,,Article,2014-06-15,10.1002/cncr.28804,,,,24895265,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2423262,https://api.altmetric.com/v1/donut/2423262_240.png 2,The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests.,Journal of Family Practice,,,Article,2000-05-01,,,,,10836772,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2377975,https://api.altmetric.com/v1/donut/2377975_240.png 2,Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry.,Journal of Nuclear Medicine,,,Article,2014-05-12,10.2967/jnumed.113.135475,,,,24819422,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2351489,https://api.altmetric.com/v1/donut/2351489_240.png 2,Proper Sequencing of Treatment for Castrate Resistant Prostate Cancer,Urology Practice,,,Article,2014-01-05,10.1016/j.urpr.2014.02.014,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2327634,https://api.altmetric.com/v1/donut/2327634_240.png 2,Genetic variation in protein specific antigen detected prostate cancer and the effect of control selection on genetic association studies.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-04-21,10.1158/1055-9965.epi-13-0889,,,,24753544,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2301416,https://api.altmetric.com/v1/donut/2301416_240.png 2,Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial.,Radiation Oncology,,,Article,2014-04-24,10.1186/1748-717x-9-96,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2300996,https://api.altmetric.com/v1/donut/2300996_240.png 2,Can we deliver randomized trials of focal therapy in prostate cancer?,Nature Reviews Clinical Oncology,,,Article,2014-04-22,10.1038/nrclinonc.2014.44,,,,24751803,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2298246,https://api.altmetric.com/v1/donut/2298246_240.png 2,Radiation Safety Considerations for the Use of 223RaCl2 DE in Men with Castration-resistant Prostate Cancer.,Health Physics,,,Article,2014-02-26,10.1097/hp.0b013e3182a82b37,,,,24562070,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2289322,https://api.altmetric.com/v1/donut/2289322_240.png 2,Retraction statement: The spectrum of morphology in non?neoplastic prostate including cancer mimics,Histopathology,,,Article,2014-04-03,10.1111/his.12418,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2232555,https://api.altmetric.com/v1/donut/2232555_240.png 2,Living with untreated prostate cancer: predictors of quality of life,Current Opinion in Urology,,,Article,2014-03-25,10.1097/mou.0000000000000038,,,,24637318,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2216898,https://api.altmetric.com/v1/donut/2216898_240.png 2,Surgery versus radiotherapy for prostate cancer,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70112-3,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2168353,https://api.altmetric.com/v1/donut/2168353_240.png 2,Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy.,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.12.005,,,,24361258,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2124840,https://api.altmetric.com/v1/donut/2124840_240.png 2,The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.,Biology Direct,,,Article,2010-04-22,10.1186/1745-6150-5-24,,,,20406442,PMC2885348,,,,,,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2069246,https://api.altmetric.com/v1/donut/2069246_240.png 2,Quality of life after robotic surgery treatment for prostate cancer. Quality of life after robotic surgery treatment for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/2504/quality-of-life-after-robotic-surgery-treatment-for-prostate-cancer.php,,,,,,,,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/2047202,https://api.altmetric.com/v1/donut/2047202_240.png 2,THE IMPACT OF PATIENT ADVOCACY: THE UNIVERSITY OF CALIFORNIA-SAN FRANCISCO EXPERIENCE,The Journal of Urology,,,Article,2004-01-01,10.1097/01.ju.0000142247.16452.f1,,,,15535445,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2026109,https://api.altmetric.com/v1/donut/2026109_240.png 2,"“We Remain Very Much the Second Sex” The Constructions of Prostate Cancer in Popular News Magazines, 2000-2010",American Journal of Men's Health,,,Article,2013-05-08,10.1177/1557988313487922,,,,23660236,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2021538,https://api.altmetric.com/v1/donut/2021538_240.png 2,Soy Isoflavones and Prostate Cancer: A Review of Molecular Mechanisms.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2013-12-24,10.1016/j.jsbmb.2013.12.010,,,,24373791,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,88,https://www.altmetric.com/details/2015316,https://api.altmetric.com/v1/donut/2015316_240.png 2,A Naturally-Derived Small Molecule Disrupts Ligand-Dependent and Ligand-Independent Androgen Receptor Signaling in Human Prostate Cancer Cells.,Molecular Cancer Therapeutics,,,Article,2013-11-20,10.1158/1535-7163.mct-13-0478,,,,24258347,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1965120,https://api.altmetric.com/v1/donut/1965120_240.png 2,Estrogen: one of the risk factors in milk for prostate cancer.,Medical Hypotheses,,,Article,2004-01-01,,,,,14729019,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1941634,https://api.altmetric.com/v1/donut/1941634_240.png 2,Scientists finally discover which prostate cancers are life-threatening,ecancer.org,,,Article,,,,,http://ecancer.org/news/4778-scientists-finally-discover-which-prostate-cancers-are-life-threatening.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1937482,https://api.altmetric.com/v1/donut/1937482_240.png 2,Erratum for “Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide”,Clinical Medicine Insights: Oncology,,,Article,2013-11-01,10.4137/cmo.s13594,,,,24324355,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1935510,https://api.altmetric.com/v1/donut/1935510_240.png 2,Evaluation of prediction models for the staging of prostate cancer,BMC Medical Informatics and Decision Making,,,Article,2013-11-15,10.1186/1472-6947-13-126,,,,24238348,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1910444,https://api.altmetric.com/v1/donut/1910444_240.png 2,Dasatinib and docetaxel in advanced prostate cancer,Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70500-x,,,,24211164,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1891296,https://api.altmetric.com/v1/donut/1891296_240.png 2,Prostate cancer: Radium-223: a new treatment option for bone-metastatic CRPC.,Nature Reviews Urology,,,Article,2013-10-15,10.1038/nrurol.2013.232,,,,24126730,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1873879,https://api.altmetric.com/v1/donut/1873879_240.png 2,The Kallikrein Panel for prostate cancer screening: Its economic impact.,The Prostate,,,Article,2013-10-26,10.1002/pros.22746,,,,24166488,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1873877,https://api.altmetric.com/v1/donut/1873877_240.png 2,Adrenomedullin blockade suppresses growth of human hormone independent prostate tumor xenograft in mice.,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-0691,,,,24100627,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1811220,https://api.altmetric.com/v1/donut/1811220_240.png 2,Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.,The Journal of Urology,,,Article,2011-03-01,10.1016/j.juro.2010.10.079,,,,21239021,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1808784,https://api.altmetric.com/v1/donut/1808784_240.png 2,ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.,Journal of Applied Econometrics,,,Article,2013-01-01,10.1002/jae.2343,,,,25620844,PMC4300990,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1807744,https://api.altmetric.com/v1/donut/1807744_240.png 2,The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance,British Journal of Cancer,,,Article,2013-09-19,10.1038/bjc.2013.537,,,,24052043,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1783845,https://api.altmetric.com/v1/donut/1783845_240.png 2,Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome.,Psychoneuroendocrinology,,,Article,2013-09-06,10.1016/j.psyneuen.2013.08.008,,,,24054763,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1779775,https://api.altmetric.com/v1/donut/1779775_240.png 2,Sexual Values as the Key to Maintaining Satisfying Sex After Prostate Cancer Treatment: The Physical Pleasure-Relational Intimacy Model of Sexual Motivation.,Archives of Sexual Behavior,,,Article,2013-09-18,10.1007/s10508-013-0168-z,,,,24045902,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1776469,https://api.altmetric.com/v1/donut/1776469_240.png 2,Pilot Study on Quality of Life and Sexual Function in Menâ??Whoâ??Haveâ??Sexâ??withâ??Men Treated for Prostate Cancer,Journal of Sexual Medicine,,,Article,2013-01-01,10.1111/jsm.12208,,,,23742184,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1690095,https://api.altmetric.com/v1/donut/1690095_240.png 2,Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3228,,,,23878190,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/1641434,https://api.altmetric.com/v1/donut/1641434_240.png 2,"Comparison of Prostate Cancer Mortality in Five Countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960–2000)",Japanese Journal of Clinical Oncology,,,Article,2005-01-01,10.1093/jjco/hyi185,,,,16306486,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1634662,https://api.altmetric.com/v1/donut/1634662_240.png 2,Time to raise the bar in localised prostate cancer,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12328,,,,23826836,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1604943,https://api.altmetric.com/v1/donut/1604943_240.png 2,"Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger",Cancer (0008543X),,,Article,1970-01-01,10.1002/cncr.27398,,,,22253020,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1597968,https://api.altmetric.com/v1/donut/1597968_240.png 2,Diagnostic tests in urology: magnetic resonance imaging (MRI) for the staging of prostate cancer.,British Journal of Urology,,,Article,2013-01-18,10.1111/j.1464-410x.2012.11447.x,,,,23320634,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1577431,https://api.altmetric.com/v1/donut/1577431_240.png 2,Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2013-06-11,10.1038/pcan.2013.16,,,,23752230,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1548375,https://api.altmetric.com/v1/donut/1548375_240.png 2,High incidence of prostate cancer metastasis in Afro-Brazilian men with low educational levels: a retrospective observational study,BMC Public Health,,,Article,2013-06-04,10.1186/1471-2458-13-537,,,,23734601,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1533612,https://api.altmetric.com/v1/donut/1533612_240.png 2,Plasma-seq: a novel strategy for metastatic prostate cancer analysis,Genome Medicine,,,Article,2013-04-29,10.1186/gm439,,,,23673197,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1419459,https://api.altmetric.com/v1/donut/1419459_240.png 2,Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation,Clinical Interventions in Aging,,,Article,2013-04-01,10.2147/cia.s27931,,,,23637525,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1415775,https://api.altmetric.com/v1/donut/1415775_240.png 2,Marital status and prostate cancer outcomes.,Canadian Journal of Urology,,,Article,2013-04-18,,,,,23587510,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1410923,https://api.altmetric.com/v1/donut/1410923_240.png 2,A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,2013-04-21,10.1007/s00280-013-2163-4,,,,23604530,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1404060,https://api.altmetric.com/v1/donut/1404060_240.png 2,"Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.46.4149,,,,23569308,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1356529,https://api.altmetric.com/v1/donut/1356529_240.png 2,"The Influence of Family Ties on Men's Prostate Cancer Screening, Biopsy, and Treatment Decisions.",American Journal of Men's Health,,,Article,2013-03-07,10.1177/1557988313480226,,,,23459024,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1295721,https://api.altmetric.com/v1/donut/1295721_240.png 2,Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer,Journal of Translational Medicine,,,Article,2013-02-11,10.1186/1479-5876-11-36,,,,23398928,,,,,,,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1293773,https://api.altmetric.com/v1/donut/1293773_240.png 2,Validation and clinical utility of prostate cancer biomarkers,Nature Reviews Clinical Oncology,,,Article,2013-03-05,10.1038/nrclinonc.2013.30,,,,23459624,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1280534,https://api.altmetric.com/v1/donut/1280534_240.png 2,"New drugs, new ways to target androgens in prostate cancer therapy",ecancer.org,,,Article,,,,,http://ecancer.org/news/3184-new-drugs--new-ways-to-target-androgens-in-prostate-cancer-therapy.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251482,https://api.altmetric.com/v1/donut/1251482_240.png 2,Beehive extract shows potential as prostate cancer treatment,ecancer,,,Article,,,,,http://ecancer.org/news/2796-beehive-extract-shows-potential-as-prostate-cancer-treatment.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251321,https://api.altmetric.com/v1/donut/1251321_240.png 2,FDA approves use of abiraterone acetate for metastaticcastration-resistant prostate cancer . ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3649-fda-approves-use-of-abiraterone-acetate-for-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251242,https://api.altmetric.com/v1/donut/1251242_240.png 2,FDA approves enzalutamide for metastatic castration-resistant prostate cancer post docetaxel.,ecancer.org,,,Article,,,,,http://ecancer.org/news/3353-fda-approves-enzalutamide-for-metastatic-castration-resistant-prostate-cancer-post-docetaxel.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250964,https://api.altmetric.com/v1/donut/1250964_240.png 2,Synthesis and Biological Evaluation of Some Substituted-2-N-(5-chloro-2-methoxy-4-methylphenylsulphonyl) Glutamic Acid Derivatives against Prostate Cancer Cell Line PC3.,Chemical and Pharmaceutical Bulletin,,,Article,2013-02-03,,,,,23370196,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1230620,https://api.altmetric.com/v1/donut/1230620_240.png 2,Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22646,,,,23389815,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1223199,https://api.altmetric.com/v1/donut/1223199_240.png 2,Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.,Cancer Prevention Research,,,Article,2013-01-11,10.1158/1940-6207.capr-12-0250,,,,23315596,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1178895,https://api.altmetric.com/v1/donut/1178895_240.png 2,Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention,Cancer Discovery,,,Article,2012-01-01,10.1158/2159-8290.cd-12-0262,,,,23258246,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1172329,https://api.altmetric.com/v1/donut/1172329_240.png 2,Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0053527,,,,23308245,PMC3538595,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1159441,https://api.altmetric.com/v1/donut/1159441_240.png 2,Exercise and prostate cancer.,Sports Medicine,,,Article,2004-05-26,,,,,15157121,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1156125,https://api.altmetric.com/v1/donut/1156125_240.png 2,Prostatic Alpha-Linolenic Acid (ALA) Is Positively Associated with Aggressive Prostate Cancer: A Relationship Which May Depend on Genetic Variation in ALA Metabolism,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0053104,,,,23285256,,10161/11293,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1146345,https://api.altmetric.com/v1/donut/1146345_240.png 2,Protons for Prostate Cancer: the Dream Versus the Reality,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djs509,,,,23243201,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1125426,https://api.altmetric.com/v1/donut/1125426_240.png 2,The Skeletal Muscle–Metabolism Axis in Prostate-Cancer Therapy,New England Journal of Medicine,,,Article,2012-12-06,10.1056/nejmc1211955,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1108570,https://api.altmetric.com/v1/donut/1108570_240.png 2,"Genetic Polymorphisms of GSTM1, GSTT1, and GSTP1 with Prostate Cancer Risk: A Meta-Analysis of 57 Studies",PLoS ONE,,,Article,2012-11-26,10.1371/journal.pone.0050587,,,,23189206,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1090593,https://api.altmetric.com/v1/donut/1090593_240.png 2,Progress in gene therapy for prostate cancer.,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00172,,,,23181221,PMC3500761,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1076311,https://api.altmetric.com/v1/donut/1076311_240.png 2,Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases,Prostate Cancer & Prostatic Diseases,,,Article,2012-11-13,10.1038/pcan.2012.42,,,,23146970,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1064053,https://api.altmetric.com/v1/donut/1064053_240.png 2,Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-11-3546,,,,22505648,,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/998169,https://api.altmetric.com/v1/donut/998169_240.png 2,Urological cancer: Aspirin and the risk of prostate cancer mortality,Nature Reviews Clinical Oncology,,,Article,2012-10-09,10.1038/nrclinonc.2012.182,,,,23044777,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/994320,https://api.altmetric.com/v1/donut/994320_240.png 2,African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center,Prostate Cancer & Prostatic Diseases,,,Article,2012-10-02,10.1038/pcan.2012.39,,,,23032361,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/978135,https://api.altmetric.com/v1/donut/978135_240.png 2,"Loss of Masculine Identity, Marital Affection, and Sexual Bother in Men with Localized Prostate Cancer",Journal of Sexual Medicine,,,Article,2012-01-01,10.1111/j.1743-6109.2012.02897.x,,,,22989267,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/952593,https://api.altmetric.com/v1/donut/952593_240.png 2,Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24–mediated toxicity,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-05-09,10.1073/pnas.1100769108,,,,21555592,PMC3102401,,2011PNAS..108.8785D,,,,0,0,0,1,8,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/917778,https://api.altmetric.com/v1/donut/917778_240.png 2,Testosterone replacement and prostate cancer.,Indian Journal of Urology,,,Article,2012-08-25,10.4103/0970-1591.98449,,,,22919126,PMC3424887,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/913861,https://api.altmetric.com/v1/donut/913861_240.png 2,The Right Therapy For Prostate Cancer,Health Affairs,,,Article,2012-01-01,10.1377/hlthaff.2012.0625,,,,22778359,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/834970,https://api.altmetric.com/v1/donut/834970_240.png 2,"Long-Term Disease-Specific Functioning Among Prostate Cancer Survivors and Noncancer Controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",Journal of Clinical Oncology,,,Article,2012-01-01,10.1200/jco.2011.41.2767,,,,22734029,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/815279,https://api.altmetric.com/v1/donut/815279_240.png 2,The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.,DNA Repair,,,Article,2012-06-05,10.1016/j.dnarep.2012.05.003,,,,22677538,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/785339,https://api.altmetric.com/v1/donut/785339_240.png 2,Inhibition Kinetics And Regulation Of Sphingosine Kinase 1 Expression In Prostate Cancer Cells: Functional Differences Between Sphingosine Kinase 1a And 1b,International Journal of Biochemistry & Cell Biology,,,Article,2012-05-01,10.1016/j.biocel.2012.05.012,,,,22634604,,11541.2/121411,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/760488,https://api.altmetric.com/v1/donut/760488_240.png 2,A specific molecular beacon probe for the detection of human prostate cancer cells.,Bioorganic & Medicinal Chemistry Letters,,,Article,2012-05-12,10.1016/j.bmcl.2012.04.055,,,,22572577,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/750744,https://api.altmetric.com/v1/donut/750744_240.png 2,Chemical Castration and Antiandrogens Induce Differential Gene Expression in Prostate Cancer,The Journal of Pathology,,,Article,2012-01-01,10.1002/path.4027,,,,22431170,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/725485,https://api.altmetric.com/v1/donut/725485_240.png 2,Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells,PLoS ONE,,,Article,2012-04-20,10.1371/journal.pone.0034973,,,,22532837,,,2012PLoSO...7E4973K,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,8,https://www.altmetric.com/details/720593,https://api.altmetric.com/v1/donut/720593_240.png 2,Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis,Cancer Science,,,Article,2012-01-01,10.1111/j.1349-7006.2012.02272.x,,,,22417066,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/709449,https://api.altmetric.com/v1/donut/709449_240.png 2,Records study finds no clear clinical benefit from proton therapy for prostate cancer,British Medical Journal,,,Article,2012-04-17,10.1136/bmj.e2767,,,,22511305,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/701700,https://api.altmetric.com/v1/donut/701700_240.png 2,Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11120.x,,,,22502816,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,2,0,0,24,https://www.altmetric.com/details/696016,https://api.altmetric.com/v1/donut/696016_240.png 2,Impairment of prostate cancer cell growth by a selective and reversible LSD1 inhibitor,International Journal of Cancer,,,Article,2012-01-01,10.1002/ijc.27555,,,,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,36,https://www.altmetric.com/details/678213,https://api.altmetric.com/v1/donut/678213_240.png 2,Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review.,Urologic Oncology,,,Article,2012-03-27,10.1016/j.urolonc.2012.01.013,,,,22459691,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/675055,https://api.altmetric.com/v1/donut/675055_240.png 2,A Prospective Study of Intake of Fish and Marine Fatty Acids and Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-01-01,,,,,12540506,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/674240,https://api.altmetric.com/v1/donut/674240_240.png 2,Oncologic Outcomes of Surgery in T3 Prostate Cancer: Experience of a Single Tertiary Center,Advances in Urology,,,Article,2012-01-01,10.1155/2012/164263,,,,22216025,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/596814,https://api.altmetric.com/v1/donut/596814_240.png 2,"Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Added Yield from a Second Screening Examination",JNCI: Journal of the National Cancer Institute,,,Article,2012-02-03,10.1093/jnci/djr549,,,,22298838,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/584928,https://api.altmetric.com/v1/donut/584928_240.png 2,Utility of Genomeâ??Wide Association Study findings: prostate cancer as a translational research paradigm,Journal of Internal Medicine,,,Article,2012-04-14,10.1111/j.1365-2796.2012.02522.x,,,,22272820,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/577512,https://api.altmetric.com/v1/donut/577512_240.png 2,Common Structural and Epigenetic Changes in the Genome of Castration Resistant Prostate Cancer,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-11-2079,,,,22158653,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/557766,https://api.altmetric.com/v1/donut/557766_240.png 2,Concordance of survival in family members with prostate cancer.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2008-04-01,10.1200/jco.2007.13.3355,,,,18375899,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,8,https://www.altmetric.com/details/512580,https://api.altmetric.com/v1/donut/512580_240.png 2,Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.,JAMA: Journal of the American Medical Association,,,Article,2008-06-18,10.1001/jama.299.23.2760,,,,18560003,PMC3076799,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,81,https://www.altmetric.com/details/512074,https://api.altmetric.com/v1/donut/512074_240.png 2,Hegemonic Masculinity and the Experience of Prostate Cancer: A Narrative Approach,Journal of Aging and Identity,,,Article,2002-01-01,10.1023/a:1014310532734,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/508814,https://api.altmetric.com/v1/donut/508814_240.png 2,Association between Preoperative Erectile Dysfunction and Prostate Cancer FeaturesAn Analysis from the Duke Prostate Center Database,Journal of Sexual Medicine,,,Article,2011-12-24,10.1111/j.1743-6109.2011.02547.x,,,,22188861,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/507852,https://api.altmetric.com/v1/donut/507852_240.png 2,Downregulation of APOBEC3G by Xenotropic Murine Leukemia-Virus Related Virus (XMRV) in Prostate Cancer Cells.,Virology Journal,,,Article,2011-12-12,10.1186/1743-422x-8-531,,,,22152111,,,,,,,0,0,0,3,0,0,4,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/490420,https://api.altmetric.com/v1/donut/490420_240.png 2,The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer,Canadian Medical Association Journal,,,Article,2011-12-15,10.1503/cmaj.110600,,,,22158408,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/489682,https://api.altmetric.com/v1/donut/489682_240.png 2,Spurious elevation of serum PSA after curative treatment for prostate cancer: clinical consequences and the role of heterophilic antibodies,Prostate Cancer and Prostatic Diseases,,,Article,2011-11-22,10.1038/pcan.2011.58,,,,22105412,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/464767,https://api.altmetric.com/v1/donut/464767_240.png 2,"Down-regulation of Androgen Receptor by 3,3?-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Both Hormone-Sensitive LNCaP and Insensitive C4-2B Prostate Cancer Cells",Cancer Research,,,Article,2006-01-01,10.1158/0008-5472.can-06-2011,,,,17047070,,,,,,,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/459352,https://api.altmetric.com/v1/donut/459352_240.png 2,Signal Amplification by Magnetic Force on Polydiacetylene Supramolecules for Detection of Prostate Cancer.,Small,,,Article,2011-11-16,10.1002/smll.201101322,,,,22081508,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/459187,https://api.altmetric.com/v1/donut/459187_240.png 2,Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.,PloS one,,,Article,2011-01-01,10.1371/journal.pone.0026539,,,,22039506,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/436683,https://api.altmetric.com/v1/donut/436683_240.png 2,Chromosomal Regions Associated with Prostate Cancer Risk Localize to Lamin B Deficient Microdomains and Exhibit Reduced Gene Transcription,The Journal of Pathology,,,Article,2011-10-27,10.1002/path.3033,,,,22025297,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/431318,https://api.altmetric.com/v1/donut/431318_240.png 2,A novel regulation of VEGF expression by HIF-1? and STAT3 in HDM2 transfected prostate cancer cells.,Journal of Cellular and Molecular Medicine,,,Article,2011-10-18,10.1111/j.1582-4934.2011.01472.x,,,,22004076,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/419779,https://api.altmetric.com/v1/donut/419779_240.png 2,Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer,World Journal of Urology,,,Article,2011-10-01,10.1007/s00345-010-0629-0,,,,21161536,PMC3189409,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/416995,https://api.altmetric.com/v1/donut/416995_240.png 2,Future directions for the Prostate Cancer Specialist Nurse in Australia,International Journal of Urological Nursing,,,Article,2011-11-01,10.1111/j.1749-771x.2011.01128.x,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/397602,https://api.altmetric.com/v1/donut/397602_240.png 2,[Molecular mechanisms of zinc in prostate cancer].,Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti,,,Article,2011-01-01,,,,,21905614,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/376615,https://api.altmetric.com/v1/donut/376615_240.png 2,Investigating prostate cancer tumour-stroma interactions – clinical and biological insights from an evolutionary game,,,,Article,2011-09-09,10.1038/npre.2011.6385.1,,,,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/260879,https://api.altmetric.com/v1/donut/260879_240.png 2,Regulation of prostate cancer progression by galectin-3.,American Journal of Pathology,,,Article,2009-04-01,10.2353/ajpath.2009.080816,,,,19286570,,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/249612,https://api.altmetric.com/v1/donut/249612_240.png 2,New role for an established drug|[quest]| Bisphosphonates as potential anticancer agents,Prostate Cancer and Prostatic Diseases,,,Article,2011-08-30,10.1038/pcan.2011.41,,,,21876554,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/248623,https://api.altmetric.com/v1/donut/248623_240.png 2,A phase II clinical trial of sorafenib in androgen-independent prostate cancer.,Clinical cancer research : an official journal of the American Association for Cancer Research,,,Article,2008-01-01,10.1158/1078-0432.ccr-07-1355,,,,18172272,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/232636,https://api.altmetric.com/v1/donut/232636_240.png 2,Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2006-04-20,10.1200/jco.2005.04.7423,,,,16622261,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,57,https://www.altmetric.com/details/226592,https://api.altmetric.com/v1/donut/226592_240.png 2,Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.,Cancer,,,Article,2007-10-01,10.1002/cncr.22933,,,,17657815,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,41,https://www.altmetric.com/details/212004,https://api.altmetric.com/v1/donut/212004_240.png 2,Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.,Journal of Clinical Oncology,,,Article,2007-06-10,10.1200/jco.2006.09.3369,,,,17557956,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,39,https://www.altmetric.com/details/211993,https://api.altmetric.com/v1/donut/211993_240.png 2,Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610,Journal of Clinical Oncology,,,Article,2008-02-01,10.1200/jco.2007.13.9881,,,,18172188,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/211968,https://api.altmetric.com/v1/donut/211968_240.png 2,"Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-06-01,10.1158/1055-9965.epi-10-0180,,,,20501771,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/211928,https://api.altmetric.com/v1/donut/211928_240.png 2,The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study.,The Journal of Urology,,,Article,2011-01-01,10.1016/j.juro.2010.09.011,,,,21074214,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,25,https://www.altmetric.com/details/211881,https://api.altmetric.com/v1/donut/211881_240.png 2,Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2007-09-20,10.1200/jco.2006.10.4067,,,,17878474,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/210535,https://api.altmetric.com/v1/donut/210535_240.png 2,Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?,Journal of Clinical Oncology,,,Article,2010-03-01,10.1200/jco.2009.23.5572,,,,20124185,PMC2834464,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/210470,https://api.altmetric.com/v1/donut/210470_240.png 2,Prostate cancer diagnosis in a resource-poor setting: the changing role of digital rectal examination.,Tropical doctor,,,Article,2011-07-01,10.1258/td.2011.110061,,,,21685477,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/206837,https://api.altmetric.com/v1/donut/206837_240.png 2,"In vitro and in vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-conjugated Antibody to Prostate-specific Membrane Antigen.",Molecular cancer therapeutics,,,Article,2011-07-12,10.1158/1535-7163.mct-11-0191,,,,21750220,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/194706,https://api.altmetric.com/v1/donut/194706_240.png 2,Computer aided screening of inhibitors to 5-? reductase type 2 for prostate cancer.,Bioinformation,,,Article,2011-01-01,,,,,21738326,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/194618,https://api.altmetric.com/v1/donut/194618_240.png 2,Effect of Low-Fat Diets on Plasma Levels of NF-?B–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer,Cancer Prevention Research,,,Article,2011-07-15,10.1158/1940-6207.capr-10-0136,,,,21764858,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,1,19,https://www.altmetric.com/details/192196,https://api.altmetric.com/v1/donut/192196_240.png 2,"Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research.",Clinical Cancer Research,,,Article,2011-06-15,10.1158/1078-0432.ccr-10-2656,,,,21680544,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/186526,https://api.altmetric.com/v1/donut/186526_240.png 2,Nutrigenetics and Prostate Cancer: 2011 and Beyond.,Journal of nutrigenetics and nutrigenomics,,,Article,2011-06-01,10.1159/000327902,,,,21646812,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/186106,https://api.altmetric.com/v1/donut/186106_240.png 2,Prostate cancer: Abiraterone increases overall survival in men with castration-resistant prostate cancer,Nature Reviews Urology,,,Article,2011-07-08,10.1038/nrurol.2011.94,,,,21743442,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/183941,https://api.altmetric.com/v1/donut/183941_240.png 2,Resveratrol and prostate cancer: Promising role for microRNAs.,Molecular nutrition & food research,,,Article,2011-06-29,10.1002/mnfr.201100141,,,,21714127,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/177129,https://api.altmetric.com/v1/donut/177129_240.png 2,Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens,BMC Medical Informatics and Decision Making,,,Article,2010-11-15,10.1186/1472-6947-10-71,,,,21078179,PMC2995775,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/177081,https://api.altmetric.com/v1/donut/177081_240.png 2,The polycomb group protein EZH2 is involved in progression of prostate cancer.,Nature,,,Article,2002-10-10,10.1038/nature01075,,,,12374981,,,,,,,0,0,0,0,26,0,0,0,0,0,0,0,1,0,0,129,https://www.altmetric.com/details/161369,https://api.altmetric.com/v1/donut/161369_240.png 2,Urinary melatonin-sulfate/cortisol ratio and the presence of prostate cancer: A case-control study,Scientific Reports,,,Article,2016-07-08,10.1038/srep29606,,,,27387675,PMC4937372,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13224380,https://api.altmetric.com/v1/donut/13224380_240.png 2,Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation,Cancer Letters,,,Article,2016-10-01,10.1016/j.canlet.2016.10.021,,,,27780719,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13165211,https://api.altmetric.com/v1/donut/13165211_240.png 2,Neurovascular bundle–sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study,Medical Dosimetry,,,Article,2016-10-01,10.1016/j.meddos.2016.08.003,,,,27745996,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12879736,https://api.altmetric.com/v1/donut/12879736_240.png 2,"Prospective assessment of the quality of life before, during and after image guided intensity modulated radiotherapy for prostate cancer",Radiation Oncology,,,Article,2016-09-07,10.1186/s13014-016-0689-4,,,,27604898,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11884815,https://api.altmetric.com/v1/donut/11884815_240.png 2,The Role of Nutrition and Diet in Prostate Cancer,,,,Article,2016-01-13,10.1007/978-3-319-22431-2_10,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4985427,https://api.altmetric.com/v1/donut/4985427_240.png 2,New approach to prostate cancer screening. Genitourinary Cancers Symposium,ecancer.org,,,Article,,,,,http://ecancer.org/conference/633-genitourinary-cancers-symposium/video/3497/new-approach-to-prostate-cancer-screening.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3750504,https://api.altmetric.com/v1/donut/3750504_240.png 2,Metastatic prostate cancer - Interpreting negative trial results. Metastatic prostate cancer - Interpreting negative trial results,ecancer.org,,,Article,,,,,http://ecancer.org/video/3501/metastatic-prostate-cancer---interpreting-negative-trial-results.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3739602,https://api.altmetric.com/v1/donut/3739602_240.png 2,Re: Decision Making in Prostate Cancer Screening Using Decision Aids vs Usual Care: A Randomized Clinical Trial,The Journal of Urology,,,Article,2014-01-05,10.1016/j.juro.2014.02.079,,,,24745485,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2362329,https://api.altmetric.com/v1/donut/2362329_240.png 2,UK NICE guidance recommends degarelix for the treatment of advanced hormone-dependent prostate cancer only in people with impending spinal cord compression,ecancer.org,,,Article,,,,,http://ecancer.org/news/5561-uk-nice-guidance-recommends-degarelix-for-the-treatment-of-advanced-hormone-dependent-prostate-cancer-only-in-people-with-impending-spinal-cord-compression.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2283192,https://api.altmetric.com/v1/donut/2283192_240.png 2,"ECC 2013: Organised screening for prostate cancer using the prostate-specific antigen test, does more harm than good",ecancer.org,,,Article,,,,,http://ecancer.org/news/4473-ecc-2013--organised-screening-for-prostate-cancer-using-the-prostate-specific-antigen-test--does-more-harm-than-good.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1789595,https://api.altmetric.com/v1/donut/1789595_240.png 2,Prostate cancer: Active surveillance appropriateness criteria [mdash] a way forward,Nature Reviews Urology,,,Article,2016-10-31,10.1038/nrurol.2016.202,,,,27797361,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13196380,https://api.altmetric.com/v1/donut/13196380_240.png 2,Therapeutic substitutions in the midst of new technology diffusion: The case of treatment for localized prostate cancer,Social Science & Medicine,,,Article,2016-02-01,10.1016/j.socscimed.2016.01.016,,,,26799678,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12998245,https://api.altmetric.com/v1/donut/12998245_240.png 2,Exposure to polychlorinated biphenyls and prostate cancer: population-based prospective cohort and experimental studies,Carcinogenesis,,,Article,2016-10-07,10.1093/carcin/bgw105,,,,27742691,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12684776,https://api.altmetric.com/v1/donut/12684776_240.png 2,Hypofractionated radiotherapy for localized prostate cancer,Strahlentherapie und Onkologie,,,Article,2016-09-14,10.1007/s00066-016-1041-5,,,,27628966,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12660731,https://api.altmetric.com/v1/donut/12660731_240.png 2,Development of an explanatory model of sexual intimacy following treatment for localised prostate cancer: A systematic review and meta-synthesis of qualitative evidence,Social Science & Medicine,,,Article,2016-08-01,10.1016/j.socscimed.2016.07.001,,,,27421074,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12619777,https://api.altmetric.com/v1/donut/12619777_240.png 2,Providing prostate cancer survivorship care in Japan: Implications from the USA care model,International Journal of Urology,,,Article,2016-09-13,10.1111/iju.13186,,,,27624609,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12032036,https://api.altmetric.com/v1/donut/12032036_240.png 2,Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients,Anti-Cancer Drugs,,,Article,2016-08-01,10.1097/cad.0000000000000428,,,http://journals.lww.com/anti-cancerdrugs/Fulltext/publishahead/Predictive_Comprehensive_Geriatric_Assessment_in.99022.aspx,27579728,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10965772,https://api.altmetric.com/v1/donut/10965772_240.png 2,Qigong/tai chi for sleep and fatigue in prostate cancer patients undergoing radiotherapy: A randomized controlled trial.,Psycho-Oncology,,,Article,2016-08-23,10.1002/pon.4256,,,,27548839,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10771805,https://api.altmetric.com/v1/donut/10771805_240.png 2,Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer,Brachytherapy,,,Article,2016-08-01,10.1016/j.brachy.2016.07.001,,,,27528590,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10642966,https://api.altmetric.com/v1/donut/10642966_240.png 2,Common medications and prostate cancer mortality: a review,World Journal of Urology,,,Article,2016-08-04,10.1007/s00345-016-1912-5,,,,27492013,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10567146,https://api.altmetric.com/v1/donut/10567146_240.png 2,Exposure to pesticides and prostate cancer: systematic review of the literature,Reviews on environmental health,,,Article,2016-01-31,10.1515/reveh-2016-0001,,,,27244877,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10270554,https://api.altmetric.com/v1/donut/10270554_240.png 2,Radiation Therapy in Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-08-01,10.1097/coc.0000000000000312,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/08000/Radiation_Therapy_in_Prostate_Cancer__Defining_the.2.aspx,27322702,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10122676,https://api.altmetric.com/v1/donut/10122676_240.png 2,MiR-34C Disrupts the Stemness of Purified CD133+ Prostatic Cancer Stem Cells,Urology,,,Article,2016-07-23,10.1016/j.urology.2016.07.021,,,,27461446,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10122019,https://api.altmetric.com/v1/donut/10122019_240.png 2,"Reply to Lu Yang, Shi Qiu and Qiang Wei's Letter to the Editor re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775–87",European Urology,,,Article,2016-07-24,10.1016/j.eururo.2016.07.016,,,,27461403,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10000547,https://api.altmetric.com/v1/donut/10000547_240.png 2,Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial,European Urology,,,Article,2016-06-01,10.1016/j.eururo.2016.06.002,,,,27344296,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/9533874,https://api.altmetric.com/v1/donut/9533874_240.png 2,Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer,Urology Case Reports,,,Article,2016-07-01,10.1016/j.eucr.2016.04.012,,,,27335798,PMC4909527,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9248454,https://api.altmetric.com/v1/donut/9248454_240.png 2,Natural resource-based industries and prostate cancer risk in Northeastern Ontario: a case–control study,Occupational and environmental medicine,,,Article,2016-05-31,10.1136/oemed-2016-103573,,,,27245375,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8807150,https://api.altmetric.com/v1/donut/8807150_240.png 2,Androgen Deprivation Therapy for Advanced Prostate Cancer: Can Evolution Be Accelerated?,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2016-06-01,,,,,27283162,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8705632,https://api.altmetric.com/v1/donut/8705632_240.png 2,Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer,American Journal of Epidemiology,,,Article,2016-06-06,10.1093/aje/kwv307,,,,27268031,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8616395,https://api.altmetric.com/v1/donut/8616395_240.png 2,DCE MRI of prostate cancer,Abdominal radiology (New York),,,Article,2016-01-02,10.1007/s00261-015-0589-3,,,,27193787,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8207293,https://api.altmetric.com/v1/donut/8207293_240.png 2,Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer,Topics in Magnetic Resonance Imaging,,,Article,2016-05-01,10.1097/rmr.0000000000000088,,,,27187164,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8207215,https://api.altmetric.com/v1/donut/8207215_240.png 2,Prostate cancer: Nucleotyping predicts recurrence post-RP,Nature Reviews Urology,,,Article,2016-05-17,10.1038/nrurol.2016.94,,,,27184724,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7548864,https://api.altmetric.com/v1/donut/7548864_240.png 2,1060 Magnetic resonance sentinel lymph node imaging in prostate cancer using intraprostatic injection of superparamagnetic iron oxide nanoparticles: The first in-human results,European Urology Supplements,,,Article,2016-03-01,10.1016/s1569-9056(16)61061-8,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7376463,https://api.altmetric.com/v1/donut/7376463_240.png 2,Why we need a vendor neutral specification for delineating prostate cancer with mpMRI,Abdominal radiology (New York),,,Article,2016-04-23,10.1007/s00261-016-0746-3,,,,27108130,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7371387,https://api.altmetric.com/v1/donut/7371387_240.png 2,Focal therapy in prostate cancer,,,,Article,2016-05-11,,,,,,,11245/1.532296,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7337782,https://api.altmetric.com/v1/donut/7337782_240.png 2,Interindividual registration and dose mapping for voxelwise population analysis of rectal toxicity in prostate cancer radiotherapy,Medical Physics,,,Article,2016-05-09,10.1118/1.4948501,,,,27277019,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7301618,https://api.altmetric.com/v1/donut/7301618_240.png 2,Feasibility for active surveillance in biopsy Gleason 3 + 4 prostate cancer: an Australian radical prostatectomy cohort,British Journal of Urology,,,Article,2016-04-01,10.1111/bju.13460,,,,27094971,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7281595,https://api.altmetric.com/v1/donut/7281595_240.png 2,Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes,Cancer (0008543X),,,Article,2016-05-03,10.1002/cncr.30045,,,,27142338,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7174966,https://api.altmetric.com/v1/donut/7174966_240.png 2,Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter–Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth,PLoS ONE,,,Article,2016-04-07,10.1371/journal.pone.0153350,,,,27054343,,,,,,,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,7,https://www.altmetric.com/details/6536346,https://api.altmetric.com/v1/donut/6536346_240.png 2,Piloting prostate cancer patient-reported outcomesin clinical practice,Supportive Care in Cancer,,,Article,2015-10-24,10.1007/s00520-015-2949-5,,,,26498748,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6402298,https://api.altmetric.com/v1/donut/6402298_240.png 2,PI-LBA09 ISOPSA: INITIAL CLINICAL PERFORMANCE EVALUATION OF A NOVEL STRUCTURE-BASED BIOMARKER FOR PROSTATE CANCER IN A MULTICENTER PROSPECTIVE TRIAL FOR GLEASON = 7,The Journal of Urology,,,Article,2016-04-01,10.1016/j.juro.2016.03.132,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6362809,https://api.altmetric.com/v1/donut/6362809_240.png 2,Interexaminer variability of digital rectal examination in detecting prostate cancer.,Urology,,,Article,1995-01-01,,,,,7529449,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6201714,https://api.altmetric.com/v1/donut/6201714_240.png 2,First application of a pixel-wise analysis on bladder dose–surface maps in prostate cancer radiotherapy,Radiotherapy & Oncology,,,Article,2016-03-01,10.1016/j.radonc.2016.02.025,,,,26993415,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6198757,https://api.altmetric.com/v1/donut/6198757_240.png 2,The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited,The Prostate,,,Article,2016-03-01,10.1002/pros.23179,,,,26989049,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6188839,https://api.altmetric.com/v1/donut/6188839_240.png 2,Active surveillance for prostate cancer,International Journal of Urology,,,Article,2016-03-30,10.1111/iju.13016,,,,26621054,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6158453,https://api.altmetric.com/v1/donut/6158453_240.png 2,p16 Expression in Prostate Cancer and Nonmalignant Lesions,Applied Immunohistochemistry & Molecular Morphology,,,Article,2016-03-01,10.1097/pai.0000000000000171,,,http://journals.lww.com/appliedimmunohist/Fulltext/2016/03000/p16_Expression_in_Prostate_Cancer_and_Nonmalignant.7.aspx,25906117,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6148177,https://api.altmetric.com/v1/donut/6148177_240.png 2,Early detection of prostate cancer: can we have our cake and eat it too?,Expert Review of Anticancer Therapy,,,Article,2016-02-03,10.1586/14737140.2016.1139459,,,,26760708,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5083521,https://api.altmetric.com/v1/donut/5083521_240.png 2,"[Insulin-like growth factor (IGF-1) and the clinical course of prostate cancer, benign hyperplasia and prostatic intraepithelial neoplasia].",,,,Article,,,,,,19069473,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4968433,https://api.altmetric.com/v1/donut/4968433_240.png 2,Patient specific modeling of palpation?based prostate cancer diagnosis: effects of pelvic cavity anatomy and intrabladder pressure,International Journal for Numerical Methods in Biomedical Engineering,,,Article,2016-01-01,10.1002/cnm.2734,,,,26190813,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4965578,https://api.altmetric.com/v1/donut/4965578_240.png 2,The Health Effects of Masculine Self-Esteem Following Treatment for Localized Prostate Cancer Among Gay Men,LGBT Health,,,Article,2015-12-30,10.1089/lgbt.2015.0090,,,,26698658,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4938126,https://api.altmetric.com/v1/donut/4938126_240.png 2,In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers.,Future Oncology,,,Article,,10.2217/fon.15.296,,,,26615920,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4908298,https://api.altmetric.com/v1/donut/4908298_240.png 2,Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia,British Journal of Cancer,,,Article,2015-12-03,10.1038/bjc.2015.411,,,,26633561,PMC4702000,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4839573,https://api.altmetric.com/v1/donut/4839573_240.png 2,Prostate cancer: Castration impairs DNA repair,Nature Reviews Urology,,,Article,2015-11-24,10.1038/nrurol.2015.285,,,,26597616,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4800439,https://api.altmetric.com/v1/donut/4800439_240.png 2,Prostate cancer: Online support reduces distress in men with prostate cancer,Nature Reviews Urology,,,Article,2015-11-10,10.1038/nrurol.2015.267,,,,26553627,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4767751,https://api.altmetric.com/v1/donut/4767751_240.png 2,Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions,Scientific Reports,,,Article,2015-10-28,10.1038/srep15651,,,,26503803,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4696399,https://api.altmetric.com/v1/donut/4696399_240.png 2,"Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion",Journal of Clinical Pathology,,,Article,2015-10-28,10.1136/jclinpath-2015-203125,,,,26500332,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4692400,https://api.altmetric.com/v1/donut/4692400_240.png 2,Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data.,The Prostate,,,Article,,10.1002/pros.23099,,,,26419619,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4640954,https://api.altmetric.com/v1/donut/4640954_240.png 2,Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2007-05-08,10.1038/sj.pcan.4500975,,,,17486110,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/4545180,https://api.altmetric.com/v1/donut/4545180_240.png 2,"NADiA ProsVue Prostate-specific Antigen Slope, CAPRA-S, and Prostate Cancer–specific Survival After Radical Prostatectomy ",Urology,,,Article,2014-12-15,10.1016/j.urology.2014.07.059,,,,25432832,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4433867,https://api.altmetric.com/v1/donut/4433867_240.png 2,Informed Decision Making Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment,Medical Decision Making,,,Article,2015-08-26,10.1177/0272989x15597226,,,,26304063,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4430080,https://api.altmetric.com/v1/donut/4430080_240.png 2,Factors Associated With the Prevalence of Prostate Cancer in Rural Saskatchewan: The Saskatchewan Rural Health Study,Journal of Rural Health,,,Article,2015-08-01,10.1111/jrh.12137,,,,26265246,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4393695,https://api.altmetric.com/v1/donut/4393695_240.png 2,Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.,,,,Article,2005-06-30,10.1158/1078-0432.ccr-04-2140,,,,16000589,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4366387,https://api.altmetric.com/v1/donut/4366387_240.png 2,Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.,Annals of the New York Academy of Sciences,,,Article,2015-07-01,10.1111/nyas.12817,,,,26214308,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4333674,https://api.altmetric.com/v1/donut/4333674_240.png 2,Laparoscopic versus Robotic-Assisted Radical Prostatectomy for the Treatment of Localised Prostate Cancer: A Systematic Review,Urologia Internationalis,,,Article,2015-07-18,10.1159/000435861,,,,26201500,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4307811,https://api.altmetric.com/v1/donut/4307811_240.png 2,(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2015-07-19,10.1016/j.clgc.2015.06.004,,,,26187349,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4293474,https://api.altmetric.com/v1/donut/4293474_240.png 2,Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling,Clinical and Experimental Metastasis,,,Article,2014-08-31,10.1007/s10585-014-9674-1,,,,25173680,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4280326,https://api.altmetric.com/v1/donut/4280326_240.png 2,Optimum Timing of Chemotherapy for Metastatic Prostate Cancer: Early or Wait?,Oncology times,,,Article,2015-07-10,10.1097/01.cot.0000469370.98619.ae,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4245696,https://api.altmetric.com/v1/donut/4245696_240.png 2,A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocol,BMJ Open,,,Article,2015-06-01,10.1136/bmjopen-2015-008470,,,,26112224,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4215503,https://api.altmetric.com/v1/donut/4215503_240.png 2,Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging,Radiology,,,Article,2015-06-24,10.1148/radiol.2015142818,,,,26098458,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/4206868,https://api.altmetric.com/v1/donut/4206868_240.png 2,RNA biomarkers to facilitate the identification of aggressive prostate cancer ,Molecular Aspects of Medicine,,,Article,,10.1016/j.mam.2015.05.003,,,,26022941,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/4187009,https://api.altmetric.com/v1/donut/4187009_240.png 2,Expression of ERG protein in prostate cancer: variability and biological correlates,Endocrine-Related Cancer,,,Article,2015-06-01,10.1530/erc-14-0586,,,,25972242,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4068601,https://api.altmetric.com/v1/donut/4068601_240.png 2,Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate,The Prostate,,,Article,2011-02-09,10.1002/pros.21346,,,,21308713,PMC3120927,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3999474,https://api.altmetric.com/v1/donut/3999474_240.png 2,Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series,The Prostate,,,Article,2015-05-14,10.1002/pros.23009,,,,25963383,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3994102,https://api.altmetric.com/v1/donut/3994102_240.png 2,BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).,World Journal of Urology,,,Article,,10.1007/s00345-015-1546-z,,,,25824539,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3907868,https://api.altmetric.com/v1/donut/3907868_240.png 2,Lower Prostate Cancer Risk in Men with Elevated Plasma Lycopene Levels Results of a Prospective Analysis,Cancer Research,,,Article,,,,,,10096552,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3889274,https://api.altmetric.com/v1/donut/3889274_240.png 2,"Commentary on “African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: Should active surveillance still be an option for them?” Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB, Schaeffer EM, Johns Hopkins University, Baltimore, MD.",Urologic Oncology,,,Article,2014-01-08,10.1016/j.urolonc.2014.01.010,,,,25087674,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3844835,https://api.altmetric.com/v1/donut/3844835_240.png 2,Do omega-3 fatty acids cause prostate cancer?,Missouri medicine,,,Article,2013-09-06,,,,,24003645,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3721898,https://api.altmetric.com/v1/donut/3721898_240.png 2,Glutathione S?Transferase?Pi Protein expression in prostate cancer – not always a useful diagnostic tool,Histopathology,,,Article,2015-04-09,10.1111/his.12671,,,,25684637,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3545791,https://api.altmetric.com/v1/donut/3545791_240.png 2,Relationship between tumor grade and geometrical complexity in prostate cancer,bioRxiv,,,Article,2015-02-08,10.1101/015016,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3437022,https://api.altmetric.com/v1/donut/3437022_240.png 2,Prostate cancer: Effects of tertiary Gleason pattern 5 on oncological outcome,Nature Reviews Urology,,,Article,2015-01-20,10.1038/nrurol.2014.370,,,,25600096,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3080802,https://api.altmetric.com/v1/donut/3080802_240.png 2,Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer.,Scientific Reports,,,Article,2015-01-07,10.1038/srep07654,,,,25563505,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3043503,https://api.altmetric.com/v1/donut/3043503_240.png 2,Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer.,Oncology Reports,,,Article,2014-12-19,10.3892/or.2014.3684,,,,25529861,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3010764,https://api.altmetric.com/v1/donut/3010764_240.png 2,Re: Vasectomy and Risk of Aggressive Prostate Cancer: A 24-year Follow-up Study,European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.042,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2983975,https://api.altmetric.com/v1/donut/2983975_240.png 2,Development of clinical models for predicting erectile function after localized prostate cancer treatment,International Journal of Urology,,,Article,2014-07-23,10.1111/iju.12566,,,,25056284,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2941587,https://api.altmetric.com/v1/donut/2941587_240.png 2,Comparative effectiveness of [18F]?fluorocholine PET?CT and pelvic MRI with diffusion?weighted imaging for staging in patients with high?risk prostate cancer,The Prostate,,,Article,2014-11-12,10.1002/pros.22921,,,,25393215,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2888955,https://api.altmetric.com/v1/donut/2888955_240.png 2,Prostate Cancer Diagnosis: Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US-MR Fusion Guidance versus Systematic Biopsy--Prospective Multicenter Study.,Radiology,,,Article,2013-04-14,10.1148/radiol.13121501,,,,23579051,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2858615,https://api.altmetric.com/v1/donut/2858615_240.png 2,Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer,The Prostate,,,Article,2014-10-18,10.1002/pros.22907,,,,25327522,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2795337,https://api.altmetric.com/v1/donut/2795337_240.png 2,Late Toxicity and Outcomes in High-risk Prostate Cancer Patients Treated With Hypofractionated IMRT and Long-term Androgen Suppression Treatment.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-10-03,10.1097/coc.0000000000000133,,,,25268067,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2769904,https://api.altmetric.com/v1/donut/2769904_240.png 2,Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab,Journal for Immunotherapy of Cancer,,,Article,2014-09-16,10.1186/s40425-014-0031-3,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2759797,https://api.altmetric.com/v1/donut/2759797_240.png 2,Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade,SpringerPlus,,,Article,2014-10-08,10.1186/2193-1801-3-586,,,,25332886,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2756874,https://api.altmetric.com/v1/donut/2756874_240.png 2,Cancer: Lipid kinase PIP5K1[alpha] as a new target in prostate cancer,Nature Reviews Drug Discovery,,,Article,2014-10-01,10.1038/nrd4446,,,,25270953,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2753343,https://api.altmetric.com/v1/donut/2753343_240.png 2,Prediction of Long-term Other-cause Mortality in Men With Early-stage Prostate Cancer: Results From the Prostate Cancer Outcomes Study,Urology,,,Article,2014-09-22,10.1016/j.urology.2014.07.003,,,,25261048,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2724774,https://api.altmetric.com/v1/donut/2724774_240.png 2,Abstract 1322: Clinical candidate galeterone (VN/124-1 or TOK-001) induces the degradation of full-length and splice variant androgen receptors in human prostate cancer cell lines via PI3K-Akt-Mdm2 pathway: implications for prostate cancer therapy.,Cancer Research,,,Article,,10.1158/1538-7445.am2013-1322,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2714927,https://api.altmetric.com/v1/donut/2714927_240.png 2,Identification of Single Nucleotide Polymorphisms (SNPs) Associated With Late Toxicity Following Radiation Therapy for Prostate Cancer Through a Meta-Analysis of Genome-Wide Association Studies (GWAS),"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-09,10.1016/j.ijrobp.2014.05.195,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2690300,https://api.altmetric.com/v1/donut/2690300_240.png 2,Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer,Molecular Cancer Research,,,Article,2014-09-04,10.1158/1541-7786.mcr-14-0273,,,,25189356,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2660963,https://api.altmetric.com/v1/donut/2660963_240.png 2,Simultaneous detection of circulating oncomiRs from body fluids for prostate cancer staging using nano-graphene oxide.,ACS Applied Materials & Interfaces,,,Article,2014-08-26,10.1021/am504190a,,,,25158299,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2631808,https://api.altmetric.com/v1/donut/2631808_240.png 2,The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used?,World Journal of Urology,,,Article,2014-05-14,10.1007/s00345-014-1317-2,,,,24825472,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2603972,https://api.altmetric.com/v1/donut/2603972_240.png 2,Patient-reported outcomes after prostate cancer treatment,Journal of Clinical Urology,,,Article,2014-02-17,10.1177/2051415814523269,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2597709,https://api.altmetric.com/v1/donut/2597709_240.png 2,Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells,PLoS ONE,,,Article,2014-08-01,10.1371/journal.pone.0101777,,,,25084170,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2571531,https://api.altmetric.com/v1/donut/2571531_240.png 2,Important Role of SUMOylation of Spliceosome Factors in Prostate Cancer Cells.,Journal of Proteome Research,,,Article,2014-07-18,10.1021/pr4012848,,,,25027693,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2534402,https://api.altmetric.com/v1/donut/2534402_240.png 2,"Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells",Carcinogenesis,,,Article,2007-01-01,10.1093/carcin/bgm069,,,,17389612,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2431391,https://api.altmetric.com/v1/donut/2431391_240.png 2,Focal therapy in prostate cancer: the current situation,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/435-focal-therapy-in-prostate-cancer-the-current-situation.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2423906,https://api.altmetric.com/v1/donut/2423906_240.png 2,[11C]Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy,Clinical Genitourinary Cancer,,,Article,2013-01-01,10.1016/j.clgc.2013.11.002,,,,24331577,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2387208,https://api.altmetric.com/v1/donut/2387208_240.png 2,Regional Biases in Mutation Screening Due to Intratumoral Heterogeneity of Prostate Cancer,The Journal of Pathology,,,Article,2014-07-11,10.1002/path.4380,,,,24870262,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2385412,https://api.altmetric.com/v1/donut/2385412_240.png 2,Apoptotic effects of proteasome and histone deacetylase inhibitors in prostate cancer cell lines.,Genetics and Molecular Research,,,Article,2014-05-24,10.4238/2014.may.9.17,,,,24854658,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2379745,https://api.altmetric.com/v1/donut/2379745_240.png 2,Nationwide prevalence of lymph node metastases in Gleason score 3?+?3?=?6 prostate cancer,Pathology,,,Article,2014-06-01,10.1097/pat.0000000000000097,,,,24798166,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2360236,https://api.altmetric.com/v1/donut/2360236_240.png 2,Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?. Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?,ecancer.org,,,Article,,,,,http://ecancer.org/video/2833/clinical-perspectives--how-far-are-we-from-personalising-treatment-for-prostate-cancer-patients.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2351642,https://api.altmetric.com/v1/donut/2351642_240.png 2,Challenges of managing elderly men with prostate cancer,Nature Reviews Clinical Oncology,,,Article,2014-05-13,10.1038/nrclinonc.2014.71,,,,24821211,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2348151,https://api.altmetric.com/v1/donut/2348151_240.png 2,Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness,BMC Medical Imaging,,,Article,2014-05-10,10.1186/1471-2342-14-15,,,,24885552,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2342245,https://api.altmetric.com/v1/donut/2342245_240.png 2,COX?2 inhibitors arrest prostate cancer cell cycle progression by down?regulation of kinetochore/centromere proteins,The Prostate,,,Article,2014-05-07,10.1002/pros.22815,,,,24802614,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2334209,https://api.altmetric.com/v1/donut/2334209_240.png 2,PSA as a marker of disease in patients with prostate cancerand bone metastases. PSA as a marker of disease in patients withprostate cancer and bone metastases. ecancer.tv - Essential viewingfor oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2696/psa-as-a-marker-of-disease-in-patients-with-prostate-cancer-and-bone-metastases.php,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2152739,https://api.altmetric.com/v1/donut/2152739_240.png 2,Balancing Toxicity and Efficacy: Learning from Trials and Treatment Using Antiresorptive Therapy in Prostate Cancer,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.07.026,,,,23948437,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2124857,https://api.altmetric.com/v1/donut/2124857_240.png 2,An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis,Cancer Chemotherapy & Pharmacology,,,Article,2003-05-07,10.1007/s00280-003-0612-1,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2100571,https://api.altmetric.com/v1/donut/2100571_240.png 2,Understanding prostate cancer heterogeneity to guidetreatment choices. Understanding prostate cancer heterogeneity toguide treatment choices. ecancer.tv - Essential viewing foroncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2642/understanding-prostate-cancer-heterogeneity-to-guide-treatment-choices.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2059759,https://api.altmetric.com/v1/donut/2059759_240.png 2,18F-Choline PET/CT Pitfalls in Image Interpretation: An Update on 300 Examined Patients With Prostate Cancer,Clinical Nuclear Medicine,,,Article,2013-12-23,10.1097/rlu.0000000000000303,,,,24368525,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2005460,https://api.altmetric.com/v1/donut/2005460_240.png 2,Clinical Utility of a Biopsy-Based Cell Cycle Gene Expression Assay in Localized Prostate Cancer.,Current Medical Research & Opinion,,,Article,2013-12-23,10.1185/03007995.2013.873398,,,,24320750,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2002029,https://api.altmetric.com/v1/donut/2002029_240.png 2,No association between egg intake and prostate cancer risk: a meta-analysis.,Asian Pacific Journal of Cancer Prevention,,,Article,2012-01-01,,,,,23167401,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1929606,https://api.altmetric.com/v1/donut/1929606_240.png 2,Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer,Radiation Oncology,,,Article,2013-11-19,10.1186/1748-717x-8-271,,,,24252686,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1928515,https://api.altmetric.com/v1/donut/1928515_240.png 2,Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI,Clinical Radiology,,,Article,2013-01-01,10.1016/j.crad.2013.07.010,,,,23993149,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1917579,https://api.altmetric.com/v1/donut/1917579_240.png 2,Genetics: Tracking clonal origin of prostate cancer,Nature Reviews Clinical Oncology,,,Article,2013-11-19,10.1038/nrclinonc.2013.220,,,,24247161,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1916299,https://api.altmetric.com/v1/donut/1916299_240.png 2,Inhibition of Hedgehog and Androgen Receptor Signaling Pathways Produced Synergistic Suppression of Castration-Resistant Prostate Cancer Progression,Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-13-0278,,,,23989930,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1913553,https://api.altmetric.com/v1/donut/1913553_240.png 2,Clinical evaluation of multi-atlas based segmentation of lymph node regions in head and neck and prostate cancer patients,Radiation Oncology,,,Article,2013-10-03,10.1186/1748-717x-8-229,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1800824,https://api.altmetric.com/v1/donut/1800824_240.png 2,Polypurine Reverse Hoogsteen Hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivo,Biochemical Pharmacology,,,Article,2013-09-01,10.1016/j.bcp.2013.09.013,,,,24070653,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1798280,https://api.altmetric.com/v1/donut/1798280_240.png 2,Social Epidemiology: A Tool for Examining Prostate Cancer Early-Detection Decision Making among Older African American Men,Social Work in Public Health,,,Article,2013-11-01,10.1080/19371918.2011.593456,,,,24074129,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1794002,https://api.altmetric.com/v1/donut/1794002_240.png 2,Prostate cancer: Oncological vs functional outcomes for RARP|[mdash]|finding a balance,Nature Reviews Urology,,,Article,2013-09-24,10.1038/nrurol.2013.217,,,,24061533,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1786319,https://api.altmetric.com/v1/donut/1786319_240.png 2,Syndecanâ??1(CD138) contributes to prostate cancer progression through stabilizing tumor initiating cells,The Journal of Pathology,,,Article,2013-01-01,10.1002/path.4271,,,,24549646,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1770753,https://api.altmetric.com/v1/donut/1770753_240.png 2,Oncogenic Herpesvirus HHV-8 Promotes Androgen-Independent Prostate Cancer Growth,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-4196,,,,24005834,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1730870,https://api.altmetric.com/v1/donut/1730870_240.png 2,"Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: Results from International Society of Paediatric Oncology (SIOP) studies: Malignant mesenchymal tumour (MMT) 84, 89 and 95",Pediatric Blood and Cancer,,,Article,2013-08-29,10.1002/pbc.24727,,,,23997024,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1723048,https://api.altmetric.com/v1/donut/1723048_240.png 2,Prostate cancer: Prostate Health Index|[mdash]|improving screening in men with family history,Nature Reviews Urology,,,Article,2013-08-13,10.1038/nrurol.2013.169,,,,23938945,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1685661,https://api.altmetric.com/v1/donut/1685661_240.png 2,Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer.,Nutrition and Cancer,,,Article,2013-08-07,10.1080/01635581.2013.767368,,,,23909737,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1683748,https://api.altmetric.com/v1/donut/1683748_240.png 2,High nuclear karyopherin |[alpha]| 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy,Modern Pathology,,,Article,2013-07-26,10.1038/modpathol.2013.127,,,,23887301,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1651305,https://api.altmetric.com/v1/donut/1651305_240.png 2,Words of wisdom. Re: EPCA-2: a highly specific serum marker for prostate cancer.,European Urology,,,Article,2008-02-02,,,,,18240414,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1613140,https://api.altmetric.com/v1/donut/1613140_240.png 2,Extraprostatic Extension into Periprostatic Fat is a More Important Determinant of Prostate Cancer Recurrence than an Invasive Phenotype,The Journal of Urology,,,Article,2013-07-01,10.1016/j.juro.2013.06.050,,,,23820055,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1597040,https://api.altmetric.com/v1/donut/1597040_240.png 2,The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer,Australian & New Zealand Journal of Surgery,,,Article,2013-01-01,10.1111/ans.12094,,,,23463964,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1386269,https://api.altmetric.com/v1/donut/1386269_240.png 2,The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature,Supportive Care in Cancer,,,Article,2013-03-03,10.1007/s00520-013-1751-5,,,,23455492,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1323877,https://api.altmetric.com/v1/donut/1323877_240.png 2,Serum folate and vitamin B12 concentrations in relation to prostate cancer risk—a Norwegian population-based nested case–control study of 3000 cases and 3000 controls within the JANUS cohort,International Journal of Epidemiology,,,Article,2013-01-01,10.1093/ije/dys199,,,,23508410,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1306918,https://api.altmetric.com/v1/donut/1306918_240.png 2,Prostate cancer: Proton therapy|[mdash]|revolutionary advance or diminishing returns?,Nature Reviews Urology,,,Article,2013-02-12,10.1038/nrurol.2013.16,,,,23399730,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1279344,https://api.altmetric.com/v1/donut/1279344_240.png 2,Molecular subtypes of prostate cancer arise from different cell types,ecancer.org,,,Article,,,,,http://ecancer.org/news/3861-molecular-subtypes-of-prostate-cancer-arise-from-different-cell-types.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1262765,https://api.altmetric.com/v1/donut/1262765_240.png 2,Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition,British Journal of Cancer,,,Article,2012-11-20,10.1038/bjc.2012.520,,,,23169298,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1260946,https://api.altmetric.com/v1/donut/1260946_240.png 2,Scientists identify new mechanism of prostate cancer cellmetabolism. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/2629-scientists-identify-new-mechanism-of-prostate-cancer-cell-metabolism.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251111,https://api.altmetric.com/v1/donut/1251111_240.png 2,Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3630,,,,23117885,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/1181917,https://api.altmetric.com/v1/donut/1181917_240.png 2,Targeted prostate cancer ablation: energy options,Current Opinion in Urology,,,Article,2013-01-02,10.1097/mou.0b013e32835d9e94,,,,23287462,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1164860,https://api.altmetric.com/v1/donut/1164860_240.png 2,Rectal fistulae after salvage highâ??intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy,British Journal of Urology,,,Article,2009-01-01,10.1111/j.1464-410x.2008.08026.x,,,,19021611,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1135996,https://api.altmetric.com/v1/donut/1135996_240.png 2,Overdiagnosis and overtreatment of early detected prostate cancer,World Journal of Urology,,,Article,2007-03-01,10.1007/s00345-007-0145-z,,,,17364211,PMC1913182,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/1074949,https://api.altmetric.com/v1/donut/1074949_240.png 2,Studying Epithelial-Stromal Interactions in Prostate Cancer Using Tissue Recombination Models,AACR Education Book,,,Article,2012-01-01,10.1158/aacr.edb-12-6303,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/981815,https://api.altmetric.com/v1/donut/981815_240.png 2,"Focal Therapy, Differential Therapy, and Radiation Treatment for Prostate Cancer",Advances in Urology,,,Article,2012-10-04,10.1155/2012/573193,,,,22666239,PMC3362011,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/981287,https://api.altmetric.com/v1/donut/981287_240.png 2,Tissue Biomarkers for Prostate Cancer Radiation Therapy,Current Molecular Medicine,,,Article,2012-07-01,10.2174/156652412800792589,,,,22292443,PMC3412203,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/981192,https://api.altmetric.com/v1/donut/981192_240.png 2,Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer,The Journal of Urology,,,Article,2012-07-25,10.1016/j.juro.2012.04.107,,,,22818143,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/945131,https://api.altmetric.com/v1/donut/945131_240.png 2,Pharmacodynamics of fish oil: protective effects against prostate cancer in TRAMP mice fed with a high fat western diet.,Asian Pacific Journal of Cancer Prevention,,,Article,2011-01-01,,,,,22471475,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/913631,https://api.altmetric.com/v1/donut/913631_240.png 2,Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice.,PLoS ONE,,,Article,2012-02-23,10.1371/journal.pone.0031213,,,,22347450,PMC3276576,,2012PLoSO...7E1213L,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/900590,https://api.altmetric.com/v1/donut/900590_240.png 2,"Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.",Endocrinology,,,Article,1993-01-01,10.1210/en.132.5.1952,,,,7682937,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/888879,https://api.altmetric.com/v1/donut/888879_240.png 2,Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer,Annals of Oncology,,,Article,2012-07-27,10.1093/annonc/mds216,,,,22831986,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/862888,https://api.altmetric.com/v1/donut/862888_240.png 2,Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program.,Cancer (0008543X),,,Article,2011-07-15,10.1002/cncr.26315,,,,21751189,PMC3195866,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/858803,https://api.altmetric.com/v1/donut/858803_240.png 2,Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review,JGIM: Journal of General Internal Medicine,,,Article,2012-07-14,10.1007/s11606-012-2086-5,,,,22798216,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/841457,https://api.altmetric.com/v1/donut/841457_240.png 2,The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.,Human Pathology,,,Article,1970-01-01,10.1016/j.humpath.2011.06.018,,,,21937078,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/830565,https://api.altmetric.com/v1/donut/830565_240.png 2,Farming and Prostate Cancer Mortality,American Journal of Epidemiology,,,Article,1994-01-01,,,,,8452135,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/791724,https://api.altmetric.com/v1/donut/791724_240.png 2,"Re: SCRIB Expression is Deregulated in Human Prostate Cancer, and its Deficiency in Mice Promotes Prostate Neoplasia",The Journal of Urology,,,Article,2012-05-17,10.1016/j.juro.2012.03.073,,,,22682867,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/782478,https://api.altmetric.com/v1/donut/782478_240.png 2,"Zyflamend, a Combination of Herbal Extracts, Attenuates Tumor Growth in Murine Xenograft Models of Prostate Cancer.",Nutrition and Cancer,,,Article,2012-06-04,10.1080/01635581.2012.689413,,,,22663543,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/779901,https://api.altmetric.com/v1/donut/779901_240.png 2,Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?,Lancet Oncology,,,Article,2012-06-01,10.1016/s1470-2045(12)70084-0,,,,22652234,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/767034,https://api.altmetric.com/v1/donut/767034_240.png 2,"Structure-Activity Relationships of ?-, ?(1)-, ?-, and ?-Tomatine and Tomatidine against Human Breast (MDA-MB-231), Gastric (KATO-III), and Prostate (PC3) Cancer Cells.",Journal of Agricultural & Food Chemistry,,,Article,2012-04-11,10.1021/jf3003027,,,,22482398,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/726129,https://api.altmetric.com/v1/donut/726129_240.png 2,Development of Novel Immune Interventions for Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2012-03-01,10.1016/j.clgc.2012.01.012,,,,22409862,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/714112,https://api.altmetric.com/v1/donut/714112_240.png 2,"Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany.",European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2012-03-17,10.1097/cej.0b013e328351c748,,,,22433633,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/661080,https://api.altmetric.com/v1/donut/661080_240.png 2,Targeting angiogenesis for the treatment of prostate cancer.,Expert Opinion on Therapeutic Targets,,,Article,2012-03-13,10.1517/14728222.2012.668887,,,,22413953,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/650651,https://api.altmetric.com/v1/donut/650651_240.png 2,Prostate Cancer Risk in Men with Prostate and Breast Cancer Family History: Results from the REDUCE study (R1),Journal of Internal Medicine,,,Article,2012-01-05,10.1111/j.1365-2796.2011.02504.x,,,,22211699,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/511150,https://api.altmetric.com/v1/donut/511150_240.png 2,Erectile dysfunction and urinary incontinence after prostate cancer treatment.,Seminars in oncology nursing,,,Article,2011-11-01,10.1016/j.soncn.2011.07.006,,,,22018407,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/434851,https://api.altmetric.com/v1/donut/434851_240.png 2,Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland.,BJU international,,,Article,2011-04-01,10.1111/j.1464-410x.2010.09988.x,,,,21492373,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/432636,https://api.altmetric.com/v1/donut/432636_240.png 2,Immunotherapy with dendritic cells for prostate cancer.,International journal of cancer. Journal international du cancer,,,Article,2007-08-01,10.1002/ijc.22859,,,,17514654,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/430021,https://api.altmetric.com/v1/donut/430021_240.png 2,Biomarkers and Prostate Cancer Progression,Journal of the National Cancer Institute,,,Article,2011-01-01,10.1093/jnci/djr444,,,,22010173,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/421296,https://api.altmetric.com/v1/donut/421296_240.png 2,"A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.",Prostate cancer and prostatic diseases,,,Article,2011-10-18,10.1038/pcan.2011.49,,,,22006050,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/419748,https://api.altmetric.com/v1/donut/419748_240.png 2,Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.,Human molecular genetics,,,Article,2010-11-15,10.1093/hmg/ddq354,,,,20729295,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/393224,https://api.altmetric.com/v1/donut/393224_240.png 2,Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.,"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",,,Article,2011-07-01,10.1038/modpathol.2011.112,,,,21725290,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/392326,https://api.altmetric.com/v1/donut/392326_240.png 2,A Content Analysis of YouTube Videos Related to Prostate Cancer,American Journal of Men's Health,,,Article,2016-09-29,10.1177/1557988316671459,,,,27694554,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12449259,https://api.altmetric.com/v1/donut/12449259_240.png 2,Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.,Neoplasia,,,Article,2016-08-28,10.1016/j.neo.2016.07.001,,,,27566105,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10873807,https://api.altmetric.com/v1/donut/10873807_240.png 2,Diagnoses of Early-Stage Prostate Cancer Fell After USPSTF Recommendation,Journal Watch,,,Article,2016-08-19,10.1056/nejm-jw.fw111936,,,,,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10694836,https://api.altmetric.com/v1/donut/10694836_240.png 2,Prostate cancer: A COX-2 far?,Nature Reviews Urology,,,Article,2016-08-17,10.1038/nrurol.2016.155,,,,27530263,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10575007,https://api.altmetric.com/v1/donut/10575007_240.png 2,The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease,British Journal of Pharmacology,,,Article,2016-01-01,10.1111/bph.13576,,,,27526115,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10524315,https://api.altmetric.com/v1/donut/10524315_240.png 2,Repair-Gene Mutations Uncovered in Metastatic Prostate Cancer,Cancer Discovery,,,Article,2016-07-26,10.1158/2159-8290.cd-nb2016-094,,,,27460689,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10061394,https://api.altmetric.com/v1/donut/10061394_240.png 2,GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-0137,,,,27458247,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10051948,https://api.altmetric.com/v1/donut/10051948_240.png 2,Anticancer Effect of Fucoidan on DU-145 Prostate Cancer Cells through Inhibition of PI3K/Akt and MAPK Pathway Expression,Marine Drugs,,,Article,2016-07-07,10.3390/md14070126,,,,27399727,PMC4962016,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9356357,https://api.altmetric.com/v1/donut/9356357_240.png 2,Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP),The Prostate,,,Article,2016-06-01,10.1002/pros.23189,,,,27271547,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9259455,https://api.altmetric.com/v1/donut/9259455_240.png 2,Epididymal Metastasis of Prostate Cancer Detected With 68Ga-PSMA-PET/CT.,Clinical Nuclear Medicine,,,Article,2016-06-30,10.1097/rlu.0000000000001302,,,http://journals.lww.com/nuclearmed/Fulltext/2016/10000/Epididymal_Metastasis_of_Prostate_Cancer_Detected.14.aspx,27355849,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9139530,https://api.altmetric.com/v1/donut/9139530_240.png 2,Men's Sexual and Relational Adaptations to Erectile Dysfunction after Prostate Cancer Treatment,International Journal of Sexual Health,,,Article,2016-06-27,10.1080/19317611.2016.1204403,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9084820,https://api.altmetric.com/v1/donut/9084820_240.png 2,Making Sense of the Statin–Prostate Cancer Relationship: Is It Time for a Randomized Controlled Trial?,European Urology Focus ,,,Article,2016-06-24,10.1016/j.euf.2016.06.008,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9004807,https://api.altmetric.com/v1/donut/9004807_240.png 2,"Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer",Cancer Letters,,,Article,2016-06-01,10.1016/j.canlet.2016.06.013,,,,27322736,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8945833,https://api.altmetric.com/v1/donut/8945833_240.png 2,Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-06-01,10.1097/coc.0000000000000308,,,http://journals.lww.com/amjclinicaloncology/Fulltext/publishahead/Targeted_Prostate_Biopsy_Gleason_Score.99043.aspx,27281263,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8778890,https://api.altmetric.com/v1/donut/8778890_240.png 2,Exosome-derived microRNAs contribute to prostate cancer chemoresistance,International Journal of Oncology,,,Article,2016-06-03,10.3892/ijo.2016.3560,,,,27278879,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8634948,https://api.altmetric.com/v1/donut/8634948_240.png 2,Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study,Quality of Life Research,,,Article,2016-05-30,10.1007/s11136-016-1325-3,,,,27240448,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/8416136,https://api.altmetric.com/v1/donut/8416136_240.png 2,"Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks",Microarrays,,,Article,2016-05-28,10.3390/microarrays5020013,,,,27600078,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8335719,https://api.altmetric.com/v1/donut/8335719_240.png 2,BAP18 coactivates androgen receptor action and promotes prostate cancer progression,Nucleic Acids Research,,,Article,2016-05-25,10.1093/nar/gkw472,,,,27226492,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8312927,https://api.altmetric.com/v1/donut/8312927_240.png 2,KIBRA promotes prostate cancer cell proliferation and motility,FEBS Journal,,,Article,2016-04-05,10.1111/febs.13718,,,,27220053,PMC4880424,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8154142,https://api.altmetric.com/v1/donut/8154142_240.png 2,Integrated and Functional Genomics Analysis Validates the Relevance of the Nuclear Variant ErbB3 80kDa in Prostate Cancer Progression,PLoS ONE,,,Article,2016-05-18,10.1371/journal.pone.0155950,,,,27191720,,,,,,,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,https://www.altmetric.com/details/7590188,https://api.altmetric.com/v1/donut/7590188_240.png 2,Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through hippo pathway,Cancer Letters,,,Article,2016-05-01,10.1016/j.canlet.2016.05.010,,,,27179930,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7483254,https://api.altmetric.com/v1/donut/7483254_240.png 2,Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3,International Journal of Nanomedicine,,,Article,2016-05-06,10.2147/ijn.s103759,,,,27226712,PMC4866752,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7291443,https://api.altmetric.com/v1/donut/7291443_240.png 2,Should Treatment with Radiation and Androgen Deprivation Therapy be Considered the ‘Gold Standard’ for Men with Unfavourable Intermediate- to High-risk and Locally Advanced Prostate Cancer?,Clinical Oncology,,,Article,2016-04-28,10.1016/j.clon.2016.04.037,,,,27133945,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7273152,https://api.altmetric.com/v1/donut/7273152_240.png 2,Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells,Genome Research,,,Article,2016-05-01,10.1101/gr.206557.116,,,,27197245,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7115046,https://api.altmetric.com/v1/donut/7115046_240.png 2,"Preclinical characterization of 3?-(N-acetyl L-cysteine methyl ester)-2a?,3-dihydrogaliellalactone (GPA512), a prodrug of a direct STAT3 inhibitor for the treatment of prostate cancer",Journal of Medicinal Chemistry,,,Article,2016-04-25,10.1021/acs.jmedchem.5b01814,,,,27111731,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7060489,https://api.altmetric.com/v1/donut/7060489_240.png 2,The Importance of DNA methylation in Prostate Cancer development.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2016-04-28,10.1016/j.jsbmb.2016.04.009,,,,27117390,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7056835,https://api.altmetric.com/v1/donut/7056835_240.png 2,Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer (CRPC),Clinical Cancer Research,,,Article,2016-04-11,10.1158/1078-0432.ccr-15-2956,,,,27060154,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6568230,https://api.altmetric.com/v1/donut/6568230_240.png 2,Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-04-04,10.1073/pnas.1603645113,,,,27044116,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6478691,https://api.altmetric.com/v1/donut/6478691_240.png 2,Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with 68Ga-PSMA-HBED-CC than with 18F-Fluoroethylcholine PET/CT,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-03-19,10.1007/s00259-016-3366-9,,,,26993315,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6245548,https://api.altmetric.com/v1/donut/6245548_240.png 2,miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression,Oncology Reports,,,Article,2016-03-08,10.3892/or.2016.4663,,,,26986507,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6229464,https://api.altmetric.com/v1/donut/6229464_240.png 2,Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity,Scientific Reports,,,Article,2016-03-16,10.1038/srep23135,,,,26979487,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6214588,https://api.altmetric.com/v1/donut/6214588_240.png 2,Influence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer,International Journal of Molecular Sciences,,,Article,2016-03-17,10.3390/ijms17030377,,,,26999116,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6205662,https://api.altmetric.com/v1/donut/6205662_240.png 2,What Are Risks for Second Cancers After Prostate Radiotherapy?,Journal Watch,,,Article,2016-03-15,10.1056/nejm-jw.na40713,,,,,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6195967,https://api.altmetric.com/v1/donut/6195967_240.png 2,Perineural Invasion in Prostate Cancer Is More Frequently Detected by Multiparametric MRI Targeted Biopsy Compared With Standard Biopsy,The American Journal of Surgical Pathology,,,Article,2016-04-01,10.1097/pas.0000000000000546,,,http://journals.lww.com/ajsp/Fulltext/2016/04000/Perineural_Invasion_in_Prostate_Cancer_Is_More.9.aspx,26523543,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6189714,https://api.altmetric.com/v1/donut/6189714_240.png 2,Organisation of Prostate Cancer Services in the English National Health Service ,Clinical Oncology,,,Article,2016-03-01,10.1016/j.clon.2016.02.004,,,,26947316,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6049768,https://api.altmetric.com/v1/donut/6049768_240.png 2,miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110,Oncotarget,,,Article,2016-02-27,10.18632/oncotarget.7572,,,,26918338,PMC4941343,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6012907,https://api.altmetric.com/v1/donut/6012907_240.png 2,Total triterpenoids from Ganoderma Lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis. - PubMed - NCBI,"Journal of Huazhong University of Science and Technology, Medical",,,Article,2015-10-22,10.1007/s11596-015-1499-x,,,,26489631,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6012578,https://api.altmetric.com/v1/donut/6012578_240.png 2,Prostate cancer: Triple combination therapy tested in mCRPC,Nature Reviews Urology,,,Article,2016-02-23,10.1038/nrurol.2016.40,,,,26902341,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5973393,https://api.altmetric.com/v1/donut/5973393_240.png 2,Development of Indicators to Assess Quality of Care for Prostate Cancer,European Urology Focus ,,,Article,2016-02-22,10.1016/j.euf.2016.01.016,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5911743,https://api.altmetric.com/v1/donut/5911743_240.png 2,"Knowledge and attitude of the population toward cancer prostate Riyadh, Saudi Arabia",Urology Annals,,,Article,2015-04-01,10.4103/0974-7796.150516,,,,25837827,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5633189,https://api.altmetric.com/v1/donut/5633189_240.png 2,Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer,Oncogene,,,Article,2016-02-16,10.1038/onc.2016.13,,,,26876202,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5617424,https://api.altmetric.com/v1/donut/5617424_240.png 2,Should we worry about positive surgical margins in prostate cancer?,British Journal of Urology,,,Article,2016-01-10,10.1111/bju.13230,,,,26750494,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5081960,https://api.altmetric.com/v1/donut/5081960_240.png 2,Re: PSA Mass Density – a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution: Author's Reply.,Urology,,,Article,2016-01-01,10.1016/j.urology.2016.01.014,,,,26820119,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5041533,https://api.altmetric.com/v1/donut/5041533_240.png 2,The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index,Value in Health (Elsevier Science),,,Article,2016-03-30,10.1016/j.jval.2015.12.002,,,,27021748,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4995143,https://api.altmetric.com/v1/donut/4995143_240.png 2,Inhibition of Hedgehog-Signaling Driven Genes in Prostate Cancer Cells by Sutherlandia frutescens Extract.,PLoS ONE,,,Article,2015-12-28,10.1371/journal.pone.0145507,,,,26710108,PMC4694108,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4931901,https://api.altmetric.com/v1/donut/4931901_240.png 2,Patient-Specific Meta-Analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.,Urology,,,Article,2016-01-03,10.1016/j.urology.2015.12.008,,,,26723180,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4918293,https://api.altmetric.com/v1/donut/4918293_240.png 2,The Clinical Impact of BRCA2 Loss in Prostate Cancer,European Urology,,,Article,2015-12-19,10.1016/j.eururo.2015.12.009,,,,26708042,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4896784,https://api.altmetric.com/v1/donut/4896784_240.png 2,Prostate Cancer: Cases of Rare Presentation and Rare Metastasis.,Case Reports in Oncology,,,Article,2015-09-01,10.1159/000442045,,,,26668576,PMC4677723,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4888255,https://api.altmetric.com/v1/donut/4888255_240.png 2,Cost–effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer,Expert Review of Pharmacoeconomics and Outcomes Research,,,Article,2016-01-08,10.1586/14737167.2016.1123624,,,,26588857,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4859215,https://api.altmetric.com/v1/donut/4859215_240.png 2,Screening for Familial and Hereditary Prostate Cancer,International Journal of Cancer,,,Article,2015-12-01,10.1002/ijc.29949,,,,26638190,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4844132,https://api.altmetric.com/v1/donut/4844132_240.png 2,"Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.",Clinical Chemistry & Laboratory Medicine,,,Article,2015-12-03,10.1515/cclm-2015-0599,,,,26630694,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4836545,https://api.altmetric.com/v1/donut/4836545_240.png 2,Locus-specific gene repositioning in prostate cancer.,Molecular Biology of the Cell,,,Article,2015-11-14,10.1091/mbc.e15-05-0280,,,,26564800,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4761894,https://api.altmetric.com/v1/donut/4761894_240.png 2,Silibinin preferentially radiosensitizes prostate cancer by inhibiting DNA repair signaling.,Molecular Cancer Therapeutics,,,Article,,10.1158/1535-7163.mct-15-0348,,,,26516160,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4755889,https://api.altmetric.com/v1/donut/4755889_240.png 2,Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers,Clinical Cancer Research,,,Article,2015-11-08,10.1158/1078-0432.ccr-15-1259,,,,26546618,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4736144,https://api.altmetric.com/v1/donut/4736144_240.png 2,The Potential Role of Lycopene for the Prevention and Therapy of Prostate Cancer: From Molecular Mechanisms to Clinical Evidence,International Journal of Molecular Sciences,,,Article,2013-07-01,10.3390/ijms140714620,,,,23857058,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,74,https://www.altmetric.com/details/4721912,https://api.altmetric.com/v1/donut/4721912_240.png 2,Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-?-dependent activation of matrix metalloproteases,Carcinogenesis,,,Article,2016-01-01,10.1093/carcin/bgv153,,,,26503968,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4714910,https://api.altmetric.com/v1/donut/4714910_240.png 2,Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-11-01,,,,,26504040,,,,,,,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,2,https://www.altmetric.com/details/4688273,https://api.altmetric.com/v1/donut/4688273_240.png 2,The Future of Prostate Cancer Risk Prediction,Current Epidemiology Reports,,,Article,2015-09-28,10.1007/s40471-015-0056-2,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4585330,https://api.altmetric.com/v1/donut/4585330_240.png 2,Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?,Journal of Nuclear Medicine,,,Article,2015-09-27,10.2967/jnumed.115.163741,,,,26405166,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4558889,https://api.altmetric.com/v1/donut/4558889_240.png 2,"PARP Inhibition Gets Responses in Prostate, Ovarian, and Breast Cancers",Oncology times,,,Article,2015-09-10,10.1097/01.cot.0000471646.48683.4e,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4535511,https://api.altmetric.com/v1/donut/4535511_240.png 2,The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer,Pathology,,,Article,2015-10-01,10.1097/pat.0000000000000315,,,,26325670,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4497546,https://api.altmetric.com/v1/donut/4497546_240.png 2,Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA–DR transgenic mouse model of prostate cancer ,Vaccine,,,Article,2015-09-01,10.1016/j.vaccine.2015.08.062,,,,26319744,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4459720,https://api.altmetric.com/v1/donut/4459720_240.png 2,Implementation of PSA-based active surveillance in prostate cancer,Biomarkers in Medicine,,,Article,2014-06-14,10.2217/bmm.14.5,,,,25123041,,,,,,,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/4449854,https://api.altmetric.com/v1/donut/4449854_240.png 2,Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.,The Prostate,,,Article,2015-08-27,10.1002/pros.23064,,,,26306637,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4443024,https://api.altmetric.com/v1/donut/4443024_240.png 2,"Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.",Systematic Reviews,,,Article,2015-08-27,10.1186/s13643-015-0099-y,,,,26307105,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/4441467,https://api.altmetric.com/v1/donut/4441467_240.png 2,Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer,Clinical Cancer Research,,,Article,2015-08-15,10.1158/1078-0432.ccr-15-0235,,,,26272062,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4396932,https://api.altmetric.com/v1/donut/4396932_240.png 2,Spirituality is associated with better prostate cancer treatment decision making experiences.,Journal of Behavioral Medicine,,,Article,2015-08-05,10.1007/s10865-015-9662-1,,,,26243642,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4363221,https://api.altmetric.com/v1/donut/4363221_240.png 2,"Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.",PLoS ONE,,,Article,2015-08-04,10.1371/journal.pone.0133449,,,,26237329,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4360065,https://api.altmetric.com/v1/donut/4360065_240.png 2,Management of advanced prostate cancer,Annals of Oncology,,,Article,2015-07-29,10.1093/annonc/mdv327,,,,26216387,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4340990,https://api.altmetric.com/v1/donut/4340990_240.png 2,Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue,American Journal of Pathology,,,Article,2015-01-07,10.1016/j.ajpath.2015.03.008,,,,25963990,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4329350,https://api.altmetric.com/v1/donut/4329350_240.png 2,Gallic acid and methyl-3-O-methyl gallate: a comparative study on their effects on prostate cancer stem cells,RSC Advances,,,Article,2015-07-22,10.1039/c5ra07988h,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4327948,https://api.altmetric.com/v1/donut/4327948_240.png 2,Prognostic value of metabolic parameters and clinical impact of 18F-fluorocholine PET/CT in biochemical recurrent prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-07-22,10.1007/s00259-015-3123-5,,,,26194716,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4303855,https://api.altmetric.com/v1/donut/4303855_240.png 2,A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer,Clinical Cancer Research,,,Article,2015-07-16,10.1158/1078-0432.ccr-15-0552,,,,26175541,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4279228,https://api.altmetric.com/v1/donut/4279228_240.png 2,Physical activity from early adulthood and risk of prostate cancer: a 24 year follow-up study among Icelandic men.,Cancer Prevention Research,,,Article,2015-07-15,10.1158/1940-6207.capr-15-0035,,,,26152935,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4268559,https://api.altmetric.com/v1/donut/4268559_240.png 2,"PEP Talk: Prostate Education Program, “Cutting Through the Uncertainty of Prostate Cancer for Black Men Using Decision Support Instruments in Barbershops”",Journal of Cancer Education,,,Article,2015-07-01,10.1007/s13187-015-0871-7,,,,26123763,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4230938,https://api.altmetric.com/v1/donut/4230938_240.png 2,SU-E-T-477: IMPT Vs. VMAT: A Treatment Planning Study for High-Risk Prostate Cancer,Medical Physics,,,Article,2015-06-01,10.1118/1.4924839,,,,26128142,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4220088,https://api.altmetric.com/v1/donut/4220088_240.png 2,SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.,Clinical Cancer Research,,,Article,2015-06-14,10.1158/1078-0432.ccr-15-0157,,,,26071481,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4146223,https://api.altmetric.com/v1/donut/4146223_240.png 2,Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer. Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3771/enzalutamide-preferable-to-bicalutamide-plus-lhrh-analogue-in-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4129305,https://api.altmetric.com/v1/donut/4129305_240.png 2,TLR9 signaling through NF-?B/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.,Oncotarget,,,Article,2015-06-06,10.18632/oncotarget.4029,,,,26046794,PMC4627309,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4105160,https://api.altmetric.com/v1/donut/4105160_240.png 2,Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention.,Current pharmacology reports,,,Article,2015-04-01,10.1007/s40495-014-0002-x,,,,26042194,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4098116,https://api.altmetric.com/v1/donut/4098116_240.png 2,Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk?associated loci,The Prostate,,,Article,2015-05-25,10.1002/pros.23008,,,,26015065,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4056775,https://api.altmetric.com/v1/donut/4056775_240.png 2,Bone Health in Adults Treated with Endocrine Therapy for Early Breast or Prostate Cancer,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2015-05-22,10.14694/edbook_am.2015.35.e567,,,,25993224,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4042430,https://api.altmetric.com/v1/donut/4042430_240.png 2,Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3192,,,,25888628,PMC4496338,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4025932,https://api.altmetric.com/v1/donut/4025932_240.png 2,Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study.,Clinical Genitourinary Cancer,,,Article,2015-05-16,10.1016/j.clgc.2015.04.004,,,,25972296,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4000920,https://api.altmetric.com/v1/donut/4000920_240.png 2,Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure.,Frontiers in oncology,,,Article,2015-03-26,10.3389/fonc.2015.00090,,,,25927031,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3907539,https://api.altmetric.com/v1/donut/3907539_240.png 2,"Reply to Kevin Lu's Letter to the Editor re: Arun A. Azad, Bernhard J. Eigl, Raya Leibowitz-Amit, et al. Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status. Eur Urol 2015;67:441-7.",European Urology,,,Article,2015-04-13,10.1016/j.eururo.2015.03.042,,,,25864159,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3890781,https://api.altmetric.com/v1/donut/3890781_240.png 2,Prostate cancer: New ligand-receptor targets,Nature Reviews Urology,,,Article,2015-03-31,10.1038/nrurol.2015.68,,,,25823376,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3854721,https://api.altmetric.com/v1/donut/3854721_240.png 2,Epidemiology of prostate cancer: current status.,European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360,,,Article,2015-03-01,,,,,25807434,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3840185,https://api.altmetric.com/v1/donut/3840185_240.png 2,Pathological Features of Localized Prostate Cancer in China: A Contemporary Analysis of Radical Prostatectomy Specimens,PLoS ONE,,,Article,2015-03-23,10.1371/journal.pone.0121076,,,,25799190,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3836093,https://api.altmetric.com/v1/donut/3836093_240.png 2,"Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-? Blocker in Prostate Cancer",Pharmaceutical Research,,,Article,2015-03-12,10.1007/s11095-015-1662-x,,,,25762087,,,,,,,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/3813374,https://api.altmetric.com/v1/donut/3813374_240.png 2,"Physical activity, alcohol consumption, BMI and smoking status before and after prostate cancer diagnosis in the ProtecT trial: Opportunities for lifestyle modification",International Journal of Cancer,,,Article,2015-04-01,10.1002/ijc.29514,,,,25761662,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3781239,https://api.altmetric.com/v1/donut/3781239_240.png 2,Current and Emerging Immunotherapies for Castration-resistant Prostate Cancer,Urology,,,Article,,10.1016/j.urology.2014.12.029,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3724835,https://api.altmetric.com/v1/donut/3724835_240.png 2,A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2015-08-09,10.1093/jnci/90.10.766,,,,9605647,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/3643398,https://api.altmetric.com/v1/donut/3643398_240.png 2,Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.,American Journal of Men's Health,,,Article,2015-02-05,10.1177/1557988314568184,,,,25657192,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3434544,https://api.altmetric.com/v1/donut/3434544_240.png 2,A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment.,Oncology Reports,,,Article,2015-01-29,10.3892/or.2015.3770,,,,25632844,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3215017,https://api.altmetric.com/v1/donut/3215017_240.png 2,Potent anti-prostate cancer immune response induced by dendritic cells transduced with recombinant adenoviruses encoding 4-1BBL combined with cytokine-induced killer cells.,Immunotherapy,,,Article,2015-01-13,10.2217/imt.14.92,,,,25572476,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3066566,https://api.altmetric.com/v1/donut/3066566_240.png 2,MD-miniRNA could be a more accurate biomarker for prostate cancer screening compared with serum prostate-specific antigen level,Tumor Biology,,,Article,2015-01-05,10.1007/s13277-014-2990-x,,,,25557788,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3036217,https://api.altmetric.com/v1/donut/3036217_240.png 2,"Re: Michael T. Schweizer, Xian C. Zhou, Hao Wang, et al. The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2014;66:646–52",European Urology,,,Article,2015-06-01,10.1016/j.eururo.2014.12.018,,,,25534667,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2994293,https://api.altmetric.com/v1/donut/2994293_240.png 2,ERG induces taxane resistance in castration-resistant prostate cancer,Nature Communications,,,Article,2014-11-25,10.1038/ncomms6548,,,,25420520,PMC4244604,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2940007,https://api.altmetric.com/v1/donut/2940007_240.png 2,"Carbohydrate intake, glycemic index and prostate cancer risk",The Prostate,,,Article,2014-11-26,10.1002/pros.22929,,,,25417840,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2931991,https://api.altmetric.com/v1/donut/2931991_240.png 2,Identification of Prostate Cancer LncRNAs by RNA-Seq.,Asian Pacific Journal of Cancer Prevention,,,Article,2014-01-01,,,,,25422238,,,,,,,0,0,0,3,0,0,0,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/2926024,https://api.altmetric.com/v1/donut/2926024_240.png 2,"Reply from Authors re: Sigrid V. Carlsson, Peter C. Albertsen. Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.10.035: Better Treatment in the Control Arm of the ERSPC Rotterdam: A Point Worth Noting?",European Urology,,,Article,2015-08-01,10.1016/j.eururo.2014.11.016,,,,25465973,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2910923,https://api.altmetric.com/v1/donut/2910923_240.png 2,Re: A Phase III Trial to Investigate the Timing of Radiotherapy for Prostate Cancer with High-Risk Features: Background and Rationale of the Radiotherapy—Adjuvant versus Early Salvage (RAVES) Trial,The Journal of Urology,,,Article,,10.1016/j.juro.2014.11.067,,,,25617271,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2890456,https://api.altmetric.com/v1/donut/2890456_240.png 2,Re: Mark K. Buyyounouski. Radiobiological Modeling and the Study of Hypofractionated Radiotherapy for Prostate Cancer. Eur Urol 2014;66:1031–2,European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.10.032,,,,25466947,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2878493,https://api.altmetric.com/v1/donut/2878493_240.png 2,Will Multi-Parametric Magnetic Resonance Imaging be the Future Tool to Detect Clinically Significant Prostate Cancer?,Frontiers in oncology,,,Article,2014-10-08,10.3389/fonc.2014.00294,,,,25408923,PMC4219420,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2850306,https://api.altmetric.com/v1/donut/2850306_240.png 2,"Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.",PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0110569,,,,25360682,,,,,,,0,0,0,20,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2842679,https://api.altmetric.com/v1/donut/2842679_240.png 2,Re: Vasectomy and Risk of Aggressive Prostate Cancer: A 24-Year Follow-up Study,The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.075,,,,25523658,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2808617,https://api.altmetric.com/v1/donut/2808617_240.png 2,Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer.,Molecular BioSystems,,,Article,2015-01-20,10.1039/c4mb00439f,,,,25385343,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2782348,https://api.altmetric.com/v1/donut/2782348_240.png 2,Income inequality and treatment of African American men with high-risk prostate cancer.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2014.09.005,,,,25306287,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2778169,https://api.altmetric.com/v1/donut/2778169_240.png 2,Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cells,European Journal of Cancer (1965),,,Article,2014-10-09,10.1016/j.ejca.2014.09.009,,,,25307750,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2772327,https://api.altmetric.com/v1/donut/2772327_240.png 2,Toward Better Use of Bone Scans Among Men With Early-stage Prostate Cancer,Urology,,,Article,2014-08-01,10.1016/j.urology.2014.06.010,,,,25096341,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2764429,https://api.altmetric.com/v1/donut/2764429_240.png 2,Androgen deprivation–induced NCoA2 promotes metastatic and castration-resistant prostate cancer,Journal of Clinical Investigation,,,Article,2014-10-08,10.1172/jci76412,,,,25295534,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2752136,https://api.altmetric.com/v1/donut/2752136_240.png 2,RE: Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial,JNCI: Journal of the National Cancer Institute,,,Article,2014-03-30,10.1093/jnci/dju014,,,,24685931,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2732856,https://api.altmetric.com/v1/donut/2732856_240.png 2,Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-07-09,10.1158/1055-9965.epi-14-0376,,,,25012998,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2691261,https://api.altmetric.com/v1/donut/2691261_240.png 2,"Reply to Yaalini Shanmugabavan, Stephanie Guillaumier and Hashim U. Ahmed's Letter to the Editor re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies. Eur Urol 2014;66:22–9",European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.08.066,,,,25194908,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2652853,https://api.altmetric.com/v1/donut/2652853_240.png 2,MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy,European Radiology,,,Article,2014-06-30,10.1007/s00330-014-3276-9,,,,24972954,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2649441,https://api.altmetric.com/v1/donut/2649441_240.png 2,Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies,Critical Reviews in Oncology/Hematology,,,Article,,10.1016/j.critrevonc.2014.05.008,,,,24952997,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2643187,https://api.altmetric.com/v1/donut/2643187_240.png 2,Autophagy as a modulator and target in prostate cancer,Nature Reviews Urology,,,Article,2014-08-19,10.1038/nrurol.2014.196,,,,25134829,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2611593,https://api.altmetric.com/v1/donut/2611593_240.png 2,"Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's Letter to the Editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling. Eur Urol 2014;66:550–60",European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.001,,,,25150174,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2610610,https://api.altmetric.com/v1/donut/2610610_240.png 2,Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.,Radiation Oncology,,,Article,2014-08-12,10.1186/1748-717x-9-178,,,,25112785,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2588963,https://api.altmetric.com/v1/donut/2588963_240.png 2,Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.,Clinical and Experimental Metastasis,,,Article,2005-09-16,10.1007/s10585-005-8393-z,,,,16158255,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2583477,https://api.altmetric.com/v1/donut/2583477_240.png 2,Stromal Androgen Receptor in Prostate Development and Cancer,American Journal of Pathology,,,Article,2014-07-30,10.1016/j.ajpath.2014.06.022,,,,25088980,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2568348,https://api.altmetric.com/v1/donut/2568348_240.png 2,Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles,"Journal of Huazhong University of Science and Technology, Medical",,,Article,2014-02-06,10.1007/s11596-014-1233-0,,,,24496681,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2562883,https://api.altmetric.com/v1/donut/2562883_240.png 2,Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer,Radiation Oncology,,,Article,2014-07-24,10.1186/1748-717x-9-163,,,,25056726,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2534280,https://api.altmetric.com/v1/donut/2534280_240.png 2,"Androgen Receptor and its Splice Variant, AR-V7, Differentially Regulate FOXA1 Sensitive Genes in LNCaP Prostate Cancer Cells.",International Journal of Biochemistry & Cell Biology,,,Article,2014-07-03,10.1016/j.biocel.2014.06.013,,,,25008967,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2531540,https://api.altmetric.com/v1/donut/2531540_240.png 2,Online adaptive planning for prostate cancer radiotherapy is necessary and ready now,Medical Physics,,,Article,2014-07-03,10.1118/1.4883875,,,,25103556,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2484043,https://api.altmetric.com/v1/donut/2484043_240.png 2,"Comments on Bruun, D.M. et al. Community-Based Recreational Football: A Novel Approach to Promote Physical Activity and Quality of Life in Prostate Cancer Survivors. Int. J. Environ. Res. Public Health 2014, 11, 5557–5585—Time to Raise Our Game",International Journal of Environmental Research and Public Health,,,Article,2014-07-02,10.3390/ijerph110706842,,,,24992487,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2481075,https://api.altmetric.com/v1/donut/2481075_240.png 2,Docetaxel rechallenge in patients with metastatic castration-resistant prostate cancer.,British Journal of Urology,,,Article,2014-06-19,10.1111/bju.12845,,,,24947139,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2452568,https://api.altmetric.com/v1/donut/2452568_240.png 2,Corpulence is the crucial factor: Association of testosterone and/or obesity with prostate cancer stage,International Journal of Urology,,,Article,2014-05-27,10.1111/iju.12494,,,,24865433,,,,,,,0,0,0,2,0,0,1,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/2388283,https://api.altmetric.com/v1/donut/2388283_240.png 2,Hereditary prostate cancer.,Post?py higieny i medycyny do?wiadczalnej,,,Article,2014-01-01,10.5604/17322693.1104682,,,,24864115,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2385242,https://api.altmetric.com/v1/donut/2385242_240.png 2,Risk of prostate cancer in patients with schizophrenia.,Comprehensive Psychiatry,,,Article,2014-05-16,10.1016/j.comppsych.2014.05.007,,,,24957959,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2375471,https://api.altmetric.com/v1/donut/2375471_240.png 2,Re: Tracking the Clonal Origin of Lethal Prostate Cancer,The Journal of Urology,,,Article,2014-01-05,10.1016/j.juro.2014.02.078,,,,24745484,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2359838,https://api.altmetric.com/v1/donut/2359838_240.png 2,Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial.,Urology,,,Article,2014-05-10,10.1016/j.urology.2014.03.015,,,,24824408,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2356594,https://api.altmetric.com/v1/donut/2356594_240.png 2,Degarelix: A Review of Its Use in Patients with Prostate Cancer,Drugs,,,Article,2014-04-23,10.1007/s40265-014-0211-y,,,,24756432,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2301445,https://api.altmetric.com/v1/donut/2301445_240.png 2,Enhancement of the T-cell Armamentarium as a Cell-based Therapy for Prostate Cancer.,Cancer Research,,,Article,2014-04-17,10.1158/0008-5472.can-14-0249,,,,24747912,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2290649,https://api.altmetric.com/v1/donut/2290649_240.png 2,Gemcitabine|[ndash]|oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed,British Journal of Cancer,,,Article,2014-04-15,10.1038/bjc.2014.204,,,,24736579,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2287591,https://api.altmetric.com/v1/donut/2287591_240.png 2,Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer,British Journal of Cancer,,,Article,2014-04-08,10.1038/bjc.2014.181,,,,24714754,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2285798,https://api.altmetric.com/v1/donut/2285798_240.png 2,Phase I|[sol]|II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks,British Journal of Cancer,,,Article,2014-04-10,10.1038/bjc.2014.191,,,,24722181,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2280640,https://api.altmetric.com/v1/donut/2280640_240.png 2,Assessment of Prostate Cancer With Dynamic Contrast-Enhanced Computed Tomography Using an En Bloc Approach,Investigative Radiology,,,Article,2014-04-04,10.1097/rli.0000000000000055,,,,24710202,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2273869,https://api.altmetric.com/v1/donut/2273869_240.png 2,ESTRO: New test developed to detect men at high risk of prostate cancer recurrence,ecancer.org,,,Article,,,,,http://ecancer.org/news/5483-estro--new-test-developed-to-detect-men-at-high-risk-of-prostate-cancer-recurrence.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2257431,https://api.altmetric.com/v1/donut/2257431_240.png 2,Initial experience with stereotactic body radiation therapy for localized prostate cancer using helical tomotherapy,Clinical and Translational Oncology,,,Article,2013-08-09,10.1007/s12094-013-1089-y,,,,23928833,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2208896,https://api.altmetric.com/v1/donut/2208896_240.png 2,Predicting the Risk of Non–organ-confined Prostate Cancer When Perineural Invasion Is Found on Biopsy,Urology,,,Article,,10.1016/j.urology.2013.12.042,,,,24655556,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2206781,https://api.altmetric.com/v1/donut/2206781_240.png 2,Androgen deprivation therapy for early prostate cancer,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70124-x,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2202241,https://api.altmetric.com/v1/donut/2202241_240.png 2,Prostate Cancer Risk Inflation as a Consequence of Image-targeted Biopsy of the Prostate: A Computer Simulation Study,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2012.12.057,,,,23312572,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2191278,https://api.altmetric.com/v1/donut/2191278_240.png 2,More intensive radiotherapy is better than less for localised prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5315-more-intensive-radiotherapy-is-better-than-less-for-localised-prostate-cancer.php,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2146389,https://api.altmetric.com/v1/donut/2146389_240.png 2,"Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts",BMC Medicine,,,Article,2014-02-13,10.1186/1741-7015-12-28,,,,24521426,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2118032,https://api.altmetric.com/v1/donut/2118032_240.png 2,Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial.,Annals of Oncology,,,Article,2014-01-29,10.1093/annonc/mdt571,,,,24478320,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2086538,https://api.altmetric.com/v1/donut/2086538_240.png 2,Prostate cancer: Should we give metformin to all men with CRPC?,Nature Reviews Urology,,,Article,2014-01-21,10.1038/nrurol.2014.7,,,,24445914,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2070173,https://api.altmetric.com/v1/donut/2070173_240.png 2,Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2014-01-14,10.1038/pcan.2013.51,,,,24418912,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2045271,https://api.altmetric.com/v1/donut/2045271_240.png 2,Type 2 diabetes and the risk of mortality among patients with prostate cancer.,Cancer Causes and Control,,,Article,2014-01-06,10.1007/s10552-013-0334-6,,,,24384808,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2040451,https://api.altmetric.com/v1/donut/2040451_240.png 2,Oncologist criticises NICE for not recommending wider use of MRI in prostate cancer,British Medical Journal,,,Article,2014-01-10,10.1136/bmj.g174,,,,24412843,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2036472,https://api.altmetric.com/v1/donut/2036472_240.png 2,MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance,Molecular Cancer,,,Article,2014-01-03,10.1186/1476-4598-13-1,,,,24387052,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2019052,https://api.altmetric.com/v1/donut/2019052_240.png 2,Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa,BMC Urology,,,Article,2013-12-29,10.1186/1471-2490-13-74,,,,24373635,PMC3882498,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2008863,https://api.altmetric.com/v1/donut/2008863_240.png 2,Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12548,,,,24180365,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1923336,https://api.altmetric.com/v1/donut/1923336_240.png 2,A steroid fraction of chloroform extract from bee pollen of Brassica campestris induces apoptosis in human prostate cancer PC-3 cells.,Phytotherapy Research,,,Article,2007-11-01,10.1002/ptr.2235,,,,17639562,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1884815,https://api.altmetric.com/v1/donut/1884815_240.png 2,Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer,Journal of Visualized Experiments,,,Article,2013-01-01,10.3791/50713,,,,24300377,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,1,7,https://www.altmetric.com/details/1878890,https://api.altmetric.com/v1/donut/1878890_240.png 2,Analytical validation of the Oncotype DX prostate cancer assay -- a clinical RT-PCR assay optimized for prostate needle biopsies,BMC Genomics,,,Article,2013-10-08,10.1186/1471-2164-14-690,,,,24103217,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,60,https://www.altmetric.com/details/1810719,https://api.altmetric.com/v1/donut/1810719_240.png 2,Measuring and Predicting Prostate Cancer Related Quality of Life Changes using the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP).,The Journal of Urology,,,Article,2013-09-26,10.1016/j.juro.2013.09.040,,,,24076307,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1784145,https://api.altmetric.com/v1/donut/1784145_240.png 2,A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy,Trials,,,Article,2010-08-12,10.1186/1745-6215-11-86,,,,20704726,PMC2925820,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1761754,https://api.altmetric.com/v1/donut/1761754_240.png 2,Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide,Clinical Medicine Insights: Oncology,,,Article,2013-08-01,10.4137/cmo.s11670,,,,24179414,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1703205,https://api.altmetric.com/v1/donut/1703205_240.png 2,Corrigendum: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression,Nature,,,Article,2013-06-05,10.1038/nature12288,,,,23739331,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1690794,https://api.altmetric.com/v1/donut/1690794_240.png 2,Coexistence of pernicious anemia and prostate cancer - 'an experiment of nature' involving vitamin B12 modulation of prostate cancer growth and metabolism: a case report,Journal of Medical Case Reports,,,Article,2009-11-24,10.1186/1752-1947-3-9295,,,,20062784,PMC2803818,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1675454,https://api.altmetric.com/v1/donut/1675454_240.png 2,"Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate",Clinical Interventions in Aging,,,Article,2013-07-01,10.2147/cia.s44772,,,,23885169,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/1614008,https://api.altmetric.com/v1/donut/1614008_240.png 2,A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy,Radiation Oncology,,,Article,2013-07-08,10.1186/1748-717x-8-170,,,,23835115,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1610203,https://api.altmetric.com/v1/donut/1610203_240.png 2,Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-0231,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1517317,https://api.altmetric.com/v1/donut/1517317_240.png 2,"The Interval to Biochemical Failure Is Prognostic for Metastasis, Prostate Cancer-Specific Mortality, and Overall Mortality After Salvage Radiation Therapy for Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-04-10,10.1016/j.ijrobp.2013.02.016,,,,23561650,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1501839,https://api.altmetric.com/v1/donut/1501839_240.png 2,A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer.,Nutrition and Cancer,,,Article,2013-01-01,10.1080/01635581.2013.775316,,,,23659447,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1465089,https://api.altmetric.com/v1/donut/1465089_240.png 2,Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer.,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-3791,,,,23649003,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1456302,https://api.altmetric.com/v1/donut/1456302_240.png 2,"A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer","Cancer Immunology, Immunotherapy",,,Article,2013-04-17,10.1007/s00262-013-1415-9,,,,23591981,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1405658,https://api.altmetric.com/v1/donut/1405658_240.png 2,Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram,Oncologist,,,Article,2012-01-01,10.1634/theoncologist.2012-0125,,,,22971522,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1320272,https://api.altmetric.com/v1/donut/1320272_240.png 2,The protoâ??oncogene ERG is a target of microRNA miRâ??145 in prostate cancer,FEBS Journal,,,Article,2013-01-01,10.1111/febs.12236,,,,,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1292311,https://api.altmetric.com/v1/donut/1292311_240.png 2,Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis,BMC Cancer,,,Article,2013-03-01,10.1186/1471-2407-13-96,,,,23448667,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1274067,https://api.altmetric.com/v1/donut/1274067_240.png 2,"Patientâ??reported outcomes after 3â??dimensional conformal, intensityâ??modulated, or proton beam radiotherapy for localized prostate cancer",Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27956,,,,23436283,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1257916,https://api.altmetric.com/v1/donut/1257916_240.png 2,"Prostate cancer study tracks long-term urinary, sexual andbowel function side effects. ecancer - News",ecancer.org,,,Article,,,,,http://ecancer.org/news/3767-prostate-cancer-study-tracks-long-term-urinary--sexual-and-bowel-function-side-effects.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251651,https://api.altmetric.com/v1/donut/1251651_240.png 2,Protein could be specific marker for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2864-protein-could-be-specific-marker-for-prostate-cancer.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251431,https://api.altmetric.com/v1/donut/1251431_240.png 2,Science explains uproar over prostate-cancer screenings,ecancer.org,,,Article,,,,,http://ecancer.org/news/2848-science-explains-uproar-over-prostate-cancer-screenings.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251397,https://api.altmetric.com/v1/donut/1251397_240.png 2,NICE green light for abiraterone for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2828-nice-green-light-for-abiraterone-for-prostate-cancer.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251375,https://api.altmetric.com/v1/donut/1251375_240.png 2,"Researchers discover biomarkers for prostate cancer detection, recurrence",ecancer.org,,,Article,,,,,http://ecancer.org/news/2827-researchers-discover-biomarkers-for-prostate-cancer-detection--recurrence.php,,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251369,https://api.altmetric.com/v1/donut/1251369_240.png 2,"Screening Smarter, Not Harder, for Prostate Cancer",Annals of Internal Medicine,,,Article,2013-01-01,10.7326/0003-4819-158-3-201302050-00001,,,,23381056,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1237968,https://api.altmetric.com/v1/donut/1237968_240.png 2,The Prostate Cancer Journey: Results of an Online Survey of Men and Their Partners,Cancer nursing (Online),,,Article,2013-01-25,10.1097/ncc.0b013e31827df2a9,,,,23357889,,1959.8/152959,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1223522,https://api.altmetric.com/v1/donut/1223522_240.png 2,Bone targeted therapies in metastatic castration-resistant prostate cancer.,Cancer Journal,,,Article,2013-01-01,10.1097/ppo.0b013e31827f123e,,,,23337759,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1192543,https://api.altmetric.com/v1/donut/1192543_240.png 2,Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djs458,,,,23266392,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1143419,https://api.altmetric.com/v1/donut/1143419_240.png 2,Re: Factors Influencing Treatment Decision Making and Information Preferences of Prostate Cancer Patients on Active Surveillance,The Journal of Urology,,,Article,2012-12-26,10.1016/j.juro.2012.10.096,,,,23312160,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1143218,https://api.altmetric.com/v1/donut/1143218_240.png 2,Dietary Resveratrol Prevents Development of High-Grade Prostatic Intraepithelial Neoplastic Lesions: Involvement of SIRT1/S6K Axis,Cancer Prevention Research,,,Article,2013-01-01,10.1158/1940-6207.capr-12-0349,,,,23248098,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1136975,https://api.altmetric.com/v1/donut/1136975_240.png 2,Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer model,Prostate Cancer & Prostatic Diseases,,,Article,2012-12-11,10.1038/pcan.2012.48,,,,23229563,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1117119,https://api.altmetric.com/v1/donut/1117119_240.png 2,Targeting PPAR? Signaling Cascade for the Prevention and Treatment of Prostate Cancer.,PPAR Research,,,Article,2012-01-01,10.1155/2012/968040,,,,23213321,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1108758,https://api.altmetric.com/v1/donut/1108758_240.png 2,Growth kinetics of CD133â??positive prostate cancer cells,The Prostate,,,Article,2012-01-01,10.1002/pros.22616,,,,23138940,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1056512,https://api.altmetric.com/v1/donut/1056512_240.png 2,Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer.,Physics in Medicine & Biology,,,Article,2012-10-13,10.1088/0031-9155/57/21/7089,,,,23051686,,,2012PMB....57.7089A,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1021573,https://api.altmetric.com/v1/donut/1021573_240.png 2,Practice Patterns of Korean Urologists for Screening and Managing Prostate Cancer according to PSA Level.,Yonsei Medical Journal,,,Article,2012-10-18,10.3349/ymj.2012.53.6.1136,,,,23074113,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1013580,https://api.altmetric.com/v1/donut/1013580_240.png 2,Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center,Prostate Cancer & Prostatic Diseases,,,Article,2012-10-16,10.1038/pcan.2012.38,,,,23069729,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1008913,https://api.altmetric.com/v1/donut/1008913_240.png 2,Prostate cancer: Is aspirin a wonder drug in prostate cancer?,Nature Reviews Urology,,,Article,2012-09-18,10.1038/nrurol.2012.180,,,,22986499,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/952030,https://api.altmetric.com/v1/donut/952030_240.png 2,Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-09-04,10.1073/pnas.1110977109,,,,22949650,,1854/LU-3040507,2012PNAS..10915312T,,,,0,0,0,3,2,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/933625,https://api.altmetric.com/v1/donut/933625_240.png 2,"Associations between Intake of Folate, Methionine, and Vitamins B-12, B-6 and Prostate Cancer Risk in American Veterans",Journal of Cancer Epidemiology,,,Article,2012-01-01,10.1155/2012/957467,,,,22927849,PMC3423941,10161/6105,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/882852,https://api.altmetric.com/v1/donut/882852_240.png 2,Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.,Biochemical Pharmacology,,,Article,2012-08-01,10.1016/j.bcp.2012.07.012,,,,22842629,,,,,,,0,0,0,0,0,0,3,0,1,0,0,0,0,0,0,40,https://www.altmetric.com/details/879271,https://api.altmetric.com/v1/donut/879271_240.png 2,A Population-Based Nested Case-Control Study in Taiwan: Use of 5?-Reductase Inhibitors Did Not Decrease Prostate Cancer Risk in Patients with Benign Prostate Hyperplasia,Oncologist,,,Article,2012-06-24,10.1634/theoncologist.2011-0464,,,,22723508,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/875890,https://api.altmetric.com/v1/donut/875890_240.png 2,Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism.,The Prostate,,,Article,2005-01-04,10.1002/pros.20155,,,,15378522,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/827891,https://api.altmetric.com/v1/donut/827891_240.png 2,Chimeric Transcript Generated by cis-Splicing of Adjacent Genes Regulates Prostate Cancer Cell Proliferation,Cancer Discovery,,,Article,2012-01-01,10.1158/2159-8290.cd-12-0042,,,,22719019,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/806921,https://api.altmetric.com/v1/donut/806921_240.png 2,Abiraterone for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (July/August),Annals of Pharmacotherapy,,,Article,2012-01-01,10.1345/aph.1q758,,,,22714819,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/800438,https://api.altmetric.com/v1/donut/800438_240.png 2,In the Middle and on the Sideline: The Experience of Spouses of Men With Prostate Cancer,Cancer nursing (Online),,,Article,2012-05-04,10.1097/ncc.0b013e31824fe1ef,,,,22565105,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/734062,https://api.altmetric.com/v1/donut/734062_240.png 2,Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.,Expert Opinion on Biological Therapy,,,Article,2012-05-05,10.1517/14712598.2012.685716,,,,22559196,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/730082,https://api.altmetric.com/v1/donut/730082_240.png 2,Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation,Molecular Cancer,,,Article,2012-05-04,10.1186/1476-4598-11-30,,,,22559324,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/728464,https://api.altmetric.com/v1/donut/728464_240.png 2,"Vitamin D–Related Genetic Variation, Plasma Vitamin D, and Risk of Lethal Prostate Cancer: A Prospective Nested Case–Control Study",JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djs189,,,,22499501,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/696128,https://api.altmetric.com/v1/donut/696128_240.png 2,Prostate Cancer Risk in Men with Baseline History of Coronary Artery Disease: Results from the REDUCE study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-01,10.1158/1055-9965.epi-11-1017,,,,22315364,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/613178,https://api.altmetric.com/v1/donut/613178_240.png 2,The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice.,PLoS One,,,Article,2012-01-15,10.1371/journal.pone.0029068,,,,22242155,PMC3252297,,2012PLoSO...7E9068O,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/587639,https://api.altmetric.com/v1/donut/587639_240.png 2,What (if anything) to do about low-risk prostate cancer,The Lancet,,,Article,2012-01-28,10.1016/s0140-6736(12)60066-x,,,,22277569,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/571578,https://api.altmetric.com/v1/donut/571578_240.png 2,Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-01-17,10.1073/pnas.1120985109,,,,22307624,,,2012PNAS..109.1643D,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/565042,https://api.altmetric.com/v1/donut/565042_240.png 2,MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer,Nucleic Acids Research,,,Article,2012-01-04,10.1093/nar/gkr1222,,,,22210864,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/523389,https://api.altmetric.com/v1/donut/523389_240.png 2,Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH,Prostate Cancer & Prostatic Diseases,,,Article,2011-12-22,10.1038/pcan.2011.63,,,,22183775,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/500755,https://api.altmetric.com/v1/donut/500755_240.png 2,Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.,European Urology,,,Article,2011-08-01,10.1016/j.eururo.2011.03.011,,,,21420229,PMC3124574,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,33,https://www.altmetric.com/details/383271,https://api.altmetric.com/v1/donut/383271_240.png 2,NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation,Oncogene,"CROFT, Laura B",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-04-18,10.1038/onc.2011.114,,,,21499299,PMC3140601,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,86,https://www.altmetric.com/details/258167,https://api.altmetric.com/v1/donut/258167_240.png 2,"Investigating prostate cancer tumour-stroma interactions - clinical and biological insights from an evolutionary game",Bone,,,Article,2011-01-01,,,,,,,,2011arXiv1108.0654B,1108.0654,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/203172,https://api.altmetric.com/v1/donut/203172_240.png 2,Prostate cancer: PSA velocity in prostate cancer screening-the debate continues.,Nature Reviews Urology,,,Article,2011-07-12,10.1038/nrurol.2011.87,,,,21750502,,,,,,,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,https://www.altmetric.com/details/190461,https://api.altmetric.com/v1/donut/190461_240.png 2,"Racial Differences in Sexuality Profiles among American, Japanese, and Japanese American Men with Localized Prostate Cancer.",The journal of sexual medicine,,,Article,2011-06-23,10.1111/j.1743-6109.2011.02362.x,,,,21699667,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/175940,https://api.altmetric.com/v1/donut/175940_240.png 2,Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project,Journal of Cancer Education,,,Article,2015-05-14,10.1007/s13187-015-0854-8,,,,25971432,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5625636,https://api.altmetric.com/v1/donut/5625636_240.png 2,Re: The Role of Surgery in High-risk Localized Prostate Cancer,European Urology,,,Article,2014-08-01,10.1016/j.eururo.2014.05.020,,,,25305786,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2500311,https://api.altmetric.com/v1/donut/2500311_240.png 2,Advances in Prostate Cancer Chemotherapy: A New Era Begins1,CA: A Cancer Journal for Clinicians ,,,Article,2009-02-24,10.3322/canjclin.55.5.300,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1778892,https://api.altmetric.com/v1/donut/1778892_240.png 2,Combined histoarchitectural and cytological biopsy grading improves grading accuracy in lowâ??grade prostate cancer,International Journal of Urology,,,Article,2011-11-23,10.1111/j.1442-2042.2011.02902.x,,,,22103602,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/466072,https://api.altmetric.com/v1/donut/466072_240.png 2,Detection of High-Grade Prostate Cancer among PLCO Participants Using a Prespecified Four Kallikrein Marker Panel,The Journal of Urology,,,Article,2016-11-05,10.1016/j.juro.2016.10.089,,,,27810449,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13258252,https://api.altmetric.com/v1/donut/13258252_240.png 2,"A Phase II, Randomized, Open Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy",Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-1790,,,,27756786,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12746739,https://api.altmetric.com/v1/donut/12746739_240.png 2,The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer,Journal of nuclear medicine technology,,,Article,2016-09-15,10.2967/jnmt.116.176859,,,,27634981,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12058803,https://api.altmetric.com/v1/donut/12058803_240.png 2,"In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database",,,,Article,2016-08-30,10.1016/j.euf.2016.08.007,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10899802,https://api.altmetric.com/v1/donut/10899802_240.png 2,Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer,PLoS ONE,,,Article,2016-07-19,10.1371/journal.pone.0158952,,,,27434372,PMC4951050,10541/618595,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10343106,https://api.altmetric.com/v1/donut/10343106_240.png 2,CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3,BMC Cancer,,,Article,2016-07-19,10.1186/s12885-016-2488-6,,,,27435207,PMC4952363,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9932102,https://api.altmetric.com/v1/donut/9932102_240.png 2,Biomarkers for Metastatic Castration-resistant Prostate Cancer (mCRPC): Yes or No? Predictive and Response Biomarkers Towards Precision Medicine in mCRPC,European Urology Focus ,,,Article,2016-07-13,10.1016/j.euf.2016.06.017,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9641906,https://api.altmetric.com/v1/donut/9641906_240.png 2,Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX,BioMed Research International,,,Article,2016-01-01,10.1155/2016/9750795,,,,27294148,PMC4887629,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8737036,https://api.altmetric.com/v1/donut/8737036_240.png 2,Prostate cancer: Prudent practice optimizes screening outcomes,Nature Reviews Urology,,,Article,2016-05-24,10.1038/nrurol.2016.90,,,,27215425,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8198143,https://api.altmetric.com/v1/donut/8198143_240.png 2,"Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review",Molecular Cancer,,,Article,2016-05-18,10.1186/s12943-016-0523-5,,,,27189160,PMC4870749,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7581202,https://api.altmetric.com/v1/donut/7581202_240.png 2,"Vitamin D, PTH, and calcium in relation to survival following prostate cancer",Cancer Causes and Control,,,Article,2016-03-29,10.1007/s10552-016-0740-7,,,,27023469,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6418585,https://api.altmetric.com/v1/donut/6418585_240.png 2,Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment,Life Sciences,,,Article,2016-03-01,10.1016/j.lfs.2016.03.036,,,,27018446,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6372748,https://api.altmetric.com/v1/donut/6372748_240.png 2,Prostate cancer: Case volume and improved outcomes across cancer care,Nature Reviews Urology,,,Article,2016-02-02,10.1038/nrurol.2016.15,,,,26832160,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5077556,https://api.altmetric.com/v1/donut/5077556_240.png 2,Hormonal Treatment for Nonmetastatic Disease Recurrence After Curative Treatment of Prostate Cancer: Only for a Select Few,European Urology,,,Article,2015-12-22,10.1016/j.eururo.2015.12.008,,,,26719013,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4907809,https://api.altmetric.com/v1/donut/4907809_240.png 2,Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.,Oncotarget,,,Article,2015-12-19,10.18632/oncotarget.6540,,,,26675257,PMC4826185,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4896048,https://api.altmetric.com/v1/donut/4896048_240.png 2,Team Jayhawks – our experience in the prostate cancer DREAM challenge
,F1000Research,,,Article,2015-11-30,10.7490/f1000research.1111088.1,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4848433,https://api.altmetric.com/v1/donut/4848433_240.png 2,Endosomal gene expression: a new indicator for prostate cancer patient prognosis?,Oncotarget,,,Article,2015-10-18,10.18632/oncotarget.6114,,,,26473288,PMC4741974,11541.2/116772,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4641776,https://api.altmetric.com/v1/donut/4641776_240.png 2,Stem cells in genetically-engineered mouse models of prostate cancer,Endocrine-Related Cancer,,,Article,2015-12-01,10.1530/erc-15-0367,,,,26341780,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4504391,https://api.altmetric.com/v1/donut/4504391_240.png 2,Statin use and the risk of breast and prostate cancer.,Epidemiology,,,Article,2002-05-01,,,,,11964926,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4435929,https://api.altmetric.com/v1/donut/4435929_240.png 2,Prostate cancer: Avoiding excess confirmatory biopsies,Nature Reviews Urology,,,Article,2015-08-04,10.1038/nrurol.2015.195,,,,26238030,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4360800,https://api.altmetric.com/v1/donut/4360800_240.png 2,Predictors of Prostate Cancer Specific Mortality after Radical Prostatectomy: 10 year oncologic outcomes from the Victorian Radical Prostatectomy Registry,British Journal of Urology,,,Article,2015-07-01,10.1111/bju.13112,,,,26176738,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4283611,https://api.altmetric.com/v1/donut/4283611_240.png 2,Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer,Scientific Reports,,,Article,2015-04-16,10.1038/srep09698,,,,25880275,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3921619,https://api.altmetric.com/v1/donut/3921619_240.png 2,Should abdominal sequences be included in prostate cancer MR staging studies?,European Journal of Radiology,,,Article,2015-03-06,10.1016/j.ejrad.2015.02.023,,,,25795196,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3863737,https://api.altmetric.com/v1/donut/3863737_240.png 2,Mannose?6?Phosphate Receptor: A Target for Theranostics of Prostate Cancer,Angewandte Chemie. International Edition,,,Article,2015-03-20,10.1002/anie.201500286,,,,25802144,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3819526,https://api.altmetric.com/v1/donut/3819526_240.png 2,ASCO GU 2015: Review of the latest data in prostate cancer. Genitourinary Cancers Symposium,ecancer.org,,,Article,,,,,http://ecancer.org/conference/633-genitourinary-cancers-symposium/video/3506/asco-gu-2015--review-of-the-latest-data-in-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3749771,https://api.altmetric.com/v1/donut/3749771_240.png 2,Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices. Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices,ecancer.org,,,Article,,,,,http://ecancer.org/video/3295/optimizing-survival-in-advanced-prostate-cancer--understanding-pc-heterogeneity-to-guide-treatment-choices.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3165800,https://api.altmetric.com/v1/donut/3165800_240.png 2,NADiA ProsVue Prostate-specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy ,Urology,,,Article,2012-12-15,10.1016/j.urology.2012.06.080,,,,23107099,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3121629,https://api.altmetric.com/v1/donut/3121629_240.png 2,Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-02,10.1016/j.ijrobp.2014.10.040,,,,25636756,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3074732,https://api.altmetric.com/v1/donut/3074732_240.png 2,"Combinations of Serum Prostate-Specific Antigen and Plasma Expression Levels of let-7c, miR-30c, miR-141, and miR-375 as Potential Better Diagnostic Biomarkers for Prostate Cancer.",DNA & Cell Biology,,,Article,2014-12-18,10.1089/dna.2014.2663,,,,25521481,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2999495,https://api.altmetric.com/v1/donut/2999495_240.png 2,TLR3 engagement induces IRF?3?dependent apoptosis in androgen?sensitive prostate cancer cells and inhibits tumour growth in vivo,Journal of Cellular and Molecular Medicine,,,Article,2014-12-02,10.1111/jcmm.12379,,,,25444175,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2962600,https://api.altmetric.com/v1/donut/2962600_240.png 2,Repackaging Prostate Cancer Support Group Research Findings An e-KT Case Study,American Journal of Men's Health,,,Article,2014-04-07,10.1177/1557988314528238,,,,24713522,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2919407,https://api.altmetric.com/v1/donut/2919407_240.png 2,"Re: The Effects of Dutasteride and Finasteride on BPH-Related Hospitalization, Surgery and Prostate Cancer Diagnosis: A Record-Linkage Analysis",The Journal of Urology,,,Article,2014-01-11,10.1016/j.juro.2014.08.029,,,,25323372,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2820584,https://api.altmetric.com/v1/donut/2820584_240.png 2,Re: Indications for Intervention during Active Surveillance of Prostate Cancer: A Comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) Protocols,The Journal of Urology,,,Article,2014-01-11,10.1016/j.juro.2014.08.041,,,,25323340,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2806103,https://api.altmetric.com/v1/donut/2806103_240.png 2,Sexual Bother in Men with Advanced Prostate Cancer Undergoing Androgen Deprivation Therapy.,Journal of Sexual Medicine,,,Article,2014-07-27,10.1111/jsm.12645,,,,25059094,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2797044,https://api.altmetric.com/v1/donut/2797044_240.png 2,Molecular insights into the development of T cell-based immunotherapy for prostate cancer.,Expert Review of Clinical Immunology,,,Article,2014-09-28,10.1586/1744666x.2014.962515,,,,25259804,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2789783,https://api.altmetric.com/v1/donut/2789783_240.png 2,Which Luteinising Hormone-Releasing Hormone Agonist Injection Schedule Do Men with Prostate Cancer Prefer? Results of a European Patient Survey,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.08.055,,,,25220374,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2682008,https://api.altmetric.com/v1/donut/2682008_240.png 2,NICE rejects abiraterone for advanced prostate cancer pre-chemotherapy,ecancer.org,,,Article,,,,,http://ecancer.org/news/6132-nice-rejects-abiraterone-for-advanced-prostate-cancer-pre-chemotherapy.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2603270,https://api.altmetric.com/v1/donut/2603270_240.png 2,Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-08-01,10.1097/coc.0b013e31824be3b4,,,,22772432,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2583240,https://api.altmetric.com/v1/donut/2583240_240.png 2,Lycopene Treatment of Prostate Cancer Cell Lines Inhibits Adhesion and Migration Properties of the Cells,International Journal of Medical Sciences,,,Article,2014-08-06,10.7150/ijms.9137,,,,25076850,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2573403,https://api.altmetric.com/v1/donut/2573403_240.png 2,The ‘Timing of Androgen?Deprivation therapy in incurable prostate cancer’ protocol (TOAD) – where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01?03 and Trans?Tasman Radiation Oncology Group 03.06 clinical trial,British Journal of Urology,,,Article,2014-07-21,10.1111/bju.12864,,,,25047091,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2528205,https://api.altmetric.com/v1/donut/2528205_240.png 2,Prostate cancer: Enzalutamide PREVAILs,Nature Reviews Urology,,,Article,2014-06-17,10.1038/nrurol.2014.139,,,,24934449,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2442783,https://api.altmetric.com/v1/donut/2442783_240.png 2,Body mass index and weight change in men with prostate cancer: progression and mortality,Cancer Causes and Control,,,Article,2014-05-09,10.1007/s10552-014-0393-3,,,,24810654,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2417036,https://api.altmetric.com/v1/donut/2417036_240.png 2,"Modified Gleason Grade of Prostatic Adenocarcinomas Detected in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",The Journal of Urology,,,Article,2014-03-03,10.1016/j.juro.2014.02.090,,,,24594407,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2157684,https://api.altmetric.com/v1/donut/2157684_240.png 2,ASCO GU: Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5148-asco-gu--enzalutamide-improves-survival-in-men-with-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2084712,https://api.altmetric.com/v1/donut/2084712_240.png 2,The genetic epidemiology of prostate cancer and its clinical implications,Nature Reviews Urology,,,Article,2013-12-03,10.1038/nrurol.2013.266,,,,24296704,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/2014434,https://api.altmetric.com/v1/donut/2014434_240.png 2,Re: Intermittent versus Continuous Androgen Deprivation in Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2013.08.102,,,,24209518,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1978843,https://api.altmetric.com/v1/donut/1978843_240.png 2,Re: Prostate Cancer Screening in Men Ages 75 and Older Fell by 8 Percentage Points after Task Force Recommendation,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2013.06.066,,,,24029318,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1772105,https://api.altmetric.com/v1/donut/1772105_240.png 2,Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study,Radiation Oncology,,,Article,2013-07-08,10.1186/1748-717x-8-171,,,,23835141,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/1618635,https://api.altmetric.com/v1/donut/1618635_240.png 2,"Prospective Investigation of Body Mass Index, Colorectal Adenoma, and Colorectal Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.48.4691,,,,23715565,PMC3691360,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1591978,https://api.altmetric.com/v1/donut/1591978_240.png 2,Treatment of earlyâ??stage prostate cancer among rural and urban patients,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28037,,,,23765584,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1555376,https://api.altmetric.com/v1/donut/1555376_240.png 2,The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing,Asian Journal of Andrology,,,Article,2013-01-01,10.1038/aja.2013.13,,,,23503423,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1533054,https://api.altmetric.com/v1/donut/1533054_240.png 2,FDA approves radium-223 dichloride for bone metastases from castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/4085-fda-approves-radium-223-dichloride-for-bone-metastases-from-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1480654,https://api.altmetric.com/v1/donut/1480654_240.png 2,Paradoxical metastatic progression following 3months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer.,Radiotherapy & Oncology,,,Article,2013-04-28,10.1016/j.radonc.2013.03.025,,,,23618502,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1452095,https://api.altmetric.com/v1/donut/1452095_240.png 2,Imagingâ??guided biopsy detects prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28140,,,,23649489,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1451459,https://api.altmetric.com/v1/donut/1451459_240.png 2,Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-4213,,,,23610450,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,78,https://www.altmetric.com/details/1408238,https://api.altmetric.com/v1/donut/1408238_240.png 2,Ki-67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-03-07,10.1016/j.ijrobp.2013.01.016,,,,23474109,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1333680,https://api.altmetric.com/v1/donut/1333680_240.png 2,Scientists solve key piece of prostate cancer puzzle,ecancer.org,,,Article,,,,,http://ecancer.org/news/3297-scientists-solve-key-piece-of-prostate-cancer-puzzle.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251661,https://api.altmetric.com/v1/donut/1251661_240.png 2,"UK prostate cancer cases hit 40,000. ecancer - News",ecancer.org,,,Article,,,,,http://ecancer.org/news/2797-uk-prostate-cancer-cases-hit-40-000.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251311,https://api.altmetric.com/v1/donut/1251311_240.png 2,Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-12-27,10.1097/coc.0b013e31827a7d2a,,,,23275277,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1164368,https://api.altmetric.com/v1/donut/1164368_240.png 2,Locally recurrent prostate cancer after initial radiation therapy: Early salvage high-intensity focused ultrasound improves oncologic outcomes.,Radiotherapy & Oncology,,,Article,2012-10-18,10.1016/j.radonc.2012.09.014,,,,23068708,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1013075,https://api.altmetric.com/v1/donut/1013075_240.png 2,Nutrition education for osteoporosis prevention in men with prostate cancer initiating androgen deprivation therapy.,Clinical Journal of Oncology Nursing,,,Article,2012-10-03,10.1188/12.cjon.497-503,,,,23022933,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/986753,https://api.altmetric.com/v1/donut/986753_240.png 2,Role of glyoxalase I in the proliferation and apoptosis control of human LNCaP and PC3 prostate cancer cells,The Prostate,,,Article,2013-01-01,10.1002/pros.22547,,,,22653787,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/772862,https://api.altmetric.com/v1/donut/772862_240.png 2,Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2011.10199.x,,,,21756276,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/455907,https://api.altmetric.com/v1/donut/455907_240.png 2,Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study,European Urology,,,Article,2016-11-01,10.1016/j.eururo.2016.10.036,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13293810,https://api.altmetric.com/v1/donut/13293810_240.png 2,Clinical Perspective of Prostate Cancer,Topics in Magnetic Resonance Imaging,,,Article,2016-06-01,10.1097/rmr.0000000000000091,,,http://journals.lww.com/topicsinmri/Fulltext/2016/06000/Clinical_Perspective_of_Prostate_Cancer.2.aspx,27187167,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13173136,https://api.altmetric.com/v1/donut/13173136_240.png 2,Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin,Oncotarget,,,Article,2016-10-24,10.18632/oncotarget.12860,,,,27788496,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13095640,https://api.altmetric.com/v1/donut/13095640_240.png 2,Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal,PharmacoEconomics,,,Article,2016-10-22,10.1007/s40273-016-0457-1,,,,27770303,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12921390,https://api.altmetric.com/v1/donut/12921390_240.png 2,A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic,Urologic Oncology,,,Article,2016-05-01,10.1016/j.urolonc.2015.11.014,,,,26705101,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12740837,https://api.altmetric.com/v1/donut/12740837_240.png 2,Quality of life outcomes from the PATCH trial evaluating LHRH agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer,British Journal of Urology,,,Article,2016-10-01,10.1111/bju.13687,,,,27753182,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12699855,https://api.altmetric.com/v1/donut/12699855_240.png 2,Evaluation of a Structured Report of Functional Prostate Magnetic Resonance Imaging in Patients with Suspicion for Prostate Cancer or under Active Surveillance,Urologia Internationalis,,,Article,2012-06-07,10.1159/000338808,,,,22677880,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12678055,https://api.altmetric.com/v1/donut/12678055_240.png 2,Immunoseroproteomic profiling in African American men with prostate cancer: evidence for an autoantibody response to glycolysis and plasminogen-associated proteins,Molecular and Cellular Proteomics (MCP Online),,,Article,2016-10-16,10.1074/mcp.m116.060244,,,,27742740,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12619660,https://api.altmetric.com/v1/donut/12619660_240.png 2,"Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline",Journal of Clinical Oncology,,,Article,2007-04-20,10.1200/jco.2006.10.1949,,,,17404365,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12607605,https://api.altmetric.com/v1/donut/12607605_240.png 2,Zerumbone inhibits prostate cancer cell viability and induces cell death by non-apoptotic pathway,Bangladesh Journal of Pharmacology,,,Article,2016-10-01,10.3329/bjp.v11i4.26728,,,,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/12446671,https://api.altmetric.com/v1/donut/12446671_240.png 2,Identification of miR-30b-3p and miR-30d-5p as direct regulators of Androgen Receptor Signaling in Prostate Cancer by complementary functional microRNA library screening,Oncotarget,,,Article,2016-09-24,10.18632/oncotarget.12241,,,,27683042,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12331889,https://api.altmetric.com/v1/donut/12331889_240.png 2,Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial,World Journal of Urology,,,Article,2016-09-19,10.1007/s00345-016-1938-8,,,,27644229,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12244813,https://api.altmetric.com/v1/donut/12244813_240.png 2,Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology,Clinical and Translational Imaging,,,Article,2016-07-20,10.1007/s40336-016-0196-5,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/12131982,https://api.altmetric.com/v1/donut/12131982_240.png 2,Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer,Oncologist,,,Article,2016-09-14,10.1634/theoncologist.2016-0161,,,,27628492,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12065334,https://api.altmetric.com/v1/donut/12065334_240.png 2,Toward the future of the functional imaging of advanced prostate cancer,European Urology Focus ,,,Article,2016-09-01,10.1016/j.euf.2016.08.013,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11986487,https://api.altmetric.com/v1/donut/11986487_240.png 2,Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer,European Urology,,,Article,2016-08-28,10.1016/j.eururo.2016.08.041,,,,27574821,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/10870713,https://api.altmetric.com/v1/donut/10870713_240.png 2,"Abstract 1736: Physical activity, sitting time and prostate cancer specific mortality: The Cancer Prevention Study II Nutrition Cohort",Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1736,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10786347,https://api.altmetric.com/v1/donut/10786347_240.png 2,Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma,European Journal of Cancer (1965),,,Article,2016-10-01,10.1016/j.ejca.2016.07.012,,,,27522247,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10759447,https://api.altmetric.com/v1/donut/10759447_240.png 2,Re: 225Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2016-08-21,10.1016/j.eururo.2016.08.028,,,,27554243,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10731546,https://api.altmetric.com/v1/donut/10731546_240.png 2,Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients,BMC Cancer,,,Article,2016-08-17,10.1186/s12885-016-2674-6,,,,27530104,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10631987,https://api.altmetric.com/v1/donut/10631987_240.png 2,Abstract 23: Caloric restriction slows tumor growth and metastases in both hormone-sensitive and hormone-resistant prostate cancers,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-23,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10442600,https://api.altmetric.com/v1/donut/10442600_240.png 2,Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort,European Urology Focus ,,,Article,2016-08-11,10.1016/j.euf.2016.07.007,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10397029,https://api.altmetric.com/v1/donut/10397029_240.png 2,Ethnicity and the prostate cancer experience: a qualitative metasynthesis,Psycho-Oncology,,,Article,2016-01-01,10.1002/pon.4222,,,,27416079,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10374667,https://api.altmetric.com/v1/donut/10374667_240.png 2,A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer,BMC Medical Genomics,,,Article,2016-07-30,10.1186/s12920-016-0212-7,,,,27475327,PMC4967295,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10178252,https://api.altmetric.com/v1/donut/10178252_240.png 2,Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10790,,,,27462923,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10088683,https://api.altmetric.com/v1/donut/10088683_240.png 2,Investigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profiling,Experimental and Therapeutic Medicine,,,Article,2016-08-01,10.3892/etm.2016.3376,,,,27446297,PMC4950782,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10009804,https://api.altmetric.com/v1/donut/10009804_240.png 2,Liquid biopsy: ready to guide therapy in advanced prostate cancer?,British Journal of Urology,,,Article,2016-07-01,10.1111/bju.13586,,,,27430478,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10002780,https://api.altmetric.com/v1/donut/10002780_240.png 2,Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients,Radiotherapy & Oncology,,,Article,2016-07-01,10.1016/j.radonc.2016.06.017,,,,27443449,,,,,,,0,0,0,8,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9930453,https://api.altmetric.com/v1/donut/9930453_240.png 2,"TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer",Health technology assessment : HTA / NHS R & D HTA Programme.,,,Article,2016-07-01,10.3310/hta20530,,,,27434595,PMC4967809,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9911161,https://api.altmetric.com/v1/donut/9911161_240.png 2,Urethral dose sparing in squamous cell carcinoma of anal canal using proton therapy matching electrons with prior brachytherapy for prostate cancer: A case study.,Medical Dosimetry,,,Article,2016-07-16,10.1016/j.meddos.2016.05.003,,,,27396941,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9762042,https://api.altmetric.com/v1/donut/9762042_240.png 2,Re: Predicting Prostate Cancer-specific Outcome After Radical Prostatectomy Among Men with Very High-risk cT3b/4 PCa: A Multi-institutional Outcome Study of 266 Patients,European Urology,,,Article,2016-07-05,10.1016/j.eururo.2016.06.030,,,,27387123,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/9232792,https://api.altmetric.com/v1/donut/9232792_240.png 2,Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis,PLoS ONE,,,Article,2016-07-01,10.1371/journal.pone.0158770,,,,27368058,PMC4930176,,,,,,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,2,https://www.altmetric.com/details/9164965,https://api.altmetric.com/v1/donut/9164965_240.png 2,Pyruvate Dehydrogenase Alpha 1 as A Target of Omega?3 Polyunsaturated Fatty Acids in Human Prostate Cancer Through a Global Phosphoproteomic Analysis,PROTEOMICS,,,Article,2016-06-01,10.1002/pmic.201600166,,,,27357730,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9135481,https://api.altmetric.com/v1/donut/9135481_240.png 2,A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients,Prostate Cancer & Prostatic Diseases,,,Article,2016-06-28,10.1038/pcan.2016.25,,,,27349496,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9128117,https://api.altmetric.com/v1/donut/9128117_240.png 2,Androgen-induced lncRNA SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2016-06-24,10.1074/jbc.m116.718536,,,,27342777,,,,,,,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9103232,https://api.altmetric.com/v1/donut/9103232_240.png 2,Editorial Statement on Gleason Scoring for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-03-02,10.1016/j.ijrobp.2016.02.055,,,,27354124,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9031558,https://api.altmetric.com/v1/donut/9031558_240.png 2,Late Radiation and Cardiovascular Adverse Effects following Androgen Deprivation and High-Dose Radiotherapy in Prostate Cancer: Results from the DART 01/05 Randomized Phase III Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-06-01,10.1016/j.ijrobp.2016.06.2445,,,,27598804,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8986779,https://api.altmetric.com/v1/donut/8986779_240.png 2,A pilot study of clinical targeted next generation sequencing for prostate cancer: Consequences for treatment and genetic counseling,The Prostate,,,Article,2016-06-21,10.1002/pros.23219,,,,27324988,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8970146,https://api.altmetric.com/v1/donut/8970146_240.png 2,Cholesterol metabolism and prostate cancer lethality,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-0903,,,,27325648,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8940314,https://api.altmetric.com/v1/donut/8940314_240.png 2,Novel gene expression signature predictive of clinical recurrence after radical prostatectomy in early stage prostate cancer patients,The Prostate,,,Article,2016-06-08,10.1002/pros.23211,,,,27272349,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8928163,https://api.altmetric.com/v1/donut/8928163_240.png 2,Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP),BMJ Open,,,Article,2016-04-01,10.1136/bmjopen-2016-011063,,,,27130167,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8735304,https://api.altmetric.com/v1/donut/8735304_240.png 2,Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder,Urologic Oncology,,,Article,2016-06-01,10.1016/j.urolonc.2016.05.008,,,,27283218,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8670902,https://api.altmetric.com/v1/donut/8670902_240.png 2,SBRT for prostate cancer: Challenges and features from a physicist prospective,Physica Medica,,,Article,2016-04-06,10.1016/j.ejmp.2016.03.011,,,,27061869,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8538533,https://api.altmetric.com/v1/donut/8538533_240.png 2,Optimal Bladder Volume at Treatment Planning for Prostate Cancer Patients Receiving Volumetric-modulated Arc Therapy,Practical Radiation Oncology,,,Article,2016-05-27,10.1016/j.prro.2016.05.007,,,,27374192,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8513506,https://api.altmetric.com/v1/donut/8513506_240.png 2,Comparative study of late rectal toxicity in prostate cancer patients treated with low-dose-rate brachytherapy: With or without supplemental external beam radiotherapy,Brachytherapy,,,Article,2016-05-01,10.1016/j.brachy.2016.04.002,,,,27180124,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8338542,https://api.altmetric.com/v1/donut/8338542_240.png 2,NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics,The Prostate,,,Article,2016-05-16,10.1002/pros.23198,,,,27197810,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8144260,https://api.altmetric.com/v1/donut/8144260_240.png 2,Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance,Prostate Cancer & Prostatic Diseases,,,Article,2016-05-17,10.1038/pcan.2016.16,,,,27184812,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8109754,https://api.altmetric.com/v1/donut/8109754_240.png 2,Systems Pharmacology Modeling of Prostate?Specific Antigen in Patients With Prostate Cancer Treated With an Androgen Receptor Antagonist and Down?Regulator,CPT: Pharmacometrics & Systems Pharmacology,,,Article,2016-05-01,10.1002/psp4.12066,,,,27299938,PMC4879474,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7532181,https://api.altmetric.com/v1/donut/7532181_240.png 2,Radical Prostatectomy Findings in White Hispanic/Latino Men With NCCN Very Low-risk Prostate Cancer Detected by Template Biopsy,The American Journal of Surgical Pathology,,,Article,2016-05-01,10.1097/pas.0000000000000656,,,http://journals.lww.com/ajsp/Fulltext/2016/08000/Radical_Prostatectomy_Findings_in_White.15.aspx,27158756,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7487297,https://api.altmetric.com/v1/donut/7487297_240.png 2,In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer,Abdominal radiology (New York),,,Article,2016-04-27,10.1007/s00261-016-0750-7,,,,27118268,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7483149,https://api.altmetric.com/v1/donut/7483149_240.png 2,Re: The Molecular Taxonomy of Primary Prostate Cancer,European Urology,,,Article,2016-06-01,10.1016/j.eururo.2016.02.024,,,,27302140,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,97,https://www.altmetric.com/details/7359110,https://api.altmetric.com/v1/donut/7359110_240.png 2,Growth Inhibition and Apoptosis Induction of Essential Oils and Extracts of Nepeta cataria L. on Human Prostatic and Breast Cancer Cell Lines.,Asian Pacific Journal of Cancer Prevention,,,Article,2016-05-12,,,,,27165249,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7357855,https://api.altmetric.com/v1/donut/7357855_240.png 2,Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer,The Prostate,,,Article,2016-06-01,10.1002/pros.23171,,,,26990456,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7319666,https://api.altmetric.com/v1/donut/7319666_240.png 2,In Vitro and In Vivo Efficacy Studies of Lavender angustifolia Essential Oil and Its Active Constituents on the Proliferation of Human Prostate Cancer,Integrative Cancer Therapies,,,Article,2016-05-05,10.1177/1534735416645408,,,,27151584,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7302523,https://api.altmetric.com/v1/donut/7302523_240.png 2,Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure,Radiotherapy & Oncology,,,Article,2016-05-08,10.1016/j.radonc.2016.04.032,,,,27165612,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7297504,https://api.altmetric.com/v1/donut/7297504_240.png 2,Multiparametric Prostate MRI and Cognitively Targeted Transperineal Biopsy in Patients with Previous Abdominoperineal Resection and Suspicion of Prostate Cancer.,Urology,,,Article,2016-05-04,10.1016/j.urology.2016.04.037,,,,27155312,,,,,,,0,0,0,6,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7150162,https://api.altmetric.com/v1/donut/7150162_240.png 2,"Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients",Radiotherapy & Oncology,,,Article,2016-05-03,10.1016/j.radonc.2016.04.005,,,,27157889,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/7139033,https://api.altmetric.com/v1/donut/7139033_240.png 2,Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer,Journal of Clinical Imaging Science,,,Article,2016-01-01,10.4103/2156-7514.181494,,,,27195184,PMC4863405,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7110898,https://api.altmetric.com/v1/donut/7110898_240.png 2,Immune Checkpoint Therapies in Prostate Cancer,Cancer Journal,,,Article,2016-01-01,10.1097/ppo.0000000000000176,,,http://journals.lww.com/journalppo/Fulltext/2016/03000/Immune_Checkpoint_Therapies_in_Prostate_Cancer.9.aspx,27111907,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6965355,https://api.altmetric.com/v1/donut/6965355_240.png 2,A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells,Tumor Biology,,,Article,2016-04-25,10.1007/s13277-016-5046-6,,,,27113741,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6958176,https://api.altmetric.com/v1/donut/6958176_240.png 2,BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer,Molecular Cancer Research,,,Article,2016-04-01,10.1158/1541-7786.mcr-15-0472,,,,26792867,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6728335,https://api.altmetric.com/v1/donut/6728335_240.png 2,Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines,Bangladesh Journal of Pharmacology,,,Article,2015-12-25,10.3329/bjp.v11i1.24149,,,,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/6665072,https://api.altmetric.com/v1/donut/6665072_240.png 2,"Re: Hashim U. Ahmed, Louise Dickinson, Susan Charman, et al. Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study. Eur Urol 2015;68:927–36",European Urology,,,Article,2016-04-14,10.1016/j.eururo.2016.03.050,,,,27085626,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6663353,https://api.altmetric.com/v1/donut/6663353_240.png 2,Higher Initial DNA Damage and Persistent Cell Cycle Arrest after Carbon Ion Irradiation Compared to X-irradiation in Prostate and Colon Cancer Cells,Frontiers in oncology,,,Article,2016-04-13,10.3389/fonc.2016.00087,,,,27148479,PMC4830044,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6649282,https://api.altmetric.com/v1/donut/6649282_240.png 2,5-Bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one targets prostate cancer cells by down-regulating inflammation-related genes,Bangladesh Journal of Pharmacology,,,Article,2016-03-26,10.3329/bjp.v11i2.23872,,,,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/6619070,https://api.altmetric.com/v1/donut/6619070_240.png 2,Anticancer activity of midostaurin in hormone refractory human prostate cancer DU145 cells,Bangladesh Journal of Pharmacology,,,Article,2016-03-24,10.3329/bjp.v11i2.24954,,,,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/6619041,https://api.altmetric.com/v1/donut/6619041_240.png 2,Questioning the Ten-Year Life Expectancy Rule for High-Grade Prostate Cancer: Comparative Effectiveness of Aggressive Vs. Non-Aggressive Treatment of High-Grade Disease in Older Men with Differing Comorbid Disease Burdens,Urology,,,Article,2016-04-01,10.1016/j.urology.2016.02.057,,,http://www.rand.org/pubs/external_publications/EP66525.html,27079130,,,,,,,0,0,0,6,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6617472,https://api.altmetric.com/v1/donut/6617472_240.png 2,Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer ,EBioMedicine,,,Article,2016-04-01,10.1016/j.ebiom.2016.03.047,,,,27322462,PMC4909608,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6525289,https://api.altmetric.com/v1/donut/6525289_240.png 2,Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer,"Cancer Immunology, Immunotherapy",,,Article,2016-04-06,10.1007/s00262-016-1831-8,,,,27052571,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6509194,https://api.altmetric.com/v1/donut/6509194_240.png 2,Prostasomes as a source of diagnostic biomarkers for prostate cancer,Journal of Clinical Investigation,,,Article,2016-04-01,10.1172/jci81128,,,,27035806,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6440211,https://api.altmetric.com/v1/donut/6440211_240.png 2,Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8365,,,,27028863,PMC5041937,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6404254,https://api.altmetric.com/v1/donut/6404254_240.png 2,Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging,Frontiers in oncology,,,Article,2016-03-31,10.3389/fonc.2016.00073,,,,27065024,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6403539,https://api.altmetric.com/v1/donut/6403539_240.png 2,Modalités de castration dans la prise en charge du cancer de la prostate : sont-elles toutes équivalentes ?,Progrès en Urologie,,,Article,2016-03-01,10.1016/j.purol.2016.02.010,,,,27017327,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6360642,https://api.altmetric.com/v1/donut/6360642_240.png 2,Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer,International review of cell and molecular biology,,,Article,2016-01-01,10.1016/bs.ircmb.2016.01.004,,,,27017010,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6359537,https://api.altmetric.com/v1/donut/6359537_240.png 2,Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen,Der Urologe A,,,Article,2016-01-28,10.1007/s00120-016-0030-8,,,,26820660,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6353630,https://api.altmetric.com/v1/donut/6353630_240.png 2,New aspects in shear-wave elastography of prostate cancer,Journal of ultrasonography,,,Article,2015-03-01,10.15557/jou.2015.0001,,,,26675385,PMC4579708,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6352653,https://api.altmetric.com/v1/donut/6352653_240.png 2,Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8220,,,,27014907,PMC5029704,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6339926,https://api.altmetric.com/v1/donut/6339926_240.png 2,Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer,Clinical Medicine Insights: Oncology,,,Article,2016-03-23,10.4137/cmo.s30751,,,,27042152,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6296375,https://api.altmetric.com/v1/donut/6296375_240.png 2,Non?invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8124,,,,26992225,PMC5008382,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6234792,https://api.altmetric.com/v1/donut/6234792_240.png 2,Dissection of Individual Prostate Lobes in Mouse Models of Prostate Cancer to Obtain High Quality RNA,Journal of Cellular Physiology,,,Article,2016-03-01,10.1002/jcp.25384,,,,26992144,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6230338,https://api.altmetric.com/v1/donut/6230338_240.png 2,Epididymal Sparing Bilateral Simple Orchiectomy: Cost-Effectiveness and Aesthetic Preservation for Men with Metastatic Prostate Cancer,Urology Practice,,,Article,2015-12-01,10.1016/j.urpr.2015.06.008,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6230224,https://api.altmetric.com/v1/donut/6230224_240.png 2,Geranylated 4-Phenylcoumarins Exhibit Anticancer Effects against Human Prostate Cancer Cells through Caspase-Independent Mechanism,PLoS ONE,,,Article,2016-03-14,10.1371/journal.pone.0151472,,,,26974436,,,,,,,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,5,https://www.altmetric.com/details/6187989,https://api.altmetric.com/v1/donut/6187989_240.png 2,A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps,Radiotherapy & Oncology,,,Article,2016-03-01,10.1016/j.radonc.2016.02.030,,,,26987473,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6186789,https://api.altmetric.com/v1/donut/6186789_240.png 2,In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8001,,,,26968813,PMC5008379,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6180217,https://api.altmetric.com/v1/donut/6180217_240.png 2,Biological determinants of cancer progression in men with prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,1999-04-21,,,,,10217055,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6178927,https://api.altmetric.com/v1/donut/6178927_240.png 2,Ability to Reach Orgasm in Patients with Prostate Cancer Treated with Robot-assisted Laparoscopic Prostatectomy,Urology,,,Article,2016-03-10,10.1016/j.urology.2015.11.066,,,,26972145,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6159619,https://api.altmetric.com/v1/donut/6159619_240.png 2,Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life,Rehabilitation Oncology,,,Article,2016-01-01,10.1097/01.reo.0000000000000004,,,http://journals.lww.com/rehabonc/Fulltext/2016/01000/Oncology_Section_EDGE_Task_Force_on_Prostate.5.aspx,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6159098,https://api.altmetric.com/v1/donut/6159098_240.png 2,Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation,The Journal of Pharmacology and Experimental Therapeutics,,,Article,2016-01-20,10.1124/jpet.115.230003,,,,26791603,,,,,,,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6147123,https://api.altmetric.com/v1/donut/6147123_240.png 2,"Childhood height, adult height, and the risk of prostate cancer",Cancer Causes and Control,,,Article,2016-03-07,10.1007/s10552-016-0731-8,,,,26951518,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6143952,https://api.altmetric.com/v1/donut/6143952_240.png 2,Cyclin A1 and P450 aromatase promote metastatic homing and growth of stem-like prostate cancer cells in the bone marrow,Cancer Research,,,Article,2016-02-26,10.1158/0008-5472.can-15-2340,,,,26921336,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6106114,https://api.altmetric.com/v1/donut/6106114_240.png 2,Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.,Clinical and Experimental Metastasis,,,Article,2013-11-17,10.1007/s10585-013-9625-2,,,,24242705,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,8,https://www.altmetric.com/details/6066154,https://api.altmetric.com/v1/donut/6066154_240.png 2,A Review of Imaging Methods for Prostate Cancer Detection,Biomedical Engineering and Computational Biology,,,Article,2016-03-02,10.4137/becb.s34255,,,,26966397,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6043148,https://api.altmetric.com/v1/donut/6043148_240.png 2,TRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY ?-ADRENERGIC STIMULATION,Molecular Medicine,,,Article,2016-03-02,10.2119/molmed.2015.00047,,,,26928389,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6040237,https://api.altmetric.com/v1/donut/6040237_240.png 2,Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy,World Journal of Urology,,,Article,2016-02-22,10.1007/s00345-016-1784-8,,,,26897499,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5911621,https://api.altmetric.com/v1/donut/5911621_240.png 2,Clonality of localized and metastatic prostate cancer.,Current Opinion in Urology,,,Article,2016-02-16,10.1097/mou.0000000000000279,,,http://journals.lww.com/co-urology/Fulltext/publishahead/Clonality_of_localized_and_metastatic_prostate.99398.aspx,26885716,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5909799,https://api.altmetric.com/v1/donut/5909799_240.png 2,Microarray analysis identifies malignant field signatures in biopsy samples at diagnosis predicting the likelihood of lethal disease in patients with localized Gleason 6 and 7 prostate cancer.,bioRxiv,,,Article,2016-02-21,10.1101/040519,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5905119,https://api.altmetric.com/v1/donut/5905119_240.png 2,Development of an International Prostate Cancer Outcomes Registry,British Journal of Urology,,,Article,2016-02-01,10.1111/bju.13258,,,,26877056,,11541.2/119508,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5634324,https://api.altmetric.com/v1/donut/5634324_240.png 2,Development of a patient decision aid for the treatment of localised prostate cancer: a participatory design approach,Journal of Clinical Nursing,,,Article,2016-02-01,10.1111/jocn.13120,,,,26880526,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5616315,https://api.altmetric.com/v1/donut/5616315_240.png 2,"Thioredoxin 1 in Prostate Tissue Is Associated with Gleason Score, Erythrocyte Antioxidant Enzyme Activity, and Dietary Antioxidants",Prostate Cancer,,,Article,2016-02-06,10.1155/2015/728046,,,,26357575,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5102686,https://api.altmetric.com/v1/donut/5102686_240.png 2,Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel.,Contemporary Oncology - Wspólczesna Onkologia,,,Article,2016-01-01,10.5114/wo.2015.56648,,,,26843836,PMC4731449,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5099826,https://api.altmetric.com/v1/donut/5099826_240.png 2,The Cumulative Effect of Gene-Gene and Gene-Environment Interactions on the Risk of Prostate Cancer in Chinese Men,International Journal of Environmental Research and Public Health,,,Article,2016-01-27,10.3390/ijerph13020162,,,,26828504,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5052744,https://api.altmetric.com/v1/donut/5052744_240.png 2,Prospects for the use of ipilimumab in treating advanced prostate cancer,Expert Opinion on Biological Therapy,,,Article,2016-01-26,10.1517/14712598.2016.1136284,,,,26698365,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5042632,https://api.altmetric.com/v1/donut/5042632_240.png 2,Reduced risk of prostate cancer in childless men as compared to fathers: a systematic review and meta-analysis,Scientific Reports,,,Article,2016-01-11,10.1038/srep19210,,,,26752096,PMC4707492,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5034119,https://api.altmetric.com/v1/donut/5034119_240.png 2,"Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer",Frontiers in oncology,,,Article,2016-01-23,10.3389/fonc.2016.00024,,,,26909338,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5031133,https://api.altmetric.com/v1/donut/5031133_240.png 2,Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy ,European Urology Focus ,,,Article,2016-01-23,10.1016/j.euf.2015.12.008,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5029295,https://api.altmetric.com/v1/donut/5029295_240.png 2,A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion,PLoS ONE,,,Article,2016-01-19,10.1371/journal.pone.0146931,,,,26784896,PMC4718621,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/5017933,https://api.altmetric.com/v1/donut/5017933_240.png 2,Testosterone Replacement Therapy and Prostate Cancer Incidence,The World Journal of Men's Health,,,Article,2015-12-01,10.5534/wjmh.2015.33.3.125,,,,26770932,PMC4709428,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/5002285,https://api.altmetric.com/v1/donut/5002285_240.png 2,Should prostate cancer be considered as a differential diagnosis in patients with osteolytic bone lesions?,European review for medical and pharmacological sciences,,,Article,2016-01-15,,,,,26744870,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4997639,https://api.altmetric.com/v1/donut/4997639_240.png 2,The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein ?.,Veterinary & Comparative Oncology,,,Article,2016-01-01,10.1111/vco.12199,,,,26762899,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4995003,https://api.altmetric.com/v1/donut/4995003_240.png 2,A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer,International Journal of Nanomedicine,,,Article,2016-01-08,10.2147/ijn.s97286,,,,26811677,PMC4712974,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4977109,https://api.altmetric.com/v1/donut/4977109_240.png 2,"Prostate Cancer, Version 1.2016.",Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2016-01-11,,,,,26733552,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4977041,https://api.altmetric.com/v1/donut/4977041_240.png 2,Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.,New England Journal of Medicine,,,Article,1999-12-09,10.1056/nejm199912093412401,,,,10588962,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/4966511,https://api.altmetric.com/v1/donut/4966511_240.png 2,Investigation of Histone Lysine-Specific Demethylase 5D (KDM5D) Isoform Expression in Prostate Cancer Cell Lines: a System Approach.,Iranian Biomedical Journal,,,Article,2016-01-06,,,,,26728332,PMC4726892,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4959661,https://api.altmetric.com/v1/donut/4959661_240.png 2,Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-01-01,10.1158/1055-9965.epi-15-0987,,,,26715424,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4943710,https://api.altmetric.com/v1/donut/4943710_240.png 2,Pudendal nerve injury in men with fecal incontinence after radiotherapy for prostate cancer,Acta Oncologica,,,Article,2015-03-03,10.3109/0284186x.2015.1010693,,,,25734401,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4936424,https://api.altmetric.com/v1/donut/4936424_240.png 2,Charting Recent Progress and Challenges in Metastatic Castration-resistant Prostate Cancer: Is There an Optimal Treatment Sequence?,,,,Article,2015-12-24,10.1016/j.euf.2015.11.008,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4919079,https://api.altmetric.com/v1/donut/4919079_240.png 2,The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.,Briefings in Functional Genomics,,,Article,2015-12-20,10.1093/bfgp/elv057,,,,26685282,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4900407,https://api.altmetric.com/v1/donut/4900407_240.png 2,A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol,European Urology,,,Article,2015-12-18,10.1016/j.eururo.2015.11.030,,,,26707868,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4892156,https://api.altmetric.com/v1/donut/4892156_240.png 2,"Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805–11",European Urology,,,Article,2015-12-17,10.1016/j.eururo.2015.11.031,,,,26706104,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4886914,https://api.altmetric.com/v1/donut/4886914_240.png 2,PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2015-12-01,,,,,26656523,,,,,,,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/4885691,https://api.altmetric.com/v1/donut/4885691_240.png 2,Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients,Value in Health (Elsevier Science),,,Article,2015-12-22,10.1016/j.jval.2015.08.012,,,,26686802,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4874879,https://api.altmetric.com/v1/donut/4874879_240.png 2,"Reply from Authors re: Tillmann Loch, Pat Fox Fulgham. Active Surveillance Challenges in Men with Prostate Cancer: Role of Imaging Today and Tomorrow. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.015: Imaging in Active Surveillance for Prostate Cancer: Where Should We Focus Our Research?",European Urology,,,Article,2015-12-12,10.1016/j.eururo.2015.11.027,,,,26691314,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4869435,https://api.altmetric.com/v1/donut/4869435_240.png 2,The effects of attachment and outness on illness adjustment among gay men with prostate cancer,Psycho-Oncology,,,Article,2015-01-01,10.1002/pon.4043,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4861780,https://api.altmetric.com/v1/donut/4861780_240.png 2,MicroRNA-145 MODULATES TUMOR SENSITIVITY TO RADIATION IN PROSTATE CANCER.,Radiation Research,,,Article,2015-12-04,10.1667/rr14185.1,,,,26632856,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4841429,https://api.altmetric.com/v1/donut/4841429_240.png 2,"Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.",Cancer Medicine,,,Article,2015-11-01,10.1002/cam4.549,,,,26628287,PMC4708896,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4831635,https://api.altmetric.com/v1/donut/4831635_240.png 2,Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? ,Reports of Practical Oncology & Radiotherapy,,,Article,2015-12-24,10.1016/j.rpor.2014.08.001,,,,26696782,PMC4661353,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4792872,https://api.altmetric.com/v1/donut/4792872_240.png 2,"Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis",Cancer Medicine,,,Article,2015-11-01,10.1002/cam4.553,,,,26590118,,,,,,,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4791387,https://api.altmetric.com/v1/donut/4791387_240.png 2,PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways,"Drug Design, Development and Therapy",,,Article,2015-11-05,10.2147/dddt.s86881,,,,26604689,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4729850,https://api.altmetric.com/v1/donut/4729850_240.png 2,When Prostate Cancer Circulates in the Bloodstream,Diagnostics,,,Article,2015-10-29,10.3390/diagnostics5040428,,,,26854164,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4712328,https://api.altmetric.com/v1/donut/4712328_240.png 2,Marked Response to 177Lu Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-10-28,10.1097/rlu.0000000000001058,,,,26505861,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4683657,https://api.altmetric.com/v1/donut/4683657_240.png 2,Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).,Cancer Treatment Reviews,,,Article,2015-10-29,10.1016/j.ctrv.2015.10.005,,,,26508669,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4668723,https://api.altmetric.com/v1/donut/4668723_240.png 2,Prostate Cancer in Elderly Men,Clinics in geriatric medicine,,,Article,2015-01-11,10.1016/j.cger.2015.07.004,,,,26476120,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4656624,https://api.altmetric.com/v1/donut/4656624_240.png 2,"Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.",PLoS ONE,,,Article,2015-10-20,10.1371/journal.pone.0140862,,,,26484677,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4656479,https://api.altmetric.com/v1/donut/4656479_240.png 2,Is there still a place for docetaxel rechallenge in prostate cancer?,World Journal of Clinical Oncology,,,Article,2015-10-10,10.5306/wjco.v6.i5.99,,,,26468445,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4641270,https://api.altmetric.com/v1/donut/4641270_240.png 2,The Effects of Partnered Exercise on Physical Intimacy in Couples Coping With Prostate Cancer.,Health Psychology,,,Article,2015-10-12,10.1037/hea0000287,,,,26462060,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4622643,https://api.altmetric.com/v1/donut/4622643_240.png 2,GSK?3? controls autophagy by modulating LKB1?AMPK pathway in prostate cancer cells,The Prostate,,,Article,2015-10-01,10.1002/pros.23106,,,,26440826,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4609976,https://api.altmetric.com/v1/donut/4609976_240.png 2,"Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study",European Urology,,,Article,2015-10-11,10.1016/j.eururo.2015.09.046,,,,26463318,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4609929,https://api.altmetric.com/v1/donut/4609929_240.png 2,Brassinin Combined with Capsaicin Enhances Apoptotic and Anti-metastatic Effects in PC-3 Human Prostate Cancer Cells.,Phytotherapy Research,,,Article,2015-01-01,10.1002/ptr.5478,,,,26426257,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4591403,https://api.altmetric.com/v1/donut/4591403_240.png 2,Rural-urban differences in the clinico-pathologic profiles of Jamaican men with prostate cancer,Infectious Agents and Cancer,,,Article,2015-09-28,10.1186/s13027-015-0023-z,,,,26417385,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4561789,https://api.altmetric.com/v1/donut/4561789_240.png 2,Imaging the Different Mechanisms of Prostate Cancer Cell-killing by Tumor-targeting Salmonella typhimurium A1-R.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-09-27,,,,,26408681,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4558388,https://api.altmetric.com/v1/donut/4558388_240.png 2,Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells,Tumor Biology,,,Article,2015-09-26,10.1007/s13277-015-4095-6,,,,26404131,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4556206,https://api.altmetric.com/v1/donut/4556206_240.png 2,Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer,Human Pathology,,,Article,2015-11-08,10.1016/j.humpath.2015.08.021,,,,26546252,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4555058,https://api.altmetric.com/v1/donut/4555058_240.png 2,Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer,Oncogene,,,Article,2015-09-15,10.1038/onc.2015.295,,,,26364608,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4511797,https://api.altmetric.com/v1/donut/4511797_240.png 2,PKC? Is an Essential Mediator of Prostate Cancer Bone Metastasis,Molecular Cancer Research,,,Article,2015-09-01,10.1158/1541-7786.mcr-15-0111,,,,26023164,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4506999,https://api.altmetric.com/v1/donut/4506999_240.png 2,Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer,Scientific Reports,,,Article,2015-09-15,10.1038/srep14045,,,,26365175,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4505562,https://api.altmetric.com/v1/donut/4505562_240.png 2,"Phase II trial of carboplatin, everolimus and prednisone in metastatic castrate resistant prostate cancer pretreated with docetaxel chemotherapy: A Prostate Cancer Clinical Trial Consortium Study",Urology,,,Article,2015-09-17,10.1016/j.urology.2015.08.008,,,,26375845,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4501923,https://api.altmetric.com/v1/donut/4501923_240.png 2,Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2?/androgen receptor signals.,Oncotarget,,,Article,2015-09-06,10.18632/oncotarget.4515,,,,26342197,PMC4695008,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4478332,https://api.altmetric.com/v1/donut/4478332_240.png 2,Discovery of Potent 17?-Hydroxywithanolides for Castration-Resistant Prostate Cancer by High-Throughput Screening of a Natural Products Library for Androgen-Induced Gene Expression Inhibitors,Journal of Medicinal Chemistry,,,Article,2015-09-10,10.1021/acs.jmedchem.5b00867,,,,26305181,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4459973,https://api.altmetric.com/v1/donut/4459973_240.png 2,CD44 Potentiates the Adherence of Metastatic Prostate and Breast Cancer Cells to Bone Marrow Endothelial Cells,Cancer Research,,,Article,2004-08-15,10.1158/0008-5472.can-04-0389,,,,15313910,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4454936,https://api.altmetric.com/v1/donut/4454936_240.png 2,The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells,BMC Cancer,,,Article,2015-08-27,10.1186/s12885-015-1612-3,,,,26310325,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4453932,https://api.altmetric.com/v1/donut/4453932_240.png 2,An electrochemiluminescence-supramolecular approach to sarcosine detection for early diagnosis of prostate cancer,Faraday Discussions of the Chemical Society,,,Article,2015-09-23,10.1039/c5fd00096c,,,,26394608,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4452980,https://api.altmetric.com/v1/donut/4452980_240.png 2,Residential Exposure to Road and Railway Noise and Risk of Prostate Cancer: A Prospective Cohort Study,PLoS ONE,,,Article,2015-08-25,10.1371/journal.pone.0135407,,,,26305219,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4451838,https://api.altmetric.com/v1/donut/4451838_240.png 2,A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer,Cancer Medicine,,,Article,2015-08-29,10.1002/cam4.517,,,,26311046,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4450591,https://api.altmetric.com/v1/donut/4450591_240.png 2,Hsa?miR?146a?5p modulates androgen?independent prostate cancer cells apoptosis by targeting ROCK1,The Prostate,,,Article,2015-08-28,10.1002/pros.23068,,,,26306811,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4444709,https://api.altmetric.com/v1/donut/4444709_240.png 2,Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC?4 treatment,Environmental Toxicology,,,Article,2015-08-26,10.1002/tox.22189,,,,26305502,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4436804,https://api.altmetric.com/v1/donut/4436804_240.png 2,Docetaxel in very elderly men with metastatic castration-resistant prostate cancer,Prostate International,,,Article,2015-06-01,10.1016/j.prnil.2015.03.003,,,,26157766,PMC4494632,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4431850,https://api.altmetric.com/v1/donut/4431850_240.png 2,Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels,Prostate International,,,Article,2015-03-01,10.1016/j.prnil.2015.02.006,,,,26157761,PMC4494633,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4431839,https://api.altmetric.com/v1/donut/4431839_240.png 2,Pro-apoptotic activity of ergosterol derivatives in human prostate cancer cells,Planta Medica,,,Article,2008-08-04,10.1055/s-0028-1084087,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4403025,https://api.altmetric.com/v1/donut/4403025_240.png 2,Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.,OncoTargets and therapy,,,Article,2015-01-01,10.2147/ott.s86637,,,,26261420,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4386880,https://api.altmetric.com/v1/donut/4386880_240.png 2,A novel shape-similarity-based elastography technique for prostate cancer assessment,Medical Physics,,,Article,2015-08-10,10.1118/1.4927572,,,,26328962,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4380813,https://api.altmetric.com/v1/donut/4380813_240.png 2,"Re: Lars Budäus, Sami-Ramzi Leyh-Bannurah, Georg Salomon, et al. Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.06.010",European Urology,,,Article,2015-08-09,10.1016/j.eururo.2015.07.055,,,,26264157,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4377150,https://api.altmetric.com/v1/donut/4377150_240.png 2,Navigating healthcare: a qualitative study exploring prostate cancer patients' and doctors' experience of consultations using a decision-support intervention.,Psycho-Oncology,,,Article,2014-02-14,10.1002/pon.3466,,,,24677394,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4373931,https://api.altmetric.com/v1/donut/4373931_240.png 2,High-dose-rate (HDR) Monotherapy for Localized Prostate Cancer: 10 year Results,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-10-08,10.1016/j.ijrobp.2015.07.2290,,,,26443877,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4362857,https://api.altmetric.com/v1/donut/4362857_240.png 2,Molecular imaging of cholinergic processes in prostate cancer using 11C-donepezil and 18F-FEOBV,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-08-01,10.1007/s00259-015-3143-1,,,,26227535,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4351883,https://api.altmetric.com/v1/donut/4351883_240.png 2,"Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells",Food & Function,,,Article,2014-09-11,10.1039/c4fo00542b,,,,25214070,,2445/67253,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4337301,https://api.altmetric.com/v1/donut/4337301_240.png 2,"Notch Pathway Inhibition Using PF-03084014, a ?-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer",Clinical Cancer Research,,,Article,2015-07-24,10.1158/1078-0432.ccr-15-0242,,,,26202948,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4309241,https://api.altmetric.com/v1/donut/4309241_240.png 2,Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential,European Urology,,,Article,2015-07-13,10.1016/j.eururo.2015.06.040,,,,26159288,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4287603,https://api.altmetric.com/v1/donut/4287603_240.png 2,Prophylactic noscapine therapy inhibits human prostate cancer progression and metastasis in a mouse model.,,,,Article,2010-02-15,,,,,20332445,,,,,,,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/4254647,https://api.altmetric.com/v1/donut/4254647_240.png 2,Noscapine inhibits human prostate cancer progression and metastasis in a mouse model.,,,,Article,,,,,,19189652,,,,,,,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/4254623,https://api.altmetric.com/v1/donut/4254623_240.png 2,Individual and Dyadic Planning Predicting Pelvic Floor Exercise Among Prostate Cancer Survivors.,Rehabilitation Psychology,,,Article,2015-07-07,10.1037/rep0000047,,,,26147239,,,,,,,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4253077,https://api.altmetric.com/v1/donut/4253077_240.png 2,Cold Atmospheric Plasma Treatment Induces Anti-Proliferative Effects in Prostate Cancer Cells by Redox and Apoptotic Signaling Pathways,PLoS ONE,,,Article,2015-07-01,10.1371/journal.pone.0130350,,,,26132846,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4243440,https://api.altmetric.com/v1/donut/4243440_240.png 2,mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity,Endocrine-Related Cancer,,,Article,2015-08-01,10.1530/erc-15-0277,,,,26113609,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4241336,https://api.altmetric.com/v1/donut/4241336_240.png 2,Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based Study.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2015-06-29,10.1097/coc.0000000000000201,,,,26125304,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4231662,https://api.altmetric.com/v1/donut/4231662_240.png 2,Problematic Use of Multiple Subgroup Analyses in Assessing the Impact of Aspirin in Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-07-01,10.1200/jco.2014.60.7010,,,,25847923,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4225435,https://api.altmetric.com/v1/donut/4225435_240.png 2,A Web application for the management of clinical workflow in image-guided and adaptive proton therapy for prostate cancer treatments.,Journal of Applied Clinical Medical Physics,,,Article,2015-06-25,,,,,26103504,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4207665,https://api.altmetric.com/v1/donut/4207665_240.png 2,Neuroendocrine Transdifferentiation in Human Prostate Cancer Cells: An Integrated Approach,Cancer Research,,,Article,2015-06-11,10.1158/0008-5472.can-14-3830,,,,26069250,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4160626,https://api.altmetric.com/v1/donut/4160626_240.png 2,Relationship between plasma carotenoids and prostate cancer.,,,,Article,,10.1207/s15327914nc5302_1,,,,16573373,,,,,,,0,0,0,10,0,0,0,0,1,0,0,0,0,0,0,14,https://www.altmetric.com/details/4143006,https://api.altmetric.com/v1/donut/4143006_240.png 2,External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer,Journal of Clinical Oncology,,,Article,2015-06-10,10.1200/jco.2015.60.9404,,,,25847937,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4118530,https://api.altmetric.com/v1/donut/4118530_240.png 2,Somatic Mutations in Catalytic Core of POLK Reported in Prostate Cancer Alter Translesion DNA Synthesis.,Human Mutation,,,Article,2015-06-07,10.1002/humu.22820,,,,26046662,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4107988,https://api.altmetric.com/v1/donut/4107988_240.png 2,MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer.,Oncotarget,,,Article,2015-05-31,10.18632/oncotarget.3923,,,,26025918,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4075406,https://api.altmetric.com/v1/donut/4075406_240.png 2,The TMPRSS2-ERG gene fusion blocks XRCC4-mediated non-homologous end-joining repair and radiosensitizes prostate cancer cells to PARP inhibition.,Molecular Cancer Therapeutics,,,Article,2015-05-31,10.1158/1535-7163.mct-14-0865,,,,26026052,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4075348,https://api.altmetric.com/v1/donut/4075348_240.png 2,Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-05-31,,,,,26026087,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4075309,https://api.altmetric.com/v1/donut/4075309_240.png 2,The experience of Japan as a clue to the etiology of testicular and prostatic cancers.,Medical Hypotheses,,,Article,2003-05-01,,,,,12710911,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,7,https://www.altmetric.com/details/4060498,https://api.altmetric.com/v1/donut/4060498_240.png 2,TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells.,The Prostate,,,Article,,10.1002/pros.22983,,,,25833062,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4032477,https://api.altmetric.com/v1/donut/4032477_240.png 2,Determination of synthetic lethal interactions to provide therapeutic direction to end aggressive prostate cancer.,Future Oncology,,,Article,,10.2217/fon.15.61,,,,25963421,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4015834,https://api.altmetric.com/v1/donut/4015834_240.png 2,Molecular Subtyping of Prostate Cancer: A Partnership Model,European Urology,,,Article,2015-05-24,10.1016/j.eururo.2015.05.012,,,,26001612,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4012671,https://api.altmetric.com/v1/donut/4012671_240.png 2,Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan,International Journal of Urology,,,Article,2015-05-10,10.1111/iju.12813,,,,25959857,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4004394,https://api.altmetric.com/v1/donut/4004394_240.png 2,Bone Metastasis in Prostate Cancer: Recurring Mitochondrial DNA Mutation Reveals Selective Pressure Exerted by the Bone Microenvironment.,BONE,,,Article,2015-05-09,10.1016/j.bone.2015.04.046,,,,25952970,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3967415,https://api.altmetric.com/v1/donut/3967415_240.png 2,Profiles of dyadic adjustment for advanced prostate cancer to inform couple-based intervention,Psychology & Health,,,Article,2015-05-01,10.1080/08870446.2015.1043301,,,,25925879,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3956556,https://api.altmetric.com/v1/donut/3956556_240.png 2,Co-Localization of Alpha1-Adrenoceptors and GPR55: A Novel Prostate Cancer Paradigm?,Pharmacology & Pharmacy,,,Article,2015-03-26,10.4236/pp.2015.64023,,,,,,,,,,,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/3933883,https://api.altmetric.com/v1/donut/3933883_240.png 2,Childhood height increases the risk of prostate cancer mortality.,European Journal of Cancer (1965),,,Article,2015-04-23,10.1016/j.ejca.2015.03.022,,,,25899985,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3927243,https://api.altmetric.com/v1/donut/3927243_240.png 2,Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.,The Prostate,,,Article,2015-04-20,10.1002/pros.23000,,,,25894097,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3925005,https://api.altmetric.com/v1/donut/3925005_240.png 2,Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: A multicenter cluster randomized controlled trial (ENGAGE),Cancer (0008543X),,,Article,2015-04-15,10.1002/cncr.29385,,,,25877784,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3913120,https://api.altmetric.com/v1/donut/3913120_240.png 2,"Optimized planning target volume margin in helical tomotherapy for prostate cancer: is there a preferred method?",,,,Article,,,,,,,,,,1504.03045,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3905107,https://api.altmetric.com/v1/donut/3905107_240.png 2,Prostate?specific antigen?based prostate cancer screening: Past and future,International Journal of Urology,,,Article,2015-04-06,10.1111/iju.12750,,,,25847604,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3896072,https://api.altmetric.com/v1/donut/3896072_240.png 2,Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-01-22,10.1158/1055-9965.epi-14-1224,,,,25613117,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3858200,https://api.altmetric.com/v1/donut/3858200_240.png 2,The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module,Cancer Research,,,Article,2015-03-13,10.1158/0008-5472.can-14-0611,,,,25769723,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3789904,https://api.altmetric.com/v1/donut/3789904_240.png 2,"Results, Questions, Perspectives of a Study on Human Polyomavirus BK and Molecular Actors in Prostate Cancer Development",Cancer Genomics & Proteomics,,,Article,,,,,,25770188,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3789883,https://api.altmetric.com/v1/donut/3789883_240.png 2,External Beam Radiation Therapy and Abiraterone in Men With Localized Prostate Cancer: Safety and Effect on Tissue Androgens.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-03-12,10.1016/j.ijrobp.2015.01.020,,,,25772183,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3786439,https://api.altmetric.com/v1/donut/3786439_240.png 2,"Treatment plan comparison of Linac step and shoot,Tomotherapy, RapidArc, and Proton therapy for prostate cancer using dosimetrical and biological index",,,,Article,,,,,,,,,,1503.03558,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3784574,https://api.altmetric.com/v1/donut/3784574_240.png 2,The effect of urologist experience on choosing active surveillance for prostate cancer,World Journal of Urology,,,Article,2015-03-12,10.1007/s00345-015-1528-1,,,,25761737,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3783403,https://api.altmetric.com/v1/donut/3783403_240.png 2,[Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence.],Progrès en Urologie,,,Article,2015-03-04,10.1016/j.purol.2015.01.018,,,,25748788,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3772659,https://api.altmetric.com/v1/donut/3772659_240.png 2,ERG/AKR1C3/AR constitutes a feed-forward loop for AR signaling in prostate cancer cells.,Clinical Cancer Research,,,Article,2015-03-09,10.1158/1078-0432.ccr-14-2352,,,,25754347,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3771159,https://api.altmetric.com/v1/donut/3771159_240.png 2,The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer,The Prostate,,,Article,2015-03-01,10.1002/pros.22973,,,,25728532,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3767573,https://api.altmetric.com/v1/donut/3767573_240.png 2,Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients.,Cancer (0008543X),,,Article,2014-08-12,10.1002/cncr.28953,,,,25111199,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3735963,https://api.altmetric.com/v1/donut/3735963_240.png 2,CXCR4 Is a Novel Target of Cancer Chemopreventative Isothiocyanates in Prostate Cancer Cells,Cancer Prevention Research,,,Article,2015-02-23,10.1158/1940-6207.capr-14-0386,,,,25712054,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3735296,https://api.altmetric.com/v1/donut/3735296_240.png 2,"Growth Inhibitory and Apoptosis-inducing Effects of Xanthohumol, a Prenylated Chalone Present in Hops, in Human Prostate Cancer Cells",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2010-10-14,,,,,20944105,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3709257,https://api.altmetric.com/v1/donut/3709257_240.png 2,Understanding heterogeneity of treatment effect in prostate cancer,Current opinion in oncology,,,Article,2015-02-13,10.1097/cco.0000000000000172,,,,25689354,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3709038,https://api.altmetric.com/v1/donut/3709038_240.png 2,A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.,Korean Journal of Urology,,,Article,2015-02-01,10.4111/kju.2015.56.2.109,,,,25685297,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3706021,https://api.altmetric.com/v1/donut/3706021_240.png 2,Biomarker and Translational Prostate Cancer Research,BioMed Research International,,,Article,,10.1155/2015/309851,,,,25664317,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3547217,https://api.altmetric.com/v1/donut/3547217_240.png 2,Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods,Journal of Translational Medicine,,,Article,2015-02-12,10.1186/s12967-015-0418-z,,,,25889691,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3543038,https://api.altmetric.com/v1/donut/3543038_240.png 2,Taxane Resistance in Prostate Cancer Mediated by AR-Independent GATA2 Regulation of IGF2,Cancer Cell,,,Article,2015-09-02,10.1016/j.ccell.2015.01.008,,,,25670076,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3522098,https://api.altmetric.com/v1/donut/3522098_240.png 2,Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.,"Cancer Immunology, Immunotherapy",,,Article,2015-02-07,10.1007/s00262-015-1660-1,,,,25662406,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3427993,https://api.altmetric.com/v1/donut/3427993_240.png 2,Poly r(C) Binding Protein-1 is Central to Maintenance of Cancer Stem Cells in Prostate Cancer Cells,Cellular Physiology & Biochemistry,,,Article,2015-02-02,10.1159/000373931,,,,25661993,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3367627,https://api.altmetric.com/v1/donut/3367627_240.png 2,Corrigendum to “Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial” [Eur Urol 2013;64:703–9],European Urology,,,Article,2015-07-08,10.1016/j.eururo.2015.01.021,,,,26149731,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3334422,https://api.altmetric.com/v1/donut/3334422_240.png 2,Targeted Biopsy Could Improve Detection of High-Risk Prostate Cancers,Journal Watch,,,Article,,10.1056/nejm-jw.fw109795,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3109867,https://api.altmetric.com/v1/donut/3109867_240.png 2,Alkylresorcinol Metabolites in Urine and Plasma as Potential Biomarkers of Rye and Wheat Fiber Consumption in Prostate Cancer Patients and Controls.,Nutrition and Cancer,,,Article,2015-01-21,10.1080/01635581.2015.989371,,,,25608053,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3098086,https://api.altmetric.com/v1/donut/3098086_240.png 2,Oxidized low-density lipoprotein is associated with advanced-stage prostate cancer,Tumor Biology,,,Article,2015-01-08,10.1007/s13277-014-2994-6,,,,25566960,,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3092355,https://api.altmetric.com/v1/donut/3092355_240.png 2,Emerging players in prostate cancer: long non-coding RNAs.,American journal of clinical and experimental urology,,,Article,2014-01-01,,,,,25606575,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3092103,https://api.altmetric.com/v1/donut/3092103_240.png 2,Comparison and Limitations of DVH-Based NTCP Models Derived From 3D-CRT and IMRT Data for Prediction of Gastrointestinal Toxicities in Prostate Cancer Patients by Using Propensity Score Matched Pair Analysis.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-02,10.1016/j.ijrobp.2014.09.046,,,,25636766,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3074722,https://api.altmetric.com/v1/donut/3074722_240.png 2,Radium-223 dichloride: a new paradigm in the treatment of prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2015-01-02,10.1586/14737140.2015.999045,,,,25555355,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3036000,https://api.altmetric.com/v1/donut/3036000_240.png 2,Cbl-b gene silencing in splenic T lymphocytes as a therapeutic strategy to target the prostate cancer RM-1 cell tumors in immune competent mice.,European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360,,,Article,2014-12-01,,,,,25555872,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3035193,https://api.altmetric.com/v1/donut/3035193_240.png 2,Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -,Radiation Oncology,,,Article,2014-12-29,10.1186/s13014-014-0302-7,,,,25544509,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3020809,https://api.altmetric.com/v1/donut/3020809_240.png 2,Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines.,Journal of B U ON official journal of the Balkan Union of Oncology,,,Article,,,,,,25536616,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/3013641,https://api.altmetric.com/v1/donut/3013641_240.png 2,"Night shift work, chronotype and prostate cancer risk in the MCC?Spain case?control study",International Journal of Cancer,,,Article,2015-01-12,10.1002/ijc.29400,,,,25530021,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3003803,https://api.altmetric.com/v1/donut/3003803_240.png 2,"Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study",Cancer Causes and Control,,,Article,2014-12-09,10.1007/s10552-014-0500-5,,,,25488826,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/2977352,https://api.altmetric.com/v1/donut/2977352_240.png 2,Epigenetics of prostate cancer.,Methods in molecular biology,,,Article,2015-01-01,10.1007/978-1-4939-1804-1_11,,,,25421662,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2926207,https://api.altmetric.com/v1/donut/2926207_240.png 2,Prognostic Impact of C-Reactive Protein in Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis,Oncology Research and Treatment,,,Article,2014-11-20,10.1159/000369545,,,,25531724,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2914200,https://api.altmetric.com/v1/donut/2914200_240.png 2,Is Proton-beam Therapy Better Than Intensity-modulated Radiation Therapy for Prostate Cancer?,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-12-01,10.1097/coc.0000000000000048,,,,24577165,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2910894,https://api.altmetric.com/v1/donut/2910894_240.png 2,Proteomic-Coupled-Network Analysis of T877A-Androgen Receptor Interactomes Can Predict Clinical Prostate Cancer Outcomes between White (Non-Hispanic) and African-American Groups,PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0113190,,,,25409505,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2907751,https://api.altmetric.com/v1/donut/2907751_240.png 2,A genetic-based approach to personalized prostate cancer screening and treatment,Current Opinion in Urology,,,Article,2014-11-15,10.1097/mou.0000000000000130,,,,25405931,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2904190,https://api.altmetric.com/v1/donut/2904190_240.png 2,Polymorphisms Influencing Prostate-Specific Antigen Concentration May Bias Genome-Wide Association Studies on Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-10-31,10.1158/1055-9965.epi-14-0863,,,,25352524,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2896470,https://api.altmetric.com/v1/donut/2896470_240.png 2,ECONOMIC EVALUATION OF DIAGNOSTIC LOCALIZATION FOLLOWING BIOCHEMICAL PROSTATE CANCER RECURRENCE,International Journal of Technology Assessment in Health Care,,,Article,,10.1017/s0266462314000476,,,,25399914,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2895033,https://api.altmetric.com/v1/donut/2895033_240.png 2,Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (?50 cm3),Radiation Oncology,,,Article,2014-11-15,10.1186/s13014-014-0241-3,,,,25398516,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2892744,https://api.altmetric.com/v1/donut/2892744_240.png 2,"SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines",Radiation Oncology,,,Article,2014-10-20,10.3389/fonc.2014.00312,,,,25426447,PMC4227393,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2876387,https://api.altmetric.com/v1/donut/2876387_240.png 2,Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels Results from a Qualitative Analysis,Medical Decision Making,,,Article,2014-11-10,10.1177/0272989x14558424,,,,25385751,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2873416,https://api.altmetric.com/v1/donut/2873416_240.png 2,Lycopene for the prevention and treatment of prostate disease.,Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer,,,Article,2014-02-19,10.1007/978-3-642-45195-9_13,,,,24531784,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2852073,https://api.altmetric.com/v1/donut/2852073_240.png 2,Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.,International Journal of Cancer,,,Article,2014-10-20,10.1002/ijc.29276,,,,25335771,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2846183,https://api.altmetric.com/v1/donut/2846183_240.png 2,Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study,Radiation Oncology,,,Article,2014-10-20,10.1186/1748-717x-9-208,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2802025,https://api.altmetric.com/v1/donut/2802025_240.png 2,Mathematical models for diffusion?weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis,Magnetic Resonance in Medicine,,,Article,2014-10-20,10.1002/mrm.25482,,,,25329932,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2796132,https://api.altmetric.com/v1/donut/2796132_240.png 2,SEOM Clinical guidelines for the treatment of metastatic prostate cancer.,Clinical and Translational Oncology,,,Article,2014-10-16,10.1007/s12094-014-1225-3,,,,25319721,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2779232,https://api.altmetric.com/v1/donut/2779232_240.png 2,Modernizing the Diagnostic and Decision-Making Pathway for Prostate Cancer,Clinical Cancer Research,,,Article,2014-10-13,10.1158/1078-0432.ccr-14-0247,,,,25316814,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2777529,https://api.altmetric.com/v1/donut/2777529_240.png 2,Cost-effectiveness analysis of abiraterone and sipuleucel-T in asymptomatic metastatic castration-resistant prostate cancer.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2014-10-01,,,,,25313181,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2777414,https://api.altmetric.com/v1/donut/2777414_240.png 2,"Reply from Authors re: Francesco Montorsi, Giorgio Gandaglia. Sentinel Node Biopsy for Prostate Cancer: A Useless Surgical Exercise? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.08.052: Removing Nodes that Count Rather than Counting Nodes that Don’t",European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.10.005,,,,25440526,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2771413,https://api.altmetric.com/v1/donut/2771413_240.png 2,Short Hairpin RNA Library-Based Functional Screening Identified Ribosomal Protein L31 That Modulates Prostate Cancer Cell Growth via p53 Pathway,PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0108743,,,,25285958,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2749071,https://api.altmetric.com/v1/donut/2749071_240.png 2,"PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche",Journal of Translational Medicine,,,Article,2014-10-03,10.1186/s12967-014-0275-1,,,,25278011,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2741119,https://api.altmetric.com/v1/donut/2741119_240.png 2,Burden of skeletal-related events in prostate cancer: unmet need in pain improvement.,Supportive Care in Cancer,,,Article,2014-10-02,10.1007/s00520-014-2437-3,,,,25270847,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2734434,https://api.altmetric.com/v1/donut/2734434_240.png 2,Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2014-09-29,10.1073/pnas.1416498111,,,,25267627,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,1,0,0,44,https://www.altmetric.com/details/2731707,https://api.altmetric.com/v1/donut/2731707_240.png 2,Androgen Deprivation Therapy for Prostate Cancer Is Associated with Cardiovascular Morbidity and Mortality: A Meta-Analysis of Population-Based Observational Studies,PLoS ONE,,,Article,2014-09-29,10.1371/journal.pone.0107516,,,,25264674,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2727729,https://api.altmetric.com/v1/donut/2727729_240.png 2,Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.,Endocrine,,,Article,2007-08-22,,,,,17709901,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2721493,https://api.altmetric.com/v1/donut/2721493_240.png 2,Stereotactic ultrasound for target volume definition in a patient with prostate cancer and bilateral total hip replacement,Practical Radiation Oncology,,,Article,,10.1016/j.prro.2014.08.008,,,,25413396,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2718278,https://api.altmetric.com/v1/donut/2718278_240.png 2,Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy,Rheumatology International,,,Article,2014-03-11,10.1007/s00296-014-2977-3,,,,24615021,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2716376,https://api.altmetric.com/v1/donut/2716376_240.png 2,Professional recommendations against routine prostate cancer screening have little effect,ecancer.org,,,Article,,,,,http://ecancer.org/news/6355-professional-recommendations-against-routine-prostate-cancer-screening-have-little-effect.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2702757,https://api.altmetric.com/v1/donut/2702757_240.png 2,"Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.",Cancer (0008543X),,,Article,2014-06-25,10.1002/cncr.28809,,,,24965506,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2699237,https://api.altmetric.com/v1/donut/2699237_240.png 2,Certain form of baldness at age 45 linked to higher risk of aggressive prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6276-certain-form-of-baldness-at-age-45-linked-to-higher-risk-of-aggressive-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2686432,https://api.altmetric.com/v1/donut/2686432_240.png 2,Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.08.007,,,,25201464,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2674780,https://api.altmetric.com/v1/donut/2674780_240.png 2,The cistrome and gene signature of androgen receptor splice variants in castration-resistant prostate cancer cells.,The Journal of Urology,,,Article,2014-08-13,10.1016/j.juro.2014.08.043,,,,25132238,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/2667228,https://api.altmetric.com/v1/donut/2667228_240.png 2,Role of the Phospholipase A2 Receptor in Liposome Drug Delivery in Prostate Cancer Cells.,Molecular Pharmaceutics,,,Article,2014-09-04,10.1021/mp500174p,,,,25189995,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2660474,https://api.altmetric.com/v1/donut/2660474_240.png 2,MR-based Interventional Radiotherapy for Prostate Cancer: One Approach to Personalized Medicine,Journal of Medical Imaging & Radiation Sciences,,,Article,2014-01-06,10.1016/j.jmir.2014.03.012,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2658862,https://api.altmetric.com/v1/donut/2658862_240.png 2,Network analysis of ChIP-Seq data reveals key genes in prostate cancer.,European Journal of Medical Research,,,Article,2014-09-03,10.1186/s40001-014-0047-7,,,,25183411,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2652960,https://api.altmetric.com/v1/donut/2652960_240.png 2,External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer,Radiotherapy & Oncology,,,Article,2014-08-27,10.1016/j.radonc.2014.07.013,,,,25174299,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2646912,https://api.altmetric.com/v1/donut/2646912_240.png 2,Affecting African American Men's Prostate Cancer Screening Decision-making through a Mobile Tablet-Mediated Intervention.,Journal of health care for the poor and underserved (Online),,,Article,2014-08-19,10.1353/hpu.2014.0148,,,,25130238,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2615003,https://api.altmetric.com/v1/donut/2615003_240.png 2,Prostate cancer: PSA update[mdash]no change yet,Nature Reviews Urology,,,Article,2014-08-19,10.1038/nrurol.2014.210,,,,25134834,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2614968,https://api.altmetric.com/v1/donut/2614968_240.png 2,Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(R) treatment for prostate cancer - a case report,Radiation Oncology,,,Article,2014-08-20,10.1186/1748-717x-9-186,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2612969,https://api.altmetric.com/v1/donut/2612969_240.png 2,Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1.,Molecular Cancer Therapeutics,,,Article,,10.1158/1535-7163.mct-13-0405,,,,25122070,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2603024,https://api.altmetric.com/v1/donut/2603024_240.png 2,"Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.","Cancer Immunology, Immunotherapy",,,Article,2014-08-04,10.1007/s00262-014-1591-2,,,,25085000,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2593347,https://api.altmetric.com/v1/donut/2593347_240.png 2,The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer,Endocrine-Related Cancer,,,Article,2014-08-04,10.1530/erc-14-0217,,,,25096064,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2588183,https://api.altmetric.com/v1/donut/2588183_240.png 2,"Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis.",American Journal of Clinical Nutrition,,,Article,2014-05-31,10.3945/ajcn.113.071290,,,,24871471,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2584253,https://api.altmetric.com/v1/donut/2584253_240.png 2,In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2006-01-08,,,,,16835506,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2567599,https://api.altmetric.com/v1/donut/2567599_240.png 2,The role of PI3K/AKT-related PIP5K1? and the discovery of its selective inhibitor for treatment of advanced prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2014-07-28,10.1073/pnas.1405801111,,,,25071204,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2565055,https://api.altmetric.com/v1/donut/2565055_240.png 2,Current State of Practice Regarding Testosterone Supplementation Therapy in Men with Prostate Cancer.,Steroids,,,Article,2014-07-31,10.1016/j.steroids.2014.07.004,,,,25072793,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2563722,https://api.altmetric.com/v1/donut/2563722_240.png 2,"Establishment and Characterization of a Highly Tumorigenic African American Prostate Cancer Cell Line, E006AA-hT.",International Journal of Biological Sciences,,,Article,2014-01-01,10.7150/ijbs.9406,,,,25076860,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2562603,https://api.altmetric.com/v1/donut/2562603_240.png 2,Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate specific membrane antigen (PSMA).,Molecular Therapy,,,Article,2014-06-23,10.1038/mt.2014.117,,,,24954476,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2558047,https://api.altmetric.com/v1/donut/2558047_240.png 2,Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancer,The Prostate,,,Article,2014-07-24,10.1002/pros.22846,,,,25065737,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2540483,https://api.altmetric.com/v1/donut/2540483_240.png 2,Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error,British Journal of Cancer,,,Article,2014-07-17,10.1038/bjc.2014.396,,,,25032733,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2528944,https://api.altmetric.com/v1/donut/2528944_240.png 2,Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo.,Journal of Cancer Therapy,,,Article,2014-04-01,10.4236/jct.2014.54044,,,,24949215,PMC4060744,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2514117,https://api.altmetric.com/v1/donut/2514117_240.png 2,Concept and viability of androgen annihilation for advanced prostate cancer.,Cancer (0008543X),,,Article,2014-04-24,10.1002/cncr.28675,,,,24771515,,,,,,,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/2511828,https://api.altmetric.com/v1/donut/2511828_240.png 2,Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells,BMC Cancer,,,Article,2014-01-31,10.1186/1471-2407-14-52,,,,24484909,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2510033,https://api.altmetric.com/v1/donut/2510033_240.png 2,Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes,Patient related outcome measures,,,Article,2014-07-01,10.2147/prom.s52788,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2502430,https://api.altmetric.com/v1/donut/2502430_240.png 2,"miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer",Clinical Cancer Research,,,Article,2014-06-23,10.1158/1078-0432.ccr-14-0305,,,,24963047,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2463800,https://api.altmetric.com/v1/donut/2463800_240.png 2,Drug costs in the management of metastatic castration-resistant prostate cancer in Canada,BMC Health Services Research,,,Article,2014-06-13,10.1186/1472-6963-14-252,,,,24927758,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2451755,https://api.altmetric.com/v1/donut/2451755_240.png 2,From ASCO[mdash]prostate cancer: Chemohormonal therapy leads the way in prostate cancer,Nature Reviews Clinical Oncology,,,Article,2014-06-17,10.1038/nrclinonc.2014.106,,,,24935015,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2449516,https://api.altmetric.com/v1/donut/2449516_240.png 2,Delivery of EZH2-shRNA with mPEG-PEI nanoparticles for the treatment of prostate cancer in vitro,International Journal of Molecular Medicine,,,Article,2014-04-11,10.3892/ijmm.2014.1724,,,,24714818,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/2446607,https://api.altmetric.com/v1/donut/2446607_240.png 2,Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79 000 women.,Human Molecular Genetics,,,Article,2014-06-06,10.1093/hmg/ddu223,,,,24895409,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2411868,https://api.altmetric.com/v1/donut/2411868_240.png 2,IGF-1 and prostate cancer.,Novartis Foundation symposium,,,Article,2004-11-26,,,,,15562830,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,1,7,https://www.altmetric.com/details/2404704,https://api.altmetric.com/v1/donut/2404704_240.png 2,Association of Colorectal Cancer and Prostate Cancer and Impact of Radiation Therapy,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-01-01,10.1158/1055-9965.epi-09-0241,,,,19531678,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2392087,https://api.altmetric.com/v1/donut/2392087_240.png 2,MSMB variation and prostate cancer risk: Clues towards a possible fungal etiology.,The Prostate,,,Article,2014-01-29,10.1002/pros.22778,,,,24464504,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2381811,https://api.altmetric.com/v1/donut/2381811_240.png 2,"Seasonality pattern of breast, colorectal, and prostate cancer is dependent on latitude",Medical science monitor international medical journal of experimental and clinical research,,,Article,2014-05-20,10.12659/msm.890062,,,,24835144,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2379764,https://api.altmetric.com/v1/donut/2379764_240.png 2,A randomized trial of diet in men with early stage prostate cancer on active surveillance: Rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]).,Contemporary Clinical Trials,,,Article,2014-05-21,10.1016/j.cct.2014.05.002,,,,24837543,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2377621,https://api.altmetric.com/v1/donut/2377621_240.png 2,Prostate tumor growth is impaired by CtBP1 depletion in high fat diet fed mice.,Clinical Cancer Research,,,Article,2014-05-18,10.1158/1078-0432.ccr-14-0322,,,,24842953,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2364677,https://api.altmetric.com/v1/donut/2364677_240.png 2,Can MRI replace serial biopsies in men on active surveillance for prostate cancer?,Current Opinion in Urology,,,Article,2014-05-01,10.1097/mou.0000000000000040,,,,24614348,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2341393,https://api.altmetric.com/v1/donut/2341393_240.png 2,Defining Young in the Context of Prostate Cancer,American Journal of Men's Health,,,Article,2014-04-28,10.1177/1557988314529991,,,,24780936,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2315848,https://api.altmetric.com/v1/donut/2315848_240.png 2,Detectable Prostate-Specific Antigen Nadir During Androgen-Deprivation Therapy Predicts Adverse Prostate Cancer–Specific Outcomes: Results from the SEARCH Database,European Urology,,,Article,2014-03-01,10.1016/j.eururo.2012.11.052,,,,23245686,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2312140,https://api.altmetric.com/v1/donut/2312140_240.png 2,Psychosocial interventions to support partners of men with prostate cancer: a systematic and critical review of the literature,Journal of Cancer Survivorship,,,Article,2014-04-22,10.1007/s11764-014-0361-7,,,,24752701,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2309515,https://api.altmetric.com/v1/donut/2309515_240.png 2,Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis,British Journal of Cancer,,,Article,2014-04-15,10.1038/bjc.2014.197,,,,24736585,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2286454,https://api.altmetric.com/v1/donut/2286454_240.png 2,Identifying how and for whom cognitive-behavioral stress management improves emotional well-being among recent prostate cancer survivors.,Psycho-Oncology,,,Article,2013-01-01,10.1002/pon.2074,,,,21932396,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2283701,https://api.altmetric.com/v1/donut/2283701_240.png 2,Management of low risk prostate cancer: active surveillance and focal therapy,Current Opinion in Urology,,,Article,2014-04-10,10.1097/mou.0000000000000055,,,,24710055,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2281687,https://api.altmetric.com/v1/donut/2281687_240.png 2,High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.03.278,,,,24726733,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2278281,https://api.altmetric.com/v1/donut/2278281_240.png 2,"Serum IgE and risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-04-09,10.1158/1055-9965.epi-13-1359,,,,24718282,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2273005,https://api.altmetric.com/v1/donut/2273005_240.png 2,Surgical Quality Is More Than Volume: The Association between Changing Urologists and Complications for Patients with Localized Prostate Cancer,Health Services Research,,,Article,2014-01-24,10.1111/1475-6773.12148,,,,24461049,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2267674,https://api.altmetric.com/v1/donut/2267674_240.png 2,Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer,PLoS ONE,,,Article,2014-03-26,10.1371/journal.pone.0092478,,,,24658061,,,,,,,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2248699,https://api.altmetric.com/v1/donut/2248699_240.png 2,Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.,The Prostate,,,Article,2013-12-19,10.1002/pros.22765,,,,24338986,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2237360,https://api.altmetric.com/v1/donut/2237360_240.png 2,Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 as Predictors of Advanced-Stage Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2002-01-01,10.1093/jnci/94.14.1099,,,,12122101,,,,,,,0,0,0,0,0,0,2,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/2236063,https://api.altmetric.com/v1/donut/2236063_240.png 2,Prognosis Related to Metastatic Burden Measured by 18F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.,Journal of Nuclear Medicine,,,Article,2014-03-31,10.2967/jnumed.113.135194,,,,24676753,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2235062,https://api.altmetric.com/v1/donut/2235062_240.png 2,Racial Disparities in Survival for Patients With Clinically Localized Prostate Cancer Adjusted for Treatment Effects,Mayo Clinic Proceedings,,,Article,,10.1016/j.mayocp.2013.11.001,,,,24582189,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2203614,https://api.altmetric.com/v1/donut/2203614_240.png 2,Intracellular Propionibacterium acnes Infection in Glandular Epithelium and Stromal Macrophages of the Prostate with or without Cancer,PLoS ONE,,,Article,2014-02-28,10.1371/journal.pone.0090324,,,,24587325,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2199108,https://api.altmetric.com/v1/donut/2199108_240.png 2,A novel randomised controlled trial design in prostate cancer,British Journal of Urology,,,Article,2014-03-14,10.1111/bju.12735,,,,24628741,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2185190,https://api.altmetric.com/v1/donut/2185190_240.png 2,Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer,Molecular Cancer,,,Article,2014-03-12,10.1186/1476-4598-13-55,,,,24618337,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/2177902,https://api.altmetric.com/v1/donut/2177902_240.png 2,"Health behaviors among breast, prostate, and colorectal cancer survivors: a US population-based case-control study, with comparisons by cancer type and gender",Journal of Cancer Survivorship,,,Article,2014-02-16,10.1007/s11764-014-0347-5,,,,24532045,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2175642,https://api.altmetric.com/v1/donut/2175642_240.png 2,Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2014-03-03,10.1073/pnas.1322198111,,,,24591637,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2162117,https://api.altmetric.com/v1/donut/2162117_240.png 2,"In Silico Functional Profiling of Individual Prostate Cancer Tumors: Many Genes, Few Functions",Cancer Genomics & Proteomics,,,Article,1970-01-01,,,,,22593245,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2153670,https://api.altmetric.com/v1/donut/2153670_240.png 2,A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom.,Journal of Medical Economics,,,Article,,10.3111/13696998.2014.893240,,,,24568188,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2146246,https://api.altmetric.com/v1/donut/2146246_240.png 2,Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer,Medical Hypotheses,,,Article,2014-02-18,10.1016/j.mehy.2014.01.016,,,,24548754,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/2133546,https://api.altmetric.com/v1/donut/2133546_240.png 2,Serum testosterone improves the accuracy of Prostate Health Index for the detection of prostate cancer,Clinical Biochemistry,,,Article,,10.1016/j.clinbiochem.2014.02.002,,,,24530341,,,,,,,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/2127685,https://api.altmetric.com/v1/donut/2127685_240.png 2,The Lethal Clone in Prostate Cancer: Redefining the Index,European Urology,,,Article,2014-09-01,10.1016/j.eururo.2013.12.052,,,,24411284,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2125134,https://api.altmetric.com/v1/donut/2125134_240.png 2,"Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer",European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.12.003,,,,24373479,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,77,https://www.altmetric.com/details/2125087,https://api.altmetric.com/v1/donut/2125087_240.png 2,Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.07.032,,,,23916692,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2124816,https://api.altmetric.com/v1/donut/2124816_240.png 2,ERG Rearrangement Is Associated with Prostate Cancer-Related Death in Chinese Prostate Cancer Patients,PLoS ONE,,,Article,2014-02-07,10.1371/journal.pone.0084959,,,,24516518,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2108172,https://api.altmetric.com/v1/donut/2108172_240.png 2,Castration-resistant prostate cancer: Adaptive responses in the androgen axis,Cancer Treatment Reviews,,,Article,2013-01-01,10.1016/j.ctrv.2013.09.011,,,,24139549,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2072052,https://api.altmetric.com/v1/donut/2072052_240.png 2,Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium,Free Radical Research,,,Article,2014-01-21,10.3109/10715762.2013.875168,,,,24437375,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2069114,https://api.altmetric.com/v1/donut/2069114_240.png 2,TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo,Scientific Reports,,,Article,2014-01-17,10.1038/srep03739,,,,24435307,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2051157,https://api.altmetric.com/v1/donut/2051157_240.png 2,ERR? augments HIF?1 signaling by directly interacting with HIF?1? in normoxic and hypoxic prostate cancer cells,The Journal of Pathology,,,Article,2014-02-05,10.1002/path.4329,,,,24425001,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2044488,https://api.altmetric.com/v1/donut/2044488_240.png 2,The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer.,Supportive Care in Cancer,,,Article,2013-10-03,10.1007/s00520-013-1989-y,,,,24197054,,1893/20102,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2042051,https://api.altmetric.com/v1/donut/2042051_240.png 2,"NAD+ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study",Radiotherapy & Oncology,,,Article,2014-01-10,10.1016/j.radonc.2013.10.039,,,,24412016,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2041986,https://api.altmetric.com/v1/donut/2041986_240.png 2,Is prostate cancer changing?: Evolving patterns of metastatic castration?resistant prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28494,,,,25302607,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2034290,https://api.altmetric.com/v1/donut/2034290_240.png 2,Metabolomic profiling identifies biochemical pathways associated with castrate resistant prostate cancer,Journal of Proteome Research,,,Article,2013-12-20,10.1021/pr401106h,,,,24359151,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2013307,https://api.altmetric.com/v1/donut/2013307_240.png 2,Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter,Asian Journal of Andrology,,,Article,,10.4103/1008-682x.122354,,,,24369144,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2009558,https://api.altmetric.com/v1/donut/2009558_240.png 2,Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer.,Urologic Oncology,,,Article,2013-12-06,10.1016/j.urolonc.2013.09.004,,,,24321259,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1972339,https://api.altmetric.com/v1/donut/1972339_240.png 2,Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?,The Prostate,,,Article,2013-11-22,10.1002/pros.22757,,,,24265090,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1967255,https://api.altmetric.com/v1/donut/1967255_240.png 2,"Biomarkers in prostate cancer surveillance and screening: past, present, and future.",Therapeutic Advances in Urology,,,Article,2013-12-01,10.1177/1756287213495915,,,,24294290,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/1966582,https://api.altmetric.com/v1/donut/1966582_240.png 2,Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.,Cancer Causes and Control,,,Article,2013-12-06,10.1007/s10552-013-0306-x,,,,24310109,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1965125,https://api.altmetric.com/v1/donut/1965125_240.png 2,"Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan.",The Prostate,,,Article,2013-11-20,10.1002/pros.22754,,,,24259155,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1965095,https://api.altmetric.com/v1/donut/1965095_240.png 2,Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study.,Canadian Urological Association Journal,,,Article,2013-11-01,10.5489/cuaj.235,,,,24282459,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1942443,https://api.altmetric.com/v1/donut/1942443_240.png 2,alpha-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway,Molecular Cancer,,,Article,2013-11-22,10.1186/1476-4598-12-147,,,,24261856,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1926989,https://api.altmetric.com/v1/donut/1926989_240.png 2,Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.,Inflammopharmacology,,,Article,2013-10-01,10.1007/s10787-013-0183-7,,,,23918298,,,,,,,0,0,0,1,1,0,0,0,0,0,1,0,0,0,0,28,https://www.altmetric.com/details/1914334,https://api.altmetric.com/v1/donut/1914334_240.png 2,Potency preservation following stereotactic body radiation therapy for prostate cancer,Radiation Oncology,,,Article,2013-11-01,10.1186/1748-717x-8-256,,,,24180317,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1877386,https://api.altmetric.com/v1/donut/1877386_240.png 2,"MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells.",Oncogene,,,Article,2013-10-28,10.1038/onc.2013.451,,,,24166498,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1873942,https://api.altmetric.com/v1/donut/1873942_240.png 2,Prostate cancer: optimizing exercise interventions for men on ADT.,Nature Reviews Urology,,,Article,2013-10-22,10.1038/nrurol.2013.245,,,,24145472,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1873871,https://api.altmetric.com/v1/donut/1873871_240.png 2,Radium-223 in Prostate Cancer,New England Journal of Medicine,,,Article,2013-10-24,10.1056/nejmc1310231,,,,24152265,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1862764,https://api.altmetric.com/v1/donut/1862764_240.png 2,Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways.,Cell Death & Disease,,,Article,2013-01-01,10.1038/cddis.2013.406,,,,24157872,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1861316,https://api.altmetric.com/v1/donut/1861316_240.png 2,Non-coding RNAs in Prostate Cancer: the Long and the Short of it,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1989,,,,24146262,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1851806,https://api.altmetric.com/v1/donut/1851806_240.png 2,Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1763,,,,24141628,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1843582,https://api.altmetric.com/v1/donut/1843582_240.png 2,The interplay of AMP?activated protein kinase and androgen receptor in prostate cancer cells,Journal of Cellular Physiology,,,Article,2013-10-14,10.1002/jcp.24494,,,,24129850,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1827644,https://api.altmetric.com/v1/donut/1827644_240.png 2,Pathogenic Intestinal Bacteria Enhance Prostate Cancer Development via Systemic Activation of Immune Cells in Mice.,PLoS ONE,"SKYHOPPER, Leia",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-08-26,10.1371/journal.pone.0073933,,,,23991210,PMC3753256,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1800892,https://api.altmetric.com/v1/donut/1800892_240.png 2,"Spirituality in Men With Advanced Prostate Cancer: ""It's a Holistic Thing . . . It's a Package""",Journal of holistic nursing (Online),,,Article,2013-09-30,10.1177/0898010113504492,,,,24080341,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1798200,https://api.altmetric.com/v1/donut/1798200_240.png 2,Correction: PTK6 Activation at the Membrane Regulates Epithelial–Mesenchymal Transition in Prostate Cancer,Cancer Research,,,Article,,10.1158/0008-5472.can-13-2555,,,,24062314,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1797188,https://api.altmetric.com/v1/donut/1797188_240.png 2,Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization|[mdash]|a correlative study with urine PCA3 and TMPRSS2-ERG,Modern Pathology,,,Article,2013-09-27,10.1038/modpathol.2013.169,,,,24072184,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1786891,https://api.altmetric.com/v1/donut/1786891_240.png 2,Somatic copy number alterations by whole exome sequencing implicates YWHAZ and PTK2 in castrationâ??resistant prostate cancer,The Journal of Pathology,,,Article,2013-01-01,10.1002/path.4274,,,,24114522,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1776232,https://api.altmetric.com/v1/donut/1776232_240.png 2,Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer,Radiation Oncology,,,Article,2013-09-23,10.1186/1748-717x-8-221,,,,24053357,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1775431,https://api.altmetric.com/v1/donut/1775431_240.png 2,New gene biomarker identified for indolent prostate cancer,Lancet Oncology,,,Article,,10.1016/s1470-2045(13)70431-5,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1769464,https://api.altmetric.com/v1/donut/1769464_240.png 2,Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases,Histopathology,,,Article,2013-10-11,10.1111/his.12262,,,,24118022,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1710446,https://api.altmetric.com/v1/donut/1710446_240.png 2,Use of EORTC Target Definition Guidelines for Dose-Intensified Salvage Radiation Therapy for Recurrent Prostate Cancer: Results of the Quality Assurance Program of the Randomized Trial SAKK 09/10,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-08-23,10.1016/j.ijrobp.2013.06.2053,,,,23972722,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1706448,https://api.altmetric.com/v1/donut/1706448_240.png 2,Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer,Genome Research,,,Article,2013-01-01,10.1101/gr.151340.112,,,,23940108,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1685010,https://api.altmetric.com/v1/donut/1685010_240.png 2,Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells,Cell Death & Disease,,,Article,2013-08-01,10.1038/cddis.2013.285,,,,23928700,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1683294,https://api.altmetric.com/v1/donut/1683294_240.png 2,PSA enzymatic activity: A new biomarker for assessing prostate cancer aggressiveness,The Prostate,,,Article,2013-01-01,10.1002/pros.22714,,,,23934862,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1682278,https://api.altmetric.com/v1/donut/1682278_240.png 2,A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer,Nuclear Medicine Communications,,,Article,2013-07-30,10.1097/mnm.0b013e328364918a,,,,23903557,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1662902,https://api.altmetric.com/v1/donut/1662902_240.png 2,PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-13-0443,,,,23856248,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1639513,https://api.altmetric.com/v1/donut/1639513_240.png 2,Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells,Cancer Research,,,Article,2010-03-12,10.1158/0008-5472.can-09-2782,,,,20215500,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/1634707,https://api.altmetric.com/v1/donut/1634707_240.png 2,Molecular Classification of Prostate Cancer Progression: Foundation for Marker-Driven Treatment of Prostate Cancer,Cancer Discovery,,,Article,2013-07-04,10.1158/2159-8290.cd-12-0460,,,,23811619,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1634613,https://api.altmetric.com/v1/donut/1634613_240.png 2,Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men,Scientific Reports,,,Article,2013-06-24,10.1038/srep02059,,,,23792811,PMC3690389,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1579103,https://api.altmetric.com/v1/donut/1579103_240.png 2,Clinical Trial Risk in Castration Resistant Prostate Cancer: Immunotherapies Show Promise.,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12309,,,,24053150,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1574283,https://api.altmetric.com/v1/donut/1574283_240.png 2,New therapeutics to treat castrate-resistant prostate cancer.,The Scientific World Journal,,,Article,2013-01-01,10.1155/2013/379641,,,,23781155,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1571181,https://api.altmetric.com/v1/donut/1571181_240.png 2,"Basic Research in Prostate Cancer, Kidney Cancer, Urinary Incontinence, Pediatric Urology and Erectile Dysfunction",International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2013.02.01,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1561169,https://api.altmetric.com/v1/donut/1561169_240.png 2,Head-to-Head Comparison of Prostate Health Index and Urinary Prostate Cancer Antigen 3 in Predicting the Presence of Cancer at Initial or Repeat Biopsy.,The Journal of Urology,,,Article,2013-03-09,10.1016/j.juro.2013.02.3184,,,,23466239,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1549849,https://api.altmetric.com/v1/donut/1549849_240.png 2,Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.,Cancer Causes and Control,,,Article,2013-05-26,10.1007/s10552-013-0230-0,,,,23702885,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1515556,https://api.altmetric.com/v1/donut/1515556_240.png 2,Incidental 11C-Choline PET/CT Brain Uptake due to Meningioma in a Patient Studied for Prostate Cancer: Correlation With MRI and Imaging Fusion.,Clinical Nuclear Medicine,,,Article,2013-03-21,10.1097/rlu.0b013e31827a22f7,,,,23698517,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1505685,https://api.altmetric.com/v1/donut/1505685_240.png 2,HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer,Investigational New Drugs,,,Article,2013-04-23,10.1007/s10637-013-9960-9,,,,23609828,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1450946,https://api.altmetric.com/v1/donut/1450946_240.png 2,Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer,"Cancer Immunology, Immunotherapy",,,Article,2012-08-03,10.1007/s00262-012-1317-2,,,,22865266,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1438158,https://api.altmetric.com/v1/donut/1438158_240.png 2,WAPC | Prostate Cancer Awareness | Prostate Cancer SupportGroups,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/take-action-prostate-cancer-awareness/,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1424200,https://api.altmetric.com/v1/donut/1424200_240.png 2,Recurrent Gene Fusions in Prostate Cancer: Their Clinical Implications and Uses,Current Urology Reports,,,Article,2013-04-28,10.1007/s11934-013-0321-1,,,,23625457,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1423212,https://api.altmetric.com/v1/donut/1423212_240.png 2,Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11639.x,,,,23464862,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1415133,https://api.altmetric.com/v1/donut/1415133_240.png 2,Polyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancer,Frontiers in Pharmacology,,,Article,2013-01-01,10.3389/fphar.2013.00029,,,,23531917,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1319356,https://api.altmetric.com/v1/donut/1319356_240.png 2,Prostate cancer prevention: strategies for agent development.,Current opinion in oncology,,,Article,2013-03-20,10.1097/cco.0b013e32835fc8d4,,,,23518594,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1317287,https://api.altmetric.com/v1/donut/1317287_240.png 2,"Probability, uncertainty, and prostate cancer.",Annals of Internal Medicine,,,Article,2013-02-07,10.7326/0003-4819-158-3-201302050-00012,,,,23381041,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1313381,https://api.altmetric.com/v1/donut/1313381_240.png 2,Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin.,Journal of Nuclear Medicine,,,Article,2013-03-14,10.2967/jnumed.112.112169,,,,23492884,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1305110,https://api.altmetric.com/v1/donut/1305110_240.png 2,Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?,Radiology,,,Article,2013-01-01,10.1148/radiol.13121325,,,,23468576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,53,https://www.altmetric.com/details/1285890,https://api.altmetric.com/v1/donut/1285890_240.png 2,"Differences in survival from prostate cancer in Denmark, Iceland and Sweden",European Journal of Cancer (1965),,,Article,2013-03-04,10.1016/j.ejca.2013.01.008,,,,23453749,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1277891,https://api.altmetric.com/v1/donut/1277891_240.png 2,Oestrogen patches could offer a new treatment option for prostate cancer patients,ecancer.org,,,Article,,,,,http://ecancer.org/news/3877-oestrogen-patches-could-offer-a-new-treatment-option-for-prostate-cancer-patients.php,,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1277617,https://api.altmetric.com/v1/donut/1277617_240.png 2,Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity,Nature Cell Biology,,,Article,2013-02-24,10.1038/ncb2697,,,,23434823,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1265374,https://api.altmetric.com/v1/donut/1265374_240.png 2,Suppression of DHTâ??induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells,The Prostate,,,Article,2013-01-01,10.1002/pros.22654,,,,23423946,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1251853,https://api.altmetric.com/v1/donut/1251853_240.png 2,Towards an understanding of the genetic basis of prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2853-towards-an-understanding-of-the-genetic-basis-of-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251414,https://api.altmetric.com/v1/donut/1251414_240.png 2,Finasteride and quality of life in prostate cancer patients.,ecancer.org,,,Article,,,,,http://ecancer.org/news/3369-finasteride-and-quality-of-life-in-prostate-cancer-patients.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251390,https://api.altmetric.com/v1/donut/1251390_240.png 2,AACR 2012: Baseline hormone levels appear to predict survival in metastatic castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2688-aacr-2012--baseline-hormone-levels-appear-to-predict-survival-in-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251184,https://api.altmetric.com/v1/donut/1251184_240.png 2,AACR 2012: Excess body weight associated with increased risk of recurrence after treatment for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2684-aacr-2012--excess-body-weight-associated-with-increased-risk-of-recurrence-after-treatment-for-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251179,https://api.altmetric.com/v1/donut/1251179_240.png 2,Noninvasive assay monitored treatment response in patients with metastatic prostate cancer .,ecancer.org,,,Article,,,,,http://ecancer.org/news/3482-noninvasive-assay-monitored-treatment-response-in-patients-with-metastatic-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251168,https://api.altmetric.com/v1/donut/1251168_240.png 2,Model confirms active surveillance as viable option for men with low-risk prostate cancer.,ecancer,,,Article,,,,,http://ecancer.org/news/3400-model-confirms-active-surveillance-as-viable-option-for-men-with-low-risk-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251064,https://api.altmetric.com/v1/donut/1251064_240.png 2,Cancer Research UK welcomes prostate cancer drug approval inWales . ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/2486-cancer-research-uk-welcomes-prostate-cancer-drug-approval-in-wales.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250954,https://api.altmetric.com/v1/donut/1250954_240.png 2,Translating the role of mTOR signalling in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2476-translating-the-role-of-mtor-signalling-in-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250951,https://api.altmetric.com/v1/donut/1250951_240.png 2,Stop-start hormone therapy better than continual hormone therapy for prostate cancer.,ecancer.org,,,Article,,,,,http://ecancer.org/news/3351-stop-start-hormone-therapy-better-than-continual-hormone-therapy-for-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250702,https://api.altmetric.com/v1/donut/1250702_240.png 2,Phase 3 trial confirms abiraterone acetate efficacy for patients with advanced prostate cancer.,ecancer.org,,,Article,,,,,http://ecancer.org/news/3379-phase-3-trial-confirms-abiraterone-acetate-efficacy-for-patients-with-advanced-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250698,https://api.altmetric.com/v1/donut/1250698_240.png 2,Protein Kinase D1 Inhibits Cell Proliferation through Matrix Metalloproteinase (MMP) -2 and -9 Secretion in Prostate Cancer,Cancer Research,,,Article,1970-01-01,10.1158/0008-5472.can-09-4155,,,,20160036,PMC3197700,,,,,,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1245168,https://api.altmetric.com/v1/donut/1245168_240.png 2,(n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers.,Journal of Nutrition,,,Article,2007-01-01,,,,,17585037,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1223172,https://api.altmetric.com/v1/donut/1223172_240.png 2,Experience with degarelix in the treatment of prostate cancer.,Therapeutic Advances in Urology,,,Article,2013-02-02,10.1177/1756287212461048,,,,23372607,PMC3547532,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1216799,https://api.altmetric.com/v1/donut/1216799_240.png 2,Men|[rsquo]|s preferences for prostate cancer screening: a discrete choice experiment,British Journal of Cancer,,,Article,2013-01-29,10.1038/bjc.2013.5,,,,23361056,,1959.8/160961,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1212905,https://api.altmetric.com/v1/donut/1212905_240.png 2,Bone Metastases from Prostate Cancer: 18F-Fluoride PET/CT in a Patient With Discordant Bone Scintigraphy and 11C-Choline PET/CT,Clinical Nuclear Medicine,,,Article,2013-02-01,10.1097/rlu.0b013e31827a20d3,,,,23334127,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1206809,https://api.altmetric.com/v1/donut/1206809_240.png 2,"Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen-deprivation therapy (ADT) for prostate cancer.",British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11777.x,,,,23351062,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1198225,https://api.altmetric.com/v1/donut/1198225_240.png 2,Re: Impact of Age and Comorbidities on Long-Term Survival of Patients with High-Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Competing-Risks Analysis,The Journal of Urology,,,Article,2013-01-23,10.1016/j.juro.2012.11.132,,,,23394638,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1193188,https://api.altmetric.com/v1/donut/1193188_240.png 2,High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2013-01-22,10.1038/pcan.2012.50,,,,23338556,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1189826,https://api.altmetric.com/v1/donut/1189826_240.png 2,Hypnosis in oncological patients: a psychossomatic study on prostate cancer patients,Psico-USF,,,Article,2012-01-01,10.1590/s1413-82712012000100016,,,,,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1182936,https://api.altmetric.com/v1/donut/1182936_240.png 2,Active surveillance: Does serial prostate biopsy increase histological inflammation|[quest]|,Prostate Cancer & Prostatic Diseases,,,Article,2013-01-15,10.1038/pcan.2012.51,,,,23318528,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1176586,https://api.altmetric.com/v1/donut/1176586_240.png 2,Rapid and Specific Electrochemical Detection of Prostate Cancer Cells Using an Aperture Sensor Array,Lab on a Chip - Miniaturisation for Chemistry & Biology,,,Article,2013-01-01,10.1039/c2lc41049d,,,,23334685,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1156437,https://api.altmetric.com/v1/donut/1156437_240.png 2,Effects of post biopsy digital rectal compression on improving prostate cancer staging using magnetic resonance imaging in localized prostate cancer.,Yonsei Medical Journal,,,Article,2012-12-13,10.3349/ymj.2013.54.1.81,,,,23225802,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1138740,https://api.altmetric.com/v1/donut/1138740_240.png 2,PRT versus IMRT Toxicity in Medicare Beneficiaries with Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djs639,,,,,,,,,,,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1138116,https://api.altmetric.com/v1/donut/1138116_240.png 2,Testosterone Therapy in Men With Prostate Cancer: Scientific and Ethical Considerations,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.11.028,,,,23234627,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1130709,https://api.altmetric.com/v1/donut/1130709_240.png 2,Prostate cancer: Third time lucky? Dutasteride for tertiary prevention of prostate cancer,Nature Reviews Urology,,,Article,2012-12-11,10.1038/nrurol.2012.241,,,,23229506,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1122459,https://api.altmetric.com/v1/donut/1122459_240.png 2,Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [?2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer,Clinical Chemistry,,,Article,2013-01-01,10.1373/clinchem.2012.195560,,,,23213079,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1110328,https://api.altmetric.com/v1/donut/1110328_240.png 2,CMDX(C)-based single source information system for simplified quality management and clinical research in prostate cancer,BMC Medical Informatics and Decision Making,,,Article,2012-12-03,10.1186/1472-6947-12-141,,,,23206574,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1108514,https://api.altmetric.com/v1/donut/1108514_240.png 2,Akt Mediates Metastasis-Associated Gene 1 (MTA1) Regulating the Expression of E-cadherin and Promoting the Invasiveness of Prostate Cancer Cells,PLoS ONE,,,Article,2012-12-05,10.1371/journal.pone.0046888,,,,23227138,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1108098,https://api.altmetric.com/v1/donut/1108098_240.png 2,The Long and Winding Road to FDA Approval of a Novel Prostate Cancer Test: Our Story,Clinical Chemistry,,,Article,2012-11-28,10.1373/clinchem.2012.198739,,,,23193060,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1096173,https://api.altmetric.com/v1/donut/1096173_240.png 2,Putative role of serum insulin-like growth factor|[ndash]|1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men,Prostate Cancer & Prostatic Diseases,,,Article,2005-03-01,10.1038/sj.pcan.4500783,,,,15775992,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1092724,https://api.altmetric.com/v1/donut/1092724_240.png 2,Expression of MicroRNAs associated with Gleason grading system in prostate cancer: miRâ??182â??5p is a useful marker for high grade prostate cancer,The Prostate,,,Article,2012-01-01,10.1002/pros.22626,,,,23184537,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1090448,https://api.altmetric.com/v1/donut/1090448_240.png 2,Preventing bone complications in prostate cancer,Current Opinion in Supportive and Palliative Care,,,Article,2012-09-01,10.1097/spc.0b013e328356da87,,,,22871982,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1087335,https://api.altmetric.com/v1/donut/1087335_240.png 2,Metabolic syndrome and lower urinary tract symptoms: the role of inflammation,Prostate Cancer & Prostatic Diseases,,,Article,2012-11-20,10.1038/pcan.2012.44,,,,23165431,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1078632,https://api.altmetric.com/v1/donut/1078632_240.png 2,A Possible Role for Perforin and Granzyme B in Resveratrol-Enhanced Radiosensitivity of Prostate Cancer,The Journal of Andrology,,,Article,2012-01-01,10.2164/jandrol.111.015164,,,,22096086,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1068132,https://api.altmetric.com/v1/donut/1068132_240.png 2,"Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.",European Journal of Cancer (1965),,,Article,2012-10-15,10.1016/j.ejca.2012.09.030,,,,23079475,,,,,,,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1066977,https://api.altmetric.com/v1/donut/1066977_240.png 2,Prostate cancer: Time for active surveillance of intermediate-risk disease?,Nature Reviews Urology,,,Article,2012-11-13,10.1038/nrurol.2012.213,,,,23147924,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1066569,https://api.altmetric.com/v1/donut/1066569_240.png 2,"MicroRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications and AKT pathways.",Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-2952,,,,23147995,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1063953,https://api.altmetric.com/v1/donut/1063953_240.png 2,Is Undetectable Prostate-Specific Antigen Always Reliable to Rule Out Prostate Cancer Recurrence After Radical Prostatectomy?,Journal of Clinical Oncology,,,Article,2012-10-05,10.1200/jco.2012.43.1767,,,,23032622,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1056878,https://api.altmetric.com/v1/donut/1056878_240.png 2,Pre-biopsy Magnetic Resonance Imaging and prostate cancer detection: comparison of random and MRI-targeted biopsies using three different techniques of MRI-TRUS image registration,The Journal of Urology,,,Article,2012-10-31,10.1016/j.juro.2012.08.195,,,,22982424,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/1033518,https://api.altmetric.com/v1/donut/1033518_240.png 2,Active surveillance beats surgery in low-risk prostate cancer,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70454-0,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/993472,https://api.altmetric.com/v1/donut/993472_240.png 2,Detection of Tumor Markers in Prostate Cancer and Comparison of Sensitivity between Real Time and Nested PCR.,Kobe journal of medical sciences,,,Article,2012-09-15,,,,,22972169,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/955327,https://api.altmetric.com/v1/donut/955327_240.png 2,Anogenital distance and the risk of prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11516.x,,,,22984847,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/952986,https://api.altmetric.com/v1/donut/952986_240.png 2,Measures of combined antioxidant and pro-oxidant exposures and risk of overall and advanced stage prostate cancer,Annals of Epidemiology,,,Article,2012-09-01,10.1016/j.annepidem.2012.07.010,,,,22986088,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/947815,https://api.altmetric.com/v1/donut/947815_240.png 2,The in Vivo Role of Androgen Receptor SUMOylation as Revealed by Androgen Insensitivity Syndrome and Prostate Cancer Mutations Targeting the Proline/Glycine Residues of Synergy Control Motifs,Journal of Biological Chemistry,,,Article,2012-01-01,10.1074/jbc.m112.395210,,,,22829593,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,6,https://www.altmetric.com/details/935172,https://api.altmetric.com/v1/donut/935172_240.png 2,PROSTATE CANCER TREATMENT: THE TIMES THEY ARE A' CHANGIN',British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11441.x,,,,22937730,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/927233,https://api.altmetric.com/v1/donut/927233_240.png 2,Molecular Pathogenesis and Prevention of Prostate Cancer,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,15160993,,,,,,,0,0,0,2,0,0,4,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/926400,https://api.altmetric.com/v1/donut/926400_240.png 2,Polyâ??gene fusion transcripts and chromothripsis in prostate cancer,"Genes, Chromosomes, and Cancer",,,Article,2012-01-01,10.1002/gcc.21999,,,,22927308,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/915300,https://api.altmetric.com/v1/donut/915300_240.png 2,"Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma.",Cancer Management and Research,,,Article,2012-08-01,10.2147/cmar.s35342,,,,22977312,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/913537,https://api.altmetric.com/v1/donut/913537_240.png 2,Association of Serum YKL-40 Level with Tumor Burden and Metastatic Stage of Prostate Cancer.,Urology Journal,,,Article,2012-08-22,,,,,22903479,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/912770,https://api.altmetric.com/v1/donut/912770_240.png 2,Racial Variation in the Quality of Surgical Care for Prostate Cancer,The Journal of Urology,"EVERDEEN, Katie",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-08-17,10.1016/j.juro.2012.06.037,,,,22902011,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/909047,https://api.altmetric.com/v1/donut/909047_240.png 2,Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?,Frontiers in oncology,,,Article,2011-01-01,10.3389/fonc.2011.00049,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/905636,https://api.altmetric.com/v1/donut/905636_240.png 2,Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study,Prostate Cancer & Prostatic Diseases,,,Article,2012-08-14,10.1038/pcan.2012.29,,,,22890389,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/886723,https://api.altmetric.com/v1/donut/886723_240.png 2,Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer,Radiation Oncology,,,Article,2012-08-13,10.1186/1748-717x-7-139,,,,22889144,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/885557,https://api.altmetric.com/v1/donut/885557_240.png 2,Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy.,Urology Journal,,,Article,2012-05-31,,,,,22641493,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/883725,https://api.altmetric.com/v1/donut/883725_240.png 2,Biopolymer-directed Synthesis of High-surface-area Magnetite Colloidal Nanocrystal Clusters for Dual Drug Delivery in Prostate Cancer,Journal of Materials Chemistry,,,Article,2012-01-01,10.1039/c2jm34877b,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/872419,https://api.altmetric.com/v1/donut/872419_240.png 2,Correction: Identification and Characterization of Nuclease-Stabilized RNA Molecules That Bind Human Prostate Cancer Cells via the Prostate-Specific Membrane Antigen,Cancer Research,,,Article,2002-01-01,10.1158/0008-5472.can-12-2152,,,,22815526,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/866947,https://api.altmetric.com/v1/donut/866947_240.png 2,Prostate cancer - the role of magnetic resonance imaging.,Biomedical Papers of the Medical Faculty of Palacky University in Olomouc,,,Article,2012-06-01,10.5507/bp.2012.025,,,,22837130,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/860917,https://api.altmetric.com/v1/donut/860917_240.png 2,Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-12-0283,,,,22815528,,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/860149,https://api.altmetric.com/v1/donut/860149_240.png 2,The impact of county-level radiation oncologist density on prostate cancer mortality in the United States,Prostate Cancer & Prostatic Diseases,,,Article,2012-01-01,10.1038/pcan.2012.28,,,,22824828,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/853765,https://api.altmetric.com/v1/donut/853765_240.png 2,"Regression of prostate cancer following administration of Genistein Combined Polysaccharide (GCP), a nutritional supplement: a case report.",Journal of Alternative & Complementary Medicine,,,Article,2002-08-01,10.1089/107555302760253694,,,,12230910,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/851147,https://api.altmetric.com/v1/donut/851147_240.png 2,Implication of pleiotrophin in human PC3 prostate cancer cell growth in vivo.,Cancer Science,,,Article,2012-08-14,10.1111/j.1349-7006.2012.02383.x,,,,22783964,,,,,,,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/844795,https://api.altmetric.com/v1/donut/844795_240.png 2,PDGF Upregulates Mcl-1 Through Activation of ?-Catenin and HIF-1?-Dependent Signaling in Human Prostate Cancer Cells,PLoS ONE,,,Article,2012-01-27,10.1371/journal.pone.0030764,,,,22276222,PMC3262835,,2012PLoSO...7E0764I,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/834421,https://api.altmetric.com/v1/donut/834421_240.png 2,"Metastatic Hormone Refractory Prostate Cancer : Recent Advances in Standard Treatment Paradigm, and Future Directions.",American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-07-03,10.1097/coc.0b013e318248dc1e,,,,22772426,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/830547,https://api.altmetric.com/v1/donut/830547_240.png 2,Cabazitaxel for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: the TROPIC study in France.,Bulletin du Cancer,,,Article,2012-06-29,10.1684/bdc.2012.1608,,,,22743148,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/817394,https://api.altmetric.com/v1/donut/817394_240.png 2,Predicting prostate biopsy outcome: Prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.,Clinica Chimica Acta,,,Article,2012-05-02,10.1016/j.cca.2012.04.017,,,,22542564,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/814378,https://api.altmetric.com/v1/donut/814378_240.png 2,Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.,Prostate Cancer & Prostatic Diseases,,,Article,2012-06-26,10.1038/pcan.2012.24,,,,22733159,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/809347,https://api.altmetric.com/v1/donut/809347_240.png 2,Splice variant PRKC-?(-PrC) is a novel biomarker of human prostate cancer.,British Journal of Cancer,,,Article,2012-06-01,10.1038/bjc.2012.162,,,,22644296,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/791660,https://api.altmetric.com/v1/donut/791660_240.png 2,Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-?B.,The Prostate,,,Article,2011-01-06,10.1002/pros.21296,,,,21456063,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/787577,https://api.altmetric.com/v1/donut/787577_240.png 2,Prostate news,Prostate Cancer & Prostatic Diseases,,,Article,2008-12-01,10.1038/pcan.2008.54,,,,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/786174,https://api.altmetric.com/v1/donut/786174_240.png 2,Is a prostate cancer screening anxiety measure invariant across two different samples of age-appropriate men?,BMC Medical Informatics and Decision Making,,,Article,2012-06-08,10.1186/1472-6947-12-52,,,,22681782,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/784889,https://api.altmetric.com/v1/donut/784889_240.png 2,"Urological cancer: For localized prostate cancer, does technology equal progress?",Nature Reviews Clinical Oncology,,,Article,2012-06-05,10.1038/nrclinonc.2012.96,,,,22665365,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/779310,https://api.altmetric.com/v1/donut/779310_240.png 2,What Was I Thinking? Eye-Tracking Experiments Underscore the Bias that Architecture Exerts on Nuclear Grading in Prostate Cancer,PLoS ONE,,,Article,2012-05-30,10.1371/journal.pone.0038023,,,,22666438,,,2012PLoSO...7E8023B,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/769264,https://api.altmetric.com/v1/donut/769264_240.png 2,Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology,International Brazilian Journal of Urology,,,Article,2012-01-01,10.1590/s1677-55382012000200003,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/762692,https://api.altmetric.com/v1/donut/762692_240.png 2,Large scale phosphoproteome analysis of LNCaP human prostate cancer cells,Molecular BioSystems,,,Article,2012-01-01,10.1039/c2mb25151e,,,,22699815,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/737644,https://api.altmetric.com/v1/donut/737644_240.png 2,"The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer",Journal of Oncology,,,Article,2012-01-01,10.1155/2012/958596,,,,22619678,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/721229,https://api.altmetric.com/v1/donut/721229_240.png 2,[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11150.x,,,,22520686,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/710409,https://api.altmetric.com/v1/donut/710409_240.png 2,Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentrationâ??dependent modulation of multiple nuclear receptorâ??mediated pathways in androgenâ??responsive prostate cancer cell LNCaP,Molecular Carcinogenesis,,,Article,2012-01-01,10.1002/mc.21906,,,,22495798,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/694276,https://api.altmetric.com/v1/donut/694276_240.png 2,"Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer",Prostate Cancer,,,Article,2012-01-01,10.1155/2012/853487,,,,22577562,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/692649,https://api.altmetric.com/v1/donut/692649_240.png 2,Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry,Prostate Cancer & Prostatic Diseases,,,Article,2012-04-10,10.1038/pcan.2012.10,,,,22487909,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/690221,https://api.altmetric.com/v1/donut/690221_240.png 2,Radical prostatectomy represents an effective treatment in patients with specimenâ??confined high pathological Gleason score prostate cancer,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2012.11114.x,,,,22487441,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/684433,https://api.altmetric.com/v1/donut/684433_240.png 2,Impact of Distance to a Urologist on Early Diagnosis of Prostate Cancer Among Black and White Patients,The Journal of Urology,,,Article,2012-01-19,10.1016/j.juro.2011.10.156,,,,22248516,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/681940,https://api.altmetric.com/v1/donut/681940_240.png 2,Vacuum Erection Devices Revisited: Its Emerging Role in the Treatment of Erectile Dysfunction and Early Penile Rehabilitation Following Prostate Cancer Therapy,Journal of Sexual Medicine,,,Article,2012-04-01,10.1111/j.1743-6109.2010.01881.x,,,,21054791,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/675735,https://api.altmetric.com/v1/donut/675735_240.png 2,"Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics",Journal of Internal Medicine,,,Article,2012-04-01,10.1111/j.1365-2796.2012.02527.x,,,,22309040,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/665475,https://api.altmetric.com/v1/donut/665475_240.png 2,Testosterone Replacement Therapy for a Man with Prostate Cancer,Reviews in Urology,,,Article,2012-03-16,,,,,16985911,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/652767,https://api.altmetric.com/v1/donut/652767_240.png 2,Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy,European Journal of Cancer (1965),,,Article,2012-03-14,10.1016/j.ejca.2012.02.003,,,,22405699,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/648765,https://api.altmetric.com/v1/donut/648765_240.png 2,Unmasking the immune recognition of prostate cancer with CTLA4 blockade,Nature Reviews Cancer,,,Article,2012-03-01,10.1038/nrc3223,,,,22378189,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,195,https://www.altmetric.com/details/628974,https://api.altmetric.com/v1/donut/628974_240.png 2,Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer,Journal of Clinical Oncology,,,Article,2011-12-19,10.1200/jco.2011.39.1300,,,,22184375,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,33,https://www.altmetric.com/details/613767,https://api.altmetric.com/v1/donut/613767_240.png 2,Math May Help to Guide Future Prostate Cancer Treatments,Cancer (0008543X),,,Article,2012-03-01,10.1002/cncr.27478,,,,22344616,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/611207,https://api.altmetric.com/v1/donut/611207_240.png 2,Increased nonâ??prostate cancer death risk in clinically diagnosed prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10811.x,,,,22288823,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/607997,https://api.altmetric.com/v1/donut/607997_240.png 2,The impact of hypertriglyceridemia on prostate cancer development in patients aged ?60 years.,British Journal of Urology,,,Article,2012-02-01,10.1111/j.1464-410x.2011.10358.x,,,,21812901,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/604408,https://api.altmetric.com/v1/donut/604408_240.png 2,MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics,Prostate Cancer & Prostatic Diseases,,,Article,2012-01-01,10.1038/pcan.2012.3,,,,22333688,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/604090,https://api.altmetric.com/v1/donut/604090_240.png 2,"Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.",Anticancer Res,,,Article,2011-10-05,,,,,21965787,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/602350,https://api.altmetric.com/v1/donut/602350_240.png 2,Communicating health decisions: an analysis of messages posted to online prostate cancer forums,Health Expectations,,,Article,2012-01-01,10.1111/j.1369-7625.2011.00745.x,,,,22296292,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/593888,https://api.altmetric.com/v1/donut/593888_240.png 2,Validation of the Antiproliferative Effects of Organic Extracts from the Green Husk of Juglans regia L. on PC-3 Human Prostate Cancer Cells by Assessment of Apoptosis-Related Genes,Evidence-Based Complementary and Alternative Medicine,,,Article,2012-01-01,10.1155/2012/103026,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/591897,https://api.altmetric.com/v1/donut/591897_240.png 2,"Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4â??phenylenebis(methylene)selenocyanate in human prostate cancer cells",International Journal of Cancer,,,Article,2012-01-01,10.1002/ijc.27468,,,,22307455,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/590613,https://api.altmetric.com/v1/donut/590613_240.png 2,"Critical Role of O-Linked ?-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis",Journal of Biological Chemistry,,,Article,2012-01-26,10.1074/jbc.m111.302547,,,,22275356,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/580121,https://api.altmetric.com/v1/donut/580121_240.png 2,Prostate cancer in the elderly: Frequency of advanced disease at presentation and disease-specific mortality.,Cancer,,,Article,2011-10-19,10.1002/cncr.26392,,,,22006014,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/572675,https://api.altmetric.com/v1/donut/572675_240.png 2,XMRV and prostate cancer|[mdash]|a 'final' perspective,Nature Reviews Urology,,,Article,2012-01-10,10.1038/nrurol.2011.225,,,,22231291,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/553950,https://api.altmetric.com/v1/donut/553950_240.png 2,Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-04-13,10.1016/j.ijrobp.2011.01.024,,,,21477939,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/552677,https://api.altmetric.com/v1/donut/552677_240.png 2,Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92-02,Journal of Clinical Oncology,,,Article,2008-10-09,10.1200/jco.2008.16.5845,,,,18779620,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/536777,https://api.altmetric.com/v1/donut/536777_240.png 2,"In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors",Clinical Cancer Research,,,Article,2009-01-03,10.1158/1078-0432.ccr-08-1726,,,,19118031,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/517847,https://api.altmetric.com/v1/donut/517847_240.png 2,Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties,PLoS ONE,,,Article,2011-12-28,10.1371/journal.pone.0029170,,,,22216200,,,2011PLoSO...6E9170M,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/510149,https://api.altmetric.com/v1/donut/510149_240.png 2,Grading the New US Preventive Services Task Force Prostate Cancer Screening Recommendation,JAMA: The Journal of the American Medical Association,,,Article,2011-01-01,10.1001/jama.2011.1893,,,,22203540,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/509259,https://api.altmetric.com/v1/donut/509259_240.png 2,Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior,Prostate Cancer and Prostatic Diseases,,,Article,2011-12-20,10.1038/pcan.2011.64,,,,22183772,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/504655,https://api.altmetric.com/v1/donut/504655_240.png 2,Body mass index and risk of BPH: a meta-analysis,Prostate Cancer and Prostatic Diseases,,,Article,2011-12-20,10.1038/pcan.2011.65,,,,22183774,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/501655,https://api.altmetric.com/v1/donut/501655_240.png 2,Correction: Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-11-3698,,,,22127922,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/495901,https://api.altmetric.com/v1/donut/495901_240.png 2,Long-Term Dietary Outcomes of the FRESH START Intervention for Breast and Prostate Cancer Survivors,Journal of the American Dietetic Association,,,Article,2011-11-30,10.1016/j.jada.2011.09.013,,,,22117660,PMC3225803,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/487114,https://api.altmetric.com/v1/donut/487114_240.png 2,PSA screening: determinants of primary-care physician practice patterns,Prostate Cancer & Prostatic Diseases,,,Article,2012-01-01,10.1038/pcan.2011.59,,,,22343837,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/473451,https://api.altmetric.com/v1/donut/473451_240.png 2,Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data,PLoS ONE,,,Article,2011-11-23,10.1371/journal.pone.0026527,,,,22132073,,,2011PLoSO...6E6527B,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/467379,https://api.altmetric.com/v1/donut/467379_240.png 2,Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients,Journal of Translational Medicine,,,Article,2011-11-10,10.1186/1479-5876-9-193,,,,22071168,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/459447,https://api.altmetric.com/v1/donut/459447_240.png 2,Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.,Cancer Cell,,,Article,2011-10-18,10.1016/j.ccr.2011.09.001,,,,22014572,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,101,https://www.altmetric.com/details/457543,https://api.altmetric.com/v1/donut/457543_240.png 2,Treatment of prostate cancer metastases: more than semantics,The Lancet,,,Article,2011-01-01,10.1016/s0140-6736(11)61540-7,,,,22093188,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/456839,https://api.altmetric.com/v1/donut/456839_240.png 2,After Prostate Cancer: A What Next Guide to a Safe and Informed Recovery,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2011.10740.x,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/453877,https://api.altmetric.com/v1/donut/453877_240.png 2,Racial Disparities in Changing to a High-volume Urologist Among Men With Localized Prostate Cancer,Medical care,,,Article,2011-11-01,10.1097/mlr.0b013e3182364019,,,,22005606,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/426204,https://api.altmetric.com/v1/donut/426204_240.png 2,"Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths",Annals of Oncology,,,Article,2011-01-01,10.1093/annonc/mdr414,,,,21965474,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/417297,https://api.altmetric.com/v1/donut/417297_240.png 2,Screening for prostate cancer: updated experience from the Tyrol study.,Canadian Journal of Urology,,,Article,2005-02-01,,,,,15780158,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/404277,https://api.altmetric.com/v1/donut/404277_240.png 2,Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models,Endocrinology,,,Article,2011-10-11,10.1210/en.2011-1056,,,,21990314,,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/403080,https://api.altmetric.com/v1/donut/403080_240.png 2,The metabolic syndrome and risk of prostate cancer in Italy.,Annals of epidemiology,,,Article,2011-11-01,10.1016/j.annepidem.2011.07.007,,,,21982487,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/401035,https://api.altmetric.com/v1/donut/401035_240.png 2,Transforming growth factor {beta}1 increase of Hydroxysteroid Dehydrogenase proteins is partly suppressed by Red Clover isoflavones in human primary prostate cancer-derived stromal cells.,Carcinogenesis,,,Article,2011-09-12,10.1093/carcin/bgr206,,,,21914638,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/269939,https://api.altmetric.com/v1/donut/269939_240.png 2,Prostate cancer and ambient pesticide exposure in agriculturally intensive areas in California.,American Journal of Epidemiology,"RIPLEY, Helena P",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-06-01,10.1093/aje/kwr003,,,,21447478,PMC3121318,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,28,https://www.altmetric.com/details/236435,https://api.altmetric.com/v1/donut/236435_240.png 2,Clamp ablation of the testes compared to bilateral orchiectomy as androgen deprivation therapy for advanced prostate cancer,International Brazilian Journal of Urology,,,Article,2011-06-01,10.1590/s1677-55382011000300008,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/222702,https://api.altmetric.com/v1/donut/222702_240.png 2,Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.,"International journal of radiation oncology, biology, physics",,,Article,2008-01-01,10.1016/j.ijrobp.2007.06.054,,,,17765406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,164,https://www.altmetric.com/details/211975,https://api.altmetric.com/v1/donut/211975_240.png 2,Regional Collaboration to Improve Radiographic Staging Practices Among Men With Early Stage Prostate Cancer.,The Journal of urology,,,Article,2011-07-23,10.1016/j.juro.2011.04.078,,,,21788043,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/198792,https://api.altmetric.com/v1/donut/198792_240.png 2,Regulation of HMGA1 Expression by MicroRNA-296 Affects Prostate Cancer Growth and Invasion,Clinical Cancer Research,,,Article,2011-03-15,10.1158/1078-0432.ccr-10-0993,,,,21138859,,,,,,,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/198330,https://api.altmetric.com/v1/donut/198330_240.png 2,Discrimination of Breast Cancer by Measuring Prostate-Specific Antigen Levels in Women's Serum,Analytical Chemistry,,,Article,2011-07-01,10.1021/ac200754x,,,,21591802,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/187454,https://api.altmetric.com/v1/donut/187454_240.png 2,Second to fourth digit ratio (2D:4D) and prostate cancer risk in the Melbourne Collaborative Cohort Study,British Journal of Cancer,,,Article,2011-07-05,10.1038/bjc.2011.253,,,,21730975,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/184062,https://api.altmetric.com/v1/donut/184062_240.png 2,"Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.","International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-01-01,,,,,14697417,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,77,https://www.altmetric.com/details/177791,https://api.altmetric.com/v1/donut/177791_240.png 2,Exercise among breast and prostate cancer survivors-what are their barriers?,Journal of Cancer Survivorship,,,Article,2011-05-20,10.1007/s11764-011-0184-8,,,,21598023,PMC3223316,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/170397,https://api.altmetric.com/v1/donut/170397_240.png 2,Mouse models of prostate cancer,"",,,Article,1999-09-20,10.1038/sj.onc.1203037,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/168829,https://api.altmetric.com/v1/donut/168829_240.png 2,Re: N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells,The Journal of Urology,,,Article,2016-11-01,10.1016/j.juro.2016.08.023,,,,27751495,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13096120,https://api.altmetric.com/v1/donut/13096120_240.png 2,Benzoxazinoids in Prostate Cancer Patients after a Rye-Intensive Diet: Methods and Initial Results,Journal of Agricultural & Food Chemistry,,,Article,2016-10-20,10.1021/acs.jafc.6b03765,,,,27718574,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12969405,https://api.altmetric.com/v1/donut/12969405_240.png 2,Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature,Cancer Treatment Reviews,,,Article,2016-09-01,10.1016/j.ctrv.2016.09.008,,,,27665366,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12636338,https://api.altmetric.com/v1/donut/12636338_240.png 2,An online psychological intervention can improve the sexual satisfaction of men following treatment for localized prostate cancer: outcomes of a Randomised Controlled Trial evaluating My Road Ahead,Psycho-Oncology,,,Article,2016-09-26,10.1002/pon.4244,,,,27503036,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12605364,https://api.altmetric.com/v1/donut/12605364_240.png 2,Factors associated with current and severe physical side?effects after prostate cancer treatment: What men report,European Journal of Cancer Care,,,Article,2016-10-11,10.1111/ecc.12589,,,,27726215,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12565730,https://api.altmetric.com/v1/donut/12565730_240.png 2,An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment,Urologia Internationalis,,,Article,2016-09-30,10.1159/000448691,,,,27684440,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12409559,https://api.altmetric.com/v1/donut/12409559_240.png 2,Prostate Cancer,Prostate Cancer,,,Article,2016-01-01,10.1016/b978-0-12-800077-9.00014-1,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12281411,https://api.altmetric.com/v1/donut/12281411_240.png 2,Treatment of Metastatic Prostate Cancer in Older Adults,Current Oncology Reports,,,Article,2016-09-01,10.1007/s11912-016-0548-3,,,,27586377,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11882265,https://api.altmetric.com/v1/donut/11882265_240.png 2,Cancer de prostate des sujets âgés : place et rôle de l’évaluation gériatrique,Progrès en Urologie,,,Article,2016-08-01,10.1016/j.purol.2016.07.002,,,,27567304,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11882195,https://api.altmetric.com/v1/donut/11882195_240.png 2,Synthetic Lethality in PTEN-mutant Prostate Cancer is Induced by Combinatorial PI3K/Akt and BCL-XL Inhibition,Molecular Cancer Research,,,Article,2016-09-02,10.1158/1541-7786.mcr-16-0202,,,,27590631,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11719778,https://api.altmetric.com/v1/donut/11719778_240.png 2,Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells,Molecular and Cellular Biochemistry,,,Article,2016-08-25,10.1007/s11010-016-2794-y,,,,27562825,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10863103,https://api.altmetric.com/v1/donut/10863103_240.png 2,Prostate cancer progression and mortality: a review of diet and lifestyle factors,World Journal of Urology,,,Article,2016-08-12,10.1007/s00345-016-1914-3,,,,27518576,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10783404,https://api.altmetric.com/v1/donut/10783404_240.png 2,Prostate Cancer and Immune Monitoring: Are We Heading Towards Better Selection of Patients and Treatment Strategies?,European Urology,,,Article,2016-08-18,10.1016/j.eururo.2016.08.014,,,,27544581,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10733937,https://api.altmetric.com/v1/donut/10733937_240.png 2,miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer,Translational Oncology,,,Article,2016-05-19,10.1016/j.tranon.2016.04.005,,,,27267842,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10128195,https://api.altmetric.com/v1/donut/10128195_240.png 2,Is STAT3 and PTEN Expression Altered in Canine Prostate Cancer?,Journal of Comparative Pathology,,,Article,2016-07-01,10.1016/j.jcpa.2016.05.016,,,,27401955,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9658885,https://api.altmetric.com/v1/donut/9658885_240.png 2,"Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer",Medical Dosimetry,,,Article,2016-07-01,10.1016/j.meddos.2016.06.002,,,,27400663,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9622040,https://api.altmetric.com/v1/donut/9622040_240.png 2,Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases,Therapeutic Advances in Urology,,,Article,2016-06-01,10.1177/1756287216629870,,,,27247627,PMC4872188,10541/614557,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9120120,https://api.altmetric.com/v1/donut/9120120_240.png 2,Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy,Prostate Cancer,,,Article,2016-01-01,10.1155/2016/3794738,,,,27293898,PMC4884827,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8697796,https://api.altmetric.com/v1/donut/8697796_240.png 2,The roles of microRNAs in the progression of castration-resistant prostate cancer,Journal of Human Genetics,,,Article,2016-06-09,10.1038/jhg.2016.69,,,,27278789,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8650695,https://api.altmetric.com/v1/donut/8650695_240.png 2,Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3,Future Oncology,,,Article,2016-06-01,10.2217/fon-2016-0113,,,,27189718,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8282348,https://api.altmetric.com/v1/donut/8282348_240.png 2,Reprogramming of the Epigenome by MLL1 Links Early-life Environmental Exposures to Prostate Cancer Risk,Molecular Endocrinology,,,Article,2016-05-24,10.1210/me.2015-1310,,,,27219490,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8224499,https://api.altmetric.com/v1/donut/8224499_240.png 2,Diffuse bone metastases on 68Ga-PSMA PET-CT in a patient with prostate cancer and normal bone scan,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-04-28,10.1007/s00259-016-3398-1,,,,27121692,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7075404,https://api.altmetric.com/v1/donut/7075404_240.png 2,Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset,BMC Research Notes,,,Article,2016-01-22,10.1186/s13104-016-1855-3,,,,26801762,PMC4724115,2328/36179,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6735425,https://api.altmetric.com/v1/donut/6735425_240.png 2,Metabolic targets for potential prostate cancer therapeutics,Current opinion in oncology,,,Article,2016-05-01,10.1097/cco.0000000000000276,,,http://journals.lww.com/co-oncology/Fulltext/2016/05000/Metabolic_targets_for_potential_prostate_cancer.10.aspx,26907571,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6728070,https://api.altmetric.com/v1/donut/6728070_240.png 2,The anti-cancerous activity of recombinant trichosanthin on prostate cancer cell PC3,Biological Research,,,Article,2016-03-25,10.1186/s40659-016-0081-8,,,,27015938,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6361976,https://api.altmetric.com/v1/donut/6361976_240.png 2,Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy–Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey,European Urology Focus ,,,Article,2016-03-06,10.1016/j.euf.2016.02.009,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6126877,https://api.altmetric.com/v1/donut/6126877_240.png 2,Visceral fat accumulation as a risk factor for prostate cancer,Obesity Research,,,Article,2004-12-15,10.1038/oby.2004.242,,,,15687393,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6124969,https://api.altmetric.com/v1/donut/6124969_240.png 2,Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer,International Journal of Cancer,,,Article,2005-06-20,10.1002/ijc.20878,,,,15688368,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6017304,https://api.altmetric.com/v1/donut/6017304_240.png 2,Current status of pelvic lymph node dissection in prostate cancer,Journal of Robotic Surgery,,,Article,2013-12-11,10.1007/s11701-013-0439-7,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5620534,https://api.altmetric.com/v1/donut/5620534_240.png 2,Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-02-01,10.1158/1055-9965.epi-14-1274,,,,26677208,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5097759,https://api.altmetric.com/v1/donut/5097759_240.png 2,"18 F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy study",BMC Cancer,,,Article,2016-01-11,10.1186/s12885-016-2047-1,,,,26753880,PMC4709935,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4985060,https://api.altmetric.com/v1/donut/4985060_240.png 2,Triptolide induces protective autophagy through activation of the CaMKK?-AMPK signaling pathway in prostate cancer cells.,Oncotarget,,,Article,2016-01-07,10.18632/oncotarget.6783,,,,26734992,PMC4868692,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4964993,https://api.altmetric.com/v1/donut/4964993_240.png 2,Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy,,,,Article,2015-12-25,10.1016/j.euf.2015.12.004,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4922228,https://api.altmetric.com/v1/donut/4922228_240.png 2,"ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.",Oncotarget,,,Article,2015-12-08,10.18632/oncotarget.6438,,,,26636648,PMC4792596,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4850831,https://api.altmetric.com/v1/donut/4850831_240.png 2,Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients.,Progrès en Urologie,,,Article,,10.1016/j.purol.2015.10.006,,,,26586639,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4794951,https://api.altmetric.com/v1/donut/4794951_240.png 2,Perineural invasion is an independent predictor of biochemical recurrence of prostate cancer after local treatment: a meta-analysis.,International Journal of Clinical and Experimental Medicine,,,Article,2015-01-01,,,,,26550252,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4751770,https://api.altmetric.com/v1/donut/4751770_240.png 2,Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.,Ontario health technology assessment series,,,Article,2015-09-15,,,,,26366236,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4510101,https://api.altmetric.com/v1/donut/4510101_240.png 2,UDP-glucuronosyltransferase Enzymes in Prostate Cancer Progression: Is Only Androgen Catabolism Involved?,European Urology,,,Article,2015-08-27,10.1016/j.eururo.2015.08.025,,,,26318705,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4497294,https://api.altmetric.com/v1/donut/4497294_240.png 2,Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.,Medical science monitor international medical journal of experimental and clinical research,,,Article,2015-08-16,10.12659/msm.893442,,,,26275075,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4401754,https://api.altmetric.com/v1/donut/4401754_240.png 2,"Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models",Tumor Biology,,,Article,2015-07-29,10.1007/s13277-015-3725-3,,,,26219891,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4386306,https://api.altmetric.com/v1/donut/4386306_240.png 2,Salvage ablative therapy in prostate cancer: International multidisciplinary consensus on trial design,Urologic Oncology,,,Article,2015-11-01,10.1016/j.urolonc.2015.06.015,,,,26231310,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4372814,https://api.altmetric.com/v1/donut/4372814_240.png 2,"Prostate Cancer Screening Among American Indians and Alaska Natives: The Health and Retirement Survey, 1996–2008","Preventing Chronic Disease: Public Health Research, Practice and Policy",,,Article,2015-08-06,10.5888/pcd12.150088,,,,26247423,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4369903,https://api.altmetric.com/v1/donut/4369903_240.png 2,Phosphodiesterase sequence variants may predispose to prostate cancer,Endocrine-Related Cancer,,,Article,2015-08-01,10.1530/erc-15-0134,,,,25979379,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4315720,https://api.altmetric.com/v1/donut/4315720_240.png 2,Regulation of Human UDP-Glucuronosyltransferase 2B15 and 2B17 by miR-376c in prostate cancer cell lines,The Journal of Pharmacology and Experimental Therapeutics,,,Article,,10.1124/jpet.115.226118,,,,26163549,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4305530,https://api.altmetric.com/v1/donut/4305530_240.png 2,Hyperactivated FRS2|[alpha]|-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients,Oncogene,,,Article,2015-06-22,10.1038/onc.2015.239,,,,26096936,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4219300,https://api.altmetric.com/v1/donut/4219300_240.png 2,SU-E-J-177: A Computational Approach for Determination of Anisotropic PTV Margins Based On Statistical Shape Analysis for Prostate Cancer Radiotherapy,Medical Physics,,,Article,2015-06-01,10.1118/1.4924262,,,,26127568,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4217247,https://api.altmetric.com/v1/donut/4217247_240.png 2,Analysis of autophagic flux in response to sulforaphane in metastatic prostate cancer cells.,Molecular Nutrition & Food Research,,,Article,2015-06-26,10.1002/mnfr.201500283,,,,26108801,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4214819,https://api.altmetric.com/v1/donut/4214819_240.png 2,Diagnostic Value of Different Systematic Prostate Biopsy Methods in the Detection of Prostate Cancer with Ultrasonographic Hypoechoic Lesions - A Comparative Study,Urologia Internationalis,,,Article,2015-06-20,10.1159/000381752,,,,26113049,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4192953,https://api.altmetric.com/v1/donut/4192953_240.png 2,NICE reject enzalutamide for advanced prostate cancer before chemotherapy,ecancer.org,,,Article,,,,,http://ecancer.org/news/7408-nice-reject-enzalutamide-for-advanced-prostate-cancer-before-chemotherapy.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4135426,https://api.altmetric.com/v1/donut/4135426_240.png 2,A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.,,,,Article,2009-01-15,10.1016/j.ejca.2008.10.010,,,,19056257,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4129028,https://api.altmetric.com/v1/donut/4129028_240.png 2,Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression,Oncologist,,,Article,2010-09-01,10.1634/theoncologist.2010-0129,,,,20798195,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/4075851,https://api.altmetric.com/v1/donut/4075851_240.png 2,Re: Nationwide prevalence of lymph node metastases in Gleason score 3?+?3?=?6 prostate cancer: authors’ reply,Pathology,,,Article,2015-06-01,10.1097/pat.0000000000000264,,,,25938367,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3998028,https://api.altmetric.com/v1/donut/3998028_240.png 2,Assessment of the American Joint Committee on Cancer Staging (Sixth and Seventh Editions) for Clinically Localized Prostate Cancer Treated With External Beam Radiotherapy and Comparison With the National Comprehensive Cancer Network Risk-Stratification Method,Cancer (0008543X),,,Article,2012-11-15,10.1002/cncr.27597,,,,22544661,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3984338,https://api.altmetric.com/v1/donut/3984338_240.png 2,Aspirin use decreases the risk of prostate cancer recurrence after post-prostatectomy radiotherapy,Journal of Radiation Oncology,,,Article,2015-04-25,10.1007/s13566-015-0197-4,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3971557,https://api.altmetric.com/v1/donut/3971557_240.png 2,The Continuum of Prostate Cancer Care: An Integrated Population Based Model of Health Care Delivery,Urology Practice,,,Article,2015-01-03,10.1016/j.urpr.2014.09.001,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3733457,https://api.altmetric.com/v1/donut/3733457_240.png 2,In PC3 prostate cancer cells ephrin receptors crosstalk to [bgr]1-integrins to strengthen adhesion to collagen type I,Scientific Reports,,,Article,2015-02-03,10.1038/srep08206,,,,25644492,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3523263,https://api.altmetric.com/v1/donut/3523263_240.png 2,Altered radiation fractionation schedules for clinically localised and locally advanced prostate cancer,Cochrane database of systematic reviews,,,Article,2015-01-12,10.1002/14651858.cd011462,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3116734,https://api.altmetric.com/v1/donut/3116734_240.png 2,Proton Beam Therapy for the Treatment of Prostate Cancer,Cancer Journal,,,Article,,10.1097/ppo.0000000000000083,,,,25415688,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3057520,https://api.altmetric.com/v1/donut/3057520_240.png 2,"Differential Effects of Tissue Culture Coating Substrates on Prostate Cancer Cell Adherence, Morphology and Behavior",PLoS ONE,,,Article,2014-11-06,10.1371/journal.pone.0112122,,,,25375165,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/2924071,https://api.altmetric.com/v1/donut/2924071_240.png 2,Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.,Scand J Urol,,,Article,2014-02-21,10.3109/21681805.2014.884160,,,,24548220,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2914858,https://api.altmetric.com/v1/donut/2914858_240.png 2,Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.,Expert Opinion on Therapeutic Targets,,,Article,2014-11-14,10.1517/14728222.2014.981153,,,,25389904,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2908055,https://api.altmetric.com/v1/donut/2908055_240.png 2,Wellbeing during active surveillance for localised prostate cancer: a systematic review of psychological morbidity and quality of life,Cancer Treatment Reviews,,,Article,,10.1016/j.ctrv.2014.11.001,,,,25467109,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2887945,https://api.altmetric.com/v1/donut/2887945_240.png 2,From bench to bedside: the realities of reducing global prostate cancer disparity in black men,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/full/458-from-bench-to-bedside-the-realities-of-reducing-global-prostate-cancer-disparity-in-black-men.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2736208,https://api.altmetric.com/v1/donut/2736208_240.png 2,An unequal burden: prostate cancer in black men is a global concern,ecancer.org,,,Article,,,,,http://ecancer.org/news/6211-an-unequal-burden--prostate-cancer-in-black-men-is-a-global-concern.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2643766,https://api.altmetric.com/v1/donut/2643766_240.png 2,Prostate cancer: Enzalutamide AFFIRMs its benefits,Nature Reviews Urology,,,Article,2014-08-26,10.1038/nrurol.2014.227,,,,25155796,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2643464,https://api.altmetric.com/v1/donut/2643464_240.png 2,"Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients.",Urologic Oncology,,,Article,2014-08-14,10.1016/j.urolonc.2014.07.007,,,,25131660,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2607180,https://api.altmetric.com/v1/donut/2607180_240.png 2,Lipid catabolism via CPT1 as a therapeutic target for prostate cancer,Molecular Cancer Therapeutics,,,Article,2014-08-12,10.1158/1535-7163.mct-14-0183,,,,25122071,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2594591,https://api.altmetric.com/v1/donut/2594591_240.png 2,Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses ,Advanced Drug Delivery Reviews,,,Article,,10.1016/j.addr.2014.06.001,,,,24969478,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/2487328,https://api.altmetric.com/v1/donut/2487328_240.png 2,Multiparametric 3D in vivo ultrasound vibroelastography imaging of prostate cancer: Preliminary results,Medical Physics,,,Article,2014-06-27,10.1118/1.4884226,,,,24989419,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2470396,https://api.altmetric.com/v1/donut/2470396_240.png 2,"Use of oral anticoagulants and risk of prostate cancer: a population-based case–control study in Montreal, Canada",Cancer Causes and Control,,,Article,2014-06-20,10.1007/s10552-014-0417-z,,,,24946744,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2468878,https://api.altmetric.com/v1/donut/2468878_240.png 2,A prospective study of calcium intake and incident and fatal prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2006-02-25,10.1158/1055-9965.epi-05-0586,,,,16492906,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2428120,https://api.altmetric.com/v1/donut/2428120_240.png 2,Nanomedicine and its applications to the treatment of prostate cancer ,Annales Pharmaceutiques Françaises,,,Article,,10.1016/j.pharma.2014.04.006,,,,25220226,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2419850,https://api.altmetric.com/v1/donut/2419850_240.png 2,Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells.,Nutrition and Cancer,,,Article,2008-12-31,10.1080/01635580902825654,,,,19838939,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2348578,https://api.altmetric.com/v1/donut/2348578_240.png 2,Determinants of vitamin D levels in men receiving androgen deprivation therapy for prostate cancer,Journal of the American Association of Nurse Practitioners,,,Article,2014-04-14,10.1002/2327-6924.12122,,,,24729531,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2279360,https://api.altmetric.com/v1/donut/2279360_240.png 2,Natural compound Alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2014-04-03,10.1158/1535-7163.mct-13-0981,,,,24688053,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2269272,https://api.altmetric.com/v1/donut/2269272_240.png 2,Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer.,Journal of Translational Medicine,,,Article,2013-04-07,10.1186/1479-5876-11-89,,,,23557194,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2258076,https://api.altmetric.com/v1/donut/2258076_240.png 2,Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status,European Urology,,,Article,,10.1016/j.eururo.2014.01.030,,,,24508071,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2125123,https://api.altmetric.com/v1/donut/2125123_240.png 2,Prostate cancer: Localized disease[mdash]are most men really suitable for focal therapy?,Nature Reviews Urology,,,Article,2013-12-10,10.1038/nrurol.2013.297,,,,24323132,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2048011,https://api.altmetric.com/v1/donut/2048011_240.png 2,Type 2 Diabetes: A Protective Factor for Prostate Cancer? An Overview of Proposed Mechanisms.,Clinical Genitourinary Cancer,,,Article,,10.1016/j.clgc.2014.01.001,,,,24513117,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2046455,https://api.altmetric.com/v1/donut/2046455_240.png 2,Helical intensity-modulated Radiotherapy of the Pelvic Lymph Nodes with Integrated Boost to the Prostate Bed - Initial Results of the PLATIN 3 Trial,BMC Cancer,,,Article,2014-01-14,10.1186/1471-2407-14-20,,,,24422782,PMC3893457,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2044596,https://api.altmetric.com/v1/donut/2044596_240.png 2,Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the ‘FC Prostate’ randomized controlled trial,BMC Cancer,,,Article,2013-12-13,10.1186/1471-2407-13-595,,,,24330570,PMC3867428,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1976438,https://api.altmetric.com/v1/donut/1976438_240.png 2,HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase,Oncogene,,,Article,2013-10-14,10.1038/onc.2013.412,,,,24121274,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1840131,https://api.altmetric.com/v1/donut/1840131_240.png 2,Suppressing tumor progression of in vitro prostate cancer cells by emitted psychosomatic power through Zen meditation.,American Journal of Chinese Medicine,,,Article,2003-01-01,10.1142/s0192415x03001132,,,,12943181,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1801333,https://api.altmetric.com/v1/donut/1801333_240.png 2,The Relative Value of Some New Drugs Used to Treat Prostate Cancer,Urology,,,Article,2007-01-01,10.1016/j.urology.2013.05.014,,,,24074974,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,192,https://www.altmetric.com/details/1784413,https://api.altmetric.com/v1/donut/1784413_240.png 2,Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer,Frontiers in oncology,,,Article,2013-01-01,10.3389/fonc.2013.00214,,,,23986881,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1710472,https://api.altmetric.com/v1/donut/1710472_240.png 2,Prostate cancer: New class of drug that interferes with AR signalling,Nature Reviews Urology,,,Article,2013-06-18,10.1038/nrurol.2013.138,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1692929,https://api.altmetric.com/v1/donut/1692929_240.png 2,"Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans",Scientific Reports,,,Article,2013-07-31,10.1038/srep02331,,,,23900262,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1664329,https://api.altmetric.com/v1/donut/1664329_240.png 2,"Re: Early detection of prostate cancer: AUA guideline: H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland, K. L. Greene, L. Holmberg, P. Kantoff, B. R. Konety, M. H. Murad, D. F. Penson and A. L. ZietmanJ Urol 2013; 190:",The Journal of Urology,,,Article,2013-07-18,10.1016/j.juro.2013.07.002,,,,23871525,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1639024,https://api.altmetric.com/v1/donut/1639024_240.png 2,Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines,Frontiers in oncology,,,Article,2013-01-01,10.3389/fonc.2013.00180,,,,23847768,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1612830,https://api.altmetric.com/v1/donut/1612830_240.png 2,Baseline 18F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer.,Journal of Nuclear Medicine,,,Article,2013-06-19,10.2967/jnumed.112.114116,,,,23785174,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1575368,https://api.altmetric.com/v1/donut/1575368_240.png 2,The incidence of acute urinary retention secondary to BPH is increasing among California men.,Prostate Cancer & Prostatic Diseases,,,Article,2013-05-09,10.1038/pcan.2013.11,,,,23648398,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1535765,https://api.altmetric.com/v1/donut/1535765_240.png 2,Coffee consumption and the risk of overall and fatal prostate cancer in the NIH-AARP Diet and Health Study.,Cancer Causes and Control,,,Article,2013-05-18,10.1007/s10552-013-0229-6,,,,23681472,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1493631,https://api.altmetric.com/v1/donut/1493631_240.png 2,Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer.,BMC Systems Biology,,,Article,2013-01-12,10.1186/1752-0509-6-s3-s13,,,,23281744,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1280279,https://api.altmetric.com/v1/donut/1280279_240.png 2,"""The only way I know how to live is to work"": A qualitative study of work following treatment for prostate cancer.",Health Psychology,,,Article,2013-01-01,10.1037/a0030387,,,,23316855,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1177013,https://api.altmetric.com/v1/donut/1177013_240.png 2,Transition Zone Prostate Cancer: Detection and Localization with 3-T Multiparametric MR Imaging,Radiology,,,Article,2012-01-01,10.1148/radiol.12120281,,,,23143029,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1175261,https://api.altmetric.com/v1/donut/1175261_240.png 2,Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes.,PLoS ONE,,,Article,2012-12-21,10.1371/journal.pone.0050999,,,,23251413,PMC3519481,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/1167046,https://api.altmetric.com/v1/donut/1167046_240.png 2,Prostate cancer may trigger paraneoplastic limbic encephalitis: A case report and a review of the literature,International Journal of Urology,,,Article,2012-01-01,10.1111/iju.12030,,,,23186204,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1092608,https://api.altmetric.com/v1/donut/1092608_240.png 2,Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11464.x,,,,23145532,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1065769,https://api.altmetric.com/v1/donut/1065769_240.png 2,"Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer",BMC Bioinformatics,,,Article,2012-10-30,10.1186/1471-2105-13-282,,,,23110677,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1031802,https://api.altmetric.com/v1/donut/1031802_240.png 2,The epidemic of prostate cancer and the medical literature: a causal association?,"",,,Article,1998-03-05,10.1038/sj.pcan.4500227,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1024520,https://api.altmetric.com/v1/donut/1024520_240.png 2,Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis,BMC Cancer,,,Article,2012-09-14,10.1186/1471-2407-12-409,,,,22974127,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/947013,https://api.altmetric.com/v1/donut/947013_240.png 2,Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 810 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11465.x,,,,22974446,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/947012,https://api.altmetric.com/v1/donut/947012_240.png 2,Exome Enrichment and SOLiD Sequencing of Formalin Fixed Paraffin Embedded (FFPE) Prostate Cancer Tissue.,International Journal of Molecular Sciences,,,Article,2012-09-04,10.3390/ijms13078933,,,,22942743,PMC3430274,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/932892,https://api.altmetric.com/v1/donut/932892_240.png 2,Dietary acrylamide and risk of prostate cancer.,International Journal of Cancer,,,Article,1970-01-01,10.1002/ijc.26383,,,,21866549,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/865839,https://api.altmetric.com/v1/donut/865839_240.png 2,Selenium and prostate cancer: the puzzle isn’t finished yet,American Journal of Clinical Nutrition,,,Article,2012-05-26,10.3945/ajcn.112.042119,,,,22623750,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/801447,https://api.altmetric.com/v1/donut/801447_240.png 2,Relationship Between Intraprostatic Tracer Deposits and Sentinel Lymph Node Mapping in Prostate Cancer Patients.,Journal of Nuclear Medicine,,,Article,2012-05-29,10.2967/jnumed.111.098517,,,,22645296,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/770358,https://api.altmetric.com/v1/donut/770358_240.png 2,80 is the new 60: Implications of Irrational Exuberance Regarding Longevity on Prostate Cancer Treatment Decisions,JGIM: Journal of General Internal Medicine,,,Article,2012-02-11,10.1007/s11606-012-2006-8,,,,22328015,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/744669,https://api.altmetric.com/v1/donut/744669_240.png 2,StatBite Cumulative Incidence of Prostate Cancer (Placebo Group vs. Vitamin E Alone),JNCI: Journal of the National Cancer Institute,,,Article,2012-01-01,10.1093/jnci/djs249,,,,22544942,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/720860,https://api.altmetric.com/v1/donut/720860_240.png 2,Prostate cancer stem cells: The case for model systems,Journal of Carcinogenesis,,,Article,2012-01-01,10.4103/1477-3163.93701,,,,22529742,PMC3327048,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/714275,https://api.altmetric.com/v1/donut/714275_240.png 2,Prospective Preference Assessment of Patientsâ?? Willingness to Participate in a Randomized Controlled Trial of Intensity-Modulated Radiotherapy Versus Proton Therapy for Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-02-29,10.1016/j.ijrobp.2011.11.072,,,,22381899,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/627177,https://api.altmetric.com/v1/donut/627177_240.png 2,Emerging novel therapies for advanced prostate cancer,Therapeutic Advances in Urology,,,Article,2012-02-03,10.1177/1756287211432777,,,,22295041,PMC3263924,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/561720,https://api.altmetric.com/v1/donut/561720_240.png 2,Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation,Molecular Cancer,,,Article,2011-10-14,10.1186/1476-4598-10-129,,,,21999842,PMC3212821,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/560458,https://api.altmetric.com/v1/donut/560458_240.png 2,The Novel Vitamin D Analog ZK191784 Inhibits Prostate Cancer Cell Invasion.,Anticancer research,,,Article,2011-12-01,,,,,22199266,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/509079,https://api.altmetric.com/v1/donut/509079_240.png 2,"Red Wine Consumption is inversely associated with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA Adduct Levels in Prostate.",Cancer Prevention Research,"SKYHOPPER, Leia",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-08-16,10.1158/1940-6207.capr-11-0100,,,,21846795,PMC3188357,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/247543,https://api.altmetric.com/v1/donut/247543_240.png 2,HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-1656,,,,27793843,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13116650,https://api.altmetric.com/v1/donut/13116650_240.png 2,Prostate cancer: Poor quality of published evidence for superiority of RALP,Nature Reviews Urology,,,Article,2010-05-01,10.1038/nrurol.2010.51,,,,20458776,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13091523,https://api.altmetric.com/v1/donut/13091523_240.png 2,"Re: Scott P. Kelly, Philip S. Rosenberg, William F. Anderson, et al. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.05.011",European Urology,,,Article,2016-10-01,10.1016/j.eururo.2016.10.024,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13088357,https://api.altmetric.com/v1/donut/13088357_240.png 2,Lifestyle interventions to improve the quality of life of men with prostate cancer: A systematic review of randomized controlled trials,Critical Reviews in Oncology/Hematology,,,Article,2016-10-01,10.1016/j.critrevonc.2016.10.007,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13075276,https://api.altmetric.com/v1/donut/13075276_240.png 2,Transgenic Expression of Mitochondrial Chaperone TRAP1 Accelerates Prostate Cancer Development,Journal of Biological Chemistry,,,Article,2016-10-17,10.1074/jbc.m116.745950,,,,27754870,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13060216,https://api.altmetric.com/v1/donut/13060216_240.png 2,The molecular underpinnings of prostate cancer: impacts on management and pathology practice,The Journal of Pathology,,,Article,2016-10-01,10.1002/path.4826,,,,27753448,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12964936,https://api.altmetric.com/v1/donut/12964936_240.png 2,Optimization of Acquisition time of 68 Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer,PLoS ONE,,,Article,2016-10-18,10.1371/journal.pone.0164392,,,,27755548,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12729389,https://api.altmetric.com/v1/donut/12729389_240.png 2,Human Periprostatic Adipose Tissue: its Influence on Prostate Cancer Cells,Cellular Physiology & Biochemistry,,,Article,2012-06-13,10.1159/000339051,,,,22759960,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12678092,https://api.altmetric.com/v1/donut/12678092_240.png 2,Testosterone Replacement Therapy in Men with Prostate Cancer: What Is the Evidence?,Sexual Medicine Reviews,,,Article,2013-09-23,10.1002/smrj.15,,,,27784552,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12641525,https://api.altmetric.com/v1/donut/12641525_240.png 2,Prostate Health Index (phi) Improves Multivariable Risk Prediction of Aggressive Prostate Cancer,British Journal of Urology,,,Article,2016-10-01,10.1111/bju.13676,,,,27743489,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12637073,https://api.altmetric.com/v1/donut/12637073_240.png 2,Active Holistic Surveillance: The Nutritional Aspect of Delayed Intervention in Prostate Cancer,Journal of Nutrition & Metabolism,,,Article,2016-10-10,10.1155/2016/2917065,,,,27274870,PMC4871970,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12540278,https://api.altmetric.com/v1/donut/12540278_240.png 2,Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer,Clinical Medicine Insights: Oncology,,,Article,2016-10-09,10.4137/cmo.s34535,,,,27773999,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12523647,https://api.altmetric.com/v1/donut/12523647_240.png 2,Images in Clinical Urology - Focal Laser Ablation of Prostate Cancer,Urology,,,Article,2016-10-11,10.1016/j.urology.2016.10.002,,,,27720973,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12476878,https://api.altmetric.com/v1/donut/12476878_240.png 2,"Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diaries.",European Journal of Clinical Nutrition,,,Article,2016-09-28,10.1038/ejcn.2016.162,,,,27677361,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12370548,https://api.altmetric.com/v1/donut/12370548_240.png 2,Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1.,Oncogene,,,Article,2016-09-20,10.1038/onc.2016.319,,,,27641328,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12099097,https://api.altmetric.com/v1/donut/12099097_240.png 2,Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer,Journal of Nuclear Medicine,,,Article,2016-09-15,10.2967/jnumed.116.178939,,,,27635024,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12058784,https://api.altmetric.com/v1/donut/12058784_240.png 2,"Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells",Oncotarget,,,Article,2015-09-02,10.18632/oncotarget.4260,,,,26246472,PMC4695164,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/12050531,https://api.altmetric.com/v1/donut/12050531_240.png 2,Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells,PLoS ONE,,,Article,2016-09-14,10.1371/journal.pone.0162977,,,,27627761,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12013000,https://api.altmetric.com/v1/donut/12013000_240.png 2,"The Use of Biomarkers to Manage Men with Metastatic Prostate Cancer: One Day, But Not Yet",European Urology Focus ,,,Article,2016-09-01,10.1016/j.euf.2016.09.001,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12012563,https://api.altmetric.com/v1/donut/12012563_240.png 2,TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer,OncoImmunology,,,Article,2016-08-01,10.1080/2162402x.2016.1197459,,,,27622067,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11991163,https://api.altmetric.com/v1/donut/11991163_240.png 2,Is a negative mpMRI really able to rule out significant prostate cancer?: The real life experience,British Journal of Urology,,,Article,2016-09-01,10.1111/bju.13657,,,,27618134,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11986250,https://api.altmetric.com/v1/donut/11986250_240.png 2,SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer,Frontiers in Pharmacology,,,Article,2016-09-13,10.3389/fphar.2016.00338,,,,27774064,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11981889,https://api.altmetric.com/v1/donut/11981889_240.png 2,Sensitive time-gated immunoluminescence detection of prostate cancer cells using a TEGylated europium ligand,Analytical Chemistry,,,Article,2016-09-05,10.1021/acs.analchem.6b02191,,,,27595303,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11887116,https://api.altmetric.com/v1/donut/11887116_240.png 2,Prostate cancer: Non-traditional CTCs indicate prognosis,Nature Reviews Urology,,,Article,2016-09-07,10.1038/nrurol.2016.174,,,,27603218,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11880796,https://api.altmetric.com/v1/donut/11880796_240.png 2,Re: Stereotactic Body Re-irradiation Therapy for Locally Recurrent Prostate Cancer After External-beam Radiation Therapy: Initial Report,European Urology,,,Article,2016-09-03,10.1016/j.eururo.2016.08.059,,,,27597238,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11672143,https://api.altmetric.com/v1/donut/11672143_240.png 2,Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach,Journal of Translational Medicine,,,Article,2016-08-30,10.1186/s12967-016-1014-6,,,,27576364,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10921244,https://api.altmetric.com/v1/donut/10921244_240.png 2,Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies,International Journal of Molecular Sciences,,,Article,2016-08-04,10.3390/ijms17081264,,,,27527157,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10887102,https://api.altmetric.com/v1/donut/10887102_240.png 2,Limitations of the National Comprehensive Cancer Network Guidelines For Prediction of Limited Life Expectancy in Men with Prostate Cancer,The Journal of Urology,,,Article,2016-09-02,10.1016/j.juro.2016.08.096,,,,27582436,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10879857,https://api.altmetric.com/v1/donut/10879857_240.png 2,Re: Molecular Imaging of Prostate Cancer,The Journal of Urology,,,Article,2016-10-19,10.1016/j.juro.2016.08.065,,,,27751454,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10772088,https://api.altmetric.com/v1/donut/10772088_240.png 2,Evaluation of focal ablation of MRI-defined prostate cancer using MRI-controlled transurethral ultrasound therapy with prostatectomy as the reference standard,The Journal of Urology,,,Article,2016-08-18,10.1016/j.juro.2016.06.100,,,,27545572,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10696579,https://api.altmetric.com/v1/donut/10696579_240.png 2,Retracted: Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells,International Journal of Cancer,,,Article,2006-07-05,10.1002/ijc.22077,,,,16823852,,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/10677570,https://api.altmetric.com/v1/donut/10677570_240.png 2,"Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism. Eur Urol. 2016;70:56–61",European Urology,,,Article,2016-08-18,10.1016/j.eururo.2016.08.021,,,,27544579,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10660867,https://api.altmetric.com/v1/donut/10660867_240.png 2,Prostate cancer: Promising early outcomes of surgery,Nature Reviews Urology,,,Article,2016-08-17,10.1038/nrurol.2016.159,,,,27530267,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10575009,https://api.altmetric.com/v1/donut/10575009_240.png 2,hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR,Tumor Biology,,,Article,2016-08-14,10.1007/s13277-016-5196-6,,,,27524492,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10534679,https://api.altmetric.com/v1/donut/10534679_240.png 2,"First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake",Journal of Nuclear Medicine,,,Article,2016-08-11,10.2967/jnumed.116.176206,,,,27516450,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10533564,https://api.altmetric.com/v1/donut/10533564_240.png 2,Re: More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat Versus Initial Transrectal Ultrasound Guided Prostate Biopsy,European Urology,,,Article,2016-08-11,10.1016/j.eururo.2016.07.038,,,,27495846,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10406123,https://api.altmetric.com/v1/donut/10406123_240.png 2,Theranostic perspectives in prostate cancer with the GRPR-antagonist NeoBOMB1 - Preclinical and first clinical results,Journal of Nuclear Medicine,,,Article,2016-08-04,10.2967/jnumed.116.178889,,,,27493272,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10315319,https://api.altmetric.com/v1/donut/10315319_240.png 2,Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial,Oncotarget,,,Article,2015-07-18,10.18632/oncotarget.10883,,,,27486817,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10261816,https://api.altmetric.com/v1/donut/10261816_240.png 2,Countries with high circumcision prevalence have lower prostate cancer mortality.,Asian Journal of Andrology,,,Article,,,,,,26323559,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10230120,https://api.altmetric.com/v1/donut/10230120_240.png 2,Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction,International Journal of Nanomedicine,,,Article,2016-07-29,10.2147/ijn.s111808,,,,27536100,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10167359,https://api.altmetric.com/v1/donut/10167359_240.png 2,"Re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775–87",European Urology,,,Article,2016-07-21,10.1016/j.eururo.2016.07.018,,,,27451134,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9916879,https://api.altmetric.com/v1/donut/9916879_240.png 2,Active Surveillance for Prostate Cancer under the Patient Protection and Affordable Care Act,Urology Practice,,,Article,2015-01-07,10.1016/j.urpr.2014.11.004,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9882023,https://api.altmetric.com/v1/donut/9882023_240.png 2,"Coumestrol Inhibits Proliferation and Migration of Prostate Cancer Cells by Regulating AKT, ERK1/2 and JNK MAPK Cell Signaling Cascades",Journal of Cellular Physiology,,,Article,2016-07-01,10.1002/jcp.25494,,,,27431052,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9847137,https://api.altmetric.com/v1/donut/9847137_240.png 2,Synthesis and Biological Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for Positron Emission Tomography of Prostate Cancer,Journal of Nuclear Medicine,,,Article,2016-07-14,10.2967/jnumed.116.175810,,,,27417647,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9750382,https://api.altmetric.com/v1/donut/9750382_240.png 2,Statin Use in Prostate Cancer: An Update,Nutrition and metabolic insights,,,Article,2016-07-14,10.4137/nmi.s38362,,,,27441003,PMC4946583,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9718472,https://api.altmetric.com/v1/donut/9718472_240.png 2,Gene Mutations as a Target in Metastatic Prostate Cancer,Journal Watch,,,Article,2016-07-08,10.1056/nejm-jw.na41782,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9635295,https://api.altmetric.com/v1/donut/9635295_240.png 2,A Perspective of Immunotherapy for Prostate Cancer,Cancers,,,Article,2016-01-01,10.3390/cancers8070064,,,,27399780,PMC4963806,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/9624881,https://api.altmetric.com/v1/donut/9624881_240.png 2,Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-07-08,10.1007/s00259-016-3449-7,,,,27392615,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9552374,https://api.altmetric.com/v1/donut/9552374_240.png 2,"Folate-targeted Amphiphilic Cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo","Nanomedicine: Nanotechnology, Biology and Medicine",,,Article,2016-07-01,10.1016/j.nano.2016.06.014,,,,27389146,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9534504,https://api.altmetric.com/v1/donut/9534504_240.png 2,Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells,International Journal of Pharmaceutics,,,Article,2016-07-01,10.1016/j.ijpharm.2016.05.027,,,,27188645,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9512410,https://api.altmetric.com/v1/donut/9512410_240.png 2,TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10382,,,,27385093,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9511020,https://api.altmetric.com/v1/donut/9511020_240.png 2,Re: Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis,European Urology,,,Article,2016-07-02,10.1016/j.eururo.2016.06.027,,,,27378030,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9176236,https://api.altmetric.com/v1/donut/9176236_240.png 2,Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins,PLoS ONE,,,Article,2016-06-28,10.1371/journal.pone.0158116,,,,27352049,PMC4924873,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9126654,https://api.altmetric.com/v1/donut/9126654_240.png 2,"A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancer",Cancer Treatment Reviews,,,Article,2016-07-01,10.1016/j.ctrv.2016.06.005,,,,27327958,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8967558,https://api.altmetric.com/v1/donut/8967558_240.png 2,Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results From A Population-Based Cohort,Urology,,,Article,2016-06-15,10.1016/j.urology.2016.06.010,,,,27318264,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8775012,https://api.altmetric.com/v1/donut/8775012_240.png 2,[Social Inequality in Utilization of Aftercare Services Among Breast and Prostate Cancer Patients].,Das Gesundheitswesen,,,Article,2016-06-15,10.1055/s-0042-108579,,,,27300091,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8757948,https://api.altmetric.com/v1/donut/8757948_240.png 2," No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase 18 F-Fluorethylcholine PET/CT for prostate cancer ",Journal of Medical Imaging & Radiation Oncology,,,Article,2016-06-13,10.1111/1754-9485.12481,,,,27297449,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8757584,https://api.altmetric.com/v1/donut/8757584_240.png 2,Prostate cancer: TRIM24 acts as a transcriptional activator,Nature Reviews Urology,,,Article,2016-06-14,10.1038/nrurol.2016.112,,,,27296649,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8727112,https://api.altmetric.com/v1/donut/8727112_240.png 2,Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era,Journal of Comparative Effectiveness Research,,,Article,2016-06-13,10.2217/cer-2015-0015,,,,27294829,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8708267,https://api.altmetric.com/v1/donut/8708267_240.png 2,Evaluation of a Home-Based Walking Exercise Program on Fatigue and Health Related Quality of Life in Prostate Cancer Patients Undergoing Radiation Therapy: A Pilot Study,,,,Article,,10.17037/pubs.02531232,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8611288,https://api.altmetric.com/v1/donut/8611288_240.png 2,Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy,Radiation Oncology,,,Article,2016-06-08,10.1186/s13014-016-0656-0,,,,27276878,PMC4898326,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8592729,https://api.altmetric.com/v1/donut/8592729_240.png 2,The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer,Expert Review of Anticancer Therapy,,,Article,2016-06-07,10.1080/14737140.2016.1192468,,,,27210425,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8561741,https://api.altmetric.com/v1/donut/8561741_240.png 2,Evolving Recommendations on Prostate Cancer Screening,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2016-06-05,10.14694/edbk_157413,,,,27249774,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8488178,https://api.altmetric.com/v1/donut/8488178_240.png 2,Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer,Journal of Contemporary Brachytherapy,,,Article,2016-01-01,10.5114/jcb.2016.59686,,,,27257412,PMC4873555,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8479266,https://api.altmetric.com/v1/donut/8479266_240.png 2,Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review,Clinical Oncology,,,Article,2016-05-01,10.1016/j.clon.2016.05.003,,,,27256655,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8437525,https://api.altmetric.com/v1/donut/8437525_240.png 2,The role of the clinical nurse specialist in caring for patients with prostate cancer: a narrative review,Nursing : Research and Reviews,,,Article,2014-07-18,10.2147/nrr.s36752,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8397219,https://api.altmetric.com/v1/donut/8397219_240.png 2,Review Article: Best Evidence Regarding Contemporary Use of Prostate Cancer Biomarkers,Urology Practice,,,Article,2016-02-11,10.1016/j.urpr.2015.06.012,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8394678,https://api.altmetric.com/v1/donut/8394678_240.png 2,"PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.",Asian Journal of Andrology,,,Article,2016-05-28,,,,,27232854,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8331056,https://api.altmetric.com/v1/donut/8331056_240.png 2,Prostate cancer in Taiwan: epidemiology and risk factors,International Journal of Andrology,,,Article,2000-04-01,10.1046/j.1365-2605.2000.00012.x,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8204014,https://api.altmetric.com/v1/donut/8204014_240.png 2," MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long lasting CD4 + T-cells ",OncoImmunology,,,Article,2016-05-02,10.1080/2162402x.2016.1178439,,,,27622033,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7903531,https://api.altmetric.com/v1/donut/7903531_240.png 2,"Reply to Giandomenico Roviello, Alberto Bottini, and Daniele Generali's Letter to the Editor re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035",European Urology,,,Article,2016-05-19,10.1016/j.eururo.2016.05.005,,,,27209539,,,,,,,0,0,0,5,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7608016,https://api.altmetric.com/v1/donut/7608016_240.png 2,FDG PET/CT in Peritoneal Metastasis From Prostate Cancer,Clinical Nuclear Medicine,,,Article,2016-05-01,10.1097/rlu.0000000000001256,,,,27187732,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7593657,https://api.altmetric.com/v1/donut/7593657_240.png 2,Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-05-16,10.1073/pnas.1600420113,,,,27185910,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7593461,https://api.altmetric.com/v1/donut/7593461_240.png 2,Variation in prostate cancer survival explained by significant prognostic factors.,The Journal of Urology,,,Article,1997-10-01,,,,,9302148,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7387774,https://api.altmetric.com/v1/donut/7387774_240.png 2,Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data,Urology,,,Article,2016-05-11,10.1016/j.urology.2016.04.041,,,,27179774,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7350716,https://api.altmetric.com/v1/donut/7350716_240.png 2,Lymphatic endothelial cells actively regulate prostate cancer cell invasion,NMR in Biomedicine,,,Article,2016-05-05,10.1002/nbm.3543,,,,27149683,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7262029,https://api.altmetric.com/v1/donut/7262029_240.png 2,Corrigendum re: “Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer” [Eur Urol 2016;69:223–8],European Urology,,,Article,2016-05-03,10.1016/j.eururo.2016.04.020,,,,27156444,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7126214,https://api.altmetric.com/v1/donut/7126214_240.png 2,Toxicity and efficacy of salvage 11C-Choline PET/CT-guided radiation therapy in patients with prostate cancer lymph nodal recurrence,British Journal of Urology,,,Article,2016-04-01,10.1111/bju.13510,,,,27104782,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6917283,https://api.altmetric.com/v1/donut/6917283_240.png 2,Grade-dependent Response to Finasteride in Early Prostate Cancer ,EBioMedicine,,,Article,2016-06-21,10.1016/j.ebiom.2016.04.022,,,,27322449,PMC4909484,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6791714,https://api.altmetric.com/v1/donut/6791714_240.png 2,PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer,Molecular Imaging & Biology,,,Article,2016-04-14,10.1007/s11307-016-0957-6,,,,27080322,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6757523,https://api.altmetric.com/v1/donut/6757523_240.png 2,Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer,Cell Reports,,,Article,2016-04-07,10.1016/j.celrep.2016.03.038,,,,27068475,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6657613,https://api.altmetric.com/v1/donut/6657613_240.png 2,Breast and prostate cancer survivors’ experiences of patient-centered cancer follow-up care from primary care physicians and oncologists,Journal of Cancer Survivorship,,,Article,2016-03-31,10.1007/s11764-016-0537-4,,,,27034260,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6439105,https://api.altmetric.com/v1/donut/6439105_240.png 2,Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes,,,,Article,2016-04-02,10.1016/j.euf.2016.03.010,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6433700,https://api.altmetric.com/v1/donut/6433700_240.png 2,PTP1B deficiency enables the ability of a high fat diet to drive the invasive character of PTEN-deficient prostate cancers,Cancer Research,,,Article,2016-03-28,10.1158/0008-5472.can-15-1501,,,,27020859,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6368364,https://api.altmetric.com/v1/donut/6368364_240.png 2,"The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells",Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8301,,,,27015368,PMC5029701,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6340913,https://api.altmetric.com/v1/donut/6340913_240.png 2,"Re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.01.029",European Urology,,,Article,2016-03-26,10.1016/j.eururo.2016.03.025,,,,27021795,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6335572,https://api.altmetric.com/v1/donut/6335572_240.png 2,68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging,European Radiology,,,Article,2016-03-24,10.1007/s00330-016-4308-4,,,,27011373,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6327451,https://api.altmetric.com/v1/donut/6327451_240.png 2,Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life,Frontiers in oncology,,,Article,2016-03-24,10.3389/fonc.2016.00070,,,,27047800,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6301800,https://api.altmetric.com/v1/donut/6301800_240.png 2,Prostate cancer: from Gleason scoring to prognostic grade grouping,Expert Review of Anticancer Therapy,,,Article,2016-03-23,10.1586/14737140.2016.1160780,,,,27008205,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6297599,https://api.altmetric.com/v1/donut/6297599_240.png 2,CD169+ macrophages mediate?pathological formation of woven bone in skeletal lesions of prostate cancer,The Journal of Pathology,,,Article,2016-03-01,10.1002/path.4718,,,,27174786,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6259168,https://api.altmetric.com/v1/donut/6259168_240.png 2,Mutations and deletions of PRC2 in prostate cancer,BioEssays,,,Article,2016-03-01,10.1002/bies.201500162,,,,27000413,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6257584,https://api.altmetric.com/v1/donut/6257584_240.png 2,MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence,The Prostate,,,Article,2016-03-15,10.1002/pros.23177,,,,26990571,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6240845,https://api.altmetric.com/v1/donut/6240845_240.png 2,Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer,Cancer Research,,,Article,2016-03-15,10.1158/0008-5472.can-15-1898,,,,26795349,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6190323,https://api.altmetric.com/v1/donut/6190323_240.png 2,Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2016-03-08,10.1517/13543784.2016.1162784,,,,26954621,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6172826,https://api.altmetric.com/v1/donut/6172826_240.png 2,Prostate Cancer Prevention: Concepts and Clinical Trials,Current Urology Reports,,,Article,2016-03-09,10.1007/s11934-016-0587-1,,,,26957512,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6158185,https://api.altmetric.com/v1/donut/6158185_240.png 2,Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE,Prostate Cancer & Prostatic Diseases,,,Article,2016-03-01,10.1038/pcan.2016.5,,,,26926927,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6034839,https://api.altmetric.com/v1/donut/6034839_240.png 2,The Molecular and Cellular Origin of Human Prostate Cancer,Biochimica et Biophysica Acta (BBA),,,Article,2016-02-24,10.1016/j.bbamcr.2016.02.016,,,,26921821,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/6016131,https://api.altmetric.com/v1/donut/6016131_240.png 2,"Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.010: Radical Prostatectomy Versus Radiation for Clinically Localized Prostate Cancer: Two Systematic Reviews and a Randomized Controlled Trial",European Urology,,,Article,2016-02-28,10.1016/j.eururo.2016.02.042,,,,26935558,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6015292,https://api.altmetric.com/v1/donut/6015292_240.png 2,"Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.010",European Urology,,,Article,2016-02-28,10.1016/j.eururo.2016.02.043,,,,26935557,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6015291,https://api.altmetric.com/v1/donut/6015291_240.png 2,"Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.010",European Urology,,,Article,2016-02-27,10.1016/j.eururo.2016.02.041,,,,26928380,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6012227,https://api.altmetric.com/v1/donut/6012227_240.png 2,"Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.010",European Urology,,,Article,2016-02-27,10.1016/j.eururo.2016.02.039,,,,26928379,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6012226,https://api.altmetric.com/v1/donut/6012226_240.png 2,"Reply from Authors re: Martin Spahn, Alan Dal Pra, Daniel Aebersold, Bertrand Tombal. Radiation Therapy Versus Radical Prostatectomy: A Never-ending Discussion. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.01.049: Prostate Cancer Treatment: Take Out the Emotion, Please",European Urology,,,Article,2016-02-26,10.1016/j.eururo.2016.02.038,,,,26924768,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6006519,https://api.altmetric.com/v1/donut/6006519_240.png 2,"Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.010",European Urology,,,Article,2016-02-25,10.1016/j.eururo.2016.02.040,,,,26922406,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6001631,https://api.altmetric.com/v1/donut/6001631_240.png 2,"Malignant field signature analysis in biopsy samples at diagnosis identifies lethal disease in patients with localized Gleason 6 and 7 prostate cancer",,,,Article,,,,,,,,,,1602.06504,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5971947,https://api.altmetric.com/v1/donut/5971947_240.png 2,Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities,Seminars in Nuclear Medicine,,,Article,2016-02-22,10.1053/j.semnuclmed.2015.10.005,,,,26897720,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5911952,https://api.altmetric.com/v1/donut/5911952_240.png 2,Isolation of Three New Annonacous Acetogenins from Graviola Fruit (Annona muricata) and their Anti-Proliferation on Human Prostate Cancer Cell PC-3 ,Bioorganic & Medicinal Chemistry Letters,,,Article,2015-06-01,10.1016/j.bmcl.2015.06.038,,,,27499453,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/5608752,https://api.altmetric.com/v1/donut/5608752_240.png 2,Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers,BMC Cancer,,,Article,2016-02-09,10.1186/s12885-016-2127-2,,,,26856686,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5310988,https://api.altmetric.com/v1/donut/5310988_240.png 2,PSMA PET in Prostate Cancer,Journal of Nuclear Medicine,,,Article,2015-08-01,10.2967/jnumed.115.157339,,,,25977465,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/5306926,https://api.altmetric.com/v1/donut/5306926_240.png 2,"Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460–7",European Urology,,,Article,2016-02-10,10.1016/j.eururo.2016.01.042,,,,26873838,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5298690,https://api.altmetric.com/v1/donut/5298690_240.png 2,Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells,Tumor Biology,,,Article,2016-02-05,10.1007/s13277-016-4925-1,,,,26846108,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5100064,https://api.altmetric.com/v1/donut/5100064_240.png 2,Phosphoproteome analysis demonstrates the potential role of THRAP3 phosphorylation in androgen-independent prostate cancer cell growth.,PROTEOMICS,,,Article,2016-02-01,10.1002/pmic.201500365,,,,26841317,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5081743,https://api.altmetric.com/v1/donut/5081743_240.png 2,Diving Into Cabazitaxel's Mode of Action: More Than a Taxane for the Treatment of Castration-Resistant Prostate Cancer Patients.,Clinical Genitourinary Cancer,,,Article,2016-02-02,10.1016/j.clgc.2015.12.030,,,,26827258,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5076199,https://api.altmetric.com/v1/donut/5076199_240.png 2,Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-28,10.1016/j.ijrobp.2016.01.032,,,,27131082,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5059511,https://api.altmetric.com/v1/donut/5059511_240.png 2,Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.,European review for medical and pharmacological sciences,,,Article,2016-01-28,,,,,26813459,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5054689,https://api.altmetric.com/v1/donut/5054689_240.png 2,Prostate cancer: MCT4 is a novel target for prostate cancer,Nature Reviews Urology,,,Article,2016-01-27,10.1038/nrurol.2016.14,,,,26813951,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5048083,https://api.altmetric.com/v1/donut/5048083_240.png 2,Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-19,10.1038/pcan.2015.66,,,,26782712,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5033395,https://api.altmetric.com/v1/donut/5033395_240.png 2,"Demographic, Social Support, and Community Differences in Predictors of African?American and White Men Receiving Prostate Cancer Screening in the United States",Public Health Nursing,,,Article,2016-01-01,10.1111/phn.12245,,,,26790837,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5029113,https://api.altmetric.com/v1/donut/5029113_240.png 2,[ 18 F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results,Radiation Oncology,,,Article,2016-01-22,10.1186/s13014-016-0586-x,,,,26796633,PMC4722628,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5024985,https://api.altmetric.com/v1/donut/5024985_240.png 2,"Surgical Guidance in Prostate Cancer: ""From Molecule to Man"" Translations.",Clinical Cancer Research,,,Article,2016-01-21,10.1158/1078-0432.ccr-15-2575,,,,26712691,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5023186,https://api.altmetric.com/v1/donut/5023186_240.png 2,Active surveillance in prostate cancer: a concept analysis,Journal of Clinical Nursing,,,Article,2016-01-01,10.1111/jocn.13111,,,,26786713,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5015106,https://api.altmetric.com/v1/donut/5015106_240.png 2,68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer,European Urology,,,Article,2016-01-20,10.1016/j.eururo.2015.12.051,,,,26810345,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5014972,https://api.altmetric.com/v1/donut/5014972_240.png 2,Correlation of intraprostatic tumor extent with 68-Ga-PSMA distribution in patients with prostate cancer.,Journal of Nuclear Medicine,,,Article,2016-01-17,10.2967/jnumed.115.169243,,,,26769858,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5004248,https://api.altmetric.com/v1/donut/5004248_240.png 2,(11)C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes.,RadioGraphics,,,Article,2016-01-14,10.1148/rg.2016150135,,,,26761541,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4992535,https://api.altmetric.com/v1/donut/4992535_240.png 2,Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.,Journal of Translational Medicine,,,Article,2016-01-13,10.1186/s12967-015-0747-y,,,,26762579,PMC4712499,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4989071,https://api.altmetric.com/v1/donut/4989071_240.png 2,(68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-01-13,10.1007/s00259-015-3302-4,,,,26753602,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4987430,https://api.altmetric.com/v1/donut/4987430_240.png 2,Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer,European Urology,,,Article,2016-02-01,10.1016/j.eururo.2015.10.059,,,,26758517,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4983357,https://api.altmetric.com/v1/donut/4983357_240.png 2,miRNAs as novel biomarkers in the management of prostate cancer,Clinical Chemistry & Laboratory Medicine,,,Article,2016-01-12,10.1515/cclm-2015-1073,,,,26751899,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4983059,https://api.altmetric.com/v1/donut/4983059_240.png 2,Invited Commentary on “Molecular Imaging of Prostate Cancer”,RadioGraphics,,,Article,,10.1148/rg.2016150238,,,,26587891,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4980180,https://api.altmetric.com/v1/donut/4980180_240.png 2,Patient educational technologies and their use by patients diagnosed with localized prostate cancer,BMC Health Services Research,,,Article,2015-09-29,10.1186/s12913-015-1090-y,,,,26420285,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4966855,https://api.altmetric.com/v1/donut/4966855_240.png 2,Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.,Japanese Journal of Clinical Oncology,,,Article,2016-01-07,10.1093/jjco/hyv181,,,,26732384,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4964860,https://api.altmetric.com/v1/donut/4964860_240.png 2,"Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.",International Journal of Clinical and Experimental Pathology,,,Article,2016-01-02,,,,,26722441,PMC4680386,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4945522,https://api.altmetric.com/v1/donut/4945522_240.png 2,Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory,International Journal of Epidemiology,,,Article,2015-12-31,10.1093/ije/dyv305,,,,26659904,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4938958,https://api.altmetric.com/v1/donut/4938958_240.png 2,"Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway.",Pharmaceutical Research,,,Article,2009-10-14,10.1007/s11095-009-9948-5,,,,19669099,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4923241,https://api.altmetric.com/v1/donut/4923241_240.png 2,Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.,Oncotarget,,,Article,2015-12-25,10.18632/oncotarget.6678,,,,26700622,PMC4826179,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4922960,https://api.altmetric.com/v1/donut/4922960_240.png 2,ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.,Cell Cycle,,,Article,2015-12-24,10.1080/15384101.2015.1127478,,,,26694952,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4919797,https://api.altmetric.com/v1/donut/4919797_240.png 2,Prostate cancer: Suppressing a wrong kind of transition,Nature Reviews Urology,,,Article,2015-12-22,10.1038/nrurol.2015.302,,,,26689841,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4910664,https://api.altmetric.com/v1/donut/4910664_240.png 2,Prostate cancer: Avoiding unnecessary MRIs,Nature Reviews Urology,,,Article,2015-12-22,10.1038/nrurol.2015.304,,,,26689839,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4910585,https://api.altmetric.com/v1/donut/4910585_240.png 2,MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.,OncoTargets and therapy,,,Article,2015-12-17,10.2147/ott.s92314,,,,26719710,PMC4689268,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/4904667,https://api.altmetric.com/v1/donut/4904667_240.png 2,The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers,Journal of Mass Spectrometry,,,Article,2016-01-01,10.1002/jms.3728,,,,26757076,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4904548,https://api.altmetric.com/v1/donut/4904548_240.png 2,Prostate cancer: Cardiac mortality associated with ADT plus radiotherapy,Nature Reviews Urology,,,Article,2015-12-15,10.1038/nrurol.2015.295,,,,26666365,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4878065,https://api.altmetric.com/v1/donut/4878065_240.png 2,"Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction.",,,,Article,,10.1159/000093805,,,,16763406,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4874646,https://api.altmetric.com/v1/donut/4874646_240.png 2,"Reply from Authors re: Giorgio Gandaglia, Alberto Briganti, Andrea Salonia, Francesco Montorsi. Excellent Erectile Function Recovery after Focal Therapy: Is This Enough? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.11.014: Focal Therapy Preserves Erectile Function in Men with Prostate Cancer",European Urology,,,Article,2015-12-14,10.1016/j.eururo.2015.11.037,,,,26695002,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4873595,https://api.altmetric.com/v1/donut/4873595_240.png 2,"Re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management Among Men aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805–11",European Urology,,,Article,2015-12-10,10.1016/j.eururo.2015.11.032,,,,26683758,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4860149,https://api.altmetric.com/v1/donut/4860149_240.png 2,HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells,Experimental Biology and Medicine,,,Article,2015-12-09,10.1177/1535370215618518,,,,26643866,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4856844,https://api.altmetric.com/v1/donut/4856844_240.png 2,Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer ,Advanced Drug Delivery Reviews,,,Article,2015-12-15,10.1016/j.addr.2015.11.017,,,,26656603,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4854090,https://api.altmetric.com/v1/donut/4854090_240.png 2,Ability of PITX2 methylation to predict survival in patients with prostate cancer,OncoTargets and therapy,,,Article,2015-11-24,10.2147/ott.s83914,,,,26648742,PMC4664542,,,,,,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4853753,https://api.altmetric.com/v1/donut/4853753_240.png 2,The landscape of prognostic outlier genes in high-risk prostate cancer,Clinical Cancer Research,,,Article,2015-12-07,10.1158/1078-0432.ccr-15-1250,,,,26631616,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4848517,https://api.altmetric.com/v1/donut/4848517_240.png 2,Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism,International Journal of Molecular Sciences,,,Article,2015-12-04,10.3390/ijms161226138,,,,26690121,PMC4691085,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4841124,https://api.altmetric.com/v1/donut/4841124_240.png 2,Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.,Oncotarget,,,Article,2015-12-02,10.18632/oncotarget.6372,,,,26625310,PMC4811464,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4831443,https://api.altmetric.com/v1/donut/4831443_240.png 2,Active Surveillance Challenges in Men with Prostate Cancer: Role of Imaging Today and Tomorrow,European Urology,,,Article,2015-12-02,10.1016/j.eururo.2015.11.015,,,,26651927,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4830291,https://api.altmetric.com/v1/donut/4830291_240.png 2,Utility of the Oncotype DX® Prostate Cancer Assay in Clinical Practice for Treatment Selection in Men Newly Diagnosed with Prostate Cancer: A Retrospective Chart Review Analysis,Urology Practice,,,Article,2015-01-11,10.1016/j.urpr.2015.02.007,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4823486,https://api.altmetric.com/v1/donut/4823486_240.png 2,Counseling men with prostate cancer and their partners,Sexual and Relationship Therapy,,,Article,,10.1080/14681994.2015.1102876,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4801458,https://api.altmetric.com/v1/donut/4801458_240.png 2,The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer.,BioMed Research International,,,Article,2015-11-21,10.1155/2015/454837,,,,26587537,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4792078,https://api.altmetric.com/v1/donut/4792078_240.png 2,Cyclin D1 promotes androgen-dependent DNA damage repair in prostate cancer cells,Cancer Research,,,Article,2015-11-20,10.1158/0008-5472.can-15-0999,,,,26582866,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4787738,https://api.altmetric.com/v1/donut/4787738_240.png 2,Principles for Developing Digital Health Interventions for Prostate Cancer: A Community-Based Design Approach with African American Men,,,,Article,2015-08-02,10.1007/978-3-319-20913-5_13,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4775681,https://api.altmetric.com/v1/donut/4775681_240.png 2,Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation,Medical Physics,,,Article,2015-11-13,10.1118/1.4935529,,,,26632056,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4759170,https://api.altmetric.com/v1/donut/4759170_240.png 2,Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells.,Journal of Visualized Experiments,,,Article,2015-11-12,10.3791/53182,,,,26555435,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4753117,https://api.altmetric.com/v1/donut/4753117_240.png 2,Integration of metabolomics and transcriptomics reveals major metabolic pathways and potential biomarker involved in prostate cancer.,Molecular and Cellular Proteomics (MCP Online),,,Article,2015-11-08,10.1074/mcp.m115.052381,,,,26545398,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4738372,https://api.altmetric.com/v1/donut/4738372_240.png 2,"A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study.",Radiotherapy & Oncology,,,Article,2015-11-10,10.1016/j.radonc.2015.10.021,,,,26549865,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4732784,https://api.altmetric.com/v1/donut/4732784_240.png 2,Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.,Cancer Investigation,,,Article,2015-11-05,10.3109/07357907.2015.1081921,,,,26536157,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4728108,https://api.altmetric.com/v1/donut/4728108_240.png 2,Treatment improves for localized prostate cancer,Cancer (0008543X),,,Article,2015-11-15,10.1002/cncr.29757,,,,26536526,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4723834,https://api.altmetric.com/v1/donut/4723834_240.png 2,Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling,Clinical Cancer Research,,,Article,2015-11-04,10.1158/1078-0432.ccr-15-1632,,,,26527749,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4718447,https://api.altmetric.com/v1/donut/4718447_240.png 2,Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2015-11-04,10.1158/1078-0432.ccr-15-1432,,,,26527750,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4718434,https://api.altmetric.com/v1/donut/4718434_240.png 2,Budget Impact Model for the Use of PCA3 Urine Testing in Prostate Cancer Screening,Urology Practice,,,Article,2015-01-11,10.1016/j.urpr.2015.05.004,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4714614,https://api.altmetric.com/v1/donut/4714614_240.png 2,Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer,Oncologist,,,Article,,10.1634/theoncologist.2015-0214,,,,26482553,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4706285,https://api.altmetric.com/v1/donut/4706285_240.png 2,PSMA ligands for diagnosis and therapy of prostate cancer,Cancer Imaging,,,Article,2014-10-09,10.1186/1470-7330-14-s1-o10,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4701668,https://api.altmetric.com/v1/donut/4701668_240.png 2,"Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study.",BMC Cancer,,,Article,2015-10-21,10.1186/s12885-015-1771-2,,,,26486598,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4655676,https://api.altmetric.com/v1/donut/4655676_240.png 2,"The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer",Journal of Experimental & Clinical Cancer Research,,,Article,2015-10-21,10.1186/s13046-015-0240-8,,,,26480944,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4653508,https://api.altmetric.com/v1/donut/4653508_240.png 2,"For Older Men with Advanced Prostate Cancer, Advice to Add Radiation Therapy to ADT",Oncology times,,,Article,2015-10-25,10.1097/01.cot.0000473100.33455.cb,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4627207,https://api.altmetric.com/v1/donut/4627207_240.png 2,Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth,PLoS ONE,,,Article,2015-10-06,10.1371/journal.pone.0139709,,,,26439622,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4609006,https://api.altmetric.com/v1/donut/4609006_240.png 2,"Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer",Clinical Cancer Research,,,Article,2015-10-09,10.1158/1078-0432.ccr-15-0256,,,,26446945,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4600865,https://api.altmetric.com/v1/donut/4600865_240.png 2,Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates,Annals of Behavioral Medicine,,,Article,2015-02-28,10.1007/s12160-015-9692-5,,,,25724634,,,,,,,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4599606,https://api.altmetric.com/v1/donut/4599606_240.png 2,Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading,Prostate Cancer & Prostatic Diseases,,,Article,2015-10-06,10.1038/pcan.2015.44,,,,26439747,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4596316,https://api.altmetric.com/v1/donut/4596316_240.png 2,Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models,PLoS ONE,,,Article,2015-10-07,10.1371/journal.pone.0139871,,,,26440411,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4595608,https://api.altmetric.com/v1/donut/4595608_240.png 2,Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease–Induced Congestive Heart Failure or Myocardial Infarction,JAMA: Journal of the American Medical Association,,,Article,2009-08-25,10.1001/jama.2009.1137,,,,19706860,,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4595159,https://api.altmetric.com/v1/donut/4595159_240.png 2,Measuring depression in prostate cancer patients: does the scale used make a difference?,European Journal of Cancer Care,,,Article,2015-09-01,10.1111/ecc.12393,,,,26428948,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4578622,https://api.altmetric.com/v1/donut/4578622_240.png 2,Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients,"Cancer Immunology, Immunotherapy",,,Article,2015-10-01,10.1007/s00262-015-1756-7,,,,26428930,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4577459,https://api.altmetric.com/v1/donut/4577459_240.png 2,What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-10-01,,,,,26408734,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4574930,https://api.altmetric.com/v1/donut/4574930_240.png 2,Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.,Tumor Biology,,,Article,2015-09-30,10.1007/s13277-015-4113-8,,,,26415734,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4570032,https://api.altmetric.com/v1/donut/4570032_240.png 2,Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer,Cancer Biology and Therapy,,,Article,2015-09-18,10.1080/15384047.2015.1078023,,,,26383180,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4562687,https://api.altmetric.com/v1/donut/4562687_240.png 2,LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer,Cell Reports,,,Article,2015-09-29,10.1016/j.celrep.2015.08.069,,,,26411689,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4561731,https://api.altmetric.com/v1/donut/4561731_240.png 2,Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy,British Journal of Cancer,,,Article,2008-01-15,10.1038/sj.bjc.6604052,,,,18182981,PMC2359682,,,,,,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4559593,https://api.altmetric.com/v1/donut/4559593_240.png 2,Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters,Carcinogenesis,,,Article,2015-11-01,10.1093/carcin/bgv137,,,,26392259,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4559335,https://api.altmetric.com/v1/donut/4559335_240.png 2,Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells ,Journal of Controlled Release,,,Article,,10.1016/j.jconrel.2015.09.031,,,,26390807,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/4555270,https://api.altmetric.com/v1/donut/4555270_240.png 2,(68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-09-25,10.1007/s00259-015-3188-1,,,,26404016,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4551936,https://api.altmetric.com/v1/donut/4551936_240.png 2,High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry.,Familial Cancer,,,Article,2014-08-12,10.1007/s10689-014-9744-1,,,,25117503,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4538078,https://api.altmetric.com/v1/donut/4538078_240.png 2,Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms,The Prostate,,,Article,2015-09-19,10.1002/pros.23092,,,,26383637,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4531122,https://api.altmetric.com/v1/donut/4531122_240.png 2,Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer,Nuclear Medicine Communications,,,Article,2015-09-18,10.1097/mnm.0000000000000383,,,,26378490,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4528747,https://api.altmetric.com/v1/donut/4528747_240.png 2,Splicing factor Prp8 interacts with NESAR and regulates androgen receptor in prostate cancer cells,Molecular Endocrinology,,,Article,2015-09-16,10.1210/me.2015-1112,,,,26371515,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4516236,https://api.altmetric.com/v1/donut/4516236_240.png 2,Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer,PeerJ,,,Article,2015-09-15,10.7717/peerj.1232,,,,26401448,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4509523,https://api.altmetric.com/v1/donut/4509523_240.png 2,ABO blood type correlates with survival on prostate cancer vaccine therapy.,Oncotarget,,,Article,2015-09-05,10.18632/oncotarget.4993,,,,26338967,PMC4741674,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4475694,https://api.altmetric.com/v1/donut/4475694_240.png 2,First Indication Chemotherapy Has Role in Adjuvant Therapy of Localized Prostate Cancer,Oncology times,,,Article,2015-08-25,10.1097/01.cot.0000471130.82578.7f,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4473386,https://api.altmetric.com/v1/donut/4473386_240.png 2,Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo.,Scientific Reports,,,Article,,10.1038/srep13006,,,,26302712,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4456287,https://api.altmetric.com/v1/donut/4456287_240.png 2,The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism,Scientific Reports,,,Article,2015-09-01,10.1038/srep13528,,,,26314494,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4445252,https://api.altmetric.com/v1/donut/4445252_240.png 2,"Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer",Radiation Oncology,,,Article,2015-08-28,10.1186/s13014-015-0488-3,,,,26310244,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4443800,https://api.altmetric.com/v1/donut/4443800_240.png 2,"Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy",Radiotherapy & Oncology,,,Article,2015-09-01,10.1016/j.radonc.2015.08.019,,,,26318662,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4441565,https://api.altmetric.com/v1/donut/4441565_240.png 2,Does Radiotherapy Plus Androgen-Deprivation Therapy Represent the Best Treatment Approach in Elderly Patients With Locally Advanced Prostate Cancer?,Journal of Clinical Oncology,,,Article,2015-09-01,10.1200/jco.2015.61.0964,,,,26215938,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4428598,https://api.altmetric.com/v1/donut/4428598_240.png 2,"Reply from Authors re: Adri C. Voogd, Rob H.A. Verhoeven. Treatment of the Primary Tumour in the Presence of Metastases: Lessons from Breast Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.06.024Reply from Authors re: Alfred I. Neugut, Edward P. Gelmann. Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.06.004: The Time Is Ripe to Test the Hypothesis that Radical Prostatectomy Improves Survival in Men with Distant Metastatic Prostate Cancer",European Urology,,,Article,2015-08-23,10.1016/j.eururo.2015.07.032,,,,26306698,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4425144,https://api.altmetric.com/v1/donut/4425144_240.png 2,Metastatic Prostate Cancer to the Left Temporal Bone: A Case Report and Review of the Literature.,Case Reports in Otolaryngology,,,Article,2015-01-01,10.1155/2015/250312,,,,26294996,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4423465,https://api.altmetric.com/v1/donut/4423465_240.png 2,A robust blood gene expression-based prognostic model for castration-resistant prostate cancer,BMC Medicine,,,Article,2015-08-21,10.1186/s12916-015-0442-0,,,,26297150,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4421383,https://api.altmetric.com/v1/donut/4421383_240.png 2,Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial,Trials,,,Article,2015-05-27,10.1186/s13063-015-0750-x,,,,26012700,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4418617,https://api.altmetric.com/v1/donut/4418617_240.png 2,Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival,Oncogene,,,Article,2015-08-17,10.1038/onc.2015.309,,,,26279298,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4414166,https://api.altmetric.com/v1/donut/4414166_240.png 2,Abstract 5314: Evaluation of C-phycocyanin and anticancer drug combination for inducing apoptosis in LNCaP prostate cancer cells,Cancer Research,,,Article,2015-08-01,10.1158/1538-7445.am2015-5314,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4406848,https://api.altmetric.com/v1/donut/4406848_240.png 2,Physical activity and prostate tumor vessel morphology: data from the Health Professionals Follow-up Study.,Cancer Prevention Research,,,Article,2015-08-16,10.1158/1940-6207.capr-15-0132,,,,26276753,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4402368,https://api.altmetric.com/v1/donut/4402368_240.png 2,The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer,American Journal of Pathology,,,Article,2015-08-15,10.1016/j.ajpath.2015.06.013,,,,26272362,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4400185,https://api.altmetric.com/v1/donut/4400185_240.png 2,Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.,,,,Article,2008-05-14,10.1056/nejmcpc0707057,,,,18480209,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/4393151,https://api.altmetric.com/v1/donut/4393151_240.png 2,Revolution in prostate cancer treatment,Trends in Urology and Men's Health,,,Article,2015-07-01,10.1002/tre.465,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4389330,https://api.altmetric.com/v1/donut/4389330_240.png 2,Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass,American Journal of Clinical Pathology,,,Article,2015-08-01,10.1309/ajcpql9mkq6vddwl,,,,26185312,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4376528,https://api.altmetric.com/v1/donut/4376528_240.png 2,Invited Commentary: Screening and the Elusive Etiology of Prostate Cancer.,American Journal of Epidemiology,,,Article,2015-08-04,10.1093/aje/kwv086,,,,26243738,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4370279,https://api.altmetric.com/v1/donut/4370279_240.png 2,PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2012-11-24,10.1007/s00259-012-2298-2,,,,23179945,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,105,https://www.altmetric.com/details/4366221,https://api.altmetric.com/v1/donut/4366221_240.png 2,Prostate Cancer: No Benefit for More Radiation in Low-Risk Disease,Oncology times,,,Article,2015-08-10,10.1097/01.cot.0000470873.69920.a5,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4347881,https://api.altmetric.com/v1/donut/4347881_240.png 2,"Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis",Radiation Oncology,,,Article,2015-07-30,10.1186/s13014-015-0470-0,,,,26220664,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4343146,https://api.altmetric.com/v1/donut/4343146_240.png 2,Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity,Cancer Research,,,Article,2015-07-27,10.1158/0008-5472.can-15-0234,,,,26208903,,,,,,,0,0,0,15,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4333498,https://api.altmetric.com/v1/donut/4333498_240.png 2,Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET/CT: preliminary report of in six patients.,Annals of translational medicine,,,Article,2015-06-01,10.3978/j.issn.2305-5839.2015.06.10,,,,26207238,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4329680,https://api.altmetric.com/v1/donut/4329680_240.png 2,The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance,Urology Practice,,,Article,2015-01-07,10.1016/j.urpr.2014.10.010,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4305532,https://api.altmetric.com/v1/donut/4305532_240.png 2,Increased expression of ARF GTPases in prostate cancer tissue,SpringerPlus,,,Article,2015-07-12,10.1186/s40064-015-1136-y,,,,26185744,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4288677,https://api.altmetric.com/v1/donut/4288677_240.png 2,Clinical evaluation of a computer-aided diagnosis system for determining cancer aggressiveness in prostate MRI.,European Radiology,,,Article,2015-06-10,10.1007/s00330-015-3743-y,,,,26060063,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4276627,https://api.altmetric.com/v1/donut/4276627_240.png 2,"Detection of Circulating Tumor Cells in Patients with Breast, Prostate, Pancreatic, Colon and Melanoma Cancer: A Blinded Comparative Study Using Healthy Donors",Journal of Cancer Therapy,,,Article,2015-07-07,10.4236/jct.2015.67059,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4254342,https://api.altmetric.com/v1/donut/4254342_240.png 2,Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.,Genetics and Molecular Research,,,Article,2015-07-01,10.4238/2015.june.29.14,,,,26125931,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4231183,https://api.altmetric.com/v1/donut/4231183_240.png 2,Prostate cancer: Transdifferentiate to prevail,Nature Reviews Urology,,,Article,2015-06-30,10.1038/nrurol.2015.156,,,,26123038,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4227562,https://api.altmetric.com/v1/donut/4227562_240.png 2,Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy,PLoS ONE,,,Article,2015-06-19,10.1371/journal.pone.0130565,,,,26090669,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4216483,https://api.altmetric.com/v1/donut/4216483_240.png 2,A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy.,Scientific Reports,,,Article,2015-06-26,10.1038/srep10544,,,,26112134,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4215483,https://api.altmetric.com/v1/donut/4215483_240.png 2,Multiplex pyrosequencing assay using AdvISER-MH-PYRO algorithm: a case for rapid and cost-effective genotyping analysis of prostate cancer risk-associated SNPs.,BMC Medical Genetics,,,Article,2015-06-25,10.1186/s12881-015-0186-x,,,,26108440,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4209808,https://api.altmetric.com/v1/donut/4209808_240.png 2,Considering race and the potential for ERG expression as a biomarker for prostate cancer,Personalized Medicine,,,Article,2014-06-01,10.2217/pme.14.26,,,,25544850,PMC4276316,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4202058,https://api.altmetric.com/v1/donut/4202058_240.png 2,The DAXX co-repressor is directly recruited to active regulatory elements genome-wide to regulate autophagy programs in a model of human prostate cancer.,Oncoscience,,,Article,2015-01-01,10.18632/oncoscience.152,,,,26097870,PMC4468322,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4199846,https://api.altmetric.com/v1/donut/4199846_240.png 2,Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer.,Nuclear Medicine and Molecular Imaging,,,Article,2015-06-01,10.1007/s13139-014-0314-0,,,,26082811,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4183717,https://api.altmetric.com/v1/donut/4183717_240.png 2,"Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.",Oncotarget,,,Article,2015-06-17,10.18632/oncotarget.4145,,,,26078335,PMC4627245,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4176801,https://api.altmetric.com/v1/donut/4176801_240.png 2,Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer,Korean Journal of Urology,,,Article,2015-06-01,10.4111/kju.2015.56.6.435,,,,26078840,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4174103,https://api.altmetric.com/v1/donut/4174103_240.png 2,Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer,International Journal of Molecular Sciences,,,Article,2015-06-11,10.3390/ijms160613322,,,,26110379,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4137231,https://api.altmetric.com/v1/donut/4137231_240.png 2,Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study,Radiation Oncology,,,Article,2015-06-10,10.1186/s13014-015-0434-4,,,,26054532,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4129035,https://api.altmetric.com/v1/donut/4129035_240.png 2,Drug discovery in prostate cancer mouse models.,Expert Opinion on Drug Discovery,,,Article,2015-06-02,10.1517/17460441.2015.1052790,,,,26027638,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4080973,https://api.altmetric.com/v1/donut/4080973_240.png 2,"Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men.",American Journal of Men's Health,,,Article,2015-05-18,10.1177/1557988315584794,,,,25986045,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4078310,https://api.altmetric.com/v1/donut/4078310_240.png 2,A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit.,"Cancer Immunology, Immunotherapy",,,Article,2015-06-01,10.1007/s00262-015-1717-1,,,,26026288,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4077323,https://api.altmetric.com/v1/donut/4077323_240.png 2,Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats.,Journal of Toxicologic Pathology,,,Article,2015-01-01,10.1293/tox.2014-0050,,,,26023257,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4073754,https://api.altmetric.com/v1/donut/4073754_240.png 2,Why Chemotherapy Should be Given Early for Men with Metastatic Prostate Cancer,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2015-05-30,10.14694/edbook_am.2015.35.e263,,,,25993184,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4073136,https://api.altmetric.com/v1/donut/4073136_240.png 2,"Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.",Pharmacoepidemiology & Drug Safety,,,Article,2015-05-27,10.1002/pds.3807,,,,26017274,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4063052,https://api.altmetric.com/v1/donut/4063052_240.png 2,Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.,,,,Article,2005-01-15,10.1002/eji.200425531,,,,15597325,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4052546,https://api.altmetric.com/v1/donut/4052546_240.png 2,Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.,Medical Oncology,,,Article,,10.1007/s12032-015-0593-z,,,,25850653,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4030375,https://api.altmetric.com/v1/donut/4030375_240.png 2,Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells,Molecular Biology of the Cell,,,Article,2015-06-01,10.1091/mbc.e14-12-1634,,,,25851605,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4030099,https://api.altmetric.com/v1/donut/4030099_240.png 2,Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.,Epigenetics,,,Article,,10.1080/15592294.2015.1022019,,,,25864488,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4026335,https://api.altmetric.com/v1/donut/4026335_240.png 2,"Commentary on: ""Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial."" Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR, CA184-043 Investigators. Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA, Electronic address: kwon.eugene@mayo.edu; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; Institut Gustave Roussy, University of Paris-Sud, Villejuif, France; Institut Gustave Roussy, Villejuif, France; VU University Medical Centre, Amsterdam, Netherlands; Vienna General Hospital, Medical University Vienna, Vienna, Austria; Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France; Centro Médico Austral, Buenos Aires, Argentina; Centre Jean Perrin, Clermont-Ferrand, France; St John of God Hospital, Subiaco, WA, Australia; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy; Hospital de Caridade de Ijuí, Ijuí, Brazil; Nottingham University Hospital, Nottingham, UK; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania; Hospital Británico de Buenos Aires, Buenos Aires, Argentina; Herlev Hospital, Herlev, Denmark; Odense University Hospital, Odense, Denmark; University of Texas MD Anderson Cancer Center, Houston, TX, USA; Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA; Bristol-Myers Squibb, Wallingford, CT, USA; Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.",Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.03.013,,,,25907621,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4023741,https://api.altmetric.com/v1/donut/4023741_240.png 2,Comparative Analysis of Prostate Cancer Gene Regulatory Networks via Hub Type Variation.,Avicenna Journal of Medical Biotechnology,,,Article,2015-01-01,,,,,25926947,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4021550,https://api.altmetric.com/v1/donut/4021550_240.png 2,Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14(+) PD-L1(+) phenotype in prostate cancer.,"Transactions of the Institute of Measurement and Control, with Measurement + Control",,,Article,2014-10-01,10.4161/21624011.2014.955331,,,,25941611,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4019744,https://api.altmetric.com/v1/donut/4019744_240.png 2,Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo.,Tumor Biology,,,Article,2015-05-21,10.1007/s13277-015-3536-6,,,,25990456,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4012837,https://api.altmetric.com/v1/donut/4012837_240.png 2,Remarkable Pathologic Change in Advanced Prostate Cancer Patient Using Dendritic Cell-Cytokine-Induced Killer Combined Therapy: A Case Report.,Clinical Genitourinary Cancer,,,Article,2015-05-21,10.1016/j.clgc.2015.04.006,,,,25979641,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4006099,https://api.altmetric.com/v1/donut/4006099_240.png 2,Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.,PLoS ONE,,,Article,2015-05-08,10.1371/journal.pone.0126672,,,,25955319,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3981161,https://api.altmetric.com/v1/donut/3981161_240.png 2,Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer.,Current Drug Targets,,,Article,,,,,,25892311,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3962897,https://api.altmetric.com/v1/donut/3962897_240.png 2,The oncogene ERG: a key factor in prostate cancer,Oncogene,,,Article,2015-04-27,10.1038/onc.2015.109,,,,25915839,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3948973,https://api.altmetric.com/v1/donut/3948973_240.png 2,Salt-Inducible Kinase 2 Regulates Mitotic Progression and Transcription in Prostate Cancer,Molecular Cancer Research,,,Article,2014-12-29,10.1158/1541-7786.mcr-13-0182-t,,,,25548099,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/3922032,https://api.altmetric.com/v1/donut/3922032_240.png 2,Bioactive Natural Products against Prostate Cancer: Mechanism of Action and Autophagic/Apoptotic Molecular Pathways,Planta Medica,,,Article,2015-04-15,10.1055/s-0035-1545845,,,,25875508,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3918621,https://api.altmetric.com/v1/donut/3918621_240.png 2,Possible immunotherapeutic potentiation with D-Fraction in prostate cancer cells,,,,Article,2015-04-17,10.1186/1756-8722-1-25,,,,19055833,PMC2613393,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3918153,https://api.altmetric.com/v1/donut/3918153_240.png 2,Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer,Investigative Radiology,,,Article,2015-04-10,10.1097/rli.0000000000000155,,,,25867657,,,,,,,0,0,0,4,0,0,3,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3912439,https://api.altmetric.com/v1/donut/3912439_240.png 2,"Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon and lung cancer ",Free Radical Biology & Medicine,,,Article,2015-04-14,10.1016/j.freeradbiomed.2015.04.001,,,,25866291,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/3907784,https://api.altmetric.com/v1/donut/3907784_240.png 2,Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices,International Journal of Cancer,,,Article,2001-12-30,10.1002/ijc.10185,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,29,https://www.altmetric.com/details/3899016,https://api.altmetric.com/v1/donut/3899016_240.png 2,Low-Dose-Rate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavourable Risk Prostate Cancer: The Results of the ASCENDE-RT* Randomized Control Trial,Brachytherapy,,,Article,,10.1016/j.brachy.2015.02.200,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3879456,https://api.altmetric.com/v1/donut/3879456_240.png 2,Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-04-07,10.1016/j.ijrobp.2015.01.051,,,,25841621,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3862204,https://api.altmetric.com/v1/donut/3862204_240.png 2,Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate–Treated Castration-Resistant Prostate Cancer Patients,Clinical Cancer Research,,,Article,2015-04-02,10.1158/1078-0432.ccr-14-1549,,,,25829400,,1854/LU-7155718,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3859549,https://api.altmetric.com/v1/donut/3859549_240.png 2,Surgery for rectal cancer after high-dose radiotherapy for prostate cancer: is sphincter preservation relevant?,Colorectal Disease,,,Article,2015-04-01,10.1111/codi.12962,,,,25824545,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3856820,https://api.altmetric.com/v1/donut/3856820_240.png 2,Implications of ubiquitin ligases in castration-resistant prostate cancer,Current opinion in oncology,,,Article,2015-03-25,10.1097/cco.0000000000000178,,,,25811345,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3846621,https://api.altmetric.com/v1/donut/3846621_240.png 2,Retraction Note: Dysregulation of cell cycle related genes and MicroRNAs distinguish the low- from high-risk of prostate cancer.,Diagnostic Pathology,,,Article,2015-03-26,10.1186/s13000-015-0241-0,,,,25884356,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3841149,https://api.altmetric.com/v1/donut/3841149_240.png 2,11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-03-17,10.1097/rlu.0000000000000783,,,,25783519,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3807849,https://api.altmetric.com/v1/donut/3807849_240.png 2,Trends and Outcome from Radical Therapy for Primary Non-Metastatic Prostate Cancer in a UK Population,PLoS ONE,,,Article,2015-03-05,10.1371/journal.pone.0119494,,,,25742020,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3768528,https://api.altmetric.com/v1/donut/3768528_240.png 2,Therapeutic Algorithm Guided by Sequential 11C-Choline PET/CT in a Patient With Metastatic Castration-Resistant Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-02-04,10.1097/rlu.0000000000000758,,,,25742237,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3763569,https://api.altmetric.com/v1/donut/3763569_240.png 2,A Phase I/II Trial of Brief Androgen Suppression and Stereotactic Radiotherapy (FASTR) for High Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-05-06,10.1016/j.ijrobp.2015.02.046,,,,25936597,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3754250,https://api.altmetric.com/v1/donut/3754250_240.png 2,Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer?. Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer?,ecancer.org,,,Article,,,,,http://ecancer.org/video/3500/is-there-a-role-for-androgen-deprivation-therapy-combined-with-radiotherapy-in-intermediate-risk-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3754113,https://api.altmetric.com/v1/donut/3754113_240.png 2,When and whether to conduct endocrine therapy in non-metastatic prostate cancer. When and whether to conduct endocrine therapy in non-metastatic prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3496/when-and-whether-to-conduct-endocrine-therapy-in-non-metastatic-prostate-cancer.php,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3753912,https://api.altmetric.com/v1/donut/3753912_240.png 2,Activated ?2-Macroglobulin Binding to Human Prostate Cancer Cells Triggers Insulin-like Responses.,Journal of Biological Chemistry,,,Article,2015-02-26,10.1074/jbc.m114.617837,,,,25720493,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3741625,https://api.altmetric.com/v1/donut/3741625_240.png 2,FOXP3–miR-146–NF-?B Axis and Therapy for Precancerous Lesions in Prostate,Cancer Research,,,Article,2015-02-23,10.1158/0008-5472.can-14-2109,,,,25712341,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3736316,https://api.altmetric.com/v1/donut/3736316_240.png 2,Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.,Oncotarget,,,Article,2015-01-16,10.18632/oncotarget.2880,,,,25714010,PMC4414162,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3734253,https://api.altmetric.com/v1/donut/3734253_240.png 2,Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice.,Oncotarget,,,Article,2015-01-31,10.18632/oncotarget.3346,,,,25704883,PMC4467427,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3723708,https://api.altmetric.com/v1/donut/3723708_240.png 2,Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells.,Journal of Cellular and Molecular Medicine,,,Article,2015-02-16,10.1111/jcmm.12402,,,,25689150,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3708533,https://api.altmetric.com/v1/donut/3708533_240.png 2,Dendritic Cells Induce Specific Cytotoxic T Lymphocytes against Prostate Cancer TRAMP-C2 Cells Loaded with Freeze- thaw Antigen and PEP-3 Peptide.,Asian Pacific Journal of Cancer Prevention,,,Article,2015-01-01,,,,,25684489,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3707289,https://api.altmetric.com/v1/donut/3707289_240.png 2,"p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines.",Chemico-Biological Interactions,,,Article,2015-02-12,10.1016/j.cbi.2015.02.002,,,,25682698,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3706303,https://api.altmetric.com/v1/donut/3706303_240.png 2,Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer,Asian Journal of Andrology,,,Article,2014-12-01,10.4103/1008-682x.142136,,,,25432498,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3693324,https://api.altmetric.com/v1/donut/3693324_240.png 2,Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study,JGIM: Journal of General Internal Medicine,,,Article,2015-02-13,10.1007/s11606-014-3171-8,,,,25678374,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3613472,https://api.altmetric.com/v1/donut/3613472_240.png 2,Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective,Urology,,,Article,2015-01-04,10.1016/j.urology.2014.11.031,,,,25681834,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3612968,https://api.altmetric.com/v1/donut/3612968_240.png 2,"Re: Farhad Islami, Daniel M. Moreira, Paolo Boffetta, Stephen J. Freedland. A Systematic Review and Meta-analysis of Tobacco Use and Prostate Cancer Mortality and Incidence in Prospective Cohort Studies. Eur Urol 2014;66:1054–64",European Urology,,,Article,2015-02-06,10.1016/j.eururo.2015.01.023,,,,25666849,,,,,,,0,0,0,5,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3428005,https://api.altmetric.com/v1/donut/3428005_240.png 2,Does obesity modify the ability of pre-biopsy PSA to detect prostate cancer on repeat biopsy? Results from the REDUCE study,The Journal of Urology,,,Article,2015-02-05,10.1016/j.juro.2015.01.111,,,,25661298,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3389438,https://api.altmetric.com/v1/donut/3389438_240.png 2,"MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer",Journal of Experimental & Clinical Cancer Research,,,Article,2015-01-31,10.1186/s13046-015-0125-x,,,,25636908,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3222696,https://api.altmetric.com/v1/donut/3222696_240.png 2,Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer,Journal of Cellular and Molecular Medicine,,,Article,2015-01-30,10.1111/jcmm.12481,,,,25639644,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3213215,https://api.altmetric.com/v1/donut/3213215_240.png 2,Effects of zoledronic acid and docetaxel on small GTP-binding proteins in prostate cancer.,Tumor Biology,,,Article,2015-01-29,10.1007/s13277-015-3140-9,,,,25631751,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3167069,https://api.altmetric.com/v1/donut/3167069_240.png 2,Active Surveillance for Localized Prostate Cancer: An Update,Journal Watch,,,Article,,10.1056/nejm-jw.na36863,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3165794,https://api.altmetric.com/v1/donut/3165794_240.png 2,Topical Treatment with Xiaozheng Zhitong Paste (XZP) Alleviates Bone Destruction and Bone Cancer Pain in a Rat Model of Prostate Cancer-Induced Bone Pain by Modulating the RANKL/RANK/OPG Signaling,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,,10.1155/2015/215892,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3108254,https://api.altmetric.com/v1/donut/3108254_240.png 2,Identifying the unmet supportive care needs of men living with and beyond prostate cancer: A systematic review,European Journal of Oncology Nursing,,,Article,2015-01-08,10.1016/j.ejon.2014.12.007,,,,25613370,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3104816,https://api.altmetric.com/v1/donut/3104816_240.png 2,Yinghao Sun: leader of research on prostate cancer in China,The Lancet (British Edition),,,Article,,10.1016/s0140-6736(15)60107-6,,,,,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3098912,https://api.altmetric.com/v1/donut/3098912_240.png 2,Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.,Expert Opinion on Therapeutic Targets,,,Article,2015-01-20,10.1517/14728222.2015.1005603,,,,25600663,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3087833,https://api.altmetric.com/v1/donut/3087833_240.png 2,Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.,The Prostate,,,Article,2015-01-16,10.1002/pros.22932,,,,25597486,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3082517,https://api.altmetric.com/v1/donut/3082517_240.png 2,Malpractice Litigation in the Setting of Prostate Cancer Diagnosis,Urology Practice,,,Article,2015-01-01,10.1016/j.urpr.2014.07.004,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3073966,https://api.altmetric.com/v1/donut/3073966_240.png 2,XAGE-1b Cancer/Testis Antigen Is a Potential Target for Immunotherapy in Prostate Cancer.,Urologia Internationalis,,,Article,2015-01-13,10.1159/000363333,,,,25572590,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3066729,https://api.altmetric.com/v1/donut/3066729_240.png 2,Re: Can Magnetic Resonance-Ultrasound Fusion Biopsy Improve Cancer Detection in Enlarged Prostates?,The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.122,,,,25582380,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3053546,https://api.altmetric.com/v1/donut/3053546_240.png 2,Switching and withdrawing hormonal agents for castration-resistant prostate cancer,Nature Reviews Urology,,,Article,2015-01-07,10.1038/nrurol.2014.345,,,,25563847,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3043045,https://api.altmetric.com/v1/donut/3043045_240.png 2,Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.,Mayo Clinic Proceedings,,,Article,2015-01-01,10.1016/j.mayocp.2014.10.005,,,,25572193,,,,,,,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,7,https://www.altmetric.com/details/3039159,https://api.altmetric.com/v1/donut/3039159_240.png 2,Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida,American Journal of Men's Health,,,Article,2014-12-26,10.1177/1557988314564593,,,,25542838,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3034494,https://api.altmetric.com/v1/donut/3034494_240.png 2,[Current status of castration resistant prostate cancer basic research].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2014-12-01,,,,,25518340,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3001750,https://api.altmetric.com/v1/donut/3001750_240.png 2,DNA methylation of PITX2 predicts poor survival in men with prostate cancer.,Biomarkers in Medicine,,,Article,2014-11-19,10.2217/bmm.14.41,,,,25402584,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2987189,https://api.altmetric.com/v1/donut/2987189_240.png 2,Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-03-06,10.1158/1055-9965.epi-08-0784,,,,19258479,PMC2750884,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2982113,https://api.altmetric.com/v1/donut/2982113_240.png 2,"Real-time, Near-Infrared Fluorescence Imaging with an Optimized Dye/Light Source/Camera Combination for Surgical Guidance of Prostate Cancer",Clinical Cancer Research,,,Article,2014-12-12,10.1158/1078-0432.ccr-14-0891,,,,25501577,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2980203,https://api.altmetric.com/v1/donut/2980203_240.png 2,"Re: Relative Value of Race, Family History and Prostate Specific Antigen as Indications for Early Initiation of Prostate Cancer Screening",The Journal of Urology,,,Article,,10.1016/j.juro.2014.09.114,,,,25476113,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2940563,https://api.altmetric.com/v1/donut/2940563_240.png 2,Effects of a dietary intervention on gastrointestinal symptoms after prostate cancer radiotherapy: Long-term results from a randomized controlled trial,Radiotherapy & Oncology,,,Article,,10.1016/j.radonc.2014.11.025,,,,25467005,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/2937142,https://api.altmetric.com/v1/donut/2937142_240.png 2,Shear Wave Elastography for Detection of Prostate Cancer: A Preliminary Study,Korean Journal of Radiology,,,Article,2014-05-14,10.3348/kjr.2014.15.3.346,,,,24843239,PMC4023053,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2933385,https://api.altmetric.com/v1/donut/2933385_240.png 2,Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.,Methods in molecular biology,,,Article,2015-01-01,10.1007/978-1-4939-1804-1_6,,,,25421657,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2927848,https://api.altmetric.com/v1/donut/2927848_240.png 2,Prostate cancer epigenome.,Methods in molecular biology,,,Article,2015-01-01,10.1007/978-1-4939-1804-1_7,,,,25421658,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/2927847,https://api.altmetric.com/v1/donut/2927847_240.png 2,MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.,Molecular Cancer,,,Article,2014-11-19,10.1186/1476-4598-13-250,,,,25406943,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2902460,https://api.altmetric.com/v1/donut/2902460_240.png 2,A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: Stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost ,Radiotherapy & Oncology,,,Article,2014-11-14,10.1016/j.radonc.2014.10.013,,,,25466371,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2891972,https://api.altmetric.com/v1/donut/2891972_240.png 2,Prostate cancer: Sniffing out prostate cancer,Nature Reviews Urology,,,Article,2014-10-15,10.1038/nrurol.2014.289,,,,25311673,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2890120,https://api.altmetric.com/v1/donut/2890120_240.png 2,Re: Multiparametric Magnetic Resonance Imaging Guided Diagnostic Biopsy Detects Significant Prostate Cancer and could Reduce Unnecessary Biopsies and Over Detection: A Prospective Study,The Journal of Urology,,,Article,,10.1016/j.juro.2014.08.118,,,,25445580,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2884948,https://api.altmetric.com/v1/donut/2884948_240.png 2,Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer.,World Journal of Urology,,,Article,2014-10-25,10.1007/s00345-014-1427-x,,,,25342516,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2879276,https://api.altmetric.com/v1/donut/2879276_240.png 2,Detection of significant prostate cancer with MR-targeted biopsies: Should TRUS-MRI fusion guided biopsies alone be a standard of care?,The Journal of Urology,,,Article,,10.1016/j.juro.2014.11.002,,,,25451824,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2878179,https://api.altmetric.com/v1/donut/2878179_240.png 2,Incidence of Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-09-16,10.1016/j.ijrobp.2014.07.032,,,,25240272,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2876523,https://api.altmetric.com/v1/donut/2876523_240.png 2,Prostate Cancer Debate: Treatment strategies and options in castration-resistant prostate cancer. SIOG 2014,ecancer.org,,,Article,,,,,http://ecancer.org/conference/600-siog-2014/video/3201/prostate-cancer-debate--treatment-strategies-and-options-in-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2854042,https://api.altmetric.com/v1/donut/2854042_240.png 2,Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep-sequencing.,Molecular Cancer Research,,,Article,2013-12-19,10.1158/1541-7786.mcr-13-0230,,,,24337069,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/2847041,https://api.altmetric.com/v1/donut/2847041_240.png 2,HIF-1alpha Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells,Molecular Cancer Research,,,Article,2014-10-27,10.1158/1541-7786.mcr-14-0153-t,,,,25349289,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2819449,https://api.altmetric.com/v1/donut/2819449_240.png 2,Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells,BMC Pharmacology and Toxicology,,,Article,2014-10-24,10.1186/2050-6511-15-59,,,,25342300,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2809091,https://api.altmetric.com/v1/donut/2809091_240.png 2,The association between prostate cancer and mood disorders: a nationwide population-based study in Taiwan.,International Psychogeriatrics,,,Article,2014-10-22,10.1017/s104161021400218x,,,,25335499,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2805505,https://api.altmetric.com/v1/donut/2805505_240.png 2,Neck Swelling and Prostate Cancer...Can They Be Related?,CHEST,,,Article,2014-10-01,10.1378/chest.1990833,,,,25334706,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2802022,https://api.altmetric.com/v1/donut/2802022_240.png 2,Sensitization of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Resistant Primary Prostate Cancer Cells by Isoegomaketone from Perilla frutescens.,Journal of Natural Products,,,Article,2014-10-16,10.1021/np500452e,,,,25320841,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2786881,https://api.altmetric.com/v1/donut/2786881_240.png 2,DNA-cytometric grading of prostate cancer systematic review with descriptive data analysis, Pathology Discovery,,,Article,2014-10-10,10.7243/2052-7896-2-7,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2763582,https://api.altmetric.com/v1/donut/2763582_240.png 2,Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.,Cell & Tissue Research,,,Article,2014-10-09,10.1007/s00441-014-2001-y,,,,25296715,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2761691,https://api.altmetric.com/v1/donut/2761691_240.png 2,"Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.",Urology,,,Article,2001-07-01,10.1016/s0090-4295(01)01014-7,,,,11445478,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,3,44,https://www.altmetric.com/details/2750387,https://api.altmetric.com/v1/donut/2750387_240.png 2,"Luteolin, Ellagic Acid and Punicic Acid are Natural Products that Inhibit Prostate Cancer Metastasis.",Carcinogenesis,,,Article,2014-07-13,10.1093/carcin/bgu145,,,,25023990,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2750310,https://api.altmetric.com/v1/donut/2750310_240.png 2,Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk,World Journal of Surgical Oncology,,,Article,2014-10-05,10.1186/1477-7819-12-304,,,,25282624,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2742629,https://api.altmetric.com/v1/donut/2742629_240.png 2,From Bench to Bedside: Immunotherapy for Prostate Cancer.,BioMed Research International,,,Article,2014-01-01,10.1155/2014/981434,,,,25276838,PMC4168152,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2739606,https://api.altmetric.com/v1/donut/2739606_240.png 2,Epigenetic DNA Methylation of Anti-oxidative Stress Regulator Nrf2 in Human Prostate Cancer.,Cancer Prevention Research,,,Article,2014-09-29,10.1158/1940-6207.capr-14-0127,,,,25266896,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2731851,https://api.altmetric.com/v1/donut/2731851_240.png 2,On the correlation of CTCF binding and c-myc amplification in human prostate cancer cell lines,bioRxiv,,,Article,2014-09-29,10.1101/009761,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2724928,https://api.altmetric.com/v1/donut/2724928_240.png 2,High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients,BMC Cancer,,,Article,2014-09-26,10.1186/1471-2407-14-717,,,,25256077,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2720617,https://api.altmetric.com/v1/donut/2720617_240.png 2,Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.,Urologic Oncology,,,Article,2013-02-27,10.1016/j.urolonc.2012.10.007,,,,23433894,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2719972,https://api.altmetric.com/v1/donut/2719972_240.png 2,Dysregulation of cell cycle related genes and MicroRNAs distinguish the low- from high-risk of prostate cancer.,Diagnostic Pathology,,,Article,2014-09-26,10.1186/s13000-014-0156-1,,,,25257132,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2719946,https://api.altmetric.com/v1/donut/2719946_240.png 2,Epithelial plasticity in prostate cancer: principles and clinical perspectives,Trends in Molecular Medicine,,,Article,2014-09-23,10.1016/j.molmed.2014.09.004,,,,25262538,,1959.8/161746,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2718948,https://api.altmetric.com/v1/donut/2718948_240.png 2,Prostate Cancer Organoids Make Debut,Cancer Discovery,,,Article,,10.1158/2159-8290.cd-nb2014-143,,,,25367931,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2715469,https://api.altmetric.com/v1/donut/2715469_240.png 2,Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer,Cancer Research,,,Article,2014-09-23,10.1158/0008-5472.can-14-1916,,,,25252916,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2714585,https://api.altmetric.com/v1/donut/2714585_240.png 2,Human glutathione S-transferase polymorphisms associated with prostate cancer in the Brazilian population.,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2014.04.04,,,,25251951,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2713786,https://api.altmetric.com/v1/donut/2713786_240.png 2,The Use of Metformin in Patients with Prostate Cancer and the Risk of Death,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-07-17,10.1158/1055-9965.epi-14-0056,,,,25017246,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2697766,https://api.altmetric.com/v1/donut/2697766_240.png 2,Trans-Pacific Variation in Outcomes for Men Treated With Primary Androgen Deprivation Therapy for Prostate Cancer.,British Journal of Urology,,,Article,2015-05-14,10.1111/bju.12937,,,,25238114,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2697716,https://api.altmetric.com/v1/donut/2697716_240.png 2,WNT5A has Anti?Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo,Journal of Bone & Mineral Research,,,Article,2015-02-16,10.1002/jbmr.2362,,,,25224731,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2696979,https://api.altmetric.com/v1/donut/2696979_240.png 2,Apoptosis by dietary agents for prevention and treatment of prostate cancer.,Endocrine-Related Cancer,,,Article,2008-01-01,10.1677/erc-09-0262,,,,19926708,PMC3064425,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,106,https://www.altmetric.com/details/2677279,https://api.altmetric.com/v1/donut/2677279_240.png 2,The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial,Trials,,,Article,2014-09-09,10.1186/1745-6215-15-354,,,,25199619,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2667564,https://api.altmetric.com/v1/donut/2667564_240.png 2,Induction of integrin alpha2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture,Molecular Cancer,,,Article,2014-09-08,10.1186/1476-4598-13-208,,,,25200184,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2666009,https://api.altmetric.com/v1/donut/2666009_240.png 2,"Re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The Role of Radical Prostatectomy and Lymph Node Dissection in Lymph Node–Positive Prostate Cancer: A Systematic Review of the Literature. Eur Urol 2014;66:191–9",European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.070,,,,25204224,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2661965,https://api.altmetric.com/v1/donut/2661965_240.png 2,Generation and Screening of Monoclonal Antibodies for ImmunoPET Imaging of IGF1R in Prostate Cancer.,Molecular Pharmaceutics,,,Article,2014-08-28,10.1021/mp5003637,,,,25157758,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2654574,https://api.altmetric.com/v1/donut/2654574_240.png 2,Novel RNA Markers in Prostate Cancer: Functional Considerations and Clinical Translation.,BioMed Research International,,,Article,,10.1155/2014/765207,,,,25250334,,,,,,,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,21,https://www.altmetric.com/details/2647933,https://api.altmetric.com/v1/donut/2647933_240.png 2,"A monoterpene, unique component of thyme honeys, induces apoptosis in prostate cancer cells via inhibition of NF-?B activity and IL-6 secretion.",Phytomedicine,,,Article,2014-06-18,10.1016/j.phymed.2014.04.032,,,,24932974,,,,,,,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,18,https://www.altmetric.com/details/2645196,https://api.altmetric.com/v1/donut/2645196_240.png 2,"A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",Journal of Thoracic Oncology,,,Article,2014-08-28,10.1097/jto.0000000000000278,,,,25170636,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2641520,https://api.altmetric.com/v1/donut/2641520_240.png 2,Update on prostate cancer in black men within the UK,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/455-update-on-prostate-cancer-in-black-men-within-the-uk.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2637134,https://api.altmetric.com/v1/donut/2637134_240.png 2,Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.,Biological Chemistry,,,Article,2014-09-01,10.1515/hsz-2013-0288,,,,25153383,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2626601,https://api.altmetric.com/v1/donut/2626601_240.png 2,"KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment.",The Prostate,,,Article,2014-07-23,10.1002/pros.22839,,,,25043536,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2612059,https://api.altmetric.com/v1/donut/2612059_240.png 2,A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.04.038,,,,23664820,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2600327,https://api.altmetric.com/v1/donut/2600327_240.png 2,Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators,Prostate Cancer,,,Article,,10.1155/2014/912943,,,,24701353,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2600027,https://api.altmetric.com/v1/donut/2600027_240.png 2,Fusing Transcriptomics to Progressive Prostate Cancer,American Journal of Pathology,,,Article,,10.1016/j.ajpath.2014.08.001,,,,25128905,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2598030,https://api.altmetric.com/v1/donut/2598030_240.png 2,"Re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling. Eur Urol 2014;66:550–60",European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.002,,,,25139198,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2597882,https://api.altmetric.com/v1/donut/2597882_240.png 2,Prostate cancer: Alkaline phosphatase velocity in nonmetastatic CRPC,Nature Reviews Urology,,,Article,2014-08-07,10.1038/nrurol.2014.192,,,,25091008,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2591911,https://api.altmetric.com/v1/donut/2591911_240.png 2,"Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse",PLoS ONE,,,Article,,10.1371/journal.pone.0100469,,,,25010045,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2576716,https://api.altmetric.com/v1/donut/2576716_240.png 2,Mechanisms of Resistance to Intermittent Androgen Deprivation in Patients with Prostate Cancer Identified by a Novel Computational Method,Cancer Research,,,Article,2014-05-25,10.1158/0008-5472.can-13-3162,,,,24853547,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2576278,https://api.altmetric.com/v1/donut/2576278_240.png 2,Selectively Targeting the DNA Binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer.,Journal of Biological Chemistry,,,Article,2014-08-01,10.1074/jbc.m114.553818,,,,25086042,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2566831,https://api.altmetric.com/v1/donut/2566831_240.png 2,Progress Toward Embracing Exercise Training As an Integral Part of Prostate Cancer Treatment,Journal of Clinical Oncology,,,Article,2014-07-06,10.1200/jco.2014.55.1879,,,,25002724,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2553724,https://api.altmetric.com/v1/donut/2553724_240.png 2,Variation in prostate cancer management ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70347-x,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2538349,https://api.altmetric.com/v1/donut/2538349_240.png 2,"Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival.",JNCI: Journal of the National Cancer Institute,,,Article,2014-05-01,10.1093/jnci/dju218,,,,25037061,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2524637,https://api.altmetric.com/v1/donut/2524637_240.png 2,Choline-PET in prostate cancer management: The point of view of the radiation oncologist.,Critical Reviews in Oncology/Hematology,,,Article,2014-05-14,10.1016/j.critrevonc.2014.04.002,,,,24813466,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2524318,https://api.altmetric.com/v1/donut/2524318_240.png 2,Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence.,Clinical Nuclear Medicine,,,Article,2014-07-17,10.1097/rlu.0000000000000516,,,,25036021,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,6,https://www.altmetric.com/details/2522990,https://api.altmetric.com/v1/donut/2522990_240.png 2,Prostate cancer: Fixed sling is superior for postprostatectomy incontinence.,Nature Reviews Urology,,,Article,2014-07-15,10.1038/nrurol.2014.170,,,,25023595,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2517926,https://api.altmetric.com/v1/donut/2517926_240.png 2,"Phase I Safety and Pharmacodynamic of Inecalcitol, a Novel VDR Agonist with Docetaxel in Metastatic Castration-Resistant Prostate Cancer Patients",Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-3247,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2501532,https://api.altmetric.com/v1/donut/2501532_240.png 2,Advantages of Evaluating Mean Nuclear Volume as an Adjunct Parameter in Prostate Cancer,PLoS ONE,,,Article,2014-07-09,10.1371/journal.pone.0102156,,,,25007252,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2500206,https://api.altmetric.com/v1/donut/2500206_240.png 2,Focal therapy in prostate cancer: the current situation,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/full/435-focal-therapy-in-prostate-cancer-the-current-situation.php,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2479730,https://api.altmetric.com/v1/donut/2479730_240.png 2,Mind the gap: Efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics,Cancer (0008543X),,,Article,2014-06-25,10.1002/cncr.28808,,,,24965362,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2466832,https://api.altmetric.com/v1/donut/2466832_240.png 2,Towards the Potential use of 1H NMR Spectroscopy in Urine Samples for Prostate Cancer Detection,Analyst,,,Article,2014-07-14,10.1039/c4an00690a,,,,24989437,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2454632,https://api.altmetric.com/v1/donut/2454632_240.png 2,Metabolic syndrome-like components and prostate cancer risk: Results from the REDUCE Study.,British Journal of Urology,,,Article,2014-06-15,10.1111/bju.12843,,,,24931061,,,,,,,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2439815,https://api.altmetric.com/v1/donut/2439815_240.png 2,Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer,BMC Cancer,,,Article,2014-05-30,10.1186/1471-2407-14-387,,,,24885350,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2414506,https://api.altmetric.com/v1/donut/2414506_240.png 2,Calcium channel blockers and prostate cancer.,Urologic Oncology,,,Article,2014-05-14,10.1016/j.urolonc.2013.08.001,,,,24814406,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2396754,https://api.altmetric.com/v1/donut/2396754_240.png 2,Management of early prostate cancer.,New England Journal of Medicine,,,Article,2014-05-29,10.1056/nejmc1403862,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2393955,https://api.altmetric.com/v1/donut/2393955_240.png 2,Clinician-led improvement in cancer care (CLICC) - testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial - study protocol,Implementation Science,,,Article,2014-05-29,10.1186/1748-5908-9-64,,,,24884877,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2388071,https://api.altmetric.com/v1/donut/2388071_240.png 2,Preoperative Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed Biochemical Recurrence in High-Risk Disease,Clinical Genitourinary Cancer,,,Article,2013-11-12,10.1016/j.clgc.2013.11.009,,,,24342128,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2387223,https://api.altmetric.com/v1/donut/2387223_240.png 2,Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer.,Urology,,,Article,2014-06-01,10.1016/j.urology.2014.02.035,,,,24862395,PMC4035700,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2385558,https://api.altmetric.com/v1/donut/2385558_240.png 2,Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study,PLoS ONE,,,Article,2014-05-22,10.1371/journal.pone.0098101,,,,24851905,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2380470,https://api.altmetric.com/v1/donut/2380470_240.png 2,Antitumor effects of oncolytic adenovirus armed with PSA-IZ-CD40L fusion gene against prostate cancer.,Gene Therapy,,,Article,2014-05-22,10.1038/gt.2014.46,,,,24849040,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2375574,https://api.altmetric.com/v1/donut/2375574_240.png 2,The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells,Molecular Cancer,,,Article,2014-05-20,10.1186/1476-4598-13-113,,,,24884804,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2362844,https://api.altmetric.com/v1/donut/2362844_240.png 2,Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions.,Medical care,,,Article,2014-06-01,10.1097/mlr.0000000000000113,,,,24824535,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2360711,https://api.altmetric.com/v1/donut/2360711_240.png 2,Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients.,British Journal of Cancer,,,Article,2013-09-01,10.1038/bjc.2013.494,,,,23989944,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2354270,https://api.altmetric.com/v1/donut/2354270_240.png 2,"Vitamin D, intermediary metabolism and prostate cancer tumor progression",Frontiers in Physiology,,,Article,2014-04-22,10.3389/fphys.2014.00183,,,,24860512,PMC4030193,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2353697,https://api.altmetric.com/v1/donut/2353697_240.png 2,Talin1 phosphorylation activates |[beta]|1 integrins: a novel mechanism to promote prostate cancer bone metastasis,Oncogene,,,Article,2014-05-07,10.1038/onc.2014.116,,,,24793790,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2344299,https://api.altmetric.com/v1/donut/2344299_240.png 2,Co-culture of Mesenchymal Stem Cells and Endothelial Cells as an Organotypic Model of Prostate Cancer Metastasis.,Molecular Pharmaceutics,,,Article,2014-05-03,10.1021/mp500141b,,,,24779855,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2333768,https://api.altmetric.com/v1/donut/2333768_240.png 2,Defining prostate cancer risk after radical prostatectomy,European Journal of Surgical Oncology,,,Article,2014-05-01,10.1016/j.ejso.2014.02.221,,,,24613741,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2324809,https://api.altmetric.com/v1/donut/2324809_240.png 2,Finasteride-Its Impact on Sexual Function and Prostate Cancer,Journal of Cutaneous & Aesthetic Surgery,,,Article,2009-01-01,10.4103/0974-2077.53093,,,,20300365,PMC2840927,,,,,,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,7,https://www.altmetric.com/details/2322374,https://api.altmetric.com/v1/donut/2322374_240.png 2,CD8+ T-cell Responses Rapidly Select for Antigen-Negative Tumor Cells in the Prostate.,Cancer immunology research,,,Article,2013-12-01,10.1158/2326-6066.cir-13-0109,,,,24778132,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2317104,https://api.altmetric.com/v1/donut/2317104_240.png 2,A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk,European Urology,,,Article,2014-01-01,10.1016/j.eururo.2012.07.027,,,,22841674,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2313274,https://api.altmetric.com/v1/donut/2313274_240.png 2,Correction: A Transgenic Mouse Model for Early Prostate Metastasis to Lymph Nodes,Cancer Research,,,Article,2014-03-30,10.1158/0008-5472.can-14-0603,,,,24686173,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2281552,https://api.altmetric.com/v1/donut/2281552_240.png 2,Anti-androgen monotherapy for metastatic prostate cancer,Lancet Oncology,,,Article,2014-04-14,10.1016/s1470-2045(14)70159-7,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2276835,https://api.altmetric.com/v1/donut/2276835_240.png 2,Advanced prostate cancer gets a new foe.,Johns Hopkins Medical Letter: Health After 50,,,Article,2014-01-10,,,,,24396891,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2255898,https://api.altmetric.com/v1/donut/2255898_240.png 2,Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers.,Epigenetics,,,Article,2014-02-06,,,,,24492483,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2255855,https://api.altmetric.com/v1/donut/2255855_240.png 2,Berberine Inhibited Radioresistant Effects and Enhanced Anti-Tumor Effects in the Irradiated-Human Prostate Cancer Cells.,Toxicol Res,,,Article,2013-11-28,10.5487/tr.2010.26.2.109,,,,24278513,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2255522,https://api.altmetric.com/v1/donut/2255522_240.png 2,"PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance.",Current Cancer Drug Targets,,,Article,2013-11-29,,,,,24274399,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2255521,https://api.altmetric.com/v1/donut/2255521_240.png 2,Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.,International Journal of Molecular Medicine,,,Article,2013-11-30,10.3892/ijmm.2013.1568,,,,24285252,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2255073,https://api.altmetric.com/v1/donut/2255073_240.png 2,Effect of thioridazine stereoisomers on the drug accumulation of mouse lymphoma and human prostate cancer cell lines in vitro.,IN VIVO,,,Article,2013-12-04,,,,,24292587,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2254755,https://api.altmetric.com/v1/donut/2254755_240.png 2,Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies.,Clinical and Experimental Metastasis,,,Article,2013-12-04,10.1007/s10585-013-9626-1,,,,24292404,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2254753,https://api.altmetric.com/v1/donut/2254753_240.png 2,Identification of miR-187 and miR-182 as biomarkers for early diagnosis and prognosis in prostate cancer patients treated with radical prostatectomy.,The Journal of Urology,,,Article,2014-02-14,10.1016/j.juro.2014.01.107,,,,24518785,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2254571,https://api.altmetric.com/v1/donut/2254571_240.png 2,Localized Prostate Cancer Detection with 18F FACBC PET/CT: Comparison with MR Imaging and Histopathologic Analysis.,Radiology,,,Article,2014-02-01,10.1148/radiol.13130240,,,,24475804,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2244699,https://api.altmetric.com/v1/donut/2244699_240.png 2,Zoledronic Acid Induces a Significant Decrease of Circulating Endothelial Cells and Circulating Endothelial Precursor Cells in the Early Prostate Cancer Neoadjuvant Setting.,Oncology (08909091),,,Article,2013-12-19,10.1159/000347226,,,,24335337,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2239631,https://api.altmetric.com/v1/donut/2239631_240.png 2,Long-term survival of participants in the prostate cancer: prevention trial.,Asian Journal of Andrology,,,Article,2014-03-16,10.4103/1008-682x.122868,,,,24625877,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2238568,https://api.altmetric.com/v1/donut/2238568_240.png 2,Complications of prostate cancer treatment,Lancet Oncology,,,Article,2014-04-01,10.1016/s1470-2045(14)70126-3,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2231552,https://api.altmetric.com/v1/donut/2231552_240.png 2,Focal magnetic resonance guided focused ultrasound for prostate cancer: Initial North American experience,Canadian Urological Association Journal,,,Article,2012-12-01,10.5489/cuaj.12218,,,,23283106,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2231216,https://api.altmetric.com/v1/donut/2231216_240.png 2,Androgen Deprivation Therapy for Localized Prostate Cancer,NEJM Journal Watch,,,Article,,10.1056/nejm-jw.na34041,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2224162,https://api.altmetric.com/v1/donut/2224162_240.png 2,Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies.,BMC Cancer,,,Article,2014-03-18,10.1186/1471-2407-14-199,,,,24641777,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2216908,https://api.altmetric.com/v1/donut/2216908_240.png 2,Prostate cancer: eNose[mdash]man's new best friend?,Nature Reviews Urology,,,Article,2014-03-18,10.1038/nrurol.2014.69,,,,24637418,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2193617,https://api.altmetric.com/v1/donut/2193617_240.png 2,"ONLINE REPORT IN REAL TIME FROM THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN, A NEW AND EFFICIENT TOOL FOR QUALITY ASSURANCE",BMJ Quality & Safety,,,Article,2014-04-01,10.1136/bmjqs-2014-002893.6,,,,24639570,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2193278,https://api.altmetric.com/v1/donut/2193278_240.png 2,Implementing newer agents for the management of castrate?resistant prostate cancer: what is known and what is needed?,British Journal of Urology,,,Article,2014-07-15,10.1111/bju.12736,,,,24628790,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2185286,https://api.altmetric.com/v1/donut/2185286_240.png 2,Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.,Journal of Translational Medicine,,,Article,2014-03-11,10.1186/1479-5876-12-66,,,,24618011,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/2178431,https://api.altmetric.com/v1/donut/2178431_240.png 2,AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.,Diagnostic Pathology,,,Article,2014-02-26,10.1186/1746-1596-9-42,,,,24571686,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2147787,https://api.altmetric.com/v1/donut/2147787_240.png 2,"Re: Predicting Risk of Prostate Cancer in Men Receiving Finasteride: Effect of Prostate Volume, Number of Biopsy Cores, and American Urological Association Symptom Score",The Journal of Urology,,,Article,2014-02-20,10.1016/j.juro.2014.02.014,,,,24745490,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2133456,https://api.altmetric.com/v1/donut/2133456_240.png 2,Re: Variation in Treatment Recommendations of Adjuvant Radiation Therapy for High-Risk Prostate Cancer by Physician Specialty,The Journal of Urology,,,Article,,10.1016/j.juro.2013.11.080,,,,24522036,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2129355,https://api.altmetric.com/v1/donut/2129355_240.png 2,Prostate cancer: Genetic differences in PSA,Nature Reviews Urology,,,Article,2014-02-18,10.1038/nrurol.2014.27,,,,24535588,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2128259,https://api.altmetric.com/v1/donut/2128259_240.png 2,Reply from Authors re: Ronald C. Chen. Making Individualized Decisions in the Midst of Uncertainties: The Case of Prostate Cancer and Biochemical Recurrence. Eur Urol 2013;64:916–8: Optimal Timing for Postoperative Radiation: Still an Unanswered Question,European Urology,,,Article,2013-12-01,10.1016/j.eururo.2013.07.030,,,,23910232,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2125077,https://api.altmetric.com/v1/donut/2125077_240.png 2,Genetic Variants in Predicting Aggressive Prostate Cancer: “Ready for Prime Time?”,European Urology,,,Article,2014-06-01,10.1016/j.eururo.2014.01.025,,,,24507781,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2125061,https://api.altmetric.com/v1/donut/2125061_240.png 2,Treatment of Lymph Node–Positive Prostate Cancer: Teaching Old Dogmas New Tricks,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.07.003,,,,23886795,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2124836,https://api.altmetric.com/v1/donut/2124836_240.png 2,Sequencing Systemic Therapies in Advanced Prostate Cancer: Spoiled for Choice But Not for Evidence,European Urology,,,Article,2014-09-01,10.1016/j.eururo.2013.12.053,,,,24411282,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2124804,https://api.altmetric.com/v1/donut/2124804_240.png 2,Adjuvant radiotherapy for lymph?node positive prostate cancer,British Journal of Urology,,,Article,2014-05-22,10.1111/bju.12659,,,,24854603,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2115492,https://api.altmetric.com/v1/donut/2115492_240.png 2,Epigenetics of Prostate Cancer: Distribution of Histone H3K27me3 Biomarkers in Peri-Tumoral Tissue.,OMICS: A Journal of Integrative Biology,,,Article,2014-02-11,10.1089/omi.2013.0117,,,,24517089,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2114951,https://api.altmetric.com/v1/donut/2114951_240.png 2,Abnormal expression of CDK11p58 in prostate cancer,Cancer Cell International,,,Article,2014-01-08,10.1186/1475-2867-14-2,,,,24397471,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2108061,https://api.altmetric.com/v1/donut/2108061_240.png 2,The PICTURE study — Prostate Imaging (multi-parametric MRI and Prostate HistoScanning™) Compared to Transperineal Ultrasound guided biopsy for significant prostate cancer Risk Evaluation,Contemporary Clinical Trials,,,Article,,10.1016/j.cct.2013.11.009,,,,24291455,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2105801,https://api.altmetric.com/v1/donut/2105801_240.png 2,Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.,Journal of Biological Chemistry,,,Article,2005-04-12,10.1074/jbc.m414091200,,,,15805113,,,,,,,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2093340,https://api.altmetric.com/v1/donut/2093340_240.png 2,Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation.,Journal of Biological Chemistry,,,Article,2006-05-30,10.1074/jbc.m604636200,,,,16754685,,,,,,,0,0,0,1,3,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2093142,https://api.altmetric.com/v1/donut/2093142_240.png 2,Re: Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djt432,,,,24399847,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2087904,https://api.altmetric.com/v1/donut/2087904_240.png 2,Kinase drug targets for prostate cancer are heterogeneous between patients but homogeneous within the same patient,ecancer.org,,,Article,,,,,http://ecancer.org/news/5165-kinase-drug-targets-for-prostate-cancer-are-heterogeneous-between-patients-but-homogeneous-within-the-same-patient.php,,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/2072125,https://api.altmetric.com/v1/donut/2072125_240.png 2,Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer.,Clinical Cancer Research,,,Article,2014-01-21,10.1158/1078-0432.ccr-13-1863,,,,24449822,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2063415,https://api.altmetric.com/v1/donut/2063415_240.png 2,The role of molecular biology in the Identification ofPredictive Factors for Prostate Cancer incidence. The role ofmolecular biology in the Identification of Predictive Factors forProstate Cancer incidence. ecancer.tv - Essential viewing foroncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2636/the-role-of-molecular-biology-in-the-identification-of-predictive-factors-for-prostate-cancer-incidence.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2044732,https://api.altmetric.com/v1/donut/2044732_240.png 2,Association Between Metformin Use and Mortality in Patients With Prostate Cancer: Explained by Confounding by Indication?,Journal of Clinical Oncology,,,Article,,10.1200/jco.2013.53.5161,,,,24395861,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2033121,https://api.altmetric.com/v1/donut/2033121_240.png 2,Investigation of key genes associated with prostate cancer using RNA-seq data.,International Journal of Biological Markers,,,Article,2013-12-19,10.5301/jbm.5000056,,,,24366848,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,1,https://www.altmetric.com/details/2017800,https://api.altmetric.com/v1/donut/2017800_240.png 2,Inhibition of Protein Kinase C / Twist1 Signaling Augments Anti-Cancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-1809,,,,24352647,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1992511,https://api.altmetric.com/v1/donut/1992511_240.png 2,"Re: Germline BRCA Mutations are Associated with Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer",The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2013.08.101,,,,24209519,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1976315,https://api.altmetric.com/v1/donut/1976315_240.png 2,"Diethylstilboestrol for the treatment of prostate cancer: past, present and future",Scandinavian journal of urology,,,Article,2013-11-21,10.3109/21681805.2013.861508,,,,24256023,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1967155,https://api.altmetric.com/v1/donut/1967155_240.png 2,Validation of the European Society of Urogenital Radiology Scoring System for Prostate Cancer Diagnosis on Multiparametric Magnetic Resonance Imaging in a Cohort of Repeat Biopsy Patients.,European Urology,,,Article,2012-12-01,10.1016/j.eururo.2012.06.044,,,,22819387,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/1945085,https://api.altmetric.com/v1/donut/1945085_240.png 2,Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint,Cancer Research,,,Article,2013-11-26,10.1158/0008-5472.can-13-1313,,,,24282282,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1937367,https://api.altmetric.com/v1/donut/1937367_240.png 2,Prostate Cancer Biomarkers,Ultrasound Clinics,,,Article,2014-01-01,10.1016/j.cult.2013.09.005,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1926739,https://api.altmetric.com/v1/donut/1926739_240.png 2,Meta-analysis of 11C-choline and 18F-choline PET/CT for management of patients with prostate cancer.,Nuclear Medicine Communications,,,Article,2013-11-14,10.1097/mnm.0000000000000040,,,http://journals.lww.com/nuclearmedicinecomm/Fulltext/2014/03000/Meta_analysis_of_11C_choline_and_18F_choline.1.aspx,24240194,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1913933,https://api.altmetric.com/v1/donut/1913933_240.png 2,Discontinuous Foci of Cancer in a Single Core of Prostatic Biopsy: When it Occurs and Performance of Quantification Methods in a Private-practice Setting.,The American Journal of Surgical Pathology,,,Article,2013-12-01,10.1097/pas.0000000000000112,,,,24225844,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1909359,https://api.altmetric.com/v1/donut/1909359_240.png 2,High dose rate brachytherapy boost for prostate cancer: A systematic review,Cancer Treatment Reviews,,,Article,2013-10-01,10.1016/j.ctrv.2013.10.006,,,,24231548,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1905486,https://api.altmetric.com/v1/donut/1905486_240.png 2,Impaired sexual function and prostate cancer: a mixed method investigation into the experiences of men and their partners,Journal of Clinical Nursing,,,Article,2013-01-01,10.1111/jocn.12190,,,,24580791,,1959.8/153740,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1905278,https://api.altmetric.com/v1/donut/1905278_240.png 2,Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle,Cancers,,,Article,2013-01-01,10.3390/cancers5041522,,,,24351670,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/1896853,https://api.altmetric.com/v1/donut/1896853_240.png 2,Dietary terpenoids and prostate cancer chemoprevention.,Frontiers in Bioscience,,,Article,2008-01-01,,,,,18508447,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1895396,https://api.altmetric.com/v1/donut/1895396_240.png 2,Prostate cancer biomarker profiles in urinary sediments and exosomes,The Journal of Urology,,,Article,2013-11-08,10.1016/j.juro.2013.11.001,,,,24211598,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/1892396,https://api.altmetric.com/v1/donut/1892396_240.png 2,Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer,Nuclear Medicine Communications,,,Article,2013-11-06,10.1097/mnm.0000000000000014,,,,24201549,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1892309,https://api.altmetric.com/v1/donut/1892309_240.png 2,Mental health of low income uninsured men with prostate cancer.,The Journal of Urology,,,Article,2005-04-01,10.1097/01.ju.0000152312.28002.ad,,,http://www.rand.org/pubs/external_publications/EP20050403.html,15758790,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1883465,https://api.altmetric.com/v1/donut/1883465_240.png 2,Anti-inflammatory activity of soy and tea in prostate cancer prevention.,Experimental Biology and Medicine,,,Article,2010-06-01,10.1258/ebm.2010.009335,,,,20511670,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1865664,https://api.altmetric.com/v1/donut/1865664_240.png 2,Patterns and Predictors of Early Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiation Therapy in Men With pT3N0 Prostate Cancer: Implications for Multimodal Therapies,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-10-24,10.1016/j.ijrobp.2013.09.015,,,,24351411,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1858334,https://api.altmetric.com/v1/donut/1858334_240.png 2,Re: The Burden of Urinary Incontinence and Urinary Bother among Elderly Prostate Cancer Survivors,The Journal of Urology,,,Article,,10.1016/j.juro.2013.07.082,,,,24120777,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1854430,https://api.altmetric.com/v1/donut/1854430_240.png 2,Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the trog 03·04 radar randomised controlled trial for locally advanced prostate cancer,British Journal of Urology,,,Article,2013-10-14,10.1111/bju.12497,,,,24512527,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1842997,https://api.altmetric.com/v1/donut/1842997_240.png 2,TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-10-07,10.1073/pnas.1308587110,,,,24101480,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/1820381,https://api.altmetric.com/v1/donut/1820381_240.png 2,"Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines",BMC Pharmacology and Toxicology,,,Article,2013-03-25,10.1186/2050-6511-14-18,,,,23521834,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1813475,https://api.altmetric.com/v1/donut/1813475_240.png 2,Prostate Cancer Survivors as Community Health Educators: Implications for Informed Decision Making and Cancer Communication.,Journal of Cancer Education,,,Article,2013-10-06,10.1007/s13187-013-0559-9,,,,24096473,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1811073,https://api.altmetric.com/v1/donut/1811073_240.png 2,Prostate cancer screening with PSA: Aequanimitas,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2013.04.01,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1805856,https://api.altmetric.com/v1/donut/1805856_240.png 2,Prostate Cancer: Current Treatment and Prevention Strategies.,Iranian Red Crescent Medical Journal,,,Article,2013-04-01,10.5812/ircmj.6499,,,,24082997,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1797693,https://api.altmetric.com/v1/donut/1797693_240.png 2,"If Less Is More, Which Outcomes Should Be Presented in Facilitating Prostate Cancer Screening Decision Making?",JAMA Internal Medicine,,,Article,,10.1001/jamainternmed.2013.8155,,,,24061391,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1780539,https://api.altmetric.com/v1/donut/1780539_240.png 2,Molecular Pathology and Prostate Cancer Therapeutics: From Biology to Bedside,The Journal of Pathology,,,Article,2013-01-01,10.1002/path.4272,,,,24108540,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/1778080,https://api.altmetric.com/v1/donut/1778080_240.png 2,Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer,Cancer Gene Therapy,,,Article,2013-09-20,10.1038/cgt.2013.56,,,,24052127,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1776853,https://api.altmetric.com/v1/donut/1776853_240.png 2,Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1026,,,,24048332,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1762813,https://api.altmetric.com/v1/donut/1762813_240.png 2,Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications.,Expert Opinion on Therapeutic Targets,,,Article,2013-09-12,10.1517/14728222.2013.834889,,,,24024908,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1747531,https://api.altmetric.com/v1/donut/1747531_240.png 2,Plasma Low-Molecular-Weight Proteome Profiling Identified Neuropeptide-Y as a Prostate Cancer Biomarker Polypeptide,Journal of Proteome Research,,,Article,2013-09-04,10.1021/pr400547s,,,,23991666,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1744000,https://api.altmetric.com/v1/donut/1744000_240.png 2,Hypoxia-Independent Downregulation of Hypoxia-Inducible Factor 1 Targets by Androgen Deprivation Therapy in Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-09-11,10.1016/j.ijrobp.2013.07.023,,,,24035332,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1743876,https://api.altmetric.com/v1/donut/1743876_240.png 2,High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2013-09-10,10.1038/pcan.2013.33,,,,24018710,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1743041,https://api.altmetric.com/v1/donut/1743041_240.png 2,Clarifying the Positive Association Between Education and Prostate Cancer A Monte Carlo Simulation Approach,Journal of Applied Gerontology,,,Article,2013-03-21,10.1177/0733464812473798,,,,24652869,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1728669,https://api.altmetric.com/v1/donut/1728669_240.png 2,Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer: Prevention and Management,ISRN Urology,,,Article,2013-01-01,10.1155/2013/240108,,,,23984103,PMC3747499,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1717838,https://api.altmetric.com/v1/donut/1717838_240.png 2,Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer,"Drug Design, Development and Therapy",,,Article,2013-08-01,10.2147/dddt.s45703,,,,24009414,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,18,https://www.altmetric.com/details/1712153,https://api.altmetric.com/v1/donut/1712153_240.png 2,Epidural Analgesia during Open Radical Prostatectomy Does Not Improve Long-Term Cancer-Related Outcome: A Retrospective Study in Patients with Advanced Prostate Cancer,PLoS ONE,,,Article,2013-08-19,10.1371/journal.pone.0072873,,,,23977366,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1708063,https://api.altmetric.com/v1/donut/1708063_240.png 2,"CTA095, a Novel Etk and Src Dual Inhibitor, Induces Apoptosis in Prostate Cancer Cells and Overcomes Resistance to Src Inhibitors",PLoS ONE,,,Article,2013-08-15,10.1371/journal.pone.0070910,,,,23967135,PMC3744530,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1696402,https://api.altmetric.com/v1/donut/1696402_240.png 2,Dual Phosphatidylinositol-3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer,The Journal of Urology,,,Article,2013-08-16,10.1016/j.juro.2013.07.101,,,,23954373,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1693864,https://api.altmetric.com/v1/donut/1693864_240.png 2,Adjuvant leuprolide with or without docetaxel in patients with highâ??risk prostate cancer after radical prostatectomy (TAXâ??3501),Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28270,,,,23943299,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1687156,https://api.altmetric.com/v1/donut/1687156_240.png 2,In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-3490,,,,23935037,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1680962,https://api.altmetric.com/v1/donut/1680962_240.png 2,Evidence for the efficacy of enzalutamide in postchemotherapy metastatic castrate-resistant prostate cancer,Therapeutic Advances in Urology,,,Article,2013-08-01,10.1177/1756287213490054,,,,23904859,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1677983,https://api.altmetric.com/v1/donut/1677983_240.png 2,What's in a Label? Radioimmunotherapy for Metastatic Prostate Cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1540,,,,23926229,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1677383,https://api.altmetric.com/v1/donut/1677383_240.png 2,"Larger Maximum Tumor Diameter at Radical Prostatectomy Is Associated With Increased Biochemical Failure, Metastasis, and Death From Prostate Cancer After Salvage Radiation for Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-07-24,10.1016/j.ijrobp.2013.05.043,,,,23886418,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1655562,https://api.altmetric.com/v1/donut/1655562_240.png 2,Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3â??CTV),Journal of Cellular Physiology,,,Article,2013-07-18,10.1002/jcp.24408,,,,23868767,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1634988,https://api.altmetric.com/v1/donut/1634988_240.png 2,Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models ,Free Radical Biology & Medicine,,,Article,2013-07-04,10.1016/j.freeradbiomed.2013.06.018,,,,23811005,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1622957,https://api.altmetric.com/v1/donut/1622957_240.png 2,Long Noncoding RNA MALAT-1 is a New Potential Therapeutic Target for Castration-Resistant Prostate Cancer,The Journal of Urology,,,Article,2013-07-09,10.1016/j.juro.2013.07.001,,,,23845456,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1622198,https://api.altmetric.com/v1/donut/1622198_240.png 2,GEMMs Shine a Light on Resistance to Androgen Deprivation Therapy for Prostate Cancer,Cancer Cell,,,Article,2013-01-01,10.1016/j.ccr.2013.06.007,,,,23845440,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1616051,https://api.altmetric.com/v1/donut/1616051_240.png 2,The mechanism of DAB2IP in chemo-resistance of prostate cancer cells,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-0954,,,,23838317,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1615100,https://api.altmetric.com/v1/donut/1615100_240.png 2,Image Guided Hypofractionated Radiotherapy and Quality of Life for Localized Prostate Cancer: Prospective Longitudinal Study in 337 Patients,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2013.01.005,,,,23313200,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1606362,https://api.altmetric.com/v1/donut/1606362_240.png 2,Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling,Oncogene,,,Article,2013-06-24,10.1038/onc.2013.233,,,,23792449,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1588183,https://api.altmetric.com/v1/donut/1588183_240.png 2,Involvement of intercellular adhesion molecule-1 up-regulation in bradykinin promotes cell motility in human prostate cancers.,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140713329,,,,23803661,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1583823,https://api.altmetric.com/v1/donut/1583823_240.png 2,Overview of the latest treatments for castration-resistant prostate cancer,Nature Reviews Urology,,,Article,2013-06-25,10.1038/nrurol.2013.137,,,,23797341,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1581397,https://api.altmetric.com/v1/donut/1581397_240.png 2,Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I,Biochemical Journal,,,Article,2013-01-01,10.1042/bj20130012,,,,23557481,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1574036,https://api.altmetric.com/v1/donut/1574036_240.png 2,A literature review of cost–effectiveness analyses of prostate-specific antigen test in prostate cancer screening,Expert Review of Pharmacoeconomics and Outcomes Research,,,Article,2013-06-01,10.1586/erp.13.26,,,,23763530,,,,,,,0,0,0,2,0,0,0,0,5,0,0,0,0,0,0,10,https://www.altmetric.com/details/1558770,https://api.altmetric.com/v1/donut/1558770_240.png 2,The problem of unnecessary treatment of prostate cancer. The problem of unnecessary treatment of prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/2004/the-problem-of-unnecessary-treatment-of-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1548444,https://api.altmetric.com/v1/donut/1548444_240.png 2,Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mdt194,,,,23723295,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1538346,https://api.altmetric.com/v1/donut/1538346_240.png 2,Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer.,Urology,,,Article,2010-09-01,10.1016/j.urology.2009.12.071,,,,20381846,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1534853,https://api.altmetric.com/v1/donut/1534853_240.png 2,Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study.,BMC Cancer,,,Article,2013-06-03,10.1186/1471-2407-13-272,,,,23731674,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1533544,https://api.altmetric.com/v1/donut/1533544_240.png 2,Review of Selenium and Prostate Cancer Prevention.,Asian Pacific Journal of Cancer Prevention,,,Article,2013-01-01,,,,,23725109,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1531153,https://api.altmetric.com/v1/donut/1531153_240.png 2,"Hypoxia, notch signalling, and prostate cancer",Nature Reviews Urology,,,Article,2013-05-28,10.1038/nrurol.2013.110,,,,23712204,,,,,,,0,0,0,1,0,0,4,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1521757,https://api.altmetric.com/v1/donut/1521757_240.png 2,Development of an ELISA detecting Tumor Protein 53-Induced Nuclear Protein 1 in serum of prostate cancer patients,Results in Immunology,,,Article,2013-05-01,10.1016/j.rinim.2013.05.002,,,,24600558,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1516337,https://api.altmetric.com/v1/donut/1516337_240.png 2,Frequent ejaculation may be linked to decreased risk of prostate cancer,British Medical Journal,,,Article,2004-04-10,10.1136/bmj.328.7444.851-a,,,,15073055,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1512846,https://api.altmetric.com/v1/donut/1512846_240.png 2,Pharmaco and diet based prostate cancer prevention.,Bulletin du Cancer,,,Article,2013-05-16,10.1684/bdc.2013.1739,,,,23694994,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1502046,https://api.altmetric.com/v1/donut/1502046_240.png 2,Prostate cancer: To EBRT or not to EBRT: Surgery or radiotherapy for localized prostate cancer? That is the question,Nature Reviews Urology,,,Article,2013-05-21,10.1038/nrurol.2013.109,,,,23689252,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1501753,https://api.altmetric.com/v1/donut/1501753_240.png 2,ASTRO Issues Statement on Proton Beam Therapy for Prostate Cancer,Oncology times,,,Article,2013-05-10,10.1097/01.cot.0000430615.31653.c4,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1482601,https://api.altmetric.com/v1/donut/1482601_240.png 2,Assessment of endothelial dysfunction by flowâ??mediated dilatation in men on longâ??term androgen deprivation therapy (ADT) for prostate cancer,Experimental Physiology,,,Article,2013-01-01,10.1113/expphysiol.2013.073353,,,,23666791,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1479307,https://api.altmetric.com/v1/donut/1479307_240.png 2,"A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment",Cancer Discovery,,,Article,2011-04-03,10.1158/2159-8274.cd-10-0020,,,,22140654,PMC3227223,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,35,https://www.altmetric.com/details/1475603,https://api.altmetric.com/v1/donut/1475603_240.png 2,Agent orange exposure linked to life-threatening prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/4068-agent-orange-exposure-linked-to-life-threatening-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1473056,https://api.altmetric.com/v1/donut/1473056_240.png 2,Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer,EMBO Journal,,,Article,2013-05-03,10.1038/emboj.2013.99,,,,23644382,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/1434359,https://api.altmetric.com/v1/donut/1434359_240.png 2,Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells,PLoS ONE,,,Article,2013-05-02,10.1371/journal.pone.0063466,,,,23658830,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1428562,https://api.altmetric.com/v1/donut/1428562_240.png 2,Identification of Drug Candidate against Prostate Cancer from the Aspect of Somatic Cell Reprogramming,Cancer Science,,,Article,2013-01-01,10.1111/cas.12183,,,,23600803,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1406483,https://api.altmetric.com/v1/donut/1406483_240.png 2,Analysis of the androgenic activity of synthetic “progestins” currently used for the treatment of prostate cancer,Journal of Steroid Biochemistry,,,Article,1987-10-01,10.1016/0022-4731(87)91054-5,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1403784,https://api.altmetric.com/v1/donut/1403784_240.png 2,Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-4619,,,,23585456,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1388002,https://api.altmetric.com/v1/donut/1388002_240.png 2,Cabazitaxel for the Second-Line Treatment of Metastatic Hormone-Refractory Prostate Cancer: A NICE Single Technology Appraisal,PharmacoEconomics,,,Article,2013-04-12,10.1007/s40273-013-0050-9,,,,23580356,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1379318,https://api.altmetric.com/v1/donut/1379318_240.png 2,Proton beam therapy and localised prostate cancer: current status and controversies,British Journal of Cancer,,,Article,2013-03-12,10.1038/bjc.2013.100,,,,,,,,,,,0,0,0,1,0,0,2,0,0,0,1,0,0,0,0,37,https://www.altmetric.com/details/1363234,https://api.altmetric.com/v1/donut/1363234_240.png 2,Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease,The Scientific World Journal,,,Article,2013-01-01,10.1155/2013/762064,,,,23653529,PMC3628499,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1330562,https://api.altmetric.com/v1/donut/1330562_240.png 2,Tumor-specific RNA Interference Targeting Pokemon Suppresses Tumor Growth and Induces Apoptosis in Prostate Cancer.,Urology,,,Article,2013-02-06,10.1016/j.urology.2012.10.011,,,,23374847,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1329969,https://api.altmetric.com/v1/donut/1329969_240.png 2,Postoperative radiotherapy for high-risk prostate cancer,The Lancet (British Edition),,,Article,2013-03-30,10.1016/s0140-6736(13)60751-5,,,,23540844,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1327606,https://api.altmetric.com/v1/donut/1327606_240.png 2,Androgen receptor-independent function of FoxA1 in prostate cancer metastasis,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3468,,,,23539448,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1327295,https://api.altmetric.com/v1/donut/1327295_240.png 2,Urinary biomarkers for prostate cancer: a review.,Asian Journal of Andrology,,,Article,2013-03-25,10.1038/aja.2013.6,,,,23524531,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,57,https://www.altmetric.com/details/1322107,https://api.altmetric.com/v1/donut/1322107_240.png 2,The impaired viability of prostate cancer cell lines by the recombinant plant kallikrein inhibitor,Journal of Biological Chemistry,,,Article,2013-01-01,10.1074/jbc.m112.404053,,,,23511635,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1311089,https://api.altmetric.com/v1/donut/1311089_240.png 2,Ductal Carcinoma Of The Prostate Shows A Different Immunophenotype From High Grade Acinar Cancer,Histopathology,,,Article,2013-01-01,10.1111/his.12129,,,,23701402,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1293605,https://api.altmetric.com/v1/donut/1293605_240.png 2,Molecular Pathways: Inhibiting steroid biosynthesis in prostate cancer.,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-0931,,,,23470964,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1288950,https://api.altmetric.com/v1/donut/1288950_240.png 2,"Pterostilbene Acts through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer",PLoS ONE,,,Article,2013-03-01,10.1371/journal.pone.0057542,,,,23469203,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1276414,https://api.altmetric.com/v1/donut/1276414_240.png 2,"Extracts from Epilobium sp. Herbs, Their Components and Gut Microbiota Metabolites of Epilobium Ellagitannins, Urolithins, Inhibit Hormone-Dependent Prostate Cancer Cells-(LNCaP) Proliferation and PSA Secretion.",Phytotherapy Research,,,Article,2013-02-25,10.1002/ptr.4941,,,,23436427,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1267016,https://api.altmetric.com/v1/donut/1267016_240.png 2,Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer,PLoS ONE,,,Article,2013-02-22,10.1371/journal.pone.0056592,,,,23451058,,,,,,,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1262024,https://api.altmetric.com/v1/donut/1262024_240.png 2,Management of Biochemically Recurrent Prostate Cancer After Local Therapy: Evolving Standards of Care and New Directions,Clinical Advances in Hematology & Oncology,,,Article,2013-01-01,,,,,23416859,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1249282,https://api.altmetric.com/v1/donut/1249282_240.png 2,Single cell transcriptomic analysis of prostate cancer cells,BMC Molecular Biology,,,Article,2013-02-16,10.1186/1471-2199-14-6,,,,23414343,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1246392,https://api.altmetric.com/v1/donut/1246392_240.png 2,Bisphenol A stimulates human prostate cancer cell migration via remodelling of calcium signalling,SpringerPlus,,,Article,2013-01-01,10.1186/2193-1801-2-54,,,,23450760,,,,,,,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1241831,https://api.altmetric.com/v1/donut/1241831_240.png 2,Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer,Radiation Oncology,,,Article,2013-01-31,10.1186/1748-717x-8-30,,,,23369294,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1239150,https://api.altmetric.com/v1/donut/1239150_240.png 2,Predicting Prostate Biopsy Outcome Using a PCA3-based Nomogram in a Polish Cohort,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,23393348,,,,,,,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/1229769,https://api.altmetric.com/v1/donut/1229769_240.png 2,Death from highâ??risk prostate cancer versus cardiovascular mortality with hormonal therapy,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27980,,,,23400678,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1228880,https://api.altmetric.com/v1/donut/1228880_240.png 2,Radiosensitization in prostate cancer: mechanisms and targets,BMC Urology,,,Article,2013-01-26,10.1186/1471-2490-13-4,,,,23351141,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1202196,https://api.altmetric.com/v1/donut/1202196_240.png 2,Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2013-01-08,10.1038/pcan.2012.49,,,,23295316,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1172836,https://api.altmetric.com/v1/donut/1172836_240.png 2,Nanoparticle PET/CT Imaging of Natriuretic Peptide Clearance Receptor in Prostate Cancer.,Bioconjugate Chemistry,,,Article,2012-12-28,10.1021/bc300473x,,,,23272904,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1149409,https://api.altmetric.com/v1/donut/1149409_240.png 2,Re: Cost-Effectiveness Analysis of Degarelix for Advanced Hormone-Dependent Prostate Cancer,The Journal of Urology,,,Article,2012-12-26,10.1016/j.juro.2012.10.097,,,,23312161,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1143650,https://api.altmetric.com/v1/donut/1143650_240.png 2,"The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis.",World Journal of Urology,,,Article,2012-12-15,10.1007/s00345-012-1000-4,,,,23239103,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1133744,https://api.altmetric.com/v1/donut/1133744_240.png 2,PRSS3/Mesotrypsin Is a Therapeutic Target for Metastatic Prostate Cancer,Molecular Cancer Research,,,Article,2012-01-01,10.1158/1541-7786.mcr-12-0314,,,,23258495,,,,,,,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1133593,https://api.altmetric.com/v1/donut/1133593_240.png 2,Retinoic Acid Induces Apoptosis of Prostate Cancer DU145 Cells through Cdk5 Overactivation,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2012-01-01,10.1155/2012/580736,,,,23304206,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1122026,https://api.altmetric.com/v1/donut/1122026_240.png 2,Re: Editorial Comment on Urologists' Self-Referral for Pathology of Biopsy Specimens Linked to Increased Use and Lower Prostate Cancer Detection (Health Aff [Millwood] 2012; 31: 741â??749) P. C. Walsh J Urol 2012; 188: 1767,The Journal of Urology,,,Article,,10.1016/j.juro.2012.11.106,,,,23234761,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1115311,https://api.altmetric.com/v1/donut/1115311_240.png 2,Levels of Beta-Microseminoprotein in Blood and Risk of Prostate Cancer in Multiple Populations,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djs486,,,,23213189,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1111522,https://api.altmetric.com/v1/donut/1111522_240.png 2,Combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line.,Journal of Basic and Clinical Physiology and Pharmacology,,,Article,2012-10-18,10.1515/jbcpp-2012-0021,,,,23072849,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1111001,https://api.altmetric.com/v1/donut/1111001_240.png 2,The prostate cancer pseudo-epidemic,Acta Oncologica,,,Article,2010-04-21,10.3109/02841860903584945,,,,20397765,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1105002,https://api.altmetric.com/v1/donut/1105002_240.png 2,"Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS).",European Urology,,,Article,2012-11-12,10.1016/j.eururo.2012.11.006,,,,23176897,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1096165,https://api.altmetric.com/v1/donut/1096165_240.png 2,An Antiâ??PSMA Bivalent Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Imaging and Therapy,Advanced Healthcare Materials,,,Article,2013-01-01,10.1002/adhm.201200254,,,,23184611,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1083282,https://api.altmetric.com/v1/donut/1083282_240.png 2,Tirucallic Acids Are Novel Pleckstrin Homology Domain-Dependent Akt Inhibitors Inducing Apoptosis in Prostate Cancer Cells,Molecular Pharmacology,,,Article,2009-12-20,10.1124/mol.109.060475,,,,20018812,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1081952,https://api.altmetric.com/v1/donut/1081952_240.png 2,Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.,American Journal of Roentgenology,,,Article,2012-05-26,10.2214/ajr.12.8510,,,,22623539,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/1072961,https://api.altmetric.com/v1/donut/1072961_240.png 2,Definition of molecular determinants of prostate cancer cell bone extravasation,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3264,,,,23149920,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1067159,https://api.altmetric.com/v1/donut/1067159_240.png 2,Brief report: a bioassay to identify primary human prostate cancer repopulating cells.,Stem Cells,,,Article,2011-06-17,10.1002/stem.668,,,,21674698,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1065765,https://api.altmetric.com/v1/donut/1065765_240.png 2,Mitochondria-Related Gene Expression Changes Are Associated With Fatigue in Patients With Nonmetastatic Prostate Cancer Receiving External Beam Radiation Therapy,Cancer nursing (Online),,,Article,2012-10-23,10.1097/ncc.0b013e318263f514,,,,23047795,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1036145,https://api.altmetric.com/v1/donut/1036145_240.png 2,Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97% of significant prostate cancers.,Scandinavian Journal of Urology & Nephrology,,,Article,2012-10-07,10.3109/00365599.2012.727859,,,,23035756,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1036049,https://api.altmetric.com/v1/donut/1036049_240.png 2,Elevated Polycyclic Aromatic Hydrocarbon-DNA adducts in Benign Prostate are a Risk Factor for Prostate Cancer in African Americans.,Carcinogenesis,"MELLARK, Pitta",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-10-17,10.1093/carcin/bgs326,,,,23066084,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1018257,https://api.altmetric.com/v1/donut/1018257_240.png 2,Nasty or Nice? Findings from a UK Survey to Evaluate the Impact of the National Institute for Health and Clinical Excellence (NICE) Clinical Guidelines on the Management of Prostate Cancer,Clinical Oncology,,,Article,2012-10-01,10.1016/j.clon.2012.09.001,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1008774,https://api.altmetric.com/v1/donut/1008774_240.png 2,ProsCan for Couples: Randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy,BMC Cancer,,,Article,2008-08-08,10.1186/1471-2407-8-226,,,,18687149,PMC2529334,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/1008471,https://api.altmetric.com/v1/donut/1008471_240.png 2,Carbon ion Radiotherapy in Advanced Hypofractionated Regimens for Prostate Cancer: From 20 to 16 Fractions.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.01.072,,,,22898380,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1007283,https://api.altmetric.com/v1/donut/1007283_240.png 2,"MicroRNA-23b represses proto-oncogene Src kinase, functions as a methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer",Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-12-2181,,,,23074286,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1005604,https://api.altmetric.com/v1/donut/1005604_240.png 2,"G31P, an Antagonist against CXC Chemokine Receptors 1 and 2, Inhibits Growth of Human Prostate Cancer Cells in Nude Mice.",Tohoku Journal of Experimental Medicine,,,Article,2012-01-01,,,,,23019013,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/972173,https://api.altmetric.com/v1/donut/972173_240.png 2,A pilot randomized controlled trial of the feasibility of a self-directed coping skills intervention for couples facing prostate cancer: Rationale and design.,Health and Quality of Life Outcomes,,,Article,2012-09-26,10.1186/1477-7525-10-119,,,,23013404,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/971208,https://api.altmetric.com/v1/donut/971208_240.png 2,Protein Arginine Methyltransferase 5 Functions in Opposite Ways in the Cytoplasm and Nucleus of Prostate Cancer Cells,PLoS ONE,,,Article,2012-08-27,10.1371/journal.pone.0044033,,,,22952863,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/936348,https://api.altmetric.com/v1/donut/936348_240.png 2,Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castrate-resistant prostate cancer,Journal of Biological Chemistry,,,Article,2012-01-01,10.1074/jbc.m112.384438,,,,22908226,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/924862,https://api.altmetric.com/v1/donut/924862_240.png 2,A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.09.015,,,,22704703,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/915587,https://api.altmetric.com/v1/donut/915587_240.png 2,A Dosimetric Comparison of Tomotherapy and Volumetric Modulated Arc Therapy in the Treatment of High-Risk Prostate Cancer With Pelvic Nodal Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-06-06,10.1016/j.ijrobp.2012.03.046,,,,22677369,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/914730,https://api.altmetric.com/v1/donut/914730_240.png 2,Treatment Outcomes in Non-Metastatic Prostate Cancer Patients With Ultra-High Prostate-Specific Antigen,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.01.041,,,,22483701,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/914718,https://api.altmetric.com/v1/donut/914718_240.png 2,"Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: influence on prostate cancer risk and interactions",Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00100,,,,22912935,PMC3418632,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/907123,https://api.altmetric.com/v1/donut/907123_240.png 2,Insulin-like Growth Factor-I Concentration and Risk of Prostate Cancer: Results from the European Prospective Investigation into Cancer and Nutrition,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-07-06,10.1158/1055-9965.epi-12-0481-t,,,,22761305,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/890139,https://api.altmetric.com/v1/donut/890139_240.png 2,Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic Acid.,European Urology,,,Article,2012-05-30,10.1016/j.eururo.2012.05.007,,,,22633317,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/887552,https://api.altmetric.com/v1/donut/887552_240.png 2,Radical Prostatectomy versus Observation for Localized Prostate Cancer,New England Journal of Medicine,,,Article,2012-08-09,10.1056/nejmx120053,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/879239,https://api.altmetric.com/v1/donut/879239_240.png 2,Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer,Journal of Human Genetics,,,Article,2012-08-02,10.1038/jhg.2012.95,,,,22854542,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/876793,https://api.altmetric.com/v1/donut/876793_240.png 2,Treating prostate cancer.,British Medical Journal,,,Article,2012-08-01,10.1136/bmj.e5122,,,,22859773,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/873261,https://api.altmetric.com/v1/donut/873261_240.png 2,Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells,BMC Cancer,,,Article,2012-08-02,10.1186/1471-2407-12-336,,,,22857708,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/869875,https://api.altmetric.com/v1/donut/869875_240.png 2,Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study,Prostate Cancer & Prostatic Diseases,,,Article,2011-11-29,10.1038/pcan.2011.60,,,,22343838,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/868206,https://api.altmetric.com/v1/donut/868206_240.png 2,NICE guidance on abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen,Lancet Oncology,,,Article,2012-08-01,10.1016/s1470-2045(12)70289-9,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/860815,https://api.altmetric.com/v1/donut/860815_240.png 2,Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality,Annals of Internal Medicine,,,Article,2012-01-01,10.7326/0003-4819-157-2-201207170-02004,,,,22801696,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/845408,https://api.altmetric.com/v1/donut/845408_240.png 2,Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.,New England Journal of Medicine,,,Article,2004-10-08,10.1056/nejmoa041318,,,,15470214,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/840246,https://api.altmetric.com/v1/donut/840246_240.png 2,3D Porous ChitosanAlginate Scaffolds: A New Matrix for Studying Prostate Cancer CellLymphocyte Interactions In Vitro,Advanced Healthcare Materials,,,Article,2012-01-01,10.1002/adhm.201100054,,,,23184794,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/825557,https://api.altmetric.com/v1/donut/825557_240.png 2,"Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells",American Journal of Physiology: Endocrinology & Metabolism,,,Article,2005-01-01,10.1152/ajpendo.00454.2004,,,,15536203,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/820717,https://api.altmetric.com/v1/donut/820717_240.png 2,Testosterone in prostate cancer: the Bethesda consensus,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2011.10719.x,,,,22129242,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/802593,https://api.altmetric.com/v1/donut/802593_240.png 2,Cost-effectiveness of Intensity-modulated Radiotherapy in Prostate Cancer.,Clinical Oncology,,,Article,2012-06-15,10.1016/j.clon.2012.05.004,,,,22705100,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/798878,https://api.altmetric.com/v1/donut/798878_240.png 2,Glycomics for Drug Discovery: Metabolic Perturbation in Androgenâ??Independent Prostate Cancer Cells Induced by Unnatural Hexosamine Mimics,Angewandte Chemie. International Edition,,,Article,2012-01-01,10.1002/anie.201108742,,,,22345046,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/771486,https://api.altmetric.com/v1/donut/771486_240.png 2,"Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells",BBA - Molecular Cell Research,,,Article,2012-05-01,10.1016/j.bbamcr.2012.05.020,,,,22640870,,,,,,,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/770402,https://api.altmetric.com/v1/donut/770402_240.png 2,Retigeric Acid B Exhibits Antitumor Activity through Suppression of Nuclear Factor-?B Signaling in Prostate Cancer Cells in Vitro and in Vivo,PLoS ONE,,,Article,2012-05-29,10.1371/journal.pone.0038000,,,,22666431,,,2012PLoSO...7E8000L,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/767379,https://api.altmetric.com/v1/donut/767379_240.png 2,Clinical Outcome of Patients Treated With 3D Conformal Radiation Therapy (3D-CRT) for Prostate Cancer on RTOG 9406,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-01-01,10.1016/j.ijrobp.2011.12.070,,,,22633552,PMC3361689,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/765692,https://api.altmetric.com/v1/donut/765692_240.png 2,Denosumab in castration-resistant prostate cancer,The Lancet,,,Article,2012-05-12,10.1016/s0140-6736(12)60764-8,,,,22579323,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/739310,https://api.altmetric.com/v1/donut/739310_240.png 2,miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.,Cell Death & Differentiation,,,Article,2012-05-05,10.1038/cdd.2012.56,,,,22555458,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/730883,https://api.altmetric.com/v1/donut/730883_240.png 2,Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome.,Virus Research,,,Article,2012-04-15,10.1016/j.virusres.2012.04.004,,,,22531412,,,,,,,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/715048,https://api.altmetric.com/v1/donut/715048_240.png 2,Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation,Journal of Molecular Histology,,,Article,2012-04-17,10.1007/s10735-012-9415-1,,,,22526510,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/703433,https://api.altmetric.com/v1/donut/703433_240.png 2,Prostate Cancer-Specific and Potent Antitumor Effect of a DD3-Controlled Oncolytic Virus Harboring the PTEN Gene,PLoS ONE,,,Article,2012-04-11,10.1371/journal.pone.0035153,,,,22509396,,,2012PLoSO...7E5153D,,,,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,10,https://www.altmetric.com/details/701123,https://api.altmetric.com/v1/donut/701123_240.png 2,Curcumin Attenuates ?-catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1,PLoS ONE,,,Article,2012-04-16,10.1371/journal.pone.0035368,,,,22523587,,,2012PLoSO...7E5368S,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/699801,https://api.altmetric.com/v1/donut/699801_240.png 2,Prostate cancer chemoprevention by soy isoflavones: Role of intestinal bacteria as the second human genome,Cancer Science,,,Article,2012-01-01,10.1111/j.1349-7006.2012.02257.x,,,,22372745,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/699455,https://api.altmetric.com/v1/donut/699455_240.png 2,Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers,Postgraduate Medical Journal,,,Article,2002-11-01,10.1136/pmj.78.925.646,,,,12496317,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/664859,https://api.altmetric.com/v1/donut/664859_240.png 2,Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal Syndrome.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.03.028,,,,21640511,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/662218,https://api.altmetric.com/v1/donut/662218_240.png 2,Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers,Molecular Cancer Research,,,Article,2011-01-01,10.1158/1541-7786.mcr-10-0490,,,,21665936,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,140,https://www.altmetric.com/details/654096,https://api.altmetric.com/v1/donut/654096_240.png 2,The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy,British Journal of Nutrition,,,Article,1970-01-01,10.1017/s0007114512000384,,,,22397815,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/645314,https://api.altmetric.com/v1/donut/645314_240.png 2,Flavone for prostate cancer,Nature India,,,Article,2012-02-15,10.1038/nindia.2012.20,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/628192,https://api.altmetric.com/v1/donut/628192_240.png 2,"RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings",Cell Research,,,Article,2012-02-21,10.1038/cr.2012.30,,,,22349460,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,187,https://www.altmetric.com/details/624417,https://api.altmetric.com/v1/donut/624417_240.png 2,"Men, Food, and Prostate Cancer: Gender Influences on Men’s Diets",American Journal of Men's Health,,,Article,2011-01-01,10.1177/1557988310379152,,,,20798140,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/620059,https://api.altmetric.com/v1/donut/620059_240.png 2,"Is Primary Prostate Cancer Treatment Influenced by Likelihood of Extraprostatic Disease? A Surveillance, Epidemiology and End Results Patterns of Care Study.","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-02-05,10.1016/j.ijrobp.2011.10.076,,,,22300560,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/599592,https://api.altmetric.com/v1/donut/599592_240.png 2,Focal laser interstitial thermotherapy (LITT) at 980?nm for prostate cancer: treatment feasibility in Dunning R3327?AT2 rat prostate tumour,British Journal of Urology,,,Article,2011-09-08,10.1111/j.1464-410x.2011.10406.x,,,,21895930,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/590304,https://api.altmetric.com/v1/donut/590304_240.png 2,"Foods, nutrients and prostate cancer.",Cancer Causes and Control,,,Article,2004-02-19,10.1023/b:caco.0000016568.25127.10,,,,14970730,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/579673,https://api.altmetric.com/v1/donut/579673_240.png 2,Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer,The Journal of Pathology,,,Article,2012-02-03,10.1002/path.3987,,,,22294438,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/549017,https://api.altmetric.com/v1/donut/549017_240.png 2,The epigenome as a therapeutic target in prostate cancer.,Nature Reviews Urology,,,Article,2010-11-11,10.1038/nrurol.2010.185,,,,21060342,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,76,https://www.altmetric.com/details/542781,https://api.altmetric.com/v1/donut/542781_240.png 2,Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.,European Urology,,,Article,2009-04-22,10.1016/j.eururo.2009.03.073,,,,19375217,PMC2738932,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/541495,https://api.altmetric.com/v1/donut/541495_240.png 2,Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth,Cancer Research,,,Article,2008-06-01,10.1158/0008-5472.can-08-0249,,,,18519708,PMC2536685,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,2,0,0,142,https://www.altmetric.com/details/517187,https://api.altmetric.com/v1/donut/517187_240.png 2,Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.,British Journal of Cancer,,,Article,2009-02-24,10.1038/sj.bjc.6604912,,,,19223910,PMC2653745,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/516887,https://api.altmetric.com/v1/donut/516887_240.png 2,Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP,Carcinogenesis,,,Article,2001-01-01,10.1093/carcin/22.9.1399,,,,11532861,,,,,,,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,9,https://www.altmetric.com/details/489173,https://api.altmetric.com/v1/donut/489173_240.png 2,"Associations of circulating 25â??hydroxyvitamin D with prostate cancer diagnosis, stage and grade",International Journal of Cancer,,,Article,1970-01-01,10.1002/ijc.27327,,,,22033893,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/482898,https://api.altmetric.com/v1/donut/482898_240.png 2,Hibiscus sabdariffa leaf induces apoptosis of human prostate cancer cells in vitro and in vivo,Food Chemistry,,,Article,2011-11-18,10.1016/j.foodchem.2011.11.057,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/479361,https://api.altmetric.com/v1/donut/479361_240.png 2,Treatment Options for Hormone-Refractory Prostate Cancer,Reviews in Urology,,,Article,2011-11-23,,,,,17554405,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/465576,https://api.altmetric.com/v1/donut/465576_240.png 2,"ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer",Modern Pathology,,,Article,2011-11-11,10.1038/modpathol.2011.176,,,,22080055,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/463273,https://api.altmetric.com/v1/donut/463273_240.png 2,Dramatic increase in prostate cancer cases by 2021,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2011.10197.x,,,,21507185,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/459286,https://api.altmetric.com/v1/donut/459286_240.png 2,"Prostate cancer support groups, health literacy and consumerism: Are community-based volunteers re-defining older men’s health?",Health (1949-4998),,,Article,2010-01-01,10.1177/1363459310364156,,,,21177714,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/447894,https://api.altmetric.com/v1/donut/447894_240.png 2,Percentage of Cancer Volume in Biopsy Cores Is Prognostic for Prostate Cancer Death and Overall Survival in Patients Treated With Dose-Escalated External Beam Radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-11-04,10.1016/j.ijrobp.2011.09.005,,,,22056069,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/442257,https://api.altmetric.com/v1/donut/442257_240.png 2,Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?,British Journal of Urology,,,Article,2011-11-01,10.1111/j.1464-410x.2011.10127.x,,,,21453344,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/439439,https://api.altmetric.com/v1/donut/439439_240.png 2,Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer,Prostate Cancer and Prostatic Diseases,,,Article,2011-11-01,10.1038/pcan.2011.52,,,,22042252,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/436581,https://api.altmetric.com/v1/donut/436581_240.png 2,PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and- independent prostate cancer cells.,Integrative Cancer Therapies,,,Article,2010-01-01,10.1177/1534735410369672,,,,20462856,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/424759,https://api.altmetric.com/v1/donut/424759_240.png 2,A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer.,Epigenetics,,,Article,2011-10-01,,,,,21946329,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/422034,https://api.altmetric.com/v1/donut/422034_240.png 2,Assessment of PET Tracer Uptake in Hormone-Independent and Hormone-Dependent Xenograft Prostate Cancer Mouse Models.,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,Article,2011-10-01,10.2967/jnumed.110.086702,,,,21859811,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/393108,https://api.altmetric.com/v1/donut/393108_240.png 2,Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.,BJU international,,,Article,2010-09-01,10.1111/j.1464-410x.2010.09232.x,,,,20151961,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/255801,https://api.altmetric.com/v1/donut/255801_240.png 2,"Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer",Bioorganic & Medicinal Chemistry,,,Article,2011-09-01,10.1016/j.bmc.2011.08.066,,,,21978946,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/251593,https://api.altmetric.com/v1/donut/251593_240.png 2,Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer,BMC Cancer,,,Article,2011-07-25,10.1186/1471-2407-11-312,,,,21787388,PMC3157459,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/207693,https://api.altmetric.com/v1/donut/207693_240.png 2,Rectal Metastasis of Prostate Cancer: About a Case,Journal of Clinical Medicine Research,,,Article,1970-01-01,10.4021/jocmr2010.05.309w,,,,21629526,PMC3104640,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/181371,https://api.altmetric.com/v1/donut/181371_240.png 2,Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy,Annals of Oncology,,,Article,2011-06-06,10.1093/annonc/mdr264,,,,21652578,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/176771,https://api.altmetric.com/v1/donut/176771_240.png 2,Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.,The Journal of experimental medicine,,,Article,2005-04-18,10.1084/jem.20042028,,,,15824085,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,70,https://www.altmetric.com/details/147673,https://api.altmetric.com/v1/donut/147673_240.png 2,Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,"DENT, Harris",Department of Life Sciences; School of Natural Sciences,Article,2011-02-22,10.1073/pnas.1013699108,,,,21300890,PMC3044355,,2011PNAS..108.3342C,,,,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,172,https://www.altmetric.com/details/130796,https://api.altmetric.com/v1/donut/130796_240.png 2,Expanding treatment options for metastatic prostate cancer.,New England Journal of Medicine,,,Article,2011-05-26,10.1056/nejme1102758,,,,21612475,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/129760,https://api.altmetric.com/v1/donut/129760_240.png 2,"Validation of prostate-specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries.",Cancer (0008543X),,,Article,2016-10-26,10.1002/cncr.30401,,,,27783399,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13343298,https://api.altmetric.com/v1/donut/13343298_240.png 2,A Western Dietary Pattern Increases Prostate Cancer Risk: A Systematic Review and Meta-Analysis,Nutrients,,,Article,2016-10-12,10.3390/nu8100626,,,,27754328,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13082206,https://api.altmetric.com/v1/donut/13082206_240.png 2,Activation of AMP-Activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells,Journal of Biological Chemistry,,,Article,2016-10-12,10.1074/jbc.m116.742247,,,,27733682,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12961347,https://api.altmetric.com/v1/donut/12961347_240.png 2,Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial,Trials,,,Article,2016-10-13,10.1186/s13063-016-1624-6,,,,27737692,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12613565,https://api.altmetric.com/v1/donut/12613565_240.png 2,136: CASARIA A Feasibility Study of Adaptive Radiation Therapy for Post-Prostatectomy Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33535-6,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11743814,https://api.altmetric.com/v1/donut/11743814_240.png 2,Abstract 1777: Prostate cancer risk factor profiles in black and white men in the NIH-AARP Diet and Health Study,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1777,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10783574,https://api.altmetric.com/v1/donut/10783574_240.png 2,"By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer.",Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4229,,,,26110567,PMC4673254,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8815171,https://api.altmetric.com/v1/donut/8815171_240.png 2,In silico identification of human miR 3654 and its targets revealed its involvement in Prostate Cancer progression.,"MicroRNA (Shariqah, United Arab Emirates)",,,Article,2016-06-16,,,,,27297584,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8773895,https://api.altmetric.com/v1/donut/8773895_240.png 2,Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: results from a 10-year cohort analysis.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2003-11-01,,,,,14529765,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8758266,https://api.altmetric.com/v1/donut/8758266_240.png 2,CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9380,,,,27191743,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7620971,https://api.altmetric.com/v1/donut/7620971_240.png 2,Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer,PLoS ONE,,,Article,2016-04-05,10.1371/journal.pone.0152861,,,,27046225,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6743616,https://api.altmetric.com/v1/donut/6743616_240.png 2,MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.,Asian Journal of Andrology,,,Article,2016-04-09,,,,,27056344,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6582525,https://api.altmetric.com/v1/donut/6582525_240.png 2,Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I–II Study ,Clinical Oncology,,,Article,2016-03-01,10.1016/j.clon.2016.02.005,,,,26961088,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6127626,https://api.altmetric.com/v1/donut/6127626_240.png 2,Application of metabolomics to prostate cancer.,Urologic Oncology,,,Article,2011-09-01,10.1016/j.urolonc.2011.08.002,,,,21930089,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/6096566,https://api.altmetric.com/v1/donut/6096566_240.png 2,The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases,EJNMMI Research,,,Article,2015-12-30,10.1186/s13550-015-0155-6,,,,26714499,PMC4695479,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4947335,https://api.altmetric.com/v1/donut/4947335_240.png 2,Local anesthesia type affects cancer detection rate in transrectal ultrasound guided prostate biopsy.,International Brazilian Journal of Urology,,,Article,2015-12-23,,,,,26689511,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4915354,https://api.altmetric.com/v1/donut/4915354_240.png 2,Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes,Radiation Oncology,,,Article,2015-10-12,10.1186/s13014-015-0515-4,,,,26458948,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4614470,https://api.altmetric.com/v1/donut/4614470_240.png 2,[The focus and prospect of prostate cancer research].,Zhonghua wai ke za zhi Chinese journal of surgery,,,Article,2015-04-01,,,,,26269156,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4396536,https://api.altmetric.com/v1/donut/4396536_240.png 2,PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer.,Seminars in Nuclear Medicine,,,Article,2015-01-07,10.1053/j.semnuclmed.2015.03.005,,,,26050657,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4102031,https://api.altmetric.com/v1/donut/4102031_240.png 2,Targeted Therapies for Prostate Cancer.,Cancer Investigation,,,Article,,10.3109/07357907.2015.1033105,,,,25951372,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4018426,https://api.altmetric.com/v1/donut/4018426_240.png 2,Uncertainty and Stigma in the Experiences of Prostate Cancer Survivors A Thematic Analysis of Narrative Elements,"Illness, Crisis & Loss",,,Article,2015-07-13,10.1177/1054137315585684,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3997293,https://api.altmetric.com/v1/donut/3997293_240.png 2,Profiling of circulating microRNAs for prostate cancer biomarker discovery.,Drug Delivery and Translational Research,,,Article,2015-03-20,10.1007/s13346-013-0169-4,,,,25786615,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3819138,https://api.altmetric.com/v1/donut/3819138_240.png 2,Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer,Scientific Reports,,,Article,2015-03-11,10.1038/srep08556,,,,25707771,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3773970,https://api.altmetric.com/v1/donut/3773970_240.png 2,Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer. Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3509/combination-of-abiraterone-and-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3757225,https://api.altmetric.com/v1/donut/3757225_240.png 2,Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer?. Genitourinary Cancers Symposium,ecancer.org,,,Article,,,,,http://ecancer.org/conference/633-genitourinary-cancers-symposium/video/3500/is-there-a-role-for-androgen-deprivation-therapy-combined-with-radiotherapy-in-intermediate-risk-prostate-cancer.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3756828,https://api.altmetric.com/v1/donut/3756828_240.png 2,ASCO GU 2015: Prostate highlights from day one. Genitourinary Cancers Symposium,ecancer.org,,,Article,,,,,http://ecancer.org/conference/633-genitourinary-cancers-symposium/video/3491/asco-gu-2015--prostate-highlights-from-day-one.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3746085,https://api.altmetric.com/v1/donut/3746085_240.png 2,New approach to prostate cancer screening. New approach to prostate cancer screening,ecancer.org,,,Article,,,,,http://ecancer.org/video/3497/new-approach-to-prostate-cancer-screening.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3739433,https://api.altmetric.com/v1/donut/3739433_240.png 2,Management of Advanced Prostate Cancer in Senior Adults: The New Landscape,Oncologist,,,Article,,10.1634/theoncologist.2012-s1-16erratum,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3433211,https://api.altmetric.com/v1/donut/3433211_240.png 2,Crowdsourcing Populates Prostate Cancer Metformin Trial,Oncology times,,,Article,2014-12-25,10.1097/01.cot.0000459924.32252.57,,,,,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3070024,https://api.altmetric.com/v1/donut/3070024_240.png 2,Re: Understanding the Pharmacological Properties of a Metabolic PET Tracer in Prostate Cancer,The Journal of Urology,,,Article,2015-01-01,10.1016/j.juro.2014.10.010,,,,25523707,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3011581,https://api.altmetric.com/v1/donut/3011581_240.png 2,Re: PSA Density Improves Prediction of Prostate Cancer,European Urology,,,Article,2014-11-01,10.1016/j.eururo.2014.08.027,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2757561,https://api.altmetric.com/v1/donut/2757561_240.png 2,The importance of perceived stress management skills for patients with prostate cancer in active surveillance,Journal of Behavioral Medicine,,,Article,2014-09-19,10.1007/s10865-014-9594-1,,,,25234859,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2725041,https://api.altmetric.com/v1/donut/2725041_240.png 2,Clinical trials: ProtecT-ing against prostate cancer,Nature Reviews Urology,,,Article,2014-09-09,10.1038/nrurol.2014.249,,,,25201617,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2679813,https://api.altmetric.com/v1/donut/2679813_240.png 2,Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer,European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.08.067,,,,25199715,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2674835,https://api.altmetric.com/v1/donut/2674835_240.png 2,Re: Prostatic Inflammation Enhances Basal-to-Luminal Differentiation and Accelerates Initiation of Prostate Cancer with a Basal Cell Origin,The Journal of Urology,,,Article,2014-01-09,10.1016/j.juro.2014.05.108,,,,25149756,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2669235,https://api.altmetric.com/v1/donut/2669235_240.png 2,Prostate cancer: USPSTF screening recommendation could lead to greater numbers of avoidable deaths,Nature Reviews Urology,,,Article,2014-08-12,10.1038/nrurol.2014.209,,,,25112861,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2664195,https://api.altmetric.com/v1/donut/2664195_240.png 2,c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine ,Biochemical Pharmacology,,,Article,,10.1016/j.bcp.2014.08.014,,,,25181458,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2663896,https://api.altmetric.com/v1/donut/2663896_240.png 2,US has seen widespread adoption of robot-assisted cancer surgery to remove the prostate,ecancer.org,,,Article,,,,,http://ecancer.org/news/6164-us-has-seen-widespread-adoption-of-robot-assisted-cancer-surgery-to-remove-the-prostate.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2627013,https://api.altmetric.com/v1/donut/2627013_240.png 2,"Incorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 3: an evaluation of SNP incorporated national health information system of Turkey for prostate cancer.",JMIR Medical Informatics,,,Article,,10.2196/medinform.3560,,,,25600087,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2608853,https://api.altmetric.com/v1/donut/2608853_240.png 2,Re: Screening for Prostate Cancer with the Prostate-Specific Antigen Test: A Review of Current Evidence,The Journal of Urology,,,Article,2014-01-08,10.1016/j.juro.2014.05.068,,,,25034992,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2579076,https://api.altmetric.com/v1/donut/2579076_240.png 2,Re: Prostate Cancer Recurrence after Radical Prostatectomy: The Role of 3-T Diffusion Imaging in Multi-Parametric Magnetic Resonance Imaging,The Journal of Urology,,,Article,2014-01-07,10.1016/j.juro.2014.04.037,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2518176,https://api.altmetric.com/v1/donut/2518176_240.png 2,Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer,Cancer Research,,,Article,,10.1158/0008-5472.can-14-0369,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2454638,https://api.altmetric.com/v1/donut/2454638_240.png 2,DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy,British Journal of Cancer,,,Article,2014-06-17,10.1038/bjc.2014.337,,,,24937670,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2446634,https://api.altmetric.com/v1/donut/2446634_240.png 2,"Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer. Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer",ecancer.org,,,Article,,,,,http://ecancer.org/video/2921/addition-of-docetaxel-to-initial-hormone-therapy-substantially-improves-survival-in-metastatic--hormone-sensitive-prostate-cancer.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2421195,https://api.altmetric.com/v1/donut/2421195_240.png 2,Prostate cancer screening rates remain stable despite recommendations against testing men with limited life expectancy,CA: A Cancer Journal for Clinicians ,,,Article,2014-05-28,10.3322/caac.21229,,,,24890093,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2386240,https://api.altmetric.com/v1/donut/2386240_240.png 2,Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localized prostate cancer using WST11?Vascular Targeted Photodynamic (VTP) therapy,British Journal of Urology,,,Article,2015-04-22,10.1111/bju.12816,,,,24841929,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2361519,https://api.altmetric.com/v1/donut/2361519_240.png 2,Analytic and Clinical Validation of a Prostate Cancer–Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.07.006,,,,23954088,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2350271,https://api.altmetric.com/v1/donut/2350271_240.png 2,Prostate cancer incidence on cystoprostatectomy specimens are directly linked to age: results from a multicenter study,British Journal of Urology,,,Article,2014-08-11,10.1111/bju.12803,,,,24825727,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2349425,https://api.altmetric.com/v1/donut/2349425_240.png 2,Altered Significance of D'Amico Risk Classification in Prostate Cancer Patients linked to a Familial Breast Cancer (kConFab) cohort,British Journal of Urology,,,Article,2014-04-29,10.1111/bju.12792,,,,24784491,,11343/44058,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2315741,https://api.altmetric.com/v1/donut/2315741_240.png 2,"Reply to E. David Crawford and Bo-Eric Persson's Letter to the Editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026",European Urology,,,Article,,10.1016/j.eururo.2014.03.043,,,,24746970,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2266473,https://api.altmetric.com/v1/donut/2266473_240.png 2,"Optimizing the Management of Pathologic, Possible, and Putative N1 Prostate Cancer",European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.10.010,,,,24269217,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2263336,https://api.altmetric.com/v1/donut/2263336_240.png 2,SPINK1 Protein Expression and Prostate Cancer Progression,Clinical Cancer Research,,,Article,2014-03-30,10.1158/1078-0432.ccr-13-1341,,,,24687926,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2228038,https://api.altmetric.com/v1/donut/2228038_240.png 2,The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate?risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low?dose rate (LDR) brachytherapy,British Journal of Urology,,,Article,2014-03-14,10.1111/bju.12587,,,,24274784,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2186340,https://api.altmetric.com/v1/donut/2186340_240.png 2,PD12-04 THE EFFECT OF AGE AT DIAGNOSIS ON PROSTATE CANCER MORTALITY: A GRADE-FOR-GRADE AND STAGE-FOR-STAGE ANALYSIS,The Journal of Urology,,,Article,,10.1016/j.juro.2013.10.091,,,,24411845,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2183525,https://api.altmetric.com/v1/donut/2183525_240.png 2,Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists,Virchows Archiv,,,Article,2014-03-04,10.1007/s00428-014-1554-1,,,,24590584,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2160825,https://api.altmetric.com/v1/donut/2160825_240.png 2,Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life,ecancer.org,,,Article,,,,,http://ecancer.org/news/5269-proton-therapy-for-prostate-cancer-results-in-long-term-patient-survival-and-excellent-quality-of-life.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2125115,https://api.altmetric.com/v1/donut/2125115_240.png 2,Prostate cancer: Tipping the balance in favour of degarelix for ADT,Nature Reviews Urology,,,Article,2014-01-28,10.1038/nrurol.2014.11,,,,24473414,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2112758,https://api.altmetric.com/v1/donut/2112758_240.png 2,Prostate cancer: What is the real IMPACT of BRCA1/BRCA2 mutation?,Nature Reviews Urology,,,Article,2014-02-04,10.1038/nrurol.2014.19,,,,24492431,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2095365,https://api.altmetric.com/v1/donut/2095365_240.png 2,Enzalutamide improves survival in men with metastaticcastration-resistant prostate cancer. Enzalutamide improvessurvival in men with metastatic castration-resistant prostatecancer. ecancer.tv - Essential viewing for oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2661/enzalutamide-improves-survival-in-men-with-metastatic-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2090515,https://api.altmetric.com/v1/donut/2090515_240.png 2,The association between cardiorespiratory fitness and prostate cancer.,Medicine & Science in Sports & Exercise,,,Article,1996-01-01,,,,,8775361,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1966687,https://api.altmetric.com/v1/donut/1966687_240.png 2,Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer,Molecular Cancer Therapeutics,,,Article,2013-01-01,10.1158/1535-7163.mct-13-0267,,,,23939374,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1889225,https://api.altmetric.com/v1/donut/1889225_240.png 2,Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model,Scientific Reports,,,Article,2013-11-06,10.1038/srep03151,,,,24193225,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1886709,https://api.altmetric.com/v1/donut/1886709_240.png 2,Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition,Actas Urologicas Espanolas - English Edition,,,Article,2013-09-01,10.1016/j.acuroe.2013.09.003,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1781248,https://api.altmetric.com/v1/donut/1781248_240.png 2,Evolution of Novel Biomarkers for Detection of Prostate Cancer,The Journal of Urology,,,Article,2013-09-16,10.1016/j.juro.2013.09.018,,,,24045221,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1752198,https://api.altmetric.com/v1/donut/1752198_240.png 2,Stromal Response to Prostate Cancer: Nanotechnology-Based Detection of Thioredoxin-Interacting Protein Partners Distinguishes Prostate Cancer Associated Stroma from That of Benign Prostatic Hyperplasia,PLoS ONE,,,Article,2013-06-06,10.1371/journal.pone.0060562,,,,23762225,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1537345,https://api.altmetric.com/v1/donut/1537345_240.png 2,The role of proteomics in prostate cancer research: Biomarker discovery and validation ,Clinical Biochemistry,,,Article,2012-12-27,10.1016/j.clinbiochem.2012.12.012,,,,23266295,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/1161654,https://api.altmetric.com/v1/donut/1161654_240.png 2,Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer,Clinical Medicine Insights: Oncology,,,Article,2012-12-01,10.4137/cmo.s7256,,,,23362372,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1136462,https://api.altmetric.com/v1/donut/1136462_240.png 2,Patient and spouse illness beliefs and quality of life in prostate cancer patients,Psychology & Health,,,Article,2012-09-15,10.1080/08870446.2012.722219,,,,22971045,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1012181,https://api.altmetric.com/v1/donut/1012181_240.png 2,A Peptidic Unconjugated GRP78/BiP Ligand Modulates the Unfolded Protein Response and Induces Prostate Cancer Cell Death,PLoS ONE,,,Article,2012-10-01,10.1371/journal.pone.0045690,,,,23049684,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/975615,https://api.altmetric.com/v1/donut/975615_240.png 2,"Re: Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3,009,258 Men",The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.05.069,,,,22883790,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/892278,https://api.altmetric.com/v1/donut/892278_240.png 2,β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model,Scientific Reports,,,Article,2012-07-24,10.1038/srep00526,,,,22829980,PMC3402831,,2012NatSR...2E.526M,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/853984,https://api.altmetric.com/v1/donut/853984_240.png 2,[Management of a hormone dependent cancer with endocrine therapy--prostate cancer].,Gan to kagaku ryoho Cancer chemotherapy,,,Article,2001-07-01,,,,,11478140,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/840325,https://api.altmetric.com/v1/donut/840325_240.png 2,Results of low threshold to biopsy following high-intensity focused ultrasound for localized prostate cancer.,Urology Annals,,,Article,2012-05-01,10.4103/0974-7796.95551,,,,22629002,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/763038,https://api.altmetric.com/v1/donut/763038_240.png 2,The Relevance of BRCA Genetics to Prostate Cancer Pathogenesis and Treatment.,Clinical Advances in Hematology & Oncology,,,Article,2012-01-20,,,,,22252577,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/725786,https://api.altmetric.com/v1/donut/725786_240.png 2,11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation.,Journal of Nuclear Medicine,,,Article,2012-02-17,10.2967/jnumed.111.096032,,,,22343504,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/615978,https://api.altmetric.com/v1/donut/615978_240.png 1,Post-diagnostic dietary changes in prostate cancer: associations with patients’ wellbeing and the perceptions of GPs,European Journal of Cancer Care,,,Article,2016-10-24,10.1111/ecc.12599,,,,27774678,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13192036,https://api.altmetric.com/v1/donut/13192036_240.png 1,POLYPHENOLIC CARBOSILANE DENDRIMERS AS ANTICANCER AGENTS AGAINST PROSTATE CANCER,New Journal of Chemistry,,,Article,2016-10-24,10.1039/c6nj02545e,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13167687,https://api.altmetric.com/v1/donut/13167687_240.png 1,The role of cholesterol in prostate cancer,Current Opinion in Clinical Nutrition and Metabolic Care,,,Article,2006-08-01,10.1097/01.mco.0000232896.66791.62,,,,16778565,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13167394,https://api.altmetric.com/v1/donut/13167394_240.png 1,New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate Cancer,Targeted Oncology,,,Article,2016-10-27,10.1007/s11523-016-0461-6,,,,27796762,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13166290,https://api.altmetric.com/v1/donut/13166290_240.png 1,Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost?,Radiotherapy & Oncology,,,Article,2016-10-01,10.1016/j.radonc.2016.09.013,,,,27776748,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13124675,https://api.altmetric.com/v1/donut/13124675_240.png 1,A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients,Radiotherapy & Oncology,,,Article,2016-10-01,10.1016/j.radonc.2016.09.016,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13124248,https://api.altmetric.com/v1/donut/13124248_240.png 1,Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2016-09-01,10.1016/j.clgc.2016.09.002,,,,27751686,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13097837,https://api.altmetric.com/v1/donut/13097837_240.png 1,Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine,The Prostate,,,Article,2016-10-24,10.1002/pros.23266,,,,27775173,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13079439,https://api.altmetric.com/v1/donut/13079439_240.png 1,Automatic Gleason Grading of Prostate Cancer Using Shearlet Transform and Multiple Kernel Learning,Journal of Imaging,,,Article,2016-09-09,10.3390/jimaging2030025,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13066176,https://api.altmetric.com/v1/donut/13066176_240.png 1,A Case of Prostate Cancer in Lynch Syndrome,Urology,,,Article,2016-09-01,10.1016/j.urology.2016.06.006,,,,27318266,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/13060298,https://api.altmetric.com/v1/donut/13060298_240.png 1," Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status ",The Prostate,,,Article,2016-10-18,10.1002/pros.23267,,,,27753122,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12979669,https://api.altmetric.com/v1/donut/12979669_240.png 1,Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer,Journal of Proteome Research,,,Article,2016-10-24,10.1021/acs.jproteome.6b00620,,,,27700103,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12957201,https://api.altmetric.com/v1/donut/12957201_240.png 1,Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy,Journal of Cellular Biochemistry,,,Article,2016-10-01,10.1002/jcb.25768,,,,27753136,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12951130,https://api.altmetric.com/v1/donut/12951130_240.png 1,Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis–Free Survival and Prostate Cancer–Specific Mortality,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-11-01,10.1016/j.ijrobp.2016.07.009,,,,27681757,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/12951051,https://api.altmetric.com/v1/donut/12951051_240.png 1,"Prostate cancer detection by prostate-specific antigen-based screening in Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection",Canadian Urological Association Journal,,,Article,2014-05-14,10.5489/cuaj.1715,,,,24940459,PMC4039596,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12856611,https://api.altmetric.com/v1/donut/12856611_240.png 1,A Cost-Utility Analysis of Prostate Cancer Screening in Australia,Applied Health Economics and Health Policy,,,Article,2016-10-18,10.1007/s40258-016-0278-6,,,,27757918,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12758685,https://api.altmetric.com/v1/donut/12758685_240.png 1,PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives,Clinical and Translational Imaging,,,Article,2016-07-04,10.1007/s40336-016-0197-4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12748809,https://api.altmetric.com/v1/donut/12748809_240.png 1,"PET imaging in prostate cancer, future trends: PSMA ligands",Clinical and Translational Imaging,,,Article,2016-06-30,10.1007/s40336-016-0194-7,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12744296,https://api.altmetric.com/v1/donut/12744296_240.png 1,Prostate cancer risk calculators: still much work ahead,British Journal of Urology,,,Article,2016-10-18,10.1111/bju.13497,,,,27753470,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12716809,https://api.altmetric.com/v1/donut/12716809_240.png 1,High-Risk Prostate Cancer: Role of Radical Prostatectomy and Radiation Therapy,Oncology Research and Treatment,,,Article,2015-11-16,10.1159/000441736,,,,26633298,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12687813,https://api.altmetric.com/v1/donut/12687813_240.png 1,Phosphodiesterase-5 Inhibitors Could Be Efficacious in the Treatment of Erectile Dysfunction after Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis,Urologia Internationalis,,,Article,2012-12-05,10.1159/000343730,,,,23221333,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12679203,https://api.altmetric.com/v1/donut/12679203_240.png 1,"High-Dose Calcitriol, Docetaxel and Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer: A Phase II Study",Urologia Internationalis,,,Article,2012-11-08,10.1159/000343780,,,,23146834,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12679040,https://api.altmetric.com/v1/donut/12679040_240.png 1,Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy,Urologia Internationalis,,,Article,2012-11-02,10.1159/000343430,,,,23128438,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12677131,https://api.altmetric.com/v1/donut/12677131_240.png 1,Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2001-11-15,,,,,11704322,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12662578,https://api.altmetric.com/v1/donut/12662578_240.png 1,The Declining Use of Brachytherapy Boost for Prostate Cancer Despite Associated Survival Advantage,Brachytherapy,,,Article,2016-05-01,10.1016/j.brachy.2016.04.014,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12662148,https://api.altmetric.com/v1/donut/12662148_240.png 1,Screening men at increased risk for prostate cancer diagnosis: Model estimates of benefits and harms,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-10-14,10.1158/1055-9965.epi-16-0434,,,,27742670,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12662090,https://api.altmetric.com/v1/donut/12662090_240.png 1,The utilisation of virtual images in patient information giving sessions for prostate cancer patients prior to radiotherapy,Radiography (00338281),,,Article,2016-11-01,10.1016/j.radi.2016.05.002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12637664,https://api.altmetric.com/v1/donut/12637664_240.png 1,Recent progress and perspectives on prostate cancer biomarkers,International Journal of Clinical Oncology,,,Article,2016-10-11,10.1007/s10147-016-1049-y,,,,27730440,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12633471,https://api.altmetric.com/v1/donut/12633471_240.png 1,Histological changes caused by meclofenamic acid in androgen-independent prostate cancer tumors: evaluation in a mouse model.,International braz j urol : official journal of the Brazilian Society of Urology,,,Article,,,,,,26689527,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12617425,https://api.altmetric.com/v1/donut/12617425_240.png 1,Age-related racial disparities in prostate cancer patients: A systematic review,Ethnicity & Health,,,Article,2016-10-05,10.1080/13557858.2016.1235682,,,,27706949,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12596066,https://api.altmetric.com/v1/donut/12596066_240.png 1,Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models,Oncogene,,,Article,2011-09-26,10.1038/onc.2011.396,,,,21996742,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,95,https://www.altmetric.com/details/12486857,https://api.altmetric.com/v1/donut/12486857_240.png 1,Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience.,The Journal of Urology,,,Article,2002-12-01,10.1097/01.ju.0000036521.21034.ec,,,,12441929,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/12453827,https://api.altmetric.com/v1/donut/12453827_240.png 1,Intrapersonal and community factors associated with prostate cancer screening among African-American males in the US,Nursing : Research and Reviews,,,Article,2016-09-28,10.2147/nrr.s96399,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12445049,https://api.altmetric.com/v1/donut/12445049_240.png 1,PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-08-25,10.1007/s00259-016-3493-3,,,,27557847,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12421170,https://api.altmetric.com/v1/donut/12421170_240.png 1,Active Surveillance of Localized Prostate Cancer: Acknowledging Uncertainty,Journal of Clinical Oncology,,,Article,,10.1200/jco.2016.67.8888,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12411639,https://api.altmetric.com/v1/donut/12411639_240.png 1,A Retrospective Feasibility Study of Salvage Pelvic Nodal Radiation in 6 Patients With Biochemical Failure Following Prostate Fossa Radiation,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-10-01,10.1097/coc.0000000000000079,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/10000/A_Retrospective_Feasibility_Study_of_Salvage.11.aspx,27655099,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12383333,https://api.altmetric.com/v1/donut/12383333_240.png 1,Ultrasound-Contrast-Agent Dispersion and Velocity Imaging for Prostate Cancer Localization,Medical Image Analysis,,,Article,2016-10-11,10.1016/j.media.2016.09.010,,,,27723564,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12374741,https://api.altmetric.com/v1/donut/12374741_240.png 1,Pan-cancer analysis of the Mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer.,Clinical Cancer Research,,,Article,2016-09-30,10.1158/1078-0432.ccr-16-0094,,,,27678455,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12313457,https://api.altmetric.com/v1/donut/12313457_240.png 1,How to Counsel Patients With Localized Prostate Cancer About Treatment Selection: Quality-of-Life Results of a Prospective Single-Institution Cohort.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-09-29,10.1016/j.ijrobp.2016.06.1967,,,,27674949,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12269516,https://api.altmetric.com/v1/donut/12269516_240.png 1,Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-?B cistrome to reprogram the prostate cancer cell transcriptome,Nucleic Acids Research,,,Article,2016-09-26,10.1093/nar/gkw855,,,,27672034,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12260581,https://api.altmetric.com/v1/donut/12260581_240.png 1,Second Malignancies as First Cause of Death in Localized Prostate Cancer Treated With Radiation Therapy: Data from Two Phase 3 Trials.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-09-28,10.1016/j.ijrobp.2016.06.462,,,,27675736,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12254747,https://api.altmetric.com/v1/donut/12254747_240.png 1,Danish Prostate Cancer Registry – methodology and early results from a novel national database,Clinical Epidemiology,,,Article,2016-09-27,10.2147/clep.s114917,,,,27729813,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12248756,https://api.altmetric.com/v1/donut/12248756_240.png 1,Insulin-Like Growth Factor (IGF) family and prostate cancer,Critical Reviews in Oncology/Hematology,,,Article,2006-01-20,10.1016/j.critrevonc.2005.10.003,,,,16387509,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/12233499,https://api.altmetric.com/v1/donut/12233499_240.png 1,The Ingredients for Prostate Cancer Nomograms: The Addition of Biomarkers Sets the Table for Future Recipes,Journal of Clinical Oncology,,,Article,2003-10-01,10.1200/jco.2003.07.083,,,,12913104,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12207132,https://api.altmetric.com/v1/donut/12207132_240.png 1,"Cancer-related masculine threat, emotional approach coping, and physical functioning following treatment for prostate cancer.",Health Psychology,,,Article,2013-01-15,10.1037/a0030020,,,,23316854,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/12161388,https://api.altmetric.com/v1/donut/12161388_240.png 1,Dispositional optimism as a predictor of men's decision-related distress after localized prostate cancer.,Health Psychology,,,Article,2006-03-15,10.1037/0278-6133.25.2.135,,,,16569104,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/12136316,https://api.altmetric.com/v1/donut/12136316_240.png 1,Future trends in prostate cancer theranostics with PSMA ligands,Clinical and Translational Imaging,,,Article,2016-07-14,10.1007/s40336-016-0184-9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12132140,https://api.altmetric.com/v1/donut/12132140_240.png 1,The urologist’s unmet clinical needs in prostate cancer,Clinical and Translational Imaging,,,Article,2016-07-28,10.1007/s40336-016-0199-2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12132088,https://api.altmetric.com/v1/donut/12132088_240.png 1,Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy.,Cancer Biology and Therapy,,,Article,2006-08-14,,,,,16855379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/12126749,https://api.altmetric.com/v1/donut/12126749_240.png 1," Effects of ? -3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial ",Nutrition and Cancer,,,Article,2016-09-20,10.1080/01635581.2016.1224365,,,,27646578,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12117227,https://api.altmetric.com/v1/donut/12117227_240.png 1,Galeterone and VNPT55 disrupts Mnk-eIF4E to inhibit prostate cancer cell migration and invasion,FEBS Journal,,,Article,2016-09-01,10.1111/febs.13895,,,,27618366,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12099529,https://api.altmetric.com/v1/donut/12099529_240.png 1,Computed Tomography Perfusion of Prostate Cancer,Journal of Computer Assisted Tomography,,,Article,2016-09-01,10.1097/rct.0000000000000432,,,http://journals.lww.com/jcat/Fulltext/2016/09000/Computed_Tomography_Perfusion_of_Prostate_Cancer__.11.aspx,27224230,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12094087,https://api.altmetric.com/v1/donut/12094087_240.png 1,The very-high-risk prostate cancer: a contemporary update,Prostate Cancer & Prostatic Diseases,,,Article,2016-09-13,10.1038/pcan.2016.40,,,,27618950,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12093863,https://api.altmetric.com/v1/donut/12093863_240.png 1,"Intrusion, avoidance, and daily negative affect among couples coping with prostate cancer: A dyadic investigation.",Journal of Family Psychology,,,Article,2012-04-14,10.1037/a0027332,,,,22369460,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/12072505,https://api.altmetric.com/v1/donut/12072505_240.png 1,Optimal healthcare decision making under multiple mathematical models: application in prostate cancer screening,Health Care Management Science,,,Article,2016-09-17,10.1007/s10729-016-9381-3,,,,27639567,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12067434,https://api.altmetric.com/v1/donut/12067434_240.png 1,Unexplained Bone Pain Is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: A Prospective Study,Urology,,,Article,2016-09-01,10.1016/j.urology.2016.09.019,,,,27645522,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12065170,https://api.altmetric.com/v1/donut/12065170_240.png 1,Evidence of prostate cancer “reverse stage migration” toward more advanced disease at diagnosis: Data from the Pennsylvania Cancer Registry,Urologic Oncology,,,Article,2016-08-01,10.1016/j.urolonc.2016.03.014,,,,27108226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12040265,https://api.altmetric.com/v1/donut/12040265_240.png 1,PSA testing: Molecular technologies and men's experience of prostate cancer survivorship,"Health, Risk & Society",,,Article,2011-03-30,10.1080/13698575.2011.556187,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/12023417,https://api.altmetric.com/v1/donut/12023417_240.png 1,Constructing bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11925,,,,27626693,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12013410,https://api.altmetric.com/v1/donut/12013410_240.png 1,"Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer",Molecular Cancer Research,,,Article,2016-09-01,10.1158/1541-7786.mcr-16-0137,,,,27341831,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12007079,https://api.altmetric.com/v1/donut/12007079_240.png 1,Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience,Ecancermedicalscience,,,Article,2016-01-01,10.3332/ecancer.2016.633,,,,27170833,PMC4854226,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11999196,https://api.altmetric.com/v1/donut/11999196_240.png 1,Low density lipoprotein receptor targeted doxorubicin/DNA-Gold Nanorods as a chemo- and thermo-dual therapy for prostate cancer,International Journal of Pharmaceutics,,,Article,2016-09-01,10.1016/j.ijpharm.2016.09.002,,,,27613256,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11998760,https://api.altmetric.com/v1/donut/11998760_240.png 1,"Shared possible selves, other-focus, and perceived wellness of couples with prostate cancer.",Journal of Family Psychology,,,Article,2014-08-10,10.1037/fam0000015,,,,25111956,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11993758,https://api.altmetric.com/v1/donut/11993758_240.png 1,Computer aided diagnosis of prostate cancer: A texton based approach,Medical Physics,,,Article,2016-09-13,10.1118/1.4962031,,,,27782724,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11979895,https://api.altmetric.com/v1/donut/11979895_240.png 1,Overview of Dietary Supplements in Prostate Cancer,Current Urology Reports,,,Article,2016-09-09,10.1007/s11934-016-0637-8,,,,27613410,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11961363,https://api.altmetric.com/v1/donut/11961363_240.png 1,Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor- B-dependent mechanism,Molecular Cancer Therapeutics,,,Article,2008-09-01,10.1158/1535-7163.mct-08-0136,,,,18790748,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/11952382,https://api.altmetric.com/v1/donut/11952382_240.png 1,Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review,Current Drug Targets,,,Article,2016-06-13,10.2174/1389450117666160613103705,,,,,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11944548,https://api.altmetric.com/v1/donut/11944548_240.png 1,Optimization of the Radiation Management of High Risk Prostate Cancer,Seminars in Radiation Oncology,,,Article,2016-09-01,10.1016/j.semradonc.2016.08.009,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11933764,https://api.altmetric.com/v1/donut/11933764_240.png 1,Diverse functions of DNA methylation: implications for prostate cancer and beyond,Endocrine-Related Cancer,,,Article,2016-09-07,10.1530/erc-16-0306,,,,27605446,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11915777,https://api.altmetric.com/v1/donut/11915777_240.png 1,Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways,Journal of Cellular Biochemistry,,,Article,2016-09-01,10.1002/jcb.25729,,,,27606834,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11910605,https://api.altmetric.com/v1/donut/11910605_240.png 1,Prostate Cancer's Hegemonic Masculinity in Select Print Mass Media Depictions (1974-1995),Health Communication,,,Article,1999-01-01,10.1207/s15327027hc1101_4,,,,16370970,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11902306,https://api.altmetric.com/v1/donut/11902306_240.png 1,"Health Behaviors, Prostate Cancer, and Masculinities: A Life Course Perspective",Men & Masculinities,,,Article,2007-08-22,10.1177/1097184x06298777,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11902305,https://api.altmetric.com/v1/donut/11902305_240.png 1,Re: Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial,European Urology,,,Article,2016-09-07,10.1016/j.eururo.2016.08.064,,,,27613062,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11872997,https://api.altmetric.com/v1/donut/11872997_240.png 1,On the importance of being ethnic: Coping with the threat of prostate cancer in relation to prostate cancer screening.,Cultural Diversity & Ethnic Minority Psychology,,,Article,2006-07-14,10.1037/1099-9809.12.3.509,,,,16881753,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11840448,https://api.altmetric.com/v1/donut/11840448_240.png 1,Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions.,Health Psychology,,,Article,2003-01-01,10.1037/0278-6133.22.5.443,,,,,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11839990,https://api.altmetric.com/v1/donut/11839990_240.png 1,"Holding back, intimacy, and psychological and relationship outcomes among couples coping with prostate cancer.",Journal of Family Psychology,,,Article,2015-01-01,10.1037/fam0000096,,,,26192132,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/11839843,https://api.altmetric.com/v1/donut/11839843_240.png 1,"Re: Family History and Probability of Prostate Cancer, Differentiated by Risk Category — A Nationwide Population-based Study",European Urology,,,Article,2016-09-06,10.1016/j.eururo.2016.08.063,,,,27609559,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11825450,https://api.altmetric.com/v1/donut/11825450_240.png 1,Genomic Rearrangements of PTEN in Prostate Cancer,Frontiers in oncology,,,Article,2016-09-05,10.3389/fonc.2013.00240,,,,24062990,PMC3775430,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/11739328,https://api.altmetric.com/v1/donut/11739328_240.png 1,Re: Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial,European Urology,,,Article,2016-09-03,10.1016/j.eururo.2016.08.056,,,,27597237,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11671905,https://api.altmetric.com/v1/donut/11671905_240.png 1,Vitamin D and prostate cancer,,,,Article,2007-01-01,,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11592342,https://api.altmetric.com/v1/donut/11592342_240.png 1,"The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition",Journal of Molecular Signaling,,,Article,2010-08-18,10.1186/1750-2187-5-14,,,,20718984,PMC2933702,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/11371821,https://api.altmetric.com/v1/donut/11371821_240.png 1,Prostate cancer: Risk SNPs modulate lncRNAs,Nature Reviews Urology,,,Article,2016-08-31,10.1038/nrurol.2016.171,,,,27578041,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11212459,https://api.altmetric.com/v1/donut/11212459_240.png 1,Utilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?,Journal of Contemporary Brachytherapy,,,Article,2016-09-21,10.5114/jcb.2016.61942,,,,27648081,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10922926,https://api.altmetric.com/v1/donut/10922926_240.png 1,The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer,Expert Review of Anticancer Therapy,,,Article,2016-08-24,10.1080/14737140.2016.1222273,,,,27501059,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10916994,https://api.altmetric.com/v1/donut/10916994_240.png 1,Association of Family History of Type 2 Diabetes with Prostate Cancer: A National Cohort Study,Frontiers in oncology,,,Article,2016-08-29,10.3389/fonc.2016.00194,,,,27622158,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10889618,https://api.altmetric.com/v1/donut/10889618_240.png 1,Adverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active Surveillance,European Urology,,,Article,2016-08-28,10.1016/j.eururo.2016.08.043,,,,27574819,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10870710,https://api.altmetric.com/v1/donut/10870710_240.png 1,Informed Decision Making About Prostate Cancer Testing in Predominantly Immigrant Black Men: A Randomized Controlled Trial,Annals of Behavioral Medicine,,,Article,2012-07-24,10.1007/s12160-012-9392-3,,,,22825933,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/10864454,https://api.altmetric.com/v1/donut/10864454_240.png 1,Longitudinal Analysis of a Model to Predict Quality of Life in Prostate Cancer Patients and their Spouses,Annals of Behavioral Medicine,,,Article,2008-09-16,10.1007/s12160-008-9058-3,,,,18830672,PMC2872798,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/10864080,https://api.altmetric.com/v1/donut/10864080_240.png 1,Quality of Life of Couples Dealing with Cancer: Dyadic and Individual Adjustment among Breast and Prostate Cancer Survivors and Their Spousal Caregivers,Annals of Behavioral Medicine,,,Article,2008-03-18,10.1007/s12160-008-9026-y,,,,18365297,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/10863922,https://api.altmetric.com/v1/donut/10863922_240.png 1,The Role of Spirituality in the Relationship Between Religiosity and Depression in Prostate Cancer Patients,Annals of Behavioral Medicine,,,Article,2009-10-06,10.1007/s12160-009-9139-y,,,,19806413,PMC2877207,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/10863880,https://api.altmetric.com/v1/donut/10863880_240.png 1,Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal,PharmacoEconomics,,,Article,2016-08-26,10.1007/s40273-016-0445-5,,,,27566699,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10851451,https://api.altmetric.com/v1/donut/10851451_240.png 1,Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway,International Journal of Cancer,,,Article,2005-11-14,10.1002/ijc.21592,,,,16287090,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/10844431,https://api.altmetric.com/v1/donut/10844431_240.png 1,Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy,Modern Pathology,,,Article,2016-08-26,10.1038/modpathol.2016.154,,,,27562498,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10844254,https://api.altmetric.com/v1/donut/10844254_240.png 1,Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target,Cancer Research,,,Article,2005-06-15,10.1158/0008-5472.can-04-3785,,,,15958559,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/10844198,https://api.altmetric.com/v1/donut/10844198_240.png 1,"Physical Health, Self-Reliance, and Emotional Control as Moderators of the Relationship between Locus of Control and Mental Health among Men Treated for Prostate Cancer",Journal of Behavioral Medicine,,,Article,2006-09-19,10.1007/s10865-006-9076-1,,,,16988886,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/10818023,https://api.altmetric.com/v1/donut/10818023_240.png 1,The importance of pelvic lymph node dissection in men with clinically localized prostate cancer.,Reviews in Urology,,,Article,,,,,,17043708,PMC1578548,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10806137,https://api.altmetric.com/v1/donut/10806137_240.png 1,Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?,World Journal of Urology,,,Article,2016-08-08,10.1007/s00345-016-1906-3,,,,27502935,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10789618,https://api.altmetric.com/v1/donut/10789618_240.png 1,Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen Therapy,The Journal of Urology,,,Article,2016-10-19,10.1016/j.juro.2016.08.078,,,,27751453,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10789200,https://api.altmetric.com/v1/donut/10789200_240.png 1,Re: 5?-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men with Prostate Cancer,The Journal of Urology,,,Article,2016-10-19,10.1016/j.juro.2016.08.044,,,,27751473,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10789199,https://api.altmetric.com/v1/donut/10789199_240.png 1,Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts,Journal of Contemporary Brachytherapy,,,Article,2015-12-01,10.5114/jcb.2015.56763,,,,26816337,PMC4716130,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10784603,https://api.altmetric.com/v1/donut/10784603_240.png 1,Id-1 expression promotes cell survival through activation of NF-?B signalling pathway in prostate cancer cells,Oncogene,,,Article,2003-07-17,10.1038/sj.onc.1206693,,,,,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/10778303,https://api.altmetric.com/v1/donut/10778303_240.png 1,MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging,World Journal of Urology,,,Article,2016-08-19,10.1007/s00345-016-1924-1,,,,27541586,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10749922,https://api.altmetric.com/v1/donut/10749922_240.png 1,Use of a novel non-parametric version of DEPTH to identify genomic regions associated with prostate cancer risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-08-18,10.1158/1055-9965.epi-16-0301,,,,27539266,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10726688,https://api.altmetric.com/v1/donut/10726688_240.png 1,MicroRNA Theranostics in Prostate Cancer Precision Medicine,Clinical Chemistry,,,Article,2016-08-18,10.1373/clinchem.2015.242800,,,,27540032,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10698426,https://api.altmetric.com/v1/donut/10698426_240.png 1,Urinary DNA methylation biomarkers for non-invasive prediction of aggressive disease in prostate cancer patients on Active Surveillance,The Journal of Urology,,,Article,2016-08-23,10.1016/j.juro.2016.08.081,,,,27545574,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10696577,https://api.altmetric.com/v1/donut/10696577_240.png 1,Heightened Optimism in the Treatment of Advanced Prostate Cancer,Home Health Care Management & Practice,,,Article,2012-12-02,10.1177/1084822312467349,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10666186,https://api.altmetric.com/v1/donut/10666186_240.png 1,From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer,Scandinavian Journal of Urology,,,Article,2016-07-14,10.1080/21681805.2016.1201858,,,,27415753,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10557536,https://api.altmetric.com/v1/donut/10557536_240.png 1,Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells,Journal of Cellular Biochemistry,,,Article,2016-08-01,10.1002/jcb.25673,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10474053,https://api.altmetric.com/v1/donut/10474053_240.png 1,A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2006-11-01,10.1158/1055-9965.epi-06-0410,,,,17119028,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/10432875,https://api.altmetric.com/v1/donut/10432875_240.png 1,Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry,Urologic Oncology,,,Article,2016-07-01,10.1016/j.urolonc.2016.06.015,,,,27432432,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10374656,https://api.altmetric.com/v1/donut/10374656_240.png 1,Preliminary Case Series of Artemisinin for Prostate Cancer in a Naturopathic Practice,Journal of Restorative Medicine,,,Article,2015-12-01,10.14200/jrm.2015.4.0103,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10374111,https://api.altmetric.com/v1/donut/10374111_240.png 1,Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10396,,,,27391263,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10344729,https://api.altmetric.com/v1/donut/10344729_240.png 1,Sexual factors and prostate cancer,British Journal of Urology,,,Article,2003-12-17,10.1111/j.1464-410x.2004.04581.x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10319201,https://api.altmetric.com/v1/donut/10319201_240.png 1,Genistein inhibits radiation-induced activation of NF-?B in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest,BMC Cancer,,,Article,2006-04-26,10.1186/1471-2407-6-107,,,,16640785,PMC1464148,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/10264040,https://api.altmetric.com/v1/donut/10264040_240.png 1," The mechanism of protriptyline-induced Ca 2+ movement and non-Ca 2+ -triggered cell death in PC3 human prostate cancer cells ",Journal of Receptor & Signal Transduction Research,,,Article,2015-06-22,10.3109/10799893.2014.1000464,,,,26096164,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10254458,https://api.altmetric.com/v1/donut/10254458_240.png 1,Stereotactic Body Radiation Therapy for Localized Prostate Cancer,Cancer Journal,,,Article,2016-01-01,10.1097/ppo.0000000000000209,,,http://journals.lww.com/journalppo/Fulltext/2016/07000/Stereotactic_Body_Radiation_Therapy_for_Localized.12.aspx,27441752,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10250245,https://api.altmetric.com/v1/donut/10250245_240.png 1,Human Prostate Cancer Hallmarks Map,Scientific Reports,,,Article,2016-08-01,10.1038/srep30691,,,,27476486,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10210865,https://api.altmetric.com/v1/donut/10210865_240.png 1,Abstract 450: Serum biomarkers in patients treated with stereotactic body radiation therapy (SBRT) for prostate cancer,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-450,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10190044,https://api.altmetric.com/v1/donut/10190044_240.png 1,Perinatal and childhood factors and risk of prostate cancer in adulthood: MCC-Spain case-control study,Cancer Epidemiology,,,Article,2016-07-05,10.1016/j.canep.2016.06.012,,,,27391546,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10176354,https://api.altmetric.com/v1/donut/10176354_240.png 1,Unfavorable Intermediate-Risk Prostate Cancer and the Odds of Upgrading to Gleason 8 or Higher at Prostatectomy,Clinical Genitourinary Cancer,,,Article,2016-06-01,10.1016/j.clgc.2016.06.001,,,,27426058,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10167051,https://api.altmetric.com/v1/donut/10167051_240.png 1,Can pre- and postoperative magnetic resonance imaging predict recurrence-free survival after whole-gland high-intensity focused ablation for prostate cancer?,European Radiology,,,Article,2016-07-19,10.1007/s00330-016-4491-3,,,,27436018,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10167033,https://api.altmetric.com/v1/donut/10167033_240.png 1,Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10523,,,,27438142,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10167018,https://api.altmetric.com/v1/donut/10167018_240.png 1,87 18-year follow up of the Gothenburg randomized population-based prostate cancer screening trial,European Urology Supplements,,,Article,2016-03-01,10.1016/s1569-9056(16)60089-1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10121463,https://api.altmetric.com/v1/donut/10121463_240.png 1,"Robotic surgery for prostate cancer achieves similar outcomes to open surgery, study shows",British Medical Journal,,,Article,2016-07-27,10.1136/bmj.i4150,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10115774,https://api.altmetric.com/v1/donut/10115774_240.png 1,Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK,British Journal of Urology,,,Article,2014-05-01,10.1111/bju.12358,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/10097370,https://api.altmetric.com/v1/donut/10097370_240.png 1,Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer,Journal of Contemporary Brachytherapy,,,Article,2016-02-01,10.5114/jcb.2016.58080,,,,26985191,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10085824,https://api.altmetric.com/v1/donut/10085824_240.png 1,Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics,Bioconjugate Chemistry,,,Article,2016-07-20,10.1021/acs.bioconjchem.6b00222,,,,27248781,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/9985726,https://api.altmetric.com/v1/donut/9985726_240.png 1,"Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1",European Urology,,,Article,2016-07-23,10.1016/j.eururo.2016.07.019,,,,27460353,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9977294,https://api.altmetric.com/v1/donut/9977294_240.png 1,Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer,Journal of Contemporary Brachytherapy,,,Article,2016-08-10,10.5114/jcb.2016.61067,,,,27504134,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9948312,https://api.altmetric.com/v1/donut/9948312_240.png 1,"Reply to Lars Egevad, Hemamali Samaratunga, John R. Srigley, Brett Delahunt's Letter to the Editor re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1",European Urology,,,Article,2016-07-22,10.1016/j.eururo.2016.07.020,,,,27452952,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9947814,https://api.altmetric.com/v1/donut/9947814_240.png 1,Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer,Pharmaceuticals,,,Article,2014-06-30,10.3390/ph7070779,,,,24983957,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/9943101,https://api.altmetric.com/v1/donut/9943101_240.png 1,Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2006-09-26,10.1073/pnas.0606836103,,,,16973750,PMC1599986,,2006PNAS..10314477G,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/9922735,https://api.altmetric.com/v1/donut/9922735_240.png 1,"[Prostate cancer microenvironment: Its structure, functions and therapeutic applications].",Progrès en Urologie,,,Article,2016-07-18,10.1016/j.purol.2016.06.006,,,,27423973,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9827079,https://api.altmetric.com/v1/donut/9827079_240.png 1,SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer,British Journal of Urology,,,Article,2013-08-14,10.1111/bju.12127,,,,23826842,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/9761701,https://api.altmetric.com/v1/donut/9761701_240.png 1,Re: Failure-Free Survival and Radiotherapy in Patients with Newly Diagnosed Nonmetastatic Prostate Cancer: Data from Patients in the Control Arm of the STAMPEDE Trial,European Urology,,,Article,2016-08-01,10.1016/j.eururo.2016.03.065,,,,27353963,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9747499,https://api.altmetric.com/v1/donut/9747499_240.png 1,"Prostate cancer: Radiotherapy might improve survival, even in the oldest men",Nature Reviews Urology,,,Article,2016-07-12,10.1038/nrurol.2016.125,,,,27400665,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9728997,https://api.altmetric.com/v1/donut/9728997_240.png 1,Correction: Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening,Clinical Cancer Research,,,Article,2016-07-15,10.1158/1078-0432.ccr-16-1195,,,,27422205,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9719208,https://api.altmetric.com/v1/donut/9719208_240.png 1,Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome,Histopathology,,,Article,2007-10-01,10.1111/j.1365-2559.2007.02819.x,,,,17880526,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9691839,https://api.altmetric.com/v1/donut/9691839_240.png 1,Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases,BMC Cancer,,,Article,2016-02-19,10.1186/s12885-016-2176-6,,,,26896160,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9660316,https://api.altmetric.com/v1/donut/9660316_240.png 1,Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI,Journal of Magnetic Resonance Imaging,,,Article,2016-07-13,10.1002/jmri.25363,,,,27405584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9654587,https://api.altmetric.com/v1/donut/9654587_240.png 1,"Your NEJM Group Today: What Clinicians Wear, Prostate Cancer Guidelines, New York Primary Care Opportunities",Journal Watch,,,Article,2016-07-12,10.1056/nejm-jw.fw111786,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9613403,https://api.altmetric.com/v1/donut/9613403_240.png 1,"Your NEJM Group Today: A Bruising Loss, Gene Mutations in Prostate Cancer, Alabama Family Medicine Opportunity",Journal Watch,,,Article,2016-07-11,10.1056/nejm-jw.fw111781,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9562421,https://api.altmetric.com/v1/donut/9562421_240.png 1,Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer,International Journal of Clinical Oncology,,,Article,2016-01-11,10.1007/s10147-016-0947-3,,,,26754596,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9561600,https://api.altmetric.com/v1/donut/9561600_240.png 1,Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy,European Journal of Pharmaceutics & Biopharmaceutics,,,Article,2016-10-01,10.1016/j.ejpb.2016.07.007,,,,27393562,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9551490,https://api.altmetric.com/v1/donut/9551490_240.png 1,Suppression of ?-catenin Signaling Pathway in Human Prostate Cancer PC3 Cells by Delphinidin,Journal of cancer prevention,,,Article,2016-06-01,10.15430/jcp.2016.21.2.110,,,,27390740,PMC4933435,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9538798,https://api.altmetric.com/v1/donut/9538798_240.png 1,Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature,Journal of Contemporary Brachytherapy,,,Article,2016-08-10,10.5114/jcb.2016.60452,,,,27504124,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9258117,https://api.altmetric.com/v1/donut/9258117_240.png 1,18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-03-10,10.1007/s00259-016-3329-1,,,,26960562,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9257758,https://api.altmetric.com/v1/donut/9257758_240.png 1,Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy,Cancer (0008543X),,,Article,2016-06-28,10.1002/cncr.30050,,,,27351298,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9250670,https://api.altmetric.com/v1/donut/9250670_240.png 1,Immortalization of Primary Human Prostate Epithelial Cells by c-Myc,Cancer Research,,,Article,2005-03-15,10.1158/0008-5472.can-03-4030,,,,15781629,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9207698,https://api.altmetric.com/v1/donut/9207698_240.png 1,Phase I trial of anti-PSMA designer CAR-T cells in prostate cancer: Possible role for interacting interleukin 2-T cell pharmacodynamics as a determinant of clinical response,The Prostate,,,Article,2016-06-01,10.1002/pros.23214,,,,27324746,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9175320,https://api.altmetric.com/v1/donut/9175320_240.png 1,"3,3'-Diindolylmethane Enhances Taxotere-Induced Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-regulation",Cancer Research,,,Article,2009-05-15,10.1158/0008-5472.can-08-4423,,,,19435906,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/9137750,https://api.altmetric.com/v1/donut/9137750_240.png 1,Down-regulation of Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Expression by Soy Isoflavones Enhances Prostate Cancer Radiotherapy In vitro and In vivo,Cancer Research,,,Article,2007-03-01,10.1158/0008-5472.can-06-2147,,,,17332344,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/9118459,https://api.altmetric.com/v1/donut/9118459_240.png 1,Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression,Podopost,,,Article,2016-03-01,10.1080/23723556.2015.1090048,,,,27308625,PMC4905394,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9115746,https://api.altmetric.com/v1/donut/9115746_240.png 1,[Current status of CT and PET/CT in prostate cancer].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2016-05-20,,,,,27344749,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9096392,https://api.altmetric.com/v1/donut/9096392_240.png 1,Chemoprevention agents for prostate cancer,Cochrane database of systematic reviews,,,Article,2016-06-10,10.1002/14651858.cd012228,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9092917,https://api.altmetric.com/v1/donut/9092917_240.png 1,PET/MRI and prostate cancer,Clinical and Translational Imaging,,,Article,2016-06-22,10.1007/s40336-016-0192-9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9038585,https://api.altmetric.com/v1/donut/9038585_240.png 1,Rasch Analysis of the Premature Ejaculation Diagnostic Tool (PEDT) and the International Index of Erectile Function (IIEF) in an Iranian Sample of Prostate Cancer Patients,PLoS ONE,,,Article,2016-06-23,10.1371/journal.pone.0157460,,,,27336626,PMC4918965,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9010624,https://api.altmetric.com/v1/donut/9010624_240.png 1,An exploratory study on the information needs of prostate cancer patients and their partners,Health Psychology Research,,,Article,2016-06-01,10.4081/hpr.2016.4786,,,,27403460,PMC4926026,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9010032,https://api.altmetric.com/v1/donut/9010032_240.png 1,MiR-4638-5p inhibits castration resistance of prostate cancer through repressing kidins220 expression and PI3K/AKT pathway activity,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10165,,,,27329728,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8993960,https://api.altmetric.com/v1/donut/8993960_240.png 1,Rationale for local treatment in the management of metastatic prostate cancer,Current Opinion in Supportive and Palliative Care,,,Article,2016-06-01,10.1097/spc.0000000000000218,,,http://journals.lww.com/co-supportiveandpalliativecare/Fulltext/2016/09000/Rationale_for_local_treatment_in_the_management_of.15.aspx,27328411,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8970112,https://api.altmetric.com/v1/donut/8970112_240.png 1,"Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies",PLoS ONE,,,Article,2016-06-21,10.1371/journal.pone.0158255,,,,27327298,PMC4915716,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8953055,https://api.altmetric.com/v1/donut/8953055_240.png 1,Visibility of prostate cancer on transrectal ultrasound during fusion with multiparametric magnetic resonance imaging for biopsy,Clinical Imaging,,,Article,2016-07-01,10.1016/j.clinimag.2016.02.005,,,,27317220,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8939890,https://api.altmetric.com/v1/donut/8939890_240.png 1,You Need to Know More to Understand My Scoring on the Survey: Free-Text Comments as Part of a PROM-Survey of Men with Prostate Cancer,Open Journal of Nursing,,,Article,2016-06-13,10.4236/ojn.2016.65038,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8897673,https://api.altmetric.com/v1/donut/8897673_240.png 1,Role of multiparametric magnetic resonance imaging in early detection of prostate cancer,Insights Into Imaging,,,Article,2016-04-01,10.1007/s13244-016-0466-9,,,,26847758,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/8896310,https://api.altmetric.com/v1/donut/8896310_240.png 1,Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer,Journal of Contemporary Brachytherapy,,,Article,2016-04-01,10.5114/jcb.2016.59336,,,,27257414,PMC4873553,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8881285,https://api.altmetric.com/v1/donut/8881285_240.png 1,Transcriptome profiling links the intrinsic properties of human prostate basal cells to prostate cancer aggressiveness,Podopost,,,Article,2016-05-01,10.1080/23723556.2016.1168508,,,,27314102,PMC4909464,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8864116,https://api.altmetric.com/v1/donut/8864116_240.png 1,Body size across the life course and prostate cancer in the Health Professionals Follow-up Study,International Journal of Cancer,,,Article,2016-02-15,10.1002/ijc.29842,,,,26355806,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,https://www.altmetric.com/details/8820058,https://api.altmetric.com/v1/donut/8820058_240.png 1," Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer ",International Journal of Cancer,,,Article,2014-09-15,10.1002/ijc.28784,,,,24523142,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/8819787,https://api.altmetric.com/v1/donut/8819787_240.png 1,Correction: Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes,PLoS ONE,,,Article,2016-06-13,10.1371/journal.pone.0157392,,,,27295211,PMC4905623,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8761001,https://api.altmetric.com/v1/donut/8761001_240.png 1,Antiandrogen withdrawal in castrate-refractory prostate cancer,Cancer (0008543X),,,Article,2008-06-01,10.1002/cncr.23473,,,,18383517,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/8759590,https://api.altmetric.com/v1/donut/8759590_240.png 1,Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study,European Journal of Cancer (1965),,,Article,2015-07-01,10.1016/j.ejca.2015.03.021,,,,25892647,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8757964,https://api.altmetric.com/v1/donut/8757964_240.png 1,Nuclear Medicine Imaging of Prostate Cancer.,RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren,,,Article,2016-06-15,10.1055/s-0042-108860,,,,27299668,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8757585,https://api.altmetric.com/v1/donut/8757585_240.png 1,Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells,Frontiers in oncology,,,Article,2016-06-15,10.3389/fonc.2016.00144,,,,27379206,PMC4908134,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8751748,https://api.altmetric.com/v1/donut/8751748_240.png 1,Men’s experience of a guided self-help intervention for hot flushes associated with prostate cancer treatment,"Psychology, Health & Medicine",,,Article,2016-06-13,10.1080/13548506.2016.1195504,,,,27294289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8728438,https://api.altmetric.com/v1/donut/8728438_240.png 1,"Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576–81",European Urology,,,Article,2016-06-14,10.1016/j.eururo.2016.05.037,,,,27311363,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8719380,https://api.altmetric.com/v1/donut/8719380_240.png 1,"Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men",Diabetologia,,,Article,2016-05-17,10.1007/s00125-016-3972-x,,,,27189066,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8706189,https://api.altmetric.com/v1/donut/8706189_240.png 1,Spinal multiparametric MRI and DEXA changes over time in men with prostate cancer treated with androgen deprivation therapy: a potential imaging biomarker of treatment toxicity,European Radiology,,,Article,2016-06-10,10.1007/s00330-016-4434-z,,,,27287481,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8691792,https://api.altmetric.com/v1/donut/8691792_240.png 1,Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line.,The Journal of Urology,,,Article,2002-08-01,,,,,12131363,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/8674817,https://api.altmetric.com/v1/donut/8674817_240.png 1,[PET/CT with 18F-Fluorocholine in Patients with Prostatic Cancer in Biochemical Recurrence].,Acta Medica Portuguesa,,,Article,2016-06-11,,,,,27285094,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8668976,https://api.altmetric.com/v1/donut/8668976_240.png 1,Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer,Journal of Human Genetics,,,Article,2016-06-09,10.1038/jhg.2016.68,,,,27278788,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8635663,https://api.altmetric.com/v1/donut/8635663_240.png 1,Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective,International Urology and Nephrology,,,Article,2016-06-02,10.1007/s11255-016-1337-5,,,,27256399,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8619504,https://api.altmetric.com/v1/donut/8619504_240.png 1,The germ cell gene TDRD1 as an ERG target gene and a novel prostate cancer biomarker,The Prostate,,,Article,2016-05-08,10.1002/pros.23213,,,,27272765,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8616463,https://api.altmetric.com/v1/donut/8616463_240.png 1,“Hit the primary”: A paradigm shift in the treatment of metastatic prostate cancer?,Critical Reviews in Oncology/Hematology,,,Article,2016-01-01,10.1016/j.critrevonc.2015.08.023,,,,26375435,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8539083,https://api.altmetric.com/v1/donut/8539083_240.png 1,Prostate cancer: Across the Finnish line,Nature Reviews Urology,,,Article,2016-06-07,10.1038/nrurol.2016.109,,,,27273378,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8530736,https://api.altmetric.com/v1/donut/8530736_240.png 1,Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results,Journal of Contemporary Brachytherapy,,,Article,2016-04-01,10.5114/jcb.2016.59216,,,,27257413,PMC4873550,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8495874,https://api.altmetric.com/v1/donut/8495874_240.png 1,The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1,Endocrine-Related Cancer,,,Article,2016-06-02,10.1530/erc-16-0160,,,,27255895,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8478741,https://api.altmetric.com/v1/donut/8478741_240.png 1,"Re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576–81",European Urology,,,Article,2016-06-02,10.1016/j.eururo.2016.05.036,,,,27262630,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8431484,https://api.altmetric.com/v1/donut/8431484_240.png 1,"Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-06-01,10.1158/1055-9965.epi-15-1223,,,,27197278,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/8409867,https://api.altmetric.com/v1/donut/8409867_240.png 1,No Association between the Mitochondrial Genome and Prostate Cancer Risk: The Multiethnic Cohort,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-06-01,10.1158/1055-9965.epi-16-0111,,,,27021046,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8409863,https://api.altmetric.com/v1/donut/8409863_240.png 1,Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy,Magnetic Resonance Imaging (0730725X),,,Article,2016-10-01,10.1016/j.mri.2016.05.006,,,,27211254,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8397323,https://api.altmetric.com/v1/donut/8397323_240.png 1,"Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.055",European Urology,,,Article,2016-05-31,10.1016/j.eururo.2016.05.028,,,,27255584,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8384543,https://api.altmetric.com/v1/donut/8384543_240.png 1,Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo,Pharmaceutical Research,,,Article,2016-05-25,10.1007/s11095-016-1945-x,,,,27225496,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8359829,https://api.altmetric.com/v1/donut/8359829_240.png 1,Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel,Clinical Nutrition ESPEN,,,Article,2016-04-22,10.1016/j.clnesp.2016.04.001,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8258888,https://api.altmetric.com/v1/donut/8258888_240.png 1,"Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies",PLoS ONE,,,Article,2016-05-19,10.1371/journal.pone.0155901,,,,27196083,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8208681,https://api.altmetric.com/v1/donut/8208681_240.png 1,Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection,Abdominal radiology (New York),,,Article,2016-01-09,10.1007/s00261-015-0619-1,,,,27193792,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8207342,https://api.altmetric.com/v1/donut/8207342_240.png 1,Prostate cancer post-treatment follow-up and recurrence evaluation,Abdominal radiology (New York),,,Article,2016-01-06,10.1007/s00261-015-0562-1,,,,27193788,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8207308,https://api.altmetric.com/v1/donut/8207308_240.png 1,MRI of Prostate Cancer,Topics in Magnetic Resonance Imaging,,,Article,2016-05-01,10.1097/rmr.0000000000000092,,,,27187166,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8207233,https://api.altmetric.com/v1/donut/8207233_240.png 1,Multiparametric MR Imaging for Detection and Locoregional Staging of Prostate Cancer,Topics in Magnetic Resonance Imaging,,,Article,2016-05-01,10.1097/rmr.0000000000000089,,,,27187165,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8207227,https://api.altmetric.com/v1/donut/8207227_240.png 1,Role of MRI in the Risk Assessment of Primary Prostate Cancer,Topics in Magnetic Resonance Imaging,,,Article,2016-05-01,10.1097/rmr.0000000000000081,,,,27187162,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8207191,https://api.altmetric.com/v1/donut/8207191_240.png 1,PSA and beyond: alternative prostate cancer biomarkers,Cellular Oncology (2211-3428),,,Article,2016-04-01,10.1007/s13402-016-0268-6,,,,26790878,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/8105769,https://api.altmetric.com/v1/donut/8105769_240.png 1,Prostate cancer detection: The effect of obesity on asian men,Urologic Oncology,,,Article,2015-10-01,10.1016/j.urolonc.2015.07.011,,,,26296263,,10757/609851,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7830865,https://api.altmetric.com/v1/donut/7830865_240.png 1,Abstract A22: Functional long noncoding RNAs in castration-resistant prostate cancer,Cancer Research,,,Article,2016-03-15,10.1158/1538-7445.nonrna15-a22,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7830343,https://api.altmetric.com/v1/donut/7830343_240.png 1,Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients,International Journal of Oncology,,,Article,2014-01-17,10.3892/ijo.2014.2260,,,,24435511,,1854/LU-4324040,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7703787,https://api.altmetric.com/v1/donut/7703787_240.png 1,Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9262,,,,27183906,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7598482,https://api.altmetric.com/v1/donut/7598482_240.png 1,Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis,Annals of Nuclear Medicine,,,Article,2016-05-12,10.1007/s12149-016-1078-7,,,,27173771,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7471739,https://api.altmetric.com/v1/donut/7471739_240.png 1,"Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration",Journal of Molecular Histology,,,Article,2016-05-13,10.1007/s10735-016-9679-y,,,,27178620,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7463212,https://api.altmetric.com/v1/donut/7463212_240.png 1,Arsenic in drinking water and prostate cancer in Illinois counties: An ecologic study,Environmental Research,,,Article,2016-07-01,10.1016/j.envres.2016.04.030,,,,27136670,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7461359,https://api.altmetric.com/v1/donut/7461359_240.png 1,Curing Lymph Node Metastasis in Prostate Cancer: The Ongoing Battle Between Improving Surgical Quality and Tumor Biology,European Urology Focus ,,,Article,2016-05-13,10.1016/j.euf.2016.04.004,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7372290,https://api.altmetric.com/v1/donut/7372290_240.png 1,Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy,Journal of Experimental & Clinical Cancer Research,,,Article,2016-05-06,10.1186/s13046-016-0351-x,,,,27151407,PMC4858851,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7277967,https://api.altmetric.com/v1/donut/7277967_240.png 1,"Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging",Magnetic Resonance Imaging (0730725X),,,Article,2016-09-01,10.1016/j.mri.2016.04.001,,,,27071309,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7263333,https://api.altmetric.com/v1/donut/7263333_240.png 1,Who pays the high health costs of older workers? Evidence from prostate cancer screening mandates,Applied Economics,,,Article,2014-08-19,10.1080/00036846.2014.948673,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7253212,https://api.altmetric.com/v1/donut/7253212_240.png 1,"Uncertainty in Breast, Prostate, and Colorectal Cancer: Implications for Supportive Care",Journal of Nursing Scholarship,,,Article,2008-03-01,10.1111/j.1547-5069.2007.00207.x,,,,18302593,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7189301,https://api.altmetric.com/v1/donut/7189301_240.png 1,Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer,Annals of Surgical Oncology,,,Article,2015-06-19,10.1245/s10434-015-4686-x,,,,26088651,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7151634,https://api.altmetric.com/v1/donut/7151634_240.png 1,Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2016-05-04,10.1155/2016/8135135,,,,27272436,PMC4870347,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7144882,https://api.altmetric.com/v1/donut/7144882_240.png 1,Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm,OncoImmunology,,,Article,2016-04-01,10.1080/2162402x.2015.1107698,,,,27141392,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7139814,https://api.altmetric.com/v1/donut/7139814_240.png 1,Dual-phase 18F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan,Clinical Imaging,,,Article,2016-05-01,10.1016/j.clinimag.2015.12.010,,,,27133692,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7124446,https://api.altmetric.com/v1/donut/7124446_240.png 1,Androgen control of lipid metabolism in prostate cancer: novel insights and future applications,Endocrine-Related Cancer,,,Article,2016-04-29,10.1530/erc-15-0556,,,,27130044,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7122146,https://api.altmetric.com/v1/donut/7122146_240.png 1,Estrogen receptor beta (ER?) mediates expression of ?-catenin and proliferation in prostate cancer cell line PC-3,Molecular & Cellular Endocrinology,,,Article,2016-07-01,10.1016/j.mce.2016.04.012,,,,27107935,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7118115,https://api.altmetric.com/v1/donut/7118115_240.png 1,The Influences of Health Insurance and Access to Information on Prostate Cancer Screening among Men in Dominican Republic,Journal of Cancer Epidemiology,,,Article,2016-05-02,10.1155/2016/7284303,,,,27034669,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7115612,https://api.altmetric.com/v1/donut/7115612_240.png 1,Magnetic resonance imaging for prostate cancer radiotherapy,Physica Medica,,,Article,2016-03-01,10.1016/j.ejmp.2016.01.484,,,,26858164,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7107166,https://api.altmetric.com/v1/donut/7107166_240.png 1,Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8915,,,,27120785,,11343/112480,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7055546,https://api.altmetric.com/v1/donut/7055546_240.png 1,Molecular imaging using PSMA PET/CT versus multiparametric MRI for initial staging of prostate cancer: comparing apples with oranges?,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-04-27,10.1007/s00259-016-3389-2,,,,27118189,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7053192,https://api.altmetric.com/v1/donut/7053192_240.png 1,Meta-analysis of soy food and risk of prostate cancer in men,International Journal of Cancer,,,Article,2005-11-20,10.1002/ijc.21266,,,,15945102,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/7045429,https://api.altmetric.com/v1/donut/7045429_240.png 1,Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases,Journal of Translational Medicine,,,Article,2016-04-27,10.1186/s12967-016-0868-y,,,,27116938,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7041549,https://api.altmetric.com/v1/donut/7041549_240.png 1,PSA testing and early management of test-detected prostate cancer- consensus at last,British Journal of Urology,,,Article,2016-04-01,10.1111/bju.13481,,,,27094969,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6984380,https://api.altmetric.com/v1/donut/6984380_240.png 1,Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10257.x,,,,21631697,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6966421,https://api.altmetric.com/v1/donut/6966421_240.png 1,MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.,Neoplasia,,,Article,2016-04-25,10.1016/j.neo.2016.01.006,,,,27108384,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6943786,https://api.altmetric.com/v1/donut/6943786_240.png 1,Multiparametric magnetic resonance imaging in prostate cancer: present and future,Current Opinion in Urology,,,Article,2008-01-01,10.1097/mou.0b013e3282f19d01,,,,18090494,PMC2804482,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6935043,https://api.altmetric.com/v1/donut/6935043_240.png 1,Can 68GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer?,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-04-23,10.1007/s00259-016-3401-x,,,,27105875,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6932443,https://api.altmetric.com/v1/donut/6932443_240.png 1,Effect of Cnidium Lactone on Serum Mutant P53 and BCL-2/BAX Expression in Human Prostate Cancer Cells PC-3 Tumor-Bearing BALB/C Nude Mouse Model,Medical science monitor international medical journal of experimental and clinical research,,,Article,2015-01-01,10.12659/msm.893745,,,,26286430,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6927558,https://api.altmetric.com/v1/donut/6927558_240.png 1,High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results,Radiotherapy & Oncology,,,Article,2016-04-22,10.1016/j.radonc.2016.04.006,,,,27118583,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6914405,https://api.altmetric.com/v1/donut/6914405_240.png 1,To PSA or not to PSA? Still a question for men with a family history of prostate cancer,British Journal of Urology,,,Article,2016-03-10,10.1111/bju.13372,,,,26969030,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6868300,https://api.altmetric.com/v1/donut/6868300_240.png 1,Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer,Molecular Oncology,,,Article,2016-03-31,10.1016/j.molonc.2016.03.007,,,,27106131,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6864373,https://api.altmetric.com/v1/donut/6864373_240.png 1,Is There a Future for Chemoprevention of Prostate Cancer?,Cancer Prevention Research,,,Article,2016-04-22,10.1158/1940-6207.capr-16-0088,,,,27099271,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6845792,https://api.altmetric.com/v1/donut/6845792_240.png 1,Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/?-catenin signalling,The Journal of Pathology,,,Article,2016-03-01,10.1002/path.4725,,,,27060981,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6816020,https://api.altmetric.com/v1/donut/6816020_240.png 1,"Response to the Letter to the Editor About the Article Submitted as an Interesting Image Entitled ""Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer"".",Clinical Nuclear Medicine,,,Article,2016-04-19,10.1097/rlu.0000000000001239,,,,27088390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6810197,https://api.altmetric.com/v1/donut/6810197_240.png 1,Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer,Urologic Oncology,,,Article,2016-04-12,10.1016/j.urolonc.2016.03.005,,,,27083114,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6780971,https://api.altmetric.com/v1/donut/6780971_240.png 1,The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma,Molecular Cancer Research,,,Article,2016-04-01,10.1158/1541-7786.mcr-15-0466,,,,26832214,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6728334,https://api.altmetric.com/v1/donut/6728334_240.png 1,The evolving role of immunotherapy in prostate cancer,Current opinion in oncology,,,Article,2016-05-01,10.1097/cco.0000000000000281,,,http://journals.lww.com/co-oncology/Fulltext/2016/05000/The_evolving_role_of_immunotherapy_in_prostate.9.aspx,26977847,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/6664885,https://api.altmetric.com/v1/donut/6664885_240.png 1,Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases,Gene Therapy,,,Article,2005-01-27,10.1038/sj.gt.3302456,,,,15674398,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6646291,https://api.altmetric.com/v1/donut/6646291_240.png 1,Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria,Urologia Internationalis,,,Article,2016-04-06,10.1159/000444197,,,,27045167,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6630206,https://api.altmetric.com/v1/donut/6630206_240.png 1,Correction: Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer,PLoS ONE,,,Article,2016-04-11,10.1371/journal.pone.0153732,,,,27065043,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6614157,https://api.altmetric.com/v1/donut/6614157_240.png 1,Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro,Life Sciences,,,Article,2016-02-01,10.1016/j.lfs.2016.01.039,,,,26827990,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,4,https://www.altmetric.com/details/6580806,https://api.altmetric.com/v1/donut/6580806_240.png 1,Investigating the roles of caveolae and PTRF in prostate cancer,,,,Article,2016-04-07,,,,,,,10523/6350,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6521037,https://api.altmetric.com/v1/donut/6521037_240.png 1,Experts call for younger men to be offered PSA test for prostate cancer,British Medical Journal,,,Article,2016-04-05,10.1136/bmj.i1929,,,,27048301,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6497952,https://api.altmetric.com/v1/donut/6497952_240.png 1,Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells,Carcinogenesis,,,Article,2014-07-01,10.1093/carcin/bgu019,,,,24451147,,,,,,,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6497608,https://api.altmetric.com/v1/donut/6497608_240.png 1,GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78,Targeted Oncology,,,Article,2012-10-22,10.1007/s11523-012-0234-9,,,,23090204,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6486278,https://api.altmetric.com/v1/donut/6486278_240.png 1,Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics,BMC Medicine,,,Article,2016-04-04,10.1186/s12916-016-0613-7,,,,27044421,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6479863,https://api.altmetric.com/v1/donut/6479863_240.png 1,Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-04-01,10.1097/coc.0000000000000037,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/04000/Limitations_of_the_Cancer_of_the_Prostate_Risk.12.aspx,24487421,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6469523,https://api.altmetric.com/v1/donut/6469523_240.png 1,Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer,Journal of Nuclear Medicine,,,Article,2008-12-01,10.2967/jnumed.108.050658,,,,18997047,PMC3310891,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6441049,https://api.altmetric.com/v1/donut/6441049_240.png 1,Genetically engineered mouse models of prostate cancer,Molecular Oncology,,,Article,2013-02-25,10.1016/j.molonc.2013.02.005,,,,23481269,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/6432051,https://api.altmetric.com/v1/donut/6432051_240.png 1,PRIMA-1met radiosensitizes prostate cancer cells independent of their MTp53-status,Radiotherapy & Oncology,,,Article,2008-01-31,10.1016/j.radonc.2008.01.001,,,,18237796,,,,,,,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6424010,https://api.altmetric.com/v1/donut/6424010_240.png 1,Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries,ESMO Open,,,Article,2016-03-01,10.1136/esmoopen-2016-000047,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6421580,https://api.altmetric.com/v1/donut/6421580_240.png 1,De-escalation of bone-targeted agents for metastatic prostate cancer,Current Oncology,,,Article,2016-02-01,10.3747/co.23.2913,,,,26966418,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6407843,https://api.altmetric.com/v1/donut/6407843_240.png 1,"Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer",International Journal of Biological Sciences,,,Article,2016-01-01,10.7150/ijbs.14090,,,,27019626,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6405461,https://api.altmetric.com/v1/donut/6405461_240.png 1,Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience,BMC Urology,,,Article,2016-03-22,10.1186/s12894-016-0132-z,,,,27001043,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6401557,https://api.altmetric.com/v1/donut/6401557_240.png 1,"Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring–Guided Gating for Prostate Cancer Radiation Therapy","International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-04-01,10.1016/j.ijrobp.2015.10.009,,,,27026307,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6395878,https://api.altmetric.com/v1/donut/6395878_240.png 1,In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in Endometrial and Prostate Cancer Cell Lines,Journal of Cancer Science & Therapy,,,Article,2016-03-14,10.4172/1948-,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6303567,https://api.altmetric.com/v1/donut/6303567_240.png 1,Statin use and mortality of patients with prostate cancer: a meta-analysis,OncoTargets and therapy,,,Article,2016-03-21,10.2147/ott.s97993,,,,27051303,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6271305,https://api.altmetric.com/v1/donut/6271305_240.png 1,Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer,Oncotarget,,,Article,2015-11-07,10.18632/oncotarget.7557,,,,26910118,PMC4941290,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/6257122,https://api.altmetric.com/v1/donut/6257122_240.png 1,SRPK1 inhibition in prostate cancer: a novel anti-angiogenic treatment through modulation of VEGF alternative splicing,Pharmacological Research,,,Article,2016-03-01,10.1016/j.phrs.2016.03.013,,,,26995304,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6250484,https://api.altmetric.com/v1/donut/6250484_240.png 1,A primer on tumour immunology and prostate cancer immunotherapy,Canadian Urological Association Journal,,,Article,2016-01-01,10.5489/cuaj.3418,,,,26977209,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6197561,https://api.altmetric.com/v1/donut/6197561_240.png 1,Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients,Journal of Translational Medicine,,,Article,2016-03-15,10.1186/s12967-016-0829-5,,,,26975354,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6194663,https://api.altmetric.com/v1/donut/6194663_240.png 1,Physicochemical characteristics of abiraterone acetate used for the treatment of prostate cancer,,,,Article,2016-03-11,10.7287/peerj.preprints.1850v1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6161244,https://api.altmetric.com/v1/donut/6161244_240.png 1,"Associations between fruit, vegetable and legume intakes and prostate cancer risk: results from the prospective Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) cohort",British Journal of Nutrition,,,Article,2016-03-07,10.1017/s0007114516000520,,,,26950824,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6147294,https://api.altmetric.com/v1/donut/6147294_240.png 1,Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. - PubMed - NCBI,World Journal of Urology,,,Article,2009-10-14,10.1007/s00345-009-0418-9,,,,19455340,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6133250,https://api.altmetric.com/v1/donut/6133250_240.png 1,Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data,Urology,,,Article,2009-10-14,10.1016/j.urology.2009.02.085,,,,19628258,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6129571,https://api.altmetric.com/v1/donut/6129571_240.png 1,Predictors of general quality of life in patients with benign prostate hyperplasia or prostate cancer,The Journal of Urology,,,Article,1997-02-01,,,,,8996350,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6129348,https://api.altmetric.com/v1/donut/6129348_240.png 1,High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. - PubMed - NCBI,The Journal of Urology,,,Article,2004-03-15,10.1097/01.ju.0000113299.34404.22,,,,14767279,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6129204,https://api.altmetric.com/v1/donut/6129204_240.png 1,Strategies to evaluate the impact of rectal volume on prostate motion during three-dimensional conformal radiotherapy for prostate cancer,Radiologia Brasileira,,,Article,2016-01-01,10.1590/0100-3984.2015.0005,,,,26929456,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6124361,https://api.altmetric.com/v1/donut/6124361_240.png 1,Toll-like receptors and prostate cancer.,Frontiers in immunology,,,Article,2014-07-23,10.3389/fimmu.2014.00352,,,,25101092,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6120023,https://api.altmetric.com/v1/donut/6120023_240.png 1,Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11?miRNA-541?androgen receptor (AR)?MMP9 signaling.,Molecular Oncology,,,Article,2014-07-28,10.1016/j.molonc.2014.07.013,,,,25135278,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6116852,https://api.altmetric.com/v1/donut/6116852_240.png 1,Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.,International Journal of Cancer,,,Article,2009-03-31,10.1002/ijc.24015,,,,19101986,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6115693,https://api.altmetric.com/v1/donut/6115693_240.png 1,Pleiotropy between genetic markers of obesity and risk of prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-08-07,10.1158/1055-9965.epi-13-0123,,,,23810916,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6104922,https://api.altmetric.com/v1/donut/6104922_240.png 1,Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.,Molecular Carcinogenesis,,,Article,2014-04-03,10.1002/mc.22139,,,,24700667,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6104711,https://api.altmetric.com/v1/donut/6104711_240.png 1,Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer.,Asian Journal of Andrology,,,Article,2014-02-28,10.4103/1008-682x.122864,,,,24589455,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6096921,https://api.altmetric.com/v1/donut/6096921_240.png 1,Mutational landscape of candidate genes in familial prostate cancer.,The Prostate,,,Article,2014-08-10,10.1002/pros.22849,,,,25111073,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/6085389,https://api.altmetric.com/v1/donut/6085389_240.png 1,The Androgen Receptor Regulates PPAR? Expression and Activity in Human Prostate Cancer Cells,Journal of Cellular Physiology,,,Article,2016-03-01,10.1002/jcp.25368,,,,26945682,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6053790,https://api.altmetric.com/v1/donut/6053790_240.png 1,Liminality as biographical disruption: unclassifiability following hormonal therapy for advanced prostate cancer,Social Science & Medicine,,,Article,2004-06-14,10.1016/j.socscimed.2003.08.029,,,,15047089,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6050272,https://api.altmetric.com/v1/donut/6050272_240.png 1,Polymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: a meta-analysis,OncoTargets and Therapy,,,Article,2016-03-01,10.2147/ott.s99428,,,,27042096,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6032795,https://api.altmetric.com/v1/donut/6032795_240.png 1,"Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overview",Urologic oncology,,,Article,2016-03-01,10.1016/j.urolonc.2016.01.006,,,,26923782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6029163,https://api.altmetric.com/v1/donut/6029163_240.png 1,Impact of a brief exercise program on the physical and psychosocial health of prostate cancer survivors: A pilot study,Asia Pacific Journal of Clinical Oncology,,,Article,2016-03-01,10.1111/ajco.12474,,,,26923217,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6029096,https://api.altmetric.com/v1/donut/6029096_240.png 1,Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients. - PubMed - NCBI,Asian Journal of Andrology,,,Article,2016-03-01,,,,,26924278,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6028895,https://api.altmetric.com/v1/donut/6028895_240.png 1,An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer,PeerJ,,,Article,2016-03-01,10.7717/peerj.1731,,,,26966665,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6026549,https://api.altmetric.com/v1/donut/6026549_240.png 1,microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients,Molecular Biology Reports,,,Article,2016-02-26,10.1007/s11033-016-3948-4,,,,26907180,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6007525,https://api.altmetric.com/v1/donut/6007525_240.png 1,Where we are with screening and risk prediction for prostate cancer in 2016,British Journal of Urology,,,Article,2016-02-15,10.1111/bju.13420,,,,26876897,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5988007,https://api.altmetric.com/v1/donut/5988007_240.png 1,Epidermal growth factor induces p38 MAPK-dependent G0/G1-to-S transition in prostate cancer cells upon androgen deprivation conditions,Growth Factors,,,Article,,10.3109/08977194.2015.1132712,,,,26880218,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5982270,https://api.altmetric.com/v1/donut/5982270_240.png 1,Body mass index in relation to serum prostate?specific antigen levels and prostate cancer risk,International Journal of Cancer,,,Article,2016-02-01,10.1002/ijc.30052,,,,26914149,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5973353,https://api.altmetric.com/v1/donut/5973353_240.png 1,Asymptotic dynamics of some t-periodic one-dimensional model with application to prostate cancer immunotherapy,Journal of Mathematical Biology,,,Article,2016-02-22,10.1007/s00285-016-0978-4,,,,26897354,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5911715,https://api.altmetric.com/v1/donut/5911715_240.png 1,UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy,Journal of Experimental & Clinical Cancer Research,,,Article,2016-02-17,10.1186/s13046-016-0308-0,,,,26884069,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5907473,https://api.altmetric.com/v1/donut/5907473_240.png 1,Racial Disparities in Sexual Dysfunction Outcomes After Prostate Cancer Treatment: Myth or Reality?,Journal of Racial and Ethnic Health Disparities,,,Article,2016-02-21,10.1007/s40615-015-0126-7,,,,26896115,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5892541,https://api.altmetric.com/v1/donut/5892541_240.png 1,Death receptor 5 expression is inversely correlated with prostate cancer progression.,Molecular Medicine Reports,,,Article,2014-08-20,10.3892/mmr.2014.2504,,,,25174820,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5780021,https://api.altmetric.com/v1/donut/5780021_240.png 1,Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels,Molecular Oncology,,,Article,2016-02-12,10.1016/j.molonc.2016.02.001,,,,26905753,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5717769,https://api.altmetric.com/v1/donut/5717769_240.png 1,Tumor Growth Kinetics Before and After First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: A Prostate-specific Antigen-based Retrospective Analysis.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-02-15,10.1097/coc.0000000000000270,,,http://journals.lww.com/amjclinicaloncology/Fulltext/publishahead/Tumor_Growth_Kinetics_Before_and_After_First_line.99069.aspx,26886944,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5633093,https://api.altmetric.com/v1/donut/5633093_240.png 1,Relative cytotoxic potencies and cell death mechanisms of ?1 -adrenoceptor antagonists in prostate cancer cell lines,The Prostate,,,Article,2016-02-18,10.1002/pros.23167,,,,26880388,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5630077,https://api.altmetric.com/v1/donut/5630077_240.png 1,Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer,Oncotarget,,,Article,2016-02-18,10.18632/oncotarget.7343,,,,26887047,PMC4924723,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5629913,https://api.altmetric.com/v1/donut/5629913_240.png 1,Increased expression of fibroblast growth factor 13 (FGF13) in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy,International Journal of Cancer,,,Article,2016-02-01,10.1002/ijc.30048,,,,26891277,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5627008,https://api.altmetric.com/v1/donut/5627008_240.png 1,Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis,World Journal of Urology,,,Article,2016-02-12,10.1007/s00345-016-1781-y,,,,26873596,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5623122,https://api.altmetric.com/v1/donut/5623122_240.png 1,Fighting Prostate Cancer with Our Eyes Open: Impact of MRI Staging on Risk Assessment and Radiation Therapy,Journal of Medical Imaging & Radiation Sciences,,,Article,2016-03-01,10.1016/j.jmir.2015.12.008,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5619688,https://api.altmetric.com/v1/donut/5619688_240.png 1,Histopathology-derived modeling of prostate cancer tumor control probability: Implications for the dose to the tumor and the gland.,Radiotherapy & Oncology,,,Article,2016-02-22,10.1016/j.radonc.2016.02.015,,,,26897517,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5618212,https://api.altmetric.com/v1/donut/5618212_240.png 1,0206?Prostate cancer risk among French farmers in the AGRICAN cohort,Occupational and environmental medicine,,,Article,2014-06-01,10.1136/oemed-2014-102362.269,,,,25018508,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5609382,https://api.altmetric.com/v1/donut/5609382_240.png 1,Is there a link between cycling and prostate cancer?,Trends in Urology and Men's Health,,,Article,2015-01-01,10.1002/tre.440,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5606933,https://api.altmetric.com/v1/donut/5606933_240.png 1,Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer,Scientific Reports,,,Article,2016-02-11,10.1038/srep20984,,,,26865432,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/5571050,https://api.altmetric.com/v1/donut/5571050_240.png 1,Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology,Tumor Biology,,,Article,2016-02-13,10.1007/s13277-016-4970-9,,,,26874727,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5533880,https://api.altmetric.com/v1/donut/5533880_240.png 1,Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer,Journal of Magnetic Resonance Imaging,,,Article,2016-02-13,10.1002/jmri.25185,,,,26872679,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5531525,https://api.altmetric.com/v1/donut/5531525_240.png 1,Molecular Profiles of Prostate Cancer: To Treat or Not to Treat,Annual Review of Medicine,,,Article,,10.1146/annurev-med-060413-112226,,,,26515982,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/5531473,https://api.altmetric.com/v1/donut/5531473_240.png 1,Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer,Oncotarget,,,Article,2016-02-13,10.18632/oncotarget.7245,,,,26871285,PMC4914299,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5529345,https://api.altmetric.com/v1/donut/5529345_240.png 1,Sleep Quality and Depressive Symptoms After Prostate Cancer: The Mechanistic Role of Cortisol.,Behavioral Neuroscience,,,Article,2016-01-28,10.1037/bne0000107,,,,26820589,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5524662,https://api.altmetric.com/v1/donut/5524662_240.png 1,Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.,Journal of Clinical Oncology,,,Article,2007-04-30,10.1200/jco.2006.08.0572,,,,17470867,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/5517184,https://api.altmetric.com/v1/donut/5517184_240.png 1,"A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam",Clinical Cancer Research,,,Article,2010-06-15,10.1158/1078-0432.ccr-10-0122,,,,20400522,PMC2891337,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,18,https://www.altmetric.com/details/5517179,https://api.altmetric.com/v1/donut/5517179_240.png 1,Intensity-modulated Radiotherapy in the Treatment of Prostate Cancer,Clinical Oncology,,,Article,2012-06-06,10.1016/j.clon.2012.05.002,,,,22673744,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,34,https://www.altmetric.com/details/5517165,https://api.altmetric.com/v1/donut/5517165_240.png 1,"The Quantitative Criteria Based on the Fractal Dimensions, Entropy, and Lacunarity for the Spatial Distribution of Cancer Cell Nuclei Enable Identification of Low or High Aggressive Prostate Carcinomas",Frontiers in Physiology,,,Article,2016-02-11,10.3389/fphys.2016.00034,,,,26903883,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5308994,https://api.altmetric.com/v1/donut/5308994_240.png 1,Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post–radical Prostatectomy,European Urology Focus ,,,Article,2016-02-10,10.1016/j.euf.2016.01.008,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5307867,https://api.altmetric.com/v1/donut/5307867_240.png 1,Enzalutamide vs. Bicalutamide for Advanced Prostate Cancer,Journal Watch,,,Article,2016-01-25,10.1056/nejm-jw.na40219,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5114548,https://api.altmetric.com/v1/donut/5114548_240.png 1,"Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer.",Journal of Nutrigenetics and Nutrigenomics,,,Article,,10.1159/000235565,,,,19776642,PMC2820568,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/5110247,https://api.altmetric.com/v1/donut/5110247_240.png 1,Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real-Time.,Clinical Cancer Research,,,Article,2016-03-15,10.1158/1078-0432.ccr-15-0503,,,,26490315,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5094232,https://api.altmetric.com/v1/donut/5094232_240.png 1,"A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.",International Journal of Biochemistry & Cell Biology,,,Article,2016-02-03,10.1016/j.biocel.2016.01.018,,,,26827675,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5080220,https://api.altmetric.com/v1/donut/5080220_240.png 1,Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science,Prostate Cancer & Prostatic Diseases,,,Article,2016-02-02,10.1038/pcan.2015.42,,,,26832363,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5080149,https://api.altmetric.com/v1/donut/5080149_240.png 1,Detection of Prostate Cancer: Quantitative Multiparametric MR Imaging Models Developed Using Registered Correlative Histopathology,Radiology,,,Article,2016-02-01,10.1148/radiol.2015151089,,,,26761720,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5069099,https://api.altmetric.com/v1/donut/5069099_240.png 1,Men with prostate cancer over the first year of illness: their experiences as biographical disruption,Supportive Care in Cancer,,,Article,2009-04-07,10.1007/s00520-009-0624-4,,,,19350286,,1893/1868,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/5068023,https://api.altmetric.com/v1/donut/5068023_240.png 1,Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.,American Journal of Clinical Nutrition,,,Article,2016-01-27,10.3945/ajcn.115.118703,,,,26817504,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/5062926,https://api.altmetric.com/v1/donut/5062926_240.png 1," The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer ",Oncotarget,,,Article,2014-04-01,10.18632/oncotarget.1846,,,,24727738,PMC4039221,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5060786,https://api.altmetric.com/v1/donut/5060786_240.png 1,Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy,Urologic Oncology,,,Article,2016-01-01,10.1016/j.urolonc.2015.12.009,,,,26822075,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5051903,https://api.altmetric.com/v1/donut/5051903_240.png 1,Citrate-selective electrochemical ?-sensor for early stage detection of prostate cancer ,Sensors & Actuators B: Chemical,,,Article,2016-06-01,10.1016/j.snb.2016.01.056,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5047727,https://api.altmetric.com/v1/donut/5047727_240.png 1,Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.,Future Oncology,,,Article,2016-01-26,10.2217/fon.15.302,,,,26776493,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5044893,https://api.altmetric.com/v1/donut/5044893_240.png 1,Optimised electroporation mediated DNA vaccination for treatment of prostate cancer,Genetic Vaccines and Therapy,,,Article,2010-02-05,10.1186/1479-0556-8-1,,,,20181099,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/5043947,https://api.altmetric.com/v1/donut/5043947_240.png 1,Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design.,Journal of clinical cellular immunology,,,Article,2015-08-01,10.4172/2155-9899.1000351,,,,26807308,PMC4721631,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5042107,https://api.altmetric.com/v1/donut/5042107_240.png 1,"Comparison of Patient-Reported Quality-of-Life and Complications in Men With Prostate Cancer, Between Two Modes of Administration",Clinical Genitourinary Cancer,,,Article,2016-01-25,10.1016/j.clgc.2015.12.016,,,,26794390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5037630,https://api.altmetric.com/v1/donut/5037630_240.png 1,Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen?independent prostate cancer cells,International Journal of Cancer,,,Article,2009-11-01,10.1002/ijc.24648,,,,19530242,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5033121,https://api.altmetric.com/v1/donut/5033121_240.png 1,Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk,Clinical Genitourinary Cancer,,,Article,2015-01-12,10.1016/j.clgc.2015.04.010,,,,26003267,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5023055,https://api.altmetric.com/v1/donut/5023055_240.png 1,Low serum dehydroepiandrosterone examined by liquid chromatography?tandem mass spectrometry correlates with poor prognosis in hormone?naïve prostate cancer,The Prostate,,,Article,2016-03-01,10.1002/pros.23129,,,,26616365,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5020674,https://api.altmetric.com/v1/donut/5020674_240.png 1,Antitumor effect of dendritic cells transfected with prostate-specific membrane antigen recombinant adenovirus on prostate cancer: An in vitro study.,Molecular Medicine Reports,,,Article,2016-01-21,10.3892/mmr.2016.4754,,,,26783185,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5019037,https://api.altmetric.com/v1/donut/5019037_240.png 1,Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-02-01,10.1097/coc.0000000000000017,,,,24390274,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5018954,https://api.altmetric.com/v1/donut/5018954_240.png 1,4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening,Urologic Clinics of North America,,,Article,2016-01-02,10.1016/j.ucl.2015.08.004,,,,26614027,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5017769,https://api.altmetric.com/v1/donut/5017769_240.png 1,Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Pur??mediated decrease in androgen receptor levels,The Prostate,,,Article,2010-02-01,10.1002/pros.21051,,,,19790234,,,,,,,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,3,https://www.altmetric.com/details/5013572,https://api.altmetric.com/v1/donut/5013572_240.png 1,Vitamin D and prostate cancer.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2001-01-01,,,,,11384870,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5008656,https://api.altmetric.com/v1/donut/5008656_240.png 1,Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.,The Prostate,,,Article,2016-01-17,10.1002/pros.23147,,,,26771888,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5003632,https://api.altmetric.com/v1/donut/5003632_240.png 1,18F-fluoride PET/CT: Experience and image quality assessment in patients with prostate cancer and suspected bone metastases.,Journal of nuclear medicine technology,,,Article,2016-01-17,10.2967/jnmt.115.167536,,,,26769600,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5003377,https://api.altmetric.com/v1/donut/5003377_240.png 1,Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance,International Urology and Nephrology,,,Article,2016-01-12,10.1007/s11255-016-1212-4,,,,26759330,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4996634,https://api.altmetric.com/v1/donut/4996634_240.png 1,"Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer ",Value in Health (Elsevier Science),,,Article,2016-03-30,10.1016/j.jval.2015.11.012,,,,27021756,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4995144,https://api.altmetric.com/v1/donut/4995144_240.png 1,Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology,European Journal of Radiology,,,Article,2016-01-01,10.1016/j.ejrad.2015.10.013,,,,26526901,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4994619,https://api.altmetric.com/v1/donut/4994619_240.png 1,Identification of Differentially Expressed Proteins in Curcumin-Treated Prostate Cancer Cell Lines.,,,,Article,2012-06-14,10.1089/omi.2011.0136,,,,22475723,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4984353,https://api.altmetric.com/v1/donut/4984353_240.png 1,Point: Surgery is the most cost-effective option for prostate cancer needing treatment.,Brachytherapy,,,Article,,10.1016/j.brachy.2015.02.393,,,,26249124,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4981471,https://api.altmetric.com/v1/donut/4981471_240.png 1,JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis,Cancer Research,,,Article,2016-01-10,10.1158/0008-5472.can-15-0906,,,,26747897,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4975839,https://api.altmetric.com/v1/donut/4975839_240.png 1,Conversion of the helical tomotherapy plans to the step-and-shoot IMRT plans for patients with hip prosthesis during radiotherapy for prostate cancer,Physica Medica,,,Article,2016-01-08,10.1016/j.ejmp.2015.11.007,,,,26674461,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4968823,https://api.altmetric.com/v1/donut/4968823_240.png 1,"Osteoporosis-Related Health Behaviors in Men With Prostate Cancer and Survivors: Exploring Osteoporosis Knowledge, Health Beliefs, and Self-Efficacy.",American Journal of Men's Health,,,Article,2016-01-06,10.1177/1557988315615956,,,,26712535,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4955940,https://api.altmetric.com/v1/donut/4955940_240.png 1,Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model,Clinical Cancer Research,,,Article,2004-11-15,10.1158/1078-0432.ccr-04-0732,,,,15570007,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4954649,https://api.altmetric.com/v1/donut/4954649_240.png 1,"Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: A prospective study",Radiotherapy & Oncology,,,Article,2016-01-09,10.1016/j.radonc.2015.12.015,,,,26743832,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4936438,https://api.altmetric.com/v1/donut/4936438_240.png 1,Co-targeting Androgen Receptor Splice Variants and mTOR signaling pathway for the Treatment of Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2015-12-30,10.1158/1078-0432.ccr-15-2119,,,,26712685,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4933756,https://api.altmetric.com/v1/donut/4933756_240.png 1,"The Flame-Retardant Tris(1,3-dichloro-2-propyl) Phosphate Represses Androgen Signaling in Human Prostate Cancer Cell Lines.",Journal of Biochemical & Molecular Toxicology,,,Article,2015-12-29,10.1002/jbt.21786,,,,26709203,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4932980,https://api.altmetric.com/v1/donut/4932980_240.png 1,Abdominopelvic post-irradiation morphea in a prostate cancer patient: the first case of an under-recognized condition.,"Acta Dermatovenerologica Alpina, Pannonica et Adriatica",,,Article,2015-12-28,,,,,26697729,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4928515,https://api.altmetric.com/v1/donut/4928515_240.png 1,Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving Radiotherapy.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2015-12-22,10.1097/coc.0000000000000234,,,,26703812,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4927697,https://api.altmetric.com/v1/donut/4927697_240.png 1,"Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines.",Journal of Biosciences,,,Article,2012-03-15,10.1007/s12038-011-9170-6,,,,22357205,,,,,,,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,https://www.altmetric.com/details/4925446,https://api.altmetric.com/v1/donut/4925446_240.png 1,Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.,Oncotarget,,,Article,2015-12-25,10.18632/oncotarget.6689,,,,26701730,PMC4811447,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4923185,https://api.altmetric.com/v1/donut/4923185_240.png 1,"Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer.",Oncotarget,,,Article,2015-12-25,10.18632/oncotarget.6690,,,,26701731,PMC4885000,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4923093,https://api.altmetric.com/v1/donut/4923093_240.png 1,Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer,ACS Medicinal Chemistry Letters,,,Article,2015-12-14,10.1021/acsmedchemlett.5b00310,,,,26819663,PMC4716597,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/4922327,https://api.altmetric.com/v1/donut/4922327_240.png 1,[11C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-02-20,10.1007/s00259-015-3015-8,,,,25697127,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4918813,https://api.altmetric.com/v1/donut/4918813_240.png 1,"New insights on the association between the prostate cancer and the small DNA tumour virus, BK polyomavirus",Journal of Translational Medicine,,,Article,2015-12-23,10.1186/s12967-015-0754-z,,,,26699530,PMC4690311,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4917933,https://api.altmetric.com/v1/donut/4917933_240.png 1,Significance of p53 and ki-67 expression in prostate cancer.,Urology Annals,,,Article,2015-10-01,10.4103/0974-7796.158507,,,,26692671,PMC4660702,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4915311,https://api.altmetric.com/v1/donut/4915311_240.png 1,The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.,International Journal of Cancer,,,Article,2015-12-01,10.1002/ijc.29977,,,,26695519,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4914141,https://api.altmetric.com/v1/donut/4914141_240.png 1,Serum bound forms of PSP94 (prostate secretory protein of 94 amino acids) in prostate cancer patients,Journal of Cellular Biochemistry,,,Article,2015-12-22,10.1002/(sici)1097-4644(20000101)76:1<71::aid-jcb8>3.0.co;2-b,,,,,,,,,,,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,https://www.altmetric.com/details/4909211,https://api.altmetric.com/v1/donut/4909211_240.png 1,Prostate cancer in Mexican?Americans: Identification of risk factors,The Prostate,,,Article,2015-12-19,10.1002/pros.20713,,,,18247399,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4897776,https://api.altmetric.com/v1/donut/4897776_240.png 1,High?grade prostate cancer and finasteride,British Journal of Urology,,,Article,2010-02-01,10.1111/j.1464-410x.2009.09089.x,,,,19930174,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,11,https://www.altmetric.com/details/4892433,https://api.altmetric.com/v1/donut/4892433_240.png 1,"Infectious Mononucleosis, Other Infections, and Prostate?Specific Antigen Concentration as a Marker of Prostate Involvement During Infection",International Journal of Cancer,,,Article,2015-12-01,10.1002/ijc.29966,,,,26678984,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4889512,https://api.altmetric.com/v1/donut/4889512_240.png 1,Re: Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in a German Chemical Company,European Urology,,,Article,2016-01-01,10.1016/j.eururo.2015.10.034,,,,,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4889070,https://api.altmetric.com/v1/donut/4889070_240.png 1,A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk,British Journal of Nutrition,,,Article,2015-11-16,10.1017/s0007114515004353,,,,26568368,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4887278,https://api.altmetric.com/v1/donut/4887278_240.png 1,"The Future of Prostate Cancer Diagnosis: Biomarkers, Biopsy, Both, or Neither?",European Urology Focus ,,,Article,2015-09-01,10.1016/j.euf.2015.07.007,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4885571,https://api.altmetric.com/v1/donut/4885571_240.png 1,PI-3 kinase p110?: a therapeutic target in advanced prostate cancers,American Journal of Clinical and Experimental Urology,,,Article,2015-12-14,,,,,25374921,PMC4219313,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4875308,https://api.altmetric.com/v1/donut/4875308_240.png 1,In vitro Combination Treatment with Perifosine and UCN-01 Demonstrates Synergism against Prostate (PC-3) and Lung (A549) Epithelial Adenocarcinoma Cell Lines,Clinical Cancer Research,,,Article,2004-08-01,10.1158/1078-0432.ccr-03-0534,,,,15297428,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4861796,https://api.altmetric.com/v1/donut/4861796_240.png 1,[Role of the Immune System and Possibilities of Immunotherapy in Prostate Cancer].,Klinická onkologie casopis Ceské a Slovenské onkologické spolecnosti,,,Article,2015-01-01,,,,,26647892,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4861411,https://api.altmetric.com/v1/donut/4861411_240.png 1,Apoptosis of human prostate cancer cells induced by marine actinomycin X2 through the mTOR pathway compounded by MiRNA144.,Anti-Cancer Drugs,,,Article,2015-12-07,10.1097/cad.0000000000000309,,,,26645890,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4858398,https://api.altmetric.com/v1/donut/4858398_240.png 1,Abstract ED01-03: The acceptability and usability of an mHealth intervention to address prostate cancer disparities: A community-based participatory approach,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-11-01,10.1158/1538-7755.disp13-ed01-03,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4853884,https://api.altmetric.com/v1/donut/4853884_240.png 1,"Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.",Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2015-09-03,,,,,26337240,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4846104,https://api.altmetric.com/v1/donut/4846104_240.png 1,Evidence for viral causes of cancer in prostate cancer transcriptomes and genomes
,F1000Research,,,Article,2015-10-08,10.7490/f1000research.1110767.1,,,,,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/4843740,https://api.altmetric.com/v1/donut/4843740_240.png 1,Multiparametric ultrasound in the diagnosis of prostate cancer,Current Opinion in Urology,,,Article,2016-01-01,10.1097/mou.0000000000000245,,,,26555694,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4841845,https://api.altmetric.com/v1/donut/4841845_240.png 1,Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors ,Cancer Letters,,,Article,2015-12-15,10.1016/j.canlet.2015.10.038,,,,26655274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4839383,https://api.altmetric.com/v1/donut/4839383_240.png 1,"Overexpression of short TRPM8 variant ? promotes cell migration and invasion, and decreases starvation-induced apoptosis in prostate cancer LNCaP cells.",Oncology Letters,,,Article,2015-09-01,10.3892/ol.2015.3373,,,,26622677,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4838193,https://api.altmetric.com/v1/donut/4838193_240.png 1,High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer.,International Journal of Clinical and Experimental Medicine,,,Article,2015-01-01,,,,,26628996,PMC4658885,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4837121,https://api.altmetric.com/v1/donut/4837121_240.png 1,Prostate Cancer: Long-Term Anti-Androgens Added to Salvage Radiation Extend Survival,Oncology times,,,Article,2015-12-10,10.1097/01.cot.0000475699.81589.17,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4836816,https://api.altmetric.com/v1/donut/4836816_240.png 1,A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-12-01,10.1158/1055-9965.epi-15-0496,,,,26404961,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4835469,https://api.altmetric.com/v1/donut/4835469_240.png 1,Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells.,Cancer Research,,,Article,2001-05-01,,,,,11325827,,,,,,,0,0,0,0,0,0,5,0,0,0,0,0,0,0,1,15,https://www.altmetric.com/details/4833616,https://api.altmetric.com/v1/donut/4833616_240.png 1,Coffee inhibits nuclear factor-kappa B in prostate cancer cells and xenografts,Journal of Nutritional Biochemistry,,,Article,2015-09-03,10.1016/j.jnutbio.2015.08.028,,,,26419686,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4823096,https://api.altmetric.com/v1/donut/4823096_240.png 1,Comparisons of Prostate Cancer Inhibitors Abiraterone and TOK-001 Binding with CYP17A1 through Molecular Dynamics ,Computational and Structural Biotechnology Journal,,,Article,2015-12-19,10.1016/j.csbj.2015.10.001,,,,26682016,PMC4652021,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4808220,https://api.altmetric.com/v1/donut/4808220_240.png 1,"A Preliminary Study of the Ability of the 4Kscore test, the Prostate Cancer Prevention Trial-Risk Calculator and the European Research Screening Prostate-Risk Calculator for Predicting High-Grade Prostate Cancer.",Actas Urológicas Españolas,,,Article,2015-11-25,10.1016/j.acuro.2015.09.006,,,,26598800,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4807464,https://api.altmetric.com/v1/donut/4807464_240.png 1,Omega-3 Fatty Acid Consumption and Prostate Cancer: A Review of Exposure Measures and Results of Epidemiological Studies,The Journal of the American College of Nutrition,,,Article,2015-11-25,10.1080/07315724.2015.1032444,,,,26595854,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4801756,https://api.altmetric.com/v1/donut/4801756_240.png 1,Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.,Urologic Oncology,,,Article,2015-11-21,10.1016/j.urolonc.2015.10.009,,,,26585945,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4791370,https://api.altmetric.com/v1/donut/4791370_240.png 1,Prostate Cancer Patients' Preferences for Intermittent vs. Continuous Androgen Deprivation—A Pilot Institutional Study,Journal of Medical Imaging & Radiation Sciences,,,Article,2015-11-20,10.1016/j.jmir.2015.09.005,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4790037,https://api.altmetric.com/v1/donut/4790037_240.png 1,Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer ,Critical Reviews in Oncology/Hematology,,,Article,,10.1016/j.critrevonc.2015.07.013,,,,26318091,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4789688,https://api.altmetric.com/v1/donut/4789688_240.png 1,The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer ,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2015.07.037,,,,26278646,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4789683,https://api.altmetric.com/v1/donut/4789683_240.png 1,Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer,Critical Reviews in Oncology/Hematology,,,Article,,10.1016/j.critrevonc.2015.07.011,,,,26363809,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4789674,https://api.altmetric.com/v1/donut/4789674_240.png 1,"Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2",Pathology,,,Article,2015-12-01,10.1097/pat.0000000000000325,,,,26517640,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4789005,https://api.altmetric.com/v1/donut/4789005_240.png 1,Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners.,,,,Article,2011-08-14,10.1007/s11136-010-9822-2,,,,21170682,PMC3117079,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4788570,https://api.altmetric.com/v1/donut/4788570_240.png 1,"Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer",Pathology,,,Article,2015-12-01,10.1097/pat.0000000000000320,,,,26517642,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4787148,https://api.altmetric.com/v1/donut/4787148_240.png 1,Prostate Cancer Rates — Along with Screening Rates — Drop in the U.S.,Journal Watch,,,Article,2015-11-17,10.1056/nejm-jw.fw110869,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4776430,https://api.altmetric.com/v1/donut/4776430_240.png 1,A microfluidic coculture and multiphoton FAD analysis assay provides insight into the influence of the bone microenvironment on prostate cancer cells,Integrative Biology,,,Article,2014-05-28,10.1039/c3ib40240a,,,,24791272,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/4770116,https://api.altmetric.com/v1/donut/4770116_240.png 1,Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer,Cancer Research,,,Article,2015-11-15,10.1158/0008-5472.can-15-1215,,,,26530902,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4767660,https://api.altmetric.com/v1/donut/4767660_240.png 1,Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer,Molecular Cancer Research,,,Article,2015-11-01,10.1158/1541-7786.mcr-15-0150-t,,,,26227317,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4758620,https://api.altmetric.com/v1/donut/4758620_240.png 1,Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer,Journal of Geriatric Oncology,,,Article,2010-01-06,10.1016/j.jgo.2010.03.001,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4756942,https://api.altmetric.com/v1/donut/4756942_240.png 1,"Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate Cancer",The Journal of Urology,,,Article,2006-01-12,10.1016/j.juro.2006.07.151,,,,17085125,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4756934,https://api.altmetric.com/v1/donut/4756934_240.png 1,To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles,PLoS ONE,,,Article,2015-11-11,10.1371/journal.pone.0142812,,,,26559947,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4753872,https://api.altmetric.com/v1/donut/4753872_240.png 1,Cell-based Hyper-interleukin 6 or Hyper-interleukin 11 secreting vaccines combined with low dose cyclophosphamide in an orthotopic murine prostate cancer model.,Contemporary Oncology - Wspólczesna Onkologia,,,Article,2015-01-01,10.5114/wo.2015.52711,,,,26557758,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4752754,https://api.altmetric.com/v1/donut/4752754_240.png 1,Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor,PLoS ONE,,,Article,2010-12-28,10.1371/journal.pone.0015627,,,,21209944,PMC3011015,,2010PLoSO...515627G,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/4745133,https://api.altmetric.com/v1/donut/4745133_240.png 1,"Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis",Clinical Cancer Research,,,Article,2008-11-01,10.1158/1078-0432.ccr-08-0903,,,,18980980,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4745130,https://api.altmetric.com/v1/donut/4745130_240.png 1,"Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells",Molecular and Cellular Biochemistry,,,Article,2007-07-17,10.1007/s11010-007-9510-x,,,,17636462,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4745128,https://api.altmetric.com/v1/donut/4745128_240.png 1,Treatment Trends for Prostate Cancer—Reply,JAMA: Journal of the American Medical Association,,,Article,2015-11-10,10.1001/jama.2015.12607,,,,26547474,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4739681,https://api.altmetric.com/v1/donut/4739681_240.png 1,Cabazitaxel for the therapy of metastatic castration-resistant prostate cancer in the aftermath of the CHAARTED trial.,British Journal of Urology,,,Article,2015-12-01,10.1111/bju.13098,,,,26542327,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4733992,https://api.altmetric.com/v1/donut/4733992_240.png 1,"Results Of A Dutch Cost-Effectiveness Model Of Radium-223 In Comparison To Cabazitaxel, Abiraterone, And Enzalutamide In Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel.",Value in Health (Elsevier Science),,,Article,2015-11-06,10.1016/j.jval.2015.09.1184,,,,26532581,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4729979,https://api.altmetric.com/v1/donut/4729979_240.png 1,Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells,PLoS ONE,,,Article,2015-11-04,10.1371/journal.pone.0140721,,,,26536025,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4729665,https://api.altmetric.com/v1/donut/4729665_240.png 1,Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.,Oncology Reports,,,Article,2015-11-05,10.3892/or.2015.4362,,,,26534764,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4727156,https://api.altmetric.com/v1/donut/4727156_240.png 1,Study of testosterone?guided androgen deprivation therapy in management of prostate cancer,The Prostate,,,Article,2015-10-01,10.1002/pros.23117,,,,26768279,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4722261,https://api.altmetric.com/v1/donut/4722261_240.png 1,Preparing Patients and Partners for the Recovery From the Side-Effects of Prostate Cancer Surgery: a Group Approach.,Urology,,,Article,2015-11-07,10.1016/j.urology.2015.07.064,,,,26541826,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4720526,https://api.altmetric.com/v1/donut/4720526_240.png 1,Prostate cancer: Mapping the course after CHAARTED,Nature Reviews Urology,,,Article,2015-11-03,10.1038/nrurol.2015.255,,,,26526753,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4715753,https://api.altmetric.com/v1/donut/4715753_240.png 1,Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway,Journal of Biomedical Science,,,Article,2015-04-01,10.1186/s12929-015-0127-1,,,,25879420,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4715405,https://api.altmetric.com/v1/donut/4715405_240.png 1,Prostate cancer survivorship: a nurse-led service model,British Journal of Nursing (BJN),,,Article,2015-10-07,10.12968/bjon.2015.24.sup18.s14,,,,26450816,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4714405,https://api.altmetric.com/v1/donut/4714405_240.png 1,Angiogenesis inhibitors in the treatment of prostate cancer,Journal of Hematology & Oncology,,,Article,2010-08-02,10.1186/1756-8722-3-26,,,,20678204,PMC2922886,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/4706112,https://api.altmetric.com/v1/donut/4706112_240.png 1,High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis,Advances in Urology,,,Article,2015-08-19,10.1155/2015/350324,,,,26357511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4705707,https://api.altmetric.com/v1/donut/4705707_240.png 1,Second Tumor Induction Risk in IMRT for Prostate Cancer: An Unbalanced Comparison Between Surgery and Radiotherapy?,Health Physics,,,Article,2015-10-30,10.1097/hp.0000000000000362,,,,26509622,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4705305,https://api.altmetric.com/v1/donut/4705305_240.png 1,"Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.",Oncotarget,,,Article,2015-10-30,10.18632/oncotarget.5879,,,,26512780,PMC4747386,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4704992,https://api.altmetric.com/v1/donut/4704992_240.png 1,The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis.,International journal of clinical and experimental medicine,,,Article,,,,,,25550896,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4701234,https://api.altmetric.com/v1/donut/4701234_240.png 1,Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-10-29,10.1007/s00259-015-3206-3,,,,26508290,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/4700482,https://api.altmetric.com/v1/donut/4700482_240.png 1,Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-07-31,10.1007/s00259-015-3125-3,,,,26227531,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4699515,https://api.altmetric.com/v1/donut/4699515_240.png 1,Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry,Journal of Endourology,,,Article,2016-01-01,10.1089/end.2015.0403,,,,26414656,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4686603,https://api.altmetric.com/v1/donut/4686603_240.png 1,Hypofractionation for prostate cancer and PROs ,Lancet Oncology,,,Article,2015-11-03,10.1016/s1470-2045(15)00364-2,,,,26522335,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4685777,https://api.altmetric.com/v1/donut/4685777_240.png 1,Ion channels in death and differentiation of prostate cancer cells,Cell Death & Differentiation,,,Article,2007-05-04,10.1038/sj.cdd.4402162,,,,17479110,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/4682845,https://api.altmetric.com/v1/donut/4682845_240.png 1,Serum zinc and prostate cancer risk in a nested case–control study: The multiethnic cohort,The Prostate,,,Article,2013-02-15,10.1002/pros.22565,,,,22851289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4680375,https://api.altmetric.com/v1/donut/4680375_240.png 1,P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway,PLoS ONE,,,Article,2015-10-27,10.1371/journal.pone.0133165,,,,26182292,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4679835,https://api.altmetric.com/v1/donut/4679835_240.png 1,Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer.,Tumor Biology,,,Article,2015-10-23,10.1007/s13277-015-4083-x,,,,26490978,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4667255,https://api.altmetric.com/v1/donut/4667255_240.png 1,Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial.,World Journal of Urology,,,Article,2015-10-22,10.1007/s00345-015-1711-4,,,,26481226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4658499,https://api.altmetric.com/v1/donut/4658499_240.png 1,Cancers of the breast and prostate: a stem cell perspective,Endocrine-Related Cancer,,,Article,2015-12-01,10.1530/erc-15-0427,,,,26487552,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4655404,https://api.altmetric.com/v1/donut/4655404_240.png 1,A time tradeoff method for eliciting partner's quality of life due to patient's health states in prostate cancer.,,,,Article,,10.1177/0272989x09349959,,,,20228288,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4647813,https://api.altmetric.com/v1/donut/4647813_240.png 1,"Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis",Carcinogenesis,,,Article,2003-05-01,10.1093/carcin/bgg023,,,,12771033,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4646643,https://api.altmetric.com/v1/donut/4646643_240.png 1,Bone metastases in prostate cancer: which scan?,British Journal of Urology,,,Article,2014-12-01,10.1111/bju.12716,,,,25407275,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4644710,https://api.altmetric.com/v1/donut/4644710_240.png 1,Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells,PLoS ONE,,,Article,2015-10-18,10.1371/journal.pone.0140745,,,,26473737,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4642413,https://api.altmetric.com/v1/donut/4642413_240.png 1,Impact of Previous Local Treatment for Prostate Cancer on Subsequent Metastatic Disease,The Journal of Urology,,,Article,2002-01-09,10.1016/s0022-5347(05)64562-4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4641189,https://api.altmetric.com/v1/donut/4641189_240.png 1,Dosimetric Benefits of Hemi-Gland Stereotactic Body Radiotherapy for Prostate Cancer: Implications for Focal Therapy.,British Journal of Radiology,,,Article,2015-10-16,10.1259/bjr.20150658,,,,26463234,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4635624,https://api.altmetric.com/v1/donut/4635624_240.png 1,Long-Term Impact of Androgen-Deprivation Therapy on Cardiovascular Morbidity after Radiotherapy for Clinically Localized Prostate Cancer,Urology,,,Article,2015-10-18,10.1016/j.urology.2015.08.029,,,,26476405,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4631678,https://api.altmetric.com/v1/donut/4631678_240.png 1,Docetaxel Resistance in Prostate Cancer: Taking It Up a Notch,Clinical Cancer Research,,,Article,2015-10-15,10.1158/1078-0432.ccr-15-1613,,,,26307134,,10161/10916,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4626647,https://api.altmetric.com/v1/donut/4626647_240.png 1,"The eMale Prostate cancer, masculinity and online support as a challenge to medical expertise",Journal of Sociology,,,Article,2005-03-01,10.1177/1440783305050965,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/4623282,https://api.altmetric.com/v1/donut/4623282_240.png 1,Evaluation of the antiproliferative effects of Essiac on in vitro and in vivo models of prostate cancer compared to paclitaxel.,,,,Article,,10.1080/01635580701328396,,,,17640165,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4614603,https://api.altmetric.com/v1/donut/4614603_240.png 1,Lack of interaction between enzalutamide and warfarin in a metastatic castration-resistant prostate cancer patient,Journal of Oncology Pharmacy Practice,,,Article,2015-10-11,10.1177/1078155215609979,,,,26454199,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4609443,https://api.altmetric.com/v1/donut/4609443_240.png 1,miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.,Oncotarget,,,Article,2015-10-10,10.18632/oncotarget.5427,,,,26451614,PMC4742155,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4609002,https://api.altmetric.com/v1/donut/4609002_240.png 1,The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.,Oncotarget,,,Article,2015-10-10,10.18632/oncotarget.6024,,,,26452038,PMC4741458,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4608255,https://api.altmetric.com/v1/donut/4608255_240.png 1,GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress,The Prostate,,,Article,2015-10-09,10.1002/pros.23111,,,,26447830,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4604822,https://api.altmetric.com/v1/donut/4604822_240.png 1,Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer,Cancers,,,Article,2015-09-29,10.3390/cancers7040871,,,,26426053,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4600290,https://api.altmetric.com/v1/donut/4600290_240.png 1,Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics,Diagnostics,,,Article,2015-07-30,10.3390/diagnostics5030358,,,,26854158,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4594156,https://api.altmetric.com/v1/donut/4594156_240.png 1,Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer.,The Prostate,,,Article,,10.1002/pros.23067,,,,26286637,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4593538,https://api.altmetric.com/v1/donut/4593538_240.png 1,The perspective of prostate cancer patients and patients' partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples,Psycho-Oncology,,,Article,2015-01-01,10.1002/pon.3930,,,,26411285,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4591819,https://api.altmetric.com/v1/donut/4591819_240.png 1,Prostate cancer: Wnt signalling induces resistance,Nature Reviews Urology,,,Article,2015-10-06,10.1038/nrurol.2015.244,,,,26439505,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4591699,https://api.altmetric.com/v1/donut/4591699_240.png 1,Global Quality of Life After Curative Treatment for Prostate Cancer: What Matters? A Study Among Members of the Norwegian Prostate Cancer Patient Association.,Clinical Genitourinary Cancer,,,Article,,10.1016/j.clgc.2015.07.004,,,,26303590,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4585530,https://api.altmetric.com/v1/donut/4585530_240.png 1,Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway,Journal of Nutritional Biochemistry,,,Article,2014-01-11,10.1016/j.jnutbio.2014.06.008,,,,25150162,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4584210,https://api.altmetric.com/v1/donut/4584210_240.png 1,Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy,PLoS ONE,,,Article,2015-10-03,10.1371/journal.pone.0136735,,,,26431041,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4583273,https://api.altmetric.com/v1/donut/4583273_240.png 1,Methodological considerations in assessing the utility of imaging in early prostate cancer,Current Opinion in Urology,,,Article,2015-11-01,10.1097/mou.0000000000000219,,,,26383038,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4581796,https://api.altmetric.com/v1/donut/4581796_240.png 1,Health-Related Quality of Life in Advanced Prostate Cancer and Its Treatments: Biochemical Failure and Metastatic Disease Populations,Clinical Genitourinary Cancer,,,Article,2015-01-04,10.1016/j.clgc.2014.08.001,,,,25262852,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/4573834,https://api.altmetric.com/v1/donut/4573834_240.png 1,Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.,The Prostate,,,Article,2015-09-30,10.1002/pros.23101,,,,26417675,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/4571730,https://api.altmetric.com/v1/donut/4571730_240.png 1,Role of of Nuclear Medicine in the multidisciplinary management of prostate cancer.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2015-09-30,,,,,26416035,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4570034,https://api.altmetric.com/v1/donut/4570034_240.png 1,Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer,The Prostate,,,Article,2015-09-01,10.1002/pros.23103,,,,26417683,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4567654,https://api.altmetric.com/v1/donut/4567654_240.png 1,Systematic Review of the Efficacy and Safety of High-intensity Focussed Ultrasound for Localised Prostate Cancer,European Urology Focus ,,,Article,2015-09-28,10.1016/j.euf.2015.04.006,,,,,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4561139,https://api.altmetric.com/v1/donut/4561139_240.png 1,"Prostate Size and Risk of High-Grade, Advanced Prostate Cancer and Biochemical Progression After Radical Prostatectomy: A Search Database Study",Journal of Clinical Oncology,,,Article,2005-10-20,10.1200/jco.2005.05.525,,,,16234520,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,28,https://www.altmetric.com/details/4557005,https://api.altmetric.com/v1/donut/4557005_240.png 1,"[Radiotherapy in elderly patients, recommendations for the main localizations: Breast, prostate and gynaecological cancers].",Cancer Radiotherapie,,,Article,,10.1016/j.canrad.2015.05.014,,,,26282214,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4550467,https://api.altmetric.com/v1/donut/4550467_240.png 1,"Your NEJM Group Today: Ptosis & the Red Sea, ADT in Prostate Cancer with Comorbidities, Multistate Internal Medicine Opportunities.",Journal Watch,,,Article,2015-09-23,10.1056/nejm-jw.fw110666,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4542392,https://api.altmetric.com/v1/donut/4542392_240.png 1,"LG308, a novel synthetic compound with anti-microtubule activity in prostate cancer cells, exerts effective antitumor activity",The Journal of Pharmacology and Experimental Therapeutics,,,Article,,10.1124/jpet.115.225912,,,,26377911,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4533078,https://api.altmetric.com/v1/donut/4533078_240.png 1,Cigarette smoking and risk of prostate cancer in middle-aged men.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2003-07-01,,,,,12869398,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4532870,https://api.altmetric.com/v1/donut/4532870_240.png 1,Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials,Reviews in Urology,,,Article,,,,,,19918338,PMC2777060,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/4529351,https://api.altmetric.com/v1/donut/4529351_240.png 1,Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells,Oncogene,,,Article,2006-11-13,10.1038/sj.onc.1210088,,,,17099727,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4528461,https://api.altmetric.com/v1/donut/4528461_240.png 1,Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2015-10-01,10.1097/coc.0b013e3182a790ce,,,,24064757,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4520613,https://api.altmetric.com/v1/donut/4520613_240.png 1,"Prostate cancer: AS[mdash]contemplation, not intervention",Nature Reviews Clinical Oncology,,,Article,2015-09-15,10.1038/nrclinonc.2015.160,,,,26370606,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4518005,https://api.altmetric.com/v1/donut/4518005_240.png 1,Blood-based gene expression profiling in castrate-resistant prostate cancer,BMC Medicine,,,Article,2015-09-14,10.1186/s12916-015-0463-8,,,,26365516,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4517762,https://api.altmetric.com/v1/donut/4517762_240.png 1,A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer ,Practical Radiation Oncology,,,Article,2014-10-18,10.1016/j.prro.2014.03.003,,,,25413432,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4513110,https://api.altmetric.com/v1/donut/4513110_240.png 1,Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer.,Korean Journal of Urology,,,Article,2015-09-15,10.4111/kju.2015.56.9.630,,,,26366275,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4511351,https://api.altmetric.com/v1/donut/4511351_240.png 1,Registered report: the androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man,PeerJ,,,Article,2015-09-15,10.7717/peerj.1231,,,,26401447,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4509512,https://api.altmetric.com/v1/donut/4509512_240.png 1,5???Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review,British Journal of Urology,,,Article,,10.1111/j.1464-410x.2010.09714.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/4509347,https://api.altmetric.com/v1/donut/4509347_240.png 1,Nonmedical information seeking amid conflicting health information: negative and positive effects on prostate cancer screening,Health Communication,,,Article,2015-09-14,10.1080/10410236.2014.963786,,,,26362829,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4507162,https://api.altmetric.com/v1/donut/4507162_240.png 1,Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes ,Journal of Controlled Release,,,Article,,10.1016/j.jconrel.2015.08.058,,,,26348387,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4502252,https://api.altmetric.com/v1/donut/4502252_240.png 1,TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2,,,,Article,2001-06-29,10.1038/sj.onc.1204504,,,,,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4500650,https://api.altmetric.com/v1/donut/4500650_240.png 1,Stat5a/b in Prostate Cancer Metastasis,American Journal of Pathology,,,Article,2015-01-09,10.1016/j.ajpath.2015.06.002,,,,26187549,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4498072,https://api.altmetric.com/v1/donut/4498072_240.png 1,SILAC-Based Mass Spectrometry Analysis Reveals That Epibrassinolide Induces Apoptosis via Activating Endoplasmic Reticulum Stress in Prostate Cancer Cells,PLoS ONE,,,Article,2015-09-10,10.1371/journal.pone.0135788,,,,26353013,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4493927,https://api.altmetric.com/v1/donut/4493927_240.png 1,FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.,Oncotarget,,,Article,2015-09-05,10.18632/oncotarget.4927,,,,26336819,PMC4745762,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4476407,https://api.altmetric.com/v1/donut/4476407_240.png 1,SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression ,Molecular Cell,,,Article,2015-09-08,10.1016/j.molcel.2015.07.026,,,,26344095,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4472173,https://api.altmetric.com/v1/donut/4472173_240.png 1,Abstract 1292: Validation study on quantitative analysis method of interrelationships between immune cells and prostate epithelial and cancer cells,Cancer Research,,,Article,2015-08-01,10.1158/1538-7445.am2015-1292,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4471592,https://api.altmetric.com/v1/donut/4471592_240.png 1,The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target,Expert Review of Anticancer Therapy,,,Article,,10.1586/14737140.2015.1064769,,,,26313417,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4468597,https://api.altmetric.com/v1/donut/4468597_240.png 1,Targeting molecular resistance in castration-resistant prostate cancer,BMC Medicine,,,Article,2015-09-01,10.1186/s12916-015-0457-6,,,,26329698,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4468367,https://api.altmetric.com/v1/donut/4468367_240.png 1,Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers.,,,,Article,2006-05-14,10.1007/s10552-005-0443-y,,,,16596288,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4465179,https://api.altmetric.com/v1/donut/4465179_240.png 1,Prostate cancer risk in relation to anthropometry and physical activity: the National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2000-09-01,,,,,11008903,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4463208,https://api.altmetric.com/v1/donut/4463208_240.png 1,A Gay Urologist's Changing Views on Prostate Cancer,Journal of Gay & Lesbian Psychotherapy,,,Article,,10.1300/j236v09n01_03,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4458662,https://api.altmetric.com/v1/donut/4458662_240.png 1,Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study).,Acta medica Indonesiana,,,Article,,,,,,26260551,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4449674,https://api.altmetric.com/v1/donut/4449674_240.png 1,The role of HOXC6 in prostate cancer development,The Prostate,,,Article,2015-08-29,10.1002/pros.23065,,,,26310814,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4447757,https://api.altmetric.com/v1/donut/4447757_240.png 1,"Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway",Pharmaceutical Research,,,Article,2008-09-01,10.1007/s11095-008-9552-0,,,,18286356,PMC2994272,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4445942,https://api.altmetric.com/v1/donut/4445942_240.png 1,"An epidemiological analysis of potential associations between C-reactive protein, inflammation, and prostate cancer in the male US population using the 2009–2010 National Health and Nutrition Examination Survey (NHANES) data",Frontiers in Chemistry,,,Article,2015-08-28,10.3389/fchem.2015.00055,,,,26380255,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4445672,https://api.altmetric.com/v1/donut/4445672_240.png 1,"Re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038",European Urology,,,Article,2015-08-27,10.1016/j.eururo.2015.08.011,,,,26318708,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4440321,https://api.altmetric.com/v1/donut/4440321_240.png 1,Impact of arterial input function selection on the accuracy of dynamic contrast?enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer,Journal of Magnetic Resonance Imaging,,,Article,2015-08-01,10.1002/jmri.25034,,,,26303794,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4430504,https://api.altmetric.com/v1/donut/4430504_240.png 1,"Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038",European Urology,,,Article,2015-08-25,10.1016/j.eururo.2015.08.012,,,,26314617,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4430031,https://api.altmetric.com/v1/donut/4430031_240.png 1,Understanding How Masculine Gender Scripts May Contribute to Men's Adjustment Following Treatment for Prostate Cancer,American Journal of Men's Health,,,Article,2007-12-01,10.1177/1557988306293380,,,,19482806,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,15,https://www.altmetric.com/details/4425007,https://api.altmetric.com/v1/donut/4425007_240.png 1,Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents ,Chemico-Biological Interactions,,,Article,2015-08-25,10.1016/j.cbi.2015.08.009,,,,26297992,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4417488,https://api.altmetric.com/v1/donut/4417488_240.png 1,Microsatellite instability and prostate cancer: clinical and pathological implications.,Current Opinion in Urology,,,Article,2002-09-01,,,,,12172428,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4417012,https://api.altmetric.com/v1/donut/4417012_240.png 1,Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.,Molecular Oncology,,,Article,2014-06-23,10.1016/j.molonc.2014.06.009,,,,25091737,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4416827,https://api.altmetric.com/v1/donut/4416827_240.png 1,[New therapies in metastatic castration resistant prostate cancer].,Bulletin du Cancer,,,Article,,10.1016/j.bulcan.2015.04.016,,,,26022286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4416342,https://api.altmetric.com/v1/donut/4416342_240.png 1,Pharmacokinetic Analysis of Prostate Cancer Using Independent Component Analysis ,Magnetic Resonance Imaging (0730725X),,,Article,2015-08-25,10.1016/j.mri.2015.08.009,,,,26297961,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4415554,https://api.altmetric.com/v1/donut/4415554_240.png 1,Assessment of long?term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy,Cancer (0008543X),,,Article,2015-08-01,10.1002/cncr.29611,,,,26280815,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4412573,https://api.altmetric.com/v1/donut/4412573_240.png 1,"Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy","Cancer Immunology, Immunotherapy",,,Article,2010-05-25,10.1007/s00262-010-0858-5,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4409600,https://api.altmetric.com/v1/donut/4409600_240.png 1,Tuberculosis of the Prostate Gland Masquerading Prostate Cancer: A Case Report,Open Journal of Urology,,,Article,2013-11-05,10.4236/oju.2013.37050,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4409156,https://api.altmetric.com/v1/donut/4409156_240.png 1,"Prostate Adenocarcinoma in Rats: Induction by 3,2?-Dimethyl-4-aminobiphenyl",JNCI: Journal of the National Cancer Institute,,,Article,1982-05-01,10.1093/jnci/68.5.867,,,,6951094,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4408989,https://api.altmetric.com/v1/donut/4408989_240.png 1,Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy.,Oncotarget,,,Article,2015-08-14,10.18632/oncotarget.4347,,,,26267320,PMC4694883,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4397420,https://api.altmetric.com/v1/donut/4397420_240.png 1,"Reply to Thorsten Derlin, Matthias Eiber, Markus Schwaiger, and Frank M. Bengel's Letter to the Editor re: Lars Budäus, Sami-Ramzi Leyh-Bannurah, Georg Salomon, et al. Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.06.010",European Urology,,,Article,2015-08-13,10.1016/j.eururo.2015.07.056,,,,26277301,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4390070,https://api.altmetric.com/v1/donut/4390070_240.png 1,Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early (18)F-FCH PET/CT?,Annals of Nuclear Medicine,,,Article,2015-08-12,10.1007/s12149-015-1015-1,,,,26261000,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4387150,https://api.altmetric.com/v1/donut/4387150_240.png 1,Hypofractioned radiotherapy in prostate cancer: is it the next step?,Expert Review of Anticancer Therapy,,,Article,2014-11-15,10.1586/14737140.2014.972380,,,,25367322,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4385217,https://api.altmetric.com/v1/donut/4385217_240.png 1,Management of bone metastases in prostate cancer: a review,Current Opinion in Supportive and Palliative Care,,,Article,2015-09-01,10.1097/spc.0000000000000157,,,,26262831,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4384504,https://api.altmetric.com/v1/donut/4384504_240.png 1,Syndecan?1 up?regulates microRNA?331?3p and mediates epithelial?to?mesenchymal transition in prostate cancer,Molecular Carcinogenesis,,,Article,2015-08-11,10.1002/mc.22381,,,,26259043,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4383937,https://api.altmetric.com/v1/donut/4383937_240.png 1,Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveals Glycoprotein Alteration in Protein Abundance and Glycosylation,Molecular and Cellular Proteomics (MCP Online),,,Article,2015-08-11,10.1074/mcp.m115.047928,,,,26256267,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4383750,https://api.altmetric.com/v1/donut/4383750_240.png 1,Design and feasibility of integrating personalized PRO dashboards into prostate cancer care,Journal of the American Medical Informatics Association,,,Article,2015-08-08,10.1093/jamia/ocv101,,,,26260247,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4382521,https://api.altmetric.com/v1/donut/4382521_240.png 1,PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer,Oncogene,,,Article,2015-08-10,10.1038/onc.2015.292,,,,26257066,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4381614,https://api.altmetric.com/v1/donut/4381614_240.png 1,TE?=?32 ms vs TE?=?100 ms echo?time 1H?magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues,Journal of Magnetic Resonance Imaging,,,Article,2015-08-01,10.1002/jmri.24875,,,,26258905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4381157,https://api.altmetric.com/v1/donut/4381157_240.png 1,Prostate cancer: AR splice variant dimerization[mdash]clinical implications,Nature Reviews Urology,,,Article,2015-08-10,10.1038/nrurol.2015.184,,,,26256859,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4380466,https://api.altmetric.com/v1/donut/4380466_240.png 1,Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein ? (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer ,Veterinary Journal,,,Article,2015-09-09,10.1016/j.tvjl.2015.08.002,,,,26346258,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4379076,https://api.altmetric.com/v1/donut/4379076_240.png 1,Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer.,,,,Article,,10.1371/journal.pone.0098786,,,,24896103,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4374973,https://api.altmetric.com/v1/donut/4374973_240.png 1,EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1,Cancer Research,,,Article,2015-08-01,10.1158/0008-5472.can-14-3380,,,,26071255,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4358181,https://api.altmetric.com/v1/donut/4358181_240.png 1,Everolimus combined with gefitinib in patients with metastatic castration?resistant prostate cancer: Phase 1/2 results and signaling pathway implications,Cancer (0008543X),,,Article,2015-07-01,10.1002/cncr.29578,,,,26178426,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4358131,https://api.altmetric.com/v1/donut/4358131_240.png 1,Do differences in age specific androgenic steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians?,,,,Article,2006-04-14,10.1111/j.1442-2042.2006.01305.x,,,,16734850,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/4355252,https://api.altmetric.com/v1/donut/4355252_240.png 1,PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor.,Neoplasia,,,Article,2014-08-14,10.1016/j.neo.2014.07.010,,,,25220591,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4340288,https://api.altmetric.com/v1/donut/4340288_240.png 1,Posttranscriptional regulation of T-type Ca2+ channel expression by interleukin-6 in prostate cancer cells ,Cytokine,,,Article,,10.1016/j.cyto.2015.07.004,,,,26205261,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4332509,https://api.altmetric.com/v1/donut/4332509_240.png 1,Heterogeneous methodology of racial/ethnic classification may be responsible for the different risk assessments for prostate cancer between Black and White men in Brazil,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2015.02.25,,,,,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4320008,https://api.altmetric.com/v1/donut/4320008_240.png 1,"Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo.",Oncotarget,,,Article,2015-07-23,10.18632/oncotarget.4578,,,,26196320,PMC4695001,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4307975,https://api.altmetric.com/v1/donut/4307975_240.png 1,Role of MTHFR A1298C gene polymorphism in the etiology of prostate cancer: A systematic review and updated meta-analysis ,Egyptian Journal of Medical Human Genetics,,,Article,,10.1016/j.ejmhg.2015.06.005,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4296139,https://api.altmetric.com/v1/donut/4296139_240.png 1,Immature Colon Carcinoma Transcript 1 Is Essential for Prostate Cancer Cell Viability and Proliferation.,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2015-07-19,10.1089/cbr.2014.1728,,,,26186090,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4293141,https://api.altmetric.com/v1/donut/4293141_240.png 1,[Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].,Progrès en Urologie,,,Article,2015-07-18,10.1016/j.purol.2015.06.003,,,,26184041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4291293,https://api.altmetric.com/v1/donut/4291293_240.png 1,Oral delivery of particulate prostate cancer vaccine: In vitro and in vivo evaluation,Journal of Drug Targeting,,,Article,2012-05-14,10.3109/1061186x.2011.654122,,,,22296308,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/4290376,https://api.altmetric.com/v1/donut/4290376_240.png 1,Men's use of networks to manage communication tensions related to a potential diagnosis of prostate cancer,European Journal of Oncology Nursing,,,Article,2016-02-01,10.1016/j.ejon.2015.06.006,,,,26138796,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4289684,https://api.altmetric.com/v1/donut/4289684_240.png 1,State-of-the-art imaging of prostate cancer,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.05.015,,,,26087969,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4285700,https://api.altmetric.com/v1/donut/4285700_240.png 1,Preventive Effects of Aspirin on Cardiovascular Complications in Prostate Cancer Cases after Endocrinotherapy.,Asian Pacific Journal of Cancer Prevention,,,Article,2015-07-16,,,,,26163614,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4285672,https://api.altmetric.com/v1/donut/4285672_240.png 1,Deuterium Depletion May Delay the Progression of Prostate Cancer,Journal of Cancer Therapy,,,Article,2011-10-31,10.4236/jct.2011.24075,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4280062,https://api.altmetric.com/v1/donut/4280062_240.png 1,Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefits,SpringerPlus,,,Article,2015-07-15,10.1186/s40064-015-1138-9,,,,26191474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4273609,https://api.altmetric.com/v1/donut/4273609_240.png 1,"Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.046",European Urology,,,Article,2015-07-14,10.1016/j.eururo.2015.07.002,,,,26184974,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4271323,https://api.altmetric.com/v1/donut/4271323_240.png 1,Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2015-07-09,10.1097/coc.0000000000000207,,,,26165416,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4269746,https://api.altmetric.com/v1/donut/4269746_240.png 1,Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer.,BioMed research international,,,Article,2015-07-12,10.1155/2015/794968,,,,26161414,PMC4486485,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4265879,https://api.altmetric.com/v1/donut/4265879_240.png 1,Fluorescence?guided surgery of human prostate cancer experimental bone metastasis in nude mice using anti?CEA dylight 650 for tumor illumination,Journal of Orthopaedic Research,,,Article,2015-06-01,10.1002/jor.22973,,,,26135883,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4254828,https://api.altmetric.com/v1/donut/4254828_240.png 1,Prostate cancer recurrence: can PSA guide imaging?,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-07-09,10.1007/s00259-015-3091-9,,,,26156533,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4254673,https://api.altmetric.com/v1/donut/4254673_240.png 1,Assessment of possible association between rs378854 and prostate cancer risk in the Serbian population,Archives of Biological Sciences,,,Article,2013-01-01,10.2298/abs1302475b,,,,,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4253205,https://api.altmetric.com/v1/donut/4253205_240.png 1,Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers,Frontiers in Genetics,,,Article,2012-02-22,10.3389/fgene.2012.00023,,,,22371711,PMC3284255,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/4252713,https://api.altmetric.com/v1/donut/4252713_240.png 1,Template-based Intensity-Modulated Radiation Therapy: A Cost-effective Intensity-Modulated Radiation Therapy Planning Procedure for Prostate Cancer,Journal of Medical Imaging & Radiation Sciences,,,Article,,10.1016/j.jmir.2015.04.013,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4243502,https://api.altmetric.com/v1/donut/4243502_240.png 1,U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer,Oncologist,,,Article,2015-08-01,10.1634/theoncologist.2015-0166,,,,26070917,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4240174,https://api.altmetric.com/v1/donut/4240174_240.png 1,"No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK",Pharmacoepidemiology & Drug Safety,,,Article,2015-07-01,10.1002/pds.3823,,,,26132313,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4231478,https://api.altmetric.com/v1/donut/4231478_240.png 1,Methodology of patient care for elevated PSA after prostate cancer treatment: A primary care perspective,Postgraduate Medicine,,,Article,2015-07-01,10.1080/00325481.2015.1059248,,,,26118565,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4229484,https://api.altmetric.com/v1/donut/4229484_240.png 1,Prostate Cancer Metastases To Inguinal Lymph Nodes Detected By 11C-Acetate PET/CTAC.,Journal of nuclear medicine technology,,,Article,2015-06-28,10.2967/jnmt.115.157594,,,,26111708,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4220699,https://api.altmetric.com/v1/donut/4220699_240.png 1,"Evaluating the Anticancer Properties of Liposomal Copper in a Nude Xenograft Mouse Model of Human Prostate Cancer: Formulation, In Vitro, In Vivo, Histology and Tissue Distribution Studies.",Pharmaceutical Research,,,Article,2014-05-21,10.1007/s11095-014-1403-6,,,,24848339,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4214459,https://api.altmetric.com/v1/donut/4214459_240.png 1,A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NF?B and androgen receptor signaling in prostate cancer.,Oncotarget,,,Article,2014-09-29,10.18632/oncotarget.2303,,,,25327559,PMC4226675,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4214146,https://api.altmetric.com/v1/donut/4214146_240.png 1,"Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer",,,,Article,,,,,,,,,,1506.07496,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4207752,https://api.altmetric.com/v1/donut/4207752_240.png 1,Oxidative stress in prostate cancer ,Cancer Letters,,,Article,2009-09-17,10.1016/j.canlet.2008.12.011,,,,19185987,PMC2789743,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/4203663,https://api.altmetric.com/v1/donut/4203663_240.png 1,Exploration on natural product anibamine side chain modification toward development of novel CCR5 antagonists and potential anti-prostate cancer agents ,Bioorganic & Medicinal Chemistry Letters,,,Article,2015-06-23,10.1016/j.bmcl.2015.06.029,,,,26096680,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4200328,https://api.altmetric.com/v1/donut/4200328_240.png 1,Sexual Health Concerns Among Cancer Survivors: Testing a Novel Information-Need Measure Among Breast and Prostate Cancer Patients,Journal of Cancer Education,,,Article,2015-06-16,10.1007/s13187-015-0865-5,,,,26076657,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4197874,https://api.altmetric.com/v1/donut/4197874_240.png 1,Stem Cell Based Gene Therapy in Prostate Cancer,BioMed Research International,,,Article,2014-07-10,10.1155/2014/549136,,,,25121103,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4193283,https://api.altmetric.com/v1/donut/4193283_240.png 1,Development of novel radio-chemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.,International Journal of Cancer,,,Article,2015-11-15,10.1002/ijc.29614,,,,26059723,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4193153,https://api.altmetric.com/v1/donut/4193153_240.png 1,"Dietary Vitamin D3 and 1,25-Dihydroxyvitamin D3 (Calcitriol) Exhibit Equivalent Anticancer Activity in Mouse Xenograft Models of Breast and Prostate Cancer",Endocrinology,,,Article,2012-06-01,10.1210/en.2011-1600,,,,22454149,PMC3359605,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4190588,https://api.altmetric.com/v1/donut/4190588_240.png 1,The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer,Practical Radiation Oncology,,,Article,2015-01-05,10.1016/j.prro.2014.10.003,,,,25491179,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4189237,https://api.altmetric.com/v1/donut/4189237_240.png 1,GLIPR1-¿TM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells,Molecular Cancer,,,Article,2015-06-19,10.1186/s12943-015-0395-0,,,,26084402,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4188940,https://api.altmetric.com/v1/donut/4188940_240.png 1,Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery.,Journal of Cancer Survivorship,,,Article,2014-09-12,10.1007/s11764-014-0399-6,,,,25216609,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4188803,https://api.altmetric.com/v1/donut/4188803_240.png 1,Increased expression of Six1 correlates with progression and prognosis of prostate cancer,Cancer Cell International,,,Article,2015-06-20,10.1186/s12935-015-0215-z,,,,26161040,PMC4497425,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4188665,https://api.altmetric.com/v1/donut/4188665_240.png 1,The dose?dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events,British Journal of Urology,,,Article,2015-07-22,10.1111/bju.13203,,,,26074405,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4182283,https://api.altmetric.com/v1/donut/4182283_240.png 1,Stability Assessment of Candidate Reference Genes in Urine Sediment of Prostate Cancer Patients for miRNA Applications,Disease Markers,,,Article,2015-06-17,10.1155/2015/973597,,,,26078486,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4182080,https://api.altmetric.com/v1/donut/4182080_240.png 1,Glycogen synthase kinase-3: A potential preventive target for prostate cancer management.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.05.006,,,,26051358,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4169064,https://api.altmetric.com/v1/donut/4169064_240.png 1,Methylglyoxal-induced apoptosis in human prostate carcinoma: potential modality for prostate cancer treatment.,European Urology,,,Article,2000-06-01,20226,,,,10828676,,,,,,,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4155488,https://api.altmetric.com/v1/donut/4155488_240.png 1,A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer,The Prostate,,,Article,2015-05-04,10.1002/pros.23003,,,,25939393,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4130613,https://api.altmetric.com/v1/donut/4130613_240.png 1,Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer,Carcinogenesis,,,Article,2005-08-01,10.1093/carcin/bgi092,,,,15845653,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4130055,https://api.altmetric.com/v1/donut/4130055_240.png 1,Development and piloting of an exercise program for prostate cancer survivors using stakeholder engagement ,Physiotherapy / Fizjoterapia,,,Article,,10.1016/j.physio.2015.03.599,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4117650,https://api.altmetric.com/v1/donut/4117650_240.png 1,"Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina?Louisiana Prostate Cancer Project (PCaP)",The Prostate,,,Article,2015-06-05,10.1002/pros.23025,,,,26053590,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4106838,https://api.altmetric.com/v1/donut/4106838_240.png 1,Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.,The Prostate,,,Article,2015-06-06,10.1002/pros.23021,,,,26047319,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4105000,https://api.altmetric.com/v1/donut/4105000_240.png 1,Prostate cancer: Why statins are beneficial,Nature Reviews Urology,,,Article,2015-05-26,10.1038/nrurol.2015.125,,,,26032545,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4100799,https://api.altmetric.com/v1/donut/4100799_240.png 1,EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.,Oncotarget,,,Article,2015-06-05,10.18632/oncotarget.4088,,,,26041887,PMC4673184,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4097327,https://api.altmetric.com/v1/donut/4097327_240.png 1,Prostate cancer cells stimulated by calcium-mediated activation of protein kinase C undergo a refractory period before re-releasing calcium-bearing microvesicles.,Biochemical & Biophysical Research Communications,,,Article,2015-03-19,10.1016/j.bbrc.2015.03.061,,,,25797625,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4093941,https://api.altmetric.com/v1/donut/4093941_240.png 1,Microvesicles released constitutively from prostate cancer cells differ biochemically and functionally to stimulated microvesicles released through sublytic C5b-9.,Biochemical & Biophysical Research Communications,,,Article,,10.1016/j.bbrc.2015.03.074,,,,25817790,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4093940,https://api.altmetric.com/v1/donut/4093940_240.png 1,Body composition in prostate cancer patients: novel insights suggest diverse prognostic roles of lean and fat mass,Endocrine,,,Article,2015-06-04,10.1007/s12020-015-0644-4,,,,26041377,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4092846,https://api.altmetric.com/v1/donut/4092846_240.png 1,Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer,Journal of Clinical Pathology,,,Article,2015-06-05,10.1136/jclinpath-2015-202859,,,,26041862,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4088187,https://api.altmetric.com/v1/donut/4088187_240.png 1,"Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer.",Biological Chemistry,,,Article,2014-08-31,10.1515/hsz-2014-0149,,,,25153393,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4086247,https://api.altmetric.com/v1/donut/4086247_240.png 1,PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.,Cancer Medicine,,,Article,2015-06-03,10.1002/cam4.463,,,,26033689,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4086147,https://api.altmetric.com/v1/donut/4086147_240.png 1,Targeting the androgen receptor in prostate and breast cancer: several new agents in development,Endocrine-Related Cancer,,,Article,2015-06-01,10.1530/erc-14-0543,,,,25722318,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4078047,https://api.altmetric.com/v1/donut/4078047_240.png 1,MRI - prostate cancer screening for the future?,ecancer.org,,,Article,,,,,http://ecancer.org/news/7318-mri---prostate-cancer-screening-for-the-future.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4077746,https://api.altmetric.com/v1/donut/4077746_240.png 1,A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195,Investigational New Drugs,,,Article,2015-05-19,10.1007/s10637-015-0252-4,,,,25983041,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4076970,https://api.altmetric.com/v1/donut/4076970_240.png 1,Replication and Heritability of Prostate Cancer Risk Variants: Impact of Population-Specific Factors,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-06-01,10.1158/1055-9965.epi-14-1372,,,,25809866,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4076872,https://api.altmetric.com/v1/donut/4076872_240.png 1,"Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study",Journal of Cancer Survivorship,,,Article,2015-01-07,10.1007/s11764-014-0419-6,,,,25563819,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4076145,https://api.altmetric.com/v1/donut/4076145_240.png 1,The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis,Cancer Research,,,Article,2006-09-01,10.1158/0008-5472.can-06-1374,,,,16951176,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/4073980,https://api.altmetric.com/v1/donut/4073980_240.png 1,Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-05-29,10.1097/rlu.0000000000000817,,,,26018683,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4072316,https://api.altmetric.com/v1/donut/4072316_240.png 1,MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.,PLoS ONE,,,Article,2015-05-29,10.1371/journal.pone.0127427,,,,26020509,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4070481,https://api.altmetric.com/v1/donut/4070481_240.png 1,Prostate cancer and pharmacokinetics: Expert discussion. Prostate cancer and pharmacokinetics: Expert discussion,ecancer.org,,,Article,,,,,http://ecancer.org/video/3694/prostate-cancer-and-pharmacokinetics--expert-discussion.php,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4062350,https://api.altmetric.com/v1/donut/4062350_240.png 1,The effect of dutasteride on the detection of prostate cancer: A set of meta-analyses.,,,,Article,,10.5489/cuaj.477,,,,23589750,PMC3612406,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/4050248,https://api.altmetric.com/v1/donut/4050248_240.png 1,"The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers.",Urologic Oncology,,,Article,2015-03-04,10.1016/j.urolonc.2015.01.018,,,,25746941,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4042030,https://api.altmetric.com/v1/donut/4042030_240.png 1,Immune Infiltration and Prostate Cancer.,Frontiers in oncology,,,Article,2015-05-22,10.3389/fonc.2015.00128,,,,26217583,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/4040260,https://api.altmetric.com/v1/donut/4040260_240.png 1,Correlation of p53 immunoexpression with DNA ploidy and apoptotic index in subsets of prostate cancer: A marker reiterated in progression and recurrence of prostate cancer.,South Asian journal of cancer,,,Article,2015-04-01,10.4103/2278-330x.155693,,,,25992349,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4037861,https://api.altmetric.com/v1/donut/4037861_240.png 1,"Prostate cancer mortality in Serbia, 1991–2010: a joinpoint regression analysis",Journal of Public Health,,,Article,2015-05-23,10.1093/pubmed/fdv064,,,,25994152,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4035713,https://api.altmetric.com/v1/donut/4035713_240.png 1,Hepcidin regulation in prostate and its disruption in prostate cancer.,Cancer Research,,,Article,2015-06-01,10.1158/0008-5472.can-14-2465,,,,25858146,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4029329,https://api.altmetric.com/v1/donut/4029329_240.png 1,FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy.,Cancer Imaging,,,Article,,10.1186/s40644-015-0038-0,,,,25889163,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4025949,https://api.altmetric.com/v1/donut/4025949_240.png 1,Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.,The Prostate,,,Article,,10.1002/pros.22997,,,,25893825,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4025111,https://api.altmetric.com/v1/donut/4025111_240.png 1,"Effect of Metformin, Rapamycin and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice.",Cancer Prevention Research,,,Article,2015-04-23,10.1158/1940-6207.capr-15-0014,,,,25908508,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4023787,https://api.altmetric.com/v1/donut/4023787_240.png 1,Words of wisdom. Re: Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer.,European Urology,,,Article,2014-12-15,,,,,25587594,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4019133,https://api.altmetric.com/v1/donut/4019133_240.png 1,Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3965,,,,25961317,PMC4546472,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4016353,https://api.altmetric.com/v1/donut/4016353_240.png 1,"The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria",BMC Public Health,,,Article,2015-04-26,10.1186/s12889-015-1754-x,,,,25927535,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4011142,https://api.altmetric.com/v1/donut/4011142_240.png 1,sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients,Journal of Experimental & Clinical Cancer Research,,,Article,2015-05-14,10.1186/s13046-015-0161-6,,,,25967040,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3993905,https://api.altmetric.com/v1/donut/3993905_240.png 1,Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.,Urologic Oncology,,,Article,2014-06-22,10.1016/j.urolonc.2014.03.007,,,,24968948,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3991960,https://api.altmetric.com/v1/donut/3991960_240.png 1,Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer.,International Brazilian Journal of Urology,,,Article,,,,,,25928509,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3982523,https://api.altmetric.com/v1/donut/3982523_240.png 1,Knockdown of WAVE3 impairs HGF induced migration and invasion of prostate cancer cells,Cancer Cell International,,,Article,2015-05-10,10.1186/s12935-015-0203-3,,,,26052252,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3982014,https://api.altmetric.com/v1/donut/3982014_240.png 1,State of the PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer.,Archivos Españoles de Urología,,,Article,2015-05-09,,,,,25948806,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3980390,https://api.altmetric.com/v1/donut/3980390_240.png 1,A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.,PLoS ONE,,,Article,2015-05-07,10.1371/journal.pone.0125560,,,,25938433,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3973576,https://api.altmetric.com/v1/donut/3973576_240.png 1,"Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial",Health Expectations,,,Article,2015-05-03,10.1111/hex.12369,,,,25940277,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3967152,https://api.altmetric.com/v1/donut/3967152_240.png 1,Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.,,,,Article,2004-08-14,10.1172/jci22206,,,,15314693,PMC503776,,,,,,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3965973,https://api.altmetric.com/v1/donut/3965973_240.png 1,"Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)",World Journal of Urology,,,Article,2014-10-31,10.1007/s00345-014-1426-y,,,,,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3964003,https://api.altmetric.com/v1/donut/3964003_240.png 1,Erratum: OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.,Molecular Cancer,,,Article,2015-05-02,10.1186/s12943-015-0341-1,,,,25927722,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3962143,https://api.altmetric.com/v1/donut/3962143_240.png 1,An Atomic Force Microscope Study Revealed Two Mechanisms in the Effect of Anticancer Drugs on Rate-Dependent Young’s Modulus of Human Prostate Cancer Cells,PloS one,,,Article,2015-05-01,10.1371/journal.pone.0126107,,,,25932632,,,,,,,0,0,0,3,0,0,0,0,0,0,1,0,0,0,0,8,https://www.altmetric.com/details/3961539,https://api.altmetric.com/v1/donut/3961539_240.png 1,MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.,Nucleic Acids Research,,,Article,2015-05-03,10.1093/nar/gkv394,,,,25934801,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3959736,https://api.altmetric.com/v1/donut/3959736_240.png 1,The Heritability of Prostate Cancer—Letter,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-05-01,10.1158/1055-9965.epi-14-0691,,,,25934833,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3959727,https://api.altmetric.com/v1/donut/3959727_240.png 1,The Heritability of Prostate Cancer—Response,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-05-01,10.1158/1055-9965.epi-15-0194,,,,25934834,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3959720,https://api.altmetric.com/v1/donut/3959720_240.png 1,"Cytoplasmic accumulation of Sequestosome 1 (p62) is a predictor of biochemical recurrence, rapid tumor cell proliferation and genomic instability in prostate cancer.",Clinical Cancer Research,,,Article,2015-05-01,10.1158/1078-0432.ccr-14-0620,,,,25925890,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3957044,https://api.altmetric.com/v1/donut/3957044_240.png 1,A randomized phase II trial of sipuleucel-T with concurrent vs sequential abiraterone acetate plus prednisone in metastatic castration resistant prostate cancer.,Clinical Cancer Research,,,Article,2015-05-01,10.1158/1078-0432.ccr-15-0079,,,,25925891,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3957039,https://api.altmetric.com/v1/donut/3957039_240.png 1,MALDI mass spectrometry in prostate cancer biomarker discovery ,BBA - Proteins & Proteomics,,,Article,2013-07-01,10.1016/j.bbapap.2013.06.015,,,,23831156,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/3952392,https://api.altmetric.com/v1/donut/3952392_240.png 1,Prognosis of Prostate Cancer With Other Primary Malignancies,Korean Journal of Urology,,,Article,2014-05-01,10.4111/kju.2014.55.5.327,,,,24868337,PMC4026659,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3951703,https://api.altmetric.com/v1/donut/3951703_240.png 1,Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells.,Journal of Biological Chemistry,,,Article,2010-08-19,10.1074/jbc.m109.063255,,,,20571029,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3946410,https://api.altmetric.com/v1/donut/3946410_240.png 1,PBK/TOPK enhances aggressive phenotype in prostate cancer via ?-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3709,,,,25909225,PMC4558173,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3943941,https://api.altmetric.com/v1/donut/3943941_240.png 1,Incidental Meningioma Detected on 18F-Fluoride With PET/CT During Initial Staging for Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-04-24,10.1097/rlu.0000000000000802,,,,25899597,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3937688,https://api.altmetric.com/v1/donut/3937688_240.png 1,Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience.,The Prostate,,,Article,2014-10-12,10.1002/pros.22904,,,,25307625,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3936352,https://api.altmetric.com/v1/donut/3936352_240.png 1,Prostate cancer: New IL-11R[alpha] drug is on target,Nature Reviews Urology,,,Article,2015-04-21,10.1038/nrurol.2015.88,,,,25896177,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3935963,https://api.altmetric.com/v1/donut/3935963_240.png 1,Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key?,Expert Review of Anticancer Therapy,,,Article,2014-12-30,10.1586/14737140.2015.999044,,,,25547524,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3935626,https://api.altmetric.com/v1/donut/3935626_240.png 1,KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1? accumulation,Molecular Cancer,,,Article,2015-04-22,10.1186/s12943-015-0365-6,,,,25896712,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3925434,https://api.altmetric.com/v1/donut/3925434_240.png 1,Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer,Radiation Oncology,,,Article,2015-04-24,10.1186/s13014-015-0400-1,,,,25903934,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3925159,https://api.altmetric.com/v1/donut/3925159_240.png 1,Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.,,,,Article,2007-03-15,10.1093/carcin/bgl189,,,,17065200,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3921822,https://api.altmetric.com/v1/donut/3921822_240.png 1,Regulation of vascular endothelial growth factor in prostate cancer,Endocrine-Related Cancer,,,Article,2015-06-01,10.1530/erc-15-0123,,,,25870249,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3921360,https://api.altmetric.com/v1/donut/3921360_240.png 1,Comprehensive gene expression analysis reveals multiple signal pathways associated with prostate cancer.,,,,Article,2013-10-23,10.1007/s13353-013-0174-9,,,,24154878,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3920249,https://api.altmetric.com/v1/donut/3920249_240.png 1,Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer,Quality of Life Research,,,Article,2015-04-16,10.1007/s11136-015-0993-8,,,,25877953,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3912472,https://api.altmetric.com/v1/donut/3912472_240.png 1,Divergent androgen regulation of unfolded protein response pathways drives prostate cancer.,EMBO Molecular Medicine,,,Article,2015-04-13,10.15252/emmm.201404509,,,,25864123,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3903149,https://api.altmetric.com/v1/donut/3903149_240.png 1,"Although the evidence is not clear, decreases in prostate cancer mortality in specific subgroups of men may be due to screening.",Evidence Based Medicine,,,Article,2015-03-13,10.1136/ebmed-2015-110166,,,,25770150,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3895036,https://api.altmetric.com/v1/donut/3895036_240.png 1,Disodium pentaborate decahydrate (DPD) induced apoptosis by decreasing hTERT enzyme activity and disrupting F-actin organization of prostate cancer cells,Tumor Biology,,,Article,2013-10-14,10.1007/s13277-013-1212-2,,,,24122279,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3892924,https://api.altmetric.com/v1/donut/3892924_240.png 1,Contrast Enhanced Ultrasound Parametric Imaging for the detection of Prostate Cancer.,British Journal of Urology,,,Article,2015-03-06,10.1111/bju.13116,,,,25754526,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/3892381,https://api.altmetric.com/v1/donut/3892381_240.png 1,In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors,Clinical Cancer Research,,,Article,2005-04-14,10.1158/1078-0432.ccr-04-1586,,,,15837762,,,,,,,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3887904,https://api.altmetric.com/v1/donut/3887904_240.png 1,Polycomb-mediated silencing in neuroendocrine prostate cancer.,Clinical Epigenetics,,,Article,2015-04-11,10.1186/s13148-015-0074-4,,,,25859291,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3883739,https://api.altmetric.com/v1/donut/3883739_240.png 1,GPs could play key role in prostate cancer survivorship programmes.,Practitioner,,,Article,2014-11-15,,,,,25597200,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3881047,https://api.altmetric.com/v1/donut/3881047_240.png 1,Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.,,,,Article,2013-09-26,10.1007/s00259-013-2525-5,,,,24072344,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,112,https://www.altmetric.com/details/3879866,https://api.altmetric.com/v1/donut/3879866_240.png 1,The Relevance of the Procedures Related to the Physiotherapy in the Interventions in Patients with Prostate Cancer: Short Review with Practice Approach,International Journal of Biomedical Science,,,Article,2014-06-01,,,,,25018676,PMC4092084,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3878029,https://api.altmetric.com/v1/donut/3878029_240.png 1,Prostate cancer prevalence in New South Wales Australia: A population-based study.,Cancer Epidemiology,,,Article,2014-12-16,10.1016/j.canep.2014.11.009,,,,25530551,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3861889,https://api.altmetric.com/v1/donut/3861889_240.png 1,Imaging Active Urokinase Plasminogen Activator in Prostate Cancer.,Cancer Research,,,Article,2015-02-11,10.1158/0008-5472.can-14-2185,,,,25672980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3858307,https://api.altmetric.com/v1/donut/3858307_240.png 1,Ad5/48 Hexon Oncolytic Virus Expressing sTGFßRIIFc Produces Reduced Hepatic and Systemic Toxicities and Inhibits Prostate Cancer Bone Metastases.,Molecular Therapy,,,Article,2014-05-04,10.1038/mt.2014.80,,,,24791939,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3855393,https://api.altmetric.com/v1/donut/3855393_240.png 1,"Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: do we have the evidence from intervention studies?",Current Opinion in Clinical Nutrition and Metabolic Care,,,Article,2006-10-21,10.1097/01.mco.0000247470.64532.34,,,,17053426,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3850069,https://api.altmetric.com/v1/donut/3850069_240.png 1,Use of Acupuncture Among Patients with Prostate Cancer Covered by National Health Insurance in Taiwan: A Retrospective Population-Based Study,Medical Acupuncture,,,Article,2011-06-01,10.1089/acu.2011.0792,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3847574,https://api.altmetric.com/v1/donut/3847574_240.png 1,"Fruit, vegetable, vitamin A intakes, and prostate cancer risk.",Prostate Cancer & Prostatic Diseases,,,Article,2007-05-24,10.1038/sj.pcan.4500979,,,,17519926,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3847554,https://api.altmetric.com/v1/donut/3847554_240.png 1,Sequences and combinations of multifaceted therapy in advanced prostate cancer,Current opinion in oncology,,,Article,2015-03-25,10.1097/cco.0000000000000187,,,,25811344,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3847213,https://api.altmetric.com/v1/donut/3847213_240.png 1,Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT.,Current Radiopharmaceuticals,,,Article,2015-03-16,,,,,25808958,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3842603,https://api.altmetric.com/v1/donut/3842603_240.png 1,Sexual Dysfunction and the Preservation of Manhood: Experiences of Men with Prostate Cancer,Journal of Health Psychology,,,Article,2016-08-09,10.1177/1359105302007003223,,,,22114252,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3836708,https://api.altmetric.com/v1/donut/3836708_240.png 1,Loss of Androgen Regulated miR-1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.,Molecular & Cellular Biology,,,Article,2015-03-23,10.1128/mcb.00008-15,,,,25802280,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3835173,https://api.altmetric.com/v1/donut/3835173_240.png 1,Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP?1: New player in tumor progression,International Journal of Cancer,,,Article,2015-04-06,10.1002/ijc.29531,,,,25808111,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3834785,https://api.altmetric.com/v1/donut/3834785_240.png 1,Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer,Journal of Clinical Oncology,,,Article,,,,,,11054432,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3833176,https://api.altmetric.com/v1/donut/3833176_240.png 1,"The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells",Endocrine-Related Cancer,,,Article,,10.1530/erc-11-0045,,,,21551258,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3822754,https://api.altmetric.com/v1/donut/3822754_240.png 1,"PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer",Endocrine-Related Cancer,,,Article,,10.1530/erc-12-0240,,,,23507703,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3817223,https://api.altmetric.com/v1/donut/3817223_240.png 1,Volumetric Modulated Arc Therapy Planning for Primary Prostate Cancer With Selective Intraprostatic Boost Determined by (18)F-Choline PET/CT.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-04,10.1016/j.ijrobp.2014.12.052,,,,25832692,,,,,,,0,0,0,5,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3817094,https://api.altmetric.com/v1/donut/3817094_240.png 1,An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy,Physics in Medicine & Biology,,,Article,2015-04-07,10.1088/0031-9155/60/7/2837,,,,25775937,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3816772,https://api.altmetric.com/v1/donut/3816772_240.png 1,Is there a favorable subset of patients with prostate cancer who develop oligometastases?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-01-01,,,,,14697414,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3815542,https://api.altmetric.com/v1/donut/3815542_240.png 1,Paradoxical and contradictory effects of imatinib in two cell line models of hormone?refractory prostate cancer,The Prostate,,,Article,2015-03-18,10.1002/pros.22976,,,,25786656,,,,,,,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3808961,https://api.altmetric.com/v1/donut/3808961_240.png 1,Prostate cancer risk-associated genetic markers and their potential clinical utility,Asian Journal of Andrology,,,Article,,10.1038/aja.2013.42,,,,23564047,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3798193,https://api.altmetric.com/v1/donut/3798193_240.png 1,Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic variation,The Prostate,,,Article,2010-12-01,10.1002/pros.21208,,,,20564319,PMC3013361,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3798192,https://api.altmetric.com/v1/donut/3798192_240.png 1,Genetic Score Is an Objective and Better Measurement of Inherited Risk of Prostate Cancer than Family History,European Urology,,,Article,2013-03-01,10.1016/j.eururo.2012.11.047,,,,23245817,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3798191,https://api.altmetric.com/v1/donut/3798191_240.png 1,Re: Identification and Characterization of Membrane Androgen Receptors in the ZIP9 Zinc Transporter Subfamily: II. Role of Human ZIP9 in Testosterone-Induced Prostate and Breast Cancer Cell Apoptosis,The Journal of Urology,,,Article,2015-05-20,10.1016/j.juro.2015.03.006,,,,25986843,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3789229,https://api.altmetric.com/v1/donut/3789229_240.png 1,Variant Gives Hints as to Which Drugs Will Work in Prostate Cancer Patients,Oncology times,,,Article,2015-03-25,10.1097/01.cot.0000462860.60219.35,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3786003,https://api.altmetric.com/v1/donut/3786003_240.png 1,Dissociation of event?based prospective memory and time?based prospective memory in patients with prostate cancer receiving androgen?deprivation therapy: a neuropsychological study,European Journal of Cancer Care,,,Article,2015-02-24,10.1111/ecc.12299,,,,25711542,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3782450,https://api.altmetric.com/v1/donut/3782450_240.png 1,Changes in susceptibility to oncolytic vesicular stomatitis virus during progression of prostate cancer.,Journal of Virology,,,Article,2015-03-07,10.1128/jvi.00257-15,,,,25741004,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3781989,https://api.altmetric.com/v1/donut/3781989_240.png 1,Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer. Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/3508/docetaxel-with-androgen-deprivation-therapy-combo-in-hormone-na--ve-metastatic-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3774630,https://api.altmetric.com/v1/donut/3774630_240.png 1,Tocopherol Transfer Protein Sensitizes Prostate Cancer Cells to Vitamin E,Journal of Biological Chemistry,,,Article,2010-11-12,10.1074/jbc.m110.169664,,,,20826775,PMC2975182,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3767938,https://api.altmetric.com/v1/donut/3767938_240.png 1,Insulin-Like Growth Factor I Suppresses Bone Morphogenetic Protein Signaling in Prostate Cancer Cells by Activating mTOR Signaling,Cancer Research,,,Article,2010-11-15,10.1158/0008-5472.can-10-1119,,,,21062988,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3767933,https://api.altmetric.com/v1/donut/3767933_240.png 1,Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results.,Urologic Oncology,,,Article,2015-02-12,10.1016/j.urolonc.2015.01.004,,,,25665509,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3767236,https://api.altmetric.com/v1/donut/3767236_240.png 1,Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-06-05,10.1158/1055-9965.epi-06-1062,,,,17548673,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3766124,https://api.altmetric.com/v1/donut/3766124_240.png 1,The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer,Radiation Oncology,,,Article,2015-03-07,10.1186/s13014-015-0366-z,,,,25884489,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3764708,https://api.altmetric.com/v1/donut/3764708_240.png 1,Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells.,Tumor Biology,,,Article,2015-03-07,10.1007/s13277-015-3278-5,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3764164,https://api.altmetric.com/v1/donut/3764164_240.png 1,Endoplasmic reticulum Ca(2+) content decrease by PKA-dependent hyperphosphorylation of type 1 IP3 receptor contributes to prostate cancer cell resistance to androgen deprivation.,Cell Calcium,,,Article,2015-02-18,10.1016/j.ceca.2015.02.004,,,,25740420,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3763204,https://api.altmetric.com/v1/donut/3763204_240.png 1,Clinical benefits of non-taxane chemotherapies in unselected symptomatic metastatic castration-resistant prostate cancer patients after docetaxel: the Getug P02 study.,British Journal of Urology,,,Article,2013-11-06,10.1111/bju.12552,,,,24180479,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3762678,https://api.altmetric.com/v1/donut/3762678_240.png 1,¹?F-NaF PRT/CT and ¹¹C-choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.,Oncology (08909091),,,Article,2014-12-01,,,,,25738199,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3757312,https://api.altmetric.com/v1/donut/3757312_240.png 1,Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Disease.,Urology,,,Article,2015-03-01,10.1016/j.urology.2014.11.024,,,,25733274,PMC4348556,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3754801,https://api.altmetric.com/v1/donut/3754801_240.png 1,A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel.,The Prostate,,,Article,2015-02-12,10.1002/pros.22969,,,,25663102,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3752997,https://api.altmetric.com/v1/donut/3752997_240.png 1,MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men.,Biomed Res Int,,,Article,2015-02-20,10.1155/2015/571708,,,,25692142,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3752995,https://api.altmetric.com/v1/donut/3752995_240.png 1,Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer.,Urologic Oncology,,,Article,2014-09-06,10.1016/j.urolonc.2014.07.014,,,,25189687,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3752994,https://api.altmetric.com/v1/donut/3752994_240.png 1,"Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.",International Journal of Urology,,,Article,2015-02-24,10.1111/iju.12704,,,,25728968,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3749733,https://api.altmetric.com/v1/donut/3749733_240.png 1,TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer.,World Journal of Urology,,,Article,2015-02-27,10.1007/s00345-015-1505-8,,,,25712310,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3749389,https://api.altmetric.com/v1/donut/3749389_240.png 1,Update on prostate cancer in black men within the UK,Ecancermedicalscience,,,Article,2015-03-02,10.3332/ecancer.2014.455,,,,25228911,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3747207,https://api.altmetric.com/v1/donut/3747207_240.png 1,Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer,Clinical Cancer Research,,,Article,2015-03-02,10.1158/1078-0432.ccr-14-2603,,,,25733599,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3746086,https://api.altmetric.com/v1/donut/3746086_240.png 1,Therapeutic Strategies for Localized and Locally Advanced Prostate Cancer: Combining Androgen Suppression with Definitive Local Therapy,Reviews in Urology,,,Article,2015-03-02,,,,,16985976,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3744297,https://api.altmetric.com/v1/donut/3744297_240.png 1,ASCO GU: Men who have had testicular cancer are more likely to develop prostate cancer. Genitourinary Cancers Symposium,ecancer.org,,,Article,,,,,http://ecancer.org/conference/633-genitourinary-cancers-symposium/news/7012-asco-gu--men-who-have-had-testicular-cancer-are-more-likely-to-develop-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3742101,https://api.altmetric.com/v1/donut/3742101_240.png 1,Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer. Genitourinary Cancers Symposium,ecancer.org,,,Article,,,,,http://ecancer.org/conference/633-genitourinary-cancers-symposium/video/3508/docetaxel-with-androgen-deprivation-therapy-combo-in-hormone-na--ve-metastatic-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3742084,https://api.altmetric.com/v1/donut/3742084_240.png 1,An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells,Journal of Cell Science,,,Article,,10.1242/jcs.030742,,,,18628304,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3740863,https://api.altmetric.com/v1/donut/3740863_240.png 1,Ipilimumab in the treatment of prostate cancer.,Future Oncology,,,Article,2015-01-14,10.2217/fon.14.196,,,,25572782,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3720040,https://api.altmetric.com/v1/donut/3720040_240.png 1,Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience,Radiation Oncology,,,Article,2015-02-22,10.1186/s13014-015-0338-3,,,,25880635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3719050,https://api.altmetric.com/v1/donut/3719050_240.png 1,Dosimetric effects of the acuros XB and anisotropic analytical algorithm on volumetric modulated arc therapy planning for prostate cancer using an endorectal balloon,Radiation Oncology,,,Article,2015-02-22,10.1186/s13014-015-0346-3,,,,25890071,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3718802,https://api.altmetric.com/v1/donut/3718802_240.png 1,Anti-tumor Effect of Novel Cationic Biomaterials in Prostate Cancer,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2014-08-14,,,,,25075020,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3710565,https://api.altmetric.com/v1/donut/3710565_240.png 1,Management of metastatic hormone-sensitive prostate cancer.,Current Urology Reports,,,Article,2015-02-15,10.1007/s11934-015-0488-8,,,,25677237,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3707991,https://api.altmetric.com/v1/donut/3707991_240.png 1,Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3?T: Comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation,Magnetic Resonance Imaging (0730725X),,,Article,2015-02-12,10.1016/j.mri.2015.02.008,,,,25683515,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3706379,https://api.altmetric.com/v1/donut/3706379_240.png 1,A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.,Journal of Clinical Epidemiology,,,Article,2015-01-14,10.1016/j.jclinepi.2015.01.006,,,,25684153,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3706317,https://api.altmetric.com/v1/donut/3706317_240.png 1,IL?17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44?VCAM?1 interaction,The Prostate,,,Article,2015-02-14,10.1002/pros.22971,,,,25683512,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3690720,https://api.altmetric.com/v1/donut/3690720_240.png 1,Quantification of 18F-Fluorocholine Kinetics in Patients with Prostate Cancer,Journal of Nuclear Medicine,,,Article,2015-02-12,10.2967/jnumed.114.148007,,,,25678491,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3682883,https://api.altmetric.com/v1/donut/3682883_240.png 1,Cross-presentation of the oncofoetal tumor antigen 5T4 from irradiated prostate cancer cells - a key role for heat shock protein 70 and receptor CD91.,Cancer immunology research,,,Article,2015-02-12,10.1158/2326-6066.cir-14-0079,,,,25678582,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3643262,https://api.altmetric.com/v1/donut/3643262_240.png 1,Managing cancer-related fatigue in men with prostate cancer: A systematic review of non-pharmacological interventions.,International Journal of Nursing Practice,,,Article,2013-11-20,10.1111/ijn.12211,,,,24237792,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3610894,https://api.altmetric.com/v1/donut/3610894_240.png 1,"Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells",Carcinogenesis,,,Article,2008-03-25,10.1093/carcin/bgn078,,,,18359761,PMC2902387,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3602187,https://api.altmetric.com/v1/donut/3602187_240.png 1,O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells.,Molecular Medicine Reports,,,Article,2014-05-29,10.3892/mmr.2014.2269,,,,24865644,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3590721,https://api.altmetric.com/v1/donut/3590721_240.png 1,"A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1? and VEGF expression, and migration in human prostate cancer cells.",International Journal of Oncology,,,Article,2013-10-09,10.3892/ijo.2013.2116,,,,24100602,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3534482,https://api.altmetric.com/v1/donut/3534482_240.png 1,Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16INK4a/pRB pathway,Carcinogenesis,,,Article,2015-06-12,10.1093/carcin/23.5.721,,,,12016143,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/3523589,https://api.altmetric.com/v1/donut/3523589_240.png 1,Anxiety in the management of localised prostate cancer by active surveillance.,British Journal of Urology,,,Article,2014-07-30,10.1111/bju.12765,,,,25070423,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/3457692,https://api.altmetric.com/v1/donut/3457692_240.png 1,Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.,Endocrine-Related Cancer,,,Article,2014-10-05,10.1530/erc-14-0402,,,,25287069,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3441784,https://api.altmetric.com/v1/donut/3441784_240.png 1,Entacapone and Prostate Cancer Risk in Patients With Parkinson's Disease,Movement Disorders,,,Article,2015-01-16,10.1002/mds.26140,,,,25639262,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3436154,https://api.altmetric.com/v1/donut/3436154_240.png 1,WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase.,Cell Cycle,,,Article,2015-02-01,10.4161/15384101.2014.977103,,,,25659037,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3433891,https://api.altmetric.com/v1/donut/3433891_240.png 1,In Silico Functional Pathway Annotation of 86 Established Prostate Cancer Risk Variants.,PLoS ONE,,,Article,,10.1371/journal.pone.0117873,,,,25658610,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3433548,https://api.altmetric.com/v1/donut/3433548_240.png 1,Prostate cancer is characterized by epigenetic silencing of 14-3-3|[sigma]| expression,Oncogene,,,Article,2004-10-18,10.1038/sj.onc.1208004,,,,15489902,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3351954,https://api.altmetric.com/v1/donut/3351954_240.png 1,Functional epigenomics identifies genes frequently silenced in prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-04-4407,,,,15899813,,,,,,,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/3313115,https://api.altmetric.com/v1/donut/3313115_240.png 1,Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.,International Journal of Molecular Medicine,,,Article,2015-01-30,10.3892/ijmm.2015.2086,,,,25647485,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3312853,https://api.altmetric.com/v1/donut/3312853_240.png 1,Graph algorithms for machine learning: a case-control study based on prostate cancer populations and high throughput transcriptomic data,BMC Bioinformatics,,,Article,2010-07-23,10.1186/1471-2105-11-s4-p21,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3305205,https://api.altmetric.com/v1/donut/3305205_240.png 1,Ginkgetin inhibits the growth of DU?145 prostate cancer cells through inhibition of STAT3 activity,Cancer Science,,,Article,2015-02-20,10.1111/cas.12608,,,,25611086,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3121680,https://api.altmetric.com/v1/donut/3121680_240.png 1,(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer.,American journal of nuclear medicine and molecular imaging,,,Article,2015-01-01,,,,,25625029,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3111576,https://api.altmetric.com/v1/donut/3111576_240.png 1,Consultation audio-recording reduces long-term decision regret after prostate cancer treatment: A non-randomised comparative cohort study.,Surgeon (Edinburgh University Press),,,Article,2015-01-27,10.1016/j.surge.2014.10.006,,,,25636362,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3110098,https://api.altmetric.com/v1/donut/3110098_240.png 1,AMP-activated protein kinase (AMPK) as a potential therapeutic target independent of PI3K/Akt signaling in prostate cancer.,Oncoscience,,,Article,2015-01-18,10.18632/oncoscience.49,,,,25594043,PMC4284621,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3097593,https://api.altmetric.com/v1/donut/3097593_240.png 1,The association between partner support and psychological distress among prostate cancer survivors in a nationwide study,Journal of Cancer Survivorship,,,Article,2015-01-21,10.1007/s11764-015-0425-3,,,,25603949,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3092183,https://api.altmetric.com/v1/donut/3092183_240.png 1,Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?,Radiotherapy & Oncology,,,Article,,10.1016/j.radonc.2015.01.005,,,,25616537,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3090321,https://api.altmetric.com/v1/donut/3090321_240.png 1,"Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database.",Clinical Genitourinary Cancer,,,Article,2015-01-13,10.1016/j.clgc.2014.07.003,,,,25571871,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3073533,https://api.altmetric.com/v1/donut/3073533_240.png 1,Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate,Nature Genetics,,,Article,2009-04-26,10.1038/ng.370,,,,19396168,,,,,,,0,0,0,0,9,0,0,0,0,0,0,0,0,0,0,138,https://www.altmetric.com/details/3072590,https://api.altmetric.com/v1/donut/3072590_240.png 1,"Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy",Physics in Medicine & Biology,,,Article,2015-02-07,10.1088/0031-9155/60/3/1237,,,,25590229,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3068857,https://api.altmetric.com/v1/donut/3068857_240.png 1,Novel Biomarkers and Advanced Imaging Modalities in the Early Detection of Prostate Cancer.,The Journal of Urology,,,Article,2015-01-14,10.1016/j.juro.2015.01.040,,,,25596362,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3065969,https://api.altmetric.com/v1/donut/3065969_240.png 1,T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression.,Cancer Immunol Res,,,Article,2014-11-03,10.1158/2326-6066.cir-14-0192,,,,25358763,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/3063247,https://api.altmetric.com/v1/donut/3063247_240.png 1,A rare presentation of metastasis of prostate adenocarcinoma to the stomach and rectum.,Journal of Gastric Cancer,,,Article,2014-12-01,10.5230/jgc.2014.14.4.271,,,,25580360,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3062393,https://api.altmetric.com/v1/donut/3062393_240.png 1,Skp2 Overexpression Is Associated with Loss of BRCA2 Protein in Human Prostate Cancer,American Journal of Pathology,,,Article,,10.1016/j.ajpath.2011.01.050,,,,21514447,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3057482,https://api.altmetric.com/v1/donut/3057482_240.png 1,Loss of BRCA2 promotes prostate cancer cell invasion through up?regulation of matrix metalloproteinase?9,Cancer Science,,,Article,2007-12-27,10.1111/j.1349-7006.2007.00719.x,,,,18167127,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3057481,https://api.altmetric.com/v1/donut/3057481_240.png 1,????????????????Cx43???????????????????The Effects of Various Chemical Factors on Prostate Tumor Cells of Cx43 and the Significance of the Cancer Treatment,World Journal of Cancer Research,,,Article,2015-01-05,10.12677/wjcr.2015.51002,,,,,,,,,,,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3056887,https://api.altmetric.com/v1/donut/3056887_240.png 1,Continued undertreatment of older men with localized prostate cancer.,Urology,,,Article,2003-11-20,,,,,14624909,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3056189,https://api.altmetric.com/v1/donut/3056189_240.png 1,"Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.",Investigational New Drugs,,,Article,2015-01-07,10.1007/s10637-014-0199-x,,,,25556680,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3055719,https://api.altmetric.com/v1/donut/3055719_240.png 1,"Transurethral electrovaporization of the prostate (TUVP) is effective, safe and durable",Prostate Cancer & Prostatic Diseases,,,Article,2003-06-01,10.1038/sj.pcan.4500654,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3044828,https://api.altmetric.com/v1/donut/3044828_240.png 1,Inhibition of Stat5a/b enhances proteasomal degradation of androgen receptor liganded by antiandrogens in prostate cancer,Molecular Cancer Therapeutics,,,Article,2014-12-31,10.1158/1535-7163.mct-14-0819,,,,25552366,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3039623,https://api.altmetric.com/v1/donut/3039623_240.png 1,The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,8687134,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3037199,https://api.altmetric.com/v1/donut/3037199_240.png 1,A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer.,Reviews in Urology,,,Article,2015-01-01,,,,,25548544,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3034539,https://api.altmetric.com/v1/donut/3034539_240.png 1,"Genetic polymorphisms in CYP17 , CYP3A4 , CYP19A1 , SRD5A2 , IGF-1 , and IGFBP-3 and prostate cancer risk in African-American men: The Flint Men's Health Study",The Prostate,,,Article,2008-02-15,10.1002/pros.20696,,,,18163429,PMC2712831,2027.42/57913,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,13,https://www.altmetric.com/details/3031886,https://api.altmetric.com/v1/donut/3031886_240.png 1,A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients.,Biomarker Research,,,Article,2014-01-01,10.1186/s40364-014-0025-9,,,,25548652,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3027387,https://api.altmetric.com/v1/donut/3027387_240.png 1,Managing bone metastases and reducing skeletal related events in prostate cancer,Nature Reviews Clinical Oncology,,,Article,2014-05-13,10.1038/nrclinonc.2014.70,,,,24821212,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3018838,https://api.altmetric.com/v1/donut/3018838_240.png 1,HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network.,EMBO Molecular Medicine,,,Article,2014-04-17,10.1002/emmm.201303581,,,,24737870,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3009694,https://api.altmetric.com/v1/donut/3009694_240.png 1,Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells.,Cancer Research,,,Article,2008-02-20,10.1158/0008-5472.can-07-2978,,,,18281494,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3006704,https://api.altmetric.com/v1/donut/3006704_240.png 1,mda?7/IL?24 differentially regulates soluble and nuclear clusterin in prostate cancer,Journal of Cellular Physiology,,,Article,2012-01-23,10.1002/jcp.22904,,,,21732348,,,,,,,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3004223,https://api.altmetric.com/v1/donut/3004223_240.png 1,Eradication of Therapy-Resistant Human Prostate Tumors Using a Cancer Terminator Virus,Cancer Research,,,Article,,10.1158/0008-5472.can-07-0195,,,,17545625,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3004219,https://api.altmetric.com/v1/donut/3004219_240.png 1,"Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy",Radiation Oncology,,,Article,2014-12-20,10.1186/s13014-014-0288-1,,,,25526901,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3003778,https://api.altmetric.com/v1/donut/3003778_240.png 1,Non?steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review,British Journal of Urology,,,Article,2015-03-23,10.1111/bju.13026,,,,25523493,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/3003579,https://api.altmetric.com/v1/donut/3003579_240.png 1,Re: Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy with or without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.12.076,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2997557,https://api.altmetric.com/v1/donut/2997557_240.png 1,"Re: Ipilimumab versus Placebo after Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer that had Progressed after Docetaxel Chemotherapy (CA184-043): A Multicentre, Randomised, Double-Blind, Phase 3 Trial",The Journal of Urology,,,Article,,10.1016/j.juro.2014.12.078,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2997533,https://api.altmetric.com/v1/donut/2997533_240.png 1,Breast and Prostate Cancer Patient Perspectives and Perceptions of Interprofessional Collaboration during Cancer Treatment: A Pilot Study,Journal of Medical Imaging & Radiation Sciences,,,Article,,10.1016/j.jmir.2014.09.004,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2996324,https://api.altmetric.com/v1/donut/2996324_240.png 1,CYP1B1 Polymorphisms and Susceptibility to Prostate Cancer: A Meta-Analysis,PLoS ONE,,,Article,,10.1371/journal.pone.0068634,,,,23861929,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2995572,https://api.altmetric.com/v1/donut/2995572_240.png 1,Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy.,European Urology,,,Article,2013-11-01,10.1016/j.eururo.2013.05.059,,,,23787357,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,112,https://www.altmetric.com/details/2992806,https://api.altmetric.com/v1/donut/2992806_240.png 1,Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence.,Prostate Cancer,,,Article,,10.1155/2014/763863,,,,25580298,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2988957,https://api.altmetric.com/v1/donut/2988957_240.png 1,Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer,British Journal of Cancer,,,Article,2007-09-11,10.1038/sj.bjc.6603962,,,,17848955,PMC2360404,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/2987875,https://api.altmetric.com/v1/donut/2987875_240.png 1,A Prostate-Specific Antigen–Activated Channel-Forming Toxin as Therapy for Prostatic Disease,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djk065,,,,17341729,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2984189,https://api.altmetric.com/v1/donut/2984189_240.png 1,Parotid gland metastasis from prostate cancer: is docetaxel still the best treatment option?,Anti-Cancer Drugs,,,Article,2014-12-06,10.1097/cad.0000000000000188,,,,25486600,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2979815,https://api.altmetric.com/v1/donut/2979815_240.png 1,Proctitis following stereotactic body radiation therapy for prostate cancer,Radiation Oncology,,,Article,2014-12-12,10.1186/s13014-014-0277-4,,,,25497602,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2979657,https://api.altmetric.com/v1/donut/2979657_240.png 1,A yardstick to measure the malignancy of prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6772-a-yardstick-to-measure-the-malignancy-of-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2978222,https://api.altmetric.com/v1/donut/2978222_240.png 1,Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects,Medical care,,,Article,2015-01-01,10.1097/mlr.0000000000000260,,,,25397964,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2977534,https://api.altmetric.com/v1/donut/2977534_240.png 1,Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy,Urologic Oncology,,,Article,,10.1016/j.urolonc.2014.10.010,,,,25456996,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2974849,https://api.altmetric.com/v1/donut/2974849_240.png 1,Both genes and lncRNAs can be used as biomarkers of prostate cancer by using high throughput sequencing data.,European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360,,,Article,2014-11-01,,,,,25491628,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2974106,https://api.altmetric.com/v1/donut/2974106_240.png 1,INITIAL ASSESSMENT OF SAFETY AND CLINICAL FEASIBILITY OF IRREVERSIBLE ELECTROPORATION IN THE FOCAL TREATMENT OF PROSTATE CANCER,Prostate Cancer & Prostatic Diseases,,,Article,2014-09-02,10.1038/pcan.2014.33,,,,25179590,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2968502,https://api.altmetric.com/v1/donut/2968502_240.png 1,A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer and their female partners.,Psycho-Oncology,,,Article,2014-12-08,10.1002/pon.3726,,,,25483780,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2966253,https://api.altmetric.com/v1/donut/2966253_240.png 1,Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.,International Journal of Cancer,,,Article,2014-12-04,10.1002/ijc.29378,,,,25471734,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2961154,https://api.altmetric.com/v1/donut/2961154_240.png 1,Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation,BMC Cancer,,,Article,2014-12-07,10.1186/1471-2407-14-921,,,,25481381,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2959669,https://api.altmetric.com/v1/donut/2959669_240.png 1,Diagnostic associations of gene expression signatures in prostate cancer tissue.,Current Opinion in Urology,,,Article,2015-01-01,10.1097/mou.0000000000000131,,,,25405934,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2954784,https://api.altmetric.com/v1/donut/2954784_240.png 1,Resistance to androgen-pathway drugs in prostate cancer.,New England Journal of Medicine,,,Article,2014-12-04,10.1056/nejmc1412594,,,,25470700,,,,,,,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2953209,https://api.altmetric.com/v1/donut/2953209_240.png 1,Resistance to Androgen-Pathway Drugs in Prostate Cancer.,New England Journal of Medicine,,,Article,2014-12-04,10.1056/nejmc1412594#sa2,,,,25470702,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2951484,https://api.altmetric.com/v1/donut/2951484_240.png 1,Minor Valepotriates from Valeriana jatamansi and Their Cytotoxicity against Metastatic Prostate Cancer Cells.,Planta Medica,,,Article,2014-12-03,10.1055/s-0034-1383369,,,,25469856,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2949764,https://api.altmetric.com/v1/donut/2949764_240.png 1,Prostate Cancer Antigen 3 Gene Expression in Peripheral Blood and Urine Sediments from Prostate Cancer and Benign Prostatic Hyperplasia Patients versus Healthy Individuals.,Urology Journal,,,Article,2014-01-01,,,,,25433473,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2941251,https://api.altmetric.com/v1/donut/2941251_240.png 1,"Prostate cancer collaborative stage data items—their definitions, quality, usage, and clinical implications: A review of SEER data for 2004?2010",Cancer (0008543X),,,Article,2014-11-20,10.1002/cncr.29052,,,,25412388,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2940554,https://api.altmetric.com/v1/donut/2940554_240.png 1,RRR-?-Vitamin E Succinate Potentiates the Antitumor Effect of Calcitriol in Prostate Cancer without Overt Side Effects,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-08-0910,,,,19118046,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2940339,https://api.altmetric.com/v1/donut/2940339_240.png 1,MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2009-03-25,10.1016/j.bbrc.2009.03.077,,,,19302977,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/2938820,https://api.altmetric.com/v1/donut/2938820_240.png 1,Association of Symptoms and Cytokines in Prostate Cancer Patients Receiving Radiation Treatment,Biological Research for Nursing,,,Article,2016-03-04,10.1177/1099800413490228,,,,23723296,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2933430,https://api.altmetric.com/v1/donut/2933430_240.png 1,Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer,Journal of Translational Medicine,,,Article,2014-11-26,10.1186/s12967-014-0313-z,,,,25424879,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2928952,https://api.altmetric.com/v1/donut/2928952_240.png 1,177Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2014-07-29,10.1007/s00259-014-2862-z,,,,25070686,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2925641,https://api.altmetric.com/v1/donut/2925641_240.png 1,A Phase 2 Trial of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer and without Prior Chemotherapy (JPN-201 Study),Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/hyu149,,,,25320340,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2923562,https://api.altmetric.com/v1/donut/2923562_240.png 1,"Isoliquiritigenin, a natural anti?oxidant, selectively inhibits the proliferation of prostate cancer cells",Clinical & Experimental Pharmacology & Physiology,,,Article,2010-04-26,10.1111/j.1440-1681.2010.05395.x,,,,20456427,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2922587,https://api.altmetric.com/v1/donut/2922587_240.png 1,Decreasing the Dose to the Rectal Wall by Using a Rectal Retractor during Radiotherapy of Prostate Cancer: A Comparative Treatment Planning Study,Journal of Radiotherapy,,,Article,,10.1155/2014/680205,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2915230,https://api.altmetric.com/v1/donut/2915230_240.png 1,‘Act on Oncology’ as a New Comprehensive Approach to Assess Prostate Cancer Centres – Method Description and Results of a Pilot Study,PLoS ONE,,,Article,2014-09-05,10.1371/journal.pone.0106743,,,,25192213,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2910862,https://api.altmetric.com/v1/donut/2910862_240.png 1,The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications,Current Opinion in Urology,,,Article,2014-11-15,10.1097/mou.0000000000000132,,,,25405932,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2903646,https://api.altmetric.com/v1/donut/2903646_240.png 1,The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol,BMJ Open,,,Article,2014-10-01,10.1136/bmjopen-2014-006382,,,,25354827,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2901720,https://api.altmetric.com/v1/donut/2901720_240.png 1,Comparison between mathematical models of intermittent androgen suppression for prostate cancer ,Journal of Theoretical Biology,,,Article,,10.1016/j.jtbi.2014.10.034,,,,25451517,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2898504,https://api.altmetric.com/v1/donut/2898504_240.png 1,Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy,The Journal of Urology,,,Article,,10.1016/j.juro.2014.11.039,,,,25617274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2890471,https://api.altmetric.com/v1/donut/2890471_240.png 1,Re: Radical Prostatectomy vs Radiotherapy vs Observation among Older Patients with Clinically Localized Prostate Cancer: A Comparative Effectiveness Evaluation.,The Journal of Urology,,,Article,2015-02-15,10.1016/j.juro.2014.11.038,,,,25617275,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2890448,https://api.altmetric.com/v1/donut/2890448_240.png 1,Clinical implications for a treatment algorithm and differential indication to hormone therapy and chemotherapy options in metastatic castrate-resistant prostate cancer: a personal view.,Expert Review of Anticancer Therapy,,,Article,2014-10-31,10.1586/14737140.2014.965686,,,,25353258,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2884920,https://api.altmetric.com/v1/donut/2884920_240.png 1,PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers,Radiation Oncology,,,Article,2014-11-11,10.1186/s13014-014-0229-z,,,,25384898,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2883660,https://api.altmetric.com/v1/donut/2883660_240.png 1,Limited evidence for the use of imaging to detect prostate cancer: A systematic review,European Journal of Radiology,,,Article,2014-01-09,10.1016/j.ejrad.2014.06.028,,,,25059597,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2881911,https://api.altmetric.com/v1/donut/2881911_240.png 1,Men's knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study,BMC Cancer,,,Article,2014-11-05,10.1186/1471-2407-14-812,,,,25374269,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2871155,https://api.altmetric.com/v1/donut/2871155_240.png 1,Epidaurus: aggregation and integration analysis of prostate cancer epigenome.,Nucleic Acids Research,,,Article,2014-11-05,10.1093/nar/gku1079,,,,25378314,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2865568,https://api.altmetric.com/v1/donut/2865568_240.png 1,"Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from “Challenges and Chances in Prostate Cancer Research Meeting 2014”",Radiation Oncology,,,Article,2014-11-04,10.1186/s13014-014-0224-4,,,,25381175,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2865186,https://api.altmetric.com/v1/donut/2865186_240.png 1,Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study,BMC Urology,,,Article,2014-11-05,10.1186/1471-2490-14-86,,,,25374000,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2862135,https://api.altmetric.com/v1/donut/2862135_240.png 1,Cancer de la prostate : mise au point 2014 ,Journal de Radiologie diagnostique et interventionnelle,,,Article,,10.1016/j.jradio.2014.04.006,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2846028,https://api.altmetric.com/v1/donut/2846028_240.png 1,Prediagnostic Circulating Anti-Müllerian Hormone Concentrations Are Not Associated with Prostate Cancer Risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-14-0803,,,,25159294,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2844704,https://api.altmetric.com/v1/donut/2844704_240.png 1,A Peripheral Circulating TH1 Cytokine Profile Is Inversely Associated with Prostate Cancer Risk in CLUE II,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-08-21,10.1158/1055-9965.epi-14-0010,,,,25150281,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2844698,https://api.altmetric.com/v1/donut/2844698_240.png 1,Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients.,International Journal of Cancer,,,Article,2005-07-09,10.1002/ijc.21331,,,,16003728,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2834348,https://api.altmetric.com/v1/donut/2834348_240.png 1,"A Study of the Frequency and Social Determinants of Exposure to Cancer-Related Direct-to-Consumer Advertising Among Breast, Prostate, and Colorectal Cancer Patients",Health Communication,,,Article,2014-10-30,10.1080/10410236.2014.921752,,,,25357119,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2832973,https://api.altmetric.com/v1/donut/2832973_240.png 1,"[Bone metabolism, renal function and immune structure in prostate cancer. Our experience].",Recenti progressi in medicina,,,Article,2013-02-28,10.1701/1226.13592,,,,23439538,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2826594,https://api.altmetric.com/v1/donut/2826594_240.png 1,Image guided focal therapy for prostate cancer.,Diagnostic and Interventional Radiology,,,Article,2014-09-12,10.5152/dir.2014.14134,,,,25205025,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2821874,https://api.altmetric.com/v1/donut/2821874_240.png 1,A Human Prostatic Bacterial Isolate Alters the Prostatic Microenvironment and Accelerates Prostate Cancer Progression,The Journal of Pathology,,,Article,2014-10-28,10.1002/path.4472,,,,25348195,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2817142,https://api.altmetric.com/v1/donut/2817142_240.png 1,"Brain Metastases from Prostate Cancer: An 11?Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis",Journal of Neuroimaging,,,Article,2012-12-28,10.1111/j.1552-6569.2012.00767.x,,,,23279641,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/2816221,https://api.altmetric.com/v1/donut/2816221_240.png 1,"Re: The Added Value of Percentage of Free to Total Prostate-Specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men",The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.074,,,,25523657,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2808654,https://api.altmetric.com/v1/donut/2808654_240.png 1,Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?,International Journal of Molecular Sciences,,,Article,2014-10-12,10.3390/ijms151018333,,,,25314297,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2806562,https://api.altmetric.com/v1/donut/2806562_240.png 1,Epigenetic modifications in prostate cancer.,Epigenomics,,,Article,2014-08-01,10.2217/epi.14.34,,,,25333850,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2802023,https://api.altmetric.com/v1/donut/2802023_240.png 1,"Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.",The Prostate,,,Article,2014-10-18,10.1002/pros.22912,,,,25327819,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2797570,https://api.altmetric.com/v1/donut/2797570_240.png 1,Neuroendocrine Prostate Cancer After Hormonal Therapy: Knowing Is Half the Battle.,Journal of Clinical Oncology,,,Article,2014-09-18,10.1200/jco.2014.57.5100,,,,25225431,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2793926,https://api.altmetric.com/v1/donut/2793926_240.png 1,Role of 11C-Choline Positron Emission Tomography in Prostate Cancer Recurrence—Potential for Delayed Cure or Just Resetting the Clock of the Disease?,The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.057,,,,25444969,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2791583,https://api.altmetric.com/v1/donut/2791583_240.png 1,"Systematic Biopsy, Targeted Biopsy or a Combination—How Should We Detect Prostate Cancer in the Future?",The Journal of Urology,,,Article,,10.1016/j.juro.2014.10.059,,,,25444952,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2791582,https://api.altmetric.com/v1/donut/2791582_240.png 1,Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and Response to Therapy in Mouse Xenograft Models of Prostate Cancer,Clinical Cancer Research,,,Article,2014-10-16,10.1158/1078-0432.ccr-14-1452,,,,25326233,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2790148,https://api.altmetric.com/v1/donut/2790148_240.png 1,Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis.,Endocrine Research,,,Article,2014-08-13,10.3109/07435800.2014.934961,,,,25105463,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2790014,https://api.altmetric.com/v1/donut/2790014_240.png 1,Stereotactic Body Radiation Therapy for Prostate Cancer: The Need to Assess Patient-Reported Outcomes,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.56.2215,,,,25185085,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2787505,https://api.altmetric.com/v1/donut/2787505_240.png 1,AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer.,Cancer Research,,,Article,2014-10-15,10.1158/0008-5472.can-14-1490,,,,25322691,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2784305,https://api.altmetric.com/v1/donut/2784305_240.png 1,Testosterone and prostate cancer: what are the risks for middle-aged men?,Urologic Clinics of North America,,,Article,2011-01-05,10.1016/j.ucl.2011.02.002,,,,21621078,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2777928,https://api.altmetric.com/v1/donut/2777928_240.png 1,BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [(18)F] Fluorocholine PET-CT (Phase I Study).,Molecular Imaging & Biology,,,Article,2014-10-15,10.1007/s11307-014-0800-x,,,,25315836,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2775876,https://api.altmetric.com/v1/donut/2775876_240.png 1,Treatment of castration?resistant prostate cancer and bone metastases with radium?223 dichloride,International Journal of Urological Nursing,,,Article,2014-10-14,10.1111/ijun.12059,,,,26097500,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2775283,https://api.altmetric.com/v1/donut/2775283_240.png 1,"""Staging the Aging"" When Considering Androgen Deprivation Therapy for Older Men With Prostate Cancer",Journal of Clinical Oncology,,,Article,2009-07-20,10.1200/jco.2009.22.9104,,,,19506150,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2774400,https://api.altmetric.com/v1/donut/2774400_240.png 1,Dosimetric evaluation of clinical target volume in the postimplant analysis of low-dose-rate brachytherapy for prostate cancer ,Brachytherapy,,,Article,,10.1016/j.brachy.2014.08.044,,,,25301338,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2773778,https://api.altmetric.com/v1/donut/2773778_240.png 1,MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.,Journal of Proteomics,,,Article,2013-08-22,10.1016/j.jprot.2013.08.003,,,,23954705,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2768631,https://api.altmetric.com/v1/donut/2768631_240.png 1,Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways.,Oncotarget,,,Article,2014-09-16,10.18632/oncotarget.2480,,,,25301725,PMC4259449,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2764726,https://api.altmetric.com/v1/donut/2764726_240.png 1,Lisa’s Story | Women Against Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/yourstory/lisas-story/,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2759686,https://api.altmetric.com/v1/donut/2759686_240.png 1,The Landscape of Somatic Chromosomal Copy Number Aberrations in GEM Models of Prostate Carcinoma.,Molecular Cancer Research,,,Article,2014-10-08,10.1158/1541-7786.mcr-14-0262,,,,25298407,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2758383,https://api.altmetric.com/v1/donut/2758383_240.png 1,Effect of Paget's disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis,British Journal of Cancer,,,Article,2012-08-07,10.1038/bjc.2012.315,,,,22805323,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2751357,https://api.altmetric.com/v1/donut/2751357_240.png 1,Advances in local and ablative treatment of oligometastasis in prostate cancer.,Asia Pacific Journal of Clinical Oncology,,,Article,2014-08-28,10.1111/ajco.12256,,,,25155557,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2751127,https://api.altmetric.com/v1/donut/2751127_240.png 1,89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2014-08-21,10.1007/s00259-014-2830-7,,,,25143071,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2748337,https://api.altmetric.com/v1/donut/2748337_240.png 1,Post-treatment MRI aspects of photodynamic therapy for prostate cancer,Insights Into Imaging,,,Article,2014-10-07,10.1007/s13244-014-0359-8,,,,25288529,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2747764,https://api.altmetric.com/v1/donut/2747764_240.png 1,Prostate Cancer Support Groups in a Local Faith Community,Journal of Christian Nursing,,,Article,,10.1097/cnj.0000000000000115,,,,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2747437,https://api.altmetric.com/v1/donut/2747437_240.png 1,[Testicular morphology in the early and late stages of prostatic cancer].,Arkhiv patologii,,,Article,1975-01-01,,,,,48367,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/2742282,https://api.altmetric.com/v1/donut/2742282_240.png 1,Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells,Cancer Research,,,Article,2004-01-01,10.1158/0008-5472.can-04-2938,,,,15604246,,,,,,,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2731751,https://api.altmetric.com/v1/donut/2731751_240.png 1,Androgen Receptor CAG Repeat Polymorphism and Risk of TMPRSS2:ERG–Positive Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-06-11,10.1158/1055-9965.epi-14-0020,,,,24925673,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2730717,https://api.altmetric.com/v1/donut/2730717_240.png 1,Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results,Radiation Oncology,,,Article,2014-09-26,10.1186/1748-717x-9-214,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2718271,https://api.altmetric.com/v1/donut/2718271_240.png 1,Bone-Targeting Radiopharmaceuticals for the Treatment of Bone-Metastatic Castration-Resistant Prostate Cancer: Exploring the Implications of New Data,Oncologist,,,Article,,10.1634/theoncologist.2013-0472,,,,25232039,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2715011,https://api.altmetric.com/v1/donut/2715011_240.png 1,How we treat early systemic prostate cancer in older men,Journal of Geriatric Oncology,,,Article,,10.1016/j.jgo.2014.09.177,,,,25248671,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2709898,https://api.altmetric.com/v1/donut/2709898_240.png 1,Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of single treatment in prostate cancer through inhibition of redox adaptation.,Free Radical Biology & Medicine,,,Article,2014-09-15,10.1016/j.freeradbiomed.2014.09.009,,,,25236740,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2709248,https://api.altmetric.com/v1/donut/2709248_240.png 1,TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer.,Oncotarget,,,Article,2014-09-08,10.18632/oncotarget.2411,,,,25237769,PMC4253449,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2706131,https://api.altmetric.com/v1/donut/2706131_240.png 1,8q24 risk alleles and prostate cancer in African-Barbadian men.,The Prostate,,,Article,2014-09-21,10.1002/pros.22871,,,,25252079,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2705326,https://api.altmetric.com/v1/donut/2705326_240.png 1,Top 10 Things Women Should Know About Prostate Cancer |Women Against Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/2012/11/top-10-things-women-should-know-about-prostate-cancer-2/,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2703662,https://api.altmetric.com/v1/donut/2703662_240.png 1,PE28: Intraoperative frozen section of the prostate to reduce the risk of positive margin whilst ensuring nerve sparing in patients with intermediate and high-risk prostate cancer during robotic radical prostatectomy – first UK centre experience ,European Urology Supplements,,,Article,,10.1016/s1569-9056(14)50219-9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2701650,https://api.altmetric.com/v1/donut/2701650_240.png 1,Expression of E6AP and PML predicts for prostate cancer progression and cancer specific death.,Annals of Oncology,,,Article,2014-09-17,10.1093/annonc/mdu454,,,,25231954,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2697662,https://api.altmetric.com/v1/donut/2697662_240.png 1,15-Year Cause Specific and All-Cause Survival Following Brachytherapy for Prostate Cancer: Negative Impact of Long-Term Hormonal Therapy,The Journal of Urology,,,Article,2014-01-09,10.1016/j.juro.2014.03.094,,,,24698961,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2687412,https://api.altmetric.com/v1/donut/2687412_240.png 1,Is Time to First Skeletal-Related Event the Best Primary End Point in the Assessment of Bisphosphonate Efficacy in Patients With Castration-Sensitive Prostate Cancer?,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.56.2017,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2686621,https://api.altmetric.com/v1/donut/2686621_240.png 1,Association of genetic and non-genetic risk factors with the development of prostate cancer in Malaysian men.,Molecular Biology Reports,,,Article,2014-01-22,10.1007/s11033-014-3107-8,,,,24443231,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2684730,https://api.altmetric.com/v1/donut/2684730_240.png 1,FGF23: Mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?,Medical Hypotheses,,,Article,2014-01-10,10.1016/j.mehy.2014.08.005,,,,25155552,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2684485,https://api.altmetric.com/v1/donut/2684485_240.png 1,Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2014-09-09,10.1016/j.bbrc.2014.09.010,,,,25218471,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2684058,https://api.altmetric.com/v1/donut/2684058_240.png 1,Over-expression of a poor prognostic marker in prostate cancer: AQP5 promotes cells growth and local invasion,World Journal of Surgical Oncology,,,Article,2014-09-13,10.1186/1477-7819-12-284,,,,25217331,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2680184,https://api.altmetric.com/v1/donut/2680184_240.png 1,"Prostate cancer, gonadal hormones, and my brain.",Journal of Sex & Marital Therapy,,,Article,2014-05-24,10.1080/0092623x.2014.921477,,,,24846435,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2675338,https://api.altmetric.com/v1/donut/2675338_240.png 1,Copy Number Variation of GSTT1 and GSTM1 and the Risk of Prostate Cancer in a Caribbean Population of African Descent.,PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0107275,,,,25198353,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2670823,https://api.altmetric.com/v1/donut/2670823_240.png 1,Luteinizing hormone-releasing hormone receptor–targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy,Molecular Cancer Therapeutics,,,Article,2009-01-01,10.1158/1535-7163.mct-08-0988,,,,19509261,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2667709,https://api.altmetric.com/v1/donut/2667709_240.png 1,"Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The Role of Radical Prostatectomy and Lymph Node Dissection in Lymph Node–Positive Prostate Cancer: A Systematic Review of the Literature. Eur Urol 2014;66:191–9",European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.071,,,,25204223,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2661961,https://api.altmetric.com/v1/donut/2661961_240.png 1,Prospective Identification of Tumorigenic Prostate Cancer Stem Cells,Cancer Research,,,Article,2005-01-01,10.1158/0008-5472.can-05-2018,,,,16322242,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,384,https://www.altmetric.com/details/2661795,https://api.altmetric.com/v1/donut/2661795_240.png 1,CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro,World Journal of Urology,,,Article,2014-09-02,10.1007/s00345-014-1389-z,,,,25179012,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2661623,https://api.altmetric.com/v1/donut/2661623_240.png 1,DNA methylation gene-based models indicating independent poor outcome in prostate cancer,BMC Cancer,,,Article,2014-09-06,10.1186/1471-2407-14-655,,,,25193387,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2660387,https://api.altmetric.com/v1/donut/2660387_240.png 1,Prostate Cancer Awareness Month WAPC Activity | WomenAgainst Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/2014/09/prostate-cancer-awareness-month-wapc-activity/,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2656802,https://api.altmetric.com/v1/donut/2656802_240.png 1,Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer,Urology Case Reports,,,Article,2014-01-09,10.1016/j.eucr.2014.06.002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2656442,https://api.altmetric.com/v1/donut/2656442_240.png 1,Global prostate cancer disparities and the parts bothgenetic and behavioural factors play. Global prostate cancerdisparities and the parts both genetic and behavioural factorsplay. ecancer.tv - Essential viewing for oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2784/global-prostate-cancer-disparities-and-the-parts-both-genetic-and-behavioural-factors-play.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2655962,https://api.altmetric.com/v1/donut/2655962_240.png 1,Are staging investigations being overused in patients with low and intermediate risk prostate cancer?,Journal of Medical Imaging & Radiation Oncology,,,Article,2014-09-04,10.1111/1754-9485.12234,,,,25186469,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2654084,https://api.altmetric.com/v1/donut/2654084_240.png 1,High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma,"Cancer Immunology, Immunotherapy",,,Article,2014-09-04,10.1007/s00262-014-1594-z,,,,25186610,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2651833,https://api.altmetric.com/v1/donut/2651833_240.png 1,"Pharmacokinetics, Antitumor and Cardioprotective Effects of Liposome-Encapsulated Phenylaminoethyl Selenide in Human Prostate Cancer Rodent Models",Pharmaceutical Research,,,Article,2014-08-27,10.1007/s11095-014-1501-5,,,,25158648,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2651367,https://api.altmetric.com/v1/donut/2651367_240.png 1,Urinary diversions after radiation for prostate cancer: indications and treatment.,Urology,,,Article,2014-08-31,10.1016/j.urology.2014.04.023,,,,25168555,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2651333,https://api.altmetric.com/v1/donut/2651333_240.png 1,Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer,Urology,,,Article,2001-01-01,10.1016/s0090-4295(00)00895-5,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/2647965,https://api.altmetric.com/v1/donut/2647965_240.png 1,Fine-Mapping IGF1 and Prostate Cancer Risk in African Americans: The Multiethnic Cohort Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-06-04,10.1158/1055-9965.epi-14-0333,,,,24904019,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2646290,https://api.altmetric.com/v1/donut/2646290_240.png 1,A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate Cancer,The Journal of Urology,,,Article,1995-07-01,10.1016/s0022-5347(01)67248-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/2645191,https://api.altmetric.com/v1/donut/2645191_240.png 1,Chapter One PSA in Screening for Prostate Cancer More Good than Harm or More Harm than Good?,Advances in clinical chemistry,,,Article,,10.1016/b978-0-12-801401-1.00001-3,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2644305,https://api.altmetric.com/v1/donut/2644305_240.png 1,Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer.,Clinical Chemistry & Laboratory Medicine,,,Article,2014-04-05,10.1515/cclm-2014-0027,,,,24695041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2640526,https://api.altmetric.com/v1/donut/2640526_240.png 1,Impact of a Clinical Trial Initiative on Clinical Trial Enrollment in a Multidisciplinary Prostate Cancer Clinic,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2014-07-14,,,,,24994920,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2639432,https://api.altmetric.com/v1/donut/2639432_240.png 1,Prostate cancer: A traffic-stopping prediction tool?,Nature Reviews Urology,,,Article,2014-08-26,10.1038/nrurol.2014.230,,,,25155794,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2638285,https://api.altmetric.com/v1/donut/2638285_240.png 1,Prostate cancer: 'Best care' is not good enough,Nature Reviews Urology,,,Article,2014-08-26,10.1038/nrurol.2014.228,,,,25155786,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2637838,https://api.altmetric.com/v1/donut/2637838_240.png 1,"Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer.",JNCI: Journal of the National Cancer Institute,,,Article,1990-06-06,,,,,2342127,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2632782,https://api.altmetric.com/v1/donut/2632782_240.png 1,Human Chorionic Gonadotropin ? Induces Migration and Invasion via Activating ERK1/2 and MMP-2 in Human Prostate Cancer DU145 Cells.,PLoS ONE,,,Article,2013-02-22,10.1371/journal.pone.0054592,,,,23424616,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2623448,https://api.altmetric.com/v1/donut/2623448_240.png 1,"Analysis of the Expression of Interleukins, Interferon ?, and Nuclear Factor-? B in Prostate Cancer and their Relationship With Biochemical Recurrence",Journal of Immunotherapy,,,Article,2014-09-01,10.1097/cji.0000000000000045,,,,25075566,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2622332,https://api.altmetric.com/v1/donut/2622332_240.png 1,"Occupation, physical activity, and risk of prostate cancer in Shanghai, People's Republic of China",Cancer Causes and Control,,,Article,1994-01-01,10.1007/bf01830259,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2618937,https://api.altmetric.com/v1/donut/2618937_240.png 1,"Human Papillomavirus 16, 18, and 33 Infections and Risk of Prostate Cancer: A Nordic Nested Case-Control Study","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2005-01-01,10.1158/1055-9965.epi-05-0602,,,,16365015,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2612577,https://api.altmetric.com/v1/donut/2612577_240.png 1,Hormonal predictors of prostate cancer: a meta-analysis.,Journal of Clinical Oncology,,,Article,2000-02-01,,,,,10673527,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2593239,https://api.altmetric.com/v1/donut/2593239_240.png 1,Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations.,The Prostate,,,Article,2014-08-11,10.1002/pros.22860,,,,25111659,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2587219,https://api.altmetric.com/v1/donut/2587219_240.png 1,The role of testicular nuclear receptor 4 in chemo-resistance of docetaxel in castration-resistant prostate cancer,Cancer Gene Therapy,,,Article,2014-08-08,10.1038/cgt.2014.41,,,,25104727,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2584923,https://api.altmetric.com/v1/donut/2584923_240.png 1,Receipt of “Best Care” According to Current Quality of Care Measures and Outcomes Among men with Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.08.001,,,,25108275,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2580869,https://api.altmetric.com/v1/donut/2580869_240.png 1,Correction: Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer,Molecular Cancer,,,Article,2014-08-08,10.1186/1476-4598-13-188,,,,25103470,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2580218,https://api.altmetric.com/v1/donut/2580218_240.png 1,The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting.,Urologic Oncology,,,Article,2012-05-05,10.1016/j.urolonc.2012.03.012,,,,22552047,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2572277,https://api.altmetric.com/v1/donut/2572277_240.png 1,Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2014-04-16,10.1016/j.bbrc.2014.03.138,,,,24727455,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2533729,https://api.altmetric.com/v1/donut/2533729_240.png 1,Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.,BMC Cancer,,,Article,2014-07-21,10.1186/1471-2407-14-528,,,,25047061,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2533472,https://api.altmetric.com/v1/donut/2533472_240.png 1,High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice,The Prostate,,,Article,2014-07-21,10.1002/pros.22843,,,,25053105,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,1,12,https://www.altmetric.com/details/2531075,https://api.altmetric.com/v1/donut/2531075_240.png 1,COEXISTING PROSTATE CANCER FOUND AT THE TIME OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA: PREDICTING ITS PRESENCE AND GRADE IN ANALYZED TISSUE.,Journal of Endourology,,,Article,2014-07-21,10.1089/end.2014.0359,,,,25046691,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2530425,https://api.altmetric.com/v1/donut/2530425_240.png 1,Editorial Comment to Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: Prospective standardized analysis of complications.,International Journal of Urology,,,Article,2014-07-08,10.1111/iju.12553,,,,25040849,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2528384,https://api.altmetric.com/v1/donut/2528384_240.png 1,Chinese Red Yeast Rice Inhibition of Prostate Tumor Growth in SCID Mice,Cancer Prevention Research,,,Article,2011-04-01,10.1158/1940-6207.capr-10-0219,,,,21278313,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2527811,https://api.altmetric.com/v1/donut/2527811_240.png 1,Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer ,Biomaterials,,,Article,2014-07-11,10.1016/j.biomaterials.2014.06.040,,,,25028336,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,74,https://www.altmetric.com/details/2525766,https://api.altmetric.com/v1/donut/2525766_240.png 1,Perineural Invasion in Prostate Cancer Patients Who Are Potential Candidates for Active Surveillance: Validation Study ,Urology,,,Article,,10.1016/j.urology.2014.04.007,,,,24976227,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2519272,https://api.altmetric.com/v1/donut/2519272_240.png 1,Racial disparities in urologist visits among elderly men with prostate cancer: A cohort analysis of patient?related and county of residence?related factors,Cancer (0008543X),,,Article,2014-06-24,10.1002/cncr.28894,,,,24962590,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2519265,https://api.altmetric.com/v1/donut/2519265_240.png 1,"RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor",Molecular Cancer Therapeutics,,,Article,2006-05-01,10.1158/1535-7163.mct-05-0520,,,,,,,,,,,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2513352,https://api.altmetric.com/v1/donut/2513352_240.png 1,Transcriptional Regulation of the Human Thromboxane A2 Receptor Gene by Wilms' tumour (WT)1 and hypermethylated in cancer (HIC) 1 in Prostate and Breast Cancer.,Biochimica et Biophysica Acta (BBA),,,Article,2014-04-23,10.1016/j.bbagrm.2014.04.010,,,,24747176,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2510135,https://api.altmetric.com/v1/donut/2510135_240.png 1,A Prospective Cohort Study of Vasectomy and Prostate Cancer in US Men,JAMA: Journal of the American Medical Association,,,Article,1993-01-01,10.1001/jama.1993.03500070053028,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2503615,https://api.altmetric.com/v1/donut/2503615_240.png 1,No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer.,World Journal of Urology,,,Article,2014-07-03,10.1007/s00345-014-1351-0,,,,24989847,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2499897,https://api.altmetric.com/v1/donut/2499897_240.png 1,Review of Exercise Studies in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy Calls for an Aggressive Research Agenda to Generate High-Quality Evidence and Guidance for Exercise As Standard of Care,Journal of Clinical Oncology,,,Article,2014-07-06,10.1200/jco.2014.55.8189,,,,25002711,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2494286,https://api.altmetric.com/v1/donut/2494286_240.png 1,Durable Complete Remission From Castration-Resistant Prostate Cancer With Sipuleucel-T After Estrogen Withdrawal ,Clinical Genitourinary Cancer,,,Article,2013-11-14,10.1016/j.clgc.2013.11.006,,,,24331572,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2487147,https://api.altmetric.com/v1/donut/2487147_240.png 1,Expression of Androgen and Estrogen Signaling Components and Stem Cell Markers to Predict Cancer Progression and Cancer-Specific Survival in Patients with Metastatic Prostate Cancer,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-1105,,,,24987058,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2485768,https://api.altmetric.com/v1/donut/2485768_240.png 1,Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.,International Journal of Cancer,,,Article,2008-12-06,10.1002/ijc.24084,,,,19058221,,,,,,,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2481106,https://api.altmetric.com/v1/donut/2481106_240.png 1,Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence.,Cancer Research,,,Article,2014-04-07,10.1158/0008-5472.can-13-2699,,,,24713434,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2477051,https://api.altmetric.com/v1/donut/2477051_240.png 1,Integrative Identification of Deregulated MiRNA/TF-Mediated Gene Regulatory Loops and Networks in Prostate Cancer,PLoS ONE,,,Article,2014-06-26,10.1371/journal.pone.0100806,,,,24968068,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2476576,https://api.altmetric.com/v1/donut/2476576_240.png 1,GSTT1 Polymorphism and the Risk of Developing Prostate Cancer,American Journal of Epidemiology,,,Article,,10.1093/aje/kwu112,,,,24907267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2473580,https://api.altmetric.com/v1/donut/2473580_240.png 1,TR4 nuclear receptor promotes prostate cancer metastasis via up-regulation of CCL2/CCR2 signaling.,International Journal of Cancer,,,Article,2014-06-27,10.1002/ijc.29049,,,,24975468,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2472841,https://api.altmetric.com/v1/donut/2472841_240.png 1,Prostate cancer: An enzalutamide antiandrogen withdrawal syndrome,Nature Reviews Urology,,,Article,2014-06-24,10.1038/nrurol.2014.145,,,,24960596,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2469102,https://api.altmetric.com/v1/donut/2469102_240.png 1,Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).,Cancer Prevention Research,,,Article,2014-06-24,10.1158/1940-6207.capr-14-0058,,,,24961880,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2465797,https://api.altmetric.com/v1/donut/2465797_240.png 1,Can 3 Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA below 10 ng/mL? ,Clinical Genitourinary Cancer,,,Article,,10.1016/j.clgc.2014.06.013,,,,25081324,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2464902,https://api.altmetric.com/v1/donut/2464902_240.png 1,"Awareness and knowledge of prostate cancer among men in Benin City, Nigeria",Journal of Medicine and Biomedical Research,,,Article,,10.4314/jmbr.v12i2.,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2463869,https://api.altmetric.com/v1/donut/2463869_240.png 1,A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis.,The Prostate,,,Article,2014-06-24,10.1002/pros.22833,,,,24961912,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2462154,https://api.altmetric.com/v1/donut/2462154_240.png 1,Evidence-based patient choice: a prostate cancer decision aid in plain language.,BMC Medical Informatics and Decision Making,,,Article,2005-06-22,10.1186/1472-6947-5-16,,,,15963238,PMC1168900,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/2455222,https://api.altmetric.com/v1/donut/2455222_240.png 1,Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer.,International Journal of Biological Sciences,,,Article,2014-01-01,10.7150/ijbs.8671,,,,24948871,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2454698,https://api.altmetric.com/v1/donut/2454698_240.png 1,Prevalence of circulating tumor cells in localized prostate cancer.,Current Urology,,,Article,2014-06-13,10.1159/000356251,,,,24917761,PMC4017740,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2445143,https://api.altmetric.com/v1/donut/2445143_240.png 1,Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells,International Journal of Cancer,,,Article,2014-06-15,10.1002/ijc.29028,,,,24931571,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2445101,https://api.altmetric.com/v1/donut/2445101_240.png 1,"Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer121Funding/support: This research was supported and funded through the Center for Prostate Disease Research (CPDR), the Uniformed Services University of the Health Sciences, the Intramural Research Program of the Clinical Research Center, and the National Cancer Institute, National Institutes of Health, Bethesda, MD, US.2Presentations: These data were presented at the 2012 Annual Meeting of the American Urological Association in Atlanta, GA. ",Urologic Oncology,,,Article,,10.1016/j.urolonc.2014.03.024,,,,24929891,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2443767,https://api.altmetric.com/v1/donut/2443767_240.png 1,Maximal Testosterone Suppression in Prostate Cancer—Free vs Total Testosterone,Urology,,,Article,2014-01-06,10.1016/j.urology.2014.02.001,,,,24713136,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2443620,https://api.altmetric.com/v1/donut/2443620_240.png 1,Altered metabolism and mitochondrial genome in prostate cancer,Journal of Clinical Pathology,,,Article,2006-01-01,10.1136/jcp.2005.027664,,,,16394275,PMC1860255,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2442599,https://api.altmetric.com/v1/donut/2442599_240.png 1,Apoptotic Death of Prostate Cancer Cells by a Gonadotropin-Releasing Hormone-II Antagonist,PLoS ONE,,,Article,2014-06-15,10.1371/journal.pone.0099723,,,,24926857,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2441724,https://api.altmetric.com/v1/donut/2441724_240.png 1,Spinal Anesthesia Does Not Impact Prostate Cancer Recurrence in a Cohort of Men Undergoing Radical Prostatectomy: An Observational Study.,Regional Anesthesia & Pain Medicine,,,Article,2014-06-10,10.1097/aap.0000000000000108,,,,24918335,,,,,,,0,0,0,14,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2429633,https://api.altmetric.com/v1/donut/2429633_240.png 1,Androgen Deprivation Therapy for Prostate Cancer and Cardiovascular Death,JAMA: Journal of the American Medical Association,,,Article,2012-01-01,10.1001/jama.2012.352,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2425190,https://api.altmetric.com/v1/donut/2425190_240.png 1,Variation in General Practice Prostate?Specific Antigen Testing and Prostate Cancer Outcomes: An Ecological Study,International Journal of Cancer,,,Article,2014-06-12,10.1002/ijc.29008,,,,24905402,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2412203,https://api.altmetric.com/v1/donut/2412203_240.png 1,Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis.,European Urology,,,Article,2012-05-30,10.1016/j.eururo.2012.04.056,,,,22633803,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2408873,https://api.altmetric.com/v1/donut/2408873_240.png 1,A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).,Cancer Prevention Research,,,Article,2014-06-03,10.1158/1940-6207.capr-14-0075,,,,24894197,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2407233,https://api.altmetric.com/v1/donut/2407233_240.png 1,Prostate Cancer: No Benefit to Immediate ADT Initiation after PSA-Only Relapse,Oncology times,,,Article,2014-06-10,10.1097/01.cot.0000451385.16799.5c,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2404504,https://api.altmetric.com/v1/donut/2404504_240.png 1,Vulnerabilities of PTEN-p53-deficient prostate cancers to compound PARP/PI3K inhibition.,Cancer Discovery,,,Article,2014-05-26,10.1158/2159-8290.cd-13-0230,,,,24866151,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2393812,https://api.altmetric.com/v1/donut/2393812_240.png 1,Prostate cancer genomics: understanding the new landscape.,Canadian Journal of Urology,,,Article,2014-02-19,,,,,24529006,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2387698,https://api.altmetric.com/v1/donut/2387698_240.png 1,Beyond Androgen Deprivation: Ancillary Integrative Strategies for Targeting the Androgen Receptor Addiction of Prostate Cancer.,Integrative Cancer Therapies,,,Article,2014-05-25,10.1177/1534735414534728,,,,24867960,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2386104,https://api.altmetric.com/v1/donut/2386104_240.png 1,Patient-reported Outcomes in Randomised Controlled Trials of Prostate Cancer: Methodological Quality and Impact on Clinical Decision Making,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.10.017,,,,24210091,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2383562,https://api.altmetric.com/v1/donut/2383562_240.png 1,Clinical Characteristics and Management of Late Urinary Symptom Flare Following Stereotactic Body Radiation Therapy for Prostate Cancer,Radiation Oncology,,,Article,2014-05-09,10.3389/fonc.2014.00122,,,,24904833,PMC4033266,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2379102,https://api.altmetric.com/v1/donut/2379102_240.png 1,Influence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer.,The Application of Clinical Genetics,,,Article,2014-05-01,10.2147/tacg.s35598,,,,24876790,PMC4036145,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2378092,https://api.altmetric.com/v1/donut/2378092_240.png 1,PD31-06 DAIRY INTAKE AND PROSTATE CANCER RISK: RESULTS FROM THE CALIFORNIA COLLABORATIVE PROSTATE CANCER STUDY,The Journal of Urology,,,Article,2014-01-04,10.1016/j.juro.2014.02.2265,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2374278,https://api.altmetric.com/v1/donut/2374278_240.png 1,Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel,Anti-Cancer Drugs,,,Article,2014-05-20,10.1097/cad.0000000000000131,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2374234,https://api.altmetric.com/v1/donut/2374234_240.png 1,Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase (PAP) in Patients with Castration-Resistant Prostate Cancer.,Clinical Cancer Research,,,Article,2014-05-20,10.1158/1078-0432.ccr-14-0169,,,,24850844,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2371387,https://api.altmetric.com/v1/donut/2371387_240.png 1,"A High-Affinity, High-Stability Photoacoustic Agent for Imaging Gastrin-Releasing Peptide Receptor in Prostate Cancer",Clinical Cancer Research,,,Article,2014-05-20,10.1158/1078-0432.ccr-13-3405,,,,24850845,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2371385,https://api.altmetric.com/v1/donut/2371385_240.png 1,Updated trends in imaging use in men diagnosed with prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-05-13,10.1038/pcan.2014.19,,,http://www.rand.org/pubs/external_publications/EP51838.html,24819235,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2371192,https://api.altmetric.com/v1/donut/2371192_240.png 1,Genetic variation across C-reactive protein and risk of prostate cancer.,The Prostate,,,Article,2014-05-19,10.1002/pros.22820,,,,24844401,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2368424,https://api.altmetric.com/v1/donut/2368424_240.png 1,"Prostate Cancer Deaths and Incident Cases Among American Indian/Alaska Native Men, 1999-2009.",American Journal of Public Health,,,Article,2014-04-25,10.2105/ajph.2013.301690,,,,24754659,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2365695,https://api.altmetric.com/v1/donut/2365695_240.png 1,Prostate cancer vaccines in combination with additional treatment modalities.,Immunologic Research,,,Article,2014-05-18,10.1007/s12026-014-8532-1,,,,24838261,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2364959,https://api.altmetric.com/v1/donut/2364959_240.png 1,Folate intake and the risk of prostate cancer: a systematic review and meta-analysis,Prostate Cancer & Prostatic Diseases,,,Article,2014-05-13,10.1038/pcan.2014.16,,,,24819234,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2361927,https://api.altmetric.com/v1/donut/2361927_240.png 1,Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.,International Journal of Oncology,,,Article,2014-05-15,10.3892/ijo.2014.2437,,,,24820027,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2359866,https://api.altmetric.com/v1/donut/2359866_240.png 1,Will Active Surveillance for Clinically Localized Prostate Cancer Survive in the Era of Individualized Medicine?,European Urology,,,Article,2014-08-01,10.1016/j.eururo.2014.04.020,,,,24836154,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2349490,https://api.altmetric.com/v1/donut/2349490_240.png 1,Prostate cancer bone metastases: not so systemic after all,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70217-7,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2348884,https://api.altmetric.com/v1/donut/2348884_240.png 1,Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy.,Transfusion,,,Article,2014-03-27,10.1111/trf.12595,,,,24660833,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2347621,https://api.altmetric.com/v1/donut/2347621_240.png 1,In vitro modeling of the prostate cancer microenvironment,Advanced Drug Delivery Reviews,,,Article,,10.1016/j.addr.2014.04.008,,,,24816064,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/2341381,https://api.altmetric.com/v1/donut/2341381_240.png 1,"Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.",Oncogene,,,Article,2003-12-05,10.1038/sj.onc.1206891,,,,14647471,,,,,,,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2341176,https://api.altmetric.com/v1/donut/2341176_240.png 1,Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.,International Journal of Cancer,,,Article,2014-04-19,10.1002/ijc.28903,,,,24740818,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2339404,https://api.altmetric.com/v1/donut/2339404_240.png 1,User-centered design of quality of life reports for clinical care of patients with prostate cancer.,Surgery,,,Article,2014-05-04,10.1016/j.surg.2013.12.007,,,,24787105,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2336684,https://api.altmetric.com/v1/donut/2336684_240.png 1,"Sustained Complete Response to CTLA-4 Blockade in a Patient with Metastatic, Castration-Resistant Prostate Cancer",Cancer Immunology Research,,,Article,2014-05-14,10.1158/2326-6066.cir-13-0193,,,,24795352,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2327086,https://api.altmetric.com/v1/donut/2327086_240.png 1,The Impact of Multiparametric Pelvic Magnetic Resonance Imaging on Risk Stratification in Patients With Localized Prostate Cancer,Urology,,,Article,,10.1016/j.urology.2014.03.012,,,,24785987,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2326829,https://api.altmetric.com/v1/donut/2326829_240.png 1,Low testosterone levels may indicate worsening of disease for men with low-risk prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5611-low-testosterone-levels-may-indicate-worsening-of-disease-for-men-with-low-risk-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2326114,https://api.altmetric.com/v1/donut/2326114_240.png 1,Comparative analysis of image guidance in two institutions for prostate cancer patients,Reports of Practical Oncology & Radiotherapy,,,Article,2013-01-01,10.1016/j.rpor.2013.12.001,,,,24936341,PMC4056535,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2324840,https://api.altmetric.com/v1/donut/2324840_240.png 1,Galiellalactone is a Direct Inhibitor of STAT3 in Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2014-04-25,10.1074/jbc.m114.564252,,,,24755219,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2322990,https://api.altmetric.com/v1/donut/2322990_240.png 1,Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor,Urologic Oncology,,,Article,2014-02-04,10.1016/j.urolonc.2013.12.001,,,,24495446,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2322406,https://api.altmetric.com/v1/donut/2322406_240.png 1,Development of Nomogram to Non-steroidal Antiandrogen Sequential Alternation in Prostate Cancer for Predictive Model.,Japanese Journal of Clinical Oncology,,,Article,2014-02-13,10.1093/jjco/hyt230,,,,24516203,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2319817,https://api.altmetric.com/v1/donut/2319817_240.png 1,Is There Any Benefit From Hypofractionation in External-Beam Irradiation for Prostate Cancer?,Journal of Clinical Oncology,,,Article,,10.1200/jco.2013.54.4247,,,,24778396,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2316467,https://api.altmetric.com/v1/donut/2316467_240.png 1,Hypofractionated Radiation Therapy for Prostate Cancer: More Food for Thought From Recent Trial,Journal of Clinical Oncology,,,Article,2014-04-27,10.1200/jco.2013.54.8123,,,,24778400,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2316397,https://api.altmetric.com/v1/donut/2316397_240.png 1,Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners.,Prostate Cancer & Prostatic Diseases,,,Article,2014-02-13,10.1038/pcan.2014.2,,,,24513649,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2316113,https://api.altmetric.com/v1/donut/2316113_240.png 1,Prostate Cancer and the Gay Male,Journal of Gay & Lesbian Psychotherapy,,,Article,2005-02-15,10.1300/j236v09n01_02,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2313333,https://api.altmetric.com/v1/donut/2313333_240.png 1,Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.,International Journal of Oncology,,,Article,2007-09-07,,,,,17786330,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2308905,https://api.altmetric.com/v1/donut/2308905_240.png 1,A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2013-10-22,10.1038/pcan.2013.49,,,,24145624,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2307613,https://api.altmetric.com/v1/donut/2307613_240.png 1,The structural analysis of MARK4 and the exploration of specific inhibitors for the MARK family: a computational approach to obstruct the role of MARK4 in prostate cancer progression,Molecular BioSystems,,,Article,2014-06-03,10.1039/c3mb70591a,,,,24763618,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2307441,https://api.altmetric.com/v1/donut/2307441_240.png 1,Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.,The Prostate,,,Article,2011-02-16,10.1002/pros.21367,,,,21321983,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2304440,https://api.altmetric.com/v1/donut/2304440_240.png 1,"Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction",Oncogene,,,Article,2009-07-29,10.1038/onc.2009.214,,,,19633685,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2304434,https://api.altmetric.com/v1/donut/2304434_240.png 1,Long-term androgen ablation and docetaxel up-regulate phosphorylated Akt in castration resistant prostate cancer.,The Journal of Urology,,,Article,2011-04-23,10.1016/j.juro.2011.02.016,,,,21511293,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2304432,https://api.altmetric.com/v1/donut/2304432_240.png 1,Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2010-02-16,10.1200/jco.2009.25.9259,,,,20159814,PMC3040042,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,94,https://www.altmetric.com/details/2302360,https://api.altmetric.com/v1/donut/2302360_240.png 1,Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology,British Journal of Urology,,,Article,2010-08-01,10.1111/j.1464-410x.2010.09334.x,,,,20346033,,10161/11295,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,72,https://www.altmetric.com/details/2302348,https://api.altmetric.com/v1/donut/2302348_240.png 1,Cancer Treatment-Induced Bone Loss in Breast and Prostate Cancer,Journal of Clinical Oncology,,,Article,2008-10-14,10.1200/jco.2008.18.4184,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/2302341,https://api.altmetric.com/v1/donut/2302341_240.png 1,Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.,Journal of Clinical Oncology,,,Article,2006-08-20,10.1200/jco.2006.05.9741,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/2302325,https://api.altmetric.com/v1/donut/2302325_240.png 1,Snail is a repressor of RKIP transcription in metastatic prostate cancer cells,Oncogene,,,Article,2007-10-22,10.1038/sj.onc.1210860,,,,,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2301411,https://api.altmetric.com/v1/donut/2301411_240.png 1,Hypermethylation of the GABRE~miR-452~miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy.,Clinical Cancer Research,,,Article,2014-04-18,10.1158/1078-0432.ccr-13-2642,,,,24737792,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2293969,https://api.altmetric.com/v1/donut/2293969_240.png 1,Newfound compassion after prostate cancer: a psychometric evaluation of additional items in the Posttraumatic Growth Inventory.,Supportive Care in Cancer,,,Article,2013-08-11,10.1007/s00520-013-1903-7,,,,23928999,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2292204,https://api.altmetric.com/v1/donut/2292204_240.png 1,Fourth and a Mile: Using Theater in Comparison to Workshop/Lecture as an Approach to Educating African American Men About Prostate Cancer,World Medical & Health Policy,,,Article,2013-01-11,10.1002/wmh3.4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2291108,https://api.altmetric.com/v1/donut/2291108_240.png 1,Lycopene/Tomato Consumption and the Risk of Prostate Cancer: A Systematic Review and Meta-Analysis of Prospective Studies,Journal of Nutritional Science & Vitaminology,,,Article,2013-01-01,10.3177/jnsv.59.213,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2287687,https://api.altmetric.com/v1/donut/2287687_240.png 1,Re: Docetaxel and Atrasentan versus Docetaxel and Placebo for Men with Advanced Castration-Resistant Prostate Cancer (SWOG S0421): A Randomised Phase 3 Trial,The Journal of Urology,,,Article,,,,,,24522033,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2285027,https://api.altmetric.com/v1/donut/2285027_240.png 1,Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer,Current opinion in oncology,,,Article,2014-05-01,10.1097/cco.0000000000000071,,,,24626126,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2281228,https://api.altmetric.com/v1/donut/2281228_240.png 1,RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced Apoptosis,Journal of Biological Chemistry,,,Article,2004-02-03,10.1074/jbc.m313816200,,,,14766752,,,,,,,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2276259,https://api.altmetric.com/v1/donut/2276259_240.png 1,Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?,European Urology,,,Article,2012-03-01,10.1016/j.eururo.2012.02.020,,,,22366187,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/2275298,https://api.altmetric.com/v1/donut/2275298_240.png 1,A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression,Cancer Cell,,,Article,2008-12-08,10.1016/j.ccr.2008.06.002,,,,18691549,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2275110,https://api.altmetric.com/v1/donut/2275110_240.png 1,B-DIM Impairs Radiation-Induced Survival Pathways Independently of Androgen Receptor Expression and Augments Radiation Efficacy in Prostate Cancer.,Cancer Letters,,,Article,2011-12-15,10.1016/j.canlet.2011.12.006,,,,22155105,,,,,,,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2275108,https://api.altmetric.com/v1/donut/2275108_240.png 1,Biological factor may be linked to prostate cancer racial disparities,Cancer (0008543X),,,Article,2014-04-08,10.1002/cncr.28692,,,,24715301,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2270772,https://api.altmetric.com/v1/donut/2270772_240.png 1,Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis,Biochemical & Biophysical Research Communications,,,Article,,10.1016/j.bbrc.2014.03.080,,,,24680678,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2267853,https://api.altmetric.com/v1/donut/2267853_240.png 1,Recent progress on nutraceutical research in prostate cancer.,Cancer and Metastasis Reviews,,,Article,2014-01-01,10.1007/s10555-013-9478-9,,,,24375392,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2267107,https://api.altmetric.com/v1/donut/2267107_240.png 1,High-intensity focused ultrasound as focal therapy of prostate cancer,Current Opinion in Urology,,,Article,2014-04-04,10.1097/mou.0000000000000053,,,,24710053,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2266911,https://api.altmetric.com/v1/donut/2266911_240.png 1,Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer.,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.03.015,,,,24725337,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2266612,https://api.altmetric.com/v1/donut/2266612_240.png 1,Living with Prostate Cancer: One Gay Man's Experience,Journal of Gay & Lesbian Psychotherapy,,,Article,2005-02-15,10.1300/j236v09n01_09,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2262060,https://api.altmetric.com/v1/donut/2262060_240.png 1,Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.,Journal of Nuclear Medicine,,,Article,2014-04-03,10.2967/jnumed.114.138180,,,,24700882,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2258828,https://api.altmetric.com/v1/donut/2258828_240.png 1,The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.,Clinical Cancer Research,,,Article,1997-05-01,,,,,9815753,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2256019,https://api.altmetric.com/v1/donut/2256019_240.png 1,Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression.,Free Radical Biology & Medicine,,,Article,2013-11-27,10.1016/j.freeradbiomed.2013.11.006,,,,24269899,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2255903,https://api.altmetric.com/v1/donut/2255903_240.png 1,Studies on the Non-Protein Thiols of a Human Prostatic Cancer Cell Line: Glutathione Content.,Cancers,,,Article,2013-11-28,10.3390/cancers2021092,,,,24281108,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2255153,https://api.altmetric.com/v1/donut/2255153_240.png 1,"Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-?B/Akt signaling in prostate cancer cells.",International Journal of Molecular Medicine,,,Article,2013-11-30,10.3892/ijmm.2013.1571,,,,24285354,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2255151,https://api.altmetric.com/v1/donut/2255151_240.png 1,The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.,Journal of Human Genetics,,,Article,2013-11-30,10.1038/jhg.2013.121,,,,24284362,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2254851,https://api.altmetric.com/v1/donut/2254851_240.png 1,Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy.,Archives of Physical Medicine & Rehabilitation,,,Article,2007-11-01,10.1016/j.apmr.2007.08.110,,,,17964881,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/2252703,https://api.altmetric.com/v1/donut/2252703_240.png 1,Favourable long-term outcomes with brachytherapy-based regimens in men ?60 years with clinically localized prostate cancer.,British Journal of Urology,,,Article,2013-04-06,10.1111/j.1464-410x.2012.11663.x,,,,23551568,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2252559,https://api.altmetric.com/v1/donut/2252559_240.png 1,A large cohort study of long-term acetaminophen use and prostate cancer incidence.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-05-19,10.1158/1055-9965.epi-11-0210,,,,21586623,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2250768,https://api.altmetric.com/v1/donut/2250768_240.png 1,Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer,Current Opinion in Urology,,,Article,2014-03-14,10.1097/mou.0000000000000039,,,,24614347,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2250382,https://api.altmetric.com/v1/donut/2250382_240.png 1,Severe hypocalcaemia associated with extensive osteoblastic metastases in a patient with prostate cancer.,The Netherlands Journal of Medicine,,,Article,2005-01-01,,,,,15719851,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2249817,https://api.altmetric.com/v1/donut/2249817_240.png 1,A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics.,Journal of Theoretical Biology,,,Article,2014-02-16,10.1016/j.jtbi.2014.02.004,,,,24524858,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2249393,https://api.altmetric.com/v1/donut/2249393_240.png 1,Use of prostate-specific antigen in black men: age-adjusted reference ranges for maximal cancer detection.,Journal of the National Medical Association,,,Article,1998-11-01,,,,,9828587,PMC2652609,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2248484,https://api.altmetric.com/v1/donut/2248484_240.png 1,Marine- and plant-derived ?-3 fatty acids differentially regulate prostate cancer cell proliferation.,Mol Clin Oncol,,,Article,2014-03-23,10.3892/mco.2013.76,,,,24649190,PMC3916163,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2245466,https://api.altmetric.com/v1/donut/2245466_240.png 1,No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-03-05,10.1158/1055-9965.epi-14-0114,,,,24585409,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2244874,https://api.altmetric.com/v1/donut/2244874_240.png 1,"Which bowel preparation is best? Comparison of a high fibre diet leaflet, daily micro-enema and no preparation in prostate cancer patients treated with radical radiotherapy to assess the effect on prostate shifts due to rectal distension.",British Journal of Radiology,,,Article,2013-09-04,10.1259/bjr.20130457,,,,23995876,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2243969,https://api.altmetric.com/v1/donut/2243969_240.png 1,Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer,Urologic Oncology,,,Article,2011-02-08,10.1016/j.urolonc.2011.06.011,,,,21816639,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2239942,https://api.altmetric.com/v1/donut/2239942_240.png 1,Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-05-10,10.1007/s00259-013-2427-6,,,,23653243,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2239633,https://api.altmetric.com/v1/donut/2239633_240.png 1,A Gay Man and His Partner Face His Prostate Cancer Together,Journal of Gay & Lesbian Psychotherapy,,,Article,2005-02-15,10.1300/j236v09n01_13,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2225665,https://api.altmetric.com/v1/donut/2225665_240.png 1,Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).,Annals of Oncology,,,Article,2013-12-22,10.1093/annonc/mdt369,,,,24356625,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/2225453,https://api.altmetric.com/v1/donut/2225453_240.png 1,Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling,Endocrinology,,,Article,2014-01-22,10.1210/en.2013-1925,,,,24437490,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,23,https://www.altmetric.com/details/2220278,https://api.altmetric.com/v1/donut/2220278_240.png 1,Re: Long-Term Survival of Participants in the Prostate Cancer Prevention Trial,The Journal of Urology,,,Article,,10.1016/j.juro.2013.11.010,,,,24411850,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2216876,https://api.altmetric.com/v1/donut/2216876_240.png 1,Updated Results from the Scandinavian Study of Early Prostate Cancer,Journal Watch,,,Article,2014-03-13,10.1056/nejm-jw.na33729,,,,,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/2212052,https://api.altmetric.com/v1/donut/2212052_240.png 1,Expression of prostate stem cell antigen (PSCA) in prostate cancer: A tissue microarray study of Iranian patients.,Pathology - Research & Practice,,,Article,2013-11-06,10.1016/j.prp.2013.09.012,,,,24183365,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,8,https://www.altmetric.com/details/2208806,https://api.altmetric.com/v1/donut/2208806_240.png 1,The prospect of prostate cancer: A challenge for gay men’s sexualities as they age,Sexuality Research & Social Policy: Journal of NSRC,,,Article,2009-01-01,10.1525/srsp.2009.6.4.38,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2208690,https://api.altmetric.com/v1/donut/2208690_240.png 1,Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer,Radiotherapy & Oncology,,,Article,2014-03-17,10.1016/j.radonc.2014.02.009,,,,24631146,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2203808,https://api.altmetric.com/v1/donut/2203808_240.png 1,Gay men and prostate cancer: voicing the concerns of a hidden population,Journal of Men's Health,,,Article,2008-01-01,10.1016/j.jomh.2008.08.005,,,,,,11541.2/112704,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2203461,https://api.altmetric.com/v1/donut/2203461_240.png 1,Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).,Journal of Clinical Oncology,,,Article,2006-08-23,10.1200/jco.2006.06.4246,,,,16921051,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2203415,https://api.altmetric.com/v1/donut/2203415_240.png 1,"Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate?risk, high?risk, localized, and locally advanced prostate cancer",Cancer (0008543X),,,Article,2014-03-03,10.1002/cncr.28594,,,,24591080,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,9,https://www.altmetric.com/details/2203037,https://api.altmetric.com/v1/donut/2203037_240.png 1,Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data.,Radiotherapy & Oncology,,,Article,2014-02-20,10.1016/j.radonc.2013.12.010,,,,24560753,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2195276,https://api.altmetric.com/v1/donut/2195276_240.png 1,Isolation of Cancer Stem Cells From Human Prostate Cancer Samples,Journal of Visualized Experiments,,,Article,,10.3791/51332,,,,24686446,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2186804,https://api.altmetric.com/v1/donut/2186804_240.png 1,Genetic Variants Reflecting Higher Vitamin E Status in Men Are Associated with Reduced Risk of Prostate Cancer,Journal of Nutrition,,,Article,,10.3945/jn.113.189928,,,,24623848,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2185474,https://api.altmetric.com/v1/donut/2185474_240.png 1, Sipuleucel-T and immunotherapy in the treatment of prostate cancer,Expert Opinion on Biological Therapy,,,Article,2014-03-12,10.1517/14712598.2014.896897,,,,24620782,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2180873,https://api.altmetric.com/v1/donut/2180873_240.png 1,"Farming, Reported Pesticide Use, and Prostate Cancer",American Journal of Men's Health,,,Article,2012-01-01,10.1177/1557988312458792,,,,22948300,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2178762,https://api.altmetric.com/v1/donut/2178762_240.png 1,Health behaviour models and patient preferences regarding nutrition and physical activity after breast or prostate cancer diagnosis,European Journal of Cancer Care,,,Article,2014-03-03,10.1111/ecc.12190,,,,24589207,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2176427,https://api.altmetric.com/v1/donut/2176427_240.png 1,A Novel Three Serum Phospholipid Panel Differentiates Normal Individuals from Those with Prostate Cancer,PLoS ONE,,,Article,2014-03-06,10.1371/journal.pone.0088841,,,,24603597,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2167738,https://api.altmetric.com/v1/donut/2167738_240.png 1,Cholesteryl Esters: Fueling the Fury of Prostate Cancer,Cell Metabolism (Science Direct),,,Article,,10.1016/j.cmet.2014.02.012,,,,24606894,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2162701,https://api.altmetric.com/v1/donut/2162701_240.png 1,A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy.,Brachytherapy,,,Article,2014-01-01,10.1016/j.brachy.2013.11.005,,,,24373762,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,26,https://www.altmetric.com/details/2147679,https://api.altmetric.com/v1/donut/2147679_240.png 1,Mechanism of activation of natural killer and CD8 T cells by interleukin 15 in the prostate cancer microenvironment,The Lancet (British Edition),,,Article,2014-02-26,10.1016/s0140-6736(14)60310-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2147264,https://api.altmetric.com/v1/donut/2147264_240.png 1,Monitoring Quality of Life Among Prostate Cancer Survivors: The Feasibility of Automated Telephone Assessment,Urology,,,Article,2012-01-01,10.1016/j.urology.2012.07.038,,,,22990056,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2145746,https://api.altmetric.com/v1/donut/2145746_240.png 1,Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients,Journal of Translational Medicine,,,Article,2014-02-24,10.1186/1479-5876-12-54,,,,24564996,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2143955,https://api.altmetric.com/v1/donut/2143955_240.png 1,First round of targeted biopsies with magnetic resonance imaging/ultrasound-fusion images compared to conventional ultrasound-guided trans-rectal biopsies for the diagnosis of localised prostate cancer.,British Journal of Urology,,,Article,,10.1111/bju.12690,,,,24552477,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2130503,https://api.altmetric.com/v1/donut/2130503_240.png 1,Is Treatment of the Primary Tumor in Metastatic Prostate Cancer Justified?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.12.011,,,,24411278,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2125062,https://api.altmetric.com/v1/donut/2125062_240.png 1,"The Rate of Overdiagnosis Inextricably Linked to Prostate-specific Antigen–Based Screening for Prostate Cancer Can Be Quantified in Several Ways, But What Is the Practicable Message?",European Urology,,,Article,2014-06-01,10.1016/j.eururo.2014.01.016,,,,24486022,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2124879,https://api.altmetric.com/v1/donut/2124879_240.png 1,A Randomised Phase 2 Study Combining LY2181308 Sodium (Survivin Antisense Oligonucleotide) with First-line Docetaxel/Prednisone in Patients with Castration-resistant Prostate Cancer,European Urology,,,Article,2014-03-01,10.1016/j.eururo.2013.10.039,,,,24246407,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2124824,https://api.altmetric.com/v1/donut/2124824_240.png 1,Metformin for Castrate-resistant Prostate Cancer: Learning More About an Old Dog's New Tricks,European Urology,,,Article,2014-09-01,10.1016/j.eururo.2014.01.013,,,,24472709,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2124801,https://api.altmetric.com/v1/donut/2124801_240.png 1,Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel,Cancer and Metastasis Reviews,,,Article,2014-01-30,10.1007/s10555-013-9470-4,,,,24477410,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2124768,https://api.altmetric.com/v1/donut/2124768_240.png 1,"Effective treatment for early-stage prostate cancer--possible, necessary, or both?",New England Journal of Medicine,,,Article,2011-05-07,10.1056/nejme1100787,,,,21542749,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2123496,https://api.altmetric.com/v1/donut/2123496_240.png 1,Enhanced detection of metastatic prostate cancer cells in human plasma with lipid bodies staining,BMC Cancer,,,Article,2014-02-15,10.1186/1471-2407-14-91,,,,24528787,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2121281,https://api.altmetric.com/v1/donut/2121281_240.png 1,Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer,Radiation Oncology,,,Article,2014-02-11,10.1186/1748-717x-9-52,,,,24512837,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2114991,https://api.altmetric.com/v1/donut/2114991_240.png 1,Redefining Prostate Cancer: An Innovative Guide to Diagnosis and Treatment,The Journal of Urology,,,Article,2014-02-07,10.1016/j.juro.2014.02.001,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2105977,https://api.altmetric.com/v1/donut/2105977_240.png 1,Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer,Urology,,,Article,2014-01-09,10.1016/j.urology.2013.10.026,,,,24411213,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2099271,https://api.altmetric.com/v1/donut/2099271_240.png 1,Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance,Radiation Oncology,,,Article,2014-02-04,10.1186/1748-717x-9-44,,,,24495815,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2096919,https://api.altmetric.com/v1/donut/2096919_240.png 1,Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence,Endocrine-Related Cancer,,,Article,,10.1530/erc-14-0036,,,,24481324,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2095931,https://api.altmetric.com/v1/donut/2095931_240.png 1,Androgen-Induced Wnt Signaling in Preosteoblasts Promotes the Growth of MDA-PCa-2b Human Prostate Cancer Cells,Cancer Research,,,Article,2007-06-15,10.1158/0008-5472.can-07-0478,,,,17575141,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2094063,https://api.altmetric.com/v1/donut/2094063_240.png 1,Cyclooxygenase-2 Suppresses Hypoxia-induced Apoptosis via a Combination of Direct and Indirect Inhibition of p53 Activity in a Human Prostate Cancer Cell Line,Journal of Biological Chemistry,,,Article,2004-11-08,10.1074/jbc.m406577200,,,,15550400,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2093817,https://api.altmetric.com/v1/donut/2093817_240.png 1,Prostaglandin E2 Induces Hypoxia-inducible Factor-1alpha Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line,Journal of Biological Chemistry,,,Article,2002-10-24,10.1074/jbc.m201095200,,,,,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2093692,https://api.altmetric.com/v1/donut/2093692_240.png 1,Role of Cyclic AMP Response Element-Binding Protein in Insulin-like Growth Factor-I Receptor Up-regulation by Sex Steroids in Prostate Cancer Cells,Cancer Research,,,Article,2009-09-08,10.1158/0008-5472.can-09-0088,,,,19738069,,,,,,,0,0,0,0,8,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2093639,https://api.altmetric.com/v1/donut/2093639_240.png 1,Epigenetic Modifications of RASSF1A Gene through Chromatin Remodeling in Prostate Cancer,Clinical Cancer Research,,,Article,2007-05-01,10.1158/1078-0432.ccr-06-2225,,,,17473182,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2093525,https://api.altmetric.com/v1/donut/2093525_240.png 1,Ribosome?inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase?1 selectively in premalignant and malignant prostate cancer cells,International Journal of Cancer,,,Article,2009-04-23,10.1002/ijc.24325,,,,19384952,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2093517,https://api.altmetric.com/v1/donut/2093517_240.png 1,"Regulation of FOXO3a/beta-Catenin/GSK-3beta Signaling by 3,3'-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Prostate Cancer Cells",Journal of Biological Chemistry,,,Article,2007-05-24,10.1074/jbc.m701978200,,,,17522055,,,,,,,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2093510,https://api.altmetric.com/v1/donut/2093510_240.png 1,Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2008-07-09,10.1016/j.bbrc.2008.06.097,,,,18602367,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2093507,https://api.altmetric.com/v1/donut/2093507_240.png 1,Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.,Cancer Prevention Research,,,Article,2011-06-16,10.1158/1940-6207.capr-11-0077,,,,21680704,,,,,,,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2093479,https://api.altmetric.com/v1/donut/2093479_240.png 1,Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.,International Journal of Cancer,,,Article,2008-04-25,10.1002/ijc.23590,,,,18431742,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/2093437,https://api.altmetric.com/v1/donut/2093437_240.png 1,Regulation of Minichromosome Maintenance Gene Family by MicroRNA-1296 and Genistein in Prostate Cancer,Cancer Research,,,Article,2010-03-23,10.1158/0008-5472.can-09-4176,,,,20332239,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2093366,https://api.altmetric.com/v1/donut/2093366_240.png 1,Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity,Oncogene,,,Article,2007-06-16,10.1038/sj.onc.1210572,,,,17563745,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2093329,https://api.altmetric.com/v1/donut/2093329_240.png 1,Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells,PLoS ONE,,,Article,2011-05-18,10.1371/journal.pone.0019771,,,,21573075,PMC3089640,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2093296,https://api.altmetric.com/v1/donut/2093296_240.png 1,Prognostication of OCT4 isoform expression in prostate cancer.,Tumor Biology,,,Article,2013-05-04,10.1007/s13277-013-0817-9,,,,23636800,,,,,,,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2093212,https://api.altmetric.com/v1/donut/2093212_240.png 1,"Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells",Oncogene,,,Article,2001-05-24,10.1038/sj.onc.1204365,,,,,,,,,,,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2093168,https://api.altmetric.com/v1/donut/2093168_240.png 1,Fibronectin Protects Prostate Cancer Cells from Tumor Necrosis Factor-?-induced Apoptosis via the AKT/Survivin Pathway,Journal of Biological Chemistry,,,Article,2003-10-16,10.1074/jbc.m307627200,,,,,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2093164,https://api.altmetric.com/v1/donut/2093164_240.png 1,"Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor- B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer",Cancer Research,,,Article,2007-04-01,10.1158/0008-5472.can-06-4277,,,,17409440,,,,,,,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2093121,https://api.altmetric.com/v1/donut/2093121_240.png 1,CpG methylation at promoter site ?140 inactivates TGF?2 receptor gene in prostate cancer,Cancer (0008543X),,,Article,2005-05-18,10.1002/cncr.21135,,,,15895377,,,,,,,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2093093,https://api.altmetric.com/v1/donut/2093093_240.png 1,Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers.,Journal of Carcinogenesis,,,Article,1970-01-01,10.4103/1477-3163.75723,,,,21297922,,,,,,,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2093028,https://api.altmetric.com/v1/donut/2093028_240.png 1,Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir,Radiation Oncology,,,Article,2014-02-02,10.1186/1748-717x-9-42,,,,24484652,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2091843,https://api.altmetric.com/v1/donut/2091843_240.png 1,Advances in prostate cancer - a decade in review. Advancesin prostate cancer - a decade in review. ecancer.tv - Essentialviewing for oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2658/advances-in-prostate-cancer---a-decade-in-review.php,,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2089423,https://api.altmetric.com/v1/donut/2089423_240.png 1,End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice,Journal of Clinical Oncology,,,Article,2011-01-01,10.1200/jco.2011.35.8648,,,,21859988,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2086621,https://api.altmetric.com/v1/donut/2086621_240.png 1,Tumor infiltrating B-cells are increased in prostate cancer tissue,Journal of Translational Medicine,,,Article,2014-01-30,10.1186/1479-5876-12-30,,,,24475900,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2084907,https://api.altmetric.com/v1/donut/2084907_240.png 1,Optimizing patient outcomes in metastaticcastration-resistant prostate cancer (mCRPC). Optimizing patientoutcomes in metastatic castration-resistant prostate cancer(mCRPC). ecancer.tv - Essential viewing for oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2643/optimizing-patient-outcomes-in-metastatic-castration-resistant-prostate-cancer--mcrpc.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2075954,https://api.altmetric.com/v1/donut/2075954_240.png 1,The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer.,Modern Pathology,,,Article,2011-05-18,10.1038/modpathol.2011.76,,,,21572396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2072685,https://api.altmetric.com/v1/donut/2072685_240.png 1,Prostate Cancer Roundtable Takes Action! | Women AgainstProstate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/2014/01/prostate-cancer-roundtable-takes-action/,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2060086,https://api.altmetric.com/v1/donut/2060086_240.png 1,To target or not to target the enemy within localized prostate cancer.,Cell Cycle,,,Article,2013-11-01,10.4161/cc.26576,,,,24091534,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2055788,https://api.altmetric.com/v1/donut/2055788_240.png 1,Re: Gene Signatures Distinguish Stage-Specific Prostate Cancer Stem Cells Isolated from Transgenic Adenocarcinoma of the Mouse Prostate Lesions and Predict the Malignancy of Human Tumors,The Journal of Urology,,,Article,2014-01-17,10.1016/j.juro.2014.01.039,,,,24703155,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2051589,https://api.altmetric.com/v1/donut/2051589_240.png 1,Utilization of prostate cancer screening according to dietary patterns and other demographic variables. The adventist health study-2.,Journal of Cancer,,,Article,2013-07-10,10.7150/jca.6442,,,,23833686,PMC3701811,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2051269,https://api.altmetric.com/v1/donut/2051269_240.png 1,Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer,Endocrine Connections,,,Article,2014-01-16,10.1530/ec-13-0086,,,,24434591,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2050671,https://api.altmetric.com/v1/donut/2050671_240.png 1,Design and Synthesis of Prostate Cancer Antigen-1(PCA-1/ALKBH3) Inhibitors as anti-Prostate Cancer Drugs,Bioorganic & Medicinal Chemistry Letters,,,Article,,10.1016/j.bmcl.2014.01.008,,,,24461353,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2042893,https://api.altmetric.com/v1/donut/2042893_240.png 1,Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform,Archivio Italiano di Urologia e Andrologia,,,Article,2013-01-01,10.4081/aiua.2013.4.164,,,,24399115,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2041491,https://api.altmetric.com/v1/donut/2041491_240.png 1,One?step TNM staging of high?risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified all?in?one imaging approach?,The Prostate,,,Article,2013-01-01,10.1002/pros.22764,,,,24375774,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2034168,https://api.altmetric.com/v1/donut/2034168_240.png 1,Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy.,Prostate Cancer & Prostatic Diseases,,,Article,2013-12-24,10.1038/pcan.2013.37,,,,24366412,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2021571,https://api.altmetric.com/v1/donut/2021571_240.png 1,Chlordecone Exposure and Risk of Prostate Cancer,Journal of Clinical Oncology,,,Article,2010-01-01,10.1200/jco.2009.27.2153,,,,20566993,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2019117,https://api.altmetric.com/v1/donut/2019117_240.png 1,[Transperitoneal versus extraperitoneal laparoscopic radical prostatectomy for localized prostate cancer: a meta analysis].,Zhonghua nan ke xue National journal of andrology,,,Article,2013-11-01,,,,,24341099,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2014642,https://api.altmetric.com/v1/donut/2014642_240.png 1,Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells.,Oncogene,,,Article,2008-08-28,10.1038/onc.2008.143,,,,18504439,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2005998,https://api.altmetric.com/v1/donut/2005998_240.png 1,Prostate cancer: embodied experience and perceptions of masculinity,Sociology of Health & Illness,,,Article,2002-01-01,10.1111/1467-9566.00320,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/2002610,https://api.altmetric.com/v1/donut/2002610_240.png 1,A TCP model for external beam treatment of intermediate-risk prostate cancer,Medical Physics,,,Article,2013-01-01,10.1118/1.4790469,,,,23464304,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1995435,https://api.altmetric.com/v1/donut/1995435_240.png 1,Changes in decisional conflict and decisional regret in patients with localised prostate cancer,Journal of Clinical Nursing,,,Article,2013-01-01,10.1111/jocn.12470,,,,24355000,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1994878,https://api.altmetric.com/v1/donut/1994878_240.png 1,FROGG high?risk prostate cancer workshop: Patterns of practice and literature review. Part II post?radical prostatectomy,Journal of Medical Imaging & Radiation Oncology,,,Article,2013-12-18,10.1111/1754-9485.12139,,,,24345209,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1989180,https://api.altmetric.com/v1/donut/1989180_240.png 1,Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells.,The Prostate,,,Article,2013-11-23,10.1002/pros.22729,,,,24272884,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1988879,https://api.altmetric.com/v1/donut/1988879_240.png 1,Circulating nucleic acids as biomarkers of prostate cancer.,Biomarkers in Medicine,,,Article,2013-12-01,10.2217/bmm.13.104,,,,24266819,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1988877,https://api.altmetric.com/v1/donut/1988877_240.png 1,Activated 5flanking region of NANOGP8 in a self?renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells,The Prostate,,,Article,2013-01-01,10.1002/pros.22759,,,,24318967,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1985799,https://api.altmetric.com/v1/donut/1985799_240.png 1,"Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model",Molecular Oncology,,,Article,2013-12-01,10.1016/j.molonc.2013.12.004,,,,24388358,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1985706,https://api.altmetric.com/v1/donut/1985706_240.png 1,Signal Transduction Pathways Mediated by Secreted and Non-secreted Forms of intact Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) and its 1-97 N-terminal Fragment in PC-3 Human Prostate Cancer Cells.,Journal of Cancer Therapy,,,Article,2013-10-01,10.4236/jct.2013.48152,,,,24273681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1983801,https://api.altmetric.com/v1/donut/1983801_240.png 1,[Features of HDR brachytherapy in patients with localized prostate cancer].,Voprosy onkologii,,,Article,2013-01-01,,,,,24260896,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1983711,https://api.altmetric.com/v1/donut/1983711_240.png 1,Detection of prostate cancer related copy number variations with SNP genotyping array.,European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360,,,Article,2013-11-01,,,,,24254561,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1983708,https://api.altmetric.com/v1/donut/1983708_240.png 1,Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.,Molecular Therapy,,,Article,2011-01-01,10.1038/mt.2010.216,,,,20940707,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/1981505,https://api.altmetric.com/v1/donut/1981505_240.png 1,Vaccine potential as prostate cancer protein unlocked,ecancer.org,,,Article,,,,,http://ecancer.org/news/4961-vaccine-potential-as-prostate-cancer-protein-unlocked.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1979741,https://api.altmetric.com/v1/donut/1979741_240.png 1,[Intensity-modulated radiation therapy (IMRT) for localized and locally advanced prostate cancer: initial result and morbidity].,Nippon Hiny?kika Gakkai zasshi. The japanese journal of urology,,,Article,2012-11-01,,,,,24261191,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1978395,https://api.altmetric.com/v1/donut/1978395_240.png 1,Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination.,Pan African Medical Journal,,,Article,2013-01-01,10.11604/pamj.2013.15.129.2489,,,,24255735,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1978295,https://api.altmetric.com/v1/donut/1978295_240.png 1,Telomere length as a risk factor for hereditary prostate cancer.,The Prostate,,,Article,2013-11-28,10.1002/pros.22755,,,,24285042,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1977275,https://api.altmetric.com/v1/donut/1977275_240.png 1,Normoxic or hypoxic CD44/CD41 a 2 B 1 integrin-positive prostate PC3 cell side fractions and cancer stem cells.,Medical Oncology,,,Article,2014-01-01,10.1007/s12032-013-0779-1,,,,24323398,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1974406,https://api.altmetric.com/v1/donut/1974406_240.png 1,Suppression of SCIN inhibits human prostate cancer cell proliferation and induces G0/G1 phase arrest.,International Journal of Oncology,,,Article,2014-01-01,10.3892/ijo.2013.2170,,,,24212916,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1972250,https://api.altmetric.com/v1/donut/1972250_240.png 1,Honokiol inhibits androgen receptor activity in prostate cancer cells,The Prostate,,,Article,2013-12-11,10.1002/pros.22762,,,,24338950,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1972119,https://api.altmetric.com/v1/donut/1972119_240.png 1,MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells.,Cell Death & Disease,,,Article,2013-01-01,10.1038/cddis.2013.458,,,,24263102,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1969965,https://api.altmetric.com/v1/donut/1969965_240.png 1,D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.,Tumor Biology,,,Article,2013-11-22,10.1007/s13277-013-1423-6,,,,24264315,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1967293,https://api.altmetric.com/v1/donut/1967293_240.png 1,Steroidogenic Factor 1 Promotes Aggressive Growth of Castration Resistant Prostate Cancer Cells By Stimulating Steroid Synthesis and Cell Proliferation.,Endocrinology,,,Article,2013-11-21,10.1210/en.2013-1583,,,,24265454,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1967256,https://api.altmetric.com/v1/donut/1967256_240.png 1,Role of SMAD4 in the mechanism of valproic acid's inhibitory effect on prostate cancer cell invasiveness.,International Urology and Nephrology,,,Article,2013-11-22,10.1007/s11255-013-0609-6,,,,24265041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1967254,https://api.altmetric.com/v1/donut/1967254_240.png 1,Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate.,Scandinavian journal of urology,,,Article,2013-11-21,10.3109/21681805.2013.860189,,,,24255983,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1967209,https://api.altmetric.com/v1/donut/1967209_240.png 1,Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study.,Scandinavian journal of urology,,,Article,2013-11-21,10.3109/21681805.2013.846936,,,,24255954,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1967207,https://api.altmetric.com/v1/donut/1967207_240.png 1,CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers.,Biomarker Research,,,Article,2013-01-01,10.1186/2050-7771-1-22,,,,24252580,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1967169,https://api.altmetric.com/v1/donut/1967169_240.png 1,In Vitro Antimetastatic Effect of Phosphatidylinositol 3-Kinase Inhibitor ZSTK474 on Prostate Cancer PC3 Cells.,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140713577,,,,23812078,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1967151,https://api.altmetric.com/v1/donut/1967151_240.png 1,Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature.,Current Opinion in Urology,,,Article,2014-01-01,10.1097/mou.0000000000000011,,,,24257431,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1967053,https://api.altmetric.com/v1/donut/1967053_240.png 1,Outcomes of high-dose intensity-modulated radiotherapy alone with 1 cm planning target volume posterior margin for localized prostate cancer,Radiation Oncology,,,Article,2013-12-06,10.1186/1748-717x-8-285,,,,24314072,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1965362,https://api.altmetric.com/v1/donut/1965362_240.png 1,Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial.,World Journal of Urology,,,Article,2013-11-21,10.1007/s00345-013-1206-0,,,,24258313,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1965121,https://api.altmetric.com/v1/donut/1965121_240.png 1,Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices.,Advances in Urology,,,Article,2013-01-01,10.1155/2013/471234,,,,24260032,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1964978,https://api.altmetric.com/v1/donut/1964978_240.png 1,[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study,The Journal of Urology,,,Article,2010-04-01,10.1016/j.juro.2009.12.056,,,,20171670,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1955830,https://api.altmetric.com/v1/donut/1955830_240.png 1,When is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2013-12-01,10.1097/coc.0b013e31823a53fa,,,,22237149,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1952432,https://api.altmetric.com/v1/donut/1952432_240.png 1,Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study,BMC Cancer,,,Article,2013-11-27,10.1186/1471-2407-13-559,,,,24283992,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1951825,https://api.altmetric.com/v1/donut/1951825_240.png 1,"Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment.",Journal of Clinical Oncology,,,Article,2011-06-20,10.1200/jco.2010.33.2999,,,,21606419,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1948696,https://api.altmetric.com/v1/donut/1948696_240.png 1,Cabozantinib and prostate cancer: inhibiting seed and disrupting soil?,Clinical Cancer Research,,,Article,2013-11-27,10.1158/1078-0432.ccr-13-2636,,,,24284057,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1941129,https://api.altmetric.com/v1/donut/1941129_240.png 1,"Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity",Radiation Oncology,,,Article,2013-11-27,10.1186/1748-717x-8-276,,,,24279376,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1936940,https://api.altmetric.com/v1/donut/1936940_240.png 1,"Commentary on ""Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial."" Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, SchoffskiSchöffski P, Scheffold C, Weitzman AL, Hussain M, University of Michigan, Ann Arbor, MI: J Clin Oncol 2013;31(4):412-9. doi: 10.1200/JCO.2012.45.0494. Epub 2012 Nov 19.",Urologic Oncology,,,Article,2013-11-01,10.1016/j.urolonc.2013.07.012,,,,24210087,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1935305,https://api.altmetric.com/v1/donut/1935305_240.png 1,Importance of 5?-Reductase Gene Polymorphisms on Circulating and Intraprostatic Androgens in Prostate Cancer,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-1100,,,,24277450,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1934506,https://api.altmetric.com/v1/donut/1934506_240.png 1,3D versus 2D Systematic Transrectal Ultrasound-Guided Prostate Biopsy: Higher Cancer Detection Rate in Clinical Practice,Prostate Cancer,,,Article,2013-01-01,10.1155/2013/783243,,,,24349788,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1927496,https://api.altmetric.com/v1/donut/1927496_240.png 1,CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update.,Canadian Urological Association Journal,,,Article,2013-08-19,10.5489/cuaj.1542,,,,24032056,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/1923884,https://api.altmetric.com/v1/donut/1923884_240.png 1,Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies.,American Journal of Public Health,,,Article,2010-04-01,10.2105/ajph.2008.150508,,,,19608952,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1921892,https://api.altmetric.com/v1/donut/1921892_240.png 1,Intermittent LHRH Therapy in the Management of Castrate-resistant Prostate Cancer (CRPCa): Results of a Multi-institutional Randomized Prospective Clinical Trial,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2013-12-01,10.1097/coc.0b013e31825d5664,,,,22868247,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1921617,https://api.altmetric.com/v1/donut/1921617_240.png 1,Beyond the androgen receptor: New approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting,The Prostate,,,Article,2013-01-01,10.1002/pros.22753,,,,24249419,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1918920,https://api.altmetric.com/v1/donut/1918920_240.png 1,Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials.,European Urology,,,Article,2013-11-01,10.1016/j.eururo.2013.04.020,,,,23628492,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,27,https://www.altmetric.com/details/1914694,https://api.altmetric.com/v1/donut/1914694_240.png 1,MicroRNA?663 Induces Castration?Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence,Journal of Cellular Physiology,,,Article,2013-01-01,10.1002/jcp.24510,,,,24243035,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1912623,https://api.altmetric.com/v1/donut/1912623_240.png 1,Toxicity outcome in patients treated with modulated arc radiotherapy for localized prostate cancer,Reports of Practical Oncology & Radiotherapy,,,Article,2013-10-01,10.1016/j.rpor.2013.09.007,,,,25061516,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1907555,https://api.altmetric.com/v1/donut/1907555_240.png 1,Liposomal nanomedicines in the treatment of prostate cancer.,Cancer Treatment Reviews,,,Article,2013-10-25,10.1016/j.ctrv.2013.10.005,,,,24216226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1903562,https://api.altmetric.com/v1/donut/1903562_240.png 1,A prospective study of trans-fatty acid levels in blood and risk of prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2008-01-01,10.1158/1055-9965.epi-07-0673,,,,18199715,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1896090,https://api.altmetric.com/v1/donut/1896090_240.png 1,Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases,Radiation Oncology,,,Article,2013-11-08,10.1186/1748-717x-8-263,,,,24207129,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1894149,https://api.altmetric.com/v1/donut/1894149_240.png 1,Mandibular metastasis of adenocarcinoma from prostate cancer: case report according to epidemiology and current therapeutical trends of the advanced prostate cancer.,Journal of Applied Oral Science,,,Article,,10.1590/1679-775720130148,,,,24212997,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1893686,https://api.altmetric.com/v1/donut/1893686_240.png 1,Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells,Journal of Clinical Biochemistry and Nutrition,,,Article,2013-01-01,10.3164/jcbn.13-28,,,,24062605,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1893380,https://api.altmetric.com/v1/donut/1893380_240.png 1,"Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis",Journal for Immunotherapy of Cancer,,,Article,2013-11-07,10.1186/2051-1426-1-s1-p255,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1889403,https://api.altmetric.com/v1/donut/1889403_240.png 1,"Multiparametric Prostate MR Imaging with T2-weighted, Diffusion-weighted, and Dynamic Contrast-enhanced Sequences: Are All Pulse Sequences Necessary to Detect Locally Recurrent Prostate Cancer after Radiation Therapy?",Radiology,,,Article,2013-08-01,10.1148/radiol.13122149,,,,23481164,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1874113,https://api.altmetric.com/v1/donut/1874113_240.png 1,Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0078479,,,,24167630,PMC3805529,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1873949,https://api.altmetric.com/v1/donut/1873949_240.png 1,Prostate cancer: Patient-reported outcomes of first-line abiraterone therapy.,Nature Reviews Urology,,,Article,2013-10-22,10.1038/nrurol.2013.236,,,,24145475,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1873946,https://api.altmetric.com/v1/donut/1873946_240.png 1,Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study.,World Journal of Urology,,,Article,2013-10-29,10.1007/s00345-013-1196-y,,,,24166289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1873944,https://api.altmetric.com/v1/donut/1873944_240.png 1,Expression of Voltage-Gated Sodium Channel Nav1.8 in Human Prostate Cancer is Associated with High Histological Grade.,Journal of clinical & experimental oncology,,,Article,2012-11-01,10.4172/2324-9110.1000102,,,,24163825,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1873939,https://api.altmetric.com/v1/donut/1873939_240.png 1,Combinatorial antitumor effect of HDAC and the PI3K-Akt-mTOR pathway inhibition in a Pten defecient model of prostate cancer.,Oncotarget,,,Article,2013-09-27,10.18632/oncotarget.1314,,,,24163230,PMC3926822,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1873938,https://api.altmetric.com/v1/donut/1873938_240.png 1,MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential of Urinary miR-205 and miR-214.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0076994,,,,24167554,PMC3805541,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1873937,https://api.altmetric.com/v1/donut/1873937_240.png 1,Future Prospects in the Diagnosis and Management of Localized Prostate Cancer.,The Scientific World Journal,,,Article,2013-01-01,10.1155/2013/347263,,,,24163619,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1873907,https://api.altmetric.com/v1/donut/1873907_240.png 1,Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1-10.0 ng/ml at population screening.,Journal of Cancer Research & Clinical Oncology,,,Article,2013-10-29,10.1007/s00432-013-1543-9,,,,24165867,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1873903,https://api.altmetric.com/v1/donut/1873903_240.png 1,Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients.,Cancer Investigation,,,Article,2013-11-01,10.3109/07357907.2013.845673,,,,24138289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1873895,https://api.altmetric.com/v1/donut/1873895_240.png 1,An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy.,Physics in Medicine & Biology,,,Article,2013-11-07,10.1088/0031-9155/58/21/7733,,,,24140847,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1873885,https://api.altmetric.com/v1/donut/1873885_240.png 1,Detection and characterization of invasive circulating tumor cells (ictcs) derived from men with metastatic castration resistant prostate cancer (mCRPC).,International Journal of Cancer,,,Article,2013-10-25,10.1002/ijc.28561,,,,24166007,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1873884,https://api.altmetric.com/v1/donut/1873884_240.png 1,Proteomic signatures of angiogenesis in androgen-independent prostate cancer.,The Prostate,,,Article,2013-10-26,10.1002/pros.22747,,,,24166580,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1873883,https://api.altmetric.com/v1/donut/1873883_240.png 1,Editorial Comment to Denonvilliers' space expansion by transperineal injection of hydrogel: Implications for focal therapy of prostate cancer.,International Journal of Urology,,,Article,2013-10-24,10.1111/iju.12329,,,,24164674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1873881,https://api.altmetric.com/v1/donut/1873881_240.png 1,Prostate cancer: Does genetic score justify early prostate biopsy?,Nature Reviews Urology,,,Article,2013-10-22,10.1038/nrurol.2013.238,,,,24145474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1873876,https://api.altmetric.com/v1/donut/1873876_240.png 1,HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy.,The Open Cancer Immunology Journal,,,Article,2010-01-01,10.2174/1876401001003010001,,,,24163711,PMC3807132,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1873875,https://api.altmetric.com/v1/donut/1873875_240.png 1,The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer.,Andrology,,,Article,2013-11-01,10.1111/j.2047-2927.2013.00137.x,,,,24127273,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1873874,https://api.altmetric.com/v1/donut/1873874_240.png 1,Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line.,ISRN Oncology,,,Article,2013-01-01,10.1155/2013/918207,,,,24167746,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1873873,https://api.altmetric.com/v1/donut/1873873_240.png 1,Prostate cancer: Prediction of node-negative status after radical prostatectomy.,Nature Reviews Urology,,,Article,2013-10-22,10.1038/nrurol.2013.240,,,,24145470,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1873872,https://api.altmetric.com/v1/donut/1873872_240.png 1,"[New therapy concepts for castration-resistant prostate cancer : Between hormone manipulation, targeted therapy and chemotherapy.]",Der Urologe A,,,Article,2013-10-26,10.1007/s00120-013-3247-9,,,,24166056,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1873870,https://api.altmetric.com/v1/donut/1873870_240.png 1,A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.,Genes & Cancer,,,Article,2013-07-01,10.1177/1947601913499155,,,,24167657,PMC3807643,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1873868,https://api.altmetric.com/v1/donut/1873868_240.png 1,The impact of PSA testing frequency on prostate cancer incidence and treatment in older men.,Prostate Cancer & Prostatic Diseases,,,Article,2011-06-28,10.1038/pcan.2011.29,,,,21709691,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/1873486,https://api.altmetric.com/v1/donut/1873486_240.png 1,Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development,Frontiers in oncology,,,Article,2013-01-01,10.3389/fonc.2013.00273,,,,24199173,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/1872787,https://api.altmetric.com/v1/donut/1872787_240.png 1,The association between measures of progression and survival in castrate-metastatic prostate cancer.,Clinical Cancer Research,,,Article,2007-03-01,10.1158/1078-0432.ccr-06-1885,,,,17332293,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1862431,https://api.altmetric.com/v1/donut/1862431_240.png 1,"Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain",Journal of Translational Medicine,,,Article,2013-10-25,10.1186/1479-5876-11-269,,,,24161123,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1860786,https://api.altmetric.com/v1/donut/1860786_240.png 1,Safety and antitumor efficacy of 153Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer,Nuclear Medicine Communications,,,Article,2013-10-23,10.1097/mnm.0000000000000023,,,,24157942,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1858669,https://api.altmetric.com/v1/donut/1858669_240.png 1,Utility of adeno-associated viruses to target members of the TGF-? superfamily in prostate cancer therapy,Advances in Bioscience and Biotechnology,,,Article,2013-09-19,10.4236/abb.2013.410a4002,,,,,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1846320,https://api.altmetric.com/v1/donut/1846320_240.png 1,Population-based study on use of chemotherapy in men with castration resistant prostate cancer.,Acta Oncologica,,,Article,2013-11-01,10.3109/0284186x.2013.770164,,,,23427879,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1844704,https://api.altmetric.com/v1/donut/1844704_240.png 1,Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.,Endocrine-Related Cancer,,,Article,2006-03-01,10.1677/erc.1.01048,,,,16601286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1827155,https://api.altmetric.com/v1/donut/1827155_240.png 1,Re: Zinc Supplement Use and Risk of Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2003-01-01,10.1093/jnci/djg088,,,,14559884,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1817358,https://api.altmetric.com/v1/donut/1817358_240.png 1,Androgen deprivation results in time?dependent hypoxia in LNCaP prostate tumours: Informed scheduling of the bioreductive drug AQ4N improves treatment response,International Journal of Cancer,,,Article,2012-01-01,10.1002/ijc.27796,,,,22915157,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1813974,https://api.altmetric.com/v1/donut/1813974_240.png 1,"Effect of vitamin C on prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesis",The Prostate,,,Article,1998-12-07,10.1002/(sici)1097-0045(19970801)32:3<188::aid-pros5>3.0.co;2-h,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1809296,https://api.altmetric.com/v1/donut/1809296_240.png 1,Contemporaneous comparison of open vs minimallyâ??invasive radical prostatectomy for highâ??risk prostate cancer,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11757.x,,,,23356390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1808023,https://api.altmetric.com/v1/donut/1808023_240.png 1,Genome-Wide Investigation of Multifocal and Unifocal Prostate Cancer — Are They Genetically Different?,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140611816,,,,23736690,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1804600,https://api.altmetric.com/v1/donut/1804600_240.png 1,Farming and prostate cancer,Occupational and environmental medicine,,,Article,2007-03-01,10.1136/oem.2006.030932,,,,17339294,PMC2092529,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1798531,https://api.altmetric.com/v1/donut/1798531_240.png 1,The grape component piceatannol induces apoptosis in DU145 human prostate cancer cells via the activation of extrinsic and intrinsic pathways.,Journal of Medicinal Food,,,Article,2009-10-01,10.1089/jmf.2008.1341,,,,19857055,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1797973,https://api.altmetric.com/v1/donut/1797973_240.png 1,beta-carboline alkaloid-enriched extract from the amazonian rain forest tree pao pereira suppresses prostate cancer cells.,Journal of the Society for Integrative Oncology,,,Article,2009-01-01,,,,,19476740,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1793019,https://api.altmetric.com/v1/donut/1793019_240.png 1,Samarium-153 treatment of bone pain in patients with metastatic prostate cancer.,Danish Medical Bulletin,,,Article,2010-06-01,,,,,20515602,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1792865,https://api.altmetric.com/v1/donut/1792865_240.png 1,Deletion of the Olfactomedin 4 Gene Is Associated with Progression of Human Prostate Cancer,American Journal of Pathology,,,Article,2013-10-01,10.1016/j.ajpath.2013.06.028,,,,24070418,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1791736,https://api.altmetric.com/v1/donut/1791736_240.png 1,Mortality following Hip Fracture in Men with Prostate Cancer,PLoS ONE,,,Article,2013-09-27,10.1371/journal.pone.0074492,,,,24086350,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1791231,https://api.altmetric.com/v1/donut/1791231_240.png 1,Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2013-05-28,10.1038/pcan.2013.15,,,,23712318,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,https://www.altmetric.com/details/1784600,https://api.altmetric.com/v1/donut/1784600_240.png 1,Male breast cancer after finasteride therapy for benign prostate hyperplasia,Urological Science,,,Article,2013-09-01,10.1016/j.urols.2012.06.001,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1784062,https://api.altmetric.com/v1/donut/1784062_240.png 1,Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mdt335,,,,23946329,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1780775,https://api.altmetric.com/v1/donut/1780775_240.png 1,Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-01-01,10.1158/1055-9965.epi-08-0554,,,,19124480,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1776717,https://api.altmetric.com/v1/donut/1776717_240.png 1,Serum level of prostate-specific antigen (PSA) in women with breast cancer,Cancer Epidemiology,,,Article,2013-01-01,10.1016/j.canep.2013.06.009,,,,23932967,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1775751,https://api.altmetric.com/v1/donut/1775751_240.png 1,Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.,Gene,,,Article,2013-08-15,10.1016/j.gene.2013.04.018,,,,23608168,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1774902,https://api.altmetric.com/v1/donut/1774902_240.png 1,"Can we improve the definition of highâ??risk, hormone naïve, nonâ??metastatic prostate cancer?",British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12469,,,,24112742,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1772667,https://api.altmetric.com/v1/donut/1772667_240.png 1,Hypofractionnement à visée curative dans le cancer de la prostate ,Cancer Radiotherapie,,,Article,2013-01-01,10.1016/j.canrad.2013.05.005,,,,23973460,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1763611,https://api.altmetric.com/v1/donut/1763611_240.png 1,Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men – A cross-sectional study,Cytokine,,,Article,2013-08-01,10.1016/j.cyto.2013.04.008,,,,23669251,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1762834,https://api.altmetric.com/v1/donut/1762834_240.png 1,Does inflammation reduce the risk of prostate cancer?,British Journal of Urology,,,Article,2013-09-13,10.1111/bju.12303,,,,24028760,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1749811,https://api.altmetric.com/v1/donut/1749811_240.png 1,"Barriers to Prostate Cancer Prevention and Community Recommended Health Education Strategies in an Urban African American Community in Jackson, Mississippi.",Social Work in Public Health,,,Article,2013-06-30,10.1080/10911359.2013.763707,,,,23805806,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1743168,https://api.altmetric.com/v1/donut/1743168_240.png 1,Accurate IMRT fluence verification for prostate cancer patients using 'in-vivo' measured EPID images and in-room acquired kilovoltage cone-beam CT scans,Radiation Oncology,,,Article,2013-09-10,10.1186/1748-717x-8-211,,,,24020393,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1741059,https://api.altmetric.com/v1/donut/1741059_240.png 1,Fenofibrate down-regulates the expressions of Androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP.,Biochemical & Biophysical Research Communications,,,Article,2013-02-14,10.1016/j.bbrc.2013.01.105,,,,23399562,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1729605,https://api.altmetric.com/v1/donut/1729605_240.png 1,Epidemiology of prostate cancer in United Arab Emirates.,Medical Journal of Malaysia,,,Article,2004-06-12,,,,,15190657,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1729177,https://api.altmetric.com/v1/donut/1729177_240.png 1,Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells,PLoS ONE,,,Article,2013-08-26,10.1371/journal.pone.0074253,,,,23991216,PMC3753304,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1725617,https://api.altmetric.com/v1/donut/1725617_240.png 1,"Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate.",Cancer Research,,,Article,1990-02-01,,,,,2105161,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1722523,https://api.altmetric.com/v1/donut/1722523_240.png 1,Use of animal models in defining efficacy of chemoprevention agents against prostate cancer.,European Urology,,,Article,1999-01-01,19879,,,,10325505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1722522,https://api.altmetric.com/v1/donut/1722522_240.png 1,Methylation of the Retinoic Acid Receptor Beta Gene Increases Risk for Prostate Cancer in African Americans.,The Journal of Urology,"GREY, Jane W",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-02-06,10.1016/j.juro.2013.01.083,,,,23376149,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1715818,https://api.altmetric.com/v1/donut/1715818_240.png 1,Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2013-03-05,10.1038/pcan.2013.5,,,,23459096,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1715507,https://api.altmetric.com/v1/donut/1715507_240.png 1,Differences in prostate cancer detection rates according to the level of glomerular filtration rate in patients with prostate specific antigen levels of 4.010.0ng/ml,International journal of clinical practice,,,Article,2013-01-01,10.1111/j.1742-1241.2012.03014.x,,,,23679906,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1709582,https://api.altmetric.com/v1/donut/1709582_240.png 1,The significance of galectin-3 as a new basal cell marker in prostate cancer,Cell Death & Disease,,,Article,2013-08-04,10.1038/cddis.2013.277,,,,23907467,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/1705062,https://api.altmetric.com/v1/donut/1705062_240.png 1,The role of metabolic imaging in radiation therapy of prostate cancer,NMR in Biomedicine,,,Article,2013-08-11,10.1002/nbm.3007,,,,23940096,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1703811,https://api.altmetric.com/v1/donut/1703811_240.png 1,Characterization of a rat model of metastatic prostate cancer bone pain,Journal of Pain Research,,,Article,2011-01-05,10.2147/jpr.s14209,,,,21197325,PMC3004636,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1702665,https://api.altmetric.com/v1/donut/1702665_240.png 1,Antiâ??proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PCâ??3) cell line,Cell Biochemistry and Function,,,Article,2013-08-21,10.1002/cbf.2993,,,,23963693,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1701247,https://api.altmetric.com/v1/donut/1701247_240.png 1,Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer,Drugs,,,Article,2013-08-20,10.1007/s40265-013-0106-3,,,,23959841,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1700508,https://api.altmetric.com/v1/donut/1700508_240.png 1,Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer.,New England Journal of Medicine,,,Article,2011-02-19,10.1056/nejmcpc1005310,,,,21323545,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,29,https://www.altmetric.com/details/1700308,https://api.altmetric.com/v1/donut/1700308_240.png 1,"Effect of Finasteride on Serum Levels of Androstenedione, Testosterone and Their 5?-Reduced Metabolites in Men at Risk for Prostate Cancer.",Journal of Steroid Biochemistry & Molecular Biology,,,Article,2013-03-12,10.1016/j.jsbmb.2013.02.015,,,,23474436,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1700133,https://api.altmetric.com/v1/donut/1700133_240.png 1,Multimodality Therapy for Patients With High-Risk Prostate Cancer: Current Status and Future Directions,Seminars in oncology,,,Article,2013-01-01,10.1053/j.seminoncol.2013.04.006,,,,23806496,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1697441,https://api.altmetric.com/v1/donut/1697441_240.png 1,"Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.",Research communications in molecular pathology and pharmacology,,,Article,2007-06-16,,,,,17564322,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1695266,https://api.altmetric.com/v1/donut/1695266_240.png 1,"Mortality After Prostate Cancer Treatment with Radical Prostatectomy, External-Beam Radiation Therapy, or Brachytherapy in Men Without Comorbidity ",European Urology,,,Article,2013-03-21,10.1016/j.eururo.2013.03.005,,,,23506834,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1690382,https://api.altmetric.com/v1/donut/1690382_240.png 1,Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).,Cancer Causes and Control,,,Article,2000-10-01,,,,,11075874,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1688549,https://api.altmetric.com/v1/donut/1688549_240.png 1,Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.,Journal of Clinical Oncology,,,Article,2005-10-01,10.1200/jco.2005.01.867,,,,16192588,PMC2231088,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,74,https://www.altmetric.com/details/1684101,https://api.altmetric.com/v1/donut/1684101_240.png 1,Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.,British Journal of Cancer,,,Article,2013-07-23,10.1038/bjc.2013.396,,,,23880827,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1683885,https://api.altmetric.com/v1/donut/1683885_240.png 1,Early versus delayed hormonal treatment in locally advanced or asymptomatic metastatic prostatic cancer patient dilemma.,World Journal of Urology,,,Article,2013-08-08,10.1007/s00345-013-1144-x,,,,23925365,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1680606,https://api.altmetric.com/v1/donut/1680606_240.png 1,Prostate cancer: ADT use associated with acute kidney injury,Nature Reviews Urology,,,Article,2013-08-06,10.1038/nrurol.2013.167,,,,23917118,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1677295,https://api.altmetric.com/v1/donut/1677295_240.png 1,An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer.,European Urology,,,Article,2008-02-01,10.1016/j.eururo.2007.10.009,,,,17949893,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1672277,https://api.altmetric.com/v1/donut/1672277_240.png 1,Castration-resistant prostate cancer: a strategy to enhance response to androgen deprivation,Asian Journal of Andrology,,,Article,2013-07-29,10.1038/aja.2013.96,,,,23893155,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1672097,https://api.altmetric.com/v1/donut/1672097_240.png 1,When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer,Cancer Management and Research,,,Article,2013-07-20,10.2147/cmar.s34685,,,,23861598,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,6,https://www.altmetric.com/details/1669957,https://api.altmetric.com/v1/donut/1669957_240.png 1,Effect of Body Mass Index on Serum Prostate-specific Antigen Levels among Patients Presenting with Lower Urinary Tract Symptoms.,Asian Pacific Journal of Cancer Prevention,,,Article,2012-02-03,,,,,22292628,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1667516,https://api.altmetric.com/v1/donut/1667516_240.png 1,You know I've joined your club I'm the hot flush boy: a qualitative exploration of hot flushes and night sweats in men undergoing androgen deprivation therapy for prostate cancer,Psycho-Oncology,,,Article,2013-01-01,10.1002/pon.3355,,,,23893467,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1667108,https://api.altmetric.com/v1/donut/1667108_240.png 1,Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids,Osteoporosis International,,,Article,2013-08-01,10.1007/s00198-013-2462-y,,,,23903956,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1665700,https://api.altmetric.com/v1/donut/1665700_240.png 1,A retrospective analysis of the prognosis of prostate cancer patients with lymph node involvement on MR lymphography: who might be cured,Radiation Oncology,,,Article,2013-07-30,10.1186/1748-717x-8-190,,,,23898991,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1658737,https://api.altmetric.com/v1/donut/1658737_240.png 1,NewsCap: Prostate cancer guidelines,American Journal of Nursing,,,Article,2013-07-27,10.1097/01.naj.0000432951.72891.a8,,,,23883988,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1658021,https://api.altmetric.com/v1/donut/1658021_240.png 1,Clamp ablation of the testes compared to bilateral orchiectomy as androgen deprivation therapy for advanced prostate cancer.,International Brazilian Journal of Urology,,,Article,2010-12-05,,,,,21756382,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1653969,https://api.altmetric.com/v1/donut/1653969_240.png 1,Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer,Gene Therapy,,,Article,2013-07-11,10.1038/gt.2013.40,,,,23842593,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1653026,https://api.altmetric.com/v1/donut/1653026_240.png 1,Highâ??grade prostate cancer is associated with low serum testosterone levels,The Prostate,,,Article,2001-01-01,10.1002/pros.1046,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1649646,https://api.altmetric.com/v1/donut/1649646_240.png 1,Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.,International Journal of Pharmaceutics,,,Article,2013-05-01,10.1016/j.ijpharm.2013.04.047,,,,23623791,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/1646896,https://api.altmetric.com/v1/donut/1646896_240.png 1,Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy,International Journal of Urology,,,Article,2013-02-07,10.1111/iju.12073,,,,23379929,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/1646886,https://api.altmetric.com/v1/donut/1646886_240.png 1,Discovery of a Selective Irreversible BMX Inhibitor for Prostate Cancer,ACS Chemical Biology,,,Article,2013-04-20,10.1021/cb4000629,,,,23594111,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,18,https://www.altmetric.com/details/1646513,https://api.altmetric.com/v1/donut/1646513_240.png 1,Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer.,European Urology,,,Article,2013-06-15,10.1016/j.eururo.2013.05.030,,,,23759326,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,28,https://www.altmetric.com/details/1646402,https://api.altmetric.com/v1/donut/1646402_240.png 1,Ejaculation Profiles of Men Following Radiation Therapy for Prostate Cancer,Journal of Sexual Medicine,,,Article,2013-02-27,10.1111/jsm.12101,,,,23433425,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/1646055,https://api.altmetric.com/v1/donut/1646055_240.png 1,Prostate cancer: Reducing IGF-1 levels unlikely to ProtecT against prostate cancer initiation,Nature Reviews Urology,,,Article,2011-12-27,10.1038/nrurol.2011.211,,,,22200832,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1645535,https://api.altmetric.com/v1/donut/1645535_240.png 1,Radium-223 Improves Survival in Advanced Prostate Cancer,Journal Watch,,,Article,2013-07-17,10.1056/nejm-jw.na31553,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1643481,https://api.altmetric.com/v1/donut/1643481_240.png 1,A new approach to understanding racial disparities in prostate cancer treatment.,Journal of Geriatric Oncology,,,Article,2013-07-07,10.1016/j.jgo.2012.07.005,,,,23828723,PMC3697868,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1642993,https://api.altmetric.com/v1/donut/1642993_240.png 1,RAMP1 Is a Direct NKX3.1 Target Gene Up-Regulated in Prostate Cancer that Promotes Tumorigenesis,American Journal of Pathology,,,Article,2013-07-01,10.1016/j.ajpath.2013.05.021,,,,23867798,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1642308,https://api.altmetric.com/v1/donut/1642308_240.png 1,Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues.,Molecular Cancer Research,,,Article,2013-07-18,10.1158/1541-7786.mcr-13-0238,,,,23867565,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1641613,https://api.altmetric.com/v1/donut/1641613_240.png 1,Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer,British Journal of Cancer,,,Article,2013-06-27,10.1038/bjc.2013.340,,,,23807167,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1638425,https://api.altmetric.com/v1/donut/1638425_240.png 1,Pigmentation-related phenotypes and risk of prostate cancer.,British Journal of Cancer,,,Article,2013-07-16,10.1038/bjc.2013.385,,,,23860522,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1636064,https://api.altmetric.com/v1/donut/1636064_240.png 1,It is time to start active treatment in senior adults with prostate cancer.,Future Oncology,,,Article,2013-07-15,10.2217/fon.13.131,,,,23855286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1631074,https://api.altmetric.com/v1/donut/1631074_240.png 1,Functional and Molecular Imaging: Applications for Diagnosis and Staging of Localised Prostate Cancer,Clinical Oncology,,,Article,2013-08-01,10.1016/j.clon.2013.05.001,,,,23722008,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1630514,https://api.altmetric.com/v1/donut/1630514_240.png 1,"Association between Literacy, Compliance with Prostate Cancer Screening, and Cancer Aggressiveness: Results from a Brazilian Screening Study.",International Brazilian Journal of Urology,,,Article,2013-01-01,,,,,23849582,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1630013,https://api.altmetric.com/v1/donut/1630013_240.png 1,Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.,Canadian Urological Association Journal,,,Article,2013-07-06,10.5489/cuaj.478,,,,23826053,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1626914,https://api.altmetric.com/v1/donut/1626914_240.png 1,"Trends in the use of postprostatectomy therapies for patients with prostate cancer: A Surveillance, Epidemiology, and End Results Medicare analysis",Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28222,,,,23842985,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1615253,https://api.altmetric.com/v1/donut/1615253_240.png 1,Assessing the most accurate formula to predict the risk of lymph node metastases from prostate cancer in contemporary patients treated with radical prostatectomy and extended pelvic lymph node dissection.,Radiotherapy & Oncology,,,Article,2013-06-30,10.1016/j.radonc.2013.05.029,,,,23823866,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1606104,https://api.altmetric.com/v1/donut/1606104_240.png 1,The development of a web- and a print-based decision aid for prostate cancer screening,BMC Medical Informatics and Decision Making,,,Article,2010-03-03,10.1186/1472-6947-10-12,,,,20199680,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1602862,https://api.altmetric.com/v1/donut/1602862_240.png 1,Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.,Oncology Reports,,,Article,2006-01-03,,,,,16465406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1600215,https://api.altmetric.com/v1/donut/1600215_240.png 1,Do Nomograms Designed to Predict Biochemical Recurrence (BCR) Do a Better Job of Predicting More Clinically Relevant Prostate Cancer Outcomes than BCR? A Report from the SEARCH Database Group.,Urology,,,Article,2013-06-29,10.1016/j.urology.2012.10.090,,,,23806388,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1598143,https://api.altmetric.com/v1/donut/1598143_240.png 1,Predictors of pathological progression among men with localized prostate cancer undergoing active surveillance â?? a sub-analysis of the REDEEM (REduction by Dutasteride of clinical progression Events in Expectant Management of prostate cancer) study,The Journal of Urology,,,Article,2013-07-01,10.1016/j.juro.2013.06.051,,,,23820059,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1597037,https://api.altmetric.com/v1/donut/1597037_240.png 1,Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer a large nested caseâ??control study within the JANUS cohort in Norway,International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.28347,,,,23797698,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1595145,https://api.altmetric.com/v1/donut/1595145_240.png 1,PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.,Biomaterials,,,Article,2013-09-01,10.1016/j.biomaterials.2013.05.055,,,,23777916,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1593046,https://api.altmetric.com/v1/donut/1593046_240.png 1,Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer,PLoS ONE,,,Article,2013-06-28,10.1371/journal.pone.0066278,,,,23840433,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1592359,https://api.altmetric.com/v1/donut/1592359_240.png 1,Disappearing Floors and Second Chances: Men's Journeys of Prostate Cancer,International Journal of Men's Health,,,Article,2007-09-01,10.3149/jmh.0603.201,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1584291,https://api.altmetric.com/v1/donut/1584291_240.png 1,GRPR antagonists for prostate cancer|[mdash]|prospects and caveats,Nature Reviews Urology,,,Article,2013-06-25,10.1038/nrurol.2013.42-c1,,,,23797339,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1582161,https://api.altmetric.com/v1/donut/1582161_240.png 1,PSA screening for prostate cancer: why so much controversy?,Asian Journal of Andrology,,,Article,2013-06-17,10.1038/aja.2013.70,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1579139,https://api.altmetric.com/v1/donut/1579139_240.png 1,Serum Isoform [-2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2-10 ng/ml: A Multicentric European Study.,European Urology,,,Article,2013-02-06,10.1016/j.eururo.2013.01.011,,,,23375961,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1578523,https://api.altmetric.com/v1/donut/1578523_240.png 1,Recurrent deletion of 3p13 targets multiple tumor suppressor genes and defines a distinct subgroup of aggressive ERG fusion positive prostate cancers,The Journal of Pathology,,,Article,2013-01-01,10.1002/path.4223,,,,23794398,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1576298,https://api.altmetric.com/v1/donut/1576298_240.png 1,Prostate-Specific Antigen Bounce After High-Dose-Rate Monotherapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.02.032,,,,23582852,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1575677,https://api.altmetric.com/v1/donut/1575677_240.png 1,Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC Map: A prospective large-scale cohort study.,Journal of Magnetic Resonance Imaging,,,Article,2012-01-18,10.1002/jmri.23587,,,,22246980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1574436,https://api.altmetric.com/v1/donut/1574436_240.png 1,Interval to Biochemical Failure Predicts Clinical Outcomes in Patients With High-Risk Prostate Cancer Treated by Combined-Modality Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.03.028,,,,23664325,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1571575,https://api.altmetric.com/v1/donut/1571575_240.png 1,Incremental Value of MRI in Clinically High-risk Prostate Cancer: A Large Single-institution Experience of 922 Radical Prostatectomy,The Journal of Urology,,,Article,2013-06-20,10.1016/j.juro.2013.06.035,,,,23791890,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1570752,https://api.altmetric.com/v1/donut/1570752_240.png 1,Selective estrogen receptor modulators for BPH: new factors on the ground,Prostate Cancer & Prostatic Diseases,,,Article,2013-06-18,10.1038/pcan.2013.17,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1567898,https://api.altmetric.com/v1/donut/1567898_240.png 1,Searching for Prostate Cancer Stem Cells: Markers and Methods,Stem Cell Reviews,,,Article,2013-06-19,10.1007/s12015-013-9453-4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1567874,https://api.altmetric.com/v1/donut/1567874_240.png 1,"Effects of Pyridine Analogs of Curcumin on Growth, Apoptosis and NF-?B Activity in Prostate Cancer PC-3 Cells.",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2013-04-10,,,,,23564771,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1561983,https://api.altmetric.com/v1/donut/1561983_240.png 1,84 TRIAGE MRI FOLLOWED BY MRI-TARGETED BIOPSY FOR MEN WITH PROSTATE CANCER: A DECISION ANALYSIS,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2013.02.1462,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1560700,https://api.altmetric.com/v1/donut/1560700_240.png 1,Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer,PLoS ONE,,,Article,2013-06-14,10.1371/journal.pone.0065064,,,,23798998,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1559724,https://api.altmetric.com/v1/donut/1559724_240.png 1,Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance.,British Journal of Urology,,,Article,2013-06-07,10.1111/bju.12152,,,,23746297,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1553182,https://api.altmetric.com/v1/donut/1553182_240.png 1,Ultraviolet index and racial differences in prostate cancer incidence and mortality.,Cancer (0008543X),,,Article,2013-06-06,10.1002/cncr.28127,,,,23744754,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1542392,https://api.altmetric.com/v1/donut/1542392_240.png 1,The histone methyltransferase MMSET|[sol]|WHSC1 activates TWIST1 to promote an epithelial|[ndash]|mesenchymal transition and invasive properties of prostate cancer,Oncogene,,,Article,2012-07-16,10.1038/onc.2012.297,,,,22797064,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/1539356,https://api.altmetric.com/v1/donut/1539356_240.png 1,Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival,Molecular Cancer,,,Article,2013-06-05,10.1186/1476-4598-12-52,,,,23734815,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1532124,https://api.altmetric.com/v1/donut/1532124_240.png 1,Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) Over Time Among Men Treated for Localized Prostate Cancer.,Journal of Personality Assessment,,,Article,2012-05-12,10.1080/00223891.2012.681819,,,,22571442,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1522786,https://api.altmetric.com/v1/donut/1522786_240.png 1,Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.,Cancer (0008543X),,,Article,1970-01-01,10.1002/cncr.26103,,,,21456009,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1520176,https://api.altmetric.com/v1/donut/1520176_240.png 1,Favourable longâ??term outcomes with brachytherapyâ??based regimens in men â?¤60 years with clinically localized prostate cancer,British Journal of Urology,,,Article,2013-05-28,10.1111/j.1464-410x.2012.11769.x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1520101,https://api.altmetric.com/v1/donut/1520101_240.png 1,Researchers identify novel class of drugs for prostate cancers,ecancer.org,,,Article,,,,,http://ecancer.org/news/4103-researchers-identify-novel-class-of-drugs-for-prostate-cancers.php,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1517302,https://api.altmetric.com/v1/donut/1517302_240.png 1,Differentially expressed genes in tumors of prostate cancer in American patients with European and African origin,Journal of Pharmacy Research,,,Article,2013-05-01,10.1016/j.jopr.2013.04.036,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1507828,https://api.altmetric.com/v1/donut/1507828_240.png 1,Hypofractionated Radiation Therapy (66 Gy in 22 Fractions at 3 Gy per Fraction) for Favorable-Risk Prostate Cancer: Long-term Outcomes,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.02.010,,,,23597418,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1507724,https://api.altmetric.com/v1/donut/1507724_240.png 1,Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be more,Asian Journal of Andrology,,,Article,2013-05-20,10.1038/aja.2013.57,,,,23685907,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1505428,https://api.altmetric.com/v1/donut/1505428_240.png 1,Variable Metastatic Potentials Correlate with Differential Plectin and Vimentin Expression in Syngeneic Androgen Independent Prostate Cancer Cells,PLoS ONE,,,Article,2013-05-22,10.1371/journal.pone.0065005,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1502375,https://api.altmetric.com/v1/donut/1502375_240.png 1,Whole-Pelvic Nodal Radiation Therapy in the Context of Hypofractionation for High-Risk Prostate Cancer Patients: A Step Forward,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-03-27,10.1016/j.ijrobp.2013.02.006,,,,23523182,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1501604,https://api.altmetric.com/v1/donut/1501604_240.png 1,Treatment of Castrate-Resistant Prostate Cancer,The Journal of Urology,,,Article,2013-05-22,10.1016/j.juro.2013.05.041,,,,23707438,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1499378,https://api.altmetric.com/v1/donut/1499378_240.png 1,MR Spectroscopic Imaging of Peripheral Zone in Prostate Cancer Using a 3T MRI Scanner: Endorectal versus External Phased Array Coils,Magnetic Resonance Insights,,,Article,2013-05-01,10.4137/mri.s10861,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1493200,https://api.altmetric.com/v1/donut/1493200_240.png 1,Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-13-0080,,,,23687346,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,86,https://www.altmetric.com/details/1492207,https://api.altmetric.com/v1/donut/1492207_240.png 1,A review of tasquinimod in the treatment of advanced prostate cancer.,"Drug Design, Development and Therapy",,,Article,2013-05-12,10.2147/dddt.s31500,,,,23662046,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1477631,https://api.altmetric.com/v1/donut/1477631_240.png 1,A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.,Cellular Signalling,,,Article,2008-04-22,10.1016/j.cellsig.2008.02.021,,,,18424072,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/1475252,https://api.altmetric.com/v1/donut/1475252_240.png 1,Photoselective vaporization of the prostate – towards a new standard,Prostate Cancer & Prostatic Diseases,,,Article,2007-03-01,10.1038/sj.pcan.4500951,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,6,https://www.altmetric.com/details/1473768,https://api.altmetric.com/v1/donut/1473768_240.png 1,Novel approaches and future directions in castration-resistant prostate cancer,Annals of Oncology,,,Article,2011-01-01,10.1093/annonc/mdq639,,,,21252057,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1470957,https://api.altmetric.com/v1/donut/1470957_240.png 1,The Synthesis of Neurotensin Antagonist SR 48692 for Prostate Cancer Research,Bioorganic & Medicinal Chemistry,,,Article,2013-05-01,10.1016/j.bmc.2013.04.075,,,,23721919,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1467833,https://api.altmetric.com/v1/donut/1467833_240.png 1,The Steroid Receptor Coactivator-3 Is Required for the Development of Castration-resistant Prostate Cancer,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3929,,,,23650284,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1465868,https://api.altmetric.com/v1/donut/1465868_240.png 1,Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer,Current Opinion in Urology,,,Article,2013-05-09,10.1097/mou.0b013e328361d467,,,,23619581,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1464701,https://api.altmetric.com/v1/donut/1464701_240.png 1,AKR1C3 is a biomarker and therapeutic target for Castration Resistant Prostate Cancer.,Molecular Medicine,,,Article,2012-12-02,10.2119/molmed.2012.00296,,,,23196782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1459281,https://api.altmetric.com/v1/donut/1459281_240.png 1,719 SALVAGE RADIATION THERAPY AFTER RECURRENT PROSTATE CANCER: HOW EARLY DO WE NEED TO BE ?,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2013.02.278,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1436530,https://api.altmetric.com/v1/donut/1436530_240.png 1,The Role of Sarcosine Metabolism in Prostate Cancer Progression,Neoplasia,,,Article,2013-05-01,,,,,23633921,PMC3638352,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/1435913,https://api.altmetric.com/v1/donut/1435913_240.png 1,A randomised controlled trial of a cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN): trial protocol,BMC Cancer,,,Article,2012-06-11,10.1186/1471-2407-12-230,,,,22687265,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1426449,https://api.altmetric.com/v1/donut/1426449_240.png 1,Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells.,Journal of Alternative & Complementary Medicine,,,Article,2003-08-01,10.1089/107555303322284776,,,,14499024,,,,,,,0,0,0,0,0,0,6,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1422315,https://api.altmetric.com/v1/donut/1422315_240.png 1,Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk,British Journal of Cancer,,,Article,2013-04-23,10.1038/bjc.2013.184,,,,23612451,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1419510,https://api.altmetric.com/v1/donut/1419510_240.png 1,Weight Gain Is Associated with an Increased Risk of Prostate Cancer Recurrence after Prostatectomy in the PSA Era,Cancer Prevention Research,,,Article,2011-01-01,10.1158/1940-6207.capr-10-0257,,,,21325564,PMC3072036,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1409193,https://api.altmetric.com/v1/donut/1409193_240.png 1,The prognostic significance of vasohibin-1 expression in patients with prostate cancer.,British Journal of Cancer,,,Article,2013-04-19,10.1038/bjc.2013.169,,,,23591203,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1408396,https://api.altmetric.com/v1/donut/1408396_240.png 1,What happens to older men after a screening test for prostate cancer?,British Medical Journal,,,Article,2013-04-17,10.1136/bmj.f2421,,,,23596225,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1398952,https://api.altmetric.com/v1/donut/1398952_240.png 1,Modulation of the unfolded protein response by GRP78 in prostate cancer.,Methods in enzymology,,,Article,2011-01-27,10.1016/b978-0-12-385116-1.00014-5,,,,21266234,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,21,https://www.altmetric.com/details/1388854,https://api.altmetric.com/v1/donut/1388854_240.png 1,Prostate volume as an independent predictor of prostate cancer in men with PSA of 10|[ndash]|50|[nbsp]|ng ml|[minus]|1,Asian Journal of Andrology,,,Article,2013-04-08,10.1038/aja.2013.11,,,,23564045,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1385753,https://api.altmetric.com/v1/donut/1385753_240.png 1,Genome-Wide Testing of Putative Functional Exonic Variants in Relationship with Breast and Prostate Cancer Risk in a Multiethnic Population,PLoS Genetics,,,Article,2013-03-28,10.1371/journal.pgen.1003419,,,,23555315,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/1385380,https://api.altmetric.com/v1/donut/1385380_240.png 1,PSA testing: an evolving relationship with prostate cancer screening,Prostate Cancer & Prostatic Diseases,,,Article,2005-11-29,10.1038/sj.pcan.4500838,,,,16314892,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1363442,https://api.altmetric.com/v1/donut/1363442_240.png 1,[5 alpha-reductase inhibitors and prostate cancer: A statement of the Committee of Cancerology of the French Association of Urology].,Progrès en Urologie,,,Article,2012-08-29,10.1016/j.purol.2012.04.007,,,,22920332,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1360552,https://api.altmetric.com/v1/donut/1360552_240.png 1,Characterization of SNPs Associated with Prostate Cancer in Men of Ashkenazic Descent from the Set of GWAS Identified SNPs: Impact of Cancer Family History and Cumulative SNP Risk Prediction,PLoS ONE,,,Article,2013-04-03,10.1371/journal.pone.0060083,,,,23573233,PMC3616024,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1337091,https://api.altmetric.com/v1/donut/1337091_240.png 1,Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-03-28,10.1016/j.ijrobp.2012.12.029,,,,23541810,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1333454,https://api.altmetric.com/v1/donut/1333454_240.png 1,Cadmium and prostate cancer.,"Journal of Toxicology and Environmental Health, Part A",,,Article,1994-11-01,10.1080/15287399409531920,,,,7966437,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1329657,https://api.altmetric.com/v1/donut/1329657_240.png 1,Interleukin-1? promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features.,Cancer Research,,,Article,2013-03-27,10.1158/0008-5472.can-12-3970,,,,23536554,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1328749,https://api.altmetric.com/v1/donut/1328749_240.png 1,Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11?380 men with serum PSA level 20-100?ng/mL.,British Journal of Urology,,,Article,2012-07-06,10.1111/j.1464-410x.2012.11320.x,,,,22758210,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/1328239,https://api.altmetric.com/v1/donut/1328239_240.png 1,"Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study.",Annals of Oncology,,,Article,2013-03-27,10.1093/annonc/mdt107,,,,23535954,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1328156,https://api.altmetric.com/v1/donut/1328156_240.png 1,Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy,Physics in Medicine & Biology,,,Article,2013-04-21,10.1088/0031-9155/58/8/2581,,,,23528429,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1326643,https://api.altmetric.com/v1/donut/1326643_240.png 1,"Study reveals the genetic variations that raise the risk of breast, prostate or ovarian cancer",ecancer.org,,,Article,,,,,http://ecancer.org/news/3959-study-reveals-the-genetic-variations-that-raise-the-risk-of-breast--prostate-or-ovarian-cancer.php,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1326087,https://api.altmetric.com/v1/donut/1326087_240.png 1,Multidisciplinary care in patients with prostate cancer: room for improvement.,Supportive Care in Cancer,,,Article,2013-03-26,10.1007/s00520-013-1791-x,,,,23529667,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1325175,https://api.altmetric.com/v1/donut/1325175_240.png 1,Prostate Cancer: Duration of Androgen Blockade Inconclusive for 18 vs. 36 Months,Oncology times,,,Article,2013-03-25,10.1097/01.cot.0000428624.15680.02,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1322267,https://api.altmetric.com/v1/donut/1322267_240.png 1,Osteoporosis after orchiectomy for prostate cancer.,The Journal of Urology,,,Article,1997-02-01,,,,,8996327,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1313469,https://api.altmetric.com/v1/donut/1313469_240.png 1,Exosomal miRNAs as Biomarkers for Prostate Cancer,Frontiers in Genetics,,,Article,2013-01-01,10.3389/fgene.2013.00036,,,,23519132,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/1313423,https://api.altmetric.com/v1/donut/1313423_240.png 1,Molecular Pathways: Blockade of the PRLR Signaling Pathway as a Novel Antihormonal Approach for the Treatment of Breast and Prostate Cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-0138,,,,23515410,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1313045,https://api.altmetric.com/v1/donut/1313045_240.png 1,Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.,Cancer Causes and Control,,,Article,2012-07-21,10.1007/s10552-012-0028-5,,,,22810146,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1309753,https://api.altmetric.com/v1/donut/1309753_240.png 1,Contrast-Enhanced Ultrasound May Aid Prostate Cancer Detection,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djt079,,,,23492350,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1301979,https://api.altmetric.com/v1/donut/1301979_240.png 1,Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer,PLoS ONE,,,Article,2013-03-12,10.1371/journal.pone.0058929,,,,23554959,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1297393,https://api.altmetric.com/v1/donut/1297393_240.png 1,Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer.,Radiotherapy & Oncology,,,Article,2010-05-01,10.1016/j.radonc.2010.03.024,,,,20430459,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,30,https://www.altmetric.com/details/1297245,https://api.altmetric.com/v1/donut/1297245_240.png 1,Pharmacoproteomic Study of the Natural Product Ebenfuran III in DU-145 Prostate Cancer Cells: The Quantitative and Temporal Interrogation of Chemically Induced Cell Death at the Protein Level,Journal of Proteome Research,,,Article,2013-02-21,10.1021/pr300968q,,,,23418717,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1297091,https://api.altmetric.com/v1/donut/1297091_240.png 1,Selenium supplementation has no effect on serum glucose levels in men at high risk for Prostate Cancer,Journal of Diabetes,,,Article,2010-01-01,10.1111/1753-0407.12041,,,,23489776,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1295621,https://api.altmetric.com/v1/donut/1295621_240.png 1,5? UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer,PLoS ONE,,,Article,2013-03-05,10.1371/journal.pone.0049721,,,,23472063,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1294439,https://api.altmetric.com/v1/donut/1294439_240.png 1,"Exercise improves fatigue during and after breast and prostate cancer treatment, with benefits seen for aerobic exercise",Evidence Based Nursing,,,Article,2013-02-28,10.1136/eb-2012-101198,,,,23449841,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1293580,https://api.altmetric.com/v1/donut/1293580_240.png 1,"Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy",PLoS ONE,,,Article,2013-02-27,10.1371/journal.pone.0057480,,,,23460864,PMC3583836,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1290883,https://api.altmetric.com/v1/donut/1290883_240.png 1,Lessons from in-vivo models of castration-resistant prostate cancer.,Current Opinion in Urology,,,Article,2013-02-08,10.1097/mou.0b013e32835e9f07,,,,23385975,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/1290206,https://api.altmetric.com/v1/donut/1290206_240.png 1,Novel Strategies to Test Biological Hypotheses in Early Drug Development for Advanced Prostate Cancer,Clinical Chemistry,,,Article,2012-01-01,10.1373/clinchem.2012.185157,,,,23204221,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1288686,https://api.altmetric.com/v1/donut/1288686_240.png 1,Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis,Core Evidence,,,Article,2013-03-01,10.2147/ce.s41178,,,,23526383,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1286321,https://api.altmetric.com/v1/donut/1286321_240.png 1,How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?,British Journal of Urology,,,Article,2013-03-04,10.1111/j.1464-410x.2012.11493.x,,,,23451984,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1280855,https://api.altmetric.com/v1/donut/1280855_240.png 1,Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells,PLoS ONE,,,Article,2013-03-04,10.1371/journal.pone.0058267,,,,23469273,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1280712,https://api.altmetric.com/v1/donut/1280712_240.png 1,"Genetic Polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) Genes Associated With Pathological Characteristics of Prostate Cancer in the Ecuadorian Population",The American Journal of the Medical Sciences,,,Article,2013-03-01,10.1097/maj.0b013e3182882578,,,,23459165,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1280251,https://api.altmetric.com/v1/donut/1280251_240.png 1,Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.,European Radiology,,,Article,2013-02-06,10.1007/s00330-013-2768-3,,,,23377546,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,28,https://www.altmetric.com/details/1273980,https://api.altmetric.com/v1/donut/1273980_240.png 1,Base pair resolution analysis of TMPRSS2â??ERG rearrangements in prostate cancer,The Journal of Pathology,,,Article,2013-01-01,10.1002/path.4186,,,,23447416,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1271636,https://api.altmetric.com/v1/donut/1271636_240.png 1,A prospective study of dietary fat and risk of prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,1993-01-01,10.1093/jnci/85.19.1571,,,,8105097,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1265976,https://api.altmetric.com/v1/donut/1265976_240.png 1,Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.,Prostate Cancer & Prostatic Diseases,,,Article,2009-07-16,10.1038/pcan.2009.10,,,,19597532,PMC2834330,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1262777,https://api.altmetric.com/v1/donut/1262777_240.png 1,Management of localized prostate cancer and an incidental ureteral duplication with upper pole ectopic ureter inserting into the prostatic urethra.,Reviews in Urology,,,Article,2009-01-17,,,,,19145274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1259768,https://api.altmetric.com/v1/donut/1259768_240.png 1,Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?,International Journal of Urology,,,Article,2013-02-09,10.1111/iju.12112,,,,23387553,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1257903,https://api.altmetric.com/v1/donut/1257903_240.png 1,"Effects of Iejimalide B, a marine macrolide, on growth and apoptosis in prostate cancer cell lines",Journal of Cellular Biochemistry,,,Article,2008-01-01,10.1002/jcb.21898,,,,18773415,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/1252816,https://api.altmetric.com/v1/donut/1252816_240.png 1,Drug could delay invasive treatment for low-risk prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2359-drug-could-delay-invasive-treatment-for-low-risk-prostate-cancer.php,,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251936,https://api.altmetric.com/v1/donut/1251936_240.png 1,Research aims to improve effectiveness of radiotherapy treatment for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/2396-research-aims-to-improve-effectiveness-of-radiotherapy-treatment-for-prostate-cancer.php,,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251922,https://api.altmetric.com/v1/donut/1251922_240.png 1,Prostate cancer risk halved for subfertile men,ecancer.org,,,Article,,,,,http://ecancer.org/news/2411-prostate-cancer-risk-halved-for-subfertile-men.php,,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251916,https://api.altmetric.com/v1/donut/1251916_240.png 1,"New prostate cancer screening guidelines face a tough sell, study suggests",ecancer.org,,,Article,,,,,http://ecancer.org/news/2863-new-prostate-cancer-screening-guidelines-face-a-tough-sell--study-suggests.php,,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251880,https://api.altmetric.com/v1/donut/1251880_240.png 1,New therapeutic target for prostate cancer identified,ecancer.org,,,Article,,,,,http://ecancer.org/news/3240-new-therapeutic-target-for-prostate-cancer-identified.php,,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251873,https://api.altmetric.com/v1/donut/1251873_240.png 1,ASTRO 2012: Sildenafil citrate improves overall sexual function of prostate cancer patients receiving radiation therapy.,ecancer.org,,,Article,,,,,http://ecancer.org/news/3522-astro-2012--sildenafil-citrate-improves-overall-sexual-function-of-prostate-cancer-patients--receiving-radiation-therapy.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251786,https://api.altmetric.com/v1/donut/1251786_240.png 1,New study confirms erroneous link between XMRV and prostate cancer-contamination was the cause.,ecancer.org,,,Article,,,,,http://ecancer.org/news/3392-new-study-confirms-erroneous-link-between-xmrv-and-prostate-cancer-contamination-was-the-cause.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250892,https://api.altmetric.com/v1/donut/1250892_240.png 1,Phase II clinical trial of cediranib in patients with metastatic castrationâ??resistant prostate cancer,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11667.x,,,,23419134,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1250215,https://api.altmetric.com/v1/donut/1250215_240.png 1,Prostate cancer: Are urologists ready to manage castration-resistant disease?,Nature Reviews Urology,,,Article,2013-02-19,10.1038/nrurol.2013.25,,,,23419493,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1248568,https://api.altmetric.com/v1/donut/1248568_240.png 1,Quantification of fractal dimension and Shannon's entropy in histological diagnosis of Prostate cancer,BMC Clinical Pathology,,,Article,2013-02-18,10.1186/1472-6890-13-6,,,,23414368,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1245773,https://api.altmetric.com/v1/donut/1245773_240.png 1,Clinical Applications of Novel ERG Immunohistochemistry in Prostate Cancer Diagnosis and Management,Advances in Anatomic Pathology,,,Article,2013-03-01,10.1097/pap.0b013e3182862ac5,,,,23399797,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1242639,https://api.altmetric.com/v1/donut/1242639_240.png 1,Immunotherapy with Sipuleucel-T (APC8015) in patients with metastatic castration-refractory prostate cancer (mCRPC): a systematic review and meta-analysis,International Brazilian Journal of Urology,,,Article,2012-01-01,10.1590/1677-553820133806717,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1242636,https://api.altmetric.com/v1/donut/1242636_240.png 1,Variability Over Time-Since- Diagnosis in the Protective Effect of Psychological Resilience Against Depression in Australian Prostate Cancer Patients Implications for Patient Treatment Models,American Journal of Men's Health,,,Article,2013-09-14,10.1177/1557988313477126,,,,23403776,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1234028,https://api.altmetric.com/v1/donut/1234028_240.png 1,Fruit and vegetable intakes and prostate cancer risk.,JNCI: Journal of the National Cancer Institute,,,Article,2000-01-05,,,,,10620635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1230448,https://api.altmetric.com/v1/donut/1230448_240.png 1,"Man to Man and Side by Side, They Cope with Prostate Cancer",Journal of Psychosocial Oncology,,,Article,2006-04-12,10.1300/j077v23n04_05,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1229531,https://api.altmetric.com/v1/donut/1229531_240.png 1,"""She's Right Behind Me All the Way"": An Analysis of Prostate Cancer Narratives and Changes in Family Relationships",Journal of Family Communication,,,Article,2005-01-04,10.1207/s15327698jfc0502_5,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1229528,https://api.altmetric.com/v1/donut/1229528_240.png 1,Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.,The Journal of Urology,,,Article,2012-12-20,10.1016/j.juro.2012.11.016,,,,23234631,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,11,https://www.altmetric.com/details/1228259,https://api.altmetric.com/v1/donut/1228259_240.png 1,Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y,PLoS ONE,,,Article,2013-02-04,10.1371/journal.pone.0055207,,,,23390522,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1228156,https://api.altmetric.com/v1/donut/1228156_240.png 1,Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy,New England Journal of Medicine,,,Article,2013-02-07,10.1056/nejmx130004,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1224626,https://api.altmetric.com/v1/donut/1224626_240.png 1,Is angiogenesis a hallmark of prostate cancer?,Frontiers in oncology,,,Article,2013-01-01,10.3389/fonc.2013.00015,,,,23390615,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1222217,https://api.altmetric.com/v1/donut/1222217_240.png 1,Re: Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.10.124,,,,23312158,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1221640,https://api.altmetric.com/v1/donut/1221640_240.png 1,Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.06.030,,,,22836052,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1220009,https://api.altmetric.com/v1/donut/1220009_240.png 1,Utilities for prostate cancer health states in men aged 60 and older.,Medical care,,,Article,2005-03-23,,,,,15778638,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1219252,https://api.altmetric.com/v1/donut/1219252_240.png 1,Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments,Prostate Cancer & Prostatic Diseases,,,Article,2013-02-05,10.1038/pcan.2013.1,,,,23381695,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1219045,https://api.altmetric.com/v1/donut/1219045_240.png 1,"Incidence of prostate, breast, lung and colorectal cancer following new consultation for musculoskeletal pain: A cohort study among UK primary care patients.",International Journal of Cancer,,,Article,2013-01-25,10.1002/ijc.28055,,,,23354595,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1207320,https://api.altmetric.com/v1/donut/1207320_240.png 1,A method for using life tables to estimate lifetime risk for prostate cancer death.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2010-02-10,,,,,20141675,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1204022,https://api.altmetric.com/v1/donut/1204022_240.png 1,2-weekly versus 3-weekly docetaxel for prostate cancer,Lancet Oncology,,,Article,2013-02-01,10.1016/s1470-2045(12)70579-x,,,,23294852,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1203257,https://api.altmetric.com/v1/donut/1203257_240.png 1,Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk,Cancer Research,,,Article,2008-01-01,10.1158/0008-5472.can-08-1827,,,,19074884,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1200638,https://api.altmetric.com/v1/donut/1200638_240.png 1,[Comparison of CT- and MRI-based clinical target volumes for 3 dimensional conformal external-beam radiotherapy of prostate cancer].,Magyar Onkológia,,,Article,2012-12-15,magyonkol.2012.56.4.267,,,,23236597,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1199401,https://api.altmetric.com/v1/donut/1199401_240.png 1,Metallothionein 1h Tumor Suppressor Activity in Prostate Cancer Is Mediated By Euchromatin Methyltransferase 1,The Journal of Pathology,,,Article,2013-06-14,10.1002/path.4169,,,,23355073,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1199010,https://api.altmetric.com/v1/donut/1199010_240.png 1,"Sabutoclax, a Mcl-1 Antagonist, Inhibits Tumorigenesis in Transgenic Mouse and Human Xenograft Models of Prostate Cancer",Neoplasia,,,Article,2012-07-01,,,,,22904682,PMC3421961,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1194345,https://api.altmetric.com/v1/donut/1194345_240.png 1,The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups.,Current Medical Research & Opinion,,,Article,2007-07-28,10.1185/030079907x219526,,,,17651539,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1192294,https://api.altmetric.com/v1/donut/1192294_240.png 1,Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer: A Phase II Study,Clinical Nuclear Medicine,,,Article,2013-02-01,10.1097/rlu.0b013e318279bf4d,,,,23334120,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1191890,https://api.altmetric.com/v1/donut/1191890_240.png 1,Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-2474,,,,23328584,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1183616,https://api.altmetric.com/v1/donut/1183616_240.png 1,Familial prostate cancer: the damage done and lessons learnt,Nature Reviews Urology,,,Article,2013-01-15,10.1038/nrurol.2012.257,,,,23318356,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1181647,https://api.altmetric.com/v1/donut/1181647_240.png 1,Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mds618,,,,23277483,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1180048,https://api.altmetric.com/v1/donut/1180048_240.png 1,Growth hormone affects gene expression and proliferation in human prostate cancer cells.,International Journal of Andrology,,,Article,2011-01-04,10.1111/j.1365-2605.2010.01064.x,,,,20546049,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1179404,https://api.altmetric.com/v1/donut/1179404_240.png 1,Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11648.x,,,,23320731,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1177809,https://api.altmetric.com/v1/donut/1177809_240.png 1,Impact of Neoadjuvant Prostate-Specific Antigen Kinetics on Biochemical Failure and Prostate Cancer Mortality: Results From a Prospective Patient Database,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.04.009,,,,22652112,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1173780,https://api.altmetric.com/v1/donut/1173780_240.png 1,Lack of reliability of nanotechnology in the of free plasma DNA in samples of patients with prostate cancer,International Archives of Medicine,,,Article,2013-01-12,10.1186/1755-7682-6-2,,,,23311763,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1172564,https://api.altmetric.com/v1/donut/1172564_240.png 1,Gracilis muscle interposition via primary rectal without urethral repair for moderate sized rectourethral fistula caused by brachytherapy for prostate cancer: a case report.,Journal of Medical Case Reports,,,Article,2012-09-28,10.1186/1752-1947-6-323,,,,23009550,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1170619,https://api.altmetric.com/v1/donut/1170619_240.png 1,"Acute Radiation-Induced Nocturia in Prostate Cancer Patients Is Associated With Pretreatment Symptoms, Radical Prostatectomy, and Genetic Markers in the TGFβ1 Gene","International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.02.061,,,,22658438,,1854/LU-3110366,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1167565,https://api.altmetric.com/v1/donut/1167565_240.png 1,Anterior gradient 2 and 3: two prototype androgen responsive genes transcriptionally upregulated by androgens and by estrogens in prostate cancer cells,FEBS Journal,,,Article,2013-01-01,10.1111/febs.12118,,,,23294566,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1158915,https://api.altmetric.com/v1/donut/1158915_240.png 1,Effect of Ukrain on cell survival and apoptosis in the androgen-independent prostate cancer cell line PC-3.,"Journal of Environmental Pathology, Toxicology & Oncology",,,Article,2011-05-27,,,,,21609312,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1155442,https://api.altmetric.com/v1/donut/1155442_240.png 1,Prostate Cancer: Focused Radiation Achieves Good Disease Control with Minimal Toxicity,Oncology times,,,Article,2013-01-10,10.1097/01.cot.0000425914.60398.2f,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1154873,https://api.altmetric.com/v1/donut/1154873_240.png 1,"Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.",The Journal of Urology,,,Article,2007-01-17,10.1016/j.juro.2006.09.053,,,,17222625,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1152223,https://api.altmetric.com/v1/donut/1152223_240.png 1,Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care.,Drug Safety,,,Article,2011-10-12,10.2165/11594540-000000000-00000,,,,21981434,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1150186,https://api.altmetric.com/v1/donut/1150186_240.png 1,Cancer of the prostate presenting with diffuse osteolytic metastatic bone lesions: a case report,Journal of Medical Case Reports,,,Article,2012-12-28,10.1186/1752-1947-6-425,,,,23273271,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1149677,https://api.altmetric.com/v1/donut/1149677_240.png 1,Singleâ??cell analysis of circulating tumor cells identifies cumulative expression patterns of EMTâ??related genes in metastatic prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22625,,,,23280481,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1148784,https://api.altmetric.com/v1/donut/1148784_240.png 1,Prostate cancer screening in a Saudi population: an explanatory trial study.,Prostate Cancer & Prostatic Diseases,,,Article,2010-01-13,10.1038/pcan.2009.60,,,,20066007,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1141927,https://api.altmetric.com/v1/donut/1141927_240.png 1,The change of prostate cancer treatment in Korea: 5 year analysis of a single institution.,Yonsei Medical Journal,,,Article,2012-12-13,10.3349/ymj.2013.54.1.87,,,,23225803,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1138741,https://api.altmetric.com/v1/donut/1138741_240.png 1,Reduction in Physician Reimbursement and Use of Hormone Therapy in Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2010-01-01,10.1093/jnci/djq417,,,,21131577,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1133672,https://api.altmetric.com/v1/donut/1133672_240.png 1,Re: Outcome Following Active Surveillance of Men with Screen-Detected Prostate Cancer. Results from the Göteborg Randomised Population-Based Prostate Cancer Screening Trial,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.10.051,,,,23235214,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1126375,https://api.altmetric.com/v1/donut/1126375_240.png 1,PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.08.036,,,,23102837,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1125334,https://api.altmetric.com/v1/donut/1125334_240.png 1,Polyazamacrocycles as potential antitumor agents for human prostate cancer cells,Chemical Biology & Drug Design,,,Article,2012-01-01,10.1111/cbdd.12098,,,,23241370,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1124357,https://api.altmetric.com/v1/donut/1124357_240.png 1,Telomerase Reverse Transcriptase (TERT) is a Therapeutic Target of Oleanane Triterpenoid CDDO-Me in Prostate Cancer,Molecules,,,Article,2012-12-11,10.3390/molecules171214795,,,,23519253,PMC3607816,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1117400,https://api.altmetric.com/v1/donut/1117400_240.png 1,Association of Type 2 Diabetes Susceptibility Variants With Advanced Prostate Cancer Risk in the Breast and Prostate Cancer Cohort Consortium.,American Journal of Epidemiology,,,Article,2012-12-01,10.1093/aje/kws191,,,,23193118,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1110464,https://api.altmetric.com/v1/donut/1110464_240.png 1,Retroperitoneal fibrosis mimicking prostate cancer,Journal of the Royal Society of Medicine,,,Article,2006-01-01,,,,,16388056,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1110350,https://api.altmetric.com/v1/donut/1110350_240.png 1,Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2012-11-13,10.1038/pcan.2012.45,,,,23146971,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1108839,https://api.altmetric.com/v1/donut/1108839_240.png 1,"Neighbourhoods matter too: the association between neighbourhood socioeconomic position, population density and breast, prostate and lung cancer incidence in Denmark between 2004 and 2008",Journal of Epidemiology and Community Health (1978),,,Article,2013-01-01,10.1136/jech-2011-200192,,,,22826293,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1106112,https://api.altmetric.com/v1/donut/1106112_240.png 1,Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2012-11-26,10.1073/pnas.1217982109,,,,23184966,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/1103850,https://api.altmetric.com/v1/donut/1103850_240.png 1,Cells of origin for cancer: an updated view from prostate cancer,Oncogene,,,Article,2012-11-26,10.1038/onc.2012.541,,,,23178496,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/1103733,https://api.altmetric.com/v1/donut/1103733_240.png 1,Association between Trace Element and Heavy Metal Levels in Hair and Nail with Prostate Cancer.,Asian Pacific Journal of Cancer Prevention,,,Article,2012-11-23,,,,,23167323,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1102802,https://api.altmetric.com/v1/donut/1102802_240.png 1,Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol,PLoS ONE,,,Article,2010-12-03,10.1371/journal.pone.0014175,,,,21151972,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1097179,https://api.altmetric.com/v1/donut/1097179_240.png 1,Molecular genetics of prostate cancer: new prospects for old challenges,Genes & Development,,,Article,1970-01-01,10.1101/gad.1965810,,,,20844012,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1095406,https://api.altmetric.com/v1/donut/1095406_240.png 1,Higher second fourth digit ratio predicts higher incidence of prostate cancer in prostate biopsy.,Archivos Españoles de Urología,,,Article,2012-11-18,,,,,23154605,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1087691,https://api.altmetric.com/v1/donut/1087691_240.png 1,Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients,BMC Cancer,,,Article,2012-11-23,10.1186/1471-2407-12-552,,,,23176254,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1086819,https://api.altmetric.com/v1/donut/1086819_240.png 1,Routine Transition Zone Biopsy During Active Surveillance for Prostate Cancer Rarely Provides Unique Evidence of Disease Progression,The Journal of Urology,,,Article,2012-10-24,10.1016/j.juro.2012.08.011,,,,23083872,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/1086478,https://api.altmetric.com/v1/donut/1086478_240.png 1,Loss of Receptor Protein Tyrosine Phosphatase ?/? (RPTP?/?) Promotes Prostate Cancer Metastasis,Journal of Biological Chemistry,,,Article,2012-01-01,10.1074/jbc.m112.405852,,,,23060448,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1086103,https://api.altmetric.com/v1/donut/1086103_240.png 1,Enzyme kinetics hypothesis to explain the Uâ??shaped risk curve for prostate cancer vs. 25â??hydroxyvitamin D in nordic countries,International Journal of Cancer,,,Article,2004-01-01,10.1002/ijc.20218,,,,15221979,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1085272,https://api.altmetric.com/v1/donut/1085272_240.png 1,Multiparametric MRI for prostate cancer localization in correlation to whole?mount histopathology,Journal of Magnetic Resonance Imaging,,,Article,2013-01-01,10.1002/jmri.23938,,,,23172614,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,84,https://www.altmetric.com/details/1085104,https://api.altmetric.com/v1/donut/1085104_240.png 1,The complexity of prostate cancer: genomic alterations and heterogeneity,Nature Reviews Urology,,,Article,2012-11-07,10.1038/nrurol.2012.185,,,,23132303,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/1079384,https://api.altmetric.com/v1/donut/1079384_240.png 1,Re: A Population-Based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.09.069,,,,23141226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1072679,https://api.altmetric.com/v1/donut/1072679_240.png 1,3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis,World Journal of Surgical Oncology,,,Article,2012-11-16,10.1186/1477-7819-10-247,,,,23158838,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1072514,https://api.altmetric.com/v1/donut/1072514_240.png 1,Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume.,International Journal of Clinical and Experimental Pathology,,,Article,2012-11-04,,,,,23119106,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1071746,https://api.altmetric.com/v1/donut/1071746_240.png 1,Expression levels of the JAK|[sol]|STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer,British Journal of Cancer,,,Article,2007-06-26,10.1038/sj.bjc.6603871,,,,17595657,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1071247,https://api.altmetric.com/v1/donut/1071247_240.png 1,A qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapy,Trials,,,Article,2012-11-14,10.1186/1745-6215-13-208,,,,23151126,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1067430,https://api.altmetric.com/v1/donut/1067430_240.png 1,Alpha-linolenic acid and the risk of prostate cancer. What is the evidence?,The Journal of Urology,,,Article,2004-03-17,10.1097/01.ju.0000116544.09581.55,,,,15017185,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1065122,https://api.altmetric.com/v1/donut/1065122_240.png 1,Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models,Cancer Gene Therapy,,,Article,2012-11-09,10.1038/cgt.2012.75,,,,23138870,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1062008,https://api.altmetric.com/v1/donut/1062008_240.png 1,Genetic Ablation of the Tetraspanin Cd151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model.,Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-12-0468,,,,23131993,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1055715,https://api.altmetric.com/v1/donut/1055715_240.png 1,Myoblasts inhibit prostate cancer growth by paracrine secretion of TNF alpha,The Journal of Urology,,,Article,2012-11-01,10.1016/j.juro.2012.10.071,,,,23123370,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1054458,https://api.altmetric.com/v1/donut/1054458_240.png 1,Short-term Androgen Deprivation Decreases Distant Metastasis and Prostate Cancer-specific Mortality in Intermediate-risk Prostate Cancer Patients Undergoing Dose Escalated External Beam Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.07.239,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1052279,https://api.altmetric.com/v1/donut/1052279_240.png 1,"Results of a Prospective Randomized Double-blind, Placebo-controlled Trial Evaluating the Use of Prophylactic Sildenafil Citrate During Radiation Therapy in the Treatment of Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.07.014,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1052236,https://api.altmetric.com/v1/donut/1052236_240.png 1,"Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.",Cancer and Metastasis Reviews,,,Article,2012-11-03,10.1007/s10555-012-9409-1,,,,23114843,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1042201,https://api.altmetric.com/v1/donut/1042201_240.png 1,"From ""death sentence"" to ""good cancer"": couples' transformation of a prostate cancer diagnosis.",Nursing Research (New York),,,Article,2002-01-01,,,,,12464759,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1040632,https://api.altmetric.com/v1/donut/1040632_240.png 1,MicroRNA Response Elements-Mediated miRNA-miRNA Interactions in Prostate Cancer.,Advances in Bioinformatics,,,Article,2012-01-01,10.1155/2012/839837,,,,23193399,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1039895,https://api.altmetric.com/v1/donut/1039895_240.png 1,"Vitamin D, Sunlight, and the Epidemiology of Prostate Cancer.",Anti-Cancer Agents in Medicinal Chemistry,,,Article,2012-10-27,,,,,23094920,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1035872,https://api.altmetric.com/v1/donut/1035872_240.png 1,"A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer.",European Urology,,,Article,2012-09-13,10.1016/j.eururo.2012.09.008,,,,23000088,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,37,https://www.altmetric.com/details/1031771,https://api.altmetric.com/v1/donut/1031771_240.png 1,"A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human ?? integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer.",Annals of Oncology,,,Article,2012-10-26,10.1093/annonc/mds505,,,,23104724,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1030639,https://api.altmetric.com/v1/donut/1030639_240.png 1,"Evaluation of Xenotropic Murine Leukemia Virus and its R426Q Polymorphism in Patients with Prostate Cancer in Kerman, Southeast of Iran.",Asian Pacific Journal of Cancer Prevention,,,Article,2012-01-01,,,,,23098452,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1026340,https://api.altmetric.com/v1/donut/1026340_240.png 1,Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-12-1335,,,,22971343,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32,https://www.altmetric.com/details/1023926,https://api.altmetric.com/v1/donut/1023926_240.png 1,Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors.,Brachytherapy,,,Article,2012-05-10,10.1016/j.brachy.2012.03.004,,,,22561217,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1022200,https://api.altmetric.com/v1/donut/1022200_240.png 1,Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.,Physics in Medicine & Biology,,,Article,2012-10-13,10.1088/0031-9155/57/21/7117,,,,23051714,,,2012PMB....57.7117R,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1021572,https://api.altmetric.com/v1/donut/1021572_240.png 1,Predicting prognosis in castrationresistant prostate cancer,Nature Reviews Cancer,,,Article,2012-10-23,10.1038/nrc3391,,,,23090028,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1021005,https://api.altmetric.com/v1/donut/1021005_240.png 1,MAPPED study design: A 6month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging,Contemporary Clinical Trials,,,Article,2012-10-01,10.1016/j.cct.2012.10.003,,,,23085153,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1018699,https://api.altmetric.com/v1/donut/1018699_240.png 1,Re: GPRC6A Regulates Prostate Cancer Progression,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.07.066,,,,23059254,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1011191,https://api.altmetric.com/v1/donut/1011191_240.png 1,Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00142,,,,23087903,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1006058,https://api.altmetric.com/v1/donut/1006058_240.png 1,Optimizing the management of prostate cancer in senior adults: call to action.,Oncologist,,,Article,2012-10-05,10.1634/theoncologist.2012-s1-01,,,,23015678,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1001124,https://api.altmetric.com/v1/donut/1001124_240.png 1,Metastatic castrateâ??resistant prostate cancer: dawn of a new age of management,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11076.x,,,,22564337,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/998669,https://api.altmetric.com/v1/donut/998669_240.png 1,TMPRSS2-ERG Fusion Transcripts in Matched Urine and Needle Rinse Material after Biopsy for the Detection of Prostate Cancer,Clinical Chemistry,,,Article,2012-01-01,10.1373/clinchem.2012.192260,,,,23045253,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/993003,https://api.altmetric.com/v1/donut/993003_240.png 1,A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk,Prostate Cancer & Prostatic Diseases,,,Article,2012-10-09,10.1038/pcan.2012.41,,,,23045290,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/990824,https://api.altmetric.com/v1/donut/990824_240.png 1,Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.,British Journal of Cancer,,,Article,2012-10-06,10.1038/bjc.2012.457,,,,23037715,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/989360,https://api.altmetric.com/v1/donut/989360_240.png 1,Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: Possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions.,Biochemical Pharmacology,,,Article,2012-08-08,10.1016/j.bcp.2012.07.026,,,,22864060,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/984656,https://api.altmetric.com/v1/donut/984656_240.png 1,Regulation of androgen receptor expression by Zâ??isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer,The Prostate,,,Article,2012-01-01,10.1002/pros.22593,,,,23038474,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/982269,https://api.altmetric.com/v1/donut/982269_240.png 1,B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-12-0820,,,,22836754,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,37,https://www.altmetric.com/details/977536,https://api.altmetric.com/v1/donut/977536_240.png 1,Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-12-0228,,,,22805308,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/977531,https://api.altmetric.com/v1/donut/977531_240.png 1,"Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer.",Expert Review of Anticancer Therapy,,,Article,2011-12-15,10.1586/era.11.196,,,,22149426,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,11,https://www.altmetric.com/details/977449,https://api.altmetric.com/v1/donut/977449_240.png 1,Washeless and Highly Sensitive Assay for Prostate Specific Antigen Cancer Detection,Analyst,,,Article,2012-01-01,10.1039/c2an36243k,,,,23086008,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/973245,https://api.altmetric.com/v1/donut/973245_240.png 1,Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a metaâ??analysis of eight cohort studies,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11527.x,,,,23017100,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/969092,https://api.altmetric.com/v1/donut/969092_240.png 1,"Phase 3, randomized, placebo?controlled study of zibotentan (ZD4054) in patients with castration?resistant prostate cancer metastatic to bone",Cancer (0008543X),,,Article,2012-07-14,10.1002/cncr.27674,,,,22786751,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/965338,https://api.altmetric.com/v1/donut/965338_240.png 1,Radical Radiotherapy for High-Risk Prostate Cancer in Older Men,Oncologist,,,Article,2012-09-25,10.1634/theoncologist.2012-s1-09,,,,23015680,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/964904,https://api.altmetric.com/v1/donut/964904_240.png 1,Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation,PLoS ONE,,,Article,2011-01-26,10.1371/journal.pone.0016332,,,,21298110,,,2011PLoSO...616332G,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/963444,https://api.altmetric.com/v1/donut/963444_240.png 1,Dynamic contrast-enhanced MR evaluation of prostate cancer before and after endorectal high-intensity focused ultrasound.,La Radiologia Medica,,,Article,2012-09-17,10.1007/s11547-012-0876-9,,,,22986696,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/954546,https://api.altmetric.com/v1/donut/954546_240.png 1,Common genetic variants associated with disease from genomeâ??wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11492.x,,,,22985493,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/953277,https://api.altmetric.com/v1/donut/953277_240.png 1,Targeting the tumor stroma as a novel therapeutic approach for prostate cancer.,Advances in Pharmacology,,,Article,2012-09-12,10.1016/b978-0-12-397927-8.00009-9,,,,22959029,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/952997,https://api.altmetric.com/v1/donut/952997_240.png 1,Focal therapy and imaging in prostate and kidney cancer: high-intensity focused ultrasound ablation of small renal tumors.,Journal of Endourology,,,Article,2010-05-01,10.1089/end.2009.0624,,,,20380511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/952543,https://api.altmetric.com/v1/donut/952543_240.png 1,A meta-analysis of efficacy and safety of the new |[alpha]|1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH,Prostate Cancer & Prostatic Diseases,,,Article,2012-09-18,10.1038/pcan.2012.36,,,,22986578,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/951625,https://api.altmetric.com/v1/donut/951625_240.png 1,"ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration",International Journal of Cancer,,,Article,2011-01-01,10.1002/ijc.26224,,,,21647875,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/943859,https://api.altmetric.com/v1/donut/943859_240.png 1,Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2002-11-08,,,,,12408995,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/942711,https://api.altmetric.com/v1/donut/942711_240.png 1,Prostate Biopsy in Response to a Change in Nadir Prostate Specific Antigen of 0.4 ng/ml after Treatment with 5?-Reductase Inhibitors Markedly Enhances the Detection Rate of Prostate Cancer.,The Journal of Urology,,,Article,2012-07-25,10.1016/j.juro.2012.04.111,,,,22818135,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/941702,https://api.altmetric.com/v1/donut/941702_240.png 1,Detection of prostate cancer by radio-frequency near-field spectroscopy in radical prostatectomy ex vivo specimens,Prostate Cancer & Prostatic Diseases,,,Article,2012-09-11,10.1038/pcan.2012.34,,,,22964689,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/939401,https://api.altmetric.com/v1/donut/939401_240.png 1,Measurement of periâ??prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.10957.x,,,,22372862,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/936849,https://api.altmetric.com/v1/donut/936849_240.png 1,18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer,Nuclear Medicine Communications,,,Article,2010-01-01,10.1097/mnm.0b013e328330adc5,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/935883,https://api.altmetric.com/v1/donut/935883_240.png 1,Targeted therapy in prostate cancer.,Histopathology,,,Article,2012-01-05,10.1111/j.1365-2559.2011.04030.x,,,,22212088,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/933444,https://api.altmetric.com/v1/donut/933444_240.png 1,Low Prostate-specific Antigen and No Gleason Score Upgrade Despite More Extensive Cancer During Active Surveillance Predicts Insignificant Prostate Cancer at Radical Prostatectomy.,Urology,,,Article,2012-08-29,10.1016/j.urology.2012.05.045,,,,22921697,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/929523,https://api.altmetric.com/v1/donut/929523_240.png 1,Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer?,The Prostate,,,Article,2013-01-01,10.1002/pros.22579,,,,22949099,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/928524,https://api.altmetric.com/v1/donut/928524_240.png 1,IGFBP7 Promoter Methylation and Gene Expression Analysis in Prostate Cancer.,The Journal of Urology,,,Article,2012-08-23,10.1016/j.juro.2012.06.002,,,,22906661,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/919835,https://api.altmetric.com/v1/donut/919835_240.png 1,Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study,BMC Systems Biology,,,Article,2012-08-28,10.1186/1752-0509-6-112,,,,22929553,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/918347,https://api.altmetric.com/v1/donut/918347_240.png 1,The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study,Prostate Cancer & Prostatic Diseases,,,Article,2012-08-28,10.1038/pcan.2012.35,,,,22929179,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/917409,https://api.altmetric.com/v1/donut/917409_240.png 1,Interpreting a rising prostate-specific antigen after brachytherapy for prostate cancer.,International Journal of Urology,,,Article,2012-08-23,10.1111/j.1442-2042.2012.03120.x,,,,22905916,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/917348,https://api.altmetric.com/v1/donut/917348_240.png 1,Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate Cancer,New England Journal of Medicine,,,Article,2001-05-03,10.1056/nejm200105033441806,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/913660,https://api.altmetric.com/v1/donut/913660_240.png 1,Reproducibility and clinical correlations of post-treatment changes on CT of prostate cancer bone metastases treated with chemotherapy.,British Journal of Radiology,,,Article,2012-09-01,10.1259/bjr/27266976,,,,22919006,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/912769,https://api.altmetric.com/v1/donut/912769_240.png 1,Clusterin mediates TGF-?-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-12-0254,,,,22896337,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/912422,https://api.altmetric.com/v1/donut/912422_240.png 1,Green and black tea intake in relation to prostate cancer risk among Singapore Chinese.,Cancer Causes and Control,,,Article,2012-08-08,10.1007/s10552-012-0041-8,,,,22864870,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/910142,https://api.altmetric.com/v1/donut/910142_240.png 1,"PROSTATE CANCER: EVIDENCE OF GENETIC AND ENVIRONMENTAL FACTORS, PARTICULARLY REGARDING OXIDATIVE STRESS",Journal of the Siena Academy of Sciences,,,Article,,10.4081/jsas.2011.43,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/909902,https://api.altmetric.com/v1/donut/909902_240.png 1,Percentage of Positive Biopsy Cores: A Better Risk Stratification Model for Prostate Cancer?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.09.043,,,,22099043,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/907373,https://api.altmetric.com/v1/donut/907373_240.png 1,"Partners' Long-term Appraisal of Their Caregiving Experience, Marital Satisfaction, Sexual Satisfaction, and Quality of Life 2 Years After Prostate Cancer Treatment",Cancer nursing (Online),,,Article,2012-07-11,10.1097/ncc.0b013e3182567c03,,,,22728952,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/901894,https://api.altmetric.com/v1/donut/901894_240.png 1,Long-term disease stabilization in a patient with castration-resistant metastatic prostate cancer by the addition of lenalidomide to low-dose dexamethasone and celecoxib.,Onkologie,,,Article,2012-08-09,10.1159/000337403,,,,22868509,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/896393,https://api.altmetric.com/v1/donut/896393_240.png 1,Magnetic resonance image-guided biopsies with a high detection rate of prostate cancer.,The Scientific World Journal,,,Article,2012-04-12,10.1100/2012/975971,,,,22489209,PMC3317570,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,11,https://www.altmetric.com/details/892797,https://api.altmetric.com/v1/donut/892797_240.png 1,Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells,Cancer Research,,,Article,2012-02-23,10.1158/0008-5472.can-11-3132,,,,22350410,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,93,https://www.altmetric.com/details/892787,https://api.altmetric.com/v1/donut/892787_240.png 1,Ultrasound- and MR-guided focused ultrasound surgery for prostate cancer.,World Journal of Radiology,,,Article,2012-07-12,10.4329/wjr.v4.i6.247,,,,22778876,PMC3391669,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,23,https://www.altmetric.com/details/892782,https://api.altmetric.com/v1/donut/892782_240.png 1,Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer,Molecular Endocrinology,,,Article,2012-01-01,10.1210/me.2012-1056,,,,22899854,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/891273,https://api.altmetric.com/v1/donut/891273_240.png 1,Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 ?F-choline PET/CT,Radiation Oncology,,,Article,2012-08-08,10.1186/1748-717x-7-134,,,,22873771,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/890058,https://api.altmetric.com/v1/donut/890058_240.png 1,A comparison of bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.,Genetic Epidemiology,,,Article,2012-01-01,10.1002/gepi.21600,,,,22890972,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/888901,https://api.altmetric.com/v1/donut/888901_240.png 1,Effects of ?-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.,Prostate Cancer & Prostatic Diseases,,,Article,2010-06-23,10.1038/pcan.2010.19,,,,20567256,PMC3010011,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/888445,https://api.altmetric.com/v1/donut/888445_240.png 1,Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate?specific antigen levels and a previous negative biopsy,British Journal of Urology,,,Article,2012-05-10,10.1111/j.1464-410x.2012.11146.x,,,,22564540,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/887553,https://api.altmetric.com/v1/donut/887553_240.png 1,PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER,The Journal of Urology,,,Article,2002-01-01,,,,,10604342,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/884341,https://api.altmetric.com/v1/donut/884341_240.png 1,"Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and lowâ??risk, localized prostate cancer",The Prostate,,,Article,2012-01-01,10.1002/pros.22572,,,,22887127,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/882684,https://api.altmetric.com/v1/donut/882684_240.png 1,"Re: Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-Up ",The Journal of Urology,,,Article,2012-07-14,10.1016/j.juro.2012.04.071,,,,22784722,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/874768,https://api.altmetric.com/v1/donut/874768_240.png 1,FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway,PLoS ONE,,,Article,2012-08-03,10.1371/journal.pone.0042456,,,,22879989,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/872257,https://api.altmetric.com/v1/donut/872257_240.png 1,The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2011-04-20,10.1038/pcan.2011.15,,,,21502968,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/869418,https://api.altmetric.com/v1/donut/869418_240.png 1,"Pomegranate Extracts Potently Suppress Proliferation, Xenograft Growth, and Invasion of Human Prostate Cancer Cells",Journal of Medicinal Food,,,Article,2004-09-01,10.1089/jmf.2004.7.274,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/868109,https://api.altmetric.com/v1/donut/868109_240.png 1,Re: Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a metaâ??analysis,International Journal of Urology,,,Article,2012-07-30,10.1111/j.1442-2042.2012.03108.x,,,,22846160,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/864655,https://api.altmetric.com/v1/donut/864655_240.png 1,Prostate cancer is known by the companionship with ATM and miRNA it keeps: craftsmen of translation have dual behaviour with tailors of life thread,Cell Biochemistry and Function,,,Article,2012-01-01,10.1002/cbf.2847,,,,22847890,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/863388,https://api.altmetric.com/v1/donut/863388_240.png 1,"Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.",European Urology,,,Article,2006-12-13,10.1016/j.eururo.2006.11.053,,,,17161520,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,28,https://www.altmetric.com/details/860096,https://api.altmetric.com/v1/donut/860096_240.png 1,Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.,The Journal of Urology,,,Article,2007-12-01,10.1016/j.juro.2007.08.039,,,,17936806,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,33,https://www.altmetric.com/details/860094,https://api.altmetric.com/v1/donut/860094_240.png 1,A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial,The Journal of Urology,,,Article,2010-11-17,10.1016/j.juro.2010.08.082,,,,21074212,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,39,https://www.altmetric.com/details/860076,https://api.altmetric.com/v1/donut/860076_240.png 1,"Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer",Prostate Cancer & Prostatic Diseases,,,Article,2011-03-24,10.1038/pcan.2011.9,,,,21423266,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/860075,https://api.altmetric.com/v1/donut/860075_240.png 1,How Does Early Detection by Screening Affect Disease Progression? Modeling Estimated Benefits in Prostate Cancer Screening,Medical Decision Making,,,Article,2010-12-07,10.1177/0272989x10396717,,,,21406620,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,19,https://www.altmetric.com/details/860074,https://api.altmetric.com/v1/donut/860074_240.png 1,Collagen I and III and metalloproteinase gene and protein expression in prostate cancer in relation to Gleason score,International Brazilian Journal of Urology,,,Article,2012-01-01,10.1590/s1677-55382012000300007,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/857150,https://api.altmetric.com/v1/donut/857150_240.png 1,Urinary phytoestrogen excretion and prostate cancer risk: a nested case|[ndash]|control study in the Multiethnic Cohort,British Journal of Cancer,,,Article,2009-06-16,10.1038/sj.bjc.6605137,,,,19536097,PMC2713708,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/854761,https://api.altmetric.com/v1/donut/854761_240.png 1,"Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma.",International Journal of Cancer,,,Article,2012-07-19,10.1002/ijc.27731,,,,22815235,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/850401,https://api.altmetric.com/v1/donut/850401_240.png 1,A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression,Journal of Biological Chemistry,,,Article,2012-06-03,10.1074/jbc.m112.370783,,,,22654108,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,https://www.altmetric.com/details/844307,https://api.altmetric.com/v1/donut/844307_240.png 1,Identification of genetic risk associated with prostate cancer using ancestry informative markers,Prostate Cancer & Prostatic Diseases,,,Article,2012-07-17,10.1038/pcan.2012.19,,,,22801071,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/843516,https://api.altmetric.com/v1/donut/843516_240.png 1,Patented prostate cancer biomarkers,Nature Reviews Urology,,,Article,2012-07-03,10.1038/nrurol.2012.130,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/841173,https://api.altmetric.com/v1/donut/841173_240.png 1,Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intraprostate fiducial markers for localized prostate cancer at a single institute in Japan,Radiation Oncology,,,Article,2012-07-06,10.1186/1748-717x-7-105,,,,22770471,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/837821,https://api.altmetric.com/v1/donut/837821_240.png 1,Unusual subtypes of prostate cancer,Modern Pathology,,,Article,2004-02-13,10.1038/modpathol.3800052,,,,14976541,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/836270,https://api.altmetric.com/v1/donut/836270_240.png 1,Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.,Cancer Research,,,Article,1980-12-01,,,,,6159971,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/835917,https://api.altmetric.com/v1/donut/835917_240.png 1,Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers,The Prostate,,,Article,2012-01-01,10.1002/pros.22554,,,,22782870,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/834759,https://api.altmetric.com/v1/donut/834759_240.png 1,Low serum neutrophil count predicts a positive prostate biopsy,Prostate Cancer & Prostatic Diseases,,,Article,2012-07-10,10.1038/pcan.2012.27,,,,22777394,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/834440,https://api.altmetric.com/v1/donut/834440_240.png 1,Exome Sequencing of Prostate Cancer Supports the Hypothesis of Independent Tumour Origins.,European Urology,,,Article,2012-04-18,10.1016/j.eururo.2012.03.050,,,,22502944,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,53,https://www.altmetric.com/details/831324,https://api.altmetric.com/v1/donut/831324_240.png 1,325 DIFFERENCES IN TMPRSS2-ERG GENE FUSION AND SPINK1 OVEREXPRESSION IN PROSTATE CANCER IN AFRICAN-AMERICAN AND CAUCASIAN MEN,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.02.385,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/828852,https://api.altmetric.com/v1/donut/828852_240.png 1,Proteomic Analysis of Microvesicles Released by the Human Prostate Cancer Cell Line PC-3,Molecular and Cellular Proteomics (MCP Online),,,Article,2012-01-01,10.1074/mcp.m111.012914,,,,22457534,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/825950,https://api.altmetric.com/v1/donut/825950_240.png 1,miRNA-mRNA Correlation-Network Modules in Human Prostate Cancer and the Differences between Primary and Metastatic Tumor Subtypes,PLoS ONE,,,Article,2012-06-29,10.1371/journal.pone.0040130,,,,22768240,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/819384,https://api.altmetric.com/v1/donut/819384_240.png 1,"Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer.",European Urology,,,Article,2011-11-16,10.1016/j.eururo.2011.10.038,,,,22078333,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/814377,https://api.altmetric.com/v1/donut/814377_240.png 1,Prostate cancer screening practices in the Republic of Ireland: the determinants of uptake,Journal of Health Services Research & Policy,,,Article,2012-01-01,10.1258/jhsrp.2012.011105,,,,22734084,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/813864,https://api.altmetric.com/v1/donut/813864_240.png 1,Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer.,Critical Reviews in Oncology/Hematology,,,Article,2012-06-20,10.1016/j.critrevonc.2012.05.003,,,,22705096,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/811044,https://api.altmetric.com/v1/donut/811044_240.png 1,Prognostic Role of Serum Parathyroid Hormone Levels in Advanced Prostate Cancer Patients Undergoing Zoledronic Acid Administration,Oncologist,,,Article,2012-01-01,10.1634/theoncologist.2011-0448,,,,22523198,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/802799,https://api.altmetric.com/v1/donut/802799_240.png 1,Activation of AMPK by pterostilbene suppresses lipogenesis and cell cycle progression in p53 positive and negative human prostate cancer cells.,Journal of Agricultural & Food Chemistry,,,Article,2012-06-09,10.1021/jf301499e,,,,22670709,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/786982,https://api.altmetric.com/v1/donut/786982_240.png 1,Bladder endometriosis developed after long-term estrogen therapy for prostate cancer.,International Journal of Urology,,,Article,2012-06-05,10.1111/j.1442-2042.2012.03064.x,,,,22672717,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/783143,https://api.altmetric.com/v1/donut/783143_240.png 1,Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml.,The Journal of Urology,,,Article,2003-11-25,10.1097/01.ju.0000095460.12999.43,,,,14634374,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/782541,https://api.altmetric.com/v1/donut/782541_240.png 1,Variants in the HEPSIN gene are associated with susceptibility to prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2012-01-01,10.1038/pcan.2012.17,,,,22665141,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/777359,https://api.altmetric.com/v1/donut/777359_240.png 1,Vav3-Rac1 Signaling Regulates Prostate Cancer Metastasis with Elevated Vav3 Expression Correlating with Prostate Cancer Progression and Posttreatment Recurrence,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-11-2502,,,,22659453,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/774757,https://api.altmetric.com/v1/donut/774757_240.png 1,COX-2 inhibitors in prostate cancer treatment|[mdash]|hold your horses?,Asian Journal of Andrology,,,Article,2012-05-28,10.1038/aja.2012.51,,,,22635163,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/774335,https://api.altmetric.com/v1/donut/774335_240.png 1,Validation study of urinary metabolites as potential biomarkers for prostate cancer detection,Bioanalysis,,,Article,2012-06-01,10.4155/bio.12.92,,,,22651561,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/773867,https://api.altmetric.com/v1/donut/773867_240.png 1,Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer.,European Urology,,,Article,2010-01-29,10.1016/j.eururo.2009.12.034,,,,20106588,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/771212,https://api.altmetric.com/v1/donut/771212_240.png 1,Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2012-05-29,10.1038/pcan.2012.18,,,,22641239,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/766363,https://api.altmetric.com/v1/donut/766363_240.png 1,Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4Gy per fraction,Radiotherapy & Oncology,,,Article,2012-01-01,10.1016/j.radonc.2011.12.020,,,,22280805,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/765698,https://api.altmetric.com/v1/donut/765698_240.png 1,Magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: initial experience,Radiologia Brasileira,,,Article,2009-01-01,10.1590/s0100-39842009000100003,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/759956,https://api.altmetric.com/v1/donut/759956_240.png 1,A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases.,American Journal of Clinical Pathology,,,Article,2012-06-01,10.1309/ajcpf3qwig8fwxih,,,,22586051,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/747405,https://api.altmetric.com/v1/donut/747405_240.png 1,Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.06.2014,,,,22099031,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/745634,https://api.altmetric.com/v1/donut/745634_240.png 1,Prospective Randomized Multicenter Study Comparing Prostate Cancer Detection Rates of End-fire and Side-fire Transrectal Ultrasound Probe Configuration.,Urology,,,Article,2012-05-10,10.1016/j.urology.2012.01.061,,,,22578920,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/745176,https://api.altmetric.com/v1/donut/745176_240.png 1,Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants.,Clinical Cancer Research,,,Article,2011-08-03,10.1158/1078-0432.ccr-11-0728,,,,21807635,PMC3184252,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,86,https://www.altmetric.com/details/744901,https://api.altmetric.com/v1/donut/744901_240.png 1,Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer,PLoS ONE,,,Article,2012-04-19,10.1371/journal.pone.0035130,,,,22545098,,,2012PLoSO...7E5130M,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/742806,https://api.altmetric.com/v1/donut/742806_240.png 1,Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial.,European Urology,,,Article,2012-04-18,10.1016/j.eururo.2012.03.053,,,,22502942,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,32,https://www.altmetric.com/details/739473,https://api.altmetric.com/v1/donut/739473_240.png 1,"Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide",British Journal of Urology,,,Article,2012-04-18,10.1111/j.1464-410x.2012.11107.x,,,,22500884,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,29,https://www.altmetric.com/details/739463,https://api.altmetric.com/v1/donut/739463_240.png 1,Automated vs. Manual Pattern Recognition of 3D 1H MRSI Data of Patients with Prostate Cancer,Academic Radiology,,,Article,2012-01-01,10.1016/j.acra.2012.02.014,,,,22578226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/737200,https://api.altmetric.com/v1/donut/737200_240.png 1,Molecular Diagnosis of Prostate Cancer: PCA3 and TMPRSS2:ERG Gene Fusion,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2011.10.133,,,,22245323,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/734705,https://api.altmetric.com/v1/donut/734705_240.png 1,Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model,Prostate Cancer & Prostatic Diseases,,,Article,2012-05-08,10.1038/pcan.2012.15,,,,22565411,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/733659,https://api.altmetric.com/v1/donut/733659_240.png 1,RELATION BETWEEN BENIGN PROSTATIC HYPERPLASIA AND CANCER OF THE PROSTATE,The Lancet,,,Article,1974-07-20,10.1016/s0140-6736(74)91551-7,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/732800,https://api.altmetric.com/v1/donut/732800_240.png 1,Prostate Cancer Foci Detected on Multiparametric Magnetic Resonance Imaging are Histologically Distinct From Those Not Detected.,The Journal of Urology,,,Article,2012-04-15,10.1016/j.juro.2012.01.074,,,,22498205,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/728042,https://api.altmetric.com/v1/donut/728042_240.png 1,PSA Lo and Behold: Prostate Cancer Stem Cells,Cell Stem Cell,,,Article,2012-01-01,10.1016/j.stem.2012.04.014,,,,22560068,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/726614,https://api.altmetric.com/v1/donut/726614_240.png 1,Toxicity in patients receiving adjuvant docetaxel |[plus]| hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial,Prostate Cancer & Prostatic Diseases,,,Article,2012-05-01,10.1038/pcan.2012.13,,,,22546837,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/725280,https://api.altmetric.com/v1/donut/725280_240.png 1,Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy.,The Journal of Urology,,,Article,2003-05-01,10.1097/01.ju.0000059584.47272.9d,,,,12686821,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/719184,https://api.altmetric.com/v1/donut/719184_240.png 1,Leuprorelin acetate affects adhesion molecule expression in human prostate cancer cells.,International Journal of Oncology,,,Article,2011-04-13,10.3892/ijo.2011.998,,,,21479359,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,https://www.altmetric.com/details/719164,https://api.altmetric.com/v1/donut/719164_240.png 1,Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence,The Journal of Urology,,,Article,2011-01-19,10.1016/j.juro.2010.10.055,,,,21239017,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,https://www.altmetric.com/details/719158,https://api.altmetric.com/v1/donut/719158_240.png 1,LHRH-conjugated lytic peptides directly target prostate cancer cells.,Biochemical Pharmacology,,,Article,2010-09-28,10.1016/j.bcp.2010.09.015,,,,20869347,PMC2997383,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,11,https://www.altmetric.com/details/719149,https://api.altmetric.com/v1/donut/719149_240.png 1,ETS transcription factors and prostate cancer: The role of the family prototype ETS-1 (Review).,International Journal of Oncology,,,Article,2012-03-01,10.3892/ijo.2012.1380,,,,22366814,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/717009,https://api.altmetric.com/v1/donut/717009_240.png 1,JBIR-120: a new growth inhibitor of hormone-refractory prostate cancer cells,Journal of Antibiotics,,,Article,2012-04-25,10.1038/ja.2012.32,,,,22534652,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/715484,https://api.altmetric.com/v1/donut/715484_240.png 1,Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?,European Journal of Anaesthesiology,,,Article,2011-09-30,10.1097/eja.0b013e32834b7d9a,,,,21946823,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/701361,https://api.altmetric.com/v1/donut/701361_240.png 1,Combined analysis of TMPRSS2ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer,"Genes, Chromosomes, and Cancer",,,Article,2012-04-16,10.1002/gcc.21963,,,,22505341,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/699456,https://api.altmetric.com/v1/donut/699456_240.png 1,[Effects by androgen suppression with luteinizing hormone on cognitive functions in men treated for cancer of prostate].,Progrès en Urologie,,,Article,2009-01-14,10.1016/j.purol.2008.09.056,,,,19135642,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/698066,https://api.altmetric.com/v1/donut/698066_240.png 1,Suppression of Tak1 Promotes Prostate Tumorigenesis,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-11-2724,,,,22467172,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/697625,https://api.altmetric.com/v1/donut/697625_240.png 1,Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells,BMC Cancer,,,Article,2012-04-11,10.1186/1471-2407-12-145,,,,22494660,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/695481,https://api.altmetric.com/v1/donut/695481_240.png 1,Serum total and HDL cholesterol and risk of prostate cancer,Cancer Causes and Control,,,Article,2011-09-16,10.1007/s10552-011-9831-7,,,,21915616,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/695335,https://api.altmetric.com/v1/donut/695335_240.png 1,Retraction: analysis of a serum test for prostate cancer that detects a second epitope of EPCAâ??2,The Prostate,,,Article,2012-04-12,10.1002/pros.22529,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/694726,https://api.altmetric.com/v1/donut/694726_240.png 1,Prevention of prostate cancer from the viewpoint of patients with arterial hypertension and diabetes mellitus,Ciência & Saúde Coletiva,,,Article,2008-01-01,10.1590/s1413-81232008000100019,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/694418,https://api.altmetric.com/v1/donut/694418_240.png 1,Racial Disparities in the Association Between Variants on 8q24 and Prostate Cancer: A Systematic Review and Meta-Analysis,Oncologist,,,Article,2012-01-01,10.1634/theoncologist.2011-0315,,,,22382457,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/690496,https://api.altmetric.com/v1/donut/690496_240.png 1,Diffusion-weighted Imaging with Relative Signal Intensity Statistical Thresholding for Delineating Prostate Cancer Tumors.,Magnetic resonance in medical sciences MRMS an official journal of Japan Society of Magnetic Resonance in Medicine,,,Article,2012-01-01,,,,,22450381,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/688985,https://api.altmetric.com/v1/donut/688985_240.png 1,Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells,Oncogene,,,Article,2011-08-22,10.1038/onc.2011.371,,,,21860423,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/688467,https://api.altmetric.com/v1/donut/688467_240.png 1,Screening for Prostate Cancer,Annals of Internal Medicine,,,Article,2012-01-01,10.1059/0003-4819-156-7-201204030-00015,,,,22473442,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/688328,https://api.altmetric.com/v1/donut/688328_240.png 1,Far-infrared rays control prostate cancer cells in vitro and in vivo,,,,Article,2008-06-17,10.1038/npre.2008.1980.1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/688187,https://api.altmetric.com/v1/donut/688187_240.png 1,The Monoamine Oxidase A gene promoter repeat and prostate cancer risk,The Prostate,,,Article,2012-01-01,10.1002/pros.22515,,,,22473857,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/687463,https://api.altmetric.com/v1/donut/687463_240.png 1,"Re: Improved Prediction of Long-Term, Other Cause Mortality in Men With Prostate Cancer: T. J. Daskivich, K. Chamie, L. Kwan, J. Labo, A. Dash, S. Greenfield and M. S. LitwinJ Urol 2011; 186: 1868â??1873",The Journal of Urology,,,Article,2012-03-19,10.1016/j.juro.2011.12.121,,,,22425053,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/686652,https://api.altmetric.com/v1/donut/686652_240.png 1,Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening,JAMA: Journal of the American Medical Association,,,Article,2012-01-01,10.1001/jama.2012.396,,,,22474197,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/684429,https://api.altmetric.com/v1/donut/684429_240.png 1,Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening—Reply,JAMA: Journal of the American Medical Association,,,Article,2012-04-03,10.1001/jama.2012.399,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/679587,https://api.altmetric.com/v1/donut/679587_240.png 1,Suitable reference genes for relative quantification of miRNA expression in prostate cancer,Experimental and Molecular Medicine,,,Article,1970-01-01,10.3858/emm.2010.42.11.076,,,,20890088,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/679459,https://api.altmetric.com/v1/donut/679459_240.png 1,Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).,British Journal of Urology,,,Article,2009-01-23,10.1111/j.1464-410x.2008.08280.x,,,,19154510,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/679454,https://api.altmetric.com/v1/donut/679454_240.png 1,Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening—Reply,JAMA: Journal of the American Medical Association,,,Article,,10.1001/jama.2012.397,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/679426,https://api.altmetric.com/v1/donut/679426_240.png 1,"A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer",Annals of Oncology,,,Article,2011-01-01,10.1093/annonc/mdr353,,,,21859898,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/678710,https://api.altmetric.com/v1/donut/678710_240.png 1,Goserelin versus leuprolide in the chemical castration of patients with prostate cancer,International Urology and Nephrology,,,Article,2012-02-08,10.1007/s11255-012-0134-z,,,,22315155,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/677143,https://api.altmetric.com/v1/donut/677143_240.png 1,"JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells",BMC Cancer,,,Article,2012-03-30,10.1186/1471-2407-12-130,,,,22462810,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/675813,https://api.altmetric.com/v1/donut/675813_240.png 1,Diagnostic accuracy of transrectal elastosonography (TRES) imaging for the diagnosis of prostate cancer: a systematic review and meta?analysis,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11106.x,,,,22616818,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/673985,https://api.altmetric.com/v1/donut/673985_240.png 1,Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10886.x,,,,22429837,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/673528,https://api.altmetric.com/v1/donut/673528_240.png 1,Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective,Asian Journal of Andrology,,,Article,2012-03-26,10.1038/aja.2011.121,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/671471,https://api.altmetric.com/v1/donut/671471_240.png 1,Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer,The Prostate,,,Article,2012-01-01,10.1002/pros.22516,,,,22457201,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/669537,https://api.altmetric.com/v1/donut/669537_240.png 1,Insights into Chinese prostate cancer with RNA-seq,Cell Research,,,Article,2012-03-27,10.1038/cr.2012.50,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/669081,https://api.altmetric.com/v1/donut/669081_240.png 1,"Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro",Prostate Cancer & Prostatic Diseases,,,Article,2012-03-27,10.1038/pcan.2012.9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/669063,https://api.altmetric.com/v1/donut/669063_240.png 1,In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.,European Urology,,,Article,2011-03-24,10.1016/j.eururo.2011.03.002,,,,21419565,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/666217,https://api.altmetric.com/v1/donut/666217_240.png 1,Life insurance and genetic testing for prostate cancer: What advice for patients?,Australian & New Zealand Journal of Surgery,,,Article,2012-01-01,10.1111/j.1445-2197.2012.06003.x,,,,22510170,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/660311,https://api.altmetric.com/v1/donut/660311_240.png 1,The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study,Prostate Cancer & Prostatic Diseases,,,Article,2012-03-20,10.1038/pcan.2012.11,,,,22430319,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/656966,https://api.altmetric.com/v1/donut/656966_240.png 1,Fibre intake and prostate cancer risk,International Journal of Cancer,,,Article,2004-03-20,10.1002/ijc.11688,,,,14750181,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,7,https://www.altmetric.com/details/655656,https://api.altmetric.com/v1/donut/655656_240.png 1,Perturbation of The EphA2-EphrinA1 System in Human Prostate Cancer Cells by Colonic (Poly)phenol Catabolites,Journal of Agricultural & Food Chemistry,,,Article,2012-03-12,10.1021/jf205305m,,,,22409255,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/650636,https://api.altmetric.com/v1/donut/650636_240.png 1,Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(12)70007-4,,,,22326922,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/649954,https://api.altmetric.com/v1/donut/649954_240.png 1,Automatic computer-aided detection of prostate cancer based on multiparametric magnetic resonance image analysis.,Physics in Medicine & Biology,,,Article,2012-03-08,10.1088/0031-9155/57/6/1527,,,,22391091,,,2012PMB....57.1527V,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/648047,https://api.altmetric.com/v1/donut/648047_240.png 1,Circulating tumor cells in prostate cancer: A potential surrogate marker of survival,Critical Reviews in Oncology/Hematology,,,Article,1970-01-01,10.1016/j.critrevonc.2011.05.004,,,,21680196,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/647576,https://api.altmetric.com/v1/donut/647576_240.png 1,The results of realâ??time brachytherapy for the management of lowâ?? and intermediateâ??risk prostate cancer in patients with prostate volumes up to 100mL,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.10931.x,,,,22332791,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/647212,https://api.altmetric.com/v1/donut/647212_240.png 1,"Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis",Journal of Molecular Signaling,,,Article,2007-10-04,10.1186/1750-2187-2-10,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/643775,https://api.altmetric.com/v1/donut/643775_240.png 1,Multi-target siRNA based on DNMT3A/B homologous conserved region influences cell cycle and apoptosis of human prostate cancer cell line TSU-PR1,Genetics and Molecular Biology,,,Article,2012-01-01,10.1590/s1415-47572012005000021,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/643737,https://api.altmetric.com/v1/donut/643737_240.png 1,Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer,BMC Cancer,,,Article,2012-02-28,10.1186/1471-2407-12-78,,,,22373240,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/641436,https://api.altmetric.com/v1/donut/641436_240.png 1,Mortality Due to Prostate Cancer in the Spanish Arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results After a 15-Year Follow-Up.,Actas Urológicas Españolas,,,Article,2012-01-26,10.1016/j.acuro.2011.10.013,,,,22269382,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/636130,https://api.altmetric.com/v1/donut/636130_240.png 1,Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy,Prostate Cancer & Prostatic Diseases,,,Article,2012-03-06,10.1038/pcan.2012.7,,,,22391584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/635914,https://api.altmetric.com/v1/donut/635914_240.png 1,"Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment",Prostate Cancer,,,Article,2012-01-01,10.1155/2012/327253,,,,22530130,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/635515,https://api.altmetric.com/v1/donut/635515_240.png 1,Elevated Serum Prostate-Specific Antigen Levels in a Woman with Metastatic Breast Cancer,New England Journal of Medicine,,,Article,2000-09-21,10.1056/nejm200009213431214,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/632203,https://api.altmetric.com/v1/donut/632203_240.png 1,Prostatitis: Men with chronic prostatitis at risk for colorectal cancer?,Nature Reviews Urology,,,Article,2012-02-28,10.1038/nrurol.2012.26,,,,22370550,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/631143,https://api.altmetric.com/v1/donut/631143_240.png 1,Hepsin immunohistochemical expression in prostate cancer in relation to Gleason's grade and serum prostate specific antigen,Indian Journal of Pathology & Microbiology,,,Article,2011-01-01,10.4103/0377-4929.85078,,,,21934206,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/629473,https://api.altmetric.com/v1/donut/629473_240.png 1,Delineation of prognostic biomarkers in prostate cancer,Nature,,,Article,2001-08-23,10.1038/35090585,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,237,https://www.altmetric.com/details/629413,https://api.altmetric.com/v1/donut/629413_240.png 1,The biological effect of hepsin on the proliferation and invasion of PC-3 prostate cancer cells,Chinese Journal of Clinical Oncology,,,Article,2006-08-01,10.1007/s11805-006-0058-4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/629360,https://api.altmetric.com/v1/donut/629360_240.png 1,HEPSIN Inhibits Cell Growth/Invasion in Prostate Cancer Cells,Cancer Research,,,Article,2002-01-01,,,,,12460890,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/629357,https://api.altmetric.com/v1/donut/629357_240.png 1,MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case|[ndash]|control studies,Prostate Cancer and Prostatic Diseases,,,Article,2012-02-28,10.1038/pcan.2012.5,,,,22370724,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/624763,https://api.altmetric.com/v1/donut/624763_240.png 1,NEW TREATMENT PARADIGM FOR PROSTATE CANCER: ABARELIX INITIATION THERAPY FOR IMMEDIATE TESTOSTERONE SUPPRESSION FOLLOWED BY A LUTEINIZING HORMONEâ??RELEASING HORMONE AGONIST,British Journal of Urology,,,Article,2012-03-01,10.1111/j.1464-410x.2012.10983.x,,,,22360806,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/619071,https://api.altmetric.com/v1/donut/619071_240.png 1,The role of surgery in highâ??risk localised prostate cancer,British Journal of Urology,,,Article,2012-03-01,10.1111/j.1464-410x.2011.10596.x,,,,21951841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/618301,https://api.altmetric.com/v1/donut/618301_240.png 1,"Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition",European Journal of Cancer Prevention,,,Article,2012-02-18,10.1097/cej.0b013e328351c732,,,,22357483,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/617930,https://api.altmetric.com/v1/donut/617930_240.png 1,Monitoring cardiovascular health in men with prostate cancer treated with androgen deprivation therapy,International Journal of Urological Nursing,,,Article,2012-03-01,10.1111/j.1749-771x.2011.01135.x,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/615269,https://api.altmetric.com/v1/donut/615269_240.png 1,"A randomized, doseâ??response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer",European Journal of Cancer,,,Article,2012-02-20,10.1016/j.ejca.2011.12.023,,,,22341993,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/612725,https://api.altmetric.com/v1/donut/612725_240.png 1,Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy,British Journal of Urology,,,Article,2012-02-01,10.1111/j.1464-410x.2011.10826.x,,,,22239225,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/612704,https://api.altmetric.com/v1/donut/612704_240.png 1,The Effect of Radiation on Semen Quality and Fertility in Men Treated With Brachytherapy for Early Stage Prostate Cancer,"Journal of Urology, The",,,Article,2012-01-01,10.1016/j.juro.2011.10.141,,,,22264453,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/608393,https://api.altmetric.com/v1/donut/608393_240.png 1,Localising Prostate Cancer: Comparison of Endorectal Magnetic Resonance (MR) Imaging and 3D-MR Spectroscopic Imaging with Transrectal Ultrasound-Guided Biopsy.,Urologia Internationalis,,,Article,2011-10-19,10.1159/000331909,,,,22004874,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/600537,https://api.altmetric.com/v1/donut/600537_240.png 1,Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy,International braz j urol,,,Article,2011-12-01,10.1590/s1677-55382011000600029,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/597513,https://api.altmetric.com/v1/donut/597513_240.png 1,Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis,International braz j urol,,,Article,2011-01-01,10.1590/s1677-55382011000600006,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/597470,https://api.altmetric.com/v1/donut/597470_240.png 1,XMRV Discovery and Prostate Cancer-Related Research.,Advances in virology,,,Article,2011-01-01,10.1155/2011/432837,,,,22312343,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/596930,https://api.altmetric.com/v1/donut/596930_240.png 1,Does Zinc Supplementation Increase the Risk of Prostate Cancer?,Archives of Ophthalmology,,,Article,2005-01-01,10.1001/archopht.123.1.102,,,,15642820,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/596879,https://api.altmetric.com/v1/donut/596879_240.png 1,Transcriptomic alterations in human prostate cancer cell LNCaP tumor xenograft modulated by dietary phenethyl isothiocyanate,Molecular Carcinogenesis,,,Article,2012-01-01,10.1002/mc.21873,,,,22308101,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/593618,https://api.altmetric.com/v1/donut/593618_240.png 1,A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions,Journal of Translational Medicine,,,Article,2011-10-28,10.1186/1479-5876-9-185,,,,22035283,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/593596,https://api.altmetric.com/v1/donut/593596_240.png 1,Replication of GWAS “Hits” by Race for Breast and Prostate Cancers in European Americans and African Americans,Frontiers in Genetics,,,Article,2011-01-01,10.3389/fgene.2011.00037,,,,22303333,PMC3268591,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/591414,https://api.altmetric.com/v1/donut/591414_240.png 1,The Great Prostate Cancer Debate,Scientific American,,,Article,2012-01-17,10.1038/scientificamerican0212-38,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/587276,https://api.altmetric.com/v1/donut/587276_240.png 1,Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion.,Clin Cancer Res,,,Article,2011-01-07,10.1158/1078-0432.ccr-11-0431,,,,21606178,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/587119,https://api.altmetric.com/v1/donut/587119_240.png 1,â??Combiâ??targetingâ?? mitozolomide: Conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer,The Prostate,,,Article,2012-02-02,10.1002/pros.22475,,,,22290742,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/582379,https://api.altmetric.com/v1/donut/582379_240.png 1,Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy,Prostate Cancer & Prostatic Diseases,,,Article,2012-01-31,10.1038/pcan.2011.70,,,,22289782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/581909,https://api.altmetric.com/v1/donut/581909_240.png 1,Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cells.,The Prostate,,,Article,2010-01-01,10.1002/pros.21035,,,,19739131,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/580108,https://api.altmetric.com/v1/donut/580108_240.png 1,Histone Deacetylase Inhibitors Restore Cell Surface Expression of the Coxsackie Adenovirus Receptor and Enhance CMV Promoter Activity in Castration-Resistant Prostate Cancer Cells,Prostate Cancer,,,Article,2012-02-01,10.1155/2012/137163,,,,22288017,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/576326,https://api.altmetric.com/v1/donut/576326_240.png 1,Psychosocial issues related to sexual functioning among Africanâ??American prostate cancer survivors and their spouses,Psycho-Oncology,,,Article,2011-01-01,10.1002/pon.1711,,,,20187071,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/575011,https://api.altmetric.com/v1/donut/575011_240.png 1,"Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.",Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,,,Article,2012-01-15,10.1016/j.fct.2012.01.009,,,,22266361,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/572736,https://api.altmetric.com/v1/donut/572736_240.png 1,"The Exercising Together project: Design and recruitment for a randomized, controlled trial to determine the benefits of partnered strength training for couples coping with prostate cancer.",Contemporary Clinical Trials,,,Article,2011-11-23,10.1016/j.cct.2011.10.015,,,,22101224,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/571599,https://api.altmetric.com/v1/donut/571599_240.png 1,Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy,Endocrine-Related Cancer,,,Article,2011-06-30,10.1530/erc-10-0339,,,,21712345,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/571242,https://api.altmetric.com/v1/donut/571242_240.png 1,Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2012-01-01,10.2174/187152012799014995,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/568671,https://api.altmetric.com/v1/donut/568671_240.png 1,Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.,BMC Cancer,,,Article,2011-04-23,10.1186/1471-2407-11-148,,,,21510865,PMC3107807,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/567028,https://api.altmetric.com/v1/donut/567028_240.png 1,Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up,BMC Cancer,,,Article,2012-01-19,10.1186/1471-2407-12-25,,,,22260413,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/566192,https://api.altmetric.com/v1/donut/566192_240.png 1,Contribution of HOGG1 Ser326Cys Polymorphism to the Development of Prostate Cancer in Smokers: Meta-Analysis of 2779 Cases and 3484 Controls,PLoS ONE,,,Article,2012-01-18,10.1371/journal.pone.0030309,,,,22279581,,,2012PLoSO...7E0309X,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/565240,https://api.altmetric.com/v1/donut/565240_240.png 1,Soluble Guanylyl Cyclase ?1 and p53 Cytoplasmic Sequestration: A Novel Mechanism for p53 Down-Regulation in Prostate Cancer.,Molecular Endocrinology,,,Article,2011-12-17,10.1210/me.2010-0394,,,,22174378,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,2,https://www.altmetric.com/details/564486,https://api.altmetric.com/v1/donut/564486_240.png 1,Younger Age Is an Independent Predictor for Poor Survival in Patients with Signet Ring Prostate Carcinoma,Prostate Cancer,,,Article,2012-01-18,10.1155/2011/216169,,,,22110982,PMC3216005,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,3,https://www.altmetric.com/details/564053,https://api.altmetric.com/v1/donut/564053_240.png 1,The causal roles of vitamin B12 and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?,International Journal of Molecular Epidemiology and Genetics,,,Article,2012-01-17,,,,,22199995,PMC3243448,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/562924,https://api.altmetric.com/v1/donut/562924_240.png 1,Adiponectin inhibits oxidative stress in human prostate carcinoma cells,Prostate Cancer and Prostatic Diseases,,,Article,2012-01-17,10.1038/pcan.2011.53,,,,22249290,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/562695,https://api.altmetric.com/v1/donut/562695_240.png 1,Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells,PLoS ONE,,,Article,2012-01-17,10.1371/journal.pone.0015288,,,,21179458,,,2010PLoSO...515288C,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/562399,https://api.altmetric.com/v1/donut/562399_240.png 1,Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon?,The EPMA Journal,,,Article,2012-01-12,10.1007/s13167-011-0138-2,,,,22738151,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/559551,https://api.altmetric.com/v1/donut/559551_240.png 1,"A network flow approach to predict drug targets from microarray data, disease genes and interactome network - case study on prostate cancer",Journal of Clinical Bioinformatics,,,Article,2012-01-13,10.1186/2043-9113-2-1,,,,22239822,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/558052,https://api.altmetric.com/v1/donut/558052_240.png 1,Dendritic cell-based immunotherapy of prostate cancer.,Critical reviews in immunology,,,Article,1998-01-01,,,,,9419453,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/557773,https://api.altmetric.com/v1/donut/557773_240.png 1,MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model,Pharmaceutical Research,,,Article,2011-12-06,10.1007/s11095-011-0635-y,,,,22139536,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/557693,https://api.altmetric.com/v1/donut/557693_240.png 1,Molecular genetics of prostate cancer: emerging appreciation of genetic complexity,Histopathology,,,Article,2012-01-01,10.1111/j.1365-2559.2011.04041.x,,,,22212086,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/552207,https://api.altmetric.com/v1/donut/552207_240.png 1,Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia,British Journal of Cancer,,,Article,2006-07-11,10.1038/sj.bjc.6603246,,,,16832417,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/551017,https://api.altmetric.com/v1/donut/551017_240.png 1,Detection of single nucleotide polymorphisms within a sequence of a gene associated with prostate cancer using a fluorophore-tagged DNA probe.,"Bioorganic padding:9px 0 0 0;"" align=""left"">",,,Article,2011-11-20,10.1016/j.bmcl.2011.11.053,,,,22169264,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/549597,https://api.altmetric.com/v1/donut/549597_240.png 1,Psychological aspects of prostate cancer: a clinical review,Prostate Cancer and Prostatic Diseases,,,Article,2012-01-03,10.1038/pcan.2011.66,,,,22212706,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/545447,https://api.altmetric.com/v1/donut/545447_240.png 1,Male infertility and prostate cancer risk: a nested case–control study,Cancer Causes and Control,,,Article,2010-06-05,10.1007/s10552-010-9592-8,,,,20524053,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,8,https://www.altmetric.com/details/542666,https://api.altmetric.com/v1/donut/542666_240.png 1,Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study,JNCI: Journal of the National Cancer Institute,,,Article,2010-06-23,10.1093/jnci/djq154,,,,20562373,PMC2897875,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,55,https://www.altmetric.com/details/542459,https://api.altmetric.com/v1/donut/542459_240.png 1,Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging,British Journal of Urology,,,Article,2009-09-17,10.1111/j.1464-410x.2009.08853.x,,,,19751256,PMC2848292,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,15,https://www.altmetric.com/details/542137,https://api.altmetric.com/v1/donut/542137_240.png 1,Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use,Cancer (0008543X),,,Article,2009-07-29,10.1002/cncr.24539,,,,19637357,PMC2779840,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,25,https://www.altmetric.com/details/541767,https://api.altmetric.com/v1/donut/541767_240.png 1,The Use of a Surgical Patch in the Prevention of Lymphoceles After Extraperitoneal Pelvic Lymphadenectomy for Prostate Cancer: A Randomized Prospective Pilot Study,The Journal of Urology,,,Article,2009-01-11,10.1016/j.juro.2009.07.033,,,,19762048,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/541734,https://api.altmetric.com/v1/donut/541734_240.png 1,Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort,Journal of Clinical Oncology,,,Article,2009-09-03,10.1200/jco.2008.21.2613,,,,19720918,PMC2799054,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/541710,https://api.altmetric.com/v1/donut/541710_240.png 1,Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.,The Journal of Urology,,,Article,2009-08-01,10.1016/j.juro.2009.04.006,,,,19524984,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,30,https://www.altmetric.com/details/541476,https://api.altmetric.com/v1/donut/541476_240.png 1,Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.,Eur Urol,,,Article,2008-11-27,10.1016/j.eururo.2008.11.011,,,,19027219,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,39,https://www.altmetric.com/details/541190,https://api.altmetric.com/v1/donut/541190_240.png 1,Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.,Journal of Clinical Oncology,,,Article,2008-12-11,10.1200/jco.2008.18.1685,,,,19064972,PMC2645854,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,43,https://www.altmetric.com/details/540984,https://api.altmetric.com/v1/donut/540984_240.png 1,Expression and prognostic relevance of annexin A3 in prostate cancer.,European Urology,,,Article,2008-01-29,10.1016/j.eururo.2008.01.001,,,,18222597,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,17,https://www.altmetric.com/details/540859,https://api.altmetric.com/v1/donut/540859_240.png 1,Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E,Oncogene,,,Article,2010-01-27,10.1038/onc.2009.479,,,,20101233,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,29,https://www.altmetric.com/details/539802,https://api.altmetric.com/v1/donut/539802_240.png 1,B-cell-derived lymphotoxin promotes castration-resistant prostate cancer,Nature,,,Article,2010-03-12,10.1038/nature08782,,,,20220849,PMC2866639,,2010Natur.464..302A,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/539777,https://api.altmetric.com/v1/donut/539777_240.png 1,Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.,Cancer research,,,Article,2007-10-01,10.1158/0008-5472.can-07-2887,,,,17909013,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,17,https://www.altmetric.com/details/538908,https://api.altmetric.com/v1/donut/538908_240.png 1,Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial,Journal of Clinical Oncology,,,Article,2011-01-02,10.1200/jco.2010.30.5979,,,,21041707,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,37,https://www.altmetric.com/details/538507,https://api.altmetric.com/v1/donut/538507_240.png 1,Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.,Eur Urol,,,Article,2010-08-31,10.1016/j.eururo.2010.08.027,,,,20800964,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,54,https://www.altmetric.com/details/538366,https://api.altmetric.com/v1/donut/538366_240.png 1,Impact of Androgen-Deprivation Therapy on Cognitive Function in Men With Nonmetastatic Prostate Cancer,Journal of Clinical Oncology,,,Article,2010-01-12,10.1200/jco.2010.30.8742,,,,21041708,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/538357,https://api.altmetric.com/v1/donut/538357_240.png 1,Image Guided Photothermal Focal Therapy for Localized Prostate Cancer: Phase I Trial,The Journal of Urology,,,Article,2009-08-19,10.1016/j.juro.2009.06.035,,,,19683262,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,36,https://www.altmetric.com/details/537484,https://api.altmetric.com/v1/donut/537484_240.png 1,Tissue Prostate-Specific Antigen Facilitates Refractory Prostate Tumor Progression via Enhancing ARA70-Regulated Androgen Receptor Transactivation,Cancer Research,,,Article,2008-01-09,10.1158/0008-5472.can-07-6507,,,,18757426,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/536761,https://api.altmetric.com/v1/donut/536761_240.png 1,Cryoablative response of prostate cancer cells is influenced by androgen receptor expression,British Journal of Urology,,,Article,2008-02-13,10.1111/j.1464-410x.2008.07499.x,,,,18261151,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/536488,https://api.altmetric.com/v1/donut/536488_240.png 1,Prostate cancer: MR imaging-guided galvanotherapy--technical development and first clinical results.,Radiology,,,Article,2007-12-01,10.1148/radiol.2453061623,,,,18024456,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/536137,https://api.altmetric.com/v1/donut/536137_240.png 1,African-American men's perceptions about prostate cancer: implications for designing educational interventions.,Social Science & Medicine,,,Article,2007-04-04,10.1016/j.socscimed.2007.01.007,,,,17399877,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,44,https://www.altmetric.com/details/535836,https://api.altmetric.com/v1/donut/535836_240.png 1,Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy,Cancer (0008543X),,,Article,2006-12-23,10.1002/cncr.22438,,,,17183557,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,17,https://www.altmetric.com/details/535797,https://api.altmetric.com/v1/donut/535797_240.png 1,Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases,Clinical Cancer Research,,,Article,2009-02-04,10.1158/1078-0432.ccr-08-1402,,,,19188148,PMC2666194,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/533407,https://api.altmetric.com/v1/donut/533407_240.png 1,Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells,Cancer Research,,,Article,2009-01-03,10.1158/0008-5472.can-08-2575,,,,19118003,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,34,https://www.altmetric.com/details/533340,https://api.altmetric.com/v1/donut/533340_240.png 1,Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance,Cancer Research,,,Article,2008-07-03,10.1158/0008-5472.can-08-0594,,,,18593950,PMC2663383,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,94,https://www.altmetric.com/details/532844,https://api.altmetric.com/v1/donut/532844_240.png 1,CyberKnife in the treatment of prostate cancer: a revolutionary system.,European Urology,,,Article,2009-02-28,10.1016/j.eururo.2009.02.020,,,,19246151,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,11,https://www.altmetric.com/details/531202,https://api.altmetric.com/v1/donut/531202_240.png 1,Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective,"Magnetic Resonance Materials in Biology, Physics, & Medicine",,,Article,2008-01-11,10.1007/s10334-008-0122-6,,,,18633658,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/530857,https://api.altmetric.com/v1/donut/530857_240.png 1,Pathologic stage T2a and T2b prostate cancer in the recent prostate?specific antigen era: Implications for unilateral ablative therapy,The Prostate,,,Article,1970-01-01,10.1002/pros.20804,,,,18543281,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,18,https://www.altmetric.com/details/530719,https://api.altmetric.com/v1/donut/530719_240.png 1,Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer,The Journal of Urology,,,Article,2008-01-23,10.1016/j.juro.2007.10.064,,,,18207190,PMC2728440,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/530449,https://api.altmetric.com/v1/donut/530449_240.png 1,Vascular Targeted Photodynamic Therapy With Palladium-Bacteriopheophorbide Photosensitizer for Recurrent Prostate Cancer Following Definitive Radiation Therapy: Assessment of Safety and Treatment Response,The Journal of Urology,,,Article,2007-01-11,10.1016/j.juro.2007.07.036,,,,17869307,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,53,https://www.altmetric.com/details/530318,https://api.altmetric.com/v1/donut/530318_240.png 1,Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer,Cell,,,Article,2009-07-29,10.1016/j.cell.2009.04.056,,,,19632176,PMC2726827,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,238,https://www.altmetric.com/details/529264,https://api.altmetric.com/v1/donut/529264_240.png 1,Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.,Cancer cell,,,Article,2007-12-01,10.1016/j.ccr.2007.11.002,,,,18068633,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,34,https://www.altmetric.com/details/528318,https://api.altmetric.com/v1/donut/528318_240.png 1,Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study,The Journal of Urology,,,Article,2010-08-21,10.1016/j.juro.2010.06.008,,,,20723940,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/528031,https://api.altmetric.com/v1/donut/528031_240.png 1,When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.,European Urology,,,Article,2010-01-04,10.1016/j.eururo.2009.12.023,,,,20034730,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,42,https://www.altmetric.com/details/527919,https://api.altmetric.com/v1/donut/527919_240.png 1,A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.,Cancer research,,,Article,2007-11-15,10.1158/0008-5472.can-07-2498,,,,18006806,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,94,https://www.altmetric.com/details/527198,https://api.altmetric.com/v1/donut/527198_240.png 1,ZEB1 Coordinately Regulates Laminin-332 and ?4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2010-08-25,10.1074/jbc.m110.136044,,,,20729552,PMC2962494,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,19,https://www.altmetric.com/details/526949,https://api.altmetric.com/v1/donut/526949_240.png 1,Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.,Endocrine-Related Cancer,,,Article,2009-07-19,10.1677/erc-09-0070,,,,19608712,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,25,https://www.altmetric.com/details/526671,https://api.altmetric.com/v1/donut/526671_240.png 1,Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down?regulated in matched lymph node metastases,The Prostate,,,Article,2011-01-04,10.1002/pros.21259,,,,20878946,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/526651,https://api.altmetric.com/v1/donut/526651_240.png 1,Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone?releasing hormone?agonist therapy for prostate cancer,British Journal of Urology,,,Article,2010-05-13,10.1111/j.1464-410x.2010.09329.x,,,,20456336,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,12,https://www.altmetric.com/details/525828,https://api.altmetric.com/v1/donut/525828_240.png 1,An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-?B,Nature Medicine,,,Article,2010-01-03,10.1038/nm.2100,,,,20154697,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,119,https://www.altmetric.com/details/525161,https://api.altmetric.com/v1/donut/525161_240.png 1,Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice.,BMC Cancer,,,Article,2010-07-30,10.1186/1471-2407-10-395,,,,20663219,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/524661,https://api.altmetric.com/v1/donut/524661_240.png 1,Residual Prostate Cancer After Radiotherapy: A Study of Radical Cystoprostatectomy Specimens,Urology,,,Article,2008-02-22,10.1016/j.urology.2007.11.020,,,,18289645,PMC2660570,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/524443,https://api.altmetric.com/v1/donut/524443_240.png 1,Mouse Models of Prostate Adenocarcinoma with the Capacity to Monitor Spontaneous Carcinogenesis by Bioluminescence or Fluorescence,Cancer Research,,,Article,2007-01-08,10.1158/0008-5472.can-07-0668,,,,17671224,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,38,https://www.altmetric.com/details/524370,https://api.altmetric.com/v1/donut/524370_240.png 1,A Model to Predict Prostate Cancer After Atypical Findings in Initial Prostate Needle Biopsy,The Journal of Urology,,,Article,2011-02-23,10.1016/j.juro.2010.11.063,,,,21334024,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,10,https://www.altmetric.com/details/524251,https://api.altmetric.com/v1/donut/524251_240.png 1,Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI,European Radiology,,,Article,2010-01-01,10.1007/s00330-009-1520-5,,,,19690866,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,34,https://www.altmetric.com/details/523842,https://api.altmetric.com/v1/donut/523842_240.png 1,Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells,Oncogene,,,Article,2010-10-06,10.1038/onc.2010.436,,,,20890304,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,38,https://www.altmetric.com/details/523685,https://api.altmetric.com/v1/donut/523685_240.png 1,TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis,Clinical Cancer Research,,,Article,2008-06-04,10.1158/1078-0432.ccr-07-2051,,,,18519769,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,44,https://www.altmetric.com/details/522858,https://api.altmetric.com/v1/donut/522858_240.png 1,Detecting prostate cancer by intracellular macrophage prostate?specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA,European Journal of Clinical Investigation,,,Article,2008-01-06,10.1111/j.1365-2362.2008.01953.x,,,,18489403,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/522667,https://api.altmetric.com/v1/donut/522667_240.png 1,"Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy.",Clinical Cancer Research,,,Article,2008-07-17,10.1158/1078-0432.ccr-07-5048,,,,18628467,PMC2682417,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/522548,https://api.altmetric.com/v1/donut/522548_240.png 1,Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment,Journal of Clinical Oncology,,,Article,2008-09-18,10.1200/jco.2007.15.0441,,,,18794550,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/522544,https://api.altmetric.com/v1/donut/522544_240.png 1,An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2007-12-11,10.1073/pnas.0706641104,,,,18056640,,,2007PNAS..10419983S,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,101,https://www.altmetric.com/details/521132,https://api.altmetric.com/v1/donut/521132_240.png 1,Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.,J Clin Oncol,,,Article,2007-03-22,10.1200/jco.2006.07.3361,,,,17369566,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,43,https://www.altmetric.com/details/520697,https://api.altmetric.com/v1/donut/520697_240.png 1,A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis.,Clinical Cancer Research,,,Article,2007-11-01,10.1158/1078-0432.ccr-07-1036,,,,17975152,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,53,https://www.altmetric.com/details/520663,https://api.altmetric.com/v1/donut/520663_240.png 1,Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.,Magnetic resonance imaging clinics of North America,,,Article,2009-05-02,10.1016/j.mric.2009.01.013,,,,19406364,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/518901,https://api.altmetric.com/v1/donut/518901_240.png 1,Regulation of PSA secretion and survival signaling by calcium?independent phopholipase A2? in prostate cancer cells,The Prostate,,,Article,2009-01-09,10.1002/pros.20968,,,,19475654,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/518819,https://api.altmetric.com/v1/donut/518819_240.png 1,Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results,Clinical Cancer Research,,,Article,2009-01-12,10.1158/1078-0432.ccr-09-1910,,,,19920098,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/518756,https://api.altmetric.com/v1/donut/518756_240.png 1,Prostate Cancer: Comparison of 3D T2-Weighted With Conventional 2D T2-Weighted Imaging for Image Quality and Tumor Detection,American Journal of Roentgenology,,,Article,2010-01-24,10.2214/ajr.09.3217,,,,20093608,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,37,https://www.altmetric.com/details/518710,https://api.altmetric.com/v1/donut/518710_240.png 1,Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.,J Urol,,,Article,2007-01-11,10.1016/j.juro.2007.06.043,,,,17870114,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,https://www.altmetric.com/details/518373,https://api.altmetric.com/v1/donut/518373_240.png 1,An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer.,"Magma (New York, N.Y.)",,,Article,2008-11-01,10.1007/s10334-008-0133-3,,,,18752015,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,24,https://www.altmetric.com/details/517013,https://api.altmetric.com/v1/donut/517013_240.png 1,Molecular cancer phenotype in normal prostate tissue.,European Urology,,,Article,2009-04-01,10.1016/j.eururo.2008.04.105,,,,18501497,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/516832,https://api.altmetric.com/v1/donut/516832_240.png 1,Sexually transmitted infections and prostate cancer among men in the U.S. military.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-10-01,10.1158/1055-9965.epi-08-1167,,,,19755645,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/516599,https://api.altmetric.com/v1/donut/516599_240.png 1,Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.,The Journal of Urology,,,Article,2010-03-01,10.1016/j.juro.2009.11.021,,,,20083275,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/516346,https://api.altmetric.com/v1/donut/516346_240.png 1,Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients.,European Urology,,,Article,2010-10-01,10.1016/j.eururo.2010.06.037,,,,20619958,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,32,https://www.altmetric.com/details/516142,https://api.altmetric.com/v1/donut/516142_240.png 1,Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.,Cell biochemistry and function,,,Article,2008-10-01,10.1002/cbf.1504,,,,18646267,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/515819,https://api.altmetric.com/v1/donut/515819_240.png 1,Androgen receptor is a tumor suppressor and proliferator in prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2008-08-26,10.1073/pnas.0804700105,,,,18723679,,,2008PNAS..10512182N,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,51,https://www.altmetric.com/details/515631,https://api.altmetric.com/v1/donut/515631_240.png 1,Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes.,"Science (New York, N.Y.)",,,Article,2008-01-11,10.1126/science.1148886,,,,18187659,,,2008Sci...319..215S,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,47,https://www.altmetric.com/details/515355,https://api.altmetric.com/v1/donut/515355_240.png 1,The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells.,The Journal of biological chemistry,,,Article,2008-02-08,10.1074/jbc.m707773200,,,,18056989,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,38,https://www.altmetric.com/details/515283,https://api.altmetric.com/v1/donut/515283_240.png 1,Role of the renin-angiotensin system in prostate cancer.,Molecular & Cellular Endocrinology,,,Article,2009-04-29,10.1016/j.mce.2008.08.032,,,,18824067,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,22,https://www.altmetric.com/details/514326,https://api.altmetric.com/v1/donut/514326_240.png 1,ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.,Cancer Cell,,,Article,2010-04-13,10.1016/j.ccr.2010.02.030,,,,20385358,PMC2881822,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,95,https://www.altmetric.com/details/513407,https://api.altmetric.com/v1/donut/513407_240.png 1,Impact of comorbidity on survival among men with localized prostate cancer.,Journal of Clinical Oncology,,,Article,2011-04-01,10.1200/jco.2010.31.2330,,,,21357791,PMC3084001,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,49,https://www.altmetric.com/details/513208,https://api.altmetric.com/v1/donut/513208_240.png 1,eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2010-08-10,10.1073/pnas.1005320107,,,,20679199,PMC2922605,,2010PNAS..10714134F,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,122,https://www.altmetric.com/details/513183,https://api.altmetric.com/v1/donut/513183_240.png 1,Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.,Cancer research,,,Article,2007-08-01,10.1158/0008-5472.can-07-0199,,,,17671215,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,55,https://www.altmetric.com/details/512559,https://api.altmetric.com/v1/donut/512559_240.png 1,Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics.,European urology,,,Article,2008-03-01,10.1016/j.eururo.2007.10.047,,,,17997011,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,33,https://www.altmetric.com/details/512279,https://api.altmetric.com/v1/donut/512279_240.png 1,Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy,Cancer (0008543X),,,Article,2011-12-20,10.1002/cncr.26732,,,,22180287,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/510838,https://api.altmetric.com/v1/donut/510838_240.png 1,Profiling prostate cancer,Proceedings of the National Academy of Sciences,,,Article,2011-12-27,10.1073/pnas.1118444109,,,,22173635,,,2011PNAS..10820861N,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/510751,https://api.altmetric.com/v1/donut/510751_240.png 1,Sexuality after Treatment for Early Prostate Cancer,JGIM: Journal of General Internal Medicine,,,Article,2001-10-01,10.1111/j.1525-1497.2001.00832.x,,,,11679031,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/508830,https://api.altmetric.com/v1/donut/508830_240.png 1,Integrating multiparametric prostate MRI into clinical practice.,Cancer imaging : the official publication of the International Cancer Imaging Society,,,Article,2011-01-01,10.1102/1470-7330.2011.9007,,,,22187067,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/508158,https://api.altmetric.com/v1/donut/508158_240.png 1,"Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists",Prostate Cancer & Prostatic Diseases,,,Article,2011-12-06,10.1038/pcan.2011.57,,,,22143447,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/504656,https://api.altmetric.com/v1/donut/504656_240.png 1,Racial and geographic disparities in late-stage prostate cancer diagnosis in Florida.,Journal of health care for the poor and underserved,,,Article,2011-01-01,10.1353/hpu.2011.0155,,,,22102314,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/502998,https://api.altmetric.com/v1/donut/502998_240.png 1,Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone,Journal of Clinical Oncology,,,Article,2011-12-22,10.1200/jco.2010.33.7675,,,,22184395,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/500540,https://api.altmetric.com/v1/donut/500540_240.png 1,Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT).,"International journal of radiation oncology, biology, physics",,,Article,2011-05-01,10.1016/j.ijrobp.2010.06.007,,,,20864274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,78,https://www.altmetric.com/details/498427,https://api.altmetric.com/v1/donut/498427_240.png 1,Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.,Cancer research,,,Article,2004-12-01,10.1158/0008-5472.can-04-2840,,,,15574782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/497933,https://api.altmetric.com/v1/donut/497933_240.png 1,Inflammation and endothelial activation in benign prostatic hyperplasia and prostate cancer,International braz j urol,,,Article,2011-01-01,10.1590/s1677-55382011000500008,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/493112,https://api.altmetric.com/v1/donut/493112_240.png 1,Hypofractionated stereotactic body radiotherapy in lowâ??risk prostate adenocarcinoma,Cancer (0008543X),,,Article,2011-12-17,10.1002/cncr.26699,,,,22170628,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/492217,https://api.altmetric.com/v1/donut/492217_240.png 1,Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy.,Cancer,,,Article,2011-11-09,10.1002/cncr.26631,,,,22071795,,,,,,,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,17,https://www.altmetric.com/details/490841,https://api.altmetric.com/v1/donut/490841_240.png 1,Novel Therapeutic Strategies for Metastatic Prostate Cancer in the Post-Docetaxel Setting,The Oncologist,,,Article,2011-01-01,10.1634/theoncologist.2010-0412,,,,22048000,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/489568,https://api.altmetric.com/v1/donut/489568_240.png 1,Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.,Nutrition and cancer,,,Article,2004-01-01,10.1207/s15327914nc4802_5,,,,15231450,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/482272,https://api.altmetric.com/v1/donut/482272_240.png 1,"Animal products, calcium and protein and prostate cancer risk in the Netherlands Cohort Study",British Journal of Cancer,,,Article,1999-06-01,10.1038/sj.bjc.6690472,,,,10362125,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/481563,https://api.altmetric.com/v1/donut/481563_240.png 1,Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme,Prostate Cancer and Prostatic Diseases,,,Article,2011-12-06,10.1038/pcan.2011.62,,,,22143446,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/481436,https://api.altmetric.com/v1/donut/481436_240.png 1,Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.,Journal of Clinical Investigation,,,Article,1993-05-01,10.1172/jci116457,,,,8486788,PMC288233,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/480849,https://api.altmetric.com/v1/donut/480849_240.png 1,"Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.","International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-04-08,10.1016/j.ijrobp.2010.11.074,,,,21481721,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/480790,https://api.altmetric.com/v1/donut/480790_240.png 1,Urological cancer: Time for another rethink on prostate cancer screening,Nature Reviews Clinical Oncology,,,Article,2011-11-29,10.1038/nrclinonc.2011.181,,,,22124367,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/479262,https://api.altmetric.com/v1/donut/479262_240.png 1,"Intake of whole-grain products and risk of prostate cancer among men in the Danish Diet, Cancer and Health cohort study",Cancer Causes & Control,,,Article,2011-06-09,10.1007/s10552-011-9789-5,,,,21656162,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/479251,https://api.altmetric.com/v1/donut/479251_240.png 1,ACR Appropriateness Criteria® Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2011-12-01,10.1097/coc.0b013e3182354a65,,,,22101389,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/470897,https://api.altmetric.com/v1/donut/470897_240.png 1,Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States,Pharmacoepidemiology & Drug Safety,,,Article,2011-11-26,10.1002/pds.2258,,,,22114014,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/469102,https://api.altmetric.com/v1/donut/469102_240.png 1,High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone.,The Journal of urology,,,Article,2011-10-01,10.1016/j.juro.2011.05.082,,,,21855947,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/467880,https://api.altmetric.com/v1/donut/467880_240.png 1,Can erectile function be predicted after prostate cancer treatment?,Asian Journal of Andrology,,,Article,2011-11-14,10.1038/aja.2011.165,,,,22080916,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/462361,https://api.altmetric.com/v1/donut/462361_240.png 1,"A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3?- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer",American Journal of Translational Research,,,Article,2011-11-17,,,,,20733950,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/459379,https://api.altmetric.com/v1/donut/459379_240.png 1,Prevalence of Prostate Cancer in High Boron-Exposed Population: A Community-Based Study,Biological Trace Element Research,,,Article,2011-03-23,10.1007/s12011-011-9023-z,,,,21431327,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/452723,https://api.altmetric.com/v1/donut/452723_240.png 1,Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer,British Journal of Cancer,,,Article,2011-11-08,10.1038/bjc.2011.462,,,,22068816,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/449293,https://api.altmetric.com/v1/donut/449293_240.png 1,MicroRNA profile analysis of human prostate cancers,Cancer Gene Therapy,,,Article,2008-10-24,10.1038/cgt.2008.77,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/447087,https://api.altmetric.com/v1/donut/447087_240.png 1,[Usefulness of prostatic specific antigen (PSA) for diagnosis and staging of patients with prostate cancer].,Archivos españoles de urología,,,Article,2011-10-01,,,,,22052750,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/445034,https://api.altmetric.com/v1/donut/445034_240.png 1,Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration.,PLoS ONE,,,Article,2011-01-01,10.1371/journal.pone.0026615,,,,22039516,PMC3200337,,2011PLoSO...6E6615K,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/437337,https://api.altmetric.com/v1/donut/437337_240.png 1,Re: An Empirical Evaluation of Guidelines on Prostate-Specific Antigen Velocity in Prostate Cancer Detection,Journal of the National Cancer Institute,,,Article,2011-01-01,10.1093/jnci/djr353,,,,21926376,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/437307,https://api.altmetric.com/v1/donut/437307_240.png 1,Re: An Empirical Evaluation of Guidelines on Prostate-Specific Antigen Velocity in Prostate Cancer Detection,Journal of the National Cancer Institute,,,Article,2011-01-01,10.1093/jnci/djr352,,,,21926375,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/437305,https://api.altmetric.com/v1/donut/437305_240.png 1,Comparing Knowledge of Colorectal and Prostate Cancer Among African American and Hispanic Men,Cancer Nursing,,,Article,2009-08-08,10.1097/ncc.0b013e3181aaf10e,,,,19661793,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/436767,https://api.altmetric.com/v1/donut/436767_240.png 1,Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells,BMC Cancer,,,Article,2011-10-31,10.1186/1471-2407-11-468,,,,22039910,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/436574,https://api.altmetric.com/v1/donut/436574_240.png 1,"Histopathological review of prostate cancer in Lokoja, Nigeria",Infectious Agents and Cancer,,,Article,2011-11-01,10.1186/1750-9378-6-s1-a2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/436542,https://api.altmetric.com/v1/donut/436542_240.png 1,Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome,Carcinogenesis,,,Article,2011-01-01,10.1093/carcin/bgr182,,,,21828059,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/435816,https://api.altmetric.com/v1/donut/435816_240.png 1,Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study.,Cancer Causes and Control,,,Article,2011-10-05,10.1007/s10552-011-9845-1,,,,21971816,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/435224,https://api.altmetric.com/v1/donut/435224_240.png 1,"Vitamin D, Sunlight and Prostate Cancer Risk",Advances in Preventive Medicine,,,Article,2011-10-29,10.4061/2011/281863,,,,21991434,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/434114,https://api.altmetric.com/v1/donut/434114_240.png 1,Antiangiogenic Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-11-0833,,,,22037878,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/433556,https://api.altmetric.com/v1/donut/433556_240.png 1,Androgen deprivation therapy as adjuvant|[sol]|neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments,British Journal of Cancer,,,Article,2011-10-18,10.1038/bjc.2011.385,,,,22009028,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/432340,https://api.altmetric.com/v1/donut/432340_240.png 1,Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients.,British journal of cancer,,,Article,2011-10-25,10.1038/bjc.2011.440,,,,22027711,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/431458,https://api.altmetric.com/v1/donut/431458_240.png 1,Prostate cancer outcome in Burkina Faso,Infectious Agents and Cancer,,,Article,2011-10-27,10.1186/1750-9378-6-s2-s6,,,,21992406,PMC3194185,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/431036,https://api.altmetric.com/v1/donut/431036_240.png 1,Prostate Cancer Visualization from MR Imagery and MR Spectroscopy,Computer Graphics Forum,,,Article,2011-06-01,10.1111/j.1467-8659.2011.01954.x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/429987,https://api.altmetric.com/v1/donut/429987_240.png 1,Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer,Prostate Cancer and Prostatic Diseases,,,Article,2011-10-25,10.1038/pcan.2011.50,,,,22025196,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/427728,https://api.altmetric.com/v1/donut/427728_240.png 1,Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells,BMC Molecular Biology,,,Article,2011-07-11,10.1186/1471-2199-12-29,,,,21745389,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/427482,https://api.altmetric.com/v1/donut/427482_240.png 1,Normal prostate-derived stromal cells stimulate prostate cancer development.,Cancer science,,,Article,2011-09-01,10.1111/j.1349-7006.2011.02008.x,,,,21672088,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/425930,https://api.altmetric.com/v1/donut/425930_240.png 1,Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells,Toxicology and Applied Pharmacology,,,Article,2011-10-08,10.1016/j.taap.2011.09.026,,,,22005276,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/425648,https://api.altmetric.com/v1/donut/425648_240.png 1,Highly sensitive molecular diagnosis of prostate cancer using surplus material washed off from biopsy needles,British Journal of Cancer,,,Article,2011-10-18,10.1038/bjc.2011.435,,,,22009027,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/425628,https://api.altmetric.com/v1/donut/425628_240.png 1,Prostate Cancer Incidence in U.S. Air Force Aviators Compared with Non-Aviators,"Aviation, Space & Environmental Medicine",,,Article,2011-11-01,10.3357/asem.3090.2011,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/425533,https://api.altmetric.com/v1/donut/425533_240.png 1,Targeted expression of E. coli purine nucleoside phosphorylase and Fludara for prostate cancer therapy,Journal of Gene Medicine - Gene Therapy Clinical Trial Database,,,Article,1970-01-01,10.1002/jgm.1620,,,,22009763,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/423765,https://api.altmetric.com/v1/donut/423765_240.png 1,"The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer",Clinical Chemistry and Laboratory Medicine,,,Article,2011-10-01,10.1515/cclm.2011.651,,,,21671822,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/423136,https://api.altmetric.com/v1/donut/423136_240.png 1,Do Patients With Localized Prostate Cancer Treatment Really Want More Aggressive Treatment?,Journal of Clinical Oncology,,,Article,2006-01-01,10.1200/jco.2006.05.9592,,,,17008699,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/422258,https://api.altmetric.com/v1/donut/422258_240.png 1,Health Behavior Changes in White and African American Prostate Cancer Survivors,Cancer Nursing,,,Article,2009-03-06,10.1097/ncc.0b013e3181982d4c,,,,19258825,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/421197,https://api.altmetric.com/v1/donut/421197_240.png 1,Microfluidic tool based on the antibodyâ??modified paramagnetic particles for detection of 8â??hydroxyâ??2â?²â??deoxyguanosine in urine of prostate cancer patients,Electrophoresis,,,Article,2011-01-11,10.1002/elps.201100430,,,,22012838,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/421100,https://api.altmetric.com/v1/donut/421100_240.png 1,Is sarcosine a biomarker for prostate cancer?,Journal of Separation Science (JSS) (formerly Journal of High Resolution Chromatography),,,Article,1970-01-01,10.1002/jssc.201100572,,,,22009695,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/419440,https://api.altmetric.com/v1/donut/419440_240.png 1,Activation of p53 Signaling and Inhibition of Androgen Receptor Mediate Tanshinone IIA Induced G1 Arrest in LNCaP Prostate Cancer Cells.,Phytotherapy research : PTR,,,Article,2011-10-13,10.1002/ptr.3616,,,,21997969,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/418828,https://api.altmetric.com/v1/donut/418828_240.png 1,Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large north american population-based cohort.,European urology,,,Article,2011-11-01,10.1016/j.eururo.2011.06.039,,,,21741762,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/418651,https://api.altmetric.com/v1/donut/418651_240.png 1,Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence,Prostate Cancer and Prostatic Diseases,,,Article,2011-10-18,10.1038/pcan.2011.48,,,,22006051,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/417380,https://api.altmetric.com/v1/donut/417380_240.png 1,The Current Use and Future Trends of Focal Surgical Therapy in the Management of Localized Prostate Cancer,The Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e318156eb99,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/415763,https://api.altmetric.com/v1/donut/415763_240.png 1,Update on Prostate Cancer Vaccines,Cancer Journal,,,Article,2011-09-30,10.1097/ppo.0b013e3182325e78,,,,21952278,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/415756,https://api.altmetric.com/v1/donut/415756_240.png 1,A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality.,European urology,,,Article,2004-03-01,10.1016/j.eururo.2003.08.018,,,,15036670,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/405410,https://api.altmetric.com/v1/donut/405410_240.png 1,Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts,Radiation Oncology,,,Article,2011-10-07,10.1186/1748-717x-6-135,,,,21981945,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/404980,https://api.altmetric.com/v1/donut/404980_240.png 1,Emerging Treatments for Castrate-Resistant Prostate Cancer,Journal of Pharmacy Practice,,,Article,2011-01-01,10.1177/0897190010397718,,,,21984773,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/404853,https://api.altmetric.com/v1/donut/404853_240.png 1,Epidermal growth factor increases LRF/Pokemon expression in human prostate cancer cells ,Experimental and Molecular Pathology,,,Article,2011-05-27,10.1016/j.yexmp.2011.05.006,,,,21640721,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/401534,https://api.altmetric.com/v1/donut/401534_240.png 1,Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice.,International journal of cancer. Journal international du cancer,,,Article,2009-04-01,10.1002/ijc.24106,,,,19115203,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/399550,https://api.altmetric.com/v1/donut/399550_240.png 1,Neighborhood deprivation and prostate cancer mortality: a multilevel analysis from Sweden,Prostate Cancer and Prostatic Diseases,,,Article,2011-10-11,10.1038/pcan.2011.46,,,,21986984,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/398692,https://api.altmetric.com/v1/donut/398692_240.png 1,Radiotherapy and Androgen Deprivation for Prostate Cancer,New England Journal of Medicine,,,Article,2011-10-06,10.1056/nejmc1109225,,,,21991967,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/397567,https://api.altmetric.com/v1/donut/397567_240.png 1,Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.,Journal of cellular biochemistry,,,Article,2004-02-15,10.1002/jcb.10661,,,,14755683,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,119,https://www.altmetric.com/details/397253,https://api.altmetric.com/v1/donut/397253_240.png 1,Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy.,ChemMedChem,,,Article,2006-03-01,10.1002/cmdc.200500044,,,,16892363,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/396163,https://api.altmetric.com/v1/donut/396163_240.png 1,Subcapsular orchiectomy in the primary therapy of patients with bone metastasis in advanced prostate cancer: an anachronistic intervention?,Advances in urology,,,Article,2012-01-01,10.1155/2012/190624,,,,21922019,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/394349,https://api.altmetric.com/v1/donut/394349_240.png 1,Focal therapy for prostate cancer - where are we in 2011?,Therapeutic advances in urology,,,Article,2011-08-01,10.1177/1756287211418724,,,,21969848,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/393356,https://api.altmetric.com/v1/donut/393356_240.png 1,Physalins A and B Inhibit Androgen-Independent Prostate Cancer Cell Growth through Activation of Cell Apoptosis and Downregulation of Androgen Receptor Expression.,Biological & pharmaceutical bulletin,,,Article,2011-01-01,,,,,21963499,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/392984,https://api.altmetric.com/v1/donut/392984_240.png 1,PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer.,International journal of oncology,,,Article,2011-01-01,,,,,21109949,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/392801,https://api.altmetric.com/v1/donut/392801_240.png 1,Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol,International Journal of Clinical Oncology,,,Article,2011-09-29,10.1007/s10147-011-0324-1,,,,21960356,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/392283,https://api.altmetric.com/v1/donut/392283_240.png 1,Translocator Protein Blockade Reduces Prostate Tumor Growth,Clinical Cancer Research,,,Article,2009-09-29,10.1158/1078-0432.ccr-09-0844,,,,19789311,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/391091,https://api.altmetric.com/v1/donut/391091_240.png 1,"Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-?B inhibitor, in human prostate cancer androgen-independent cell lines.",International journal of molecular medicine,,,Article,2011-12-01,10.3892/ijmm.2011.760,,,,21805026,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/390588,https://api.altmetric.com/v1/donut/390588_240.png 1,A novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells.,Journal of Biological Chemistry,,,Article,2011-08-30,10.1074/jbc.m111.265124,,,,21878636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,22,https://www.altmetric.com/details/390016,https://api.altmetric.com/v1/donut/390016_240.png 1,"Cohort analysis finds that the proportion of people who meet high risk criteria for colorectal, breast or prostate cancer screening based on family history increases between age 30 and 50.",Evidence Based Medicine,,,Article,2011-09-30,10.1136/ebm.2011.100190,,,,21965625,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/388550,https://api.altmetric.com/v1/donut/388550_240.png 1,Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age,The Prostate,,,Article,2011-10-01,10.1002/pros.21492,,,,21956681,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/387177,https://api.altmetric.com/v1/donut/387177_240.png 1,"BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.",Cancer biology & therapy,,,Article,2010-08-01,10.4161/cbt.10.4.12424,,,,20574166,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/385016,https://api.altmetric.com/v1/donut/385016_240.png 1,Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.,Cancer Cell,,,Article,2011-06-14,10.1016/j.ccr.2011.05.006,,,,21620777,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,119,https://www.altmetric.com/details/383858,https://api.altmetric.com/v1/donut/383858_240.png 1,Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-05-10,10.1073/pnas.1105243108,,,,21518863,PMC3093518,,2011PNAS..108.7962M,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,31,https://www.altmetric.com/details/382741,https://api.altmetric.com/v1/donut/382741_240.png 1,Aging and osteoporosis in breast and prostate cancer.,CA: A Cancer Journal for Clinicians ,,,Article,2004-01-01,10.3322/caac.20103,,,,21543824,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/380451,https://api.altmetric.com/v1/donut/380451_240.png 1,Predicting Prostate Cancer Aggressiveness through a Nanoparticle Test,,,,Article,2011-09-13,10.1038/npre.2011.6409.1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/377776,https://api.altmetric.com/v1/donut/377776_240.png 1,Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells,BMC Biology,,,Article,2010-01-21,10.1186/1741-7007-8-6,,,,20092614,PMC2845099,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/260691,https://api.altmetric.com/v1/donut/260691_240.png 1,Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry,Cytometry Part A,,,Article,2011-09-30,10.1002/cyto.a.21134,,,,21948732,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/260344,https://api.altmetric.com/v1/donut/260344_240.png 1,Prevalence of BPH and lower urinary tract symptoms in West Africans,Prostate Cancer and Prostatic Diseases,,,Article,2011-09-13,10.1038/pcan.2011.43,,,,21912428,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/259894,https://api.altmetric.com/v1/donut/259894_240.png 1,Impact of androgen deprivation therapy on depressive symptoms in men with nonmetastatic prostate cancer,Cancer (0008543X),,,Article,2011-01-01,10.1002/cncr.26477,,,,22009684,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/259353,https://api.altmetric.com/v1/donut/259353_240.png 1,Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer,Oncogene,,,Article,2011-09-12,10.1038/onc.2011.401,,,,21909140,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/258864,https://api.altmetric.com/v1/donut/258864_240.png 1,Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.,The Canadian journal of urology,,,Article,2011-08-01,,,,,21854712,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/257475,https://api.altmetric.com/v1/donut/257475_240.png 1,A pilot study on understanding the journey of advanced prostate cancer patients.,Studies in health technology and informatics,,,Article,2011-01-01,,,,,21893925,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/255170,https://api.altmetric.com/v1/donut/255170_240.png 1,Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer,Proceedings of the National Academy of Sciences,,,Article,2007-06-12,10.1073/pnas.0703867104,,,,17548809,,,2007PNAS..10410170Z,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/254878,https://api.altmetric.com/v1/donut/254878_240.png 1,Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells,Oncogene,,,Article,1970-01-01,10.1038/sj.onc.1209071,,,,16205645,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/254276,https://api.altmetric.com/v1/donut/254276_240.png 1,The association of diabetes and positive prostate biopsy in a US veteran population,Prostate Cancer and Prostatic Diseases,,,Article,2011-09-06,10.1038/pcan.2011.40,,,,21894176,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/254084,https://api.altmetric.com/v1/donut/254084_240.png 1,Prostate cancer stem cells: Are they androgen-responsive?,Molecular and cellular endocrinology,,,Article,2011-07-23,10.1016/j.mce.2011.07.008,,,,21802490,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/246016,https://api.altmetric.com/v1/donut/246016_240.png 1,Construct validity in a high-fidelity prostate exam simulator,Prostate Cancer and Prostatic Diseases,,,Article,2011-08-23,10.1038/pcan.2011.38,,,,21860409,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/243359,https://api.altmetric.com/v1/donut/243359_240.png 1,Prostate cancer: Operate or wait? Nomogram decides,Nature Reviews Urology,,,Article,2011-08-16,10.1038/nrurol.2011.116,,,,21844902,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/242877,https://api.altmetric.com/v1/donut/242877_240.png 1,Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy.,Psychosomatic Medicine (Highwire),,,Article,2011-04-01,10.1097/psy.0b013e31820a1c26,,,,21257977,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/242386,https://api.altmetric.com/v1/donut/242386_240.png 1,Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer,Clinical Cancer Research,,,Article,2011-05-10,10.1158/1078-0432.ccr-10-3223,,,,21558406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/239768,https://api.altmetric.com/v1/donut/239768_240.png 1,Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines,PLoS ONE,,,Article,2011-08-04,10.1371/journal.pone.0023144,,,,21829708,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/237004,https://api.altmetric.com/v1/donut/237004_240.png 1,Intimacy-enhancing psychological intervention for men diagnosed with prostate cancer and their partners: a pilot study.,Journal of Sexual Medicine,,,Article,2011-04-01,10.1111/j.1743-6109.2010.02163.x,,,,21210958,PMC3070795,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,43,https://www.altmetric.com/details/236058,https://api.altmetric.com/v1/donut/236058_240.png 1,Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.,Journal of Clinical Oncology,,,Article,2010-12-01,10.1200/jco.2010.29.8091,,,,21041715,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,32,https://www.altmetric.com/details/235817,https://api.altmetric.com/v1/donut/235817_240.png 1,Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy.,The Journal of urology,,,Article,2010-11-01,10.1016/j.juro.2010.06.099,,,,20850836,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/235642,https://api.altmetric.com/v1/donut/235642_240.png 1,Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group.,"International journal of radiation oncology, biology, physics",,,Article,2010-07-15,10.1016/j.ijrobp.2009.06.038,,,,19864082,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,34,https://www.altmetric.com/details/234432,https://api.altmetric.com/v1/donut/234432_240.png 1,Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids.,Biomaterials,,,Article,2009-06-01,10.1016/j.biomaterials.2009.02.047,,,,19304321,PMC2675053,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,189,https://www.altmetric.com/details/233651,https://api.altmetric.com/v1/donut/233651_240.png 1,Predictors of response to sildenafil citrate following radiation therapy for prostate cancer.,The journal of sexual medicine,,,Article,2009-04-01,10.1111/j.1743-6109.2008.01170.x,,,,19210713,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/233517,https://api.altmetric.com/v1/donut/233517_240.png 1,"Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.",The Journal of urology,,,Article,2009-03-01,10.1016/j.juro.2008.11.012,,,,19150092,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/233437,https://api.altmetric.com/v1/donut/233437_240.png 1,Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid--first clinical experiences.,Urology,,,Article,2008-08-01,10.1016/j.urology.2007.12.086,,,,18405945,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,17,https://www.altmetric.com/details/232835,https://api.altmetric.com/v1/donut/232835_240.png 1,A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer.,British journal of cancer,,,Article,2008-01-15,10.1038/sj.bjc.6604051,,,,18182976,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/232646,https://api.altmetric.com/v1/donut/232646_240.png 1,In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.,British Journal of Cancer,,,Article,2007-05-21,10.1038/sj.bjc.6603767,,,,17453001,PMC2359953,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,17,https://www.altmetric.com/details/231916,https://api.altmetric.com/v1/donut/231916_240.png 1,Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials.,Human gene therapy,,,Article,2007-04-01,10.1089/hum.2006.131,,,,17408358,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/231806,https://api.altmetric.com/v1/donut/231806_240.png 1,Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.,AJR. American journal of roentgenology,,,Article,2007-03-01,10.2214/ajr.06.0165,,,,17312072,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,27,https://www.altmetric.com/details/231515,https://api.altmetric.com/v1/donut/231515_240.png 1,Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.,"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",,,Article,2007-02-01,10.1158/1055-9965.epi-06-0621,,,,17301264,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,https://www.altmetric.com/details/231481,https://api.altmetric.com/v1/donut/231481_240.png 1,Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.,The Journal of Urology,,,Article,2007-02-01,10.1016/j.juro.2006.09.063,,,,17222618,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/231174,https://api.altmetric.com/v1/donut/231174_240.png 1,Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2006-06-20,10.1200/jco.2005.05.4767,,,,16782914,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,https://www.altmetric.com/details/229820,https://api.altmetric.com/v1/donut/229820_240.png 1,Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.,Cancer research,,,Article,2005-11-15,10.1158/0008-5472.can-05-0824,,,,16288033,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/228246,https://api.altmetric.com/v1/donut/228246_240.png 1,"Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.",The Journal of Urology,,,Article,2005-08-01,10.1097/01.ju.0000165342.85300.14,,,,16006930,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/227885,https://api.altmetric.com/v1/donut/227885_240.png 1,Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.,The Prostate,,,Article,2004-03-01,10.1002/pros.10349,,,,14968441,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/227599,https://api.altmetric.com/v1/donut/227599_240.png 1,"Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.",Cancer,,,Article,2005-03-01,10.1002/cncr.20855,,,,15651057,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/226604,https://api.altmetric.com/v1/donut/226604_240.png 1,Estimated impact of the Prostate Cancer Prevention Trial on population mortality.,Cancer,,,Article,2005-04-01,10.1002/cncr.20919,,,,15739207,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/226602,https://api.altmetric.com/v1/donut/226602_240.png 1,PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.,"International journal of radiation oncology, biology, physics",,,Article,2006-03-15,10.1016/j.ijrobp.2005.07.006,,,,16198506,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/226596,https://api.altmetric.com/v1/donut/226596_240.png 1,Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.,The Journal of urology,,,Article,2006-02-01,10.1016/s0022-5347(05)00211-9,,,,16406977,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/226594,https://api.altmetric.com/v1/donut/226594_240.png 1,Prognostic factors in lymph node-positive prostate cancer.,Urology,,,Article,2006-05-01,10.1016/j.urology.2005.10.055,,,,16698361,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/226588,https://api.altmetric.com/v1/donut/226588_240.png 1,Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy,Journal of Clinical Oncology,,,Article,2006-05-01,10.1200/jco.2005.05.2530,,,,16648499,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,137,https://www.altmetric.com/details/226582,https://api.altmetric.com/v1/donut/226582_240.png 1,Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.,Urology,,,Article,2006-06-01,10.1016/j.urology.2005.12.003,,,,16678888,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/226577,https://api.altmetric.com/v1/donut/226577_240.png 1,Impact of increased number of biopsies on the nature of prostate cancer identified.,The Journal of urology,,,Article,2006-07-01,10.1016/s0022-5347(06)00493-9,,,,16753368,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/226570,https://api.altmetric.com/v1/donut/226570_240.png 1,The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer.,Journal of Cancer Research & Clinical Oncology,,,Article,2006-08-01,10.1007/s00432-006-0132-6,,,,16896884,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/226565,https://api.altmetric.com/v1/donut/226565_240.png 1,"Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam.",Urology,,,Article,2006-09-01,10.1016/j.urology.2006.03.015,,,,17010732,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/226556,https://api.altmetric.com/v1/donut/226556_240.png 1,Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.,Journal of the National Cancer Institute,,,Article,2006-08-16,10.1093/jnci/djj308,,,,16912266,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/226551,https://api.altmetric.com/v1/donut/226551_240.png 1,"Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.",Cancer,,,Article,2006-12-01,10.1002/cncr.22279,,,,17039498,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/226550,https://api.altmetric.com/v1/donut/226550_240.png 1,Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.,Journal of the National Cancer Institute,,,Article,2006-11-01,10.1093/jnci/djj410,,,,17077354,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/226545,https://api.altmetric.com/v1/donut/226545_240.png 1,"Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis.",Cancer,,,Article,2006-11-15,10.1002/cncr.22261,,,,17041884,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/226539,https://api.altmetric.com/v1/donut/226539_240.png 1,Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer.,Urology,,,Article,2007-01-01,10.1016/j.urology.2006.09.018,,,,17270635,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/226536,https://api.altmetric.com/v1/donut/226536_240.png 1,Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?,Cancer,,,Article,2007-01-15,10.1002/cncr.22403,,,,17167758,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/226535,https://api.altmetric.com/v1/donut/226535_240.png 1,The burden of depression in prostate cancer,Psycho-Oncology,,,Article,2011-08-13,10.1002/pon.2032,,,,21837637,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/223675,https://api.altmetric.com/v1/donut/223675_240.png 1,"Impact of Consumption of Vegetable, Fruit, Grain, and High Glycemic Index Foods on Aggressive Prostate Cancer Risk.",Nutrition and Cancer,,,Article,2011-07-20,10.1080/01635581.2011.582224,,,,21774611,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/222936,https://api.altmetric.com/v1/donut/222936_240.png 1,In vivo pharmacodynamics of indoleâ??3â??carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: Involvement of Nrf2 and cell cycle/apoptosis signaling pathways,Molecular Carcinogenesis,"JONES, India",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-01-01,10.1002/mc.20841,,,,21837756,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/222700,https://api.altmetric.com/v1/donut/222700_240.png 1,Baculoviruses as gene therapy vectors for human prostate cancer.,Journal of invertebrate pathology,,,Article,2011-07-01,10.1016/j.jip.2011.05.006,,,,21784232,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/212070,https://api.altmetric.com/v1/donut/212070_240.png 1,Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.,Urology,,,Article,2007-01-01,10.1016/j.urology.2006.09.008,,,,17270638,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/212033,https://api.altmetric.com/v1/donut/212033_240.png 1,Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).,Journal of the National Cancer Institute,,,Article,2007-05-16,10.1093/jnci/djk178,,,,17505072,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/212030,https://api.altmetric.com/v1/donut/212030_240.png 1,Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.,Cancer (0008543X),,,Article,2007-07-01,10.1002/cncr.22737,,,,17530618,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/212020,https://api.altmetric.com/v1/donut/212020_240.png 1,Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.,The Journal of urology,,,Article,2007-07-01,10.1016/j.juro.2007.03.018,,,,17499306,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/212017,https://api.altmetric.com/v1/donut/212017_240.png 1,Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.,"International journal of radiation oncology, biology, physics",,,Article,2007-02-01,10.1016/j.ijrobp.2006.08.056,,,,17084558,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/212016,https://api.altmetric.com/v1/donut/212016_240.png 1,"Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.",Journal of the National Cancer Institute,,,Article,2007-09-05,10.1093/jnci/djm101,,,,17728218,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/212002,https://api.altmetric.com/v1/donut/212002_240.png 1,The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer.,Cancer,,,Article,2008-01-01,10.1002/cncr.23139,,,,17968996,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/211979,https://api.altmetric.com/v1/donut/211979_240.png 1,Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial,JNCI: Journal of the National Cancer Institute,,,Article,2008-08-20,10.1093/jnci/djn255,,,http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-36113,18695132,PMC2518167,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,146,https://www.altmetric.com/details/211952,https://api.altmetric.com/v1/donut/211952_240.png 1,Statin use and risk of prostate cancer: results from a population-based epidemiologic study.,American journal of epidemiology,,,Article,2008-08-01,10.1093/aje/kwn141,,,,18556686,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/211948,https://api.altmetric.com/v1/donut/211948_240.png 1,Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden.,The lancet oncology,,,Article,2010-05-01,10.1016/s1470-2045(10)70038-3,,,,20395174,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/211932,https://api.altmetric.com/v1/donut/211932_240.png 1,Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer.,Annals of internal medicine,,,Article,2010-05-18,10.1059/0003-4819-152-10-201005180-00002,,,,20479027,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/211927,https://api.altmetric.com/v1/donut/211927_240.png 1,"Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.",British Journal of Urology,,,Article,2010-07-01,10.1111/j.1464-410x.2009.08981.x,,,,19912212,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/211921,https://api.altmetric.com/v1/donut/211921_240.png 1,Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.,"International journal of radiation oncology, biology, physics",,,Article,2010-08-01,10.1016/j.ijrobp.2009.06.061,,,,20138442,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/211917,https://api.altmetric.com/v1/donut/211917_240.png 1,Quantification of tumor cell burden by analysis of single cell lymph node disaggregates in metastatic prostate cancer.,The Prostate,,,Article,2010-07-01,10.1002/pros.21145,,,,20503396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/211914,https://api.altmetric.com/v1/donut/211914_240.png 1,A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.,"Cancer immunology, immunotherapy : CII",,,Article,2010-07-01,10.1007/s00262-010-0822-4,,,,20146063,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/211911,https://api.altmetric.com/v1/donut/211911_240.png 1,"Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy.",The Prostate,,,Article,2010-09-01,10.1002/pros.21168,,,,20623633,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/211910,https://api.altmetric.com/v1/donut/211910_240.png 1,Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy.,The Journal of urology,,,Article,2010-09-01,10.1016/j.juro.2010.05.043,,,,20643452,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/211907,https://api.altmetric.com/v1/donut/211907_240.png 1,Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study.,International journal of urology : official journal of the Japanese Urological Association,,,Article,2010-08-01,10.1111/j.1442-2042.2010.02568.x,,,,20529139,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/211906,https://api.altmetric.com/v1/donut/211906_240.png 1,Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer.,International journal of urology : official journal of the Japanese Urological Association,,,Article,2010-09-01,10.1111/j.1442-2042.2010.02585.x,,,,20569272,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/211898,https://api.altmetric.com/v1/donut/211898_240.png 1,"Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial.",British Journal of Urology,,,Article,2010-10-01,10.1111/j.1464-410x.2010.09638.x,,,,20840318,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/211883,https://api.altmetric.com/v1/donut/211883_240.png 1,Synergistic antimicrotubule therapy for prostate cancer.,Biochemical Pharmacology,,,Article,2011-02-15,10.1016/j.bcp.2010.11.006,,,,21087597,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/211874,https://api.altmetric.com/v1/donut/211874_240.png 1,Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer.,Urology,,,Article,2011-04-01,10.1016/j.urology.2010.07.539,,,,21195465,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/211867,https://api.altmetric.com/v1/donut/211867_240.png 1,Early development of castrate resistance varies with different dosing regimens of luteinizing hormone releasing hormone agonist in primary hormonal therapy for prostate cancer.,Urology,,,Article,2011-02-01,10.1016/j.urology.2010.08.037,,,,21111460,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/211865,https://api.altmetric.com/v1/donut/211865_240.png 1,Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.,American journal of human genetics,,,Article,2010-12-10,10.1016/j.ajhg.2010.11.001,,,,21129724,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/211863,https://api.altmetric.com/v1/donut/211863_240.png 1,Diagnosis of prostate cancer using differentially expressed genes in stroma.,Cancer Research,,,Article,2011-04-01,10.1158/0008-5472.can-10-2585,,,,21459804,PMC3071046,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/211851,https://api.altmetric.com/v1/donut/211851_240.png 1,TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate.,European Urology,,,Article,2011-07-14,10.1016/j.eururo.2011.07.011,,,,21802835,PMC3185163,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/211732,https://api.altmetric.com/v1/donut/211732_240.png 1,Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2008-01-10,10.1200/jco.2007.12.4008,,,,18182665,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,165,https://www.altmetric.com/details/210519,https://api.altmetric.com/v1/donut/210519_240.png 1,Does treatment duration affect outcome after radiotherapy for prostate cancer?,"International journal of radiation oncology, biology, physics",,,Article,2008-12-01,10.1016/j.ijrobp.2008.03.011,,,,18472368,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/210484,https://api.altmetric.com/v1/donut/210484_240.png 1,The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.,Journal of Clinical Investigation,,,Article,2010-12-01,10.1172/jci44239,,,,21099110,PMC2993601,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/210148,https://api.altmetric.com/v1/donut/210148_240.png 1,PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo,Prostate Cancer and Prostatic Diseases,,,Article,2011-08-09,10.1038/pcan.2011.34,,,,21826098,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/207694,https://api.altmetric.com/v1/donut/207694_240.png 1,Immunotherapy: A vaccine for prostate cancer?,Nature Reviews Cancer,,,Article,2011-07-22,10.1038/nrc3117,,,,17387370,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/203795,https://api.altmetric.com/v1/donut/203795_240.png 1,Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy,Prostate Cancer and Prostatic Diseases,,,Article,2011-08-02,10.1038/pcan.2011.36,,,,21808286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/202497,https://api.altmetric.com/v1/donut/202497_240.png 1,Inducible expression of antizyme 1 in prostate cancer cell lines after lentivirus mediated gene transfer.,Amino acids,,,Article,2011-07-29,10.1007/s00726-011-1033-9,,,,21800259,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/201236,https://api.altmetric.com/v1/donut/201236_240.png 1,Feasibility of Adenovirus-Mediated hNIS Gene Transfer and 131I Radioiodine Therapy as a Definitive Treatment for Localized Prostate Cancer,Molecular Therapy,,,Article,2011-05-17,10.1038/mt.2011.89,,,,21587209,PMC3129572,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/198013,https://api.altmetric.com/v1/donut/198013_240.png 1,"Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial",British Journal of Nutrition,,,Article,2011-08-14,10.1017/s0007114511001590,,,,21736838,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/197700,https://api.altmetric.com/v1/donut/197700_240.png 1,"Prostate cancer: Searching for bone metastases|[mdash]|how, when and why?",Nature Reviews Urology,,,Article,2011-05-31,10.1038/nrurol.2011.70,,,,21629219,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/197418,https://api.altmetric.com/v1/donut/197418_240.png 1,Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.,Oncogene,,,Article,2011-07-18,10.1038/onc.2011.304,,,,21765474,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,88,https://www.altmetric.com/details/193266,https://api.altmetric.com/v1/donut/193266_240.png 1,Statins and Prostate Cancer Diagnosis and Grade in a Veterans Population,JNCI Journal of the National Cancer Institute,,,Article,2011-04-15,10.1093/jnci/djr108,,,,21498780,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/187489,https://api.altmetric.com/v1/donut/187489_240.png 1,Comprehensive resequence analysis of a 123â??kb region of chromosome 11q13 associated with prostate cancer,The Prostate,,,Article,2012-01-01,10.1002/pros.21450,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/186748,https://api.altmetric.com/v1/donut/186748_240.png 1,"Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness.",Urologic Oncology,,,Article,2011-07-07,10.1016/j.urolonc.2011.05.011,,,,21741862,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/186172,https://api.altmetric.com/v1/donut/186172_240.png 1,Suppression of STAT3 and HIF-1 Alpha Mediates Anti-Angiogenic Activity of Betulinic Acid in Hypoxic PC-3 Prostate Cancer Cells.,PloS one,,,Article,2011-01-01,10.1371/journal.pone.0021492,,,,21731766,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/183378,https://api.altmetric.com/v1/donut/183378_240.png 1,"Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation",JNCI Journal of the National Cancer Institute,,,Article,2011-05-23,10.1093/jnci/djr173,,,,21606442,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/182217,https://api.altmetric.com/v1/donut/182217_240.png 1,Predictive value of digital rectal examination for prostate cancer detection is modified by obesity,Prostate Cancer & Prostatic Diseases,,,Article,2011-07-05,10.1038/pcan.2011.31,,,,21727906,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/179745,https://api.altmetric.com/v1/donut/179745_240.png 1,Predicting survival in prostate cancer: the role of quality of life assessment,Supportive Care in Cancer,,,Article,2011-06-28,10.1007/s00520-011-1213-x,,,,21710307,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/178451,https://api.altmetric.com/v1/donut/178451_240.png 1,Androgen receptor gene polymorphisms and alterations in prostate cancer: Of humanized mice and men.,Molecular & Cellular Endocrinology,,,Article,2011-06-12,10.1016/j.mce.2011.06.003,,,,21689727,PMC3188356,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/175005,https://api.altmetric.com/v1/donut/175005_240.png 1,Omega-3 Fatty Acid Inhibition of Prostate Cancer Progression to Hormone Independence Is Associated With Suppression of mTOR Signaling and Androgen Receptor Expression.,Nutrition and cancer,,,Article,2011-06-10,10.1080/01635581.2011.570892,,,,21667400,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/170310,https://api.altmetric.com/v1/donut/170310_240.png 1,Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis,Prostate Cancer and Prostatic Diseases,,,Article,2011-06-21,10.1038/pcan.2011.27,,,,21691281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/170290,https://api.altmetric.com/v1/donut/170290_240.png 1,"Comparison of Prophylactic Naftopidil, Tamsulosin, and Silodosin for (125)I Brachytherapy-Induced Lower Urinary Tract Symptoms in Patients with Prostate Cancer: Randomized Controlled Trial.","International journal of radiation oncology, biology, physics",,,Article,2011-06-08,10.1016/j.ijrobp.2011.04.026,,,,21664068,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/169025,https://api.altmetric.com/v1/donut/169025_240.png 1,Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?,Nature Clinical Practice Urology,,,Article,2008-01-01,10.1038/ncpuro0995,,,,18185511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/168875,https://api.altmetric.com/v1/donut/168875_240.png 1,Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-04-01,10.1158/1055-9965.epi-10-1309,,,,21297042,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/168484,https://api.altmetric.com/v1/donut/168484_240.png 1,Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.,The Journal of biological chemistry,,,Article,2003-09-05,10.1074/jbc.m303313200,,,,12824193,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,28,https://www.altmetric.com/details/157720,https://api.altmetric.com/v1/donut/157720_240.png 1,Diagnostic potential of serum proteomic patterns in prostate cancer.,The Journal of Urology,,,Article,2003-08-01,10.1097/01.ju.0000069431.95404.56,,,,12853795,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,17,https://www.altmetric.com/details/157492,https://api.altmetric.com/v1/donut/157492_240.png 1,Application of in-gel protease assay in a biological sample: characterization and identification of urokinase-type plasminogen activator (uPA) in secreted proteins from a prostate cancer cell line PC-3.,Electrophoresis,,,Article,2004-04-01,10.1002/elps.200305778,,,,15095458,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/153480,https://api.altmetric.com/v1/donut/153480_240.png 1,Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.,Nature genetics,,,Article,2004-09-01,10.1038/ng1408,,,,15300251,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,49,https://www.altmetric.com/details/151759,https://api.altmetric.com/v1/donut/151759_240.png 1,Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2004-08-24,10.1073/pnas.0404956101,,,,15314219,,,2004PNAS..10112561S,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,82,https://www.altmetric.com/details/151620,https://api.altmetric.com/v1/donut/151620_240.png 1,Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.,American journal of human genetics,,,Article,2005-01-01,10.1086/427224,,,,15570555,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/149940,https://api.altmetric.com/v1/donut/149940_240.png 1,Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice.,Cancer Research,,,Article,2005-03-15,10.1158/0008-5472.can-04-3992,,,,15781616,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,7,https://www.altmetric.com/details/148047,https://api.altmetric.com/v1/donut/148047_240.png 1,"The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.",Cancer research,,,Article,2005-06-15,10.1158/0008-5472.can-04-1941,,,,15958594,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,https://www.altmetric.com/details/146608,https://api.altmetric.com/v1/donut/146608_240.png 1,Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.,Clinical cancer research : an official journal of the American Association for Cancer Research,,,Article,2005-07-01,10.1158/1078-0432.ccr-05-0525,,,,16000557,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,34,https://www.altmetric.com/details/146282,https://api.altmetric.com/v1/donut/146282_240.png 1,Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.,The Prostate,,,Article,2006-02-15,10.1002/pros.20346,,,,16245280,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,16,https://www.altmetric.com/details/144398,https://api.altmetric.com/v1/donut/144398_240.png 1,"NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.",Cancer cell,,,Article,2006-05-01,10.1016/j.ccr.2006.03.031,,,,16697957,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,57,https://www.altmetric.com/details/140788,https://api.altmetric.com/v1/donut/140788_240.png 1,"Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.",The Journal of Urology,,,Article,2006-09-01,10.1016/j.juro.2006.04.011,,,,16890670,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/139372,https://api.altmetric.com/v1/donut/139372_240.png 1,The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.,The Journal of urology,,,Article,2006-10-01,10.1016/j.juro.2006.06.087,,,,16952708,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,20,https://www.altmetric.com/details/138892,https://api.altmetric.com/v1/donut/138892_240.png 1,Androgen receptor decoy molecules block the growth of prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2007-01-23,10.1073/pnas.0606718104,,,,17227854,,,2007PNAS..104.1331Q,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,22,https://www.altmetric.com/details/136671,https://api.altmetric.com/v1/donut/136671_240.png 1,Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.,Cancer research,,,Article,2007-01-15,10.1158/0008-5472.can-06-1478,,,,17234758,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,30,https://www.altmetric.com/details/136628,https://api.altmetric.com/v1/donut/136628_240.png 1,Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.,Cancer research,,,Article,2007-01-15,10.1158/0008-5472.can-06-2593,,,,17234763,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,9,https://www.altmetric.com/details/136627,https://api.altmetric.com/v1/donut/136627_240.png 1,Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.,Nature,,,Article,2007-08-02,10.1038/nature06024,,,,17671502,,,2007Natur.448..595T,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,4,https://www.altmetric.com/details/133725,https://api.altmetric.com/v1/donut/133725_240.png 1,A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.,Molecular cell,,,Article,2007-08-03,10.1016/j.molcel.2007.05.041,,,,17679089,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,138,https://www.altmetric.com/details/133697,https://api.altmetric.com/v1/donut/133697_240.png 1,Soy and prostate cancer study results mixed.,Journal of the National Cancer Institute,,,Article,2007-09-19,10.1093/jnci/djm162,,,,17848664,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,2,https://www.altmetric.com/details/133570,https://api.altmetric.com/v1/donut/133570_240.png 1,Regulation of epithelial branching morphogenesis and cancer cell growth of the prostate by Wnt signaling.,PloS one,,,Article,2008-01-01,10.1371/journal.pone.0002186,,,,18478098,,,2008PLoSO...3.2186W,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,26,https://www.altmetric.com/details/133318,https://api.altmetric.com/v1/donut/133318_240.png 1,Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.,Cancer Research,,,Article,2008-08-01,10.1158/0008-5472.can-07-5997,,,,18676866,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,86,https://www.altmetric.com/details/133202,https://api.altmetric.com/v1/donut/133202_240.png 1,Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.,Cancer research,,,Article,2008-09-01,10.1158/0008-5472.can-08-0578,,,,18757402,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,15,https://www.altmetric.com/details/133168,https://api.altmetric.com/v1/donut/133168_240.png 1,Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2009-04-01,10.1200/jco.2008.17.0563,,,,19237635,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,5,https://www.altmetric.com/details/132879,https://api.altmetric.com/v1/donut/132879_240.png 1,Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model.,PloS one,,,Article,2009-01-01,10.1371/journal.pone.0005662,,,,19461893,,,2009PLoSO...4.5662K,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,19,https://www.altmetric.com/details/132646,https://api.altmetric.com/v1/donut/132646_240.png 1,"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.",Nature Medicine,,,Article,2010-07-01,10.1038/nm.2166,,,,20526349,PMC2903732,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,166,https://www.altmetric.com/details/131606,https://api.altmetric.com/v1/donut/131606_240.png 1,Kindlin-2 controls sensitivity of prostate cancer cells to cisplatin-induced cell death.,Cancer letters,,,Article,2010-12-18,10.1016/j.canlet.2010.08.003,,,,20813451,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,13,https://www.altmetric.com/details/131325,https://api.altmetric.com/v1/donut/131325_240.png 1,Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells.,Nature Cell Biology,,,Article,2010-12-01,10.1038/ncb2122,,,,21076414,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,109,https://www.altmetric.com/details/131085,https://api.altmetric.com/v1/donut/131085_240.png 1,Integrative Gene Network Construction for Predicting a Set of Complementary Prostate Cancer Genes,Bioinformatics,,,Article,2011-05-06,10.1093/bioinformatics/btr283,,,,21551151,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/130360,https://api.altmetric.com/v1/donut/130360_240.png 1,[Cryotherapy of prostatic cancer].,Ugeskrift for laeger,,,Article,2011-04-04,,,,,21591477,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/129759,https://api.altmetric.com/v1/donut/129759_240.png 1,"The role of inflammation and infection in prostate cancer: Importance in prevention, diagnosis and treatment.","Drugs of today (Barcelona, Spain : 1998)",,,Article,2010-12-01,10.1358/dot.2010.46.12.1537942,,,,21589950,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/129758,https://api.altmetric.com/v1/donut/129758_240.png 1,Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an Italian clinical experience.,European review for medical and pharmacological sciences,,,Article,2011-03-01,,,,,21528780,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/129755,https://api.altmetric.com/v1/donut/129755_240.png 1,"Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose.",Cancer,,,Article,2011-05-15,10.1002/cncr.25758,,,,21523720,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/129754,https://api.altmetric.com/v1/donut/129754_240.png 1,Metabolic risk factors in prostate cancer.,Cancer (0008543X),,,Article,2011-05-15,10.1002/cncr.25749,,,,21523712,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/129752,https://api.altmetric.com/v1/donut/129752_240.png 1,Cytogenomic aberrations associated with prostate cancer.,Cancer genetics,,,Article,2011-02-01,10.1016/j.cancergencyto.2010.10.003,,,,21504704,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/129750,https://api.altmetric.com/v1/donut/129750_240.png 1,Prostate cancer stem cells and their potential roles in metastasis.,Journal of surgical oncology,,,Article,2011-05-01,10.1002/jso.21806,,,,21480250,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/129748,https://api.altmetric.com/v1/donut/129748_240.png 1,Patients' perspectives on fecal incontinence after brachytherapy for localized prostate cancer.,Diseases of the colon and rectum,,,Article,2011-05-01,10.1007/dcr.0b013e318207f85f,,,,21471764,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/129745,https://api.altmetric.com/v1/donut/129745_240.png 1,Dutasteride: novel milestones in prostate cancer chemoprevention.,"Drugs of today (Barcelona, Spain : 1998)",,,Article,2011-02-01,10.1358/dot.2011.47.2.1561069,,,,21431101,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/129739,https://api.altmetric.com/v1/donut/129739_240.png 1,From a woman's perspective: life as a partner of a prostate cancer survivor.,Journal of midwifery & women's health,,,Article,2011-01-01,10.1111/j.1542-2011.2010.00017.x,,,,21429081,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/129738,https://api.altmetric.com/v1/donut/129738_240.png 1,Steps in prostate cancer progression that lead to bone metastasis.,International Journal of Cancer,,,Article,2011-06-01,10.1002/ijc.26024,,,,21365645,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/129735,https://api.altmetric.com/v1/donut/129735_240.png 1,Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells.,Cell death & disease,,,Article,2010-01-01,10.1038/cddis.2010.52,,,,21364678,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/129734,https://api.altmetric.com/v1/donut/129734_240.png 1,Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells.,Cell Death & Disease,,,Article,2010-01-01,10.1038/cddis.2010.50,,,,21364676,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/129733,https://api.altmetric.com/v1/donut/129733_240.png 1,Functional and oncological outcomes of men under 60 years of age having endoscopic surgery for prostate cancer are optimal following intrafascial endoscopic extraperitoneal radical prostatectomy.,Surgeon (Edinburgh University Press),,,Article,2011-04-01,10.1016/j.surge.2010.07.005,,,,21342669,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/129732,https://api.altmetric.com/v1/donut/129732_240.png 1,Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial,American Journal of Epidemiology,,,Article,2011-05-03,10.1093/aje/kwq493,,,,21540324,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/100886,https://api.altmetric.com/v1/donut/100886_240.png 1,Altered glycosylation in prostate cancer.,Advances in cancer research,,,Article,,10.1016/bs.acr.2014.12.001,,,,25727153,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3920008,https://api.altmetric.com/v1/donut/3920008_240.png 1,The 20th Annual Prostate Cancer Foundation Scientific Retreat report,The Prostate,,,Article,2014-04-09,10.1002/pros.22808,,,,24719035,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2278430,https://api.altmetric.com/v1/donut/2278430_240.png 1,The Role of 11C-Choline PET Imaging in the Early Detection of Recurrence in Surgically Treated Prostate Cancer Patients With Very Low PSA Level <0.5 ng/mL.,Clinical Nuclear Medicine,,,Article,2013-06-27,10.1097/rlu.0b013e31829af913,,,,23797218,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2240373,https://api.altmetric.com/v1/donut/2240373_240.png 1,Human fucosyltransferase 6 enables prostate cancer metastasis to bone,British Journal of Cancer,,,Article,2013-10-31,10.1038/bjc.2013.690,,,,24178760,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1979679,https://api.altmetric.com/v1/donut/1979679_240.png 1,Increasing rates of low-risk prostate cancer incidence in USAF servicemen and selection of treatments,The Journal of Urology,,,Article,2011-06-01,10.1016/j.juro.2011.02.052,,,,21496842,PMC3171171,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1942824,https://api.altmetric.com/v1/donut/1942824_240.png 1,Hedgehog Signaling in Prostate Cancer and Its Therapeutic Implication,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140713979,,,,23880852,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1604853,https://api.altmetric.com/v1/donut/1604853_240.png 1,Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics,PLoS ONE,,,Article,2012-08-20,10.1371/journal.pone.0043470,,,,22916267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1261120,https://api.altmetric.com/v1/donut/1261120_240.png 1,Modulation of signaling pathways in prostate cancer by green tea polyphenols.,Biochemical Pharmacology,,,Article,2012-10-01,10.1016/j.bcp.2012.09.027,,,,23041649,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/991081,https://api.altmetric.com/v1/donut/991081_240.png 1,"Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancer",Radiation Oncology,,,Article,2012-09-18,10.1186/1748-717x-7-160,,,,22989046,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/956785,https://api.altmetric.com/v1/donut/956785_240.png 1,Excess body weight linked to an increased risk of recurrence after prostate cancer treatment,Cancer (0008543X),,,Article,2012-07-20,10.1002/cncr.27750,,,,22821133,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/849249,https://api.altmetric.com/v1/donut/849249_240.png 1,Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy,Cancer (0008543X),,,Article,2010-01-01,10.1002/cncr.24750,,,,20052734,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/794142,https://api.altmetric.com/v1/donut/794142_240.png 1,Intermittent androgen blockade should be regarded as standard therapy in prostate cancer,Nature Clinical Practice Oncology,,,Article,2008-07-15,10.1038/ncponc1180,,,,18628739,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/775366,https://api.altmetric.com/v1/donut/775366_240.png 1,Other methods for improved prostate cancer detection?,Cancer (0008543X),,,Article,2012-05-01,10.1002/cncr.27584,,,,22522609,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/706504,https://api.altmetric.com/v1/donut/706504_240.png 1,Identification of markers of prostate cancer progression using candidate gene expression,British Journal of Cancer,,,Article,2011-11-10,10.1038/bjc.2011.490,,,,22075945,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/451432,https://api.altmetric.com/v1/donut/451432_240.png 1,High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients.,Clinical Oncology,,,Article,,10.1016/j.clon.2016.06.013,,,,27389021,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13320864,https://api.altmetric.com/v1/donut/13320864_240.png 1,DNA-Repair Gene Mutations in Metastatic Prostate Cancer,New England Journal of Medicine,,,Article,2016-11-03,10.1056/nejmc1611137,,,,27806229,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13296711,https://api.altmetric.com/v1/donut/13296711_240.png 1,"Patterns of Care for Prostate Cancer Patients: Predictors of Care, But For Whom?",European Urology,,,Article,2016-11-01,10.1016/j.eururo.2016.10.020,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13264644,https://api.altmetric.com/v1/donut/13264644_240.png 1,Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer,American Journal of Epidemiology,,,Article,2016-10-24,10.1093/aje/kww084,,,,27777219,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13227675,https://api.altmetric.com/v1/donut/13227675_240.png 1,Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer,Medicine,,,Article,2016-10-01,10.1097/md.0000000000004636,,,http://journals.lww.com/md-journal/Fulltext/2016/10250/Targeting_the_androgenic_pathway_in_elderly.2.aspx,27787354,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13168261,https://api.altmetric.com/v1/donut/13168261_240.png 1,Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy,ACS Applied Materials & Interfaces,,,Article,2016-10-27,10.1021/acsami.6b10029,,,,27786455,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13161007,https://api.altmetric.com/v1/donut/13161007_240.png 1,Hypofractionation for Prostate Cancer: Time to Change,Clinical Oncology,,,Article,2016-10-01,10.1016/j.clon.2016.09.020,,,,27777147,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13142057,https://api.altmetric.com/v1/donut/13142057_240.png 1,Should we Perform Genetic Testing on Men with Metastatic Prostate Cancer?,Clinical Oncology,,,Article,2016-10-01,10.1016/j.clon.2016.10.004,,,,27789128,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13142055,https://api.altmetric.com/v1/donut/13142055_240.png 1,Prostate cancer: N-Myc expression drives neuroendocrine disease,Nature Reviews Urology,,,Article,2016-10-25,10.1038/nrurol.2016.218,,,,27779225,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13010691,https://api.altmetric.com/v1/donut/13010691_240.png 1,Prostate cancer: Proteomic assay predicts biochemical recurrence,Nature Reviews Urology,,,Article,2016-10-25,10.1038/nrurol.2016.215,,,,27779223,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13010688,https://api.altmetric.com/v1/donut/13010688_240.png 1,Emerging data on androgen receptor splice variants in prostate cancer,Endocrine-Related Cancer,,,Article,2016-10-04,10.1530/erc-16-0298,,,,27702752,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12991114,https://api.altmetric.com/v1/donut/12991114_240.png 1,Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,1994-02-02,,,,,7506797,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,93,https://www.altmetric.com/details/12921686,https://api.altmetric.com/v1/donut/12921686_240.png 1,The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer,Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000216,,,http://journals.lww.com/journalppo/Fulltext/2016/09000/The_Role_of_Testosterone_in_the_Treatment_of.5.aspx,27749326,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12743646,https://api.altmetric.com/v1/donut/12743646_240.png 1,Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects,British Journal of Cancer,,,Article,2005-02-14,10.1038/sj.bjc.6602301,,,,15685244,PMC2362084,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/12662520,https://api.altmetric.com/v1/donut/12662520_240.png 1,Therapeutic management of bone metastasis in prostate cancer: an update,Expert Review of Anticancer Therapy,,,Article,2016-10-06,10.1080/14737140.2016.1241148,,,,27666299,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12466789,https://api.altmetric.com/v1/donut/12466789_240.png 1,PARP inhibitors and stratified treatment of prostate cancer,Expert Review of Anticancer Therapy,,,Article,2016-09-30,10.1080/14737140.2016.1243474,,,,27686597,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12441950,https://api.altmetric.com/v1/donut/12441950_240.png 1,Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-09-30,10.1073/pnas.1614529113,,,,27694579,,,,,,,0,0,0,1,0,0,0,0,0,0,3,0,0,0,0,0,https://www.altmetric.com/details/12356034,https://api.altmetric.com/v1/donut/12356034_240.png 1,Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting,The Prostate,,,Article,2016-09-29,10.1002/pros.23260,,,,27679977,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12332109,https://api.altmetric.com/v1/donut/12332109_240.png 1,A Qualitative Study on Decision-Making by Prostate Cancer Physicians during Active Surveillance,British Journal of Urology,,,Article,2016-09-01,10.1111/bju.13651,,,,27611479,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12286274,https://api.altmetric.com/v1/donut/12286274_240.png 1,Addressing erectile dysfunction in prostate cancer survivors after radical prostatectomy,Expert Review of Quality of Life in Cancer Care,,,Article,,10.1080/23809000.2016.1236660,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12258922,https://api.altmetric.com/v1/donut/12258922_240.png 1,Re: Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy,European Urology,,,Article,2016-10-01,10.1016/j.eururo.2016.09.017,,,,27687819,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12231512,https://api.altmetric.com/v1/donut/12231512_240.png 1,Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis,Journal of Pharmaceutical Sciences,,,Article,2016-09-01,10.1016/j.xphs.2016.08.013,,,,27665127,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12216953,https://api.altmetric.com/v1/donut/12216953_240.png 1,Comparisons of nomograms and urologists' predictions in prostate cancer.,Seminars in Urologic Oncology,,,Article,2002-05-01,,,,,12012293,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/12202585,https://api.altmetric.com/v1/donut/12202585_240.png 1,How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases,Journal of Visualized Experiments,,,Article,2016-09-20,10.3791/54230,,,,27684203,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12169615,https://api.altmetric.com/v1/donut/12169615_240.png 1,“Textural analysis of multiparametric MRI detects transition zone prostate cancer”,European Radiology,,,Article,2016-09-12,10.1007/s00330-016-4579-9,,,,27620864,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/12084287,https://api.altmetric.com/v1/donut/12084287_240.png 1,"The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-09-15,10.1158/1055-9965.epi-16-0506,,,,27635065,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12058818,https://api.altmetric.com/v1/donut/12058818_240.png 1,Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer,Scandinavian Journal of Urology,,,Article,2016-09-14,10.1080/21681805.2016.1227876,,,,27628623,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12031064,https://api.altmetric.com/v1/donut/12031064_240.png 1,Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines,Scientific Reports,,,Article,2016-09-14,10.1038/srep32611,,,,27623747,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/12012786,https://api.altmetric.com/v1/donut/12012786_240.png 1,Molecular Imaging and Precision Medicine in Prostate Cancer,PET Clinics,,,Article,2016-09-01,10.1016/j.cpet.2016.08.004,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11998547,https://api.altmetric.com/v1/donut/11998547_240.png 1,"Re: Claude Schulman, Erik Cornel, Vsevolod Matveev, et al. Intermittent Versus Continuous Androgen Deprivation Therapy in Patients with Relapsing or Locally Advanced Prostate Cancer: A Phase 3b Randomised Study (ICELAND). Eur Urol 2016;69:720–7",European Urology,,,Article,2016-09-18,10.1016/j.eururo.2016.08.067,,,,27638093,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11986401,https://api.altmetric.com/v1/donut/11986401_240.png 1,Prostate cancer: More cycles of docetaxel improve survival,Nature Reviews Urology,,,Article,2016-09-13,10.1038/nrurol.2016.181,,,,27618769,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11975035,https://api.altmetric.com/v1/donut/11975035_240.png 1,Signatures of prostate-derived Ets factor (PDEF) in cancer,Tumor Biology,,,Article,2016-09-10,10.1007/s13277-016-5326-1,,,,27612480,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11946465,https://api.altmetric.com/v1/donut/11946465_240.png 1,Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture,International Journal of Molecular Sciences,,,Article,2016-09-01,10.3390/ijms17091458,,,,27598125,,,,,,,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,6,https://www.altmetric.com/details/11907098,https://api.altmetric.com/v1/donut/11907098_240.png 1,Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers,PLoS ONE,,,Article,2016-09-06,10.1371/journal.pone.0162217,,,,27598335,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11884036,https://api.altmetric.com/v1/donut/11884036_240.png 1,Life-threatening hemorrhage from acquired hemophilia A as a presenting manifestation of prostate cancer,Journal of Community Hospital Internal Medicine Perspectives,,,Article,2016-09-07,10.3402/jchimp.v6.32461,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11882565,https://api.altmetric.com/v1/donut/11882565_240.png 1,Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer,International Journal of Molecular Sciences,,,Article,2016-08-31,10.3390/ijms17091434,,,,27589731,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11673676,https://api.altmetric.com/v1/donut/11673676_240.png 1,Anti-cancer effect of pristimerin by inhibition of HIF-1? involves the SPHK-1 pathway in hypoxic prostate cancer cells,BMC Cancer,,,Article,2016-08-31,10.1186/s12885-016-2730-2,,,,27581969,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11185087,https://api.altmetric.com/v1/donut/11185087_240.png 1,"Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.021",European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.08.049,,,,27591933,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10957747,https://api.altmetric.com/v1/donut/10957747_240.png 1,"RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers",JNCI: Journal of the National Cancer Institute,,,Article,2016-12-01,10.1093/jnci/djw172,,,,27582380,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10937657,https://api.altmetric.com/v1/donut/10937657_240.png 1,The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-?B signaling.,Life Sciences,,,Article,2016-08-30,10.1016/j.lfs.2016.08.019,,,,27569589,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10904369,https://api.altmetric.com/v1/donut/10904369_240.png 1,Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer,Journal of Medical Economics,,,Article,2016-08-29,10.1080/13696998.2016.1229670,,,,27570999,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10904080,https://api.altmetric.com/v1/donut/10904080_240.png 1,"Reply to Mieke Van Hemelrijck, Hans Garmo, Jan Adolfsson, and Pär Stattin's Letter to the Editor re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism. Eur Urol. 2016;70:56–61",European Urology,,,Article,2016-08-24,10.1016/j.eururo.2016.08.022,,,,27567205,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10791707,https://api.altmetric.com/v1/donut/10791707_240.png 1,Second harmonic generation (SHG) imaging of cancer heterogeneity in ultrasound guided biopsies of prostate in men suspected with prostate cancer,Journal of Biophotonics,,,Article,2016-08-22,10.1002/jbio.201600090,,,,27545683,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10745455,https://api.altmetric.com/v1/donut/10745455_240.png 1,The MET/VEGFR-targeted tyrosine kinase inhibitor attenuates FMS-dependent osteoclast differentiation and bone destruction induced by prostate cancer,Journal of Biological Chemistry,,,Article,2016-08-18,10.1074/jbc.m116.727875,,,,27539855,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10724483,https://api.altmetric.com/v1/donut/10724483_240.png 1,"Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033",European Urology,,,Article,2016-08-17,10.1016/j.eururo.2016.08.010,,,,27543166,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10562173,https://api.altmetric.com/v1/donut/10562173_240.png 1,Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer,Journal of Diabetes Research,,,Article,2016-07-31,10.1155/2016/2656814,,,,27547763,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10318828,https://api.altmetric.com/v1/donut/10318828_240.png 1,Liver Protects Metastatic Prostate Cancer From Induced Death by Activating E-cadherin Signaling,Hepatology,,,Article,2016-08-01,10.1002/hep.28755,,,,27482645,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10308640,https://api.altmetric.com/v1/donut/10308640_240.png 1,Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy,Nanomedicine,,,Article,2016-07-27,10.2217/nnm-2016-0062,,,,27463088,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10283538,https://api.altmetric.com/v1/donut/10283538_240.png 1,The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-0124,,,,27486174,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10222455,https://api.altmetric.com/v1/donut/10222455_240.png 1,Prostate cancer: 6-monthly PSA test predicts survival,Nature Reviews Urology,,,Article,2016-08-02,10.1038/nrurol.2016.145,,,,27480949,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10205883,https://api.altmetric.com/v1/donut/10205883_240.png 1,Prostate cancer: 'Equivocal' lymphovascular invasion?,Nature Reviews Urology,,,Article,2016-08-02,10.1038/nrurol.2016.143,,,,27480946,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10205881,https://api.altmetric.com/v1/donut/10205881_240.png 1,Prescribing Patterns of Oral Antineoplastic Therapies Observed in the Treatment of Patients With Advanced Prostate Cancer Between 2012 and 2014: Results of an Oncology EMR Analysis,Clinical Therapeutics,,,Article,2016-08-01,10.1016/j.clinthera.2016.07.004,,,,27491282,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10191366,https://api.altmetric.com/v1/donut/10191366_240.png 1,Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses,OncoImmunology,,,Article,2016-06-01,10.1080/2162402x.2016.1165377,,,,27471641,PMC4938302,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10137411,https://api.altmetric.com/v1/donut/10137411_240.png 1,One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling,International Journal of Molecular Sciences,,,Article,2016-07-27,10.3390/ijms17081208,,,,27472325,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10131022,https://api.altmetric.com/v1/donut/10131022_240.png 1,An Enzyme-Responsive Conjugate Improves the Delivery of a PI3K Inhibitor to Prostate Cancer,"Nanomedicine: Nanotechnology, Biology and Medicine",,,Article,2016-07-29,10.1016/j.nano.2016.07.007,,,,27478108,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10123033,https://api.altmetric.com/v1/donut/10123033_240.png 1,microRNA-145 mediates the inhibitory effect of adipose tissue-derived stromal cells on prostate cancer,Stem Cells & Development,,,Article,2016-07-27,10.1089/scd.2016.0093,,,,27465939,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10120463,https://api.altmetric.com/v1/donut/10120463_240.png 1,Clinical states in prostate cancer: toward a dynamic model of disease progression.,Urology,,,Article,,,,,,10699601,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/9850347,https://api.altmetric.com/v1/donut/9850347_240.png 1,A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer,Medicine,,,Article,2016-07-01,10.1097/md.0000000000003845,,,http://journals.lww.com/md-journal/Fulltext/2016/07050/A_meta_analysis_and_systematic_review_of.6.aspx,27399062,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9823722,https://api.altmetric.com/v1/donut/9823722_240.png 1,"Focalyx Dx, Bx, Tx et Apps: A novel contemporary fusion paradigm for the management of prostate cancer.",Archivos Españoles de Urología (Ed. impresa),,,Article,2016-07-01,,,,,27416639,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9731366,https://api.altmetric.com/v1/donut/9731366_240.png 1,Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer,PLoS ONE,,,Article,2016-07-14,10.1371/journal.pone.0159044,,,,27414029,PMC4944994,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9731208,https://api.altmetric.com/v1/donut/9731208_240.png 1,TRPM8 Puts the Chill on Prostate Cancer,Pharmaceuticals,,,Article,2016-01-01,10.3390/ph9030044,,,,27409624,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9713021,https://api.altmetric.com/v1/donut/9713021_240.png 1,Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer,Urologic Oncology,,,Article,2016-07-01,10.1016/j.urolonc.2016.05.020,,,,27381896,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9307498,https://api.altmetric.com/v1/donut/9307498_240.png 1,Re: Intermittent Androgen Deprivation (IAD) in Prostate Cancer (PC): Are We Ready To Quit?,European Urology,,,Article,2016-07-05,10.1016/j.eururo.2016.06.028,,,,27387125,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9232794,https://api.altmetric.com/v1/donut/9232794_240.png 1,8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity.,Anti-Cancer Drugs,,,Article,2016-07-01,10.1097/cad.0000000000000399,,,http://journals.lww.com/anti-cancerdrugs/Fulltext/publishahead/8_Farnesyloxycoumarin_induces_apoptosis_in_PC_3.99051.aspx,27362790,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9158962,https://api.altmetric.com/v1/donut/9158962_240.png 1,Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer.,European Journal of Endocrinology,,,Article,2016-06-23,10.1530/eje-16-0200,,,,27340081,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9034798,https://api.altmetric.com/v1/donut/9034798_240.png 1,The association between regular use of aspirin and the prevalence of prostate cancer,Medicine,,,Article,2016-06-01,10.1097/md.0000000000003909,,,http://journals.lww.com/md-journal/Fulltext/2016/06210/The_association_between_regular_use_of_aspirin_and.21.aspx,27336878,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9010695,https://api.altmetric.com/v1/donut/9010695_240.png 1,Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10051,,,,27322147,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8947349,https://api.altmetric.com/v1/donut/8947349_240.png 1,PBX3 is a putative biomarker of aggressive Prostate Cancer,International Journal of Cancer,,,Article,2016-06-01,10.1002/ijc.30220,,,,27273830,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8737912,https://api.altmetric.com/v1/donut/8737912_240.png 1,"Case Presentation: Fit Patient with Nonmetastatic Castration-resistant Prostate Cancer, Lower Urinary Tract Symptoms, and Severe Recurrent Haematuria",,,,Article,2016-06-14,10.1016/j.euf.2016.06.005,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8719391,https://api.altmetric.com/v1/donut/8719391_240.png 1,KAT8 regulates androgen signaling in prostate cancer cells,Molecular Endocrinology,,,Article,2016-06-07,10.1210/me.2016-1024,,,,27268279,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8626731,https://api.altmetric.com/v1/donut/8626731_240.png 1,The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancer,Expert Review of Molecular Diagnostics,,,Article,2016-06-02,10.1080/14737159.2016.1197121,,,,27254598,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8612381,https://api.altmetric.com/v1/donut/8612381_240.png 1,Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells,International Journal of Biochemistry & Cell Biology,,,Article,2016-05-01,10.1016/j.biocel.2016.05.020,,,,27247025,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8437392,https://api.altmetric.com/v1/donut/8437392_240.png 1,Pre-biopsy 3T MRI and targeted biopsy of the index prostate cancer - correlation with robot assisted radical prostatectomy,British Journal of Urology,,,Article,2016-05-01,10.1111/bju.13525,,,,27153933,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8319703,https://api.altmetric.com/v1/donut/8319703_240.png 1,PGC1? drives a metabolic block on prostate cancer progression,Nature Cell Biology,,,Article,2016-05-27,10.1038/ncb3365,,,,27230528,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8317373,https://api.altmetric.com/v1/donut/8317373_240.png 1,Comparison of prostate cancer survival in Germany and the United States: Can differences be attributed to differences in stage distributions?,British Journal of Urology,,,Article,2016-05-01,10.1111/bju.13537,,,,27208546,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8315635,https://api.altmetric.com/v1/donut/8315635_240.png 1,BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9513,,,,27223260,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8282488,https://api.altmetric.com/v1/donut/8282488_240.png 1,Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-06-01,10.1097/coc.0000000000000050,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/06000/Does_Race_Influence_Health_related_Quality_of_Life.8.aspx,24710124,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8278414,https://api.altmetric.com/v1/donut/8278414_240.png 1," Impact of genetic and epigenetic variations within the FADS cluster on the composition and metabolism of polyunsaturated fatty acids in prostate cancer ",The Prostate,,,Article,2016-05-16,10.1002/pros.23205,,,,27197070,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7875959,https://api.altmetric.com/v1/donut/7875959_240.png 1,The prognostic significance of OCT4 expression in patients with prostate cancer,Human Pathology,,,Article,2015-12-29,10.1016/j.humpath.2015.12.008,,,,27067776,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7630968,https://api.altmetric.com/v1/donut/7630968_240.png 1,"Re: Risk of Malignant Melanoma in Men with Prostate Cancer. Nationwide, Population-based Cohort Study",European Urology,,,Article,2016-06-01,10.1016/j.eururo.2016.02.026,,,,27302141,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7359112,https://api.altmetric.com/v1/donut/7359112_240.png 1,Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes,PLoS ONE,,,Article,2016-05-06,10.1371/journal.pone.0154967,,,,27152724,PMC4859494,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7276896,https://api.altmetric.com/v1/donut/7276896_240.png 1,Digoxin use after diagnosis of prostate cancer and survival: a population?based cohort study,Pharmacoepidemiology & Drug Safety,,,Article,2016-01-01,10.1002/pds.4018,,,,27146482,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7153079,https://api.altmetric.com/v1/donut/7153079_240.png 1,Fractionated changes in prostate cancer radiotherapy using cone-beam computed tomography,Medical Dosimetry,,,Article,2015-02-12,10.1016/j.meddos.2014.12.003,,,,25683282,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7142520,https://api.altmetric.com/v1/donut/7142520_240.png 1,Re: Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery,European Urology,,,Article,2016-05-01,10.1016/j.eururo.2016.02.011,,,,27301991,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6967597,https://api.altmetric.com/v1/donut/6967597_240.png 1,Re: Acute Toxicity and Quality of Life After Dose-intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10,European Urology,,,Article,2016-05-01,10.1016/j.eururo.2016.02.013,,,,27301993,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6967596,https://api.altmetric.com/v1/donut/6967596_240.png 1,Threat of Sexual Disqualification: The Consequences of Erectile Dysfunction and Other Sexual Changes for Gay and Bisexual Men With Prostate Cancer,Archives of Sexual Behavior,,,Article,2016-04-21,10.1007/s10508-016-0728-0,,,,27102603,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6943994,https://api.altmetric.com/v1/donut/6943994_240.png 1,Symptomatic and quality of life outcomes following treatment for clinically localized prostate cancer: a systematic review,British Journal of Urology,,,Article,2016-04-01,10.1111/bju.13499,,,,27087414,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6931659,https://api.altmetric.com/v1/donut/6931659_240.png 1,A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer,PLoS ONE,,,Article,2016-04-21,10.1371/journal.pone.0153727,,,,27100877,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6923768,https://api.altmetric.com/v1/donut/6923768_240.png 1,Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8846,,,,27105511,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6920557,https://api.altmetric.com/v1/donut/6920557_240.png 1,How can we optimize the use of prostate cancer registries?,Future Oncology,,,Article,2016-05-01,10.2217/fon-2016-0001,,,,26926226,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6850426,https://api.altmetric.com/v1/donut/6850426_240.png 1,Metabolic syndrome in prostate cancer: impact on risk and outcomes,Future Oncology,,,Article,2016-04-12,10.2217/fon-2016-0061,,,,27067408,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6640327,https://api.altmetric.com/v1/donut/6640327_240.png 1,Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications.,European review for medical and pharmacological sciences,,,Article,2016-04-07,,,,,27049248,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6527989,https://api.altmetric.com/v1/donut/6527989_240.png 1,Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go?,Academic Radiology,,,Article,2016-03-15,10.1016/j.acra.2016.02.003,,,,26992738,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6504133,https://api.altmetric.com/v1/donut/6504133_240.png 1,Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study,BioMed Research International,,,Article,2013-01-01,10.1155/2013/270457,,,,23509700,PMC3586456,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6499675,https://api.altmetric.com/v1/donut/6499675_240.png 1,Laser Illumination Modality of Photoacoustic Imaging Technique for Prostate Cancer,Journal of Physics: Conference Series,,,Article,2016-04-04,10.1088/1742-6596/679/1/012026,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6468351,https://api.altmetric.com/v1/donut/6468351_240.png 1,Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data,Journal of Applied Statistics,,,Article,2016-04-01,10.1080/02664763.2014.999032,,,,,,2117/85035,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6461971,https://api.altmetric.com/v1/donut/6461971_240.png 1,"Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors",Cell Cycle,,,Article,2016-03-30,10.1080/15384101.2016.1148836,,,,27029529,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6422111,https://api.altmetric.com/v1/donut/6422111_240.png 1,"A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers",Annals of Oncology,,,Article,2016-02-18,10.1093/annonc/mdw068,,,,27022067,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6387657,https://api.altmetric.com/v1/donut/6387657_240.png 1,Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique,European Journal of Radiology,,,Article,2016-02-26,10.1016/j.ejrad.2016.02.020,,,,27130048,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6377888,https://api.altmetric.com/v1/donut/6377888_240.png 1,Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate Cancer Patients,Clinical Genitourinary Cancer,,,Article,2015-01-30,10.1016/j.clgc.2015.01.011,,,,25735198,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6362965,https://api.altmetric.com/v1/donut/6362965_240.png 1,Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer,Expert Opinion on Therapeutic Targets,,,Article,2016-03-21,10.1517/14728222.2016.1159676,,,,26927611,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6321094,https://api.altmetric.com/v1/donut/6321094_240.png 1,Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Quantitative Multiparametric Magnetic Resonance Imaging,Journal of Computer Assisted Tomography,,,Article,2016-01-01,10.1097/rct.0000000000000353,,,http://journals.lww.com/jcat/Fulltext/2016/03000/Differentiating_Transition_Zone_Cancers_From.6.aspx,26760185,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6270963,https://api.altmetric.com/v1/donut/6270963_240.png 1,Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches,Cellular & Molecular Life Sciences,,,Article,2016-03-12,10.1007/s00018-016-2176-3,,,,26970978,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6186361,https://api.altmetric.com/v1/donut/6186361_240.png 1,Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.,Oncotarget,,,Article,2016-08-26,10.18632/oncotarget.3651,,,,25895025,PMC4546459,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6116847,https://api.altmetric.com/v1/donut/6116847_240.png 1,Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model.,PLoS ONE,,,Article,2015-07-21,10.1371/journal.pone.0131232,,,,26196517,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6086834,https://api.altmetric.com/v1/donut/6086834_240.png 1,Disseminated tumor cells and dormancy in prostate cancer metastasis ,Current Opinion in Biotechnology,,,Article,2016-08-01,10.1016/j.copbio.2016.02.002,,,,26900985,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6044448,https://api.altmetric.com/v1/donut/6044448_240.png 1,Prostate Cancer: Box clever [mdash] YB-1 has a role in CRPC,Nature Reviews Urology,,,Article,2016-02-23,10.1038/nrurol.2016.43,,,,26902340,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6009291,https://api.altmetric.com/v1/donut/6009291_240.png 1,Prostate cancer: Enzalutamide plus docetaxel tested in mCRPC,Nature Reviews Urology,,,Article,2016-02-23,10.1038/nrurol.2016.39,,,,26902335,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5973392,https://api.altmetric.com/v1/donut/5973392_240.png 1,"MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer",Oncotarget,,,Article,2016-02-21,10.18632/oncotarget.7405,,,,26895100,PMC4924743,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5890115,https://api.altmetric.com/v1/donut/5890115_240.png 1,The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients,Oncology Reports,,,Article,2013-09-08,10.3892/or.2013.2725,,,,24026706,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5692599,https://api.altmetric.com/v1/donut/5692599_240.png 1,Practical Guidance on the Role of Corticosteroids in the Treatment of Metastatic Castration-Resistant Prostate Cancer,Urology,,,Article,2016-02-18,10.1016/j.urology.2016.02.010,,,,26905032,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5635423,https://api.altmetric.com/v1/donut/5635423_240.png 1,Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer,European Urology,,,Article,2016-03-01,10.1016/j.eururo.2015.12.027,,,,26867727,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5623778,https://api.altmetric.com/v1/donut/5623778_240.png 1,The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism,Prostate Cancer & Prostatic Diseases,,,Article,2016-02-09,10.1038/pcan.2016.2,,,,26857022,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5621260,https://api.altmetric.com/v1/donut/5621260_240.png 1,Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: a Systematic Review and Meta-Analysis,Urology,,,Article,2016-02-16,10.1016/j.urology.2016.01.034,,,,26896733,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5621215,https://api.altmetric.com/v1/donut/5621215_240.png 1,Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence,The Journal of Molecular Diagnostics,,,Article,2016-01-02,10.1016/j.jmoldx.2015.10.001,,,,26752304,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5619613,https://api.altmetric.com/v1/donut/5619613_240.png 1,Addressing overtreatment following the diagnosis of localized prostate cancer,Expert Review of Anticancer Therapy,,,Article,,10.1586/14737140.2016.1143779,,,,26776104,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5578987,https://api.altmetric.com/v1/donut/5578987_240.png 1,Signal transduction by M3 muscarinic acetylcholine receptor in prostate cancer,Oncology Letters,,,Article,2016-01-01,10.3892/ol.2015.3830,,,,26870222,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5529611,https://api.altmetric.com/v1/donut/5529611_240.png 1,The Long-Term Disease-Specific Mortality of Low-Risk Localized Prostate Cancer: a Prospective Population-Based Register Study Over Two Decades.,Urology,,,Article,2016-02-12,10.1016/j.urology.2016.01.033,,,,26879734,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5528134,https://api.altmetric.com/v1/donut/5528134_240.png 1,Successful external validation of a model to predict other cause mortality in localized prostate cancer,BMC Medicine,,,Article,2016-02-09,10.1186/s12916-016-0572-z,,,,26860993,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5309391,https://api.altmetric.com/v1/donut/5309391_240.png 1,"Status and Interrelationship of Zinc, Copper, Iron, Calcium and Selenium in Prostate Cancer.",Indian Journal of Clinical Biochemistry,,,Article,2016-03-01,10.1007/s12291-015-0497-x,,,,26855488,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5306369,https://api.altmetric.com/v1/donut/5306369_240.png 1,Role of taxanes in advanced prostate cancer.,Clinical and Translational Oncology,,,Article,2016-02-10,10.1007/s12094-015-1480-y,,,,26856599,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5298872,https://api.altmetric.com/v1/donut/5298872_240.png 1,"Reply to Daniela Wittmann, Ted A. Skolarus’ Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2014;67:460–7",European Urology,,,Article,2016-02-10,10.1016/j.eururo.2016.01.041,,,,26873843,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5298693,https://api.altmetric.com/v1/donut/5298693_240.png 1,Prostate cancer: The TRAPEZE swings for treatment results,Nature Reviews Urology,,,Article,2016-02-09,10.1038/nrurol.2016.32,,,,26856883,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5113993,https://api.altmetric.com/v1/donut/5113993_240.png 1,"Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03)",Radiotherapy & Oncology,,,Article,2016-02-01,10.1016/j.radonc.2016.01.016,,,,26867970,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5112581,https://api.altmetric.com/v1/donut/5112581_240.png 1,MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer.,Molecular Medicine Reports,,,Article,2016-02-07,10.3892/mmr.2016.4841,,,,26847233,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5103971,https://api.altmetric.com/v1/donut/5103971_240.png 1,"Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.",Oncology Reports,,,Article,2016-02-06,10.3892/or.2016.4611,,,,26846372,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5101277,https://api.altmetric.com/v1/donut/5101277_240.png 1,Poultry consumption and prostate cancer risk: a meta-analysis,PeerJ,,,Article,2016-02-02,10.7717/peerj.1646,,,,26855875,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5075728,https://api.altmetric.com/v1/donut/5075728_240.png 1,Trichomonas vaginalis infection and risk of advanced prostate cancer.,The Prostate,,,Article,2016-01-30,10.1002/pros.23153,,,,26818005,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5065552,https://api.altmetric.com/v1/donut/5065552_240.png 1,Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.,Oncotarget,,,Article,2016-01-30,10.18632/oncotarget.7039,,,,26824323,PMC4914298,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5065285,https://api.altmetric.com/v1/donut/5065285_240.png 1,Evaluating the Role of mpMRI in Prostate Cancer Assessment,Expert Review of Medical Devices,,,Article,2016-01-29,10.1586/17434440.2016.1134311,,,,26690507,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5060816,https://api.altmetric.com/v1/donut/5060816_240.png 1,Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA?194,Molecular Nutrition & Food Research,,,Article,2016-01-29,10.1002/mnfr.201500918,,,,26820911,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5060613,https://api.altmetric.com/v1/donut/5060613_240.png 1,Missing link between microRNA and prostate cancer.,Tumor Biology,,,Article,2016-01-28,10.1007/s13277-016-4900-x,,,,26822307,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5060475,https://api.altmetric.com/v1/donut/5060475_240.png 1,Prostate Cancer Susceptibility in Men of African Ancestry at 8q24,JNCI: Journal of the National Cancer Institute,,,Article,2016-07-01,10.1093/jnci/djv431,,,,26823525,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5053159,https://api.altmetric.com/v1/donut/5053159_240.png 1,"Salvage radiotherapy in prostate cancer patients. Planning, treatment response and prognosis using (11)C-choline PET/CT.",Revista espanola de medicina nuclear e imagen molecular,,,Article,2016-01-25,10.1016/j.remn.2015.11.007,,,,26803491,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5037138,https://api.altmetric.com/v1/donut/5037138_240.png 1,An RBF-PSO Based Approach for Modeling Prostate Cancer,,,,Article,,,,,,,,,,1601.05436,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5024639,https://api.altmetric.com/v1/donut/5024639_240.png 1,Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer,Radiation Oncology,,,Article,2016-01-21,10.1186/s13014-016-0585-y,,,,26792201,PMC4721063,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5020147,https://api.altmetric.com/v1/donut/5020147_240.png 1,EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment,Nanomedicine,,,Article,2016-01-13,10.2217/nnm.15.183,,,,26654241,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4987378,https://api.altmetric.com/v1/donut/4987378_240.png 1,Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough Strategy,Frontiers in oncology,,,Article,2016-01-11,10.3389/fonc.2015.00304,,,,26793621,PMC4707543,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4978683,https://api.altmetric.com/v1/donut/4978683_240.png 1,Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.,Nucleic Acids Research,,,Article,2016-01-09,10.1093/nar/gkv1528,,,,26743006,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4969166,https://api.altmetric.com/v1/donut/4969166_240.png 1,Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.,Journal of Proteomics & Bioinformatics,,,Article,2012-11-01,10.4172/jpb.1000232,,,,24009409,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4969107,https://api.altmetric.com/v1/donut/4969107_240.png 1,Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy,Radiotherapy & Oncology,,,Article,2016-01-19,10.1016/j.radonc.2015.11.036,,,,26777123,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4964316,https://api.altmetric.com/v1/donut/4964316_240.png 1,Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.,Oncology Reports,,,Article,2016-01-02,10.3892/or.2015.4537,,,,26718024,,,,,,,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4,https://www.altmetric.com/details/4946702,https://api.altmetric.com/v1/donut/4946702_240.png 1,Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells ,Steroids,,,Article,2016-01-09,10.1016/j.steroids.2015.12.021,,,,26742628,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4946267,https://api.altmetric.com/v1/donut/4946267_240.png 1,Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer,Journal of Palliative Medicine,,,Article,2015-11-01,10.1089/jpm.2015.0171,,,,26241733,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4942313,https://api.altmetric.com/v1/donut/4942313_240.png 1,Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LC-MS—A technical report ,EuPA Open Proteomics,,,Article,,10.1016/j.euprot.2015.11.001,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4937949,https://api.altmetric.com/v1/donut/4937949_240.png 1,Cost Prediction Using a Survival Grouping Algorithm: An Application to Incident Prostate Cancer Cases.,PharmacoEconomics,,,Article,2015-12-29,10.1007/s40273-015-0368-6,,,,26714688,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4934889,https://api.altmetric.com/v1/donut/4934889_240.png 1,Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy,Radiation Oncology,,,Article,2015-12-24,10.1186/s13014-015-0574-6,,,,26704623,PMC4690270,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4922351,https://api.altmetric.com/v1/donut/4922351_240.png 1,Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements,Cancer Letters,,,Article,2016-01-03,10.1016/j.canlet.2015.12.018,,,,26723876,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4918860,https://api.altmetric.com/v1/donut/4918860_240.png 1,Re: Chemohormonal Therapy in Metastatic Hormone-sensitive Prostate Cancer,European Urology,,,Article,2016-01-01,10.1016/j.eururo.2015.10.037,,,,,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4889068,https://api.altmetric.com/v1/donut/4889068_240.png 1,Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment,The Prostate,,,Article,2015-12-01,10.1002/pros.23132,,,,26643154,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4883278,https://api.altmetric.com/v1/donut/4883278_240.png 1,N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.,Journal of Proteomics & Bioinformatics,,,Article,2012-05-07,10.4172/jpb.1000218,,,,25284963,PMC4183219,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4878559,https://api.altmetric.com/v1/donut/4878559_240.png 1,"Malformin A1 promotes cell death through induction of apoptosis, necrosis and autophagy in prostate cancer cells",Cancer Chemotherapy & Pharmacology,,,Article,2015-12-10,10.1007/s00280-015-2915-4,,,,26645406,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4861194,https://api.altmetric.com/v1/donut/4861194_240.png 1,MIR-150 promotes prostate cancer stem cell development via suppressing p27Kip1.,European review for medical and pharmacological sciences,,,Article,2015-12-06,,,,,26636522,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4846264,https://api.altmetric.com/v1/donut/4846264_240.png 1,Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.,Medical science monitor international medical journal of experimental and clinical research,,,Article,2015-12-04,,,,,26628405,PMC4671457,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4838969,https://api.altmetric.com/v1/donut/4838969_240.png 1,Virus encoded circulatory miRNAs for early detection of prostate cancer,BMC Urology,,,Article,2015-11-26,10.1186/s12894-015-0111-9,,,,26612689,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4837585,https://api.altmetric.com/v1/donut/4837585_240.png 1,Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells,BMC Molecular Biology,,,Article,2015-12-03,10.1186/s12867-015-0049-1,,,,26627478,PMC4667504,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4836217,https://api.altmetric.com/v1/donut/4836217_240.png 1,One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-05-14,10.1158/1055-9965.epi-08-1193,,,,19423531,,,,,,,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4833618,https://api.altmetric.com/v1/donut/4833618_240.png 1,Significance of prostate cancer missed on needle biopsy tools for retrieving missed cancer.,The Prostate,,,Article,2015-12-01,10.1002/pros.23128,,,,26616257,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4828512,https://api.altmetric.com/v1/donut/4828512_240.png 1,"KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models",BMC Cancer,,,Article,2015-12-01,10.1186/s12885-015-1936-z,,,,26620414,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4824987,https://api.altmetric.com/v1/donut/4824987_240.png 1,Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re?expressing the epigenetically repressed tumor suppressor—estrogen receptor ?,Molecular Carcinogenesis,,,Article,2015-11-25,10.1002/mc.22433,,,,26599461,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4807202,https://api.altmetric.com/v1/donut/4807202_240.png 1,MRI versus (68)Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-11-25,10.1007/s00259-015-3257-5,,,,26592938,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4806502,https://api.altmetric.com/v1/donut/4806502_240.png 1,Distribution Features of Skeletal Metastases: A Comparative Study between Pulmonary and Prostate Cancers,PLoS ONE,,,Article,2015-11-23,10.1371/journal.pone.0143437,,,,26599401,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4802743,https://api.altmetric.com/v1/donut/4802743_240.png 1,Effects of oxygen on the antigenic landscape of prostate cancer cells,BMC Research Notes,,,Article,2015-11-20,10.1186/s13104-015-1633-7,,,,26581192,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4789316,https://api.altmetric.com/v1/donut/4789316_240.png 1,Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer,Oncologist,,,Article,2015-12-01,10.1634/theoncologist.2015-0220,,,,26542984,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4765740,https://api.altmetric.com/v1/donut/4765740_240.png 1,VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin.,Tumor Biology,,,Article,2015-11-13,10.1007/s13277-015-4383-1,,,,26566625,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4762298,https://api.altmetric.com/v1/donut/4762298_240.png 1,Persistent androgen receptor addiction in castration-resistant prostate cancer,Journal of Hematology & Oncology,,,Article,2015-11-13,10.1186/s13045-015-0225-2,,,,26566796,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4759400,https://api.altmetric.com/v1/donut/4759400_240.png 1,Treatment Trends for Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2015-11-10,10.1001/jama.2015.12601,,,,26547472,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4740876,https://api.altmetric.com/v1/donut/4740876_240.png 1,Health-related quality of life in men with metastatic castration–resistant prostate cancer,Expert Review of Pharmacoeconomics and Outcomes Research,,,Article,,10.1586/14737167.2015.1107479,,,,26512743,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4731486,https://api.altmetric.com/v1/donut/4731486_240.png 1,Moderate Hypofractionated Protracted Radiotherapy and Dose Escalation for Prostate Cancer: Does Dose and Overall Treatment Time Matter?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-10,10.1016/j.ijrobp.2015.10.055,,,,26853336,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4710277,https://api.altmetric.com/v1/donut/4710277_240.png 1,"Your NEJM Group Today: Hyperandrogenism Clinical Pearl, Ovarian Cancer Drug for Prostate Cancer, Ariz. Family Medicine Opportunity",Journal Watch,,,Article,2015-10-29,10.1056/nejm-jw.fw110794,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4698714,https://api.altmetric.com/v1/donut/4698714_240.png 1,A comparison of the acute toxicities using moderate hypo-fractionated intensity-modulated radiation therapy or volumetric modulated arc therapy for the treatment of early-stage prostate cancer,Journal of Radiotherapy in Practice,,,Article,2015-06-11,10.1017/s1460396915000242,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4682887,https://api.altmetric.com/v1/donut/4682887_240.png 1,"Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.",Medical Principles & Practice,,,Article,2015-10-27,10.1159/000439307,,,,26501150,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4679481,https://api.altmetric.com/v1/donut/4679481_240.png 1,Flavonoids with Therapeutic Potential in Prostate Cancer.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,,,,,,26446382,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4674378,https://api.altmetric.com/v1/donut/4674378_240.png 1,Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.,Disease Markers,,,Article,2015-10-23,10.1155/2015/241301,,,,26491211,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4665395,https://api.altmetric.com/v1/donut/4665395_240.png 1,Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy.,Medicine,,,Article,2015-10-01,10.1097/md.0000000000001473,,,,26469891,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4645247,https://api.altmetric.com/v1/donut/4645247_240.png 1,"Androgen deprivation therapy should be used with caution in some prostate cancer cases, study warns",British Medical Journal,,,Article,2015-09-22,10.1136/bmj.h5043,,,,26395365,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4606149,https://api.altmetric.com/v1/donut/4606149_240.png 1,Radiotherapy for early-stage prostate cancer in men under 70 years of age.,Tumori,,,Article,,10.5301/tj.5000433,,,,26429649,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4585626,https://api.altmetric.com/v1/donut/4585626_240.png 1,[The Role of MiRNAs in the Development of Prostate Cancer].,Genetika,,,Article,2015-07-01,,,,,26410927,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4567259,https://api.altmetric.com/v1/donut/4567259_240.png 1,Putative Prostate Cancer Risk SNP in an AR Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in AR Target Sites.,Human Mutation,,,Article,2015-09-29,10.1002/humu.22909,,,,26411452,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4564696,https://api.altmetric.com/v1/donut/4564696_240.png 1,PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer.,PET Clinics,,,Article,2015-09-21,10.1016/j.cpet.2015.05.004,,,,26384595,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4536112,https://api.altmetric.com/v1/donut/4536112_240.png 1,African Americans' Perceptions of Prostate-Specific Antigen Prostate Cancer Screening.,Health Education & Behavior,,,Article,2015-01-23,10.1177/1090198114566453,,,,25616411,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4535966,https://api.altmetric.com/v1/donut/4535966_240.png 1,Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean,Epidemiology and Health,,,Article,2015-09-19,10.4178/epih/e2015015,,,,25773442,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4531577,https://api.altmetric.com/v1/donut/4531577_240.png 1,Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1,Molecular and Cellular Biochemistry,,,Article,2015-09-16,10.1007/s11010-015-2564-2,,,,26369530,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4520222,https://api.altmetric.com/v1/donut/4520222_240.png 1,3D Porous Chitosan–Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer,Biomacromolecules,,,Article,,10.1021/acs.biomac.5b01032,,,,26347946,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4503573,https://api.altmetric.com/v1/donut/4503573_240.png 1,Asthma and Risk of Prostate Cancer: A Population-Based Case-Cohort Study in Taiwan,"Medicine (Abingdon. 1995, UK ed.)",,,Article,2015-09-12,10.1097/md.0000000000001371,,,,26356691,,,,,,,0,0,0,4,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4500792,https://api.altmetric.com/v1/donut/4500792_240.png 1,MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo,Tumor Biology,,,Article,2015-09-09,10.1007/s13277-015-3996-8,,,,26346167,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4490794,https://api.altmetric.com/v1/donut/4490794_240.png 1,MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma,Journal of Experimental & Clinical Cancer Research,,,Article,2015-09-06,10.1186/s13046-015-0209-7,,,,26338045,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4477643,https://api.altmetric.com/v1/donut/4477643_240.png 1,Self-rated health supersedes patient satisfaction with service quality as a predictor of survival in prostate cancer,Health and Quality of Life Outcomes,,,Article,2015-09-04,10.1186/s12955-015-0334-1,,,,26337960,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4472776,https://api.altmetric.com/v1/donut/4472776_240.png 1,Breast and Prostate Cancer Survivor Responses to Group Exercise and Supportive Group Psychotherapy,Journal of Psychosocial Oncology,,,Article,2015-09-01,10.1080/07347332.2015.1082166,,,,26315617,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4461709,https://api.altmetric.com/v1/donut/4461709_240.png 1,"Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460–7",European Urology,,,Article,2015-08-29,10.1016/j.eururo.2015.08.015,,,,26323947,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4448627,https://api.altmetric.com/v1/donut/4448627_240.png 1,Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer,Endocrine-Related Cancer,,,Article,2015-08-28,10.1530/erc-15-0225,,,,26311513,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4445815,https://api.altmetric.com/v1/donut/4445815_240.png 1,In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth.,Oncogene,,,Article,2014-07-27,10.1038/onc.2014.206,,,,25065596,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4445772,https://api.altmetric.com/v1/donut/4445772_240.png 1,Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?,The Prostate,,,Article,2015-08-27,10.1002/pros.23086,,,,26306920,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4440412,https://api.altmetric.com/v1/donut/4440412_240.png 1,Older Men With Locally Advanced Prostate Cancer: To Treat or Not to Treat?,Journal of Clinical Oncology,,,Article,2015-09-01,10.1200/jco.2015.62.3173,,,,26215967,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4429283,https://api.altmetric.com/v1/donut/4429283_240.png 1,Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression,"Cancer Immunology, Immunotherapy",,,Article,2015-08-22,10.1007/s00262-015-1752-y,,,,26289091,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4421157,https://api.altmetric.com/v1/donut/4421157_240.png 1,"Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates",BMC Urology,,,Article,2015-08-21,10.1186/s12894-015-0077-7,,,,26294063,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4421097,https://api.altmetric.com/v1/donut/4421097_240.png 1,Neutrophil count is associated with survival in localized prostate cancer,BMC Cancer,,,Article,2015-08-21,10.1186/s12885-015-1599-9,,,,26292807,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4420513,https://api.altmetric.com/v1/donut/4420513_240.png 1,Glycogen synthase kinase-3? inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.,Oncotarget,,,Article,2014-10-14,10.18632/oncotarget.1510,,,,25344861,PMC4253412,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4389287,https://api.altmetric.com/v1/donut/4389287_240.png 1,miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer ,Biochemical & Biophysical Research Communications,,,Article,2015-09-01,10.1016/j.bbrc.2015.07.127,,,,26231797,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4384307,https://api.altmetric.com/v1/donut/4384307_240.png 1,Expression and potential role of the peptide orexin-A in prostate cancer ,Biochemical & Biophysical Research Communications,,,Article,2015-09-01,10.1016/j.bbrc.2015.07.124,,,,26220343,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4378630,https://api.altmetric.com/v1/donut/4378630_240.png 1,"Reply to Carsten Stephan, Henning Cammann, and Klaus Jung's Letter to the Editor re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039",European Urology,,,Article,2015-08-06,10.1016/j.eururo.2015.07.027,,,,26242717,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4368469,https://api.altmetric.com/v1/donut/4368469_240.png 1,Preoperative Serum Prostate Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens.,Urology,,,Article,2015-08-10,10.1016/j.urology.2015.07.029,,,,26255036,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4367271,https://api.altmetric.com/v1/donut/4367271_240.png 1,Development of enzalutamide for metastatic castration-resistant prostate cancer.,Annals of the New York Academy of Sciences,,,Article,2015-08-01,10.1111/nyas.12846,,,,26384731,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4362221,https://api.altmetric.com/v1/donut/4362221_240.png 1,Two splice variants of Y Chromosome-located Lysine-specific Demethylase 5D Have Distinct Function in Prostate Cancer Cell Line (DU-145),Journal of Proteome Research,,,Article,2015-09-04,10.1021/acs.jproteome.5b00333,,,,26215926,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4360353,https://api.altmetric.com/v1/donut/4360353_240.png 1,"MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer",Journal of Cancer Research & Clinical Oncology,,,Article,2015-08-02,10.1007/s00432-015-2016-0,,,,26227059,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4354041,https://api.altmetric.com/v1/donut/4354041_240.png 1,Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program,PLoS ONE,,,Article,2015-07-28,10.1371/journal.pone.0134134,,,,26218594,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4338725,https://api.altmetric.com/v1/donut/4338725_240.png 1,The Effects of Social Support on Health-Related Quality of Life of Patients with Metastatic Prostate Cancer,Journal of Cancer Education,,,Article,2015-07-15,10.1007/s13187-015-0884-2,,,,26174117,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4333383,https://api.altmetric.com/v1/donut/4333383_240.png 1,Hypoxia-inducible miR-182 enhances HIF1? signaling via targeting PHD2 and FIH1 in prostate cancer,Scientific Reports,,,Article,2015-07-26,10.1038/srep12495,,,,26205124,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4328586,https://api.altmetric.com/v1/donut/4328586_240.png 1,Advances in sentinel node dissection in prostate cancer from a technical perspective,International Journal of Urology,,,Article,2015-07-01,10.1111/iju.12863,,,,26173593,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4307134,https://api.altmetric.com/v1/donut/4307134_240.png 1,"Capsule Commentary on Shelton et al., Reducing PSA-Based Prostate Cancer Screening in Men ? 75 Years Old with Highly Specific Computerized Clinical Decision Support",JGIM: Journal of General Internal Medicine,,,Article,2015-03-25,10.1007/s11606-015-3286-6,,,,25805504,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4305044,https://api.altmetric.com/v1/donut/4305044_240.png 1,Integration of Multiethnic Fine-mapping and Genomic Annotation to Prioritize Candidate Functional SNPs at Prostate Cancer Susceptibility Regions.,Human Molecular Genetics,,,Article,2015-07-15,10.1093/hmg/ddv269,,,,26162851,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4278134,https://api.altmetric.com/v1/donut/4278134_240.png 1,Proteomic Comparison and MRM Based Comparative Analysis of Metabolites Reveals Metabolic Shift in Human Prostate Cancer Cell Lines,Journal of Proteome Research,,,Article,,10.1021/acs.jproteome.5b00464,,,,26147661,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4272709,https://api.altmetric.com/v1/donut/4272709_240.png 1,REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer,Nucleic Acids Research,,,Article,2014-01-01,10.1093/nar/gkt921,,,,24163104,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4240807,https://api.altmetric.com/v1/donut/4240807_240.png 1,Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers.,International Neurourology Journal,,,Article,2015-06-01,10.5213/inj.2015.19.2.74,,,,26126436,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4238427,https://api.altmetric.com/v1/donut/4238427_240.png 1,Epigenetically altered miR?193b targets cyclin D1 in prostate cancer,Cancer Medicine,,,Article,2015-07-03,10.1002/cam4.486,,,,26129688,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4237438,https://api.altmetric.com/v1/donut/4237438_240.png 1,Redox-Sensitive PEG–Polypeptide Nanoporous Particles for Survivin Silencing in Prostate Cancer Cells,Biomacromolecules,,,Article,2015-06-30,10.1021/acs.biomac.5b00562,,,,26120930,,11343/90858,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4227134,https://api.altmetric.com/v1/donut/4227134_240.png 1,Heat-shock factor 2 is a suppressor of prostate cancer invasion,Oncogene,,,Article,2015-06-29,10.1038/onc.2015.241,,,,26119944,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/4224706,https://api.altmetric.com/v1/donut/4224706_240.png 1,(11)C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study.,EJNMMI Research,,,Article,2014-12-01,10.1186/s13550-014-0055-1,,,,26116118,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4223109,https://api.altmetric.com/v1/donut/4223109_240.png 1,WE-EF-210-07: Development of a Minimally Invasive Photo Acoustic Imaging System for Early Prostate Cancer Detection.,Medical Physics,,,Article,2015-06-01,10.1118/1.4926030,,,,26129328,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4219830,https://api.altmetric.com/v1/donut/4219830_240.png 1,Evaluation of hGM-CSF/hTNF¿ surface-modified prostate cancer therapeutic vaccine in the huPBL-SCID chimeric mouse model,Journal of Hematology & Oncology,,,Article,2015-06-26,10.1186/s13045-015-0175-8,,,,26108270,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4216163,https://api.altmetric.com/v1/donut/4216163_240.png 1,Age-Related Use and Perceptions of eHealth in Men With Prostate Cancer: A Web-Based Survey,JMIR Cancer,,,Article,2015-06-25,10.2196/cancer.4178,,,,,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4210327,https://api.altmetric.com/v1/donut/4210327_240.png 1,Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.,BMC Genomics,,,Article,2015-06-24,10.1186/1471-2164-16-s7-s3,,,,26100580,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4204606,https://api.altmetric.com/v1/donut/4204606_240.png 1,Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.,Advances in cancer research,,,Article,2015-06-22,10.1016/bs.acr.2015.03.001,,,,26093899,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4197825,https://api.altmetric.com/v1/donut/4197825_240.png 1,Identification and Functional Validation of Reciprocal microRNA–mRNA Pairings in African American Prostate Cancer Disparities,Clinical Cancer Research,,,Article,2015-06-20,10.1158/1078-0432.ccr-14-1566,,,,26089375,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4189089,https://api.altmetric.com/v1/donut/4189089_240.png 1,CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells.,Oncotarget,,,Article,2015-06-19,10.18632/oncotarget.4293,,,,26087476,PMC4673169,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/4188263,https://api.altmetric.com/v1/donut/4188263_240.png 1,"Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes",Journal of Cancer Research & Clinical Oncology,,,Article,2015-06-06,10.1007/s00432-015-1992-4,,,,26048031,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4182262,https://api.altmetric.com/v1/donut/4182262_240.png 1,Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer.,Disease Markers,,,Article,2015-06-16,10.1155/2015/402963,,,,26074659,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4168615,https://api.altmetric.com/v1/donut/4168615_240.png 1,Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer.,European Urology,,,Article,2015-06-20,10.1016/j.eururo.2015.03.054,,,,26088731,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4154440,https://api.altmetric.com/v1/donut/4154440_240.png 1,Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.,The Prostate,,,Article,2015-04-27,10.1002/pros.22972,,,,25917126,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4153005,https://api.altmetric.com/v1/donut/4153005_240.png 1,Robotic vs. open retropubic prostatectomy: A history of prostate cancer,OR Nurse,,,Article,2015-06-08,10.1097/01.orn.0000466723.63893.60,,,,,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4142929,https://api.altmetric.com/v1/donut/4142929_240.png 1,Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy,Clinical Nuclear Medicine,,,Article,2015-11-01,10.1097/rlu.0000000000000841,,,,26053712,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4134885,https://api.altmetric.com/v1/donut/4134885_240.png 1,Gabarapl1 mediates androgen-regulated autophagy in prostate cancer,Tumor Biology,,,Article,2015-06-08,10.1007/s13277-015-3542-8,,,,26050226,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4114163,https://api.altmetric.com/v1/donut/4114163_240.png 1,"ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer. ASCO 2015",ecancer.org,,,Article,,,,,http://ecancer.org/conference/677-asco-2015/news/7350-asco-2015--first-effective-adjuvant-chemotherapy-for-high-risk--localised-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4101785,https://api.altmetric.com/v1/donut/4101785_240.png 1,Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species -mediated endoplasmic reticulum stress,Scientific Reports,,,Article,2015-05-28,10.1038/srep10420,,,,26013662,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4066594,https://api.altmetric.com/v1/donut/4066594_240.png 1,Estrogen induces androgen?repressed SOX4 expression to promote progression of prostate cancer cells,The Prostate,,,Article,2015-05-28,10.1002/pros.23017,,,,26015225,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4066408,https://api.altmetric.com/v1/donut/4066408_240.png 1,TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.,Frontiers in endocrinology,,,Article,2015-05-27,10.3389/fendo.2015.00078,,,,26074876,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4063290,https://api.altmetric.com/v1/donut/4063290_240.png 1,Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort.,Oncotarget,,,Article,2015-05-27,10.18632/oncotarget.3938,,,,26011940,PMC4673214,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4062132,https://api.altmetric.com/v1/donut/4062132_240.png 1,Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3404,,,,26002551,PMC4558177,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4057861,https://api.altmetric.com/v1/donut/4057861_240.png 1,Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins Experience,Clinical Genitourinary Cancer,,,Article,2015-05-26,10.1016/j.clgc.2015.04.011,,,,26003268,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4056830,https://api.altmetric.com/v1/donut/4056830_240.png 1,Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia.,Archives of Medical Science,,,Article,2015-04-25,10.5114/aoms.2015.50970,,,,25995756,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4051526,https://api.altmetric.com/v1/donut/4051526_240.png 1,Immunotherapeutic Approaches in Prostate Cancer: Combinations and Clinical Integration,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2015-05-21,10.14694/edbook_am.2015.35.e275,,,,25993186,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4037217,https://api.altmetric.com/v1/donut/4037217_240.png 1,"Mitotic quiescence, but not unique ""stemness,"" marks the phenotype of bone metastasis-initiating cells in prostate cancer.",FASEB Journal,,,Article,2015-04-17,10.1096/fj.14-266379,,,,25888599,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4026081,https://api.altmetric.com/v1/donut/4026081_240.png 1,ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3425,,,,25906745,PMC4599293,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4023779,https://api.altmetric.com/v1/donut/4023779_240.png 1,Development of a microparticulate prostate cancer vaccine and evaluating the effect of route of administration on its efficacy via the skin.,Journal of Microencapsulation,,,Article,2015-05-20,10.3109/02652048.2015.1017615,,,,25985824,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4022238,https://api.altmetric.com/v1/donut/4022238_240.png 1,TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.,Oncotarget,,,Article,2015-05-20,10.18632/oncotarget.3948,,,,25980497,PMC4627303,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4022013,https://api.altmetric.com/v1/donut/4022013_240.png 1,Pre-existing levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab.,Cancer Immunology Research,,,Article,,10.1158/2326-6066.cir-14-0227,,,,25968455,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4011974,https://api.altmetric.com/v1/donut/4011974_240.png 1,Contouring variability of human- and deformable-generated contours in radiotherapy for prostate cancer.,Physics in Medicine & Biology,,,Article,2015-05-19,10.1088/0031-9155/60/11/4429,,,,25988718,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4010716,https://api.altmetric.com/v1/donut/4010716_240.png 1,Expression of cell cycle?regulated genes and prostate cancer prognosis in a population?based cohort,The Prostate,,,Article,2015-05-18,10.1002/pros.23016,,,,25990700,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4007725,https://api.altmetric.com/v1/donut/4007725_240.png 1,Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives,Investigative Radiology,,,Article,2015-05-13,10.1097/rli.0000000000000163,,,,25974203,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3998366,https://api.altmetric.com/v1/donut/3998366_240.png 1,Overexpression of miR-145-5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression.,Cancer Investigation,,,Article,,10.3109/07357907.2015.1025407,,,,25951106,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3995076,https://api.altmetric.com/v1/donut/3995076_240.png 1,"Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report",BMC Cancer,,,Article,2015-05-07,10.1186/s12885-015-1390-y,,,,25948240,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3975270,https://api.altmetric.com/v1/donut/3975270_240.png 1,Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway.,Molecular Carcinogenesis,,,Article,2015-04-27,10.1002/mc.22324,,,,25917875,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3974449,https://api.altmetric.com/v1/donut/3974449_240.png 1,Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature,World Journal of Surgical Oncology,,,Article,2015-05-07,10.1186/s12957-015-0598-2,,,,25943541,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3973767,https://api.altmetric.com/v1/donut/3973767_240.png 1,"Diagnostic Intervals and Its Association with Breast, Prostate, Lung and Colorectal Cancer Survival in England: Historical Cohort Study Using the Clinical Practice Research Datalink",PLoS ONE,,,Article,2015-05-01,10.1371/journal.pone.0126608,,,,25933397,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3962083,https://api.altmetric.com/v1/donut/3962083_240.png 1,Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines,Cancer Chemotherapy & Pharmacology,,,Article,2015-04-30,10.1007/s00280-015-2756-1,,,,25925002,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3955755,https://api.altmetric.com/v1/donut/3955755_240.png 1,"Distress, delay of gratification and preference for palliative care in men with prostate cancer.",Psycho-Oncology,,,Article,2015-04-21,10.1002/pon.3822,,,,25899740,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3946530,https://api.altmetric.com/v1/donut/3946530_240.png 1,Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.,European Radiology,,,Article,2014-06-02,10.1007/s00330-014-3240-8,,,,24889997,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3939484,https://api.altmetric.com/v1/donut/3939484_240.png 1,Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.,The Prostate,,,Article,2015-04-15,10.1002/pros.23002,,,,25877612,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3922301,https://api.altmetric.com/v1/donut/3922301_240.png 1,Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer,Investigative Radiology,,,Article,2015-04-10,10.1097/rli.0000000000000157,,,,25867656,,,,,,,0,0,0,1,0,0,3,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3908970,https://api.altmetric.com/v1/donut/3908970_240.png 1,Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer.,Current Pharmaceutical Biotechnology,,,Article,,,,,,25860066,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3904499,https://api.altmetric.com/v1/donut/3904499_240.png 1,Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.,American Journal of Epidemiology,,,Article,,10.1093/aje/kwu344,,,,25852077,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3900673,https://api.altmetric.com/v1/donut/3900673_240.png 1,Influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer.,Reports of Practical Oncology & Radiotherapy,,,Article,2015-03-01,10.1016/j.rpor.2014.11.008,,,,25859399,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3899727,https://api.altmetric.com/v1/donut/3899727_240.png 1,Exploring Important Influences on the Healthfulness of Prostate Cancer Survivors’ Diets,Qualitative Health Research,,,Article,2015-04-11,10.1177/1049732315580108,,,,25857653,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3896526,https://api.altmetric.com/v1/donut/3896526_240.png 1,Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer,Frontiers in oncology,,,Article,2015-02-11,10.3389/fonc.2015.00048,,,,25905037,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3884499,https://api.altmetric.com/v1/donut/3884499_240.png 1,Fluorine-18-Fluoroethylcholine PET/CT in the detection of prostate cancer: A South African experience.,Hellenic Journal of Nuclear Medicine,,,Article,2015-01-01,,,,,25840573,,,,,,,0,0,0,3,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3880422,https://api.altmetric.com/v1/donut/3880422_240.png 1,Proteomic Serum Profile of Fatigued Men Receiving Localized External Beam Radiation Therapy for Non-Metastatic Prostate Cancer.,,,,Article,2013-07-30,10.1016/j.jpainsymman.2013.05.016,,,,23916682,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3877217,https://api.altmetric.com/v1/donut/3877217_240.png 1,Separation of Circulating Tumor Cells from Castrate Resistant Prostate Cancer Patients using Resettable Cell Traps,Lab on a Chip - Miniaturisation for Chemistry & Biology,,,Article,2015-04-02,10.1039/c5lc00226e,,,,25876237,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3864497,https://api.altmetric.com/v1/donut/3864497_240.png 1,(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-03-26,10.1007/s00259-015-3042-5,,,,25808631,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3843428,https://api.altmetric.com/v1/donut/3843428_240.png 1,New MRI Technique Could Lead to More Accurate Prostate Cancer Diagnosis and Treatment,Journal of Clinical Engineering,,,Article,,10.1097/jce.0000000000000086,,,,,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3839160,https://api.altmetric.com/v1/donut/3839160_240.png 1,Inflammation and prostate cancer: friends or foe?,Inflammation Research,,,Article,2015-03-19,10.1007/s00011-015-0812-2,,,,25788425,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3813519,https://api.altmetric.com/v1/donut/3813519_240.png 1,Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism,American Journal of Health-System Pharmacy,,,Article,,10.2146/ajhp140128,,,,25788507,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3809688,https://api.altmetric.com/v1/donut/3809688_240.png 1,Overexpression of Periostin in Stroma Positively Associated with Aggressive Prostate Cancer,PLoS ONE,,,Article,2015-03-17,10.1371/journal.pone.0121502,,,,25781169,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3803445,https://api.altmetric.com/v1/donut/3803445_240.png 1,Extended pelvic lymph node dissection for clinically localized prostate cancer: a West Australian experience,Australian & New Zealand Journal of Surgery,,,Article,2015-03-17,10.1111/ans.13035,,,,25780994,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3802597,https://api.altmetric.com/v1/donut/3802597_240.png 1,MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.,Current pharmacology reports,,,Article,2015-04-01,10.1007/s40495-014-0009-3,,,,25774339,PMC4354897,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3799333,https://api.altmetric.com/v1/donut/3799333_240.png 1,Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer.,PLoS ONE,,,Article,,10.1371/journal.pone.0120159,,,,25768283,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3790465,https://api.altmetric.com/v1/donut/3790465_240.png 1,Corticosteroids in the management of prostate cancer: a critical review.,Current Treatment Options in Oncology,,,Article,2015-02-01,10.1007/s11864-014-0320-6,,,,25762121,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3788014,https://api.altmetric.com/v1/donut/3788014_240.png 1,Active Surveillance for Low-Risk Prostate Cancer,Current Urology Reports,,,Article,2015-03-13,10.1007/s11934-015-0492-z,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3783302,https://api.altmetric.com/v1/donut/3783302_240.png 1,Chest-Wall Metastasis of Prostate Cancer,JGIM: Journal of General Internal Medicine,,,Article,2015-03-11,10.1007/s11606-015-3270-1,,,,25759188,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3773068,https://api.altmetric.com/v1/donut/3773068_240.png 1,Computer-assisted interpretation of planar whole-body bone scintigraphy in patients with newly diagnosed prostate cancer.,Nuclear Medicine Communications,,,Article,2015-03-09,10.1097/mnm.0000000000000307,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3772936,https://api.altmetric.com/v1/donut/3772936_240.png 1,Moving the goal posts in prostate cancer trials ,Lancet Oncology,,,Article,,10.1016/s1470-2045(15)70071-9,,,,25701172,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3742278,https://api.altmetric.com/v1/donut/3742278_240.png 1,Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.,Clinical Chemistry & Laboratory Medicine,,,Article,2015-01-10,10.1515/cclm-2014-1000,,,,25720086,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3737885,https://api.altmetric.com/v1/donut/3737885_240.png 1,Discovery and Development of Galeterone (TOK-001 or VN/124-1) for Treatment of all Stages of Prostate Cancer.,Journal of Medicinal Chemistry,,,Article,2015-01-17,10.1021/jm501239f,,,,25591066,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3730324,https://api.altmetric.com/v1/donut/3730324_240.png 1,Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.,BMC Cancer,,,Article,2014-06-03,10.1186/1471-2407-14-308,,,,24885368,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3726001,https://api.altmetric.com/v1/donut/3726001_240.png 1,Prostate cancer vaccines: the long road to clinical application,"Cancer Immunology, Immunotherapy",,,Article,2015-02-19,10.1007/s00262-015-1667-7,,,,25690791,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3714837,https://api.altmetric.com/v1/donut/3714837_240.png 1,Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer,PLoS ONE,,,Article,2015-02-19,10.1371/journal.pone.0094048,,,,25126949,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3713134,https://api.altmetric.com/v1/donut/3713134_240.png 1,CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer,Tumor Biology,,,Article,2015-02-15,10.1007/s13277-015-3222-8,,,,25682287,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3702791,https://api.altmetric.com/v1/donut/3702791_240.png 1,"Reply to the Letter to the Editor ""Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis"" by Louie et al.",Annals of Oncology,,,Article,2015-02-11,10.1093/annonc/mdv068,,,,25672895,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3590153,https://api.altmetric.com/v1/donut/3590153_240.png 1,Effect of E-Cadherin (CDH1) -160C/A polymorphism on prostate cancer risk: a meta-analysis,bioRxiv,,,Article,2015-02-11,10.1101/015123,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3539050,https://api.altmetric.com/v1/donut/3539050_240.png 1,Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer,The Prostate,,,Article,2015-02-07,10.1002/pros.22954,,,,25662931,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3538117,https://api.altmetric.com/v1/donut/3538117_240.png 1,The Noninvasive Detection of RAR?2 Promoter Methylation for the Diagnosis of Prostate Cancer,Cell Biochemistry and Biophysics,,,Article,2014-10-12,10.1007/s12013-014-0285-x,,,,25308859,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3429241,https://api.altmetric.com/v1/donut/3429241_240.png 1,Tumor?suppressive microRNA?145 induces growth arrest by targeting SENP1 in human prostate cancer cells,Cancer Science,,,Article,2015-02-02,10.1111/cas.12626,,,,25645686,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3333986,https://api.altmetric.com/v1/donut/3333986_240.png 1,Observer agreement and accuracy in the evaluation of bone scans in newly diagnosed prostate cancer,Nuclear Medicine Communications,,,Article,2015-02-02,10.1097/mnm.0000000000000279,,,,25646705,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3324944,https://api.altmetric.com/v1/donut/3324944_240.png 1,miR?204 is Dysregulated in Metastatic Prostate Cancer In Vitro,Molecular Carcinogenesis,,,Article,2015-01-28,10.1002/mc.22263,,,,25630658,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3303409,https://api.altmetric.com/v1/donut/3303409_240.png 1,The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2015.01.002,,,,25618827,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3222496,https://api.altmetric.com/v1/donut/3222496_240.png 1,The Potential Harm of Prostate Cancer Health Supplements,American Journal of Lifestyle Medicine,,,Article,2015-01-27,10.1177/1559827614567846,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3108430,https://api.altmetric.com/v1/donut/3108430_240.png 1,"Capsule Commentary on Hoffman et al., Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study",JGIM: Journal of General Internal Medicine,,,Article,2015-01-27,10.1007/s11606-015-3188-7,,,,25623301,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3106206,https://api.altmetric.com/v1/donut/3106206_240.png 1,"Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy",European Journal of Cancer (1965),,,Article,2015-01-19,10.1016/j.ejca.2015.01.003,,,,25613441,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3100384,https://api.altmetric.com/v1/donut/3100384_240.png 1,Extracapsular Extension of Prostate Cancer: Diagnostic Value of Combined Multiparametric Magnetic Resonance Imaging and Isovoxel 3-Dimensional T2-Weighted Imaging at 1.5 T,Journal of Computer Assisted Tomography,,,Article,2014-10-20,10.1097/rct.0000000000000172,,,,25340587,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3099470,https://api.altmetric.com/v1/donut/3099470_240.png 1,Changes in Prognostic and Therapeutic Parameters in Prostate Cancer from an Epidemiological View over 20 Years.,Oncology Research and Treatment,,,Article,2015-01-26,10.1159/000371717,,,,25633491,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3098944,https://api.altmetric.com/v1/donut/3098944_240.png 1,POTENTIAL APPLICATIONS OF IMAGE-GUIDED RADIOTHERAPY FOR RADIATION DOSE ESCALATION IN PATIENTS WITH EARLY STAGE HIGH-RISK PROSTATE CANCER,Frontiers in oncology,,,Article,2015-01-15,10.3389/fonc.2015.00018,,,,25699239,PMC4313771,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3097655,https://api.altmetric.com/v1/donut/3097655_240.png 1,Multi-Institutional Registry for Prostate Cancer Radiosurgery: A Prospective Observational Clinical Trial,Frontiers in oncology,,,Article,2014-12-04,10.3389/fonc.2014.00369,,,,25657929,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3093524,https://api.altmetric.com/v1/donut/3093524_240.png 1,Functional significance of aberrantly expressed microRNAs in prostate cancer,International Journal of Urology,,,Article,2015-01-20,10.1111/iju.12700,,,,25599923,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3090405,https://api.altmetric.com/v1/donut/3090405_240.png 1,Prostate cancer: The main risk and protective factors - Epigenetic modifications.,Annales d'Endocrinologie,,,Article,2015-01-18,10.1016/j.ando.2014.09.001,,,,25592466,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/3089009,https://api.altmetric.com/v1/donut/3089009_240.png 1,Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells,BMC Cancer,,,Article,2015-01-16,10.1186/s12885-015-1012-8,,,,25592066,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3075740,https://api.altmetric.com/v1/donut/3075740_240.png 1,Down-Regulation of mir-221 and mir-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1.,PLoS ONE,,,Article,2014-06-04,10.1371/journal.pone.0098833,,,,24892674,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3065949,https://api.altmetric.com/v1/donut/3065949_240.png 1,A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.,Progress in Earth and Planetary Science,,,Article,2014-09-07,,,,,25580468,PMC4287984,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3064440,https://api.altmetric.com/v1/donut/3064440_240.png 1,Value of bimodal 18F-choline-PET/MRI and trimodal 18F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy.,Abdominal Imaging,,,Article,2015-01-13,10.1007/s00261-014-0345-0,,,,25579170,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3060211,https://api.altmetric.com/v1/donut/3060211_240.png 1,TCAF1 puts a chill on prostate cancer,Journal of Cell Biology,,,Article,,10.1083/jcb.2081iti1,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3052621,https://api.altmetric.com/v1/donut/3052621_240.png 1,Radium-223 Dichloride A Novel Treatment Option for Castration-Resistant Prostate Cancer Patients With Symptomatic Bone Metastases,Annals of Pharmacotherapy,,,Article,2015-01-08,10.1177/1060028014565444,,,,25573268,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3050306,https://api.altmetric.com/v1/donut/3050306_240.png 1,Active Estrogen Synthesis and its Function in Prostate Cancer-derived Stromal Cells,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,25550554,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3030298,https://api.altmetric.com/v1/donut/3030298_240.png 1,BET bromodomain inhibitors-A novel epigenetic approach in castration-resistant prostate cancer.,Cancer Biology and Therapy,,,Article,2014-12-02,10.4161/15384047.2014.962297,,,,25535892,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3013017,https://api.altmetric.com/v1/donut/3013017_240.png 1,Evolving Personalized Therapy for Castration-Resistant Prostate Cancer.,Biomedicine publiée pour l A A I C I G,,,Article,2014-01-01,10.7603/s40681-014-0002-5,,,,25520915,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/2999114,https://api.altmetric.com/v1/donut/2999114_240.png 1,The role of TXNDC5 in castration-resistant prostate cancer|[mdash]|involvement of androgen receptor signaling pathway,Oncogene,,,Article,2014-12-15,10.1038/onc.2014.401,,,,25500540,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2997306,https://api.altmetric.com/v1/donut/2997306_240.png 1,[New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer.],Magyar Onkológia,,,Article,2014-12-12,,,,,25517448,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2995635,https://api.altmetric.com/v1/donut/2995635_240.png 1,Family history in the finnish prostate cancer screening trial.,International Journal of Cancer,,,Article,2014-10-03,10.1002/ijc.29243,,,,25274038,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2989000,https://api.altmetric.com/v1/donut/2989000_240.png 1,Decisional outcomes following use of an interactive web-based decision aid for prostate cancer screening,Translational Behavioral Medicine,,,Article,2014-12-16,10.1007/s13142-014-0301-0,,,,26029281,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2985514,https://api.altmetric.com/v1/donut/2985514_240.png 1,Toward a prostate cancer precision medicine ,Urologic Oncology,,,Article,,10.1016/j.urolonc.2014.10.011,,,,25465299,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2974981,https://api.altmetric.com/v1/donut/2974981_240.png 1,Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options,Radiation Oncology,,,Article,2014-12-11,10.1186/s13014-014-0258-7,,,,25497220,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2972845,https://api.altmetric.com/v1/donut/2972845_240.png 1,Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers.,Chemical Communications,,,Article,2015-03-03,10.1039/c4cc08331h,,,,25490716,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2969583,https://api.altmetric.com/v1/donut/2969583_240.png 1,CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study.,Cancer Research and Treatment : Official Journal of Korean Cancer Association,,,Article,2014-10-13,10.4143/crt.2014.015,,,,25483747,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2966848,https://api.altmetric.com/v1/donut/2966848_240.png 1,"Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point's definition?",Annals of Oncology,,,Article,2014-12-05,10.1093/annonc/mdu553,,,,25480877,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2960348,https://api.altmetric.com/v1/donut/2960348_240.png 1,Comparison of Image-guided Radiotherapy Technologies for Prostate Cancer.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-12-01,10.1097/coc.0b013e31827e4eb9,,,,23428948,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2959807,https://api.altmetric.com/v1/donut/2959807_240.png 1,Advances in systemic therapies for metastatic castration-resistant prostate cancer.,Future Oncology,,,Article,2014-11-01,10.2217/fon.14.128,,,,25471035,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2954964,https://api.altmetric.com/v1/donut/2954964_240.png 1,Radionuclide Therapy for Osseous Metastases in Prostate Cancer.,Seminars in Nuclear Medicine,,,Article,2015-01-01,10.1053/j.semnuclmed.2014.07.006,,,,25475380,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2953099,https://api.altmetric.com/v1/donut/2953099_240.png 1,Resistance to Androgen-Pathway Drugs in Prostate Cancer.,New England Journal of Medicine,,,Article,2014-12-04,10.1056/nejmc1412594#sa3,,,,25470703,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2952718,https://api.altmetric.com/v1/donut/2952718_240.png 1,The Glycosyltransferase LARGE2 is Repressed by Snail and ZEB1 in Prostate Cancer.,Cancer Biology and Therapy,,,Article,2014-12-02,10.4161/15384047.2014.987078,,,,25455932,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2946860,https://api.altmetric.com/v1/donut/2946860_240.png 1,A Dose–Response Analysis of Biochemical Control Outcomes After 125I Monotherapy for Patients With Favorable-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-12,10.1016/j.ijrobp.2014.08.340,,,,25539368,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2931733,https://api.altmetric.com/v1/donut/2931733_240.png 1,Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report,Journal of Community Hospital Internal Medicine Perspectives,,,Article,2014-11-24,10.3402/jchimp.v4.25176,,,,25432647,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2922652,https://api.altmetric.com/v1/donut/2922652_240.png 1,Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer,Journal of Nuclear Medicine,,,Article,2014-11-20,10.2967/jnumed.114.141143,,,,25413139,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2915717,https://api.altmetric.com/v1/donut/2915717_240.png 1,Serum markers in prostate cancer detection,Current Opinion in Urology,,,Article,2014-11-15,10.1097/mou.0000000000000128,,,,25393274,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2913096,https://api.altmetric.com/v1/donut/2913096_240.png 1,Men's preferences and trade?offs for prostate cancer screening: a discrete choice experiment,Health Expectations,,,Article,2014-11-10,10.1111/hex.12301,,,,25382490,,11541.2/120239,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2911249,https://api.altmetric.com/v1/donut/2911249_240.png 1,Evidence of histidine and aspartic acid phosphorylation in human prostate cancer cells,Naunyn-Schmiedeberg's Archives of Pharmacology,,,Article,2014-11-06,10.1007/s00210-014-1063-4,,,,25373728,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2906661,https://api.altmetric.com/v1/donut/2906661_240.png 1,Galeterone shows activity in a variant form of castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6615-galeterone-shows-activity-in-a-variant-form-of-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2903189,https://api.altmetric.com/v1/donut/2903189_240.png 1,Management and Characteristics of Patients with Metastatic Prostate Cancer in a Cohort of New Zealand Men.,Oncology (08909091),,,Article,2014-11-15,10.1159/000368319,,,,25402412,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2899453,https://api.altmetric.com/v1/donut/2899453_240.png 1,Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells.,Oncology Reports,,,Article,2014-11-07,10.3892/or.2014.3586,,,,25370833,,,,,,,0,0,0,11,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2893691,https://api.altmetric.com/v1/donut/2893691_240.png 1,Incidental detection of increased 18F-FDG uptake and its follow-up in patients with granulomatous prostatitis after BCG treatment for urinary bladder cancer.,Hellenic Journal of Nuclear Medicine,,,Article,2014-11-12,10.1967/s002449910146,,,,25397626,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2891008,https://api.altmetric.com/v1/donut/2891008_240.png 1,Have screening harms become newsworthy? News coverage of prostate and colorectal cancer screening since the 2008 USPSTF recommendation changes.,Journal of Behavioral Medicine,,,Article,2014-05-24,10.1007/s10865-014-9572-7,,,,24859436,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2886934,https://api.altmetric.com/v1/donut/2886934_240.png 1,Prostate cancer survivors' beliefs about screening and treatment decision?making experiences in an era of controversy,Psycho-Oncology,,,Article,2014-11-10,10.1002/pon.3721,,,,25382436,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2874488,https://api.altmetric.com/v1/donut/2874488_240.png 1,Arctigenin in combination with quercetin synergistically enhances the anti?proliferative effect in prostate cancer cells,Molecular Nutrition & Food Research,,,Article,2014-11-07,10.1002/mnfr.201400558,,,,25380086,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2865287,https://api.altmetric.com/v1/donut/2865287_240.png 1,RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization,BMC Cancer,,,Article,2014-11-04,10.1186/1471-2407-14-808,,,,25369795,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2854952,https://api.altmetric.com/v1/donut/2854952_240.png 1,"The Anti-Proliferative Effects of Enterolactone in Prostate Cancer Cells: Evidence for the Role of DNA Licencing Genes, mi-R106b Cluster Expression, and PTEN Dosage",Nutrients,,,Article,2014-11-03,10.3390/nu6114839,,,,25372501,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2847317,https://api.altmetric.com/v1/donut/2847317_240.png 1,Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasis.,Journal of Cancer Research & Clinical Oncology,,,Article,2014-05-28,10.1007/s00432-014-1710-7,,,,24858569,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2843642,https://api.altmetric.com/v1/donut/2843642_240.png 1,Androgen receptor interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen?deficient conditions,International Journal of Cancer,,,Article,2014-10-30,10.1002/ijc.29303,,,,25359680,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2843054,https://api.altmetric.com/v1/donut/2843054_240.png 1,Complementary Medicine Down-regulates Side-effects of Hormone Therapy in Prostate Cancer Patients,IN VIVO,,,Article,,,,,,25189917,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2814299,https://api.altmetric.com/v1/donut/2814299_240.png 1,Knockdown of clusterin expression increases the in vitro sensitivity of human prostate cancer cells to Paclitaxel.,"Journal of Toxicology and Environmental Health, Part A",,,Article,2014-10-25,10.1080/15287394.2014.951760,,,,25343293,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2813440,https://api.altmetric.com/v1/donut/2813440_240.png 1,Psychosocial adjustments in patients with prostate cancer from pre?diagnosis to 6 months post?treatment,International Journal of Nursing Practice,,,Article,2014-10-13,10.1111/ijn.12360,,,,25307968,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2795343,https://api.altmetric.com/v1/donut/2795343_240.png 1,Incidence variation of prostate and cervical cancer according to socioeconomic level in the Girona Health Region,BMC Public Health,,,Article,2014-10-17,10.1186/1471-2458-14-1079,,,,25325921,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2791146,https://api.altmetric.com/v1/donut/2791146_240.png 1,"ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157.",Current Medicinal Chemistry,,,Article,2014-10-16,,,,,25312334,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2788935,https://api.altmetric.com/v1/donut/2788935_240.png 1,"Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: Who, when, where and how?",Cancer Radiotherapie,,,Article,2014-09-08,10.1016/j.canrad.2014.07.153,,,,25192626,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2788761,https://api.altmetric.com/v1/donut/2788761_240.png 1,HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation,The Prostate,,,Article,2014-10-13,10.1002/pros.22888,,,,25307178,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2773065,https://api.altmetric.com/v1/donut/2773065_240.png 1,The Hot Flush Beliefs and Behaviour Scale for Men (HFBBS-Men) undergoing treatment for prostate cancer ,Maturitas,,,Article,2014-12-15,10.1016/j.maturitas.2014.09.014,,,,25449665,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2757488,https://api.altmetric.com/v1/donut/2757488_240.png 1,Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence,Nuclear Medicine Communications,,,Article,2014-10-08,10.1097/mnm.0000000000000207,,,,,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2755867,https://api.altmetric.com/v1/donut/2755867_240.png 1,Variability in Depressive Symptoms of Cognitive Deficit and Cognitive Bias During the First 2 Years After Diagnosis in Australian Men With Prostate Cancer,American Journal of Men's Health,,,Article,2014-10-07,10.1177/1557988314552669,,,,25294866,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2754513,https://api.altmetric.com/v1/donut/2754513_240.png 1,Tpl2 induces castration resistant prostate cancer progression and metastasis.,International Journal of Cancer,,,Article,2014-09-30,10.1002/ijc.29248,,,,25274482,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2753670,https://api.altmetric.com/v1/donut/2753670_240.png 1,Magnolol Causes Alterations in the Cell Cycle in Androgen Insensitive Human Prostate Cancer Cells In Vitro by Affecting Expression of Key Cell Cycle Regulatory Proteins.,Nutrition and Cancer,,,Article,2014-10-01,10.1080/01635581.2014.951736,,,,25264561,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2753561,https://api.altmetric.com/v1/donut/2753561_240.png 1,Inhibition of TGF??/SMADs Signal by MiR?155 is Involved in Arsenic Trioxide?induced Anti?angiogenesis in Prostate Cancer,Cancer Science,,,Article,2014-10-05,10.1111/cas.12548,,,,25283513,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2751114,https://api.altmetric.com/v1/donut/2751114_240.png 1,The Relationship Between Prostate Cancer and Presence of Metabolic Syndrome and Late-onset Hypogonadism,Urology,,,Article,,10.1016/j.urology.2014.07.015,,,,25281522,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2743732,https://api.altmetric.com/v1/donut/2743732_240.png 1,INPP4B suppresses prostate cancer cell invasion.,Cell Communication and Signaling,,,Article,2014-09-25,10.1186/s12964-014-0061-y,,,,25248616,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2736544,https://api.altmetric.com/v1/donut/2736544_240.png 1,"Androgen Suppresses the Proliferation of Androgen Receptor-Positive Castration-Resistant Prostate Cancer Cells via Inhibition of Cdk2, CyclinA, and Skp2",PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0109170,,,,25271736,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2735131,https://api.altmetric.com/v1/donut/2735131_240.png 1,Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer,Molecular Cancer Therapeutics,,,Article,2014-08-16,10.1158/1535-7163.mct-14-0451,,,,25122066,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2698606,https://api.altmetric.com/v1/donut/2698606_240.png 1,Imaging Prostate Cancer with 11C-Choline PET/CT,Journal of Nuclear Medicine,,,Article,2006-01-01,,,,,16883001,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2686909,https://api.altmetric.com/v1/donut/2686909_240.png 1,FDG PET in Prostate Cancer,PET Clinics,,,Article,2009-04-01,10.1016/j.cpet.2009.05.002,,,,20161051,PMC2746691,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2686905,https://api.altmetric.com/v1/donut/2686905_240.png 1,A Transient Increase in Eosinophils Is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T.,Cancer Immunology Research,,,Article,2014-09-03,10.1158/2326-6066.cir-14-0073,,,,25189164,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2685217,https://api.altmetric.com/v1/donut/2685217_240.png 1,Periprostatic Adiposity Measured on Magnetic Resonance Imaging Correlates with Prostate Cancer Aggressiveness.,Urology Journal,,,Article,2014-09-07,,,,,25194078,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2671773,https://api.altmetric.com/v1/donut/2671773_240.png 1,Blood test for 'nicked' protein predicts prostate cancer treatment response,ecancer.org,,,Article,,,,,http://ecancer.org/news/6247-blood-test-for--nicked--protein-predicts-prostate-cancer-treatment-response.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2656660,https://api.altmetric.com/v1/donut/2656660_240.png 1,Prostate cancer: TMPRSS2 promotes metastasis through proteolysis,Nature Reviews Urology,,,Article,2014-09-02,10.1038/nrurol.2014.238,,,,25179500,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2655483,https://api.altmetric.com/v1/donut/2655483_240.png 1,Prostate cancer: Getting on your nerves[mdash]prostatectomy imaging,Nature Reviews Urology,,,Article,2014-09-02,10.1038/nrurol.2014.239,,,,25179499,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2652480,https://api.altmetric.com/v1/donut/2652480_240.png 1,A Comparison of Web-Based Versus Print-Based Decision Aids for Prostate Cancer Screening: Participants’ Evaluation and Utilization,JGIM: Journal of General Internal Medicine,,,Article,2014-09-03,10.1007/s11606-014-2994-7,,,,25183475,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2650883,https://api.altmetric.com/v1/donut/2650883_240.png 1,Hyperpolarized 13C MR for Molecular Imaging of Prostate Cancer,Journal of Nuclear Medicine,,,Article,2014-08-28,10.2967/jnumed.114.141705,,,,25168625,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2640146,https://api.altmetric.com/v1/donut/2640146_240.png 1,Real-Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models.,Biometrics,,,Article,2013-02-07,10.1111/j.1541-0420.2012.01823.x,,,,23379600,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2626323,https://api.altmetric.com/v1/donut/2626323_240.png 1,Two Different Intensity-modulated Radiotherapy Strategies for Patients with High-risk Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2014-07-03,,,,,24982397,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2618802,https://api.altmetric.com/v1/donut/2618802_240.png 1,RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels,The Prostate,,,Article,2014-08-10,10.1002/pros.22842,,,,25111005,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2613879,https://api.altmetric.com/v1/donut/2613879_240.png 1,Subverting ER-Stress towards Apoptosis by Nelfinavir and Curcumin Coexposure Augments Docetaxel Efficacy in Castration Resistant Prostate Cancer Cells.,PLoS ONE,,,Article,2014-08-16,10.1371/journal.pone.0103109,,,,25121735,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2612458,https://api.altmetric.com/v1/donut/2612458_240.png 1,Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2014.03.03,,,,25010296,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2609929,https://api.altmetric.com/v1/donut/2609929_240.png 1,Survival disparities between M?ori and non-M?ori men with prostate cancer in New Zealand.,British Journal of Urology,,,Article,2014-08-13,10.1111/bju.12900,,,,25124231,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2605779,https://api.altmetric.com/v1/donut/2605779_240.png 1,Role of bisphosphonates in non-metastatic prostate cancer,Lancet Oncology,,,Article,2014-08-15,10.1016/s1470-2045(14)70363-8,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2600581,https://api.altmetric.com/v1/donut/2600581_240.png 1,Down?modulation of Bcl?2 sensitizes PTEN?mutated prostate cancer cells to starvation and taxanes,The Prostate,,,Article,2014-08-11,10.1002/pros.22857,,,,25111376,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2598527,https://api.altmetric.com/v1/donut/2598527_240.png 1,1-Stearoylglycerol is associated with risk of prostate cancer: results from a serum metabolomic profiling analysis,Metabolomics,,,Article,2014-03-07,10.1007/s11306-014-0643-0,,,,25254003,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2594877,https://api.altmetric.com/v1/donut/2594877_240.png 1,PAX2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.,FEBS Journal,,,Article,2014-08-26,10.1111/febs.12959,,,,25132193,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2585817,https://api.altmetric.com/v1/donut/2585817_240.png 1,Senescent stroma promotes prostate cancer progression: The role of miR-210.,Molecular Oncology,,,Article,2014-07-21,10.1016/j.molonc.2014.07.009,,,,25091736,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2575846,https://api.altmetric.com/v1/donut/2575846_240.png 1,New prostate cancer drugs: extending and improving life,Lancet Oncology,,,Article,2014-08-05,10.1016/s1470-2045(14)70332-8,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2574758,https://api.altmetric.com/v1/donut/2574758_240.png 1,Hormone and Radiotherapy versus Hormone or Radiotherapy Alone for Non-metastatic Prostate Cancer: A Systematic Review with Meta-analyses,Clinical Oncology,,,Article,2014-07-21,10.1016/j.clon.2014.06.016,,,,25059922,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2569191,https://api.altmetric.com/v1/donut/2569191_240.png 1,Intravoxel Incoherent Motion (IVIM) Diffusion Imaging in Prostate Cancer - What Does It Add?,Journal of Computer Assisted Tomography,,,Article,,10.1097/rct.0000000000000088,,,,24733005,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2554091,https://api.altmetric.com/v1/donut/2554091_240.png 1,Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta?analysis of 11 cohort studies,Diabetes/Metabolism Research & Reviews,,,Article,2014-09-14,10.1002/dmrr.2582,,,,25066306,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2548685,https://api.altmetric.com/v1/donut/2548685_240.png 1,Prostate cancer: Say no to ADT for localized disease,Nature Reviews Urology,,,Article,2014-07-29,10.1038/nrurol.2014.187,,,,25069734,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2547295,https://api.altmetric.com/v1/donut/2547295_240.png 1,Identification of Novel GRM1 Mutations and Single Nucleotide Polymorphisms in Prostate Cancer Cell Lines and Tissues.,PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0103204,,,,25062106,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2541172,https://api.altmetric.com/v1/donut/2541172_240.png 1,Oxidative Stress and DNA Methylation in Prostate Cancer,Obstetrics & Gynecology International,,,Article,2010-01-01,10.1155/2010/302051,,,,20671914,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/2537990,https://api.altmetric.com/v1/donut/2537990_240.png 1,Prostate cancer: Predicting response to androgen receptor signalling inhibition,Nature Reviews Urology,,,Article,2014-07-22,10.1038/nrurol.2014.179,,,,25048863,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2537123,https://api.altmetric.com/v1/donut/2537123_240.png 1,Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4) Promotes Human Prostate Cancer Metastasis,PLoS ONE,,,Article,,10.1371/journal.pone.0102289,,,,25019290,PMC4096757,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2536764,https://api.altmetric.com/v1/donut/2536764_240.png 1,Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin.,Oncotarget,,,Article,2014-06-26,10.18632/oncotarget.2133,,,,25015118,PMC4170639,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2505561,https://api.altmetric.com/v1/donut/2505561_240.png 1,Childhood body mass index and the risk of prostate cancer in adult men,British Journal of Cancer,,,Article,2014-05-27,10.1038/bjc.2014.266,,,,24867696,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2498075,https://api.altmetric.com/v1/donut/2498075_240.png 1,Canine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivo,The Prostate,,,Article,2014-07-06,10.1002/pros.22838,,,,25043424,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2494769,https://api.altmetric.com/v1/donut/2494769_240.png 1,Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patient May Benefit from a Restaging 11C-Choline PET/CT Scan Before Salvage Radiation Therapy?,Journal of Nuclear Medicine,,,Article,2014-06-16,10.2967/jnumed.114.138313,,,,24935990,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2445733,https://api.altmetric.com/v1/donut/2445733_240.png 1,Clinical and Policy Perspectives on the Adoption of Active Surveillance for Low-risk Prostate Cancer,Medical care,,,Article,2014-07-01,10.1097/mlr.0000000000000173,,,,24926703,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2445484,https://api.altmetric.com/v1/donut/2445484_240.png 1,Bone health in patients with prostate cancer.,Actas Urológicas Españolas,,,Article,,10.1016/j.acuro.2014.05.003,,,,24934457,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2439227,https://api.altmetric.com/v1/donut/2439227_240.png 1,"The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis.",European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.05.008,,,,24910418,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2427576,https://api.altmetric.com/v1/donut/2427576_240.png 1,Brachytherapy for Prostate Cancer: Feasible but Oncologic Equivalence Unproven,British Journal of Urology,,,Article,2015-01-21,10.1111/bju.12837,,,,24916778,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2426426,https://api.altmetric.com/v1/donut/2426426_240.png 1,"Tendencies of mortality by prostate cancer in the states of the Central-West Region of Brazil, 1980 - 2011",Revista Brasileira de Epidemiologia,,,Article,,10.1590/1809-4503201400020009eng,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2415421,https://api.altmetric.com/v1/donut/2415421_240.png 1,Clinical Phenotypes of Castration-Resistant Prostate Cancer.,Clinical Advances in Hematology & Oncology,,,Article,2013-11-01,,,,,24896544,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2406826,https://api.altmetric.com/v1/donut/2406826_240.png 1,Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2014.03.012,,,,24929162,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2406074,https://api.altmetric.com/v1/donut/2406074_240.png 1,Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.,Oncogene,,,Article,2014-06-02,10.1038/onc.2014.147,,,,24882580,,,,,,,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2399390,https://api.altmetric.com/v1/donut/2399390_240.png 1,Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer,EMBO Journal,,,Article,2014-05-15,10.15252/embj.201386874,,,,24837709,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/2395582,https://api.altmetric.com/v1/donut/2395582_240.png 1,Closing the controversies gap in prostate cancer?,Nature Reviews Clinical Oncology,,,Article,2014-05-29,10.1038/nrclinonc.2014.87,,,,24871647,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2390959,https://api.altmetric.com/v1/donut/2390959_240.png 1,"Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.",Clinical and Translational Oncology,,,Article,2014-04-02,10.1007/s12094-013-1121-2,,,,24682792,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2387831,https://api.altmetric.com/v1/donut/2387831_240.png 1,Prostate cancer: Laparoscopic radical prostatectomy for high-risk disease,Nature Reviews Urology,,,Article,2014-05-27,10.1038/nrurol.2014.124,,,,24861328,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2381521,https://api.altmetric.com/v1/donut/2381521_240.png 1,"Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.",Skeletal Radiology,,,Article,2014-05-20,10.1007/s00256-014-1903-9,,,,24841276,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2370473,https://api.altmetric.com/v1/donut/2370473_240.png 1,Florid Basal Cell Hyperplasia and Other Benign Mimics of Prostate Cancer,Pathology Case Reviews,,,Article,,10.1097/pcr.0000000000000038,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2364979,https://api.altmetric.com/v1/donut/2364979_240.png 1,MicroRNA?224 inhibits progression of human prostate cancer by downregulating TRIB1,International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.28707,,,,24382668,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2360192,https://api.altmetric.com/v1/donut/2360192_240.png 1,Development of cabozantinib for the treatment of prostate cancer [Corrigendum],Core Evidence,,,Article,2014-05-01,10.2147/ce.s67095,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2359949,https://api.altmetric.com/v1/donut/2359949_240.png 1,Re: TOOKAD® Soluble Vascular-Targeted Photodynamic (VTP) Therapy: Determination of Optimal Treatment Conditions and Assessment of Effects in Patients with Localised Prostate Cancer,The Journal of Urology,,,Article,2014-01-04,10.1016/j.juro.2014.01.075,,,,24703118,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2358698,https://api.altmetric.com/v1/donut/2358698_240.png 1,Re: Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer,The Journal of Urology,,,Article,2014-01-04,10.1016/j.juro.2014.01.074,,,,24703117,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2356867,https://api.altmetric.com/v1/donut/2356867_240.png 1,"Re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications. Eur Urol 2014;65:115–23",European Urology,,,Article,2014-08-01,10.1016/j.eururo.2014.04.017,,,,24830626,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2346538,https://api.altmetric.com/v1/donut/2346538_240.png 1,Future of bisphosphonates and denosumab for men with advanced prostate cancer,Cancer Management and Research,,,Article,2014-05-01,10.2147/cmar.s40151,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2331069,https://api.altmetric.com/v1/donut/2331069_240.png 1,Monoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.,ACS Chemical Biology,,,Article,2014-04-27,10.1021/cb500120x,,,,24762008,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2330081,https://api.altmetric.com/v1/donut/2330081_240.png 1,Immunotherapy for Prostate Cancer: Lessons from Responses to Tumor-Associated Antigens,Frontiers in immunology,,,Article,2014-04-17,10.3389/fimmu.2014.00191,,,,24834066,PMC4018526,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2329032,https://api.altmetric.com/v1/donut/2329032_240.png 1,Pattern of occult nodal relapse diagnosed with 18F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.,Radiotherapy & Oncology,,,Article,2014-04-26,10.1016/j.radonc.2014.03.008,,,,24780635,,,,,,,0,0,0,3,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2321304,https://api.altmetric.com/v1/donut/2321304_240.png 1,Development of cabozantinib for the treatment of prostate cancer,Core Evidence,,,Article,2014-04-01,10.2147/ce.s48498,,,,24790591,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2308301,https://api.altmetric.com/v1/donut/2308301_240.png 1,Association Between Penile Dynamic Contrast?Enhanced MRI?Derived Quantitative Parameters and Self?Reported Sexual Function in Patients with Newly Diagnosed Prostate Cancer,Journal of Sexual Medicine,,,Article,2014-04-23,10.1111/jsm.12555,,,,24754351,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2304113,https://api.altmetric.com/v1/donut/2304113_240.png 1,"A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting ?v Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy",European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.05.051,,,,23791392,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2297425,https://api.altmetric.com/v1/donut/2297425_240.png 1,Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancer.,Current opinion in oncology,,,Article,2014-05-01,10.1097/cco.0000000000000066,,,,24626129,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2291856,https://api.altmetric.com/v1/donut/2291856_240.png 1,Chronic inflammation may be linked to aggressive prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5570-chronic-inflammation-may-be-linked-to-aggressive-prostate-cancer.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2291610,https://api.altmetric.com/v1/donut/2291610_240.png 1,Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-resistant Prostate Cancer After Docetaxel-based Chemotherapy,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.09.005,,,,24099659,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/2290269,https://api.altmetric.com/v1/donut/2290269_240.png 1,"Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents ",Bioorganic & Medicinal Chemistry Letters,,,Article,2014-04-16,10.1016/j.bmcl.2014.03.073,,,,24731275,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2289807,https://api.altmetric.com/v1/donut/2289807_240.png 1,Neuropilin-1-Targeted Gold Nanoparticles Enhance Therapeutic Efficacy of Platinum(IV) Drug for Prostate Cancer Treatment.,ACS Nano,,,Article,2014-04-14,10.1021/nn500152u,,,,24730557,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2283377,https://api.altmetric.com/v1/donut/2283377_240.png 1,Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer,Frontiers in oncology,,,Article,2014-03-31,10.3389/fonc.2014.00079,,,,24782989,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2280616,https://api.altmetric.com/v1/donut/2280616_240.png 1,Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer,British Journal of Urology,,,Article,2014-04-10,10.1111/bju.12769,,,,24725760,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2273612,https://api.altmetric.com/v1/donut/2273612_240.png 1,Prostate cancer: Radiotherapy after surgery,Nature Reviews Urology,,,Article,2014-04-08,10.1038/nrurol.2014.82,,,,24709969,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2262724,https://api.altmetric.com/v1/donut/2262724_240.png 1,Reply from Authors re: Bertrand Tombal. Zometa European Study (ZEUS): Another Failed Crusade for the Holy Grail of Prostate Cancer Bone Metastases Prevention? Eur Urol. In press.: ZEUS: The Quest for the Holy Grail of Prostate Cancer Bone Metastases Prevention Continues,European Urology,,,Article,,10.1016/j.eururo.2014.03.027,,,,24726855,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2257403,https://api.altmetric.com/v1/donut/2257403_240.png 1,Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores.,European Urology,,,Article,2011-11-16,10.1016/j.eururo.2011.10.044,,,,22078338,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/2251198,https://api.altmetric.com/v1/donut/2251198_240.png 1,Hyperglycaemia-induced chemo-resistance of prostate cancer cells due to IGFBP-2.,Endocrine-Related Cancer,,,Article,2013-08-22,10.1530/erc-13-0077,,,,23959956,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2250841,https://api.altmetric.com/v1/donut/2250841_240.png 1,Evaluation of urinary prostate cancer antigen?3 (PCA3) and TMPRSS2?ERG score changes when starting androgen?deprivation therapy with triptorelin 6?month formulation in patients with locally advanced and metastatic prostate cancer,British Journal of Urology,,,Article,2014-04-04,10.1111/bju.12542,,,,24806330,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2246937,https://api.altmetric.com/v1/donut/2246937_240.png 1,Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody.,Journal of Nuclear Medicine,,,Article,2014-02-09,10.2967/jnumed.113.120873,,,,24504052,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2243749,https://api.altmetric.com/v1/donut/2243749_240.png 1,Association of DSC3 mRNA Down-Regulation in Prostate Cancer with Promoter Hypermethylation and Poor Prognosis.,PLoS ONE,,,Article,2014-03-27,10.1371/journal.pone.0092815,,,,24664224,PMC3963953,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2236191,https://api.altmetric.com/v1/donut/2236191_240.png 1,CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy,Cancer Research,,,Article,2014-02-03,10.1158/0008-5472.can-13-1659,,,,24491799,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2227156,https://api.altmetric.com/v1/donut/2227156_240.png 1,Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer,Journal of Nuclear Medicine,,,Article,2014-03-17,10.2967/jnumed.113.126979,,,,24639459,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2208540,https://api.altmetric.com/v1/donut/2208540_240.png 1,Prostate cancer: New data on risks of selenium and vitamin E,Nature Reviews Urology,,,Article,2014-03-11,10.1038/nrurol.2014.58,,,,24619375,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2197457,https://api.altmetric.com/v1/donut/2197457_240.png 1,Does family history of prostate cancer affect outcomes following radiotherapy?,Radiotherapy & Oncology,,,Article,2014-02-20,10.1016/j.radonc.2013.11.014,,,,24560758,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2195328,https://api.altmetric.com/v1/donut/2195328_240.png 1,Prostate cancer: Substratification of intermediate-risk disease using the current NCCN criteria,Nature Reviews Urology,,,Article,2014-03-18,10.1038/nrurol.2014.66,,,,24637419,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2193634,https://api.altmetric.com/v1/donut/2193634_240.png 1,Purposeful Normalization When Caring for Husbands Recovering From Prostate Cancer.,Qualitative Health Research,,,Article,2014-03-03,10.1177/1049732314523842,,,,24590418,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2170050,https://api.altmetric.com/v1/donut/2170050_240.png 1,Burden of Disease Matters When It Comes to Systemic Therapy for Prostate Cancer,European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.02.032,,,,24612662,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2162769,https://api.altmetric.com/v1/donut/2162769_240.png 1,ALCAM/CD166 Is a TGF-?–Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone,Cancer Research,,,Article,2014-01-02,10.1158/0008-5472.can-13-1296,,,,24385212,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2156788,https://api.altmetric.com/v1/donut/2156788_240.png 1,PHARMACOLOGICAL SUPPRESSION OF JAK1/2 BY JAK1/2 INHIBITOR AZD1480 POTENTLY INHIBITS IL-6-INDUCED EXPERIMENTAL PROSTATE CANCER METASTASES FORMATION.,Molecular Cancer Therapeutics,,,Article,2014-02-27,10.1158/1535-7163.mct-13-0605,,,,24577942,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2155504,https://api.altmetric.com/v1/donut/2155504_240.png 1,Re: Punctuated Evolution of Prostate Cancer Genomes,European Urology,,,Article,2014-03-01,10.1016/j.eururo.2013.11.022,,,,24484760,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2147257,https://api.altmetric.com/v1/donut/2147257_240.png 1,HOLMIUM LASER ENUCLEATION OF THE PROSTATE AND PERIOPERATIVE DIAGNOSIS OF PROSTATE CANCER: AN OUTCOMES ANALYSIS.,Journal of Endourology,,,Article,2014-02-05,10.1089/end.2014.0009,,,,24484284,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2146557,https://api.altmetric.com/v1/donut/2146557_240.png 1,New Treatments for Men with Castration-resistant Prostate Cancer: Can We Move from Small Steps to Giant Leaps?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.059,,,,24054873,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2145745,https://api.altmetric.com/v1/donut/2145745_240.png 1,Stratification of patients with intermediate?risk prostate cancer,British Journal of Urology,,,Article,2015-03-27,10.1111/bju.12703,,,,24612460,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2144042,https://api.altmetric.com/v1/donut/2144042_240.png 1,Melanoma of Non-Sun Exposed Skin in a Man with Previous Prostate Cancer: Recognition of a Recently Confirmed Association,Dermatology and Therapy,,,Article,2014-02-22,10.1007/s13555-014-0045-2,,,,24563423,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2141344,https://api.altmetric.com/v1/donut/2141344_240.png 1,Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.,British Journal of Urology,,,Article,2014-02-20,10.1111/bju.12554,,,,24712895,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2134250,https://api.altmetric.com/v1/donut/2134250_240.png 1,Visceral Disease in Castration-resistant Prostate Cancer ,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.10.055,,,,24295792,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2125118,https://api.altmetric.com/v1/donut/2125118_240.png 1,Re: Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance,European Urology,,,Article,2014-02-01,10.1016/j.eururo.2013.10.049,,,,24407205,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2125109,https://api.altmetric.com/v1/donut/2125109_240.png 1,Salvage Radical Prostatectomy in Nonmetastatic Castration-resistant Prostate Cancer Patients Who Received Previous Radiotherapy: A Feasibility Study,European Urology,,,Article,2014-01-01,10.1016/j.eururo.2013.08.050,,,,24012205,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2124878,https://api.altmetric.com/v1/donut/2124878_240.png 1,Overdiagnosis and Overtreatment of Prostate Cancer,European Urology,,,Article,2014-06-01,10.1016/j.eururo.2013.12.062,,,,24439788,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,120,https://www.altmetric.com/details/2124854,https://api.altmetric.com/v1/donut/2124854_240.png 1,"Reply to Bernard Tombal's Letter to the Editor re: Alessandro Sciarra, Per Anders Abrahamsson, Maurizio Brausi, et al. Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials. Eur Urol 2013;64:722–30",European Urology,,,Article,2014-04-01,10.1016/j.eururo.2013.12.015,,,,24388442,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2124833,https://api.altmetric.com/v1/donut/2124833_240.png 1,"Re: M. Minhaj Siddiqui, Soroush Rais-Bahrami, Hong Truong, et al. Magnetic Resonance Imaging/Ultrasound–Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy. Eur Urol 2013;64:713–9 and Re: Mark Emberton. Has Magnetic Resonance–Guided Biopsy of the Prostate Become the Standard of Care? Eur Urol 2013;64:720–1",European Urology,,,Article,,10.1016/j.eururo.2013.12.056,,,,24411989,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2124805,https://api.altmetric.com/v1/donut/2124805_240.png 1,"PC?SPES, a dietary supplement for the treatment of hormone?refractory prostate cancer",British Journal of Urology,,,Article,2000-01-01,10.1046/j.1464-410x.2000.00476.x,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2122350,https://api.altmetric.com/v1/donut/2122350_240.png 1,"Subditine, a New Monoterpenoid Indole Alkaloid from Bark of Nauclea subdita (Korth.) Steud. Induces Apoptosis in Human Prostate Cancer Cells",PLoS ONE,,,Article,2014-02-14,10.1371/journal.pone.0087286,,,,24551054,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2121546,https://api.altmetric.com/v1/donut/2121546_240.png 1,Aberrant Presentation of HPA-reactive Carbohydrates Implies Selectin-Independent Metastasis Formation in Human Prostate Cancer,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-2308,,,,24526735,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2120665,https://api.altmetric.com/v1/donut/2120665_240.png 1,Cofilin Drives Cell Invasive and Metastatic Responses to TGF-? in Prostate Cancer,Cancer Research,,,Article,2014-04-15,10.1158/0008-5472.can-13-3058,,,,24509905,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2107380,https://api.altmetric.com/v1/donut/2107380_240.png 1,Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments,Cancer Gene Therapy,,,Article,2014-01-10,10.1038/cgt.2013.77,,,,24407349,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2096156,https://api.altmetric.com/v1/donut/2096156_240.png 1,5-epi-Torrubiellutin C shows antiproliferative activity on DU145 prostate cancer cells through inactivation of the AKT/mTOR pathway,Anti-Cancer Drugs,,,Article,2014-01-18,10.1097/cad.0000000000000064,,,,24445589,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2057316,https://api.altmetric.com/v1/donut/2057316_240.png 1,The Economic Burden of Skeletal-Related Events Among Elderly Men with Metastatic Prostate Cancer.,PharmacoEconomics,,,Article,2014-01-17,10.1007/s40273-013-0121-y,,,,24435407,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2050554,https://api.altmetric.com/v1/donut/2050554_240.png 1,An incidence model of the cost of advanced prostate cancer in Spain.,Journal of Medical Economics,,,Article,2013-12-18,10.3111/13696998.2013.877020,,,,24350997,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2033685,https://api.altmetric.com/v1/donut/2033685_240.png 1,"Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients.",Medical Oncology,,,Article,2014-02-01,10.1007/s12032-013-0829-8,,,,24390417,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2028050,https://api.altmetric.com/v1/donut/2028050_240.png 1,Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer,Anti-Cancer Drugs,,,Article,2014-01-03,10.1097/cad.0000000000000072,,,,24394473,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2026482,https://api.altmetric.com/v1/donut/2026482_240.png 1,The Role of Prostatitis in Prostate Cancer: Meta-Analysis,PLoS ONE,,,Article,2013-12-31,10.1371/journal.pone.0085179,,,,24391995,,,,,,,0,0,0,1,0,0,1,0,0,0,1,0,0,0,0,10,https://www.altmetric.com/details/2014909,https://api.altmetric.com/v1/donut/2014909_240.png 1,Genetic Profiling to Determine Risk of Relapse Free Survival in High-risk Localized Prostate Cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1775,,,,24352642,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1992521,https://api.altmetric.com/v1/donut/1992521_240.png 1,"Re: Early Detection of Prostate Cancer: AUA Guideline: J. W. Moul, P. C. Walsh, M. S. Rendell, H. T. Lynch, S. W. Leslie, O. Kosoko-Lasaki, W. P. Fitzgibbons, I. Powell, A. V. D'Amico and W. J. Catalona J Urol 2013; 190: 1134–1139",The Journal of Urology,,,Article,2013-12-17,10.1016/j.juro.2013.08.113,,,,24355135,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1986157,https://api.altmetric.com/v1/donut/1986157_240.png 1,Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0081594,,,,24282613,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1975341,https://api.altmetric.com/v1/donut/1975341_240.png 1,Phosphorus Magnetic Resonance Spectroscopic Imaging at 7 T in Patients With Prostate Cancer,Investigative Radiology,,,Article,2013-12-10,10.1097/rli.0000000000000012,,,,24335715,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1973240,https://api.altmetric.com/v1/donut/1973240_240.png 1,Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers.,Biomarkers in cancer,,,Article,2011-01-01,10.4137/bic.s6484,,,,24179387,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1937783,https://api.altmetric.com/v1/donut/1937783_240.png 1,Prostate Sparing Cystectomy for Bladder Cancer: 20 Years Single Center Experience,The Journal of Urology,,,Article,2013-11-26,10.1016/j.juro.2013.11.031,,,,24286830,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1934878,https://api.altmetric.com/v1/donut/1934878_240.png 1,Does illness perception explain quality of life of patients with prostate cancer?,Medicina (Buenos Aires),,,Article,2013-01-01,,,,,24247920,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1924625,https://api.altmetric.com/v1/donut/1924625_240.png 1,"Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) Induces Apoptosis in LNCaP Prostate Cancer Cells",Toxins,,,Article,2013-01-01,10.3390/toxins5112241,,,,24284827,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1923928,https://api.altmetric.com/v1/donut/1923928_240.png 1,Re: The Prostate Cancer Prevention Trial Risk Calculator and the Relationship between Prostate-Specific Antigen and Biopsy Outcome,The Journal of Urology,,,Article,2013-11-18,10.1016/j.juro.2013.11.013,,,,24411854,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1913609,https://api.altmetric.com/v1/donut/1913609_240.png 1,Re: Long-Term Survival of Participants in the Prostate Cancer Prevention Trial,The Journal of Urology,,,Article,2013-11-18,10.1016/j.juro.2013.11.011,,,,24411852,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1913603,https://api.altmetric.com/v1/donut/1913603_240.png 1,A Comparative Study of Radiolabeled Bombesin Analogs for the PET Imaging of Prostate Cancer.,Journal of Nuclear Medicine,,,Article,2013-11-06,10.2967/jnumed.113.121533,,,,24198391,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1892221,https://api.altmetric.com/v1/donut/1892221_240.png 1,Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model,International Journal of Nanomedicine,,,Article,2013-11-01,10.2147/ijn.s51621,,,,24235831,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1882114,https://api.altmetric.com/v1/donut/1882114_240.png 1,Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling.,Cancer Research,,,Article,2013-10-31,10.1158/0008-5472.can-13-0594,,,,24177177,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1880387,https://api.altmetric.com/v1/donut/1880387_240.png 1,A Case of Small-cell Prostate Cancer with a Metastasis to the Scalp,Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/hyt165,,,,24186938,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1876254,https://api.altmetric.com/v1/donut/1876254_240.png 1,Advances in prostate cancer treatment,Nature Reviews Drug Discovery,,,Article,2013-10-31,10.1038/nrd4068,,,,24172327,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1872489,https://api.altmetric.com/v1/donut/1872489_240.png 1,"Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer",Advances in Urology,,,Article,2013-10-26,10.1155/2013/275945,,,,24159331,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1861021,https://api.altmetric.com/v1/donut/1861021_240.png 1,Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling,PLoS ONE,,,Article,2013-10-25,10.1371/journal.pone.0078881,,,,24205338,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1860414,https://api.altmetric.com/v1/donut/1860414_240.png 1,Featured in NEJM Journal Watch: Economic Considerations in Radiotherapy for Prostate Cancer,Journal Watch,,,Article,2013-10-24,10.1056/nejm-jw.fw108065,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1854743,https://api.altmetric.com/v1/donut/1854743_240.png 1,"Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer",Drugs,,,Article,2013-10-15,10.1007/s40265-013-0129-9,,,,24127223,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1851925,https://api.altmetric.com/v1/donut/1851925_240.png 1,Stat Bite Age Standardized lncidence Rates For Prostate Cancer (2008),JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djt080,,,,23492351,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1835133,https://api.altmetric.com/v1/donut/1835133_240.png 1,Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5year follow-up,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.05.038,,,,23849168,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1826939,https://api.altmetric.com/v1/donut/1826939_240.png 1,"Mechanism of Androgen Receptor Corepression by CKBP2/CRIF1, a Multifunctional Transcription Factor Coregulator Expressed in Prostate Cancer.",Molecular & Cellular Endocrinology,,,Article,2013-10-05,10.1016/j.mce.2013.09.036,,,,24103312,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1816307,https://api.altmetric.com/v1/donut/1816307_240.png 1,Molecular Imaging of Prostate Cancer with PET.,Journal of Nuclear Medicine,,,Article,2013-10-01,10.2967/jnumed.113.126094,,,,24084704,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1800555,https://api.altmetric.com/v1/donut/1800555_240.png 1,Denosumab as a promising novel bone-targeted agent in castration resistant prostate cancer.,Expert Opinion on Biological Therapy,,,Article,2013-09-27,10.1517/14712598.2013.840582,,,,24074253,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1788901,https://api.altmetric.com/v1/donut/1788901_240.png 1,Targeting Fibroblast Growth Factor Pathways in Prostate Cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1550,,,,24052019,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1769735,https://api.altmetric.com/v1/donut/1769735_240.png 1,Radium-223 chloride: extending life in prostate cancer patients by treating bone metastases,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1896,,,,24052017,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1769733,https://api.altmetric.com/v1/donut/1769733_240.png 1,"Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancerspecific death in patients receiving salvage radiation therapy following radical prostatectomy",Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28215,,,,23821578,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1734260,https://api.altmetric.com/v1/donut/1734260_240.png 1,Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections,BMC Cancer,,,Article,2013-09-05,10.1186/1471-2407-13-408,,,,24010502,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1730847,https://api.altmetric.com/v1/donut/1730847_240.png 1,MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent,Journal of Visualized Experiments,,,Article,2012-01-01,10.3791/50565,,,,24056726,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,https://www.altmetric.com/details/1727447,https://api.altmetric.com/v1/donut/1727447_240.png 1,Steroidogenic Enzyme AKR1C3 is a Novel Androgen Receptor-Selective Coactivator That Promotes Prostate Cancer Growth,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1151,,,,23995860,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1721324,https://api.altmetric.com/v1/donut/1721324_240.png 1,Characterization and clinical relevance of ALDHbright populations in prostate cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-2857,,,,23969936,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1706842,https://api.altmetric.com/v1/donut/1706842_240.png 1,Prostate Stem Cells in the Development of Benign Prostate Hyperplasia and Prostate Cancer: Emerging Role and Concepts,BioMed Research International,,,Article,2013-01-01,10.1155/2013/107954,,,,23936768,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1690339,https://api.altmetric.com/v1/donut/1690339_240.png 1,Survival for advanced prostate cancer 'triples' for men on trials,ecancer.org,,,Article,,,,,http://ecancer.org/news/4280-survival-for-advanced-prostate-cancer--triples--for-men-on-trials.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1669805,https://api.altmetric.com/v1/donut/1669805_240.png 1,Nanotechnology and Prostate Cancer,,,,Article,2013-01-01,10.1007/978-1-4471-2864-9_45,,,http://link.springer.com/chapter/10.1007%2F978-1-4471-2864-9_45,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1668024,https://api.altmetric.com/v1/donut/1668024_240.png 1,Incidental Detection of Leydig Cell Tumor Via Fluorine-18-Choline PET/CT in a Patient With Recurrent Prostate Cancer Disease.,Clinical Nuclear Medicine,,,Article,2013-07-17,10.1097/rlu.0b013e31829af8a6,,,,23856823,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1634349,https://api.altmetric.com/v1/donut/1634349_240.png 1,Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2008-01-01,10.1158/1055-9965.epi-07-0392,,,,18199713,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1621000,https://api.altmetric.com/v1/donut/1621000_240.png 1,Second primary cancers after radiation for prostate cancer: a review of data from planning studies,Radiation Oncology,,,Article,2013-07-08,10.1186/1748-717x-8-172,,,,23835163,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1618307,https://api.altmetric.com/v1/donut/1618307_240.png 1,Mutual regulation between Raf/MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-3705,,,,23838318,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1615090,https://api.altmetric.com/v1/donut/1615090_240.png 1,Perspectives on treatment of metastatic castration-resistant prostate cancer.,Oncologist,,,Article,2013-07-03,10.1634/theoncologist.2012-0478erratum,,,,23814165,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1605624,https://api.altmetric.com/v1/donut/1605624_240.png 1,Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy,Radiation Oncology,,,Article,2013-06-07,10.1186/1748-717x-8-137,,,,23759081,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1600552,https://api.altmetric.com/v1/donut/1600552_240.png 1,Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer,British Journal of Cancer,,,Article,2013-05-21,10.1038/bjc.2013.248,,,,23695019,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1599276,https://api.altmetric.com/v1/donut/1599276_240.png 1,The role of Câ??reactive protein in prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28211,,,,23817779,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1598002,https://api.altmetric.com/v1/donut/1598002_240.png 1,Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer.,The AAPS Journal,,,Article,2011-01-09,10.1208/s12248-011-9279-4,,,,21560017,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1585857,https://api.altmetric.com/v1/donut/1585857_240.png 1,Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-06-14,10.1016/j.ijrobp.2013.04.043,,,,23755923,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1578801,https://api.altmetric.com/v1/donut/1578801_240.png 1,"Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation",ClinicoEconomics and Outcomes Research: CEOR,,,Article,2013-06-01,10.2147/ceor.s44855,,,,23836996,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1578316,https://api.altmetric.com/v1/donut/1578316_240.png 1,Constructing higher-order miRNA-mRNA interaction networks in prostate cancer via hypergraph-based learning,BMC Systems Biology,,,Article,2013-06-19,10.1186/1752-0509-7-47,,,,23782521,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1572345,https://api.altmetric.com/v1/donut/1572345_240.png 1,Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion,Nature Genetics,,,Article,2013-06-02,10.1038/ng.2654,,,,23727861,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/1542404,https://api.altmetric.com/v1/donut/1542404_240.png 1,Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer,Journal of Medicinal Chemistry,,,Article,2013-06-07,10.1021/jm400048v,,,,23713567,PMC3959744,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1541200,https://api.altmetric.com/v1/donut/1541200_240.png 1,Early versus deferred androgen suppression therapy for patients with lymph node-positive prostate cancer after local therapy with curative intent: a systematic review,BMC Cancer,,,Article,2013-03-22,10.1186/1471-2407-13-131,,,,23510155,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1535652,https://api.altmetric.com/v1/donut/1535652_240.png 1,Change in PSA levels over time can predict aggressive prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28191,,,,23733607,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1533843,https://api.altmetric.com/v1/donut/1533843_240.png 1,99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer.,Journal of Nuclear Medicine,,,Article,2013-06-03,10.2967/jnumed.112.116624,,,,23733925,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1533520,https://api.altmetric.com/v1/donut/1533520_240.png 1,miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.,British Journal of Cancer,,,Article,2013-04-12,10.1038/bjc.2013.131,,,,23571738,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1531984,https://api.altmetric.com/v1/donut/1531984_240.png 1,Defining the threshold for significant versus insignificant prostate cancer,Nature Reviews Urology,,,Article,2013-05-28,10.1038/nrurol.2013.112,,,,23712205,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1517954,https://api.altmetric.com/v1/donut/1517954_240.png 1,Biochemical Response to Androgen Deprivation Therapy Before External Beam Radiation Therapy Predicts Long-term Prostate Cancer Survival Outcomes,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.02.004,,,,23523323,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1510232,https://api.altmetric.com/v1/donut/1510232_240.png 1,The genomic landscape of prostate cancer.,International Journal of Molecular Sciences,,,Article,2012-01-01,10.3390/ijms140610822,,,,23708091,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,82,https://www.altmetric.com/details/1503873,https://api.altmetric.com/v1/donut/1503873_240.png 1,Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy.,Radiotherapy & Oncology,,,Article,2013-05-21,10.1016/j.radonc.2013.04.007,,,,23684585,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1501695,https://api.altmetric.com/v1/donut/1501695_240.png 1,Immunohistochemical Expression of ERG in the Molecular Epidemiology of Fatal Prostate Cancer Study,The Prostate,,,Article,2013-01-01,10.1002/pros.22684,,,,23661613,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1495172,https://api.altmetric.com/v1/donut/1495172_240.png 1,ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-kB and drives prostate cancer progression.,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-4537,,,,23687337,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1483152,https://api.altmetric.com/v1/donut/1483152_240.png 1,Reducing rectal injury during external beam radiotherapy for prostate cancer,Nature Reviews Urology,,,Article,2013-05-14,10.1038/nrurol.2013.96,,,,23670182,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1481543,https://api.altmetric.com/v1/donut/1481543_240.png 1,Technology diffusion and diagnostic testing for prostate cancer,The Journal of Urology,,,Article,2013-05-13,10.1016/j.juro.2013.05.007,,,,23669564,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1470215,https://api.altmetric.com/v1/donut/1470215_240.png 1,"Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer",The Journal of Urology,,,Article,2013-05-10,10.1016/j.juro.2013.05.004,,,,23665271,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1463673,https://api.altmetric.com/v1/donut/1463673_240.png 1,Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results,Radiation Oncology,,,Article,2013-04-09,10.1186/1748-717x-8-84,,,,23570391,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1456147,https://api.altmetric.com/v1/donut/1456147_240.png 1,Is It Time to Reevaluate Definitive Therapy in Prostate Cancer?,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt094,,,,23615688,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1427810,https://api.altmetric.com/v1/donut/1427810_240.png 1,Diabetes mellitus and prostate cancer risk of different grade or stage: A systematic review and meta-analysis,Diabetes Research & Clinical Practice,,,Article,2013-01-01,10.1016/j.diabres.2012.12.003,,,,23298664,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1424210,https://api.altmetric.com/v1/donut/1424210_240.png 1,Percentage of Biopsy Cores Positive for Malignancy and Biochemical Failure Following Prostate Cancer Radiotherapy in 3264 Men: Statistical Significance Without Predictive Performance,Ultrasound quarterly,,,Article,2008-09-01,10.1097/01.ruq.0000335204.59842.b6,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1410411,https://api.altmetric.com/v1/donut/1410411_240.png 1,Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy,Current Opinion in Urology,,,Article,2013-05-01,10.1097/mou.0b013e32835e9ef4,,,,23385974,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1408575,https://api.altmetric.com/v1/donut/1408575_240.png 1,"Phyllanthus Suppresses Prostate Cancer Cell, PC-3, Proliferation and Induces Apoptosis through Multiple Signalling Pathways (MAPKs, PI3K/Akt, NFB, and Hypoxia)",Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2013-01-01,10.1155/2013/609581,,,,23690850,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1404712,https://api.altmetric.com/v1/donut/1404712_240.png 1,Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2005-10-11,10.1073/pnas.0505870102,,,,16192356,PMC1253570,,2005PNAS..10214813M,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,1,92,https://www.altmetric.com/details/1403089,https://api.altmetric.com/v1/donut/1403089_240.png 1,MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1? (HIF-1?) in Prostate Cancer Cells,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms14048422,,,,23594994,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1393792,https://api.altmetric.com/v1/donut/1393792_240.png 1,Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-04-06,10.1007/s00259-013-2398-7,,,,23564037,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1360953,https://api.altmetric.com/v1/donut/1360953_240.png 1,PMS1077 Sensitizes TNF-? Induced Apoptosis in Human Prostate Cancer Cells by Blocking NF-?B Signaling Pathway,PLoS ONE,,,Article,2013-04-09,10.1371/journal.pone.0061132,,,,23593410,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1360342,https://api.altmetric.com/v1/donut/1360342_240.png 1,Suppression of interactions between prostate tumor cell integrin ?v ?3 and endothelial ICAM-1 by simvastatin inhibits prostate cancer micrometastasis.,Journal of Cellular Physiology,,,Article,2013-04-05,10.1002/jcp.24381,,,,23559257,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1346323,https://api.altmetric.com/v1/donut/1346323_240.png 1,Altered DNA methylation landscapes of polycomb-repressed loci are associated with Gleason score and ERG oncogene expression in prostate cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-3139,,,,23549870,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1335882,https://api.altmetric.com/v1/donut/1335882_240.png 1,Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.,Expert Opinion on Investigational Drugs,,,Article,2013-04-01,10.1517/13543784.2013.787409,,,,23540855,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1332571,https://api.altmetric.com/v1/donut/1332571_240.png 1,Meta-analysis of Diffusion-Weighted Magnetic Resonance Imaging in Detecting Prostate Cancer,Journal of Computer Assisted Tomography,,,Article,1970-01-01,10.1097/rct.0b013e3182801ae1,,,,23493208,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1329531,https://api.altmetric.com/v1/donut/1329531_240.png 1,Trop-2 promotes prostate cancer metastasis by modulating ?1 integrin functions,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3266,,,,23536555,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1328747,https://api.altmetric.com/v1/donut/1328747_240.png 1,Transrectal quantitative shear wave elastography in the detection and characterisation of prostate cancer.,Surgical Endoscopy,,,Article,2013-03-23,10.1007/s00464-013-2906-7,,,,23525883,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1321715,https://api.altmetric.com/v1/donut/1321715_240.png 1,Genes associated with prostate cancer are differentially expressed in African American and European American men,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-01-01,10.1158/1055-9965.epi-12-1238,,,,23515145,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1318716,https://api.altmetric.com/v1/donut/1318716_240.png 1,"Hsp27 regulates epithelial mesenchymal transition, metastasis and circulating tumor cells in prostate cancer",Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3979,,,,23492367,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/1302326,https://api.altmetric.com/v1/donut/1302326_240.png 1,Effect of Erythropoietin on Bone Marrow Uptake of 18F-Fluorocholine in Prostate Cancer: Comparison With 18F-Fluoride Uptake,Clinical Nuclear Medicine,,,Article,2013-03-01,10.1097/rlu.0b013e31827a2294,,,,23354033,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1272367,https://api.altmetric.com/v1/donut/1272367_240.png 1,The Role of Radical Prostatectomy in Patients with Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djt040,,,,,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1268368,https://api.altmetric.com/v1/donut/1268368_240.png 1,Magnetic Resonance Imaging (MRI) Markers for MRI-Guided High-Dose-Rate Brachytherapy: Novel Marker-Flange for Cervical Cancer and Marker Catheters for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-02-21,10.1016/j.ijrobp.2012.12.026,,,,23433797,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1265102,https://api.altmetric.com/v1/donut/1265102_240.png 1,The endocrine fibroblast growth factor FGF19 promotes prostate cancer progression,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-4108,,,,23440425,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1264481,https://api.altmetric.com/v1/donut/1264481_240.png 1,1.5-T Magnetic Resonance-Guided Transgluteal Biopsies of the Prostate in Patients With Clinically Suspected Prostate Cancer: Technique and Feasibility,Investigative Radiology,,,Article,2013-02-08,10.1097/rli.0b013e31827c394b,,,,23385402,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1255451,https://api.altmetric.com/v1/donut/1255451_240.png 1,Prostate Cancer Debate 2013; Evolving treatment options in castration-resistant prostate cancer. Prostate Cancer Debate 2013; Evolving treatment options in castration-resistant prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/1854/prostate-cancer-debate-2013--evolving-treatment-options-in-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251488,https://api.altmetric.com/v1/donut/1251488_240.png 1,ASCO 2012: Metastatic castration-resistant prostate cancer;abiraterone acetate COU-AA-302 study. ASCO 2012: Metastaticcastration-resistant prostate cancer; abiraterone acetateCOU-AA-302 study. ecancer.tv - Essential viewing foroncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/1463/asco-2012--metastatic-castration-resistant-prostate-cancer--abiraterone-acetate-cou-aa-302-study.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251264,https://api.altmetric.com/v1/donut/1251264_240.png 1,SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer,Osteoporosis International,,,Article,2012-05-16,10.1007/s00198-012-2012-z,,,,22588185,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1242131,https://api.altmetric.com/v1/donut/1242131_240.png 1,Feasibility of 3T Dynamic Contrast-Enhanced Magnetic Resonance-Guided Biopsy in Localizing Local Recurrence of Prostate Cancer After External Beam Radiation Therapy,Investigative Radiology,,,Article,2010-03-01,10.1097/rli.0b013e3181c7bcda,,,,20065860,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1240662,https://api.altmetric.com/v1/donut/1240662_240.png 1,Chemotherapy for prostate cancer: when should a urologist refer a patient to a medical oncologist|[quest]|,Prostate Cancer & Prostatic Diseases,,,Article,2012-07-03,10.1038/pcan.2012.23,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1236322,https://api.altmetric.com/v1/donut/1236322_240.png 1,Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study,Prostate Cancer & Prostatic Diseases,,,Article,2012-08-21,10.1038/pcan.2012.33,,,,22907511,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1236117,https://api.altmetric.com/v1/donut/1236117_240.png 1, Radium-223 for the treatment of prostate cancer,Expert Opinion on Investigational Drugs,,,Article,2013-01-17,10.1517/13543784.2013.761974,,,,23316941,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1233823,https://api.altmetric.com/v1/donut/1233823_240.png 1,DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion,Oncogene,,,Article,2013-02-04,10.1038/onc.2013.7,,,,23376848,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1231978,https://api.altmetric.com/v1/donut/1231978_240.png 1,Prostate Brachytherapy: The â??Can't Missâ?? Approach for Patients Undergoing Definitive Radiation for Prostate Cancer?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2012.09.002,,,,23374989,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1213910,https://api.altmetric.com/v1/donut/1213910_240.png 1,Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site,Molecular Cancer,,,Article,2013-02-01,10.1186/1476-4598-12-7,,,,23369005,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1213478,https://api.altmetric.com/v1/donut/1213478_240.png 1,Castration therapy results in decreased Ku70 levels in prostate cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-2795,,,,23349316,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1197115,https://api.altmetric.com/v1/donut/1197115_240.png 1,Early growth response 3 (egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0054096,,,,23342084,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1195131,https://api.altmetric.com/v1/donut/1195131_240.png 1,"Insulinâ??like growth factor pathway genes and blood concentrations, dietary protein, and risk of prostate cancer in the NCI breast and prostate cancer cohort consortium (BPC3)",International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.28042,,,,23341348,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1193483,https://api.altmetric.com/v1/donut/1193483_240.png 1,From bevacizumab to tasquinimod: angiogenesis as a therapeutic target in prostate cancer.,Cancer Journal,,,Article,2013-01-01,10.1097/ppo.0b013e31827e0b86,,,,23337763,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1192369,https://api.altmetric.com/v1/donut/1192369_240.png 1,Targeting MET and Vascular Endothelial Growth Factor Receptor Signaling in Castration-Resistant Prostate Cancer.,Cancer Journal,,,Article,2013-01-01,10.1097/ppo.0b013e318281e280,,,,23337762,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1192368,https://api.altmetric.com/v1/donut/1192368_240.png 1,Caveolin-1-LRP6 Signaling Module Stimulates Aerobic Glycolysis in Prostate Cancer,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3040,,,,23302227,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1184900,https://api.altmetric.com/v1/donut/1184900_240.png 1,Cardiovascular Comorbidity and Mortality in Men With Prostate Cancer Treated With Brachytherapy-based Radiation With or Without Hormonal Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-16,10.1016/j.ijrobp.2012.11.039,,,,23332383,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1179548,https://api.altmetric.com/v1/donut/1179548_240.png 1,Intermittent and continuous androgen deprivation did not differ for mortality after radiotherapy for prostate cancer.,Annals of Internal Medicine,,,Article,2013-01-15,10.7326/0003-4819-158-2-201301150-02009,,,,23318343,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1179049,https://api.altmetric.com/v1/donut/1179049_240.png 1,Selenium and Prostate Cancer: Where Do We Go From Here?,Clinical Nutrition Insight,,,Article,2013-01-01,10.1097/01.nmd.0000425970.53249.9a,,,,,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1177804,https://api.altmetric.com/v1/donut/1177804_240.png 1,Prostate cancer in 2012: Paradigm shifts in prostate cancer diagnosis and treatment,Nature Reviews Urology,,,Article,2013-01-08,10.1038/nrurol.2012.251,,,,23295236,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1161216,https://api.altmetric.com/v1/donut/1161216_240.png 1,Effect of Whole Pelvic Radiotherapy for Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy and Long-Term Androgen Deprivation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2010.12.003,,,,21277100,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1158736,https://api.altmetric.com/v1/donut/1158736_240.png 1,PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.,Biomaterials,,,Article,2012-11-29,10.1016/j.biomaterials.2012.10.073,,,,23182923,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1155003,https://api.altmetric.com/v1/donut/1155003_240.png 1,"Cancer in M?ori: lessons from prostate, colorectal and gastric cancer and progress in hereditary stomach cancer in New Zealand.",Australian & New Zealand Journal of Surgery,,,Article,2012-12-20,10.1111/ans.12042,,,,23279256,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1152049,https://api.altmetric.com/v1/donut/1152049_240.png 1,Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin k3 and ascorbate to trigger cell death.,PLoS ONE,,,Article,2012-12-29,10.1371/journal.pone.0052263,,,,23272231,PMC3525640,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1149233,https://api.altmetric.com/v1/donut/1149233_240.png 1,Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells,Oncogene,,,Article,2012-12-17,10.1038/onc.2012.561,,,,23246967,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1137508,https://api.altmetric.com/v1/donut/1137508_240.png 1,Differing perceptions of quality of life in patients with prostate cancer and their doctors.,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.11.032,,,,23234635,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1135958,https://api.altmetric.com/v1/donut/1135958_240.png 1,Adaptation or selection|[mdash]|mechanisms of castration-resistant prostate cancer,Nature Reviews Urology,,,Article,2012-12-18,10.1038/nrurol.2012.237,,,,23247694,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1131493,https://api.altmetric.com/v1/donut/1131493_240.png 1,Effect of an all-trans-retinoic acid conjugate with spermine on viability of human prostate cancer and endothelial cells in vitro and angiogenesis in vivo,European Journal of Pharmacology,,,Article,2012-11-01,10.1016/j.ejphar.2012.11.007,,,,23178525,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1095473,https://api.altmetric.com/v1/donut/1095473_240.png 1,The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer.,Radiotherapy & Oncology,,,Article,2012-11-22,10.1016/j.radonc.2012.09.020,,,,23182057,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1094332,https://api.altmetric.com/v1/donut/1094332_240.png 1,The Role of Genetic Markers in the Management of Prostate Cancer ,European Urology,,,Article,2012-06-16,10.1016/j.eururo.2012.05.054,,,,22695242,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1093899,https://api.altmetric.com/v1/donut/1093899_240.png 1,Vitamin D and prostate cancer prevention and treatment.,Trends in Endocrinology & Metabolism,,,Article,2003-01-11,,,,,14580762,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1089875,https://api.altmetric.com/v1/donut/1089875_240.png 1,Measuring Oncogenic Signaling Pathways in Cancer with PET: An Emerging Paradigm from Studies in Castration-Resistant Prostate Cancer,Cancer Discovery,,,Article,2012-01-01,10.1158/2159-8290.cd-12-0178,,,,23043150,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1083521,https://api.altmetric.com/v1/donut/1083521_240.png 1,Prostate Cancer Aggressiveness: In Vivo Assessment of MR Spectroscopy and Diffusion-weighted Imaging at 3 T,Radiology,,,Article,2012-01-01,10.1148/radiol.12111744,,,,22843767,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1076933,https://api.altmetric.com/v1/donut/1076933_240.png 1,Responding to a Diagnosis of Localized Prostate Cancer: Men's Experiences of Normal Distress During the First 3 Postdiagnostic Months,Cancer nursing (Online),,,Article,2012-11-14,10.1097/ncc.0b013e3182747bef,,,,23154517,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1073672,https://api.altmetric.com/v1/donut/1073672_240.png 1,Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer.,Radiotherapy & Oncology,,,Article,2012-11-08,10.1016/j.radonc.2012.09.018,,,,23127770,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1068134,https://api.altmetric.com/v1/donut/1068134_240.png 1,An inherited NBN mutation is associated with poor prognosis prostate cancer,British Journal of Cancer,,,Article,2012-11-13,10.1038/bjc.2012.486,,,,23149842,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1067352,https://api.altmetric.com/v1/donut/1067352_240.png 1,Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics,PLoS ONE,,,Article,2012-11-12,10.1371/journal.pone.0048889,,,,23152813,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/1064855,https://api.altmetric.com/v1/donut/1064855_240.png 1,Downregulation and Prognostic Performance of MicroRNA 224 Expression in Prostate Cancer,Clinical Chemistry,,,Article,2013-01-01,10.1373/clinchem.2012.191502,,,,23136246,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1064505,https://api.altmetric.com/v1/donut/1064505_240.png 1,Common genetic variation of the calcium sensing receptor and lethal prostate cancer risk,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-01-01,10.1158/1055-9965.epi-12-0670-t,,,,23125333,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1061941,https://api.altmetric.com/v1/donut/1061941_240.png 1,Dendritic Cell-Directed Vaccination with a Lentivector Encoding PSCA for Prostate Cancer in Mice,PLoS ONE,,,Article,2012-11-06,10.1371/journal.pone.0048866,,,,23139820,PMC3490948,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1052547,https://api.altmetric.com/v1/donut/1052547_240.png 1,Rectal Toxicity 7 Years After High-dose Radiation for Prostate Cancer: Clinical and Dosimetric Predictors,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.07.044,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1048270,https://api.altmetric.com/v1/donut/1048270_240.png 1,SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis,Oncogene,,,Article,2012-01-16,10.1038/onc.2011.612,,,,22249256,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/1040228,https://api.altmetric.com/v1/donut/1040228_240.png 1,Polymorphisms in Thioredoxin Reductase and Selenoprotein K Genes and Selenium Status Modulate Risk of Prostate Cancer,PLoS ONE,,,Article,2012-11-01,10.1371/journal.pone.0048709,,,,23133653,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1039022,https://api.altmetric.com/v1/donut/1039022_240.png 1,The Enzymatic Activity of Apoptosis Inducing Factor Supports Energy Metabolism Benefitting the Growth and Invasiveness of Advanced Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2012-01-01,10.1074/jbc.m112.407650,,,,23118229,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1036809,https://api.altmetric.com/v1/donut/1036809_240.png 1,The impact of doseâ??escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.27857,,,,23096533,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1021970,https://api.altmetric.com/v1/donut/1021970_240.png 1,Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.,Oncogene,,,Article,2012-10-18,10.1038/onc.2012.425,,,,23069658,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1014973,https://api.altmetric.com/v1/donut/1014973_240.png 1,Targeting the oncogenic e3 ligase skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.,PLoS ONE,,,Article,2012-10-17,10.1371/journal.pone.0047298,,,,23071779,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1011376,https://api.altmetric.com/v1/donut/1011376_240.png 1,Remission of hormone-refractory prostate cancer attributed to Essiac.,Canadian Journal of Urology,,,Article,2005-01-10,,,,,16274521,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1000083,https://api.altmetric.com/v1/donut/1000083_240.png 1,Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 T: Unbiased Cancer Identification by Matching to Histopathology,Investigative Radiology,,,Article,2012-09-24,10.1097/rli.0b013e318263f0fd,,,,23011187,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/968966,https://api.altmetric.com/v1/donut/968966_240.png 1,TRAIL and /or Noxa are selectively up-regulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by non-replicating Sendai virus particles,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-1595,,,,23014529,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/968617,https://api.altmetric.com/v1/donut/968617_240.png 1,Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer,Journal of Biological Chemistry,,,Article,2012-01-01,10.1074/jbc.m112.389015,,,,22989880,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/959541,https://api.altmetric.com/v1/donut/959541_240.png 1,Intensity Modulated Proton and Photon Therapy for Early Prostate Cancer With or Without Transperineal Injection of a Polyethylen Glycol Spacer: A Treatment Planning Comparison Study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.03.028,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/959089,https://api.altmetric.com/v1/donut/959089_240.png 1,Upon the tightrope in prostate cancer: two acrobats on the same tightrope to cross the finishline.,Molecular and Cellular Biochemistry,,,Article,2011-12-29,10.1007/s11010-011-1204-8,,,,22200977,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/958084,https://api.altmetric.com/v1/donut/958084_240.png 1,"Urology Meeting Highlights Prostate, Bladder Cancers",JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djs405,,,,22984200,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/951900,https://api.altmetric.com/v1/donut/951900_240.png 1,Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort,Cancer Prevention Research,,,Article,2012-01-01,10.1158/1940-6207.capr-12-0171,,,,22961777,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/948833,https://api.altmetric.com/v1/donut/948833_240.png 1,"Talking About Sexuality: Desire, Virility, and Intimacy in the Context of Prostate Cancer Associations.",American Journal of Men's Health,,,Article,2012-09-08,10.1177/1557988312458143,,,,22954556,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/943198,https://api.altmetric.com/v1/donut/943198_240.png 1,"Notch Activation Is Dispensable for D, L-Sulforaphane-Mediated Inhibition of Human Prostate Cancer Cell Migration",PLoS ONE,,,Article,2012-09-07,10.1371/journal.pone.0044957,,,,22970326,PMC3436754,,,,,,0,0,0,1,0,0,5,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/935168,https://api.altmetric.com/v1/donut/935168_240.png 1,A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection.,BMC Urology,,,Article,2012-06-06,10.1186/1471-2490-12-16,,,,22672250,,1854/LU-3168785,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/921203,https://api.altmetric.com/v1/donut/921203_240.png 1,In Regard to Modeling the Data Collected From a Large Extended Pelvic Lymph Node Dissection Series: Predicting the Risk of Nodal Metastasis for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.04.027,,,,22901418,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/915129,https://api.altmetric.com/v1/donut/915129_240.png 1,Oncology Scan â?? Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/s0360-3016(12)00817-6,,,,22776702,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/914900,https://api.altmetric.com/v1/donut/914900_240.png 1,Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis,Oncogene,,,Article,2012-08-13,10.1038/onc.2012.309,,,,22890325,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/892671,https://api.altmetric.com/v1/donut/892671_240.png 1,Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12â??year followâ??up study,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10924.x,,,,22300458,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/892513,https://api.altmetric.com/v1/donut/892513_240.png 1,Androgen Receptor Antagonism by Divalent Ethisterone Conjugates in Castrate-Resistant Prostate Cancer Cells.,ACS Chemical Biology,,,Article,2012-08-10,10.1021/cb300332w,,,,22871957,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/884171,https://api.altmetric.com/v1/donut/884171_240.png 1,Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer.,Cancer (0008543X),,,Article,1993-02-01,,,,,7679045,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/860116,https://api.altmetric.com/v1/donut/860116_240.png 1,Bevacizumab treatment of prostate cancer.,Expert Opinion on Biological Therapy,,,Article,2012-07-09,10.1517/14712598.2012.704015,,,,22775507,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/834996,https://api.altmetric.com/v1/donut/834996_240.png 1,Inducible Silencing of Protein Kinase D3 Inhibits Secretion of Tumor-Promoting Factors in Prostate Cancer,Molecular Cancer Therapeutics,,,Article,2012-01-01,10.1158/1535-7163.mct-11-0887,,,,22532599,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/827670,https://api.altmetric.com/v1/donut/827670_240.png 1,Polyphenols: Key Issues Involved in Chemoprevention of Prostate Cancer,Oxidative Medicine & Cellular Longetivity,,,Article,2012-07-05,10.1155/2012/632959,,,,22690272,PMC3368543,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/824459,https://api.altmetric.com/v1/donut/824459_240.png 1,Monascuspiloin Enhances the Radiation Sensitivity of Human Prostate Cancer Cells by Stimulating Endoplasmic Reticulum Stress and Inducing Autophagy,PLoS ONE,,,Article,2012-07-03,10.1371/journal.pone.0040462,,,,22802963,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/821318,https://api.altmetric.com/v1/donut/821318_240.png 1,"Indications For and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial",American Journal of Epidemiology,,,Article,2012-01-01,10.1093/aje/kwr524,,,,22759721,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/819983,https://api.altmetric.com/v1/donut/819983_240.png 1,Steroids with inhibitory activity against the prostate cancer cells and chemical diversity of marine alga Tydemania expeditionis ,Fitoterapia,,,Article,2012-05-10,10.1016/j.fitote.2012.04.019,,,,22561913,,,,,,,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,3,https://www.altmetric.com/details/819340,https://api.altmetric.com/v1/donut/819340_240.png 1,Late gastrointestinal and urogenital side-effects after radiotherapy - Incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer.,Radiotherapy & Oncology,,,Article,2012-06-26,10.1016/j.radonc.2012.05.007,,,,22727264,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/814357,https://api.altmetric.com/v1/donut/814357_240.png 1,"Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-Blind, Placebo-Controlled Trial",The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.03.102,,,,22682825,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/804463,https://api.altmetric.com/v1/donut/804463_240.png 1,Colour Doppler and Microbubble Contrast Agent Ultrasonography Do Not Improve Cancer Detection Rate in Transrectal Systematic Prostate Biopsy Sampling,Ultrasound quarterly,,,Article,2012-06-01,10.1097/01.ruq.0000415527.59505.f5,,,,22634780,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/795743,https://api.altmetric.com/v1/donut/795743_240.png 1,The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: An analysis of the 4- versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01).,Radiotherapy & Oncology,,,Article,2012-06-08,10.1016/j.radonc.2012.05.001,,,,22682750,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/793535,https://api.altmetric.com/v1/donut/793535_240.png 1,Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer,Radiation Oncology,,,Article,2012-06-12,10.1186/1748-717x-7-87,,,,22691293,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/793512,https://api.altmetric.com/v1/donut/793512_240.png 1,Factors Associated With Prostate Cancer Patients' and Their Spouses' Satisfaction With a Family-Based Intervention,Cancer nursing (Online),,,Article,1970-01-01,10.1097/ncc.0b013e3181b311e9,,,,19816159,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/789615,https://api.altmetric.com/v1/donut/789615_240.png 1,Flavonoid Ampelopsin Inhibits the Growth and Metastasis of Prostate Cancer In Vitro and in Mice,PLoS ONE,,,Article,2012-06-05,10.1371/journal.pone.0038802,,,,22693649,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/778242,https://api.altmetric.com/v1/donut/778242_240.png 1,New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.,Cancer Biology and Therapy,,,Article,2011-12-02,,,,,22130093,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/776062,https://api.altmetric.com/v1/donut/776062_240.png 1,Angiotensinâ??(1â??7) attenuates metastatic prostate cancer and reduces osteoclastogenesis,The Prostate,,,Article,2012-01-01,10.1002/pros.22542,,,,22644942,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/767289,https://api.altmetric.com/v1/donut/767289_240.png 1,Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy,Advances in Urology,,,Article,2012-01-01,10.1155/2012/921674,,,,22693495,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/764980,https://api.altmetric.com/v1/donut/764980_240.png 1,The bioactive compounds alpha-chaconine and gallic acid in potato extracts decrease survival and induce apoptosis in LNCaP and PC3 prostate cancer cells.,Nutrition and Cancer,,,Article,2009-12-31,10.1080/01635580903532358,,,,20574921,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/763904,https://api.altmetric.com/v1/donut/763904_240.png 1,[PSA-screening for prostate cancer--yes or no?].,Therapeutische Umschau,,,Article,2004-07-16,,,,,15253159,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/762981,https://api.altmetric.com/v1/donut/762981_240.png 1,Epigenetic markers of prostate cancer in plasma circulating DNA.,Human Molecular Genetics,,,Article,2012-05-22,10.1093/hmg/dds192,,,,22619380,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/759525,https://api.altmetric.com/v1/donut/759525_240.png 1,Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.07.005,,,,22079736,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/749759,https://api.altmetric.com/v1/donut/749759_240.png 1,In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line,Journal of Experimental & Clinical Cancer Research,,,Article,2012-01-01,10.1186/1756-9966-31-40,,,,22549243,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/724555,https://api.altmetric.com/v1/donut/724555_240.png 1,Biochemical Control With Radiotherapy Improves Overall Survival in Intermediate and High-Risk Prostate Cancer Patients Who Have an Estimated 10-Year Overall Survival of >90%,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.05.076,,,,22079724,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/706104,https://api.altmetric.com/v1/donut/706104_240.png 1,Adverse effects of prolactin in rodents and humans: breast and prostate cancer,Journal of Psychopharmacology,,,Article,2008-08-20,10.1177/0269881107082624,,,,18709700,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/702832,https://api.altmetric.com/v1/donut/702832_240.png 1,Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects.,Journal of Sexual Medicine,,,Article,2012-03-01,10.1111/j.1743-6109.2011.02590.x,,,,22248394,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/693728,https://api.altmetric.com/v1/donut/693728_240.png 1,Q Fever masquerading as prostate cancer metastases.,Clinical Nuclear Medicine,,,Article,2012-04-06,10.1097/rlu.0b013e31823ea70a,,,,22475908,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/687192,https://api.altmetric.com/v1/donut/687192_240.png 1,Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-11-2711,,,,22465832,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/675529,https://api.altmetric.com/v1/donut/675529_240.png 1,Radiotherapy Doses of 80 Gy and Higher Are Associated With Lower Mortality in Men With Gleason Score 8 to 10 Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.04.005,,,,21763081,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/660241,https://api.altmetric.com/v1/donut/660241_240.png 1,Does Local Recurrence of Prostate Cancer After Radiation Therapy Occur at the Site of Primary Tumor? Results of a Longitudinal MRI and MRSI Study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.11.030,,,,22331003,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/656495,https://api.altmetric.com/v1/donut/656495_240.png 1,Effect of Dietary Vitamin D and Calcium on the Growth of Androgen-insensitive Human Prostate Tumor in a Murine Model.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2012-03-01,,,,,22399584,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/642282,https://api.altmetric.com/v1/donut/642282_240.png 1,Contrast-Enhanced Ultrasonography for the Detection and Characterization of Prostate Cancer: Correlation With Microvessel Density and Gleason Score,Ultrasound quarterly,,,Article,2012-03-01,10.1097/01.ruq.0000412986.42964.2f,,,,22357243,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/641565,https://api.altmetric.com/v1/donut/641565_240.png 1,A Treatment Planning and Acute Toxicity Comparison of Two Pelvic Nodal Volume Delineation Techniques and Delivery Comparison of Intensity-Modulated Radiotherapy Versus Volumetric Modulated Arc Therapy for Hypofractionated High-Risk Prostate Cancer Radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.09.006,,,,22245189,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/635277,https://api.altmetric.com/v1/donut/635277_240.png 1,Nitrosamines and heme iron and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-20,10.1158/1055-9965.epi-11-1181,,,,22253298,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/630236,https://api.altmetric.com/v1/donut/630236_240.png 1,Psychosocial Adjustment of Men During the First Year of Prostate Cancer,Cancer Nursing,,,Article,1970-01-01,10.1097/ncc.0b013e31821f1b81,,,,21760494,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/623907,https://api.altmetric.com/v1/donut/623907_240.png 1,Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience,BMC Urology,,,Article,2012-02-22,10.1186/1471-2490-12-3,,,,22353627,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/615179,https://api.altmetric.com/v1/donut/615179_240.png 1,A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer,Nutrition Research,,,Article,2011-01-01,10.1016/j.nutres.2011.01.002,,,,21310299,,,,,,,0,0,0,0,0,0,2,0,0,0,1,0,0,0,0,29,https://www.altmetric.com/details/610051,https://api.altmetric.com/v1/donut/610051_240.png 1,Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era,"Journal of Urology, The",,,Article,2012-02-15,10.1016/j.juro.2011.11.084,,,,22335870,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/608390,https://api.altmetric.com/v1/donut/608390_240.png 1,"Growth Inhibitory, Antiandrogenic, and Pro-apoptotic Effects of Punicic Acid in LNCaP Human Prostate Cancer Cells.",Journal of Agricultural & Food Chemistry,,,Article,2010-11-13,10.1021/jf103306k,,,,21067181,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/607091,https://api.altmetric.com/v1/donut/607091_240.png 1,"Socioeconomic, Rural-Urban, and Racial Inequalities in US Cancer Mortality: Part I—All Cancers and Lung Cancer and Part II—Colorectal, Prostate, Breast, and Cervical Cancers",Journal of Cancer Epidemiology,,,Article,2011-01-01,10.1155/2011/107497,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/605461,https://api.altmetric.com/v1/donut/605461_240.png 1,Prostate cancer pain management: EAU guidelines on pain management,World Journal of Urology,,,Article,2012-02-09,10.1007/s00345-012-0825-1,,,,22318612,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/599081,https://api.altmetric.com/v1/donut/599081_240.png 1,Rubin h. Flocks and colloidal gold treatments for prostate cancer.,The Scientific World Journal,,,Article,2012-01-11,10.1100/tsw.2011.145,,,,22224070,PMC3201627,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/598509,https://api.altmetric.com/v1/donut/598509_240.png 1,Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer.,Advances in virology,,,Article,2011-01-01,10.1155/2011/341294,,,,22315600,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/596583,https://api.altmetric.com/v1/donut/596583_240.png 1,Prostate cancer: Making the switch from LHRH antagonist to LHRH agonist,Nature Reviews Urology,,,Article,2012-01-31,10.1038/nrurol.2012.5,,,,22289702,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/584626,https://api.altmetric.com/v1/donut/584626_240.png 1,An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice,Disease Models and Mechanisms,,,Article,2012-01-01,10.1242/dmm.008458,,,,22279083,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/579962,https://api.altmetric.com/v1/donut/579962_240.png 1,Automated lymph node detection and classification on breast and prostate cancer SPECT-CT images.,Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference,,,Article,2011-08-01,10.1109/iembs.2011.6090928,,,,22255077,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/566122,https://api.altmetric.com/v1/donut/566122_240.png 1,Prostate cancer in Germany among migrants from the Former Soviet Union,Global Health Action,,,Article,2012-01-16,10.3402/gha.v5i0.9135,,,,22229025,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/561639,https://api.altmetric.com/v1/donut/561639_240.png 1,Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: A novel therapeutic modality.,Cell Cycle,,,Article,2012-01-10,,,,,22223138,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/557223,https://api.altmetric.com/v1/donut/557223_240.png 1,The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study,BMJ Open,,,Article,2012-01-01,10.1136/bmjopen-2011-000587,,,,22226686,,11541.2/115325,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/554446,https://api.altmetric.com/v1/donut/554446_240.png 1,Trends in Chinese Medicine Use Among Prostate Cancer Patients Under National Health Insurance in Taiwan,Integrative Cancer Therapies,,,Article,2011-01-01,10.1177/1534735410392576,,,,21382965,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/537523,https://api.altmetric.com/v1/donut/537523_240.png 1,"Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants – In vivo evidence",Journal of Carcinogenesis,,,Article,2011-12-28,10.4103/1477-3163.90438,,,,22190869,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/509796,https://api.altmetric.com/v1/donut/509796_240.png 1,"Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment.",Cancer imaging : the official publication of the International Cancer Imaging Society,,,Article,2011-01-01,10.1102/1470-7330.2011.9003,,,,22187023,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/508155,https://api.altmetric.com/v1/donut/508155_240.png 1,Prostate cancer: localizing the cancer in patients with persistent negative biopsies.,Cancer imaging : the official publication of the International Cancer Imaging Society,,,Article,2011-01-01,10.1102/1470-7330.2011.9001,,,,22187006,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/508154,https://api.altmetric.com/v1/donut/508154_240.png 1,Principal Component Analysis of Dynamic Contrast Enhanced MRI in Human Prostate Cancer,Investigative Radiology,,,Article,2010-04-01,10.1097/rli.0b013e3181d0a02f,,,,20177391,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/507327,https://api.altmetric.com/v1/donut/507327_240.png 1,Epigenetics in prostate cancer.,Prostate cancer,,,Article,2011-01-01,10.1155/2011/580318,,,,22191037,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/505513,https://api.altmetric.com/v1/donut/505513_240.png 1,The role of Melancholia in prostate cancer patients' depression,BMC Psychiatry,,,Article,2011-12-20,10.1186/1471-244x-11-201,,,,22185620,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/505198,https://api.altmetric.com/v1/donut/505198_240.png 1,Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer,BMC Bioinformatics,,,Article,2011-12-21,10.1186/1471-2105-12-488,,,,22188670,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/502480,https://api.altmetric.com/v1/donut/502480_240.png 1,Andropause Syndrome in Men Treated for Metastatic Prostate Cancer: A Qualitative Study of the Impact of Symptoms,Cancer Nursing,,,Article,2011-09-05,10.1097/ncc.0b013e318211fa92,,,,21558849,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/497591,https://api.altmetric.com/v1/donut/497591_240.png 1,Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells.,Free Radical Research,,,Article,2011-12-07,10.3109/10715762.2011.647009,,,,22145923,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/494188,https://api.altmetric.com/v1/donut/494188_240.png 1,Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial,BMC Cancer,,,Article,2011-12-13,10.1186/1471-2407-11-517,,,,22166044,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/494172,https://api.altmetric.com/v1/donut/494172_240.png 1,Location of residual cancer after transrectal highâ??intensity focused ultrasound ablation for clinically localized prostate cancer,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2011.10251.x,,,,21711432,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/467814,https://api.altmetric.com/v1/donut/467814_240.png 1,Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.,Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],,,Article,2011-11-17,10.1007/s00066-011-1106-4,,,,22105769,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/466196,https://api.altmetric.com/v1/donut/466196_240.png 1,Impact of Health Information-Seeking Behavior and Personal Factors on Preferred Role in Treatment Decision Making in Men With Newly Diagnosed Prostate Cancer,Cancer Nursing,,,Article,2011-11-14,10.1097/ncc.0b013e318236565a,,,,22067700,,,,,,,0,0,0,4,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/466176,https://api.altmetric.com/v1/donut/466176_240.png 1,Risk Loci on Chromosome 8q24 are Associated With Prostate Cancer in Northern Chinese Men.,The Journal of urology,,,Article,2011-11-16,10.1016/j.juro.2011.09.011,,,,22099997,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/465866,https://api.altmetric.com/v1/donut/465866_240.png 1,Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.,Biochemical Pharmacology,,,Article,2011-11-01,10.1016/j.bcp.2011.07.078,,,,21803027,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/464991,https://api.altmetric.com/v1/donut/464991_240.png 1,Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer,PLoS ONE,,,Article,2011-11-14,10.1371/journal.pone.0026753,,,,22110593,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/454870,https://api.altmetric.com/v1/donut/454870_240.png 1,"Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer.",The Journal of Urology,,,Article,2011-07-23,10.1016/j.juro.2011.04.070,,,,21788048,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/443199,https://api.altmetric.com/v1/donut/443199_240.png 1,Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis.,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,Article,2011-10-05,10.2967/jnumed.111.093674,,,,21976530,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/396228,https://api.altmetric.com/v1/donut/396228_240.png 1,Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy,British Journal of Urology,,,Article,2011-10-01,10.1111/j.1464-410x.2010.10037.x,,,,21410629,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/385199,https://api.altmetric.com/v1/donut/385199_240.png 1,"Age and Grade Trends in Prostate Cancer (1974-2003): A Surveillance, Epidemiology, and End Results Registry Analysis",American journal of clinical oncology,,,Article,2008-08-01,10.1097/coc.0b013e3181637384,,,,18845997,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/375551,https://api.altmetric.com/v1/donut/375551_240.png 1,Provider and partner interactions in the treatment decisionâ??making process for newly diagnosed localized prostate cancer,British Journal of Urology,,,Article,2011-09-01,10.1111/j.1464-410x.2010.09945.x,,,,21244609,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/255112,https://api.altmetric.com/v1/donut/255112_240.png 1,Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3,Clinics,,,Article,2011-06-01,10.1590/s1807-59322011000600026,,,,21808878,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/244346,https://api.altmetric.com/v1/donut/244346_240.png 1,"ASCO highlights new findings on cancer screening discoveries connected to ovarian, cervical, and prostate cancers",Cancer (0008543X),,,Article,2011-08-15,10.1002/cncr.26399,,,,21815131,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/227394,https://api.altmetric.com/v1/donut/227394_240.png 1,Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - Acute toxicity of 12C for PC.,"Acta oncologica (Stockholm, Sweden)",,,Article,2011-08-01,10.3109/0284186x.2011.584558,,,,21767175,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/198727,https://api.altmetric.com/v1/donut/198727_240.png 1,SECONDARY HORMONAL MANIPULATIONS IN THE TREATMENT OF CASTRATION REFRACTORY PROSTATE CANCER,British Journal of Urology,,,Article,2011-07-01,10.1111/j.1464-410x.2010.09970.x,,,,21410863,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/188152,https://api.altmetric.com/v1/donut/188152_240.png 1,Prostate stem cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC-EURGAST Study.,International Journal of Cancer,,,Article,2011-06-16,10.1002/ijc.26243,,,,21681742,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/188063,https://api.altmetric.com/v1/donut/188063_240.png 1,Six yearsâ?? experience with highâ??intensity focused ultrasonography for prostate cancer: oncological outcomes using the new â??Stuttgartâ?? definition for biochemical failure,British Journal of Urology,,,Article,2011-06-01,10.1111/j.1464-410x.2010.09710.x,,,,21083637,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/112127,https://api.altmetric.com/v1/donut/112127_240.png 1,Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study.,"Radiation oncology (London, England)",,,Article,2011-06-08,10.1186/1748-717x-6-65,,,,21651782,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/101409,https://api.altmetric.com/v1/donut/101409_240.png 1,Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer,Cancer immunology research,,,Article,2016-09-29,10.1158/2326-6066.cir-16-0042,,,,27688020,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13314726,https://api.altmetric.com/v1/donut/13314726_240.png 1,Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study,European Journal of Clinical Nutrition,,,Article,2016-10-19,10.1038/ejcn.2016.184,,,,27759068,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13312142,https://api.altmetric.com/v1/donut/13312142_240.png 1,Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer,European Urology,,,Article,2016-11-01,10.1016/j.eururo.2016.10.031,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13293809,https://api.altmetric.com/v1/donut/13293809_240.png 1,Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers,International Journal of Molecular Sciences,,,Article,2016-10-26,10.3390/ijms17111784,,,,27792187,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13280979,https://api.altmetric.com/v1/donut/13280979_240.png 1,Anticancer effects of ethanolic neem leaf extract on prostate cancer cell line (PC-3),Journal of Ethnopharmacology,,,Article,2006-04-01,10.1016/j.jep.2005.11.006,,,,16378700,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13211364,https://api.altmetric.com/v1/donut/13211364_240.png 1,The Voice of the Patient Methodology: A Novel Mixed-Methods Approach to Identifying Treatment Goals for Men with Prostate Cancer,The Patient,,,Article,2016-10-31,10.1007/s40271-016-0203-y,,,,27798815,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13204169,https://api.altmetric.com/v1/donut/13204169_240.png 1,Prostate cancer: What is the optimal treatment sequence for mCRPC?,Nature Reviews Urology,,,Article,2016-10-31,10.1038/nrurol.2016.205,,,,27797362,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13196381,https://api.altmetric.com/v1/donut/13196381_240.png 1,Mens health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer,American Journal of Clinical Nutrition,,,Article,2016-10-26,10.3945/ajcn.115.119958,,,,27797706,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13167993,https://api.altmetric.com/v1/donut/13167993_240.png 1,The Role of Next-Generation Sequencing in Castration-Resistant Prostate Cancer Treatment,Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000217,,,http://journals.lww.com/journalppo/Fulltext/2016/09000/The_Role_of_Next_Generation_Sequencing_in.10.aspx,27749331,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13121668,https://api.altmetric.com/v1/donut/13121668_240.png 1,Immune Therapy for Prostate Cancer,Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000223,,,http://journals.lww.com/journalppo/Fulltext/2016/09000/Immune_Therapy_for_Prostate_Cancer.6.aspx,27749327,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13091181,https://api.altmetric.com/v1/donut/13091181_240.png 1,Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer,Nuclear Medicine Communications,,,Article,2016-10-25,10.1097/mnm.0000000000000606,,,http://journals.lww.com/nuclearmedicinecomm/Fulltext/publishahead/Post_therapeutic_dosimetry_of_177Lu_DKFZ_PSMA_617.98787.aspx,27782913,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13082971,https://api.altmetric.com/v1/donut/13082971_240.png 1,Recent Advances in Clinical Research that Impact the Office Management of Prostate Cancer,Urology Practice,,,Article,2016-10-01,10.1016/j.urpr.2016.08.002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13073953,https://api.altmetric.com/v1/donut/13073953_240.png 1,"Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate",Anti-Cancer Drugs,,,Article,2016-10-21,10.1097/cad.0000000000000434,,,http://journals.lww.com/anti-cancerdrugs/Fulltext/publishahead/Duration_of_response_to_first_androgen_deprivation.99005.aspx,27763885,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12986314,https://api.altmetric.com/v1/donut/12986314_240.png 1,Isotope Therapy for Castrate-Resistant Prostate Cancer,Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000218,,,http://journals.lww.com/journalppo/Fulltext/2016/09000/Isotope_Therapy_for_Castrate_Resistant_Prostate.7.aspx,27749328,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12986164,https://api.altmetric.com/v1/donut/12986164_240.png 1,Psychological benefits of prostate cancer screening: the role of reassurance,Health Expectations,,,Article,2002-05-28,10.1046/j.1369-6513.2002.00166.x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/12970986,https://api.altmetric.com/v1/donut/12970986_240.png 1,Cell-free and circulating tumor cell–based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?,Urologic Oncology,,,Article,2016-10-01,10.1016/j.urolonc.2016.09.001,,,,27771279,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12957060,https://api.altmetric.com/v1/donut/12957060_240.png 1,"Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients",Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000220,,,http://journals.lww.com/journalppo/Fulltext/2016/09000/Clinical_Validity_of_Detecting_Circulating_Tumor.1.aspx,27749322,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12927111,https://api.altmetric.com/v1/donut/12927111_240.png 1,Incidental prostate cancer in Asian men: High prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy,The Prostate,,,Article,2015-02-19,10.1002/pros.22966,,,,25704311,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/12813663,https://api.altmetric.com/v1/donut/12813663_240.png 1,What is the best way not to treat prostate cancer?,Urologic Oncology,,,Article,2016-10-01,10.1016/j.urolonc.2016.09.003,,,,27746147,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12722321,https://api.altmetric.com/v1/donut/12722321_240.png 1,ANDROGEN RECEPTOR VARIATION AFFECTS PROSTATE CANCER PROGRESSION AND DRUG RESISTANCE,Pharmacological Research,,,Article,2016-10-01,10.1016/j.phrs.2016.10.001,,,,27725309,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12704663,https://api.altmetric.com/v1/donut/12704663_240.png 1,Use of shear waves for diagnosis and ablation monitoring of prostate cancer: a feasibility study,Journal of Physics: Conference Series,,,Article,2016-01-01,10.1088/1742-6596/684/1/012006,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12702595,https://api.altmetric.com/v1/donut/12702595_240.png 1,Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer,Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000221,,,http://journals.lww.com/journalppo/Fulltext/2016/09000/Prostate_Specific_Membrane_Antigen_Directed.8.aspx,27749329,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12691714,https://api.altmetric.com/v1/donut/12691714_240.png 1,Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer,Cellular Physiology & Biochemistry,,,Article,2015-11-27,10.1159/000438577,,,,26610246,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12691073,https://api.altmetric.com/v1/donut/12691073_240.png 1,Role of Focal Therapy with High-Intensity Focused Ultrasound in the Management of Clinically Localized Prostate Cancer,Oncology Research and Treatment,,,Article,2015-11-09,10.1159/000441600,,,,26632846,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12690650,https://api.altmetric.com/v1/donut/12690650_240.png 1,Gene Expression of Aurora Kinases in Prostate Cancer and Nodular Hyperplasia Tissues,Medical Principles & Practice,,,Article,2012-10-13,10.1159/000342679,,,,23075505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12678714,https://api.altmetric.com/v1/donut/12678714_240.png 1,Hyperbaric Oxygen Therapy for Radiation Cystitis in Patients with Prostate Cancer: A Long-Term Follow-Up Study,Urologia Internationalis,,,Article,2012-07-10,10.1159/000338910,,,,22797611,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12678258,https://api.altmetric.com/v1/donut/12678258_240.png 1,Competing Mortality Contributes to Excess Mortality in Patients with Poor-Risk Lymph Node-Positive Prostate Cancer Treated with Radical Prostatectomy,Urologia Internationalis,,,Article,2012-07-19,10.1159/000339279,,,,22813937,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12677763,https://api.altmetric.com/v1/donut/12677763_240.png 1,High-Intensity Focused Ultrasound and Cryotherapy as Salvage Treatment in Local Radio-Recurrent Prostate Cancer,Urologia Internationalis,,,Article,2012-07-10,10.1159/000339616,,,,22797110,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12677746,https://api.altmetric.com/v1/donut/12677746_240.png 1,PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report,Case Reports in Oncology,,,Article,2012-04-18,10.1159/000336481,,,,22666210,PMC3364036,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12677361,https://api.altmetric.com/v1/donut/12677361_240.png 1,The Interleukin-6 ?174G/C Polymorphism and Prostate Cancer Risk: A Systematic Review and Meta-Analysis,Urologia Internationalis,,,Article,2012-04-17,10.1159/000335207,,,,22516897,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12677346,https://api.altmetric.com/v1/donut/12677346_240.png 1,Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style,Journal of Health Psychology,,,Article,2016-10-09,10.1177/1359105316671188,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12672783,https://api.altmetric.com/v1/donut/12672783_240.png 1,Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia,Journal of Magnetic Resonance Imaging,,,Article,2016-10-11,10.1002/jmri.25504,,,,27726240,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12621452,https://api.altmetric.com/v1/donut/12621452_240.png 1,"Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials",Quality of Life Research,,,Article,2016-10-13,10.1007/s11136-016-1429-9,,,,27738867,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12591337,https://api.altmetric.com/v1/donut/12591337_240.png 1,Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A Review,Cancer Journal,,,Article,2016-09-01,10.1097/ppo.0000000000000215,,,http://journals.lww.com/journalppo/Fulltext/2016/09000/Chemohormonal_Therapy_for_Hormone_Sensitive.3.aspx,27749324,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12522487,https://api.altmetric.com/v1/donut/12522487_240.png 1,"Prostate cancer metastasis to calcaneus: a solitary lesion at an atypical site, dormant for more than 10 years",JRSM Open,,,Article,2016-10-01,10.1177/2054270416660934,,,,27757245,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12467759,https://api.altmetric.com/v1/donut/12467759_240.png 1,Understanding the role of new systemic agents in the treatment of prostate cancer,British Journal of Urology,,,Article,2016-10-06,10.1111/bju.13633,,,,27709828,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12466558,https://api.altmetric.com/v1/donut/12466558_240.png 1,"Re: Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023 Radical Treatment in Very High-risk Prostate Cancer: Venturing Down a Path Less Travelled",European Urology,,,Article,2016-10-09,10.1016/j.eururo.2016.09.038,,,,27717521,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12432611,https://api.altmetric.com/v1/donut/12432611_240.png 1,Asia prostate cancer study (A-CaP Study) launch symposium,Prostate International,,,Article,2016-09-01,10.1016/j.prnil.2016.03.001,,,,27689065,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12404642,https://api.altmetric.com/v1/donut/12404642_240.png 1,MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer,Seminars in Interventional Radiology,,,Article,2016-09-01,10.1055/s-0036-1586151,,,,27582607,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12390280,https://api.altmetric.com/v1/donut/12390280_240.png 1,Diabetes and mortality in patients with prostate cancer: a meta-analysis,SpringerPlus,,,Article,2016-01-01,10.1186/s40064-016-3233-y,,,,27652121,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12388698,https://api.altmetric.com/v1/donut/12388698_240.png 1,Oxidative stress in prostate cancer patients: A systematic review of case control studies,Prostate International,,,Article,2016-09-01,10.1016/j.prnil.2016.05.002,,,,27689064,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12368640,https://api.altmetric.com/v1/donut/12368640_240.png 1,Synergistic Antitumor Cytotoxic Actions of Ascorbate and Menadione on Human Prostate (DU145) Cancer Cells In Vitro: Nucleus and Other Injuries Preceding Cell Death by Autoschizis,Ultrastructural Pathology,,,Article,2014-01-24,10.3109/01913123.2013.852645,,,,24460713,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/12320003,https://api.altmetric.com/v1/donut/12320003_240.png 1,Presenting Treatment Options to Men with Clinically Localized Prostate Cancer: The Acceptability of Active Surveillance/Monitoring,Journal of the National Cancer Institute. Monographs,,,Article,2012-09-01,10.1093/jncimonographs/lgs030,,,,23271772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/12307743,https://api.altmetric.com/v1/donut/12307743_240.png 1,Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer,Stem Cells Translational Medicine,,,Article,2016-09-29,10.5966/sctm.2016-0243,,,,27686757,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12307157,https://api.altmetric.com/v1/donut/12307157_240.png 1,Abstract 3193: Expression analysis reveals candidate genes involved in highly invasive high-hyaluronan binding subpopulations of prostate cancer cell lines,Cancer Research,,,Article,2015-08-01,10.1158/1538-7445.am2015-3193,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12285396,https://api.altmetric.com/v1/donut/12285396_240.png 1,Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-09-29,10.1016/j.ijrobp.2016.06.339,,,,27675620,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12281971,https://api.altmetric.com/v1/donut/12281971_240.png 1,Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer,Anti-Cancer Drugs,,,Article,2016-09-23,10.1097/cad.0000000000000438,,,http://journals.lww.com/anti-cancerdrugs/Fulltext/publishahead/Docetaxel_and_mitoxantrone_before_radical.99015.aspx,27669423,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12268570,https://api.altmetric.com/v1/donut/12268570_240.png 1,Insulin Receptor Isoform Variations in Prostate Cancer Cells,Frontiers in endocrinology,,,Article,2016-09-28,10.3389/fendo.2016.00132,,,,27733843,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12262500,https://api.altmetric.com/v1/donut/12262500_240.png 1,"Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer",American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-09-26,10.1097/coc.0000000000000325,,,"http://journals.lww.com/amjclinicaloncology/Fulltext/publishahead/Patient_reported_Urinary,_Bowel,_and_Sexual.99020.aspx",27635624,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12256726,https://api.altmetric.com/v1/donut/12256726_240.png 1,"Association between lifetime alcohol consumption and prostate cancer risk: A case-control study in Montreal, Canada",Cancer Epidemiology,,,Article,2016-12-01,10.1016/j.canep.2016.09.004,,,,27664387,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/12243341,https://api.altmetric.com/v1/donut/12243341_240.png 1,Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.,Oncogene,,,Article,2016-09-19,10.1038/onc.2016.159,,,,27641331,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12222395,https://api.altmetric.com/v1/donut/12222395_240.png 1,"BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer",Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-0718,,,,27663589,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12172714,https://api.altmetric.com/v1/donut/12172714_240.png 1,A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer,Scientific Reports,,,Article,2016-09-22,10.1038/srep33894,,,,27654169,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12142317,https://api.altmetric.com/v1/donut/12142317_240.png 1,Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis,Cancer Biology and Therapy,,,Article,2016-09-13,10.1080/15384047.2016.1219817,,,,27624889,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12130061,https://api.altmetric.com/v1/donut/12130061_240.png 1,Associations between aerobic exercise levels and physical and mental health outcomes in men with bone metastatic prostate cancer: a cross-sectional investigation,European Journal of Cancer Care,,,Article,2016-09-20,10.1111/ecc.12575,,,,27647712,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12119692,https://api.altmetric.com/v1/donut/12119692_240.png 1,"Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.021",European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.09.021,,,,27663049,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/12112538,https://api.altmetric.com/v1/donut/12112538_240.png 1,The role of MRI in prostate cancer diagnosis and management,"Future oncology (London, England)",,,Article,2016-09-20,10.2217/fon-2016-0169,,,,27641839,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12104065,https://api.altmetric.com/v1/donut/12104065_240.png 1,Androgen-Deprivation Therapy and Cardiovascular Disease Risk – The Role of Exercise in Prostate Cancer Treatment,Frontiers in oncology,,,Article,2016-09-19,10.3389/fonc.2016.00200,,,,27699155,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12079678,https://api.altmetric.com/v1/donut/12079678_240.png 1,"Ecotropic viral integration site 1, a novel oncogene in prostate cancer",Oncogene,,,Article,2016-09-12,10.1038/onc.2016.325,,,,27617580,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12059794,https://api.altmetric.com/v1/donut/12059794_240.png 1,Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence,Journal of the Egyptian National Cancer Institute,,,Article,2016-09-01,10.1016/j.jnci.2016.08.003,,,,27634416,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12058696,https://api.altmetric.com/v1/donut/12058696_240.png 1,Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/j.radonc.2016.08.026,,,,27647458,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12052379,https://api.altmetric.com/v1/donut/12052379_240.png 1,Evaluation of a supervised multi-modal physical exercise program for prostate cancer survivors in the rehabilitation phase: Rationale and study protocol of the ProCaLife study,Contemporary Clinical Trials,,,Article,2015-11-01,10.1016/j.cct.2015.09.020,,,,26427561,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/12018346,https://api.altmetric.com/v1/donut/12018346_240.png 1,Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11941,,,,27626485,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12012985,https://api.altmetric.com/v1/donut/12012985_240.png 1,Re: The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer,European Urology,,,Article,2016-09-18,10.1016/j.eururo.2016.08.062,,,,27638091,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11986484,https://api.altmetric.com/v1/donut/11986484_240.png 1,Correction: Measuring the effects of fractionated radiation therapy in a 3D prostate cancer model system using SERS nanosensors,Analyst,,,Article,2016-09-13,10.1039/c6an90079h,,,,27704094,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11979088,https://api.altmetric.com/v1/donut/11979088_240.png 1,Impact of obesity upon prostate cancer-associated mortality: A meta?analysis of 17 cohort studies,Oncology Letters,,,Article,2015-03-15,10.3892/ol.2014.2841,,,,25663903,PMC4315023,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11967226,https://api.altmetric.com/v1/donut/11967226_240.png 1,IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-?B pathway,International Immunopharmacology,,,Article,2016-11-01,10.1016/j.intimp.2016.08.017,,,,27611862,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11933550,https://api.altmetric.com/v1/donut/11933550_240.png 1,Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma,Clinical Nuclear Medicine,,,Article,2016-09-01,10.1097/rlu.0000000000001350,,,,27607157,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11913358,https://api.altmetric.com/v1/donut/11913358_240.png 1,Improved biopsy efficiency with MR/ultrasound fusion-guided prostate biopsy,JNCI: Journal of the National Cancer Institute,,,Article,2016-09-01,10.1093/jnci/djw040,,,,27130934,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11901887,https://api.altmetric.com/v1/donut/11901887_240.png 1,Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.,International Journal of Biochemistry & Cell Biology,,,Article,2016-09-08,10.1016/j.biocel.2016.08.043,,,,27594411,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11891692,https://api.altmetric.com/v1/donut/11891692_240.png 1,A comparison of the acute toxicities using moderate hypo-fractionated intensity-modulated radiation therapy or volumetric modulated arc therapy for the treatment of early-stage prostate cancer,,,,Article,,,,,,,,1959.13/1317393; uon:23408; ISSN:1460-3969,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11873434,https://api.altmetric.com/v1/donut/11873434_240.png 1,Consensus Guidelines for Reporting Prostate Cancer Gleason Grade,Urology,,,Article,2016-09-01,10.1016/j.urology.2016.07.006,,,,27592526,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11532573,https://api.altmetric.com/v1/donut/11532573_240.png 1,A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon,PLoS ONE,,,Article,2016-08-18,10.1371/journal.pone.0161084,,,,27536883,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10991686,https://api.altmetric.com/v1/donut/10991686_240.png 1,Pubic Bone Resection Provides Objective Pain Control in the Prostate Cancer Survivor with Pubic Bone Osteomyelitis with an Associated Urinary Tract to Pubic Symphysis Fistula.,Urology,,,Article,2016-09-07,10.1016/j.urology.2016.08.035,,,,27591809,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10955340,https://api.altmetric.com/v1/donut/10955340_240.png 1,"Erratum: “A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy” [Med. Phys. 43, 734–747 (2016)]",Medical Physics,,,Article,2016-08-31,10.1118/1.4960371,,,,27587059,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10940283,https://api.altmetric.com/v1/donut/10940283_240.png 1,"Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study",Journal of Geriatric Oncology,,,Article,2016-07-01,10.1016/j.jgo.2016.07.011,,,,27480793,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10917112,https://api.altmetric.com/v1/donut/10917112_240.png 1,The utility of quantitative ADC values for differentiating high-risk from low-risk prostate cancer: a systematic review and meta-analysis,Abdominal Radiology,,,Article,2016-08-25,10.1007/s00261-016-0848-y,,,,27562768,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10864722,https://api.altmetric.com/v1/donut/10864722_240.png 1,"Fit Patient with Nonmetastatic Castration-resistant Prostate Cancer, Lower Urinary Tract Symptoms, and Severe Recurrent Haematuria",,,,Article,2016-08-27,10.1016/j.euf.2016.08.008,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10857819,https://api.altmetric.com/v1/donut/10857819_240.png 1,Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11391,,,,27556357,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10815242,https://api.altmetric.com/v1/donut/10815242_240.png 1,"Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.047",European Urology,,,Article,2016-08-25,10.1016/j.eururo.2016.08.036,,,,27568062,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10806147,https://api.altmetric.com/v1/donut/10806147_240.png 1,Networking and matchmaking in prostate cancer,Science Translational Medicine,,,Article,2016-08-24,10.1126/scitranslmed.aah5497,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10801628,https://api.altmetric.com/v1/donut/10801628_240.png 1,Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer,PLoS ONE,,,Article,2016-08-18,10.1371/journal.pone.0158667,,,,27537362,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10794376,https://api.altmetric.com/v1/donut/10794376_240.png 1,"Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients",Journal of Molecular Medicine,,,Article,2016-08-18,10.1007/s00109-016-1458-4,,,,27534968,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10783831,https://api.altmetric.com/v1/donut/10783831_240.png 1,Evaluation of an Automated Analysis Tool for Prostate Cancer Prediction Using Multiparametric Magnetic Resonance Imaging,PLoS ONE,,,Article,2016-07-25,10.1371/journal.pone.0159803,,,,27454770,PMC4959716,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10781243,https://api.altmetric.com/v1/donut/10781243_240.png 1,The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups,Frontiers in oncology,,,Article,2016-08-23,10.3389/fonc.2016.00184,,,,27602330,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10777997,https://api.altmetric.com/v1/donut/10777997_240.png 1,A Bayesian hierarchical model for prediction of latent health states from multiple data sources with application to active surveillance of prostate cancer,Biometrics,,,Article,2016-08-22,10.1111/biom.12577,,,,27548645,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10760849,https://api.altmetric.com/v1/donut/10760849_240.png 1,Antitumoral action of icaritin in LNCaP prostate cancer cells by regulating PEA3/HER2/AR signaling,Anti-Cancer Drugs,,,Article,2016-08-17,10.1097/cad.0000000000000420,,,http://journals.lww.com/anti-cancerdrugs/Fulltext/publishahead/Antitumoral_action_of_icaritin_in_LNCaP_prostate.99031.aspx,27537398,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10732251,https://api.altmetric.com/v1/donut/10732251_240.png 1,Harnessing novel modalities: field carcinogenesis detection for personalizing prostate cancer management,Future Oncology,,,Article,2015-10-01,10.2217/fon.15.182,,,,26374598,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10699919,https://api.altmetric.com/v1/donut/10699919_240.png 1,Abstract 1738: A pooled analysis of carbohydrate and dietary fiber intake and prostate cancer risk,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1738,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10682901,https://api.altmetric.com/v1/donut/10682901_240.png 1,The evolving role of chemotherapy in prostate cancer,Current Opinion in Supportive and Palliative Care,,,Article,2016-09-01,10.1097/spc.0000000000000216,,,http://journals.lww.com/co-supportiveandpalliativecare/Fulltext/2016/09000/The_evolving_role_of_chemotherapy_in_prostate.14.aspx,27489183,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10675419,https://api.altmetric.com/v1/donut/10675419_240.png 1,Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer,Medicine,,,Article,2016-08-01,10.1097/md.0000000000004475,,,http://journals.lww.com/md-journal/Fulltext/2016/08020/Complementary_traditional_Chinese_medicine_therapy.74.aspx,27495088,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10660255,https://api.altmetric.com/v1/donut/10660255_240.png 1,The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11128,,,,27528026,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10657264,https://api.altmetric.com/v1/donut/10657264_240.png 1,Sci-Fri AM: MRI and Diagnostic Imaging - 04: How does prostate biopsy guidance error impact pathologic cancer risk assessment?,Medical Physics,,,Article,2016-08-01,10.1118/1.4961835,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10630127,https://api.altmetric.com/v1/donut/10630127_240.png 1,Poster - 47: A parametrized prediction model of rectal toxicity in focal SBRT of low risk prostate cancer,Medical Physics,,,Article,2016-08-01,10.1118/1.4961821,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10630013,https://api.altmetric.com/v1/donut/10630013_240.png 1,"Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases",Tumor Biology,,,Article,2016-08-05,10.1007/s13277-016-5277-6,,,,27495232,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10573314,https://api.altmetric.com/v1/donut/10573314_240.png 1,Blocking mtDNA Replication Upregulates the Expression of Stemness-related Genes in Prostate Cancer Cell Lines,Ultrastructural Pathology,,,Article,2013-08-14,10.3109/01913123.2013.770112,,,,23634795,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10555640,https://api.altmetric.com/v1/donut/10555640_240.png 1,Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial,BMC Cancer,,,Article,2016-08-16,10.1186/s12885-016-2687-1,,,,27530156,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10553891,https://api.altmetric.com/v1/donut/10553891_240.png 1,Communication networks of men facing a diagnosis of prostate cancer,Journal of Clinical Nursing,,,Article,2016-08-15,10.1111/jocn.13369,,,,27524489,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10525271,https://api.altmetric.com/v1/donut/10525271_240.png 1,Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer,Scientific Reports,,,Article,2016-08-09,10.1038/srep30386,,,,27503267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10486648,https://api.altmetric.com/v1/donut/10486648_240.png 1,Combination Therapy of Paclitaxel and Cyclopamine Polymer-Drug Conjugates to Treat Advanced Prostate Cancer,"Nanomedicine: Nanotechnology, Biology and Medicine",,,Article,2016-08-09,10.1016/j.nano.2016.07.017,,,,27520724,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10370365,https://api.altmetric.com/v1/donut/10370365_240.png 1,Audit of PSA requesting practices in primary care compared to guidelines established by the Prostate Cancer Risk Management programme in the Avon region of the South West of England,Journal of Clinical Urology,,,Article,2013-07-04,10.1177/2051415813485945,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10355426,https://api.altmetric.com/v1/donut/10355426_240.png 1,COX-2 Inhibition for Prostate Cancer Chemoprevention: Double-Blind Randomized Study of Pre-Prostatectomy Celecoxib or Placebo,British Journal of Urology,,,Article,2016-08-01,10.1111/bju.13612,,,,27480340,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10313504,https://api.altmetric.com/v1/donut/10313504_240.png 1,Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New Biomarkers,PLoS ONE,,,Article,2016-03-09,10.1371/journal.pone.0150253,,,,26958841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10262449,https://api.altmetric.com/v1/donut/10262449_240.png 1,Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor ?2 immunohistochemistry in prostate cancer,Diagnostic Pathology,,,Article,2016-08-03,10.1186/s13000-016-0511-5,,,,27401406,PMC4940862,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10251753,https://api.altmetric.com/v1/donut/10251753_240.png 1,Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer Radiotherapy,Frontiers in oncology,,,Article,2016-08-03,10.3389/fonc.2016.00178,,,,27536556,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10250236,https://api.altmetric.com/v1/donut/10250236_240.png 1,"Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1",Tumor Biology,,,Article,2016-07-23,10.1007/s13277-016-5158-z,,,,27449037,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10218649,https://api.altmetric.com/v1/donut/10218649_240.png 1,The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis,Scientific Reports,,,Article,2016-07-07,10.1038/srep29106,,,,27384548,PMC4935858,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10198317,https://api.altmetric.com/v1/donut/10198317_240.png 1,The experiences of prostate cancer survivors: Changes to physical function and its impact on quality of life,International Journal of Therapy & Rehabilitation,,,Article,2016-07-02,10.12968/ijtr.2016.23.7.323,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10176318,https://api.altmetric.com/v1/donut/10176318_240.png 1,Erratum to: Association of a CYP17 Polymorphism With Overall Survival in Caucasian Patients With Androgen-independent Prostate Cancer,Urology,,,Article,2016-07-13,10.1016/j.urology.2016.05.047,,,,17826473,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10127628,https://api.altmetric.com/v1/donut/10127628_240.png 1,"Association of Comorbidity, Age and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma",Urology,,,Article,2016-07-07,10.1016/j.urology.2016.06.015,,,,27397095,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10124963,https://api.altmetric.com/v1/donut/10124963_240.png 1,Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells,The Prostate,,,Article,2016-07-15,10.1002/pros.23230,,,,27416770,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10055483,https://api.altmetric.com/v1/donut/10055483_240.png 1,Examination of CK2? and NF-?B p65 expression in human benign prostatic hyperplasia and prostate cancer tissues,Molecular and Cellular Biochemistry,,,Article,2016-07-19,10.1007/s11010-016-2765-3,,,,27435858,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10051115,https://api.altmetric.com/v1/donut/10051115_240.png 1,Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling,Hormones and Cancer,,,Article,2016-07-22,10.1007/s12672-016-0271-4,,,,27447901,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10013888,https://api.altmetric.com/v1/donut/10013888_240.png 1,Secondary consent to biospecimen use in a prostate cancer biorepository,BMC Research Notes,,,Article,2016-07-18,10.1186/s13104-016-2159-3,,,,27431491,PMC4949745,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10003924,https://api.altmetric.com/v1/donut/10003924_240.png 1,Prostate Cancer and the Will Rogers Phenomenon,JNCI: Journal of the National Cancer Institute,,,Article,2005-09-06,10.1093/jnci/dji248,,,,16145045,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/9925055,https://api.altmetric.com/v1/donut/9925055_240.png 1,Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients,Journal of Endocrinological Investigation,,,Article,2016-01-19,10.1007/s40618-016-0430-z,,,,26786788,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9919347,https://api.altmetric.com/v1/donut/9919347_240.png 1,miRNA-30a functions as a tumor suppressor by downregulating cyclin E2 expression in castration-resistant prostate cancer,Molecular Medicine Reports,,,Article,2016-07-06,10.3892/mmr.2016.5469,,,,27431942,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9916788,https://api.altmetric.com/v1/donut/9916788_240.png 1,MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1,Febs Letters,,,Article,2015-06-04,10.1016/j.febslet.2015.04.037,,,,25936765,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9885123,https://api.altmetric.com/v1/donut/9885123_240.png 1,CSR1 Suppresses Tumor Growth and Metastasis of Prostate Cancer,American Journal of Pathology,,,Article,2006-01-02,10.2353/ajpath.2006.050620,,,,16436673,PMC1606498,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9881797,https://api.altmetric.com/v1/donut/9881797_240.png 1,Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures,Journal of Sexual Medicine,,,Article,2016-03-01,10.1016/j.jsxm.2016.01.005,,,,26944466,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9877547,https://api.altmetric.com/v1/donut/9877547_240.png 1,Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction?,Journal of Sexual Medicine,,,Article,2016-04-01,10.1016/j.jsxm.2016.02.160,,,,27045263,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9871880,https://api.altmetric.com/v1/donut/9871880_240.png 1,Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design,Frontiers in oncology,,,Article,2016-07-20,10.3389/fonc.2016.00167,,,,27489794,PMC4951492,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9871197,https://api.altmetric.com/v1/donut/9871197_240.png 1,Focal Therapy in Prostate Cancer: A Review of Seven Common Controversies,Cancer Treatment Reviews,,,Article,2016-07-01,10.1016/j.ctrv.2016.07.004,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9855542,https://api.altmetric.com/v1/donut/9855542_240.png 1,Online Versus Telephone Methods to Recruit and Interview Older Gay and Bisexual Men Treated for Prostate Cancer: Findings from the Restore Study,JMIR Cancer,,,Article,2016-07-19,10.2196/cancer.5578,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9852712,https://api.altmetric.com/v1/donut/9852712_240.png 1,SPOCK1 promotes tumor growth and metastasis in human prostate cancer,"Drug Design, Development and Therapy",,,Article,2016-07-18,10.2147/dddt.s91321,,,,27486308,PMC4958368,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9834755,https://api.altmetric.com/v1/donut/9834755_240.png 1,Daytime Blue Light Enhances the Nighttime Circadian Melatonin Inhibition of Human Prostate Cancer Growth.,Comparative Medicine,,,Article,2015-12-01,,,,,26678364,PMC4681241,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9808491,https://api.altmetric.com/v1/donut/9808491_240.png 1,Co-targeting HSP90 and its client proteins for treatment of prostate cancer,Molecular Cancer Therapeutics,,,Article,2016-01-01,10.1158/1535-7163.mct-16-0241,,,,27390342,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9802556,https://api.altmetric.com/v1/donut/9802556_240.png 1,Correlation between methylation of the E-Cadherin gene and malignancy of prostate cancer,Genetics and Molecular Research,,,Article,2016-01-01,10.4238/gmr.15028046,,,,27420993,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9747205,https://api.altmetric.com/v1/donut/9747205_240.png 1,STAMPEDE trial and patients with non-metastatic prostate cancer ,The Lancet,,,Article,2016-07-01,10.1016/s0140-6736(16)31038-8,,,,27479564,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9716430,https://api.altmetric.com/v1/donut/9716430_240.png 1,Radiotherapy for Prostate Cancer: is it ‘what you do’ or ‘the way that you do it’? A UK Perspective on Technique and Quality Assurance ,Clinical Oncology,,,Article,2016-07-20,10.1016/j.clon.2016.05.011,,,,27425582,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9674536,https://api.altmetric.com/v1/donut/9674536_240.png 1,68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2016-07-14,10.1097/rlu.0000000000001286,,,http://journals.lww.com/nuclearmed/Fulltext/2016/09000/68Ga_PSMA_11_PET_Represents_the_Tumoricidal_Effect.6.aspx,27405025,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9667546,https://api.altmetric.com/v1/donut/9667546_240.png 1,Neuronal trans-differentiation in prostate cancer cells,The Prostate,,,Article,2016-06-12,10.1002/pros.23221,,,,27403603,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9653590,https://api.altmetric.com/v1/donut/9653590_240.png 1,"Food Habits, Lifestyle Factors, and Risk of Prostate Cancer in Central Argentina: A Case Control Study Involving Self-Motivated Health Behavior Modifications after Diagnosis",Nutrients,,,Article,2016-07-09,10.3390/nu8070419,,,,27409631,PMC4963895,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9571433,https://api.altmetric.com/v1/donut/9571433_240.png 1,A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy,BMC Urology,,,Article,2016-07-08,10.1186/s12894-016-0159-1,,,,27391229,PMC4938932,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9533193,https://api.altmetric.com/v1/donut/9533193_240.png 1,"Re: Alison J. Price, Ruth C. Travis, Paul N. Appleby, et al. Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.03.029",European Urology,,,Article,2016-07-09,10.1016/j.eururo.2016.06.022,,,,27402059,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9527661,https://api.altmetric.com/v1/donut/9527661_240.png 1,Metastasis in urothelial carcinoma mimicking prostate cancer metastasis in Ga-68 prostate-specific membrane antigen positron emission tomography-computed tomography in a case of synchronous malignancy,Indian Journal of Nuclear Medicine,,,Article,2016-07-01,10.4103/0972-3919.183615,,,,27385897,PMC4918490,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9512711,https://api.altmetric.com/v1/donut/9512711_240.png 1,Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT),Supportive Care in Cancer,,,Article,2016-07-02,10.1007/s00520-016-3320-1,,,,27370648,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9408602,https://api.altmetric.com/v1/donut/9408602_240.png 1,Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue,International Neurourology Journal,,,Article,2016-06-01,10.5213/inj.1632552.276,,,,27377944,PMC4932644,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9281224,https://api.altmetric.com/v1/donut/9281224_240.png 1,Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells,IUBMB Life,,,Article,2013-07-11,10.1002/iub.1188,,,,23847086,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9271756,https://api.altmetric.com/v1/donut/9271756_240.png 1,New 3D-Culture Approaches to Study Interactions of Bone Marrow Adipocytes with Metastatic Prostate Cancer Cells,Frontiers in endocrinology,,,Article,2016-07-06,10.3389/fendo.2016.00084,,,,27458427,PMC4933721,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9269657,https://api.altmetric.com/v1/donut/9269657_240.png 1,Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10313,,,,27366948,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9183597,https://api.altmetric.com/v1/donut/9183597_240.png 1,Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy,Medicine,,,Article,2016-06-01,10.1097/md.0000000000003948,,,http://journals.lww.com/md-journal/Fulltext/2016/06210/Long_term_cancer_related_fatigue_outcomes_in.33.aspx,27336890,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9165569,https://api.altmetric.com/v1/donut/9165569_240.png 1,KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach,British Journal of Cancer,,,Article,2016-06-23,10.1038/bjc.2016.169,,,,27336609,PMC4947696,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9159613,https://api.altmetric.com/v1/donut/9159613_240.png 1,Prostate cancer: EBRT + ADT outcomes for node-positive patients,Nature Reviews Urology,,,Article,2016-06-28,10.1038/nrurol.2016.120,,,,27349373,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9153766,https://api.altmetric.com/v1/donut/9153766_240.png 1,Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy,Metabolomics,,,Article,2016-06-30,10.1007/s11306-016-1055-0,,,,27429605,PMC4927592,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9148860,https://api.altmetric.com/v1/donut/9148860_240.png 1,Epigenome-wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-lethal Progression in Men with Clinically Localized Prostate Cancer,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-0549,,,,27358489,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9127839,https://api.altmetric.com/v1/donut/9127839_240.png 1,The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells,PeerJ,,,Article,2016-06-29,10.7717/peerj.2168,,,,27413637,PMC4933087,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9115512,https://api.altmetric.com/v1/donut/9115512_240.png 1,Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score,BMC Urology,,,Article,2016-06-17,10.1186/s12894-016-0151-9,,,,27316330,PMC4912823,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9104825,https://api.altmetric.com/v1/donut/9104825_240.png 1,The effect of strength training on muscle cellular stress in prostate cancer patients on ADT.,Endocrine Connections,,,Article,2016-03-01,10.1530/ec-15-0120,,,,27169606,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9097504,https://api.altmetric.com/v1/donut/9097504_240.png 1,"An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer",Cancer Letters,,,Article,2016-06-01,10.1016/j.canlet.2016.06.017,,,,27343980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9095597,https://api.altmetric.com/v1/donut/9095597_240.png 1,Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer,Frontiers in oncology,,,Article,2016-06-28,10.3389/fonc.2016.00157,,,,27446803,PMC4923265,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9088271,https://api.altmetric.com/v1/donut/9088271_240.png 1,Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials,Brachytherapy,,,Article,2015-09-01,10.1016/j.brachy.2015.05.001,,,,26051802,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9086696,https://api.altmetric.com/v1/donut/9086696_240.png 1,Monomethyl auristatin e phosphate inhibits human prostate cancer growth,The Prostate,,,Article,2016-06-01,10.1002/pros.23226,,,,27325602,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9056390,https://api.altmetric.com/v1/donut/9056390_240.png 1,Integration of Bone and Computed Tomography Scans to Assess Bone Metastasis in Metastatic Castration-Resistant Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2016-05-01,10.1016/j.clgc.2016.05.009,,,,27338517,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9037009,https://api.altmetric.com/v1/donut/9037009_240.png 1,Prostate cancer follow-up needs: do patients and professionals agree?,British Journal of Nursing (BJN),,,Article,2014-05-08,10.12968/bjon.2014.23.sup9.s12,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9009663,https://api.altmetric.com/v1/donut/9009663_240.png 1,GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression,Cellular Signalling,,,Article,2016-09-01,10.1016/j.cellsig.2016.06.002,,,,27267060,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8969882,https://api.altmetric.com/v1/donut/8969882_240.png 1,Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.,Medical science monitor international medical journal of experimental and clinical research,,,Article,2016-06-22,,,,,27327120,PMC4920099,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8968345,https://api.altmetric.com/v1/donut/8968345_240.png 1,Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10061,,,,27323813,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8967891,https://api.altmetric.com/v1/donut/8967891_240.png 1,Low-lycopene containing tomato powder diet does not protect against prostate cancer in TRAMP mice,Nutrition Research,,,Article,2015-10-01,10.1016/j.nutres.2015.07.003,,,,26255194,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/8967848,https://api.altmetric.com/v1/donut/8967848_240.png 1,Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic,International Journal of Urology,,,Article,2016-06-01,10.1111/iju.13137,,,,27302572,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8881729,https://api.altmetric.com/v1/donut/8881729_240.png 1,Androgen Receptor and E2F-1 Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer,Cancer Research,,,Article,2007-08-14,10.1158/0008-5472.can-07-1483,,,,17699783,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8864212,https://api.altmetric.com/v1/donut/8864212_240.png 1,Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis,PLoS ONE,,,Article,2016-06-16,10.1371/journal.pone.0157660,,,,27308831,PMC4911003,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8799485,https://api.altmetric.com/v1/donut/8799485_240.png 1,TRIM-ing Ligand Dependence in Castration-Resistant Prostate Cancer,Cancer Cell,,,Article,2016-06-13,10.1016/j.ccell.2016.05.014,,,,27300431,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8787807,https://api.altmetric.com/v1/donut/8787807_240.png 1,Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg,British Journal of Urology,,,Article,2006-07-01,10.1111/j.1464-410x.2006.06204.x,,,,16831143,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8759724,https://api.altmetric.com/v1/donut/8759724_240.png 1,"Reply to Cédric Annweiler, Pierre Bigot, and Spyridon N. Karras’ Letter to the Editor re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.03.027",European Urology,,,Article,2016-06-15,10.1016/j.eururo.2016.05.052,,,,27317088,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8751611,https://api.altmetric.com/v1/donut/8751611_240.png 1,Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer,Frontiers in oncology,,,Article,2016-06-14,10.3389/fonc.2016.00146,,,,27379208,PMC4905954,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8719932,https://api.altmetric.com/v1/donut/8719932_240.png 1,Modeling and Analysis of Hormone and Mitogenic Signal Integration in Prostate Cancer,bioRxiv,,,Article,2016-06-13,10.1101/058552,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8708639,https://api.altmetric.com/v1/donut/8708639_240.png 1,Characterization of fibroblast-free CWR-R1ca castration-recurrent prostate cancer cell line,The Prostate,,,Article,2016-04-01,10.1002/pros.23190,,,,27271795,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8685699,https://api.altmetric.com/v1/donut/8685699_240.png 1,Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2016-06-10,10.1097/rlu.0000000000001264,,,http://journals.lww.com/nuclearmed/Fulltext/2016/09000/Clinical_Impact_of_68Ga_PSMA_PET_CT_in_a_Patient.39.aspx,27276202,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8630554,https://api.altmetric.com/v1/donut/8630554_240.png 1,Reducing the Cost of Proton Radiation Therapy: The Feasibility of a Streamlined Treatment Technique for Prostate Cancer,Cancers,,,Article,2015-04-24,10.3390/cancers7020688,,,,25920039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8625075,https://api.altmetric.com/v1/donut/8625075_240.png 1,Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer,British Journal of Urology,,,Article,2015-09-25,10.1111/bju.13306,,,,26332050,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8611442,https://api.altmetric.com/v1/donut/8611442_240.png 1,Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses,Clinical Genitourinary Cancer,,,Article,2016-05-06,10.1016/j.clgc.2016.04.016,,,,27246360,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8606817,https://api.altmetric.com/v1/donut/8606817_240.png 1,Health Care Costs among Men with Clinically Localized Prostate Cancer Managed with Observation Strategies Versus Immediate Treatment in an Integreated Health Care System,Value in Health (Elsevier Science),,,Article,2016-05-01,10.1016/j.jval.2016.03.1582,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8587305,https://api.altmetric.com/v1/donut/8587305_240.png 1,S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer,Tumor Biology,,,Article,2016-05-30,10.1007/s13277-016-5096-9,,,,27240591,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8561476,https://api.altmetric.com/v1/donut/8561476_240.png 1,Prostate cancer characterization on MR images using fractal features,Medical Physics,,,Article,2010-12-16,10.1118/1.3521470,,,,,,,2011MedPh..38...83L,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/8483107,https://api.altmetric.com/v1/donut/8483107_240.png 1,Stratifying risk of prostate cancer recurrence following external beam radiation therapy: Comparing prostate MRI with prostate biopsy pathology.,bioRxiv,,,Article,2016-06-03,10.1101/056879,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8466245,https://api.altmetric.com/v1/donut/8466245_240.png 1,"Re: Complications, Recovery, and Early Functional Outcomes and Oncologic Control following In-Bore Focal Laser Ablation of Prostate Cancer",The Journal of Urology,,,Article,2016-03-16,10.1016/j.juro.2016.03.026,,,,27191072,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8444880,https://api.altmetric.com/v1/donut/8444880_240.png 1,Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal Transplant Recipients,Transplantation Proceedings,,,Article,2016-04-01,10.1016/j.transproceed.2016.01.031,,,,27234765,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8438559,https://api.altmetric.com/v1/donut/8438559_240.png 1,Partner’s Perspective on Long-term Sexual Dysfunction After Prostate Cancer Treatment,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-06-01,10.1097/coc.0000000000000067,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/06000/Partner_s_Perspective_on_Long_term_Sexual.11.aspx,24685887,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8438011,https://api.altmetric.com/v1/donut/8438011_240.png 1,Automated prostate tissue referencing for cancer detection and diagnosis,BMC Bioinformatics,,,Article,2016-06-01,10.1186/s12859-016-1086-6,,,,27247129,PMC4888626,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8421661,https://api.altmetric.com/v1/donut/8421661_240.png 1,"Erratum: “Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment” [Med. Phys. 41(10), 101705 (14pp.) (2014)]",Medical Physics,,,Article,2016-06-01,10.1118/1.4950704,,,,27277064,PMC4902805,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8421205,https://api.altmetric.com/v1/donut/8421205_240.png 1," Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) model ",NMR in Biomedicine,,,Article,2016-05-31,10.1002/nbm.3556,,,,27241215,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8416645,https://api.altmetric.com/v1/donut/8416645_240.png 1,Automated multistructure atlas-assisted detection of lymph nodes using pelvic MR lymphography in prostate cancer patients,Medical Physics,,,Article,2016-05-31,10.1118/1.4951726,,,,27277059,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8395015,https://api.altmetric.com/v1/donut/8395015_240.png 1,Whole-Body 3D T1-weighted MR Imaging in Patients with Prostate Cancer: Feasibility and Evaluation in Screening for Metastatic Disease,Radiology,,,Article,2014-12-15,10.1148/radiol.14141242,,,,25513855,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/8337892,https://api.altmetric.com/v1/donut/8337892_240.png 1,"Tetrahydroisoquinoline-derived urea and 2,5-diketopiperazine derivatives as selective antagonists of the transient receptor potential melastatin 8 (TRPM8) channel receptor and anti-prostate cancer agents",Journal of Medicinal Chemistry,,,Article,2016-05-27,10.1021/acs.jmedchem.5b01448,,,,27232526,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8331275,https://api.altmetric.com/v1/donut/8331275_240.png 1,Cardiovascular Disease Risk Factors: How Relevant in African Men With Prostate Cancer Receiving Androgen-Deprivation Therapy?,Journal of Global Oncology,,,Article,2016-05-25,10.1200/jgo.2015.002790,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8322148,https://api.altmetric.com/v1/donut/8322148_240.png 1," Regulation of Ca 2+ signaling in prostate cancer cells ",Channels,,,Article,2016-01-08,10.1080/19336950.2015.1137176,,,,26745455,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8321719,https://api.altmetric.com/v1/donut/8321719_240.png 1,Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique,Radiotherapy & Oncology,,,Article,2016-05-01,10.1016/j.radonc.2016.05.012,,,,27237059,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8313243,https://api.altmetric.com/v1/donut/8313243_240.png 1,Abstract B67: Matriptase is involved in COX-2 signaling-induced prostate cancer cell invasion,Cancer Research,,,Article,2016-04-01,10.1158/1538-7445.tummet15-b67,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8308354,https://api.altmetric.com/v1/donut/8308354_240.png 1,"Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer",Investigational New Drugs,,,Article,2016-05-10,10.1007/s10637-016-0357-4,,,,27159981,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8270932,https://api.altmetric.com/v1/donut/8270932_240.png 1,Prostate cancer epigenetics and its clinical implications.,Asian Journal of Andrology,,,Article,2016-05-24,,,,,27212125,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8151064,https://api.altmetric.com/v1/donut/8151064_240.png 1,"Targeting PARP in Prostate Cancer: Novelty, Pitfalls, and Promise.",Oncology (08909091),,,Article,2016-05-01,,,,,27188668,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8134535,https://api.altmetric.com/v1/donut/8134535_240.png 1,Commentary on “Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy”,Brachytherapy,,,Article,2013-02-14,10.1016/j.brachy.2013.01.001,,,,23415049,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8114424,https://api.altmetric.com/v1/donut/8114424_240.png 1,Two-dimensional in vivo rectal dosimetry using an endorectal balloon with unfoldable radiochromic film during prostate cancer radiotherapy,Radiotherapy & Oncology,,,Article,2016-05-21,10.1016/j.radonc.2016.05.003,,,,27222297,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8111640,https://api.altmetric.com/v1/donut/8111640_240.png 1,Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.,The Prostate,,,Article,2016-05-21,10.1002/pros.23194,,,,27199259,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8080467,https://api.altmetric.com/v1/donut/8080467_240.png 1,ODAM is a predictor for biomedical recurrence and inhibits the migration and invasion of prostate cancer.,American Journal of Translational Research,,,Article,2016-01-01,,,,,27158359,PMC4846916,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7990060,https://api.altmetric.com/v1/donut/7990060_240.png 1,"Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024",European Urology,,,Article,2016-05-20,10.1016/j.eururo.2016.05.006,,,,27210462,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7857388,https://api.altmetric.com/v1/donut/7857388_240.png 1,MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor,Prostate Cancer & Prostatic Diseases,,,Article,2016-05-10,10.1038/pcan.2016.11,,,,27165976,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7826962,https://api.altmetric.com/v1/donut/7826962_240.png 1,Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9350,,,,27191265,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7622156,https://api.altmetric.com/v1/donut/7622156_240.png 1,GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9359,,,,27191986,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7620822,https://api.altmetric.com/v1/donut/7620822_240.png 1,Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction,Frontiers in oncology,,,Article,2016-05-18,10.3389/fonc.2016.00122,,,,27242962,PMC4870496,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7577410,https://api.altmetric.com/v1/donut/7577410_240.png 1,Effects of Brassicaceae Isothiocyanates on Prostate Cancer,Molecules,,,Article,2016-05-12,10.3390/molecules21050626,,,,27187332,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7547951,https://api.altmetric.com/v1/donut/7547951_240.png 1,"Rap2B promotes cell proliferation, migration and invasion in prostate cancer",Medical Oncology,,,Article,2016-05-06,10.1007/s12032-016-0771-7,,,,27154636,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7482181,https://api.altmetric.com/v1/donut/7482181_240.png 1,Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3,International Journal of Molecular Sciences,,,Article,2016-05-14,10.3390/ijms17050738,,,,27187384,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7471719,https://api.altmetric.com/v1/donut/7471719_240.png 1,T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance,European Journal of Radiology,,,Article,2016-06-01,10.1016/j.ejrad.2016.03.014,,,,27161055,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7365321,https://api.altmetric.com/v1/donut/7365321_240.png 1,Investigation of the Impact of Cell Cycle Stage on Freeze Response Sensitivity of Androgen-Insensitive Prostate Cancer,Technology in Cancer Research and Treatment,,,Article,2016-05-09,10.1177/1533034616648059,,,,27161856,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7339334,https://api.altmetric.com/v1/donut/7339334_240.png 1,MiR-30a and miR-205 are downregulated in hypoxia and modulate radiosensitivity of prostate cancer cells by inhibiting autophagy via TP53INP1.,European review for medical and pharmacological sciences,,,Article,2016-05-11,,,,,27160121,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7339184,https://api.altmetric.com/v1/donut/7339184_240.png 1,A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer,Archives of Biochemistry & Biophysics,,,Article,2016-04-01,10.1016/j.abb.2016.04.014,,,,27132038,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7329608,https://api.altmetric.com/v1/donut/7329608_240.png 1,miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer,Scientific Reports,,,Article,2016-05-09,10.1038/srep25602,,,,27157642,PMC4860600,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7323875,https://api.altmetric.com/v1/donut/7323875_240.png 1,Nanotherapy Silencing the Interleukin-8 Gene Produces Regression of Prostate Cancer by Inhibition of Angiogenesis,Immunology,,,Article,2016-05-01,10.1111/imm.12618,,,,27159450,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7318850,https://api.altmetric.com/v1/donut/7318850_240.png 1,Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer,Anti-Cancer Drugs,,,Article,2016-04-20,10.1097/cad.0000000000000375,,,http://journals.lww.com/anti-cancerdrugs/Fulltext/publishahead/Cabazitaxel_as_second_line_or_third_line_therapy.99074.aspx,27148775,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7268196,https://api.altmetric.com/v1/donut/7268196_240.png 1,Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience,Frontiers in oncology,,,Article,2016-05-06,10.3389/fonc.2016.00114,,,,27200300,PMC4858516,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7217491,https://api.altmetric.com/v1/donut/7217491_240.png 1,Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer,Cell Death & Disease,,,Article,2016-05-01,10.1038/cddis.2016.114,,,,27148684,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7216306,https://api.altmetric.com/v1/donut/7216306_240.png 1,Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial,BMC Cancer,,,Article,2016-05-05,10.1186/s12885-016-2332-z,,,,27150293,PMC4858903,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7201256,https://api.altmetric.com/v1/donut/7201256_240.png 1,miR-301a expression: A prognostic marker for prostate cancer,Urologic Oncology,,,Article,2016-04-01,10.1016/j.urolonc.2016.03.009,,,,27133223,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7147216,https://api.altmetric.com/v1/donut/7147216_240.png 1,Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases.,Asian Journal of Andrology,,,Article,2016-05-04,,,,,27140652,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7139800,https://api.altmetric.com/v1/donut/7139800_240.png 1,Lessons from tissue compartment-specific analysis of androgen receptor alterations in prostate cancer,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2016-04-01,10.1016/j.jsbmb.2016.04.016,,,,27133384,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7124819,https://api.altmetric.com/v1/donut/7124819_240.png 1,Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy,Journal of Controlled Release,,,Article,2016-04-01,10.1016/j.jconrel.2016.04.034,,,,27126903,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7095648,https://api.altmetric.com/v1/donut/7095648_240.png 1,Multifaceted and personalized therapy of advanced prostate cancer,Current opinion in oncology,,,Article,2016-05-01,10.1097/cco.0000000000000284,,,http://journals.lww.com/co-oncology/Fulltext/2016/05000/Multifaceted_and_personalized_therapy_of_advanced.8.aspx,26992199,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7092879,https://api.altmetric.com/v1/donut/7092879_240.png 1,Prostate-specific membrane antigen positron emission tomography in prostate cancer,Current opinion in oncology,,,Article,2016-05-01,10.1097/cco.0000000000000277,,,http://journals.lww.com/co-oncology/Fulltext/2016/05000/Prostate_specific_membrane_antigen_positron.7.aspx,26967720,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7079869,https://api.altmetric.com/v1/donut/7079869_240.png 1,Striking Growth-inhibitory Effects of Minocycline on Human Prostate Cancer Cell Lines,Urology,,,Article,2013-12-18,10.1016/j.urology.2013.10.029,,,,24360070,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7064670,https://api.altmetric.com/v1/donut/7064670_240.png 1,Amplification of the 9p13.3 Chromosomal Region in Prostate Cancer,"Genes, Chromosomes, and Cancer",,,Article,2016-04-01,10.1002/gcc.22364,,,,27074291,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7054058,https://api.altmetric.com/v1/donut/7054058_240.png 1,The cross-talk between Wnt/?-Catenin and CIP2A/Plk1 signaling in prostate cancer: promising therapeutic implications.,Molecular & Cellular Biology,,,Article,2016-04-18,10.1128/mcb.00130-16,,,,27090640,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6984894,https://api.altmetric.com/v1/donut/6984894_240.png 1," Expressional Profiling of Prostate Cancer Risk SNPs at 11q13.5 Identifies DGAT2 As a New Target Gene ","Genes, Chromosomes, and Cancer",,,Article,2016-04-01,10.1002/gcc.22368,,,,27113481,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6983575,https://api.altmetric.com/v1/donut/6983575_240.png 1,An original patient-derived xenograft of prostate cancer with cyst formation,The Prostate,,,Article,2016-04-01,10.1002/pros.23188,,,,27098584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6972325,https://api.altmetric.com/v1/donut/6972325_240.png 1," Analysis and Management of Rectal Gas with Kampo Formulas During Intensity-Modulated Radiotherapy of Prostate Cancer: A Case Series Study ",Journal of Alternative & Complementary Medicine,,,Article,2016-04-25,10.1089/acm.2015.0271,,,,27110721,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6961202,https://api.altmetric.com/v1/donut/6961202_240.png 1,Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.,Cancer Letters,,,Article,2016-04-25,10.1016/j.canlet.2016.04.028,,,,27126362,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6955586,https://api.altmetric.com/v1/donut/6955586_240.png 1,"Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer",Journal of Controlled Release,,,Article,2016-04-01,10.1016/j.jconrel.2016.04.019,,,,27090164,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6919452,https://api.altmetric.com/v1/donut/6919452_240.png 1,Third-line Enzalutamide Following Docetaxel and Abiraterone in Metastatic Castrate-resistant Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2016-04-01,,,,,27069162,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6874025,https://api.altmetric.com/v1/donut/6874025_240.png 1,Androgen Receptor Antagonists Suppress Immunotherapy in Prostate Cancer,Cancer Discovery,,,Article,2016-04-23,10.1158/2159-8290.cd-rw2016-073,,,,27102077,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6869814,https://api.altmetric.com/v1/donut/6869814_240.png 1,"Feasibility of brachytherapy as monotherapy for high-volume, low-risk prostate cancer",Journal of Cancer Research & Therapeutics,,,Article,2016-01-01,10.4103/0973-1482.180083,,,,27072271,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6868812,https://api.altmetric.com/v1/donut/6868812_240.png 1,The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer,Epigenomics,,,Article,2016-04-20,10.2217/epi.16.6,,,,27096814,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6850871,https://api.altmetric.com/v1/donut/6850871_240.png 1,Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer,Oncologist,,,Article,2016-04-18,10.1634/theoncologist.2015-0502,,,,27091421,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6836232,https://api.altmetric.com/v1/donut/6836232_240.png 1,Interstitial pneumonitis secondary to leuprorelin acetate for prostate cancer,Respirology Case Reports,,,Article,2016-03-31,10.1002/rcr2.146,,,,27081487,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6823626,https://api.altmetric.com/v1/donut/6823626_240.png 1,Joint modelling of longitudinal and multi?state processes: application to clinical progressions in prostate cancer,Statistics in Medicine,,,Article,2016-01-01,10.1002/sim.6972,,,,27090611,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6788544,https://api.altmetric.com/v1/donut/6788544_240.png 1," 17?-Hydroxy-18-acetoxywithanolides from Aeroponically Grown Physalis crassifolia and Their Potent and Selective Cytotoxicity for Prostate Cancer Cells ",Journal of Natural Products,,,Article,2016-04-12,10.1021/acs.jnatprod.5b00911,,,,27071003,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6785066,https://api.altmetric.com/v1/donut/6785066_240.png 1,Molecular subtyping of prostate cancer,Current Opinion in Urology,,,Article,2016-05-01,10.1097/mou.0000000000000285,,,http://journals.lww.com/co-urology/Fulltext/2016/05000/Molecular_subtyping_of_prostate_cancer.2.aspx,26986650,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6760368,https://api.altmetric.com/v1/donut/6760368_240.png 1,New developments in prostate cancer biomarkers,Current opinion in oncology,,,Article,2016-05-01,10.1097/cco.0000000000000279,,,http://journals.lww.com/co-oncology/Fulltext/2016/05000/New_developments_in_prostate_cancer_biomarkers.11.aspx,26974844,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6752105,https://api.altmetric.com/v1/donut/6752105_240.png 1,Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8666,,,,27074561,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6710413,https://api.altmetric.com/v1/donut/6710413_240.png 1,Long noncoding RNAs in prostate cancer: overview and clinical implications.,Asian Journal of Andrology,,,Article,2016-04-14,,,,,27072044,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6687573,https://api.altmetric.com/v1/donut/6687573_240.png 1,Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer,Reports of Practical Oncology & Radiotherapy,,,Article,2016-05-01,10.1016/j.rpor.2015.12.003,,,,27601945,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6665175,https://api.altmetric.com/v1/donut/6665175_240.png 1,CACUL1 functions as a negative regulator of androgen receptor in prostate cancer cells,Cancer Letters,,,Article,2016-04-13,10.1016/j.canlet.2016.04.019,,,,27085459,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6661417,https://api.altmetric.com/v1/donut/6661417_240.png 1,Defining and Targeting the Oncogenic Drivers of Neuroendocrine Prostate Cancer,Cancer Cell,,,Article,2016-04-11,10.1016/j.ccell.2016.03.023,,,,27070695,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6643085,https://api.altmetric.com/v1/donut/6643085_240.png 1,Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2016-04-01,,,,,27059190,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6611328,https://api.altmetric.com/v1/donut/6611328_240.png 1,Precision medicine for advanced prostate cancer,Current Opinion in Urology,,,Article,2016-05-01,10.1097/mou.0000000000000278,,,http://journals.lww.com/co-urology/Fulltext/2016/05000/Precision_medicine_for_advanced_prostate_cancer.5.aspx,26909474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6565494,https://api.altmetric.com/v1/donut/6565494_240.png 1,Have we overcome choline PET/CT for early detection of prostate cancer recurrence?,Nuclear Medicine Communications,,,Article,2016-04-04,10.1097/mnm.0000000000000514,,,http://journals.lww.com/nuclearmedicinecomm/Fulltext/publishahead/Have_we_overcome_choline_PET_CT_for_early.98873.aspx,27045965,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6504791,https://api.altmetric.com/v1/donut/6504791_240.png 1,"A Triad of Telomerase, Androgen Receptor and Early Growth Response 1 in Prostate Cancer Cells",Cancer Biology and Therapy,,,Article,2016-03-22,10.1080/15384047.2016.1156255,,,,27003515,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6496826,https://api.altmetric.com/v1/donut/6496826_240.png 1,Hydrogel Spacing for Radiotherapy of Prostate Cancer: A Review of the Literature,Urology Practice,,,Article,2014-04-21,10.1016/j.urpr.2014.03.004,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6487919,https://api.altmetric.com/v1/donut/6487919_240.png 1,Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2016-04-01,10.1097/coc.0000000000000032,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/04000/Long_term_Outcomes_Following_Radiation_Therapy_For.11.aspx,24441584,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6434995,https://api.altmetric.com/v1/donut/6434995_240.png 1,"ASC-J9®, and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals",Cancer Letters,,,Article,2016-04-01,10.1016/j.canlet.2016.01.057,,,,27045473,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6432024,https://api.altmetric.com/v1/donut/6432024_240.png 1,MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.,Cancer Investigation,,,Article,2016-04-01,10.3109/07357907.2016.1156690,,,,27031291,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6425800,https://api.altmetric.com/v1/donut/6425800_240.png 1,"Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.01.029",European Urology,,,Article,2016-03-29,10.1016/j.eururo.2016.03.024,,,,27025587,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6370181,https://api.altmetric.com/v1/donut/6370181_240.png 1,MP40-20 RELATIONSHIP BETWEEN NON-TUMOR PROSTATE VOLUME AND RISK OF POSITIVE SURGICAL MARGIN IN ORGAN CONFINED PROSTATE CANCER,The Journal of Urology,,,Article,2016-04-01,10.1016/j.juro.2016.02.166,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6365801,https://api.altmetric.com/v1/donut/6365801_240.png 1,Weight Management to Reduce Prostate Cancer Risk: A Survey of Men’s Needs and Interests,Cancer and Clinical Oncology,,,Article,2016-03-20,10.5539/cco.v5n1p43,,,,27547287,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6364131,https://api.altmetric.com/v1/donut/6364131_240.png 1,IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2,American Journal of Pathology,,,Article,2016-04-01,10.1016/j.ajpath.2015.12.009,,,,27012192,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6355174,https://api.altmetric.com/v1/donut/6355174_240.png 1,Hibiscus sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF-kB/MMP-9 Pathway,Nutrients,,,Article,2015-06-24,10.3390/nu7075065,,,,26115086,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6341074,https://api.altmetric.com/v1/donut/6341074_240.png 1,Association of single nucleotide polymorphism rs6983267 with the risk of prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8186,,,,27009866,PMC5041923,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6332609,https://api.altmetric.com/v1/donut/6332609_240.png 1,"12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression",FASEB Journal,,,Article,2016-03-10,10.1096/fj.201500076,,,,26965684,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6320551,https://api.altmetric.com/v1/donut/6320551_240.png 1,Correlation between the germline methylation status in ER? promoter and the risk in prostate cancer: a prospective study,Familial Cancer,,,Article,2015-11-07,10.1007/s10689-015-9850-8,,,,26547439,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6294518,https://api.altmetric.com/v1/donut/6294518_240.png 1,"Rapid (""warm"") autopsy study for procurement of metastatic prostate cancer.",Clinical Cancer Research,,,Article,2000-03-01,,,,,10741732,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6263889,https://api.altmetric.com/v1/donut/6263889_240.png 1,USE OF PATIENT ASSESSED HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS IN PROSTATE CANCER RESEARCH: A SYSTEMATIC REVIEW OF THE LITERATURE 2002–15,International Journal of Technology Assessment in Health Care,,,Article,2016-03-22,10.1017/s0266462316000118,,,,27001542,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6261388,https://api.altmetric.com/v1/donut/6261388_240.png 1,Novel roles for class II Phosphoinositide 3-Kinase C2? in signalling pathways involved in prostate cancer cell invasion,Scientific Reports,,,Article,2016-03-17,10.1038/srep23277,,,,26983806,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6250927,https://api.altmetric.com/v1/donut/6250927_240.png 1,Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8043,,,,26993766,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6249760,https://api.altmetric.com/v1/donut/6249760_240.png 1,"Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and Borderline High Prostate-Specific Antigen: A Pilot Study",CardioVascular and Interventional Radiology,,,Article,2016-03-08,10.1007/s00270-016-1322-5,,,,26957011,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6243545,https://api.altmetric.com/v1/donut/6243545_240.png 1,Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8061,,,,26988912,PMC5008401,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6243425,https://api.altmetric.com/v1/donut/6243425_240.png 1,Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells,PLoS ONE,,,Article,2016-03-17,10.1371/journal.pone.0151525,,,,26986969,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6231032,https://api.altmetric.com/v1/donut/6231032_240.png 1,Lycopene consumption and reduction of incidence in subjects at high risk of prostate cancer,Medwave,,,Article,2013-03-01,10.5867/medwave.2013.02.5626,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6205577,https://api.altmetric.com/v1/donut/6205577_240.png 1,New Genetic Markers for Prostate Cancer,Urologic Clinics of North America,,,Article,2016-02-01,10.1016/j.ucl.2015.08.002,,,,26614025,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6199956,https://api.altmetric.com/v1/donut/6199956_240.png 1,Sulforaphane Inhibits c?Myc?Mediated Prostate Cancer Stem?Like Traits,Journal of Cellular Biochemistry,,,Article,2016-03-01,10.1002/jcb.25541,,,,26990292,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6198392,https://api.altmetric.com/v1/donut/6198392_240.png 1,CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models,PLoS ONE,,,Article,2016-03-15,10.1371/journal.pone.0151468,,,,26978528,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6193937,https://api.altmetric.com/v1/donut/6193937_240.png 1,"MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator",Molecular & Cellular Endocrinology,,,Article,2016-03-01,10.1016/j.mce.2016.02.023,,,,26940039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6193791,https://api.altmetric.com/v1/donut/6193791_240.png 1,Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials,Critical Reviews in Oncology/Hematology,,,Article,2016-02-01,10.1016/j.critrevonc.2016.02.013,,,,26971992,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6192148,https://api.altmetric.com/v1/donut/6192148_240.png 1,Hypoxia?responsive miR?124 and miR?144 reduce hypoxia?induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1,Cancer Medicine,,,Article,2016-03-01,10.1002/cam4.664,,,,26990493,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6187827,https://api.altmetric.com/v1/donut/6187827_240.png 1,Edelfosine Promotes Apoptosis in Androgen Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity,Molecular Cancer Therapeutics,,,Article,2016-03-04,10.1158/1535-7163.mct-15-0332,,,,26944919,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6180973,https://api.altmetric.com/v1/donut/6180973_240.png 1,Focal therapy using magnetic resonance image-guided focused ultrasound in patients with localized prostate cancer,Journal of Therapeutic Ultrasound,,,Article,2016-03-11,10.1186/s40349-016-0054-y,,,,26973790,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6177048,https://api.altmetric.com/v1/donut/6177048_240.png 1,Nuclear Receptor Corepressor 1 expression and output declines with prostate cancer progression,Clinical Cancer Research,,,Article,2016-03-13,10.1158/1078-0432.ccr-15-1983,,,,26968201,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6174623,https://api.altmetric.com/v1/donut/6174623_240.png 1,Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells,Journal of Cellular Biochemistry,,,Article,2008-06-30,10.1002/jcb.21721,,,,18320583,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6169988,https://api.altmetric.com/v1/donut/6169988_240.png 1,PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells,Tumor Biology,,,Article,2016-03-09,10.1007/s13277-016-5012-3,,,,26960690,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6152844,https://api.altmetric.com/v1/donut/6152844_240.png 1,Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling,Biochemical & Biophysical Research Communications,,,Article,2016-02-01,10.1016/j.bbrc.2016.02.101,,,,26921446,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6152705,https://api.altmetric.com/v1/donut/6152705_240.png 1,A new contemporary prostate cancer grading system: message to the Italian pathologists.,Pathologica,,,Article,2015-09-01,,,,,26946878,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6149416,https://api.altmetric.com/v1/donut/6149416_240.png 1,Early toxicity of hypofractionated radiotherapy for prostate cancer,Biomedical Papers of the Medical Faculty of Palacky University in Olomouc,,,Article,2016-03-04,10.5507/bp.2016.008,,,,26948031,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6146469,https://api.altmetric.com/v1/donut/6146469_240.png 1,C/EBP? regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion,Cancer Letters,,,Article,2016-03-08,10.1016/j.canlet.2016.03.005,,,,26968249,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6143219,https://api.altmetric.com/v1/donut/6143219_240.png 1,The prostate cancer immunome: in silico functional analysis of antigenic proteins from microarray profiling with IgG,PROTEOMICS,,,Article,2016-03-01,10.1002/pmic.201500378,,,,27089054,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6138159,https://api.altmetric.com/v1/donut/6138159_240.png 1,Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial,Trials,,,Article,2016-03-07,10.1186/s13063-016-1248-x,,,,26948468,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6138090,https://api.altmetric.com/v1/donut/6138090_240.png 1,Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells,Cancer Letters,,,Article,2016-03-07,10.1016/j.canlet.2016.02.056,,,,26965996,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6135366,https://api.altmetric.com/v1/donut/6135366_240.png 1,Approaches to minimize castration in the treatment of advanced prostate cancer,Urologic Oncology,,,Article,,10.1016/j.urolonc.2016.02.001,,,,26944450,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6135346,https://api.altmetric.com/v1/donut/6135346_240.png 1,"New insights into the androgen biotransformation in prostate cancer: A regulatory network among androgen, androgen receptors and UGTs ",Pharmacological Research,,,Article,,10.1016/j.phrs.2016.02.021,,,,26926093,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6128429,https://api.altmetric.com/v1/donut/6128429_240.png 1,Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway,Oncology Reports,,,Article,2016-03-06,10.3892/or.2016.4649,,,,26935264,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6127665,https://api.altmetric.com/v1/donut/6127665_240.png 1,4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus,Scientific Reports,,,Article,2016-03-05,10.1038/srep22462,,,,26934861,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6124667,https://api.altmetric.com/v1/donut/6124667_240.png 1,"Gastrin?releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer",The Prostate,,,Article,2016-03-01,10.1002/pros.23154,,,,26939805,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6124231,https://api.altmetric.com/v1/donut/6124231_240.png 1,TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGF?R2/p-Smad3 signals.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3778,,,,25980442,PMC4558159,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6105352,https://api.altmetric.com/v1/donut/6105352_240.png 1,Paraneoplastic Palmar Fasciitis and Polyarthritis Syndrome in a Patient With Advanced Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2013-06-28,10.1016/j.clgc.2013.05.008,,,,23820064,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6075646,https://api.altmetric.com/v1/donut/6075646_240.png 1,Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.,"Cancer Immunology, Immunotherapy",,,Article,2013-07-08,10.1007/s00262-013-1448-0,,,,23836412,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6061990,https://api.altmetric.com/v1/donut/6061990_240.png 1,Comorbidity and the Receipt of Curative Therapy for Favorable-risk Prostate Cancer Prior to and Following the Publication of PIVOT,,,,Article,2016-03-04,10.1016/j.euf.2016.02.007,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6049094,https://api.altmetric.com/v1/donut/6049094_240.png 1,"Abiraterone acetate for metastatic castration?resistant prostate cancer after docetaxel failure: A randomized, double?blind, placebo?controlled phase 3 bridging study",International Journal of Urology,,,Article,2016-02-01,10.1111/iju.13051,,,,26879374,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6048223,https://api.altmetric.com/v1/donut/6048223_240.png 1,Impact of cosmetic result on selection of surgical treatment in patients with localized prostate cancer. - PubMed - NCBI,Journal of the Society of Laparoendoscopic Surgeons (JSLS),,,Article,2014-10-15,10.4293/jsls.2014.00024,,,,25516703,PMC4266226,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6046927,https://api.altmetric.com/v1/donut/6046927_240.png 1,Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy ,European Journal of Radiology,,,Article,2016-03-15,10.1016/j.ejrad.2016.01.008,,,,26971421,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6045984,https://api.altmetric.com/v1/donut/6045984_240.png 1,"Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest",International Journal of Molecular Sciences,,,Article,2016-02-22,10.3390/ijms17020264,,,,26907265,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6044998,https://api.altmetric.com/v1/donut/6044998_240.png 1,The primary care physician's role in the monitoring and management of the potential sequelae of the medical treatment of prostate cancer: early and..,Canadian Journal of Urology,,,Article,2016-03-02,,,,,26924593,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6040277,https://api.altmetric.com/v1/donut/6040277_240.png 1,Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer,Cell Death & Disease,,,Article,2016-02-01,10.1038/cddis.2015.403,,,,26913603,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6032145,https://api.altmetric.com/v1/donut/6032145_240.png 1,Anger Proneness and Prognostic Pessimism in Men With Prostate Cancer,American journal of hospice & palliative care,,,Article,2016-03-01,10.1177/1049909116636358,,,,26922817,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6031644,https://api.altmetric.com/v1/donut/6031644_240.png 1,"Prostate Cancer Knowledge, Prevention, and Screening Behaviors in Jamaican Men",Journal of Cancer Education,,,Article,2016-02-03,10.1007/s13187-016-0991-8,,,,26842816,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6020540,https://api.altmetric.com/v1/donut/6020540_240.png 1,High-intensity focused ultrasound for prostate cancer: a systematic review,Clinical Oncology,,,Article,2011-03-15,10.1016/j.clon.2010.09.002,,,,20932728,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6017968,https://api.altmetric.com/v1/donut/6017968_240.png 1,Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients,Archives of Toxicology,,,Article,2014-01-22,10.1007/s00204-014-1196-8,,,,24448834,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6014217,https://api.altmetric.com/v1/donut/6014217_240.png 1,Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy,Medicine,,,Article,2016-02-01,10.1097/md.0000000000002551,,,http://journals.lww.com/md-journal/Fulltext/2016/02150/Absence_of_Bladder_Outlet_Obstruction_Is_an.5.aspx,26886598,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6013445,https://api.altmetric.com/v1/donut/6013445_240.png 1,Systematic review: does endocrine therapy prolong survival in patients with prostate cancer?,Scandinavian journal of urology,,,Article,2016-02-27,10.3109/21681805.2016.1142472,,,,26907159,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6012677,https://api.altmetric.com/v1/donut/6012677_240.png 1,Protein regulator of cytokinesis 1 overexpression predicts biochemical recurrence in men with prostate cancer. - PubMed - NCBI,Biomedicine & Pharmacotherapy,,,Article,,10.1016/j.biopha.2016.01.004,,,,26898432,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6006823,https://api.altmetric.com/v1/donut/6006823_240.png 1,Advancing Treatment Strategies in Metastatic Castration-resistant Prostate Cancer: The Urologists Role,Urology,,,Article,2016-02-25,10.1016/j.urology.2015.12.018,,,,26924221,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6005563,https://api.altmetric.com/v1/donut/6005563_240.png 1,Beyond D’Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier,Radiation Oncology,,,Article,2016-02-24,10.1186/s13014-016-0599-5,,,,26911291,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5991668,https://api.altmetric.com/v1/donut/5991668_240.png 1,Diffusion in prostate cancer detection on a 3T scanner: How many b?values are needed?,Journal of Magnetic Resonance Imaging,,,Article,2016-02-01,10.1002/jmri.25206,,,,26914964,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5974562,https://api.altmetric.com/v1/donut/5974562_240.png 1,Novel Prostate Cancer Biomarkers Derived from Autoantibody Signatures,Translational Oncology,,,Article,2015-04-01,10.1016/j.tranon.2015.02.003,,,,25926076,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/5974516,https://api.altmetric.com/v1/donut/5974516_240.png 1,Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy,Journal of Robotic Surgery,,,Article,2016-02-17,10.1007/s11701-016-0565-0,,,,26885662,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5911356,https://api.altmetric.com/v1/donut/5911356_240.png 1,Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients,Medical science monitor international medical journal of experimental and clinical research,,,Article,,,,,,26881880,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5742153,https://api.altmetric.com/v1/donut/5742153_240.png 1,Therapeutic Vaccines for Prostate Cancer: Recent Advances and Future Directions,Expert Review of Vaccines,,,Article,2016-02-19,10.1586/14760584.2016.1155988,,,,26889831,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5690523,https://api.altmetric.com/v1/donut/5690523_240.png 1,What Prevents Men Aged 40-64 Years from Prostate Cancer Screening in Namibia?,Journal of Cancer Epidemiology,,,Article,2016-01-01,10.1155/2016/7962502,,,,26880917,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5637615,https://api.altmetric.com/v1/donut/5637615_240.png 1,Prostate cancer risk prediction and the persistence of uncertainty,British Journal of Urology,,,Article,2016-02-15,10.1111/bju.13356,,,,26876898,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5628975,https://api.altmetric.com/v1/donut/5628975_240.png 1,Stratification of aggressive prostate cancer from indolent disease—Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue,Urologic Oncology,,,Article,2016-02-05,10.1016/j.urolonc.2015.12.014,,,,26857646,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5628662,https://api.altmetric.com/v1/donut/5628662_240.png 1,PBOV1 promotes prostate cancer proliferation by promoting G1/S transition,OncoTargets and therapy,,,Article,2016-02-16,10.2147/ott.s92682,,,,26937201,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5624386,https://api.altmetric.com/v1/donut/5624386_240.png 1,Editorial: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer,Current Drug Targets,,,Article,2016-02-17,,,,,26876024,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5621159,https://api.altmetric.com/v1/donut/5621159_240.png 1,Lifestyle and dietary factors in relation to prostate cancer risk,International Journal of Food Sciences & Nutrition,,,Article,,10.3109/09637486.2015.1077786,,,,26327471,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5613364,https://api.altmetric.com/v1/donut/5613364_240.png 1,Prostate cancer?derived cathelicidin?related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages,The Prostate,,,Article,2016-01-01,10.1002/pros.23155,,,,26856684,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5607606,https://api.altmetric.com/v1/donut/5607606_240.png 1,Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2016-02-01,10.1016/j.clgc.2015.07.006,,,,26382223,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5586744,https://api.altmetric.com/v1/donut/5586744_240.png 1,Racial differences in the association between preoperative serum cholesterol and prostate cancer recurrence: results from the SEARCH database.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-03-01,10.1158/1055-9965.epi-15-0876,,,,26809276,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5571628,https://api.altmetric.com/v1/donut/5571628_240.png 1,Predictors of adherence to a 12-week exercise program among men treated for prostate cancer: ENGAGE study,Cancer Medicine,,,Article,2016-02-14,10.1002/cam4.639,,,,26872005,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5533626,https://api.altmetric.com/v1/donut/5533626_240.png 1,miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6,Oncology Letters,,,Article,2016-01-01,10.3892/ol.2015.3970,,,,26870245,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5533361,https://api.altmetric.com/v1/donut/5533361_240.png 1,Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer,Oncotarget,,,Article,2016-02-13,10.18632/oncotarget.7287,,,,26872377,PMC4924697,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5532812,https://api.altmetric.com/v1/donut/5532812_240.png 1,Management of Prostate Cancer in the Elderly,Clinics in geriatric medicine,,,Article,2015-10-09,10.1016/j.cger.2015.08.001,,,,26614864,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5532142,https://api.altmetric.com/v1/donut/5532142_240.png 1,Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells,Oncology Letters,,,Article,2016-01-01,10.3892/ol.2015.3854,,,,26870186,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5529892,https://api.altmetric.com/v1/donut/5529892_240.png 1,PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells,Molecular and Clinical Oncology,,,Article,2016-01-01,10.3892/mco.2015.673,,,,26835011,PMC4726986,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5521026,https://api.altmetric.com/v1/donut/5521026_240.png 1,Neoadjuvant chemotherapy using reduced?dose docetaxel followed by radical prostatectomy for patients with intermediate and high?risk prostate cancer: a single?center study,The Prostate,,,Article,2016-02-01,10.1002/pros.23165,,,,26864707,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5517640,https://api.altmetric.com/v1/donut/5517640_240.png 1,Trends in Metastatic Breast and Prostate Cancer.,New England Journal of Medicine,,,Article,2016-02-11,10.1056/nejmc1515983#sa2,,,,26863370,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5309796,https://api.altmetric.com/v1/donut/5309796_240.png 1,Trends in Metastatic Breast and Prostate Cancer.,New England Journal of Medicine,,,Article,2016-02-11,10.1056/nejmc1515983#sa3,,,,26863371,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5309795,https://api.altmetric.com/v1/donut/5309795_240.png 1,Trends in Metastatic Breast and Prostate Cancer.,New England Journal of Medicine,,,Article,2016-02-11,10.1056/nejmc1515983#sa1,,,,26863369,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5309794,https://api.altmetric.com/v1/donut/5309794_240.png 1,Prostatic specific antigen. From its early days until becoming a prostate cancer biomarker.,Archivos Españoles de Urología,,,Article,2016-02-11,,,,,26856734,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5308403,https://api.altmetric.com/v1/donut/5308403_240.png 1,Detection of Sarcomatoid Lung Metastasis With 68GA-PSMA PET/CT in a Patient With Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2016-02-10,10.1097/rlu.0000000000001157,,,http://journals.lww.com/nuclearmed/Fulltext/2016/05000/Detection_of_Sarcomatoid_Lung_Metastasis_With.25.aspx,26859209,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5299062,https://api.altmetric.com/v1/donut/5299062_240.png 1,Implication of high risk Human papillomavirus HR-HPV infection in prostate cancer in Indian population- A pioneering case-control analysis.,Scientific reports,,,Article,2015-01-16,10.1038/srep07822,,,,25592643,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/5298651,https://api.altmetric.com/v1/donut/5298651_240.png 1,A shared-parameter joint model for prostate cancer risk and psa longitudinal profiles,,,,Article,2016-02-08,,,,,,,2117/82670,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5112791,https://api.altmetric.com/v1/donut/5112791_240.png 1,Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy,Psycho-Oncology,,,Article,2016-01-01,10.1002/pon.4100,,,,26857160,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5112609,https://api.altmetric.com/v1/donut/5112609_240.png 1,Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers,Molecular Therapy — Oncolytics,,,Article,2016-02-03,10.1038/mto.2015.21,,,,26900598,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5109503,https://api.altmetric.com/v1/donut/5109503_240.png 1,Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer,Journal of Nutritional Biochemistry,,,Article,2010-11-01,10.1016/j.jnutbio.2010.06.003,,,,21062672,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/5105602,https://api.altmetric.com/v1/donut/5105602_240.png 1,"International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption",Cancer (0008543X),,,Article,1986-12-01,10.1002/1097-0142(19861201)58:11<2363::aid-cncr2820581102>3.0.co;2-#,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5104350,https://api.altmetric.com/v1/donut/5104350_240.png 1,A prospective study examining elder-relevant outcomes in older adults with prostate cancer undergoing treatment with chemotherapy or abiraterone ,Journal of Geriatric Oncology,,,Article,2016-02-01,10.1016/j.jgo.2016.01.003,,,,26853769,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5104323,https://api.altmetric.com/v1/donut/5104323_240.png 1,Stereotactic Body Radiotherapy for Clinically Localized Prostate Cancer: Toxicity and Biochemical Disease-Free Outcomes from a Multi-Institutional Patient Registry.,Cure?us,,,Article,2015-01-01,10.7759/cureus.395,,,,26798571,PMC4699985,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5102255,https://api.altmetric.com/v1/donut/5102255_240.png 1,Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer,Scientific Reports,,,Article,2016-01-25,10.1038/srep19608,,,,26804196,PMC4726263,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/5095060,https://api.altmetric.com/v1/donut/5095060_240.png 1,Gene-expression profiling of localized prostate cancer: still miles to go before we sleep.,Future Oncology,,,Article,2016-02-04,10.2217/fon.15.316,,,,26814711,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5089653,https://api.altmetric.com/v1/donut/5089653_240.png 1,Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study,European Urology Focus ,,,Article,2016-02-04,10.1016/j.euf.2016.01.005,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5088753,https://api.altmetric.com/v1/donut/5088753_240.png 1,p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.,Molecular Cancer Research,,,Article,2014-12-15,10.1158/1541-7786.mcr-14-0277-t,,,,25512615,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5081569,https://api.altmetric.com/v1/donut/5081569_240.png 1,Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality,International braz j urol,,,Article,2011-12-01,10.1590/s1677-55382011000600028,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5080991,https://api.altmetric.com/v1/donut/5080991_240.png 1,Signaling lansdscape of prostate cancer.,Cellular and molecular biology,,,Article,2016-02-02,,,,,26828986,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5078377,https://api.altmetric.com/v1/donut/5078377_240.png 1,The current and future role of magnetic resonance imaging in prostate cancer detection and management,Translational Andrology and Urology,,,Article,2015-06-01,10.3978/j.issn.2223-4683.2015.06.05,,,,26816833,PMC4708229,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5073314,https://api.altmetric.com/v1/donut/5073314_240.png 1,18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.,Clinical Nuclear Medicine,,,Article,2016-02-01,10.1097/rlu.0000000000001113,,,http://journals.lww.com/nuclearmed/Fulltext/2016/05000/18F_Choline_PET_CT_Positive_Lytic_Bone_Lesions_in.13.aspx,26825195,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5069057,https://api.altmetric.com/v1/donut/5069057_240.png 1,"Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells ",Pharmacological Research,,,Article,2016-01-31,10.1016/j.phrs.2016.01.012,,,,26808083,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5067339,https://api.altmetric.com/v1/donut/5067339_240.png 1,Kallikreins Panel for Prostate Cancer Aggressiveness Prediction: More Is Not Enough,,,,Article,2016-01-31,10.1016/j.euf.2016.01.007,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5066678,https://api.altmetric.com/v1/donut/5066678_240.png 1,Primary prevention and early diagnosis of prostate cancer: recommendations from the prevention and early diagnosis working group of the Spanish Society of Medical Oncology (SEOM),European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2016-03-01,10.1097/cej.0000000000000149,,,,25793920,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5063795,https://api.altmetric.com/v1/donut/5063795_240.png 1,Abstract 906: Decreasing omega-6 to omega-3 polyunsaturated fatty acid dietary ratios inhibit tumorigenesis in prostate cancer cells in vitro and in vivo,Cancer Research,,,Article,2015-08-01,10.1158/1538-7445.am2015-906,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5062442,https://api.altmetric.com/v1/donut/5062442_240.png 1,Cost?effectiveness analysis of intensity?modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer,European Journal of Cancer Care,,,Article,2016-01-01,10.1111/ecc.12430,,,,26782759,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5062300,https://api.altmetric.com/v1/donut/5062300_240.png 1,MiR-205 suppresses autophagy and enhances radiosensitivity of prostate cancer cells by targeting TP53INP1.,European review for medical and pharmacological sciences,,,Article,2016-01-28,,,,,26813458,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5054686,https://api.altmetric.com/v1/donut/5054686_240.png 1,Sipuleucel?T for metastatic castration?resistant prostate cancer,Cochrane database of systematic reviews,,,Article,2016-01-21,10.1002/14651858.cd012046,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5050967,https://api.altmetric.com/v1/donut/5050967_240.png 1,In vivo measurement of dose distribution in patients' lymphocytes: helical tomotherapy versus step-and-shoot IMRT in prostate cancer.,Journal of radiation research,,,Article,2014-10-31,10.1093/jrr/rru096,,,,25361548,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5042779,https://api.altmetric.com/v1/donut/5042779_240.png 1,Impacts of anti-EGFR monoclonal antibody in prostate cancer PC3 cells.,,,,Article,,10.3233/hab-2010-0229,,,,20826931,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5041031,https://api.altmetric.com/v1/donut/5041031_240.png 1,Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.,Oncology Reports,,,Article,2016-01-26,10.3892/or.2016.4582,,,,26797252,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5039454,https://api.altmetric.com/v1/donut/5039454_240.png 1,PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.,Oncotarget,,,Article,2016-01-25,10.18632/oncotarget.6955,,,,26799286,PMC4884961,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/5034118,https://api.altmetric.com/v1/donut/5034118_240.png 1,The role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner,Scientific Reports,,,Article,2016-01-20,10.1038/srep16993,,,,26787499,PMC4726385,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5031585,https://api.altmetric.com/v1/donut/5031585_240.png 1,Transdermal estradiol therapy for advanced prostate cancer--forward to the past?,The Journal of Urology,,,Article,2003-05-01,10.1097/01.ju.0000061024.75334.40,,,,12686820,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5030581,https://api.altmetric.com/v1/donut/5030581_240.png 1,A feed forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.,Cancer Letters,,,Article,2016-01-01,10.1016/j.canlet.2016.01.033,,,,26808578,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5029062,https://api.altmetric.com/v1/donut/5029062_240.png 1,CtBP2 overexpression is associated with tumorigenesis and poor clinical outcome of prostate cancer.,Archives of Medical Science,,,Article,2015-12-10,10.5114/aoms.2015.56359,,,,26788097,PMC4697064,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5026953,https://api.altmetric.com/v1/donut/5026953_240.png 1,Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer.,New England Journal of Medicine,,,Article,2016-01-22,10.1056/nejmc1511800#sa1,,,,26789884,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5025164,https://api.altmetric.com/v1/donut/5025164_240.png 1,HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells.,Oncology Reports,,,Article,2016-01-21,10.3892/or.2016.4563,,,,26781690,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5022857,https://api.altmetric.com/v1/donut/5022857_240.png 1,Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2014.0451,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5014752,https://api.altmetric.com/v1/donut/5014752_240.png 1,Choline-phospholipids inter-conversion is altered in elderly patients with prostate cancer.,Biochimie,,,Article,2016-01-19,10.1016/j.biochi.2016.01.003,,,,26776756,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5010975,https://api.altmetric.com/v1/donut/5010975_240.png 1,Influence of abiraterone acetate on circulating neuromediators in chemotherapy?naïve castration?resistant prostate cancer,The Prostate,,,Article,2016-01-01,10.1002/pros.23152,,,,26779767,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5002331,https://api.altmetric.com/v1/donut/5002331_240.png 1,"Rapid, nongenomic signaling effects of several xenoestrogens involved in early- vs. late-stage prostate cancer cell proliferation",Endocrine Disruptors,,,Article,,10.4161/23273747.2014.995003,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5002053,https://api.altmetric.com/v1/donut/5002053_240.png 1," In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer",Journal of Biomedical Nanotechnology,,,Article,2016-01-01,10.1166/jbn.2016.2144,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4996343,https://api.altmetric.com/v1/donut/4996343_240.png 1,"Physical exercise for functional capacity, blood immune function, fatigue and quality of life in high-risk prostate cancer patients during radiotherapy. A prospective, randomised clinical study.",European Journal of Physical and Rehabilitation Medicine,,,Article,2016-01-14,,,,,26761561,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4994389,https://api.altmetric.com/v1/donut/4994389_240.png 1,A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells,Molecular BioSystems,,,Article,2016-01-14,10.1039/c5mb00554j,,,,26759180,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4993690,https://api.altmetric.com/v1/donut/4993690_240.png 1,"The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",Annals of Epidemiology,,,Article,,10.1016/j.annepidem.2015.10.003,,,,26611771,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4992669,https://api.altmetric.com/v1/donut/4992669_240.png 1,Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases,Cancer Medicine,,,Article,2016-01-01,10.1002/cam4.594,,,,26765317,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4991334,https://api.altmetric.com/v1/donut/4991334_240.png 1,Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer.,Iranian Red Crescent medical journal,,,Article,2015-12-01,10.5812/ircmj.19439,,,,26744630,PMC4700873,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4973745,https://api.altmetric.com/v1/donut/4973745_240.png 1,"Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer",Radiotherapy & Oncology,,,Article,2016-01-20,10.1016/j.radonc.2015.11.035,,,,26780999,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4972912,https://api.altmetric.com/v1/donut/4972912_240.png 1,"Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines",Radiotherapy & Oncology,,,Article,2016-01-19,10.1016/j.radonc.2015.12.023,,,,26776443,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4972910,https://api.altmetric.com/v1/donut/4972910_240.png 1,Olaparib Targets Some Advanced Prostate Cancers,Cancer Discovery,,,Article,2016-01-01,10.1158/2159-8290.cd-nb2015-161,,,,26658963,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4970305,https://api.altmetric.com/v1/donut/4970305_240.png 1,The way of prostate cancer diagnostics.,Clinical Chemistry & Laboratory Medicine,,,Article,2016-01-08,10.1515/cclm-2015-1114,,,,26741349,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4969881,https://api.altmetric.com/v1/donut/4969881_240.png 1,Use of androgen receptor signaling-targeted therapies in chemotherapy-naive metastatic castration-resistant prostate cancer: a call for patient-centered studies.,Journal of Comparative Effectiveness Research,,,Article,2016-01-06,10.2217/cer.15.61,,,,26690748,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4960887,https://api.altmetric.com/v1/donut/4960887_240.png 1,Triple cancer: chronic lymphocytic leukemia with bladder and prostate carcinoma.,The Malaysian Journal of Pathology,,,Article,2015-08-01,,,,,26277675,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4954491,https://api.altmetric.com/v1/donut/4954491_240.png 1,Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen?detection in older (65+) men,International Journal of Cancer,,,Article,2015-12-01,10.1002/ijc.29976,,,,26695380,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4953998,https://api.altmetric.com/v1/donut/4953998_240.png 1,Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer,Radiotherapy & Oncology,,,Article,2016-01-13,10.1016/j.radonc.2015.12.018,,,,26755165,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4947643,https://api.altmetric.com/v1/donut/4947643_240.png 1,Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.,Toxicology & Applied Pharmacology,,,Article,2016-01-03,10.1016/j.taap.2015.12.013,,,,26721309,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4947602,https://api.altmetric.com/v1/donut/4947602_240.png 1,The Expression of Ubiquitous Mitochondrial Creatine Kinase Is Downregulated as Prostate Cancer Progression.,Journal of Cancer,,,Article,2016-01-01,10.7150/jca.13207,,,,26722360,PMC4679381,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4945895,https://api.altmetric.com/v1/donut/4945895_240.png 1,"Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",Carcinogenesis,,,Article,2011-01-01,10.1093/carcin/bgq204,,,,20929901,PMC3010173,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4938163,https://api.altmetric.com/v1/donut/4938163_240.png 1,Metastasis of Prostate Cancer to Pleura,Journal of Pulmonary & Respiratory Medicine,,,Article,2013-03-21,10.4172/2161-105x.1000135,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4934259,https://api.altmetric.com/v1/donut/4934259_240.png 1,The role of ATP?binding cassette transporter genes in the progression of prostate cancer,The Prostate,,,Article,2015-12-01,10.1002/pros.23137,,,,26708806,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4931970,https://api.altmetric.com/v1/donut/4931970_240.png 1,What is the mechanism effect that links social support to coping and psychological outcome within individuals affected by prostate cancer? Real time data collection using mobile technology,European Journal of Oncology Nursing,,,Article,,10.1016/j.ejon.2015.09.002,,,,26440544,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4929753,https://api.altmetric.com/v1/donut/4929753_240.png 1,PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?,International Journal of Environmental Research and Public Health,,,Article,2015-12-22,10.3390/ijerph13010012,,,,26703666,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4929020,https://api.altmetric.com/v1/donut/4929020_240.png 1,A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E),Biomaterials Science,,,Article,2015-12-15,10.1039/c5bm00375j,,,,26553555,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4925182,https://api.altmetric.com/v1/donut/4925182_240.png 1,Repeatability of quantitative 18F-fluoromethylcholine PET/CT studies in prostate cancer.,Journal of Nuclear Medicine,,,Article,2015-12-26,10.2967/jnumed.115.167692,,,,26697964,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4924535,https://api.altmetric.com/v1/donut/4924535_240.png 1,Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy.,Canadian Journal of Urology,,,Article,2015-12-23,,,,,26688133,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4914261,https://api.altmetric.com/v1/donut/4914261_240.png 1,Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1,Genetics and Molecular Biology,,,Article,2015-12-23,10.1590/s1415-475738420150028,,,,26692161,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4909634,https://api.altmetric.com/v1/donut/4909634_240.png 1,Dramatic PSA Increase With Tumor Shrinkage After Initiating Degarelix in Advanced Prostate Cancer,Clinical Genitourinary Cancer,,,Article,,10.1016/j.clgc.2015.09.012,,,,26508365,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4904666,https://api.altmetric.com/v1/donut/4904666_240.png 1,Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis,Archivio italiano di urologia andrologia organo ufficiale di Società italiana di ecografia urologica e nefrologica,,,Article,2015-07-07,10.4081/aiua.2015.2.121,,,,26150028,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4903555,https://api.altmetric.com/v1/donut/4903555_240.png 1,Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.,Oncology Reports,,,Article,2015-12-20,10.3892/or.2015.4481,,,,26676551,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4900952,https://api.altmetric.com/v1/donut/4900952_240.png 1,Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment).,Current Radiopharmaceuticals,,,Article,2015-12-16,,,,,26655262,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4883614,https://api.altmetric.com/v1/donut/4883614_240.png 1,Corrigendum: TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.,Nature Communications,,,Article,2015-12-15,10.1038/ncomms10265,,,,26655830,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4880745,https://api.altmetric.com/v1/donut/4880745_240.png 1,Dose–volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation,Radiotherapy & Oncology,,,Article,2015-12-26,10.1016/j.radonc.2015.11.020,,,,26702990,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4878015,https://api.altmetric.com/v1/donut/4878015_240.png 1,Estimation of late rectal normal tissue complication probability parameters in carbon ion therapy for prostate cancer,Radiotherapy & Oncology,,,Article,2015-12-25,10.1016/j.radonc.2015.11.023,,,,26700600,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4878012,https://api.altmetric.com/v1/donut/4878012_240.png 1,"Risk of malignant melanoma in men with prostate cancer. Nationwide, population?based cohort study",International Journal of Cancer,,,Article,2015-12-01,10.1002/ijc.29961,,,,26662367,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4875301,https://api.altmetric.com/v1/donut/4875301_240.png 1,Efficacy of Robotic-Assisted Prostatectomy in Localized Prostate Cancer: A Systematic Review of Clinical Trials,Advances in Urology,,,Article,2015-12-14,10.1155/2013/105651,,,,24312127,PMC3842052,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4874331,https://api.altmetric.com/v1/donut/4874331_240.png 1,Immunotherapy in prostate cancer: challenges and opportunities,Immunotherapy,,,Article,2015-12-13,10.2217/imt.15.101,,,,26642100,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4871649,https://api.altmetric.com/v1/donut/4871649_240.png 1,Selective and augmented ?-glucuronidase expression combined with DOX-GA3 application elicits the potent suppression of prostate cancer.,Oncology Reports,,,Article,2015-12-12,10.3892/or.2015.4454,,,,26648021,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4869510,https://api.altmetric.com/v1/donut/4869510_240.png 1,SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells.,Molecular Medicine Reports,,,Article,2015-12-11,10.3892/mmr.2015.4585,,,,26648419,PMC4686115,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4866940,https://api.altmetric.com/v1/donut/4866940_240.png 1,"S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.",Current Cancer Drug Targets,,,Article,2015-12-08,,,,,26638886,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4854225,https://api.altmetric.com/v1/donut/4854225_240.png 1,Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression.,Tumor Biology,,,Article,2015-12-05,10.1007/s13277-015-4488-6,,,,26638170,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4845616,https://api.altmetric.com/v1/donut/4845616_240.png 1,"Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer.",AIMS Medical Science ,,,Article,2015-01-01,10.3934/medsci.2015.4.271,,,,26636131,PMC4664461,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4843853,https://api.altmetric.com/v1/donut/4843853_240.png 1,Prostate cancer: Radiosensitization through reduced DNA repair,Nature Reviews Cancer,,,Article,2015-11-24,10.1038/nrc4051,,,,26597521,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4837485,https://api.altmetric.com/v1/donut/4837485_240.png 1,FDA Clears Another High-Intensity Focused Ultrasound Treatment for Prostate Cancer,Oncology times,,,Article,2015-12-10,10.1097/01.cot.0000475727.82482.86,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4836408,https://api.altmetric.com/v1/donut/4836408_240.png 1,An in vitro system to characterize prostate cancer progression identified signaling required for self?renewal,Molecular Carcinogenesis,,,Article,2015-12-02,10.1002/mc.22444,,,,26621780,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4832038,https://api.altmetric.com/v1/donut/4832038_240.png 1,microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells.,Oncology Letters,,,Article,2015-10-01,10.3892/ol.2015.3551,,,,26622795,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4831472,https://api.altmetric.com/v1/donut/4831472_240.png 1,Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients,Translational Oncology,,,Article,2015-01-02,10.1016/j.tranon.2014.11.005,,,,25749174,PMC4350638,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4825809,https://api.altmetric.com/v1/donut/4825809_240.png 1,The Prostate Health Index: Its Utility in Prostate Cancer Detection.,Urologic Clinics of North America,,,Article,2016-02-01,10.1016/j.ucl.2015.08.001,,,,26614024,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4825332,https://api.altmetric.com/v1/donut/4825332_240.png 1,JAK/STAT pathway interacts with intercellular cell adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) while prostate cancer stem cells form tumor spheroids.,Journal of B U ON official journal of the Balkan Union of Oncology,,,Article,2015-09-01,,,,,26537072,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4820408,https://api.altmetric.com/v1/donut/4820408_240.png 1,Development and evaluation of a support program for prostate cancer survivors in Alaska.,International Journal of Circumpolar Health,,,Article,2015-11-29,,,,,26612829,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4818797,https://api.altmetric.com/v1/donut/4818797_240.png 1,A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.,Oncotarget,,,Article,2015-11-25,10.18632/oncotarget.6360,,,,26594800,PMC4811461,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4807092,https://api.altmetric.com/v1/donut/4807092_240.png 1,Clinical Predictors of Fatigue in Men With Non-Metastatic Prostate Cancer Receiving External Beam Radiation Therapy.,Clinical Journal of Oncology Nursing,,,Article,,10.1188/15.cjon.744-750,,,,26583638,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4794531,https://api.altmetric.com/v1/donut/4794531_240.png 1,Re: Androgen Deprivation Therapy plus Docetaxel and Estramustine Versus Androgen Deprivation Therapy Alone for High-risk Localised Prostate Cancer (GETUG 12): A Phase 3 Randomised Controlled Trial,European Urology,,,Article,2015-12-01,10.1016/j.eururo.2015.08.047,,,,26545569,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4794466,https://api.altmetric.com/v1/donut/4794466_240.png 1,"DIET, OBESITY, AND RISK OF FATAL PROSTATE CANCER",American Journal of Epidemiology,,,Article,1984-08-01,,,,,6465122,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4791351,https://api.altmetric.com/v1/donut/4791351_240.png 1,Erratum: Shear Wave Elastography for Detection of Prostate Cancer: A Preliminary Study.,Korean Journal of Radiology,,,Article,2015-11-19,10.3348/kjr.2015.16.6.1373,,,,26576129,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4784165,https://api.altmetric.com/v1/donut/4784165_240.png 1,Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer.,Expert Review of Endocrinology & Metabolism,,,Article,2011-05-14,10.1586/eem.11.33,,,,22389648,PMC3289283,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4780779,https://api.altmetric.com/v1/donut/4780779_240.png 1,Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis,BMJ Open,,,Article,2015-11-01,10.1136/bmjopen-2015-008217,,,,26567252,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4777698,https://api.altmetric.com/v1/donut/4777698_240.png 1,Sniffing out prostate cancer: a new clinical opportunity.,Central European journal of urology,,,Article,2015-01-01,10.5173/ceju.2015.593,,,,26568871,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4776200,https://api.altmetric.com/v1/donut/4776200_240.png 1,An Overview of Current Screening and Management Approaches for Prostate Cancer.,Current Drug Metabolism,,,Article,,,,,,26560323,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4763988,https://api.altmetric.com/v1/donut/4763988_240.png 1,A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact,Genetic Epidemiology,,,Article,2011-09-01,10.1002/gepi.20605,,,,21769933,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4762875,https://api.altmetric.com/v1/donut/4762875_240.png 1,Pelvic lymph node displacement in high-risk prostate cancer patients treated with image guided intensity modulated radiation therapy with 2 independent target volumes.,Practical Radiation Oncology,,,Article,,10.1016/j.prro.2015.05.002,,,,26127006,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4762459,https://api.altmetric.com/v1/donut/4762459_240.png 1,Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structure.,,,,Article,2007-08-14,10.1093/glycob/cwm054,,,,17513886,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/4754803,https://api.altmetric.com/v1/donut/4754803_240.png 1,Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside.,Current pharmacology reports,,,Article,2015-11-01,10.1007/s40495-015-0034-x,,,,26557472,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4753077,https://api.altmetric.com/v1/donut/4753077_240.png 1,[Focal therapy for prostate cancer : German version].,Der Urologe A,,,Article,2015-02-15,10.1007/s00120-014-3668-0,,,,25690574,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4752773,https://api.altmetric.com/v1/donut/4752773_240.png 1,[Cryoablation of prostate cancer.],Der Urologe A,,,Article,2015-02-08,10.1007/s00120-014-3667-1,,,,25659982,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4752767,https://api.altmetric.com/v1/donut/4752767_240.png 1,Nucleoporin 62 and Ca(2+) /calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.,The Prostate,,,Article,2015-11-11,10.1002/pros.23121,,,,26552607,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4748986,https://api.altmetric.com/v1/donut/4748986_240.png 1,Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.,Molecular Imaging & Biology,,,Article,2015-11-11,10.1007/s11307-015-0908-7,,,,26552656,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4748866,https://api.altmetric.com/v1/donut/4748866_240.png 1,Prognostic and predictive biomarkers in prostate cancer,Expert Review of Molecular Diagnostics,,,Article,2015-11-10,10.1586/14737159.2015.1110022,,,,26548550,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4744672,https://api.altmetric.com/v1/donut/4744672_240.png 1,Should docetaxel be administered earlier in prostate cancer therapy?,Expert Review of Anticancer Therapy,,,Article,,10.1586/14737140.2015.1074042,,,,26223224,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4741826,https://api.altmetric.com/v1/donut/4741826_240.png 1,Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial,BMC Cancer,,,Article,2015-11-07,10.1186/s12885-015-1886-5,,,,26547188,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4736798,https://api.altmetric.com/v1/donut/4736798_240.png 1,The curative management of synchronous rectal and prostate cancer.,British Journal of Radiology,,,Article,2015-11-06,10.1259/bjr.20150292,,,,26539631,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4732060,https://api.altmetric.com/v1/donut/4732060_240.png 1,Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.,Oncotarget,,,Article,2015-11-06,10.18632/oncotarget.6102,,,,26540468,PMC4791269,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4731965,https://api.altmetric.com/v1/donut/4731965_240.png 1,Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer.,Clinical and Translational Oncology,,,Article,,10.1007/s12094-015-1414-8,,,,26482722,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4728712,https://api.altmetric.com/v1/donut/4728712_240.png 1,A pilot study of the association of manganese superoxide dismutase and glutathione peroxidase 1 single gene polymorphisms with prostate cancer and serum prostate specific antigen levels.,Archives of Medical Science,,,Article,2015-10-12,10.5114/aoms.2015.54853,,,,26528342,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4728231,https://api.altmetric.com/v1/donut/4728231_240.png 1,Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.,The Prostate,,,Article,2015-10-01,10.1002/pros.23120,,,,26764246,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4721130,https://api.altmetric.com/v1/donut/4721130_240.png 1,Atypical Small Acinar Proliferation: Repeat Biopsy and Detection of High Grade Prostate Cancer.,Prostate Cancer,,,Article,2015-01-01,10.1155/2015/810159,,,,26451257,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4718775,https://api.altmetric.com/v1/donut/4718775_240.png 1,Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells.,Biochemical & Biophysical Research Communications,,,Article,2015-11-03,10.1016/j.bbrc.2015.10.143,,,,26522224,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4716449,https://api.altmetric.com/v1/donut/4716449_240.png 1,Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,,10.1038/pcan.2015.50,,,,26503109,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4715782,https://api.altmetric.com/v1/donut/4715782_240.png 1,Prostate cancer: ODM-201 tablets complete phase I,Nature Reviews Urology,,,Article,2015-11-03,10.1038/nrurol.2015.268,,,,26526759,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4715752,https://api.altmetric.com/v1/donut/4715752_240.png 1,Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand,BMC Cancer,,,Article,2015-11-02,10.1186/s12885-015-1843-3,,,,26525985,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4715217,https://api.altmetric.com/v1/donut/4715217_240.png 1,Novel C-4 Heteroaryl 13-Cis Retinamide Mnk/AR Degrading Agents Inhibit Cell Proliferation and Migration and Induce Apoptosis in Human Breast and Prostate Cancer Cells and Suppress Growth of MDA-MB-231 Human Breast and CWR22Rv1 Human Prostate Tumor Xenografts in Mice.,Journal of Medicinal Chemistry,,,Article,2015-01-29,10.1021/jm501792c,,,,25634130,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4714986,https://api.altmetric.com/v1/donut/4714986_240.png 1,miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells,Tumor Biology,,,Article,2015-11-02,10.1007/s13277-015-4336-8,,,,26520443,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4713883,https://api.altmetric.com/v1/donut/4713883_240.png 1,SPOP-Driven ERG Proteolysis Suppresses Prostate Tumorigenesis,Cancer Discovery,,,Article,2015-11-01,10.1158/2159-8290.cd-rw2015-175,,,,26382141,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4713199,https://api.altmetric.com/v1/donut/4713199_240.png 1,Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment,International Journal of Nanomedicine,,,Article,2015-10-30,10.2147/ijn.s93752,,,,26586945,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4712025,https://api.altmetric.com/v1/donut/4712025_240.png 1,[Early detection of prostate cancer - Recommendations after 13 years of follow-up in the European randomised study].,Nederlands Tijdschrift voor Geneeskunde,,,Article,,,,,,25850455,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4709789,https://api.altmetric.com/v1/donut/4709789_240.png 1,"Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case-control study.",Cancer Causes and Control,,,Article,2015-10-30,10.1007/s10552-015-0684-3,,,,26518197,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4708227,https://api.altmetric.com/v1/donut/4708227_240.png 1,Dose–surface maps identifying local dose–effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer,Radiotherapy & Oncology,,,Article,2015-11-03,10.1016/j.radonc.2015.10.020,,,,26522060,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4705840,https://api.altmetric.com/v1/donut/4705840_240.png 1,"Third of men with treatment resistant prostate cancer respond to drug that targets gene defect, study finds",British Medical Journal,,,Article,2015-10-30,10.1136/bmj.h5783,,,,26518710,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4705329,https://api.altmetric.com/v1/donut/4705329_240.png 1,Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.,BMB reports,,,Article,2014-12-02,,,,,25441423,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4702267,https://api.altmetric.com/v1/donut/4702267_240.png 1,Methylseleninic acid super-activates P53-senescence cancer progression barrier in prostate lesions of Pten-knockout mouse.,Cancer Prevention Research,,,Article,2015-10-30,10.1158/1940-6207.capr-15-0236,,,,26511486,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4699235,https://api.altmetric.com/v1/donut/4699235_240.png 1,Tumor?suppressive microRNA?223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer,Cancer Science,,,Article,2015-10-01,10.1111/cas.12842,,,,26509963,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4696138,https://api.altmetric.com/v1/donut/4696138_240.png 1,Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition.,Molecular Medicine Reports,,,Article,2015-10-27,10.3892/mmr.2015.4438,,,,26496926,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4679968,https://api.altmetric.com/v1/donut/4679968_240.png 1,Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer,Endocrine-Related Cancer,,,Article,2016-01-01,10.1530/erc-15-0343,,,,26483423,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4676231,https://api.altmetric.com/v1/donut/4676231_240.png 1,Radioactive iodine labeling of monoclonal antibody against Hsp90? and its use in diagnostic imaging in prostate cancer xenograft model.,European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360,,,Article,2015-03-15,,,,,25807438,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4676069,https://api.altmetric.com/v1/donut/4676069_240.png 1,Use of Agricultural Pesticides and Prostate Cancer Risk in the Agricultural Health Study Cohort,American Journal of Epidemiology,,,Article,2003-05-01,10.1093/aje/kwg040,,,,12727674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/4669662,https://api.altmetric.com/v1/donut/4669662_240.png 1,CA1 Analysis of the Relationship Between Patient-Reported Outcomes (Pros) and Clinical Outcomes In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients without Prior Chemotherapy ,Value in Health (Elsevier Science),,,Article,2015-11-05,10.1016/j.jval.2015.09.116,,,,26531898,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4667215,https://api.altmetric.com/v1/donut/4667215_240.png 1,Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer,Journal of Cellular Physiology,,,Article,2016-02-01,10.1002/jcp.25099,,,,26201947,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4662880,https://api.altmetric.com/v1/donut/4662880_240.png 1,The role of multi-parametric MRI in loco-regional staging of men diagnosed with early prostate cancer,Current Opinion in Urology,,,Article,2015-11-01,10.1097/mou.0000000000000215,,,,26372039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4659358,https://api.altmetric.com/v1/donut/4659358_240.png 1,The many ways to make a luminal cell and a prostate cancer cell,Endocrine-Related Cancer,,,Article,2015-12-01,10.1530/erc-15-0195,,,,26307022,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4655406,https://api.altmetric.com/v1/donut/4655406_240.png 1,Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy,Radiation Research,,,Article,2015-10-21,10.1667/rr14173.1,,,,26484401,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4653395,https://api.altmetric.com/v1/donut/4653395_240.png 1,Prostate cancer and exposure to pesticides in agricultural settings.,International Journal of Cancer,,,Article,2003-04-20,10.1002/ijc.10955,,,,12584743,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4651771,https://api.altmetric.com/v1/donut/4651771_240.png 1,A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer,Current Opinion in Urology,,,Article,2015-11-01,10.1097/mou.0000000000000220,,,,26372036,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4649808,https://api.altmetric.com/v1/donut/4649808_240.png 1,Reply to the letter to the editor ‘Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015’ by Gillessen et al.,Annals of Oncology,,,Article,,10.1093/annonc/mdv360,,,,26347101,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4643323,https://api.altmetric.com/v1/donut/4643323_240.png 1,The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC).,Canadian Urological Association Journal,,,Article,2015-03-01,10.5489/cuaj.2526,,,,26085865,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4642762,https://api.altmetric.com/v1/donut/4642762_240.png 1,TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.,Oncogene,,,Article,2014-09-28,10.1038/onc.2014.308,,,,25263440,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/4641908,https://api.altmetric.com/v1/donut/4641908_240.png 1,Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.,Biochemistry and Cell Biology,,,Article,2015-10-16,10.1139/bcb-2015-0038,,,,26458818,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4635749,https://api.altmetric.com/v1/donut/4635749_240.png 1,Development and external validation of a prostate health index-based nomogram for predicting prostate cancer,Scientific Reports,,,Article,2015-10-16,10.1038/srep15341,,,,26471350,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4634025,https://api.altmetric.com/v1/donut/4634025_240.png 1,Erectile Function Following External Beam Radiotherapy for Clinically Organ-confined or Locally Advanced Prostate Cancer,Japanese Journal of Clinical Oncology,,,Article,2004-05-01,10.1093/jjco/hyh041,,,,15231862,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4631151,https://api.altmetric.com/v1/donut/4631151_240.png 1,Impact of tumour invasion on seminal vesicles mobility in radiotherapy of prostate cancer ,Radiotherapy & Oncology,,,Article,2015-10-20,10.1016/j.radonc.2015.09.031,,,,26476561,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4628511,https://api.altmetric.com/v1/donut/4628511_240.png 1,Molecular genetic mechanisms of drug resistance in prostate cancer,Molecular Biology,,,Article,2015-10-10,10.1134/s0026893315050118,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4626606,https://api.altmetric.com/v1/donut/4626606_240.png 1,Preoperative extended field radiation with I-125 seed implant in prostatic cancer: a preliminary report of a randomized study.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,1979-11-01,,,,,544574,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4614492,https://api.altmetric.com/v1/donut/4614492_240.png 1,Current State of ERG as Biomarker in Prostatic Adenocarcinoma.,Current Cancer Drug Targets,,,Article,2015-10-12,,,,,26452381,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4614349,https://api.altmetric.com/v1/donut/4614349_240.png 1,"Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Jesse D. Sammon, Firas Abdollah, Anthony D’Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756–65",European Urology,,,Article,2015-10-10,10.1016/j.eururo.2015.09.041,,,,26461111,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4607578,https://api.altmetric.com/v1/donut/4607578_240.png 1,Can multiparametric MRI rule in or rule out significant prostate cancer?,Current Opinion in Urology,,,Article,2015-11-01,10.1097/mou.0000000000000218,,,,26414607,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4606660,https://api.altmetric.com/v1/donut/4606660_240.png 1,"Measures of birth size in relation to risk of prostate cancer: the Malmö Diet and Cancer Study, Sweden.",Journal of Developmental Origins of Health and Disease,,,Article,2012-12-15,10.1017/s2040174412000402,,,,25084297,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4605328,https://api.altmetric.com/v1/donut/4605328_240.png 1,Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.,Oncotarget,,,Article,2015-10-09,10.18632/oncotarget.5655,,,,26447757,PMC4741862,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4604670,https://api.altmetric.com/v1/donut/4604670_240.png 1,A high-affinity [18?F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer,Nuclear Medicine & Biology,,,Article,2015-01-10,10.1016/j.nucmedbio.2015.06.003,,,,26169882,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4596642,https://api.altmetric.com/v1/donut/4596642_240.png 1,MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence.,Oncotarget,,,Article,2015-10-07,10.18632/oncotarget.5920,,,,26439987,PMC4741465,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4595025,https://api.altmetric.com/v1/donut/4595025_240.png 1,"Re: Jesse D. Sammon, Firas Abdollah, Anthony D’Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756–65.",European Urology,,,Article,2015-10-06,10.1016/j.eururo.2015.09.043,,,,26456682,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4590834,https://api.altmetric.com/v1/donut/4590834_240.png 1,Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.,Oncotarget,,,Article,2015-10-04,10.18632/oncotarget.5866,,,,26431498,PMC4741609,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4583753,https://api.altmetric.com/v1/donut/4583753_240.png 1,GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes.,Clinical and Experimental Metastasis,,,Article,2015-10-03,10.1007/s10585-015-9745-y,,,,26429724,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4583020,https://api.altmetric.com/v1/donut/4583020_240.png 1,AMBRA1 and SQSTM1 expression pattern in prostate cancer.,Apoptosis,,,Article,2015-10-02,10.1007/s10495-015-1176-3,,,,26423274,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4578865,https://api.altmetric.com/v1/donut/4578865_240.png 1,Improving Outcomes from Prostate Cancer: Unlocking the Treasure Trove of Information in Cancer Registries,European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.07.022,,,,26215611,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4577322,https://api.altmetric.com/v1/donut/4577322_240.png 1,MicroRNA in prostate cancer ,Clinica Chimica Acta,,,Article,2015-10-01,10.1016/j.cca.2015.09.022,,,,26415820,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4573300,https://api.altmetric.com/v1/donut/4573300_240.png 1,Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,26408674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4563853,https://api.altmetric.com/v1/donut/4563853_240.png 1,Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2015-05-26,10.1038/pcan.2015.23,,,,26171883,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4562722,https://api.altmetric.com/v1/donut/4562722_240.png 1,"Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links",Prostate Cancer & Prostatic Diseases,,,Article,2015-09-22,10.1038/pcan.2015.43,,,,26391088,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4562705,https://api.altmetric.com/v1/donut/4562705_240.png 1,A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer,The Prostate,,,Article,2015-09-01,10.1002/pros.23089,,,,26383260,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4560001,https://api.altmetric.com/v1/donut/4560001_240.png 1,Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.,The Prostate,,,Article,2015-09-22,10.1002/pros.23094,,,,26390914,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4558610,https://api.altmetric.com/v1/donut/4558610_240.png 1,Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview.,Clinical Nuclear Medicine,,,Article,2015-09-25,10.1097/rlu.0000000000000993,,,,26402127,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4552418,https://api.altmetric.com/v1/donut/4552418_240.png 1,microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.,DNA & Cell Biology,,,Article,2015-09-24,10.1089/dna.2015.3021,,,,26394192,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4547473,https://api.altmetric.com/v1/donut/4547473_240.png 1,Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer,Radiotherapy & Oncology,,,Article,2015-09-28,10.1016/j.radonc.2015.09.019,,,,26409832,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4543581,https://api.altmetric.com/v1/donut/4543581_240.png 1,Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2008-07-09,10.1001/jama.300.2.236,,,,18612121,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4536760,https://api.altmetric.com/v1/donut/4536760_240.png 1,Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer,Journal of Drug Targeting,,,Article,,10.3109/1061186x.2015.1086360,,,,26373825,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4536176,https://api.altmetric.com/v1/donut/4536176_240.png 1,The origin of prostate metastases: emerging insights,Cancer and Metastasis Reviews,,,Article,2015-09-12,10.1007/s10555-015-9597-6,,,,26363603,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4533674,https://api.altmetric.com/v1/donut/4533674_240.png 1,miRNA Expression Analyses in Prostate Cancer Clinical Tissues.,Journal of Visualized Experiments,,,Article,2015-09-19,10.3791/53123,,,,26382040,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4532565,https://api.altmetric.com/v1/donut/4532565_240.png 1,The biology of castration-resistant prostate cancer.,Current Problems in Cancer,,,Article,2014-11-25,10.1016/j.currproblcancer.2014.11.004,,,,25547388,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4527998,https://api.altmetric.com/v1/donut/4527998_240.png 1,KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway,PLoS ONE,,,Article,2015-09-09,10.1371/journal.pone.0137589,,,,26352139,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4521822,https://api.altmetric.com/v1/donut/4521822_240.png 1,Screening for cancer of the prostate: Do we have a state of the art?,Scandinavian Journal of Public Health,,,Article,2015-08-25,10.1177/1403494815597871,,,,26307766,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4519292,https://api.altmetric.com/v1/donut/4519292_240.png 1,Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?,Korean Journal of Urology,,,Article,2015-09-16,10.4111/kju.2015.56.9.624,,,,26366274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4515008,https://api.altmetric.com/v1/donut/4515008_240.png 1,Preclinical Evaluation of Intraoperative Low-Energy Photon Radiotherapy Using Spherical Applicators in Locally Advanced Prostate Cancer,Frontiers in oncology,,,Article,2015-09-15,10.3389/fonc.2015.00204,,,,26442216,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4509839,https://api.altmetric.com/v1/donut/4509839_240.png 1,Robot-assisted radical prostatectomy in prostate cancer.,Future Oncology,,,Article,,10.2217/fon.15.169,,,,26358012,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4509235,https://api.altmetric.com/v1/donut/4509235_240.png 1,Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga?PSMA?positron emission tomography/computerized tomography,The Prostate,,,Article,2015-09-12,10.1002/pros.23091,,,,26356236,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4499150,https://api.altmetric.com/v1/donut/4499150_240.png 1,Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer,American Journal of Pathology,,,Article,2015-01-09,10.1016/j.ajpath.2015.04.026,,,,26362718,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4498093,https://api.altmetric.com/v1/donut/4498093_240.png 1,Cigarette smoke modulates PC3 prostate cancer cell migration by altering adhesion molecules and the extracellular matrix.,Molecular Medicine Reports,,,Article,2015-09-11,10.3892/mmr.2015.4302,,,,26351771,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4497195,https://api.altmetric.com/v1/donut/4497195_240.png 1,Analysis of Prostate Cancer Susceptibility Variants in South African Men: Replicating Associations on Chromosomes 8q24 and 10q11.,Prostate Cancer,,,Article,2015-01-01,10.1155/2015/465184,,,,26347821,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4490095,https://api.altmetric.com/v1/donut/4490095_240.png 1,The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells.,BMC Cancer,,,Article,2015-09-09,10.1186/s12885-015-1640-z,,,,26345371,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4488249,https://api.altmetric.com/v1/donut/4488249_240.png 1,Evaluating a 4?marker signature of aggressive prostate cancer using time?dependent AUC,The Prostate,,,Article,2015-10-16,10.1002/pros.23090,,,,26469352,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4484707,https://api.altmetric.com/v1/donut/4484707_240.png 1,Cardiolipin composition correlates with prostate cancer cell proliferation,Molecular and Cellular Biochemistry,,,Article,2015-08-28,10.1007/s11010-015-2549-1,,,,26314254,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4484598,https://api.altmetric.com/v1/donut/4484598_240.png 1,"Reply to Masaki Shiota and Akira Yokomizo's Letter to the Editor re: Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam, et al. Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer. Eur Urol 2015;67:981–5",European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.07.024,,,,26233533,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4483511,https://api.altmetric.com/v1/donut/4483511_240.png 1,Reply from Authors re: Vincent Khoo. Is There Another Bite of the Cherry? The Case for Radical Local Therapy for Oligometastatic Disease in Prostate Cancer. Eur Urol. In press. http//dx.doi.org/10.1016/j.eururo.2015.07.073: Oligometastatic Prostate Cancer: More Than Just Cherry-picking?,European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.08.036,,,,26361170,,1854/LU-7142780,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4483136,https://api.altmetric.com/v1/donut/4483136_240.png 1,The Resveratrol Tetramer r?Viniferin Induces a Cell Cycle Arrest Followed by Apoptosis in the Prostate Cancer Cell Line LNCaP,Phytotherapy Research,,,Article,2015-01-01,10.1002/ptr.5443,,,,26331691,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4479665,https://api.altmetric.com/v1/donut/4479665_240.png 1,"Correlation between agricultural production, clinical and demographic variables and prostate cancer: an ecological study",Ciência & Saúde Coletiva,,,Article,2015-09-05,10.1590/1413-81232015209.00582015,,,,26331512,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4475272,https://api.altmetric.com/v1/donut/4475272_240.png 1,Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer,Carcinogenesis,,,Article,2015-06-01,10.1093/carcin/bgv046,,,,25863125,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4475121,https://api.altmetric.com/v1/donut/4475121_240.png 1,"Trends and Patterns of Late and Unstaged Lung, Colorectal, Female Breast, and Prostate Cancers among American Indians in the Northern Plains, 2002–2009",Journal of health care for the poor and underserved (Online),,,Article,,10.1353/hpu.2015.0089,,,,26320932,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4467585,https://api.altmetric.com/v1/donut/4467585_240.png 1,Computer Aided Diagnosis: Detection and Localisation of Prostate Cancer within the Peripheral Zone,International Journal for Numerical Methods in Biomedical Engineering,,,Article,2015-01-01,10.1002/cnm.2745,,,,26313267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4467441,https://api.altmetric.com/v1/donut/4467441_240.png 1,"Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.",European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2015-08-27,10.1097/cej.0000000000000189,,,,26313229,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4463788,https://api.altmetric.com/v1/donut/4463788_240.png 1,"Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells",PLoS ONE,,,Article,2010-10-18,10.1371/journal.pone.0013428,,,,20976141,PMC2956649,,2010PLoSO...513428G,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4457480,https://api.altmetric.com/v1/donut/4457480_240.png 1,Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs,Cellular Physiology & Biochemistry,,,Article,2015-08-20,10.1159/000430350,,,,26302893,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4451131,https://api.altmetric.com/v1/donut/4451131_240.png 1,"Androgen receptor inhibits epithelial–mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells",Cancer Letters,,,Article,,10.1016/j.canlet.2015.08.001,,,,26297988,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4449774,https://api.altmetric.com/v1/donut/4449774_240.png 1,No association between fiber intake and prostate cancer risk: a meta-analysis of epidemiological studies,World Journal of Surgical Oncology,,,Article,2015-08-28,10.1186/s12957-015-0681-8,,,,26315558,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4446053,https://api.altmetric.com/v1/donut/4446053_240.png 1,"Reply to Kevin Lu's Letter to the Editor re: Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al. Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. Eur Urol 2015;68:147–53",European Urology,,,Article,2015-08-28,10.1016/j.eururo.2015.08.018,,,,26320376,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4444586,https://api.altmetric.com/v1/donut/4444586_240.png 1,"Re: Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al. Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. Eur Urol 2015;68:147–53",European Urology,,,Article,2015-08-27,10.1016/j.eururo.2015.08.017,,,,26318711,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4440336,https://api.altmetric.com/v1/donut/4440336_240.png 1,Evaluation of pT0 prostate cancer in radical prostatectomy patients,British Journal of Urology,,,Article,2015-08-26,10.1111/bju.13266,,,,26305996,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4434149,https://api.altmetric.com/v1/donut/4434149_240.png 1,Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.,International Journal of Urology,,,Article,,10.1111/iju.12898,,,,26290306,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4427769,https://api.altmetric.com/v1/donut/4427769_240.png 1,Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.,Oncotarget,,,Article,2015-08-23,10.18632/oncotarget.4626,,,,26293672,PMC4695038,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4425218,https://api.altmetric.com/v1/donut/4425218_240.png 1,The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients,World Journal of Urology,,,Article,2015-08-22,10.1007/s00345-015-1661-x,,,,26296371,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4423931,https://api.altmetric.com/v1/donut/4423931_240.png 1,Coverage-based treatment planning to accommodate delineation uncertainties in prostate cancer treatment,Medical Physics,,,Article,2015-08-21,10.1118/1.4928490,,,,26328992,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4421319,https://api.altmetric.com/v1/donut/4421319_240.png 1,The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy,World Journal of Urology,,,Article,2015-08-21,10.1007/s00345-015-1671-8,,,,26293117,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4420630,https://api.altmetric.com/v1/donut/4420630_240.png 1,STIM1 accelerates cell senescence in a remodeled microenvironment but enhances the epithelial-to-mesenchymal transition in prostate cancer,Scientific Reports,,,Article,2015-08-10,10.1038/srep11754,,,,26257076,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4414445,https://api.altmetric.com/v1/donut/4414445_240.png 1,ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells ,Cellular Signalling,,,Article,,10.1016/j.cellsig.2015.08.002,,,,26257301,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4409976,https://api.altmetric.com/v1/donut/4409976_240.png 1,"Expression of IL?17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia",The Prostate,,,Article,2015-08-01,10.1002/pros.23058,,,,26356122,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4409446,https://api.altmetric.com/v1/donut/4409446_240.png 1,Integrating Immunotherapies in Prostate Cancer,Current Oncology Reports,,,Article,2015-08-16,10.1007/s11912-015-0469-6,,,,26275784,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4402451,https://api.altmetric.com/v1/donut/4402451_240.png 1,Impact of E6-associated protein on the proliferation and invasion of prostate cancer cells in bone metastasis.,International Journal of Clinical and Experimental Pathology,,,Article,,,,,,26261538,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4401039,https://api.altmetric.com/v1/donut/4401039_240.png 1,Androgen Deprivation Therapy and Secondary Hormone Therapy in the Management of Hormone-Sensitive and Castration Resistant Prostate Cancer,Urology,,,Article,2015-08-19,10.1016/j.urology.2015.07.034,,,,26282624,,,,,,,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4399007,https://api.altmetric.com/v1/donut/4399007_240.png 1,Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer.,Expert Opinion on Investigational Drugs,,,Article,2010-05-14,10.1517/13543781003789388,,,,20367532,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4398106,https://api.altmetric.com/v1/donut/4398106_240.png 1,High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer ,European Journal of Cancer (1965),,,Article,2001-05-01,10.1016/s0959-8049(00)00448-2,,,,11313172,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4397634,https://api.altmetric.com/v1/donut/4397634_240.png 1,ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).,The Prostate,,,Article,2015-08-14,10.1002/pros.23035,,,,26268879,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4396225,https://api.altmetric.com/v1/donut/4396225_240.png 1,Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer.,Yonsei Medical Journal,,,Article,,10.3349/ymj.2015.56.5.1206,,,,26256961,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4391376,https://api.altmetric.com/v1/donut/4391376_240.png 1,The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer,Cancer Letters,,,Article,,10.1016/j.canlet.2015.07.026,,,,26231734,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4389115,https://api.altmetric.com/v1/donut/4389115_240.png 1,Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Results of a cohort study,Radiotherapy & Oncology,,,Article,2015-08-16,10.1016/j.radonc.2015.07.048,,,,26276529,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4386178,https://api.altmetric.com/v1/donut/4386178_240.png 1,"Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer",Tumor Biology,,,Article,2015-08-05,10.1007/s13277-015-3853-9,,,,26242267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4380052,https://api.altmetric.com/v1/donut/4380052_240.png 1,[miRNA-101 inhibits the expression of the enhancer of zeste homolog 2 in androgen-independent prostate cancer LNCaP cell line].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-06-01,,,,,26242038,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4370789,https://api.altmetric.com/v1/donut/4370789_240.png 1,Immuno?based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer,International Journal of Cancer,,,Article,2015-07-01,10.1002/ijc.29664,,,,26139298,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/4370617,https://api.altmetric.com/v1/donut/4370617_240.png 1,"The value of MR/US fusion prostate biopsy platforms in prostate cancer detection, a systematic review.",British Journal of Urology,,,Article,,10.1111/bju.13247,,,,26237632,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4369079,https://api.altmetric.com/v1/donut/4369079_240.png 1,"Incidental Prostate Cancer Diagnosis During Holmium Laser Enucleation: Assessment of Predictors, Survival, and Disease Progression.",Urology,,,Article,,10.1016/j.urology.2015.06.002,,,,26216838,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4363482,https://api.altmetric.com/v1/donut/4363482_240.png 1,Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival,Anti-Cancer Drugs,,,Article,2015-09-01,10.1097/cad.0000000000000258,,,,26207428,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4355810,https://api.altmetric.com/v1/donut/4355810_240.png 1,The P275A Polymorphism in the Macrophage Scavenger Receptor 1 Gene and Prostate Cancer Risk: a Meta-Analysis.,Asian Pacific Journal of Cancer Prevention,,,Article,2015-08-02,,,,,26225686,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4355109,https://api.altmetric.com/v1/donut/4355109_240.png 1,Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?,BMC Urology,,,Article,2015-07-30,10.1186/s12894-015-0072-z,,,,26223353,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4344364,https://api.altmetric.com/v1/donut/4344364_240.png 1,Prostate Cancer as a chronic disease: cost-effectiveness and proper follow-up.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2015-07-24,,,,,26213138,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4344272,https://api.altmetric.com/v1/donut/4344272_240.png 1,Pituitary tumor-transforming gene 1 regulates invasion of prostate cancer cells through MMP13,Tumor Biology,,,Article,2015-07-23,10.1007/s13277-015-3796-1,,,,26201898,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4342253,https://api.altmetric.com/v1/donut/4342253_240.png 1,Magnetic resonance imaging-directed transperineal limited-mapping prostatic biopsies to diagnose prostate cancer: a Scottish experience.,Scottish Medical Journal,,,Article,2014-10-13,10.1177/0036933014556197,,,,25314954,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4342137,https://api.altmetric.com/v1/donut/4342137_240.png 1,Influence of source batch SK dispersion on dosimetry for prostate cancer treatment with permanent implants,Medical Physics,,,Article,2015-07-29,10.1118/1.4926848,,,,26233219,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4341530,https://api.altmetric.com/v1/donut/4341530_240.png 1,Establishment of primary patient?derived xenografts of palliative TURP specimens to study castrate?resistant prostate cancer,The Prostate,,,Article,2015-06-01,10.1002/pros.23039,,,,26177841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4335625,https://api.altmetric.com/v1/donut/4335625_240.png 1,Editorial Comment to Advances in sentinel node dissection in prostate cancer from a technical perspective,International Journal of Urology,,,Article,2015-07-01,10.1111/iju.12879,,,,26213282,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4334115,https://api.altmetric.com/v1/donut/4334115_240.png 1,TRAIL-Troglitazone-induced apoptosis in prostate Cancer Cells involve AMP-activated protein kinase,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m115.663526,,,,26198640,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4330910,https://api.altmetric.com/v1/donut/4330910_240.png 1,Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4463,,,,26203773,PMC4695192,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4330105,https://api.altmetric.com/v1/donut/4330105_240.png 1,RE: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2015-09-01,10.1093/jnci/djv200,,,,26209710,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4321755,https://api.altmetric.com/v1/donut/4321755_240.png 1,HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases,Targeted Oncology,,,Article,2015-07-22,10.1007/s11523-015-0379-4,,,,26194363,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4312461,https://api.altmetric.com/v1/donut/4312461_240.png 1,Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.,American Journal of Roentgenology,,,Article,2015-07-24,10.2214/ajr.14.13098,,,,26204305,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4312380,https://api.altmetric.com/v1/donut/4312380_240.png 1,PSA below 3 predicts low risk of developing prostate cancer,Oncology Times - UK edition,,,Article,2011-04-01,10.1097/01.otu.0000397072.69804.84,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4311945,https://api.altmetric.com/v1/donut/4311945_240.png 1,Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report,Frontiers in oncology,,,Article,2015-07-22,10.3389/fonc.2015.00169,,,,26258074,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4309341,https://api.altmetric.com/v1/donut/4309341_240.png 1,A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer,PLoS ONE,,,Article,2015-07-20,10.1371/journal.pone.0133803,,,,26192308,,,,,,,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,4,https://www.altmetric.com/details/4296816,https://api.altmetric.com/v1/donut/4296816_240.png 1,"A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases",Journal of Nuclear Medicine,,,Article,2015-07-19,10.2967/jnumed.115.157123,,,,26182965,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4293719,https://api.altmetric.com/v1/donut/4293719_240.png 1,Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.,Expert Review of Molecular Diagnostics,,,Article,,10.1586/14737159.2015.1069711,,,,26174441,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4292701,https://api.altmetric.com/v1/donut/4292701_240.png 1,A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?,Clinical Genitourinary Cancer,,,Article,2015-02-21,10.1016/j.clgc.2015.02.006,,,,25777681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4292166,https://api.altmetric.com/v1/donut/4292166_240.png 1,Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.,Oncotarget,,,Article,2015-07-18,10.18632/oncotarget.4448,,,,26183399,PMC4695170,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4292161,https://api.altmetric.com/v1/donut/4292161_240.png 1,Inhibition of Recombining Binding Protein Suppressor of Hairless (RBPJ) Impairs the Growth of Prostate Cancer,Cellular Physiology & Biochemistry,,,Article,2015-07-17,10.1159/000430166,,,,26202358,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4291583,https://api.altmetric.com/v1/donut/4291583_240.png 1,"Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects.",OncoTargets and therapy,,,Article,2015-01-01,10.2147/ott.s84034,,,,26185455,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4291340,https://api.altmetric.com/v1/donut/4291340_240.png 1,The risk of distant metastases and cancer-specific survival in men with serum prostate-specific antigen values above 100 ng/ml,The Journal of Urology,,,Article,2015-07-21,10.1016/j.juro.2015.07.082,,,,26192253,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4289913,https://api.altmetric.com/v1/donut/4289913_240.png 1,Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.,Korean Journal of Urology,,,Article,,10.4111/kju.2015.56.7.505,,,,26175869,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4289659,https://api.altmetric.com/v1/donut/4289659_240.png 1,Characterization of Kallireins and microRNAs in Urine Sediment for the Discrimination of Prostate Cancer from Benign Prostatic Hyperplasia,Journal of Cancer Science & Therapy,,,Article,2015-05-01,10.4172/1948-5956.1000337,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4288201,https://api.altmetric.com/v1/donut/4288201_240.png 1,Disabled homolog 2 is required for migration and invasion of prostate cancer cells,Frontiers of Medicine,,,Article,2015-07-05,10.1007/s11684-015-0401-3,,,,26143155,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4283884,https://api.altmetric.com/v1/donut/4283884_240.png 1,Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases,Cancer and Metastasis Reviews,,,Article,2014-01-12,10.1007/s10555-014-9494-4,,,,24414228,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4280315,https://api.altmetric.com/v1/donut/4280315_240.png 1,Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy,Journal of Medical Imaging,,,Article,2014-10-01,10.1117/1.jmi.1.3.035001,,,,26158070,PMC4478957,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4280305,https://api.altmetric.com/v1/donut/4280305_240.png 1,SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.,European Journal of Cancer (1965),,,Article,2015-07-15,10.1016/j.ejca.2015.06.122,,,,26169017,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4278596,https://api.altmetric.com/v1/donut/4278596_240.png 1,Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment Paradigms,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2015-07-01,,,,,26150586,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4273460,https://api.altmetric.com/v1/donut/4273460_240.png 1,"""Natural course"" of disease in patients with metastatic castrate-resistant prostate cancer: Survival and prognostic factors without life-prolonging treatment.",Scandinavian journal of urology,,,Article,,10.3109/21681805.2015.1059881,,,,26139461,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4273105,https://api.altmetric.com/v1/donut/4273105_240.png 1,Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression,Tumor Biology,,,Article,2015-07-04,10.1007/s13277-015-3628-3,,,,26138584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4266637,https://api.altmetric.com/v1/donut/4266637_240.png 1,Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer,World Journal of Urology,,,Article,2015-07-10,10.1007/s00345-015-1628-y,,,,26160006,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4260170,https://api.altmetric.com/v1/donut/4260170_240.png 1,Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines,Tumor Biology,,,Article,2015-06-30,10.1007/s13277-015-3689-3,,,,26124008,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4252453,https://api.altmetric.com/v1/donut/4252453_240.png 1,An NKX3.1 Binding Site Polymorphism in the L?plastin Promoter Leads to Differential Gene Expression in Human Prostate Cancer,International Journal of Cancer,,,Article,2015-07-01,10.1002/ijc.29677,,,,26148677,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4250217,https://api.altmetric.com/v1/donut/4250217_240.png 1,Androgen Receptor Targeted Conjugate for Bimodal Photodynamic Therapy of Prostate Cancer in Vitro,Bioconjugate Chemistry,,,Article,,10.1021/acs.bioconjchem.5b00261,,,,26108715,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4248018,https://api.altmetric.com/v1/donut/4248018_240.png 1,Crude extract of Euphorbia formosana induces apoptosis of DU145 human prostate cancer cells acts through the caspase?dependent and independent signaling pathway,Environmental Toxicology,,,Article,2015-06-30,10.1002/tox.22164,,,,26122529,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4244772,https://api.altmetric.com/v1/donut/4244772_240.png 1,Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity.,Urology Journal,,,Article,2015-07-04,,,,,26135933,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4241947,https://api.altmetric.com/v1/donut/4241947_240.png 1,"Effectiveness of inhibitor rapamycin, saracatinib, linsitinib and JNJ-38877605 against human prostate cancer cells.",International Journal of Clinical and Experimental Medicine,,,Article,2015-01-01,,,,,26131286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4237470,https://api.altmetric.com/v1/donut/4237470_240.png 1,Genetic Interaction Analysis of TCF7L2 for Biochemical Recurrence after Radical Prostatectomy in Localized Prostate Cancer.,International Journal of Medical Sciences,,,Article,,10.7150/ijms.10953,,,,25678841,PMC4323362,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4235273,https://api.altmetric.com/v1/donut/4235273_240.png 1,Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non–castration-resistant prostate cancer,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.05.012,,,,26092557,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4229532,https://api.altmetric.com/v1/donut/4229532_240.png 1,Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ?Np63?,PLoS ONE,,,Article,2015-06-25,10.1371/journal.pone.0130118,,,,26110651,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4227675,https://api.altmetric.com/v1/donut/4227675_240.png 1,SRD5A2 gene expression inhibits cell migration and invasion in prostate cancer cell line via F-actin reorganization,Molecular and Cellular Biochemistry,,,Article,2015-06-20,10.1007/s11010-015-2478-z,,,,26092425,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4221332,https://api.altmetric.com/v1/donut/4221332_240.png 1,Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer ,Genes & Diseases,,,Article,2015-06-01,10.1016/j.gendis.2015.01.003,,,,26114156,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4219180,https://api.altmetric.com/v1/donut/4219180_240.png 1,Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN,World Journal of Urology,,,Article,2014-11-27,10.1007/s00345-014-1453-8,,,,25428792,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4217138,https://api.altmetric.com/v1/donut/4217138_240.png 1,Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.,Oncotarget,,,Article,2014-08-18,10.18632/oncotarget.2365,,,,25237833,PMC4226713,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4214188,https://api.altmetric.com/v1/donut/4214188_240.png 1,Survival and PSA-markers for mortality and metastasis in nonmetastatic prostate cancer treated with androgen deprivation therapy.,Cancer Epidemiology,,,Article,2015-06-24,10.1016/j.canep.2015.05.008,,,,26100365,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4204554,https://api.altmetric.com/v1/donut/4204554_240.png 1,Advanced prostate cancer: Every Voice Matters.,Future Oncology,,,Article,,10.2217/fon.15.88,,,,26075438,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4204311,https://api.altmetric.com/v1/donut/4204311_240.png 1,Genetic Variants Associated With Predisposition to Prostate Cancer and Potential Clinical Implications.,Journal of Internal Medicine,,,Article,2012-04-14,10.1111/j.1365-2796.2012.02511.x,,,,22308973,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4202190,https://api.altmetric.com/v1/donut/4202190_240.png 1,Lipids and prostate cancer adenocarcinoma,Clinical Lipidology,,,Article,2014-12-01,10.2217/clp.14.51,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4201966,https://api.altmetric.com/v1/donut/4201966_240.png 1,Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?,International Urology and Nephrology,,,Article,,10.1007/s11255-015-1029-6,,,,26071871,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4200527,https://api.altmetric.com/v1/donut/4200527_240.png 1,Image-based monitoring of targeted biopsy-proven prostate cancer on active surveillance: 11-year experience.,World Journal of Urology,,,Article,2015-06-23,10.1007/s00345-015-1619-z,,,,26093647,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4200473,https://api.altmetric.com/v1/donut/4200473_240.png 1,The oncologic role of local treatment in primary metastatic prostate cancer,World Journal of Urology,,,Article,2014-07-05,10.1007/s00345-014-1347-9,,,,24997127,,1854/LU-6843184,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4197411,https://api.altmetric.com/v1/donut/4197411_240.png 1,Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis,Tumor Biology,,,Article,2015-06-19,10.1007/s13277-015-3658-x,,,,26084613,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4195635,https://api.altmetric.com/v1/donut/4195635_240.png 1,11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome,Clinical Nuclear Medicine,,,Article,2015-08-01,10.1097/rlu.0000000000000826,,,,26018697,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4193640,https://api.altmetric.com/v1/donut/4193640_240.png 1,Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer.,Oncotarget,,,Article,2015-06-19,10.18632/oncotarget.4197,,,,26087186,PMC4673182,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4188530,https://api.altmetric.com/v1/donut/4188530_240.png 1,miR-195 inhibits tumor progression by targeting RPS6KB1 in human prostate cancer.,Clinical Cancer Research,,,Article,2015-06-19,10.1158/1078-0432.ccr-15-0217,,,,26080838,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4187519,https://api.altmetric.com/v1/donut/4187519_240.png 1,Efficacy of treatment with a GnRH antagonist in prostate cancer patients previously treated with a GnRH agonist,Cancer Chemotherapy & Pharmacology,,,Article,2015-06-09,10.1007/s00280-015-2798-4,,,,26055219,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4159835,https://api.altmetric.com/v1/donut/4159835_240.png 1,Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience,Anti-Cancer Drugs,,,Article,2015-05-26,10.1097/cad.0000000000000257,,,,26053281,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4159012,https://api.altmetric.com/v1/donut/4159012_240.png 1,Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5 ,Brachytherapy,,,Article,,10.1016/j.brachy.2015.02.389,,,,25911994,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4156925,https://api.altmetric.com/v1/donut/4156925_240.png 1,NF-kappaB2/p52:c-Myc:hnRNPA1 pathway regulates expression of androgen receptor splice variants and enzalutamide sensitivity in prostate cancer.,Molecular Cancer Therapeutics,,,Article,2015-06-08,10.1158/1535-7163.mct-14-1057,,,,26056150,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4156383,https://api.altmetric.com/v1/donut/4156383_240.png 1,"Risks, benefits, and approaches to hormonal blockade in prostate cancer. Highlights from the European Association of Urology Meeting, March 20-24, 2015, Madrid, Spain.",Canadian Journal of Urology,,,Article,2015-06-14,,,,,26068639,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4150011,https://api.altmetric.com/v1/donut/4150011_240.png 1,Shp2 promotes metastasis of prostate cancer by attenuating the PAR3|[sol]|PAR6|[sol]|aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition,Oncogene,,,Article,2015-06-08,10.1038/onc.2015.184,,,,26050620,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4147419,https://api.altmetric.com/v1/donut/4147419_240.png 1,The economic burden of prostate cancer.,,,,Article,2011-09-14,10.1111/j.1464-410x.2011.10365.x,,,,21884356,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,70,https://www.altmetric.com/details/4146848,https://api.altmetric.com/v1/donut/4146848_240.png 1,Androgen pathway resistance in prostate cancer and therapeutic implications.,Expert Opinion on Pharmacotherapy,,,Article,2015-06-13,10.1517/14656566.2015.1055249,,,,26067250,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4146145,https://api.altmetric.com/v1/donut/4146145_240.png 1,Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.,Urologic Oncology,,,Article,2015-06-13,10.1016/j.urolonc.2015.05.013,,,,26066969,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4146100,https://api.altmetric.com/v1/donut/4146100_240.png 1,MicroRNA?205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer,International Journal of Urology,,,Article,2015-06-11,10.1111/iju.12829,,,,26059417,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4136564,https://api.altmetric.com/v1/donut/4136564_240.png 1,Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2015.02.11,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4125416,https://api.altmetric.com/v1/donut/4125416_240.png 1,miR-22 and miR-29a are members of the androgen receptor cistrome modulating LAMC1 and Mcl-1 in prostate cancer.,Molecular Endocrinology,,,Article,2015-06-09,10.1210/me.2014-1358,,,,26052614,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4122678,https://api.altmetric.com/v1/donut/4122678_240.png 1,Prostate cancer risk assessment tools in an unscreened population,World Journal of Urology,,,Article,2014-08-05,10.1007/s00345-014-1365-7,,,,25091862,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4117523,https://api.altmetric.com/v1/donut/4117523_240.png 1,Gene interference strategies as a new tool for the treatment of prostate cancer.,Endocrine,,,Article,2015-06-08,10.1007/s12020-015-0629-3,,,,26049369,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4114113,https://api.altmetric.com/v1/donut/4114113_240.png 1,Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression,Oncogene,,,Article,2015-06-01,10.1038/onc.2015.170,,,,26028029,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4110536,https://api.altmetric.com/v1/donut/4110536_240.png 1,Clinical significance of CUL4A in human prostate cancer,Tumor Biology,,,Article,2015-06-03,10.1007/s13277-015-3580-2,,,,26036759,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4108143,https://api.altmetric.com/v1/donut/4108143_240.png 1,LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.,American Journal of Cancer Research,,,Article,2015-01-01,,,,,26045991,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4104725,https://api.altmetric.com/v1/donut/4104725_240.png 1,"Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.",Oncotarget,,,Article,2015-06-05,10.18632/oncotarget.4091,,,,26041888,PMC4673272,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4098078,https://api.altmetric.com/v1/donut/4098078_240.png 1,Stratifying Prostate Cancer Patients for Olaparib.,Cancer Discovery,,,Article,,10.1158/2159-8290.cd-nb2015-061,,,,25904654,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4087185,https://api.altmetric.com/v1/donut/4087185_240.png 1,Genome Sequencing Reveals Metastatic Seeding Patterns in Prostate Cancer,Cancer Discovery,,,Article,2015-06-01,10.1158/2159-8290.cd-rw2015-070,,,,25883020,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4080564,https://api.altmetric.com/v1/donut/4080564_240.png 1,Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study,Urologia Internationalis,,,Article,2015-05-30,10.1159/000431024,,,,26044747,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4072543,https://api.altmetric.com/v1/donut/4072543_240.png 1,"CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells",Clinical and Translational Oncology,,,Article,2015-05-20,10.1007/s12094-015-1288-9,,,,25990505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4066733,https://api.altmetric.com/v1/donut/4066733_240.png 1,Experience with androgen deprivation therapy for prostate cancer in Japan and future perspectives.,Current Cancer Drug Targets,,,Article,2015-05-26,,,,,26003144,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4057492,https://api.altmetric.com/v1/donut/4057492_240.png 1,MicroRNAs targeting prostate cancer stem cells,Experimental Biology and Medicine,,,Article,2015-05-12,10.1177/1535370215584935,,,,25966983,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4053881,https://api.altmetric.com/v1/donut/4053881_240.png 1,Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer,International Journal of Cancer,,,Article,2015-05-27,10.1002/ijc.29613,,,,26009879,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4052062,https://api.altmetric.com/v1/donut/4052062_240.png 1,Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.,British Journal of General Practice,,,Article,2014-12-15,10.3399/bjgp14x682861,,,,25452543,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4046617,https://api.altmetric.com/v1/donut/4046617_240.png 1,Digital rectal examination can detect early prostate cancer.,Evidence Based Medicine,,,Article,2015-06-01,10.1136/ebmed-2014-110162,,,,25758963,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4046616,https://api.altmetric.com/v1/donut/4046616_240.png 1,Periostin Mediates TGF-?-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells,Cellular Physiology & Biochemistry,,,Article,2015-05-22,10.1159/000430139,,,,26021267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4039982,https://api.altmetric.com/v1/donut/4039982_240.png 1,Developments of tumour control probability (TCP) models for prostate cancer patients. Developments of tumour control probability (TCP) models for prostate cancer patients,ecancer.org,,,Article,,,,,http://ecancer.org/video/3664/developments-of-tumour-control-probability--tcp--models-for-prostate-cancer-patients.php,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4038168,https://api.altmetric.com/v1/donut/4038168_240.png 1,"In 2124, half of all men can count on developing prostate cancer",Current Oncology,,,Article,2015-02-01,10.3747/co.22.2102,,,,25684983,PMC4324338,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4037268,https://api.altmetric.com/v1/donut/4037268_240.png 1,Genome-Wide DNA Methylation Modified by Soy Phytoestrogens: Role for Epigenetic Therapeutics in Prostate Cancer?,OMICS: A Journal of Integrative Biology,,,Article,,10.1089/omi.2014.0142,,,,25831061,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4032964,https://api.altmetric.com/v1/donut/4032964_240.png 1,Post-void Residual Urinary Volume Is An Independent Predictor of Biopsy Results in Men at Risk for Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,25862875,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4028913,https://api.altmetric.com/v1/donut/4028913_240.png 1,Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer.,The Journal of community and supportive oncology,,,Article,2015-03-01,10.12788/jcso.0115,,,,25880672,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4027134,https://api.altmetric.com/v1/donut/4027134_240.png 1,Immunotherapy in Prostate Cancer,Current Urology Reports,,,Article,2015-04-17,10.1007/s11934-015-0509-7,,,,25894495,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4025336,https://api.altmetric.com/v1/donut/4025336_240.png 1,"MicroRNA-135b regulates ER?, AR and HIF1AN and affects breast and prostate cancer cell growth.",Molecular Oncology,,,Article,,10.1016/j.molonc.2015.03.001,,,,25907805,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4023774,https://api.altmetric.com/v1/donut/4023774_240.png 1,Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3845,,,,25915538,PMC4599278,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/4023080,https://api.altmetric.com/v1/donut/4023080_240.png 1,[Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].,Medwave,,,Article,,,,,,25919660,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4022946,https://api.altmetric.com/v1/donut/4022946_240.png 1,Can magnetic resonance imaging solve the prostate cancer conundrum?,Medical Journal of Australia,,,Article,,,,,,25929494,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4021027,https://api.altmetric.com/v1/donut/4021027_240.png 1,[Current role of protatic specific antigen (PSA) and its by-products in the diagnosis of prostate cancer].,Archivos Españoles de Urología,,,Article,,,,,,25948795,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4018460,https://api.altmetric.com/v1/donut/4018460_240.png 1,Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3782,,,,25962960,PMC4621903,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4015941,https://api.altmetric.com/v1/donut/4015941_240.png 1,Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.,American journal of nuclear medicine and molecular imaging,,,Article,2015-01-01,,,,,25973339,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4014631,https://api.altmetric.com/v1/donut/4014631_240.png 1,Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland,Strahlentherapie und Onkologie,,,Article,2015-05-19,10.1007/s00066-015-0849-8,,,,25986251,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4010521,https://api.altmetric.com/v1/donut/4010521_240.png 1,Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3?AR axis inhibition,The Prostate,,,Article,2015-05-13,10.1002/pros.23015,,,,25970160,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4003679,https://api.altmetric.com/v1/donut/4003679_240.png 1,Metabolic syndrome in castration?resistant prostate cancer patients treated with abiraterone,The Prostate,,,Article,2015-05-15,10.1002/pros.23014,,,,25982919,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4000772,https://api.altmetric.com/v1/donut/4000772_240.png 1,The ONCOTYROL Prostate Cancer Outcome and Policy Model Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening,Medical Decision Making,,,Article,2015-05-16,10.1177/0272989x15585114,,,,25977360,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3998226,https://api.altmetric.com/v1/donut/3998226_240.png 1,Current role of multiparametric magnetic resonance imaging in the management of prostate cancer.,Korean Journal of Urology,,,Article,2015-05-14,10.4111/kju.2015.56.5.337,,,,25964833,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3995351,https://api.altmetric.com/v1/donut/3995351_240.png 1,Silibinin Combination with Arsenic Strongly Inhibits Survival and Invasiveness of Human Prostate Carcinoma Cells.,Nutrition and Cancer,,,Article,,10.1080/01635581.2015.1019635,,,,25868784,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3994759,https://api.altmetric.com/v1/donut/3994759_240.png 1,"Erratum for the Research Article: “Prostate cancer cell–stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases” by X. Wan, P. G. Corn, J. Yang, N. Palanisamy, M. W. Starbuck, E. Efstathiou, E. M. Tapia, A. J. Zurita, A. Aparicio, M. K. Ravoori, E. S. Vazquez, D. R. Robinson, Y.-M. Wu, X. Cao, M. K. Iyer, W. McKeehan, V. Kundra, F. Wang, P. Troncoso, A. M. Chinnaiyan, C. J. Logothetis, N. M. Navone",Science Translational Medicine,,,Article,2015-05-13,10.1126/scitranslmed.aac4473,,,,25971997,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3993627,https://api.altmetric.com/v1/donut/3993627_240.png 1,"Sotalol, but not digoxin is associated with decreased prostate cancer risk. A population-based case-control study.",International Journal of Cancer,,,Article,2015-02-05,10.1002/ijc.29470,,,,25656312,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3988276,https://api.altmetric.com/v1/donut/3988276_240.png 1,Re: Nationwide prevalence of lymph node metastases in Gleason score 3?+?3?=?6 prostate cancer,Pathology,,,Article,2015-06-01,10.1097/pat.0000000000000263,,,,25938366,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3986913,https://api.altmetric.com/v1/donut/3986913_240.png 1,Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer,Molecular Therapy — Oncolytics,,,Article,2016-01-15,10.1038/mto.2015.6,,,,26767191,PMC4707660,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3984249,https://api.altmetric.com/v1/donut/3984249_240.png 1,Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer,Journal of Translational Medicine,,,Article,2015-05-08,10.1186/s12967-015-0509-x,,,,25953027,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3979332,https://api.altmetric.com/v1/donut/3979332_240.png 1,"Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.",The Prostate,,,Article,2015-05-04,10.1002/pros.23004,,,,25939480,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3979048,https://api.altmetric.com/v1/donut/3979048_240.png 1,Egr1 Promotes Growth and Survival of Prostate Cancer Cells IDENTIFICATION OF NOVEL Egr1 TARGET GENES,Journal of Biological Chemistry,,,Article,2003-04-04,10.1074/jbc.m210279200,,,,12556466,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3978163,https://api.altmetric.com/v1/donut/3978163_240.png 1,A Radiographic Biomarker of Response in Prostate Cancer,Journal Watch,,,Article,,10.1056/nejm-jw.na37746,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3975950,https://api.altmetric.com/v1/donut/3975950_240.png 1,Anterior apical cores in the initial prostate biopsy does not increase detection of significant prostate cancer.,Urology Journal,,,Article,,,,,,25923153,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3964111,https://api.altmetric.com/v1/donut/3964111_240.png 1,Prostate cancer and its mimics at multiparametric prostate MRI,British Journal of Radiology,,,Article,2014-05-01,10.1259/bjr.20130659,,,,24646125,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3961441,https://api.altmetric.com/v1/donut/3961441_240.png 1,Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer,BMC Cancer,,,Article,2015-05-01,10.1186/s12885-015-1330-x,,,,25929438,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3960628,https://api.altmetric.com/v1/donut/3960628_240.png 1,Relation between Ku80 and microRNA-99a expression and late rectal bleeding after radiotherapy for prostate cancer.,Radiotherapy & Oncology,,,Article,2015-05-06,10.1016/j.radonc.2015.04.008,,,,25937401,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3959888,https://api.altmetric.com/v1/donut/3959888_240.png 1,Patient performance–based plan parameter optimization for prostate cancer in tomotherapy,Medical Dosimetry,,,Article,,10.1016/j.meddos.2015.03.005,,,,25869936,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3954391,https://api.altmetric.com/v1/donut/3954391_240.png 1,"AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies",Investigational New Drugs,,,Article,2015-04-30,10.1007/s10637-015-0235-5,,,,25920479,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3953579,https://api.altmetric.com/v1/donut/3953579_240.png 1,hOGG1 C1245G gene polymorphism associated with prostate cancer: a meta-analysis.,International Journal of Biological Markers,,,Article,2015-04-26,10.5301/jbm.5000144,,,,25907663,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3942948,https://api.altmetric.com/v1/donut/3942948_240.png 1,Characterization of the roles of suppressor of cytokine signaling?3 in prostate cancer development and progression,Asia Pacific Journal of Clinical Oncology,,,Article,2015-04-20,10.1111/ajco.12357,,,,25899712,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3942399,https://api.altmetric.com/v1/donut/3942399_240.png 1,Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.,Oncotarget,,,Article,2014-04-26,10.18632/oncotarget.1928,,,,24980827,PMC4147312,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3941801,https://api.altmetric.com/v1/donut/3941801_240.png 1,Radical treatment of localised prostate cancer in the elderly,British Journal of Urology,,,Article,2015-03-23,10.1111/bju.13128,,,,25810141,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3935948,https://api.altmetric.com/v1/donut/3935948_240.png 1,The Effects of Serum from Prostate Cancer Patients with Elevated Body Mass Index on Prostate Cancer Cells In Vitro,Lipid insights,,,Article,2015-04-01,10.4137/lpi.s23135,,,,25987846,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3935445,https://api.altmetric.com/v1/donut/3935445_240.png 1,Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells,RNA,,,Article,2015-04-24,10.1261/rna.045559.114,,,,25904138,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3934496,https://api.altmetric.com/v1/donut/3934496_240.png 1,Large cell differentiation of metastatic prostate cancer after androgen deprivation therapy.,Canadian Journal of Urology,,,Article,2015-04-23,,,,,25891342,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3934449,https://api.altmetric.com/v1/donut/3934449_240.png 1,"Locoregional Prostate Cancer Treatment Pattern Variation in Independent Cancer Centers: Policy Effect, Patient Preference, or Physician Incentive?",Health Services Insights,,,Article,2015-04-01,10.4137/hsi.s24092,,,,25922580,,,,,,,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3928579,https://api.altmetric.com/v1/donut/3928579_240.png 1,Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men,PLoS ONE,,,Article,,10.1371/journal.pone.0124668,,,,25861033,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3927827,https://api.altmetric.com/v1/donut/3927827_240.png 1,Active surveillance for favorable risk prostate cancer,Current Opinion in Urology,,,Article,2015-05-01,10.1097/mou.0000000000000167,,,,25730328,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3927504,https://api.altmetric.com/v1/donut/3927504_240.png 1,"Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study",BMJ Open,,,Article,,10.1136/bmjopen-2014-006851,,,,25888474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3927006,https://api.altmetric.com/v1/donut/3927006_240.png 1,Oestrogen patches (OP) to treat prostate cancer (PC) – Are different commercial brands interchangeable?,Maturitas,,,Article,,10.1016/j.maturitas.2015.02.320,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3926976,https://api.altmetric.com/v1/donut/3926976_240.png 1,Magnetic Resonance Sentinel Lymph Node Detection in Prostate Cancer,Academic Radiology,,,Article,2015-03-19,10.1016/j.acra.2015.02.007,,,,25797301,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3924786,https://api.altmetric.com/v1/donut/3924786_240.png 1,Decision aids for benign prostatic hyperplasia and prostate cancer.,"American Journal of Managed Care, The",,,Article,2015-04-18,,,,,25880488,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3920821,https://api.altmetric.com/v1/donut/3920821_240.png 1,Prostate cancer screening in Europe,The Lancet (British Edition),,,Article,2015-05-02,10.1016/s0140-6736(15)60746-2,,,,25933274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3915881,https://api.altmetric.com/v1/donut/3915881_240.png 1,Dual Targeting of the Androgen Receptor and Hypoxia-inducible Factor 1? Pathways Synergistically Inhibits Castration-Resistant Prostate Cancer Cells.,Molecular Pharmacology,,,Article,,10.1124/mol.114.097477,,,,25829060,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3910138,https://api.altmetric.com/v1/donut/3910138_240.png 1,Urinary biomarkers for the detection of prostate cancer in patients with high?grade prostatic intraepithelial neoplasia,The Prostate,,,Article,2015-04-01,10.1002/pros.22995,,,,25845829,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3906901,https://api.altmetric.com/v1/donut/3906901_240.png 1,Focal therapy of prostate cancer: making steady progress toward a first-line image-guided treatment modality,Current Opinion in Urology,,,Article,2015-05-01,10.1097/mou.0000000000000171,,,,25775366,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3905582,https://api.altmetric.com/v1/donut/3905582_240.png 1,Known susceptibility SNPs for sporadic prostate cancer show a similar association with “hereditary” prostate cancer,The Prostate,,,Article,2015-01-05,10.1002/pros.22933,,,,25560306,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3903444,https://api.altmetric.com/v1/donut/3903444_240.png 1,Advances in imaging modalities in prostate cancer,Current opinion in oncology,,,Article,2015-05-01,10.1097/cco.0000000000000174,,,,25715326,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3898361,https://api.altmetric.com/v1/donut/3898361_240.png 1,Evaluation and Management of Rectourethral Fistulas After Prostate Cancer Treatment,Current Bladder Dysfunction Reports,,,Article,2015-04-11,10.1007/s11884-015-0297-4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3897423,https://api.altmetric.com/v1/donut/3897423_240.png 1,Sesamin inhibits lipopolysaccharide-induced proliferation and invasion through the p38-MAPK and NF-?B signaling pathways in prostate cancer cells.,Oncology Reports,,,Article,2015-04-09,10.3892/or.2015.3888,,,,25845399,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3892893,https://api.altmetric.com/v1/donut/3892893_240.png 1,miRSNP-Based Approach Identifies a miRNA That Regulates Prostate-Specific Antigen in an Allele-Specific Manner.,Cancer Discovery,,,Article,2015-04-09,10.1158/2159-8290.cd-15-0230,,,,25847955,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3890361,https://api.altmetric.com/v1/donut/3890361_240.png 1,Rapid progression of prostate cancer in men with a BRCA2 mutation,British Journal of Cancer,,,Article,2008-06-24,10.1038/sj.bjc.6604453,,,,18577985,PMC2480973,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3884910,https://api.altmetric.com/v1/donut/3884910_240.png 1,Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral population,Irish Journal of Medical Science (1971 -),,,Article,2015-04-07,10.1007/s11845-015-1291-8,,,,25843017,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3882754,https://api.altmetric.com/v1/donut/3882754_240.png 1,"Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels",Basic and Clinical Andrology,,,Article,,10.1186/s12610-015-0019-y,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3880332,https://api.altmetric.com/v1/donut/3880332_240.png 1,Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation.,The Prostate,,,Article,2015-04-01,10.1002/pros.22988,,,,25833156,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3861166,https://api.altmetric.com/v1/donut/3861166_240.png 1,Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?,Frontiers in oncology,,,Article,2015-03-13,10.3389/fonc.2015.00077,,,,25874188,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3856143,https://api.altmetric.com/v1/donut/3856143_240.png 1,DUPA Conjugation of a Cytotoxic Indenoisoquinoline Topoisomerase I Inhibitor for Selective Prostate Cancer Cell Targeting,Journal of Medicinal Chemistry,,,Article,2015-03-31,10.1021/jm5018384,,,,25822623,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3855702,https://api.altmetric.com/v1/donut/3855702_240.png 1,LUTS After Radiotherapy for Prostate Cancer: Evaluation and Treatment,Current Bladder Dysfunction Reports,,,Article,2015-03-31,10.1007/s11884-015-0292-9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3852361,https://api.altmetric.com/v1/donut/3852361_240.png 1,Correspondence of physical activity and fruit/vegetable consumption among prostate cancer survivors and their spouses,European Journal of Cancer Care,,,Article,2015-03-26,10.1111/ecc.12316,,,,25807856,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3849212,https://api.altmetric.com/v1/donut/3849212_240.png 1,Combining Paclitaxel with ABT-263 Has a Synergistic Effect on Paclitaxel Resistant Prostate Cancer Cells,PLoS ONE,,,Article,2015-03-26,10.1371/journal.pone.0120913,,,,25811469,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3846458,https://api.altmetric.com/v1/donut/3846458_240.png 1,Natural history of surgically treated high-risk prostate cancer,Urologic Oncology,,,Article,2015-02-06,10.1016/j.urolonc.2014.11.018,,,,25665508,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3841233,https://api.altmetric.com/v1/donut/3841233_240.png 1,The role of tumor suppressor gene SOX11 in prostate cancer,Tumor Biology,,,Article,2015-03-14,10.1007/s13277-015-3296-3,,,,25773392,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3840668,https://api.altmetric.com/v1/donut/3840668_240.png 1,"Prevalence and Correlates of Strength Exercise Among Breast, Prostate, and Colorectal Cancer Survivors.",Oncology Nursing Forum,,,Article,2015-03-01,10.1188/15.onf.42-02ap,,,,25806879,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3840502,https://api.altmetric.com/v1/donut/3840502_240.png 1,Contribution of transrectal ultrasonography-guided biopsy in the diagnosis of prostate cancer: looking back and ahead,Radiologia Brasileira,,,Article,,10.1590/0100-3984.2015.48.1e2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3832824,https://api.altmetric.com/v1/donut/3832824_240.png 1,Enzalutamide After Docetaxel and Abiraterone Acetate Treatment in Prostate Cancer: A Pooled Analysis of 10 Case Series.,Clinical Genitourinary Cancer,,,Article,2014-12-05,10.1016/j.clgc.2014.10.006,,,,25466676,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3831979,https://api.altmetric.com/v1/donut/3831979_240.png 1,"Potent Anti-Proliferative, Pro-Apoptotic Activity of the Maytenus Royleanus Extract against Prostate Cancer Cells: Evidence in In-Vitro and In-Vivo Models",PLoS ONE,,,Article,2015-07-01,10.1371/journal.pone.0119859,,,,25798940,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3830469,https://api.altmetric.com/v1/donut/3830469_240.png 1,Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2014-12-25,10.1517/14656566.2015.995090,,,,25534660,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3825753,https://api.altmetric.com/v1/donut/3825753_240.png 1,Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program.,Expert Opinion on Drug Safety,,,Article,2014-07-09,10.1517/14740338.2014.939583,,,,25001524,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3820101,https://api.altmetric.com/v1/donut/3820101_240.png 1,A Semi-Mechanistic Integrated Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of the Gonadotropin-Releasing Hormone Agonist Leuprolide in Prostate Cancer Patients,Clinical Pharmacokinetics,,,Article,2015-03-20,10.1007/s40262-015-0251-9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3812686,https://api.altmetric.com/v1/donut/3812686_240.png 1,Sequencing current therapies in the treatment of metastatic prostate cancer.,Cancer Treatment Reviews,,,Article,2015-03-04,10.1016/j.ctrv.2015.02.010,,,,25784591,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3811165,https://api.altmetric.com/v1/donut/3811165_240.png 1,Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate’s egg,Quality of Life Research,,,Article,2015-03-20,10.1007/s11136-015-0958-y,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3808874,https://api.altmetric.com/v1/donut/3808874_240.png 1,Micro-ribonucleic acid 29b inhibits cell proliferation and invasion and enhances cell apoptosis and chemotherapy effects of cisplatin via targeting of DNMT3b and AKT3 in prostate cancer.,OncoTargets and therapy,,,Article,2015-01-01,10.2147/ott.s76484,,,,25784815,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3808555,https://api.altmetric.com/v1/donut/3808555_240.png 1,miR-150 is a factor of survival in prostate cancer patients.,Journal of B U ON official journal of the Balkan Union of Oncology,,,Article,,,,,,25778313,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3806790,https://api.altmetric.com/v1/donut/3806790_240.png 1,Quality of life in patients with high?risk prostate cancer improves with shorter course of androgen deprivation therapy,Cancer (0008543X),,,Article,2015-03-18,10.1002/cncr.29285,,,,25787835,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3804581,https://api.altmetric.com/v1/donut/3804581_240.png 1,Use of the Prostate Health Index for the Detection of Aggressive Prostate Cancer at Radical Prostatectomy,Urologia Internationalis,,,Article,2015-03-17,10.1159/000379758,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3795673,https://api.altmetric.com/v1/donut/3795673_240.png 1,Prostate cancer prevention: a review of the literature,Ciência & Saúde Coletiva,,,Article,,10.1590/s1413-81232008000100027,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3793270,https://api.altmetric.com/v1/donut/3793270_240.png 1,Genome rearrangement affects RNA virus adaptability on prostate cancer cells,Frontiers in Genetics,,,Article,2015-03-13,10.3389/fgene.2015.00121,,,,25883601,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3791052,https://api.altmetric.com/v1/donut/3791052_240.png 1,Clinical activity of enzalutamide in Docetaxel?naïve and Docetaxel?pretreated patients with metastatic castration?resistant prostate cancer,The Prostate,,,Article,2014-11-01,10.1002/pros.22874,,,,25176007,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3789141,https://api.altmetric.com/v1/donut/3789141_240.png 1,Oral ethinylestradiol in castration?resistant prostate cancer: A 10?year experience,International Journal of Urology,,,Article,2015-01-01,10.1111/iju.12613,,,,25186970,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3789139,https://api.altmetric.com/v1/donut/3789139_240.png 1,[11C-choline PET/CT in the diagnosis of prostate cancer].,Magyar Onkológia,,,Article,2015-03-11,,,,,25763910,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3783988,https://api.altmetric.com/v1/donut/3783988_240.png 1,Guideline for referral of patients with suspected prostate cancer by family physicians and other primary care providers.,Canadian Family Physician,,,Article,2015-01-01,,,,,25756141,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3782032,https://api.altmetric.com/v1/donut/3782032_240.png 1,"[Study and therapy of metastatic castration-resistant prostate cancer : A randomized, double blind, multicenter, parallel-group, phase III study to evaluate efficacy and safety of DCVAC/PCa versus placebo in men with metastatic castration resistant prostate cancer eligible for first line chemotherapy (VIABLE) - AUO study AP 78/13].",Der Urologe A,,,Article,2015-03-12,10.1007/s00120-015-3801-8,,,,25758238,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3782007,https://api.altmetric.com/v1/donut/3782007_240.png 1,Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.,Future Oncology,,,Article,2015-03-01,10.2217/fon.14.284,,,,25760977,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3782003,https://api.altmetric.com/v1/donut/3782003_240.png 1,Dexamethasone may be the most efficacious corticosteroid for use as monotherapy in castration-resistant prostate cancer,Cancer Biology and Therapy,,,Article,2015-02-01,10.1080/15384047.2014.1002687,,,,25756508,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3778592,https://api.altmetric.com/v1/donut/3778592_240.png 1,A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation.,Cancer Letters,,,Article,2015-03-05,10.1016/j.canlet.2015.02.046,,,,25749421,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3773363,https://api.altmetric.com/v1/donut/3773363_240.png 1,Vesicocutaneous fistula presenting 17 years post-radiotherapy for prostate cancer,International Urology and Nephrology,,,Article,2015-03-11,10.1007/s11255-015-0941-0,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3771468,https://api.altmetric.com/v1/donut/3771468_240.png 1,Evidence of epithelial-mesenchymal transition in canine prostate cancer metastasis ,Research in Veterinary Science,,,Article,,10.1016/j.rvsc.2015.03.001,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/3768605,https://api.altmetric.com/v1/donut/3768605_240.png 1,"SD-208, a Novel Protein Kinase D Inhibitor, Blocks Prostate Cancer Cell Proliferation and Tumor Growth In Vivo by Inducing G2/M Cell Cycle Arrest.",PLoS ONE,,,Article,2015-03-06,10.1371/journal.pone.0119346,,,,25747583,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3763206,https://api.altmetric.com/v1/donut/3763206_240.png 1,Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration resistant prostate cancer.,British Journal of Urology,,,Article,2013-12-06,10.1111/bju.12589,,,,24298897,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3762692,https://api.altmetric.com/v1/donut/3762692_240.png 1,The Role of Pathology Correlation Approach in Prostate Cancer Index Lesion Detection and Quantitative Analysis with Multiparametric MRI.,Academic Radiology,,,Article,2015-02-12,10.1016/j.acra.2014.12.022,,,,25683501,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3761896,https://api.altmetric.com/v1/donut/3761896_240.png 1,Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology,Journal of Cancer Research & Clinical Oncology,,,Article,2015-03-04,10.1007/s00432-015-1946-x,,,,25736982,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3758479,https://api.altmetric.com/v1/donut/3758479_240.png 1,Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells,The Prostate,,,Article,2015-02-03,10.1002/pros.22952,,,,25650269,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3757921,https://api.altmetric.com/v1/donut/3757921_240.png 1,Developing New Small Molecular Drugs for Prostate Cancer Therapy,Journal of Cancer Therapy,,,Article,2013-04-25,10.4236/jct.2013.44a009,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3756416,https://api.altmetric.com/v1/donut/3756416_240.png 1,EphB4 localises to the nucleus of prostate cancer cells ,Experimental Cell Research,,,Article,2015-02-24,10.1016/j.yexcr.2015.02.015,,,,25724901,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3743239,https://api.altmetric.com/v1/donut/3743239_240.png 1,Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population,Quality of Life Research,,,Article,2015-02-28,10.1007/s11136-015-0950-6,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3740389,https://api.altmetric.com/v1/donut/3740389_240.png 1,Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate,World Journal of Urology,,,Article,2014-05-08,10.1007/s00345-014-1310-9,,,,24804843,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3740309,https://api.altmetric.com/v1/donut/3740309_240.png 1,Should I Be Tested for Prostate Cancer?,CA: A Cancer Journal for Clinicians ,,,Article,2010-03-01,10.3322/caac.20062,,,,20200112,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3739229,https://api.altmetric.com/v1/donut/3739229_240.png 1,Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels,Biofactors,,,Article,2015-02-26,10.1002/biof.1200,,,,25728635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3735090,https://api.altmetric.com/v1/donut/3735090_240.png 1,Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm.,European Radiology,,,Article,2015-02-20,10.1007/s00330-014-3539-5,,,,25693661,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3732037,https://api.altmetric.com/v1/donut/3732037_240.png 1,"Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients",World Journal of Surgical Oncology,,,Article,2015-02-22,10.1186/s12957-015-0503-z,,,,25884478,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3728485,https://api.altmetric.com/v1/donut/3728485_240.png 1,Factors associated with overall survival prostate cancer in Florida: a multilevel analysis.,Journal of health care for the poor and underserved (Online),,,Article,2015-01-01,10.1353/hpu.2015.0007,,,,25702742,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3728280,https://api.altmetric.com/v1/donut/3728280_240.png 1,Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells.,Cancers,,,Article,2013-11-14,10.3390/cancers5020617,,,,24216994,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3726646,https://api.altmetric.com/v1/donut/3726646_240.png 1,Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.,The Prostate,,,Article,2006-01-09,10.1002/pros.20464,,,,16705739,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3726645,https://api.altmetric.com/v1/donut/3726645_240.png 1,Modulators of Estrogen Receptor inhibit proliferation and migration of prostate cancer cells.,Pharmacological Research,,,Article,2013-11-06,10.1016/j.phrs.2013.10.002,,,,24184124,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3726643,https://api.altmetric.com/v1/donut/3726643_240.png 1,Metformin Association with Lower Prostate Cancer Recurrence in Type 2 Diabetes: a Systematic Review and Meta-analysis.,Asian Pacific Journal of Cancer Prevention,,,Article,2015-02-18,,,,,25684493,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3725875,https://api.altmetric.com/v1/donut/3725875_240.png 1,SMAD Signaling And Redox Imbalance Cooperate To Induce Prostate Cancer Cell Dormancy,Cell Cycle,,,Article,2015-02-23,10.1080/15384101.2015.1014145,,,,25706341,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3724875,https://api.altmetric.com/v1/donut/3724875_240.png 1,Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multi?ethnic cohort of South African patients via label?free mass spectrometry,PROTEOMICS - Clinical Applications,,,Article,2015-02-24,10.1002/prca.201400197,,,,25708745,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3724430,https://api.altmetric.com/v1/donut/3724430_240.png 1,Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome.,BioMed Research International,,,Article,2015-02-21,10.1155/2015/198543,,,,25695051,,1854/LU-5824214,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3723317,https://api.altmetric.com/v1/donut/3723317_240.png 1,Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells,Molecular and Cellular Proteomics (MCP Online),,,Article,2015-05-01,10.1074/mcp.m113.036764,,,,25693800,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3721042,https://api.altmetric.com/v1/donut/3721042_240.png 1,Geography: an increasingly important variable in prostate cancer clinical trials.,British Journal of Urology,,,Article,2014-12-18,10.1111/bju.12930,,,,25510569,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3720493,https://api.altmetric.com/v1/donut/3720493_240.png 1,Prevention and Management of Depression and Suicidal Behavior in Men with Prostate Cancer,Frontiers in Public Health,,,Article,2015-02-04,10.3389/fpubh.2015.00028,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3715644,https://api.altmetric.com/v1/donut/3715644_240.png 1,"Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls",World Journal of Surgical Oncology,,,Article,2015-02-15,10.1186/s12957-015-0479-8,,,,25888980,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3711867,https://api.altmetric.com/v1/donut/3711867_240.png 1,Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer.,Oncotarget,,,Article,2015-01-21,10.18632/oncotarget.2932,,,,25682877,PMC4414161,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3709184,https://api.altmetric.com/v1/donut/3709184_240.png 1,Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN ,Methods,,,Article,,10.1016/j.ymeth.2015.02.005,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3705927,https://api.altmetric.com/v1/donut/3705927_240.png 1,A Comparison of 120 W Laser Photoselective Vaporization versus Transurethral Resection of the Prostate for Bladder Outlet Obstruction by Prostate Cancer,Urologia Internationalis,,,Article,2015-02-17,10.1159/000366209,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3705199,https://api.altmetric.com/v1/donut/3705199_240.png 1,"Comparing the Cost-Effectiveness of Low-Dose-Rate Brachytherapy, High-Dose-Rate Brachytherapy, and Hypofactionated Intensity Modulated Radiation Therapy for the Treatment of Low-/Intermediate-Risk Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-09,10.1016/j.ijrobp.2014.05.1766,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3695640,https://api.altmetric.com/v1/donut/3695640_240.png 1,"Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, Germany",Urologia Internationalis,,,Article,2015-02-10,10.1159/000371725,,,,25677365,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3628007,https://api.altmetric.com/v1/donut/3628007_240.png 1,Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers.,Journal of pharmaceutical sciences and pharmacology,,,Article,2014-03-01,10.1166/jpsp.2014.1008,,,,25679011,PMC4322943,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3620924,https://api.altmetric.com/v1/donut/3620924_240.png 1,Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer,Abdominal Imaging,,,Article,2014-09-16,10.1007/s00261-014-0246-2,,,,25223523,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/3613982,https://api.altmetric.com/v1/donut/3613982_240.png 1,STAMP2 increases oxidative stress and is critical for prostate cancer,EMBO Molecular Medicine,,,Article,,10.15252/emmm.201404181,,,,25680860,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3606128,https://api.altmetric.com/v1/donut/3606128_240.png 1,GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.,Clinical Genitourinary Cancer,,,Article,2015-01-03,10.1016/j.clgc.2014.12.018,,,,25662905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3535048,https://api.altmetric.com/v1/donut/3535048_240.png 1,Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo,The Prostate,,,Article,2015-02-08,10.1002/pros.22963,,,,25663076,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3436969,https://api.altmetric.com/v1/donut/3436969_240.png 1,Bisphosphonate Induced Mandible Bone Osteonecrosis in A Patient with Prostate Cancer,"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",,,Article,2015-01-03,10.1016/j.oooo.2014.07.381,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3430734,https://api.altmetric.com/v1/donut/3430734_240.png 1,Erratum to “Inflammation and Its Role in Prostate Cancer” [Journal of Cancer Therapy 5 (2014) 836-844],Journal of Cancer Therapy,,,Article,2014-12-26,10.4236/jct.2015.61011,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3306081,https://api.altmetric.com/v1/donut/3306081_240.png 1,Isolated Testicular Metastasis of Prostate Cancer after Radical Prostatectomy: Case Report and Literature Review,Urologia Internationalis,,,Article,2015-02-04,10.1159/000368720,,,,25659846,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3303396,https://api.altmetric.com/v1/donut/3303396_240.png 1,"The role of NFATc1 in prostate cancer progression: Cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion",The Prostate,,,Article,2015-01-28,10.1002/pros.22937,,,,25631176,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3266310,https://api.altmetric.com/v1/donut/3266310_240.png 1,Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells.,American Journal of Cancer Research,,,Article,2015-01-31,,,,,25628938,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3266133,https://api.altmetric.com/v1/donut/3266133_240.png 1,Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features: Comparative Analysis of Long-term Outcomes,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2015-02-01,10.1097/coc.0b013e318287bb6b,,,,24051934,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3265414,https://api.altmetric.com/v1/donut/3265414_240.png 1,Genetic Variants of DICE1/INTS6 in German Prostate Cancer Families with Linkage to 13q14,Urologia Internationalis,,,Article,2015-01-31,10.1159/000366229,,,,25660097,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3222892,https://api.altmetric.com/v1/donut/3222892_240.png 1,High-sensitivity immunoassay with surface plasmon field-enhanced fluorescence spectroscopy (SPFS) using a plastic sensor chip: Application to quantitative analysis of total PSA and LacdiNAc-PSA for prostate cancer diagnosis.,Analytical Chemistry,,,Article,2014-12-31,10.1021/ac503735e,,,,25546230,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3202432,https://api.altmetric.com/v1/donut/3202432_240.png 1,Urinary biomarkers for prostate cancer,Current Opinion in Urology,,,Article,2015-01-01,10.1097/mou.0000000000000133,,,,25405933,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3117160,https://api.altmetric.com/v1/donut/3117160_240.png 1,Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study.,The Journal of Urology,,,Article,1994-11-01,,,,,7523737,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3109947,https://api.altmetric.com/v1/donut/3109947_240.png 1,Relationship between LSD1 expression and E-cadherin expression in prostate cancer,International Urology and Nephrology,,,Article,2015-01-28,10.1007/s11255-015-0915-2,,,,25627913,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3109928,https://api.altmetric.com/v1/donut/3109928_240.png 1,Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.,The Journal of Urology,,,Article,2010-01-07,10.1016/j.juro.2010.03.025,,,,20478578,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3106223,https://api.altmetric.com/v1/donut/3106223_240.png 1,"??oryzanol reduces caveolin?1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines",The Prostate,,,Article,2015-01-25,10.1002/pros.22960,,,,25619388,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3103886,https://api.altmetric.com/v1/donut/3103886_240.png 1,What is the Real Gain with Treatment? Assessing Quality of Life and Needs of Older Patients with Prostate Cancer (S795),Journal of Pain & Symptom Management,,,Article,2015-01-02,10.1016/j.jpainsymman.2014.11.274,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3102581,https://api.altmetric.com/v1/donut/3102581_240.png 1,Clinical significance of ER? in breast and prostate cancer from biological aspects,Cancer Science,,,Article,2015-03-09,10.1111/cas.12613,,,,25611678,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3101237,https://api.altmetric.com/v1/donut/3101237_240.png 1,Downregulation of EphA5 by promoter methylation in human prostate cancer,BMC Cancer,,,Article,2015-01-22,10.1186/s12885-015-1025-3,,,,25609195,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3097612,https://api.altmetric.com/v1/donut/3097612_240.png 1,Top associated SNPs in prostate cancer are significantly enriched in cis-expression quantitative trait loci and at transcription factor binding sites.,Oncotarget,,,Article,2014-07-16,10.18632/oncotarget.2179,,,,25026280,PMC4171620,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3095570,https://api.altmetric.com/v1/donut/3095570_240.png 1,X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.,International Journal of Biological Markers,,,Article,2014-09-30,10.5301/jbm.5000111,,,,25262700,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3094997,https://api.altmetric.com/v1/donut/3094997_240.png 1,Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.,Oncotarget,,,Article,2014-12-26,10.18632/oncotarget.3077,,,,25605014,PMC4413643,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3092039,https://api.altmetric.com/v1/donut/3092039_240.png 1,Performance Comparison of 1.5-T Endorectal Coil MRI with 3.0-T Nonendorectal Coil MRI in Patients with Prostate Cancer ,Academic Radiology,,,Article,2015-01-08,10.1016/j.acra.2014.11.007,,,,25579637,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3089978,https://api.altmetric.com/v1/donut/3089978_240.png 1,CD117+ cells in the circulation are predictive of advanced prostate cancer.,Oncotarget,,,Article,2015-01-18,10.18632/oncotarget.2796,,,,25595903,PMC4359340,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3088070,https://api.altmetric.com/v1/donut/3088070_240.png 1,Future burden of prostate cancer mortality in Brazil: a population-based study,,,,Article,,10.1590/0102-311x00007314,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3085212,https://api.altmetric.com/v1/donut/3085212_240.png 1,NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells,The Prostate,,,Article,2015-01-13,10.1002/pros.22938,,,,25585568,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3084979,https://api.altmetric.com/v1/donut/3084979_240.png 1,Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer.,Urologic Oncology,,,Article,2015-01-14,10.1016/j.urolonc.2014.11.020,,,,25596644,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3081272,https://api.altmetric.com/v1/donut/3081272_240.png 1,The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.,Endocrine,,,Article,2015-01-17,10.1007/s12020-015-0525-x,,,,25588772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3080975,https://api.altmetric.com/v1/donut/3080975_240.png 1,"Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characterisitics and clinical outcomes.",Annals of Oncology,,,Article,2015-01-16,10.1093/annonc/mdv004,,,,25595936,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3076871,https://api.altmetric.com/v1/donut/3076871_240.png 1,Imaging biomarkers in prostate cancer: role of PET/CT and MRI.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-01-17,10.1007/s00259-014-2982-5,,,,25595344,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3076840,https://api.altmetric.com/v1/donut/3076840_240.png 1,Low intensity focused ultrasound (LOFU) modulates unfolded protein response and sensitizes prostate cancer to 17AAG.,Oncoscience,,,Article,2014-01-01,10.18632/oncoscience.48,,,,25594042,PMC4284617,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3075442,https://api.altmetric.com/v1/donut/3075442_240.png 1,Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution,Nuclear Medicine & Biology,,,Article,2015-01-14,10.1016/j.nucmedbio.2014.12.012,,,,25577038,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3075246,https://api.altmetric.com/v1/donut/3075246_240.png 1,Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy ,Urologic Oncology,,,Article,,10.1016/j.urolonc.2014.12.002,,,,25575715,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3073875,https://api.altmetric.com/v1/donut/3073875_240.png 1,Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.,Oncology Reports,,,Article,2015-01-13,10.3892/or.2014.3696,,,,25572120,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3071772,https://api.altmetric.com/v1/donut/3071772_240.png 1,Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences?,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2014-05-24,,,,,24853213,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3068866,https://api.altmetric.com/v1/donut/3068866_240.png 1,Current role of cabozantinib in metastatic castration-resistant prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2015-01-14,10.1586/14737140.2015.1003047,,,,25586337,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3067821,https://api.altmetric.com/v1/donut/3067821_240.png 1,"Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer",Cancer (0008543X),,,Article,2015-01-13,10.1002/cncr.29233,,,,25639219,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3062415,https://api.altmetric.com/v1/donut/3062415_240.png 1,Crosstalking between Androgen and PI3K/AKT Signaling Pathways in Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2014-12-19,10.1074/jbc.m114.607846,,,,25527506,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3059779,https://api.altmetric.com/v1/donut/3059779_240.png 1,?-Adrenergic receptor signaling in prostate cancer,Frontiers in oncology,,,Article,2014-12-16,10.3389/fonc.2014.00375,,,,25629002,PMC4290544,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3059081,https://api.altmetric.com/v1/donut/3059081_240.png 1,Do New Zealand men with prostate cancer benefit from a Mediterranean-style diet?,,,,Article,2015-01-11,10.7287/peerj.preprints.783v1,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3058892,https://api.altmetric.com/v1/donut/3058892_240.png 1,Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP?1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer,The Prostate,,,Article,2015-01-05,10.1002/pros.22945,,,,25560638,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3055778,https://api.altmetric.com/v1/donut/3055778_240.png 1,Going BATty to fight prostate cancer,Science,,,Article,2015-01-09,10.1126/science.347.6218.141-c,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3048502,https://api.altmetric.com/v1/donut/3048502_240.png 1,"Terrestrosin D, a Steroidal Saponin from Tribulus terrestris L., Inhibits Growth and Angiogenesis of Human Prostate Cancer in vitro and in vivo",Pathobiology,,,Article,2014-03-08,10.1159/000357622,,,,24642631,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3048104,https://api.altmetric.com/v1/donut/3048104_240.png 1,Prostate cancer risk after anti-androgen treatment for priapism,International Urology and Nephrology,,,Article,2013-10-18,10.1007/s11255-013-0583-z,,,,24136185,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3046991,https://api.altmetric.com/v1/donut/3046991_240.png 1,Soy isoflavone genistein in prevention and treatment of prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2007-10-09,10.1038/sj.pcan.4501000,,,,,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3046087,https://api.altmetric.com/v1/donut/3046087_240.png 1,Establishing prostate cancer patient derived xenografts: Lessons learned from older studies,The Prostate,,,Article,2015-01-05,10.1002/pros.22946,,,,25560784,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3041154,https://api.altmetric.com/v1/donut/3041154_240.png 1,"Capsule Commentary on Tomko et al., A Comparison of Web- Versus Print-Based Decision Aids for Prostate Cancer Screening: Participants’ Evaluation and Utilization",JGIM: Journal of General Internal Medicine,,,Article,2014-09-30,10.1007/s11606-014-3039-y,,,,25266409,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3039593,https://api.altmetric.com/v1/donut/3039593_240.png 1,CIP2A mediates prostate cancer progression via the c-MYC signaling pathway,Tumor Biology,,,Article,2015-01-06,10.1007/s13277-014-2995-5,,,,25560487,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3039397,https://api.altmetric.com/v1/donut/3039397_240.png 1,Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers.,Theranostics,,,Article,2015-01-02,10.7150/thno.10349,,,,25553114,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3034788,https://api.altmetric.com/v1/donut/3034788_240.png 1,Impact of Prostate-specific Antigen on a Baseline Prostate Cancer Risk Assessment Including Genetic Risk,Urology,,,Article,2015-01-01,10.1016/j.urology.2014.07.081,,,,25530379,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3032271,https://api.altmetric.com/v1/donut/3032271_240.png 1,Upregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells.,Journal of Cancer,,,Article,2015-01-01,10.7150/jca.9591,,,,25553085,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3031941,https://api.altmetric.com/v1/donut/3031941_240.png 1,"RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer.",Oncotarget,,,Article,2014-12-30,10.18632/oncotarget.2949,,,,25537508,PMC4385850,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3030179,https://api.altmetric.com/v1/donut/3030179_240.png 1,Molecular Foundations for Personalized Therapy in Prostate Cancer.,Current Drug Targets,,,Article,2014-12-29,,,,,25547910,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3029123,https://api.altmetric.com/v1/donut/3029123_240.png 1,The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA?10ng/ml.,Urologic Oncology,,,Article,2013-02-27,10.1016/j.urolonc.2012.11.021,,,,23434425,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3029077,https://api.altmetric.com/v1/donut/3029077_240.png 1,Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies,PLoS ONE,,,Article,2014-12-29,10.1371/journal.pone.0116327,,,,25545701,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3026489,https://api.altmetric.com/v1/donut/3026489_240.png 1,Kallikreins as Biomarkers for Prostate Cancer.,Biomed Res Int,,,Article,2014-05-09,10.1155/2014/526341,,,,24809052,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3017483,https://api.altmetric.com/v1/donut/3017483_240.png 1,Cryotherapy for prostate cancer: ready for prime time?,Current Opinion in Urology,,,Article,2010-05-01,10.1097/mou.0b013e3283385570,,,,20224411,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3014032,https://api.altmetric.com/v1/donut/3014032_240.png 1,Secretome Analysis of an Osteogenic Prostate Tumor Identifies Complex Signaling Networks Mediating Cross-talk of Cancer and Stromal Cells Within the Tumor Microenvironment,Molecular and Cellular Proteomics (MCP Online),,,Article,2014-12-19,10.1074/mcp.m114.039909,,,,25527621,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3004215,https://api.altmetric.com/v1/donut/3004215_240.png 1,Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (?ct2) patients,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2014.05.05,,,,25498272,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3002125,https://api.altmetric.com/v1/donut/3002125_240.png 1,[MicroRNA in prostate cancer].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2014-12-01,,,,,25518362,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3001717,https://api.altmetric.com/v1/donut/3001717_240.png 1,[Genetic analysis in prostate cancer].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2014-12-01,,,,,25518361,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3001057,https://api.altmetric.com/v1/donut/3001057_240.png 1,Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form,Urology,,,Article,2015-01-01,10.1016/j.urology.2014.08.044,,,,25530370,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2999350,https://api.altmetric.com/v1/donut/2999350_240.png 1,Current Status of Cryotherapy for Prostate and Kidney Cancer.,Korean Journal of Urology,,,Article,2014-12-01,10.4111/kju.2014.55.12.780,,,,25512811,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2996978,https://api.altmetric.com/v1/donut/2996978_240.png 1,The acute effects of exercise on cortical excitation and psychosocial outcomes in men treated for prostate cancer: a randomized controlled trial.,Frontiers in Aging Neuroscience,,,Article,2014-01-01,10.3389/fnagi.2014.00332,,,,25505413,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2995758,https://api.altmetric.com/v1/donut/2995758_240.png 1,MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.,Scientific Reports,,,Article,2014-12-18,10.1038/srep07546,,,,25519054,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2995607,https://api.altmetric.com/v1/donut/2995607_240.png 1,Is pathology necessary to predict mortality among men with prostate-cancer?,BMC Medical Informatics and Decision Making,,,Article,2014-12-12,10.1186/s12911-014-0114-6,,,,25495664,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2992459,https://api.altmetric.com/v1/donut/2992459_240.png 1,Emerging trends in prostate cancer literature: medical progress or marketing hype?,British Journal of Urology,,,Article,2014-12-11,10.1111/bju.13015,,,,25496244,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2990697,https://api.altmetric.com/v1/donut/2990697_240.png 1,Prostate cancer incidence and mortality trends in 37 European countries: an overview.,European Journal of Cancer (1965),,,Article,2010-01-11,10.1016/j.ejca.2010.09.013,,,,21047585,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,70,https://www.altmetric.com/details/2987368,https://api.altmetric.com/v1/donut/2987368_240.png 1,Synthesis and evaluation of linear furanocoumarins as potential anti-breast and anti-prostate cancer agents,Medicinal Chemistry Research,,,Article,2014-12-16,10.1007/s00044-014-1312-6,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2985660,https://api.altmetric.com/v1/donut/2985660_240.png 1,"SOX2 expression in the developing, adult, as well as, diseased prostate",Prostate Cancer & Prostatic Diseases,,,Article,2014-08-05,10.1038/pcan.2014.29,,,,25091041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2985072,https://api.altmetric.com/v1/donut/2985072_240.png 1,"Quantitative Analysis of ERG Expression and Its Splice Isoforms in Formalin-Fixed, Paraffin-Embedded Prostate Cancer Samples: Association With Seminal Vesicle Invasion and Biochemical Recurrence.",American Journal of Clinical Pathology,,,Article,2014-09-23,10.1309/ajcph88qhxarisup,,,,25239421,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2984520,https://api.altmetric.com/v1/donut/2984520_240.png 1,Beyond ten cycles of cabazitaxel for castrate-resistant prostate cancer.,Indian Journal of Cancer,,,Article,,10.4103/0019-509x.146721,,,,25494139,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2977142,https://api.altmetric.com/v1/donut/2977142_240.png 1,SOD3 Acts as a Tumor Suppressor in PC-3 Prostate Cancer Cells via Hydrogen Peroxide Accumulation,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2014-06-14,,,,,24922645,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2975683,https://api.altmetric.com/v1/donut/2975683_240.png 1,TGF?-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1.,Cell Cycle,,,Article,2014-08-01,10.4161/cc.29339,,,,25483191,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2968881,https://api.altmetric.com/v1/donut/2968881_240.png 1,Hereditary link: Scientists seek clues in genetic risks for prostate cancer.,Cancer (0008543X),,,Article,2014-12-04,10.1002/cncr.29156,,,,25474225,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2963800,https://api.altmetric.com/v1/donut/2963800_240.png 1,Androgen biosynthesis in castration-resistant prostate cancer,Endocrine-Related Cancer,,,Article,2014-05-13,10.1530/erc-14-0109,,,,24829267,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2960484,https://api.altmetric.com/v1/donut/2960484_240.png 1,Immunotherapy in prostate cancer: review of the current evidence,Clinical and Translational Oncology,,,Article,2014-12-06,10.1007/s12094-014-1259-6,,,,25480118,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2960464,https://api.altmetric.com/v1/donut/2960464_240.png 1,Endothelin-A Receptor Antagonists and Advanced Prostate Cancer,Reviews in Urology,,,Article,,,,,,16985575,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2957867,https://api.altmetric.com/v1/donut/2957867_240.png 1,Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era.,Advances in Urology,,,Article,2014-05-31,10.1155/2014/627290,,,,24876835,PMC4022114,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2954142,https://api.altmetric.com/v1/donut/2954142_240.png 1,SPOP Mutations Alter the Ubiquitin Landscape in Prostate Cancer,Cancer Discovery,,,Article,,10.1158/2159-8290.cd-rw2014-214,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2950242,https://api.altmetric.com/v1/donut/2950242_240.png 1,NCOA2 Drives Development of Castration-Resistant Prostate Cancer,Cancer Discovery,,,Article,,10.1158/2159-8290.cd-rw2014-221,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2950241,https://api.altmetric.com/v1/donut/2950241_240.png 1,Prostate cancer cells induce osteoblastic differentiation via semaphorin 3A,The Prostate,,,Article,2014-11-24,10.1002/pros.22923,,,,25421946,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2947560,https://api.altmetric.com/v1/donut/2947560_240.png 1,Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.,Urologic Oncology,,,Article,2006-03-09,10.1016/j.urolonc.2005.11.002,,,,16520276,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2947305,https://api.altmetric.com/v1/donut/2947305_240.png 1,A rare case of prostatic brucellosis mimicking prostate cancer.,Urology Journal,,,Article,2014-12-01,,,,,25433480,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2945126,https://api.altmetric.com/v1/donut/2945126_240.png 1,"High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir <=0.2 to Select Men for Short-term Hormonal Therapy.",American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-11-26,10.1097/coc.0000000000000161,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2940378,https://api.altmetric.com/v1/donut/2940378_240.png 1,Rectal toxicity after intensity modulated radiotherapy for prostate cancer: Which rectal dose volume constraints should we use?,Radiotherapy & Oncology,,,Article,2014-11-28,10.1016/j.radonc.2014.10.014,,,,25441610,,1854/LU-5862561,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2935801,https://api.altmetric.com/v1/donut/2935801_240.png 1,The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc,Neoplasia,,,Article,2014-11-01,10.1016/j.neo.2014.09.001,,,,25425964,PMC4240923,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2930481,https://api.altmetric.com/v1/donut/2930481_240.png 1,The cytotoxic and pro?apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn2+?chelation and inhibiting the serine protease Omi/HtrA2,The Prostate,,,Article,2014-11-18,10.1002/pros.22922,,,,25408502,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2929237,https://api.altmetric.com/v1/donut/2929237_240.png 1,Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study,Prostate Cancer & Prostatic Diseases,,,Article,2014-08-19,10.1038/pcan.2014.31,,,,25134939,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2920298,https://api.altmetric.com/v1/donut/2920298_240.png 1,Steroids in Prostate Cancer: The Jury Is Still Out... and Even More Confused,European Urology,,,Article,2015-04-01,10.1016/j.eururo.2014.11.002,,,,25465980,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2917414,https://api.altmetric.com/v1/donut/2917414_240.png 1,Osteoporosis in patients with breast and prostate cancer. Effect of disease and treatment modalities.,"Endocrine, Metabolic & Immune Disorders - Drug Targets",,,Article,2012-12-20,,,,,23244490,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2917346,https://api.altmetric.com/v1/donut/2917346_240.png 1,Evaluation of data quality in the National Prostate Cancer Register of Sweden,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.10.025,,,,25465187,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2911109,https://api.altmetric.com/v1/donut/2911109_240.png 1,Effects of luteinizing hormone receptor signaling in prostate cancer cells,The Prostate,,,Article,2014-11-12,10.1002/pros.22899,,,,25393079,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2908900,https://api.altmetric.com/v1/donut/2908900_240.png 1,Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-09-30,10.1158/1055-9965.epi-13-0333-t,,,,24083995,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2903022,https://api.altmetric.com/v1/donut/2903022_240.png 1,Spirituality influences health related quality of life in men with prostate cancer,Psycho-Oncology,,,Article,2005-05-10,10.1002/pon.929,,,,15880458,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2894731,https://api.altmetric.com/v1/donut/2894731_240.png 1,Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells.,PLoS ONE,,,Article,2014-11-07,10.1371/journal.pone.0112453,,,,25380390,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2892645,https://api.altmetric.com/v1/donut/2892645_240.png 1,Malignant acanthosis nigricans associated with prostate cancer: a case report,BMC Urology,,,Article,2014-11-15,10.1186/1471-2490-14-88,,,,25399333,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2892269,https://api.altmetric.com/v1/donut/2892269_240.png 1,MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer,Tumor Biology,,,Article,2014-11-15,10.1007/s13277-014-2805-0,,,,25394900,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2892066,https://api.altmetric.com/v1/donut/2892066_240.png 1,Adherence patterns for abiraterone acetate and concomitant prednisone use in patients with prostate cancer.,Journal of Managed Care Pharmacy,,,Article,2014-04-26,,,,,24761819,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2890011,https://api.altmetric.com/v1/donut/2890011_240.png 1,"A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up",Radiation Oncology,,,Article,2014-09-27,10.3389/fonc.2014.00279,,,,25452933,PMC4231837,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2888984,https://api.altmetric.com/v1/donut/2888984_240.png 1,Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report,Oncology Letters,,,Article,2014-12-01,10.3892/ol.2014.2588,,,,25364402,PMC4214463,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2884417,https://api.altmetric.com/v1/donut/2884417_240.png 1,"AR, the cell cycle, and prostate cancer.",Nuclear Receptor Signaling,,,Article,2008-02-28,10.1621/nrs.06001,,,,18301781,PMC2254330,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,107,https://www.altmetric.com/details/2878337,https://api.altmetric.com/v1/donut/2878337_240.png 1,Biomarkers in prostate cancer: what's new?,Current opinion in oncology,,,Article,2014-05-01,10.1097/cco.0000000000000065,,,,24626128,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/2878083,https://api.altmetric.com/v1/donut/2878083_240.png 1,Post genome-wide association studies functional characterization of prostate cancer risk loci.,BMC Genomics,,,Article,2014-02-27,10.1186/1471-2164-14-s8-s9,,,,24564736,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2874819,https://api.altmetric.com/v1/donut/2874819_240.png 1,MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer,American journal of clinical and experimental urology,,,Article,2014-01-01,,,,,25374924,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2862386,https://api.altmetric.com/v1/donut/2862386_240.png 1,Oligophrenin-1 Is Associated with Cell Adhesion and Migration in Prostate Cancer,Pathobiology,,,Article,2014-08-27,10.1159/000363345,,,,25170626,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2861696,https://api.altmetric.com/v1/donut/2861696_240.png 1,Epithelial–mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure,The Prostate,,,Article,2014-10-17,10.1002/pros.22908,,,,25327565,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2859183,https://api.altmetric.com/v1/donut/2859183_240.png 1,Heterogeneity of DNA methylation in multifocal prostate cancer,Virchows Archiv,,,Article,2014-11-05,10.1007/s00428-014-1678-3,,,,25369892,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2856986,https://api.altmetric.com/v1/donut/2856986_240.png 1,Effects of exercise on disablement process model outcomes in prostate cancer patients undergoing androgen deprivation therapy.,The Journal of community and supportive oncology,,,Article,2014-08-01,,,,,25372364,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2855787,https://api.altmetric.com/v1/donut/2855787_240.png 1,Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).,PLoS ONE,,,Article,2011-03-05,10.1371/journal.pone.0016914,,,,21373201,PMC3044148,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2850759,https://api.altmetric.com/v1/donut/2850759_240.png 1, My Road Ahead study protocol: a randomised controlled trial of an online psychological intervention for men following treatment for localised prostate cancer,BMC Cancer,,,Article,2014-02-11,10.1186/1471-2407-14-83,,,,24517384,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2846277,https://api.altmetric.com/v1/donut/2846277_240.png 1,Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.,The Prostate,,,Article,2014-08-13,10.1002/pros.22862,,,,25111810,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2843073,https://api.altmetric.com/v1/donut/2843073_240.png 1,Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation,Anti-Cancer Drugs,,,Article,2014-10-21,10.1097/cad.0000000000000180,,,,25340916,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2841004,https://api.altmetric.com/v1/donut/2841004_240.png 1,A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines,Molecular and Cellular Biochemistry,,,Article,2013-10-09,10.1007/s11010-013-1857-6,,,,24104455,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2840841,https://api.altmetric.com/v1/donut/2840841_240.png 1,Prostate cancer: Important steps and considerations in the design of therapeutic vaccines.,"Transactions of the Institute of Measurement and Control, with Measurement + Control",,,Article,2014-10-25,10.4161/onci.28049,,,,25340006,PMC4203569,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2837190,https://api.altmetric.com/v1/donut/2837190_240.png 1,Low Percentage of Free Prostate-specific Antigen (PSA) Is a Strong Predictor of Later Detection of Prostate Cancer Among Japanese Men With Serum Levels of Total PSA of 4.0 ng/mL or Less,Urology,,,Article,2014-01-11,10.1016/j.urology.2014.04.055,,,,25443923,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2836823,https://api.altmetric.com/v1/donut/2836823_240.png 1,"MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.",Cancer and Metastasis Reviews,,,Article,2014-10-22,10.1007/s10555-014-9519-z,,,,25332143,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2832923,https://api.altmetric.com/v1/donut/2832923_240.png 1,Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program,Cancer Chemotherapy & Pharmacology,,,Article,2014-09-06,10.1007/s00280-014-2579-5,,,,25193433,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2830285,https://api.altmetric.com/v1/donut/2830285_240.png 1,Enzalutamide in Metastatic Prostate Cancer before Chemotherapy.,New England Journal of Medicine,,,Article,2014-10-30,10.1056/nejmc1410239#sa1,,,,25354112,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2827101,https://api.altmetric.com/v1/donut/2827101_240.png 1,Key papers in prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2014-10-28,10.1586/14737140.2014.974565,,,,25348075,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2824191,https://api.altmetric.com/v1/donut/2824191_240.png 1,Prostate Cancer Survivorship: A Different Type of Management,Journal of Men's Health,,,Article,2014-12-01,10.1089/jomh.2014.0056,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2821549,https://api.altmetric.com/v1/donut/2821549_240.png 1,"Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study",Radiation Oncology,,,Article,2014-10-14,10.3389/fonc.2014.00301,,,,25389521,PMC4211385,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2819224,https://api.altmetric.com/v1/donut/2819224_240.png 1,Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.,Expert Opinion on Emerging Drugs,,,Article,2014-10-25,10.1517/14728214.2014.969239,,,,25345821,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2817831,https://api.altmetric.com/v1/donut/2817831_240.png 1,Technology Diffusion and Prostate Cancer Quality of Care ,Urology,,,Article,,10.1016/j.urology.2014.06.067,,,,25443905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2817614,https://api.altmetric.com/v1/donut/2817614_240.png 1,Development of a Nomogram Model Predicting Current Bone Scan Positivity in Patients Treated with Androgen-Deprivation Therapy for Prostate Cancer,Frontiers in oncology,,,Article,2014-10-10,10.3389/fonc.2014.00296,,,,25386410,PMC4209823,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2812989,https://api.altmetric.com/v1/donut/2812989_240.png 1,RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer ,Journal of Controlled Release,,,Article,,10.1016/j.jconrel.2014.10.012,,,,25456829,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2811644,https://api.altmetric.com/v1/donut/2811644_240.png 1,Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer,European Journal of Cancer (1965),,,Article,2014-01-11,10.1016/j.ejca.2014.08.006,,,,25204805,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2811367,https://api.altmetric.com/v1/donut/2811367_240.png 1,Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosis,British Journal of Urology,,,Article,2014-02-20,10.1111/bju.12519,,,,24131890,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2808151,https://api.altmetric.com/v1/donut/2808151_240.png 1,Radical prostatectomy versus external beam radiotherapy for localized prostate cancer,Strahlentherapie und Onkologie,,,Article,2014-10-23,10.1007/s00066-014-0765-3,,,,25339310,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2806849,https://api.altmetric.com/v1/donut/2806849_240.png 1,Abstract 1263: Dietary patterns after prostate cancer diagnosis in relation to disease-specific and total mortality,Cancer Research,,,Article,2014-10-01,10.1158/1538-7445.am2014-1263,,,,,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2803894,https://api.altmetric.com/v1/donut/2803894_240.png 1,Improved Irritative Voiding Symptoms 3 Years after Stereotactic Body Radiation Therapy for Prostate Cancer,Radiation Oncology,,,Article,2014-10-07,10.3389/fonc.2014.00290,,,,25374844,PMC4204455,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2800495,https://api.altmetric.com/v1/donut/2800495_240.png 1,Risk of Acute Myocardial Infarction after Androgen Deprivation Therapy for Prostate Cancer in the Chinese Population,British Journal of Urology,,,Article,2015-03-07,10.1111/bju.12967,,,,25327618,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2796083,https://api.altmetric.com/v1/donut/2796083_240.png 1,Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-10-14,10.1097/coc.0000000000000139,,,,25319322,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2796009,https://api.altmetric.com/v1/donut/2796009_240.png 1,Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer.,Journal of Cancer Research & Clinical Oncology,,,Article,2014-10-18,10.1007/s00432-014-1856-3,,,,25326347,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2792449,https://api.altmetric.com/v1/donut/2792449_240.png 1,Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer,The Prostate,,,Article,2014-10-18,10.1002/pros.22915,,,,25327941,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2791631,https://api.altmetric.com/v1/donut/2791631_240.png 1,Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2014-09-24,10.1517/14656566.2014.960390,,,,25234584,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2789859,https://api.altmetric.com/v1/donut/2789859_240.png 1,Toxicity of Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: A Potential Comparison Bias,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.56.3213,,,,25185086,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2787504,https://api.altmetric.com/v1/donut/2787504_240.png 1,Perils of Comparing Toxicities Between Stereotactic Body Radiation and Intensity-Modulated Radiation Therapy for Prostate Cancer on the Basis of Incomplete Demographic Registries,Journal of Clinical Oncology,,,Article,,10.1200/jco.2014.56.4229,,,,25185084,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2787497,https://api.altmetric.com/v1/donut/2787497_240.png 1,Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer,BMC Urology,,,Article,2014-10-16,10.1186/1471-2490-14-81,,,,25323845,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2785996,https://api.altmetric.com/v1/donut/2785996_240.png 1,Pathologic fracture in patients with metastatic prostate cancer,Current Opinion in Urology,,,Article,2014-11-01,10.1097/mou.0000000000000105,,,,25166424,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2783984,https://api.altmetric.com/v1/donut/2783984_240.png 1,Capsaicin: A novel radio-sensitizing agent for prostate cancer.,The Prostate,,,Article,,10.1002/pros.22896,,,,25307418,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2781793,https://api.altmetric.com/v1/donut/2781793_240.png 1,VMAT technique enables concomitant radiotherapy of prostate cancer and pelvic bone metastases.,Acta Oncologica,,,Article,2014-10-13,10.3109/0284186x.2014.962665,,,,25307406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2776296,https://api.altmetric.com/v1/donut/2776296_240.png 1,Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a 177Lu-Labeled Peptide.,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2014-09-18,10.1089/cbr.2014.1660,,,,25226447,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2769808,https://api.altmetric.com/v1/donut/2769808_240.png 1,Serum proteomic patterns for detection of prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2002-10-16,,,,,12381711,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/2769351,https://api.altmetric.com/v1/donut/2769351_240.png 1,Role of 3.0 T multiparametric MRI in local staging in prostate cancer and clinical implications for radiation oncology,Clinical and Translational Oncology,,,Article,2014-05-28,10.1007/s12094-014-1186-6,,,,24865628,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2764927,https://api.altmetric.com/v1/donut/2764927_240.png 1,Change in the risk stratification of prostate cancer after Slide Review by a uropathologist: the experience of a reference center for the treatment of prostate cancer,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2014.04.03,,,,25251950,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2762743,https://api.altmetric.com/v1/donut/2762743_240.png 1,Design and synthesis of optically pure 3-aryl-6-methyl-2-thioxotetrahydropyrimidin-4(1H)-ones as anti-prostate cancer agents,RSC Advances,,,Article,2014-08-21,10.1039/c4ra06391k,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2762417,https://api.altmetric.com/v1/donut/2762417_240.png 1,"Protective effect of Acticoa powder, a cocoa polyphenolic extract, on prostate carcinogenesis in Wistar-Unilever rats.",European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2007-12-21,10.1097/cej.0b013e3280145b33,,,,18090911,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2759875,https://api.altmetric.com/v1/donut/2759875_240.png 1,Evaluation of different mathematical models for diffusion?weighted imaging of normal prostate and prostate cancer using high b?values: A repeatability study,Magnetic Resonance in Medicine,,,Article,2014-07-12,10.1002/mrm.25323,,,,25046482,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2755129,https://api.altmetric.com/v1/donut/2755129_240.png 1,Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.,The Prostate,,,Article,2014-10-04,10.1002/pros.22892,,,,25284284,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2750190,https://api.altmetric.com/v1/donut/2750190_240.png 1,Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS),Quality of Life Research,,,Article,2014-05-01,10.1007/s11136-014-0701-0,,,,24789667,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2750107,https://api.altmetric.com/v1/donut/2750107_240.png 1,PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples,International Brazilian Journal of Urology,,,Article,2013-01-01,10.1590/s1677-5538.ibju.2013.05.06,,,,24267108,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2746057,https://api.altmetric.com/v1/donut/2746057_240.png 1,Radiation Therapy for Clinically Node-Positive Prostate Cancer and Survival: Results from the National Cancer Data Base,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-09,10.1016/j.ijrobp.2014.05.096,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2744706,https://api.altmetric.com/v1/donut/2744706_240.png 1,XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa),Journal of Hematology & Oncology,,,Article,2014-10-05,10.1186/1756-8722-7-46,,,,25284315,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2743603,https://api.altmetric.com/v1/donut/2743603_240.png 1,Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.,Nutrition and Cancer,,,Article,2010-01-27,10.1080/01635580903305383,,,,20099188,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2741370,https://api.altmetric.com/v1/donut/2741370_240.png 1,New FDA Indication for Xtandi for Prostate Cancer,Oncology times,,,Article,2014-10-10,10.1097/01.cot.0000455792.27702.d1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2741129,https://api.altmetric.com/v1/donut/2741129_240.png 1,Magnetic resonance elastography of prostate cancer,,,,Article,,,,,,,,2429/45191,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2740503,https://api.altmetric.com/v1/donut/2740503_240.png 1,Re: Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dju292,,,,25269488,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2730583,https://api.altmetric.com/v1/donut/2730583_240.png 1,"In Older Men, Lower Plasma 25-Hydroxyvitamin D Is Associated with Reduced Incidence of Prostate, but Not Colorectal or Lung Cancer",PLoS ONE,,,Article,2014-06-20,10.1371/journal.pone.0099954,,,,24949795,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2728198,https://api.altmetric.com/v1/donut/2728198_240.png 1,Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: considering the role of social support and stress,Psycho-Oncology,,,Article,2014-09-23,10.1002/pon.3681,,,,25251737,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2723664,https://api.altmetric.com/v1/donut/2723664_240.png 1,Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.,Anti-Cancer Drugs,,,Article,2014-09-25,10.1097/cad.0000000000000171,,,,25243457,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2722977,https://api.altmetric.com/v1/donut/2722977_240.png 1,Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.,Urologic Oncology,,,Article,2014-01-01,10.1016/j.urolonc.2013.03.006,,,,23769269,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2719932,https://api.altmetric.com/v1/donut/2719932_240.png 1,Prostate cancer: Targeting the FGFR curbs bone metastasis,Nature Reviews Urology,,,Article,2014-09-23,10.1038/nrurol.2014.270,,,,25245247,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2718838,https://api.altmetric.com/v1/donut/2718838_240.png 1,Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences,British Journal of Cancer,,,Article,2014-05-27,10.1038/bjc.2014.268,,,,24867689,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2711910,https://api.altmetric.com/v1/donut/2711910_240.png 1,Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?,International Journal of Urology,,,Article,2014-09-22,10.1111/iju.12623,,,,25243521,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2708402,https://api.altmetric.com/v1/donut/2708402_240.png 1,Development of Targeted Near-Infrared Imaging Agents For Prostate Cancer.,Molecular Cancer Therapeutics,,,Article,2014-09-19,10.1158/1535-7163.mct-14-0422,,,,25239933,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2708339,https://api.altmetric.com/v1/donut/2708339_240.png 1,Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.,Urologic Oncology,,,Article,2014-09-16,10.1016/j.urolonc.2014.08.007,,,,25238700,,1854/LU-6843320,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2707120,https://api.altmetric.com/v1/donut/2707120_240.png 1,"Epibrassinolide?induced apoptosis regardless of p53 expression via activating polyamine catabolic machinery, a common target for androgen sensitive and insensitive prostate cancer cells",The Prostate,,,Article,2014-09-11,10.1002/pros.22879,,,,25214240,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2703547,https://api.altmetric.com/v1/donut/2703547_240.png 1,Update on prostate cancer in black men within the UK,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/full/455-update-on-prostate-cancer-in-black-men-within-the-uk.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2695062,https://api.altmetric.com/v1/donut/2695062_240.png 1,Re: Accuracy of Multiparametric Magnetic Resonance Imaging in Confirming Eligibility for Active Surveillance for Men with Prostate Cancer,The Journal of Urology,,,Article,,10.1016/j.juro.2014.07.032,,,,25304556,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2692196,https://api.altmetric.com/v1/donut/2692196_240.png 1,Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments,Quality of Life Research,,,Article,2014-04-19,10.1007/s11136-014-0678-8,,,,24748557,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2690894,https://api.altmetric.com/v1/donut/2690894_240.png 1,Is DHT Production by 5?-Reductase Friend or Foe in Prostate Cancer?,Frontiers in oncology,,,Article,2014-08-29,10.3389/fonc.2014.00247,,,,25279351,PMC4165281,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2687692,https://api.altmetric.com/v1/donut/2687692_240.png 1,Active surveillance for African-American men with prostate cancer: proceed with caution. Con.,Oncology (Williston Park),,,Article,2014-04-03,,,,,24683725,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2685486,https://api.altmetric.com/v1/donut/2685486_240.png 1,Elimination of Ascorbic Acid following High?Dose Infusion in Prostate Cancer Patients: A Pharmacokinetic Evaluation,Basic & Clinical Pharmacology & Toxicology,,,Article,2014-10-07,10.1111/bcpt.12323,,,,25220574,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2684713,https://api.altmetric.com/v1/donut/2684713_240.png 1,Lifestyle and health factors associated with progressing and remitting trajectories of untreated lower urinary tract symptoms among elderly men,Prostate Cancer & Prostatic Diseases,,,Article,2014-07-08,10.1038/pcan.2014.22,,,,25000909,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2683298,https://api.altmetric.com/v1/donut/2683298_240.png 1,Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway,Molecular Cancer,,,Article,2014-09-12,10.1186/1476-4598-13-214,,,,25216853,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2682872,https://api.altmetric.com/v1/donut/2682872_240.png 1,BMI is associated with larger index tumors and worse outcome after radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2014-05-20,10.1038/pcan.2014.15,,,,24841331,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2672040,https://api.altmetric.com/v1/donut/2672040_240.png 1,Prostate Cancer and New Insights in Angiogenesis,Frontiers in oncology,,,Article,2014-08-21,10.3389/fonc.2014.00243,,,,25309869,PMC4159983,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2671913,https://api.altmetric.com/v1/donut/2671913_240.png 1,Network-based approach reveals Y chromosome influences prostate cancer susceptibility.,Computers in Biology & Medicine,,,Article,2014-08-26,10.1016/j.compbiomed.2014.08.020,,,,25199846,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2670577,https://api.altmetric.com/v1/donut/2670577_240.png 1,New Guideline on Treating Advanced Prostate Cancer,Journal Watch,,,Article,2014-09-09,10.1056/nejm-jw.fw109264,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2666670,https://api.altmetric.com/v1/donut/2666670_240.png 1,The Effects of Androgen Deprivation Therapy on Cardiac Function and Heart Failure: Implications for Management of Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2014-08-01,10.1016/j.clgc.2014.07.009,,,,25193364,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2662148,https://api.altmetric.com/v1/donut/2662148_240.png 1,The clinic-pathological characteristics of prostate cancer in an Irish subpopulation with a serum PSA less than 4.0ng/ml,Journal of Clinical Urology,,,Article,2014-04-07,10.1177/2051415814530290,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2662079,https://api.altmetric.com/v1/donut/2662079_240.png 1,2'-Hydroxy-4-methylsulfonylchalcone enhances TRAIL-induced apoptosis in prostate cancer cells.,Anti-Cancer Drugs,,,Article,2014-09-04,10.1097/cad.0000000000000163,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2661548,https://api.altmetric.com/v1/donut/2661548_240.png 1,Advanced prostate cancer - patient survival and potential impact of enzalutamide and other emerging therapies.,Therapeutics and Clinical Risk Management,,,Article,2014-08-31,10.2147/tcrm.s57509,,,,25170270,PMC4144843,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2657560,https://api.altmetric.com/v1/donut/2657560_240.png 1,Serum tri? and tetra?antennary N?glycan is a potential predictive biomarker for castration?resistant prostate cancer,The Prostate,,,Article,2014-08-23,10.1002/pros.22869,,,,25154914,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2654356,https://api.altmetric.com/v1/donut/2654356_240.png 1,A Better Understating of the Morphological Features and Molecular Characteristics of Intraductal Carcinoma Helps Clinicians Further Explain Prostate Cancer Aggressiveness,European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.08.060,,,,25194910,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2654141,https://api.altmetric.com/v1/donut/2654141_240.png 1,Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2014-08-15,10.1007/s00259-014-2872-x,,,,25182750,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2654082,https://api.altmetric.com/v1/donut/2654082_240.png 1,Resource utilization and use of life-extending therapies and corticosteroids in prostate cancer patients with corticosteroid-sensitive comorbidities.,Current Medical Research & Opinion,,,Article,2014-08-20,10.1185/03007995.2014.955170,,,,25133961,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2653681,https://api.altmetric.com/v1/donut/2653681_240.png 1,Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-08-31,10.1158/1055-9965.epi-14-0700,,,,25178985,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2649444,https://api.altmetric.com/v1/donut/2649444_240.png 1,Dietary Factors and Risks for Prostate Cancer among Blacks and Whites in the United States,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,1999-01-01,,,,,9950236,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2645660,https://api.altmetric.com/v1/donut/2645660_240.png 1,Current state of prostate cancer treatment in Jamaica,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/456-current-state-of-prostate-cancer-treatment-in-jamaica.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2643649,https://api.altmetric.com/v1/donut/2643649_240.png 1,Latino men and familial risk communication about prostate cancer.,Oncology Nursing Forum,,,Article,2014-08-29,10.1188/14.onf.509-516,,,,25158656,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2641066,https://api.altmetric.com/v1/donut/2641066_240.png 1,Prostate cancer cells home to bone using a novel in vivo model: Modulation by the integrin antagonist GLPG0187,International Journal of Cancer,,,Article,2014-08-22,10.1002/ijc.29165,,,,25156971,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2640736,https://api.altmetric.com/v1/donut/2640736_240.png 1,ERG expression in prostate cancer: The prognostic paradox,The Prostate,,,Article,2014-08-29,10.1002/pros.22863,,,,25175352,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2639833,https://api.altmetric.com/v1/donut/2639833_240.png 1,Italianity is associated with lower risk of prostate cancer mortality in Switzerland,Cancer Causes and Control,,,Article,2014-08-22,10.1007/s10552-014-0456-5,,,,25146443,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2634788,https://api.altmetric.com/v1/donut/2634788_240.png 1,Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy.,Value in Health (Elsevier Science),,,Article,2011-01-09,10.1016/j.jval.2010.10.023,,,,21211489,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2633344,https://api.altmetric.com/v1/donut/2633344_240.png 1,Preoperative therapy for localized prostate cancer: A comprehensive overview,Maturitas,,,Article,2013-01-01,10.1016/j.maturitas.2012.10.012,,,,23158077,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2633045,https://api.altmetric.com/v1/donut/2633045_240.png 1,Prostate cancer: Enzalutamide improves quality of life in mCRPC.,Nature Reviews Clinical Oncology,,,Article,2014-08-26,10.1038/nrclinonc.2014.144,,,,25155172,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2632259,https://api.altmetric.com/v1/donut/2632259_240.png 1,Theranostic Graphene Oxide for Prostate Cancer Detection and Treatment,Particle & Particle Systems Characterization,,,Article,2014-08-27,10.1002/ppsc.201400143,,,,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2631029,https://api.altmetric.com/v1/donut/2631029_240.png 1,Computational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis.,Theoretical Biology and Medical Modelling,,,Article,2014-08-23,10.1186/1742-4682-11-37,,,,25151146,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2626599,https://api.altmetric.com/v1/donut/2626599_240.png 1,Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T,Prostate Cancer & Prostatic Diseases,,,Article,2014-06-24,10.1038/pcan.2014.21,,,,24957547,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2623947,https://api.altmetric.com/v1/donut/2623947_240.png 1,"Serum 25-hydroxyvitamin D, vitamin D binding protein, and risk of colorectal cancer in the prostate, Lung, colorectal, and Ovarian cancer screening trial.",International Journal of Cancer,,,Article,2014-08-22,10.1002/ijc.29157,,,,25156182,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2623584,https://api.altmetric.com/v1/donut/2623584_240.png 1,The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2014-08-01,10.1097/cej.0000000000000075,,,,25075878,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2623287,https://api.altmetric.com/v1/donut/2623287_240.png 1,An investigation of the support needs of men and partners throughout the prostate cancer journey,Psycho-Oncology,,,Article,2014-08-12,10.1002/pon.3655,,,,25116753,,11541.2/111822,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2621395,https://api.altmetric.com/v1/donut/2621395_240.png 1,The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors,International Journal of Cancer,,,Article,2014-08-27,10.1002/ijc.29147,,,,25138562,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2621140,https://api.altmetric.com/v1/donut/2621140_240.png 1,Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2014-08-21,10.1586/14737140.2014.952288,,,,25148431,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2620297,https://api.altmetric.com/v1/donut/2620297_240.png 1,Phase?1 Study of Abiraterone Acetate in Chemotherapy?nave Japanese Patients with Castration?Resistant Prostate Cancer,Cancer Science,,,Article,2014-10-04,10.1111/cas.12496,,,,25117615,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2616401,https://api.altmetric.com/v1/donut/2616401_240.png 1,PTEN Loss-Mediated Akt Activation Increases the Properties of Cancer Stem-Like Cell Populations in Prostate Cancer.,Oncology (08909091),,,Article,2014-08-15,10.1159/000363186,,,,25139413,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2615661,https://api.altmetric.com/v1/donut/2615661_240.png 1,Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?,Urologic Oncology,,,Article,2014-08-21,10.1016/j.urolonc.2014.04.016,,,,25159013,,,,,,,0,0,0,1,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2614329,https://api.altmetric.com/v1/donut/2614329_240.png 1,MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo,Oncogenesis,,,Article,2014-04-01,10.1038/oncsis.2014.12,,,,24752237,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2610718,https://api.altmetric.com/v1/donut/2610718_240.png 1,Approach and avoidance coping: Diurnal cortisol rhythm in prostate cancer survivors.,Psychoneuroendocrinology,,,Article,2014-07-16,10.1016/j.psyneuen.2014.07.007,,,,25108161,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2605208,https://api.altmetric.com/v1/donut/2605208_240.png 1,AKT/GSK-3? regulates stability and transcription of snail which is crucial for bFGF-induced epithelial–mesenchymal transition of prostate cancer cells ,BBA - General Subjects,,,Article,,10.1016/j.bbagen.2014.07.018,,,,25088797,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2604915,https://api.altmetric.com/v1/donut/2604915_240.png 1,EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.,Oncotarget,,,Article,2014-08-16,10.18632/oncotarget.2262,,,,25115397,PMC4196193,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2600778,https://api.altmetric.com/v1/donut/2600778_240.png 1,The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.,Oncotarget,,,Article,2014-08-16,10.18632/oncotarget.2228,,,,25115390,PMC4171641,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2600706,https://api.altmetric.com/v1/donut/2600706_240.png 1,A pilot |[lsquo]|window of opportunity|[rsquo]| neoadjuvant study of metformin in localised prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-05-27,10.1038/pcan.2014.20,,,,24861559,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2599884,https://api.altmetric.com/v1/donut/2599884_240.png 1,Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided,BioMed Research International,,,Article,,10.1155/2014/439171,,,,25126559,PMC4122009,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2599241,https://api.altmetric.com/v1/donut/2599241_240.png 1,Strategies for targeting the androgen receptor axis in prostate cancer ,Drug Discovery Today,,,Article,,10.1016/j.drudis.2014.07.008,,,,25107669,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2596651,https://api.altmetric.com/v1/donut/2596651_240.png 1,Src: Marker or Actor in Prostate Cancer Aggressiveness,Frontiers in oncology,,,Article,2014-08-02,10.3389/fonc.2014.00222,,,,25184116,PMC4135356,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2594668,https://api.altmetric.com/v1/donut/2594668_240.png 1,High-dose-rate brachytherapy as monotherapy for prostate cancer,Brachytherapy,,,Article,2014-08-01,10.1016/j.brachy.2014.03.002,,,,25085454,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2591132,https://api.altmetric.com/v1/donut/2591132_240.png 1,Getting Black Men to Undergo Prostate Cancer Screening The Role of Social Capital,American Journal of Men's Health,,,Article,2014-08-11,10.1177/1557988314546491,,,,25117538,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2590345,https://api.altmetric.com/v1/donut/2590345_240.png 1,The role of palliative surgery in castration-resistant prostate cancer,Current Opinion in Supportive and Palliative Care,,,Article,2014-09-01,10.1097/spc.0000000000000078,,,,25090289,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2589047,https://api.altmetric.com/v1/donut/2589047_240.png 1,Polymeric nanoparticles for targeted radiosensitization of prostate cancer cells,"Journal of Biomedical Materials Research, Part A",,,Article,2014-08-01,10.1002/jbm.a.35300,,,,25088162,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2586762,https://api.altmetric.com/v1/donut/2586762_240.png 1,"Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.",Cancer (0008543X),,,Article,2014-01-03,10.1002/cncr.28518,,,,24382803,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2575092,https://api.altmetric.com/v1/donut/2575092_240.png 1,Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone,Endocrine-Related Cancer,,,Article,2014-07-21,10.1530/erc-14-0199,,,,25052474,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2567448,https://api.altmetric.com/v1/donut/2567448_240.png 1,Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.,Clinical and Translational Oncology,,,Article,2014-07-26,10.1007/s12094-014-1206-6,,,,25060568,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2545622,https://api.altmetric.com/v1/donut/2545622_240.png 1,Does cycling increase prostate cancer risk?,ecancer.org,,,Article,,,,,http://ecancer.org/news/5995-does-cycling-increase-prostate-cancer-risk.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2538102,https://api.altmetric.com/v1/donut/2538102_240.png 1,New recommendations in prostate cancer screening and treatment,JAAPA: Journal of the American Academy of Physician Assistants,,,Article,2014-08-01,10.1097/01.jaa.0000451872.86566.bf,,,,24988136,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2537724,https://api.altmetric.com/v1/donut/2537724_240.png 1,miR?34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression,The Prostate,,,Article,2014-07-22,10.1002/pros.22848,,,,25053345,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/2536459,https://api.altmetric.com/v1/donut/2536459_240.png 1,Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer,Molecular and Cellular Proteomics (MCP Online),,,Article,2014-07-22,10.1074/mcp.m114.038836,,,,25056937,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2535738,https://api.altmetric.com/v1/donut/2535738_240.png 1,Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case series,Prostate Cancer & Prostatic Diseases,,,Article,2013-12-10,10.1038/pcan.2013.52,,,,24323329,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2534549,https://api.altmetric.com/v1/donut/2534549_240.png 1,Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients.,Future Oncology,,,Article,2014-06-14,10.2217/fon.14.71,,,,25052746,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2534379,https://api.altmetric.com/v1/donut/2534379_240.png 1,Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression,European Journal of Cancer (1965),,,Article,,10.1016/j.ejca.2014.06.014,,,,25060826,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2532704,https://api.altmetric.com/v1/donut/2532704_240.png 1,"Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells",Cell Death & Differentiation,,,Article,2014-07-11,10.1038/cdd.2014.97,,,,25012501,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2522922,https://api.altmetric.com/v1/donut/2522922_240.png 1,Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models,Investigational New Drugs,,,Article,2014-07-08,10.1007/s10637-014-0131-4,,,,25000999,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2518120,https://api.altmetric.com/v1/donut/2518120_240.png 1,Localized Prostate Cancer: Regional Variation and National Policy,Medical care,,,Article,2014-08-01,10.1097/mlr.0000000000000192,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2517527,https://api.altmetric.com/v1/donut/2517527_240.png 1,Influence of hormonal therapy in prostate cancer patients undergoing 18Fluoromethylcholine PET/CT: a retrospective study.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2014-07-14,,,,,25017896,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2515881,https://api.altmetric.com/v1/donut/2515881_240.png 1,"Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.",Preventive Medicine,,,Article,,10.1016/j.ypmed.2014.07.013,,,,25038532,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2514820,https://api.altmetric.com/v1/donut/2514820_240.png 1,Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.,British Journal of Cancer,,,Article,2014-02-09,10.1038/bjc.2014.48,,,,24504368,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2513053,https://api.altmetric.com/v1/donut/2513053_240.png 1,"Two different BRCA2 mutations found in a multigenerational family with a history of breast, prostate, and lung cancers",Advances in Genomics and Genetics,,,Article,2014-06-01,10.2147/agg.s63411,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2511738,https://api.altmetric.com/v1/donut/2511738_240.png 1,Long-term outcome of early stage prostate cancer treated with brachytherapy analysis after a mean follow-up of 7 years,SpringerPlus,,,Article,2014-07-15,10.1186/2193-1801-3-357,,,,25089248,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2509974,https://api.altmetric.com/v1/donut/2509974_240.png 1,The Personal Patient Profile-Prostate decision support for men localized prostate cancer: A multi-center randomized trial.,Urologic Oncology,,,Article,2011-12-15,10.1016/j.urolonc.2011.10.004,,,,22153756,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2509151,https://api.altmetric.com/v1/donut/2509151_240.png 1,Pre-operative tumor localization and evaluation of extra-capsular extension of prostate cancer: how misleading can it be?,Urology Journal,,,Article,2014-01-01,,,,,25015607,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2507626,https://api.altmetric.com/v1/donut/2507626_240.png 1,Management of low risk prostate cancer-active surveillance and focal therapy.,Nature Reviews Clinical Oncology,,,Article,2014-05-15,10.1038/nrclinonc.2014.73,,,,24821214,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2506146,https://api.altmetric.com/v1/donut/2506146_240.png 1,Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality,Proteome Science,,,Article,2014-07-12,10.1186/1477-5956-12-40,,,,25075204,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2503546,https://api.altmetric.com/v1/donut/2503546_240.png 1,Feasibility and Preliminary Experience of Quantitative T2* Mapping at 3.0 T for Detection and Assessment of Aggressiveness of Prostate Cancer,Academic Radiology,,,Article,,10.1016/j.acra.2014.04.007,,,,25018074,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2501006,https://api.altmetric.com/v1/donut/2501006_240.png 1,Spontaneous antibodies against Engrailed?2 (EN2) protein in patients with prostate cancer,Clinical & Experimental Immunology,,,Article,2014-03-24,10.1111/cei.12332,,,,24654775,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2499163,https://api.altmetric.com/v1/donut/2499163_240.png 1,Study of inter- and intra-observer reproducibility in the interpretation of [(18)F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment.,EJNMMI Research,,,Article,2014-01-01,10.1186/s13550-014-0025-7,,,,25006544,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2498854,https://api.altmetric.com/v1/donut/2498854_240.png 1,Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases,Applied Health Economics and Health Policy,,,Article,2014-07-09,10.1007/s40258-014-0101-1,,,,25005491,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2495508,https://api.altmetric.com/v1/donut/2495508_240.png 1,Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.,International Journal of Clinical and Experimental Medicine,,,Article,2014-01-01,,,,,24995075,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2489277,https://api.altmetric.com/v1/donut/2489277_240.png 1,Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer.,International Journal of Oncology,,,Article,2014-09-01,10.3892/ijo.2014.2529,,,,24990514,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2488601,https://api.altmetric.com/v1/donut/2488601_240.png 1,Simple prognostic score for metastatic castration?resistant prostate cancer with incorporation of neutrophil?to?lymphocyte ratio,Cancer (0008543X),,,Article,2014-07-02,10.1002/cncr.28890,,,,24995769,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2486853,https://api.altmetric.com/v1/donut/2486853_240.png 1,lncRNA H19/MiR?675 axis represses prostate cancer metastasis by targeting TGFBI,FEBS Journal,,,Article,2014-07-21,10.1111/febs.12902,,,,24988946,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2481651,https://api.altmetric.com/v1/donut/2481651_240.png 1,New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist.,British Journal of Urology,,,Article,2011-11-20,10.1111/j.1464-410x.2011.10708.x,,,,22093775,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2476935,https://api.altmetric.com/v1/donut/2476935_240.png 1,Trends in Disparate Treatment of African American Men With Localized Prostate Cancer Across National Comprehensive Cancer Network Risk Groups,Urology,,,Article,,10.1016/j.urology.2014.05.009,,,,24975710,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2473874,https://api.altmetric.com/v1/donut/2473874_240.png 1,Rapid aptasensor capable of simply diagnosing prostate cancer.,Biosensors & Bioelectronics,,,Article,2014-06-13,10.1016/j.bios.2014.06.015,,,,24973540,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2470981,https://api.altmetric.com/v1/donut/2470981_240.png 1,Feasibility of Detecting Prostate Cancer by Ultra Performance Liquid Chromatography-Mass Spectrometry Serum Metabolomics.,Journal of Proteome Research,,,Article,2014-06-14,10.1021/pr500409q,,,,24922590,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2468179,https://api.altmetric.com/v1/donut/2468179_240.png 1,Will new AR inhibitors reshape the prostate cancer landscape? ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70292-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2467910,https://api.altmetric.com/v1/donut/2467910_240.png 1,TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression,Cancer Research,,,Article,,10.1158/0008-5472.can-13-3718,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2462824,https://api.altmetric.com/v1/donut/2462824_240.png 1,AKR1C3 Inhibition Therapy in Castration-Resistant Prostate Cancer and Breast Cancer: Lessons from Responses to SN33638,Frontiers in oncology,,,Article,2014-06-06,10.3389/fonc.2014.00162,,,,25003082,PMC4066440,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2457984,https://api.altmetric.com/v1/donut/2457984_240.png 1,DOC-2/DAB2 Interacting Protein Status in High-Risk Prostate Cancer Correlates With Outcome for Patients Treated With Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-05-23,10.1016/j.ijrobp.2014.03.035,,,,24867541,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2456832,https://api.altmetric.com/v1/donut/2456832_240.png 1,Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer.,International Journal of Biological Sciences,,,Article,2014-01-01,10.7150/ijbs.8389,,,,24948874,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2454961,https://api.altmetric.com/v1/donut/2454961_240.png 1,Multiparametric MRI for prostate cancer: Seeing is believing,Cancer (0008543X),,,Article,2014-06-10,10.1002/cncr.28787,,,,24916963,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2452761,https://api.altmetric.com/v1/donut/2452761_240.png 1,Metformin Sensitizes Prostate Cancer Cells to Radiation Through EGFR/p-DNA-PKCS In Vitro and In Vivo.,Radiation Research,,,Article,2014-05-24,10.1667/rr13561.1,,,,24844651,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2452262,https://api.altmetric.com/v1/donut/2452262_240.png 1,MED12 overexpression is a frequent event in castration-resistant prostate cancer.,Endocrine-Related Cancer,,,Article,2014-06-17,10.1530/erc-14-0171,,,,24938407,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2448939,https://api.altmetric.com/v1/donut/2448939_240.png 1,"The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17?-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer",Frontiers in oncology,,,Article,2014-06-05,10.3389/fonc.2014.00159,,,,24995161,PMC4061482,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2445411,https://api.altmetric.com/v1/donut/2445411_240.png 1,Current management of erectile dysfunction in prostate cancer survivors,Current Opinion in Urology,,,Article,2014-07-01,10.1097/mou.0000000000000072,,,,24809413,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2440907,https://api.altmetric.com/v1/donut/2440907_240.png 1,Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian study,Australian & New Zealand Journal of Surgery,,,Article,2012-12-10,10.1111/ans.12015,,,,23216652,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2439177,https://api.altmetric.com/v1/donut/2439177_240.png 1,Anorectal toxicity of external beam radiotherapy in the treatment of prostate cancer,Journal of Clinical Urology,,,Article,2013-09-26,10.1177/2051415813506578,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2439162,https://api.altmetric.com/v1/donut/2439162_240.png 1,Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high?risk pathologic features,Cancer (0008543X),,,Article,2014-06-09,10.1002/cncr.28856,,,,24917426,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2425852,https://api.altmetric.com/v1/donut/2425852_240.png 1,Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos,The Prostate,,,Article,2014-06-09,10.1002/pros.22791,,,,24909781,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2422720,https://api.altmetric.com/v1/donut/2422720_240.png 1,"miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance.",PLoS ONE,,,Article,2014-06-05,10.1371/journal.pone.0098597,,,,24893170,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2421255,https://api.altmetric.com/v1/donut/2421255_240.png 1,Novel bone-targeting agents in prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2014-03-25,10.1038/pcan.2014.12,,,,24662963,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2418162,https://api.altmetric.com/v1/donut/2418162_240.png 1,Is There an Increase in Genitourinary Toxicity in Patients Treated With Transurethral Resection of the Prostate and Radiotherapy?: A Systematic Review,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-06-01,10.1097/coc.0b013e3182546821,,,,22706173,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2417094,https://api.altmetric.com/v1/donut/2417094_240.png 1,Lethal Prostate Cancer Variants,JAMA: Journal of the American Medical Association,,,Article,2011-01-01,10.1001/jama.2011.1389,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2403058,https://api.altmetric.com/v1/donut/2403058_240.png 1,Androgen dynamics and serum PSA in patients treated with abiraterone acetate,Prostate Cancer & Prostatic Diseases,,,Article,2014-03-18,10.1038/pcan.2014.8,,,,24637537,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2401983,https://api.altmetric.com/v1/donut/2401983_240.png 1,Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy?,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-06-01,10.1097/coc.0000000000000093,,,,24879473,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2398026,https://api.altmetric.com/v1/donut/2398026_240.png 1,Resveratrol–zinc combination for prostate cancer management,Cell Cycle,,,Article,2014-05-27,10.4161/cc.29334,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2397541,https://api.altmetric.com/v1/donut/2397541_240.png 1,ASCO 2014: Advances in prostate cancer discussion. ASCO 2014: Advances in prostate cancer discussion,ecancer.org,,,Article,,,,,http://ecancer.org/video/2851/asco-2014--advances-in-prostate-cancer-discussion.php,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2397132,https://api.altmetric.com/v1/donut/2397132_240.png 1,"The Dietary Charred Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Acts as Both a Tumor Initiator and Promoter in the Rat Ventral Prostate",Cancer Research,,,Article,2007-01-01,10.1158/0008-5472.can-06-1336,,,,17264317,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2385375,https://api.altmetric.com/v1/donut/2385375_240.png 1,Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis,World Journal of Surgical Oncology,,,Article,2014-04-30,10.1186/1477-7819-12-134,,,,24885947,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2384029,https://api.altmetric.com/v1/donut/2384029_240.png 1,Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223,Therapeutics and Clinical Risk Management,,,Article,2014-05-01,10.2147/tcrm.s45667,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2383136,https://api.altmetric.com/v1/donut/2383136_240.png 1,The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy na|[iuml]|ve men with PSA less than 20|[thinsp]|ng|[thinsp]|ml|[minus]|1,Prostate Cancer & Prostatic Diseases,,,Article,2014-03-04,10.1038/pcan.2014.4,,,,24590360,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2379468,https://api.altmetric.com/v1/donut/2379468_240.png 1,Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trial,Trials,,,Article,2014-05-24,10.1186/1745-6215-15-183,,,,24886676,PMC4039315,1893/20436,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2375815,https://api.altmetric.com/v1/donut/2375815_240.png 1,ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-06-01,10.1097/coc.0000000000000049,,,,25180754,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2374783,https://api.altmetric.com/v1/donut/2374783_240.png 1,A novel approach to identify driver genes involved in androgen-independent prostate cancer,Molecular Cancer,,,Article,2014-05-23,10.1186/1476-4598-13-120,,,,24885513,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2374704,https://api.altmetric.com/v1/donut/2374704_240.png 1,Rac1-Dependent Lamellipodial Motility in Prostate Cancer PC-3 Cells Revealed by Optogenetic Control of Rac1 Activity,PLoS ONE,,,Article,2014-05-21,10.1371/journal.pone.0097749,,,,24848679,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2369728,https://api.altmetric.com/v1/donut/2369728_240.png 1,Prostate Cancer Grading: Contemporary Practice and Controversies,Pathology Case Reviews,,,Article,,10.1097/pcr.0000000000000033,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2364941,https://api.altmetric.com/v1/donut/2364941_240.png 1,Prostate Cancer Screening.,Primary care,,,Article,2014-05-18,10.1016/j.pop.2014.02.009,,,,24830612,,10161/12932,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2364727,https://api.altmetric.com/v1/donut/2364727_240.png 1,Increased Risk of Prostate Cancer: Vitamin D Deficiency or Low Serum Calcium Levels?,Nutrition and Cancer,,,Article,2014-05-15,10.1080/01635581.2014.904910,,,,24820253,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2361922,https://api.altmetric.com/v1/donut/2361922_240.png 1,Erectile Function Following Prostate Cancer Treatment: Factors Predicting Recovery,Sexual Medicine Reviews,,,Article,2013-01-01,10.1002/smrj.11,,,,27784588,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2359927,https://api.altmetric.com/v1/donut/2359927_240.png 1,ETS fusion genes in prostate cancer,Endocrine-Related Cancer,,,Article,,10.1530/erc-13-0390,,,,24659477,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2356865,https://api.altmetric.com/v1/donut/2356865_240.png 1,Laser ablation as focal therapy for prostate cancer,Current Opinion in Urology,,,Article,2014-05-01,10.1097/mou.0000000000000044,,,,24625427,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2356713,https://api.altmetric.com/v1/donut/2356713_240.png 1,NF-?B Gene Signature Predicts Prostate Cancer Progression,Cancer Research,,,Article,2014-03-30,10.1158/0008-5472.can-13-2543,,,,24686169,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2354109,https://api.altmetric.com/v1/donut/2354109_240.png 1,Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA1) Activation in Human Breast and Prostate Cancers,PLoS ONE,,,Article,2014-05-14,10.1371/journal.pone.0097771,,,,24828490,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2352536,https://api.altmetric.com/v1/donut/2352536_240.png 1,IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness,Research and Reports in Urology,,,Article,2014-05-01,10.2147/rru.s58643,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2351701,https://api.altmetric.com/v1/donut/2351701_240.png 1,Overdetection in screening for prostate cancer,Current Opinion in Urology,,,Article,2014-05-01,10.1097/mou.0000000000000054,,,,24670870,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2344641,https://api.altmetric.com/v1/donut/2344641_240.png 1,Can non-urological doctors play a role in early prostate cancer detection?,Urology Journal,,,Article,2014-01-01,,,,,24807755,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2341423,https://api.altmetric.com/v1/donut/2341423_240.png 1,Relationship between two year PSA nadir and biochemical recurrence in prostate cancer patients treated with iodine-125 brachytherapy,Radiologia Brasileira,,,Article,,10.1590/s0100-39842014000200010,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2340476,https://api.altmetric.com/v1/donut/2340476_240.png 1,Are there specific health-related factors that can accentuate the risk of suicide among men with prostate cancer?,Supportive Care in Cancer,,,Article,2014-02-11,10.1007/s00520-014-2150-2,,,,24515278,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2336268,https://api.altmetric.com/v1/donut/2336268_240.png 1,Whole body irradiation increases the magnitude and persistence of adoptively transferred T cells associated with tumor regression in a mouse model of prostate cancer,Cancer Immunology Research,,,Article,2014-05-05,10.1158/2326-6066.cir-13-0164,,,,24801834,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2332809,https://api.altmetric.com/v1/donut/2332809_240.png 1,Tumor Microenvironment and Metabolism in Prostate Cancer,Seminars in oncology,,,Article,,10.1053/j.seminoncol.2014.03.004,,,,24787298,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2330343,https://api.altmetric.com/v1/donut/2330343_240.png 1,"Contemporary lymphadenectomy templates: kidney, prostate and bladder cancer",Current Opinion in Urology,,,Article,2014-03-01,10.1097/mou.0000000000000026,,,,24445555,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2329818,https://api.altmetric.com/v1/donut/2329818_240.png 1,Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report,Journal of Medical Case Reports,,,Article,2014-05-05,10.1186/1752-1947-8-136,,,,24886457,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2328743,https://api.altmetric.com/v1/donut/2328743_240.png 1,Beta-blocker usage and prostate cancer survival: A nested case-control study in the UK Clinical Practice Research Datalink cohort.,Cancer Epidemiology,,,Article,2014-04-28,10.1016/j.canep.2014.03.011,,,,24786858,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2323148,https://api.altmetric.com/v1/donut/2323148_240.png 1,New targeted therapy for advanced prostate cancer showsanti-tumour activity in phase I clinical trials. ecancer -News,ecancer,,,Article,,,,,http://ecancer.org/news/3540-new-targeted-therapy-for-advanced-prostate-cancer-shows-anti-tumour-activity-in-phase-i-clinical-trials.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2321505,https://api.altmetric.com/v1/donut/2321505_240.png 1,The transcription factor COUP-TFII is a biomarker foraggressive prostate cancer. ecancer - News,ecancer,,,Article,,,,,http://ecancer.org/news/3589-the-transcription-factor-coup-tfii-is-a-biomarker-for-aggressive-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2321484,https://api.altmetric.com/v1/donut/2321484_240.png 1,How prostate cancer therapies compare by cost andeffectiveness. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3688-how-prostate-cancer-therapies-compare-by-cost-and-effectiveness.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2321430,https://api.altmetric.com/v1/donut/2321430_240.png 1,Prostate cancer lifetime risk trebles in 25 years. ecancer -News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3731-prostate-cancer-lifetime-risk-trebles-in-25-years.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2321412,https://api.altmetric.com/v1/donut/2321412_240.png 1,Baldness at 40 linked to prostate cancer. ecancer -News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3742-baldness-at-40-linked-to-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2321398,https://api.altmetric.com/v1/donut/2321398_240.png 1,Factors influencing prostate cancer in black men . Factors influencing prostate cancer in black men . ecancer.tv - Essential viewing for oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/1252/factors-influencing-prostate-cancer-in-black-men.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2321344,https://api.altmetric.com/v1/donut/2321344_240.png 1,A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the hormone-Insensitive Prostate Cancer Cell Line PC3.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2014-03-20,,,,,24628239,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2320026,https://api.altmetric.com/v1/donut/2320026_240.png 1,NY?ESO?1 expression is tightly linked to TMPRSS2ERG fusion in prostate cancer,The Prostate,,,Article,2014-05-01,10.1002/pros.22816,,,,24789172,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2319996,https://api.altmetric.com/v1/donut/2319996_240.png 1,Focal radiotherapy as focal therapy of prostate cancer,Current Opinion in Urology,,,Article,2014-05-01,10.1097/mou.0000000000000042,,,,24637315,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2315398,https://api.altmetric.com/v1/donut/2315398_240.png 1,Screening for prostate cancer: are digital rectal examinations being performed?,Hospital Practice,,,Article,2014-04-01,10.3810/hp.2014.04.1108,,,,24769789,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2311893,https://api.altmetric.com/v1/donut/2311893_240.png 1,Effects of 14 frequently used drugs on prostate-specific antigen expression in prostate cancer LNCaP cells.,Oncology Letters,,,Article,2014-04-26,10.3892/ol.2014.1936,,,,24765197,PMC3997723,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2309859,https://api.altmetric.com/v1/donut/2309859_240.png 1,Biopsy strategies for selecting patients for focal therapy for prostate cancer,Current Opinion in Urology,,,Article,2014-05-01,10.1097/mou.0000000000000046,,,,24670871,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2309224,https://api.altmetric.com/v1/donut/2309224_240.png 1,How to select the right patients for focal therapy of prostate cancer?,Current Opinion in Urology,,,Article,2014-05-01,10.1097/mou.0000000000000045,,,,24625428,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2307683,https://api.altmetric.com/v1/donut/2307683_240.png 1,Counts of Slackia sp. strain NATTS in Intestinal Flora are Correlated to Serum Concentrations of Equol both in Prostate Cancer Cases and Controls in Japanese Men.,Asian Pacific Journal of Cancer Prevention,,,Article,2014-01-01,,,,,24761887,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2307522,https://api.altmetric.com/v1/donut/2307522_240.png 1,Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance.,Urologic Oncology,,,Article,2012-02-05,10.1016/j.urolonc.2011.12.018,,,,22300755,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2306840,https://api.altmetric.com/v1/donut/2306840_240.png 1,Circulating biomarkers for discriminating indolent from aggressive disease in prostate cancer active surveillance,Current Opinion in Urology,,,Article,2014-05-01,10.1097/mou.0000000000000050,,,,24710054,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2304085,https://api.altmetric.com/v1/donut/2304085_240.png 1,Transient Induction of ING4 by Myc Drives Prostate Epithelial Cell Differentiation and Its Disruption Drives Prostate Tumorigenesis,Cancer Research,,,Article,2014-04-23,10.1158/0008-5472.can-13-3076,,,,24762396,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2303802,https://api.altmetric.com/v1/donut/2303802_240.png 1,Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results.,World Journal of Urology,,,Article,2013-11-27,10.1007/s00345-013-1211-3,,,,24270968,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2298060,https://api.altmetric.com/v1/donut/2298060_240.png 1,"Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report",Journal of Medical Case Reports,,,Article,2014-04-09,10.1186/1752-1947-8-122,,,,24717107,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2296545,https://api.altmetric.com/v1/donut/2296545_240.png 1,Statin Use and the Risk of Recurrence After Radical Prostatectomy in a Cohort of Men With Inherited and/or Early-onset Forms of Prostate Cancer,Urology,,,Article,2014-04-14,10.1016/j.urology.2014.02.015,,,,24745796,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2293453,https://api.altmetric.com/v1/donut/2293453_240.png 1,The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-04-11,10.1097/coc.0000000000000071,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/08000/The_Influence_of_Age_and_Comorbidity_on_the.10.aspx,24732810,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2280741,https://api.altmetric.com/v1/donut/2280741_240.png 1,The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.,Cancers,,,Article,2014-04-12,10.3390/cancers6020829,,,,24722453,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2277594,https://api.altmetric.com/v1/donut/2277594_240.png 1,"Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner.",PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0093713,,,,24722580,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2276549,https://api.altmetric.com/v1/donut/2276549_240.png 1,Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.,Biochemical & Biophysical Research Communications,,,Article,2014-04-07,10.1016/j.bbrc.2014.03.154,,,,24721431,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2274954,https://api.altmetric.com/v1/donut/2274954_240.png 1,Re: Treatment of Prostate Cancer with Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized Trials,European Urology,,,Article,2014-05-01,10.1016/j.eururo.2013.12.041,,,,24646499,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2269923,https://api.altmetric.com/v1/donut/2269923_240.png 1,Preclinical Evaluation of the Supercritical Extract of Azadirachta Indica (Neem) Leaves In Vitro and In Vivo on Inhibition of Prostate Cancer Tumor Growth.,Molecular Cancer Therapeutics,,,Article,2014-03-31,10.1158/1535-7163.mct-13-0699,,,,24674886,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2269289,https://api.altmetric.com/v1/donut/2269289_240.png 1,TGF?? cascade regulation by PPP1 and its interactors –impact on prostate cancer development and therapy,Journal of Cellular and Molecular Medicine,,,Article,2014-03-15,10.1111/jcmm.12266,,,,24629090,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2265676,https://api.altmetric.com/v1/donut/2265676_240.png 1,What You Should Know About Omega-3 Fatty Acids and Prostate Cancer,Journal of Dietary Supplements,,,Article,2014-04-04,10.3109/19390211.2014.902003,,,,24689516,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2262178,https://api.altmetric.com/v1/donut/2262178_240.png 1,Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0069735,,,,23936089,,2445/53291,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2260849,https://api.altmetric.com/v1/donut/2260849_240.png 1,Suicide Risk in Men with Prostate-Specific Antigen–Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study from PCBaSe Sweden,European Urology,,,Article,2010-01-01,10.1016/j.eururo.2009.10.035,,,,19914773,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2260597,https://api.altmetric.com/v1/donut/2260597_240.png 1,Evaluation of protein biomarkers of prostate cancer aggressiveness.,BMC Cancer,,,Article,2014-04-05,10.1186/1471-2407-14-244,,,,24708576,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2259709,https://api.altmetric.com/v1/donut/2259709_240.png 1,"Nanoparticle?Enabled, Image?Guided Treatment Planning of Target Specific RNAi Therapeutics in an Orthotopic Prostate Cancer Model",Small,,,Article,2014-04-06,10.1002/smll.201303842,,,,24706435,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2259130,https://api.altmetric.com/v1/donut/2259130_240.png 1,Therapeutic modulation of prostate cancer metastasis.,Future Medicinal Chemistry,,,Article,2014-01-30,10.4155/fmc.13.201,,,,24467245,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2256422,https://api.altmetric.com/v1/donut/2256422_240.png 1,Complications after cystectomy and urinary diversion in patients previously treated for localized prostate cancer.,Urology,,,Article,2005-10-19,10.1016/j.urology.2005.04.046,,,,16230146,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2256288,https://api.altmetric.com/v1/donut/2256288_240.png 1,Radical cystectomy in patients previously treated for localized prostate cancer.,Urology,,,Article,2010-12-01,10.1016/j.urology.2010.01.048,,,,20381130,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2256286,https://api.altmetric.com/v1/donut/2256286_240.png 1,Radical cystectomy for bladder cancer after definitive prostate cancer treatment.,Urology,,,Article,2003-02-01,,,,,12597943,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2256284,https://api.altmetric.com/v1/donut/2256284_240.png 1,Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth.,Molecular & Cellular Endocrinology,,,Article,2014-02-06,10.1016/j.mce.2014.01.012,,,,24491388,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2256033,https://api.altmetric.com/v1/donut/2256033_240.png 1,Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9® to better battle prostate cancer progression.,"Transactions of the Institute of Measurement and Control, with Measurement + Control",,,Article,2014-02-07,10.4161/onci.26853,,,,24498558,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2255869,https://api.altmetric.com/v1/donut/2255869_240.png 1,External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.,The Prostate,,,Article,2012-07-25,10.1002/pros.22559,,,,22821742,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2251199,https://api.altmetric.com/v1/donut/2251199_240.png 1,Prostate cancer: Antisense nucleic acids-tough delivery.,Nature Reviews Urology,,,Article,2013-11-21,10.1038/nrurol.2013.271,,,,24247424,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2248033,https://api.altmetric.com/v1/donut/2248033_240.png 1,Patterns of progression in prostate cancer.,The Lancet (British Edition),,,Article,1986-01-11,,,,,2867314,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2247986,https://api.altmetric.com/v1/donut/2247986_240.png 1,Enzalutamide Shows Strong Activity in Prostate Cancer,Cancer Discovery,,,Article,,10.1158/2159-8290.cd-nb2014-028,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2247577,https://api.altmetric.com/v1/donut/2247577_240.png 1,The optimal timing to perform 18F/11C-choline PET/CT in patients with suspicion of relapse of prostate cancer: trigger PSA versus PSA velocity and PSA doubling time.,International Journal of Biological Markers,,,Article,2014-01-31,10.5301/jbm.5000068,,,,24474456,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2244853,https://api.altmetric.com/v1/donut/2244853_240.png 1,[Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].,Zhonghua wai ke za zhi Chinese journal of surgery,,,Article,2014-02-08,,,,,24499718,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2243987,https://api.altmetric.com/v1/donut/2243987_240.png 1,Charlson comorbidity index is an important prognostic factor for long-term survival outcomes in korean men with prostate cancer after radical prostatectomy.,Yonsei Medical Journal,,,Article,2014-02-19,10.3349/ymj.2014.55.2.316,,,,24532498,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2242617,https://api.altmetric.com/v1/donut/2242617_240.png 1,Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels.,Journal of Biomedical Optics,,,Article,2013-08-07,10.1117/1.jbo.18.8.087002,,,,23912761,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2241401,https://api.altmetric.com/v1/donut/2241401_240.png 1,Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer.,Neoplasia,,,Article,2013-11-11,,,,,24204196,PMC3819633,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2241397,https://api.altmetric.com/v1/donut/2241397_240.png 1,11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2014-03-08,10.1007/s00259-014-2734-6,,,,24599378,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2239934,https://api.altmetric.com/v1/donut/2239934_240.png 1,Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: Does the anaesthetic technique matter?,European Journal of Surgical Oncology,,,Article,2014-03-14,10.1016/j.ejso.2014.02.223,,,,24613743,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2239360,https://api.altmetric.com/v1/donut/2239360_240.png 1,Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.,Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer,,,Article,2014-02-19,10.1007/978-3-642-45195-9_14,,,,24531785,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2232426,https://api.altmetric.com/v1/donut/2232426_240.png 1,Variation in prostate cancer detection rates in a statewide quality improvement collaborative,The Journal of Urology,,,Article,,10.1016/j.juro.2014.02.088,,,,24582538,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2231742,https://api.altmetric.com/v1/donut/2231742_240.png 1,Application of 99mTechnetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: A first-in-man study.,Nuclear Medicine & Biology,,,Article,2013-08-01,10.1016/j.nucmedbio.2013.05.009,,,,23891351,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2230847,https://api.altmetric.com/v1/donut/2230847_240.png 1,"Blood ?-Tocopherol, ?-Tocopherol Levels and Risk of Prostate Cancer: A Meta-Analysis of Prospective Studies",PLoS ONE,,,Article,2014-03-25,10.1371/journal.pone.0093044,,,,24667740,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2225500,https://api.altmetric.com/v1/donut/2225500_240.png 1,Reduced Expression of the Androgen Receptor by Third Generation of Antisense Shows Antitumor Activity in Models of Prostate Cancer,Molecular Cancer Therapeutics,,,Article,2011-01-01,10.1158/1535-7163.mct-11-0329,,,,22027692,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2219763,https://api.altmetric.com/v1/donut/2219763_240.png 1,Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors.,Cancer (0008543X),,,Article,2014-03-25,10.1002/cncr.28646,,,,24668563,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2214667,https://api.altmetric.com/v1/donut/2214667_240.png 1,Efficacy and Toxicity of Every 2 Weeks Docetaxel Regimen in Comparison With Weekly or Every 3 Weeks in Metastatic Prostate Cancer: A Retrospective Analysis,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2014-03-21,10.1097/coc.0000000000000054,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2016/06000/Efficacy_and_Toxicity_of_Every_2_Weeks_Docetaxel.9.aspx,24662265,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2212280,https://api.altmetric.com/v1/donut/2212280_240.png 1,The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression,Frontiers in oncology,,,Article,2014-03-12,10.3389/fonc.2014.00060,,,,24724054,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/2211183,https://api.altmetric.com/v1/donut/2211183_240.png 1,Impact of applied progressive deep muscle relaxation training on the health related quality of life among prostate cancer patients — A quasi experimental trial,Preventive Medicine,,,Article,2013-01-01,10.1016/j.ypmed.2013.02.011,,,,23454597,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2205837,https://api.altmetric.com/v1/donut/2205837_240.png 1,"The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines",Anatomy & Cell Biology,,,Article,,10.5115/acb.2014.47.1.1,,,,24693477,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/2204953,https://api.altmetric.com/v1/donut/2204953_240.png 1,DKK-1 in prostate cancer diagnosis and follow up,BMC Clinical Pathology,,,Article,2014-03-21,10.1186/1472-6890-14-11,,,,24655661,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2204102,https://api.altmetric.com/v1/donut/2204102_240.png 1,Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT.,World Journal of Urology,,,Article,2014-03-20,10.1007/s00345-014-1269-6,,,,24647879,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2203158,https://api.altmetric.com/v1/donut/2203158_240.png 1,A Prostate Cancer Model Build by a Novel SVM-ID3 Hybrid Feature Selection Method Using Both Genotyping and Phenotype Data from dbGaP,PLoS ONE,,,Article,2014-03-20,10.1371/journal.pone.0091404,,,,24651484,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2202655,https://api.altmetric.com/v1/donut/2202655_240.png 1,Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation,Molecular Cancer,,,Article,2014-03-19,10.1186/1476-4598-13-61,,,,24642271,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2198174,https://api.altmetric.com/v1/donut/2198174_240.png 1,Monotherapeutic high-dose-rate brachytherapy for prostate cancer: A dose reduction trial,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.10.015,,,,24183062,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2188968,https://api.altmetric.com/v1/donut/2188968_240.png 1,Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/dju033,,,,24634505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2188663,https://api.altmetric.com/v1/donut/2188663_240.png 1,"Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival",Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.09.026,,,,24246414,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/2187884,https://api.altmetric.com/v1/donut/2187884_240.png 1,An Intergenerational Approach to Prostate Cancer Education: Findings from a Pilot Project in the Southeastern USA,Journal of Cancer Education,,,Article,2014-02-22,10.1007/s13187-014-0618-x,,,,24557505,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2186184,https://api.altmetric.com/v1/donut/2186184_240.png 1,Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: Potential effects on the tumor microenvironment,Cancer Biology and Therapy,,,Article,2014-01-14,10.4161/cbt.27627,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2176524,https://api.altmetric.com/v1/donut/2176524_240.png 1,New UK approach to prostate cancer screening needed,ecancer.org,,,Article,,,,,http://ecancer.org/news/5383-new-uk-approach-to-prostate-cancer-screening-needed.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2175847,https://api.altmetric.com/v1/donut/2175847_240.png 1,"A CONVENIENT, LARGE-SCALE SYNTHESIS OF ABIRATERONE ACETATE [3?-ACETOXY-17-(3-PYRIDYL)ANDROSTA-5,16-DIENE], A POTENTIAL NEW DRUG FOR THE TREATMENT OF PROSTATE CANCER",Organic Preparations and Procedures International,,,Article,1997-02-01,10.1080/00304949709355175,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2171220,https://api.altmetric.com/v1/donut/2171220_240.png 1,Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-refractory Prostate Cancer,IN VIVO: International Journal of Experimental and Clinical Pathophysiology and Drug Research,,,Article,2010-01-01,,,,,20554995,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2168425,https://api.altmetric.com/v1/donut/2168425_240.png 1,Evaluation of the Prostate Imaging Reporting and Data System for the Detection of Prostate Cancer by the Results of Targeted Biopsy of the Prostate,Investigative Radiology,,,Article,2014-03-04,10.1097/rli.0000000000000030,,,,24598440,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2167897,https://api.altmetric.com/v1/donut/2167897_240.png 1,Prostate cancer: Treatment sequencing for CRPC[mdash]what do we know?,Nature Reviews Urology,,,Article,2014-03-04,10.1038/nrurol.2014.36,,,,24595127,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2165938,https://api.altmetric.com/v1/donut/2165938_240.png 1,Biological Correlates of Prostate Cancer Perineural Invasion Diameter,Human Pathology,,,Article,2014-03-03,10.1016/j.humpath.2014.02.011,,,,24768607,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2160341,https://api.altmetric.com/v1/donut/2160341_240.png 1,From radiobiology to technology: what is changing in radiotherapy for prostate cancer,Expert Review of Anticancer Therapy,,,Article,2014-03-03,10.1586/14737140.2014.883282,,,,24579695,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2159982,https://api.altmetric.com/v1/donut/2159982_240.png 1,GPX2 overexpression is involved in cell proliferation and prognosis of castration resistant prostate cancer,Carcinogenesis,,,Article,,10.1093/carcin/bgu048,,,,24562575,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2157769,https://api.altmetric.com/v1/donut/2157769_240.png 1,Surgery or radiotherapy for prostate cancer?,British Medical Journal,,,Article,2014-02-26,10.1136/bmj.g1580,,,,24574475,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2154074,https://api.altmetric.com/v1/donut/2154074_240.png 1,Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer,Cancer Research,,,Article,2012-01-01,10.1158/0008-5472.can-11-3892,,,,22710436,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,79,https://www.altmetric.com/details/2153257,https://api.altmetric.com/v1/donut/2153257_240.png 1,"Pre-clinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer.",Hum Gene Ther Clin Dev,,,Article,2014-02-21,10.1089/hum.2013.181,,,,24548052,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2150099,https://api.altmetric.com/v1/donut/2150099_240.png 1,The value of randomised trials for prostate cancer management,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)70081-6,,,,24581939,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2145808,https://api.altmetric.com/v1/donut/2145808_240.png 1,SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin,Molecular Cancer,,,Article,2014-02-24,10.1186/1476-4598-13-37,,,,24565133,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/2144474,https://api.altmetric.com/v1/donut/2144474_240.png 1,Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature,Investigational New Drugs,,,Article,2014-01-18,10.1007/s10637-014-0063-z,,,,24442368,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2131220,https://api.altmetric.com/v1/donut/2131220_240.png 1,Male Pattern Baldness and Clinical Prostate Cancer in the Epidemiologic Follow-Up of the First National Health and Nutrition Examination Survey,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2000-01-01,,,,,10815699,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2127069,https://api.altmetric.com/v1/donut/2127069_240.png 1,Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial ,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.05.024,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2125076,https://api.altmetric.com/v1/donut/2125076_240.png 1,"Reply to Michael Froehner's Letter to the Editor re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality After Prostate Cancer Treatment with Radical Prostatectomy, External-Beam Radiation Therapy, or Brachytherapy in Men Without Comorbidity. Eur Urol 2013;64:372–8",European Urology,,,Article,2014-03-01,10.1016/j.eururo.2013.11.036,,,,24315707,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2125070,https://api.altmetric.com/v1/donut/2125070_240.png 1,Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09),European Urology,,,Article,2014-09-01,10.1016/j.eururo.2013.12.057,,,,24412228,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2124845,https://api.altmetric.com/v1/donut/2124845_240.png 1,Castration-resistant Prostate Cancer: Adaptation or Clonal Selection? Insight from the EORTC 30891 Trial,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.11.047,,,,24341957,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2124807,https://api.altmetric.com/v1/donut/2124807_240.png 1,Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF-?B-Dependent Autophagy,Journal of Virology,,,Article,2013-01-01,10.1128/jvi.03406-13,,,,24371063,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2118909,https://api.altmetric.com/v1/donut/2118909_240.png 1,Reduced Activity of Double-Strand Break Repair Genes in Prostate Cancer Patients With Late Normal Tissue Radiation Toxicity,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2013.11.219,,,,24411188,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2118906,https://api.altmetric.com/v1/donut/2118906_240.png 1,Src signaling pathways in prostate cancer,Cancer and Metastasis Reviews,,,Article,2014-02-13,10.1007/s10555-013-9481-1,,,,24522479,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/2118397,https://api.altmetric.com/v1/donut/2118397_240.png 1,A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy,BMC Cancer,,,Article,2012-03-21,10.1186/1471-2407-12-103,,,,22436542,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2113698,https://api.altmetric.com/v1/donut/2113698_240.png 1,"Dosimetric Considerations to Determine the Optimal Technique for Localized Prostate Cancer Among External Photon, Proton, or Carbon-Ion Therapy and High-Dose-Rate or Low-Dose-Rate Brachytherapy","International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2013.11.241,,,,24521685,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/2113628,https://api.altmetric.com/v1/donut/2113628_240.png 1,Prostate cancer: HOXB13 and a SNP collaborate to increase risk.,Nature Reviews Urology,,,Article,2014-01-28,10.1038/nrurol.2014.8,,,,24473413,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2112759,https://api.altmetric.com/v1/donut/2112759_240.png 1,Role of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer,Current Urology Reports,,,Article,2014-01-17,10.1007/s11934-013-0387-9,,,,24430169,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2110013,https://api.altmetric.com/v1/donut/2110013_240.png 1,Joint modeling techniques for analyzing survival and longitudinal data with applications to the european randomized screening for prostate cancer study,,,,Article,,,,,,,,2099.1/20552,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2094112,https://api.altmetric.com/v1/donut/2094112_240.png 1,Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer,Carcinogenesis,,,Article,2013-10-07,10.1093/carcin/bgt334,,,,24104552,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2089882,https://api.altmetric.com/v1/donut/2089882_240.png 1,Circulating Tumor Cells in Prostate Cancer,Cancers,,,Article,2013-12-01,10.3390/cancers5041676,,,,24305656,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/2082855,https://api.altmetric.com/v1/donut/2082855_240.png 1,Patient–physician communication about early stage prostate cancer: analysis of overall visit structure,Health Expectations,,,Article,2013-01-01,10.1111/hex.12168,,,,24372758,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2067535,https://api.altmetric.com/v1/donut/2067535_240.png 1,Herbal/Hormonal Dietary Supplement Possibly Associated with Prostate Cancer Progression,Clinical Cancer Research,,,Article,2008-01-01,10.1158/1078-0432.ccr-07-1576,,,,18223237,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2060553,https://api.altmetric.com/v1/donut/2060553_240.png 1,Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil.,Journal of Nuclear Medicine,,,Article,2014-01-16,10.2967/jnumed.113.123018,,,,24434294,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2053665,https://api.altmetric.com/v1/donut/2053665_240.png 1,Receipt of Guideline-Concordant Treatment in Elderly Prostate Cancer Patients,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2013.11.004,,,,24411605,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2051560,https://api.altmetric.com/v1/donut/2051560_240.png 1,Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validity,Urologic Oncology,,,Article,,10.1016/j.urolonc.2013.10.005,,,,24433753,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2051393,https://api.altmetric.com/v1/donut/2051393_240.png 1,Prostate cancer in 2013: The changing role of imaging in clinical care,Nature Reviews Urology,,,Article,2014-01-14,10.1038/nrurol.2013.319,,,,24418808,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2051079,https://api.altmetric.com/v1/donut/2051079_240.png 1,Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy,Therapeutic Advances in Urology,,,Article,2013-01-01,10.1177/1756287213509677,,,,24489604,PMC3891292,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2042091,https://api.altmetric.com/v1/donut/2042091_240.png 1,Maximizing survival in metastatic Castration-ResistantProstate Cancer (mCRPC). Maximizing survival in metastaticCastration-Resistant Prostate Cancer (mCRPC). ecancer.tv -Essential viewing for oncologists,ecancer,,,Article,,,,,http://ecancer.org/video/2626/maximizing-survival-in-metastatic-castration-resistant-prostate-cancer--mcrpc.php,,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2040482,https://api.altmetric.com/v1/donut/2040482_240.png 1,Histological changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in high-risk prostate cancer patients,American Journal of Clinical Pathology,,,Article,2010-04-01,10.1309/ajcp8el5ftzsobih,,,,20231619,PMC3047497,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2037223,https://api.altmetric.com/v1/donut/2037223_240.png 1,Dependence of Castration?Resistant Prostate Cancer (CRPC) Stem Cells on CRPC?Associated Fibroblasts,Journal of Cellular Physiology,,,Article,2014-01-10,10.1002/jcp.24546,,,,24752784,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2034010,https://api.altmetric.com/v1/donut/2034010_240.png 1,Bone-targeting agents in prostate cancer.,Cancer and Metastasis Reviews,,,Article,2014-01-08,10.1007/s10555-013-9480-2,,,,24398856,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2033161,https://api.altmetric.com/v1/donut/2033161_240.png 1,Biomarkers and mechanisms associated with recurrent prostate cancer.,Frontiers in Bioscience,,,Article,2014-01-01,,,,,24389188,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2033123,https://api.altmetric.com/v1/donut/2033123_240.png 1,Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis.,Cancer Causes and Control,,,Article,2005-11-01,10.1007/s10552-005-0334-2,,,,16184479,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2028044,https://api.altmetric.com/v1/donut/2028044_240.png 1,Complications of androgen deprivation therapy in prostate cancer,Current Opinion in Urology,,,Article,2009-05-01,10.1097/mou.0b013e32832a082c,,,,19318949,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2021207,https://api.altmetric.com/v1/donut/2021207_240.png 1,Selective modulation of endoplasmic reticulum stress markers in prostate cancer cells by a standardized mangosteen fruit extract.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0081572,,,,24367485,PMC3867317,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2019280,https://api.altmetric.com/v1/donut/2019280_240.png 1,Clinical Use of Novel Urine and Blood Based Prostate Cancer Biomarkers: a review.,Clinical Biochemistry,,,Article,2013-01-01,10.1016/j.clinbiochem.2013.10.023,,,,24177197,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/2019248,https://api.altmetric.com/v1/donut/2019248_240.png 1,"Prostate Cancer, Version 1.2014",Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2013-01-01,,,,,24335682,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2017973,https://api.altmetric.com/v1/donut/2017973_240.png 1,A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients : prolongation of prostate-specific antigen doubling time,BMC Cancer,,,Article,2013-12-30,10.1186/1471-2407-13-613,,,,24373380,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2014639,https://api.altmetric.com/v1/donut/2014639_240.png 1,"No detection of xenotropic murine leukemia virus-related viruses in prostate cancer in sanandaj, west of iran.",Asian Pacific Journal of Cancer Prevention,,,Article,2013-01-01,,,,,24377628,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2014116,https://api.altmetric.com/v1/donut/2014116_240.png 1,Treatment options for localized prostate cancer,Canadian Family Physician,,,Article,2013-01-01,,,,,24336537,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2011773,https://api.altmetric.com/v1/donut/2011773_240.png 1,Chromogranin a staining as a prognostic variable in newly diagnosed Gleason score 7–10 prostate cancer treated with definitive radiotherapy,The Prostate,,,Article,2013-01-01,10.1002/pros.22771,,,,24375481,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2011369,https://api.altmetric.com/v1/donut/2011369_240.png 1,5-alpha reductase inhibitors and PSA screening for prostate cancer,Pathology,,,Article,2014-01-01,10.1097/pat.0000000000000041,,,,24300730,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2006510,https://api.altmetric.com/v1/donut/2006510_240.png 1,Expression profiles and functional associations of endogenous androgen receptor and caveolin?1 in prostate cancer cell lines,The Prostate,,,Article,,10.1002/pros.22767,,,,24375805,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2004583,https://api.altmetric.com/v1/donut/2004583_240.png 1,The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers,Urologic Oncology,,,Article,,10.1016/j.urolonc.2013.08.002,,,,24360663,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1997992,https://api.altmetric.com/v1/donut/1997992_240.png 1,Long-term oncological outcome in men with T3 prostate cancer: radical prostatectomy versus external-beam radiation therapy at a single institution.,International Journal of Clinical Oncology,,,Article,2013-12-19,10.1007/s10147-013-0654-2,,,,24346487,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1994920,https://api.altmetric.com/v1/donut/1994920_240.png 1,5-alpha reductase inhibitors and PSA screening for prostate cancer,Pathology,,,Article,2014-01-01,10.1097/pat.0000000000000040,,,,24300722,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1991064,https://api.altmetric.com/v1/donut/1991064_240.png 1,The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: A systematic review.,Health Psychology,,,Article,2013-11-18,10.1037/hea0000006,,,,24245841,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1979020,https://api.altmetric.com/v1/donut/1979020_240.png 1,Prostate cancer: Intermediate efficacy end points to assess modern therapies,Nature Reviews Urology,,,Article,2013-11-26,10.1038/nrurol.2013.269,,,,24276080,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1977988,https://api.altmetric.com/v1/donut/1977988_240.png 1,Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis.,Clinical Chemistry & Laboratory Medicine,,,Article,2013-12-05,10.1515/cclm-2013-0675,,,,24310773,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1962621,https://api.altmetric.com/v1/donut/1962621_240.png 1,Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival,Journal of Clinical Oncology,,,Article,2011-01-01,10.1200/jco.2010.30.2075,,,,21135285,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1954573,https://api.altmetric.com/v1/donut/1954573_240.png 1,Prostate cancer: Non-O blood type is VTE risk factor after radical prostatectomy,Nature Reviews Urology,,,Article,2013-11-05,10.1038/nrurol.2013.255,,,,24189930,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1954480,https://api.altmetric.com/v1/donut/1954480_240.png 1,KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.,International Journal of Clinical and Experimental Pathology,,,Article,2013-01-01,,,,,24294372,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1954003,https://api.altmetric.com/v1/donut/1954003_240.png 1,"Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis.",European Urology,,,Article,2013-05-21,10.1016/j.eururo.2013.05.023,,,,23759328,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1946830,https://api.altmetric.com/v1/donut/1946830_240.png 1,Impact of previous local treatment for prostate cancer on subsequent metastatic disease.,The Journal of Urology,,,Article,2002-09-01,10.1097/01.ju.0000026656.62692.67,,,,12187210,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1946611,https://api.altmetric.com/v1/donut/1946611_240.png 1,Circulating microRNAs and Kallikreins before and after Radical Prostatectomy: Are They Really Prostate Cancer Markers?,BioMed research international,,,Article,2013-01-01,10.1155/2013/241780,,,,24288670,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1945991,https://api.altmetric.com/v1/donut/1945991_240.png 1,RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0078254,,,,24223781,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1942515,https://api.altmetric.com/v1/donut/1942515_240.png 1,Factors associated with downgrading in patients with high grade prostate cancer.,Urologic Oncology,,,Article,2013-05-01,10.1016/j.urolonc.2011.02.010,,,,21478037,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1939265,https://api.altmetric.com/v1/donut/1939265_240.png 1,The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: A pooled analysis of 41 sets of data from case-control studies.,Gene,,,Article,2013-10-29,10.1016/j.gene.2013.10.042,,,,24177231,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1937647,https://api.altmetric.com/v1/donut/1937647_240.png 1,Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Leads to Greater Anti-tumor Activity of Docetaxel in Advanced Prostate Cancer.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0076169,,,,24155892,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1937474,https://api.altmetric.com/v1/donut/1937474_240.png 1,Relative effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of localised prostate cancer: a systematic review and mixed treatment comparison meta-analysis.,British Journal of Urology,,,Article,2013-10-01,10.1111/bju.12247,,,,23890416,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1935108,https://api.altmetric.com/v1/donut/1935108_240.png 1,The Impact of Technology Diffusion on Treatment for Prostate Cancer,Medical care,,,Article,2013-12-01,10.1097/mlr.0000000000000019,,,,24226306,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1933832,https://api.altmetric.com/v1/donut/1933832_240.png 1,Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2013-09-01,10.1038/pcan.2013.18,,,,23835622,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1931469,https://api.altmetric.com/v1/donut/1931469_240.png 1,The Role of Magnetic Resonance Imaging in Focal Therapy for Prostate Cancer: Recommendations from a Consensus Panel.,British Journal of Urology,,,Article,2013-11-12,10.1111/bju.12243,,,,24215670,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1931260,https://api.altmetric.com/v1/donut/1931260_240.png 1,Prostate-Specific Membrane Antigen Protein Expression in Tumor Tissue and Risk of Lethal Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-10-15,10.1158/1055-9965.epi-13-0668,,,,24130224,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1927428,https://api.altmetric.com/v1/donut/1927428_240.png 1,Scoparone Exerts Anti-Tumor Activity against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0080391,,,,24260381,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1924776,https://api.altmetric.com/v1/donut/1924776_240.png 1,A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.,BMC Urology,,,Article,2013-10-17,10.1186/1471-2490-13-49,,,,24134138,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1924671,https://api.altmetric.com/v1/donut/1924671_240.png 1,Low?grade prostate cancers may not become aggressive with time,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28474,,,,24249393,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1922850,https://api.altmetric.com/v1/donut/1922850_240.png 1,Risk of prostate and bladder cancers in patients with spinal cord injury: A population-based cohort study1,Urologic Oncology,,,Article,2013-11-18,10.1016/j.urolonc.2013.07.019,,,,24239459,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1919640,https://api.altmetric.com/v1/donut/1919640_240.png 1,Advanced generation anti?prostate specific membrane antigen designer T Cells for prostate cancer immunotherapy,The Prostate,,,Article,2013-10-30,10.1002/pros.22749,,,,24174378,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1916456,https://api.altmetric.com/v1/donut/1916456_240.png 1,Lack of High-Dose Radiation Mediated Prostate Cancer Promotion and Low-Dose Radiation Adaptive Response in the TRAMP Mouse Model,Radiation Research,,,Article,2013-10-01,10.1667/rr3381.2,,,,23971516,,11541.2/119827,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1914448,https://api.altmetric.com/v1/donut/1914448_240.png 1,Silencing of LASS2/TMSG1 Enhances Invasion and Metastasis Capacity of Prostate Cancer Cell,Journal of Cellular Biochemistry,,,Article,2014-01-23,10.1002/jcb.24716,,,,24453046,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1910092,https://api.altmetric.com/v1/donut/1910092_240.png 1,Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T.,Expert Review of Anticancer Therapy,,,Article,2013-11-13,10.1586/14737140.2014.848065,,,,24224900,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1909819,https://api.altmetric.com/v1/donut/1909819_240.png 1,Value of 3-T Multiparametric Magnetic Resonance Imaging and Magnetic Resonance-Guided Biopsy for Early Risk Restratification in Active Surveillance of Low-Risk Prostate Cancer: A Prospective Multicenter Cohort Study,Investigative Radiology,,,Article,2013-11-11,10.1097/rli.0000000000000008,,,,24220253,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1907861,https://api.altmetric.com/v1/donut/1907861_240.png 1,Novel antidote to prostate cancer,Nature India,,,Article,2013-11-15,10.1038/nindia.2013.149,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1907745,https://api.altmetric.com/v1/donut/1907745_240.png 1,Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel,Anti-Cancer Drugs,,,Article,2013-11-08,10.1097/cad.0000000000000045,,,,24217332,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1900277,https://api.altmetric.com/v1/donut/1900277_240.png 1,Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response.,The Journal of Urology,,,Article,2011-10-01,10.1016/j.juro.2011.05.055,,,,21849187,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1898014,https://api.altmetric.com/v1/donut/1898014_240.png 1,Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants,PLoS ONE,,,Article,2013-11-07,10.1371/journal.pone.0077407,,,,24244276,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1897774,https://api.altmetric.com/v1/donut/1897774_240.png 1,"Silymarin Encapsulated Poly(D, L-lactic-co-glycolic acid) Nanoparticles: A Prospective Candidate for Prostate Cancer Therapy",Journal of Biomedical Nanotechnology,,,Article,2014-04-01,10.1166/jbn.2014.1735,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1893833,https://api.altmetric.com/v1/donut/1893833_240.png 1,Stat Bite Prostate Cancer Death Rates By Race/Ethnicity (2006-2010),JNCI: Journal of the National Cancer Institute,,,Article,2013-11-06,10.1093/jnci/djt345,,,,24198331,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1893213,https://api.altmetric.com/v1/donut/1893213_240.png 1,Outcomes and Tolerance of Human Immunodeficiency Virus-Positive U.S. Veterans Undergoing Dose-Escalated External Beam Radiotherapy for Localized Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2013-10-28,10.1016/j.clgc.2013.07.008,,,,24176940,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1890559,https://api.altmetric.com/v1/donut/1890559_240.png 1,The National Prostate Cancer Audit — Introducing a New Generation of Cancer Audit,Clinical Oncology,,,Article,2013-11-01,10.1016/j.clon.2013.10.006,,,,24211033,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1887799,https://api.altmetric.com/v1/donut/1887799_240.png 1,Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.,Actas Urológicas Españolas,,,Article,2013-10-26,10.1016/j.acuro.2013.09.007,,,,24169211,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1879205,https://api.altmetric.com/v1/donut/1879205_240.png 1,Whole-Genome Methylation Sequencing Reveals Distinct Impact of Differential Methylations on Gene Transcription in Prostate Cancer,American Journal of Pathology,,,Article,2013-10-09,10.1016/j.ajpath.2013.08.018,,,,24113458,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1876392,https://api.altmetric.com/v1/donut/1876392_240.png 1,"Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease",Quality of Life Research,,,Article,2013-11-01,10.1007/s11136-013-0562-y,,,,24178630,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1873591,https://api.altmetric.com/v1/donut/1873591_240.png 1,Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptoms - a retrospective feasibility study.,Journal of Endourology,,,Article,2013-10-22,10.1089/end.2013.0432,,,,24147796,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1873334,https://api.altmetric.com/v1/donut/1873334_240.png 1,A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer,Brachytherapy,,,Article,2013-09-01,10.1016/j.brachy.2013.03.003,,,,23622710,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1872791,https://api.altmetric.com/v1/donut/1872791_240.png 1,Assessment of Prostate Cancer Aggressiveness Using Dynamic Contrast-enhanced Magnetic Resonance Imaging at 3 T,European Urology,,,Article,2013-09-01,10.1016/j.eururo.2013.05.045,,,,23751135,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1872764,https://api.altmetric.com/v1/donut/1872764_240.png 1,Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification,Urologic Oncology,,,Article,2012-01-01,10.1016/j.urolonc.2012.04.013,,,,22591746,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1872573,https://api.altmetric.com/v1/donut/1872573_240.png 1,Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013,Lancet Oncology,,,Article,2013-11-01,10.1016/s1470-2045(13)70451-0,,,,24176571,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1871966,https://api.altmetric.com/v1/donut/1871966_240.png 1,Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro,Lipids in Health and Disease,,,Article,2013-10-29,10.1186/1476-511x-12-160,,,,24168453,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1869337,https://api.altmetric.com/v1/donut/1869337_240.png 1,An Evaluation of a Community-Academic-Clinical Partnership to Reduce Prostate Cancer Disparities in the South.,Journal of Cancer Education,,,Article,2013-09-28,10.1007/s13187-013-0550-5,,,,24078315,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1868223,https://api.altmetric.com/v1/donut/1868223_240.png 1,mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.,Translational Oncology,,,Article,2013-01-01,,,,,24151538,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1863645,https://api.altmetric.com/v1/donut/1863645_240.png 1,MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.,Genetics and Molecular Research,,,Article,2013-01-01,10.4238/2013.april.2.17,,,,23613247,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1861393,https://api.altmetric.com/v1/donut/1861393_240.png 1,Self-referral for IMRT in prostate cancer treatment,Lancet Oncology,,,Article,2013-01-01,10.1016/s1470-2045(13)70507-2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1857897,https://api.altmetric.com/v1/donut/1857897_240.png 1,Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth,EMBO Journal,,,Article,1970-01-01,10.1038/emboj.2011.154,,,,21556051,PMC3116285,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1856714,https://api.altmetric.com/v1/donut/1856714_240.png 1,Piperlongumine inhibits NF??B activity and attenuates aggressive growth characteristics of prostate cancer cells,The Prostate,,,Article,2013-10-21,10.1002/pros.22739,,,,24151226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1854178,https://api.altmetric.com/v1/donut/1854178_240.png 1,Durable improvements in prostate cancer screening from online spaced education a randomized controlled trial.,American Journal of Preventive Medicine,,,Article,2010-11-01,10.1016/j.amepre.2010.07.016,,,,20965387,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/1848017,https://api.altmetric.com/v1/donut/1848017_240.png 1,Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressivenes.,Actas Urológicas Españolas,,,Article,2013-10-01,10.1016/j.acuro.2013.09.001,,,,24156935,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1847409,https://api.altmetric.com/v1/donut/1847409_240.png 1,Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer.,Journal of Medical Imaging & Radiation Oncology,,,Article,2013-10-07,10.1111/1754-9485.12124,,,,24118850,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1828320,https://api.altmetric.com/v1/donut/1828320_240.png 1,Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer.,Cancer (0008543X),,,Article,2013-10-07,10.1002/cncr.28396,,,,24122296,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1827585,https://api.altmetric.com/v1/donut/1827585_240.png 1,Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer,Clinical Physiology & Functional Imaging,,,Article,2013-09-30,10.1111/cpf.12084,,,,24119067,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1827073,https://api.altmetric.com/v1/donut/1827073_240.png 1,Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy.,Journal of Medical Imaging & Radiation Oncology,,,Article,2013-10-04,10.1111/1754-9485.12115,,,,24118798,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1826836,https://api.altmetric.com/v1/donut/1826836_240.png 1,What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?,Acta Oncologica,,,Article,2013-11-01,10.3109/0284186x.2013.821206,,,,24102178,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1823972,https://api.altmetric.com/v1/donut/1823972_240.png 1,Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer,Clinical Cancer Research,,,Article,2007-01-01,10.1158/1078-0432.ccr-06-1772,,,,17332294,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1821839,https://api.altmetric.com/v1/donut/1821839_240.png 1,Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines,Anti-Cancer Drugs,,,Article,2013-10-09,10.1097/cad.0000000000000036,,,,24113592,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1818714,https://api.altmetric.com/v1/donut/1818714_240.png 1,Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo,Journal of Cellular Physiology,,,Article,2013-01-01,10.1002/jcp.24489,,,,24122301,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1816923,https://api.altmetric.com/v1/donut/1816923_240.png 1,Dosimetric predictors of biochemical control of prostate cancer in patients randomised to external beam radiotherapy with a boost of high dose rate brachytherapy,Radiotherapy & Oncology,,,Article,2013-10-01,10.1016/j.radonc.2013.08.043,,,,24100150,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1816402,https://api.altmetric.com/v1/donut/1816402_240.png 1,Generation of Prostate Tumor-initiating Cells is Associated with Elevation of Reactive Oxygen Species and IL6/STAT3 Signaling.,Cancer Research,,,Article,2013-10-07,10.1158/0008-5472.can-13-1560,,,,24101153,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1816305,https://api.altmetric.com/v1/donut/1816305_240.png 1,Tumor Suppressor BRCA1 Is Expressed in Prostate Cancer and Controls Insulin-like Growth Factor I Receptor (IGF-IR) Gene Transcription in an Androgen Receptor–Dependent Manner,Clinical Cancer Research,,,Article,2009-01-01,10.1158/1078-0432.ccr-08-1440,,,,19223505,PMC2935172,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1813728,https://api.altmetric.com/v1/donut/1813728_240.png 1,"Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells",Anti-Cancer Drugs,,,Article,2013-10-05,10.1097/cad.0000000000000013,,,,24100277,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1813318,https://api.altmetric.com/v1/donut/1813318_240.png 1,Prostate cancer: 10-year sexual function outcomes after prostatectomy,Nature Reviews Urology,,,Article,2013-09-17,10.1038/nrurol.2013.209,,,,24042566,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1812881,https://api.altmetric.com/v1/donut/1812881_240.png 1,The PFP/RAG2 Double-Knockout Mouse in Metastasis Research: Small-Cell Lung Cancer and Prostate Cancer.,Methods in molecular biology,,,Article,2014-01-01,10.1007/978-1-4614-8244-4_14,,,,24092441,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1810507,https://api.altmetric.com/v1/donut/1810507_240.png 1,Couple distress after localised prostate cancer,Supportive Care in Cancer,,,Article,2013-06-12,10.1007/s00520-013-1868-6,,,,23756617,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1808737,https://api.altmetric.com/v1/donut/1808737_240.png 1,Minimally invasive vs open radical prostatectomy in highâ??risk prostate cancer: comparing apples and pears?,British Journal of Urology,,,Article,2013-10-01,10.1111/bju.12302,,,,24028761,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1808010,https://api.altmetric.com/v1/donut/1808010_240.png 1,"Circulating Adipokine Levels and Endometrial Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial",Obstetrical and Gynecological Survey,,,Article,2013-09-01,10.1097/01.ogx.0000435526.35453.45,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1797424,https://api.altmetric.com/v1/donut/1797424_240.png 1,Prostate cancer screening: yes or no?,Urology Journal,,,Article,2013-01-01,,,,,24078514,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1797318,https://api.altmetric.com/v1/donut/1797318_240.png 1,Exploring Prostate Cancer Literacy and Family Cancer Awareness in College Students: Getting Ahead of the Curve in Cancer Education.,Journal of Cancer Education,,,Article,2013-10-01,10.1007/s13187-013-0546-1,,,,24078345,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1795496,https://api.altmetric.com/v1/donut/1795496_240.png 1,Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial.,Journal of Cancer,,,Article,2013-01-01,10.7150/jca.7123,,,,24069070,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1794001,https://api.altmetric.com/v1/donut/1794001_240.png 1,Automated Multiplexing Quantum Dots in Situ Hybridization Assay for Simultaneous Detection of ERG and PTEN Gene Status in Prostate Cancer,The Journal of Molecular Diagnostics,,,Article,2013-08-30,10.1016/j.jmoldx.2013.06.005,,,,23994645,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1787746,https://api.altmetric.com/v1/donut/1787746_240.png 1,Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling.,Journal of Nutritional Biochemistry,,,Article,2012-03-01,10.1016/j.jnutbio.2010.11.019,,,,21497499,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1787063,https://api.altmetric.com/v1/donut/1787063_240.png 1,Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer,"Cancer Immunology, Immunotherapy",,,Article,2009-10-07,10.1007/s00262-009-0769-5,,,,19820934,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1786774,https://api.altmetric.com/v1/donut/1786774_240.png 1,Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.,The Prostate,,,Article,2013-08-29,10.1002/pros.22717,,,,24038157,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1785954,https://api.altmetric.com/v1/donut/1785954_240.png 1,A National Survey of Radiation Oncologists and Urologists on Recommendations of Prostate-Specific Antigen Screening for Prostate Cancer.,British Journal of Urology,,,Article,2013-08-23,10.1111/bju.12422,,,,24053213,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1782453,https://api.altmetric.com/v1/donut/1782453_240.png 1,Perception of body odorâ??an overlooked consequence of long-term gastrointestinal and urinary symptoms after radiation therapy for prostate cancer,Journal of Cancer Survivorship,,,Article,2013-08-23,10.1007/s11764-013-0304-8,,,,23975611,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1781112,https://api.altmetric.com/v1/donut/1781112_240.png 1,Inhibition of androgen receptor and ?-catenin activity in prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-09-24,10.1073/pnas.1218168110,,,,24019458,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1779808,https://api.altmetric.com/v1/donut/1779808_240.png 1,ICP: A novel approach to predict prognosis of prostate cancer with inner-class clustering of gene expression data,Computers in Biology & Medicine,,,Article,2013-01-01,10.1016/j.compbiomed.2013.06.014,,,,24034727,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1775558,https://api.altmetric.com/v1/donut/1775558_240.png 1,The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy.,Aging Male,,,Article,2013-07-17,10.3109/13685538.2013.818113,,,,23862577,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1774437,https://api.altmetric.com/v1/donut/1774437_240.png 1,Prostate-Specific Antigen and Prostate Cancer Mortality: A Systematic Review,American Journal of Preventive Medicine,,,Article,2013-01-01,10.1016/j.amepre.2013.04.015,,,,23953359,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1772584,https://api.altmetric.com/v1/donut/1772584_240.png 1,Convergent RANK- and c-Met-Mediated Signaling Components Predict Survival of Patients with Prostate Cancer: An Interracial Comparative Study,PLoS ONE,,,Article,2013-09-16,10.1371/journal.pone.0073081,,,,24066029,PMC3774681,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1771614,https://api.altmetric.com/v1/donut/1771614_240.png 1,HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects,Journal of Controlled Release,,,Article,2013-09-01,10.1016/j.jconrel.2013.09.005,,,,24041709,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1769883,https://api.altmetric.com/v1/donut/1769883_240.png 1,Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife.,Journal of Applied Clinical Medical Physics,,,Article,2013-01-01,10.1120/jacmp.v14i5.4333,,,,24036869,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1769303,https://api.altmetric.com/v1/donut/1769303_240.png 1,"Prostate Cancer Screening: A Complicated Puzzle, Explanation Needed",JGIM: Journal of General Internal Medicine,,,Article,2013-07-04,10.1007/s11606-013-2542-x,,,,23824908,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1761812,https://api.altmetric.com/v1/donut/1761812_240.png 1,Prostate cancer: A role for neoneurogenesis in tumour progression?,Nature Reviews Urology,,,Article,2013-07-30,10.1038/nrurol.2013.166,,,,23897502,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1761075,https://api.altmetric.com/v1/donut/1761075_240.png 1,Update on positron emission tomography for imaging of prostate cancer,International Journal of Urology,,,Article,2013-01-01,10.1111/iju.12250,,,,23991644,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1759276,https://api.altmetric.com/v1/donut/1759276_240.png 1,Efficient Delivery of Therapeutic Small Nucleic Acids to Prostate Cancer Cells Using Ketal Nucleoside Lipid Nanoparticles.,Journal of Controlled Release,,,Article,2013-09-13,10.1016/j.jconrel.2013.09.006,,,,24041711,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1758431,https://api.altmetric.com/v1/donut/1758431_240.png 1,Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.,Urologic Oncology,,,Article,2013-04-01,10.1016/j.urolonc.2011.02.005,,,,21803612,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1756540,https://api.altmetric.com/v1/donut/1756540_240.png 1,Exploring glyoxalase 1 expression in prostate cancer tissues: Targeting the enzyme by ethyl pyruvate defangs some malignancyâ??associated properties,The Prostate,,,Article,2013-09-16,10.1002/pros.22728,,,,24105621,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1756171,https://api.altmetric.com/v1/donut/1756171_240.png 1,"Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase II inhibitor, promotes apoptosis in prostate cancer cells.",Cancer Letters,,,Article,2013-08-28,10.1016/j.canlet.2013.05.022,,,,23693077,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1755022,https://api.altmetric.com/v1/donut/1755022_240.png 1,BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0073880,,,,24040105,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1754899,https://api.altmetric.com/v1/donut/1754899_240.png 1,"Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.",British Journal of Cancer,,,Article,2013-06-25,10.1038/bjc.2013.270,,,,23722472,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1754544,https://api.altmetric.com/v1/donut/1754544_240.png 1,SOCS2 mediates the crosstalk between androgen and growth hormone signaling in prostate cancer.,Carcinogenesis,,,Article,2013-09-12,10.1093/carcin/bgt304,,,,24031028,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1751931,https://api.altmetric.com/v1/donut/1751931_240.png 1,Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland,Cancer Causes and Control,,,Article,2010-06-01,10.1007/s10552-010-9581-y,,,,20514514,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1743225,https://api.altmetric.com/v1/donut/1743225_240.png 1,DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer,Journal of Clinical Oncology,,,Article,2013-01-01,10.1200/jco.2012.47.1847,,,,23918943,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1741650,https://api.altmetric.com/v1/donut/1741650_240.png 1,The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer,Journal of radiation research,,,Article,2013-01-01,10.1093/jrr/rrt027,,,,23543798,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1741491,https://api.altmetric.com/v1/donut/1741491_240.png 1,Ca2+ clearance mechanisms in cancer cell lines and stromal cells of the prostate,The Prostate,,,Article,2013-01-01,10.1002/pros.22724,,,,24037789,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1739811,https://api.altmetric.com/v1/donut/1739811_240.png 1,ETS Factors Regulate AR to Induce Prostate-Specific Transformation,Cancer Discovery,,,Article,,10.1158/2159-8290.cd-rw2013-151,,,,24019337,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1738491,https://api.altmetric.com/v1/donut/1738491_240.png 1,Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes.,Japanese Journal of Clinical Oncology,,,Article,2013-07-01,10.1093/jjco/hyt071,,,,23723314,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1734402,https://api.altmetric.com/v1/donut/1734402_240.png 1,Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients,Frontiers in endocrinology,,,Article,2013-01-01,10.3389/fendo.2013.00116,,,,24027559,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1728911,https://api.altmetric.com/v1/donut/1728911_240.png 1,IMPACT Study: Targeted Prostate Cancer Screening.,Oncologist,,,Article,2013-08-31,10.1634/theoncologist.2013-0221,,,,23986348,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1726000,https://api.altmetric.com/v1/donut/1726000_240.png 1,Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.,The Prostate,,,Article,2008-12-25,10.1002/pros.20888,,,,19107861,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1724551,https://api.altmetric.com/v1/donut/1724551_240.png 1,High-Density Lipoprotein and Prostate Cancer: An Overview,Journal of Epidemiology,,,Article,2013-01-01,10.2188/jea.je20130006,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1720865,https://api.altmetric.com/v1/donut/1720865_240.png 1,Obesity and Prostate Cancer Incidence and Mortality: A Systematic Review of Prospective Cohort Studies.,Urologia Internationalis,,,Article,2013-08-16,10.1159/000351325,,,,23942223,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1717872,https://api.altmetric.com/v1/donut/1717872_240.png 1,Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.,EMBO Molecular Medicine,,,Article,2013-08-27,10.1002/emmm.201202367,,,,23982944,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1717764,https://api.altmetric.com/v1/donut/1717764_240.png 1,The Twist Box Domain is Required for Twist1-induced Prostate Cancer Metastasis,Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-13-0218-t,,,,23982216,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1717246,https://api.altmetric.com/v1/donut/1717246_240.png 1,Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells.,Nutrition and Cancer,,,Article,2007-07-21,10.1080/01635580701328339,,,,17640163,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1713773,https://api.altmetric.com/v1/donut/1713773_240.png 1,Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice â?? A quantitative study using microCT and Raman spectroscopy,BONE,,,Article,2013-01-01,10.1016/j.bone.2013.07.006,,,,23867219,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1710389,https://api.altmetric.com/v1/donut/1710389_240.png 1,Future prospects: who is the patient who still dies of prostate cancer following local treatment of high-risk prostate cancer? Can we prolong their lives using modern treatment approaches?,Current Opinion in Urology,,,Article,2013-07-01,10.1097/mou.0b013e328361ebea,,,,23665741,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1709373,https://api.altmetric.com/v1/donut/1709373_240.png 1,Childhood Height and Birth Weight in Relation to Future Prostate Cancer Risk in the Copenhagen School Health Records Register Cohort,Annals of Epidemiology,,,Article,,10.1016/j.annepidem.2013.06.018,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1701282,https://api.altmetric.com/v1/donut/1701282_240.png 1,Immunohistochemical Localization of Parathyroid Hormone-related Protein in Human Prostate Cancer,Cancer Research,,,Article,1993-01-01,,,,,8467485,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1697328,https://api.altmetric.com/v1/donut/1697328_240.png 1,Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.,BMJ Case Reports,,,Article,2013-08-16,10.1136/bcr-2013-010395,,,,23943809,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1697156,https://api.altmetric.com/v1/donut/1697156_240.png 1,Complementary and alternative medicine (CAM) in prostate and bladder cancer.,British Journal of Urology,,,Article,2013-08-16,10.1111/bju.12062,,,,23944379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1696310,https://api.altmetric.com/v1/donut/1696310_240.png 1,Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis.,International Journal of Oncology,,,Article,2013-08-14,10.3892/ijo.2013.2057,,,,23934233,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1695300,https://api.altmetric.com/v1/donut/1695300_240.png 1,Positron Emission Tomography–Magnetic Resonance Imaging with Gallium 68 Prostate-specific Membrane Antigen: A Next Step for Imaging of Recurrent Prostate Cancer—Preliminary Results,European Urology,,,Article,2013-08-01,10.1016/j.eururo.2013.08.003,,,,23954084,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1690495,https://api.altmetric.com/v1/donut/1690495_240.png 1,Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser727 on STAT3 in prostate cancer cells.,American Journal of Physiology: Endocrinology & Metabolism,,,Article,2013-08-13,10.1152/ajpendo.00615.2012,,,,23941877,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1690011,https://api.altmetric.com/v1/donut/1690011_240.png 1,Whole Exome Sequencing to Map the Genomic Evolution of Metastatic Prostate Cancer,Human Mutation,,,Article,2013-01-01,10.1002/humu.22194,,,,23946101,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1688769,https://api.altmetric.com/v1/donut/1688769_240.png 1,Our Shifting Understanding of Factors Influencing Prostate-Specific Antigen,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt218,,,,23943863,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1686622,https://api.altmetric.com/v1/donut/1686622_240.png 1,Prostate cancer: MRI/US-guided biopsy|[mdash]|a viable alternative to TRUS-guidance,Nature Reviews Urology,,,Article,2013-08-13,10.1038/nrurol.2013.179,,,,23938941,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1686319,https://api.altmetric.com/v1/donut/1686319_240.png 1,Salvage Radiation Therapy Improves Metastasis-free Survival for Clinically Aggressive and Indolent Prostate Cancer Recurrences After Radical Prostatectomy.,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2013-08-07,10.1097/coc.0b013e31829e17db,,,,23822986,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1681597,https://api.altmetric.com/v1/donut/1681597_240.png 1,Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin,BMC Medical Informatics and Decision Making,,,Article,2013-08-08,10.1186/1472-6947-13-83,,,,23915212,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1681312,https://api.altmetric.com/v1/donut/1681312_240.png 1,The changing landscape in metastatic castration-resistant prostate cancer,Current Opinion in Supportive and Palliative Care,,,Article,2013-09-01,10.1097/spc.0b013e328362ffef,,,,23817317,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1680905,https://api.altmetric.com/v1/donut/1680905_240.png 1,The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer,International Journal of Clinical and Experimental Pathology,,,Article,2013-08-09,,,,,21738818,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1678406,https://api.altmetric.com/v1/donut/1678406_240.png 1,J&J Buys Aragon for Prostate Cancer Drug,Cancer Discovery,,,Article,2013-01-01,10.1158/2159-8290.cd-nb2013-101,,,,23928784,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1677170,https://api.altmetric.com/v1/donut/1677170_240.png 1,Differential effects of thapsigargin analogues on apoptosis of prostate cancer cells: complex regulation by intracellular calcium,FEBS Journal,,,Article,2013-01-01,10.1111/febs.12475,,,,23927406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1677093,https://api.altmetric.com/v1/donut/1677093_240.png 1,A step toward functionally characterized prostate cancer molecular subtypes,Nature Medicine,,,Article,2013-08-06,10.1038/nm.3285,,,,23921739,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1673457,https://api.altmetric.com/v1/donut/1673457_240.png 1,Prostate cancer: AUA|[ndash]|ASTRO guidelines for post-RP radiation fail to go nuclear,Nature Reviews Urology,,,Article,2013-08-06,10.1038/nrurol.2013.163,,,,23917121,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1672308,https://api.altmetric.com/v1/donut/1672308_240.png 1,The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.,Molecular & Cellular Endocrinology,,,Article,2013-08-03,10.1016/j.mce.2013.07.017,,,,23906537,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1669157,https://api.altmetric.com/v1/donut/1669157_240.png 1,The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?,Nuclear Medicine Communications,,,Article,2013-09-01,10.1097/mnm.0b013e3283636eaf,,,,23887227,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1668252,https://api.altmetric.com/v1/donut/1668252_240.png 1,Single nucleotide polymorphisms in FGF23 (fibroblast growth factor receptor 23) gene are associated with prostate cancer risk,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12396,,,,24053368,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1663435,https://api.altmetric.com/v1/donut/1663435_240.png 1,Nâ??substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce proâ??apoptosis in human hormoneâ??independent prostate cancer cell lines,Chemical Biology & Drug Design,,,Article,2013-01-01,10.1111/cbdd.12195,,,,23906044,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1662559,https://api.altmetric.com/v1/donut/1662559_240.png 1,A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-4414,,,,23887973,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1662473,https://api.altmetric.com/v1/donut/1662473_240.png 1,Vaccine-Instructed Intratumoral IFN-? Enables Regression of Autochthonous Mouse Prostate Cancer in Allogeneic T-Cell Transplantation,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-3464,,,,23749644,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1662472,https://api.altmetric.com/v1/donut/1662472_240.png 1,Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs.,The Prostate,,,Article,2013-07-24,10.1002/pros.22661,,,,23868750,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1656712,https://api.altmetric.com/v1/donut/1656712_240.png 1,Prostate Cancer: Prognosis and Recurrence,International Brazilian Journal of Urology,,,Article,2013-01-01,10.1590/s1677-5538.ibju.2013.03.01,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1654044,https://api.altmetric.com/v1/donut/1654044_240.png 1,Perspectives on the Role of Isoflavones in Prostate Cancer.,The AAPS Journal,,,Article,2013-07-06,10.1208/s12248-013-9507-1,,,,23824838,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1652006,https://api.altmetric.com/v1/donut/1652006_240.png 1,Association of Intensive Morphine Treatment and Increased Stroke Incidence in Prostate Cancer Patients: A Population-based Nested Case–Control Study,Japanese Journal of Clinical Oncology,,,Article,2013-01-01,10.1093/jjco/hyt080,,,,23797791,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1651691,https://api.altmetric.com/v1/donut/1651691_240.png 1,Snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles induce apoptosis and growth arrest in human prostate cancer cells.,Apoptosis,,,Article,2012-12-15,10.1007/s10495-012-0787-1,,,,23238991,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1643159,https://api.altmetric.com/v1/donut/1643159_240.png 1,Molecularly targeted agents as radiosensitizers in cancer therapy-focus on prostate cancer.,International Journal of Molecular Sciences,,,Article,2013-07-20,10.3390/ijms140714800,,,,23863691,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1640217,https://api.altmetric.com/v1/donut/1640217_240.png 1,Radical prostatectomy does not improve survival compared to observation for localised prostate cancer in a prospective randomised trial,Evidence Based Medicine,,,Article,2013-08-01,10.1136/eb-2012-100994,,,,23086567,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1639304,https://api.altmetric.com/v1/donut/1639304_240.png 1,Prostate Cancer Screening and Health Care System Distrust in Philadelphia,Journal of Aging & Health,,,Article,2013-01-01,10.1177/0898264313490199,,,,23775208,PMC3761213,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1638423,https://api.altmetric.com/v1/donut/1638423_240.png 1,Synthesis and Vaccine Evaluation of the Tumor-Associated Carbohydrate Antigen RM2 from Prostate Cancer,Journal of the American Chemical Society,,,Article,2013-07-05,10.1021/ja403609x,,,,23819648,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1636466,https://api.altmetric.com/v1/donut/1636466_240.png 1,The Omega-3 Polyunsaturated Fatty Acid DHA Induces Simultaneous Apoptosis and Autophagy via Mitochondrial ROS-Mediated Akt-mTOR Signaling in Prostate Cancer Cells Expressing Mutant p53.,Biomed Res Int,,,Article,2013-07-12,10.1155/2013/568671,,,,23841076,PMC3691929,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1634020,https://api.altmetric.com/v1/donut/1634020_240.png 1,Prostate Cancer Metastatic to the Pancreas,Journal of Clinical Oncology,,,Article,2013-06-13,10.1200/jco.2012.45.1427,,,,23752113,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1633984,https://api.altmetric.com/v1/donut/1633984_240.png 1,Defining high-risk prostate cancer,Current Opinion in Urology,,,Article,2013-07-01,10.1097/mou.0b013e328361dba6,,,,23665740,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1629024,https://api.altmetric.com/v1/donut/1629024_240.png 1,AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure.,Prostate Cancer & Prostatic Diseases,,,Article,2012-06-28,10.1038/pcan.2012.22,,,,22733158,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1627674,https://api.altmetric.com/v1/donut/1627674_240.png 1,Adjuvant radiotherapy or early salvage radiotherapy in pT3R0 or pT3R1 prostate cancer,Current Opinion in Urology,,,Article,2013-07-01,10.1097/mou.0b013e328361d3ed,,,,23619579,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1621766,https://api.altmetric.com/v1/donut/1621766_240.png 1,Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines.,The Prostate,,,Article,1991-01-01,,,,,2020620,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1621247,https://api.altmetric.com/v1/donut/1621247_240.png 1,Effect of Dietary Polyunsaturated Fatty Acids on Castration-resistant Pten-null Prostate Cancer.,Carcinogenesis,,,Article,2011-12-15,10.1093/carcin/bgr290,,,,22159221,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1621246,https://api.altmetric.com/v1/donut/1621246_240.png 1,Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer,Clinical Medicine Insights: Urology,,,Article,2013-07-01,10.4137/cmu.s8337,,,,24482578,PMC3904375,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1620360,https://api.altmetric.com/v1/donut/1620360_240.png 1,"Evaluation of a new, rapid, qualitative, one-step PSA Test for prostate cancer screening: the PSA RapidScreen test",Prostate Cancer & Prostatic Diseases,,,Article,2005-05-17,10.1038/sj.pcan.4500802,,,,15897915,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1618993,https://api.altmetric.com/v1/donut/1618993_240.png 1,Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro.,Nutrition and Cancer,,,Article,2004-10-20,10.1207/s15327914nc4902_12,,,,15489213,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1618985,https://api.altmetric.com/v1/donut/1618985_240.png 1,Evidence for a Pro-Proliferative Feedback Loop in Prostate Cancer: The Role of Epac1 and COX-2-Dependent Pathways,PLoS ONE,,,Article,2013-04-30,10.1371/journal.pone.0063150,,,,23646189,PMC3640024,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1618858,https://api.altmetric.com/v1/donut/1618858_240.png 1,Deregulation of FoxO3a Accelerates Prostate Cancer Progression in TRAMP Mice.,The Prostate,,,Article,2013-06-15,10.1002/pros.22698,,,,23765843,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1618857,https://api.altmetric.com/v1/donut/1618857_240.png 1,Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial,American Journal of Epidemiology,,,Article,2008-01-01,10.1093/aje/kwn272,,,,18945688,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1618012,https://api.altmetric.com/v1/donut/1618012_240.png 1,Metabolomic signatures of aggressive prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22704,,,,23824564,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,66,https://www.altmetric.com/details/1617442,https://api.altmetric.com/v1/donut/1617442_240.png 1,Results of hormone therapy as first-line treatment for high-risk prostate cancer,Current Opinion in Urology,,,Article,2013-07-01,10.1097/mou.0b013e328361f503,,,,23665742,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1616126,https://api.altmetric.com/v1/donut/1616126_240.png 1,Hypofractionation for Clinically Localized Prostate Cancer,Seminars in Radiation Oncology,,,Article,2013-06-15,10.1016/j.semradonc.2013.01.005,,,,23763885,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1612969,https://api.altmetric.com/v1/donut/1612969_240.png 1,Mouse prostate epithelial luminal cells lineage originate in the Basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells.,BioMed Research International,,,Article,2013-07-04,10.1155/2013/913179,,,,23819124,PMC3683430,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1608298,https://api.altmetric.com/v1/donut/1608298_240.png 1,Prognostic Factors for Newly Diagnosed Prostate Cancer and Their Role in Treatment Selection,Seminars in Radiation Oncology,,,Article,2013-01-01,10.1016/j.semradonc.2013.01.002,,,,23763882,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1606393,https://api.altmetric.com/v1/donut/1606393_240.png 1,XiAP-ping Castration-Resistant Prostate Cancer,Science Translational Medicine,,,Article,2013-01-01,10.1126/scitranslmed.3006880,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1602197,https://api.altmetric.com/v1/donut/1602197_240.png 1,Prostate cancer: The growing evidence supporting mid-life PSA testing,Nature Reviews Urology,,,Article,2013-07-02,10.1038/nrurol.2013.144,,,,23817409,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1599427,https://api.altmetric.com/v1/donut/1599427_240.png 1,Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-1343,,,,23667174,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1595236,https://api.altmetric.com/v1/donut/1595236_240.png 1,Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.,Molecular & Cellular Endocrinology,,,Article,2002-11-29,,,,,12431817,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1593417,https://api.altmetric.com/v1/donut/1593417_240.png 1,On chip screening for Prostate cancer: an EIS microfluidic platform for contemporary detection of free and total PSA.,Analyst,,,Article,2013-01-01,10.1039/c3an00911d,,,,23884165,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1587507,https://api.altmetric.com/v1/donut/1587507_240.png 1,Localized Prostate Cancer: Quality of Life Meets Whitmore's Legacy,JNCI: Journal of the National Cancer Institute,,,Article,2004-01-01,10.1093/jnci/djh282,,,,15367562,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1585617,https://api.altmetric.com/v1/donut/1585617_240.png 1,An Integrative Review of Nursing Research on Active Surveillance in an Older Adult Prostate Cancer Population,Oncology Nursing Forum,,,Article,2013-01-01,10.1188/13.onf.40-04ap,,,,23823629,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1584947,https://api.altmetric.com/v1/donut/1584947_240.png 1,Targeting Aurora Kinases for the Treatment of Prostate Cancer,Cancer Research,,,Article,2006-01-01,10.1158/0008-5472.can-05-2796,,,,16707419,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1583285,https://api.altmetric.com/v1/donut/1583285_240.png 1,Prostate cancer imaging.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-07-01,10.1007/s00259-013-2444-5,,,,23775347,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1581042,https://api.altmetric.com/v1/donut/1581042_240.png 1,Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mdt234,,,,23798673,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1579144,https://api.altmetric.com/v1/donut/1579144_240.png 1,Ginkgetin induces apoptosis via activation of caspase and inhibition of survival genes in PC-3 prostate cancer cells.,Bioorganic & Medicinal Chemistry Letters,,,Article,2013-03-27,10.1016/j.bmcl.2013.02.080,,,,23523142,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1579127,https://api.altmetric.com/v1/donut/1579127_240.png 1,Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer.,PLoS ONE,,,Article,2013-06-13,10.1371/journal.pone.0065798,,,,23755281,PMC3673925,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1577628,https://api.altmetric.com/v1/donut/1577628_240.png 1,Prostate cancer: Of mice and men|[mdash]|a co-clinical approach to CRPC,Nature Reviews Urology,,,Article,2013-06-18,10.1038/nrurol.2013.141,,,,23774961,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1573060,https://api.altmetric.com/v1/donut/1573060_240.png 1,Novel imaging techniques reshape the landscape in high-risk prostate cancers,Current Opinion in Urology,,,Article,2013-07-01,10.1097/mou.0b013e328361d451,,,,23619580,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1572621,https://api.altmetric.com/v1/donut/1572621_240.png 1,Results of surgery for high-risk prostate cancer,Current Opinion in Urology,,,Article,2013-07-01,10.1097/mou.0b013e3283620f60,,,,23702565,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1567764,https://api.altmetric.com/v1/donut/1567764_240.png 1,The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients,BMC Cancer,,,Article,2013-06-17,10.1186/1471-2407-13-292,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1566773,https://api.altmetric.com/v1/donut/1566773_240.png 1,Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer,BONE,,,Article,2013-01-01,10.1016/j.bone.2013.04.012,,,,23685544,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1564183,https://api.altmetric.com/v1/donut/1564183_240.png 1,Increased Bisecting Nâ??Acetylglucosamine and Decreased Branched Chain Glycans of Nâ??linked Glycoproteins in Expressed Prostatic Secretions Associated with Prostate Cancer Progression,PROTEOMICS - Clinical Applications,,,Article,2013-01-01,10.1002/prca.201200134,,,,23775902,PMC3969874,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1562741,https://api.altmetric.com/v1/donut/1562741_240.png 1,Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of |[beta]|-catenin activation of the DKK1 promoter in prostate cancer,Oncogene,,,Article,2013-06-10,10.1038/onc.2013.203,,,,23752183,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1561987,https://api.altmetric.com/v1/donut/1561987_240.png 1,Magnetic Resonance Image in the diagnosis and evaluation of extra-prostatic extension and involvement of seminal vesicles of prostate cancer: a systematic review of literature and meta-analysis,International Brazilian Journal of Urology,,,Article,2013-01-01,10.1590/s1677-5538.ibju.2013.02.02,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1561171,https://api.altmetric.com/v1/donut/1561171_240.png 1,Study of testosterone as a predictor of tumor aggressiveness in patients with prostate cancer,International Brazilian Journal of Urology,,,Article,,10.1590/s1677-5538.ibju.2013.02.04,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1561170,https://api.altmetric.com/v1/donut/1561170_240.png 1,"High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapy",Current Opinion in Urology,,,Article,2013-07-01,10.1097/mou.0b013e328361ebfd,,,,23673512,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1560152,https://api.altmetric.com/v1/donut/1560152_240.png 1,Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2013-06-11,10.1097/coc.0b013e31829a2954,,,,23764680,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1557429,https://api.altmetric.com/v1/donut/1557429_240.png 1,Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer,Current Opinion in Urology,,,Article,2013-05-01,10.1097/mou.0b013e32835fa889,,,,23492838,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1556588,https://api.altmetric.com/v1/donut/1556588_240.png 1,Aptamerâ??Conjugated Nanorods for Targeted Photothermal Therapy of Prostate Cancer Stem Cells,Chemistry - An Asian Journal,,,Article,2013-01-01,10.1002/asia.201300375,,,,23757285,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1548505,https://api.altmetric.com/v1/donut/1548505_240.png 1,Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: Is immunosuppression to blame?,Journal of Oncology Pharmacy Practice,,,Article,2013-06-09,10.1177/1078155213484787,,,,23676505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1546330,https://api.altmetric.com/v1/donut/1546330_240.png 1,"Men, Masculinities, and Prostate Cancer: Australian and Canadian Patient Perspectives of Communication With Male Physicians",Qualitative Health Research,,,Article,2007-01-01,10.1177/1049732306297695,,,,17220387,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1544297,https://api.altmetric.com/v1/donut/1544297_240.png 1,Is it necessary to cure prostate cancer when it is possible? (Understanding the role of prostate inflammation resolution to prostate cancer evolution),Clinical Interventions in Aging,,,Article,2007-03-01,,,,,18044088,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1541845,https://api.altmetric.com/v1/donut/1541845_240.png 1,Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis.,Medical Journal of Australia,,,Article,2013-01-01,10.5694/mja12.11597,,,,23725269,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1541315,https://api.altmetric.com/v1/donut/1541315_240.png 1,"Prostate Cancer: Where We Have Been, Where We Are, and Where We Are Going",Seminars in Radiation Oncology,,,Article,2013-07-01,10.1016/j.semradonc.2013.03.001,,,,23763880,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1538972,https://api.altmetric.com/v1/donut/1538972_240.png 1,Re: Active Surveillance for Prostate Cancer Compared with Immediate Treatment: An Economic Analysis,The Journal of Urology,,,Article,,10.1016/j.juro.2013.02.116,,,,23663603,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1534606,https://api.altmetric.com/v1/donut/1534606_240.png 1,Prostate cancer: Intermittent ADT|[mdash]|tales from a 27-year odyssey,Nature Reviews Urology,,,Article,2013-05-28,10.1038/nrurol.2013.118,,,,23712199,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1533647,https://api.altmetric.com/v1/donut/1533647_240.png 1,microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer,British Journal of Cancer,,,Article,2013-03-28,10.1038/bjc.2013.125,,,,23538390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1530670,https://api.altmetric.com/v1/donut/1530670_240.png 1,Prognostic Significance of Histopathological Features of Extraâ??Prostatic Extension of Prostate Cancer,Histopathology,,,Article,2013-01-01,10.1111/his.12199,,,,23889260,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1525589,https://api.altmetric.com/v1/donut/1525589_240.png 1,Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology.,Actas Urológicas Españolas,,,Article,2013-05-29,10.1016/j.acuro.2013.04.001,,,,23706692,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1525072,https://api.altmetric.com/v1/donut/1525072_240.png 1,Pelvic bone marrow involvement in metastatic prostatic cancer – the role of isotope bone scan: Erratum,Nuclear Medicine Communications,,,Article,2013-07-01,10.1097/mnm.0b013e3283631ed2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1523344,https://api.altmetric.com/v1/donut/1523344_240.png 1,Prostate Cancer Screening in BRCA and Lynch Syndrome Mutation Carriers.,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2013-01-01,10.1200/edbook_am.2013.33.e50,,,,23714454,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1522099,https://api.altmetric.com/v1/donut/1522099_240.png 1,Treatment of local|[ndash]|regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors,British Journal of Cancer,,,Article,2013-05-14,10.1038/bjc.2013.198,,,,23674085,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1517845,https://api.altmetric.com/v1/donut/1517845_240.png 1,Evolution of prostate cancer gene mutations,Lancet Oncology,,,Article,2013-06-01,10.1016/s1470-2045(13)70205-5,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1516762,https://api.altmetric.com/v1/donut/1516762_240.png 1,"Patient Demographics, Quality of Life, and Disease Features of Men With Newly Diagnosed Prostate Cancer: Trends in the PSA Era.",Urology,,,Article,2013-05-21,10.1016/j.urology.2013.01.072,,,,23706257,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1515543,https://api.altmetric.com/v1/donut/1515543_240.png 1,Immunotherapy and Immune Evasion in Prostate Cancer,Cancers,,,Article,2013-01-01,10.3390/cancers5020569,,,,24216992,PMC3730318,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1514708,https://api.altmetric.com/v1/donut/1514708_240.png 1,Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-04-07,10.1007/s00259-013-2385-z,,,,23558687,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1511961,https://api.altmetric.com/v1/donut/1511961_240.png 1,5â??year oncologic outcomes of Endoscopic Extraperitoneal Radical Prostatectomy (EERPE) for prostate cancer: Results from a mediumâ??volume United Kingdom centre,British Journal of Urology,,,Article,2013-01-01,10.1111/bju.12260,,,,23980640,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1508991,https://api.altmetric.com/v1/donut/1508991_240.png 1,FGFR1 is Essential for Prostate Cancer Progression and Metastasis,Cancer Research,,,Article,2013-04-13,10.1158/0008-5472.can-12-3274,,,,23576558,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1496550,https://api.altmetric.com/v1/donut/1496550_240.png 1,"A Flavonoid Antioxidant, Silymarin, Inhibits Activation of erbB1 Signaling and Induces Cyclin-dependent Kinase Inhibitors, G1 Arrest, and Anticarcinogenic Effects in Human Prostate Carcinoma DU145 Cells",Cancer Research,,,Article,1998-01-01,,,,,9581834,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1482541,https://api.altmetric.com/v1/donut/1482541_240.png 1,An introduction to acinar pressures in BPH and prostate cancer,Nature Reviews Urology,,,Article,2013-05-14,10.1038/nrurol.2013.86,,,,23670181,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1480999,https://api.altmetric.com/v1/donut/1480999_240.png 1,Prostate specific antigen testing: age-related interpretation in early prostate cancer detection,Pathology,,,Article,2013-06-01,10.1097/pat.0b013e3283619a77,,,,23619589,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1480693,https://api.altmetric.com/v1/donut/1480693_240.png 1,Role of (18)F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-05-14,10.1007/s00259-013-2433-8,,,,23670521,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1479251,https://api.altmetric.com/v1/donut/1479251_240.png 1,Targeting psychoemotional stress to treat prostate cancer,Asian Journal of Andrology,,,Article,2013-04-15,10.1038/aja.2013.30,,,,23584381,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1478181,https://api.altmetric.com/v1/donut/1478181_240.png 1,Re: Proton vs Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity,JNCI: Journal of the National Cancer Institute,,,Article,2013-01-01,10.1093/jnci/djt074,,,,23559544,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1476798,https://api.altmetric.com/v1/donut/1476798_240.png 1,Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging.,Urology,,,Article,2001-09-01,,,,,11549490,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1468893,https://api.altmetric.com/v1/donut/1468893_240.png 1,Elevated Prostate-Specific Antigen Levels Up to 25 Years Prior to Death from Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2004-01-01,,,,,15006911,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1468892,https://api.altmetric.com/v1/donut/1468892_240.png 1,Prostate cancer: Multiparametric MRI scans could be a useful adjunct for active surveillance in prostate cancer,Nature Reviews Urology,,,Article,2013-03-26,10.1038/nrurol.2013.56,,,,23528701,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1467513,https://api.altmetric.com/v1/donut/1467513_240.png 1,A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy,Anti-Cancer Drugs,,,Article,2013-05-06,10.1097/cad.0b013e328361feb0,,,,23652277,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1459509,https://api.altmetric.com/v1/donut/1459509_240.png 1,Prostate cancer genomics by high-throughput technologies: genome-wide association study and sequencing analysis,Endocrine-Related Cancer,,,Article,2013-01-01,10.1530/erc-13-0113,,,,23625613,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1457483,https://api.altmetric.com/v1/donut/1457483_240.png 1,Sperm banking is of key importance in patients with prostate cancer,Fertility & Sterility,,,Article,2013-05-06,10.1016/j.fertnstert.2013.03.049,,,,23651627,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1456593,https://api.altmetric.com/v1/donut/1456593_240.png 1,The current and future role of sequence-based analysis in prostate cancer treatment,Personalized Medicine,,,Article,2013-05-01,10.2217/pme.13.13,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1456281,https://api.altmetric.com/v1/donut/1456281_240.png 1,It’s Prostate Cancer Awareness Month | Women AgainstProstate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/2011/09/its-prostate-cancer-awareness-month/,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1426268,https://api.altmetric.com/v1/donut/1426268_240.png 1,Loss of SUMOylation on ATF3 Inhibits Proliferation of Prostate Cancer Cells by Modulating CCND1/2 Activity.,International Journal of Molecular Sciences,,,Article,2013-04-19,10.3390/ijms14048367,,,,23591848,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1425346,https://api.altmetric.com/v1/donut/1425346_240.png 1,Prostate cancer: Prostatic swelling and shift upon HIFU,Nature Reviews Urology,,,Article,2013-04-30,10.1038/nrurol.2013.98,,,,23628808,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1425158,https://api.altmetric.com/v1/donut/1425158_240.png 1,"Exercise Does Not Counteract the Effects of a ""Westernized"" Diet on Prostate Cancer Xenografts.",The Prostate,,,Article,2013-04-30,10.1002/pros.22673,,,,23630020,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1424477,https://api.altmetric.com/v1/donut/1424477_240.png 1,Submit Your Prostate Cancer Story | Women Against ProstateCancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/yourstory/submit/,,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1424198,https://api.altmetric.com/v1/donut/1424198_240.png 1,STAT3 mediates TGF-?1-induced TWIST1 expression and prostate cancer invasion.,Cancer Letters,,,Article,2013-04-25,10.1016/j.canlet.2013.04.024,,,,23623921,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1422040,https://api.altmetric.com/v1/donut/1422040_240.png 1,Timing of hormone therapy for prostate cancer,Lancet Oncology,,,Article,2013-05-01,10.1016/s1470-2045(13)70117-7,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1420530,https://api.altmetric.com/v1/donut/1420530_240.png 1,Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group.,Oncotarget,,,Article,2013-04-19,10.18632/oncotarget.918,,,,23592338,PMC3720607,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1420024,https://api.altmetric.com/v1/donut/1420024_240.png 1,The epidemiology of high-risk prostate cancer.,Current Opinion in Urology,,,Article,2013-04-27,10.1097/mou.0b013e328361d48e,,,,23619582,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1419789,https://api.altmetric.com/v1/donut/1419789_240.png 1,Homeostatic housecleaning effect of selenium: Evidence that noncytotoxic oxidantâ??induced damage sensitizes prostate cancer cells to organic seleniumâ??triggered apoptosis,Biofactors,,,Article,2013-04-29,10.1002/biof.1106,,,,23625367,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1418852,https://api.altmetric.com/v1/donut/1418852_240.png 1,Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-04-05,10.1007/s00259-013-2379-x,,,,23549758,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1418828,https://api.altmetric.com/v1/donut/1418828_240.png 1,Quantified KLK15 Gene Expression Levels Discriminate Prostate Cancer From Benign Tumors and Constitute a Novel Independent Predictor of Disease Progression,The Prostate,,,Article,2013-01-01,10.1002/pros.22667,,,,23620432,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1417952,https://api.altmetric.com/v1/donut/1417952_240.png 1,Adaptation and clonal selection models of castration-resistant prostate cancer: Current perspective.,International Journal of Urology,,,Article,2012-11-22,10.1111/iju.12005,,,,23163774,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1415815,https://api.altmetric.com/v1/donut/1415815_240.png 1,Functional Role of MicroRNAs in Prostate Cancer and Therapeutic Opportunities.,Critical Reviews? in Oncogenesis,,,Article,2013-01-01,,,,,23614617,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1415258,https://api.altmetric.com/v1/donut/1415258_240.png 1,Abiraterone acetate in castration-resistant prostate cancer,Anti-Cancer Drugs,,,Article,2012-03-01,10.1097/cad.0b013e32834e696c,,,,22123334,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1413567,https://api.altmetric.com/v1/donut/1413567_240.png 1,Prostate cancer: Risk versus benefit of lymph node dissection during prostatectomy,Nature Reviews Urology,,,Article,2013-04-23,10.1038/nrurol.2013.77,,,,23609844,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1409408,https://api.altmetric.com/v1/donut/1409408_240.png 1,Prostate cancer: is it time to expand the research focus to early-life exposures?,Nature Reviews Cancer,,,Article,2013-04-12,10.1038/nrc3520,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1409135,https://api.altmetric.com/v1/donut/1409135_240.png 1,Knowledge and perceptions of prostate cancer among Nigerian male immigrants.,ABNF Journal,,,Article,2013-04-19,,,,,23589969,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1408401,https://api.altmetric.com/v1/donut/1408401_240.png 1,Exogenous SPARC suppresses proliferation and migration of prostate cancer by interacting with integrin 1,The Prostate,,,Article,2013-01-01,10.1002/pros.22664,,,,23532895,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1406961,https://api.altmetric.com/v1/donut/1406961_240.png 1,Transcriptional network of androgen receptor in prostate cancer progression,International Journal of Urology,,,Article,2013-01-01,10.1111/iju.12146,,,,23600948,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1406208,https://api.altmetric.com/v1/donut/1406208_240.png 1,Increased chemo-sensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer,Journal of Biological Chemistry,,,Article,2013-01-01,10.1074/jbc.m112.448142,,,,23609451,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1405590,https://api.altmetric.com/v1/donut/1405590_240.png 1,Urine of patients with early prostate cancer contains lower levels of light chain fragments of interâ??alphaâ??trypsin inhibitor and saposin B but increased expression of an interâ??alphaâ??trypsin inhibitor heavy chain 4 fragment,Electrophoresis,,,Article,2013-01-01,10.1002/elps.201200583,,,,23417432,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1401407,https://api.altmetric.com/v1/donut/1401407_240.png 1,Point: impact of prostate-specific antigen velocity on management decisions and recommendations.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2013-03-16,,,,,23486454,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1401289,https://api.altmetric.com/v1/donut/1401289_240.png 1,Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway,British Journal of Cancer,,,Article,2013-04-18,10.1038/bjc.2013.160,,,,23598299,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1401277,https://api.altmetric.com/v1/donut/1401277_240.png 1,Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mdt074,,,,23524863,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1397630,https://api.altmetric.com/v1/donut/1397630_240.png 1,Obese men with benign biopsy at high risk for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/4014-obese-men-with-benign-biopsy-at-high-risk-for-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1396182,https://api.altmetric.com/v1/donut/1396182_240.png 1,Biological determinants of health disparities in prostate cancer,Current opinion in oncology,,,Article,2013-05-01,10.1097/cco.0b013e32835eb5d1,,,,23399519,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1389185,https://api.altmetric.com/v1/donut/1389185_240.png 1,Patient-health care provider communication among patients with newly diagnosed prostate cancer: Findings from a population-based survey,Patient Education & Counseling,,,Article,2013-01-23,10.1016/j.pec.2012.12.002,,,,23332967,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1388605,https://api.altmetric.com/v1/donut/1388605_240.png 1,Genetics and genomics of prostate cancer,Asian Journal of Andrology,,,Article,2013-04-08,10.1038/aja.2013.29,,,,23564043,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1385063,https://api.altmetric.com/v1/donut/1385063_240.png 1,SULT2B1b Sulfotransferase: Induction by Vitamin D Receptor and Reduced Expression in Prostate Cancer.,Molecular Endocrinology,,,Article,2013-04-11,10.1210/me.2012-1369,,,,23579488,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1379756,https://api.altmetric.com/v1/donut/1379756_240.png 1,Metabolic and toxicological considerations of newly approved prostate cancer drugs.,Expert Opinion on Drug Metabolism & Toxicology,,,Article,2013-04-12,10.1517/17425255.2013.789019,,,,23581700,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1378149,https://api.altmetric.com/v1/donut/1378149_240.png 1,Genome-Wide Methylation Analysis of Prostate Tissues Reveals Global Methylation Patterns of Prostate Cancer,American Journal of Pathology,,,Article,2013-04-12,10.1016/j.ajpath.2013.02.040,,,,23583283,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1375779,https://api.altmetric.com/v1/donut/1375779_240.png 1,Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-04-11,10.1007/s00259-013-2404-0,,,,23576101,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1372873,https://api.altmetric.com/v1/donut/1372873_240.png 1,Original Paper: Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial,Journal of Medical Screening,,,Article,2003-01-01,10.1258/096914103321610789,,,,12790313,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1363766,https://api.altmetric.com/v1/donut/1363766_240.png 1,Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer,PLoS ONE,,,Article,2013-04-09,10.1371/journal.pone.0061064,,,,23585871,PMC3621663,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1362657,https://api.altmetric.com/v1/donut/1362657_240.png 1,PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells.,PLoS ONE,,,Article,2013-01-01,10.1371/journal.pone.0060408,,,,23565244,PMC3614551,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1361665,https://api.altmetric.com/v1/donut/1361665_240.png 1,Sphingolipids' role in radiotherapy for prostate cancer.,Handbook of experimental pharmacology,,,Article,2013-01-01,10.1007/978-3-7091-1511-4_6,,,,23563654,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1361579,https://api.altmetric.com/v1/donut/1361579_240.png 1,Comparison of Prostate-Specific Promoters and the Use of PSP-Driven Virotherapy for Prostate Cancer.,BioMed research international,,,Article,2013-01-01,10.1155/2013/624632,,,,23484134,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1351192,https://api.altmetric.com/v1/donut/1351192_240.png 1,The Xenoestrogen Bisphenol A Induces Inappropriate Androgen Receptor Activation and Mitogenesis in Prostatic Adenocarcinoma Cells 1 This work was supported by NIH Training Grant ES07250-13 (to Y. B. W.; Environmental Mutagenesis and Cancer) and NIH Grant R01 CA93404-01 (to K. E. K.).1,Molecular Cancer Therapeutics,,,Article,2002-01-01,,,,,12479269,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,25,https://www.altmetric.com/details/1345836,https://api.altmetric.com/v1/donut/1345836_240.png 1,Radiotherapy Treatment of Early-Stage Prostate Cancer with IMRT and Protons: A Treatment Planning Comparison,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2007-05-23,10.1016/j.ijrobp.2007.03.018,,,,17513063,PMC2695934,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,62,https://www.altmetric.com/details/1342562,https://api.altmetric.com/v1/donut/1342562_240.png 1,A Case of Sweet's Panniculitis Associated with Spinal Metastasis from Prostate Cancer,Annals of Dermatology,,,Article,2010-11-01,10.5021/ad.2010.22.4.478,,,,21165226,PMC2991733,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1334491,https://api.altmetric.com/v1/donut/1334491_240.png 1,"Lesterâ??Coll NH, Goldhaber SZ, Sher DJ, and D'Amico AV. Death from highâ??risk prostate cancer versus cardiovascular mortality with hormonal therapy. Cancer doi: 10.1002/cncr.27980",Cancer (0008543X),,,Article,2013-04-02,10.1002/cncr.28073,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1334043,https://api.altmetric.com/v1/donut/1334043_240.png 1,The inhibition of p85PI3KSer83 phosphorylation prevents cell proliferation and invasion in prostate cancer cells,Journal of Cellular Biochemistry,,,Article,2013-07-18,10.1002/jcb.24558,,,,23553770,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1331034,https://api.altmetric.com/v1/donut/1331034_240.png 1,Postoperative radiotherapy for high-risk prostate cancer – Authors' reply,The Lancet (British Edition),,,Article,2013-03-30,10.1016/s0140-6736(13)60752-7,,,,23540845,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1330020,https://api.altmetric.com/v1/donut/1330020_240.png 1,Robotic Surgery: Review of Prostate and Bladder Cancer,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e318289dbd5,,,,23528721,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1329509,https://api.altmetric.com/v1/donut/1329509_240.png 1,HDR Brachytherapy Alone for High-Risk Prostate Cancer: A Safe Approach for Patients With Localized Disease?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.10.041,,,,23517806,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1327938,https://api.altmetric.com/v1/donut/1327938_240.png 1,Symptom selfâ??management strategies in patients with nonâ??metastatic prostate cancer,Journal of Clinical Nursing,,,Article,2013-03-29,10.1111/jocn.12178,,,,23551614,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1327349,https://api.altmetric.com/v1/donut/1327349_240.png 1,Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart,The Prostate,,,Article,2013-01-01,10.1002/pros.22635,,,,23280623,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1326426,https://api.altmetric.com/v1/donut/1326426_240.png 1,Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology,Biosensors & Bioelectronics,,,Article,2013-03-01,10.1016/j.bios.2013.02.052,,,,23567627,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1326124,https://api.altmetric.com/v1/donut/1326124_240.png 1,Cholesterol Sulfate Imaging in Human Prostate Cancer Tissue by Desorption Electrospray Ionization Mass Spectrometry,Analytical Chemistry,,,Article,2010-04-10,10.1021/ac9029482,,,,20373810,PMC2872194,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1324456,https://api.altmetric.com/v1/donut/1324456_240.png 1,Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice.,Molecular and Cellular Proteomics (MCP Online),,,Article,2006-10-01,10.1074/mcp.m500371-mcp200,,,,16714762,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1324453,https://api.altmetric.com/v1/donut/1324453_240.png 1,Zinc transporters in prostate cancer,Molecular Aspects of Medicine,,,Article,2013-04-01,10.1016/j.mam.2012.11.007,,,,23506906,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1323366,https://api.altmetric.com/v1/donut/1323366_240.png 1,Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer,Scientific Reports,,,Article,2013-03-25,10.1038/srep01528,,,,23524847,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1322550,https://api.altmetric.com/v1/donut/1322550_240.png 1,Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens(?),Urologic Oncology,,,Article,2013-03-15,10.1016/j.urolonc.2013.01.005,,,,23506965,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1312244,https://api.altmetric.com/v1/donut/1312244_240.png 1,Prostate cancer: Could a single blood test replace TRUS for predicting prostate cancer risk?,Nature Reviews Urology,,,Article,2013-03-19,10.1038/nrurol.2013.50,,,,23507932,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1311897,https://api.altmetric.com/v1/donut/1311897_240.png 1,Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer,Frontiers in endocrinology,,,Article,2013-01-01,10.3389/fendo.2013.00031,,,,23519101,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1311778,https://api.altmetric.com/v1/donut/1311778_240.png 1,ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients,Genes & Development,,,Article,2013-01-01,10.1101/gad.211011.112,,,,23512661,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1311699,https://api.altmetric.com/v1/donut/1311699_240.png 1,"A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice—the ProCaRis study: study protocol",BMJ Open,,,Article,2013-01-01,10.1136/bmjopen-2012-002452,,,,23457331,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1309063,https://api.altmetric.com/v1/donut/1309063_240.png 1,Monitoring potential prostate cancer biomarkers in urine by capillary electrophoresis–tandem mass spectrometry ,Journal of Chromatography A,,,Article,2012-07-26,10.1016/j.chroma.2012.07.021,,,,22824219,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1304049,https://api.altmetric.com/v1/donut/1304049_240.png 1,MicroRNA-182 and MicroRNA-200a Control G-protein Subunit ?-13 (GNA13) Expression and Cell Invasion Synergistically in Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2013-01-01,10.1074/jbc.m112.437749,,,,23329838,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1303635,https://api.altmetric.com/v1/donut/1303635_240.png 1,Castrate-resistant prostate cancer: postdocetaxel management,Current Opinion in Urology,,,Article,2013-03-08,10.1097/mou.0b013e32835e2253,,,,23344012,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1298004,https://api.altmetric.com/v1/donut/1298004_240.png 1,Vascular Endothelial Growth Factor Receptor 2-Specific Microbubbles for Molecular Ultrasound Detection of Prostate Cancer in a Rat Model,Investigative Radiology,,,Article,2010-10-01,10.1097/rli.0b013e3181efd6b2,,,,20733504,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1288665,https://api.altmetric.com/v1/donut/1288665_240.png 1,Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla,Investigative Radiology,,,Article,2009-09-01,10.1097/rli.0b013e3181b4c10e,,,,19692841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/1285463,https://api.altmetric.com/v1/donut/1285463_240.png 1,A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms14035239,,,,23459235,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1277402,https://api.altmetric.com/v1/donut/1277402_240.png 1,Does Positive Family History of Prostate Cancer Increase the Risk of Prostate Cancer on Initial Prostate Biopsy?,Urology,,,Article,2013-02-27,10.1016/j.urology.2012.10.074,,,,23434102,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1276613,https://api.altmetric.com/v1/donut/1276613_240.png 1,Cortical Blindness due to Bilateral Occipital Infarcts in a Renal Failure Patient with Prostate Cancer: A Rare Complication of Hemodialysis.,Case Reports in Medicine,,,Article,2013-02-22,10.1155/2013/539761,,,,23424594,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1276057,https://api.altmetric.com/v1/donut/1276057_240.png 1,Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer,Endocrine-Related Cancer,,,Article,2013-01-01,10.1530/erc-12-0394,,,,23456430,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/1275219,https://api.altmetric.com/v1/donut/1275219_240.png 1,Inhibitory effects of Rhenium-188-labeled Herceptin on prostate cancer cell growth: A possible radioimmunotherapy to prostate carcinoma,International Journal of Radiation Biology,,,Article,2013-01-10,10.3109/09553002.2013.762136,,,,23294030,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1268369,https://api.altmetric.com/v1/donut/1268369_240.png 1,CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy.,Neoplasia,,,Article,2012-09-07,,,,,22952424,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1267697,https://api.altmetric.com/v1/donut/1267697_240.png 1,Long Pentraxinâ??3 As An Epithelialâ??Stromal Fibroblast Growth Factorâ??Targeting Inhibitor In Prostate Cancer,The Journal of Pathology,,,Article,2013-01-01,10.1002/path.4181,,,,23424081,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1262802,https://api.altmetric.com/v1/donut/1262802_240.png 1,Complex interaction between serum folate levels and genetic polymorphisms in folate pathway genes: biomarkers of prostate cancer aggressiveness,Genes & Nutrition,,,Article,2012-09-25,10.1007/s12263-012-0321-7,,,,23007265,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1262542,https://api.altmetric.com/v1/donut/1262542_240.png 1,Development of Potent and Selective Indomethacin Analogs for the Inhibition of AKR1C3 (Type 5 17?-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer,Journal of Medicinal Chemistry,"JONES, India",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-02-22,10.1021/jm3017656,,,,23432095,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1261769,https://api.altmetric.com/v1/donut/1261769_240.png 1,Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII: Quality of Life and Adverse Effects.,European Urology,,,Article,2012-08-05,10.1016/j.eururo.2012.07.040,,,,22857983,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1261536,https://api.altmetric.com/v1/donut/1261536_240.png 1,Prostate Cancer: Computer-aided Diagnosis with Multiparametric 3-T MR Imaging—Effect on Observer Performance,Radiology,,,Article,2013-01-01,10.1148/radiol.12111634,,,,23204542,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1260091,https://api.altmetric.com/v1/donut/1260091_240.png 1,"Lumican expression, localization and antitumor activity in prostate cancer ",Experimental Cell Research,,,Article,2013-02-14,10.1016/j.yexcr.2013.01.023,,,,23399832,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1255400,https://api.altmetric.com/v1/donut/1255400_240.png 1,Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancer ,Biochimica et Biophysica Acta (BBA),,,Article,2013-02-13,10.1016/j.bbcan.2013.01.003,,,,23396052,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1253068,https://api.altmetric.com/v1/donut/1253068_240.png 1,Scientists identify genetic signatures for aggressive formof prostate cancer. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/3495-scientists-identify-genetic-signatures-for-aggressive-form-of-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251769,https://api.altmetric.com/v1/donut/1251769_240.png 1,MRI helps identify patients with prostate cancer who maybenefit from active surveillance. ecancer - News,ecancer,,,Article,,,,,http://ecancer.org/news/3414-mri-helps-identify-patients-with-prostate-cancer-who-may-benefit-from-active-surveillance.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251726,https://api.altmetric.com/v1/donut/1251726_240.png 1,NICE guidance on cabazitaxel for hormone-refractorymetastatic prostate cancer previously treated with adocetaxel-containing regimen. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/2817-nice-guidance-on-cabazitaxel-for-hormone-refractory-metastatic-prostate-cancer-previously-treated-with-a-docetaxel-containing-regimen.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251351,https://api.altmetric.com/v1/donut/1251351_240.png 1,Scientists identify new mechanism of prostate cancer cellmetabolism. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/2615-scientists-identify-new-mechanism-of-prostate-cancer-cell-metabolism.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251101,https://api.altmetric.com/v1/donut/1251101_240.png 1,PSA screening reduces prostate cancer deaths . ecancer -News,ecancer.org,,,Article,,,,,http://ecancer.org/news/2576-psa-screening-reduces-prostate-cancer-deaths.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1251044,https://api.altmetric.com/v1/donut/1251044_240.png 1,Initial results suggest MDV3100 extends life by nearly 5months for prostate cancer post-chemo. ecancer - News,ecancer.org,,,Article,,,,,http://ecancer.org/news/2525-initial-results-suggest-mdv3100-extends-life-by-nearly-5-months-for-prostate-cancer-post-chemo.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250983,https://api.altmetric.com/v1/donut/1250983_240.png 1,Prostate cancer treatment overused in some older patients,ecancer.org,,,Article,,,,,http://ecancer.org/news/2514-prostate-cancer-treatment-overused-in-some-older-patients.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1250961,https://api.altmetric.com/v1/donut/1250961_240.png 1,Prostate cancer: Improving PSA testing by adjusting for genetic background,Nature Reviews Urology,,,Article,2013-02-19,10.1038/nrurol.2013.28,,,,23419491,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1248350,https://api.altmetric.com/v1/donut/1248350_240.png 1,"The significance of biological, environmental, and social risk factors for prostate cancer in a cohort study in Brazil",International Brazilian Journal of Urology,,,Article,,10.1590/1677-553820133806769,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1242638,https://api.altmetric.com/v1/donut/1242638_240.png 1,The accuracy of pathological data for the prediction of insignificant prostate cancer,International Brazilian Journal of Urology,,,Article,,10.1590/1677-553820133806760,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1242637,https://api.altmetric.com/v1/donut/1242637_240.png 1,Demystifying Immunotherapy in Prostate Cancer: Understanding Current and Future Treatment Strategies,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e31828160a9,,,,23337757,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1238561,https://api.altmetric.com/v1/donut/1238561_240.png 1,Nine-Year Outcome and Toxicity in Patients treated with IMRT for Localized Prostate Cancer,The Journal of Urology,,,Article,2013-02-13,10.1016/j.juro.2013.02.012,,,,23415964,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1237389,https://api.altmetric.com/v1/donut/1237389_240.png 1,Diffusion-Weighted MRI at 3 T for the Evaluation of Prostate Cancer,American Journal of Roentgenology,,,Article,2010-01-01,10.2214/ajr.09.3654,,,,20489084,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/1234627,https://api.altmetric.com/v1/donut/1234627_240.png 1,Potential Predictive Biomarkers for Individualizing Treatment for Men With Castration-Resistant Prostate Cancer,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e31827e0b9c,,,,23337754,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1228852,https://api.altmetric.com/v1/donut/1228852_240.png 1,Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions,Modern Pathology,,,Article,2013-02-01,10.1038/modpathol.2012.236,,,,23370768,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1225221,https://api.altmetric.com/v1/donut/1225221_240.png 1,In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T,Acta Radiologica,,,Article,2012-01-01,10.1258/ar.2012.120232,,,,23081956,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1224615,https://api.altmetric.com/v1/donut/1224615_240.png 1,Downâ??regulation of miRâ??200bâ??3p by low p73 contributes to the androgenâ??independence of prostate cancer cells,The Prostate,,,Article,2013-01-01,10.1002/pros.22652,,,,23389960,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1223604,https://api.altmetric.com/v1/donut/1223604_240.png 1,Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense,BMC Cancer,,,Article,2011-01-28,10.1186/1471-2407-11-43,,,,21276246,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1220658,https://api.altmetric.com/v1/donut/1220658_240.png 1,A Community-Driven Intervention for Prostate Cancer Screening in African Americans,Health Education & Behavior,,,Article,2012-01-01,10.1177/1090198111431275,,,,22508702,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1220618,https://api.altmetric.com/v1/donut/1220618_240.png 1,Robotic Real-time Near Infrared Targeted Fluorescence Imaging in a Murine Model of Prostate Cancer: A Feasibility Study.,Urology,,,Article,2013-02-01,10.1016/j.urology.2012.02.075,,,,23374828,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1219830,https://api.altmetric.com/v1/donut/1219830_240.png 1,A model for managing erectile dysfunction following prostate cancer treatment,Current Opinion in Urology,,,Article,2013-03-01,10.1097/mou.0b013e32835d4d41,,,,23321631,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1217955,https://api.altmetric.com/v1/donut/1217955_240.png 1,Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells ,International Journal of Biochemistry & Cell Biology,,,Article,2012-12-30,10.1016/j.biocel.2012.12.012,,,,23270728,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1217433,https://api.altmetric.com/v1/donut/1217433_240.png 1,Down-regulation of androgen receptor transcription by promoter G-quadruplex stabilization as a potential alternative treatment for castrate-resistant prostate cancer.,Biochemistry (00062979),,,Article,2013-02-02,10.1021/bi301349c,,,,23363071,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1217221,https://api.altmetric.com/v1/donut/1217221_240.png 1,Inhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitro ,Food Chemistry,,,Article,2012-12-27,10.1016/j.foodchem.2012.09.102,,,,23265454,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1216350,https://api.altmetric.com/v1/donut/1216350_240.png 1,Potentials and limitations of real-time elastography for prostate cancer detection: a whole-mount step section analysis.,The Scientific World Journal,,,Article,2013-01-26,10.1100/2012/193213,,,,23346015,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1215217,https://api.altmetric.com/v1/donut/1215217_240.png 1,Agents That Target Androgen Synthesis in Castration-Resistant Prostate Cancer,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e31827e0b6f,,,,23337755,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1211790,https://api.altmetric.com/v1/donut/1211790_240.png 1,Highâ??dose rate brachytherapy compared with open radical prostatectomy for the treatment of highâ??risk prostate cancer: 10 year biochemical freedom from relapse,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11480.x,,,,23194129,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1211204,https://api.altmetric.com/v1/donut/1211204_240.png 1,The log-beta Weibull regression model with application to predict recurrence of prostate cancer,Statistical Papers,,,Article,2011-11-24,10.1007/s00362-011-0414-1,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1211167,https://api.altmetric.com/v1/donut/1211167_240.png 1,Chemoprevention of Prostate Cancer: Soy Isoflavones and Curcumin,Korean Journal of Urology,,,Article,2012-10-01,10.4111/kju.2012.53.10.665,,,,23136625,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1211063,https://api.altmetric.com/v1/donut/1211063_240.png 1,Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma.,International Journal of Oncology,,,Article,2013-01-24,10.3892/ijo.2013.1783,,,,23338489,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1210946,https://api.altmetric.com/v1/donut/1210946_240.png 1,N-Cadherin Dependent Collective Cell Invasion of Prostate Cancer Cells Is Regulated by the N-Terminus of ?-Catenin,PLoS ONE,,,Article,2013-01-24,10.1371/journal.pone.0055069,,,,23359820,PMC3554680,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/1208645,https://api.altmetric.com/v1/donut/1208645_240.png 1,Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species.,Experimental Biology and Medicine,,,Article,2010-01-01,10.1258/ebm.2010.009369,,,,20511679,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1206189,https://api.altmetric.com/v1/donut/1206189_240.png 1,Prostate cancer therapy: going forwards by going backwards,Lancet Oncology,,,Article,2013-02-01,10.1016/s1470-2045(12)70591-0,,,,23306099,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1205993,https://api.altmetric.com/v1/donut/1205993_240.png 1,Abiraterone and castration-resistant prostate cancer,Lancet Oncology,,,Article,2013-02-01,10.1016/s1470-2045(12)70585-5,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1203606,https://api.altmetric.com/v1/donut/1203606_240.png 1,Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts,Molecular Cancer Therapeutics,,,Article,2013-01-01,10.1158/1535-7163.mct-12-0648,,,,23348048,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1201279,https://api.altmetric.com/v1/donut/1201279_240.png 1,Prostate cancer cell phenotypes based on AGR2 and CD10 expression,Modern Pathology,,,Article,2013-01-25,10.1038/modpathol.2012.238,,,,23348903,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1200413,https://api.altmetric.com/v1/donut/1200413_240.png 1,From the Guest Editor: Progress in the Treatment of Advanced Prostate: New Data and Horizons,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e318282cde3,,,,23337752,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1200153,https://api.altmetric.com/v1/donut/1200153_240.png 1,Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer,PLoS ONE,,,Article,2013-01-24,10.1371/journal.pone.0054627,,,,23359804,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1199934,https://api.altmetric.com/v1/donut/1199934_240.png 1,Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).,Journal of Applied Clinical Medical Physics,,,Article,2013-01-17,,,,,23318379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1199786,https://api.altmetric.com/v1/donut/1199786_240.png 1,Targeting the Apoptosis Pathway in Prostate Cancer,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e3182801cf7,,,,23337761,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1198830,https://api.altmetric.com/v1/donut/1198830_240.png 1,Presence or absence of a positive pathological margin outperforms any other marginâ??associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11665.x,,,,23350712,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1198283,https://api.altmetric.com/v1/donut/1198283_240.png 1,The Changing Natural History of Metastatic Prostate Cancer,Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e318281197e,,,,23337753,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1196501,https://api.altmetric.com/v1/donut/1196501_240.png 1,Generation of Potent Cytotoxic T Lymphocytes Against Castrationâ??Resistant Prostate Cancer Cells by Dendritic Cells Loaded With Dying Allogeneic Prostate Cancer Cells,Scandinavian Journal of Immunology,,,Article,2012-01-01,10.1111/sji.12007,,,,23126536,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1195770,https://api.altmetric.com/v1/donut/1195770_240.png 1,Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer,BMC Cancer,,,Article,2013-01-22,10.1186/1471-2407-13-27,,,,23336502,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1191153,https://api.altmetric.com/v1/donut/1191153_240.png 1,Prostate cancer: Benefit and safety of adjuvant radiation therapy,Nature Reviews Urology,,,Article,2013-01-22,10.1038/nrurol.2012.260,,,,23338521,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1189853,https://api.altmetric.com/v1/donut/1189853_240.png 1,Patient Recruitment Methods to Evaluate Treatment Decision Making for Localized Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2010-08-01,10.1097/coc.0b013e3181b215d5,,,,20010079,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1185943,https://api.altmetric.com/v1/donut/1185943_240.png 1,Serum Total and Free Prostate-specific Antigen for Breast Cancer Diagnosis in Women,Clinical Cancer Research,,,Article,2000-01-01,,,,,10690525,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1183054,https://api.altmetric.com/v1/donut/1183054_240.png 1,"Phase II open label, multiâ??center clinical trial of modulation of intermediate endpoint biomarkers by 1â??hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin",The Prostate,,,Article,2013-01-01,10.1002/pros.22644,,,,23335089,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1182700,https://api.altmetric.com/v1/donut/1182700_240.png 1,Thermotherapy using magnetic cationic liposomes powerfully suppresses prostate cancer bone metastasis in a novel rat model,The Prostate,,,Article,2013-01-01,10.1002/pros.22637,,,,23334935,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1182699,https://api.altmetric.com/v1/donut/1182699_240.png 1,Excellent Results From High Dose Rate Brachytherapy and External Beam for Prostate Cancer are Not Improved by Androgen Deprivation,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2009-08-01,10.1097/coc.0b013e31818cd277,,,,19398902,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1178918,https://api.altmetric.com/v1/donut/1178918_240.png 1,Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer,International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.28025,,,,23319146,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1177808,https://api.altmetric.com/v1/donut/1177808_240.png 1,Upâ??regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castrationâ??resistant prostate cancer,International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.28026,,,,23319273,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1177807,https://api.altmetric.com/v1/donut/1177807_240.png 1,Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?,Indian Journal of Urology,,,Article,2012-01-01,10.4103/0970-1591.105750,,,,23450674,PMC3579118,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1168753,https://api.altmetric.com/v1/donut/1168753_240.png 1,The association between calcium channel blocker use and prostate cancer outcome,The Prostate,,,Article,2012-01-01,10.1002/pros.22632,,,,23280547,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1168612,https://api.altmetric.com/v1/donut/1168612_240.png 1,GreenLight HPS 120-W laser photoselective vaporization of the prostate as early therapy for acute urinary retention in advanced prostate cancer patients.,Lasers in Medical Science,,,Article,2013-01-05,10.1007/s10103-012-1252-7,,,,23283570,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1167140,https://api.altmetric.com/v1/donut/1167140_240.png 1,Editorial Comment to Standard and saturation transrectal prostate biopsy techniques are equally accurate among prostate cancer active surveillance candidates,International Journal of Urology,,,Article,2013-01-08,10.1111/iju.12076,,,,23294147,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1161964,https://api.altmetric.com/v1/donut/1161964_240.png 1,A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer,Anti-Cancer Drugs,,,Article,2012-06-01,10.1097/cad.0b013e32835006f5,,,,22481061,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1159063,https://api.altmetric.com/v1/donut/1159063_240.png 1,SERUM PRO-PROSTATE SPECIFIC ANTIGEN PREFERENTIALLY DETECTS AGGRESSIVE PROSTATE CANCERS IN MEN WITH 2 TO 4 NG/ML PROSTATE SPECIFIC ANTIGEN,The Journal of Urology,,,Article,2004-06-01,10.1097/01.ju.0000127737.94221.3e,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1157709,https://api.altmetric.com/v1/donut/1157709_240.png 1,"A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France",BMC Cancer,,,Article,2010-11-27,10.1186/1471-2407-10-635,,,,21092177,PMC2996396,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1157423,https://api.altmetric.com/v1/donut/1157423_240.png 1,Cellular Immunotherapy Study of Prostate Cancer Patients and Resulting IgG Responses to Peptide Epitopes Predicted From Prostate Tumor-associated Autoantigens,Journal of Immunotherapy,,,Article,2013-01-01,10.1097/cji.0b013e3182780abc,,,,23211622,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1155402,https://api.altmetric.com/v1/donut/1155402_240.png 1,Sexuality in the Context of Prostate Cancer Narratives.,Qualitative Health Research,,,Article,2012-07-08,10.1177/1049732312449208,,,,22767700,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1150382,https://api.altmetric.com/v1/donut/1150382_240.png 1,"Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges.",Anti-Cancer Agents in Medicinal Chemistry,,,Article,2012-12-14,,,,,23272970,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1149660,https://api.altmetric.com/v1/donut/1149660_240.png 1,Nearâ??infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases,The Prostate,,,Article,2013-01-01,10.1002/pros.22630,,,,23280511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1149583,https://api.altmetric.com/v1/donut/1149583_240.png 1,"An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer",American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2009-08-01,10.1097/coc.0b013e31818b946b,,,,19363437,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1146580,https://api.altmetric.com/v1/donut/1146580_240.png 1,The influence of prostate size on cancer detection.,Urology,,,Article,1995-12-01,,,,,7502425,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1146458,https://api.altmetric.com/v1/donut/1146458_240.png 1,Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death,BMC Cancer,,,Article,2012-12-28,10.1186/1471-2407-12-625,,,,23273263,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1146228,https://api.altmetric.com/v1/donut/1146228_240.png 1,Bone-targeted agents: preventing skeletal complications in prostate cancer.,Urologic Clinics of North America,,,Article,2012-10-24,10.1016/j.ucl.2012.07.009,,,,23084529,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1144881,https://api.altmetric.com/v1/donut/1144881_240.png 1,Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.,Biochimica et Biophysica Acta (BBA),,,Article,2012-12-19,10.1016/j.bbalip.2012.12.005,,,,23262399,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,3,8,https://www.altmetric.com/details/1142340,https://api.altmetric.com/v1/donut/1142340_240.png 1,Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response.,Oncoimmunology,,,Article,2012-12-01,10.4161/onci.22564,,,,23264901,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1142079,https://api.altmetric.com/v1/donut/1142079_240.png 1,Peg-filgrastim and cabazitaxel in prostate cancer patients,Anti-Cancer Drugs,,,Article,2013-01-01,10.1097/cad.0b013e32835a56bc,,,,23044721,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1140177,https://api.altmetric.com/v1/donut/1140177_240.png 1,Interscanner Comparison of Dynamic Contrast-Enhanced MRI in Prostate Cancer: 1.5 Versus 3 T MRI,Investigative Radiology,,,Article,2012-12-17,10.1097/rli.0b013e31827bbcbe,,,,23249646,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1138568,https://api.altmetric.com/v1/donut/1138568_240.png 1,"Efficacy of Taxotere, Thalidomide, and Prednisolone in Patients with Hormone-Resistant Metastatic Prostate cancer.",Urology Journal,,,Article,2012-12-15,,,,,23235972,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1136899,https://api.altmetric.com/v1/donut/1136899_240.png 1,Prostate cancer predicting factors: a preliminary report from tehran.,Urology Journal,,,Article,2012-12-15,,,,,23235971,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1136897,https://api.altmetric.com/v1/donut/1136897_240.png 1,"Association of G/A Polymorphism, rs266882, in AREI Region of the Prostate-Specific Antigen Gene with Prostate Cancer Risk and Clinicopathological Features.",Urology Journal,,,Article,2012-12-15,,,,,23235975,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1136895,https://api.altmetric.com/v1/donut/1136895_240.png 1,Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3.,Oncogene,,,Article,2004-02-28,10.1038/sj.onc.1207284,,,,14985701,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1135161,https://api.altmetric.com/v1/donut/1135161_240.png 1,Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France,Journal of Medical Economics,,,Article,2012-12-14,10.3111/13696998.2012.757552,,,,23231342,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1134863,https://api.altmetric.com/v1/donut/1134863_240.png 1,Over-expressing transporters associated with antigen processing increases antitumor immunity response in prostate cancer.,Cellular Immunology,,,Article,2012-10-29,10.1016/j.cellimm.2012.10.004,,,,23246678,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1133044,https://api.altmetric.com/v1/donut/1133044_240.png 1,Early detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel of TMPRSS2:ETS fusion gene markers,Cancer Medicine,,,Article,2013-01-01,10.1002/cam4.49,,,,24133629,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1130881,https://api.altmetric.com/v1/donut/1130881_240.png 1,"An Analysis of Leukapheresis and Central Venous Catheter Use in the Randomized, Placebo Controlled, Phase 3 IMPACT Trial of Sipuleucel-T for Metastatic Castrate Resistant Prostate Cancer",The Journal of Urology,,,Article,2012-12-17,10.1016/j.juro.2012.09.029,,,,23253957,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1128960,https://api.altmetric.com/v1/donut/1128960_240.png 1,Unmet demand for and satisfaction with a communityâ??based prostate cancer detection programme,Trends in Urology and Men's Health,,,Article,2012-11-22,10.1002/tre.298,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1127967,https://api.altmetric.com/v1/donut/1127967_240.png 1,"Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases",The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.07.023,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1124431,https://api.altmetric.com/v1/donut/1124431_240.png 1,Transurethral Resection Versus Intermittent Catheterization in Patients with Retention after Combined Brachytherapy/External Beam Radiotherapy for Prostate Cancer: Transurethral Resection,The Journal of Urology,,,Article,2012-12-13,10.1016/j.juro.2012.12.018,,,,23246854,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1122601,https://api.altmetric.com/v1/donut/1122601_240.png 1,Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition,American Journal of Clinical Nutrition,,,Article,2010-01-01,10.3945/ajcn.2009.28831,,,,20427733,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1122468,https://api.altmetric.com/v1/donut/1122468_240.png 1,"AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk",The Prostate,,,Article,2011-04-01,10.1002/pros.21267,,,,20945498,PMC3148811,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1122467,https://api.altmetric.com/v1/donut/1122467_240.png 1,Purple Corn Color Inhibition of Prostate Carcinogenesis By Targeting Cell Growth Pathways,Cancer Science,,,Article,2013-01-20,10.1111/cas.12078,,,,23199305,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1120673,https://api.altmetric.com/v1/donut/1120673_240.png 1,Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth,Oncogene,,,Article,2012-12-03,10.1038/onc.2012.523,,,,23208508,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/1118751,https://api.altmetric.com/v1/donut/1118751_240.png 1,P21-activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2),Journal of Biological Chemistry,,,Article,2012-11-06,10.1074/jbc.m112.384289,,,,23132866,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1117903,https://api.altmetric.com/v1/donut/1117903_240.png 1,Follow-Up of Thrombin Generation after Prostate Cancer Surgery: Global Test for Increased Hypercoagulability,PLoS ONE,,,Article,2012-12-07,10.1371/journal.pone.0051299,,,,23236465,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1113339,https://api.altmetric.com/v1/donut/1113339_240.png 1,Definitive Radiotherapy for Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2008-10-01,10.1097/coc.0b013e31816d1ca6,,,,18838889,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1112207,https://api.altmetric.com/v1/donut/1112207_240.png 1,Neuroendocrineâ??derived peptides promote prostate cancer cell survival through activation of IGFâ??1R signaling,The Prostate,,,Article,2012-01-01,10.1002/pros.22624,,,,23192379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1108278,https://api.altmetric.com/v1/donut/1108278_240.png 1,The Impact of Diabetes Mellitus on Survival in Men With Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-12-01,10.1097/coc.0b013e31822dfd8a,,,,22134514,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1103024,https://api.altmetric.com/v1/donut/1103024_240.png 1,"Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers",Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00168,,,,23316473,PMC3540928,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1102179,https://api.altmetric.com/v1/donut/1102179_240.png 1,Prostate cancer: Abiraterone benefit extends to bone-related symptoms,Nature Reviews Urology,,,Article,2012-11-27,10.1038/nrurol.2012.232,,,,23183952,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1096690,https://api.altmetric.com/v1/donut/1096690_240.png 1,"Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.",Prescrire international,,,Article,2012-10-01,,,,,23185849,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1096524,https://api.altmetric.com/v1/donut/1096524_240.png 1,Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D,Journal of Biological Chemistry,,,Article,2013-01-01,10.1074/jbc.m112.395947,,,,23188821,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1095762,https://api.altmetric.com/v1/donut/1095762_240.png 1,Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate,Cancer Cell,,,Article,2009-01-01,10.1016/j.ccr.2009.08.016,,,,19800578,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/1093858,https://api.altmetric.com/v1/donut/1093858_240.png 1,"Molecular markers in Key Steroidogenic Pathways, Circulating steroid levels and Prostate Cancer progression.",Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-2812,,,,23186779,,,,,,,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1093002,https://api.altmetric.com/v1/donut/1093002_240.png 1,Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2009-03-03,10.1073/pnas.0810473106,,,,19202053,,,2009PNAS..106.3443S,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1089277,https://api.altmetric.com/v1/donut/1089277_240.png 1,Treatment with finasteride and prostate cancer survival.,Scandinavian Journal of Urology & Nephrology,,,Article,2012-11-11,10.3109/00365599.2012.737366,,,,23137166,,,,,,,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,2,https://www.altmetric.com/details/1088773,https://api.altmetric.com/v1/donut/1088773_240.png 1,Active Surveillance for Localized Prostate Cancer,Lancet Oncology,,,Article,2012-12-01,10.1016/s1470-2045(12)70543-0,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1087925,https://api.altmetric.com/v1/donut/1087925_240.png 1,Prostate cancer in younger and older patients: do we treat them differently?,Asian Pacific Journal of Cancer Prevention,,,Article,2012-01-01,,,,,23167383,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1085266,https://api.altmetric.com/v1/donut/1085266_240.png 1,PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity,BMC Cancer,,,Article,2012-11-22,10.1186/1471-2407-12-543,,,,23171135,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1085107,https://api.altmetric.com/v1/donut/1085107_240.png 1,Clinically Significant Prostate Cancer is Rarely Missed by Ablative Procedures of the Prostate in Men with Prostate Specific Antigen Less Than 4 ng/ml.,The Journal of Urology,,,Article,2012-11-16,10.1016/j.juro.2012.08.093,,,,23164392,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1083764,https://api.altmetric.com/v1/donut/1083764_240.png 1,Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancer.,Physics in Medicine & Biology,,,Article,2012-11-18,10.1088/0031-9155/57/23/n469,,,,23154795,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1082571,https://api.altmetric.com/v1/donut/1082571_240.png 1,Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials,BMC Medical Informatics and Decision Making,,,Article,2012-11-13,10.1186/1472-6947-12-130,,,,23148458,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1076064,https://api.altmetric.com/v1/donut/1076064_240.png 1,Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy.,Annals of Oncology,,,Article,2012-11-14,10.1093/annonc/mds585,,,,23152362,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1074273,https://api.altmetric.com/v1/donut/1074273_240.png 1,Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection,World Journal of Surgical Oncology,,,Article,2012-11-16,10.1186/1477-7819-10-249,,,,23158926,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1074035,https://api.altmetric.com/v1/donut/1074035_240.png 1,The Impact of Clinical Stage on Prostate Cancer Survival Following Radical Prostatectomy,The Journal of Urology,,,Article,2012-11-16,10.1016/j.juro.2012.11.065,,,,23159265,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1072940,https://api.altmetric.com/v1/donut/1072940_240.png 1,New ADC Effective against Prostate Cancer,Cancer Discovery,,,Article,2012-11-15,10.1158/2159-8290.cd-nb2012-137,,,,23319771,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1072414,https://api.altmetric.com/v1/donut/1072414_240.png 1,"Poly[3-(3, 4-dihydroxyphenyl) glyceric acid] from Comfrey exerts anti-cancer efficacy against human prostate cancer via targeting androgen receptor, cell cycle arrest and apoptosis",Carcinogenesis,,,Article,2012-01-01,10.1093/carcin/bgs202,,,,22693258,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1069028,https://api.altmetric.com/v1/donut/1069028_240.png 1,Genetic Sequence Variants Are Associated With Both Severity Of Lower Urinary Tract Symptoms And Prostate Cancer Susceptibility,The Journal of Urology,,,Article,2012-11-14,10.1016/j.juro.2012.11.044,,,,23159463,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1066906,https://api.altmetric.com/v1/donut/1066906_240.png 1,Salvage Lymph Node Dissection with Adjuvant Radiotherapy for Nodal Recurrence of Prostate Cancer,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.08.041,,,,23083862,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1062140,https://api.altmetric.com/v1/donut/1062140_240.png 1,Androgens and prevention of prostate cancer,"Current Opinion in Endocrinology, Diabetes and Obesity",,,Article,2008-06-01,10.1097/med.0b013e3282fc7038,,,,18438176,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1060134,https://api.altmetric.com/v1/donut/1060134_240.png 1,"You're putting thoughts into my head: a qualitative study of the readiness of patients with breast, lung or prostate cancer to address emotional needs through the first 18months after diagnosis",Psycho-Oncology,,,Article,2012-01-01,10.1002/pon.3156,,,,22890719,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/1055379,https://api.altmetric.com/v1/donut/1055379_240.png 1,Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.,Urologic Oncology,,,Article,2012-10-25,10.1016/j.urolonc.2012.03.007,,,,23089540,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1054396,https://api.altmetric.com/v1/donut/1054396_240.png 1,Expression of splice variants of cancer-testis genes ODF3 and ODF4 in the testis of a prostate cancer patient.,Genetics and Molecular Research,,,Article,2012-10-27,10.4238/2012.october.4.11,,,,23096689,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1052746,https://api.altmetric.com/v1/donut/1052746_240.png 1,Genomic and epigenomic alterations in prostate cancer,Frontiers in endocrinology,,,Article,2012-01-01,10.3389/fendo.2012.00128,,,,23133437,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1043301,https://api.altmetric.com/v1/donut/1043301_240.png 1,"Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested caseâ??control study in the Nordic countries",International Journal of Cancer,,,Article,2004-01-01,10.1002/ijc.11375,,,,14618623,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1039913,https://api.altmetric.com/v1/donut/1039913_240.png 1,Identification of New Differentially Methylated Genes That Have Potential Functional Consequences in Prostate Cancer,PLoS ONE,,,Article,2012-10-31,10.1371/journal.pone.0048455,,,,23119026,PMC3485209,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1035909,https://api.altmetric.com/v1/donut/1035909_240.png 1,Diethylstilbestrol in castrationâ??resistant prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11546.x,,,,23110500,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1032264,https://api.altmetric.com/v1/donut/1032264_240.png 1,A Volumetric Trend Analysis of the Prostate and Seminal Vesicles During a Course of Intensity-Modulated Radiation Therapy,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2010-04-01,10.1097/coc.0b013e3181a31c1a,,,,20010077,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1029195,https://api.altmetric.com/v1/donut/1029195_240.png 1,Variation in IL10 and Other Genes Involved in the Immune Response and in Oxidation and Prostate Cancer Recurrence,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-01,10.1158/1055-9965.epi-12-0458,,,,22859398,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1027563,https://api.altmetric.com/v1/donut/1027563_240.png 1,Deriving margins in prostate cancer radiotherapy treatment: comparison of neural network and fuzzy logic models.,International Journal of Bioinformatics Research and Applications,,,Article,2012-10-13,10.1504/ijbra.2012.049620,,,,23060414,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1021570,https://api.altmetric.com/v1/donut/1021570_240.png 1,Transcript Levels of Androgen Receptor Variant AR-V1 or AR-V7 Do Not Predict Recurrence in Patients with Prostate Cancer at Indeterminate Risk for Progression,The Journal of Urology,,,Article,2012-10-22,10.1016/j.juro.2012.08.014,,,,23088973,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1019405,https://api.altmetric.com/v1/donut/1019405_240.png 1,Fine-Mapping of IL16 Gene and Prostate Cancer Risk in African Americans,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-01,10.1158/1055-9965.epi-12-0707,,,,22923025,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1018177,https://api.altmetric.com/v1/donut/1018177_240.png 1,Management of docetaxel failures in metastatic castrate-resistant prostate cancer.,Urologic Clinics of North America,,,Article,2012-11-01,10.1016/j.ucl.2012.07.013,,,,23084533,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1017996,https://api.altmetric.com/v1/donut/1017996_240.png 1,18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.,Nuclear Medicine Communications,,,Article,2010-01-01,,,,,19972635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1014764,https://api.altmetric.com/v1/donut/1014764_240.png 1,Evaluating Genetic Risk for Prostate Cancer among Japanese and Latinos,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-01,10.1158/1055-9965.epi-12-0598,,,,22923026,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1013708,https://api.altmetric.com/v1/donut/1013708_240.png 1,Value of Prostate Specific Antigen Density and Percent Free Prostate Specific Antigen for Prostate Cancer Prognosis,The Journal of Urology,,,Article,2012-10-18,10.1016/j.juro.2012.07.106,,,,23083861,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1008977,https://api.altmetric.com/v1/donut/1008977_240.png 1,Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy,Prostate Cancer & Prostatic Diseases,,,Article,2012-06-26,10.1038/pcan.2012.12,,,,22733160,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1008387,https://api.altmetric.com/v1/donut/1008387_240.png 1,Clinical trials involving vitamin D analogs in prostate cancer.,Cancer Journal,,,Article,2005-11-02,,,,,16259866,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1008110,https://api.altmetric.com/v1/donut/1008110_240.png 1,Beware of the focal uptake at the ischium on the bone scan in prostate cancer,Nuclear Medicine Communications,,,Article,2011-04-01,10.1097/mnm.0b013e328342ff50,,,,21224744,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1007810,https://api.altmetric.com/v1/donut/1007810_240.png 1,Nuclear factorâ??kappa B and interleukinâ??6 related docetaxel resistance in castrationâ??resistant prostate cancer,The Prostate,,,Article,2013-01-01,10.1002/pros.22591,,,,23038213,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1007627,https://api.altmetric.com/v1/donut/1007627_240.png 1,The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression.,The Journal of Urology,,,Article,2012-04-18,10.1016/j.juro.2012.01.080,,,,22503022,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1007574,https://api.altmetric.com/v1/donut/1007574_240.png 1,Inhibition of Progression of Androgen-Dependent Prostate LNCaP Tumors to Androgen Independence in SCID Mice by Oral Caffeine and Voluntary Exercise.,Nutrition and Cancer,,,Article,2012-10-01,10.1080/01635581.2012.716899,,,,23061906,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1004337,https://api.altmetric.com/v1/donut/1004337_240.png 1,"Activation of AMP-Activated Protein Kinase by 3,3'-Diindolylmethane (DIM) Is Associated with Human Prostate Cancer Cell Death In Vitro and In Vivo.",PLoS ONE,,,Article,2012-10-13,10.1371/journal.pone.0047186,,,,23056607,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1003020,https://api.altmetric.com/v1/donut/1003020_240.png 1,Management of advanced prostate cancer in senior adults: the new landscape.,Oncologist,,,Article,2012-10-05,10.1634/theoncologist.2012-s1-16,,,,23015681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1001121,https://api.altmetric.com/v1/donut/1001121_240.png 1,Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2,The Prostate,,,Article,2013-01-01,10.1002/pros.22598,,,,23060003,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/997365,https://api.altmetric.com/v1/donut/997365_240.png 1,Isolation and characterization of circulating tumor cells in prostate cancer,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00131,,,,23087897,PMC3468833,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/995760,https://api.altmetric.com/v1/donut/995760_240.png 1,The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00138,,,,23087901,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/995759,https://api.altmetric.com/v1/donut/995759_240.png 1,"Reproducibility, Performance, and Clinical Utility of a Genetic Risk Prediction Model for Prostate Cancer in Japanese",PLoS ONE,,,Article,2012-10-10,10.1371/journal.pone.0046454,,,,23071574,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/995304,https://api.altmetric.com/v1/donut/995304_240.png 1,A prospective study of diet and prostate cancer in Japanese men.,Cancer Causes and Control,,,Article,2004-12-05,10.1007/s10552-004-1683-y,,,,15577293,,,,,,,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,4,https://www.altmetric.com/details/995053,https://api.altmetric.com/v1/donut/995053_240.png 1,Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin.,International Journal of Oncology,,,Article,2007-01-09,,,,,17671687,,,,,,,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,12,https://www.altmetric.com/details/995050,https://api.altmetric.com/v1/donut/995050_240.png 1,Assessing the Acceptability and Usability of an Interactive Serious Game in Aiding Treatment Decisions for Patients with Localized Prostate Cancer,Journal of Medical Internet Research,,,Article,2011-01-01,10.2196/jmir.1519,,,,21239374,PMC3221354,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/994702,https://api.altmetric.com/v1/donut/994702_240.png 1,"Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer.",Cancer Causes and Control,,,Article,2010-11-13,10.1007/s10552-010-9671-x,,,,21069447,PMC3117232,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/992658,https://api.altmetric.com/v1/donut/992658_240.png 1,A Model of the Cost-effectiveness of Intensity-modulated Radiotherapy in Comparison with Three-dimensional Conformal Radiotherapy for the Treatment of Localised Prostate Cancer.,Clinical Oncology,,,Article,2012-10-03,10.1016/j.clon.2012.09.003,,,,23040143,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/992249,https://api.altmetric.com/v1/donut/992249_240.png 1,The role of oxidative stress in prostate cancer.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2011-08-23,10.1097/cej.0b013e32834a8002,,,,21857523,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/991703,https://api.altmetric.com/v1/donut/991703_240.png 1,"Arsenic, syphilis, and cancer of the prostate.",Journal of Epidemiology and Community Health (1978),,,Article,1985-09-01,10.1136/jech.39.3.227,,,,4045364,PMC1052440,,,,,,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,11,https://www.altmetric.com/details/990210,https://api.altmetric.com/v1/donut/990210_240.png 1,Androgenâ??dependent activation of human cytomegalovirus major immediateâ??early promoter in prostate cancer cells,The Prostate,,,Article,2008-01-01,10.1002/pros.20817,,,,18615458,,,,,,,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,6,https://www.altmetric.com/details/990209,https://api.altmetric.com/v1/donut/990209_240.png 1,NEW MODELS OF FOLLOWâ??UP IN PROSTATE CANCER: A ROLE FOR INFORMATION TECHNOLOGY?,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11443.x,,,,23043529,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/990040,https://api.altmetric.com/v1/donut/990040_240.png 1,Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups,Radiation Oncology,,,Article,2012-09-17,10.1186/1748-717x-7-158,,,,22978763,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/985694,https://api.altmetric.com/v1/donut/985694_240.png 1,Multiparametric 3T Prostate Magnetic Resonance Imaging to Detect Cancer: Histopathological Correlation Using Prostatectomy Specimens Processed in Customized Magnetic Resonance Imaging Based Molds,The Journal of Urology,,,Article,2011-01-01,10.1016/j.juro.2011.07.013,,,,21944089,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,109,https://www.altmetric.com/details/982236,https://api.altmetric.com/v1/donut/982236_240.png 1,Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer.,Endocrine-Related Cancer,,,Article,2012-10-02,10.1530/erc-12-0232,,,,23033314,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/981189,https://api.altmetric.com/v1/donut/981189_240.png 1,Immunohistochemistry contribution to the diagnosis of prostate cancer,Jornal Brasileiro de Patologia e Medicina Laboratorial,,,Article,2012-01-01,10.1590/s1676-24442012000400008,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/980312,https://api.altmetric.com/v1/donut/980312_240.png 1,Effect of bisphosphonates on anticancer activity in prostate cancer cells.,Yakugaku Zasshi = Journal of Pharmaceutical Society of Japan,,,Article,2012-10-02,,,,,23023419,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/980311,https://api.altmetric.com/v1/donut/980311_240.png 1,Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches,International Journal of Urology,,,Article,2013-01-01,10.1111/j.1442-2042.2012.03175.x,,,,23020893,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/975920,https://api.altmetric.com/v1/donut/975920_240.png 1,Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer,Integrative Biology,,,Article,2012-01-01,10.1039/c2ib20108a,,,,22890797,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/974992,https://api.altmetric.com/v1/donut/974992_240.png 1,"Conventional imaging and Multiparametric Magnetic Resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer.",Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2012-09-28,,,,,23013663,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/973856,https://api.altmetric.com/v1/donut/973856_240.png 1,CAND1 Promotes PLK4-Mediated Centriole Overduplication and Is Frequently Disrupted in Prostate Cancer.,Neoplasia,,,Article,2012-09-01,,,,,23019411,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/972800,https://api.altmetric.com/v1/donut/972800_240.png 1,Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer,Health and Quality of Life Outcomes,,,Article,2012-09-28,10.1186/1477-7525-10-123,,,,23021156,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/971282,https://api.altmetric.com/v1/donut/971282_240.png 1,Value of PET/CT and MR Lymphography in Treatment of Prostate Cancer Patients with Lymph Node Metastases.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.12.093,,,,22417806,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/969649,https://api.altmetric.com/v1/donut/969649_240.png 1,General Commentary to the “Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer” by Darwish O. M. and Raj G. V.,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00126,,,,23061043,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/968535,https://api.altmetric.com/v1/donut/968535_240.png 1,[Recommendations against prostate cancer screening with PSA.],Atención Primaria (ScienceDirect),,,Article,2012-04-25,10.1016/j.aprim.2012.02.005,,,,22520080,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/968364,https://api.altmetric.com/v1/donut/968364_240.png 1,The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and meta-analysis,International Brazilian Journal of Urology,,,Article,2012-01-01,10.1590/s1677-55382012000400002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/967910,https://api.altmetric.com/v1/donut/967910_240.png 1,PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35?,International Brazilian Journal of Urology,,,Article,2012-01-01,10.1590/s1677-55382012000400008,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/967909,https://api.altmetric.com/v1/donut/967909_240.png 1,MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer,Oncogene,,,Article,2012-09-17,10.1038/onc.2012.424,,,,22986525,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/962233,https://api.altmetric.com/v1/donut/962233_240.png 1,"IGF-I, insulin and prostate cancer.",Arquivos Brasileiros de Endocrinologia e Metabologia,,,Article,2010-02-05,,,,,20126849,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/960488,https://api.altmetric.com/v1/donut/960488_240.png 1,Expression Profile and Functional Activity of Peptide Transporters in Prostate Cancer Cells,Molecular Pharmaceutics,,,Article,2012-09-07,10.1021/mp300364k,,,,22950754,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/960115,https://api.altmetric.com/v1/donut/960115_240.png 1,Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy,Journal of Bone & Mineral Research,,,Article,2013-01-01,10.1002/jbmr.1771,,,,22991066,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/953041,https://api.altmetric.com/v1/donut/953041_240.png 1,CRITICAL ROLE OF PROSTATE BIOPSY MORTALITY IN THE NUMBER OF YEARS OF LIFE GAINED AND LOST WITHIN A PROSTATE CANCER SCREENING PROGRAMME,British Journal of Urology,,,Article,2012-09-18,10.1111/j.1464-410x.2012.11522.x,,,,22984891,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/952992,https://api.altmetric.com/v1/donut/952992_240.png 1,ANOGENITAL DISTANCE AND THE RISK OF PROSTATE CANCER,British Journal of Urology,,,Article,2012-09-18,10.1111/j.1464-410x.2012.11524.x,,,,22984939,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/952991,https://api.altmetric.com/v1/donut/952991_240.png 1,Serum Levels of Secreted Group IIA Phospholipase A(2) in Benign Prostatic Hyperplasia and Prostate Cancer: A Biomarker for Inflammation or Neoplasia?,Inflammation,,,Article,2011-12-24,10.1007/s10753-011-9418-1,,,,22189868,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/951534,https://api.altmetric.com/v1/donut/951534_240.png 1,Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer,Molecular and Cellular Proteomics (MCP Online),,,Article,2012-01-01,10.1074/mcp.m112.017889,,,,22986220,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/951182,https://api.altmetric.com/v1/donut/951182_240.png 1,Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment,PLoS ONE,,,Article,2012-09-05,10.1371/journal.pone.0040217,,,,22957009,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/947070,https://api.altmetric.com/v1/donut/947070_240.png 1,Prostate cancer: germline prediction for a commonly variable malignancy,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11450.x,,,,22974436,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/946225,https://api.altmetric.com/v1/donut/946225_240.png 1,Genetic Association of the KLK4 Locus with Risk of Prostate Cancer.,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0044520,,,,22970239,PMC3435290,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/944261,https://api.altmetric.com/v1/donut/944261_240.png 1,Vitamin D and prostate cancer: a prediagnostic study with stored sera.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,1993-01-01,,,,,8220092,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/943097,https://api.altmetric.com/v1/donut/943097_240.png 1,Computer-aided quantitative bone scan assessment of prostate cancer treatment response: Erratum,Nuclear Medicine Communications,,,Article,2012-07-01,10.1097/mnm.0b013e32835611f9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/942439,https://api.altmetric.com/v1/donut/942439_240.png 1,"Angiogenesis in prostate cancer: onset, progression and imaging",British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11444.x,,,,22958524,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/935173,https://api.altmetric.com/v1/donut/935173_240.png 1,"Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF.",PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0043726,,,,22952749,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/933819,https://api.altmetric.com/v1/donut/933819_240.png 1,A prospective cohort study of vasectomy and prostate cancer in US men.,JAMA: Journal of the American Medical Association,,,Article,1993-02-17,,,,,8426446,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/932275,https://api.altmetric.com/v1/donut/932275_240.png 1,Vasectomy and the risk of prostate cancer.,The Journal of Urology,,,Article,2008-12-01,10.1016/j.juro.2008.08.042,,,,18930503,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/932152,https://api.altmetric.com/v1/donut/932152_240.png 1,Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11201.x,,,,22568691,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/931805,https://api.altmetric.com/v1/donut/931805_240.png 1,[Docetaxel plus prednisone versus mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer: long-term effects and safety].,Zhonghua wai ke za zhi Chinese journal of surgery,,,Article,2012-06-01,,,,,22943949,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/929825,https://api.altmetric.com/v1/donut/929825_240.png 1,The Essential Role of Gi?2 in Prostate Cancer Cell Migration.,Molecular Cancer Research,,,Article,2012-09-01,10.1158/1541-7786.mcr-12-0219,,,,22936789,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/927101,https://api.altmetric.com/v1/donut/927101_240.png 1,The evolving role of immunotherapy in prostate cancer,Annals of Oncology,,,Article,2012-01-01,10.1093/annonc/mds259,,,,22918924,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/926758,https://api.altmetric.com/v1/donut/926758_240.png 1,PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer.,Oncogene,,,Article,2009-01-15,10.1038/onc.2008.384,,,,18850006,PMC3786571,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/923551,https://api.altmetric.com/v1/donut/923551_240.png 1,Radical prostatectomy versus observation for prostate cancer,Lancet Oncology,,,Article,2012-09-01,10.1016/s1470-2045(12)70350-9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/918554,https://api.altmetric.com/v1/donut/918554_240.png 1,"Microfluidic, Label-Free Enrichment of Prostate Cancer Cells in Blood Based on Acoustophoresis.",Analytical Chemistry,,,Article,2012-08-19,10.1021/ac301723s,,,,22897670,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,97,https://www.altmetric.com/details/918104,https://api.altmetric.com/v1/donut/918104_240.png 1,Gene expression analysis in prostate cancer: The importance of the endogenous control,The Prostate,,,Article,2013-01-01,10.1002/pros.22578,,,,22926970,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/917844,https://api.altmetric.com/v1/donut/917844_240.png 1,Sun Exposure and Prostate Cancer Risk: Evidence for a Protective Effect of Early-Life Exposure,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-01-01,10.1158/1055-9965.epi-06-1053,,,,17548698,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/914614,https://api.altmetric.com/v1/donut/914614_240.png 1,Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).,Human Genetics,,,Article,2011-12-28,10.1007/s00439-011-1136-0,,,,22198737,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/912870,https://api.altmetric.com/v1/donut/912870_240.png 1,Is it possible to predict low?volume and insignificant prostate cancer by core needle biopsies?,APMIS,,,Article,2012-01-01,10.1111/j.1600-0463.2012.02965.x,,,,23030402,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/909833,https://api.altmetric.com/v1/donut/909833_240.png 1,Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer,Frontiers in Pharmacology,,,Article,2012-01-01,10.3389/fphar.2012.00151,,,,22888320,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/905486,https://api.altmetric.com/v1/donut/905486_240.png 1,Early quality of life outcomes in patients with prostate cancer managed by highâ??doseâ??rate brachytherapy as monotherapy,International Journal of Urology,,,Article,2013-01-01,10.1111/j.1442-2042.2012.03125.x,,,,22905941,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/898561,https://api.altmetric.com/v1/donut/898561_240.png 1,"Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort",Carcinogenesis,,,Article,2008-01-01,10.1093/carcin/bgn056,,,,18296681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/898176,https://api.altmetric.com/v1/donut/898176_240.png 1,How do you want your steak prepared?: The impact of meat consumption and preparation on prostate cancer.,Cancer Biology and Therapy,,,Article,2012-08-17,,,,,22892841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/894990,https://api.altmetric.com/v1/donut/894990_240.png 1,Marked heterogeneity of ERG expression in large primary prostate cancers,Modern Pathology,,,Article,2012-08-17,10.1038/modpathol.2012.130,,,,22899295,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/894241,https://api.altmetric.com/v1/donut/894241_240.png 1,"14-3-3?, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival",Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-0281,,,,22904106,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/893478,https://api.altmetric.com/v1/donut/893478_240.png 1,Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9,Cancer Gene Therapy,,,Article,2012-08-17,10.1038/cgt.2012.53,,,,22898899,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/893172,https://api.altmetric.com/v1/donut/893172_240.png 1,The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.,Cancer Biology and Therapy,,,Article,2012-11-01,,,,,22895074,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/892169,https://api.altmetric.com/v1/donut/892169_240.png 1,Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment.,Physics in Medicine & Biology,,,Article,2012-08-08,10.1088/0031-9155/57/17/5361,,,,22863976,,,2012PMB....57.5361W,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/890316,https://api.altmetric.com/v1/donut/890316_240.png 1,Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy,Prostate Cancer & Prostatic Diseases,,,Article,2012-01-31,10.1038/pcan.2011.71,,,,22289781,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/890177,https://api.altmetric.com/v1/donut/890177_240.png 1,Clarification of data for a meta-analysis: p53 codon 72 polymorphism and prostate cancer risk.,Genetics and Molecular Research,,,Article,2012-08-09,10.4238/2012.july.19.15,,,,22869551,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/887985,https://api.altmetric.com/v1/donut/887985_240.png 1,Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.,Human Mutation,,,Article,2012-08-07,10.1002/humu.22176,,,,22887727,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/887032,https://api.altmetric.com/v1/donut/887032_240.png 1,[The factors for continuing docetaxel-based chemotherapy for castration-resistant prostate cancer].,Hinyokika kiyo Acta urologica Japonica,,,Article,2012-06-01,,,,,22874505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/881744,https://api.altmetric.com/v1/donut/881744_240.png 1,Comparison of mAbs Targeting Epithelial Cell Adhesion Molecule for the Detection of Prostate Cancer Lymph Node Metastases with Multimodal Contrast Agents: Quantitative Small-Animal PET/CT and NIRF.,Journal of Nuclear Medicine,,,Article,2012-08-07,10.2967/jnumed.112.106302,,,,22872743,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/879890,https://api.altmetric.com/v1/donut/879890_240.png 1,Cyclosporin A suppresses prostate cancer cell growth through CaMKK?/AMPK-mediated inhibition of mTORC1 signaling.,Biochemical Pharmacology,,,Article,2012-05-30,10.1016/j.bcp.2012.05.009,,,,22634404,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/877592,https://api.altmetric.com/v1/donut/877592_240.png 1,"Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.",Neoplasma,,,Article,2011-11-23,,,,,22103900,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/875662,https://api.altmetric.com/v1/donut/875662_240.png 1,Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.,International Journal of Oncology,,,Article,2012-06-13,10.3892/ijo.2012.1509,,,,22684500,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/875661,https://api.altmetric.com/v1/donut/875661_240.png 1,"Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis.",International Journal of Oncology,,,Article,2012-06-29,10.3892/ijo.2012.1527,,,,22735465,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/875660,https://api.altmetric.com/v1/donut/875660_240.png 1,Risk Communication and Prostate Cancer: Identifying Which Summary Statistics Are Best Understood by Men.,American Journal of Men's Health,,,Article,2012-07-15,10.1177/1557988312453616,,,,22791627,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/873845,https://api.altmetric.com/v1/donut/873845_240.png 1,"No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial.",International Journal of Cancer,,,Article,2010-03-18,10.1002/ijc.25327,,,,20232386,PMC2970721,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/873042,https://api.altmetric.com/v1/donut/873042_240.png 1,New Views into the Prostate Cancer Genome,Cancer Cell,,,Article,2010-01-01,10.1016/j.ccr.2010.06.011,,,,20609345,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/870796,https://api.altmetric.com/v1/donut/870796_240.png 1,Integrative Genomic Profiling of Human Prostate Cancer,Cancer Cell,,,Article,2010-06-24,10.1016/j.ccr.2010.05.026,,,,20579941,PMC3198787,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,394,https://www.altmetric.com/details/870795,https://api.altmetric.com/v1/donut/870795_240.png 1,Validation of a Multiplex Immunoassay for Serum Angiogenic Factors as Biomarkers for Aggressive Prostate Cancer.,Clinica Chimica Acta,,,Article,2012-06-24,10.1016/j.cca.2012.06.017,,,,22722017,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/868704,https://api.altmetric.com/v1/donut/868704_240.png 1,Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.,Genetics and Molecular Research,,,Article,2012-06-03,10.4238/2012.may.18.1,,,,22653589,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/866676,https://api.altmetric.com/v1/donut/866676_240.png 1,A common genetic variant of 5p15.33 is associated with risk for prostate cancer in the Chinese population.,Genetics and Molecular Research,,,Article,2012-06-03,10.4238/2012.may.15.5,,,,22653581,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/866675,https://api.altmetric.com/v1/donut/866675_240.png 1,Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer.,Genetics and Molecular Research,,,Article,2012-07-13,10.4238/2012.june.15.13,,,,22782583,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/866674,https://api.altmetric.com/v1/donut/866674_240.png 1,"Genetic Variants in CASP3, BMP5, and IRS2 Genes May Influence Survival in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy",PLoS ONE,,,Article,2012-07-23,10.1371/journal.pone.0041219,,,,22844442,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/862643,https://api.altmetric.com/v1/donut/862643_240.png 1,New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs non-stem/progenitor cells,Journal of Molecular Cell Biology,,,Article,2013-01-01,10.1093/jmcb/mjs042,,,,22831834,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/862411,https://api.altmetric.com/v1/donut/862411_240.png 1,Preclinical Safety and Efficacy of in Situ REIC/Dkk-3 Gene Therapy for Prostate Cancer.,Acta medicinae Okayama,,,Article,2012-02-25,,,,,22358134,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/860536,https://api.altmetric.com/v1/donut/860536_240.png 1,LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system.,Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences,"BOND, Jim C",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-03-21,10.1016/j.jchromb.2012.02.029,,,,22425387,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/859463,https://api.altmetric.com/v1/donut/859463_240.png 1,Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant.,Cancer Biology and Therapy,,,Article,2012-09-01,,,,,22825325,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/855907,https://api.altmetric.com/v1/donut/855907_240.png 1,"M-HIFU Inhibits Tumor Growth, Suppresses STAT3 Activity and Enhances Tumor Specific Immunity in a Transplant Tumor Model of Prostate Cancer",PLoS ONE,,,Article,2012-07-24,10.1371/journal.pone.0041632,,,,22911830,PMC3404041,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/854778,https://api.altmetric.com/v1/donut/854778_240.png 1,"Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status",Stem Cells,,,Article,2012-08-01,10.1002/stem.1141,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/854616,https://api.altmetric.com/v1/donut/854616_240.png 1,Implementation and scientific evaluation of rehabilitative sports groups for prostate cancer patients: study protocol of the ProRehab Study,BMC Cancer,,,Article,2012-07-24,10.1186/1471-2407-12-312,,,,22827935,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/854243,https://api.altmetric.com/v1/donut/854243_240.png 1,Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djs279,,,,22825556,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/852341,https://api.altmetric.com/v1/donut/852341_240.png 1,Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population.,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0041201,,,,22815971,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/850426,https://api.altmetric.com/v1/donut/850426_240.png 1,"Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.",The Prostate,,,Article,2001-01-01,10.1002/pros.1074,,,,11398177,,,,,,,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/849889,https://api.altmetric.com/v1/donut/849889_240.png 1,"DNA methyltransferase 3b (DNMT3b), tumor tissue DNA methylation, Gleason score, and prostate cancer mortality: investigating causal relationships.",Cancer Causes and Control,,,Article,2012-07-19,10.1007/s10552-012-0032-9,,,,22810147,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/849718,https://api.altmetric.com/v1/donut/849718_240.png 1,Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma?,International Journal of Andrology,,,Article,2012-02-12,10.1111/j.1365-2605.2011.01246.x,,,,22321000,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/848505,https://api.altmetric.com/v1/donut/848505_240.png 1,Circulating microRNAs: macro-utility as markers of prostate cancer?,Endocrine-Related Cancer,,,Article,2012-01-01,10.1530/erc-12-0010,,,,22492480,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/848123,https://api.altmetric.com/v1/donut/848123_240.png 1,Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy,Therapeutic Advances in Urology,,,Article,2012-01-01,10.1177/1756287212447092,,,,22852025,PMC3398599,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/841625,https://api.altmetric.com/v1/donut/841625_240.png 1,"Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma.",International Journal of Urology,,,Article,2012-07-14,10.1111/j.1442-2042.2012.03082.x,,,,22788411,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/841362,https://api.altmetric.com/v1/donut/841362_240.png 1,Suppression of CX43 expression and promotion of prostate cancer cell progression by miR-20a.,Cancer Biology and Therapy,,,Article,2012-08-01,,,,,22785209,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/839566,https://api.altmetric.com/v1/donut/839566_240.png 1,"Isolated, disseminated and circulating tumour cells in prostate cancer",Nature Reviews Urology,,,Article,2012-07-10,10.1038/nrurol.2012.136,,,,22777287,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/835014,https://api.altmetric.com/v1/donut/835014_240.png 1,Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-0782,,,,22573351,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/830589,https://api.altmetric.com/v1/donut/830589_240.png 1,Abiraterone inhibits 3?-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.,Clinical Cancer Research,,,Article,2012-07-01,10.1158/1078-0432.ccr-12-0908,,,,22753664,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/827454,https://api.altmetric.com/v1/donut/827454_240.png 1,Wnt/?-catenin signalling in prostate cancer.,Nature Reviews Urology,,,Article,2012-06-19,10.1038/nrurol.2012.116,,,,22710668,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/822241,https://api.altmetric.com/v1/donut/822241_240.png 1,Prospective Study of Changes in the Metabolomic Profiles of Men during Their First Three Months of Androgen Deprivation Therapy for Prostate Cancer,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-11-3209,,,,22589396,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/820564,https://api.altmetric.com/v1/donut/820564_240.png 1,Primary androgen deprivation (AD) Followed by active surveillance (AS) for newly diagnosed prostate cancer (PC): A retrospective study,The Prostate,,,Article,2012-01-01,10.1002/pros.22543,,,,,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/819593,https://api.altmetric.com/v1/donut/819593_240.png 1,Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax.,Oncology Letters,,,Article,2012-04-01,10.3892/ol.2012.572,,,,22741011,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/816773,https://api.altmetric.com/v1/donut/816773_240.png 1,Prostate cancer stem cells: molecular characterization for targeted therapy,Asian Journal of Andrology,,,Article,2012-06-25,10.1038/aja.2012.62,,,,22728671,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/810363,https://api.altmetric.com/v1/donut/810363_240.png 1,The prostate cancer conundrum revisited: Further insights,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.27718,,,,22736235,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/810222,https://api.altmetric.com/v1/donut/810222_240.png 1,Urologists and oncologists: adapting to a new treatment paradigm in castrationâ??resistant prostate cancer (CRPC),British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2011.10818.x,,,,22712568,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/806815,https://api.altmetric.com/v1/donut/806815_240.png 1,Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1? signalling.,British Journal of Nutrition,,,Article,2012-04-13,10.1017/s0007114512000967,,,,22716951,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/804275,https://api.altmetric.com/v1/donut/804275_240.png 1,THE CONTINUING ROLE OF PROSTATEâ??SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: DO NOT THROW THE BABY OUT WITH THE BATH WATER,British Journal of Urology,,,Article,2009-01-01,10.1111/j.1464-410x.2009.08881.x,,,,19725821,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/800827,https://api.altmetric.com/v1/donut/800827_240.png 1,Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer.,American Journal of Pathology,,,Article,2012-06-12,10.1016/j.ajpath.2012.04.026,,,,22705054,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/800297,https://api.altmetric.com/v1/donut/800297_240.png 1,A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.,BMC Cancer,,,Article,2009-07-02,10.1186/1471-2407-9-210,,,,19563641,PMC2713263,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/798782,https://api.altmetric.com/v1/donut/798782_240.png 1,"Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.",British Journal of Urology,,,Article,2008-03-15,10.1111/j.1464-410x.2008.07539.x,,,,18336606,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/798781,https://api.altmetric.com/v1/donut/798781_240.png 1,Changes in Gene Transcription Underlying the Aberrant Citrate and Choline Metabolism in Human Prostate Cancer Samples,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-11-2929,,,,22510345,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/796755,https://api.altmetric.com/v1/donut/796755_240.png 1,Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.,Genes & Cancer,,,Article,2011-10-01,10.1177/1947601912436422,,,,22701762,PMC3374630,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/795429,https://api.altmetric.com/v1/donut/795429_240.png 1,Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.,International Journal of Cancer,,,Article,2011-04-20,10.1002/ijc.26138,,,,21500190,PMC3155664,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/784782,https://api.altmetric.com/v1/donut/784782_240.png 1,Prostate-Cancer Mortality after PSA Screening.,New England Journal of Medicine,,,Article,2012-06-07,10.1056/nejmc1204298#sa4,,,,22670917,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/783892,https://api.altmetric.com/v1/donut/783892_240.png 1,Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate.,Canadian Urological Association Journal,,,Article,2012-06-01,10.5489/cuaj.11278,,,,22664629,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/780808,https://api.altmetric.com/v1/donut/780808_240.png 1,Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover,BONE,,,Article,2012-01-01,10.1016/j.bone.2012.04.016,,,,22579776,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/780613,https://api.altmetric.com/v1/donut/780613_240.png 1,Prostate cancer: New PSA screening guideline faces widespread opposition,Nature Reviews Urology,,,Article,2012-06-05,10.1038/nrurol.2012.124,,,,22664931,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/779138,https://api.altmetric.com/v1/donut/779138_240.png 1,Combined Cryoablation and GM-CSF Treatment for Metastatic Hormone Refractory Prostate Cancer,Journal of Immunotherapy,,,Article,2009-01-01,10.1097/cji.0b013e31818df785,,,,19307997,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/777515,https://api.altmetric.com/v1/donut/777515_240.png 1,"Replication and Fine Mapping for Association of the C2orf43, FOXP4, GPRC6A and RFX6 Genes with Prostate Cancer in the Chinese Population.",PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0037866,,,,22662242,,,2012PLoSO...7E7866L,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/777489,https://api.altmetric.com/v1/donut/777489_240.png 1,Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKC?/c-Src dependent signaling pathway.,The Prostate,,,Article,2012-06-02,10.1002/pros.22544,,,,22653778,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/776729,https://api.altmetric.com/v1/donut/776729_240.png 1,"A Local Paracrine and Endocrine Network Involving TGF?, Cox-2, ROS, and Estrogen Receptor ? Influences Reactive Stromal Cell Regulation of Prostate Cancer Cell Motility.",Molecular Endocrinology,,,Article,2012-05-19,10.1210/me.2011-1371,,,,22593181,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/773185,https://api.altmetric.com/v1/donut/773185_240.png 1,Role of 5α-Reductase Inhibitors in Prostate Cancer Prevention and Treatment,Urology,,,Article,2012-01-01,10.1016/j.urology.2012.01.024,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/772748,https://api.altmetric.com/v1/donut/772748_240.png 1,Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer.,Journal of Experimental Therapeutics & Oncology,,,Article,2006-10-10,,,,,17024972,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/772474,https://api.altmetric.com/v1/donut/772474_240.png 1,Stokes shift spectroscopy pilot study for cancerous and normal prostate tissues,Applied Optics,,,Article,2012-01-01,10.1364/ao.51.003642,,,,,,,2012ApOpt..51.3642E,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/771820,https://api.altmetric.com/v1/donut/771820_240.png 1,A Cytomegalovirus-based Vaccine Expressing a Single Tumor-specific CD8+ T-cell Epitope Delays Tumor Growth in a Murine Model of Prostate Cancer,Journal of Immunotherapy,,,Article,2012-06-01,10.1097/cji.0b013e3182585d50,,,,22576344,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/767932,https://api.altmetric.com/v1/donut/767932_240.png 1,Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert,Therapeutic Advances in Urology,,,Article,2012-01-01,10.1177/1756287212440302,,,,22654962,PMC3361746,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/767555,https://api.altmetric.com/v1/donut/767555_240.png 1,NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen,Lancet Oncology,,,Article,2012-06-01,10.1016/s1470-2045(12)70220-6,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/767035,https://api.altmetric.com/v1/donut/767035_240.png 1,"Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer",International Brazilian Journal of Urology,,,Article,2012-01-01,10.1590/s1677-55382012000200004,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/762861,https://api.altmetric.com/v1/donut/762861_240.png 1,Identification of a potential Tumor Differentiation Factor receptor candidate in prostate cancer cells,FEBS Journal,,,Article,2012-01-01,10.1111/j.1742-4658.2012.08641.x,,,,22613557,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/754073,https://api.altmetric.com/v1/donut/754073_240.png 1,"Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells",Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,,,Article,2012-04-01,10.1016/j.mrfmmm.2012.04.005,,,,22561209,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/753731,https://api.altmetric.com/v1/donut/753731_240.png 1,“Benign Essential” Prostate Cancer?,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2009-04-01,10.1097/coc.0b013e318185fa10,,,,19346819,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/752490,https://api.altmetric.com/v1/donut/752490_240.png 1,"Prostate cancer surgery better at teaching hospitals, study finds",Cancer (0008543X),,,Article,2012-06-01,10.1002/cncr.27644,,,,22611012,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/750431,https://api.altmetric.com/v1/donut/750431_240.png 1,"Targeted Antivascular Therapy with the Apolipoprotein(a) Kringle V, rhLK8, Inhibits the Growth and Metastasis of Human Prostate Cancer in an Orthotopic Nude Mouse Model.",Neoplasia,,,Article,2012-05-13,,,,,22577348,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/748567,https://api.altmetric.com/v1/donut/748567_240.png 1,Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells,The Prostate,,,Article,2012-01-01,10.1002/pros.22535,,,,22592999,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/747744,https://api.altmetric.com/v1/donut/747744_240.png 1,The dynamics of death in prostate cancer.,American Journal of Clinical Pathology,,,Article,2012-06-01,10.1309/ajcpjk9v9lumuetv,,,,22586055,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/747406,https://api.altmetric.com/v1/donut/747406_240.png 1,Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer,Molecular Cancer Therapeutics,,,Article,2011-05-25,10.1158/1535-7163.mct-10-0985,,,,21613449,PMC3154574,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/746307,https://api.altmetric.com/v1/donut/746307_240.png 1,"Re: Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up",JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djs205,,,,22491229,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/745085,https://api.altmetric.com/v1/donut/745085_240.png 1,"Response: Re: Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up",JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djs206,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/745084,https://api.altmetric.com/v1/donut/745084_240.png 1,Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.,Human Heredity,,,Article,2011-11-17,10.1159/000331222,,,,22086326,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/743534,https://api.altmetric.com/v1/donut/743534_240.png 1,The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.01.122,,,,22498230,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/742400,https://api.altmetric.com/v1/donut/742400_240.png 1,"No Evidence for Infection of UK Prostate Cancer Patients with XMRV, BK Virus, Trichomonas vaginalis or Human Papilloma Viruses.",PLoS ONE,,,Article,2012-04-05,10.1371/journal.pone.0034221,,,,22470540,,,2012PLoSO...7E4221G,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/741918,https://api.altmetric.com/v1/donut/741918_240.png 1,Biochemical and Functional Outcomes Following Brachytherapy With or Without Supplemental Therapies in Men <=50 Years of Age With Clinically Organ-Confined Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2008-12-01,10.1097/coc.0b013e318172dcb7,,,,19060584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/741741,https://api.altmetric.com/v1/donut/741741_240.png 1,Silencing of a novel tumor metastasis suppressor gene LASS2/TMSG1 promotes invasion of prostate cancer cell in vitro through increase of vacuolar ATPase activity.,Journal of Cellular Biochemistry,,,Article,2012-05-11,10.1002/jcb.24106,,,,22573553,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/741009,https://api.altmetric.com/v1/donut/741009_240.png 1,The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer.,International Journal of Cancer,,,Article,2012-05-10,10.1002/ijc.27628,,,,22573467,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/740609,https://api.altmetric.com/v1/donut/740609_240.png 1,Denosumab in castration-resistant prostate cancer – Authors' reply,The Lancet (British Edition),,,Article,2012-05-12,10.1016/s0140-6736(12)60765-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/739311,https://api.altmetric.com/v1/donut/739311_240.png 1,Constitutive and Treatment-Induced CXCL8-Signalling Selectively Modulates the Efficacy of Anti-Metabolite Therapeutics in Metastatic Prostate Cancer,PLoS ONE,,,Article,2012-05-09,10.1371/journal.pone.0036545,,,,22590561,,,2012PLoSO...7E6545W,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/736631,https://api.altmetric.com/v1/donut/736631_240.png 1,A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients.,Journal of Nuclear Medicine,,,Article,2012-05-08,10.2967/jnumed.111.099408,,,,22570328,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/736275,https://api.altmetric.com/v1/donut/736275_240.png 1,Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group,World Journal of Urology,,,Article,2012-04-26,10.1007/s00345-012-0869-2,,,,22527674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/731353,https://api.altmetric.com/v1/donut/731353_240.png 1,Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-01-01,10.1158/1055-9965.epi-11-0053,,,,21415361,PMC3176661,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/726201,https://api.altmetric.com/v1/donut/726201_240.png 1,Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.,Cancer Epidemiology,,,Article,2012-04-26,10.1016/j.canep.2012.04.002,,,,22542949,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/723702,https://api.altmetric.com/v1/donut/723702_240.png 1,Clinical and Demographic Characteristics Associated With Prostate Cancer Progression in Patients on Active Surveillance,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2011.12.082,,,,22425088,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/723505,https://api.altmetric.com/v1/donut/723505_240.png 1,Prodrug Strategy for PSMA-Targeted Delivery of TGX-221 to Prostate Cancer Cells,Molecular Pharmaceutics,,,Article,2012-05-01,10.1021/mp3000309,,,,22494444,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/722746,https://api.altmetric.com/v1/donut/722746_240.png 1,Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: analysis of 388 biopsy-prostatectomy pairs.,American Journal of Clinical Pathology,,,Article,2012-04-25,10.1309/ajcpwiz9x2dmbebm,,,,22523212,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/721534,https://api.altmetric.com/v1/donut/721534_240.png 1,Deprivation of arginine by recombinant human arginase in prostate cancer cells,Journal of Hematology & Oncology,,,Article,2012-01-01,10.1186/1756-8722-5-17,,,,22546217,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/721233,https://api.altmetric.com/v1/donut/721233_240.png 1,Integrative Molecular Profiling Reveals Asparagine Synthetase Is a Target in Castration-Resistant Prostate Cancer.,American Journal of Pathology,,,Article,2012-01-18,10.1016/j.ajpath.2011.11.030,,,,22245216,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/720321,https://api.altmetric.com/v1/donut/720321_240.png 1,A transcriptional repressor co-regulatory network governing androgen response in prostate cancers,EMBO Journal,,,Article,2012-04-24,10.1038/emboj.2012.112,,,,22531786,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/719029,https://api.altmetric.com/v1/donut/719029_240.png 1,PDEF downregulates stathmin expression in prostate cancer.,International Journal of Oncology,,,Article,2012-03-03,10.3892/ijo.2012.1392,,,,22378487,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/717885,https://api.altmetric.com/v1/donut/717885_240.png 1,Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer.,PLoS ONE,,,Article,2011-05-24,10.1371/journal.pone.0020034,,,,21603581,PMC3095647,,2011PLoSO...6E0034N,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/715784,https://api.altmetric.com/v1/donut/715784_240.png 1,Pooled Sample-Based GWAS: A Cost-Effective Alternative for Identifying Colorectal and Prostate Cancer Risk Variants in the Polish Population.,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0035307,,,,22532847,,,2012PLoSO...7E5307G,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/715081,https://api.altmetric.com/v1/donut/715081_240.png 1,Third Nerve Palsy as the Initial Presenting Sign of Metastatic Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2008-08-01,10.1097/01.coc.0000217590.98344.54,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/712573,https://api.altmetric.com/v1/donut/712573_240.png 1,Vaccination With Agonist Peptide PSA: 154-163 (155L) Derived From Prostate Specific Antigen Induced CD8 T-Cell Response to the Native Peptide PSA: 154-163 But Failed to Induce the Reactivity Against Tumor Targets Expressing PSA: A Phase 2 Study in Patients With Recurrent Prostate Cancer,Journal of Immunotherapy,,,Article,1970-01-01,10.1097/cji.0b013e3181a80e0d,,,,19483644,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/711148,https://api.altmetric.com/v1/donut/711148_240.png 1,Do we need to obtain consent for penile shortening as a complication of treatment for organâ??confined prostate cancer?,British Journal of Urology,,,Article,2012-04-23,10.1111/j.1464-410x.2012.11102.x,,,,22520266,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/710431,https://api.altmetric.com/v1/donut/710431_240.png 1,Ability of Câ??reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxelâ??based chemotherapy,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11148.x,,,,22520631,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/710408,https://api.altmetric.com/v1/donut/710408_240.png 1,Late Fecal Incontinence After High-Dose Radiotherapy for Prostate Cancer: Better Prediction Using Longitudinal Definitions,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.06.1953,,,,21985939,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/706105,https://api.altmetric.com/v1/donut/706105_240.png 1,Active surveillance for early-stage prostate cancer: review of the current literature.,Cancer (0008543X),,,Article,2008-03-01,10.1002/cncr.23373,,,,18306379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/704917,https://api.altmetric.com/v1/donut/704917_240.png 1,Sarcoma of the Prostate: A Single Institutional Review,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2009-02-01,10.1097/coc.0b013e31817b6061,,,,19194120,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/703417,https://api.altmetric.com/v1/donut/703417_240.png 1,Abstract 4611: Effect of pomegranate and diet on prostate cancer tumor growth and survival,Cancer Research,,,Article,2011-07-12,10.1158/1538-7445.am2011-4611,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/702534,https://api.altmetric.com/v1/donut/702534_240.png 1,Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility,European Urology,,,Article,1999-01-01,19909,,,,10325489,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/699440,https://api.altmetric.com/v1/donut/699440_240.png 1,How we manage prostate biopsy and prostate cancer therapy in men with haemophilia,Haemophilia,,,Article,2012-01-01,10.1111/j.1365-2516.2012.02787.x,,,,22500858,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/698850,https://api.altmetric.com/v1/donut/698850_240.png 1,Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-Hairpin RNA Library Screening,PLoS ONE,,,Article,2012-04-11,10.1371/journal.pone.0034414,,,,22509301,PMC3324507,,2012PLoSO...7E4414D,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/693078,https://api.altmetric.com/v1/donut/693078_240.png 1,Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,2000-06-28,,,,,10866869,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/692724,https://api.altmetric.com/v1/donut/692724_240.png 1,The effect of ethnicity and sexual preference on prostate-cancer-related quality of life,Nature Reviews Urology,,,Article,2012-04-10,10.1038/nrurol.2012.56,,,,22487871,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/690081,https://api.altmetric.com/v1/donut/690081_240.png 1,Recent changes in the clinicopathologic features of korean men with prostate cancer: a comparison with Western populations.,Yonsei Medical Journal,,,Article,2012-04-06,10.3349/ymj.2012.53.3.543,,,,22476998,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/688991,https://api.altmetric.com/v1/donut/688991_240.png 1,Comparison of Pelvic Phased-Array versus Endorectal Coil Magnetic Resonance Imaging at 3 Tesla for Local Staging of Prostate Cancer.,Yonsei Medical Journal,,,Article,2012-04-06,10.3349/ymj.2012.53.3.550,,,,22476999,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/688986,https://api.altmetric.com/v1/donut/688986_240.png 1,Prostate and Lymph Node Proton Magnetic Resonance (MR) Spectroscopic Imaging with External Array Coils at 3 T to Detect Recurrent Prostate Cancer After Radiation Therapy,Investigative Radiology,,,Article,2007-06-01,10.1097/01.rli.0000262759.46364.50,,,,17507814,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/688131,https://api.altmetric.com/v1/donut/688131_240.png 1,Chemoaffinity capture of preâ??targeted prostate cancer cells with magnetic beads,The Prostate,,,Article,2012-01-01,10.1002/pros.22508,,,,22488169,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/684664,https://api.altmetric.com/v1/donut/684664_240.png 1,Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer,Radiation Oncology,,,Article,2012-04-02,10.1186/1748-717x-7-56,,,,22472040,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/683321,https://api.altmetric.com/v1/donut/683321_240.png 1,Re: should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.,European Urology,,,Article,2011-11-30,10.1016/j.eururo.2011.10.015,,,,22122873,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/683054,https://api.altmetric.com/v1/donut/683054_240.png 1,Racial Differences in Bone Mineral Density and Fractures in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.,The Journal of Urology,,,Article,2012-01-18,10.1016/j.juro.2011.10.136,,,,22245322,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/681739,https://api.altmetric.com/v1/donut/681739_240.png 1,Low dosed interferon alpha augments the antiâ??tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion,The Prostate,,,Article,2012-01-01,10.1002/pros.22525,,,,22473339,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/679597,https://api.altmetric.com/v1/donut/679597_240.png 1,Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening—Reply,JAMA: Journal of the American Medical Association,,,Article,2012-01-01,10.1001/jama.2012.398,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/679427,https://api.altmetric.com/v1/donut/679427_240.png 1,Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer.,The Prostate,,,Article,2012-04-01,,,,,22468268,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/679062,https://api.altmetric.com/v1/donut/679062_240.png 1,State?of?the?Art Imaging of Prostate Cancer,Contemporary Diagnostic Radiology,,,Article,2008-12-31,10.1097/01.cdr.0000342344.81082.49,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/678450,https://api.altmetric.com/v1/donut/678450_240.png 1,Thwarting High-risk Prostate Cancer: The Right Treatments for the Right Patients,European Urology,,,Article,2012-03-01,10.1016/j.eururo.2012.03.037,,,,22475772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/678031,https://api.altmetric.com/v1/donut/678031_240.png 1,Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.,Urology,,,Article,2011-04-23,10.1016/j.urology.2011.02.025,,,,21507471,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/677324,https://api.altmetric.com/v1/donut/677324_240.png 1,“What's New ? What's Changing in Prostate Cancer?”,International journal of clinical practice,,,Article,2012-01-01,10.1111/j.1742-1241.2012.02915.x,,,,22469149,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/675790,https://api.altmetric.com/v1/donut/675790_240.png 1,Using graded response model for the prediction of prostate cancer risk.,Human Genetics,,,Article,2012-03-30,10.1007/s00439-012-1160-8,,,,22461065,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/675633,https://api.altmetric.com/v1/donut/675633_240.png 1,MicroRNA in Prostate Cancer: An Opportunity to Individualize Patient Care,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.01.028,,,,22335879,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/675276,https://api.altmetric.com/v1/donut/675276_240.png 1,Diagnostic accuracy of transrectal elastosonography (TRES) imaging for the diagnosis of prostate cancer: a systematic review and meta?analysis,British Journal of Urology,,,Article,2012-11-01,10.1111/j.1464-410x.2012.11131.x,,,,23030788,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/674670,https://api.altmetric.com/v1/donut/674670_240.png 1,Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11072.x,,,,22462566,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/674665,https://api.altmetric.com/v1/donut/674665_240.png 1,Radical Prostatectomy Outcome in Men 65 Years Old or Older With Low Risk Prostate Cancer,The Journal of Urology,,,Article,2012-03-15,10.1016/j.juro.2011.12.072,,,,22425079,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/672767,https://api.altmetric.com/v1/donut/672767_240.png 1,An Interobserver Study of Prostatic Fossa Clinical Target Volume Delineation in Clinical Practice: Are Regions of Recurrence Adequately Targeted?,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2011-04-01,10.1097/coc.0b013e3181d2edc3,,,,20523209,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/671335,https://api.altmetric.com/v1/donut/671335_240.png 1,"Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese",Nature Genetics,,,Article,2012-02-26,10.1038/ng.1104,,,,22366784,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/670878,https://api.altmetric.com/v1/donut/670878_240.png 1,Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM.,PLoS ONE,,,Article,2012-03-26,10.1371/journal.pone.0033729,,,,22442719,PMC3307758,,2012PLoSO...7E3729K,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/669279,https://api.altmetric.com/v1/donut/669279_240.png 1,"Screening for prostate cancer: a public campaign, evidence-based-medicine and conflicting interests",European Journal of Public Health,,,Article,2009-01-01,10.1093/eurpub/ckn110,,,,19001462,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/663709,https://api.altmetric.com/v1/donut/663709_240.png 1,Body image predicts quality of life in men with prostate cancer,Psycho-Oncology,,,Article,2012-03-01,10.1002/pon.3063,,,,22422671,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/661115,https://api.altmetric.com/v1/donut/661115_240.png 1,Retraction: Role of Ribosomal Protein RPS2 in Controlling let-7a Expression in Human Prostate Cancer,Molecular Cancer Research,,,Article,,10.1158/1541-7786.mcr-12-0085,,,,22434856,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/660855,https://api.altmetric.com/v1/donut/660855_240.png 1,Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer,International Journal of Urology,,,Article,2012-01-01,10.1111/j.1442-2042.2012.02995.x,,,,22435389,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/660312,https://api.altmetric.com/v1/donut/660312_240.png 1,"Racial/Ethnic Differences in Treatment Discussed, Preferred, and Received for Prostate Cancer in a Tri-Ethnic Population",American Journal of Men's Health,,,Article,2012-03-13,10.1177/1557988311432467,,,,22419652,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/655821,https://api.altmetric.com/v1/donut/655821_240.png 1,Prostateâ??specific antigen kinetics in localized and advanced prostate cancer,British Journal of Urology,,,Article,2009-03-01,10.1111/j.1464-410x.2009.08345.x,,,,19210674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/654257,https://api.altmetric.com/v1/donut/654257_240.png 1,Serum PSA halfâ??life as a predictor of survival for hormoneâ??refractory prostate cancer patients: Modelization using a standardized set of response criteria,The Prostate,,,Article,2007-10-01,10.1002/pros.20627,,,,17705243,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/654253,https://api.altmetric.com/v1/donut/654253_240.png 1,The United States Preventive Services Task Force Recommendation against Prostate-Specific Antigen Screening--Point,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-02-07,10.1158/1055-9965.epi-12-0058,,,,22315362,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/652902,https://api.altmetric.com/v1/donut/652902_240.png 1,Serum-autoantibodies for discovery of prostate cancer specific biomarkers.,The Prostate,,,Article,2011-11-07,10.1002/pros.21444,,,,22012634,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/652718,https://api.altmetric.com/v1/donut/652718_240.png 1,Prostate cancer: Modeling the outcomes of prostate cancer screening,Nature Reviews Urology,,,Article,2012-03-13,10.1038/nrurol.2012.34,,,,22410678,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/650222,https://api.altmetric.com/v1/donut/650222_240.png 1,In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy.,International Journal of Radiation Biology,,,Article,2012-03-14,10.3109/09553002.2012.666002,,,http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-80775,22348555,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/649710,https://api.altmetric.com/v1/donut/649710_240.png 1,Longâ??term potency preservation following brachytherapy for prostate cancer,British Journal of Urology,,,Article,2012-02-16,10.1111/j.1464-410x.2011.10800.x,,,,22734475,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/648558,https://api.altmetric.com/v1/donut/648558_240.png 1," DNA Repair System and Prostate Cancer Progression: The Role of Polymorphism (rs1805794) ",DNA & Cell Biology,,,Article,2012-03-13,10.1089/dna.2011.1562,,,,22413803,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/648046,https://api.altmetric.com/v1/donut/648046_240.png 1,MicroRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling.,Molecular Cancer Therapeutics,,,Article,2012-03-11,10.1158/1535-7163.mct-12-0100,,,,22402125,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/647924,https://api.altmetric.com/v1/donut/647924_240.png 1,Prostate Size Does Not Predict High Grade Cancer.,The Journal of Urology,,,Article,2011-12-20,10.1016/j.juro.2011.10.042,,,,22177152,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/647384,https://api.altmetric.com/v1/donut/647384_240.png 1,"Targeting Bone Remodeling by Isoflavone and 3,3?-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis",PLoS ONE,,,Article,2012-03-07,10.1371/journal.pone.0033011,,,,22412975,PMC3296768,,2012PLoSO...7E3011L,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/640062,https://api.altmetric.com/v1/donut/640062_240.png 1,Epigenetic Biomarkers in Prostate Cancer: Current and Future Uses.,Cancer Letters,,,Article,2012-03-02,10.1016/j.canlet.2012.02.011,,,,22391123,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/639256,https://api.altmetric.com/v1/donut/639256_240.png 1,Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.,Endocrine-Related Cancer,,,Article,2012-03-03,10.1530/erc-11-0298,,,,22383427,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/637617,https://api.altmetric.com/v1/donut/637617_240.png 1,Individualized Decision-Making for Older Men With Prostate Cancer: Balancing Cancer Control With Treatment Consequences Across the Clinical Spectrum,Seminars in oncology,,,Article,2011-01-01,10.1053/j.seminoncol.2011.01.011,,,,21421119,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/636542,https://api.altmetric.com/v1/donut/636542_240.png 1,Hospice Use and High-Intensity Care in Men Dying of Prostate Cancer,Archives of Internal Medicine,,,Article,2011-02-14,10.1001/archinternmed.2010.394,,,,20937914,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/636242,https://api.altmetric.com/v1/donut/636242_240.png 1,"Hypoxia, Androgen Deprivation and Systemic Metastases in Prostate Cancer (In Response to â??Antivascular Effects of Neoadjuvant Androgen Deprivation for Prostate Cancer: An In Vivo Human Study Using Susceptibility and Relaxitivity Dynamic MRIâ??: In Regard to Alonzi R et al. (Int J Radiat Oncol Biol Phys 2011;80(3):721â??727)","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.11.017,,,,22385713,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/631708,https://api.altmetric.com/v1/donut/631708_240.png 1,"Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial",Cancer Chemotherapy & Pharmacology,,,Article,2011-10-22,10.1007/s00280-011-1759-9,,,,22020316,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/628874,https://api.altmetric.com/v1/donut/628874_240.png 1,Fifth Joint Meeting of J-CaP and CaPSURE: Advancing the Global Understanding of Prostate Cancer and Its Management,Japanese Journal of Clinical Oncology,,,Article,2012-01-01,10.1093/jjco/hyr194,,,,22217576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/625147,https://api.altmetric.com/v1/donut/625147_240.png 1,"Differences in Disease Presentation, Treatment Outcomes, and Toxicities in African American Patients Treated With Radiation Therapy for Prostate Cancer",American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-02-05,10.1097/coc.0b013e3182208262,,,,21694572,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/620308,https://api.altmetric.com/v1/donut/620308_240.png 1,Late rectal bleeding after 3D-CRT for prostate cancer: development of a neural-network-based predictive model.,Physics in Medicine & Biology,,,Article,2012-02-22,10.1088/0031-9155/57/5/1399,,,,22349550,,,2012PMB....57.1399T,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/619493,https://api.altmetric.com/v1/donut/619493_240.png 1,Diffusion-Weighted MRI for Locally Recurrent Prostate Cancer After External Beam Radiotherapy,American Journal of Roentgenology,,,Article,2012-01-01,10.2214/ajr.11.7162,,,,22357998,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/617257,https://api.altmetric.com/v1/donut/617257_240.png 1,"Assessment of late urinary, bowel and sexual function after dose escalation from 70 to 76 Gy using image-guided radiotherapy in curative treatment of prostate cancer.",Scandinavian Journal of Urology & Nephrology,,,Article,2012-02-22,10.3109/00365599.2012.659205,,,,22352316,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/617156,https://api.altmetric.com/v1/donut/617156_240.png 1,Robotic radical prostatectomy as the initial step in multimodal therapy for men with highâ??risk localised prostate cancer: initial experience of 160 men,British Journal of Urology,,,Article,2012-03-01,10.1111/j.1464-410x.2011.10548.x,,,,21992472,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/616513,https://api.altmetric.com/v1/donut/616513_240.png 1,External-Beam Radiation Therapy and Highâ??Dose Rate Brachytherapy Combined With Long-Term Androgen Deprivation Therapy in High and Very High Prostate Cancer: Preliminary Data on Clinical Outcome,International Journal of Radiation Oncology * Biology * Physics,,,Article,2012-01-01,10.1016/j.ijrobp.2011.08.002,,,,22284039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/612711,https://api.altmetric.com/v1/donut/612711_240.png 1,"Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: A population-based cohort study.",Radiotherapy & Oncology,,,Article,2012-02-15,10.1016/j.radonc.2012.01.006,,,,22326573,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/612536,https://api.altmetric.com/v1/donut/612536_240.png 1,PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer,Journal of Immunotherapy,,,Article,1970-01-01,10.1097/cji.0b013e318247a4e7,,,,22306905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/612277,https://api.altmetric.com/v1/donut/612277_240.png 1,Re: Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force,"Journal of Urology, The",,,Article,2012-02-15,10.1016/j.juro.2012.01.012,,,,22423910,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/611075,https://api.altmetric.com/v1/donut/611075_240.png 1,Are Clinically Insignificant Prostate Cancers Really Insignificant among Korean Men?,Yonsei Medical Journal,,,Article,2012-02-11,10.3349/ymj.2012.53.2.358,,,,22318824,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/605428,https://api.altmetric.com/v1/donut/605428_240.png 1,Overcoming the challenges of robot-assisted radical prostatectomy,Prostate Cancer and Prostatic Diseases,,,Article,2011-08-16,10.1038/pcan.2011.37,,,,21844888,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/601727,https://api.altmetric.com/v1/donut/601727_240.png 1,Prostate cancer: Does denosumab have a role in metastasis prevention?,Nature Reviews Urology,,,Article,2011-12-27,10.1038/nrurol.2011.196,,,,22200817,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/598039,https://api.altmetric.com/v1/donut/598039_240.png 1,"No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population.",Advances in Virology,,,Article,2011-01-01,10.1155/2011/782353,,,,22312352,PMC3265314,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/596896,https://api.altmetric.com/v1/donut/596896_240.png 1,Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2012-02-05,10.1097/coc.0b013e31821dee4e,,,http://journals.lww.com/amjclinicaloncology/Fulltext/2013/10000/Androgen_Deprivation_Therapy_and_Definitive.20.aspx,21694574,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/595541,https://api.altmetric.com/v1/donut/595541_240.png 1,Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.,Journal of Human Genetics,,,Article,2011-06-03,10.1038/jhg.2011.48,,,,21633361,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/594352,https://api.altmetric.com/v1/donut/594352_240.png 1,Androgens and the molecular epidemiology of prostate cancer,"Current Opinion in Endocrinology, Diabetes and Obesity",,,Article,2008-06-01,10.1097/med.0b013e3282febcf6,,,,18438175,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/594105,https://api.altmetric.com/v1/donut/594105_240.png 1,MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer,Frontiers in Genetics,,,Article,2011-01-01,10.3389/fgene.2011.00062,,,,22303357,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/592860,https://api.altmetric.com/v1/donut/592860_240.png 1,"Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.",Eur Urol,,,Article,2011-01-10,10.1016/j.eururo.2011.06.016,,,,21705134,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/590521,https://api.altmetric.com/v1/donut/590521_240.png 1,Effects of the MTHFR C677T Polymorphism on Prostate Specific Antigen and Prostate Cancer.,Asian Pacific journal of cancer prevention : APJCP,,,Article,2011-01-01,,,,,22296369,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/589341,https://api.altmetric.com/v1/donut/589341_240.png 1,Improvement in Prostate Cancer Survival Over Time: A 20-Year Analysis,The Cancer Journal,,,Article,1970-01-01,10.1097/ppo.0b013e3182467419,,,,22290249,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/588996,https://api.altmetric.com/v1/donut/588996_240.png 1,ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality,European Journal of Cancer (1965),,,Article,2012-02-03,10.1016/j.ejca.2012.01.001,,,,22300588,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/588454,https://api.altmetric.com/v1/donut/588454_240.png 1,Prostate Cancer Risk and Vitamin E—Reply,JAMA: The Journal of the American Medical Association,,,Article,2012-01-31,10.1001/jama.2012.56,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/585076,https://api.altmetric.com/v1/donut/585076_240.png 1,Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry.,Human Genetics,,,Article,2012-01-26,10.1007/s00439-012-1139-5,,,,22271044,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/584264,https://api.altmetric.com/v1/donut/584264_240.png 1,Prostate cancer in 2011: Hitting old targets better and identifying new targets,Nature Reviews Clinical Oncology,,,Article,2012-01-10,10.1038/nrclinonc.2011.213,,,,22231760,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/583999,https://api.altmetric.com/v1/donut/583999_240.png 1,Expert Panel Advocates Surveillance for Men With Low-Risk Prostate Cancer,JAMA: The Journal of the American Medical Association,,,Article,2012-01-01,10.1001/jama.2011.1965,,,,22235075,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/583863,https://api.altmetric.com/v1/donut/583863_240.png 1,Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.,"International journal of radiation oncology, biology, physics",,,Article,2012-03-01,10.1016/j.ijrobp.2011.05.035,,,,22284038,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/583258,https://api.altmetric.com/v1/donut/583258_240.png 1,Outcomes in Transplant Patients Undergoing Brachytherapy for Prostate Cancer,American Journal of Clinical Oncology,,,Article,2012-02-01,10.1097/coc.0b013e31820059b6,,,,21293246,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/579311,https://api.altmetric.com/v1/donut/579311_240.png 1,The effect of hormonal treatment on conspicuity of prostate cancer: Implications for focal boosting radiotherapy.,Radiotherapy & Oncology,,,Article,2012-01-25,10.1016/j.radonc.2011.12.007,,,,22265733,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/578568,https://api.altmetric.com/v1/donut/578568_240.png 1,A possible link between the pubertal growth of girls and prostate cancer in their sons,American Journal of Human Biology,,,Article,2012-02-01,10.1002/ajhb.22222,,,,22287160,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/577818,https://api.altmetric.com/v1/donut/577818_240.png 1,"Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9â??2.2) Gy",International Journal of Radiation Oncology * Biology * Physics,,,Article,2011-01-01,10.1016/j.ijrobp.2010.10.075,,,,21324610,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/577697,https://api.altmetric.com/v1/donut/577697_240.png 1,Gene expressional changes in prostate fibroblasts from cancerous tissue,APMIS,,,Article,2012-01-01,10.1111/j.1600-0463.2011.02865.x,,,,22716211,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/577513,https://api.altmetric.com/v1/donut/577513_240.png 1,Correction: Endoglin Regulates Cancer–Stromal Cell Interactions in Prostate Tumors,Cancer Research,,,Article,2012-01-28,10.1158/0008-5472.can-11-3979,,,,22277912,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/575076,https://api.altmetric.com/v1/donut/575076_240.png 1,Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases,Proceedings of the National Academy of Sciences,,,Article,2012-01-18,10.1073/pnas.1120588109,,,,22307626,,,2012PNAS..109.1655R,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/574403,https://api.altmetric.com/v1/donut/574403_240.png 1,"Detection of Prostate Cancer With Magnetic Resonance Imaging: Optimization of T1-Weighted, T2-Weighted, Dynamic-Enhanced T1-Weighted, Diffusion-Weighted Imaging Apparent Diffusion Coefficient Mapping Sequences and MR Spectroscopy, Correlated With Biopsy and Histopathological Findings",Journal of Computer Assisted Tomography,,,Article,2012-01-22,10.1097/rct.0b013e31823f6263,,,,22261768,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/574396,https://api.altmetric.com/v1/donut/574396_240.png 1,Diet and prostate cancer prevention,World Journal of Urology,,,Article,2012-01-17,10.1007/s00345-011-0810-0,,,,22249340,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/573309,https://api.altmetric.com/v1/donut/573309_240.png 1,Advances in the management of highâ??risk localised and metastatic prostate cancer,British Journal of Urology,,,Article,2012-03-01,10.1111/j.1464-410x.2011.10871.x,,,,22257099,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/569627,https://api.altmetric.com/v1/donut/569627_240.png 1,"Evaluation ofalpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers.",Neoplasma,,,Article,2012-01-18,,,,,22248277,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/567165,https://api.altmetric.com/v1/donut/567165_240.png 1,Prostate cancer in 2011: Redefining the therapeutic landscape for CRPC,Nature Reviews Urology,,,Article,2012-01-17,10.1038/nrurol.2011.235,,,,22249187,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/562993,https://api.altmetric.com/v1/donut/562993_240.png 1,"Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion and Metastasis, and Suppresses Tumor Angiogenesis and EMT in TRAMP Mice",Clinical Cancer Research,,,Article,1970-01-01,10.1158/1078-0432.ccr-08-1309,,,,19047104,PMC2639624,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/562400,https://api.altmetric.com/v1/donut/562400_240.png 1,Immunohistochemical verification of ductal differentiation in prostate cancer,APMIS,,,Article,2012-01-01,10.1111/j.1600-0463.2011.02862.x,,,,22583364,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/561028,https://api.altmetric.com/v1/donut/561028_240.png 1,Interrogating genomic and epigenomic data to understand prostate cancer.,Biochimica et Biophysica Acta (BBA),,,Article,2012-01-03,10.1016/j.bbcan.2011.12.003,,,,22240201,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/559448,https://api.altmetric.com/v1/donut/559448_240.png 1,High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.,The Prostate,,,Article,2011-12-27,10.1002/pros.22460,,,,22213442,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/548182,https://api.altmetric.com/v1/donut/548182_240.png 1,"Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer",World Journal of Surgical Oncology,,,Article,2012-01-04,10.1186/1477-7819-10-1,,,,22214417,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/546688,https://api.altmetric.com/v1/donut/546688_240.png 1,Hypofractionated radiotherapy for prostate cancer,Lancet Oncology,,,Article,2012-01-01,10.1016/s1470-2045(11)70347-3,,,,22169267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/546412,https://api.altmetric.com/v1/donut/546412_240.png 1,Weight change and prostate cancer incidence and mortality,International Journal of Cancer,,,Article,2012-01-05,10.1002/ijc.27414,,,,22213024,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/544859,https://api.altmetric.com/v1/donut/544859_240.png 1,Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaP.,Genes & cancer,,,Article,2011-07-01,10.1177/1947601911426007,,,,22207900,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/543592,https://api.altmetric.com/v1/donut/543592_240.png 1,Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.,"Molecular medicine (Cambridge, Mass.)",,,Article,2011-01-01,10.2119/molmed.2010.00143,,,,21365123,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/511146,https://api.altmetric.com/v1/donut/511146_240.png 1,"Epidemiologic, clinical, and molecular characteristics of hereditary prostate cancer in latvia.","Medicina (Kaunas, Lithuania)",,,Article,2011-01-01,,,,,22186123,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/509143,https://api.altmetric.com/v1/donut/509143_240.png 1,Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes.,Epigenomics,,,Article,2010-10-01,10.2217/epi.10.48,,,,22122051,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/508210,https://api.altmetric.com/v1/donut/508210_240.png 1,12. 3-T MRI and DWI in prostate cancer imaging: a district general hospital perspective.,Cancer imaging : the official publication of the International Cancer Imaging Society,,,Article,2011-01-01,10.1102/1470-7330.2011.9075,,,,22185791,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/508157,https://api.altmetric.com/v1/donut/508157_240.png 1,Tracer Kinetic Model Selection for Dynamic Contrast-Enhanced Computed Tomography Imaging of Prostate Cancer,Investigative Radiology,,,Article,2012-01-01,10.1097/rli.0b013e31821c0ea7,,,,21610505,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/507710,https://api.altmetric.com/v1/donut/507710_240.png 1,PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.,"Genes, chromosomes & cancer",,,Article,2012-02-01,10.1002/gcc.20939,,,,22045666,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/506383,https://api.altmetric.com/v1/donut/506383_240.png 1,Prognostic Determinants in Prostate Cancer,Cancer Journal,,,Article,2011-12-15,10.1097/ppo.0b013e31823b042c,,,,22157287,PMC3240856,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/505646,https://api.altmetric.com/v1/donut/505646_240.png 1,Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk.,Genetics and molecular research : GMR,,,Article,2011-01-01,10.4238/2011.november.29.3,,,,22179964,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/504716,https://api.altmetric.com/v1/donut/504716_240.png 1,Genetic polymorphism of the glutathione-S-transferase P1 gene (GSTP1) and susceptibility to prostate cancer in the Kashmiri population.,Genetics and molecular research : GMR,,,Article,2011-01-01,10.4238/2011.december.6.4,,,,22180037,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/504715,https://api.altmetric.com/v1/donut/504715_240.png 1,Elevated osteonectin|[sol]|SPARC expression in primary prostate cancer predicts metastatic progression,Prostate Cancer and Prostatic Diseases,,,Article,2011-12-20,10.1038/pcan.2011.68,,,,22183773,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/504657,https://api.altmetric.com/v1/donut/504657_240.png 1,Osteoblasts in prostate cancer metastasis to bone,Nature Reviews Cancer,,,Article,2005-01-01,10.1038/nrc1528,,,,15630412,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,154,https://www.altmetric.com/details/504582,https://api.altmetric.com/v1/donut/504582_240.png 1,Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis,Cancer Cell International,,,Article,2011-12-02,10.1186/1475-2867-11-42,,,,22136382,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/504494,https://api.altmetric.com/v1/donut/504494_240.png 1,Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion.,Nucleic Acids Research,,,Article,2011-12-19,10.1093/nar/gkr1219,,,,22187159,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/504009,https://api.altmetric.com/v1/donut/504009_240.png 1,"Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: Assembly of a multi-protein signaling complex.",Journal of Cellular Biochemistry,,,Article,2011-12-15,10.1002/jcb.24018,,,,22173835,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/499934,https://api.altmetric.com/v1/donut/499934_240.png 1,"Faith Among Low-Income, African American/Black Men Treated for Prostate Cancer",Cancer Nursing,,,Article,2009-12-11,10.1097/ncc.0b013e3181e1f7ff,,,,20555257,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/496589,https://api.altmetric.com/v1/donut/496589_240.png 1,Low risk prostate cancer in men > 70 years old: to treat or not to treat,International braz j urol,,,Article,2011-01-01,10.1590/s1677-55382011000500030,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/493114,https://api.altmetric.com/v1/donut/493114_240.png 1,Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy,International braz j urol,,,Article,,10.1590/s1677-55382011000500021,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/493113,https://api.altmetric.com/v1/donut/493113_240.png 1,"Estrogen receptor ? and 17?-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-12-13,10.1073/pnas.1117772108,,,,22114194,,,2011PNAS..10820090M,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/493006,https://api.altmetric.com/v1/donut/493006_240.png 1,Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.,Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,,,Article,2011-11-25,10.1016/j.radonc.2011.10.025,,,,22119374,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/492869,https://api.altmetric.com/v1/donut/492869_240.png 1,Prostate specific antigen testing for the diagnosis of prostate cancer,Pathology,,,Article,2011-08-01,10.1097/pat.0b013e32834915fc,,,,21753713,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/491189,https://api.altmetric.com/v1/donut/491189_240.png 1,Discovery of 3-Aryloxy-Lactam Analogs as Potent Androgen Receptor Full Antagonists for Treating Castration Resistant Prostate Cancer ,Bioorganic & Medicinal Chemistry Letters,,,Article,2011-12-09,10.1016/j.bmcl.2011.11.068,,,,22197140,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/491107,https://api.altmetric.com/v1/donut/491107_240.png 1,NutriTRAILomics in prostate cancer: time to have two strings to one's bow.,Molecular biology reports,,,Article,2011-12-06,10.1007/s11033-011-1286-0,,,,22143879,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/489471,https://api.altmetric.com/v1/donut/489471_240.png 1,Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer,Journal of Clinical Endocrinology & Metabolism,,,Article,2011-12-15,10.1210/jc.2011-2353,,,,22162475,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/485031,https://api.altmetric.com/v1/donut/485031_240.png 1,TMPRSS2-ERG-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-beta signaling.,BMC cancer,,,Article,2011-12-05,10.1186/1471-2407-11-507,,,,22142399,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/484678,https://api.altmetric.com/v1/donut/484678_240.png 1,"Role of heparan sulfate 2-o-sulfotransferase in prostate cancer cell proliferation, invasion, and growth factor signaling.",Prostate cancer,,,Article,2011-01-01,10.1155/2011/893208,,,,22135748,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/478654,https://api.altmetric.com/v1/donut/478654_240.png 1,Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization,The Prostate,,,Article,2011-12-01,10.1002/pros.22465,,,,22127986,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/476906,https://api.altmetric.com/v1/donut/476906_240.png 1,MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.,Journal of Biological Chemistry,,,Article,2011-11-28,10.1074/jbc.m111.278705,,,,22128178,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/476655,https://api.altmetric.com/v1/donut/476655_240.png 1,"New Data, New Paradigms for Treating Prostate Cancer Patients-VI: Novel Hormonal Therapy Approaches.",Urology,,,Article,2011-11-01,10.1016/j.urology.2011.06.058,,,,22054921,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/476012,https://api.altmetric.com/v1/donut/476012_240.png 1,"Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer",European Journal of Cancer,,,Article,2011-11-30,10.1016/j.ejca.2011.10.014,,,,22129890,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/474490,https://api.altmetric.com/v1/donut/474490_240.png 1,"Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.",Oncogene,,,Article,2011-11-28,10.1038/onc.2011.512,,,,22120715,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,94,https://www.altmetric.com/details/473291,https://api.altmetric.com/v1/donut/473291_240.png 1,Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.,Carcinogenesis,,,Article,2011-11-23,10.1093/carcin/bgr279,,,,22114074,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/470789,https://api.altmetric.com/v1/donut/470789_240.png 1,"N-Acetyltransferase 2 Polymorphisms, Tobacco Smoking, and Breast Cancer Risk in the Breast and Prostate Cancer Cohort Consortium",American Journal of Epidemiology,,,Article,2011-01-01,10.1093/aje/kwr257,,,,22074863,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/469860,https://api.altmetric.com/v1/donut/469860_240.png 1,Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer.,Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición,,,Article,2011-11-01,10.1016/j.endonu.2011.07.007,,,,22014882,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/469495,https://api.altmetric.com/v1/donut/469495_240.png 1,Toxicity Associated With Postoperative Radiation Therapy for Prostate Cancer,American Journal of Clinical Oncology,,,Article,2011-12-01,10.1097/coc.0b013e3181f946dc,,,,21150565,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/468672,https://api.altmetric.com/v1/donut/468672_240.png 1,Metabolic sequelae associated with androgen deprivation therapy for prostate cancer,"Current Opinion in Endocrinology, Diabetes and Obesity",,,Article,2010-06-01,10.1097/med.0b013e3283391fd1,,,,20404727,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/464405,https://api.altmetric.com/v1/donut/464405_240.png 1,Blood lipid levels and prostate cancer risk; a cohort study,Prostate Cancer & Prostatic Diseases,,,Article,2011-07-05,10.1038/pcan.2011.30,,,,21727905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/463682,https://api.altmetric.com/v1/donut/463682_240.png 1,African American men significantly underestimate their risk of having prostate cancer at the time of biopsy.,Psycho-Oncology,,,Article,2011-11-16,10.1002/pon.2098,,,,22095786,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/463531,https://api.altmetric.com/v1/donut/463531_240.png 1,Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate,Cancer Prevention Research,,,Article,2011-01-01,10.1158/1940-6207.capr-11-0035,,,,21836023,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/462939,https://api.altmetric.com/v1/donut/462939_240.png 1,NF-?B signaling in prostate cancer: A promising therapeutic target?,World journal of urology,,,Article,2011-11-16,10.1007/s00345-011-0792-y,,,,22085980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/460496,https://api.altmetric.com/v1/donut/460496_240.png 1,Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: technical considerations and review of the literature.,ISRN urology,,,Article,2011-01-01,10.5402/2011/201408,,,,22084791,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/459940,https://api.altmetric.com/v1/donut/459940_240.png 1,Atypical Sites of Bony Metastases in a Prostate Cancer Patient,Clinical Nuclear Medicine,,,Article,2011-12-01,10.1097/rlu.0b013e3182335d40,,,,22064084,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/459923,https://api.altmetric.com/v1/donut/459923_240.png 1,Zinc and prostatic cancer,Current Opinion in Clinical Nutrition & Metabolic Care,,,Article,2009-11-01,10.1097/mco.0b013e32833106ee,,,,19684515,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/459846,https://api.altmetric.com/v1/donut/459846_240.png 1,Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.,"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",,,Article,2011-11-01,10.1038/modpathol.2011.131,,,,22048235,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/459384,https://api.altmetric.com/v1/donut/459384_240.png 1,"Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.","European journal of cancer (Oxford, England : 1990)",,,Article,2011-05-01,10.1016/j.ejca.2010.11.034,,,,21211963,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/459207,https://api.altmetric.com/v1/donut/459207_240.png 1,Prostate cancer: Vitamin E and prostate cancer-what is the real risk?,Nature reviews. Urology,,,Article,2011-11-15,10.1038/nrurol.2011.166,,,,22083245,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/458733,https://api.altmetric.com/v1/donut/458733_240.png 1,A Replication Study Examining Novel Common Single Nucleotide Polymorphisms Identified Through a Prostate Cancer Genome-wide Association Study in a Japanese Population,American Journal of Epidemiology,,,Article,2011-01-01,10.1093/aje/kwr271,,,,22085625,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/457142,https://api.altmetric.com/v1/donut/457142_240.png 1,"Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?",Psycho-oncology,,,Article,2011-11-13,10.1002/pon.2095,,,,22081540,,,,,,,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/455794,https://api.altmetric.com/v1/donut/455794_240.png 1,Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.,Seminars in urologic oncology,,,Article,2002-02-01,,,,,11828353,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/455099,https://api.altmetric.com/v1/donut/455099_240.png 1,Nepal Trek Raises Funds for Prostate Cancer Research,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2011.10744.x,,,,22077551,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/454546,https://api.altmetric.com/v1/donut/454546_240.png 1,[Adaptive IG-IMRT for prostate cancer].,Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti,,,Article,2011-01-01,,,,,22070018,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/452698,https://api.altmetric.com/v1/donut/452698_240.png 1,Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-11-3240,,,,22080570,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/452585,https://api.altmetric.com/v1/donut/452585_240.png 1,Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.,"Cell cycle (Georgetown, Tex.)",,,Article,2011-10-15,10.4161/cc.10.20.17842,,,,22067658,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/451816,https://api.altmetric.com/v1/donut/451816_240.png 1,Androgen Receptor Antagonists and Anti-prostate Cancer Activities of Some Synthesized Steroidal Candidates.,Chemical & pharmaceutical bulletin,,,Article,2011-01-01,,,,,22041072,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/449427,https://api.altmetric.com/v1/donut/449427_240.png 1,"Initial combined treatment with anticholinergics and |[alpha]|-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study",Prostate Cancer and Prostatic Diseases,,,Article,2011-07-26,10.1038/pcan.2011.22,,,,21788967,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/449303,https://api.altmetric.com/v1/donut/449303_240.png 1,Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer.,Journal of Translational Medicine,,,Article,2011-11-05,10.1186/1479-5876-9-191,,,,22053850,PMC3219573,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/445735,https://api.altmetric.com/v1/donut/445735_240.png 1,High Perceived Stress Is Linked to Afternoon Cortisol Levels and Greater Symptom Distress in Patients With Localized Prostate Cancer,Cancer Nursing,,,Article,2011-03-05,10.1097/ncc.0b013e31820a5943,,,,21372704,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/441369,https://api.altmetric.com/v1/donut/441369_240.png 1,LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells.,Cancer Research,,,Article,2011-10-06,10.1158/0008-5472.can-11-2381,,,,21978933,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/403082,https://api.altmetric.com/v1/donut/403082_240.png 1,Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC|[sol]|CCDH1,Oncogene,,,Article,2011-10-10,10.1038/onc.2011.464,,,,21986944,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/403074,https://api.altmetric.com/v1/donut/403074_240.png 1,MicroRNAs Associated with Metastatic Prostate Cancer,PLoS ONE,,,Article,2011-09-30,10.1371/journal.pone.0024950,,,,21980368,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,75,https://www.altmetric.com/details/403073,https://api.altmetric.com/v1/donut/403073_240.png 1,A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2/neu-Expressing Prostate Cancer,Human Gene Therapy,,,Article,2011-10-12,10.1089/hum.2011.016,,,,21875358,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/402117,https://api.altmetric.com/v1/donut/402117_240.png 1,Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,,,Article,2002-08-01,,,,,12149293,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/397911,https://api.altmetric.com/v1/donut/397911_240.png 1,"Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses.",The Prostate,,,Article,2002-10-01,10.1002/pros.10138,,,,12242723,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/397797,https://api.altmetric.com/v1/donut/397797_240.png 1,The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2003-10-28,10.1073/pnas.1735443100,,,,14583590,,,2003PNAS..10012590S,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/397387,https://api.altmetric.com/v1/donut/397387_240.png 1,Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.,International journal of cancer. Journal international du cancer,,,Article,2005-09-01,10.1002/ijc.21014,,,,15800947,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/396755,https://api.altmetric.com/v1/donut/396755_240.png 1,E-cadherin plasticity in prostate cancer stem cell invasion,American Journal of Cancer Research,,,Article,2011-10-08,,,,,21968440,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/396407,https://api.altmetric.com/v1/donut/396407_240.png 1,Targeted elimination of prostate cancer by genetically directed human T lymphocytes.,Cancer research,,,Article,2005-10-01,10.1158/0008-5472.can-05-0436,,,,16204083,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/396357,https://api.altmetric.com/v1/donut/396357_240.png 1,A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.,Clinical cancer research : an official journal of the American Association for Cancer Research,,,Article,2007-07-01,10.1158/1078-0432.ccr-06-2202,,,,17606734,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/395853,https://api.altmetric.com/v1/donut/395853_240.png 1,2-5A ligands--a new concept for the treatment of prostate cancer.,"Nucleosides, nucleotides & nucleic acids",,,Article,2007-01-01,10.1080/15257770701542652,,,,18066809,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/395379,https://api.altmetric.com/v1/donut/395379_240.png 1,Clinical trials of cancer therapies targeting prostate-specific membrane antigen.,Reviews on recent clinical trials,,,Article,2007-09-01,,,,,18474004,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/395224,https://api.altmetric.com/v1/donut/395224_240.png 1,Suggestive evidence of linkage identified at chromosomes 12q24 and 2p16 in African American prostate cancer families from louisiana,The Prostate,,,Article,2012-01-01,10.1002/pros.21496,,,,22615067,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/395178,https://api.altmetric.com/v1/donut/395178_240.png 1,"Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis.",Cancer research,,,Article,2008-11-01,10.1158/0008-5472.can-08-2328,,,,18974153,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/395170,https://api.altmetric.com/v1/donut/395170_240.png 1,Understanding fragmentation of prostate cancer survivorship care,Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.26601,,,,22370955,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/394994,https://api.altmetric.com/v1/donut/394994_240.png 1,One size fits all in prostate cancer: a story tale whose time has come and gone.,The International journal of biological markers,,,Article,2000-01-01,10.5301/jbm.2011.8368,,,,21623584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/394898,https://api.altmetric.com/v1/donut/394898_240.png 1,Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy,International braz j urol,,,Article,2011-08-01,10.1590/s1677-55382011000400010,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/391108,https://api.altmetric.com/v1/donut/391108_240.png 1,Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients,Cancer,,,Article,2011-01-01,10.1002/cncr.26234,,,,21751185,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/391082,https://api.altmetric.com/v1/donut/391082_240.png 1,Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer: review of the literature.,Cancer treatment reviews,,,Article,2011-10-01,10.1016/j.ctrv.2010.12.006,,,,21277093,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/390825,https://api.altmetric.com/v1/donut/390825_240.png 1,Dietetic Factors Associated With Prostate Cancer. Protective Effects of Mediterranean Diet.,Actas Urológicas Españolas,,,Article,2011-09-27,10.1016/j.acuro.2011.08.002,,,,21959061,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/389215,https://api.altmetric.com/v1/donut/389215_240.png 1,Statin Clinical Trial (REALITY) for prostate cancer: an over 15-year wait is finally over thanks to a dietary supplement.,The Urologic clinics of North America,,,Article,2011-08-01,10.1016/j.ucl.2011.05.002,,,,21798395,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/388107,https://api.altmetric.com/v1/donut/388107_240.png 1,"There is no way to identify patients who will harbor small volume, unilateral prostate cancer at final pathology. Implications for focal therapies",The Prostate,,,Article,2011-10-05,10.1002/pros.21497,,,,21965006,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/387622,https://api.altmetric.com/v1/donut/387622_240.png 1,Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells.,The American journal of clinical nutrition,,,Article,2010-06-01,10.3945/ajcn.2009.28666,,,,20392890,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/384457,https://api.altmetric.com/v1/donut/384457_240.png 1,The association between statin use and the diagnosis of prostate cancer in a population based cohort.,The Journal of urology,,,Article,2010-08-01,10.1016/j.juro.2010.03.149,,,,20620405,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/384391,https://api.altmetric.com/v1/donut/384391_240.png 1,Is single fraction 15Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?,Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,,,Article,2011-09-14,10.1016/j.radonc.2011.08.022,,,,21924511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/381872,https://api.altmetric.com/v1/donut/381872_240.png 1,Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer.,The Journal of Urology,"BOND, Jim C",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-06-01,10.1016/j.juro.2011.02.020,,,,21496850,PMC3093434,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/380662,https://api.altmetric.com/v1/donut/380662_240.png 1,Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer.,The Journal of Urology,,,Article,2011-08-01,10.1016/j.juro.2011.03.111,,,,21679977,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/380162,https://api.altmetric.com/v1/donut/380162_240.png 1,GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.,Clinical Cancer Research,,,Article,2011-09-20,10.1158/1078-0432.ccr-11-1899,,,,21933889,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/380148,https://api.altmetric.com/v1/donut/380148_240.png 1,Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases,The Prostate,,,Article,2011-01-01,10.1002/pros.21473,,,,21882211,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/379603,https://api.altmetric.com/v1/donut/379603_240.png 1,Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-?B.,The Prostate,,,Article,2011-09-15,10.1002/pros.21359,,,,21360560,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/376602,https://api.altmetric.com/v1/donut/376602_240.png 1,Deletions of the Androgen-Metabolizing UGT2B Genes Have an Effect on Circulating Steroid Levels and Biochemical Recurrence after Radical Prostatectomy in Localized Prostate Cancer,Journal of Clinical Endocrinology & Metabolism,,,Article,2011-07-06,10.1210/jc.2011-1049,,,,21733997,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/376368,https://api.altmetric.com/v1/donut/376368_240.png 1,American College of Radiology Appropriateness Criteria® — Locally Advanced (High-risk) Prostate Cancer?,Clinical Oncology,,,Article,2011-01-01,10.1016/j.clon.2011.08.003,,,,21875782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/375003,https://api.altmetric.com/v1/donut/375003_240.png 1,"Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer.",The Prostate,,,Article,2011-09-14,10.1002/pros.21487,,,,21919029,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/374502,https://api.altmetric.com/v1/donut/374502_240.png 1,Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot study.,Disease markers,,,Article,2011-01-01,10.3233/dma-2011-0774,,,,21694442,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/374498,https://api.altmetric.com/v1/donut/374498_240.png 1,THE JAMES LIND ALLIANCE APPROACH TO PRIORITY SETTING FOR PROSTATE CANCER RESEARCH: AN INTEGRATIVE METHODOLOGY BASED ON PATIENT AND CLINICIAN PARTICIPATION,British Journal of Urology,,,Article,2011-10-01,10.1111/j.1464-410x.2011.10609.x,,,,21914107,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/374426,https://api.altmetric.com/v1/donut/374426_240.png 1,GERMLINE CAG REPEAT LENGTH OF THE ANDROGEN RECEPTOR AND TIME TO PROGRESSION IN PATIENTS WITH PROSTATE CANCER TREATED WITH ANDROGEN DEPRIVATION THERAPY,British Journal of Urology,,,Article,2011-10-01,10.1111/j.1464-410x.2011.10541.x,,,,21914109,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/374425,https://api.altmetric.com/v1/donut/374425_240.png 1,5-? reductase inhibitors and prostate cancer prevention: where do we turn now?,BMC Medicine,,,Article,2011-09-15,10.1186/1741-7015-9-105,,,,21920036,PMC3180399,10161/8912,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/336611,https://api.altmetric.com/v1/donut/336611_240.png 1,No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients.,Medical microbiology and immunology,,,Article,2011-09-06,10.1007/s00430-011-0215-0,,,,21898167,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/255984,https://api.altmetric.com/v1/donut/255984_240.png 1,Hair loss at 20 associated with prostate cancer risk later in life,Cancer (0008543X),,,Article,2011-09-15,10.1002/cncr.26509,,,,21898872,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/252831,https://api.altmetric.com/v1/donut/252831_240.png 1,Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer.,Cancer research,,,Article,2011-08-31,10.1158/0008-5472.can-11-2127,,,,21880588,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/252708,https://api.altmetric.com/v1/donut/252708_240.png 1,An internet intervention for management of uncertainty during active surveillance for prostate cancer.,Oncology Nursing Forum,,,Article,2011-09-01,10.1188/11.onf.561-568,,,,21875843,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/251711,https://api.altmetric.com/v1/donut/251711_240.png 1,Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone.,Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,,,Article,2011-08-22,10.1016/j.radonc.2011.07.005,,,,21864925,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/249484,https://api.altmetric.com/v1/donut/249484_240.png 1,Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients.,"Cancer Immunology, Immunotherapy",,,Article,2011-08-27,10.1007/s00262-011-1095-2,,,,21874303,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/249267,https://api.altmetric.com/v1/donut/249267_240.png 1,Sentinel node mapping in the prostate cancer. Meta-analysis.,Nuklearmedizin. Nuclear medicine,,,Article,2011-01-01,10.3413/nukmed-0339-10-07,,,,21264441,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/247638,https://api.altmetric.com/v1/donut/247638_240.png 1,Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients.,The patient,,,Article,2008-07-01,10.2165/1312067-200801030-00006,,,,20119493,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/244925,https://api.altmetric.com/v1/donut/244925_240.png 1,Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer.,The British journal of radiology,,,Article,2011-09-01,10.1259/bjr/25741415,,,,21849366,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/244471,https://api.altmetric.com/v1/donut/244471_240.png 1,Combination of Dose Escalation with Technological Advances (Intensity-Modulated and Image-Guided Radiotherapy) Is Not Associated with Increased Morbidity for Patients with Prostate Cancer.,Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],,,Article,2011-08-01,10.1007/s00066-011-2249-z,,,,21789739,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/244135,https://api.altmetric.com/v1/donut/244135_240.png 1,Understanding the impact of RapidArc therapy delivery errors for prostate cancer.,Journal of applied clinical medical physics / American College of Medical Physics,,,Article,2011-01-01,,,,,21844850,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/241493,https://api.altmetric.com/v1/donut/241493_240.png 1,Re: Coffee Consumption and Prostate Cancer Risk and Progression in the Health Professionals Follow-up Study,JNCI Journal of the National Cancer Institute,,,Article,2011-08-17,10.1093/jnci/djr305,,,,21849659,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/239409,https://api.altmetric.com/v1/donut/239409_240.png 1,XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis,Prostate Cancer and Prostatic Diseases,,,Article,2011-06-07,10.1038/pcan.2011.26,,,,21647176,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/237078,https://api.altmetric.com/v1/donut/237078_240.png 1,Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer.,Scandinavian Journal of Urology & Nephrology,,,Article,2011-08-15,10.3109/00365599.2011.604790,,,,21843041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/230403,https://api.altmetric.com/v1/donut/230403_240.png 1,Comparison of real-time elastography with grey-scale ultrasonography for detection of organ-confined prostate cancer and extra capsular extension: a prospective analysis using whole mount sections after radical prostatectomy.,BJU international,,,Article,2011-08-05,10.1111/j.1464-410x.2011.10209.x,,,,21819532,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/226314,https://api.altmetric.com/v1/donut/226314_240.png 1,Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant ?-tocotrienol,Life Sciences,,,Article,2006-01-18,10.1016/j.lfs.2005.12.005,,,,16413038,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/221597,https://api.altmetric.com/v1/donut/221597_240.png 1,IGFBP-3 Is a Metastasis Suppression Gene in Prostate Cancer,Cancer Research,,,Article,2011-06-22,10.1158/0008-5472.can-10-4513,,,,21697285,PMC3148406,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/221583,https://api.altmetric.com/v1/donut/221583_240.png 1,Macrophage Dependent Cleavage of the Laminin Receptor {alpha}6{beta}1 in Prostate Cancer.,Molecular Cancer Research,"LYNGSTAD, Anna",School of Medicine & Medical Science; Department of Life Sciences,Article,2011-08-08,10.1158/1541-7786.mcr-11-0080,,,,21824975,PMC3196809,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/219618,https://api.altmetric.com/v1/donut/219618_240.png 1,"High-intensity focused ultrasound (HIFU) in prostate cancer: a single centre experience in patients with low, intermediate or high-risk of progression.","Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia",,,Article,2010-12-01,,,,,21341574,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/215012,https://api.altmetric.com/v1/donut/215012_240.png 1,Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme,British Journal of Urology,,,Article,2011-08-01,10.1111/j.1464-410x.2010.09974.x,,,,21176083,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/207807,https://api.altmetric.com/v1/donut/207807_240.png 1,NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.,BMC cancer,,,Article,2011-08-02,10.1186/1471-2407-11-327,,,,21810217,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/204583,https://api.altmetric.com/v1/donut/204583_240.png 1,Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.,The Prostate,,,Article,2011-08-01,10.1002/pros.21466,,,,21809350,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/203496,https://api.altmetric.com/v1/donut/203496_240.png 1,siRNA Knockdown of Ribosomal Protein Gene RPL19 Abrogates the Aggressive Phenotype of Human Prostate Cancer.,PloS one,,,Article,2011-01-01,10.1371/journal.pone.0022672,,,,21799931,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/201750,https://api.altmetric.com/v1/donut/201750_240.png 1,Predictive Performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.,The Prostate,,,Article,2011-07-27,10.1002/pros.21462,,,,21796652,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/200682,https://api.altmetric.com/v1/donut/200682_240.png 1,Primary care perspectives on prostate cancer survivorship: Implications for improving quality of care.,Urologic oncology,,,Article,2011-07-18,10.1016/j.urolonc.2011.06.002,,,,21775171,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/199625,https://api.altmetric.com/v1/donut/199625_240.png 1,Atorvastatin induces autophagy in prostate cancer PC3 cells through activation of LC3 transcription.,Cancer biology & therapy,,,Article,2011-10-15,10.4161/cbt.12.8.15978,,,,21768780,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/197388,https://api.altmetric.com/v1/donut/197388_240.png 1,"A survey of green plant tRNA 3'-end processing enzyme tRNase Zs, homologs of the candidate prostate cancer susceptibility protein ELAC2",BMC Evolutionary Biology,,,Article,2011-07-23,10.1186/1471-2148-11-219,,,,21781332,PMC3161902,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/195863,https://api.altmetric.com/v1/donut/195863_240.png 1,PPAR? disease gene network and identification of therapeutic targets for prostate cancer.,Journal of Drug Targeting,,,Article,2011-07-23,10.3109/1061186x.2011.568062,,,,21780947,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/195855,https://api.altmetric.com/v1/donut/195855_240.png 1,Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells,British Journal of Urology,,,Article,2011-01-01,10.1111/j.1464-410x.2011.10437.x,,,,21771248,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/195524,https://api.altmetric.com/v1/donut/195524_240.png 1,Prioritizing candidate disease miRNAs by topological features in the miRNA-target dysregulated network: case study of prostate cancer.,Molecular cancer therapeutics,,,Article,2011-07-18,10.1158/1535-7163.mct-11-0055,,,,21768329,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/195355,https://api.altmetric.com/v1/donut/195355_240.png 1,miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression.,International journal of oncology,,,Article,2011-07-18,10.3892/ijo.2011.1128,,,,21769427,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/194943,https://api.altmetric.com/v1/donut/194943_240.png 1,URORECTAL FISTULAE FOLLOWING THE TREATMENT OF PROSTATE CANCER,British Journal of Urology,,,Article,2011-08-01,10.1111/j.1464-410x.2011.10299_1.x,,,,21771235,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/194616,https://api.altmetric.com/v1/donut/194616_240.png 1,EXTENDING THE INDICATIONS AND ANATOMICAL LIMITS OF PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: IMPROVED STAGING OR INCREASED MORBIDITY?,British Journal of Urology,,,Article,2011-08-01,10.1111/j.1464-410x.2011.10497.x,,,,21771243,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/194615,https://api.altmetric.com/v1/donut/194615_240.png 1,Insulin increases de novo steroidogenesis in prostate cancer cells,Cancer Research,,,Article,2011-07-11,10.1158/0008-5472.can-10-2470,,,,21747118,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/188944,https://api.altmetric.com/v1/donut/188944_240.png 1,"Prostate cancer: XMRV-contaminant, not cause?",Nature reviews. Urology,,,Article,2011-07-12,10.1038/nrurol.2011.101,,,,21750499,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/188170,https://api.altmetric.com/v1/donut/188170_240.png 1,Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice.,The Prostate,,,Article,2011-07-11,10.1002/pros.21455,,,,21748757,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/187530,https://api.altmetric.com/v1/donut/187530_240.png 1,Influence of Genistein Isoflavone on Matrix Metalloproteinase-2 Expression in Prostate Cancer Cells,Journal of Medicinal Food,,,Article,2006-12-01,10.1089/jmf.2006.9.491,,,,17201635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/187462,https://api.altmetric.com/v1/donut/187462_240.png 1,"XMRV, prostate cancer and chronic fatigue syndrome.",British Medical Bulletin,,,Article,2011-01-01,10.1093/bmb/ldr010,,,,21551158,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/186152,https://api.altmetric.com/v1/donut/186152_240.png 1,Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact.,Oncotarget,,,Article,2011-05-01,10.18632/oncotarget.287,,,,21642749,PMC3248192,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/185929,https://api.altmetric.com/v1/donut/185929_240.png 1,MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.,Carcinogenesis,,,Article,2011-05-01,10.1093/carcin/bgr036,,,,21349819,PMC3086703,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/183198,https://api.altmetric.com/v1/donut/183198_240.png 1,Global risk transformative prioritization for prostate cancer candidate genes in molecular networks,Molecular BioSystems,,,Article,2011-07-07,10.1039/c1mb05134b,,,,21735017,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/183126,https://api.altmetric.com/v1/donut/183126_240.png 1,"Seeking Mind, Body and Spirit Healing—Why Some Men with Prostate Cancer Choose CAM (Complementary and Alternative Medicine) over Conventional Cancer Treatments",Integrative Medicine Insights,,,Article,2011-07-07,,,,,21614154,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/181463,https://api.altmetric.com/v1/donut/181463_240.png 1,North American cranberry (Vaccinium macrocarpon) stimulates apoptotic pathways in DU145 human prostate cancer cells in vitro.,Nutrition and cancer,,,Article,2011-01-01,10.1080/01635581.2010.516876,,,,21161819,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/180917,https://api.altmetric.com/v1/donut/180917_240.png 1,Epigenetics in Prostate Cancer: Biologic and Clinical Relevance.,European Urology,,,Article,2011-06-22,10.1016/j.eururo.2011.06.035,,,,21719191,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,100,https://www.altmetric.com/details/179184,https://api.altmetric.com/v1/donut/179184_240.png 1,Induction of Immune Mediators in Glioma and Prostate Cancer Cells by Non-Lethal Photodynamic Therapy,"",,,Article,2011-06-30,10.1371/journal.pone.0021834,,,,21738796,,,2011PLoSO...6E1834K,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/178150,https://api.altmetric.com/v1/donut/178150_240.png 1,Optimal Duration of Androgen Deprivation in Combination with Radiation Therapy for Japanese Men with High-Risk Prostate Cancer.,Urologia Internationalis,,,Article,2011-06-23,10.1159/000324478,,,,21701133,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/174616,https://api.altmetric.com/v1/donut/174616_240.png 1,Green Tea Extract (Epigallocatechin-3-Gallate) Reduces Efficacy of Radiotherapy on Prostate Cancer Cells.,Urology,,,Article,2011-06-13,10.1016/j.urology.2011.03.031,,,,21676444,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/174016,https://api.altmetric.com/v1/donut/174016_240.png 1,Aberrant expression of katanin p60 in prostate cancer bone metastasis.,The Prostate,,,Article,2011-06-16,10.1002/pros.21431,,,,21681775,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/168546,https://api.altmetric.com/v1/donut/168546_240.png 1,Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts.,Biomaterials,,,Article,2011-09-01,10.1016/j.biomaterials.2011.04.070,,,,21612822,PMC3110559,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/103687,https://api.altmetric.com/v1/donut/103687_240.png 1,Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population,Scientific Reports,,,Article,2016-11-03,10.1038/srep36264,,,,27808252,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13343165,https://api.altmetric.com/v1/donut/13343165_240.png 1,Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2002-05-28,10.1073/pnas.102014399,,,,12032296,PMC124244,,2002PNAS...99.7408Z,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13315568,https://api.altmetric.com/v1/donut/13315568_240.png 1,Prostate Cancer: Is It a Battle Lost to Age?,Geriatrics,,,Article,2016-11-03,10.3390/geriatrics1040027,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13306758,https://api.altmetric.com/v1/donut/13306758_240.png 1,Association between serum 25(OH)D and death from prostate cancer,British Journal of Cancer,,,Article,2009-02-10,10.1038/sj.bjc.6604865,,,,19156140,PMC2658536,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13277924,https://api.altmetric.com/v1/donut/13277924_240.png 1,Molecular signature to risk-stratify prostate cancer of intermediate risk,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-2400,,,,27803045,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13277735,https://api.altmetric.com/v1/donut/13277735_240.png 1,Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study,The Journal of Urology,,,Article,2016-11-05,10.1016/j.juro.2016.10.090,,,,27810448,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13258253,https://api.altmetric.com/v1/donut/13258253_240.png 1,Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression,The Prostate,,,Article,2016-10-24,10.1002/pros.23269,,,,27775154,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13224529,https://api.altmetric.com/v1/donut/13224529_240.png 1,Structure and Function of a Prostate Cancer Dissemination Permissive Extracellular Matrix,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-1516,,,,27799248,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13206166,https://api.altmetric.com/v1/donut/13206166_240.png 1,URI Regulates KAP1 Phosphorylation and Transcriptional Repression Via PP2A Phosphatase in Prostate Cancer Cells,Journal of Biological Chemistry,,,Article,2016-10-25,10.1074/jbc.m116.741660,,,,27780869,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13182611,https://api.altmetric.com/v1/donut/13182611_240.png 1,"Prospective study of Type 2 Diabetes Mellitus, anti-diabetic drugs, and risk of prostate cancer",International Journal of Cancer,,,Article,2016-10-01,10.1002/ijc.30480,,,,27770555,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13168635,https://api.altmetric.com/v1/donut/13168635_240.png 1,Monensin Induces PC-3 Prostate Cancer Cell Apoptosis via ROS Production and Ca2+ Homeostasis Disruption.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2016-10-30,,,,,27793906,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13165408,https://api.altmetric.com/v1/donut/13165408_240.png 1,Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2016-10-24,10.1073/pnas.1615400113,,,,27791181,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13143035,https://api.altmetric.com/v1/donut/13143035_240.png 1,Fiduciels intraprostatiques dans le cadre de la radiothérapie stéréotaxique du cancer de la prostate,Cancer Radiotherapie,,,Article,2016-10-01,10.1016/j.canrad.2016.07.097,,,,27793529,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13132237,https://api.altmetric.com/v1/donut/13132237_240.png 1,Abstract 664: Amanitin-based antibody-drug conjugates targeting the prostate-specific membrane antigen,Cancer Research,,,Article,2014-10-01,10.1158/1538-7445.am2014-664,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13107219,https://api.altmetric.com/v1/donut/13107219_240.png 1,"How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer",Urologic Oncology,,,Article,2016-10-01,10.1016/j.urolonc.2016.09.007,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13090650,https://api.altmetric.com/v1/donut/13090650_240.png 1,Association of prostate volume with incidence and aggressiveness of prostate cancer,Research and Reports in Urology,,,Article,2016-10-26,10.2147/rru.s117963,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13081142,https://api.altmetric.com/v1/donut/13081142_240.png 1,LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway,Tumor Biology,,,Article,2016-10-14,10.1007/s13277-016-5429-8,,,,27743383,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13069402,https://api.altmetric.com/v1/donut/13069402_240.png 1,"PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion",Experimental Cell Research,,,Article,2016-10-01,10.1016/j.yexcr.2016.10.013,,,,27756608,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13064724,https://api.altmetric.com/v1/donut/13064724_240.png 1,Psychological Characteristics and Traits for Finding Benefit From Prostate Cancer,Cancer nursing (Online),,,Article,2016-11-01,10.1097/ncc.0000000000000323,,,http://journals.lww.com/cancernursingonline/Fulltext/2016/11000/Psychological_Characteristics_and_Traits_for.4.aspx,26632882,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13049496,https://api.altmetric.com/v1/donut/13049496_240.png 1,Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathway,Cancer Medicine,,,Article,2016-10-11,10.1002/cam4.916,,,,27726305,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12965247,https://api.altmetric.com/v1/donut/12965247_240.png 1,Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075,Molecular Cancer Research,,,Article,2016-01-01,10.1158/1541-7786.mcr-16-0221,,,,27707886,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12956772,https://api.altmetric.com/v1/donut/12956772_240.png 1,The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome,The Prostate,,,Article,2016-10-08,10.1002/pros.23259,,,,27718274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12951909,https://api.altmetric.com/v1/donut/12951909_240.png 1,6 -Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells,Molecular Cancer Therapeutics,,,Article,2016-01-01,10.1158/1535-7163.mct-16-0325,,,,27760837,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12942351,https://api.altmetric.com/v1/donut/12942351_240.png 1,Differential requirements for ?-catenin in murine prostate cancer originating from basal versus luminal cells,The Journal of Pathology,,,Article,2015-04-08,10.1002/path.4521,,,,25712462,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12816802,https://api.altmetric.com/v1/donut/12816802_240.png 1,Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients,Physics in Medicine & Biology,,,Article,2015-11-18,10.1088/0031-9155/60/24/9329,,,,26581022,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12767828,https://api.altmetric.com/v1/donut/12767828_240.png 1,Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness,Physics in Medicine & Biology,,,Article,2015-03-13,10.1088/0031-9155/60/7/2685,,,,25768265,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12755650,https://api.altmetric.com/v1/donut/12755650_240.png 1,HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer,Oncotarget,,,Article,2015-11-07,10.18632/oncotarget.12543,,,,27732966,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12721120,https://api.altmetric.com/v1/donut/12721120_240.png 1,Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer,Expert Review of Molecular Diagnostics,,,Article,2016-10-14,10.1080/14737159.2016.1243057,,,,27679869,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12691916,https://api.altmetric.com/v1/donut/12691916_240.png 1,Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer,Urologic Oncology,,,Article,2016-10-22,10.1016/j.urolonc.2016.07.005,,,,27765518,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12690094,https://api.altmetric.com/v1/donut/12690094_240.png 1,The comparison of 5-field conformal radiotherapy techniques for the treatment of prostate cancer: The best for femoral head sparing,Medical Dosimetry,,,Article,2016-09-01,10.1016/j.meddos.2016.06.008,,,,27623735,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12627684,https://api.altmetric.com/v1/donut/12627684_240.png 1,Abstract 1760: Saturated fat intake and prostate cancer aggressiveness: Results from the population-based North Carolina-Louisiana prostate cancer project,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1760,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12608844,https://api.altmetric.com/v1/donut/12608844_240.png 1,Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies,Translational Oncology,,,Article,2016-08-01,10.1016/j.tranon.2016.05.004,,,,27567960,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/12565977,https://api.altmetric.com/v1/donut/12565977_240.png 1,"What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer.",Journal of Nuclear Medicine,,,Article,2016-10-01,10.2967/jnumed.115.170142,,,,27694176,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12538853,https://api.altmetric.com/v1/donut/12538853_240.png 1,Dietary supplements and prostate cancer prevention,Trends in Urology & Men's Health,,,Article,2016-01-26,10.1002/tre.500,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12522149,https://api.altmetric.com/v1/donut/12522149_240.png 1,Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low Risk Prostate Cancer,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-1454,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12495415,https://api.altmetric.com/v1/donut/12495415_240.png 1,Outcomes after adjuvant radiation therapy for prostate cancer at a comprehensive cancer center,Journal of Radiation Oncology,,,Article,2016-04-26,10.1007/s13566-016-0248-5,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12494045,https://api.altmetric.com/v1/donut/12494045_240.png 1,Lesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with PIRADS score,British Journal of Urology,,,Article,2016-10-04,10.1111/bju.13649,,,,27608292,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12418017,https://api.altmetric.com/v1/donut/12418017_240.png 1,CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis,PLoS ONE,,,Article,2016-09-29,10.1371/journal.pone.0163678,,,,27684938,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12380538,https://api.altmetric.com/v1/donut/12380538_240.png 1,Regulation of PCGEM1 by p54/nrb in prostate cancer,Scientific Reports,,,Article,2016-09-29,10.1038/srep34529,,,,27682980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12374699,https://api.altmetric.com/v1/donut/12374699_240.png 1, 3 1 Integrin suppresses prostate cancer metastasis via regulation of the Hippo pathway,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-1483,,,,27680681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12369778,https://api.altmetric.com/v1/donut/12369778_240.png 1,Socioeconomic determinants of prostate-specific antigen testing and estimation of the prevalence of undiagnosed prostate cancer in an elderly Polish population based on the PolSenior study,Archives of Medical Science,,,Article,2016-01-01,10.5114/aoms.2015.55271,,,,27695494,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12367304,https://api.altmetric.com/v1/donut/12367304_240.png 1,Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional QoLiTime study,British Journal of Urology,,,Article,2016-09-30,10.1111/bju.13658,,,,27618249,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12309430,https://api.altmetric.com/v1/donut/12309430_240.png 1,Molecular imaging and prostate cancer: unmet clinical needs and future perspectives,Clinical and Translational Imaging,,,Article,2016-09-29,10.1007/s40336-016-0210-y,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12307676,https://api.altmetric.com/v1/donut/12307676_240.png 1,Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin,Radiotherapy & Oncology,,,Article,2016-08-01,10.1016/j.radonc.2016.07.018,,,,27576431,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/12306805,https://api.altmetric.com/v1/donut/12306805_240.png 1,Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancer,Expert Review of Molecular Diagnostics,,,Article,2016-09-28,10.1080/14737159.2016.1240031,,,,27665838,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12270356,https://api.altmetric.com/v1/donut/12270356_240.png 1,Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide,International Journal of Pharmaceutics,,,Article,2016-11-01,10.1016/j.ijpharm.2016.09.039,,,,27633281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12270198,https://api.altmetric.com/v1/donut/12270198_240.png 1,227: Prognostic Significance of Tonsl Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33626-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12233772,https://api.altmetric.com/v1/donut/12233772_240.png 1,Dietary habits and prostate cancer detection: a case-control study.,Canadian Urological Association Journal,,,Article,2008-10-01,,,,,18953447,PMC2572247,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/12226215,https://api.altmetric.com/v1/donut/12226215_240.png 1,Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer,Urologic Oncology,,,Article,2016-09-01,10.1016/j.urolonc.2016.07.004,,,,27665357,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12223944,https://api.altmetric.com/v1/donut/12223944_240.png 1,A New Oxopiperazin?Based Peptidomimetic Molecule Inhibits Prostatic Acid Phosphatase Secretion and Induces Prostate Cancer Cell Apoptosis,CHEMISTRYSELECT,,,Article,2016-09-26,10.1002/slct.201600987,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12220214,https://api.altmetric.com/v1/donut/12220214_240.png 1,Intracellular calcium oscillations in strongly metastatic human breast and prostate cancer cells: control by voltage-gated sodium channel activity,European Biophysics Journal,,,Article,2016-09-24,10.1007/s00249-016-1170-x,,,,27665102,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12216967,https://api.altmetric.com/v1/donut/12216967_240.png 1,No man’s land: information needs and resources of men with metastatic castrate resistant prostate cancer,Supportive Care in Cancer,,,Article,2016-07-28,10.1007/s00520-016-3358-0,,,,27470260,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/12214869,https://api.altmetric.com/v1/donut/12214869_240.png 1,"51: Preventive Effect of Malva on Urinary Toxicity after Radiation Therapy in Prostate Cancer Patients: A Multicentric, Double-Blind, Randomized Clinical Trial",Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33450-8,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12214582,https://api.altmetric.com/v1/donut/12214582_240.png 1,53: Acute and Late Toxicity in High-Risk Prostate Cancer Patients Treated with Androgen Suppression and Hypofractionated Radiotherapy (Hyport) to the Prostate and Pelvic Nodes,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33452-1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12214578,https://api.altmetric.com/v1/donut/12214578_240.png 1,52: Correlation of Multiparametric MRI (MPMRI) with PSA in Assessment of Response to Combined HDR Prostate Brachytherapy and External Beam Radiotherapy for Upper Tier Intermediate and High-Risk Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33451-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12214577,https://api.altmetric.com/v1/donut/12214577_240.png 1,"DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis",Neoplasia,,,Article,2016-09-01,10.1016/j.neo.2016.07.007,,,,27659015,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/12189820,https://api.altmetric.com/v1/donut/12189820_240.png 1,41: Evaluation of an Automated Deformable Registration Algorithm for MRI-Guided Focal Boost Integrated with Ultrasound-Based High Dose-Rate Brachytherapy in the Treatment of Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33440-5,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12182538,https://api.altmetric.com/v1/donut/12182538_240.png 1,Early Post-Operative Radiotherapy is Associated with Worse Functional Outcomes in Prostate Cancer Patients,The Journal of Urology,,,Article,2016-09-28,10.1016/j.juro.2016.09.079,,,,27670915,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12181392,https://api.altmetric.com/v1/donut/12181392_240.png 1,Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer,Oncotarget,,,Article,2015-11-09,10.18632/oncotarget.6075,,,,26462181,PMC4741960,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12167938,https://api.altmetric.com/v1/donut/12167938_240.png 1,[Personalized medicine and prostate cancer. The reality of change].,Archivos Españoles de Urología,,,Article,,,,,,25948808,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12155593,https://api.altmetric.com/v1/donut/12155593_240.png 1,The use of 68 Ga?PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer,British Journal of Urology,,,Article,2016-09-23,10.1111/bju.13616,,,,27659411,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12152281,https://api.altmetric.com/v1/donut/12152281_240.png 1,Chemotherapy in frail elderly patients with metastatic castration-resistant prostate cancer?,Urologic Oncology,,,Article,2016-09-01,10.1016/j.urolonc.2016.08.009,,,,27665359,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12140446,https://api.altmetric.com/v1/donut/12140446_240.png 1,Long term outcome of high dose rate (HDR) brachytherapy for intermediate and high risk prostate cancer with a median follow up of 10 years,British Journal of Urology,,,Article,2016-09-01,10.1111/bju.13659,,,,27628127,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12139384,https://api.altmetric.com/v1/donut/12139384_240.png 1,"miR-15/miR-16 loss, miR-21 upregulation, or deregulation of their target genes predicts poor prognosis in prostate cancer patients",Podopost,,,Article,2016-07-01,10.1080/23723556.2015.1109744,,,,27652312,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12134132,https://api.altmetric.com/v1/donut/12134132_240.png 1,46: Factors Affecting Access to Radiotherapy Following Prostatectomy for Prostate Cancer Patients in Ontario in a Contemporary Cohort,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33445-4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12131390,https://api.altmetric.com/v1/donut/12131390_240.png 1,Radiology Data from The Cancer Genome Atlas Prostate Adenocarcinoma [TCGA-PRAD] collection,,,,Article,2016-01-01,10.7937/k9/tcia.2016.yxoglm4y,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12131138,https://api.altmetric.com/v1/donut/12131138_240.png 1,"Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2016-09-19,10.1200/jco.2016.69.7748,,,,27646950,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12127538,https://api.altmetric.com/v1/donut/12127538_240.png 1,Polysaccharides from Polygonatum Inhibit the Proliferation of Prostate Cancer-Associated Fibroblasts.,Asian Pacific Journal of Cancer Prevention,,,Article,2016-09-21,,,,,27644624,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12117140,https://api.altmetric.com/v1/donut/12117140_240.png 1,71: Low-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer: A Dose-Response Analysis for 3392 Consecutive 125-Iodine Monotherapy Patients,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33470-3,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12114239,https://api.altmetric.com/v1/donut/12114239_240.png 1,Corrigendum re: “Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial” [Eur Urol 2016;70:566–73],European Urology,,,Article,2016-09-01,10.1016/j.eururo.2016.09.014,,,,27663047,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12112537,https://api.altmetric.com/v1/donut/12112537_240.png 1,The Role of Palliative Surgery in Castration-Resistant Prostate Cancer,Oncology research and treatment,,,Article,2015-11-23,10.1159/000442268,,,,26632812,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12098412,https://api.altmetric.com/v1/donut/12098412_240.png 1,"All care, but whose responsibility? Community juries reason about expert and patient responsibilities in prostate-specific antigen screening for prostate cancer",Health (1949-4998),,,Article,2016-08-03,10.1177/1363459316660862,,,,27491944,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12087483,https://api.altmetric.com/v1/donut/12087483_240.png 1,"68: Intermediate-Risk Prostate Cancer, Androgen Deprivation Therapy and the Risk of Death",Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33467-3,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12081175,https://api.altmetric.com/v1/donut/12081175_240.png 1,39: Long-Term Outcomes of a Phase II Trial of Moderate Hypofractionated Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) for Localized Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33438-7,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12069111,https://api.altmetric.com/v1/donut/12069111_240.png 1,Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer,Oncotarget,,,Article,2016-09-15,10.18632/oncotarget.12031,,,,27634912,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12065242,https://api.altmetric.com/v1/donut/12065242_240.png 1,Estimating bias in causes of death ascertainment in the Finnish Randomized Study of Screening for Prostate Cancer,Cancer Epidemiology,,,Article,2016-12-01,10.1016/j.canep.2016.08.022,,,,27636505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12059796,https://api.altmetric.com/v1/donut/12059796_240.png 1,72: Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer - Early Report from a Prospective Study,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33471-5,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12052372,https://api.altmetric.com/v1/donut/12052372_240.png 1,A Prostate Cancer Care Process Example of Using Data from Internet of Things,"2015 IEEE International Conference on Computer and Information Technology; Ubiquitous Computing and Communications; Dependable, Autonomic and Secure Computing; Pervasive Intelligence and Computing",,,Article,2015-10-01,10.1109/cit/iucc/dasc/picom.2015.340,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12042026,https://api.altmetric.com/v1/donut/12042026_240.png 1,The Utility of Serum CA9 for Prognostication in Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2016-09-16,,,,,27630286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12039908,https://api.altmetric.com/v1/donut/12039908_240.png 1,"Reply from Authors re: Emmanuel S. Antonarakis, Howard I. Scher. Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.08.038 Unsplicing a Conflict",European Urology,,,Article,2016-09-20,10.1016/j.eururo.2016.08.071,,,,27641787,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12030413,https://api.altmetric.com/v1/donut/12030413_240.png 1,"MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer",Scientific Reports,,,Article,2016-09-14,10.1038/srep33153,,,,27624283,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12012996,https://api.altmetric.com/v1/donut/12012996_240.png 1,Proton therapy for early stage prostate cancer: is there a case?,OncoTargets and therapy,,,Article,2016-09-09,10.2147/ott.s108559,,,,27672328,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12002630,https://api.altmetric.com/v1/donut/12002630_240.png 1,"Long-term health care costs for patients with prostate cancer: A population-wide longitudinal study in New South Wales, Australia.",Asia Pacific Journal of Clinical Oncology,,,Article,2016-09-14,10.1111/ajco.12582,,,,27619777,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11990366,https://api.altmetric.com/v1/donut/11990366_240.png 1,DNA-Repair Gene Mutations in Metastatic Prostate Cancer: Critical Reading,,,,Article,2016-09-25,10.13140/rg.2.2.22014.38727,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11977365,https://api.altmetric.com/v1/donut/11977365_240.png 1,Effects of Serum Triglycerides on Prostate Cancer and Breast Cancer Risk: A Meta-Analysis of Prospective Studies,Nutrition and Cancer,,,Article,2016-08-11,10.1080/01635581.2016.1206582,,,,27618148,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11974277,https://api.altmetric.com/v1/donut/11974277_240.png 1,RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3,Cancer Research,,,Article,2016-01-01,10.1158/0008-5472.can-16-0440,,,,27634756,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11970365,https://api.altmetric.com/v1/donut/11970365_240.png 1,Transcultural Adaptation and Validation of Champion's Health Belief Model Scales for Prostate Cancer Screening,Journal of nursing measurement,,,Article,2016-08-01,10.1891/1061-3749.24.2.296,,,,27535316,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11966445,https://api.altmetric.com/v1/donut/11966445_240.png 1,4: Patterns of Care Among Canadian Radiation Oncologists and Urologists Related to Post-Operative Radiotherapy for Patients with Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33403-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11955720,https://api.altmetric.com/v1/donut/11955720_240.png 1,Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer,Ecancermedicalscience,,,Article,2016-01-01,10.3332/ecancer.2016.671,,,,27610197,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11953112,https://api.altmetric.com/v1/donut/11953112_240.png 1,32: Multicentre Canadian Experience using Intraoperative Prostate Brachytherapy for Treatment of Low and Intermediate-Risk Prostate Cancer; an Evaluation of Long-Term Biochemical Relapse-Free Survival Outcomes,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33431-4,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11944371,https://api.altmetric.com/v1/donut/11944371_240.png 1,Psychosocial Screening for Patients with Prostate Cancer: the Development and Validation of the Psychosocial Distress Questionnaire-Prostate Cancer (PDQ-PC).,Journal of Psychosocial Oncology,,,Article,2016-09-10,10.1080/07347332.2016.1233925,,,,27610695,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11933534,https://api.altmetric.com/v1/donut/11933534_240.png 1,35: A Multicentre Mixed-Methods Evaluation of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) as a Patient-Reported Assessment Tool in Men with Early-Stage Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33434-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11929937,https://api.altmetric.com/v1/donut/11929937_240.png 1,PSMA PET and Radionuclide Therapy in Prostate Cancer ,Seminars in Nuclear Medicine,,,Article,,10.1053/j.semnuclmed.2016.07.006,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11917342,https://api.altmetric.com/v1/donut/11917342_240.png 1,Reconfiguring the AR-TIF2 Protein–Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen,Assay and Drug Development Technologies,,,Article,2016-09-08,10.1089/adt.2016.741,,,,27606620,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11915372,https://api.altmetric.com/v1/donut/11915372_240.png 1,Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years,Journal of Cranio-Maxillofacial Surgery,,,Article,2016-08-01,10.1016/j.jcms.2016.07.026,,,,27555374,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11907037,https://api.altmetric.com/v1/donut/11907037_240.png 1,Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells.,International Journal of Radiation Biology,,,Article,2016-09-08,10.1080/09553002.2017.1231946,,,,27600766,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11895081,https://api.altmetric.com/v1/donut/11895081_240.png 1,PSA flare phenomenon induced by Abiraterone Acetate in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer,Clinical Genitourinary Cancer,,,Article,2016-08-01,10.1016/j.clgc.2016.07.026,,,,27601278,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11894715,https://api.altmetric.com/v1/donut/11894715_240.png 1,78: CARO Fellowship Serum Exosomal Micrornas (MIRNAS) as Non-Invasive Biomarkers to Guide Post-Operative Radiotherapy in Prostate Cancer (PCA) Patients Treated with Radical Prostatectomy (RP),Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33477-6,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11890793,https://api.altmetric.com/v1/donut/11890793_240.png 1,Synthesis of novel C2-symmetric testosterone dimers and evaluation of antiproliferative activity on androgen-dependent and -independent prostate cancer cell lines,Steroids,,,Article,2016-11-01,10.1016/j.steroids.2016.08.012,,,,27553724,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11887379,https://api.altmetric.com/v1/donut/11887379_240.png 1,25: CARO Fellowship the Biological Role and Clinical Significance of Long Non-Coding RNA Urothelial Carcinoma Associated 1 (UCA1) in Prostate Cancer (PCA),Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33424-7,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11873397,https://api.altmetric.com/v1/donut/11873397_240.png 1,Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer,Clinical Nuclear Medicine,,,Article,2016-09-01,10.1097/rlu.0000000000001273,,,http://journals.lww.com/nuclearmed/Fulltext/2016/09000/Intrapatient_Comparison_of_111In_PSMA_I_T_SPECT_CT.34.aspx,27276206,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11737466,https://api.altmetric.com/v1/donut/11737466_240.png 1,Targeting CDK9: a promising therapeutic opportunity in prostate cancer,Endocrine-Related Cancer,,,Article,2016-08-31,10.1530/erc-16-0299,,,,27582311,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11720533,https://api.altmetric.com/v1/donut/11720533_240.png 1,139: What are Prostate Cancer Patients’ Preferences for Information and Decision support? A Systematic Survey of Patients Diagnosed in Each of Three Provinces,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33538-1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11717101,https://api.altmetric.com/v1/donut/11717101_240.png 1,138: Low Baseline Testosterone is a Prognostic Factor in Radiotherapy for Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33537-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11717100,https://api.altmetric.com/v1/donut/11717100_240.png 1,Predictors of response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617,Journal of Nuclear Medicine,,,Article,2016-09-01,10.2967/jnumed.116.178228,,,,27587707,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11716626,https://api.altmetric.com/v1/donut/11716626_240.png 1,Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective,Expert Review of Anticancer Therapy,,,Article,2016-08-26,10.1080/14737140.2016.1226137,,,,27534689,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11710074,https://api.altmetric.com/v1/donut/11710074_240.png 1,Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT,Journal of Magnetic Resonance Imaging,,,Article,2016-09-01,10.1002/jmri.25384,,,,27586519,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11701296,https://api.altmetric.com/v1/donut/11701296_240.png 1,Characterization of Prostate Cancer in a Functional Eunuch.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2016-09-01,,,,,27587619,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11679179,https://api.altmetric.com/v1/donut/11679179_240.png 1,MicroRNAs and epithelial-mesenchymal transition in prostate cancer.,Oncotarget,,,Article,2016-09-03,10.18632/oncotarget.11708,,,,27588490,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11678714,https://api.altmetric.com/v1/donut/11678714_240.png 1,Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells,Oncology Letters,,,Article,2016-09-01,10.3892/ol.2016.4880,,,,27588130,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11674621,https://api.altmetric.com/v1/donut/11674621_240.png 1,ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3?/?-catenin signaling pathway,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11699,,,,27588482,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11674125,https://api.altmetric.com/v1/donut/11674125_240.png 1,Epidemiology of Prostate and Testicular Cancer,Seminars in Interventional Radiology,,,Article,2016-09-01,10.1055/s-0036-1586146,,,,27582605,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11002366,https://api.altmetric.com/v1/donut/11002366_240.png 1,Metabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate Cancer,Scientific Reports,,,Article,2016-08-31,10.1038/srep32272,,,,27578275,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10993998,https://api.altmetric.com/v1/donut/10993998_240.png 1,Influence of adipocytokines in periprostatic adipose tissue on prostate cancer aggressiveness,Cytokine,,,Article,2016-09-01,10.1016/j.cyto.2016.06.019,,,,27371773,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10961215,https://api.altmetric.com/v1/donut/10961215_240.png 1,Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen deprivation therapy,British Journal of Urology,,,Article,2016-02-01,10.1111/bju.13455,,,,26919403,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10960243,https://api.altmetric.com/v1/donut/10960243_240.png 1,144: Evaluation of Milk of Magnesia to Reduce Variation in Rectal Filling in Image Guided Volumetric Modulated Arch Therapy of Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33543-5,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10958708,https://api.altmetric.com/v1/donut/10958708_240.png 1,140: Indentification of Curculating MIRNA Associated with Development of Castrate Resistance in High-Risk and Biochemically Recurrent Prostate Cancer Patients,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33539-3,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10958707,https://api.altmetric.com/v1/donut/10958707_240.png 1,141: Validation of a French Canadian Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC),Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33540-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10958703,https://api.altmetric.com/v1/donut/10958703_240.png 1,90: Combined Salicylate (SAL) - Metformin (MET) Treatment Induces Increased Tumour Suppression and Radiosensitization in Preclinical Models of Prostate Cancer (PRCA),Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33489-2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10919175,https://api.altmetric.com/v1/donut/10919175_240.png 1,Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer,British Journal of Urology,,,Article,2016-08-01,10.1111/bju.13631,,,,27539393,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10912669,https://api.altmetric.com/v1/donut/10912669_240.png 1,"Suppression of met expression: a possible cancer treatment. Commentary re: S. J. Kim et al., reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Clin. Cancer Res., 14: 5161-5170, 2003.",Clinical Cancer Research,,,Article,2003-11-01,,,,,14613985,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10910826,https://api.altmetric.com/v1/donut/10910826_240.png 1,Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway,Experimental Cell Research,,,Article,2016-08-01,10.1016/j.yexcr.2016.08.019,,,,27569004,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10910390,https://api.altmetric.com/v1/donut/10910390_240.png 1,Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT,Strahlentherapie und Onkologie,,,Article,2016-01-07,10.1007/s00066-015-0935-y,,,,26742732,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10909209,https://api.altmetric.com/v1/donut/10909209_240.png 1,SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.,Gene,,,Article,2016-08-30,10.1016/j.gene.2016.08.030,,,,27570179,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10905639,https://api.altmetric.com/v1/donut/10905639_240.png 1,82: Planned Versus ‘Delivered’ Bladder Dose Reconstructed using Solid and Hollow Organ Models During Prostate Cancer IMRT,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33481-8,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10899923,https://api.altmetric.com/v1/donut/10899923_240.png 1,"Abstract 1755: Weight change, prostate cancer-specific mortality, and biochemical recurrence in a prospective cohort study of U.S. men",Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1755,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10896892,https://api.altmetric.com/v1/donut/10896892_240.png 1,Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial- mesenchymal- transition in prostate cancer cell.,Oncotarget,,,Article,2016-08-28,10.18632/oncotarget.11549,,,,27566588,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10873879,https://api.altmetric.com/v1/donut/10873879_240.png 1,98: Concomitant Hypofractionated Imrt Boost for Localized High-Risk Prostate Cancer: Five Year Results of a Prospective Trial,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33497-1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10870802,https://api.altmetric.com/v1/donut/10870802_240.png 1,MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer,Cellular Physiology & Biochemistry,,,Article,2016-08-26,10.1159/000447819,,,,27562849,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10867013,https://api.altmetric.com/v1/donut/10867013_240.png 1,Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-08-24,10.1007/s00259-016-3490-6,,,,27557844,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10847005,https://api.altmetric.com/v1/donut/10847005_240.png 1,The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition,Biochemical & Biophysical Research Communications,,,Article,2016-08-01,10.1016/j.bbrc.2016.08.120,,,,27558961,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10843304,https://api.altmetric.com/v1/donut/10843304_240.png 1,Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer,Seminars in Nuclear Medicine,,,Article,2016-09-01,10.1053/j.semnuclmed.2016.04.004,,,,27553466,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/10843259,https://api.altmetric.com/v1/donut/10843259_240.png 1,Cholesterol and prostate cancer risk: a long-term prospective cohort study,BMC Cancer,,,Article,2016-08-17,10.1186/s12885-016-2691-5,,,,27535659,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10841175,https://api.altmetric.com/v1/donut/10841175_240.png 1,106: Biochemical Control Rates and Toxicity of 3 Regimens of HDR Brachytherapy Boost for Localized Prostate Cancer,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33505-8,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10837495,https://api.altmetric.com/v1/donut/10837495_240.png 1,Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11404,,,,27557496,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10815267,https://api.altmetric.com/v1/donut/10815267_240.png 1,Abstract 2674: High fat diet accelerates MYC-driven prostate cancer through metabolic and epigenomic rewiring,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-2674,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10786160,https://api.altmetric.com/v1/donut/10786160_240.png 1,Abstract 1776: Aspirin use among African American men reduces prostate cancer risk: Findings from the NCI-Maryland Prostate Cancer Case-Control study,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1776,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10785277,https://api.altmetric.com/v1/donut/10785277_240.png 1,Abstract 5208: Trends in fatal prostate cancer incidence by race among US men,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-5208,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10782083,https://api.altmetric.com/v1/donut/10782083_240.png 1,116: Fighting Prostate Cancer with our Eyes Open: Impact of MRI Staging on Risk Assessment and Radiation Therapy,Radiotherapy & Oncology,,,Article,2016-09-01,10.1016/s0167-8140(16)33515-0,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10764231,https://api.altmetric.com/v1/donut/10764231_240.png 1,Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer,Oncology (08909091),,,Article,2016-08-20,10.1159/000448219,,,,27544669,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10749684,https://api.altmetric.com/v1/donut/10749684_240.png 1,Big Data Equals Big Challenges for Prostate Cancer.,Canadian Journal of Urology,,,Article,2016-08-22,,,,,27544553,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10746013,https://api.altmetric.com/v1/donut/10746013_240.png 1,Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11326,,,,27542219,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10726704,https://api.altmetric.com/v1/donut/10726704_240.png 1,Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.11301,,,,27542265,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10724469,https://api.altmetric.com/v1/donut/10724469_240.png 1,Engineering chemically modified viruses for prostate cancer cell recognition,Molecular BioSystems,,,Article,2015-01-01,10.1039/c5mb00511f,,,,26463253,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10723475,https://api.altmetric.com/v1/donut/10723475_240.png 1,Value of Endorectal MRI in Romanian Men for High Risk of Prostate Cancer: MRI Findings Compared with Saturation Biopsy.,Chirurgia,,,Article,2015-05-01,,,,,26158736,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10699821,https://api.altmetric.com/v1/donut/10699821_240.png 1," Silibinin inhibits hypoxia-induced HIF-1?-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics ",Molecular Carcinogenesis,,,Article,2016-08-01,10.1002/mc.22537,,,,27533043,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10675774,https://api.altmetric.com/v1/donut/10675774_240.png 1,MicroRNA-132/212 Upregulation Inhibits TGF-?-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4,The Prostate,,,Article,2016-08-16,10.1002/pros.23241,,,,27527117,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10662172,https://api.altmetric.com/v1/donut/10662172_240.png 1,Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo-Adjuvant Hormonal Therapy in Prostate Cancer Patients,The Prostate,,,Article,2016-08-16,10.1002/pros.23244,,,,27527525,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10651428,https://api.altmetric.com/v1/donut/10651428_240.png 1,Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells,Asian Journal of Surgery,,,Article,2016-08-01,10.1016/j.asjsur.2016.07.001,,,,27519795,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10568948,https://api.altmetric.com/v1/donut/10568948_240.png 1,Dual modality imaging of prostate cancer with a fluorescent and radiogallium-labeled GRP receptor antagonist,Journal of Nuclear Medicine,,,Article,2016-08-11,10.2967/jnumed.116.176099,,,,27516447,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10561961,https://api.altmetric.com/v1/donut/10561961_240.png 1,Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer,Biomedicine & Pharmacotherapy,,,Article,2016-10-01,10.1016/j.biopha.2016.08.013,,,,27522256,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10549586,https://api.altmetric.com/v1/donut/10549586_240.png 1,Roles of MicroRNA21 and MicroRNA29a in Regulating Cell Adhesion Related Genes in Bone Metastasis Secondary to Prostate Cancer.,Asian Pacific Journal of Cancer Prevention,,,Article,2016-08-13,,,,,27509989,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10473677,https://api.altmetric.com/v1/donut/10473677_240.png 1,Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial,Radiotherapy & Oncology,,,Article,2016-08-12,10.1016/j.radonc.2016.07.021,,,,27528117,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10462793,https://api.altmetric.com/v1/donut/10462793_240.png 1,Prostate Cancer in Deceased Liver Donors,Transplantation Proceedings,,,Article,2016-06-01,10.1016/j.transproceed.2016.03.012,,,,27496409,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10444949,https://api.altmetric.com/v1/donut/10444949_240.png 1,A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer,Molecular BioSystems,,,Article,2016-01-01,10.1039/c6mb00359a,,,,27507663,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10426413,https://api.altmetric.com/v1/donut/10426413_240.png 1,Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4926,,,,26337470,PMC4745689,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10407646,https://api.altmetric.com/v1/donut/10407646_240.png 1,Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples,Analytica Chimica Acta,,,Article,2016-07-01,10.1016/j.aca.2016.06.043,,,,27506346,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10401856,https://api.altmetric.com/v1/donut/10401856_240.png 1,Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies,International Journal of Food Sciences & Nutrition,,,Article,2016-08-09,10.1080/09637486.2016.1216525,,,,27687296,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10375595,https://api.altmetric.com/v1/donut/10375595_240.png 1,Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis,Analytical Chemistry,,,Article,2016-08-07,10.1021/acs.analchem.6b01594,,,,27498854,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/10364474,https://api.altmetric.com/v1/donut/10364474_240.png 1,"Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs",Oncology Reports,,,Article,2016-08-02,10.3892/or.2016.4997,,,,27498716,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10354563,https://api.altmetric.com/v1/donut/10354563_240.png 1,Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine,Oncology Reports,,,Article,2016-08-03,10.3892/or.2016.5000,,,,27499010,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10353621,https://api.altmetric.com/v1/donut/10353621_240.png 1,Abstract 1775: Differential expression of exosomes-associated onco-microRNAs in African Americans with prostate cancer,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-1775,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10351968,https://api.altmetric.com/v1/donut/10351968_240.png 1,Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer,Cytokine,,,Article,2016-10-01,10.1016/j.cyto.2016.07.006,,,,27500645,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10351133,https://api.altmetric.com/v1/donut/10351133_240.png 1,Dihydrotestosterone enhances castration-resistant prostate cancer cell proliferation through STAT5 activation via glucocorticoid receptor pathway,The Prostate,,,Article,2014-07-07,10.1002/pros.22841,,,,25043756,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10343721,https://api.altmetric.com/v1/donut/10343721_240.png 1,Abstract 3098: Epigenetic therapy to target neuroendocrine prostate cancer using precision medicine models,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-3098,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10331366,https://api.altmetric.com/v1/donut/10331366_240.png 1,The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer,Expert Review of Anticancer Therapy,,,Article,2016-08-05,10.1080/14737140.2016.1218279,,,,27464256,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10308923,https://api.altmetric.com/v1/donut/10308923_240.png 1,"Abstract 36: Light exposure at night influences host/cancer circadian regulatory dynamics, Warburg effect, and human prostate cancer progression in nude rats",Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-36,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10302228,https://api.altmetric.com/v1/donut/10302228_240.png 1,68Ga-PSMA PET/MR Showing Intense PSMA Uptake in Nodular Fasciitis Mimicking Prostate Cancer Metastasis.,Clinical Nuclear Medicine,,,Article,2016-08-06,10.1097/rlu.0000000000001310,,,,27488427,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10290345,https://api.altmetric.com/v1/donut/10290345_240.png 1,The Utility of Molecular Imaging in Prostate Cancer,Current Urology Reports,,,Article,2016-02-19,10.1007/s11934-015-0573-z,,,,26894753,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/10279934,https://api.altmetric.com/v1/donut/10279934_240.png 1,Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10953,,,,27487149,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10263258,https://api.altmetric.com/v1/donut/10263258_240.png 1,mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells,Apoptosis,,,Article,2016-08-02,10.1007/s10495-016-1275-9,,,,27484210,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10262357,https://api.altmetric.com/v1/donut/10262357_240.png 1,Association of AR-V7 and prostate specific antigen RNA levels in blood with efficacy of abiraterone acetate and enzalutamide treatment in men with prostate cancer,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-1070,,,,27489290,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10255268,https://api.altmetric.com/v1/donut/10255268_240.png 1,Identification of prostate cancer biomarkers in urinary exosomes.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4851,,,,26196085,PMC4745805,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/10249717,https://api.altmetric.com/v1/donut/10249717_240.png 1,Abstract 4955: Isolation and characterization of circulating tumor cells (CTCs) in breast and prostate cancer: Comparison of Harpoon CTC assay performance with the CellSearch CTC Test,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-4955,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10207277,https://api.altmetric.com/v1/donut/10207277_240.png 1,Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms,Oncotarget,,,Article,2016-07-28,10.18632/oncotarget.10868,,,,27487134,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10202977,https://api.altmetric.com/v1/donut/10202977_240.png 1,Testosterone Therapy Among Prostate Cancer Survivors,Sexual Medicine Reviews,,,Article,2016-07-01,10.1016/j.sxmr.2016.06.005,,,,27474995,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/10193792,https://api.altmetric.com/v1/donut/10193792_240.png 1,Diagnostic Value of Systematic Biopsy Methods in the Investigation of Prostate Cancer: A Systematic Review,The Journal of Urology,,,Article,2006-05-14,10.1016/s0022-5347(05)00957-2,,,http://www.rand.org/pubs/external_publications/EP66569.html,16600713,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/10145426,https://api.altmetric.com/v1/donut/10145426_240.png 1,"Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy","Nanomedicine: Nanotechnology, Biology and Medicine",,,Article,2016-07-04,10.1016/j.nano.2016.06.010,,,,24471504,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10124267,https://api.altmetric.com/v1/donut/10124267_240.png 1,Febrile Neutropenia Rates in Men Treated with Docetaxel Chemotherapy for Metastatic Hormone-sensitive Prostate Cancer,Clinical Oncology,,,Article,2016-09-01,10.1016/j.clon.2016.06.006,,,,27342950,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10118919,https://api.altmetric.com/v1/donut/10118919_240.png 1,Abstract 140: LSAMP gene deletion is associated with rapid disease progression in prostate cancer of African American men,Cancer Research,,,Article,2016-07-15,10.1158/1538-7445.am2016-140,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10118398,https://api.altmetric.com/v1/donut/10118398_240.png 1,Molecular Profiling of Potential Human Prostate Cancer Stem Cells,Journal of Stem Cell Research & Therapy,,,Article,2011-08-11,10.4172/2157-7633.s7-001,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10117195,https://api.altmetric.com/v1/donut/10117195_240.png 1,Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-Related Events,Clinical Therapeutics,,,Article,2016-07-29,10.1016/j.clinthera.2016.06.018,,,,27478111,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10116676,https://api.altmetric.com/v1/donut/10116676_240.png 1,Concurrent Androgen and Estrogen Ablation and Inhibition of Steroid Biosynthetic Enzyme Treatment for Castration-resistant Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2016-07-29,,,,,27466486,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10113206,https://api.altmetric.com/v1/donut/10113206_240.png 1,Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10729,,,,27449098,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10111986,https://api.altmetric.com/v1/donut/10111986_240.png 1,Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1,Journal of Proteome Research,,,Article,2016-07-27,10.1021/acs.jproteome.5b01148,,,,27378148,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10075246,https://api.altmetric.com/v1/donut/10075246_240.png 1,miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10652,,,,27447749,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10016460,https://api.altmetric.com/v1/donut/10016460_240.png 1,Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP,NuclearMedicine,,,Article,2016-07-22,10.3413/nukmed-0828-16-05,,,,27443809,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10009839,https://api.altmetric.com/v1/donut/10009839_240.png 1,Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer,Molecular Medicine Reports,,,Article,2016-08-01,10.3892/mmr.2016.5414,,,,27357524,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9993070,https://api.altmetric.com/v1/donut/9993070_240.png 1,Using serological proteome analysis to identify serum anti-nucleophosmin 1 autoantibody as a potential biomarker in European-American and African-American patients with prostate cancer,The Prostate,,,Article,2016-07-01,10.1002/pros.23217,,,,27418398,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9949603,https://api.altmetric.com/v1/donut/9949603_240.png 1,A model describing diffusion in prostate cancer,Magnetic Resonance in Medicine,,,Article,2016-07-21,10.1002/mrm.26340,,,,27439379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9949305,https://api.altmetric.com/v1/donut/9949305_240.png 1,"[IDENTIFICATION OF A NEW DIAGNOSTIC MARKERS OF PROSTATIC CANCER, USING NOTI-MICROCHIPS].",Klinicheskaia khirurgiia,,,Article,2016-04-01,,,,,27434957,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9932808,https://api.altmetric.com/v1/donut/9932808_240.png 1,Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide,PLoS ONE,,,Article,2016-07-20,10.1371/journal.pone.0159675,,,,27438712,PMC4954648,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9930798,https://api.altmetric.com/v1/donut/9930798_240.png 1,11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored,PLoS ONE,,,Article,2016-07-21,10.1371/journal.pone.0159867,,,,27442248,PMC4956299,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,4,https://www.altmetric.com/details/9929166,https://api.altmetric.com/v1/donut/9929166_240.png 1,Branched chain RNA in situ hybridization for androgen receptor splice variant AR-V7 as a prognostic biomarker for metastatic castration-sensitive prostate cancer,Clinical Cancer Research,,,Article,2016-01-01,10.1158/1078-0432.ccr-16-0237,,,,27440270,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9923493,https://api.altmetric.com/v1/donut/9923493_240.png 1,Dickkopf�2�promotes proliferation and invasion via Wnt signaling in prostate cancer,Molecular Medicine Reports,,,Article,2016-07-11,10.3892/mmr.2016.5502,,,,27431620,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9913514,https://api.altmetric.com/v1/donut/9913514_240.png 1,MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer,Cancer Biomarkers,,,Article,2016-07-11,10.3233/cbm-160634,,,,27434290,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9913078,https://api.altmetric.com/v1/donut/9913078_240.png 1,Corrigendum: Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice,Frontiers in Cell and Developmental Biology,,,Article,2016-07-11,10.3389/fcell.2016.00074,,,,27583246,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9911448,https://api.altmetric.com/v1/donut/9911448_240.png 1,Gene expression profile of FVII and AR in primary prostate cancer,Cancer Biomarkers,,,Article,2016-07-11,10.3233/cbm-160647,,,,27434295,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9910976,https://api.altmetric.com/v1/donut/9910976_240.png 1,Prostate-specific antigen in clinical practice,Cancer Letters,,,Article,2007-04-27,10.1016/j.canlet.2006.12.022,,,,17258389,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/9882676,https://api.altmetric.com/v1/donut/9882676_240.png 1,From Inflammation to Prostate Cancer: The Role of Inflammasomes,Advances in Urology,,,Article,2016-01-01,10.1155/2016/3140372,,,,27429614,PMC4939357,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9870750,https://api.altmetric.com/v1/donut/9870750_240.png 1," Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo ",Drug Delivery,,,Article,2015-07-23,10.3109/10717544.2015.1069423,,,,26203689,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5,https://www.altmetric.com/details/9863084,https://api.altmetric.com/v1/donut/9863084_240.png 1,"High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde",Molecular Cancer,,,Article,2011-04-24,10.1186/1476-4598-10-46,,,,21513580,PMC3094320,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/9826813,https://api.altmetric.com/v1/donut/9826813_240.png 1,“Our people has got to come to terms with that”: Changing perceptions of the digital rectal examination as a barrier to prostate cancer diagnosis in African-Caribbean men,Psycho-Oncology,,,Article,2016-01-01,10.1002/pon.4219,,,,27423059,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9822193,https://api.altmetric.com/v1/donut/9822193_240.png 1,Proteomics in diagnosis of prostate cancer.,Contributions of Macedonian Academy of Sciences & Arts,,,Article,2015-01-01,,,,,26076772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9748744,https://api.altmetric.com/v1/donut/9748744_240.png 1,Determining intrafractional prostate motion using four dimensional ultrasound system,BMC Cancer,,,Article,2016-07-15,10.1186/s12885-016-2533-5,,,,27422044,PMC4947261,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9741984,https://api.altmetric.com/v1/donut/9741984_240.png 1,"MOR209/ES414, A Novel Bispecific Antibody Targeting PSMA For The Treatment of Metastatic Castration-Resistant Prostate Cancer",Molecular Cancer Therapeutics,,,Article,2016-07-12,10.1158/1535-7163.mct-15-0242,,,,27406985,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9720044,https://api.altmetric.com/v1/donut/9720044_240.png 1,"Mitochondrial Beta-Carotene 9, 10 Oxygenase Modulates Prostate Cancer Growth via NF-kappaB Inhibition: a Lycopene-Independent Function",Molecular Cancer Research,,,Article,2016-07-12,10.1158/1541-7786.mcr-16-0075,,,,27406826,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9716497,https://api.altmetric.com/v1/donut/9716497_240.png 1,STAMPEDE trial and patients with non-metastatic prostate cancer – Authors' reply ,The Lancet,,,Article,2016-07-01,10.1016/s0140-6736(16)31041-8,,,,27479566,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9716428,https://api.altmetric.com/v1/donut/9716428_240.png 1,"Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers",Future Oncology,,,Article,2016-07-12,10.2217/fon-2016-0178,,,,27400645,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9645722,https://api.altmetric.com/v1/donut/9645722_240.png 1,miR-132 mediates a metabolic shift in prostate cancer cells by targeting Glut1,FEBS Open Bio,,,Article,2016-07-01,10.1002/2211-5463.12086,,,,27398313,PMC4932453,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9629521,https://api.altmetric.com/v1/donut/9629521_240.png 1,Role of Protein S in castration-resistant prostate cancer-like cells,Endocrine-Related Cancer,,,Article,2016-06-24,10.1530/erc-16-0126,,,,27342144,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9556435,https://api.altmetric.com/v1/donut/9556435_240.png 1,Automated Region-based Prostate Cancer Cell Nuclei Localization. Part of a Prognostic Modality Tool for Prostate Cancer Patients.,Analytical and quantitative cytopathology and histopathology,,,Article,2016-04-01,,,,,27386626,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9537003,https://api.altmetric.com/v1/donut/9537003_240.png 1,Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10333,,,,27384993,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9513113,https://api.altmetric.com/v1/donut/9513113_240.png 1,Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer,American Journal of Men's Health,,,Article,2016-06-29,10.1177/1557988316657041,,,,27365211,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9511805,https://api.altmetric.com/v1/donut/9511805_240.png 1,Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease HSP90 and the Androgen Receptor Levels and Inhibit Viability in Enzalutamide Resistant C4-2 Prostate Cancer Cells,Molecular Pharmacology,,,Article,2016-07-05,10.1124/mol.116.103416,,,,27382012,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9294701,https://api.altmetric.com/v1/donut/9294701_240.png 1,Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade,Cancer Causes and Control,,,Article,2016-07-05,10.1007/s10552-016-0782-x,,,,27379990,PMC4958547,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9271315,https://api.altmetric.com/v1/donut/9271315_240.png 1,OLIGOPELVIS – GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer,BMC Cancer,,,Article,2015-09-25,10.1186/s12885-015-1579-0,,,,26408012,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9183816,https://api.altmetric.com/v1/donut/9183816_240.png 1,Bilateral BRVO in a patient with recurrent prostate cancer,BMJ Case Reports,,,Article,2015-10-21,10.1136/bcr-2015-212463,,,,26491002,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9161330,https://api.altmetric.com/v1/donut/9161330_240.png 1,"A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial",Cancer Causes and Control,,,Article,2016-06-29,10.1007/s10552-016-0779-5,,,,27357932,PMC4958123,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9160760,https://api.altmetric.com/v1/donut/9160760_240.png 1,Difference in the rate of rectal complications following prostate brachytherapy based on the prostate-rectum distance and the prostate longitudinal length among early prostate cancer patients,Korean Journal of Urology,,,Article,2015-01-01,10.4111/kju.2015.56.9.637,,,,26366276,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9158927,https://api.altmetric.com/v1/donut/9158927_240.png 1,SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity,Clinical Oncology,,,Article,2016-06-10,10.1016/j.clon.2016.05.005,,,,27298241,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9157273,https://api.altmetric.com/v1/donut/9157273_240.png 1,Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.,Discovery Medicine,,,Article,2016-06-30,,,,,27355337,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9139263,https://api.altmetric.com/v1/donut/9139263_240.png 1,Chemotherapy for metastatic castration-sensitive prostate cancer,International Journal of Urology,,,Article,2016-06-01,10.1111/iju.13148,,,,27345496,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9138807,https://api.altmetric.com/v1/donut/9138807_240.png 1,Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer.,The Journal of Urology,,,Article,2002-01-01,,,,,11743288,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9138276,https://api.altmetric.com/v1/donut/9138276_240.png 1,Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells,Prostate Cancer & Prostatic Diseases,,,Article,2016-06-28,10.1038/pcan.2016.21,,,,27349498,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9132512,https://api.altmetric.com/v1/donut/9132512_240.png 1,Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2016-06-28,10.1038/pcan.2016.20,,,,27349499,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9132510,https://api.altmetric.com/v1/donut/9132510_240.png 1,Pulmonary metastasis as sole manifestation of relapse in previously treated localised prostate cancer: three exceptional case reports,Ecancermedicalscience,,,Article,2016-01-01,10.3332/ecancer.2016.645,,,,27350790,PMC4898933,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9126453,https://api.altmetric.com/v1/donut/9126453_240.png 1,Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer,Radiotherapy & Oncology,,,Article,2016-06-28,10.1016/j.radonc.2016.05.026,,,,27370205,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9118493,https://api.altmetric.com/v1/donut/9118493_240.png 1,Value in prostate cancer treatment,Journal of Surgical Oncology,,,Article,2016-06-01,10.1002/jso.24285,,,,27349215,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9090586,https://api.altmetric.com/v1/donut/9090586_240.png 1,Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable-risk prostate cancer,Journal of Radiation Oncology,,,Article,2016-04-30,10.1007/s13566-016-0253-8,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9038630,https://api.altmetric.com/v1/donut/9038630_240.png 1,"Vitamins, metabolomics, and prostate cancer",World Journal of Urology,,,Article,2016-06-23,10.1007/s00345-016-1878-3,,,,27339624,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9034694,https://api.altmetric.com/v1/donut/9034694_240.png 1,Bipolar androgen therapy for men with androgen ablation naïve prostate cancer: Results from the phase II BATMAN study.,The Prostate,,,Article,2016-06-25,10.1002/pros.23209,,,,27338150,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9034483,https://api.altmetric.com/v1/donut/9034483_240.png 1,The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA,International Urology and Nephrology,,,Article,2016-05-28,10.1007/s11255-016-1328-6,,,,27236298,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9020397,https://api.altmetric.com/v1/donut/9020397_240.png 1,The effect of extremely narrow MLC leaf width on the plan quality of VMAT for prostate cancer,Radiation Oncology,,,Article,2016-06-23,10.1186/s13014-016-0664-0,,,,27338929,PMC4917980,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8998050,https://api.altmetric.com/v1/donut/8998050_240.png 1,Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617,Clinical Nuclear Medicine,,,Article,2016-07-01,10.1097/rlu.0000000000001200,,,http://journals.lww.com/nuclearmed/Fulltext/2016/07000/Metastatic_Prostate_Cancer_With_Restored.12.aspx,26909718,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8978328,https://api.altmetric.com/v1/donut/8978328_240.png 1,Developments in Advanced Prostate Cancer in 2016,European Oncology & Haematology,,,Article,2016-01-01,10.17925/eoh.2016.12.01.17,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8962263,https://api.altmetric.com/v1/donut/8962263_240.png 1,My advanced prostate cancer experience,Trends in Urology and Men's Health,,,Article,2016-05-01,10.1002/tre.523,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8954075,https://api.altmetric.com/v1/donut/8954075_240.png 1,Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer,Journal of Radiation Oncology,,,Article,2016-01-23,10.1007/s13566-015-0237-0,,,,27335630,PMC4893387,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8946745,https://api.altmetric.com/v1/donut/8946745_240.png 1,"Correction: Vaidyanathan et al. Are We Eating Our Way to Prostate Cancer—A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150. Non-Coding RNA 2016, 2, 2.",Non-Coding RNA,,,Article,2016-06-20,10.3390/ncrna2020006,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8900371,https://api.altmetric.com/v1/donut/8900371_240.png 1,"miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer",Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10020,,,,27317765,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8883053,https://api.altmetric.com/v1/donut/8883053_240.png 1,Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study,European Journal of Cancer (1965),,,Article,2016-08-01,10.1016/j.ejca.2016.05.020,,,,27318002,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8882244,https://api.altmetric.com/v1/donut/8882244_240.png 1,Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301,OncoTargets and therapy,,,Article,2016-01-01,10.2147/ott.s102862,,,,27307749,PMC4888721,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8844835,https://api.altmetric.com/v1/donut/8844835_240.png 1,The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP,Neoplasia,,,Article,2016-06-01,10.1016/j.neo.2016.04.008,,,,27292025,PMC4909715,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8751536,https://api.altmetric.com/v1/donut/8751536_240.png 1,"Being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff point",Cancer (0008543X),,,Article,2016-06-10,10.1002/cncr.30098,,,,27284681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8734179,https://api.altmetric.com/v1/donut/8734179_240.png 1,Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation.,American Journal of Cancer Research,,,Article,2016-01-01,,,,,27294000,PMC4889721,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8733837,https://api.altmetric.com/v1/donut/8733837_240.png 1," Structure–Activity Relationship of 18 F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer ",Journal of Medicinal Chemistry,,,Article,2016-06-13,10.1021/acs.jmedchem.5b01850,,,,27228467,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8722339,https://api.altmetric.com/v1/donut/8722339_240.png 1,Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer,Infectious Agents and Cancer,,,Article,2016-06-09,10.1186/s13027-016-0074-9,,,,27284286,PMC4899914,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8672888,https://api.altmetric.com/v1/donut/8672888_240.png 1,Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9869,,,,27286458,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8668762,https://api.altmetric.com/v1/donut/8668762_240.png 1,Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3226,,,,25844599,PMC4673300,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/8668473,https://api.altmetric.com/v1/donut/8668473_240.png 1,TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9837,,,,27285981,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8667476,https://api.altmetric.com/v1/donut/8667476_240.png 1,Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9215,,,,27281612,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8635307,https://api.altmetric.com/v1/donut/8635307_240.png 1,"Non-steroidal anti-inflammatory drugs and cancer in Finnish men. An epidemiologic study on prostate cancer risk, survival and overall cancer mortality",,,,Article,2016-06-10,,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8627356,https://api.altmetric.com/v1/donut/8627356_240.png 1,Genetic Susceptibility Factors for Prostate Cancer at Chromosomal Region 11q13.5,,,,Article,2016-06-10,,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8627355,https://api.altmetric.com/v1/donut/8627355_240.png 1,MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.,Journal of B U ON official journal of the Balkan Union of Oncology,,,Article,2016-03-01,,,,,27273955,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8626591,https://api.altmetric.com/v1/donut/8626591_240.png 1,Translation of genomics and epigenomics in prostate cancer: progress and promising directions.,Asian Journal of Andrology,,,Article,2016-06-10,,,,,27270344,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8626078,https://api.altmetric.com/v1/donut/8626078_240.png 1,Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?,OncoTargets and therapy,,,Article,2016-01-01,10.2147/ott.s105174,,,,27274277,PMC4869660,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8617529,https://api.altmetric.com/v1/donut/8617529_240.png 1,The reverse-mode NCX1 activity inhibitor KB-R7943 promotes prostate cancer cell death by activating the JNK pathway and blocking autophagic flux,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9806,,,,27275542,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8616266,https://api.altmetric.com/v1/donut/8616266_240.png 1,A novel mechanism of methylglyoxal cytotoxicity in prostate cancer cells,International Journal of Biochemistry & Cell Biology,,,Article,2013-04-14,10.1016/j.biocel.2013.01.003,,,,23333621,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8605922,https://api.altmetric.com/v1/donut/8605922_240.png 1,"Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case–control study among Japanese men",International Urology and Nephrology,,,Article,2016-06-04,10.1007/s11255-016-1335-7,,,,27262851,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8545529,https://api.altmetric.com/v1/donut/8545529_240.png 1,Irreversible Electroporation of Prostate Cancer: Patient-Specific Pretreatment Simulation by Electric Field Measurement in a 3D Bioprinted Textured Prostate Cancer Model to Achieve Optimal Electroporation Parameters for Image-Guided Focal Ablation,CardioVascular and Interventional Radiology,,,Article,2016-06-02,10.1007/s00270-016-1390-6,,,,27256102,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8498807,https://api.altmetric.com/v1/donut/8498807_240.png 1,miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C,Biomedicine & Pharmacotherapy,,,Article,2016-07-01,10.1016/j.biopha.2016.03.043,,,,27261573,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8496521,https://api.altmetric.com/v1/donut/8496521_240.png 1,PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells,Biomedicine & Pharmacotherapy,,,Article,2016-07-01,10.1016/j.biopha.2016.03.030,,,,27261570,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8489724,https://api.altmetric.com/v1/donut/8489724_240.png 1,Histone deacetylase inhibitor sulforaphane: The phytochemical with vibrant activity against prostate cancer,Biomedicine & Pharmacotherapy,,,Article,2016-07-01,10.1016/j.biopha.2016.04.022,,,,27261601,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8488923,https://api.altmetric.com/v1/donut/8488923_240.png 1,Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells ? androgen receptor (AR) ? miRNA32 signals,Molecular Oncology,,,Article,2015-08-01,10.1016/j.molonc.2015.02.010,,,,25817444,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8484107,https://api.altmetric.com/v1/donut/8484107_240.png 1,"Re: The Memorial Sloan Kettering cancer center recommendations for prostate cancer screening. Andrew J Vickers et al. Urology 91: 12-18, 2016.",Urology,,,Article,2016-06-01,10.1016/j.urology.2016.05.049,,,,27262396,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8428145,https://api.altmetric.com/v1/donut/8428145_240.png 1,Reply to RE: The Memorial Sloan Kettering Cancer Center recommendations for prostate cancer screening,Urology,,,Article,2016-06-01,10.1016/j.urology.2016.05.046,,,,27262394,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8428142,https://api.altmetric.com/v1/donut/8428142_240.png 1,"Estimation of breast, prostate, and colorectal cancer incidence using a French administrative database (general sample of health insurance beneficiaries)",Revue d Epidemiologie et de Sante Publique (ScienceDirect),,,Article,2016-05-01,10.1016/j.respe.2015.12.020,,,,27238161,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8390116,https://api.altmetric.com/v1/donut/8390116_240.png 1,Quality of Prostate Cancer Treatment Information on Cancer Center Websites,Cure?us,,,Article,2016-01-01,10.7759/cureus.580,,,,27226941,PMC4876006,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8377309,https://api.altmetric.com/v1/donut/8377309_240.png 1,Associations of serum organohalogen levels and prostate cancer risk: Results from a case–control study in Singapore,Chemosphere,,,Article,2016-02-01,10.1016/j.chemosphere.2015.10.020,,,,26498098,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8367414,https://api.altmetric.com/v1/donut/8367414_240.png 1,"Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer",British Journal of Urology,,,Article,2011-06-14,10.1111/j.1464-410x.2010.09726.x,,,,20950306,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,13,https://www.altmetric.com/details/8358048,https://api.altmetric.com/v1/donut/8358048_240.png 1,PlncRNA-1 induces apoptosis through the Her-2 pathway in prostate cancer cells.,Asian Journal of Andrology,,,Article,2016-05-28,,,,,27232851,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8331368,https://api.altmetric.com/v1/donut/8331368_240.png 1,Lack of expression of preproorexin and orexin receptors genes in human normal and prostate cancer cell lines,Folia Histochemica et Cytobiologica,,,Article,2016-01-07,10.5603/fhc.a2015.0035,,,,26714447,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8331141,https://api.altmetric.com/v1/donut/8331141_240.png 1,Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer,Diagnostic Pathology,,,Article,2016-05-25,10.1186/s13000-016-0495-1,,,,27225200,PMC4880832,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8318559,https://api.altmetric.com/v1/donut/8318559_240.png 1,ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the androgen receptor,eLife,,,Article,2016-05-16,10.7554/elife.13964,,,,27183006,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/8295083,https://api.altmetric.com/v1/donut/8295083_240.png 1,"Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population",Journal of Advanced Research,,,Article,2016-05-01,10.1016/j.jare.2016.03.008,,,,27222754,PMC4856822,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8291678,https://api.altmetric.com/v1/donut/8291678_240.png 1,Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9526,,,,27224919,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8282976,https://api.altmetric.com/v1/donut/8282976_240.png 1,Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen,BMC Cancer,,,Article,2016-05-25,10.1186/s12885-016-2378-y,,,,27225190,PMC4880970,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8279930,https://api.altmetric.com/v1/donut/8279930_240.png 1,"Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.",Cancer Research,,,Article,1998-10-01,,,,,9766654,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8272779,https://api.altmetric.com/v1/donut/8272779_240.png 1,Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC),Supportive Care in Cancer,,,Article,2016-02-04,10.1007/s00520-016-3092-7,,,,26847348,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8272681,https://api.altmetric.com/v1/donut/8272681_240.png 1,Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy,BMC Cancer,,,Article,2016-05-24,10.1186/s12885-016-2363-5,,,,27222030,PMC4879724,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8227858,https://api.altmetric.com/v1/donut/8227858_240.png 1,PD32-11 GENE EXPRESSION ANALYSIS OF BONE METASTASIS AND CIRCULATING TUMOR CELLS FROM METASTATIC CASTRATE-RESISTANT PROSTATE CANCER PATIENTS,The Journal of Urology,,,Article,2016-04-01,10.1016/j.juro.2016.02.687,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8207978,https://api.altmetric.com/v1/donut/8207978_240.png 1,Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer,International Journal of Oncology,,,Article,2016-05-16,10.3892/ijo.2016.3522,,,,27212625,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8201262,https://api.altmetric.com/v1/donut/8201262_240.png 1,Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer,Brachytherapy,,,Article,2016-05-01,10.1016/j.brachy.2016.03.011,,,,27220699,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8197890,https://api.altmetric.com/v1/donut/8197890_240.png 1,Audit of febrile neutropenic (FN) episodes in men receiving docetaxel for hormone-sensitive metastatic prostate cancer (HSMPC),Clinical Oncology,,,Article,2016-06-01,10.1016/j.clon.2016.04.022,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8197850,https://api.altmetric.com/v1/donut/8197850_240.png 1,Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer,Journal of the Egyptian National Cancer Institute,,,Article,2015-09-01,10.1016/j.jnci.2015.07.001,,,,26227217,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8170488,https://api.altmetric.com/v1/donut/8170488_240.png 1,Validation of Selection Criteria for Active Surveillance in Prostate Cancer.,Journal of clinical and diagnostic research : JCDR,,,Article,2016-04-01,10.7860/jcdr/2016/16401.7589,,,,27190877,PMC4866175,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8163200,https://api.altmetric.com/v1/donut/8163200_240.png 1,"Coexpression of CAV-1, AT1-R and FOXM1 in prostate and breast cancer and normal cell lines and their influence on metastatic properties",Acta Biochimica Polonica,,,Article,2016-05-20,10.18388/abp.2015_1016,,,,27213551,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8151057,https://api.altmetric.com/v1/donut/8151057_240.png 1,Interval to biochemical failure is prognostic for distant metastases after salvage radiation therapy for prostate cancer,Journal of Radiation Oncology,,,Article,2015-07-26,10.1007/s13566-015-0208-5,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8144270,https://api.altmetric.com/v1/donut/8144270_240.png 1,Radiotherapy versus Prostatectomy: a Question of Survival or Survivorship? Addressing Ongoing Questions and Controversies in the Management of Localised Prostate Cancer in the UK,Clinical Oncology,,,Article,2016-05-01,10.1016/j.clon.2016.04.050,,,,27212440,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8110105,https://api.altmetric.com/v1/donut/8110105_240.png 1,Solitary brain metastasis from prostate cancer: a case report,Annals of palliative medicine,,,Article,2016-05-01,10.21037/apm.2016.04.02,,,,27199272,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8080760,https://api.altmetric.com/v1/donut/8080760_240.png 1,Activation of the Lin28/let7 axis by loss of ESE3/EHF promotes a tumorigenic and stem-like phenotype in prostate cancer,Cancer Research,,,Article,2016-05-02,10.1158/0008-5472.can-15-2665,,,,27197175,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7924991,https://api.altmetric.com/v1/donut/7924991_240.png 1,A phase II experience evaluating quality of life and survival in linac-based SBRT for prostate cancer,Journal of Radiation Oncology,,,Article,2016-05-14,10.1007/s13566-016-0249-4,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7866536,https://api.altmetric.com/v1/donut/7866536_240.png 1,Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9344,,,,27191985,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7620802,https://api.altmetric.com/v1/donut/7620802_240.png 1,Supercritical Fluid Extraction of Citrus iyo Hort. ex Tanaka Pericarp Inhibits Growth and Induces Apoptosis Through Abrogation of STAT3 Regulated Gene Products in Human Prostate Cancer Xenograft Mouse Model,Integrative Cancer Therapies,,,Article,2016-05-16,10.1177/1534735416649659,,,,27185319,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7597070,https://api.altmetric.com/v1/donut/7597070_240.png 1,Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.,Journal of Nuclear Medicine,,,Article,,10.2967/jnumed.115.160085,,,,26315832,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7545344,https://api.altmetric.com/v1/donut/7545344_240.png 1,Predictors of long-term survival for localized prostate cancer treated with high-dose IMRT stratified by NCCN 2015 guidelines in a community hospital setting,Journal of Radiation Oncology,,,Article,2015-10-19,10.1007/s13566-015-0224-5,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7497439,https://api.altmetric.com/v1/donut/7497439_240.png 1,Dietary Total Antioxidant Capacity is Inversely Associated with Prostate Cancer Aggressiveness in a Population-Based Study,Nutrition and Cancer,,,Article,2016-02-04,10.1080/01635581.2016.1134596,,,,26847416,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7494851,https://api.altmetric.com/v1/donut/7494851_240.png 1,Patient-Derived Prostate Cancer: from Basic Science to the Clinic,Hormones and Cancer,,,Article,2016-05-13,10.1007/s12672-016-0266-1,,,,27177552,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7481774,https://api.altmetric.com/v1/donut/7481774_240.png 1,"Systems Medicine approaches to improving understanding, treatment, and clinical management of Neuroendocrine Prostate Cancer.",Current Pharmaceutical Design,,,Article,2016-05-15,,,,,27174811,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7473207,https://api.altmetric.com/v1/donut/7473207_240.png 1,Exogenous estrogen and the risk of biliary tract cancer – a population-based study in a cohort of Swedish men treated for prostate cancer,Acta Oncologica,,,Article,2016-05-13,10.3109/0284186x.2015.1131333,,,,27173637,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7471508,https://api.altmetric.com/v1/donut/7471508_240.png 1,Cratylia mollis lectin nanoelectrode for differential diagnostic of prostate cancer and benign prostatic hyperplasia based on label-free detection,Biosensors & Bioelectronics,,,Article,2016-11-01,10.1016/j.bios.2016.05.004,,,,27176915,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7471499,https://api.altmetric.com/v1/donut/7471499_240.png 1,Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer,Journal of Applied Clinical Medical Physics,,,Article,2016-05-08,10.1120/jacmp.v17i3.6088,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7371359,https://api.altmetric.com/v1/donut/7371359_240.png 1,Acute and Late Genitourinary Toxicity after 72 Gy of Conventionally Fractionated Conformal Radiotherapy for Localised Prostate Cancer: Impact of Individual and Clinical Parameters,Clinical Oncology,,,Article,2016-05-01,10.1016/j.clon.2016.04.041,,,,27184943,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7366334,https://api.altmetric.com/v1/donut/7366334_240.png 1,Prostate Cancer Ambassadors: Process and Outcomes of a Prostate Cancer Informed Decision-Making Training Program,American Journal of Men's Health,,,Article,2016-04-19,10.1177/1557988316644979,,,,27099348,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7365921,https://api.altmetric.com/v1/donut/7365921_240.png 1,Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance,World Journal of Radiology,,,Article,2016-04-28,10.4329/wjr.v8.i4.410,,,,27158428,PMC4840199,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7365022,https://api.altmetric.com/v1/donut/7365022_240.png 1,State of the Art in Locally Advanced and Recurrent Non-metastatic Prostate Cancer,Oncology & Hematology Review (US),,,Article,2014-01-01,10.17925/ohr.2014.10.2.123,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7353248,https://api.altmetric.com/v1/donut/7353248_240.png 1,Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer,Clinical Nuclear Medicine,,,Article,2016-06-01,10.1097/rlu.0000000000001195,,,http://journals.lww.com/nuclearmed/Fulltext/2016/06000/Positive_Influence_of_177Lu_PSMA_617_Therapy_on.14.aspx,26909716,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7316284,https://api.altmetric.com/v1/donut/7316284_240.png 1,Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2016-04-01,10.1016/j.jsbmb.2016.04.008,,,,27125450,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7283554,https://api.altmetric.com/v1/donut/7283554_240.png 1,68Ga-Labeled Anti–Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer,Clinical Nuclear Medicine,,,Article,2016-05-01,10.1097/rlu.0000000000001158,,,http://journals.lww.com/nuclearmed/Fulltext/2016/05000/68Ga_Labeled_Anti_Prostate_Specific_Membrane.26.aspx,26859213,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7279329,https://api.altmetric.com/v1/donut/7279329_240.png 1,Using Daily Diagnostic Quality Images To validate Planning Margins for Inter-fractional Variations of Prostate Cancer,Journal of Applied Clinical Medical Physics,,,Article,2016-05-08,10.1120/jacmp.v17i3.5923,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7276115,https://api.altmetric.com/v1/donut/7276115_240.png 1,Precision Medicine Path for Prostate Cancer,Cancer Discovery,,,Article,2015-06-16,10.1158/2159-8290.cd-nb2015-089,,,,26080836,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7221485,https://api.altmetric.com/v1/donut/7221485_240.png 1,Calcium sensing receptor tumor expression and lethal prostate cancer progression,The Journal of Clinical Endocrinology & Metabolism,,,Article,2016-04-26,10.1210/jc.2016-1082,,,,27115058,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7218801,https://api.altmetric.com/v1/donut/7218801_240.png 1,Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies,Prostate Cancer & Prostatic Diseases,,,Article,2016-05-03,10.1038/pcan.2016.12,,,,27136741,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7147597,https://api.altmetric.com/v1/donut/7147597_240.png 1,High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice.,Clinical Oncology,,,Article,,10.1016/j.clon.2016.03.006,,,,27131755,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7145753,https://api.altmetric.com/v1/donut/7145753_240.png 1,Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells,OncoImmunology,,,Article,2016-04-01,10.1080/2162402x.2015.1105431,,,,27141390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7141374,https://api.altmetric.com/v1/donut/7141374_240.png 1,"Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer",Translational Research: The Journal of Laboratory & Clinical Medicine,,,Article,2016-04-01,10.1016/j.trsl.2016.04.002,,,,27140699,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7140998,https://api.altmetric.com/v1/donut/7140998_240.png 1,Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non–Small Cell Lung Cancer,Clinical Nuclear Medicine,,,Article,2016-05-01,10.1097/rlu.0000000000001139,,,http://journals.lww.com/nuclearmed/Fulltext/2016/05000/Elevated_68Ga_Prostate_Specific_Membrane_Antigen.22.aspx,26828144,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7121445,https://api.altmetric.com/v1/donut/7121445_240.png 1,Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancer,Clinical Cancer Research,,,Article,2016-05-04,10.1158/1078-0432.ccr-15-2901,,,,27140928,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7118017,https://api.altmetric.com/v1/donut/7118017_240.png 1,Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3610,,,,25915156,PMC4558156,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7088908,https://api.altmetric.com/v1/donut/7088908_240.png 1,SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9002,,,,27129164,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7088700,https://api.altmetric.com/v1/donut/7088700_240.png 1,Capsaicin causes inactivation and degradation of the androgen receptor by inducing the restoration of miR-449a in prostate cancer,Oncology Reports,,,Article,2015-06-11,10.3892/or.2015.4055,,,,26081756,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7088117,https://api.altmetric.com/v1/donut/7088117_240.png 1,miR186 suppresses prostate cancer progression by targeting Twist1,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8887,,,,27121312,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7085293,https://api.altmetric.com/v1/donut/7085293_240.png 1,[ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF 11C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER].,Vestnik khirurgii imeni I I Grekova,,,Article,2015-01-01,,,,,27066654,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7084626,https://api.altmetric.com/v1/donut/7084626_240.png 1,Abstract A48: Treatment decision making in a population-based sample of black and white men with localized prostate cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-03-01,10.1158/1538-7755.disp15-a48,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7083977,https://api.altmetric.com/v1/donut/7083977_240.png 1,Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect,Oncotarget,,,Article,2015-11-07,10.18632/oncotarget.8944,,,,27121323,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7077512,https://api.altmetric.com/v1/donut/7077512_240.png 1,High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-?B pathway,International Journal of Molecular Medicine,,,Article,2016-04-25,10.3892/ijmm.2016.2575,,,,27121695,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7068723,https://api.altmetric.com/v1/donut/7068723_240.png 1,MR-T2-weighted signal intensity: a new imaging biomarker of prostate cancer aggressiveness,Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization,,,Article,2014-04-15,10.1080/21681163.2014.910476,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7065216,https://api.altmetric.com/v1/donut/7065216_240.png 1,Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8953,,,,27120795,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7053177,https://api.altmetric.com/v1/donut/7053177_240.png 1,Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer,Oncotarget,,,Article,2015-11-07,10.18632/oncotarget.8499,,,,27049720,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7041306,https://api.altmetric.com/v1/donut/7041306_240.png 1,"In vitro anti-proliferative activities of Aloe perryi flowers extract on human liver, colon, breast, lung, prostate and epithelial cancer cell lines.",Pakistan Journal of Pharmaceutical Sciences,,,Article,2016-03-01,,,,,27113311,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6983439,https://api.altmetric.com/v1/donut/6983439_240.png 1,Epigenetic and miRNAs dysregulation in prostate cancer: the role of nutraceuticals.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2016-04-26,,,,,27109021,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6975175,https://api.altmetric.com/v1/donut/6975175_240.png 1,Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway.,Biochemical & Biophysical Research Communications,,,Article,2016-04-26,10.1016/j.bbrc.2016.04.107,,,,27109471,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6974020,https://api.altmetric.com/v1/donut/6974020_240.png 1,Hypoxia inducible factor-1?-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells,Oncology Reports,,,Article,2016-04-25,10.3892/or.2016.4766,,,,27108616,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6970479,https://api.altmetric.com/v1/donut/6970479_240.png 1,Somatostatin Imaging of Neuroendocrine-Differentiated Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-06-01,10.1097/rlu.0000000000000776,,,http://journals.lww.com/nuclearmed/Fulltext/2015/06000/Somatostatin_Imaging_of.26.aspx,25783510,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6968643,https://api.altmetric.com/v1/donut/6968643_240.png 1,"Accuracy of Medicare Claim–based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases",Medical care,,,Article,2016-04-01,10.1097/mlr.0000000000000539,,,,27111753,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6965630,https://api.altmetric.com/v1/donut/6965630_240.png 1,Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial,PLoS ONE,,,Article,2016-04-21,10.1371/journal.pone.0153413,,,,27100876,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6952759,https://api.altmetric.com/v1/donut/6952759_240.png 1,New evidence that a heart-healthy diet also helps fight prostate cancer. Replace refined carbs with vegetable fats to slow early stage cancer from progressing to a more lethal form.,Harvard Men's Health Watch,,,Article,2013-10-01,,,,,27024777,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6933899,https://api.altmetric.com/v1/donut/6933899_240.png 1,Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer,Oncologist,,,Article,2016-04-22,10.1634/theoncologist.2016-0108,,,,27107001,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6932306,https://api.altmetric.com/v1/donut/6932306_240.png 1,The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer in vitro and xenograft formation and growth in vivo,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8832,,,,27105540,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6915863,https://api.altmetric.com/v1/donut/6915863_240.png 1,TGF Induces a Pro-Bone Metastasis Program in Prostate Cancer,Cancer Discovery,,,Article,2015-05-28,10.1158/2159-8290.cd-rw2015-098,,,,26022606,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6878555,https://api.altmetric.com/v1/donut/6878555_240.png 1,Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis,PLoS ONE,,,Article,2016-04-20,10.1371/journal.pone.0153981,,,,27096158,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6,https://www.altmetric.com/details/6840049,https://api.altmetric.com/v1/donut/6840049_240.png 1,Lung Metastasis From Prostate Cancer Revealed by 18F-FDG PET/CT Without Osseous Metastasis on Bone Scan,Clinical Nuclear Medicine,,,Article,2016-05-01,10.1097/rlu.0000000000001107,,,http://journals.lww.com/nuclearmed/Fulltext/2016/05000/Lung_Metastasis_From_Prostate_Cancer_Revealed_by.12.aspx,26859201,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6830025,https://api.altmetric.com/v1/donut/6830025_240.png 1,How I Do It: Genetic counseling and genetic testing for inherited prostate cancer.,Canadian Journal of Urology,,,Article,2016-04-18,,,,,27085833,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6778108,https://api.altmetric.com/v1/donut/6778108_240.png 1," Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn 2+ chelator TPEN inducing oxidative stress in prostate cancer cells ",Nanomedicine,,,Article,2016-04-14,10.2217/nnm-2015-0017,,,,27077564,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6769607,https://api.altmetric.com/v1/donut/6769607_240.png 1,Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone,Molecular Medicine Reports,,,Article,2016-04-08,10.3892/mmr.2016.5095,,,,27081843,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6759483,https://api.altmetric.com/v1/donut/6759483_240.png 1,Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.,Asian Journal of Andrology,,,Article,2016-04-16,,,,,27080480,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6754841,https://api.altmetric.com/v1/donut/6754841_240.png 1,"Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate",Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8705,,,,27081698,PMC5053751,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6754628,https://api.altmetric.com/v1/donut/6754628_240.png 1,Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus,The American Journal of the Medical Sciences,,,Article,2016-04-01,10.1016/j.amjms.2016.01.013,,,,27079349,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6754518,https://api.altmetric.com/v1/donut/6754518_240.png 1,"Titanocene–Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro",Organometallics,,,Article,2016-04-15,10.1021/acs.organomet.6b00051,,,,27182101,PMC4863200,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6746232,https://api.altmetric.com/v1/donut/6746232_240.png 1,Lost Labor Productivity Costs of Prostate Cancer to Patients and Their Spouses: Evidence From US National Survey Data.,Journal of Occupational & Environmental Medicine,,,Article,2016-04-01,10.1097/jom.0000000000000621,,,http://journals.lww.com/joem/Fulltext/2016/04000/Lost_Labor_Productivity_Costs_of_Prostate_Cancer.6.aspx,27058474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6724428,https://api.altmetric.com/v1/donut/6724428_240.png 1,"miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines",Urologia Internationalis,,,Article,2016-04-14,10.1159/000445252,,,,27074041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6681051,https://api.altmetric.com/v1/donut/6681051_240.png 1,S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors,British Journal of Cancer,,,Article,2004-08-15,10.1038/sj.bjc.6602034,,,,15280928,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6666704,https://api.altmetric.com/v1/donut/6666704_240.png 1,DUP1 peptide modified micelle efficiently targeted delivery paclitaxel and enhance mitochondrial apoptosis on PSMA-negative prostate cancer cells,SpringerPlus,,,Article,2016-01-01,10.1186/s40064-016-1992-0,,,,27066372,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6666445,https://api.altmetric.com/v1/donut/6666445_240.png 1,Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry,PLoS ONE,,,Article,2016-04-13,10.1371/journal.pone.0153609,,,,27074016,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,3,https://www.altmetric.com/details/6658625,https://api.altmetric.com/v1/donut/6658625_240.png 1,SOCS3 Modulates the Response to Enzalutamide and is Regulated by AR Signaling and CpG Methylation in Prostate Cancer Cells,Molecular Cancer Research,,,Article,2016-04-06,10.1158/1541-7786.mcr-15-0495,,,,27053681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6626296,https://api.altmetric.com/v1/donut/6626296_240.png 1,"Successful sperm extraction and live birth after radiation, androgen deprivation and surgical castration for treatment of metastatic prostate cancer",International Journal of Clinical Oncology,,,Article,2016-04-06,10.1111/and.12578,,,,27062395,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6625140,https://api.altmetric.com/v1/donut/6625140_240.png 1,A monte carlo study of restricted diffusion: Implications for diffusion MRI of prostate cancer,Magnetic Resonance in Medicine,,,Article,2016-03-05,10.1002/mrm.26230,,,,27059769,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6613967,https://api.altmetric.com/v1/donut/6613967_240.png 1,Targeting persistent androgen receptor signaling in castration-resistant prostate cancer,Medical Oncology,,,Article,2016-04-04,10.1007/s12032-016-0759-3,,,,27042852,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6599462,https://api.altmetric.com/v1/donut/6599462_240.png 1,Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancer,OncoImmunology,,,Article,2016-02-01,10.1080/2162402x.2015.1078060,,,,27057455,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6592782,https://api.altmetric.com/v1/donut/6592782_240.png 1,Association between genetic variant in hsa-miR-146a gene and prostate cancer progression: evidence from Serbian population,Cancer Causes and Control,,,Article,2014-08-01,10.1007/s10552-014-0452-9,,,,25084752,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6592718,https://api.altmetric.com/v1/donut/6592718_240.png 1,Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone?sensitive prostate cancer,International Journal of Urology,,,Article,2016-04-01,10.1111/iju.13091,,,,27062039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6580182,https://api.altmetric.com/v1/donut/6580182_240.png 1,Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8594,,,,27058421,PMC5053719,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6579480,https://api.altmetric.com/v1/donut/6579480_240.png 1,3T multiparametric MRI of the prostate: Does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone?,European Journal of Radiology,,,Article,2016-04-01,10.1016/j.ejrad.2016.01.006,,,,26971425,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6570232,https://api.altmetric.com/v1/donut/6570232_240.png 1,Prostate cancer is not breast cancer,Indian Journal of Medical & Paediatric Oncology,,,Article,2016-01-01,10.4103/0971-5851.176980,,,,27051149,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6528203,https://api.altmetric.com/v1/donut/6528203_240.png 1,"Under conditions of large geometric miss, tumor control probability can be higher for static gantry intensity-modulated radiation therapy compared to volume-modulated arc therapy for prostate cancer",Medical Dosimetry,,,Article,2016-04-01,10.1016/j.meddos.2015.12.004,,,,27067229,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6507783,https://api.altmetric.com/v1/donut/6507783_240.png 1,SATB1 promotes prostate cancer metastasis by the regulation of epithelial–mesenchymal transition,Biomedicine & Pharmacotherapy,,,Article,2016-04-01,10.1016/j.biopha.2016.01.038,,,,27044805,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6498968,https://api.altmetric.com/v1/donut/6498968_240.png 1,Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy,The Prostate,,,Article,2016-04-04,10.1002/pros.23187,,,,27040772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6491443,https://api.altmetric.com/v1/donut/6491443_240.png 1,miR-539 inhibits prostate cancer progression by directly targeting SPAG5,Journal of Experimental & Clinical Cancer Research,,,Article,2016-04-01,10.1186/s13046-016-0337-8,,,,27037000,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6453817,https://api.altmetric.com/v1/donut/6453817_240.png 1,"miR?19a?3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion",Molecular Medicine Reports,,,Article,2016-03-21,10.3892/mmr.2016.5033,,,,27035427,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6447737,https://api.altmetric.com/v1/donut/6447737_240.png 1,Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8440,,,,27034170,PMC5041999,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6442896,https://api.altmetric.com/v1/donut/6442896_240.png 1,Current and Emerging Therapies in Metastatic Prostate Cancer,Oncology & Hematology Review (US),,,Article,2015-01-01,10.17925/ohr.2015.11.01.58,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6436020,https://api.altmetric.com/v1/donut/6436020_240.png 1,Genomic predictors for treatment of late stage prostate cancer.,Asian Journal of Andrology,,,Article,2016-04-01,,,,,27030083,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6423230,https://api.altmetric.com/v1/donut/6423230_240.png 1,Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer,BMC Cancer,,,Article,2016-03-31,10.1186/s12885-016-2291-4,,,,27036119,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6415155,https://api.altmetric.com/v1/donut/6415155_240.png 1,Early Real Life Experience of Radium 223 (Ra223) in Castrate Resistant Prostate Cancer (CRPC),Clinical Oncology,,,Article,2016-05-01,10.1016/j.clon.2015.12.006,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6411543,https://api.altmetric.com/v1/donut/6411543_240.png 1,Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8389,,,,27029063,PMC5041989,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6405332,https://api.altmetric.com/v1/donut/6405332_240.png 1,Correlation of High PIRADS Score on Three-Tesla Magnetic Resonance with In-Gantry Magnetic Resonance Guided Biopsy in Patients with Clinical Risk of Prostate Cancer,Open Journal of Radiology,,,Article,2016-03-09,10.4236/ojrad.2016.61009,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6382313,https://api.altmetric.com/v1/donut/6382313_240.png 1,MiRNA 34a: a therapeutic target for castration-resistant prostate cancer,Expert Opinion on Therapeutic Targets,,,Article,2016-03-28,10.1517/14728222.2016.1162294,,,,26942553,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6380652,https://api.altmetric.com/v1/donut/6380652_240.png 1," MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis ",The Prostate,,,Article,2016-03-28,10.1002/pros.23183,,,,27017949,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6378500,https://api.altmetric.com/v1/donut/6378500_240.png 1,Analysis of Prostate Deformation during a Course of Radiation Therapy for Prostate Cancer,PLoS ONE,,,Article,2015-06-29,10.1371/journal.pone.0131822,,,,26120840,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6373659,https://api.altmetric.com/v1/donut/6373659_240.png 1,A comprehensive repertoire of tRNA-derived fragments in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.8293,,,,27015120,PMC5029740,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6366988,https://api.altmetric.com/v1/donut/6366988_240.png 1,NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnostics,Expert Review of Molecular Diagnostics,,,Article,2016-03-25,10.1586/14737159.2016.1164037,,,,26959614,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6346899,https://api.altmetric.com/v1/donut/6346899_240.png 1,Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3494,,,,25869206,PMC4494960,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6344293,https://api.altmetric.com/v1/donut/6344293_240.png 1,Prostate cancer,InnovAiT,,,Article,2016-03-24,10.1177/1755738016639070,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6330297,https://api.altmetric.com/v1/donut/6330297_240.png 1,Enhancement of HIFU Effect by Simultaneous Short Course Degarelix for Early Stage Prostate Cancer: A Pilot Study,Open Journal of Urology,,,Article,2016-03-08,10.4236/oju.2016.63010,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6326568,https://api.altmetric.com/v1/donut/6326568_240.png 1,Albumin–polymer conjugate nanoparticles and their interactions with prostate cancer cells in 2D and 3D culture: comparison between PMMA and PCL,Journal of Materials Chemistry B: Materials for biology and medicine,,,Article,2016-03-09,10.1039/c5tb02576a,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6319200,https://api.altmetric.com/v1/donut/6319200_240.png 1,Beliefs Regarding Prostate Cancer Screening Among Black Males Aged 18 to 40 Years,American Journal of Men's Health,,,Article,2016-03-18,10.1177/1557988316637879,,,,26993999,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6316501,https://api.altmetric.com/v1/donut/6316501_240.png 1,A comparison of genetic risk score with family history for estimating prostate cancer risk.,Asian Journal of Andrology,,,Article,2016-03-24,,,,,27004541,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6308554,https://api.altmetric.com/v1/donut/6308554_240.png 1,Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426],Clinical Oncology,,,Article,2016-02-01,10.1016/j.clon.2015.11.009,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6302867,https://api.altmetric.com/v1/donut/6302867_240.png 1,Prostate cancer: In the balance: screening intensity versus overdiagnosis,Nature Reviews Urology,,,Article,2015-09-08,10.1038/nrurol.2015.229,,,,26345212,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6300746,https://api.altmetric.com/v1/donut/6300746_240.png 1,Steroid co-introduction with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare,British Journal of Urology,,,Article,2016-03-01,10.1111/bju.13483,,,,26991851,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6234917,https://api.altmetric.com/v1/donut/6234917_240.png 1,Preclinical imaging and radiotherapy of prostate cancer using the theranostic twins(68Ga/177Lu)-radiolabeled peptides,Radiotherapy & Oncology,,,Article,2016-02-15,10.1016/s0167-8140(16)30137-2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6231324,https://api.altmetric.com/v1/donut/6231324_240.png 1,PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with Lu-177 labeled PSMA-617,Journal of Nuclear Medicine,,,Article,2016-03-16,10.2967/jnumed.115.171397,,,,26985056,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6230221,https://api.altmetric.com/v1/donut/6230221_240.png 1,"Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.",Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3667,,,,25991668,PMC4496411,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6229260,https://api.altmetric.com/v1/donut/6229260_240.png 1,Metabolically-stabilized 68Ga-NOTA-bombesin for PET Imaging of prostate cancer and influence of protease inhibitor Phosphoramidon,Molecular Pharmaceutics,,,Article,2016-03-14,10.1021/acs.molpharmaceut.5b00970,,,,26973098,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6227449,https://api.altmetric.com/v1/donut/6227449_240.png 1,Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy,PLoS ONE,,,Article,2016-03-16,10.1371/journal.pone.0151646,,,,26982980,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,https://www.altmetric.com/details/6200131,https://api.altmetric.com/v1/donut/6200131_240.png 1,Prostate Apoptosis Response-4 (PAR4) Suppresses Growth and Invasion of Breast Cancer Cells and Is Positively Associated with Patient Survival.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2016-03-16,,,,,26977019,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6197606,https://api.altmetric.com/v1/donut/6197606_240.png 1,"New Roles of Osteocytes in Proliferation, Migration and Invasion of Breast and Prostate Cancer Cells.",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2016-03-16,,,,,26977015,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6197601,https://api.altmetric.com/v1/donut/6197601_240.png 1,Barbershop Prostate Cancer Education: Factors Associated With Client Knowledge,American Journal of Men's Health,,,Article,2016-03-03,10.1177/1557988316632979,,,,26940533,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6194155,https://api.altmetric.com/v1/donut/6194155_240.png 1,Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2016-03-14,10.1007/s00259-016-3346-0,,,,26971788,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6192788,https://api.altmetric.com/v1/donut/6192788_240.png 1,Prostate Cancer Screening.,American Family Physician,,,Article,,,,,,26554408,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6186416,https://api.altmetric.com/v1/donut/6186416_240.png 1,"The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.",Hormones and Cancer,,,Article,2016-03-14,10.1007/s12672-016-0259-0,,,,26969590,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6180045,https://api.altmetric.com/v1/donut/6180045_240.png 1,Overcoming Cancer Radioresistance Factors of radioresistance in prostate cancer,Radiotherapy & Oncology,,,Article,2016-02-15,10.1016/s0167-8140(16)30128-1,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6178132,https://api.altmetric.com/v1/donut/6178132_240.png 1,Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate Cancer.,Israel Medical Association Journal,,,Article,2016-01-01,,,,,26964281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6176938,https://api.altmetric.com/v1/donut/6176938_240.png 1,"Cross-sectional relationships between dyadic coping and anxiety, depression, and relationship satisfaction for patients with prostate cancer and their spouses",Patient Education & Counseling,,,Article,2014-05-12,10.1016/j.pec.2014.04.010,,,,24880791,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6176331,https://api.altmetric.com/v1/donut/6176331_240.png 1,7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer,Bioorganic & Medicinal Chemistry Letters,,,Article,2016-03-01,10.1016/j.bmcl.2016.02.088,,,,26965862,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6176177,https://api.altmetric.com/v1/donut/6176177_240.png 1,Optimizing prostate cancer irradiation: from technology to fractionation,Radiotherapy & Oncology,,,Article,2016-02-15,10.1016/s0167-8140(16)30152-9,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6165505,https://api.altmetric.com/v1/donut/6165505_240.png 1,Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer,Journal of Pathology Informatics,,,Article,2016-01-01,10.4103/2153-3539.175376,,,,26955501,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6159343,https://api.altmetric.com/v1/donut/6159343_240.png 1,Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro,Journal of the Chinese Medical Association,,,Article,2014-09-19,10.1016/j.jcma.2014.03.008,,,,25249301,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6156526,https://api.altmetric.com/v1/donut/6156526_240.png 1,Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer.,Acta Oncologica,,,Article,2016-03-10,10.3109/0284186x.2015.1127417,,,,26959297,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6155795,https://api.altmetric.com/v1/donut/6155795_240.png 1,Artificial neural network for predicting pathological stage of clinically localized prostate cancer in a Taiwanese population,Journal of the Chinese Medical Association,,,Article,2014-08-26,10.1016/j.jcma.2014.06.014,,,,25175002,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6154616,https://api.altmetric.com/v1/donut/6154616_240.png 1,"Long non-coding RNA, a newly deciphered “code” in prostate cancer",Cancer Letters,,,Article,2016-03-07,10.1016/j.canlet.2016.03.003,,,,26965999,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6135355,https://api.altmetric.com/v1/donut/6135355_240.png 1,Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies,Expert Opinion on Therapeutic Targets,,,Article,,10.1517/14728222.2016.1147560,,,,26941073,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6135345,https://api.altmetric.com/v1/donut/6135345_240.png 1,External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis,Cancer (0008543X),,,Article,2008-02-15,10.1002/cncr.23241,,,,18098220,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6129256,https://api.altmetric.com/v1/donut/6129256_240.png 1,MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the PAI..,Free Radical Biology & Medicine,,,Article,2016-03-06,10.1016/j.freeradbiomed.2016.02.036,,,,26944191,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6128663,https://api.altmetric.com/v1/donut/6128663_240.png 1,Predictive values of vascular endothelial growth factor and microvessel-density levels in initial biopsy for prostate cancer. - PubMed - NCBI,The Kaohsiung Journal of Medical Sciences,,,Article,2016-03-06,10.1016/j.kjms.2015.12.001,,,,26944325,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6128265,https://api.altmetric.com/v1/donut/6128265_240.png 1,Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer,Current Treatment Options in Oncology,,,Article,2015-11-04,10.1007/s11864-015-0375-z,,,,26537882,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6125702,https://api.altmetric.com/v1/donut/6125702_240.png 1,Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. - PubMed - NCBI,Oncotarget,,,Article,2016-03-05,10.18632/oncotarget.7841,,,,26943043,PMC4951302,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6124788,https://api.altmetric.com/v1/donut/6124788_240.png 1,Imaging yield from 133 consecutive patients with prostate cancer and low trigger PSA from a single institution ,Clinical Radiology,,,Article,,10.1016/j.crad.2015.12.006,,,,26767544,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6124780,https://api.altmetric.com/v1/donut/6124780_240.png 1,Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3873,,,,25965833,PMC4599261,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6117544,https://api.altmetric.com/v1/donut/6117544_240.png 1,Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review,BMC Cancer,,,Article,2016-03-03,10.1186/s12885-016-2221-5,,,,26940836,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6102375,https://api.altmetric.com/v1/donut/6102375_240.png 1,Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-08-12,10.1158/1055-9965.epi-15-0394,,,,26269564,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6095933,https://api.altmetric.com/v1/donut/6095933_240.png 1,Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.,Medical Dosimetry,,,Article,2015-01-13,10.1016/j.meddos.2014.11.003,,,,25595491,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6075398,https://api.altmetric.com/v1/donut/6075398_240.png 1,Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.,,,,Article,,,,,,20552926,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6073235,https://api.altmetric.com/v1/donut/6073235_240.png 1,Chemopreventive effects of Korean Angelica vs. its major pyranocoumarins on two lineages of transgenic adenocarcinoma of mouse prostate carcinogenesis.,Cancer Prevention Research,,,Article,2015-06-26,10.1158/1940-6207.capr-15-0051,,,,26116406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6057233,https://api.altmetric.com/v1/donut/6057233_240.png 1,Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer,PLoS ONE,,,Article,2016-03-03,10.1371/journal.pone.0150241,,,,26939004,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6047190,https://api.altmetric.com/v1/donut/6047190_240.png 1,"Renal donors with prostate cancer, no longer a reason to decline ",Transplantation Reviews,,,Article,,10.1016/j.trre.2015.06.001,,,,26275676,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6044818,https://api.altmetric.com/v1/donut/6044818_240.png 1,Toward a better understanding of the comparatively high prostate cancer incidence rates in Utah,BMC Cancer,,,Article,2016-03-02,10.1186/1471-2407-3-14,,,,12720571,PMC156634,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5,https://www.altmetric.com/details/6041868,https://api.altmetric.com/v1/donut/6041868_240.png 1,Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction,Magnetic Resonance in Medicine,,,Article,2016-03-01,10.1002/mrm.26169,,,,26924552,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6030157,https://api.altmetric.com/v1/donut/6030157_240.png 1,Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer,BMC Cancer,,,Article,2016-02-29,10.1186/s12885-016-2192-6,,,,26923772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6024174,https://api.altmetric.com/v1/donut/6024174_240.png 1,miR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells,Biochemical & Biophysical Research Communications,,,Article,2016-02-28,10.1016/j.bbrc.2016.02.093,,,,26920049,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6015726,https://api.altmetric.com/v1/donut/6015726_240.png 1,"Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process",Urologia,,,Article,2016-02-28,10.5301/uro.5000166,,,,26917215,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6014981,https://api.altmetric.com/v1/donut/6014981_240.png 1,Immunoscintigraphy With 99mTc-Nimotuzumab for Planning Immunotherapy in Patients With Bone Metastases Due to Prostate Cancer,Clinical Nuclear Medicine,,,Article,2016-03-01,10.1097/rlu.0000000000001011,,,http://journals.lww.com/nuclearmed/Fulltext/2016/03000/Immunoscintigraphy_With_99mTc_Nimotuzumab_for.22.aspx,26447381,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6011689,https://api.altmetric.com/v1/donut/6011689_240.png 1,Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer,Cancer Genomics & Proteomics,,,Article,2016-02-26,,,,,26912805,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6008824,https://api.altmetric.com/v1/donut/6008824_240.png 1,Advanced prostate cancer presenting as bilateral testicular hydrocele,Indian Journal of Cancer,,,Article,2016-02-26,10.4103/0019-509x.176754,,,,26905104,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6008137,https://api.altmetric.com/v1/donut/6008137_240.png 1,EMERGING IMMUNOTARGETS AND IMMUNOTHERAPIES IN PROSTATE CANCER,Current Drug Targets,,,Article,2016-02-24,,,,,26898309,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5987381,https://api.altmetric.com/v1/donut/5987381_240.png 1,Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker,Oncology Letters,,,Article,2016-02-01,10.3892/ol.2015.4014,,,,26893719,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5822388,https://api.altmetric.com/v1/donut/5822388_240.png 1,E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer,International Journal of Oncology,,,Article,2016-02-20,10.3892/ijo.2016.3364,,,,26891801,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5780878,https://api.altmetric.com/v1/donut/5780878_240.png 1,Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo,Nanoscale,,,Article,2016-02-15,10.1039/c5nr08966b,,,,26875690,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5780081,https://api.altmetric.com/v1/donut/5780081_240.png 1,Saw Palmetto for Symptom Management During Radiation Therapy for Prostate Cancer. - PubMed - NCBI,Journal of Pain & Symptom Management,,,Article,2016-02-20,10.1016/j.jpainsymman.2015.12.315,,,,26891611,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5779522,https://api.altmetric.com/v1/donut/5779522_240.png 1,Exercise interventions for men with prostate cancer,Cochrane database of systematic reviews,,,Article,2015-12-25,10.1002/14651858.cd011251.pub2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5734159,https://api.altmetric.com/v1/donut/5734159_240.png 1,Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer. - PubMed - NCBI,Oncotarget,,,Article,2015-01-22,10.18632/oncotarget.2879,,,,25686826,PMC4414171,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5688560,https://api.altmetric.com/v1/donut/5688560_240.png 1,Prostate Cancer Education in African American Barbershops: Baseline Client Survey Results and Differences in Decisional Conflict and Stage of Decis..,American Journal of Men's Health,,,Article,2016-02-09,10.1177/1557988316630952,,,,26860126,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5634586,https://api.altmetric.com/v1/donut/5634586_240.png 1,Long-Term Oncologic Outcome of an Initial Series of Laparoscopic Radical Prostatectomy for Clinically Localized Prostate Cancer After a Median Follow-up of 10 Years,Clinical Genitourinary Cancer,,,Article,2015-11-17,10.1016/j.clgc.2015.11.006,,,,26710661,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5634189,https://api.altmetric.com/v1/donut/5634189_240.png 1,Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy,Radiotherapy & Oncology,,,Article,2016-02-17,10.1016/j.radonc.2016.02.002,,,,26897512,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5632960,https://api.altmetric.com/v1/donut/5632960_240.png 1,"Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.",European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2016-02-16,10.1097/cej.0000000000000230,,,http://journals.lww.com/eurjcancerprev/Fulltext/publishahead/Interactive_effects_of_9_cis_retinoic_acid_and.99440.aspx,26886237,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5628880,https://api.altmetric.com/v1/donut/5628880_240.png 1,Laparoscopic Radical Prostatectomy Plus Extended Lymph Node Dissection in Combination With Immediate Androgen Deprivation Therapy for Cases of pT3-4N0-1M0 Prostate Cancer: A Multimodal Study of 8 Years' Follow-up,Clinical Genitourinary Cancer,,,Article,2015-11-17,10.1016/j.clgc.2015.11.009,,,,26691668,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5626351,https://api.altmetric.com/v1/donut/5626351_240.png 1,Glycosylation status of serum immunoglobulin G in patients with prostate diseases,Cancer Medicine,,,Article,2016-02-01,10.1002/cam4.662,,,,26880719,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5615842,https://api.altmetric.com/v1/donut/5615842_240.png 1,In Vivo Suppression of Hormone-Refractory Prostate Cancer Growth by Inositol Hexaphosphate Induction of Insulin-Like Growth Factor Binding Protein-3 and Inhibition of Vascular Endothelial Growth Factor,Clinical Cancer Research,,,Article,2004-01-01,10.1158/1078-0432.ccr-1080-3,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5612445,https://api.altmetric.com/v1/donut/5612445_240.png 1,Validation of 3 T MRI including diffusion-weighted imaging for nodal staging of newly diagnosed intermediate- and high-risk prostate cancer ,Clinical Radiology,,,Article,,10.1016/j.crad.2015.12.001,,,,26774372,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5609240,https://api.altmetric.com/v1/donut/5609240_240.png 1,Testosterone therapy for men at risk for or with history of prostate cancer,Current Treatment Options in Oncology,,,Article,2006-09-14,,,,,16904053,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5606934,https://api.altmetric.com/v1/donut/5606934_240.png 1,Mangiferin inhibition of proliferation and induction of apoptosis in human prostate cancer cells is correlated with downregulation of B-cell lympho..,Oncology Letters,,,Article,2016-01-01,10.3892/ol.2015.3924,,,,26870290,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5533184,https://api.altmetric.com/v1/donut/5533184_240.png 1,Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synt... - PubMed - NCBI,Oncotarget,,,Article,2016-02-13,10.18632/oncotarget.7296,,,,26871944,PMC4924668,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5532864,https://api.altmetric.com/v1/donut/5532864_240.png 1,Urinary bladder dose–response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy,Radiotherapy & Oncology,,,Article,2016-02-12,10.1016/j.radonc.2016.01.013,,,,26879287,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5532218,https://api.altmetric.com/v1/donut/5532218_240.png 1,Prediction of treatment efficacy for prostate cancer using a mathematical model. - PubMed - NCBI,Scientific Reports,,,Article,2016-02-13,10.1038/srep21599,,,,26868634,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/5531796,https://api.altmetric.com/v1/donut/5531796_240.png 1,An electrochemical biosensor to simultaneously detect VEGF and PSA for early prostate cancer diagnosis based on graphene oxide/ssDNA/PLLA nanoparti..,Biosensors & Bioelectronics,,,Article,2016-02-13,10.1016/j.bios.2016.01.077,,,,26868935,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5531702,https://api.altmetric.com/v1/donut/5531702_240.png 1,G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells,Oncotarget,,,Article,2016-02-13,10.18632/oncotarget.7313,,,,26871479,PMC4914324,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5529840,https://api.altmetric.com/v1/donut/5529840_240.png 1,DNA-PKcs expression is a predictor of biochemical recurrence after permanent iodine-125 interstitial brachytherapy for prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-10,10.1016/j.ijrobp.2016.02.015,,,,27113564,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5309241,https://api.altmetric.com/v1/donut/5309241_240.png 1,Prostate cancer risk among French farmers in the AGRICAN cohort.,"Scandinavian journal of work, environment & health",,,Article,2016-03-05,10.5271/sjweh.3552,,,,26932763,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5308309,https://api.altmetric.com/v1/donut/5308309_240.png 1,"Abstract A55: Phase 1 results of emibetuzumab (LY2875358), a bivalent MET antibody, in patients with advanced castration-resistant prostate cancer, and MET positive renal cell carcinoma, non-small cell lung cancer, and hepatocellular carcinoma",Molecular Cancer Therapeutics,,,Article,2015-12-01,10.1158/1535-7163.targ-15-a55,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,https://www.altmetric.com/details/5301362,https://api.altmetric.com/v1/donut/5301362_240.png 1,Association between CYP2E1 polymorphisms and susceptibility to prostate cancer.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2003-06-01,10.1097/01.cej.0000073081.42031.54,,,,12771559,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5299455,https://api.altmetric.com/v1/donut/5299455_240.png 1,Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.,International Journal of Clinical and Experimental Pathology,,,Article,,,,,,25973080,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5298174,https://api.altmetric.com/v1/donut/5298174_240.png 1,The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.,Journal of B U ON official journal of the Balkan Union of Oncology,,,Article,2015-11-01,,,,,26854458,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5155649,https://api.altmetric.com/v1/donut/5155649_240.png 1,[Palliative chemotherapy with 5 FU and CPM in cancer of the prostate with bone metastases resistant to oestrogens. A clinical trial (author's transl)].,Journal d urologie et de néphrologie,,,Article,1979-10-01,,,,,94108,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5110568,https://api.altmetric.com/v1/donut/5110568_240.png 1,RNA tumor virus-like activities in human prostate: possible novel pharmacologic approaches.,Cancer treatment reports,,,Article,1977-03-01,,,,,68816,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5109957,https://api.altmetric.com/v1/donut/5109957_240.png 1,Is Targeted Therapy of Prostate Cancer Ready for Prime Time?,European Urology,,,Article,2016-02-01,10.1016/j.eururo.2015.06.049,,,,26189690,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5109614,https://api.altmetric.com/v1/donut/5109614_240.png 1,Lycopene and Soy Isoflavones in the Treatment of Prostate Cancer,Nutrition and Cancer,,,Article,2007-09-11,10.1080/01635580701413934,,,,17927495,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/5107260,https://api.altmetric.com/v1/donut/5107260_240.png 1,MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer Progression,Cancer Research,,,Article,2010-04-01,10.1158/0008-5472.can-09-3718,,,,20332243,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/5104097,https://api.altmetric.com/v1/donut/5104097_240.png 1,"Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration",European Journal of Cancer (1965),,,Article,2016-04-01,10.1016/j.ejca.2016.01.002,,,,26854828,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5103695,https://api.altmetric.com/v1/donut/5103695_240.png 1,Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores,European Radiology,,,Article,2015-05-21,10.1007/s00330-015-3701-8,,,,25991476,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/5099062,https://api.altmetric.com/v1/donut/5099062_240.png 1,Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study,BMC Cancer,,,Article,2016-02-04,10.1186/s12885-016-2085-8,,,,26846521,PMC4743098,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5098935,https://api.altmetric.com/v1/donut/5098935_240.png 1,Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials.,Critical Reviews in Oncology/Hematology,,,Article,2015-11-17,10.1016/j.critrevonc.2015.11.009,,,,26638863,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5098560,https://api.altmetric.com/v1/donut/5098560_240.png 1,Increase in apoptotic effect of Panax ginseng by microwave processing in human prostate cancer cells: in vitro and in vivo studies.,Journal of Ginseng Research,,,Article,2016-01-01,10.1016/j.jgr.2015.04.007,,,,26843823,PMC4703806,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5095673,https://api.altmetric.com/v1/donut/5095673_240.png 1,Orbital Compartment Syndrome as the Presenting Sign of Disseminated Intravascular Coagulation From Metastatic Prostatic Cancer to the Orbit,Urology,,,Article,2015-07-09,10.1016/j.urology.2015.05.017,,,,26165617,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5094544,https://api.altmetric.com/v1/donut/5094544_240.png 1,"Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.",Tumor Biology,,,Article,2016-02-04,10.1007/s13277-016-4883-7,,,,26831660,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5093928,https://api.altmetric.com/v1/donut/5093928_240.png 1,Galectin-3 cleavage alters bone remodeling: Different outcomes in breast and prostate cancer skeletal metastasis.,Cancer Research,,,Article,2016-02-04,10.1158/0008-5472.can-15-1793,,,,26837763,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5089882,https://api.altmetric.com/v1/donut/5089882_240.png 1,Feasibility and initial dosimetric findings for a randomized trial using dose painted Multi-parametric-MRI Defined targets in Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-03,10.1016/j.ijrobp.2016.01.052,,,,27020109,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5089280,https://api.altmetric.com/v1/donut/5089280_240.png 1,"Effects of a novel carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleoside on pleiotropic induction of cell death in prostate cancer cells with different androgen responsiveness.",Bioorganic & Medicinal Chemistry Letters,,,Article,2016-02-03,10.1016/j.bmcl.2016.01.057,,,,26832220,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5084139,https://api.altmetric.com/v1/donut/5084139_240.png 1,Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality?adjusted life?year analysis,Cancer (0008543X),,,Article,2016-01-01,10.1002/cncr.29892,,,,26828716,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5071787,https://api.altmetric.com/v1/donut/5071787_240.png 1,Expression of store-operated channel components in prostate cancer: the prognostic paradox.,Human Pathology,,,Article,2016-01-31,10.1016/j.humpath.2015.09.042,,,,26826413,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5067084,https://api.altmetric.com/v1/donut/5067084_240.png 1,Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.,International Journal of Clinical and Experimental Pathology,,,Article,2016-01-31,,,,,26823749,PMC4713535,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5066421,https://api.altmetric.com/v1/donut/5066421_240.png 1,Abnormal 18F-FDG uptakes in the prostate due to two different conditions of urine reflux: a mimicker of prostate cancer,SpringerPlus,,,Article,2016-01-20,10.1186/s40064-016-1696-5,,,,26835226,PMC4718920,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5064890,https://api.altmetric.com/v1/donut/5064890_240.png 1,Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer ,Brachytherapy,,,Article,2016-01-01,10.1016/j.brachy.2015.12.004,,,,26832674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5064351,https://api.altmetric.com/v1/donut/5064351_240.png 1,Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience.,Oncogene,,,Article,2015-02-09,10.1038/onc.2015.5,,,,25659583,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/5064002,https://api.altmetric.com/v1/donut/5064002_240.png 1,Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer.,Technology in Cancer Research and Treatment,,,Article,2016-01-29,10.1177/1533034615626614,,,,26818025,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5060552,https://api.altmetric.com/v1/donut/5060552_240.png 1,[Clinical outcomes of laparoscopic radical prostatectomy for high risk prostate cancer].,Zhonghua wai ke za zhi Chinese journal of surgery,,,Article,2015-11-01,,,,,26813840,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5054555,https://api.altmetric.com/v1/donut/5054555_240.png 1,AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth,The Prostate,,,Article,2016-01-01,10.1002/pros.23151,,,,26771938,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5053161,https://api.altmetric.com/v1/donut/5053161_240.png 1,"Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer",,,,Article,2016-01-25,10.1021/acs.bioconjchem.5b00687.s004,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5049059,https://api.altmetric.com/v1/donut/5049059_240.png 1,Risk of prostate cancer specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence,British Journal of Urology,,,Article,2016-01-01,10.1111/bju.13428,,,,26805930,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5045372,https://api.altmetric.com/v1/donut/5045372_240.png 1,"Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.",American Journal of Cancer Research,,,Article,2015-01-01,,,,,26807321,PMC4697687,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5043047,https://api.altmetric.com/v1/donut/5043047_240.png 1,[Synergistic antitumor effects of tanshinone II A in combination with cisplatin via apoptosis in the prostate cancer cells].,,,,Article,2013-05-14,,,,,23888689,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5042892,https://api.altmetric.com/v1/donut/5042892_240.png 1,The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-26,10.1038/pcan.2015.60,,,,26810014,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5042411,https://api.altmetric.com/v1/donut/5042411_240.png 1,Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen Increases.,Clinical Genitourinary Cancer,,,Article,2016-01-26,10.1016/j.clgc.2015.12.006,,,,26804605,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5041929,https://api.altmetric.com/v1/donut/5041929_240.png 1,5?alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial,International Journal of Cancer,,,Article,2016-01-01,10.1002/ijc.30017,,,,26804670,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5035353,https://api.altmetric.com/v1/donut/5035353_240.png 1,Antiproliferative Effects of New Dimeric Ellagitannin from Cornus alba in Prostate Cancer Cells Including Apoptosis-Related S-Phase Arrest,Molecules,,,Article,2016-01-23,10.3390/molecules21020137,,,,26805810,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5035234,https://api.altmetric.com/v1/donut/5035234_240.png 1,Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium.,Breast Cancer Research and Treatment,,,Article,2016-01-24,10.1007/s10549-016-3681-7,,,,26802016,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5033073,https://api.altmetric.com/v1/donut/5033073_240.png 1,CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and ?v?3 integrin clustering.,Oncotarget,,,Article,2016-01-23,10.18632/oncotarget.6944,,,,26799186,PMC4872790,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5031418,https://api.altmetric.com/v1/donut/5031418_240.png 1,Long non-coding RNA lnc-MX1-1 is associated with poor clinical features and promotes cellular proliferation and invasiveness in prostate cancer.,Biochemical & Biophysical Research Communications,,,Article,2016-01-23,10.1016/j.bbrc.2016.01.056,,,,26797523,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5031253,https://api.altmetric.com/v1/donut/5031253_240.png 1,Re: The Impact of Definitive Local Therapy for Lymph Node–positive Prostate Cancer: A Population-based Study,European Urology,,,Article,2015-07-01,10.1016/j.eururo.2015.03.052,,,,26088730,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5029367,https://api.altmetric.com/v1/donut/5029367_240.png 1,Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice,PLoS ONE,,,Article,2016-01-22,10.1371/journal.pone.0147173,,,,26799485,PMC4723068,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5029124,https://api.altmetric.com/v1/donut/5029124_240.png 1,Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.,Tumor Biology,,,Article,2016-01-21,10.1007/s13277-016-4847-y,,,,26797783,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5023852,https://api.altmetric.com/v1/donut/5023852_240.png 1,The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer,Current Oncology Reports,,,Article,2015-10-08,10.1007/s11912-015-0478-5,,,,26449841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5022026,https://api.altmetric.com/v1/donut/5022026_240.png 1,"Estrogen receptor ? in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment",Molecular Cancer,,,Article,2016-01-20,10.1186/s12943-015-0488-9,,,,26790618,PMC4721150,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/5019970,https://api.altmetric.com/v1/donut/5019970_240.png 1,MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility.,Molecular Medicine Reports,,,Article,2016-01-20,10.3892/mmr.2016.4756,,,,26780929,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5016037,https://api.altmetric.com/v1/donut/5016037_240.png 1,Involving a Citizens’ Jury in Decisions on Individual Screening for Prostate Cancer,PLoS ONE,,,Article,2016-01-11,10.1371/journal.pone.0143176,,,,26751212,PMC4709131,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5013830,https://api.altmetric.com/v1/donut/5013830_240.png 1,Abstract A10: High-fat diet enhances MYC-driven prostate cancer through epigenomic and metabolomic rewiring,Cancer Research,,,Article,2016-01-15,10.1158/1538-7445.chromepi15-a10,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5012651,https://api.altmetric.com/v1/donut/5012651_240.png 1,Lycopene acts through inhibition of I?B kinase to suppress NF-?B signaling in human prostate and breast cancer cells.,Tumor Biology,,,Article,2016-01-16,10.1007/s13277-016-4798-3,,,,26779636,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5003219,https://api.altmetric.com/v1/donut/5003219_240.png 1,MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.,The Prostate,,,Article,2016-01-16,10.1002/pros.23143,,,,26771762,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5001713,https://api.altmetric.com/v1/donut/5001713_240.png 1,Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.,Oncotarget,,,Article,2016-01-16,10.18632/oncotarget.6899,,,,26771841,PMC4872752,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/5001185,https://api.altmetric.com/v1/donut/5001185_240.png 1,Anticancer properties of carotenoids in prostate cancer: A review.,Histology and Histopathology,,,Article,,10.14670/hh-11-635,,,,26058846,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4998426,https://api.altmetric.com/v1/donut/4998426_240.png 1,Radium223—Where Does It Fit in the Metastatic Castration-resistant Prostate Cancer Treatment Landscape?,Oncology & Hematology Review (US),,,Article,2015-01-01,10.17925/ohr.2015.11.02.135,,,,,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4993977,https://api.altmetric.com/v1/donut/4993977_240.png 1,"Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.",Journal of Hematology & Oncology,,,Article,2016-01-14,10.1186/s13045-016-0233-x,,,,26759222,PMC4709959,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4993689,https://api.altmetric.com/v1/donut/4993689_240.png 1,Primary Gleason Pattern Does Not Affect Recurrence-Free Survival in Patients Receiving Radiotherapy for Prostate Cancer,Journal of Nuclear Medicine & Radiation Therapy,,,Article,2014-08-05,10.4172/2155-9619.1000186,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4993268,https://api.altmetric.com/v1/donut/4993268_240.png 1,Interconnection of Estrogen/ Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.,Current Molecular Pharmacology,,,Article,2016-01-14,,,,,26758947,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4992332,https://api.altmetric.com/v1/donut/4992332_240.png 1,Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.,Molecular Cancer Research,,,Article,2016-01-14,10.1158/1541-7786.mcr-15-0330,,,,26753621,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4990068,https://api.altmetric.com/v1/donut/4990068_240.png 1,In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI,Prostate Cancer & Prostatic Diseases,,,Article,2016-01-12,10.1038/pcan.2015.61,,,,26754261,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4984407,https://api.altmetric.com/v1/donut/4984407_240.png 1,"The MCT4 Gene: a Novel, Potential Target for Therapy of Advanced Prostate Cancer",Clinical Cancer Research,,,Article,2016-01-13,10.1158/1078-0432.ccr-15-1624,,,,26755530,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4983862,https://api.altmetric.com/v1/donut/4983862_240.png 1,"Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models",BMC Cancer,,,Article,2016-01-11,10.1186/s12885-015-2046-7,,,,26753765,PMC4707722,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4980472,https://api.altmetric.com/v1/donut/4980472_240.png 1,"Target Volume Heterogeneity Index, a Potentially Valuable Metric in IMRT Prostate Cancer Treatment Planning",Journal of Nuclear Medicine & Radiation Therapy,,,Article,2014-10-22,10.4172/2155-9619.1000192,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4980363,https://api.altmetric.com/v1/donut/4980363_240.png 1,Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells,OncoTargets and Therapy,,,Article,2016-01-08,10.2147/ott.s96710,,,,26811691,PMC4712973,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4977480,https://api.altmetric.com/v1/donut/4977480_240.png 1,miR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.,International Journal of Molecular Medicine,,,Article,2016-01-09,10.3892/ijmm.2016.2449,,,,26743688,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4974582,https://api.altmetric.com/v1/donut/4974582_240.png 1,Adding Docetaxel or Zoledronic Acid to ADT for Advanced Prostate Cancer?,Journal Watch,,,Article,2016-01-07,10.1056/nejm-jw.na40039,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4974549,https://api.altmetric.com/v1/donut/4974549_240.png 1,Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2014-02-21,10.1016/j.jsbmb.2014.02.006,,,,24565566,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/4972818,https://api.altmetric.com/v1/donut/4972818_240.png 1,Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor.,,,,Article,2008-12-15,10.1016/j.jnutbio.2007.11.006,,,,18479901,PMC2610864,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/4972817,https://api.altmetric.com/v1/donut/4972817_240.png 1,Bicalutamide causes heart failure in an elderly patient with prostate cancer,Expert Opinion on Drug Safety,,,Article,2016-01-09,10.1517/14740338.2015.1131819,,,,26745594,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4972115,https://api.altmetric.com/v1/donut/4972115_240.png 1,"Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.",Oncotarget,,,Article,2016-01-07,10.18632/oncotarget.6801,,,,26734997,PMC4868713,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4965866,https://api.altmetric.com/v1/donut/4965866_240.png 1,The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells.,Oncotarget,,,Article,2016-01-07,10.18632/oncotarget.6267,,,,26733491,PMC4791278,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4965087,https://api.altmetric.com/v1/donut/4965087_240.png 1,Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).,NMR in Biomedicine,,,Article,2016-01-06,10.1002/nbm.3452,,,,26730884,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4960316,https://api.altmetric.com/v1/donut/4960316_240.png 1,A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.,"Cancer Immunology, Immunotherapy",,,Article,2016-01-04,10.1007/s00262-015-1781-6,,,,26728480,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4953105,https://api.altmetric.com/v1/donut/4953105_240.png 1,miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression.,Oncology Letters,,,Article,2015-11-01,10.3892/ol.2015.3645,,,,26722316,PMC4665267,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4947151,https://api.altmetric.com/v1/donut/4947151_240.png 1,Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-08-29,10.1007/s00259-015-3174-7,,,,26318602,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4945976,https://api.altmetric.com/v1/donut/4945976_240.png 1,Formulation and in vitro efficacy of liposomes containing the hsp90 inhibitor 6BrCaQ in prostate cancer cells.,International Journal of Pharmaceutics,,,Article,2016-01-02,10.1016/j.ijpharm.2015.12.053,,,,26721724,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4945946,https://api.altmetric.com/v1/donut/4945946_240.png 1,Role of DNA Methylation in Cabazitaxel Resistance in Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2016-01-02,,,,,26722040,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4945656,https://api.altmetric.com/v1/donut/4945656_240.png 1,MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.,Oncology Reports,,,Article,2016-01-01,10.3892/or.2015.4458,,,,26718483,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4944575,https://api.altmetric.com/v1/donut/4944575_240.png 1,Targeting survivin using a combination of miR?494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.,Molecular Medicine Reports,,,Article,2016-01-01,10.3892/mmr.2015.4739,,,,26718651,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4944303,https://api.altmetric.com/v1/donut/4944303_240.png 1,CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-?/EGFR pathway in hypoxic androgen?independent prostate cancer cells.,Oncology Reports,,,Article,2016-01-01,10.3892/or.2015.4470,,,,26718770,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4943851,https://api.altmetric.com/v1/donut/4943851_240.png 1,SET8 induces epithelial?mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.,Molecular Medicine Reports,,,Article,2016-01-01,10.3892/mmr.2015.4733,,,,26717907,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4943843,https://api.altmetric.com/v1/donut/4943843_240.png 1,Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia,BMC Urology,,,Article,2015-12-30,10.1186/s12894-015-0117-3,,,,26715039,PMC4696233,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4940477,https://api.altmetric.com/v1/donut/4940477_240.png 1,Secondary Cancers After Radiation Therapy for Primary Prostate or Rectal Cancer.,World Journal of Surgery,,,Article,2015-12-30,10.1007/s00268-015-3324-x,,,,26711638,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4937125,https://api.altmetric.com/v1/donut/4937125_240.png 1,A prospective comparison of the effects of interfractional variations on proton therapy and IMRT for prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-26,10.1016/j.ijrobp.2015.12.366,,,,26907917,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4936085,https://api.altmetric.com/v1/donut/4936085_240.png 1,Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer ,Clinical Radiology,,,Article,2016-01-08,10.1016/j.crad.2015.11.013,,,,26738964,,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4935877,https://api.altmetric.com/v1/donut/4935877_240.png 1,Targeted Prodrug Approaches for Hormone Refractory Prostate Cancer.,Medicinal Research Reviews,,,Article,2014-12-22,10.1002/med.21333,,,,25529338,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4935619,https://api.altmetric.com/v1/donut/4935619_240.png 1,Epididymal Sparing Bilateral Orchidectomy with Epididymoplasty for Advanced Cancer Prostate: Our Experience in Rural Setup,Medical & Surgical Urology,,,Article,2013-01-15,10.4172/2168-9857.1000106,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4935264,https://api.altmetric.com/v1/donut/4935264_240.png 1,Next generation biomarkers in prostate cancer.,Frontiers in Bioscience,,,Article,2015-12-29,,,,,26709776,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4933940,https://api.altmetric.com/v1/donut/4933940_240.png 1,Treatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world data.,Cancer Medicine,,,Article,2015-12-01,10.1002/cam4.576,,,,26710718,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4932401,https://api.altmetric.com/v1/donut/4932401_240.png 1,Intraoperative Management of an Incidentally Identified Ectopic Ureter Inserting Into the Prostate of a Patient Undergoing Radical Prostatectomy for Prostate Cancer: A Case Report,Medicine,,,Article,2015-08-01,10.1097/md.0000000000001261,,,,26266359,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4931878,https://api.altmetric.com/v1/donut/4931878_240.png 1,"Association between glutathione S-transferases M1, T1 and P1 gene polymorphisms and prostate cancer in Koreans",Genes & Genomics,,,Article,2015-12-28,10.1007/s13258-015-0382-2,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4930622,https://api.altmetric.com/v1/donut/4930622_240.png 1,"In the Era of Shared Decision Making, How Would An Iranian Urologist Screen Himself For Prostate Cancer?",Urology Journal,,,Article,2015-12-28,,,,,26706736,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4929564,https://api.altmetric.com/v1/donut/4929564_240.png 1,Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop.,Oncotarget,,,Article,2015-12-27,10.18632/oncotarget.6643,,,,26700819,PMC4826255,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4926755,https://api.altmetric.com/v1/donut/4926755_240.png 1,Expression of ERK1 and ERK2 in prostate cancer,MAP Kinase,,,Article,2015-12-18,10.4081/mk.2015.5265,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4926223,https://api.altmetric.com/v1/donut/4926223_240.png 1,MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.,Biochemical & Biophysical Research Communications,,,Article,2015-12-26,10.1016/j.bbrc.2015.12.054,,,,26703210,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4926013,https://api.altmetric.com/v1/donut/4926013_240.png 1,A predictive signature for therapy assignment and risk assessment in prostate cancer.,Oncoscience,,,Article,2015-01-01,10.18632/oncoscience.271,,,,26697526,PMC4675789,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4920203,https://api.altmetric.com/v1/donut/4920203_240.png 1,[177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-01-09,10.1007/s00259-014-2978-1,,,,25573634,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4919446,https://api.altmetric.com/v1/donut/4919446_240.png 1,The HSP90 inhibitor 17-PAG effectively inhibits the proliferation and migration of androgen-independent prostate cancer cells.,American Journal of Cancer Research,,,Article,2015-01-01,,,,,26693070,PMC4656741,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4919425,https://api.altmetric.com/v1/donut/4919425_240.png 1,Expression of arginase II in prostate cancer.,,,,Article,2008-02-15,,,,,18202758,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4916947,https://api.altmetric.com/v1/donut/4916947_240.png 1,Prostate Cancer Virtual Special Issue ,Clinical Oncology,,,Article,2016-01-05,10.1016/j.clon.2015.12.005,,,,26726168,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4915096,https://api.altmetric.com/v1/donut/4915096_240.png 1,"Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-?B signaling pathway.",Oncology Reports,,,Article,,10.3892/or.2015.4341,,,,26497618,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4907849,https://api.altmetric.com/v1/donut/4907849_240.png 1,The interplay between autophagy and apoptosis induced by tanshinone IIA in prostate cancer cells.,Tumor Biology,,,Article,2015-12-21,10.1007/s13277-015-4602-9,,,,26687918,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4905119,https://api.altmetric.com/v1/donut/4905119_240.png 1,"Influence of polymorphisms of UDP-glycosyltransferases (UGT) 2B family genes UGT2B15, UGT2B17 and UGT2B28 on the development of prostate cancer in Korean men",Genes & Genomics,,,Article,2015-12-19,10.1007/s13258-015-0379-x,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4902874,https://api.altmetric.com/v1/donut/4902874_240.png 1,Antitumoral and Antioxidant Potential of Egyptian Propolis Against the PC3 Prostate Cancer Cell Line.,Asian Pacific Journal of Cancer Prevention,,,Article,,,,,,26625775,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4901963,https://api.altmetric.com/v1/donut/4901963_240.png 1,A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy ,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.07.004,,,,26338414,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4901151,https://api.altmetric.com/v1/donut/4901151_240.png 1,"The pentacyclic triterpenoid, plectranthoic acid, a novel activator of AMPK induces apoptotic death in prostate cancer cells.",Oncotarget,,,Article,2015-12-20,10.18632/oncotarget.6625,,,,26683363,PMC4826172,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4900284,https://api.altmetric.com/v1/donut/4900284_240.png 1,Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI,European Radiology,,,Article,2015-03-29,10.1007/s00330-015-3688-1,,,,25820537,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4898599,https://api.altmetric.com/v1/donut/4898599_240.png 1,"High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer.",Oxidative Medicine & Cellular Longetivity,,,Article,2015-12-19,10.1155/2016/5845061,,,,26682011,PMC4670870,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4897329,https://api.altmetric.com/v1/donut/4897329_240.png 1,[Aberrant expression of long noncoding RNA in prostate cancer].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-10-01,,,,,26665688,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4889575,https://api.altmetric.com/v1/donut/4889575_240.png 1,Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.,Advances in experimental medicine and biology,,,Article,2016-01-01,10.1007/978-94-017-7417-8_8,,,http://link.springer.com/chapter/10.1007%2F978-94-017-7417-8_8,26659491,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4881541,https://api.altmetric.com/v1/donut/4881541_240.png 1,Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface.,Materials Science & Engineering: C,,,Article,2015-12-15,10.1016/j.msec.2015.11.032,,,,26652466,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4881124,https://api.altmetric.com/v1/donut/4881124_240.png 1,Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.,Journal of Cancer Research & Clinical Oncology,,,Article,2015-12-15,10.1007/s00432-015-2093-0,,,,26660495,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4879807,https://api.altmetric.com/v1/donut/4879807_240.png 1,"Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?",Journal of Cancer Research & Clinical Oncology,,,Article,2015-12-15,10.1007/s00432-015-2089-9,,,,26660324,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4879783,https://api.altmetric.com/v1/donut/4879783_240.png 1,"NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect.",Oncotarget,,,Article,2014-12-26,10.18632/oncotarget.3067,,,,25605246,PMC4413623,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4879572,https://api.altmetric.com/v1/donut/4879572_240.png 1,NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-01,10.1016/j.ijrobp.2015.10.049,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4869517,https://api.altmetric.com/v1/donut/4869517_240.png 1,"Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-01,10.1016/j.ijrobp.2015.10.046,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4869515,https://api.altmetric.com/v1/donut/4869515_240.png 1,Nodal clearance rate and long-term efficacy of individualized sentinel node based pelvic IMRT for high risk prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-10,10.1016/j.ijrobp.2015.10.031,,,,26853335,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4869514,https://api.altmetric.com/v1/donut/4869514_240.png 1,Effects of Pomegranate Chemical Constituents/Intestinal Microbial Metabolites on CYP1B1 in 22Rv1 Prostate Cancer Cells,,,,Article,2009-11-25,10.1021/jf902716r,,,,19919114,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/4866520,https://api.altmetric.com/v1/donut/4866520_240.png 1,Comment on: Radiation Dose to the Penile Structures and Patient?Reported Sexual Dysfunction in Long?Term Prostate Cancer Survivors,Journal of Sexual Medicine,,,Article,2016-01-01,10.1111/jsm.13064,,,,26663828,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4865914,https://api.altmetric.com/v1/donut/4865914_240.png 1,"Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA","International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-01,10.1016/j.ijrobp.2015.10.048,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4865778,https://api.altmetric.com/v1/donut/4865778_240.png 1,MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.,International Journal of Molecular Medicine,,,Article,2015-12-11,10.3892/ijmm.2015.2355,,,,26647850,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4864713,https://api.altmetric.com/v1/donut/4864713_240.png 1,"let-7a and its target, insulin-like growth factor 1 receptor, are differentially expressed in recurrent prostate cancer.",International Journal of Molecular Medicine,,,Article,2015-12-11,10.3892/ijmm.2015.2357,,,,26648141,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4864571,https://api.altmetric.com/v1/donut/4864571_240.png 1,Chemotherapy Plus Estramustine for Management of Castration-Resistant Prostate Cancer: Meta-Analysis of Randomized Controlled Trials.,Actas Urológicas Españolas,,,Article,2014-02-05,10.1016/j.acuro.2013.07.010,,,,24507454,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4861677,https://api.altmetric.com/v1/donut/4861677_240.png 1,"Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trials.","Drug Design, Development and Therapy",,,Article,,10.2147/dddt.s87304,,,,26451085,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4861674,https://api.altmetric.com/v1/donut/4861674_240.png 1,"Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan.",Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/hyv149,,,,26486824,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4861669,https://api.altmetric.com/v1/donut/4861669_240.png 1,Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip,Biomicrofluidics,,,Article,2015-11-12,10.1063/1.4934715,,,,26594265,PMC4644147,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4860795,https://api.altmetric.com/v1/donut/4860795_240.png 1,Radiation Therapy With or Without Short-Term Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer: Results of a Phase 3 Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-01,10.1016/j.ijrobp.2015.10.038,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4860157,https://api.altmetric.com/v1/donut/4860157_240.png 1,PSMA-Specific Theranostic Nanoplex for Combination of TRAIL Gene and 5-FC Prodrug Therapy of Prostate Cancer ,Biomaterials,,,Article,2015-12-27,10.1016/j.biomaterials.2015.11.048,,,,26706476,PMC4706473,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4857845,https://api.altmetric.com/v1/donut/4857845_240.png 1,"Preventive effect of Malva on urinary toxicity after radiation therapy in prostate cancer patients: A multi-centric, double-blind, randomized clinical trial.",Electronic Physician,,,Article,2015-09-01,10.14661/1220,,,,26435820,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4855692,https://api.altmetric.com/v1/donut/4855692_240.png 1,Improved Outcomes for Prostate Cancer Using Hypofractionated Radiotherapy and Dose Escalation to 55Gy,Journal of Nuclear Medicine & Radiation Therapy,,,Article,2014-10-22,10.4172/2155-9619.1000188,,,,,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4855527,https://api.altmetric.com/v1/donut/4855527_240.png 1,Sister Mary joseph nodule from prostate cancer.,,,,Article,2012-07-14,,,,,22802547,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4854230,https://api.altmetric.com/v1/donut/4854230_240.png 1,"MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1.",Journal of Cancer,,,Article,2015-01-01,10.7150/jca.13176,,,,26640590,PMC4643086,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4853094,https://api.altmetric.com/v1/donut/4853094_240.png 1,The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer.,International Journal of Medical Sciences,,,Article,2015-12-08,10.7150/ijms.11713,,,,26640404,PMC4643075,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4852409,https://api.altmetric.com/v1/donut/4852409_240.png 1,"A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-12-08,10.1158/1055-9965.epi-15-0649,,,,26637267,PMC4713268,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4852045,https://api.altmetric.com/v1/donut/4852045_240.png 1,Comparison between conventional imaging (abdominal–pelvic computed tomography and bone scan) and [18F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis,Scandinavian Journal of Urology,,,Article,2015-02-03,10.3109/21681805.2015.1005665,,,,25649494,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4850754,https://api.altmetric.com/v1/donut/4850754_240.png 1,Prostate Cancer Ambassadors: Enhancing a Theory-Informed Training Program for Informed Decision-Making,Journal of Cancer Education,,,Article,2015-12-02,10.1007/s13187-015-0955-4,,,,26627905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4849602,https://api.altmetric.com/v1/donut/4849602_240.png 1,Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen,Clinical and Experimental Metastasis,,,Article,,10.1023/a:1006783330996,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4848727,https://api.altmetric.com/v1/donut/4848727_240.png 1,Transitions in Symptom Cluster Subgroups Among Men Undergoing Prostate Cancer Radiation Therapy,Cancer nursing (Online),,,Article,2015-02-27,10.1097/ncc.0000000000000236,,,,25730597,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4842493,https://api.altmetric.com/v1/donut/4842493_240.png 1,MiR-592 represses FOXO3 expression and promotes the proliferation of prostate cancer cells.,International Journal of Clinical and Experimental Medicine,,,Article,2015-01-01,,,,,26629010,PMC4658899,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4838580,https://api.altmetric.com/v1/donut/4838580_240.png 1,Bortezomib inhibits cell proliferation in prostate cancer.,Experimental and Therapeutic Medicine,,,Article,2015-09-01,10.3892/etm.2015.2617,,,,26622468,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4831913,https://api.altmetric.com/v1/donut/4831913_240.png 1,Piwil2 modulates the invasion and metastasis of prostate cancer by regulating the expression of matrix metalloproteinase-9 and epithelial-mesenchymal transitions.,Oncology Letters,,,Article,2015-09-01,10.3892/ol.2015.3392,,,,26622742,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4831329,https://api.altmetric.com/v1/donut/4831329_240.png 1,"NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.",Scientific Reports,,,Article,2015-12-01,10.1038/srep17426,,,,26616394,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4826527,https://api.altmetric.com/v1/donut/4826527_240.png 1,"Psychological Well-being and Private and Professional Psychosocial Support After Prostate Cancer Surgery: A Follow-up at 3, 12, and 24 Months After Surgery",,,,Article,2015-12-01,10.1016/j.euf.2015.10.005,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4825503,https://api.altmetric.com/v1/donut/4825503_240.png 1,Urinary Biomarkers for Prostate Cancer.,Urologic Clinics of North America,,,Article,2015-11-29,10.1016/j.ucl.2015.08.003,,,,26614026,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4819373,https://api.altmetric.com/v1/donut/4819373_240.png 1,Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.,,,,Article,2011-02-15,10.1016/j.eururo.2010.10.040,,,,21093145,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4814754,https://api.altmetric.com/v1/donut/4814754_240.png 1,Work ability in prostate cancer survivors after radical prostatectomy.,Scandinavian journal of urology,,,Article,2015-11-27,10.3109/21681805.2015.1100674,,,,26609896,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4813964,https://api.altmetric.com/v1/donut/4813964_240.png 1,Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.,"Cancer Immunology, Immunotherapy",,,Article,2015-11-26,10.1007/s00262-015-1774-5,,,,26611618,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4813549,https://api.altmetric.com/v1/donut/4813549_240.png 1,PSMA-Based Detection of Prostate Cancer Bone Lesions With (18)F-DCFPyL PET/CT: A Sensitive Alternative to (99m)Tc-MDP Bone Scan and Na(18)F PET/CT?,Clinical Genitourinary Cancer,,,Article,2015-11-26,10.1016/j.clgc.2015.09.011,,,,26603549,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4810270,https://api.altmetric.com/v1/donut/4810270_240.png 1,"Anti-LRP/LR specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells.",,,,Article,2012-05-24,10.1016/j.jmb.2012.02.035,,,,22391421,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4806057,https://api.altmetric.com/v1/donut/4806057_240.png 1,"Trends in stage?specific incidence of prostate cancer in Norway, 1980–2010: a population?based study",British Journal of Urology,,,Article,2015-11-01,10.1111/bju.13364,,,,26497872,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4804447,https://api.altmetric.com/v1/donut/4804447_240.png 1,"A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study",Investigational New Drugs,,,Article,2015-11-18,10.1007/s10637-015-0307-6,,,,26581400,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4802674,https://api.altmetric.com/v1/donut/4802674_240.png 1,Pharmacokinetic and pharmacodynamic profile of degarelix for prostate cancer,Expert Opinion on Drug Metabolism & Toxicology,,,Article,,10.1517/17425255.2015.1085506,,,,26513436,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4798863,https://api.altmetric.com/v1/donut/4798863_240.png 1,"Diagnosis matters: the differing ?clinical trajectories for terminal prostate, ?lung and haematological cancers.",Australian Family Physician,,,Article,2015-11-23,,,,,26590493,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4796014,https://api.altmetric.com/v1/donut/4796014_240.png 1,PSA Screening for Prostate Cancer Declined from 2007 to 2013,Journal Watch,,,Article,2015-11-19,10.1056/nejm-jw.na39631,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4792398,https://api.altmetric.com/v1/donut/4792398_240.png 1,Inorganic Arsenic Related Changes in the Stromal Tumor Microenvironment in a Prostate Cancer Cell-Conditioned Media Model.,Environmental Health Perspectives,,,Article,2015-11-21,10.1289/ehp.1510090,,,,26588813,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4791512,https://api.altmetric.com/v1/donut/4791512_240.png 1,"Acceptance of Cancer in Patients Diagnosed with Lung, Breast, Colorectal and Prostate Carcinoma.",Iranian Journal of Public Health,,,Article,2015-08-01,,,,,26587478,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4791201,https://api.altmetric.com/v1/donut/4791201_240.png 1,Editorial Comment on “The Impact of Prostate Cancer Treatment on the Sexual Quality of Life for Men?Who?Have?Sex?with?Men”,Journal of Sexual Medicine,,,Article,2015-12-01,10.1111/jsm.13049,,,,26584955,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4787143,https://api.altmetric.com/v1/donut/4787143_240.png 1,Prostate Cancer Screening,,,,Article,2015-11-18,10.1007/978-1-4939-3237-5_13,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4779063,https://api.altmetric.com/v1/donut/4779063_240.png 1,Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression,PLoS ONE,,,Article,2015-11-11,10.1371/journal.pone.0142327,,,,26560244,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4768839,https://api.altmetric.com/v1/donut/4768839_240.png 1,PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-07-11,10.1007/s00259-015-3106-6,,,,26162799,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4767179,https://api.altmetric.com/v1/donut/4767179_240.png 1,"Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.",European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2015-11-14,10.1007/s00259-015-3240-1,,,,26563121,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4762450,https://api.altmetric.com/v1/donut/4762450_240.png 1,[miR-141-3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells].,Xi bao yu fen zi mian yi xue za zhi Chinese journal of cellular and molecular immunology,,,Article,2015-06-01,,,,,26062412,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4760792,https://api.altmetric.com/v1/donut/4760792_240.png 1,Recent progress in urinary proteome analysis for prostate cancer diagnosis and management,Expert Review of Molecular Diagnostics,,,Article,,10.1586/14737159.2015.1104248,,,,26491818,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4755781,https://api.altmetric.com/v1/donut/4755781_240.png 1,Patient Participation in Communication about Treatment Decision-Making for Localized Prostate Cancer during Consultation Visits,Health,,,Article,2015-11-04,10.4236/health.2015.711156,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4751642,https://api.altmetric.com/v1/donut/4751642_240.png 1,[Effects of long non-coding RNA-HOTAIR on the cell cycle and invasiveness of prostate cancer].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-09-01,,,,,26552211,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4749398,https://api.altmetric.com/v1/donut/4749398_240.png 1,"Fatalism, medical mistrust, and pretreatment health?related quality of life in ethnically diverse prostate cancer patients",Psycho-Oncology,,,Article,2015-01-01,10.1002/pon.4030,,,,26553139,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4749356,https://api.altmetric.com/v1/donut/4749356_240.png 1,The Role of 18F-Flourocholine PET/CT in Biochemically Relapsed Prostate Cancer: A Case of Osteolytic Prostate Metastasis.,Clinical Nuclear Medicine,,,Article,2015-01-20,10.1097/rlu.0000000000000681,,,,25608148,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4748346,https://api.altmetric.com/v1/donut/4748346_240.png 1,"Gypensapogenin H, a novel dammarane-type triterpene induces cell cycle arrest and apoptosis on prostate cancer cells ",Steroids,,,Article,,10.1016/j.steroids.2015.10.014,,,,26514740,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4746491,https://api.altmetric.com/v1/donut/4746491_240.png 1,Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway.,International Journal of Clinical and Experimental Medicine,,,Article,2015-01-01,,,,,26550172,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4745174,https://api.altmetric.com/v1/donut/4745174_240.png 1,Erratum to: Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer.,Nuclear Medicine and Molecular Imaging,,,Article,2015-12-01,10.1007/s13139-015-0329-1,,,,26550058,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4744885,https://api.altmetric.com/v1/donut/4744885_240.png 1,Complex?I alteration and enhanced mitochondrial fusion are associated with prostate cancer progression,Journal of Cellular Physiology,,,Article,2015-11-01,10.1002/jcp.25240,,,,26530043,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4737382,https://api.altmetric.com/v1/donut/4737382_240.png 1,Apoptosis Induction by Ocimum sanctum Extract in LNCaP Prostate Cancer Cells.,Journal of Medicinal Food,,,Article,2015-02-18,10.1089/jmf.2014.0008,,,,25692494,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4737277,https://api.altmetric.com/v1/donut/4737277_240.png 1,SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.,Oncotarget,,,Article,2015-11-06,10.18632/oncotarget.6029,,,,26540632,PMC4914291,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4731792,https://api.altmetric.com/v1/donut/4731792_240.png 1,Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/?-catenin signaling,Clinical and Translational Oncology,,,Article,2015-10-26,10.1007/s12094-015-1431-7,,,,26497355,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4726461,https://api.altmetric.com/v1/donut/4726461_240.png 1,"Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells.",Advances in biological regulation,,,Article,2015-11-05,10.1016/j.jbior.2015.10.001,,,,26525204,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4726382,https://api.altmetric.com/v1/donut/4726382_240.png 1,Inhibition of the GTPase Rac1 mediates the anti-migratory effects of metformin in prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2014-12-19,10.1158/1535-7163.mct-14-0102,,,,25527635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4724593,https://api.altmetric.com/v1/donut/4724593_240.png 1,PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration?resistant prostate cancer?like cells,The Prostate,,,Article,2015-10-01,10.1002/pros.23118,,,,26499308,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4724348,https://api.altmetric.com/v1/donut/4724348_240.png 1,"Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial.",BMC Cancer,,,Article,2015-11-02,10.1186/s12885-015-1871-z,,,,26526623,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4720162,https://api.altmetric.com/v1/donut/4720162_240.png 1,Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells,PLoS ONE,,,Article,2015-10-28,10.1371/journal.pone.0141589,,,,26509262,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4718250,https://api.altmetric.com/v1/donut/4718250_240.png 1,Characterization of a novel metastatic prostate cancer cell line of LNCaP origin,The Prostate,,,Article,2015-10-01,10.1002/pros.23115,,,,26499105,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4711948,https://api.altmetric.com/v1/donut/4711948_240.png 1,Very-high-risk localized prostate cancer: outcomes following definitive radiation,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-10,10.1016/j.ijrobp.2015.10.056,,,,26853334,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4710279,https://api.altmetric.com/v1/donut/4710279_240.png 1,Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study.,Journal of Cancer,,,Article,2015-01-01,10.7150/jca.13397,,,,26516365,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4709732,https://api.altmetric.com/v1/donut/4709732_240.png 1,LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.,Oncotarget,,,Article,2015-10-31,10.18632/oncotarget.5728,,,,26516927,PMC4747388,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4709321,https://api.altmetric.com/v1/donut/4709321_240.png 1,Differences in cancer dynamics may explain why prostate screening has cut metastatic disease while breast screening has not.,British Medical Journal,,,Article,2015-10-31,,,,,26516234,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4709145,https://api.altmetric.com/v1/donut/4709145_240.png 1,PARP Inhibition in Advanced Prostate Cancer,Journal Watch,,,Article,2015-10-28,10.1056/nejm-jw.na39373,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4707192,https://api.altmetric.com/v1/donut/4707192_240.png 1,Inhibition on Proteasome ?1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells,PLoS ONE,,,Article,2015-10-29,10.1371/journal.pone.0141681,,,,26512898,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4702327,https://api.altmetric.com/v1/donut/4702327_240.png 1,Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery,Journal of Surgical Oncology,,,Article,2015-10-01,10.1002/jso.24075,,,,26511216,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4701287,https://api.altmetric.com/v1/donut/4701287_240.png 1,Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment ,Brachytherapy,,,Article,2014-11-07,10.1016/j.brachy.2014.09.012,,,,25454576,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4697827,https://api.altmetric.com/v1/donut/4697827_240.png 1,Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer.,BioMed research international,,,Article,2015-10-28,10.1155/2015/238757,,,,26504789,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4694088,https://api.altmetric.com/v1/donut/4694088_240.png 1,Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.,American Journal of Chinese Medicine,,,Article,2015-10-28,10.1142/s0192415x15500834,,,,26503559,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4683250,https://api.altmetric.com/v1/donut/4683250_240.png 1,Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.,Computational & Mathematical Methods in Medicine,,,Article,2015-10-28,10.1155/2015/462363,,,,26504486,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4683236,https://api.altmetric.com/v1/donut/4683236_240.png 1,Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: Development and validation,Statistical Methods in Medical Research,,,Article,2014-05-19,10.1177/0962280214535763,,,,24847900,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4682300,https://api.altmetric.com/v1/donut/4682300_240.png 1,Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.,Oncology Reports,,,Article,2015-10-27,10.3892/or.2015.4331,,,,26499184,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4678613,https://api.altmetric.com/v1/donut/4678613_240.png 1,Prevalence and management of prostate cancer among East Asian men: Current trends and future perspectives,Urologic Oncology,,,Article,,10.1016/j.urolonc.2015.09.003,,,,26493449,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4675015,https://api.altmetric.com/v1/donut/4675015_240.png 1,Self-modeling ordinal regression with time invariant covariates – An application to prostate cancer data,Statistical Methods in Medical Research,,,Article,2015-07-28,10.1177/0962280215594493,,,,26220536,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4673324,https://api.altmetric.com/v1/donut/4673324_240.png 1,The biology and clinical implications of prostate cancer dormancy and metastasis,Journal of Molecular Medicine,,,Article,2015-10-21,10.1007/s00109-015-1353-4,,,,26489605,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4672349,https://api.altmetric.com/v1/donut/4672349_240.png 1,Clinical impact of prostate specific antigen (PSA) inter-assay variability on management of prostate cancer ,Clinical Biochemistry,,,Article,2015-10-28,10.1016/j.clinbiochem.2015.10.013,,,,26506115,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4670732,https://api.altmetric.com/v1/donut/4670732_240.png 1,Immunostimulatory early phenotype of tumor-associated macrophages does not predict tumor growth outcome in an HLA-DR mouse model of prostate cancer.,"Cancer Immunology, Immunotherapy",,,Article,,10.1007/s00262-015-1697-1,,,,25893810,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4669757,https://api.altmetric.com/v1/donut/4669757_240.png 1,Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: a comparative study,Radiation Oncology,,,Article,2015-10-24,10.1186/s13014-015-0526-1,,,,26499473,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4669567,https://api.altmetric.com/v1/donut/4669567_240.png 1,Stress-Related Signaling Pathways in Lethal and Non-Lethal Prostate Cancer,Clinical Cancer Research,,,Article,2015-10-23,10.1158/1078-0432.ccr-15-0101,,,,26490316,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4661524,https://api.altmetric.com/v1/donut/4661524_240.png 1,Does the Presence of a Major Psychiatric Disorder Affect Tolerance and Outcomes in Men With Prostate Cancer Receiving Radiation Therapy?,American Journal of Men's Health,,,Article,2015-10-22,10.1177/1557988315610626,,,,26487340,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4661102,https://api.altmetric.com/v1/donut/4661102_240.png 1,Working Toward Normalcy Post-Treatment: A Qualitative Study of Older Adult Breast and Prostate Cancer Survivors.,Oncology Nursing Forum,,,Article,2015-10-22,10.1188/15.onf.e358-e367,,,,26488842,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4660627,https://api.altmetric.com/v1/donut/4660627_240.png 1,Should Elderly Prostate Cancer Patients with Comorbidity be Spared from Prostate Radiation Dose Escalation? ,Clinical Oncology,,,Article,2015-10-22,10.1016/j.clon.2015.10.001,,,,26482454,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4660053,https://api.altmetric.com/v1/donut/4660053_240.png 1,"Symptoms and self-care strategies during and six months after radiotherapy for prostate cancer – Scoping the perspectives of patients, professionals and literature ",European Journal of Oncology Nursing,,,Article,2015-10-22,10.1016/j.ejon.2015.09.004,,,,26482003,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4659631,https://api.altmetric.com/v1/donut/4659631_240.png 1,Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.,Supportive Care in Cancer,,,Article,2015-10-21,10.1007/s00520-015-2985-1,,,,26482379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4653465,https://api.altmetric.com/v1/donut/4653465_240.png 1,Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis.,Journal of radiation research,,,Article,2014-09-07,10.1093/jrr/rru061,,,,25204643,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4651719,https://api.altmetric.com/v1/donut/4651719_240.png 1,A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer.,Japanese Journal of Clinical Oncology,,,Article,,10.1093/jjco/hyv070,,,,25981621,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4651150,https://api.altmetric.com/v1/donut/4651150_240.png 1,What Aspects of Personal Care are Most Important to Patients Undergoing Radiotherapy for Prostate Cancer?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-02-10,10.1016/j.ijrobp.2015.10.023,,,,26853337,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4643815,https://api.altmetric.com/v1/donut/4643815_240.png 1,Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.,Cancer Genetics,,,Article,2015-10-18,10.1016/j.cancergen.2015.09.001,,,,26471812,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4642493,https://api.altmetric.com/v1/donut/4642493_240.png 1,EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.,Scientific Reports,,,Article,2015-10-18,10.1038/srep15270,,,,26471237,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4642415,https://api.altmetric.com/v1/donut/4642415_240.png 1,"Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer.",Prostate international,,,Article,2015-09-01,10.1016/j.prnil.2015.07.001,,,,26473150,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4641937,https://api.altmetric.com/v1/donut/4641937_240.png 1,Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis.,Prostate international,,,Article,2015-09-01,10.1016/j.prnil.2014.09.001,,,,26473147,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4640992,https://api.altmetric.com/v1/donut/4640992_240.png 1,CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.,The Prostate,,,Article,,10.1002/pros.23007,,,,26073897,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4639906,https://api.altmetric.com/v1/donut/4639906_240.png 1,"MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.",Cancer Medicine,,,Article,2015-10-01,10.1002/cam4.555,,,,26471763,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4634331,https://api.altmetric.com/v1/donut/4634331_240.png 1,Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression.,PLoS ONE,,,Article,2015-10-16,10.1371/journal.pone.0140671,,,,26469707,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4634162,https://api.altmetric.com/v1/donut/4634162_240.png 1,Strategies for prostate cancer prevention: Review of the literature,Indian Journal of Urology,,,Article,2008-07-01,10.4103/0970-1591.42608,,,,19468457,PMC2684344,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4633579,https://api.altmetric.com/v1/donut/4633579_240.png 1,Antitumor Activity of Garcinol in Human Prostate Cancer Cells and Xenograft Mice,Journal of Agricultural & Food Chemistry,,,Article,,10.1021/acs.jafc.5b03851,,,,26442822,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4628177,https://api.altmetric.com/v1/donut/4628177_240.png 1,On complexity and homogeneity measures in predicting biological aggressiveness of prostate cancer; Implication of the cellular automata model of tumor growth,Journal of Surgical Oncology,,,Article,2015-10-01,10.1002/jso.24069,,,,26462459,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4622047,https://api.altmetric.com/v1/donut/4622047_240.png 1,Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior ,Journal of Ethnopharmacology,,,Article,2014-06-15,10.1016/j.jep.2014.06.008,,,,24945396,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,18,https://www.altmetric.com/details/4619785,https://api.altmetric.com/v1/donut/4619785_240.png 1,[Prostate cancer treated with androgen deprivation therapy: Care and monitoring in daily practice].,Progrès en Urologie,,,Article,2015-10-13,10.1016/j.purol.2015.08.004,,,,26455778,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4617492,https://api.altmetric.com/v1/donut/4617492_240.png 1,"Abstract A29: Racial disparities in prostate cancer: Estimating the role of diet, lifestyle, and genetic factors among African-American and Caucasian-American men",Cancer Prevention Research,,,Article,2015-10-01,10.1158/1940-6215.prev-14-a29,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4614276,https://api.altmetric.com/v1/donut/4614276_240.png 1,Apoptotic and anti-angiogenic effects of Salvia triloba extract in prostate cancer cell lines.,Tumor Biology,,,Article,2015-10-12,10.1007/s13277-015-4208-2,,,,26459311,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4614222,https://api.altmetric.com/v1/donut/4614222_240.png 1,"Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging",Radiology,,,Article,2011-10-14,10.1148/radiol.11091822,,,,21931141,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,120,https://www.altmetric.com/details/4614153,https://api.altmetric.com/v1/donut/4614153_240.png 1,Outcomes Associated with Three Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-01-23,10.1016/j.ijrobp.2015.10.011,,,,26797541,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4612700,https://api.altmetric.com/v1/donut/4612700_240.png 1,Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations.,Supportive Care in Cancer,,,Article,2015-10-11,10.1007/s00520-015-2980-6,,,,26452488,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4610585,https://api.altmetric.com/v1/donut/4610585_240.png 1,ER? regulation of NF-kB activation in prostate cancer is mediated by HIF-1.,Oncotarget,,,Article,2015-10-10,10.18632/oncotarget.5377,,,,26450901,PMC4741892,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4608980,https://api.altmetric.com/v1/donut/4608980_240.png 1,Both IGF1R and INSR knockdown exert anti-tumorigenic effects in prostate cancer in vitro and in vivo.,Molecular Endocrinology,,,Article,2015-10-10,10.1210/me.2015-1073,,,,26452103,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4608445,https://api.altmetric.com/v1/donut/4608445_240.png 1,"Editorial: The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task.",Reviews on Recent Clinical Trials,,,Article,,,,,,26435287,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4604562,https://api.altmetric.com/v1/donut/4604562_240.png 1,Expression Prolife and Role of miRNAs in Prostate Cancer.,Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae,,,Article,2015-02-12,10.3881/j.issn.1000-503x.2015.01.022,,,,25676281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4602553,https://api.altmetric.com/v1/donut/4602553_240.png 1,CSL regulates AKT to mediate androgen independence in prostate cancer progression.,The Prostate,,,Article,2015-10-07,10.1002/pros.23104,,,,26437743,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4596306,https://api.altmetric.com/v1/donut/4596306_240.png 1,Absolute configuration of podophyllotoxone and its inhibitory activity against human prostate cancer cells.,Chinese journal of natural medicines,,,Article,2015-01-15,10.1016/s1875-5364(15)60007-3,,,,25660289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4595790,https://api.altmetric.com/v1/donut/4595790_240.png 1,Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2015-10-03,10.1016/j.jsbmb.2015.09.037,,,,26429394,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4583195,https://api.altmetric.com/v1/donut/4583195_240.png 1,"A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.",Oncotarget,,,Article,2015-10-03,10.18632/oncotarget.5291,,,,26427334,PMC4741763,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4582493,https://api.altmetric.com/v1/donut/4582493_240.png 1,Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone.,Oncotarget,,,Article,2014-10-11,10.18632/oncotarget.2558,,,,25504434,PMC4322993,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4582081,https://api.altmetric.com/v1/donut/4582081_240.png 1,Prostate cancer educational intervention among men in Western Jamaica ,Preventive Medicine Reports,,,Article,2015-11-17,10.1016/j.pmedr.2015.09.008,,,,26568910,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4581296,https://api.altmetric.com/v1/donut/4581296_240.png 1,Intake of meat mutagens and risk of prostate cancer in a cohort of U.S. health professionals.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2015-10-01,10.1158/1055-9965.epi-15-0068-t,,,,26224797,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4573544,https://api.altmetric.com/v1/donut/4573544_240.png 1,The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.,International Journal of Cancer,,,Article,2015-03-06,10.1002/ijc.29505,,,,25754273,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4567463,https://api.altmetric.com/v1/donut/4567463_240.png 1,Low self-efficacy is associated with decreased emergency department use in underserved men with prostate cancer.,Urologic Oncology,,,Article,2015-09-29,10.1016/j.urolonc.2015.08.017,,,,26411548,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4564636,https://api.altmetric.com/v1/donut/4564636_240.png 1,Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort.,Sleep,,,Article,,,,,,26118562,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4561632,https://api.altmetric.com/v1/donut/4561632_240.png 1,Does Multimedia Education with 3D Animation Impact Quality and Duration of Urologists’ Interactions with their Prostate Cancer Patients?,Advances in Therapy,,,Article,2015-09-25,10.1007/s12325-015-0248-7,,,,26407808,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4561563,https://api.altmetric.com/v1/donut/4561563_240.png 1,Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-09-27,,,,,26408786,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4558479,https://api.altmetric.com/v1/donut/4558479_240.png 1,[Changes of CD4 + CD25 + Foxp3 + regulatory T cells in the peripheral blood and their correlation with insulin resistance in different stages of prostate cancer].,Zhonghua nan ke xue National journal of andrology,,,Article,,,,,,26117939,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4557893,https://api.altmetric.com/v1/donut/4557893_240.png 1,"Erratum to: Wattson DA, Chen M-H, Moul JW, et al. The number of high-risk factors and the risk of prostate cancer–specific mortality after brachytherapy: Implications for treatment selection. Int J Radiat Oncol Biol Phys 2012;82:e773-e779.","International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-11,10.1016/j.ijrobp.2015.06.038,,,,26461024,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4555240,https://api.altmetric.com/v1/donut/4555240_240.png 1,Role of the pathologist in active surveillance for prostate cancer.,Analytical and quantitative cytopathology and histopathology,,,Article,2015-02-01,,,,,26072636,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4548789,https://api.altmetric.com/v1/donut/4548789_240.png 1,Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.,Clinical Proteomics,,,Article,2015-01-01,10.1186/s12014-015-9096-3,,,,26388710,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4539829,https://api.altmetric.com/v1/donut/4539829_240.png 1,Differential IKK/NF-?B Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells,Molecular Cancer Research,,,Article,2015-12-01,10.1158/1541-7786.mcr-15-0213,,,,26374334,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4534683,https://api.altmetric.com/v1/donut/4534683_240.png 1,Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.,The Prostate,,,Article,2015-09-19,10.1002/pros.23093,,,,26383847,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4531204,https://api.altmetric.com/v1/donut/4531204_240.png 1,Targeting the glucocorticoid receptor in breast and prostate cancers.,Science Translational Medicine,,,Article,2015-09-18,10.1126/scitranslmed.aac7531,,,,26378243,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4527838,https://api.altmetric.com/v1/donut/4527838_240.png 1,Metastatic castration-resistant prostate cancer: time for innovation.,Future Oncology,,,Article,2015-01-15,10.2217/fon.14.145,,,,25572785,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4527068,https://api.altmetric.com/v1/donut/4527068_240.png 1,Emerging agents for the therapy of advanced prostate cancer.,Future Oncology,,,Article,2015-09-15,10.2217/fon.15.224,,,,26367474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4509881,https://api.altmetric.com/v1/donut/4509881_240.png 1,Peliosis hepatis disseminated rapidly throughout the liver in a patient with prostate cancer: a case report,Journal of Medical Case Reports,,,Article,2015-09-12,10.1186/s13256-015-0682-9,,,,26362063,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4506897,https://api.altmetric.com/v1/donut/4506897_240.png 1,Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2015-09-12,,,,,26358797,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4499815,https://api.altmetric.com/v1/donut/4499815_240.png 1,Prostate cancer Lncap stem-like cells demonstrate resistance to the hydros-induced apoptosis during the formation of spheres.,Biomedicine & Pharmacotherapy,,,Article,2015-09-10,10.1016/j.biopha.2015.05.007,,,,26349956,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4495428,https://api.altmetric.com/v1/donut/4495428_240.png 1,"Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.","Drug design, development and therapy",,,Article,,10.2147/dddt.s71677,,,,25609920,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4493066,https://api.altmetric.com/v1/donut/4493066_240.png 1,TGF-?1 mediates the radiation response of prostate cancer.,Journal of Molecular Medicine,,,Article,2014-09-17,10.1007/s00109-014-1206-6,,,,25228112,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4492582,https://api.altmetric.com/v1/donut/4492582_240.png 1,"Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819–22",European Urology,,,Article,2015-09-08,10.1016/j.eururo.2015.07.011,,,,26215609,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4483510,https://api.altmetric.com/v1/donut/4483510_240.png 1,The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review,"Drug Design, Development and Therapy",,,Article,2015-09-07,10.2147/dddt.s82475,,,,26379424,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4482938,https://api.altmetric.com/v1/donut/4482938_240.png 1,Active Surveillance in localized prostate cancer: Comparison of incidental tumors (T1a/b) and tumors diagnosed by core needle biopsy (T1c/T2a). Results from the HAROW Study,British Journal of Urology,,,Article,2015-08-01,10.1111/bju.13308,,,,26332209,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4481722,https://api.altmetric.com/v1/donut/4481722_240.png 1,"Modeling Long-term Outcomes and Treatment Effects After Androgen Deprivation Therapy for Prostate Cancer",,,,Article,,,,,,,,,,1509.01275,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4479783,https://api.altmetric.com/v1/donut/4479783_240.png 1,Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.,International Journal of Clinical and Experimental Pathology,,,Article,2015-09-05,,,,,26339409,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4476834,https://api.altmetric.com/v1/donut/4476834_240.png 1,Associations Between Personality and End-of-Life Care Preferences Among Men with Prostate Cancer: A Clustering Approach ,Journal of Pain & Symptom Management,,,Article,2015-09-08,10.1016/j.jpainsymman.2015.08.005,,,,26344553,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4476554,https://api.altmetric.com/v1/donut/4476554_240.png 1,New Acquisition Protocol of (18) F-Choline PET/CT in Prostate Cancer Patients: Review of the Literature about Methodology and Proposal of Standardization.,BioMed research international,,,Article,,10.1155/2014/215650,,,,25121090,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4473923,https://api.altmetric.com/v1/donut/4473923_240.png 1,"Probability modeling of the number of positive cores in a prostate cancer biopsy session, with applications",Statistics in Medicine,,,Article,2015-09-05,10.1002/sim.6636,,,,26337506,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4471074,https://api.altmetric.com/v1/donut/4471074_240.png 1,(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,,10.1007/s00259-015-3177-4,,,,26323576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4469698,https://api.altmetric.com/v1/donut/4469698_240.png 1,Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients,Quality of Life Research,,,Article,2015-09-03,10.1007/s11136-014-0794-5,,,,25326871,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/4467553,https://api.altmetric.com/v1/donut/4467553_240.png 1,Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.,Journal of Clinical Oncology,,,Article,1996-06-01,,,,,8656243,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4466798,https://api.altmetric.com/v1/donut/4466798_240.png 1,Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1.,International Journal of Biological Macromolecules,,,Article,2015-09-01,10.1016/j.ijbiomac.2015.08.048,,,,26314905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4460823,https://api.altmetric.com/v1/donut/4460823_240.png 1,Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-?B Activity.,Journal of clinical cellular immunology,,,Article,2015-04-01,10.4172/2155-9899.1000308,,,,26317041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4460730,https://api.altmetric.com/v1/donut/4460730_240.png 1,[Differential expressions of the receptor for advanced glycation end products in prostate cancer and normal prostate].,,,,Article,2010-05-14,,,,,20684319,,,,,,,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4460551,https://api.altmetric.com/v1/donut/4460551_240.png 1,"Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancer","Cancer Immunology, Immunotherapy",,,Article,2012-06-28,10.1007/s00262-012-1310-9,,,,22740161,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4457476,https://api.altmetric.com/v1/donut/4457476_240.png 1,"Bayesian Joint Hierarchical Model for Prediction of Latent Health States with Application to Active Surveillance of Prostate Cancer",,,,Article,,,,,,,,,,1508.07511,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4456945,https://api.altmetric.com/v1/donut/4456945_240.png 1,Clinical significance of D4A in prostate cancer therapy with abiraterone.,Cell Cycle,,,Article,,10.1080/15384101.2015.1086201,,,,26313523,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4456119,https://api.altmetric.com/v1/donut/4456119_240.png 1,Feasibility and acceptability of SMS text messaging in a prostate cancer educational intervention for African American men,Health Informatics Journal,,,Article,2015-09-02,10.1177/1460458215598636,,,,26324051,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4455132,https://api.altmetric.com/v1/donut/4455132_240.png 1,Re: Comparison of MR/Ultrasound Fusion–guided Biopsy with Ultrasound-guided Biopsy for the Diagnosis of Prostate Cancer,European Urology,,,Article,2015-09-01,10.1016/j.eururo.2015.05.026,,,,26282353,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4448700,https://api.altmetric.com/v1/donut/4448700_240.png 1,The efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone in patients with androgen-independent prostate cancer: a systematic review,Scientific Reports,,,Article,2014-04-27,10.1038/srep04818,,,,24769540,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4447933,https://api.altmetric.com/v1/donut/4447933_240.png 1,Riluzole induces apoptotic cell death in human prostate cancer cells via endoplasmic reticulum stress.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2009-07-01,,,,,19528481,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4447931,https://api.altmetric.com/v1/donut/4447931_240.png 1,"Denbinobin, a Phenanthrene from Dendrobium nobile, Impairs Prostate Cancer Migration by Inhibiting Rac1 Activity.",American Journal of Chinese Medicine,,,Article,2014-11-27,10.1142/s0192415x14500967,,,,25427623,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4446370,https://api.altmetric.com/v1/donut/4446370_240.png 1,The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells.,Molecular Nutrition & Food Research,,,Article,2015-08-27,10.1002/mnfr.201500470,,,,26307544,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4441537,https://api.altmetric.com/v1/donut/4441537_240.png 1,Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules.,Molecular Carcinogenesis,,,Article,2013-12-17,10.1002/mc.22124,,,,24347249,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,73,https://www.altmetric.com/details/4440775,https://api.altmetric.com/v1/donut/4440775_240.png 1,Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression,Molecular Cancer Research,,,Article,2015-12-01,10.1158/1541-7786.mcr-14-0626,,,,26271487,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4439608,https://api.altmetric.com/v1/donut/4439608_240.png 1,Abiraterone acetate and prednisolone for metastatic castration-resistant prostate cancer failing androgen deprivation and docetaxel-based chemotherapy: A phase?II bridging study in Korean and Taiwanese patients.,International Journal of Urology,,,Article,2014-08-05,10.1111/iju.12589,,,,25099185,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4436881,https://api.altmetric.com/v1/donut/4436881_240.png 1,SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3767,,,,25980436,PMC4537039,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4435767,https://api.altmetric.com/v1/donut/4435767_240.png 1,The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b,OncoTargets and Therapy,,,Article,2015-08-10,10.2147/ott.s85443,,,,26309412,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4435569,https://api.altmetric.com/v1/donut/4435569_240.png 1,Treatment patterns for older veterans with localized prostate cancer,Cancer Epidemiology,,,Article,,10.1016/j.canep.2015.07.005,,,,26228494,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4433737,https://api.altmetric.com/v1/donut/4433737_240.png 1,Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.,Oncotarget,,,Article,2015-08-25,10.18632/oncotarget.4664,,,,26296974,PMC4694913,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4433082,https://api.altmetric.com/v1/donut/4433082_240.png 1,The Role of Soy Phytoestrogens on Genetic and Epigenetic Mechanisms of Prostate Cancer.,The Enzymes,,,Article,2015-01-01,10.1016/bs.enz.2015.05.004,,,,26298461,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4432590,https://api.altmetric.com/v1/donut/4432590_240.png 1,Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer Cells.,Cancers,,,Article,2015-01-01,10.3390/cancers7030854,,,,26295410,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4423993,https://api.altmetric.com/v1/donut/4423993_240.png 1,Factor Structure of the Gotland Scale of Male Depression in Two Samples of Men With Prostate Cancer Implications for Treating Male Depression,American Journal of Men's Health,,,Article,2015-08-13,10.1177/1557988315599029,,,,26272886,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4422128,https://api.altmetric.com/v1/donut/4422128_240.png 1,Biomarkers for determination prostate cancer: implication for diagnosis and prognosis.,Neoplasma,,,Article,2015-08-17,10.4149/neo_2015_082,,,,26278153,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4414364,https://api.altmetric.com/v1/donut/4414364_240.png 1,"Abstract CT329: Phase I study of the PI3K?/? inhibitor AZD8186 in patients with advanced castration resistant prostate cancer, triple negative breast cancer, squamous non-small cell lung cancer or PTEN deficient solid tumors: update from dose-finding",Cancer Research,,,Article,2015-08-01,10.1158/1538-7445.am2015-ct329,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,https://www.altmetric.com/details/4409294,https://api.altmetric.com/v1/donut/4409294_240.png 1,"Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case–control study in Japanese men",Environmental Health and Preventive Medicine,,,Article,2015-08-07,10.1007/s12199-015-0471-5,,,,26251204,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4408790,https://api.altmetric.com/v1/donut/4408790_240.png 1,AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.,American Journal of Cancer Research,,,Article,2015-01-01,,,,,26175942,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4403578,https://api.altmetric.com/v1/donut/4403578_240.png 1,Findings from a prostate cancer screening program in a Japanese population.,Asian Journal of Andrology,,,Article,2014-09-01,10.4103/1008-682x.135128,,,,25219907,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4401273,https://api.altmetric.com/v1/donut/4401273_240.png 1,Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.,Asian Journal of Andrology,,,Article,2014-09-01,10.4103/1008-682x.135122,,,,25219906,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4398515,https://api.altmetric.com/v1/donut/4398515_240.png 1,MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer.,American Journal of Cancer Research,,,Article,2015-01-01,,,,,26269764,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4396919,https://api.altmetric.com/v1/donut/4396919_240.png 1,Dosimetric comparison of intensity-modulated solutions for intact prostate cancer.,Medical Dosimetry,,,Article,2014-08-07,10.1016/j.meddos.2014.06.006,,,,25113813,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4396703,https://api.altmetric.com/v1/donut/4396703_240.png 1,Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.,Medical Dosimetry,,,Article,2014-07-29,10.1016/j.meddos.2014.05.008,,,,25087084,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4396701,https://api.altmetric.com/v1/donut/4396701_240.png 1,Chemotherapy in Prostate Cancer,Current Oncology Reports,,,Article,2015-07-28,10.1007/s11912-015-0468-7,,,,26216506,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4393252,https://api.altmetric.com/v1/donut/4393252_240.png 1,Increased Dietary Inflammatory Index (DII) Is Associated With Increased Risk of Prostate Cancer in Jamaican Men,Nutrition and Cancer,,,Article,,10.1080/01635581.2015.1062117,,,,26226289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4385019,https://api.altmetric.com/v1/donut/4385019_240.png 1,[Are the properties of peripheral blood lymphocytes of patients with prostate cancer connected with the efficiency of radiation therapy?].,Radiatsionnaia biologiia radioecologiia,,,Article,,,,,,25764831,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4384945,https://api.altmetric.com/v1/donut/4384945_240.png 1,Relationship between serum response factor and androgen receptor in prostate cancer.,The Prostate,,,Article,2015-11-07,10.1002/pros.23051,,,,26250344,,10197/7430,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4384510,https://api.altmetric.com/v1/donut/4384510_240.png 1,Ever and Annual Use of Prostate Cancer Screening in African American Men,American Journal of Men's Health,,,Article,2015-08-03,10.1177/1557988315596225,,,,26240090,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4381548,https://api.altmetric.com/v1/donut/4381548_240.png 1,Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer.,Canadian Urological Association Journal,,,Article,2015-04-13,10.5489/cuaj.2545,,,,26085869,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4376367,https://api.altmetric.com/v1/donut/4376367_240.png 1,IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer.,PLoS ONE,,,Article,2015-08-08,10.1371/journal.pone.0134366,,,,26252635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4375382,https://api.altmetric.com/v1/donut/4375382_240.png 1,"Zerumbone, a ginger sesquiterpene, induces apoptosis and autophagy in human hormone-refractory prostate cancers through tubulin binding and crosstalk between endoplasmic reticulum stress and mitochondrial insult.",Naunyn-Schmiedeberg's Archives of Pharmacology,,,Article,2015-08-08,10.1007/s00210-015-1152-z,,,,26246051,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4374970,https://api.altmetric.com/v1/donut/4374970_240.png 1,Protein interaction network constructing based on text mining and reinforcement learning with application to prostate cancer.,IET Systems Biology,,,Article,2015-08-01,10.1049/iet-syb.2014.0050,,,,26243825,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4368376,https://api.altmetric.com/v1/donut/4368376_240.png 1,Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody,Theoretical Biology and Medical Modelling,,,Article,2015-08-06,10.1186/s12976-015-0010-5,,,,26246000,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4366640,https://api.altmetric.com/v1/donut/4366640_240.png 1,What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?,European Radiology,,,Article,2015-07-03,10.1007/s00330-015-3894-x,,,,26135002,,1854/LU-6884501,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/4366218,https://api.altmetric.com/v1/donut/4366218_240.png 1,"Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells.",,,,Article,2014-08-04,10.1039/c4ra06616b,,,,25243063,PMC4166488,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4366055,https://api.altmetric.com/v1/donut/4366055_240.png 1,Epidemiology of Prostate Cancer.,Asian Pacific Journal of Cancer Prevention,,,Article,,,,,,26225642,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4355951,https://api.altmetric.com/v1/donut/4355951_240.png 1,The antitumor potential of Interleukin-27 in prostate cancer.,Oncotarget,,,Article,2013-12-28,10.18632/oncotarget.1425,,,,24681516,PMC4279376,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4354007,https://api.altmetric.com/v1/donut/4354007_240.png 1,Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.,eLife,,,Article,2015-08-01,10.7554/elife.06434,,,,26231042,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4352067,https://api.altmetric.com/v1/donut/4352067_240.png 1,Prostate-specific RNA aptamer: promising nucleic acid antibody-like cancer detection,Scientific Reports,,,Article,2015-07-15,10.1038/srep12090,,,,26174796,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4350103,https://api.altmetric.com/v1/donut/4350103_240.png 1,Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency,Radiotherapy & Oncology,,,Article,2015-08-02,10.1016/j.radonc.2015.07.027,,,,26232129,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4340010,https://api.altmetric.com/v1/donut/4340010_240.png 1,Editorial Comment to MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.,International Journal of Urology,,,Article,2015-07-29,10.1111/iju.12883,,,,26211479,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4339175,https://api.altmetric.com/v1/donut/4339175_240.png 1,Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.,NuclearMedicine,,,Article,2015-07-29,10.3413/nukmed-0737-15-04,,,,26213186,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4338728,https://api.altmetric.com/v1/donut/4338728_240.png 1,Erratum: Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options,Radiation Oncology,,,Article,2015-07-28,10.1186/s13014-015-0444-2,,,,26216408,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4336502,https://api.altmetric.com/v1/donut/4336502_240.png 1,Prostate cancer: Baseline atrophy reduces prostate cancer risk,Nature Reviews Urology,,,Article,2015-07-28,10.1038/nrurol.2015.189,,,,26215692,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4335827,https://api.altmetric.com/v1/donut/4335827_240.png 1,Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography.,"Journal of medical imaging (Bellingham, Wash.)",,,Article,2015-07-01,10.1117/1.jmi.2.3.037501,,,,26171414,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4335176,https://api.altmetric.com/v1/donut/4335176_240.png 1,Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation.,,,,Article,2007-11-15,10.1111/j.1464-410x.2007.07133.x,,,,17711511,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4329858,https://api.altmetric.com/v1/donut/4329858_240.png 1,Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer.,Asian Journal of Andrology,,,Article,2015-07-26,,,,,26208396,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4329019,https://api.altmetric.com/v1/donut/4329019_240.png 1,[Prostate cancer: papillomaviruses as a possible cause].,Vestnik Rossi?sko? akademii meditsinskikh nauk,,,Article,2015-01-01,,,,,26027277,,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4315209,https://api.altmetric.com/v1/donut/4315209_240.png 1,Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.,International Journal of Oncology,,,Article,2015-07-24,10.3892/ijo.2015.3086,,,,26202882,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4312988,https://api.altmetric.com/v1/donut/4312988_240.png 1,Personality and Utilization of Prostate Cancer Testing,SAGE Open,,,Article,2015-07-01,10.1177/2158244015593324,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4310279,https://api.altmetric.com/v1/donut/4310279_240.png 1,[Management of patients with castrationresistant metastatic prostate cancer].,Klinická onkologie casopis Ceské a Slovenské onkologické spolecnosti,,,Article,,,,,,25692752,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4308233,https://api.altmetric.com/v1/donut/4308233_240.png 1,Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer,Frontiers in oncology,,,Article,2015-07-03,10.3389/fonc.2015.00151,,,,26191507,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4304855,https://api.altmetric.com/v1/donut/4304855_240.png 1,Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.,Gene,,,Article,,10.1016/j.gene.2015.07.017,,,,26164758,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4303543,https://api.altmetric.com/v1/donut/4303543_240.png 1,"Antioxidant, antiangiogenic and antiproliferative activities of root methanol extract of Calliandra portoricensis in human prostate cancer cells.",Journal of Integrative Medicine,,,Article,2015-05-01,10.1016/s2095-4964(15)60175-3,,,,26006031,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4299540,https://api.altmetric.com/v1/donut/4299540_240.png 1,Dietary Factors and Epigenetic Regulation for Prostate Cancer Prevention,Advances in Nutrition,,,Article,2011-11-01,10.3945/an.111.001032,,,,22332092,PMC3226387,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/4294003,https://api.altmetric.com/v1/donut/4294003_240.png 1,Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study,Prostate Cancer & Prostatic Diseases,,,Article,2003-12-01,10.1038/sj.pcan.4500679,,,,14663471,,,,,,,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/4294001,https://api.altmetric.com/v1/donut/4294001_240.png 1,Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review,Korean Journal of Urology,,,Article,2010-10-01,10.4111/kju.2010.51.10.665,,,,21031084,PMC2963777,,,,,,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4294000,https://api.altmetric.com/v1/donut/4294000_240.png 1,MicroRNA in prostate cancer: Practical aspects.,Histology and Histopathology,,,Article,2015-07-18,10.14670/hh-11-647,,,,26186079,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4291768,https://api.altmetric.com/v1/donut/4291768_240.png 1,Evolving Role of Immunotherapy in Prostate Cancer.,Current Molecular Pharmacology,,,Article,2015-07-17,,,,,26177645,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4288902,https://api.altmetric.com/v1/donut/4288902_240.png 1,Garlic Constituent Diallyl Trisulfide Suppresses X-Linked Inhibitor of Apoptosis Protein in Prostate Cancer Cells in Culture and In Vivo,Cancer Prevention Research,,,Article,2011-06-14,10.1158/1940-6207.capr-10-0323,,,,21411500,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4287812,https://api.altmetric.com/v1/donut/4287812_240.png 1,Garlic Constituent Diallyl Trisulfide Prevents Development of Poorly Differentiated Prostate Cancer and Pulmonary Metastasis Multiplicity in TRAMP Mice,Cancer Research,,,Article,2008-11-15,10.1158/0008-5472.can-08-1677,,,,19010926,PMC2597366,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4287811,https://api.altmetric.com/v1/donut/4287811_240.png 1,Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.,The Prostate,,,Article,2015-07-17,10.1002/pros.23044,,,,26178291,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4287476,https://api.altmetric.com/v1/donut/4287476_240.png 1,Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2.,In Vitro Cellular & Developmental Biology - Animal,,,Article,2015-07-15,10.1007/s11626-015-9932-9,,,,26170224,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4279622,https://api.altmetric.com/v1/donut/4279622_240.png 1,Focal therapy for prostate cancer: The current status,Prostate International,,,Article,2015-06-01,10.1016/j.prnil.2015.03.007,,,,26157765,PMC4494637,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/4277889,https://api.altmetric.com/v1/donut/4277889_240.png 1,Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.,,,,Article,2013-09-18,10.1517/13543784.2013.833183,,,,24050482,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4275156,https://api.altmetric.com/v1/donut/4275156_240.png 1,Unmet Needs in the Prediction and Detection of Metastases in Prostate Cancer.,,,,Article,,10.1634/theoncologist.2013-0027,,,,23650019,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4270970,https://api.altmetric.com/v1/donut/4270970_240.png 1,MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor.,Cellular Physiology & Biochemistry,,,Article,2015-07-12,10.1159/000430313,,,,26160610,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4265985,https://api.altmetric.com/v1/donut/4265985_240.png 1,Cellular Plasticity in Prostate Cancer Bone Metastasis,Prostate Cancer,,,Article,2015-07-09,10.1155/2015/651580,,,,26146569,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4258580,https://api.altmetric.com/v1/donut/4258580_240.png 1,Role of Surgery in locally advanced prostate cancer.,Pakistan Journal of Medical Sciences,,,Article,2015-01-01,10.12669/pjms.313.7103,,,,26150873,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4254952,https://api.altmetric.com/v1/donut/4254952_240.png 1,Hypoxia dose painting in prostate and cervix cancer.,Acta Oncologica,,,Article,2015-07-07,10.3109/0284186x.2015.1061692,,,,26148050,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4251205,https://api.altmetric.com/v1/donut/4251205_240.png 1,What Nurses and Patients Need to Know About Sipulecucel-T Immunotherapy for Prostate Cancer.,ONS Connect,,,Article,2015-06-01,,,,,26146750,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4250866,https://api.altmetric.com/v1/donut/4250866_240.png 1,Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review,BoneKEy Reports,,,Article,2015-06-24,10.1038/bonekey.2015.85,,,,26131363,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4249667,https://api.altmetric.com/v1/donut/4249667_240.png 1,Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms,Urologic Oncology,,,Article,2015-07-05,10.1016/j.urolonc.2015.05.030,,,,26141678,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4244186,https://api.altmetric.com/v1/donut/4244186_240.png 1,Genome-wide analysis of androgen receptor binding sites in prostate cancer cells.,Experimental and Therapeutic Medicine,,,Article,2015-06-01,10.3892/etm.2015.2406,,,,26136980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4239281,https://api.altmetric.com/v1/donut/4239281_240.png 1,"Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000–2009",BMC Public Health,,,Article,2015-07-02,10.1186/1471-2458-14-356,,,,24731197,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4235882,https://api.altmetric.com/v1/donut/4235882_240.png 1,miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression.,Oncotarget,,,Article,2015-07-01,10.18632/oncotarget.4372,,,,26124181,PMC4695135,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4233366,https://api.altmetric.com/v1/donut/4233366_240.png 1,"3,3'-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and -independent prostate cancer cells.",Genes & Cancer,,,Article,2015-05-01,10.18632/genesandcancer.60,,,,26124925,PMC4482247,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4231233,https://api.altmetric.com/v1/donut/4231233_240.png 1,Prostate Cancer and PFOA,Journal of Occupational & Environmental Medicine,,,Article,2015-06-01,10.1097/jom.0000000000000446,,,,26053370,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4230491,https://api.altmetric.com/v1/donut/4230491_240.png 1,Improving psychosocial health in men with prostate cancer through an intervention that reinforces masculine values – exercise,Psycho-Oncology,,,Article,2015-06-18,10.1002/pon.3867,,,,26086938,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4229479,https://api.altmetric.com/v1/donut/4229479_240.png 1,[MicroRNAs and prostate cancer].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-06-30,,,,,26117946,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4229265,https://api.altmetric.com/v1/donut/4229265_240.png 1,CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer.,BioMed research international,,,Article,,10.1155/2014/230183,,,,25197632,PMC4150478,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4229132,https://api.altmetric.com/v1/donut/4229132_240.png 1,"Assessment of association between genetic variants in microRNA genes hsa-miR-499, hsa-miR-196a2 and hsa-miR-27a and prostate cancer risk in Serbian population.",Experimental & Molecular Pathology,,,Article,2015-06-28,10.1016/j.yexmp.2015.06.009,,,,26112096,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4220474,https://api.altmetric.com/v1/donut/4220474_240.png 1,Study: Docetaxel Should Be Routine for Selected Men with Metastatic Prostate Cancer,Oncology times,,,Article,2015-06-25,10.1097/01.cot.0000467325.73255.90,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4219928,https://api.altmetric.com/v1/donut/4219928_240.png 1,Correction: Estrogen Receptor ?2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1? in Prostate Cancer.,PLoS ONE,,,Article,2015-06-27,10.1371/journal.pone.0132085,,,,26114299,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4219559,https://api.altmetric.com/v1/donut/4219559_240.png 1,SU-E-T-143: Automatic PBS Treatment Planning for Prostate Cancer,Medical Physics,,,Article,2015-06-01,10.1118/1.4924505,,,,26127808,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4217804,https://api.altmetric.com/v1/donut/4217804_240.png 1,SU-E-J-183: Quantification of Motion During Hypo-Fractionated Prostate Cancer Radiation Therapy,Medical Physics,,,Article,2015-06-01,10.1118/1.4924269,,,,26127576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4217727,https://api.altmetric.com/v1/donut/4217727_240.png 1,SU-E-J-01: MR Guided Pulsed Focused Ultrasound Mediated Targeted Chemotherapeutic-Agent Delivery in Management of Prostate Cancer,Medical Physics,,,Article,2015-06-01,10.1118/1.4924089,,,,26127394,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4217157,https://api.altmetric.com/v1/donut/4217157_240.png 1,SU-E-J-17: Intra-Fractional Prostate Movement Correction During Treatment Delivery Period for Prostate Cancer Using the Intra-Fractional Orthogonal KV-MV Image Pairs,Medical Physics,,,Article,2015-06-01,10.1118/1.4924105,,,,26127413,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4216728,https://api.altmetric.com/v1/donut/4216728_240.png 1,SU-E-J-67: Evaluation of Adaptive MLC Morphing for Online Correction of Prostate Cancer Radiotherapy,Medical Physics,,,Article,2015-06-01,10.1118/1.4924154,,,,26127462,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4216493,https://api.altmetric.com/v1/donut/4216493_240.png 1,SU-E-I-82: PET Radiopharmaceuticals for Prostate Cancer Imaging: A Review,Medical Physics,,,Article,2015-06-01,10.1118/1.4924079,,,,26127388,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4215955,https://api.altmetric.com/v1/donut/4215955_240.png 1,"5-? reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer",Cancer Causes and Control,,,Article,2015-06-25,10.1007/s10552-015-0622-4,,,,26109464,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4215815,https://api.altmetric.com/v1/donut/4215815_240.png 1,Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression.,PLoS ONE,,,Article,2015-06-25,10.1371/journal.pone.0130060,,,,26107383,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4209447,https://api.altmetric.com/v1/donut/4209447_240.png 1,MiR200c targets IRS1 and suppresses prostate cancer cell growth.,The Prostate,,,Article,2015-02-14,10.1002/pros.22968,,,,25683382,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4208378,https://api.altmetric.com/v1/donut/4208378_240.png 1,Using circulating tumor cells to inform on prostate cancer biology and clinical utility.,Critical Reviews in Clinical Laboratory Sciences,,,Article,2015-06-16,10.3109/10408363.2015.1023430,,,,26079252,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4202139,https://api.altmetric.com/v1/donut/4202139_240.png 1,Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology,Critical Reviews in Oncology/Hematology,,,Article,2015-06-22,10.1016/j.critrevonc.2015.05.014,,,,26092320,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4195986,https://api.altmetric.com/v1/donut/4195986_240.png 1,Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway,Clinical & Experimental Pharmacology & Physiology,,,Article,2015-06-04,10.1111/1440-1681.12409,,,,25903858,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4195347,https://api.altmetric.com/v1/donut/4195347_240.png 1,Invasive prostate carcinoma to the rectum with lymphatic dissemination simulating a rectal cancer: case report,Revista Brasileira de Coloproctologia,,,Article,,10.1590/s0101-98802010000100010,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4191153,https://api.altmetric.com/v1/donut/4191153_240.png 1,Prostate cancer identification: quantitative analysis of T2-weighted MR images based on a back propagation artificial neural network model.,Science China Life Sciences,,,Article,,10.1007/s11427-015-4876-6,,,,26025283,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4190716,https://api.altmetric.com/v1/donut/4190716_240.png 1,Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation.,Oncotarget,,,Article,2015-06-19,10.18632/oncotarget.4479,,,,26087400,PMC4673203,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4188474,https://api.altmetric.com/v1/donut/4188474_240.png 1,"Pifithrin-?, an Inhibitor of Heat-Shock Protein 70, Can Increase the Antitumor Effects of Hyperthermia Against Human Prostate Cancer Cells",,,,Article,2015-06-17,10.1371/journal.pone.0078772,,,,24244355,PMC3828328,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4176576,https://api.altmetric.com/v1/donut/4176576_240.png 1,Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study,Radiotherapy & Oncology,,,Article,2015-06-21,10.1016/j.radonc.2015.05.021,,,,26091575,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4175786,https://api.altmetric.com/v1/donut/4175786_240.png 1,Re-distribution of brachytherapy dose using a differential dose prescription adapted to risk of local failure in low-risk prostate cancer patients,Radiotherapy & Oncology,,,Article,2015-06-21,10.1016/j.radonc.2015.05.015,,,,26091576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4175785,https://api.altmetric.com/v1/donut/4175785_240.png 1,miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells.,The Prostate,,,Article,2015-06-16,10.1002/pros.23031,,,,26074357,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4170583,https://api.altmetric.com/v1/donut/4170583_240.png 1,"Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer.",Cancer immunology research,,,Article,2014-02-15,10.1158/2326-6066.cir-13-0108,,,,24778277,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/4170288,https://api.altmetric.com/v1/donut/4170288_240.png 1,A THEORETICAL STUDY ON PARTIALLY AUTOMATED METHOD FOR (PROSTATE) CANCER PINPOINT USING MAGNETIC RESONANCE IMAGING (MRI),International Journal of Research in Engineering and Technology,,,Article,2014-01-25,10.15623/ijret.2014.0301050,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4163095,https://api.altmetric.com/v1/donut/4163095_240.png 1,Alpha-methylacyl-CoA racemase and hepsin as urinary prostate cancer markers.,International Journal of Biological Markers,,,Article,,10.5301/jbm.5000146,,,,25982684,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4154296,https://api.altmetric.com/v1/donut/4154296_240.png 1,Optimal sequence of bone target drugs in metastatic prostatic cancer,Expert Review of Anticancer Therapy,,,Article,2015-06-12,10.1586/14737140.2015.1054813,,,,26070344,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4150839,https://api.altmetric.com/v1/donut/4150839_240.png 1,RLIP76-Dependent Suppression of PI3K/AKT/Bcl-2 Pathway by miR-101 Induces Apoptosis in Prostate Cancer.,Biochemical & Biophysical Research Communications,,,Article,2015-06-13,10.1016/j.bbrc.2015.06.032,,,,26067553,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4148231,https://api.altmetric.com/v1/donut/4148231_240.png 1,Autocrine activation of CHRM3 promotes prostate cancer growth and castration resistance via CaM/CaMKK-mediated phosphorylation of Akt,Clinical Cancer Research,,,Article,2015-06-14,10.1158/1078-0432.ccr-14-3163,,,,26071486,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4146241,https://api.altmetric.com/v1/donut/4146241_240.png 1,MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.,International Journal of Oncology,,,Article,2015-06-13,10.3892/ijo.2015.3043,,,,26063484,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4145184,https://api.altmetric.com/v1/donut/4145184_240.png 1,Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial,Radiotherapy & Oncology,,,Article,2015-06-16,10.1016/j.radonc.2015.05.016,,,,26072289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/4139565,https://api.altmetric.com/v1/donut/4139565_240.png 1,COFFEE CONSUMPTION AND MORTALITY FOR PROSTATE CANCER.,Tohoku Journal of Experimental Medicine,,,Article,1964-04-25,,,,,14166832,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4137170,https://api.altmetric.com/v1/donut/4137170_240.png 1,Estrogen Receptor Alpha (ER?)-Associated Fibroblasts Promote Cell Growth in Prostate Cancer,Cell Biochemistry and Biophysics,,,Article,2015-06-11,10.1007/s12013-015-0700-y,,,,27259327,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4135436,https://api.altmetric.com/v1/donut/4135436_240.png 1,A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA.,Cancer Letters,,,Article,2015-06-11,10.1016/j.canlet.2015.05.003,,,,26054847,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/4133467,https://api.altmetric.com/v1/donut/4133467_240.png 1,Molecular biology of prostate-cancer pathogenesis,Current Opinion in Urology,,,Article,2006-05-01,10.1097/01.mou.0000193384.39351.64,,,,16679847,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/4127760,https://api.altmetric.com/v1/donut/4127760_240.png 1,Epigenetic Alterations in Human Prostate Cancers,Endocrinology,,,Article,2009-09-14,10.1210/en.2009-0573,,,,19520778,PMC2736081,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/4127750,https://api.altmetric.com/v1/donut/4127750_240.png 1,Biomarkers for Prostate Cancer,Annual Review of Medicine,,,Article,2009-02-01,10.1146/annurev.med.60.042307.110714,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4127746,https://api.altmetric.com/v1/donut/4127746_240.png 1,"Management of castration-resistant (advanced) prostate cancer (CRPC): rationale, progress and future directions.",Australian Family Physician,,,Article,,,,,,26042402,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4123604,https://api.altmetric.com/v1/donut/4123604_240.png 1,T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.,,,,Article,2010-10-20,10.1016/j.molmed.2010.09.006,,,,20971039,PMC3039708,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/4123110,https://api.altmetric.com/v1/donut/4123110_240.png 1,A Paracrine Role for IL-6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.,Cancer immunology research,,,Article,2015-06-07,10.1158/2326-6066.cir-15-0013,,,,26048576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4109775,https://api.altmetric.com/v1/donut/4109775_240.png 1,Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Detecting Residual or Recurrent Prostate Cancer After Radical Prostatectomy: A Pooled Analysis of 12 Individual Studies,Cell Biochemistry and Biophysics,,,Article,2015-06-06,10.1007/s12013-015-0519-6,,,,27352188,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4107214,https://api.altmetric.com/v1/donut/4107214_240.png 1,Radium 223: How Can We Optimize This New Tool for Metastatic Castration-Resistant Prostate Cancer?,American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting,,,Article,2015-06-05,10.14694/edbook_am.2015.35.e270,,,,25993185,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4099829,https://api.altmetric.com/v1/donut/4099829_240.png 1,Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.,PLoS ONE,,,Article,2015-06-04,10.1371/journal.pone.0128235,,,,26039628,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/4092345,https://api.altmetric.com/v1/donut/4092345_240.png 1,"Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients.",Biological Chemistry,,,Article,2014-08-31,10.1515/hsz-2014-0150,,,,25153390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4090967,https://api.altmetric.com/v1/donut/4090967_240.png 1,Personalized Medicine for Advanced Prostate Cancer: Encouraging Results,Journal Watch,,,Article,,10.1056/nejm-jw.na38031,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4082675,https://api.altmetric.com/v1/donut/4082675_240.png 1,"Effective adjuvant chemotherapy for high-risk, localised prostate cancer. ASCO 2015",ecancer.org,,,Article,,,,,http://ecancer.org/conference/677-asco-2015/video/3722/effective-adjuvant-chemotherapy-for-high-risk--localised-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4078725,https://api.altmetric.com/v1/donut/4078725_240.png 1,ASCO 2015: Latest developments in prostate cancer treatment. ASCO 2015,ecancer.org,,,Article,,,,,http://ecancer.org/conference/677-asco-2015/video/3738/asco-2015--latest-developments-in-prostate-cancer-treatment.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4077826,https://api.altmetric.com/v1/donut/4077826_240.png 1,Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy.,"Cancer Immunology, Immunotherapy",,,Article,2015-05-31,10.1007/s00262-015-1707-3,,,,26025563,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/4075542,https://api.altmetric.com/v1/donut/4075542_240.png 1,Circulating Cytokine Levels in Patients with Prostate Cancer: Effects of Neoadjuvant Hormonal Therapy and External-beam Radiotherapy.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-05-31,,,,,26026098,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4075319,https://api.altmetric.com/v1/donut/4075319_240.png 1,Diode Laser Ablation of Prostate and Channel Transure¬thral Resection of Prostate in Patients with Prostate Cancer and Bladder Outlet Obstruction Symptoms.,Urology Journal,,,Article,2014-09-05,,,,,25194077,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4073457,https://api.altmetric.com/v1/donut/4073457_240.png 1,"Bisbibenzyls, novel proteasome inhibitors, suppress androgen receptor transcriptional activity and expression accompanied by activation of autophagy in prostate cancer LNCaP cells.",Pharmaceutical Biology,,,Article,2015-05-29,10.3109/13880209.2015.1049278,,,,26017567,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4070162,https://api.altmetric.com/v1/donut/4070162_240.png 1,Transcriptional regulation of BNIP3 by Sp3 in prostate cancer.,The Prostate,,,Article,2015-05-28,10.1002/pros.23029,,,,26012884,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4067636,https://api.altmetric.com/v1/donut/4067636_240.png 1,Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study,The Prostate,,,Article,2015-05-27,10.1002/pros.23019,,,,26012482,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4067218,https://api.altmetric.com/v1/donut/4067218_240.png 1,Combined unsupervised-supervised classification of multiparametric PET/MRI data: application to prostate cancer.,NMR in Biomedicine,,,Article,2015-05-28,10.1002/nbm.3329,,,,26014883,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/4066689,https://api.altmetric.com/v1/donut/4066689_240.png 1,"ERG Monoclonal Antibody in the Diagnosis and Biological Stratification of Prostate Cancer: Delineation of Minimal Epitope, Critical Residues for Binding, and Molecular Basis of Specificity.",,,,Article,2014-08-14,10.1089/mab.2014.0026,,,,25170998,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4065808,https://api.altmetric.com/v1/donut/4065808_240.png 1,Corrigendum: Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue,Nature Genetics,,,Article,2015-05-27,10.1038/ng0615-689b,,,,26018901,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4064847,https://api.altmetric.com/v1/donut/4064847_240.png 1,Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?,Current Opinion in Urology,,,Article,2015-03-12,10.1097/mou.0000000000000168,,,,25768694,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4064818,https://api.altmetric.com/v1/donut/4064818_240.png 1,Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings.,Clinical Genitourinary Cancer,,,Article,2015-05-27,10.1016/j.clgc.2015.03.006,,,,26007708,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/4063788,https://api.altmetric.com/v1/donut/4063788_240.png 1,Molecular and clinico-histological data in aggressive prostate cancer patients from Bulgaria.,Journal of B U ON official journal of the Balkan Union of Oncology,,,Article,2015-03-01,,,,,26011342,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4062746,https://api.altmetric.com/v1/donut/4062746_240.png 1,Estrogen Receptor ?2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1? in Prostate Cancer.,PLoS ONE,,,Article,2015-05-27,10.1371/journal.pone.0128239,,,,26010887,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4062608,https://api.altmetric.com/v1/donut/4062608_240.png 1,PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.,Oncotarget,,,Article,2015-05-27,10.18632/oncotarget.3931,,,,26011939,PMC4653010,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4062057,https://api.altmetric.com/v1/donut/4062057_240.png 1,Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer.,Supportive Care in Cancer,,,Article,2014-07-04,10.1007/s00520-014-2328-7,,,,24996830,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/4061265,https://api.altmetric.com/v1/donut/4061265_240.png 1,Heterogeneous methodology of racial/ethnic classification may be responsible for the different risk assessments for prostate cancer between Black and White men in Brazil.,International Brazilian Journal of Urology,,,Article,2015-05-27,,,,,26005980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4060311,https://api.altmetric.com/v1/donut/4060311_240.png 1,Microdissecting the role of microRNAs in the pathogenesis of prostate cancer.,Cancer Genetics,,,Article,2015-05-26,10.1016/j.cancergen.2015.02.010,,,,26004033,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/4059802,https://api.altmetric.com/v1/donut/4059802_240.png 1,Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer,PLoS ONE,,,Article,2015-05-18,10.1371/journal.pone.0127295,,,,25993660,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4055852,https://api.altmetric.com/v1/donut/4055852_240.png 1,Expression of Prostate-Specific Membrane Antigen in Lung Cancer Cells and Tumor Neovasculature Endothelial Cells and Its Clinical Significance.,PLoS ONE,,,Article,,10.1371/journal.pone.0125924,,,,25978404,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,6,https://www.altmetric.com/details/4054349,https://api.altmetric.com/v1/donut/4054349_240.png 1,New treatment options in castration-resistant prostate cancer.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2015-05-24,,,,,25995432,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4053030,https://api.altmetric.com/v1/donut/4053030_240.png 1,Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy.,Medical journal of the Islamic Republic of Iran,,,Article,2015-01-01,,,,,26000254,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4052327,https://api.altmetric.com/v1/donut/4052327_240.png 1,Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors.,Journal of Cancer,,,Article,2015-01-01,10.7150/jca.8213,,,,26000039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4051716,https://api.altmetric.com/v1/donut/4051716_240.png 1,Prostate cancer: New gene panel for aggressive prostate cancer,Nature Reviews Urology,,,Article,2015-04-07,10.1038/nrurol.2015.76,,,,25850791,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4045338,https://api.altmetric.com/v1/donut/4045338_240.png 1,"Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.",,,,Article,2011-06-09,10.1200/jco.2010.32.0994,,,,21537051,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/4034471,https://api.altmetric.com/v1/donut/4034471_240.png 1,Roles of Autophagy Induced by Natural Compounds in Prostate Cancer.,BioMed research international,,,Article,,10.1155/2015/121826,,,,25821782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/4034155,https://api.altmetric.com/v1/donut/4034155_240.png 1,Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.,"Drug Design, Development and Therapy",,,Article,,10.2147/dddt.s75976,,,,25834399,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4032473,https://api.altmetric.com/v1/donut/4032473_240.png 1,Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.,Tumor Biology,,,Article,,10.1007/s13277-015-3326-1,,,,25833693,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4032381,https://api.altmetric.com/v1/donut/4032381_240.png 1,Successful delivery of chemotherapy to treat small-cell prostate cancer in a patient undergoing haemodialysis.,Clinical Kidney Journal,,,Article,2014-12-01,10.1093/ckj/sfu097,,,,25859378,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4029480,https://api.altmetric.com/v1/donut/4029480_240.png 1,Regulation and Methylation of Tumor Suppressor MiR-124 by Androgen Receptor in Prostate Cancer Cells.,PLoS ONE,,,Article,,10.1371/journal.pone.0116197,,,,25860954,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4029384,https://api.altmetric.com/v1/donut/4029384_240.png 1,Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,25862866,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4029023,https://api.altmetric.com/v1/donut/4029023_240.png 1,Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort.,PLoS ONE,,,Article,,10.1371/journal.pone.0124245,,,,25874774,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/4027337,https://api.altmetric.com/v1/donut/4027337_240.png 1,Expression Profile of Autophagy-related Markers in Localized Prostate Cancer: Correlation With Biochemical Recurrence After Radical Prostatectomy.,Urology,,,Article,,10.1016/j.urology.2015.03.006,,,,25881865,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/4026693,https://api.altmetric.com/v1/donut/4026693_240.png 1,PET/CT Dose Planning for Volumetric Modulated arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients.,Current Radiopharmaceuticals,,,Article,,,,,,25882786,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4026517,https://api.altmetric.com/v1/donut/4026517_240.png 1,Target acquired: progress and promise of targeted therapeutics in the treatment of prostate cancer.,Current Cancer Drug Targets,,,Article,2016-05-18,10.2174/1568009615666150416113453,,,,25882061,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4026446,https://api.altmetric.com/v1/donut/4026446_240.png 1,Intensified autophagy compromises the efficacy of radiotherapy against prostate cancer.,Biochemical & Biophysical Research Communications,,,Article,,10.1016/j.bbrc.2015.04.014,,,,25887800,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4026279,https://api.altmetric.com/v1/donut/4026279_240.png 1,Comparative Effectiveness of Mitoxantrone Plus Prednisone Versus Prednisone Alone in Metastatic Castrate-Resistant Prostate Cancer After Docetaxel Failure.,Oncologist,,,Article,,10.1634/theoncologist.2014-0432,,,,25888270,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/4026266,https://api.altmetric.com/v1/donut/4026266_240.png 1,The hallmarks of castration-resistant prostate cancers.,Cancer Treatment Reviews,,,Article,2015-05-20,10.1016/j.ctrv.2015.05.003,,,,25981454,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/4026216,https://api.altmetric.com/v1/donut/4026216_240.png 1,Erratum to: (18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,,10.1007/s00259-015-3069-7,,,,25900277,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4024902,https://api.altmetric.com/v1/donut/4024902_240.png 1,Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m115.658765,,,,25903140,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/4024487,https://api.altmetric.com/v1/donut/4024487_240.png 1,"Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.",Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3144,,,,25915662,PMC4537051,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4022660,https://api.altmetric.com/v1/donut/4022660_240.png 1,Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-?1/Smad/MMP9 signals.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3619,,,,25940439,PMC4494941,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4019801,https://api.altmetric.com/v1/donut/4019801_240.png 1,Changes of protein expression in prostate cancer having lost its androgen sensitivity.,International Urology and Nephrology,,,Article,,10.1007/s11255-015-0985-1,,,,25953123,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/4017334,https://api.altmetric.com/v1/donut/4017334_240.png 1,Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-¿B/p65 and MUC1-C,Journal of Experimental & Clinical Cancer Research,,,Article,2015-05-15,10.1186/s13046-015-0168-z,,,,25971429,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4015521,https://api.altmetric.com/v1/donut/4015521_240.png 1,Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients.,American journal of nuclear medicine and molecular imaging,,,Article,2015-01-01,,,,,25973337,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4015128,https://api.altmetric.com/v1/donut/4015128_240.png 1,Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy.,Journal of Hematology & Oncology,,,Article,,10.1186/s13045-015-0149-x,,,,25966929,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4014622,https://api.altmetric.com/v1/donut/4014622_240.png 1,Radium-223 for the treatment of castration-resistant prostate cancer,OncoTargets and therapy,,,Article,2015-06-10,10.2147/ott.s44291,,,,26056474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/4012742,https://api.altmetric.com/v1/donut/4012742_240.png 1,Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients,Osteoporosis International,,,Article,2015-05-20,10.1007/s00198-015-3135-9,,,,25990353,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4011923,https://api.altmetric.com/v1/donut/4011923_240.png 1,NICE guidance on enzalutamide for metastatic hormone-relapsed prostate cancer,Lancet Oncology,,,Article,2014-01-09,10.1016/s1470-2045(14)70346-8,,,,25328938,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/4010079,https://api.altmetric.com/v1/donut/4010079_240.png 1,Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling.,,,,Article,2007-09-14,,,,,17671686,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/4007591,https://api.altmetric.com/v1/donut/4007591_240.png 1,MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells,Cancer Cell International,,,Article,2015-05-06,10.1186/s12935-015-0189-x,,,,25969668,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4005842,https://api.altmetric.com/v1/donut/4005842_240.png 1,Optimization of Invasion-Specific Effects of Betulin Derivatives on Prostate Cancer Cells through Lead Development,PLoS ONE,,,Article,2015-05-12,10.1371/journal.pone.0126111,,,,25965345,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/4004452,https://api.altmetric.com/v1/donut/4004452_240.png 1,Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer,Radiotherapy & Oncology,,,Article,2015-05-21,10.1016/j.radonc.2015.04.026,,,,25991382,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/4003438,https://api.altmetric.com/v1/donut/4003438_240.png 1,Re: Multiparametric Magnetic Resonance Imaging (MRI) and Subsequent MRI/Ultrasonography Fusion-guided Biopsy Increase the Detection of Anteriorly Located Prostate Cancers,European Urology,,,Article,,10.1016/j.eururo.2015.02.015,,,,25944035,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4002532,https://api.altmetric.com/v1/donut/4002532_240.png 1,Re: Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries,European Urology,,,Article,,10.1016/j.eururo.2015.02.014,,,,25944034,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/4002531,https://api.altmetric.com/v1/donut/4002531_240.png 1,Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells,Acta Pharmacologica Sinica,,,Article,2011-03-01,10.1038/aps.2010.219,,,,21372825,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/4001296,https://api.altmetric.com/v1/donut/4001296_240.png 1,Long-term quality of life outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with androgen deprivation.,Medical Oncology,,,Article,2014-06-14,10.1007/s12032-014-0991-7,,,,24848281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3998899,https://api.altmetric.com/v1/donut/3998899_240.png 1,Metabolic reprogramming and vulnerabilities of prostate cancer stem cells independent or epithelial-mesenchymal transition,,,,Article,2015-02-23,,,,,,,2445/65534,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3995286,https://api.altmetric.com/v1/donut/3995286_240.png 1,Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.,Oncotarget,,,Article,2014-05-31,10.18632/oncotarget.2052,,,,24970800,PMC4148108,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3994592,https://api.altmetric.com/v1/donut/3994592_240.png 1,Advantages and limitations of navigation-based multicriteria optimization (MCO) for localized prostate cancer IMRT planning.,Medical Dosimetry,,,Article,2014-03-12,10.1016/j.meddos.2014.02.002,,,,24630909,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3992027,https://api.altmetric.com/v1/donut/3992027_240.png 1,"Antiproliferative activity of the dietary isothiocyanate erucin, a bioactive compound from cruciferous vegetables, on human prostate cancer cells",,,,Article,,,,,,,,10261/111545,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3990953,https://api.altmetric.com/v1/donut/3990953_240.png 1,"KU675, a Concomitant Heat Shock Protein Inhibitor of Hsp90 and Hsc70 that Manifests Isoform Selectivity for Hsp90? in Prostate Cancer Cells",Molecular Pharmacology,,,Article,,10.1124/mol.114.097303,,,,25939977,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3990312,https://api.altmetric.com/v1/donut/3990312_240.png 1,The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.,Tumor Biology,,,Article,2014-09-25,10.1007/s13277-014-2642-1,,,,25256673,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3989367,https://api.altmetric.com/v1/donut/3989367_240.png 1,Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer,PLoS ONE,,,Article,2015-05-01,10.1371/journal.pone.0125277,,,,25933120,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3985539,https://api.altmetric.com/v1/donut/3985539_240.png 1,Plasma nitrate and prostate cancer - Letter.,,,,Article,2013-07-04,10.1158/1055-9965.epi-13-0641,,,,23833123,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3985112,https://api.altmetric.com/v1/donut/3985112_240.png 1,"Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.002.",,,,Article,2013-09-14,10.1016/j.eururo.2013.04.017,,,,23623050,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3985110,https://api.altmetric.com/v1/donut/3985110_240.png 1,Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology,Journal of Magnetic Resonance Imaging,,,Article,2014-11-19,10.1002/jmri.24801,,,,25408104,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3984938,https://api.altmetric.com/v1/donut/3984938_240.png 1,Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration,PLoS ONE,,,Article,2015-05-05,10.1371/journal.pone.0126056,,,,25942420,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3983824,https://api.altmetric.com/v1/donut/3983824_240.png 1,Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis,Cancer Research,,,Article,,10.1158/0008-5472.can-14-3476,,,,25948589,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/3981947,https://api.altmetric.com/v1/donut/3981947_240.png 1,A Novel Measure of Dietary Change in a Prostate Cancer Dietary Program Incorporating Mindfulness Training,Journal of the Academy of Nutrition and Dietetics,,,Article,2012-11-01,10.1016/j.jand.2012.06.008,,,,22853988,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/3981611,https://api.altmetric.com/v1/donut/3981611_240.png 1,Androgen Receptor-dependent Expression of Low-density Lipoprotein Receptor-related Protein 6 is Necessary for Prostate Cancer Cell Proliferation,The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology,,,Article,2015-05-01,10.4196/kjpp.2015.19.3.235,,,,25954128,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3981347,https://api.altmetric.com/v1/donut/3981347_240.png 1,MRI?based prostate volume?adjusted prostate?specific antigen in the diagnosis of prostate cancer,Journal of Magnetic Resonance Imaging,,,Article,2015-05-06,10.1002/jmri.24944,,,,25946664,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3972714,https://api.altmetric.com/v1/donut/3972714_240.png 1,Antiproliferative Activities of Fagara xanthoxyloides and Pseudocedrela kotschyi Against Prostate Cancer Cell Lines.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2015-03-15,,,,,25750297,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3971802,https://api.altmetric.com/v1/donut/3971802_240.png 1,Patient comorbidity is associated with conservative treatment of localized prostate cancer.,Scandinavian journal of urology,,,Article,,10.3109/21681805.2015.1026936,,,,25903072,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3965430,https://api.altmetric.com/v1/donut/3965430_240.png 1,Electrochemical red-ox therapy of prostate cancer in nude mice ,Bioelectrochemistry,,,Article,2014-12-19,10.1016/j.bioelechem.2014.12.004,,,,25578541,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3964593,https://api.altmetric.com/v1/donut/3964593_240.png 1,"Increased Acid Ceramidase Expression depends on Upregulation of Androgen-dependent Deubiquitinases, USP2, in a Human Prostate Cancer Cell Line, LNCaP",Journal of Biochemistry,,,Article,,10.1093/jb/mvv039,,,,25888580,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3964238,https://api.altmetric.com/v1/donut/3964238_240.png 1,TGF-? and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.,Molecular Immunology,,,Article,2015-01-22,10.1016/j.molimm.2014.12.017,,,,25618241,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3963927,https://api.altmetric.com/v1/donut/3963927_240.png 1,Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer,Cell Cycle,,,Article,2015-04-30,10.1080/15384101.2015.1041689,,,,25927139,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3963768,https://api.altmetric.com/v1/donut/3963768_240.png 1,Inorganic Arsenic and Human Prostate Cancer,Environmental Health Perspectives,,,Article,2008-02-01,10.1289/ehp.10423,,,,18288312,PMC2235216,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3962278,https://api.altmetric.com/v1/donut/3962278_240.png 1,The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior.,Urologic Oncology,,,Article,2015-05-01,10.1016/j.urolonc.2015.03.002,,,,25920548,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3959387,https://api.altmetric.com/v1/donut/3959387_240.png 1,[Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].,,,,Article,2009-05-14,10.1007/s00120-009-1954-z,,,,19296069,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3951925,https://api.altmetric.com/v1/donut/3951925_240.png 1,"Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP",PLoS ONE,,,Article,2015-04-28,10.1371/journal.pone.0125151,,,,25919866,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3950403,https://api.altmetric.com/v1/donut/3950403_240.png 1,"Probable prostate cancer in a pre-Incaic individual from Pukara de la Cueva, northwestern Argentina.",Anthropologischer Anzeiger,,,Article,2015-02-17,10.1127/anthranz/2015/0463,,,,25807398,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3946755,https://api.altmetric.com/v1/donut/3946755_240.png 1,Cardiometabolic and Skeletal Risk Factors in Black Men with Prostate Cancer Starting Androgen Deprivation Therapy,Cancers,,,Article,2015-04-22,10.3390/cancers7020679,,,,25913100,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3945709,https://api.altmetric.com/v1/donut/3945709_240.png 1,Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.,Biochimica et Biophysica Acta (BBA),,,Article,2014-11-13,10.1016/j.bbamcr.2014.11.004,,,,25447541,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3941545,https://api.altmetric.com/v1/donut/3941545_240.png 1,Image quality and cancer visibility of T2-weighted Magnetic Resonance Imaging of the prostate at 7 Tesla.,European Radiology,,,Article,2014-05-27,10.1007/s00330-014-3234-6,,,,24865699,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3941062,https://api.altmetric.com/v1/donut/3941062_240.png 1,Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer.,Pathology - Research & Practice,,,Article,2013-10-28,10.1016/j.prp.2013.08.013,,,,24252309,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3939950,https://api.altmetric.com/v1/donut/3939950_240.png 1,Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-05-31,10.1073/pnas.1100489108,,,,21571633,PMC3107329,,2011PNAS..108.9172K,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3938785,https://api.altmetric.com/v1/donut/3938785_240.png 1,Pathophysiology of late anorectal dysfunction following external beam radiotherapy for prostate cancer.,Acta Oncologica,,,Article,2014-06-23,10.3109/0284186x.2014.926029,,,,24960583,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3938761,https://api.altmetric.com/v1/donut/3938761_240.png 1,Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.,Oncotarget,,,Article,2014-06-14,10.18632/oncotarget.1994,,,,25004126,PMC4116519,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3937704,https://api.altmetric.com/v1/donut/3937704_240.png 1,Sero?epidemiologal association between human?papillomavirus infection and risk of prostate cancer,International Journal of Cancer,,,Article,1998-12-06,10.1002/(sici)1097-0215(19980209)75:4<564::aid-ijc12>3.0.co;2-9,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3936591,https://api.altmetric.com/v1/donut/3936591_240.png 1,Factors Associated with Men’s Assessment of Prostate Cancer Treatment Choice,Journal of Cancer Education,,,Article,2015-04-18,10.1007/s13187-015-0837-9,,,,25893926,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3936022,https://api.altmetric.com/v1/donut/3936022_240.png 1,The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells,Molecular and Cellular Biochemistry,,,Article,2015-04-17,10.1007/s11010-015-2409-z,,,,25876877,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3934928,https://api.altmetric.com/v1/donut/3934928_240.png 1,Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced V?9Vd2 T cell cytotoxicity in PC-3 prostate cancer cells.,Cancer Letters,,,Article,2014-11-21,10.1016/j.canlet.2014.11.030,,,,25444923,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3933388,https://api.altmetric.com/v1/donut/3933388_240.png 1,"Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.",The Prostate,,,Article,2015-04-23,10.1002/pros.22980,,,,25893276,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3933149,https://api.altmetric.com/v1/donut/3933149_240.png 1,Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer,PloS one,,,Article,2015-04-22,10.1371/journal.pone.0122498,,,,25897494,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3930898,https://api.altmetric.com/v1/donut/3930898_240.png 1,"MK591, a Second Generation Leukotriene Biosynthesis Inhibitor, Prevents Invasion and Induces Apoptosis in the Bone-Invading C4-2B Human Prostate Cancer Cells: Implications for the Treatment of Castration-Resistant, Bone-Metastatic Prostate Cancer",PLoS ONE,,,Article,,10.1371/journal.pone.0122805,,,,25875826,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3928270,https://api.altmetric.com/v1/donut/3928270_240.png 1,"GE132+Natural: Novel promising dietetic supplement with antiproliferative influence on prostate, colon, and breast cancer cells.",,,,Article,,,,,,23818369,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3924399,https://api.altmetric.com/v1/donut/3924399_240.png 1,Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy,American Journal of Men's Health,,,Article,2015-04-22,10.1177/1557988315581396,,,,25891393,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3923994,https://api.altmetric.com/v1/donut/3923994_240.png 1,Analysis of Tim-3 as a therapeutic target in prostate cancer.,Tumor Biology,,,Article,2014-08-14,10.1007/s13277-014-2464-1,,,,25119597,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3921319,https://api.altmetric.com/v1/donut/3921319_240.png 1,Overexpression of the Novel Senescence Marker ?-Galactosidase (GLB1) in Prostate Cancer Predicts Reduced PSA Recurrence.,PLoS ONE,,,Article,2015-04-15,10.1371/journal.pone.0124366,,,,25876105,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3921151,https://api.altmetric.com/v1/donut/3921151_240.png 1,Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis,JNCI: Journal of the National Cancer Institute,,,Article,,10.1093/jnci/djh147,,,,15126594,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3920863,https://api.altmetric.com/v1/donut/3920863_240.png 1,Prostate cancer screening in Europe – Authors' reply,The Lancet (British Edition),,,Article,2015-05-02,10.1016/s0140-6736(15)60749-8,,,,25933276,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3919493,https://api.altmetric.com/v1/donut/3919493_240.png 1,"Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases",Human Genetics,,,Article,2015-02-26,10.1007/s00439-015-1534-9,,,,25715684,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3918855,https://api.altmetric.com/v1/donut/3918855_240.png 1,Quantitative Graphical Analysis of Simultaneous Dynamic PET/MRI For Assessment of Prostate Cancer,Clinical Nuclear Medicine,,,Article,2015-04-01,10.1097/rlu.0000000000000673,,,,25608166,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3912899,https://api.altmetric.com/v1/donut/3912899_240.png 1,Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer.,The Prostate,,,Article,2014-10-17,10.1002/pros.22910,,,,25327687,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3909022,https://api.altmetric.com/v1/donut/3909022_240.png 1,Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.,The Prostate,,,Article,2014-10-17,10.1002/pros.22916,,,,25327986,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3908967,https://api.altmetric.com/v1/donut/3908967_240.png 1,Systematic Review of the Cost Effectiveness of Radiation Therapy for Prostate Cancer from 2003 to 2013.,Applied Health Economics and Health Policy,,,Article,2014-07-14,10.1007/s40258-014-0106-9,,,,25022451,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/3906713,https://api.altmetric.com/v1/donut/3906713_240.png 1,[Detection of second tumors in 11C-choline PET/CT studies performed due to biochemical recurrence of prostate cancer.],,,,Article,2013-03-13,10.1016/j.remn.2013.01.007,,,,23499124,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3906376,https://api.altmetric.com/v1/donut/3906376_240.png 1,[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].,,,,Article,2004-08-14,10.1055/s-2004-818510,,,,15459874,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3905710,https://api.altmetric.com/v1/donut/3905710_240.png 1,18F-fluoromethylcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision,Nuclear Medicine & Biology,,,Article,2015-01-07,10.1016/j.nucmedbio.2014.12.019,,,,25618796,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3903734,https://api.altmetric.com/v1/donut/3903734_240.png 1,miR-25 modulates invasiveness and dissemination of human prostate cancer cells via regulation of ?v- and ?6 integrin expression.,Cancer Research,,,Article,2015-04-12,10.1158/0008-5472.can-14-2155,,,,25858144,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3899810,https://api.altmetric.com/v1/donut/3899810_240.png 1,Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.,Expert Opinion on Investigational Drugs,,,Article,2015-04-12,10.1517/13543784.2015.1035708,,,,25858813,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3899627,https://api.altmetric.com/v1/donut/3899627_240.png 1,Systematic review of clinical features of suspected prostate cancer in primary care.,Canadian Family Physician,,,Article,2015-01-15,,,,,25756146,PMC4301783,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3892943,https://api.altmetric.com/v1/donut/3892943_240.png 1,Ipilimumab: A potential immunologic agent in the treatment of metastatic castration-resistant prostate cancer.,Cancer Biology and Therapy,,,Article,2014-07-20,,,,,25046606,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3885461,https://api.altmetric.com/v1/donut/3885461_240.png 1,Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer,Radiotherapy & Oncology,,,Article,2015-04-11,10.1016/j.radonc.2015.03.018,,,,25857696,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3882876,https://api.altmetric.com/v1/donut/3882876_240.png 1,Supportive care for men with prostate cancer: why are the trials not working? A systematic review and recommendations for future trials,Cancer Medicine,,,Article,2015-04-01,10.1002/cam4.446,,,,25828811,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3880930,https://api.altmetric.com/v1/donut/3880930_240.png 1,The burden of out-of-pocket and indirect costs of prostate cancer.,,,,Article,2010-08-14,10.1002/pros.21161,,,,20658653,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3878220,https://api.altmetric.com/v1/donut/3878220_240.png 1,"Low dose, alternating electric current inhibits growth of prostate cancer.",,,,Article,2010-03-31,10.1002/pros.21087,,,,19938042,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3877964,https://api.altmetric.com/v1/donut/3877964_240.png 1,Regulation of GLUT transporters by flavonoids in androgen-sensitive and insensitive prostate cancer cells.,Endocrinology,,,Article,2014-06-15,10.1210/en.2014-1260,,,,24932809,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3856923,https://api.altmetric.com/v1/donut/3856923_240.png 1,Healthcare providers' perspectives of the supportive care needs of men with advanced prostate cancer.,Oncology Nursing Forum,,,Article,2014-06-30,10.1188/14.onf.421-430,,,,24969251,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3855051,https://api.altmetric.com/v1/donut/3855051_240.png 1,Plasma carotenoid- and retinol-weighted gene scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-03-23,10.1158/1055-9965.epi-13-0017,,,,23515144,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3849898,https://api.altmetric.com/v1/donut/3849898_240.png 1,Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options,Canadian Urological Association Journal,,,Article,2010-04-01,,,,,20368898,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3849884,https://api.altmetric.com/v1/donut/3849884_240.png 1,Guidance on Patient Consultation. Current Evidence for Prostate-Specific Antigen Screening in Healthy Men and Treatment Options for Men with Proven Localised Prostate Cancer,Current Urology Reports,,,Article,2015-03-17,10.1007/s11934-015-0502-1,,,,25773347,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3848568,https://api.altmetric.com/v1/donut/3848568_240.png 1,Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer,Radiotherapy & Oncology,,,Article,2015-03-31,10.1016/j.radonc.2015.03.005,,,,25818395,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3847538,https://api.altmetric.com/v1/donut/3847538_240.png 1,Arkansas Prostate Cancer Foundation Supporting ProstateHealth in Arkansas,arprostatecancer.org,,,Article,,,,,http://arprostatecancer.org/,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3845065,https://api.altmetric.com/v1/donut/3845065_240.png 1,Androstenedione is the preferred androgen source in hormone refractory prostate cancer-response.,Clinical Cancer Research,,,Article,2014-09-17,10.1158/1078-0432.ccr-14-1536,,,,25225066,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3844332,https://api.altmetric.com/v1/donut/3844332_240.png 1,"A prospective study on dietary fat and incidence of prostate cancer (Malmö, Sweden).",Cancer Causes and Control,,,Article,2007-01-12,10.1007/s10552-007-9050-4,,,,17726648,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3842777,https://api.altmetric.com/v1/donut/3842777_240.png 1,microRNA and non-canonical TGF-? signalling: Implications for prostate cancer therapy ,Critical Reviews in Oncology/Hematology,,,Article,,10.1016/j.critrevonc.2014.05.011,,,,24985060,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3838611,https://api.altmetric.com/v1/donut/3838611_240.png 1,"Visceral Metastases and Prostate Cancer Treatment: 'Die Hard,' 'Tough Neighborhoods,' or 'Evil Humors'?",Oncology (08909091),,,Article,2014-11-20,,,,,25403629,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3838457,https://api.altmetric.com/v1/donut/3838457_240.png 1,Final Report from COU-AA-302: Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer Prolonged with Abiraterone,Oncology times,,,Article,2015-03-25,10.1097/01.cot.0000462855.37349.12,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3836689,https://api.altmetric.com/v1/donut/3836689_240.png 1,Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.,Clinical and Experimental Metastasis,,,Article,2015-03-24,10.1007/s10585-015-9714-5,,,,25802102,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3835795,https://api.altmetric.com/v1/donut/3835795_240.png 1,Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients.,Prostate Cancer,,,Article,2015-01-01,10.1155/2015/285193,,,,25802762,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3835260,https://api.altmetric.com/v1/donut/3835260_240.png 1,PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.,Autophagy,,,Article,2015-03-24,10.1080/15548627.2015.1017182,,,,25803782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3835185,https://api.altmetric.com/v1/donut/3835185_240.png 1,[Treatment of prostate cancer using cryoablation: a prospective study].,Urologii?a?,,,Article,,,,,,25799731,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3835094,https://api.altmetric.com/v1/donut/3835094_240.png 1,A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.,Oncotarget,,,Article,2015-03-08,10.18632/oncotarget.3480,,,,25797256,PMC4480709,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3832763,https://api.altmetric.com/v1/donut/3832763_240.png 1,Denosumab prevents bone metastasis in men with castration-resistant prostate cancer,BoneKEy Reports,,,Article,2014-01-15,10.1038/bonekey.2013.236,,,,24466419,PMC3899567,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3831245,https://api.altmetric.com/v1/donut/3831245_240.png 1,Protein arginine methyltransferase 10 is required for androgen-dependent proliferation of LNCaP prostate cancer cells.,"Bioscience, Biotechnology, and Biochemistry",,,Article,2015-03-23,10.1080/09168451.2015.1025035,,,,25799006,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3827423,https://api.altmetric.com/v1/donut/3827423_240.png 1,Diet and prostate cancer - a holistic approach to management.,Archivos Españoles de Urología,,,Article,2011-11-05,,,,,22052755,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3823616,https://api.altmetric.com/v1/donut/3823616_240.png 1,Evaluation of Online/Offline Image Guidance/Adaptation Approaches for Prostate Cancer Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-04,10.1016/j.ijrobp.2014.12.043,,,,25832693,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3820783,https://api.altmetric.com/v1/donut/3820783_240.png 1,A urologic oncology roundtable discussion: how to choose among the available therapies for the treatment of castration-resistant prostate cancer.,Postgraduate Medicine,,,Article,2013-11-11,10.3810/pgm.2013.11.2718,,,,24200767,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3820714,https://api.altmetric.com/v1/donut/3820714_240.png 1,Management of Advanced Prostate Cancer – Role of the Urologist,Current Urology Reports,,,Article,2014-05-10,10.1007/s11934-014-0419-0,,,,24817261,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3820713,https://api.altmetric.com/v1/donut/3820713_240.png 1,Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study,International Journal of Cancer,,,Article,,10.1002/ijc.23594,,,,18521907,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3819970,https://api.altmetric.com/v1/donut/3819970_240.png 1,Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy,Cancer Biology and Therapy,,,Article,2014-03-21,10.4161/cbt.28554,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3813246,https://api.altmetric.com/v1/donut/3813246_240.png 1,"Androgen deprivation therapy is ineffective for early prostate cancer, US study shows",British Medical Journal,,,Article,2014-03-20,10.1136/bmj.g2230,,,,24652998,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3808226,https://api.altmetric.com/v1/donut/3808226_240.png 1,Predictive Models for Newly Diagnosed Prostate Cancer Patients,Reviews in Urology,,,Article,,,,,,19918337,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3806186,https://api.altmetric.com/v1/donut/3806186_240.png 1,"Unravelling ""off-target"" effects of redox-active polymers and polymer multilayered capsules in prostate cancer cells.",Nanoscale,,,Article,2015-03-17,10.1039/c4nr07240e,,,,25779724,,11343/55098,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3802547,https://api.altmetric.com/v1/donut/3802547_240.png 1,"Nonlinear Mixed-Effect Models for Prostate-Specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: a Comparison by Simulation of Two-Stage and Joint Approaches",,,,Article,,,,,,,,,,1503.05103,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3801093,https://api.altmetric.com/v1/donut/3801093_240.png 1,Arkansas Prostate Cancer Foundation Trumann: CommunityHealth Fair,arprostatecancer.org,,,Article,,,,,http://arprostatecancer.org/event/trumann-screening/,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3800335,https://api.altmetric.com/v1/donut/3800335_240.png 1,Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States),Cancer Causes and Control,,,Article,,10.1007/s10552-006-0077-8,,,,17186423,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3797328,https://api.altmetric.com/v1/donut/3797328_240.png 1,Boric acid inhibits human prostate cancer cell proliferation,Cancer Letters,,,Article,2004-08-12,10.1016/j.canlet.2004.06.001,,,,15500945,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3797327,https://api.altmetric.com/v1/donut/3797327_240.png 1,Quality-of-life assessment tools for men with prostate cancer,Nature Reviews Urology,,,Article,2014-05-20,10.1038/nrurol.2014.101,,,,24841165,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3792710,https://api.altmetric.com/v1/donut/3792710_240.png 1,P21 activated kinase-1 mediates transforming growth factor ?1-induced prostate cancer cell epithelial to mesenchymal transition ,BBA - Molecular Cell Research,,,Article,,10.1016/j.bbamcr.2015.02.023,,,,25746720,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3792477,https://api.altmetric.com/v1/donut/3792477_240.png 1,Roles of Ubiquitination and SUMOylation on Prostate Cancer: Mechanisms and Clinical Implications,International Journal of Molecular Sciences,,,Article,2015-02-27,10.3390/ijms16034560,,,,25734985,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3790148,https://api.altmetric.com/v1/donut/3790148_240.png 1,"A retrospective, Canadian multi?center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration?resistant prostate cancer",The Prostate,,,Article,2014-11-01,10.1002/pros.22872,,,,25175831,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/3789140,https://api.altmetric.com/v1/donut/3789140_240.png 1,"Downregulation of miR-221, -30d, and -15a Contributes to Pathogenesis of Prostate Cancer by Targeting Bmi-1.",Biochemistry (00062979),,,Article,2015-03-01,10.1134/s0006297915030037,,,,25761682,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3786434,https://api.altmetric.com/v1/donut/3786434_240.png 1,A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer,BMC Cancer,,,Article,2014-05-21,10.1186/1471-2407-14-352,,,,24886074,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3786373,https://api.altmetric.com/v1/donut/3786373_240.png 1,A randomised controlled trial of a brief cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN),Psycho-Oncology,,,Article,2015-03-09,10.1002/pon.3794,,,,25753889,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3783465,https://api.altmetric.com/v1/donut/3783465_240.png 1,High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success.,Radiotherapy & Oncology,,,Article,2015-03-11,10.1016/j.radonc.2015.02.023,,,,25770875,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3783098,https://api.altmetric.com/v1/donut/3783098_240.png 1,Ischemia-modified albumin and inflammatory biomarkers in patients with prostate cancer.,Clinical Laboratory,,,Article,2015-02-07,,,,,25651717,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3781380,https://api.altmetric.com/v1/donut/3781380_240.png 1,"Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer","",,,Article,2014-12-06,,,,,25473696,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3776971,https://api.altmetric.com/v1/donut/3776971_240.png 1,Flavonoids can block PSA production by breast and prostate cancer cell lines ,Clinica Chimica Acta,,,Article,,10.1016/s0009-8981(01)00698-2,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3776904,https://api.altmetric.com/v1/donut/3776904_240.png 1,Molecular and Clinicopathological Aspects of Prostate Cancer in Bulgarian Probands.,Pathology & Oncology Research,,,Article,2015-03-10,10.1007/s12253-015-9915-x,,,,25753984,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3775788,https://api.altmetric.com/v1/donut/3775788_240.png 1,Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways.,Biochemical & Biophysical Research Communications,,,Article,2011-03-05,10.1016/j.bbrc.2011.02.124,,,,21371438,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3770865,https://api.altmetric.com/v1/donut/3770865_240.png 1,"“First, do no harm”: Managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer",Internal Medicine Journal,,,Article,2016-02-22,10.1111/imj.12731,,,,25732203,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3768980,https://api.altmetric.com/v1/donut/3768980_240.png 1,Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer,Journal of Drug Targeting,,,Article,2015-03-06,10.3109/1061186x.2015.1018910,,,,25738990,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3765884,https://api.altmetric.com/v1/donut/3765884_240.png 1,Methylation of Integrin ?4 and E-Cadherin Genes in Human Prostate Cancer.,Pathology & Oncology Research,,,Article,2015-03-06,10.1007/s12253-015-9917-8,,,,25743258,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3764491,https://api.altmetric.com/v1/donut/3764491_240.png 1,Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.,Tumor Biology,,,Article,2015-03-04,10.1007/s13277-015-3284-7,,,,25736928,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3758071,https://api.altmetric.com/v1/donut/3758071_240.png 1,PET/CT in prostate cancer: an unmet clinical need.,Oncology (08909091),,,Article,2014-12-01,,,,,25738198,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3757308,https://api.altmetric.com/v1/donut/3757308_240.png 1,MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.,The Prostate,,,Article,2015-03-01,10.1002/pros.22961,,,,25731699,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3755041,https://api.altmetric.com/v1/donut/3755041_240.png 1,Acute Toxicity After Image-Guided Intensity Modulated Radiation Therapy Compared to 3D Conformal Radiation Therapy in Prostate Cancer Patients.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-03-15,10.1016/j.ijrobp.2014.12.017,,,,25752386,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/3755019,https://api.altmetric.com/v1/donut/3755019_240.png 1,Insomnia in men treated with radical prostatectomy for prostate cancer.,Psycho-Oncology,,,Article,2004-09-24,10.1002/pon.830,,,,15386779,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3754370,https://api.altmetric.com/v1/donut/3754370_240.png 1,Electrogenerated chemiluminescence biosensing for the detection of prostate PC-3 cancer cells incorporating antibody as capture probe and ruthenium complex-labelled wheat germ agglutinin as signal probe.,Analytica Chimica Acta,,,Article,2015-03-10,10.1016/j.aca.2014.09.001,,,,25732307,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3753811,https://api.altmetric.com/v1/donut/3753811_240.png 1,Managing advanced prostate cancer: the rapidly changing treatment landscape.,"American Journal of Managed Care, The",,,Article,2014-12-01,,,,,25734964,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3753418,https://api.altmetric.com/v1/donut/3753418_240.png 1,"Pubic symphysis osteomyelitis in the prostate cancer survivor: clinical presentation, evaluation, and management.",Urology,,,Article,2015-03-01,10.1016/j.urology.2014.11.020,,,,25733290,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3753140,https://api.altmetric.com/v1/donut/3753140_240.png 1,Reprint of: The prostate cancer genome: Perspectives and potential.,Urologic Oncology,,,Article,2015-02-01,10.1016/j.urolonc.2015.01.002,,,,25726356,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/3750237,https://api.altmetric.com/v1/donut/3750237_240.png 1,Metastatic prostate cancer - Interpreting negative trial results. Genitourinary Cancers Symposium,ecancer.org,,,Article,,,,,http://ecancer.org/conference/633-genitourinary-cancers-symposium/video/3501/metastatic-prostate-cancer---interpreting-negative-trial-results.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3745745,https://api.altmetric.com/v1/donut/3745745_240.png 1,Proinflammatory cytokines in prostate cancer development and progression promoted by high-fat diet.,BioMed research international,,,Article,2015-01-01,10.1155/2015/249741,,,,25722971,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3741882,https://api.altmetric.com/v1/donut/3741882_240.png 1,A Retrospective Analysis Investigating Feasibility of the Prostate-Rectum Interface Soft-Tissue Image Matching Procedure for Prostate Cancer Patients without Gold Seeds at the Durham Regional Cancer Centre,Journal of Medical Imaging & Radiation Sciences,,,Article,2015-01-03,10.1016/j.jmir.2015.01.016,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3740158,https://api.altmetric.com/v1/donut/3740158_240.png 1,miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.,Oncotarget,,,Article,2015-01-21,10.18632/oncotarget.3341,,,,25714029,PMC4467424,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3735249,https://api.altmetric.com/v1/donut/3735249_240.png 1,The Cost of Thromboembolic Events in Hospitalized Patients with Breast or Prostate Cancer in France,Advances in Therapy,,,Article,2015-02-26,10.1007/s12325-015-0187-3,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3734815,https://api.altmetric.com/v1/donut/3734815_240.png 1,AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction.,"Cancer Immunology, Immunotherapy",,,Article,2014-07-24,10.1007/s00262-014-1582-3,,,,25052849,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3733798,https://api.altmetric.com/v1/donut/3733798_240.png 1,[Correlation of autophagy-associated gene Atg5 with tumorigenesis of prostate cancer].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-01-01,,,,,25707136,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3730621,https://api.altmetric.com/v1/donut/3730621_240.png 1,Hypoxia-induced STAT3 Contributes to Chemoresistance and Epithelial-Mesenchymal Transition in Prostate Cancer Cells.,Biochemical & Biophysical Research Communications,,,Article,2015-02-18,10.1016/j.bbrc.2015.02.027,,,,25701777,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3728900,https://api.altmetric.com/v1/donut/3728900_240.png 1,Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers.,Human Pathology,,,Article,2014-06-26,10.1016/j.humpath.2014.06.006,,,,25701228,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3728721,https://api.altmetric.com/v1/donut/3728721_240.png 1,Prostate cancer relevant antigens and enzymes for targeted drug delivery.,Journal of Controlled Release,,,Article,2014-06-01,10.1016/j.jconrel.2014.05.035,,,,24878184,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/3725899,https://api.altmetric.com/v1/donut/3725899_240.png 1,The National Prostate Cancer Audit – Results from the Organisational Survey of NHS Trusts in England ,Clinical Oncology,,,Article,,10.1016/j.clon.2014.11.007,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3724819,https://api.altmetric.com/v1/donut/3724819_240.png 1,Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Gene Deletion Promotes Cancer Growth in TRAMP Prostate Cancer Prone Mice.,PLoS ONE,,,Article,2015-02-19,10.1371/journal.pone.0115189,,,,25695521,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3718334,https://api.altmetric.com/v1/donut/3718334_240.png 1,"Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancer.",Expert Opinion on Pharmacotherapy,,,Article,2015-02-17,10.1517/14656566.2015.1016911,,,,25687355,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3710343,https://api.altmetric.com/v1/donut/3710343_240.png 1,Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells.,Cell Journal (Yakhteh),,,Article,2015-01-01,,,,,25685739,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3706572,https://api.altmetric.com/v1/donut/3706572_240.png 1,Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer.,Hellenic Journal of Nuclear Medicine,,,Article,2015-02-15,10.1967/s002449910168,,,,25679079,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3704970,https://api.altmetric.com/v1/donut/3704970_240.png 1,Community-Based Free Prostate Cancer Screening Program,"Progress in Community Health Partnerships: Research, Education, and Action",,,Article,2015-02-16,,,,,19129926,,,,,,,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3702809,https://api.altmetric.com/v1/donut/3702809_240.png 1,G-CSF off-target effect on nerve outgrowth promotes prostate cancer development.,International Journal of Cancer,,,Article,2014-07-01,10.1002/ijc.29046,,,,24975135,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3700372,https://api.altmetric.com/v1/donut/3700372_240.png 1,Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Expanded access in North America.,The Prostate,,,Article,2015-02-14,10.1002/pros.22965,,,,25683285,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3693864,https://api.altmetric.com/v1/donut/3693864_240.png 1,Dosimetry and first clinical evaluation of the new 18F radiolabeled Bombesin Analogue BAY 864367 in patients with prostate cancer.,Journal of Nuclear Medicine,,,Article,2015-02-12,10.2967/jnumed.114.147116,,,,25678494,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3680560,https://api.altmetric.com/v1/donut/3680560_240.png 1,Unusual Lymph Node Metastases of Prostate Cancer Detected by 18F-Fluorocholine PET/CT.,Clinical Nuclear Medicine,,,Article,2015-02-11,10.1097/rlu.0000000000000708,,,,25674860,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3614320,https://api.altmetric.com/v1/donut/3614320_240.png 1,Peroxisome proliferator?activated receptor ? agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.,Molecular Medicine Reports,,,Article,2014-05-21,10.3892/mmr.2014.2232,,,,24842333,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3613590,https://api.altmetric.com/v1/donut/3613590_240.png 1,Magnetic Resonance–invisible Versus Magnetic Resonance–visible Prostate Cancer in Active Surveillance: A Preliminary Report on Disease Outcomes,Urology,,,Article,,10.1016/j.urology.2014.06.085,,,,25440986,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3610526,https://api.altmetric.com/v1/donut/3610526_240.png 1,Atorvastatin induces autophagic cell death in prostate cancer cells in vitro.,Molecular Medicine Reports,,,Article,2015-02-11,10.3892/mmr.2015.3334,,,,25672364,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3588942,https://api.altmetric.com/v1/donut/3588942_240.png 1,"Lupeol triterpene, a novel diet-based microtubule targeting agent: Disrupts survivin/cFLIP activation in prostate cancer cells ",Biochemical & Biophysical Research Communications,,,Article,2009-10-22,10.1016/j.bbrc.2009.08.060,,,,19683515,PMC2761704,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3578433,https://api.altmetric.com/v1/donut/3578433_240.png 1,Practical guide to the use of chemotherapy in castration resistant prostate cancer.,Canadian Journal of Urology,,,Article,2014-04-30,,,,,24775728,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3555411,https://api.altmetric.com/v1/donut/3555411_240.png 1,CD147 modulates autophagy through the PI3K/Akt/mTOR pathway in human prostate cancer PC-3 cells.,Oncology Letters,,,Article,2015-03-01,10.3892/ol.2015.2849,,,,25663928,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3555326,https://api.altmetric.com/v1/donut/3555326_240.png 1,Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer.,Journal of Cancer,,,Article,2015-01-01,10.7150/jca.11038,,,,25663948,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3548438,https://api.altmetric.com/v1/donut/3548438_240.png 1,"The Hippo Pathway Effector, YAP, Regulates Motility, Invasion and Castration-Resistant Growth of Prostate Cancer Cells",Molecular & Cellular Biology,,,Article,,10.1128/mcb.00102-15,,,,25645929,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3437296,https://api.altmetric.com/v1/donut/3437296_240.png 1,Leading causes of castration-resistant prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2015-02-05,10.1586/14737140.2015.1007957,,,,25645203,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3435835,https://api.altmetric.com/v1/donut/3435835_240.png 1,Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial,Trials,,,Article,2009-06-11,10.1186/1745-6215-10-39,,,,19519885,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/3387217,https://api.altmetric.com/v1/donut/3387217_240.png 1,"DLEC1, a 3p tumor suppressor, represses NF-?B signaling and is methylated in prostate cancer.",Journal of Molecular Medicine,,,Article,2015-02-05,10.1007/s00109-015-1255-5,,,,25648635,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3355193,https://api.altmetric.com/v1/donut/3355193_240.png 1,Novel biophysical determination of miRNAs related to prostate and head and neck cancers.,European Biophysics Journal,,,Article,2015-02-04,10.1007/s00249-015-1008-y,,,,25650273,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3354198,https://api.altmetric.com/v1/donut/3354198_240.png 1,Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.,Biochemical & Biophysical Research Communications,,,Article,2014-12-04,10.1016/j.bbrc.2014.10.073,,,,25450398,PMC4254650,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3351964,https://api.altmetric.com/v1/donut/3351964_240.png 1,Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males.,Experimental & Molecular Pathology,,,Article,2014-12-04,10.1016/j.yexmp.2014.11.005,,,,25445501,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3348324,https://api.altmetric.com/v1/donut/3348324_240.png 1,Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial,Trials,,,Article,2011-12-05,10.1186/1745-6215-12-255,,,,22141598,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/3334657,https://api.altmetric.com/v1/donut/3334657_240.png 1,Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ER?) in human prostate cancer.,The Prostate,,,Article,2012-10-12,10.1002/pros.22599,,,,23060014,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3333760,https://api.altmetric.com/v1/donut/3333760_240.png 1,Burden of Hospital Admissions and Utilization of Hospice Care in Metastatic Prostate Cancer Patients ,Urology,,,Article,2015-02-15,10.1016/j.urology.2014.09.053,,,,25623683,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3327711,https://api.altmetric.com/v1/donut/3327711_240.png 1,Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis',Annals of Oncology,,,Article,2015-02-02,10.1093/annonc/mdv038,,,,25646367,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3321099,https://api.altmetric.com/v1/donut/3321099_240.png 1,Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET.,Journal of Nuclear Medicine,,,Article,2014-12-04,10.2967/jnumed.114.145185,,,,25453051,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3257158,https://api.altmetric.com/v1/donut/3257158_240.png 1,Multidrug resistance protein 1 localization in lipid raft domains and prostasomes in prostate cancer cell lines,,,,Article,,10.2147/ott.s69530,,,,25525371,,2445/62225,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3236689,https://api.altmetric.com/v1/donut/3236689_240.png 1,Regulation of Autophagy of Prostate Cancer Cells by ?-Catenin Signaling.,Cellular Physiology & Biochemistry,,,Article,2015-01-01,10.1159/000369749,,,,25633614,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3214272,https://api.altmetric.com/v1/donut/3214272_240.png 1,Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression,Journal of Biological Chemistry,,,Article,2016-02-13,10.1074/jbc.m804491200,,,,19017637,PMC2629082,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/3210507,https://api.altmetric.com/v1/donut/3210507_240.png 1,Does cassava help to control prostate cancer? A case report,journal of Pharmaceutical Technology and Drug Research,,,Article,2013-01-10,10.7243/2050-120x-2-3,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3168045,https://api.altmetric.com/v1/donut/3168045_240.png 1,Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.,The Prostate,,,Article,2015-01-28,10.1002/pros.22935,,,,25631036,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3166309,https://api.altmetric.com/v1/donut/3166309_240.png 1,PROSTVAC® targeted immunotherapy candidate for prostate cancer.,Immunotherapy,,,Article,2014-04-26,10.2217/imt.13.176,,,,24762070,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3165928,https://api.altmetric.com/v1/donut/3165928_240.png 1,Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells,Journal of Experimental & Clinical Cancer Research,,,Article,2014-09-10,10.1186/s13046-014-0072-y,,,,25200485,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3162807,https://api.altmetric.com/v1/donut/3162807_240.png 1,Is low serum free testosterone a marker for high grade prostate cancer?,The Journal of Urology,,,Article,2000-03-01,,,,,10687985,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3151851,https://api.altmetric.com/v1/donut/3151851_240.png 1,Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy,Clinical Cancer Research,,,Article,2012-07-01,10.1158/1078-0432.ccr-11-2799,,,,22589393,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3147930,https://api.altmetric.com/v1/donut/3147930_240.png 1,Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises.,Journal of biological regulators and homeostatic agents,,,Article,,,,,,25620167,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3108082,https://api.altmetric.com/v1/donut/3108082_240.png 1,Prostate cancer: BAT-ting CRPC,Nature Reviews Urology,,,Article,2015-01-27,10.1038/nrurol.2015.6,,,,25624145,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3107070,https://api.altmetric.com/v1/donut/3107070_240.png 1,Osteoporosis due to androgen deprivation therapy in men with prostate cancer.,Urology,,,Article,2001-08-01,,,,,11502461,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/3106189,https://api.altmetric.com/v1/donut/3106189_240.png 1,Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms,Prostate Cancer,,,Article,,10.1155/2013/210686,,,,24069538,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/3103502,https://api.altmetric.com/v1/donut/3103502_240.png 1,Cytotoxicity of obacunone and obacunone glucoside in human prostate cancer cells involves Akt-mediated programmed cell death ,Toxicology,,,Article,,10.1016/j.tox.2015.01.008,,,,25592883,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3102844,https://api.altmetric.com/v1/donut/3102844_240.png 1,Metastatic prostate cancer cell-specific phage-like particles as a targeted gene-delivery system,Journal of Nanobiotechnology,,,Article,2013-09-23,10.1186/1477-3155-11-31,,,,24059645,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3101423,https://api.altmetric.com/v1/donut/3101423_240.png 1,MYC activity mitigates response to rapamycin in prostate cancer through 4EBP1-mediated inhibition of autophagy,Cancer Research,,,Article,2009-10-01,10.1158/0008-5472.can-09-0910,,,,19773438,PMC2756305,10161/4170,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/3098823,https://api.altmetric.com/v1/donut/3098823_240.png 1,Polarization of Prostate Cancer Associated Macrophages is Induced by Milk-Fat Globule-EGF Factor 8 (MFG-E8) Mediated Efferocytosis.,Journal of Biological Chemistry,,,Article,2014-07-10,10.1074/jbc.m114.571620,,,,25006249,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3098796,https://api.altmetric.com/v1/donut/3098796_240.png 1,"Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore.",Annals of the Academy of Medicine Singapore,,,Article,2007-10-01,,,,,17987231,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3096266,https://api.altmetric.com/v1/donut/3096266_240.png 1,MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.,Tumor Biology,,,Article,2015-01-22,10.1007/s13277-015-3057-3,,,,25604141,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3095445,https://api.altmetric.com/v1/donut/3095445_240.png 1,Adiponectin inhibits VEGF-A in prostate cancer cells,Tumor Biology,,,Article,2015-01-15,10.1007/s13277-015-3067-1,,,,25586350,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3093680,https://api.altmetric.com/v1/donut/3093680_240.png 1,Methoxyacetic acid suppresses prostate cancer cell growth by inducing growth arrest and apoptosis.,American journal of clinical and experimental urology,,,Article,2014-01-01,,,,,25606576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3092409,https://api.altmetric.com/v1/donut/3092409_240.png 1,MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells.,Oncoscience,,,Article,2015-01-18,10.18632/oncoscience.30,,,,25594017,PMC4278297,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3089019,https://api.altmetric.com/v1/donut/3089019_240.png 1,"[Efficacy of Flutamide-Combined Androgen Blockade Therapy in Advanced Prostate Cancer Patients: A Phase III Randomized, Comparative Trial].",Gan to kagaku ryoho Cancer chemotherapy,,,Article,2015-01-18,,,,,25596054,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3085870,https://api.altmetric.com/v1/donut/3085870_240.png 1,Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer,Urologic Oncology,,,Article,,10.1016/j.urolonc.2014.11.010,,,,25595576,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3084411,https://api.altmetric.com/v1/donut/3084411_240.png 1,Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,,,,,,25583770,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3083621,https://api.altmetric.com/v1/donut/3083621_240.png 1,"Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.",The Prostate,,,Article,2015-01-18,10.1002/pros.22942,,,,25597828,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3082152,https://api.altmetric.com/v1/donut/3082152_240.png 1,MicroRNA 363 mediated positive regulation of c-myc translation affect prostate cancer development and progress.,Neoplasma,,,Article,2015-01-17,10.4149/neo_2015_024,,,,25591584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3076404,https://api.altmetric.com/v1/donut/3076404_240.png 1,Chronic inflammatory mediators enhance prostate cancer development and progression.,Biochemical Pharmacology,,,Article,2015-01-12,10.1016/j.bcp.2014.12.023,,,,25593038,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3075845,https://api.altmetric.com/v1/donut/3075845_240.png 1,Hepsin inhibits CDK11p58 IRES activity by suppressing unr expression and eIF-2? phosphorylation in prostate cancer.,Cellular Signalling,,,Article,2015-01-14,10.1016/j.cellsig.2014.12.020,,,,25576733,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3075230,https://api.altmetric.com/v1/donut/3075230_240.png 1,Dietary soy and tea mitigate chronic inflammation and prostate cancer via NF?B pathway in the Noble rat model,Journal of Nutritional Biochemistry,,,Article,,10.1016/j.jnutbio.2010.04.006,,,,20801632,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/3075074,https://api.altmetric.com/v1/donut/3075074_240.png 1,Emerging biomarkers in the detection and prognosis of prostate cancer.,Clinical Chemistry & Laboratory Medicine,,,Article,2015-01-14,10.1515/cclm-2014-0988,,,,25581761,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/3074976,https://api.altmetric.com/v1/donut/3074976_240.png 1,"Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort.",Cancer Epidemiology,,,Article,2014-03-30,10.1016/j.canep.2014.02.007,,,,24667037,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3074525,https://api.altmetric.com/v1/donut/3074525_240.png 1,Prostate stromal cells express the progesterone receptor to control cancer cell mobility.,PLoS ONE,,,Article,2014-03-27,10.1371/journal.pone.0092714,,,,24664419,PMC3963951,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/3072947,https://api.altmetric.com/v1/donut/3072947_240.png 1,[MicroRNA as prognostic biomarkers in prostatic cancer].,Zhonghua bing li xue za zhi Chinese journal of pathology,,,Article,2014-11-01,,,,,25582264,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3071692,https://api.altmetric.com/v1/donut/3071692_240.png 1,New developments in the treatment of castration-resistant prostate cancer.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2014-05-24,,,,,24853214,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3070122,https://api.altmetric.com/v1/donut/3070122_240.png 1,Screening for prostate cancer in the US? Reduce the harms and keep the benefit,International Journal of Cancer,,,Article,2014-08-12,10.1002/ijc.29136,,,,25123412,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3070025,https://api.altmetric.com/v1/donut/3070025_240.png 1,Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer,BMC Cancer,,,Article,2014-01-13,10.1186/1471-2407-14-16,,,,24418414,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/3069011,https://api.altmetric.com/v1/donut/3069011_240.png 1,LEF1 Targeting EMT in Prostate Cancer Invasion is Regulated by miR-34a.,Molecular Cancer Research,,,Article,2015-01-13,10.1158/1541-7786.mcr-14-0503,,,,25587085,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3068568,https://api.altmetric.com/v1/donut/3068568_240.png 1,Inhibitory action of pristimerin on hypoxia?mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.,Oncology Reports,,,Article,2015-01-07,10.3892/or.2015.3708,,,,25571882,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3064695,https://api.altmetric.com/v1/donut/3064695_240.png 1,Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.,Oncotarget,,,Article,2014-03-05,10.18632/oncotarget.1776,,,,24583788,PMC3996656,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/3063190,https://api.altmetric.com/v1/donut/3063190_240.png 1,[Long noncoding RNAs in prostate cancer].,Zhonghua nan ke xue National journal of andrology,,,Article,2014-11-01,,,,,25577829,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3061664,https://api.altmetric.com/v1/donut/3061664_240.png 1,Skeletal-Related Events among Breast and Prostate Cancer Patients: Towards New Treatment Initiation in Malaysia's Hospital Setting.,Asian Pacific Journal of Cancer Prevention,,,Article,2013-06-28,,,,,23803129,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3060698,https://api.altmetric.com/v1/donut/3060698_240.png 1,"SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-?B/ERK/Akt signaling pathway",Medical Oncology,,,Article,2015-01-01,10.1007/s12032-014-0444-3,,,,25550157,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3058104,https://api.altmetric.com/v1/donut/3058104_240.png 1,S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2007-04-13,10.1158/1535-7163.mct-05-0414,,,,17431115,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3056980,https://api.altmetric.com/v1/donut/3056980_240.png 1,Critical role of the c-JunNH2-terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2005-12-24,,,,,16374231,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3056594,https://api.altmetric.com/v1/donut/3056594_240.png 1,Technological aspects of delivering cryotherapy for prostate cancer,Expert Review of Medical Devices,,,Article,2015-01-08,10.1586/17434440.2015.990377,,,,25569713,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3055127,https://api.altmetric.com/v1/donut/3055127_240.png 1,Re: Androgen Receptor and MicroRNA-21 Axis Downregulates Transforming Growth Factor Beta Receptor II (TGFBR2) Expression in Prostate Cancer,The Journal of Urology,,,Article,2015-04-22,10.1016/j.juro.2015.01.003,,,,25890570,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3053572,https://api.altmetric.com/v1/donut/3053572_240.png 1,Transfected poly(I:C) activates different dsRNA receptors leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells.,Journal of Biological Chemistry,,,Article,2015-01-07,10.1074/jbc.m114.601625,,,,25568326,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/3051037,https://api.altmetric.com/v1/donut/3051037_240.png 1,"The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis",Frontiers in oncology,,,Article,2014-11-29,10.3389/fonc.2014.00364,,,,25566502,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/3050356,https://api.altmetric.com/v1/donut/3050356_240.png 1,The Carboxyl Tail of Connexin32 Regulates Gap Junction Assembly in Human Prostate and Pancreatic Cancer Cells,Journal of Biological Chemistry,,,Article,2014-12-29,10.1074/jbc.m114.586057,,,,25548281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3047785,https://api.altmetric.com/v1/donut/3047785_240.png 1,Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy.,Core Evidence,,,Article,2015-01-01,10.2147/ce.s54712,,,,25565923,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/3046797,https://api.altmetric.com/v1/donut/3046797_240.png 1,"The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.",The Prostate,,,Article,2010-01-09,10.1002/pros.21108,,,,20058239,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3045352,https://api.altmetric.com/v1/donut/3045352_240.png 1,Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells ,European Journal of Pharmacology,,,Article,,10.1016/j.ejphar.2014.12.021,,,,25557765,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/3043221,https://api.altmetric.com/v1/donut/3043221_240.png 1,Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes,Tumor Biology,,,Article,2014-12-12,10.1007/s13277-014-2919-4,,,,25501281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3040213,https://api.altmetric.com/v1/donut/3040213_240.png 1,Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF.,Clinical Genitourinary Cancer,,,Article,2014-12-09,10.1016/j.clgc.2014.12.004,,,,25557266,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3040075,https://api.altmetric.com/v1/donut/3040075_240.png 1,Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-? from degradation and induce apoptosis in prostate cancer cells.,European Journal of Nutrition,,,Article,2014-11-21,10.1007/s00394-014-0803-z,,,,25408199,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/3037866,https://api.altmetric.com/v1/donut/3037866_240.png 1,Estrogen receptor ? upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.,Oncogene,,,Article,2013-10-01,10.1038/onc.2013.384,,,,24077289,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/3037864,https://api.altmetric.com/v1/donut/3037864_240.png 1,A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.,Am J Clin Exp Urol,,,Article,2014-11-08,,,,,25374914,PMC4219304,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,20,https://www.altmetric.com/details/3037117,https://api.altmetric.com/v1/donut/3037117_240.png 1,Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.,BMC Medical Genomics,,,Article,2014-12-31,10.1186/s12920-014-0074-9,,,,25551447,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3029630,https://api.altmetric.com/v1/donut/3029630_240.png 1,Baseline Neutrophil-Lymphocyte Ratio (NLR) is Associated with Survival and Response to Treatment with Second-Line Chemotherapy for Advanced Prostate Cancer Independent of Baseline Steroid Use.,Annals of Oncology,,,Article,2014-12-23,10.1093/annonc/mdu587,,,,25538172,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/3027877,https://api.altmetric.com/v1/donut/3027877_240.png 1,[Peptide vaccination for castration-resistant prostate cancer].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2014-12-20,,,,,25518349,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3027689,https://api.altmetric.com/v1/donut/3027689_240.png 1,PSA testing for prostate cancer screening – Authors' reply ,Lancet Oncology,,,Article,,10.1016/s1470-2045(14)71189-1,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3026488,https://api.altmetric.com/v1/donut/3026488_240.png 1,Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.,Tumor Biology,,,Article,2014-12-28,10.1007/s13277-014-2993-7,,,,25544710,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/3024643,https://api.altmetric.com/v1/donut/3024643_240.png 1,Application of a two-stage fuzzy neural network to a prostate cancer prognosis system.,Artificial Intelligence in Medicine,,,Article,,10.1016/j.artmed.2014.12.008,,,,25576196,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/3023362,https://api.altmetric.com/v1/donut/3023362_240.png 1,Prostate cancer screening: A primary care survey,Health (1949-4998),,,Article,2010-10-26,10.4236/health.2010.210173,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3021528,https://api.altmetric.com/v1/donut/3021528_240.png 1,Determinants of primary care physicians’ practice of prostate cancer counseling and screening,Health (1949-4998),,,Article,2010-11-19,10.4236/health.2010.211195,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/3021486,https://api.altmetric.com/v1/donut/3021486_240.png 1,"Olfactomedin?4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers",PROTEOMICS - Clinical Applications,,,Article,2014-12-28,10.1002/prca.201400083,,,,25400027,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/3020572,https://api.altmetric.com/v1/donut/3020572_240.png 1,Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer.,Human Pathology,,,Article,2014-11-26,10.1016/j.humpath.2014.10.027,,,,25532941,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/3014825,https://api.altmetric.com/v1/donut/3014825_240.png 1,The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.,BMC Cancer,,,Article,2014-12-23,10.1186/1471-2407-14-994,,,,25535400,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/3013005,https://api.altmetric.com/v1/donut/3013005_240.png 1,HIF1A expression in localized prostate cancer treated with dose escalation radiation therapy.,Cancer Biomarkers,,,Article,2015-01-01,10.3233/cbm-140439,,,,25524941,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/3002815,https://api.altmetric.com/v1/donut/3002815_240.png 1,Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy ,Brachytherapy,,,Article,,10.1016/j.brachy.2014.11.008,,,,25533416,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/3001952,https://api.altmetric.com/v1/donut/3001952_240.png 1,[Elucidating the molecular mechanism of prostate cancer progression under chronic hypoxia and development of the novel therapeutic approach].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2014-12-01,,,,,25518347,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/3001703,https://api.altmetric.com/v1/donut/3001703_240.png 1,[Current status and prospects of immunotherapy for castration-resistant prostate cancer].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2014-12-01,,,,,25518354,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/3000432,https://api.altmetric.com/v1/donut/3000432_240.png 1,Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.,BMC Cancer,,,Article,2014-12-18,10.1186/1471-2407-14-977,,,,25519703,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2999361,https://api.altmetric.com/v1/donut/2999361_240.png 1,Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications.,Asian Journal of Andrology,,,Article,2014-01-19,10.4103/1008-682x.122585,,,,24435055,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2998221,https://api.altmetric.com/v1/donut/2998221_240.png 1,miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1.,The Prostate,,,Article,2014-09-13,10.1002/pros.22878,,,,25214035,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2997859,https://api.altmetric.com/v1/donut/2997859_240.png 1,"The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions",Asian Journal of Andrology,,,Article,2014-04-07,10.4103/1008-682x.127813,,,,24759585,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2996090,https://api.altmetric.com/v1/donut/2996090_240.png 1,Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer.,Neoplasia,,,Article,2014-12-01,10.1016/j.neo.2014.10.003,,,,25499215,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2993830,https://api.altmetric.com/v1/donut/2993830_240.png 1,Role of the Technical Aspects of Hypofractionated Radiation Therapy Treatment of Prostate Cancer: A Review,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-01,10.1016/j.ijrobp.2014.08.006,,,,25835624,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2989998,https://api.altmetric.com/v1/donut/2989998_240.png 1,Oncology Scan—New Treatment and No Treatment: Enduring Issues in the Management of Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-01,10.1016/j.ijrobp.2014.08.346,,,,25835615,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2989996,https://api.altmetric.com/v1/donut/2989996_240.png 1,Need for Consensus When Prescribing Stereotactic Body Radiation Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2015-01-01,10.1016/j.ijrobp.2014.09.025,,,,25835627,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2989993,https://api.altmetric.com/v1/donut/2989993_240.png 1,P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells,PLoS ONE,,,Article,2014-12-08,10.1371/journal.pone.0114371,,,,25486274,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2982179,https://api.altmetric.com/v1/donut/2982179_240.png 1,The clinical significance of persistent cancer cells on prostate biopsy after high dose-rate brachytherapy boost for intermediate-risk prostate cancer,Brachytherapy,,,Article,,10.1016/j.brachy.2014.10.003,,,,25466361,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2974596,https://api.altmetric.com/v1/donut/2974596_240.png 1,The Molecular Signature of the Stroma Response in Prostate Cancer-Induced Osteoblastic Bone Metastasis Highlights Expansion of Hematopoietic and Prostate Epithelial Stem Cell Niches,PLoS ONE,,,Article,2014-12-08,10.1371/journal.pone.0114530,,,,25485970,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2968802,https://api.altmetric.com/v1/donut/2968802_240.png 1,mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer.,Human vaccines immunotherapeutics,,,Article,2014-07-07,10.4161/hv.29553,,,,25483661,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2967950,https://api.altmetric.com/v1/donut/2967950_240.png 1,Management of hot flashes in men with prostate cancer being treated with androgen deprivation therapy.,Supportive Cancer Therapy,,,Article,2006-01-10,10.3816/sct.2006.n.029,,,,18632464,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2967895,https://api.altmetric.com/v1/donut/2967895_240.png 1,Protein kinase A type II-? regulatory subunit regulates the response of prostate cancer cells to taxane treatment.,Cell Cycle,,,Article,2014-10-15,10.4161/15384101.2014.949501,,,,25485509,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2967381,https://api.altmetric.com/v1/donut/2967381_240.png 1,Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.,Cancer Biology and Therapy,,,Article,2014-08-22,10.4161/15384047.2014.955989,,,,25482949,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2965958,https://api.altmetric.com/v1/donut/2965958_240.png 1,Length of life gained with surgical treatment of prostate cancer: A population-based analysis.,Scandinavian Journal of Urology,,,Article,2014-12-04,10.3109/21681805.2014.984324,,,,25438988,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2963578,https://api.altmetric.com/v1/donut/2963578_240.png 1,Nanoparticulate delivery of LHRH analogue for the treatment of prostate cancer.,Pharmaceutical Development & Technology,,,Article,2012-03-03,10.3109/10837450.2012.663389,,,,22380019,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2961716,https://api.altmetric.com/v1/donut/2961716_240.png 1,Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo.,International Journal of Nanomedicine,,,Article,2014-01-01,10.2147/ijn.s71101,,,,25473281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2955582,https://api.altmetric.com/v1/donut/2955582_240.png 1,Resistance to Androgen-Pathway Drugs in Prostate Cancer.,New England Journal of Medicine,,,Article,2014-12-04,10.1056/nejmc1412594#sa1,,,,25470701,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2950570,https://api.altmetric.com/v1/donut/2950570_240.png 1,Bacillus Calmette-Guérin therapy-associated granulomatous prostatitis mimicking prostate cancer on MRI: A case report and literature review.,Molecular and clinical oncology,,,Article,2015-01-01,10.3892/mco.2014.422,,,,25469304,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2949719,https://api.altmetric.com/v1/donut/2949719_240.png 1,[Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer.],Revista espanola de medicina nuclear e imagen molecular,,,Article,2014-11-15,10.1016/j.remn.2014.08.001,,,,25443648,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2947644,https://api.altmetric.com/v1/donut/2947644_240.png 1,HIV drug blocks bone metastases in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6683-hiv-drug-blocks-bone-metastases-in-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2946231,https://api.altmetric.com/v1/donut/2946231_240.png 1,Equivocal test results and prognostic staging uncertainties in the evaluation of patients with cancer of the prostate.,Yale Journal of Biology and Medicine,,,Article,,,,,,3962339,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2945189,https://api.altmetric.com/v1/donut/2945189_240.png 1,MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.,Oncotarget,,,Article,2014-11-25,10.18632/oncotarget.2690,,,,25436980,PMC4381606,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2942596,https://api.altmetric.com/v1/donut/2942596_240.png 1,Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell lines.,International Journal of Biological Markers,,,Article,2013-12-26,10.5301/jbm.5000062,,,,24366849,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2940541,https://api.altmetric.com/v1/donut/2940541_240.png 1,What is the next generation therapeutic strategy for castration-resistant prostate cancer.,Asian Journal of Andrology,,,Article,2014-11-18,10.4103/1008-682x.143311,,,,25432503,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2936533,https://api.altmetric.com/v1/donut/2936533_240.png 1,Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in Vitro and in Vivo.,Current Cancer Drug Targets,,,Article,2014-11-27,,,,,25431082,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2934966,https://api.altmetric.com/v1/donut/2934966_240.png 1,ERG positive prostatic cancer may show a more angiogenetic phenotype ,Pathology - Research & Practice,,,Article,,10.1016/j.prp.2014.07.009,,,,25220615,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2933388,https://api.altmetric.com/v1/donut/2933388_240.png 1,Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126),"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-12,10.1016/j.ijrobp.2014.10.035,,,,25539384,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2932005,https://api.altmetric.com/v1/donut/2932005_240.png 1,Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer,Radiotherapy & Oncology,,,Article,,10.1016/j.radonc.2014.10.007,,,,25544648,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2931294,https://api.altmetric.com/v1/donut/2931294_240.png 1,Detection of Circulatory MicroRNAs in Prostate Cancer.,Methods in molecular biology,,,Article,2015-01-01,10.1007/978-1-4939-1804-1_27,,,,25421678,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2928035,https://api.altmetric.com/v1/donut/2928035_240.png 1,Use of Tanning Potential as a Predictor for Prostate Cancer Risk in African-American Men.,IN VIVO,,,Article,2014-11-17,,,,,25398820,,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2926610,https://api.altmetric.com/v1/donut/2926610_240.png 1,High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy.,BMC Cancer,,,Article,2014-11-21,10.1186/1471-2407-14-859,,,,25416653,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2924480,https://api.altmetric.com/v1/donut/2924480_240.png 1,"Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.",Journal of Cancer,,,Article,2014-11-06,10.7150/jca.9726,,,,25368673,PMC4216797,,,,,,0,0,0,9,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2921541,https://api.altmetric.com/v1/donut/2921541_240.png 1,Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells.,Biomolecules therapeutics,,,Article,2014-11-22,10.4062/biomolther.2014.061,,,,25414773,PMC4201228,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2918066,https://api.altmetric.com/v1/donut/2918066_240.png 1,Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population.,Asian Journal of Andrology,,,Article,2014-11-14,10.4103/1008-682x.143245,,,,25412674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2915816,https://api.altmetric.com/v1/donut/2915816_240.png 1,Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer.,The Journal of Pharmacology and Experimental Therapeutics,,,Article,2011-01-04,10.1124/jpet.110.177246,,,,21205921,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2915360,https://api.altmetric.com/v1/donut/2915360_240.png 1,Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line.,Adv Pharm Bull,,,Article,2014-11-06,10.5681/apb.2014.067,,,,25364662,PMC4213785,,,,,,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2914443,https://api.altmetric.com/v1/donut/2914443_240.png 1,Analysis of tumor necrosis factor ?-induced and nuclear factor ?B-silenced LNCaP prostate cancer cells by RT-qPCR.,Experimental and Therapeutic Medicine,,,Article,2014-11-07,10.3892/etm.2014.2032,,,,25371717,PMC4218634,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2913257,https://api.altmetric.com/v1/donut/2913257_240.png 1,The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2014-11-20,10.1007/s00259-014-2949-6,,,,25411132,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,92,https://www.altmetric.com/details/2912988,https://api.altmetric.com/v1/donut/2912988_240.png 1,Cytoskeleton targeting value in prostate cancer treatment.,Am J Clin Exp Urol,,,Article,2014-11-08,,,,,25374905,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2912262,https://api.altmetric.com/v1/donut/2912262_240.png 1,Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy.,Tumor Biology,,,Article,2014-11-09,10.1007/s13277-014-2748-5,,,,25377160,,,,,,,0,0,0,12,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2911879,https://api.altmetric.com/v1/donut/2911879_240.png 1,Downregulation of LRPPRC Induces Apoptosis in Prostate Cancer Cells Through the Mitochondria-Mediated Pathway.,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2014-11-09,10.1089/cbr.2014.1661,,,,25379610,,,,,,,0,0,0,10,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2911341,https://api.altmetric.com/v1/donut/2911341_240.png 1,Fish intake and risk of prostate cancer.,Post?py higieny i medycyny do?wiadczalnej,,,Article,2014-11-09,10.5604/17322693.1125649,,,,25380202,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2911213,https://api.altmetric.com/v1/donut/2911213_240.png 1,EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin,FASEB Journal,,,Article,,10.1096/fj.14-249367,,,,25381040,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2909470,https://api.altmetric.com/v1/donut/2909470_240.png 1,Circadian clock genes and risk of fatal prostate cancer.,Cancer Causes and Control,,,Article,2014-11-14,10.1007/s10552-014-0478-z,,,,25388799,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2909397,https://api.altmetric.com/v1/donut/2909397_240.png 1,Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro.,Molecular Medicine Reports,,,Article,2014-11-12,10.3892/mmr.2014.2929,,,,25394789,,,,,,,0,0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2907991,https://api.altmetric.com/v1/donut/2907991_240.png 1,NSK-01105 inhibits proliferation and induces apoptosis of prostate cancer cells by blocking the Raf/MEK/ERK and PI3K/Akt/mTOR signal pathways.,Tumor Biology,,,Article,2014-11-16,10.1007/s13277-014-2824-x,,,,25398692,,,,,,,0,0,0,13,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2906968,https://api.altmetric.com/v1/donut/2906968_240.png 1,The effects of phenoxodiol on the cell cycle of prostate cancer cell lines.,Cancer Cell International,,,Article,2014-11-08,10.1186/s12935-014-0110-z,,,,25400509,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2906737,https://api.altmetric.com/v1/donut/2906737_240.png 1,?4-integrin-mediated cytotoxic activity of AexU in human prostate cancer PC3 cells,Oncology Letters,,,Article,2013-11-01,10.3892/ol.2013.1542,,,,24179545,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2906212,https://api.altmetric.com/v1/donut/2906212_240.png 1,Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6.,PLoS ONE,,,Article,2014-01-01,10.1371/journal.pone.0113039,,,,25401698,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2899477,https://api.altmetric.com/v1/donut/2899477_240.png 1,Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.,Cancer and Metastasis Reviews,,,Article,2001-01-01,,,,,12085970,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2896009,https://api.altmetric.com/v1/donut/2896009_240.png 1,Darinaparsin inhibits prostate tumor initiating cells and Du 145 xenografts and is an inhibitor of hedgehog signaling.,Molecular Cancer Therapeutics,,,Article,,10.1158/1535-7163.mct-13-1040,,,,25381261,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2893896,https://api.altmetric.com/v1/donut/2893896_240.png 1,"Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.",Lancet Oncology,,,Article,2009-02-15,10.1016/s1470-2045(08)70340-1,,,,19213602,PMC2774131,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,118,https://www.altmetric.com/details/2892199,https://api.altmetric.com/v1/donut/2892199_240.png 1,Unusual presentation of advanced prostate cancer masquerading as metastatic and obstructing rectosigmoid cancer,Australian & New Zealand Journal of Surgery,,,Article,2014-11-12,10.1111/ans.12917,,,,25388794,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2883838,https://api.altmetric.com/v1/donut/2883838_240.png 1,Pomegranate Juice and Prostate Cancer: Importance of the Characterisation of the Active Principle,Phytotherapy Research,,,Article,2014-06-03,10.1002/ptr.5181,,,,24895232,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2880875,https://api.altmetric.com/v1/donut/2880875_240.png 1,Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis,PLoS ONE,,,Article,2014-10-30,10.1371/journal.pone.0111545,,,,25356728,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2878271,https://api.altmetric.com/v1/donut/2878271_240.png 1,Image guidance procedures in radiotherapy for prostate cancer and the influence of body mass index,Journal of Radiotherapy in Practice,,,Article,2014-04-23,10.1017/s1460396914000193,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2876706,https://api.altmetric.com/v1/donut/2876706_240.png 1,Complex Impacts of PI3K/AKT Inhibitors to Androgen Receptor Gene Expression in Prostate Cancer Cells,PLoS ONE,,,Article,2014-10-31,10.1371/journal.pone.0108780,,,,25360799,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2875606,https://api.altmetric.com/v1/donut/2875606_240.png 1,Prostate Cancer Outcomes: The Three Questions,European Urology,,,Article,2015-03-01,10.1016/j.eururo.2014.10.023,,,,25454610,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2873400,https://api.altmetric.com/v1/donut/2873400_240.png 1,Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis.,World Journal of Urology,,,Article,2014-11-01,10.1007/s00345-014-1431-1,,,,25354720,,,,,,,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2867721,https://api.altmetric.com/v1/donut/2867721_240.png 1,Models of neuroendocrine prostate cancer,Endocrine-Related Cancer,,,Article,2014-10-27,10.1530/erc-14-0393,,,,25349195,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2867144,https://api.altmetric.com/v1/donut/2867144_240.png 1,Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling.,Molecular Cancer Therapeutics,,,Article,2014-11-07,10.1158/1535-7163.mct-14-0542-t,,,,25381262,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2866721,https://api.altmetric.com/v1/donut/2866721_240.png 1,Improved robotic stereotactic body radiation therapy plan quality and planning efficacy for organ-confined prostate cancer utilizing overlap-volume histogram-driven planning methodology,Radiotherapy & Oncology,,,Article,,10.1016/j.radonc.2014.07.009,,,,25108808,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2863111,https://api.altmetric.com/v1/donut/2863111_240.png 1,Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.,BMC Cancer,,,Article,2014-03-21,10.1186/1471-2407-14-202,,,,24641841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2862203,https://api.altmetric.com/v1/donut/2862203_240.png 1,"Biography: Dr Iain Frame, director of research, prostate cancer UK.",Expert Review of Anticancer Therapy,,,Article,2014-11-01,10.1586/14737140.2014.974898,,,,25367320,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2858353,https://api.altmetric.com/v1/donut/2858353_240.png 1,[Impact of AR-V7 expression on overall survival for patients with metastatic prostate cancer].,Zhonghua wai ke za zhi Chinese journal of surgery,,,Article,2014-08-01,,,,,25370765,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2854934,https://api.altmetric.com/v1/donut/2854934_240.png 1,ERG Oncoprotein Inhibits ANXA2 Expression and Function in Prostate Cancer,Molecular Cancer Research,,,Article,2014-10-23,10.1158/1541-7786.mcr-14-0275-t,,,,25344575,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2850683,https://api.altmetric.com/v1/donut/2850683_240.png 1,DuraSeal® as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer,Radiotherapy & Oncology,,,Article,,10.1016/j.radonc.2014.08.012,,,,25201125,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2850405,https://api.altmetric.com/v1/donut/2850405_240.png 1,Patient-reported gastrointestinal symptoms among long-term survivors after radiation therapy for prostate cancer,Radiotherapy & Oncology,,,Article,2014-09-03,10.1016/j.radonc.2014.08.008,,,,25201126,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2850403,https://api.altmetric.com/v1/donut/2850403_240.png 1,Furosemide diminishes 18F-fluoroethylcholine uptake in prostate cancer in vivo,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2014-06-21,10.1007/s00259-014-2829-0,,,,24952174,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2846014,https://api.altmetric.com/v1/donut/2846014_240.png 1,Oral administration of naturally occurring chitosan based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.,Carcinogenesis,,,Article,2013-09-29,10.1093/carcin/bgt321,,,,24072771,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/2845451,https://api.altmetric.com/v1/donut/2845451_240.png 1,Breaking immune tolerance by targeting CD25+ regulatory T cells is essential for the anti-tumor effect of the CTLA-4 blockade in an HLA-DR transgenic mouse model of prostate cancer.,The Prostate,,,Article,2014-08-13,10.1002/pros.22858,,,,25111463,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2843474,https://api.altmetric.com/v1/donut/2843474_240.png 1,Beyond immune checkpoint blockade: New approaches to targeting host-tumor interactions in prostate cancer: Report from the 2014 Coffey-Holden prostate cancer Academy meeting.,The Prostate,,,Article,2014-10-30,10.1002/pros.22920,,,,25358693,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2843321,https://api.altmetric.com/v1/donut/2843321_240.png 1,microRNA?155 promotes the proliferation of prostate cancer cells by targeting annexin 7.,Molecular Medicine Reports,,,Article,2014-10-25,10.3892/mmr.2014.2744,,,,25339368,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2837114,https://api.altmetric.com/v1/donut/2837114_240.png 1,Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA?21.,Molecular Medicine Reports,,,Article,2014-10-29,10.3892/mmr.2014.2813,,,,25354548,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2835035,https://api.altmetric.com/v1/donut/2835035_240.png 1,A functional variant in miR-143 promoter contributes to prostate cancer risk.,Archives of Toxicology,,,Article,2014-10-30,10.1007/s00204-014-1396-2,,,,25354797,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2834527,https://api.altmetric.com/v1/donut/2834527_240.png 1,Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.,Molecular Medicine Reports,,,Article,2014-10-27,10.3892/mmr.2014.2782,,,,25351256,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2829040,https://api.altmetric.com/v1/donut/2829040_240.png 1,Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer,Chemistry & Biology,,,Article,,10.1016/j.chembiol.2014.09.012,,,,25459660,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2827694,https://api.altmetric.com/v1/donut/2827694_240.png 1,Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/476-perfusion-ct-is-a-valuable-diagnostic-method-for-prostate-cancer-a-prospective-study-of-94-patients.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2825422,https://api.altmetric.com/v1/donut/2825422_240.png 1,Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches.,Expert Opinion on Investigational Drugs,,,Article,2014-02-06,10.1517/13543784.2014.885950,,,,24490883,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2824131,https://api.altmetric.com/v1/donut/2824131_240.png 1,Re: Enzalutamide in Metastatic Prostate Cancer before Chemotherapy,The Journal of Urology,,,Article,2014-01-11,10.1016/j.juro.2014.08.040,,,,25323339,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2819186,https://api.altmetric.com/v1/donut/2819186_240.png 1,Two new bufadienolides from the rhizomes of Helleborus thibetanus with inhibitory activities against prostate cancer cells.,Natural Product Research,,,Article,2014-04-06,10.1080/14786419.2014.891200,,,,24697315,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2817441,https://api.altmetric.com/v1/donut/2817441_240.png 1,CN2 Primary Treatments for Intermediate-Risk Prostate Cancer: a Cost-Effectiveness and Value-of-Information Analysis ,Value in Health (Elsevier Science),,,Article,2016-05-22,10.1016/j.jval.2014.08.566,,,,27200531,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2816618,https://api.altmetric.com/v1/donut/2816618_240.png 1,Optimal source distribution for focal boosts using high dose rate (HDR) brachytherapy alone in prostate cancer,Radiotherapy & Oncology,,,Article,,10.1016/j.radonc.2014.09.001,,,,25263244,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2813688,https://api.altmetric.com/v1/donut/2813688_240.png 1,miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.,Medical Oncology,,,Article,2014-03-20,10.1007/s12032-014-0910-y,,,,24633705,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2807706,https://api.altmetric.com/v1/donut/2807706_240.png 1,"Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent",Prostate Cancer,,,Article,,10.1155/2013/560857,,,,23476788,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/2807000,https://api.altmetric.com/v1/donut/2807000_240.png 1,The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer.,Reviews in Urology,,,Article,2014-01-01,,,,,25337042,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2806185,https://api.altmetric.com/v1/donut/2806185_240.png 1,Designing a gold nanoparticle based nanocarrier for MicroRNA transfection into the prostate and breast cancer cells.,Journal of Gene Medicine - Gene Therapy Clinical Trial Database,,,Article,2014-10-20,10.1002/jgm.2810,,,,25331590,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2804214,https://api.altmetric.com/v1/donut/2804214_240.png 1,"Abstract 1265: Carbohydrate intake, glycemic index and prostate cancer risk",Cancer Research,,,Article,2014-09-30,10.1158/1538-7445.am2014-1265,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2803901,https://api.altmetric.com/v1/donut/2803901_240.png 1,Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist,Virchows Archiv,,,Article,2014-10-16,10.1007/s00428-014-1668-5,,,,25316188,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2803104,https://api.altmetric.com/v1/donut/2803104_240.png 1,Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia.,Oncotarget,,,Article,2014-08-27,10.18632/oncotarget.2396,,,,25333253,PMC4253426,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2803035,https://api.altmetric.com/v1/donut/2803035_240.png 1,Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy ,Food & Chemical Toxicology,,,Article,2013-10-14,10.1016/j.fct.2013.08.007,,,,23939040,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2802931,https://api.altmetric.com/v1/donut/2802931_240.png 1,Quality assurance for the clinical implementation of kilovoltage intrafraction monitoring for prostate cancer VMAT,Medical Physics,,,Article,2014-10-21,10.1118/1.4898119,,,,25370626,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2800161,https://api.altmetric.com/v1/donut/2800161_240.png 1,Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.,The Prostate,,,Article,2014-07-25,10.1002/pros.22850,,,,25053443,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2790641,https://api.altmetric.com/v1/donut/2790641_240.png 1,Targeting the androgen receptor in prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2014-06-05,10.1517/14656566.2014.915313,,,,24890318,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2790377,https://api.altmetric.com/v1/donut/2790377_240.png 1,Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancer,Expert Review of Anticancer Therapy,,,Article,2014-08-29,10.1586/14737140.2014.953937,,,,25159199,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2789989,https://api.altmetric.com/v1/donut/2789989_240.png 1,Robotic and minimal access surgery: technology and surgical outcomes of radical prostatectomy for prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2014-10-02,10.1586/14737140.2014.965689,,,,25266367,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2789739,https://api.altmetric.com/v1/donut/2789739_240.png 1,Biopsy sampling and histopathological markers for diagnosis of prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2014-10-05,10.1586/14737140.2014.965688,,,,25278357,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2789719,https://api.altmetric.com/v1/donut/2789719_240.png 1,Prostate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volume.,Radiology,,,Article,2011-08-30,10.1148/radiol.11110457,,,,21873255,PMC3198223,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2788780,https://api.altmetric.com/v1/donut/2788780_240.png 1,Induction of Apoptosis in Hormone-resistant Human Prostate Cancer PC3 Cells by Inactivated Sendai Virus.,Biomedical & Environmental Sciences,,,Article,2014-08-01,10.3967/bes2014.082,,,,25073909,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2787545,https://api.altmetric.com/v1/donut/2787545_240.png 1,ProNGF Correlates with Gleason Score and Is a Potential Driver of Nerve Infiltration in Prostate Cancer ,American Journal of Pathology,,,Article,,10.1016/j.ajpath.2014.08.009,,,,25285721,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2783817,https://api.altmetric.com/v1/donut/2783817_240.png 1,Dietary patterns and prostate cancer risk in the National Health and Nutrition Examination Survey Epidemiological Follow-up Study cohort.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2004-01-28,,,,,14744736,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2783218,https://api.altmetric.com/v1/donut/2783218_240.png 1,Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines,Tumor Biology,,,Article,2014-10-09,10.1007/s13277-014-2682-6,,,,25293519,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2783110,https://api.altmetric.com/v1/donut/2783110_240.png 1,LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6,Annals of Occupational and Environmental Medicine,,,Article,2014-10-01,10.1038/oncsis.2014.34,,,,25285406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2778073,https://api.altmetric.com/v1/donut/2778073_240.png 1,Regulation of SOD2 and ?-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cells ,European Journal of Cell Biology,,,Article,,10.1016/j.ejcb.2014.05.004,,,,24939178,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2778006,https://api.altmetric.com/v1/donut/2778006_240.png 1,Profile and predictors of global distress: Can the DT guide nursing practice in prostate cancer?,Palliative & Supportive Care,,,Article,2013-08-09,10.1017/s1478951513000060,,,,23919955,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2776902,https://api.altmetric.com/v1/donut/2776902_240.png 1,What Evidence Do We Need to Support the Use of Extended Pelvic Lymph Node Dissection in Prostate Cancer?,European Urology,,,Article,2015-04-01,10.1016/j.eururo.2014.09.025,,,,25281390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2775220,https://api.altmetric.com/v1/donut/2775220_240.png 1,MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients' Samples.,BioMed research international,,,Article,2014-01-01,10.1155/2014/146170,,,,25309903,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2773430,https://api.altmetric.com/v1/donut/2773430_240.png 1,AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy,Tumor Biology,,,Article,2014-10-03,10.1007/s13277-014-2664-8,,,,25277659,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2771155,https://api.altmetric.com/v1/donut/2771155_240.png 1,Targeted local therapy in oligometastatic prostate cancer: a promising potential opportunity after failed primary treatment,British Journal of Urology,,,Article,2014-10-12,10.1111/bju.12957,,,,25308065,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2768238,https://api.altmetric.com/v1/donut/2768238_240.png 1,Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development.,Biochimica et Biophysica Acta (BBA),,,Article,2014-07-17,10.1016/j.bbagrm.2014.07.001,,,,25017995,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2762061,https://api.altmetric.com/v1/donut/2762061_240.png 1,"[Prostatic cancer: ""N of 1"" case reports in the era of whole-genome sequencing.]",Progrès en Urologie,,,Article,2014-10-08,10.1016/j.purol.2014.09.036,,,,25288584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2761755,https://api.altmetric.com/v1/donut/2761755_240.png 1,Resveratrol inhibits hypoxia-inducible factor-1?-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.,Journal of Nutritional Science & Vitaminology,,,Article,2014-01-01,,,,,25297617,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2759860,https://api.altmetric.com/v1/donut/2759860_240.png 1,Operator Dependent Choice of Prostate Cancer Biopsy Has Limited Impact on a Gene Signature Analysis for the Highly Expressed Genes IGFBP3 and F3 in Prostate Cancer Epithelial Cells,PLoS ONE,,,Article,2014-10-08,10.1371/journal.pone.0109610,,,,25296164,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2756541,https://api.altmetric.com/v1/donut/2756541_240.png 1,Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.,Biochimica et Biophysica Acta (BBA),,,Article,2014-10-01,10.1016/j.bbagrm.2014.09.015,,,,25281873,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2743337,https://api.altmetric.com/v1/donut/2743337_240.png 1,Obesity Promotes Aerobic Glycolysis in Prostate Cancer Cells.,Nutrition and Cancer,,,Article,2014-10-01,10.1080/01635581.2014.951738,,,,25264717,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2742352,https://api.altmetric.com/v1/donut/2742352_240.png 1,Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.,Oncotarget,,,Article,2014-09-15,10.18632/oncotarget.2313,,,,25277202,PMC4202166,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2742019,https://api.altmetric.com/v1/donut/2742019_240.png 1,Role of miRNA Let-7 and Its Major Targets in Prostate Cancer.,BioMed research international,,,Article,2014-01-01,10.1155/2014/376326,,,,25276782,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2739238,https://api.altmetric.com/v1/donut/2739238_240.png 1,[Capabilities of diffusion-weighted magnetic resonance imaging to evaluate the efficiency of treatment for prostate cancer].,Vestnik rentgenologii i radiologii,,,Article,,,,,,25272722,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2739122,https://api.altmetric.com/v1/donut/2739122_240.png 1,A role for STEAP2 in prostate cancer progression,Clinical and Experimental Metastasis,,,Article,2014-09-24,10.1007/s10585-014-9679-9,,,,25248617,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2737050,https://api.altmetric.com/v1/donut/2737050_240.png 1,[First experience of Ho:YAG laser urethrotomy in the treatment of strictures in patients with prostate cancer].,Urologii?a?,,,Article,2014-09-14,,,,,25211930,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2735373,https://api.altmetric.com/v1/donut/2735373_240.png 1,Destruction of DDIT3/CHOP Protein by Wild?Type SPOP but Not Prostate Cancer?Associated Mutants,Human Mutation,,,Article,2014-07-23,10.1002/humu.22614,,,,24990631,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2732451,https://api.altmetric.com/v1/donut/2732451_240.png 1,Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer.,Tumor Biology,,,Article,2014-09-30,10.1007/s13277-014-2646-x,,,,25266801,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2731836,https://api.altmetric.com/v1/donut/2731836_240.png 1,Nrf1 and nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells.,PLoS ONE,,,Article,2014-01-29,10.1371/journal.pone.0087204,,,,24466341,PMC3899380,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2728724,https://api.altmetric.com/v1/donut/2728724_240.png 1,Treatment options in castration-resistant prostate cancer: Expert discussion. Treatment options in castration-resistant prostate cancer: Expert discussion,ecancer.org,,,Article,,,,,http://ecancer.org/video/3104/treatment-options-in-castration-resistant-prostate-cancer--expert-discussion.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2727603,https://api.altmetric.com/v1/donut/2727603_240.png 1,In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells,BMC Cancer,,,Article,2014-09-18,10.1186/1471-2407-14-675,,,,25234292,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2725299,https://api.altmetric.com/v1/donut/2725299_240.png 1,UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation,Oncogene,,,Article,2014-09-22,10.1038/onc.2014.307,,,,25241896,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/2722567,https://api.altmetric.com/v1/donut/2722567_240.png 1,Autophagy proteins in prostate cancer: Relation with anaerobic metabolism and Gleason score.,Urologic Oncology,,,Article,2013-06-23,10.1016/j.urolonc.2013.04.003,,,,23787295,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2721235,https://api.altmetric.com/v1/donut/2721235_240.png 1,Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control.,Journal of Experimental & Clinical Cancer Research,,,Article,2013-12-19,10.1186/1756-9966-32-103,,,,24330467,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2720431,https://api.altmetric.com/v1/donut/2720431_240.png 1,[Salvage 125I brachytherapy of locally recurrent prostate cancer.],Magyar Onkológia,,,Article,2014-09-26,,,,,25260087,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2720078,https://api.altmetric.com/v1/donut/2720078_240.png 1,[The use of the gold radiopaque markers implanted into the prostate for image guided radiotherapy of prostate cancer patients. The presentation of side effects caused by the marker implantation.],Magyar Onkológia,,,Article,2014-09-26,,,,,25260082,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2719969,https://api.altmetric.com/v1/donut/2719969_240.png 1,Anti-tumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer.,Molecular Cancer Therapeutics,,,Article,2014-09-24,10.1158/1535-7163.mct-14-0522,,,,25253786,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2717770,https://api.altmetric.com/v1/donut/2717770_240.png 1,Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer.,Nature Communications,,,Article,2014-01-01,10.1038/ncomms5988,,,,25255306,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/2717328,https://api.altmetric.com/v1/donut/2717328_240.png 1,Resveratrol: Inhibitory Effects on Metastatic Cell Behaviors and Voltage-Gated Na+ Channel Activity in Rat Prostate Cancer In Vitro.,Nutrition and Cancer,,,Article,2014-08-09,10.1080/01635581.2014.939291,,,,25102135,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2716757,https://api.altmetric.com/v1/donut/2716757_240.png 1,Screening: Raman-based prostate cancer detection that avoids PSA?,Nature Reviews Urology,,,Article,2014-09-23,10.1038/nrurol.2014.266,,,,25245238,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2715624,https://api.altmetric.com/v1/donut/2715624_240.png 1,Antitumor Effects of Saffron-Derived Carotenoids in Prostate Cancer Cell Models,BioMed Research International,,,Article,,10.1155/2014/135048,,,,24900952,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2714329,https://api.altmetric.com/v1/donut/2714329_240.png 1,Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment,Medical Physics,,,Article,2014-09-24,10.1118/1.4894701,,,,25281944,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2711014,https://api.altmetric.com/v1/donut/2711014_240.png 1,153Sm-EDTMP for Pain Relief of Bone Metastases from Prostate and Breast Cancer and Other Malignancies.,Archives of Medical Research,,,Article,2014-04-02,10.1016/j.arcmed.2014.03.006,,,,24681187,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2710009,https://api.altmetric.com/v1/donut/2710009_240.png 1,"Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis ",Toxicology & Applied Pharmacology,,,Article,2014-07-22,10.1016/j.taap.2014.07.012,,,,25064160,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2709557,https://api.altmetric.com/v1/donut/2709557_240.png 1,Prognostic DNA Methylation Markers for Prostate Cancer.,International Journal of Molecular Sciences,,,Article,2014-01-01,10.3390/ijms150916544,,,,25238417,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2707557,https://api.altmetric.com/v1/donut/2707557_240.png 1,The co-chaperone p23 promotes prostate cancer motility and metastasis.,Molecular Oncology,,,Article,2014-09-06,10.1016/j.molonc.2014.08.014,,,,25241147,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2706872,https://api.altmetric.com/v1/donut/2706872_240.png 1,Chronic use of NSAIDs and/or Statins does not Impact Longitudinal PSA or PSA velocity in Men at High Risk for Prostate Cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-07-27,10.1158/1055-9965.epi-14-0605,,,,25060669,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2706866,https://api.altmetric.com/v1/donut/2706866_240.png 1,Increase in Serum Ca2+/Mg2+ Ratio Promotes Proliferation of Prostate Cancer Cells by Activating TRPM7 Channels,Journal of Biological Chemistry,,,Article,2013-01-04,10.1074/jbc.m112.393918,,,,23168410,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2705579,https://api.altmetric.com/v1/donut/2705579_240.png 1,"Reflection on the Discovery of Carcinoembryonic Antigen, Prostate-Specific Antigen, and Cancer Antigens CA125 and CA19-9.",Clinical Chemistry,,,Article,2012-12-05,10.1373/clinchem.2012.187047,,,,23204222,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2703973,https://api.altmetric.com/v1/donut/2703973_240.png 1,Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone,Clinical and Experimental Metastasis,,,Article,2014-09-16,10.1007/s10585-014-9680-3,,,,25223386,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2700913,https://api.altmetric.com/v1/donut/2700913_240.png 1,iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.,Journal of Proteome Research,,,Article,2008-02-02,10.1021/pr070378x,,,,18232632,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2698301,https://api.altmetric.com/v1/donut/2698301_240.png 1,Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes.,Stem Cells,,,Article,2014-04-11,10.1002/stem.1619,,,,24715691,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/2695786,https://api.altmetric.com/v1/donut/2695786_240.png 1,The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model,Cancer Prevention Research,,,Article,2009-06-01,10.1158/1940-6207.capr-08-0188,,,,19470786,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2695549,https://api.altmetric.com/v1/donut/2695549_240.png 1,Phosphodiesterase 4D Inhibitors Limit Prostate Cancer Growth Potential,Molecular Cancer Research,,,Article,2014-08-21,10.1158/1541-7786.mcr-14-0110,,,,25149359,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2694931,https://api.altmetric.com/v1/donut/2694931_240.png 1,PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials,Tumor Biology,,,Article,2014-09-07,10.1007/s13277-014-2559-8,,,,25195134,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2692124,https://api.altmetric.com/v1/donut/2692124_240.png 1,"Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment",Clinical Genitourinary Cancer,,,Article,,,,,,,,2445/57308,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2690924,https://api.altmetric.com/v1/donut/2690924_240.png 1,CtBP2 modulates the androgen receptor to promote prostate cancer progression,Cancer Research,,,Article,,10.1158/0008-5472.can-14-1030,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2690609,https://api.altmetric.com/v1/donut/2690609_240.png 1,The impact of prostate cancer on men's everyday life,European Journal of Cancer Care,,,Article,2014-09-09,10.1111/ecc.12233,,,,25204357,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2687886,https://api.altmetric.com/v1/donut/2687886_240.png 1,Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients,Tumor Biology,,,Article,2014-09-12,10.1007/s13277-014-2604-7,,,,25213701,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2687874,https://api.altmetric.com/v1/donut/2687874_240.png 1,"A feasible roadmap for developing volumetric probability atlas of localized prostate cancer",,,,Article,,,,,,,,,,1409.4139,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2685940,https://api.altmetric.com/v1/donut/2685940_240.png 1,MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.,Molecular Cancer,,,Article,2014-09-12,10.1186/1476-4598-13-212,,,,25216674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2682447,https://api.altmetric.com/v1/donut/2682447_240.png 1,Genetic variation: effect on prostate cancer ,BBA - Reviews on Cancer,,,Article,2014-09-04,10.1016/j.bbcan.2014.08.007,,,,25199985,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/2681442,https://api.altmetric.com/v1/donut/2681442_240.png 1,TBLR1 as an AR coactivator selectively activates AR target genes to inhibit prostate cancer growth.,Endocrine-Related Cancer,,,Article,2013-11-20,10.1530/erc-13-0293,,,,24243687,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2681062,https://api.altmetric.com/v1/donut/2681062_240.png 1,Tolerance of Phellodendron amurense Bark Extract (Nexrutine) in Patients with Human Prostate Cancer,Phytotherapy Research,,,Article,2014-09-08,10.1002/ptr.5221,,,,25205619,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2679899,https://api.altmetric.com/v1/donut/2679899_240.png 1,Prostate cancer: REDUCE-ing the link between smoking and prostate cancer,Nature Reviews Urology,,,Article,2014-09-09,10.1038/nrurol.2014.250,,,,25201623,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2679815,https://api.altmetric.com/v1/donut/2679815_240.png 1,Prostate cancer: Androgen suppression duration and zoledronic acid: under the RADAR,Nature Reviews Urology,,,Article,2014-09-09,10.1038/nrurol.2014.252,,,,25201618,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2679814,https://api.altmetric.com/v1/donut/2679814_240.png 1,Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer--a prospective multicenter study with long-term follow-up.,European Urology,,,Article,2008-02-26,10.1016/j.eururo.2008.02.002,,,,18294761,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2678091,https://api.altmetric.com/v1/donut/2678091_240.png 1,Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.,Journal of Cellular and Molecular Medicine,,,Article,2014-09-11,10.1111/jcmm.12394,,,,25211630,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2678058,https://api.altmetric.com/v1/donut/2678058_240.png 1,An Incidental Finding of Mucinous Colon Cancer by (18)F-Choline PET/CT Determining a Change in Clinical Management of a Patient with Recurrent Prostate Adenocarcinoma.,Case Reports in Oncological Medicine,,,Article,2014-01-01,10.1155/2014/297031,,,,25197590,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2672884,https://api.altmetric.com/v1/donut/2672884_240.png 1,Oxidative stress and body composition in prostate cancer and benign prostatic hyperplasia patients.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2014-09-01,,,,,25202090,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2671492,https://api.altmetric.com/v1/donut/2671492_240.png 1,Prostate cancer: Androgen suppression duration and zoledronic acid: under the RADAR,Nature Reviews Clinical Oncology,,,Article,2014-09-09,10.1038/nrclinonc.2014.150,,,,25200412,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2670927,https://api.altmetric.com/v1/donut/2670927_240.png 1,A Natural Androgen Receptor Antagonist Induces Cellular Senescence in Prostate Cancer Cells.,Molecular Endocrinology,,,Article,2014-09-09,10.1210/me.2014-1170,,,,25203674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2670561,https://api.altmetric.com/v1/donut/2670561_240.png 1,Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.,Science Translational Medicine,,,Article,2014-09-03,10.1126/scitranslmed.3009332,,,,25186177,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2669195,https://api.altmetric.com/v1/donut/2669195_240.png 1,Targeting Btk|[sol]|Etk of prostate cancer cells by a novel dual inhibitor,Cell Death & Disease,,,Article,2014-09-01,10.1038/cddis.2014.343,,,,25188519,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2665486,https://api.altmetric.com/v1/donut/2665486_240.png 1,Re: Urologists’ Use of Intensity-Modulated Radiation Therapy for Prostate Cancer,The Journal of Urology,,,Article,2014-01-09,10.1016/j.juro.2014.06.054,,,,25149714,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2664395,https://api.altmetric.com/v1/donut/2664395_240.png 1,Optimization of Cat’s Whiskers Tea (Orthosiphon stamineus) Using Supercritical Carbon Dioxide and Selective Chemotherapeutic Potential against Prostate Cancer Cells,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,,10.1155/2014/396016,,,,25276215,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2662193,https://api.altmetric.com/v1/donut/2662193_240.png 1,Vitamin D3 Regulates the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer Cells,PLoS ONE,,,Article,,10.1371/journal.pone.0106437,,,,25188420,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2661757,https://api.altmetric.com/v1/donut/2661757_240.png 1,(P085) exploiting androgen-induced DNA double-strand breaks: optimal sequencing of androgen suppression and radiation for superior tumor control in the treatment of prostate cancer.,Oncology (Williston Park),,,Article,2014-09-03,,,,,25181149,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2657212,https://api.altmetric.com/v1/donut/2657212_240.png 1,Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response ,Experimental Cell Research,,,Article,,10.1016/j.yexcr.2014.08.016,,,,25149681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2657099,https://api.altmetric.com/v1/donut/2657099_240.png 1,The newest precision medicine tool: Prostate cancer organoids,ecancer.org,,,Article,,,,,http://ecancer.org/news/6230-the-newest-precision-medicine-tool--prostate-cancer-organoids.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2656704,https://api.altmetric.com/v1/donut/2656704_240.png 1,Radium-223 dichloride for the treatment of metastatic prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2014-09-03,10.1517/14656566.2014.955016,,,,25186336,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2655970,https://api.altmetric.com/v1/donut/2655970_240.png 1,Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.,Human Molecular Genetics,,,Article,2014-08-27,10.1093/hmg/ddu426,,,,25149474,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/2649835,https://api.altmetric.com/v1/donut/2649835_240.png 1,Mini-review: Prostate cancer: Leading and misleading routes to TRAIL of death.,Pakistan Journal of Pharmaceutical Sciences,,,Article,2014-09-01,,,,,25176369,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2647594,https://api.altmetric.com/v1/donut/2647594_240.png 1,The pluripotency factor nanog is directly upregulated by the androgen receptor in prostate cancer cells.,The Prostate,,,Article,2014-08-31,10.1002/pros.22870,,,,25175748,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2647495,https://api.altmetric.com/v1/donut/2647495_240.png 1,"Prostate cancer: Despite screening, BRCA2 associated with poorer survival",Nature Reviews Urology,,,Article,2014-08-26,10.1038/nrurol.2014.235,,,,25155787,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2647126,https://api.altmetric.com/v1/donut/2647126_240.png 1,Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia.,Virchows Archiv,,,Article,2014-08-30,10.1007/s00428-014-1646-y,,,,25172328,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2642022,https://api.altmetric.com/v1/donut/2642022_240.png 1,Minireview: SLCO and ABC Transporters: A Role for Steroid Transport in Prostate Cancer Progression.,Endocrinology,,,Article,2014-08-27,10.1210/en.2014-1337,,,,25147980,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2641414,https://api.altmetric.com/v1/donut/2641414_240.png 1,Ureteral metastasis from prostate cancer,BMJ Case Reports,,,Article,2014-08-28,10.1136/bcr-2014-206736,,,,25168825,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2637582,https://api.altmetric.com/v1/donut/2637582_240.png 1,Need for and relevance of prostate cancer screening in Nigeria,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/457-need-for-and-relevance-of-prostate-cancer-screening-in-nigeria.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2637123,https://api.altmetric.com/v1/donut/2637123_240.png 1,From bench to bedside: the realities of reducing global prostate cancer disparity in black men,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/458-from-bench-to-bedside-the-realities-of-reducing-global-prostate-cancer-disparity-in-black-men.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2637118,https://api.altmetric.com/v1/donut/2637118_240.png 1,Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/journal/8/459-polyisoprenylated-methylated-protein-methyl-esterase-as-a-putative-drug-target-for-androgen-insensitive-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2637117,https://api.altmetric.com/v1/donut/2637117_240.png 1,Oncologic Outcomes of Cryosurgery as Primary Treatment in T3 Prostate Cancer: Experience of a Single Center,British Journal of Urology,,,Article,2015-01-21,10.1111/bju.12914,,,,25168692,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2633019,https://api.altmetric.com/v1/donut/2633019_240.png 1,Extended Pelvic Lymph Node Dissection in Prostate Cancer Patients Previously Treated With Surgery for Lower Urinary Tract Symptoms,British Journal of Urology,,,Article,2015-01-21,10.1111/bju.12912,,,,25168453,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2633015,https://api.altmetric.com/v1/donut/2633015_240.png 1,Reply from Authors re: Christian Stief. Mere Extension of the Field of Resection Cannot Be the Answer to Surgery for Metastatic Spread: We Need Individualized Approaches Based on Modern Imaging Techniques. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.07.026: Does Extended Pelvic Lymph Node Dissection Really Improve Survival in Prostate Cancer Patients with Node-positive Disease? Or Is It the Will Rogers Phenomenon Again?,European Urology,,,Article,,10.1016/j.eururo.2014.08.026,,,,25168618,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2627440,https://api.altmetric.com/v1/donut/2627440_240.png 1,Role of lncRNAs in prostate cancer development and progression.,Biological Chemistry,,,Article,2014-08-19,10.1515/hsz-2014-0201,,,,25153594,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2626658,https://api.altmetric.com/v1/donut/2626658_240.png 1,Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer,Oncogenesis,,,Article,2014-08-01,10.1038/oncsis.2014.30,,,,25133482,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2625010,https://api.altmetric.com/v1/donut/2625010_240.png 1,A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction,Naunyn-Schmiedeberg's Archives of Pharmacology,,,Article,2014-08-20,10.1007/s00210-014-1035-8,,,,25138575,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2624156,https://api.altmetric.com/v1/donut/2624156_240.png 1,Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer,Tumor Biology,,,Article,2014-08-19,10.1007/s13277-014-2462-3,,,,25135428,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2622509,https://api.altmetric.com/v1/donut/2622509_240.png 1,Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer.,British Journal of Cancer,,,Article,2014-08-21,10.1038/bjc.2014.463,,,,25144624,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2617975,https://api.altmetric.com/v1/donut/2617975_240.png 1,Whole-Body 18F-Fluorocholine (FCH) PET/CT and MRI of the Spine for Monitoring Patients With Castration-Resistant Prostate Cancer Metastatic to Bone: A Pilot Study.,Clinical Nuclear Medicine,,,Article,2014-08-19,10.1097/rlu.0000000000000562,,,,25140552,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2616861,https://api.altmetric.com/v1/donut/2616861_240.png 1,"Carbohydrate-to-carbohydrate interactions between alpha2,3- linked sialic acids on alpha2 integrin subunits and asialo-GM1 underlie the bone metastatic behavior of LNCaP-derivative C4-2B prostate cancer cells",Bioscience Reports,,,Article,2014-08-18,10.1042/bsr20140096,,,,25137483,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2615582,https://api.altmetric.com/v1/donut/2615582_240.png 1,Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: A systematic review,Maturitas,,,Article,2012-01-08,10.1016/j.maturitas.2012.04.014,,,,22633187,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/2611307,https://api.altmetric.com/v1/donut/2611307_240.png 1,Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies.,American Journal of Clinical Nutrition,,,Article,1997-01-01,,,,,9394709,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2611104,https://api.altmetric.com/v1/donut/2611104_240.png 1,"Histone H1.5, a novel prostatic cancer marker: an immunohistochemical study.",Human Pathology,,,Article,2014-07-03,10.1016/j.humpath.2014.06.015,,,,25130394,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2607937,https://api.altmetric.com/v1/donut/2607937_240.png 1,Perioperative changes in pro and anticoagulant factors in prostate cancer patients undergoing laparoscopic and robotic radical prostatectomy with different anaesthetic techniques.,Journal of Experimental & Clinical Cancer Research,,,Article,2014-08-17,10.1186/preaccept-4972819951260515,,,,25129475,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2605571,https://api.altmetric.com/v1/donut/2605571_240.png 1,A genetic screen in Drosophila for regulators of human prostate cancer progression.,Biochemical & Biophysical Research Communications,,,Article,2014-08-16,10.1016/j.bbrc.2014.08.015,,,,25117438,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2603625,https://api.altmetric.com/v1/donut/2603625_240.png 1,Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1?,Oncology Letters,,,Article,2014-08-16,10.3892/ol.2014.2259,,,,25120692,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2602352,https://api.altmetric.com/v1/donut/2602352_240.png 1,Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1? expression is involved in prostate epithelial malignancy.,Oncology Letters,,,Article,2014-08-16,10.3892/ol.2014.2274,,,,25120646,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2602210,https://api.altmetric.com/v1/donut/2602210_240.png 1,Reply from Authors re: David Margel. Metformin to Prevent Prostate Cancer: A Call to Unite. Eur Urol 2014;66:1021–2,European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.005,,,,25139199,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2597884,https://api.altmetric.com/v1/donut/2597884_240.png 1,Comparison of NaF and FDG PET/CT for Assessment of Treatment Response in Castration-Resistant Prostate Cancers With Osseous Metastases.,Clinical Genitourinary Cancer,,,Article,2014-07-15,10.1016/j.clgc.2014.07.001,,,,25128349,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2597167,https://api.altmetric.com/v1/donut/2597167_240.png 1,Immunotherapy for Advanced Prostate Cancer,Journal Watch,,,Article,2007-01-01,10.1056/oh200708140000008,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,https://www.altmetric.com/details/2596362,https://api.altmetric.com/v1/donut/2596362_240.png 1,Re: Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer: The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial,European Urology,,,Article,2014-09-01,10.1016/j.eururo.2014.06.029,,,,25306179,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2589372,https://api.altmetric.com/v1/donut/2589372_240.png 1,Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort,British Journal of Urology,,,Article,2014-08-11,10.1111/bju.12754,,,,24684511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2586089,https://api.altmetric.com/v1/donut/2586089_240.png 1,Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer,PLoS ONE,,,Article,,10.1371/journal.pone.0103680,,,,25072314,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2579621,https://api.altmetric.com/v1/donut/2579621_240.png 1,"Prostate cancer screening can save lives but it is too early for a national programme, study finds",British Medical Journal,,,Article,2014-08-07,10.1136/bmj.g5055,,,,25102993,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2578152,https://api.altmetric.com/v1/donut/2578152_240.png 1,"European trial with 13-year follow-up shows prostate cancer screening reduces deaths by a fifth, but does not recommend routine screening at this time",ecancer.org,,,Article,,,,,http://ecancer.org/news/6066-european-trial-with-13-year-follow-up-shows-prostate-cancer-screening-reduces-deaths-by-a-fifth--but-does-not-recommend-routine-screening-at-this-time.php,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2577778,https://api.altmetric.com/v1/donut/2577778_240.png 1,Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.,American Journal of Cancer Research,,,Article,2014-07-26,,,,,25057439,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2573491,https://api.altmetric.com/v1/donut/2573491_240.png 1,Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.,International Journal of Oncology,,,Article,2011-02-04,10.3892/ijo.2011.930,,,,21286663,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,30,https://www.altmetric.com/details/2572344,https://api.altmetric.com/v1/donut/2572344_240.png 1,Altered Endosome Biogenesis in Prostate Cancer has Biomarker Potential.,Molecular Cancer Research,,,Article,2014-07-29,10.1158/1541-7786.mcr-14-0074,,,,25080433,,1959.8/161860,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2569798,https://api.altmetric.com/v1/donut/2569798_240.png 1,Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.,Journal of Molecular Endocrinology,,,Article,2013-09-04,10.1530/jme-13-0169,,,,23997240,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2555076,https://api.altmetric.com/v1/donut/2555076_240.png 1,Personalizing prostate cancer therapy: the way forward ,Drug Discovery Today,,,Article,,10.1016/j.drudis.2014.07.006,,,,25046532,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2554602,https://api.altmetric.com/v1/donut/2554602_240.png 1,Re: The Long Noncoding RNA SChLAP1 Promotes Aggressive Prostate Cancer and Antagonizes the SWI/SNF Complex,The Journal of Urology,,,Article,2014-01-08,10.1016/j.juro.2014.05.031,,,,25035039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2553781,https://api.altmetric.com/v1/donut/2553781_240.png 1,Prostate cancer cell malignancy via modulation of HIF-1? pathway with isoflurane and propofol alone and in combination.,British Journal of Cancer,,,Article,2014-07-29,10.1038/bjc.2014.426,,,,25072260,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2553307,https://api.altmetric.com/v1/donut/2553307_240.png 1,Targeting SMAD3 for inhibiting prostate cancer metastasis,Tumor Biology,,,Article,2014-07-24,10.1007/s13277-014-2368-0,,,,25056536,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2549816,https://api.altmetric.com/v1/donut/2549816_240.png 1,The importance of knowing testosterone levels in patients with prostate cancer,British Journal of Urology,,,Article,2014-07-28,10.1111/bju.12739,,,,25070137,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2547684,https://api.altmetric.com/v1/donut/2547684_240.png 1,Prostate cancer: Brachyury[mdash]a biomarker for progression and prognosis?,Nature Reviews Urology,,,Article,2014-07-29,10.1038/nrurol.2014.184,,,,25069730,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2547296,https://api.altmetric.com/v1/donut/2547296_240.png 1,New accurate epigenetic test could eliminate unnecessary repeat biopsies for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/6020-new-accurate-epigenetic-test-could-eliminate-unnecessary-repeat-biopsies-for-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2547231,https://api.altmetric.com/v1/donut/2547231_240.png 1,Quantification of skeletal metastases in castrate?resistant prostate cancer predicts progression?free and overall survival,British Journal of Urology,,,Article,2014-03-03,10.1111/bju.12717,,,,24589330,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2542665,https://api.altmetric.com/v1/donut/2542665_240.png 1,Prostate cancer: Unravelling bias in vasectomy associations,Nature Reviews Urology,,,Article,2014-07-22,10.1038/nrurol.2014.182,,,,25048862,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2537120,https://api.altmetric.com/v1/donut/2537120_240.png 1,"Differential Requirement for Src-family Tyrosine Kinases in the Initiation, Progression and Metastasis of Prostate Cancer.",Molecular Cancer Research,,,Article,2014-07-22,10.1158/1541-7786.mcr-13-0490-t,,,,25053806,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2535690,https://api.altmetric.com/v1/donut/2535690_240.png 1,The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer,Molecular Cancer Research,,,Article,2014-07-15,10.1158/1541-7786.mcr-14-0257,,,,25030374,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2531470,https://api.altmetric.com/v1/donut/2531470_240.png 1,Argument for prostate cancer screening in populations of African?Caribbean origin,British Journal of Urology,,,Article,2014-07-20,10.1111/bju.12869,,,,25046681,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2525799,https://api.altmetric.com/v1/donut/2525799_240.png 1,"Prostate cancer survivorship: lifestyle changes, much needed!",World Journal of Urology,,,Article,2014-07-10,10.1007/s00345-014-1346-x,,,,25007991,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2525145,https://api.altmetric.com/v1/donut/2525145_240.png 1,Screening for Prostate Cancer: Reflecting on the Quality of Evidence from the ERSPC and PLCO Studies.,Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer,,,Article,2014-02-19,10.1007/978-3-642-45195-9_8,,,,24531779,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2525048,https://api.altmetric.com/v1/donut/2525048_240.png 1,Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly.,Urologic Oncology,,,Article,2014-07-16,10.1016/j.urolonc.2014.06.003,,,,25017694,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2519449,https://api.altmetric.com/v1/donut/2519449_240.png 1,Prostate cancer: Targeted GRPR photoacoustic imaging shows promise,Nature Reviews Urology,,,Article,2014-07-16,10.1038/nrurol.2014.168,,,,25023596,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2518479,https://api.altmetric.com/v1/donut/2518479_240.png 1,Prostate cancer: Phasing in new treatment,Nature Reviews Urology,,,Article,2014-07-16,10.1038/nrurol.2014.173,,,,25023597,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2518478,https://api.altmetric.com/v1/donut/2518478_240.png 1,Kr|[uuml]|ppel-like factor 4 mediates lysophosphatidic acid-stimulated migration and proliferation of PC3M prostate cancer cells,Experimental and Molecular Medicine,,,Article,2014-07-01,10.1038/emm.2014.34,,,,24993134,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2515772,https://api.altmetric.com/v1/donut/2515772_240.png 1,Depressed men with prostate cancer are diagnosed with later stage disease and get less effective therapies,ecancer.org,,,Article,,,,,http://ecancer.org/news/5967-depressed-men-with-prostate-cancer-are-diagnosed-with-later-stage-disease-and-get-less-effective-therapies.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2514030,https://api.altmetric.com/v1/donut/2514030_240.png 1,KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy.,American Journal of Pathology,,,Article,2014-07-09,10.1016/j.ajpath.2014.05.022,,,,25016185,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2505545,https://api.altmetric.com/v1/donut/2505545_240.png 1,"Vasectomy and the risk of prostate cancer: a meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy",Prostate Cancer & Prostatic Diseases,,,Article,2002-09-12,10.1038/sj.pcan.4500586,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2503623,https://api.altmetric.com/v1/donut/2503623_240.png 1,The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2009-01-10,,,,,19846929,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,12,https://www.altmetric.com/details/2501914,https://api.altmetric.com/v1/donut/2501914_240.png 1,Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union.,Health and Quality of Life Outcomes,,,Article,2014-07-07,10.1186/s12955-014-0104-5,,,,24989428,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2501739,https://api.altmetric.com/v1/donut/2501739_240.png 1,Who benefits from hypofractionated radiation therapy for clinically localized prostate cancer: evidence from meta-analysis.,Tumor Biology,,,Article,2014-07-08,10.1007/s13277-014-2297-y,,,,24997620,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2501731,https://api.altmetric.com/v1/donut/2501731_240.png 1,Re: Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer,European Urology,,,Article,2014-08-01,10.1016/j.eururo.2014.05.019,,,,25305785,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2498632,https://api.altmetric.com/v1/donut/2498632_240.png 1,MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.,Oncotarget,,,Article,2014-06-14,10.18632/oncotarget.1953,,,,25004396,PMC4116499,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2496745,https://api.altmetric.com/v1/donut/2496745_240.png 1,MiR-26a inhibits prostate cancer progression by repression of Wnt5a,Tumor Biology,,,Article,2014-06-28,10.1007/s13277-014-2206-4,,,,24972966,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2494086,https://api.altmetric.com/v1/donut/2494086_240.png 1,Normoxic regulation of HIF-1[alpha] in prostate cancer,Nature Reviews Urology,,,Article,2014-07-01,10.1038/nrurol.2013.110-c2,,,,24980197,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2492823,https://api.altmetric.com/v1/donut/2492823_240.png 1,Prostate cancer: GTx-758 reduces testosterone,Nature Reviews Urology,,,Article,2014-07-08,10.1038/nrurol.2014.165,,,,25002202,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2492817,https://api.altmetric.com/v1/donut/2492817_240.png 1,Prostate cancer: Intriguing data on inflammation and prostate cancer,Nature Reviews Urology,,,Article,2014-07-01,10.1038/nrurol.2014.143,,,,24980193,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2492815,https://api.altmetric.com/v1/donut/2492815_240.png 1,A recipe for targeted therapy in prostate cancer,Nature Reviews Urology,,,Article,2014-07-01,10.1038/nrurol.2013.110-c1,,,,24980194,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2492813,https://api.altmetric.com/v1/donut/2492813_240.png 1,Targeting notch in prostate cancer[mdash]combination is the key,Nature Reviews Urology,,,Article,2014-07-01,10.1038/nrurol.2013.110-c3,,,,24980190,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2492811,https://api.altmetric.com/v1/donut/2492811_240.png 1,Elevated YKL40 is associated with advanced prostate cancer,Endocrine-Related Cancer,,,Article,,10.1530/erc-14-0267,,,,24981110,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2490424,https://api.altmetric.com/v1/donut/2490424_240.png 1,"From skid row to main street: the bowery series and the transformation of prostate cancer, 1951-1966.",Bulletin of the History of Medicine,,,Article,2014-07-02,10.1353/bhm.2014.0037,,,,24976163,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2488767,https://api.altmetric.com/v1/donut/2488767_240.png 1,Prostate cancer: Niclosamide jumps the hurdle of enzalutamide resistance,Nature Reviews Urology,,,Article,2014-07-02,10.1038/nrurol.2014.160,,,,24980198,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2486388,https://api.altmetric.com/v1/donut/2486388_240.png 1,Prostate cancer: Multiparametric MRI is better than a nomogram for predicting high-risk disease,Nature Reviews Urology,,,Article,2014-07-02,10.1038/nrurol.2014.161,,,,24980200,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2486387,https://api.altmetric.com/v1/donut/2486387_240.png 1,DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer,PLoS ONE,,,Article,2014-06-23,10.1371/journal.pone.0100243,,,,24956390,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/2479540,https://api.altmetric.com/v1/donut/2479540_240.png 1,Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?,Nature Reviews Urology,,,Article,2011-06-22,10.1038/nrurol.2011.85,,,,21691304,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,56,https://www.altmetric.com/details/2479192,https://api.altmetric.com/v1/donut/2479192_240.png 1,Tanshinones from Chinese Medicinal Herb Danshen (Salvia miltiorrhiza Bunge) Suppress Prostate Cancer Growth and Androgen Receptor Signaling.,Pharmaceutical Research,,,Article,2012-01-29,10.1007/s11095-012-0670-3,,,,22281759,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,9,https://www.altmetric.com/details/2476534,https://api.altmetric.com/v1/donut/2476534_240.png 1,Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer,Molecular Cancer Therapeutics,,,Article,,,,,,,,2445/55264,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2469541,https://api.altmetric.com/v1/donut/2469541_240.png 1,"Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis",Medical Physics,,,Article,2014-06-25,10.1118/1.4883838,,,,24989418,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2468684,https://api.altmetric.com/v1/donut/2468684_240.png 1,Health technology assessment in evolution - focal therapy in localised prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2014-06-24,10.1586/14737140.2014.932692,,,,24965212,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2467149,https://api.altmetric.com/v1/donut/2467149_240.png 1,"Glycans and Galectins in prostate cancer biology, angiogenesis and metastasis",Glycobiology,,,Article,,10.1093/glycob/cwu055,,,,24939371,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2461428,https://api.altmetric.com/v1/donut/2461428_240.png 1,Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer,Oncogene,,,Article,2014-06-16,10.1038/onc.2014.144,,,,24931166,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2461182,https://api.altmetric.com/v1/donut/2461182_240.png 1,Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis.,OncoTargets and therapy,,,Article,2014-06-20,10.2147/ott.s62046,,,,24940075,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2458832,https://api.altmetric.com/v1/donut/2458832_240.png 1,Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer,BMC Cancer,,,Article,2014-06-19,10.1186/1471-2407-14-457,,,,24947166,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2455373,https://api.altmetric.com/v1/donut/2455373_240.png 1,Re: Metformin Use and All-cause and Prostate Cancer–Specific Mortality Among Men with Diabetes,European Urology,,,Article,2014-07-01,10.1016/j.eururo.2014.03.037,,,,24929079,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2451938,https://api.altmetric.com/v1/donut/2451938_240.png 1,Re: Matching Tumor Risk with Aggressiveness of Treatment in Men with Multiple Comorbidities and Early-stage Prostate Cancer,European Urology,,,Article,2014-07-01,10.1016/j.eururo.2014.03.035,,,,24929077,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2451937,https://api.altmetric.com/v1/donut/2451937_240.png 1,Prostate cancer: Extended pelvic lymph node removal[mdash]extended survival,Nature Reviews Urology,,,Article,2014-06-17,10.1038/nrurol.2014.137,,,,24934448,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2442785,https://api.altmetric.com/v1/donut/2442785_240.png 1,Prostate cancer: Viral gene therapy can improve IMRT,Nature Reviews Urology,,,Article,2014-06-17,10.1038/nrurol.2014.138,,,,24934446,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2442782,https://api.altmetric.com/v1/donut/2442782_240.png 1,Generation and Characterisation of a Canine EGFP-HMGA2 Prostate Cancer In Vitro Model,PLoS ONE,,,Article,2014-06-10,10.1371/journal.pone.0098788,,,,24914948,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2438346,https://api.altmetric.com/v1/donut/2438346_240.png 1,miR?124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway,The Prostate,,,Article,2014-06-09,10.1002/pros.22822,,,,24913567,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2437219,https://api.altmetric.com/v1/donut/2437219_240.png 1,Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration resistant prostate cancer,Molecular Endocrinology,,,Article,2014-06-12,10.1210/me.2014-1100,,,,24921661,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2436654,https://api.altmetric.com/v1/donut/2436654_240.png 1,Utility of FDG-PET in clinical neuroendocrine prostate cancer.,The Prostate,,,Article,2014-06-09,10.1002/pros.22831,,,,24913988,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2429571,https://api.altmetric.com/v1/donut/2429571_240.png 1,Androgen sensitivity related proteins in hormone-sensitive and hormone-insensitive prostate cancer cell lines treated by androgen antagonist bicalutamide.,Neoplasma,,,Article,2001-01-01,,,,,11845989,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2426852,https://api.altmetric.com/v1/donut/2426852_240.png 1,"Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men",British Journal of Cancer,,,Article,2003-06-02,10.1038/sj.bjc.6600946,,,,12771980,PMC2377147,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/2426788,https://api.altmetric.com/v1/donut/2426788_240.png 1,5?-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium,The Journal of Urology,,,Article,2003-11-01,10.1097/01.ju.0000091804.20183.81,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2424774,https://api.altmetric.com/v1/donut/2424774_240.png 1,"Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates prostate cancer growth",Diabetes,,,Article,,10.2337/db13-1169,,,,24879833,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2424575,https://api.altmetric.com/v1/donut/2424575_240.png 1,"Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.",Journal of Applied Clinical Medical Physics,,,Article,2014-06-04,10.1120/jacmp.v15i3.4611,,,,24892333,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2410641,https://api.altmetric.com/v1/donut/2410641_240.png 1,Manumycin induces apoptosis in prostate cancer cells,OncoTargets and therapy,,,Article,2014-05-01,10.2147/ott.s60253,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2408175,https://api.altmetric.com/v1/donut/2408175_240.png 1,"ASCO 2014: Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer",ecancer,,,Article,,,,,http://ecancer.org/news/5732-asco-2014--addition-of-docetaxel-to-initial-hormone-therapy-substantially-improves-survival-in-metastatic--hormone-sensitive-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2402779,https://api.altmetric.com/v1/donut/2402779_240.png 1,Up-regulation of eEF1A2 promotes proliferation and inhibits apoptosis in prostate cancer,Biochemical & Biophysical Research Communications,,,Article,,10.1016/j.bbrc.2014.05.045,,,,24853801,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2400861,https://api.altmetric.com/v1/donut/2400861_240.png 1,A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy among Men with High-Risk Characteristics Following Prostatectomy for Prostate Cancer,Value in Health (Elsevier Science),,,Article,2014-07-14,10.1016/j.jval.2014.04.010,,,,25128047,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2400587,https://api.altmetric.com/v1/donut/2400587_240.png 1,Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT Imaging in Prostate Cancer Patients,BioMed Research International,,,Article,,10.1155/2014/305182,,,,24991547,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2397224,https://api.altmetric.com/v1/donut/2397224_240.png 1,"Non-metastatic castration-resistant prostate cancer (CPRCM0), an old scenario with renewed clinical interest.",Actas Urológicas Españolas,,,Article,2014-05-24,10.1016/j.acuro.2014.02.016,,,,24866537,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2388185,https://api.altmetric.com/v1/donut/2388185_240.png 1,Prevention of prostate cancer: outcomes of clinical trials and future opportunities.,Am Soc Clin Oncol Educ Book,,,Article,2014-05-27,10.14694/edbook_am.2014.34.e76,,,,24857150,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2386959,https://api.altmetric.com/v1/donut/2386959_240.png 1,Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.,Cancer Prevention Research,,,Article,2014-02-08,10.1158/1940-6207.capr-13-0427-t,,,,24501325,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2386765,https://api.altmetric.com/v1/donut/2386765_240.png 1,DNA methylation of prostate cancer and clinical application.,Yi chuan Hereditas,,,Article,2014-05-24,,,,,24846991,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2384694,https://api.altmetric.com/v1/donut/2384694_240.png 1,Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis.,Scientific Reports,,,Article,2014-05-23,10.1038/srep05012,,,,24852453,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2384257,https://api.altmetric.com/v1/donut/2384257_240.png 1,Significance of androgen receptor variants in castration resistant prostate cancer.,Endocrine-Related Cancer,,,Article,2014-05-23,10.1530/erc-13-0470,,,,24859991,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2382256,https://api.altmetric.com/v1/donut/2382256_240.png 1,Prostate cancer: Mixed responses to ipilimumab,Nature Reviews Urology,,,Article,2014-05-27,10.1038/nrurol.2014.121,,,,24861332,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2381517,https://api.altmetric.com/v1/donut/2381517_240.png 1,Prostate cancer: European urologists prefer surgery for high-risk prostate cancer,Nature Reviews Urology,,,Article,2014-05-27,10.1038/nrurol.2014.122,,,,24861331,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2381514,https://api.altmetric.com/v1/donut/2381514_240.png 1,Community-Based Recreational Football: A Novel Approach to Promote Physical Activity and Quality of Life in Prostate Cancer Survivors,International Journal of Environmental Research and Public Health,,,Article,2014-05-26,10.3390/ijerph110605567,,,,24865394,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/2379766,https://api.altmetric.com/v1/donut/2379766_240.png 1,Sexual orientation and testing for prostate and colorectal cancers among men in California.,Medical care,,,Article,2008-01-12,10.1097/mlr.0b013e31817d697f,,,,19300314,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2377780,https://api.altmetric.com/v1/donut/2377780_240.png 1,Cutaneous metastasis of prostate cancer: a case report and review of the literature with bioinformatics analysis of multiple healthcare delivery networks,Journal of Cutaneous Pathology,,,Article,2014-02-26,10.1111/cup.12296,,,,24456209,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2377226,https://api.altmetric.com/v1/donut/2377226_240.png 1,The mechanism of bifonazole-induced [Ca2+]i rises and non-Ca2+-triggered cell death in PC3 human prostate cancer cells.,Journal of Receptor & Signal Transduction Research,,,Article,2014-05-21,10.3109/10799893.2014.921201,,,,24849495,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2373404,https://api.altmetric.com/v1/donut/2373404_240.png 1,Sexually transmitted protozoan parasite implicated in prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5699-sexually-transmitted-protozoan-parasite-implicated-in-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2370716,https://api.altmetric.com/v1/donut/2370716_240.png 1,Will a new blood-based biomarker panel lead to prostate cancer diagnosis before patients show symptoms?,ecancer.org,,,Article,,,,,http://ecancer.org/news/5696-will-a-new-blood-based-biomarker-panel-lead-to-prostate-cancer-diagnosis-before-patients-show-symptoms.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2370486,https://api.altmetric.com/v1/donut/2370486_240.png 1,VDR Activity is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells,Molecular Cancer Research,,,Article,2014-05-12,10.1158/1541-7786.mcr-13-0395,,,,24825850,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2368741,https://api.altmetric.com/v1/donut/2368741_240.png 1,The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study,Hereditary Cancer in Clinical Practice,,,Article,2013-12-23,10.1186/1897-4287-11-19,,,,24359571,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2368624,https://api.altmetric.com/v1/donut/2368624_240.png 1,Molecular Characterization of Prostate Cancer Following Androgen Deprivation: The Devil in the Details,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.056,,,,24011425,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2366277,https://api.altmetric.com/v1/donut/2366277_240.png 1,Re: Prostate Cancer Imaging Trends after a Nationwide Effort to Discourage Inappropriate Prostate Cancer Imaging,The Journal of Urology,,,Article,2014-01-05,10.1016/j.juro.2014.02.081,,,,24745486,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2365831,https://api.altmetric.com/v1/donut/2365831_240.png 1,Prostate Cancer: Optimal Tissue Processing for Diagnosis and Prognosis,Pathology Case Reviews,,,Article,,10.1097/pcr.0000000000000034,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2364957,https://api.altmetric.com/v1/donut/2364957_240.png 1,Register today for the Women Against Prostate CancerAdvocacy Day 2010 | Women Against Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/2010/04/advocacyday/,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2364166,https://api.altmetric.com/v1/donut/2364166_240.png 1,Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer,Molecular Cancer Therapeutics,,,Article,2014-05-08,10.1158/1535-7163.mct-14-0017,,,,24817628,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2362487,https://api.altmetric.com/v1/donut/2362487_240.png 1,Lecture: Future strategies and targets for prostate cancer. Lecture: Future strategies and targets for prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/video/2832/lecture--future-strategies-and-targets-for-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2362086,https://api.altmetric.com/v1/donut/2362086_240.png 1,Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.,Nanomedicine,,,Article,2011-01-01,10.2217/nnm.10.101,,,,21182420,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2360954,https://api.altmetric.com/v1/donut/2360954_240.png 1,Delaying androgen deprivation therapy may be safe for men with prostate cancer relapse detected by PSA testing,ecancer.org,,,Article,,,,,http://ecancer.org/news/5671-delaying-androgen-deprivation-therapy-may-be-safe-for-men-with-prostate-cancer-relapse-detected-by-psa-testing.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2355670,https://api.altmetric.com/v1/donut/2355670_240.png 1,Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.07.022,,,,23910941,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2353139,https://api.altmetric.com/v1/donut/2353139_240.png 1,"Reply to Sarah Willis, Alec Miners, and Jan van der Meulen's Letter to the Editor re: Maarten de Rooij, Simone Crienen, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers, Janneke P.C. Grutters. Cost-effectiveness of Magnetic Resonance (MR) Imaging and MR-guided Targeted Biopsy Versus Systematic Transrectal Ultrasound–guided Biopsy in Diagnosing Prostate Cancer: A Modelling Study from a Health Care Perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012",European Urology,,,Article,,10.1016/j.eururo.2014.04.012,,,,24837186,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2352592,https://api.altmetric.com/v1/donut/2352592_240.png 1,Prostate cancer: Novel targeting of androgen signalling in CRPC,Nature Reviews Urology,,,Article,2014-05-13,10.1038/nrurol.2014.107,,,,24818852,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2347503,https://api.altmetric.com/v1/donut/2347503_240.png 1,Prostate cancer: Combined FEC-PET/MRI improves diagnostic accuracy,Nature Reviews Urology,,,Article,2014-05-13,10.1038/nrurol.2014.111,,,,24818855,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2347501,https://api.altmetric.com/v1/donut/2347501_240.png 1,"Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle Changes for Improving Disease-specific Quality of Life in Sedentary Men on Long-term Androgen-Deprivation Therapy for Advanced Prostate Cancer: A Randomised Controlled Trial. Eur Urol 2014;65:865–72Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A Multicentre Year-long Randomised Controlled Trial of Exercise Training Targeting Physical Functioning in Men with Prostate Cancer Previously Treated with Androgen Suppression and Radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856–64Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O’Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer. Eur Urol 2014;65:816–24Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol 2014;65:704–9",European Urology,,,Article,,10.1016/j.eururo.2014.04.018,,,,24813269,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2338054,https://api.altmetric.com/v1/donut/2338054_240.png 1,Re: Early Detection of Prostate Cancer: AUA Guideline,European Urology,,,Article,2014-06-01,10.1016/j.eururo.2014.02.024,,,,24774826,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2332763,https://api.altmetric.com/v1/donut/2332763_240.png 1,"Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.",Bioorganic & Medicinal Chemistry Letters,,,Article,2013-05-08,10.1016/j.bmcl.2013.04.007,,,,23643730,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,13,https://www.altmetric.com/details/2332715,https://api.altmetric.com/v1/donut/2332715_240.png 1,Laparoscopic radical prostatectomy for high?risk prostate cancer,British Journal of Urology,,,Article,2014-08-11,10.1111/bju.12797,,,,24802619,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2331941,https://api.altmetric.com/v1/donut/2331941_240.png 1,Prostate cancer: Assay to predict negative repeat biopsies validated,Nature Reviews Urology,,,Article,2014-05-06,10.1038/nrurol.2014.103,,,,24798701,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2329174,https://api.altmetric.com/v1/donut/2329174_240.png 1,Prostate cancer: High prevalence of screen-detected disease in Ghana,Nature Reviews Urology,,,Article,2014-05-06,10.1038/nrurol.2014.105,,,,24798702,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2329173,https://api.altmetric.com/v1/donut/2329173_240.png 1,Prostate cancer: Validated tool for predicting docetaxel response in CRPC,Nature Reviews Urology,,,Article,2014-05-06,10.1038/nrurol.2014.106,,,,24798700,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2329172,https://api.altmetric.com/v1/donut/2329172_240.png 1,A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer. ESMO 2012. ecancer - Conference highlights and events calendar,ecancer,,,Article,,,,,http://ecancer.org/conference/153-esmo-2012/video/1624/a-proof-of-concept-study-of-odm-201-in-patients-with-progressive-castration-resistant-prostate-cancer.php,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,https://www.altmetric.com/details/2321349,https://api.altmetric.com/v1/donut/2321349_240.png 1,"Reply to Julia Klap and K.R. Loughlin's Letter to the Editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications. Eur Urol 2014;65:115–23",European Urology,,,Article,,10.1016/j.eururo.2014.04.016,,,,24836155,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2318824,https://api.altmetric.com/v1/donut/2318824_240.png 1,"Re: Maarten de Rooij, Simone Crienen, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers, Janneke P.C. Grutters. Cost Effectiveness of Magnetic Resonance (MR) Imaging and MR-guided Targeted Biopsy Versus Systematic Transrectal Ultrasound–guided Biopsy in Diagnosing Prostate Cancer: A Modelling Study from a Health Care Perspective. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.12.012",European Urology,,,Article,,10.1016/j.eururo.2014.04.011,,,,24830624,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2318822,https://api.altmetric.com/v1/donut/2318822_240.png 1,Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells.,Oncology Reports,,,Article,2013-08-02,10.3892/or.2013.2635,,,,23900512,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2316927,https://api.altmetric.com/v1/donut/2316927_240.png 1,Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-12-19,10.1007/s00259-013-2660-z,,,,24352789,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/2316185,https://api.altmetric.com/v1/donut/2316185_240.png 1,Utility of LHRH antagonists for advanced prostate cancer.,Canadian Journal of Urology,,,Article,2014-04-01,,,,,24775720,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2315518,https://api.altmetric.com/v1/donut/2315518_240.png 1,"Prostate cancer: Alcohol, cancer and 5[alpha]-reductase inhibitors[mdash]is there a link?",Nature Reviews Urology,,,Article,2014-04-29,10.1038/nrurol.2014.90,,,,24776974,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2312108,https://api.altmetric.com/v1/donut/2312108_240.png 1,Prostate cancer: Tools to predict insignificant prostate cancer are inaccurate in unscreened men,Nature Reviews Urology,,,Article,2014-04-29,10.1038/nrurol.2014.97,,,,24776975,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2312105,https://api.altmetric.com/v1/donut/2312105_240.png 1,The use of complementary therapies among breast and prostate cancer patients in Finland,European Journal of Cancer Care,,,Article,2008-07-18,10.1111/j.1365-2354.2002.00295.x,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2308140,https://api.altmetric.com/v1/donut/2308140_240.png 1,Canonical Androstenedione Reduction is the Predominant Source of Signalling Androgens in Hormone Refractory Prostate Cancer,Clinical Cancer Research,,,Article,2014-04-24,10.1158/1078-0432.ccr-13-3483,,,,24771644,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2306483,https://api.altmetric.com/v1/donut/2306483_240.png 1,"Sustained Exposure to the Investigational Kisspeptin Analog, TAK-448, Down-Regulates Testosterone into the Castration Range in Healthy Males and in Patients With Prostate Cancer: Results From Two Phase 1 Studies",The Journal of Clinical Endocrinology & Metabolism,,,Article,2014-04-23,10.1210/jc.2013-4236,,,,24762108,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2305795,https://api.altmetric.com/v1/donut/2305795_240.png 1,Lclet 4 enhances pro-apoptotic and anti-invasive effects of mitoxantrone on human prostate cancer cells - in vitro study.,Acta Biochimica Polonica,,,Article,2013-07-24,,,,,23869350,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2304487,https://api.altmetric.com/v1/donut/2304487_240.png 1,"Re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026",European Urology,,,Article,2014-08-01,10.1016/j.eururo.2014.03.044,,,,24768492,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2304320,https://api.altmetric.com/v1/donut/2304320_240.png 1,Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer,Radiation Oncology,,,Article,,,,,,,,2445/53623,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2304062,https://api.altmetric.com/v1/donut/2304062_240.png 1,CC Chemokine Ligand 18 and IGF-Binding Protein 6 as Potential Serum Biomarkers for Prostate Cancer.,Tohoku Journal of Experimental Medicine,,,Article,2014-04-23,,,,,24747338,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2303491,https://api.altmetric.com/v1/donut/2303491_240.png 1,Prostate cancer: Tadalafil does not protect erectile function from radiation,Nature Reviews Urology,,,Article,2014-04-22,10.1038/nrurol.2014.92,,,,24752210,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2295198,https://api.altmetric.com/v1/donut/2295198_240.png 1,Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells.,Oncotarget,,,Article,2014-04-02,10.18632/oncotarget.1849,,,,24742967,PMC4039240,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2292148,https://api.altmetric.com/v1/donut/2292148_240.png 1,Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.,Cancer Research,,,Article,2001-06-01,,,,,11389052,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2291057,https://api.altmetric.com/v1/donut/2291057_240.png 1,A Novel Therapeutic Option for Castration-resistant Prostate Cancer: After or Before Chemotherapy?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.06.034,,,,23838638,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2289336,https://api.altmetric.com/v1/donut/2289336_240.png 1,[Bortezomib enhances the sensitivity of prostate cancer cells to natural killer cell-mediated cytotoxicity].,Zhonghua nan ke xue National journal of andrology,,,Article,2014-03-01,,,,,24738457,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2289269,https://api.altmetric.com/v1/donut/2289269_240.png 1,Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.,Cancer Cell International,,,Article,2014-04-17,10.1186/1475-2867-14-34,,,,24739220,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2289165,https://api.altmetric.com/v1/donut/2289165_240.png 1,Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.,Cancer Research,,,Article,2010-03-25,10.1158/0008-5472.can-09-3185,,,,20332231,PMC2848908,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2285881,https://api.altmetric.com/v1/donut/2285881_240.png 1,Hemi salvage high?intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two?centre study,British Journal of Urology,,,Article,2014-04-16,10.1111/bju.12545,,,,24930692,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2283665,https://api.altmetric.com/v1/donut/2283665_240.png 1,"Comparative Analysis of Innate Immune System Function in Metastatic Breast, Colorectal, and Prostate Cancer Patients with Circulating Tumor Cells.",Experimental & Molecular Pathology,,,Article,2014-04-11,10.1016/j.yexmp.2014.04.001,,,,24731923,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2283349,https://api.altmetric.com/v1/donut/2283349_240.png 1,Prostate cancer: Validated tool predicts survival of men taking abiraterone after docetaxel,Nature Reviews Urology,,,Article,2014-04-15,10.1038/nrurol.2014.85,,,,24731997,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2280784,https://api.altmetric.com/v1/donut/2280784_240.png 1,Study finds prostate cancer tests underestimate disease in half of cases,ecancer.org,,,Article,,,,,http://ecancer.org/news/5545-study-finds-prostate-cancer-tests-underestimate-disease-in-half-of-cases.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2276040,https://api.altmetric.com/v1/donut/2276040_240.png 1,"Oncology Scan—Rising Stars, Fading Stars, and Shooting Stars: New Trends in Prostate Cancer Management","International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2013.01.039,,,,24725683,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2275735,https://api.altmetric.com/v1/donut/2275735_240.png 1,AACR: Blood-based biomarker may identify prostate cancers that will Be resistant to enzalutamide,ecancer.org,,,Article,,,,,http://ecancer.org/news/5503-aacr--blood-based-biomarker-may-identify-prostate-cancers-that-will-be-resistant-to-enzalutamide.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2272767,https://api.altmetric.com/v1/donut/2272767_240.png 1,"Reply from Authors re: Andrea Gallina, Alessandro Nin, Francesco Montorsi, Alberto Briganti. Metabolic Syndrome as a Marker for Prostate Cancer: Still a Work in Progress. Eur Urol. In press.",European Urology,,,Article,2015-01-01,10.1016/j.eururo.2014.04.001,,,,24746105,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2272199,https://api.altmetric.com/v1/donut/2272199_240.png 1,Cryosurgery for clinical T3 prostate cancer,British Journal of Urology,,,Article,2014-04-09,10.1111/bju.12512,,,,24717057,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2269281,https://api.altmetric.com/v1/donut/2269281_240.png 1,Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary Artery Disease,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2012.08.070,,,,22981136,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2268538,https://api.altmetric.com/v1/donut/2268538_240.png 1,ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate cancer,ecancer.org,,,Article,,,,,http://ecancer.org/news/5487-estro--six-months-hormonal-treatment-in-addition-to-radiotherapy-improves-survival-for-men-with-localised-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2260384,https://api.altmetric.com/v1/donut/2260384_240.png 1,Genetic variants of IgG1 antibodies and Fc?RIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells.,Oncoimmunology,,,Article,2014-01-01,10.4161/onci.27317,,,,24701371,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2258205,https://api.altmetric.com/v1/donut/2258205_240.png 1,ESTRO: Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment outcomes,ecancer.org,,,Article,,,,,http://ecancer.org/news/5482-estro--brachytherapy-helps-maintain-erectile-function-in-prostate-cancer-patients-without-compromising-treatment-outcomes.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2257433,https://api.altmetric.com/v1/donut/2257433_240.png 1,Lymphotropic Nanoparticle-enhanced MRI in Prostate Cancer: Value and Therapeutic Potential.,Current Urology Reports,,,Article,2014-01-18,10.1007/s11934-013-0389-7,,,,24430170,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2256043,https://api.altmetric.com/v1/donut/2256043_240.png 1,Prostate cancer nomograms: a review of their use in cancer detection and treatment.,Current Urology Reports,,,Article,2014-01-25,10.1007/s11934-013-0391-0,,,,24452739,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2254794,https://api.altmetric.com/v1/donut/2254794_240.png 1,New perspectives for prostate cancer treatment: in vitro inhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media.,Aging Male,,,Article,2014-03-08,10.3109/13685538.2014.896894,,,,24597941,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2250810,https://api.altmetric.com/v1/donut/2250810_240.png 1,Risk of prostate cancer and thrombosis-related factor polymorphisms.,Biomed Rep,,,Article,2014-03-23,10.3892/br.2013.180,,,,24649068,PMC3917059,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2249143,https://api.altmetric.com/v1/donut/2249143_240.png 1,Joint modelling analysis of prostate cancer incidence: frequentist and bayesian approaches,,,,Article,,,,,,,,2117/22507,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2246332,https://api.altmetric.com/v1/donut/2246332_240.png 1,[Pitfalls with (18)F-Choline PET/CT in patients with prostate cancer.],Revista Española de Medicina Nuclear e Imagen Molecular,,,Article,2012-11-29,10.1016/j.remn.2012.01.005,,,,23177342,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2244888,https://api.altmetric.com/v1/donut/2244888_240.png 1,"Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer : The DEGRO-QUIRO trial.",Strahlentherapie und Onkologie,,,Article,2013-10-17,10.1007/s00066-013-0440-0,,,,24126939,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/2243385,https://api.altmetric.com/v1/donut/2243385_240.png 1,EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2014-02-14,10.1038/pcan.2013.53,,,,24518515,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2243213,https://api.altmetric.com/v1/donut/2243213_240.png 1,Detection of lymph node metastases in patients with nodal prostate cancer relapse using 18F/11C-choline-PET/CT - influence of size of nodal tumor infiltration and accuracy related to lymph node regions.,The Journal of Urology,,,Article,2014-02-14,10.1016/j.juro.2013.12.054,,,,24518792,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2243179,https://api.altmetric.com/v1/donut/2243179_240.png 1,18F-FDG PET/CT Superscan in Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2014-02-27,10.1097/rlu.0000000000000376,,,,24566401,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2241400,https://api.altmetric.com/v1/donut/2241400_240.png 1,Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells.,International Journal of Oncology,,,Article,2014-03-16,10.3892/ijo.2014.2335,,,,24626333,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2238657,https://api.altmetric.com/v1/donut/2238657_240.png 1,Prostate cancer survivorship,Trends in Urology and Men's Health,,,Article,2014-03-27,10.1002/tre.389,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2235988,https://api.altmetric.com/v1/donut/2235988_240.png 1,Prostate cancer: Updated analysis of first-line abiraterone confirms benefit,Nature Reviews Urology,,,Article,2014-04-01,10.1038/nrurol.2014.79,,,,24686524,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2227929,https://api.altmetric.com/v1/donut/2227929_240.png 1,Basic research: Preclinical model of prostate cancer bone metastasis,Nature Reviews Urology,,,Article,2014-04-01,10.1038/nrurol.2014.81,,,,24686527,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2227928,https://api.altmetric.com/v1/donut/2227928_240.png 1,Prostate cancer: MRI reduces low-risk prostate cancer diagnosis and biopsy,Nature Reviews Urology,,,Article,2014-04-01,10.1038/nrurol.2014.77,,,,24686525,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2227927,https://api.altmetric.com/v1/donut/2227927_240.png 1,External validation of the Briganti nomogram to estimate the probability of specimen?confined disease in patients with high?risk prostate cancer,British Journal of Urology,,,Article,2014-08-13,10.1111/bju.12763,,,,24684584,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/2224328,https://api.altmetric.com/v1/donut/2224328_240.png 1,The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2014.01.008,,,,24661660,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/2219992,https://api.altmetric.com/v1/donut/2219992_240.png 1,Fully Automated Volumetric Modulated Arc Therapy Plan Generation for Prostate Cancer Patients,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2013.12.046,,,,24529714,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2219987,https://api.altmetric.com/v1/donut/2219987_240.png 1,Steroidogenic Germline Polymorphism Predictors of Prostate Cancer Progression in the Estradiol Pathway,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-2567,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2216086,https://api.altmetric.com/v1/donut/2216086_240.png 1,Adherence to Performance Measures and Outcomes among Men Treated for Prostate Cancer,The Journal of Urology,,,Article,2014-03-26,10.1016/j.juro.2014.03.091,,,,24681332,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/2214580,https://api.altmetric.com/v1/donut/2214580_240.png 1,Soy protein and recurrence of prostate cancer--reply.,JAMA: Journal of the American Medical Association,,,Article,2013-12-04,10.1001/jama.2013.278613,,,,24302097,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2214374,https://api.altmetric.com/v1/donut/2214374_240.png 1,Brain metastasis from prostatic cancer,Journal of Surgical Oncology,,,Article,2006-07-19,10.1002/jso.2930230310,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2213331,https://api.altmetric.com/v1/donut/2213331_240.png 1,Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study,The Prostate,,,Article,2003-02-15,10.1002/pros.10177,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2213046,https://api.altmetric.com/v1/donut/2213046_240.png 1,Prostate cancer: Predicting high-risk prostate cancer[mdash]a novel stratification tool,Nature Reviews Urology,,,Article,2014-03-25,10.1038/nrurol.2014.70,,,,24662730,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2210902,https://api.altmetric.com/v1/donut/2210902_240.png 1,High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.09.025,,,,24231242,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2206625,https://api.altmetric.com/v1/donut/2206625_240.png 1,The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients,Radiotherapy & Oncology,,,Article,2014-01-07,10.1016/j.radonc.2013.11.011,,,,24411226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2205565,https://api.altmetric.com/v1/donut/2205565_240.png 1,Prostate cancer: Cabozantinib reduces pain and narcotic use in men with CRPC.,Nature Reviews Urology,,,Article,2014-03-14,10.1038/nrurol.2014.57,,,,24619377,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2203971,https://api.altmetric.com/v1/donut/2203971_240.png 1,Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: Quantitative analysis of imaging contour compared to whole-mount histopathology,Radiotherapy & Oncology,,,Article,2014-01-17,10.1016/j.radonc.2013.12.003,,,,24444524,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2203943,https://api.altmetric.com/v1/donut/2203943_240.png 1,Re: Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?,The Journal of Urology,,,Article,2014-03-20,10.1016/j.juro.2014.03.044,,,,25280283,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2200357,https://api.altmetric.com/v1/donut/2200357_240.png 1,Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer,Radiotherapy & Oncology,,,Article,2014-02-04,10.1016/j.radonc.2014.01.007,,,,24507766,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2198159,https://api.altmetric.com/v1/donut/2198159_240.png 1,Possible implications of arginase and diamine oxidase in prostatic carcinoma.,Cancer Detection & Prevention,,,Article,2001-01-01,,,,,11270424,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2198052,https://api.altmetric.com/v1/donut/2198052_240.png 1,Re: TALEN-Engineered AR Gene Rearrangements Reveal Endocrine Uncoupling of Androgen Receptor in Prostate Cancer,The Journal of Urology,,,Article,2014-03-19,10.1016/j.juro.2014.03.010,,,,25280326,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2197488,https://api.altmetric.com/v1/donut/2197488_240.png 1,Re: Bispecific Small Molecule-Antibody Conjugate Targeting Prostate Cancer,The Journal of Urology,,,Article,2014-03-19,10.1016/j.juro.2014.03.011,,,,25280327,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2197482,https://api.altmetric.com/v1/donut/2197482_240.png 1,Prostate cancer: A consensus on trial design for focal therapy,Nature Reviews Urology,,,Article,2014-03-18,10.1038/nrurol.2014.64,,,,24637422,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2193615,https://api.altmetric.com/v1/donut/2193615_240.png 1,Mapping the FACT-P to the Preference-Based EQ-5D Questionnaire in Metastatic Castration-Resistant Prostate Cancer,Value in Health (Elsevier Science),,,Article,2014-03-15,10.1016/j.jval.2013.12.005,,,,24636382,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2187777,https://api.altmetric.com/v1/donut/2187777_240.png 1,Chemopreventive effects of zinc on prostate carcinogenesis induced by N-methyl-N-nitrosourea and testosterone in adult male Sprague-Dawley rats.,Journal of Cancer Research & Clinical Oncology,,,Article,2010-06-17,10.1007/s00432-010-0926-4,,,,20552224,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,5,https://www.altmetric.com/details/2176313,https://api.altmetric.com/v1/donut/2176313_240.png 1,Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial,Prostate Cancer,,,Article,,10.1155/2014/478983,,,,24693436,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2175611,https://api.altmetric.com/v1/donut/2175611_240.png 1,Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-1588,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2170948,https://api.altmetric.com/v1/donut/2170948_240.png 1,SOD Mimetics: A Novel Class of Androgen Receptor Inhibitors That Suppresses Castration-Resistant Growth of Prostate Cancer,Molecular Cancer Therapeutics,,,Article,2012-01-01,10.1158/1535-7163.mct-11-0540,,,,22172488,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2167148,https://api.altmetric.com/v1/donut/2167148_240.png 1,Prostate cancer: Poor performance status reduces efficacy of abiraterone,Nature Reviews Urology,,,Article,2014-03-04,10.1038/nrurol.2014.46,,,,24595123,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2162075,https://api.altmetric.com/v1/donut/2162075_240.png 1,Impact of comorbidity on health?related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies,British Journal of Urology,,,Article,2014-08-16,10.1111/bju.12723,,,,24588845,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2157288,https://api.altmetric.com/v1/donut/2157288_240.png 1,Influence of free fatty acids on glucose uptake in prostate cancer cells,Nuclear Medicine & Biology,,,Article,,10.1016/j.nucmedbio.2013.12.005,,,,24440212,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2153052,https://api.altmetric.com/v1/donut/2153052_240.png 1,Targeting kallikrein-related peptidases in prostate cancer,Expert Opinion on Therapeutic Targets,,,Article,2014-02-27,10.1517/14728222.2014.880693,,,,24571737,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2151853,https://api.altmetric.com/v1/donut/2151853_240.png 1,Quality of Life and Health Status Among Prostate Cancer Survivors and Noncancer Population Controls,Urology,,,Article,,10.1016/j.urology.2013.12.009,,,,24581528,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2151336,https://api.altmetric.com/v1/donut/2151336_240.png 1,Identification of an Anabolic Selective Androgen Receptor Modulator that Actively Induces Death of Androgen-Independent Prostate Cancer Cells,Journal of Steroid Biochemistry & Molecular Biology,,,Article,,10.1016/j.jsbmb.2014.02.005,,,,24565564,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/2146920,https://api.altmetric.com/v1/donut/2146920_240.png 1,Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells,Molecular Biology Reports,,,Article,2007-03-13,10.1007/s11033-007-9059-5,,,,17431821,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/2146316,https://api.altmetric.com/v1/donut/2146316_240.png 1,Prostate cancer: The role of local therapy for metastatic prostate cancer,Nature Reviews Urology,,,Article,2014-02-25,10.1038/nrurol.2014.33,,,,24567085,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2144168,https://api.altmetric.com/v1/donut/2144168_240.png 1,Can the Results of the European Randomized Study of Screening for Prostate Cancer Be Decontaminated?,European Urology,,,Article,2014-02-01,10.1016/j.eururo.2013.08.058,,,,24050792,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2142329,https://api.altmetric.com/v1/donut/2142329_240.png 1,Abiraterone in the treatment of metastatic castration-resistant prostate cancer.,Cancer Management and Research,,,Article,2014-02-08,10.2147/cmar.s39318,,,,24501545,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/2140340,https://api.altmetric.com/v1/donut/2140340_240.png 1,Metabolic atrophy and 3?T 1H?magnetic resonance spectroscopy correlation after radiation therapy for prostate cancer,British Journal of Urology,,,Article,2014-02-20,10.1111/bju.12553,,,,24180518,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2134249,https://api.altmetric.com/v1/donut/2134249_240.png 1,"Long term oncologic outcomes of a Phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localized, high?risk prostate cancer",British Journal of Urology,,,Article,2014-02-19,10.1111/bju.12676,,,,24552276,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2130604,https://api.altmetric.com/v1/donut/2130604_240.png 1,Prostate cancer: Biomarkers PCA3 and TMPRSS2-ERG: better together,Nature Reviews Urology,,,Article,2014-02-18,10.1038/nrurol.2014.38,,,,24535584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2128260,https://api.altmetric.com/v1/donut/2128260_240.png 1,Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-13-1869,,,,24536060,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2127834,https://api.altmetric.com/v1/donut/2127834_240.png 1,"Re: Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput, Guido W. Jenster, Jan Trapman. A 36-gene Signature Predicts Clinical Progression in a Subgroup of ERG-positive Prostate Cancers. Eur Urol 2013;64:941–50",European Urology,,,Article,2014-06-01,10.1016/j.eururo.2014.01.038,,,,24565966,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2125122,https://api.altmetric.com/v1/donut/2125122_240.png 1,Towards Random Sequencing or Precision Medicine in Castration-resistant Prostate Cancer?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.09.019,,,,24075577,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2125113,https://api.altmetric.com/v1/donut/2125113_240.png 1,Re: Short Term Outcomes of Prostate Biopsy in Men Tested for Cancer by Prostate Specific Antigen: Prospective Evaluation Within ProtecT Study,European Urology,,,Article,2014-02-01,10.1016/j.eururo.2013.10.050,,,,24407206,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,104,https://www.altmetric.com/details/2125112,https://api.altmetric.com/v1/donut/2125112_240.png 1,"Re: Anna Bill-Axelson, Hans Garmo, Lars Holmberg, et al. Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial. Eur Urol 2013;64:920–8.",European Urology,,,Article,2014-06-01,10.1016/j.eururo.2014.02.010,,,,24565967,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2125102,https://api.altmetric.com/v1/donut/2125102_240.png 1,Health-Related Quality of Life in the Finnish Trial of Screening for Prostate Cancer ,European Urology,,,Article,2012-01-01,10.1016/j.eururo.2012.11.041,,,,23265387,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/2125100,https://api.altmetric.com/v1/donut/2125100_240.png 1,Long-term Continence Outcomes in Men Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.006,,,,23957946,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/2125093,https://api.altmetric.com/v1/donut/2125093_240.png 1,A 36-gene Signature Predicts Clinical Progression in a Subgroup of ERG-positive Prostate Cancers,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.02.039,,,,23490727,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/2125085,https://api.altmetric.com/v1/donut/2125085_240.png 1,"Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study. Eur Urol 2014;65:1058–66",European Urology,,,Article,2014-06-01,10.1016/j.eururo.2013.12.009,,,,24365126,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/2125083,https://api.altmetric.com/v1/donut/2125083_240.png 1,Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.02.025,,,,23465517,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/2125078,https://api.altmetric.com/v1/donut/2125078_240.png 1,Personalizing the Management of Men with Intermediate-risk Prostate Cancer,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.03.038,,,,23545122,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/2125073,https://api.altmetric.com/v1/donut/2125073_240.png 1,Re: Topography of Lymph Node Metastases in Prostate Cancer Patients Undergoing Radical Prostatectomy and Extended Lymphadenectomy: Results of a Combined Molecular and Histopathologic Mapping Study,European Urology,,,Article,2014-02-01,10.1016/j.eururo.2013.10.052,,,,24407208,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2124874,https://api.altmetric.com/v1/donut/2124874_240.png 1,The Robotic Approach Does Not Change the Current Paradigms of Pelvic Lymph Node Dissection for Prostate Cancer,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.05.017,,,,23684940,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2124861,https://api.altmetric.com/v1/donut/2124861_240.png 1,"Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-based Study. Eur Urol 2014;65:1058–66",European Urology,,,Article,2014-06-01,10.1016/j.eururo.2013.12.060,,,,24411281,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2124846,https://api.altmetric.com/v1/donut/2124846_240.png 1,"Re: Alessandro Sciarra, Per Anders Abrahamsson, Maurizio Brausi, et al. Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials. Eur Urol 2013;64:722–30",European Urology,,,Article,2014-04-01,10.1016/j.eururo.2013.12.016,,,,24380648,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2124831,https://api.altmetric.com/v1/donut/2124831_240.png 1,Patterns and Predictors of Amelioration of Genitourinary Toxicity After High-dose Intensity-modulated Radiation Therapy for Localized Prostate Cancer: Implications for Defining Postradiotherapy Urinary Toxicity,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.02.001,,,,23522772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2124826,https://api.altmetric.com/v1/donut/2124826_240.png 1,Cautious Optimism for Extreme Dose Escalation in Prostate Cancer,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.02.035,,,,23506832,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2124825,https://api.altmetric.com/v1/donut/2124825_240.png 1,Ferumoxtran-10 Ultrasmall Superparamagnetic Iron Oxide–Enhanced Diffusion-weighted Imaging Magnetic Resonance Imaging for Detection of Metastases in Normal-sized Lymph Nodes in Patients with Bladder and Prostate Cancer: Do We Enter the Era After Extended Pelvic Lymph Node Dissection?,European Urology,,,Article,2013-01-01,10.1016/j.eururo.2013.08.017,,,,23972400,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2124817,https://api.altmetric.com/v1/donut/2124817_240.png 1,"Re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality After Prostate Cancer Treatment with Radical Prostatectomy, External-Beam Radiation Therapy, or Brachytherapy in Men Without Comorbidity. Eur Urol 2013;64:372–8",European Urology,,,Article,2014-03-01,10.1016/j.eururo.2013.11.035,,,,24315704,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2124808,https://api.altmetric.com/v1/donut/2124808_240.png 1,Multiparametric MRI and Subsequent MR/Ultrasound Fusion?Guided Biopsy Increase the Detection of Anteriorly Located Prostate Cancers,British Journal of Urology,,,Article,2014-02-12,10.1111/bju.12670,,,,24712649,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/2115263,https://api.altmetric.com/v1/donut/2115263_240.png 1,Prostate cancer: Updated prognostic model for overall survival in mCRPC,Nature Reviews Urology,,,Article,2014-02-11,10.1038/nrurol.2014.29,,,,24515086,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2112293,https://api.altmetric.com/v1/donut/2112293_240.png 1,Prostate cancer: New data on dietary lycopene suggests reduced risk,Nature Reviews Urology,,,Article,2014-02-11,10.1038/nrurol.2014.31,,,,24515088,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/2112292,https://api.altmetric.com/v1/donut/2112292_240.png 1,Reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease with degarelix compared to LHRH agonists,ecancer.org,,,Article,,,,,http://ecancer.org/news/5224-reduction-in-cardiac-events-for-prostate-cancer-patients-with-pre-existing-cardiovascular-disease-with-degarelix-compared-to-lhrh-agonists.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2105335,https://api.altmetric.com/v1/donut/2105335_240.png 1,"A D-amino acid containing peptide as a potent, noncovalent inhibitor of ?5?1 integrin in human prostate cancer invasion and lung colonization.",Clinical and Experimental Metastasis,,,Article,2014-01-29,10.1007/s10585-013-9634-1,,,,24464034,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2098334,https://api.altmetric.com/v1/donut/2098334_240.png 1,Prostate cancer: Superior outcomes after a long learning curve with RARP,Nature Reviews Urology,,,Article,2014-02-04,10.1038/nrurol.2014.10,,,,24492435,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/2095363,https://api.altmetric.com/v1/donut/2095363_240.png 1,Prostate cancer: Post-treatment complications of radiotherapy and prostatectomy,Nature Reviews Urology,,,Article,2014-02-04,10.1038/nrurol.2014.18,,,,24492436,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2095361,https://api.altmetric.com/v1/donut/2095361_240.png 1,Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways,Regulatory Peptides,,,Article,2002-01-01,10.1016/s0167-0115(02)00007-1,,,,11891011,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2089467,https://api.altmetric.com/v1/donut/2089467_240.png 1,Racial differences in prostate cancer risk remain among US servicemen with equal access to care.,The Prostate,,,Article,2009-12-25,10.1002/pros.21105,,,,20033887,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/2088724,https://api.altmetric.com/v1/donut/2088724_240.png 1,CAF-secreted Annexin A1 Induces Prostate Cancer Cells to Gain Stem Cell-like Features,Molecular Cancer Research,,,Article,2014-01-24,10.1158/1541-7786.mcr-13-0469,,,,24464914,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/2088447,https://api.altmetric.com/v1/donut/2088447_240.png 1,ASCO GU: Long-term data confirms radiotherapy plus anti-androgen therapy substantially improves 10- and 15-year prostate cancer survival rates,ecancer.org,,,Article,,,,,http://ecancer.org/news/5149-asco-gu--long-term-data-confirms-radiotherapy-plus-anti-androgen-therapy-substantially-improves-10--and-15-year-prostate-cancer-survival-rates.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2084716,https://api.altmetric.com/v1/donut/2084716_240.png 1,The Role of Magnetic Resonance Imaging in Delineating Clinically Significant Prostate Cancer,Urology,,,Article,2014-02-15,10.1016/j.urology.2013.09.045,,,,24468511,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/2076251,https://api.altmetric.com/v1/donut/2076251_240.png 1,Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer,Molecular Cancer,,,Article,2014-01-23,10.1186/1476-4598-8-130,,,,20035634,PMC2807430,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/2068007,https://api.altmetric.com/v1/donut/2068007_240.png 1,Is Intermittent Androgen Deprivation Therapy Beneficial For Advanced Prostate Cancer Patients?,British Journal of Urology,,,Article,2014-04-16,10.1111/bju.12626,,,,24433259,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/2050656,https://api.altmetric.com/v1/donut/2050656_240.png 1,Impact of Dose to the Bladder Trigone on Long-Term Urinary Function After High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-02-01,10.1016/j.ijrobp.2013.10.042,,,,24411606,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2048434,https://api.altmetric.com/v1/donut/2048434_240.png 1,Salvage therapy of small volume prostate cancer nodal failures: A review of the literature.,Critical Reviews in Oncology/Hematology,,,Article,2013-12-11,10.1016/j.critrevonc.2013.11.003,,,,24315428,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/2047198,https://api.altmetric.com/v1/donut/2047198_240.png 1,A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer,Mathematical Biosciences,,,Article,2008-01-01,10.1016/j.mbs.2008.03.001,,,,18420226,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2046307,https://api.altmetric.com/v1/donut/2046307_240.png 1,Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer.,Annals of Oncology,,,Article,2014-01-12,10.1093/annonc/mdt563,,,,24419235,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2046088,https://api.altmetric.com/v1/donut/2046088_240.png 1,Reply to 'Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer' by T. Kawada.,Annals of Oncology,,,Article,2014-01-12,10.1093/annonc/mdt565,,,,24419238,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2045577,https://api.altmetric.com/v1/donut/2045577_240.png 1,Successful Treatment of Radiation-Induced Proctitis Pain by Blockade of the Ganglion Impar in an Elderly Patient with Prostate Cancer: A Case Report.,Pain Medicine,,,Article,2013-03-08,10.1111/pme.12065,,,,23461840,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/2045188,https://api.altmetric.com/v1/donut/2045188_240.png 1," Resveratrol-Loaded Nanoparticles Based on Poly(epsilon-caprolactone) and Poly( , -lactic- -glycolic acid)–Poly(ethylene glycol) Blend for Prostate Cancer Treatment ",Molecular Pharmaceutics,,,Article,2013-09-04,10.1021/mp400342f,,,,23968375,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/2021953,https://api.altmetric.com/v1/donut/2021953_240.png 1,Phytoestrogens selective for the estrogen receptor beta exert anti-androgenic effects in castration resistant prostate cancer.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2014-01-01,10.1016/j.jsbmb.2013.06.009,,,,23872207,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/2016195,https://api.altmetric.com/v1/donut/2016195_240.png 1,Reduced Port Surgery for Prostate Cancer is Feasible: Comparative Study of 2-port Laparoendoscopic and Conventional 5-port Laparoscopic Radical Prostatectomy.,Asian Pacific Journal of Cancer Prevention,,,Article,2013-01-01,,,,,24377523,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2013961,https://api.altmetric.com/v1/donut/2013961_240.png 1,Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients,Prostate Cancer & Prostatic Diseases,,,Article,2013-12-24,10.1038/pcan.2013.56,,,,24366413,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2013663,https://api.altmetric.com/v1/donut/2013663_240.png 1,Prostate cancer: Overexpression of ERG in HGPIN predicts prostate cancer,Nature Reviews Urology,,,Article,2013-12-17,10.1038/nrurol.2013.312,,,,24346013,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/2011573,https://api.altmetric.com/v1/donut/2011573_240.png 1,Molecular signaling pathways mediating Osteoclastogenesis induced by Prostate Cancer Cells,BMC Cancer,,,Article,2013-12-26,10.1186/1471-2407-13-605,,,,24370273,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/2007004,https://api.altmetric.com/v1/donut/2007004_240.png 1,The Prevalence of Persistent Prostate Cancer After Radiotherapy Detected at Radical Cystoprostatectomy for Bladder Cancer,The Journal of Urology,,,Article,2013-12-26,10.1016/j.juro.2013.12.037,,,,24373801,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/2005542,https://api.altmetric.com/v1/donut/2005542_240.png 1,Dietary and Serum Lycopene Levels in Prostate Cancer Patients Undergoing Intensity-Modulated Radiation Therapy,Journal of Medicinal Food,,,Article,2013-12-01,10.1089/jmf.2012.0223,,,,24180552,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/2000691,https://api.altmetric.com/v1/donut/2000691_240.png 1,Maximizing survival in metastatic castration-resistant prostate cancer: discussion and take home messages. Maximizing survival in metastatic castration-resistant prostate cancer: discussion and take home messages,ecancer.org,,,Article,,,,,http://ecancer.org/video/2608/maximizing-survival-in-metastatic-castration-resistant-prostate-cancer--discussion-and-take-home-messages.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1998040,https://api.altmetric.com/v1/donut/1998040_240.png 1,Maximizing survival in metastatic castration-resistantprostate cancer: Introduction. Maximizing survival in metastaticcastration-resistant prostate cancer: Introduction. ecancer.tv -Essential viewing for oncologists,ecancer.org,,,Article,,,,,http://ecancer.org/video/2613/maximizing-survival-in-metastatic-castration-resistant-prostate-cancer--introduction.php,,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1996371,https://api.altmetric.com/v1/donut/1996371_240.png 1,Imaging Axl Expression in Pancreatic and Prostate Cancer Xenografts.,Biochemical & Biophysical Research Communications,,,Article,2013-12-10,10.1016/j.bbrc.2013.12.014,,,,24333418,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1991023,https://api.altmetric.com/v1/donut/1991023_240.png 1,"Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: A review of the literature",European Journal of Oncology Nursing,,,Article,2013-01-01,10.1016/j.ejon.2013.04.002,,,,23732014,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1986548,https://api.altmetric.com/v1/donut/1986548_240.png 1,Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design,ImmunoTargets and Therapy,,,Article,2013-12-01,10.2147/itt.s30821,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1984878,https://api.altmetric.com/v1/donut/1984878_240.png 1,Dutasteride and Prostate Cancer,New England Journal of Medicine,,,Article,2010-08-19,10.1056/nejmc1005498,,,,20718671,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1979391,https://api.altmetric.com/v1/donut/1979391_240.png 1,Group Exercise versus Personal Training for Prostate Cancer Patients: A Pilot Randomized Trial,Journal of Cancer Therapy,,,Article,2012-01-01,10.4236/jct.2012.32020,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1978920,https://api.altmetric.com/v1/donut/1978920_240.png 1,Comparison of Different Fractionation Schedules Toward a Single Fraction in High-Dose-Rate Brachytherapy as Monotherapy for Low-Risk Prostate Cancer Using 3-Dimensional Radiobiological Models,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-01-01,10.1016/j.ijrobp.2013.10.016,,,http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-100096,24331667,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1977809,https://api.altmetric.com/v1/donut/1977809_240.png 1,Tumor target volume for focal therapy of prostate cancer: Does multiparametric MRI allow for a reliable estimation?,The Journal of Urology,,,Article,2013-12-12,10.1016/j.juro.2013.12.006,,,,24333516,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1975298,https://api.altmetric.com/v1/donut/1975298_240.png 1,Urinary PCA3 as a predictor for prostate cancer in a cohort of 3073 men undergoing initial prostate biopsy,The Journal of Urology,,,Article,2013-12-12,10.1016/j.juro.2013.12.005,,,,24333241,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1975288,https://api.altmetric.com/v1/donut/1975288_240.png 1,Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.09.012,,,,24183863,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1975246,https://api.altmetric.com/v1/donut/1975246_240.png 1,Inter-observer agreement of charlson scale and CIRS-G in a sample of elder patients with prostate cancer,Journal of Geriatric Oncology,,,Article,,10.1016/j.jgo.2013.09.102,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1974796,https://api.altmetric.com/v1/donut/1974796_240.png 1,Advances in Robotic-Assisted Radical Prostatectomy over Time.,Prostate Cancer,,,Article,2013-01-01,10.1155/2013/902686,,,,24327925,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1974712,https://api.altmetric.com/v1/donut/1974712_240.png 1,Inflammation in prostate biopsies may indicate reduced prostate cancer risk,ecancer.org,,,Article,,,,,http://ecancer.org/news/4923-inflammation-in-prostate-biopsies-may-indicate-reduced-prostate-cancer-risk.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1968136,https://api.altmetric.com/v1/donut/1968136_240.png 1,Prostate cancer in deceased organ donors: A review,Transplantation Reviews,,,Article,2014-01-01,10.1016/j.trre.2013.10.003,,,,24321301,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1967049,https://api.altmetric.com/v1/donut/1967049_240.png 1,Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: Early late toxicity and 3-year clinical outcome,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.08.006,,,,24016677,,1854/LU-4298250,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1964024,https://api.altmetric.com/v1/donut/1964024_240.png 1,FDA approves new drug for advanced prostate cancer,ecancer,,,Article,,,,,http://ecancer.org/news/4879-fda-approves-new-drug-for-advanced-prostate-cancer.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1962274,https://api.altmetric.com/v1/donut/1962274_240.png 1,Value of Transition Zone Biopsy in Active Surveillance of Prostate Cancer,The Journal of Urology,,,Article,2013-12-06,10.1016/j.juro.2013.11.058,,,,24316092,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1961075,https://api.altmetric.com/v1/donut/1961075_240.png 1,Systems Modeling of Anti-apoptotic Pathways in Prostate Cancer: Psychological Stress Triggers a Synergism Pattern Switch in Drug Combination Therapy,PLoS Computational Biology,,,Article,2013-12-05,10.1371/journal.pcbi.1003358,,,,24339759,PMC3854132,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1959437,https://api.altmetric.com/v1/donut/1959437_240.png 1,Chromosome inversions in lymphocytes of prostate cancer patients treated with X-rays and carbon ions,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.09.021,,,,24183064,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1957964,https://api.altmetric.com/v1/donut/1957964_240.png 1,Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: Implications for focal salvage brachytherapy,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.10.028,,,,24231238,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1957963,https://api.altmetric.com/v1/donut/1957963_240.png 1,Prostate cancer progression attributed to autonomic nerve development: Potential for therapeutic prevention of localized and metastatic disease,Cancer Biology and Therapy,,,Article,2013-11-01,10.4161/cbt.26339,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1956219,https://api.altmetric.com/v1/donut/1956219_240.png 1,Risk factors for prostate cancer in Universiti Kebangsaan Malaysia Medical Centre: a case-control study.,Asian Pacific Journal of Cancer Prevention,,,Article,2009-01-01,,,,,20192575,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1955249,https://api.altmetric.com/v1/donut/1955249_240.png 1,"Re: Aflibercept versus Placebo in Combination with Docetaxel and Prednisone for Treatment of Men with Metastatic Castration-Resistant Prostate Cancer (VENICE): A Phase 3, Double-Blind Randomised Trial",The Journal of Urology,,,Article,2013-12-04,10.1016/j.juro.2013.11.086,,,,24522032,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1954928,https://api.altmetric.com/v1/donut/1954928_240.png 1,Anterior tumors of the prostate: clinicopathological features and outcomes,Prostate Cancer & Prostatic Diseases,,,Article,2013-12-03,10.1038/pcan.2013.54,,,,24296774,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1952538,https://api.altmetric.com/v1/donut/1952538_240.png 1,Emerging drugs for prostate cancer.,Expert Opinion on Emerging Drugs,,,Article,2013-12-01,10.1517/14728214.2013.864635,,,,24274615,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1940966,https://api.altmetric.com/v1/donut/1940966_240.png 1,A brief couples' workshop for improving sexual experiences after prostate cancer treatment: a feasibility study,Supportive Care in Cancer,,,Article,2013-08-10,10.1007/s00520-013-1922-4,,,,23934226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1937956,https://api.altmetric.com/v1/donut/1937956_240.png 1,Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer,Human Pathology,,,Article,2013-01-01,10.1016/j.humpath.2013.07.019,,,,24074533,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1929022,https://api.altmetric.com/v1/donut/1929022_240.png 1,Targeted Biocompatible Nanoparticles for the Delivery of (?)-Epigallocatechin 3-Gallate to Prostate Cancer Cells,Journal of Medicinal Chemistry,,,Article,2011-03-10,10.1021/jm1013715,,,,21306166,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/1920081,https://api.altmetric.com/v1/donut/1920081_240.png 1,The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1,PLoS ONE,,,Article,2013-11-19,10.1371/journal.pone.0080807,,,,24260486,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1918783,https://api.altmetric.com/v1/donut/1918783_240.png 1,Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges.,PharmacoEconomics,,,Article,2013-04-01,10.1007/s40273-013-0037-6,,,,23519744,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1916867,https://api.altmetric.com/v1/donut/1916867_240.png 1,Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death,International Journal of Nanomedicine,,,Article,2013-08-01,10.2147/ijn.s40766,,,,23990723,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1914206,https://api.altmetric.com/v1/donut/1914206_240.png 1,Salvage CT-guided transgluteal cryoablation for locally recurrent prostate cancer: initial experiences.,Journal of Vascular and Interventional Radiology,,,Article,2013-05-01,10.1016/j.jvir.2013.01.493,,,,23622040,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1909383,https://api.altmetric.com/v1/donut/1909383_240.png 1,Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.,British Journal of Urology,,,Article,2013-08-01,10.1111/j.1464-410x.2012.11506.x,,,,23186331,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1905233,https://api.altmetric.com/v1/donut/1905233_240.png 1,Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Prostate Cancer - EORTC QLQ-PR25.,Oncology (08909091),,,Article,2013-11-06,10.1159/000355689,,,,24217330,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1903732,https://api.altmetric.com/v1/donut/1903732_240.png 1,Prospective Multicenter Study of Bone Scintigraphy in Consecutive Patients With Newly Diagnosed Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2013-11-07,10.1097/rlu.0000000000000291,,,,24217537,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1902700,https://api.altmetric.com/v1/donut/1902700_240.png 1,Ethanolic Extract of Polish Propolis: Chemical Composition and TRAIL-R2 Death Receptor Targeting Apoptotic Activity against Prostate Cancer Cells,Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2013-01-01,10.1155/2013/757628,,,,24324518,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1900216,https://api.altmetric.com/v1/donut/1900216_240.png 1,Treatment patterns and characteristics of European patients with castration-resistant prostate cancer,BMC Urology,,,Article,2013-11-09,10.1186/1471-2490-13-58,,,,24206580,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1894596,https://api.altmetric.com/v1/donut/1894596_240.png 1,"Prostate Cancer: Current Status, New Developments and Applications in Radiotherapy",Clinical Oncology,,,Article,2013-01-01,10.1016/j.clon.2013.05.004,,,,23756325,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1888698,https://api.altmetric.com/v1/donut/1888698_240.png 1,Golden age of prostate cancer drug discovery and development as NICE draft guidance recommends new prostate cancer drug,ecancer.org,,,Article,,,,,http://ecancer.org/news/4638-golden-age-of-prostate-cancer-drug-discovery-and-development-as-nice-draft-guidance-recommends-new-prostate-cancer-drug.php,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1884230,https://api.altmetric.com/v1/donut/1884230_240.png 1,Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients,BMC Genomics,,,Article,2013-11-05,10.1186/1471-2164-14-757,,,,24191917,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1883840,https://api.altmetric.com/v1/donut/1883840_240.png 1,Chemoprevention of prostate cancer by major dietary phytochemicals.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2013-10-01,,,,,24122979,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1881455,https://api.altmetric.com/v1/donut/1881455_240.png 1,Acquisition of epithelial|[ndash]|mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K|[sol]|Akt|[sol]|mTOR pathway in prostate cancer radioresistance,Cell Death & Disease,,,Article,2013-10-01,10.1038/cddis.2013.407,,,,24157869,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/1879871,https://api.altmetric.com/v1/donut/1879871_240.png 1,MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases,PLoS ONE,,,Article,2013-11-01,10.1371/journal.pone.0078023,,,,24223753,PMC3815229,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1878607,https://api.altmetric.com/v1/donut/1878607_240.png 1,Chemotherapeutic inhibitors in the treatment of prostate cancer,Expert Opinion on Pharmacotherapy,,,Article,2013-10-25,10.1517/14656566.2014.852184,,,,24156780,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1872762,https://api.altmetric.com/v1/donut/1872762_240.png 1,Prostate Cancer Risk Profiles in Asian Americans: Disentangling the Effects of Immigration Status and Race/Ethnicity,The Journal of Urology,,,Article,2013-10-28,10.1016/j.juro.2013.10.075,,,,24513166,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1864439,https://api.altmetric.com/v1/donut/1864439_240.png 1,A reciprocal role of prostate cancer on stromal DNA damage,Oncogene,,,Article,2013-10-21,10.1038/onc.2013.431,,,,24141771,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1861525,https://api.altmetric.com/v1/donut/1861525_240.png 1,Diffuse osteosclerosis in a patient with prostate cancer,Osteoporosis International,,,Article,2013-10-18,10.1007/s00198-013-2545-9,,,,24136106,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1855399,https://api.altmetric.com/v1/donut/1855399_240.png 1,Adaptive radiotherapy in locally advanced prostate cancer using a statistical deformable motion model,Acta Oncologica,,,Article,2013-10-01,10.3109/0284186x.2013.818249,,,,23964658,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1852442,https://api.altmetric.com/v1/donut/1852442_240.png 1,Is amisulpride safe when prescribed to breast and prostate cancer patients?,Medical Hypotheses,,,Article,2013-09-18,10.1016/j.mehy.2013.08.031,,,,24134827,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1845320,https://api.altmetric.com/v1/donut/1845320_240.png 1,Combined Treatment Effects of Radiation and Immunotherapy: Studies in an Autochthonous Prostate Cancer Model,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.07.015,,,,24064321,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1844815,https://api.altmetric.com/v1/donut/1844815_240.png 1,A right atrial mass in a patient with metastatic melanoma and prostate cancer.,Journal of Cardiothoracic and Vascular Anesthesia,,,Article,2013-08-01,10.1053/j.jvca.2012.04.001,,,,22592136,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1843301,https://api.altmetric.com/v1/donut/1843301_240.png 1,Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer.,Journal of Magnetic Resonance Imaging,,,Article,2013-04-01,10.1002/jmri.23885,,,,23097411,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1839128,https://api.altmetric.com/v1/donut/1839128_240.png 1,A Prospective Pilot Study of 89Zr-J591/PSMA Positron Emission Tomography (PET) in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy,The Journal of Urology,,,Article,2013-10-16,10.1016/j.juro.2013.10.041,,,,24135437,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1830516,https://api.altmetric.com/v1/donut/1830516_240.png 1,Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?,International Journal of Obesity,,,Article,2009-08-01,10.1586/14737140.2013.836303,,,,24124755,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1828757,https://api.altmetric.com/v1/donut/1828757_240.png 1,Quality of life among prostate cancer patients: A prospective longitudinal population-based study,Radiotherapy & Oncology,,,Article,2013-01-01,10.1016/j.radonc.2013.06.039,,,,23932157,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1821593,https://api.altmetric.com/v1/donut/1821593_240.png 1,IGF-IR Promotes Prostate Cancer Growth by Stabilizing ?5?1 Integrin Protein Levels,PLoS ONE,,,Article,2013-10-09,10.1371/journal.pone.0076513,,,,24130778,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1815733,https://api.altmetric.com/v1/donut/1815733_240.png 1,Re: CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer,The Journal of Urology,,,Article,2013-10-08,10.1016/j.juro.2013.10.007,,,,24331512,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1811616,https://api.altmetric.com/v1/donut/1811616_240.png 1,Factors Associated With Improved Outcomes Following Decompressive Surgery for Prostate Cancer Metastatic to the Spine,Neurosurgery,,,Article,2013-10-01,10.1227/neu.0000000000000070,,,,23839521,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1810685,https://api.altmetric.com/v1/donut/1810685_240.png 1,Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer,Urologic Oncology,,,Article,2013-06-19,10.1016/j.urolonc.2013.04.002,,,,23787297,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1808288,https://api.altmetric.com/v1/donut/1808288_240.png 1,Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations.,Seminars in Urologic Oncology,,,Article,2000-05-01,,,,,10875454,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1805280,https://api.altmetric.com/v1/donut/1805280_240.png 1,"Ellagic acid, pomegranate and prostate cancer -- a mini review.",Journal of Pharmacy & Pharmacology,,,Article,2008-02-01,10.1211/jpp.60.2.0001,,,,18237460,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1802535,https://api.altmetric.com/v1/donut/1802535_240.png 1,'Call to Action’ for improving high quality care in prostate cancer for all men in Europe,ecancer.org,,,Article,,,,,http://ecancer.org/news/4528-call-to-action----for-improving-high-quality-care-in-prostate-cancer-for-all-men-in-europe.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1799917,https://api.altmetric.com/v1/donut/1799917_240.png 1,Prostate cancer in a transgender woman 41 years after initiation of feminization.,JAMA: Journal of the American Medical Association,,,Article,2006-11-15,10.1001/jama.296.19.2316,,,,17105793,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1798326,https://api.altmetric.com/v1/donut/1798326_240.png 1,Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.,Radiotherapy & Oncology,,,Article,2013-02-01,10.1016/j.radonc.2012.11.009,,,,23333011,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1794535,https://api.altmetric.com/v1/donut/1794535_240.png 1,Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer,Scientific Reports,,,Article,2013-09-30,10.1038/srep02792,,,,24077328,PMC3786294,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1791619,https://api.altmetric.com/v1/donut/1791619_240.png 1,High-Risk Prostate Cancer in the Modern Era: Does a Single Standard of Care Exist?,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.06.006,,,,24074916,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1788730,https://api.altmetric.com/v1/donut/1788730_240.png 1,The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NF?B through the RAGE Receptor,Genes & Cancer,,,Article,2013-05-01,10.1177/1947601913492420,,,,24069509,PMC3782007,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1787476,https://api.altmetric.com/v1/donut/1787476_240.png 1,ASTRO 2013: Long-term hormonal therapy in intermediate-risk prostate cancer patients does not improve overall survival,ecancer.org,,,Article,,,,,http://ecancer.org/news/4497-astro-2013--long-term-hormonal-therapy-in-intermediate-risk-prostate-cancer-patients-does-not-improve-overall-survival.php,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1786706,https://api.altmetric.com/v1/donut/1786706_240.png 1,"If Less Is More, Which Outcomes Should Be Presented in Facilitating Prostate Cancer Screening Decision Making?—Reply",JAMA Internal Medicine,,,Article,,10.1001/jamainternmed.2013.8132,,,,24061393,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1781626,https://api.altmetric.com/v1/donut/1781626_240.png 1,Electrical property sensing biopsy needle for prostate cancer detection,The Prostate,,,Article,2013-01-01,10.1002/pros.22695,,,,23996675,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1777871,https://api.altmetric.com/v1/donut/1777871_240.png 1,Late Side Effects in Men With Intermediate- and High-Risk Prostate Cancer Treated With High-Dose Radiation Therapy and Androgen Deprivation (DART 01/05): Secondary Endpoints From a Phase 3 Clinical Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-10-01,10.1016/j.ijrobp.2013.06.272,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1774709,https://api.altmetric.com/v1/donut/1774709_240.png 1,Aspirin Linked to Reduced Mortality in Prostate Cancer,Journal Watch,,,Article,2012-01-01,10.1056/fw201208290000002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1769248,https://api.altmetric.com/v1/donut/1769248_240.png 1,"FDA Approves Drugs for Prostate Cancer, Constipation, and Neutropenia",Journal Watch,,,Article,2012-01-01,10.1056/fw201209040000007,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1769238,https://api.altmetric.com/v1/donut/1769238_240.png 1,Stomach Metastasis in a Patient with Prostate Cancer 4 Years after the Initial Diagnosis: A Case Report and a Literature Review,Case Reports in Oncological Medicine,,,Article,,10.1155/2012/292140,,,,23243531,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1768855,https://api.altmetric.com/v1/donut/1768855_240.png 1,Treatment Mode Has Little Effect on Long-Term Function in Prostate Cancer,Journal Watch,,,Article,2013-01-31,10.1056/fw201301310000002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1768613,https://api.altmetric.com/v1/donut/1768613_240.png 1,Smarter PSA Screening for Prostate Cancer,Journal Watch,,,Article,2013-02-05,10.1056/fw201302050000002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1768595,https://api.altmetric.com/v1/donut/1768595_240.png 1,Shorter Course of Prostate Cancer Therapy May Be as Effective as Standard Length,Journal Watch,,,Article,2013-02-14,10.1056/fw201302140000001,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1768551,https://api.altmetric.com/v1/donut/1768551_240.png 1,"New, Albeit Expensive, Prostate Cancer Tests Might Reduce Unnecessary Treatments",Journal Watch,,,Article,2013-03-28,10.1056/fw201303280000005,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1768228,https://api.altmetric.com/v1/donut/1768228_240.png 1,Intermittent Androgen Deprivation Offers No Improvement for Prostate Cancer,Journal Watch,,,Article,2013-04-04,10.1056/fw201304040000003,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1768173,https://api.altmetric.com/v1/donut/1768173_240.png 1,Exposure to Agent Orange Associated with Increased Risk for High-Grade Prostate Cancers,Journal Watch,,,Article,2013-05-14,10.1056/fw201305140000002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1762385,https://api.altmetric.com/v1/donut/1762385_240.png 1,"Treatment of New Prostate Cancers Unlikely to Benefit Older, Sicker Men",NEJM Journal Watch,,,Article,,10.1056/fw201305210000004,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1762320,https://api.altmetric.com/v1/donut/1762320_240.png 1,Drug Approved for Metastatic Prostate Cancer,Journal Watch,,,Article,2013-05-16,10.1056/fw201305160000005,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1762304,https://api.altmetric.com/v1/donut/1762304_240.png 1,A New Achilles Heel for Prostate Cancer,Science Translational Medicine,,,Article,2013-09-18,10.1126/scitranslmed.3007556,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1759244,https://api.altmetric.com/v1/donut/1759244_240.png 1,Translational Molecular Imaging of Prostate Cancer,Current Radiology Reports,,,Article,2013-07-17,10.1007/s40134-013-0020-1,,,,24159427,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1758834,https://api.altmetric.com/v1/donut/1758834_240.png 1,Estimating Rates of Metastatic Prostate Cancer in the Absence of PSA Screening,Journal Watch,,,Article,2012-01-01,10.1056/fw201207310000004,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1758487,https://api.altmetric.com/v1/donut/1758487_240.png 1,Optimal bone health management strategies in patients with prostate cancer,Indian Journal of Urology,,,Article,1970-01-01,10.4103/0970-1591.114024,,,,23956508,PMC3737681,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1750801,https://api.altmetric.com/v1/donut/1750801_240.png 1,TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.,British Journal of Urology,,,Article,2013-10-01,10.1111/bju.12265,,,,24028764,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/1749870,https://api.altmetric.com/v1/donut/1749870_240.png 1,The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrateâ??resistant prostate cancer,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28285,,,,23913744,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1748650,https://api.altmetric.com/v1/donut/1748650_240.png 1,Metastatic Prostate Cancer Proven by 18F-FCH PET/CT Staging Scan in Patient With Normal PSA but High PSA Doubling Time,Clinical Nuclear Medicine,,,Article,2013-09-01,10.1097/rlu.0b013e31829b9d6b,,,,23816948,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1735716,https://api.altmetric.com/v1/donut/1735716_240.png 1,Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase Inhibitors,ACS Chemical Biology,,,Article,2013-09-04,10.1021/cb400542w,,,,24004176,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1730590,https://api.altmetric.com/v1/donut/1730590_240.png 1,Intratumoral conversion of adrenal androgen precursors drives androgen receptorâ??activated cell growth in prostate cancer more potently than de novo steroidogenesis,The Prostate,,,Article,2013-01-01,10.1002/pros.22655,,,,23996639,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1726325,https://api.altmetric.com/v1/donut/1726325_240.png 1,Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140917958,,,,24005860,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1726154,https://api.altmetric.com/v1/donut/1726154_240.png 1,Re: Transition Zone Prostate Cancer: Detection and Localization with 3-T Multiparametric MR Imaging,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2013.05.046,,,,23931195,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1720770,https://api.altmetric.com/v1/donut/1720770_240.png 1,Higher ?-3 Fatty Acid Levels Are Associated with Risk for Prostate Cancer,Journal Watch,,,Article,2013-08-08,10.1056/nejm-jw.na31812,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1716111,https://api.altmetric.com/v1/donut/1716111_240.png 1,A Personalized Automated Messaging System to Improve Adherence to Prostate Cancer Screening: Research Protocol,JMIR Research Protocols,,,Article,2012-01-01,10.2196/resprot.2398,,,,23612443,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1716029,https://api.altmetric.com/v1/donut/1716029_240.png 1,Conformal radiation therapy in prostate cancer - a review.,gulf journal of oncology,,,Article,2010-03-03,,,,,20194087,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1715465,https://api.altmetric.com/v1/donut/1715465_240.png 1,Re: Does Benign Prostatic Hyperplasia Treatment with Alpha-Blockers Affect Prostate Cancer Risk?,The Journal of Urology,,,Article,2013-08-27,10.1016/j.juro.2013.08.042,,,,24209525,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1713509,https://api.altmetric.com/v1/donut/1713509_240.png 1,Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer,Advances in Therapy,,,Article,2013-08-27,10.1007/s12325-013-0050-3,,,,23979793,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1713008,https://api.altmetric.com/v1/donut/1713008_240.png 1,The Influence of Prostate Volume on Outcome After High-Dose-Rate Brachytherapy Alone for Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.05.022,,,,23849693,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1706229,https://api.altmetric.com/v1/donut/1706229_240.png 1,Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR,PLoS ONE,,,Article,2013-08-01,10.1371/journal.pone.0070372,,,,23936419,PMC3731248,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1690898,https://api.altmetric.com/v1/donut/1690898_240.png 1,"Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5â??reductase inhibitors",The Prostate,,,Article,2013-01-01,10.1002/pros.22694,,,,23813697,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1690494,https://api.altmetric.com/v1/donut/1690494_240.png 1,Integrative analysis of prostate cancer aggressiveness,The Prostate,,,Article,2013-01-01,10.1002/pros.22688,,,,23813660,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1690483,https://api.altmetric.com/v1/donut/1690483_240.png 1,[Use of hydrogel as spacer in Denovier's space : Optimization of IMRT radiotherapy of localized prostate cancer.],Der Urologe A,,,Article,2013-08-14,10.1007/s00120-013-3290-6,,,,23942724,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1690326,https://api.altmetric.com/v1/donut/1690326_240.png 1,Transcriptional regulation of CXCR4 in prostate tumor cells: Significance of TMPRSS2-ERG fusions,Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-12-0705,,,,23918819,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1686300,https://api.altmetric.com/v1/donut/1686300_240.png 1,Thiosulfate in urine: new hope or new failure of a biomarker for prostate cancer?,Clinical Chemistry & Laboratory Medicine,,,Article,2013-08-10,10.1515/cclm-2013-0540,,,,23934642,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1685520,https://api.altmetric.com/v1/donut/1685520_240.png 1,Potential use of custirsen to treat prostate cancer,OncoTargets and therapy,,,Article,2013-07-11,10.2147/ott.s33077,,,,23836992,PMC3699352,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1682360,https://api.altmetric.com/v1/donut/1682360_240.png 1,Prostate Gland Lengths and Iceball Dimensions Predict Micturition Functional Outcome Following Salvage Prostate Cryotherapy in Men with Radiation Recurrent Prostate Cancer,PLoS ONE,,,Article,2013-08-09,10.1371/journal.pone.0069243,,,,23950886,PMC3739755,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1679437,https://api.altmetric.com/v1/donut/1679437_240.png 1,A Multi-institutional Clinical Trial of Rectal Dose Reduction via Injected Polyethylene-Glycol Hydrogel During Intensity Modulated Radiation Therapy for Prostate Cancer: Analysis of Dosimetric Outcomes,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.12.019,,,,23414766,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/1679246,https://api.altmetric.com/v1/donut/1679246_240.png 1,The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer,Cancers,,,Article,2013-01-01,10.3390/cancers5030998,,,,24202331,PMC3795376,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1678826,https://api.altmetric.com/v1/donut/1678826_240.png 1,A Knowledge-Based Approach to Improving and Homogenizing Intensity Modulated Radiation Therapy Planning Quality Among Treatment Centers: An Example Application to Prostate Cancer Planning,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.03.015,,,,23623460,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1678203,https://api.altmetric.com/v1/donut/1678203_240.png 1,Phase 1 Trial of Neoadjuvant Radiation Therapy Before Prostatectomy for High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.05.014,,,,23790772,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1676431,https://api.altmetric.com/v1/donut/1676431_240.png 1,TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-13-1049,,,,23918607,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1672237,https://api.altmetric.com/v1/donut/1672237_240.png 1,Magnetic Resonance Imaging-guided Cryoablation of Recurrent Prostate Cancer After Radical Prostatectomy: Initial Single Institution Experience.,Urology,,,Article,2013-08-01,10.1016/j.urology.2013.06.011,,,,23910089,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1671878,https://api.altmetric.com/v1/donut/1671878_240.png 1,Causes of Mortality After Dose-Escalated Radiation Therapy and Androgen Deprivation for High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.05.044,,,,23920389,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1671475,https://api.altmetric.com/v1/donut/1671475_240.png 1,Mechanisms of resveratrol-induced changes in [Ca2+]i and cell viability in PC3 human prostate cancer cells.,Journal of Receptor & Signal Transduction Research,,,Article,2013-07-30,10.3109/10799893.2013.822886,,,,23898810,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1660019,https://api.altmetric.com/v1/donut/1660019_240.png 1,Urological cancer: Nerves linked to prostate cancer,Nature Reviews Clinical Oncology,,,Article,2013-07-30,10.1038/nrclinonc.2013.139,,,,23897079,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1658245,https://api.altmetric.com/v1/donut/1658245_240.png 1,Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.,Food Chemistry,,,Article,2013-07-24,10.1016/j.foodchem.2013.04.109,,,,23870911,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1652008,https://api.altmetric.com/v1/donut/1652008_240.png 1,"Prostate biopsy: what to expect. Here are the benefits, risks, and uncertainties of the only diagnostic procedure that can tell you whether you have prostate cancer.",Harvard Men's Health Watch,,,Article,2013-07-05,,,,,23819189,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1651025,https://api.altmetric.com/v1/donut/1651025_240.png 1,Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up,British Journal of Cancer,,,Article,2013-07-23,10.1038/bjc.2013.394,,,,23880826,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1648871,https://api.altmetric.com/v1/donut/1648871_240.png 1,Testosterone boosts for treatment of castration resistant prostate cancer: An experimental implementation of intermittent androgen deprivation,The Prostate,,,Article,2013-01-01,10.1002/pros.22711,,,,23868789,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1648549,https://api.altmetric.com/v1/donut/1648549_240.png 1,Prostate cancer risk in testosterone-treated men.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2006-12-01,10.1016/j.jsbmb.2006.09.032,,,,17113983,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1647764,https://api.altmetric.com/v1/donut/1647764_240.png 1,Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer,British Journal of Cancer,,,Article,2013-07-23,10.1038/bjc.2013.399,,,,23880823,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1645457,https://api.altmetric.com/v1/donut/1645457_240.png 1,Differential Expression of Thrombospondin (THBS1) in Tumorigenic and Non-Tumorigenic Prostate Epithelial Cells in Response to a Chromatin-Binding Soy Peptide,Nutrition and Cancer,,,Article,2011-05-01,10.1080/01635581.2011.539312,,,,21526452,PMC3210036,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1642547,https://api.altmetric.com/v1/donut/1642547_240.png 1,"4FISH-IF, a Four-Color Dual-Gene FISH Combined with p63 Immunofluorescence to Evaluate NKX3.1 and MYC Status in Prostate Cancer",Journal of Histochemistry and Cytochemistry,,,Article,2013-01-01,10.1369/0022155413490946,,,,23640976,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1640079,https://api.altmetric.com/v1/donut/1640079_240.png 1,Lycopene and prostate cancer,"",,,Article,2002-03-06,10.1038/sj/pcan/4500560,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1635230,https://api.altmetric.com/v1/donut/1635230_240.png 1,Featured in NEJM Journal Watch: Radium-223 Improves Survival in Advanced Prostate Cancer,Journal Watch,,,Article,2013-07-18,10.1056/nejm-jw.fw107710,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1632118,https://api.altmetric.com/v1/donut/1632118_240.png 1,Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.,Journal of Applied Clinical Medical Physics,,,Article,2013-07-11,,,,,23835376,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1624443,https://api.altmetric.com/v1/donut/1624443_240.png 1,A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.04.014,,,,23726001,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1623386,https://api.altmetric.com/v1/donut/1623386_240.png 1,Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL.,Clinical Chemistry & Laboratory Medicine,,,Article,2013-07-06,10.1515/cclm-2013-0069,,,,23843582,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1620655,https://api.altmetric.com/v1/donut/1620655_240.png 1,5 Tips for Women on How to Encourage Men to be Healthier |Women Against Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/2013/06/5-tips-for-women-on-how-to-encourage-men-to-be-healthier/,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1620364,https://api.altmetric.com/v1/donut/1620364_240.png 1,Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract.,Planta Medica,,,Article,2000-02-01,10.1055/s-2000-11117,,,,10705733,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1619448,https://api.altmetric.com/v1/donut/1619448_240.png 1,Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,1996-01-01,,,,,8850272,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1618453,https://api.altmetric.com/v1/donut/1618453_240.png 1,Is Prostate-Specific Antigen Effective for Population Screening of Prostate Cancer? A Systematic Review,Annals of Laboratory Medicine,,,Article,2013-07-01,10.3343/alm.2013.33.4.233,,,,23826558,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1617680,https://api.altmetric.com/v1/donut/1617680_240.png 1,Predictive Factors and Management of Rectal Bleeding Side Effects Following Prostate Cancer Brachytherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.04.033,,,,23845840,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1617561,https://api.altmetric.com/v1/donut/1617561_240.png 1,Smoking and prostate cancer in a multiâ??ethnic cohort,The Prostate,,,Article,2013-01-01,10.1002/pros.22699,,,,23824512,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1617455,https://api.altmetric.com/v1/donut/1617455_240.png 1,"Efficacy, Patient-Reported Outcomes (PROs), and Tolerability of the Changing Therapeutic Landscape in Patients with Metastatic Prostate Cancer (MPC): A Systematic Literature Review",Value in Health (Elsevier Science),,,Article,2013-07-01,10.1016/j.jval.2013.03.1628,,,,23947983,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1614539,https://api.altmetric.com/v1/donut/1614539_240.png 1,"Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells",Oncology Letters,,,Article,2011-03-01,10.3892/ol.2011.237,,,,21415930,PMC3057076,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1602572,https://api.altmetric.com/v1/donut/1602572_240.png 1,Epithelial Cell Adhesion Molecule-positive Circulating Tumor Cells as Predictive Biomarker in Patients With Prostate Cancer,Urology,,,Article,2013-01-01,10.1016/j.urology.2012.10.041,,,,23622774,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1599823,https://api.altmetric.com/v1/donut/1599823_240.png 1,Tumour angiogenesis: an elusive target in castration-resistant prostate cancer,Lancet Oncology,,,Article,2013-07-01,10.1016/s1470-2045(13)70239-0,,,,23742876,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1599342,https://api.altmetric.com/v1/donut/1599342_240.png 1,Urological cancer: Poorer prostate cancer outcomes in African American men,Nature Reviews Clinical Oncology,,,Article,2013-07-02,10.1038/nrclinonc.2013.114,,,,23820638,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1598758,https://api.altmetric.com/v1/donut/1598758_240.png 1,"Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial",Carcinogenesis,,,Article,2013-01-01,10.1093/carcin/bgt176,,,,23698636,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1597907,https://api.altmetric.com/v1/donut/1597907_240.png 1,The association between Câ??reactive protein (CRP) level and biochemical failureâ??free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate,Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28185,,,,23818401,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1597032,https://api.altmetric.com/v1/donut/1597032_240.png 1,Contrast-Ultrasound Dispersion Imaging for Prostate Cancer Localization by Improved Spatiotemporal Similarity Analysis,Ultrasound in Medicine & Biology,,,Article,2013-06-26,10.1016/j.ultrasmedbio.2013.03.004,,,,23791350,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1595784,https://api.altmetric.com/v1/donut/1595784_240.png 1,Folate and B12 in prostate cancer.,Advances in clinical chemistry,,,Article,2013-06-05,,,,,23724740,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1595575,https://api.altmetric.com/v1/donut/1595575_240.png 1,"Synthesis, Spectroscopic Characterization and Anti-cancer Properties of New Gold(III)-alkanediamine Complexes against Gastric, Prostate and Ovarian Cancer Cells; Crystal Structure of [Au2(pn)2(Cl)2]Cl2·H2O",Polyhedron,,,Article,2013-06-01,10.1016/j.poly.2013.05.054,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1592607,https://api.altmetric.com/v1/donut/1592607_240.png 1,Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease,PLoS ONE,,,Article,2013-06-24,10.1371/journal.pone.0067514,,,,23826311,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1590984,https://api.altmetric.com/v1/donut/1590984_240.png 1,Radiation Therapy Modalities for Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,,10.1001/jama.2012.8112,,,,22851100,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1588316,https://api.altmetric.com/v1/donut/1588316_240.png 1,Mismatch repair proteins in recurrent prostate cancer.,Advances in clinical chemistry,,,Article,2013-06-05,,,,,23724741,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1587222,https://api.altmetric.com/v1/donut/1587222_240.png 1,Image-guided robotic interventions for prostate cancer,Nature Reviews Urology,,,Article,2013-06-18,10.1038/nrurol.2013.129,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1580470,https://api.altmetric.com/v1/donut/1580470_240.png 1,Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumorâ??bearing mice,"Nanomedicine: Nanotechnology, Biology and Medicine",,,Article,2010-01-01,10.1016/j.nano.2009.11.001,,,,19914401,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,88,https://www.altmetric.com/details/1577031,https://api.altmetric.com/v1/donut/1577031_240.png 1,Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target,Cancer Research,,,Article,2009-01-01,10.1158/0008-5472.can-09-2805,,,,19920184,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1575694,https://api.altmetric.com/v1/donut/1575694_240.png 1,Decision Regret in Men Undergoing Dose-Escalated Radiation Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.03.006,,,,23608238,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1571552,https://api.altmetric.com/v1/donut/1571552_240.png 1,Genetics: ZBTB7A suppresses castration-resistant prostate cancer,Nature Reviews Clinical Oncology,,,Article,2013-06-18,10.1038/nrclinonc.2013.107,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1567745,https://api.altmetric.com/v1/donut/1567745_240.png 1,The Present and Future of Prostate Cancer Urine Biomarkers,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140612620,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/1567150,https://api.altmetric.com/v1/donut/1567150_240.png 1,GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update,Radiotherapy & Oncology,,,Article,2013-06-01,10.1016/j.radonc.2013.05.002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/1563957,https://api.altmetric.com/v1/donut/1563957_240.png 1,Transrectal electrical impedance tomography of the prostate: Spatially coregistered pathological findings for prostate cancer detection,Medical Physics,,,Article,2013-01-01,10.1118/1.4803498,,,,23718610,PMC3676380,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1556476,https://api.altmetric.com/v1/donut/1556476_240.png 1,Controversy concerning hormone therapy in patients with prostate cancer,Reports of Practical Oncology & Radiotherapy,,,Article,2013-06-01,10.1016/j.rpor.2013.03.479,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1556385,https://api.altmetric.com/v1/donut/1556385_240.png 1,"Oncotype DX Test for Prostate Cancer Validated, and Now Available",Oncology times,,,Article,2013-06-10,10.1097/01.cot.0000431598.53112.cc,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1553854,https://api.altmetric.com/v1/donut/1553854_240.png 1,RGS17: an emerging therapeutic target for lung and prostate cancers.,Future Medicinal Chemistry,,,Article,2013-06-07,10.4155/fmc.13.91,,,,23734683,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1548775,https://api.altmetric.com/v1/donut/1548775_240.png 1,Re: Retrospective Evaluation Reveals that Long-Term Androgen Deprivation Therapy Improves Cause-Specific and Overall Survival in the Setting of Dose-Escalated Radiation for High-Risk Prostate Cancer,The Journal of Urology,,,Article,2013-06-10,10.1016/j.juro.2013.05.102,,,,23931191,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1547626,https://api.altmetric.com/v1/donut/1547626_240.png 1,Re: Androgen-Deprivation Therapy and Diabetes Control among Diabetic Men with Prostate Cancer,The Journal of Urology,,,Article,2013-06-10,10.1016/j.juro.2013.05.101,,,,23931190,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1547624,https://api.altmetric.com/v1/donut/1547624_240.png 1,Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial.,European Urology,,,Article,2012-06-06,10.1016/j.eururo.2012.05.025,,,,22658758,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1546772,https://api.altmetric.com/v1/donut/1546772_240.png 1,Re: p21-Activated Kinase 6 (PAK6) Inhibits Prostate Cancer Growth via Phosphorylation of Androgen Receptor and Tumorigenic E3 Ligase Murine Double Minute-2 (Mdm2),The Journal of Urology,,,Article,2013-06-06,10.1016/j.juro.2013.05.069,,,,23931236,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1537649,https://api.altmetric.com/v1/donut/1537649_240.png 1,Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms140611981,,,,23739676,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1533594,https://api.altmetric.com/v1/donut/1533594_240.png 1,"TRPV2 Mediates Adrenomedullin Stimulation of Prostate and Urothelial Cancer Cell Adhesion, Migration and Invasion",PLoS ONE,,,Article,2013-05-31,10.1371/journal.pone.0064885,,,,23741410,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1533459,https://api.altmetric.com/v1/donut/1533459_240.png 1,Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome,PLoS ONE,,,Article,2013-05-31,10.1371/journal.pone.0064570,,,,23741342,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1533441,https://api.altmetric.com/v1/donut/1533441_240.png 1,Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP.,Oncology Reports,,,Article,2008-01-12,,,,,19020719,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1529779,https://api.altmetric.com/v1/donut/1529779_240.png 1,Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation,PLoS ONE,,,Article,2013-05-21,10.1371/journal.pone.0063563,,,,23704919,PMC3660401,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/1524798,https://api.altmetric.com/v1/donut/1524798_240.png 1,Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.,British Journal of Urology,,,Article,2013-04-06,10.1111/j.1464-410x.2013.11397_9.x,,,,23551452,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1522751,https://api.altmetric.com/v1/donut/1522751_240.png 1,Re: Robotic Real-Time Near Infrared Targeted Fluorescence Imaging in a Murine Model of Prostate Cancer: A Feasibility Study,The Journal of Urology,,,Article,2013-05-28,10.1016/j.juro.2013.05.044,,,,23931239,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1516031,https://api.altmetric.com/v1/donut/1516031_240.png 1,Two years of testosterone therapy associated with decline in prostate-specific antigen in a man with untreated prostate cancer.,Journal of Sexual Medicine,,,Article,2009-02-14,10.1111/j.1743-6109.2008.01066.x,,,,19215619,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1509582,https://api.altmetric.com/v1/donut/1509582_240.png 1,Patients' Satisfaction with Different Modalities of Prostate Cancer Therapy – A Retrospective Survey among 634 Patients,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2011-01-01,,,,,22110217,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1509526,https://api.altmetric.com/v1/donut/1509526_240.png 1,[Management of prostate cancer in the elderly.],Der Urologe A,,,Article,2013-05-23,10.1007/s00120-013-3152-2,,,,23695158,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1501283,https://api.altmetric.com/v1/donut/1501283_240.png 1,A Combination of Micronutrients Is Beneficial in Reducing the Incidence of Prostate Cancer and Increasing Survival in the Lady Transgenic Model,Cancer Prevention Research,,,Article,2009-01-01,10.1158/1940-6207.capr-08-0124,,,,19401531,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1500499,https://api.altmetric.com/v1/donut/1500499_240.png 1,Differential Effects of Dehydroepiandrosterone and Testosterone in Prostate and Colon Cancer Cell Apoptosis: The Role of Nerve Growth Factor (NGF) Receptors,Endocrinology,,,Article,2013-01-01,10.1210/en.2012-2249,,,,23696568,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1497532,https://api.altmetric.com/v1/donut/1497532_240.png 1,Dendrimer Nanoscaffolds for Potential Theranostics of Prostate Cancer with a Focus on Radiochemistry,Molecular Pharmaceutics,,,Article,2013-01-10,10.1021/mp3005325,,,,23294202,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1494680,https://api.altmetric.com/v1/donut/1494680_240.png 1,"Circadian Disruption, Sleep Loss and Prostate Cancer Risk: A Systematic Review of Epidemiological Studies","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-07-01,10.1158/1055-9965.epi-12-0116,,,,22564869,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1491782,https://api.altmetric.com/v1/donut/1491782_240.png 1,Breast and prostate cancer: more similar than different.,Nature Reviews Cancer,,,Article,2010-02-13,10.1038/nrc2795,,,,20147902,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,150,https://www.altmetric.com/details/1491167,https://api.altmetric.com/v1/donut/1491167_240.png 1,RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro,PLoS ONE,,,Article,2013-05-16,10.1371/journal.pone.0063153,,,,23696795,PMC3656033,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1482871,https://api.altmetric.com/v1/donut/1482871_240.png 1,The evolving biology and treatment of prostate cancer,Journal of Clinical Investigation,,,Article,2007-01-01,10.1172/jci31791,,,,17786228,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1472612,https://api.altmetric.com/v1/donut/1472612_240.png 1,[A case of prostate cancer with disseminated carcinomatosis of bone marrow which responded to Zoledronic acid].,Hinyokika kiyo Acta urologica Japonica,,,Article,2011-01-06,,,,,21795838,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1465449,https://api.altmetric.com/v1/donut/1465449_240.png 1,Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.,The Prostate,,,Article,2008-06-04,10.1002/pros.20801,,,,18512730,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1463998,https://api.altmetric.com/v1/donut/1463998_240.png 1,Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent,Genes & Immunity,,,Article,2013-05-09,10.1038/gene.2013.22,,,,23657238,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1463939,https://api.altmetric.com/v1/donut/1463939_240.png 1,"Interfractional variations in the set-up of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,1970-01-01,10.1016/j.ijrobp.2010.08.006,,,,20947266,PMC3026870,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1463489,https://api.altmetric.com/v1/donut/1463489_240.png 1,Radiotherapy with rectangular fields is associated with fewer clinical failures than conformal fields in the high-risk prostate cancer subgroup: Results from a randomized trial,Radiotherapy & Oncology,,,Article,2013-05-01,10.1016/j.radonc.2013.03.019,,,,23647756,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1460747,https://api.altmetric.com/v1/donut/1460747_240.png 1,Management of high-risk prostate cancer: Radiation therapy and hormonal therapy,Cancer Treatment Reviews,,,Article,2013-05-01,10.1016/j.ctrv.2013.04.003,,,,23648323,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1459560,https://api.altmetric.com/v1/donut/1459560_240.png 1,Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century.,Medical Hypotheses,,,Article,2009-03-25,10.1016/j.mehy.2009.01.025,,,,19307063,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1458509,https://api.altmetric.com/v1/donut/1458509_240.png 1,VEGFR1 and NRP1 Endothelial Expressions Predict Distant Relapse after Radical Prostatectomy in Clinically Localized Prostate Cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2013-05-01,,,,,23645757,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1452321,https://api.altmetric.com/v1/donut/1452321_240.png 1,National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer,Annals of Internal Medicine,,,Article,2012-01-01,10.7326/0003-4819-156-8-201204170-00010,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1451554,https://api.altmetric.com/v1/donut/1451554_240.png 1,Salvage HDR Brachytherapy for Recurrent Prostate Cancer After Previous Definitive Radiation Therapy: 5-Year Outcomes,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2013.01.027,,,,23474112,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/1446270,https://api.altmetric.com/v1/donut/1446270_240.png 1,The Benefits of Exercise for Prostate Cancer Patients andTheir Families,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/2011/06/let%e2%80%99s-get-physical/,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1437857,https://api.altmetric.com/v1/donut/1437857_240.png 1,Impact of Tumor Vascularity on Responsiveness to Antiangiogenesis in a Prostate Cancer Stem Cell-Derived Tumor Model.,Molecular Cancer Therapeutics,,,Article,2013-05-01,10.1158/1535-7163.mct-12-1240,,,,23635653,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1432593,https://api.altmetric.com/v1/donut/1432593_240.png 1,Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center,Annals of Oncology,,,Article,2013-01-01,10.1093/annonc/mdt120,,,,23508825,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1431661,https://api.altmetric.com/v1/donut/1431661_240.png 1,Choline PET/CT for imaging prostate cancer: an update.,Annals of Nuclear Medicine,,,Article,2013-04-30,10.1007/s12149-013-0731-7,,,,23632880,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1427943,https://api.altmetric.com/v1/donut/1427943_240.png 1,Contact Us | Women Against Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/contact-us/,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1424202,https://api.altmetric.com/v1/donut/1424202_240.png 1,WAPC | Support Groups – Prostate Cancer Stories | WifeSupport for Prostate Cancer,www.womenagainstprostatecancer.org,,,Article,,,,,http://www.womenagainstprostatecancer.org/yourstory/,,,,,,,,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1424199,https://api.altmetric.com/v1/donut/1424199_240.png 1,The dosimetric impact of daily setup error on target volumes and surrounding normal tissue in the treatment of prostate cancer with intensity-modulated radiation therapy.,Medical Dosimetry,,,Article,2012-04-28,10.1016/j.meddos.2012.03.003,,,,22534138,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1421983,https://api.altmetric.com/v1/donut/1421983_240.png 1,Microvessel density and expression of vascular endothelial growth factor in clinically localized prostate cancer.,Polish journal of pathology official journal of the Polish Society of Pathologists,,,Article,2013-03-01,,,,,23625598,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1421953,https://api.altmetric.com/v1/donut/1421953_240.png 1,Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer,Prostate Cancer,,,Article,2013-01-01,10.1155/2013/920612,,,,23738079,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1419559,https://api.altmetric.com/v1/donut/1419559_240.png 1,"Evaluation of androgen-induced effects on the uptake of [18F]FDG, [11C]choline and [11C]acetate in an androgen-sensitive and androgen-independent prostate cancer xenograft model.",EJNMMI Research,,,Article,2013-04-24,10.1186/2191-219x-3-31,,,,23618081,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1417734,https://api.altmetric.com/v1/donut/1417734_240.png 1,Anti-Oxidative and Anti-Proliferative Activity on Human Prostate Cancer Cells Lines of the Phenolic Compounds from Corylopsis coreana Uyeki,Molecules,,,Article,2013-01-01,10.3390/molecules18054876,,,,23615534,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1408924,https://api.altmetric.com/v1/donut/1408924_240.png 1,"Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer.",British Journal of Urology,,,Article,2012-09-30,10.1111/j.1464-410x.2012.11536.x,,,,23016517,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1408847,https://api.altmetric.com/v1/donut/1408847_240.png 1,Diagnosing Prostate Cancer: Getting to the Core Question,The Journal of Urology,,,Article,2013-04-22,10.1016/j.juro.2013.04.047,,,,23608039,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1405800,https://api.altmetric.com/v1/donut/1405800_240.png 1,An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer,OncoTargets and therapy,,,Article,2013-04-01,10.2147/ott.s32426,,,,23620672,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1404691,https://api.altmetric.com/v1/donut/1404691_240.png 1,Methylselenol prodrug enhances MDV3100 efficacy for treatment of castrationâ??resistant prostate cancer,International Journal of Cancer,,,Article,2013-01-01,10.1002/ijc.28202,,,,23575870,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1397592,https://api.altmetric.com/v1/donut/1397592_240.png 1,Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: Nuclear HO-1 promotes vascular endothelial growth factor secretion.,International Journal of Oncology,,,Article,2013-04-17,10.3892/ijo.2013.1910,,,,23591596,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1397210,https://api.altmetric.com/v1/donut/1397210_240.png 1,Comparison of (18)F-FACBC and (11)C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-04-17,10.1007/s00259-013-2373-3,,,,23591953,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1396926,https://api.altmetric.com/v1/donut/1396926_240.png 1,Proteoglycan Expression in Normal Human Prostate Tissue and Prostate Cancer,ISRN Oncology,,,Article,2013-01-01,10.1155/2013/680136,,,,23691363,PMC3654277,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1396837,https://api.altmetric.com/v1/donut/1396837_240.png 1,Fruit and vegetable intake and prostate cancer risk: A metaâ??analysis,Asia Pacific Journal of Clinical Oncology,,,Article,2013-04-01,10.1111/ajco.12067,,,,23551391,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1393994,https://api.altmetric.com/v1/donut/1393994_240.png 1,"Genetics: The COGS are turning in breast, ovarian and prostate cancer",Nature Reviews Clinical Oncology,,,Article,2013-04-16,10.1038/nrclinonc.2013.56,,,,23591321,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1390689,https://api.altmetric.com/v1/donut/1390689_240.png 1,"(18)F-Choline, (11)C-choline and (11)C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.",European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-04-12,10.1007/s00259-013-2358-2,,,,23579863,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1381634,https://api.altmetric.com/v1/donut/1381634_240.png 1,Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer,"Cancer Immunology, Immunotherapy",,,Article,2012-05-27,10.1007/s00262-012-1257-x,,,,22644735,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1379479,https://api.altmetric.com/v1/donut/1379479_240.png 1,Hyperpolarized [1-13C]Dehydroascorbate MR Spectroscopy in a Murine Model of Prostate Cancer: Comparison with 18F-FDG PET.,Journal of Nuclear Medicine,,,Article,2013-04-10,10.2967/jnumed.112.115402,,,,23575993,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1373185,https://api.altmetric.com/v1/donut/1373185_240.png 1,The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.,Journal of Immunotoxicology,,,Article,2009-11-18,10.3109/15476910903241696,,,,19908944,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,8,https://www.altmetric.com/details/1372665,https://api.altmetric.com/v1/donut/1372665_240.png 1,"Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism",International Journal of Cancer,,,Article,1970-01-01,10.1002/ijc.22761,,,,17443494,PMC2565646,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,9,https://www.altmetric.com/details/1372664,https://api.altmetric.com/v1/donut/1372664_240.png 1,A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells,Biochemical & Biophysical Research Communications,,,Article,1970-01-01,10.1016/j.bbrc.2005.05.049,,,,15919052,PMC1450257,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,10,https://www.altmetric.com/details/1372663,https://api.altmetric.com/v1/donut/1372663_240.png 1,Retrospective Evaluation Reveals That Long-term Androgen Deprivation Therapy Improves Cause-Specific and Overall Survival in the Setting of Dose-Escalated Radiation for High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.11.024,,,,23462420,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1367383,https://api.altmetric.com/v1/donut/1367383_240.png 1,Cost–effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer,Expert Review of Pharmacoeconomics and Outcomes Research,,,Article,2013-04-01,10.1586/erp.13.13,,,,23570437,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1364285,https://api.altmetric.com/v1/donut/1364285_240.png 1,Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer,Expert Review of Pharmacoeconomics and Outcomes Research,,,Article,2013-04-01,10.1586/erp.13.12,,,,23570436,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1364280,https://api.altmetric.com/v1/donut/1364280_240.png 1,Molecular Study of the PCA3 Gene: Genotypic Analysis of PCA3 Polymorphism -845G>A and Metastatic Prostate Cancer.,Genetic Testing,,,Article,2012-02-02,10.1089/gtmb.2011.0160,,,,22288776,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1363562,https://api.altmetric.com/v1/donut/1363562_240.png 1,Novel bourgeonal fragrance conjugates for the detection of prostate cancer.,Investigational New Drugs,,,Article,2013-03-21,10.1007/s10637-013-9943-x,,,,23508273,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1363557,https://api.altmetric.com/v1/donut/1363557_240.png 1,Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer,International Journal of Molecular Sciences,,,Article,2013-01-01,10.3390/ijms14047757,,,,23574937,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1359624,https://api.altmetric.com/v1/donut/1359624_240.png 1,The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells.,Journal of Cancer,,,Article,2013-01-01,10.7150/jca.5788,,,,23569462,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1359363,https://api.altmetric.com/v1/donut/1359363_240.png 1,Genetic predisposition to early recurrence in clinically localized prostate cancer,British Journal of Urology,,,Article,2012-01-01,10.1111/j.1464-410x.2012.11333.x,,,,22759231,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,6,https://www.altmetric.com/details/1357159,https://api.altmetric.com/v1/donut/1357159_240.png 1,Does androgen?ablation therapy (AAT) associated autophagy have a pro?survival effect in LNCaP human prostate cancer cells?,British Journal of Urology,,,Article,2012-08-19,10.1111/j.1464-410x.2012.11409.x,,,,22897391,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,11,https://www.altmetric.com/details/1353368,https://api.altmetric.com/v1/donut/1353368_240.png 1,Nanoparticle-induced vascular blockade in human prostate cancer,Blood,,,Article,2010-01-01,10.1182/blood-2010-03-274258,,,,20587786,PMC2974592,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/1353344,https://api.altmetric.com/v1/donut/1353344_240.png 1,Gross Hematuria in Patients with Prostate Cancer: Etiology and Management,ISRN Surgery,,,Article,2013-03-24,10.1155/2013/685327,,,,23634305,PMC3619630,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1348592,https://api.altmetric.com/v1/donut/1348592_240.png 1,Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone,PLoS ONE,,,Article,2013-04-05,10.1371/journal.pone.0060983,,,,23577181,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1346563,https://api.altmetric.com/v1/donut/1346563_240.png 1,Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomas,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2004-08-03,10.1073/pnas.0404572101,,,,15280533,,,2004PNAS..10111428M,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,20,https://www.altmetric.com/details/1343217,https://api.altmetric.com/v1/donut/1343217_240.png 1,"Prostate cancer screening in black menâ??new questions, few answers",Cancer (0008543X),,,Article,2013-01-01,10.1002/cncr.28041,,,,23559391,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1339187,https://api.altmetric.com/v1/donut/1339187_240.png 1,Deregulated Expression of Urokinase and its Inhibitor Type 1 in Prostate Cancer Cells: Role of Epigenetic Mechanisms.,Experimental & Molecular Pathology,,,Article,2013-03-26,10.1016/j.yexmp.2013.03.006,,,,23541763,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1333251,https://api.altmetric.com/v1/donut/1333251_240.png 1,Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies.,Nutrition and Cancer,,,Article,2008-12-31,10.1080/01635580903285056,,,,20155624,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1331588,https://api.altmetric.com/v1/donut/1331588_240.png 1,Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel,Cancer Management and Research,,,Article,2013-03-01,10.2147/cmar.s41667,,,,23516140,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1325372,https://api.altmetric.com/v1/donut/1325372_240.png 1,Survival Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiotherapy in Patients With Prostate Cancer: The Impact of Competing Causes of Mortality and Patient Stratification.,European Urology,,,Article,2013-03-13,10.1016/j.eururo.2013.03.006,,,,23506833,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1321408,https://api.altmetric.com/v1/donut/1321408_240.png 1,Improved detection of localized prostate cancer using co-registered MRI and (11)C-acetate PET/CT.,European Journal of Radiology,,,Article,2012-02-23,10.1016/j.ejrad.2011.12.043,,,,22342610,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1320103,https://api.altmetric.com/v1/donut/1320103_240.png 1,Prognostic Importance of Gleason 7 Disease Among Patients Treated With External Beam Radiation Therapy for Prostate Cancer: Results of a Detailed Biopsy Core Analysis,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.10.013,,,,23182392,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1318981,https://api.altmetric.com/v1/donut/1318981_240.png 1,"PSA, PCA3 and the phi losophy of prostate cancer management.",Clinical Chemistry & Laboratory Medicine,,,Article,2013-04-01,10.1515/cclm-2013-0156,,,,23518451,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1317175,https://api.altmetric.com/v1/donut/1317175_240.png 1,Age and Comorbid Illness Are Associated With Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.10.042,,,,23265567,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1316931,https://api.altmetric.com/v1/donut/1316931_240.png 1,Estimation of a Self-Consistent Set of Radiobiological Parameters From Hypofractionated Versus Standard Radiation Therapy of Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.11.033,,,,23332226,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1315221,https://api.altmetric.com/v1/donut/1315221_240.png 1,Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia ,Experimental & Molecular Pathology,,,Article,2013-03-09,10.1016/j.yexmp.2013.02.002,,,,23470460,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1314305,https://api.altmetric.com/v1/donut/1314305_240.png 1,"Antioxidant Effects of Lycopene in African American Men with Prostate Cancer or Benign Prostate Hyperplasia: A Randomized, Controlled Trial",Cancer Prevention Research,,,Article,2011-01-01,10.1158/1940-6207.capr-10-0288,,,,21430075,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1306673,https://api.altmetric.com/v1/donut/1306673_240.png 1,Increased risk of prostate cancer following sexually transmitted infection in an Asian population.,Epidemiology & Infection,,,Article,2013-03-08,10.1017/s0950268813000459,,,,23461984,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1304430,https://api.altmetric.com/v1/donut/1304430_240.png 1,Two Innovative Pharmaceutical Forms of Leuprorelin: Results from 818 Patients with Advanced Prostate Cancer,Advances in Therapy,,,Article,2013-03-01,10.1007/s12325-013-0010-y,,,,23460040,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1303414,https://api.altmetric.com/v1/donut/1303414_240.png 1,ELF3 is a repressor of androgen receptor action in prostate cancer cells,Oncogene,,,Article,2013-02-25,10.1038/onc.2013.15,,,,23435425,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1286847,https://api.altmetric.com/v1/donut/1286847_240.png 1,Chemoprevention of Prostate Cancer: Myths and Realities,Journal of the American Board of Family Medicine (formerly Journal of the American Board of Family Practice),,,Article,2012-01-01,10.3122/jabfm.2012.01.110117,,,,22218632,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1286715,https://api.altmetric.com/v1/donut/1286715_240.png 1,KML001 Cytotoxic Activity Is Associated with Its Binding to Telomeric Sequences and Telomere Erosion in Prostate Cancer Cells,Clinical Cancer Research,,,Article,2008-01-01,10.1158/1078-0432.ccr-07-4572,,,,18628474,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1286228,https://api.altmetric.com/v1/donut/1286228_240.png 1,Short-term Androgen-Deprivation Therapy Improves Prostate Cancer-Specific Mortality in Intermediate-Risk Prostate Cancer Patients Undergoing Dose-Escalated External Beam Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.07.2374,,,,22981709,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/1284970,https://api.altmetric.com/v1/donut/1284970_240.png 1,Treatment-Related Morbidity in Prostate Cancer: A Comparison of 3-Dimensional Conformal Radiation Therapy With and Without Image Guidance Using Implanted Fiducial Markers,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.07.2376,,,,23040222,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1284967,https://api.altmetric.com/v1/donut/1284967_240.png 1,A Biodistribution and Toxicity Study of Cobalt Dichloride-N-Acetyl Cysteine in an Implantable MRI Marker for Prostate Cancer Treatment,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.09.007,,,,23092727,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1282192,https://api.altmetric.com/v1/donut/1282192_240.png 1,Upregulation of Drug Transporter Expression by Osteopontin in Prostate Cancer Cells,Molecular Pharmacology,,,Article,2013-01-01,10.1124/mol.112.082339,,,,23434829,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1280963,https://api.altmetric.com/v1/donut/1280963_240.png 1,"CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3|[plus]| regulatory T cells with respect to lethal prostate cancer",Modern Pathology,,,Article,2012-10-05,10.1038/modpathol.2012.164,,,,23041830,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1279141,https://api.altmetric.com/v1/donut/1279141_240.png 1,Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation ,Biochemical Pharmacology,,,Article,2013-02-20,10.1016/j.bcp.2013.02.010,,,,23416117,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/1268171,https://api.altmetric.com/v1/donut/1268171_240.png 1,Late toxicity rates following definitive radiotherapy for prostate cancer.,Canadian Journal of Urology,,,Article,2012-08-17,,,,,22892261,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1267467,https://api.altmetric.com/v1/donut/1267467_240.png 1,Barriers to prostate cancer screening: psychological aspects and descriptive variables---is there a correlation?,Aging Male,,,Article,2011-01-03,10.3109/13685538.2010.522277,,,,20937009,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1266272,https://api.altmetric.com/v1/donut/1266272_240.png 1,Grape Seed Extract Regulates Androgen Receptor-Mediated Transcription in Prostate Cancer Cells Through Potent Anti–Histone Acetyltransferase Activity,Journal of Medicinal Food,,,Article,2011-01-20,10.1089/jmf.2010.1264,,,,21244239,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1261232,https://api.altmetric.com/v1/donut/1261232_240.png 1,A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells,Cell Biology International,,,Article,2013-01-01,10.1002/cbin.10055,,,,23418075,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1260586,https://api.altmetric.com/v1/donut/1260586_240.png 1,Imaging evaluation of prostate cancer with (18)F-fluorodeoxyglucose PET/CT: utility and limitations.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-02-22,10.1007/s00259-013-2361-7,,,,23429934,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1260406,https://api.altmetric.com/v1/donut/1260406_240.png 1,Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer,Research and Reports in Urology,,,Article,2013-01-01,10.2147/rru.s38093,,,,24400232,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1256747,https://api.altmetric.com/v1/donut/1256747_240.png 1,Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy.,The Journal of Urology,,,Article,2011-08-26,10.1016/j.juro.2011.05.075,,,,21862072,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1256692,https://api.altmetric.com/v1/donut/1256692_240.png 1,Neoadjuvant Chemotherapy prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer: A Systematic Review,Chemotherapy Research & Practice,,,Article,2013-01-01,10.1155/2013/386809,,,,23509625,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1255086,https://api.altmetric.com/v1/donut/1255086_240.png 1,Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms,Cancer Letters,,,Article,2013-02-15,10.1016/j.canlet.2013.02.001,,,,23402817,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1254131,https://api.altmetric.com/v1/donut/1254131_240.png 1,Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E,PLoS ONE,,,Article,2013-02-15,10.1371/journal.pone.0054727,,,,23457453,PMC3574137,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1244559,https://api.altmetric.com/v1/donut/1244559_240.png 1,"Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment ",Steroids,,,Article,2013-02-07,10.1016/j.steroids.2013.01.005,,,,23380371,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1239696,https://api.altmetric.com/v1/donut/1239696_240.png 1,Hormone Therapy in Prostate Cancer.,Journal of nuclear medicine technology,,,Article,2013-02-12,10.2967/jnmt.112.118034,,,,23404051,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1239479,https://api.altmetric.com/v1/donut/1239479_240.png 1,Role of WNT7B-induced non-canonical pathway in advanced prostate cancer,Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-12-0520,,,,23386686,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1238263,https://api.altmetric.com/v1/donut/1238263_240.png 1,Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.11.017,,,,23234628,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1234716,https://api.altmetric.com/v1/donut/1234716_240.png 1,Differential Expression of the Androgen-Conjugating UGT2B15 and UGT2B17 Enzymes in Prostate Tumor Cells during Cancer Progression,The Journal of Clinical Endocrinology & Metabolism,,,Article,2012-01-01,10.1210/jc.2011-2064,,,,22170718,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1228723,https://api.altmetric.com/v1/donut/1228723_240.png 1,Tumour volume delineation in prostate cancer assessed by [(11)C]choline PET/CT: validation with surgical specimens.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-02-07,10.1007/s00259-013-2345-7,,,,23389430,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1227568,https://api.altmetric.com/v1/donut/1227568_240.png 1,Prostate cancer: The androgen receptor remains front and centre,Nature Reviews Clinical Oncology,,,Article,2013-02-05,10.1038/nrclinonc.2013.14,,,,23381000,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1225245,https://api.altmetric.com/v1/donut/1225245_240.png 1,The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.,Molecular Oncology,,,Article,2013-01-19,10.1016/j.molonc.2013.01.003,,,,23384557,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1224841,https://api.altmetric.com/v1/donut/1224841_240.png 1,Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications,World Journal of Urology,,,Article,2013-01-29,10.1007/s00345-013-1029-z,,,,23358790,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1223619,https://api.altmetric.com/v1/donut/1223619_240.png 1,Expression of leukemia/lymphoma related factor (LRF/Pokemon) in human benign prostate hyperplasia and prostate cancer.,Experimental & Molecular Pathology,,,Article,2011-01-22,10.1016/j.yexmp.2011.01.003,,,,21251909,,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,9,https://www.altmetric.com/details/1223085,https://api.altmetric.com/v1/donut/1223085_240.png 1,Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy,EJNMMI Research,,,Article,2013-02-06,10.1186/2191-219x-3-9,,,,23384286,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1222531,https://api.altmetric.com/v1/donut/1222531_240.png 1,"Is There an Advantage in Designing Adapted, Patient-Specific PTV Margins in Intensity Modulated Proton Beam Therapy for Prostate Cancer?","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.05.046,,,,22818417,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/1220010,https://api.altmetric.com/v1/donut/1220010_240.png 1,A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome After Radiation Therapy for Localized Prostate Cancer,Clinical Cancer Research,,,Article,2013-01-01,10.1158/1078-0432.ccr-12-2718,,,,23382116,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1219059,https://api.altmetric.com/v1/donut/1219059_240.png 1,Hyperbaric oxygen â?? an effective tool to treat radiation morbidity in prostate cancer,Radiotherapy & Oncology,,,Article,2001-01-01,,,,,11690680,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1218334,https://api.altmetric.com/v1/donut/1218334_240.png 1,Re: Visualisation of the Lymph Node Pathway in Real Time by Laparoscopic Radioisotope- and Fluorescence-Guided Sentinel Lymph Node Dissection in Prostate Cancer Staging,The Journal of Urology,,,Article,2013-01-31,10.1016/j.juro.2013.01.073,,,,23594634,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1211412,https://api.altmetric.com/v1/donut/1211412_240.png 1,"Re: A Phase 3, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study",The Journal of Urology,,,Article,2013-01-31,10.1016/j.juro.2013.01.075,,,,23594627,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1211411,https://api.altmetric.com/v1/donut/1211411_240.png 1,Targeting Constitutively Activated ?1 Integrin inhibits Prostate Cancer Metastasis,Molecular Cancer Research,,,Article,2013-01-01,10.1158/1541-7786.mcr-12-0551,,,,23339185,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/1210676,https://api.altmetric.com/v1/donut/1210676_240.png 1,Expression patterns of epithelialmesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11551.x,,,,23107154,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1206495,https://api.altmetric.com/v1/donut/1206495_240.png 1,Serum Insulin-Like Growth Factor-I Levels and Prostate Cancer Risk—Interpreting the Evidence,JNCI: Journal of the National Cancer Institute,,,Article,1998-01-01,10.1093/jnci/90.12.876,,,,9637133,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1203129,https://api.altmetric.com/v1/donut/1203129_240.png 1,[The treatment of castration-resistant prostate cancer].,Magyar Onkológia,,,Article,2012-12-15,magyonkol.2012.56.4.219,,,,23236591,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1199346,https://api.altmetric.com/v1/donut/1199346_240.png 1,Novel Therapies for the Treatment of Advanced Prostate Cancer.,Current Treatment Options in Oncology,,,Article,2013-01-18,10.1007/s11864-012-0222-4,,,,23322116,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1198316,https://api.altmetric.com/v1/donut/1198316_240.png 1,[Effects of PPAR-gamma on the proliferation and glycolysis metabolism of prostate cancer cells].,Zhonghua nan ke xue National journal of andrology,,,Article,2012-09-02,,,,,22934513,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1195172,https://api.altmetric.com/v1/donut/1195172_240.png 1,Dynamic PET/CT measurements of induced positron activity in a prostate cancer patient after 50-MV photon radiation therapy,EJNMMI Research,,,Article,2013-01-23,10.1186/2191-219x-3-6,,,,23343347,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1192831,https://api.altmetric.com/v1/donut/1192831_240.png 1,MiRNA Targets of Prostate Cancer.,Methods in molecular biology,,,Article,2012-09-27,10.1007/978-1-62703-083-0_27,,,,23007521,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1184664,https://api.altmetric.com/v1/donut/1184664_240.png 1,Proteomic analysis of prostate cancer metastasis-derived prostasomes.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2010-03-26,,,,,20332430,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1183794,https://api.altmetric.com/v1/donut/1183794_240.png 1,The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells,Molecular Cancer,,,Article,2013-01-08,10.1186/1476-4598-12-3,,,,23298185,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1182715,https://api.altmetric.com/v1/donut/1182715_240.png 1,Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.,British Journal of Cancer,,,Article,2013-01-15,10.1038/bjc.2012.549,,,,23322201,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1181784,https://api.altmetric.com/v1/donut/1181784_240.png 1,In vitro and in vivo imaging of prostate cancer angiogenesis using anti-vascular endothelial growth factor receptor 2 antibody-conjugated quantum dot.,Korean Journal of Radiology,,,Article,2013-01-01,10.3348/kjr.2013.14.1.30,,,,23323028,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1181446,https://api.altmetric.com/v1/donut/1181446_240.png 1,Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Prostate Cancer: a Systematic Review with Meta-analysis.,Asian Pacific Journal of Cancer Prevention,,,Article,2012-01-01,,,,,23317235,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1179437,https://api.altmetric.com/v1/donut/1179437_240.png 1,Association of prostate specific antigen concentration with lifestyle characteristics in korean men.,Asian Pacific Journal of Cancer Prevention,,,Article,2012-01-01,,,,,23317241,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1179042,https://api.altmetric.com/v1/donut/1179042_240.png 1,Health care resource use in advanced prostate cancer patients treated with docetaxel.,Journal of Medical Economics,,,Article,2012-04-04,10.3111/13696998.2012.681718,,,,22463616,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1176603,https://api.altmetric.com/v1/donut/1176603_240.png 1,Patient Positioning Based on a Radioactive Tracer Implanted in Patients With Localized Prostate Cancer: A Performance and Safety Evaluation,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.03.064,,,,22652103,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1173776,https://api.altmetric.com/v1/donut/1173776_240.png 1,Feasibility of MR Imaging/MR Spectroscopy-Planned Focal Partial Salvage Permanent Prostate Implant (PPI) for Localized Recurrence After Initial PPI for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.04.028,,,,22672747,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/1172760,https://api.altmetric.com/v1/donut/1172760_240.png 1,Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer,PLoS ONE,,,Article,2013-01-11,10.1371/journal.pone.0053701,,,,23326489,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/1172486,https://api.altmetric.com/v1/donut/1172486_240.png 1,"Association of self-reported consumption of cooked meat, fish, seafood and eggs with prostate cancer risk among Nigerians",Infectious Agents and Cancer,,,Article,2013-01-12,10.1186/1750-9378-4-s1-s6,,,,19208211,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1171858,https://api.altmetric.com/v1/donut/1171858_240.png 1,Abstract 4618: Oral administration of bitter melon extract prevents initiation of prostate cancer in TRAMP model,Cancer Research,,,Article,2011-07-12,10.1158/1538-7445.am2011-4618,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1171234,https://api.altmetric.com/v1/donut/1171234_240.png 1,Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer.,Journal of radiation research,,,Article,2012-08-01,10.1093/jrr/rrs016,,,,22843627,PMC3393351,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1170152,https://api.altmetric.com/v1/donut/1170152_240.png 1,A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer.,The Prostate,,,Article,2009-03-10,10.1002/pros.20940,,,,19267349,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1169989,https://api.altmetric.com/v1/donut/1169989_240.png 1,Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins.,Molecular and Cellular Proteomics (MCP Online),,,Article,2009-02-11,10.1074/mcp.m800443-mcp200,,,,19204029,PMC2690478,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/1169976,https://api.altmetric.com/v1/donut/1169976_240.png 1,Preoperative 3-Tesla Multiparametric Endorectal Magnetic Resonance Imaging Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.08.032,,,,23040223,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1169009,https://api.altmetric.com/v1/donut/1169009_240.png 1,Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cellâ??derived factorâ??1,Journal of Cellular and Molecular Medicine,,,Article,2013-01-01,10.1111/jcmm.12010,,,,23301946,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1168616,https://api.altmetric.com/v1/donut/1168616_240.png 1,"Dp44mT targets the AKT, TGF-|[beta]| and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells",British Journal of Cancer,,,Article,2013-01-03,10.1038/bjc.2012.582,,,,23287991,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1167860,https://api.altmetric.com/v1/donut/1167860_240.png 1,Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease,Cancer Management and Research,,,Article,2013-01-01,10.2147/cmar.s25537,,,,23326203,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/1166119,https://api.altmetric.com/v1/donut/1166119_240.png 1,Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis,Cancer Letters,,,Article,2012-12-27,10.1016/j.canlet.2012.12.012,,,,23266572,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1156635,https://api.altmetric.com/v1/donut/1156635_240.png 1,Combined Dynamic Alterations in Urinary VEGF Levels and Tissue ADAM9 Expression as Markers for Lethal Phenotypic Progression of Prostate Cancer.,Chinese journal of physiology,,,Article,2012-12-31,10.4077/cjp.2012.baa075,,,,23286446,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1155912,https://api.altmetric.com/v1/donut/1155912_240.png 1,Restaging prostate cancer patients with biochemical failure with PET/CT and radiolabeled choline.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2012-09-29,,,,,23013665,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1154743,https://api.altmetric.com/v1/donut/1154743_240.png 1,The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer,Research and Reports in Urology,,,Article,2012-12-01,10.2147/rru.s23386,,,,24400229,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1154385,https://api.altmetric.com/v1/donut/1154385_240.png 1,Histotripsy Focal Ablation of Implanted Prostate Tumor in an ACE-1 Canine Cancer Model,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.07.006,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1153281,https://api.altmetric.com/v1/donut/1153281_240.png 1,A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasis,British Journal of Cancer,,,Article,2012-11-20,10.1038/bjc.2012.500,,,,23169284,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1150763,https://api.altmetric.com/v1/donut/1150763_240.png 1,Targeting angiogenesis as a promising modality for the treatment of prostate cancer.,Urologic Clinics of North America,,,Article,2012-10-24,10.1016/j.ucl.2012.07.010,,,,23084530,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/1144536,https://api.altmetric.com/v1/donut/1144536_240.png 1,Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues,Andrology,,,Article,2013-01-01,10.1111/j.2047-2927.2012.00026.x,,,,23258647,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1139274,https://api.altmetric.com/v1/donut/1139274_240.png 1,Enzalutamide in prostate cancer after chemotherapy.,New England Journal of Medicine,,,Article,2012-12-20,10.1056/nejmc1212940#sa1,,,,23252532,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1137493,https://api.altmetric.com/v1/donut/1137493_240.png 1,"Blocked Autophagy Using Lysosomotropic Agents Sensitizes Resistant Prostate Tumor Cells to the Novel Akt Inhibitor, AZD5363",Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-3114,,,,23258740,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/1137424,https://api.altmetric.com/v1/donut/1137424_240.png 1,Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression,Cancer Research,,,Article,2013-01-01,10.1158/0008-5472.can-12-2968,,,,23233736,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1136679,https://api.altmetric.com/v1/donut/1136679_240.png 1,Diagnostic Role of (18)F-FECH-PET/CT Compared with Bone Scan in Evaluating the Prostate Cancer Patients Referring with Biochemical Recurrence.,ISRN Oncology,,,Article,2012-01-01,10.5402/2012/815234,,,,23251818,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1135760,https://api.altmetric.com/v1/donut/1135760_240.png 1,Loss of LARGE2 Disrupts Functional Glycosylation of [&alpha]-Dystroglycan in Prostate Cancer,Journal of Biological Chemistry,"GREY, Jane W",School of Medicine & Medical Science; Department of Life Sciences,Article,2013-01-01,10.1074/jbc.m112.432807,,,,23223448,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/1134135,https://api.altmetric.com/v1/donut/1134135_240.png 1,Senescence-associated exosome release from human prostate cancer cells.,Cancer Research,,,Article,2008-10-03,10.1158/0008-5472.can-07-6538,,,,18829542,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,99,https://www.altmetric.com/details/1133964,https://api.altmetric.com/v1/donut/1133964_240.png 1,Androgens Promote Prostate Cancer Cell Growth through Induction of Autophagy,Molecular Endocrinology,,,Article,2013-01-01,10.1210/me.2012-1260,,,,23250485,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1131853,https://api.altmetric.com/v1/donut/1131853_240.png 1,Role of OGR1 in myeloid-derived cells in prostate cancer,Oncogene,,,Article,2012-12-10,10.1038/onc.2012.566,,,,23222714,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1131478,https://api.altmetric.com/v1/donut/1131478_240.png 1,"Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus Bicalutamide",Clinical Oncology,,,Article,2012-12-01,10.1016/j.clon.2012.09.010,,,,23257248,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1130475,https://api.altmetric.com/v1/donut/1130475_240.png 1,Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients.,Urologia Internationalis,,,Article,2012-12-14,10.1159/000342814,,,,23235105,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1128005,https://api.altmetric.com/v1/donut/1128005_240.png 1,Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk,PLoS ONE,,,Article,2012-12-14,10.1371/journal.pone.0051680,,,,23272139,PMC3522730,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1127626,https://api.altmetric.com/v1/donut/1127626_240.png 1,Early Salvage Hormonal Therapy for Biochemical Failure Improved Survival in Prostate Cancer Patients After Neoadjuvant Hormonal Therapy Plus Radiation Therapyâ??A Secondary Analysis of Irish Clinical Oncology Research Group 97-01,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.03.001,,,,22658512,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1127448,https://api.altmetric.com/v1/donut/1127448_240.png 1,Oxidative Stress Markers in Prostate Cancer Patients after HDR Brachytherapy Combined with External Beam Radiation,Oxidative Medicine & Cellular Longetivity,,,Article,2012-01-01,10.1155/2012/789870,,,,23365695,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1126996,https://api.altmetric.com/v1/donut/1126996_240.png 1,Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario.,Future Oncology,,,Article,2012-12-14,10.2217/fon.12.156,,,,23231520,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1126796,https://api.altmetric.com/v1/donut/1126796_240.png 1,A 2-Stage Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms Associated With Development of Erectile Dysfunction Following Radiation Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.08.003,,,,23021708,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1126618,https://api.altmetric.com/v1/donut/1126618_240.png 1,TRPM8 Ion Channels Differentially Modulate Proliferation and Cell Cycle Distribution of Normal and Cancer Prostate Cells,PLoS ONE,,,Article,2012-12-14,10.1371/journal.pone.0051825,,,,23251635,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1126426,https://api.altmetric.com/v1/donut/1126426_240.png 1,Cathepsin H mediates the processing of talin and regulates migration of prostate cancer cells,Journal of Biological Chemistry,,,Article,2013-01-01,10.1074/jbc.m112.436394,,,,23204516,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/1123559,https://api.altmetric.com/v1/donut/1123559_240.png 1,Urethral Pain Among Prostate Cancer Survivors 1 to 14 Years After Radiation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2013-01-01,10.1016/j.ijrobp.2012.08.037,,,,23237005,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1123209,https://api.altmetric.com/v1/donut/1123209_240.png 1,Re: Radical Prostatectomy Versus Observation for Localized Prostate Cancer,The Journal of Urology,,,Article,2013-01-01,10.1016/j.juro.2012.10.049,,,,23235212,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/1123153,https://api.altmetric.com/v1/donut/1123153_240.png 1,The skeletal muscle-metabolism axis in prostate-cancer therapy.,New England Journal of Medicine,,,Article,2012-12-06,10.1056/nejmc1211955#sa1,,,,23215572,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1121128,https://api.altmetric.com/v1/donut/1121128_240.png 1,Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells,PLoS ONE,,,Article,2012-12-12,10.1371/journal.pone.0051470,,,,23251544,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/1121059,https://api.altmetric.com/v1/donut/1121059_240.png 1,Sequencing the transcriptional network of androgen receptor in prostate cancer ,Cancer Letters,,,Article,2012-12-02,10.1016/j.canlet.2012.11.009,,,,23196061,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1120225,https://api.altmetric.com/v1/donut/1120225_240.png 1,The Potential Benefits of Diet and Physical Activity Among Active Surveillance Patients with Low-Burden Prostate Cancer,,,,Article,2016-02-02,10.1007/978-1-61779-912-9_12,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1120060,https://api.altmetric.com/v1/donut/1120060_240.png 1,Vitamin D Levels in Subjects with Prostate Cancer Compared to Age-Matched Controls,Prostate Cancer,,,Article,2012-01-01,10.1155/2012/524206,,,,23304521,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1119233,https://api.altmetric.com/v1/donut/1119233_240.png 1,Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer,Modern Pathology,,,Article,2012-06-08,10.1038/modpathol.2012.104,,,,22684219,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/1117513,https://api.altmetric.com/v1/donut/1117513_240.png 1,Low incidence of prostate cancer identified in the transition and anterior zones with transperineal biopsy,Research and Reports in Urology,,,Article,2012-12-01,10.2147/rru.s37868,,,,24199184,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1117411,https://api.altmetric.com/v1/donut/1117411_240.png 1,Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer : Matched-pair analysis.,Strahlentherapie und Onkologie,,,Article,2012-08-31,10.1007/s00066-012-0172-6,,,,22933033,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1116116,https://api.altmetric.com/v1/donut/1116116_240.png 1,Analysis of urological procedures in men who died from prostate cancer using a populationâ??based approach,British Journal of Urology,,,Article,2013-01-01,10.1111/j.1464-410x.2012.11517.x,,,,23130676,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1111676,https://api.altmetric.com/v1/donut/1111676_240.png 1,Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis,Growth Hormone & IGF Research,,,Article,2010-02-01,10.1016/j.ghir.2009.09.003,,,,19853487,PMC2815223,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1104977,https://api.altmetric.com/v1/donut/1104977_240.png 1,Effects of Genetically Engineered Stem Cells Expressing Cytosine Deaminase and Interferon-Beta or Carboxyl Esterase on the Growth of LNCaP Prostate Cancer Cells.,International Journal of Molecular Sciences,,,Article,2012-01-01,10.3390/ijms131012519,,,,23202910,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/1104672,https://api.altmetric.com/v1/donut/1104672_240.png 1,"Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer.",Journal of Nuclear Medicine,,,Article,2012-12-01,10.2967/jnumed.112.104661,,,,23203246,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1104640,https://api.altmetric.com/v1/donut/1104640_240.png 1,Current concepts and significance of estrogen receptor ? in prostate cancer ,Steroids,,,Article,2012-07-26,10.1016/j.steroids.2012.07.002,,,,22824289,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1101453,https://api.altmetric.com/v1/donut/1101453_240.png 1,Abiraterone acetate for the treatment of prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2012-11-30,10.1517/14656566.2013.745852,,,,23199349,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1099963,https://api.altmetric.com/v1/donut/1099963_240.png 1,Circulating and Disseminated Tumor Cells in the Management of Advanced Prostate Cancer,Advances in Urology,,,Article,2012-01-01,10.1155/2012/135281,,,,21869883,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/1088481,https://api.altmetric.com/v1/donut/1088481_240.png 1,LHRH Agonists for the Treatment of Prostate Cancer: 2012.,Reviews in Urology,,,Article,2012-01-01,,,,,23172994,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/1085479,https://api.altmetric.com/v1/donut/1085479_240.png 1,Second to fourth digit ratio and prostate cancer severity,Prostate Cancer & Prostatic Diseases,,,Article,2012-11-13,10.1038/pcan.2012.46,,,,23146972,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1084780,https://api.altmetric.com/v1/donut/1084780_240.png 1,Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.,British Journal of Cancer,,,Article,2011-04-07,10.1038/bjc.2011.118,,,,21468051,PMC3093360,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/1084095,https://api.altmetric.com/v1/donut/1084095_240.png 1,Inhibition of prostate cancer-cell proliferation by Essiac.,Journal of Alternative & Complementary Medicine,,,Article,2004-09-10,10.1089/acm.2004.10.687,,,,15353028,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1082117,https://api.altmetric.com/v1/donut/1082117_240.png 1,A Novel Interplay between Rap1 and PKA Regulates Induction of Angiogenesis in Prostate Cancer.,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0049893,,,,23166790,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1080898,https://api.altmetric.com/v1/donut/1080898_240.png 1,Performance Characteristics of MR Imaging in the Evaluation of Clinically Low-Risk Prostate Cancer: A Prospective Study,Radiology,,,Article,2012-01-01,10.1148/radiol.12120041,,,,22952382,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/1076930,https://api.altmetric.com/v1/donut/1076930_240.png 1,The Chicken Ovalbumin Upstream Promoter-Transcription Factor II Negatively Regulates the Transactivation of Androgen Receptor in Prostate Cancer Cells,PLoS ONE,,,Article,2012-11-07,10.1371/journal.pone.0049026,,,,23145053,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1075974,https://api.altmetric.com/v1/donut/1075974_240.png 1,"Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage impact of tissue environment",NMR in Biomedicine,,,Article,2011-01-01,10.1002/nbm.1738,,,,21793074,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/1075830,https://api.altmetric.com/v1/donut/1075830_240.png 1,Cross-talk between Paracrine-Acting Cytokine and Chemokine Pathways Promotes Malignancy in Benign Human Prostatic Epithelium,Cancer Research,,,Article,2007-01-01,10.1158/0008-5472.can-06-3946,,,,17483336,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/1075389,https://api.altmetric.com/v1/donut/1075389_240.png 1,Altered TGF-? Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis,Cancer Research,,,Article,2011-01-01,10.1158/0008-5472.can-10-3142,,,,21303979,PMC3076790,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/1075385,https://api.altmetric.com/v1/donut/1075385_240.png 1,[Primary Diffuse Large B-Cell Lymphoma of the Prostate Presenting with Urinary Retention and Dyschezia for Which Rituximab-Combined CHOP Therapy Was Effective-A Case Presentation.],Gan to kagaku ryoho Cancer chemotherapy,,,Article,2012-11-01,,,,,23152030,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1072355,https://api.altmetric.com/v1/donut/1072355_240.png 1,The spectrum of morphology in nonâ??neoplastic prostate including cancer mimics,Histopathology,,,Article,2012-01-01,10.1111/j.1365-2559.2011.04000.x,,,,22212077,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/1071963,https://api.altmetric.com/v1/donut/1071963_240.png 1,Precursors of prostate cancer,Histopathology,,,Article,2012-01-01,10.1111/j.1365-2559.2011.04007.x,,,,22212075,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/1071959,https://api.altmetric.com/v1/donut/1071959_240.png 1,"Prostate cancer: towards the standardization and synthesis of morphology, genetics, and prognosis",Histopathology,,,Article,2012-01-01,10.1111/j.1365-2559.2011.04080.x,,,,22212074,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1071958,https://api.altmetric.com/v1/donut/1071958_240.png 1,Functional imaging for prostate cancer: therapeutic implications.,Seminars in Nuclear Medicine,,,Article,2012-08-01,10.1053/j.semnuclmed.2012.04.004,,,,22840598,PMC3408625,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1067322,https://api.altmetric.com/v1/donut/1067322_240.png 1,A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer: SEC14L1 and TCEB1 Genes Are Potential Markers of Progression,American Journal of Pathology,,,Article,2012-01-01,10.1016/j.ajpath.2012.08.005,,,,23083832,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/1064952,https://api.altmetric.com/v1/donut/1064952_240.png 1,Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells,Cancer Management and Research,,,Article,2012-11-01,10.2147/cmar.s38022,,,,23204869,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/1061517,https://api.altmetric.com/v1/donut/1061517_240.png 1,Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase 2 Study and Biomarker Analysis With Rilotumumab Plus Mitoxantrone and Prednisone,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-2605,,,,23136195,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/1055594,https://api.altmetric.com/v1/donut/1055594_240.png 1,Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report.,Journal of Medical Case Reports,,,Article,2012-11-06,10.1186/1752-1947-6-378,,,,23130841,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/1055546,https://api.altmetric.com/v1/donut/1055546_240.png 1,Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer.,Journal of Receptor & Signal Transduction Research,,,Article,2012-11-07,10.3109/10799893.2012.733885,,,,23134344,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1055118,https://api.altmetric.com/v1/donut/1055118_240.png 1,Operational Characteristics Of 11 C-Choline PET/CT For Prostate Cancer Patients With Biochemical Recurrence Following Initial Treatment.,The Journal of Urology,,,Article,2012-10-30,10.1016/j.juro.2012.10.069,,,,23123372,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1052991,https://api.altmetric.com/v1/donut/1052991_240.png 1,Increased PrLZ-mediated androgen receptor transactivation promotes castration resistant prostate cancer growth,Carcinogenesis,,,Article,2013-01-01,10.1093/carcin/bgs337,,,,23104178,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/1051719,https://api.altmetric.com/v1/donut/1051719_240.png 1,The role of Snail in prostate cancer,Cell Adhesion & Migration,,,Article,2012-01-01,10.4161/cam.21687,,,,23076049,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/1042053,https://api.altmetric.com/v1/donut/1042053_240.png 1,"Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer.",PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0047730,,,,23118893,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1038800,https://api.altmetric.com/v1/donut/1038800_240.png 1,"Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.",Cancer Biology and Therapy,,,Article,2012-10-31,,,,,23114714,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/1037133,https://api.altmetric.com/v1/donut/1037133_240.png 1,Diet and survival after prostate cancer diagnosis.,Nutrition Reviews,,,Article,2007-09-01,,,,,17958206,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1037066,https://api.altmetric.com/v1/donut/1037066_240.png 1,"Zyflamend®, a Unique Herbal Preparation With Nonselective OX Inhibitory Activity, Induces Apoptosis of Prostate Cancer Cells That Lack COX-2 Expression",Nutrition and Cancer,,,Article,2004-12-31,10.1207/s15327914nc5202_10,,,,16201851,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/1036075,https://api.altmetric.com/v1/donut/1036075_240.png 1,[Metabolic impact of androgen deprivation therapy for prostate cancer].,Progrès en Urologie,,,Article,2012-09-01,10.1016/s1166-7087(12)70035-0,,,,23098789,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1034865,https://api.altmetric.com/v1/donut/1034865_240.png 1,Risk Factors for Metastatic Castration-Resistant Prostate Cancer (CRPC) Predict Long-Term Treatment with Docetaxel,PLoS ONE,,,Article,2012-10-30,10.1371/journal.pone.0048186,,,,23118948,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1034432,https://api.altmetric.com/v1/donut/1034432_240.png 1,"Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.",Molecular Biology Reports,,,Article,2012-02-10,10.1007/s11033-012-1556-5,,,,22311043,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1033504,https://api.altmetric.com/v1/donut/1033504_240.png 1,"1620 THE TERE1(UBIAD1) PROTEIN REDUCES CHOLESTEROL IN C81-LNCAP PROSTATE CANCER CELLS: INDUCTION BY 1,25-OH VITAMIN D3 OR ECTOPIC EXPRESSION",The Journal of Urology,,,Article,2011-04-01,10.1016/j.juro.2011.02.1728,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/1031440,https://api.altmetric.com/v1/donut/1031440_240.png 1,Frequency of brain metastases from prostate cancer: an 18-year single-institution experience,Journal of Neuro-Oncology,,,Article,2012-10-26,10.1007/s11060-012-0994-1,,,,23096134,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1029136,https://api.altmetric.com/v1/donut/1029136_240.png 1,The Potential of Circulating Tumor Cells as a Liquid Biopsy to Guide Therapy in Prostate Cancer,Cancer Discovery,,,Article,2012-10-26,10.1158/2159-8290.cd-12-0432,,,,23093252,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/1028855,https://api.altmetric.com/v1/donut/1028855_240.png 1,"Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression",PLoS ONE,,,Article,2012-10-25,10.1371/journal.pone.0047994,,,,23133535,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/1025667,https://api.altmetric.com/v1/donut/1025667_240.png 1,Zinc ?2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.,British Journal of Urology,,,Article,2012-10-03,10.1111/j.1464-410x.2012.11501.x,,,,23020913,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/1023276,https://api.altmetric.com/v1/donut/1023276_240.png 1,"Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5",Autophagy,,,Article,2012-01-01,10.4161/auto.22397,,,,23075929,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/1016575,https://api.altmetric.com/v1/donut/1016575_240.png 1,Simultaneous Analysis of Glycosylated and Sialylated Prostate-Specific Antigen Revealing Differential Distribution of Glycosylated Prostate-Specific Antigen Isoforms in Prostate Cancer Tissues,Analytical Chemistry,,,Article,2010-12-16,10.1021/ac102319g,,,,21141837,PMC3031300,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/1013145,https://api.altmetric.com/v1/donut/1013145_240.png 1,Hypofractionated High-Dose Radiation Therapy for Prostate Cancer: Long-Term Results of a Multi-Institutional Phase II Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.04.012,,,,22677370,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/1011845,https://api.altmetric.com/v1/donut/1011845_240.png 1,Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer.,Urology,,,Article,2012-08-01,10.1016/j.urology.2012.04.048,,,,22749428,PMC3461589,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/1003891,https://api.altmetric.com/v1/donut/1003891_240.png 1,Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells,PLoS ONE,,,Article,2012-10-15,10.1371/journal.pone.0047440,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/1002582,https://api.altmetric.com/v1/donut/1002582_240.png 1,Prostate Cancer Epigenomics,The Journal of Urology,,,Article,2012-10-15,10.1016/j.juro.2012.10.015,,,,23063895,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/1001989,https://api.altmetric.com/v1/donut/1001989_240.png 1,"Nutrition, suppléments alimentaires et cancer de la prostate ",Progrès en Urologie,,,Article,2010-09-15,10.1016/j.purol.2010.03.010,,,,20832032,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/999695,https://api.altmetric.com/v1/donut/999695_240.png 1,Chemoprevention of Prostate Cancer with Cruciferous Vegetables: Role of Epigenetics,,,,Article,2012-01-01,10.1007/978-94-007-2923-0_3,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/998460,https://api.altmetric.com/v1/donut/998460_240.png 1,"A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians",Human Molecular Genetics,,,Article,1970-01-01,10.1093/hmg/ddq210,,,,20484221,PMC2901143,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/991976,https://api.altmetric.com/v1/donut/991976_240.png 1,Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents ,European Journal of Medicinal Chemistry,,,Article,2012-08-22,10.1016/j.ejmech.2012.07.049,,,,22901310,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/991712,https://api.altmetric.com/v1/donut/991712_240.png 1,Body mass index and the risk of prostate cancer,Open Access Medical Statistics,,,Article,2012-09-01,10.2147/oams.s34645,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/991340,https://api.altmetric.com/v1/donut/991340_240.png 1,"Electromagnetic Fields, Polychlorinated Biphenyls, and Prostate Cancer Mortality in Electric Utility Workers",American Journal of Epidemiology,,,Article,2003-01-01,10.1093/aje/kwg044,,,,12697572,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/990639,https://api.altmetric.com/v1/donut/990639_240.png 1,"Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer",Cancer (0008543X),,,Article,2009-01-01,10.1002/cncr.24365,,,,19415730,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/990090,https://api.altmetric.com/v1/donut/990090_240.png 1,Differential expression of VEGF ligands and receptors in prostate cancer.,The Prostate,,,Article,2012-10-04,10.1002/pros.22596,,,,23038639,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/985486,https://api.altmetric.com/v1/donut/985486_240.png 1,A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer.,Cancer Gene Therapy,,,Article,2012-10-05,10.1038/cgt.2012.68,,,,23037808,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/985352,https://api.altmetric.com/v1/donut/985352_240.png 1,Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer,Cancer Medicine,,,Article,2012-01-01,10.1002/cam4.16,,,,23342267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/983034,https://api.altmetric.com/v1/donut/983034_240.png 1,Cell-Intrinsic Abrogation of TGF-? Signaling Delays but Does Not Prevent Dysfunction of Self/Tumor-Specific CD8 T Cells in a Murine Model of Autochthonous Prostate Cancer,The Journal of Immunology,,,Article,2012-01-01,10.4049/jimmunol.1201415,,,,22984076,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/982167,https://api.altmetric.com/v1/donut/982167_240.png 1,"Dentatin Induces Apoptosis in Prostate Cancer Cells via Bcl-2, Bcl-xL, Survivin Downregulation, Caspase-9, -3/7 Activation, and NF-κB Inhibition",Evidence-based Complementary & Alternative Medicine (eCAM),,,Article,2012-01-01,10.1155/2012/856029,,,,23091559,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/979699,https://api.altmetric.com/v1/donut/979699_240.png 1,Towards the Detection of Prostate Cancer in Urine: A Critical Analysis.,The Journal of Urology,,,Article,2012-09-29,10.1016/j.juro.2012.04.143,,,,23017522,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/975140,https://api.altmetric.com/v1/donut/975140_240.png 1,"Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines",Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2012-01-01,,,,,22956807,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/972888,https://api.altmetric.com/v1/donut/972888_240.png 1,Enrollment Criteria Controversies for Active Surveillance and Triggers for Conversion to Treatment in Prostate Cancer,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2012-01-01,,,,,22956809,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/972887,https://api.altmetric.com/v1/donut/972887_240.png 1,"Antitumor Action of ?1-Adrenoceptor Blockers on Human Bladder, Prostate and Renal Cancer Cells",Pharmacology,,,Article,2012-01-01,10.1159/000342797,,,,23007551,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/972596,https://api.altmetric.com/v1/donut/972596_240.png 1,Prostate cancer in Jamaica and the wider Caribbean: it is time to consider screening.,West Indian Medical Journal,,,Article,2012-07-21,,,,,22808573,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/971602,https://api.altmetric.com/v1/donut/971602_240.png 1,Pretreatment Endorectal Coil Magnetic Resonance Imaging Findings Predict Biochemical Tumor Control in Prostate Cancer Patients Treated With Combination Brachytherapy and External-Beam Radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.01.009,,,,22425220,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/969642,https://api.altmetric.com/v1/donut/969642_240.png 1,Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.12.089,,,,22436789,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/967356,https://api.altmetric.com/v1/donut/967356_240.png 1,"Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids.",Biomaterials,,,Article,2012-09-19,10.1016/j.biomaterials.2012.08.061,,,,22999468,PMC3466381,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,70,https://www.altmetric.com/details/964201,https://api.altmetric.com/v1/donut/964201_240.png 1,"Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.",Journal of the South Carolina Medical Association,,,Article,2006-08-01,,,,,17319238,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/963371,https://api.altmetric.com/v1/donut/963371_240.png 1,"A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.",Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,,,Article,2004-10-13,10.1016/j.mrfmmm.2004.05.017,,,,15476849,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/961204,https://api.altmetric.com/v1/donut/961204_240.png 1,Cancer immunotherapy: a paradigm shift for prostate cancer treatment,Nature Reviews Urology,,,Article,2012-05-29,10.1038/nrurol.2012.106,,,,22641164,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/961032,https://api.altmetric.com/v1/donut/961032_240.png 1,[Inhibitory effect of dihydroartemisinin on the growth of human prostate cancer PC-3M cells and its mechanism].,Zhonghua nan ke xue National journal of andrology,,,Article,2012-07-01,,,,,22994042,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/960105,https://api.altmetric.com/v1/donut/960105_240.png 1,Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy,PLoS ONE,,,Article,2012-09-20,10.1371/journal.pone.0045756,,,,23029225,PMC3447865,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/957863,https://api.altmetric.com/v1/donut/957863_240.png 1,The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer,Journal of Molecular Medicine,,,Article,2012-09-06,10.1007/s00109-012-0949-1,,,,22945237,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/952540,https://api.altmetric.com/v1/donut/952540_240.png 1,Placement of retrievable self-expandable metallic stents with barbs into patients with obstructive prostate cancer.,European Radiology,,,Article,2012-09-16,10.1007/s00330-012-2650-8,,,,22983316,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/951458,https://api.altmetric.com/v1/donut/951458_240.png 1,Activation of Nuclear Factor-Kappa B (NF?B) in Prostate Cancer is Mediated by PKC Epsilon (PKC?),Journal of Biological Chemistry,,,Article,2012-01-01,10.1074/jbc.m112.398925,,,,22955280,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/948722,https://api.altmetric.com/v1/donut/948722_240.png 1,"Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer.",Radiation Oncology,,,Article,2012-09-11,10.1186/1748-717x-7-154,,,,22967802,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/944662,https://api.altmetric.com/v1/donut/944662_240.png 1,Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07),Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-2219,,,,22977195,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/943448,https://api.altmetric.com/v1/donut/943448_240.png 1,Intensity-modulated radiation therapy for prostate cancer is cost effective and improves therapeutic ratio,Expert Review of Pharmacoeconomics and Outcomes Research,,,Article,2012-08-01,10.1586/erp.12.46,,,,22971031,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/943035,https://api.altmetric.com/v1/donut/943035_240.png 1,Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-l-lysine nanocarrier to suppress prostate cancer growth in mice.,European Journal of Pharmaceutical Sciences,,,Article,2011-12-23,10.1016/j.ejps.2011.11.024,,,,22186295,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/939710,https://api.altmetric.com/v1/donut/939710_240.png 1,A perspective on the role of estrogen in hormone-induced prostate carcinogenesis,Cancer Letters,,,Article,2012-09-05,10.1016/j.canlet.2012.08.027,,,,22939996,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/936912,https://api.altmetric.com/v1/donut/936912_240.png 1,High-Intensity Focused Ultrasound Studied as New Prostate Cancer Treatment,Journal of Clinical Engineering,,,Article,1970-01-01,10.1097/01.jce.0000415310.27693.b6,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/932633,https://api.altmetric.com/v1/donut/932633_240.png 1,Focal Therapy for Localised Unifocal and Multifocal Prostate Cancer: A Prospective Development Study,Journal of Clinical Engineering,,,Article,1970-01-01,10.1097/01.jce.0000415311.04822.6c,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/932631,https://api.altmetric.com/v1/donut/932631_240.png 1,Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis,Apoptosis,,,Article,2012-08-29,10.1007/s10495-012-0752-z,,,,22923157,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/932150,https://api.altmetric.com/v1/donut/932150_240.png 1,MicroRNA regulation of oncolytic adenovirus 6 for selective treatment of castration-resistant prostate cancer,Molecular Cancer Therapeutics,,,Article,2012-01-01,10.1158/1535-7163.mct-12-0157,,,,22914437,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/927100,https://api.altmetric.com/v1/donut/927100_240.png 1,Mean Absorbed Dose to the Anal-Sphincter Region and Fecal Leakage among Irradiated Prostate Cancer Survivors,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.03.065,,,,22677373,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/923426,https://api.altmetric.com/v1/donut/923426_240.png 1,Elevated osteonectin|[sol]|SPARC expression in primary prostate cancer predicts metastatic progression,Prostate Cancer & Prostatic Diseases,,,Article,2011-11-29,10.1038/pcan.2011.61,,,,22343836,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/919179,https://api.altmetric.com/v1/donut/919179_240.png 1,Increasing use of radical prostatectomy for non-lethal prostate cancer in Sweden,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-1537,,,,22927485,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/916885,https://api.altmetric.com/v1/donut/916885_240.png 1,Adaptive Image-Guided Radiotherapy (IGRT) Eliminates the Risk of Biochemical Failure Caused by the Bias of Rectal Distension in Prostate Cancer Treatment Planning: Clinical Evidence,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.08.025,,,,22208964,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/915660,https://api.altmetric.com/v1/donut/915660_240.png 1,Impact of Concurrent Androgen Deprivation on Fiducial Marker Migration in External-beam Radiation Therapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2012.02.016,,,,22541962,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/915388,https://api.altmetric.com/v1/donut/915388_240.png 1,High-Dose-Rate Brachytherapy and External-Beam Radiotherapy for Hormone-Naïve Low- and Intermediate-Risk Prostate Cancer: A 7-Year Experience,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.10.055,,,,22285661,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/914963,https://api.altmetric.com/v1/donut/914963_240.png 1,Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSA,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.10.047,,,,22401922,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/914948,https://api.altmetric.com/v1/donut/914948_240.png 1,Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using 11C-choline Positron Emission Tomography Scans,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2012.01.087,,,,22658218,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/914921,https://api.altmetric.com/v1/donut/914921_240.png 1,The Use of Photon Beams of a Flattening Filter-free Linear Accelerator for Hypofractionated Volumetric Modulated Arc Therapy in Localized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.10.019,,,,22572080,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/914915,https://api.altmetric.com/v1/donut/914915_240.png 1,Effect of Statins and Anticoagulants on Prostate Cancer Aggressiveness,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.09.042,,,,22270166,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/914745,https://api.altmetric.com/v1/donut/914745_240.png 1,Postoperative Radiotherapy in Prostate Cancer: The Case of the Missing Target,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.09.039,,,,22270169,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/914743,https://api.altmetric.com/v1/donut/914743_240.png 1,Implementation of High-Dose-Rate Brachytherapy and Androgen Deprivation in Patients With Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.08.028,,,,22138456,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/914605,https://api.altmetric.com/v1/donut/914605_240.png 1,High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.05.001,,,,22197086,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/914588,https://api.altmetric.com/v1/donut/914588_240.png 1,Implanted Dosimeters Identify Radiation Overdoses During IMRT for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.12.094,,,,22633553,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/914505,https://api.altmetric.com/v1/donut/914505_240.png 1,A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo,PLoS ONE,,,Article,2012-08-15,10.1371/journal.pone.0042120,,,,22916121,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/914439,https://api.altmetric.com/v1/donut/914439_240.png 1,Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress,British Journal of Cancer,,,Article,2012-01-03,10.1038/bjc.2011.530,,,,22215106,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,87,https://www.altmetric.com/details/911182,https://api.altmetric.com/v1/donut/911182_240.png 1,Lysophosphatidic Acid Enhances Vascular Endothelial Growth Factor-C Expression in Human Prostate Cancer PC-3 Cells.,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0041096,,,,22911748,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/908312,https://api.altmetric.com/v1/donut/908312_240.png 1,Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells ,Journal of Ethnopharmacology,,,Article,1970-01-01,10.1016/j.jep.2010.04.038,,,,20438825,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/907230,https://api.altmetric.com/v1/donut/907230_240.png 1,Toward Maximizing Immunotherapy in Metastatic Castration-Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy,Frontiers in oncology,,,Article,2012-01-01,10.3389/fonc.2012.00043,,,,22662316,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/906363,https://api.altmetric.com/v1/donut/906363_240.png 1,Prostate cancer – a biomarker perspective,Frontiers in endocrinology,,,Article,2012-01-01,10.3389/fendo.2012.00072,,,,22661971,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/906352,https://api.altmetric.com/v1/donut/906352_240.png 1,Cardiometabolic Complications after Androgen Deprivation Therapy in a Man with Prostate Cancer: Effects of 3?Years Intermittent Testosterone Supplementation,Frontiers in endocrinology,,,Article,2012-01-01,10.3389/fendo.2012.00017,,,,22645517,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/906320,https://api.altmetric.com/v1/donut/906320_240.png 1,Authentication of Algorithm to Detect Metastases in Men with Prostate Cancer Using ICD-9 Codes,Epidemiology Research International,,,Article,2012-01-01,10.1155/2012/970406,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/902920,https://api.altmetric.com/v1/donut/902920_240.png 1,Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results,Investigative Radiology,,,Article,2007-12-01,10.1097/rli.0b013e3181461d21,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/902668,https://api.altmetric.com/v1/donut/902668_240.png 1,Symptoms and Symptom Distress in Localized Prostate Cancer,Cancer nursing (Online),,,Article,1970-01-01,10.1097/01.ncc.0000300163.13639.bc,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/901957,https://api.altmetric.com/v1/donut/901957_240.png 1,Acute Toxicity After CyberKnife-Delivered Hypofractionated Radiotherapy for Treatment of Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2011-02-01,10.1097/coc.0b013e3181c4c7c4,,,,20065849,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/901531,https://api.altmetric.com/v1/donut/901531_240.png 1,ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2011-02-01,10.1097/coc.0b013e3182005319,,,,21270599,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/901524,https://api.altmetric.com/v1/donut/901524_240.png 1,Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells,PLoS ONE,,,Article,2012-08-03,10.1371/journal.pone.0042564,,,,22880034,PMC3411798,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/898195,https://api.altmetric.com/v1/donut/898195_240.png 1,"Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells",Journal of Biological Chemistry,,,Article,2012-01-01,10.1074/jbc.m112.374686,,,,22908221,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/897784,https://api.altmetric.com/v1/donut/897784_240.png 1,"A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products",Biochemical Journal,,,Article,2012-01-01,10.1042/bj20120545,,,,22657538,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/895402,https://api.altmetric.com/v1/donut/895402_240.png 1,Castration-resistant prostate cancer: potential targets and therapies,Biologics: Targets & Therapy,,,Article,2012-08-01,10.2147/btt.s23954,,,,22956858,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/891508,https://api.altmetric.com/v1/donut/891508_240.png 1,Updated Results of Magnetic Resonance Imaging Guided Partial Prostate Brachytherapy for Favorable Risk Prostate Cancer: Implications for Focal Therapy,The Journal of Urology,,,Article,2012-08-16,10.1016/j.juro.2012.06.010,,,,22901567,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/890826,https://api.altmetric.com/v1/donut/890826_240.png 1,[Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer.],Wiener Medizinische Wochenschrift (WMW),,,Article,2012-08-09,10.1007/s10354-012-0106-z,,,,22875632,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/881497,https://api.altmetric.com/v1/donut/881497_240.png 1,Expression changes in the stroma of prostate cancer predict subsequent relapse.,PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0041371,,,,22870216,PMC3411675,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/878407,https://api.altmetric.com/v1/donut/878407_240.png 1,The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors.,Journal of Cancer Research & Clinical Oncology,,,Article,2012-08-07,10.1007/s00432-012-1295-y,,,,22868821,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/878207,https://api.altmetric.com/v1/donut/878207_240.png 1,Glycosylation potential of human prostate cancer cell lines,Glycoconjugate Journal,,,Article,2012-08-01,10.1007/s10719-012-9428-8,,,,22843320,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/875762,https://api.altmetric.com/v1/donut/875762_240.png 1,A Phase II Pharmacodynamic Study of Preoperative Figitumumab in Patients with Localized Prostate Cancer,Clinical Cancer Research,,,Article,2012-01-01,10.1158/1078-0432.ccr-12-0482,,,,22553344,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/873670,https://api.altmetric.com/v1/donut/873670_240.png 1,C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.,British Journal of Urology,,,Article,2005-01-05,10.1111/j.1464-410x.2005.05447.x,,,,15839913,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/872951,https://api.altmetric.com/v1/donut/872951_240.png 1,Induced apoptosis in human prostate cancer cells by blocking of vascular endothelial growth factor by siRNA.,Clinical and Translational Oncology,,,Article,2012-07-24,10.1007/s12094-012-0868-1,,,,22855159,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/871283,https://api.altmetric.com/v1/donut/871283_240.png 1,Radiation therapy modalities for prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,2012-08-01,10.1001/jama.2012.8108,,,,22851099,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/870511,https://api.altmetric.com/v1/donut/870511_240.png 1,How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer?,Cancer (0008543X),,,Article,2011-01-01,10.1002/cncr.26713,,,,22180041,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/870199,https://api.altmetric.com/v1/donut/870199_240.png 1,The Interaction between Pesticide Use and Genetic Variants Involved in Lipid Metabolism on Prostate Cancer Risk,Journal of Cancer Epidemiology,,,Article,2012-01-01,10.1155/2012/358076,,,,22919386,PMC3419400,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/869481,https://api.altmetric.com/v1/donut/869481_240.png 1,Dietary Calcium and Risk for Prostate Cancer: A Case-Control Study Among US Veterans,"Preventing Chronic Disease: Public Health Research, Practice and Policy",,,Article,2011-12-01,10.5888/pcd9.110125,,,,22239754,PMC3310142,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/867668,https://api.altmetric.com/v1/donut/867668_240.png 1,Effects of TRPM8 on the proliferation and angiogenesis of prostate cancer PC-3 cells in vivo.,Oncology Letters,,,Article,2011-11-01,10.3892/ol.2011.410,,,,22848290,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/867381,https://api.altmetric.com/v1/donut/867381_240.png 1,Effect of diindolylmethane on Ca2(+) homeostasis and viability in PC3 human prostate cancer cells.,Journal of Receptor & Signal Transduction Research,,,Article,2012-07-31,10.3109/10799893.2012.707212,,,,22845469,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/866854,https://api.altmetric.com/v1/donut/866854_240.png 1,Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Antiâ??Tumour Potency on Prostate Cancer Cells,Basic & Clinical Pharmacology & Toxicology,,,Article,2013-01-01,10.1111/j.1742-7843.2012.00923.x,,,,22762560,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/865751,https://api.altmetric.com/v1/donut/865751_240.png 1,The Desmosomal Armadillo Protein Plakoglobin Regulates Prostate Cancer Cell Adhesion and Motility through Vitronectin-Dependent Src Signaling,PLoS ONE,,,Article,2012-07-30,10.1371/journal.pone.0042132,,,,22860065,PMC3408445,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/864503,https://api.altmetric.com/v1/donut/864503_240.png 1,"Survival of prostate cancer patients in central and northern Denmark, 1998–2009",Clinical Epidemiology,,,Article,2012-07-28,10.2147/clep.s20625,,,,21814469,PMC3144777,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/862116,https://api.altmetric.com/v1/donut/862116_240.png 1,Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population,Cancer Management and Research,,,Article,2012-07-28,10.2147/cmr.s21033,,,,21792332,PMC3139484,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/862055,https://api.altmetric.com/v1/donut/862055_240.png 1,Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects,OncoTargets and therapy,,,Article,2012-07-22,10.2147/ott.s32559,,,,22815644,PMC3400487,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/861667,https://api.altmetric.com/v1/donut/861667_240.png 1,The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development,Cancer Management and Research,,,Article,2012-07-01,10.2147/cmar.s32839,,,,22904640,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/861339,https://api.altmetric.com/v1/donut/861339_240.png 1,Evaluation of Tumor Angiogenesis in a Mouse PC-3 Prostate Cancer Model Using Dynamic Contrast-Enhanced Sonography.,Journal of Ultrasound in Medicine,,,Article,2012-08-01,,,,,22837286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/860756,https://api.altmetric.com/v1/donut/860756_240.png 1,Sorafenib Sensitizes (?)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation,Molecular Cancer Therapeutics,,,Article,2011-12-24,10.1158/1535-7163.mct-11-0559,,,,22188816,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/857896,https://api.altmetric.com/v1/donut/857896_240.png 1,Molecular expression and functional activity of sodium dependent multivitamin transporter in human prostate cancer cells.,International Journal of Pharmaceutics,,,Article,2012-06-28,10.1016/j.ijpharm.2012.06.011,,,,22732670,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/854880,https://api.altmetric.com/v1/donut/854880_240.png 1,Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2012-07-17,10.1093/jnci/djs280,,,,22825555,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/852389,https://api.altmetric.com/v1/donut/852389_240.png 1,Application of affymetrix array and massively parallel signature sequencing for identification of genes involved in prostate cancer progression,BMC Cancer,,,Article,2005-07-22,10.1186/1471-2407-5-86,,,,16042785,PMC1187880,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/852124,https://api.altmetric.com/v1/donut/852124_240.png 1,"Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro).",European Journal of Cancer (1965),,,Article,2012-06-10,10.1016/j.ejca.2012.05.014,,,,22677260,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/850990,https://api.altmetric.com/v1/donut/850990_240.png 1,Prevalence and Correlates of Vitamin and Supplement Usage Among Men With a Family History of Prostate Cancer,Integrative Cancer Therapies,,,Article,2011-01-01,10.1177/1534735411413262,,,,21821653,PMC3213317,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/849661,https://api.altmetric.com/v1/donut/849661_240.png 1,Assessment of the Quality of Medical Care Among Patients with Early Stage Prostate Cancer Undergoing Expectant Management in the United States,The Journal of Urology,,,Article,2012-07-20,10.1016/j.juro.2012.04.106,,,,22818140,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/849282,https://api.altmetric.com/v1/donut/849282_240.png 1,"Rac1 activation driven by 14-3-3? dimerization promotes prostate cancer cell-matrix interactions, motility and transendothelial migration.",PLoS ONE,,,Article,2012-01-01,10.1371/journal.pone.0040594,,,,22808202,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/848643,https://api.altmetric.com/v1/donut/848643_240.png 1,"Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens",Cancer Prevention Research,,,Article,2011-01-01,10.1158/1940-6207.capr-10-0195,,,,21372036,PMC3085251,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/847676,https://api.altmetric.com/v1/donut/847676_240.png 1,Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.,Cancer (0008543X),,,Article,2006-01-02,10.1002/cncr.21642,,,,16388523,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/846151,https://api.altmetric.com/v1/donut/846151_240.png 1,"Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",Cancer Causes and Control,,,Article,2008-07-12,10.1007/s10552-008-9198-6,,,,18618278,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/846149,https://api.altmetric.com/v1/donut/846149_240.png 1,Association between Plasma Total Cholesterol Concentration and Incident Prostate Cancer in the CLUE II Cohort,Cancer Causes and Control,,,Article,2010-01-01,10.1007/s10552-009-9434-8,,,,19806465,PMC3004752,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/841061,https://api.altmetric.com/v1/donut/841061_240.png 1,"Structural Modeling and DNA Binding Autoinhibition Analysis of Ergp55, a Critical Transcription Factor in Prostate Cancer",PLoS ONE,,,Article,2012-07-15,10.1371/journal.pone.0039850,,,,22761914,PMC3386182,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/841060,https://api.altmetric.com/v1/donut/841060_240.png 1,Endocrine treatment of prostate cancer.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2005-01-26,10.1016/j.jsbmb.2004.10.005,,,,15663992,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/840298,https://api.altmetric.com/v1/donut/840298_240.png 1,High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.10.036,,,,22245201,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/836377,https://api.altmetric.com/v1/donut/836377_240.png 1,Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl 2 ) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer,BMC Cancer,,,Article,2012-07-11,10.1186/1471-2407-12-284,,,,22784304,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/835335,https://api.altmetric.com/v1/donut/835335_240.png 1,Inhibitory effects of antagonists of growth hormone-releasing hormone (GHRH) on growth and invasiveness of PC3 human prostate cancer.,International Journal of Cancer,,,Article,2012-07-09,10.1002/ijc.27716,,,,22777643,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/834834,https://api.altmetric.com/v1/donut/834834_240.png 1,VEGF/Neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-1R define a novel mechanism of aggressive prostate cancer.,Cancer Discovery,,,Article,2012-07-09,10.1158/2159-8290.cd-12-0085,,,,22777769,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/834720,https://api.altmetric.com/v1/donut/834720_240.png 1,Identification of Kinases Regulating Prostate Cancer Cell Growth Using an RNAi Phenotypic Screen,PLoS ONE,,,Article,2012-06-27,10.1371/journal.pone.0038950,,,,22761715,PMC3384611,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/832126,https://api.altmetric.com/v1/donut/832126_240.png 1,Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells,FASEB Journal,,,Article,2012-01-01,10.1096/fj.12-206656,,,,22751009,PMC3448774,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/828214,https://api.altmetric.com/v1/donut/828214_240.png 1,Inhibition of JNK-1 by small interfering RNA induces apoptotic signaling in PC-3 prostate cancer cells.,International Journal of Molecular Medicine,,,Article,2012-07-05,10.3892/ijmm.2012.1055,,,,22766602,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/826942,https://api.altmetric.com/v1/donut/826942_240.png 1,Performance of an Adipokine Pathway-Based Multilocus Genetic Risk Score for Prostate Cancer Risk Prediction,PLoS ONE,,,Article,2012-06-29,10.1371/journal.pone.0039236,,,,22792137,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/816550,https://api.altmetric.com/v1/donut/816550_240.png 1,Aggressive Prostate Cancer Is Prevented in ER?KO Mice and Stimulated in ER?KO TRAMP Mice,Endocrinology,,,Article,2012-01-01,10.1210/en.2012-1030,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/816348,https://api.altmetric.com/v1/donut/816348_240.png 1,"Slug, a Unique Androgen-Regulated Transcription Factor, Coordinates Androgen Receptor to Facilitate Castration Resistance in Prostate Cancer",Molecular Endocrinology,,,Article,2012-01-01,10.1210/me.2011-1360,,,,22745193,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/815639,https://api.altmetric.com/v1/donut/815639_240.png 1,Maspin Reprograms the Gene Expression Profile of Prostate Carcinoma Cells for Differentiation,Genes & Cancer,,,Article,2012-01-01,10.1177/1947601912440170,,,,22737267,PMC3379563,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/805903,https://api.altmetric.com/v1/donut/805903_240.png 1,A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells,Biochemical Journal,,,Article,2012-01-01,10.1042/bj20120433,,,,22509934,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/804504,https://api.altmetric.com/v1/donut/804504_240.png 1,"Dietary Patterns Differ between Urban and Rural Older, Long-Term Survivors of Breast, Prostate, and Colorectal Cancer and Are Associated with Body Mass Index.",Journal of the Academy of Nutrition and Dietetics,,,Article,2012-06-01,10.1016/j.jand.2012.02.021,,,,22709810,PMC3378989,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/801084,https://api.altmetric.com/v1/donut/801084_240.png 1,"Vascular endothelial growth factor A, secreted in response to transforming growth factor-?1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells.",Cellular & Molecular Immunology,,,Article,2012-06-18,10.1038/aja.2011.197,,,,22705563,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/799025,https://api.altmetric.com/v1/donut/799025_240.png 1,Differential Expression of Epithelial and Mesenchymal Proteins in a Panel of Prostate Cancer Cell Lines,The Journal of Urology,,,Article,2012-06-18,10.1016/j.juro.2012.03.114,,,,22704442,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/797525,https://api.altmetric.com/v1/donut/797525_240.png 1,[18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy: influence of antiandrogen therapy - a preliminary study.,Nuclear Medicine Communications,,,Article,2012-06-10,10.1097/mnm.0b013e328355990f,,,,22692582,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/792138,https://api.altmetric.com/v1/donut/792138_240.png 1,Pharmacokinetic/Pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer,The Journal of Pharmacology and Experimental Therapeutics,,,Article,2012-01-01,10.1124/jpet.112.195560,,,,22691297,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/791935,https://api.altmetric.com/v1/donut/791935_240.png 1,Re: Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation,The Journal of Urology,,,Article,2012-01-01,10.1016/j.juro.2012.03.076,,,,22682870,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/783562,https://api.altmetric.com/v1/donut/783562_240.png 1,Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.,The Prostate,,,Article,2012-05-29,10.1002/pros.22540,,,,22644934,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/770936,https://api.altmetric.com/v1/donut/770936_240.png 1,Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer,Journal of Biomedical Science,,,Article,2011-08-23,10.1186/1423-0127-18-63,,,,21859492,,,,,,,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/764913,https://api.altmetric.com/v1/donut/764913_240.png 1,Small molecule inhibitors of PSMA incorporating technetium-99m for imaging prostate cancer: Effects of chelate design on pharmacokinetics,Inorganica Chimica Acta,,,Article,2012-03-01,10.1016/j.ica.2012.03.002,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/763658,https://api.altmetric.com/v1/donut/763658_240.png 1,Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines.,Urologic Oncology,,,Article,2012-05-17,10.1016/j.urolonc.2012.03.003,,,,22608542,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/758396,https://api.altmetric.com/v1/donut/758396_240.png 1,Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.,Cell Biology International,,,Article,2012-05-21,10.1042/cbi20110662,,,,22612256,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/757148,https://api.altmetric.com/v1/donut/757148_240.png 1,MYC Is Activated by USP2a-Mediated Modulation of MicroRNAs in Prostate Cancer.,Cancer Discovery,,,Article,2012-03-01,10.1158/2159-8290.cd-11-0219,,,,22585994,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/749053,https://api.altmetric.com/v1/donut/749053_240.png 1,A Double-Blind Placebo-Controlled Randomized Clinical Trial With Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.07.030,,,,22099039,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/747881,https://api.altmetric.com/v1/donut/747881_240.png 1,Intensity-Modulated Radiotherapy Causes Fewer Side Effects than Three-Dimensional Conformal Radiotherapy When Used in Combination With Brachytherapy for the Treatment of Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.06.2013,,,,22099032,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/747879,https://api.altmetric.com/v1/donut/747879_240.png 1,"Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Induced Prostate Carcinogenesis in CYP1A-humanized Mice.",Cancer Prevention Research,"POWERS, Justin K",School of Medicine & Medical Science; Department of Life Sciences,Article,2012-05-11,10.1158/1940-6207.capr-12-0023,,,,22581815,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/744452,https://api.altmetric.com/v1/donut/744452_240.png 1,Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study,Advances in Urology,,,Article,2012-01-01,10.1155/2012/651061,,,,22666241,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/744365,https://api.altmetric.com/v1/donut/744365_240.png 1,Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients,The Prostate,,,Article,2012-01-01,10.1002/pros.22538,,,,22585386,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/743969,https://api.altmetric.com/v1/donut/743969_240.png 1,Early Changes in Apparent Diffusion Coefficient From Diffusion-Weighted MR Imaging During Radiotherapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.06.2009,,,,22154286,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/743516,https://api.altmetric.com/v1/donut/743516_240.png 1,"Split-Course, High-Dose Palliative Pelvic Radiotherapy for Locally Progressive Hormone-Refractory Prostate Cancer","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.12.028,,,,22342096,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/743512,https://api.altmetric.com/v1/donut/743512_240.png 1,Early Proctoscopy is a Surrogate Endpoint of Late Rectal Toxicity in Prostate Cancer Treated With Radiotherapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.12.046,,,,22361084,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/741876,https://api.altmetric.com/v1/donut/741876_240.png 1,In regard to â??Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series.â?? (Int J Radiat Oncol Biol Phys 2012;83:624â??629),"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2012.01.015,,,,22579372,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/740989,https://api.altmetric.com/v1/donut/740989_240.png 1,Focal therapy for prostate cancer: revolution or evolution?,BMC Urology,,,Article,2009-04-23,10.1186/1471-2490-9-2,,,,19386137,PMC2679056,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/729677,https://api.altmetric.com/v1/donut/729677_240.png 1,Selective Cleavage of Human Sex Hormone-Binding Globulin by Kallikrein-Related Peptidases and Effects on Androgen Action in LNCaP Prostate Cancer Cells,Endocrinology,,,Article,2012-01-01,10.1210/en.2012-1011,,,,22547569,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/725184,https://api.altmetric.com/v1/donut/725184_240.png 1,"The prognostic value of expression of HIF1alpha, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy.",Radiation Oncology,,,Article,2012-04-30,10.1186/1748-717x-7-66,,,,22546016,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/723372,https://api.altmetric.com/v1/donut/723372_240.png 1,Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.,Journal of Biological Chemistry,,,Article,2012-04-24,10.1074/jbc.m112.353094,,,,22532569,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/717071,https://api.altmetric.com/v1/donut/717071_240.png 1,Improving Positioning in High-Dose Radiotherapy for Prostate Cancer: Safety and Visibility of Frequently Used Gold Fiducial Markers,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.05.058,,,,22014956,,1854/LU-2018599,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/712970,https://api.altmetric.com/v1/donut/712970_240.png 1,Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: The case of previous abdominal surgery. Results from a prospective trial.,Radiotherapy & Oncology,,,Article,2012-04-19,10.1016/j.radonc.2012.03.012,,,,22521747,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/712136,https://api.altmetric.com/v1/donut/712136_240.png 1,The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer,Prostate Cancer,,,Article,2012-01-01,10.1155/2012/280278,,,,22619727,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/711791,https://api.altmetric.com/v1/donut/711791_240.png 1,Beta-carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians' Health Study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.05.032,,,,22079732,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/708593,https://api.altmetric.com/v1/donut/708593_240.png 1,Epidural anesthesia with intravenous dexmedetomidine sedation in the successful anesthetic management of MRI-guided focused ultrasound ablation of early prostatic cancer.,Journal of Anesthesia,,,Article,2011-01-10,10.1007/s00540-011-1189-1,,,,21706220,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/706025,https://api.altmetric.com/v1/donut/706025_240.png 1,Lifestyle and dietary factors in the prevention of lethal prostate cancer.,Asian Journal of Andrology,,,Article,2012-04-16,10.1038/aja.2011.142,,,,22504869,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/702425,https://api.altmetric.com/v1/donut/702425_240.png 1,Integrative Analysis of N-linked Human Glycopro-teomic Datasets Reveals PTPRF Ectodomain as a Novel Plasma Biomarker Candidate for Prostate Cancer.,Journal of Proteome Research,,,Article,2012-04-11,10.1021/pr201200n,,,,22494190,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/696183,https://api.altmetric.com/v1/donut/696183_240.png 1,Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.,The Prostate,,,Article,2012-04-11,10.1002/pros.22523,,,,22495819,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/695434,https://api.altmetric.com/v1/donut/695434_240.png 1,The Impact of Real-Time Elastography Guiding a Systematic Prostate Biopsy to Improve Cancer Detection Rate: A Prospective Study of 353 Patients,The Journal of Urology,,,Article,2012-04-12,10.1016/j.juro.2012.01.063,,,,22498211,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/694211,https://api.altmetric.com/v1/donut/694211_240.png 1,Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings.,"Brain, Behavior & Immunity",,,Article,2012-04-06,10.1016/j.bbi.2012.03.001,,,,22475653,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/687187,https://api.altmetric.com/v1/donut/687187_240.png 1,Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer,PLoS ONE,,,Article,2012-04-06,10.1371/journal.pone.0035222,,,,22493742,PMC3320876,,2012PLoSO...7E5222J,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/686055,https://api.altmetric.com/v1/donut/686055_240.png 1,[Inhibitory effect of CMTM5 on xenografted human prostatic cancer in nude mice].,Zhonghua nan ke xue National journal of andrology,,,Article,2012-03-01,,,,,22474980,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/685693,https://api.altmetric.com/v1/donut/685693_240.png 1,Hemostatic gelatin sponge is a superior matrix to matrigel for establishment of LNCaP human prostate cancer in nude mice.,The Prostate,,,Article,2012-04-02,10.1002/pros.22520,,,,22473906,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/683616,https://api.altmetric.com/v1/donut/683616_240.png 1,"Interactions Between Genome-wide Significant Genetic Variants and Circulating Concentrations of Insulin-like Growth Factor 1, Sex Hormones, and Binding Proteins in Relation to Prostate Cancer Risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium",American Journal of Epidemiology,,,Article,2012-01-01,10.1093/aje/kwr423,,,,22459122,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/682100,https://api.altmetric.com/v1/donut/682100_240.png 1,Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications,Asian Journal of Andrology,,,Article,2012-02-20,10.1038/aja.2011.109,,,,22343494,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/672044,https://api.altmetric.com/v1/donut/672044_240.png 1,Practical Method of Adaptive Radiotherapy for Prostate Cancer Using Real-Time Electromagnetic Tracking,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.01.040,,,,21470786,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/671712,https://api.altmetric.com/v1/donut/671712_240.png 1,Induction of Apoptosis Coupled to Endoplasmic Reticulum Stress in Human Prostate Cancer Cells by n-butylidenephthalide,PLoS ONE,,,Article,2012-03-28,10.1371/journal.pone.0033742,,,,22470469,,,2012PLoSO...7E3742C,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/671266,https://api.altmetric.com/v1/donut/671266_240.png 1,Anticancer activities of genisteinâ?? topotecan combination in prostate cancer cells,Journal of Cellular and Molecular Medicine,,,Article,2012-01-01,10.1111/j.1582-4934.2012.01576.x,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/670398,https://api.altmetric.com/v1/donut/670398_240.png 1,High-Dose-Rate Brachytherapy as a Monotherapy for Favorable-Risk Prostate Cancer: A Phase II Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2010.09.006,,,,21550182,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/664608,https://api.altmetric.com/v1/donut/664608_240.png 1,[The diagnosis of prostate cancer from the clinical guidelines].,Archivos Españoles de Urología,,,Article,2011-11-05,,,,,22052760,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/662507,https://api.altmetric.com/v1/donut/662507_240.png 1,Megavoltage Cone Beam Computed Tomography Dose and the Necessity of Reoptimization for Imaging Dose-Integrated Intensity-Modulated Radiotherapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.03.034,,,,21620584,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/662225,https://api.altmetric.com/v1/donut/662225_240.png 1,"Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999â??2007","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.11.024,,,,22331001,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/658437,https://api.altmetric.com/v1/donut/658437_240.png 1,Phase I Trial of Pelvic Nodal Dose Escalation with Hypofractionated IMRT for High-Risk Prostate Cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-12-19,10.1016/j.ijrobp.2010.09.018,,,,21163590,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/657949,https://api.altmetric.com/v1/donut/657949_240.png 1,Classifying Prostate Cancer Malignancy by Quantitative Histomorphometry,The Journal of Urology,,,Article,2012-03-19,10.1016/j.juro.2011.12.054,,,,22424674,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/655747,https://api.altmetric.com/v1/donut/655747_240.png 1,Towards a selective cytotoxic agent for prostate cancer: Interaction of zinc complexes of polyhydroxybenzaldehyde thiosemicarbazones with topoisomerase I ,Polyhedron,,,Article,2012-01-01,10.1016/j.poly.2012.03.014,,,,,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/651028,https://api.altmetric.com/v1/donut/651028_240.png 1,The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancer.,The Prostate,,,Article,2012-03-13,10.1002/pros.22506,,,,22415934,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/650014,https://api.altmetric.com/v1/donut/650014_240.png 1,"Three-Dimensional Conformal Radiotherapy in Prostate Cancer Patients: Rise in Interleukin 6 (IL-6) but not IL-2, IL-4, IL-5, Tumor Necrosis Factor-α, MIP-1-α, and LIF Levels","International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.04.040,,,,21640501,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/642455,https://api.altmetric.com/v1/donut/642455_240.png 1,High Occurrence of Aberrant Lymph Node Spread on Magnetic Resonance Lymphography in Prostate Cancer Patients With a Biochemical Recurrence After Radical Prostatectomy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.04.054,,,,21640507,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/642452,https://api.altmetric.com/v1/donut/642452_240.png 1,Redefining High-Risk Prostate Cancer Based on Distant Metastases and Mortality After High-Dose Radiotherapy With Androgen Deprivation Therapy,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.04.042,,,,21665379,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/640767,https://api.altmetric.com/v1/donut/640767_240.png 1,High-Dose-Rate Brachytherapy Alone for Localized Prostate Cancer in Patients at Moderate or High Risk of Biochemical Recurrence,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.04.031,,,,21680108,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/640765,https://api.altmetric.com/v1/donut/640765_240.png 1,Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.04.067,,,,21708431,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/638876,https://api.altmetric.com/v1/donut/638876_240.png 1,Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer.,Angiogenesis,,,Article,2011-08-13,10.1007/s10456-011-9230-4,,,,21833623,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/638121,https://api.altmetric.com/v1/donut/638121_240.png 1,KAI1 suppresses HIF-1alpha and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.,BMC Cancer,,,Article,2012-03-06,10.1186/1471-2407-12-81,,,,22390300,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/638071,https://api.altmetric.com/v1/donut/638071_240.png 1,Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiation Therapy in the Treatment of Intermediate-Risk Prostate Cancer â?? Long Term Results,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.05.025,,,,21784585,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/637211,https://api.altmetric.com/v1/donut/637211_240.png 1,Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-01-01,10.1016/j.ijrobp.2011.09.002,,,,22208976,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/635281,https://api.altmetric.com/v1/donut/635281_240.png 1,Castration-resistant metastatic prostate cancer: current status and treatment possibilities.,Clinical and Translational Oncology,,,Article,2012-03-01,,,,,22374419,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/634009,https://api.altmetric.com/v1/donut/634009_240.png 1,"Pelvic Nodal Radiotherapy in Patients With Unfavorable Intermediate and High-Risk Prostate Cancer: Evidence, Rationale, and Future Directions: In Regard to Morikawa and Roach III (Int J Radiat Oncol Biol Phys 2011 May 1;80:6â??16).","International Journal of Radiation Oncology, Biology, Physics",,,Article,2012-01-01,10.1016/j.ijrobp.2011.11.061,,,,22385711,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/633651,https://api.altmetric.com/v1/donut/633651_240.png 1,[Application of basic research to the treatment of prostate cancer].,Nihon rinsho Japanese journal of clinical medicine,,,Article,2012-01-04,,,,,22207935,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/630073,https://api.altmetric.com/v1/donut/630073_240.png 1,HOXB13 and prostate cancer,Nature Genetics,,,Article,2012-02-27,10.1038/ng.2212,,,,22366864,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/628826,https://api.altmetric.com/v1/donut/628826_240.png 1,Do African American Men Have Lower Survival From Prostate Cancer Compared With White Men? A Meta-analysis,American Journal of Men's Health,,,Article,2010-01-01,10.1177/1557988309353934,,,,20483872,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/623545,https://api.altmetric.com/v1/donut/623545_240.png 1,"Antinuclear autoantibodies in prostate cancer: Immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis",The Prostate,,,Article,2005-01-01,10.1002/pros.20112,,,,15389814,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/622587,https://api.altmetric.com/v1/donut/622587_240.png 1,"Prostate cancer, masculinity and food. Rationales for perceived diet change",Appetite,,,Article,2010-12-01,10.1016/j.appet.2010.07.009,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/620064,https://api.altmetric.com/v1/donut/620064_240.png 1,miR-21 as an Independent Biochemical Recurrence Predictor and Potential Therapeutic Target for Prostate Cancer,"Journal of Urology, The",,,Article,2012-02-20,10.1016/j.juro.2011.11.082,,,,22341810,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/612838,https://api.altmetric.com/v1/donut/612838_240.png 1,Antigen Specific T-Cell Responses Against Tumor Antigens are Controlled by Regulatory T Cells in Patients With Prostate Cancer,"Journal of Urology, The",,,Article,2012-02-17,10.1016/j.juro.2011.11.083,,,,22341271,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/609878,https://api.altmetric.com/v1/donut/609878_240.png 1,"Detection of Prostate Cancer in an Ethnically Diverse, Disadvantaged Population With Multiple Prostate Specific Antigen Measurements Before Biopsy","Journal of Urology, The",,,Article,2012-02-15,10.1016/j.juro.2011.11.090,,,,22335862,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/608391,https://api.altmetric.com/v1/donut/608391_240.png 1,Early Management of Prostate Cancer: How to Respond to an Elevated PSA?,Annual Review of Medicine,,,Article,2002-02-01,10.1146/annurev.med.53.082901.104000,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/605042,https://api.altmetric.com/v1/donut/605042_240.png 1,Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.,International journal of urology : official journal of the Japanese Urological Association,,,Article,2012-02-10,10.1111/j.1442-2042.2012.02967.x,,,,22324515,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/604390,https://api.altmetric.com/v1/donut/604390_240.png 1,Resveratrol Induces Prostate Cancer Cell Entry into S Phase and Inhibits DNA Synthesis,Cancer Research,,,Article,2002-01-01,,,,,11980638,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/603314,https://api.altmetric.com/v1/donut/603314_240.png 1,"Differential Effects on Growth, Cell Cycle Arrest, and Induction of Apoptosis by Resveratrol in Human Prostate Cancer Cell Lines,",Experimental Cell Research,,,Article,1999-05-25,10.1006/excr.1999.4471,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/603313,https://api.altmetric.com/v1/donut/603313_240.png 1,Complications and Functional Results of Surgery for Locally Advanced Prostate Cancer,Advances in Urology,,,Article,2012-02-07,10.1155/2012/706309,,,,22291698,PMC3265055,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/592554,https://api.altmetric.com/v1/donut/592554_240.png 1,Efficient Delivery of Sticky siRNA and Potent Gene Silencing in a Prostate Cancer Model Using a Generation 5 Triethanolamine-Core PAMAM Dendrimer,Molecular Pharmaceutics,,,Article,2012-01-20,10.1021/mp2006104,,,,22208617,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/568452,https://api.altmetric.com/v1/donut/568452_240.png 1,"Interactions and relationships of PTEN, ERG, SPINK1 and AR in castrationâ??resistant prostate cancer",Histopathology,,,Article,2012-01-22,10.1111/j.1365-2559.2011.04116.x,,,,22260502,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/567051,https://api.altmetric.com/v1/donut/567051_240.png 1,Olfactory detection of prostate cancer by dogs,Journal of Veterinary Behavior: Clinical Applications and Research,,,Article,2012-01-01,10.1016/j.jveb.2011.12.003,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/564823,https://api.altmetric.com/v1/donut/564823_240.png 1,Diffusion-Weighted Imaging of a Prostate Cancer Xenograft Model Seen on a 7 Tesla Animal MR Scanner: Comparison of ADC Values and Pathologic Findings.,Korean journal of radiology : official journal of the Korean Radiological Society,,,Article,2012-01-01,10.3348/kjr.2012.13.1.82,,,,22247640,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/562792,https://api.altmetric.com/v1/donut/562792_240.png 1,"Prostate Cancer characteristics and survival in Males of African Ancestry according to place of birth: Data from Brooklyn - New York, Guyana, Tobago and Trinidad",The Prostate,,,Article,1970-01-01,10.1002/pros.21144,,,,20503395,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/561759,https://api.altmetric.com/v1/donut/561759_240.png 1,Factors implicated in radiation therapy failure and radiosensitization of prostate cancer.,Prostate cancer,,,Article,2012-01-01,10.1155/2012/593241,,,,22229096,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/554158,https://api.altmetric.com/v1/donut/554158_240.png 1,Influence of antiflatulent dietary advice on intrafraction motion for prostate cancer radiotherapy.,Int J Radiat Oncol Biol Phys,,,Article,1970-01-01,10.1016/j.ijrobp.2011.04.062,,,,21664067,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/552602,https://api.altmetric.com/v1/donut/552602_240.png 1,"Effects of a 1-Week Inpatient Course Including Information, Physical Activity, and Group Sessions for Prostate Cancer Patients",Journal of Cancer Education,,,Article,2011-12-01,10.1007/s13187-011-0245-8,,,,21626449,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/547097,https://api.altmetric.com/v1/donut/547097_240.png 1,Progress of molecular targeted therapies for prostate cancers.,BBA - Reviews on Cancer,,,Article,2011-11-29,10.1016/j.bbcan.2011.11.003,,,,22146293,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/543370,https://api.altmetric.com/v1/donut/543370_240.png 1,Demonstrating the importance of Polymer-Conjugate Conformation in Solution on its Therapeutic Output: Diethylstilbestrol (DES)-Polyacetals as prostate cancer treatment,Journal of Controlled Release,,,Article,2012-01-12,10.1016/j.jconrel.2011.12.035,,,,22230343,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/541406,https://api.altmetric.com/v1/donut/541406_240.png 1,"Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies.",British Journal of Urology,,,Article,2004-05-16,10.1111/j.1464-410x.2004.04795.x,,,,15142129,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/530942,https://api.altmetric.com/v1/donut/530942_240.png 1,We Need a Better Marker for Prostate Cancer. How About Renaming PSA?,Urology,,,Article,2011-12-01,10.1016/j.urology.2011.10.058,,,,22196413,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/506900,https://api.altmetric.com/v1/donut/506900_240.png 1,Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer,Annals of Oncology,,,Article,2012-01-01,10.1093/annonc/mdr056,,,,21467126,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/504802,https://api.altmetric.com/v1/donut/504802_240.png 1,Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551.,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",,,Article,2011-12-15,10.2967/jnumed.111.090829,,,,22173843,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/498385,https://api.altmetric.com/v1/donut/498385_240.png 1,"Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-?B/AP-1 dependent- and independent-signaling.",Clinical & experimental metastasis,,,Article,2011-12-14,10.1007/s10585-011-9439-z,,,,22167622,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/495593,https://api.altmetric.com/v1/donut/495593_240.png 1,The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells.,Carcinogenesis,,,Article,2008-11-01,10.1093/carcin/bgn018,,,,18635524,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/495304,https://api.altmetric.com/v1/donut/495304_240.png 1,The influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort study,BMC Cancer,,,Article,2011-12-15,10.1186/1471-2407-11-519,,,,22172009,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/494499,https://api.altmetric.com/v1/donut/494499_240.png 1,DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines.,Epigenomics,,,Article,2011-12-01,10.2217/epi.11.103,,,,22126297,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/494451,https://api.altmetric.com/v1/donut/494451_240.png 1,"Prostatic carcinomas with neuroendocrine differentiation diagnosed in needle biopsies, a morphologic study of 7 cases among 465 sequential biopsies in a tertiary cancer center",International braz j urol,,,Article,2011-01-01,10.1590/s1677-55382011000500005,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/493293,https://api.altmetric.com/v1/donut/493293_240.png 1,The HOPE fixation technique - a promising alternative to common prostate cancer biobanking approaches,BMC Cancer,,,Article,2011-12-07,10.1186/1471-2407-11-511,,,,22151117,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/486869,https://api.altmetric.com/v1/donut/486869_240.png 1,Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone,The Journal of Experimental Medicine,,,Article,2011-01-01,10.1084/jem.20110840,,,,22124112,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/484189,https://api.altmetric.com/v1/donut/484189_240.png 1,Clinical utility of diffusionâ??weighted magnetic resonance imaging in prostate cancer,British Journal of Urology,,,Article,2011-12-01,10.1111/j.1464-410x.2011.10256.x,,,,21631696,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/483356,https://api.altmetric.com/v1/donut/483356_240.png 1,Vitamin E and Prostate Cancer: Research Focus Turns to Biologic Mechanisms,Journal of the National Cancer Institute,,,Article,2011-01-01,10.1093/jnci/djr504,,,,22100581,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/482821,https://api.altmetric.com/v1/donut/482821_240.png 1,Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model.,Pharmaceutical Research,,,Article,2011-12-03,10.1007/s11095-011-0625-0,,,,22139534,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/481647,https://api.altmetric.com/v1/donut/481647_240.png 1,Urinary incontinence after treatment for prostate cancer,British Medical Journal,,,Article,2011-12-05,10.1136/bmj.d7850,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/480379,https://api.altmetric.com/v1/donut/480379_240.png 1,Risk of prostate cancer in a population-based cohort of men with coeliac disease.,British journal of cancer,,,Article,2011-12-01,10.1038/bjc.2011.536,,,,22134505,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/479927,https://api.altmetric.com/v1/donut/479927_240.png 1,Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.,Clinical and investigative medicine. Médecine clinique et experimentale,,,Article,2011-01-01,,,,,22129926,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/479578,https://api.altmetric.com/v1/donut/479578_240.png 1,Pain in castration-resistant prostate cancer with bone metastases: a qualitative study,Health and Quality of Life Outcomes,,,Article,2011-12-02,10.1186/1477-7525-9-88,,,,21992720,PMC3222603,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/477497,https://api.altmetric.com/v1/donut/477497_240.png 1,Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis.,AJR. American journal of roentgenology,,,Article,2011-12-01,10.2214/ajr.11.6861,,,,22109293,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,82,https://www.altmetric.com/details/467705,https://api.altmetric.com/v1/donut/467705_240.png 1,Review of prostate cancer research in Nigeria,Infectious Agents and Cancer,,,Article,2011-11-18,10.1186/1750-9378-6-s2-s8,,,,21992456,PMC3194187,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/460499,https://api.altmetric.com/v1/donut/460499_240.png 1,Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer.,Prostate cancer and prostatic diseases,,,Article,2011-11-15,10.1038/pcan.2011.56,,,,22083266,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/459749,https://api.altmetric.com/v1/donut/459749_240.png 1,LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling,PLoS ONE,,,Article,2011-11-16,10.1371/journal.pone.0027720,,,,22110740,PMC3218022,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/459668,https://api.altmetric.com/v1/donut/459668_240.png 1,Role and expression of FRS2 and FRS3 in prostate cancer,BMC Cancer,,,Article,2011-11-11,10.1186/1471-2407-11-484,,,,22078327,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/459182,https://api.altmetric.com/v1/donut/459182_240.png 1,Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.,The Prostate,,,Article,2011-05-15,10.1002/pros.21288,,,,20954195,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/458135,https://api.altmetric.com/v1/donut/458135_240.png 1,"Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1? and induces G2/M arrest under hypoxia in prostate cancer cells.",Prostate cancer and prostatic diseases,,,Article,2011-11-15,10.1038/pcan.2011.51,,,,22083267,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/457874,https://api.altmetric.com/v1/donut/457874_240.png 1,Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer,JNCI: Journal of the National Cancer Institute,,,Article,2011-01-01,10.1093/jnci/djr362,,,,21917607,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/456690,https://api.altmetric.com/v1/donut/456690_240.png 1,Calcitriol and Genistein Actions to Inhibit the Prostaglandin Pathway: Potential Combination Therapy to Treat Prostate Cancer,The Journal of Nutrition,,,Article,2007-01-01,,,,,17182827,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/450741,https://api.altmetric.com/v1/donut/450741_240.png 1,In Vivo Near-Infrared Fluorescence Imaging of Integrin ?2?1 in Prostate Cancer with Cell-Penetrating-Peptide-Conjugated DGEA Probe.,Journal of Nuclear Medicine,,,Article,2011-11-07,10.2967/jnumed.111.091256,,,,22065876,,,,,,,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/449203,https://api.altmetric.com/v1/donut/449203_240.png 1,Impact of health system challenges on prostate cancer control: health care experiences in Nigeria,Infectious Agents and Cancer,,,Article,2011-11-10,10.1186/1750-9378-6-s2-s5,,,,21992224,PMC3194184,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/448934,https://api.altmetric.com/v1/donut/448934_240.png 1,Metastatic Prostate Cancer: Single Infusion of Ibandronate as Effective as Single Dose of Radiation in Relieving Pain,Oncology times,,,Article,2011-11-10,10.1097/01.cot.0000407945.98750.64,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/447361,https://api.altmetric.com/v1/donut/447361_240.png 1,The 5?-Androstanedione Pathway to Dihydrotestosterone in Castration-Resistant Prostate Cancer,Journal of Investigative Medicine,,,Article,2011-11-04,10.231/jim.0b013e31823874a4,,,,22064602,,,,,,,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/445970,https://api.altmetric.com/v1/donut/445970_240.png 1,Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence,Journal of the American Medical Informatics Association,,,Article,2011-07-01,10.1136/amiajnl-2011-000178,,,,21672909,PMC3128407,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/444021,https://api.altmetric.com/v1/donut/444021_240.png 1,Time schedule-dependent effect of the CK2 inhibitor TBB on PC-3 human prostate cancer cell viability.,Oncology reports,,,Article,2012-01-01,10.3892/or.2011.1500,,,,21993828,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/443065,https://api.altmetric.com/v1/donut/443065_240.png 1,The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.,Journal of experimental therapeutics & oncology,,,Article,2004-12-01,,,,,15844659,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/442885,https://api.altmetric.com/v1/donut/442885_240.png 1,Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line,Biochemical and Biophysical Research Communications,,,Article,2011-04-28,10.1016/j.bbrc.2011.04.109,,,,21549092,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/424754,https://api.altmetric.com/v1/donut/424754_240.png 1,"Prostate Cancer Research Roundup from Genitourinary Cancers Symposium: Clinical Guidelines, New Drugs, Old Drugs, & RTOG 94-08 Final Results",Oncology times,,,Article,2010-06-10,10.1097/01.cot.0000383058.51415.23,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/415537,https://api.altmetric.com/v1/donut/415537_240.png 1,Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer.,The Prostate,,,Article,2002-05-01,10.1002/pros.10058,,,,11948965,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/404930,https://api.altmetric.com/v1/donut/404930_240.png 1,Long-term vs. Short-term Androgen Deprivation Combined with High-dose Radiotherapy for Intermediate and High-risk Prostate Cancer: Preliminary Results of a GICOR Phase III Randomized Trial,International Journal of Radiation Oncology*Biology*Physics,,,Article,2011-10-14,10.1016/j.ijrobp.2011.06.082,,,,,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/403669,https://api.altmetric.com/v1/donut/403669_240.png 1,Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein.,Molecular urology,,,Article,2000-01-01,,,,,10851300,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/400066,https://api.altmetric.com/v1/donut/400066_240.png 1,Overall and worst gleason scores are equally good predictors of prostate cancer progression,BMC Urology,,,Article,2011-10-06,10.1186/1471-2490-11-21,,,,21978318,PMC3193164,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/399755,https://api.altmetric.com/v1/donut/399755_240.png 1,New Developments in the Medical Management of Prostate Cancer,Mayo Clinic Proceedings,,,Article,2009-12-30,10.4065/mcp.2009.0442,,,,20042563,PMC2800284,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/397455,https://api.altmetric.com/v1/donut/397455_240.png 1,MET and VEGF: synergistic targets in castration-resistant prostate cancer.,Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,,,Article,2011-10-01,,,,,21975330,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/395635,https://api.altmetric.com/v1/donut/395635_240.png 1,Oncostatin M and IL-6 Induce u-PA and VEGF in Prostate Cancer Cells and Correlate In Vivo.,Anticancer research,,,Article,2011-10-01,,,,,21965736,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/391349,https://api.altmetric.com/v1/donut/391349_240.png 1,Antihypertensive Drugs and the Risk of Prostate Cancer.,European urology,,,Article,2011-09-17,10.1016/j.eururo.2011.09.009,,,,21962717,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/391242,https://api.altmetric.com/v1/donut/391242_240.png 1,Malignant Priapism Secondary to Metastatic Prostate Cancer: A Case Report and Review of Literature,Reviews in Urology,,,Article,2011-09-26,,,,,21935340,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/382171,https://api.altmetric.com/v1/donut/382171_240.png 1,Prostate Cancer and Race,Current Problems in Cancer,,,Article,2007-06-01,10.1016/j.currproblcancer.2007.01.006,,,,17543949,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/375552,https://api.altmetric.com/v1/donut/375552_240.png 1,Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.,Technology in cancer research & treatment,,,Article,2009-06-01,,,,,19445537,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/375550,https://api.altmetric.com/v1/donut/375550_240.png 1,"A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.",American journal of clinical oncology,,,Article,2010-12-01,10.1097/coc.0b013e3181c4c6e1,,,,20051808,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/375549,https://api.altmetric.com/v1/donut/375549_240.png 1,Bortezomib represses HIF-1? protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells.,"Journal of molecular medicine (Berlin, Germany)",,,Article,2011-09-10,10.1007/s00109-011-0805-8,,,,21909688,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/259943,https://api.altmetric.com/v1/donut/259943_240.png 1,Genome-wide association study identifies new prostate cancer susceptibility loci,Human Molecular Genetics,,,Article,2011-07-08,10.1093/hmg/ddr295,,,,21743057,PMC3168287,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/256290,https://api.altmetric.com/v1/donut/256290_240.png 1,"Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy.",Cancer,,,Article,2011-04-14,10.1002/cncr.26136,,,,21495024,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/253942,https://api.altmetric.com/v1/donut/253942_240.png 1,Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.,Acta biochimica Polonica,,,Article,2011-08-29,,,,,21887406,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/252246,https://api.altmetric.com/v1/donut/252246_240.png 1,Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis,PLoS ONE,,,Article,2011-04-20,10.1371/journal.pone.0018801,,,,21533099,,,2011PLoSO...6E8801D,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/251182,https://api.altmetric.com/v1/donut/251182_240.png 1,Treatment of low-risk prostate cancer with radical hypofractionated accelerated radiotherapy with cytoprotection (HypoARC): an interim analysis of toxicity and efficacy.,Anticancer research,,,Article,2011-05-01,,,,,21617234,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/248673,https://api.altmetric.com/v1/donut/248673_240.png 1,"Solid Lipid–PEI Hybrid Nanocarrier: An Integrated Approach To Provide Extended, Targeted, and Safer siRNA Therapy of Prostate Cancer in an All-in-One Manner",ACS Nano,,,Article,2011-08-18,10.1021/nn201659z,,,,21838301,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/240155,https://api.altmetric.com/v1/donut/240155_240.png 1,Quantitative Glycoproteomic Analysis of Optimal Cutting Temperature-Embedded Frozen Tissues Identifying Glycoproteins Associated with Aggressive Prostate Cancer,Analytical Chemistry,,,Article,2011-08-18,10.1021/ac200815q,,,,21780747,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/239656,https://api.altmetric.com/v1/donut/239656_240.png 1,Detection of Xenotropic Murine Leukemia Virus–Related Virus in Normal and Tumor Tissue of Patients from the Southern United States with Prostate Cancer Is Dependent on Specific Polymerase Chain Reaction Conditions,The Journal of Infectious Diseases,,,Article,2010-11-15,10.1086/656146,,,,20936978,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/238352,https://api.altmetric.com/v1/donut/238352_240.png 1,Prostate Cancer Screening Decisions: Results From the National Survey of Medical Decisions (DECISIONS Study),Archives of Internal Medicine,,,Article,2009-09-28,10.1001/archinternmed.2009.262,,,,19786681,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/227417,https://api.altmetric.com/v1/donut/227417_240.png 1,Genetics: Predictor for prostate cancer,Nature Reviews Clinical Oncology,,,Article,2011-03-08,10.1038/nrclinonc.2011.29,,,,21451494,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/227355,https://api.altmetric.com/v1/donut/227355_240.png 1,Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England,British Journal of Urology,,,Article,2011-03-29,10.1111/j.1464-410x.2011.10165.x,,,,21438985,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/224183,https://api.altmetric.com/v1/donut/224183_240.png 1,Antiâ??proliferative effects of vitamin D on prostate cancer cells in vitro,Journal of Human Nutrition & Dietetics,,,Article,2011-06-01,10.1111/j.1365-277x.2011.01175_12.x,,,,,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/224164,https://api.altmetric.com/v1/donut/224164_240.png 1,Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy,Journal of Osteoporosis,,,Article,2011-08-12,10.4061/2011/924595,,,,21826255,PMC3150775,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/222844,https://api.altmetric.com/v1/donut/222844_240.png 1,Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization,The Prostate,,,Article,2009-06-15,10.1002/pros.20949,,,,19267368,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/221388,https://api.altmetric.com/v1/donut/221388_240.png 1,Mixed Tocotrienols Inhibit Prostate Carcinogenesis in TRAMP Mice,Nutrition and Cancer,,,Article,2010-07-23,10.1080/01635581003605896,,,,20661828,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/221321,https://api.altmetric.com/v1/donut/221321_240.png 1,Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.,Nutrition and Cancer,,,Article,2010-01-01,10.1080/01635581.2010.509839,,,,20924975,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/221052,https://api.altmetric.com/v1/donut/221052_240.png 1,Prostate cancer susceptibility variants confer increased risk of disease progression.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-09-01,10.1158/1055-9965.epi-10-0268,,,,20651075,PMC2950095,,,,,,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,5,https://www.altmetric.com/details/217920,https://api.altmetric.com/v1/donut/217920_240.png 1,Screening for prostate cancer,British Medical Journal,,,Article,2010-01-01,10.1136/bmj.c4538,,,,20843936,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/216400,https://api.altmetric.com/v1/donut/216400_240.png 1,Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of highâ??risk men: effect of TMPRSS2 Met160Val,British Journal of Urology,,,Article,2011-02-01,10.1111/j.1464-410x.2010.09522.x,,,,20735386,PMC3052292,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/215878,https://api.altmetric.com/v1/donut/215878_240.png 1,Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer,British Journal of Urology,,,Article,2011-02-01,10.1111/j.1464-410x.2010.09533.x,,,,20804486,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/215877,https://api.altmetric.com/v1/donut/215877_240.png 1,PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer,British Journal of Urology,,,Article,2011-02-01,10.1111/j.1464-410x.2010.09470.x,,,,20590547,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/215876,https://api.altmetric.com/v1/donut/215876_240.png 1,Clinical significance of runtâ??related transcription factor 1 polymorphism in prostate cancer,British Journal of Urology,,,Article,2011-02-01,10.1111/j.1464-410x.2010.09512.x,,,,20735389,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/215875,https://api.altmetric.com/v1/donut/215875_240.png 1,Trends in the treatment of localized prostate cancer using supplemented cancer registry data,British Journal of Urology,,,Article,2011-02-01,10.1111/j.1464-410x.2010.09514.x,,,,20735387,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/215866,https://api.altmetric.com/v1/donut/215866_240.png 1,Five year Expanded Prostate cancer Index Compositeâ??based quality of life outcomes after prostatectomy for localized prostate cancer,British Journal of Urology,,,Article,2011-02-01,10.1111/j.1464-410x.2010.09579.x,,,,20804482,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/215865,https://api.altmetric.com/v1/donut/215865_240.png 1,Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells,Molecular Cancer Therapeutics,,,Article,2010-12-14,10.1158/1535-7163.mct-10-0368,,,,21159605,,,,,,,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/215632,https://api.altmetric.com/v1/donut/215632_240.png 1,The changing therapeutic landscape of castration-resistant prostate cancer,Nature Reviews Clinical Oncology,,,Article,2011-08-09,10.1038/nrclinonc.2011.117,,,,21826082,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/207993,https://api.altmetric.com/v1/donut/207993_240.png 1,A novel inhibitor of hypoxia-inducible factor-1alpha P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells.,BMC cancer,,,Article,2011-08-05,10.1186/1471-2407-11-338,,,,21819554,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/207815,https://api.altmetric.com/v1/donut/207815_240.png 1,Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2.,The Prostate,,,Article,2011-08-01,10.1002/pros.21472,,,,21809353,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/203178,https://api.altmetric.com/v1/donut/203178_240.png 1,Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers.,The Prostate,,,Article,2011-07-01,10.1002/pros.21319,,,,21557269,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/198721,https://api.altmetric.com/v1/donut/198721_240.png 1,Is XMRV a causal virus for prostate cancer?,Asian journal of andrology,,,Article,2011-07-18,10.1038/aja.2011.32,,,,21765437,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/192046,https://api.altmetric.com/v1/donut/192046_240.png 1,"Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma",BMC Cancer,,,Article,2011-07-18,10.1186/1471-2407-11-302,,,,21767383,PMC3199863,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/191914,https://api.altmetric.com/v1/donut/191914_240.png 1,Validation of pre- and postoperative nomograms used to predict the pathological stage and prostate cancer recurrence after radical prostatectomy: a multi-institutional study.,Journal of B.U.ON. : official journal of the Balkan Union of Oncology,,,Article,2011-01-01,,,,,21766504,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/191900,https://api.altmetric.com/v1/donut/191900_240.png 1,[Information needs of patients with prostate cancer : Pronounced differences between individuals after diagnosis of localised prostate carcinoma.],Der Urologe. Ausg. A,,,Article,2011-07-02,10.1007/s00120-011-2626-3,,,,21720833,,,,,,,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/178666,https://api.altmetric.com/v1/donut/178666_240.png 0,Androgen receptor CAG repeats and prostate cancer.,American Journal of Epidemiology,,,Article,2002-05-15,,,,,11994226,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13393048,https://api.altmetric.com/v1/donut/13393048_240.png 0,Negative information-seeking experiences of long-term prostate cancer survivors,Journal of Cancer Survivorship,,,Article,2016-05-26,10.1007/s11764-016-0552-5,,,,27229868,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13392941,https://api.altmetric.com/v1/donut/13392941_240.png 0,Farmers at risk for prostate cancer,British Journal of Urology,,,Article,2003-10-29,10.1046/j.1464-410x.1996.07751.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13392929,https://api.altmetric.com/v1/donut/13392929_240.png 0,Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2016-08-01,10.1016/j.clgc.2016.08.006,,,,27641657,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13380890,https://api.altmetric.com/v1/donut/13380890_240.png 0,Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2016-08-01,10.1016/j.clgc.2016.08.006,,,,27641657,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13380889,https://api.altmetric.com/v1/donut/13380889_240.png 0,A Pilot Clinical Trial of Radioprotective Effects of Curcumin Supplementation in Patients with Prostate Cancer,Journal of Cancer Science & Therapy,,,Article,2013-10-09,10.4172/1948-5956.1000222,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13377991,https://api.altmetric.com/v1/donut/13377991_240.png 0,Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells Is Independent of NCoR and SMRT Corepressors,Cancer Research,,,Article,2007-08-31,10.1158/0008-5472.can-07-0617,,,,17804755,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13375071,https://api.altmetric.com/v1/donut/13375071_240.png 0,"Abstract 2767: Genetic variation in obesity-related genes ADBR2, ADBR3, GHRL, HSD11B1, and SHC1 and risk of prostate cancer: A VA case-control study",Cancer Research,,,Article,2014-11-13,10.1158/1538-7445.am2011-2767,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13374886,https://api.altmetric.com/v1/donut/13374886_240.png 0,Abstract B18: Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer in men of African descent,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-04-15,10.1158/1538-7755.disp15-b18,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13374847,https://api.altmetric.com/v1/donut/13374847_240.png 0,"Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models",Oncotarget,,,Article,2016-10-28,10.18632/oncotarget.12975,,,,27806313,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13374556,https://api.altmetric.com/v1/donut/13374556_240.png 0,Treatment-related neuroendocrine prostate cancer resulting in Cushing's syndrome,International Journal of Urology,,,Article,2016-10-21,10.1111/iju.13225,,,,27766686,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13373601,https://api.altmetric.com/v1/donut/13373601_240.png 0,Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy,Radiotherapy & Oncology,,,Article,2016-11-01,10.1016/j.radonc.2016.10.019,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13363938,https://api.altmetric.com/v1/donut/13363938_240.png 0,Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer,Radiation Oncology,,,Article,2016-11-04,10.1186/s13014-016-0721-8,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13358931,https://api.altmetric.com/v1/donut/13358931_240.png 0,Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer,British Journal of Cancer,,,Article,2016-11-01,10.1038/bjc.2016.353,,,,27802450,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13348519,https://api.altmetric.com/v1/donut/13348519_240.png 0,Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient,Journal of Cancer Research & Clinical Oncology,,,Article,2013-10-16,10.1007/s00432-013-1538-6,,,,24132461,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13339695,https://api.altmetric.com/v1/donut/13339695_240.png 0,Anti—Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab Plus Doxorubicin in the Treatment of Metastatic Castration-Resistant Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2009-10-14,10.3816/cgc.2009.n.028,,,,19815486,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13256053,https://api.altmetric.com/v1/donut/13256053_240.png 0,Prostate-Specific Membrane Antigen Vaccines: Naked DNA and Protein Approaches,Clinical Genitourinary Cancer,,,Article,2005-09-01,10.3816/cgc.2005.n.020,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13256050,https://api.altmetric.com/v1/donut/13256050_240.png 0,A Measure of Health-Related Quality of Life Among Patients with Localized Prostate Cancer: Results from Ongoing Scale Development,Clinical Genitourinary Cancer,,,Article,2005-09-01,10.3816/cgc.2005.n.017,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13256049,https://api.altmetric.com/v1/donut/13256049_240.png 0,Second-Line Chemotherapy for Prostate Cancer: Patient Characteristics and Survival,Clinical Genitourinary Cancer,,,Article,2005-09-01,10.3816/cgc.2005.n.015,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13256048,https://api.altmetric.com/v1/donut/13256048_240.png 0,Active Surveillance for Prostate Cancer with Selective Delayed Definitive Therapy,Clinical Genitourinary Cancer,,,Article,2005-06-01,10.3816/cgc.2005.n.011,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13256047,https://api.altmetric.com/v1/donut/13256047_240.png 0,Incremental Value of Multiplanar Cross-Referencing for Prostate Cancer Staging with Endorectal MRI,American Journal of Roentgenology,,,Article,2007-01-15,10.2214/ajr.05.1783,,,,17179351,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13254887,https://api.altmetric.com/v1/donut/13254887_240.png 0,Combined Endorectal and Phased-Array MRI in the Prediction of Pelvic Lymph Node Metastasis in Prostate Cancer,American Journal of Roentgenology,,,Article,2006-03-15,10.2214/ajr.04.1682,,,,16498101,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13254880,https://api.altmetric.com/v1/donut/13254880_240.png 0,Focal low-dose rate brachytherapy for the treatment of prostate cancer,Cancer Management and Research,,,Article,2013-09-12,10.2147/cmar.s33056,,,,24049459,PMC3775638,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13254837,https://api.altmetric.com/v1/donut/13254837_240.png 0,Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging,International braz j urol,,,Article,2010-02-01,10.1590/s1677-55382010000100018,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253938,https://api.altmetric.com/v1/donut/13253938_240.png 0,Prostatic specific antigen for prostate cancer detection,International braz j urol,,,Article,2009-10-01,10.1590/s1677-55382009000500003,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253936,https://api.altmetric.com/v1/donut/13253936_240.png 0,A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue,Biological Chemistry,,,Article,2007-03-15,10.1515/bc.2007.032,,,,17338636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253653,https://api.altmetric.com/v1/donut/13253653_240.png 0,Update on Prostate-Specific Antigen Testing for the Early Detection of Prostate Cancer,Laboratory Medicine,,,Article,2008-10-01,10.1309/lm6c66ptqdspjqet,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253342,https://api.altmetric.com/v1/donut/13253342_240.png 0,"Do the Data Support the Comorbidity Hypothesis for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Results?",Journal of Clinical Oncology,,,Article,2011-04-30,10.1200/jco.2011.34.9027,,,,21422419,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253097,https://api.altmetric.com/v1/donut/13253097_240.png 0,"Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer",Journal of Clinical Oncology,,,Article,2011-05-31,10.1200/jco.2010.32.8815,,,,21483004,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253091,https://api.altmetric.com/v1/donut/13253091_240.png 0,"Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate",Journal of Clinical Oncology,,,Article,2010-03-20,10.1200/jco.2009.24.6819,,,,20159823,PMC2849770,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253051,https://api.altmetric.com/v1/donut/13253051_240.png 0,Phase I Study of Samarium-153 Lexidronam With Docetaxel in Castration-Resistant Metastatic Prostate Cancer,Journal of Clinical Oncology,,,Article,2009-05-19,10.1200/jco.2008.20.4164,,,,19364960,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13253035,https://api.altmetric.com/v1/donut/13253035_240.png 0,Phase II Trial of Docetaxel With Rapid Androgen Cycling for Progressive Noncastrate Prostate Cancer,Journal of Clinical Oncology,,,Article,2008-06-19,10.1200/jco.2007.15.1928,,,,18565882,PMC3051836,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252992,https://api.altmetric.com/v1/donut/13252992_240.png 0,Phase I Trial of the Prostate-Specific Membrane Antigen-Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer,Journal of Clinical Oncology,,,Article,2008-04-30,10.1200/jco.2007.15.0532,,,,18362364,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252991,https://api.altmetric.com/v1/donut/13252991_240.png 0,American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer,Journal of Clinical Oncology,,,Article,2007-10-09,10.1200/jco.2007.13.4536,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252974,https://api.altmetric.com/v1/donut/13252974_240.png 0,"Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population",Journal of Clinical Oncology,,,Article,2008-02-20,10.1200/jco.2007.13.1490,,,,18281654,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252970,https://api.altmetric.com/v1/donut/13252970_240.png 0,Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy,Journal of Clinical Oncology,,,Article,2007-05-19,10.1200/jco.2006.08.9607,,,,17513807,PMC2670394,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252942,https://api.altmetric.com/v1/donut/13252942_240.png 0,Targeting HER2 in Prostate Cancer: Where to Next?,Journal of Clinical Oncology,,,Article,2007-01-20,10.1200/jco.2006.08.8187,,,,17235040,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252937,https://api.altmetric.com/v1/donut/13252937_240.png 0,"Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy",Journal of Clinical Oncology,,,Article,2007-02-20,10.1200/jco.2006.07.0649,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252923,https://api.altmetric.com/v1/donut/13252923_240.png 0,Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer,Journal of Clinical Oncology,,,Article,2005-03-01,10.1200/jco.2005.09.042,,,,15735119,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252892,https://api.altmetric.com/v1/donut/13252892_240.png 0,Role of Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Radiation Therapy,Journal of Clinical Oncology,,,Article,2005-11-10,10.1200/jco.2005.03.1468,,,,16278473,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252848,https://api.altmetric.com/v1/donut/13252848_240.png 0,Outcome Predictors for the Increasing PSA State After Definitive External-Beam Radiotherapy for Prostate Cancer,Journal of Clinical Oncology,,,Article,2005-02-01,10.1200/jco.2005.02.111,,,,15681527,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252838,https://api.altmetric.com/v1/donut/13252838_240.png 0,Using Circulating Tumor Cells as a Prognostic Indicator in Metastatic Castration-Resistant Prostate Cancer,Clinical Journal of Oncology Nursing,,,Article,2012-04-14,10.1188/12.cjon.e44-e47,,,,22459536,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252815,https://api.altmetric.com/v1/donut/13252815_240.png 0,Ketoconazole as a Secondary Hormonal Intervention in Advanced Prostate Cancer,Clinical Journal of Oncology Nursing,,,Article,2006-06-14,10.1188/06.cjon.361-366,,,,16789581,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13252789,https://api.altmetric.com/v1/donut/13252789_240.png 0,Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model,Journal of Clinical Investigation,,,Article,2008-09-14,10.1172/jci34764,,,,18725989,PMC2518074,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13251139,https://api.altmetric.com/v1/donut/13251139_240.png 0,Improved prediction of prostate cancer recurrence through systems pathology,Journal of Clinical Investigation,,,Article,2007-07-14,10.1172/jci31399,,,,17557117,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13251135,https://api.altmetric.com/v1/donut/13251135_240.png 0,Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells,Molecular Cancer Therapeutics,,,Article,2008-11-01,10.1158/1535-7163.mct-08-0512,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250789,https://api.altmetric.com/v1/donut/13250789_240.png 0,Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation,Molecular Cancer Therapeutics,,,Article,2007-01-15,10.1158/1535-7163.mct-06-0144,,,,17218635,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250779,https://api.altmetric.com/v1/donut/13250779_240.png 0,Quantitative Analysis of Circulating Tumor Cells as a Survival Predictor in Metastatic Castration-Resistant Prostate Cancer: Missing Parts in a Superb Study,Clinical Cancer Research,,,Article,2009-02-15,10.1158/1078-0432.ccr-08-2580,,,,19228753,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250742,https://api.altmetric.com/v1/donut/13250742_240.png 0,Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2007-12-01,10.1158/1078-0432.ccr-07-1506,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250716,https://api.altmetric.com/v1/donut/13250716_240.png 0,Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases,Clinical Cancer Research,,,Article,2007-10-01,10.1158/1078-0432.ccr-07-1269,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250715,https://api.altmetric.com/v1/donut/13250715_240.png 0,Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer,Clinical Cancer Research,,,Article,2007-03-31,10.1158/1078-0432.ccr-06-2701,,,,17404082,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250687,https://api.altmetric.com/v1/donut/13250687_240.png 0,A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer,Clinical Cancer Research,,,Article,2007-03-15,10.1158/1078-0432.ccr-06-2318,,,,17363537,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250685,https://api.altmetric.com/v1/donut/13250685_240.png 0,Rapid Androgen Cycling as Treatment for Patients with Prostate Cancer,Clinical Cancer Research,,,Article,2006-12-22,10.1158/1078-0432.ccr-06-1496,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250674,https://api.altmetric.com/v1/donut/13250674_240.png 0,Time to Detectable Metastatic Disease in Patients with Rising Prostate-Specific Antigen Values following Surgery or Radiation Therapy,Clinical Cancer Research,,,Article,2005-12-15,10.1158/1078-0432.ccr-05-1668,,,,16361552,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250657,https://api.altmetric.com/v1/donut/13250657_240.png 0,Optimizing Prostate Cancer Treatment by Combining Local Radiation Therapy with Systemic Vaccination,Clinical Cancer Research,,,Article,2005-09-30,10.1158/1078-0432.ccr-05-0644,,,,16203760,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250652,https://api.altmetric.com/v1/donut/13250652_240.png 0,Prognostic Significance of Baseline Reverse Transcriptase-PCR for Prostate-Specific Antigen in Men with Hormone-Refractory Prostate Cancer Treated with Chemotherapy,Clinical Cancer Research,,,Article,2005-07-14,10.1158/1078-0432.ccr-05-0431,,,,16033836,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250650,https://api.altmetric.com/v1/donut/13250650_240.png 0,Inhibition of Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Is Not Sufficient to Account for Indole-3-Carbinol-Induced Apoptosis in Some Breast and Prostate Tumor Cells,Clinical Cancer Research,,,Article,2005-12-01,10.1158/1078-0432.ccr-05-0348,,,,16322316,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250647,https://api.altmetric.com/v1/donut/13250647_240.png 0,"Prostate Cancer Clinical Trial End Points: ""RECIST""ing a Step Backwards",Clinical Cancer Research,,,Article,2005-07-14,10.1158/1078-0432.ccr-05-0109,,,,16033840,PMC1852496,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250642,https://api.altmetric.com/v1/donut/13250642_240.png 0,Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy,Clinical Cancer Research,,,Article,2005-04-30,10.1158/1078-0432.ccr-04-2034,,,,15867215,PMC2040333,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250633,https://api.altmetric.com/v1/donut/13250633_240.png 0,Diabetes Mellitus and Prostate Cancer Risk; A Nationwide Case-Control Study within PCBaSe Sweden,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-06-14,10.1158/1055-9965.epi-12-1046,,,,23580698,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250624,https://api.altmetric.com/v1/donut/13250624_240.png 0,"Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-07-14,10.1158/1055-9965.epi-09-0146,,,,19567505,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250618,https://api.altmetric.com/v1/donut/13250618_240.png 0,The SWI/SNF ATPase Brm Is a Gatekeeper of Proliferative Control in Prostate Cancer,Cancer Research,,,Article,2008-12-15,10.1158/0008-5472.can-08-1794,,,,19074882,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250554,https://api.altmetric.com/v1/donut/13250554_240.png 0,The Nuclear Factor- B Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth,Cancer Research,,,Article,2008-08-14,10.1158/0008-5472.can-08-0107,,,,18701501,PMC2840631,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250548,https://api.altmetric.com/v1/donut/13250548_240.png 0,Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer,Cancer Research,,,Article,2008-03-31,10.1158/0008-5472.can-07-6055,,,,18381418,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250543,https://api.altmetric.com/v1/donut/13250543_240.png 0,Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine Rich Tetratricopeptide Repeat Containing Protein ,Cancer Research,,,Article,2007-10-15,10.1158/0008-5472.can-07-1646,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250531,https://api.altmetric.com/v1/donut/13250531_240.png 0,Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression,Cancer Research,,,Article,2007-08-31,10.1158/0008-5472.can-07-1297,,,,17804737,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250527,https://api.altmetric.com/v1/donut/13250527_240.png 0,Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development,Cancer Research,,,Article,2007-06-30,10.1158/0008-5472.can-06-4202,,,,17616663,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250521,https://api.altmetric.com/v1/donut/13250521_240.png 0,"Reassessment of Id1 Protein Expression in Human Mammary, Prostate, and Bladder Cancers Using a Monospecific Rabbit Monoclonal Anti-Id1 Antibody",Cancer Research,,,Article,2006-11-15,10.1158/0008-5472.can-06-2643,,,,17108123,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250516,https://api.altmetric.com/v1/donut/13250516_240.png 0,Critical Function for ADAM9 in Mouse Prostate Cancer,Cancer Research,,,Article,2005-10-14,10.1158/0008-5472.can-05-1063,,,,16230393,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13250487,https://api.altmetric.com/v1/donut/13250487_240.png 0,Characterization and three-dimensional localization of cancerous prostate tissue using backscattering scanning polarization imaging and independent component analysis,Journal of Biomedical Optics,,,Article,2012-08-14,10.1117/1.jbo.17.8.081419,,,,23224180,,,2012JBO....17h1419P,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249633,https://api.altmetric.com/v1/donut/13249633_240.png 0,High-risk prostate cancer: too risky for the robotic learning curve,British Journal of Urology,,,Article,2013-08-14,10.1111/j.1464-410x.2012.11496.x,,,,23879915,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249288,https://api.altmetric.com/v1/donut/13249288_240.png 0,Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors,British Journal of Urology,,,Article,2012-05-14,10.1111/j.1464-410x.2011.10610.x,,,,21992661,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249277,https://api.altmetric.com/v1/donut/13249277_240.png 0,Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?,British Journal of Urology,,,Article,2011-08-14,10.1111/j.1464-410x.2010.09877.x,,,,21199284,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249263,https://api.altmetric.com/v1/donut/13249263_240.png 0,Other biomarkers for detecting prostate cancer,British Journal of Urology,,,Article,2010-01-15,10.1111/j.1464-410x.2009.09088.x,,,,19930175,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249243,https://api.altmetric.com/v1/donut/13249243_240.png 0,Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer,British Journal of Urology,,,Article,2008-06-14,10.1111/j.1464-410x.2008.07519.x,,,,18422773,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249220,https://api.altmetric.com/v1/donut/13249220_240.png 0,The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis,British Journal of Urology,,,Article,2007-04-14,10.1111/j.1464-410x.2007.06689.x,,,,17223922,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249212,https://api.altmetric.com/v1/donut/13249212_240.png 0,The clinical features of anterior prostate cancers,British Journal of Urology,,,Article,2006-12-15,10.1111/j.1464-410x.2006.06578.x,,,,17026586,PMC2239295,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249210,https://api.altmetric.com/v1/donut/13249210_240.png 0,Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging,British Journal of Urology,,,Article,2007-01-15,10.1111/j.1464-410x.2006.06515.x,,,,17227490,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249209,https://api.altmetric.com/v1/donut/13249209_240.png 0,Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation,British Journal of Urology,,,Article,2006-07-14,10.1111/j.1464-410x.2006.06345.x,,,,16831167,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249207,https://api.altmetric.com/v1/donut/13249207_240.png 0,Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer,British Journal of Urology,,,Article,2006-07-14,10.1111/j.1464-410x.2006.06182.x,,,,16626308,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13249204,https://api.altmetric.com/v1/donut/13249204_240.png 0,A quadratic classifier based on multispectral texture features for prostate cancer diagnosis,"Seventh International Symposium on Signal Processing and Its Applications, 2003. Proceedings.",,,Article,2003-01-01,10.1109/isspa.2003.1224809,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13246970,https://api.altmetric.com/v1/donut/13246970_240.png 0,Pitfalls or Promise in Prostate Cancer Immunotherapy???Which Is Winning?,Cancer Journal,,,Article,2008-01-01,10.1097/ppo.0b013e318161bffa,,,,18303480,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13243420,https://api.altmetric.com/v1/donut/13243420_240.png 0,Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer,Current Opinion in Urology,,,Article,2009-05-14,10.1097/mou.0b013e32832a2d10,,,,19318948,PMC2782618,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13243289,https://api.altmetric.com/v1/donut/13243289_240.png 0,The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery,Current Opinion in Urology,,,Article,2008-01-15,10.1097/mou.0b013e3282f13ac3,,,,18090496,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13243282,https://api.altmetric.com/v1/donut/13243282_240.png 0,Imaging of prostate cancer,Current opinion in oncology,,,Article,2007-05-14,10.1097/cco.0b013e3280ad439b,,,,17414646,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13243113,https://api.altmetric.com/v1/donut/13243113_240.png 0,Management of Prostate Cancer,New England Journal of Medicine,,,Article,2008-12-11,10.1056/nejmclde0805491,,,,19073981,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13241281,https://api.altmetric.com/v1/donut/13241281_240.png 0,616 THE RISK OF PROSTATE CANCER AMONGST BLACK MEN IN THE UNITED KINGDOM: THE PROCESS COHORT STUDY,European Urology Supplements,,,Article,2007-03-01,10.1016/s1569-9056(07)60614-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13237344,https://api.altmetric.com/v1/donut/13237344_240.png 0,504 MALONDIALDEHYDE-DEOXYGUANOSINE (M1G) ADDUCTS AS A BIOMARKER OF PROSTATE CANCER PREVENTION BY TEA POLYPHENOLS,European Urology Supplements,,,Article,2007-03-01,10.1016/s1569-9056(07)60502-8,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13237342,https://api.altmetric.com/v1/donut/13237342_240.png 0,GALIELLALACTONE INHIBITS GROWTH OF PROSTATE CANCER CELL XENOGRAFTS AND INDUCES APOPTOSIS OF HUMAN PROSTATE CANCER CELLS EXPRESSING ACTIVE STAT3,European Urology Supplements,,,Article,2006-09-01,10.1016/s1569-9056(06)61292-x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13237340,https://api.altmetric.com/v1/donut/13237340_240.png 0,"TUMOR-ASSOCIATED TRYPSIN INHIBITOR (TATI, PSTI, SPINK1) EXPRESSION IN PROSTATE CANCER IS RELATED TO TUMOR GRADE",European Urology Supplements,,,Article,2006-09-01,10.1016/s1569-9056(06)61267-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13237338,https://api.altmetric.com/v1/donut/13237338_240.png 0,Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial,Year Book of Urology,,,Article,2008-01-01,10.1016/s0084-4071(08)79171-1,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235973,https://api.altmetric.com/v1/donut/13235973_240.png 0,Prognostic Impact of Positive Surgical Margins in Surgically Treated Prostate Cancer: Multi-institutional Assessment of 5831 Patients,Year Book of Urology,,,Article,2006-01-01,10.1016/s0084-4071(08)70365-8,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235969,https://api.altmetric.com/v1/donut/13235969_240.png 0,"The Association Between Total and Positive Lymph Node Counts, and Disease Progression in Clinically Localized Prostate Cancer",Year Book of Urology,,,Article,2006-01-01,10.1016/s0084-4071(08)70364-6,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235968,https://api.altmetric.com/v1/donut/13235968_240.png 0,Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy,Year Book of Urology,,,Article,2007-01-01,10.1016/s0084-4071(08)70136-2,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235964,https://api.altmetric.com/v1/donut/13235964_240.png 0,Long-Term Prediction of Prostate Cancer Up to 25 Years Before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 Years,Year Book of Urology,,,Article,2007-01-01,10.1016/s0084-4071(08)70114-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235962,https://api.altmetric.com/v1/donut/13235962_240.png 0,Screening and Prostate-Cancer Mortality in a Randomized European Study,Year Book of Medicine,,,Article,2010-01-01,10.1016/s0084-3873(10)79880-1,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235942,https://api.altmetric.com/v1/donut/13235942_240.png 0,LAPAROSCOPIC PELVIC LYMPHADENECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: A RISK VS. BENEFIT ANALYSIS,The Journal of Urology,,,Article,2009-04-01,10.1016/s0022-5347(09)61631-1,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235708,https://api.altmetric.com/v1/donut/13235708_240.png 0,PREDICTORS OF RESPONSE TO SILDENAFIL CITRATE FOLLOWING RADIATION THERAPY FOR PROSTATE CANCER,The Journal of Urology,,,Article,2008-04-01,10.1016/s0022-5347(08)61260-4,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235704,https://api.altmetric.com/v1/donut/13235704_240.png 0,OUTCOMES FOLLOWING NEGATIVE PROSTATE BIOPSY FOR PATIENTS WITH PERSISTENT DISEASE AFTER RADIOTHERAPY FOR PROSTATE CANCER,The Journal of Urology,,,Article,2008-04-01,10.1016/s0022-5347(08)60335-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235699,https://api.altmetric.com/v1/donut/13235699_240.png 0,B7-H3 AND B7x ARE HIGHLY EXPRESSED IN HUMAN PROSTATE CANCER AND ASSOCIATED WITH DISEASE SPREAD AND POOR OUTCOME,The Journal of Urology,,,Article,2008-04-01,10.1016/s0022-5347(08)60301-8,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235698,https://api.altmetric.com/v1/donut/13235698_240.png 0,A MULTI-INSTITUTIONAL COHORT OF ACTIVE SURVEILLANCE FOR LOW-RISK LOCALIZED PROSTATE CANCER,The Journal of Urology,,,Article,2008-04-01,10.1016/s0022-5347(08)60191-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235697,https://api.altmetric.com/v1/donut/13235697_240.png 0,Gleason Grade Remains an Important Prognostic Predictor in Men Diagnosed With Prostate Cancer While on Finasteride Therapy,The Journal of Urology,,,Article,2005-07-01,10.1016/s0022-5347(05)60043-2,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235693,https://api.altmetric.com/v1/donut/13235693_240.png 0,Prostate Cancer Diagnosed After Repeat Biopsies Have a Favorable Pathological Outcome but Similar Recurrence Rate,The Journal of Urology,,,Article,2006-03-15,10.1016/s0022-5347(05)00350-2,,,,16469581,PMC1951512,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235691,https://api.altmetric.com/v1/donut/13235691_240.png 0,Biological Correlates of p27 Compartmental Expression in Prostate Cancer,The Journal of Urology,,,Article,2006-02-15,10.1016/s0022-5347(05)00151-5,,,,16406988,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13235689,https://api.altmetric.com/v1/donut/13235689_240.png 0,The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance,Oncotarget,,,Article,2016-10-13,10.18632/oncotarget.12635,,,,27779102,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13120698,https://api.altmetric.com/v1/donut/13120698_240.png 0,The role of transcription factors in prostate cancer and potential for future RNA interference therapy,Expert Opinion on Therapeutic Targets,,,Article,2014-03-24,10.1517/14728222.2014.896904,,,,24660778,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13032707,https://api.altmetric.com/v1/donut/13032707_240.png 0,Prostate cancer grading: Gland segmentation and structural features,Pattern Recognition Letters,,,Article,2012-05-01,10.1016/j.patrec.2011.10.001,,,,,,11541.2/119617,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/13023835,https://api.altmetric.com/v1/donut/13023835_240.png 0,Prostate Cancer Grading: Use of Graph Cut and Spatial Arrangement of Nuclei,IEEE Transactions on Medical Imaging,,,Article,2014-07-09,10.1109/tmi.2014.2336883,,,,25029379,,11541.2/119643,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/13008988,https://api.altmetric.com/v1/donut/13008988_240.png 0,"A New Method for Synthesizing Radiation Dose–Response Data From Multiple Trials Applied to Prostate Cancer: In Regard to Diez P, et al. (Int J Radiat Oncol Biol Phys 2010;77:1066–1071)","International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-05-31,10.1016/j.ijrobp.2010.12.011,,,,21549251,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12970406,https://api.altmetric.com/v1/donut/12970406_240.png 0,Long-term Survival Outcomes for Men Who Provided Ejaculate Specimens for Prostate Cancer Research: Implications for Patient Management,European Urology Focus ,,,Article,2015-09-01,10.1016/j.euf.2015.04.002,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/12963058,https://api.altmetric.com/v1/donut/12963058_240.png 0,Re: Miocinovic et al.: Avoiding Androgen Deprivation Therapy in Men With High-risk Prostate Cancer: the Role of Radical Prostatectomy as Initial Treatment. (Urology 2011;77:946-950),Urology,,,Article,2011-09-14,10.1016/j.urology.2011.05.039,,,,21884924,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12950254,https://api.altmetric.com/v1/donut/12950254_240.png 0,Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer,British Journal of Cancer,,,Article,2013-08-07,10.1038/bjc.2013.446,,,,23928659,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/12926753,https://api.altmetric.com/v1/donut/12926753_240.png 0,Caveola-forming proteins caveolin-1 and PTRF in prostate cancer,Nature Reviews Urology,,,Article,2013-09-14,10.1038/nrurol.2013.168,,,,23938946,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/12926745,https://api.altmetric.com/v1/donut/12926745_240.png 0,Patients’ and urologists’ preferences for prostate cancer treatment: a discrete choice experiment,British Journal of Cancer,,,Article,2013-08-05,10.1038/bjc.2013.370,,,,23860533,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12924431,https://api.altmetric.com/v1/donut/12924431_240.png 0,Constrained-beam inverse planning for intensity-modulated radiation therapy of prostate cancer patients with bilateral hip prostheses,Journal of Medical Imaging & Radiation Oncology,,,Article,2012-12-15,10.1111/j.1754-9485.2012.02456.x,,,,23210592,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12923048,https://api.altmetric.com/v1/donut/12923048_240.png 0,"Adiponectin, an Anti-Carcinogenic Hormone? a Systematic Review on Breast, Colorectal, Liver and Prostate Cancer",Current Medicinal Chemistry,,,Article,2012-10-01,10.2174/092986712803833137,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12922586,https://api.altmetric.com/v1/donut/12922586_240.png 0," Knockout of the tetraspanin Cd9 in the TRAMP model of de novo prostate cancer increases spontaneous metastases in an organ-specific manner ",International Journal of Cancer,,,Article,2013-10-14,10.1002/ijc.28204,,,,23575960,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/12920909,https://api.altmetric.com/v1/donut/12920909_240.png 0,Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer,Future Oncology,,,Article,2012-10-14,10.2217/fon.12.129,,,,23130925,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12919224,https://api.altmetric.com/v1/donut/12919224_240.png 0,Educating Men About Prostate Cancer in the Workplace,American Journal of Men's Health,,,Article,2013-07-14,10.1177/1557988312467050,,,,23154199,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12916131,https://api.altmetric.com/v1/donut/12916131_240.png 0,Do prostate cancer patients suffer more from depressed mood or anhedonia?,Psycho-Oncology,,,Article,2013-08-14,10.1002/pon.3203,,,,23019092,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/12915141,https://api.altmetric.com/v1/donut/12915141_240.png 0,Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin,Reproductive Biology and Endocrinology,,,Article,2013-07-22,10.1186/1477-7827-11-70,,,,23879975,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12912970,https://api.altmetric.com/v1/donut/12912970_240.png 0,Systematic Review of Research into the Psychological Aspects of Prostate Cancer in Asia: What do we Know?,Asian Pacific Journal of Cancer Prevention,,,Article,2013-04-30,10.7314/apjcp.2013.14.4.2621,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12912810,https://api.altmetric.com/v1/donut/12912810_240.png 0,"Perspectives on knowledge, information seeking and decision-making behaviour about prostate cancer among Australian men",Journal of Men's Health,,,Article,2013-03-01,10.1016/j.jomh.2012.10.004,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12912222,https://api.altmetric.com/v1/donut/12912222_240.png 0,Breast and Prostate Cancer Survivors in a Diabetic Cohort: Results from the Living With Diabetes Study,Clinical Medicine & Research,,,Article,2013-05-12,10.3121/cmr.2013.1156,,,,23669614,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12912025,https://api.altmetric.com/v1/donut/12912025_240.png 0,Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study,Clinical Medicine & Research,,,Article,2013-05-07,10.3121/cmr.2013.1160,,,,23656798,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12911484,https://api.altmetric.com/v1/donut/12911484_240.png 0,"Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells",Bioscience Reports,,,Article,2013-06-10,10.1042/bsr20130042,,,,23634903,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/12907889,https://api.altmetric.com/v1/donut/12907889_240.png 0,How can food extracts consumed in the Mediterranean and East Asia suppress prostate cancer proliferation?,British Journal of Nutrition,,,Article,2012-08-14,10.1017/s0007114511005770,,,,22067725,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/12907189,https://api.altmetric.com/v1/donut/12907189_240.png 0,Distinct expression and activity of GSK-3? and GSK-3? in prostate cancer,International Journal of Cancer,,,Article,2012-09-14,10.1002/ijc.27620,,,,22539113,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/12903175,https://api.altmetric.com/v1/donut/12903175_240.png 0,Picking the Optimal Duration of Hormonal Therapy in Men With High-Risk and Locally Advanced Prostate Cancer Treated With Radiotherapy,Seminars in Radiation Oncology,,,Article,2013-07-14,10.1016/j.semradonc.2013.01.008,,,,23763887,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/12902538,https://api.altmetric.com/v1/donut/12902538_240.png 0,A Retrospective Planning Analysis Comparing Volumetric-Modulated Arc Therapy (VMAT) to Intensity-Modulated Radiation Therapy (IMRT) for Radiotherapy Treatment of Prostate Cancer,Journal of Medical Imaging & Radiation Sciences,,,Article,2013-06-01,10.1016/j.jmir.2012.06.002,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/12900461,https://api.altmetric.com/v1/donut/12900461_240.png 0,Breaking through a roadblock in prostate cancer research: An update on human model systems,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2012-09-14,10.1016/j.jsbmb.2012.01.005,,,,22342674,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/12897857,https://api.altmetric.com/v1/donut/12897857_240.png 0,A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer,Investigational New Drugs,,,Article,2012-08-14,10.1007/s10637-011-9722-5,,,,21785998,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12896729,https://api.altmetric.com/v1/donut/12896729_240.png 0,Stem-Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer,Stem Cells,,,Article,2012-06-14,10.1002/stem.1087,,,,22438320,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/12893341,https://api.altmetric.com/v1/donut/12893341_240.png 0,Activins and activin antagonists in the prostate and prostate cancer,Molecular & Cellular Endocrinology,,,Article,2012-08-14,10.1016/j.mce.2011.07.005,,,,21787836,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/12892093,https://api.altmetric.com/v1/donut/12892093_240.png 0,Diamide Linked ?-Cyclodextrin Dimers as Molecular-Scale Delivery Systems for the Medicinal Pigment Curcumin to Prostate Cancer Cells,Molecular Pharmaceutics,,,Article,2013-10-26,10.1021/mp400309s,,,,24160991,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/12892044,https://api.altmetric.com/v1/donut/12892044_240.png 0,"Cytosolic phospholipase A2? sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells",Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids,,,Article,2013-06-14,10.1016/j.bbalip.2013.02.011,,,,23500889,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/12890010,https://api.altmetric.com/v1/donut/12890010_240.png 0,The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer,Advances in Urology,,,Article,2012-01-01,10.1155/2012/248607,,,,22548055,PMC3324133,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12889790,https://api.altmetric.com/v1/donut/12889790_240.png 0,How prostate cancer patients cope: evaluation and refinement of the Prostate Cancer Patients’ Coping Strategies Questionnaire,Journal of Men's Health,,,Article,2012-06-01,10.1016/j.jomh.2012.01.003,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/12889652,https://api.altmetric.com/v1/donut/12889652_240.png 0,IGF2 increases de novo steroidogenesis in prostate cancer cells,Endocrine-Related Cancer,,,Article,2013-04-14,10.1530/erc-12-0250,,,,23319492,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12889111,https://api.altmetric.com/v1/donut/12889111_240.png 0,New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication,International Journal of Cell Biology,,,Article,2013-01-01,10.1155/2013/834684,,,,23573093,PMC3614121,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12887888,https://api.altmetric.com/v1/donut/12887888_240.png 0,"Optimization and characterization of a rat model of prostate cancer-induced bone pain using behavioral, pharmacological, radiological, histological and immunohistochemical methods","Pharmacology, Biochemistry & Behavior",,,Article,2013-05-14,10.1016/j.pbb.2013.02.020,,,,23500189,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12882340,https://api.altmetric.com/v1/donut/12882340_240.png 0,Do Patient-Reported Androgen-Deprivation Therapy Side Effects Predict Anxiety and Depression Among Prostate Cancer Patients Undergoing Radiotherapy? Implications for Psychosocial Therapy Interventions,Journal of Psychosocial Oncology,,,Article,2012-03-15,10.1080/07347332.2011.651261,,,,22416955,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12882147,https://api.altmetric.com/v1/donut/12882147_240.png 0,Daxx regulates mitotic progression and prostate cancer predisposition,Carcinogenesis,,,Article,2013-04-14,10.1093/carcin/bgs391,,,,23239745,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12881730,https://api.altmetric.com/v1/donut/12881730_240.png 0,Are Somatic Symptoms a Legitimate Part of the Depression Profile in Prostate Cancer Patients?,Onkologie,,,Article,2013-01-01,10.1159/000348531,,,,23485998,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12874684,https://api.altmetric.com/v1/donut/12874684_240.png 0,Androgen Deprivation Therapy for Prostate Cancer Does Not Increase Cardiovascular Mortality in the Long Term,Oncology (08909091),,,Article,2012-01-01,10.1159/000334999,,,,22310055,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12873631,https://api.altmetric.com/v1/donut/12873631_240.png 0,A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a,Annals of Oncology,,,Article,2012-01-15,10.1093/annonc/mdr336,,,,21765178,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12862042,https://api.altmetric.com/v1/donut/12862042_240.png 0,Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer,Journal of Molecular Endocrinology,,,Article,2013-04-14,10.1530/jme-12-0150,,,,23267039,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12861654,https://api.altmetric.com/v1/donut/12861654_240.png 0,Common gene pathways and families altered by DNA methylation in breast and prostate cancers,Endocrine-Related Cancer,,,Article,2013-07-01,10.1530/erc-13-0204,,,,23818572,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12860684,https://api.altmetric.com/v1/donut/12860684_240.png 0,Factors associated with adherence to physical activity guidelines in patients with prostate cancer,Psycho-Oncology,,,Article,2013-06-06,10.1002/pon.3310,,,,23749430,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/12860683,https://api.altmetric.com/v1/donut/12860683_240.png 0,Hsp90: Still a viable target in prostate cancer,Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,,,Article,2013-04-14,10.1016/j.bbcan.2012.12.005,,,,23287571,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/12859818,https://api.altmetric.com/v1/donut/12859818_240.png 0,"Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy",Psycho-Oncology,,,Article,2013-03-11,10.1002/pon.3269,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/12855273,https://api.altmetric.com/v1/donut/12855273_240.png 0,False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer models,Transgenic Research,,,Article,2013-10-14,10.1007/s11248-013-9694-7,,,,23423848,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12852579,https://api.altmetric.com/v1/donut/12852579_240.png 0,Translating Clinical Evidence-Based Medicine into the Real World: Single-Center Experience with Cabazitaxel in Metastatic Prostate Cancer Patients,Chemotherapy (0009-3157),,,Article,2016-01-12,10.1159/000441379,,,,26757168,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12691467,https://api.altmetric.com/v1/donut/12691467_240.png 0,Low-Dose Docetaxel Combined with Dexamethasone Is Feasible for Patients with Castration-Resistant Prostate Cancer,Chemotherapy (0009-3157),,,Article,2015-11-04,10.1159/000440942,,,,26528957,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12690583,https://api.altmetric.com/v1/donut/12690583_240.png 0,Detection of Tear Biomarkers for Future Prostate Cancer Diagnosis,Open Biomarkers Journal,,,Article,2014-05-30,10.2174/1875318301003010026,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12673474,https://api.altmetric.com/v1/donut/12673474_240.png 0,Abstract 3307: Angiomotin regulates the Hippo pathway to increase prostate cancer cell growth,Cancer Research,,,Article,2014-10-01,10.1158/1538-7445.am2014-3307,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12649690,https://api.altmetric.com/v1/donut/12649690_240.png 0,Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases,Oncotarget,,,Article,2016-09-23,10.18632/oncotarget.12204,,,,27683107,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12575214,https://api.altmetric.com/v1/donut/12575214_240.png 0,Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- and Intermediate-Risk Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2016-10-01,10.1016/j.ijrobp.2016.06.1266,,,,27674191,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12555574,https://api.altmetric.com/v1/donut/12555574_240.png 0,Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy,Oncotarget,,,Article,2016-09-30,10.18632/oncotarget.12368,,,,27708237,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12527403,https://api.altmetric.com/v1/donut/12527403_240.png 0,OLDER MEN ASSOCIATED WITH ADVANCED DISEASE AND POOR OUTCOME: AN ANALYSIS OF 14601 PROSTATE CANCER MEN IN DUKE PROSTATE CENTER,The Journal of Urology,,,Article,2008-04-01,10.1016/s0022-5347(08)61875-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12461625,https://api.altmetric.com/v1/donut/12461625_240.png 0,Recovery of sexual function after prostate cancer treatment,Current Opinion in Urology,,,Article,2006-11-15,10.1097/01.mou.0000250285.60237.7d,,,,17053525,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12461617,https://api.altmetric.com/v1/donut/12461617_240.png 0,Special concerns for survivors of prostate cancer.,Clinical Advances in Hematology & Oncology,,,Article,,,,,,27673285,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12461524,https://api.altmetric.com/v1/donut/12461524_240.png 0,"A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study",Cancer Epidemiology,,,Article,2012-02-15,10.1016/j.canep.2011.08.001,,,,21907655,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/12362131,https://api.altmetric.com/v1/donut/12362131_240.png 0,Consensus guidelines for reporting prostate cancer Gleason Grade,British Journal of Urology,,,Article,2016-09-14,10.1111/bju.13596,,,,27524719,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12362125,https://api.altmetric.com/v1/donut/12362125_240.png 0,Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial,BMJ Open,,,Article,2015-09-18,10.1136/bmjopen-2015-008953,,,,26384727,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/12362121,https://api.altmetric.com/v1/donut/12362121_240.png 0,Re: Samaratunga et al: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade,Urology,,,Article,2016-07-01,10.1016/j.urology.2016.07.005,,,,27443466,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12362114,https://api.altmetric.com/v1/donut/12362114_240.png 0,Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2016-09-27,10.1038/pcan.2016.44,,,,27670718,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/12247473,https://api.altmetric.com/v1/donut/12247473_240.png 0,Commentary on genitourinary cancer survivorship: physical activity and prostate cancer survivorship,Translational andrology and urology,,,Article,2016-08-01,10.21037/tau.2016.05.02,,,,27649839,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12232279,https://api.altmetric.com/v1/donut/12232279_240.png 0,Abstract 5523: A novel aptamer targeting agent for prostate cancer,Cancer Research,,,Article,2015-08-02,10.1158/1538-7445.am2015-5523,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12232245,https://api.altmetric.com/v1/donut/12232245_240.png 0,Editorial Comment to Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan,International Journal of Urology,,,Article,2015-08-05,10.1111/iju.12881,,,,26147189,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12199873,https://api.altmetric.com/v1/donut/12199873_240.png 0,Re: Enzalutamide in Metastatic Prostate Cancer Before Chemotherapy,European Urology,,,Article,2014-10-14,10.1016/j.eururo.2014.07.049,,,,25218073,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/12199857,https://api.altmetric.com/v1/donut/12199857_240.png 0,Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up,European Urology,,,Article,2014-12-01,10.1016/j.eururo.2014.08.044,,,,25587592,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12199855,https://api.altmetric.com/v1/donut/12199855_240.png 0,Re: Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial,European Urology,,,Article,2013-12-15,10.1016/j.eururo.2013.09.032,,,,24209450,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/12199844,https://api.altmetric.com/v1/donut/12199844_240.png 0,Case Discussion: Intermediate-risk Prostate Cancer: The Case for Radical Treatment,European Urology Focus ,,,Article,2015-09-01,10.1016/j.euf.2015.06.007,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12199840,https://api.altmetric.com/v1/donut/12199840_240.png 0,Active surveillance in prostate cancer: a critical review.,Minerva Urologica E Nefrologica,,,Article,2015-06-09,,,,,26054412,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/12199835,https://api.altmetric.com/v1/donut/12199835_240.png 0,Role of salvage lymph node dissection in prostate cancer,Current Opinion in Urology,,,Article,2016-08-01,10.1097/mou.0000000000000343,,,,27584024,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12181664,https://api.altmetric.com/v1/donut/12181664_240.png 0,External beam radiation treatment for prostate cancer: still the gold standard.,Oncology (08909091),,,Article,1992-03-01,,,,,1533146,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/12066375,https://api.altmetric.com/v1/donut/12066375_240.png 0,Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation,Asian Journal of Andrology,,,Article,2014-02-21,10.4103/1008-682x.123669,,,,24589459,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/12050634,https://api.altmetric.com/v1/donut/12050634_240.png 0,RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques,Asian Journal of Andrology,,,Article,2014-06-19,10.4103/1008-682x.129942,,,,24969055,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/12050629,https://api.altmetric.com/v1/donut/12050629_240.png 0,Neuroendocrine differentiation of prostate cancer,Asian Journal of Andrology,,,Article,2013-05-14,10.1038/aja.2013.7,,,,23503426,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/12008109,https://api.altmetric.com/v1/donut/12008109_240.png 0,Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer,European Journal of Cancer (1965),,,Article,2013-09-14,10.1016/j.ejca.2013.04.026,,,,23726266,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/12008101,https://api.altmetric.com/v1/donut/12008101_240.png 0,African American Primary Care Physicians' Prostate Cancer Screening Practices,Journal of Primary Care & Community Health,,,Article,2013-10-16,10.1177/2150131913507454,,,,24327595,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11996616,https://api.altmetric.com/v1/donut/11996616_240.png 0,US Primary Care Physicians' Prostate Cancer Screening Practices: A Vignette-Based Analysis of Screening Men at High Risk,Health Services Research & Managerial Epidemiology,,,Article,2014-01-01,10.1177/2333392814562909,,,,27104210,PMC4836062,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11996613,https://api.altmetric.com/v1/donut/11996613_240.png 0,TGF-? Effects on Prostate Cancer Cell Migration and Invasion Require FosB,The Prostate,,,Article,2016-09-08,10.1002/pros.23250,,,,27604827,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11983788,https://api.altmetric.com/v1/donut/11983788_240.png 0,Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer,American Journal of Preventive Medicine,,,Article,2015-12-01,10.1016/j.amepre.2015.08.016,,,,26590643,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/11979108,https://api.altmetric.com/v1/donut/11979108_240.png 0,Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy,Cancer (0008543X),,,Article,2004-03-01,10.1002/cncr.20056,,,,14983482,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/11864399,https://api.altmetric.com/v1/donut/11864399_240.png 0,Advances in advanced prostate cancer - the continuing journey,British Journal of Urology,,,Article,2016-07-04,10.1111/bju.13350,,,,26456636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11859870,https://api.altmetric.com/v1/donut/11859870_240.png 0,"Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study",Investigational New Drugs,,,Article,2014-04-26,10.1007/s10637-014-0101-x,,,,24771350,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11856949,https://api.altmetric.com/v1/donut/11856949_240.png 0,Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer,British Journal of Cancer,,,Article,2014-06-18,10.1038/bjc.2014.316,,,,24946001,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/11856538,https://api.altmetric.com/v1/donut/11856538_240.png 0,The effect of aerobic exercise on treatment-related acute toxicity in men receiving radical external beam radiotherapy for localised prostate cancer,European Journal of Cancer Care,,,Article,2010-09-14,10.1111/j.1365-2354.2009.01083.x,,,,20030701,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/11851893,https://api.altmetric.com/v1/donut/11851893_240.png 0,NF?B signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression,British Journal of Cancer,,,Article,2012-10-22,10.1038/bjc.2012.372,,,,23093296,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/11851763,https://api.altmetric.com/v1/donut/11851763_240.png 0,The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study,British Journal of Cancer,,,Article,2012-07-23,10.1038/bjc.2012.289,,,,22759881,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11850542,https://api.altmetric.com/v1/donut/11850542_240.png 0,506 THE ROLE OF ANDROGEN RECEPTOR PHOSPHORYLATION AT 3 DIFFERENT SERINE PHOSPHORYLATION SITES IN THE DEVELOPMENT OF HORMONE REFRACTORY PROSTATE CANCER,European Urology Supplements,,,Article,2009-03-01,10.1016/s1569-9056(09)60502-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11847946,https://api.altmetric.com/v1/donut/11847946_240.png 0,617 PROSTATE CANCER INCIDENCE IN PATIENTS ON FINASTERIDE FOR LOWER URINARY TRACT SYMPTOMS,European Urology Supplements,,,Article,2007-03-01,10.1016/s1569-9056(07)60615-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11847943,https://api.altmetric.com/v1/donut/11847943_240.png 0,168 Grp78 activity is associated with Androgen Receptor status and upregulated in Hormone-Refractory prostate cancer,EJC Supplements,,,Article,2010-06-01,10.1016/s1359-6349(10)70975-7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11847916,https://api.altmetric.com/v1/donut/11847916_240.png 0,543 RNA Polymerase III transcription deregulation in cancer: study of Brf1 expression in prostate cancer,EJC Supplements,,,Article,2010-06-01,10.1016/s1359-6349(10)71344-6,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11847915,https://api.altmetric.com/v1/donut/11847915_240.png 0,Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer,British Journal of Cancer,,,Article,2011-10-24,10.1038/bjc.2011.367,,,,21952621,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/11847912,https://api.altmetric.com/v1/donut/11847912_240.png 0,"GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer",The Journal of Pathology,,,Article,2011-01-28,10.1002/path.2795,,,,21031481,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/11847874,https://api.altmetric.com/v1/donut/11847874_240.png 0,Management of metastatic castration-resistant prostate cancer after first-line docetaxel,European Journal of Cancer (1965),,,Article,2011-09-14,10.1016/j.ejca.2011.04.036,,,,21658937,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11847678,https://api.altmetric.com/v1/donut/11847678_240.png 0,Presence of tumoural C-reactive protein correlates with progressive prostate cancer,Prostate Cancer & Prostatic Diseases,,,Article,2011-06-14,10.1038/pcan.2011.5,,,,21358753,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11847304,https://api.altmetric.com/v1/donut/11847304_240.png 0,Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer,British Journal of Cancer,,,Article,2011-06-06,10.1038/bjc.2011.163,,,,21559022,PMC3111196,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/11847201,https://api.altmetric.com/v1/donut/11847201_240.png 0,The RNA Helicase p68 Is a Novel Androgen Receptor Coactivator Involved in Splicing and Is Overexpressed in Prostate Cancer,Cancer Research,,,Article,2008-09-30,10.1158/0008-5472.can-08-0932,,,,18829551,PMC2561211,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/11846856,https://api.altmetric.com/v1/donut/11846856_240.png 0,Systemic Inflammatory Response and Survival in Patients with Localised Prostate Cancer: 10-Year Follow-Up,Urologia Internationalis,,,Article,2010-01-01,10.1159/000313364,,,,20395655,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11845434,https://api.altmetric.com/v1/donut/11845434_240.png 0,Value of Information and Value of Implementation: Application of an Analytic Framework to Inform Resource Allocation Decisions in Metastatic Hormone-Refractory Prostate Cancer,Value in Health (Elsevier Science),,,Article,2009-03-01,10.1111/j.1524-4733.2008.00431.x,,,,18657098,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/11844760,https://api.altmetric.com/v1/donut/11844760_240.png 0,The role of murine models of prostate cancer in drug target discovery and validation,Expert Opinion on Drug Discovery,,,Article,2009-08-14,10.1517/17460440903049308,,,,23496273,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11844489,https://api.altmetric.com/v1/donut/11844489_240.png 0,Novel genetic loci associated with prostate cancer in the Japanese population,Asian Journal of Andrology,,,Article,2011-01-15,10.1038/aja.2010.118,,,,20935669,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11834928,https://api.altmetric.com/v1/donut/11834928_240.png 0,Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy,Cancer Research,,,Article,2010-12-06,10.1158/0008-5472.can-10-1605,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11834927,https://api.altmetric.com/v1/donut/11834927_240.png 0,Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer,British Journal of Urology,,,Article,2016-08-30,10.1111/bju.13607,,,,27469289,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11801896,https://api.altmetric.com/v1/donut/11801896_240.png 0,213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model,British Journal of Cancer,,,Article,2002-04-08,10.1038/sj.bjc.6600179,,,,11953871,PMC2364168,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11799878,https://api.altmetric.com/v1/donut/11799878_240.png 0,Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice,Cancer Letters,,,Article,2006-02-20,10.1016/j.canlet.2005.03.051,,,,15927363,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11792113,https://api.altmetric.com/v1/donut/11792113_240.png 0,Prostate Cancer and Masculinity in Australian Society: A Case of Stolen Identity?,International Journal of Men's Health,,,Article,2004-05-01,10.3149/jmh.0302.73,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11786952,https://api.altmetric.com/v1/donut/11786952_240.png 0,MP60-04 QUANTITATIVE ASSESSMENT OF T2-WEIGHTED MRI TO BETTER IDENTIFY PATIENTS WITH PROSTATE CANCER IN A SCREENING POPULATION,The Journal of Urology,,,Article,2015-04-01,10.1016/j.juro.2015.02.2206,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11782028,https://api.altmetric.com/v1/donut/11782028_240.png 0,Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer,Australasian Radiology,,,Article,2004-12-01,10.1111/j.1440-1673.2004.01354.x,,,,15601330,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11781773,https://api.altmetric.com/v1/donut/11781773_240.png 0," Prostate Cancer in a Male with Holt-Oram Syndrome: First Clinical Association of the TBX5 Mutation ",Case Reports in Urology,,,Article,2013-01-01,10.1155/2013/405343,,,,23984174,PMC3748406,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11779793,https://api.altmetric.com/v1/donut/11779793_240.png 0,Benefits of less frequent injections in advanced prostate cancer.,Australian Family Physician,,,Article,,,,,,26209999,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11777876,https://api.altmetric.com/v1/donut/11777876_240.png 0,Oral Cyclophosphamide for the Management of Hormone-refractory Prostate Cancer,British Journal of Urology,,,Article,1993-11-01,10.1111/j.1464-410x.1993.tb16222.x,,,,10071550,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11777234,https://api.altmetric.com/v1/donut/11777234_240.png 0,Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer,OncoTargets and therapy,,,Article,2014-08-01,10.2147/ott.s65238,,,,25210465,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/11773598,https://api.altmetric.com/v1/donut/11773598_240.png 0,Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression,Urologic Oncology,,,Article,2001-05-01,10.1016/s1078-1439(00)00119-8,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11773091,https://api.altmetric.com/v1/donut/11773091_240.png 0,"Authors' reply to: Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: A case-control study",International Journal of Cancer,,,Article,2012-11-01,10.1002/ijc.27474,,,,22323213,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11771900,https://api.altmetric.com/v1/donut/11771900_240.png 0,"Correction to: ""Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment""",Molecular Pharmacology,,,Article,2016-07-13,10.1124/mol.115.031153err,,,,27411395,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11771856,https://api.altmetric.com/v1/donut/11771856_240.png 0,Abstract 4950: Hypercholesterolemia promotes prostate cancer PC-3 metastases in orthotopic xenograft mice,Cancer Research,,,Article,2014-09-30,10.1158/1538-7445.am2014-4950,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11770600,https://api.altmetric.com/v1/donut/11770600_240.png 0,PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer,Oncogene,,,Article,2013-08-11,10.1038/onc.2013.315,,,,23934189,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11769745,https://api.altmetric.com/v1/donut/11769745_240.png 0,"Overexpression of a key regulator of lipid homeostasis, Scap, promotes respiration in prostate cancer cells",Febs Letters,,,Article,2013-04-01,10.1016/j.febslet.2013.02.040,,,,23454642,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/11769695,https://api.altmetric.com/v1/donut/11769695_240.png 0,"Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial","International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-11-15,10.1016/j.ijrobp.2004.04.033,,,,15519779,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11769619,https://api.altmetric.com/v1/donut/11769619_240.png 0,Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine,British Journal of Cancer,,,Article,1997-01-01,10.1038/bjc.1997.272,,,,9184173,PMC2223533,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11768719,https://api.altmetric.com/v1/donut/11768719_240.png 0,Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network,The Prostate,,,Article,2006-04-30,10.1002/pros.20381,,,,16388506,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11768632,https://api.altmetric.com/v1/donut/11768632_240.png 0,Lower levels of nuclear ?-catenin predict for a poorer prognosis in localized prostate cancer,International Journal of Cancer,,,Article,2005-01-20,10.1002/ijc.20599,,,,15455387,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11768631,https://api.altmetric.com/v1/donut/11768631_240.png 0,Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Slows Cancer Development but Increases Metastases in TRAMP Prostate Cancer Prone Mice,PLoS ONE,,,Article,2012-08-27,10.1371/journal.pone.0043833,,,,22952779,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/11768176,https://api.altmetric.com/v1/donut/11768176_240.png 0,Expression of phosphorylated-mTOR during the development of prostate cancer,The Prostate,,,Article,2014-07-06,10.1002/pros.22840,,,,25043667,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11767982,https://api.altmetric.com/v1/donut/11767982_240.png 0,International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy,Journal of Clinical Oncology,,,Article,2002-08-01,10.1200/jco.2002.12.019,,,,12149292,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/11766814,https://api.altmetric.com/v1/donut/11766814_240.png 0,Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate Cancer,Journal of Clinical Oncology,,,Article,2002-02-15,10.1200/jco.20.4.951,,,,11844816,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11766735,https://api.altmetric.com/v1/donut/11766735_240.png 0,Osteoprotegerin in Prostate Cancer Bone Metastasis,Cancer Research,,,Article,2005-03-01,10.1158/0008-5472.can-04-2033,,,,15753366,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11766058,https://api.altmetric.com/v1/donut/11766058_240.png 0,Men's reactions to disclosed and undisclosed opportunistic PSA screening for prostate cancer.,Medical Journal of Australia,,,Article,2005-04-17,,,,,15850434,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/11766045,https://api.altmetric.com/v1/donut/11766045_240.png 0,A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening,Patient Education & Counseling,,,Article,2005-05-14,10.1016/j.pec.2004.05.011,,,,15911190,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/11766039,https://api.altmetric.com/v1/donut/11766039_240.png 0,Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies,"Cancer Immunology, Immunotherapy",,,Article,2004-05-14,10.1007/s00262-003-0457-9,,,,14722668,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/11765900,https://api.altmetric.com/v1/donut/11765900_240.png 0,"The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study.",Cancer (0008543X),,,Article,2001-09-15,10.1002/1097-0142(20010915)92:6<1444::aid-cncr1468>3.0.co;2-m,,,,11745221,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11765585,https://api.altmetric.com/v1/donut/11765585_240.png 0,OSTEOPOROSIS AND SPINAL FRACTURES IN MEN WITH PROSTATE CANCER: RISK FACTORS AND EFFECTS OF ANDROGEN DEPRIVATION THERAPY,The Journal of Urology,,,Article,2004-08-01,10.1097/01.ju.0000130508.61020.66,,,,15247721,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11765569,https://api.altmetric.com/v1/donut/11765569_240.png 0,Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted ?-therapy with 213Bi-conjugates,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-11-01,10.1016/j.ijrobp.2004.04.035,,,,15465208,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11765188,https://api.altmetric.com/v1/donut/11765188_240.png 0,"Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: A case-control study",International Journal of Cancer,,,Article,2012-08-31,10.1002/ijc.27400,,,,22173996,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11765116,https://api.altmetric.com/v1/donut/11765116_240.png 0,Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer.,Cancer Research,,,Article,1999-05-15,,,,,10344737,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11764517,https://api.altmetric.com/v1/donut/11764517_240.png 0,Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.,Cancer Research,,,Article,2000-03-15,,,,,10749127,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11764148,https://api.altmetric.com/v1/donut/11764148_240.png 0,Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?,Molecular Urology,,,Article,2000-01-01,,,,,11156711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11763849,https://api.altmetric.com/v1/donut/11763849_240.png 0,Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients.,Clinical Cancer Research,,,Article,2001-03-01,,,,,11297246,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11763735,https://api.altmetric.com/v1/donut/11763735_240.png 0,Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models.,Journal of Clinical Oncology,,,Article,2001-08-15,,,,,11504751,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11763598,https://api.altmetric.com/v1/donut/11763598_240.png 0,Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells,Oncogene,,,Article,2002-02-07,10.1038/sj.onc.1205153,,,,11850822,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/11763364,https://api.altmetric.com/v1/donut/11763364_240.png 0,A Comparative Study of Growth-Inhibitory Effects of Isoflavones and Their Metabolites on Human Breast and Prostate Cancer Cell Lines,Nutrition and Cancer,,,Article,2002-01-01,10.1207/s15327914nc422_12,,,,12416264,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11763024,https://api.altmetric.com/v1/donut/11763024_240.png 0,Evaluation of an instrument to assess the needs of men diagnosed with prostate carcinoma,Cancer (0008543X),,,Article,2003-02-15,10.1002/cncr.11156,,,,12569598,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11762919,https://api.altmetric.com/v1/donut/11762919_240.png 0,Oncogenic Action of Secreted Phospholipase A2 in Prostate Cancer,Cancer Research,,,Article,2004-09-30,10.1158/0008-5472.can-03-3018,,,,15466184,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/11762853,https://api.altmetric.com/v1/donut/11762853_240.png 0,Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy,Cancer (0008543X),,,Article,2003-04-15,10.1002/cncr.11263,,,,12673714,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/11762814,https://api.altmetric.com/v1/donut/11762814_240.png 0,Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis,Molecular Carcinogenesis,,,Article,2003-11-15,10.1002/mc.10154,,,,14587098,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11762379,https://api.altmetric.com/v1/donut/11762379_240.png 0,Is Year of Radical Prostatectomy a Predictor of Outcome in Prostate Cancer?,The Journal of Urology,,,Article,2004-02-15,10.1097/01.ju.0000107260.98031.0e,,,,14713788,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11762272,https://api.altmetric.com/v1/donut/11762272_240.png 0,Prostate cancer bone metastases promote both osteolytic and osteoblastic activity,Journal of Cellular Biochemistry,,,Article,2004-03-01,10.1002/jcb.10662,,,,14991763,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/11762192,https://api.altmetric.com/v1/donut/11762192_240.png 0,Targeted ?-therapy for control of micrometastatic prostate cancer,Expert Review of Anticancer Therapy,,,Article,2004-06-14,10.1586/14737140.4.3.459,,,,15161444,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11762096,https://api.altmetric.com/v1/donut/11762096_240.png 0,Molecular markers of prostate cancer outcome,European Journal of Cancer (1965),,,Article,2005-04-14,10.1016/j.ejca.2004.12.035,,,,15808955,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/11761596,https://api.altmetric.com/v1/donut/11761596_240.png 0,Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology.,,,,Article,2005-06-14,,,,,15870888,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11761558,https://api.altmetric.com/v1/donut/11761558_240.png 0,EphB4 Expression and Biological Significance in Prostate Cancer,Cancer Research,,,Article,2005-05-31,10.1158/0008-5472.can-04-2667,,,,15930280,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/11761510,https://api.altmetric.com/v1/donut/11761510_240.png 0,Evaluation of a revised instrument to assess the needs of men diagnosed with prostate cancer,Supportive Care in Cancer,,,Article,2005-11-15,10.1007/s00520-005-0808-5,,,,16025261,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/11761440,https://api.altmetric.com/v1/donut/11761440_240.png 0,Oncogenic action of phospholipase A2 in prostate cancer,Cancer Letters,,,Article,2006-08-17,10.1016/j.canlet.2005.08.012,,,,16182442,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/11761336,https://api.altmetric.com/v1/donut/11761336_240.png 0,Patterns of practice in the management of prostate cancer: results from multidisciplinary surveys of clinicians in Australia and New Zealand in 1995 and 2000,British Journal of Urology,,,Article,2006-05-14,10.1111/j.1464-410x.2006.06065.x,,,,16542341,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/11761062,https://api.altmetric.com/v1/donut/11761062_240.png 0,Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model,Cancer Biology and Therapy,,,Article,2006-04-01,10.4161/cbt.5.4.2478,,,,16575210,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11761027,https://api.altmetric.com/v1/donut/11761027_240.png 0,Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression Are Early Events in Prostate Cancer Development and Are Associated with Poor Prognosis,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2006-04-14,10.1158/1055-9965.epi-05-0752,,,,16614113,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/11760953,https://api.altmetric.com/v1/donut/11760953_240.png 0,Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer?,Human Pathology,,,Article,2006-11-15,10.1016/j.humpath.2006.05.002,,,,16949925,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/11760625,https://api.altmetric.com/v1/donut/11760625_240.png 0,Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy,JNCI: Journal of the National Cancer Institute,,,Article,2006-10-03,10.1093/jnci/djj378,,,,17018789,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11760549,https://api.altmetric.com/v1/donut/11760549_240.png 0,Androgen decreases osteoprotegerin expression in prostate cancer cells,Prostate Cancer & Prostatic Diseases,,,Article,2006-12-26,10.1038/sj.pcan.4500927,,,,17189957,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/11760399,https://api.altmetric.com/v1/donut/11760399_240.png 0,Serum Macrophage Inhibitory Cytokine-1 Concentrations Correlate with the Presence of Prostate Cancer Bone Metastases,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-03-15,10.1158/1055-9965.epi-06-0841,,,,17372249,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11760195,https://api.altmetric.com/v1/donut/11760195_240.png 0,Targeting uPA/uPAR in prostate cancer,Cancer Treatment Reviews,,,Article,2007-10-14,10.1016/j.ctrv.2007.06.003,,,,17658220,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/11759768,https://api.altmetric.com/v1/donut/11759768_240.png 0,Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells,British Journal of Cancer,,,Article,2009-02-24,10.1038/sj.bjc.6604920,,,,19209173,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/11758586,https://api.altmetric.com/v1/donut/11758586_240.png 0,Effect of laminin tyrosine–isoleucine–glycine–serine–arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro,European Journal of Pharmacology,,,Article,2009-08-14,10.1016/j.ejphar.2009.06.050,,,,19577562,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/11758457,https://api.altmetric.com/v1/donut/11758457_240.png 0,Molecular and traditional chemotherapy: A united front against prostate cancer,Cancer Letters,,,Article,2010-06-30,10.1016/j.canlet.2009.11.019,,,,20117879,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/11758293,https://api.altmetric.com/v1/donut/11758293_240.png 0,A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer,Asia Pacific Journal of Clinical Oncology,,,Article,2010-12-15,10.1111/j.1743-7563.2010.01328.x,,,,21114779,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/11757973,https://api.altmetric.com/v1/donut/11757973_240.png 0,Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens,Pathology,,,Article,2011-08-14,10.1097/pat.0b013e328348a6b3,,,,21716159,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/11757744,https://api.altmetric.com/v1/donut/11757744_240.png 0,Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer,Current Cancer Drug Targets,,,Article,2012-02-01,10.2174/156800912799095180,,,,22229247,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/11757527,https://api.altmetric.com/v1/donut/11757527_240.png 0,Role of the EpCAM (CD326) in prostate cancer metastasis and progression,Cancer and Metastasis Reviews,,,Article,2012-12-15,10.1007/s10555-012-9389-1,,,,22718399,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/11757232,https://api.altmetric.com/v1/donut/11757232_240.png 0,Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2? via AKT in prostate cancer cells,Oncotarget,,,Article,2014-08-01,10.18632/oncotarget.2198,,,,25026288,PMC4171630,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/11756699,https://api.altmetric.com/v1/donut/11756699_240.png 0,Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy,Cancer and Metastasis Reviews,,,Article,2014-01-21,10.1007/s10555-014-9493-5,,,,24445654,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11753570,https://api.altmetric.com/v1/donut/11753570_240.png 0,Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry,Cancer Epidemiology,,,Article,2013-10-04,10.1016/j.canep.2013.09.008,,,,24103424,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11753282,https://api.altmetric.com/v1/donut/11753282_240.png 0,Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.,Cancer Research,,,Article,2001-01-15,,,,,11212224,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/11752644,https://api.altmetric.com/v1/donut/11752644_240.png 0,Frequent loss of estrogen receptor-beta expression in prostate cancer.,Cancer Research,,,Article,2001-07-15,,,,,11454669,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/11752641,https://api.altmetric.com/v1/donut/11752641_240.png 0,Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.,Cancer Research,,,Article,2003-08-15,,,,,12941831,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/11752443,https://api.altmetric.com/v1/donut/11752443_240.png 0,A Preoperative Nomogram Identifying Decreased Risk of Positive Pelvic Lymph Nodes in Patients With Prostate Cancer,The Journal of Urology,,,Article,2003-11-01,10.1097/01.ju.0000091805.98960.13,,,,14532779,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/11752440,https://api.altmetric.com/v1/donut/11752440_240.png 0,The Propeptide Mediates Formation of Stromal Stores of PROMIC-1: Role in Determining Prostate Cancer Outcome,Cancer Research,,,Article,2005-03-15,10.1158/0008-5472.can-04-3827,,,,15781647,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/11752309,https://api.altmetric.com/v1/donut/11752309_240.png 0,SUBJECTIVE AND OBJECTIVE ANALYSIS OF THE PREVALENCE OF PEYRONIE’S DISEASE IN A POPULATION OF MEN PRESENTING FOR PROSTATE CANCER SCREENING,The Journal of Urology,,,Article,2004-06-01,10.1097/01.ju.0000127744.18878.f1,,,,15126819,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/11752256,https://api.altmetric.com/v1/donut/11752256_240.png 0,Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis,Clinical Cancer Research,,,Article,2006-01-01,10.1158/1078-0432.ccr-05-1331,,,,16397029,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11752194,https://api.altmetric.com/v1/donut/11752194_240.png 0,Abstract A283: PI3K/Akt/mTOR dual inhibitors have an advantage over single inhibitors in overcoming prostate cancer radioresistance.,Molecular Cancer Therapeutics,,,Article,2014-01-30,10.1158/1535-7163.targ-13-a283,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11750003,https://api.altmetric.com/v1/donut/11750003_240.png 0,Growth factor involvement in progression of prostate cancer.,Clinical Chemistry,,,Article,1998-04-01,,,,,9554481,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/11745890,https://api.altmetric.com/v1/donut/11745890_240.png 0,CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations,Oncotarget,,,Article,2015-08-06,10.18632/oncotarget.3875,,,,25965834,PMC4637312,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/11745172,https://api.altmetric.com/v1/donut/11745172_240.png 0,Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer.,The Journal of Urology,,,Article,1991-05-01,,,,,1826749,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11744906,https://api.altmetric.com/v1/donut/11744906_240.png 0,A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer,Cancer Research,,,Article,2007-01-01,10.1158/0008-5472.can-06-2971,,,,17210694,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/11742264,https://api.altmetric.com/v1/donut/11742264_240.png 0,"A pilot, multisite, randomized controlled trial of a self-directed coping skills training intervention for couples facing prostate cancer: accrual, retention, and data collection issues",Supportive Care in Cancer,,,Article,2015-07-17,10.1007/s00520-015-2833-3,,,,26184499,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/11742146,https://api.altmetric.com/v1/donut/11742146_240.png 0,Gene Based Prediction of Clinically Localized Prostate Cancer Progression After Radical Prostatectomy,The Journal of Urology,,,Article,2010-10-14,10.1016/j.juro.2010.05.084,,,,20723930,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/11741519,https://api.altmetric.com/v1/donut/11741519_240.png 0,Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective,Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,,,Article,2013-04-14,10.1016/j.bbcan.2013.01.002,,,,23357067,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/11741331,https://api.altmetric.com/v1/donut/11741331_240.png 0," Abstract 4005: CD44 isoform variant 6 is associated with prostate cancer progression, metastasis and chemo-/radio-resistance via PI3K/Akt/mTOR and Wnt/?-catenin signaling pathways in vitro ",Cancer Research,,,Article,2014-09-30,10.1158/1538-7445.am2014-4005,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/11740838,https://api.altmetric.com/v1/donut/11740838_240.png 0,In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen,Prostate Cancer & Prostatic Diseases,,,Article,2002-01-01,10.1038/sj/pcan/4500543,,,,15195129,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/11740834,https://api.altmetric.com/v1/donut/11740834_240.png 0,"In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers",Critical Reviews in Oncology/Hematology,,,Article,2001-07-01,10.1016/s1040-8428(01)00113-5,,,,11418311,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/11740833,https://api.altmetric.com/v1/donut/11740833_240.png 0,Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer.,Molecular Cancer Therapeutics,,,Article,2004-08-14,,,,,15299075,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/11740709,https://api.altmetric.com/v1/donut/11740709_240.png 0,Suppression of Androgen Receptor Signaling in Prostate Cancer Cells by an Inhibitory Receptor Variant,Molecular Endocrinology,,,Article,2006-05-14,10.1210/me.2004-0401,,,,16423882,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/11706268,https://api.altmetric.com/v1/donut/11706268_240.png 0,Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies,Carcinogenesis,,,Article,2007-10-04,10.1093/carcin/bgm253,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10992465,https://api.altmetric.com/v1/donut/10992465_240.png 0,TNF polymorphisms and prostate cancer risk,The Prostate,,,Article,2008-03-01,10.1002/pros.20694,,,,18196539,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/10992464,https://api.altmetric.com/v1/donut/10992464_240.png 0,Targeting HOX transcription factors in prostate cancer,BMC Urology,,,Article,2014-02-05,10.1186/1471-2490-14-17,,,,24499138,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/10987094,https://api.altmetric.com/v1/donut/10987094_240.png 0,"The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies",British Journal of Radiology,,,Article,2012-04-14,10.1259/bjr/24514638,,,,22010028,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/10984958,https://api.altmetric.com/v1/donut/10984958_240.png 0,"Cellular localization, accumulation and trafficking of double-walled carbon nanotubes in human prostate cancer cells",Nano Research,,,Article,2012-02-22,10.1007/s12274-012-0202-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/10984877,https://api.altmetric.com/v1/donut/10984877_240.png 0,Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer,The Prostate,,,Article,2016-08-23,10.1002/pros.23248,,,,27550197,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10984205,https://api.altmetric.com/v1/donut/10984205_240.png 0,Supportive care needs of men living with prostate cancer in England: a survey,British Journal of Cancer,,,Article,2008-06-16,10.1038/sj.bjc.6604406,,,,18506142,PMC2441950,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/10982800,https://api.altmetric.com/v1/donut/10982800_240.png 0,The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression.,BMC Genomics,,,Article,2006-03-29,10.1186/1471-2164-7-65,,,,16573809,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/10982095,https://api.altmetric.com/v1/donut/10982095_240.png 0,Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?,Cancer (0008543X),,,Article,2007-02-01,10.1002/cncr.22439,,,,17186531,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10959950,https://api.altmetric.com/v1/donut/10959950_240.png 0,Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression,Cancer Research,,,Article,2008-12-01,10.1158/0008-5472.can-08-2229,,,,19047143,PMC3100895,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/10959618,https://api.altmetric.com/v1/donut/10959618_240.png 0,"Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer",The Prostate,,,Article,2009-05-14,10.1002/pros.20928,,,,19189306,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/10959616,https://api.altmetric.com/v1/donut/10959616_240.png 0,A Seminal Finding for Prostate Cancer?,New England Journal of Medicine,,,Article,2010-01-14,10.1056/nejmcibr0909965,,,,20071710,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10959614,https://api.altmetric.com/v1/donut/10959614_240.png 0,Re: Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer,European Urology,,,Article,2010-04-14,10.1016/j.eururo.2010.01.028,,,,20965042,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10959612,https://api.altmetric.com/v1/donut/10959612_240.png 0,Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer,Cancer Chemotherapy & Pharmacology,,,Article,1993-01-01,10.1007/bf00686149,,,,7679331,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10957430,https://api.altmetric.com/v1/donut/10957430_240.png 0," Molecular alterations in AKT1 , AKT2 and AKT3 detected in breast and prostatic cancer by FISH ",Histopathology,,,Article,2010-01-15,10.1111/j.1365-2559.2009.03467.x,,,,20102399,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/10951704,https://api.altmetric.com/v1/donut/10951704_240.png 0,Analysis of Wnt Gene Expression in Prostate Cancer: Mutual Inhibition by WNT11 and the Androgen Receptor,Cancer Research,,,Article,2004-11-01,10.1158/0008-5472.can-04-2704,,,,15520198,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/10950917,https://api.altmetric.com/v1/donut/10950917_240.png 0,NF-?B activation upregulates fibroblast growth factor 8 expression in prostate cancer cells,The Prostate,,,Article,2006-07-31,10.1002/pros.20376,,,,16683270,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10950915,https://api.altmetric.com/v1/donut/10950915_240.png 0,The role of self-reported stress in the development of breast cancer and prostate cancer: A prospective cohort study of employed males and females with 30 years of follow-up,European Journal of Cancer (1965),,,Article,2007-04-14,10.1016/j.ejca.2007.01.027,,,,17336053,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10949779,https://api.altmetric.com/v1/donut/10949779_240.png 0,The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer,British Journal of Cancer,,,Article,2004-08-01,10.1038/sj.bjc.6601943,,,,15266325,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10949728,https://api.altmetric.com/v1/donut/10949728_240.png 0,"Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer",International Journal of Cancer,,,Article,2006-02-15,10.1002/ijc.21451,,,,16106418,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10949351,https://api.altmetric.com/v1/donut/10949351_240.png 0,The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease,British Journal of Cancer,,,Article,2004-11-15,10.1038/sj.bjc.6602211,,,,15505624,PMC2410056,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10949346,https://api.altmetric.com/v1/donut/10949346_240.png 0,The role of c-Jun and c-Fos expression in androgen-independent prostate cancer,The Journal of Pathology,,,Article,2004-10-14,10.1002/path.1605,,,,15378488,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/10948914,https://api.altmetric.com/v1/donut/10948914_240.png 0,Advances in mouse models of prostate cancer,Expert Reviews in Molecular Medicine,,,Article,2008-06-08,10.1017/s1462399408000689,,,,18538039,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/10948766,https://api.altmetric.com/v1/donut/10948766_240.png 0,A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer,Health technology assessment : HTA / NHS R & D HTA Programme.,,,Article,2007-01-01,10.3310/hta11020,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10948464,https://api.altmetric.com/v1/donut/10948464_240.png 0,Raf-1 expression may influence progression to androgen insensitive prostate cancer,The Prostate,,,Article,2005-06-14,10.1002/pros.20211,,,,15666389,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/10945289,https://api.altmetric.com/v1/donut/10945289_240.png 0,Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer,The Journal of Pathology,,,Article,2005-03-15,10.1002/path.1735,,,,15685688,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10945288,https://api.altmetric.com/v1/donut/10945288_240.png 0,"Reply from Authors re: Julia Verne, Luke Hounsome, Roger Kockelbergh, Jem Rashbass. Improving Outcomes from Prostate Cancer: Unlocking the Treasure Trove of Information in Cancer Registries. Eur Urol 2016;69:1013–4",European Urology,,,Article,2016-06-01,10.1016/j.eururo.2015.09.036,,,,26443428,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10944501,https://api.altmetric.com/v1/donut/10944501_240.png 0,Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility,Endocrine-Related Cancer,,,Article,2011-02-15,10.1677/erc-10-0112,,,,20959441,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/10936936,https://api.altmetric.com/v1/donut/10936936_240.png 0,"Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project.",The Journal of Urology,,,Article,1991-08-01,,,,,1856935,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10934756,https://api.altmetric.com/v1/donut/10934756_240.png 0,Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.9485,,,,27223078,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10925366,https://api.altmetric.com/v1/donut/10925366_240.png 0,Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks,Asia Pacific Journal of Clinical Oncology,,,Article,2016-08-25,10.1111/ajco.12570,,,,27558311,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10914944,https://api.altmetric.com/v1/donut/10914944_240.png 0,Reversible Parkinson's Dementia Associated with Withdrawal of Androgen-Deprivation Therapy for Prostate Cancer,Journal of the American Geriatrics Society,,,Article,2016-08-26,10.1111/jgs.14417,,,,27564790,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10913972,https://api.altmetric.com/v1/donut/10913972_240.png 0,"Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)",Annals of Oncology,,,Article,2016-08-08,10.1093/annonc/mdw313,,,,27502724,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10910788,https://api.altmetric.com/v1/donut/10910788_240.png 0,[Growth inhibition of prostate cancer cells by epigallocatechin-3-gallate in the presence of Zn2+ in vitro].,Journal of Molecular Cell Biology,,,Article,2008-12-15,,,,,19137815,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10899306,https://api.altmetric.com/v1/donut/10899306_240.png 0,Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90,Cancers,,,Article,2016-01-01,10.3390/cancers8090077,,,,27563925,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10898595,https://api.altmetric.com/v1/donut/10898595_240.png 0,In Vitro Affinity Maturation of an Anti-PSA Antibody for Prostate Cancer Diagnostic Assay,Journal of Molecular Biology,,,Article,2011-12-09,10.1016/j.jmb.2011.10.008,,,,22019475,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/10892981,https://api.altmetric.com/v1/donut/10892981_240.png 0,Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: Correlation with histopathology,Journal of Medical Imaging & Radiation Oncology,,,Article,2014-06-15,10.1111/1754-9485.12189,,,,24935089,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/10892816,https://api.altmetric.com/v1/donut/10892816_240.png 0,909 QUALITATIVE AND QUANTITATIVE PSAMRNA DETECTION IN PROSTATE CANCER - A USEFUL TOOL FOR THE CLINICIAN?,European Urology Supplements,,,Article,2007-03-01,10.1016/s1569-9056(07)60904-x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10863056,https://api.altmetric.com/v1/donut/10863056_240.png 0,Novel Androgen Receptor Signaling Inhibitors for Nonmetastatic Castration-Resistant Prostate Cancer: The Light at the End of the Tunnel-or an Oncoming Train?,Oncology (08909091),,,Article,2016-04-15,,,,,27085333,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10861772,https://api.altmetric.com/v1/donut/10861772_240.png 0,Abstract 4249: High-Frequency of TMPRSS2-ERG fusion gene identifies a non-random androgen-driven event of chromosomal instability in BRCA mutated prostate cancer,Cancer Research,,,Article,2015-08-02,10.1158/1538-7445.am2015-4249,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10855449,https://api.altmetric.com/v1/donut/10855449_240.png 0,Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate,Prostate Cancer & Prostatic Diseases,,,Article,2004-10-12,10.1038/sj.pcan.4500760,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10838510,https://api.altmetric.com/v1/donut/10838510_240.png 0,HER2 and COX2 expression in human prostate cancer,European Journal of Cancer (1965),,,Article,2004-01-01,10.1016/j.ejca.2003.08.010,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10838247,https://api.altmetric.com/v1/donut/10838247_240.png 0,Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer,British Journal of Cancer,,,Article,2003-08-04,10.1038/sj.bjc.6601127,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/10838238,https://api.altmetric.com/v1/donut/10838238_240.png 0,Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer,The Journal of Pathology,,,Article,2002-10-01,10.1002/path.1206,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/10838237,https://api.altmetric.com/v1/donut/10838237_240.png 0,Rectal complication probability from composite volumes derived from daily cone beam computed tomography in prostate cancer radiotherapy,Journal of Cancer Research & Therapeutics,,,Article,2016-01-01,10.4103/0973-1482.174529,,,,27072266,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10824812,https://api.altmetric.com/v1/donut/10824812_240.png 0,Increased expression of non-sulfated chondroitin correlates with adverse clinicopathological parameters in prostate cancer,Modern Pathology,,,Article,2008-07-14,10.1038/modpathol.2008.70,,,,18487997,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10805184,https://api.altmetric.com/v1/donut/10805184_240.png 0,"Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate",Cancer Science,,,Article,2008-07-14,10.1111/j.1349-7006.2008.00816.x,,,,18422756,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10767827,https://api.altmetric.com/v1/donut/10767827_240.png 0,Quality of life three years after diagnosis of localised prostate cancer: population based cohort study,British Medical Journal,,,Article,2009-11-27,10.1136/bmj.b4817,,,,19945997,PMC2784818,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/10748900,https://api.altmetric.com/v1/donut/10748900_240.png 0,Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin ?-conjugate,Cancer Letters,,,Article,2004-03-18,10.1016/j.canlet.2003.10.035,,,,15036648,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/10745680,https://api.altmetric.com/v1/donut/10745680_240.png 0,A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study.,Progress in Clinical & Biological Research,,,Article,1989-01-01,,,,,2528739,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10730422,https://api.altmetric.com/v1/donut/10730422_240.png 0,Abstract 2612: The PROFILE study; Germline genetic profiling: Correlation with targeted prostate cancer screening and treatment,Cancer Research,,,Article,2014-11-21,10.1158/1538-7445.am2012-2612,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10663472,https://api.altmetric.com/v1/donut/10663472_240.png 0,High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.9876,,,,27283984,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10557528,https://api.altmetric.com/v1/donut/10557528_240.png 0,Abstract LB-448: Genome-wide association study identifies new prostate cancer susceptibility loci,Cancer Research,,,Article,2011-07-12,10.1158/1538-7445.am2011-lb-448,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10527914,https://api.altmetric.com/v1/donut/10527914_240.png 0,The third analysis of the bicalutamide Early Prostate Cancer programme,British Journal of Urology,,,Article,2006-02-10,10.1111/j.1464-410x.2006.06118.x,,,,16469002,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10514919,https://api.altmetric.com/v1/donut/10514919_240.png 0,Precision of the SonArray Ultrasound Device for Patients Undergoing Radical Conformal Radiotherapy for Prostate Cancer,Clinical Oncology,,,Article,2007-04-01,10.1016/j.clon.2007.01.421,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10429178,https://api.altmetric.com/v1/donut/10429178_240.png 0,Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer,Journal of Biological Chemistry,,,Article,2004-08-05,10.1074/jbc.m401781200,,,,15166229,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/10398708,https://api.altmetric.com/v1/donut/10398708_240.png 0,Serum Antibodies to Huntingtin Interacting Protein-1: A New Blood Test for Prostate Cancer,Cancer Research,,,Article,2005-05-14,10.1158/0008-5472.can-04-4658,,,,15899803,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/10396617,https://api.altmetric.com/v1/donut/10396617_240.png 0,What is the role of sipuleucel-T in the treatment of patients with advanced prostate cancer? An update on the evidence,Therapeutic Advances in Urology,,,Article,2016-05-02,10.1177/1756287216645314,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10396327,https://api.altmetric.com/v1/donut/10396327_240.png 0,Moderators of the benefits of psychoeducational interventions for men with prostate cancer.,Health Psychology,,,Article,2006-05-14,10.1037/0278-6133.25.3.348,,,,16719606,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/10366167,https://api.altmetric.com/v1/donut/10366167_240.png 0,The oncologists’ unmet clinical needs for imaging in advanced prostate cancer,Clinical and Translational Imaging,,,Article,2016-08-04,10.1007/s40336-016-0204-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10325239,https://api.altmetric.com/v1/donut/10325239_240.png 0,Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.10476,,,,27409172,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10202568,https://api.altmetric.com/v1/donut/10202568_240.png 0,Abstract 3220: The effects of cholesterol treatment drugs alone and in combination on prostate tumor xenograft growth,Cancer Research,,,Article,2014-11-21,10.1158/1538-7445.am2012-3220,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10202346,https://api.altmetric.com/v1/donut/10202346_240.png 0,Focal Cryotherapy for Localized Prostate Cancer.,Archivos Españoles de Urología (Ed. impresa),,,Article,2016-07-01,,,,,27416635,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/10201377,https://api.altmetric.com/v1/donut/10201377_240.png 0,Integration of multiparametric MRI into active surveillance of prostate cancer,Future Oncology,,,Article,2016-06-20,10.2217/fon-2016-0142,,,,27322161,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10201376,https://api.altmetric.com/v1/donut/10201376_240.png 0,The ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer,British Journal of Urology,,,Article,2016-07-01,10.1111/bju.13593,,,,27431584,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10198640,https://api.altmetric.com/v1/donut/10198640_240.png 0,Evaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance Imaging,PLoS ONE,,,Article,2016-07-28,10.1371/journal.pone.0159652,,,,27467064,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10196833,https://api.altmetric.com/v1/donut/10196833_240.png 0,Relationship between colorectal and prostate cancer,Diseases of the Colon & Rectum,,,Article,1995-05-01,10.1007/bf02148862,,,,7736892,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10194095,https://api.altmetric.com/v1/donut/10194095_240.png 0,"""The news is [not] all good"": misrepresentations and inaccuracies in Australian news media reports on prostate cancer screening.",Medical Journal of Australia,,,Article,2007-11-05,,,,,17979615,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/10180380,https://api.altmetric.com/v1/donut/10180380_240.png 0,E-selectin up-regulation allows for targeted drug delivery in prostate cancer.,Cancer Research,,,Article,2003-10-01,,,,,14559828,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10180126,https://api.altmetric.com/v1/donut/10180126_240.png 0,Experience with docetaxel in hormone-refractory prostate cancer (HRPC) at three Australian cancer centers: A retrospective study,Asia Pacific Journal of Clinical Oncology,,,Article,2007-09-01,10.1111/j.1743-7563.2007.00099.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10178780,https://api.altmetric.com/v1/donut/10178780_240.png 0,Chemotherapy in the treatment of prostate cancer--is there a role?,Australian Family Physician,,,Article,2007-09-01,,,,,17885709,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10176479,https://api.altmetric.com/v1/donut/10176479_240.png 0,Docetaxel prolongs life in men with hormone refractory prostate cancer,British Medical Journal,,,Article,2004-10-16,10.1136/bmj.329.7471.877,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10105267,https://api.altmetric.com/v1/donut/10105267_240.png 0,Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer,Molecular Diagnosis & Therapy,,,Article,2016-03-28,10.1007/s40291-016-0196-1,,,,27020582,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10083619,https://api.altmetric.com/v1/donut/10083619_240.png 0,Fast cine-magnetic resonance imaging point tracking for prostate cancer radiation therapy planning,Journal of Physics: Conference Series,,,Article,2014-03-24,10.1088/1742-6596/489/1/012027,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/10064837,https://api.altmetric.com/v1/donut/10064837_240.png 0,Effect of CT-based treatment planning on portal field size and outcome in radiation treatment of localized prostate cancer,Radiotherapy & Oncology,,,Article,2000-04-01,10.1016/s0167-8140(00)00151-1,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/10060097,https://api.altmetric.com/v1/donut/10060097_240.png 0,A study on planning organ at risk volume for the rectum using cone beam computed tomography in the treatment of prostate cancer,Medical Dosimetry,,,Article,2014-01-08,10.1016/j.meddos.2013.09.003,,,,24412028,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/10049922,https://api.altmetric.com/v1/donut/10049922_240.png 0,Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes,Radiation Oncology,,,Article,2011-01-10,10.1186/1748-717x-6-3,,,,21219625,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/10033542,https://api.altmetric.com/v1/donut/10033542_240.png 0,SELENIUM AND PROSTATE CANCER,British Journal of Urology,,,Article,2010-02-15,10.1111/j.1464-410x.2010.09254.x,,,,20149194,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/10032442,https://api.altmetric.com/v1/donut/10032442_240.png 0,The unfolded protein response during prostate cancer development,Cancer and Metastasis Reviews,,,Article,2009-06-14,10.1007/s10555-008-9180-5,,,,19172382,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/10032209,https://api.altmetric.com/v1/donut/10032209_240.png 0,Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE™ (cancer of the prostate strategic urologic research endeavor) database,Quality of Life Research,,,Article,2009-10-14,10.1007/s11136-009-9526-7,,,,19697155,PMC2744792,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/10031658,https://api.altmetric.com/v1/donut/10031658_240.png 0,Spirituality and end-of-life care in disadvantaged men dying of prostate cancer,World Journal of Urology,,,Article,2011-02-15,10.1007/s00345-010-0610-y,,,,21170717,PMC3024492,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/10021332,https://api.altmetric.com/v1/donut/10021332_240.png 0,Denosumab Reduces the Incidence of New Vertebral Fractures in Men With Prostate Cancer,Current Osteoporosis Reports,,,Article,2010-03-15,10.1007/s11914-010-0001-8,,,,20425083,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/10020803,https://api.altmetric.com/v1/donut/10020803_240.png 0,Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men,Cancer Causes and Control,,,Article,2010-04-10,10.1007/s10552-010-9557-y,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/10020547,https://api.altmetric.com/v1/donut/10020547_240.png 0,Comments on the article “Biomarkers for prostate cancer” by Eric Schiffer,World Journal of Urology,,,Article,2009-08-14,10.1007/s00345-009-0435-8,,,,19543735,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/10019943,https://api.altmetric.com/v1/donut/10019943_240.png 0,Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75,Molecular Cancer,,,Article,2009-08-27,10.1186/1476-4598-8-68,,,,19715609,PMC2741463,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/10019819,https://api.altmetric.com/v1/donut/10019819_240.png 0,Prostate cancer nodal oligometastasis accurately assessed using prostate-specific membrane antigen positron emission tomography-computed tomography and confirmed histologically following robotic-assisted lymph node dissection,Urology Annals,,,Article,2016-04-01,10.4103/0974-7796.179237,,,,27141207,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9999305,https://api.altmetric.com/v1/donut/9999305_240.png 0,Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years,Prostate International,,,Article,2016-03-01,10.1016/j.prnil.2015.10.016,,,,27014658,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9999202,https://api.altmetric.com/v1/donut/9999202_240.png 0,Australian patterns of prostate cancer care: Are they evolving?,Prostate International,,,Article,2016-03-01,10.1016/j.prnil.2015.11.001,,,,27014660,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9998266,https://api.altmetric.com/v1/donut/9998266_240.png 0,"Equol: A Comparison of the Effects of the Racemic Compound With That of the Purified S-Enantiomer on the Growth, Invasion, and DNA Integrity of Breast and Prostate Cells In Vitro",Nutrition and Cancer,,,Article,2006-07-01,10.1207/s15327914nc5402_10,,,,16898868,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/9978749,https://api.altmetric.com/v1/donut/9978749_240.png 0,Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell linein vitro,Molecular Nutrition & Food Research,,,Article,2008-05-14,10.1002/mnfr.200700052,,,,18398867,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9970690,https://api.altmetric.com/v1/donut/9970690_240.png 0,A System for Studying Epithelial-Stromal Interactions Reveals Distinct Inductive Abilities of Stromal Cells from Benign Prostatic Hyperplasia and Prostate Cancer,Endocrinology,,,Article,2005-01-15,10.1210/en.2004-1123,,,,15471963,PMC3033046,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/9968973,https://api.altmetric.com/v1/donut/9968973_240.png 0,Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells,Oncogene,,,Article,2005-08-31,10.1038/sj.onc.1208747,,,,16007208,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9968923,https://api.altmetric.com/v1/donut/9968923_240.png 0,"An elevated PSA, which normalizes, does not exclude the presence of prostate cancer",Prostate Cancer & Prostatic Diseases,,,Article,2005-07-12,10.1038/sj.pcan.4500819,,,,16010283,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9968897,https://api.altmetric.com/v1/donut/9968897_240.png 0,Relationship between milk consumption and prostate cancer: a short review,Nutrition Bulletin,,,Article,2008-12-01,10.1111/j.1467-3010.2008.00728.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9967982,https://api.altmetric.com/v1/donut/9967982_240.png 0,Treatment of gynecomastia in patients with prostate cancer and androgen deprivation,Actas Urologicas Espanolas - English Edition,,,Article,2014-01-01,10.1016/j.acuroe.2013.10.002,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9882208,https://api.altmetric.com/v1/donut/9882208_240.png 0,Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No.,International braz j urol : official journal of the Brazilian Society of Urology,,,Article,2016-07-20,10.1590/s1677-5538.ibju.2016.03.04,,,,27286102,PMC4920556,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9869165,https://api.altmetric.com/v1/donut/9869165_240.png 0,Advances in Prostate Cancer Immunotherapies,Drugs & Aging,,,Article,2007-01-01,10.2165/00002512-200724030-00003,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/9857931,https://api.altmetric.com/v1/donut/9857931_240.png 0,Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies,Cancer Treatment Reviews,,,Article,2013-10-14,10.1016/j.ctrv.2012.12.003,,,,23290320,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/9855668,https://api.altmetric.com/v1/donut/9855668_240.png 0,Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma,"Cancer Immunology, Immunotherapy",,,Article,2006-12-15,10.1007/s00262-006-0157-3,,,,16612599,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/9855102,https://api.altmetric.com/v1/donut/9855102_240.png 0,Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulation,The Prostate,,,Article,2005-08-31,10.1002/pros.20231,,,,15754347,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9854714,https://api.altmetric.com/v1/donut/9854714_240.png 0,Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk,PLoS ONE,,,Article,2008-10-27,10.1371/journal.pone.0003533,,,,,,,2008PLoSO...3.3533D,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/9852779,https://api.altmetric.com/v1/donut/9852779_240.png 0,"Phytoestrogen consumption and association with breast, prostate and colorectal cancer in EPIC Norfolk",Archives of Biochemistry & Biophysics,,,Article,2010-08-31,10.1016/j.abb.2010.05.018,,,,20494649,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/9851524,https://api.altmetric.com/v1/donut/9851524_240.png 0," Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate Cancer ",Korean Journal of Urology,,,Article,2013-06-14,10.4111/kju.2013.54.6.359,,,,23789042,PMC3685633,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9782322,https://api.altmetric.com/v1/donut/9782322_240.png 0,P0043 Going beyond age for comorbidity evaluation in prostate cancer patients treated with radiation,European Journal of Cancer (1965),,,Article,2014-05-01,10.1016/j.ejca.2014.03.087,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9780565,https://api.altmetric.com/v1/donut/9780565_240.png 0,Optimised Robust Treatment Plans for Prostate Cancer Focal Brachytherapy,Procedia Computer Science,,,Article,2015-01-01,10.1016/j.procs.2015.05.225,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9780176,https://api.altmetric.com/v1/donut/9780176_240.png 0,Abstract CT238: Phase I safety and biodistribution study of 124I-PEG-AVP0458 diabody in patients with TAG-72 positive ovarian and prostate cancer,Cancer Research,,,Article,2015-08-02,10.1158/1538-7445.am2015-ct238,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9778299,https://api.altmetric.com/v1/donut/9778299_240.png 0," Androgen Regulates ADAMTS15 Gene Expression in Prostate Cancer Cells ",Cancer Investigation,,,Article,2010-08-14,10.3109/07357907.2010.489538,,,,20590445,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9767632,https://api.altmetric.com/v1/donut/9767632_240.png 0,The Survival Effect of Prolactin on PC3 Prostate Cancer Cells,European Urology,,,Article,2003-03-01,10.1016/s0302-2838(03)00038-1,,,,12600435,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/9767450,https://api.altmetric.com/v1/donut/9767450_240.png 0,Bone marrow stromal cells promote growth and survival of prostate cancer cells,Biochemical Society Transactions,,,Article,2007-08-14,10.1042/bst0350698,,,,17635126,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9767448,https://api.altmetric.com/v1/donut/9767448_240.png 0,EZH2 promotes proliferation and invasiveness of prostate cancer cells,The Prostate,,,Article,2007-03-31,10.1002/pros.20550,,,,17252556,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/9767445,https://api.altmetric.com/v1/donut/9767445_240.png 0,Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor,PLoS ONE,,,Article,2010-06-17,10.1371/journal.pone.0011208,,,,20585447,,,2010PLoSO...511208K,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/9763323,https://api.altmetric.com/v1/donut/9763323_240.png 0,Suramin for breast and prostate cancer: a pilot study of intermittent short infusions without adaptive control.,Annals of Oncology,,,Article,1994-09-01,,,,,7993834,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9761735,https://api.altmetric.com/v1/donut/9761735_240.png 0,Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-04-14,10.1158/1055-9965.epi-10-1143,,,,21335510,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9761700,https://api.altmetric.com/v1/donut/9761700_240.png 0,Obesity and prostate cancer: Is there a link?,e-SPEN Journal,,,Article,2014-06-01,10.1016/j.clnme.2014.04.001,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9761685,https://api.altmetric.com/v1/donut/9761685_240.png 0,Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer,The Prostate,,,Article,2010-05-31,10.1002/pros.21121,,,,20127735,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9761683,https://api.altmetric.com/v1/donut/9761683_240.png 0,Promoter hypermethylation in circulating blood cells identifies prostate cancer progression,International Journal of Cancer,,,Article,2008-02-15,10.1002/ijc.23196,,,,17960617,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/9761681,https://api.altmetric.com/v1/donut/9761681_240.png 0,Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage,Clinical Cancer Research,,,Article,2007-03-15,10.1158/1078-0432.ccr-06-2467,,,,17363525,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/9761679,https://api.altmetric.com/v1/donut/9761679_240.png 0,Human Bone Marrow Stromal Cells Protect Prostate Cancer Cells From TRAIL-Induced Apoptosis,Journal of Bone & Mineral Research,,,Article,2004-10-14,10.1359/jbmr.040703,,,,15355567,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9760825,https://api.altmetric.com/v1/donut/9760825_240.png 0,Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer,Current Cancer Drug Targets,,,Article,2015-08-05,10.2174/1568009615666150506092443,,,,25968899,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9760817,https://api.altmetric.com/v1/donut/9760817_240.png 0,TMPRSS2 fusions in prostate cancer,Diagnostic Histopathology,,,Article,2008-03-01,10.1016/j.mpdhp.2008.02.001,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9760692,https://api.altmetric.com/v1/donut/9760692_240.png 0,BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype,The Journal of Pathology,,,Article,2008-02-01,10.1002/path.2292,,,,18072288,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/9760656,https://api.altmetric.com/v1/donut/9760656_240.png 0,Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer,The Prostate,,,Article,2013-03-15,10.1002/pros.22581,,,,22996647,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/9760655,https://api.altmetric.com/v1/donut/9760655_240.png 0,The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells,The Prostate,,,Article,2008-02-15,10.1002/pros.20705,,,,18095286,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9760638,https://api.altmetric.com/v1/donut/9760638_240.png 0,Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A,The Prostate,,,Article,2007-12-01,10.1002/pros.20654,,,,17929277,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/9760637,https://api.altmetric.com/v1/donut/9760637_240.png 0,DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer,The Prostate,,,Article,2007-03-01,10.1002/pros.20401,,,,17219414,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9760635,https://api.altmetric.com/v1/donut/9760635_240.png 0,Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer,Oncogene,,,Article,2006-05-10,10.1038/sj.onc.1209262,,,,16547507,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/9760633,https://api.altmetric.com/v1/donut/9760633_240.png 0,Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer,The Prostate,,,Article,2005-12-01,10.1002/pros.20302,,,,16015609,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9760629,https://api.altmetric.com/v1/donut/9760629_240.png 0,Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions,Human Pathology,,,Article,2004-11-15,10.1016/j.humpath.2004.07.015,,,,15668896,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/9760625,https://api.altmetric.com/v1/donut/9760625_240.png 0,Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: A pilot study,Urology,,,Article,2004-12-15,10.1016/j.urology.2004.06.063,,,,15596215,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/9760624,https://api.altmetric.com/v1/donut/9760624_240.png 0,Combination of Polymorphisms From Genes Related to Estrogen Metabolism and Risk of Prostate Cancers: The Hidden Face of Estrogens,Journal of Clinical Oncology,,,Article,2007-08-19,10.1200/jco.2007.11.0908,,,,17704407,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/9760320,https://api.altmetric.com/v1/donut/9760320_240.png 0,Efficacy of bisphosphonates and other bone-targeted agents in metastatic bone disease from solid tumors other than breast and prostate cancers.,Clinical Advances in Hematology & Oncology,,,Article,2013-05-14,,,,,23880711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9759836,https://api.altmetric.com/v1/donut/9759836_240.png 0,OC6. Endo180 function in metastatic prostate cancer bone lesions,Cancer Treatment Reviews,,,Article,2008-01-01,10.1016/j.ctrv.2008.03.032,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9759830,https://api.altmetric.com/v1/donut/9759830_240.png 0,Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer,Neoplasia,,,Article,2010-09-01,10.1593/neo.10610,,,,20824045,PMC2933689,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9759820,https://api.altmetric.com/v1/donut/9759820_240.png 0,The role of bisphosphonates in breast and prostate cancers,Endocrine-Related Cancer,,,Article,2004-06-01,10.1677/erc.0.0110207,,,,15163299,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/9759809,https://api.altmetric.com/v1/donut/9759809_240.png 0,Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer,Urology,,,Article,2007-08-14,10.1016/j.urology.2007.03.071,,,,17826496,PMC3047396,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/9759805,https://api.altmetric.com/v1/donut/9759805_240.png 0,Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer,Clinical Cancer Research,,,Article,2006-05-31,10.1158/1078-0432.ccr-06-0269,,,,16740758,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/9759804,https://api.altmetric.com/v1/donut/9759804_240.png 0,An observational study of cancers among female partners of UK-resident prostate cancer patients,Cancer Letters,,,Article,2006-10-07,10.1016/j.canlet.2005.10.038,,,,16338069,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9758108,https://api.altmetric.com/v1/donut/9758108_240.png 0,Prostate cancer: a systems approach overview,Diagnostic Histopathology,,,Article,2008-03-01,10.1016/j.mpdhp.2008.02.002,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9757701,https://api.altmetric.com/v1/donut/9757701_240.png 0,Markers of bone turnover for the management of patients with bone metastases from prostate cancer.,British Journal of Cancer,,,Article,2000-02-01,10.1054/bjoc.1999.1012,,,,10732759,PMC2374389,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/9757539,https://api.altmetric.com/v1/donut/9757539_240.png 0,Prostate cancer: Targeted therapy for prostate cancer metastases to bone,Nature Reviews Urology,,,Article,2011-05-16,10.1038/nrurol.2011.63,,,,21587226,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/9757522,https://api.altmetric.com/v1/donut/9757522_240.png 0,Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment,Cancer Treatment Reviews,,,Article,2003-06-01,10.1016/s0305-7372(03)00071-9,,,,12787713,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9757450,https://api.altmetric.com/v1/donut/9757450_240.png 0,Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer,Urology,,,Article,2004-05-14,10.1016/j.urology.2004.01.034,,,,15134985,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/9757440,https://api.altmetric.com/v1/donut/9757440_240.png 0,Gene therapy for prostate cancer: Current strategies and new cell-based approaches,The Prostate,,,Article,2006-03-31,10.1002/pros.20388,,,,16353250,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9749623,https://api.altmetric.com/v1/donut/9749623_240.png 0,Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.,Clinical Cancer Research,,,Article,2005-02-01,,,,,15709174,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/9747299,https://api.altmetric.com/v1/donut/9747299_240.png 0,Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer,Journal of Cancer Research & Clinical Oncology,,,Article,2008-11-15,10.1007/s00432-008-0403-5,,,,18465142,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9708321,https://api.altmetric.com/v1/donut/9708321_240.png 0,"Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer",British Journal of Urology,,,Article,1994-04-01,10.1111/j.1464-410x.1994.tb07602.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9703780,https://api.altmetric.com/v1/donut/9703780_240.png 0,Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis,British Journal of Cancer,,,Article,1994-12-01,10.1038/bjc.1994.482,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/9703718,https://api.altmetric.com/v1/donut/9703718_240.png 0,Protein Kinase C Isoenzyme Patterns Characteristically Modulated in Early Prostate Cancer,American Journal of Pathology,,,Article,1999-01-01,10.1016/s0002-9440(10)65260-1,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9703688,https://api.altmetric.com/v1/donut/9703688_240.png 0,Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells,FEBS Letters,,,Article,1998-02-13,10.1016/s0014-5793(98)00050-7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9701106,https://api.altmetric.com/v1/donut/9701106_240.png 0,A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells,Experimental Cell Research,,,Article,2007-11-15,10.1016/j.yexcr.2007.07.032,,,,17727841,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9696328,https://api.altmetric.com/v1/donut/9696328_240.png 0,Complex patterns of ETS gene alteration arise during cancer development in the human prostate,Oncogene,,,Article,2007-10-08,10.1038/sj.onc.1210843,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/9691842,https://api.altmetric.com/v1/donut/9691842_240.png 0,SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation,Cancer Research,,,Article,2010-02-01,10.1158/0008-5472.can-09-2370,,,,20103652,PMC3083842,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/9691837,https://api.altmetric.com/v1/donut/9691837_240.png 0,Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?,British Journal of Urology,,,Article,2005-05-14,10.1111/j.1464-410x.2005.05449.x,,,,15839915,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9691836,https://api.altmetric.com/v1/donut/9691836_240.png 0,p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer,British Journal of Urology,,,Article,2009-07-14,10.1111/j.1464-410x.2009.08407.x,,,,19239456,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/9691832,https://api.altmetric.com/v1/donut/9691832_240.png 0,Molecular prostate cancer pathology: Current issues and achievements,Scandinavian Journal of Urology and Nephrology,,,Article,2005-05-14,10.1080/03008880510030950,,,,16019760,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9691831,https://api.altmetric.com/v1/donut/9691831_240.png 0,Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study,British Journal of Cancer,,,Article,2009-03-24,10.1038/sj.bjc.6604951,,,,19293807,PMC2661778,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/9691829,https://api.altmetric.com/v1/donut/9691829_240.png 0,Concepts of epigenetics in prostate cancer development,British Journal of Cancer,,,Article,2008-11-11,10.1038/sj.bjc.6604771,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,81,https://www.altmetric.com/details/9691828,https://api.altmetric.com/v1/donut/9691828_240.png 0,"Effect of peripheral biopsies in maximising early prostate cancer detection in 8-, 10- or 12-core biopsy regimens",British Journal of Urology,,,Article,2004-06-14,10.1111/j.1464-410x.2004.04857.x,,,,15180609,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9691825,https://api.altmetric.com/v1/donut/9691825_240.png 0,Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies,The Prostate,,,Article,2005-06-30,10.1002/pros.20239,,,,15712218,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9691820,https://api.altmetric.com/v1/donut/9691820_240.png 0,A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo,Prostate Cancer & Prostatic Diseases,,,Article,2005-08-09,10.1038/sj.pcan.4500796,,,,16088330,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9691819,https://api.altmetric.com/v1/donut/9691819_240.png 0,Long-term outcome among men with conservatively treated localised prostate cancer,British Journal of Cancer,,,Article,2006-11-06,10.1038/sj.bjc.6603411,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/9691817,https://api.altmetric.com/v1/donut/9691817_240.png 0,Local Progression among Men with Conservatively Treated Localized Prostate Cancer: Results from the Transatlantic Prostate Group,European Urology,,,Article,2008-02-15,10.1016/j.eururo.2007.05.015,,,,17544572,PMC2646888,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9691814,https://api.altmetric.com/v1/donut/9691814_240.png 0,Prostate cancer diagnosis: should patients with prostate specific antigen >10ng/mL have stratified prostate biopsy protocols?,Cancer Detection & Prevention,,,Article,2009-01-01,10.1016/j.cdp.2008.12.004,,,,19193497,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9691809,https://api.altmetric.com/v1/donut/9691809_240.png 0,Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement,British Journal of Cancer,,,Article,2009-10-05,10.1038/sj.bjc.6605227,,,,19707199,PMC2768089,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/9691498,https://api.altmetric.com/v1/donut/9691498_240.png 0,Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer,British Journal of Cancer,,,Article,2005-01-31,10.1038/sj.bjc.6602261,,,,15583692,PMC2361840,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/9691497,https://api.altmetric.com/v1/donut/9691497_240.png 0,Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience,Oncology Reports,,,Article,2008-10-01,10.3892/or_00000088,,,,18813832,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9682886,https://api.altmetric.com/v1/donut/9682886_240.png 0,Diffuse primary leptomeningeal melanocytosis in a patient receiving a novel cancer cell vaccine for prostate cancer,BMJ Case Reports,,,Article,2010-05-04,10.1136/bcr.11.2009.2495,,,,22736604,PMC3047541,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/9682676,https://api.altmetric.com/v1/donut/9682676_240.png 0,Inhibition of Human ?-Methylacyl CoA Racemase (AMACR): a Target for Prostate Cancer,ChemMedChem,,,Article,2013-08-07,10.1002/cmdc.201300179,,,,23929631,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9682021,https://api.altmetric.com/v1/donut/9682021_240.png 0,Urinary Volatile Organic Compounds for the Detection of Prostate Cancer,PLoS ONE,,,Article,2015-11-24,10.1371/journal.pone.0143283,,,,26599280,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/9681677,https://api.altmetric.com/v1/donut/9681677_240.png 0,Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells.,International Journal of Cancer,,,Article,1997-05-29,10.1002/(sici)1097-0215(19970529)71:5<832::aid-ijc22>3.0.co;2-8,,,,9180153,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9681392,https://api.altmetric.com/v1/donut/9681392_240.png 0,"Abstract CT322: DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer",Cancer Research,,,Article,2015-08-02,10.1158/1538-7445.am2015-ct322,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9681072,https://api.altmetric.com/v1/donut/9681072_240.png 0,CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule.,,,,Article,2004-10-14,,,,,15375484,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9680928,https://api.altmetric.com/v1/donut/9680928_240.png 0,"Relationship between upregulated oestrogen receptors and expression of growth factors in cultured, human, prostatic stromal cells exposed to estradiol or dihydrotestosterone",Prostate Cancer & Prostatic Diseases,,,Article,2004-03-01,10.1038/sj.pcan.4500692,,,,14999240,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9680883,https://api.altmetric.com/v1/donut/9680883_240.png 0,Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer,Human Pathology,,,Article,2007-09-14,10.1016/j.humpath.2007.02.011,,,,17599389,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9680878,https://api.altmetric.com/v1/donut/9680878_240.png 0,Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression,International Journal of Oncology,,,Article,2011-04-14,10.3892/ijo.2011.932,,,,21290088,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9680876,https://api.altmetric.com/v1/donut/9680876_240.png 0,PRKC- Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention,Genes & Cancer,,,Article,2010-05-14,10.1177/1947601910376079,,,,21779455,PMC3092210,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/9680874,https://api.altmetric.com/v1/donut/9680874_240.png 0,Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts,International Journal of Oncology,,,Article,2009-11-19,10.3892/ijo_00000476,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9680872,https://api.altmetric.com/v1/donut/9680872_240.png 0,"Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol",Prostate Cancer & Prostatic Diseases,,,Article,2002-01-01,10.1038/sj.pcan.4500571,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9680865,https://api.altmetric.com/v1/donut/9680865_240.png 0,Molecular Mechanisms Involved in the Transition of Prostate Cancer Cells from Androgen Dependant to Castration Resistant State,Journal of Andrology and Gynaecology,,,Article,2014-01-01,10.13188/2332-3442.1000017,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9680864,https://api.altmetric.com/v1/donut/9680864_240.png 0,Analysis of Normal-Tumour Tissue Interaction in Tumours: Prediction of Prostate Cancer Features from the Molecular Profile of Adjacent Normal Cells,PLoS ONE,,,Article,2011-03-29,10.1371/journal.pone.0016492,,,,21479216,PMC3068146,,2011PLoSO...6E6492T,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/9680591,https://api.altmetric.com/v1/donut/9680591_240.png 0,Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells,Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids,,,Article,2005-04-30,10.1016/j.bbalip.2005.01.008,,,,15866478,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/9679785,https://api.altmetric.com/v1/donut/9679785_240.png 0,The expression of C-FABP and PPAR? and their prognostic significance in prostate cancer,International Journal of Oncology,,,Article,2013-11-05,10.3892/ijo.2013.2166,,,,24189640,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9679633,https://api.altmetric.com/v1/donut/9679633_240.png 0,Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter,Oncotarget,,,Article,2016-02-22,10.18632/oncotarget.6975,,,,26814431,PMC4891043,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9679622,https://api.altmetric.com/v1/donut/9679622_240.png 0,"Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models",Anti-Cancer Agents in Medicinal Chemistry,,,Article,2014-03-27,10.2174/1871520614666140327152607,,,,24712326,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9679459,https://api.altmetric.com/v1/donut/9679459_240.png 0,Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2011-03-01,10.2174/187152011795347496,,,,21426298,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9679349,https://api.altmetric.com/v1/donut/9679349_240.png 0,PARP Inhibition in Prostate Cancer: A Promising Approach.,Oncology (08909091),,,Article,2016-05-01,,,,,27188669,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9679226,https://api.altmetric.com/v1/donut/9679226_240.png 0,"How low is the ?/? ratio for prostate cancer? in regard to Wang et al., IJROBP 2003;55:194–203","International Journal of Radiation Oncology, Biology, Physics",,,Article,2003-10-01,10.1016/s0360-3016(03)00364-x,,,,12957275,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/9678461,https://api.altmetric.com/v1/donut/9678461_240.png 0,Correlations between dose–surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2001-02-01,10.1016/s0360-3016(00)01496-6,,,,11173143,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/9678320,https://api.altmetric.com/v1/donut/9678320_240.png 0,"Correlation between bone scans and serum levels of osteocalcin, prostate-specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostate",The Prostate,,,Article,1989-01-01,10.1002/pros.2990150302,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9678265,https://api.altmetric.com/v1/donut/9678265_240.png 0,Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer,PLoS ONE,,,Article,2011-05-23,10.1371/journal.pone.0020311,,,,21629734,PMC3100351,,2011PLoSO...6E0311S,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/9648475,https://api.altmetric.com/v1/donut/9648475_240.png 0,Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer,British Journal of Urology,,,Article,2008-07-07,10.1046/j.1464-410x.2001.02350.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9648469,https://api.altmetric.com/v1/donut/9648469_240.png 0,The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer,British Journal of Urology,,,Article,2002-09-13,10.1046/j.1464-410x.2002.02981.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9648466,https://api.altmetric.com/v1/donut/9648466_240.png 0,Is PTEN loss associated with clinical outcome measures in human prostate cancer?,British Journal of Cancer,,,Article,2008-10-21,10.1038/sj.bjc.6604680,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/9648454,https://api.altmetric.com/v1/donut/9648454_240.png 0,Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer,Oncogene,,,Article,2007-12-10,10.1038/sj.onc.1210963,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9648452,https://api.altmetric.com/v1/donut/9648452_240.png 0,Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients,British Journal of Cancer,,,Article,2008-03-25,10.1038/sj.bjc.6604152,,,,18349820,PMC2275485,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9648451,https://api.altmetric.com/v1/donut/9648451_240.png 0,Bad expression influences time to androgen escape in prostate cancer,British Journal of Urology,,,Article,2007-09-14,10.1111/j.1464-410x.2007.07001.x,,,,17542986,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9648449,https://api.altmetric.com/v1/donut/9648449_240.png 0,"Editorial Comment on: Increased Expression of Tumor-Associated Trypsin Inhibitor, TATI, in Prostate Cancer and in Androgen-Independent 22Rv1 Cells",European Urology,,,Article,2007-12-01,10.1016/j.eururo.2007.01.098,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9648447,https://api.altmetric.com/v1/donut/9648447_240.png 0,The Role of HER1-HER4 and EGFRvIII in Hormone-Refractory Prostate Cancer,Clinical Cancer Research,,,Article,2006-01-01,10.1158/1078-0432.ccr-05-1445,,,,16397033,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/9648446,https://api.altmetric.com/v1/donut/9648446_240.png 0,The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor,British Journal of Urology,,,Article,2005-06-14,10.1111/j.1464-410x.2005.05526.x,,,,15892825,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/9648445,https://api.altmetric.com/v1/donut/9648445_240.png 0,The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: androgen-receptor cofactors and bypass pathways,British Journal of Urology,,,Article,2005-06-14,10.1111/j.1464-410x.2005.05527.x,,,,15892826,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/9648444,https://api.altmetric.com/v1/donut/9648444_240.png 0,The relationship between angiogenesis and cyclooxygenase-2 expression in prostate cancer,British Journal of Urology,,,Article,2005-07-14,10.1111/j.1464-410x.2005.05568.x,,,,15963122,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9648443,https://api.altmetric.com/v1/donut/9648443_240.png 0,Prostate Cancer - From Bench to Bedside,,,,Article,2011-11-25,10.5772/26971,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9648401,https://api.altmetric.com/v1/donut/9648401_240.png 0,The RNA-binding protein hnRNPA2 regulates ?-catenin protein expression and is overexpressed in prostate cancer,RNA Biology,,,Article,2014-04-24,10.4161/rna.28800,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9648397,https://api.altmetric.com/v1/donut/9648397_240.png 0,Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer,BMJ Open,,,Article,2015-10-19,10.1136/bmjopen-2015-007925,,,,26482768,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9648369,https://api.altmetric.com/v1/donut/9648369_240.png 0,Emerging treatments for recurrent prostate cancer,Future Oncology,,,Article,2015-11-01,10.2217/fon.15.228,,,,26436556,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/9648367,https://api.altmetric.com/v1/donut/9648367_240.png 0,Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence,Molecular Carcinogenesis,,,Article,2015-10-23,10.1002/mc.22417,,,,26495772,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9648015,https://api.altmetric.com/v1/donut/9648015_240.png 0,Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients,British Journal of Cancer,,,Article,2013-01-15,10.1038/bjc.2012.480,,,,23321516,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/9647974,https://api.altmetric.com/v1/donut/9647974_240.png 0,Androgen receptor phosphorylation at serine 308 and serine 791 predicts enhanced survival in castrate resistant prostate cancer patients.,International Journal of Molecular Sciences,,,Article,2013-08-12,10.3390/ijms140816656,,,,23945560,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/9647963,https://api.altmetric.com/v1/donut/9647963_240.png 0,Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution,Oncotarget,,,Article,2016-06-13,10.18632/oncotarget.9245,,,,27175597,,11343/113679,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9623597,https://api.altmetric.com/v1/donut/9623597_240.png 0,Survival after initiation of androgen deprivation therapy for prostate cancer of Australian men,Cancer Epidemiology,,,Article,2015-12-01,10.1016/j.canep.2015.10.017,,,,26651446,,11541.2/118600,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9588148,https://api.altmetric.com/v1/donut/9588148_240.png 0,Impact of Percentage of Positive Biopsy Cores on Biochemical Outcome in Patients Treated With Low-Dose Rate (Iodine-125) Brachytherapy for Prostate Cancer,Open Prostate Cancer Journal,,,Article,2012-07-11,10.2174/1876822901205010015,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/9583149,https://api.altmetric.com/v1/donut/9583149_240.png 0,Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial,Journal of Sexual Medicine,,,Article,2016-06-01,10.1016/j.jsxm.2016.05.013,,,,27345218,,1893/23447,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9579941,https://api.altmetric.com/v1/donut/9579941_240.png 0,"2548 The Prostate Cancer Registry: First results from an international, prospective, observational study of men with metastatic castration-resistant prostate cancer (mCRPC)",European Journal of Cancer (1965),,,Article,2015-09-01,10.1016/s0959-8049(16)31367-3,,,,,,1854/LU-7054274,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9567216,https://api.altmetric.com/v1/donut/9567216_240.png 0,"Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms",Endocrine-Related Cancer,,,Article,2005-12-15,10.1677/erc.1.01062,,,,16322328,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/9510199,https://api.altmetric.com/v1/donut/9510199_240.png 0,Prostate Cancer - From Bench to Bedside,,,,Article,2011-11-25,10.5772/1285,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9509069,https://api.altmetric.com/v1/donut/9509069_240.png 0,Advances in Prostate Cancer,,,,Article,2013-01-16,10.5772/45948,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/9506815,https://api.altmetric.com/v1/donut/9506815_240.png 0,"Emerging Putative Biomarkers: The Role of Alpha 2 and 6 Integrins in Susceptibility, Treatment, and Prognosis",Prostate Cancer,,,Article,2012-01-01,10.1155/2012/298732,,,,22900191,PMC3415072,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/9505895,https://api.altmetric.com/v1/donut/9505895_240.png 0,Down-regulation of ATM Protein Sensitizes Human Prostate Cancer Cells to Radiation-induced Apoptosis,Journal of Biological Chemistry,,,Article,2005-06-16,10.1074/jbc.m503701200,,,,15837784,PMC1855286,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9505630,https://api.altmetric.com/v1/donut/9505630_240.png 0," Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer ",British Journal of Urology,,,Article,2009-05-14,10.1111/j.1464-410x.2008.08200.x,,,,19040532,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/9504796,https://api.altmetric.com/v1/donut/9504796_240.png 0,Epigenetic regulation of prostate cancer,Clinical Epigenetics,,,Article,2011-08-14,10.1007/s13148-011-0041-7,,,,22704335,PMC3365395,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/9504428,https://api.altmetric.com/v1/donut/9504428_240.png 0,Australian general practitioners' views and use of tests to detect early prostate cancer,Australian and New Zealand Journal of Public Health,,,Article,1998-06-01,10.1111/j.1467-842x.1998.tb01394.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9497400,https://api.altmetric.com/v1/donut/9497400_240.png 0,Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk,American Journal of Epidemiology,,,Article,2010-08-31,10.1093/aje/kwq175,,,,20688905,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/9495168,https://api.altmetric.com/v1/donut/9495168_240.png 0,Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer,BMC Cancer,,,Article,2008-08-10,10.1186/1471-2407-8-230,,,,18694509,PMC2519091,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/9495145,https://api.altmetric.com/v1/donut/9495145_240.png 0,Comparative Cost-effectiveness of Robot-assisted and Standard Laparoscopic Prostatectomy as Alternatives to Open Radical Prostatectomy for Treatment of Men with Localised Prostate Cancer: A Health Technology Assessment from the Perspective of the UK National Health Service,European Urology,,,Article,2013-09-14,10.1016/j.eururo.2013.02.040,,,,23498062,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/9258159,https://api.altmetric.com/v1/donut/9258159_240.png 0,Abstract 2106: Estrogen receptor alpha drives proliferation of prostate cancer through PI3K and MAPK signaling,Cancer Research,,,Article,2014-09-30,10.1158/1538-7445.am2014-2106,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/9252334,https://api.altmetric.com/v1/donut/9252334_240.png 0,9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer.,Clinical Cancer Research,,,Article,1997-02-01,,,,,9815685,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/9233012,https://api.altmetric.com/v1/donut/9233012_240.png 0,Use of Individual Fraction Size Data from 3756 Patients to Directly Determine the ?/? Ratio of Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2007-04-30,10.1016/j.ijrobp.2006.12.036,,,,17448868,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/9215226,https://api.altmetric.com/v1/donut/9215226_240.png 0,"The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis.",Medical Journal of Australia,,,Article,2009-04-05,,,,,19351300,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/9215221,https://api.altmetric.com/v1/donut/9215221_240.png 0,PCaAnalyser: A 2D-Image Analysis Based Module for Effective Determination of Prostate Cancer Progression in 3D Culture,PLoS ONE,,,Article,2013-11-20,10.1371/journal.pone.0079865,,,,24278197,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/9067120,https://api.altmetric.com/v1/donut/9067120_240.png 0,"The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior.",Health Psychology,,,Article,2013-03-25,10.1037/a0031622,,,,23527518,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/9065748,https://api.altmetric.com/v1/donut/9065748_240.png 0,"Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: a large cohort study",Cancer Causes and Control,,,Article,2012-04-14,10.1007/s10552-012-9931-z,,,,22382868,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/9064965,https://api.altmetric.com/v1/donut/9064965_240.png 0,Mindfulness groups for men with advanced prostate cancer: a pilot study to assess feasibility and effectiveness and the role of peer support,Supportive Care in Cancer,,,Article,2012-06-14,10.1007/s00520-011-1195-8,,,,21625914,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/9064927,https://api.altmetric.com/v1/donut/9064927_240.png 0,Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer,Psycho-Oncology,,,Article,2013-05-26,10.1002/pon.3312,,,,23712946,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/9064799,https://api.altmetric.com/v1/donut/9064799_240.png 0,Intervening to improve psychological outcomes for men with prostate cancer,Psycho-Oncology,,,Article,2013-05-14,10.1002/pon.3095,,,,22549800,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/9064797,https://api.altmetric.com/v1/donut/9064797_240.png 0,Elevated expression of FGF-2 does not cause prostate cancer progression in LNCaP cells.,The Prostate,,,Article,1999-06-15,10.1002/(sici)1097-0045(19990615)40:1<1::aid-pros1>3.0.co;2-k,,,,10344718,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8935794,https://api.altmetric.com/v1/donut/8935794_240.png 0,Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines,Molecular Cancer Therapeutics,,,Article,2011-09-14,10.1158/1535-7163.mct-11-0182,,,,21709130,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/8917439,https://api.altmetric.com/v1/donut/8917439_240.png 0,Therapy escape mechanisms in the malignant prostate,Seminars in Cancer Biology,,,Article,2015-12-01,10.1016/j.semcancer.2015.08.005,,,,26299608,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8915612,https://api.altmetric.com/v1/donut/8915612_240.png 0,The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence,Reproductive Biology and Endocrinology,,,Article,2015-08-07,10.1186/s12958-015-0087-z,,,,26251134,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8915600,https://api.altmetric.com/v1/donut/8915600_240.png 0,"Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility",Endocrine-Related Cancer,,,Article,2009-09-14,10.1677/erc-08-0175,,,,19509068,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8907078,https://api.altmetric.com/v1/donut/8907078_240.png 0,Adenoviral-Mediated Endothelial Precursor Cell Delivery of Soluble CD115 Suppresses Human Prostate Cancer Xenograft Growth in Mice,Stem Cells,,,Article,2009-09-14,10.1002/stem.145,,,,19522014,PMC2879317,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8905442,https://api.altmetric.com/v1/donut/8905442_240.png 0,Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer,The Prostate,,,Article,2013-06-13,10.1002/pros.22691,,,,23765731,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/8905438,https://api.altmetric.com/v1/donut/8905438_240.png 0,PAGE4 Positivity Is Associated with Attenuated AR Signaling and Predicts Patient Survival in Hormone-Naive Prostate Cancer,American Journal of Pathology,,,Article,2012-10-14,10.1016/j.ajpath.2012.06.040,,,,22885105,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8905436,https://api.altmetric.com/v1/donut/8905436_240.png 0,"EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205",British Journal of Cancer,,,Article,2014-07-02,10.1038/bjc.2014.366,,,,24992580,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/8903591,https://api.altmetric.com/v1/donut/8903591_240.png 0,PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells,Oncotarget,,,Article,2014-12-02,10.18632/oncotarget.2658,,,,25474038,PMC4322998,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8902878,https://api.altmetric.com/v1/donut/8902878_240.png 0,SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer,Endocrine-Related Cancer,,,Article,2013-11-26,10.1530/erc-13-0446,,,,24280133,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8902840,https://api.altmetric.com/v1/donut/8902840_240.png 0,Diverse Functions of IGF/Insulin Signaling in Malignant and Noncancerous Prostate Cells: Proliferation in Cancer Cells and Differentiation in Noncancerous Cells,Endocrinology,,,Article,2012-10-14,10.1210/en.2012-1348,,,,22903612,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/8902827,https://api.altmetric.com/v1/donut/8902827_240.png 0,Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205,American Journal of Pathology,,,Article,2012-12-15,10.1016/j.ajpath.2012.08.011,,,,23041061,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/8902819,https://api.altmetric.com/v1/donut/8902819_240.png 0,PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21,American Journal of Pathology,,,Article,2012-05-01,10.1016/j.ajpath.2012.01.026,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8902814,https://api.altmetric.com/v1/donut/8902814_240.png 0,High-dose-rate brachytherapy boost for prostate cancer: Outcomes and genitourinary toxicity,Brachytherapy,,,Article,2015-09-01,10.1016/j.brachy.2015.04.004,,,,25976294,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8895572,https://api.altmetric.com/v1/donut/8895572_240.png 0,Prostate cancer in dogs and men: A unique opportunity to study the disease,Veterinary Journal,,,Article,2009-05-14,10.1016/j.tvjl.2008.08.012,,,,18835203,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/8886739,https://api.altmetric.com/v1/donut/8886739_240.png 0,Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.,Ontario health technology assessment series,,,Article,,,,,,26366237,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8867812,https://api.altmetric.com/v1/donut/8867812_240.png 0,Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review.,,,,Article,,,,,,14609482,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8857851,https://api.altmetric.com/v1/donut/8857851_240.png 0,Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling,Carcinogenesis,,,Article,2006-05-14,10.1093/carcin/bgi287,,,,16314398,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8834166,https://api.altmetric.com/v1/donut/8834166_240.png 0,Establishment of an organotypic in vitro culture system and its relevance to the characterization of human prostate epithelial cancer cells and their stromal interactions,Pathology - Research & Practice,,,Article,2007-04-01,10.1016/j.prp.2007.02.004,,,,17442502,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8834164,https://api.altmetric.com/v1/donut/8834164_240.png 0,Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer,Molecular Oncology,,,Article,2007-09-14,10.1016/j.molonc.2007.05.007,,,,18521193,PMC2408886,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8834161,https://api.altmetric.com/v1/donut/8834161_240.png 0,Determination of amino acids in urine of patients with prostate cancer and benign prostate growth,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2016-05-01,10.1097/cej.0000000000000248,,,,27222937,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8719738,https://api.altmetric.com/v1/donut/8719738_240.png 0,2220 MAGNETIC RESONANCE IMAGING DETECTS SIGNIFICANT PROSTATE CANCER AND COULD BE USED TO REDUCE UNNECESSARY BIOPSIES: INITIAL RESULTS FROM A PROSPECTIVE TRIAL,The Journal of Urology,,,Article,2013-04-01,10.1016/j.juro.2013.02.2129,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8697827,https://api.altmetric.com/v1/donut/8697827_240.png 0,Cancer Stem Cells in Prostate Cancer Chemoresistance,Current Cancer Drug Targets,,,Article,2014-05-01,10.2174/1568009614666140328152459,,,,24720286,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8696519,https://api.altmetric.com/v1/donut/8696519_240.png 0,CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance,The Prostate,,,Article,2014-02-12,10.1002/pros.22775,,,,24615685,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/8696516,https://api.altmetric.com/v1/donut/8696516_240.png 0,680 Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: Oncologic outcomes and prognostic factors,European Urology Supplements,,,Article,2016-03-01,10.1016/s1569-9056(16)60682-6,,,,,,1854/LU-7206351,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8696128,https://api.altmetric.com/v1/donut/8696128_240.png 0,"Age, Health, and Education Determine Supportive Care Needs of Men Younger Than 70 Years With Prostate Cancer",Journal of Clinical Oncology,,,Article,2007-06-19,10.1200/jco.2006.09.8046,,,,17577034,,10453/4640,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/8664599,https://api.altmetric.com/v1/donut/8664599_240.png 0,BPH and prostate cancer risk,Indian Journal of Urology,,,Article,2014-04-14,10.4103/0970-1591.126909,,,,24744523,PMC3989826,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8663347,https://api.altmetric.com/v1/donut/8663347_240.png 0,Comparative Oncologic and Toxicity Outcomes of Salvage Radical Prostatectomy Versus Nonsurgical Therapies for Radiorecurrent Prostate Cancer: A Meta–Regression Analysis,European Urology Focus ,,,Article,2016-06-01,10.1016/j.euf.2015.09.004,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8652950,https://api.altmetric.com/v1/donut/8652950_240.png 0,Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures.,Asian Journal of Andrology,,,Article,2016-07-05,10.4103/1008-682x.173453,,,,26924279,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8652948,https://api.altmetric.com/v1/donut/8652948_240.png 0,Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2003-05-01,,,,,12894551,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8630986,https://api.altmetric.com/v1/donut/8630986_240.png 0,Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.,Gene Therapy,,,Article,2002-06-01,10.1038/sj/gt/3301698,,,,12040457,,10453/14940,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8565356,https://api.altmetric.com/v1/donut/8565356_240.png 0,Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.,Journal of Gene Medicine - Gene Therapy Clinical Trial Database,,,Article,2004-01-01,10.1002/jbm.474,,,,14716676,,10453/15553,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8565200,https://api.altmetric.com/v1/donut/8565200_240.png 0,Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer,"Cancer Immunology, Immunotherapy",,,Article,2004-11-15,10.1007/s00262-004-0527-7,,,,15449043,,10453/15543,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8565158,https://api.altmetric.com/v1/donut/8565158_240.png 0,Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer,Journal of Gene Medicine - Gene Therapy Clinical Trial Database,,,Article,2004-12-15,10.1002/jgm.629,,,,15493036,,10453/15496,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8565157,https://api.altmetric.com/v1/donut/8565157_240.png 0," In Vivo Gene Therapy for Prostate Cancer: Preclinical Evaluation of Two Different Enzyme-Directed Prodrug Therapy Systems Delivered by Identical Adenovirus Vectors ",Human Gene Therapy,,,Article,1998-07-20,10.1089/hum.1998.9.11-1617,,,,9694160,,10453/15519,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8560906,https://api.altmetric.com/v1/donut/8560906_240.png 0,Combined Hypermethylation of APC and GSTP1 as a Molecular Marker for Prostate Cancer: Quantitative Pyrosequencing Analysis,Journal of Biomolecular Screening,,,Article,2012-08-14,10.1177/1087057112444445,,,,22511308,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8560788,https://api.altmetric.com/v1/donut/8560788_240.png 0,Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis,Supportive Care in Cancer,,,Article,2015-08-06,10.1007/s00520-015-2857-8,,,,26245495,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8560198,https://api.altmetric.com/v1/donut/8560198_240.png 0,Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice,Journal of Gene Medicine - Gene Therapy Clinical Trial Database,,,Article,2006-09-14,10.1002/jgm.944,,,,16832832,,10453/15694,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8559512,https://api.altmetric.com/v1/donut/8559512_240.png 0,Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer,British Journal of Cancer,,,Article,2012-02-14,10.1038/bjc.2011.552,,,,22274410,,10453/18819,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/8555025,https://api.altmetric.com/v1/donut/8555025_240.png 0,In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147,PLoS ONE,,,Article,2012-08-03,10.1371/journal.pone.0040716,,,,22870202,PMC3411712,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/8506040,https://api.altmetric.com/v1/donut/8506040_240.png 0,Abstract 469: CD151 and cell motility in prostate cancer,Cancer Research,,,Article,2014-11-21,10.1158/1538-7445.am2012-469,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8499891,https://api.altmetric.com/v1/donut/8499891_240.png 0,Identifying the dominant prostate cancer focal lesion using image analysis and planning of a simultaneous integrated stereotactic boost,Acta Oncologica,,,Article,2015-09-23,10.3109/0284186x.2015.1063782,,,,26397055,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8467053,https://api.altmetric.com/v1/donut/8467053_240.png 0,Mapping Fact-P To EQ-5D In Metastatic Castration-Resistant Prostate Cancer (MCRPC): Performance Of A Previously Developed Algorithm When Applied On A Sample With A Different Disease Stage,Value in Health (Elsevier Science),,,Article,2014-11-01,10.1016/j.jval.2014.08.1890,,,,27201884,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8449258,https://api.altmetric.com/v1/donut/8449258_240.png 0,Sleep and daily functioning during androgen deprivation therapy for prostate cancer,European Journal of Cancer Care,,,Article,2011-07-14,10.1111/j.1365-2354.2010.01226.x,,,,20825464,PMC3017240,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8429130,https://api.altmetric.com/v1/donut/8429130_240.png 0,Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels,International Journal of Cancer,,,Article,2016-05-01,10.1002/ijc.30206,,,,27225428,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8428470,https://api.altmetric.com/v1/donut/8428470_240.png 0,Abstract 1969: Mapping the cross talk between parathyroid hormone related protein (PTHrP) and Integrins ?6 and ?4 in prostate cancer cells,Cancer Research,,,Article,2014-11-13,10.1158/1538-7445.am2011-1969,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8378363,https://api.altmetric.com/v1/donut/8378363_240.png 0,The E3 Ubiquitin Ligase Siah2 Contributes to Castration-Resistant Prostate Cancer by Regulation of Androgen Receptor Transcriptional Activity,Cancer Cell,,,Article,2013-06-01,10.1016/j.ccr.2013.05.018,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8371755,https://api.altmetric.com/v1/donut/8371755_240.png 0,Control of prostate cancer spheroid growth using213Bi-labeled multiple targeted ? radioimmunoconjugates,The Prostate,,,Article,2006-12-01,10.1002/pros.20502,,,,16955401,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8367634,https://api.altmetric.com/v1/donut/8367634_240.png 0,CD44 is a biomarker associated with human prostate cancer radiation sensitivity,Clinical and Experimental Metastasis,,,Article,2012-01-15,10.1007/s10585-011-9423-7,,,,21953074,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8367633,https://api.altmetric.com/v1/donut/8367633_240.png 0,Phosphoproteomic Profiling Identifies Focal Adhesion Kinase as a Mediator of Docetaxel Resistance in Castrate-Resistant Prostate Cancer,Molecular Cancer Therapeutics,,,Article,2013-11-05,10.1158/1535-7163.mct-13-0225-t,,,,24194567,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/8367033,https://api.altmetric.com/v1/donut/8367033_240.png 0,The effects of prostate cancer on intimate relationships,The Journal of Men's Health & Gender,,,Article,2007-09-01,10.1016/j.jmhg.2007.04.008,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8365246,https://api.altmetric.com/v1/donut/8365246_240.png 0,The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer,Current Opinion in Urology,,,Article,2013-05-14,10.1097/mou.0b013e32835e9f1a,,,,23385973,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8363934,https://api.altmetric.com/v1/donut/8363934_240.png 0,Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis,Cancer Research,,,Article,2006-09-30,10.1158/0008-5472.can-06-1488,,,,17018613,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8363010,https://api.altmetric.com/v1/donut/8363010_240.png 0,The current status of MRI in ?prostate cancer.,Australian Family Physician,,,Article,,,,,,25901408,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8357196,https://api.altmetric.com/v1/donut/8357196_240.png 0,BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis,The Prostate,,,Article,2005-09-14,10.1002/pros.20255,,,,15800936,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8350491,https://api.altmetric.com/v1/donut/8350491_240.png 0,"Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer",International Journal of Biochemistry & Cell Biology,,,Article,2005-02-15,10.1016/j.biocel.2004.07.011,,,,15474988,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/8350490,https://api.altmetric.com/v1/donut/8350490_240.png 0,PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.,BMC Cancer,,,Article,2006-03-06,10.1186/1471-2407-6-53,,,,16519808,PMC1450298,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/8350486,https://api.altmetric.com/v1/donut/8350486_240.png 0,Dose distribution and morbidity after high dose rate brachytherapy for prostate cancer: Influence of V150 and V200 parameters,Australasian Radiology,,,Article,2002-12-01,10.1046/j.1440-1673.2002.01091.x,,,,12452909,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8345735,https://api.altmetric.com/v1/donut/8345735_240.png 0,Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-11-15,10.1016/j.ijrobp.2004.04.048,,,,15519778,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8345734,https://api.altmetric.com/v1/donut/8345734_240.png 0,Trends in the use of androgen deprivation in prostate cancer,Acta Oncologica,,,Article,2004-01-01,10.1080/02841860410029500,,,,15303500,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8345731,https://api.altmetric.com/v1/donut/8345731_240.png 0,What defines intermediate-risk prostate cancer? Variability in published prognostic models,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-01-01,10.1016/s0360-3016(03)00820-4,,,,14697415,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8345729,https://api.altmetric.com/v1/donut/8345729_240.png 0,A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?,Brachytherapy,,,Article,2006-10-01,10.1016/j.brachy.2006.08.007,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8345725,https://api.altmetric.com/v1/donut/8345725_240.png 0,How Early Is Early: Androgen Deprivation for Prostate-Specific Antigen Relapse in Prostate Cancer,Journal of Clinical Oncology,,,Article,2006-06-19,10.1200/jco.2006.05.8420,,,,16782936,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8345724,https://api.altmetric.com/v1/donut/8345724_240.png 0,An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2006-05-31,10.1016/j.ijrobp.2005.12.007,,,,16530339,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8345723,https://api.altmetric.com/v1/donut/8345723_240.png 0,"Tribulations of a prostate cancer trial - Lessons learned from TOAD, a Cancer Council Victoria and Transtasman Radiation Oncology Group trial",Journal of Medical Imaging & Radiation Oncology,,,Article,2010-10-20,10.1111/j.1754-9485.2010.02204.x,,,,20976993,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8345721,https://api.altmetric.com/v1/donut/8345721_240.png 0,"A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer",Journal of Medical Imaging & Radiation Oncology,,,Article,2013-02-15,10.1111/j.1754-9485.2012.02461.x,,,,23374559,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8345720,https://api.altmetric.com/v1/donut/8345720_240.png 0," Abstract 2402: Prostate cancer cell homing to bone invivo is modulated by zoledronic acid ",Cancer Research,,,Article,2014-11-13,10.1158/1538-7445.am2011-2402,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8330986,https://api.altmetric.com/v1/donut/8330986_240.png 0,"Efficacy of High-dose Palliative Radiotherapy for Localised, Castration-resistant Prostate Cancer",Clinical Oncology,,,Article,2014-10-14,10.1016/j.clon.2014.09.013,,,,25445554,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8309111,https://api.altmetric.com/v1/donut/8309111_240.png 0,Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: Current practice,International Journal of Urology,,,Article,2007-02-15,10.1111/j.1442-2042.2006.01659.x,,,,17302562,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8308673,https://api.altmetric.com/v1/donut/8308673_240.png 0,Abstract 4495: Clinical implications of family history of prostate cancer in an active surveillance cohort,Cancer Research,,,Article,2014-11-21,10.1158/1538-7445.am2012-4495,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8296408,https://api.altmetric.com/v1/donut/8296408_240.png 0,Abstract B133: Regulation of the androgen receptor function by a metabolic kinase in prostate cancer.,Molecular Cancer Therapeutics,,,Article,2014-01-30,10.1158/1535-7163.targ-13-b133,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8296374,https://api.altmetric.com/v1/donut/8296374_240.png 0,New and emerging treatments for advanced prostate cancer.,Clinical Advances in Hematology & Oncology,,,Article,,,,,,22361744,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8278501,https://api.altmetric.com/v1/donut/8278501_240.png 0,Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model,Organogenesis,,,Article,2014-10-27,10.4161/org.6.3.12041,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/8267657,https://api.altmetric.com/v1/donut/8267657_240.png 0,"Food Extracts Consumed in Mediterranean Countries and East Asia Reduce Protein Concentrations of Androgen Receptor, Phospho-Protein Kinase B, and Phospho-Cytosolic Phospholipase A2 in Human Prostate Cancer Cells",Journal of Nutrition,,,Article,2010-04-14,10.3945/jn.109.118745,,,,20164368,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8266674,https://api.altmetric.com/v1/donut/8266674_240.png 0,Inflammatory Genetic Markers of Prostate Cancer Risk,Cancers,,,Article,2010-06-07,10.3390/cancers2021198,,,,24281113,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/8265747,https://api.altmetric.com/v1/donut/8265747_240.png 0,Overview of Tumor-Associated Antigens (TAAs) as Potential Therapeutic Targets for Prostate Cancer Therapy,Current Cancer Therapy Reviews,,,Article,2008-11-01,10.2174/157339408786413371,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8262615,https://api.altmetric.com/v1/donut/8262615_240.png 0,CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer,Current Cancer Drug Targets,,,Article,2010-05-01,10.2174/156800910791190193,,,,20370680,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8262566,https://api.altmetric.com/v1/donut/8262566_240.png 0,Role of the Akt Pathway in Prostate Cancer,Current Cancer Drug Targets,,,Article,2009-03-01,10.2174/156800909787581006,,,,19275757,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8262565,https://api.altmetric.com/v1/donut/8262565_240.png 0,Prostatic Tumor Stroma: A Key Player in Cancer Progression,Current Cancer Drug Targets,,,Article,2008-09-01,10.2174/156800908785699351,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/8262563,https://api.altmetric.com/v1/donut/8262563_240.png 0,Potential role of EPB41L3 (Protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer,Expert Opinion on Therapeutic Targets,,,Article,2008-07-14,10.1517/14728222.12.7.845,,,,18554153,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8260271,https://api.altmetric.com/v1/donut/8260271_240.png 0,"Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells",Biological Chemistry,,,Article,2010-04-14,10.1515/bc.2010.043,,,,20180647,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8260123,https://api.altmetric.com/v1/donut/8260123_240.png 0,Positive (But Not Negative) Punishment Predicts Anxiety and Depression Among Prostate Cancer Patients: An Exploration of the Behaviour Analytic Model of Depression,Behaviour Change,,,Article,2009-12-01,10.1375/bech.26.4.235,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8259469,https://api.altmetric.com/v1/donut/8259469_240.png 0,GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2?-Deoxycytidine Efficacy in Human Prostate Cancer Cells,PLoS ONE,,,Article,2011-09-28,10.1371/journal.pone.0025634,,,,21980513,PMC3182253,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/8259268,https://api.altmetric.com/v1/donut/8259268_240.png 0,Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model,PLoS ONE,,,Article,2011-05-16,10.1371/journal.pone.0019389,,,,21603655,PMC3095598,,2011PLoSO...6E9389H,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8259171,https://api.altmetric.com/v1/donut/8259171_240.png 0,A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells,RNA,,,Article,2010-06-14,10.1261/rna.2019810,,,,20406994,PMC2874168,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8257817,https://api.altmetric.com/v1/donut/8257817_240.png 0,Structural Decay of Bone Microarchitecture in Men with Prostate Cancer Treated with Androgen Deprivation Therapy,The Journal of Clinical Endocrinology & Metabolism,,,Article,2010-12-15,10.1210/jc.2010-0902,,,,20881261,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8256978,https://api.altmetric.com/v1/donut/8256978_240.png 0,Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer,Journal of Clinical Oncology,,,Article,2011-12-10,10.1200/jco.2011.37.0726,,,,22042952,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/8256736,https://api.altmetric.com/v1/donut/8256736_240.png 0,Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer,Molecular Cytogenetics,,,Article,2009-09-25,10.1186/1755-8166-2-18,,,,19781100,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8256374,https://api.altmetric.com/v1/donut/8256374_240.png 0,Laparoscopic insertion of pelvic tissue expander to prevent radiation enteritis prior to radiotherapy for prostate cancer,Radiation Oncology,,,Article,2011-05-13,10.1186/1748-717x-6-47,,,,21569584,PMC3118358,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8256333,https://api.altmetric.com/v1/donut/8256333_240.png 0,"Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells",Molecular Cancer,,,Article,2010-03-10,10.1186/1476-4598-9-55,,,,20219091,PMC2846888,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/8256024,https://api.altmetric.com/v1/donut/8256024_240.png 0,A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-? therapy,Cancer Cell International,,,Article,2010-09-30,10.1186/1475-2867-10-36,,,,20920299,PMC2958862,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/8255931,https://api.altmetric.com/v1/donut/8255931_240.png 0,ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer,BMC Cancer,,,Article,2008-07-23,10.1186/1471-2407-8-207,,,,18651985,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8255576,https://api.altmetric.com/v1/donut/8255576_240.png 0,Efficacy of a referral and physical activity program for survivors of prostate cancer [ENGAGE]: Rationale and design for a cluster randomised controlled trial,BMC Cancer,,,Article,2011-06-12,10.1186/1471-2407-11-237,,,,21663698,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/8255567,https://api.altmetric.com/v1/donut/8255567_240.png 0,Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities,BMC Cancer,,,Article,2010-08-22,10.1186/1471-2407-10-452,,,,20731875,PMC2936907,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8255565,https://api.altmetric.com/v1/donut/8255565_240.png 0,How Prostate Cancer Support Groups Do and Do Not Survive: British Columbian Perspectives,American Journal of Men's Health,,,Article,2008-06-14,10.1177/1557988307304147,,,,19477778,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/8254599,https://api.altmetric.com/v1/donut/8254599_240.png 0,Health Promotion and Illness Demotion at Prostate Cancer Support Groups,Health Promotion Practice,,,Article,2010-07-14,10.1177/1524839908328990,,,,19129436,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8254545,https://api.altmetric.com/v1/donut/8254545_240.png 0,Gold Nanoparticle Mediated Detection of Prostate Cancer Cells Using Photoacoustic Flowmetry with Optical Reflectance,Journal of Biomedical Nanotechnology,,,Article,2010-04-01,10.1166/jbn.2010.1105,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8252047,https://api.altmetric.com/v1/donut/8252047_240.png 0,Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer,Molecular Cancer Research,,,Article,2011-12-15,10.1158/1541-7786.mcr-11-0379,,,,21987172,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8251315,https://api.altmetric.com/v1/donut/8251315_240.png 0,Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer,Molecular Cancer Research,,,Article,2009-01-15,10.1158/1541-7786.mcr-08-0218,,,,19147544,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8251310,https://api.altmetric.com/v1/donut/8251310_240.png 0,Molecular Chemotherapy and Chemotherapy: A New Front against Late-Stage Hormone-Refractory Prostate Cancer,Clinical Cancer Research,,,Article,2011-06-14,10.1158/1078-0432.ccr-11-0248,,,,21531822,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/8251292,https://api.altmetric.com/v1/donut/8251292_240.png 0,Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer,Clinical Cancer Research,,,Article,2009-11-01,10.1158/1078-0432.ccr-08-3126,,,,19843661,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/8251277,https://api.altmetric.com/v1/donut/8251277_240.png 0,Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted Radioimmunoconjugates,Clinical Cancer Research,,,Article,2009-02-01,10.1158/1078-0432.ccr-08-1203,,,,19188157,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8251265,https://api.altmetric.com/v1/donut/8251265_240.png 0,Cytosolic Phospholipase A2- : A Potential Therapeutic Target for Prostate Cancer,Clinical Cancer Research,,,Article,2008-12-15,10.1158/1078-0432.ccr-08-0566,,,,19088022,PMC2605658,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8251260,https://api.altmetric.com/v1/donut/8251260_240.png 0,Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-01-15,10.1158/1055-9965.epi-10-0719,,,,21098650,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/8251243,https://api.altmetric.com/v1/donut/8251243_240.png 0,Immunohistochemical Level of Unsulfated Chondroitin Disaccharides in the Cancer Stroma Is an Independent Predictor of Prostate Cancer Relapse,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2008-09-14,10.1158/1055-9965.epi-08-0204,,,,18768520,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8251227,https://api.altmetric.com/v1/donut/8251227_240.png 0,FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth,Cancer Research,,,Article,2011-02-01,10.1158/0008-5472.can-10-0874,,,,21169411,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/8251215,https://api.altmetric.com/v1/donut/8251215_240.png 0,A Gonadotropin-Releasing Hormone-II Antagonist Induces Autophagy of Prostate Cancer Cells,Cancer Research,,,Article,2009-02-01,10.1158/0008-5472.can-08-2115,,,,19176390,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8251188,https://api.altmetric.com/v1/donut/8251188_240.png 0,Could mining be protective against prostate cancer? A study and literature review,Occupational and environmental medicine,,,Article,2010-06-14,10.1136/oem.2009.047092,,,,19819854,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8249727,https://api.altmetric.com/v1/donut/8249727_240.png 0,Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study,BMJ Open,,,Article,2011-04-06,10.1136/bmjopen-2011-000104,,,,22021763,PMC3191396,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8249524,https://api.altmetric.com/v1/donut/8249524_240.png 0,"Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor- Pathways in Prostate Cancer",Molecular Pharmacology,,,Article,2009-03-15,10.1124/mol.108.053066,,,,19052170,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8248549,https://api.altmetric.com/v1/donut/8248549_240.png 0,Forkhead Box Protein A1 Regulates UDP-Glucuronosyltransferase 2B15 Gene Transcription in LNCaP Prostate Cancer Cells,Drug Metabolism and Disposition,,,Article,2010-12-15,10.1124/dmd.110.035436,,,,20736324,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8248507,https://api.altmetric.com/v1/donut/8248507_240.png 0,Effects of interval between diagnosis and time of survey upon preferred information format for prostate cancer patients,Journal of Medical Imaging & Radiation Oncology,,,Article,2009-04-14,10.1111/j.1754-9485.2009.02064.x,,,,19527371,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8247610,https://api.altmetric.com/v1/donut/8247610_240.png 0,"Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation",Australian and New Zealand Journal of Public Health,,,Article,2008-10-01,10.1111/j.1753-6405.2008.00272.x,,,,18959543,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8247484,https://api.altmetric.com/v1/donut/8247484_240.png 0,Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer,Nutrition Reviews,,,Article,2010-09-14,10.1111/j.1753-4887.2010.00314.x,,,,20796219,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/8247451,https://api.altmetric.com/v1/donut/8247451_240.png 0,Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort,Asia Pacific Journal of Clinical Oncology,,,Article,2009-12-01,10.1111/j.1743-7563.2009.01237.x,,,,,,1959.8/136758,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8246674,https://api.altmetric.com/v1/donut/8246674_240.png 0,An investigation of fludarabine as a potential radiation sensitizer of human prostate cancer cells in vitro,Asia Pacific Journal of Clinical Oncology,,,Article,2008-03-01,10.1111/j.1743-7563.2008.00149.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8246658,https://api.altmetric.com/v1/donut/8246658_240.png 0,Prolonging androgen sensitivity in prostate cancer - a role for COX inhibitors?,Australian & New Zealand Journal of Surgery,,,Article,2009-09-14,10.1111/j.1445-2197.2009.05020.x,,,,19895521,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8242349,https://api.altmetric.com/v1/donut/8242349_240.png 0,Coping in men with prostate cancer and their partners: a quantitative and qualitative study,European Journal of Cancer Care,,,Article,2011-03-15,10.1111/j.1365-2354.2010.01225.x,,,,20825459,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/8238572,https://api.altmetric.com/v1/donut/8238572_240.png 0,A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer,European Journal of Cancer Care,,,Article,2009-11-15,10.1111/j.1365-2354.2008.01046.x,,,,19686273,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8238566,https://api.altmetric.com/v1/donut/8238566_240.png 0,Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy,Clinical Endocrinology,,,Article,2011-03-15,10.1111/j.1365-2265.2010.03942.x,,,,21118287,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/8238532,https://api.altmetric.com/v1/donut/8238532_240.png 0,Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer,Nucleic Acids Research,,,Article,2010-06-14,10.1093/nar/gkq084,,,,20159994,PMC2887957,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8231376,https://api.altmetric.com/v1/donut/8231376_240.png 0,"Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer",Annals of Oncology,,,Article,2010-06-14,10.1093/annonc/mdp524,,,,19917571,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8229810,https://api.altmetric.com/v1/donut/8229810_240.png 0,A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67,Annals of Oncology,,,Article,2009-07-15,10.1093/annonc/mdp244,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8229792,https://api.altmetric.com/v1/donut/8229792_240.png 0,The hedgehog/Gli signaling paradigm in prostate cancer,Expert Review of Endocrinology & Metabolism,,,Article,2014-01-10,10.1586/eem.11.24,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8229697,https://api.altmetric.com/v1/donut/8229697_240.png 0,Variability in Anxiety and Depression Over Time Following Diagnosis in Patients with Prostate Cancer,Journal of Psychosocial Oncology,,,Article,2010-11-15,10.1080/07347332.2010.516810,,,,21058161,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8216934,https://api.altmetric.com/v1/donut/8216934_240.png 0,"Antiproliferative Mechanisms of the Flavonoids 2,2?-Dihydroxychalcone and Fisetin in Human Prostate Cancer Cells",Nutrition and Cancer,,,Article,2010-06-25,10.1080/01635581003605524,,,,20574928,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8215764,https://api.altmetric.com/v1/donut/8215764_240.png 0,An Inverse Association Between Preserved Fish and Prostate Cancer: Results From a Population-Based Case-Control Study in Canada,Nutrition and Cancer,,,Article,2008-03-01,10.1080/01635580701684864,,,,18444154,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8215755,https://api.altmetric.com/v1/donut/8215755_240.png 0,miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer,Journal of Biological Chemistry,,,Article,2009-09-10,10.1074/jbc.m109.030098,,,,19584056,PMC2757173,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/8213798,https://api.altmetric.com/v1/donut/8213798_240.png 0,Estrogen receptor- activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNF mediated,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2010-02-16,10.1073/pnas.0905524107,,,,20133657,,,2010PNAS..107.3123M,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/8213663,https://api.altmetric.com/v1/donut/8213663_240.png 0,"The TGF-?, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer",Biochemical Journal,,,Article,2009-01-15,10.1042/bj20081610,,,,19099539,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8207436,https://api.altmetric.com/v1/donut/8207436_240.png 0,?-Subunits of voltage-gated sodium channels in human prostate cancer: quantitative in vitro and in vivo analyses of mRNA expression,Prostate Cancer & Prostatic Diseases,,,Article,2007-09-25,10.1038/sj.pcan.4501012,,,,17893701,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8204382,https://api.altmetric.com/v1/donut/8204382_240.png 0,Orphan nuclear receptor estrogen-related receptor-? suppresses in vitro and in vivo growth of prostate cancer cells via p21WAF1/CIP1 induction and as a potential therapeutic target in prostate cancer,Oncogene,,,Article,2007-12-10,10.1038/sj.onc.1210986,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8204378,https://api.altmetric.com/v1/donut/8204378_240.png 0,"Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression",British Journal of Cancer,,,Article,2010-09-27,10.1038/sj.bjc.6605839,,,,20736947,PMC2965856,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/8204281,https://api.altmetric.com/v1/donut/8204281_240.png 0,Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer,British Journal of Cancer,,,Article,2008-08-04,10.1038/sj.bjc.6604486,,,,18648369,PMC2527792,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8204254,https://api.altmetric.com/v1/donut/8204254_240.png 0,Prostate biopsy in Western Australia 1998–2004,Prostate Cancer & Prostatic Diseases,,,Article,2010-09-14,10.1038/pcan.2010.7,,,,20351758,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8204157,https://api.altmetric.com/v1/donut/8204157_240.png 0,A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes,Oncogene,,,Article,2009-10-29,10.1038/onc.2009.243,,,,19684615,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8204132,https://api.altmetric.com/v1/donut/8204132_240.png 0,"The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer",Modern Pathology,,,Article,2007-12-14,10.1038/modpathol.3800988,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8203667,https://api.altmetric.com/v1/donut/8203667_240.png 0,"Serum levels of folate, lycopene, ?-carotene, retinol and vitamin E and prostate cancer risk",European Journal of Clinical Nutrition,,,Article,2010-10-14,10.1038/ejcn.2010.124,,,,20683458,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/8203234,https://api.altmetric.com/v1/donut/8203234_240.png 0,Redox-Active Polymer Microcapsules for the Delivery of a Survivin-Specific siRNA in Prostate Cancer Cells,ACS Nano,,,Article,2011-02-22,10.1021/nn103044z,,,,21226510,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/8195314,https://api.altmetric.com/v1/donut/8195314_240.png 0,Risk of Developing Prostate Cancer in the Future: Overview of Prognostic Biomarkers,Urology,,,Article,2009-05-14,10.1016/j.urology.2009.02.022,,,,19375623,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/8190674,https://api.altmetric.com/v1/donut/8190674_240.png 0,"Gender relations, prostate cancer and diet: Re-inscribing hetero-normative food practices",Social Science & Medicine,,,Article,2011-05-14,10.1016/j.socscimed.2011.03.012,,,,21497972,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/8189113,https://api.altmetric.com/v1/donut/8189113_240.png 0,Women and prostate cancer support groups: The gender connect?,Social Science & Medicine,,,Article,2008-03-15,10.1016/j.socscimed.2007.11.018,,,,18164111,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/8189054,https://api.altmetric.com/v1/donut/8189054_240.png 0,Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03),Radiotherapy & Oncology,,,Article,2011-12-15,10.1016/j.radonc.2011.07.016,,,,21985948,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/8188050,https://api.altmetric.com/v1/donut/8188050_240.png 0,A systematic review of psychosocial interventions for men with prostate cancer and their partners,Patient Education & Counseling,,,Article,2011-11-15,10.1016/j.pec.2011.01.027,,,,21334159,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/8186628,https://api.altmetric.com/v1/donut/8186628_240.png 0,"HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer",Molecular & Cellular Endocrinology,,,Article,2009-03-25,10.1016/j.mce.2008.11.021,,,,19100308,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8182904,https://api.altmetric.com/v1/donut/8182904_240.png 0,Issues Faced by Unaffected Men With a Family History of Prostate Cancer: A Multidisciplinary Overview,The Journal of Urology,,,Article,2008-07-14,10.1016/j.juro.2008.03.020,,,,18485397,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8181841,https://api.altmetric.com/v1/donut/8181841_240.png 0,How prostate cancer patients cope with the effects of diagnosis and treatment: development of the Effects of Prostate Cancer Coping Strategies Scale,Journal of Men's Health,,,Article,2011-03-01,10.1016/j.jomh.2010.12.003,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8180894,https://api.altmetric.com/v1/donut/8180894_240.png 0,Incidence and nature of anxiety–depression comorbidity in prostate cancer patients,Journal of Men's Health,,,Article,2010-06-01,10.1016/j.jomh.2010.03.003,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/8180890,https://api.altmetric.com/v1/donut/8180890_240.png 0," Helping prostate cancer patients understand the causes of anxiety and depression: comparing cancer-caused vs patient response events ",Journal of Men's Health,,,Article,2009-12-01,10.1016/j.jomh.2009.08.193,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8180888,https://api.altmetric.com/v1/donut/8180888_240.png 0,CDC25A Functions as a Novel Ar Corepressor in Prostate Cancer Cells,Journal of Molecular Biology,,,Article,2009-01-01,10.1016/j.jmb.2008.10.070,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8180315,https://api.altmetric.com/v1/donut/8180315_240.png 0,T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-?1 Cytokine,Immunity,,,Article,2011-07-21,10.1016/j.immuni.2011.04.019,,,,21757379,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/8177393,https://api.altmetric.com/v1/donut/8177393_240.png 0,Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells,European Journal of Pharmacology,,,Article,2008-09-27,10.1016/j.ejphar.2008.06.085,,,,18639541,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8171728,https://api.altmetric.com/v1/donut/8171728_240.png 0,PTRF–cavin-1 expression decreases the migration of PC3 prostate cancer cells: Role of matrix metalloprotease 9,European Journal of Cell Biology,,,Article,2011-02-01,10.1016/j.ejcb.2010.06.004,,,,20732728,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/8171592,https://api.altmetric.com/v1/donut/8171592_240.png 0,Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens,European Journal of Cancer (1965),,,Article,2010-12-15,10.1016/j.ejca.2010.07.053,,,,20970322,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8171581,https://api.altmetric.com/v1/donut/8171581_240.png 0,Endo180 expression with cofunctional partners MT1-MMP and uPAR–uPA is correlated with prostate cancer progression,European Journal of Cancer (1965),,,Article,2009-03-01,10.1016/j.ejca.2008.11.023,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/8171560,https://api.altmetric.com/v1/donut/8171560_240.png 0,Innovative biomarkers for prostate cancer early diagnosis and progression,Critical Reviews in Oncology/Hematology,,,Article,2010-01-15,10.1016/j.critrevonc.2009.02.007,,,,19328712,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/8170298,https://api.altmetric.com/v1/donut/8170298_240.png 0,In Pursuit of Individualised Margins for Prostate Cancer Patients Undergoing Image-guided Radiotherapy: The Effect of Body Mass Index on Intrafraction Prostate Motion,Clinical Oncology,,,Article,2011-09-14,10.1016/j.clon.2011.01.511,,,,21376547,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/8169097,https://api.altmetric.com/v1/donut/8169097_240.png 0,Patients’ experiences of high-dose-rate brachytherapy boost for prostate cancer using an inpatient protocol,Brachytherapy,,,Article,2011-09-01,10.1016/j.brachy.2011.01.008,,,,21345743,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8167414,https://api.altmetric.com/v1/donut/8167414_240.png 0,Incidence and risk factors for low trauma fractures in men with prostate cancer,BONE,,,Article,2008-09-14,10.1016/j.bone.2008.05.003,,,,18585119,,10453/28737,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8167305,https://api.altmetric.com/v1/donut/8167305_240.png 0,Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment,Biomaterials,,,Article,2010-11-15,10.1016/j.biomaterials.2010.06.055,,,,20688384,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/8166881,https://api.altmetric.com/v1/donut/8166881_240.png 0,Decrease in expression or activity of cytosolic phospholipase A2? increases cyclooxygenase-1 action: A cross-talk between key enzymes in arachidonic acid pathway in prostate cancer cells,Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids,,,Article,2010-07-14,10.1016/j.bbalip.2010.03.003,,,,20227521,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8166325,https://api.altmetric.com/v1/donut/8166325_240.png 0,Dietary Patterns Identified Using Factor Analysis and Prostate Cancer Risk: A Case Control Study in Western Australia,Annals of Epidemiology,,,Article,2008-05-14,10.1016/j.annepidem.2007.11.010,,,,18261927,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8164967,https://api.altmetric.com/v1/donut/8164967_240.png 0,Informing Men about Prostate Cancer Screening: A Randomized Controlled Trial of Patient Education Materials,JGIM: Journal of General Internal Medicine,,,Article,2008-04-14,10.1007/s11606-007-0466-z,,,,18373146,PMC2359522,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/8162623,https://api.altmetric.com/v1/donut/8162623_240.png 0,Early decision and psychosocial support intervention for men with localised prostate cancer: an integrated approach,Supportive Care in Cancer,,,Article,2007-10-25,10.1007/s00520-007-0351-7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/8157125,https://api.altmetric.com/v1/donut/8157125_240.png 0,Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer,Cell & Tissue Research,,,Article,2010-02-15,10.1007/s00441-009-0902-y,,,,20012321,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8156725,https://api.altmetric.com/v1/donut/8156725_240.png 0,The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research,World Journal of Urology,,,Article,2008-10-14,10.1007/s00345-008-0279-7,,,,18548254,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/8156165,https://api.altmetric.com/v1/donut/8156165_240.png 0,A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group,Cancer Chemotherapy & Pharmacology,,,Article,2010-10-14,10.1007/s00280-009-1228-x,,,,20082080,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8155941,https://api.altmetric.com/v1/donut/8155941_240.png 0,The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression,"Cancer Immunology, Immunotherapy",,,Article,2008-09-14,10.1007/s00262-008-0473-x,,,,18273614,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8155785,https://api.altmetric.com/v1/donut/8155785_240.png 0,Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer,Australasian Physical & Engineering Science in Medicine,,,Article,2009-06-01,10.1007/bf03178629,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8154541,https://api.altmetric.com/v1/donut/8154541_240.png 0,"Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer",The Prostate,,,Article,2011-11-15,10.1002/pros.21381,,,,21432866,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8153833,https://api.altmetric.com/v1/donut/8153833_240.png 0,Prostate cancer outcome and tissue levels of metal ions,The Prostate,,,Article,2011-07-31,10.1002/pros.21339,,,,21271612,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8153832,https://api.altmetric.com/v1/donut/8153832_240.png 0,ETS1 regulates NKX3.1 5? promoter activity and expression in prostate cancer cells,The Prostate,,,Article,2011-03-01,10.1002/pros.21254,,,,20842667,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8153831,https://api.altmetric.com/v1/donut/8153831_240.png 0,Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer,The Prostate,,,Article,2010-06-30,10.1002/pros.21148,,,,20503398,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8153828,https://api.altmetric.com/v1/donut/8153828_240.png 0,Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model,The Prostate,,,Article,2010-03-01,10.1002/pros.21072,,,,19866465,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/8153827,https://api.altmetric.com/v1/donut/8153827_240.png 0,A novel model of bone-metastatic prostate cancer in immunocompetent Mice,The Prostate,,,Article,2009-11-01,10.1002/pros.21010,,,,19585491,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/8153826,https://api.altmetric.com/v1/donut/8153826_240.png 0,Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss,The Prostate,,,Article,2009-04-30,10.1002/pros.20913,,,,19152406,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/8153823,https://api.altmetric.com/v1/donut/8153823_240.png 0,Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer,The Prostate,,,Article,2008-09-14,10.1002/pros.20809,,,,18615486,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/8153821,https://api.altmetric.com/v1/donut/8153821_240.png 0,Sequence variants of ?-methylacyl-CoA racemase are associated with prostate cancer risk: A replication study in an ethnically homogeneous population,The Prostate,,,Article,2008-09-14,10.1002/pros.20798,,,,18537123,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8153820,https://api.altmetric.com/v1/donut/8153820_240.png 0," Elevated levels of HER-2/ neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential ",The Prostate,,,Article,2008-05-31,10.1002/pros.20747,,,,18324648,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8153819,https://api.altmetric.com/v1/donut/8153819_240.png 0,Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer,The Prostate,,,Article,2008-03-31,10.1002/pros.20714,,,,18247402,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8153818,https://api.altmetric.com/v1/donut/8153818_240.png 0,‘Why I feel bad’: refinement of the Effects of Prostate Cancer Upon Lifestyle Questionnaire and an initial exploration of its links with anxiety and depression among prostate cancer patients,Psycho-Oncology,,,Article,2010-08-14,10.1002/pon.1623,,,,19777538,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8153725,https://api.altmetric.com/v1/donut/8153725_240.png 0,"Connecting humor, health, and masculinities at prostate cancer support groups",Psycho-Oncology,,,Article,2009-09-14,10.1002/pon.1415,,,,19137527,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/8153708,https://api.altmetric.com/v1/donut/8153708_240.png 0,Understanding the causes of depression among prostate cancer patients: development of the effects of prostate cancer on lifestyle questionnaire,Psycho-Oncology,,,Article,2009-02-15,10.1002/pon.1382,,,,18613289,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8153707,https://api.altmetric.com/v1/donut/8153707_240.png 0,"Tea, Coffee and Prostate Cancer",Molecular Nutrition & Food Research,,,Article,2009-02-01,10.1002/mnfr.200800218,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8153172,https://api.altmetric.com/v1/donut/8153172_240.png 0,"Soy, isoflavones, and prostate cancer",Molecular Nutrition & Food Research,,,Article,2009-02-01,10.1002/mnfr.200800167,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/8153171,https://api.altmetric.com/v1/donut/8153171_240.png 0,Promising tumor-associated antigens for future prostate cancer therapy,Medicinal Research Reviews,,,Article,2010-01-15,10.1002/med.20165,,,,19536865,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8153151,https://api.altmetric.com/v1/donut/8153151_240.png 0,Angiogenesis as a strategic target for prostate cancer therapy,Medicinal Research Reviews,,,Article,2010-01-15,10.1002/med.20161,,,,19536866,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/8153150,https://api.altmetric.com/v1/donut/8153150_240.png 0," A novel splice variant of the ?-tropomyosin ( TPM2 ) gene in prostate cancer ",Molecular Carcinogenesis,,,Article,2010-06-14,10.1002/mc.20626,,,,20336778,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8153100,https://api.altmetric.com/v1/donut/8153100_240.png 0,DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer,International Journal of Cancer,,,Article,2009-05-14,10.1002/ijc.24243,,,,19173284,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8152233,https://api.altmetric.com/v1/donut/8152233_240.png 0,Adjuvant radiotherapy following radical prostatectomy for prostate cancer,,,,Article,1996-09-01,10.1002/14651858.cd007234,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8151983,https://api.altmetric.com/v1/donut/8151983_240.png 0,Patient-reported experience with the Viadur 12-month leuprolide implant for prostate cancer.,Urology,,,Article,,,,,,97800711846710,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8099861,https://api.altmetric.com/v1/donut/8099861_240.png 0,Reacting to the diagnosis of prostate cancer: patient learning in a community of practice,Patient Education & Counseling,,,Article,2003-03-01,10.1016/s0738-3991(02)00184-2,,,,12642193,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8090400,https://api.altmetric.com/v1/donut/8090400_240.png 0,Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer,Patient Education & Counseling,,,Article,2011-04-01,10.1016/j.pec.2010.05.025,,,,20580521,,11343/29054,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/8087439,https://api.altmetric.com/v1/donut/8087439_240.png 0,Editorial Comment from Dr Sengupta and Dr Webb to Pelvic lymph node dissection for prostate cancer: Adherence and accuracy of the recent guidelines,International Journal of Urology,,,Article,2013-04-17,10.1111/j.1442-2042.2012.03208.x,,,,23075160,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8086907,https://api.altmetric.com/v1/donut/8086907_240.png 0,High-intensity focused ultrasound for treating prostate cancer,British Journal of Urology,,,Article,2007-01-15,10.1111/j.1464-410x.2006.06523.x,,,,17034499,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8086805,https://api.altmetric.com/v1/donut/8086805_240.png 0,Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer,British Journal of Radiology,,,Article,2009-07-14,10.1259/bjr/38306763,,,,19153185,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/8086793,https://api.altmetric.com/v1/donut/8086793_240.png 0,"Estimating the Need for Radiotherapy for Patients With Prostate, Breast, and Lung Cancers: Verification of Model Estimates of Need With Radiotherapy Utilization Data From British Columbia","International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-03-31,10.1016/j.ijrobp.2009.12.070,,,,20605338,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8085871,https://api.altmetric.com/v1/donut/8085871_240.png 0,Palliative prostate radiotherapy for symptomatic advanced prostate cancer,Radiotherapy & Oncology,,,Article,2009-11-15,10.1016/j.radonc.2009.04.017,,,,19464745,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/8081799,https://api.altmetric.com/v1/donut/8081799_240.png 0,Urban-rural differences in prostate cancer outcomes in Australia: what has changed?,Medical Journal of Australia,,,Article,2011-03-21,,,,,21426283,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/8080165,https://api.altmetric.com/v1/donut/8080165_240.png 0,Metastatic prostate cancer to lung with normal prostate specific antigen levels.,,,,Article,2004-02-15,,,,,14997781,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8079654,https://api.altmetric.com/v1/donut/8079654_240.png 0,EFFECTIVENESS OF CYPROTERONE ACETATE IN ACHIEVING CASTRATION AND PREVENTING LUTEINIZING HORMONE RELEASING HORMONE ANALOGUE INDUCED TESTOSTERONE SURGE IN PATIENTS WITH PROSTATE CANCER,The Journal of Urology,,,Article,2005-07-14,10.1097/01.ju.0000161591.86721.e5,,,,15947599,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8079652,https://api.altmetric.com/v1/donut/8079652_240.png 0,Nutraceuticals and prostate cancer prevention: a current review,Nature Reviews Urology,,,Article,2010-01-15,10.1038/nrurol.2009.234,,,,19997071,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/8079636,https://api.altmetric.com/v1/donut/8079636_240.png 0,Role of surgery in high-risk localized prostate cancer,Current Oncology,,,Article,2010-09-01,10.3747/co.v17i0.705,,,,20882128,PMC2935705,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8079630,https://api.altmetric.com/v1/donut/8079630_240.png 0,Focal Laser Ablation for Prostate Cancer Followed by Radical Prostatectomy: Validation of Focal Therapy and Imaging Accuracy,European Urology,,,Article,2010-06-14,10.1016/j.eururo.2010.03.008,,,,20346578,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/8079627,https://api.altmetric.com/v1/donut/8079627_240.png 0,Prevention strategies in prostate cancer,Current Oncology,,,Article,2010-09-01,10.3747/co.v17i0.703,,,,20882132,PMC2935709,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8079625,https://api.altmetric.com/v1/donut/8079625_240.png 0,"Focal therapy in prostate cancer: modalities, findings and future considerations",Nature Reviews Urology,,,Article,2010-10-14,10.1038/nrurol.2010.142,,,,20842187,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/8079624,https://api.altmetric.com/v1/donut/8079624_240.png 0,Image guidance for focal therapy of prostate cancer,World Journal of Urology,,,Article,2010-12-15,10.1007/s00345-010-0604-9,,,,20963422,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/8079622,https://api.altmetric.com/v1/donut/8079622_240.png 0,Focal Laser Ablation for Localized Prostate Cancer,Journal of Endourology,,,Article,2010-05-14,10.1089/end.2009.0440,,,,20477544,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8079619,https://api.altmetric.com/v1/donut/8079619_240.png 0,Recent advances in magnetic resonance imaging of prostate cancer,F1000 Medicine Reports,,,Article,2010-12-08,10.3410/m2-86,,,,21283654,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/8079616,https://api.altmetric.com/v1/donut/8079616_240.png 0,Surgical margin status among men with organ-confined (pT2) prostate cancer: a population-based study,Canadian Urological Association Journal,,,Article,2011-06-14,10.5489/cuaj.10085,,,,21672475,PMC3114023,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/8079609,https://api.altmetric.com/v1/donut/8079609_240.png 0,The pursuit of the “perfect” biomarker in prostate cancer,Canadian Urological Association Journal,,,Article,2011-12-15,10.5489/cuaj.11281,,,,22154634,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8079608,https://api.altmetric.com/v1/donut/8079608_240.png 0,Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort,British Journal of Urology,,,Article,2011-10-14,10.1111/j.1464-410x.2011.10207.x,,,,21507190,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8079606,https://api.altmetric.com/v1/donut/8079606_240.png 0,The role of magnetic resonance imaging in prostate cancer,Australian & New Zealand Journal of Surgery,,,Article,2013-04-14,10.1111/ans.12082,,,,23556487,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8079598,https://api.altmetric.com/v1/donut/8079598_240.png 0,Hypocalcemic and Normocalcemic Hyperparathyroidism in Patients with Advanced Prostatic Cancer,The Journal of Clinical Endocrinology & Metabolism,,,Article,2001-09-01,10.1210/jc.86.9.4133,,,,11549639,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8077179,https://api.altmetric.com/v1/donut/8077179_240.png 0,Recording a patient diet over the radical course of radiotherapy for prostate cancer using a diet diary: a feasibility study,Journal of Radiotherapy in Practice,,,Article,2011-11-21,10.1017/s1460396911000422,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8075511,https://api.altmetric.com/v1/donut/8075511_240.png 0,A New Preoperative Nomogram to Predict Minimal Prostate Cancer: Accuracy and Error Rates Compared to Other Tools to Select Patients for Active Surveillance,The Journal of Urology,,,Article,2011-11-15,10.1016/j.juro.2011.06.060,,,,21944097,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8072175,https://api.altmetric.com/v1/donut/8072175_240.png 0,Low Dose Metronomic Oral Cyclophosphamide for Hormone Resistant Prostate Cancer: A Phase II Study,The Journal of Urology,,,Article,2007-06-14,10.1016/j.juro.2007.01.143,,,,17509300,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8072014,https://api.altmetric.com/v1/donut/8072014_240.png 0,Is prostate cancer a Lynch syndrome cancer?,Asian Journal of Andrology,,,Article,2013-09-14,10.1038/aja.2013.87,,,,23817498,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/8071866,https://api.altmetric.com/v1/donut/8071866_240.png 0,An Imaging Biomarker of Early Treatment Response in Prostate Cancer that Has Metastasized to the Bone,Cancer Research,,,Article,2007-04-14,10.1158/0008-5472.can-06-4236,,,,17440058,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/8071483,https://api.altmetric.com/v1/donut/8071483_240.png 0,Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting,Internal Medicine Journal,,,Article,2010-03-15,10.1111/j.1445-5994.2009.01987.x,,,,19460063,,11343/28748,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8071177,https://api.altmetric.com/v1/donut/8071177_240.png 0,Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2003-09-01,10.1016/s0360-3016(03)00539-x,,,,12909211,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/8069414,https://api.altmetric.com/v1/donut/8069414_240.png 0,2154 BRCA2 MUTATION WITH A DIAGNOSIS OF PROSTATE CANCER FROM HIGH RISK BREAST CANCER FAMILIES CONFERS A SUBSTANTIALLY INCREASED RISK OF CANCER RELATED MORTALITY,The Journal of Urology,,,Article,2010-04-01,10.1016/j.juro.2010.02.2256,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8064503,https://api.altmetric.com/v1/donut/8064503_240.png 0,Should Follow-up Biopsies for Men on Active Surveillance for Prostate Cancer Be Restricted to Limited Templates?,Urology,,,Article,2013-08-14,10.1016/j.urology.2013.03.057,,,,23735610,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/8063582,https://api.altmetric.com/v1/donut/8063582_240.png 0,Imaging in prostate cancer with multiparametric magnetic resonance imaging and gallium positron emission tomography-computed tomography: ‘the real deal'?,British Journal of Urology,,,Article,2015-04-01,10.1111/bju.13094,,,,25828170,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8063580,https://api.altmetric.com/v1/donut/8063580_240.png 0,Heterogeneous copper concentrations in cancerous human prostate tissues,The Prostate,,,Article,2015-10-27,10.1002/pros.23022,,,,26012532,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8059992,https://api.altmetric.com/v1/donut/8059992_240.png 0,"A novel transcript from theKLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus",The Prostate,,,Article,2008-03-01,10.1002/pros.20685,,,,18196551,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/8059839,https://api.altmetric.com/v1/donut/8059839_240.png 0,MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer,Journal of Medical Imaging & Radiation Oncology,,,Article,2014-04-14,10.1111/1754-9485.12107,,,,24690247,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8059377,https://api.altmetric.com/v1/donut/8059377_240.png 0,Abstract B31: Targeting PI3K and RAS pathways in a novel preclinical model of prostate cancer,Molecular Cancer Therapeutics,,,Article,2015-07-06,10.1158/1538-8514.pi3k14-b31,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/8058419,https://api.altmetric.com/v1/donut/8058419_240.png 0,Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate Cancer,Molecular Pharmaceutics,,,Article,2015-08-03,10.1021/mp500671j,,,,26132879,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/8058281,https://api.altmetric.com/v1/donut/8058281_240.png 0,Validating the Interval to Biochemical Failure for the Identification of Potentially Lethal Prostate Cancer,Journal of Clinical Oncology,,,Article,2012-05-19,10.1200/jco.2011.35.1924,,,,22508816,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/8054317,https://api.altmetric.com/v1/donut/8054317_240.png 0,Contemporary Issues in Radiotherapy for Clinically Localized Prostate Cancer,Hematology/oncology clinics of North America,,,Article,2013-12-15,10.1016/j.hoc.2013.08.006,,,,24188256,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/8054314,https://api.altmetric.com/v1/donut/8054314_240.png 0,Operator is an Independent Predictor of Detecting Prostate Cancer at Transrectal Ultrasound Guided Prostate Biopsy,The Journal of Urology,,,Article,2009-12-15,10.1016/j.juro.2009.08.036,,,,19836804,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/8053317,https://api.altmetric.com/v1/donut/8053317_240.png 0,"Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status",Stem Cells,,,Article,2012-06-14,10.1002/stem.1094,,,,22593016,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/7943970,https://api.altmetric.com/v1/donut/7943970_240.png 0,Regular Transition Zone Biopsy during Active Surveillance for Prostate Cancer May Improve Detection of Pathological Progression,The Journal of Urology,,,Article,2014-04-13,10.1016/j.juro.2014.04.010,,,,24742593,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7894839,https://api.altmetric.com/v1/donut/7894839_240.png 0,The Zinc Finger Protein Ras-Responsive Element Binding Protein-1 Is a Coregulator of the Androgen Receptor: Implications for the Role of the Ras Pathway in Enhancing Androgenic Signaling in Prostate Cancer,Molecular Endocrinology,,,Article,2007-09-01,10.1210/me.2006-0503,,,,17550981,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/7892120,https://api.altmetric.com/v1/donut/7892120_240.png 0,Online prostate cancer screening decision aid for at-risk men: A randomized trial.,Health Psychology,,,Article,2013-11-25,10.1037/a0034405,,,,24274808,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7869191,https://api.altmetric.com/v1/donut/7869191_240.png 0,Expression and localization of GLUT1 and GLUT12 in prostate carcinoma,Cancer (0008543X),,,Article,2003-04-15,10.1002/cncr.11293,,,,12673735,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/7867274,https://api.altmetric.com/v1/donut/7867274_240.png 0,Toward an Understanding of the Molecular Genetics of Prostate Cancer Progression,"Journal of Environmental Pathology, Toxicology & Oncology",,,Article,2003-01-01,10.1615/jenvpathtoxoncol.v22.i1.10,,,,12678401,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7865776,https://api.altmetric.com/v1/donut/7865776_240.png 0,The migration and invasion of human prostate cancer cell lines involves CD151 expression,Oncology Reports,,,Article,2010-10-26,10.3892/or_00001022,,,,21042756,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7865762,https://api.altmetric.com/v1/donut/7865762_240.png 0,Recent developments in prostate cancer biomarker research: therapeutic implications,British Journal of Clinical Pharmacology,,,Article,2011-02-15,10.1111/j.1365-2125.2010.03766.x,,,,21219396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/7865751,https://api.altmetric.com/v1/donut/7865751_240.png 0,CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo,Oncology Reports,,,Article,2013-10-29,10.3892/or.2013.2823,,,,24174171,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7865734,https://api.altmetric.com/v1/donut/7865734_240.png 0,Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications.,Cancer (0008543X),,,Article,1993-02-01,10.1002/1097-0142(19930201)71:3+<959::aid-cncr2820711411>3.0.co;2-l,,,,7679046,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7865061,https://api.altmetric.com/v1/donut/7865061_240.png 0,Radioimmunotherapy of Prostate Cancer: Does Tumor Size Matter?,Journal of Clinical Oncology,,,Article,2005-07-19,10.1200/jco.2005.01.903,,,,15837975,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7862939,https://api.altmetric.com/v1/donut/7862939_240.png 0,Interleukin-6: minor player or starring role in the development of hormone-refractory prostate cancer?,British Journal of Urology,,,Article,2003-04-01,10.1046/j.1464-410x.2003.04025.x,,,,12656913,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7861377,https://api.altmetric.com/v1/donut/7861377_240.png 0,Contemporary view of prostate cancer diagnosis and treatment.,Australian Family Physician,,,Article,2003-06-01,,,,,12833761,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7861375,https://api.altmetric.com/v1/donut/7861375_240.png 0,Inorganic Selenium Retards Progression of Experimental Hormone Refractory Prostate Cancer,The Journal of Urology,,,Article,2004-02-15,10.1097/01.ju.0000092859.16817.8e,,,,14713851,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7861374,https://api.altmetric.com/v1/donut/7861374_240.png 0,Combined low-dose imatinib mesylate and paclitaxel lack synergy in an experimental model of extra-osseous hormone-refractory prostate cancer,British Journal of Urology,,,Article,2005-09-14,10.1111/j.1464-410x.2005.05699.x,,,,16104925,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7861371,https://api.altmetric.com/v1/donut/7861371_240.png 0,ENDORECTAL MAGNETIC RESONANCE IMAGING STAGING OF PROSTATE CANCER,Australian & New Zealand Journal of Surgery,,,Article,2007-10-14,10.1111/j.1445-2197.2007.04259.x,,,,17803549,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7861353,https://api.altmetric.com/v1/donut/7861353_240.png 0,Salvage robotic-assisted laparoscopic radical prostatectomy following failed primary high-intensity focussed ultrasound treatment for localised prostate cancer,Journal of Robotic Surgery,,,Article,2008-07-26,10.1007/s11701-008-0097-3,,,,27628262,,11343/29311,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7861343,https://api.altmetric.com/v1/donut/7861343_240.png 0,Revisiting the role of radical surgery in early stage prostate cancer.,Medical Journal of Australia,,,Article,2005-09-18,,,,,16167865,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7861337,https://api.altmetric.com/v1/donut/7861337_240.png 0,Prostate cancer: perspectives on quality of life and impact of treatment on patients and their partners.,Urologic Nursing,,,Article,2003-08-01,,,,,14552074,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7861334,https://api.altmetric.com/v1/donut/7861334_240.png 0,EARLY ONCOLOGICAL OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR HIGH-GRADE PROSTATE CANCER,British Journal of Urology,,,Article,2011-03-15,10.1111/j.1464-410x.2011.10145_1.x,,,,21392212,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7861316,https://api.altmetric.com/v1/donut/7861316_240.png 0,Utility of RhoC and ZAG protein expression as biomarkers for prediction of pSa failure following radical prostatectomy for high grade prostate cancer,Pathology,,,Article,2012-10-14,10.1097/pat.0b013e3283581780,,,,22935975,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7861314,https://api.altmetric.com/v1/donut/7861314_240.png 0,The dilemmas of prostate cancer screening,Medical Journal of Australia,,,Article,2013-11-04,10.5694/mja13.10779,,,,24182216,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7861302,https://api.altmetric.com/v1/donut/7861302_240.png 0,"A randomised, wait-list controlled trial: evaluation of a cognitive-behavioural group intervention on psycho-sexual adjustment for men with localised prostate cancer",Psycho-Oncology,,,Article,2013-04-09,10.1002/pon.3273,,,,23576518,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/7861297,https://api.altmetric.com/v1/donut/7861297_240.png 0,Interfering with cell-survival signalling as a treatment strategy for prostate cancer,British Journal of Urology,,,Article,2006-06-14,10.1111/j.1464-410x.2006.06198.x,,,,16686702,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7856499,https://api.altmetric.com/v1/donut/7856499_240.png 0,Circulating endothelial cells as biomarkers of prostate cancer,Nature Clinical Practice Urology,,,Article,2008-08-14,10.1038/ncpuro1188,,,,18682720,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7856494,https://api.altmetric.com/v1/donut/7856494_240.png 0,Paraneoplastic syndromes in prostate cancer,Nature Reviews Urology,,,Article,2010-12-15,10.1038/nrurol.2010.186,,,,21139643,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7856485,https://api.altmetric.com/v1/donut/7856485_240.png 0,Curated MicroRNAs in Urine and Blood Fail to Validate as Predictive Biomarkers for High-Risk Prostate Cancer,PLoS ONE,,,Article,2014-04-04,10.1371/journal.pone.0091729,,,,24705338,PMC3976264,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/7856472,https://api.altmetric.com/v1/donut/7856472_240.png 0,"Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men.",Medical Journal of Australia,,,Article,1999-08-16,,,,,10494233,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7855299,https://api.altmetric.com/v1/donut/7855299_240.png 0,Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996.,Medical Journal of Australia,,,Article,1998-07-06,,,,,9695697,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7855286,https://api.altmetric.com/v1/donut/7855286_240.png 0,Gata3 antagonizes cancer progression in Pten-deficient prostates,Human Molecular Genetics,,,Article,2013-06-14,10.1093/hmg/ddt088,,,,23428429,,1854/LU-4099425,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7836654,https://api.altmetric.com/v1/donut/7836654_240.png 0,Body size and composition and prostate cancer risk: systematic review and meta-regression analysis,Cancer Causes and Control,,,Article,2006-10-14,10.1007/s10552-006-0049-z,,,,16933050,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7831850,https://api.altmetric.com/v1/donut/7831850_240.png 0,Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells,International Journal of Oncology,,,Article,2009-04-02,10.3892/ijo_00000268,,,,,,1854/LU-700329,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7831322,https://api.altmetric.com/v1/donut/7831322_240.png 0,Hypofractionated Intensity-Modulated Arc Therapy for Lymph Node Metastasized Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-11-15,10.1016/j.ijrobp.2008.12.047,,,,19386427,,1854/LU-817838,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7830311,https://api.altmetric.com/v1/donut/7830311_240.png 0,ssDNA-Binding Protein 2 Is Frequently Hypermethylated and Suppresses Cell Growth in Human Prostate Cancer,Clinical Cancer Research,,,Article,2008-06-14,10.1158/1078-0432.ccr-07-4763,,,,18559593,PMC3082869,1854/LU-791311,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7827528,https://api.altmetric.com/v1/donut/7827528_240.png 0,O12 Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: Deferring androgen deprivation therapy,European Urology Supplements,,,Article,2012-11-01,10.1016/s1569-9056(13)60381-4,,,,,,1854/LU-6900055,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7823122,https://api.altmetric.com/v1/donut/7823122_240.png 0,170 Workshop Intensity modulated radiotherapy (IMRT) for prostate cancer: acute toxicity of 102 patients treated,Radiotherapy & Oncology,,,Article,2002-09-01,10.1016/s0167-8140(02)82489-6,,,,,,1854/LU-156557,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7811024,https://api.altmetric.com/v1/donut/7811024_240.png 0,VE18: Robot-assisted salvage extended pelvic lymph node dissection in prostate cancer,European Urology Supplements,,,Article,2014-09-01,10.1016/s1569-9056(14)50135-2,,,,,,1854/LU-5706797,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7810857,https://api.altmetric.com/v1/donut/7810857_240.png 0,Agreement of Gleason Score on Prostate Biopsy and Radical Prostatectomy Specimen: Is There Improvement With Increased Number of Biopsy Cylinders and the 2005 Revised Gleason Scoring?,Clinical Genitourinary Cancer,,,Article,2013-11-12,10.1016/j.clgc.2013.11.008,,,,24361055,,1854/LU-5673702,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7798216,https://api.altmetric.com/v1/donut/7798216_240.png 0,The Role of Androgen Receptor Expression in the Curative Treatment of Prostate Cancer with Radiotherapy: A Pilot Study,BioMed Research International,,,Article,2015-01-01,10.1155/2015/812815,,,,25793207,PMC4352440,1854/LU-6863079,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7794261,https://api.altmetric.com/v1/donut/7794261_240.png 0,Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate Cancer,Clinical Pharmacokinetics,,,Article,2014-09-09,10.1007/s40262-014-0178-6,,,,25204404,,1854/LU-5841626,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7793279,https://api.altmetric.com/v1/donut/7793279_240.png 0,Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience,Acta Oncologica,,,Article,2014-11-11,10.3109/0284186x.2014.974826,,,,25387271,,1854/LU-5838503,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7793268,https://api.altmetric.com/v1/donut/7793268_240.png 0,Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer,Advances in Urology,,,Article,2012-01-01,10.1155/2012/368528,,,,22190918,,1854/LU-2028781,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7790751,https://api.altmetric.com/v1/donut/7790751_240.png 0,Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer,Radiotherapy & Oncology,,,Article,2009-07-14,10.1016/j.radonc.2009.03.013,,,,19356817,,1854/LU-817856,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7787052,https://api.altmetric.com/v1/donut/7787052_240.png 0,Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase-independent form of cell death,Phytotherapy Research,,,Article,2008-02-15,10.1002/ptr.2286,,,,17726738,,1854/LU-396069,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/7780237,https://api.altmetric.com/v1/donut/7780237_240.png 0,Re: Increased Risk of High-Grade Prostate Cancer Among Infertile Men,European Urology,,,Article,2010-09-01,10.1016/j.eururo.2010.06.016,,,,,,1854/LU-1097847,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7759676,https://api.altmetric.com/v1/donut/7759676_240.png 0,"Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies",Annals of Internal Medicine,,,Article,2008-10-07,10.7326/0003-4819-149-7-200810070-00006,,,,18838726,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/7752456,https://api.altmetric.com/v1/donut/7752456_240.png 0,Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer,Genes & Cancer,,,Article,2013-11-15,10.1177/1947601913506009,,,,24386513,PMC3877662,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7751765,https://api.altmetric.com/v1/donut/7751765_240.png 0,An Update on Occupation and Prostate Cancer,Asian Pacific Journal of Cancer Prevention,,,Article,2014-01-30,10.7314/apjcp.2014.15.2.501,,,,24568454,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7751751,https://api.altmetric.com/v1/donut/7751751_240.png 0,Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer,World Journal of Urology,,,Article,2013-07-03,10.1007/s00345-013-1125-0,,,,23824175,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7751729,https://api.altmetric.com/v1/donut/7751729_240.png 0,A case control study investigating the effects of levels of physical activity at work as a risk factor for prostate cancer,Environmental Health: A Global Access Science Source,,,Article,2014-08-06,10.1186/1476-069x-13-64,,,,25103150,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7751644,https://api.altmetric.com/v1/donut/7751644_240.png 0,Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms—A whole of population study,Prostate International,,,Article,2015-09-01,10.1016/j.prnil.2015.06.004,,,,26473148,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7751403,https://api.altmetric.com/v1/donut/7751403_240.png 0,Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: Prospective standardized analysis of complications,International Journal of Urology,,,Article,2014-06-24,10.1111/iju.12534,,,,24964296,,1854/LU-5673729,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7750059,https://api.altmetric.com/v1/donut/7750059_240.png 0,Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program,Urologic Oncology,,,Article,2016-06-01,10.1016/j.urolonc.2015.12.017,,,,26850781,,1854/LU-7137177,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7749347,https://api.altmetric.com/v1/donut/7749347_240.png 0,Long-term experience of residual symptoms following treatment for localized prostate cancer: An Australian sample,Asia-Pacific Journal of Clinical Oncology,,,Article,2007-12-03,10.1111/j.1743-7563.2007.00134.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7749038,https://api.altmetric.com/v1/donut/7749038_240.png 0,"Psychological adjustment of survivors of localised prostate cancer: investigating the role of dyadic adjustment, cognitive appraisal and coping style",Psycho-Oncology,,,Article,2007-11-15,10.1002/pon.1159,,,,17278153,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/7749028,https://api.altmetric.com/v1/donut/7749028_240.png 0,A Matched Control Analysis of Adjuvant and Salvage High-Dose Postoperative Intensity-Modulated Radiotherapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-08-01,10.1016/j.ijrobp.2010.04.039,,,,,,1854/LU-2028517,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/7746475,https://api.altmetric.com/v1/donut/7746475_240.png 0,Prostate cancer in Cowden syndrome: somatic loss and germline mutation of the PTEN gene,Cancer Genetics,,,Article,2011-04-14,10.1016/j.cancergen.2010.12.011,,,,21536243,,1854/LU-1260425,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/7746394,https://api.altmetric.com/v1/donut/7746394_240.png 0,Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer,The Prostate,,,Article,2013-11-08,10.1002/pros.22750,,,,24395565,,1854/LU-4267615,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/7742810,https://api.altmetric.com/v1/donut/7742810_240.png 0,Variations in the exome of the LNCaP prostate cancer cell line,The Prostate,,,Article,2012-08-31,10.1002/pros.22480,,,,22213130,,1854/LU-3095017,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7742050,https://api.altmetric.com/v1/donut/7742050_240.png 0,P064 To prospectively compare F18-Choline PET/CT and axial skeleton MRI for the detection of bone metastases in patients with biochemically recurrent prostate cancer (PCa),European Urology Supplements,,,Article,2014-11-01,10.1016/s1569-9056(14)61287-2,,,,,,1854/LU-5833328,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7731843,https://api.altmetric.com/v1/donut/7731843_240.png 0,"The Prostate Cancer Registry: Analysis of Medical Resource Utilisation (Mru) in An International, Prospective, Observational Study of Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc)",Value in Health (Elsevier Science),,,Article,2015-11-01,10.1016/j.jval.2015.09.1315,,,,26532708,,1854/LU-7054256,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7729858,https://api.altmetric.com/v1/donut/7729858_240.png 0,Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinations,Urologic Oncology,,,Article,2015-02-20,10.1016/j.urolonc.2015.01.008,,,,25708954,,1854/LU-7054211,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/7719621,https://api.altmetric.com/v1/donut/7719621_240.png 0,Prostate cancer immunology - an update for Urologists,British Journal of Urology,,,Article,2011-04-14,10.1111/j.1464-410x.2010.09820.x,,,,21070575,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/7710875,https://api.altmetric.com/v1/donut/7710875_240.png 0,Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer,The Prostate,,,Article,2008-03-01,10.1002/pros.20709,,,,18196513,,1854/LU-791326,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7706961,https://api.altmetric.com/v1/donut/7706961_240.png 0,Adjuvant High-Dose Intensity-Modulated Radiotherapy after Radical Prostatectomy for Prostate Cancer: Clinical Results in 104 Patients,European Urology,,,Article,2009-10-14,10.1016/j.eururo.2009.05.041,,,,19501453,,1854/LU-817848,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7704817,https://api.altmetric.com/v1/donut/7704817_240.png 0,Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire,Acta Clinica Belgica,,,Article,2015-03-27,10.1179/2295333715y.0000000015,,,,25816107,,1854/LU-6862936,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7704094,https://api.altmetric.com/v1/donut/7704094_240.png 0,Imaging treated prostate cancer,Abdominal Imaging,,,Article,2013-04-19,10.1007/s00261-013-9998-3,,,,23604966,,1854/LU-4419637,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/7703922,https://api.altmetric.com/v1/donut/7703922_240.png 0,Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: Toxicity and matched case comparison with postoperative prostate bed-only radiotherapy,Radiotherapy & Oncology,,,Article,2013-09-05,10.1016/j.radonc.2013.08.021,,,,24016674,,1854/LU-4298264,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7703409,https://api.altmetric.com/v1/donut/7703409_240.png 0,Carbon ion irradiation of the human prostate cancer cell line PC3: A whole genome microarray study,International Journal of Oncology,,,Article,2014-02-03,10.3892/ijo.2014.2287,,,,24504141,,1854/LU-6854798,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7702917,https://api.altmetric.com/v1/donut/7702917_240.png 0,Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation,Journal of radiation research,,,Article,2014-09-03,10.1093/jrr/rru070,,,,25190155,,1854/LU-6855099,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7702913,https://api.altmetric.com/v1/donut/7702913_240.png 0,Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-01-01,10.1016/j.ijrobp.2008.04.005,,,,18538488,,1854/LU-700649,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/7701272,https://api.altmetric.com/v1/donut/7701272_240.png 0,Developments in External Beam Radiotherapy for Prostate Cancer,Urology,,,Article,2013-07-14,10.1016/j.urology.2013.03.043,,,,23706252,,1854/LU-4094302,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/7699257,https://api.altmetric.com/v1/donut/7699257_240.png 0,High intensity focused ultrasound may be superior to radiation therapy for the treatment of early stage prostate cancer,Medical Physics,,,Article,2011-07-01,10.1118/1.3561500,,,,,,1854/LU-2028532,2011MedPh..38.3909B,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7676615,https://api.altmetric.com/v1/donut/7676615_240.png 0,Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: Making informed decisions,Radiotherapy & Oncology,,,Article,2014-06-16,10.1016/j.radonc.2014.04.005,,,,24951017,,1854/LU-5705831,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7664070,https://api.altmetric.com/v1/donut/7664070_240.png 0,A Comparison of the Acute Toxicity Profile between Two-dimensional and Three-dimensional Image-guided Radiotherapy for Postoperative Prostate Cancer,Clinical Oncology,,,Article,2011-06-14,10.1016/j.clon.2011.01.505,,,,21353504,,1854/LU-2028549,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7663505,https://api.altmetric.com/v1/donut/7663505_240.png 0,"Inflammation, prostatitis, proliferative inflammatory atrophy: ‘Fertile ground’ for prostate cancer development?",Molecular Medicine Reports,,,Article,2009-11-20,10.3892/mmr_00000211,,,,21472193,,1854/LU-844016,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7656814,https://api.altmetric.com/v1/donut/7656814_240.png 0,191 High-dose intensity-modulated arc radiotherapy for lymph node metastasized prostate cancer: Toxicity and early clinical outcome,European Urology Supplements,,,Article,2013-03-01,10.1016/s1569-9056(13)60679-x,,,,,,1854/LU-6900038,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7653280,https://api.altmetric.com/v1/donut/7653280_240.png 0,01 Chromosome X polysomy is associated with increased androgen receptor expression in epithelial cells and reduced expression in stromal cells in treatment-naive prostate cancer,European Urology Supplements,,,Article,2014-11-01,10.1016/s1569-9056(14)61222-7,,,,,,1854/LU-5766371,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7650486,https://api.altmetric.com/v1/donut/7650486_240.png 0,Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer,The Prostate,,,Article,2014-10-30,10.1002/pros.22918,,,,25358590,,1854/LU-5923604,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7649081,https://api.altmetric.com/v1/donut/7649081_240.png 0,Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT,Radiotherapy & Oncology,,,Article,2013-06-14,10.1016/j.radonc.2013.05.014,,,,23791364,,1854/LU-4123760,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/7648772,https://api.altmetric.com/v1/donut/7648772_240.png 0,Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer,Electrophoresis,,,Article,2013-11-20,10.1002/elps.201300332,,,,24254641,,1854/LU-4250897,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7646729,https://api.altmetric.com/v1/donut/7646729_240.png 0,A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects.,Cancer (0008543X),,,Article,2001-08-15,10.1002/1097-0142(20010815)92:43.0.co;2-p,,,,11550169,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7642407,https://api.altmetric.com/v1/donut/7642407_240.png 0,Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.,Medical Journal of Australia,,,Article,2011-03-21,,,,,21426285,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/7641498,https://api.altmetric.com/v1/donut/7641498_240.png 0,Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?,Clinical Endocrinology,,,Article,2011-03-15,10.1111/j.1365-2265.2010.03939.x,,,,21092052,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/7641484,https://api.altmetric.com/v1/donut/7641484_240.png 0,Androgens and prostate cancer; pathogenesis and deprivation therapy,Best Practice & Research Clinical Endocrinology & Metabolism,,,Article,2013-08-14,10.1016/j.beem.2013.05.001,,,,24054933,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7641234,https://api.altmetric.com/v1/donut/7641234_240.png 0,Decay of cortical bone structure in males with prostate cancer treated with 12 months androgen deprivation therapy,BONE,,,Article,2009-05-01,10.1016/j.bone.2009.01.231,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7641167,https://api.altmetric.com/v1/donut/7641167_240.png 0,What to do for prostate cancer patients with a rising PSA?—a survey of Australian practice,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2003-03-15,10.1016/s0360-3016(02)04213-x,,,,12605977,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7613225,https://api.altmetric.com/v1/donut/7613225_240.png 0,Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer,Asia Pacific Journal of Clinical Oncology,,,Article,2007-09-01,10.1111/j.1743-7563.2007.00101.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7613208,https://api.altmetric.com/v1/donut/7613208_240.png 0,Brain metastases in hormone refractory prostate cancer: a changing natural history?,Internal Medicine Journal,,,Article,2009-03-15,10.1111/j.1445-5994.2008.01848.x,,,,19383072,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7613201,https://api.altmetric.com/v1/donut/7613201_240.png 0,Prostate cancer presenting with fever and rigors,Internal Medicine Journal,,,Article,2005-10-14,10.1111/j.1445-5994.2005.00953.x,,,,16207268,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7613198,https://api.altmetric.com/v1/donut/7613198_240.png 0,"Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer",British Journal of Cancer,,,Article,2010-08-09,10.1038/sj.bjc.6605798,,,,20648008,PMC2939789,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7613197,https://api.altmetric.com/v1/donut/7613197_240.png 0,Phytoestrogens and prostate cancer: possible preventive role.,Medical Journal of Australia,,,Article,1998-05-04,,,,,9612462,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7613167,https://api.altmetric.com/v1/donut/7613167_240.png 0," Evaluation of the safety, pharmacokinetics and treatment effects of an ? ? ? 3 integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases ",Asia Pacific Journal of Clinical Oncology,,,Article,2010-03-15,10.1111/j.1743-7563.2009.01266.x,,,,20398037,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7613157,https://api.altmetric.com/v1/donut/7613157_240.png 0,Management of metastatic prostate cancer.,Medical Journal of Australia,,,Article,1998-07-06,,,,,9695702,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7613155,https://api.altmetric.com/v1/donut/7613155_240.png 0,Advances in the management of prostate cancer,Internal Medicine Journal,,,Article,2000-10-01,10.1111/j.1445-5994.2000.tb00861.x,,,,11108070,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7613151,https://api.altmetric.com/v1/donut/7613151_240.png 0,Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study,European Journal of Oncology Nursing,,,Article,2013-04-14,10.1016/j.ejon.2012.04.003,,,,22608878,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7610424,https://api.altmetric.com/v1/donut/7610424_240.png 0,"Description of the international consortium for prostate cancer genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13",The Prostate,,,Article,2005-05-15,10.1002/pros.20198,,,,15599943,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7610307,https://api.altmetric.com/v1/donut/7610307_240.png 0,"Objectively assessed physical activity, sedentary time and waist circumference among prostate cancer survivors: findings from the National Health and Nutrition Examination Survey (2003-2006)",European Journal of Cancer Care,,,Article,2011-07-14,10.1111/j.1365-2354.2010.01205.x,,,,20597954,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/7606523,https://api.altmetric.com/v1/donut/7606523_240.png 0,Lymphatic vessel density and lymph node metastasis in prostate cancer,The Prostate,,,Article,2005-11-01,10.1002/pros.20288,,,,15948136,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7598902,https://api.altmetric.com/v1/donut/7598902_240.png 0,Accuracy and completeness in reporting family history of prostate cancer by unaffected men,Urology,,,Article,2004-06-14,10.1016/j.urology.2003.12.032,,,,15183962,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7594640,https://api.altmetric.com/v1/donut/7594640_240.png 0,Prostate Cancer Screening in Men with a Family History of Prostate Cancer: The Role of Partners in Influencing Men’s Screening Uptake,Urology,,,Article,2007-10-01,10.1016/j.urology.2007.06.1093,,,,17991547,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7594627,https://api.altmetric.com/v1/donut/7594627_240.png 0,"The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer",Genetics in Medicine,,,Article,2008-06-14,10.1097/gim.0b013e31817701c1,,,,18496220,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7594626,https://api.altmetric.com/v1/donut/7594626_240.png 0,Genetic services for men: The preferences of men with a family history of prostate cancer,Genetics in Medicine,,,Article,2006-12-15,10.1097/01.gim.0000250204.97620.36,,,,17172940,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7594615,https://api.altmetric.com/v1/donut/7594615_240.png 0,Prostate Cancer in Bone: Importance of Context for Inhibition of Matrix Metalloproteinases,JNCI: Journal of the National Cancer Institute,,,Article,2002-01-02,10.1093/jnci/94.1.4,,,,11773268,PMC3027556,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7592882,https://api.altmetric.com/v1/donut/7592882_240.png 0,ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix,Oncogene,,,Article,2006-06-28,10.1038/sj.onc.1209418,,,,16474848,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7592857,https://api.altmetric.com/v1/donut/7592857_240.png 0,Investigations with FDG-PET Scanning in Prostate Cancer Show Limited Value for Clinical Practice,Acta Oncologica,,,Article,2002-01-01,10.1080/028418602320405005,,,,12442917,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7591172,https://api.altmetric.com/v1/donut/7591172_240.png 0,Nurses lead the way in prostate cancer care.,Australian Nursing Journal,,,Article,2007-05-14,,,,,17539336,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7589202,https://api.altmetric.com/v1/donut/7589202_240.png 0,Development of a Psychoeducational Intervention for Men with Prostate Cancer,Journal of Psychosocial Oncology,,,Article,2009-02-11,10.1080/07347330802616100,,,,19197682,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/7589187,https://api.altmetric.com/v1/donut/7589187_240.png 0,The psychosocial impact of prostate cancer on patients and their partners.,Medical Journal of Australia,,,Article,2006-10-15,,,,,17137432,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7587241,https://api.altmetric.com/v1/donut/7587241_240.png 0,Psychological adjustment of men with prostate cancer: a review of the literature.,BioPsychoSocial Medicine,,,Article,2007-01-10,10.1186/1751-0759-1-2,,,,17371571,PMC1805773,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7587219,https://api.altmetric.com/v1/donut/7587219_240.png 0,Coping Patterns and Psychosocial Distress in Female Partners of Prostate Cancer Patients,Psychosomatics,,,Article,2009-07-01,10.1176/appi.psy.50.4.375,,,,19687178,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7587209,https://api.altmetric.com/v1/donut/7587209_240.png 0,Psychosocial adaptation in female partners of men with prostate cancer,European Journal of Cancer Care,,,Article,2010-03-15,10.1111/j.1365-2354.2008.01012.x,,,,19686355,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/7587205,https://api.altmetric.com/v1/donut/7587205_240.png 0,Cognitive Existential Couple Therapy for newly diagnosed prostate cancer patients and their partners: a descriptive pilot study,Psycho-Oncology,,,Article,2013-02-15,10.1002/pon.2085,,,,21990204,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/7587204,https://api.altmetric.com/v1/donut/7587204_240.png 0,Nuclear Localization of Factor Inhibitor Hypoxia-Inducible Factor in Prostate Cancer Is Associated With Poor Prognosis,The Journal of Urology,,,Article,2011-04-14,10.1016/j.juro.2010.12.001,,,,21334674,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7585327,https://api.altmetric.com/v1/donut/7585327_240.png 0," High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer ",British Journal of Urology,,,Article,2012-12-15,10.1111/j.1464-410x.2012.11519.x,,,,23035815,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/7585302,https://api.altmetric.com/v1/donut/7585302_240.png 0,Expression of Vascular Endothelial Growth Factor Receptor-3 by Lymphatic Endothelial Cells Is Associated with Lymph Node Metastasis in Prostate Cancer,Clinical Cancer Research,,,Article,2004-07-31,10.1158/1078-0432.ccr-03-0434,,,,15297417,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7581214,https://api.altmetric.com/v1/donut/7581214_240.png 0,Elevated level of inhibin-? subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer,British Journal of Cancer,,,Article,2009-06-01,10.1038/sj.bjc.6605089,,,,19436293,PMC2695696,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7581169,https://api.altmetric.com/v1/donut/7581169_240.png 0,Possible mechanism for differences in sensitivity to cis-platinum in human prostate tumor cell lines,Cancer Letters,,,Article,1986-05-01,10.1016/0304-3835(86)90007-8,,,,3697960,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7579174,https://api.altmetric.com/v1/donut/7579174_240.png 0,Androgen metabolism by human prostatic tumours in organ culture,European Journal of Cancer and Clinical Oncology,,,Article,1983-07-01,10.1016/0277-5379(83)90060-3,,,,6684049,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7579162,https://api.altmetric.com/v1/donut/7579162_240.png 0,In vitro responses of human prostate tumour cell lines to a range of antitumour agents,International Journal of Cancer,,,Article,1983-09-15,10.1002/ijc.2910320315,,,,6885184,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7579157,https://api.altmetric.com/v1/donut/7579157_240.png 0,Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate,Cancer Detection & Prevention,,,Article,2007-01-01,10.1016/j.cdp.2007.08.002,,,,18031950,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7574781,https://api.altmetric.com/v1/donut/7574781_240.png 0,Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines,The Prostate,,,Article,2008-04-30,10.1002/pros.20738,,,,18288685,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7574779,https://api.altmetric.com/v1/donut/7574779_240.png 0,Expression and function of ATIP/MTUS1 in human prostate cancer cell lines,The Prostate,,,Article,2010-09-30,10.1002/pros.21192,,,,20687230,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7574778,https://api.altmetric.com/v1/donut/7574778_240.png 0,"The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer",Cancers,,,Article,2011-10-10,10.3390/cancers3043824,,,,24213113,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7574777,https://api.altmetric.com/v1/donut/7574777_240.png 0,Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer,Biochemical Journal,,,Article,2011-05-31,10.1042/bj20110123,,,,21426304,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7574172,https://api.altmetric.com/v1/donut/7574172_240.png 0,Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers,Biomarkers in Medicine,,,Article,2013-12-15,10.2217/bmm.13.100,,,,24266820,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7573617,https://api.altmetric.com/v1/donut/7573617_240.png 0,Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?,Canadian Urological Association Journal,,,Article,2015-05-01,10.5489/cuaj.2619,,,,26029290,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7573613,https://api.altmetric.com/v1/donut/7573613_240.png 0,The Role of Hypoxia-Inducible Factor 1? in Determining the Properties of Castrate-Resistant Prostate Cancers,PLoS ONE,,,Article,2013-01-16,10.1371/journal.pone.0054251,,,,23342109,,11343/43837,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7573119,https://api.altmetric.com/v1/donut/7573119_240.png 0," The effects of nonspecific HIF1 ? inhibitors on development of castrate resistance and metastases in prostate cancer ",Cancer medicine,,,Article,2014-01-27,10.1002/cam4.189,,,,24464861,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7573102,https://api.altmetric.com/v1/donut/7573102_240.png 0,HIF1? Expression under Normoxia in Prostate Cancer— Which Pathways to Target?,The Journal of Urology,,,Article,2014-10-19,10.1016/j.juro.2014.10.085,,,,25444956,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7573086,https://api.altmetric.com/v1/donut/7573086_240.png 0,Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells,ACS Chemical Biology,,,Article,2013-05-23,10.1021/cb400198p,,,,23656859,,11343/43936,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/7572981,https://api.altmetric.com/v1/donut/7572981_240.png 0,Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register,Australian and New Zealand Journal of Public Health,,,Article,2014-06-23,10.1111/1753-6405.12210,,,,24962513,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7569242,https://api.altmetric.com/v1/donut/7569242_240.png 0,"Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy",British Journal of Cancer,,,Article,2012-10-22,10.1038/bjc.2012.439,,,,23047552,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7568944,https://api.altmetric.com/v1/donut/7568944_240.png 0,Reply: On the clinical relevance of circulating endothelial cells and platelets in prostate cancer,British Journal of Cancer,,,Article,2013-04-01,10.1038/bjc.2012.529,,,,23412103,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7568935,https://api.altmetric.com/v1/donut/7568935_240.png 0,Validation of the Supportive Care Needs Survey-short form 34 with a simplified response format in men with prostate cancer,Psycho-Oncology,,,Article,2012-10-14,10.1002/pon.2016,,,,21800397,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7568651,https://api.altmetric.com/v1/donut/7568651_240.png 0,Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology,Clinical and Experimental Metastasis,,,Article,2013-10-01,10.1007/s10585-013-9617-2,,,,24085599,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7568240,https://api.altmetric.com/v1/donut/7568240_240.png 0,Cost Minimisation Analysis: Kilovoltage Imaging with Automated Repositioning Versus Electronic Portal Imaging in Image-guided Radiotherapy for Prostate Cancer,Clinical Oncology,,,Article,2012-10-14,10.1016/j.clon.2012.04.004,,,,22694787,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7567786,https://api.altmetric.com/v1/donut/7567786_240.png 0,Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer,Australasian Physical & Engineering Science in Medicine,,,Article,2007-09-01,10.1007/bf03178424,,,,18044301,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7567053,https://api.altmetric.com/v1/donut/7567053_240.png 0,"Percentage of Biopsy Cores Positive for Malignancy and Biochemical Failure Following Prostate Cancer Radiotherapy in 3,264 Men: Statistical Significance Without Predictive Performance","International Journal of Radiation Oncology, Biology, Physics",,,Article,2008-03-15,10.1016/j.ijrobp.2007.08.021,,,,17967518,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7567045,https://api.altmetric.com/v1/donut/7567045_240.png 0,Urethral stricture following high dose rate brachytherapy for prostate cancer,Radiotherapy & Oncology,,,Article,2009-05-14,10.1016/j.radonc.2008.11.013,,,,19097660,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7567032,https://api.altmetric.com/v1/donut/7567032_240.png 0,Determining if pretreatment PSA doubling time predicts PSA trajectories after radiation therapy for localized prostate cancer,Radiotherapy & Oncology,,,Article,2009-03-01,10.1016/j.radonc.2008.09.014,,,,18977051,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7567029,https://api.altmetric.com/v1/donut/7567029_240.png 0,ORIGINAL ARTICLE: Pilot comparison of 18F-fluorocholine and 18F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer,Journal of Medical Imaging & Radiation Oncology,,,Article,2010-08-14,10.1111/j.1754-9485.2010.02178.x,,,,20718912,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7567017,https://api.altmetric.com/v1/donut/7567017_240.png 0," Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties ",British Journal of Radiology,,,Article,2012-02-15,10.1259/bjr/13553326,,,,21976627,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/7566995,https://api.altmetric.com/v1/donut/7566995_240.png 0,Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy,Prostate International,,,Article,2015-12-01,10.1016/j.prnil.2015.09.006,,,,26779455,PMC4685231,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7565945,https://api.altmetric.com/v1/donut/7565945_240.png 0,Prostate Cancer Methods and Protocols,Methods in molecular medicine,,,Article,2003-01-01,10.1385/1-59259-372-0:333,,,,12725130,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7497424,https://api.altmetric.com/v1/donut/7497424_240.png 0,The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK,World Journal of Urology,,,Article,2016-04-20,10.1007/s00345-016-1818-2,,,,27097892,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7459403,https://api.altmetric.com/v1/donut/7459403_240.png 0,Changes in health-related quality of life of men with prostate cancer 3 months after diagnosis: the role of psychosocial factors and comparisment with benign prostate hyperplasia patients,Patient Education & Counseling,,,Article,2003-03-01,10.1016/s0738-3991(02)00221-5,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7440447,https://api.altmetric.com/v1/donut/7440447_240.png 0,Introduction: prostate cancer: from basic science to clinical application?,Urology,,,Article,2003-11-01,10.1016/s0090-4295(03)00757-x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7440407,https://api.altmetric.com/v1/donut/7440407_240.png 0,Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro,The Prostate,,,Article,2005-02-15,10.1002/pros.20150,,,,15389777,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7436815,https://api.altmetric.com/v1/donut/7436815_240.png 0,Innovations in Serum and Urine Markers in Prostate Cancer,European Urology,,,Article,2005-12-15,10.1016/j.eururo.2005.06.009,,,,16054748,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/7436792,https://api.altmetric.com/v1/donut/7436792_240.png 0,PSA and staging of localized prostate cancer.,Urologic Clinics of North America,,,Article,1993-11-01,,,,,97890902116410,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7436376,https://api.altmetric.com/v1/donut/7436376_240.png 0,C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer,European Urology,,,Article,2003-07-01,10.1016/s0302-2838(03)00207-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7421358,https://api.altmetric.com/v1/donut/7421358_240.png 0,Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23–qter and identifies underlying candidate tumor suppressor genes in prostate cancer,Oncogene,,,Article,2004-04-21,10.1038/sj.onc.1207474,,,,15007382,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/7420302,https://api.altmetric.com/v1/donut/7420302_240.png 0,In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2005-06-14,10.1007/s00259-004-1741-4,,,,15765234,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7418965,https://api.altmetric.com/v1/donut/7418965_240.png 0,Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials,European Journal of Cancer (1965),,,Article,2006-07-14,10.1016/j.ejca.2006.02.011,,,,16730974,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7417374,https://api.altmetric.com/v1/donut/7417374_240.png 0,Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial,The Prostate,,,Article,2007-06-30,10.1002/pros.20606,,,,17458908,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7415812,https://api.altmetric.com/v1/donut/7415812_240.png 0,Serum Bone Turnover Markers (PINP and ICTP) for the Early Detection of Bone Metastases in Patients With Prostate Cancer: A Longitudinal Approach,The Journal of Urology,,,Article,2007-09-14,10.1016/j.juro.2007.05.029,,,,17631330,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7415544,https://api.altmetric.com/v1/donut/7415544_240.png 0,"LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion",Current Medical Research & Opinion,,,Article,2007-05-14,10.1185/030079907x187973,,,,17519074,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7415518,https://api.altmetric.com/v1/donut/7415518_240.png 0,"Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group",Radiotherapy & Oncology,,,Article,2007-08-14,10.1016/j.radonc.2007.07.017,,,,17706307,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,87,https://www.altmetric.com/details/7415272,https://api.altmetric.com/v1/donut/7415272_240.png 0,Re: Serum Bone Turnover Markers (PINP and ICTP) for the Early Detection of Bone Metastases in Patients With Prostate Cancer: A Longitudinal Approach,European Urology,,,Article,2007-11-01,10.1016/j.eururo.2007.08.014,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7415053,https://api.altmetric.com/v1/donut/7415053_240.png 0,CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3),"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2007-11-01,10.1158/1055-9965.epi-07-0589,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7414948,https://api.altmetric.com/v1/donut/7414948_240.png 0,Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4?years?,British Journal of Urology,,,Article,2008-02-01,10.1111/j.1464-410x.2007.07267.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7414718,https://api.altmetric.com/v1/donut/7414718_240.png 0,Grading-System-Dependent Volume Effects for Late Radiation-Induced Rectal Toxicity After Curative Radiotherapy for Prostate Cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2008-03-01,10.1016/j.ijrobp.2007.07.2363,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/7414325,https://api.altmetric.com/v1/donut/7414325_240.png 0,Ferruginol suppresses survival signaling pathways in androgen-independent human prostate cancer cells,Biochimie,,,Article,2008-06-14,10.1016/j.biochi.2008.01.011,,,,18294971,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7413606,https://api.altmetric.com/v1/donut/7413606_240.png 0,Genetically Engineered Mouse Models of Prostate Cancer,European Urology Supplements,,,Article,2008-08-01,10.1016/j.eursup.2008.01.019,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/7413446,https://api.altmetric.com/v1/donut/7413446_240.png 0,Hyperglycaemia and reduced risk of prostate cancer,Diabetologia,,,Article,2009-02-15,10.1007/s00125-008-1214-6,,,,19020857,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7412533,https://api.altmetric.com/v1/donut/7412533_240.png 0,Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review,Radiotherapy & Oncology,,,Article,2009-03-15,10.1016/j.radonc.2008.10.022,,,,19038468,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/7411927,https://api.altmetric.com/v1/donut/7411927_240.png 0,"Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial",European Urology,,,Article,2009-05-14,10.1016/j.eururo.2008.11.002,,,,19042080,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/7411797,https://api.altmetric.com/v1/donut/7411797_240.png 0,"Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer",The Prostate,,,Article,2009-06-30,10.1002/pros.20957,,,,19343734,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7411434,https://api.altmetric.com/v1/donut/7411434_240.png 0,Epac inhibits migration and proliferation of human prostate carcinoma cells,British Journal of Cancer,,,Article,2009-12-15,10.1038/sj.bjc.6605439,,,,19920825,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/7410400,https://api.altmetric.com/v1/donut/7410400_240.png 0,Healthcare costs associated with prostate cancer: estimates from a population-based study,British Journal of Urology,,,Article,2010-02-15,10.1111/j.1464-410x.2009.08758.x,,,,19594734,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/7410183,https://api.altmetric.com/v1/donut/7410183_240.png 0,Balancing the harms and benefits of early detection of prostate cancer,Cancer (0008543X),,,Article,2010-10-14,10.1002/cncr.25474,,,,20839233,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7408199,https://api.altmetric.com/v1/donut/7408199_240.png 0,Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer,European Journal of Cancer (1965),,,Article,2010-11-15,10.1016/j.ejca.2010.09.033,,,,21047590,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7407784,https://api.altmetric.com/v1/donut/7407784_240.png 0,Solid lipid nanoparticles for gene delivery into prostate cancer cells,Drug Discovery Today,,,Article,2010-12-01,10.1016/j.drudis.2010.09.429,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7407695,https://api.altmetric.com/v1/donut/7407695_240.png 0,Prostate Cancer Detection and Dutasteride: Utility and Limitations of Prostate-Specific Antigen in Men with Previous Negative Biopsies,European Urology,,,Article,2011-02-15,10.1016/j.eururo.2010.09.035,,,,21130560,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/7407565,https://api.altmetric.com/v1/donut/7407565_240.png 0," 99m Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7–14) as a Targeted Imaging Agent with MicroSPECT in a PC-3 Prostate Cancer Xenograft Model ",Molecular Pharmaceutics,,,Article,2011-07-31,10.1021/mp200014h,,,,21699202,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7405824,https://api.altmetric.com/v1/donut/7405824_240.png 0,"Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572–83",European Urology,,,Article,2011-11-15,10.1016/j.eururo.2011.08.009,,,,21855205,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7405317,https://api.altmetric.com/v1/donut/7405317_240.png 0,Design of solid lipid nanoparticles for gene delivery into prostate cancer,Journal of Controlled Release,,,Article,2010-11-20,10.1016/j.jconrel.2010.07.065,,,,21529650,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7405274,https://api.altmetric.com/v1/donut/7405274_240.png 0,Identifying the Best Candidate for Radical Prostatectomy Among Patients with High-Risk Prostate Cancer,European Urology,,,Article,2012-03-15,10.1016/j.eururo.2011.11.043,,,,22153925,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/7404562,https://api.altmetric.com/v1/donut/7404562_240.png 0,CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy,Neoplasia,,,Article,2012-08-01,10.1593/neo.12324,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/7403134,https://api.altmetric.com/v1/donut/7403134_240.png 0,Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer,Amino Acids,,,Article,2013-02-15,10.1007/s00726-012-1369-9,,,,22833158,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7402285,https://api.altmetric.com/v1/donut/7402285_240.png 0,"Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review",World Journal of Urology,,,Article,2013-04-14,10.1007/s00345-012-0928-8,,,,22903773,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/7401743,https://api.altmetric.com/v1/donut/7401743_240.png 0," Preclinical Evaluation of a Novel 111 In-Labeled Bombesin Homodimer for Improved Imaging of GRPR-Positive Prostate Cancer ",Molecular Pharmaceutics,,,Article,2013-05-05,10.1021/mp3005462,,,,23590837,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7401544,https://api.altmetric.com/v1/donut/7401544_240.png 0,Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial,Journal of Medical Screening,,,Article,2013-03-01,10.1258/jms.2013.012026,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7401222,https://api.altmetric.com/v1/donut/7401222_240.png 0,Plakophilin-associated RNA-binding proteins in prostate cancer and their implications in tumor progression and metastasis,Virchows Archiv,,,Article,2013-09-14,10.1007/s00428-013-1452-y,,,,23881279,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7400890,https://api.altmetric.com/v1/donut/7400890_240.png 0,"CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model",Clinical and Experimental Metastasis,,,Article,2014-08-25,10.1007/s10585-014-9673-2,,,,25154297,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7389878,https://api.altmetric.com/v1/donut/7389878_240.png 0,"PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy",International Journal of Molecular Sciences,,,Article,2014-04-09,10.3390/ijms15046046,,,,24727373,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/7389877,https://api.altmetric.com/v1/donut/7389877_240.png 0,Increases in core body temperature precede hot flashes in a prostate cancer patient,Psycho-Oncology,,,Article,2009-05-14,10.1002/pon.1476,,,,19025973,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7389030,https://api.altmetric.com/v1/donut/7389030_240.png 0,Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer,Cancer Research,,,Article,2014-09-23,10.1158/0008-5472.can-14-0594,,,,25252911,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/7388566,https://api.altmetric.com/v1/donut/7388566_240.png 0,"Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.",Tumori,,,Article,,10.1700/1578.17198,,,,25076236,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7388078,https://api.altmetric.com/v1/donut/7388078_240.png 0,GRPR-selective PET imaging of prostate cancer using [18F]-lanthionine-bombesin analogs,Peptides,,,Article,2015-03-19,10.1016/j.peptides.2015.03.004,,,,25797109,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7385438,https://api.altmetric.com/v1/donut/7385438_240.png 0,Molecular Imaging of Prostate Cancer: Tapping into the Opportunities,Journal of Nuclear Medicine,,,Article,2014-12-31,10.2967/jnumed.114.150219,,,,25552669,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7385276,https://api.altmetric.com/v1/donut/7385276_240.png 0," Targeting human prostate cancer with 111 In-labeled D2B IgG, F(ab?) 2 and Fab fragments in nude mice with PSMA-expressing xenografts ",Contrast Media and Molecular Imaging,,,Article,2014-04-24,10.1002/cmmi.1596,,,,24764162,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7384325,https://api.altmetric.com/v1/donut/7384325_240.png 0,A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey,Trials,,,Article,2015-12-15,10.1186/s13063-015-0598-0,,,,25778596,PMC4355995,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/7384128,https://api.altmetric.com/v1/donut/7384128_240.png 0,"Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).",Cancer Research,,,Article,1999-05-15,,,,,10344749,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/7369664,https://api.altmetric.com/v1/donut/7369664_240.png 0,Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).,Clinical Cancer Research,,,Article,1998-08-01,,,,,9717816,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7369662,https://api.altmetric.com/v1/donut/7369662_240.png 0,"Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.",Journal of Clinical Oncology,,,Article,2001-01-01,,,,,11134194,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7369661,https://api.altmetric.com/v1/donut/7369661_240.png 0,PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2001-04-01,,,,,11319185,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7369660,https://api.altmetric.com/v1/donut/7369660_240.png 0,Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report.,Seminars in oncology,,,Article,2001-08-01,10.1016/s0093-7754(01)90153-8,,,,11685727,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/7369656,https://api.altmetric.com/v1/donut/7369656_240.png 0,Plasma Levels of Heat Shock Protein 70 in Patients with Prostate Cancer: A Potential Biomarker for Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2004-06-01,10.3816/cgc.2004.n.013,,,,15279691,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7369654,https://api.altmetric.com/v1/donut/7369654_240.png 0,Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy,Clinical Genitourinary Cancer,,,Article,2005-06-01,10.3816/cgc.2005.n.014,,,,15992464,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7369651,https://api.altmetric.com/v1/donut/7369651_240.png 0,Prostate-Specific Antigen Endpoints in Hormone-Refractory Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2005-06-01,10.3816/cgc.2005.n.006,,,,15992455,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7369650,https://api.altmetric.com/v1/donut/7369650_240.png 0,Mutations in Ribonuclease L Gene Do NotOccur at a Greater Frequency in Patients with Familial Prostate Cancer Compared with Patients with Sporadic Prostate Cancer,Clinical Genitourinary Cancer,,,Article,2003-12-01,10.3816/cgc.2003.n.027,,,,15040862,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7369649,https://api.altmetric.com/v1/donut/7369649_240.png 0,Prostate-specific antigen as a risk factor for skeletal metastasis in native ethnic African Men with prostate cancer: A case-control study,World Journal of Nuclear Medicine,,,Article,2016-01-01,10.4103/1450-1147.181150,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7350080,https://api.altmetric.com/v1/donut/7350080_240.png 0,Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop,Australasian Radiology,,,Article,2004-12-01,10.1111/j.1440-1673.2004.01355.x,,,,15601331,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7298194,https://api.altmetric.com/v1/donut/7298194_240.png 0,Next-generation therapy for residual prostate cancer,Immunotherapy,,,Article,2013-11-15,10.2217/imt.13.127,,,,24188677,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7297089,https://api.altmetric.com/v1/donut/7297089_240.png 0,Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA,Journal of the International AIDS Society,,,Article,2014-11-02,10.7448/ias.17.4.19510,,,,25394019,PMC4224942,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7296316,https://api.altmetric.com/v1/donut/7296316_240.png 0,"Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody","Cancer Immunology, Immunotherapy",,,Article,2004-06-14,10.1007/s00262-003-0460-1,,,,14722669,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7291979,https://api.altmetric.com/v1/donut/7291979_240.png 0,Derivation of MPR and TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategies,Urologic Oncology,,,Article,2002-05-01,10.1016/s1078-1439(01)00180-6,,,,12474544,,10453/15644,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/7288662,https://api.altmetric.com/v1/donut/7288662_240.png 0,Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway,The Prostate,,,Article,2007-11-01,10.1002/pros.20638,,,,17823933,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7285402,https://api.altmetric.com/v1/donut/7285402_240.png 0,Autonomous Hedgehog signalling is undetectable in PC-3 prostate cancer cells,Biochemical & Biophysical Research Communications,,,Article,2008-08-14,10.1016/j.bbrc.2008.05.169,,,,18544338,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/7284736,https://api.altmetric.com/v1/donut/7284736_240.png 0,Differential expression of PCA3 and BMCC1 in prostate cancer,The Prostate,,,Article,2009-12-01,10.1002/pros.21068,,,,19852006,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7284105,https://api.altmetric.com/v1/donut/7284105_240.png 0,"Cholesterol Homeostasis in Two Commonly Used Human Prostate Cancer Cell-Lines, LNCaP and PC-3",PLoS ONE,,,Article,2009-12-30,10.1371/journal.pone.0008496,,,,20041144,PMC2794383,,2009PLoSO...4.8496K,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/7284025,https://api.altmetric.com/v1/donut/7284025_240.png 0,Bone disease in prostate cancer,Asia Pacific Journal of Clinical Oncology,,,Article,2010-03-15,10.1111/j.1743-7563.2010.01281.x,,,,20398032,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7283836,https://api.altmetric.com/v1/donut/7283836_240.png 0,Modeling prostate cancer: a perspective on transgenic mouse models,Cancer and Metastasis Reviews,,,Article,2010-03-15,10.1007/s10555-010-9212-9,,,,20143131,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/7269352,https://api.altmetric.com/v1/donut/7269352_240.png 0,"Growth inhibition, nuclear uptake, and retention of anthracycline-formaldehyde conjugates in prostate cancer cells relative to clinical anthracyclines.",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,1999-03-01,,,,,10368676,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/7177457,https://api.altmetric.com/v1/donut/7177457_240.png 0,Dynamics of spheroid self-assembly in liquid-overlay culture of DU 145 human prostate cancer cells.,Biotechnology & Bioengineering,,,Article,2001-03-20,10.1002/1097-0290(20010320)72:6<579::aid-bit1023>3.0.co;2-l,,,,11460249,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/7176763,https://api.altmetric.com/v1/donut/7176763_240.png 0,Aggregation kinetics of well and poorly differentiated human prostate cancer cells,Biotechnology & Bioengineering,,,Article,2002-12-05,10.1002/bit.10394,,,,12355469,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/7176188,https://api.altmetric.com/v1/donut/7176188_240.png 0,Studies of Targeting and Intracellular Trafficking of an Anti-Androgen Doxorubicin?Formaldehyde Conjugate in PC-3 Prostate Cancer Cells Bearing Androgen Receptor-GFP Chimera,Journal of Medicinal Chemistry,,,Article,2004-11-04,10.1021/jm0495226,,,,15509168,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/7175237,https://api.altmetric.com/v1/donut/7175237_240.png 0,A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer,British Journal of Urology,,,Article,2010-07-14,10.1111/j.1464-410x.2009.09078.x,,,,19922545,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/7172492,https://api.altmetric.com/v1/donut/7172492_240.png 0,Abstract 4681: Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish arm of the European randomised study of screening for prostate cancer (ERSPC),Cancer Research,,,Article,2015-08-02,10.1158/1538-7445.am2015-4681,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7134535,https://api.altmetric.com/v1/donut/7134535_240.png 0,"Prostate Cancer, Birthweight, and Diet",Epidemiology,,,Article,1998-03-01,10.1097/00001648-199803000-00024,,,,9504297,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7111103,https://api.altmetric.com/v1/donut/7111103_240.png 0,An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients,Cancer Treatment Communications,,,Article,2015-01-01,10.1016/j.ctrc.2015.11.003,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7109301,https://api.altmetric.com/v1/donut/7109301_240.png 0,Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?,American Journal of Roentgenology,,,Article,2016-04-11,10.2214/ajr.15.15878,,,,27064383,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7109162,https://api.altmetric.com/v1/donut/7109162_240.png 0,Multigene Methylation Biomarker Analysis in Prostate Cancer,Epigenetic Diagnosis & Therapy,,,Article,2015-04-17,10.2174/2214083201666150221001559,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7100504,https://api.altmetric.com/v1/donut/7100504_240.png 0,"Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.",Cancer Research,,,Article,1996-11-01,,,,,8895739,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/7067793,https://api.altmetric.com/v1/donut/7067793_240.png 0,HDR brachytherapy combined with external beam radiation for localised prostate cancer: Early experience from the Sydney Cancer Centre,Journal of Medical Imaging & Radiation Oncology,,,Article,2012-04-14,10.1111/j.1754-9485.2012.02358.x,,,,22498197,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/7046061,https://api.altmetric.com/v1/donut/7046061_240.png 0,AMINOGLUTETHIMIDE AND PROSTATIC CANCER,The Lancet,,,Article,1980-12-20,10.1016/s0140-6736(80)92440-x,,,,6109190,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7042109,https://api.altmetric.com/v1/donut/7042109_240.png 0,A Novel Prostate Cancer Classification Technique Using Intermediate Memory Tabu Search,EURASIP Journal on Advances in Signal Processing,,,Article,2005-01-01,10.1155/asp.2005.2241,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/7032408,https://api.altmetric.com/v1/donut/7032408_240.png 0,Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells.,Cancer Research,,,Article,1998-10-15,,,,,9788603,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/7028707,https://api.altmetric.com/v1/donut/7028707_240.png 0,Portrayals of treatment decision-making on popular breast and prostate cancer web sites,European Journal of Cancer Care,,,Article,2005-05-14,10.1111/j.1365-2354.2005.00544.x,,,,15842467,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/7026038,https://api.altmetric.com/v1/donut/7026038_240.png 0,Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence,British Journal of Urology,,,Article,2000-06-01,10.1046/j.1464-410x.2000.00659.x,,,,10848691,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6778305,https://api.altmetric.com/v1/donut/6778305_240.png 0,Abstract 2001: Identification of lactate dehydrogenase A (LDHA) as a potential therapeutic target for prostate cancer radiotherapy,Cancer Research,,,Article,2015-08-02,10.1158/1538-7445.am2015-2001,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6776133,https://api.altmetric.com/v1/donut/6776133_240.png 0,Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer,British Journal of Urology,,,Article,2014-07-01,10.1111/bju.12858,,,,24989062,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6774970,https://api.altmetric.com/v1/donut/6774970_240.png 0,Experimental investigation of the cytotoxicity of medium-borne signals in human prostate cancer cell line,Acta Oncologica,,,Article,2012-11-15,10.3109/0284186x.2012.670264,,,,22524215,,11541.2/116547,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6735599,https://api.altmetric.com/v1/donut/6735599_240.png 0,Assessment of normal tissue complications following prostate cancer irradiation: Comparison of radiation treatment modalities using NTCP models,Medical Physics,,,Article,2010-01-01,10.1118/1.3481514,,,,,,11541.2/116439,2010MedPh..37.5126T,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6735585,https://api.altmetric.com/v1/donut/6735585_240.png 0,Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death,Radiotherapy & Oncology,,,Article,2013-05-14,10.1016/j.radonc.2013.03.030,,,,23623726,,1959.8/153874,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6733369,https://api.altmetric.com/v1/donut/6733369_240.png 0,Insulin-like growth factor-1 and 17?-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells,International Journal of Molecular Medicine,,,Article,2011-09-14,10.3892/ijmm.2011.691,,,,21567071,,11541.2/119996,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6731919,https://api.altmetric.com/v1/donut/6731919_240.png 0,Steroid 5- -Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review,American Journal of Epidemiology,,,Article,2010-01-01,10.1093/aje/kwp318,,,,19914946,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6719713,https://api.altmetric.com/v1/donut/6719713_240.png 0,"Medical history, body size, and cigarette smoking in relation to fatal prostate cancer.",Cancer Causes and Control,,,Article,2009-10-09,10.1007/s10552-009-9441-9[doi,,,,19816779,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6719666,https://api.altmetric.com/v1/donut/6719666_240.png 0,Years of potential life lost caused by prostate cancer deaths in the United States—Projection from 2004 through 2050,Cancer Epidemiology,,,Article,2010-08-14,10.1016/j.canep.2010.04.015,,,,20510666,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6719217,https://api.altmetric.com/v1/donut/6719217_240.png 0,Treatment for Older Prostate Cancer Patients,Medical care,,,Article,2010-10-14,10.1097/mlr.0b013e3181eb31a8,,,,20733530,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6718797,https://api.altmetric.com/v1/donut/6718797_240.png 0,Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene,Cancer Epidemiology,,,Article,2010-08-14,10.1016/j.canep.2010.04.009,,,,20466611,PMC2939726,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6718776,https://api.altmetric.com/v1/donut/6718776_240.png 0,The Effect of Race and Rural Residence on Prostate Cancer Treatment Choice Among Men in Georgia,Urology,,,Article,2011-03-15,10.1016/j.urology.2010.10.020,,,,21377006,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6717767,https://api.altmetric.com/v1/donut/6717767_240.png 0,"Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population",International Journal of General Medicine,,,Article,2011-06-01,10.2147/ijgm.s19609,,,,21760749,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6717327,https://api.altmetric.com/v1/donut/6717327_240.png 0,Primary Care Physician Reports of Amount of Time Spent with Male Patients in Prostate Cancer Screening Discussions,Journal of Primary Care & Community Health,,,Article,2011-06-30,10.1177/2150131911402087,,,,23804801,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6717308,https://api.altmetric.com/v1/donut/6717308_240.png 0,Prostate cancer treatment ascertained from several sources: analysis of disagreement and error,Annals of Oncology,,,Article,2012-01-15,10.1093/annonc/mdr040,,,,21471565,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6716627,https://api.altmetric.com/v1/donut/6716627_240.png 0,The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system,British Journal of Urology,,,Article,2008-08-14,10.1111/j.1464-410x.2008.07611.x,,,,18336608,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6716233,https://api.altmetric.com/v1/donut/6716233_240.png 0,The MTHFR 677C?T polymorphism and risk of prostate cancer: results from the CAPS study,Cancer Causes and Control,,,Article,2007-12-15,10.1007/s10552-007-9055-z,,,,17846906,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6716232,https://api.altmetric.com/v1/donut/6716232_240.png 0,Risk of prostate cancer among cancer survivors in the Netherlands,Cancer Epidemiology,,,Article,2013-04-14,10.1016/j.canep.2012.11.004,,,,23265853,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6716230,https://api.altmetric.com/v1/donut/6716230_240.png 0,Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis,Cancer Causes and Control,,,Article,2011-03-15,10.1007/s10552-010-9706-3,,,,21203822,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6716226,https://api.altmetric.com/v1/donut/6716226_240.png 0,"A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study).",,,,Article,2010-03-31,,,,,21537389,PMC3076770,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6716222,https://api.altmetric.com/v1/donut/6716222_240.png 0,Commentary on the State-of-the-Science Conference on the Role of Active Surveillance in the Management of Men With Localized Prostate Cancer,Journal of the National Cancer Institute. Monographs,,,Article,2012-12-15,10.1093/jncimonographs/lgs040,,,,23271762,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6715364,https://api.altmetric.com/v1/donut/6715364_240.png 0,"Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008",The Prostate,,,Article,2015-01-25,10.1002/pros.22958,,,,25619191,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6713519,https://api.altmetric.com/v1/donut/6713519_240.png 0,Detecting soluble Clusterin in in-vitro and in-vivo models of prostate cancer,Neoplasma,,,Article,2010-01-01,10.4149/neo_2010_05_488,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6711875,https://api.altmetric.com/v1/donut/6711875_240.png 0,External Validation of the 2007 and 2001 Partin Tables in Irish Prostate Cancer Patients,Urologia Internationalis,,,Article,2010-01-01,10.1159/000277594,,,,20215821,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6711872,https://api.altmetric.com/v1/donut/6711872_240.png 0,Role of targeted therapy in the treatment of advanced prostate cancer,British Journal of Urology,,,Article,2010-03-15,10.1111/j.1464-410x.2010.09236.x,,,,20353536,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6711869,https://api.altmetric.com/v1/donut/6711869_240.png 0,Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4?+?3 as high or intermediate grade,British Journal of Urology,,,Article,2010-03-15,10.1111/j.1464-410x.2009.08810.x,,,,19732053,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6711868,https://api.altmetric.com/v1/donut/6711868_240.png 0,Evaluation of Zinc-?-2-Glycoprotein and Proteasome Subunit ?-Type 6 Expression in Prostate Cancer Using Tissue Microarray Technology,Applied immunohistochemistry molecular morphology AIMM,,,Article,2010-07-22,10.1097/pai.0b013e3181e29998,,,,20661134,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6711865,https://api.altmetric.com/v1/donut/6711865_240.png 0,PHYTOESTROGENS DERIVED FROM BELAMCANDA CHINENSIS HAVE AN ANTIPROLIFERATIVE EFFECT ON PROSTATE CANCER CELLS IN VITRO,The Journal of Urology,,,Article,2004-12-01,10.1097/01.ju.0000143537.86596.66,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6711864,https://api.altmetric.com/v1/donut/6711864_240.png 0,Core fucosylation and 2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia,Glycobiology,,,Article,2011-02-15,10.1093/glycob/cwq147,,,,20861084,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6711860,https://api.altmetric.com/v1/donut/6711860_240.png 0,Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: A review,Biomarkers,,,Article,2008-10-08,10.1080/13547500600799821,,,,16966158,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6711858,https://api.altmetric.com/v1/donut/6711858_240.png 0,Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines,Prostate Cancer & Prostatic Diseases,,,Article,2008-05-13,10.1038/pcan.2008.23,,,,18475288,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6711854,https://api.altmetric.com/v1/donut/6711854_240.png 0,"Targeting Death Receptors in Bladder, Prostate and Renal Cancer",The Journal of Urology,,,Article,2006-02-15,10.1016/s0022-5347(05)00160-6,,,,16406966,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6711852,https://api.altmetric.com/v1/donut/6711852_240.png 0,Prostate Cancer,,,,Article,2003-01-01,10.1016/b978-012286981-5/50007-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6711849,https://api.altmetric.com/v1/donut/6711849_240.png 0,"Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis",The Prostate,,,Article,2011-02-01,10.1002/pros.21227,,,,20665530,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6711848,https://api.altmetric.com/v1/donut/6711848_240.png 0,Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms,The Prostate,,,Article,2007-11-01,10.1002/pros.20653,,,,17823925,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6711847,https://api.altmetric.com/v1/donut/6711847_240.png 0,An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNF? mediated apoptosis,The Prostate,,,Article,2004-05-31,10.1002/pros.10371,,,,15065090,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6711846,https://api.altmetric.com/v1/donut/6711846_240.png 0,"Resistance to caspase-dependent, hypoxia-induced apoptosis is not hypoxia-inducible factor-1 alpha mediated in prostate carcinoma cells",Cancer (0008543X),,,Article,2005-03-31,10.1002/cncr.20918,,,,15719438,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6711465,https://api.altmetric.com/v1/donut/6711465_240.png 0,"Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells",International Journal of Cancer,,,Article,2007-11-20,10.1002/ijc.23185,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6711051,https://api.altmetric.com/v1/donut/6711051_240.png 0,Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA,Glycobiology,,,Article,2006-02-15,10.1093/glycob/cwj042,,,,16177264,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/6710744,https://api.altmetric.com/v1/donut/6710744_240.png 0,Commercialized biomarkers: new horizons in prostate cancer diagnostics,Expert Review of Molecular Diagnostics,,,Article,2015-02-24,10.1586/14737159.2015.1011622,,,,25711191,,10197/7433,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6710087,https://api.altmetric.com/v1/donut/6710087_240.png 0,The emerging roles of DNA methylation in the clinical management of prostate cancer,Endocrine-Related Cancer,,,Article,2006-06-14,10.1677/erc.1.01184,,,,16728568,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6709991,https://api.altmetric.com/v1/donut/6709991_240.png 0,Docetaxel maintains its cytotoxic activity under hypoxic conditions in prostate cancer cells,Urologic Oncology,,,Article,2012-11-01,10.1016/j.urolonc.2010.08.015,,,,21176881,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6709990,https://api.altmetric.com/v1/donut/6709990_240.png 0,"Biomarker research in prostate cancer—towards utility, not futility",Nature Reviews Urology,,,Article,2011-03-15,10.1038/nrurol.2011.11,,,,21394176,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6709986,https://api.altmetric.com/v1/donut/6709986_240.png 0,"Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation",Molecular Cancer,,,Article,2009-06-22,10.1186/1476-4598-8-39,,,,19549337,PMC2706796,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6709707,https://api.altmetric.com/v1/donut/6709707_240.png 0,Inhibitors of apoptosis proteins in prostate cancer cell lines,The Prostate,,,Article,2002-05-01,10.1002/pros.10061,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6709694,https://api.altmetric.com/v1/donut/6709694_240.png 0," Hypoxia increases normal prostate epithelial cell resistance to receptor-mediated apoptosis via AKT activation ",International Journal of Cancer,,,Article,2009-04-14,10.1002/ijc.24145,,,,19142871,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6709692,https://api.altmetric.com/v1/donut/6709692_240.png 0,2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer,Journal of Proteome Research,,,Article,2009-02-15,10.1021/pr800570s,,,,19093873,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6709631,https://api.altmetric.com/v1/donut/6709631_240.png 0,Effects of the dual 5 ?-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines,Cancer (0008543X),,,Article,2006-06-14,10.1002/cncr.21938,,,,16703599,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6709630,https://api.altmetric.com/v1/donut/6709630_240.png 0,"The creation, internal validation and external validation of a novel clinical prediction model for the early diagnosis of prostate cancer",International Journal of Surgery,,,Article,2015-11-01,10.1016/j.ijsu.2015.07.573,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6707807,https://api.altmetric.com/v1/donut/6707807_240.png 0,Analysis of pro [-2] PSA: A novel biomarker that significantly improves the detection of prostate cancer,International Journal of Surgery,,,Article,2015-11-01,10.1016/j.ijsu.2015.07.016,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6707806,https://api.altmetric.com/v1/donut/6707806_240.png 0,19 The creation and internal validation of a novel risk stratification tool for the early diagnosis of prostate cancer,European Urology Supplements,,,Article,2015-04-01,10.1016/s1569-9056(15)60022-7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6705651,https://api.altmetric.com/v1/donut/6705651_240.png 0,Gene-based therapy in prostate cancer,Lancet Oncology,,,Article,2004-08-14,10.1016/s1470-2045(04)01525-6,,,,15288235,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6705520,https://api.altmetric.com/v1/donut/6705520_240.png 0,Androgen hypersensitivity in prostate cancer: Molecular perspectives on androgen deprivation therapy strategies,The Prostate,,,Article,2011-04-14,10.1002/pros.21266,,,,20945429,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6705519,https://api.altmetric.com/v1/donut/6705519_240.png 0,Urinary markers for prostate cancer,British Journal of Urology,,,Article,2007-02-15,10.1111/j.1464-410x.2006.06610.x,,,,17092277,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6704756,https://api.altmetric.com/v1/donut/6704756_240.png 0,Androgens target prohibitin to regulate proliferation of prostate cancer cells,Oncogene,,,Article,2004-04-14,10.1038/sj.onc.1207444,,,,14968116,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6704749,https://api.altmetric.com/v1/donut/6704749_240.png 0,"National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers",Clinical Chemistry,,,Article,2008-12-15,10.1373/clinchem.2008.105601,,,,19042984,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,83,https://www.altmetric.com/details/6704669,https://api.altmetric.com/v1/donut/6704669_240.png 0,Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?,Annals of Clinical Biochemistry,,,Article,2011-07-14,10.1258/acb.2011.010273,,,,21525152,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6704666,https://api.altmetric.com/v1/donut/6704666_240.png 0,Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA Level of 2–10 ng/ml: Systematic Review and Meta-Analysis,European Urology,,,Article,2005-09-14,10.1016/j.eururo.2005.04.015,,,,15982797,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6704641,https://api.altmetric.com/v1/donut/6704641_240.png 0,Ensemble based system for whole-slide prostate cancer probability mapping using color texture features,Computerized Medical Imaging & Graphics,,,Article,2011-10-01,10.1016/j.compmedimag.2010.12.005,,,,21269807,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/6703819,https://api.altmetric.com/v1/donut/6703819_240.png 0,Applying Random Forests To Identify Biomarker Panels in Serum 2D-DIGE Data for the Detection and Staging of Prostate Cancer,Journal of Proteome Research,,,Article,2011-03-04,10.1021/pr1011069,,,,21166384,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6702598,https://api.altmetric.com/v1/donut/6702598_240.png 0,The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells,Biomolecules,,,Article,2013-06-10,10.3390/biom3020316,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6697273,https://api.altmetric.com/v1/donut/6697273_240.png 0,"Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells",Oncotarget,,,Article,2016-03-29,10.18632/oncotarget.7693,,,,26934645,PMC4941342,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6696847,https://api.altmetric.com/v1/donut/6696847_240.png 0,Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery,PLoS ONE,,,Article,2013-06-18,10.1371/journal.pone.0065880,,,,23823321,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6696562,https://api.altmetric.com/v1/donut/6696562_240.png 0,In Vitro Model of Metastasis to Bone Marrow Mediates Prostate Cancer Castration Resistant Growth through Paracrine and Extracellular Matrix Factors,PLoS ONE,,,Article,2012-08-01,10.1371/journal.pone.0040372,,,,22870197,PMC3411611,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6696554,https://api.altmetric.com/v1/donut/6696554_240.png 0,HIP1 as a marker of aggressive prostate cancer,Clinical Genetics,,,Article,2002-11-11,10.1034/j.1399-0004.2002.620503_4.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6687042,https://api.altmetric.com/v1/donut/6687042_240.png 0,"Variation of Prostate-specific Antigen Value in Men and Risk of High-grade Prostate Cancer: Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study",Urology,,,Article,2015-05-01,10.1016/j.urology.2015.02.013,,,,25917734,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6685345,https://api.altmetric.com/v1/donut/6685345_240.png 0,Nuclear factor ?B predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor,Human Pathology,,,Article,2012-09-14,10.1016/j.humpath.2011.11.009,,,,22406367,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6683889,https://api.altmetric.com/v1/donut/6683889_240.png 0,Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group,European Urology,,,Article,2009-06-14,10.1016/j.eururo.2009.02.016,,,,19249153,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6683812,https://api.altmetric.com/v1/donut/6683812_240.png 0,The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells,Cellular Signalling,,,Article,2013-04-14,10.1016/j.cellsig.2013.01.002,,,,23314175,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6683296,https://api.altmetric.com/v1/donut/6683296_240.png 0,GRP Receptor Imaging of Prostate Cancer Using [99mTc]Demobesin 4: a First-in-Man Study,Molecular Imaging & Biology,,,Article,2014-06-10,10.1007/s11307-014-0754-z,,,,24915934,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6682563,https://api.altmetric.com/v1/donut/6682563_240.png 0,Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk,Cancer Research,,,Article,2004-02-01,10.1158/0008-5472.can-03-2670,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6678603,https://api.altmetric.com/v1/donut/6678603_240.png 0,Organochlorines and Risk of Prostate Cancer,Journal of Occupational & Environmental Medicine,,,Article,2003-07-01,10.1097/01.jom.0000071510.96740.0b,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6677222,https://api.altmetric.com/v1/donut/6677222_240.png 0,CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE Review,American Journal of Epidemiology,,,Article,2004-11-01,10.1093/aje/kwh294,,,,15496535,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6676692,https://api.altmetric.com/v1/donut/6676692_240.png 0,Comorbidity and Primary Treatment for Localized Prostate Cancer: Data From CaPSURE™,The Journal of Urology,,,Article,2006-04-14,10.1016/s0022-5347(05)00647-6,,,,16515991,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6672065,https://api.altmetric.com/v1/donut/6672065_240.png 0,Health-related quality of life for men with prostate cancer and diabetes: A longitudinal analysis from CaPSURE,Urology,,,Article,2006-12-15,10.1016/j.urology.2006.08.1096,,,,17141841,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6671892,https://api.altmetric.com/v1/donut/6671892_240.png 0,Quality of Life for Men Receiving a Second Treatment for Prostate Cancer,The Journal of Urology,,,Article,2007-01-15,10.1016/j.juro.2006.08.061,,,,17162062,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6671551,https://api.altmetric.com/v1/donut/6671551_240.png 0,Prostate cancer incidence and survival in relation to education (United States),Cancer Causes and Control,,,Article,2004-11-15,10.1007/s10552-004-2231-5,,,,15577296,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6669667,https://api.altmetric.com/v1/donut/6669667_240.png 0,Abstract 4606: Fine mapping of 64 prostate cancer GWAS regions identifies multiple novel association signals,Cancer Research,,,Article,2015-08-02,10.1158/1538-7445.am2015-4606,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6661873,https://api.altmetric.com/v1/donut/6661873_240.png 0,Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry,Oncotarget,,,Article,2016-02-22,10.18632/oncotarget.6983,,,,26814433,PMC4891008,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6656655,https://api.altmetric.com/v1/donut/6656655_240.png 0,A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing,British Journal of Urology,,,Article,2013-03-15,10.1111/j.1464-410x.2012.11316.x,,,,23030810,,1893/11692,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6650429,https://api.altmetric.com/v1/donut/6650429_240.png 0,The use of Circulating Tumor Cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer,Cancer Treatment Reviews,,,Article,2016-04-12,10.1016/j.ctrv.2016.04.001,,,,27107266,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6635762,https://api.altmetric.com/v1/donut/6635762_240.png 0,RACGP training registrars' perceptions and practice of prostate cancer screening.,Australian Family Physician,,,Article,2004-03-15,,,,,15054989,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6613220,https://api.altmetric.com/v1/donut/6613220_240.png 0,The Patient’s Dilemma: Prostate Cancer Treatment Choices,The Journal of Urology,,,Article,2003-03-01,10.1097/01.ju.0000052056.27609.8a,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6590170,https://api.altmetric.com/v1/donut/6590170_240.png 0,Synthesis and biological evaluation of nitric oxide-donating analogues of sulindac for prostate cancer treatment,Bioorganic & Medicinal Chemistry,,,Article,2013-12-12,10.1016/j.bmc.2013.12.014,,,,24387865,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6583887,https://api.altmetric.com/v1/donut/6583887_240.png 0,Admixture mapping of prostate cancer in African Americans participating in the North Carolina-Louisiana Prostate Cancer Project (PCaP),The Prostate,,,Article,2013-09-03,10.1002/pros.22722,,,,24037755,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6583666,https://api.altmetric.com/v1/donut/6583666_240.png 0,Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safety,Prostate Cancer & Prostatic Diseases,,,Article,1998-04-29,10.1038/sj.pcan.4500220,,,,12496911,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6574444,https://api.altmetric.com/v1/donut/6574444_240.png 0,European Association of Urology Position Statement on Screening for Prostate Cancer,European Urology,,,Article,2009-08-14,10.1016/j.eururo.2009.05.024,,,,19481336,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6574367,https://api.altmetric.com/v1/donut/6574367_240.png 0,Prostate cancer proteomics: The urgent need for clinically validated biomarkers,PROTEOMICS - Clinical Applications,,,Article,2009-02-01,10.1002/prca.200800154,,,,26238619,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6573898,https://api.altmetric.com/v1/donut/6573898_240.png 0,Eight-plex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression: An exploratory study,The Prostate,,,Article,2010-08-31,10.1002/pros.21167,,,,20623638,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6573897,https://api.altmetric.com/v1/donut/6573897_240.png 0,Prognostic Value of Biochemical Response to Neoadjuvant Androgen Deprivation before External Beam Radiotherapy for Prostate Cancer: A Systematic Review of the Literature,Cancer Treatment Reviews,,,Article,2016-04-07,10.1016/j.ctrv.2016.03.016,,,,27082769,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6549521,https://api.altmetric.com/v1/donut/6549521_240.png 0,"The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population",Infectious Agents and Cancer,,,Article,2007-03-02,10.1186/1750-9378-2-6,,,,17331260,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6466011,https://api.altmetric.com/v1/donut/6466011_240.png 0,Geographical epidemiology of prostate cancer: is there an association with infection?,Cancer surveys,,,Article,1995-01-01,,,,,7621476,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6465960,https://api.altmetric.com/v1/donut/6465960_240.png 0,PD46-08 PROSPECTIVE STUDY OF PRE-BIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MPMRI) COMPARED TO TRANSPERINEAL TEMPLATE MAPPING BIOPSY (TTMB) FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: IS IT ACCURATE ENOUGH TO GUIDE SELECTION OF MEN FOR BIOPSY?,The Journal of Urology,,,Article,2015-04-01,10.1016/j.juro.2015.02.2739,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6464500,https://api.altmetric.com/v1/donut/6464500_240.png 0,ITRAQ-FACILITATED PROTEOMIC ANALYSIS OF HUMAN PROSTATE CANCER CELLS IDENTIFIES PROTEINS ASSOCIATED WITH PROGRESSION,European Urology Supplements,,,Article,2008-03-01,10.1016/s1569-9056(08)60721-6,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6438135,https://api.altmetric.com/v1/donut/6438135_240.png 0,Identifying Clinically Significant Prostate Cancers using 3-D in Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology Validation,Ultrasound in Medicine & Biology,,,Article,2016-03-01,10.1016/j.ultrasmedbio.2016.01.004,,,,26947445,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6436566,https://api.altmetric.com/v1/donut/6436566_240.png 0,RAISED BLOOD PRESSURE PREDICTS PROSTATE CANCER AND ELEVATED PSA IN A LARGE UNSELECTED POPULATION OF MEN PARTICIPATING IN THE PROTECT STUDY,European Urology Supplements,,,Article,2008-03-01,10.1016/s1569-9056(08)60505-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6433661,https://api.altmetric.com/v1/donut/6433661_240.png 0,Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina-Louisiana Prostate Cancer Project,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2016-04-01,10.1158/1055-9965.epi-15-0631,,,,26819265,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6418682,https://api.altmetric.com/v1/donut/6418682_240.png 0,Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A,Cellular Physiology & Biochemistry,,,Article,2015-06-25,10.1159/000430286,,,,26111475,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6372701,https://api.altmetric.com/v1/donut/6372701_240.png 0,Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging,PLoS ONE,,,Article,2015-06-25,10.1371/journal.pone.0127419,,,,26111008,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6372698,https://api.altmetric.com/v1/donut/6372698_240.png 0,"Presentation, management, and outcomes of complications following prostate cancer therapy.",Translational andrology and urology,,,Article,2014-06-01,10.3978/j.issn.2223-4683.2014.04.05,,,,26816763,PMC4708165,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6369905,https://api.altmetric.com/v1/donut/6369905_240.png 0,Urethroplasty After Radiation Therapy for Prostate Cancer,Urology,,,Article,2012-06-14,10.1016/j.urology.2011.11.077,,,,22521189,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6369902,https://api.altmetric.com/v1/donut/6369902_240.png 0,Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer,BMC Research Notes,,,Article,2015-08-05,10.1186/s13104-015-1297-3,,,,26242866,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6340510,https://api.altmetric.com/v1/donut/6340510_240.png 0,Effectiveness and cost-effectiveness of prognostic markers in prostate cancer,British Journal of Cancer,,,Article,2003-01-13,10.1038/sj.bjc.6600630,,,,12556955,PMC2376796,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6337288,https://api.altmetric.com/v1/donut/6337288_240.png 0,Re: Knowledge and Use of Finasteride for the Prevention of Prostate Cancer,The Journal of Urology,,,Article,2011-08-01,10.1016/j.juro.2011.04.051,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6337075,https://api.altmetric.com/v1/donut/6337075_240.png 0,Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review.,Health technology assessment : HTA / NHS R & D HTA Programme.,,,Article,2016-04-02,10.3310/htal3050,,,,19128541,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6337073,https://api.altmetric.com/v1/donut/6337073_240.png 0,Prostate-specific Antigen Bounce After Intensity-modulated Radiotherapy for Prostate Cancer,Urology,,,Article,2010-09-14,10.1016/j.urology.2009.04.074,,,,19616279,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6288832,https://api.altmetric.com/v1/donut/6288832_240.png 0,Recall and attitudes in patients with prostate cancer,Urology,,,Article,1999-01-01,10.1016/s0090-4295(98)00456-7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6288620,https://api.altmetric.com/v1/donut/6288620_240.png 0,Therapeutic Targets for Metastatic Prostate Cancer,Current Drug Targets,,,Article,2003-04-01,10.2174/1389450033491127,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6288618,https://api.altmetric.com/v1/donut/6288618_240.png 0,CTV margins in prostate cancer irradiation. In regard to Teh et al.: IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease (int j radiat oncol biol phys 2003;56:184–191,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-04-30,10.1016/j.ijrobp.2004.01.008,,,,15093933,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6288509,https://api.altmetric.com/v1/donut/6288509_240.png 0,EFFECTS OF SYSTEMATIC 12-CORE BIOPSY ON THE PERFORMANCE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR PROSTATE CANCER DETECTION,The Journal of Urology,,,Article,2004-09-14,10.1097/01.ju.0000134619.72675.8d,,,,15310993,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6288008,https://api.altmetric.com/v1/donut/6288008_240.png 0,Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer,Urologic Oncology,,,Article,2008-09-01,10.1016/j.urolonc.2008.03.002,,,,18774459,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6287777,https://api.altmetric.com/v1/donut/6287777_240.png 0,"Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer",Urologic Oncology,,,Article,2013-02-15,10.1016/j.urolonc.2010.11.005,,,,21719325,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6287730,https://api.altmetric.com/v1/donut/6287730_240.png 0,Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer,Molecular Therapy,,,Article,2001-04-01,10.1006/mthe.2001.0298,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6287664,https://api.altmetric.com/v1/donut/6287664_240.png 0,Biological Response Determinants in HSV-tk + Ganciclovir Gene Therapy for Prostate Cancer,Molecular Therapy,,,Article,2006-04-14,10.1016/j.ymthe.2005.11.022,,,,16480930,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6287551,https://api.altmetric.com/v1/donut/6287551_240.png 0,Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance,Human Pathology,,,Article,2014-05-22,10.1016/j.humpath.2014.05.004,,,,24993314,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6287480,https://api.altmetric.com/v1/donut/6287480_240.png 0,Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-05-31,10.1016/j.ijrobp.2004.01.020,,,,15145177,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6287428,https://api.altmetric.com/v1/donut/6287428_240.png 0,Combining Radiotherapy with Gene Therapy (From the Bench to the Bedside): A Novel Treatment Strategy for Prostate Cancer,Oncologist,,,Article,2002-10-01,10.1634/theoncologist.7-5-458,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6287376,https://api.altmetric.com/v1/donut/6287376_240.png 0,Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824,Molecular Cancer Therapeutics,,,Article,2005-09-14,10.1158/1535-7163.mct-04-0287,,,,16170022,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6287175,https://api.altmetric.com/v1/donut/6287175_240.png 0,Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers,PROTEOMICS,,,Article,2003-01-01,10.1002/pmic.200390009,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6287078,https://api.altmetric.com/v1/donut/6287078_240.png 0,The Danger of Applying Group-level Utilities in Decision Analyses of the Treatment of Localized Prostate Cancer in Individual Patients,Medical Decision Making,,,Article,1998-10-01,10.1177/0272989x9801800404,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6286959,https://api.altmetric.com/v1/donut/6286959_240.png 0,Familial aggregation of prostate cancer in African-Americans and white Americans,The Prostate,,,Article,2003-09-01,10.1002/pros.10252,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6286797,https://api.altmetric.com/v1/donut/6286797_240.png 0,Transforming growth factor ?1 as a biomarker for prostate cancer,Journal of Cellular Biochemistry,,,Article,1992-01-01,10.1002/jcb.240501212,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6286250,https://api.altmetric.com/v1/donut/6286250_240.png 0,Tolerance of Endorectal Balloon in 396 Patients Treated With Intensity-Modulated Radiation Therapy (IMRT) for Prostate Cancer,American Journal of Clinical Oncology: Cancer Clinical Trials,,,Article,2006-02-15,10.1097/01.coc.0000195099.26957.63,,,,16462495,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6286207,https://api.altmetric.com/v1/donut/6286207_240.png 0,Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models,The Prostate,,,Article,2012-09-30,10.1002/pros.22509,,,,22415461,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6285958,https://api.altmetric.com/v1/donut/6285958_240.png 0,Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose–volume analysis,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2001-03-01,10.1016/s0360-3016(00)01428-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6285887,https://api.altmetric.com/v1/donut/6285887_240.png 0,Testosterone replacement therapy in the setting of prostate cancer treated with radiation,International Journal of Impotence Research,,,Article,2013-01-15,10.1038/ijir.2012.29,,,,22971614,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6285768,https://api.altmetric.com/v1/donut/6285768_240.png 0,The emerging role of the PI3-K-Akt pathway in prostate cancer progression,Prostate Cancer & Prostatic Diseases,,,Article,2005-02-22,10.1038/sj.pcan.4500776,,,,15724144,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6285639,https://api.altmetric.com/v1/donut/6285639_240.png 0,A feasibility study of magnetic resonance electrical impedance tomography for prostate cancer detection,Physiological Measurement,,,Article,2014-03-12,10.1088/0967-3334/35/4/567,,,,24621653,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6285447,https://api.altmetric.com/v1/donut/6285447_240.png 0,Estrogen Receptors ?1 and ?2 Have Opposing Roles in Regulating Proliferation and Bone Metastasis Genes in the Prostate Cancer Cell Line PC3,Molecular Endocrinology,,,Article,2012-12-15,10.1210/me.2012.1227,,,,23028063,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6285336,https://api.altmetric.com/v1/donut/6285336_240.png 0,Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer,The Prostate,,,Article,2004-09-30,10.1002/pros.20097,,,,15305337,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6285214,https://api.altmetric.com/v1/donut/6285214_240.png 0,Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer,Neoplasia,,,Article,2008-11-01,10.1593/neo.08922,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6285033,https://api.altmetric.com/v1/donut/6285033_240.png 0,Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression,The Prostate,,,Article,2003-01-01,10.1002/pros.10163,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6284985,https://api.altmetric.com/v1/donut/6284985_240.png 0,The Effects of a Presurgical Stress Management Intervention for Men With Prostate Cancer Undergoing Radical Prostatectomy,Journal of Clinical Oncology,,,Article,2009-06-30,10.1200/jco.2007.16.0036,,,,19349551,PMC2716938,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6284690,https://api.altmetric.com/v1/donut/6284690_240.png 0,Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism,Clinical Cancer Research,,,Article,2005-03-01,10.1158/1078-0432.ccr-04-1877,,,,15756026,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6284655,https://api.altmetric.com/v1/donut/6284655_240.png 0,IMRT for prostate cancer: Defining target volume based on correlated pathologic volume of disease,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2003-05-01,10.1016/s0360-3016(03)00085-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6284508,https://api.altmetric.com/v1/donut/6284508_240.png 0,Editorial: Prostate Cancer--Staging and Prognosis,The Journal of Urology,,,Article,1996-04-01,10.1016/s0022-5347(01)66265-7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6284043,https://api.altmetric.com/v1/donut/6284043_240.png 0,"Improved Detection of Clinically Significant, Curable Prostate Cancer With Systematic 12-Core Biopsy",The Journal of Urology,,,Article,2004-03-15,10.1097/01.ju.0000112763.74119.d4,,,,14767277,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6284009,https://api.altmetric.com/v1/donut/6284009_240.png 0,Cross-platform method for identifying candidate network biomarkers for prostate cancer,IET Systems Biology,,,Article,2009-11-15,10.1049/iet-syb.2008.0168,,,,19947776,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6283944,https://api.altmetric.com/v1/donut/6283944_240.png 0,IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer,Cancer Gene Therapy,,,Article,2007-10-01,10.1038/sj.cgt.7701084,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6283447,https://api.altmetric.com/v1/donut/6283447_240.png 0,"Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of l-Selenomethionine: a Southwest Oncology Group Study",Clinical Cancer Research,,,Article,2006-03-31,10.1158/1078-0432.ccr-05-0937,,,,16609032,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6283405,https://api.altmetric.com/v1/donut/6283405_240.png 0,CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer,Clinical Cancer Research,,,Article,2007-12-01,10.1158/1078-0432.ccr-07-0842,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6283383,https://api.altmetric.com/v1/donut/6283383_240.png 0,Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee,Cancer Research,,,Article,2004-03-15,10.1158/0008-5472.can-03-0946,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6283375,https://api.altmetric.com/v1/donut/6283375_240.png 0,A Decision Analysis for Treatment of Clinically Localized Prostate Cancer,JGIM: Journal of General Internal Medicine,,,Article,1997-05-01,10.1046/j.1525-1497.1997.012005299.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6283332,https://api.altmetric.com/v1/donut/6283332_240.png 0,Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice,The Prostate,,,Article,2005-11-01,10.1002/pros.20283,,,,15948138,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6283061,https://api.altmetric.com/v1/donut/6283061_240.png 0,Preoperative Clinical and Pathological Characteristics of pT0 Prostate Cancer in Radical Prostatectomy,Korean Journal of Urology,,,Article,2010-06-14,10.4111/kju.2010.51.6.386,,,,20577604,PMC2890054,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6283005,https://api.altmetric.com/v1/donut/6283005_240.png 0,The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer,The American Journal of Surgical Pathology,,,Article,1993-12-01,10.1097/00000478-199312000-00006,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6282798,https://api.altmetric.com/v1/donut/6282798_240.png 0,Stereotactic body radiation therapy for prostate cancer,Future Oncology,,,Article,2011-09-14,10.2217/fon.11.86,,,,21919695,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6282674,https://api.altmetric.com/v1/donut/6282674_240.png 0,Estrogen Receptor Polymorphism Is Associated with Prostate Cancer Risk,Clinical Cancer Research,,,Article,2006-03-15,10.1158/1078-0432.ccr-05-0269,,,,16551880,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6282534,https://api.altmetric.com/v1/donut/6282534_240.png 0,Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer—A preliminary report,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2001-11-01,10.1016/s0360-3016(01)01692-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6282385,https://api.altmetric.com/v1/donut/6282385_240.png 0,Predictors of Extracapsular Extension and Its Radial Distance in Prostate Cancer,Cancer Journal,,,Article,2003-11-01,10.1097/00130404-200311000-00004,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6282380,https://api.altmetric.com/v1/donut/6282380_240.png 0,Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer,Urology,,,Article,2004-05-14,10.1016/j.urology.2003.12.037,,,,15134977,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6282249,https://api.altmetric.com/v1/donut/6282249_240.png 0,Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2004-03-31,10.1016/j.ijrobp.2003.09.083,,,,15050332,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6282206,https://api.altmetric.com/v1/donut/6282206_240.png 0,Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization,Medical Dosimetry,,,Article,2002-06-01,10.1016/s0958-3947(02)00092-4,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6282052,https://api.altmetric.com/v1/donut/6282052_240.png 0,Rectal wall sparing by dosimetric effect of rectal balloon used during Intensity-Modulated Radiation Therapy (IMRT) for prostate cancer,Medical Dosimetry,,,Article,2005-03-01,10.1016/j.meddos.2004.10.005,,,,15749008,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6281963,https://api.altmetric.com/v1/donut/6281963_240.png 0,Entertainment education for prostate cancer screening: A randomized trial among primary care patients with low health literacy,Patient Education & Counseling,,,Article,2008-12-15,10.1016/j.pec.2008.07.033,,,,18760888,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/6281936,https://api.altmetric.com/v1/donut/6281936_240.png 0,Cytopathic effect of in situ gene therapy in prostate cancer,Human Pathology,,,Article,2000-07-01,10.1053/hupa.2000.8453,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6281795,https://api.altmetric.com/v1/donut/6281795_240.png 0,Conditional Deletion of Rb Causes Early Stage Prostate Cancer,Cancer Research,,,Article,2004-08-31,10.1158/0008-5472.can-03-2509,,,,15342382,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6281599,https://api.altmetric.com/v1/donut/6281599_240.png 0,Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer,Gene Therapy,,,Article,2007-02-15,10.1038/sj.gt.3302788,,,,17024109,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6281591,https://api.altmetric.com/v1/donut/6281591_240.png 0,Gene therapy for prostate cancer,Urology,,,Article,2001-01-01,10.1016/s0090-4295(00)00903-1,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6281502,https://api.altmetric.com/v1/donut/6281502_240.png 0,"1?,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells",The Prostate,,,Article,2008-05-14,10.1002/pros.20739,,,,18247401,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6281334,https://api.altmetric.com/v1/donut/6281334_240.png 0,Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2006-04-30,10.1016/j.ijrobp.2005.11.009,,,,16472937,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6281288,https://api.altmetric.com/v1/donut/6281288_240.png 0,Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies,Urology,,,Article,1996-07-01,10.1016/s0090-4295(96)00149-5,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6281284,https://api.altmetric.com/v1/donut/6281284_240.png 0,In Vivo Surgical Resection Plus Adjuvant Gene Therapy in the Treatment of Mammary and Prostate Cancer,Molecular Therapy,,,Article,2001-04-01,10.1006/mthe.2001.0285,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6281283,https://api.altmetric.com/v1/donut/6281283_240.png 0,Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression,Neoplasia,,,Article,2012-10-01,10.1593/neo.121192,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6280686,https://api.altmetric.com/v1/donut/6280686_240.png 0,Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance,Human Pathology,,,Article,2006-06-14,10.1016/j.humpath.2006.01.027,,,,16733214,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6280635,https://api.altmetric.com/v1/donut/6280635_240.png 0,Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model,The Prostate,,,Article,2003-05-15,10.1002/pros.10215,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/6280483,https://api.altmetric.com/v1/donut/6280483_240.png 0,Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer,Neoplasia,,,Article,2008-02-01,10.1593/neo.07822,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,142,https://www.altmetric.com/details/6280204,https://api.altmetric.com/v1/donut/6280204_240.png 0,Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL,Urology,,,Article,2000-12-01,10.1016/s0090-4295(00)00830-x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6280145,https://api.altmetric.com/v1/donut/6280145_240.png 0,Intensity Modulated Radiation Therapy (IMRT) in the Management of Prostate Cancer,Cancer Investigation,,,Article,2004-11-23,10.1081/cnv-200039674,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6279746,https://api.altmetric.com/v1/donut/6279746_240.png 0,Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis,Human Pathology,,,Article,2007-11-15,10.1016/j.humpath.2007.03.024,,,,17707459,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6279442,https://api.altmetric.com/v1/donut/6279442_240.png 0,Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer,World Journal of Urology,,,Article,2013-06-13,10.1007/s00345-013-1111-6,,,,23765315,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6279202,https://api.altmetric.com/v1/donut/6279202_240.png 0,"1997 AMERICAN UROLOGICAL ASSOCIATION GALLUP SURVEY: CHANGES IN DIAGNOSIS AND MANAGEMENT OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA, AND OTHER PRACTICE TRENDS FROM 1994 TO 1997",The Journal of Urology,,,Article,1998-11-01,10.1016/s0022-5347(01)62418-2,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6279158,https://api.altmetric.com/v1/donut/6279158_240.png 0,Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2001-02-01,10.1016/s0360-3016(00)01474-7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6278930,https://api.altmetric.com/v1/donut/6278930_240.png 0,Radiation proctopathy in the treatment of prostate cancer,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2006-12-01,10.1016/j.ijrobp.2006.07.1386,,,,17126204,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6278915,https://api.altmetric.com/v1/donut/6278915_240.png 0,Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy,Urology,,,Article,2006-10-01,10.1016/j.urology.2006.04.029,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6278900,https://api.altmetric.com/v1/donut/6278900_240.png 0,Predictors of Prostate Cancer After Initial Negative Systematic 12 Core Biopsy,The Journal of Urology,,,Article,2004-05-14,10.1097/01.ju.0000119667.86071.e7,,,,15076292,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6278805,https://api.altmetric.com/v1/donut/6278805_240.png 0,Strategies for Prostate Cancer Gene Therapy,American Journal of Cancer,,,Article,2004-01-01,10.2165/00024669-200403020-00002,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6278793,https://api.altmetric.com/v1/donut/6278793_240.png 0,Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer,Cancer Cell,,,Article,2013-04-01,10.1016/j.ccr.2013.04.005,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6278714,https://api.altmetric.com/v1/donut/6278714_240.png 0,Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies,FASEB Journal,,,Article,2013-09-29,10.1096/fj.13-236109,,,,24081904,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6278705,https://api.altmetric.com/v1/donut/6278705_240.png 0,Transurethral Resection Versus Intermittent Catheterization in Patients with Retention after Combined Brachytherapy/External Beam Radiotherapy for Prostate Cancer: Intermittent Catheterization,The Journal of Urology,,,Article,2013-03-15,10.1016/j.juro.2012.12.019,,,,23246852,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6278293,https://api.altmetric.com/v1/donut/6278293_240.png 0,"Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers",Journal of Clinical Oncology,,,Article,2009-10-19,10.1200/jco.2009.21.9410,,,,19720908,PMC2799055,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6277958,https://api.altmetric.com/v1/donut/6277958_240.png 0,Novel Mutations of Epidermal Growth Factor Receptor in Localized Prostate Cancer,Frontiers in Bioscience,,,Article,2006-01-01,10.2741/1986,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6277395,https://api.altmetric.com/v1/donut/6277395_240.png 0,Matched-pair analysis and dosimetric variations of two types of software for interstitial permanent brachytherapy for prostate cancer,Medical Dosimetry,,,Article,2012-03-01,10.1016/j.meddos.2011.01.004,,,,21937217,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6277377,https://api.altmetric.com/v1/donut/6277377_240.png 0,Dimensions of quality of life expressed by men treated for metastatic prostate cancer,Social Science & Medicine,,,Article,1997-10-01,10.1016/s0277-9536(97)00058-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6277170,https://api.altmetric.com/v1/donut/6277170_240.png 0,Differential expression of cell cycle regulatory molecules and evidence for a ?cyclin switch? during progression of prostate cancer,The Prostate,,,Article,2004-03-01,10.1002/pros.10341,,,,14968434,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6277169,https://api.altmetric.com/v1/donut/6277169_240.png 0,Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRT,Medical Dosimetry,,,Article,2005-03-01,10.1016/j.meddos.2004.10.001,,,,15749004,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6277092,https://api.altmetric.com/v1/donut/6277092_240.png 0,The Use of Rectal Balloon During the Delivery of Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer,Cancer Journal,,,Article,2002-11-01,10.1097/00130404-200211000-00012,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6276939,https://api.altmetric.com/v1/donut/6276939_240.png 0,Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy,JAMA: Journal of the American Medical Association,,,Article,2004-03-17,10.1001/jama.291.11.1325,,,,15026399,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6276896,https://api.altmetric.com/v1/donut/6276896_240.png 0,"VARIATION IN PROSTATE SPECIFIC ANTIGEN RESULTS FROM 2 DIFFERENT ASSAY PLATFORMS: CLINICAL IMPACT ON 2,304 PATIENTS UNDERGOING PROSTATE CANCER SCREENING",The Journal of Urology,,,Article,2004-06-01,10.1097/01.ju.0000127736.86597.e7,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6276627,https://api.altmetric.com/v1/donut/6276627_240.png 0,An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up,Cancer (0008543X),,,Article,2002-11-15,10.1002/cncr.10919,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6276556,https://api.altmetric.com/v1/donut/6276556_240.png 0,Randomized Phase II Trial Evaluation of Erectile Function after Attempted Unilateral Cavernous Nerve-Sparing Retropubic Radical Prostatectomy With Versus Without Unilateral Sural Nerve Grafting for Clinically Localized Prostate Cancer,European Urology,,,Article,2009-05-14,10.1016/j.eururo.2008.08.051,,,,18783876,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6276391,https://api.altmetric.com/v1/donut/6276391_240.png 0,AZGP-1 Immunohistochemical Marker in Prostate Cancer,Applied immunohistochemistry molecular morphology AIMM,,,Article,2014-02-06,10.1097/pai.0000000000000015,,,,24508823,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6276213,https://api.altmetric.com/v1/donut/6276213_240.png 0,Regulation of the pentose phosphate pathway by an androgen receptor–mTOR-mediated mechanism and its role in prostate cancer cell growth,Oncogenesis,,,Article,2014-05-25,10.1038/oncsis.2014.18,,,,24861463,PMC4035695,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6275924,https://api.altmetric.com/v1/donut/6275924_240.png 0,IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer,Cancer Gene Therapy,,,Article,2007-10-14,10.1038/sj.cgt.7701069,,,,17627292,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6275707,https://api.altmetric.com/v1/donut/6275707_240.png 0,Interleukin-1 Receptor Antagonist Polymorphism in Patients with Prostate Cancer and Benign Prostatic Hyperplasia: A Case Control Study from North India,UroOncology,,,Article,2015-07-16,10.1080/15610950400006678,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6275285,https://api.altmetric.com/v1/donut/6275285_240.png 0,Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?,Clinical Genetics,,,Article,2005-07-14,10.1111/j.1399-0004.2005.00450.x,,,,15952987,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6274909,https://api.altmetric.com/v1/donut/6274909_240.png 0,Human sensitivity to PhIP: A novel marker for prostate cancer risk,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,,,Article,2006-10-09,10.1016/j.mrfmmm.2006.05.023,,,,16889804,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6274806,https://api.altmetric.com/v1/donut/6274806_240.png 0,"Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?",Steroids,,,Article,2007-04-14,10.1016/j.steroids.2006.12.004,,,,17257635,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6274771,https://api.altmetric.com/v1/donut/6274771_240.png 0,Chromosomal Instability in Peripheral Blood Lymphocytes and Risk of Prostate Cancer,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2005-03-15,10.1158/1055-9965.epi-04-0236,,,,15767363,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6274611,https://api.altmetric.com/v1/donut/6274611_240.png 0,Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog,The Prostate,,,Article,2005-01-01,10.1002/pros.20114,,,,15389812,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6274609,https://api.altmetric.com/v1/donut/6274609_240.png 0,Association of Vitamin D Receptor Gene Polymorphism and Risk of Prostate Cancer in India,Urologia Internationalis,,,Article,2005-01-01,10.1159/000084429,,,,15897695,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6274415,https://api.altmetric.com/v1/donut/6274415_240.png 0,"Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells",Oncotarget,,,Article,2015-10-12,10.18632/oncotarget.5585,,,,26378018,PMC4741655,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6274307,https://api.altmetric.com/v1/donut/6274307_240.png 0,"Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy",Urologic Oncology,,,Article,2016-01-01,10.1016/j.urolonc.2015.08.004,,,,26345648,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6274126,https://api.altmetric.com/v1/donut/6274126_240.png 0,The importance of surgical margins in prostate cancer,Journal of Surgical Oncology,,,Article,2016-03-01,10.1002/jso.24109,,,,27004601,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6271825,https://api.altmetric.com/v1/donut/6271825_240.png 0,"Planning magnetic resonance imaging for prostate cancer intensity-modulated radiation therapy: Impact on target volumes, radiotherapy dose and androgen deprivation administration",Asia Pacific Journal of Clinical Oncology,,,Article,2014-09-15,10.1111/ajco.12266,,,,25227727,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6250735,https://api.altmetric.com/v1/donut/6250735_240.png 0,The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care?,Journal of Molecular Medicine,,,Article,2006-11-15,10.1007/s00109-006-0110-0,,,,17021907,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6240417,https://api.altmetric.com/v1/donut/6240417_240.png 0,500 MOLECULAR DIAGNOSIS OF LOCALIZED PROSTATE CANCER BY QUANTITATIVE METHYLATION-SPECIFIC PCR GENE PATTERNS IN URINE CELLS OBTAINED BY PROSTATE MASSAGE,European Urology Supplements,,,Article,2007-03-01,10.1016/s1569-9056(07)60498-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6240415,https://api.altmetric.com/v1/donut/6240415_240.png 0,PROMOTER HYPERMETHYLATION IN CIRCULATING BLOOD CELLS IDENTIFIES PROSTATE CANCER PROGRESSION,European Urology Supplements,,,Article,2008-03-01,10.1016/s1569-9056(08)60731-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6240041,https://api.altmetric.com/v1/donut/6240041_240.png 0,"OSTEOPOROSIS IN PATIENTS WITH PROSTATE CANCER ON LONG-TERM ANDROGEN DEPRIVATION THERAPY: AN INCREASING, BUT UNDER-RECOGNIZED PROBLEM",British Journal of Urology,,,Article,2010-04-14,10.1111/j.1464-410x.2010.09251.x,,,,20201833,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6238366,https://api.altmetric.com/v1/donut/6238366_240.png 0,Markers for Detection of Prostate Cancer,Cancers,,,Article,2010-06-03,10.3390/cancers2021125,,,,24281110,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6237642,https://api.altmetric.com/v1/donut/6237642_240.png 0,Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: Involvement of the insulin like growth factor-1 receptor,The Prostate,,,Article,2010-05-31,10.1002/pros.21119,,,,20127733,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6236865,https://api.altmetric.com/v1/donut/6236865_240.png 0,Recent advances in the histopathology and molecular biology of prostate cancer,British Journal of Urology,,,Article,2000-01-01,10.1046/j.1464-410x.2000.00422.x,,,,10619953,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6236709,https://api.altmetric.com/v1/donut/6236709_240.png 0,Androgen Deprivation Therapy for Prostate Cancer Prevention: What Impact Do Related Adverse Events Have on Quality of Life?,Health Outcomes Research in Medicine,,,Article,2012-08-01,10.1016/j.ehrm.2012.04.002,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6235555,https://api.altmetric.com/v1/donut/6235555_240.png 0,NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells,NMR in Biomedicine,,,Article,2014-03-17,10.1002/nbm.3101,,,,24639007,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6234333,https://api.altmetric.com/v1/donut/6234333_240.png 0,Docetaxel-Resistant Prostate Cancer Cells Remain Sensitive to S-Trityl-L-Cysteine-Mediated Eg5 Inhibition,Molecular Cancer Therapeutics,,,Article,2010-06-14,10.1158/1535-7163.mct-09-1103,,,,20515952,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6234212,https://api.altmetric.com/v1/donut/6234212_240.png 0,DEVELOPMENT OF A DORSAL SKINFOLD CHAMBER (DSC) METATARSAL MODEL FOR THE QUANTIFICATION OF PROSTATE CANCER MICROMETASTASES IN VIVO,European Urology Supplements,,,Article,2008-03-01,10.1016/s1569-9056(08)60420-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6233820,https://api.altmetric.com/v1/donut/6233820_240.png 0,Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer,Medical Oncology,,,Article,2015-03-15,10.1007/s12032-015-0529-7,,,,25698533,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6229760,https://api.altmetric.com/v1/donut/6229760_240.png 0,"Adjuvant radiotherapy versus observation alone, after radical prostatectomy in high risk prostate cancer",Revista da Associação Médica Brasileira,,,Article,2015-08-01,10.1590/1806-9282.61.04.324,,,,26466213,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6229158,https://api.altmetric.com/v1/donut/6229158_240.png 0,Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2.,EJNMMI Research,,,Article,2016-12-01,10.1186/s13550-016-0181-z,,,,26983637,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6228597,https://api.altmetric.com/v1/donut/6228597_240.png 0,[Radical prostatectomy and radiation therapy for high-risk prostate cancer: An update].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-07-01,,,,,26333232,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6205006,https://api.altmetric.com/v1/donut/6205006_240.png 0,[Pro-prostate-specific antigen and its related indexes in the diagnosis of prostate cancer].,Zhonghua nan ke xue National journal of andrology,,,Article,2015-07-01,,,,,26333230,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6205003,https://api.altmetric.com/v1/donut/6205003_240.png 0,Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells,Cancer Cell International,,,Article,2016-03-15,10.1186/s12935-016-0295-4,,,,26981049,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6194572,https://api.altmetric.com/v1/donut/6194572_240.png 0,Editorial Comment to Prostate-specific antigen-based prostate cancer screening: Past and future,International Journal of Urology,,,Article,2015-06-09,10.1111/iju.12783,,,,25854711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6192291,https://api.altmetric.com/v1/donut/6192291_240.png 0,Stereotactic ablative radiotherapy with CyberKnife in the treatment of locally advanced prostate cancer: preliminary results,Tumori,,,Article,2015-05-21,10.5301/tj.5000355,,,,26045107,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6192014,https://api.altmetric.com/v1/donut/6192014_240.png 0,Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer,BMC Cancer,,,Article,2016-03-14,10.1186/s12885-016-2260-y,,,,26975660,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6188938,https://api.altmetric.com/v1/donut/6188938_240.png 0,Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes,BioMed Research International,,,Article,2015-01-01,10.1155/2015/696439,,,,26539522,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6182439,https://api.altmetric.com/v1/donut/6182439_240.png 0,Pion conformal radiation of prostate cancer: results of a randomized study,"International Journal of Radiation Oncology, Biology, Physics",,,Article,1999-01-01,10.1016/s0360-3016(98)00371-x,,,,9989513,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6182106,https://api.altmetric.com/v1/donut/6182106_240.png 0,Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance,Critical Reviews in Oncology/Hematology,,,Article,2015-12-01,10.1016/j.critrevonc.2015.07.005,,,,26253360,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6181866,https://api.altmetric.com/v1/donut/6181866_240.png 0,Androgen receptor and caveolin-1 in prostate cancer,IUBMB Life,,,Article,2009-10-14,10.1002/iub.244,,,,19787702,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6181070,https://api.altmetric.com/v1/donut/6181070_240.png 0,Bone health in prostate cancer,Expert Review of Endocrinology & Metabolism,,,Article,2014-01-10,10.1586/eem.11.4,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6180937,https://api.altmetric.com/v1/donut/6180937_240.png 0,CANCER OF THE PROSTATE IN INFANTS AND CHILDREN,Journal of the American Medical Association,,,Article,1952-10-25,10.1001/jama.1952.63680080003012b,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6180815,https://api.altmetric.com/v1/donut/6180815_240.png 0,435 THE POLYCOMB GROUP PROTEIN EZH2 IS REQUIRED FOR TRANSCRIPTIONAL REPRESSION OF P21 AND MMP7 IN PROSTATE CANCER CELLS,European Urology Supplements,,,Article,2007-03-01,10.1016/s1569-9056(07)60433-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6172947,https://api.altmetric.com/v1/donut/6172947_240.png 0,The homing of prostate cancer to bone in vivo is modulated by Zoledronic acid,BONE,,,Article,2011-01-01,10.1016/j.bone.2010.10.128,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6172946,https://api.altmetric.com/v1/donut/6172946_240.png 0,Spontaneous fusion between prostate cancer cells: A driver for development of tumor heterogeneity and growth in bone,BONE,,,Article,2011-01-01,10.1016/j.bone.2010.10.131,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6172945,https://api.altmetric.com/v1/donut/6172945_240.png 0,21?Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer,British Journal of Urology,,,Article,2006-03-01,10.1111/j.1464-410x.2006.06085_21.x,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6171908,https://api.altmetric.com/v1/donut/6171908_240.png 0,Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.,Cancer Research,,,Article,2002-03-15,,,,,11912131,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6170318,https://api.altmetric.com/v1/donut/6170318_240.png 0,Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer,The Prostate,,,Article,2004-05-14,10.1002/pros.20016,,,,15042606,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6170262,https://api.altmetric.com/v1/donut/6170262_240.png 0,Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells,International Journal of Cancer,,,Article,2005-01-20,10.1002/ijc.20602,,,,15455384,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6170035,https://api.altmetric.com/v1/donut/6170035_240.png 0,Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing but under-recognised problem,BJU International,,,Article,2010-09-14,10.1111/j.1464-410x.2010.09605_1.x,,,,21050352,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6168626,https://api.altmetric.com/v1/donut/6168626_240.png 0,Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial,BONE,,,Article,2011-01-01,10.1016/j.bone.2010.10.042,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6168620,https://api.altmetric.com/v1/donut/6168620_240.png 0,"Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?",British Journal of Cancer,,,Article,2013-05-27,10.1038/bjc.2013.211,,,,23632481,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6168579,https://api.altmetric.com/v1/donut/6168579_240.png 0,The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer,BONE,,,Article,2007-12-01,10.1016/j.bone.2007.07.024,,,,17945547,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6167985,https://api.altmetric.com/v1/donut/6167985_240.png 0,High risk genes predisposing to prostate cancer development—do they exist?,Prostate Cancer & Prostatic Diseases,,,Article,2000-12-01,10.1038/sj.pcan.4500478,,,,12497071,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6166105,https://api.altmetric.com/v1/donut/6166105_240.png 0,"Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer",Future Oncology,,,Article,2014-02-15,10.2217/fon.13.250,,,,24490608,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6157720,https://api.altmetric.com/v1/donut/6157720_240.png 0,Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.7882,,,,26959883,PMC5008341,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6154693,https://api.altmetric.com/v1/donut/6154693_240.png 0,Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer,JAMA: Journal of the American Medical Association,,,Article,2016-03-08,10.1001/jama.2015.17567,,,,26954419,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6142917,https://api.altmetric.com/v1/donut/6142917_240.png 0,Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects,Advances in experimental medicine and biology,,,Article,2015-01-01,10.1007/978-94-017-7215-0_7,,,,26530362,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6138599,https://api.altmetric.com/v1/donut/6138599_240.png 0,390 POSTER Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer,EJC Supplements,,,Article,2006-11-01,10.1016/s1359-6349(06)70395-0,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6131086,https://api.altmetric.com/v1/donut/6131086_240.png 0,Mouse models for studying prostate cancer bone metastasis.,BoneKEy Reports,,,Article,2016-01-01,10.1038/bonekey.2016.4,,,,26916039,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6121780,https://api.altmetric.com/v1/donut/6121780_240.png 0,Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy.,World Journal of Urology,,,Article,2003-09-01,10.1007/s00345-003-0363-y,,,,12920560,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6121716,https://api.altmetric.com/v1/donut/6121716_240.png 0,[European Association of Urology. Position statement on screening for prostate cancer].,Actas Urológicas Españolas,,,Article,2016-04-02,10.1016/j.acuro.2010.03.021,,,,20416237,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6120911,https://api.altmetric.com/v1/donut/6120911_240.png 0,Clinical Predictors and Recommendations for Staging Computed Tomography Scan Among Men With Prostate Cancer.,Urology,,,Article,2014-10-03,10.1016/j.urology.2014.07.051,,,,25288575,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6120115,https://api.altmetric.com/v1/donut/6120115_240.png 0,Post-translational regulation of COX2 activity by FYN in prostate cancer cells.,Oncotarget,,,Article,2014-05-17,10.18632/oncotarget.1983,,,,24970799,PMC4147319,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6120114,https://api.altmetric.com/v1/donut/6120114_240.png 0,Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model.,British Journal of Cancer,,,Article,2014-03-18,10.1038/bjc.2014.141,,,,24642616,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6120056,https://api.altmetric.com/v1/donut/6120056_240.png 0,Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.,International Journal of Cancer,,,Article,2014-09-30,10.1002/ijc.29241,,,,25273821,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6120025,https://api.altmetric.com/v1/donut/6120025_240.png 0,Prostate cancer SubtyPINg biomarKers and outcome: is clarity emERGing?,Clinical Cancer Research,,,Article,2014-06-17,10.1158/1078-0432.ccr-14-0818,,,,24944315,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6119966,https://api.altmetric.com/v1/donut/6119966_240.png 0,"Comprehensive serial molecular profiling of an ""N of 1"" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.",Journal of Hematology & Oncology,,,Article,,10.1186/s13045-015-0204-7,,,,26444865,PMC4596504,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6119965,https://api.altmetric.com/v1/donut/6119965_240.png 0,Poxviral-based vaccine elicits immunologic responses in prostate cancer patients.,Oncoimmunology,,,Article,,10.4161/onci.28611,,,,25097802,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6119926,https://api.altmetric.com/v1/donut/6119926_240.png 0,Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types.,Cancer cell & microenvironment,,,Article,2014-01-01,10.14800/ccm.90,,,,26005704,PMC4441270,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6119895,https://api.altmetric.com/v1/donut/6119895_240.png 0,20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.,PloS one,,,Article,,10.1371/journal.pone.0111201,,,,25375370,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6119807,https://api.altmetric.com/v1/donut/6119807_240.png 0,Proteasome Inhibition by Bortezomib Increases IL-8 Expression in Androgen-Independent Prostate Cancer Cells: The Role of IKK?,The Journal of Immunology,,,Article,2013-07-25,10.4049/jimmunol.1300895,,,,23894194,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6119777,https://api.altmetric.com/v1/donut/6119777_240.png 0,Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice.,The Prostate,,,Article,2015-01-25,10.1002/pros.22941,,,,25620467,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6119755,https://api.altmetric.com/v1/donut/6119755_240.png 0,Differential sensitization of different prostate cancer cells to apoptosis.,Genes & Cancer,,,Article,2010-08-14,10.1177/1947601910381645,,,,21132068,PMC2995449,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6119740,https://api.altmetric.com/v1/donut/6119740_240.png 0,"Muscadine Grape Skin Extract (MSKE) can Antagonize Snail-Cathepsin L-Mediated Invasion, Migration and Osteoclastogenesis in Prostate and Breast Cancer Cells.",Carcinogenesis,,,Article,,10.1093/carcin/bgv084,,,,26069256,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6119676,https://api.altmetric.com/v1/donut/6119676_240.png 0,Interplay Between Genomic Alterations and Androgen Receptor Signaling During Prostate Cancer Development and Progression.,Hormones and Cancer,,,Article,2013-04-14,10.1007/s12672-013-0131-4,,,,23307762,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6119672,https://api.altmetric.com/v1/donut/6119672_240.png 0,A C-14 labeled Py-Im polyamide localizes to a subcutaneous prostate cancer tumor.,Bioorganic & Medicinal Chemistry,,,Article,2014-04-15,10.1016/j.bmc.2014.04.010,,,,24780272,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6119654,https://api.altmetric.com/v1/donut/6119654_240.png 0,Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research.,Experimental Biology and Medicine,,,Article,2014-05-29,10.1177/1535370214536669,,,,24879423,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6119617,https://api.altmetric.com/v1/donut/6119617_240.png 0,Aminomethylphosphonic Acid and methoxyacetic Acid induce apoptosis in prostate cancer cells.,International Journal of Molecular Sciences,,,Article,,10.3390/ijms160511750,,,,26006246,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6119481,https://api.altmetric.com/v1/donut/6119481_240.png 0,In vitro and in vivo model systems used in prostate cancer research.,Journal of Biological Methods,,,Article,2015-01-01,10.14440/jbm.2015.63,,,,26146646,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6119480,https://api.altmetric.com/v1/donut/6119480_240.png 0,Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment.,The Prostate,,,Article,2014-03-31,10.1002/pros.22805,,,,24691769,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6119479,https://api.altmetric.com/v1/donut/6119479_240.png 0,Current treatments and novel therapeutic targets for castration resistant prostate cancer with bone metastasis.,American journal of clinical and experimental urology,,,Article,,,,,,25374898,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6119469,https://api.altmetric.com/v1/donut/6119469_240.png 0,Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells.,Clinical and Experimental Metastasis,,,Article,2013-06-08,10.1007/s10585-013-9590-9,,,,23748470,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6119458,https://api.altmetric.com/v1/donut/6119458_240.png 0,Mechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC).,Journal of Steroid Biochemistry & Molecular Biology,,,Article,,10.1016/j.jsbmb.2015.05.010,,,,26032458,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6119303,https://api.altmetric.com/v1/donut/6119303_240.png 0,Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.,Molecular Carcinogenesis,,,Article,,10.1002/mc.22425,,,,26512949,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6119228,https://api.altmetric.com/v1/donut/6119228_240.png 0,The steroidogenic enzyme AKR1C3 regulates stability of the ubiquitin ligase Siah2 in prostate cancer cells.,Journal of Biological Chemistry,,,Article,,10.1074/jbc.m115.662155,,,,26160177,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6119226,https://api.altmetric.com/v1/donut/6119226_240.png 0,YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.,Oncotarget,,,Article,2015-03-03,10.18632/oncotarget.3477,,,,25797255,PMC4480693,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6119152,https://api.altmetric.com/v1/donut/6119152_240.png 0,PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance.,Asian Journal of Andrology,,,Article,2014-04-17,10.4103/1008-682x.122876,,,,24759575,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6119151,https://api.altmetric.com/v1/donut/6119151_240.png 0,Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells.,International Journal of Oncology,,,Article,2013-08-14,10.3892/ijo.2013.1983,,,,23760770,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6119137,https://api.altmetric.com/v1/donut/6119137_240.png 0,FOXO3a: A Potential Target in Prostate Cancer.,Austin journal of urology,,,Article,,,,,,25584362,PMC4288772,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6119057,https://api.altmetric.com/v1/donut/6119057_240.png 0,Spatial extended hazard model with application to prostate cancer survival.,Biometrics,,,Article,2014-12-17,10.1111/biom.12268,,,,25521422,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6119056,https://api.altmetric.com/v1/donut/6119056_240.png 0,Clinical presentation of prostate cancer in Black South Africans.,The Prostate,,,Article,2014-04-08,10.1002/pros.22806,,,,24723425,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6118976,https://api.altmetric.com/v1/donut/6118976_240.png 0,Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells.,Cytotherapy,,,Article,2014-01-11,10.1016/j.jcyt.2013.11.012,,,,24424267,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6118950,https://api.altmetric.com/v1/donut/6118950_240.png 0,Statins and Finasteride Use Differentially Modify the Impact of Metformin on Prostate Cancer Incidence in Men with Type 2 Diabetes.,Annals of translational medicine & epidemiology,,,Article,,,,,,25621309,PMC4300536,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6118836,https://api.altmetric.com/v1/donut/6118836_240.png 0,Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer.,Molecular Endocrinology,,,Article,2013-05-14,10.1210/me.2013-1007,,,,23592429,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6118803,https://api.altmetric.com/v1/donut/6118803_240.png 0,Mechanisms of Androgen Receptor Activation in Castration-Resistant Prostate Cancer.,Endocrinology,,,Article,2013-09-02,10.1210/en.2013-1466,,,,24002034,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6118802,https://api.altmetric.com/v1/donut/6118802_240.png 0,Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.,Cell death & disease,,,Article,2014-05-07,10.1038/cddis.2014.180,,,,24810046,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6118794,https://api.altmetric.com/v1/donut/6118794_240.png 0,Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cells.,Journal of Biomedical Optics,,,Article,2014-11-01,10.1117/1.jbo.19.11.111605,,,,24933682,PMC4059341,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6118685,https://api.altmetric.com/v1/donut/6118685_240.png 0,Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.,Oncotarget,,,Article,2015-01-29,10.18632/oncotarget.3119,,,,25730905,PMC4466655,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6118476,https://api.altmetric.com/v1/donut/6118476_240.png 0,"Mitochondrial uncoupling protein 2 is up-regulated in human head and neck, skin, pancreatic, and prostate tumors.",Cancer Biomarkers,,,Article,2013-01-01,10.3233/cbm-130369,,,,24440978,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6118416,https://api.altmetric.com/v1/donut/6118416_240.png 0,Vasectomy: potential links to an increased risk of aggressive prostate cancer?,Expert Review of Anticancer Therapy,,,Article,,10.1586/14737140.2015.1086648,,,,26402245,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6118341,https://api.altmetric.com/v1/donut/6118341_240.png 0,Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor.,The Prostate,,,Article,,10.1002/pros.23036,,,,26177608,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6118123,https://api.altmetric.com/v1/donut/6118123_240.png 0,Metabolic reprogramming and validation of hyperpolarized 13 C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.,The Prostate,,,Article,2013-08-14,10.1002/pros.22665,,,,23532911,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6118122,https://api.altmetric.com/v1/donut/6118122_240.png 0,Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2014-04-30,10.1016/j.ijrobp.2014.01.050,,,,24725694,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6118049,https://api.altmetric.com/v1/donut/6118049_240.png 0,Pharmacokinetic and Biodistribution Assessment of a Near Infrared-Labeled PSMA-Specific Small Molecule in Tumor-Bearing Mice.,Prostate Cancer,,,Article,,10.1155/2014/104248,,,,24804103,PMC3997074,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6118026,https://api.altmetric.com/v1/donut/6118026_240.png 0,Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.,Genes & Cancer,,,Article,2014-07-14,10.18632/genesandcancer.25,,,,25221645,PMC4162137,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6118009,https://api.altmetric.com/v1/donut/6118009_240.png 0,ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2014-01-28,10.1038/pcan.2013.62,,,,24469092,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6118008,https://api.altmetric.com/v1/donut/6118008_240.png 0,Evaluation of ERG responsive proteome in prostate cancer.,The Prostate,,,Article,2013-09-20,10.1002/pros.22731,,,,24115221,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6118007,https://api.altmetric.com/v1/donut/6118007_240.png 0,Differences in Frequency of ERG Oncoprotein Expression Between Index Tumors of Caucasian and African American Patients With Prostate Cancer.,Urology,,,Article,2012-10-14,10.1016/j.urology.2012.07.001,,,,22950997,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6118005,https://api.altmetric.com/v1/donut/6118005_240.png 0,Prostate cancer marker panel with single cell sensitivity in urine.,The Prostate,,,Article,2015-03-23,10.1002/pros.22981,,,,25808739,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6118003,https://api.altmetric.com/v1/donut/6118003_240.png 0,Predominance of ERG-negative high-grade prostate cancers in African American men.,Molecular and clinical oncology,,,Article,2014-11-15,10.3892/mco.2014.378,,,,25279185,PMC4179793,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6118002,https://api.altmetric.com/v1/donut/6118002_240.png 0,Common gene rearrangements in prostate cancer.,Journal of Clinical Oncology,,,Article,2011-09-19,10.1200/jco.2011.35.1916,,,,21859993,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,89,https://www.altmetric.com/details/6117962,https://api.altmetric.com/v1/donut/6117962_240.png 0,Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential.,Current Drug Targets,,,Article,2013-04-14,,,,,23410129,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6117961,https://api.altmetric.com/v1/donut/6117961_240.png 0,Upgrading prostate cancer following proton beam therapy.,Urology Annals,,,Article,2015-04-01,10.4103/0974-7796.152944,,,,25837674,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6117669,https://api.altmetric.com/v1/donut/6117669_240.png 0,Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy.,Abdominal Imaging,,,Article,,10.1007/s00261-015-0426-8,,,,25916869,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6117668,https://api.altmetric.com/v1/donut/6117668_240.png 0,Crosstalk between Nuclear MET and SOX9/?-Catenin Correlates with Castration Resistant Prostate Cancer.,Molecular Endocrinology,,,Article,2014-08-05,10.1210/me.2014-1078,,,,25099011,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6117616,https://api.altmetric.com/v1/donut/6117616_240.png 0,Does the microenvironment influence the cell types of origin for prostate cancer?,Genes & Development,,,Article,2013-07-14,10.1101/gad.222380.113,,,,23873937,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6117570,https://api.altmetric.com/v1/donut/6117570_240.png 0,Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer.,Journal of Probability & Statistics,,,Article,,10.1155/2012/873570,,,,25419216,PMC4240515,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6117567,https://api.altmetric.com/v1/donut/6117567_240.png 0,High Circulating Estrogens and Selective Expression of ER? in Prostate Tumors: Implications for Racial Disparity of Prostate Cancer.,Carcinogenesis,,,Article,2013-09-14,10.1093/carcin/bgt156,,,,23658372,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6117543,https://api.altmetric.com/v1/donut/6117543_240.png 0,Preferential autoimmune response in prostate cancer to cyclin b1 in a panel of tumor-associated antigens.,Journal of immunology research,,,Article,,10.1155/2014/827827,,,,24860838,PMC4016862,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6117502,https://api.altmetric.com/v1/donut/6117502_240.png 0,Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer.,Molecular and cellular pharmacology,,,Article,2011-01-01,,,,,22379500,PMC3287394,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6117444,https://api.altmetric.com/v1/donut/6117444_240.png 0,Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.,International Journal of Cancer,,,Article,2014-05-04,10.1002/ijc.28948,,,,24798488,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6117443,https://api.altmetric.com/v1/donut/6117443_240.png 0,"Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival and interphase NuMA localization.",Journal of Cellular Biochemistry,,,Article,2013-04-14,10.1002/jcb.24421,,,,23097092,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6117347,https://api.altmetric.com/v1/donut/6117347_240.png 0,microRNA Dysregulation in Prostate Cancer: Network Analysis Reveals Preferential Regulation of Highly Connected Nodes.,Chemistry & Biodiversity,,,Article,2012-05-14,10.1002/cbdv.201100386,,,,22589088,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6117307,https://api.altmetric.com/v1/donut/6117307_240.png 0,Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the ? Subunit of the Translation Initiation Factor 2.,,,,Article,,10.1371/journal.pone.0055257,,,,23405127,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6117238,https://api.altmetric.com/v1/donut/6117238_240.png 0,"The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.",Biochimica et Biophysica Acta (BBA),,,Article,2014-03-13,10.1016/j.bbamcr.2014.03.005,,,,24632071,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6117237,https://api.altmetric.com/v1/donut/6117237_240.png 0,TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.,The Prostate,,,Article,2013-10-14,10.1002/pros.22706,,,,23824605,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6117236,https://api.altmetric.com/v1/donut/6117236_240.png 0,"A New Chalcone Derivative (E)-3-(4-Methoxyphenyl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one Suppresses Prostate Cancer Involving p53-mediated Cell Cycle Arrests and Apoptosis.",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2012-09-14,,,,,22993307,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6117208,https://api.altmetric.com/v1/donut/6117208_240.png 0,YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin.,Oncotarget,,,Article,2014-02-19,10.18632/oncotarget.1790,,,,24770864,PMC4058019,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6117093,https://api.altmetric.com/v1/donut/6117093_240.png 0,Dietary flavonoid fisetin binds to ?-tubulin and disrupts microtubule dynamics in prostate cancer cells.,Cancer Letters,,,Article,,10.1016/j.canlet.2015.07.030,,,,26235140,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6117090,https://api.altmetric.com/v1/donut/6117090_240.png 0,The molecular basis for ethnic variation and histological subtype differences in prostate cancer.,Science China Life Sciences,,,Article,2013-09-14,10.1007/s11427-013-4522-0,,,,23852643,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6117017,https://api.altmetric.com/v1/donut/6117017_240.png 0,Pathogenesis of prostatic small cell carcinoma involves the inactivation of the p53 pathway.,Endocrine-Related Cancer,,,Article,2012-06-14,10.1530/erc-11-0368,,,,22389383,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6117016,https://api.altmetric.com/v1/donut/6117016_240.png 0,The miR-124-Prolyl Hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.,Oncotarget,,,Article,2014-07-11,10.18632/oncotarget.2208,,,,25115393,PMC4196154,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6116954,https://api.altmetric.com/v1/donut/6116954_240.png 0,Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity.,Prostate Cancer,,,Article,,10.1155/2012/543970,,,,23304522,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6116908,https://api.altmetric.com/v1/donut/6116908_240.png 0,The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.,Cancer Research,,,Article,2011-04-30,10.1158/0008-5472.can-10-2769,,,,21398406,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6116907,https://api.altmetric.com/v1/donut/6116907_240.png 0,Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.,Critical Reviews? in Eukaryotic Gene Expression,,,Article,,,,,,23557339,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6116906,https://api.altmetric.com/v1/donut/6116906_240.png 0,CXC receptor-1 silencing inhibits androgen-independent prostate cancer.,Cancer Research,,,Article,2009-11-01,10.1158/0008-5472.can-09-0374,,,,19861539,PMC2788615,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6116903,https://api.altmetric.com/v1/donut/6116903_240.png 0,Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.,Cancer Letters,,,Article,2012-03-15,10.1016/j.canlet.2011.10.006,,,,22154085,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6116873,https://api.altmetric.com/v1/donut/6116873_240.png 0,Targeting Androgen Receptor Leads to Suppression of Prostate Cancer via Induction of Autophagy.,The Journal of Urology,,,Article,2012-10-14,10.1016/j.juro.2012.06.004,,,,22906664,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6116872,https://api.altmetric.com/v1/donut/6116872_240.png 0,The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.,Neoplasia,,,Article,,10.1016/j.neo.2015.02.005,,,,25925376,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6116871,https://api.altmetric.com/v1/donut/6116871_240.png 0,BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts.,International Journal of Oncology,,,Article,,10.3892/ijo.2015.3060,,,,26095189,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6116870,https://api.altmetric.com/v1/donut/6116870_240.png 0,PPAR? vs TR4 nuclear receptor differential roles in prostate cancer and metabolic diseases.,Endocrine-Related Cancer,,,Article,2014-03-12,10.1530/erc-13-0529,,,,24623743,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6116868,https://api.altmetric.com/v1/donut/6116868_240.png 0,Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.,Clinical Investigation,,,Article,2014-10-01,10.4155/cli.14.77,,,,26594314,PMC4652646,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6116867,https://api.altmetric.com/v1/donut/6116867_240.png 0,Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling.,,,,Article,2013-08-07,10.1038/cddis.2013.270,,,,23928703,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6116866,https://api.altmetric.com/v1/donut/6116866_240.png 0,Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation.,Tumor Biology,,,Article,2013-10-10,10.1007/s13277-013-1253-6,,,,24122203,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6116850,https://api.altmetric.com/v1/donut/6116850_240.png 0,Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies.,,,,Article,,10.1371/journal.pone.0069457,,,,23922715,PMC3724855,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6116813,https://api.altmetric.com/v1/donut/6116813_240.png 0,14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-13-0578,,,,23774214,PMC3745528,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6116723,https://api.altmetric.com/v1/donut/6116723_240.png 0,ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.,Oncology Reports,,,Article,,10.3892/or.2012.2079,,,,23076342,PMC3494775,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6116722,https://api.altmetric.com/v1/donut/6116722_240.png 0,Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3544,,,,25926554,PMC4484414,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6116703,https://api.altmetric.com/v1/donut/6116703_240.png 0,Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.,Journal of Biological Chemistry,,,Article,2014-12-24,10.1074/jbc.m114.599035,,,,25540201,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6116571,https://api.altmetric.com/v1/donut/6116571_240.png 0,"Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKC? without inhibiting Akt.",International Journal of Oncology,,,Article,,10.3892/ijo.2012.1664,,,,23076676,PMC3541032,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6116570,https://api.altmetric.com/v1/donut/6116570_240.png 0,TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4535,,,,26327448,PMC4694862,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6116535,https://api.altmetric.com/v1/donut/6116535_240.png 0,Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.,Molecular and cellular pharmacology,,,Article,2014-01-01,,,,,25893034,PMC4397568,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6116482,https://api.altmetric.com/v1/donut/6116482_240.png 0,Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.,Genes & Cancer,,,Article,2011-02-15,10.1177/1947601911410424,,,,21779485,PMC3111250,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6116391,https://api.altmetric.com/v1/donut/6116391_240.png 0,Inverse Relationship between PSA and IL-8 in Prostate Cancer: An Insight into a NF-?B-Mediated Mechanism.,,,,Article,,10.1371/journal.pone.0032905,,,,22403723,PMC3293904,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6116358,https://api.altmetric.com/v1/donut/6116358_240.png 0,EBP1 inhibits translation of androgen receptor mRNA in castration resistant prostate cancer cells.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2011-10-14,,,,,21965718,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6116287,https://api.altmetric.com/v1/donut/6116287_240.png 0,Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3449,,,,25960544,PMC4484482,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6116200,https://api.altmetric.com/v1/donut/6116200_240.png 0,Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.,Molecular Cancer Research,,,Article,2011-01-15,10.1158/1541-7786.mcr-10-0235,,,,21076047,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6116015,https://api.altmetric.com/v1/donut/6116015_240.png 0,ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2011-06-30,10.1016/j.bbrc.2011.05.074,,,,21627959,PMC3163383,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6116014,https://api.altmetric.com/v1/donut/6116014_240.png 0,The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species.,Journal of Natural Medicines,,,Article,2013-07-14,10.1007/s11418-012-0722-3,,,,23179315,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6116013,https://api.altmetric.com/v1/donut/6116013_240.png 0,Cysteine (C)-X-C Receptor 4 Regulates NADPH Oxidase-2 During Oxidative Stress in Prostate Cancer Cells.,Cancer Microenvironment,,,Article,2013-09-27,10.1007/s12307-013-0136-0,,,,24078461,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6116012,https://api.altmetric.com/v1/donut/6116012_240.png 0,ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells.,Molecular and Cellular Biochemistry,,,Article,2013-04-14,10.1007/s11010-012-1549-7,,,,23315288,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6116011,https://api.altmetric.com/v1/donut/6116011_240.png 0,Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells.,,,,Article,,10.1371/journal.pone.0057194,,,,23468933,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6116010,https://api.altmetric.com/v1/donut/6116010_240.png 0,Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.,Endocrinology,,,Article,2010-11-15,10.1210/en.2010-0436,,,,20881251,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6115969,https://api.altmetric.com/v1/donut/6115969_240.png 0,Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analysis.,Tomography : a journal for imaging research,,,Article,2015-09-01,10.18383/j.tom.2015.00130,,,,26726317,PMC4696775,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6115950,https://api.altmetric.com/v1/donut/6115950_240.png 0,Multimodality imaging in biochemical recurrence of prostate cancer: Utility of (18)F-NaF PET/CT in early detection of metastasis.,Revista Española de Medicina Nuclear e Imagen Molecular,,,Article,,10.1016/j.remn.2012.03.008,,,,22980132,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6115949,https://api.altmetric.com/v1/donut/6115949_240.png 0,Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.,Nature Reviews Urology,,,Article,2009-06-14,10.1038/nrurol.2009.81,,,,19434102,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6115947,https://api.altmetric.com/v1/donut/6115947_240.png 0,Role of Imaging in Prostate Cancer.,,,,Article,2009-03-31,10.1016/j.cpet.2009.05.003,,,,20161047,PMC2746671,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6115946,https://api.altmetric.com/v1/donut/6115946_240.png 0,Inguinal hernia after radical prostatectomy for prostate cancer: results from a randomized setting and a nonrandomized setting.,European Urology,,,Article,2010-11-15,10.1016/j.eururo.2010.08.006,,,,20728265,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6115941,https://api.altmetric.com/v1/donut/6115941_240.png 0,"Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.",European Urology,,,Article,2009-02-15,10.1016/j.eururo.2008.08.054,,,,18783877,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6115940,https://api.altmetric.com/v1/donut/6115940_240.png 0,Synthesis and In Vitro and In Vivo Evaluation of Hypoxia-Enhanced 111In-Bombesin Conjugates for Prostate Cancer Imaging.,Journal of Nuclear Medicine,,,Article,2013-07-28,10.2967/jnumed.112.117986,,,,23896558,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6115873,https://api.altmetric.com/v1/donut/6115873_240.png 0,"Development of Hypoxia Enhanced 111In-labeled Bombesin Conjugates: Design, Synthesis and In Vitro Evaluation in PC-3 Human Prostate Cancer.",Bioconjugate Chemistry,,,Article,2012-03-21,10.1021/bc200600w,,,,22296619,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6115872,https://api.altmetric.com/v1/donut/6115872_240.png 0,Caveolin-1 and prostate cancer progression.,Advances in experimental medicine and biology,,,Article,,10.1007/978-1-4614-1222-9_7,,,,22411316,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6115841,https://api.altmetric.com/v1/donut/6115841_240.png 0,"Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.",European Urology,,,Article,2010-09-14,10.1016/j.eururo.2010.05.003,,,,20537788,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6115839,https://api.altmetric.com/v1/donut/6115839_240.png 0,CD4+ lymphocytes modulate prostate cancer progression in mice.,International Journal of Cancer,,,Article,2009-08-14,10.1002/ijc.24452,,,,19408303,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6115699,https://api.altmetric.com/v1/donut/6115699_240.png 0,Advances in androgen receptor targeted therapy for prostate cancer.,Journal of Cellular Physiology,,,Article,2013-08-21,10.1002/jcp.24456,,,,24037862,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6115695,https://api.altmetric.com/v1/donut/6115695_240.png 0,"Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.",Journal of Cellular Biochemistry,,,Article,2009-05-31,10.1002/jcb.22152,,,,19330806,PMC2738995,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6115694,https://api.altmetric.com/v1/donut/6115694_240.png 0,Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.,,,,Article,,,,,,22347519,PMC3275434,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6115690,https://api.altmetric.com/v1/donut/6115690_240.png 0,Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.,,,,Article,,,,,,23145211,PMC3493023,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6115689,https://api.altmetric.com/v1/donut/6115689_240.png 0,Deregulation of FOXO3A during prostate cancer progression.,International Journal of Oncology,,,Article,2009-06-14,,,,,19424579,PMC2683383,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6115688,https://api.altmetric.com/v1/donut/6115688_240.png 0,IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients.,,,,Article,2011-08-14,,,,,21904631,PMC3160607,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6115682,https://api.altmetric.com/v1/donut/6115682_240.png 0,RE: Serum Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial.,JNCI: Journal of the National Cancer Institute,,,Article,2014-03-30,10.1093/jnci/dju023,,,,24685923,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6115677,https://api.altmetric.com/v1/donut/6115677_240.png 0,Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression.,Cancer Research,,,Article,2009-04-14,10.1158/0008-5472.can-08-3506,,,,19351846,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6115619,https://api.altmetric.com/v1/donut/6115619_240.png 0,Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer.,Cancer Letters,,,Article,2010-06-27,10.1016/j.canlet.2009.11.023,,,,20044205,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6115617,https://api.altmetric.com/v1/donut/6115617_240.png 0,Novel biomarkers for prostate cancer including noncoding transcripts.,American Journal of Pathology,,,Article,2009-12-15,10.2353/ajpath.2009.080868,,,,19893039,PMC2789638,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6115616,https://api.altmetric.com/v1/donut/6115616_240.png 0,Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.,Gene Therapy,,,Article,2010-06-14,10.1038/gt.2010.20,,,,20220784,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6115554,https://api.altmetric.com/v1/donut/6115554_240.png 0,Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures.,Gene Therapy,,,Article,2009-12-15,10.1038/gt.2009.94,,,,19693098,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6115552,https://api.altmetric.com/v1/donut/6115552_240.png 0,Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.,Cancer Gene Therapy,,,Article,2009-07-14,10.1038/cgt.2009.10,,,,19197321,PMC2843507,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6115551,https://api.altmetric.com/v1/donut/6115551_240.png 0,Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes.,PLoS ONE,,,Article,,10.1371/journal.pone.0135982,,,,26295840,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6115500,https://api.altmetric.com/v1/donut/6115500_240.png 0,Integrin ? 7 Binds Tissue Inhibitor of Metalloproteinase 3 to Suppress Growth of Prostate Cancer Cells.,American Journal of Pathology,,,Article,2013-09-14,10.1016/j.ajpath.2013.05.010,,,,23830872,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6115498,https://api.altmetric.com/v1/donut/6115498_240.png 0,Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft.,Cancer Research,,,Article,2009-11-15,10.1158/0008-5472.can-09-1782,,,,19861534,PMC2783669,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6115324,https://api.altmetric.com/v1/donut/6115324_240.png 0,Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study.,,,,Article,2013-07-19,10.1186/1472-6963-13-279,,,,23870420,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6115062,https://api.altmetric.com/v1/donut/6115062_240.png 0,The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells.,Genes & Cancer,,,Article,2011-01-01,10.1177/1947601910395578,,,,21373373,PMC3046414,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6115042,https://api.altmetric.com/v1/donut/6115042_240.png 0,Development of PROSTVAC immunotherapy in prostate cancer.,Future Oncology,,,Article,,10.2217/fon.15.120,,,,26235179,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6115012,https://api.altmetric.com/v1/donut/6115012_240.png 0,Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals.,Gastroenterology,,,Article,2011-02-15,10.1053/j.gastro.2010.11.001,,,,21070776,PMC3031760,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6114861,https://api.altmetric.com/v1/donut/6114861_240.png 0,"Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-09-14,10.1158/1055-9965.epi-10-0400,,,,20699371,PMC2936681,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6114842,https://api.altmetric.com/v1/donut/6114842_240.png 0,"Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",American Journal of Clinical Nutrition,,,Article,2010-02-15,10.3945/ajcn.2009.28433,,,,20007302,PMC2806895,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6114841,https://api.altmetric.com/v1/donut/6114841_240.png 0,Immunotherapy in prostate cancer: emerging strategies against a formidable foe.,Vaccine,,,Article,2011-09-01,10.1016/j.vaccine.2011.06.088,,,,21741424,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6114720,https://api.altmetric.com/v1/donut/6114720_240.png 0,Germline genetic variants associated with prostate cancer and potential relevance to clinical practice.,Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer,,,Article,,10.1007/978-3-642-45195-9_2,,,,24531773,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6114346,https://api.altmetric.com/v1/donut/6114346_240.png 0,The role of BRCA1 and BRCA2 in prostate cancer.,Asian Journal of Andrology,,,Article,2012-05-14,10.1038/aja.2011.150,,,,22522501,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6114345,https://api.altmetric.com/v1/donut/6114345_240.png 0,"Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.",The Prostate,,,Article,2014-05-21,10.1002/pros.22826,,,,24854630,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6114293,https://api.altmetric.com/v1/donut/6114293_240.png 0,A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: A step towards practical implementation.,Magnetic Resonance Imaging (0730725X),,,Article,2014-01-21,10.1016/j.mri.2014.01.004,,,,24560287,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6114205,https://api.altmetric.com/v1/donut/6114205_240.png 0,Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance.,Frontiers in oncology,,,Article,,10.3389/fonc.2015.00004,,,,25674540,PMC4306300,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6114014,https://api.altmetric.com/v1/donut/6114014_240.png 0,Delineation and visualization of prostate cancer in multiparametric MRI.,Practical Radiation Oncology,,,Article,,10.1016/j.prro.2013.01.105,,,,24674544,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6114013,https://api.altmetric.com/v1/donut/6114013_240.png 0,Resveratrol-zinc combination for prostate cancer management.,Cell Cycle,,,Article,2014-05-26,,,,,24866157,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6113947,https://api.altmetric.com/v1/donut/6113947_240.png 0,Communication and intimacy-enhancing interventions for men diagnosed with prostate cancer and their partners.,Journal of Sexual Medicine,,,Article,2013-02-15,10.1111/jsm.12049,,,,23387918,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6113943,https://api.altmetric.com/v1/donut/6113943_240.png 0,Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.,The Prostate,,,Article,2011-07-14,10.1002/pros.21321,,,,21557271,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6113907,https://api.altmetric.com/v1/donut/6113907_240.png 0,Blocking IKK? expression inhibits prostate cancer invasiveness.,Pharmaceutical Research,,,Article,2011-06-14,10.1007/s11095-010-0351-z,,,,21191633,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6113894,https://api.altmetric.com/v1/donut/6113894_240.png 0,Development of a peptide-drug conjugate for prostate cancer therapy.,Molecular Pharmaceutics,,,Article,2011-06-05,10.1021/mp200007b,,,,21510670,PMC3163154,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6113893,https://api.altmetric.com/v1/donut/6113893_240.png 0,Androgen receptor signaling and mutations in prostate cancer.,Asian Journal of Andrology,,,Article,2010-09-14,10.1038/aja.2010.89,,,,20711217,PMC3006239,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6113880,https://api.altmetric.com/v1/donut/6113880_240.png 0,Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.,,,,Article,2010-07-07,10.1371/journal.pone.0011475,,,,20628607,PMC2900211,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6113879,https://api.altmetric.com/v1/donut/6113879_240.png 0,Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer.,Asian Journal of Andrology,,,Article,2010-05-14,10.1038/aja.2010.5,,,,20173765,PMC3008322,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6113878,https://api.altmetric.com/v1/donut/6113878_240.png 0,Androgen receptor mutations and polymorphisms in african american prostate cancer.,International journal of biological sciences,,,Article,,10.7150/ijbs.8974,,,,24948877,PMC4062957,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6113877,https://api.altmetric.com/v1/donut/6113877_240.png 0,Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.,Urologic Oncology,,,Article,2013-12-11,10.1016/j.urolonc.2013.09.018,,,,24332649,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6113624,https://api.altmetric.com/v1/donut/6113624_240.png 0,TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression.,,,,Article,2012-04-25,10.4172/1948-5956.1000119,,,,23264855,PMC3527835,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6113512,https://api.altmetric.com/v1/donut/6113512_240.png 0,Antioxidants for prostate cancer chemoprevention: Challenges and opportunities.,Biochemical Pharmacology,,,Article,2012-05-14,10.1016/j.bcp.2011.12.027,,,,22248733,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6113406,https://api.altmetric.com/v1/donut/6113406_240.png 0,Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy.,Cancer and Metastasis Reviews,,,Article,2014-01-12,10.1007/s10555-013-9482-0,,,,24414227,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6113398,https://api.altmetric.com/v1/donut/6113398_240.png 0,Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment.,Journal of Geriatric Oncology,,,Article,2014-09-17,10.1016/j.jgo.2014.08.004,,,,25240918,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6113358,https://api.altmetric.com/v1/donut/6113358_240.png 0,The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer.,Journal of Geriatric Oncology,,,Article,,10.1016/j.jgo.2012.08.007,,,,23482846,PMC3591488,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6113357,https://api.altmetric.com/v1/donut/6113357_240.png 0,MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells.,,,,Article,2013-08-08,10.1371/journal.pone.0070987,,,,23951060,PMC3739799,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6113250,https://api.altmetric.com/v1/donut/6113250_240.png 0,The ubiquitin ligase Siah2 is revealed as an accomplice of the androgen receptor in castration resistant prostate cancer.,Asian Journal of Andrology,,,Article,2013-07-14,10.1038/aja.2013.62,,,,23708461,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6113249,https://api.altmetric.com/v1/donut/6113249_240.png 0,Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression.,Journal of Cancer Science & Therapy,,,Article,2010-01-01,10.4172/1948-5956.1000030,,,,20808724,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6113202,https://api.altmetric.com/v1/donut/6113202_240.png 0,Androgen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-02-15,10.1158/1055-9965.epi-12-1137,,,,23292083,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6113171,https://api.altmetric.com/v1/donut/6113171_240.png 0,Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients.,Molecular Carcinogenesis,,,Article,2014-07-06,10.1002/mc.22193,,,,25043940,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6113168,https://api.altmetric.com/v1/donut/6113168_240.png 0,Nanoways to overcome docetaxel resistance in prostate cancer.,Drug Resistance Updates,,,Article,2014-04-04,10.1016/j.drup.2014.04.001,,,,24853766,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6113036,https://api.altmetric.com/v1/donut/6113036_240.png 0,Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer.,,,,Article,2012-01-15,,,,,21892919,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6113033,https://api.altmetric.com/v1/donut/6113033_240.png 0,CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells.,"Cancer Immunology, Immunotherapy",,,Article,2011-06-14,10.1007/s00262-011-0987-5,,,,21350948,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6112982,https://api.altmetric.com/v1/donut/6112982_240.png 0,Preclinical and clinical development of DNA vaccines for prostate cancer.,Urologic Oncology,,,Article,2013-12-11,10.1016/j.urolonc.2013.09.014,,,,24332642,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6112981,https://api.altmetric.com/v1/donut/6112981_240.png 0,DNA Vaccines for Prostate Cancer.,Current Cancer Therapy Reviews,,,Article,2012-11-01,10.2174/157339412804143113,,,,24587772,PMC3935480,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6112978,https://api.altmetric.com/v1/donut/6112978_240.png 0,Sipuleucel-T: immunotherapy for advanced prostate cancer.,Open access journal of urology,,,Article,2011-05-02,10.2147/oaju.s13069,,,,24198636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6112977,https://api.altmetric.com/v1/donut/6112977_240.png 0,A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.,Clinical Chemistry,,,Article,2010-01-15,10.1373/clinchem.2009.133272,,,,19910504,PMC2858593,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6112935,https://api.altmetric.com/v1/donut/6112935_240.png 0,From AR to c-Met: Androgen deprivation leads to a signaling pathway switch in prostate cancer cells.,International Journal of Oncology,,,Article,2013-10-14,10.3892/ijo.2013.2020,,,,23877345,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6112871,https://api.altmetric.com/v1/donut/6112871_240.png 0,Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.,Bioorganic & Medicinal Chemistry Letters,,,Article,2012-06-14,10.1016/j.bmcl.2012.04.110,,,,22607680,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6112869,https://api.altmetric.com/v1/donut/6112869_240.png 0,Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells.,International Journal of Oncology,,,Article,2012-12-15,10.3892/ijo.2012.1649,,,,23041906,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6112868,https://api.altmetric.com/v1/donut/6112868_240.png 0,Prolonged androgen deprivation leads to overexpression of calpain 2: Implications for prostate cancer progression.,International Journal of Oncology,,,Article,2013-11-29,10.3892/ijo.2013.2196,,,,24297527,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6112864,https://api.altmetric.com/v1/donut/6112864_240.png 0,Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.,International Journal of Oncology,,,Article,2014-01-10,10.3892/ijo.2014.2256,,,,24424840,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6112863,https://api.altmetric.com/v1/donut/6112863_240.png 0,Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer.,Bioconjugate Chemistry,,,Article,2014-08-25,10.1021/bc500362n,,,,25157916,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6112862,https://api.altmetric.com/v1/donut/6112862_240.png 0,Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.,Bioorganic & Medicinal Chemistry Letters,,,Article,2013-01-15,10.1016/j.bmcl.2012.11.015,,,,23232055,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6112861,https://api.altmetric.com/v1/donut/6112861_240.png 0,Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5.,Life Sciences,,,Article,2010-02-27,10.1016/j.lfs.2010.01.008,,,,20096292,PMC3003259,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6112851,https://api.altmetric.com/v1/donut/6112851_240.png 0,A novel approach for establishing benchmark CBCT/CT deformable image registrations in prostate cancer radiotherapy.,Physics in Medicine & Biology,,,Article,2013-10-31,10.1088/0031-9155/58/22/8077,,,,24171908,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6112740,https://api.altmetric.com/v1/donut/6112740_240.png 0,Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.,Oncogene,,,Article,2014-12-22,10.1038/onc.2014.426,,,,25531328,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6112643,https://api.altmetric.com/v1/donut/6112643_240.png 0,Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells.,Cancer Letters,,,Article,2013-08-31,10.1016/j.canlet.2013.05.014,,,,23684928,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6112598,https://api.altmetric.com/v1/donut/6112598_240.png 0,"Withaferin A, a Steroidal Lactone from Withania somnifera, Induces Mitotic Catastrophe and Growth Arrest in Prostate Cancer Cells.",Journal of Natural Products,,,Article,2013-09-29,10.1021/np400441f,,,,24079846,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6112597,https://api.altmetric.com/v1/donut/6112597_240.png 0,"Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells.",Molecular Cancer Therapeutics,,,Article,2010-03-15,10.1158/1535-7163.mct-09-1013,,,,20179163,PMC3228252,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6112594,https://api.altmetric.com/v1/donut/6112594_240.png 0,"Pathobiological Implications of the Expression of EGFR, pAkt, NF-?B and MIC-1 in Prostate Cancer Stem Cells and Their Progenies.",,,,Article,,10.1371/journal.pone.0031919,,,,22384099,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6112593,https://api.altmetric.com/v1/donut/6112593_240.png 0,Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.,Molecular Medicine,,,Article,2011-01-01,10.2119/molmed.2011.00115,,,,21607288,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6112592,https://api.altmetric.com/v1/donut/6112592_240.png 0,Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.,British Journal of Cancer,,,Article,2013-03-19,10.1038/bjc.2012.484,,,,23449353,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6112591,https://api.altmetric.com/v1/donut/6112591_240.png 0,"Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKC{varepsilon}, Stat3 and neuroendocrine markers.",Carcinogenesis,,,Article,2012-12-15,10.1093/carcin/bgs291,,,,22976928,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6112590,https://api.altmetric.com/v1/donut/6112590_240.png 0,Hierarchical Clustering Method to Improve Transrectal Ultrasound-guided Diffuse Optical Tomography for Prostate Cancer Imaging.,Academic Radiology,,,Article,2014-02-15,10.1016/j.acra.2013.11.003,,,,24439338,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6112572,https://api.altmetric.com/v1/donut/6112572_240.png 0,Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.,Clinical Cancer Research,,,Article,2011-08-14,10.1158/1078-0432.ccr-10-2619,,,,21159887,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6112562,https://api.altmetric.com/v1/donut/6112562_240.png 0,Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.,Clinical Cancer Research,,,Article,2010-11-15,10.1158/1078-0432.ccr-10-1461,,,,21062931,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6112497,https://api.altmetric.com/v1/donut/6112497_240.png 0,Opposing Roles of Folate in Prostate Cancer.,Urology,,,Article,2013-08-27,10.1016/j.urology.2013.07.012,,,,23992971,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6112494,https://api.altmetric.com/v1/donut/6112494_240.png 0,Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.,The Prostate,,,Article,2012-07-31,10.1002/pros.22472,,,,22212909,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6112493,https://api.altmetric.com/v1/donut/6112493_240.png 0,AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.,Experimental Cell Research,,,Article,2013-07-14,10.1016/j.yexcr.2013.05.008,,,,23701950,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6112490,https://api.altmetric.com/v1/donut/6112490_240.png 0,Reduced-FOV Excitation Decreases Susceptibility Artifact in Diffusion-Weighted MRI with Endorectal Coil for Prostate Cancer Detection.,Magnetic Resonance Imaging (0730725X),,,Article,2014-09-04,10.1016/j.mri.2014.08.040,,,,25200645,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6112450,https://api.altmetric.com/v1/donut/6112450_240.png 0,Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound.,Clinical Imaging,,,Article,,10.1016/j.clinimag.2011.11.028,,,,22920360,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6112448,https://api.altmetric.com/v1/donut/6112448_240.png 0,Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease.,American Journal of Roentgenology,,,Article,2011-12-15,10.2214/ajr.11.6425,,,,22109291,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6112446,https://api.altmetric.com/v1/donut/6112446_240.png 0,Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance.,Abdominal Imaging,,,Article,2014-04-16,10.1007/s00261-014-0136-7,,,,24740760,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6112444,https://api.altmetric.com/v1/donut/6112444_240.png 0,Endorectal MRI and MR spectroscopic imaging of prostate cancer: Developing selection criteria for MR-guided focal therapy.,Journal of Magnetic Resonance Imaging,,,Article,2013-05-15,10.1002/jmri.24187,,,,23681669,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6112443,https://api.altmetric.com/v1/donut/6112443_240.png 0,PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer.,Cancer Research,,,Article,2012-03-15,10.1158/0008-5472.can-11-2602,,,,22282656,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6112439,https://api.altmetric.com/v1/donut/6112439_240.png 0,"A rare variant, which destroys a FoxA1 site at 8q24, is associated with prostate cancer risk.",Cell Cycle,,,Article,2013-01-15,,,,,23255135,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6112431,https://api.altmetric.com/v1/donut/6112431_240.png 0,Knockdown of the co-chaperone SGTA results in the suppression of androgen and PI3K/AKT signaling and inhibition of prostate cancer cell proliferation.,International Journal of Cancer,,,Article,2013-06-05,10.1002/ijc.28310,,,,23740762,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6112430,https://api.altmetric.com/v1/donut/6112430_240.png 0,Simulation-Based Cryosurgery Training: Variable Insertion Depth Planning in Prostate Cryosurgery.,Technology in Cancer Research and Treatment,,,Article,,10.1177/1533034615611509,,,,26546576,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6112321,https://api.altmetric.com/v1/donut/6112321_240.png 0,Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines.,Oncotarget,,,Article,2014-12-26,10.18632/oncotarget.3084,,,,25605250,PMC4413647,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6112251,https://api.altmetric.com/v1/donut/6112251_240.png 0,Prostate cancer mortality and birth or adult residence in the southern United States.,Cancer Causes and Control,,,Article,2012-07-14,10.1007/s10552-012-9970-5,,,,22547136,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6112187,https://api.altmetric.com/v1/donut/6112187_240.png 0,The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.,International Journal of Biochemistry & Cell Biology,,,Article,2012-07-14,10.1016/j.biocel.2012.04.005,,,,22531714,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6112169,https://api.altmetric.com/v1/donut/6112169_240.png 0,Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?,Urologic Oncology,,,Article,2013-03-15,10.1016/j.urolonc.2013.01.003,,,,23506962,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6111933,https://api.altmetric.com/v1/donut/6111933_240.png 0,Laparoscopic prostatectomy for prostate cancer: continued role in urology.,Surgical oncology clinics of North America,,,Article,2013-01-15,10.1016/j.soc.2012.08.001,,,,23158089,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6111932,https://api.altmetric.com/v1/donut/6111932_240.png 0,Postradiation osteosarcoma in an older prostate cancer survivor: case study and literature review with emphasis on geriatric principles.,,,,Article,2013-05-14,10.1159/000351588,,,,23741219,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6111931,https://api.altmetric.com/v1/donut/6111931_240.png 0,Treatment and Mortality in Men with Localized Prostate Cancer: A Population-Based Study in California.,,,,Article,,,,,,23997838,PMC3758138,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6111786,https://api.altmetric.com/v1/donut/6111786_240.png 0,"Using CBPR to Extend Prostate Cancer Education, Counseling, and Screening Opportunities to Urban-Dwelling African-Americans.",Journal of Cancer Education,,,Article,2016-10-21,10.1007/s13187-015-0849-5,,,,25948412,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6111736,https://api.altmetric.com/v1/donut/6111736_240.png 0,Patterns of information behavior and prostate cancer knowledge among african-american men.,Journal of Cancer Education,,,Article,2011-12-15,10.1007/s13187-011-0241-z,,,,21626265,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6111734,https://api.altmetric.com/v1/donut/6111734_240.png 0,Differential Tumorigenic Potential and Matriptase Activation between PDGF B vs. PDGF D in Prostate Cancer.,Molecular Cancer Research,,,Article,2012-08-14,10.1158/1541-7786.mcr-12-0071,,,,22689130,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6111718,https://api.altmetric.com/v1/donut/6111718_240.png 0,Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.,"Cancer Immunology, Immunotherapy",,,Article,2011-03-15,10.1007/s00262-010-0939-5,,,,21088965,PMC3042529,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6111629,https://api.altmetric.com/v1/donut/6111629_240.png 0,Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap.,BJU International,,,Article,2010-08-14,10.1111/j.1464-410x.2010.09467.x,,,,20553251,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6111531,https://api.altmetric.com/v1/donut/6111531_240.png 0,Health related quality of life for men treated for localized prostate cancer with long-term followup.,The Journal of Urology,,,Article,2010-06-14,10.1016/j.juro.2010.02.013,,,,20399462,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6111530,https://api.altmetric.com/v1/donut/6111530_240.png 0,Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.,Journal of Clinical Oncology,,,Article,2010-02-20,10.1200/jco.2009.26.2469,,,,20100957,PMC2834431,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6111529,https://api.altmetric.com/v1/donut/6111529_240.png 0,Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells.,The Prostate,,,Article,2010-05-31,10.1002/pros.21114,,,,20054820,PMC2860659,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6111473,https://api.altmetric.com/v1/donut/6111473_240.png 0,Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.,Clinical Cancer Research,,,Article,2009-05-14,10.1158/1078-0432.ccr-08-0826,,,,19417030,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6111332,https://api.altmetric.com/v1/donut/6111332_240.png 0,MiRNA 26a expression in a novel panel of African American prostate cancer cell lines.,Ethnicity and Disease,,,Article,,,,,,20521394,PMC3118047,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6111243,https://api.altmetric.com/v1/donut/6111243_240.png 0,Molecular Cycloencapsulation Augments Solubility and Improves Therapeutic Index of Brominated Noscapine in Prostate Cancer Cells.,Molecular Pharmaceutics,,,Article,2012-05-06,10.1021/mp300063v,,,,22540277,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6111239,https://api.altmetric.com/v1/donut/6111239_240.png 0,Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.,,,,Article,2011-09-13,10.1186/1476-4598-10-112,,,,21917149,PMC3180433,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6111237,https://api.altmetric.com/v1/donut/6111237_240.png 0,Increasing prostate cancer screening among African American men.,Journal of health care for the poor and underserved (Online),,,Article,2010-08-14,10.1353/hpu.0.0366,,,,20675948,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6111236,https://api.altmetric.com/v1/donut/6111236_240.png 0,Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient.,,,,Article,2010-12-15,,,,,21042716,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6111235,https://api.altmetric.com/v1/donut/6111235_240.png 0,DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer.,Endocrine-Related Cancer,,,Article,2009-06-14,10.1677/erc-08-0205,,,,19240183,PMC3072142,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6111159,https://api.altmetric.com/v1/donut/6111159_240.png 0,Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.,International Journal of Cancer,,,Article,2011-07-14,10.1002/ijc.25705,,,,20878981,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6111149,https://api.altmetric.com/v1/donut/6111149_240.png 0,Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.,Journal of Proteome Research,,,Article,2009-02-15,10.1021/pr8007539,,,,19035787,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/6111148,https://api.altmetric.com/v1/donut/6111148_240.png 0,Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion.,BONE,,,Article,2011-03-01,10.1016/j.bone.2010.11.003,,,,21073986,PMC3039095,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6111108,https://api.altmetric.com/v1/donut/6111108_240.png 0,"Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.",Cancer Letters,,,Article,2009-09-27,10.1016/j.canlet.2009.03.022,,,,19375853,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6111091,https://api.altmetric.com/v1/donut/6111091_240.png 0,Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.,International Journal of Cancer,,,Article,2009-11-15,10.1002/ijc.24574,,,,19610059,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6111086,https://api.altmetric.com/v1/donut/6111086_240.png 0,Understanding the loss-of-function in a triple missense mutant of DNA polymerase ? found in prostate cancer.,International Journal of Oncology,,,Article,2013-10-14,10.3892/ijo.2013.2022,,,,23877444,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6110983,https://api.altmetric.com/v1/donut/6110983_240.png 0,Historical Prostate Cancer Screening and Treatment Outcomes from a Single Institution.,Clinical Medicine & Research,,,Article,2012-08-14,10.3121/cmr.2011.1042,,,,22537761,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6110933,https://api.altmetric.com/v1/donut/6110933_240.png 0,Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.,Journal of the Society for Integrative Oncology,,,Article,,,,,,20205984,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6110908,https://api.altmetric.com/v1/donut/6110908_240.png 0,Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.,Biostatistics,,,Article,2010-07-14,10.1093/biostatistics/kxq004,,,,20173101,PMC2883301,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6110888,https://api.altmetric.com/v1/donut/6110888_240.png 0,Chemoprevention of prostate cancer.,The Journal of Urology,,,Article,,10.1016/j.juro.2009.04.015,,,,19524966,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6110886,https://api.altmetric.com/v1/donut/6110886_240.png 0,Re: Long-term survival of participants in the Prostate Cancer Prevention Trial.,Asian Journal of Andrology,,,Article,,,,,,24914438,PMC4023368,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6110885,https://api.altmetric.com/v1/donut/6110885_240.png 0,"Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients with Colorectal versus Breast, Lung or Prostate Cancer: Results from a Prospective Multicenter Study.",Journal of Pain & Symptom Management,,,Article,2015-01-13,10.1016/j.jpainsymman.2014.11.300,,,,25596011,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6110868,https://api.altmetric.com/v1/donut/6110868_240.png 0,Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial).,European Urology,,,Article,2009-01-15,10.1016/j.eururo.2008.09.008,,,,18823693,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6110816,https://api.altmetric.com/v1/donut/6110816_240.png 0,The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.,Oncotarget,,,Article,2014-03-26,10.18632/oncotarget.1850,,,,24681825,PMC4039239,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6110705,https://api.altmetric.com/v1/donut/6110705_240.png 0,Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4430,,,,26158290,PMC4599305,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6110700,https://api.altmetric.com/v1/donut/6110700_240.png 0,Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.,The Prostate,,,Article,2011-05-14,10.1002/pros.21292,,,,21031435,PMC3107902,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6110699,https://api.altmetric.com/v1/donut/6110699_240.png 0,Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.,Clinical Cancer Research,,,Article,2009-09-14,10.1158/1078-0432.ccr-09-0911,,,,19737960,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6110665,https://api.altmetric.com/v1/donut/6110665_240.png 0,Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA.,Urology,,,Article,2009-11-15,10.1016/j.urology.2009.01.087,,,,19647299,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6110664,https://api.altmetric.com/v1/donut/6110664_240.png 0,Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.,Urologic Oncology,,,Article,2013-07-14,10.1016/j.urolonc.2011.04.001,,,,21600800,PMC3210917,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,67,https://www.altmetric.com/details/6110663,https://api.altmetric.com/v1/donut/6110663_240.png 0,Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer.,Cancer Causes and Control,,,Article,2013-01-15,10.1007/s10552-012-0103-y,,,,23179660,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6110649,https://api.altmetric.com/v1/donut/6110649_240.png 0,Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.,Genetic Epidemiology,,,Article,2011-09-14,10.1002/gepi.20600,,,,21618606,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6110647,https://api.altmetric.com/v1/donut/6110647_240.png 0,Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-03-15,10.1158/1055-9965.epi-09-0618,,,,20200442,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6110646,https://api.altmetric.com/v1/donut/6110646_240.png 0,Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-05-14,10.1158/1055-9965.epi-09-1181,,,,20406958,PMC2866032,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6110645,https://api.altmetric.com/v1/donut/6110645_240.png 0,Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-01-15,10.1158/1055-9965.epi-08-0539,,,,19124512,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6110644,https://api.altmetric.com/v1/donut/6110644_240.png 0,Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).,BMC Cancer,,,Article,2009-07-28,10.1186/1471-2407-9-257,,,,19640273,PMC2729775,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6110643,https://api.altmetric.com/v1/donut/6110643_240.png 0,Common genetic variants in prostate cancer risk prediction - Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-03-15,10.1158/1055-9965.epi-11-1038,,,,22237985,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6110640,https://api.altmetric.com/v1/donut/6110640_240.png 0,Replication of Five Prostate Cancer Loci Identified in an Asian Population--Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-15,10.1158/1055-9965.epi-11-0870-t,,,,22056501,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6110639,https://api.altmetric.com/v1/donut/6110639_240.png 0,Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.,PLoS ONE,,,Article,2011-02-24,10.1371/journal.pone.0017142,,,,21390317,PMC3044744,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6110638,https://api.altmetric.com/v1/donut/6110638_240.png 0,Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-04-14,10.1158/1055-9965.epi-08-0327,,,,19336566,PMC2697376,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6110613,https://api.altmetric.com/v1/donut/6110613_240.png 0,Genome-wide linkage scan for prostate cancer susceptibility in Finland: evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22.,International Journal of Cancer,,,Article,2011-11-15,10.1002/ijc.25906,,,,21207418,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6110612,https://api.altmetric.com/v1/donut/6110612_240.png 0,Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-11-15,10.1158/1055-9965.epi-09-0772,,,,19861517,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6110610,https://api.altmetric.com/v1/donut/6110610_240.png 0,Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-10-14,10.1158/1055-9965.epi-09-0068,,,,19755651,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6110601,https://api.altmetric.com/v1/donut/6110601_240.png 0,Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-06-14,10.1158/1055-9965.epi-09-0076,,,,19505920,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6110599,https://api.altmetric.com/v1/donut/6110599_240.png 0,Incorporation of Detailed Family History from the Swedish Family-Cancer Database into the Prostate Cancer Prevention Trial Risk Calculator.,The Journal of Urology,,,Article,2014-09-17,10.1016/j.juro.2014.09.018,,,,25242395,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6110598,https://api.altmetric.com/v1/donut/6110598_240.png 0,A case control study of sarcosine as an early prostate cancer detection biomarker.,BMC Urology,,,Article,,10.1186/s12894-015-0095-5,,,,26429735,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6110597,https://api.altmetric.com/v1/donut/6110597_240.png 0,Retraction: Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.,The Prostate,,,Article,2012-06-30,,,,,22803194,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6110575,https://api.altmetric.com/v1/donut/6110575_240.png 0,Small integrin-binding proteins as serum markers for prostate cancer detection.,Clinical Cancer Research,,,Article,2009-08-14,10.1158/1078-0432.ccr-09-0783,,,,19671866,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6110574,https://api.altmetric.com/v1/donut/6110574_240.png 0,Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.,The Prostate,,,Article,2009-07-31,10.1002/pros.20963,,,,19418497,PMC3178806,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6110573,https://api.altmetric.com/v1/donut/6110573_240.png 0,Pathological features of lymph node metastases in predicting biochemical recurrence after radical prostatectomy for prostate cancer.,The Journal of Urology,,,Article,2013-04-14,10.1016/j.juro.2012.10.027,,,,23085057,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6109998,https://api.altmetric.com/v1/donut/6109998_240.png 0,Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer.,British Journal of Urology,,,Article,2011-09-14,10.1111/j.1464-410x.2010.09924.x,,,,21166755,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6109983,https://api.altmetric.com/v1/donut/6109983_240.png 0,Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.,Urology,,,Article,2010-02-15,10.1016/j.urology.2009.04.061,,,,19643467,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6109975,https://api.altmetric.com/v1/donut/6109975_240.png 0,Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.,The Journal of Urology,,,Article,2010-05-14,10.1016/j.juro.2010.01.014,,,,20299035,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6109972,https://api.altmetric.com/v1/donut/6109972_240.png 0,A multi-institutional evaluation of active surveillance for low risk prostate cancer.,The Journal of Urology,,,Article,2009-04-14,10.1016/j.juro.2008.11.109,,,,19233410,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6109966,https://api.altmetric.com/v1/donut/6109966_240.png 0,"Interleukin-1? mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.",Cancer Research,,,Article,2011-07-31,10.1158/0008-5472.can-10-2160,,,,21653679,PMC3148300,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6109950,https://api.altmetric.com/v1/donut/6109950_240.png 0,Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2014-06-12,10.1586/14737140.2014.928594,,,,24927631,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6109838,https://api.altmetric.com/v1/donut/6109838_240.png 0,Metastasis as a therapeutic target in prostate cancer: a conceptual framework.,American journal of clinical and experimental urology,,,Article,2014-04-14,,,,,25360439,PMC4211109,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6109685,https://api.altmetric.com/v1/donut/6109685_240.png 0,"EZH2, an epigenetic driver of prostate cancer.",Protein & Cell,,,Article,2013-05-14,10.1007/s13238-013-2093-2,,,,23636686,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/6109653,https://api.altmetric.com/v1/donut/6109653_240.png 0,Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-01-15,10.1158/1055-9965.epi-12-0922-t,,,,23129590,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6109528,https://api.altmetric.com/v1/donut/6109528_240.png 0,Targeting bone physiology for the treatment of metastatic prostate cancer.,Clinical Advances in Hematology & Oncology,,,Article,2013-03-15,,,,,23598981,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6109407,https://api.altmetric.com/v1/donut/6109407_240.png 0,Case report: responses to cabazitaxel in metastatic castration-resistant prostate cancer after extensive docetaxel treatment.,Clinical Genitourinary Cancer,,,Article,2011-12-15,10.1016/j.clgc.2011.06.001,,,,21816687,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6109354,https://api.altmetric.com/v1/donut/6109354_240.png 0,The burden of skeletal-related events in patients with prostate cancer and bone metastasis.,Urologic Oncology,,,Article,2014-10-30,10.1016/j.urolonc.2014.09.010,,,,25443265,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6109352,https://api.altmetric.com/v1/donut/6109352_240.png 0,Treatment With Galeterone in an Elderly Man With Castration-Resistant Prostate Cancer: A Case Report.,Clinical Genitourinary Cancer,,,Article,2014-12-31,10.1016/j.clgc.2014.12.015,,,,25600761,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6109350,https://api.altmetric.com/v1/donut/6109350_240.png 0,"Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer.",Cancer (0008543X),,,Article,,10.1002/cncr.29398,,,,25903013,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6109348,https://api.altmetric.com/v1/donut/6109348_240.png 0,Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls.,Translational oncology,,,Article,2014-02-15,,,,,24772215,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6109347,https://api.altmetric.com/v1/donut/6109347_240.png 0,Mental health outcomes in elderly men with prostate cancer.,Urologic Oncology,,,Article,2014-08-17,10.1016/j.urolonc.2014.05.005,,,,25153773,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6109345,https://api.altmetric.com/v1/donut/6109345_240.png 0,"Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer.",Prostate Cancer & Prostatic Diseases,,,Article,2014-08-04,10.1038/pcan.2014.28,,,,25091040,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6109343,https://api.altmetric.com/v1/donut/6109343_240.png 0,Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer.,Hematology/oncology clinics of North America,,,Article,2013-12-15,10.1016/j.hoc.2013.08.009,,,,24188262,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6109338,https://api.altmetric.com/v1/donut/6109338_240.png 0,Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.,Drugs,,,Article,2013-08-12,10.1007/s40265-013-0107-2,,,,23943203,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6109333,https://api.altmetric.com/v1/donut/6109333_240.png 0,Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study.,Cancer Causes and Control,,,Article,2009-11-15,10.1007/s10552-009-9407-y,,,,19653109,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6109318,https://api.altmetric.com/v1/donut/6109318_240.png 0,Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.,The Journal of Urology,,,Article,2010-06-14,10.1016/j.juro.2010.02.017,,,,20399459,PMC2903223,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6109300,https://api.altmetric.com/v1/donut/6109300_240.png 0,PKC? activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells.,The Prostate,,,Article,2011-06-14,10.1002/pros.21310,,,,21541971,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6109278,https://api.altmetric.com/v1/donut/6109278_240.png 0,Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses.,Human Immunology,,,Article,2010-05-14,10.1016/j.humimm.2010.02.007,,,,20153396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6109226,https://api.altmetric.com/v1/donut/6109226_240.png 0,Androgen-responsive Serum Response Factor (SRF) target genes regulate prostate cancer cell migration.,Carcinogenesis,,,Article,2013-08-14,10.1093/carcin/bgt126,,,,23576568,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6109141,https://api.altmetric.com/v1/donut/6109141_240.png 0,Castration-resistant prostate cancer: latest evidence and therapeutic implications.,Therapeutic Advances in Medical Oncology,,,Article,2014-07-14,10.1177/1758834014529176,,,,25057303,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6109136,https://api.altmetric.com/v1/donut/6109136_240.png 0,Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-11-15,10.1016/j.ijrobp.2010.06.019,,,,20970033,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6108899,https://api.altmetric.com/v1/donut/6108899_240.png 0,Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer.,Urologic Oncology,,,Article,2012-11-01,10.1016/j.urolonc.2011.02.002,,,,21795078,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6108746,https://api.altmetric.com/v1/donut/6108746_240.png 0,Dietary factors and risk for advanced prostate cancer.,European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP),,,Article,2013-07-17,10.1097/cej.0b013e3283647394,,,,23872953,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6108684,https://api.altmetric.com/v1/donut/6108684_240.png 0,"Clinical Profile, Quality of Care, and Recurrence in Arab-American and Caucasians Prostate Cancer Patients in Michigan.",Journal of Immigrant & Minority Health,,,Article,2013-08-14,10.1007/s10903-012-9662-y,,,,22763459,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6108617,https://api.altmetric.com/v1/donut/6108617_240.png 0,"Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study.",,,,Article,2010-01-15,10.1371/journal.pone.0008736,,,,20090948,PMC2806913,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6108597,https://api.altmetric.com/v1/donut/6108597_240.png 0,Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California.,Cancer Causes and Control,,,Article,2009-06-13,10.1007/s10552-009-9369-0,,,,19526319,PMC2746891,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6108594,https://api.altmetric.com/v1/donut/6108594_240.png 0,Observation versus initial treatment for prostate cancer.,Annals of Internal Medicine,,,Article,2013-10-14,10.7326/0003-4819-159-8-201310150-00016,,,,24126653,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6108545,https://api.altmetric.com/v1/donut/6108545_240.png 0,Sexual self-schema and depressive symptoms after prostate cancer.,Psycho-Oncology,,,Article,2014-06-11,10.1002/pon.3601,,,,24920457,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6108422,https://api.altmetric.com/v1/donut/6108422_240.png 0,Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis.,Nature Communications,,,Article,2015-10-26,10.1038/ncomms9802,,,,26499136,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6108395,https://api.altmetric.com/v1/donut/6108395_240.png 0,A review of African American-white differences in risk factors for cancer: prostate cancer.,Cancer Causes and Control,,,Article,2011-03-15,10.1007/s10552-010-9712-5,,,,21184263,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6108351,https://api.altmetric.com/v1/donut/6108351_240.png 0,Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.,BMC Family Practice,,,Article,2009-03-18,10.1186/1471-2296-10-19,,,,19296843,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6108328,https://api.altmetric.com/v1/donut/6108328_240.png 0,Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.,Journal of Health Communication,,,Article,,10.1080/10810730.2015.1018618,,,,26066011,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6108324,https://api.altmetric.com/v1/donut/6108324_240.png 0,Physician Behaviors to Promote Informed Decisions for Prostate Cancer Screening: a National Research Network Study.,Journal of Cancer Education,,,Article,2014-02-02,10.1007/s13187-014-0613-2,,,,24488590,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6108321,https://api.altmetric.com/v1/donut/6108321_240.png 0,Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.,Cancer (0008543X),,,Article,2011-03-01,10.1002/cncr.25671,,,,21351084,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6108302,https://api.altmetric.com/v1/donut/6108302_240.png 0,A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.,Bioorganic & Medicinal Chemistry Letters,,,Article,2010-12-01,10.1016/j.bmcl.2010.09.057,,,,20947349,PMC3201797,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6108182,https://api.altmetric.com/v1/donut/6108182_240.png 0,Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.,Cancer Letters,,,Article,2010-09-30,10.1016/j.canlet.2010.04.003,,,,20452720,PMC3201799,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6108181,https://api.altmetric.com/v1/donut/6108181_240.png 0,Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists.,Cancer Letters,,,Article,2010-07-27,10.1016/j.canlet.2010.01.012,,,,20347216,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6108024,https://api.altmetric.com/v1/donut/6108024_240.png 0,Adaptive radiation therapy for prostate cancer.,Seminars in Radiation Oncology,,,Article,2010-04-14,10.1016/j.semradonc.2009.11.007,,,,20219551,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,99,https://www.altmetric.com/details/6107989,https://api.altmetric.com/v1/donut/6107989_240.png 0,Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.,Magnetic Resonance in Medicine,,,Article,2011-03-15,10.1002/mrm.22652,,,,20928869,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6107969,https://api.altmetric.com/v1/donut/6107969_240.png 0,"Multicenter phase II trial of the heat shock protein 90 inhibitor, retaspimycin hydrochloride (IPI-504), in patients with castration-resistant prostate cancer.",Urology,,,Article,2011-09-14,10.1016/j.urology.2011.04.041,,,,21762967,PMC3166448,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6107942,https://api.altmetric.com/v1/donut/6107942_240.png 0,Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.,Molecular & Cellular Endocrinology,,,Article,2012-05-05,10.1016/j.mce.2011.08.032,,,,21914459,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6107769,https://api.altmetric.com/v1/donut/6107769_240.png 0,The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells.,The Prostate,,,Article,2012-04-30,10.1002/pros.21464,,,,21796654,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6107755,https://api.altmetric.com/v1/donut/6107755_240.png 0,Selective apoptosis induction by the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamide is achieved by modulating mitochondrial bioenergetics in premalignant and malignant human prostate epithelial cells.,Apoptosis,,,Article,2009-07-14,10.1007/s10495-009-0356-4,,,,19421858,PMC2891029,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6107752,https://api.altmetric.com/v1/donut/6107752_240.png 0,"Teriflunomide (leflunomide) promotes cytostatic, antioxidant, and apoptotic effects in transformed prostate epithelial cells: evidence supporting a role for teriflunomide in prostate cancer chemoprevention.",Neoplasia,,,Article,2010-06-14,,,,,20563249,PMC2887087,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6107751,https://api.altmetric.com/v1/donut/6107751_240.png 0,Housekeeping genes in prostate tumorigenesis.,International Journal of Cancer,,,Article,2009-12-01,10.1002/ijc.24680,,,,19551858,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6107750,https://api.altmetric.com/v1/donut/6107750_240.png 0,Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.,,,,Article,2010-12-09,10.1038/cddis.2010.85,,,,21368878,PMC3004480,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6107734,https://api.altmetric.com/v1/donut/6107734_240.png 0,Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.,Clinical Genetics,,,Article,2014-07-01,10.1111/cge.12447,,,,24989076,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6107696,https://api.altmetric.com/v1/donut/6107696_240.png 0,In vivo imaging of orthotopic prostate cancer with far-red gene reporter fluorescence tomography and in vivo and ex vivo validation.,Journal of Biomedical Optics,,,Article,2013-10-14,10.1117/1.jbo.18.10.101305,,,,23797877,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6107664,https://api.altmetric.com/v1/donut/6107664_240.png 0,Activation of AKR1C1/ER? induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3417,,,,25816367,PMC4484479,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6107656,https://api.altmetric.com/v1/donut/6107656_240.png 0,Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer management.,,,,Article,2010-05-14,,,,,20370708,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6107655,https://api.altmetric.com/v1/donut/6107655_240.png 0,The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers.,Physics in Medicine & Biology,,,Article,2011-08-06,10.1088/0031-9155/56/15/016,,,,21772076,PMC3154133,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6107532,https://api.altmetric.com/v1/donut/6107532_240.png 0,AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.,Medical Physics,,,Article,2009-11-15,,,,,19994539,PMC2776817,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,109,https://www.altmetric.com/details/6107530,https://api.altmetric.com/v1/donut/6107530_240.png 0,Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells.,Molecular Pharmaceutics,,,Article,,10.1021/mp8002682,,,,19344119,PMC2692824,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6107321,https://api.altmetric.com/v1/donut/6107321_240.png 0,Combination therapy of prostate cancer with HPMA copolymer conjugates containing PI3K/mTOR inhibitor and docetaxel.,European Journal of Pharmaceutics & Biopharmaceutics,,,Article,2014-12-03,10.1016/j.ejpb.2014.11.025,,,,25481033,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6107320,https://api.altmetric.com/v1/donut/6107320_240.png 0,Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer.,Journal of Drug Targeting,,,Article,2013-12-15,10.3109/1061186x.2013.833207,,,,24160903,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6107319,https://api.altmetric.com/v1/donut/6107319_240.png 0,Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.,Macromolecular Bioscience,,,Article,2012-03-15,,,,,22493797,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6107318,https://api.altmetric.com/v1/donut/6107318_240.png 0,Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.,Biomaterials,,,Article,2012-02-15,10.1016/j.biomaterials.2011.11.029,,,,22138033,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6107317,https://api.altmetric.com/v1/donut/6107317_240.png 0,PINing down the origin of prostate cancer.,Science Translational Medicine,,,Article,2010-08-03,10.1126/scitranslmed.3001445,,,,20686176,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6107275,https://api.altmetric.com/v1/donut/6107275_240.png 0,Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer.,PLoS ONE,,,Article,2009-05-28,10.1371/journal.pone.0005722,,,,19478945,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6107272,https://api.altmetric.com/v1/donut/6107272_240.png 0,LL-37 as a therapeutic target for late stage prostate cancer.,The Prostate,,,Article,2011-05-14,10.1002/pros.21282,,,,20957672,PMC3025071,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6107193,https://api.altmetric.com/v1/donut/6107193_240.png 0,Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer.,,,,Article,2009-01-27,,,,,19223836,PMC2949274,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6107152,https://api.altmetric.com/v1/donut/6107152_240.png 0,Monte Carlo fast dose calculator for proton radiotherapy: application to a voxelized geometry representing a patient with prostate cancer.,Physics in Medicine & Biology,,,Article,2009-01-07,10.1088/0031-9155/54/1/n03,,,,19075361,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6107151,https://api.altmetric.com/v1/donut/6107151_240.png 0,Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer.,Physics in Medicine & Biology,,,Article,2010-12-07,10.1088/0031-9155/55/23/s13,,,,21076190,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6107141,https://api.altmetric.com/v1/donut/6107141_240.png 0,AMBIENT DOSE EQUIVALENT VERSUS EFFECTIVE DOSE FOR QUANTIFYING STRAY RADIATION EXPOSURES TO A PATIENT RECEIVING PROTON THERAPY FOR PROSTATE CANCER.,,,,Article,2009-09-30,,,,,20844596,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6107132,https://api.altmetric.com/v1/donut/6107132_240.png 0,Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-05-31,10.1016/j.ijrobp.2009.01.001,,,,19427561,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/6107129,https://api.altmetric.com/v1/donut/6107129_240.png 0,Promotion of tumor development in prostate cancer by progerin.,,,,Article,2010-11-24,10.1186/1475-2867-10-47,,,,21106101,PMC3003644,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6107125,https://api.altmetric.com/v1/donut/6107125_240.png 0,Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.,International Journal of Cancer,,,Article,2009-03-31,10.1002/ijc.24118,,,,19089921,PMC2913418,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6107122,https://api.altmetric.com/v1/donut/6107122_240.png 0,Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.,International Journal of Oncology,,,Article,2010-02-15,,,,,20043082,PMC2929386,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6107050,https://api.altmetric.com/v1/donut/6107050_240.png 0,Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide.,Cancer Letters,,,Article,,10.1016/j.canlet.2010.07.012,,,,20675041,PMC2956783,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6107049,https://api.altmetric.com/v1/donut/6107049_240.png 0,Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.,The Prostate,,,Article,2009-05-31,10.1002/pros.20937,,,,19189297,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6107007,https://api.altmetric.com/v1/donut/6107007_240.png 0,Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin.,International Journal of Oncology,,,Article,2014-07-24,10.3892/ijo.2014.2561,,,,25175770,PMC4151800,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6107001,https://api.altmetric.com/v1/donut/6107001_240.png 0,Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway.,Journal of carcinogenesis & mutagenesis,,,Article,2013-11-05,10.4172/2157-2518.s6-005,,,,24877026,PMC4035051,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6106999,https://api.altmetric.com/v1/donut/6106999_240.png 0,Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer.,,,,Article,,10.3390/cancers3033353,,,,21961053,PMC3180910,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6106992,https://api.altmetric.com/v1/donut/6106992_240.png 0,"MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer.",,,,Article,,10.1371/journal.pone.0055502,,,,23383207,PMC3559583,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6106953,https://api.altmetric.com/v1/donut/6106953_240.png 0,"Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells.",NMR in Biomedicine,,,Article,2013-03-15,10.1002/nbm.2848,,,,22945392,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6106943,https://api.altmetric.com/v1/donut/6106943_240.png 0,The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.,Asian Journal of Andrology,,,Article,2014-03-07,10.4103/1008-682x.125907,,,,24625885,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6106845,https://api.altmetric.com/v1/donut/6106845_240.png 0,Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.,The Prostate,,,Article,2013-08-25,10.1002/pros.22721,,,,24037738,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6106844,https://api.altmetric.com/v1/donut/6106844_240.png 0,A novel Germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.,The Prostate,,,Article,2013-01-15,10.1002/pros.22552,,,,22718278,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6106843,https://api.altmetric.com/v1/donut/6106843_240.png 0,Genome-wide two-locus epistasis scans in prostate cancer using two European populations.,Human Genetics,,,Article,2012-07-14,10.1007/s00439-012-1148-4,,,,22367438,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6106842,https://api.altmetric.com/v1/donut/6106842_240.png 0,A Genome-Wide Survey over the ChIP-On-Chip Identified Androgen Receptor-Binding Genomic Regions Identifies a Novel Prostate Cancer Susceptibility Locus at 12q13.13.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-11-15,10.1158/1055-9965.epi-11-0523,,,,21960693,PMC3210915,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6106841,https://api.altmetric.com/v1/donut/6106841_240.png 0,Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer.,Human Molecular Genetics,,,Article,2011-07-14,10.1093/hmg/ddr189,,,,21531787,PMC3118760,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6106840,https://api.altmetric.com/v1/donut/6106840_240.png 0,New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.,The Prostate,,,Article,2010-05-31,10.1002/pros.21116,,,,20058240,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6106733,https://api.altmetric.com/v1/donut/6106733_240.png 0,Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2009-06-08,10.1073/pnas.0900258106,,,,19458261,PMC2695075,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6106613,https://api.altmetric.com/v1/donut/6106613_240.png 0,Gene variants in the angiogenesis pathway and prostate cancer.,Carcinogenesis,,,Article,2012-07-14,10.1093/carcin/bgs150,,,,22523086,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6106535,https://api.altmetric.com/v1/donut/6106535_240.png 0,Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness.,Urology,,,Article,2011-10-14,10.1016/j.urology.2011.04.055,,,,21802122,PMC3190039,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6106534,https://api.altmetric.com/v1/donut/6106534_240.png 0,Promoter hypermethylation in prostate cancer.,Cancer Control: Journal of the Moffitt Cancer Center,,,Article,2010-10-14,,,,,20861812,PMC3167691,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6106533,https://api.altmetric.com/v1/donut/6106533_240.png 0,DNA methylation in promoter region as biomarkers in prostate cancer.,Methods in molecular biology,,,Article,,10.1007/978-1-61779-612-8_5,,,,22359288,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6106532,https://api.altmetric.com/v1/donut/6106532_240.png 0,Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.,Methods in molecular biology,,,Article,2009-01-01,10.1007/978-1-59745-416-2_18,,,,19109789,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6106531,https://api.altmetric.com/v1/donut/6106531_240.png 0,"miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases.",Asian Journal of Andrology,,,Article,2013-03-15,10.1038/aja.2012.160,,,,23353719,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6106530,https://api.altmetric.com/v1/donut/6106530_240.png 0,Androgen Receptor Primes Prostate Cancer Cells to Apoptosis Through Down-regulation of Basal p21 Expression.,Biochemical & Biophysical Research Communications,,,Article,2013-01-04,10.1016/j.bbrc.2012.10.135,,,,23159636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6106481,https://api.altmetric.com/v1/donut/6106481_240.png 0,Zinc Finger 280B Regulates sGC?1 and p53 in Prostate Cancer Cells.,PloS one,,,Article,2013-11-13,10.1371/journal.pone.0078766,,,,24236047,PMC3827277,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6106431,https://api.altmetric.com/v1/donut/6106431_240.png 0,Potential stages for prostate cancer prevention with selenium: implications for cancer survivors.,Cancer Research,,,Article,2009-03-31,10.1158/0008-5472.can-08-4359,,,,19318549,PMC2909787,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6106423,https://api.altmetric.com/v1/donut/6106423_240.png 0,"Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.",Cancer Treatment Reviews,,,Article,2013-08-06,10.1016/j.ctrv.2013.07.008,,,,23993415,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/6106276,https://api.altmetric.com/v1/donut/6106276_240.png 0,Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.,Cancer Research,,,Article,2009-05-14,10.1158/0008-5472.can-08-4102,,,,19435909,PMC3084614,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6106238,https://api.altmetric.com/v1/donut/6106238_240.png 0,Human RecQL4 helicase plays critical roles in prostate carcinogenesis.,Cancer Research,,,Article,2010-11-15,10.1158/0008-5472.can-10-1743,,,,21045146,PMC3058916,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6106230,https://api.altmetric.com/v1/donut/6106230_240.png 0,Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.,Cancer Prevention Research,,,Article,2009-05-14,10.1158/1940-6207.capr-08-0173,,,,19401524,PMC2822708,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6106177,https://api.altmetric.com/v1/donut/6106177_240.png 0,A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model.,Cancer Prevention Research,,,Article,2010-07-14,10.1158/1940-6207.capr-09-0273,,,,20587701,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6106176,https://api.altmetric.com/v1/donut/6106176_240.png 0,Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.,,,,Article,2010-05-14,,,,,20370687,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6106175,https://api.altmetric.com/v1/donut/6106175_240.png 0,In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.,Molecular Cancer Therapeutics,,,Article,2009-03-15,10.1158/1535-7163.mct-08-0908,,,,19276161,PMC2822709,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6106174,https://api.altmetric.com/v1/donut/6106174_240.png 0,Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.,Nutrition and Cancer,,,Article,,10.1080/01635581.2011.563029,,,,21614726,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6106173,https://api.altmetric.com/v1/donut/6106173_240.png 0,Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.,Neoplasia,,,Article,2010-05-14,,,,,20454510,PMC2864476,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6106172,https://api.altmetric.com/v1/donut/6106172_240.png 0,Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.,Neoplasia,,,Article,2011-01-15,,,,,21245938,PMC3022426,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6106170,https://api.altmetric.com/v1/donut/6106170_240.png 0,"""Topological significance"" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response.",,,,Article,2010-06-02,10.1371/journal.pone.0010936,,,,20532174,PMC2880599,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6106115,https://api.altmetric.com/v1/donut/6106115_240.png 0,The Mutational Landscape of Prostate Cancer.,European Urology,,,Article,2013-10-14,10.1016/j.eururo.2013.05.029,,,,23759327,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,95,https://www.altmetric.com/details/6106022,https://api.altmetric.com/v1/donut/6106022_240.png 0,Oncogenic transcription factors as master regulators of chromatin topology: A new role for ERG in prostate cancer.,Cell Cycle,,,Article,2012-09-14,,,,,22918253,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6106021,https://api.altmetric.com/v1/donut/6106021_240.png 0,Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.,The Prostate,,,Article,2009-09-30,10.1002/pros.20998,,,,19514049,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6105964,https://api.altmetric.com/v1/donut/6105964_240.png 0,Lycopene and apo-12'-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells.,Nutrition and Cancer,,,Article,2011-02-01,10.1080/01635581.2011.523494,,,,21207319,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6105951,https://api.altmetric.com/v1/donut/6105951_240.png 0,Tomato-based food products for prostate cancer prevention: what have we learned?,Cancer and Metastasis Reviews,,,Article,2010-09-14,10.1007/s10555-010-9246-z,,,,20803054,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77,https://www.altmetric.com/details/6105949,https://api.altmetric.com/v1/donut/6105949_240.png 0,The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells.,Oncogene,,,Article,2010-01-14,10.1038/onc.2009.331,,,,19838218,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6105941,https://api.altmetric.com/v1/donut/6105941_240.png 0,Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia.,Cancer Letters,,,Article,2012-01-01,10.1016/j.canlet.2011.09.021,,,,22004727,PMC3225593,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6105937,https://api.altmetric.com/v1/donut/6105937_240.png 0,Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2009-05-14,10.1158/1535-7163.mct-08-1136,,,,19417145,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6105745,https://api.altmetric.com/v1/donut/6105745_240.png 0,SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.,Molecular Endocrinology,,,Article,2009-03-15,10.1210/me.2008-0219,,,,19116244,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6105707,https://api.altmetric.com/v1/donut/6105707_240.png 0,Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancer.,Molecular Cancer Therapeutics,,,Article,2011-09-14,10.1158/1535-7163.mct-10-1033,,,,21712477,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6105706,https://api.altmetric.com/v1/donut/6105706_240.png 0,KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.,Journal of Biological Chemistry,,,Article,2011-05-26,10.1074/jbc.m111.232637,,,,21454613,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6105701,https://api.altmetric.com/v1/donut/6105701_240.png 0,Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.,Neoplasia,,,Article,2009-11-15,,,,,19881949,PMC2767215,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6105699,https://api.altmetric.com/v1/donut/6105699_240.png 0,Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.,,,,Article,2010-05-31,10.1186/1471-2407-10-248,,,,20515470,PMC2886047,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6105545,https://api.altmetric.com/v1/donut/6105545_240.png 0,"Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation, and metastasis.",Carcinogenesis,,,Article,2012-07-14,10.1093/carcin/bgs153,,,,22535887,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6105456,https://api.altmetric.com/v1/donut/6105456_240.png 0,An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer.,Journal of Men's Health,,,Article,2012-08-31,,,,,24416090,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6105455,https://api.altmetric.com/v1/donut/6105455_240.png 0,"The Heat Shock Protein 90 Inhibitor, Epigallocatechin Gallate, has Anti-Cancer Activity in a Novel Human Prostate Cancer Progression Model.",Cancer Prevention Research,,,Article,2015-01-20,10.1158/1940-6207.capr-14-0224,,,,25604133,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6105453,https://api.altmetric.com/v1/donut/6105453_240.png 0,Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.,International Journal of Nanomedicine,,,Article,,10.2147/ijn.s34381,,,,22915856,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6105451,https://api.altmetric.com/v1/donut/6105451_240.png 0,"Prostate cancer targeting motifs: Expression of ?(?) ?(3) , neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts.",The Prostate,,,Article,2012-04-14,10.1002/pros.21454,,,,21748756,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6105450,https://api.altmetric.com/v1/donut/6105450_240.png 0,Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors.,,,,Article,2013-08-12,10.1371/journal.pone.0072407,,,,23967299,PMC3742533,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6105405,https://api.altmetric.com/v1/donut/6105405_240.png 0,Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration.,Carcinogenesis,,,Article,2010-03-15,10.1093/carcin/bgp217,,,,19736306,PMC2832542,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6105403,https://api.altmetric.com/v1/donut/6105403_240.png 0,Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.,Oncogene,,,Article,2010-06-23,10.1038/onc.2010.121,,,,20440270,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/6105357,https://api.altmetric.com/v1/donut/6105357_240.png 0,Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.,Molecular cancer,,,Article,2015-01-27,10.1186/s12943-014-0281-1,,,,25623427,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6105354,https://api.altmetric.com/v1/donut/6105354_240.png 0,TR4 nuclear receptor alters the prostate cancer CD133+ stem/progenitor cell invasion via modulating the EZH2-related metastasis gene expression.,Molecular Cancer Therapeutics,,,Article,,10.1158/1535-7163.mct-14-0971,,,,25833838,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6105353,https://api.altmetric.com/v1/donut/6105353_240.png 0,Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.,British Journal of Pharmacology,,,Article,2014-06-04,10.1111/bph.12800,,,,24903412,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6105345,https://api.altmetric.com/v1/donut/6105345_240.png 0,No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2009.03.031,,,,19523862,PMC3782416,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6105332,https://api.altmetric.com/v1/donut/6105332_240.png 0,The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-03-31,10.1016/j.ijrobp.2010.01.013,,,,20605361,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6105331,https://api.altmetric.com/v1/donut/6105331_240.png 0,Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.,Cancer Research,,,Article,2009-12-15,10.1158/0008-5472.can-09-0648,,,,19934327,PMC2955869,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6105321,https://api.altmetric.com/v1/donut/6105321_240.png 0,"The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.",Molecular Cancer,,,Article,2010-06-22,10.1186/1476-4598-9-162,,,,20573255,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6105292,https://api.altmetric.com/v1/donut/6105292_240.png 0,"Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth.",International Journal of Cancer,,,Article,2010-10-14,10.1002/ijc.25210,,,,20112340,PMC2888737,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6105291,https://api.altmetric.com/v1/donut/6105291_240.png 0,Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth.,The Prostate,,,Article,2010-02-01,10.1002/pros.21052,,,,19790232,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6105216,https://api.altmetric.com/v1/donut/6105216_240.png 0,Catheter-based ultrasound hyperthermia with HDR brachytherapy for treatment of locally advanced cancer of the prostate and cervix.,Proceedings Society of Photo Optical Instrumentation Engineers,,,Article,2011-02-22,10.1117/12.876401,,,,25076820,PMC4112774,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6105212,https://api.altmetric.com/v1/donut/6105212_240.png 0,A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer.,,,,Article,,10.1371/journal.pone.0020293,,,,21629784,PMC3100337,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6105175,https://api.altmetric.com/v1/donut/6105175_240.png 0,Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.,Biochemical Pharmacology,,,Article,2010-02-01,10.1016/j.bcp.2009.09.006,,,,19782051,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6105108,https://api.altmetric.com/v1/donut/6105108_240.png 0,Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.,Carcinogenesis,,,Article,2011-05-14,10.1093/carcin/bgr030,,,,21325633,PMC3086702,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6105100,https://api.altmetric.com/v1/donut/6105100_240.png 0,"Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia.",The Prostate,,,Article,,10.1002/pros.21218,,,,20583127,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6105017,https://api.altmetric.com/v1/donut/6105017_240.png 0,Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.,The Prostate,,,Article,2011-05-14,10.1002/pros.21291,,,,21031434,PMC3116049,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6104999,https://api.altmetric.com/v1/donut/6104999_240.png 0,Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer.,Cancer Gene Therapy,,,Article,2013-07-14,10.1038/cgt.2013.34,,,,23764901,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6104950,https://api.altmetric.com/v1/donut/6104950_240.png 0,Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.,Cancer Letters,,,Article,,10.1016/j.canlet.2012.10.010,,,,23079532,PMC3513505,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6104921,https://api.altmetric.com/v1/donut/6104921_240.png 0,Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.,Psycho-Oncology,,,Article,,10.1002/pon.1401,,,,18636420,PMC2853938,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6104864,https://api.altmetric.com/v1/donut/6104864_240.png 0,Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection.,Magnetic Resonance in Medicine,,,Article,2013-01-15,10.1002/mrm.24211,,,,22457233,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/6104848,https://api.altmetric.com/v1/donut/6104848_240.png 0,Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.,British Journal of Cancer,,,Article,2010-09-27,10.1038/sj.bjc.6605850,,,,20717117,PMC2965863,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6104751,https://api.altmetric.com/v1/donut/6104751_240.png 0,Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease.,Clinical Cancer Research,,,Article,2009-03-15,10.1158/1078-0432.ccr-08-2332,,,,19276266,PMC2991083,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6104743,https://api.altmetric.com/v1/donut/6104743_240.png 0,In vitro and in vivo effects of water extract of white cocoa tea (Camellia ptilophylla) against human prostate cancer.,Pharmaceutical Research,,,Article,2010-06-14,10.1007/s11095-010-0052-7,,,,20224992,PMC2992824,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6104741,https://api.altmetric.com/v1/donut/6104741_240.png 0,Dietary zinc and prostate cancer in the TRAMP mouse model.,Journal of Medicinal Food,,,Article,2010-02-15,10.1089/jmf.2009.0042,,,,20136438,PMC2991100,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6104740,https://api.altmetric.com/v1/donut/6104740_240.png 0,Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells.,Carcinogenesis,,,Article,2010-08-14,10.1093/carcin/bgq115,,,,20530556,PMC2915634,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6104738,https://api.altmetric.com/v1/donut/6104738_240.png 0,Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.,Clinical Cancer Research,,,Article,2009-01-15,10.1158/1078-0432.ccr-08-1631,,,,19147749,PMC2951134,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6104737,https://api.altmetric.com/v1/donut/6104737_240.png 0,Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer.,Physics in Medicine & Biology,,,Article,2014-02-07,10.1088/0031-9155/59/3/647,,,,24434775,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6104639,https://api.altmetric.com/v1/donut/6104639_240.png 0,Preliminary evaluation of the dosimetric accuracy of the in vivo plastic scintillation detector OARtrac system for prostate cancer treatments.,Physics in Medicine & Biology,,,Article,2014-05-06,10.1088/0031-9155/59/9/n27,,,,24732073,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6104638,https://api.altmetric.com/v1/donut/6104638_240.png 0,Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.,Oncology Reports,,,Article,2011-06-14,10.3892/or.2011.1237,,,,21455584,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6104540,https://api.altmetric.com/v1/donut/6104540_240.png 0,The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells.,International Journal of Oncology,,,Article,2010-03-15,,,,,20126983,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6104539,https://api.altmetric.com/v1/donut/6104539_240.png 0,Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.,Carcinogenesis,,,Article,2010-11-15,10.1093/carcin/bgq188,,,,20837598,PMC2981059,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6104538,https://api.altmetric.com/v1/donut/6104538_240.png 0,Physicians' attitudes about shared decision making for prostate cancer screening.,Family Medicine Journal,,,Article,2011-04-14,,,,,21499999,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6104462,https://api.altmetric.com/v1/donut/6104462_240.png 0,Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer.,Cancer (0008543X),,,Article,2010-03-31,10.1002/cncr.24960,,,,20143429,PMC2846994,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6104434,https://api.altmetric.com/v1/donut/6104434_240.png 0,Genetic and epigenetic inactivation of LPL gene in human prostate cancer.,International Journal of Cancer,,,Article,,10.1002/ijc.23972,,,,19004026,PMC3667349,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6104429,https://api.altmetric.com/v1/donut/6104429_240.png 0,Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.,The Prostate,,,Article,2009-02-15,10.1002/pros.20882,,,,19035483,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6104428,https://api.altmetric.com/v1/donut/6104428_240.png 0,"Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.",Clinical and Experimental Metastasis,,,Article,2010-03-15,10.1007/s10585-010-9316-1,,,,20339907,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6104410,https://api.altmetric.com/v1/donut/6104410_240.png 0,Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion.,Journal of Molecular Medicine,,,Article,2009-02-14,10.1007/s00109-009-0446-3,,,,19219419,PMC2796542,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6104377,https://api.altmetric.com/v1/donut/6104377_240.png 0,Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.,Oncogene,,,Article,2009-05-06,10.1038/onc.2009.63,,,,19347029,PMC2679420,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6104374,https://api.altmetric.com/v1/donut/6104374_240.png 0,"Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth.",Genes & Cancer,,,Article,2010-08-14,10.1177/1947601910383416,,,,21442031,PMC3063649,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6104370,https://api.altmetric.com/v1/donut/6104370_240.png 0,Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study.,Journal of Nutritional Biochemistry,,,Article,2009-12-15,10.1016/j.jnutbio.2008.09.004,,,,19071009,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6104017,https://api.altmetric.com/v1/donut/6104017_240.png 0,Combined measure of pro- and anti-oxidant exposures in relation to prostate cancer and colorectal adenoma risk: an update.,Annals of Epidemiology,,,Article,2010-12-15,10.1016/j.annepidem.2010.08.011,,,,21074110,PMC3008422,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6104009,https://api.altmetric.com/v1/donut/6104009_240.png 0,Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer.,Clinical Cancer Research,,,Article,2009-08-31,10.1158/1078-0432.ccr-08-2584,,,,19706826,PMC2884979,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6103994,https://api.altmetric.com/v1/donut/6103994_240.png 0,p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.,Cancer Research,,,Article,2009-02-01,10.1158/0008-5472.can-08-3115,,,,19176374,PMC2633420,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6103926,https://api.altmetric.com/v1/donut/6103926_240.png 0,Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.,Journal of Molecular Medicine,,,Article,2012-10-14,10.1007/s00109-012-0885-0,,,,22422151,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6103872,https://api.altmetric.com/v1/donut/6103872_240.png 0,Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4712,,,,26308072,PMC4694827,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6103870,https://api.altmetric.com/v1/donut/6103870_240.png 0,Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.,Magnetic Resonance Imaging (0730725X),,,Article,2013-07-14,10.1016/j.mri.2013.02.007,,,,23602725,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6103843,https://api.altmetric.com/v1/donut/6103843_240.png 0,Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.,European Radiology,,,Article,2012-10-14,10.1007/s00330-012-2475-5,,,,22661019,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6103842,https://api.altmetric.com/v1/donut/6103842_240.png 0,"Diagnosis of localized, screen-detected, prostate cancer--crisis or opportunity?",JNCI: Journal of the National Cancer Institute,,,Article,2010-07-06,10.1093/jnci/djq219,,,,20562372,PMC2897880,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6103834,https://api.altmetric.com/v1/donut/6103834_240.png 0,Contemporary risk profile of prostate cancer in the United States.,JNCI: Journal of the National Cancer Institute,,,Article,2009-09-15,10.1093/jnci/djp262,,,,19713548,PMC2744729,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6103833,https://api.altmetric.com/v1/donut/6103833_240.png 0,Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.,Genome Research,,,Article,2011-01-15,10.1101/gr.110684.110,,,,21036922,PMC3012926,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,102,https://www.altmetric.com/details/6103811,https://api.altmetric.com/v1/donut/6103811_240.png 0,Testing mutual exclusivity of ETS rearranged prostate cancer.,Laboratory Investigation,,,Article,2011-03-15,10.1038/labinvest.2010.179,,,,20975660,PMC3130188,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6103810,https://api.altmetric.com/v1/donut/6103810_240.png 0,ERG rearrangement metastasis patterns in locally advanced prostate cancer.,Urology,,,Article,2010-04-14,10.1016/j.urology.2009.10.010,,,,20018353,PMC2850965,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6103809,https://api.altmetric.com/v1/donut/6103809_240.png 0,Genistein Increases Estrogen Receptor Beta Expression in Prostate Cancer via Reducing its Promoter Methylation.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,,10.1016/j.jsbmb.2015.04.018,,,,25931004,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6103786,https://api.altmetric.com/v1/donut/6103786_240.png 0,The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis.,Bioinformatics,,,Article,2009-01-01,10.1093/bioinformatics/btn354,,,,18628288,PMC2638928,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6103781,https://api.altmetric.com/v1/donut/6103781_240.png 0,miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes.,,,,Article,2010-12-22,10.1371/journal.pone.0014356,,,,21203553,PMC3008681,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6103642,https://api.altmetric.com/v1/donut/6103642_240.png 0,A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells.,Cancer Research,,,Article,2010-03-31,10.1158/0008-5472.can-09-4572,,,,20233868,PMC2848907,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6103641,https://api.altmetric.com/v1/donut/6103641_240.png 0,RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells.,Annals of the New York Academy of Sciences,,,Article,2010-07-14,10.1111/j.1749-6632.2010.05613.x,,,,20649549,PMC3107504,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6103640,https://api.altmetric.com/v1/donut/6103640_240.png 0,RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2010-04-14,10.1158/1535-7163.mct-09-1001,,,,20371728,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6103639,https://api.altmetric.com/v1/donut/6103639_240.png 0,RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.,Cancer Research,,,Article,2009-04-14,10.1158/0008-5472.can-08-4635,,,,19351823,PMC2756761,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6103638,https://api.altmetric.com/v1/donut/6103638_240.png 0,Redox-Mediated and Ionizing Radiation-Induced Inflammatory Mediators in Prostate Cancer Development and Treatment.,Antioxidants & Redox Signaling,,,Article,2013-10-04,10.1089/ars.2013.5637,,,,24093432,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6103636,https://api.altmetric.com/v1/donut/6103636_240.png 0,"D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.",Molecular Cancer Therapeutics,,,Article,2009-07-14,10.1158/1535-7163.mct-09-0104,,,,19584240,PMC2779717,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6103550,https://api.altmetric.com/v1/donut/6103550_240.png 0,Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer.,Apoptosis,,,Article,2014-02-23,10.1007/s10495-014-0971-6,,,,24563225,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6103547,https://api.altmetric.com/v1/donut/6103547_240.png 0,A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer.,Clinical Cancer Research,,,Article,2010-01-01,10.1158/1078-0432.ccr-09-0948,,,,20028763,PMC2854027,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6103539,https://api.altmetric.com/v1/donut/6103539_240.png 0,An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2008-09-09,10.1038/pcan.2008.45,,,,18779856,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6103538,https://api.altmetric.com/v1/donut/6103538_240.png 0,Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells.,Nutrition and Cancer,,,Article,2009-05-07,10.1080/01635580802582751,,,,19373614,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6103536,https://api.altmetric.com/v1/donut/6103536_240.png 0,Targeting tyrosine kinases and autophagy in prostate cancer.,Hormones and Cancer,,,Article,2011-02-15,10.1007/s12672-010-0053-3,,,,21350583,PMC3020299,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6103364,https://api.altmetric.com/v1/donut/6103364_240.png 0,Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors.,Genes & Cancer,,,Article,2010-01-15,10.1177/1947601909358324,,,,20811583,PMC2930266,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6103363,https://api.altmetric.com/v1/donut/6103363_240.png 0,The Development of an eHealth Tool Suite for Prostate Cancer Patients and Their Partners.,The Journal of Supportive Oncology,,,Article,2012-09-01,10.1016/j.suponc.2012.02.003,,,,22591675,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6103346,https://api.altmetric.com/v1/donut/6103346_240.png 0,Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.,Molecular Medicine,,,Article,2011-01-01,10.2119/molmed.2010.00136,,,,20882260,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6103236,https://api.altmetric.com/v1/donut/6103236_240.png 0,Differentiation of Prostate Cancer Cells by Using Flexible Fluorescent Polymers.,Analytical Chemistry,,,Article,2012-01-03,10.1021/ac202301k,,,,22148518,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6103092,https://api.altmetric.com/v1/donut/6103092_240.png 0,Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.,International Journal of Biochemistry & Cell Biology,,,Article,2011-10-14,10.1016/j.biocel.2011.06.007,,,,21704724,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6103051,https://api.altmetric.com/v1/donut/6103051_240.png 0,Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.,Cancer Prevention Research,,,Article,2010-11-15,10.1158/1940-6207.capr-10-0123,,,,20959517,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6102989,https://api.altmetric.com/v1/donut/6102989_240.png 0,Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells.,Clinical Cancer Research,,,Article,2009-07-31,10.1158/1078-0432.ccr-09-0512,,,,19622577,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6102986,https://api.altmetric.com/v1/donut/6102986_240.png 0,Site-specific S-nitrosylation of Integrin ?6 Increases Prostate Cancer Cell Migration by Increasing Integrin ?1 Association and Reducing Adherence to Laminin-1.,Biochemistry (00062979),,,Article,2012-12-04,10.1021/bi3012324,,,,23106339,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6102940,https://api.altmetric.com/v1/donut/6102940_240.png 0,"Estrogens and prostate cancer: etiology, mediators, prevention, and management.",Endocrinology and metabolism clinics of North America (Print),,,Article,2011-09-14,10.1016/j.ecl.2011.05.002,,,,21889723,PMC3167093,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6102938,https://api.altmetric.com/v1/donut/6102938_240.png 0,Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer.,The Prostate,,,Article,2010-05-14,10.1002/pros.21109,,,,20054818,PMC2857536,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6102937,https://api.altmetric.com/v1/donut/6102937_240.png 0,"Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.",Cell Death & Differentiation,,,Article,2010-09-14,10.1038/cdd.2010.20,,,,20203690,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6102935,https://api.altmetric.com/v1/donut/6102935_240.png 0,"Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.",Endocrine-Related Cancer,,,Article,2010-09-14,10.1677/erc-09-0294,,,,20501637,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6102933,https://api.altmetric.com/v1/donut/6102933_240.png 0,A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model.,Artificial Intelligence in Medicine,,,Article,2009-06-14,10.1016/j.artmed.2008.12.002,,,,19157811,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/6102931,https://api.altmetric.com/v1/donut/6102931_240.png 0,Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: Potential effects on the tumor microenvironment.,Cancer Biology and Therapy,,,Article,2014-01-14,,,,,24423651,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6102849,https://api.altmetric.com/v1/donut/6102849_240.png 0,Trading in your spindles for blebs: the amoeboid tumor cell phenotype in prostate cancer.,Asian Journal of Andrology,,,Article,2014-02-21,10.4103/1008-682x.122877,,,,24589458,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6102848,https://api.altmetric.com/v1/donut/6102848_240.png 0,alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis.,Carcinogenesis,,,Article,2009-07-14,10.1093/carcin/bgp112,,,,19420015,PMC2704284,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6102823,https://api.altmetric.com/v1/donut/6102823_240.png 0,Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.,,,,Article,,10.1371/journal.pone.0067149,,,,23840605,PMC3686768,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6102818,https://api.altmetric.com/v1/donut/6102818_240.png 0,Suppression of Prostate Epithelial Proliferation and Intraprostatic Pro-Growth Signaling in Transgenic Mice by a New Energy Restriction-Mimetic Agent.,Cancer Prevention Research,,,Article,2013-03-15,10.1158/1940-6207.capr-12-0057,,,,23275006,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6102817,https://api.altmetric.com/v1/donut/6102817_240.png 0,Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.,The Prostate,,,Article,2012-12-01,10.1002/pros.22530,,,,22539223,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6102815,https://api.altmetric.com/v1/donut/6102815_240.png 0,Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.,Journal of Biological Chemistry,,,Article,2011-03-25,10.1074/jbc.m110.203240,,,,21282102,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6102812,https://api.altmetric.com/v1/donut/6102812_240.png 0,Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.,Oncogene,,,Article,2013-08-21,10.1038/onc.2012.412,,,,22986532,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6102803,https://api.altmetric.com/v1/donut/6102803_240.png 0,Androgen receptor levels are upregulated by Akt in prostate cancer.,Endocrine-Related Cancer,,,Article,2011-04-14,10.1530/erc-10-0204,,,,21317204,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6102802,https://api.altmetric.com/v1/donut/6102802_240.png 0,"FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.",Investigational New Drugs,,,Article,2010-06-14,10.1007/s10637-009-9232-x,,,,19274441,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6102719,https://api.altmetric.com/v1/donut/6102719_240.png 0,"Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer.",Cancer Causes and Control,,,Article,,10.1007/s10552-015-0668-3,,,,26407952,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6102715,https://api.altmetric.com/v1/donut/6102715_240.png 0,Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.,Clinical Cancer Research,,,Article,2011-03-01,10.1158/1078-0432.ccr-10-0881,,,,21343373,PMC3059497,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6102714,https://api.altmetric.com/v1/donut/6102714_240.png 0,Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2009-10-05,10.1073/pnas.0905707106,,,,19805094,PMC2761305,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6102673,https://api.altmetric.com/v1/donut/6102673_240.png 0,Identification of extracellular delta-catenin accumulation for prostate cancer detection.,The Prostate,,,Article,2009-03-01,10.1002/pros.20902,,,,19116988,PMC2633034,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6102639,https://api.altmetric.com/v1/donut/6102639_240.png 0,?-Catenin promotes E-cadherin processing and activates ?-catenin-mediated signaling: Implications on human prostate cancer progression.,Biochimica et Biophysica Acta (BBA),,,Article,2012-04-14,10.1016/j.bbadis.2011.12.015,,,,22261283,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6102636,https://api.altmetric.com/v1/donut/6102636_240.png 0,delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles.,Molecular Cancer,,,Article,2009-03-10,10.1186/1476-4598-8-19,,,,19284555,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6102626,https://api.altmetric.com/v1/donut/6102626_240.png 0,Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer.,Oncogene,,,Article,,10.1038/onc.2008.399,,,,18978817,PMC2678952,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6102625,https://api.altmetric.com/v1/donut/6102625_240.png 0,"1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.",Cancer Prevention Research,,,Article,2010-08-14,10.1158/1940-6207.capr-10-0054,,,,20606040,PMC2923922,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6102612,https://api.altmetric.com/v1/donut/6102612_240.png 0,Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.,Cancer Prevention Research,,,Article,2009-07-14,10.1158/1940-6207.capr-09-0047,,,,19584079,PMC2902275,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6102610,https://api.altmetric.com/v1/donut/6102610_240.png 0,Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia.,Cancer medicine,,,Article,2014-02-07,10.1002/cam4.198,,,,24515947,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6102608,https://api.altmetric.com/v1/donut/6102608_240.png 0,Methylseleninic acid downregulates hypoxia-inducible factor-1? in invasive prostate cancer.,International Journal of Cancer,,,Article,2012-03-15,10.1002/ijc.26141,,,,21500193,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6102604,https://api.altmetric.com/v1/donut/6102604_240.png 0,The hedgehog/Gli signaling paradigm in prostate cancer.,Expert Review of Endocrinology & Metabolism,,,Article,2014-01-10,10.1586/eem.11.2,,,,21776292,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6102580,https://api.altmetric.com/v1/donut/6102580_240.png 0,Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells.,,,,Article,2009-01-01,,,,,19158486,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6102579,https://api.altmetric.com/v1/donut/6102579_240.png 0,MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.,Cancer Prevention Research,,,Article,2011-01-15,10.1158/1940-6207.capr-10-0167,,,,21071579,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6102562,https://api.altmetric.com/v1/donut/6102562_240.png 0,Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.,Cancer (0008543X),,,Article,2010-01-01,10.1002/cncr.24662,,,,19885928,PMC3954042,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6102554,https://api.altmetric.com/v1/donut/6102554_240.png 0,The Effect of Differing Gleason Scores at Biopsy on the Odds of Upgrading and the Risk of Death From Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2014-03-03,10.1016/j.clgc.2014.02.008,,,,24721618,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6102485,https://api.altmetric.com/v1/donut/6102485_240.png 0,Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the ?1 integrin-RACK1 axis.,Journal of Cellular Physiology,,,Article,2012-11-15,10.1002/jcp.24074,,,,22378065,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6102451,https://api.altmetric.com/v1/donut/6102451_240.png 0,Integrin signaling aberrations in prostate cancer.,,,,Article,2009-04-19,,,,,19956432,PMC2757165,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6102449,https://api.altmetric.com/v1/donut/6102449_240.png 0,The search for a better prostate cancer biomarker.,The Journal of Urology,,,Article,2011-11-15,10.1016/j.juro.2011.08.019,,,,21944983,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6102447,https://api.altmetric.com/v1/donut/6102447_240.png 0,Molecular targets for radiation oncology in prostate cancer.,Frontiers in oncology,,,Article,,10.3389/fonc.2011.00017,,,,22645712,PMC3355820,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6102446,https://api.altmetric.com/v1/donut/6102446_240.png 0,"CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells.",,,,Article,2010-03-15,,,,,20407603,PMC2855629,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6102445,https://api.altmetric.com/v1/donut/6102445_240.png 0,"Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.",Cancer (0008543X),,,Article,2013-09-15,10.1002/cncr.28345,,,,24104703,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6102378,https://api.altmetric.com/v1/donut/6102378_240.png 0,RhoGDI? suppresses growth and survival of prostate cancer cells.,The Prostate,,,Article,2012-03-15,10.1002/pros.21441,,,,21681778,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6102358,https://api.altmetric.com/v1/donut/6102358_240.png 0,MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth.,,,,Article,,10.1371/journal.pone.0032832,,,,22479342,PMC3316551,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6102357,https://api.altmetric.com/v1/donut/6102357_240.png 0,NF-kappaB2/p52 induces resistance to Enzalutamide in Prostate Cancer: Role of androgen receptor and its variants.,Molecular Cancer Therapeutics,,,Article,2013-07-31,10.1158/1535-7163.mct-13-0027,,,,23699654,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6102356,https://api.altmetric.com/v1/donut/6102356_240.png 0,Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.,The Prostate,,,Article,2012-01-15,10.1002/pros.21409,,,,21538419,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6102355,https://api.altmetric.com/v1/donut/6102355_240.png 0,Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer.,Genes & Cancer,,,Article,2011-02-15,10.1177/1947601911409744,,,,21779488,PMC3111248,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6102353,https://api.altmetric.com/v1/donut/6102353_240.png 0,Molecular mechanisms of castration-resistant prostate cancer progression.,Future Oncology,,,Article,2009-11-15,10.2217/fon.09.117,,,,19903068,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6102352,https://api.altmetric.com/v1/donut/6102352_240.png 0,Interleukin-6 regulates androgen synthesis in prostate cancer cells.,Clinical Cancer Research,,,Article,2009-07-31,10.1158/1078-0432.ccr-09-0640,,,,19638459,PMC3041150,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6102351,https://api.altmetric.com/v1/donut/6102351_240.png 0,RhoGDI? downregulates androgen receptor signaling in prostate cancer cells.,The Prostate,,,Article,2013-08-05,10.1002/pros.22615,,,,23922223,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6102350,https://api.altmetric.com/v1/donut/6102350_240.png 0,Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.,The Prostate,,,Article,2010-02-15,10.1002/pros.21062,,,,19827050,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6102349,https://api.altmetric.com/v1/donut/6102349_240.png 0,Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.,Cancer Research,,,Article,2010-04-14,10.1158/0008-5472.can-09-3703,,,,20388792,PMC3041633,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6102348,https://api.altmetric.com/v1/donut/6102348_240.png 0,Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2.,Molecular Cancer Therapeutics,,,Article,2009-03-15,10.1158/1535-7163.mct-08-0823,,,,19240160,PMC3041173,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6102347,https://api.altmetric.com/v1/donut/6102347_240.png 0,Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination.,Magnetic Resonance Imaging (0730725X),,,Article,2009-05-14,10.1016/j.mri.2008.08.001,,,,18823731,PMC2720831,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6102306,https://api.altmetric.com/v1/donut/6102306_240.png 0,Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.,Molecular & Cellular Endocrinology,,,Article,2011-08-05,10.1016/j.mce.2011.05.023,,,,21664238,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6102276,https://api.altmetric.com/v1/donut/6102276_240.png 0,Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.,Molecular Cancer,,,Article,2010-09-22,10.1186/1476-4598-9-258,,,,20863401,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,74,https://www.altmetric.com/details/6102275,https://api.altmetric.com/v1/donut/6102275_240.png 0,Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model.,Laboratory Investigation,,,Article,2013-03-15,10.1038/labinvest.2012.179,,,,23358109,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6102131,https://api.altmetric.com/v1/donut/6102131_240.png 0,Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis.,Clinical Cancer Research,,,Article,2009-12-01,10.1158/1078-0432.ccr-09-1938,,,,19920103,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6102128,https://api.altmetric.com/v1/donut/6102128_240.png 0,Autophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cells.,The Prostate,,,Article,2012-09-14,10.1002/pros.22489,,,,22294520,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6101937,https://api.altmetric.com/v1/donut/6101937_240.png 0,Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels.,Cancer Research,,,Article,2009-03-15,10.1158/0008-5472.can-08-3083,,,,19244115,PMC2657818,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6101934,https://api.altmetric.com/v1/donut/6101934_240.png 0,Systemic blockade of the hyaluronan receptor for endocytosis (HARE) prevents lymph node metastasis of prostate cancer.,International Journal of Cancer,,,Article,2012-08-31,10.1002/ijc.27427,,,,22234863,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6101932,https://api.altmetric.com/v1/donut/6101932_240.png 0,(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.,Molecular Cancer Therapeutics,,,Article,2011-05-14,10.1158/1535-7163.mct-10-0936,,,,21372225,PMC3227412,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6101903,https://api.altmetric.com/v1/donut/6101903_240.png 0,GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression.,Cancer Research,,,Article,2009-02-01,10.1158/0008-5472.can-08-2537,,,,19176382,PMC2668918,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6101897,https://api.altmetric.com/v1/donut/6101897_240.png 0,Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.,Cancer Research,,,Article,2009-07-14,10.1158/0008-5472.can-09-0755,,,,19567671,PMC2724674,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6101893,https://api.altmetric.com/v1/donut/6101893_240.png 0,Angiogenin as a molecular target for the treatment of prostate cancer.,Current Cancer Therapy Reviews,,,Article,2011-05-14,,,,,21743803,PMC3131147,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6101812,https://api.altmetric.com/v1/donut/6101812_240.png 0,Angiogenin-stimulated rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia.,Molecular Cancer Research,,,Article,2009-03-15,10.1158/1541-7786.mcr-08-0137,,,,19258415,PMC2668135,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6101808,https://api.altmetric.com/v1/donut/6101808_240.png 0,Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.,Clinical Cancer Research,,,Article,2009-03-15,10.1158/1078-0432.ccr-08-2593,,,,19276260,PMC2670466,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6101807,https://api.altmetric.com/v1/donut/6101807_240.png 0,Angiogenin mediates androgen-stimulated growth of prostate cancer cells and correlates with castration resistance.,Molecular Cancer Research,,,Article,2013-07-11,10.1158/1541-7786.mcr-13-0072,,,,23851444,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6101799,https://api.altmetric.com/v1/donut/6101799_240.png 0,Combined treatment targeting HIF-1? and Stat3 is a potent strategy for prostate cancer therapy.,The Prostate,,,Article,2011-12-15,10.1002/pros.21397,,,,21480310,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6101686,https://api.altmetric.com/v1/donut/6101686_240.png 0,Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate.,Magnetic Resonance in Medicine,,,Article,2009-11-15,10.1002/mrm.22120,,,,19780158,PMC2783184,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6101598,https://api.altmetric.com/v1/donut/6101598_240.png 0,Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model.,Cancer Biology and Therapy,,,Article,2011-12-15,,,,,22156800,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6101596,https://api.altmetric.com/v1/donut/6101596_240.png 0,Clinical trial update and novel therapeutic approaches for metastatic prostate cancer.,,,,Article,,,,,,21864277,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6101367,https://api.altmetric.com/v1/donut/6101367_240.png 0,Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells.,Journal of Cellular Physiology,,,Article,2010-07-14,10.1002/jcp.22071,,,,20232320,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6101366,https://api.altmetric.com/v1/donut/6101366_240.png 0,Targeting JunD: A potential strategy to counteract hormone-refractory prostate cancer.,Cell Cycle,,,Article,2011-10-14,10.4161/cc.10.20.17668,,,,22030692,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6101335,https://api.altmetric.com/v1/donut/6101335_240.png 0,"Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-04-06,10.1158/1055-9965.epi-13-0670,,,,24711484,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6101319,https://api.altmetric.com/v1/donut/6101319_240.png 0,Immunohistochemical expression of BRCA1 and lethal prostate cancer.,Cancer Research,,,Article,2010-04-14,10.1158/0008-5472.can-09-4100,,,,20388772,PMC3049266,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6101303,https://api.altmetric.com/v1/donut/6101303_240.png 0,"Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer.",International Journal of Oncology,,,Article,2010-06-14,,,,,20428765,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6101229,https://api.altmetric.com/v1/donut/6101229_240.png 0,The amino-terminal peptide of Bax perturbs intracellular Ca2+ homeostasis to enhance apoptosis in prostate cancer cells.,American Journal of Physiology: Cell Physiology,,,Article,2009-02-15,10.1152/ajpcell.00390.2008,,,,19091958,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6101128,https://api.altmetric.com/v1/donut/6101128_240.png 0,"FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.",Cellular Signalling,,,Article,2010-10-14,10.1016/j.cellsig.2010.05.022,,,,20570726,,1959.8/155865,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6100732,https://api.altmetric.com/v1/donut/6100732_240.png 0,Change point-cure models with application to estimating the change-point effect of age of diagnosis among prostate cancer patients.,Journal of Applied Statistics,,,Article,,10.1080/02664763.2011.626849,,,,22544992,PMC3337711,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6100641,https://api.altmetric.com/v1/donut/6100641_240.png 0,"In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer.",Molecular Cancer Therapeutics,,,Article,2012-11-15,10.1158/1535-7163.mct-12-0164,,,,22896667,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6100632,https://api.altmetric.com/v1/donut/6100632_240.png 0,Impact of hypoxia on the metastatic potential of human prostate cancer cells.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-09-30,10.1016/j.ijrobp.2011.04.027,,,,21640519,PMC3163803,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6100422,https://api.altmetric.com/v1/donut/6100422_240.png 0,"Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.",Journal of Biological Chemistry,,,Article,2011-07-21,10.1074/jbc.m110.211292,,,,21636851,PMC3138273,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6100298,https://api.altmetric.com/v1/donut/6100298_240.png 0,The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.,Experimental Cell Research,,,Article,2011-11-01,10.1016/j.yexcr.2011.08.008,,,,21871886,PMC3189339,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6100297,https://api.altmetric.com/v1/donut/6100297_240.png 0,Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.,Cell & Bioscience,,,Article,2015-01-01,10.1186/s13578-015-0033-y,,,,26185616,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6100293,https://api.altmetric.com/v1/donut/6100293_240.png 0,"Discovery of Novel N-Alkyl 4-Anilinofuro[2,3-b]Quinoline Derivatives (CIL-102 Derivatives) Against Castration-Resistant Human Prostate Cancers.",Anti-Cancer Agents in Medicinal Chemistry,,,Article,2015-01-21,,,,,25612680,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6100291,https://api.altmetric.com/v1/donut/6100291_240.png 0,Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells.,Cancer Letters,,,Article,2014-07-18,10.1016/j.canlet.2014.07.002,,,,25050738,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6100290,https://api.altmetric.com/v1/donut/6100290_240.png 0,Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.,Free Radical Biology & Medicine,,,Article,2012-06-30,10.1016/j.freeradbiomed.2012.03.024,,,,22561705,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6100287,https://api.altmetric.com/v1/donut/6100287_240.png 0,TNF? enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands.,Biochemical & Biophysical Research Communications,,,Article,2011-06-09,10.1016/j.bbrc.2011.05.019,,,,21596021,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6100286,https://api.altmetric.com/v1/donut/6100286_240.png 0,Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.,Cancer Letters,,,Article,2011-12-08,10.1016/j.canlet.2011.07.015,,,,21862211,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6100285,https://api.altmetric.com/v1/donut/6100285_240.png 0,p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.,Cancer and Metastasis Reviews,,,Article,2010-03-15,10.1007/s10555-010-9213-8,,,,20111892,PMC2909029,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6100283,https://api.altmetric.com/v1/donut/6100283_240.png 0,"Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.",Journal of Biological Chemistry,,,Article,,10.1074/jbc.m109.098301,,,,20498373,PMC2911278,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6100282,https://api.altmetric.com/v1/donut/6100282_240.png 0,Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment.,Cancer Letters,,,Article,2009-11-18,10.1016/j.canlet.2009.04.041,,,,19467571,PMC2780578,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6100281,https://api.altmetric.com/v1/donut/6100281_240.png 0,Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.,The Prostate,,,Article,2011-05-14,10.1002/pros.21284,,,,20945404,PMC3027848,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6100280,https://api.altmetric.com/v1/donut/6100280_240.png 0,Copy number alterations in prostate tumors and disease aggressiveness.,"Genes, Chromosomes, and Cancer",,,Article,2012-01-15,10.1002/gcc.20932,,,,21965145,PMC3209417,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6100278,https://api.altmetric.com/v1/donut/6100278_240.png 0,"Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer.",,,,Article,2010-10-07,10.3390/ph3103127,,,,24023525,PMC3766748,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6100275,https://api.altmetric.com/v1/donut/6100275_240.png 0,Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.,,,,Article,2009-02-26,10.1186/1471-2407-9-69,,,,19245716,PMC2657151,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6100274,https://api.altmetric.com/v1/donut/6100274_240.png 0,Prostate cancer genomics: towards a new understanding.,Nature Reviews Genetics,,,Article,2009-02-15,10.1038/nrg2507,,,,19104501,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,82,https://www.altmetric.com/details/6100273,https://api.altmetric.com/v1/donut/6100273_240.png 0,Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) Tumor Biomarker for Identifying Recurrent Disease in African American Patients.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-06-01,10.1158/1055-9965.epi-13-1124,,,,24891551,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6100272,https://api.altmetric.com/v1/donut/6100272_240.png 0,Personalized prostate cancer screening: improving PSA tests with genomic information.,Science Translational Medicine,,,Article,2010-12-15,10.1126/scitranslmed.3001861,,,,21160075,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6100269,https://api.altmetric.com/v1/donut/6100269_240.png 0,ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migration.,Cancer Letters,,,Article,2011-01-28,10.1016/j.canlet.2010.09.017,,,,21041019,PMC2994978,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6100012,https://api.altmetric.com/v1/donut/6100012_240.png 0,HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.,Molecular Cancer Research,,,Article,2011-06-14,10.1158/1541-7786.mcr-10-0505,,,,21622623,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6099871,https://api.altmetric.com/v1/donut/6099871_240.png 0,Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion.,Epigenetics,,,Article,2012-08-14,,,,,22805767,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6099791,https://api.altmetric.com/v1/donut/6099791_240.png 0,Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.,,,,Article,,10.1371/journal.pone.0045045,,,,23024790,PMC3443231,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6099790,https://api.altmetric.com/v1/donut/6099790_240.png 0,Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.,,,,Article,2010-08-26,10.1371/journal.pone.0012445,,,,20805998,PMC2929211,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,127,https://www.altmetric.com/details/6099788,https://api.altmetric.com/v1/donut/6099788_240.png 0,N-glycosylation status of beta-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases.,International Journal of Oncology,,,Article,2010-01-15,,,,,19956848,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6099625,https://api.altmetric.com/v1/donut/6099625_240.png 0,Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.,Clinical Cancer Research,,,Article,2009-05-31,10.1158/1078-0432.ccr-08-2453,,,,19435838,PMC2811524,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6099376,https://api.altmetric.com/v1/donut/6099376_240.png 0,Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2008.07.055,,,,18990509,PMC2692099,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6099374,https://api.altmetric.com/v1/donut/6099374_240.png 0,Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1 H magnetic resonance spectroscopic imaging.,Journal of Magnetic Resonance Imaging,,,Article,2013-11-15,10.1002/jmri.24487,,,,24243554,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6099372,https://api.altmetric.com/v1/donut/6099372_240.png 0,Normal Central Zone of the Prostate and Central Zone Involvement by Prostate Cancer: Clinical and MR Imaging Implications.,Radiology,,,Article,2012-03-15,10.1148/radiol.11110663,,,,22357889,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/6099371,https://api.altmetric.com/v1/donut/6099371_240.png 0,The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience.,American Journal of Roentgenology,,,Article,2012-08-14,10.2214/ajr.11.6923,,,,22826397,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6099370,https://api.altmetric.com/v1/donut/6099370_240.png 0,Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.,Radiology,,,Article,2011-06-14,10.1148/radiol.11102066,,,,21436085,PMC3099046,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70,https://www.altmetric.com/details/6099368,https://api.altmetric.com/v1/donut/6099368_240.png 0,Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results.,European Radiology,,,Article,2011-09-14,10.1007/s00330-011-2130-6,,,,21533634,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6099367,https://api.altmetric.com/v1/donut/6099367_240.png 0,Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer.,European Radiology,,,Article,2010-04-14,10.1007/s00330-009-1625-x,,,,19921205,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6099366,https://api.altmetric.com/v1/donut/6099366_240.png 0,Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?,BJU International,,,Article,2010-11-15,10.1111/j.1464-410x.2010.09346.x,,,,20394616,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6099365,https://api.altmetric.com/v1/donut/6099365_240.png 0,Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-11-01,10.1016/j.ijrobp.2009.08.040,,,,20133067,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6099364,https://api.altmetric.com/v1/donut/6099364_240.png 0,Accelerated Migration And Invasion Of Prostate Cancer Cells After A Photodynamic Therapy-Like Challenge: Role Of Nitric Oxide.,Nitric Oxide,,,Article,,10.1016/j.niox.2015.05.006,,,,26068242,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6099007,https://api.altmetric.com/v1/donut/6099007_240.png 0,Pro-Survival and Pro-Growth Effects of Stress-Induced Nitric Oxide in a Prostate Cancer Photodynamic Therapy Model.,Cancer Letters,,,Article,2013-09-26,10.1016/j.canlet.2013.09.025,,,,24080338,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6099005,https://api.altmetric.com/v1/donut/6099005_240.png 0,The role of caveolin-1 in prostate cancer: clinical implications.,Prostate Cancer & Prostatic Diseases,,,Article,2010-03-15,10.1038/pcan.2009.29,,,,19581923,PMC2887695,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6098900,https://api.altmetric.com/v1/donut/6098900_240.png 0,Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.,,,,Article,2009-12-15,,,,,19923922,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6098899,https://api.altmetric.com/v1/donut/6098899_240.png 0,Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression.,Molecular Cancer Research,,,Article,2009-09-14,10.1158/1541-7786.mcr-09-0071,,,,19737975,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6098898,https://api.altmetric.com/v1/donut/6098898_240.png 0,Anti-caveolin-1 Antibodies As Anti-Prostate Cancer Therapeutics.,Hybridoma: A Journal of Molecular Immunology & Experimental & Clinical Immunotherapy,,,Article,2012-04-14,10.1089/hyb.2011.0100,,,,22509911,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6098896,https://api.altmetric.com/v1/donut/6098896_240.png 0,Communication message strategies for increasing knowledge about prostate cancer screening.,Journal of Cancer Education,,,Article,,10.1080/08858190902935498,,,,19526414,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6098879,https://api.altmetric.com/v1/donut/6098879_240.png 0,Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.,Journal of the American College of Radiology,,,Article,2009-06-14,10.1016/j.jacr.2008.11.008,,,,19467491,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6098772,https://api.altmetric.com/v1/donut/6098772_240.png 0,"Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.",Cancer Science,,,Article,2011-11-15,10.1111/j.1349-7006.2011.02043.x,,,,21781227,PMC3200457,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6098644,https://api.altmetric.com/v1/donut/6098644_240.png 0,Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.,Cancer Letters,,,Article,,10.1016/j.canlet.2008.10.001,,,,18977589,PMC2980538,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6098641,https://api.altmetric.com/v1/donut/6098641_240.png 0,Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.,Gene Therapy,,,Article,2011-10-14,10.1038/gt.2011.51,,,,21512508,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6098467,https://api.altmetric.com/v1/donut/6098467_240.png 0,Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.,The Prostate,,,Article,,10.1002/pros.21233,,,,20672321,PMC3669684,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6098457,https://api.altmetric.com/v1/donut/6098457_240.png 0,SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1.,Molecular Endocrinology,,,Article,2014-04-15,10.1210/me.2013-1339,,,,24739041,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6098362,https://api.altmetric.com/v1/donut/6098362_240.png 0,Differential transformation capacity of Src family kinases during the initiation of prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-04-18,10.1073/pnas.1103904108,,,,21464326,PMC3080985,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6098227,https://api.altmetric.com/v1/donut/6098227_240.png 0,First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts.,Nuclear Medicine & Biology,,,Article,2013-07-14,10.1016/j.nucmedbio.2013.03.001,,,,23602763,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6097380,https://api.altmetric.com/v1/donut/6097380_240.png 0,Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells.,Free Radical Research,,,Article,2011-09-14,10.3109/10715762.2011.591391,,,,21682664,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6097337,https://api.altmetric.com/v1/donut/6097337_240.png 0,Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus.,Human Molecular Genetics,,,Article,2010-09-30,10.1093/hmg/ddq283,,,,20631155,PMC2935853,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6097217,https://api.altmetric.com/v1/donut/6097217_240.png 0,DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.,Oncotarget,,,Article,2014-12-10,10.18632/oncotarget.3040,,,,25575823,PMC4385841,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6097215,https://api.altmetric.com/v1/donut/6097215_240.png 0,Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.,Clinical Cancer Research,,,Article,2009-04-30,10.1158/1078-0432.ccr-08-2190,,,,19366831,PMC2707085,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6097214,https://api.altmetric.com/v1/donut/6097214_240.png 0,Mechanisms of the androgen receptor splicing in prostate cancer cells.,Oncogene,,,Article,2013-07-14,10.1038/onc.2013.284,,,,23851510,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/6097212,https://api.altmetric.com/v1/donut/6097212_240.png 0,Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-06-14,10.1158/1055-9965.epi-10-1299,,,,21467234,PMC3111761,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6097211,https://api.altmetric.com/v1/donut/6097211_240.png 0,Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.,The Prostate,,,Article,2009-03-01,10.1002/pros.20887,,,,19058137,PMC2788301,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6097210,https://api.altmetric.com/v1/donut/6097210_240.png 0,Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-01-15,10.1158/1055-9965.epi-09-0800,,,,20056646,PMC2825566,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6097208,https://api.altmetric.com/v1/donut/6097208_240.png 0,CYP17 polymorphisms and prostate cancer outcomes.,The Prostate,,,Article,2010-06-30,10.1002/pros.21143,,,,20503394,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6097207,https://api.altmetric.com/v1/donut/6097207_240.png 0,Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.,Cancer Epidemiology,,,Article,2013-08-19,10.1016/j.canep.2013.07.005,,,,23972671,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6097206,https://api.altmetric.com/v1/donut/6097206_240.png 0,Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.,The Prostate,,,Article,2010-06-14,10.1002/pros.21137,,,,20209490,PMC2875326,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6097205,https://api.altmetric.com/v1/donut/6097205_240.png 0,A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis.,Clinical Cancer Research,,,Article,2011-04-14,10.1158/1078-0432.ccr-10-3077,,,,21349995,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6097203,https://api.altmetric.com/v1/donut/6097203_240.png 0,Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.,Anti-Cancer Drugs,,,Article,2010-04-14,10.1097/cad.0b013e328336f57b,,,,20130467,PMC2953769,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6097201,https://api.altmetric.com/v1/donut/6097201_240.png 0,Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality.,The Prostate,,,Article,2013-06-14,10.1002/pros.22636,,,,23334893,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6097200,https://api.altmetric.com/v1/donut/6097200_240.png 0,Vitamin D pathway gene variants and prostate cancer risk.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-06-14,10.1158/1055-9965.epi-09-0113,,,,19454612,PMC2743676,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6097198,https://api.altmetric.com/v1/donut/6097198_240.png 0,Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.,Molecular Cancer Research,,,Article,2010-01-15,10.1158/1541-7786.mcr-09-0277,,,,20068069,PMC2808437,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6097197,https://api.altmetric.com/v1/donut/6097197_240.png 0,Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD.,Cancer Research,,,Article,2010-03-15,10.1158/0008-5472.can-09-3252,,,,20197463,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6097196,https://api.altmetric.com/v1/donut/6097196_240.png 0,Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.,The Prostate,,,Article,,10.1002/pros.21216,,,,20583134,PMC3104406,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6097195,https://api.altmetric.com/v1/donut/6097195_240.png 0,Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression.,Journal of Molecular Cell Biology,,,Article,2012-06-14,10.1093/jmcb/mjs020,,,,22561841,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6097193,https://api.altmetric.com/v1/donut/6097193_240.png 0,Testosterone regulates tight junction proteins and influences prostatic autoimmune responses.,Hormones and Cancer,,,Article,2011-06-14,10.1007/s12672-010-0063-1,,,,21761342,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6097190,https://api.altmetric.com/v1/donut/6097190_240.png 0,Association of hepsin gene variants with prostate cancer risk and prognosis.,The Prostate,,,Article,2010-06-14,10.1002/pros.21135,,,,20166135,PMC2875316,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6097189,https://api.altmetric.com/v1/donut/6097189_240.png 0,Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation.,Journal of Clinical Oncology,,,Article,2010-05-31,10.1200/jco.2009.25.1330,,,,20421544,PMC2881848,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6097188,https://api.altmetric.com/v1/donut/6097188_240.png 0,Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14.,European Journal of Human Genetics,,,Article,2010-10-14,10.1038/ejhg.2010.49,,,,20407467,PMC2921483,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6097187,https://api.altmetric.com/v1/donut/6097187_240.png 0,ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.,Cancer Research,,,Article,2010-04-14,10.1158/0008-5472.can-09-3186,,,,20388787,PMC2999007,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6097186,https://api.altmetric.com/v1/donut/6097186_240.png 0,CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.,The Prostate,,,Article,2010-03-01,10.1002/pros.21077,,,,19866475,PMC2931415,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6097185,https://api.altmetric.com/v1/donut/6097185_240.png 0,Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence.,Clinical Cancer Research,,,Article,2009-01-15,10.1158/1078-0432.ccr-08-1754,,,,19147774,PMC3162324,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6097183,https://api.altmetric.com/v1/donut/6097183_240.png 0,Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage.,Human Molecular Genetics,,,Article,2009-05-14,10.1093/hmg/ddp100,,,,19251732,PMC2671990,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6097182,https://api.altmetric.com/v1/donut/6097182_240.png 0,Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.,The Journal of Urology,,,Article,2009-12-15,10.1016/j.juro.2009.08.026,,,,19836772,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6097180,https://api.altmetric.com/v1/donut/6097180_240.png 0,Prostate cancer-associated gene expression alterations determined from needle biopsies.,Clinical Cancer Research,,,Article,2009-04-30,10.1158/1078-0432.ccr-08-1982,,,,19366833,PMC2929837,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6097179,https://api.altmetric.com/v1/donut/6097179_240.png 0,Relationships Between Times to Testosterone and Prostate-Specific Antigen Rises During the First Off-Treatment Interval of Intermittent Androgen Deprivation are Prognostic for Castration Resistance in Men With Nonmetastatic Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2014-08-09,10.1016/j.clgc.2014.08.003,,,,25242417,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6097177,https://api.altmetric.com/v1/donut/6097177_240.png 0,Practical guide to the use of abiraterone in castration resistant prostate cancer.,Canadian Journal of Urology,,,Article,2014-04-14,,,,,24775725,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6097174,https://api.altmetric.com/v1/donut/6097174_240.png 0,Glucocorticoids and prostate cancer treatment: friend or foe?,Asian Journal of Andrology,,,Article,2014-03-07,10.4103/1008-682x.125392,,,,24625881,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6097173,https://api.altmetric.com/v1/donut/6097173_240.png 0,Orteronel for the treatment of prostate cancer.,Future Oncology,,,Article,2014-04-14,10.2217/fon.14.35,,,,24799061,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6097171,https://api.altmetric.com/v1/donut/6097171_240.png 0,Is digoxin use for cardiovascular disease associated with risk of prostate cancer?,The Prostate,,,Article,2014-01-15,10.1002/pros.22733,,,,24318956,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6097170,https://api.altmetric.com/v1/donut/6097170_240.png 0,Steroid hormone synthetic pathways in prostate cancer.,Translational andrology and urology,,,Article,2013-09-01,10.3978/j.issn.2223-4683.2013.09.16,,,,25379460,PMC4219921,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6097169,https://api.altmetric.com/v1/donut/6097169_240.png 0,MSMB gene variant alters the association between prostate cancer and number of sexual partners.,The Prostate,,,Article,2013-08-22,10.1002/pros.22719,,,,24037734,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6097165,https://api.altmetric.com/v1/donut/6097165_240.png 0,A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers: The Canary Prostate Cancer Tissue Microarray.,Advances in Anatomic Pathology,,,Article,2013-01-15,10.1097/pap.0b013e31827b665b,,,,23232570,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6097164,https://api.altmetric.com/v1/donut/6097164_240.png 0,Co-targeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancer.,Molecular Cancer Therapeutics,,,Article,2012-08-14,10.1158/1535-7163.mct-12-0072,,,,22675041,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6097162,https://api.altmetric.com/v1/donut/6097162_240.png 0,Integrin-linked kinase (ILK) as a target for ERG-mediated invasive properties in prostate cancer models.,Carcinogenesis,,,Article,2012-12-15,10.1093/carcin/bgs285,,,,23027626,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6097161,https://api.altmetric.com/v1/donut/6097161_240.png 0,Distinct Epigenetic Mechanisms DistinguishTMPRSS2-ERG Fusion-Positive and -Negative Prostate Cancers.,Cancer Discovery,,,Article,2012-11-15,10.1158/2159-8290.cd-12-0392,,,,23148372,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6097160,https://api.altmetric.com/v1/donut/6097160_240.png 0,Susceptibility loci associated with prostate cancer progression and mortality.,Clinical Cancer Research,,,Article,2010-05-14,10.1158/1078-0432.ccr-10-0028,,,,20460480,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6097042,https://api.altmetric.com/v1/donut/6097042_240.png 0,Copy number and gene expression differences between African American and Caucasian American prostate cancer.,Journal of Translational Medicine,,,Article,2010-07-21,10.1186/1479-5876-8-70,,,,20649978,PMC2913940,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6097041,https://api.altmetric.com/v1/donut/6097041_240.png 0,Prostate cancer topography and patterns of lymph node metastasis.,The American Journal of Surgical Pathology,,,Article,2010-12-15,10.1097/pas.0b013e3181fc679e,,,,21107093,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6097035,https://api.altmetric.com/v1/donut/6097035_240.png 0,Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-05-14,10.1158/1055-9965.epi-09-1251,,,,20406957,PMC2866147,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6097034,https://api.altmetric.com/v1/donut/6097034_240.png 0,"Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.",Cancer (0008543X),,,Article,2010-05-31,10.1002/cncr.25010,,,,20336781,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6097028,https://api.altmetric.com/v1/donut/6097028_240.png 0,Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.,The Prostate,,,Article,2009-03-01,10.1002/pros.20908,,,,19116992,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6097026,https://api.altmetric.com/v1/donut/6097026_240.png 0,ETS rearrangements and prostate cancer initiation.,Nature,,,Article,2009-02-12,10.1038/nature07738,,,,19212347,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,45,https://www.altmetric.com/details/6097025,https://api.altmetric.com/v1/donut/6097025_240.png 0,Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.,Clinical Cancer Research,,,Article,2010-03-31,10.1158/1078-0432.ccr-09-2871,,,,20215531,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6097024,https://api.altmetric.com/v1/donut/6097024_240.png 0,"The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.",Prostate Cancer & Prostatic Diseases,,,Article,2010-06-14,10.1038/pcan.2010.2,,,,20177423,PMC2917588,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6097023,https://api.altmetric.com/v1/donut/6097023_240.png 0,Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.,International Journal of Cancer,,,Article,,10.1002/ijc.23983,,,,19003994,PMC2776773,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6097021,https://api.altmetric.com/v1/donut/6097021_240.png 0,"A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-02-15,10.1158/1055-9965.epi-10-1003,,,,21148123,PMC3035761,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6097017,https://api.altmetric.com/v1/donut/6097017_240.png 0,"A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.",British Journal of Cancer,,,Article,2010-08-23,10.1038/sj.bjc.6605815,,,,20664589,PMC2938258,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6097014,https://api.altmetric.com/v1/donut/6097014_240.png 0,Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.,Virchows Archiv,,,Article,2010-11-15,10.1007/s00428-010-0971-z,,,,20827488,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6097012,https://api.altmetric.com/v1/donut/6097012_240.png 0,Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease.,British Journal of Urology,,,Article,2010-02-15,10.1111/j.1464-410x.2009.08747.x,,,,19624594,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6097010,https://api.altmetric.com/v1/donut/6097010_240.png 0,Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.,Clinical Cancer Research,,,Article,2009-03-15,10.1158/1078-0432.ccr-08-2036,,,,19276271,PMC2875199,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6097004,https://api.altmetric.com/v1/donut/6097004_240.png 0,Prostate cancer: estimating the benefits of PSA screening.,Nature Reviews Urology,,,Article,2009-06-14,10.1038/nrurol.2009.95,,,,19498406,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6097001,https://api.altmetric.com/v1/donut/6097001_240.png 0,Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.,Clinical Chemistry,,,Article,2009-04-14,10.1373/clinchem.2008.117952,,,,19233911,PMC2782624,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6096999,https://api.altmetric.com/v1/donut/6096999_240.png 0,Critical review of prostate cancer predictive tools.,Future Oncology,,,Article,2009-12-15,10.2217/fon.09.121,,,,20001796,PMC2933457,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6096992,https://api.altmetric.com/v1/donut/6096992_240.png 0,Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.,Cancer (0008543X),,,Article,2009-03-01,10.1002/cncr.24083,,,,19156928,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6096990,https://api.altmetric.com/v1/donut/6096990_240.png 0,Identification of plasma protein profiles associated with risk groups of prostate cancer patients.,PROTEOMICS - Clinical Applications,,,Article,2014-09-05,10.1002/prca.201300059,,,,25196118,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6096987,https://api.altmetric.com/v1/donut/6096987_240.png 0,"Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort.",European Journal of Cancer (1965),,,Article,2013-05-15,10.1016/j.ejca.2013.04.015,,,,23684783,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6096984,https://api.altmetric.com/v1/donut/6096984_240.png 0,Re: Comparative Effectiveness of Alternative Prostate-specific Antigen-Based Prostate Cancer Screening Strategies: Model Estimates of Potential Benefits and Harms.,European Urology,,,Article,2013-10-14,10.1016/j.eururo.2013.07.016,,,,23998500,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6096981,https://api.altmetric.com/v1/donut/6096981_240.png 0,Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.,Clinical Chemistry & Laboratory Medicine,,,Article,2012-11-15,10.1515/cclm-2011-0967,,,,22718641,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6096976,https://api.altmetric.com/v1/donut/6096976_240.png 0,Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men.,European Urology,,,Article,2012-03-15,10.1016/j.eururo.2011.10.047,,,,22101116,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6096968,https://api.altmetric.com/v1/donut/6096968_240.png 0,A Case Report of Putative Autoimmunity to Prostate Cancer After Immune-Mediated Rejection of Melanoma Through a Shared Tumor Antigen.,Clinical Genitourinary Cancer,,,Article,2012-06-14,10.1016/j.clgc.2011.12.002,,,,22284755,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6096964,https://api.altmetric.com/v1/donut/6096964_240.png 0,Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2012-05-14,10.1089/cbr.2011.1088,,,,22489659,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6096963,https://api.altmetric.com/v1/donut/6096963_240.png 0,Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.,British Journal of Urology,,,Article,2011-06-14,10.1111/j.1464-410x.2010.09761.x,,,,20955263,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6096959,https://api.altmetric.com/v1/donut/6096959_240.png 0,An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.,Modern Pathology,,,Article,2011-01-15,10.1038/modpathol.2010.182,,,,20834240,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6096957,https://api.altmetric.com/v1/donut/6096957_240.png 0,Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.,The Journal of Urology,,,Article,2011-02-15,10.1016/j.juro.2010.09.095,,,,21167529,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6096956,https://api.altmetric.com/v1/donut/6096956_240.png 0,NanoVelcro Chip for CTC enumeration in prostate cancer patients.,Methods,,,Article,2013-06-28,10.1016/j.ymeth.2013.06.019,,,,23816790,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6096955,https://api.altmetric.com/v1/donut/6096955_240.png 0,Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.,Cancer Research,,,Article,2010-03-31,10.1158/0008-5472.can-09-1162,,,,20233880,PMC2995454,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6096945,https://api.altmetric.com/v1/donut/6096945_240.png 0,A Molecular Imaging System Based on Both Transcriptional and Genomic Amplification to Detect Prostate Cancer Cells In Vivo.,Molecular Therapy,,,Article,2013-03-15,10.1038/mt.2012.259,,,,23247102,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6096940,https://api.altmetric.com/v1/donut/6096940_240.png 0,Combination of Rad001 (Everolimus) and Propachlor synergistically induces apoptosis through enhanced autophagy in prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2012-06-14,10.1158/1535-7163.mct-11-0954,,,,22491797,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6096938,https://api.altmetric.com/v1/donut/6096938_240.png 0,Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model.,Journal of Endocrinology,,,Article,2011-12-15,10.1530/joe-11-0240,,,,21903863,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6096936,https://api.altmetric.com/v1/donut/6096936_240.png 0,Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.,Cancer Research,,,Article,2009-02-01,10.1158/0008-5472.can-08-2216,,,,19176386,PMC3219545,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6096934,https://api.altmetric.com/v1/donut/6096934_240.png 0,Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation.,Molecular Endocrinology,,,Article,2009-10-14,10.1210/me.2008-0365,,,,19556345,PMC2754899,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6096933,https://api.altmetric.com/v1/donut/6096933_240.png 0,Non-invasive molecular imaging of prostate cancer lymph node metastasis.,Trends in Molecular Medicine,,,Article,2009-06-14,10.1016/j.molmed.2009.04.004,,,,19482514,PMC2798142,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6096932,https://api.altmetric.com/v1/donut/6096932_240.png 0,Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line.,Molecular Cancer Research,,,Article,2009-09-14,10.1158/1541-7786.mcr-09-0121,,,,19723877,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6096930,https://api.altmetric.com/v1/donut/6096930_240.png 0,PET Imaging of Prostate Cancer Using C-Acetate.,,,,Article,2009-04-14,10.1016/j.cpet.2009.05.001,,,,21984877,PMC3188983,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6096929,https://api.altmetric.com/v1/donut/6096929_240.png 0,"Prostate cancer severity among low income, uninsured men.",The Journal of Urology,,,Article,2009-02-15,10.1016/j.juro.2008.10.010,,,http://www.rand.org/pubs/external_publications/EP20090205.html,19100580,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6096926,https://api.altmetric.com/v1/donut/6096926_240.png 0,Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.,American Journal of Roentgenology,,,Article,,10.2214/ajr.14.13285,,,,26102423,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6096925,https://api.altmetric.com/v1/donut/6096925_240.png 0,Risk stratification of prostate cancer in the modern era.,Current Opinion in Urology,,,Article,2015-02-27,10.1097/mou.0000000000000164,,,,25730325,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6096924,https://api.altmetric.com/v1/donut/6096924_240.png 0,Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy.,NMR in Biomedicine,,,Article,,10.1002/nbm.3373,,,,26346702,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6096922,https://api.altmetric.com/v1/donut/6096922_240.png 0,Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models.,,,,Article,2010-12-08,10.1371/journal.pone.0015482,,,,21151630,PMC2999571,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6096909,https://api.altmetric.com/v1/donut/6096909_240.png 0,Mechanism of lymph node metastasis in prostate cancer.,Future Oncology,,,Article,2010-05-14,10.2217/fon.10.33,,,,20465393,PMC2892838,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6096908,https://api.altmetric.com/v1/donut/6096908_240.png 0,Thrombin expression in prostate: a novel finding.,Cancer Investigation,,,Article,2011-01-15,10.3109/07357907.2010.535057,,,,21166500,PMC3136353,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6096907,https://api.altmetric.com/v1/donut/6096907_240.png 0,Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.,The Prostate,,,Article,2010-03-01,10.1002/pros.21078,,,,19902470,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6096904,https://api.altmetric.com/v1/donut/6096904_240.png 0,Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.,The Prostate,,,Article,2009-12-01,10.1002/pros.21022,,,,19676081,PMC2783419,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6096901,https://api.altmetric.com/v1/donut/6096901_240.png 0,Engineered measles virus as a novel oncolytic therapy against prostate cancer.,The Prostate,,,Article,,10.1002/pros.20857,,,,18973133,PMC2737678,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6096900,https://api.altmetric.com/v1/donut/6096900_240.png 0,"A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.",Gene Therapy,,,Article,2010-11-15,10.1038/gt.2010.63,,,,20428214,PMC2914818,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6096897,https://api.altmetric.com/v1/donut/6096897_240.png 0,Unraveling the complexities of androgen receptor signaling in prostate cancer cells.,Cancer Cell,,,Article,2009-04-06,10.1016/j.ccr.2009.03.009,,,,19345321,PMC2718563,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6096894,https://api.altmetric.com/v1/donut/6096894_240.png 0,Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases.,Clinical Cancer Research,,,Article,2009-03-15,10.1158/1078-0432.ccr-08-2262,,,,19276267,PMC2676580,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6096893,https://api.altmetric.com/v1/donut/6096893_240.png 0,Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.,Cancer Research,,,Article,2009-07-31,10.1158/0008-5472.can-09-0552,,,,19638584,PMC2752731,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6096889,https://api.altmetric.com/v1/donut/6096889_240.png 0,Androgen receptor abnormalities in castration-recurrent prostate cancer.,Expert Review of Endocrinology & Metabolism,,,Article,2009-08-31,10.1586/eem.09.34,,,,20228873,PMC2835169,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6096887,https://api.altmetric.com/v1/donut/6096887_240.png 0,Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.,Cancer Research,,,Article,2009-12-15,10.1158/0008-5472.can-09-1903,,,,19934328,PMC2795008,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6096886,https://api.altmetric.com/v1/donut/6096886_240.png 0,Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.,Cancer Research,,,Article,2009-10-14,10.1158/0008-5472.can-09-0941,,,,19789348,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6096882,https://api.altmetric.com/v1/donut/6096882_240.png 0,Prognostic value of discs large homolog 7 transcript levels in prostate cancer.,PloS one,,,Article,2013-12-09,10.1371/journal.pone.0082833,,,,24349376,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6096879,https://api.altmetric.com/v1/donut/6096879_240.png 0,Germline predictors of androgen deprivation therapy response in advanced prostate cancer.,Mayo Clinic Proceedings,,,Article,2012-03-15,10.1016/j.mayocp.2011.09.009,,,,22386179,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6096874,https://api.altmetric.com/v1/donut/6096874_240.png 0,The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.,Mayo Clinic Proceedings,,,Article,2012-06-14,10.1016/j.mayocp.2012.01.017,,,,22677074,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6096873,https://api.altmetric.com/v1/donut/6096873_240.png 0,Targeting 5?-reductase for prostate cancer prevention and treatment.,Nature Reviews Urology,,,Article,2011-05-30,10.1038/nrurol.2011.67,,,,21629218,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6096871,https://api.altmetric.com/v1/donut/6096871_240.png 0,Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.,Molecular Endocrinology,,,Article,2011-06-14,10.1210/me.2010-0469,,,,21436259,PMC3100605,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6096869,https://api.altmetric.com/v1/donut/6096869_240.png 0,"Bone Metastases in Castration-Resistant Prostate Cancer: Associations between Morphologic CT Patterns, Glycolytic Activity, and Androgen Receptor Expression on PET and Overall Survival.",Radiology,,,Article,2013-11-18,10.1148/radiol.13130625,,,,24475817,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6096818,https://api.altmetric.com/v1/donut/6096818_240.png 0,Molecular imaging of prostate cancer.,Current Opinion in Urology,,,Article,2012-07-14,10.1097/mou.0b013e32835483d5,,,,22617062,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6096816,https://api.altmetric.com/v1/donut/6096816_240.png 0,A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.,European Urology,,,Article,2012-07-14,10.1016/j.eururo.2012.01.037,,,,22306323,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6096815,https://api.altmetric.com/v1/donut/6096815_240.png 0,Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer.,Clinical Cancer Research,,,Article,2010-12-15,10.1158/1078-0432.ccr-10-1357,,,,20975102,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6096814,https://api.altmetric.com/v1/donut/6096814_240.png 0,A spotlight from prostate cancer.,Cancer Discovery,,,Article,2012-04-14,10.1158/2159-8290.cd-12-0067,,,,22576205,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6096750,https://api.altmetric.com/v1/donut/6096750_240.png 0,Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression.,Oncology Reports,,,Article,2014-05-12,10.3892/or.2014.3174,,,,24841903,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6096586,https://api.altmetric.com/v1/donut/6096586_240.png 0,Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer.,The Prostate,,,Article,2010-09-30,10.1002/pros.21196,,,,20607766,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6096584,https://api.altmetric.com/v1/donut/6096584_240.png 0,MYC and Prostate Cancer.,Genes & Cancer,,,Article,2010-06-14,10.1177/1947601910379132,,,,21779461,PMC3092219,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,90,https://www.altmetric.com/details/6096583,https://api.altmetric.com/v1/donut/6096583_240.png 0,Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer.,International Journal of Radiation Biology,,,Article,2010-03-15,10.3109/09553000903419338,,,,20201650,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6096578,https://api.altmetric.com/v1/donut/6096578_240.png 0,Prostate cancer as a model for tumour immunotherapy.,Nature Reviews Immunology,,,Article,2010-08-14,10.1038/nri2817,,,,20651745,PMC3082366,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,179,https://www.altmetric.com/details/6096576,https://api.altmetric.com/v1/donut/6096576_240.png 0,"Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening.",Cancer Research,,,Article,,10.1158/0008-5472.can-10-1760,,,,20670952,PMC2995819,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6096575,https://api.altmetric.com/v1/donut/6096575_240.png 0,"The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer.",Cell Cycle,,,Article,2010-03-01,,,,,20160498,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6096573,https://api.altmetric.com/v1/donut/6096573_240.png 0,miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.,Cancer Research,,,Article,2009-09-14,10.1158/0008-5472.can-09-1448,,,,19738047,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,97,https://www.altmetric.com/details/6096572,https://api.altmetric.com/v1/donut/6096572_240.png 0,Management of metastatic castration-resistant prostate cancer.,,,,Article,,,,,,23789039,PMC3685202,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6096570,https://api.altmetric.com/v1/donut/6096570_240.png 0,PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.,Clinical Cancer Research,,,Article,2011-10-14,10.1158/1078-0432.ccr-11-1244,,,,21878536,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,56,https://www.altmetric.com/details/6096568,https://api.altmetric.com/v1/donut/6096568_240.png 0,Phase I trial with a combination of docetaxel and ¹?³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2009.10.003,,,,19962920,PMC3483074,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6096567,https://api.altmetric.com/v1/donut/6096567_240.png 0,Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells.,Free Radical Biology & Medicine,,,Article,2011-01-15,10.1016/j.freeradbiomed.2010.11.011,,,,21078383,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6096563,https://api.altmetric.com/v1/donut/6096563_240.png 0,The unfolding treatment landscape for men with castration-resistant prostate cancer.,Clinical Investigation,,,Article,2011-11-15,10.4155/cli.11.138,,,,23115711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6096562,https://api.altmetric.com/v1/donut/6096562_240.png 0,Prostate cancer: New answers prompt new questions regarding cell of origin.,Nature Reviews Urology,,,Article,2010-12-15,10.1038/nrurol.2010.188,,,,21139640,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6096560,https://api.altmetric.com/v1/donut/6096560_240.png 0,Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer.,Expert Review of Endocrinology & Metabolism,,,Article,2010-09-14,10.1586/eem.10.49,,,,21318111,PMC3035007,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6096556,https://api.altmetric.com/v1/donut/6096556_240.png 0,"Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study.",Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-10-1928,,,,20978144,PMC3444815,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6096554,https://api.altmetric.com/v1/donut/6096554_240.png 0,HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides.,Current Cancer Drug Targets,,,Article,2009-11-15,,,,,20025575,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6096552,https://api.altmetric.com/v1/donut/6096552_240.png 0,Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer.,Surgical Oncology,,,Article,2009-09-14,10.1016/j.suronc.2009.02.004,,,,19394814,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6096543,https://api.altmetric.com/v1/donut/6096543_240.png 0,"Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.",British Journal of Urology,,,Article,,10.1111/j.1464-410x.2008.08127.x,,,,19007374,PMC3340925,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6096542,https://api.altmetric.com/v1/donut/6096542_240.png 0,Endoglin (CD105) as a urinary and serum marker of prostate cancer.,International Journal of Cancer,,,Article,,10.1002/ijc.24007,,,,19004009,PMC2666305,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6096541,https://api.altmetric.com/v1/donut/6096541_240.png 0,Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.,The Prostate,,,Article,2009-05-31,10.1002/pros.20933,,,,19267370,PMC3016874,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6096540,https://api.altmetric.com/v1/donut/6096540_240.png 0,Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo.,Molecular Cancer Therapeutics,,,Article,2009-04-14,10.1158/1535-7163.mct-08-1076,,,,19372553,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6096538,https://api.altmetric.com/v1/donut/6096538_240.png 0,DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.,Urology,,,Article,2009-05-14,10.1016/j.urology.2008.09.060,,,,19193410,PMC2697847,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6096537,https://api.altmetric.com/v1/donut/6096537_240.png 0,Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis.,Oncoscience,,,Article,2014-10-15,10.18632/oncoscience.88,,,,25485289,PMC4254774,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6096531,https://api.altmetric.com/v1/donut/6096531_240.png 0,Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer.,The Prostate,,,Article,2014-07-21,10.1002/pros.22847,,,,25053236,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6096530,https://api.altmetric.com/v1/donut/6096530_240.png 0,Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer.,Oncotarget,,,Article,2014-07-06,10.18632/oncotarget.2174,,,,25026284,PMC4171616,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6096529,https://api.altmetric.com/v1/donut/6096529_240.png 0,Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.,FASEB Journal,,,Article,2013-07-23,10.1096/fj.12-222893,,,,23884428,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6096527,https://api.altmetric.com/v1/donut/6096527_240.png 0,"Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens.",PROTEOMICS,,,Article,,10.1002/pmic.201200541,,,,23716368,PMC4235679,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6096526,https://api.altmetric.com/v1/donut/6096526_240.png 0,Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.,Cancer Biology and Therapy,,,Article,2013-04-30,,,,,23377825,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6096524,https://api.altmetric.com/v1/donut/6096524_240.png 0,Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.,Urologic Oncology,,,Article,2013-07-14,10.1016/j.urolonc.2011.05.002,,,,21664838,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6096522,https://api.altmetric.com/v1/donut/6096522_240.png 0,Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion.,Prostate Cancer & Prostatic Diseases,,,Article,2013-06-14,10.1038/pcan.2013.8,,,,23545904,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6096521,https://api.altmetric.com/v1/donut/6096521_240.png 0,Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer.,Asian Journal of Andrology,,,Article,2012-05-14,10.1038/aja.2011.144,,,,22343492,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6096520,https://api.altmetric.com/v1/donut/6096520_240.png 0,Development of a castrate resistant transplant tumor model of prostate cancer.,The Prostate,,,Article,2012-04-30,10.1002/pros.21465,,,,21796655,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6096519,https://api.altmetric.com/v1/donut/6096519_240.png 0,Current status of immunological approaches for the treatment of prostate cancer.,Current Opinion in Urology,,,Article,2012-05-14,10.1097/mou.0b013e3283519ad5,,,,22328018,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6096518,https://api.altmetric.com/v1/donut/6096518_240.png 0,Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model.,The Prostate,,,Article,2012-04-14,10.1002/pros.21453,,,,21761425,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6096517,https://api.altmetric.com/v1/donut/6096517_240.png 0,"An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.",Cancer (0008543X),,,Article,2012-12-15,10.1002/cncr.27689,,,,22674438,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6096516,https://api.altmetric.com/v1/donut/6096516_240.png 0,Cyr61 is a potential prognostic marker for prostate cancer.,Asian Journal of Andrology,,,Article,2012-05-14,10.1038/aja.2011.149,,,,22343491,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6096515,https://api.altmetric.com/v1/donut/6096515_240.png 0,Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.,The Prostate,,,Article,2012-04-14,10.1002/pros.21449,,,,21748755,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6096514,https://api.altmetric.com/v1/donut/6096514_240.png 0,Global Levels of H3K27me3 Track with Differentiation in Vivo and Are Deregulated by MYC in Prostate Cancer.,American Journal of Pathology,,,Article,2012-08-14,10.1016/j.ajpath.2012.04.021,,,,22713676,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6096513,https://api.altmetric.com/v1/donut/6096513_240.png 0,Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.,The Prostate,,,Article,2012-06-14,10.1002/pros.21501,,,,22025384,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6096512,https://api.altmetric.com/v1/donut/6096512_240.png 0,Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation.,Oncogene,,,Article,2012-03-08,10.1038/onc.2011.319,,,,21822302,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6096511,https://api.altmetric.com/v1/donut/6096511_240.png 0,Abiraterone for the Treatment of Advanced Prostate Cancer.,,,,Article,2012-08-31,,,,,23795335,PMC3689308,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6096507,https://api.altmetric.com/v1/donut/6096507_240.png 0,Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy.,Current opinion in oncology,,,Article,2012-05-14,10.1097/cco.0b013e32835205a0,,,,22410456,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6096506,https://api.altmetric.com/v1/donut/6096506_240.png 0,Enzymatically active prostate-specific antigen promotes growth of human prostate cancers.,The Prostate,,,Article,2011-11-15,10.1002/pros.21375,,,,21394741,PMC3116061,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6096504,https://api.altmetric.com/v1/donut/6096504_240.png 0,"Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.",Cancer Research,,,Article,2010-03-15,10.1158/0008-5472.can-09-3515,,,,20215503,PMC2840052,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/6096500,https://api.altmetric.com/v1/donut/6096500_240.png 0,Molecular Profiling of Prostatic Acinar Morphogenesis Identifies PDCD4 and KLF6 as Tissue Architecture-Specific Prognostic Markers in Prostate Cancer.,American Journal of Pathology,,,Article,2013-02-15,10.1016/j.ajpath.2012.10.024,,,,23219426,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6096492,https://api.altmetric.com/v1/donut/6096492_240.png 0,Redefining hormone resistance in prostate cancer.,Therapeutic Advances in Medical Oncology,,,Article,2010-03-01,10.1177/1758834009356433,,,,20543967,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6096409,https://api.altmetric.com/v1/donut/6096409_240.png 0,Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.,Cancer Research,,,Article,2010-11-01,10.1158/0008-5472.can-10-1646,,,,20940396,PMC3064856,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6096100,https://api.altmetric.com/v1/donut/6096100_240.png 0,Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells.,Radiotherapy & Oncology,,,Article,2009-09-14,10.1016/j.radonc.2009.04.003,,,,19433338,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6095991,https://api.altmetric.com/v1/donut/6095991_240.png 0,Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.,Carcinogenesis,,,Article,2011-10-14,10.1093/carcin/bgr139,,,,21771722,PMC3179424,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6095938,https://api.altmetric.com/v1/donut/6095938_240.png 0,"Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial.",Cancer (0008543X),,,Article,2009-08-14,10.1002/cncr.24423,,,,19598210,PMC2739798,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6095937,https://api.altmetric.com/v1/donut/6095937_240.png 0,PCR-free method detects high frequency of genomic instability in prostate cancer.,Nucleic Acids Research,,,Article,2009-12-15,10.1093/nar/gkp761,,,,19797393,PMC2794161,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6095935,https://api.altmetric.com/v1/donut/6095935_240.png 0,Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.,Cancer Causes and Control,,,Article,2014-10-31,10.1007/s10552-014-0480-5,,,,25359302,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6095932,https://api.altmetric.com/v1/donut/6095932_240.png 0,"1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.",The Prostate,,,Article,,10.1002/pros.21201,,,,20583132,PMC3039487,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6095840,https://api.altmetric.com/v1/donut/6095840_240.png 0,Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.,Neoplasia,,,Article,2010-10-14,,,,,20927321,PMC2950332,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6095838,https://api.altmetric.com/v1/donut/6095838_240.png 0,Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.,Biochimica et Biophysica Acta (BBA),,,Article,2010-11-15,10.1016/j.bbamcr.2010.06.011,,,,20620173,PMC2939279,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6095834,https://api.altmetric.com/v1/donut/6095834_240.png 0,Autophagy switches to apoptosis in prostate cancer cells infected with melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24).,Autophagy,,,Article,2011-09-14,,,,,21610321,PMC3210317,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6095810,https://api.altmetric.com/v1/donut/6095810_240.png 0,Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2010-10-18,10.1073/pnas.1006965107,,,,20884855,PMC2964209,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6095797,https://api.altmetric.com/v1/donut/6095797_240.png 0,FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.,Molecular & Cellular Biology,,,Article,2010-03-15,10.1128/mcb.01891-08,,,,20048054,PMC2820886,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6095794,https://api.altmetric.com/v1/donut/6095794_240.png 0,Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.,Oncogene,,,Article,2013-03-18,10.1038/onc.2013.77,,,,23503464,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6095793,https://api.altmetric.com/v1/donut/6095793_240.png 0,"Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17 and LPIN2 genes.",Cancer Biology and Therapy,,,Article,2013-06-20,,,,,23792589,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6095791,https://api.altmetric.com/v1/donut/6095791_240.png 0,The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer.,British Journal of Urology,,,Article,,10.1111/j.1464-410x.2010.09356.x,,,,20977594,PMC4507368,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6095787,https://api.altmetric.com/v1/donut/6095787_240.png 0,The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.,Cancer Research,,,Article,2009-09-14,10.1158/0008-5472.can-08-4687,,,,19706771,PMC2803023,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6095782,https://api.altmetric.com/v1/donut/6095782_240.png 0,Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.,Neoplasia,,,Article,2009-01-15,,,,,19107233,PMC2606120,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6095781,https://api.altmetric.com/v1/donut/6095781_240.png 0,Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.,Cancer Research,,,Article,2011-02-15,10.1158/0008-5472.can-10-1343,,,,21303972,PMC3075600,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6095209,https://api.altmetric.com/v1/donut/6095209_240.png 0,Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone.,Clinical Cancer Research,,,Article,2011-09-14,10.1158/1078-0432.ccr-11-0644,,,,21705451,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6095207,https://api.altmetric.com/v1/donut/6095207_240.png 0,Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities.,Journal of Cellular and Molecular Medicine,,,Article,2015-03-04,10.1111/jcmm.12515,,,,25736582,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6095205,https://api.altmetric.com/v1/donut/6095205_240.png 0,Re: Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents.,European Urology,,,Article,2014-09-14,10.1016/j.eururo.2014.06.032,,,,25306183,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6095204,https://api.altmetric.com/v1/donut/6095204_240.png 0,More evidence intratumoral DHT synthesis drives castration-resistant prostate cancer.,Asian Journal of Andrology,,,Article,,10.4103/1008-682x.122200,,,,24369139,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6095203,https://api.altmetric.com/v1/donut/6095203_240.png 0,Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.,,,,Article,,10.1371/journal.pone.0030192,,,,22272301,PMC3260230,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6095200,https://api.altmetric.com/v1/donut/6095200_240.png 0,Androgen quantitation in prostate cancer tissue using liquid chromatography tandem mass spectrometry.,Methods in molecular biology,,,Article,2011-01-01,10.1007/978-1-61779-243-4_3,,,,21796519,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6095198,https://api.altmetric.com/v1/donut/6095198_240.png 0,Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer.,Analytical Chemistry,,,Article,2010-07-14,10.1021/ac100460x,,,,20560527,PMC2928567,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6095195,https://api.altmetric.com/v1/donut/6095195_240.png 0,Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy.,The Journal of Urology,,,Article,2009-02-15,10.1016/j.juro.2008.10.014,,,,19091347,PMC2851185,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6095193,https://api.altmetric.com/v1/donut/6095193_240.png 0,14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer.,Clinical Cancer Research,,,Article,2009-12-15,10.1158/1078-0432.ccr-08-1976,,,,19996220,PMC2795092,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6095191,https://api.altmetric.com/v1/donut/6095191_240.png 0,Multiparametric MRI of prostate cancer: An update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.,Journal of Magnetic Resonance Imaging,,,Article,2013-05-14,10.1002/jmri.23860,,,,23606141,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,99,https://www.altmetric.com/details/6095122,https://api.altmetric.com/v1/donut/6095122_240.png 0,Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study.,Brachytherapy,,,Article,,10.1016/j.brachy.2009.01.004,,,,19428311,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6095092,https://api.altmetric.com/v1/donut/6095092_240.png 0,Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities - a radiologist's perspective.,NMR in Biomedicine,,,Article,2013-09-02,10.1002/nbm.3002,,,,24000133,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6095084,https://api.altmetric.com/v1/donut/6095084_240.png 0,Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model.,Molecular Cancer Therapeutics,,,Article,2009-08-14,10.1158/1535-7163.mct-09-0262,,,,19671741,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6094607,https://api.altmetric.com/v1/donut/6094607_240.png 0,Participation of older patients with prostate cancer in Medicare eligible trials.,The Journal of Urology,,,Article,2010-09-14,10.1016/j.juro.2010.04.076,,,,20643449,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6094240,https://api.altmetric.com/v1/donut/6094240_240.png 0,Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells.,International Journal of Hyperthermia,,,Article,,10.3109/02656736.2010.486778,,,,20858083,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6094234,https://api.altmetric.com/v1/donut/6094234_240.png 0,Nanoshell-mediated laser surgery simulation for prostate cancer treatment.,Engineering with Computers,,,Article,,10.1007/s00366-008-0109-y,,,,20648233,PMC2905827,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6094229,https://api.altmetric.com/v1/donut/6094229_240.png 0,Challenges in clinical prostate cancer: role of imaging.,American Journal of Roentgenology,,,Article,2009-06-14,10.2214/ajr.09.2579,,,,19457806,PMC2893141,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6094190,https://api.altmetric.com/v1/donut/6094190_240.png 0,Phase II study of sunitinib in men with advanced prostate cancer.,Annals of Oncology,,,Article,2009-05-14,10.1093/annonc/mdp111,,,,19403935,PMC2674960,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6094189,https://api.altmetric.com/v1/donut/6094189_240.png 0,Prostate cancer: How can we improve the health of men who receive ADT?,Nature Reviews Urology,,,Article,2009-10-14,10.1038/nrurol.2009.195,,,,19806171,PMC2900772,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6094188,https://api.altmetric.com/v1/donut/6094188_240.png 0,Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.,Journal of Clinical Oncology,,,Article,2009-01-01,10.1200/jco.2007.12.3752,,,,19047297,PMC2645096,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6094186,https://api.altmetric.com/v1/donut/6094186_240.png 0,Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.,The Journal of Urology,,,Article,2009-12-15,10.1016/j.juro.2009.08.048,,,,19836774,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6094185,https://api.altmetric.com/v1/donut/6094185_240.png 0,Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.,JGIM: Journal of General Internal Medicine,,,Article,2009-11-15,10.1007/s11606-009-0968-y,,,,19838837,PMC2763167,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6094183,https://api.altmetric.com/v1/donut/6094183_240.png 0,Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks.,European Urology,,,Article,,10.1016/j.eururo.2008.10.008,,,,18945543,PMC3090670,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6094182,https://api.altmetric.com/v1/donut/6094182_240.png 0,Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy.,Cancer (0008543X),,,Article,2013-02-15,10.1002/cncr.27830,,,,23065626,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6094179,https://api.altmetric.com/v1/donut/6094179_240.png 0,Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer.,Journal of Clinical Oncology,,,Article,2012-09-09,10.1200/jco.2011.38.8850,,,,22649143,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6094177,https://api.altmetric.com/v1/donut/6094177_240.png 0,Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism.,European Urology,,,Article,2012-06-14,10.1016/j.eururo.2012.01.045,,,,22336376,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6094176,https://api.altmetric.com/v1/donut/6094176_240.png 0,Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer.,The Journal of Urology,,,Article,2011-12-15,10.1016/j.juro.2011.07.090,,,,22014807,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6094175,https://api.altmetric.com/v1/donut/6094175_240.png 0,Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention?,British Journal of Urology,,,Article,2011-05-14,10.1111/j.1464-410x.2010.09652.x,,,,20860650,PMC3082632,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6094174,https://api.altmetric.com/v1/donut/6094174_240.png 0,Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response.,Clinical Cancer Research,,,Article,2011-07-14,10.1158/1078-0432.ccr-11-0815,,,,21632851,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6094173,https://api.altmetric.com/v1/donut/6094173_240.png 0,Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer.,Journal of Bone & Mineral Research,,,Article,2011-12-15,10.1002/jbmr.492,,,,21898590,PMC3222788,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6094172,https://api.altmetric.com/v1/donut/6094172_240.png 0,Bone health and prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2010-03-15,10.1038/pcan.2009.50,,,,19901958,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6094169,https://api.altmetric.com/v1/donut/6094169_240.png 0,Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer.,The Journal of Urology,,,Article,2010-06-14,10.1016/j.juro.2010.02.022,,,,20399451,PMC2900634,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6094168,https://api.altmetric.com/v1/donut/6094168_240.png 0,Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.,The Journal of Urology,,,Article,2010-10-14,10.1016/j.juro.2010.06.022,,,,20723926,PMC3047407,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6094167,https://api.altmetric.com/v1/donut/6094167_240.png 0,"Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer.",The Journal of Urology,,,Article,2010-12-15,10.1016/j.juro.2010.08.012,,,,20952020,PMC3047399,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6094166,https://api.altmetric.com/v1/donut/6094166_240.png 0,NCCN clinical practice guidelines in oncology: prostate cancer.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2010-02-15,,,,,20141676,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6094164,https://api.altmetric.com/v1/donut/6094164_240.png 0,Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2010-02-15,,,,,20141678,PMC2900630,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6094163,https://api.altmetric.com/v1/donut/6094163_240.png 0,Hormonal therapies: ADT for prostate cancer: true love or heartbreak?,Nature Reviews Clinical Oncology,,,Article,2010-03-15,10.1038/nrclinonc.2010.12,,,,20190794,PMC2900769,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6094162,https://api.altmetric.com/v1/donut/6094162_240.png 0,The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.,British Journal of Urology,,,Article,2010-05-14,10.1111/j.1464-410x.2010.09290.x,,,,20346051,PMC3090683,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6094161,https://api.altmetric.com/v1/donut/6094161_240.png 0,Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-04-14,10.1158/1055-9965.epi-10-1023,,,,21266523,PMC3073610,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6094075,https://api.altmetric.com/v1/donut/6094075_240.png 0,Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.,Cancer Research,,,Article,2010-02-15,10.1158/0008-5472.can-09-2509,,,,20124490,PMC2822890,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6094074,https://api.altmetric.com/v1/donut/6094074_240.png 0,Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.,Urologic Oncology,,,Article,2009-05-01,10.1016/j.urolonc.2009.03.016,,,,19414113,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6094073,https://api.altmetric.com/v1/donut/6094073_240.png 0,Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate.,Prostate Cancer & Prostatic Diseases,,,Article,2014-07-21,10.1038/pcan.2014.27,,,,25047002,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6094032,https://api.altmetric.com/v1/donut/6094032_240.png 0,Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.,Journal of Clinical Oncology,,,Article,2010-03-20,10.1200/jco.2009.24.1281,,,,20159824,PMC2849769,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/6094031,https://api.altmetric.com/v1/donut/6094031_240.png 0,A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.,Oncology Reports,,,Article,2012-01-15,10.3892/or.2011.1487,,,,21971890,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6094030,https://api.altmetric.com/v1/donut/6094030_240.png 0,Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2010.06.014,,,,20884247,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6094029,https://api.altmetric.com/v1/donut/6094029_240.png 0,"Clinical Presentation and Outcomes of Prostate Cancer in an Urban Cohort of Predominantly African American, Human Immunodeficiency Virus-infected Patients.",Urology,,,Article,2015-02-15,10.1016/j.urology.2014.09.054,,,,25623706,PMC4308815,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6093946,https://api.altmetric.com/v1/donut/6093946_240.png 0,Increasing use of observation among men at low risk for prostate cancer mortality.,The Journal of Urology,,,Article,2014-09-03,10.1016/j.juro.2014.08.102,,,,25196658,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6093865,https://api.altmetric.com/v1/donut/6093865_240.png 0,A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.,The Prostate,,,Article,2010-05-31,10.1002/pros.21118,,,,20127732,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6093784,https://api.altmetric.com/v1/donut/6093784_240.png 0,Out-of-Pocket Expenses and Treatment Choice for Men With Prostate Cancer.,Urology,,,Article,2012-12-15,10.1016/j.urology.2012.08.027,,,,23102446,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6093764,https://api.altmetric.com/v1/donut/6093764_240.png 0,Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-11-15,10.1016/j.ijrobp.2011.02.006,,,,21498008,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6093761,https://api.altmetric.com/v1/donut/6093761_240.png 0,Distinct genomic aberrations associated with ERG rearranged prostate cancer.,"Genes, Chromosomes, and Cancer",,,Article,2009-04-14,10.1002/gcc.20647,,,,19156837,PMC2674964,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6093713,https://api.altmetric.com/v1/donut/6093713_240.png 0,ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.,Modern Pathology,,,Article,2010-08-14,10.1038/modpathol.2010.87,,,,20473283,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6093709,https://api.altmetric.com/v1/donut/6093709_240.png 0,The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy.,Prostate Cancer,,,Article,,10.1155/2011/245642,,,,22096652,PMC3196931,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6093602,https://api.altmetric.com/v1/donut/6093602_240.png 0,Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity.,Cancer Causes and Control,,,Article,2009-12-15,10.1007/s10552-009-9385-0,,,,19568698,PMC2777237,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6093600,https://api.altmetric.com/v1/donut/6093600_240.png 0,Use of thiazolidinediones does not affect prostate-specific antigen levels in men with diabetes.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-06-14,10.1158/1055-9965.epi-09-0215,,,,19454610,PMC2711005,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6093543,https://api.altmetric.com/v1/donut/6093543_240.png 0,Targeting monoamine oxidase A in advanced prostate cancer.,Journal of Cancer Research & Clinical Oncology,,,Article,2010-11-15,10.1007/s00432-010-0835-6,,,,20204405,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6093343,https://api.altmetric.com/v1/donut/6093343_240.png 0,Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.,The Prostate,,,Article,2009-06-14,10.1002/pros.20946,,,,19267366,PMC2736596,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6093341,https://api.altmetric.com/v1/donut/6093341_240.png 0,"Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.",BMC Medical Genomics,,,Article,2009-08-19,10.1186/1755-8794-2-55,,,,19691856,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6093339,https://api.altmetric.com/v1/donut/6093339_240.png 0,Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation.,Journal of Biological Chemistry,,,Article,2011-10-13,10.1074/jbc.c111.269050,,,,21890624,PMC3195584,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6093295,https://api.altmetric.com/v1/donut/6093295_240.png 0,The androgen receptor and stem cell pathways in prostate and bladder cancers (Review).,International Journal of Oncology,,,Article,2012-01-15,10.3892/ijo.2011.1212,,,,21956088,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6093142,https://api.altmetric.com/v1/donut/6093142_240.png 0,Prostate Cancer Discrimination in the Peripheral Zone With a Reduced Field-of-View T2-mapping MRI Sequence.,Magnetic Resonance Imaging (0730725X),,,Article,2015-02-13,10.1016/j.mri.2015.02.006,,,,25687187,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6093081,https://api.altmetric.com/v1/donut/6093081_240.png 0,A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing.,Cancer Research,,,Article,,10.1158/0008-5472.can-10-1008,,,,20610630,PMC2912945,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6093067,https://api.altmetric.com/v1/donut/6093067_240.png 0,Basal epithelial stem cells are efficient targets for prostate cancer initiation.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2010-02-09,10.1073/pnas.0913873107,,,,20133806,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/6093031,https://api.altmetric.com/v1/donut/6093031_240.png 0,Perspectives and potential applications of nanomedicine in breast and prostate cancer.,Medicinal Research Reviews,,,Article,2013-01-15,10.1002/med.20233,,,,23239045,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6092920,https://api.altmetric.com/v1/donut/6092920_240.png 0,Role for stromal heterogeneity in prostate tumorigenesis.,Cancer Research,,,Article,2011-05-14,10.1158/0008-5472.can-10-2999,,,,21444670,PMC3096737,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6092802,https://api.altmetric.com/v1/donut/6092802_240.png 0,A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging.,Amino Acids,,,Article,2011-07-14,10.1007/s00726-010-0762-5,,,,20936525,PMC3102790,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6092732,https://api.altmetric.com/v1/donut/6092732_240.png 0,Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.,Molecular Cancer Therapeutics,,,Article,2009-10-14,10.1158/1535-7163.mct-09-0293,,,,19825806,PMC2808126,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6092701,https://api.altmetric.com/v1/donut/6092701_240.png 0,Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells.,"Nanomedicine: Nanotechnology, Biology and Medicine",,,Article,2011-04-14,10.1016/j.nano.2010.09.004,,,,20887814,PMC3062699,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,79,https://www.altmetric.com/details/6092559,https://api.altmetric.com/v1/donut/6092559_240.png 0,MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans.,Biotechnic & Histochemistry,,,Article,2013-10-14,10.3109/10520295.2013.807069,,,,23901944,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6092419,https://api.altmetric.com/v1/donut/6092419_240.png 0,Nuclear Kaiso Indicates Aggressive Prostate Cancers and Promotes Migration and Invasiveness of Prostate Cancer Cells.,American Journal of Pathology,,,Article,2012-11-15,10.1016/j.ajpath.2012.08.008,,,,22974583,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6092416,https://api.altmetric.com/v1/donut/6092416_240.png 0,Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells.,Journal of pharmaceutical sciences and pharmacology,,,Article,2014-09-01,10.1166/jpsp.2014.1022,,,,25745638,PMC4347898,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6092395,https://api.altmetric.com/v1/donut/6092395_240.png 0,"Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.",International Journal of Oncology,,,Article,2011-07-14,10.3892/ijo.2011.1014,,,,21519790,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6092383,https://api.altmetric.com/v1/donut/6092383_240.png 0,CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation.,Cell Proliferation,,,Article,2011-08-14,10.1111/j.1365-2184.2011.00757.x,,,,21645150,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6092380,https://api.altmetric.com/v1/donut/6092380_240.png 0,Prostate cancer incidence and mortality among Puerto Ricans: an updated analysis comparing men in Puerto Rico with US racial/ethnic groups.,Puerto Rico Health Sciences Journal,,,Article,2012-09-14,,,,,23038882,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6092147,https://api.altmetric.com/v1/donut/6092147_240.png 0,Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling.,Cancer Investigation,,,Article,2011-05-14,10.3109/07357907.2011.554477,,,,21345070,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6092127,https://api.altmetric.com/v1/donut/6092127_240.png 0,Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.,Cancer Prevention Research,,,Article,2011-07-14,10.1158/1940-6207.capr-10-0333,,,,21430074,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6092126,https://api.altmetric.com/v1/donut/6092126_240.png 0,p53 Pro72Arg polymorphism and prostate cancer in men of African descent.,The Prostate,,,Article,2010-12-01,10.1002/pros.21209,,,,20593380,PMC3057117,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6092125,https://api.altmetric.com/v1/donut/6092125_240.png 0,"Synthesis and cytotoxic activities of some 2-Arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.",Investigational New Drugs,,,Article,2012-08-14,10.1007/s10637-011-9635-3,,,,21243402,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6092123,https://api.altmetric.com/v1/donut/6092123_240.png 0,Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment.,International Journal of Oncology,,,Article,2012-04-14,10.3892/ijo.2012.1335,,,,22266918,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6092121,https://api.altmetric.com/v1/donut/6092121_240.png 0,"Design, synthesis and evaluation of pH-dependent hydrolysable emetine analogs as treatment for prostate cancer.",Journal of Medicinal Chemistry,,,Article,2012-09-12,10.1021/jm300426q,,,,22867001,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6092118,https://api.altmetric.com/v1/donut/6092118_240.png 0,Apoptotic Effects of Novel Dithiocarbamate Analogs of Emetine in Prostate Cancer Cell Lines.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,26254362,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6092112,https://api.altmetric.com/v1/donut/6092112_240.png 0,"Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines.",Bioorganic & Medicinal Chemistry,,,Article,,10.1016/j.bmc.2015.06.072,,,,26187015,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6092110,https://api.altmetric.com/v1/donut/6092110_240.png 0,ARF Represses Androgen Receptor Transactivation in Prostate Cancer.,Molecular Endocrinology,,,Article,2013-04-14,10.1210/me.2012-1294,,,,23449888,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6092100,https://api.altmetric.com/v1/donut/6092100_240.png 0,Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.,,,,Article,2009-01-15,,,,,19164938,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6092098,https://api.altmetric.com/v1/donut/6092098_240.png 0,A cell permeable peptide analog as a potential-specific PET imaging probe for prostate cancer detection.,Amino Acids,,,Article,2011-11-15,10.1007/s00726-010-0515-5,,,,20221650,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6092038,https://api.altmetric.com/v1/donut/6092038_240.png 0,Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2010-02-09,10.1073/pnas.0908133107,,,,20080667,PMC2823864,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/6092024,https://api.altmetric.com/v1/donut/6092024_240.png 0,Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.,Supportive Care in Cancer,,,Article,2010-03-15,10.1007/s00520-009-0655-x,,,,19468757,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6091468,https://api.altmetric.com/v1/donut/6091468_240.png 0,Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer : Analysis of RTOG 0215.,Supportive Care in Cancer,,,Article,2012-11-15,10.1007/s00520-012-1409-8,,,,22354624,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6091436,https://api.altmetric.com/v1/donut/6091436_240.png 0,COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP (SWOG) INNOVATIONS IN ADVANCED PROSTATE CANCER.,Therapeutic Advances in Medical Oncology,,,Article,,10.1177/1758834009343454,,,,21085622,PMC2981166,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6091425,https://api.altmetric.com/v1/donut/6091425_240.png 0,"A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.",,,,Article,2010-02-24,10.1186/1479-5876-8-20,,,,20178647,PMC2837641,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6091334,https://api.altmetric.com/v1/donut/6091334_240.png 0,Phase II Trial of Weekly Ixabepilone in Men With Metastatic Castrate-Resistant Prostate Cancer (E3803): A Trial of the Eastern Cooperative Oncology Group.,Clinical Genitourinary Cancer,,,Article,2012-06-14,10.1016/j.clgc.2012.01.009,,,,22386239,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6091319,https://api.altmetric.com/v1/donut/6091319_240.png 0,Factors influencing prostate cancer screening in low-income African Americans in Tennessee.,Journal of health care for the poor and underserved (Online),,,Article,2010-02-15,10.1353/hpu.0.0235,,,,20173288,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6091132,https://api.altmetric.com/v1/donut/6091132_240.png 0,Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer.,Journal of Pain & Symptom Management,,,Article,2010-05-14,10.1016/j.jpainsymman.2009.09.013,,,,20471547,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6091094,https://api.altmetric.com/v1/donut/6091094_240.png 0,Racial differences in social support and coping among family caregivers of patients with prostate cancer.,Journal of Psychosocial Oncology,,,Article,,10.1080/07347332.2013.778931,,,,23656257,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6091093,https://api.altmetric.com/v1/donut/6091093_240.png 0,"Race, healthcare access and physician trust among prostate cancer patients.",Cancer Causes and Control,,,Article,2010-01-15,10.1007/s10552-009-9431-y,,,,19777359,PMC2811408,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6091084,https://api.altmetric.com/v1/donut/6091084_240.png 0,Barbers against prostate cancer: a feasibility study for training barbers to deliver prostate cancer education in an urban African American community.,Journal of Cancer Education,,,Article,2010-03-15,10.1007/s13187-009-0021-1,,,,20146044,PMC2862382,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6091081,https://api.altmetric.com/v1/donut/6091081_240.png 0,Barbershop communications on prostate cancer screening using barber health advisers.,American Journal of Men's Health,,,Article,2011-03-15,10.1177/1557988310365167,,,,20413392,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6091074,https://api.altmetric.com/v1/donut/6091074_240.png 0,"Soil zinc content, groundwater usage, and prostate cancer incidence in South Carolina.",Cancer Causes and Control,,,Article,,10.1007/s10552-008-9248-0,,,,18949566,PMC2959174,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6091052,https://api.altmetric.com/v1/donut/6091052_240.png 0,Addressing the challenge of informed decision making in prostate cancer community outreach to african american men.,American Journal of Men's Health,,,Article,2011-11-15,10.1177/1557988311411909,,,,21816861,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6091045,https://api.altmetric.com/v1/donut/6091045_240.png 0,Prostate cancer screening among chinese american men: a structural model.,American Journal of Health Behavior,,,Article,2012-07-14,10.5993/ajhb.36.4.6,,,,22488399,PMC3325499,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6091032,https://api.altmetric.com/v1/donut/6091032_240.png 0,Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal Treatment-Related Neuroendocrine Prostate Cancer.,Neoplasia,,,Article,2013-01-15,,,,,23358695,PMC3556934,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6091006,https://api.altmetric.com/v1/donut/6091006_240.png 0,Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.,Human Pathology,,,Article,2014-06-25,10.1016/j.humpath.2014.06.008,,,,25128228,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6091004,https://api.altmetric.com/v1/donut/6091004_240.png 0,Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2013-06-14,10.1038/pcan.2013.4,,,,23381693,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6091003,https://api.altmetric.com/v1/donut/6091003_240.png 0,Lineage relationship of prostate cancer cell types based on gene expression.,BMC Medical Genomics,,,Article,2011-05-22,10.1186/1755-8794-4-46,,,,21605402,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6090994,https://api.altmetric.com/v1/donut/6090994_240.png 0,Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes.,BMC Cancer,,,Article,2009-09-07,10.1186/1471-2407-9-317,,,,19737398,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6090992,https://api.altmetric.com/v1/donut/6090992_240.png 0,Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine.,The Prostate,,,Article,2012-06-14,10.1002/pros.21508,,,,22072305,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6090991,https://api.altmetric.com/v1/donut/6090991_240.png 0,Global reactivation of epigenetically silenced genes in prostate cancer.,Cancer Prevention Research,,,Article,2010-09-14,10.1158/1940-6207.capr-10-0039,,,,20699414,PMC2933318,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6090984,https://api.altmetric.com/v1/donut/6090984_240.png 0,"Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada.",International Journal of Cancer,,,Article,2014-01-20,10.1002/ijc.28732,,,,24443367,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6090946,https://api.altmetric.com/v1/donut/6090946_240.png 0,What if i don't treat my PSA-detected prostate cancer? Answers from three natural history models.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-05-14,10.1158/1055-9965.epi-10-0718,,,,21546365,PMC3091266,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6090945,https://api.altmetric.com/v1/donut/6090945_240.png 0,Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.,JNCI: Journal of the National Cancer Institute,,,Article,2010-03-03,10.1093/jnci/djp533,,,,20142584,PMC2831048,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6090944,https://api.altmetric.com/v1/donut/6090944_240.png 0,Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.,Clinical Cancer Research,,,Article,2009-08-31,10.1158/1078-0432.ccr-08-2892,,,,19690195,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6090929,https://api.altmetric.com/v1/donut/6090929_240.png 0,Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.,Molecular Cancer Therapeutics,,,Article,2010-06-14,10.1158/1535-7163.mct-09-0880,,,,20501799,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6090762,https://api.altmetric.com/v1/donut/6090762_240.png 0,"Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.",Pharmacogenetics and Genomics,,,Article,2011-10-14,10.1097/fpc.0b013e3283493a57,,,,21716162,PMC3172373,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6090734,https://api.altmetric.com/v1/donut/6090734_240.png 0,"Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.",Annals of Epidemiology,,,Article,2013-07-22,10.1016/j.annepidem.2013.06.006,,,,23890797,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6090730,https://api.altmetric.com/v1/donut/6090730_240.png 0,"Genetic variation in nucleotide excision repair pathway genes, pesticide exposure, and prostate cancer risk.",Carcinogenesis,,,Article,2012-02-15,10.1093/carcin/bgr258,,,,22102698,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6090729,https://api.altmetric.com/v1/donut/6090729_240.png 0,Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study.,Cancer Epidemiology,,,Article,2011-08-14,10.1016/j.canep.2010.11.005,,,,21167804,PMC3142317,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6090653,https://api.altmetric.com/v1/donut/6090653_240.png 0,Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.,Cancer Prevention Research,,,Article,2010-10-14,10.1158/1940-6207.capr-10-0053,,,,20858760,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6090647,https://api.altmetric.com/v1/donut/6090647_240.png 0,Cigarette smoking and prostate cancer recurrence after prostatectomy.,JNCI: Journal of the National Cancer Institute,,,Article,2011-05-17,10.1093/jnci/djr124,,,,21498781,PMC3096800,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6090641,https://api.altmetric.com/v1/donut/6090641_240.png 0,Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.,Clinical Cancer Research,,,Article,2010-12-01,10.1158/1078-0432.ccr-10-1200,,,,21138874,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6090639,https://api.altmetric.com/v1/donut/6090639_240.png 0,SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,26124326,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6090637,https://api.altmetric.com/v1/donut/6090637_240.png 0,Correction: Overexpression of Periostin in Stroma Positively Associated with Aggressive Prostate Cancer.,PLoS ONE,,,Article,,10.1371/journal.pone.0130333,,,,26043260,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6090530,https://api.altmetric.com/v1/donut/6090530_240.png 0,Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector.,,,,Article,,10.1371/journal.pone.0046981,,,,23056548,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6090462,https://api.altmetric.com/v1/donut/6090462_240.png 0,Association of diabetes with prostate cancer risk in the multiethnic cohort.,American Journal of Epidemiology,,,Article,2009-04-14,10.1093/aje/kwp003,,,,19240222,PMC2727229,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6090323,https://api.altmetric.com/v1/donut/6090323_240.png 0,"Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-09-14,10.1158/1055-9965.epi-09-0293,,,,19723920,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6090317,https://api.altmetric.com/v1/donut/6090317_240.png 0,"Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-07-14,10.1158/1055-9965.epi-10-0231,,,,20570911,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6090292,https://api.altmetric.com/v1/donut/6090292_240.png 0,"Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort.",The Prostate,,,Article,2010-05-31,10.1002/pros.21125,,,,20166103,PMC2860643,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6090290,https://api.altmetric.com/v1/donut/6090290_240.png 0,Galectin-3 regulates p21 stability in human prostate cancer cells.,Oncogene,,,Article,2012-11-19,10.1038/onc.2012.528,,,,23160381,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6090262,https://api.altmetric.com/v1/donut/6090262_240.png 0,Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment.,,,,Article,2010-11-18,10.1038/cddis.2010.79,,,,21368866,PMC3032324,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6090259,https://api.altmetric.com/v1/donut/6090259_240.png 0,"Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.",American Journal of Epidemiology,,,Article,2010-03-01,10.1093/aje/kwp406,,,,20142396,PMC2842217,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6090128,https://api.altmetric.com/v1/donut/6090128_240.png 0,Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-12-15,10.1158/1055-9965.epi-10-0942,,,,20935064,PMC3005534,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6090124,https://api.altmetric.com/v1/donut/6090124_240.png 0,"Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-04-14,10.1158/1055-9965.epi-08-0984,,,,19336558,PMC2717001,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6090123,https://api.altmetric.com/v1/donut/6090123_240.png 0,"Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.",The Prostate,,,Article,2009-08-31,10.1002/pros.20974,,,,19475640,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6090117,https://api.altmetric.com/v1/donut/6090117_240.png 0,"C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.",Cancer Causes and Control,,,Article,2009-09-14,10.1007/s10552-009-9320-4,,,,19267250,PMC2846958,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6090115,https://api.altmetric.com/v1/donut/6090115_240.png 0,Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.,Genetics in Medicine,,,Article,2009-05-14,10.1097/gim.0b013e31819b2425,,,,19346959,PMC2683189,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6090053,https://api.altmetric.com/v1/donut/6090053_240.png 0,Characterization of SV-40 Tag rats as a model to study prostate cancer.,,,,Article,2009-01-26,10.1186/1471-2407-9-30,,,,19171036,PMC2639608,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6089964,https://api.altmetric.com/v1/donut/6089964_240.png 0,Dietary Omega-6 and Omega-3 Fatty Acids and Prostate Cancer - Letter.,Cancer Prevention Research,,,Article,2012-05-14,10.1158/1940-6207.capr-12-0032,,,,22490435,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6089943,https://api.altmetric.com/v1/donut/6089943_240.png 0,Integrating Structural and Functional Imaging for Computer Assisted Detection of Prostate Cancer on Multi-Protocol In Vivo 3 Tesla MRI.,Proceedings of SPIE,,,Article,2009-02-27,10.1117/12.811899,,,,25301989,PMC4188347,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6089866,https://api.altmetric.com/v1/donut/6089866_240.png 0,Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.,Psycho-Oncology,,,Article,2014-06-12,10.1002/pon.3608,,,,24924331,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6089651,https://api.altmetric.com/v1/donut/6089651_240.png 0,Bcl-2 modulation to activate apoptosis in prostate cancer.,Molecular Cancer Research,,,Article,2009-09-14,10.1158/1541-7786.mcr-09-0166,,,,19737977,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6089559,https://api.altmetric.com/v1/donut/6089559_240.png 0,Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment.,,,,Article,2009-02-01,,,,,20046540,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6089235,https://api.altmetric.com/v1/donut/6089235_240.png 0,Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation.,European Journal of Pharmacology,,,Article,2009-01-05,10.1016/j.ejphar.2008.10.053,,,,19026633,PMC2637082,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6089209,https://api.altmetric.com/v1/donut/6089209_240.png 0,Salinomycin suppresses LRP6 expression and inhibits both Wnt/?-catenin and mTORC1 signaling in breast and prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2014-06-05,10.1002/jcb.24850,,,,24905570,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6089208,https://api.altmetric.com/v1/donut/6089208_240.png 0,Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/?-catenin and mTORC1 signaling in prostate and breast cancer cells.,Cellular Signalling,,,Article,2014-03-06,10.1016/j.cellsig.2014.02.018,,,,24607787,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6089207,https://api.altmetric.com/v1/donut/6089207_240.png 0,"3,3'-diindolylmethane, but not indol-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.",Toxicology & Applied Pharmacology,,,Article,2012-09-14,10.1016/j.taap.2012.07.007,,,,22800507,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6089135,https://api.altmetric.com/v1/donut/6089135_240.png 0,Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.,Molecular Nutrition & Food Research,,,Article,2014-07-13,10.1002/mnfr.201400269,,,,25044704,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6089134,https://api.altmetric.com/v1/donut/6089134_240.png 0,Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.,"Translational medicine (Sunnyvale, Calif.)",,,Article,2012-12-31,10.4172/2161-1025.s2-005,,,,24527269,PMC3920581,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6089086,https://api.altmetric.com/v1/donut/6089086_240.png 0,EphB2 SNPs and sporadic prostate cancer risk in African American men.,,,,Article,,10.1371/journal.pone.0019494,,,,21603658,PMC3095601,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6089072,https://api.altmetric.com/v1/donut/6089072_240.png 0,"Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.",The Prostate,,,Article,2010-02-15,10.1002/pros.21061,,,,19902474,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6089071,https://api.altmetric.com/v1/donut/6089071_240.png 0,Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.,The Prostate,,,Article,2011-07-31,10.1002/pros.21335,,,,21656830,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6089070,https://api.altmetric.com/v1/donut/6089070_240.png 0,GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.,PLoS ONE,,,Article,2009-08-03,10.1371/journal.pone.0006511,,,,19652704,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,85,https://www.altmetric.com/details/6089063,https://api.altmetric.com/v1/donut/6089063_240.png 0,Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model.,Cancer Research,,,Article,2009-11-15,10.1158/0008-5472.can-08-4673,,,,19887604,PMC2783355,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/6089011,https://api.altmetric.com/v1/donut/6089011_240.png 0,Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence.,Cancer Prevention Research,,,Article,2010-01-15,10.1158/1940-6207.capr-09-0059,,,,20051379,PMC2803700,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6088990,https://api.altmetric.com/v1/donut/6088990_240.png 0,"Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.",Journal of Cellular Physiology,,,Article,2009-04-14,10.1002/jcp.21650,,,,19062173,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6088902,https://api.altmetric.com/v1/donut/6088902_240.png 0,Novel polypyridyl chelators deplete cellular zinc and destabilize the X-linked inhibitor of apoptosis protein (XIAP) prior to induction of apoptosis in human prostate and breast cancer cells.,Journal of Cellular Biochemistry,,,Article,2012-08-14,10.1002/jcb.24132,,,,22415943,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6088889,https://api.altmetric.com/v1/donut/6088889_240.png 0,Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.,Current Drug Targets,,,Article,2010-06-14,,,,,20298150,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6088879,https://api.altmetric.com/v1/donut/6088879_240.png 0,Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.,,,,Article,2010-01-05,10.1371/journal.pone.0008579,,,,20062804,PMC2799519,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/6088684,https://api.altmetric.com/v1/donut/6088684_240.png 0,Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.,Acta Pharmacologica Sinica,,,Article,2010-09-14,10.1038/aps.2010.147,,,,20729872,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6088683,https://api.altmetric.com/v1/donut/6088683_240.png 0,Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model.,Cancer Research,,,Article,2009-08-31,10.1158/0008-5472.can-09-0597,,,,19706764,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6088681,https://api.altmetric.com/v1/donut/6088681_240.png 0,Fibronectin matrix-mediated cohesion suppresses invasion of prostate cancer cells.,,,,Article,2012-03-20,10.1186/1471-2407-12-94,,,,22433434,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6088665,https://api.altmetric.com/v1/donut/6088665_240.png 0,Synthesis and Characterization of a Novel Prostate Cancer-Targeted PI3 Kinase Inhibitor Prodrug.,Journal of Medicinal Chemistry,,,Article,2012-09-26,10.1021/jm300881a,,,,22924393,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6088587,https://api.altmetric.com/v1/donut/6088587_240.png 0,Expression of the Bcl-2 protein BAD promotes prostate cancer growth.,PLoS ONE,,,Article,2009-07-12,10.1371/journal.pone.0006224,,,,19593445,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6088586,https://api.altmetric.com/v1/donut/6088586_240.png 0,Assessing prostate cancer growth with mRNA of spermine metabolic enzymes.,Cancer Biology and Therapy,,,Article,2010-04-30,,,,,20215859,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6088443,https://api.altmetric.com/v1/donut/6088443_240.png 0,A decade in prostate cancer: from NMR to metabolomics.,Nature Reviews Urology,,,Article,2011-05-16,10.1038/nrurol.2011.53,,,,21587223,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6088442,https://api.altmetric.com/v1/donut/6088442_240.png 0,Magnetic resonance spectroscopy: a promising tool for the diagnostics of human prostate cancer?,Urologic Oncology,,,Article,2011-09-01,10.1016/j.urolonc.2011.05.016,,,,21930088,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6088440,https://api.altmetric.com/v1/donut/6088440_240.png 0,Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles.,The Prostate,,,Article,2010-05-14,10.1002/pros.21103,,,,20017167,PMC2909586,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6088439,https://api.altmetric.com/v1/donut/6088439_240.png 0,KIF3a Promotes Proliferation and Invasion via Wnt Signaling in Advanced Prostate Cancer.,Molecular Cancer Research,,,Article,2014-01-10,10.1158/1541-7786.mcr-13-0418,,,,24413182,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6088435,https://api.altmetric.com/v1/donut/6088435_240.png 0,Identification of speckle-type POZ protein somatic mutations in African American prostate cancer.,Asian Journal of Andrology,,,Article,2014-06-23,10.4103/1008-682x.132470,,,,24994784,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6088434,https://api.altmetric.com/v1/donut/6088434_240.png 0,Prostate cancer risk associated loci in African Americans.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-07-14,10.1158/1055-9965.epi-09-0091,,,,19549807,PMC2729762,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6088295,https://api.altmetric.com/v1/donut/6088295_240.png 0,Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.,Cancer Research,,,Article,2009-03-15,10.1158/0008-5472.can-08-3151,,,,19258504,PMC2743179,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6088294,https://api.altmetric.com/v1/donut/6088294_240.png 0,Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.,Human Molecular Genetics,,,Article,2009-03-31,10.1093/hmg/ddp035,,,,19153072,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6088293,https://api.altmetric.com/v1/donut/6088293_240.png 0,A novel prostate cancer susceptibility locus at 19q13.,Cancer Research,,,Article,2009-03-31,10.1158/0008-5472.can-08-3347,,,,19318570,PMC2803342,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6088292,https://api.altmetric.com/v1/donut/6088292_240.png 0,Sequence variants at 22q13 are associated with prostate cancer risk.,Cancer Research,,,Article,2009-01-01,10.1158/0008-5472.can-08-3464,,,,19117981,PMC2705898,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6088291,https://api.altmetric.com/v1/donut/6088291_240.png 0,Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-04-14,10.1158/1055-9965.epi-09-1176,,,,20332264,PMC2852494,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6088290,https://api.altmetric.com/v1/donut/6088290_240.png 0,"Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.",The Prostate,,,Article,2009-07-31,10.1002/pros.20970,,,,19434657,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6088289,https://api.altmetric.com/v1/donut/6088289_240.png 0,Two independent prostate cancer risk-associated Loci at 11q13.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-06-14,10.1158/1055-9965.epi-08-0983,,,,19505914,PMC2802212,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6088288,https://api.altmetric.com/v1/donut/6088288_240.png 0,Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-07-14,10.1158/1055-9965.epi-08-1221,,,,19549809,PMC2795389,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6088287,https://api.altmetric.com/v1/donut/6088287_240.png 0,"Overexpression of alpha (1,6) fucosyltransferase associated with aggressive prostate cancer.",Glycobiology,,,Article,2014-06-04,10.1093/glycob/cwu051,,,,24906821,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6088239,https://api.altmetric.com/v1/donut/6088239_240.png 0,Tissue mimicking materials for the detection of prostate cancer using shear wave elastography: A validation study.,Medical Physics,,,Article,2013-02-15,10.1118/1.4773315,,,,23387774,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6088205,https://api.altmetric.com/v1/donut/6088205_240.png 0,Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.,The Prostate,,,Article,,10.1002/pros.20867,,,,19016247,PMC2936923,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6088003,https://api.altmetric.com/v1/donut/6088003_240.png 0,Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.,Cancer Research,,,Article,2010-06-30,10.1158/0008-5472.can-09-4610,,,,20570899,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6087971,https://api.altmetric.com/v1/donut/6087971_240.png 0,Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation.,Cancer Research,,,Article,2010-10-14,10.1158/0008-5472.can-10-1418,,,,20940411,PMC2955807,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6087889,https://api.altmetric.com/v1/donut/6087889_240.png 0,Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.,Clinical Cancer Research,,,Article,2009-01-01,10.1158/1078-0432.ccr-08-1691,,,,19118040,PMC2845536,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6087885,https://api.altmetric.com/v1/donut/6087885_240.png 0,Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.,Journal of Cellular Physiology,,,Article,2010-08-14,10.1002/jcp.22148,,,,20432447,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6087828,https://api.altmetric.com/v1/donut/6087828_240.png 0,Synthesis and Evaluation of a Targeted Nanoglobular Dual-Modal Imaging Agent for MR Imaging and Image-Guided Surgery of Prostate Cancer.,Pharmaceutical Research,,,Article,2013-03-08,10.1007/s11095-013-1008-5,,,,23471641,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6087710,https://api.altmetric.com/v1/donut/6087710_240.png 0,Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.,Bioconjugate Chemistry,,,Article,2012-08-14,10.1021/bc300009t,,,,22812444,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6087708,https://api.altmetric.com/v1/donut/6087708_240.png 0,MUC1 oncoprotein is a druggable target in human prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2009-11-15,10.1158/1535-7163.mct-09-0646,,,,19887552,PMC2783220,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6087693,https://api.altmetric.com/v1/donut/6087693_240.png 0,MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.,The Prostate,,,Article,2012-11-15,10.1002/pros.22519,,,,22473899,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6087684,https://api.altmetric.com/v1/donut/6087684_240.png 0,"A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.",Oncogene,,,Article,2012-01-19,10.1038/onc.2011.236,,,,21685943,PMC3179816,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6087599,https://api.altmetric.com/v1/donut/6087599_240.png 0,Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?,Cancer Biology and Therapy,,,Article,2010-04-14,,,,,20150768,PMC3024832,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6087598,https://api.altmetric.com/v1/donut/6087598_240.png 0,Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.,PLoS Genetics,,,Article,2009-07-14,10.1371/journal.pgen.1000542,,,,19578399,PMC2697385,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6087597,https://api.altmetric.com/v1/donut/6087597_240.png 0,An assessment of the shared allelic architecture between type 2 diabetes and prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-08-14,10.1158/1055-9965.epi-13-0476,,,,23704474,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6087543,https://api.altmetric.com/v1/donut/6087543_240.png 0,Diabetes and prostate cancer screening in black and white men.,Cancer Causes and Control,,,Article,2013-10-14,10.1007/s10552-013-0257-2,,,,23860952,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6087527,https://api.altmetric.com/v1/donut/6087527_240.png 0,Photoacoustic tomography: a potential new tool for prostate cancer.,,,,Article,2010-10-06,10.1364/boe.1.001117,,,,21258534,PMC3018085,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6087445,https://api.altmetric.com/v1/donut/6087445_240.png 0,Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.,The Prostate,,,Article,2009-06-30,10.1002/pros.20960,,,,19343732,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6087431,https://api.altmetric.com/v1/donut/6087431_240.png 0,AKR1C3 as a Target in Castrate Resistant Prostate Cancer.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2013-06-05,10.1016/j.jsbmb.2013.05.012,,,,23748150,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6087423,https://api.altmetric.com/v1/donut/6087423_240.png 0,Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer.,Bioorganic & Medicinal Chemistry Letters,,,Article,2012-05-14,10.1016/j.bmcl.2012.03.085,,,,22507964,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6087421,https://api.altmetric.com/v1/donut/6087421_240.png 0,Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.,BMC Cancer,,,Article,,10.1186/1471-2407-10-672,,,,21134280,PMC3013086,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6087412,https://api.altmetric.com/v1/donut/6087412_240.png 0,Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.,Acta Oncologica,,,Article,2010-10-14,10.3109/0284186x.2010.509736,,,,20831493,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6087313,https://api.altmetric.com/v1/donut/6087313_240.png 0,Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry.,The Prostate,,,Article,2011-07-14,10.1002/pros.21320,,,,21557270,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6087304,https://api.altmetric.com/v1/donut/6087304_240.png 0,EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2009-07-14,10.1158/1535-7163.mct-09-0064,,,,19584236,PMC2727128,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6087270,https://api.altmetric.com/v1/donut/6087270_240.png 0,Calcium intake increases risk of prostate cancer among Singapore Chinese.,Cancer Research,,,Article,2010-06-14,10.1158/0008-5472.can-09-4544,,,,20516117,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6087197,https://api.altmetric.com/v1/donut/6087197_240.png 0,Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.,The Prostate,,,Article,2014-05-05,10.1002/pros.22818,,,,24796539,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6087143,https://api.altmetric.com/v1/donut/6087143_240.png 0,Hereditary prostate cancer as a feature of Lynch syndrome.,Familial Cancer,,,Article,2011-03-15,10.1007/s10689-010-9388-8,,,,20872076,PMC3089958,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6087142,https://api.altmetric.com/v1/donut/6087142_240.png 0,Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.,The Prostate,,,Article,2011-02-15,10.1002/pros.21234,,,,20717903,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6087141,https://api.altmetric.com/v1/donut/6087141_240.png 0,Regression of prostate cancer xenografts by RLIP76 depletion.,Biochemical Pharmacology,,,Article,2009-03-15,10.1016/j.bcp.2008.11.013,,,,19073149,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6087076,https://api.altmetric.com/v1/donut/6087076_240.png 0,Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.,Cell death & disease,,,Article,2014-01-23,10.1038/cddis.2013.532,,,,24457960,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6086870,https://api.altmetric.com/v1/donut/6086870_240.png 0,Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.,Radiology,,,Article,2009-04-14,10.1148/radiol.2511080409,,,,19332850,PMC2663583,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/6086846,https://api.altmetric.com/v1/donut/6086846_240.png 0,Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer.,Journal of Magnetic Resonance Imaging,,,Article,2012-08-14,10.1002/jmri.23672,,,,22535708,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6086844,https://api.altmetric.com/v1/donut/6086844_240.png 0,Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors.,Hormones and Cancer,,,Article,2010-02-15,10.1007/s12672-009-0005-y,,,,20631921,PMC2903072,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6086843,https://api.altmetric.com/v1/donut/6086843_240.png 0,Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.,Cancer Research,,,Article,2010-09-14,10.1158/0008-5472.can-09-3982,,,,20807814,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6086842,https://api.altmetric.com/v1/donut/6086842_240.png 0,Runx2 regulates survivin expression in prostate cancer cells.,Laboratory Investigation,,,Article,2010-02-15,10.1038/labinvest.2009.128,,,,19949374,PMC2815261,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6086841,https://api.altmetric.com/v1/donut/6086841_240.png 0,Current mouse and cell models in prostate cancer research.,Endocrine-Related Cancer,,,Article,,10.1530/erc-12-0285,,,,23580590,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/6086840,https://api.altmetric.com/v1/donut/6086840_240.png 0,"PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.",Hormones and Cancer,,,Article,2011-10-14,10.1007/s12672-011-0084-4,,,,21948155,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6086837,https://api.altmetric.com/v1/donut/6086837_240.png 0,Cancer stem cells and microenvironment in prostate cancer progression.,Hormones and Cancer,,,Article,2010-12-15,10.1007/s12672-010-0051-5,,,,21761361,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6086836,https://api.altmetric.com/v1/donut/6086836_240.png 0,PTEN knockout prostate cancer as a model for experimental immunotherapy.,The Journal of Urology,,,Article,,10.1016/j.juro.2008.08.124,,,,19010487,PMC2838731,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6086835,https://api.altmetric.com/v1/donut/6086835_240.png 0,"Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth.",American Journal of Pathology,,,Article,2009-03-15,10.2353/ajpath.2009.080735,,,,19179604,PMC2665763,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6086662,https://api.altmetric.com/v1/donut/6086662_240.png 0,Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.,,,,Article,2012-04-29,10.1186/1755-8794-5-11,,,,22546513,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6086621,https://api.altmetric.com/v1/donut/6086621_240.png 0,"No association between variant N-acetyltransferase genes, cigarette smoking and Prostate Cancer susceptibility among men of African descent.",,,,Article,2011-02-03,10.4137/bic.s6111,,,,21709725,PMC3122269,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6086618,https://api.altmetric.com/v1/donut/6086618_240.png 0,"Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland.",Biochemical Genetics,,,Article,2011-02-15,10.1007/s10528-010-9386-4,,,,20931357,PMC3155982,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6086617,https://api.altmetric.com/v1/donut/6086617_240.png 0,No association between variant DNA repair genes and prostate cancer risk among men of African descent.,The Prostate,,,Article,2010-02-01,10.1002/pros.21048,,,,19760636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6086615,https://api.altmetric.com/v1/donut/6086615_240.png 0,CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.,Cancer Research,,,Article,2011-07-14,10.1158/0008-5472.can-10-4576,,,,21593191,PMC3138908,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6086528,https://api.altmetric.com/v1/donut/6086528_240.png 0,Androgen receptor-driven chromatin looping in prostate cancer.,Trends in Endocrinology & Metabolism,,,Article,2011-12-15,10.1016/j.tem.2011.07.006,,,,21889355,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6086527,https://api.altmetric.com/v1/donut/6086527_240.png 0,Histone modifications and chromatin organization in prostate cancer.,Epigenomics,,,Article,2010-08-14,10.2217/epi.10.31,,,,21318127,PMC3035388,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6086526,https://api.altmetric.com/v1/donut/6086526_240.png 0,Hyperspectral imaging and quantitative analysis for prostate cancer detection.,Journal of Biomedical Optics,,,Article,2012-07-14,10.1117/1.jbo.17.7.076005,,,,22894488,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/6086463,https://api.altmetric.com/v1/donut/6086463_240.png 0,Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent.,Carcinogenesis,,,Article,2011-09-14,10.1093/carcin/bgr119,,,,21705483,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6086119,https://api.altmetric.com/v1/donut/6086119_240.png 0,Hospital racial composition and the treatment of localized prostate cancer.,Cancer (0008543X),,,Article,2011-12-15,10.1002/cncr.26232,,,,21692067,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6086118,https://api.altmetric.com/v1/donut/6086118_240.png 0,Sociocultural determinants of men's reactions to prostate cancer diagnosis.,Psycho-Oncology,,,Article,2010-05-14,10.1002/pon.1574,,,,19408346,PMC2861153,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6086117,https://api.altmetric.com/v1/donut/6086117_240.png 0,Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-09-14,10.1158/1055-9965.epi-10-0173,,,,20826827,PMC2972664,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6086115,https://api.altmetric.com/v1/donut/6086115_240.png 0,Racial differences in medical mistrust among men diagnosed with prostate cancer.,Cancer (0008543X),,,Article,2009-05-31,10.1002/cncr.24249,,,,19296516,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6086114,https://api.altmetric.com/v1/donut/6086114_240.png 0,Racial differences in the impact of comorbidities on survival among elderly men with prostate cancer.,Medical Care Research & Review,,,Article,2009-08-14,10.1177/1077558709333996,,,,19357389,PMC2780425,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6086113,https://api.altmetric.com/v1/donut/6086113_240.png 0,Temporal trends and racial disparities in global prostate cancer prevalence.,Canadian Journal of Urology,,,Article,2014-10-14,,,,,25347377,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6086111,https://api.altmetric.com/v1/donut/6086111_240.png 0,Racial differences in quality of life following prostate cancer diagnosis.,Urology,,,Article,2010-09-14,10.1016/j.urology.2009.09.090,,,,20207396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6086108,https://api.altmetric.com/v1/donut/6086108_240.png 0,Prostate stem cell antigen: a Jekyll and Hyde molecule?,Clinical Cancer Research,,,Article,2010-07-14,10.1158/1078-0432.ccr-09-3169,,,,20501618,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6085665,https://api.altmetric.com/v1/donut/6085665_240.png 0,Blood Levels of Saturated and Monounsaturated Fatty Acids as Markers of De Novo Lipogenesis and Risk of Prostate Cancer.,American Journal of Epidemiology,,,Article,2013-08-27,10.1093/aje/kwt136,,,,23989197,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6085611,https://api.altmetric.com/v1/donut/6085611_240.png 0,Loss of Wave1 gene defines a subtype of lethal prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3564,,,,25906751,PMC4494945,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6085610,https://api.altmetric.com/v1/donut/6085610_240.png 0,Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.,BJU International,,,Article,2011-01-15,10.1111/j.1464-410x.2010.09344.x,,,,20477822,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6085608,https://api.altmetric.com/v1/donut/6085608_240.png 0,Metabolic alterations and targeted therapies in prostate cancer.,The Journal of Pathology,,,Article,2011-01-15,10.1002/path.2809,,,,21125681,PMC3197856,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/6085607,https://api.altmetric.com/v1/donut/6085607_240.png 0,Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.,PLoS Genetics,,,Article,2010-11-11,10.1371/journal.pgen.1001204,,,,21085629,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6085606,https://api.altmetric.com/v1/donut/6085606_240.png 0,Molecular sampling of prostate cancer: a dilemma for predicting disease progression.,,,,Article,2010-03-16,10.1186/1755-8794-3-8,,,,20233430,PMC2855514,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/6085605,https://api.altmetric.com/v1/donut/6085605_240.png 0,"Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-07-14,10.1158/1055-9965.epi-10-0216,,,,20615892,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6085604,https://api.altmetric.com/v1/donut/6085604_240.png 0,Evaluation of the 8q24 prostate cancer risk locus and MYC expression.,Cancer Research,,,Article,2009-06-30,10.1158/0008-5472.can-09-0387,,,,19549893,PMC2884104,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/6085603,https://api.altmetric.com/v1/donut/6085603_240.png 0,The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-08-14,10.1158/1055-9965.epi-10-0112,,,,20647401,PMC2923431,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6085601,https://api.altmetric.com/v1/donut/6085601_240.png 0,Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.,Clinical Cancer Research,,,Article,2010-11-01,10.1158/1078-0432.ccr-10-1261,,,,20855462,PMC2970725,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6085600,https://api.altmetric.com/v1/donut/6085600_240.png 0,New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK.,Clinical Cancer Research,,,Article,2010-06-30,10.1158/1078-0432.ccr-09-1955,,,,20423984,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/6085598,https://api.altmetric.com/v1/donut/6085598_240.png 0,Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2009-03-31,10.1093/jnci/djp030,,,,19318631,PMC2664091,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68,https://www.altmetric.com/details/6085596,https://api.altmetric.com/v1/donut/6085596_240.png 0,The fat side of Prostate Cancer.,Biochimica et Biophysica Acta (BBA),,,Article,2013-04-01,10.1016/j.bbalip.2013.03.010,,,,23562839,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,86,https://www.altmetric.com/details/6085593,https://api.altmetric.com/v1/donut/6085593_240.png 0,The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer.,The Prostate,,,Article,2012-06-30,10.1002/pros.22456,,,,22127852,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6085590,https://api.altmetric.com/v1/donut/6085590_240.png 0,ANDROGEN RECEPTOR ENHANCES p27 DEGRADATION IN PROSTATE CANCER CELLS THROUGH RAPID AND SELECTIVE TORC2 ACTIVATION.,Journal of Biological Chemistry,,,Article,2012-01-13,10.1074/jbc.m111.323303,,,,22139837,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6085589,https://api.altmetric.com/v1/donut/6085589_240.png 0,In Silico Discovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer.,Molecular Endocrinology,,,Article,2012-11-15,10.1210/me.2012-1222,,,,23023563,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6085587,https://api.altmetric.com/v1/donut/6085587_240.png 0,The Impact of Common Genetic Variations in Genes of the Sex Hormone Metabolic Pathways on Steroid Hormone Levels and Prostate Cancer Aggressiveness.,Cancer Prevention Research,,,Article,2011-12-15,10.1158/1940-6207.capr-11-0283,,,,21900597,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6085586,https://api.altmetric.com/v1/donut/6085586_240.png 0,"Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-10-14,10.1158/1055-9965.epi-11-0373,,,,21953116,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6085585,https://api.altmetric.com/v1/donut/6085585_240.png 0,Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.,Cancer Prevention Research,,,Article,2011-05-14,10.1158/1940-6207.capr-10-0292,,,,21367958,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6085584,https://api.altmetric.com/v1/donut/6085584_240.png 0,"Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.",Journal of Clinical Investigation,,,Article,2009-05-14,10.1172/jci35079,,,,19363294,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6085583,https://api.altmetric.com/v1/donut/6085583_240.png 0,A computer-tailored intervention to promote informed decision making for prostate cancer screening among African American men.,American Journal of Men's Health,,,Article,2009-12-15,10.1177/1557988308325460,,,,19477736,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6085582,https://api.altmetric.com/v1/donut/6085582_240.png 0,Reactivation of androgen receptor-regulated TMPRSS2:ERG gene expression in castration-resistant prostate cancer.,Cancer Research,,,Article,2009-07-31,10.1158/0008-5472.can-09-0395,,,,19584279,PMC2859723,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6085581,https://api.altmetric.com/v1/donut/6085581_240.png 0,[(18)F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments.,Translational oncology,,,Article,2015-06-01,10.1016/j.tranon.2015.03.004,,,,26055171,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6085579,https://api.altmetric.com/v1/donut/6085579_240.png 0,A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.,EMBO Molecular Medicine,,,Article,2014-02-04,10.1002/emmm.201302734,,,,24497570,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6085576,https://api.altmetric.com/v1/donut/6085576_240.png 0,MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.,Oncogene,,,Article,,10.1038/onc.2013.230,,,,23770851,PMC3883998,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6085575,https://api.altmetric.com/v1/donut/6085575_240.png 0,JunD-mediated repression of GADD45? and ? regulates escape from cell death in prostate cancer.,,,,Article,2011-07-31,,,,,21734453,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6085570,https://api.altmetric.com/v1/donut/6085570_240.png 0,"8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2010-05-24,10.1073/pnas.0910668107,,,,20453196,PMC2906844,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6085566,https://api.altmetric.com/v1/donut/6085566_240.png 0,A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer.,Neoplasia,,,Article,2014-12-15,10.1016/j.neo.2014.11.006,,,,25499224,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6085390,https://api.altmetric.com/v1/donut/6085390_240.png 0,"Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer.",The Prostate,,,Article,2014-07-06,10.1002/pros.22836,,,,25043157,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6085388,https://api.altmetric.com/v1/donut/6085388_240.png 0,Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort.,Clinical Cancer Research,,,Article,,10.1158/1078-0432.ccr-10-2015,,,,21135144,PMC3060307,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6085385,https://api.altmetric.com/v1/donut/6085385_240.png 0,Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression.,Neoplasia,,,Article,2012-10-14,,,,,23097625,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6085383,https://api.altmetric.com/v1/donut/6085383_240.png 0,"Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.",Proceedings of the National Academy of Sciences of the United States of America,,,Article,2009-11-17,10.1073/pnas.0906074106,,,,19889975,PMC2780742,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6085381,https://api.altmetric.com/v1/donut/6085381_240.png 0,Confirmation of a low ?/? ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2009.10.008,,,,20381268,PMC4122313,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6085380,https://api.altmetric.com/v1/donut/6085380_240.png 0,ERK5 signalling in prostate cancer promotes an invasive phenotype.,British Journal of Cancer,,,Article,2011-02-15,10.1038/sj.bjc.6606062,,,,21266977,PMC3049582,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6085379,https://api.altmetric.com/v1/donut/6085379_240.png 0,Bayesian inference for the stereotype regression model: Application to a case-control study of prostate cancer.,Statistics in Medicine,,,Article,2009-11-10,10.1002/sim.3693,,,,19731262,PMC3103066,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6085377,https://api.altmetric.com/v1/donut/6085377_240.png 0,"Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423.",Bioorganic & Medicinal Chemistry Letters,,,Article,,10.1016/j.bmcl.2009.11.056,,,,19963382,PMC2818594,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6085376,https://api.altmetric.com/v1/donut/6085376_240.png 0,Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques.,Journal of Nuclear Medicine,,,Article,2009-10-14,10.2967/jnumed.109.063396,,,,19759109,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6085375,https://api.altmetric.com/v1/donut/6085375_240.png 0,Correlation of Urine TMPRSS2:ERG and PCA3 to ERG+ and Total Prostate Cancer Burden.,American Journal of Clinical Pathology,,,Article,2012-11-15,10.1309/ajcpu7ppwupyg8oh,,,,23086769,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6085374,https://api.altmetric.com/v1/donut/6085374_240.png 0,The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse.,Radiotherapy & Oncology,,,Article,2011-12-15,10.1016/j.radonc.2011.05.080,,,,21703711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6085370,https://api.altmetric.com/v1/donut/6085370_240.png 0,Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.,British Journal of Cancer,,,Article,2009-12-15,10.1038/sj.bjc.6605433,,,,19935797,PMC2795448,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6085367,https://api.altmetric.com/v1/donut/6085367_240.png 0,Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.,The Prostate,,,Article,2009-06-14,10.1002/pros.20943,,,,19267350,PMC2729404,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6085366,https://api.altmetric.com/v1/donut/6085366_240.png 0,Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.,Clinical Cancer Research,,,Article,2009-07-14,10.1158/1078-0432.ccr-08-2927,,,,19584163,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/6085362,https://api.altmetric.com/v1/donut/6085362_240.png 0,Targeted Radiosensitization of ETS Fusion-Positive Prostate Cancer through PARP1 Inhibition.,Neoplasia,,,Article,2013-10-14,,,,,24204199,PMC3819636,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6085360,https://api.altmetric.com/v1/donut/6085360_240.png 0,Circulating fibroblast-like cells in men with metastatic prostate cancer.,The Prostate,,,Article,2013-01-15,10.1002/pros.22553,,,,22718300,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6085359,https://api.altmetric.com/v1/donut/6085359_240.png 0,FGFR-4 Arg³?? enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.,Clinical Cancer Research,,,Article,2011-06-30,10.1158/1078-0432.ccr-10-2858,,,,21622724,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6085246,https://api.altmetric.com/v1/donut/6085246_240.png 0,"1?,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.",The Prostate,,,Article,2011-01-01,10.1002/pros.21226,,,,20632309,PMC2966519,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6085243,https://api.altmetric.com/v1/donut/6085243_240.png 0,"Frequent Heterogeneous Missense Mutations of GGAP2 in Prostate Cancer: Implications for Tumor Biology, Clonality and Mutation Analysis.",,,,Article,,10.1371/journal.pone.0032708,,,,22389719,PMC3289671,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6085230,https://api.altmetric.com/v1/donut/6085230_240.png 0,Global gene expression analysis of reactive stroma in prostate cancer.,Clinical Cancer Research,,,Article,2009-06-14,10.1158/1078-0432.ccr-08-1899,,,,19509179,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6085221,https://api.altmetric.com/v1/donut/6085221_240.png 0,Biologic correlates and significance of axonogenesis in prostate cancer.,Human Pathology,,,Article,2014-02-28,10.1016/j.humpath.2014.02.009,,,,24767770,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6085219,https://api.altmetric.com/v1/donut/6085219_240.png 0,Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-?B Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer.,,,,Article,,10.1371/journal.pone.0058391,,,,23554889,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6085203,https://api.altmetric.com/v1/donut/6085203_240.png 0,Genomic profiling of prostate cancers from African American men.,Neoplasia,,,Article,2009-03-15,,,,,19242612,PMC2647733,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6085164,https://api.altmetric.com/v1/donut/6085164_240.png 0,Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis.,Oncotarget,,,Article,2015-01-31,10.18632/oncotarget.3366,,,,25749044,PMC4467437,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6085160,https://api.altmetric.com/v1/donut/6085160_240.png 0,FGF23 promotes prostate cancer progression.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4174,,,,26019137,PMC4627308,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6085155,https://api.altmetric.com/v1/donut/6085155_240.png 0,Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer.,Cancer Research,,,Article,2014-09-30,10.1158/0008-5472.can-14-0476,,,,25274033,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6085139,https://api.altmetric.com/v1/donut/6085139_240.png 0,The Prostate Cancer TMPRSS2:ERG Fusion Synergizes with the Vitamin D Receptor (VDR) to Induce CYP24A1 Expression Limiting VDR Signaling.,Endocrinology,,,Article,2014-06-12,10.1210/en.2013-2019,,,,24926821,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6085128,https://api.altmetric.com/v1/donut/6085128_240.png 0,miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer.,PloS one,,,Article,,10.1371/journal.pone.0098675,,,,24967583,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6085125,https://api.altmetric.com/v1/donut/6085125_240.png 0,Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.,Oncogene,,,Article,2013-01-03,10.1038/onc.2012.27,,,,22349817,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6085092,https://api.altmetric.com/v1/donut/6085092_240.png 0,Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.,Oncogene,,,Article,2012-09-12,10.1038/onc.2011.590,,,,22179824,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6085077,https://api.altmetric.com/v1/donut/6085077_240.png 0,A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging.,Bioorganic & Medicinal Chemistry Letters,,,Article,2011-09-14,10.1016/j.bmcl.2011.07.055,,,,21821417,PMC3159814,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6084990,https://api.altmetric.com/v1/donut/6084990_240.png 0,Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt high-throughput flow cytometry system.,Journal of Biomolecular Screening,,,Article,2009-07-14,10.1177/1087057109335671,,,,19470718,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6084976,https://api.altmetric.com/v1/donut/6084976_240.png 0,Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.,Cancer Research,,,Article,2009-04-14,10.1158/0008-5472.can-08-3440,,,,19318566,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6084944,https://api.altmetric.com/v1/donut/6084944_240.png 0,Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer.,Molecular Cancer Therapeutics,,,Article,2013-09-14,10.1158/1535-7163.mct-13-0208,,,,23861346,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6084942,https://api.altmetric.com/v1/donut/6084942_240.png 0,Difference in Protein Expression Profile and Chemotherapy Drugs Response of Different Progression Stages of LNCaP Sublines and Other Human Prostate Cancer Cells.,PloS one,,,Article,2013-12-05,10.1371/journal.pone.0082625,,,,24349321,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6084934,https://api.altmetric.com/v1/donut/6084934_240.png 0,Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.,Cancer Research,,,Article,2009-01-15,10.1158/0008-5472.can-08-3157,,,,19147587,PMC2629384,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6084917,https://api.altmetric.com/v1/donut/6084917_240.png 0,Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors.,Journal of Biological Chemistry,,,Article,2013-12-02,10.1074/jbc.m113.492140,,,,24297183,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6084894,https://api.altmetric.com/v1/donut/6084894_240.png 0,Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells.,PloS one,,,Article,,10.1371/journal.pone.0088556,,,,24551118,PMC3925144,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6084872,https://api.altmetric.com/v1/donut/6084872_240.png 0,Lin28 promotes growth of prostate cancer cells and activates the androgen receptor.,American Journal of Pathology,,,Article,2013-07-14,10.1016/j.ajpath.2013.03.011,,,,23790802,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6084866,https://api.altmetric.com/v1/donut/6084866_240.png 0,Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans.,Magnetic Resonance in Medicine,,,Article,2009-04-14,10.1002/mrm.21896,,,,19215051,PMC3080096,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6084835,https://api.altmetric.com/v1/donut/6084835_240.png 0,NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer.,NIH consensus and state of the science statements,,,Article,,,,,,23392076,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6084543,https://api.altmetric.com/v1/donut/6084543_240.png 0,Differentiation of prostate cancer from normal tissue in radical prostatectomy specimens by desorption electrospray ionization and touch spray ionization mass spectrometry.,Analyst,,,Article,2014-12-18,10.1039/c4an02039a,,,,25521825,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6084484,https://api.altmetric.com/v1/donut/6084484_240.png 0,Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.,Cancer Research,,,Article,2011-01-15,10.1158/0008-5472.can-10-1229,,,,21098088,PMC3022112,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,92,https://www.altmetric.com/details/6084445,https://api.altmetric.com/v1/donut/6084445_240.png 0,HOXB13 Mutation and Prostate Cancer: Studies of Siblings and Agressive Disease.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-04-14,10.1158/1055-9965.epi-12-1154,,,,23396964,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6084443,https://api.altmetric.com/v1/donut/6084443_240.png 0,Current and emerging therapies for bone metastatic castration-resistant prostate cancer.,Cancer Control: Journal of the Moffitt Cancer Center,,,Article,2015-01-15,,,,,25504285,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6084390,https://api.altmetric.com/v1/donut/6084390_240.png 0,Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer.,Asian Journal of Andrology,,,Article,2014-02-25,10.4103/1008-682x.123684,,,,24589464,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6084379,https://api.altmetric.com/v1/donut/6084379_240.png 0,Dynamic Regulation of Rad51 by E2F1 and p53 in Prostate Cancer Cells upon DrugInduced DNA Damage under Hypoxia.,Molecular Pharmacology,,,Article,2014-03-13,10.1124/mol.113.090688,,,,24627085,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6084370,https://api.altmetric.com/v1/donut/6084370_240.png 0,Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.,Prostate Cancer,,,Article,,10.1155/2014/129582,,,,25097786,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6084366,https://api.altmetric.com/v1/donut/6084366_240.png 0,Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study.,Prostate Cancer,,,Article,,10.1155/2013/384594,,,,24386569,PMC3872424,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6084347,https://api.altmetric.com/v1/donut/6084347_240.png 0,Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer?,European Urology,,,Article,2012-12-15,10.1016/j.eururo.2012.05.003,,,,22608160,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6084293,https://api.altmetric.com/v1/donut/6084293_240.png 0,Transdermal estradiol in castrate and chemotherapy resistant prostate cancer.,Medical science monitor international medical journal of experimental and clinical research,,,Article,2012-04-14,,,,,22460098,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6084289,https://api.altmetric.com/v1/donut/6084289_240.png 0,Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study.,Prostate Cancer & Prostatic Diseases,,,Article,2011-12-15,10.1038/pcan.2011.17,,,,21519347,PMC3151329,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6084282,https://api.altmetric.com/v1/donut/6084282_240.png 0,Obesity and prostate cancer detection: insights from three national surveys.,American Journal of Medicine,,,Article,2010-09-14,10.1016/j.amjmed.2010.05.011,,,,20800152,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6084280,https://api.altmetric.com/v1/donut/6084280_240.png 0,Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies.,The Prostate,,,Article,2010-09-14,10.1002/pros.21172,,,,20687211,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6084278,https://api.altmetric.com/v1/donut/6084278_240.png 0,Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.,Oncology Reports,,,Article,2013-11-29,10.3892/or.2013.2885,,,,24296978,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6084261,https://api.altmetric.com/v1/donut/6084261_240.png 0,Combination of Lipitor and Celebrex Inhibits Prostate Cancer VCaP Cells In Vitro and In Vivo.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2014-07-14,,,,,24982340,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6084256,https://api.altmetric.com/v1/donut/6084256_240.png 0,ERG and CHD1 heterogeniety in prostate cancer: Use of confocal microscopy in assessment of microscopic foci.,The Prostate,,,Article,2014-08-28,10.1002/pros.22873,,,,25175909,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6084254,https://api.altmetric.com/v1/donut/6084254_240.png 0,A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2014-10-22,10.1016/j.clgc.2014.08.007,,,,25450031,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6084185,https://api.altmetric.com/v1/donut/6084185_240.png 0,"Pharmacotherapeutic Management of Metastatic, Castration-Resistant Prostate Cancer in the Elderly: Focus on Non-Chemotherapy Agents.",Drugs & Aging,,,Article,2014-11-12,10.1007/s40266-014-0224-y,,,,25387443,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6084178,https://api.altmetric.com/v1/donut/6084178_240.png 0,Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.,PloS one,,,Article,,10.1371/journal.pone.0091666,,,,24626295,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6084175,https://api.altmetric.com/v1/donut/6084175_240.png 0,C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2009.11.012,,,,20207556,PMC2894303,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6084163,https://api.altmetric.com/v1/donut/6084163_240.png 0,The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.,The Journal of Urology,,,Article,2010-05-14,10.1016/j.juro.2009.12.098,,,,20303520,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6083960,https://api.altmetric.com/v1/donut/6083960_240.png 0,Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.,,,,Article,2009-12-21,10.1371/journal.pone.0008384,,,,20027305,PMC2793011,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6083926,https://api.altmetric.com/v1/donut/6083926_240.png 0,Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-07-14,10.1158/1055-9965.epi-08-1223,,,,19567509,PMC2813685,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6083914,https://api.altmetric.com/v1/donut/6083914_240.png 0,N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.,International Journal of Biochemistry & Cell Biology,,,Article,2010-12-15,10.1016/j.biocel.2010.09.008,,,,20854925,PMC2982800,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6083550,https://api.altmetric.com/v1/donut/6083550_240.png 0,AMP-activated protein kinase promotes human prostate cancer cell growth and survival.,Molecular Cancer Therapeutics,,,Article,2009-04-14,10.1158/1535-7163.mct-08-0631,,,,19372545,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6083549,https://api.altmetric.com/v1/donut/6083549_240.png 0,Pushing the Limits of Radiation Therapy for Prostate Cancer: Where Do We Go Next?,Seminars in oncology,,,Article,2013-06-14,10.1053/j.seminoncol.2013.04.005,,,,23806495,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6083528,https://api.altmetric.com/v1/donut/6083528_240.png 0,Systematic review of hypofractionated radiation therapy for prostate cancer.,Cancer Treatment Reviews,,,Article,2013-11-15,10.1016/j.ctrv.2013.01.008,,,,23453861,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6083526,https://api.altmetric.com/v1/donut/6083526_240.png 0,Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling.,European Journal of Cancer (1965),,,Article,2012-04-14,10.1016/j.ejca.2011.08.013,,,,21945099,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6083513,https://api.altmetric.com/v1/donut/6083513_240.png 0,Sortilin regulates progranulin action in castration-resistant prostate cancer cells.,Endocrinology,,,Article,2014-11-03,10.1210/en.2014-1590,,,,25365768,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6083491,https://api.altmetric.com/v1/donut/6083491_240.png 0,Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: A population-based study.,Cancer (0008543X),,,Article,2012-11-15,10.1002/cncr.27578,,,,22544633,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6083425,https://api.altmetric.com/v1/donut/6083425_240.png 0,PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.,Cancer Research,,,Article,2009-01-01,10.1158/0008-5472.can-08-2922,,,,19117992,PMC2614304,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6083365,https://api.altmetric.com/v1/donut/6083365_240.png 0,The Association of Long-term Treatment-related Side Effects With Cancer-specific and General Quality of Life Among Prostate Cancer Survivors.,Urology,,,Article,2014-06-25,10.1016/j.urology.2014.04.036,,,,24975711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6083324,https://api.altmetric.com/v1/donut/6083324_240.png 0,Novel Nuclear Localization of Fatty Acid Synthase Correlates with Prostate Cancer Aggressiveness.,American Journal of Pathology,,,Article,2014-06-03,10.1016/j.ajpath.2014.04.012,,,,24907642,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6083274,https://api.altmetric.com/v1/donut/6083274_240.png 0,Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer.,British Journal of Cancer,,,Article,2012-08-06,10.1038/bjc.2012.312,,,,22805325,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6083211,https://api.altmetric.com/v1/donut/6083211_240.png 0,Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice.,Nutrition and Cancer,,,Article,,10.1080/01635580802419798,,,,19235043,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6083169,https://api.altmetric.com/v1/donut/6083169_240.png 0,"Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.",European Journal of Nutrition,,,Article,,10.1007/s00394-013-0588-5,,,,24092501,PMC3972300,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6083120,https://api.altmetric.com/v1/donut/6083120_240.png 0,Low-dose diethylstilbestrol for the treatment of advanced prostate cancer.,Urologic Oncology,,,Article,2013-02-15,10.1016/j.urolonc.2010.12.004,,,,21795073,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6083005,https://api.altmetric.com/v1/donut/6083005_240.png 0,"Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.",Hormones and Cancer,,,Article,2015-01-29,10.1007/s12672-014-0215-9,,,,25631336,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6082839,https://api.altmetric.com/v1/donut/6082839_240.png 0,AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.,Journal of Cellular Biochemistry,,,Article,2010-07-31,10.1002/jcb.22633,,,,20589722,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6082802,https://api.altmetric.com/v1/donut/6082802_240.png 0,Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2009-07-14,10.1016/j.ijrobp.2009.03.057,,,,19545787,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6082740,https://api.altmetric.com/v1/donut/6082740_240.png 0,Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.,Cancer Research,,,Article,2009-05-14,10.1158/0008-5472.can-08-3605,,,,19366804,PMC2765801,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6082719,https://api.altmetric.com/v1/donut/6082719_240.png 0,The prostate cancer genome: Perspectives and potential.,Urologic Oncology,,,Article,2013-11-13,10.1016/j.urolonc.2013.08.025,,,,24239470,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,57,https://www.altmetric.com/details/6082681,https://api.altmetric.com/v1/donut/6082681_240.png 0,Re: use of advanced treatment technologies among men at low risk of dying from prostate cancer.,European Urology,,,Article,2014-01-15,10.1016/j.eururo.2013.10.024,,,,24289855,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6082680,https://api.altmetric.com/v1/donut/6082680_240.png 0,Activation of Akt signaling in prostate induces a TGF?-mediated restraint on cancer progression and metastasis.,Oncogene,,,Article,2013-09-01,10.1038/onc.2013.342,,,,23995785,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6082613,https://api.altmetric.com/v1/donut/6082613_240.png 0,Prostate Cancer Induced by Loss of Apc Is Restrained by TGF? Signaling.,PloS one,,,Article,,10.1371/journal.pone.0092800,,,,24651496,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6082585,https://api.altmetric.com/v1/donut/6082585_240.png 0,Oral thrombostatin FM19 inhibits prostate cancer.,Thrombosis and Haemostasis,,,Article,2010-11-15,10.1160/th09-08-0570,,,,20886199,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6082413,https://api.altmetric.com/v1/donut/6082413_240.png 0,Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells.,Cancer Research,,,Article,2009-03-15,10.1158/0008-5472.can-08-3961,,,,19276350,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6082403,https://api.altmetric.com/v1/donut/6082403_240.png 0,Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study.,Molecular Carcinogenesis,,,Article,2009-03-15,10.1002/mc.20475,,,,18726972,PMC2647985,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6082378,https://api.altmetric.com/v1/donut/6082378_240.png 0,Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer.,International Journal of Cancer,,,Article,2010-01-15,10.1002/ijc.24820,,,,19676054,PMC2794918,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6082320,https://api.altmetric.com/v1/donut/6082320_240.png 0,Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells.,Oncogene,,,Article,2009-08-12,10.1038/onc.2009.145,,,,19503095,PMC2726905,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6082270,https://api.altmetric.com/v1/donut/6082270_240.png 0,Novel biomarkers for risk of prostate cancer: results from a case-control study.,The Prostate,,,Article,2009-01-01,10.1002/pros.20850,,,,18816637,PMC2588647,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6082260,https://api.altmetric.com/v1/donut/6082260_240.png 0,Elevated expression of L-selectin ligand in lymph node-derived human prostate cancer cells correlates with increased tumorigenicity.,Glycoconjugate Journal,,,Article,2009-01-15,10.1007/s10719-008-9167-z,,,,18670876,PMC2775476,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6082242,https://api.altmetric.com/v1/donut/6082242_240.png 0,Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis.,Molecular Cancer Research,,,Article,2011-04-14,10.1158/1541-7786.mcr-10-0471,,,,21303901,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6082035,https://api.altmetric.com/v1/donut/6082035_240.png 0,Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4279,,,,26091350,PMC4673146,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6081912,https://api.altmetric.com/v1/donut/6081912_240.png 0,Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.,American journal of cancer research,,,Article,,,,,,25520873,PMC4266717,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6081849,https://api.altmetric.com/v1/donut/6081849_240.png 0,Plk1-Dependent Microtubule Dynamics Promotes Androgen Receptor Signaling in Prostate Cancer.,The Prostate,,,Article,2013-09-14,10.1002/pros.22683,,,,23661607,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6081823,https://api.altmetric.com/v1/donut/6081823_240.png 0,Co-targeting Polo-like kinase 1(Plk1) and the Wnt/?-catenin signaling pathway in castration-resistant prostate cancer.,Molecular & Cellular Biology,,,Article,,10.1128/mcb.00825-15,,,,26438599,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6081797,https://api.altmetric.com/v1/donut/6081797_240.png 0,Patient perspective on watchful waiting/active surveillance for localized prostate cancer.,Journal of the American Board of Family Medicine (formerly Journal of the American Board of Family Practice),,,Article,,10.3122/jabfm.2012.06.120128,,,,23136314,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6081558,https://api.altmetric.com/v1/donut/6081558_240.png 0,The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis.,Archivos Españoles de Urología (Ed. impresa),,,Article,2011-10-14,,,,,22052754,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6081537,https://api.altmetric.com/v1/donut/6081537_240.png 0,A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.,Cancer Research,,,Article,2010-12-01,10.1158/0008-5472.can-10-0511,,,,21098708,PMC3058856,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6081534,https://api.altmetric.com/v1/donut/6081534_240.png 0,Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer.,The Prostate,,,Article,2014-02-05,10.1002/pros.22781,,,,24500903,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6081468,https://api.altmetric.com/v1/donut/6081468_240.png 0,Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.,,,,Article,,,,,,23573364,PMC3612515,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6081441,https://api.altmetric.com/v1/donut/6081441_240.png 0,Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer.,Cancer (0008543X),,,Article,2014-08-21,10.1002/cncr.28971,,,,25155428,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6080524,https://api.altmetric.com/v1/donut/6080524_240.png 0,Comparing PROMIS computer-adaptive tests to the Brief Symptom Inventory in patients with prostate cancer.,Quality of Life Research,,,Article,2014-02-16,10.1007/s11136-014-0647-2,,,,24532436,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6080346,https://api.altmetric.com/v1/donut/6080346_240.png 0,"Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.",Molecular Cancer Research,,,Article,2009-11-15,10.1158/1541-7786.mcr-09-0255,,,,19903767,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6080238,https://api.altmetric.com/v1/donut/6080238_240.png 0,Sexual dysfunction and spousal communication in couples coping with prostate cancer.,Psycho-Oncology,,,Article,2009-07-14,10.1002/pon.1449,,,,19061199,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/6080167,https://api.altmetric.com/v1/donut/6080167_240.png 0,The Validity and Utility of the MD Anderson Symptom Inventory in Patients With Prostate Cancer: Evidence From the Symptom Outcomes and Practice Patterns (SOAPP) Data From the Eastern Cooperative Oncology Group.,Clinical Genitourinary Cancer,,,Article,2013-10-11,10.1016/j.clgc.2013.07.003,,,,24126238,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6079858,https://api.altmetric.com/v1/donut/6079858_240.png 0,Systemic GLIPR1-?TM protein as a novel therapeutic approach for prostate cancer.,International Journal of Cancer,,,Article,2014-04-14,10.1002/ijc.28529,,,,24590455,PMC3942887,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6079831,https://api.altmetric.com/v1/donut/6079831_240.png 0,Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.,Cell Cycle,,,Article,2014-04-13,,,,,24732589,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6079828,https://api.altmetric.com/v1/donut/6079828_240.png 0,Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2014-04-29,10.1158/1535-7163.mct-13-1004,,,,24785255,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6079742,https://api.altmetric.com/v1/donut/6079742_240.png 0,Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy.,Supportive Care in Cancer,,,Article,2013-10-21,10.1007/s00520-013-2008-z,,,,24146343,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6079690,https://api.altmetric.com/v1/donut/6079690_240.png 0,Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.,Current Metabolomics,,,Article,2014-04-15,10.2174/2213235x02666140301002510,,,,25632377,PMC4306198,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6079680,https://api.altmetric.com/v1/donut/6079680_240.png 0,Cixutumumab-Associated Pancolitis in a Patient With Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2013-06-14,10.1016/j.clgc.2012.09.009,,,,23083799,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6079553,https://api.altmetric.com/v1/donut/6079553_240.png 0,An MRI-based dose-response analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial.,Brachytherapy,,,Article,,10.1016/j.brachy.2012.10.006,,,,23466360,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6079422,https://api.altmetric.com/v1/donut/6079422_240.png 0,Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-? Mice.,,,,Article,,10.1371/journal.pone.0056903,,,,23451107,PMC3579939,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6079406,https://api.altmetric.com/v1/donut/6079406_240.png 0,Heme Oxygenase-1 (HO-1) Expression in Prostate Cancer Cells Modulates the Oxidative Response in Bone Cells.,PloS one,,,Article,2013-11-04,10.1371/journal.pone.0080315,,,,24224047,PMC3817116,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6079368,https://api.altmetric.com/v1/donut/6079368_240.png 0,The lack of predictors for rapid progression in prostate cancer patients receiving sipuleucel-T.,Cancers,,,Article,2013-05-05,10.3390/cancers5020511,,,,24216988,PMC3730335,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6079363,https://api.altmetric.com/v1/donut/6079363_240.png 0,Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy.,British Journal of Cancer,,,Article,2013-05-27,10.1038/bjc.2013.180,,,,23632483,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6079280,https://api.altmetric.com/v1/donut/6079280_240.png 0,Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer.,Brachytherapy,,,Article,,10.1016/j.brachy.2012.10.001,,,,23380383,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6079266,https://api.altmetric.com/v1/donut/6079266_240.png 0,Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy.,Brachytherapy,,,Article,,10.1016/j.brachy.2011.12.013,,,,22673704,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6079253,https://api.altmetric.com/v1/donut/6079253_240.png 0,Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer.,Practical Radiation Oncology,,,Article,,10.1016/j.prro.2012.10.004,,,,24674406,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6079200,https://api.altmetric.com/v1/donut/6079200_240.png 0,Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression.,Computational & Mathematical Methods in Medicine,,,Article,,10.1155/2013/917502,,,,24367394,PMC3866878,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6079173,https://api.altmetric.com/v1/donut/6079173_240.png 0,Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients.,Prostate Cancer & Prostatic Diseases,,,Article,2013-08-12,10.1038/pcan.2013.26,,,,23939133,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6079172,https://api.altmetric.com/v1/donut/6079172_240.png 0,Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.,American Journal of Roentgenology,,,Article,2012-10-14,10.2214/ajr.11.7805,,,,22997374,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6079155,https://api.altmetric.com/v1/donut/6079155_240.png 0,Prostate Cancer Stem Cells.,Clinical Genitourinary Cancer,,,Article,2012-06-14,10.1016/j.clgc.2012.01.002,,,,22421313,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/6079072,https://api.altmetric.com/v1/donut/6079072_240.png 0,Outcomes after prostate brachytherapy are even better than predicted.,Cancer (0008543X),,,Article,2012-02-01,10.1002/cncr.26307,,,,21751187,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6079029,https://api.altmetric.com/v1/donut/6079029_240.png 0,Effect of transforming growth factor beta (TGF-?) receptor I kinase inhibitor on prostate cancer bone growth.,BONE,,,Article,2012-03-15,10.1016/j.bone.2011.11.022,,,,22173053,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6078948,https://api.altmetric.com/v1/donut/6078948_240.png 0,"Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.",Clinical Cancer Research,,,Article,2011-04-14,10.1158/1078-0432.ccr-10-2943,,,,21343372,PMC3078947,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6078935,https://api.altmetric.com/v1/donut/6078935_240.png 0,Prolonged remission of fulminant castrate-resistant prostate cancer: a case report.,Clinical Genitourinary Cancer,,,Article,2011-12-15,10.1016/j.clgc.2011.04.003,,,,21729684,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6078917,https://api.altmetric.com/v1/donut/6078917_240.png 0,Androgen regulation of 5?-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.,,,,Article,,10.1371/journal.pone.0028840,,,,22194926,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6078758,https://api.altmetric.com/v1/donut/6078758_240.png 0,GLIPR1 suppresses prostate cancer development by targeted oncoprotein destruction.,Cancer Research,,,Article,2011-12-15,10.1158/0008-5472.can-11-1714,,,,22025562,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6078738,https://api.altmetric.com/v1/donut/6078738_240.png 0,Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model.,,,,Article,2010-03-28,10.1371/journal.pone.0009854,,,,20360964,PMC2847943,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6078694,https://api.altmetric.com/v1/donut/6078694_240.png 0,Grappling with the androgen receptor: a new approach for treating advanced prostate cancer.,Cancer Cell,,,Article,2010-06-14,10.1016/j.ccr.2010.05.018,,,,20541694,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6078674,https://api.altmetric.com/v1/donut/6078674_240.png 0,Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.,Cancer Prevention Research,,,Article,2010-03-15,10.1158/1940-6207.capr-09-0176,,,,20145190,PMC2945242,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6078443,https://api.altmetric.com/v1/donut/6078443_240.png 0,Decreased expression of stromal estrogen receptor ? and ? in prostate cancer.,American journal of translational research,,,Article,,,,,,24489993,PMC3902224,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6078429,https://api.altmetric.com/v1/donut/6078429_240.png 0,Mifepristone Inhibits GR? Coupled Prostate Cancer Cell Proliferation.,The Journal of Urology,,,Article,2012-09-14,10.1016/j.juro.2012.04.102,,,,22819113,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6078391,https://api.altmetric.com/v1/donut/6078391_240.png 0,Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.,Cancer Prevention Research,,,Article,2010-03-15,10.1158/1940-6207.capr-09-0152,,,,20179302,PMC2833232,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6078363,https://api.altmetric.com/v1/donut/6078363_240.png 0,Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.,Journal of Magnetic Resonance Imaging,,,Article,2014-02-25,10.1002/jmri.24598,,,,24616064,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6078331,https://api.altmetric.com/v1/donut/6078331_240.png 0,Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.,American Journal of Roentgenology,,,Article,,10.2214/ajr.15.14482,,,,26587927,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6078323,https://api.altmetric.com/v1/donut/6078323_240.png 0,Epithelial and stromal expression of miRNAs during prostate cancer progression.,American journal of translational research,,,Article,,,,,,25075250,PMC4113495,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6078319,https://api.altmetric.com/v1/donut/6078319_240.png 0,Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo.,Molecular Cancer Therapeutics,,,Article,2009-03-15,10.1158/1535-7163.mct-08-0544,,,,19276168,PMC2703491,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6078174,https://api.altmetric.com/v1/donut/6078174_240.png 0,Amide proton transfer MR imaging of prostate cancer: a preliminary study.,Journal of Magnetic Resonance Imaging,,,Article,2011-03-15,10.1002/jmri.22480,,,,21563248,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6078086,https://api.altmetric.com/v1/donut/6078086_240.png 0,Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.,Cancer Prevention Research,,,Article,,10.1158/1940-6207.capr-14-0465,,,,26276749,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6078062,https://api.altmetric.com/v1/donut/6078062_240.png 0,Survivin is a potential mediator of prostate cancer metastasis.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-11-15,10.1016/j.ijrobp.2009.09.007,,,,20231071,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6078050,https://api.altmetric.com/v1/donut/6078050_240.png 0,Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer.,Cancer Research,,,Article,2011-11-01,10.1158/0008-5472.can-11-1882,,,,21900400,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6078012,https://api.altmetric.com/v1/donut/6078012_240.png 0,Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.,,,,Article,2009-07-14,,,,,19513537,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6077977,https://api.altmetric.com/v1/donut/6077977_240.png 0,Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein.,Nutrition and Cancer,,,Article,2009-05-07,10.1080/01635580802582728,,,,19373613,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6077972,https://api.altmetric.com/v1/donut/6077972_240.png 0,Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.,PloS one,,,Article,,10.1371/journal.pone.0086238,,,,24497940,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6077941,https://api.altmetric.com/v1/donut/6077941_240.png 0,Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair.,Cancer Letters,,,Article,2012-06-27,10.1016/j.canlet.2012.01.004,,,,22261337,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6077856,https://api.altmetric.com/v1/donut/6077856_240.png 0,Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKC?-independent pathway.,Biochemical Pharmacology,,,Article,2012-06-30,10.1016/j.bcp.2012.03.023,,,,22490701,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6077831,https://api.altmetric.com/v1/donut/6077831_240.png 0,Reduced Mitochondrial DNA Content Associates with Poor Prognosis of Prostate Cancer in African American Men.,,,,Article,2013-09-22,10.1371/journal.pone.0074688,,,,24086362,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6077794,https://api.altmetric.com/v1/donut/6077794_240.png 0,AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia.,Cellular Signalling,,,Article,2011-09-14,10.1016/j.cellsig.2011.04.008,,,,21554950,PMC3115439,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6077790,https://api.altmetric.com/v1/donut/6077790_240.png 0,Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer.,Molecular & Cellular Biology,,,Article,2010-09-14,10.1128/mcb.00235-10,,,,20584988,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6077777,https://api.altmetric.com/v1/donut/6077777_240.png 0,"The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.",Current Drug Targets,,,Article,2013-04-14,,,,,23565755,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6077768,https://api.altmetric.com/v1/donut/6077768_240.png 0,Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress.,Cellular Signalling,,,Article,2010-10-14,10.1016/j.cellsig.2010.05.024,,,,20570728,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6077762,https://api.altmetric.com/v1/donut/6077762_240.png 0,Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2010-10-14,,,,,21036700,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6077751,https://api.altmetric.com/v1/donut/6077751_240.png 0,Dietary Folate Deficiency Blocks Prostate Cancer Progression in the TRAMP Model.,Cancer Prevention Research,,,Article,2011-11-15,10.1158/1940-6207.capr-11-0140,,,,21836022,PMC3208799,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6077736,https://api.altmetric.com/v1/donut/6077736_240.png 0,The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction.,Cancer Biology and Therapy,,,Article,2010-06-14,,,,,20404538,PMC2939298,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6077717,https://api.altmetric.com/v1/donut/6077717_240.png 0,Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.,Cancer Prevention Research,,,Article,2009-12-15,10.1158/1940-6207.capr-09-0010,,,,19934341,PMC2789312,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6077700,https://api.altmetric.com/v1/donut/6077700_240.png 0,Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor.,"Cancer Immunology, Immunotherapy",,,Article,2009-08-14,10.1007/s00262-008-0647-6,,,,19142636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6077693,https://api.altmetric.com/v1/donut/6077693_240.png 0,Chemotherapeutic sensitization by endoplasmic reticulum stress: increasing the efficacy of taxane against prostate cancer.,Cancer Biology and Therapy,,,Article,2009-01-15,,,,,19182512,PMC2714659,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6077671,https://api.altmetric.com/v1/donut/6077671_240.png 0,Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone.,Molecular Cancer Research,,,Article,2009-09-14,10.1158/1541-7786.mcr-08-0546,,,,19737972,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6077670,https://api.altmetric.com/v1/donut/6077670_240.png 0,Alternative approaches to prevent androgen action in prostate cancer: Are we there yet?,Discovery Medicine,,,Article,2014-05-14,,,,,24882718,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6077646,https://api.altmetric.com/v1/donut/6077646_240.png 0,"ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: Study in African-American and Caucasian prostate cancer models.",International Journal of Cancer,,,Article,2014-04-19,10.1002/ijc.28919,,,,24752651,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6077629,https://api.altmetric.com/v1/donut/6077629_240.png 0,New serum biomarkers for prostate cancer diagnosis.,Clinical Cancer Investigation Journal,,,Article,,10.4103/2278-0513.125802,,,,25593898,PMC4292911,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6077620,https://api.altmetric.com/v1/donut/6077620_240.png 0,Src controls castration recurrence of CWR22 prostate cancer xenografts.,Cancer medicine,,,Article,2013-12-15,10.1002/cam4.144,,,,24403252,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6077611,https://api.altmetric.com/v1/donut/6077611_240.png 0,Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.,Oncotarget,,,Article,2013-04-14,10.18632/oncotarget.934,,,,23592399,PMC3720608,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6077593,https://api.altmetric.com/v1/donut/6077593_240.png 0,Expression of spermidine/spermine N(1) -acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis.,The Prostate,,,Article,,10.1002/pros.22996,,,,25893668,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6077432,https://api.altmetric.com/v1/donut/6077432_240.png 0,"Eastern Cooperative Oncology Group Phase II Trial of lapatinib in men with biochemically relapsed, androgen dependent prostate cancer(,).",Urologic Oncology,,,Article,2013-02-15,10.1016/j.urolonc.2011.01.002,,,,21784672,PMC3223557,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6077399,https://api.altmetric.com/v1/donut/6077399_240.png 0,"Plumbagin inhibits prostate carcinogenesis in intact and castrated PTEN knockout mice via targeting PKC?, Stat3 and epithelial to mesenchymal transition markers.",Cancer Prevention Research,,,Article,2015-01-27,10.1158/1940-6207.capr-14-0231,,,,25627799,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6077393,https://api.altmetric.com/v1/donut/6077393_240.png 0,"Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.",Molecular Oncology,,,Article,2013-06-14,10.1016/j.molonc.2012.12.001,,,,23273564,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6077392,https://api.altmetric.com/v1/donut/6077392_240.png 0,Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells.,Cancer Research,,,Article,2010-05-31,10.1158/0008-5472.can-09-3596,,,,20460526,PMC2909607,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6077379,https://api.altmetric.com/v1/donut/6077379_240.png 0,A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-07-14,10.1016/j.ijrobp.2009.06.013,,,,19880260,PMC2891420,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6077371,https://api.altmetric.com/v1/donut/6077371_240.png 0,The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer.,"Cancer Immunology, Immunotherapy",,,Article,2013-03-15,10.1007/s00262-012-1363-9,,,,23108626,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6077364,https://api.altmetric.com/v1/donut/6077364_240.png 0,Regulation of prostate cancer cell invasion by modulation of extra- and intracellular redox balance.,Free Radical Biology & Medicine,,,Article,2012-01-15,10.1016/j.freeradbiomed.2011.10.489,,,,22120495,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6077360,https://api.altmetric.com/v1/donut/6077360_240.png 0,Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.,Cancer Research,,,Article,2011-03-15,10.1158/0008-5472.can-10-4170,,,,21406403,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6077328,https://api.altmetric.com/v1/donut/6077328_240.png 0,"A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer.",Investigational New Drugs,,,Article,2011-02-15,10.1007/s10637-009-9318-5,,,,19763400,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6077324,https://api.altmetric.com/v1/donut/6077324_240.png 0,Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression.,Free Radical Biology & Medicine,,,Article,2010-12-15,10.1016/j.freeradbiomed.2010.10.691,,,,20955789,PMC3010556,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6077296,https://api.altmetric.com/v1/donut/6077296_240.png 0,"An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.",Clinical Cancer Research,,,Article,2009-04-30,10.1158/1078-0432.ccr-08-2985,,,,19366825,PMC2921915,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6077285,https://api.altmetric.com/v1/donut/6077285_240.png 0,Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer.,Clinical Cancer Research,,,Article,2009-12-01,10.1158/1078-0432.ccr-09-1691,,,,19920114,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6077263,https://api.altmetric.com/v1/donut/6077263_240.png 0,High resolution ultrasound features of prostatic rib metastasis: a prospective feasibility study with implication in the high-risk prostate cancer patient.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2012.08.014,,,,23481369,PMC4160069,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6077199,https://api.altmetric.com/v1/donut/6077199_240.png 0,Targeting androgen receptor and JunD interaction for prevention of prostate cancer progression.,The Prostate,,,Article,2014-03-20,10.1002/pros.22800,,,,24647988,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6077183,https://api.altmetric.com/v1/donut/6077183_240.png 0,A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer.,Urologic Oncology,,,Article,2013-05-14,10.1016/j.urolonc.2011.02.007,,,,21481618,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6077126,https://api.altmetric.com/v1/donut/6077126_240.png 0,Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.,Biomaterials,,,Article,2013-07-14,10.1016/j.biomaterials.2013.03.006,,,,23582862,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,62,https://www.altmetric.com/details/6077116,https://api.altmetric.com/v1/donut/6077116_240.png 0,A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy.,Clinical Genitourinary Cancer,,,Article,2013-07-04,10.1016/j.clgc.2013.04.029,,,,23835291,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6077089,https://api.altmetric.com/v1/donut/6077089_240.png 0,Efficacy of Oxaliplatin Plus Pemetrexed in Chemotherapy Pretreated Metastatic Castration-Resistant Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2013-10-03,10.1016/j.clgc.2013.07.011,,,,24099865,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6077020,https://api.altmetric.com/v1/donut/6077020_240.png 0,Selective roles for CBP and p300 as coregulators for androgen-regulated gene expression in advanced prostate cancer cells.,Journal of Biological Chemistry,,,Article,2012-02-03,10.1074/jbc.m111.300194,,,,22174411,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6077008,https://api.altmetric.com/v1/donut/6077008_240.png 0,Ethnic differences in neuroendocrine expression in prostate cancer tissue.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2011-11-15,,,,,22110216,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6076990,https://api.altmetric.com/v1/donut/6076990_240.png 0,Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer.,Maturitas,,,Article,2011-08-14,10.1016/j.maturitas.2011.04.012,,,,21621934,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6076984,https://api.altmetric.com/v1/donut/6076984_240.png 0,One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer.,Cancer Biotherapy & Radiopharmaceuticals,,,Article,2015-03-06,10.1089/cbr.2014.1802,,,,25746633,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6076972,https://api.altmetric.com/v1/donut/6076972_240.png 0,Association of overall survival with glycolytic activity of castrate-resistant prostate cancer metastases.,Radiology,,,Article,2015-02-15,10.1148/radiol.14141593,,,,25625748,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6076970,https://api.altmetric.com/v1/donut/6076970_240.png 0,Prostate cancer susceptibility genes on 8p21-23 in a Dutch population.,Prostate Cancer & Prostatic Diseases,,,Article,2013-09-14,10.1038/pcan.2013.9,,,,23628848,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6076851,https://api.altmetric.com/v1/donut/6076851_240.png 0,"Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.",Nutrition and Cancer,,,Article,,10.1080/01635581.2010.492085,,,,21058191,PMC2993162,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6076747,https://api.altmetric.com/v1/donut/6076747_240.png 0,"Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.",The Prostate,,,Article,2009-11-01,10.1002/pros.21017,,,,19670229,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6076729,https://api.altmetric.com/v1/donut/6076729_240.png 0,Development of a spiritually based educational intervention to increase informed decision making for prostate cancer screening among church-attending African American men.,Journal of Health Communication,,,Article,2009-09-14,10.1080/10810730903120534,,,,19731129,PMC2828866,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6076678,https://api.altmetric.com/v1/donut/6076678_240.png 0,A comparison of a spiritually based and non-spiritually based educational intervention for informed decision making for prostate cancer screening among church-attending African-American men.,Urologic Nursing,,,Article,,,,,,19718941,PMC2836722,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/6076663,https://api.altmetric.com/v1/donut/6076663_240.png 0,"A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging.",Gene Therapy,,,Article,2014-07-23,10.1038/gt.2014.68,,,,25056609,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6076637,https://api.altmetric.com/v1/donut/6076637_240.png 0,Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.,Biotechnic & Histochemistry,,,Article,2013-01-15,10.3109/10520295.2012.724713,,,,23167625,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6076625,https://api.altmetric.com/v1/donut/6076625_240.png 0,African American prostate cancer survivors' treatment decision-making and quality of life.,Patient Education & Counseling,,,Article,2013-01-15,10.1016/j.pec.2012.08.007,,,,22940374,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6076594,https://api.altmetric.com/v1/donut/6076594_240.png 0,Polyunsaturated Fatty Acids Affect the Localization and Signaling of PIP3/AKT in Prostate Cancer Cells.,Carcinogenesis,,,Article,2013-09-14,10.1093/carcin/bgt147,,,,23633519,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6076586,https://api.altmetric.com/v1/donut/6076586_240.png 0,BAD Dephosphorylation and Decreased Expression of MCL-1 Induce Rapid Apoptosis in Prostate Cancer Cells.,,,,Article,2013-09-04,10.1371/journal.pone.0074561,,,,24040284,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6076584,https://api.altmetric.com/v1/donut/6076584_240.png 0,Novel 3D Co-Culture Model for Epithelial-Stromal Cells Interaction in Prostate Cancer.,,,,Article,2013-09-19,10.1371/journal.pone.0075187,,,,24073251,PMC3779160,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6076582,https://api.altmetric.com/v1/donut/6076582_240.png 0,Intake of plant foods and associated nutrients in prostate cancer risk.,Nutrition and Cancer,,,Article,,10.1080/01635580802419756,,,,19235037,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6076554,https://api.altmetric.com/v1/donut/6076554_240.png 0,Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2014-04-30,10.1073/pnas.1405240111,,,,24785505,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6076505,https://api.altmetric.com/v1/donut/6076505_240.png 0,Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer.,Prostate Cancer,,,Article,,10.1155/2014/781438,,,,24900923,PMC4037573,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6076502,https://api.altmetric.com/v1/donut/6076502_240.png 0,A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-10-14,10.1158/1055-9965.epi-10-0427,,,,20736317,PMC3041671,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6076462,https://api.altmetric.com/v1/donut/6076462_240.png 0,Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-08-14,10.1158/1055-9965.epi-10-0431,,,,20696662,PMC2946372,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6076431,https://api.altmetric.com/v1/donut/6076431_240.png 0,Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.,Cancer Prevention Research,,,Article,2010-05-14,10.1158/1940-6207.capr-09-0206,,,,20424135,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6076419,https://api.altmetric.com/v1/donut/6076419_240.png 0,Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer.,Urology,,,Article,2010-11-15,10.1016/j.urology.2010.01.067,,,,20430423,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6076411,https://api.altmetric.com/v1/donut/6076411_240.png 0,Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.,European Urology,,,Article,2011-12-15,10.1016/j.eururo.2011.08.029,,,,21889832,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6076365,https://api.altmetric.com/v1/donut/6076365_240.png 0,2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.,Journal of Nuclear Medicine,,,Article,2009-10-14,10.2967/jnumed.109.064212,,,,19759108,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6076319,https://api.altmetric.com/v1/donut/6076319_240.png 0,Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.,Magnetic Resonance in Medicine,,,Article,2009-11-15,10.1002/mrm.22137,,,,19780165,PMC2859036,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6076315,https://api.altmetric.com/v1/donut/6076315_240.png 0,Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy.,The Prostate,,,Article,2014-10-17,10.1002/pros.22902,,,,25327412,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6076297,https://api.altmetric.com/v1/donut/6076297_240.png 0,Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer.,Acta Oncologica,,,Article,,10.3109/0284186x.2015.1063779,,,,26340136,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6076278,https://api.altmetric.com/v1/donut/6076278_240.png 0,SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts.,Neoplasia,,,Article,2014-01-15,,,,,24563616,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6076244,https://api.altmetric.com/v1/donut/6076244_240.png 0,Insignificant disease among men with intermediate-risk prostate cancer.,World Journal of Urology,,,Article,2014-09-26,10.1007/s00345-014-1413-3,,,,25261260,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6076191,https://api.altmetric.com/v1/donut/6076191_240.png 0,"Reply to Leah Bensimon, Samy Suissa, and Laurent Azoulay's Letter to the Editor re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality. Eur Urol 2013;63:709-16.",European Urology,,,Article,2013-08-14,10.1016/j.eururo.2013.04.015,,,,23619389,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6076151,https://api.altmetric.com/v1/donut/6076151_240.png 0,Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer.,British Journal of Cancer,,,Article,2013-01-15,10.1038/bjc.2012.510,,,,23321517,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6076144,https://api.altmetric.com/v1/donut/6076144_240.png 0,A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer.,Cancer Chemotherapy & Pharmacology,,,Article,2013-07-02,10.1007/s00280-013-2224-8,,,,23820963,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6076129,https://api.altmetric.com/v1/donut/6076129_240.png 0,Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam.,European Urology,,,Article,2013-11-15,10.1016/j.eururo.2013.04.040,,,,23683475,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6076127,https://api.altmetric.com/v1/donut/6076127_240.png 0,Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.,British Journal of Cancer,,,Article,2013-02-05,10.1038/bjc.2012.598,,,,23329234,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6076097,https://api.altmetric.com/v1/donut/6076097_240.png 0,Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.,Clinical Biochemistry,,,Article,2013-05-14,10.1016/j.clinbiochem.2013.01.019,,,,23391636,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6076081,https://api.altmetric.com/v1/donut/6076081_240.png 0,Metformin and Prostate Cancer: Benefit for Development of Castration-resistant Disease and Prostate Cancer Mortality.,European Urology,,,Article,2013-04-14,10.1016/j.eururo.2012.12.004,,,,23287698,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,44,https://www.altmetric.com/details/6076070,https://api.altmetric.com/v1/donut/6076070_240.png 0,"Re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis. Eur Urol 2012;62:472-87: Statistical Concerns with Briganti Radiotherapy Analysis.",European Urology,,,Article,2013-04-14,10.1016/j.eururo.2012.12.031,,,,23305879,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6076056,https://api.altmetric.com/v1/donut/6076056_240.png 0,"A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.",Investigational New Drugs,,,Article,2014-05-02,10.1007/s10637-014-0106-5,,,,24788563,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6076039,https://api.altmetric.com/v1/donut/6076039_240.png 0,Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.,Cancer Biology and Therapy,,,Article,2013-04-14,,,,,23358469,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6076032,https://api.altmetric.com/v1/donut/6076032_240.png 0,Preventive care in prostate cancer patients: following diagnosis and for five-year survivors.,Journal of Cancer Survivorship,,,Article,2011-09-14,10.1007/s11764-011-0181-y,,,,21553320,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6076009,https://api.altmetric.com/v1/donut/6076009_240.png 0,Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy.,The Journal of Urology,,,Article,2009-11-15,10.1016/j.juro.2009.07.030,,,,19758646,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6075991,https://api.altmetric.com/v1/donut/6075991_240.png 0,The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.,British Journal of Urology,,,Article,2012-12-15,10.1111/j.1464-410x.2012.11286.x,,,,22702837,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6075974,https://api.altmetric.com/v1/donut/6075974_240.png 0,Progression of Prostate Carcinogenesis and Dietary Methyl Donors: Temporal Dependence.,Cancer Prevention Research,,,Article,2012-02-15,10.1158/1940-6207.capr-11-0357,,,,22139053,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6075972,https://api.altmetric.com/v1/donut/6075972_240.png 0,Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.,The Prostate,,,Article,2012-04-30,10.1002/pros.21467,,,,21837778,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6075966,https://api.altmetric.com/v1/donut/6075966_240.png 0,Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases.,Human Pathology,,,Article,2012-11-15,10.1016/j.humpath.2012.01.007,,,,22554381,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6075962,https://api.altmetric.com/v1/donut/6075962_240.png 0,A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer.,Annals of Oncology,,,Article,2012-10-14,10.1093/annonc/mds078,,,,22553195,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6075960,https://api.altmetric.com/v1/donut/6075960_240.png 0,Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.,The Prostate,,,Article,2012-09-14,10.1002/pros.22503,,,,22396312,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6075958,https://api.altmetric.com/v1/donut/6075958_240.png 0,"Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.",BJU International,,,Article,2011-08-14,10.1111/j.1464-410x.2010.09907.x,,,,21176082,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6075915,https://api.altmetric.com/v1/donut/6075915_240.png 0,TNF-blockade in patients with advanced hormone refractory prostate cancer.,Investigational New Drugs,,,Article,2011-02-15,10.1007/s10637-009-9346-1,,,,19844660,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6075900,https://api.altmetric.com/v1/donut/6075900_240.png 0,Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer.,Journal of Clinical Oncology,,,Article,2010-10-19,10.1200/jco.2010.30.7025,,,,20855838,PMC2974340,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6075881,https://api.altmetric.com/v1/donut/6075881_240.png 0,Is abiraterone acetate well tolerated and effective in the treatment of castration-resistant prostate cancer?,Nature Clinical Practice Oncology,,,Article,,10.1038/ncponc1262,,,,18957947,PMC4014058,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6075857,https://api.altmetric.com/v1/donut/6075857_240.png 0,"Bacterial Prostatitis Enhances 2-amino-1-methyl-6-phenylimidazo[4,5-?]pyridine (PhIP)-Induced Cancer at Multiple Sites.",Cancer Prevention Research,,,Article,,10.1158/1940-6207.capr-15-0090,,,,25990088,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6075855,https://api.altmetric.com/v1/donut/6075855_240.png 0,Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study.,Urology,,,Article,,10.1016/j.urology.2015.02.014,,,,25917733,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6075826,https://api.altmetric.com/v1/donut/6075826_240.png 0,PROTEASE-ACTIVATED PORE-FORMING PEPTIDES FOR THE TREATMENT AND IMAGING OF PROSTATE CANCER.,Molecular Cancer Therapeutics,,,Article,2014-12-23,10.1158/1535-7163.mct-14-0744,,,,25537662,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6075809,https://api.altmetric.com/v1/donut/6075809_240.png 0,Nanowire analysis of cancer-testis antigens as biomarkers of aggressive prostate cancer.,Urology,,,Article,2015-03-15,10.1016/j.urology.2014.12.004,,,,25733303,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6075807,https://api.altmetric.com/v1/donut/6075807_240.png 0,High-Dose Itraconazole As a Noncastrating Therapy for a Patient With Biochemically Recurrent Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2013-11-14,10.1016/j.clgc.2013.11.015,,,,24332506,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6075799,https://api.altmetric.com/v1/donut/6075799_240.png 0,Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.,The Prostate,,,Article,2014-07-21,10.1002/pros.22844,,,,25053178,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6075770,https://api.altmetric.com/v1/donut/6075770_240.png 0,The potential role of antigen spread in immunotherapy for prostate cancer.,Clinical Advances in Hematology & Oncology,,,Article,2014-05-14,,,,,25003491,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6075762,https://api.altmetric.com/v1/donut/6075762_240.png 0,Immunotherapy for prostate cancer: recent developments and future challenges.,Cancer and Metastasis Reviews,,,Article,2014-01-30,10.1007/s10555-013-9479-8,,,,24477411,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6075738,https://api.altmetric.com/v1/donut/6075738_240.png 0,Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer.,Cancer medicine,,,Article,2014-07-02,10.1002/cam4.289,,,,24989836,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6075737,https://api.altmetric.com/v1/donut/6075737_240.png 0,Growth factor and signaling pathways and their relevance to prostate cancer therapeutics.,Cancer and Metastasis Reviews,,,Article,2014-01-09,10.1007/s10555-013-9475-z,,,,24402967,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6075736,https://api.altmetric.com/v1/donut/6075736_240.png 0,The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.,Prostate Cancer & Prostatic Diseases,,,Article,2013-10-07,10.1038/pcan.2013.40,,,,24100642,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6075733,https://api.altmetric.com/v1/donut/6075733_240.png 0,Chemotherapy and its evolving role in the management of advanced prostate cancer.,Asian Journal of Andrology,,,Article,2014-01-10,10.4103/1008-682x.122593,,,,24435058,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6075721,https://api.altmetric.com/v1/donut/6075721_240.png 0,A synthesis of clinical recommendations and primary research for survivors of prostate or breast cancer.,Clinical Journal of Oncology Nursing,,,Article,2014-12-01,10.1188/14.cjon.667-673,,,,25427700,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6075718,https://api.altmetric.com/v1/donut/6075718_240.png 0,Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network.,The Prostate,,,Article,2013-09-20,10.1002/pros.22730,,,,24115205,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6075716,https://api.altmetric.com/v1/donut/6075716_240.png 0,Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment.,Endocrine-Related Cancer,,,Article,,10.1530/erc-13-0151,,,,23975882,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6075689,https://api.altmetric.com/v1/donut/6075689_240.png 0,Complete Biochemical (Prostate-specific Antigen) Response to Sipuleucel-T With Enzalutamide in Castration-resistant Prostate Cancer: A Case Report With Implications for Future Research.,Urology,,,Article,2013-02-15,10.1016/j.urology.2012.10.044,,,,23374810,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6075676,https://api.altmetric.com/v1/donut/6075676_240.png 0,Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.,Epigenetics,,,Article,2013-07-18,,,,,23880963,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6075666,https://api.altmetric.com/v1/donut/6075666_240.png 0,Infections and inflammation in prostate cancer.,American journal of clinical and experimental urology,,,Article,2013-12-25,,,,,25110720,PMC4124632,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6075653,https://api.altmetric.com/v1/donut/6075653_240.png 0,Comparison of Biochemical RecurrenceFree Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer.,International Journal of Surgical Pathology,,,Article,2013-08-14,10.1177/1066896913482729,,,,23564700,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6075651,https://api.altmetric.com/v1/donut/6075651_240.png 0,Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the national health and nutrition examination survey.,Nutrition and Cancer,,,Article,,10.1080/01635581.2013.801999,,,,23909724,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6075632,https://api.altmetric.com/v1/donut/6075632_240.png 0,Increased Incidence of Pathologically Nonorgan Confined Prostate Cancer in African-American Men Eligible for Active Surveillance.,Urology,,,Article,2013-04-14,10.1016/j.urology.2012.12.046,,,,23465143,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6075624,https://api.altmetric.com/v1/donut/6075624_240.png 0,Management of patients with biochemical recurrence after local therapy for prostate cancer.,Hematology/oncology clinics of North America,,,Article,2013-12-15,10.1016/j.hoc.2013.08.005,,,,24188259,PMC3818691,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6075609,https://api.altmetric.com/v1/donut/6075609_240.png 0,Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases.,Cancer Letters,,,Article,2012-10-27,10.1016/j.canlet.2012.04.001,,,,22521546,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6075591,https://api.altmetric.com/v1/donut/6075591_240.png 0,Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-05-31,10.1016/j.ijrobp.2010.02.040,,,,21050673,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6075567,https://api.altmetric.com/v1/donut/6075567_240.png 0,Prevalence of the HOXB13 G84E Mutation Among Unaffected Men with a Family History of Prostate Cancer.,Journal of Genetic Counseling,,,Article,2013-12-07,10.1007/s10897-013-9672-5,,,,24310616,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6075524,https://api.altmetric.com/v1/donut/6075524_240.png 0,Assessing the Clinical Role of Genetic Markers of Early-Onset Prostate Cancer among High-Risk Men Enrolled in Prostate Cancer Early Detection.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-01-15,10.1158/1055-9965.epi-11-0727,,,,22144497,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6075523,https://api.altmetric.com/v1/donut/6075523_240.png 0,Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.,British Journal of Urology,,,Article,2010-02-15,10.1111/j.1464-410x.2009.08793.x,,,,19709072,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6075480,https://api.altmetric.com/v1/donut/6075480_240.png 0,The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.,Clinical Cancer Research,,,Article,2009-08-31,10.1158/1078-0432.ccr-08-2704,,,,19706804,PMC2763098,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6075463,https://api.altmetric.com/v1/donut/6075463_240.png 0,Integration of prostate cancer clinical data using an ontology.,Journal of Biomedical Informatics,,,Article,2009-12-15,10.1016/j.jbi.2009.05.007,,,,19497389,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6075454,https://api.altmetric.com/v1/donut/6075454_240.png 0,Prostate cancer early detection program recruitment methods and show rates in men at high risk.,The Journal of Urology,,,Article,2009-11-15,10.1016/j.juro.2009.07.021,,,,19758657,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6075432,https://api.altmetric.com/v1/donut/6075432_240.png 0,"Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.",Cancer Prevention Research,,,Article,2009-03-15,10.1158/1940-6207.capr-08-0150,,,,19240249,PMC2652509,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6075420,https://api.altmetric.com/v1/donut/6075420_240.png 0,"Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer.",Cancer Causes and Control,,,Article,2009-12-15,10.1007/s10552-009-9389-9,,,,19578936,PMC2895954,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6075417,https://api.altmetric.com/v1/donut/6075417_240.png 0,Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques.,Practical Radiation Oncology,,,Article,2014-10-29,10.1016/j.prro.2014.09.004,,,,25424586,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6075407,https://api.altmetric.com/v1/donut/6075407_240.png 0,Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.,British Journal of Urology,,,Article,2013-06-04,10.1111/bju.12264,,,,23937305,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6075381,https://api.altmetric.com/v1/donut/6075381_240.png 0,Anti-angiogenesis in prostate cancer: knocked down but not out.,Asian Journal of Andrology,,,Article,2014-04-07,10.4103/1008-682x.125903,,,,24759579,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6075376,https://api.altmetric.com/v1/donut/6075376_240.png 0,Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men.,Prostate Cancer & Prostatic Diseases,,,Article,2013-09-23,10.1038/pcan.2013.36,,,,24061634,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6075369,https://api.altmetric.com/v1/donut/6075369_240.png 0,Evaluation of nuclear factor ?B and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610.,British Journal of Urology,,,Article,2011-07-14,10.1111/j.1464-410x.2010.09884.x,,,,21156016,PMC3062644,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6075322,https://api.altmetric.com/v1/donut/6075322_240.png 0,Young age under 60years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer.,Radiotherapy & Oncology,,,Article,2011-12-15,10.1016/j.radonc.2011.07.022,,,,21889222,PMC3225561,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6075319,https://api.altmetric.com/v1/donut/6075319_240.png 0,Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.,Journal of Biological Chemistry,,,Article,2010-05-13,10.1074/jbc.m109.085696,,,,20231295,PMC2865293,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6075284,https://api.altmetric.com/v1/donut/6075284_240.png 0,Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.,Molecular Cancer Therapeutics,,,Article,2011-01-15,10.1158/1535-7163.mct-10-0778,,,,21220489,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6074893,https://api.altmetric.com/v1/donut/6074893_240.png 0,Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide.,Prostate Cancer & Prostatic Diseases,,,Article,2011-03-15,10.1038/pcan.2010.47,,,,21116286,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6074807,https://api.altmetric.com/v1/donut/6074807_240.png 0,Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).,Contemporary Clinical Trials,,,Article,2011-05-14,10.1016/j.cct.2011.01.013,,,,21300181,PMC3082285,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6074793,https://api.altmetric.com/v1/donut/6074793_240.png 0,Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.,Molecular Medicine Reports,,,Article,2013-02-15,10.3892/mmr.2012.1189,,,,23165940,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6074453,https://api.altmetric.com/v1/donut/6074453_240.png 0,Reduced glycosylation of ?-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.,The Prostate,,,Article,2011-07-31,10.1002/pros.21330,,,,21656825,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6074438,https://api.altmetric.com/v1/donut/6074438_240.png 0,Plasma levels of nitrate and risk of prostate cancer: a prospective study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-07-14,10.1158/1055-9965.epi-13-0134,,,,23677578,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6074383,https://api.altmetric.com/v1/donut/6074383_240.png 0,Energetics in colorectal and prostate cancer.,Journal of Clinical Oncology,,,Article,2010-09-09,10.1200/jco.2009.26.8797,,,,20644082,PMC2982797,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6074378,https://api.altmetric.com/v1/donut/6074378_240.png 0,Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.,International Journal of Cancer,,,Article,2011-02-01,10.1002/ijc.25381,,,,20473871,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6074377,https://api.altmetric.com/v1/donut/6074377_240.png 0,"Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.",Journal of Clinical Oncology,,,Article,2010-08-31,10.1200/jco.2009.27.0793,,,,20679621,PMC2940394,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6074375,https://api.altmetric.com/v1/donut/6074375_240.png 0,Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study.,Journal of Clinical Oncology,,,Article,2009-11-20,10.1200/jco.2008.20.8876,,,,19858401,PMC2792955,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6074374,https://api.altmetric.com/v1/donut/6074374_240.png 0,No Association of ApoE Genotype with Risk of Prostate Cancer: A Nested Case-Control Study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-15-0367,,,,26189769,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6074366,https://api.altmetric.com/v1/donut/6074366_240.png 0,Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.,Cancer Causes and Control,,,Article,2014-03-25,10.1007/s10552-014-0369-3,,,,24664287,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6074365,https://api.altmetric.com/v1/donut/6074365_240.png 0,Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study.,International Journal of Cancer,,,Article,2009-03-15,10.1002/ijc.24044,,,,19058180,PMC2680190,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6074330,https://api.altmetric.com/v1/donut/6074330_240.png 0,A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.,European Journal of Cancer (1965),,,Article,2010-06-14,10.1016/j.ejca.2010.02.017,,,,20303260,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6073955,https://api.altmetric.com/v1/donut/6073955_240.png 0,Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.,Journal of Controlled Release,,,Article,2011-02-10,10.1016/j.jconrel.2010.10.030,,,,21047537,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6073950,https://api.altmetric.com/v1/donut/6073950_240.png 0,ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.,Neoplasia,,,Article,2010-12-15,,,,,21170267,PMC3003138,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6073947,https://api.altmetric.com/v1/donut/6073947_240.png 0,In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.,Journal of Nuclear Medicine,,,Article,2010-01-15,10.2967/jnumed.109.067108,,,,20008977,PMC2821016,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6073929,https://api.altmetric.com/v1/donut/6073929_240.png 0,Biodistributions of 177Lu- and 111In-labeled 7E11 antibodies to prostate-specific membrane antigen in xenograft model of prostate cancer and potential use of 111In-7E11 as a pre-therapeutic agent for 177Lu-7E11 radioimmunotherapy.,Molecular Imaging & Biology,,,Article,,10.1007/s11307-008-0185-9,,,,19034582,PMC2841328,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6073927,https://api.altmetric.com/v1/donut/6073927_240.png 0,Combined SPECT and Multidetector CT for Prostate Cancer Evaluations.,,,,Article,,,,,,22267999,PMC3260786,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6073926,https://api.altmetric.com/v1/donut/6073926_240.png 0,Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference.,The Prostate,,,Article,2011-09-14,10.1002/pros.21355,,,,21321978,PMC3123672,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6073735,https://api.altmetric.com/v1/donut/6073735_240.png 0,Correlates of colorectal cancer screening adherence among men who have been screened for prostate cancer.,Journal of Cancer Education,,,Article,2011-06-14,10.1007/s13187-011-0194-2,,,,21360029,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6073691,https://api.altmetric.com/v1/donut/6073691_240.png 0,Androgen deprivation therapy and cataract incidence among elderly prostate cancer patients in the United States.,Annals of Epidemiology,,,Article,2011-03-15,10.1016/j.annepidem.2010.10.003,,,,21109456,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6073634,https://api.altmetric.com/v1/donut/6073634_240.png 0,"Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.",Prostate Cancer & Prostatic Diseases,,,Article,2010-12-15,10.1038/pcan.2010.27,,,,20697428,PMC2978765,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6073633,https://api.altmetric.com/v1/donut/6073633_240.png 0,Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.,The Prostate,,,Article,2009-03-01,10.1002/pros.20891,,,,19035517,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6073631,https://api.altmetric.com/v1/donut/6073631_240.png 0,Racial differences in risk of prostate cancer associated with metabolic syndrome.,Urology,,,Article,2009-07-14,10.1016/j.urology.2009.03.013,,,,19428088,PMC2704922,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6073630,https://api.altmetric.com/v1/donut/6073630_240.png 0,"Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer.",Journal of Cancer Survivorship,,,Article,2009-12-06,10.1007/s11764-009-0109-y,,,,19967408,PMC2828868,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/6073577,https://api.altmetric.com/v1/donut/6073577_240.png 0,"Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey.",Medical Decision Making,,,Article,,10.1177/0272989x10378701,,,,20881154,PMC3139436,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,71,https://www.altmetric.com/details/6073380,https://api.altmetric.com/v1/donut/6073380_240.png 0,Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study.,,,,Article,2013-08-14,10.1186/1472-6963-13-314,,,,23947435,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6073346,https://api.altmetric.com/v1/donut/6073346_240.png 0,Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.,,,,Article,2012-09-24,10.1186/1472-6963-12-340,,,,23009152,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6073345,https://api.altmetric.com/v1/donut/6073345_240.png 0,"Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study.",Cancer Causes and Control,,,Article,2012-07-14,10.1007/s10552-012-9988-8,,,,22674292,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6073325,https://api.altmetric.com/v1/donut/6073325_240.png 0,A feasibility study of novel ultrasonic tissue characterization for prostate-cancer diagnosis: 2D spectrum analysis of in vivo data with histology as gold standard.,Medical Physics,,,Article,2009-08-14,,,,,19746784,PMC2832027,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6073305,https://api.altmetric.com/v1/donut/6073305_240.png 0,The PPAR? ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.,Experimental Cell Research,,,Article,2010-12-10,10.1016/j.yexcr.2010.09.015,,,,20932825,PMC2977976,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6073298,https://api.altmetric.com/v1/donut/6073298_240.png 0,Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.,Molecular Cancer Therapeutics,,,Article,2010-07-14,10.1158/1535-7163.mct-09-0924,,,,20571066,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6073297,https://api.altmetric.com/v1/donut/6073297_240.png 0,Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.,,,,Article,2010-08-09,10.1186/1471-2407-10-418,,,,20698994,PMC2928796,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6073296,https://api.altmetric.com/v1/donut/6073296_240.png 0,Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.,The Prostate,,,Article,2010-08-31,10.1002/pros.21162,,,,20623629,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6073295,https://api.altmetric.com/v1/donut/6073295_240.png 0,Methylselenocysteine preventing castration-resistant progression of prostate cancer.,The Prostate,,,Article,2015-03-08,10.1002/pros.22987,,,,25754033,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6073294,https://api.altmetric.com/v1/donut/6073294_240.png 0,"Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer.",Clinical Cancer Research,,,Article,2010-05-31,10.1158/1078-0432.ccr-09-3122,,,,20484019,PMC2898710,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6073244,https://api.altmetric.com/v1/donut/6073244_240.png 0,"Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy.",Community Oncology,,,Article,2010-10-14,,,,,21274408,PMC3026283,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6073240,https://api.altmetric.com/v1/donut/6073240_240.png 0,Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.,Journal of Clinical Oncology,,,Article,2009-05-19,10.1200/jco.2008.19.9810,,,,19380444,PMC2684851,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6073187,https://api.altmetric.com/v1/donut/6073187_240.png 0,Is there a standard of care for pathologic stage T3 prostate cancer?,Journal of Clinical Oncology,,,Article,2009-06-19,10.1200/jco.2008.20.9460,,,,19433682,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6073184,https://api.altmetric.com/v1/donut/6073184_240.png 0,Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109.,Urology,,,Article,2012-03-15,10.1016/j.urology.2011.11.019,,,,22386416,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6073181,https://api.altmetric.com/v1/donut/6073181_240.png 0,Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.,JNCI: Journal of the National Cancer Institute,,,Article,2009-02-18,10.1093/jnci/djn489,,,,19211454,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6073145,https://api.altmetric.com/v1/donut/6073145_240.png 0,Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.,Journal of Clinical Oncology,,,Article,2009-04-30,10.1200/jco.2008.17.4052,,,,19307511,PMC2674000,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6073139,https://api.altmetric.com/v1/donut/6073139_240.png 0,"Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.","International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2008.05.020,,,,18990504,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6073133,https://api.altmetric.com/v1/donut/6073133_240.png 0,Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,,10.1016/j.ijrobp.2008.06.1489,,,,18977097,PMC2678565,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6073132,https://api.altmetric.com/v1/donut/6073132_240.png 0,Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer--reply.,JAMA: Journal of the American Medical Association,,,Article,2014-08-19,10.1001/jama.2014.7923,,,,25138339,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6073110,https://api.altmetric.com/v1/donut/6073110_240.png 0,RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients.,Prostate Cancer & Prostatic Diseases,,,Article,2013-09-30,10.1038/pcan.2013.35,,,,24080992,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6073107,https://api.altmetric.com/v1/donut/6073107_240.png 0,Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-03-31,10.1016/j.ijrobp.2010.01.009,,,,21414514,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6073094,https://api.altmetric.com/v1/donut/6073094_240.png 0,Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-01-01,10.1016/j.ijrobp.2009.01.062,,,,19577865,PMC2795116,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6073086,https://api.altmetric.com/v1/donut/6073086_240.png 0,Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-12-01,10.1016/j.ijrobp.2009.09.073,,,,20378270,PMC2920356,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6073084,https://api.altmetric.com/v1/donut/6073084_240.png 0,Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach.,Biostatistics,,,Article,2009-07-14,10.1093/biostatistics/kxp009,,,,19369642,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,54,https://www.altmetric.com/details/6073072,https://api.altmetric.com/v1/donut/6073072_240.png 0,ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-08-04,10.1073/pnas.1303558110,,,,23918374,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6072979,https://api.altmetric.com/v1/donut/6072979_240.png 0,The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer.,Oncotarget,,,Article,2012-12-15,10.18632/oncotarget.771,,,,23242005,PMC3681479,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6072978,https://api.altmetric.com/v1/donut/6072978_240.png 0,Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.,Cancer Research,,,Article,2009-03-01,10.1158/0008-5472.can-07-6817,,,,19223557,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6072973,https://api.altmetric.com/v1/donut/6072973_240.png 0,Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.,Differentiation,,,Article,2009-01-15,10.1016/j.diff.2008.09.010,,,,19281769,PMC2828345,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6072972,https://api.altmetric.com/v1/donut/6072972_240.png 0,"Merkel cell polyomavirus is not detected in prostate cancers, surrounding stroma, or benign prostate controls.",Journal of Clinical Virology,,,Article,2009-02-15,10.1016/j.jcv.2008.11.008,,,,19129009,PMC2676318,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6072834,https://api.altmetric.com/v1/donut/6072834_240.png 0,The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.,Oncotarget,,,Article,2014-09-25,10.18632/oncotarget.2528,,,,25296977,PMC4279402,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6072788,https://api.altmetric.com/v1/donut/6072788_240.png 0,Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer.,Hormones and Cancer,,,Article,2014-03-11,10.1007/s12672-014-0173-2,,,,24615402,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6072741,https://api.altmetric.com/v1/donut/6072741_240.png 0,Genome-wide association study of prostate cancer mortality.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-10-0601,,,,20978177,PMC3197738,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6072561,https://api.altmetric.com/v1/donut/6072561_240.png 0,mRNA expression signature of Gleason grade predicts lethal prostate cancer.,Journal of Clinical Oncology,,,Article,2011-06-09,10.1200/jco.2010.32.6421,,,,21537050,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/6072560,https://api.altmetric.com/v1/donut/6072560_240.png 0,"Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-12-15,10.1158/1055-9965.epi-11-0434,,,,21960694,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6072558,https://api.altmetric.com/v1/donut/6072558_240.png 0,"Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-02-15,10.1158/1055-9965.epi-09-0836,,,,20142246,PMC2820127,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6072556,https://api.altmetric.com/v1/donut/6072556_240.png 0,Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.,International Journal of Cancer,,,Article,2009-05-31,10.1002/ijc.24241,,,,19189403,PMC2667697,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6072552,https://api.altmetric.com/v1/donut/6072552_240.png 0,Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?,Journal of Clinical Oncology,,,Article,2009-07-19,10.1200/jco.2008.20.4669,,,,19433685,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6072551,https://api.altmetric.com/v1/donut/6072551_240.png 0,Tumor expression of Adiponectin Receptor 2 and lethal prostate cancer.,Carcinogenesis,,,Article,,10.1093/carcin/bgv048,,,,25863129,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6072547,https://api.altmetric.com/v1/donut/6072547_240.png 0,"Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.",The Prostate,,,Article,2013-05-14,10.1002/pros.22611,,,,23129481,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6072534,https://api.altmetric.com/v1/donut/6072534_240.png 0,Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.,The Prostate,,,Article,2012-02-01,10.1002/pros.21423,,,,21563195,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6072530,https://api.altmetric.com/v1/donut/6072530_240.png 0,Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.,Carcinogenesis,,,Article,2011-06-14,10.1093/carcin/bgr050,,,,21421545,PMC3106437,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6072526,https://api.altmetric.com/v1/donut/6072526_240.png 0,Genetic variation in RNASEL associated with prostate cancer risk and progression.,Carcinogenesis,,,Article,2010-09-14,10.1093/carcin/bgq132,,,,20576793,PMC2930803,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6072521,https://api.altmetric.com/v1/donut/6072521_240.png 0,Aberrant cytoplasmic expression of p63 and prostate cancer mortality.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-02-15,10.1158/1055-9965.epi-08-0785,,,,19155438,PMC2692093,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6072516,https://api.altmetric.com/v1/donut/6072516_240.png 0,Toll-like receptor signaling pathway variants and prostate cancer mortality.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-06-14,10.1158/1055-9965.epi-08-0981,,,,19505919,PMC2833418,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6072515,https://api.altmetric.com/v1/donut/6072515_240.png 0,Silencing of DLC1 Upregulates PAI-1 Expression and Reduces Migration in Normal Prostate Cells.,Molecular Cancer Research,,,Article,2012-01-15,10.1158/1541-7786.mcr-11-0450,,,,22064653,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6072493,https://api.altmetric.com/v1/donut/6072493_240.png 0,Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells.,Oncogene,,,Article,2011-12-08,10.1038/onc.2011.200,,,,21643011,PMC3170684,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6072481,https://api.altmetric.com/v1/donut/6072481_240.png 0,Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7.,Cancer Gene Therapy,,,Article,2010-10-14,10.1038/cgt.2010.25,,,,20539323,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6072479,https://api.altmetric.com/v1/donut/6072479_240.png 0,Integrin alpha 7 interacts with high temperature requirement A2 (HtrA2) to induce prostate cancer cell death.,American Journal of Pathology,,,Article,2010-09-14,10.2353/ajpath.2010.091026,,,,20651226,PMC2928952,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6072478,https://api.altmetric.com/v1/donut/6072478_240.png 0,"(-)-Epigallocatechin-3-gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix protein.",Cancer Science,,,Article,2010-03-15,10.1111/j.1349-7006.2009.01425.x,,,,20002680,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6072477,https://api.altmetric.com/v1/donut/6072477_240.png 0,"Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis.",,,,Article,2011-12-05,10.1186/1476-072x-10-63,,,,22142274,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6072436,https://api.altmetric.com/v1/donut/6072436_240.png 0,A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis.,Chemistry & Biology,,,Article,2011-04-21,10.1016/j.chembiol.2011.02.008,,,,21513884,PMC3119342,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6072406,https://api.altmetric.com/v1/donut/6072406_240.png 0,Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.,Molecular & Cellular Biology,,,Article,2011-12-15,10.1128/mcb.05934-11,,,,21969603,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6072396,https://api.altmetric.com/v1/donut/6072396_240.png 0,Racial disparities in traumatic stress in prostate cancer patients: secondary analysis of a National URCC CCOP Study of 317 men.,Supportive Care in Cancer,,,Article,2011-07-14,10.1007/s00520-010-0880-3,,,,20414685,PMC3110634,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6072312,https://api.altmetric.com/v1/donut/6072312_240.png 0,Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer.,Critical Reviews in Oncology/Hematology,,,Article,2010-08-14,10.1016/j.critrevonc.2010.06.009,,,,20656210,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6072307,https://api.altmetric.com/v1/donut/6072307_240.png 0,The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.,Chemico-Biological Interactions,,,Article,2014-12-13,10.1016/j.cbi.2014.12.012,,,,25514466,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6072295,https://api.altmetric.com/v1/donut/6072295_240.png 0,Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.,Clinical Cancer Research,,,Article,2009-04-30,10.1158/1078-0432.ccr-08-2733,,,,19366828,PMC2878092,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6072283,https://api.altmetric.com/v1/donut/6072283_240.png 0,Post-diagnostic statin use and the risk of lethal prostate cancer in the Health Professionals Follow-up Study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,,10.1158/1055-9965.epi-15-0671,,,,26189767,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6072274,https://api.altmetric.com/v1/donut/6072274_240.png 0,Index-based Dietary Patterns and the Risk of Prostate Cancer in the NIH-AARP Diet and Health Study.,American Journal of Epidemiology,,,Article,2013-03-15,10.1093/aje/kws261,,,,23408548,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6072264,https://api.altmetric.com/v1/donut/6072264_240.png 0,Homogeneous prostate cancer mortality in the Nordic countries over four decades.,European Urology,,,Article,2010-09-14,10.1016/j.eururo.2010.05.040,,,,20541313,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6072257,https://api.altmetric.com/v1/donut/6072257_240.png 0,Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.,Thrombosis and Haemostasis,,,Article,2013-07-31,10.1160/th13-04-0275,,,,23903407,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6072240,https://api.altmetric.com/v1/donut/6072240_240.png 0,Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.,American Journal of Health Promotion,,,Article,2014-06-25,10.4278/ajhp.130904-qual-463,,,,24968183,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6072218,https://api.altmetric.com/v1/donut/6072218_240.png 0,Informed decision making among first-degree relatives of prostate cancer survivors: A pilot randomized trial.,Contemporary Clinical Trials,,,Article,2014-10-23,10.1016/j.cct.2014.10.007,,,,25465497,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6072217,https://api.altmetric.com/v1/donut/6072217_240.png 0,Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.,Metabolism: Clinical and Experimental,,,Article,2011-09-14,10.1016/j.metabol.2011.01.005,,,,21397927,PMC3134585,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6072127,https://api.altmetric.com/v1/donut/6072127_240.png 0,miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2011-02-15,,,,,21378318,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6071831,https://api.altmetric.com/v1/donut/6071831_240.png 0,Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.,Cancer Research,,,Article,2009-01-15,10.1158/0008-5472.can-08-3415,,,,19147588,PMC2629396,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,84,https://www.altmetric.com/details/6071829,https://api.altmetric.com/v1/donut/6071829_240.png 0,Risk Prediction for Prostate Cancer Recurrence Through Regularized Estimation with Simultaneous Adjustment for Nonlinear Clinical Effects.,The Annals of Applied Statistics,,,Article,2011-08-31,,,,,22081781,PMC3212400,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6071828,https://api.altmetric.com/v1/donut/6071828_240.png 0,"The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways.",American Journal of Pathology,,,Article,2010-02-15,10.2353/ajpath.2010.090657,,,,20019190,PMC2808058,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6071825,https://api.altmetric.com/v1/donut/6071825_240.png 0,E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.,Cancer Research,,,Article,2009-03-15,10.1158/0008-5472.can-08-4113,,,,19276347,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6071704,https://api.altmetric.com/v1/donut/6071704_240.png 0,Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment.,Journal of Cancer Research & Clinical Oncology,,,Article,2013-06-14,10.1007/s00432-013-1398-0,,,,23463096,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6071703,https://api.altmetric.com/v1/donut/6071703_240.png 0,Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.,Molecular Imaging & Biology,,,Article,2015-01-06,10.1007/s11307-014-0814-4,,,,25561013,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6071558,https://api.altmetric.com/v1/donut/6071558_240.png 0,Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF ?2.,Molecular Carcinogenesis,,,Article,2014-02-24,10.1002/mc.22135,,,,24615813,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6071557,https://api.altmetric.com/v1/donut/6071557_240.png 0,Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.,Cancer Prevention Research,,,Article,2011-08-14,10.1158/1940-6207.capr-10-0370,,,,21546539,PMC3151351,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6071556,https://api.altmetric.com/v1/donut/6071556_240.png 0,"Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-?B, and androgen receptor signaling.",Molecular Carcinogenesis,,,Article,2010-10-14,10.1002/mc.20670,,,,20721970,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6071554,https://api.altmetric.com/v1/donut/6071554_240.png 0,Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.,Clinical Cancer Research,,,Article,2009-01-15,10.1158/1078-0432.ccr-08-1846,,,,19147767,PMC2629529,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6071553,https://api.altmetric.com/v1/donut/6071553_240.png 0,Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.,Cancer Research,,,Article,2009-04-30,10.1158/0008-5472.can-09-0096,,,,19366793,PMC2679526,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6071552,https://api.altmetric.com/v1/donut/6071552_240.png 0,"Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.",Oncotarget,,,Article,2014-09-15,10.18632/oncotarget.2488,,,,25294820,PMC4259402,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6071551,https://api.altmetric.com/v1/donut/6071551_240.png 0,The strategies to control prostate cancer by chemoprevention approaches.,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,,,Article,2014-01-02,10.1016/j.mrfmmm.2013.12.003,,,,24389535,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6071549,https://api.altmetric.com/v1/donut/6071549_240.png 0,Mechanisms of prostate cancer initiation and progression.,Advances in cancer research,,,Article,,10.1016/b978-0-12-380890-5.00001-6,,,,21070913,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6071527,https://api.altmetric.com/v1/donut/6071527_240.png 0,p66Shc is indispensable for phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells.,Cancer Research,,,Article,2010-04-14,10.1158/0008-5472.can-09-4451,,,,20354186,PMC2855757,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6071439,https://api.altmetric.com/v1/donut/6071439_240.png 0,Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes.,Pharmaceutical Research,,,Article,2010-12-15,10.1007/s11095-010-0278-4,,,,20872049,PMC2987529,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6071438,https://api.altmetric.com/v1/donut/6071438_240.png 0,Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.,Cancer Prevention Research,,,Article,2010-04-14,10.1158/1940-6207.capr-09-0250,,,,20233902,PMC2853726,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6071437,https://api.altmetric.com/v1/donut/6071437_240.png 0,Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer.,JNCI: Journal of the National Cancer Institute,,,Article,2011-04-05,10.1093/jnci/djr029,,,,21330634,PMC3071352,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6071436,https://api.altmetric.com/v1/donut/6071436_240.png 0,Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.,Pharmaceutical Research,,,Article,2010-04-14,10.1007/s11095-010-0079-9,,,,20182772,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6071435,https://api.altmetric.com/v1/donut/6071435_240.png 0,"Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species.",Pharmaceutical Research,,,Article,2009-07-14,10.1007/s11095-009-9883-5,,,,19384467,PMC2744077,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6071434,https://api.altmetric.com/v1/donut/6071434_240.png 0,Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells.,Cancer Research,,,Article,2009-04-14,10.1158/0008-5472.can-08-4344,,,,19336571,PMC2669844,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6071433,https://api.altmetric.com/v1/donut/6071433_240.png 0,Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.,The Prostate,,,Article,2014-07-06,10.1002/pros.22837,,,,25043291,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6071432,https://api.altmetric.com/v1/donut/6071432_240.png 0,Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.,The Prostate,,,Article,2012-06-30,10.1002/pros.22457,,,,22161756,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6071426,https://api.altmetric.com/v1/donut/6071426_240.png 0,Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.,Trends in Endocrinology & Metabolism,,,Article,2010-05-14,10.1016/j.tem.2010.01.002,,,,20138542,PMC2862880,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/6071178,https://api.altmetric.com/v1/donut/6071178_240.png 0,"Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.",Clinical Cancer Research,,,Article,2009-08-31,10.1158/1078-0432.ccr-08-2865,,,,19706803,PMC2849314,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6071172,https://api.altmetric.com/v1/donut/6071172_240.png 0,Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer.,Oncogene,,,Article,2009-02-19,10.1038/onc.2008.446,,,,19079343,PMC2852245,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6071171,https://api.altmetric.com/v1/donut/6071171_240.png 0,AR function in promoting metastatic prostate cancer.,Cancer and Metastasis Reviews,,,Article,2014-01-15,10.1007/s10555-013-9471-3,,,,24425228,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6071170,https://api.altmetric.com/v1/donut/6071170_240.png 0,Molecular Pathogenesis and Progression of Prostate Cancer.,Seminars in oncology,,,Article,2013-06-14,10.1053/j.seminoncol.2013.04.001,,,,23806491,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6071169,https://api.altmetric.com/v1/donut/6071169_240.png 0,mTOR is a selective effector of the radiation therapy response in androgen receptor positive prostate cancer.,Endocrine-Related Cancer,,,Article,2012-02-15,10.1530/erc-11-0072,,,,21903859,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6071167,https://api.altmetric.com/v1/donut/6071167_240.png 0,Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer.,Nature Reviews Urology,,,Article,2011-08-01,10.1038/nrurol.2011.107,,,,21811228,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6071165,https://api.altmetric.com/v1/donut/6071165_240.png 0,CpG Island Hypermethylation Frequently Silences FILIP1L Isoform 2 Expression in Prostate Cancer.,The Journal of Urology,,,Article,2013-01-15,10.1016/j.juro.2012.08.188,,,,23174249,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6070929,https://api.altmetric.com/v1/donut/6070929_240.png 0,Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence.,British Journal of Cancer,,,Article,2012-06-25,10.1038/bjc.2012.216,,,,22596233,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6070928,https://api.altmetric.com/v1/donut/6070928_240.png 0,Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer.,,,,Article,2012-08-14,,,,,22937180,PMC3431038,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6070927,https://api.altmetric.com/v1/donut/6070927_240.png 0,Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.,The Prostate,,,Article,2011-11-15,10.1002/pros.21379,,,,21432864,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6070926,https://api.altmetric.com/v1/donut/6070926_240.png 0,Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer.,Neoplasia,,,Article,2013-04-14,,,,,23555185,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6070924,https://api.altmetric.com/v1/donut/6070924_240.png 0,HP1gamma expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy.,,,,Article,2013-03-23,10.1186/1471-2407-13-148,,,,23522301,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6070923,https://api.altmetric.com/v1/donut/6070923_240.png 0,Analysis of promoter non-CG methylation in prostate cancer.,Epigenomics,,,Article,2013-02-15,10.2217/epi.12.67,,,,23414321,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6070922,https://api.altmetric.com/v1/donut/6070922_240.png 0,Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.,Trends in Endocrinology & Metabolism,,,Article,2010-11-15,10.1016/j.tem.2010.08.004,,,,20846877,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6070851,https://api.altmetric.com/v1/donut/6070851_240.png 0,Prolactin in breast and prostate cancer: molecular and genetic perspectives.,Discovery Medicine,,,Article,2011-04-14,,,,,21524385,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6070849,https://api.altmetric.com/v1/donut/6070849_240.png 0,Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.,Molecular Cancer Therapeutics,,,Article,2009-03-15,10.1158/1535-7163.mct-08-0693,,,,19276166,PMC2748671,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6070839,https://api.altmetric.com/v1/donut/6070839_240.png 0,Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion.,Carcinogenesis,,,Article,2010-09-14,10.1093/carcin/bgq086,,,,20466759,PMC2930800,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6070768,https://api.altmetric.com/v1/donut/6070768_240.png 0,Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2013-07-14,10.1016/j.jsbmb.2012.10.002,,,,23098689,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6070767,https://api.altmetric.com/v1/donut/6070767_240.png 0,Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer.,PloS one,,,Article,,10.1371/journal.pone.0089555,,,,24586868,PMC3935875,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6070765,https://api.altmetric.com/v1/donut/6070765_240.png 0,Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.,Carcinogenesis,,,Article,2013-02-15,10.1093/carcin/bgs331,,,,23087083,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6070763,https://api.altmetric.com/v1/donut/6070763_240.png 0,Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.,The Prostate,,,Article,2011-02-01,10.1002/pros.21228,,,,20717900,PMC2989344,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6070703,https://api.altmetric.com/v1/donut/6070703_240.png 0,Characterization of Infectivity-Enhanced Conditionally Replicating Adenovectors for Prostate Cancer Radiovirotherapy.,Human Gene Therapy,,,Article,2012-09-14,10.1089/hum.2012.047,,,,22694073,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6070665,https://api.altmetric.com/v1/donut/6070665_240.png 0,Estimation of effective imaging dose for kilovoltage intratreatment monitoring of the prostate position during cancer radiotherapy.,Physics in Medicine & Biology,,,Article,2013-09-06,10.1088/0031-9155/58/17/5983,,,,23938470,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6070638,https://api.altmetric.com/v1/donut/6070638_240.png 0,Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.,Radiology,,,Article,2010-12-15,10.1148/radiol.10100021,,,,20843992,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6070516,https://api.altmetric.com/v1/donut/6070516_240.png 0,Computer-aided detection of prostate cancer on tissue sections.,Applied immunohistochemistry molecular morphology AIMM,,,Article,2009-10-14,10.1097/pai.0b013e31819e6d65,,,,19417626,PMC2836393,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6070509,https://api.altmetric.com/v1/donut/6070509_240.png 0,Seminal Vesicle Invasion in Prostate Cancer: Evaluation by Using Multiparametric Endorectal MR Imaging.,Radiology,,,Article,2013-06-14,10.1148/radiol.13121319,,,,23440325,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6070507,https://api.altmetric.com/v1/donut/6070507_240.png 0,MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.,International Journal of Cancer,,,Article,2012-02-01,10.1002/ijc.26005,,,,21351092,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6070444,https://api.altmetric.com/v1/donut/6070444_240.png 0,From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis.,,,,Article,,10.3390/cancers3010478,,,,21603150,PMC3096870,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6070441,https://api.altmetric.com/v1/donut/6070441_240.png 0,Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.,Annals of Oncology,,,Article,2011-12-15,10.1093/annonc/mdr020,,,,21415239,PMC3221513,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6070436,https://api.altmetric.com/v1/donut/6070436_240.png 0,Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines.,Molecular & Cellular Endocrinology,,,Article,2013-04-29,10.1016/j.mce.2013.01.010,,,,23380421,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6070410,https://api.altmetric.com/v1/donut/6070410_240.png 0,Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.,Molecular Pharmacology,,,Article,2010-09-14,10.1124/mol.110.064741,,,,20516369,PMC2939481,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6070409,https://api.altmetric.com/v1/donut/6070409_240.png 0,Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.,Journal of Biological Chemistry,,,Article,2010-08-19,10.1074/jbc.m110.128371,,,,20566643,PMC2924002,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6070408,https://api.altmetric.com/v1/donut/6070408_240.png 0,PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens.,Molecular Carcinogenesis,,,Article,2009-03-15,10.1002/mc.20476,,,,18756441,PMC3113613,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6070407,https://api.altmetric.com/v1/donut/6070407_240.png 0,ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.,Journal of Biological Chemistry,,,Article,2009-10-22,10.1074/jbc.m109.007971,,,,19667069,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6070406,https://api.altmetric.com/v1/donut/6070406_240.png 0,Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.,Journal of the American Statistical Association,,,Article,2012-06-14,10.1080/01621459.2011.641416,,,,22956855,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6070290,https://api.altmetric.com/v1/donut/6070290_240.png 0,Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases.,Journal of Interferon & Cytokine Research,,,Article,2011-07-14,10.1089/jir.2010.0142,,,,21323568,PMC3163391,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6070287,https://api.altmetric.com/v1/donut/6070287_240.png 0,A Bayesian hierarchical mixture model for platelet derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer.,Journal of the Royal Statistical Society: Series C (Applied Statistics),,,Article,2009-09-02,10.1111/j.1467-9876.2009.00680.x,,,,20390057,PMC2853262,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6070282,https://api.altmetric.com/v1/donut/6070282_240.png 0,Cytokine genetic polymorphisms and prostate cancer aggressiveness.,Carcinogenesis,,,Article,2009-08-14,10.1093/carcin/bgp124,,,,19474090,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6070234,https://api.altmetric.com/v1/donut/6070234_240.png 0,The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2010-03-01,10.1002/jcb.22463,,,,20082326,PMC2925394,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6070055,https://api.altmetric.com/v1/donut/6070055_240.png 0,PSA regulates androgen receptor expression in prostate cancer cells.,The Prostate,,,Article,2012-05-14,10.1002/pros.21482,,,,21956655,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6070054,https://api.altmetric.com/v1/donut/6070054_240.png 0,Prostate cancer regulatory networks.,Journal of Cellular Biochemistry,,,Article,2009-07-31,10.1002/jcb.22162,,,,19492418,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6070052,https://api.altmetric.com/v1/donut/6070052_240.png 0,Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model.,Journal of Cancer Science & Therapy,,,Article,2011-11-19,,,,,24032073,PMC3768133,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6069965,https://api.altmetric.com/v1/donut/6069965_240.png 0,Mouse models of prostate cancer: picking the best model for the question.,Cancer and Metastasis Reviews,,,Article,2014-01-23,10.1007/s10555-013-9487-8,,,,24452759,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6069898,https://api.altmetric.com/v1/donut/6069898_240.png 0,"Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates ?-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.",,,,Article,2010-11-24,10.1186/1476-4598-9-304,,,,21106062,PMC3009707,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6069896,https://api.altmetric.com/v1/donut/6069896_240.png 0,Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.,The Prostate,,,Article,2010-04-30,10.1002/pros.21093,,,,19938013,PMC2925264,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6069895,https://api.altmetric.com/v1/donut/6069895_240.png 0,SPARCL1 suppresses metastasis in prostate cancer.,Molecular Oncology,,,Article,2013-07-19,10.1016/j.molonc.2013.07.008,,,,23916135,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6069894,https://api.altmetric.com/v1/donut/6069894_240.png 0,Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells.,Cancer Research,,,Article,2011-06-14,10.1158/0008-5472.can-10-4610,,,,21555367,PMC3117105,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6069729,https://api.altmetric.com/v1/donut/6069729_240.png 0,A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.,The Prostate,,,Article,2013-06-14,10.1002/pros.22648,,,,23389852,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6069692,https://api.altmetric.com/v1/donut/6069692_240.png 0,Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.,Cancer Research,,,Article,2010-07-14,10.1158/0008-5472.can-10-0617,,,,20587525,PMC2928678,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6069671,https://api.altmetric.com/v1/donut/6069671_240.png 0,Vitamin D deficiency and insufficiency among patients with prostate cancer.,British Journal of Urology,,,Article,2009-10-14,10.1111/j.1464-410x.2009.08531.x,,,,19426195,PMC2889216,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6069665,https://api.altmetric.com/v1/donut/6069665_240.png 0,"Inhibition of protein kinase CK2 reduces CYP24A1 expression and enhances 1,25-dihydroxyvitamin D3 anti-tumor activity in human prostate cancer cells.",Cancer Research,,,Article,2013-03-31,10.1158/0008-5472.can-12-4119,,,,23358686,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6069663,https://api.altmetric.com/v1/donut/6069663_240.png 0,Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.,The Prostate,,,Article,2011-03-01,10.1002/pros.21250,,,,20812224,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6069661,https://api.altmetric.com/v1/donut/6069661_240.png 0,Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.,American Journal of Pathology,,,Article,2011-01-15,10.1016/j.ajpath.2010.09.042,,,,21224046,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6069455,https://api.altmetric.com/v1/donut/6069455_240.png 0,The reactive stroma microenvironment and prostate cancer progression.,Endocrine-Related Cancer,,,Article,2012-12-15,10.1530/erc-12-0085,,,,22930558,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/6069451,https://api.altmetric.com/v1/donut/6069451_240.png 0,Stromal TGF-? signaling induces AR activation in prostate cancer.,Oncotarget,,,Article,2014-10-13,10.18632/oncotarget.2536,,,,25333263,PMC4279415,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6069448,https://api.altmetric.com/v1/donut/6069448_240.png 0,Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.,Cancer Research,,,Article,2011-03-15,10.1158/0008-5472.can-10-3268,,,,21278236,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6069447,https://api.altmetric.com/v1/donut/6069447_240.png 0,A role for the clock gene per1 in prostate cancer.,Cancer Research,,,Article,2009-09-30,10.1158/0008-5472.can-08-4199,,,,19752089,PMC2756309,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6068897,https://api.altmetric.com/v1/donut/6068897_240.png 0,"Inecalcitol, an analog of 1?,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells.",International Journal of Cancer,,,Article,2012-05-14,10.1002/ijc.26279,,,,21732345,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6068874,https://api.altmetric.com/v1/donut/6068874_240.png 0,DNA methylation changes in prostate cancer: current developments and future clinical implementation.,Expert Review of Molecular Diagnostics,,,Article,2009-04-14,10.1586/erm.09.10,,,,19379083,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6068736,https://api.altmetric.com/v1/donut/6068736_240.png 0,Endoglin regulates cancer-stromal cell interactions in prostate tumors.,Cancer Research,,,Article,2011-05-14,10.1158/0008-5472.can-10-2665,,,,21444673,PMC3096740,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6068721,https://api.altmetric.com/v1/donut/6068721_240.png 0,Is statin use associated with prostate cancer aggressiveness?,British Journal of Urology,,,Article,2010-05-14,10.1111/j.1464-410x.2009.09007.x,,,,19888973,PMC3081618,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6068719,https://api.altmetric.com/v1/donut/6068719_240.png 0,Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.,The Journal of Urology,,,Article,2010-08-14,10.1016/j.juro.2010.04.032,,,,20620408,PMC3164535,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6068718,https://api.altmetric.com/v1/donut/6068718_240.png 0,Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach.,Journal of Clinical Oncology,,,Article,2010-03-31,10.1200/jco.2008.20.3422,,,,20177031,PMC2849765,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6068716,https://api.altmetric.com/v1/donut/6068716_240.png 0,Endoglin suppresses human prostate cancer metastasis.,Clinical and Experimental Metastasis,,,Article,,10.1007/s10585-010-9356-6,,,,20981476,PMC3046557,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6068714,https://api.altmetric.com/v1/donut/6068714_240.png 0,Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression.,The Prostate,,,Article,2010-11-01,10.1002/pros.21202,,,,20607747,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6068709,https://api.altmetric.com/v1/donut/6068709_240.png 0,"MEK4 function, genistein treatment, and invasion of human prostate cancer cells.",JNCI: Journal of the National Cancer Institute,,,Article,2009-08-18,10.1093/jnci/djp227,,,,19638505,PMC2728746,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6068708,https://api.altmetric.com/v1/donut/6068708_240.png 0,HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.,Molecular Endocrinology,,,Article,2009-12-15,10.1210/me.2009-0188,,,,19855091,PMC2796151,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6068707,https://api.altmetric.com/v1/donut/6068707_240.png 0,Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-? and IGF signaling.,BioMed Research International,,,Article,,10.1155/2014/502093,,,,25089270,PMC4095744,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6068705,https://api.altmetric.com/v1/donut/6068705_240.png 0,The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2014-03-21,10.1016/j.jsbmb.2014.03.004,,,,24662325,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6068703,https://api.altmetric.com/v1/donut/6068703_240.png 0,Prostate cancer risk alleles are associated with prostate cancer tumor volume and prostate size.,The Journal of Urology,,,Article,2013-12-14,10.1016/j.juro.2013.12.030,,,,24345439,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6068702,https://api.altmetric.com/v1/donut/6068702_240.png 0,Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study.,The Prostate,,,Article,2014-02-15,,,,,24571013,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6068700,https://api.altmetric.com/v1/donut/6068700_240.png 0,"miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis.",PloS one,,,Article,2013-12-31,10.1371/journal.pone.0083991,,,,24391862,PMC3877136,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6068696,https://api.altmetric.com/v1/donut/6068696_240.png 0,Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.,Cancer Microenvironment,,,Article,2013-02-26,10.1007/s12307-013-0132-4,,,,23440596,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6068695,https://api.altmetric.com/v1/donut/6068695_240.png 0,Deregulation of a Hox Protein Regulatory Network Spanning Prostate Cancer Initiation and Progression.,Clinical Cancer Research,,,Article,2012-08-14,10.1158/1078-0432.ccr-12-0373,,,,22723371,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6068691,https://api.altmetric.com/v1/donut/6068691_240.png 0,The United States Preventive Services Task Force Recommendation Against Prostate-Specific Antigen Screening-Counterpoint.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-03-15,10.1158/1055-9965.epi-12-0059,,,,22315363,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6068686,https://api.altmetric.com/v1/donut/6068686_240.png 0,Prostate cancer risk alleles and their associations with other malignancies.,Urology,,,Article,2011-10-14,10.1016/j.urology.2011.05.035,,,,21820706,PMC3190015,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6068683,https://api.altmetric.com/v1/donut/6068683_240.png 0,"TGF-? regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.",,,,Article,,10.1371/journal.pone.0025168,,,,21980391,PMC3184137,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6068682,https://api.altmetric.com/v1/donut/6068682_240.png 0,Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.,Urology,,,Article,2010-11-15,10.1016/j.urology.2009.11.056,,,,20846711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6068679,https://api.altmetric.com/v1/donut/6068679_240.png 0,Number of prostate cancer risk alleles may identify possibly 'insignificant' disease.,British Journal of Urology,,,Article,2010-12-15,10.1111/j.1464-410x.2010.09440.x,,,,20590552,PMC3072834,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6068675,https://api.altmetric.com/v1/donut/6068675_240.png 0,Prostate cancer: utility of the risk indicator model in screening.,Nature Reviews Urology,,,Article,,10.1038/nrurol.2010.41,,,,20383184,PMC3130616,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6068674,https://api.altmetric.com/v1/donut/6068674_240.png 0,Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-04-30,10.1016/j.ijrobp.2009.04.074,,,,19695789,PMC3049990,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6068672,https://api.altmetric.com/v1/donut/6068672_240.png 0,Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2010-02-15,,,,,20141681,PMC3107541,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6068671,https://api.altmetric.com/v1/donut/6068671_240.png 0,Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml.,The Journal of Urology,,,Article,2009-06-14,10.1016/j.juro.2009.01.102,,,,19371879,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6068669,https://api.altmetric.com/v1/donut/6068669_240.png 0,Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?,British Journal of Urology,,,Article,2009-11-15,10.1111/j.1464-410x.2009.08656.x,,,,19627283,PMC3168555,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6068666,https://api.altmetric.com/v1/donut/6068666_240.png 0,The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.,Cancer Prevention Research,,,Article,2009-09-14,10.1158/1940-6207.capr-09-0066,,,,19737984,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6068665,https://api.altmetric.com/v1/donut/6068665_240.png 0,Pathological outcomes associated with the 17q prostate cancer risk variants.,The Journal of Urology,,,Article,2009-06-14,10.1016/j.juro.2009.01.109,,,,19371897,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6068663,https://api.altmetric.com/v1/donut/6068663_240.png 0,Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.,The Prostate,,,Article,2009-09-30,10.1002/pros.20999,,,,19562729,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6068660,https://api.altmetric.com/v1/donut/6068660_240.png 0,Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.,Molecular Cancer Therapeutics,,,Article,2010-02-15,10.1158/1535-7163.mct-09-0589,,,,20124447,PMC2821808,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6068522,https://api.altmetric.com/v1/donut/6068522_240.png 0,Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-? enhanced cryotherapy in an in vivo prostate cancer model system.,Cryobiology,,,Article,2010-12-15,10.1016/j.cryobiol.2010.09.006,,,,20940007,PMC3017718,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6068481,https://api.altmetric.com/v1/donut/6068481_240.png 0,Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice.,PloS one,,,Article,,10.1371/journal.pone.0109970,,,,25333839,PMC4198192,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6068440,https://api.altmetric.com/v1/donut/6068440_240.png 0,PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols.,World Journal of Urology,,,Article,2011-10-14,10.1007/s00345-010-0623-6,,,,21152924,PMC3189407,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6068217,https://api.altmetric.com/v1/donut/6068217_240.png 0,Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels.,,,,Article,2011-02-15,,,,,21403837,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6068205,https://api.altmetric.com/v1/donut/6068205_240.png 0,Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressiveness.,Urologic Oncology,,,Article,2014-04-28,10.1016/j.urolonc.2014.01.018,,,,24794250,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6068119,https://api.altmetric.com/v1/donut/6068119_240.png 0,"Generation of ""virtual"" control groups for single arm prostate cancer adjuvant trials.",PloS one,,,Article,2014-01-21,10.1371/journal.pone.0085010,,,,24465467,PMC3897405,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6068108,https://api.altmetric.com/v1/donut/6068108_240.png 0,Updating risk prediction tools: A case study in prostate cancer.,Biometrical Journal,,,Article,2012-01-15,10.1002/bimj.201100062,,,,22095849,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6067981,https://api.altmetric.com/v1/donut/6067981_240.png 0,"Predicting Risk of Prostate Cancer in Men Receiving Finasteride: Effect of Prostate Volume, Number of Biopsy Cores, and American Urological Association Symptom Score.",Urology,,,Article,2013-09-18,10.1016/j.urology.2013.07.041,,,,24055241,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6067964,https://api.altmetric.com/v1/donut/6067964_240.png 0,Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NF?B/FLIP.,Molecular Carcinogenesis,,,Article,2014-07-06,10.1002/mc.22192,,,,25043857,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6067960,https://api.altmetric.com/v1/donut/6067960_240.png 0,Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2010-03-15,,,,,20393007,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6067927,https://api.altmetric.com/v1/donut/6067927_240.png 0,"Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-02-15,10.1158/1055-9965.epi-09-0864,,,,20086112,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6067918,https://api.altmetric.com/v1/donut/6067918_240.png 0,Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.,Urology,,,Article,2010-11-15,10.1016/j.urology.2010.04.060,,,,20739049,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6067916,https://api.altmetric.com/v1/donut/6067916_240.png 0,Blockade of transforming growth factor-beta (TGF?) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line.,The Prostate,,,Article,2011-09-14,10.1002/pros.21361,,,,21321980,PMC3108007,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6067892,https://api.altmetric.com/v1/donut/6067892_240.png 0,Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.,The Journal of Urology,,,Article,2011-01-15,10.1016/j.juro.2010.08.088,,,,21074193,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6067886,https://api.altmetric.com/v1/donut/6067886_240.png 0,Prostate cancer detection: a view of the future.,European Urology,,,Article,2011-02-15,10.1016/j.eururo.2010.11.019,,,,21130561,PMC3060941,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6067877,https://api.altmetric.com/v1/donut/6067877_240.png 0,Active surveillance for prostate cancer.,JAMA: Journal of the American Medical Association,,,Article,2010-12-01,10.1001/jama.2010.1761,,,,21119090,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6067869,https://api.altmetric.com/v1/donut/6067869_240.png 0,Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.,The Journal of Urology,,,Article,2009-10-14,10.1016/j.juro.2009.06.016,,,,19683737,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6067857,https://api.altmetric.com/v1/donut/6067857_240.png 0,Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.,The Journal of Urology,,,Article,2009-12-15,10.1016/j.juro.2009.08.056,,,,19836788,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6067854,https://api.altmetric.com/v1/donut/6067854_240.png 0,Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2009-01-15,10.1016/j.jsbmb.2008.11.002,,,,19084597,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6067846,https://api.altmetric.com/v1/donut/6067846_240.png 0,Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.,Clinical Cancer Research,,,Article,2009-03-01,10.1158/1078-0432.ccr-08-1389,,,,19223508,PMC2714369,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6067843,https://api.altmetric.com/v1/donut/6067843_240.png 0,"Improving Patient Prostate Cancer Risk Assessment: Moving From Static, Globally-Applied to Dynamic, Practice-Specific Cancer Risk Calculators.",Journal of Biomedical Informatics,,,Article,,10.1016/j.jbi.2015.05.001,,,,25989018,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6067829,https://api.altmetric.com/v1/donut/6067829_240.png 0,"Validation of copy number variants associated with prostate cancer risk and prognosis?,???>",Urologic Oncology,,,Article,2013-09-16,10.1016/j.urolonc.2013.06.004,,,,24054869,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6067814,https://api.altmetric.com/v1/donut/6067814_240.png 0,The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancer.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-12-02,10.1158/1055-9965.epi-13-0574,,,,24296854,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6067806,https://api.altmetric.com/v1/donut/6067806_240.png 0,Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer.,Oncogene,,,Article,2013-09-15,10.1038/onc.2013.374,,,,24037531,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6067801,https://api.altmetric.com/v1/donut/6067801_240.png 0,Prostate cancer risk prediction in a urology clinic in Mexico.,Urologic Oncology,,,Article,2012-02-03,10.1016/j.urolonc.2011.12.023,,,,22306115,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6067775,https://api.altmetric.com/v1/donut/6067775_240.png 0,Temporal changes in the clinical approach to diagnosing prostate cancer.,Journal of the National Cancer Institute. Monographs,,,Article,2012-12-15,10.1093/jncimonographs/lgs038,,,,23271768,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6067765,https://api.altmetric.com/v1/donut/6067765_240.png 0,Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population.,Prostate Cancer,,,Article,,10.1155/2014/481697,,,,24868468,PMC4020167,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6067436,https://api.altmetric.com/v1/donut/6067436_240.png 0,The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.,Journal of Cellular Physiology,,,Article,2010-08-14,10.1002/jcp.22149,,,,20432448,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6067391,https://api.altmetric.com/v1/donut/6067391_240.png 0,Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.,Prostate Cancer,,,Article,,10.1155/2011/249290,,,,21949592,PMC3177701,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6067347,https://api.altmetric.com/v1/donut/6067347_240.png 0,Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer.,Nutrition and Cancer,,,Article,,10.1080/01635581.2010.516476,,,,21128179,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6067340,https://api.altmetric.com/v1/donut/6067340_240.png 0,Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer.,American Journal of Men's Health,,,Article,2011-05-14,10.1177/1557988310390030,,,,21613377,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6067334,https://api.altmetric.com/v1/donut/6067334_240.png 0,Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.,Cancer Prevention Research,,,Article,2010-08-14,10.1158/1940-6207.capr-09-0143,,,,20647337,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6067319,https://api.altmetric.com/v1/donut/6067319_240.png 0,No effect of selenium supplementation on serum glucose levels in men with prostate cancer.,American Journal of Medicine,,,Article,,10.1016/j.amjmed.2010.02.018,,,,20670733,PMC2913148,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6067313,https://api.altmetric.com/v1/donut/6067313_240.png 0,Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer.,,,,Article,2009-01-01,10.2174/1876822900902010059,,,,22081777,PMC3212735,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6067283,https://api.altmetric.com/v1/donut/6067283_240.png 0,Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.,Cancer Research,,,Article,2009-06-14,10.1158/0008-5472.can-09-0354,,,,19491258,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6067274,https://api.altmetric.com/v1/donut/6067274_240.png 0,Primary cilia are lost in preinvasive and invasive prostate cancer.,,,,Article,,10.1371/journal.pone.0068521,,,,23844214,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6067203,https://api.altmetric.com/v1/donut/6067203_240.png 0,"Differences in characteristics of men with localized prostate cancer who demonstrate low, intermediate or high PSA velocity.",Internal Medicine Journal,,,Article,2012-04-14,10.1111/j.1445-5994.2011.02473.x,,,,21395960,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6067190,https://api.altmetric.com/v1/donut/6067190_240.png 0,"Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines.",The Prostate,,,Article,2010-04-30,10.1002/pros.21112,,,,20087897,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6067129,https://api.altmetric.com/v1/donut/6067129_240.png 0,Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.,Endocrine-Related Cancer,,,Article,2013-09-15,10.1530/erc-13-0100,,,,24042462,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6067111,https://api.altmetric.com/v1/donut/6067111_240.png 0,Enrichment of putative prostate cancer stem cells after androgen deprivation: Upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.,The Prostate,,,Article,2013-05-30,10.1002/pros.22685,,,,23728788,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6067107,https://api.altmetric.com/v1/donut/6067107_240.png 0,Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.,Urologic Oncology,,,Article,2014-07-10,10.1016/j.urolonc.2014.04.003,,,,25027689,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6067003,https://api.altmetric.com/v1/donut/6067003_240.png 0,Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.,Clinical Cancer Research,,,Article,2010-11-15,10.1158/1078-0432.ccr-10-0272,,,,20935156,PMC2992073,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6066935,https://api.altmetric.com/v1/donut/6066935_240.png 0,n-3 Fatty acids and prostate cancer risk.,British Journal of Nutrition,,,Article,2012-11-14,10.1017/s0007114512003431,,,,22906807,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6066814,https://api.altmetric.com/v1/donut/6066814_240.png 0,Androgen action and metabolism in prostate cancer.,Molecular & Cellular Endocrinology,,,Article,,10.1016/j.mce.2011.09.046,,,,22453214,PMC4124858,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/6066801,https://api.altmetric.com/v1/donut/6066801_240.png 0,Identification of a clinically relevant androgen-dependent gene signature in prostate cancer.,Cancer Research,,,Article,2011-03-01,10.1158/0008-5472.can-10-2512,,,,21324924,PMC3077061,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6066784,https://api.altmetric.com/v1/donut/6066784_240.png 0,Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3960,,,,26015409,PMC4546469,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6066458,https://api.altmetric.com/v1/donut/6066458_240.png 0,IL-1? induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2014-08-06,10.1002/jcb.24897,,,,25103771,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6066413,https://api.altmetric.com/v1/donut/6066413_240.png 0,p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines.,The Prostate,,,Article,2013-09-29,10.1002/pros.22737,,,,24122957,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6066412,https://api.altmetric.com/v1/donut/6066412_240.png 0,Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.,The Prostate,,,Article,2011-02-01,10.1002/pros.21231,,,,20665531,PMC2972389,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6066410,https://api.altmetric.com/v1/donut/6066410_240.png 0,Fatostatin Displays High Anti-Tumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling.,Molecular Cancer Therapeutics,,,Article,2014-02-03,10.1158/1535-7163.mct-13-0797,,,,24493696,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6066405,https://api.altmetric.com/v1/donut/6066405_240.png 0,"An Inherited Heteroplasmic Mutation in Mitochondrial Gene COI in a Patient with Prostate Cancer Alters Reactive Oxygen, Reactive Nitrogen and Proliferation.",BioMed Research International,,,Article,,10.1155/2013/239257,,,,23509693,PMC3591245,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6066401,https://api.altmetric.com/v1/donut/6066401_240.png 0,Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression.,,,,Article,,10.1371/journal.pone.0042653,,,,22880071,PMC3411834,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6066399,https://api.altmetric.com/v1/donut/6066399_240.png 0,Mitochondrial Cytochrome c Oxidase subunit 1 Sequence Variation in Prostate Cancer.,,,,Article,,10.6064/2012/701810,,,,24124627,PMC3795349,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6066395,https://api.altmetric.com/v1/donut/6066395_240.png 0,Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.,The Prostate,,,Article,,10.1002/pros.20854,,,,18850577,PMC2753601,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6066394,https://api.altmetric.com/v1/donut/6066394_240.png 0,Rapamycin selectively reduces the association of transcripts containing complex 5' UTRs with ribosomes in C4-2B prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2009-05-31,10.1002/jcb.22145,,,,19347904,PMC2913290,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6066392,https://api.altmetric.com/v1/donut/6066392_240.png 0,Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells.,Biomaterials,,,Article,2009-10-14,10.1016/j.biomaterials.2009.07.054,,,,19695694,PMC2782556,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,97,https://www.altmetric.com/details/6066391,https://api.altmetric.com/v1/donut/6066391_240.png 0,microRNAs and Prostate Cancer.,Advances in experimental medicine and biology,,,Article,2015-01-01,10.1007/978-3-319-23730-5_7,,,,26658999,PMC4736547,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,127,https://www.altmetric.com/details/6066390,https://api.altmetric.com/v1/donut/6066390_240.png 0,SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.6398,,,,26624980,PMC4792542,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6066389,https://api.altmetric.com/v1/donut/6066389_240.png 0,Matrilysin/Matrix Metalloproteinase-7(MMP7) Cleavage of Perlecan/HSPG2 Creates A Molecular Switch to Alter Prostate Cancer Cell Behavior.,Matrix Biology,,,Article,2014-05-11,10.1016/j.matbio.2014.04.005,,,,24833109,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6066382,https://api.altmetric.com/v1/donut/6066382_240.png 0,TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition.,Neoplasia,,,Article,2013-09-14,,,,,24027431,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6066302,https://api.altmetric.com/v1/donut/6066302_240.png 0,"Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.",Journal of Cellular Biochemistry,,,Article,2013-11-15,10.1002/jcb.24592,,,,23696192,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6066300,https://api.altmetric.com/v1/donut/6066300_240.png 0,Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.,The Prostate,,,Article,2011-05-14,10.1002/pros.21277,,,,20957670,PMC3025080,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6066297,https://api.altmetric.com/v1/donut/6066297_240.png 0,"ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.",,,,Article,,,,,,21282737,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6066296,https://api.altmetric.com/v1/donut/6066296_240.png 0,Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis.,Journal of Bone & Mineral Research,,,Article,2011-01-15,10.1002/jbmr.204,,,,20684002,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6066294,https://api.altmetric.com/v1/donut/6066294_240.png 0,Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.,Oncogene,,,Article,2010-02-11,10.1038/onc.2009.389,,,,19915614,PMC2820596,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/6066293,https://api.altmetric.com/v1/donut/6066293_240.png 0,p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.,Cancer Research,,,Article,2010-12-01,10.1158/0008-5472.can-10-0440,,,,21098705,PMC3059079,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6066292,https://api.altmetric.com/v1/donut/6066292_240.png 0,Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.,JNCI: Journal of the National Cancer Institute,,,Article,2010-04-20,10.1093/jnci/djq044,,,,20233997,PMC2857800,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52,https://www.altmetric.com/details/6066291,https://api.altmetric.com/v1/donut/6066291_240.png 0,CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.,Cytokine & Growth Factor Reviews,,,Article,2010-02-15,10.1016/j.cytogfr.2009.11.009,,,,20005149,PMC2857769,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/6066286,https://api.altmetric.com/v1/donut/6066286_240.png 0,Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression.,Cancer Research,,,Article,2010-01-15,10.1158/0008-5472.can-09-2863,,,,20068185,PMC3086494,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6066285,https://api.altmetric.com/v1/donut/6066285_240.png 0,Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.,The Prostate,,,Article,2009-07-31,10.1002/pros.20975,,,,19434660,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6066282,https://api.altmetric.com/v1/donut/6066282_240.png 0,Understanding and targeting osteoclastic activity in prostate cancer bone metastases.,Current Molecular Medicine,,,Article,2013-05-14,,,,,23061677,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6066279,https://api.altmetric.com/v1/donut/6066279_240.png 0,Prostate cancer stem cell biology.,Minerva Urologica E Nefrologica,,,Article,2012-03-15,,,,,22402315,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6066277,https://api.altmetric.com/v1/donut/6066277_240.png 0,Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.,Neoplasia,,,Article,2012-05-14,,,,,22745589,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6066275,https://api.altmetric.com/v1/donut/6066275_240.png 0,Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine.,Neoplasia,,,Article,2012-01-15,,,,,22355275,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6066274,https://api.altmetric.com/v1/donut/6066274_240.png 0,Prostate cancer and parasitism of the bone hematopoietic stem cell niche.,Critical Reviews? in Eukaryotic Gene Expression,,,Article,,,,,,22856431,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6066269,https://api.altmetric.com/v1/donut/6066269_240.png 0,Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.,Endocrine-Related Cancer,,,Article,2012-06-14,10.1530/erc-11-0278,,,,22291434,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6066265,https://api.altmetric.com/v1/donut/6066265_240.png 0,Development of a brain metastatic canine prostate cancer cell line.,The Prostate,,,Article,2011-09-14,10.1002/pros.21341,,,,21321976,PMC3139788,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6066264,https://api.altmetric.com/v1/donut/6066264_240.png 0,"CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.",Neoplasia,,,Article,2009-12-15,,,,,20019839,PMC2794512,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6066261,https://api.altmetric.com/v1/donut/6066261_240.png 0,EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.,The Prostate,,,Article,2009-03-31,10.1002/pros.20903,,,,19143022,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6066260,https://api.altmetric.com/v1/donut/6066260_240.png 0,Possible mechanism of CCL2-induced Akt activation in prostate cancer cells.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2009-08-14,,,,,19661323,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6066259,https://api.altmetric.com/v1/donut/6066259_240.png 0,A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.,Cancer Research,,,Article,2009-02-15,10.1158/0008-5472.can-08-2164,,,,19176388,PMC2698812,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6066258,https://api.altmetric.com/v1/donut/6066258_240.png 0,Expression of PGK1 by prostate cancer cells induces bone formation.,Molecular Cancer Research,,,Article,2009-10-14,10.1158/1541-7786.mcr-09-0072,,,,19825988,PMC2771860,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6066257,https://api.altmetric.com/v1/donut/6066257_240.png 0,Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts.,Journal of Cellular Biochemistry,,,Article,2009-03-01,10.1002/jcb.22021,,,,19170075,PMC2776620,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6066253,https://api.altmetric.com/v1/donut/6066253_240.png 0,The Role of Osteoclasts in Early Dissemination of Prostate Cancer Tumor Cells.,Journal of cancer stem cell research,,,Article,2015-01-01,,,,,26097863,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6066252,https://api.altmetric.com/v1/donut/6066252_240.png 0,Parathyroid Hormone-related Protein Drives a CD11b+Gr1+ cell-mediated Positive Feedback Loop to Support Prostate Cancer Growth.,Cancer Research,,,Article,2013-09-25,10.1158/0008-5472.can-12-4692,,,,24072746,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6066249,https://api.altmetric.com/v1/donut/6066249_240.png 0,Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques.,Academic Radiology,,,Article,2010-05-14,10.1016/j.acra.2010.01.003,,,,20188602,PMC2854219,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6066220,https://api.altmetric.com/v1/donut/6066220_240.png 0,Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-07-14,10.1007/s00259-013-2382-2,,,,23503575,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6066209,https://api.altmetric.com/v1/donut/6066209_240.png 0,The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer.,Hormones and Cancer,,,Article,2014-05-05,10.1007/s12672-014-0177-y,,,,24798453,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6066189,https://api.altmetric.com/v1/donut/6066189_240.png 0,Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.,Cancer Letters,,,Article,2014-07-02,10.1016/j.canlet.2014.06.014,,,,24998678,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6066186,https://api.altmetric.com/v1/donut/6066186_240.png 0,Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis.,Oncotarget,,,Article,2014-03-16,10.18632/oncotarget.1817,,,,24657880,PMC4012739,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6066185,https://api.altmetric.com/v1/donut/6066185_240.png 0,Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.,American Journal of Pathology,,,Article,2011-07-14,10.1016/j.ajpath.2011.03.028,,,,21703419,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6066184,https://api.altmetric.com/v1/donut/6066184_240.png 0,Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical setting.,Methods in molecular biology,,,Article,2011-01-01,10.1007/978-1-61779-243-4_17,,,,21796533,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6066183,https://api.altmetric.com/v1/donut/6066183_240.png 0,Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.,Experimental Cell Research,,,Article,2010-05-14,10.1016/j.yexcr.2010.03.007,,,,20338164,PMC2873092,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6066182,https://api.altmetric.com/v1/donut/6066182_240.png 0,The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.,The Prostate,,,Article,2010-03-01,10.1002/pros.21075,,,,19866469,PMC2929015,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6066181,https://api.altmetric.com/v1/donut/6066181_240.png 0,CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.,Modern Pathology,,,Article,2010-10-14,10.1038/modpathol.2010.122,,,,20562849,PMC2948633,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6066180,https://api.altmetric.com/v1/donut/6066180_240.png 0,Expression of cancer/testis antigens in prostate cancer is associated with disease progression.,The Prostate,,,Article,,10.1002/pros.21214,,,,20583133,PMC4403006,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6066179,https://api.altmetric.com/v1/donut/6066179_240.png 0,Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells.,Molecular & Cellular Endocrinology,,,Article,2010-07-28,10.1016/j.mce.2010.04.017,,,,20417685,PMC2896981,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6066178,https://api.altmetric.com/v1/donut/6066178_240.png 0,Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1.,International Journal of Cancer,,,Article,2010-02-01,10.1002/ijc.24904,,,,19795418,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6066177,https://api.altmetric.com/v1/donut/6066177_240.png 0,Molecular assays for the detection of microRNAs in prostate cancer.,,,,Article,2009-03-06,10.1186/1476-4598-8-17,,,,19267923,PMC2656451,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,48,https://www.altmetric.com/details/6066176,https://api.altmetric.com/v1/donut/6066176_240.png 0,Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.,The Prostate,,,Article,2013-06-14,10.1002/pros.22639,,,,23334979,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6066175,https://api.altmetric.com/v1/donut/6066175_240.png 0,"A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors.",,,,Article,2013-09-29,10.1371/journal.pone.0074671,,,,24098661,PMC3787014,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6066174,https://api.altmetric.com/v1/donut/6066174_240.png 0,Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration resistant prostate cancer: results from the University of Washington rapid autopsy series.,Journal of Bone & Mineral Research,,,Article,2013-02-15,10.1002/jbmr.1749,,,,22936276,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6066173,https://api.altmetric.com/v1/donut/6066173_240.png 0,AR Variant AR(v567es) Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer.,Neoplasia,,,Article,2013-09-14,,,,,24027426,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6066172,https://api.altmetric.com/v1/donut/6066172_240.png 0,A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.,Cancer Genetics,,,Article,,10.1016/j.cancergen.2012.12.004,,,,23352841,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6066171,https://api.altmetric.com/v1/donut/6066171_240.png 0,Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia.,,,,Article,,10.1371/journal.pone.0069239,,,,23935962,PMC3728349,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6066170,https://api.altmetric.com/v1/donut/6066170_240.png 0,Integrin alpha(2)beta (1) (? (2)? (1)) promotes prostate cancer skeletal metastasis.,Clinical and Experimental Metastasis,,,Article,2013-06-14,10.1007/s10585-012-9561-6,,,,23242739,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6066169,https://api.altmetric.com/v1/donut/6066169_240.png 0,New hormonal therapies for castration-resistant prostate cancer.,Endocrinology and metabolism clinics of North America (Print),,,Article,2011-09-14,10.1016/j.ecl.2011.05.013,,,,21889725,PMC3167094,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6066167,https://api.altmetric.com/v1/donut/6066167_240.png 0,Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.,Neoplasia,,,Article,2010-02-15,,,,,20126477,PMC2814357,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6066166,https://api.altmetric.com/v1/donut/6066166_240.png 0,Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.,Cancer Research,,,Article,2009-09-30,10.1158/0008-5472.can-08-3810,,,,19773449,PMC2771763,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6066163,https://api.altmetric.com/v1/donut/6066163_240.png 0,Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.,Current Cancer Drug Targets,,,Article,2009-03-15,,,,,19275762,PMC2921605,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/6066161,https://api.altmetric.com/v1/donut/6066161_240.png 0,"Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.",BMC Cancer,,,Article,2009-12-18,10.1186/1471-2407-9-452,,,,20021671,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6066160,https://api.altmetric.com/v1/donut/6066160_240.png 0,Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.,The Prostate,,,Article,2009-05-14,10.1002/pros.20920,,,,19170048,PMC2720055,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6066159,https://api.altmetric.com/v1/donut/6066159_240.png 0,Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition.,Clinical Cancer Research,,,Article,2009-12-15,10.1158/1078-0432.ccr-09-0264,,,,19996218,PMC2795132,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6066158,https://api.altmetric.com/v1/donut/6066158_240.png 0,Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.,Cancer Research,,,Article,2009-06-30,10.1158/0008-5472.can-08-3860,,,,19549916,PMC2853876,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77,https://www.altmetric.com/details/6066157,https://api.altmetric.com/v1/donut/6066157_240.png 0,The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.,The Prostate,,,Article,2013-11-19,10.1002/pros.22752,,,,24249383,,10197/7434,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6066156,https://api.altmetric.com/v1/donut/6066156_240.png 0,PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer.,Clinical and Experimental Metastasis,,,Article,2013-10-25,10.1007/s10585-013-9620-7,,,,24162257,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6066155,https://api.altmetric.com/v1/donut/6066155_240.png 0,Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature.,Cancer Research,,,Article,2011-03-01,10.1158/0008-5472.can-10-3674,,,,21343392,PMC3076642,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6065919,https://api.altmetric.com/v1/donut/6065919_240.png 0,"Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort.",Cancer Causes and Control,,,Article,2009-09-14,10.1007/s10552-009-9304-4,,,,19212706,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6065868,https://api.altmetric.com/v1/donut/6065868_240.png 0,Radium-223 in metastatic castration resistant prostate cancer.,Asian Journal of Andrology,,,Article,2014-03-28,10.4103/1008-682x.127812,,,,24713838,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6065682,https://api.altmetric.com/v1/donut/6065682_240.png 0,Enzalutamide for the treatment of prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2013-04-14,10.1517/14656566.2013.775251,,,,23441761,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6065675,https://api.altmetric.com/v1/donut/6065675_240.png 0,Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer.,Clinical Genitourinary Cancer,,,Article,2012-12-15,10.1016/j.clgc.2012.03.007,,,,22575202,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6065665,https://api.altmetric.com/v1/donut/6065665_240.png 0,Current paradigms and Evolving concepts in metastatic castration-resistant prostate cancer.,Asian Journal of Andrology,,,Article,2011-09-14,10.1038/aja.2011.35,,,,21602834,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6065663,https://api.altmetric.com/v1/donut/6065663_240.png 0,New therapies for castrate-resistant prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2011-09-14,10.1517/14656566.2011.590133,,,,21663529,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6065661,https://api.altmetric.com/v1/donut/6065661_240.png 0,Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.,Diagnostic and Interventional Radiology,,,Article,2014-04-29,10.5152/dir.2014.13319,,,,24808435,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6065615,https://api.altmetric.com/v1/donut/6065615_240.png 0,Controversies surrounding lymph node dissection for prostate cancer.,Urologic Clinics of North America,,,Article,2010-02-15,10.1016/j.ucl.2009.11.002,,,,20152520,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6065605,https://api.altmetric.com/v1/donut/6065605_240.png 0,Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology.,Journal of Magnetic Resonance Imaging,,,Article,2013-11-15,10.1002/jmri.24317,,,,24243824,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6065571,https://api.altmetric.com/v1/donut/6065571_240.png 0,"Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer.",Biomarkers in Medicine,,,Article,2013-12-15,10.2217/bmm.13.112,,,,24266816,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6065513,https://api.altmetric.com/v1/donut/6065513_240.png 0,Multimodal microscopy for automated histologic analysis of prostate cancer.,,,,Article,2011-02-09,10.1186/1471-2407-11-62,,,,21303560,PMC3045985,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,61,https://www.altmetric.com/details/6065411,https://api.altmetric.com/v1/donut/6065411_240.png 0,The role of secreted frizzled-related protein 2 expression in prostate cancer.,Histopathology,,,Article,2011-12-15,10.1111/j.1365-2559.2011.04073.x,,,,22175903,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6065380,https://api.altmetric.com/v1/donut/6065380_240.png 0,Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer.,,,,Article,,,,,,21969236,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6065284,https://api.altmetric.com/v1/donut/6065284_240.png 0,VEGF inhibitors and prostate cancer therapy.,Current Molecular Pharmacology,,,Article,2009-06-14,,,,,19617926,PMC2711630,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6065196,https://api.altmetric.com/v1/donut/6065196_240.png 0,A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.,American Journal of Roentgenology,,,Article,,10.2214/ajr.14.13009,,,,26102381,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6065194,https://api.altmetric.com/v1/donut/6065194_240.png 0,Angiogenesis inhibitors in the treatment of prostate cancer.,Chemical immunology,,,Article,,10.1159/000353255,,,,24217611,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6065193,https://api.altmetric.com/v1/donut/6065193_240.png 0,"Hepcidin, anaemia, and prostate cancer.",BJU International,,,Article,2011-02-15,10.1111/j.1464-410x.2011.10108.x,,,,21276178,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6065192,https://api.altmetric.com/v1/donut/6065192_240.png 0,Cabazitaxel: a new drug for metastatic prostate cancer.,Asian Journal of Andrology,,,Article,2011-03-15,10.1038/aja.2010.161,,,,21151153,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6065191,https://api.altmetric.com/v1/donut/6065191_240.png 0,Tumor angiogenesis as an early marker of long-term prostate cancer mortality.,Future Oncology,,,Article,2010-03-15,10.2217/fon.09.177,,,,20222790,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6065190,https://api.altmetric.com/v1/donut/6065190_240.png 0,Angiogenesis inhibition in prostate cancer: current uses and future promises.,Journal of Oncology,,,Article,,10.1155/2010/361836,,,,20169138,PMC2821752,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6065189,https://api.altmetric.com/v1/donut/6065189_240.png 0,Novel Androgen Deprivation Therapy (ADT) in the Treatment of Advanced Prostate Cancer.,,,,Article,2010-06-30,10.1016/j.ddstr.2011.02.004,,,,21922023,PMC3172154,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6065188,https://api.altmetric.com/v1/donut/6065188_240.png 0,About tyrosine kinase inhibitors (TKIs) in prostate cancer: where do we go from here?,Annals of Oncology,,,Article,2010-01-15,10.1093/annonc/mdp467,,,,19903718,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6065187,https://api.altmetric.com/v1/donut/6065187_240.png 0,Revisiting the ultimate target of treatment for prostate cancer.,The Lancet,,,Article,2010-04-23,10.1016/s0140-6736(10)60400-x,,,,20398924,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6065186,https://api.altmetric.com/v1/donut/6065186_240.png 0,Angiogenesis inhibitors in the treatment of prostate cancer.,Expert Opinion on Pharmacotherapy,,,Article,2010-02-15,10.1517/14656560903451716,,,,20088745,PMC2811534,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6065036,https://api.altmetric.com/v1/donut/6065036_240.png 0,Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.,The Prostate,,,Article,2009-01-01,10.1002/pros.20856,,,,18942092,PMC2597150,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6065020,https://api.altmetric.com/v1/donut/6065020_240.png 0,Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study.,Cancer Research,,,Article,2011-04-30,10.1158/0008-5472.can-10-2646,,,,21372204,PMC3085580,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6064893,https://api.altmetric.com/v1/donut/6064893_240.png 0,Alcoholic beverages and prostate cancer in a prospective US cohort study.,American Journal of Epidemiology,,,Article,2010-09-30,10.1093/aje/kwq200,,,,20813803,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6064849,https://api.altmetric.com/v1/donut/6064849_240.png 0,Cigarette smoking and prostate cancer in a prospective US cohort study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-09-14,10.1158/1055-9965.epi-09-0252,,,,19706848,PMC2742569,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6064847,https://api.altmetric.com/v1/donut/6064847_240.png 0,Age-specific physical activity and prostate cancer risk among white men and black men.,Cancer (0008543X),,,Article,2009-11-01,10.1002/cncr.24538,,,,19645029,PMC2767425,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6064841,https://api.altmetric.com/v1/donut/6064841_240.png 0,Adipokine genes and prostate cancer risk.,International Journal of Cancer,,,Article,2009-02-15,10.1002/ijc.24043,,,,19035456,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6064831,https://api.altmetric.com/v1/donut/6064831_240.png 0,Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk.,Cancer Research,,,Article,2009-02-15,10.1158/0008-5472.can-08-2343,,,,19190344,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6064829,https://api.altmetric.com/v1/donut/6064829_240.png 0,Serum creatinine and prostate cancer risk in a prospective study.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-10-14,10.1158/1055-9965.epi-09-0322,,,,19755655,PMC2759851,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6064824,https://api.altmetric.com/v1/donut/6064824_240.png 0,Association of serum ?-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk.,Cancer Causes and Control,,,Article,2011-06-14,10.1007/s10552-011-9753-4,,,,21424597,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6064817,https://api.altmetric.com/v1/donut/6064817_240.png 0,"Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.",JNCI: Journal of the National Cancer Institute,,,Article,2009-09-15,10.1093/jnci/djp260,,,,19700655,PMC2744728,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6064800,https://api.altmetric.com/v1/donut/6064800_240.png 0,"The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.",Aging Cell,,,Article,2009-08-14,10.1111/j.1474-9726.2009.00485.x,,,,19493248,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/6064787,https://api.altmetric.com/v1/donut/6064787_240.png 0,What are the consequences if i postpone treatment of my PSA-detected prostate cancer?,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-05-14,10.1158/1055-9965.epi-11-0057,,,,21546364,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6064703,https://api.altmetric.com/v1/donut/6064703_240.png 0,Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.,Cancer Prevention Research,,,Article,2010-03-15,10.1158/1940-6207.capr-09-0188,,,,20179296,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6064685,https://api.altmetric.com/v1/donut/6064685_240.png 0,Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men.,The Prostate,,,Article,2010-03-01,10.1002/pros.21076,,,,19866473,PMC3078699,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6064684,https://api.altmetric.com/v1/donut/6064684_240.png 0,Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.,Cancer Prevention Research,,,Article,2010-04-14,10.1158/1940-6207.capr-09-0201,,,,20332306,PMC2853720,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6064683,https://api.altmetric.com/v1/donut/6064683_240.png 0,Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.,International Journal of Cancer,,,Article,2009-04-30,10.1002/ijc.24144,,,,19117055,PMC2682694,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6064681,https://api.altmetric.com/v1/donut/6064681_240.png 0,High prevalence of screen-detected prostate cancer in West Africans: implications for racial disparity of prostate cancer.,The Journal of Urology,,,Article,2014-04-16,10.1016/j.juro.2014.04.017,,,,24747091,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6064680,https://api.altmetric.com/v1/donut/6064680_240.png 0,DNA damage phenotype and prostate cancer risk.,Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,,,Article,2011-02-03,10.1016/j.mrgentox.2010.11.005,,,,21095241,PMC3038618,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6064679,https://api.altmetric.com/v1/donut/6064679_240.png 0,Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men.,Cancer Science,,,Article,2011-10-14,10.1111/j.1349-7006.2011.02036.x,,,,21756274,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6064678,https://api.altmetric.com/v1/donut/6064678_240.png 0,"Energy intake and risk of postmenopausal breast cancer: an expanded analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-11-15,10.1158/1055-9965.epi-09-0087,,,,19843674,PMC2783562,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6064642,https://api.altmetric.com/v1/donut/6064642_240.png 0,"Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.",Cancer Research,,,Article,2009-02-15,10.1158/0008-5472.can-08-2694,,,,19208842,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6064610,https://api.altmetric.com/v1/donut/6064610_240.png 0,Nitric oxide synthase gene polymorphisms and prostate cancer risk.,Carcinogenesis,,,Article,2009-04-14,10.1093/carcin/bgp028,,,,19168583,PMC2664454,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6064608,https://api.altmetric.com/v1/donut/6064608_240.png 0,"Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.",Cancer Research,,,Article,2009-03-01,10.1158/0008-5472.can-08-2447,,,,19223546,PMC2662592,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6064607,https://api.altmetric.com/v1/donut/6064607_240.png 0,"A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.",Carcinogenesis,,,Article,2014-01-07,10.1093/carcin/bgt495,,,,24398668,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6064604,https://api.altmetric.com/v1/donut/6064604_240.png 0,"Circulating adipokine levels and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-07-14,10.1158/1055-9965.epi-13-0258,,,,23696194,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6064602,https://api.altmetric.com/v1/donut/6064602_240.png 0,"Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.",Gynecologic Oncology,,,Article,2011-03-15,10.1016/j.ygyno.2010.11.015,,,,21144559,PMC3040283,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6064599,https://api.altmetric.com/v1/donut/6064599_240.png 0,"Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.",Cancer Causes and Control,,,Article,2011-07-14,10.1007/s10552-011-9772-1,,,,21553078,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6064598,https://api.altmetric.com/v1/donut/6064598_240.png 0,"Intra-individual variability over time in serum cytokine levels among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",Cytokine,,,Article,2011-11-15,10.1016/j.cyto.2011.06.012,,,,21764327,PMC3185107,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6064596,https://api.altmetric.com/v1/donut/6064596_240.png 0,"Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",,,,Article,,10.1371/journal.pone.0021731,,,,21750727,PMC3131287,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6064595,https://api.altmetric.com/v1/donut/6064595_240.png 0,Large-scale fine mapping of the HNF1B locus and prostate cancer risk.,Human Molecular Genetics,,,Article,2011-08-14,10.1093/hmg/ddr213,,,,21576123,PMC3140817,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6064594,https://api.altmetric.com/v1/donut/6064594_240.png 0,"Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-04-14,10.1158/1055-9965.epi-09-1121,,,,20332255,PMC2857993,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6064593,https://api.altmetric.com/v1/donut/6064593_240.png 0,"Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.",American Journal of Gastroenterology,,,Article,2010-12-15,10.1038/ajg.2010.349,,,,20808298,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6064592,https://api.altmetric.com/v1/donut/6064592_240.png 0,Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.,Cancer Research,,,Article,2010-03-15,10.1158/0008-5472.can-09-3575,,,,20197460,PMC2840184,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6064591,https://api.altmetric.com/v1/donut/6064591_240.png 0,"HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.",The Prostate,,,Article,2010-04-30,10.1002/pros.21094,,,,19998368,PMC3086139,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6064590,https://api.altmetric.com/v1/donut/6064590_240.png 0,Reduced risk of prostate cancer in U.S. Men with AIDS.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-11-15,10.1158/1055-9965.epi-10-0741,,,,20837717,PMC2976800,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6064562,https://api.altmetric.com/v1/donut/6064562_240.png 0,"Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial.",Cancer Prevention Research,,,Article,2011-09-14,10.1158/1940-6207.capr-11-0103,,,,21685236,PMC3168068,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6064394,https://api.altmetric.com/v1/donut/6064394_240.png 0,"Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.",British Journal of Cancer,,,Article,2009-07-06,10.1038/sj.bjc.6605118,,,,19513076,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6064391,https://api.altmetric.com/v1/donut/6064391_240.png 0,"Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2010-02-15,10.1158/1055-9965.epi-09-1080,,,,20142255,PMC2820385,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6064379,https://api.altmetric.com/v1/donut/6064379_240.png 0,"Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.",Cancer (0008543X),,,Article,2012-01-01,10.1002/cncr.26241,,,,21717433,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/6064235,https://api.altmetric.com/v1/donut/6064235_240.png 0,Prediagnostic Serum Organochlorine Concentrations and Metastatic Prostate Cancer: A Nested Case-Control Study in the Norwegian Janus Serum Bank Cohort.,Environmental Health Perspectives,,,Article,2015-03-03,10.1289/ehp.1408245,,,,25734605,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6064172,https://api.altmetric.com/v1/donut/6064172_240.png 0,"Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk.",Environmental Health Perspectives,,,Article,2011-12-15,10.1289/ehp.1103454,,,,21810555,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6064135,https://api.altmetric.com/v1/donut/6064135_240.png 0,Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer.,Cancer Research,,,Article,,10.1158/0008-5472.can-10-1078,,,,20978189,PMC2982856,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6064127,https://api.altmetric.com/v1/donut/6064127_240.png 0,Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells.,Cancer Gene Therapy,,,Article,2009-05-14,10.1038/cgt.2008.96,,,,19096446,PMC2857530,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6064020,https://api.altmetric.com/v1/donut/6064020_240.png 0,Lymph node staging in prostate cancer.,Current Urology Reports,,,Article,2015-05-15,10.1007/s11934-015-0505-y,,,,25773350,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6063734,https://api.altmetric.com/v1/donut/6063734_240.png 0,Comprehensive microRNA Profiling of Prostate Cancer.,,,,Article,,10.7150/jca.6394,,,,23781281,PMC3677622,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,64,https://www.altmetric.com/details/6063726,https://api.altmetric.com/v1/donut/6063726_240.png 0,Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer.,Pharmaceutical Development & Technology,,,Article,2014-11-07,10.3109/10837450.2014.979946,,,,25380396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6063557,https://api.altmetric.com/v1/donut/6063557_240.png 0,Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.,"Cancer Immunology, Immunotherapy",,,Article,2010-12-15,10.1007/s00262-010-0897-y,,,,20734041,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6063398,https://api.altmetric.com/v1/donut/6063398_240.png 0,Defining Molecular Signature of Pro-Immunogenic Radiotherapy Targets in Human Prostate Cancer Cells.,Radiation Research,,,Article,2014-07-07,10.1667/rr13731.1,,,,25003313,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6063378,https://api.altmetric.com/v1/donut/6063378_240.png 0,Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.,Asian Journal of Andrology,,,Article,2011-09-14,10.1038/aja.2011.78,,,,21685924,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6063375,https://api.altmetric.com/v1/donut/6063375_240.png 0,Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer.,Clinical & Developmental Immunology,,,Article,,10.1155/2009/363914,,,,20224813,PMC2834955,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6063372,https://api.altmetric.com/v1/donut/6063372_240.png 0,An update on androgen deprivation therapy for prostate cancer.,Endocrine-Related Cancer,,,Article,2010-12-15,10.1677/erc-10-0187,,,,20861285,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6063353,https://api.altmetric.com/v1/donut/6063353_240.png 0,A poxviral-based cancer vaccine targeting the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.4442,,,,26317648,PMC4695054,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6063347,https://api.altmetric.com/v1/donut/6063347_240.png 0,PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo.,Cancer Biology and Therapy,,,Article,2009-01-15,,,,,19029835,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6063343,https://api.altmetric.com/v1/donut/6063343_240.png 0,BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.,Molecular Cancer Research,,,Article,2011-08-14,10.1158/1541-7786.mcr-11-0155,,,,21700680,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6063194,https://api.altmetric.com/v1/donut/6063194_240.png 0,BRCA1 and p53 regulate critical prostate cancer pathways.,Prostate Cancer & Prostatic Diseases,,,Article,2013-09-14,10.1038/pcan.2013.12,,,,23670255,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6063191,https://api.altmetric.com/v1/donut/6063191_240.png 0,Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model.,Stem Cells,,,Article,2010-12-15,10.1002/stem.538,,,,20936707,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6063059,https://api.altmetric.com/v1/donut/6063059_240.png 0,Critical and reciprocal regulation of KLF4 and SLUG in TGF?-initiated prostate cancer EMT.,Molecular & Cellular Biology,,,Article,2012-03-15,10.1128/mcb.06306-11,,,,22203039,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6063057,https://api.altmetric.com/v1/donut/6063057_240.png 0,Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.,Molecular Cancer,,,Article,,10.1186/1476-4598-9-267,,,,20929579,PMC2958982,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6063032,https://api.altmetric.com/v1/donut/6063032_240.png 0,Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.,Clinical and Experimental Metastasis,,,Article,2009-02-17,10.1007/s10585-009-9242-2,,,,19221883,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6063030,https://api.altmetric.com/v1/donut/6063030_240.png 0,Targeting prostate cancer stem cells.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2009-12-15,,,,,19925394,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6063027,https://api.altmetric.com/v1/donut/6063027_240.png 0,Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells.,Molecular Biology Reports,,,Article,2011-10-14,10.1007/s11033-010-0442-2,,,,21755295,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6062779,https://api.altmetric.com/v1/donut/6062779_240.png 0,Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment.,Clinical Cancer Research,,,Article,2010-01-01,10.1158/1078-0432.ccr-09-0982,,,,20028742,PMC2802676,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6062705,https://api.altmetric.com/v1/donut/6062705_240.png 0,Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-?B and CHOP expression.,Cellular Signalling,,,Article,2011-05-14,10.1016/j.cellsig.2011.01.010,,,,21276850,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6062667,https://api.altmetric.com/v1/donut/6062667_240.png 0,Fractionated Radiation Alters Oncomir and Tumor Suppressor miRNAs in Human Prostate Cancer Cells.,Radiation Research,,,Article,2012-09-14,,,,,22827214,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6062639,https://api.altmetric.com/v1/donut/6062639_240.png 0,Improving PET spatial resolution and detectability for prostate cancer imaging.,Physics in Medicine & Biology,,,Article,2014-07-21,10.1088/0031-9155/59/15/4411,,,,25049221,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6062631,https://api.altmetric.com/v1/donut/6062631_240.png 0,Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer.,Journal of the National Comprehensive Cancer Network (JNCCN),,,Article,2012-12-01,,,,,23221788,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6062630,https://api.altmetric.com/v1/donut/6062630_240.png 0,From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer.,Expert Review of Vaccines,,,Article,2011-06-14,10.1586/erv.11.70,,,,21692697,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6062629,https://api.altmetric.com/v1/donut/6062629_240.png 0,Prostate cancer immunotherapy.,Clinical Cancer Research,,,Article,2011-08-14,10.1158/1078-0432.ccr-10-3402,,,,21700764,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6062626,https://api.altmetric.com/v1/donut/6062626_240.png 0,The current and emerging role of immunotherapy in prostate cancer.,Clinical Genitourinary Cancer,,,Article,2010-12-01,10.3816/cgc.2010.n.002,,,,21208850,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6062625,https://api.altmetric.com/v1/donut/6062625_240.png 0,Current perspectives in prostate cancer vaccines.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2009-12-15,,,,,19719454,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6062624,https://api.altmetric.com/v1/donut/6062624_240.png 0,Promising novel immunotherapies and combinations for prostate cancer.,Future Oncology,,,Article,2009-03-15,10.2217/14796694.5.2.187,,,,19284377,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6062623,https://api.altmetric.com/v1/donut/6062623_240.png 0,Cancer vaccines: current directions and perspectives in prostate cancer.,Current Opinion in Molecular Therapeutics,,,Article,2009-02-15,,,,,19169957,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6062622,https://api.altmetric.com/v1/donut/6062622_240.png 0,Ipilimumab in prostate cancer.,Expert Opinion on Biological Therapy,,,Article,2013-02-15,10.1517/14712598.2012.754421,,,,23265575,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6062618,https://api.altmetric.com/v1/donut/6062618_240.png 0,Sipuleucel-T: harbinger of a new age of therapeutics for prostate cancer.,Expert Review of Vaccines,,,Article,2011-02-15,10.1586/erv.10.173,,,,21332262,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6062614,https://api.altmetric.com/v1/donut/6062614_240.png 0,Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer.,Immunotherapy,,,Article,2011-01-15,10.2217/imt.10.77,,,,21174555,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6062613,https://api.altmetric.com/v1/donut/6062613_240.png 0,Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer.,Expert Opinion on Investigational Drugs,,,Article,2009-07-14,10.1517/13543780902997928,,,,19548854,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6062600,https://api.altmetric.com/v1/donut/6062600_240.png 0,Intravoxel incoherent motion MR imaging for prostate cancer: An evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations.,Magnetic Resonance in Medicine,,,Article,2013-02-15,10.1002/mrm.24277,,,,22488794,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,83,https://www.altmetric.com/details/6062561,https://api.altmetric.com/v1/donut/6062561_240.png 0,Use of Patient-specific MRI-based Prostate Mold for Validation of Multiparametric MRI in Localization of Prostate Cancer.,Urology,,,Article,2012-01-15,10.1016/j.urology.2011.10.002,,,,22202553,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6062559,https://api.altmetric.com/v1/donut/6062559_240.png 0,Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.,Cancer Imaging,,,Article,2011-03-28,10.1102/1470-7330.2011.0007,,,,21450548,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6062556,https://api.altmetric.com/v1/donut/6062556_240.png 0,Identification of EpCAM as a molecular target of prostate cancer stroma.,American Journal of Pathology,,,Article,2009-12-15,10.2353/ajpath.2009.090013,,,,19850885,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6062553,https://api.altmetric.com/v1/donut/6062553_240.png 0,Imaging localized prostate cancer: current approaches and new developments.,American Journal of Roentgenology,,,Article,2009-06-14,10.2214/ajr.09.2527,,,,19457807,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6062552,https://api.altmetric.com/v1/donut/6062552_240.png 0,New horizons in prostate cancer imaging.,European Journal of Radiology,,,Article,,10.1016/j.ejrad.2008.09.019,,,,18993004,PMC2702141,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6062550,https://api.altmetric.com/v1/donut/6062550_240.png 0,Imaging techniques for prostate cancer: implications for focal therapy.,Nature Reviews Urology,,,Article,2009-04-14,10.1038/nrurol.2009.27,,,,19352394,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6062549,https://api.altmetric.com/v1/donut/6062549_240.png 0,The role of MRI in active surveillance for prostate cancer.,Current Urology Reports,,,Article,,10.1007/s11934-015-0507-9,,,,26017850,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6062548,https://api.altmetric.com/v1/donut/6062548_240.png 0,Functional MRI in Prostate Cancer Detection.,BioMed Research International,,,Article,,10.1155/2014/590638,,,,25215284,PMC4158139,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6062544,https://api.altmetric.com/v1/donut/6062544_240.png 0,Computer Aided-Diagnosis of Prostate Cancer on Multiparametric MRI: A Technical Review of Current Research.,BioMed Research International,,,Article,,10.1155/2014/789561,,,,25525604,PMC4267002,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6062543,https://api.altmetric.com/v1/donut/6062543_240.png 0,The Role of MRI in Prostate Cancer Active Surveillance.,BioMed Research International,,,Article,,10.1155/2014/203906,,,,25525592,PMC4266760,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6062542,https://api.altmetric.com/v1/donut/6062542_240.png 0,Functional and molecular imaging of localized and recurrent prostate cancer.,European Journal of Nuclear Medicine & Molecular Imaging,,,Article,2013-07-14,10.1007/s00259-013-2419-6,,,,23649462,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6062540,https://api.altmetric.com/v1/donut/6062540_240.png 0,Progress in prostate cancer imaging.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2012.09.008,,,,23218070,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6062536,https://api.altmetric.com/v1/donut/6062536_240.png 0,Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2011-05-31,10.1016/j.ijrobp.2010.06.050,,,,20932672,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6062534,https://api.altmetric.com/v1/donut/6062534_240.png 0,D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.,The Journal of Urology,,,Article,2011-03-15,10.1016/j.juro.2010.10.076,,,,21239006,PMC3169005,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/6062533,https://api.altmetric.com/v1/donut/6062533_240.png 0,Accelerated T2 mapping for characterization of prostate cancer.,Magnetic Resonance in Medicine,,,Article,2011-05-14,10.1002/mrm.22874,,,,21394778,PMC3079019,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6062532,https://api.altmetric.com/v1/donut/6062532_240.png 0,Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.,Future Oncology,,,Article,2010-12-15,10.2217/fon.10.149,,,,21142863,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6062470,https://api.altmetric.com/v1/donut/6062470_240.png 0,A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.,Pharmacogenomics Journal,,,Article,2010-06-14,10.1038/tpj.2009.57,,,,20038957,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/6062467,https://api.altmetric.com/v1/donut/6062467_240.png 0,Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer.,Cancer Research,,,Article,2010-11-01,10.1158/0008-5472.can-10-1435,,,,20959486,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6062395,https://api.altmetric.com/v1/donut/6062395_240.png 0,Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.,"Cancer Immunology, Immunotherapy",,,Article,,10.1007/s00262-010-0927-9,,,,20976449,PMC3202216,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6062385,https://api.altmetric.com/v1/donut/6062385_240.png 0,Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.,Cancer Prevention Research,,,Article,2010-12-15,10.1158/1940-6207.capr-09-0256,,,,21149329,PMC3058741,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6062328,https://api.altmetric.com/v1/donut/6062328_240.png 0,A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer.,The Journal of Urology,,,Article,2010-06-14,10.1016/j.juro.2010.02.020,,,,20399458,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6062326,https://api.altmetric.com/v1/donut/6062326_240.png 0,Urine analysis and protein networking identify met as a marker of metastatic prostate cancer.,Clinical Cancer Research,,,Article,2009-06-30,10.1158/1078-0432.ccr-09-0599,,,,19549766,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6062325,https://api.altmetric.com/v1/donut/6062325_240.png 0,Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer.,Anti-Cancer Agents in Medicinal Chemistry,,,Article,2009-12-15,,,,,19719457,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6062322,https://api.altmetric.com/v1/donut/6062322_240.png 0,A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.,The Journal of Urology,,,Article,2009-03-15,10.1016/j.juro.2008.11.026,,,,19167733,PMC2838198,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6062321,https://api.altmetric.com/v1/donut/6062321_240.png 0,Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.,British Journal of Urology,,,Article,2009-06-14,10.1111/j.1464-410x.2008.08327.x,,,,19154507,PMC2818665,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6062320,https://api.altmetric.com/v1/donut/6062320_240.png 0,Beyond PSA: Managing Modern Therapeutic Options in Metastatic Castration-Resistant Prostate Cancer.,Southern Medical Journal,,,Article,,10.14423/smj.0000000000000266,,,,25871992,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6062319,https://api.altmetric.com/v1/donut/6062319_240.png 0,Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer.,Urologic Oncology,,,Article,2013-02-20,10.1016/j.urolonc.2012.11.017,,,,23433892,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6062317,https://api.altmetric.com/v1/donut/6062317_240.png 0,Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1alpha/p300 complex in a preclinical model of prostate cancer.,Molecular Cancer,,,Article,2014-04-27,10.1186/1476-4598-13-91,,,,24775564,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6062316,https://api.altmetric.com/v1/donut/6062316_240.png 0,Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity.,Clinical Genitourinary Cancer,,,Article,2013-05-15,10.1016/j.clgc.2013.04.007,,,,23684781,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6062315,https://api.altmetric.com/v1/donut/6062315_240.png 0,Prostate cancer progression attributed to autonomic nerve development: Potential for therapeutic prevention of localized and metastatic disease.,Cancer Biology and Therapy,,,Article,2013-09-03,,,,,24025357,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6062313,https://api.altmetric.com/v1/donut/6062313_240.png 0,Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,22753695,PMC3997992,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6062312,https://api.altmetric.com/v1/donut/6062312_240.png 0,Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures.,Journal of Hematology & Oncology,,,Article,,10.1186/1756-8722-5-35,,,,22747660,PMC3425086,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6062311,https://api.altmetric.com/v1/donut/6062311_240.png 0,More than an accessory: implications of type III transforming growth factor-beta receptor loss in prostate cancer.,British Journal of Urology,,,Article,2010-04-14,10.1111/j.1464-410x.2009.08999.x,,,,20067462,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6062310,https://api.altmetric.com/v1/donut/6062310_240.png 0,Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway.,American journal of therapeutics (Print),,,Article,,10.1097/mjt.0b013e3181c6c0b2,,,,20019584,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6062308,https://api.altmetric.com/v1/donut/6062308_240.png 0,Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer.,,,,Article,2013-02-14,10.1186/1476-4598-12-13,,,,23409773,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6062231,https://api.altmetric.com/v1/donut/6062231_240.png 0,Prostate cancer genomic signature offers prognostic value.,,,,Article,2010-12-01,,,,,21088497,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6062166,https://api.altmetric.com/v1/donut/6062166_240.png 0,Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.,The Journal of Urology,,,Article,2010-12-15,10.1016/j.juro.2010.08.005,,,,20952028,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6062165,https://api.altmetric.com/v1/donut/6062165_240.png 0,Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.,Cancer Causes and Control,,,Article,2011-08-14,10.1007/s10552-011-9787-7,,,,21667068,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6062164,https://api.altmetric.com/v1/donut/6062164_240.png 0,SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.,Journal of Clinical Oncology,,,Article,2011-06-19,10.1200/jco.2010.31.2405,,,,21606417,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6062163,https://api.altmetric.com/v1/donut/6062163_240.png 0,Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.,The Prostate,,,Article,2010-04-30,10.1002/pros.21092,,,,19938041,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6062162,https://api.altmetric.com/v1/donut/6062162_240.png 0,Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2009-11-15,10.1158/1055-9965.epi-09-0472,,,,19887582,PMC2877916,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6062160,https://api.altmetric.com/v1/donut/6062160_240.png 0,A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.,Therapeutics and Clinical Risk Management,,,Article,2010-11-19,10.2147/tcrm.s14303,,,,21151627,PMC2999510,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6062159,https://api.altmetric.com/v1/donut/6062159_240.png 0,Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer.,Cancer Biology and Therapy,,,Article,2010-06-30,,,,,20495366,PMC3040830,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6062157,https://api.altmetric.com/v1/donut/6062157_240.png 0,Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.,BMC Cancer,,,Article,2010-09-26,10.1186/1471-2407-10-511,,,,20875115,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6062156,https://api.altmetric.com/v1/donut/6062156_240.png 0,Genetic variant associated with aggressive not indolent prostate cancer.,Cancer Biology and Therapy,,,Article,,,,,,20581469,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6062155,https://api.altmetric.com/v1/donut/6062155_240.png 0,Androgen receptor sequence and variations in several common prostate cancer cell lines.,Cancer Biology and Therapy,,,Article,2010-03-01,,,,,20061791,PMC2874092,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6062154,https://api.altmetric.com/v1/donut/6062154_240.png 0,"Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study.",International Journal of Cancer,,,Article,2009-08-31,10.1002/ijc.24423,,,,19431146,PMC2838373,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6062153,https://api.altmetric.com/v1/donut/6062153_240.png 0,Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivation.,Cancer Biology and Therapy,,,Article,2014-07-08,,,,,25007053,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6062151,https://api.altmetric.com/v1/donut/6062151_240.png 0,The androgen receptor transcriptional program in castration-resistant prostate cancer: Cell lines vs. tissue samples.,Cancer Biology and Therapy,,,Article,2013-11-19,,,,,24253417,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6062150,https://api.altmetric.com/v1/donut/6062150_240.png 0,Uncovering the genetic landscape driving castration-resistant prostate cancer.,Cancer Biology and Therapy,,,Article,2013-04-30,10.4161/cbt.24426,,,,23917376,PMC3672183,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6062149,https://api.altmetric.com/v1/donut/6062149_240.png 0,"Associations of serum sex steroid hormones and 5?-androstane-3?,17?-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-10-14,10.1158/1055-9965.epi-12-0695,,,,22879203,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6062148,https://api.altmetric.com/v1/donut/6062148_240.png 0,Dihydrotestosterone synthesis from adrenal precursors does not involve testosterone in castration-resistant prostate cancer.,Cancer Biology and Therapy,,,Article,2012-03-15,,,,,22336886,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6062147,https://api.altmetric.com/v1/donut/6062147_240.png 0,"Estrogen receptor ? and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy.",The Journal of Clinical Endocrinology & Metabolism,,,Article,2011-02-15,10.1210/jc.2010-2070,,,,21106711,PMC3048329,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6062145,https://api.altmetric.com/v1/donut/6062145_240.png 0,SLCO transport genes in prostate cancer--letter.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-10-14,10.1158/1055-9965.epi-11-0606,,,,21896883,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6062144,https://api.altmetric.com/v1/donut/6062144_240.png 0,Vaccines as monotherapy and in combination therapy for prostate cancer.,CTS: Clinical & Translational Science,,,Article,2010-06-14,10.1111/j.1752-8062.2010.00186.x,,,,20590682,PMC2914613,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6061986,https://api.altmetric.com/v1/donut/6061986_240.png 0,A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients.,Clinical Cancer Research,,,Article,2010-07-31,10.1158/1078-0432.ccr-10-0948,,,,20562209,PMC2912964,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6061985,https://api.altmetric.com/v1/donut/6061985_240.png 0,Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.,"Genes, Chromosomes, and Cancer",,,Article,2012-10-14,10.1002/gcc.21977,,,,22733720,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6061960,https://api.altmetric.com/v1/donut/6061960_240.png 0,Crystal Structure of Crataeva tapia Bark Protein (CrataBL) and Its Effect in Human Prostate Cancer Cell Lines.,,,,Article,,10.1371/journal.pone.0064426,,,,23823708,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6061872,https://api.altmetric.com/v1/donut/6061872_240.png 0,Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.,Molecular Cancer Therapeutics,,,Article,2010-02-15,10.1158/1535-7163.mct-09-0507,,,,20124455,PMC2820604,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6061603,https://api.altmetric.com/v1/donut/6061603_240.png 0,Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer.,AIDS Review,,,Article,,,,,,20842203,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6061602,https://api.altmetric.com/v1/donut/6061602_240.png 0,"Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.",International Journal of Oncology,,,Article,2010-04-14,,,,,20198346,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6061587,https://api.altmetric.com/v1/donut/6061587_240.png 0,Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2012-04-05,10.1016/j.bbrc.2012.02.158,,,,22425986,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6061582,https://api.altmetric.com/v1/donut/6061582_240.png 0,Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts.,Human Genetics,,,Article,2012-09-14,10.1007/s00439-012-1182-2,,,,22661295,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6061456,https://api.altmetric.com/v1/donut/6061456_240.png 0,New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.,"Cancer Immunology, Immunotherapy",,,Article,2010-01-15,10.1007/s00262-009-0723-6,,,,19495750,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6061263,https://api.altmetric.com/v1/donut/6061263_240.png 0,Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.,The Prostate,,,Article,2010-04-30,10.1002/pros.21097,,,,20058236,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6060948,https://api.altmetric.com/v1/donut/6060948_240.png 0,Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2009-05-11,10.1073/pnas.0902104106,,,,19383797,PMC2671324,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6060826,https://api.altmetric.com/v1/donut/6060826_240.png 0,Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.,Human Genetics,,,Article,2009-12-15,10.1007/s00439-009-0723-9,,,,19644707,PMC2778717,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6060825,https://api.altmetric.com/v1/donut/6060825_240.png 0,Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells.,ChemBioChem,,,Article,2011-05-15,10.1002/cbic.201100064,,,,21542090,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,55,https://www.altmetric.com/details/6060571,https://api.altmetric.com/v1/donut/6060571_240.png 0,RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.,Cancer Research,,,Article,2010-10-14,10.1158/0008-5472.can-09-4729,,,,20876802,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60,https://www.altmetric.com/details/6060570,https://api.altmetric.com/v1/donut/6060570_240.png 0,Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2010-01-15,10.1158/1535-7163.mct-09-0486,,,,20053773,PMC2806502,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6060381,https://api.altmetric.com/v1/donut/6060381_240.png 0,Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.,Journal of Nutritional Biochemistry,,,Article,2014-01-15,10.1016/j.jnutbio.2013.09.005,,,,24314868,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6060377,https://api.altmetric.com/v1/donut/6060377_240.png 0,Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.,Physical Biology,,,Article,2012-02-15,10.1088/1478-3975/9/1/016002,,,,22306736,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6060313,https://api.altmetric.com/v1/donut/6060313_240.png 0,"Suppression of prostate cancer cell rolling and adhesion to endothelium by 1?,25-dihydroxyvitamin D3.",American Journal of Pathology,,,Article,2011-02-15,10.1016/j.ajpath.2010.10.036,,,,21281819,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6060298,https://api.altmetric.com/v1/donut/6060298_240.png 0,Enrichment of prostate cancer cells from blood cells with a hybrid dielectrophoresis and immunocapture microfluidic system.,Biomedical Microdevices,,,Article,2013-06-26,10.1007/s10544-013-9784-6,,,,23807279,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6060285,https://api.altmetric.com/v1/donut/6060285_240.png 0,Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.,Biomedical Microdevices,,,Article,2012-04-14,10.1007/s10544-011-9616-5,,,,22143878,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6060276,https://api.altmetric.com/v1/donut/6060276_240.png 0,CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.,Oncogene,,,Article,2013-01-14,10.1038/onc.2012.602,,,,23318417,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6060217,https://api.altmetric.com/v1/donut/6060217_240.png 0,Consistent interactions between tumor cell IL-6 and macrophage TNF-? enhance the growth of human prostate cancer cells in the bone of nude mouse.,International Immunopharmacology,,,Article,2011-07-14,10.1016/j.intimp.2011.01.004,,,,21251905,PMC3086935,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6060095,https://api.altmetric.com/v1/donut/6060095_240.png 0,Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.,Journal of Microencapsulation,,,Article,2014-03-24,10.3109/02652048.2013.879932,,,,24654943,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6060069,https://api.altmetric.com/v1/donut/6060069_240.png 0,Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells.,Journal of Cellular Biochemistry,,,Article,2011-08-14,10.1002/jcb.23134,,,,21465536,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6059971,https://api.altmetric.com/v1/donut/6059971_240.png 0,Oligometastatic prostate cancer to the navicular bone: case report.,Urology Case Reports,,,Article,2015-05-01,10.1016/j.eucr.2015.03.003,,,,26029631,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6059964,https://api.altmetric.com/v1/donut/6059964_240.png 0,Correlation of Sprouty1 and Jagged1 with Aggressive Prostate Cancer Cells with Different Sensitivities to Androgen Deprivation.,Journal of Cellular Biochemistry,,,Article,2014-03-07,10.1002/jcb.24805,,,,24604720,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6059960,https://api.altmetric.com/v1/donut/6059960_240.png 0,Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.,Oncotarget,,,Article,2015-01-31,10.18632/oncotarget.3359,,,,25749039,PMC4467434,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6059859,https://api.altmetric.com/v1/donut/6059859_240.png 0,DOT1L-HES6 fusion drives androgen independent growth in prostate cancer.,EMBO Molecular Medicine,,,Article,2014-07-07,10.15252/emmm.201404210,,,,25006183,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6059857,https://api.altmetric.com/v1/donut/6059857_240.png 0,Evidence for an alternate molecular progression in prostate cancer.,Disease Models and Mechanisms,,,Article,2012-11-15,10.1242/dmm.008995,,,,22563073,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6059798,https://api.altmetric.com/v1/donut/6059798_240.png 0,Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2013-12-23,10.1073/pnas.1318157111,,,,24367088,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6059751,https://api.altmetric.com/v1/donut/6059751_240.png 0,FGFR1-WNT-TGF-? signaling in prostate cancer mouse models recapitulates human reactive stroma.,Cancer Research,,,Article,2013-12-04,10.1158/0008-5472.can-13-1093,,,,24305876,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6059750,https://api.altmetric.com/v1/donut/6059750_240.png 0,Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression.,Clinical Cancer Research,,,Article,2012-07-14,10.1158/1078-0432.ccr-11-3214,,,,22573348,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6059747,https://api.altmetric.com/v1/donut/6059747_240.png 0,A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis.,Oncogene,,,Article,2013-07-14,10.1038/onc.2013.281,,,,23851498,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6059744,https://api.altmetric.com/v1/donut/6059744_240.png 0,No association of type 2 diabetes risk variants and prostate cancer risk: the multiethnic cohort and PAGE.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-09-14,10.1158/1055-9965.epi-11-0019,,,,21750171,PMC3175821,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6059706,https://api.altmetric.com/v1/donut/6059706_240.png 0,Capillary force seeding of sphere-templated hydrogels for tissue engineered prostate cancer xenografts.,Tissue Engineering Part C: Methods,,,Article,2013-09-14,10.1089/ten.tec.2012.0388,,,,23373788,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6059695,https://api.altmetric.com/v1/donut/6059695_240.png 0,Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escape.,Biomaterials,,,Article,2014-06-14,10.1016/j.biomaterials.2014.04.090,,,,24942815,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6059679,https://api.altmetric.com/v1/donut/6059679_240.png 0,Perceptions of Prostate Cancer Fatalism and Screening Behavior Between United States-Born and Caribbean-Born Black Males.,Journal of Immigrant & Minority Health,,,Article,2013-04-10,10.1007/s10903-013-9825-5,,,,23576029,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6059646,https://api.altmetric.com/v1/donut/6059646_240.png 0,Circulatory miR-628-5p is downregulated in prostate cancer patients.,Tumor Biology,,,Article,2014-01-30,10.1007/s13277-014-1638-1,,,,24477576,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6059640,https://api.altmetric.com/v1/donut/6059640_240.png 0,TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.,,,,Article,2011-01-18,10.1371/journal.pone.0016205,,,,21267413,PMC3022761,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6059634,https://api.altmetric.com/v1/donut/6059634_240.png 0,Variants at IRX4 as prostate cancer expression quantitative trait loci.,European Journal of Human Genetics,,,Article,2013-09-10,10.1038/ejhg.2013.195,,,,24022300,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6059531,https://api.altmetric.com/v1/donut/6059531_240.png 0,The androgen/androgen receptor axis in prostate cancer.,Current opinion in oncology,,,Article,2012-05-14,10.1097/cco.0b013e32835105b3,,,,22327838,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6059474,https://api.altmetric.com/v1/donut/6059474_240.png 0,Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.,Cancer Research,,,Article,2011-10-14,10.1158/0008-5472.can-11-0532,,,,21868758,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/6059473,https://api.altmetric.com/v1/donut/6059473_240.png 0,PPP2R2C loss promotes castration-resistant prostate cancer growth and is associated with increased prostate cancer-specific mortality.,Molecular Cancer Research,,,Article,2013-06-14,10.1158/1541-7786.mcr-12-0710,,,,23493267,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6059472,https://api.altmetric.com/v1/donut/6059472_240.png 0,Watchful waiting and quality of life among prostate cancer survivors in the physicians' health study.,The Journal of Urology,,,Article,2011-11-15,10.1016/j.juro.2011.06.058,,,,21944095,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6059467,https://api.altmetric.com/v1/donut/6059467_240.png 0,Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer.,The Journal of Urology,,,Article,2011-09-14,10.1016/j.juro.2011.04.085,,,,21788038,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6059466,https://api.altmetric.com/v1/donut/6059466_240.png 0,"Localized Prostate Cancer in Norway, the United States, and Spain: Between-Country Differences of Variables Before Treatment Among Patients Eligible for Curative Treatment.",Clinical Genitourinary Cancer,,,Article,2014-01-03,10.1016/j.clgc.2013.12.007,,,,24524968,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6059465,https://api.altmetric.com/v1/donut/6059465_240.png 0,Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).,British Journal of Urology,,,Article,2013-02-15,10.1111/j.1464-410x.2012.11423.x,,,,22928860,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6059464,https://api.altmetric.com/v1/donut/6059464_240.png 0,Survivorship after prostate cancer treatment: spouses' quality of life at 36 months.,Oncology Nursing Forum,,,Article,2013-11-01,10.1188/13.onf.567-573,,,,24161635,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6059462,https://api.altmetric.com/v1/donut/6059462_240.png 0,Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis.,Cancer (0008543X),,,Article,2012-06-14,10.1002/cncr.26609,,,,22025192,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6059458,https://api.altmetric.com/v1/donut/6059458_240.png 0,Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes.,The Journal of Urology,,,Article,2010-04-14,10.1016/j.juro.2009.12.021,,,,20188381,PMC2866516,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6059457,https://api.altmetric.com/v1/donut/6059457_240.png 0,Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer-How Long Does it Last?,The Journal of Urology,,,Article,2013-01-15,10.1016/j.juro.2012.08.091,,,,23164376,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6059404,https://api.altmetric.com/v1/donut/6059404_240.png 0,Late gastrointestinal toxicities following radiation therapy for prostate cancer.,European Urology,,,Article,2011-11-15,10.1016/j.eururo.2011.05.052,,,,21684064,PMC3185133,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6059403,https://api.altmetric.com/v1/donut/6059403_240.png 0,Randomized trial of print messaging: the role of the partner and monitoring style in promoting provider discussions about prostate cancer screening among African American men.,Psycho-Oncology,,,Article,2013-10-14,10.1002/pon.3437,,,,24130097,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6059383,https://api.altmetric.com/v1/donut/6059383_240.png 0,Dormancy in solid tumors: implications for prostate cancer.,Cancer and Metastasis Reviews,,,Article,2013-04-23,10.1007/s10555-013-9422-z,,,,23612741,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6059372,https://api.altmetric.com/v1/donut/6059372_240.png 0,Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells.,The Prostate,,,Article,2013-11-15,10.1002/pros.22705,,,,23999913,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6059356,https://api.altmetric.com/v1/donut/6059356_240.png 0,Structure-Function Studies of the bHLH Phosphorylation Domain of TWIST1 in Prostate Cancer Cells.,Neoplasia,,,Article,2015-01-15,10.1016/j.neo.2014.10.009,,,,25622896,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6059354,https://api.altmetric.com/v1/donut/6059354_240.png 0,The upregulation of PI3K/Akt and MAP kinase pathways is associated with resistance of microtubule-targeting drugs in prostate cancer.,Journal of Cellular Biochemistry,,,Article,2015-01-31,10.1002/jcb.25091,,,,25640606,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6059353,https://api.altmetric.com/v1/donut/6059353_240.png 0,Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.,Oncotarget,,,Article,2014-11-16,10.18632/oncotarget.2766,,,,25426557,PMC4381583,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6059349,https://api.altmetric.com/v1/donut/6059349_240.png 0,Natriuretic peptide receptor a as a novel target for prostate cancer.,,,,Article,2011-05-16,10.1186/1476-4598-10-56,,,,21586128,PMC3121714,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6059320,https://api.altmetric.com/v1/donut/6059320_240.png 0,Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.,Molecular Cancer Research,,,Article,2010-04-14,10.1158/1541-7786.mcr-09-0445,,,,20332212,PMC2946627,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6059273,https://api.altmetric.com/v1/donut/6059273_240.png 0,Hybrid multidimensional T2 and diffusion-weighted MRI for prostate cancer detection.,Journal of Magnetic Resonance Imaging,,,Article,2013-07-31,10.1002/jmri.24212,,,,23908146,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6059249,https://api.altmetric.com/v1/donut/6059249_240.png 0,Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer.,American Journal of Roentgenology,,,Article,2013-11-15,10.2214/ajr.13.10591,,,,24147475,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6059247,https://api.altmetric.com/v1/donut/6059247_240.png 0,Reactive oxygen species-dependent apoptosis by gugulipid extract of Ayurvedic medicine plant Commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase.,Molecular Pharmacology,,,Article,2011-03-15,10.1124/mol.110.068551,,,,21115635,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6059231,https://api.altmetric.com/v1/donut/6059231_240.png 0,"Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.",Journal of Nuclear Medicine,,,Article,2011-01-15,10.2967/jnumed.110.077941,,,,21149473,PMC3012154,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,91,https://www.altmetric.com/details/6059228,https://api.altmetric.com/v1/donut/6059228_240.png 0,PET/CT in prostate cancer: non-choline radiopharmaceuticals.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2012-08-14,,,,,23013666,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6059227,https://api.altmetric.com/v1/donut/6059227_240.png 0,[18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.,Molecular Imaging,,,Article,,,,,,22954187,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6059226,https://api.altmetric.com/v1/donut/6059226_240.png 0,Prostate cancer.,Methods in molecular biology,,,Article,,10.1007/978-1-61779-062-1_15,,,,21331939,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6059225,https://api.altmetric.com/v1/donut/6059225_240.png 0,Targeted ?-Particle Therapy of Bone Metastases in Prostate Cancer.,Clinical Nuclear Medicine,,,Article,2013-12-15,10.1097/rlu.0000000000000290,,,,24212441,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6059223,https://api.altmetric.com/v1/donut/6059223_240.png 0,Molecular Imaging of Prostate Cancer: PET Radiotracers.,American Journal of Roentgenology,,,Article,2012-08-14,10.2214/ajr.12.8816,,,,22826388,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6059222,https://api.altmetric.com/v1/donut/6059222_240.png 0,SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.,The Prostate,,,Article,2013-04-14,10.1002/pros.22592,,,,23038275,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6059173,https://api.altmetric.com/v1/donut/6059173_240.png 0,Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression.,Cancer Research,,,Article,2011-03-15,10.1158/0008-5472.can-10-1998,,,,21248069,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6059169,https://api.altmetric.com/v1/donut/6059169_240.png 0,AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.,Oncogene,,,Article,2012-11-08,10.1038/onc.2011.637,,,,22266865,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6059168,https://api.altmetric.com/v1/donut/6059168_240.png 0,Androgen receptor splice variants activate AR target genes and support aberrant prostate cancer cell growth independent of the canonical AR nuclear localization signal.,Journal of Biological Chemistry,,,Article,2012-05-31,10.1074/jbc.m112.352930,,,,22532567,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6059167,https://api.altmetric.com/v1/donut/6059167_240.png 0,Gold nanoparticle mediated detection of prostate cancer cells using photoacoustic flowmetry with optical reflectance.,,,,Article,2010-04-14,,,,,20738074,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6059003,https://api.altmetric.com/v1/donut/6059003_240.png 0,Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation.,Molecular Cancer Therapeutics,,,Article,2011-07-14,10.1158/1535-7163.mct-11-0061,,,,21571912,PMC3140695,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6058965,https://api.altmetric.com/v1/donut/6058965_240.png 0,Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2011-09-14,10.1586/era.11.134,,,,21929308,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,69,https://www.altmetric.com/details/6058915,https://api.altmetric.com/v1/donut/6058915_240.png 0,A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases.,Journal of Translational Medicine,,,Article,2011-04-18,10.1186/1479-5876-9-43,,,,21504557,PMC3102624,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6058907,https://api.altmetric.com/v1/donut/6058907_240.png 0,Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.,American Journal of Pathology,,,Article,2011-07-14,10.1016/j.ajpath.2011.03.014,,,,21703427,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6058891,https://api.altmetric.com/v1/donut/6058891_240.png 0,Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance.,Canadian Journal of Urology,,,Article,2013-04-14,,,,,23587506,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6058889,https://api.altmetric.com/v1/donut/6058889_240.png 0,Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment.,Journal of Nuclear Medicine,,,Article,2010-03-15,10.2967/jnumed.109.069492,,,,20150269,PMC2832590,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6058885,https://api.altmetric.com/v1/donut/6058885_240.png 0,Patterns and predictors of symptom incongruence in older couples coping with prostate cancer.,Supportive Care in Cancer,,,Article,2013-12-17,10.1007/s00520-013-2092-0,,,,24337765,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6058862,https://api.altmetric.com/v1/donut/6058862_240.png 0,"Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.",Clinical Cancer Research,,,Article,2011-08-14,10.1158/1078-0432.ccr-11-0916,,,,21712449,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6058745,https://api.altmetric.com/v1/donut/6058745_240.png 0,Enhanced Cytotoxicity from Deoxyguanosine-Enriched T-oligo in Prostate Cancer Cells.,Nucleic Acid Therapeutics,,,Article,2013-08-23,10.1089/nat.2013.0420,,,,23971906,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6058733,https://api.altmetric.com/v1/donut/6058733_240.png 0,Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide.,International Journal of Cancer,,,Article,2012-02-01,10.1002/ijc.26054,,,,21400505,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6058721,https://api.altmetric.com/v1/donut/6058721_240.png 0,The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts.,Biomaterials,,,Article,2010-10-14,10.1016/j.biomaterials.2010.06.031,,,,20630586,PMC2924909,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/6058710,https://api.altmetric.com/v1/donut/6058710_240.png 0,Tunable plasmonic nanoprobes for theranostics of prostate cancer.,,,,Article,2011-01-10,,,,,21547151,PMC3086615,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6058703,https://api.altmetric.com/v1/donut/6058703_240.png 0,"Microbubble-Assisted P53, Rb, And P130 Gene Transfer In Combination With Radiation Therapy In Prostate Cancer.",Current Gene Therapy,,,Article,2013-05-31,,,,,23531191,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6058612,https://api.altmetric.com/v1/donut/6058612_240.png 0,Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse.,Prostate Cancer & Prostatic Diseases,,,Article,2011-06-14,10.1038/pcan.2010.57,,,,21263453,PMC3094480,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6058539,https://api.altmetric.com/v1/donut/6058539_240.png 0,The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.,Clinical Cancer Research,,,Article,2011-06-30,10.1158/1078-0432.ccr-10-2370,,,,21555373,PMC3131476,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6058415,https://api.altmetric.com/v1/donut/6058415_240.png 0,Efficacy of abiraterone acetate in post-docetaxel castration-resistant prostate cancer.,Expert Review of Anticancer Therapy,,,Article,2010-07-14,10.1586/era.10.84,,,,20645691,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6058352,https://api.altmetric.com/v1/donut/6058352_240.png 0,Bayesian Parametric Accelerated Failure Time Spatial Model and its Application to Prostate Cancer.,Journal of Applied Statistics,,,Article,2011-03-15,10.1080/02664760903521476,,,,21475617,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6058320,https://api.altmetric.com/v1/donut/6058320_240.png 0,Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.,,,,Article,,10.1371/journal.pone.0021417,,,,21789170,PMC3138744,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46,https://www.altmetric.com/details/6058303,https://api.altmetric.com/v1/donut/6058303_240.png 0,Effects of androgen deprivation on brain function in prostate cancer patients ¿ a prospective observational cohort analysis.,,,,Article,2012-08-26,10.1186/1471-2407-12-371,,,,22925152,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6058287,https://api.altmetric.com/v1/donut/6058287_240.png 0,Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.,Carcinogenesis,,,Article,2013-09-24,10.1093/carcin/bgt316,,,,24067903,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6058264,https://api.altmetric.com/v1/donut/6058264_240.png 0,Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications.,Molecular Cancer Therapeutics,,,Article,2011-05-14,10.1158/1535-7163.mct-10-1096,,,,21393425,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6058259,https://api.altmetric.com/v1/donut/6058259_240.png 0,"Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.",Carcinogenesis,,,Article,2012-06-14,10.1093/carcin/bgs134,,,,22431717,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6058253,https://api.altmetric.com/v1/donut/6058253_240.png 0,Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.,,,,Article,2010-02-18,,,,,20657713,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6058189,https://api.altmetric.com/v1/donut/6058189_240.png 0,Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase 3 metastatic castration resistant prostate cancer trial.,International Journal of Cancer,,,Article,2014-09-12,10.1002/ijc.29212,,,,25219358,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6058040,https://api.altmetric.com/v1/donut/6058040_240.png 0,High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?,Asian Journal of Andrology,,,Article,2012-05-14,10.1038/aja.2011.182,,,,22306913,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6057859,https://api.altmetric.com/v1/donut/6057859_240.png 0,Reducing bias in the assessment of treatment effectiveness: androgen deprivation therapy for prostate cancer.,Medical care,,,Article,2012-05-14,10.1097/mlr.0b013e318245a086,,,,22635250,PMC3361681,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6057858,https://api.altmetric.com/v1/donut/6057858_240.png 0,"Androgen deprivation for prostate cancer: The case for ""first, do no harm""",Cancer (0008543X),,,Article,2012-06-30,10.1002/cncr.26624,,,,22072504,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6057857,https://api.altmetric.com/v1/donut/6057857_240.png 0,Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.,The Prostate,,,Article,2011-06-14,10.1002/pros.21311,,,,21541972,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6057844,https://api.altmetric.com/v1/donut/6057844_240.png 0,"Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.",Cancer Gene Therapy,,,Article,2010-09-14,10.1038/cgt.2010.16,,,,20448670,PMC2919627,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6057551,https://api.altmetric.com/v1/donut/6057551_240.png 0,Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.,Oncogene,,,Article,2009-08-05,10.1038/onc.2009.134,,,,19503093,PMC2722685,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6057547,https://api.altmetric.com/v1/donut/6057547_240.png 0,Small interfering RNA-directed knockdown of uracil DNA glycosylase induces apoptosis and sensitizes human prostate cancer cells to genotoxic stress.,Molecular Cancer Research,,,Article,2009-08-14,10.1158/1541-7786.mcr-08-0508,,,,19671688,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6057546,https://api.altmetric.com/v1/donut/6057546_240.png 0,Estrogen Receptor ? in Cancer Associated Fibroblasts Suppresses Prostate Cancer Invasion via Modulation of Thrombospondin-2 and Matrix Metalloproteinase 3.,Carcinogenesis,,,Article,2013-12-28,10.1093/carcin/bgt488,,,,24374826,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6057401,https://api.altmetric.com/v1/donut/6057401_240.png 0,Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.,Cancer Research,,,Article,2010-06-30,10.1158/0008-5472.can-09-4416,,,,20551048,PMC2896434,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6057372,https://api.altmetric.com/v1/donut/6057372_240.png 0,Cediranib inhibits both the intraosseous growth of PDGF D-Positive prostate cancer cells and the associated bone reaction.,The Prostate,,,Article,2012-08-31,10.1002/pros.22481,,,,22213159,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6057370,https://api.altmetric.com/v1/donut/6057370_240.png 0,PTEN Regulates PDGF Ligand Switch for ?-PDGFR Signaling in Prostate Cancer.,American Journal of Pathology,,,Article,2012-03-15,10.1016/j.ajpath.2011.11.021,,,,22209699,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6057369,https://api.altmetric.com/v1/donut/6057369_240.png 0,Radioresistance of prostate cancer cells with low proteasome activity.,The Prostate,,,Article,2012-05-31,10.1002/pros.21489,,,,21932424,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6057305,https://api.altmetric.com/v1/donut/6057305_240.png 0,Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential.,Molecular Diagnosis & Therapy,,,Article,2014-05-08,10.1007/s40291-014-0101-8,,,,24809501,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6057258,https://api.altmetric.com/v1/donut/6057258_240.png 0,Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2009.12.023,,,,20451413,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6057257,https://api.altmetric.com/v1/donut/6057257_240.png 0,Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer.,Cancer Research,,,Article,2011-09-14,10.1158/0008-5472.can-11-1417,,,,21799031,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,58,https://www.altmetric.com/details/6057256,https://api.altmetric.com/v1/donut/6057256_240.png 0,"1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1? and signaling in LNCaP prostate cancer cells.",,,,Article,,,,,,21048308,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6057237,https://api.altmetric.com/v1/donut/6057237_240.png 0,Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1.,Carcinogenesis,,,Article,2009-05-14,10.1093/carcin/bgp059,,,,19269999,PMC2675654,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6057236,https://api.altmetric.com/v1/donut/6057236_240.png 0,Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.,Molecular Cancer Therapeutics,,,Article,2009-10-14,10.1158/1535-7163.mct-09-0288,,,,19825802,PMC2838500,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6057235,https://api.altmetric.com/v1/donut/6057235_240.png 0,Galbanic acid decreases androgen receptor abundance and signaling and induces G(1) arrest in prostate cancer cells.,International Journal of Cancer,,,Article,2012-01-01,10.1002/ijc.25993,,,,21328348,PMC3137900,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6057231,https://api.altmetric.com/v1/donut/6057231_240.png 0,Mouse Prostate Proteome Changes Induced by Oral Pentagalloylglucose Treatment Suggest Targets for Cancer Chemoprevention.,Current Cancer Drug Targets,,,Article,2011-09-14,,,,,21762084,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6057230,https://api.altmetric.com/v1/donut/6057230_240.png 0,Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer.,PLoS ONE,,,Article,,10.1371/journal.pone.0123877,,,,25859981,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6057174,https://api.altmetric.com/v1/donut/6057174_240.png 0,HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.,"Cancer Immunology, Immunotherapy",,,Article,2010-06-14,10.1007/s00262-010-0820-6,,,,20140431,PMC3038205,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6057060,https://api.altmetric.com/v1/donut/6057060_240.png 0,Therapeutic vaccines for prostate cancer.,Current Opinion in Molecular Therapeutics,,,Article,2010-02-15,,,,,20140819,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6057059,https://api.altmetric.com/v1/donut/6057059_240.png 0,Beyond Sipuleucel-T: Immune Approaches to Treating Prostate Cancer.,Current Treatment Options in Oncology,,,Article,2014-01-10,10.1007/s11864-013-0267-z,,,,24402184,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6057058,https://api.altmetric.com/v1/donut/6057058_240.png 0,Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients.,The Journal of Immunology,,,Article,2012-09-30,10.4049/jimmunol.1201529,,,,22956585,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6057057,https://api.altmetric.com/v1/donut/6057057_240.png 0,Immunotherapy for prostate cancer: biology and therapeutic approaches.,Journal of Clinical Oncology,,,Article,2011-09-19,10.1200/jco.2010.34.5025,,,,21825260,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6057056,https://api.altmetric.com/v1/donut/6057056_240.png 0,In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer.,Journal of Nuclear Medicine,,,Article,2011-03-15,10.2967/jnumed.110.082826,,,,21321264,PMC3088991,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6057024,https://api.altmetric.com/v1/donut/6057024_240.png 0,In vitro and in vivo evaluation of a (64)Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.,Nuclear Medicine & Biology,,,Article,2012-07-14,10.1016/j.nucmedbio.2011.12.004,,,,22261146,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6057022,https://api.altmetric.com/v1/donut/6057022_240.png 0,Integrin ?3?1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization.,Clinical and Experimental Metastasis,,,Article,2013-04-14,10.1007/s10585-012-9558-1,,,,23224938,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6056995,https://api.altmetric.com/v1/donut/6056995_240.png 0,Early onset prostate cancer has a significant genetic component.,The Prostate,,,Article,2012-02-01,10.1002/pros.21414,,,,21538423,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6056968,https://api.altmetric.com/v1/donut/6056968_240.png 0,Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.,Familial Cancer,,,Article,2012-12-15,10.1007/s10689-012-9555-1,,,,22864661,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6056966,https://api.altmetric.com/v1/donut/6056966_240.png 0,Genome-wide association scan for variants associated with early-onset prostate cancer.,PloS one,,,Article,,10.1371/journal.pone.0093436,,,,24740154,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6056965,https://api.altmetric.com/v1/donut/6056965_240.png 0,Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.,Journal of Clinical Oncology,,,Article,2011-06-09,10.1200/jco.2010.30.9880,,,,21537045,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6056910,https://api.altmetric.com/v1/donut/6056910_240.png 0,Blood and tissue biomarkers in prostate cancer: state of the art.,Urologic Clinics of North America,,,Article,2010-02-15,10.1016/j.ucl.2009.11.006,,,,20152526,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6056909,https://api.altmetric.com/v1/donut/6056909_240.png 0,"Protein expression of PTEN, insulin-like growth factor I receptor (IGF1R), and lethal prostate cancer: a prospective study.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2013-08-26,10.1158/1055-9965.epi-13-0349,,,,23983239,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6056908,https://api.altmetric.com/v1/donut/6056908_240.png 0,"The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: a Cohort Study and Meta-analysis.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2012-09-14,10.1158/1055-9965.epi-12-0042,,,,22736790,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6056907,https://api.altmetric.com/v1/donut/6056907_240.png 0,Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2014-11-04,10.1158/1055-9965.epi-14-0694-t,,,,25371445,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6056906,https://api.altmetric.com/v1/donut/6056906_240.png 0,Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.,Molecular Cancer Therapeutics,,,Article,,10.1158/1535-7163.mct-12-0181,,,,22752225,PMC3632183,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6056872,https://api.altmetric.com/v1/donut/6056872_240.png 0,Semi supervised multi kernel (SeSMiK) graph embedding: identifying aggressive prostate cancer via magnetic resonance imaging and spectroscopy.,,,,Article,,,,,,20879458,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,39,https://www.altmetric.com/details/6056801,https://api.altmetric.com/v1/donut/6056801_240.png 0,High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models.,Medical Image Analysis,,,Article,2010-08-14,10.1016/j.media.2010.04.007,,,,20493759,PMC2916937,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/6056788,https://api.altmetric.com/v1/donut/6056788_240.png 0,A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).,Medical Physics,,,Article,2009-09-14,,,,,19810465,PMC2738739,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6056785,https://api.altmetric.com/v1/donut/6056785_240.png 0,Selective invocation of shape priors for deformable segmentation and morphologic classification of prostate cancer tissue microarrays.,Computerized Medical Imaging & Graphics,,,Article,2014-11-12,10.1016/j.compmedimag.2014.11.001,,,,25466771,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6056784,https://api.altmetric.com/v1/donut/6056784_240.png 0,Predicting classifier performance with limited training data: applications to computer-aided diagnosis in breast and prostate cancer.,PLoS ONE,,,Article,,10.1371/journal.pone.0117900,,,,25993029,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6056782,https://api.altmetric.com/v1/donut/6056782_240.png 0,Selecting features with group-sparse nonnegative supervised canonical correlation analysis: multimodal prostate cancer prognosis.,Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention,,,Article,,,,,,25320823,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6056781,https://api.altmetric.com/v1/donut/6056781_240.png 0,Identifying Quantitative In Vivo Multi-Parametric MRI Features For Treatment Related Changes after Laser Interstitial Thermal Therapy of Prostate Cancer.,Neurocomputing,,,Article,2014-11-20,10.1016/j.neucom.2014.03.065,,,,25346574,PMC4205765,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6056775,https://api.altmetric.com/v1/donut/6056775_240.png 0,Cell orientation entropy (COrE): predicting biochemical recurrence from prostate cancer tissue microarrays.,Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention,,,Article,,,,,,24505786,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6056771,https://api.altmetric.com/v1/donut/6056771_240.png 0,Quantitative Evaluation of Treatment Related Changes on Multi-Parametric MRI after Laser Interstitial Thermal Therapy of Prostate Cancer.,Proceedings Society of Photo Optical Instrumentation Engineers,,,Article,2013-03-15,10.1117/12.2008037,,,,24817802,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6056767,https://api.altmetric.com/v1/donut/6056767_240.png 0,"Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS.",Medical Image Analysis,,,Article,2013-02-15,10.1016/j.media.2012.10.004,,,,23294985,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,49,https://www.altmetric.com/details/6056766,https://api.altmetric.com/v1/donut/6056766_240.png 0,A Boosted Bayesian Multi-Resolution Classifier for Prostate Cancer Detection from Digitized Needle Biopsies.,IEEE Transactions on Biomedical Engineering,,,Article,2012-05-14,10.1109/tbme.2010.2053540,,,,20570758,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,63,https://www.altmetric.com/details/6056762,https://api.altmetric.com/v1/donut/6056762_240.png 0,Multimodal wavelet embedding representation for data combination (MaWERiC): integrating magnetic resonance imaging and spectroscopy for prostate cancer detection.,NMR in Biomedicine,,,Article,2012-04-14,10.1002/nbm.1777,,,,21960175,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6056761,https://api.altmetric.com/v1/donut/6056761_240.png 0,Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer.,Computerized Medical Imaging & Graphics,,,Article,,10.1016/j.compmedimag.2010.12.003,,,,21255974,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,72,https://www.altmetric.com/details/6056750,https://api.altmetric.com/v1/donut/6056750_240.png 0,Detection of prostate cancer on histopathology using color fractals and Probabilistic Pairwise Markov models.,Conference proceedings Annual International Conference of the IEEE Engineering in Medicine and Biology Society,,,Article,,10.1109/iembs.2011.6090927,,,,22255076,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6056747,https://api.altmetric.com/v1/donut/6056747_240.png 0,Adaptive energy selective active contour with shape priors for nuclear segmentation and gleason grading of prostate cancer.,,,,Article,,,,,,22003675,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,34,https://www.altmetric.com/details/6056746,https://api.altmetric.com/v1/donut/6056746_240.png 0,Enhanced Multi-Protocol Analysis via Intelligent Supervised Embedding (EMPrAvISE): Detecting Prostate Cancer on Multi-Parametric MRI.,Proceedings of SPIE,,,Article,2011-03-04,10.1117/12.878312,,,,25301991,PMC4187222,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6056745,https://api.altmetric.com/v1/donut/6056745_240.png 0,Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer.,Molecular and Cellular Proteomics (MCP Online),,,Article,2011-06-14,10.1074/mcp.m110.007294,,,,21447706,PMC3108840,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6056560,https://api.altmetric.com/v1/donut/6056560_240.png 0,The proteomics of prostate cancer exosomes.,Expert Review of Proteomics,,,Article,2014-02-25,10.1586/14789450.2014.890894,,,,24564711,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6056557,https://api.altmetric.com/v1/donut/6056557_240.png 0,Urinary estrogen metabolites and prostate cancer risk: a pilot study.,The Prostate,,,Article,2011-04-14,10.1002/pros.21262,,,,20886539,PMC3037420,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6056548,https://api.altmetric.com/v1/donut/6056548_240.png 0,Clinical and Biological Significance of KISS1 Expression in Prostate Cancer.,American Journal of Pathology,,,Article,2012-03-15,10.1016/j.ajpath.2011.11.020,,,,22226740,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6056501,https://api.altmetric.com/v1/donut/6056501_240.png 0,Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen.,Cancer Research,,,Article,2009-05-14,10.1158/0008-5472.can-08-3901,,,,19401450,PMC2710962,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6056433,https://api.altmetric.com/v1/donut/6056433_240.png 0,64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer.,Journal of Medicinal Chemistry,,,Article,2014-02-17,10.1021/jm401921j,,,,24533799,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6056389,https://api.altmetric.com/v1/donut/6056389_240.png 0,PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen.,Current Topics in Medicinal Chemistry,,,Article,,,,,,23590171,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6056385,https://api.altmetric.com/v1/donut/6056385_240.png 0,68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.,Journal of Medicinal Chemistry,,,Article,2010-07-21,10.1021/jm100623e,,,,20568777,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6056384,https://api.altmetric.com/v1/donut/6056384_240.png 0,Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen.,Angewandte Chemie International Edition,,,Article,2011-09-18,10.1002/anie.201102872,,,,21861274,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6056381,https://api.altmetric.com/v1/donut/6056381_240.png 0,"2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET Imaging Agent for Prostate Cancer.",Clinical Cancer Research,,,Article,2011-12-15,10.1158/1078-0432.ccr-11-1357,,,,22042970,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/6056380,https://api.altmetric.com/v1/donut/6056380_240.png 0,Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer.,Bioorganic & Medicinal Chemistry,,,Article,2009-07-14,10.1016/j.bmc.2009.06.012,,,,19541487,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6056377,https://api.altmetric.com/v1/donut/6056377_240.png 0,Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.,Cancer Research,,,Article,2009-08-31,10.1158/0008-5472.can-09-1682,,,,19706750,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40,https://www.altmetric.com/details/6056376,https://api.altmetric.com/v1/donut/6056376_240.png 0,New agents and techniques for imaging prostate cancer.,Journal of Nuclear Medicine,,,Article,2009-09-14,10.2967/jnumed.109.061838,,,,19690043,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6056375,https://api.altmetric.com/v1/donut/6056375_240.png 0,Prostate-Specific Membrane Antigen as a target for cancer imaging and therapy.,Quarterly Journal of Nuclear Medicine and Molecular Imaging,,,Article,2015-07-24,,,,,26213140,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6056374,https://api.altmetric.com/v1/donut/6056374_240.png 0,Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer.,Current Medicinal Chemistry,,,Article,,,,,,22214450,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6056369,https://api.altmetric.com/v1/donut/6056369_240.png 0,Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.,,,,Article,,,,,,21804946,PMC3144474,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6056338,https://api.altmetric.com/v1/donut/6056338_240.png 0,The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells.,Autophagy,,,Article,2010-11-15,10.1038/cdd.2010.74,,,,20930561,PMC3039723,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6056336,https://api.altmetric.com/v1/donut/6056336_240.png 0,Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.,Current Drug Targets,,,Article,2010-06-14,,,,,20298153,PMC2998062,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6056335,https://api.altmetric.com/v1/donut/6056335_240.png 0,Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.,,,,Article,2010-12-10,10.1371/journal.pone.0014153,,,,21170316,PMC3000808,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6056334,https://api.altmetric.com/v1/donut/6056334_240.png 0,A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.,BMC Cancer,,,Article,2009-11-06,10.1186/1471-2407-9-392,,,,19895686,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6056333,https://api.altmetric.com/v1/donut/6056333_240.png 0,Posttranslational modification of the androgen receptor in prostate cancer.,,,,Article,2013-07-15,10.3390/ijms140714833,,,,23863692,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6056171,https://api.altmetric.com/v1/donut/6056171_240.png 0,FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.,Cancer Research,,,Article,2011-04-30,10.1158/0008-5472.can-10-2603,,,,21505104,PMC3108023,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6056169,https://api.altmetric.com/v1/donut/6056169_240.png 0,Androgens repress expression of the f-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.,The Prostate,,,Article,2012-02-01,10.1002/pros.21430,,,,21630295,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6056166,https://api.altmetric.com/v1/donut/6056166_240.png 0,Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.,,,,Article,2011-09-14,,,,,21969818,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6056165,https://api.altmetric.com/v1/donut/6056165_240.png 0,Targeting the Androgen Receptor by Taxol in Castration-Resistant Prostate Cancer.,,,,Article,2010-01-01,,,,,20419056,PMC2858463,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6056163,https://api.altmetric.com/v1/donut/6056163_240.png 0,Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.,Cancer Research,,,Article,2009-11-01,10.1158/0008-5472.can-09-1504,,,,19826044,PMC2783542,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/6056162,https://api.altmetric.com/v1/donut/6056162_240.png 0,P300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.,Cancer Research,,,Article,2014-01-30,10.1158/0008-5472.can-13-2485,,,,24480624,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,29,https://www.altmetric.com/details/6056161,https://api.altmetric.com/v1/donut/6056161_240.png 0,COMPUTER-AIDED GLEASON GRADING OF PROSTATE CANCER HISTOPATHOLOGICAL IMAGES USING TEXTON FORESTS.,2010 IEEE International Symposium on Biomedical Imaging: From Nano to Macro,,,Article,2010-04-16,10.1109/isbi.2010.5490096,,,,21221421,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6056157,https://api.altmetric.com/v1/donut/6056157_240.png 0,"Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism.",,,,Article,2010-07-08,10.1186/1476-4598-9-183,,,,20618956,PMC3044330,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6056152,https://api.altmetric.com/v1/donut/6056152_240.png 0,The Effect of 5-Aminolevulinic Acid and Its Derivatives on Protoporphyrin IX Accumulation and Apoptotic Cell Death in Castrate-resistant Prostate Cancer Cells.,Urology,,,Article,2012-12-15,10.1016/j.urology.2012.07.008,,,,22950992,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6056150,https://api.altmetric.com/v1/donut/6056150_240.png 0,Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.,Carcinogenesis,,,Article,2011-12-15,10.1093/carcin/bgr212,,,,21940908,PMC3220607,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6056149,https://api.altmetric.com/v1/donut/6056149_240.png 0,Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.,Urology,,,Article,2011-10-14,10.1016/j.urology.2011.07.1384,,,,21982018,PMC3190126,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6056148,https://api.altmetric.com/v1/donut/6056148_240.png 0,Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.,Radiotherapy & Oncology,,,Article,,10.1016/j.radonc.2013.05.001,,,,23719583,PMC3787843,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6056132,https://api.altmetric.com/v1/donut/6056132_240.png 0,A Two-Stage Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms Associated with Development of Urinary Symptoms Following Radiotherapy for Prostate Cancer.,The Journal of Urology,,,Article,2013-07-14,10.1016/j.juro.2013.01.096,,,,23376709,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6056131,https://api.altmetric.com/v1/donut/6056131_240.png 0,YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion.,PLoS ONE,,,Article,2011-04-28,10.1371/journal.pone.0019343,,,,21559405,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,47,https://www.altmetric.com/details/6056046,https://api.altmetric.com/v1/donut/6056046_240.png 0,Transcription of Nrdp1 by the androgen receptor is regulated by nuclear Filamin A in prostate cancer.,Endocrine-Related Cancer,,,Article,2015-03-10,10.1530/erc-15-0021,,,,25759396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6055892,https://api.altmetric.com/v1/donut/6055892_240.png 0,Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins.,,,,Article,,,,,,21984972,PMC3186052,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6055891,https://api.altmetric.com/v1/donut/6055891_240.png 0,Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.,Cancer Research,,,Article,2010-07-14,10.1158/0008-5472.can-09-4440,,,,20587519,PMC2905475,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6055889,https://api.altmetric.com/v1/donut/6055889_240.png 0,Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines.,Endocrine-Related Cancer,,,Article,2010-12-15,10.1677/erc-10-0081,,,,20634343,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6055888,https://api.altmetric.com/v1/donut/6055888_240.png 0,Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1?-Hydroxyvitamin D5 - a calcitriol analog.,Genes & Cancer,,,Article,2010-11-16,10.1177/1947601910385450,,,,21552398,PMC3089062,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6055887,https://api.altmetric.com/v1/donut/6055887_240.png 0,Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block.,"Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry",,,Article,2011-06-14,10.2174/187152211795495643,,,,21603064,PMC3095967,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,30,https://www.altmetric.com/details/6055885,https://api.altmetric.com/v1/donut/6055885_240.png 0,Dual blockade of PKA and NF-?B inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.,Hormones and Cancer,,,Article,2011-08-14,10.1007/s12672-011-0076-4,,,,21789713,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6055884,https://api.altmetric.com/v1/donut/6055884_240.png 0,Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3.,Clinical Cancer Research,,,Article,2011-09-30,10.1158/1078-0432.ccr-11-1548,,,,21844010,PMC3186857,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6055883,https://api.altmetric.com/v1/donut/6055883_240.png 0,What controls PTEN and what it controls (in prostate cancer).,Asian Journal of Andrology,,,Article,2012-01-15,10.1038/aja.2011.122,,,,21946231,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6055882,https://api.altmetric.com/v1/donut/6055882_240.png 0,"Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.",Redox biology,,,Article,2014-12-10,10.1016/j.redox.2014.12.001,,,,25560241,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32,https://www.altmetric.com/details/6055861,https://api.altmetric.com/v1/donut/6055861_240.png 0,"Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.","Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-09-14,10.1158/1055-9965.epi-11-0236,,,,21846818,PMC3169727,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6055749,https://api.altmetric.com/v1/donut/6055749_240.png 0,Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.,The Prostate,,,Article,2011-03-01,10.1002/pros.21256,,,,20878950,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6055748,https://api.altmetric.com/v1/donut/6055748_240.png 0,Inherited susceptibility for aggressive prostate cancer.,Asian Journal of Andrology,,,Article,2012-05-14,10.1038/aja.2011.146,,,,22543676,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6055747,https://api.altmetric.com/v1/donut/6055747_240.png 0,Fluorescence-guided surgery of prostate cancer bone metastasis.,Journal of Surgical Research,,,Article,2014-05-22,10.1016/j.jss.2014.05.049,,,,24972740,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6055686,https://api.altmetric.com/v1/donut/6055686_240.png 0,Inhibition of metastasis of circulating human prostate cancer cells in the chick embryo by an extracellular matrix produced by foreskin fibroblasts in culture.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2012-05-14,,,,,22593434,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6055658,https://api.altmetric.com/v1/donut/6055658_240.png 0,Comparative chemosensitivity of circulating human prostate cancer cells and primary cancer cells.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,,,,,,22753751,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6055657,https://api.altmetric.com/v1/donut/6055657_240.png 0,"Novel RNA Hybridization Method for the In Situ Detection of ETV1, ETV4, and ETV5 Gene Fusions in Prostate Cancer.",Applied immunohistochemistry molecular morphology AIMM,,,Article,2014-09-14,10.1097/pai.0000000000000095,,,,25203299,PMC4159774,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6055643,https://api.altmetric.com/v1/donut/6055643_240.png 0,Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.,Genome Research,,,Article,2011-07-14,10.1101/gr.119347.110,,,,21724842,PMC3129246,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,131,https://www.altmetric.com/details/6055642,https://api.altmetric.com/v1/donut/6055642_240.png 0,Characterization of KRAS Rearrangements in Metastatic Prostate Cancer.,Cancer Discovery,,,Article,2011-06-14,10.1158/2159-8274.cd-10-0022,,,,22140652,PMC3227139,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6055641,https://api.altmetric.com/v1/donut/6055641_240.png 0,Antibody-based detection of ERG rearrangement-positive prostate cancer.,Neoplasia,,,Article,2010-07-14,,,,,20651988,PMC2907585,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,41,https://www.altmetric.com/details/6055640,https://api.altmetric.com/v1/donut/6055640_240.png 0,The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.,Oncogene,,,Article,2010-09-29,10.1038/onc.2010.269,,,,20622896,PMC2948081,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6055639,https://api.altmetric.com/v1/donut/6055639_240.png 0,TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers.,Cancer Research,,,Article,2011-08-14,10.1158/0008-5472.can-11-0876,,,,21676887,PMC3156376,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6055638,https://api.altmetric.com/v1/donut/6055638_240.png 0,SLC45A3-ELK4 Chimera in Prostate Cancer: Spotlight on cis-Splicing.,Cancer Discovery,,,Article,2012-07-14,10.1158/2159-8290.cd-12-0212,,,,22787087,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6055637,https://api.altmetric.com/v1/donut/6055637_240.png 0,Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.,Modern Pathology,,,Article,2009-08-14,10.1038/modpathol.2009.69,,,,19407851,PMC2760294,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6055635,https://api.altmetric.com/v1/donut/6055635_240.png 0,Novel targets for prostate cancer chemoprevention.,Endocrine-Related Cancer,,,Article,2010-09-14,10.1677/erc-10-0074,,,,20576802,PMC2976036,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6055544,https://api.altmetric.com/v1/donut/6055544_240.png 0,Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2014-01-06,10.1073/pnas.1323102111,,,,24395797,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6055515,https://api.altmetric.com/v1/donut/6055515_240.png 0,A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells.,Oncotarget,,,Article,2014-10-14,10.18632/oncotarget.2346,,,,25344862,PMC4253414,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6055514,https://api.altmetric.com/v1/donut/6055514_240.png 0,Novel Interaction Between the Co-chaperone Cdc37 and Rho GTPase Exchange Factor Vav3 Promotes Androgen Receptor Activity and Prostate Cancer Growth.,Journal of Biological Chemistry,,,Article,2013-02-22,10.1074/jbc.m112.390963,,,,23281476,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6055513,https://api.altmetric.com/v1/donut/6055513_240.png 0,Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival.,Molecular Endocrinology,,,Article,2012-12-15,10.1210/me.2012-1165,,,,23023561,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6055512,https://api.altmetric.com/v1/donut/6055512_240.png 0,The microRNA -23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells.,,,,Article,,10.1371/journal.pone.0052106,,,,23300597,PMC3530545,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6055511,https://api.altmetric.com/v1/donut/6055511_240.png 0,A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.,Oncogene,,,Article,2012-02-09,10.1038/onc.2011.273,,,,21765461,PMC3203328,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6055509,https://api.altmetric.com/v1/donut/6055509_240.png 0,Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation.,Cancer Research,,,Article,2011-02-01,10.1158/0008-5472.can-10-3172,,,,21189328,PMC3033220,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6055498,https://api.altmetric.com/v1/donut/6055498_240.png 0,Association of prostate cancer risk with snps in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.,The Prostate,,,Article,2012-03-15,10.1002/pros.21439,,,,21671247,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6055396,https://api.altmetric.com/v1/donut/6055396_240.png 0,Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.,Carcinogenesis,,,Article,2011-11-15,10.1093/carcin/bgr187,,,,21856995,PMC3204347,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,59,https://www.altmetric.com/details/6055395,https://api.altmetric.com/v1/donut/6055395_240.png 0,Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.,Carcinogenesis,,,Article,2011-07-14,10.1093/carcin/bgr082,,,,21551127,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6055394,https://api.altmetric.com/v1/donut/6055394_240.png 0,Employing the Epigenetic Field Defect to Detect Prostate Cancer in Biopsy-Negative Patients.,The Journal of Urology,,,Article,2013-06-14,10.1016/j.juro.2012.11.074,,,,23159584,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6055333,https://api.altmetric.com/v1/donut/6055333_240.png 0,Antiandrogen Gold Nanoparticles Dual-Target and Overcome Treatment Resistance in Hormone-Insensitive Prostate Cancer Cells.,Bioconjugate Chemistry,,,Article,2012-08-14,10.1021/bc300158k,,,,22768914,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31,https://www.altmetric.com/details/6055311,https://api.altmetric.com/v1/donut/6055311_240.png 0,The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer?,Journal of Clinical Investigation,,,Article,2010-12-15,10.1172/jci45406,,,,21099103,PMC2993607,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19,https://www.altmetric.com/details/6055302,https://api.altmetric.com/v1/donut/6055302_240.png 0,Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.,,,,Article,2013-08-29,10.1186/1476-4598-12-99,,,,24001151,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6055268,https://api.altmetric.com/v1/donut/6055268_240.png 0,Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.,Open Prostate Cancer Journal,,,Article,2010-01-01,,,,,24790681,PMC4002166,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6055090,https://api.altmetric.com/v1/donut/6055090_240.png 0,Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.,Oncogene,,,Article,2012-08-29,10.1038/onc.2011.554,,,,22139082,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6055062,https://api.altmetric.com/v1/donut/6055062_240.png 0,Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.,The Prostate,,,Article,2009-06-30,10.1002/pros.20962,,,,19367568,PMC2976666,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6055028,https://api.altmetric.com/v1/donut/6055028_240.png 0,Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-10-14,10.1158/1055-9965.epi-11-0344,,,,21784953,PMC3189295,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6055010,https://api.altmetric.com/v1/donut/6055010_240.png 0,Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.,,,,Article,2010-05-04,10.1186/1472-6769-10-5,,,,20444281,PMC2873968,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6055004,https://api.altmetric.com/v1/donut/6055004_240.png 0,A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activities.,Carcinogenesis,,,Article,2011-08-14,10.1093/carcin/bgr113,,,,21665893,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6055000,https://api.altmetric.com/v1/donut/6055000_240.png 0,New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells.,,,,Article,2013-09-22,10.1371/journal.pone.0075601,,,,24086585,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054999,https://api.altmetric.com/v1/donut/6054999_240.png 0,PKD2 and PKD3 Promote Prostate Cancer Cell Invasion via uPA by Shifting Balance Between NF-?B and HDAC1.,Journal of Cell Science,,,Article,2012-10-14,10.1242/jcs.106542,,,,22797919,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6054998,https://api.altmetric.com/v1/donut/6054998_240.png 0,Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication.,Statistics in Medicine,,,Article,2013-07-02,10.1002/sim.5890,,,,23824930,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6054976,https://api.altmetric.com/v1/donut/6054976_240.png 0,Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2010-01-15,10.1016/j.jsbmb.2009.09.016,,,,19837161,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6054905,https://api.altmetric.com/v1/donut/6054905_240.png 0,Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells.,Journal of Steroid Biochemistry & Molecular Biology,,,Article,2010-10-14,10.1016/j.jsbmb.2010.06.006,,,,20558290,PMC2949446,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6054904,https://api.altmetric.com/v1/donut/6054904_240.png 0,Id4 Promotes Senescence and Sensitivity to Doxorubicin-induced Apoptosis in DU145 Prostate Cancer Cells.,Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2013-10-14,,,,,24122992,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6054902,https://api.altmetric.com/v1/donut/6054902_240.png 0,Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGF? effects on cell proliferation and migration in prostate cancer cells.,The Prostate,,,Article,2013-05-14,10.1002/pros.22603,,,,23060149,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6054901,https://api.altmetric.com/v1/donut/6054901_240.png 0,Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.,Biochemical & Biophysical Research Communications,,,Article,2012-05-24,10.1016/j.bbrc.2012.04.126,,,,22564737,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6054900,https://api.altmetric.com/v1/donut/6054900_240.png 0,Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer.,Biological Chemistry,,,Article,2010-04-14,10.1515/bc.2010.044,,,,20180648,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6054864,https://api.altmetric.com/v1/donut/6054864_240.png 0,Inhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis.,The Prostate,,,Article,2012-05-31,10.1002/pros.21486,,,,21919028,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6054851,https://api.altmetric.com/v1/donut/6054851_240.png 0,Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.,The Prostate,,,Article,2010-03-01,10.1002/pros.21070,,,,19902467,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6054808,https://api.altmetric.com/v1/donut/6054808_240.png 0,Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.,Molecular Therapy,,,Article,2010-02-15,10.1038/mt.2009.252,,,,19888195,PMC2839288,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6054803,https://api.altmetric.com/v1/donut/6054803_240.png 0,Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic.,,,,Article,2011-01-15,,,,,21276410,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/6054789,https://api.altmetric.com/v1/donut/6054789_240.png 0,Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24.,Cancer Research,,,Article,2010-04-30,10.1158/0008-5472.can-09-3647,,,,20406981,PMC2874885,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6054788,https://api.altmetric.com/v1/donut/6054788_240.png 0,Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells.,Cancer Gene Therapy,,,Article,2010-07-14,10.1038/cgt.2009.91,,,,20150932,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6054786,https://api.altmetric.com/v1/donut/6054786_240.png 0,Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.,Oncogene,,,Article,2010-01-21,10.1038/onc.2009.343,,,,19881538,PMC2809784,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51,https://www.altmetric.com/details/6054771,https://api.altmetric.com/v1/donut/6054771_240.png 0,Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression.,,,,Article,2010-11-11,10.1021/ml100110x,,,,21116437,PMC2992379,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6054699,https://api.altmetric.com/v1/donut/6054699_240.png 0,Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer.,Translational andrology and urology,,,Article,2013-09-14,10.3978/j.issn.2223-4683.2013.09.05,,,,25285271,PMC4180428,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6054612,https://api.altmetric.com/v1/donut/6054612_240.png 0,Inhibition of ?2-Microglobulin/Hemochromatosis Enhances Radiation Sensitivity by Induction of Iron Overload in Prostate Cancer Cells.,,,,Article,,10.1371/journal.pone.0068366,,,,23874600,PMC3707913,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6054611,https://api.altmetric.com/v1/donut/6054611_240.png 0,"Interracial differences in prostate cancer progression among patients from the United States, China and Japan.",Asian Journal of Andrology,,,Article,2013-07-21,10.1038/aja.2013.86,,,,23872663,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/6054609,https://api.altmetric.com/v1/donut/6054609_240.png 0,Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells.,The Prostate,,,Article,2010-06-30,10.1002/pros.21146,,,,20333698,PMC3180889,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6054608,https://api.altmetric.com/v1/donut/6054608_240.png 0,Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.,The Prostate,,,Article,2010-03-31,10.1002/pros.21086,,,,19918799,PMC3180894,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054607,https://api.altmetric.com/v1/donut/6054607_240.png 0,Serum prosaposin levels are increased in patients with advanced prostate cancer.,The Prostate,,,Article,2012-02-15,10.1002/pros.21427,,,,21630292,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6054605,https://api.altmetric.com/v1/donut/6054605_240.png 0,Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.,The Prostate,,,Article,2010-06-14,10.1002/pros.21133,,,,20166133,PMC3180892,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6054604,https://api.altmetric.com/v1/donut/6054604_240.png 0,Future perspectives of prostate cancer therapy.,,,,Article,2012-01-03,10.3978/j.issn.2223-4683.2012.01.03,,,,22773967,PMC3389805,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6054603,https://api.altmetric.com/v1/donut/6054603_240.png 0,"Activation of androgen receptor, lipogenesis and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.",Molecular Cancer Research,,,Article,2012-01-15,10.1158/1541-7786.mcr-11-0206,,,,22064655,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,38,https://www.altmetric.com/details/6054602,https://api.altmetric.com/v1/donut/6054602_240.png 0,Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.,The Prostate,,,Article,2011-12-15,10.1002/pros.21388,,,,21520153,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6054601,https://api.altmetric.com/v1/donut/6054601_240.png 0,Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.,The Prostate,,,Article,,10.1002/pros.21237,,,,20672324,PMC3174735,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6054600,https://api.altmetric.com/v1/donut/6054600_240.png 0,Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer.,,,,Article,,10.1371/journal.pone.0028670,,,,22205960,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6054599,https://api.altmetric.com/v1/donut/6054599_240.png 0,EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.,Oncogene,,,Article,2011-12-15,10.1038/onc.2011.199,,,,21625216,PMC3165108,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6054597,https://api.altmetric.com/v1/donut/6054597_240.png 0,PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.,Cancer Research,,,Article,2011-03-15,10.1158/0008-5472.can-10-1791,,,,21385902,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054596,https://api.altmetric.com/v1/donut/6054596_240.png 0,Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells.,Journal of Biological Chemistry,,,Article,2010-03-12,10.1074/jbc.m109.092759,,,,20071336,PMC2832945,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6054595,https://api.altmetric.com/v1/donut/6054595_240.png 0,Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells.,Clinical Cancer Research,,,Article,2011-04-14,10.1158/1078-0432.ccr-10-2523,,,,21355075,PMC3085118,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6054593,https://api.altmetric.com/v1/donut/6054593_240.png 0,Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.,In Vitro Cellular & Developmental Biology - Animal,,,Article,,10.1007/s11626-010-9309-z,,,,20383666,PMC2875468,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054592,https://api.altmetric.com/v1/donut/6054592_240.png 0,Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells.,Biochemical & Biophysical Research Communications,,,Article,2011-01-07,10.1016/j.bbrc.2010.11.044,,,,21093414,PMC3021188,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6054591,https://api.altmetric.com/v1/donut/6054591_240.png 0,Tumor-stroma co-evolution in prostate cancer progression and metastasis.,Seminars in Cell & Developmental Biology,,,Article,2010-02-15,10.1016/j.semcdb.2009.11.016,,,,19948237,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6054590,https://api.altmetric.com/v1/donut/6054590_240.png 0,Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells.,Molecular Cancer,,,Article,2010-01-19,10.1186/1476-4598-9-9,,,,20085644,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6054589,https://api.altmetric.com/v1/donut/6054589_240.png 0,Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots.,Urology,,,Article,2009-08-14,10.1016/j.urology.2009.01.023,,,,19428067,PMC2907732,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6054587,https://api.altmetric.com/v1/donut/6054587_240.png 0,Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.,PloS one,,,Article,,10.1371/journal.pone.0088967,,,,24551200,PMC3925210,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20,https://www.altmetric.com/details/6054585,https://api.altmetric.com/v1/donut/6054585_240.png 0,Characterization of the phosphoproteome in androgen-repressed human prostate cancer cells by Fourier transform ion cyclotron resonance mass spectrometry.,Journal of Proteome Research,,,Article,2011-09-01,10.1021/pr2000144,,,,21786837,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6054583,https://api.altmetric.com/v1/donut/6054583_240.png 0,Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models.,Urologic Oncology,,,Article,,10.1016/j.urolonc.2009.09.016,,,,20451417,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054580,https://api.altmetric.com/v1/donut/6054580_240.png 0,Mitochondrial Hsp90 chaperones as novel molecular targets in prostate cancer.,Future Oncology,,,Article,2010-04-14,10.2217/fon.10.26,,,,20373861,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6054516,https://api.altmetric.com/v1/donut/6054516_240.png 0,"Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer.",Clinical Cancer Research,,,Article,2010-09-30,10.1158/1078-0432.ccr-10-1818,,,,20876793,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6054515,https://api.altmetric.com/v1/donut/6054515_240.png 0,Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.,British Journal of Cancer,,,Article,2011-02-15,10.1038/bjc.2011.9,,,,21285984,PMC3049604,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6054513,https://api.altmetric.com/v1/donut/6054513_240.png 0,Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.,Oncotarget,,,Article,2016-10-20,10.18632/oncotarget.3391,,,,25868388,PMC4496348,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6054442,https://api.altmetric.com/v1/donut/6054442_240.png 0,Validation of genome-wide prostate cancer associations in men of African descent.,"Cancer Epidemiology, Biomarkers & Prevention",,,Article,2011-01-15,10.1158/1055-9965.epi-10-0698,,,,21071540,PMC3110616,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/6054441,https://api.altmetric.com/v1/donut/6054441_240.png 0,BMP4 promotes prostate tumor growth in bone through osteogenesis.,Cancer Research,,,Article,2011-07-31,10.1158/0008-5472.can-10-4374,,,,21670081,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6054440,https://api.altmetric.com/v1/donut/6054440_240.png 0,Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression.,Prostate Cancer & Prostatic Diseases,,,Article,2010-09-14,10.1038/pcan.2010.9,,,,20386565,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6054435,https://api.altmetric.com/v1/donut/6054435_240.png 0,Prioritizing genes associated with prostate cancer development.,,,,Article,2010-11-02,10.1186/1471-2407-10-599,,,,21044312,PMC2988752,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6054434,https://api.altmetric.com/v1/donut/6054434_240.png 0,Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification.,European Urology,,,Article,2010-06-14,10.1016/j.eururo.2009.10.020,,,,19853370,PMC2962710,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6054432,https://api.altmetric.com/v1/donut/6054432_240.png 0,A new therapy paradigm for prostate cancer founded on clinical observations.,Clinical Cancer Research,,,Article,2010-02-15,10.1158/1078-0432.ccr-09-1215,,,,20145177,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054431,https://api.altmetric.com/v1/donut/6054431_240.png 0,Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.,Current protocols in pharmacology,,,Article,2010-12-15,10.1002/0471141755.ph1415s51,,,,21483646,PMC3072580,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,37,https://www.altmetric.com/details/6054430,https://api.altmetric.com/v1/donut/6054430_240.png 0,Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer.,The Prostate,,,Article,2013-06-14,10.1002/pros.22645,,,,23371521,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6054426,https://api.altmetric.com/v1/donut/6054426_240.png 0,Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.,Molecular Oncology,,,Article,2013-06-14,10.1016/j.molonc.2012.12.005,,,,23333597,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6054417,https://api.altmetric.com/v1/donut/6054417_240.png 0,Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.,Future Medicinal Chemistry,,,Article,2012-01-15,10.4155/fmc.11.161,,,,22168167,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6054412,https://api.altmetric.com/v1/donut/6054412_240.png 0,Mitosis phase enrichment with identification of mitotic centromere-associated Kinesin as a therapeutic target in castration-resistant prostate cancer.,,,,Article,,10.1371/journal.pone.0031259,,,,22363599,PMC3281954,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/6054408,https://api.altmetric.com/v1/donut/6054408_240.png 0,Activation of ?-Catenin Signaling in Androgen Receptor-Negative Prostate Cancer Cells.,Clinical Cancer Research,,,Article,2012-02-01,10.1158/1078-0432.ccr-11-2521,,,,22298898,PMC3271798,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,33,https://www.altmetric.com/details/6054407,https://api.altmetric.com/v1/donut/6054407_240.png 0,Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways.,,,,Article,,10.1371/journal.pone.0051189,,,,23300537,PMC3530555,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054405,https://api.altmetric.com/v1/donut/6054405_240.png 0,Understanding the lethal variant of prostate cancer: power of examining extremes.,Cancer Discovery,,,Article,2011-11-15,10.1158/2159-8290.cd-11-0259,,,,22586648,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6054401,https://api.altmetric.com/v1/donut/6054401_240.png 0,The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials.,Expert Opinion on Investigational Drugs,,,Article,2011-12-15,10.1517/13543784.2011.631523,,,,22035268,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6054397,https://api.altmetric.com/v1/donut/6054397_240.png 0,Dietary Energy Balance Modulates Prostate Cancer Progression in Hi-Myc Mice.,Cancer Prevention Research,,,Article,2011-12-15,10.1158/1940-6207.capr-11-0182,,,,21952584,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6054396,https://api.altmetric.com/v1/donut/6054396_240.png 0,"Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles.",The Prostate,,,Article,2011-05-31,10.1002/pros.21301,,,,21456067,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054392,https://api.altmetric.com/v1/donut/6054392_240.png 0,Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.,Cancer Research,,,Article,2010-05-31,10.1158/0008-5472.can-09-3016,,,,20484040,PMC2923552,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6054390,https://api.altmetric.com/v1/donut/6054390_240.png 0,Androgen depletion up-regulates cadherin-11 expression in prostate cancer.,The Journal of Pathology,,,Article,2010-05-14,10.1002/path.2687,,,,20191612,PMC2936767,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054389,https://api.altmetric.com/v1/donut/6054389_240.png 0,Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.,Cancer Biology and Therapy,,,Article,2009-11-15,,,,,19855158,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/6054388,https://api.altmetric.com/v1/donut/6054388_240.png 0,Overexpression of FGF9 in Prostate Epithelial Cells Augments Reactive Stroma Formation and Promotes Prostate Cancer Progression.,International Journal of Biological Sciences,,,Article,,10.7150/ijbs.12468,,,,26157349,PMC4495412,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6054386,https://api.altmetric.com/v1/donut/6054386_240.png 0,"RSK Promotes Prostate Cancer Progression in Bone through ING3, CKAP2 and PTK6-mediated Cell Survival.",Molecular Cancer Research,,,Article,2014-09-03,10.1158/1541-7786.mcr-14-0384-t,,,,25189355,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6054385,https://api.altmetric.com/v1/donut/6054385_240.png 0,Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.,The Prostate,,,Article,2011-12-15,10.1002/pros.21389,,,,21446014,PMC3128180,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6054177,https://api.altmetric.com/v1/donut/6054177_240.png 0,p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.,Molecular Cancer Research,,,Article,2010-08-14,10.1158/1541-7786.mcr-10-0174,,,,20647331,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,28,https://www.altmetric.com/details/6054171,https://api.altmetric.com/v1/donut/6054171_240.png 0,"Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells.",Molecular Cancer Therapeutics,,,Article,2009-06-14,10.1158/1535-7163.mct-08-1037,,,,19509254,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6054169,https://api.altmetric.com/v1/donut/6054169_240.png 0,Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells.,Journal of Virology,,,Article,2010-07-14,10.1128/jvi.00274-10,,,,20410264,PMC2903252,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6054090,https://api.altmetric.com/v1/donut/6054090_240.png 0,Influence of Vascular Comorbidities and Race on Erectile Dysfunction after Prostate Cancer Radiotherapy.,Journal of Sexual Medicine,,,Article,2013-08-14,10.1111/jsm.12215,,,,23742221,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6054054,https://api.altmetric.com/v1/donut/6054054_240.png 0,SOX4 interacts with plakoglobin in a Wnt3a-dependent manner in prostate cancer cells.,,,,Article,2011-11-19,10.1186/1471-2121-12-50,,,,22098624,PMC3227594,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/6054046,https://api.altmetric.com/v1/donut/6054046_240.png 0,Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.,Cancer Cell,,,Article,2010-07-01,10.1016/j.ccr.2010.05.024,,,,20609350,PMC2919332,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,65,https://www.altmetric.com/details/6053925,https://api.altmetric.com/v1/donut/6053925_240.png 0,The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.,Oncotarget,,,Article,2010-09-14,10.18632/oncotarget.171,,,,21037926,PMC2964873,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6053921,https://api.altmetric.com/v1/donut/6053921_240.png 0,Coordinate transcriptional regulation by ERG and androgen receptor in fusion-positive prostate cancers.,Cancer Cell,,,Article,2010-05-17,10.1016/j.ccr.2010.04.022,,,,20478521,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/6053665,https://api.altmetric.com/v1/donut/6053665_240.png 0,Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target.,Lancet Oncology,,,Article,2009-10-14,10.1016/s1470-2045(09)70229-3,,,,19796750,PMC2935850,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,115,https://www.altmetric.com/details/6053664,https://api.altmetric.com/v1/donut/6053664_240.png 0,Prostate cancer organoids: a potential new tool for testing drug sensitivity.,Expert Review of Anticancer Therapy,,,Article,2015-01-20,10.1586/14737140.2015.1003046,,,,25603995,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6053663,https://api.altmetric.com/v1/donut/6053663_240.png 0,"Breast, colorectal and prostate cancer screening for cancer survivors and non-cancer patients in community practices.",JGIM: Journal of General Internal Medicine,,,Article,2009-11-15,10.1007/s11606-009-1036-3,,,,19838855,PMC2763158,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6053418,https://api.altmetric.com/v1/donut/6053418_240.png 0,Successful subject recruitment for a prostate cancer behavioral intervention trial.,Clinical Trials,,,Article,2010-08-14,10.1177/1740774510373491,,,,20571136,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6053410,https://api.altmetric.com/v1/donut/6053410_240.png 0,Prostate Cancer Knowledge and Decision Making Among African-American Men and Women in the Southeastern United States.,International Journal of Men's Health,,,Article,2015-01-01,,,,,26190946,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6053403,https://api.altmetric.com/v1/donut/6053403_240.png 0,African American Men's and Women's Perceptions of Clinical Trials Research: Focusing on Prostate Cancer among a High-Risk Population in the South.,Journal of health care for the poor and underserved (Online),,,Article,,10.1353/hpu.2013.0187,,,,24185170,PMC3818250,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16,https://www.altmetric.com/details/6053401,https://api.altmetric.com/v1/donut/6053401_240.png 0,Developing Partnerships and Recruiting Dyads for a Prostate Cancer Informed Decision Making Program: Lessons Learned From a Community-Academic-Clinical Team.,Journal of Cancer Education,,,Article,2012-06-14,10.1007/s13187-012-0353-0,,,,22528633,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/6053397,https://api.altmetric.com/v1/donut/6053397_240.png 0,"A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer.",Cancer Epidemiology,,,Article,2012-04-14,10.1016/j.canep.2011.09.008,,,,22018935,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/6053396,https://api.altmetric.com/v1/donut/6053396_240.png 0,Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina.,Cancer Causes and Control,,,Article,2011-11-15,10.1007/s10552-011-9836-2,,,,21877121,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6053368,https://api.altmetric.com/v1/donut/6053368_240.png 0,Cardiorespiratory fitness and risk of prostate cancer: findings from the Aerobics Center Longitudinal Study.,Cancer Epidemiology,,,Article,2011-02-15,10.1016/j.canep.2010.07.013,,,,20708996,PMC3062068,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/6053367,https://api.altmetric.com/v1/donut/6053367_240.png 0,A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy.,BMC Cancer,,,Article,2013-04-16,10.1186/1471-2407-13-195,,,,23594731,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6053295,https://api.altmetric.com/v1/donut/6053295_240.png 0,Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?,Urology,,,Article,,10.1016/j.urology.2013.01.021,,,,23477756,PMC3634906,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/6053263,https://api.altmetric.com/v1/donut/6053263_240.png 0,"Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8.",Oncogene,,,Article,2012-05-09,10.1038/onc.2011.422,,,,21996749,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9,https://www.altmetric.com/details/6053186,https://api.altmetric.com/v1/donut/6053186_240.png 0,"Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.",Molecular Cancer Research,,,Article,,10.1158/1541-7786.mcr-11-0615,,,,22452883,PMC3557528,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,26,https://www.altmetric.com/details/6053185,https://api.altmetric.com/v1/donut/6053185_240.png 0,Comparative morbidity of ablative energy-based salvage treatments for radio-recurrent prostate cancer.,Canadian Urological Association Journal,,,Article,2015-09-01,10.5489/cuaj.3113,,,,26644804,PMC4662393,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6051938,https://api.altmetric.com/v1/donut/6051938_240.png 0,Custirsen (OGX-011): Clusterin Inhibitor in Metastatic Prostate Cancer.,Current Oncology Reports,,,Article,2013-04-14,10.1007/s11912-012-0285-1,,,,23266703,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6051865,https://api.altmetric.com/v1/donut/6051865_240.png 0,A full inversion unconstrained ultrasound elastography technique for prostate cancer assessment,,,,Article,,10.1117/12.2007068,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6051749,https://api.altmetric.com/v1/donut/6051749_240.png 0,Method for data analysis in different institutions: example of image guidance of prostate cancer patients.,Physica Medica,,,Article,2014-03-01,10.1016/j.ejmp.2013.05.001,,,,23721940,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6051734,https://api.altmetric.com/v1/donut/6051734_240.png 0,Ultrasound-based characterization of prostate cancer: an in vivo clinical feasibility study.,Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention,,,Article,,,,,,24579151,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6051077,https://api.altmetric.com/v1/donut/6051077_240.png 0,ECF chemotherapy for liver metastases due to castration-resistant prostate cancer.,Canadian Urological Association Journal,,,Article,2014-09-15,10.5489/cuaj.2029,,,,25408803,PMC4216294,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/6051033,https://api.altmetric.com/v1/donut/6051033_240.png 0,Salvage High-intensity Focused Ultrasound for Patients With Recurrent Prostate Cancer After Brachytherapy.,Urology,,,Article,2014-11-15,10.1016/j.urology.2014.06.054,,,,25443920,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23,https://www.altmetric.com/details/6050856,https://api.altmetric.com/v1/donut/6050856_240.png 0,Perineural invasion and TRUS findings are complementary in predicting prostate cancer biology.,Canadian Journal of Urology,,,Article,2013-04-14,,,,,23587509,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6050853,https://api.altmetric.com/v1/donut/6050853_240.png 0,Multiparametric MR imaging of prostate cancer foci: assessing the detectability and localizability of Gleason 7 peripheral zone cancers based on image contrasts,,,,Article,,10.1117/12.2043324,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6050687,https://api.altmetric.com/v1/donut/6050687_240.png 0,Toward quantitative digital histopathology for prostate cancer: comparison of inter-slide interpolation methods for tumour measurement,,,,Article,,10.1117/12.2007103,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/6050686,https://api.altmetric.com/v1/donut/6050686_240.png 0,Prostate Histopathology: Learning Tissue Component Histograms for Cancer Detection and Classification.,IEEE Transactions on Medical Imaging,,,Article,2013-05-30,10.1109/tmi.2013.2265334,,,,23739794,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,43,https://www.altmetric.com/details/6050681,https://api.altmetric.com/v1/donut/6050681_240.png 0,Re: Salvage Focal Prostate Cryoablation for Locally Recurrent Prostate Cancer After Radiotherapy: Initial Results from the Cryo On-line Data Registry.,European Urology,,,Article,2015-04-15,10.1016/j.eururo.2014.12.048,,,,25765209,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/6050355,https://api.altmetric.com/v1/donut/6050355_240.png 0,The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men,Patient Education & Counseling,,,Article,2009-02-01,10.1016/j.pec.2008.08.013,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,35,https://www.altmetric.com/details/6035772,https://api.altmetric.com/v1/donut/6035772_240.png 0,"Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.",BMC Health Services Research,,,Article,2011-10-05,10.1186/1472-6963-11-253,,,,21978077,PMC3206422,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/6028432,https://api.altmetric.com/v1/donut/6028432_240.png 0,The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line.,Australian & New Zealand Journal of Surgery,,,Article,2003-03-01,10.1046/j.1445-2197.2003.02652.x,,,,12608980,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6028281,https://api.altmetric.com/v1/donut/6028281_240.png 0,Novel gene-directed enzyme prodrug therapies against prostate cancer.,Expert Opinion on Investigational Drugs,,,Article,2006-08-14,10.1517/13543784.15.8.947,,,,16859396,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12,https://www.altmetric.com/details/6028183,https://api.altmetric.com/v1/donut/6028183_240.png 0,Insulin Resistance and Prostate Cancer Risk,JNCI: Journal of the National Cancer Institute,,,Article,2003-01-01,10.1093/jnci/95.1.67,,,,12509402,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/6016015,https://api.altmetric.com/v1/donut/6016015_240.png 0,Long-term survival of patients with locally advanced prostate cancer managed with neoadjuvant docetaxel and radical prostatectomy,Urologic Oncology,,,Article,2015-02-06,10.1016/j.urolonc.2015.01.001,,,,25665510,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/6013345,https://api.altmetric.com/v1/donut/6013345_240.png 0,What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a..,Urologic Oncology,,,Article,2015-01-22,10.1016/j.urolonc.2014.12.011,,,,25620154,,1854/LU-6843532,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,18,https://www.altmetric.com/details/6013341,https://api.altmetric.com/v1/donut/6013341_240.png 0,Silibinin suppresses CD44 expression in prostate cancer cells,American Journal of Translational Research,,,Article,2016-02-25,,,,,19966941,PMC2776293,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11,https://www.altmetric.com/details/6002599,https://api.altmetric.com/v1/donut/6002599_240.png 0,"Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.",International Journal of Cancer,,,Article,2004-01-01,10.1002/ijc.11496,,,,14618611,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/6000967,https://api.altmetric.com/v1/donut/6000967_240.png 0,Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis.,British Journal of Cancer,,,Article,2004-11-15,10.1038/sj.bjc.6602193,,,,15494717,PMC2410047,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/6000965,https://api.altmetric.com/v1/donut/6000965_240.png 0,"Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001-2003.",British Journal of Cancer,,,Article,2006-04-09,10.1038/sj.bjc.6603031,,,,16523198,PMC2361230,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5999381,https://api.altmetric.com/v1/donut/5999381_240.png 0,Views of health professionals on the role of primary care in the follow-up of men with prostate cancer.,Family Practise,,,Article,2011-12-15,10.1093/fampra/cmr034,,,,21693683,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/5997990,https://api.altmetric.com/v1/donut/5997990_240.png 0,Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy.,Annals of Oncology,,,Article,2012-06-14,10.1093/annonc/mdr447,,,,22007078,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15,https://www.altmetric.com/details/5997987,https://api.altmetric.com/v1/donut/5997987_240.png 0,Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia.,The Prostate,,,Article,2011-02-15,10.1002/pros.21244,,,,20812209,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/5996852,https://api.altmetric.com/v1/donut/5996852_240.png 0,Clinically relevant fatigue in recurrence-free prostate cancer survivors.,Annals of Oncology,,,Article,2012-01-15,10.1093/annonc/mdr034,,,,21436185,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21,https://www.altmetric.com/details/5994808,https://api.altmetric.com/v1/donut/5994808_240.png 0,"Prediction of a gene regulatory network linked to prostate cancer from gene expression, microRNA and clinical data.",Bioinformatics,,,Article,2010-09-14,10.1093/bioinformatics/btq395,,,,20823333,PMC2935430,1854/LU-1061935,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36,https://www.altmetric.com/details/5994402,https://api.altmetric.com/v1/donut/5994402_240.png 0,"""I wish I'd told them"": a qualitative study examining the unmet psychosexual needs of prostate cancer patients during follow-up after treatment.",Patient Education & Counseling,,,Article,2011-08-14,10.1016/j.pec.2010.07.006,,,,20702055,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/5994333,https://api.altmetric.com/v1/donut/5994333_240.png 0,Risk of prostate cancer associated with benign prostate disease: a primary care case-control study.,British Journal of General Practice,,,Article,2011-11-15,10.3399/bjgp11x606573,,,,22054323,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5993630,https://api.altmetric.com/v1/donut/5993630_240.png 0,Follow-up care for men with prostate cancer and the role of primary care: a systematic review of international guidelines.,British Journal of Cancer,,,Article,2009-06-15,10.1038/sj.bjc.6605080,,,,19436297,PMC2714251,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,https://www.altmetric.com/details/5993427,https://api.altmetric.com/v1/donut/5993427_240.png 0,Results from a prostate cancer admixture mapping study in African-American men.,Human Genetics,,,Article,2009-11-15,10.1007/s00439-009-0712-z,,,,19568772,PMC2975267,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,42,https://www.altmetric.com/details/5993189,https://api.altmetric.com/v1/donut/5993189_240.png 0,Experiences of follow-up after treatment in patients with prostate cancer: a qualitative study.,British Journal of Urology,,,Article,2010-10-14,10.1111/j.1464-410x.2010.09292.x,,,,20230391,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5992241,https://api.altmetric.com/v1/donut/5992241_240.png 0,A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer,Journal of Medicinal Chemistry,,,Article,2009-01-22,10.1021/jm800994j,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,53,https://www.altmetric.com/details/5991624,https://api.altmetric.com/v1/donut/5991624_240.png 0,FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.,Prostate Cancer & Prostatic Diseases,,,Article,2010-03-15,10.1038/pcan.2009.49,,,,19918264,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5991568,https://api.altmetric.com/v1/donut/5991568_240.png 0,Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate Cancer,Clinical Cancer Research,,,Article,2009-05-15,10.1158/1078-0432.ccr-08-1857,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5990936,https://api.altmetric.com/v1/donut/5990936_240.png 0,HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer.,Proceedings of the National Academy of Sciences of the United States of America,,,Article,2011-09-26,10.1073/pnas.1101263108,,,,21930937,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,25,https://www.altmetric.com/details/5990930,https://api.altmetric.com/v1/donut/5990930_240.png 0,Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer,The Prostate,,,Article,2016-02-01,10.1002/pros.23166,,,,26880312,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5982716,https://api.altmetric.com/v1/donut/5982716_240.png 0,A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.,Oncotarget,,,Article,2014-11-09,10.18632/oncotarget.7250,,,,26881390,PMC5008293,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,https://www.altmetric.com/details/5981724,https://api.altmetric.com/v1/donut/5981724_240.png 0,Primary cryotherapy with salvage external beam radiotherapy for locally recurrent prostate cancer.,Clinical Oncology,,,Article,2008-06-14,10.1016/j.clon.2008.03.009,,,,18420393,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,https://www.altmetric.com/details/5977716,https://api.altmetric.com/v1/donut/5977716_240.png 0,"In regards to Da Silva Franca et al.: ""Localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy"" (Brachytherapy 2010; 9(4): 307-312).",Brachytherapy,,,Article,2014-06-23,10.1016/j.brachy.2014.05.004,,,,24972861,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,https://www.altmetric.com/details/5965148,https://api.altmetric.com/v1/donut/5965148_240.png 0,"Prostate-specific antigen (PSA)-mediated proliferation, androgenic regulation and inhibitory effects of LY312340 in HOS-TE85 (TE85) human osteosarcoma cells.",Anticancer Research: International Journal of Cancer Research and Treatment,,,Article,2002-09-01,,,,,12529988,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,https://www.altmetric.com/details/5963521,https://api.altmetric.com/v1/donut/5963521_240.png 0,"A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants.",Supportive Care in Cancer,,,Article,2008-09-14,10.1007/s00520-008-0411-7,,,,18274783,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/5945564,https://api.altmetric.com/v1/donut/5945564_240.png 0,Do women have a role in early detection of prostate cancer? - Lessons from a qualitative study.,,,,Article,2007-05-14,,,,,17492077,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5944362,https://api.altmetric.com/v1/donut/5944362_240.png 0,Prostate Cancer Methods and Protocols,,,,Article,2003-04-17,10.1385/1-59259-372-0:219,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,https://www.altmetric.com/details/5943914,https://api.altmetric.com/v1/donut/5943914_240.png 0,Treatment of prostatic cancer.,British Medical Journal,,,Article,1988-02-27,10.1136/bmj.296.6622.644-c,,,,3126943,PMC2545271,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5943422,https://api.altmetric.com/v1/donut/5943422_240.png 0,Transcription-targeted gene therapy for androgen-independent prostate cancer.,Cancer Gene Therapy,,,Article,2002-05-01,10.1038/sj.cgt.7700451,,,,11961667,,10453/17074,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5942704,https://api.altmetric.com/v1/donut/5942704_240.png 0,Do men with prostate cancer and their partners receive the information they need for optimal illness self-management in the immediate post-diagnostic phase?,The Asia-Pacific Journal of Oncology Nursing,,,Article,2015-01-01,10.4103/2347-5625.160969,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5911533,https://api.altmetric.com/v1/donut/5911533_240.png 0,Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin,Cancer Medicine,,,Article,2016-02-01,10.1002/cam4.675,,,,26899963,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5910181,https://api.altmetric.com/v1/donut/5910181_240.png 0,Symptomatic diagnosis of prostate cancer in primary care: a structured review.,British Journal of General Practice,,,Article,2004-08-14,,,,,15296564,PMC1324845,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,https://www.altmetric.com/details/5907440,https://api.altmetric.com/v1/donut/5907440_240.png 0,The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro.,British Journal of Cancer,,,Article,2003-07-07,10.1038/sj.bjc.6601059,,,,12838309,PMC2394218,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24,https://www.altmetric.com/details/5907078,https://api.altmetric.com/v1/donut/5907078_240.png 0,Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium.,Cancer (0008543X),,,Article,2009-12-01,10.1002/cncr.24597,,,,19711464,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,https://www.altmetric.com/details/5906694,https://api.altmetric.com/v1/donut/5906694_240.png 0,Drug Management of Prostate Cancer,,,,Article,2010-01-01,10.1007/978-1-60327-829-4_34,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5906691,https://api.altmetric.com/v1/donut/5906691_240.png 0,Obesity and prostate cancer: epidemiology and clinical implications.,European Urology,,,Article,2007-08-14,10.1016/j.eururo.2007.04.069,,,,17507151,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,27,https://www.altmetric.com/details/5905722,https://api.altmetric.com/v1/donut/5905722_240.png 0,Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.,Prostate Cancer & Prostatic Diseases,,,Article,2008-04-22,10.1038/pcan.2008.18,,,,18427570,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,https://www.altmetric.com/details/5905704,https://api.altmetric.com/v1/donut/5905704_240.png 0,Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience.,Cancer (0008543X),,,Article,2010-10-14,10.1002/cncr.25447,,,,20589748,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5905663,https://api.altmetric.com/v1/donut/5905663_240.png 0,Associations of benign prostatic hyperplasia with prostate cancer: the debate continues.,European Urology,,,Article,2011-10-14,10.1016/j.eururo.2011.07.005,,,,21802829,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6,https://www.altmetric.com/details/5905642,https://api.altmetric.com/v1/donut/5905642_240.png 0,High-Risk Prostate Cancer: From Definition to Contemporary Management.,European Urology,,,Article,2012-06-14,10.1016/j.eururo.2012.02.031,,,,22386839,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,https://www.altmetric.com/details/5905636,https://api.altmetric.com/v1/donut/5905636_240.png 0,Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.,"International Journal of Radiation Oncology, Biology, Physics",,,Article,2010-02-01,10.1016/j.ijrobp.2009.02.006,,,,19394158,PMC2847420,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,107,https://www.altmetric.com/details/5905320,https://api.altmetric.com/v1/donut/5905320_240.png 0,The changing face of prostate cancer.,Journal of Clinical Oncology,,,Article,2005-11-10,10.1200/jco.2005.02.9751,,,,16278465,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10,https://www.altmetric.com/details/5905226,https://api.altmetric.com/v1/donut/5905226_240.png 0,EARLY QUALITY OF LIFE ASSESSMENT IN MEN TREATED WITH PERMANENT SOURCE INTERSTITIAL BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER,The Journal of Urology,,,Article,1999-08-01,10.1016/s0022-5347(05)68570-9,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5904926,https://api.altmetric.com/v1/donut/5904926_240.png 0,Clinical and Biochemical Evidence of Control of Prostate Cancer at 5 Years After External Beam Radiation,The Journal of Urology,,,Article,1995-08-01,10.1016/s0022-5347(01)67073-3,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5904875,https://api.altmetric.com/v1/donut/5904875_240.png 0,Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer.,Journal of Clinical Oncology,,,Article,2007-08-31,10.1200/jco.2007.11.4769,,,,17761981,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,https://www.altmetric.com/details/5904669,https://api.altmetric.com/v1/donut/5904669_240.png 0,,Prostate Cancer & Prostatic Diseases,,,Article,2002-09-16,10.1038/sj.pcan.4500627,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,https://www.altmetric.com/details/5904115,https://api.altmetric.com/v1/donut/5904115_240.png 0,Clinical staging of prostate cancer: Reproducibility and clarification of issues,International Journal of Cancer,,,Article,2001-06-20,10.1002/ijc.1017,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8,https://www.altmetric.com/details/5904091,https://api.altmetric.com/v1/donut/5904091_240.png 0,